TTD - Therapeutic Targets Database Full Data Download File Title - TTD drugs information in raw format Version 10.1.01 (2024.01.10) Provided by IDRB Lab of Innovative Drug Reasearch and Bioinformatics College of Pharmaceutical Sciences Zhejiang University https://idrblab.org/ Provided by BIDD BioInformatic and Drug Design Group Department of Pharmacy National Unviersity of Singapore https://bidd.group/ Any question about data provided here, please contact with: Dr. Zhou (zhou_ying@zju.edu.cn) and Dr. Zhang (zhangyintao@zju.edu.cn) _______________________________________________________________________ Abbreviations: DRUG__ID DRUG ID TRADNAME Trade Name DRUGCOMP Company THERCLAS Therapeutic Class DRUGTYPE Drug Type DRUGINCH InChI DRUGINKE InChIKey DRUGSMIL Canonical SMILES HIGHSTAT Highest status COMPCLAS Compound Class _______________________________________________________________________ D00UZR DRUG__ID D00UZR D00UZR TRADNAME Ibrance D00UZR DRUGCOMP Onyx Pharmaceuticals; Pfizer D00UZR THERCLAS Anticancer Agents D00UZR DRUGTYPE Small molecular drug D00UZR DRUGINCH 1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29) D00UZR DRUGINKE AHJRHEGDXFFMBM-UHFFFAOYSA-N D00UZR DRUGSMIL CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C D00UZR HIGHSTAT Approved D07NVU DRUG__ID D07NVU D07NVU TRADNAME Rydapt D07NVU DRUGCOMP Novartis D07NVU THERCLAS Anticancer Agents D07NVU DRUGTYPE Small molecular drug D07NVU DRUGINCH 1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1 D07NVU DRUGINKE BMGQWWVMWDBQGC-IIFHNQTCSA-N D07NVU DRUGSMIL CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC D07NVU HIGHSTAT Approved D0DN0W DRUG__ID D0DN0W D0DN0W TRADNAME Zejula D0DN0W DRUGCOMP Tesaro D0DN0W THERCLAS Antihypertensive Agents D0DN0W DRUGTYPE Small molecular drug D0DN0W DRUGINCH 1S/C19H20N4O.C7H8O3S/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14;1-6-2-4-7(5-3-6)11(8,9)10/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24);2-5H,1H3,(H,8,9,10)/t14-;/m1./s1 D0DN0W DRUGINKE LCPFHXWLJMNKNC-PFEQFJNWSA-N D0DN0W DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N D0DN0W HIGHSTAT Approved D0IA9Y DRUG__ID D0IA9Y D0IA9Y TRADNAME Zavzpret D0IA9Y DRUGCOMP Pfizer D0IA9Y THERCLAS Antiviral Agents D0IA9Y DRUGTYPE Small molecular drug D0IA9Y DRUGINCH 1S/C36H46N8O3/c1-24-19-25(20-28-23-37-40-33(24)28)21-32(35(46)43-17-15-42(16-18-43)29-9-11-41(2)12-10-29)39-36(47)44-13-7-26(8-14-44)30-22-27-5-3-4-6-31(27)38-34(30)45/h3-6,19-20,22-23,26,29,32H,7-18,21H2,1-2H3,(H,37,40)(H,38,45)(H,39,47)/t32-/m1/s1 D0IA9Y DRUGINKE JJVAPHYEOZSKJZ-JGCGQSQUSA-N D0IA9Y DRUGSMIL CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O D0IA9Y HIGHSTAT Approved D0K0MW DRUG__ID D0K0MW D0K0MW TRADNAME Lucemyra D0K0MW DRUGCOMP US WorldMeds D0K0MW THERCLAS Antihypertensive Agents D0K0MW DRUGTYPE Small molecular drug D0K0MW DRUGINCH 1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15) D0K0MW DRUGINKE KSMAGQUYOIHWFS-UHFFFAOYSA-N D0K0MW DRUGSMIL CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl D0K0MW HIGHSTAT Approved D0U5QK DRUG__ID D0U5QK D0U5QK TRADNAME Aceta (TN); Actimin (TN); Anacin-3; Apacet (TN); Atasol (TN); Banesin (TN); Bickie-mol; Crocin (TN); Dapa (TN); DayQuil (TN); Depon (TN); Dolo (TN); Eu-Med; Febro-Gesic; Feverall (TN); Few Drops (TN); Fibi (TN); Fibi plus (TN); Genapap (TN); Genebs (TN); Geralgine-P; Lekadol (TN); Liquiprin (TN); Lupocet (TN); Maximum (TN); Neo-Fepramol; Neopap (TN); Oraphen-PD; Panado-Co; Panadol (TN); Papa-Deine; Para-Suppo; Paralen (TN); Pe-Tam; Percocet-5; Phenaphen (TN); Plicet (TN); Pyregesic-C; Redutemp (TN); Snaplets-FR; Suppap (TN); Supramol-M; Tamen (TN); Tapanol (TN); Tempra (TN); Tylenol (TN); Valorin (TN); Xcel (TN); Anacin-3 (TN); Datril Extra-Strength (TN); Ny-Quil (TN); Oraphen-PD (TN); Snaplets-FR (TN) D0U5QK DRUGCOMP Beximco Pharma D0U5QK THERCLAS Analgesics D0U5QK DRUGTYPE Small molecular drug D0U5QK DRUGINCH 1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10) D0U5QK DRUGINKE RZVAJINKPMORJF-UHFFFAOYSA-N D0U5QK DRUGSMIL CC(=O)NC1=CC=C(C=C1)O D0U5QK HIGHSTAT Approved D00AOJ DRUG__ID D00AOJ D00AOJ DRUGCOMP Avanir Pharmaceuticals D00AOJ THERCLAS Antiviral Agents D00AOJ DRUGTYPE Small molecular drug D00AOJ DRUGINCH 1S/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H3 D00AOJ DRUGINKE NOPFSRXAKWQILS-UHFFFAOYSA-N D00AOJ DRUGSMIL CCCCCCCCCCCCCCCCCCCCCCO D00AOJ HIGHSTAT Approved D00AWT DRUG__ID D00AWT D00AWT DRUGCOMP Sanofi-Aventis D00AWT THERCLAS Antipsychotic Agents D00AWT DRUGTYPE Small molecular drug D00AWT DRUGINCH 1S/C21H23N3OS/c22-15-16-6-7-21-19(14-16)24(18-4-1-2-5-20(18)26-21)11-3-10-23-12-8-17(25)9-13-23/h1-2,4-7,14,17,25H,3,8-13H2 D00AWT DRUGINKE LUALIOATIOESLM-UHFFFAOYSA-N D00AWT DRUGSMIL C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N D00AWT HIGHSTAT Approved D00AXJ DRUG__ID D00AXJ D00AXJ DRUGCOMP Janssen Pharmaceutica D00AXJ THERCLAS Antifungal Agents D00AXJ DRUGTYPE Small molecular drug D00AXJ DRUGINCH 1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2 D00AXJ DRUGINKE BYBLEWFAAKGYCD-UHFFFAOYSA-N D00AXJ DRUGSMIL C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl D00AXJ HIGHSTAT Approved D00BCG DRUG__ID D00BCG D00BCG DRUGCOMP Zeneca Pharmaceuticals D00BCG THERCLAS Anticancer Agents D00BCG DRUGTYPE Small molecular drug D00BCG DRUGINCH 1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1 D00BCG DRUGINKE BLCLNMBMMGCOAS-URPVMXJPSA-N D00BCG DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6 D00BCG HIGHSTAT Approved D00CTS DRUG__ID D00CTS D00CTS DRUGCOMP Takeda D00CTS THERCLAS Anticonstipation Agents D00CTS DRUGTYPE Small molecular drug D00CTS DRUGINCH 1S/C20H32F2O5/c1-2-3-11-19(21,22)20(26)12-10-15-14(16(23)13-17(15)27-20)8-6-4-5-7-9-18(24)25/h14-15,17,26H,2-13H2,1H3,(H,24,25)/t14-,15-,17-,20-/m1/s1 D00CTS DRUGINKE WGFOBBZOWHGYQH-MXHNKVEKSA-N D00CTS DRUGSMIL CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F D00CTS HIGHSTAT Approved D00DKK DRUG__ID D00DKK D00DKK DRUGCOMP Roche Pharmaceuticals D00DKK THERCLAS Antiacne Agents D00DKK DRUGTYPE Small molecular drug D00DKK DRUGINCH 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14- D00DKK DRUGINKE SHGAZHPCJJPHSC-XFYACQKRSA-N D00DKK DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D00DKK HIGHSTAT Approved D00EEL DRUG__ID D00EEL D00EEL DRUGCOMP Merck & Co D00EEL THERCLAS Hypnotics and Sedatives D00EEL DRUGTYPE Small molecular drug D00EEL DRUGINCH 1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9) D00EEL DRUGINKE ZXRVKCBLGJOCEE-UHFFFAOYSA-N D00EEL DRUGSMIL C1CNCC2=C1C(=O)NO2 D00EEL HIGHSTAT Approved D00FGR DRUG__ID D00FGR D00FGR DRUGCOMP Aeterna Zentaris D00FGR THERCLAS Antifungal Agents D00FGR DRUGTYPE Small molecular drug D00FGR DRUGINCH 1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3 D00FGR DRUGINKE PQLXHQMOHUQAKB-UHFFFAOYSA-N D00FGR DRUGSMIL CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C D00FGR HIGHSTAT Approved D00FGV DRUG__ID D00FGV D00FGV DRUGCOMP McNeil Laboratories D00FGV THERCLAS Antihistamines D00FGV DRUGTYPE Small molecular drug D00FGV DRUGINCH 1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3 D00FGV DRUGINKE OJFSXZCBGQGRNV-UHFFFAOYSA-N D00FGV DRUGSMIL CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2 D00FGV HIGHSTAT Approved D00GPQ DRUG__ID D00GPQ D00GPQ TRADNAME Ogsiveo D00GPQ DRUGCOMP Springworks D00GPQ DRUGTYPE Small molecular drug D00GPQ DRUGINCH 1S/C27H41F2N5O/c1-7-8-23(32-20-10-9-18-11-19(28)12-22(29)21(18)13-20)25(35)33-24-14-34(17-31-24)27(5,6)16-30-15-26(2,3)4/h11-12,14,17,20,23,30,32H,7-10,13,15-16H2,1-6H3,(H,33,35)/t20-,23-/m0/s1 D00GPQ DRUGINKE VFCRKLWBYMDAED-REWPJTCUSA-N D00GPQ DRUGSMIL CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F D00GPQ HIGHSTAT Approved D00HCQ DRUG__ID D00HCQ D00HCQ DRUGCOMP Roche D00HCQ THERCLAS Anticancer Agents D00HCQ DRUGTYPE Small molecular drug D00HCQ DRUGINCH 1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1 D00HCQ DRUGINKE GAGWJHPBXLXJQN-UORFTKCHSA-N D00HCQ DRUGSMIL CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O D00HCQ HIGHSTAT Approved D00HDU DRUG__ID D00HDU D00HDU DRUGCOMP Ucb Inc D00HDU THERCLAS Antihypertensive Agents D00HDU DRUGTYPE Small molecular drug D00HDU DRUGINCH 1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1 D00HDU DRUGINKE UWWDHYUMIORJTA-HSQYWUDLSA-N D00HDU DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC D00HDU HIGHSTAT Approved D00HPK DRUG__ID D00HPK D00HPK DRUGCOMP Merz Pharmaceuticals Llc D00HPK THERCLAS Antifungal Agents D00HPK DRUGTYPE Small molecular drug D00HPK DRUGINCH 1S/C21H21N/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20/h2-15H,16-17H2,1H3/b11-8+ D00HPK DRUGINKE OZGNYLLQHRPOBR-DHZHZOJOSA-N D00HPK DRUGSMIL CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32 D00HPK HIGHSTAT Approved D00HZV DRUG__ID D00HZV D00HZV DRUGCOMP Odyssey Pharmaceuticals Inc D00HZV THERCLAS Antidepressants D00HZV DRUGTYPE Small molecular drug D00HZV DRUGINCH 1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3 D00HZV DRUGINKE ZSCDBOWYZJWBIY-UHFFFAOYSA-N D00HZV DRUGSMIL CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C D00HZV HIGHSTAT Approved D00IBN DRUG__ID D00IBN D00IBN DRUGCOMP Pfizer Pharmaceuticals D00IBN THERCLAS Analgesics D00IBN DRUGTYPE Small molecular drug D00IBN DRUGINCH 1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20) D00IBN DRUGINKE QYSPLQLAKJAUJT-UHFFFAOYSA-N D00IBN DRUGSMIL CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3 D00IBN HIGHSTAT Approved D00IUG DRUG__ID D00IUG D00IUG DRUGCOMP Allergan Pharmaceuticals D00IUG THERCLAS Sympatholytics D00IUG DRUGTYPE Small molecular drug D00IUG DRUGINCH 1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1 D00IUG DRUGINKE IXHBTMCLRNMKHZ-LBPRGKRZSA-N D00IUG DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O D00IUG HIGHSTAT Approved D00JAU DRUG__ID D00JAU D00JAU DRUGCOMP Bristol-Myers Squibb D00JAU THERCLAS Antihypertensive Agents D00JAU DRUGTYPE Small molecular drug D00JAU DRUGINCH 1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30) D00JAU DRUGINKE YOSHYTLCDANDAN-UHFFFAOYSA-N D00JAU DRUGSMIL CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D00JAU HIGHSTAT Approved D00JVR DRUG__ID D00JVR D00JVR DRUGCOMP Meda Pharmaceuticals Inc D00JVR THERCLAS Antiallergic Agents D00JVR DRUGTYPE Small molecular drug D00JVR DRUGINCH 1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3 D00JVR DRUGINKE MBUVEWMHONZEQD-UHFFFAOYSA-N D00JVR DRUGSMIL CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl D00JVR HIGHSTAT Approved D00KHM DRUG__ID D00KHM D00KHM DRUGCOMP Janssen Pharmaceutica D00KHM THERCLAS Antipsychotic Agents D00KHM DRUGTYPE Small molecular drug D00KHM DRUGINCH 1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34) D00KHM DRUGINKE YVUQSNJEYSNKRX-UHFFFAOYSA-N D00KHM DRUGSMIL C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F D00KHM HIGHSTAT Approved D00KVO DRUG__ID D00KVO D00KVO DRUGCOMP GlaxoSmithKline D00KVO THERCLAS Antiprotozoal Agents D00KVO DRUGTYPE Small molecular drug D00KVO DRUGINCH 1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16) D00KVO DRUGINKE HXHWSAZORRCQMX-UHFFFAOYSA-N D00KVO DRUGSMIL CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC D00KVO HIGHSTAT Approved D00MDP DRUG__ID D00MDP D00MDP DRUGCOMP Pfizer D00MDP THERCLAS Anticancer Agents D00MDP DRUGTYPE Small molecular drug D00MDP DRUGINCH 1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1 D00MDP DRUGINKE YKPYIPVDTNNYCN-INIZCTEOSA-N D00MDP DRUGSMIL CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=NC=C3)C(=O)NO)C D00MDP HIGHSTAT Approved D00MYQ DRUG__ID D00MYQ D00MYQ DRUGCOMP Teva Womens Health Inc D00MYQ THERCLAS Antidepressants D00MYQ DRUGTYPE Small molecular drug D00MYQ DRUGINCH 1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3 D00MYQ DRUGINKE BWPIARFWQZKAIA-UHFFFAOYSA-N D00MYQ DRUGSMIL CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13 D00MYQ HIGHSTAT Approved D00MYT DRUG__ID D00MYT D00MYT DRUGCOMP Abbott Laboratories D00MYT THERCLAS Hypnotics and Sedatives D00MYT DRUGTYPE Small molecular drug D00MYT DRUGINCH 1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16) D00MYT DRUGINKE IUJDSEJGGMCXSG-UHFFFAOYSA-N D00MYT DRUGSMIL CCCC(C)C1(C(=O)NC(=S)NC1=O)CC D00MYT HIGHSTAT Approved D00NAX DRUG__ID D00NAX D00NAX DRUGCOMP Wyeth Pharmaceuticals D00NAX THERCLAS Antipsychotic Agents D00NAX DRUGTYPE Small molecular drug D00NAX DRUGINCH 1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3 D00NAX DRUGINKE ZGUGWUXLJSTTMA-UHFFFAOYSA-N D00NAX DRUGSMIL CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31 D00NAX HIGHSTAT Approved D00NPP DRUG__ID D00NPP D00NPP DRUGCOMP GlaxoSmithKline D00NPP THERCLAS Antiviral Agents D00NPP DRUGTYPE Small molecular drug D00NPP DRUGINCH 1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1 D00NPP DRUGINKE ARAIBEBZBOPLMB-UFGQHTETSA-N D00NPP DRUGSMIL CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N D00NPP HIGHSTAT Approved D00QET DRUG__ID D00QET D00QET DRUGCOMP Schering-Plough Corporation D00QET THERCLAS Antiasthmatic Agents D00QET DRUGTYPE Small molecular drug D00QET DRUGINCH 1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1 D00QET DRUGINKE UCHDWCPVSPXUMX-TZIWLTJVSA-N D00QET DRUGSMIL CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O D00QET HIGHSTAT Approved D00RJJ DRUG__ID D00RJJ D00RJJ DRUGCOMP Organon International D00RJJ THERCLAS Abortifacient Agents D00RJJ DRUGTYPE Small molecular drug D00RJJ DRUGINCH 1S/C80H113ClN18O13/c1-9-84-79(85-10-2)88-38-17-15-24-60(70(104)94-62(41-49(5)6)71(105)93-61(25-16-18-39-89-80(86-11-3)87-12-4)78(112)99-40-20-26-68(99)77(111)90-50(7)69(82)103)92-73(107)64(44-53-30-35-59(102)36-31-53)97-76(110)67(48-100)98-75(109)66(46-55-21-19-37-83-47-55)96-74(108)65(43-52-28-33-58(81)34-29-52)95-72(106)63(91-51(8)101)45-54-27-32-56-22-13-14-23-57(56)42-54/h13-14,19,21-23,27-37,42,47,49-50,60-68,100,102H,9-12,15-18,20,24-26,38-41,43-46,48H2,1-8H3,(H2,82,103)(H,90,111)(H,91,101)(H,92,107)(H,93,105)(H,94,104)(H,95,106)(H,96,108)(H,97,110)(H,98,109)(H2,84,85,88)(H2,86,87,89)/t50-,60-,61+,62+,63-,64+,65-,66-,67+,68+/m1/s1 D00RJJ DRUGINKE GJNXBNATEDXMAK-PFLSVRRQSA-N D00RJJ DRUGSMIL CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC D00RJJ HIGHSTAT Approved D00RWW DRUG__ID D00RWW D00RWW TRADNAME Fexinidazole D00RWW DRUGCOMP Sanofi/DNDi D00RWW DRUGTYPE Small molecular drug D00RWW DRUGINCH 1S/C12H13N3O3S/c1-14-11(13-7-12(14)15(16)17)8-18-9-3-5-10(19-2)6-4-9/h3-7H,8H2,1-2H3 D00RWW DRUGINKE MIWWSGDADVMLTG-UHFFFAOYSA-N D00RWW DRUGSMIL CN1C(=CN=C1COC2=CC=C(C=C2)SC)[N+](=O)[O-] D00RWW HIGHSTAT Approved D00SEB DRUG__ID D00SEB D00SEB DRUGCOMP Merck & Co D00SEB THERCLAS Antihypertensive Agents D00SEB DRUGTYPE Small molecular drug D00SEB DRUGINCH 1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1 D00SEB DRUGINKE GBXSMTUPTTWBMN-XIRDDKMYSA-N D00SEB DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O D00SEB HIGHSTAT Approved D00SJE DRUG__ID D00SJE D00SJE DRUGCOMP Eli Lilly D00SJE THERCLAS Hypnotics and Sedatives D00SJE DRUGTYPE Small molecular drug D00SJE DRUGINCH 1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17) D00SJE DRUGINKE KQPKPCNLIDLUMF-UHFFFAOYSA-N D00SJE DRUGSMIL CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C D00SJE HIGHSTAT Approved D00STL DRUG__ID D00STL D00STL DRUGCOMP Novartis AG D00STL THERCLAS Anticancer Agents D00STL DRUGTYPE Small molecular drug D00STL DRUGINCH 1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37) D00STL DRUGINKE HHZIURLSWUIHRB-UHFFFAOYSA-N D00STL DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 D00STL HIGHSTAT Approved D00TLN DRUG__ID D00TLN D00TLN DRUGCOMP Merck & Co D00TLN THERCLAS Antihistamines D00TLN DRUGTYPE Small molecular drug D00TLN DRUGINCH 1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3 D00TLN DRUGINKE JJCFRYNCJDLXIK-UHFFFAOYSA-N D00TLN DRUGSMIL CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1 D00TLN HIGHSTAT Approved D00TLP DRUG__ID D00TLP D00TLP DRUGCOMP Johnson & Johnson D00TLP THERCLAS Antiinfective Agents D00TLP DRUGTYPE Small molecular drug D00TLP DRUGINCH 1S/C38H47N5O7S2/c1-21(2)30-20-51-35(40-30)29-18-32(26-13-14-31(49-5)22(3)33(26)39-29)50-24-16-27-28(17-24)36(45)43(4)15-9-7-6-8-10-23-19-38(23,41-34(27)44)37(46)42-52(47,48)25-11-12-25/h8,10,13-14,18,20-21,23-25,27-28H,6-7,9,11-12,15-17,19H2,1-5H3,(H,41,44)(H,42,46)/b10-8-/t23-,24-,27-,28-,38-/m1/s1 D00TLP DRUGINKE JTZZSQYMACOLNN-VDWJNHBNSA-N D00TLP DRUGSMIL CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC D00TLP HIGHSTAT Approved D00USF DRUG__ID D00USF D00USF DRUGCOMP Angelini research laboratories D00USF THERCLAS Antidepressants D00USF DRUGTYPE Small molecular drug D00USF DRUGINCH 1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2 D00USF DRUGINKE PHLBKPHSAVXXEF-UHFFFAOYSA-N D00USF DRUGSMIL C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl D00USF HIGHSTAT Approved D00UYE DRUG__ID D00UYE D00UYE DRUGCOMP Apotex Inc D00UYE THERCLAS Anesthetics D00UYE DRUGTYPE Small molecular drug D00UYE DRUGINCH 1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3 D00UYE DRUGINKE XADCESSVHJOZHK-UHFFFAOYSA-N D00UYE DRUGSMIL CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2 D00UYE HIGHSTAT Approved D00YLW DRUG__ID D00YLW D00YLW DRUGCOMP Aventis Pharmaceuticals Inc. D00YLW THERCLAS Antiemetics D00YLW DRUGTYPE Small molecular drug D00YLW DRUGINCH 1S/C19H20N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,20H,5-8,10H2/t11?,12-,13+,14? D00YLW DRUGINKE UKTAZPQNNNJVKR-AKJUYKBHSA-N D00YLW DRUGSMIL C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54 D00YLW HIGHSTAT Approved D00YVF DRUG__ID D00YVF D00YVF DRUGCOMP Eli Lilly D00YVF THERCLAS Hypoglycemic Agents D00YVF DRUGTYPE Small molecular drug D00YVF DRUGINCH 1S/C184H282N50O60S/c1-16-94(10)147(178(289)213-114(52-58-144(257)258)163(274)218-121(73-101-77-195-105-39-24-23-38-103(101)105)168(279)215-116(68-90(2)3)165(276)205-107(41-26-28-61-186)158(269)219-122(75-134(189)243)154(265)198-79-135(244)196-83-139(248)231-63-30-43-129(231)175(286)225-127(87-238)174(285)223-125(85-236)155(266)200-80-136(245)202-96(12)181(292)233-65-32-45-131(233)183(294)234-66-33-46-132(234)182(293)232-64-31-44-130(232)176(287)222-124(84-235)150(190)261)229-170(281)119(71-99-34-19-17-20-35-99)217-166(277)117(69-91(4)5)214-159(270)108(42-29-62-194-184(191)192)212-177(288)146(93(8)9)228-151(262)95(11)203-156(267)111(49-55-141(251)252)208-161(272)112(50-56-142(253)254)209-162(273)113(51-57-143(255)256)210-164(275)115(59-67-295-15)211-160(271)110(47-53-133(188)242)207-157(268)106(40-25-27-60-185)206-172(283)126(86-237)224-167(278)118(70-92(6)7)216-169(280)123(76-145(259)260)220-173(284)128(88-239)226-180(291)149(98(14)241)230-171(282)120(72-100-36-21-18-22-37-100)221-179(290)148(97(13)240)227-138(247)82-199-153(264)109(48-54-140(249)250)204-137(246)81-197-152(263)104(187)74-102-78-193-89-201-102/h17-24,34-39,77-78,89-98,104,106-132,146-149,195,235-241H,16,25-33,40-76,79-88,185-187H2,1-15H3,(H2,188,242)(H2,189,243)(H2,190,261)(H,193,201)(H,196,244)(H,197,263)(H,198,265)(H,199,264)(H,200,266)(H,202,245)(H,203,267)(H,204,246)(H,205,276)(H,206,283)(H,207,268)(H,208,272)(H,209,273)(H,210,275)(H,211,271)(H,212,288)(H,213,289)(H,214,270)(H,215,279)(H,216,280)(H,217,277)(H,218,274)(H,219,269)(H,220,284)(H,221,290)(H,222,287)(H,223,285)(H,224,278)(H,225,286)(H,226,291)(H,227,247)(H,228,262)(H,229,281)(H,230,282)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,259,260)(H4,191,192,194)/t94-,95-,96-,97+,98+,104-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,146-,147-,148-,149-/m0/s1 D00YVF DRUGINKE HTQBXNHDCUEHJF-XWLPCZSASA-N D00YVF DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N D00YVF HIGHSTAT Approved D00YWP DRUG__ID D00YWP D00YWP DRUGCOMP Aspen Global Inc D00YWP THERCLAS Anabolic Agents D00YWP DRUGTYPE Small molecular drug D00YWP DRUGINCH 1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1 D00YWP DRUGINKE NPAGDVCDWIYMMC-IZPLOLCNSA-N D00YWP DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34 D00YWP HIGHSTAT Approved D00ZCN DRUG__ID D00ZCN D00ZCN DRUGCOMP Merck & Co D00ZCN THERCLAS Antifungal Agents D00ZCN DRUGTYPE Small molecular drug D00ZCN DRUGINCH 1S/C52H88N10O15/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(69)56-34-26-38(68)46(55-22-21-54)60-50(75)43-37(67)19-23-61(43)52(77)41(36(66)18-20-53)58-49(74)42(45(71)44(70)31-14-16-32(64)17-15-31)59-48(73)35-25-33(65)27-62(35)51(76)40(30(4)63)57-47(34)72/h14-17,28-30,33-38,40-46,55,63-68,70-71H,5-13,18-27,53-54H2,1-4H3,(H,56,69)(H,57,72)(H,58,74)(H,59,73)(H,60,75)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40+,41+,42+,43+,44+,45+,46+/m1/s1 D00ZCN DRUGINKE JYIKNQVWKBUSNH-OGZDCFRISA-N D00ZCN DRUGSMIL CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O D00ZCN HIGHSTAT Approved D01AHO DRUG__ID D01AHO D01AHO DRUGCOMP Speciality European Pharma D01AHO THERCLAS Anticancer Agents D01AHO DRUGTYPE Small molecular drug D01AHO DRUGINCH 1S/C72H95ClN14O14/c1-41(2)32-54(64(93)80-53(17-10-11-30-77-42(3)4)72(101)87-31-13-18-60(87)69(98)78-43(5)63(75)92)81-68(97)58(38-62(74)91)84-70(99)61(37-46-22-27-52(90)28-23-46)86(7)71(100)59(40-88)85-67(96)57(36-48-14-12-29-76-39-48)83-66(95)56(34-45-20-25-51(73)26-21-45)82-65(94)55(79-44(6)89)35-47-19-24-49-15-8-9-16-50(49)33-47/h8-9,12,14-16,19-29,33,39,41-43,53-61,77,88,90H,10-11,13,17-18,30-32,34-38,40H2,1-7H3,(H2,74,91)(H2,75,92)(H,78,98)(H,79,89)(H,80,93)(H,81,97)(H,82,94)(H,83,95)(H,84,99)(H,85,96)/t43-,53+,54+,55-,56-,57-,58-,59+,60+,61+/m1/s1 D01AHO DRUGINKE AIWRTTMUVOZGPW-HSPKUQOVSA-N D01AHO DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D01AHO HIGHSTAT Approved D01AJY DRUG__ID D01AJY D01AJY DRUGCOMP Norvatis Phamaceuticals Corporation D01AJY THERCLAS Muscle Relaxants D01AJY DRUGTYPE Small molecular drug D01AJY DRUGINCH 1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14) D01AJY DRUGINKE KPYSYYIEGFHWSV-UHFFFAOYSA-N D01AJY DRUGSMIL C1=CC(=CC=C1C(CC(=O)O)CN)Cl D01AJY HIGHSTAT Approved D01AXB DRUG__ID D01AXB D01AXB DRUGCOMP Eli Lilly D01AXB THERCLAS Antidepressants D01AXB DRUGTYPE Small molecular drug D01AXB DRUGINCH 1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1 D01AXB DRUGINKE ZEUITGRIYCTCEM-KRWDZBQOSA-N D01AXB DRUGSMIL CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32 D01AXB HIGHSTAT Approved D01AYJ DRUG__ID D01AYJ D01AYJ DRUGCOMP Celtic Pharma D01AYJ THERCLAS Antifungal Agents D01AYJ DRUGTYPE Small molecular drug D01AYJ DRUGINCH 1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+ D01AYJ DRUGINKE DOMXUEMWDBAQBQ-WEVVVXLNSA-N D01AYJ DRUGSMIL CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21 D01AYJ HIGHSTAT Approved D01AZG DRUG__ID D01AZG D01AZG DRUGCOMP Janssen-Cilag D01AZG THERCLAS Antipsychotic Agents D01AZG DRUGTYPE Small molecular drug D01AZG DRUGINCH 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 D01AZG DRUGINKE RAPZEAPATHNIPO-UHFFFAOYSA-N D01AZG DRUGSMIL CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F D01AZG HIGHSTAT Approved D01BQC DRUG__ID D01BQC D01BQC DRUGCOMP Glaxosmithkline D01BQC THERCLAS Antibiotics D01BQC DRUGTYPE Small molecular drug D01BQC DRUGINCH 1S/C18H18N6O8S3/c25-13(9-4-2-1-3-5-9)14(26)19-11-15(27)24-12(17(28)29)10(6-33-16(11)24)7-34-18-20-21-22-23(18)8-35(30,31)32/h1-5,11,13,16,25H,6-8H2,(H,19,26)(H,28,29)(H,30,31,32)/t11-,13-,16-/m1/s1 D01BQC DRUGINKE DYAIAHUQIPBDIP-AXAPSJFSSA-N D01BQC DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O D01BQC HIGHSTAT Approved D01FGR DRUG__ID D01FGR D01FGR DRUGCOMP Johnson & Johnson D01FGR THERCLAS Antiallergic Agents D01FGR DRUGTYPE Small molecular drug D01FGR DRUGINCH 1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 D01FGR DRUGINKE ZZVUWRFHKOJYTH-UHFFFAOYSA-N D01FGR DRUGSMIL CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2 D01FGR HIGHSTAT Approved D01GBY DRUG__ID D01GBY D01GBY DRUGCOMP Schering-Plough D01GBY THERCLAS Antiallergic Agents D01GBY DRUGTYPE Small molecular drug D01GBY DRUGINCH 1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2 D01GBY DRUGINKE JAUOIFJMECXRGI-UHFFFAOYSA-N D01GBY DRUGSMIL C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4 D01GBY HIGHSTAT Approved D01GUS DRUG__ID D01GUS D01GUS DRUGCOMP Dong-A Pharmaceutical D01GUS THERCLAS Vasodilator Agents D01GUS DRUGTYPE Small molecular drug D01GUS DRUGINCH 1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32) D01GUS DRUGINKE IYFNEFQTYQPVOC-UHFFFAOYSA-N D01GUS DRUGSMIL CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C D01GUS HIGHSTAT Approved D01HTL DRUG__ID D01HTL D01HTL DRUGCOMP GlaxoSmithKline D01HTL THERCLAS Anticancer Agents D01HTL DRUGTYPE Small molecular drug D01HTL DRUGINCH 1S/C45H54N4O8/c1-8-27-19-28-22-44(40(51)55-6,36-30(25-48(23-27)24-28)29-13-10-11-14-33(29)46-36)32-20-31-34(21-35(32)54-5)47(4)38-43(31)16-18-49-17-12-15-42(9-2,37(43)49)39(57-26(3)50)45(38,53)41(52)56-7/h10-15,19-21,28,37-39,46,53H,8-9,16-18,22-25H2,1-7H3/t28-,37-,38+,39+,42+,43+,44-,45-/m0/s1 D01HTL DRUGINKE GBABOYUKABKIAF-IELIFDKJSA-N D01HTL DRUGSMIL CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC D01HTL HIGHSTAT Approved D01HVT DRUG__ID D01HVT D01HVT TRADNAME Kisqali D01HVT DRUGCOMP Novartis D01HVT DRUGTYPE Small molecular drug D01HVT DRUGINCH 1S/C23H30N8O.C4H6O4/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;5-3(6)1-2-4(7)8/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1-2H2,(H,5,6)(H,7,8) D01HVT DRUGINKE NHANOMFABJQAAH-UHFFFAOYSA-N D01HVT DRUGSMIL CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5.C(CC(=O)O)C(=O)O D01HVT HIGHSTAT Approved D01JFT DRUG__ID D01JFT D01JFT DRUGCOMP Allergan Pharmaceutical D01JFT THERCLAS Ophthalmologicals D01JFT DRUGTYPE Small molecular drug D01JFT DRUGINCH 1S/C19H29NO5/c1-18(2,3)16(22)24-14-9-8-12(13(21)11-20-7)10-15(14)25-17(23)19(4,5)6/h8-10,13,20-21H,11H2,1-7H3 D01JFT DRUGINKE OCUJLLGVOUDECM-UHFFFAOYSA-N D01JFT DRUGSMIL CC(C)(C)C(=O)OC1=C(C=C(C=C1)C(CNC)O)OC(=O)C(C)(C)C D01JFT HIGHSTAT Approved D01JUF DRUG__ID D01JUF D01JUF DRUGCOMP Bedford Laboratories D01JUF THERCLAS Antihypertensive Agents D01JUF DRUGTYPE Small molecular drug D01JUF DRUGINCH 1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19) D01JUF DRUGINKE MRBDMNSDAVCSSF-UHFFFAOYSA-N D01JUF DRUGSMIL CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O D01JUF HIGHSTAT Approved D01KHH DRUG__ID D01KHH D01KHH DRUGCOMP Janssen Research And Development Llc D01KHH THERCLAS Antidepressants D01KHH DRUGTYPE Small molecular drug D01KHH DRUGINCH 1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3 D01KHH DRUGINKE JURKNVYFZMSNLP-UHFFFAOYSA-N D01KHH DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31 D01KHH HIGHSTAT Approved D01KKQ DRUG__ID D01KKQ D01KKQ DRUGCOMP AstraZeneca D01KKQ THERCLAS Anticancer Agents D01KKQ DRUGTYPE Small molecular drug D01KKQ DRUGINCH 1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1 D01KKQ DRUGINKE IVTVGDXNLFLDRM-HNNXBMFYSA-N D01KKQ DRUGSMIL CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1 D01KKQ HIGHSTAT Approved D01KPV DRUG__ID D01KPV D01KPV DRUGCOMP Sanofi-Aventis D01KPV THERCLAS Antiallergic Agents D01KPV DRUGTYPE Small molecular drug D01KPV DRUGINCH 1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36) D01KPV DRUGINKE RWTNPBWLLIMQHL-UHFFFAOYSA-N D01KPV DRUGSMIL CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O D01KPV HIGHSTAT Approved D01KQA DRUG__ID D01KQA D01KQA DRUGCOMP Endo Pharmaceuticals D01KQA THERCLAS Analgesics D01KQA DRUGTYPE Small molecular drug D01KQA DRUGINCH 1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1 D01KQA DRUGINKE NETZHAKZCGBWSS-CEDHKZHLSA-N D01KQA DRUGSMIL C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O D01KQA HIGHSTAT Approved D01MDT DRUG__ID D01MDT D01MDT DRUGCOMP Elan Pharmaceuticals D01MDT THERCLAS Analgesics D01MDT DRUGTYPE Small molecular drug D01MDT DRUGINCH 1S/C9H8ClN5S/c10-5-1-2-6-8(15-16-14-6)7(5)13-9-11-3-4-12-9/h1-2H,3-4H2,(H2,11,12,13) D01MDT DRUGINKE XFYDIVBRZNQMJC-UHFFFAOYSA-N D01MDT DRUGSMIL C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl D01MDT HIGHSTAT Approved D01MUR DRUG__ID D01MUR D01MUR DRUGCOMP Alcon Laboratories D01MUR THERCLAS Antiglaucomic Agents D01MUR DRUGTYPE Small molecular drug D01MUR DRUGINCH 1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1 D01MUR DRUGINKE HCRKCZRJWPKOAR-JTQLQIEISA-N D01MUR DRUGSMIL CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC D01MUR HIGHSTAT Approved D01NLB DRUG__ID D01NLB D01NLB DRUGCOMP Neurox/Parke Davis D01NLB THERCLAS Analgesics D01NLB DRUGTYPE Small molecular drug D01NLB DRUGINCH 1S/C102H172N36O32S7/c1-50(2)34-63-91(161)127-62(26-33-171-5)90(160)129-64(35-53-22-24-54(143)25-23-53)92(162)130-65(36-78(148)149)93(163)135-72-48-175-173-45-69(80(108)150)133-86(156)58(18-8-12-29-105)121-76(146)39-117-85(155)66(41-139)131-88(158)61(21-15-32-114-102(111)112)126-96(166)70-46-176-177-47-71(97(167)132-68(43-141)95(165)125-60(87(157)128-63)20-14-31-113-101(109)110)134-89(159)59(19-9-13-30-106)123-81(151)51(3)119-74(144)37-115-83(153)56(16-6-10-27-103)120-75(145)38-116-84(154)57(17-7-11-28-104)124-82(152)55(107)44-172-174-49-73(137-98(72)168)99(169)138-79(52(4)142)100(170)118-40-77(147)122-67(42-140)94(164)136-70/h22-25,50-52,55-73,79,139-143H,6-21,26-49,103-107H2,1-5H3,(H2,108,150)(H,115,153)(H,116,154)(H,117,155)(H,118,170)(H,119,144)(H,120,145)(H,121,146)(H,122,147)(H,123,151)(H,124,152)(H,125,165)(H,126,166)(H,127,161)(H,128,157)(H,129,160)(H,130,162)(H,131,158)(H,132,167)(H,133,156)(H,134,159)(H,135,163)(H,136,164)(H,137,168)(H,138,169)(H,148,149)(H4,109,110,113)(H4,111,112,114)/t51-,52+,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,79-/m0/s1 D01NLB DRUGINKE BPKIMPVREBSLAJ-QTBYCLKRSA-N D01NLB DRUGSMIL CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)N3)CO)C(C)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN D01NLB HIGHSTAT Approved D01OUE DRUG__ID D01OUE D01OUE DRUGCOMP Eli Lilly And Co D01OUE THERCLAS Antihistamines D01OUE DRUGTYPE Small molecular drug D01OUE DRUGINCH 1S/C5H9N3/c6-3-1-5-2-4-7-8-5/h2,4H,1,3,6H2,(H,7,8) D01OUE DRUGINKE JXDFEQONERDKSS-UHFFFAOYSA-N D01OUE DRUGSMIL C1=C(NN=C1)CCN D01OUE HIGHSTAT Approved D01PLN DRUG__ID D01PLN D01PLN DRUGCOMP Eli Lilly D01PLN THERCLAS Antibiotics D01PLN DRUGTYPE Small molecular drug D01PLN DRUGINCH 1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1 D01PLN DRUGINKE XIURVHNZVLADCM-IUODEOHRSA-N D01PLN DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O D01PLN HIGHSTAT Approved D01QIN DRUG__ID D01QIN D01QIN DRUGCOMP Pfizer Pharmaceuticals D01QIN THERCLAS Anticholesteremic Agents D01QIN DRUGTYPE Small molecular drug D01QIN DRUGINCH 1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 D01QIN DRUGINKE XUKUURHRXDUEBC-KAYWLYCHSA-N D01QIN DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 D01QIN HIGHSTAT Approved D01QML DRUG__ID D01QML D01QML DRUGCOMP Wyeth Ayerst Laboratories D01QML THERCLAS Antipsychotic Agents D01QML DRUGTYPE Small molecular drug D01QML DRUGINCH 1S/C24H31N3O2S/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28/h3-4,6-9,18,28H,2,5,10-17H2,1H3 D01QML DRUGINKE XZSMZRXAEFNJCU-UHFFFAOYSA-N D01QML DRUGSMIL CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO D01QML HIGHSTAT Approved D01QUS DRUG__ID D01QUS D01QUS DRUGCOMP LEO Pharma Inc D01QUS THERCLAS Antipsoriatic Agents D01QUS DRUGTYPE Small molecular drug D01QUS DRUGINCH 1S/C27H40O3/c1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b13-6+,19-7+,21-10-/t17-,22-,23-,24+,25-,26+,27-/m1/s1 D01QUS DRUGINKE LWQQLNNNIPYSNX-UROSTWAQSA-N D01QUS DRUGSMIL CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D01QUS HIGHSTAT Approved D01STB DRUG__ID D01STB D01STB DRUGCOMP Sanofi-Aventis D01STB THERCLAS Antihypertensive Agents D01STB DRUGTYPE Small molecular drug D01STB DRUGINCH 1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1 D01STB DRUGINKE HDACQVRGBOVJII-JBDAPHQKSA-N D01STB DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O D01STB HIGHSTAT Approved D01TSI DRUG__ID D01TSI D01TSI DRUGCOMP Eli Lilly D01TSI THERCLAS Analgesics D01TSI DRUGTYPE Small molecular drug D01TSI DRUGINCH 1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1 D01TSI DRUGINKE XCGSFFUVFURLIX-VFGNJEKYSA-N D01TSI DRUGSMIL CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CN(C6CC7=CNC8=CC=CC(=C78)C6=C5)C D01TSI HIGHSTAT Approved D01UTL DRUG__ID D01UTL D01UTL DRUGCOMP Sanofi Aventis Us Llc D01UTL THERCLAS Antidepressants D01UTL DRUGTYPE Small molecular drug D01UTL DRUGINCH 1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3 D01UTL DRUGINKE HCYAFALTSJYZDH-UHFFFAOYSA-N D01UTL DRUGSMIL CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31 D01UTL HIGHSTAT Approved D01XDL DRUG__ID D01XDL D01XDL DRUGCOMP Ben Venue Laboratories D01XDL THERCLAS Anticancer Agents D01XDL DRUGTYPE Small molecular drug D01XDL DRUGINCH 1S/C26H27NO9/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3/t10-,15-,16-,17-,21+,26-/m0/s1 D01XDL DRUGINKE XDXDZDZNSLXDNA-TZNDIEGXSA-N D01XDL DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O D01XDL HIGHSTAT Approved D01XLM DRUG__ID D01XLM D01XLM DRUGCOMP Glaxosmithkline D01XLM THERCLAS Antinematodal Agents D01XLM DRUGTYPE Small molecular drug D01XLM DRUGINCH 1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2 D01XLM DRUGINKE GLUUGHFHXGJENI-UHFFFAOYSA-N D01XLM DRUGSMIL C1CNCCN1 D01XLM HIGHSTAT Approved D01XNB DRUG__ID D01XNB D01XNB DRUGCOMP AstraZeneca D01XNB THERCLAS Antiulcer Agents D01XNB DRUGTYPE Small molecular drug D01XNB DRUGINCH 1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20) D01XNB DRUGINKE SUBDBMMJDZJVOS-UHFFFAOYSA-N D01XNB DRUGSMIL CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC D01XNB HIGHSTAT Approved D01XYJ DRUG__ID D01XYJ D01XYJ DRUGCOMP GlaxoSmithKline D01XYJ THERCLAS Anti-HIV Agents D01XYJ DRUGTYPE Small molecular drug D01XYJ DRUGINCH 1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1 D01XYJ DRUGINKE HBOMLICNUCNMMY-XLPZGREQSA-N D01XYJ DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-] D01XYJ HIGHSTAT Approved D01ZAQ DRUG__ID D01ZAQ D01ZAQ TRADNAME Truqap D01ZAQ DRUGCOMP AstraZeneca D01ZAQ DRUGTYPE Small molecular drug D01ZAQ DRUGINCH 1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1 D01ZAQ DRUGINKE JDUBGYFRJFOXQC-KRWDZBQOSA-N D01ZAQ DRUGSMIL C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4 D01ZAQ HIGHSTAT Approved D01ZII DRUG__ID D01ZII D01ZII DRUGCOMP GlaxoSmithKline D01ZII THERCLAS Antipsychotic Agents D01ZII DRUGTYPE Small molecular drug D01ZII DRUGINCH 1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3 D01ZII DRUGINKE ZPEIMTDSQAKGNT-UHFFFAOYSA-N D01ZII DRUGSMIL CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl D01ZII HIGHSTAT Approved D01ZJK DRUG__ID D01ZJK D01ZJK DRUGCOMP Celcius Laboratories D01ZJK THERCLAS Anticoagulants D01ZJK DRUGTYPE Small molecular drug D01ZJK DRUGINCH 1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54) D01ZJK DRUGINKE HTTJABKRGRZYRN-UHFFFAOYSA-N D01ZJK DRUGSMIL CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O D01ZJK HIGHSTAT Approved D01ZRI DRUG__ID D01ZRI D01ZRI DRUGCOMP Pfizer D01ZRI THERCLAS Anticancer Agents D01ZRI DRUGTYPE Small molecular drug D01ZRI DRUGINCH 1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+ D01ZRI DRUGINKE RITAVMQDGBJQJZ-FMIVXFBMSA-N D01ZRI DRUGSMIL CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4 D01ZRI HIGHSTAT Approved D01ZSO DRUG__ID D01ZSO D01ZSO DRUGCOMP Hoffmann-La Roche pharmaceutical company D01ZSO THERCLAS Antidepressants D01ZSO DRUGTYPE Small molecular drug D01ZSO DRUGINCH 1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17) D01ZSO DRUGINKE YHXISWVBGDMDLQ-UHFFFAOYSA-N D01ZSO DRUGSMIL C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl D01ZSO HIGHSTAT Approved D02DGU DRUG__ID D02DGU D02DGU DRUGCOMP Roche Pharmaceuticals D02DGU THERCLAS Keratolytic Agents D02DGU DRUGTYPE Small molecular drug D02DGU DRUGINCH 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ D02DGU DRUGINKE SHGAZHPCJJPHSC-YCNIQYBTSA-N D02DGU DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D02DGU HIGHSTAT Approved D02DMQ DRUG__ID D02DMQ D02DMQ DRUGCOMP Pfizer Inc D02DMQ THERCLAS Antimigraine Agents D02DMQ DRUGTYPE Small molecular drug D02DMQ DRUGINCH 1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1 D02DMQ DRUGINKE PWVXXGRKLHYWKM-LJQANCHMSA-N D02DMQ DRUGSMIL CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4 D02DMQ HIGHSTAT Approved D02DPA DRUG__ID D02DPA D02DPA DRUGCOMP GlaxoSmithKline D02DPA THERCLAS Antiulcer Agents D02DPA DRUGTYPE Small molecular drug D02DPA DRUGINCH 1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14) D02DPA DRUGINKE AQIXAKUUQRKLND-UHFFFAOYSA-N D02DPA DRUGSMIL CC1=C(N=CN1)CSCCNC(=NC)NC#N D02DPA HIGHSTAT Approved D02GIU DRUG__ID D02GIU D02GIU DRUGCOMP Merck D02GIU THERCLAS Antibiotics D02GIU DRUGTYPE Small molecular drug D02GIU DRUGINCH 1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1 D02GIU DRUGINKE DHSUYTOATWAVLW-WFVMDLQDSA-N D02GIU DRUGSMIL CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C D02GIU HIGHSTAT Approved D02HED DRUG__ID D02HED D02HED DRUGCOMP Schering-Plough Corporation D02HED THERCLAS Antipsychotic Agents D02HED DRUGTYPE Small molecular drug D02HED DRUGINCH 1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2 D02HED DRUGINKE RGCVKNLCSQQDEP-UHFFFAOYSA-N D02HED DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO D02HED HIGHSTAT Approved D02IIE DRUG__ID D02IIE D02IIE DRUGCOMP Glaxosmithkline D02IIE THERCLAS Antiinfective Agents D02IIE DRUGTYPE Small molecular drug D02IIE DRUGINCH 1S/C16H18N2O5S.K/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);/q;+1/p-1/t11-,12+,14-;/m1./s1 D02IIE DRUGINKE HCTVWSOKIJULET-LQDWTQKMSA-M D02IIE DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)[O-])C.[K+] D02IIE HIGHSTAT Approved D02IIW DRUG__ID D02IIW D02IIW DRUGCOMP Suntory D02IIW THERCLAS Respiratory Agents D02IIW DRUGTYPE Small molecular drug D02IIW DRUGINCH 1S/C12H15NO5S/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6/h5-7,11,14H,2-4H2,1H3,(H,16,17)/t5-,6-,7+,11-/m1/s1 D02IIW DRUGINKE HGGAKXAHAYOLDJ-FHZUQPTBSA-N D02IIW DRUGSMIL CC(C1C2N(C1=O)C(=C(S2)C3CCCO3)C(=O)O)O D02IIW HIGHSTAT Approved D02IQY DRUG__ID D02IQY D02IQY DRUGCOMP Sandoz D02IQY THERCLAS Vasodilator Agents D02IQY DRUGTYPE Small molecular drug D02IQY DRUGINCH 1S/C33H45N5O5/c1-7-31(4,5)27-29(40)37-13-9-12-25(37)33(42)38(27)30(41)32(43-33,18(2)3)35-28(39)20-14-22-21-10-8-11-23-26(21)19(16-34-23)15-24(22)36(6)17-20/h8,10-11,16,18,20,22,24-25,27,34,42H,7,9,12-15,17H2,1-6H3,(H,35,39) D02IQY DRUGINKE YLXBZBPHTNJZQE-UHFFFAOYSA-N D02IQY DRUGSMIL CCC(C)(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O D02IQY HIGHSTAT Approved D02KOF DRUG__ID D02KOF D02KOF DRUGCOMP Pharmacia Corp D02KOF THERCLAS Antibiotics D02KOF DRUGTYPE Small molecular drug D02KOF DRUGINCH 1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25) D02KOF DRUGINKE ZEKZLJVOYLTDKK-UHFFFAOYSA-N D02KOF DRUGSMIL CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O D02KOF HIGHSTAT Approved D02LDN DRUG__ID D02LDN D02LDN DRUGCOMP Mitsuwa Kinzoku Co D02LDN THERCLAS Analgesics D02LDN DRUGTYPE Small molecular drug D02LDN DRUGINCH 1S/Mg.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2 D02LDN DRUGINKE CSNNHWWHGAXBCP-UHFFFAOYSA-L D02LDN DRUGSMIL [O-]S(=O)(=O)[O-].[Mg+2] D02LDN HIGHSTAT Approved D02LDV DRUG__ID D02LDV D02LDV DRUGCOMP Eli Lilly And Co D02LDV THERCLAS Neurology Agents D02LDV DRUGTYPE Small molecular drug D02LDV DRUGINCH 1S/C12H17N4OS.2ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);2*1H/q+1;;/p-1 D02LDV DRUGINKE DPJRMOMPQZCRJU-UHFFFAOYSA-M D02LDV DRUGSMIL CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-] D02LDV HIGHSTAT Approved D02MLW DRUG__ID D02MLW D02MLW DRUGCOMP Pfizer Pharmaceuticals D02MLW THERCLAS Antiarrhythmic Agents D02MLW DRUGTYPE Small molecular drug D02MLW DRUGINCH 1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3 D02MLW DRUGINKE ALOBUEHUHMBRLE-UHFFFAOYSA-N D02MLW DRUGSMIL CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O D02MLW HIGHSTAT Approved D02MZY DRUG__ID D02MZY D02MZY DRUGCOMP Wyeth Ayerst Laboratories D02MZY THERCLAS Antibiotics D02MZY DRUGTYPE Small molecular drug D02MZY DRUGINCH 1S/C25H24N8O7S2/c1-11-7-16(35)15(8-26-11)20(36)27-17(12-3-5-14(34)6-4-12)21(37)28-18-22(38)33-19(24(39)40)13(9-41-23(18)33)10-42-25-29-30-31-32(25)2/h3-8,17-18,23,34H,9-10H2,1-2H3,(H,26,35)(H,27,36)(H,28,37)(H,39,40)/t17-,18-,23-/m1/s1 D02MZY DRUGINKE PWAUCHMQEXVFJR-PMAPCBKXSA-N D02MZY DRUGSMIL CC1=CC(=O)C(=CN1)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O D02MZY HIGHSTAT Approved D02NSF DRUG__ID D02NSF D02NSF DRUGCOMP Pain Therapeutics Inc D02NSF THERCLAS Neurology Agents D02NSF DRUGTYPE Small molecular drug D02NSF DRUGINCH 1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1 D02NSF DRUGINKE UQCNKQCJZOAFTQ-ISWURRPUSA-N D02NSF DRUGSMIL CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O D02NSF HIGHSTAT Approved D02NTO DRUG__ID D02NTO D02NTO DRUGCOMP Schering-Plough D02NTO THERCLAS Antifungal Agents D02NTO DRUGTYPE Small molecular drug D02NTO DRUGINCH 1S/C19H17NOS/c1-14-6-5-9-17(12-14)20(2)19(22)21-18-11-10-15-7-3-4-8-16(15)13-18/h3-13H,1-2H3 D02NTO DRUGINKE FUSNMLFNXJSCDI-UHFFFAOYSA-N D02NTO DRUGSMIL CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2 D02NTO HIGHSTAT Approved D02OZE DRUG__ID D02OZE D02OZE DRUGCOMP GlaxoSmithKline D02OZE THERCLAS Antiarrhythmic Agents D02OZE DRUGTYPE Small molecular drug D02OZE DRUGINCH 1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1 D02OZE DRUGINKE LTMHDMANZUZIPE-PUGKRICDSA-N D02OZE DRUGSMIL CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O D02OZE HIGHSTAT Approved D02OZY DRUG__ID D02OZY D02OZY DRUGCOMP Abbott Laboratories D02OZY THERCLAS Anticonvulsants D02OZY DRUGTYPE Small molecular drug D02OZY DRUGINCH 1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14) D02OZY DRUGINKE FWJKNZONDWOGMI-UHFFFAOYSA-N D02OZY DRUGSMIL CCC1(C(=O)NC(=O)N(C1=O)C)CC D02OZY HIGHSTAT Approved D02PAH DRUG__ID D02PAH D02PAH DRUGCOMP Crescent Pharmaceuticals D02PAH THERCLAS Antihypertensive Agents D02PAH DRUGTYPE Small molecular drug D02PAH DRUGINCH 1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23) D02PAH DRUGINKE HDWIHXWEUNVBIY-UHFFFAOYSA-N D02PAH DRUGSMIL C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2 D02PAH HIGHSTAT Approved D02PCR DRUG__ID D02PCR D02PCR DRUGCOMP Pharmacia & Upjohn Company D02PCR THERCLAS Antibiotics D02PCR DRUGTYPE Small molecular drug D02PCR DRUGINCH 1S/C14H24N2O7/c1-5-4-6(17)14(20)13(21-5)22-12-10(19)7(15-2)9(18)8(16-3)11(12)23-14/h5,7-13,15-16,18-20H,4H2,1-3H3/t5-,7-,8+,9+,10+,11-,12-,13+,14+/m1/s1 D02PCR DRUGINKE UNFWWIHTNXNPBV-WXKVUWSESA-N D02PCR DRUGSMIL CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O D02PCR HIGHSTAT Approved D02PMO DRUG__ID D02PMO D02PMO DRUGCOMP GlaxoSmithKline D02PMO THERCLAS Anticancer Agents D02PMO DRUGTYPE Small molecular drug D02PMO DRUGINCH 1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1 D02PMO DRUGINKE UCFGDBYHRUNTLO-QHCPKHFHSA-N D02PMO DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O D02PMO HIGHSTAT Approved D02PPN DRUG__ID D02PPN D02PPN DRUGCOMP Novartis D02PPN THERCLAS Central Nervous System Stimulants D02PPN DRUGTYPE Small molecular drug D02PPN DRUGINCH 1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3 D02PPN DRUGINKE DUGOZIWVEXMGBE-UHFFFAOYSA-N D02PPN DRUGSMIL COC(=O)C(C1CCCCN1)C2=CC=CC=C2 D02PPN HIGHSTAT Approved D02QFW DRUG__ID D02QFW D02QFW TRADNAME Daybue D02QFW DRUGCOMP Acadia Pharmaceuticals D02QFW DRUGTYPE Small molecular drug D02QFW DRUGINCH 1S/C13H21N3O6/c1-13(5-2-6-16(13)9(17)7-14)12(22)15-8(11(20)21)3-4-10(18)19/h8H,2-7,14H2,1H3,(H,15,22)(H,18,19)(H,20,21)/t8-,13-/m0/s1 D02QFW DRUGINKE BUSXWGRAOZQTEY-SDBXPKJASA-N D02QFW DRUGSMIL CC1(CCCN1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O D02QFW HIGHSTAT Approved D02RQU DRUG__ID D02RQU D02RQU DRUGCOMP Bristol-Myers Squibb D02RQU THERCLAS Anticholesteremic Agents D02RQU DRUGTYPE Small molecular drug D02RQU DRUGINCH 1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1 D02RQU DRUGINKE TUZYXOIXSAXUGO-PZAWKZKUSA-N D02RQU DRUGSMIL CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O D02RQU HIGHSTAT Approved D02RSN DRUG__ID D02RSN D02RSN DRUGCOMP Sanofi-Aventis D02RSN THERCLAS Antibiotics D02RSN DRUGTYPE Small molecular drug D02RSN DRUGINCH 1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1 D02RSN DRUGINKE GSDSWSVVBLHKDQ-JTQLQIEISA-N D02RSN DRUGSMIL CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O D02RSN HIGHSTAT Approved D02TBI DRUG__ID D02TBI D02TBI DRUGCOMP Roerig Div Pfizer Inc D02TBI THERCLAS Antibiotics D02TBI DRUGTYPE Small molecular drug D02TBI DRUGINCH 1S/C17H18N2O6S/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25)/t9?,10-,11+,14-/m1/s1 D02TBI DRUGINKE FPPNZSSZRUTDAP-UWFZAAFLSA-N D02TBI DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)O)C(=O)O)C D02TBI HIGHSTAT Approved D02ULU DRUG__ID D02ULU D02ULU TRADNAME Ozempic D02ULU DRUGCOMP Novo Nordisk D02ULU DRUGTYPE Small molecular drug D02ULU DRUGINCH 1S/C187H291N45O59/c1-18-105(10)154(180(282)208-108(13)159(261)216-133(86-114-89-200-119-50-40-39-49-117(114)119)170(272)218-129(82-102(4)5)171(273)228-152(103(6)7)178(280)215-121(53-44-72-199-186(192)193)162(264)201-91-141(242)209-120(52-43-71-198-185(190)191)161(263)204-94-151(257)258)230-172(274)131(83-111-45-33-31-34-46-111)219-167(269)126(64-69-149(253)254)214-166(268)122(51-41-42-70-195-144(245)98-290-79-78-289-76-74-197-145(246)99-291-80-77-288-75-73-196-139(240)66-61-127(183(285)286)211-140(241)54-37-29-27-25-23-21-19-20-22-24-26-28-30-38-55-146(247)248)212-158(260)107(12)206-157(259)106(11)207-165(267)125(60-65-138(189)239)210-142(243)92-202-163(265)123(62-67-147(249)250)213-168(270)128(81-101(2)3)217-169(271)130(85-113-56-58-116(238)59-57-113)220-175(277)135(95-233)223-177(279)137(97-235)224-179(281)153(104(8)9)229-174(276)134(88-150(255)256)221-176(278)136(96-234)225-182(284)156(110(15)237)231-173(275)132(84-112-47-35-32-36-48-112)222-181(283)155(109(14)236)227-143(244)93-203-164(266)124(63-68-148(251)252)226-184(287)187(16,17)232-160(262)118(188)87-115-90-194-100-205-115/h31-36,39-40,45-50,56-59,89-90,100-110,118,120-137,152-156,200,233-238H,18-30,37-38,41-44,51-55,60-88,91-99,188H2,1-17H3,(H2,189,239)(H,194,205)(H,195,245)(H,196,240)(H,197,246)(H,201,264)(H,202,265)(H,203,266)(H,204,263)(H,206,259)(H,207,267)(H,208,282)(H,209,242)(H,210,243)(H,211,241)(H,212,260)(H,213,270)(H,214,268)(H,215,280)(H,216,261)(H,217,271)(H,218,272)(H,219,269)(H,220,277)(H,221,278)(H,222,283)(H,223,279)(H,224,281)(H,225,284)(H,226,287)(H,227,244)(H,228,273)(H,229,276)(H,230,274)(H,231,275)(H,232,262)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,285,286)(H4,190,191,198)(H4,192,193,199)/t105-,106-,107-,108-,109+,110+,118-,120-,121-,122-,123-,124-,125-,126-,127+,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,152-,153-,154-,155-,156-/m0/s1 D02ULU DRUGINKE DLSWIYLPEUIQAV-CCUURXOWSA-N D02ULU DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N D02ULU HIGHSTAT Approved D02URM DRUG__ID D02URM D02URM TRADNAME Rezzayo D02URM DRUGCOMP Cidara Therapeutics D02URM DRUGTYPE Small molecular drug D02URM DRUGINCH 1S/C63H84N8O17/c1-8-9-10-28-87-45-25-21-40(22-26-45)38-13-11-37(12-14-38)39-15-17-42(18-16-39)56(80)64-46-31-48(76)61(88-29-27-71(5,6)7)68-60(84)52-53(77)34(2)32-70(52)63(86)50(36(4)73)66-59(83)51(55(79)54(78)41-19-23-43(74)24-20-41)67-58(82)47-30-44(75)33-69(47)62(85)49(35(3)72)65-57(46)81/h11-26,34-36,44,46-55,61,72-73,75-79H,8-10,27-33H2,1-7H3,(H5-,64,65,66,67,68,74,80,81,82,83,84)/p+1/t34-,35+,36+,44+,46-,47-,48+,49-,50-,51-,52-,53-,54-,55-,61+/m0/s1 D02URM DRUGINKE LNFCWEXGZIEGJW-TXSVMFMRSA-O D02URM DRUGSMIL CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)OCC[N+](C)(C)C)O D02URM HIGHSTAT Approved D02VFC DRUG__ID D02VFC D02VFC DRUGCOMP Merck & Co D02VFC THERCLAS Antibiotics D02VFC DRUGTYPE Small molecular drug D02VFC DRUGINCH 1S/C16H17N3O7S2/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22)/t14-,16+/m1/s1 D02VFC DRUGINKE WZOZEZRFJCJXNZ-ZBFHGGJFSA-N D02VFC DRUGSMIL COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3 D02VFC HIGHSTAT Approved D02VPX DRUG__ID D02VPX D02VPX DRUGCOMP United Research Laboratories D02VPX THERCLAS Vitamins D02VPX DRUGTYPE Small molecular drug D02VPX DRUGINCH 1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 D02VPX DRUGINKE JWUBBDSIWDLEOM-DTOXIADCSA-N D02VPX DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C D02VPX HIGHSTAT Approved D02WIW DRUG__ID D02WIW D02WIW DRUGCOMP Schering Corp Sub Schering Plough Corp D02WIW THERCLAS Antihistamines D02WIW DRUGTYPE Small molecular drug D02WIW DRUGINCH 1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1 D02WIW DRUGINKE ZDIGNSYAACHWNL-HNNXBMFYSA-N D02WIW DRUGSMIL CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2 D02WIW HIGHSTAT Approved D02XIY DRUG__ID D02XIY D02XIY DRUGCOMP Norvatis Phamaceuticals Corporation D02XIY THERCLAS Anabolic Agents D02XIY DRUGTYPE Small molecular drug D02XIY DRUGINCH 1S/C49H66N10O10S2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+/m1/s1 D02XIY DRUGINKE DEQANNDTNATYII-OULOTJBUSA-N D02XIY DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O D02XIY HIGHSTAT Approved D02XJY DRUG__ID D02XJY D02XJY DRUGCOMP Shire Canada Inc D02XJY THERCLAS Vasoconstrictor Agents D02XJY DRUGTYPE Small molecular drug D02XJY DRUGINCH 1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16) D02XJY DRUGINKE PTKSEFOSCHHMPD-UHFFFAOYSA-N D02XJY DRUGSMIL COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O D02XJY HIGHSTAT Approved D02XSA DRUG__ID D02XSA D02XSA TRADNAME Diacomit D02XSA DRUGCOMP Biocodex D02XSA DRUGTYPE Small molecular drug D02XSA DRUGINCH 1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+ D02XSA DRUGINKE IBLNKMRFIPWSOY-FNORWQNLSA-N D02XSA DRUGSMIL CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O D02XSA HIGHSTAT Approved D02YIZ DRUG__ID D02YIZ D02YIZ DRUGCOMP Eli Lilly D02YIZ THERCLAS Antibiotics D02YIZ DRUGTYPE Small molecular drug D02YIZ DRUGINCH 1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 D02YIZ DRUGINKE ULGZDMOVFRHVEP-RWJQBGPGSA-N D02YIZ DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O D02YIZ HIGHSTAT Approved D02YPG DRUG__ID D02YPG D02YPG DRUGCOMP Janssen Pharmaceutica D02YPG THERCLAS Analgesics D02YPG DRUGTYPE Small molecular drug D02YPG DRUGINCH 1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1 D02YPG DRUGINKE NPUKDXXFDDZOKR-LLVKDONJSA-N D02YPG DRUGSMIL CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2 D02YPG HIGHSTAT Approved D02YYF DRUG__ID D02YYF D02YYF DRUGCOMP Hospira Inc D02YYF THERCLAS Antiarrhythmic Agents D02YYF DRUGTYPE Small molecular drug D02YYF DRUGINCH 1S/C11H17BrN/c1-4-13(2,3)9-10-7-5-6-8-11(10)12/h5-8H,4,9H2,1-3H3/q+1 D02YYF DRUGINKE AAQOQKQBGPPFNS-UHFFFAOYSA-N D02YYF DRUGSMIL CC[N+](C)(C)CC1=CC=CC=C1Br D02YYF HIGHSTAT Approved D02ZTJ DRUG__ID D02ZTJ D02ZTJ DRUGCOMP Watson Laboratories D02ZTJ THERCLAS Antiinflammatory Agents D02ZTJ DRUGTYPE Small molecular drug D02ZTJ DRUGINCH 1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25) D02ZTJ DRUGINKE NCEXYHBECQHGNR-UHFFFAOYSA-N D02ZTJ DRUGSMIL C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O D02ZTJ HIGHSTAT Approved D02ZXM DRUG__ID D02ZXM D02ZXM DRUGCOMP Glaxo Smith Kline Pharmaceuticals D02ZXM THERCLAS Anticancer Agents D02ZXM DRUGTYPE Small molecular drug D02ZXM DRUGINCH 1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11) D02ZXM DRUGINKE WYWHKKSPHMUBEB-UHFFFAOYSA-N D02ZXM DRUGSMIL C1=NC2=C(N1)C(=S)N=C(N2)N D02ZXM HIGHSTAT Approved D03BLF DRUG__ID D03BLF D03BLF DRUGCOMP Aventis Pharmaceuticals Inc. D03BLF THERCLAS Antiinflammatory Agents D03BLF DRUGTYPE Small molecular drug D03BLF DRUGINCH 1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1 D03BLF DRUGINKE GFNANZIMVAIWHM-OBYCQNJPSA-N D03BLF DRUGSMIL CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O D03BLF HIGHSTAT Approved D03CJL DRUG__ID D03CJL D03CJL DRUGCOMP Janssen Pharmaceutica D03CJL THERCLAS Antipsychotic Agents D03CJL DRUGTYPE Small molecular drug D03CJL DRUGINCH 1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28) D03CJL DRUGINKE RMEDXOLNCUSCGS-UHFFFAOYSA-N D03CJL DRUGSMIL C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F D03CJL HIGHSTAT Approved D03CQE DRUG__ID D03CQE D03CQE DRUGCOMP Bristol-Myers Squibb D03CQE THERCLAS Antiinfective Agents D03CQE DRUGTYPE Small molecular drug D03CQE DRUGINCH 1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26) D03CQE DRUGINKE XUBOMFCQGDBHNK-UHFFFAOYSA-N D03CQE DRUGSMIL CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F D03CQE HIGHSTAT Approved D03CUF DRUG__ID D03CUF D03CUF DRUGCOMP GlaxoSmithKline D03CUF THERCLAS Antiinfective Agents D03CUF DRUGTYPE Small molecular drug D03CUF DRUGINCH 1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+ D03CUF DRUGINKE PLHJDBGFXBMTGZ-WEVVVXLNSA-N D03CUF DRUGSMIL C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-] D03CUF HIGHSTAT Approved D03DAP DRUG__ID D03DAP D03DAP DRUGCOMP 3M pharmaceuticals D03DAP THERCLAS Antiarrhythmic Agents D03DAP DRUGTYPE Small molecular drug D03DAP DRUGINCH 1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26) D03DAP DRUGINKE DJBNUMBKLMJRSA-UHFFFAOYSA-N D03DAP DRUGSMIL C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F D03DAP HIGHSTAT Approved D03DDR DRUG__ID D03DDR D03DDR DRUGCOMP Pfizer Pharmaceuticals D03DDR THERCLAS Antimalarials D03DDR DRUGTYPE Small molecular drug D03DDR DRUGINCH 1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1 D03DDR DRUGINKE LOUPRKONTZGTKE-WZBLMQSHSA-N D03DDR DRUGSMIL COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O D03DDR HIGHSTAT Approved D03DIG DRUG__ID D03DIG D03DIG DRUGCOMP Forest Pharmaceuticals D03DIG THERCLAS Analgesics D03DIG DRUGTYPE Small molecular drug D03DIG DRUGINCH 1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1 D03DIG DRUGINKE OROGSEYTTFOCAN-DNJOTXNNSA-N D03DIG DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O D03DIG HIGHSTAT Approved D03DXN DRUG__ID D03DXN D03DXN DRUGCOMP Wyeth Ayerst Laboratories D03DXN THERCLAS Anticancer Agents D03DXN DRUGTYPE Small molecular drug D03DXN DRUGINCH 1S/C18H25O5P/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)23-24(20,21)22/h3,5,10,14-17,19H,2,4,6-9H2,1H3,(H2,20,21,22)/t14-,15-,16+,17+,18+/m1/s1 D03DXN DRUGINKE BBWXLCKRYRQQPL-ZBRFXRBCSA-N D03DXN DRUGSMIL CC12CCC3C(C1CCC2OP(=O)(O)O)CCC4=C3C=CC(=C4)O D03DXN HIGHSTAT Approved D03ELL DRUG__ID D03ELL D03ELL DRUGCOMP Sanofi-Aventis D03ELL THERCLAS Antipsychotic Agents D03ELL DRUGTYPE Small molecular drug D03ELL DRUGINCH 1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21) D03ELL DRUGINKE NTJOBXMMWNYJFB-UHFFFAOYSA-N D03ELL DRUGSMIL CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC D03ELL HIGHSTAT Approved D03FLC DRUG__ID D03FLC D03FLC DRUGCOMP GSK D03FLC THERCLAS Anticonvulsants D03FLC DRUGTYPE Small molecular drug D03FLC DRUGINCH 1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16) D03FLC DRUGINKE PYZRQGJRPPTADH-UHFFFAOYSA-N D03FLC DRUGSMIL C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N D03FLC HIGHSTAT Approved D03GCJ DRUG__ID D03GCJ D03GCJ DRUGCOMP CIBA Vision Sterile Mfg D03GCJ THERCLAS Antihypertensive Agents D03GCJ DRUGTYPE Small molecular drug D03GCJ DRUGINCH 1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20) D03GCJ DRUGINKE LWAFSWPYPHEXKX-UHFFFAOYSA-N D03GCJ DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O D03GCJ HIGHSTAT Approved D03HCZ DRUG__ID D03HCZ D03HCZ DRUGCOMP Xanodyne Pharmaceutics Inc D03HCZ THERCLAS Neurology Agents D03HCZ DRUGTYPE Small molecular drug D03HCZ DRUGINCH 1S/C22H29NO2.ClH/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19;/h6-15,18H,5,16-17H2,1-4H3;1H/t18-,22+;/m1./s1 D03HCZ DRUGINKE QMQBBUPJKANITL-MYXGOWFTSA-N D03HCZ DRUGSMIL CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.Cl D03HCZ HIGHSTAT Approved D03HFG DRUG__ID D03HFG D03HFG DRUGCOMP IVAX Pharmaceuticals D03HFG THERCLAS Antidepressants D03HFG DRUGTYPE Small molecular drug D03HFG DRUGINCH 1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+ D03HFG DRUGINKE CJOFXWAVKWHTFT-XSFVSMFZSA-N D03HFG DRUGSMIL COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F D03HFG HIGHSTAT Approved D03HYQ DRUG__ID D03HYQ D03HYQ DRUGCOMP CV Therapeutics D03HYQ THERCLAS Analgesics D03HYQ DRUGTYPE Small molecular drug D03HYQ DRUGINCH 1S/C24H33N3O4/c1-18-7-6-8-19(2)24(18)25-23(29)16-27-13-11-26(12-14-27)15-20(28)17-31-22-10-5-4-9-21(22)30-3/h4-10,20,28H,11-17H2,1-3H3,(H,25,29) D03HYQ DRUGINKE XKLMZUWKNUAPSZ-UHFFFAOYSA-N D03HYQ DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O D03HYQ HIGHSTAT Approved D03HYX DRUG__ID D03HYX D03HYX DRUGCOMP Schering-Plough D03HYX THERCLAS Antiinflammatory Agents D03HYX DRUGTYPE Small molecular drug D03HYX DRUGINCH 1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1 D03HYX DRUGINKE QLIIKPVHVRXHRI-CXSFZGCWSA-N D03HYX DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C D03HYX HIGHSTAT Approved D03IGH DRUG__ID D03IGH D03IGH DRUGCOMP Tibotec D03IGH THERCLAS Antiviral Agents D03IGH DRUGTYPE Small molecular drug D03IGH DRUGINCH 1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1 D03IGH DRUGINKE CJBJHOAVZSMMDJ-HEXNFIEUSA-N D03IGH DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N D03IGH HIGHSTAT Approved D03IKT DRUG__ID D03IKT D03IKT DRUGCOMP Eli Lilly And Co D03IKT THERCLAS Antiinflammatory Agents D03IKT DRUGTYPE Small molecular drug D03IKT DRUGINCH 1S/C22H29FO5/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-20(15,2)19(13)17(26)9-21(14,3)22(11,28)18(27)10-24/h4-5,7,11,13-14,16-17,19,24,26,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20+,21+,22+/m1/s1 D03IKT DRUGINKE MKPDWECBUAZOHP-AFYJWTTESA-N D03IKT DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)F D03IKT HIGHSTAT Approved D03JSJ DRUG__ID D03JSJ D03JSJ DRUGCOMP GlaxoSmithKline D03JSJ THERCLAS Antibiotics D03JSJ DRUGTYPE Small molecular drug D03JSJ DRUGINCH 1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1 D03JSJ DRUGINKE MINDHVHHQZYEEK-HBBNESRFSA-N D03JSJ DRUGSMIL CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O D03JSJ HIGHSTAT Approved D03KOZ DRUG__ID D03KOZ D03KOZ DRUGCOMP Eskayef Bangladesh Limited D03KOZ THERCLAS Hypoglycemic Agents D03KOZ DRUGTYPE Small molecular drug D03KOZ DRUGINCH 1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7+,12-8- D03KOZ DRUGINKE CHNUOJQWGUIOLD-NFZZJPOKSA-N D03KOZ DRUGSMIL CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O D03KOZ HIGHSTAT Approved D03KQF DRUG__ID D03KQF D03KQF DRUGCOMP Norvatis Phamaceuticals Corporation D03KQF THERCLAS Antidepressants D03KQF DRUGTYPE Small molecular drug D03KQF DRUGINCH 1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3 D03KQF DRUGINKE QSLMDECMDJKHMQ-UHFFFAOYSA-N D03KQF DRUGSMIL CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24 D03KQF HIGHSTAT Approved D03LGY DRUG__ID D03LGY D03LGY DRUGCOMP Abbott Laboratories D03LGY THERCLAS Anticonvulsants D03LGY DRUGTYPE Small molecular drug D03LGY DRUGINCH 1S/2C8H16O2.Na/c2*1-3-5-7(6-4-2)8(9)10;/h2*7H,3-6H2,1-2H3,(H,9,10);/q;;+1/p-1 D03LGY DRUGINKE MSRILKIQRXUYCT-UHFFFAOYSA-M D03LGY DRUGSMIL CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+] D03LGY HIGHSTAT Approved D03LJR DRUG__ID D03LJR D03LJR DRUGCOMP Wyeth D03LJR THERCLAS Immunosuppressive Agents D03LJR DRUGTYPE Small molecular drug D03LJR DRUGINCH 1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1 D03LJR DRUGINKE QFJCIRLUMZQUOT-HPLJOQBZSA-N D03LJR DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC D03LJR HIGHSTAT Approved D03LWG DRUG__ID D03LWG D03LWG TRADNAME Truseltiq D03LWG DRUGCOMP BridgeBio D03LWG DRUGTYPE Small molecular drug D03LWG DRUGINCH 1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9,14-16H,5,10-13H2,1-4H3,(H,32,36)(H,29,30,31) D03LWG DRUGINKE QADPYRIHXKWUSV-UHFFFAOYSA-N D03LWG DRUGSMIL CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl D03LWG HIGHSTAT Approved D03MIR DRUG__ID D03MIR D03MIR DRUGCOMP Pfizer Pharmaceuticals D03MIR THERCLAS Antihypertensive Agents D03MIR DRUGTYPE Small molecular drug D03MIR DRUGINCH 1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26) D03MIR DRUGINKE RUZYUOTYCVRMRZ-UHFFFAOYSA-N D03MIR DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC D03MIR HIGHSTAT Approved D03NHW DRUG__ID D03NHW D03NHW DRUGCOMP Janssen Pharmaceutica D03NHW THERCLAS Antibiotics D03NHW DRUGTYPE Small molecular drug D03NHW DRUGINCH 1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25) D03NHW DRUGINKE GSDSWSVVBLHKDQ-UHFFFAOYSA-N D03NHW DRUGSMIL CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O D03NHW HIGHSTAT Approved D03NPH DRUG__ID D03NPH D03NPH DRUGCOMP Schering-Plough D03NPH THERCLAS Hypnotics and Sedatives D03NPH DRUGTYPE Small molecular drug D03NPH DRUGINCH 1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2 D03NPH DRUGINKE IKMPWMZBZSAONZ-UHFFFAOYSA-N D03NPH DRUGSMIL C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F D03NPH HIGHSTAT Approved D03OFF DRUG__ID D03OFF D03OFF DRUGCOMP Takeda Pharmaceuticals D03OFF THERCLAS Hypoglycemic Agents D03OFF DRUGTYPE Small molecular drug D03OFF DRUGINCH 1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23) D03OFF DRUGINKE HYAFETHFCAUJAY-UHFFFAOYSA-N D03OFF DRUGSMIL CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D03OFF HIGHSTAT Approved D03QGM DRUG__ID D03QGM D03QGM DRUGCOMP Arrow Generics D03QGM THERCLAS Antipsychotic Agents D03QGM DRUGTYPE Small molecular drug D03QGM DRUGINCH 1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) D03QGM DRUGINKE BGRJTUBHPOOWDU-UHFFFAOYSA-N D03QGM DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC D03QGM HIGHSTAT Approved D03ROX DRUG__ID D03ROX D03ROX DRUGCOMP Lorex Pharmaceuticals D03ROX THERCLAS Antihypertensive Agents D03ROX DRUGTYPE Small molecular drug D03ROX DRUGINCH 1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3 D03ROX DRUGINKE NWIUTZDMDHAVTP-UHFFFAOYSA-N D03ROX DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O D03ROX HIGHSTAT Approved D03RTS DRUG__ID D03RTS D03RTS DRUGCOMP Pfizer D03RTS THERCLAS Analgesics D03RTS DRUGTYPE Small molecular drug D03RTS DRUGINCH 1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25) D03RTS DRUGINKE RZEKVGVHFLEQIL-UHFFFAOYSA-N D03RTS DRUGSMIL CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F D03RTS HIGHSTAT Approved D03SKD DRUG__ID D03SKD D03SKD DRUGCOMP Watson Laboratories D03SKD THERCLAS Analgesics D03SKD DRUGTYPE Small molecular drug D03SKD DRUGINCH 1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1 D03SKD DRUGINKE BRUQQQPBMZOVGD-XFKAJCMBSA-N D03SKD DRUGSMIL CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O D03SKD HIGHSTAT Approved D03SKR DRUG__ID D03SKR D03SKR DRUGCOMP Intas Pharmaceuticals D03SKR THERCLAS Antihypertensive Agents D03SKR DRUGTYPE Small molecular drug D03SKR DRUGINCH 1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14) D03SKR DRUGINKE GJSURZIOUXUGAL-UHFFFAOYSA-N D03SKR DRUGSMIL C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl D03SKR HIGHSTAT Approved D03SRY DRUG__ID D03SRY D03SRY DRUGCOMP Pfizer Pharmaceuticals D03SRY THERCLAS Anticancer Agents D03SRY DRUGTYPE Small molecular drug D03SRY DRUGINCH 1S/C23H31Cl2NO3/c1-23-9-8-18-17-5-3-16(29-22(28)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)27/h3,5,14,18-21,27H,2,4,6-13H2,1H3/t18-,19-,20+,21+,23+/m1/s1 D03SRY DRUGINKE FRPJXPJMRWBBIH-RBRWEJTLSA-N D03SRY DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl D03SRY HIGHSTAT Approved D03SSE DRUG__ID D03SSE D03SSE DRUGCOMP Recordati Rare Diseases Inc D03SSE THERCLAS Anticancer Agents D03SSE DRUGTYPE Small molecular drug D03SSE DRUGINCH 1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3 D03SSE DRUGINKE HAWPXGHAZFHHAD-UHFFFAOYSA-N D03SSE DRUGSMIL CN(CCCl)CCCl D03SSE HIGHSTAT Approved D03SVX DRUG__ID D03SVX D03SVX DRUGCOMP Norvatis Phamaceuticals Corporation D03SVX THERCLAS Antihypertensive Agents D03SVX DRUGTYPE Small molecular drug D03SVX DRUGINCH 1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1 D03SVX DRUGINKE UXOWGYHJODZGMF-QORCZRPOSA-N D03SVX DRUGSMIL CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N D03SVX HIGHSTAT Approved D03UQM DRUG__ID D03UQM D03UQM DRUGCOMP GlaxoSmithKline D03UQM THERCLAS Antibiotics D03UQM DRUGTYPE Small molecular drug D03UQM DRUGINCH 1S/C30H47NO4S/c1-7-28(4)16-24(35-25(33)17-36-22-14-20-8-9-21(15-22)31(20)6)29(5)18(2)10-12-30(19(3)27(28)34)13-11-23(32)26(29)30/h7,18-22,24,26-27,34H,1,8-17H2,2-6H3/t18-,19+,20-,21+,22?,24-,26+,27+,28-,29+,30+/m1/s1 D03UQM DRUGINKE STZYTFJPGGDRJD-FJJJPKKESA-N D03UQM DRUGSMIL CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C D03UQM HIGHSTAT Approved D03UVS DRUG__ID D03UVS D03UVS DRUGCOMP Eli Lilly D03UVS THERCLAS Anticancer Agents D03UVS DRUGTYPE Small molecular drug D03UVS DRUGINCH 1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1 D03UVS DRUGINKE SDUQYLNIPVEERB-QPPQHZFASA-N D03UVS DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F D03UVS HIGHSTAT Approved D03VPC DRUG__ID D03VPC D03VPC DRUGCOMP Otsuka Pharmaceutical Co D03VPC THERCLAS Vasodilator Agents D03VPC DRUGTYPE Small molecular drug D03VPC DRUGINCH 1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26) D03VPC DRUGINKE RRGUKTPIGVIEKM-UHFFFAOYSA-N D03VPC DRUGSMIL C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4 D03VPC HIGHSTAT Approved D03VZH DRUG__ID D03VZH D03VZH DRUGCOMP Abbott Laboratories D03VZH THERCLAS Hypnotics and Sedatives D03VZH DRUGTYPE Small molecular drug D03VZH DRUGINCH 1S/C7H9ClO/c1-3-7(9,4-2)5-6-8/h1,5-6,9H,4H2,2H3/b6-5+ D03VZH DRUGINKE ZEHYJZXQEQOSON-AATRIKPKSA-N D03VZH DRUGSMIL CCC(C=CCl)(C#C)O D03VZH HIGHSTAT Approved D03WPA DRUG__ID D03WPA D03WPA DRUGCOMP Pfizer Pharmaceuticals D03WPA THERCLAS Antiinfective Agents D03WPA DRUGTYPE Small molecular drug D03WPA DRUGINCH 1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16? D03WPA DRUGINKE WVPSKSLAZQPAKQ-SOSAQKQKSA-N D03WPA DRUGSMIL C1C2C(C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F D03WPA HIGHSTAT Approved D03XSJ DRUG__ID D03XSJ D03XSJ DRUGCOMP McNeil Laboratories D03XSJ THERCLAS Antihistamines D03XSJ DRUGTYPE Small molecular drug D03XSJ DRUGINCH 1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3 D03XSJ DRUGINKE MOYGZHXDRJNJEP-UHFFFAOYSA-N D03XSJ DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl D03XSJ HIGHSTAT Approved D03XTC DRUG__ID D03XTC D03XTC DRUGCOMP Bedford Laboratories D03XTC THERCLAS Antihypertensive Agents D03XTC DRUGTYPE Small molecular drug D03XTC DRUGINCH 1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3 D03XTC DRUGINKE AQNDDEOPVVGCPG-UHFFFAOYSA-N D03XTC DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O D03XTC HIGHSTAT Approved D03XYW DRUG__ID D03XYW D03XYW DRUGCOMP Typharm Limited D03XYW THERCLAS Antiinflammatory Agents D03XYW DRUGTYPE Small molecular drug D03XYW DRUGINCH 1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17) D03XYW DRUGINKE RDJGLLICXDHJDY-UHFFFAOYSA-N D03XYW DRUGSMIL CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O D03XYW HIGHSTAT Approved D03YGR DRUG__ID D03YGR D03YGR DRUGCOMP Amgen D03YGR THERCLAS Calcimimetics D03YGR DRUGTYPE Small molecular drug D03YGR DRUGINCH 1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1 D03YGR DRUGINKE VDHAWDNDOKGFTD-MRXNPFEDSA-N D03YGR DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F D03YGR HIGHSTAT Approved D03ZZK DRUG__ID D03ZZK D03ZZK DRUGCOMP Taro Pharmaceuticals Inc D03ZZK THERCLAS Antiinflammatory Agents D03ZZK DRUGTYPE Small molecular drug D03ZZK DRUGINCH 1S/C26H32F2O7/c1-13(29)33-12-20(32)26-21(34-22(2,3)35-26)10-15-16-9-18(27)17-8-14(30)6-7-23(17,4)25(16,28)19(31)11-24(15,26)5/h6-8,15-16,18-19,21,31H,9-12H2,1-5H3/t15-,16-,18-,19-,21+,23-,24-,25-,26+/m0/s1 D03ZZK DRUGINKE WJOHZNCJWYWUJD-IUGZLZTKSA-N D03ZZK DRUGSMIL CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C D03ZZK HIGHSTAT Approved D04AAN DRUG__ID D04AAN D04AAN DRUGCOMP Norvatis Phamaceuticals Corporation D04AAN THERCLAS Antipsychotic Agents D04AAN DRUGTYPE Small molecular drug D04AAN DRUGINCH 1S/C21H26N2OS2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(26(2)24)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3 D04AAN DRUGINKE SLVMESMUVMCQIY-UHFFFAOYSA-N D04AAN DRUGSMIL CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C D04AAN HIGHSTAT Approved D04AAW DRUG__ID D04AAW D04AAW DRUGCOMP Pfizer Pharmaceuticals D04AAW THERCLAS Anti-HIV Agents D04AAW DRUGTYPE Small molecular drug D04AAW DRUGINCH 1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1 D04AAW DRUGINKE VWFCHDSQECPREK-LURJTMIESA-N D04AAW DRUGSMIL C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O D04AAW HIGHSTAT Approved D04AQH DRUG__ID D04AQH D04AQH DRUGCOMP Emd Serono Inc D04AQH THERCLAS Hormone Replacement Agents D04AQH DRUGTYPE Small molecular drug D04AQH DRUGINCH 1S/C149H246N44O42S/c1-20-77(13)116(191-122(211)81(17)168-132(221)104(66-113(204)205)178-121(210)79(15)167-123(212)88(152)62-84-39-43-86(198)44-40-84)145(234)185-102(63-83-32-23-22-24-33-83)138(227)193-118(82(18)197)146(235)186-103(65-111(155)202)137(226)189-108(71-196)142(231)182-101(64-85-41-45-87(199)46-42-85)136(225)175-93(38-31-56-165-149(161)162)126(215)174-91(35-26-28-53-151)131(220)190-115(76(11)12)143(232)184-97(58-72(3)4)124(213)166-68-112(203)170-94(47-49-109(153)200)128(217)180-100(61-75(9)10)135(224)188-106(69-194)140(229)169-80(16)120(209)172-92(37-30-55-164-148(159)160)125(214)173-90(34-25-27-52-150)127(216)179-99(60-74(7)8)134(223)181-98(59-73(5)6)133(222)176-95(48-50-110(154)201)129(218)183-105(67-114(206)207)139(228)192-117(78(14)21-2)144(233)177-96(51-57-236-19)130(219)187-107(70-195)141(230)171-89(119(156)208)36-29-54-163-147(157)158/h22-24,32-33,39-46,72-82,88-108,115-118,194-199H,20-21,25-31,34-38,47-71,150-152H2,1-19H3,(H2,153,200)(H2,154,201)(H2,155,202)(H2,156,208)(H,166,213)(H,167,212)(H,168,221)(H,169,229)(H,170,203)(H,171,230)(H,172,209)(H,173,214)(H,174,215)(H,175,225)(H,176,222)(H,177,233)(H,178,210)(H,179,216)(H,180,217)(H,181,223)(H,182,231)(H,183,218)(H,184,232)(H,185,234)(H,186,235)(H,187,219)(H,188,224)(H,189,226)(H,190,220)(H,191,211)(H,192,228)(H,193,227)(H,204,205)(H,206,207)(H4,157,158,163)(H4,159,160,164)(H4,161,162,165)/t77-,78-,79-,80-,81-,82+,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,115-,116-,117-,118-/m0/s1 D04AQH DRUGINKE WGWPRVFKDLAUQJ-MITYVQBRSA-N D04AQH DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N D04AQH HIGHSTAT Approved D04BNP DRUG__ID D04BNP D04BNP DRUGCOMP Mylan Inc D04BNP THERCLAS Hypnotics and Sedatives D04BNP DRUGTYPE Small molecular drug D04BNP DRUGINCH 1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3 D04BNP DRUGINKE SEQDDYPDSLOBDC-UHFFFAOYSA-N D04BNP DRUGSMIL CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3 D04BNP HIGHSTAT Approved D04CFW DRUG__ID D04CFW D04CFW DRUGCOMP Pfizer Pharmaceuticals D04CFW THERCLAS Antibiotics D04CFW DRUGTYPE Small molecular drug D04CFW DRUGINCH 1S/C21H27N3O7S/c1-5-29-20(28)31-11(2)30-19(27)15-21(3,4)32-18-14(17(26)24(15)18)23-16(25)13(22)12-9-7-6-8-10-12/h6-11,13-15,18H,5,22H2,1-4H3,(H,23,25)/t11?,13-,14-,15+,18-/m1/s1 D04CFW DRUGINKE PFOLLRNADZZWEX-FFGRCDKISA-N D04CFW DRUGSMIL CCOC(=O)OC(C)OC(=O)C1C(SC2N1C(=O)C2NC(=O)C(C3=CC=CC=C3)N)(C)C D04CFW HIGHSTAT Approved D04CRL DRUG__ID D04CRL D04CRL DRUGCOMP Teva Pharmaceuticals D04CRL THERCLAS Immunosuppressive Agents D04CRL DRUGTYPE Small molecular drug D04CRL DRUGINCH 1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2.C2H4O2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6;1-2(3)4/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1-2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6);1H3,(H,3,4)/t8-;5-;3-;2-;/m0000./s1 D04CRL DRUGINKE FHEAIOHRHQGZPC-KIWGSFCNSA-N D04CRL DRUGSMIL CC(C(=O)O)N.CC(=O)O.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N D04CRL HIGHSTAT Approved D04EGX DRUG__ID D04EGX D04EGX DRUGCOMP Pfizer Pharmaceuticals D04EGX THERCLAS Anticancer Agents D04EGX DRUGTYPE Small molecular drug D04EGX DRUGINCH 1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1 D04EGX DRUGINKE KORNTPPJEAJQIU-KJXAQDMKSA-N D04EGX DRUGSMIL CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C D04EGX HIGHSTAT Approved D04EYC DRUG__ID D04EYC D04EYC DRUGCOMP Merck Sharp & Dohme Pharmaceuticals D04EYC THERCLAS Antihypertensive Agents D04EYC DRUGTYPE Small molecular drug D04EYC DRUGINCH 1S/C9H13NO2/c1-6(10)9(12)7-3-2-4-8(11)5-7/h2-6,9,11-12H,10H2,1H3/t6-,9-/m0/s1 D04EYC DRUGINKE WXFIGDLSSYIKKV-RCOVLWMOSA-N D04EYC DRUGSMIL CC(C(C1=CC(=CC=C1)O)O)N D04EYC HIGHSTAT Approved D04FBR DRUG__ID D04FBR D04FBR DRUGCOMP Roche D04FBR THERCLAS Immunosuppressive Agents D04FBR DRUGTYPE Small molecular drug D04FBR DRUGINCH 1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+ D04FBR DRUGINKE RTGDFNSFWBGLEC-SYZQJQIISA-N D04FBR DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)OCCN3CCOCC3)O D04FBR HIGHSTAT Approved D04FVU DRUG__ID D04FVU D04FVU DRUGCOMP Eisai Inc D04FVU THERCLAS Antiemetics D04FVU DRUGTYPE Small molecular drug D04FVU DRUGINCH 1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17-/m1/s1 D04FVU DRUGINKE CPZBLNMUGSZIPR-NVXWUHKLSA-N D04FVU DRUGSMIL C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5 D04FVU HIGHSTAT Approved D04GJN DRUG__ID D04GJN D04GJN DRUGCOMP Bristol Myers Squibb D04GJN THERCLAS Anticancer Agents D04GJN DRUGTYPE Small molecular drug D04GJN DRUGINCH 1S/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1 D04GJN DRUGINKE VXIMPSPISRVBPZ-NWUMPJBXSA-N D04GJN DRUGSMIL CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C D04GJN HIGHSTAT Approved D04GYO DRUG__ID D04GYO D04GYO DRUGCOMP Fougera Pharmaceuticals Inc D04GYO THERCLAS Antifungal Agents D04GYO DRUGTYPE Small molecular drug D04GYO DRUGINCH 1S/C18H13Cl4N3O/c19-13-2-1-12(16(21)7-13)10-26-24-18(9-25-6-5-23-11-25)15-4-3-14(20)8-17(15)22/h1-8,11H,9-10H2/b24-18+ D04GYO DRUGINKE QRJJEGAJXVEBNE-HKOYGPOVSA-N D04GYO DRUGSMIL C1=CC(=C(C=C1Cl)Cl)CON=C(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl D04GYO HIGHSTAT Approved D04JCN DRUG__ID D04JCN D04JCN DRUGCOMP Valeant Pharmaceuticals D04JCN THERCLAS Antiparkinson Agents D04JCN DRUGTYPE Small molecular drug D04JCN DRUGINCH 1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1 D04JCN DRUGINKE YEHCICAEULNIGD-MZMPZRCHSA-N D04JCN DRUGSMIL CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC D04JCN HIGHSTAT Approved D04JEE DRUG__ID D04JEE D04JEE DRUGCOMP AstraZeneca plc D04JEE THERCLAS Antianxiety Agents D04JEE DRUGTYPE Small molecular drug D04JEE DRUGINCH 1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3 D04JEE DRUGINKE AQHHHDLHHXJYJD-UHFFFAOYSA-N D04JEE DRUGSMIL CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O D04JEE HIGHSTAT Approved D04JHN DRUG__ID D04JHN D04JHN DRUGCOMP Knoll D04JHN THERCLAS Analgesics D04JHN DRUGTYPE Small molecular drug D04JHN DRUGINCH 1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1 D04JHN DRUGINKE WVLOADHCBXTIJK-YNHQPCIGSA-N D04JHN DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4 D04JHN HIGHSTAT Approved D04KJO DRUG__ID D04KJO D04KJO DRUGCOMP Norvatis Phamaceuticals Corporation D04KJO THERCLAS Sympathomimetics D04KJO DRUGTYPE Small molecular drug D04KJO DRUGINCH 1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22) D04KJO DRUGINKE BPZSYCZIITTYBL-UHFFFAOYSA-N D04KJO DRUGSMIL CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O D04KJO HIGHSTAT Approved D04KTZ DRUG__ID D04KTZ D04KTZ DRUGCOMP Beecham phamaceuticals D04KTZ THERCLAS Antibiotics D04KTZ DRUGTYPE Small molecular drug D04KTZ DRUGINCH 1S/C19H18ClN3O5S/c1-8-11(12(22-28-8)9-6-4-5-7-10(9)20)15(24)21-13-16(25)23-14(18(26)27)19(2,3)29-17(13)23/h4-7,13-14,17H,1-3H3,(H,21,24)(H,26,27)/t13-,14+,17-/m1/s1 D04KTZ DRUGINKE LQOLIRLGBULYKD-JKIFEVAISA-N D04KTZ DRUGSMIL CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O D04KTZ HIGHSTAT Approved D04KYY DRUG__ID D04KYY D04KYY DRUGCOMP GlaxoSmithKline D04KYY THERCLAS Antimetabolites D04KYY DRUGTYPE Small molecular drug D04KYY DRUGINCH 1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) D04KYY DRUGINKE OFCNXPDARWKPPY-UHFFFAOYSA-N D04KYY DRUGSMIL C1=NNC2=C1C(=O)NC=N2 D04KYY HIGHSTAT Approved D04NDM DRUG__ID D04NDM D04NDM DRUGCOMP King Pharmaceuticals D04NDM THERCLAS Antibiotics D04NDM DRUGTYPE Small molecular drug D04NDM DRUGINCH 1S/C23H45N5O14/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22/h5-23,29-36H,1-4,24-28H2/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1 D04NDM DRUGINKE UOZODPSAJZTQNH-LSWIJEOBSA-N D04NDM DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N D04NDM HIGHSTAT Approved D04OBB DRUG__ID D04OBB D04OBB DRUGCOMP Aventis Pharmaceuticals Inc. D04OBB THERCLAS Antiallergic Agents D04OBB DRUGTYPE Small molecular drug D04OBB DRUGINCH 1S/C16H20N2/c1-18(2)13-11-15(14-8-4-3-5-9-14)16-10-6-7-12-17-16/h3-10,12,15H,11,13H2,1-2H3 D04OBB DRUGINKE IJHNSHDBIRRJRN-UHFFFAOYSA-N D04OBB DRUGSMIL CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2 D04OBB HIGHSTAT Approved D04ODH DRUG__ID D04ODH D04ODH DRUGCOMP Hikma (Maple) Ltd D04ODH THERCLAS Fertility Agents D04ODH DRUGTYPE Small molecular drug D04ODH DRUGINCH 1S/C55H75N17O13/c1-29(2)19-38(49(80)67-37(9-5-17-60-55(57)58)54(85)72-18-6-10-43(72)53(84)62-25-44(56)75)66-46(77)26-63-47(78)39(20-30-11-13-33(74)14-12-30)68-52(83)42(27-73)71-50(81)40(21-31-23-61-35-8-4-3-7-34(31)35)69-51(82)41(22-32-24-59-28-64-32)70-48(79)36-15-16-45(76)65-36/h3-4,7-8,11-14,23-24,28-29,36-43,61,73-74H,5-6,9-10,15-22,25-27H2,1-2H3,(H2,56,75)(H,59,64)(H,62,84)(H,63,78)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,82)(H,70,79)(H,71,81)(H4,57,58,60)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 D04ODH DRUGINKE XLXSAKCOAKORKW-AQJXLSMYSA-N D04ODH DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6 D04ODH HIGHSTAT Approved D04OSE DRUG__ID D04OSE D04OSE DRUGCOMP Bayer D04OSE THERCLAS Analgesics D04OSE DRUGTYPE Small molecular drug D04OSE DRUGINCH 1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3 D04OSE DRUGINKE HYIMSNHJOBLJNT-UHFFFAOYSA-N D04OSE DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC D04OSE HIGHSTAT Approved D04QJD DRUG__ID D04QJD D04QJD DRUGCOMP GlaxoSmithKline D04QJD THERCLAS Antiviral Agents D04QJD DRUGTYPE Small molecular drug D04QJD DRUGINCH 1S/C13H20N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20)/t8-/m0/s1 D04QJD DRUGINKE HDOVUKNUBWVHOX-QMMMGPOBSA-N D04QJD DRUGSMIL CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N D04QJD HIGHSTAT Approved D04QLR DRUG__ID D04QLR D04QLR DRUGCOMP Astrazeneca Lp D04QLR THERCLAS Anesthetics D04QLR DRUGTYPE Small molecular drug D04QLR DRUGINCH 1S/C18H27NO2/c1-2-3-15-21-17-9-7-16(8-10-17)18(20)11-14-19-12-5-4-6-13-19/h7-10H,2-6,11-15H2,1H3 D04QLR DRUGINKE BZEWSEKUUPWQDQ-UHFFFAOYSA-N D04QLR DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2 D04QLR HIGHSTAT Approved D04QSJ DRUG__ID D04QSJ D04QSJ TRADNAME Motegrity D04QSJ DRUGCOMP Shire/Takeda D04QSJ DRUGTYPE Small molecular drug D04QSJ DRUGINCH 1S/C18H26ClN3O3/c1-24-9-2-6-22-7-3-12(4-8-22)21-18(23)14-11-15(19)16(20)13-5-10-25-17(13)14/h11-12H,2-10,20H2,1H3,(H,21,23) D04QSJ DRUGINKE ZPMNHBXQOOVQJL-UHFFFAOYSA-N D04QSJ DRUGSMIL COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl D04QSJ HIGHSTAT Approved D04QWE DRUG__ID D04QWE D04QWE DRUGCOMP Hoffmann La Roche Inc D04QWE THERCLAS Antinarcotic Agents D04QWE DRUGTYPE Small molecular drug D04QWE DRUGINCH 1S/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18+,19+/m0/s1 D04QWE DRUGINKE OZYUPQUCAUTOBP-QXAKKESOSA-N D04QWE DRUGSMIL C=CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O D04QWE HIGHSTAT Approved D04URO DRUG__ID D04URO D04URO DRUGCOMP Alpes Selection D04URO THERCLAS Thrombolytic Agents D04URO DRUGTYPE Small molecular drug D04URO DRUGINCH 1S/C11H19NO2/c13-11(14)10-6-9(7-12-10)8-4-2-1-3-5-8/h8-10,12H,1-7H2,(H,13,14) D04URO DRUGINKE XRZWVSXEDRYQGC-UHFFFAOYSA-N D04URO DRUGSMIL C1CCC(CC1)C2CC(NC2)C(=O)O D04URO HIGHSTAT Approved D04VEJ DRUG__ID D04VEJ D04VEJ DRUGCOMP Galderma D04VEJ THERCLAS Antibiotics D04VEJ DRUGTYPE Small molecular drug D04VEJ DRUGINCH 1S/C29H38N4O10/c1-28(42)13-7-6-9-17(34)18(13)22(35)19-14(28)11-15-21(33(2)3)23(36)20(25(38)29(15,43)24(19)37)26(39)32-12-31-10-5-4-8-16(30)27(40)41/h6-7,9,14-16,21,31,34-35,38,42-43H,4-5,8,10-12,30H2,1-3H3,(H,32,39)(H,40,41)/t14-,15-,16-,21-,28+,29-/m0/s1 D04VEJ DRUGINKE PZTCVADFMACKLU-UEPZRUIBSA-N D04VEJ DRUGSMIL CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCNCCCCC(C(=O)O)N)N(C)C)O D04VEJ HIGHSTAT Approved D04VFJ DRUG__ID D04VFJ D04VFJ DRUGCOMP Prostrakan Inc D04VFJ THERCLAS Anticancer Agents D04VFJ DRUGTYPE Small molecular drug D04VFJ DRUGINCH 1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25- D04VFJ DRUGINKE XFCLJVABOIYOMF-QPLCGJKRSA-N D04VFJ DRUGSMIL CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3 D04VFJ HIGHSTAT Approved D04VKS DRUG__ID D04VKS D04VKS DRUGCOMP Schering Corp Sub Schering Plough Corp D04VKS THERCLAS Antiinfective Agents D04VKS DRUGTYPE Small molecular drug D04VKS DRUGINCH 1S/C13H10N2.C12H18O2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h1-8H,(H2,14,15);7-9,13-14H,2-6H2,1H3 D04VKS DRUGINKE YZODJQFXMFEJRM-UHFFFAOYSA-N D04VKS DRUGSMIL CCCCCCC1=C(C=C(C=C1)O)O.C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)N D04VKS HIGHSTAT Approved D04VMT DRUG__ID D04VMT D04VMT DRUGCOMP Bristol-Myers Squibb D04VMT THERCLAS Antiarrhythmic Agents D04VMT DRUGTYPE Small molecular drug D04VMT DRUGINCH 1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3 D04VMT DRUGINKE ZBMZVLHSJCTVON-UHFFFAOYSA-N D04VMT DRUGSMIL CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O D04VMT HIGHSTAT Approved D04VPA DRUG__ID D04VPA D04VPA DRUGCOMP Shire Development Inc D04VPA THERCLAS Antiarrhythmic Agents D04VPA DRUGTYPE Small molecular drug D04VPA DRUGINCH 1S/C22H25N3O4S/c1-2-29-22(27)23-16-7-8-20-18(15-16)25(17-5-3-4-6-19(17)30-20)21(26)9-10-24-11-13-28-14-12-24/h3-8,15H,2,9-14H2,1H3,(H,23,27) D04VPA DRUGINKE FUBVWMNBEHXPSU-UHFFFAOYSA-N D04VPA DRUGSMIL CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4 D04VPA HIGHSTAT Approved D04VXN DRUG__ID D04VXN D04VXN DRUGCOMP Eli Lilly And Co D04VXN THERCLAS Antiinfective Agents D04VXN DRUGTYPE Small molecular drug D04VXN DRUGINCH 1S/C20H20N6O9S.2Na/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9;;/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32);;/q;2*+1/p-2/t12?,18-,20+;;/m1../s1 D04VXN DRUGINKE GRIXGZQULWMCLU-HUTAOCTPSA-L D04VXN DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)[O-])OC)OC2)C(=O)[O-].[Na+].[Na+] D04VXN HIGHSTAT Approved D04XDT DRUG__ID D04XDT D04XDT TRADNAME Baxdela D04XDT DRUGCOMP Melinta Therapeutics D04XDT DRUGTYPE Small molecular drug D04XDT DRUGINCH 1S/C18H12ClF3N4O4.C7H17NO5/c19-12-13-7(1-9(20)14(12)25-3-6(27)4-25)15(28)8(18(29)30)5-26(13)17-11(22)2-10(21)16(23)24-17;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-2,5-6,27H,3-4H2,(H2,23,24)(H,29,30);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1 D04XDT DRUGINKE AHJGUEMIZPMAMR-WZTVWXICSA-N D04XDT DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O D04XDT HIGHSTAT Approved D04XEG DRUG__ID D04XEG D04XEG DRUGCOMP Boehriger Ingelheim D04XEG THERCLAS Bronchodilator Agents D04XEG DRUGTYPE Small molecular drug D04XEG DRUGINCH 1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3 D04XEG DRUGINKE LSLYOANBFKQKPT-UHFFFAOYSA-N D04XEG DRUGSMIL CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O D04XEG HIGHSTAT Approved D04XGT DRUG__ID D04XGT D04XGT TRADNAME Benznidazole D04XGT DRUGCOMP Chemo Research D04XGT DRUGTYPE Small molecular drug D04XGT DRUGINCH 1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17) D04XGT DRUGINKE CULUWZNBISUWAS-UHFFFAOYSA-N D04XGT DRUGSMIL C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-] D04XGT HIGHSTAT Approved D04YHR DRUG__ID D04YHR D04YHR DRUGCOMP Lantheus Medical Imaging Inc D04YHR THERCLAS Neurology Agents D04YHR DRUGTYPE Small molecular drug D04YHR DRUGINCH 1S/C6H20N2O12P4.5Na.Sm/c9-21(10,11)3-7(4-22(12,13)14)1-2-8(5-23(15,16)17)6-24(18,19)20;;;;;;/h1-6H2,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20);;;;;;/q;5*+1;+3/p-8/i;;;;;;1+3 D04YHR DRUGINKE SZZACTGRBZTAKY-NKNBZPHVSA-F D04YHR DRUGSMIL C(CN(CP(=O)([O-])[O-])CP(=O)([O-])[O-])N(CP(=O)([O-])[O-])CP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Sm+3] D04YHR HIGHSTAT Approved D04YMH DRUG__ID D04YMH D04YMH DRUGCOMP Norvatis Phamaceuticals Corporation D04YMH THERCLAS Antiinflammatory Agents D04YMH DRUGTYPE Small molecular drug D04YMH DRUGINCH 1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20) D04YMH DRUGINKE KHPKQFYUPIUARC-UHFFFAOYSA-N D04YMH DRUGSMIL CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O D04YMH HIGHSTAT Approved D04ZAH DRUG__ID D04ZAH D04ZAH DRUGCOMP Wyeth D04ZAH THERCLAS Antibiotics D04ZAH DRUGTYPE Small molecular drug D04ZAH DRUGINCH 1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1 D04ZAH DRUGINKE IVBHGBMCVLDMKU-GXNBUGAJSA-N D04ZAH DRUGSMIL CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O D04ZAH HIGHSTAT Approved D04ZBT DRUG__ID D04ZBT D04ZBT DRUGCOMP Jerini AG D04ZBT THERCLAS Antiinflammatory Agents D04ZBT DRUGTYPE Small molecular drug D04ZBT DRUGINCH 1S/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38-,39-,40-,41-,42-,43-,44-,45-,46+/m0/s1 D04ZBT DRUGINKE QURWXBZNHXJZBE-SKXRKSCCSA-N D04ZBT DRUGSMIL C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O D04ZBT HIGHSTAT Approved D04ZTY DRUG__ID D04ZTY D04ZTY DRUGCOMP Takeda D04ZTY THERCLAS Hypoglycemic Agents D04ZTY DRUGTYPE Small molecular drug D04ZTY DRUGINCH 1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1 D04ZTY DRUGINKE FZNCGRZWXLXZSZ-CIQUZCHMSA-N D04ZTY DRUGSMIL C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO D04ZTY HIGHSTAT Approved D05AHE DRUG__ID D05AHE D05AHE DRUGCOMP Edison Therapeutics Llc D05AHE THERCLAS Oxytocics D05AHE DRUGTYPE Small molecular drug D05AHE DRUGINCH 1S/C20H25N3O2/c1-3-14(11-24)22-20(25)13-7-16-15-5-4-6-17-19(15)12(9-21-17)8-18(16)23(2)10-13/h4-7,9,13-14,18,21,24H,3,8,10-11H2,1-2H3,(H,22,25)/t13-,14+,18-/m1/s1 D05AHE DRUGINKE UNBRKDKAWYKMIV-QWQRMKEZSA-N D05AHE DRUGSMIL CCC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C D05AHE HIGHSTAT Approved D05ARP DRUG__ID D05ARP D05ARP DRUGCOMP Bausch & Lomb Pharmaceuticals, Inc. D05ARP THERCLAS Antiviral Agents D05ARP DRUGTYPE Small molecular drug D05ARP DRUGINCH 1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17) D05ARP DRUGINKE IRSCQMHQWWYFCW-UHFFFAOYSA-N D05ARP DRUGSMIL C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N D05ARP HIGHSTAT Approved D05BJD DRUG__ID D05BJD D05BJD DRUGCOMP Pharmacyclics, Inc D05BJD THERCLAS Anticancer Agents D05BJD DRUGTYPE Small molecular drug D05BJD DRUGINCH 1S/C48H66N5O10.2C2H4O2.Gd/c1-7-35-36(8-2)40-28-42-38(12-10-14-55)34(4)46(53-42)32-50-44-30-48(63-26-24-61-22-20-59-18-16-57-6)47(62-25-23-60-21-19-58-17-15-56-5)29-43(44)49-31-45-33(3)37(11-9-13-54)41(52-45)27-39(35)51-40;2*1-2(3)4;/h27-32,54-55H,7-26H2,1-6H3;2*1H3,(H,3,4);/q-1;;;+3/p-2 D05BJD DRUGINKE VAZLWPAHMORDGR-UHFFFAOYSA-L D05BJD DRUGSMIL CCC1=C(C2=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=N5)C=C1[N-]2)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)[O-].CC(=O)[O-].[Gd+3] D05BJD HIGHSTAT Approved D05CEU DRUG__ID D05CEU D05CEU DRUGCOMP Janssen Pharmaceutica D05CEU THERCLAS Anticonvulsants D05CEU DRUGTYPE Small molecular drug D05CEU DRUGINCH 1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+ D05CEU DRUGINKE SMANXXCATUTDDT-QPJJXVBHSA-N D05CEU DRUGSMIL C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D05CEU HIGHSTAT Approved D05CHI DRUG__ID D05CHI D05CHI DRUGCOMP Adria Laboratories D05CHI THERCLAS Antibiotics D05CHI DRUGTYPE Small molecular drug D05CHI DRUGINCH 1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,48,52-55H,16-19,21H2,1-11H3/b13-12+,20-15+,24-14-,47-36?/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1 D05CHI DRUGINKE ZWBTYMGEBZUQTK-PVLSIAFMSA-N D05CHI DRUGSMIL CC1C=CC=C(C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)OC(C6=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C D05CHI HIGHSTAT Approved D05DVP DRUG__ID D05DVP D05DVP DRUGCOMP AstraZeneca plc D05DVP THERCLAS Antiasthmatic Agents D05DVP DRUGTYPE Small molecular drug D05DVP DRUGINCH 1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35) D05DVP DRUGINKE YEEZWCHGZNKEEK-UHFFFAOYSA-N D05DVP DRUGSMIL CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC D05DVP HIGHSTAT Approved D05EPM DRUG__ID D05EPM D05EPM DRUGCOMP Ovation Pharmaceuticals D05EPM THERCLAS Anticonvulsants D05EPM DRUGTYPE Small molecular drug D05EPM DRUGINCH 1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15) D05EPM DRUGINKE SZQIFWWUIBRPBZ-UHFFFAOYSA-N D05EPM DRUGSMIL CCN1C(=O)C(NC1=O)C2=CC=CC=C2 D05EPM HIGHSTAT Approved D05GJW DRUG__ID D05GJW D05GJW DRUGCOMP EMD Serono Rockland, MA D05GJW THERCLAS Anticancer Agents D05GJW DRUGTYPE Small molecular drug D05GJW DRUGINCH 1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1 D05GJW DRUGINKE PTOAARAWEBMLNO-KVQBGUIXSA-N D05GJW DRUGSMIL C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O D05GJW HIGHSTAT Approved D05GKD DRUG__ID D05GKD D05GKD DRUGCOMP Chemie Grunenthal of Stolberg-am-Rhein D05GKD THERCLAS Analgesics D05GKD DRUGTYPE Small molecular drug D05GKD DRUGINCH 1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3/t14-,16+/m1/s1 D05GKD DRUGINKE TVYLLZQTGLZFBW-ZBFHGGJFSA-N D05GKD DRUGSMIL CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O D05GKD HIGHSTAT Approved D05GPO DRUG__ID D05GPO D05GPO DRUGCOMP Alcon D05GPO THERCLAS Antiallergic Agents D05GPO DRUGTYPE Small molecular drug D05GPO DRUGINCH 1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8- D05GPO DRUGINKE JBIMVDZLSHOPLA-LSCVHKIXSA-N D05GPO DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O D05GPO HIGHSTAT Approved D05HPI DRUG__ID D05HPI D05HPI DRUGCOMP Cubist Pharmaceuticals D05HPI THERCLAS Antibiotics D05HPI DRUGTYPE Small molecular drug D05HPI DRUGINCH 1S/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45+,46+,47+,48+,49+,50-,60+,61+/m1/s1 D05HPI DRUGINKE DOAKLVKFURWEDJ-RWDRXURGSA-N D05HPI DRUGSMIL CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C D05HPI HIGHSTAT Approved D05HXX DRUG__ID D05HXX D05HXX DRUGCOMP Daiichi Sankyo Pharma Development D05HXX THERCLAS Antifibrinolytic Agents D05HXX DRUGTYPE Small molecular drug D05HXX DRUGINCH 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11) D05HXX DRUGINKE GYDJEQRTZSCIOI-UHFFFAOYSA-N D05HXX DRUGSMIL C1CC(CCC1CN)C(=O)O D05HXX HIGHSTAT Approved D05JDR DRUG__ID D05JDR D05JDR DRUGCOMP Shionogi USA D05JDR THERCLAS Antibiotics D05JDR DRUGTYPE Small molecular drug D05JDR DRUGINCH 1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1 D05JDR DRUGINKE UNJFKXSSGBWRBZ-BJCIPQKHSA-N D05JDR DRUGSMIL C1C=C(N2C(S1)C(C2=O)NC(=O)C(=CCC(=O)O)C3=CSC(=N3)N)C(=O)O D05JDR HIGHSTAT Approved D05KON DRUG__ID D05KON D05KON DRUGCOMP MedPointe D05KON THERCLAS Antiepileptic Agents D05KON DRUGTYPE Small molecular drug D05KON DRUGINCH 1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15) D05KON DRUGINKE WKGXYQFOCVYPAC-UHFFFAOYSA-N D05KON DRUGSMIL C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N D05KON HIGHSTAT Approved D05LEO DRUG__ID D05LEO D05LEO DRUGCOMP Hoffmann-La Roche pharmaceutical company D05LEO THERCLAS Immunosuppressive Agents D05LEO DRUGTYPE Small molecular drug D05LEO DRUGINCH 1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) D05LEO DRUGINKE GHASVSINZRGABV-UHFFFAOYSA-N D05LEO DRUGSMIL C1=C(C(=O)NC(=O)N1)F D05LEO HIGHSTAT Approved D05LKP DRUG__ID D05LKP D05LKP DRUGCOMP Lilly D05LKP THERCLAS Antiinfective Agents D05LKP DRUGTYPE Small molecular drug D05LKP DRUGINCH 1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14) D05LKP DRUGINKE SEEPANYCNGTZFQ-UHFFFAOYSA-N D05LKP DRUGSMIL C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N D05LKP HIGHSTAT Approved D05LQX DRUG__ID D05LQX D05LQX TRADNAME Vyzulta D05LQX DRUGCOMP Bausch and Lomb/Valeant Pharmaceuticals D05LQX DRUGTYPE Small molecular drug D05LQX DRUGINCH 1S/C27H41NO8/c29-22(15-14-21-10-4-3-5-11-21)16-17-24-23(25(30)20-26(24)31)12-6-1-2-7-13-27(32)35-18-8-9-19-36-28(33)34/h1,3-6,10-11,22-26,29-31H,2,7-9,12-20H2/b6-1-/t22-,23+,24+,25-,26+/m0/s1 D05LQX DRUGINKE LOVMMUBRQUFEAH-UIEAZXIASA-N D05LQX DRUGSMIL C1C(C(C(C1O)CC=CCCCC(=O)OCCCCO[N+](=O)[O-])CCC(CCC2=CC=CC=C2)O)O D05LQX HIGHSTAT Approved D05LYX DRUG__ID D05LYX D05LYX DRUGCOMP Nigerian-German Chemicals D05LYX THERCLAS Hypoglycemic Agents D05LYX DRUGTYPE Small molecular drug D05LYX DRUGINCH 1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29) D05LYX DRUGINKE ZNNLBTZKUZBEKO-UHFFFAOYSA-N D05LYX DRUGSMIL COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 D05LYX HIGHSTAT Approved D05MBZ DRUG__ID D05MBZ D05MBZ DRUGCOMP Yamanouchi Pharmaceuticals D05MBZ THERCLAS Anticancer Agents D05MBZ DRUGTYPE Small molecular drug D05MBZ DRUGINCH 1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1 D05MBZ DRUGINKE DRHKJLXJIQTDTD-OAHLLOKOSA-N D05MBZ DRUGSMIL CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N D05MBZ HIGHSTAT Approved D05MFA DRUG__ID D05MFA D05MFA DRUGCOMP Glaxosmithkline D05MFA THERCLAS Antiinfective Agents D05MFA DRUGTYPE Small molecular drug D05MFA DRUGINCH 1S/C13H20N6O4.ClH/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20;/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20);1H/t8-;/m0./s1 D05MFA DRUGINKE ZCDDBUOENGJMLV-QRPNPIFTSA-N D05MFA DRUGSMIL CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N.Cl D05MFA HIGHSTAT Approved D05MQK DRUG__ID D05MQK D05MQK DRUGCOMP Eli Lilly D05MQK THERCLAS Antiimpotence Agents D05MQK DRUGTYPE Small molecular drug D05MQK DRUGINCH 1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1 D05MQK DRUGINKE WOXKDUGGOYFFRN-IIBYNOLFSA-N D05MQK DRUGSMIL CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36 D05MQK HIGHSTAT Approved D05NOS DRUG__ID D05NOS D05NOS DRUGCOMP Bristol-Myers Squibb D05NOS THERCLAS Antipsychotic Agents D05NOS DRUGTYPE Small molecular drug D05NOS DRUGINCH 1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3 D05NOS DRUGINKE XSCGXQMFQXDFCW-UHFFFAOYSA-N D05NOS DRUGSMIL CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F D05NOS HIGHSTAT Approved D05OFX DRUG__ID D05OFX D05OFX DRUGCOMP Schwarz Pharma D05OFX THERCLAS Analgesics D05OFX DRUGTYPE Small molecular drug D05OFX DRUGINCH 1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1 D05OFX DRUGINKE VPPJLAIAVCUEMN-GFCCVEGCSA-N D05OFX DRUGSMIL CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1 D05OFX HIGHSTAT Approved D05PIZ DRUG__ID D05PIZ D05PIZ DRUGCOMP Roxane Laboratories D05PIZ THERCLAS Analgesics D05PIZ DRUGTYPE Small molecular drug D05PIZ DRUGINCH 1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m0/s1 D05PIZ DRUGINKE XBMIVRRWGCYBTQ-AVRDEDQJSA-N D05PIZ DRUGSMIL CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C D05PIZ HIGHSTAT Approved D05RHI DRUG__ID D05RHI D05RHI DRUGCOMP Monarch Pharmaceuticals D05RHI THERCLAS Antiviral Agents D05RHI DRUGTYPE Small molecular drug D05RHI DRUGINCH 1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1 D05RHI DRUGINKE VSQQQLOSPVPRAZ-RRKCRQDMSA-N D05RHI DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O D05RHI HIGHSTAT Approved D05SBO DRUG__ID D05SBO D05SBO TRADNAME Verzenio D05SBO DRUGCOMP Eli Lilly D05SBO DRUGTYPE Small molecular drug D05SBO DRUGINCH 1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34) D05SBO DRUGINKE UZWDCWONPYILKI-UHFFFAOYSA-N D05SBO DRUGSMIL CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F D05SBO HIGHSTAT Approved D05SHK DRUG__ID D05SHK D05SHK DRUGCOMP Apotex Inc D05SHK THERCLAS Antihypertensive Agents D05SHK DRUGTYPE Small molecular drug D05SHK DRUGINCH 1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1 D05SHK DRUGINKE VWPOSFSPZNDTMJ-UCWKZMIHSA-N D05SHK DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O D05SHK HIGHSTAT Approved D05TIB DRUG__ID D05TIB D05TIB DRUGCOMP Allergan Pharmaceuticals D05TIB THERCLAS Parasympatholytics D05TIB DRUGTYPE Small molecular drug D05TIB DRUGINCH 1S/C25H30NO3/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26/h1-6,9-12,21-23,28H,7-8,13-18H2/q+1/t21-,22+,23? D05TIB DRUGINKE OYYDSUSKLWTMMQ-AIZNXBIQSA-N D05TIB DRUGSMIL C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O D05TIB HIGHSTAT Approved D05UBX DRUG__ID D05UBX D05UBX DRUGCOMP Pharmacia And Upjohn Co D05UBX THERCLAS Antibiotics D05UBX DRUGTYPE Small molecular drug D05UBX DRUGINCH 1S/C15H17N7O5S3/c1-21-14(18-19-20-21)30-6-8-5-29-13-15(27-2,17-9(23)7-28-4-3-16)12(26)22(13)10(8)11(24)25/h13H,4-7H2,1-2H3,(H,17,23)(H,24,25)/t13-,15+/m1/s1 D05UBX DRUGINKE SNBUBQHDYVFSQF-HIFRSBDPSA-N D05UBX DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O D05UBX HIGHSTAT Approved D05UVD DRUG__ID D05UVD D05UVD DRUGCOMP Merck Frosst D05UVD THERCLAS Antiarrhythmic Agents D05UVD DRUGTYPE Small molecular drug D05UVD DRUGINCH 1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1 D05UVD DRUGINKE BLJRIMJGRPQVNF-JTQLQIEISA-N D05UVD DRUGSMIL CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O D05UVD HIGHSTAT Approved D05UYW DRUG__ID D05UYW D05UYW DRUGCOMP Merck & Co D05UYW THERCLAS Antihypertensive Agents D05UYW DRUGTYPE Small molecular drug D05UYW DRUGINCH 1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16)/t6-,8-/m0/s1 D05UYW DRUGINKE IAVUPMFITXYVAF-XPUUQOCRSA-N D05UYW DRUGSMIL CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C D05UYW HIGHSTAT Approved D05VIL DRUG__ID D05VIL D05VIL DRUGCOMP Eurohealth International Sarl D05VIL THERCLAS Anticraving Agents D05VIL DRUGTYPE Small molecular drug D05VIL DRUGINCH 1S/C21H25NO3/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13/h4-5,13,16,19,23-24H,1-3,6-11H2/t16-,19+,20+,21-/m1/s1 D05VIL DRUGINKE WJBLNOPPDWQMCH-MBPVOVBZSA-N D05VIL DRUGSMIL C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O D05VIL HIGHSTAT Approved D05VIX DRUG__ID D05VIX D05VIX DRUGCOMP Pfizer Pharmaceuticals D05VIX THERCLAS Antilipemic Agents D05VIX DRUGTYPE Small molecular drug D05VIX DRUGINCH 1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17) D05VIX DRUGINKE HEMJJKBWTPKOJG-UHFFFAOYSA-N D05VIX DRUGSMIL CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O D05VIX HIGHSTAT Approved D05VLS DRUG__ID D05VLS D05VLS DRUGCOMP Merck & Co D05VLS THERCLAS Antiinflammatory Agents D05VLS DRUGTYPE Small molecular drug D05VLS DRUGINCH 1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3 D05VLS DRUGINKE RZJQGNCSTQAWON-UHFFFAOYSA-N D05VLS DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3 D05VLS HIGHSTAT Approved D05ZIK DRUG__ID D05ZIK D05ZIK DRUGCOMP Organon International D05ZIK THERCLAS Antidepressants D05ZIK DRUGTYPE Small molecular drug D05ZIK DRUGINCH 1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3 D05ZIK DRUGINKE RONZAEMNMFQXRA-UHFFFAOYSA-N D05ZIK DRUGSMIL CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4 D05ZIK HIGHSTAT Approved D05ZTH DRUG__ID D05ZTH D05ZTH DRUGCOMP Actelion Pharmaceuticals D05ZTH THERCLAS Antihypertensive Agents D05ZTH DRUGTYPE Small molecular drug D05ZTH DRUGINCH 1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1 D05ZTH DRUGINKE HIFJCPQKFCZDDL-ACWOEMLNSA-N D05ZTH DRUGSMIL CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O D05ZTH HIGHSTAT Approved D05ZTJ DRUG__ID D05ZTJ D05ZTJ DRUGCOMP Merck And Co Inc D05ZTJ THERCLAS Neurology Agents D05ZTJ DRUGTYPE Small molecular drug D05ZTJ DRUGINCH 1S/C22H28N2O2.2ClH/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18;;/h3-11H,2,12-17,23H2,1H3;2*1H D05ZTJ DRUGINKE ZYTHLJLPPSSDIP-UHFFFAOYSA-N D05ZTJ DRUGSMIL CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3.Cl.Cl D05ZTJ HIGHSTAT Approved D06ABF DRUG__ID D06ABF D06ABF DRUGCOMP Schering-Plough Corporation D06ABF THERCLAS Antihistamines D06ABF DRUGTYPE Small molecular drug D06ABF DRUGINCH 1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3 D06ABF DRUGINKE JCCNYMKQOSZNPW-UHFFFAOYSA-N D06ABF DRUGSMIL CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1 D06ABF HIGHSTAT Approved D06AEO DRUG__ID D06AEO D06AEO DRUGCOMP Schering-Plough D06AEO THERCLAS Anticancer Agents D06AEO DRUGTYPE Small molecular drug D06AEO DRUGINCH 1S/C22H27ClO3/c1-11(24)22(26)7-5-14-12-9-18(23)17-10-19(25)13-8-16(13)21(17,3)15(12)4-6-20(14,22)2/h9-10,12-16,26H,4-8H2,1-3H3/t12-,13+,14-,15-,16-,20-,21-,22-/m0/s1 D06AEO DRUGINKE DUSHUSLJJMDGTE-ZJPMUUANSA-N D06AEO DRUGSMIL CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)O D06AEO HIGHSTAT Approved D06AWE DRUG__ID D06AWE D06AWE DRUGCOMP Reckitt; Colman D06AWE THERCLAS Analgesics D06AWE DRUGTYPE Small molecular drug D06AWE DRUGINCH 1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1 D06AWE DRUGINKE RMRJXGBAOAMLHD-IHFGGWKQSA-N D06AWE DRUGSMIL CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O D06AWE HIGHSTAT Approved D06BEP DRUG__ID D06BEP D06BEP DRUGCOMP Patheon Pharmaceuticals Inc D06BEP THERCLAS Antianxiety Agents D06BEP DRUGTYPE Small molecular drug D06BEP DRUGINCH 1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3 D06BEP DRUGINKE BUCORZSTKDOEKQ-UHFFFAOYSA-N D06BEP DRUGSMIL CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O D06BEP HIGHSTAT Approved D06CTE DRUG__ID D06CTE D06CTE DRUGCOMP INova Pharmaceuticals D06CTE THERCLAS Antiviral Agents D06CTE DRUGTYPE Small molecular drug D06CTE DRUGINCH 1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17) D06CTE DRUGINKE DOUYETYNHWVLEO-UHFFFAOYSA-N D06CTE DRUGSMIL CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N D06CTE HIGHSTAT Approved D06DLI DRUG__ID D06DLI D06DLI TRADNAME Radicava D06DLI DRUGCOMP Mitsubishi Tanabe D06DLI DRUGTYPE Small molecular drug D06DLI DRUGINCH 1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3 D06DLI DRUGINKE QELUYTUMUWHWMC-UHFFFAOYSA-N D06DLI DRUGSMIL CC1=NN(C(=O)C1)C2=CC=CC=C2 D06DLI HIGHSTAT Approved D06FDR DRUG__ID D06FDR D06FDR DRUGCOMP Bristol-Myers Squibb D06FDR THERCLAS Anti-HIV Agents D06FDR DRUGTYPE Small molecular drug D06FDR DRUGINCH 1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1 D06FDR DRUGINKE BXZVVICBKDXVGW-NKWVEPMBSA-N D06FDR DRUGSMIL C1CC(OC1CO)N2C=NC3=C2N=CNC3=O D06FDR HIGHSTAT Approved D06FEA DRUG__ID D06FEA D06FEA DRUGCOMP Pfizer Pharmaceuticals D06FEA THERCLAS Prostaglandins D06FEA DRUGTYPE Small molecular drug D06FEA DRUGINCH 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1 D06FEA DRUGINKE XEYBRNLFEZDVAW-ARSRFYASSA-N D06FEA DRUGSMIL CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O D06FEA HIGHSTAT Approved D06FES DRUG__ID D06FES D06FES DRUGCOMP Pfizer Pharmaceuticals D06FES THERCLAS Antidepressants D06FES DRUGTYPE Small molecular drug D06FES DRUGINCH 1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11+ D06FES DRUGINKE ODQWQRRAPPTVAG-GZTJUZNOSA-N D06FES DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31 D06FES HIGHSTAT Approved D06FPQ DRUG__ID D06FPQ D06FPQ DRUGCOMP Vernalis D06FPQ THERCLAS Antimigraine Agents D06FPQ DRUGTYPE Small molecular drug D06FPQ DRUGINCH 1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1 D06FPQ DRUGINKE XPSQPHWEGNHMSK-SECBINFHSA-N D06FPQ DRUGSMIL CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N D06FPQ HIGHSTAT Approved D06FWC DRUG__ID D06FWC D06FWC DRUGCOMP Dainippon Sumitomo Pharma D06FWC THERCLAS Antianxiety Agents D06FWC DRUGTYPE Small molecular drug D06FWC DRUGINCH 1S/C16H12ClFN2O/c1-20-14-7-6-10(17)8-12(14)16(19-9-15(20)21)11-4-2-3-5-13(11)18/h2-8H,9H2,1H3 D06FWC DRUGINKE ROYOYTLGDLIGBX-UHFFFAOYSA-N D06FWC DRUGSMIL CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F D06FWC HIGHSTAT Approved D06GBQ DRUG__ID D06GBQ D06GBQ DRUGCOMP Hoffmann-La Roche pharmaceutical company D06GBQ THERCLAS Anti-HIV Agents D06GBQ DRUGTYPE Small molecular drug D06GBQ DRUGINCH 1S/C206H304N52O66/c1-20-103(15)168(254-197(315)137(75-101(11)12)239-202(320)151(94-261)252-192(310)143(82-113-90-216-96-221-113)249-205(323)169(104(16)21-2)255-198(316)138(76-102(13)14)240-203(321)152(95-262)253-206(324)170(106(18)263)256-199(317)148(258-257-107(19)264)78-109-45-47-114(265)48-46-109)204(322)234-132(58-68-165(283)284)180(298)229-131(57-67-164(281)282)184(302)251-150(93-260)200(318)233-126(52-62-156(212)269)181(299)246-145(84-158(214)271)193(311)230-125(51-61-155(211)268)177(295)225-123(49-59-153(209)266)175(293)227-127(53-63-160(273)274)178(296)223-121(43-31-33-69-207)174(292)245-144(83-157(213)270)194(312)232-128(54-64-161(275)276)179(297)226-124(50-60-154(210)267)176(294)228-129(55-65-162(277)278)182(300)235-134(72-98(5)6)187(305)237-133(71-97(3)4)186(304)231-130(56-66-163(279)280)183(301)236-135(73-99(7)8)189(307)248-147(86-166(285)286)196(314)224-122(44-32-34-70-208)173(291)242-140(79-110-87-217-118-40-28-25-37-115(110)118)185(303)222-105(17)171(289)250-149(92-259)201(319)238-136(74-100(9)10)188(306)243-142(81-112-89-219-120-42-30-27-39-117(112)120)191(309)247-146(85-159(215)272)195(313)244-141(80-111-88-218-119-41-29-26-38-116(111)119)190(308)241-139(172(290)220-91-167(287)288)77-108-35-23-22-24-36-108/h22-30,35-42,45-48,87-90,96-106,121-152,168-170,217-219,258-263,265H,20-21,31-34,43-44,49-86,91-95,207-208H2,1-19H3,(H2,209,266)(H2,210,267)(H2,211,268)(H2,212,269)(H2,213,270)(H2,214,271)(H2,215,272)(H,216,221)(H,220,290)(H,222,303)(H,223,296)(H,224,314)(H,225,295)(H,226,297)(H,227,293)(H,228,294)(H,229,298)(H,230,311)(H,231,304)(H,232,312)(H,233,318)(H,234,322)(H,235,300)(H,236,301)(H,237,305)(H,238,319)(H,239,320)(H,240,321)(H,241,308)(H,242,291)(H,243,306)(H,244,313)(H,245,292)(H,246,299)(H,247,309)(H,248,307)(H,249,323)(H,250,289)(H,251,302)(H,252,310)(H,253,324)(H,254,315)(H,255,316)(H,256,317)(H,257,264)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)/t103-,104-,105-,106+,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,168-,169-,170-/m0/s1 D06GBQ DRUGINKE BWVBEUNZTQWGMR-CKVIKZOTSA-N D06GBQ DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)NCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NNC(=O)C D06GBQ HIGHSTAT Approved D06GDY DRUG__ID D06GDY D06GDY DRUGCOMP GlaxoSmithKline D06GDY THERCLAS Antidepressants D06GDY DRUGTYPE Small molecular drug D06GDY DRUGINCH 1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1 D06GDY DRUGINKE AHOUBRCZNHFOSL-YOEHRIQHSA-N D06GDY DRUGSMIL C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4 D06GDY HIGHSTAT Approved D06GKN DRUG__ID D06GKN D06GKN DRUGCOMP Prometheus Laboratories Inc D06GKN THERCLAS Gastrointestinal Agents D06GKN DRUGTYPE Small molecular drug D06GKN DRUGINCH 1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19) D06GKN DRUGINKE JSWZEAMFRNKZNL-UHFFFAOYSA-N D06GKN DRUGSMIL CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C D06GKN HIGHSTAT Approved D06GWF DRUG__ID D06GWF D06GWF DRUGCOMP Roche Laboratories Inc D06GWF THERCLAS Antiviral Agents D06GWF DRUGTYPE Small molecular drug D06GWF DRUGINCH 1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8?,9-/m0/s1 D06GWF DRUGINKE WPVFJKSGQUFQAP-GKAPJAKFSA-N D06GWF DRUGSMIL CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N D06GWF HIGHSTAT Approved D06HBQ DRUG__ID D06HBQ D06HBQ DRUGCOMP Boehriger Ingelheim D06HBQ THERCLAS Hypoglycemic Agents D06HBQ DRUGTYPE Small molecular drug D06HBQ DRUGINCH 1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33) D06HBQ DRUGINKE LLJFMFZYVVLQKT-UHFFFAOYSA-N D06HBQ DRUGSMIL CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C D06HBQ HIGHSTAT Approved D06HLY DRUG__ID D06HLY D06HLY DRUGCOMP Alcon Laboratories D06HLY THERCLAS Cholinergic Agents D06HLY DRUGTYPE Small molecular drug D06HLY DRUGINCH 1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1 D06HLY DRUGINKE QCHFTSOMWOSFHM-WPRPVWTQSA-N D06HLY DRUGSMIL CCC1C(COC1=O)CC2=CN=CN2C D06HLY HIGHSTAT Approved D06IAQ DRUG__ID D06IAQ D06IAQ DRUGCOMP Sanofi Aventis Us Llc D06IAQ THERCLAS Antiarrhythmic Agents D06IAQ DRUGTYPE Small molecular drug D06IAQ DRUGINCH 1S/C28H40Cl2N4O2/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30/h9-16H,5-8,17-22H2,1-4H3/p+2 D06IAQ DRUGINKE OMHBPUNFVFNHJK-UHFFFAOYSA-P D06IAQ DRUGSMIL CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl D06IAQ HIGHSTAT Approved D06IGU DRUG__ID D06IGU D06IGU DRUGCOMP Bayer Pharmaceuticals Corporation D06IGU THERCLAS Antibiotics D06IGU DRUGTYPE Small molecular drug D06IGU DRUGINCH 1S/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20+,21-,22+,23+,24+,25+,26-,30-,31-,32-,33-,34-,35-,36-,37+,40-,41+/m0/s1 D06IGU DRUGINKE LQCLVBQBTUVCEQ-QTFUVMRISA-N D06IGU DRUGSMIL CC1CC(C(C(O1)OC2C(CC3(CO3)C(=O)C(C(C(C(OC(=O)C(C(C2C)OC4CC(C(C(O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C D06IGU HIGHSTAT Approved D06JPB DRUG__ID D06JPB D06JPB DRUGCOMP Eli Lilly D06JPB THERCLAS Vitamins D06JPB DRUGTYPE Small molecular drug D06JPB DRUGINCH 1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1 D06JPB DRUGINKE MECHNRXZTMCUDQ-RKHKHRCZSA-N D06JPB DRUGSMIL CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C D06JPB HIGHSTAT Approved D06KKS DRUG__ID D06KKS D06KKS DRUGCOMP Kent Pharms D06KKS THERCLAS Antibiotics D06KKS DRUGTYPE Small molecular drug D06KKS DRUGINCH 1S/C16H19N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1 D06KKS DRUGINKE RDLPVSKMFDYCOR-UEKVPHQBSA-N D06KKS DRUGSMIL CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O D06KKS HIGHSTAT Approved D06LYG DRUG__ID D06LYG D06LYG DRUGCOMP Astrazeneca Lp D06LYG THERCLAS Anesthetics D06LYG DRUGTYPE Small molecular drug D06LYG DRUGINCH 1S/C13H20N2O/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2/h5-8,11,14H,4,9H2,1-3H3,(H,15,16) D06LYG DRUGINKE MVFGUOIZUNYYSO-UHFFFAOYSA-N D06LYG DRUGSMIL CCCNC(C)C(=O)NC1=CC=CC=C1C D06LYG HIGHSTAT Approved D06NSS DRUG__ID D06NSS D06NSS DRUGCOMP Zambon Group D06NSS THERCLAS Antiasthmatic Agents D06NSS DRUGTYPE Small molecular drug D06NSS DRUGINCH 1S/C23H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30) D06NSS DRUGINKE IMZMKUWMOSJXDT-UHFFFAOYSA-N D06NSS DRUGSMIL C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O D06NSS HIGHSTAT Approved D06NXY DRUG__ID D06NXY D06NXY DRUGCOMP Schering-Plough D06NXY THERCLAS Estrogens D06NXY DRUGTYPE Small molecular drug D06NXY DRUGINCH 1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1 D06NXY DRUGINKE BFPYWIDHMRZLRN-SLHNCBLASA-N D06NXY DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O D06NXY HIGHSTAT Approved D06OIV DRUG__ID D06OIV D06OIV DRUGCOMP Pharmacia And Upjohn Co D06OIV THERCLAS Hypoglycemic Agents D06OIV DRUGTYPE Small molecular drug D06OIV DRUGINCH 1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15) D06OIV DRUGINKE JLRGJRBPOGGCBT-UHFFFAOYSA-N D06OIV DRUGSMIL CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C D06OIV HIGHSTAT Approved D06OMK DRUG__ID D06OMK D06OMK DRUGCOMP Fujisawa; Sucampo D06OMK THERCLAS Immunosuppressive Agents D06OMK DRUGTYPE Small molecular drug D06OMK DRUGINCH 1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1 D06OMK DRUGINKE QJJXYPPXXYFBGM-LFZNUXCKSA-N D06OMK DRUGSMIL CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC D06OMK HIGHSTAT Approved D06OMW DRUG__ID D06OMW D06OMW DRUGCOMP Teva Pharmaceutical Industries Ltd D06OMW THERCLAS Antiparkinson Agents D06OMW DRUGTYPE Small molecular drug D06OMW DRUGINCH 1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1 D06OMW DRUGINKE RUOKEQAAGRXIBM-GFCCVEGCSA-N D06OMW DRUGSMIL C#CCNC1CCC2=CC=CC=C12 D06OMW HIGHSTAT Approved D06OVY DRUG__ID D06OVY D06OVY DRUGCOMP Wyeth Pharmaceuticals D06OVY THERCLAS Antibiotics D06OVY DRUGTYPE Small molecular drug D06OVY DRUGINCH 1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1 D06OVY DRUGINKE OKBVVJOGVLARMR-QSWIMTSFSA-N D06OVY DRUGSMIL C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O D06OVY HIGHSTAT Approved D06PSS DRUG__ID D06PSS D06PSS DRUGCOMP Norvatis Phamaceuticals Corporation D06PSS THERCLAS Hypoglycemic Agents D06PSS DRUGTYPE Small molecular drug D06PSS DRUGINCH 1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1 D06PSS DRUGINKE OELFLUMRDSZNSF-OFLPRAFFSA-N D06PSS DRUGSMIL CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O D06PSS HIGHSTAT Approved D06RCB DRUG__ID D06RCB D06RCB DRUGCOMP Lederle Laboratories Div American Cyanamid Co D06RCB THERCLAS Anthelmintics D06RCB DRUGTYPE Small molecular drug D06RCB DRUGINCH 1S/C10H21N3O/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13/h4-9H2,1-3H3 D06RCB DRUGINKE RCKMWOKWVGPNJF-UHFFFAOYSA-N D06RCB DRUGSMIL CCN(CC)C(=O)N1CCN(CC1)C D06RCB HIGHSTAT Approved D06RGG DRUG__ID D06RGG D06RGG DRUGCOMP Abbott Laboratories D06RGG THERCLAS Antithyroid Agents D06RGG DRUGTYPE Small molecular drug D06RGG DRUGINCH 1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1 D06RGG DRUGINKE XUIIKFGFIJCVMT-LBPRGKRZSA-N D06RGG DRUGSMIL C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N D06RGG HIGHSTAT Approved D06TOE DRUG__ID D06TOE D06TOE DRUGCOMP Astellas Pharma D06TOE THERCLAS Antifungal Agents D06TOE DRUGTYPE Small molecular drug D06TOE DRUGINCH 1S/C56H71N9O23S/c1-4-5-6-17-86-32-14-11-28(12-15-32)39-21-33(63-87-39)27-7-9-29(10-8-27)49(75)58-34-20-38(70)52(78)62-54(80)45-46(72)25(2)23-65(45)56(82)43(37(69)22-41(57)71)60-53(79)44(48(74)47(73)30-13-16-36(68)40(18-30)88-89(83,84)85)61-51(77)35-19-31(67)24-64(35)55(81)42(26(3)66)59-50(34)76/h7-16,18,21,25-26,31,34-35,37-38,42-48,52,66-70,72-74,78H,4-6,17,19-20,22-24H2,1-3H3,(H2,57,71)(H,58,75)(H,59,76)(H,60,79)(H,61,77)(H,62,80)(H,83,84,85)/t25-,26+,31+,34-,35-,37+,38+,42-,43-,44-,45-,46-,47-,48-,52+/m0/s1 D06TOE DRUGINKE PIEUQSKUWLMALL-YABMTYFHSA-N D06TOE DRUGSMIL CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O D06TOE HIGHSTAT Approved D06TQZ DRUG__ID D06TQZ D06TQZ DRUGCOMP Beecham phamaceuticals D06TQZ THERCLAS Antibiotics D06TQZ DRUGTYPE Small molecular drug D06TQZ DRUGINCH 1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1 D06TQZ DRUGINKE RJQXTJLFIWVMTO-TYNCELHUSA-N D06TQZ DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C D06TQZ HIGHSTAT Approved D06UDG DRUG__ID D06UDG D06UDG DRUGCOMP Norvatis Phamaceuticals Corporation D06UDG THERCLAS Antihypertensive Agents D06UDG DRUGTYPE Small molecular drug D06UDG DRUGINCH 1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 D06UDG DRUGINKE ACWBQPMHZXGDFX-QFIPXVFZSA-N D06UDG DRUGSMIL CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O D06UDG HIGHSTAT Approved D06UDO DRUG__ID D06UDO D06UDO DRUGCOMP Amarin Pharmaceuticals D06UDO THERCLAS Antihistamines D06UDO DRUGTYPE Small molecular drug D06UDO DRUGINCH 1S/C19H19N/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14/h2-10,19H,11-13H2,1H3 D06UDO DRUGINKE ISFHAYSTHMVOJR-UHFFFAOYSA-N D06UDO DRUGSMIL CN1CCC2=C(C1)C(C3=CC=CC=C23)C4=CC=CC=C4 D06UDO HIGHSTAT Approved D06UVD DRUG__ID D06UVD D06UVD DRUGCOMP Bristol-Myers Squibb D06UVD THERCLAS Anticancer Agents D06UVD DRUGTYPE Small molecular drug D06UVD DRUGINCH 1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1/t21-,22+,23+,24-,25-,29?,30?,34-,35-,36-,37?,38?,39?,40?,41-,42?,43?,53?,54?/m0/s1 D06UVD DRUGINKE OYVAGSVQBOHSSS-WXFSZRTFSA-O D06UVD DRUGSMIL CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O D06UVD HIGHSTAT Approved D06WTZ DRUG__ID D06WTZ D06WTZ DRUGCOMP Atos Pharma D06WTZ THERCLAS Anticholesteremic Agents D06WTZ DRUGTYPE Small molecular drug D06WTZ DRUGINCH 1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1 D06WTZ DRUGINKE PCZOHLXUXFIOCF-BXMDZJJMSA-N D06WTZ DRUGSMIL CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C D06WTZ HIGHSTAT Approved D06XXH DRUG__ID D06XXH D06XXH TRADNAME Vizimpro D06XXH DRUGCOMP Pfizer D06XXH DRUGTYPE Small molecular drug D06XXH DRUGINCH 1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+ D06XXH DRUGINKE LVXJQMNHJWSHET-AATRIKPKSA-N D06XXH DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4 D06XXH HIGHSTAT Approved D06XZW DRUG__ID D06XZW D06XZW DRUGCOMP Daiichi Sankyo Pharma Development D06XZW THERCLAS Antiinflammatory Agents D06XZW DRUGTYPE Small molecular drug D06XZW DRUGINCH 1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28) D06XZW DRUGINKE GXPHKUHSUJUWKP-UHFFFAOYSA-N D06XZW DRUGSMIL CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C D06XZW HIGHSTAT Approved D06YFA DRUG__ID D06YFA D06YFA DRUGCOMP Norvatis Phamaceuticals Corporation D06YFA THERCLAS Antiparkinson Agents D06YFA DRUGTYPE Small molecular drug D06YFA DRUGINCH 1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1 D06YFA DRUGINKE OZVBMTJYIDMWIL-AYFBDAFISA-N D06YFA DRUGSMIL CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O D06YFA HIGHSTAT Approved D06YHL DRUG__ID D06YHL D06YHL DRUGCOMP Eli Lilly D06YHL THERCLAS Antibiotics D06YHL DRUGTYPE Small molecular drug D06YHL DRUGINCH 1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29)/t11-,13-,16-/m1/s1 D06YHL DRUGINKE OLVCFLKTBJRLHI-AXAPSJFSSA-N D06YHL DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(C4=CC=CC=C4)O)SC2)C(=O)O D06YHL HIGHSTAT Approved D06ZEE DRUG__ID D06ZEE D06ZEE DRUGCOMP GlaxoSmithKline D06ZEE THERCLAS Antifungal Agents D06ZEE DRUGTYPE Small molecular drug D06ZEE DRUGINCH 1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,24H,5-8H2 D06ZEE DRUGINKE BSJMWHQBCZFXBR-UHFFFAOYSA-N D06ZEE DRUGSMIL C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O D06ZEE HIGHSTAT Approved D06ZII DRUG__ID D06ZII D06ZII DRUGCOMP GSK D06ZII THERCLAS Hypnotics and Sedatives D06ZII DRUGTYPE Small molecular drug D06ZII DRUGINCH 1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1 D06ZII DRUGINKE GBBSUAFBMRNDJC-INIZCTEOSA-N D06ZII DRUGSMIL CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl D06ZII HIGHSTAT Approved D06ZUK DRUG__ID D06ZUK D06ZUK DRUGCOMP Novartis Pharmaceuticals Corp D06ZUK THERCLAS Antidepressants D06ZUK DRUGTYPE Small molecular drug D06ZUK DRUGINCH 1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3 D06ZUK DRUGINKE BCGWQEUPMDMJNV-UHFFFAOYSA-N D06ZUK DRUGSMIL CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31 D06ZUK HIGHSTAT Approved D07ABV DRUG__ID D07ABV D07ABV DRUGCOMP Schering-Plough D07ABV THERCLAS Antifungal Agents D07ABV DRUGTYPE Small molecular drug D07ABV DRUGINCH 1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1 D07ABV DRUGINKE RAGOYPUPXAKGKH-XAKZXMRKSA-N D07ABV DRUGSMIL CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F D07ABV HIGHSTAT Approved D07ACT DRUG__ID D07ACT D07ACT DRUGCOMP Hoffmann-La Roche pharmaceutical company D07ACT THERCLAS Antibiotics D07ACT DRUGTYPE Small molecular drug D07ACT DRUGINCH 1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9-,15-/m1/s1 D07ACT DRUGINKE VAAUVRVFOQPIGI-SPQHTLEESA-N D07ACT DRUGSMIL CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O D07ACT HIGHSTAT Approved D07BCT DRUG__ID D07BCT D07BCT DRUGCOMP Bausch & Lomb Pharmaceuticals, Inc. D07BCT THERCLAS Antibiotics D07BCT DRUGTYPE Small molecular drug D07BCT DRUGINCH 1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1 D07BCT DRUGINKE NLVFBUXFDBBNBW-PBSUHMDJSA-N D07BCT DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N D07BCT HIGHSTAT Approved D07CPU DRUG__ID D07CPU D07CPU DRUGCOMP Sanofi-Aventis D07CPU THERCLAS Antiinfective Agents D07CPU DRUGTYPE Small molecular drug D07CPU DRUGINCH 1S/C17H14N2O3/c1-2-19-10-14(17(21)22)16(20)13-4-3-12(9-15(13)19)11-5-7-18-8-6-11/h3-10H,2H2,1H3,(H,21,22) D07CPU DRUGINKE XBPZXDSZHPDXQU-UHFFFAOYSA-N D07CPU DRUGSMIL CCN1C=C(C(=O)C2=C1C=C(C=C2)C3=CC=NC=C3)C(=O)O D07CPU HIGHSTAT Approved D07DVK DRUG__ID D07DVK D07DVK DRUGCOMP Shire Pharmaceuticals D07DVK THERCLAS Antiasthmatic Agents D07DVK DRUGTYPE Small molecular drug D07DVK DRUGINCH 1S/C22H29ClO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1 D07DVK DRUGINKE NBMKJKDGKREAPL-DVTGEIKXSA-N D07DVK DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C D07DVK HIGHSTAT Approved D07FEC DRUG__ID D07FEC D07FEC TRADNAME Trulance D07FEC DRUGCOMP Synergy Pharmaceuticals D07FEC DRUGTYPE Small molecular drug D07FEC DRUGINCH 1S/C65H104N18O26S4/c1-25(2)15-34-55(98)80-41-24-113-110-21-38(58(101)77-37(65(108)109)16-26(3)4)71-44(87)20-69-62(105)50(30(10)84)83-61(104)40(78-51(94)29(9)70-63(106)48(27(5)6)81-57(100)35(18-43(68)86)76-64(107)49(28(7)8)82-60(41)103)23-112-111-22-39(59(102)73-32(53(96)75-34)11-13-45(88)89)79-54(97)33(12-14-46(90)91)72-56(99)36(19-47(92)93)74-52(95)31(66)17-42(67)85/h25-41,48-50,84H,11-24,66H2,1-10H3,(H2,67,85)(H2,68,86)(H,69,105)(H,70,106)(H,71,87)(H,72,99)(H,73,102)(H,74,95)(H,75,96)(H,76,107)(H,77,101)(H,78,94)(H,79,97)(H,80,98)(H,81,100)(H,82,103)(H,83,104)(H,88,89)(H,90,91)(H,92,93)(H,108,109)/t29-,30+,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,48-,49-,50-/m0/s1 D07FEC DRUGINKE NSPHQWLKCGGCQR-DLJDZFDSSA-N D07FEC DRUGSMIL CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N D07FEC HIGHSTAT Approved D07HGR DRUG__ID D07HGR D07HGR DRUGCOMP Merck & Co D07HGR THERCLAS Antihypertensive Agents D07HGR DRUGTYPE Small molecular drug D07HGR DRUGINCH 1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1 D07HGR DRUGINKE RLAWWYSOJDYHDC-BZSNNMDCSA-N D07HGR DRUGSMIL C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O D07HGR HIGHSTAT Approved D07HOB DRUG__ID D07HOB D07HOB DRUGCOMP Pfizer Pharmaceuticals D07HOB THERCLAS Anticancer Agents D07HOB DRUGTYPE Small molecular drug D07HOB DRUGINCH 1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1 D07HOB DRUGINKE UWKQSNNFCGGAFS-XIFFEERXSA-N D07HOB DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7 D07HOB HIGHSTAT Approved D07HQC DRUG__ID D07HQC D07HQC DRUGCOMP Cephalon Inc D07HQC THERCLAS Neurology Agents D07HQC DRUGTYPE Small molecular drug D07HQC DRUGINCH 1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17) D07HQC DRUGINKE YFGHCGITMMYXAQ-UHFFFAOYSA-N D07HQC DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N D07HQC HIGHSTAT Approved D07INL DRUG__ID D07INL D07INL TRADNAME Brexafemme D07INL DRUGCOMP Scynexis D07INL DRUGTYPE Small molecular drug D07INL DRUGINCH 1S/C44H67N5O4/c1-27(2)28(3)39(7)18-19-41(9)30-12-13-33-40(8)23-52-25-44(33,31(30)14-17-42(41,10)34(39)37(50)51)22-32(35(40)53-24-43(11,45)38(4,5)6)49-36(47-26-48-49)29-15-20-46-21-16-29/h14-16,20-21,26-28,30,32-35H,12-13,17-19,22-25,45H2,1-11H3,(H,50,51)/t28-,30+,32-,33+,34-,35+,39-,40-,41-,42+,43+,44+/m1/s1 D07INL DRUGINKE BODYFEUFKHPRCK-ZCZMVWJSSA-N D07INL DRUGSMIL CC(C)C(C)C1(CCC2(C3CCC4C5(COCC4(C3=CCC2(C1C(=O)O)C)CC(C5OCC(C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C D07INL HIGHSTAT Approved D07IQS DRUG__ID D07IQS D07IQS DRUGCOMP Bristol-Myers Squibb D07IQS THERCLAS Anti-HIV Agents D07IQS DRUGTYPE Small molecular drug D07IQS DRUGINCH 1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1 D07IQS DRUGINKE AXRYRYVKAWYZBR-GASGPIRDSA-N D07IQS DRUGSMIL CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC D07IQS HIGHSTAT Approved D07JHH DRUG__ID D07JHH D07JHH DRUGCOMP Johnson And Johnson Consumer Companies Inc D07JHH THERCLAS Antibiotics D07JHH DRUGTYPE Small molecular drug D07JHH DRUGINCH 1S/C22H21ClN2O8/c1-6-9-7(23)4-5-8(26)11(9)16(27)12-10(6)17(28)14-15(25(2)3)18(29)13(21(24)32)20(31)22(14,33)19(12)30/h4-5,10,14-15,17,26-28,31,33H,1H2,2-3H3,(H2,24,32)/t10-,14-,15+,17+,22+/m1/s1 D07JHH DRUGINKE RNIADBXQDMCFEN-IWVLMIASSA-N D07JHH DRUGSMIL CN(C)C1C2C(C3C(=C)C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O D07JHH HIGHSTAT Approved D07JVS DRUG__ID D07JVS D07JVS DRUGCOMP Eli Lilly D07JVS THERCLAS Antibiotics D07JVS DRUGTYPE Small molecular drug D07JVS DRUGINCH 1S/C15H21N3O7S/c1-7-6-26-12(18-10(7)14(22)23)11(15(24)25)17-9(19)5-3-2-4-8(16)13(20)21/h8,11-12H,1-6,16H2,(H,17,19)(H,20,21)(H,22,23)(H,24,25)/t8-,11+,12-/m1/s1 D07JVS DRUGINKE JGKXEMYIHDYWCZ-JFUSQASVSA-N D07JVS DRUGSMIL C=C1CSC(N=C1C(=O)O)C(C(=O)O)NC(=O)CCCCC(C(=O)O)N D07JVS HIGHSTAT Approved D07JZF DRUG__ID D07JZF D07JZF DRUGCOMP Abbott Laboratories D07JZF THERCLAS Antibiotics D07JZF DRUGTYPE Small molecular drug D07JZF DRUGINCH 1S/C21H41N5O7/c1-4-26-13-7-12(24)16(32-19-11(23)6-5-10(8-22)31-19)14(27)17(13)33-20-15(28)18(25-3)21(2,29)9-30-20/h5,11-20,25-29H,4,6-9,22-24H2,1-3H3/t11-,12+,13-,14+,15-,16-,17+,18-,19-,20-,21+/m1/s1 D07JZF DRUGINKE CIDUJQMULVCIBT-MQDUPKMGSA-N D07JZF DRUGSMIL CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N D07JZF HIGHSTAT Approved D07KSG DRUG__ID D07KSG D07KSG DRUGCOMP AstraZeneca plc D07KSG THERCLAS Anticancer Agents D07KSG DRUGTYPE Small molecular drug D07KSG DRUGINCH 1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25- D07KSG DRUGINKE NKANXQFJJICGDU-QPLCGJKRSA-N D07KSG DRUGSMIL CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 D07KSG HIGHSTAT Approved D07KYT DRUG__ID D07KYT D07KYT TRADNAME Vanflyta D07KYT DRUGCOMP Daiichi Sankyo D07KYT DRUGTYPE Small molecular drug D07KYT DRUGINCH 1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36) D07KYT DRUGINKE CVWXJKQAOSCOAB-UHFFFAOYSA-N D07KYT DRUGSMIL CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3 D07KYT HIGHSTAT Approved D07MOX DRUG__ID D07MOX D07MOX DRUGCOMP Bedford Laboratories D07MOX THERCLAS Vasoconstrictor Agents D07MOX DRUGTYPE Small molecular drug D07MOX DRUGINCH 1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1 D07MOX DRUGINKE SFLSHLFXELFNJZ-QMMMGPOBSA-N D07MOX DRUGSMIL C1=CC(=C(C=C1C(CN)O)O)O D07MOX HIGHSTAT Approved D07MVK DRUG__ID D07MVK D07MVK DRUGCOMP GlaxoSmithKline D07MVK THERCLAS Antimalarials D07MVK DRUGTYPE Small molecular drug D07MVK DRUGINCH 1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3 D07MVK DRUGINKE FOHHNHSLJDZUGQ-UHFFFAOYSA-N D07MVK DRUGSMIL CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O D07MVK HIGHSTAT Approved D07NAJ DRUG__ID D07NAJ D07NAJ DRUGCOMP Abbott Laboratories D07NAJ THERCLAS Anesthetics D07NAJ DRUGTYPE Small molecular drug D07NAJ DRUGINCH 1S/C13H19ClN2O2/c1-3-16(4-2)7-8-18-13(17)11-6-5-10(15)9-12(11)14/h5-6,9H,3-4,7-8,15H2,1-2H3 D07NAJ DRUGINKE VDANGULDQQJODZ-UHFFFAOYSA-N D07NAJ DRUGSMIL CCN(CC)CCOC(=O)C1=C(C=C(C=C1)N)Cl D07NAJ HIGHSTAT Approved D07POC DRUG__ID D07POC D07POC DRUGCOMP OSI Pharma D07POC THERCLAS Anticancer Agents D07POC DRUGTYPE Small molecular drug D07POC DRUGINCH 1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) D07POC DRUGINKE AAKJLRGGTJKAMG-UHFFFAOYSA-N D07POC DRUGSMIL COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC D07POC HIGHSTAT Approved D07QCE DRUG__ID D07QCE D07QCE DRUGCOMP GlaxoSmithKline D07QCE THERCLAS Immunosuppressive Agents D07QCE DRUGTYPE Small molecular drug D07QCE DRUGINCH 1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13) D07QCE DRUGINKE LMEKQMALGUDUQG-UHFFFAOYSA-N D07QCE DRUGSMIL CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-] D07QCE HIGHSTAT Approved D07RGW DRUG__ID D07RGW D07RGW DRUGCOMP Norvatis Phamaceuticals Corporation D07RGW THERCLAS Anticonvulsants D07RGW DRUGTYPE Small molecular drug D07RGW DRUGINCH 1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16) D07RGW DRUGINKE GMHKMTDVRCWUDX-UHFFFAOYSA-N D07RGW DRUGSMIL CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2 D07RGW HIGHSTAT Approved D07RYI DRUG__ID D07RYI D07RYI TRADNAME Parsabiv D07RYI DRUGCOMP Amgen/Kai Pharmaceuticals D07RYI DRUGTYPE Small molecular drug D07RYI DRUGINCH 1S/C38H73N21O10S2/c1-18(28(62)56-22(27(40)61)8-4-12-49-35(41)42)53-30(64)23(9-5-13-50-36(43)44)58-32(66)25(11-7-15-52-38(47)48)59-31(65)24(10-6-14-51-37(45)46)57-29(63)19(2)54-33(67)26(55-20(3)60)17-71-70-16-21(39)34(68)69/h18-19,21-26H,4-17,39H2,1-3H3,(H2,40,61)(H,53,64)(H,54,67)(H,55,60)(H,56,62)(H,57,63)(H,58,66)(H,59,65)(H,68,69)(H4,41,42,49)(H4,43,44,50)(H4,45,46,51)(H4,47,48,52)/t18-,19-,21+,22-,23-,24-,25-,26-/m1/s1 D07RYI DRUGINKE ANIAZGVDEUQPRI-ZJQCGQFWSA-N D07RYI DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CSSCC(C(=O)O)N)NC(=O)C D07RYI HIGHSTAT Approved D07SUG DRUG__ID D07SUG D07SUG DRUGCOMP GlaxoSmithKline D07SUG THERCLAS Anticancer Agents D07SUG DRUGTYPE Small molecular drug D07SUG DRUGINCH 1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3 D07SUG DRUGINKE COVZYZSDYWQREU-UHFFFAOYSA-N D07SUG DRUGSMIL CS(=O)(=O)OCCCCOS(=O)(=O)C D07SUG HIGHSTAT Approved D07SYJ DRUG__ID D07SYJ D07SYJ DRUGCOMP Bayer Healthcare Pharmaceuticals Inc D07SYJ THERCLAS Antiinfective Agents D07SYJ DRUGTYPE Small molecular drug D07SYJ DRUGINCH 1S/C11H12N4O3S/c1-18-9-6-13-11(14-7-9)15-19(16,17)10-4-2-8(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15) D07SYJ DRUGINKE GPTONYMQFTZPKC-UHFFFAOYSA-N D07SYJ DRUGSMIL COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N D07SYJ HIGHSTAT Approved D07TQV DRUG__ID D07TQV D07TQV DRUGCOMP Glaxo Smith Kline Pharmaceuticals D07TQV THERCLAS Anti-HIV Agents D07TQV DRUGTYPE Small molecular drug D07TQV DRUGINCH 1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1 D07TQV DRUGINKE JTEGQNOMFQHVDC-NKWVEPMBSA-N D07TQV DRUGSMIL C1C(OC(S1)CO)N2C=CC(=NC2=O)N D07TQV HIGHSTAT Approved D07TWN DRUG__ID D07TWN D07TWN TRADNAME Krintafel D07TWN DRUGCOMP Medicines for Malaria Venture/GlaxoSmithKline D07TWN DRUGTYPE Small molecular drug D07TWN DRUGINCH 1S/C24H28F3N3O3/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3 D07TWN DRUGINKE LBHLFPGPEGDCJG-UHFFFAOYSA-N D07TWN DRUGSMIL CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC D07TWN HIGHSTAT Approved D07UYO DRUG__ID D07UYO D07UYO DRUGCOMP Pfizer Pharmaceuticals D07UYO THERCLAS Antibiotics D07UYO DRUGTYPE Small molecular drug D07UYO DRUGINCH 1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 D07UYO DRUGINKE TYZROVQLWOKYKF-ZDUSSCGKSA-N D07UYO DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F D07UYO HIGHSTAT Approved D07VDZ DRUG__ID D07VDZ D07VDZ DRUGCOMP Ortho-McNell Pharmaceutical D07VDZ THERCLAS Anticonvulsants D07VDZ DRUGTYPE Small molecular drug D07VDZ DRUGINCH 1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1 D07VDZ DRUGINKE KJADKKWYZYXHBB-XBWDGYHZSA-N D07VDZ DRUGSMIL CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C D07VDZ HIGHSTAT Approved D07VLY DRUG__ID D07VLY D07VLY DRUGCOMP Sequus Pharmaceuticals Inc D07VLY THERCLAS Anticancer Agents D07VLY DRUGTYPE Small molecular drug D07VLY DRUGINCH 1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 D07VLY DRUGINKE AOJJSUZBOXZQNB-TZSSRYMLSA-N D07VLY DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O D07VLY HIGHSTAT Approved D07WXI DRUG__ID D07WXI D07WXI TRADNAME Livtencity D07WXI DRUGCOMP Takeda D07WXI DRUGTYPE Small molecular drug D07WXI DRUGINCH 1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13-,14-/m0/s1 D07WXI DRUGINKE KJFBVJALEQWJBS-XUXIUFHCSA-N D07WXI DRUGSMIL CC(C)NC1=NC2=CC(=C(C=C2N1C3C(C(C(O3)CO)O)O)Cl)Cl D07WXI HIGHSTAT Approved D07XGR DRUG__ID D07XGR D07XGR DRUGCOMP Abbott Laboratories D07XGR THERCLAS Antilipemic Agents D07XGR DRUGTYPE Small molecular drug D07XGR DRUGINCH 1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3 D07XGR DRUGINKE YMTINGFKWWXKFG-UHFFFAOYSA-N D07XGR DRUGSMIL CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl D07XGR HIGHSTAT Approved D07XJM DRUG__ID D07XJM D07XJM DRUGCOMP Peckforton Pharmaceuticals D07XJM THERCLAS Anticholinergic Agents D07XJM DRUGTYPE Small molecular drug D07XJM DRUGINCH 1S/C19H35NO2/c1-3-20(4-2)15-16-22-18(21)19(13-9-6-10-14-19)17-11-7-5-8-12-17/h17H,3-16H2,1-2H3 D07XJM DRUGINKE CURUTKGFNZGFSE-UHFFFAOYSA-N D07XJM DRUGSMIL CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2 D07XJM HIGHSTAT Approved D07XSN DRUG__ID D07XSN D07XSN DRUGCOMP Upjohn Corporation D07XSN THERCLAS Anticancer Agents D07XSN DRUGTYPE Small molecular drug D07XSN DRUGINCH 1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1 D07XSN DRUGINKE UHDGCWIWMRVCDJ-CCXZUQQUSA-N D07XSN DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O D07XSN HIGHSTAT Approved D07XVN DRUG__ID D07XVN D07XVN DRUGCOMP Pfizer Pharmaceuticals D07XVN THERCLAS Anticancer Agents D07XVN DRUGTYPE Small molecular drug D07XVN DRUGINCH 1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)/t7-/m0/s1 D07XVN DRUGINKE BMKDZUISNHGIBY-ZETCQYMHSA-N D07XVN DRUGSMIL CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2 D07XVN HIGHSTAT Approved D07XYV DRUG__ID D07XYV D07XYV DRUGCOMP AstraZeneca D07XYV THERCLAS Bronchodilator Agents D07XYV DRUGTYPE Small molecular drug D07XYV DRUGINCH 1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3 D07XYV DRUGINKE ANZXOIAKUNOVQU-UHFFFAOYSA-N D07XYV DRUGSMIL CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O D07XYV HIGHSTAT Approved D07ZTO DRUG__ID D07ZTO D07ZTO DRUGCOMP Merck & Co D07ZTO THERCLAS Parasympathomimetics D07ZTO DRUGTYPE Small molecular drug D07ZTO DRUGINCH 1S/C7H16N2O2/c1-6(11-7(8)10)5-9(2,3)4/h6H,5H2,1-4H3,(H-,8,10)/p+1 D07ZTO DRUGINKE NZUPCNDJBJXXRF-UHFFFAOYSA-O D07ZTO DRUGSMIL CC(C[N+](C)(C)C)OC(=O)N D07ZTO HIGHSTAT Approved D08BTB DRUG__ID D08BTB D08BTB DRUGCOMP Abbott Laboratories Pharmaceutical Products Div D08BTB THERCLAS Neurology Agents D08BTB DRUGTYPE Small molecular drug D08BTB DRUGINCH 1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12-/m0/s1 D08BTB DRUGINKE XNSAINXGIQZQOO-SRVKXCTJSA-N D08BTB DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C(=O)N D08BTB HIGHSTAT Approved D08CDI DRUG__ID D08CDI D08CDI DRUGCOMP GlaxoSmithKline D08CDI THERCLAS Anticancer Agents D08CDI DRUGTYPE Small molecular drug D08CDI DRUGINCH 1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35) D08CDI DRUGINKE BCFGMOOMADDAQU-UHFFFAOYSA-N D08CDI DRUGSMIL CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl D08CDI HIGHSTAT Approved D08EBN DRUG__ID D08EBN D08EBN DRUGCOMP Unimed Pharmaceuticals D08EBN THERCLAS Antiparasitic Agents D08EBN DRUGTYPE Small molecular drug D08EBN DRUGINCH 1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17) D08EBN DRUGINKE YQNQNVDNTFHQSW-UHFFFAOYSA-N D08EBN DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-] D08EBN HIGHSTAT Approved D08EOD DRUG__ID D08EOD D08EOD DRUGCOMP Pfizer Pharmaceuticals D08EOD THERCLAS Anticonvulsants D08EOD DRUGTYPE Small molecular drug D08EOD DRUGINCH 1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3 D08EOD DRUGINKE AJXPJJZHWIXJCJ-UHFFFAOYSA-N D08EOD DRUGSMIL CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2 D08EOD HIGHSTAT Approved D08FJL DRUG__ID D08FJL D08FJL DRUGCOMP Pfizer Pharmaceuticals D08FJL THERCLAS Antitocolytic Agents D08FJL DRUGTYPE Small molecular drug D08FJL DRUGINCH 1S/C45H69N11O12S/c1-6-25(4)38-44(66)51-28(15-16-34(46)57)40(62)52-31(21-35(47)58)41(63)54-32(23-69-18-8-10-37(60)50-30(42(64)55-38)20-26-11-13-27(68-5)14-12-26)45(67)56-17-7-9-33(56)43(65)53-29(19-24(2)3)39(61)49-22-36(48)59/h11-14,24-25,28-33,38H,6-10,15-23H2,1-5H3,(H2,46,57)(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,62)(H,53,65)(H,54,63)(H,55,64)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1 D08FJL DRUGINKE NSTRIRCPWQHTIA-DTRKZRJBSA-N D08FJL DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSCCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OC)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D08FJL HIGHSTAT Approved D08GYO DRUG__ID D08GYO D08GYO DRUGCOMP Sigma-Tau Pharmaceuticals D08GYO THERCLAS Anticancer Agents D08GYO DRUGTYPE Small molecular drug D08GYO DRUGINCH 1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16) D08GYO DRUGINKE CPTBDICYNRMXFX-UHFFFAOYSA-N D08GYO DRUGSMIL CC(C)NC(=O)C1=CC=C(C=C1)CNNC D08GYO HIGHSTAT Approved D08HRJ DRUG__ID D08HRJ D08HRJ DRUGCOMP Seatrace Pharmaceuticals D08HRJ THERCLAS Antiemetics D08HRJ DRUGTYPE Small molecular drug D08HRJ DRUGINCH 1S/C18H22N2/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18H,12-15H2,1H3 D08HRJ DRUGINKE UVKZSORBKUEBAZ-UHFFFAOYSA-N D08HRJ DRUGSMIL CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3 D08HRJ HIGHSTAT Approved D08HZL DRUG__ID D08HZL D08HZL DRUGCOMP Allergan Herbert Skin Care Div Allergan Inc D08HZL THERCLAS Antihistamines D08HZL DRUGTYPE Small molecular drug D08HZL DRUGINCH 1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3 D08HZL DRUGINKE ZZHLYYDVIOPZBE-UHFFFAOYSA-N D08HZL DRUGSMIL CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C D08HZL HIGHSTAT Approved D08IWD DRUG__ID D08IWD D08IWD DRUGCOMP Merck D08IWD THERCLAS Antihyperplasia Agents D08IWD DRUGTYPE Small molecular drug D08IWD DRUGINCH 1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1 D08IWD DRUGINKE DBEPLOCGEIEOCV-WSBQPABSSA-N D08IWD DRUGSMIL CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C D08IWD HIGHSTAT Approved D08JIV DRUG__ID D08JIV D08JIV DRUGCOMP Dainippon Sumitomo D08JIV THERCLAS Antihypertensive Agents D08JIV DRUGTYPE Small molecular drug D08JIV DRUGINCH 1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3 D08JIV DRUGINKE HTIQEAQVCYTUBX-UHFFFAOYSA-N D08JIV DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN D08JIV HIGHSTAT Approved D08KVZ DRUG__ID D08KVZ D08KVZ DRUGCOMP Abbott Laboratories D08KVZ THERCLAS Appetite Depressants D08KVZ DRUGTYPE Small molecular drug D08KVZ DRUGINCH 1S/C17H26ClN/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14/h6-9,13,16H,5,10-12H2,1-4H3 D08KVZ DRUGINKE UNAANXDKBXWMLN-UHFFFAOYSA-N D08KVZ DRUGSMIL CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C D08KVZ HIGHSTAT Approved D08LFZ DRUG__ID D08LFZ D08LFZ DRUGCOMP Merck & Co D08LFZ THERCLAS Analgesics D08LFZ DRUGTYPE Small molecular drug D08LFZ DRUGINCH 1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18) D08LFZ DRUGINKE HUPFGZXOMWLGNK-UHFFFAOYSA-N D08LFZ DRUGSMIL C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O D08LFZ HIGHSTAT Approved D08LTU DRUG__ID D08LTU D08LTU DRUGCOMP Lederle Laboratories D08LTU THERCLAS Antibiotics D08LTU DRUGTYPE Small molecular drug D08LTU DRUGINCH 1S/C23H27N3O7/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32)/t9-,11-,17-,23-/m0/s1 D08LTU DRUGINKE FFTVPQUHLQBXQZ-KVUCHLLUSA-N D08LTU DRUGSMIL CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C D08LTU HIGHSTAT Approved D08MRN DRUG__ID D08MRN D08MRN DRUGCOMP Merck & Co D08MRN THERCLAS Anesthetics D08MRN DRUGTYPE Small molecular drug D08MRN DRUGINCH 1S/C16H23NO2/c1-13(12-17-15-10-6-3-7-11-15)19-16(18)14-8-4-2-5-9-14/h2,4-5,8-9,13,15,17H,3,6-7,10-12H2,1H3 D08MRN DRUGINKE DKLKMKYDWHYZTD-UHFFFAOYSA-N D08MRN DRUGSMIL CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2 D08MRN HIGHSTAT Approved D08NQZ DRUG__ID D08NQZ D08NQZ DRUGCOMP Pfizer Inc D08NQZ THERCLAS Antibiotics D08NQZ DRUGTYPE Small molecular drug D08NQZ DRUGINCH 1S/C22H24N2O8/c1-21(31)8-5-4-6-11(25)12(8)16(26)13-9(21)7-10-15(24(2)3)17(27)14(20(23)30)19(29)22(10,32)18(13)28/h4-6,9-10,15,25-26,29,31-32H,7H2,1-3H3,(H2,23,30)/t9-,10-,15-,21+,22-/m0/s1 D08NQZ DRUGINKE NWXMGUDVXFXRIG-WESIUVDSSA-N D08NQZ DRUGSMIL CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O D08NQZ HIGHSTAT Approved D08PIE DRUG__ID D08PIE D08PIE TRADNAME Alunbrig D08PIE DRUGCOMP Ariad Pharmaceuticals/Takeda D08PIE DRUGTYPE Small molecular drug D08PIE DRUGINCH 1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34) D08PIE DRUGINKE AILRADAXUVEEIR-UHFFFAOYSA-N D08PIE DRUGSMIL CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC D08PIE HIGHSTAT Approved D08PIQ DRUG__ID D08PIQ D08PIQ DRUGCOMP Pharmacia And Upjohn Co D08PIQ THERCLAS Anticancer Agents D08PIQ DRUGTYPE Small molecular drug D08PIQ DRUGINCH 1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1 D08PIQ DRUGINKE VHRSUDSXCMQTMA-PJHHCJLFSA-N D08PIQ DRUGSMIL CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O D08PIQ HIGHSTAT Approved D08QME DRUG__ID D08QME D08QME DRUGCOMP Macleods Pharmaceutical. Ltd D08QME THERCLAS Antitubercular Agents D08QME DRUGTYPE Small molecular drug D08QME DRUGINCH 1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1 D08QME DRUGINKE AEUTYOVWOVBAKS-UWVGGRQHSA-N D08QME DRUGSMIL CCC(CO)NCCNC(CC)CO D08QME HIGHSTAT Approved D08RBC DRUG__ID D08RBC D08RBC DRUGCOMP Forest Laboratories D08RBC THERCLAS Antidepressants D08RBC DRUGTYPE Small molecular drug D08RBC DRUGINCH 1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1 D08RBC DRUGINKE WSEQXVZVJXJVFP-FQEVSTJZSA-N D08RBC DRUGSMIL CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F D08RBC HIGHSTAT Approved D08ROP DRUG__ID D08ROP D08ROP DRUGCOMP Sanofi-Aventis D08ROP THERCLAS Antiinflammatory Agents D08ROP DRUGTYPE Small molecular drug D08ROP DRUGINCH 1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18) D08ROP DRUGINKE VHOGYURTWQBHIL-UHFFFAOYSA-N D08ROP DRUGSMIL CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F D08ROP HIGHSTAT Approved D08SEI DRUG__ID D08SEI D08SEI DRUGCOMP Janssen Pharmaceutica D08SEI THERCLAS Antiallergic Agents D08SEI DRUGTYPE Small molecular drug D08SEI DRUGINCH 1S/C26H29FN2O2/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20/h2-10,19,23H,11-17H2,1H3,(H,30,31)/t19-,23?,25?,26-/m1/s1 D08SEI DRUGINKE ZCGOMHNNNFPNMX-YHYDXASRSA-N D08SEI DRUGSMIL CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F D08SEI HIGHSTAT Approved D08SJZ DRUG__ID D08SJZ D08SJZ DRUGCOMP Roche; GlaxoSmithKline D08SJZ THERCLAS Bone Density Conservation Agents D08SJZ DRUGTYPE Small molecular drug D08SJZ DRUGINCH 1S/C9H23NO7P2/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17) D08SJZ DRUGINKE MPBVHIBUJCELCL-UHFFFAOYSA-N D08SJZ DRUGSMIL CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O D08SJZ HIGHSTAT Approved D08UMH DRUG__ID D08UMH D08UMH DRUGCOMP Ovation Pharmaceuticals D08UMH THERCLAS Hypnotics and Sedatives D08UMH DRUGTYPE Small molecular drug D08UMH DRUGINCH 1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18) D08UMH DRUGINKE ALARQZQTBTVLJV-UHFFFAOYSA-N D08UMH DRUGSMIL CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2 D08UMH HIGHSTAT Approved D08USU DRUG__ID D08USU D08USU DRUGCOMP GlaxoSmithKline D08USU THERCLAS Antibiotics D08USU DRUGTYPE Small molecular drug D08USU DRUGINCH 1S/C15H16N2O6S2/c1-15(2)9(14(22)23)17-11(19)8(12(17)25-15)16-10(18)7(13(20)21)6-3-4-24-5-6/h3-5,7-9,12H,1-2H3,(H,16,18)(H,20,21)(H,22,23)/t7-,8-,9+,12-/m1/s1 D08USU DRUGINKE OHKOGUYZJXTSFX-KZFFXBSXSA-N D08USU DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C D08USU HIGHSTAT Approved D08VRO DRUG__ID D08VRO D08VRO DRUGCOMP Janssen Pharmaceutica D08VRO THERCLAS Antihypertensive Agents D08VRO DRUGTYPE Small molecular drug D08VRO DRUGINCH 1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29) D08VRO DRUGINKE FPCCSQOGAWCVBH-UHFFFAOYSA-N D08VRO DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O D08VRO HIGHSTAT Approved D08VXO DRUG__ID D08VXO D08VXO DRUGCOMP Alpharma Us Pharmaceuticals Division D08VXO THERCLAS Antiallergic Agents D08VXO DRUGTYPE Small molecular drug D08VXO DRUGINCH 1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3 D08VXO DRUGINKE ZDIGNSYAACHWNL-UHFFFAOYSA-N D08VXO DRUGSMIL CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2 D08VXO HIGHSTAT Approved D08VYV DRUG__ID D08VYV D08VYV DRUGCOMP Sanofi-Aventis D08VYV THERCLAS Antiemetics D08VYV DRUGTYPE Small molecular drug D08VYV DRUGINCH 1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19) D08VYV DRUGINKE TTWJBBZEZQICBI-UHFFFAOYSA-N D08VYV DRUGSMIL CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl D08VYV HIGHSTAT Approved D08WYM DRUG__ID D08WYM D08WYM DRUGCOMP Pfizer Pharmaceuticals D08WYM THERCLAS Fertility Agents D08WYM DRUGTYPE Small molecular drug D08WYM DRUGINCH 1S/C66H83N17O13/c1-36(2)25-48(58(89)76-47(13-7-23-71-66(68)69)65(96)83-24-8-14-54(83)64(95)73-33-55(67)86)77-60(91)50(28-38-15-18-39-9-3-4-10-40(39)26-38)78-59(90)49(27-37-16-19-43(85)20-17-37)79-63(94)53(34-84)82-61(92)51(29-41-31-72-45-12-6-5-11-44(41)45)80-62(93)52(30-42-32-70-35-74-42)81-57(88)46-21-22-56(87)75-46/h3-6,9-12,15-20,26,31-32,35-36,46-54,72,84-85H,7-8,13-14,21-25,27-30,33-34H2,1-2H3,(H2,67,86)(H,70,74)(H,73,95)(H,75,87)(H,76,89)(H,77,91)(H,78,90)(H,79,94)(H,80,93)(H,81,88)(H,82,92)(H4,68,69,71)/t46-,47-,48-,49-,50+,51-,52-,53-,54-/m0/s1 D08WYM DRUGINKE RWHUEXWOYVBUCI-ITQXDASVSA-N D08WYM DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 D08WYM HIGHSTAT Approved D08XAC DRUG__ID D08XAC D08XAC DRUGCOMP Bristol-Myers Squibb D08XAC THERCLAS Antifungal Agents D08XAC DRUGTYPE Small molecular drug D08XAC DRUGINCH 1S/C47H75NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-36(53)35(52)20-19-31(49)21-32(50)22-33(51)23-39(55)62-29(3)28(2)42(27)56/h5-6,8,10-18,27-38,40-44,46,49-54,56-58,61H,7,9,19-26,48H2,1-4H3,(H,59,60)/b6-5+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31?,32?,33?,34?,35?,36?,37?,38?,40?,41-,42+,43+,44-,46+,47+/m0/s1 D08XAC DRUGINKE VQOXZBDYSJBXMA-RKEBNKJGSA-N D08XAC DRUGSMIL CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O D08XAC HIGHSTAT Approved D08XFV DRUG__ID D08XFV D08XFV DRUGCOMP West-ward Pharmaceutical Corp D08XFV THERCLAS Hypnotics and Sedatives D08XFV DRUGTYPE Small molecular drug D08XFV DRUGINCH 1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3 D08XFV DRUGINKE SAADBVWGJQAEFS-UHFFFAOYSA-N D08XFV DRUGSMIL CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F D08XFV HIGHSTAT Approved D09ANG DRUG__ID D09ANG D09ANG DRUGCOMP Pfizer Pharmaceuticals D09ANG THERCLAS Abortifacient Agents D09ANG DRUGTYPE Small molecular drug D09ANG DRUGINCH 1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1 D09ANG DRUGINKE OJLOPKGSLYJEMD-URPKTTJQSA-N D09ANG DRUGSMIL CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O D09ANG HIGHSTAT Approved D09BHB DRUG__ID D09BHB D09BHB DRUGCOMP Ortho Mcneil Janssen Pharmaceuticals Inc D09BHB THERCLAS Antiinflammatory Agents D09BHB DRUGTYPE Small molecular drug D09BHB DRUGINCH 1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18) D09BHB DRUGINKE UPSPUYADGBWSHF-UHFFFAOYSA-N D09BHB DRUGSMIL CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O D09BHB HIGHSTAT Approved D09CZA DRUG__ID D09CZA D09CZA DRUGCOMP Alcon Canada Inc D09CZA THERCLAS Ophthalmologicals D09CZA DRUGTYPE Small molecular drug D09CZA DRUGINCH 1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1 D09CZA DRUGINKE MKPLKVHSHYCHOC-AHTXBMBWSA-N D09CZA DRUGSMIL CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O D09CZA HIGHSTAT Approved D09DWL DRUG__ID D09DWL D09DWL DRUGCOMP King Pharm D09DWL THERCLAS Hypnotics and Sedatives D09DWL DRUGTYPE Small molecular drug D09DWL DRUGINCH 1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3 D09DWL DRUGINKE HUNXMJYCHXQEGX-UHFFFAOYSA-N D09DWL DRUGSMIL CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C D09DWL HIGHSTAT Approved D09EBS DRUG__ID D09EBS D09EBS DRUGCOMP Schein Pharmaceutical D09EBS THERCLAS Nasal Decongestants D09EBS DRUGTYPE Small molecular drug D09EBS DRUGINCH 1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18) D09EBS DRUGINKE WYWIFABBXFUGLM-UHFFFAOYSA-N D09EBS DRUGSMIL CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C D09EBS HIGHSTAT Approved D09EGZ DRUG__ID D09EGZ D09EGZ DRUGCOMP Medreich Sterilab Ltd D09EGZ THERCLAS Antimalarials D09EGZ DRUGTYPE Small molecular drug D09EGZ DRUGINCH 1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21) D09EGZ DRUGINKE WHTVZRBIWZFKQO-UHFFFAOYSA-N D09EGZ DRUGSMIL CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl D09EGZ HIGHSTAT Approved D09FAZ DRUG__ID D09FAZ D09FAZ DRUGCOMP Celgene D09FAZ THERCLAS Anticancer Agents D09FAZ DRUGTYPE Small molecular drug D09FAZ DRUGINCH 1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1 D09FAZ DRUGINKE NMUSYJAQQFHJEW-KVTDHHQDSA-N D09FAZ DRUGSMIL C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N D09FAZ HIGHSTAT Approved D09GFL DRUG__ID D09GFL D09GFL DRUGCOMP Lederle Laboratories Div American Cyanamid Co D09GFL THERCLAS Antiparkinson Agents D09GFL DRUGTYPE Small molecular drug D09GFL DRUGINCH 1S/C20H31NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2 D09GFL DRUGINKE HWHLPVGTWGOCJO-UHFFFAOYSA-N D09GFL DRUGSMIL C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O D09GFL HIGHSTAT Approved D09GOS DRUG__ID D09GOS D09GOS DRUGCOMP Bayer Pharmaceuticals Corporation D09GOS THERCLAS Antifungal Agents D09GOS DRUGTYPE Small molecular drug D09GOS DRUGINCH 1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H D09GOS DRUGINKE VNFPBHJOKIVQEB-UHFFFAOYSA-N D09GOS DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4 D09GOS HIGHSTAT Approved D09GYT DRUG__ID D09GYT D09GYT DRUGCOMP Glaxosmithkline D09GYT THERCLAS Antihypertensive Agents D09GYT DRUGTYPE Small molecular drug D09GYT DRUGINCH 1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3 D09GYT DRUGINKE WJAJPNHVVFWKKL-UHFFFAOYSA-N D09GYT DRUGSMIL CC(C(C1=C(C=CC(=C1)OC)OC)O)N D09GYT HIGHSTAT Approved D09HNR DRUG__ID D09HNR D09HNR DRUGCOMP Sanofi-Aventis D09HNR THERCLAS Antibiotics D09HNR DRUGTYPE Small molecular drug D09HNR DRUGINCH 1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1 D09HNR DRUGINKE LJVAJPDWBABPEJ-PNUFFHFMSA-N D09HNR DRUGSMIL CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C D09HNR HIGHSTAT Approved D09IMS DRUG__ID D09IMS D09IMS DRUGCOMP Pierre Fabre SA D09IMS THERCLAS Antihistamines D09IMS DRUGTYPE Small molecular drug D09IMS DRUGINCH 1S/C20H22N2S/c1-3-7-19-17(5-1)22(18-6-2-4-8-20(18)23-19)14-16-13-21-11-9-15(16)10-12-21/h1-8,15-16H,9-14H2 D09IMS DRUGINKE HOKDBMAJZXIPGC-UHFFFAOYSA-N D09IMS DRUGSMIL C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53 D09IMS HIGHSTAT Approved D09JUG DRUG__ID D09JUG D09JUG DRUGCOMP Cornerstone Therapeutics Inc D09JUG THERCLAS Antiinflammatory Agents D09JUG DRUGTYPE Small molecular drug D09JUG DRUGINCH 1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14) D09JUG DRUGINKE MWLSOWXNZPKENC-UHFFFAOYSA-N D09JUG DRUGSMIL CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O D09JUG HIGHSTAT Approved D09KDN DRUG__ID D09KDN D09KDN DRUGCOMP Fujisawa Pharmaceutical Co D09KDN THERCLAS Antibiotics D09KDN DRUGTYPE Small molecular drug D09KDN DRUGINCH 1S/C14H14N8O4S3/c1-6-17-18-14(29-6)28-4-7-3-27-12-9(11(24)22(12)10(7)13(25)26)16-8(23)2-21-5-15-19-20-21/h5,9,12H,2-4H2,1H3,(H,16,23)(H,25,26)/t9-,12-/m1/s1 D09KDN DRUGINKE MLYYVTUWGNIJIB-BXKDBHETSA-N D09KDN DRUGSMIL CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O D09KDN HIGHSTAT Approved D09KLR DRUG__ID D09KLR D09KLR DRUGCOMP Teva Pharmaceuticals D09KLR THERCLAS Bone Density Conservation Agents D09KLR DRUGTYPE Small molecular drug D09KLR DRUGINCH 1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12) D09KLR DRUGINKE OGSPWJRAVKPPFI-UHFFFAOYSA-N D09KLR DRUGSMIL C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN D09KLR HIGHSTAT Approved D09LDR DRUG__ID D09LDR D09LDR DRUGCOMP Genus Pharms D09LDR THERCLAS Hypnotics and Sedatives D09LDR DRUGTYPE Small molecular drug D09LDR DRUGINCH 1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19) D09LDR DRUGINKE ADIMAYPTOBDMTL-UHFFFAOYSA-N D09LDR DRUGSMIL C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O D09LDR HIGHSTAT Approved D09LNI DRUG__ID D09LNI D09LNI DRUGCOMP Pfizer D09LNI THERCLAS Antifungal Agents D09LNI DRUGTYPE Small molecular drug D09LNI DRUGINCH 1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2 D09LNI DRUGINKE RFHAOTPXVQNOHP-UHFFFAOYSA-N D09LNI DRUGSMIL C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O D09LNI HIGHSTAT Approved D09LWS DRUG__ID D09LWS D09LWS DRUGCOMP Schering-Plough D09LWS THERCLAS Anticholesteremic Agents D09LWS DRUGTYPE Small molecular drug D09LWS DRUGINCH 1S/C24H21F2NO3/c25-17-5-1-15(2-6-17)22(29)14-13-21-23(16-3-11-20(28)12-4-16)27(24(21)30)19-9-7-18(26)8-10-19/h1-12,21-23,28-29H,13-14H2/t21-,22+,23-/m1/s1 D09LWS DRUGINKE OLNTVTPDXPETLC-XPWALMASSA-N D09LWS DRUGSMIL C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O D09LWS HIGHSTAT Approved D09MGR DRUG__ID D09MGR D09MGR DRUGCOMP Merck & Co D09MGR THERCLAS Antiinflammatory Agents D09MGR DRUGTYPE Small molecular drug D09MGR DRUGINCH 1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3 D09MGR DRUGINKE MNJVRJDLRVPLFE-UHFFFAOYSA-N D09MGR DRUGSMIL CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C D09MGR HIGHSTAT Approved D09MWJ DRUG__ID D09MWJ D09MWJ DRUGCOMP Sanofi-Aventis D09MWJ THERCLAS Antihypertensive Agents D09MWJ DRUGTYPE Small molecular drug D09MWJ DRUGINCH 1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23) D09MWJ DRUGINKE WNMJYKCGWZFFKR-UHFFFAOYSA-N D09MWJ DRUGSMIL CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC D09MWJ HIGHSTAT Approved D09NNA DRUG__ID D09NNA D09NNA DRUGCOMP Eli Lilly And Co D09NNA THERCLAS Anabolic Agents D09NNA DRUGTYPE Small molecular drug D09NNA DRUGINCH 1S/C20H32O2/c1-12-11-20(3)13(10-17(12)21)4-5-14-15-6-7-18(22)19(15,2)9-8-16(14)20/h12-16,18,22H,4-11H2,1-3H3/t12-,13+,14+,15+,16+,18+,19+,20+/m1/s1 D09NNA DRUGINKE IKXILDNPCZPPRV-RFMGOVQKSA-N D09NNA DRUGSMIL CC1CC2(C(CCC3C2CCC4(C3CCC4O)C)CC1=O)C D09NNA HIGHSTAT Approved D09OJQ DRUG__ID D09OJQ D09OJQ DRUGCOMP Eli Lilly D09OJQ THERCLAS Analgesics D09OJQ DRUGTYPE Small molecular drug D09OJQ DRUGINCH 1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3 D09OJQ DRUGINKE USSIQXCVUWKGNF-UHFFFAOYSA-N D09OJQ DRUGSMIL CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2 D09OJQ HIGHSTAT Approved D09OLZ DRUG__ID D09OLZ D09OLZ DRUGCOMP Merck Serono D09OLZ THERCLAS Infertility Agents D09OLZ DRUGTYPE Small molecular drug D09OLZ DRUGINCH 1S/C70H92ClN17O14/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+/m1/s1 D09OLZ DRUGINKE SBNPWPIBESPSIF-MHWMIDJBSA-N D09OLZ DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D09OLZ HIGHSTAT Approved D09OZC DRUG__ID D09OZC D09OZC DRUGCOMP Spectrum D09OZC THERCLAS Anticancer Agents D09OZC DRUGTYPE Small molecular drug D09OZC DRUGINCH 1S/C20H24N2OS/c1-4-22(5-2)13-12-21-16-11-10-14(3)20-18(16)19(23)15-8-6-7-9-17(15)24-20/h6-11,21H,4-5,12-13H2,1-3H3 D09OZC DRUGINKE FBQPGGIHOFZRGH-UHFFFAOYSA-N D09OZC DRUGSMIL CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O D09OZC HIGHSTAT Approved D09PNY DRUG__ID D09PNY D09PNY DRUGCOMP Alcon Laboratories Inc D09PNY THERCLAS Diagnostic Agents D09PNY DRUGTYPE Small molecular drug D09PNY DRUGINCH 1S/C17H20N2O2/c1-2-19(12-14-8-10-18-11-9-14)17(21)16(13-20)15-6-4-3-5-7-15/h3-11,16,20H,2,12-13H2,1H3 D09PNY DRUGINKE BGDKAVGWHJFAGW-UHFFFAOYSA-N D09PNY DRUGSMIL CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2 D09PNY HIGHSTAT Approved D09QEI DRUG__ID D09QEI D09QEI DRUGCOMP Aventis Pharmaceuticals Inc. D09QEI THERCLAS Vasodilator Agents D09QEI DRUGTYPE Small molecular drug D09QEI DRUGINCH 1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3 D09QEI DRUGINKE BYPFEZZEUUWMEJ-UHFFFAOYSA-N D09QEI DRUGSMIL CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C D09QEI HIGHSTAT Approved D09QUQ DRUG__ID D09QUQ D09QUQ DRUGCOMP AstraZeneca D09QUQ THERCLAS Anesthetics D09QUQ DRUGTYPE Small molecular drug D09QUQ DRUGINCH 1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21)/t16-/m0/s1 D09QUQ DRUGINKE LEBVLXFERQHONN-INIZCTEOSA-N D09QUQ DRUGSMIL CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C D09QUQ HIGHSTAT Approved D09QVV DRUG__ID D09QVV D09QVV DRUGCOMP Mayne Pharma Limited D09QVV THERCLAS Anticancer Agents D09QVV DRUGTYPE Small molecular drug D09QVV DRUGINCH 1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37+,38-,39-,42+,43-,44-,45+,46+/m1/s1 D09QVV DRUGINKE OGWKCGZFUXNPDA-XQKSVPLYSA-N D09QVV DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O D09QVV HIGHSTAT Approved D09RHQ DRUG__ID D09RHQ D09RHQ DRUGCOMP AstraZeneca D09RHQ THERCLAS Anesthetics D09RHQ DRUGTYPE Small molecular drug D09RHQ DRUGINCH 1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1 D09RHQ DRUGINKE ZKMNUMMKYBVTFN-HNNXBMFYSA-N D09RHQ DRUGSMIL CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C D09RHQ HIGHSTAT Approved D09TBD DRUG__ID D09TBD D09TBD DRUGCOMP Hoffmann La Roche Inc D09TBD THERCLAS Antiinfective Agents D09TBD DRUGTYPE Small molecular drug D09TBD DRUGINCH 1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3 D09TBD DRUGINKE NHUHCSRWZMLRLA-UHFFFAOYSA-N D09TBD DRUGSMIL CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N D09TBD HIGHSTAT Approved D09UZO DRUG__ID D09UZO D09UZO DRUGCOMP Novopharm D09UZO THERCLAS Anticancer Agents D09UZO DRUGTYPE Small molecular drug D09UZO DRUGINCH 1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) D09UZO DRUGINKE GLVAUDGFNGKCSF-UHFFFAOYSA-N D09UZO DRUGSMIL C1=NC2=C(N1)C(=S)N=CN2 D09UZO HIGHSTAT Approved D09VGC DRUG__ID D09VGC D09VGC DRUGCOMP Silesia Laboratories D09VGC THERCLAS Antidepressants D09VGC DRUGTYPE Small molecular drug D09VGC DRUGINCH 1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1 D09VGC DRUGINKE GJJFMKBJSRMPLA-HIFRSBDPSA-N D09VGC DRUGSMIL CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2 D09VGC HIGHSTAT Approved D09WYX DRUG__ID D09WYX D09WYX TRADNAME Emflaza D09WYX DRUGCOMP PTC Therapeutics D09WYX DRUGTYPE Small molecular drug D09WYX DRUGINCH 1S/C25H31NO6/c1-13-26-25(20(30)12-31-14(2)27)21(32-13)10-18-17-6-5-15-9-16(28)7-8-23(15,3)22(17)19(29)11-24(18,25)4/h7-9,17-19,21-22,29H,5-6,10-12H2,1-4H3/t17-,18-,19-,21+,22+,23-,24-,25+/m0/s1 D09WYX DRUGINKE FBHSPRKOSMHSIF-GRMWVWQJSA-N D09WYX DRUGSMIL CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C D09WYX HIGHSTAT Approved D09XQF DRUG__ID D09XQF D09XQF DRUGCOMP Roche Pharmaceuticals D09XQF THERCLAS Antitubercular Agents D09XQF DRUGTYPE Small molecular drug D09XQF DRUGINCH 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) D09XQF DRUGINKE QRXWMOHMRWLFEY-UHFFFAOYSA-N D09XQF DRUGSMIL C1=CN=CC=C1C(=O)NN D09XQF HIGHSTAT Approved D09XZB DRUG__ID D09XZB D09XZB DRUGCOMP AstraZeneca D09XZB THERCLAS Anticancer Agents D09XZB DRUGTYPE Small molecular drug D09XZB DRUGINCH 1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27) D09XZB DRUGINKE XGALLCVXEZPNRQ-UHFFFAOYSA-N D09XZB DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 D09XZB HIGHSTAT Approved D09YHJ DRUG__ID D09YHJ D09YHJ DRUGCOMP Merck & Co D09YHJ THERCLAS Antiprotozoal Agents D09YHJ DRUGTYPE Small molecular drug D09YHJ DRUGINCH 1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 D09YHJ DRUGINKE AZSNMRSAGSSBNP-XPNPUAGNSA-N D09YHJ DRUGSMIL CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C D09YHJ HIGHSTAT Approved D09ZIO DRUG__ID D09ZIO D09ZIO DRUGCOMP Millennium Pharmaceuticals D09ZIO THERCLAS Anticoagulants D09ZIO DRUGTYPE Small molecular drug D09ZIO DRUGINCH 1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1 D09ZIO DRUGINKE CZKPOZZJODAYPZ-LROMGURASA-N D09ZIO DRUGSMIL C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N D09ZIO HIGHSTAT Approved D09ZIS DRUG__ID D09ZIS D09ZIS DRUGCOMP Eisai D09ZIS THERCLAS Analgesics D09ZIS DRUGTYPE Small molecular drug D09ZIS DRUGINCH 1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12) D09ZIS DRUGINKE UBQNRHZMVUUOMG-UHFFFAOYSA-N D09ZIS DRUGSMIL C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N D09ZIS HIGHSTAT Approved D0A0FL DRUG__ID D0A0FL D0A0FL DRUGCOMP AstraZeneca D0A0FL THERCLAS Anesthetics D0A0FL DRUGTYPE Small molecular drug D0A0FL DRUGINCH 1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21) D0A0FL DRUGINKE LEBVLXFERQHONN-UHFFFAOYSA-N D0A0FL DRUGSMIL CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C D0A0FL HIGHSTAT Approved D0A0OO DRUG__ID D0A0OO D0A0OO DRUGCOMP GlaxoSmithKline D0A0OO THERCLAS Anti-HIV Agents D0A0OO DRUGTYPE Small molecular drug D0A0OO DRUGINCH 1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1 D0A0OO DRUGINKE YMARZQAQMVYCKC-OEMFJLHTSA-N D0A0OO DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N D0A0OO HIGHSTAT Approved D0A1CB DRUG__ID D0A1CB D0A1CB DRUGCOMP Bristol-Myers Squibb D0A1CB THERCLAS Antibiotics D0A1CB DRUGTYPE Small molecular drug D0A1CB DRUGINCH 1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12-/t13-,17-/m1/s1 D0A1CB DRUGINKE HVFLCNVBZFFHBT-ZKDACBOMSA-N D0A1CB DRUGSMIL C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-] D0A1CB HIGHSTAT Approved D0A1PX DRUG__ID D0A1PX D0A1PX DRUGCOMP Abbott Laboratories D0A1PX THERCLAS Antiinflammatory Agents D0A1PX DRUGTYPE Small molecular drug D0A1PX DRUGINCH 1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18) D0A1PX DRUGINKE SYTBZMRGLBWNTM-UHFFFAOYSA-N D0A1PX DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O D0A1PX HIGHSTAT Approved D0A2ZX DRUG__ID D0A2ZX D0A2ZX DRUGCOMP Pfizer Pharmaceuticals D0A2ZX THERCLAS Antiinfective Agents D0A2ZX DRUGTYPE Small molecular drug D0A2ZX DRUGINCH 1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3 D0A2ZX DRUGINKE VAOCPAMSLUNLGC-UHFFFAOYSA-N D0A2ZX DRUGSMIL CC1=NC=C(N1CCO)[N+](=O)[O-] D0A2ZX HIGHSTAT Approved D0A3HB DRUG__ID D0A3HB D0A3HB DRUGCOMP AstraZeneca D0A3HB THERCLAS Hypnotics and Sedatives D0A3HB DRUGTYPE Small molecular drug D0A3HB DRUGINCH 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 D0A3HB DRUGINKE OLBCVFGFOZPWHH-UHFFFAOYSA-N D0A3HB DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)O D0A3HB HIGHSTAT Approved D0A4IJ DRUG__ID D0A4IJ D0A4IJ DRUGCOMP GlaxoSmithKline D0A4IJ THERCLAS Anti-HIV Agents D0A4IJ DRUGTYPE Small molecular drug D0A4IJ DRUGINCH 1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1 D0A4IJ DRUGINKE MCGSCOLBFJQGHM-SCZZXKLOSA-N D0A4IJ DRUGSMIL C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO D0A4IJ HIGHSTAT Approved D0A4YE DRUG__ID D0A4YE D0A4YE DRUGCOMP Pharmaceutical Research Assoc Inc D0A4YE THERCLAS Antiinfective Agents D0A4YE DRUGTYPE Small molecular drug D0A4YE DRUGINCH 1S/C15H14N4O2S/c16-12-6-8-14(9-7-12)22(20,21)18-15-10-11-17-19(15)13-4-2-1-3-5-13/h1-11,18H,16H2 D0A4YE DRUGINKE QWCJHSGMANYXCW-UHFFFAOYSA-N D0A4YE DRUGSMIL C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N D0A4YE HIGHSTAT Approved D0A5FM DRUG__ID D0A5FM D0A5FM DRUGCOMP NB therapeutics; University of Akron D0A5FM THERCLAS Bronchodilator Agents D0A5FM DRUGTYPE Small molecular drug D0A5FM DRUGINCH 1S/NO/c1-2 D0A5FM DRUGINKE MWUXSHHQAYIFBG-UHFFFAOYSA-N D0A5FM DRUGSMIL [N]=O D0A5FM HIGHSTAT Approved D0A5LH DRUG__ID D0A5LH D0A5LH DRUGCOMP Eli Lilly And Co D0A5LH THERCLAS Antiinfective Agents D0A5LH DRUGTYPE Small molecular drug D0A5LH DRUGINCH 1S/C16H18N2O4S.C13H20N2O2.H2O/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);5-8H,3-4,9-10,14H2,1-2H3;1H2/t11-,12+,14-;;/m1../s1 D0A5LH DRUGINKE KZDCMKVLEYCGQX-UDPGNSCCSA-N D0A5LH DRUGSMIL CCN(CC)CCOC(=O)C1=CC=C(C=C1)N.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.O D0A5LH HIGHSTAT Approved D0A6CQ DRUG__ID D0A6CQ D0A6CQ DRUGCOMP Alcon Pharmaceuticals Ltd D0A6CQ THERCLAS Cardiotonic Agents D0A6CQ DRUGTYPE Small molecular drug D0A6CQ DRUGINCH 1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3/t17-/m0/s1 D0A6CQ DRUGINKE NWIUTZDMDHAVTP-KRWDZBQOSA-N D0A6CQ DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O D0A6CQ HIGHSTAT Approved D0A8XN DRUG__ID D0A8XN D0A8XN DRUGCOMP Allen & Handbury D0A8XN THERCLAS Antihypertensive Agents D0A8XN DRUGTYPE Small molecular drug D0A8XN DRUGINCH 1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24) D0A8XN DRUGINKE SGUAFYQXFOLMHL-UHFFFAOYSA-N D0A8XN DRUGSMIL CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O D0A8XN HIGHSTAT Approved D0A9YA DRUG__ID D0A9YA D0A9YA DRUGCOMP GSK D0A9YA THERCLAS Anticancer Agents D0A9YA DRUGTYPE Small molecular drug D0A9YA DRUGINCH 1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1 D0A9YA DRUGINKE JWJOTENAMICLJG-QWBYCMEYSA-N D0A9YA DRUGSMIL CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C D0A9YA HIGHSTAT Approved D0AA0L DRUG__ID D0AA0L D0AA0L DRUGCOMP Organon International D0AA0L THERCLAS Neuromuscular Nondepolarizing Agents D0AA0L DRUGTYPE Small molecular drug D0AA0L DRUGINCH 1S/C35H60N2O4/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36/h26-33H,7-23H2,1-6H3/q+2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-/m0/s1 D0AA0L DRUGINKE GVEAYVLWDAFXET-XGHATYIMSA-N D0AA0L DRUGSMIL CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C D0AA0L HIGHSTAT Approved D0AA2D DRUG__ID D0AA2D D0AA2D DRUGCOMP Bayer Pharmaceuticals Corporation D0AA2D THERCLAS Antifungal Agents D0AA2D DRUGTYPE Small molecular drug D0AA2D DRUGINCH 1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H D0AA2D DRUGINKE OCAPBUJLXMYKEJ-UHFFFAOYSA-N D0AA2D DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4 D0AA2D HIGHSTAT Approved D0AD5C DRUG__ID D0AD5C D0AD5C DRUGCOMP Bayer D0AD5C THERCLAS Hypoglycemic Agents D0AD5C DRUGTYPE Small molecular drug D0AD5C DRUGINCH 1S/C25H43NO18/c1-6-11(26-8-2-7(3-27)12(30)15(33)13(8)31)14(32)19(37)24(40-6)43-22-10(5-29)42-25(20(38)17(22)35)44-21-9(4-28)41-23(39)18(36)16(21)34/h2,6,8-39H,3-5H2,1H3/t6-,8+,9-,10-,11-,12-,13+,14+,15+,16-,17-,18-,19-,20-,21-,22-,23?,24-,25-/m1/s1 D0AD5C DRUGINKE XUFXOAAUWZOOIT-UGEKTDRHSA-N D0AD5C DRUGSMIL CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO D0AD5C HIGHSTAT Approved D0AJ5L DRUG__ID D0AJ5L D0AJ5L DRUGCOMP Janssen Pharmaceutica D0AJ5L THERCLAS Antiallergic Agents D0AJ5L DRUGTYPE Small molecular drug D0AJ5L DRUGINCH 1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32) D0AJ5L DRUGINKE BAINIUMDFURPJM-UHFFFAOYSA-N D0AJ5L DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5 D0AJ5L HIGHSTAT Approved D0AO5H DRUG__ID D0AO5H D0AO5H DRUGCOMP GlaxoSmithKline D0AO5H THERCLAS Antiinfective Agents D0AO5H DRUGTYPE Small molecular drug D0AO5H DRUGINCH 1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18) D0AO5H DRUGINKE IEDVJHCEMCRBQM-UHFFFAOYSA-N D0AO5H DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N D0AO5H HIGHSTAT Approved D0AP9T DRUG__ID D0AP9T D0AP9T DRUGCOMP AstraZeneca D0AP9T THERCLAS Antibiotics D0AP9T DRUGTYPE Small molecular drug D0AP9T DRUGINCH 1S/C17H17N7O8S4/c1-23-16(20-21-22-23)34-4-5-3-33-15-17(32-2,14(31)24(15)7(5)11(29)30)19-9(26)13-35-12(36-13)6(8(18)25)10(27)28/h13,15H,3-4H2,1-2H3,(H2,18,25)(H,19,26)(H,27,28)(H,29,30)/t13?,15-,17+/m1/s1 D0AP9T DRUGINKE SRZNHPXWXCNNDU-RHBCBLIFSA-N D0AP9T DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O D0AP9T HIGHSTAT Approved D0AT8C DRUG__ID D0AT8C D0AT8C DRUGCOMP Amgen Inc D0AT8C THERCLAS Immunomodulatory Agents D0AT8C DRUGTYPE Small molecular drug D0AT8C DRUGINCH 1S/C27H46N4O19/c1-10(16(28)23(40)41)48-24-18(30-11(2)33)21(39)20(38)14(49-24)9-47-27(25(42)43)6-12(34)17(22(50-27)19(37)13(35)8-32)31-15(36)7-29-26(44)46-5-4-45-3/h10,12-14,16-22,24,32,34-35,37-39H,4-9,28H2,1-3H3,(H,29,44)(H,30,33)(H,31,36)(H,40,41)(H,42,43)/t10-,12+,13-,14-,16+,17-,18-,19-,20+,21-,22-,24+,27-/m1/s1 D0AT8C DRUGINKE GAQMWPRWVIGRRV-IVDGIBIRSA-N D0AT8C DRUGSMIL CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C D0AT8C HIGHSTAT Approved D0AV3G DRUG__ID D0AV3G D0AV3G DRUGCOMP Janssen Pharmaceutica D0AV3G THERCLAS Antiemetics D0AV3G DRUGTYPE Small molecular drug D0AV3G DRUGINCH 1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30) D0AV3G DRUGINKE FGXWKSZFVQUSTL-UHFFFAOYSA-N D0AV3G DRUGSMIL C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O D0AV3G HIGHSTAT Approved D0AZ3C DRUG__ID D0AZ3C D0AZ3C DRUGCOMP Novartis AG D0AZ3C THERCLAS Anticancer Agents D0AZ3C DRUGTYPE Small molecular drug D0AZ3C DRUGINCH 1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) D0AZ3C DRUGINKE KTUFNOKKBVMGRW-UHFFFAOYSA-N D0AZ3C DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 D0AZ3C HIGHSTAT Approved D0B1EV DRUG__ID D0B1EV D0B1EV DRUGCOMP Akorn Inc D0B1EV THERCLAS Parasympatholytics D0B1EV DRUGTYPE Small molecular drug D0B1EV DRUGINCH 1S/C17H25NO3/c1-18(2)12-13-21-16(19)15(14-8-4-3-5-9-14)17(20)10-6-7-11-17/h3-5,8-9,15,20H,6-7,10-13H2,1-2H3 D0B1EV DRUGINKE SKYSRIRYMSLOIN-UHFFFAOYSA-N D0B1EV DRUGSMIL CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O D0B1EV HIGHSTAT Approved D0B2GI DRUG__ID D0B2GI D0B2GI DRUGCOMP Sanofi-Aventis D0B2GI THERCLAS Hypoglycemic Agents D0B2GI DRUGTYPE Small molecular drug D0B2GI DRUGINCH 1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30) D0B2GI DRUGINKE WIGIZIANZCJQQY-UHFFFAOYSA-N D0B2GI DRUGSMIL CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C D0B2GI HIGHSTAT Approved D0B2UZ DRUG__ID D0B2UZ D0B2UZ DRUGCOMP GlaxoSmithKline D0B2UZ THERCLAS Antipsychotic Agents D0B2UZ DRUGTYPE Small molecular drug D0B2UZ DRUGINCH 1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3 D0B2UZ DRUGINKE WIKYUJGCLQQFNW-UHFFFAOYSA-N D0B2UZ DRUGSMIL CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl D0B2UZ HIGHSTAT Approved D0B3HD DRUG__ID D0B3HD D0B3HD DRUGCOMP Ben Venue Laboratories D0B3HD THERCLAS Antihypertensive Agents D0B3HD DRUGTYPE Small molecular drug D0B3HD DRUGINCH 1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3 D0B3HD DRUGINKE RYYVLZVUVIJVGH-UHFFFAOYSA-N D0B3HD DRUGSMIL CN1C=NC2=C1C(=O)N(C(=O)N2C)C D0B3HD HIGHSTAT Approved D0B4DC DRUG__ID D0B4DC D0B4DC DRUGCOMP Schering-Plough D0B4DC THERCLAS Antifungal Agents D0B4DC DRUGTYPE Small molecular drug D0B4DC DRUGINCH 1S/C23H27N/c1-23(2,3)21-14-12-18(13-15-21)16-24(4)17-20-10-7-9-19-8-5-6-11-22(19)20/h5-15H,16-17H2,1-4H3 D0B4DC DRUGINKE ABJKWBDEJIDSJZ-UHFFFAOYSA-N D0B4DC DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32 D0B4DC HIGHSTAT Approved D0B4IF DRUG__ID D0B4IF D0B4IF DRUGCOMP Johnson & Johnson D0B4IF THERCLAS Antifungal Agents D0B4IF DRUGTYPE Small molecular drug D0B4IF DRUGINCH 1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m0/s1 D0B4IF DRUGINKE XMAYWYJOQHXEEK-OZXSUGGESA-N D0B4IF DRUGSMIL CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl D0B4IF HIGHSTAT Approved D0B4JQ DRUG__ID D0B4JQ D0B4JQ DRUGCOMP Norvatis Phamaceuticals Corporation D0B4JQ THERCLAS Antiallergic Agents D0B4JQ DRUGTYPE Small molecular drug D0B4JQ DRUGINCH 1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3 D0B4JQ DRUGINKE UFLGIAIHIAPJJC-UHFFFAOYSA-N D0B4JQ DRUGSMIL CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2 D0B4JQ HIGHSTAT Approved D0B4TN DRUG__ID D0B4TN D0B4TN DRUGCOMP Knoll Pharma D0B4TN THERCLAS Antiparkinson Agents D0B4TN DRUGTYPE Small molecular drug D0B4TN DRUGINCH 1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2 D0B4TN DRUGINKE YSXKPIUOCJLQIE-UHFFFAOYSA-N D0B4TN DRUGSMIL C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O D0B4TN HIGHSTAT Approved D0B5MP DRUG__ID D0B5MP D0B5MP DRUGCOMP GlaxoSmithKline D0B5MP THERCLAS Antiviral Agents D0B5MP DRUGTYPE Small molecular drug D0B5MP DRUGINCH 1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15) D0B5MP DRUGINKE MKUXAQIIEYXACX-UHFFFAOYSA-N D0B5MP DRUGSMIL C1=NC2=C(N1COCCO)N=C(NC2=O)N D0B5MP HIGHSTAT Approved D0B6CC DRUG__ID D0B6CC D0B6CC DRUGCOMP Hoffmann La Roche Inc D0B6CC THERCLAS Antihypertensive Agents D0B6CC DRUGTYPE Small molecular drug D0B6CC DRUGINCH 1S/C22H25N2OS/c25-22-23(14-17-8-3-1-4-9-17)19-16-26-13-7-12-20(26)21(19)24(22)15-18-10-5-2-6-11-18/h1-6,8-11,19-21H,7,12-16H2/q+1 D0B6CC DRUGINKE CHQOEHPMXSHGCL-UHFFFAOYSA-N D0B6CC DRUGSMIL C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5 D0B6CC HIGHSTAT Approved D0B6TW DRUG__ID D0B6TW D0B6TW DRUGCOMP Hospira Inc D0B6TW THERCLAS Anticancer Agents D0B6TW DRUGTYPE Small molecular drug D0B6TW DRUGINCH 1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12?,13-;/m0./s1 D0B6TW DRUGINKE KVUAALJSMIVURS-ZEDZUCNESA-L D0B6TW DRUGSMIL C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2] D0B6TW HIGHSTAT Approved D0B7EB DRUG__ID D0B7EB D0B7EB DRUGCOMP Bristol Myers Squibb Co Pharmaceutical Research Institute D0B7EB THERCLAS Anticancer Agents D0B7EB DRUGTYPE Small molecular drug D0B7EB DRUGINCH 1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1 D0B7EB DRUGINKE VJJPUSNTGOMMGY-MRVIYFEKSA-N D0B7EB DRUGSMIL CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O D0B7EB HIGHSTAT Approved D0B7NG DRUG__ID D0B7NG D0B7NG DRUGCOMP Schering-Plough Corporation D0B7NG THERCLAS Antiallergic Agents D0B7NG DRUGTYPE Small molecular drug D0B7NG DRUGINCH 1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3 D0B7NG DRUGINKE SOYKEARSMXGVTM-UHFFFAOYSA-N D0B7NG DRUGSMIL CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2 D0B7NG HIGHSTAT Approved D0B7YT DRUG__ID D0B7YT D0B7YT DRUGCOMP Norvatis Phamaceuticals Corporation D0B7YT THERCLAS Antispasmodics D0B7YT DRUGTYPE Small molecular drug D0B7YT DRUGINCH 1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13-,14+,15-,16+/m1/s1 D0B7YT DRUGINKE STECJAGHUSJQJN-USLFZFAMSA-N D0B7YT DRUGSMIL CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4 D0B7YT HIGHSTAT Approved D0B8UJ DRUG__ID D0B8UJ D0B8UJ DRUGCOMP GlaxoSmithKline D0B8UJ THERCLAS Anticancer Agents D0B8UJ DRUGTYPE Small molecular drug D0B8UJ DRUGINCH 1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1 D0B8UJ DRUGINKE IXOXBSCIXZEQEQ-UHTZMRCNSA-N D0B8UJ DRUGSMIL COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N D0B8UJ HIGHSTAT Approved D0B8WN DRUG__ID D0B8WN D0B8WN DRUGCOMP GlaxoSmithKline D0B8WN THERCLAS Antiulcer Agents D0B8WN DRUGTYPE Small molecular drug D0B8WN DRUGINCH 1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+ D0B8WN DRUGINKE VMXUWOKSQNHOCA-UKTHLTGXSA-N D0B8WN DRUGSMIL CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C D0B8WN HIGHSTAT Approved D0BA6T DRUG__ID D0BA6T D0BA6T DRUGCOMP Ivax pharmaceutical D0BA6T THERCLAS Antihypertensive Agents D0BA6T DRUGTYPE Small molecular drug D0BA6T DRUGINCH 1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1 D0BA6T DRUGINKE CJCSPKMFHVPWAR-JTQLQIEISA-N D0BA6T DRUGSMIL CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N D0BA6T HIGHSTAT Approved D0BD8D DRUG__ID D0BD8D D0BD8D DRUGCOMP Janssen Pharmaceutica D0BD8D THERCLAS Gastrointestinal Agents D0BD8D DRUGTYPE Small molecular drug D0BD8D DRUGINCH 1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1 D0BD8D DRUGINKE DCSUBABJRXZOMT-IRLDBZIGSA-N D0BD8D DRUGSMIL COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F D0BD8D HIGHSTAT Approved D0BG4W DRUG__ID D0BG4W D0BG4W DRUGCOMP Abraxis Pharmaceutical Products D0BG4W THERCLAS Antiinfective Agents D0BG4W DRUGTYPE Small molecular drug D0BG4W DRUGINCH 1S/Cu.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2 D0BG4W DRUGINKE ARUVKPQLZAKDPS-UHFFFAOYSA-L D0BG4W DRUGSMIL [O-]S(=O)(=O)[O-].[Cu+2] D0BG4W HIGHSTAT Approved D0BM5G DRUG__ID D0BM5G D0BM5G DRUGCOMP Allergan Pharmaceuticals D0BM5G THERCLAS Dermatologic Agents D0BM5G DRUGTYPE Small molecular drug D0BM5G DRUGINCH 1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3 D0BM5G DRUGINKE OGQICQVSFDPSEI-UHFFFAOYSA-N D0BM5G DRUGSMIL CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C D0BM5G HIGHSTAT Approved D0BN9X DRUG__ID D0BN9X D0BN9X DRUGCOMP Medicure Pharma D0BN9X THERCLAS Fibrinolytic Agents D0BN9X DRUGTYPE Small molecular drug D0BN9X DRUGINCH 1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1 D0BN9X DRUGINKE COKMIXFXJJXBQG-NRFANRHFSA-N D0BN9X DRUGSMIL CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O D0BN9X HIGHSTAT Approved D0BV3J DRUG__ID D0BV3J D0BV3J TRADNAME Macrilen D0BV3J DRUGCOMP Aeterna Zentaris D0BV3J DRUGTYPE Small molecular drug D0BV3J DRUGINCH 1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1 D0BV3J DRUGINKE UJVDJAPJQWZRFR-DHIUTWEWSA-N D0BV3J DRUGSMIL CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)NC=O)N D0BV3J HIGHSTAT Approved D0BZ7W DRUG__ID D0BZ7W D0BZ7W DRUGCOMP Pfizer Pharmaceuticals D0BZ7W THERCLAS Antispasmodics D0BZ7W DRUGTYPE Small molecular drug D0BZ7W DRUGINCH 1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1 D0BZ7W DRUGINKE OOGJQPCLVADCPB-HXUWFJFHSA-N D0BZ7W DRUGSMIL CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2 D0BZ7W HIGHSTAT Approved D0C1IW DRUG__ID D0C1IW D0C1IW DRUGCOMP Pfizer Pharmaceuticals D0C1IW THERCLAS Oxytocics D0C1IW DRUGTYPE Small molecular drug D0C1IW DRUGINCH 1S/C19H23N3O2/c1-11(10-23)21-19(24)13-6-15-14-4-3-5-16-18(14)12(8-20-16)7-17(15)22(2)9-13/h3-6,8,11,13,17,20,23H,7,9-10H2,1-2H3,(H,21,24)/t11-,13+,17+/m0/s1 D0C1IW DRUGINKE WVVSZNPYNCNODU-XTQGRXLLSA-N D0C1IW DRUGSMIL CC(CO)NC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C D0C1IW HIGHSTAT Approved D0C2EP DRUG__ID D0C2EP D0C2EP DRUGCOMP Hoffmann-La Roche pharmaceutical company D0C2EP THERCLAS Antihypertensive Agents D0C2EP DRUGTYPE Small molecular drug D0C2EP DRUGINCH 1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1 D0C2EP DRUGINKE UXIGZRQVLGFTOU-VQXQMPIVSA-N D0C2EP DRUGSMIL CC(C)(C)S(=O)(=O)CC(CC1=CC=CC=C1)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC3CCCCC3)C(C(C4CC4)O)O D0C2EP HIGHSTAT Approved D0C2YB DRUG__ID D0C2YB D0C2YB DRUGCOMP Pfizer Pharmaceuticals D0C2YB THERCLAS Antibiotics D0C2YB DRUGTYPE Small molecular drug D0C2YB DRUGINCH 1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1 D0C2YB DRUGINKE GCFBRXLSHGKWDP-XCGNWRKASA-N D0C2YB DRUGSMIL CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O D0C2YB HIGHSTAT Approved D0C4HG DRUG__ID D0C4HG D0C4HG DRUGCOMP Abbott Laboratories D0C4HG THERCLAS Cardiotonic Agents D0C4HG DRUGTYPE Small molecular drug D0C4HG DRUGINCH 1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1 D0C4HG DRUGINKE WHXMKTBCFHIYNQ-SECBINFHSA-N D0C4HG DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N D0C4HG HIGHSTAT Approved D0C4LF DRUG__ID D0C4LF D0C4LF TRADNAME Mektovi D0C4LF DRUGCOMP Array BioPharma D0C4LF DRUGTYPE Small molecular drug D0C4LF DRUGINCH 1S/C17H15BrF2N4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) D0C4LF DRUGINKE ACWZRVQXLIRSDF-UHFFFAOYSA-N D0C4LF DRUGSMIL CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO D0C4LF HIGHSTAT Approved D0C5XC DRUG__ID D0C5XC D0C5XC DRUGCOMP Norvatis Phamaceuticals Corporation D0C5XC THERCLAS Antiallergic Agents D0C5XC DRUGTYPE Small molecular drug D0C5XC DRUGINCH 1S/C21H26ClNO/c1-21(17-7-4-3-5-8-17,18-10-12-19(22)13-11-18)24-16-14-20-9-6-15-23(20)2/h3-5,7-8,10-13,20H,6,9,14-16H2,1-2H3/t20-,21-/m1/s1 D0C5XC DRUGINKE YNNUSGIPVFPVBX-NHCUHLMSSA-N D0C5XC DRUGSMIL CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C D0C5XC HIGHSTAT Approved D0C6DT DRUG__ID D0C6DT D0C6DT DRUGCOMP AstraZeneca D0C6DT THERCLAS Antiulcer Agents D0C6DT DRUGTYPE Small molecular drug D0C6DT DRUGINCH 1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1 D0C6DT DRUGINKE SUBDBMMJDZJVOS-DEOSSOPVSA-N D0C6DT DRUGSMIL CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC D0C6DT HIGHSTAT Approved D0C6NM DRUG__ID D0C6NM D0C6NM DRUGCOMP Pfizer Pharmaceuticals D0C6NM THERCLAS Antihypertensive Agents D0C6NM DRUGTYPE Small molecular drug D0C6NM DRUGINCH 1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1 D0C6NM DRUGINKE GGXICVAJURFBLW-CEYXHVGTSA-N D0C6NM DRUGSMIL CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O D0C6NM HIGHSTAT Approved D0C8EU DRUG__ID D0C8EU D0C8EU DRUGCOMP Schering-Plough D0C8EU THERCLAS Anticancer Agents D0C8EU DRUGTYPE Small molecular drug D0C8EU DRUGINCH 1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13) D0C8EU DRUGINKE BPEGJWRSRHCHSN-UHFFFAOYSA-N D0C8EU DRUGSMIL CN1C(=O)N2C=NC(=C2N=N1)C(=O)N D0C8EU HIGHSTAT Approved D0C9SY DRUG__ID D0C9SY D0C9SY DRUGCOMP Bayer Pharmaceuticals Corporation D0C9SY THERCLAS Antiimpotence Agents D0C9SY DRUGTYPE Small molecular drug D0C9SY DRUGINCH 1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30) D0C9SY DRUGINKE SECKRCOLJRRGGV-UHFFFAOYSA-N D0C9SY DRUGSMIL CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C D0C9SY HIGHSTAT Approved D0C9XJ DRUG__ID D0C9XJ D0C9XJ DRUGCOMP Pfizer Pharmaceuticals D0C9XJ THERCLAS Anticancer Agents D0C9XJ DRUGTYPE Small molecular drug D0C9XJ DRUGINCH 1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1 D0C9XJ DRUGINKE AOJJSUZBOXZQNB-VTZDEGQISA-N D0C9XJ DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O D0C9XJ HIGHSTAT Approved D0CF2Q DRUG__ID D0CF2Q D0CF2Q DRUGCOMP Janssen Pharmaceutica D0CF2Q THERCLAS Anticancer Agents D0CF2Q DRUGTYPE Small molecular drug D0CF2Q DRUGINCH 1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1 D0CF2Q DRUGINKE HLFSDGLLUJUHTE-SNVBAGLBSA-N D0CF2Q DRUGSMIL C1CSC2=NC(CN21)C3=CC=CC=C3 D0CF2Q HIGHSTAT Approved D0CL9S DRUG__ID D0CL9S D0CL9S DRUGCOMP Idenix D0CL9S THERCLAS Antiviral Agents D0CL9S DRUGTYPE Small molecular drug D0CL9S DRUGINCH 1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m1/s1 D0CL9S DRUGINKE IQFYYKKMVGJFEH-CSMHCCOUSA-N D0CL9S DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O D0CL9S HIGHSTAT Approved D0CP4E DRUG__ID D0CP4E D0CP4E DRUGCOMP Roche Pharmaceuticals D0CP4E THERCLAS Anticonvulsants D0CP4E DRUGTYPE Small molecular drug D0CP4E DRUGINCH 1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20) D0CP4E DRUGINKE DGBIGWXXNGSACT-UHFFFAOYSA-N D0CP4E DRUGSMIL C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl D0CP4E HIGHSTAT Approved D0CS2F DRUG__ID D0CS2F D0CS2F DRUGCOMP Janssen Pharmaceutica D0CS2F THERCLAS Antidiarrheals D0CS2F DRUGTYPE Small molecular drug D0CS2F DRUGINCH 1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3 D0CS2F DRUGINKE RDOIQAHITMMDAJ-UHFFFAOYSA-N D0CS2F DRUGSMIL CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4 D0CS2F HIGHSTAT Approved D0CT9C DRUG__ID D0CT9C D0CT9C DRUGCOMP Baxter International Inc D0CT9C THERCLAS Anticancer Agents D0CT9C DRUGTYPE Small molecular drug D0CT9C DRUGINCH 1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12) D0CT9C DRUGINKE CMSMOCZEIVJLDB-UHFFFAOYSA-N D0CT9C DRUGSMIL C1CNP(=O)(OC1)N(CCCl)CCCl D0CT9C HIGHSTAT Approved D0D1AL DRUG__ID D0D1AL D0D1AL DRUGCOMP Janssen Pharmaceutica D0D1AL THERCLAS Antipsychotic Agents D0D1AL DRUGTYPE Small molecular drug D0D1AL DRUGINCH 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 D0D1AL DRUGINKE LNEPOXFFQSENCJ-UHFFFAOYSA-N D0D1AL DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F D0D1AL HIGHSTAT Approved D0D1DI DRUG__ID D0D1DI D0D1DI DRUGCOMP Sepracor phamaceuticals D0D1DI THERCLAS Bronchodilator Agents D0D1DI DRUGTYPE Small molecular drug D0D1DI DRUGINCH 1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1 D0D1DI DRUGINKE BPZSYCZIITTYBL-YJYMSZOUSA-N D0D1DI DRUGSMIL CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O D0D1DI HIGHSTAT Approved D0D1HA DRUG__ID D0D1HA D0D1HA DRUGCOMP Roussel Uclaf D0D1HA THERCLAS Antibiotics D0D1HA DRUGTYPE Small molecular drug D0D1HA DRUGINCH 1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1 D0D1HA DRUGINKE GPRBEKHLDVQUJE-QSWIMTSFSA-N D0D1HA DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O D0D1HA HIGHSTAT Approved D0D1HW DRUG__ID D0D1HW D0D1HW DRUGCOMP Shire Phamaceuticals D0D1HW THERCLAS Antithrombotic Agents D0D1HW DRUGTYPE Small molecular drug D0D1HW DRUGINCH 1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16) D0D1HW DRUGINKE OTBXOEAOVRKTNQ-UHFFFAOYSA-N D0D1HW DRUGSMIL C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3 D0D1HW HIGHSTAT Approved D0D1MA DRUG__ID D0D1MA D0D1MA DRUGCOMP Novartis Pharmaceuticals Corp D0D1MA THERCLAS Parasympatholytics D0D1MA DRUGTYPE Small molecular drug D0D1MA DRUGINCH 1S/C21H34NO3/c1-4-22(3,5-2)16-17-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6,8-9,12-13,19,24H,4-5,7,10-11,14-17H2,1-3H3/q+1 D0D1MA DRUGINKE GFRUPHOKLBPHTQ-UHFFFAOYSA-N D0D1MA DRUGSMIL CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O D0D1MA HIGHSTAT Approved D0D1SG DRUG__ID D0D1SG D0D1SG DRUGCOMP Schering Corp Sub Schering Plough Corp D0D1SG THERCLAS Anticancer Agents D0D1SG DRUGTYPE Small molecular drug D0D1SG DRUGINCH 1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 D0D1SG DRUGINKE OIGNJSKKLXVSLS-VWUMJDOOSA-N D0D1SG DRUGSMIL CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O D0D1SG HIGHSTAT Approved D0D3DU DRUG__ID D0D3DU D0D3DU DRUGCOMP Hospira Inc D0D3DU THERCLAS Anticancer Agents D0D3DU DRUGTYPE Small molecular drug D0D3DU DRUGINCH 1S/C20H22N8O5.2Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);;/q;2*+1/p-2/t13-;;/m0../s1 D0D3DU DRUGINKE DASQOOZCTWOQPA-GXKRWWSZSA-L D0D3DU DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+] D0D3DU HIGHSTAT Approved D0D5SQ DRUG__ID D0D5SQ D0D5SQ DRUGCOMP AstraZeneca D0D5SQ THERCLAS Antihypertensive Agents D0D5SQ DRUGTYPE Small molecular drug D0D5SQ DRUGINCH 1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29) D0D5SQ DRUGINKE HTQMVQVXFRQIKW-UHFFFAOYSA-N D0D5SQ DRUGSMIL CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O D0D5SQ HIGHSTAT Approved D0D5ZJ DRUG__ID D0D5ZJ D0D5ZJ TRADNAME Ojjaara D0D5ZJ DRUGCOMP GSK D0D5ZJ DRUGTYPE Small molecular drug D0D5ZJ DRUGINCH 1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28) D0D5ZJ DRUGINKE ZVHNDZWQTBEVRY-UHFFFAOYSA-N D0D5ZJ DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N D0D5ZJ HIGHSTAT Approved D0D7KC DRUG__ID D0D7KC D0D7KC DRUGCOMP GSK D0D7KC THERCLAS Analgesics D0D7KC DRUGTYPE Small molecular drug D0D7KC DRUGINCH 1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1 D0D7KC DRUGINKE UPNUIXSCZBYVBB-JVFUWBCBSA-N D0D7KC DRUGSMIL CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O D0D7KC HIGHSTAT Approved D0D7LA DRUG__ID D0D7LA D0D7LA DRUGCOMP Bristol-Myers Squibb D0D7LA THERCLAS Hypoglycemic Agents D0D7LA DRUGTYPE Small molecular drug D0D7LA DRUGINCH 1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8) D0D7LA DRUGINKE XZWYZXLIPXDOLR-UHFFFAOYSA-N D0D7LA DRUGSMIL CN(C)C(=N)N=C(N)N D0D7LA HIGHSTAT Approved D0D8DD DRUG__ID D0D8DD D0D8DD DRUGCOMP Janssen Pharmaceutica D0D8DD THERCLAS Anesthetics D0D8DD DRUGTYPE Small molecular drug D0D8DD DRUGINCH 1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3 D0D8DD DRUGINKE GGCSSNBKKAUURC-UHFFFAOYSA-N D0D8DD DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC D0D8DD HIGHSTAT Approved D0D9FV DRUG__ID D0D9FV D0D9FV DRUGCOMP 3M Pharmaceuticals D0D9FV THERCLAS Antiparkinson Agents D0D9FV DRUGTYPE Small molecular drug D0D9FV DRUGINCH 1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3 D0D9FV DRUGINKE QVYRGXJJSLMXQH-UHFFFAOYSA-N D0D9FV DRUGSMIL CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C D0D9FV HIGHSTAT Approved D0D9HW DRUG__ID D0D9HW D0D9HW DRUGCOMP Gilead Sciences D0D9HW THERCLAS Anti-HIV Agents D0D9HW DRUGTYPE Small molecular drug D0D9HW DRUGINCH 1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1 D0D9HW DRUGINKE SGOIRFVFHAKUTI-ZCFIWIBFSA-N D0D9HW DRUGSMIL CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O D0D9HW HIGHSTAT Approved D0D9JW DRUG__ID D0D9JW D0D9JW DRUGCOMP Laboratorios Syntex SA D0D9JW THERCLAS Analgesics D0D9JW DRUGTYPE Small molecular drug D0D9JW DRUGINCH 1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19) D0D9JW DRUGINKE OZWKMVRBQXNZKK-UHFFFAOYSA-N D0D9JW DRUGSMIL C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O D0D9JW HIGHSTAT Approved D0DD0K DRUG__ID D0DD0K D0DD0K DRUGCOMP Merck & Co D0DD0K THERCLAS Antihypertensive Agents D0DD0K DRUGTYPE Small molecular drug D0DD0K DRUGINCH 1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) D0DD0K DRUGINKE PSIFNNKUMBGKDQ-UHFFFAOYSA-N D0DD0K DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl D0DD0K HIGHSTAT Approved D0DK8V DRUG__ID D0DK8V D0DK8V DRUGCOMP Pfizer Pharmaceuticals D0DK8V THERCLAS Antiallergic Agents D0DK8V DRUGTYPE Small molecular drug D0DK8V DRUGINCH 1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26) D0DK8V DRUGINKE ZKLPARSLTMPFCP-UHFFFAOYSA-N D0DK8V DRUGSMIL C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl D0DK8V HIGHSTAT Approved D0DT5E DRUG__ID D0DT5E D0DT5E DRUGCOMP Eli Lilly And Co D0DT5E THERCLAS Antiinfective Agents D0DT5E DRUGTYPE Small molecular drug D0DT5E DRUGINCH 1S/C16H16N2O6S2.Na/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10;/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23);/q;+1/p-1/t12-,15-;/m1./s1 D0DT5E DRUGINKE VUFGUVLLDPOSBC-XRZFDKQNSA-M D0DT5E DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+] D0DT5E HIGHSTAT Approved D0DV3O DRUG__ID D0DV3O D0DV3O DRUGCOMP Allergan Pharmaceuticals D0DV3O THERCLAS Antihistamines D0DV3O DRUGTYPE Small molecular drug D0DV3O DRUGINCH 1S/C16H15N3/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16/h1-8,15H,9-10H2,(H2,17,18) D0DV3O DRUGINKE WHWZLSFABNNENI-UHFFFAOYSA-N D0DV3O DRUGSMIL C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N D0DV3O HIGHSTAT Approved D0E0LQ DRUG__ID D0E0LQ D0E0LQ DRUGCOMP Pfizer Pharmaceuticals D0E0LQ THERCLAS Antipsychotic Agents D0E0LQ DRUGTYPE Small molecular drug D0E0LQ DRUGINCH 1S/C23H29N3O2S2/c1-24(2)30(27,28)18-10-11-23-21(17-18)19(20-7-4-5-9-22(20)29-23)8-6-12-26-15-13-25(3)14-16-26/h4-5,7-11,17H,6,12-16H2,1-3H3/b19-8- D0E0LQ DRUGINKE GFBKORZTTCHDGY-UWVJOHFNSA-N D0E0LQ DRUGSMIL CN1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C D0E0LQ HIGHSTAT Approved D0E0OG DRUG__ID D0E0OG D0E0OG DRUGCOMP Wyeth Pharmaceuticals D0E0OG THERCLAS Antianxiety Agents D0E0OG DRUGTYPE Small molecular drug D0E0OG DRUGINCH 1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20) D0E0OG DRUGINKE DIWRORZWFLOCLC-UHFFFAOYSA-N D0E0OG DRUGSMIL C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl D0E0OG HIGHSTAT Approved D0E0WQ DRUG__ID D0E0WQ D0E0WQ DRUGCOMP Schering-Plough D0E0WQ THERCLAS Hypnotics and Sedatives D0E0WQ DRUGTYPE Small molecular drug D0E0WQ DRUGINCH 1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13) D0E0WQ DRUGINKE FTOAOBMCPZCFFF-UHFFFAOYSA-N D0E0WQ DRUGSMIL CCC1(C(=O)NC(=O)NC1=O)CC D0E0WQ HIGHSTAT Approved D0E1WI DRUG__ID D0E1WI D0E1WI DRUGCOMP Janssen Pharmaceuticals Inc D0E1WI THERCLAS Neurology Agents D0E1WI DRUGTYPE Small molecular drug D0E1WI DRUGINCH 1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3 D0E1WI DRUGINKE PJMPHNIQZUBGLI-UHFFFAOYSA-N D0E1WI DRUGSMIL CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3 D0E1WI HIGHSTAT Approved D0E1XL DRUG__ID D0E1XL D0E1XL DRUGCOMP UCB Pharmaceuticals Inc D0E1XL THERCLAS Anticonvulsants D0E1XL DRUGTYPE Small molecular drug D0E1XL DRUGINCH 1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1 D0E1XL DRUGINKE HPHUVLMMVZITSG-LURJTMIESA-N D0E1XL DRUGSMIL CCC(C(=O)N)N1CCCC1=O D0E1XL HIGHSTAT Approved D0E3FD DRUG__ID D0E3FD D0E3FD DRUGCOMP Hoffmann-La Roche pharmaceutical company D0E3FD THERCLAS Hypnotics and Sedatives D0E3FD DRUGTYPE Small molecular drug D0E3FD DRUGINCH 1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19) D0E3FD DRUGINKE VMIYHDSEFNYJSL-UHFFFAOYSA-N D0E3FD DRUGSMIL C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3 D0E3FD HIGHSTAT Approved D0E3OF DRUG__ID D0E3OF D0E3OF DRUGCOMP Pharmaceutical Research Assoc Inc D0E3OF THERCLAS Anticoagulants D0E3OF DRUGTYPE Small molecular drug D0E3OF DRUGINCH 1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3 D0E3OF DRUGINKE PJVWKTKQMONHTI-UHFFFAOYSA-N D0E3OF DRUGSMIL CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O D0E3OF HIGHSTAT Approved D0E3RW DRUG__ID D0E3RW D0E3RW DRUGCOMP Cornerstone BioPharma D0E3RW THERCLAS Antibiotics D0E3RW DRUGTYPE Small molecular drug D0E3RW DRUGINCH 1S/C19H18N6O5S3/c1-8-11(33-7-21-8)4-3-9-5-31-17-13(16(27)25(17)14(9)18(28)29)23-15(26)12(24-30-2)10-6-32-19(20)22-10/h3-4,6-7,13,17H,5H2,1-2H3,(H2,20,22)(H,23,26)(H,28,29)/b4-3-,24-12-/t13-,17-/m1/s1 D0E3RW DRUGINKE KMIPKYQIOVAHOP-YLGJWRNMSA-N D0E3RW DRUGSMIL CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O D0E3RW HIGHSTAT Approved D0E4DW DRUG__ID D0E4DW D0E4DW DRUGCOMP Mylan Laboratories D0E4DW THERCLAS Anticonvulsants D0E4DW DRUGTYPE Small molecular drug D0E4DW DRUGINCH 1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19) D0E4DW DRUGINKE CXOFVDLJLONNDW-UHFFFAOYSA-N D0E4DW DRUGSMIL C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3 D0E4DW HIGHSTAT Approved D0E6BB DRUG__ID D0E6BB D0E6BB TRADNAME Zemdri D0E6BB DRUGCOMP Achaogen D0E6BB DRUGTYPE Small molecular drug D0E6BB DRUGINCH 1S/C25H48N6O10/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+/m1/s1 D0E6BB DRUGINKE IYDYFVUFSPQPPV-PEXOCOHZSA-N D0E6BB DRUGSMIL CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O D0E6BB HIGHSTAT Approved D0E6XR DRUG__ID D0E6XR D0E6XR DRUGCOMP Bristol Myers Squibb D0E6XR THERCLAS Anticancer Agents D0E6XR DRUGTYPE Small molecular drug D0E6XR DRUGINCH 1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27) D0E6XR DRUGINKE ZBNZXTGUTAYRHI-UHFFFAOYSA-N D0E6XR DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO D0E6XR HIGHSTAT Approved D0E7PQ DRUG__ID D0E7PQ D0E7PQ DRUGCOMP Merck D0E7PQ THERCLAS Anticancer Agents D0E7PQ DRUGTYPE Small molecular drug D0E7PQ DRUGINCH 1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18) D0E7PQ DRUGINKE WAEXFXRVDQXREF-UHFFFAOYSA-N D0E7PQ DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO D0E7PQ HIGHSTAT Approved D0E7ZU DRUG__ID D0E7ZU D0E7ZU TRADNAME Austedo D0E7ZU DRUGCOMP Teva D0E7ZU DRUGTYPE Small molecular drug D0E7ZU DRUGINCH 1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3/t14-,16-/m1/s1/i3D3,4D3 D0E7ZU DRUGINKE MKJIEFSOBYUXJB-VFJJUKLQSA-N D0E7ZU DRUGSMIL CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC D0E7ZU HIGHSTAT Approved D0E9WL DRUG__ID D0E9WL D0E9WL DRUGCOMP Eli Lilly D0E9WL THERCLAS Antibiotics D0E9WL DRUGTYPE Small molecular drug D0E9WL DRUGINCH 1S/C16H16ClN3O4/c17-9-6-7-10-12(15(22)20(10)13(9)16(23)24)19-14(21)11(18)8-4-2-1-3-5-8/h1-5,10-12H,6-7,18H2,(H,19,21)(H,23,24)/t10-,11-,12+/m1/s1 D0E9WL DRUGINKE JAPHQRWPEGVNBT-UTUOFQBUSA-N D0E9WL DRUGSMIL C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl D0E9WL HIGHSTAT Approved D0EC6Q DRUG__ID D0EC6Q D0EC6Q DRUGCOMP 3m Pharmaceuticals Inc D0EC6Q THERCLAS Anesthetics D0EC6Q DRUGTYPE Small molecular drug D0EC6Q DRUGINCH 1S/C17H20ClNO/c1-19(2)13-12-17(20,14-8-4-3-5-9-14)15-10-6-7-11-16(15)18/h3-11,20H,12-13H2,1-2H3 D0EC6Q DRUGINKE WRCHFMBCVFFYEQ-UHFFFAOYSA-N D0EC6Q DRUGSMIL CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2Cl)O D0EC6Q HIGHSTAT Approved D0ED7U DRUG__ID D0ED7U D0ED7U DRUGCOMP Cephalon D0ED7U THERCLAS Anticonvulsants D0ED7U DRUGTYPE Small molecular drug D0ED7U DRUGINCH 1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1 D0ED7U DRUGINKE PBJUNZJWGZTSKL-MRXNPFEDSA-N D0ED7U DRUGSMIL CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C D0ED7U HIGHSTAT Approved D0EP0C DRUG__ID D0EP0C D0EP0C DRUGCOMP Pfizer Pharmaceuticals D0EP0C THERCLAS Diuretics D0EP0C DRUGTYPE Small molecular drug D0EP0C DRUGINCH 1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1 D0EP0C DRUGINKE LXMSZDCAJNLERA-ZHYRCANASA-N D0EP0C DRUGSMIL CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C D0EP0C HIGHSTAT Approved D0EP8X DRUG__ID D0EP8X D0EP8X DRUGCOMP Jazz Pharmaceuticals D0EP8X THERCLAS Anesthetics D0EP8X DRUGTYPE Small molecular drug D0EP8X DRUGINCH 1S/C4H8O3/c5-3-1-2-4(6)7/h5H,1-3H2,(H,6,7) D0EP8X DRUGINKE SJZRECIVHVDYJC-UHFFFAOYSA-N D0EP8X DRUGSMIL C(CC(=O)O)CO D0EP8X HIGHSTAT Approved D0EV6T DRUG__ID D0EV6T D0EV6T DRUGCOMP Boehriger Ingelheim D0EV6T THERCLAS Anti-HIV Agents D0EV6T DRUGTYPE Small molecular drug D0EV6T DRUGINCH 1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 D0EV6T DRUGINKE SUJUHGSWHZTSEU-FYBSXPHGSA-N D0EV6T DRUGSMIL CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4 D0EV6T HIGHSTAT Approved D0EV8E DRUG__ID D0EV8E D0EV8E DRUGCOMP Merz Pharmaceuticals Llc D0EV8E THERCLAS Antifungal Agents D0EV8E DRUGTYPE Small molecular drug D0EV8E DRUGINCH 1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2 D0EV8E DRUGINKE LEZWWPYKPKIXLL-UHFFFAOYSA-N D0EV8E DRUGSMIL C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl D0EV8E HIGHSTAT Approved D0F0YZ DRUG__ID D0F0YZ D0F0YZ DRUGCOMP Oak Pharmaceuticals Inc D0F0YZ THERCLAS Hypnotics and Sedatives D0F0YZ DRUGTYPE Small molecular drug D0F0YZ DRUGINCH 1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16) D0F0YZ DRUGINKE WEXRUCMBJFQVBZ-UHFFFAOYSA-N D0F0YZ DRUGSMIL CCCC(C)C1(C(=O)NC(=O)NC1=O)CC D0F0YZ HIGHSTAT Approved D0F1EX DRUG__ID D0F1EX D0F1EX DRUGCOMP GlaxoSmithKline D0F1EX THERCLAS Antiinflammatory Agents D0F1EX DRUGTYPE Small molecular drug D0F1EX DRUGINCH 1S/C22H29ClO5/c1-11-6-14-18-15(23)8-12-7-13(25)4-5-20(12,2)19(18)16(26)9-21(14,3)22(11,28)17(27)10-24/h4-5,7,11,14-16,18-19,24,26,28H,6,8-10H2,1-3H3/t11-,14+,15-,16+,18-,19+,20+,21+,22+/m1/s1 D0F1EX DRUGINKE FJXOGVLKCZQRDN-PHCHRAKRSA-N D0F1EX DRUGSMIL CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl D0F1EX HIGHSTAT Approved D0F1LZ DRUG__ID D0F1LZ D0F1LZ DRUGCOMP Actavis Mid Atlantic Llc D0F1LZ THERCLAS Antiinfective Agents D0F1LZ DRUGTYPE Small molecular drug D0F1LZ DRUGINCH 1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4) D0F1LZ DRUGINKE QTBSBXVTEAMEQO-UHFFFAOYSA-N D0F1LZ DRUGSMIL CC(=O)O D0F1LZ HIGHSTAT Approved D0F1UL DRUG__ID D0F1UL D0F1UL DRUGCOMP Solvay Pharmaceuticals D0F1UL THERCLAS Progesterones D0F1UL DRUGTYPE Small molecular drug D0F1UL DRUGINCH 1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1 D0F1UL DRUGINKE JGMOKGBVKVMRFX-HQZYFCCVSA-N D0F1UL DRUGSMIL CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C D0F1UL HIGHSTAT Approved D0F2PO DRUG__ID D0F2PO D0F2PO DRUGCOMP Tocris Bioscience D0F2PO THERCLAS Antihypertensive Agents D0F2PO DRUGTYPE Small molecular drug D0F2PO DRUGINCH 1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3 D0F2PO DRUGINKE JZQKKSLKJUAGIC-UHFFFAOYSA-N D0F2PO DRUGSMIL CC(C)NCC(COC1=CC=CC2=C1C=CN2)O D0F2PO HIGHSTAT Approved D0F2XQ DRUG__ID D0F2XQ D0F2XQ DRUGCOMP Genzyme Corp D0F2XQ THERCLAS Anticancer Agents D0F2XQ DRUGTYPE Small molecular drug D0F2XQ DRUGINCH 1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6+,9-/m1/s1 D0F2XQ DRUGINKE HBUBKKRHXORPQB-FJFJXFQQSA-N D0F2XQ DRUGSMIL C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N D0F2XQ HIGHSTAT Approved D0F2XV DRUG__ID D0F2XV D0F2XV DRUGCOMP Bristol-Myers Squibb Company D0F2XV THERCLAS Antibiotics D0F2XV DRUGTYPE Small molecular drug D0F2XV DRUGINCH 1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1 D0F2XV DRUGINKE WZPBZJONDBGPKJ-VEHQQRBSSA-N D0F2XV DRUGSMIL CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N D0F2XV HIGHSTAT Approved D0F5MT DRUG__ID D0F5MT D0F5MT DRUGCOMP GlaxoSmithKline D0F5MT THERCLAS Anti-HIV Agents D0F5MT DRUGTYPE Small molecular drug D0F5MT DRUGINCH 1S/C25H36N3O9PS/c1-18(2)15-28(39(33,34)22-10-8-20(26)9-11-22)16-24(37-38(30,31)32)23(14-19-6-4-3-5-7-19)27-25(29)36-21-12-13-35-17-21/h3-11,18,21,23-24H,12-17,26H2,1-2H3,(H,27,29)(H2,30,31,32)/t21-,23-,24+/m0/s1 D0F5MT DRUGINKE MLBVMOWEQCZNCC-OEMFJLHTSA-N D0F5MT DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N D0F5MT HIGHSTAT Approved D0F6EO DRUG__ID D0F6EO D0F6EO DRUGCOMP AstraZeneca D0F6EO THERCLAS Antibiotics D0F6EO DRUGTYPE Small molecular drug D0F6EO DRUGINCH 1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1 D0F6EO DRUGINKE LSQZJLSUYDQPKJ-NJBDSQKTSA-N D0F6EO DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C D0F6EO HIGHSTAT Approved D0F6JC DRUG__ID D0F6JC D0F6JC TRADNAME Jesduvroq D0F6JC DRUGCOMP GSK D0F6JC DRUGTYPE Small molecular drug D0F6JC DRUGINCH 1S/C19H27N3O6/c23-14(24)11-20-16(25)15-17(26)21(12-7-3-1-4-8-12)19(28)22(18(15)27)13-9-5-2-6-10-13/h12-13,15H,1-11H2,(H,20,25)(H,23,24) D0F6JC DRUGINKE RUEYEZADQJCKGV-UHFFFAOYSA-N D0F6JC DRUGSMIL C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O D0F6JC HIGHSTAT Approved D0F7NZ DRUG__ID D0F7NZ D0F7NZ DRUGCOMP Merck Sharp And Dohme Corp D0F7NZ THERCLAS Neurology Agents D0F7NZ DRUGTYPE Small molecular drug D0F7NZ DRUGINCH 1S/CH5N3.ClH/c2-1(3)4;/h(H5,2,3,4);1H D0F7NZ DRUGINKE PJJJBBJSCAKJQF-UHFFFAOYSA-N D0F7NZ DRUGSMIL C(=N)(N)N.Cl D0F7NZ HIGHSTAT Approved D0F8CM DRUG__ID D0F8CM D0F8CM DRUGCOMP Ortho-McNeil Pharmaceutical D0F8CM THERCLAS Anticoagulants D0F8CM DRUGTYPE Small molecular drug D0F8CM DRUGINCH 1S/C10H18O21S4/c11-3-1-26-10(8(31-35(22,23)24)5(3)28-32(13,14)15)27-4-2-25-9(12)7(30-34(19,20)21)6(4)29-33(16,17)18/h3-12H,1-2H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)/t3-,4-,5+,6+,7-,8-,9-,10+/m1/s1 D0F8CM DRUGINKE FCCNSUIJIOOXEZ-SJYYZXOBSA-N D0F8CM DRUGSMIL C1C(C(C(C(O1)OC2COC(C(C2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O D0F8CM HIGHSTAT Approved D0F8RA DRUG__ID D0F8RA D0F8RA DRUGCOMP Purdue Pharma D0F8RA THERCLAS Bronchodilator Agents D0F8RA DRUGTYPE Small molecular drug D0F8RA DRUGINCH 1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9) D0F8RA DRUGINKE ZFXYFBGIUFBOJW-UHFFFAOYSA-N D0F8RA DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC=N2 D0F8RA HIGHSTAT Approved D0F9BY DRUG__ID D0F9BY D0F9BY DRUGCOMP Pfizer Pharmaceuticals D0F9BY THERCLAS Antifungal Agents D0F9BY DRUGTYPE Small molecular drug D0F9BY DRUGINCH 1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1 D0F9BY DRUGINKE JHVAMHSQVVQIOT-MFAJLEFUSA-N D0F9BY DRUGSMIL CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O D0F9BY HIGHSTAT Approved D0F9GE DRUG__ID D0F9GE D0F9GE DRUGCOMP FISCHER and ROCH D0F9GE THERCLAS Vasodilator Agents D0F9GE DRUGTYPE Small molecular drug D0F9GE DRUGINCH 1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2 D0F9GE DRUGINKE IZEKFCXSFNUWAM-UHFFFAOYSA-N D0F9GE DRUGSMIL C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO D0F9GE HIGHSTAT Approved D0FD0H DRUG__ID D0FD0H D0FD0H DRUGCOMP Intelfarm Co. D0FD0H THERCLAS Antifibrinolytic Agents D0FD0H DRUGTYPE Small molecular drug D0FD0H DRUGINCH 1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9) D0FD0H DRUGINKE SLXKOJJOQWFEFD-UHFFFAOYSA-N D0FD0H DRUGSMIL C(CCC(=O)O)CCN D0FD0H HIGHSTAT Approved D0FL5V DRUG__ID D0FL5V D0FL5V DRUGCOMP Fougera Pharmaceuticals Inc D0FL5V THERCLAS Antiinflammatory Agents D0FL5V DRUGTYPE Small molecular drug D0FL5V DRUGINCH 1S/C22H28ClFO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1 D0FL5V DRUGINKE FCSHDIVRCWTZOX-DVTGEIKXSA-N D0FL5V DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C D0FL5V HIGHSTAT Approved D0FX2Q DRUG__ID D0FX2Q D0FX2Q TRADNAME Aemcolo D0FX2Q DRUGCOMP Cosmo Technologies D0FX2Q DRUGTYPE Small molecular drug D0FX2Q DRUGINCH 1S/C37H47NO12/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46)/b11-10+,14-13+,17-12-/t16-,18+,19+,20+,25-,29-,30+,33+,37-/m0/s1 D0FX2Q DRUGINKE HJYYPODYNSCCOU-ODRIEIDWSA-N D0FX2Q DRUGSMIL CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C D0FX2Q HIGHSTAT Approved D0G1OZ DRUG__ID D0G1OZ D0G1OZ DRUGCOMP Baxter Healthcare Corp Anesthesia Critical Care D0G1OZ THERCLAS Vasoconstrictor Agents D0G1OZ DRUGTYPE Small molecular drug D0G1OZ DRUGINCH 1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3 D0G1OZ DRUGINKE RXQCGGRTAILOIN-UHFFFAOYSA-N D0G1OZ DRUGSMIL CC(C)(CC1=CC=CC=C1)NC D0G1OZ HIGHSTAT Approved D0G3DL DRUG__ID D0G3DL D0G3DL DRUGCOMP Norvatis Phamaceuticals Corporation D0G3DL THERCLAS Antituberculosis Agents D0G3DL DRUGTYPE Small molecular drug D0G3DL DRUGINCH 1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,49-53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,44-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1 D0G3DL DRUGINKE JQXXHWHPUNPDRT-WLSIYKJHSA-N D0G3DL DRUGSMIL CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C D0G3DL HIGHSTAT Approved D0G3PI DRUG__ID D0G3PI D0G3PI DRUGCOMP Ligand Pharmaceuticals D0G3PI THERCLAS Anticancer Agents D0G3PI DRUGTYPE Small molecular drug D0G3PI DRUGINCH 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+ D0G3PI DRUGINKE SHGAZHPCJJPHSC-ZVCIMWCZSA-N D0G3PI DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D0G3PI HIGHSTAT Approved D0G3SH DRUG__ID D0G3SH D0G3SH DRUGCOMP Axcan Pharma D0G3SH THERCLAS Cholagogues and Choleretics D0G3SH DRUGTYPE Small molecular drug D0G3SH DRUGINCH 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20+,22+,23+,24-/m1/s1 D0G3SH DRUGINKE RUDATBOHQWOJDD-UZVSRGJWSA-N D0G3SH DRUGSMIL CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C D0G3SH HIGHSTAT Approved D0G4OD DRUG__ID D0G4OD D0G4OD DRUGCOMP Wyeth Pharmaceuticals D0G4OD THERCLAS Antibiotics D0G4OD DRUGTYPE Small molecular drug D0G4OD DRUGINCH 1S/C29H39N5O8/c1-28(2,3)31-11-17(35)32-15-10-16(33(4)5)13-8-12-9-14-21(34(6)7)24(38)20(27(30)41)26(40)29(14,42)25(39)18(12)23(37)19(13)22(15)36/h10,12,14,21,31,36-37,40,42H,8-9,11H2,1-7H3,(H2,30,41)(H,32,35)/t12-,14-,21-,29-/m0/s1 D0G4OD DRUGINKE SOVUOXKZCCAWOJ-HJYUBDRYSA-N D0G4OD DRUGSMIL CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C D0G4OD HIGHSTAT Approved D0G5QB DRUG__ID D0G5QB D0G5QB DRUGCOMP Janssen Pharmaceutica D0G5QB THERCLAS Anesthetics D0G5QB DRUGTYPE Small molecular drug D0G5QB DRUGINCH 1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3 D0G5QB DRUGINKE IDBPHNDTYPBSNI-UHFFFAOYSA-N D0G5QB DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC D0G5QB HIGHSTAT Approved D0G5UB DRUG__ID D0G5UB D0G5UB DRUGCOMP Access Pharmaceuticals D0G5UB THERCLAS Antiulcer Agents D0G5UB DRUGTYPE Small molecular drug D0G5UB DRUGINCH 1S/C16H14N2O4/c1-7(2)8-3-4-12-9(5-8)13(19)10-6-11(16(20)21)14(17)18-15(10)22-12/h3-7H,1-2H3,(H2,17,18)(H,20,21) D0G5UB DRUGINKE SGRYPYWGNKJSDL-UHFFFAOYSA-N D0G5UB DRUGSMIL CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N D0G5UB HIGHSTAT Approved D0G6QF DRUG__ID D0G6QF D0G6QF DRUGCOMP AstraZeneca D0G6QF THERCLAS Anticancer Agents D0G6QF DRUGTYPE Small molecular drug D0G6QF DRUGINCH 1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27) D0G6QF DRUGINKE UHTHHESEBZOYNR-UHFFFAOYSA-N D0G6QF DRUGSMIL CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC D0G6QF HIGHSTAT Approved D0G6SD DRUG__ID D0G6SD D0G6SD DRUGCOMP Pfizer Pharmaceuticals D0G6SD THERCLAS Anti-HIV Agents D0G6SD DRUGTYPE Small molecular drug D0G6SD DRUGINCH 1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3 D0G6SD DRUGINKE WHBIGIKBNXZKFE-UHFFFAOYSA-N D0G6SD DRUGSMIL CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C D0G6SD HIGHSTAT Approved D0G6SE DRUG__ID D0G6SE D0G6SE TRADNAME Giapreza D0G6SE DRUGCOMP La Jolla Pharmaceutical Company D0G6SE DRUGTYPE Small molecular drug D0G6SE DRUGINCH 1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1 D0G6SE DRUGINKE CZGUSIXMZVURDU-JZXHSEFVSA-N D0G6SE DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N D0G6SE HIGHSTAT Approved D0G7DJ DRUG__ID D0G7DJ D0G7DJ DRUGCOMP Astrazeneca Lp D0G7DJ THERCLAS Neurology Agents D0G7DJ DRUGTYPE Small molecular drug D0G7DJ DRUGINCH 1S/C17H28N2O/c1-6-12-19(8-3)15(7-2)17(20)18-16-13(4)10-9-11-14(16)5/h9-11,15H,6-8,12H2,1-5H3,(H,18,20) D0G7DJ DRUGINKE VTUSIVBDOCDNHS-UHFFFAOYSA-N D0G7DJ DRUGSMIL CCCN(CC)C(CC)C(=O)NC1=C(C=CC=C1C)C D0G7DJ HIGHSTAT Approved D0G7KJ DRUG__ID D0G7KJ D0G7KJ DRUGCOMP Pharmacia And Upjohn Co D0G7KJ THERCLAS Antiinflammatory Agents D0G7KJ DRUGTYPE Small molecular drug D0G7KJ DRUGINCH 1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13-,14-,16-,17-,19-,20-,21-,22-/m0/s1 D0G7KJ DRUGINKE WXURHACBFYSXBI-XHIJKXOTSA-N D0G7KJ DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F D0G7KJ HIGHSTAT Approved D0G8NN DRUG__ID D0G8NN D0G8NN DRUGCOMP Intas Pharma D0G8NN THERCLAS Antiparkinson Agents D0G8NN DRUGTYPE Small molecular drug D0G8NN DRUGINCH 1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1 D0G8NN DRUGINKE FASDKYOPVNHBLU-ZETCQYMHSA-N D0G8NN DRUGSMIL CCCNC1CCC2=C(C1)SC(=N2)N D0G8NN HIGHSTAT Approved D0G8PA DRUG__ID D0G8PA D0G8PA TRADNAME Prevymis D0G8PA DRUGCOMP Merck & Co. D0G8PA DRUGTYPE Small molecular drug D0G8PA DRUGINCH 1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1 D0G8PA DRUGINKE FWYSMLBETOMXAG-QHCPKHFHSA-N D0G8PA DRUGSMIL COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O D0G8PA HIGHSTAT Approved D0G9IU DRUG__ID D0G9IU D0G9IU DRUGCOMP Sanofi-Aventis D0G9IU THERCLAS Antituberculosis Agents D0G9IU DRUGTYPE Small molecular drug D0G9IU DRUGINCH 1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1 D0G9IU DRUGINKE WDZCUPBHRAEYDL-GZAUEHORSA-N D0G9IU DRUGSMIL CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C D0G9IU HIGHSTAT Approved D0G9YH DRUG__ID D0G9YH D0G9YH DRUGCOMP Travenol Laboratories Inc D0G9YH THERCLAS Anticancer Agents D0G9YH DRUGTYPE Small molecular drug D0G9YH DRUGINCH 1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23) D0G9YH DRUGINKE XCPGHVQEEXUHNC-UHFFFAOYSA-N D0G9YH DRUGSMIL COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42 D0G9YH HIGHSTAT Approved D0GL7U DRUG__ID D0GL7U D0GL7U DRUGCOMP Parke Davis Div Warner Lambert Co D0GL7U THERCLAS Contraceptive Agents D0GL7U DRUGTYPE Small molecular drug D0GL7U DRUGINCH 1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1 D0GL7U DRUGINKE VIKNJXKGJWUCNN-XGXHKTLJSA-N D0GL7U DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34 D0GL7U HIGHSTAT Approved D0GQ7K DRUG__ID D0GQ7K D0GQ7K DRUGCOMP Hoffmann-La Roche pharmaceutical company D0GQ7K THERCLAS Antimalarials D0GQ7K DRUGTYPE Small molecular drug D0GQ7K DRUGINCH 1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2 D0GQ7K DRUGINKE XEEQGYMUWCZPDN-UHFFFAOYSA-N D0GQ7K DRUGSMIL C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O D0GQ7K HIGHSTAT Approved D0GU4K DRUG__ID D0GU4K D0GU4K DRUGCOMP Merck & Co D0GU4K THERCLAS Antiemetics D0GU4K DRUGTYPE Small molecular drug D0GU4K DRUGINCH 1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1 D0GU4K DRUGINKE ATALOFNDEOCMKK-OITMNORJSA-N D0GU4K DRUGSMIL CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F D0GU4K HIGHSTAT Approved D0GV8J DRUG__ID D0GV8J D0GV8J TRADNAME Talzenna D0GV8J DRUGCOMP Pfizer D0GV8J DRUGTYPE Small molecular drug D0GV8J DRUGINCH 1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1 D0GV8J DRUGINKE HWGQMRYQVZSGDQ-HZPDHXFCSA-N D0GV8J DRUGSMIL CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F D0GV8J HIGHSTAT Approved D0GY5Z DRUG__ID D0GY5Z D0GY5Z DRUGCOMP Bayer Pharmaceuticals Corporation D0GY5Z THERCLAS Analgesics D0GY5Z DRUGTYPE Small molecular drug D0GY5Z DRUGINCH 1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) D0GY5Z DRUGINKE BSYNRYMUTXBXSQ-UHFFFAOYSA-N D0GY5Z DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)O D0GY5Z HIGHSTAT Approved D0H0HJ DRUG__ID D0H0HJ D0H0HJ DRUGCOMP GlaxoSmithKline plc D0H0HJ THERCLAS Antidepressants D0H0HJ DRUGTYPE Small molecular drug D0H0HJ DRUGINCH 1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9+/m0/s1 D0H0HJ DRUGINKE AELCINSCMGFISI-DTWKUNHWSA-N D0H0HJ DRUGSMIL C1C(C1N)C2=CC=CC=C2 D0H0HJ HIGHSTAT Approved D0H0KB DRUG__ID D0H0KB D0H0KB DRUGCOMP Sanofi-Aventis D0H0KB THERCLAS Anticonvulsants D0H0KB DRUGTYPE Small molecular drug D0H0KB DRUGINCH 1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) D0H0KB DRUGINKE FTALBRSUTCGOEG-UHFFFAOYSA-N D0H0KB DRUGSMIL C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N D0H0KB HIGHSTAT Approved D0H0ND DRUG__ID D0H0ND D0H0ND DRUGCOMP Merck & Co D0H0ND THERCLAS Anticholesteremic Agents D0H0ND DRUGTYPE Small molecular drug D0H0ND DRUGINCH 1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 D0H0ND DRUGINKE RYMZZMVNJRMUDD-HGQWONQESA-N D0H0ND DRUGSMIL CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C D0H0ND HIGHSTAT Approved D0H2SY DRUG__ID D0H2SY D0H2SY DRUGCOMP Norvatis Phamaceuticals Corporation D0H2SY THERCLAS Anesthetics D0H2SY DRUGTYPE Small molecular drug D0H2SY DRUGINCH 1S/C17H28N2O3/c1-4-7-11-21-16-13-14(8-9-15(16)18)17(20)22-12-10-19(5-2)6-3/h8-9,13H,4-7,10-12,18H2,1-3H3 D0H2SY DRUGINKE CMHHMUWAYWTMGS-UHFFFAOYSA-N D0H2SY DRUGSMIL CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N D0H2SY HIGHSTAT Approved D0H3HM DRUG__ID D0H3HM D0H3HM DRUGCOMP Bristol-Myers Squibb; Otsuka Pharmaceutical Co., Ltd D0H3HM THERCLAS Antipsychotic Agents D0H3HM DRUGTYPE Small molecular drug D0H3HM DRUGINCH 1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29) D0H3HM DRUGINKE CEUORZQYGODEFX-UHFFFAOYSA-N D0H3HM DRUGSMIL C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl D0H3HM HIGHSTAT Approved D0H3MG DRUG__ID D0H3MG D0H3MG DRUGCOMP AstraZeneca D0H3MG THERCLAS Vasoconstrictor Agents D0H3MG DRUGTYPE Small molecular drug D0H3MG DRUGINCH 1S/C46H65N13O11S2/c47-18-8-7-14-29(40(64)52-23-38(51)62)54-45(69)35-15-9-19-59(35)46(70)34-25-72-71-24-28(48)39(63)55-31(20-26-10-3-1-4-11-26)43(67)56-32(21-27-12-5-2-6-13-27)42(66)53-30(16-17-36(49)60)41(65)57-33(22-37(50)61)44(68)58-34/h1-6,10-13,28-35H,7-9,14-25,47-48H2,(H2,49,60)(H2,50,61)(H2,51,62)(H,52,64)(H,53,66)(H,54,69)(H,55,63)(H,56,67)(H,57,65)(H,58,68)/t28-,29-,30-,31-,32-,33-,34-,35-/m0/s1 D0H3MG DRUGINKE SFKQVVDKFKYTNA-DZCXQCEKSA-N D0H3MG DRUGSMIL C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=CC=C4)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N D0H3MG HIGHSTAT Approved D0H3TD DRUG__ID D0H3TD D0H3TD DRUGCOMP Merck & Co D0H3TD THERCLAS Antibiotics D0H3TD DRUGTYPE Small molecular drug D0H3TD DRUGINCH 1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1 D0H3TD DRUGINKE ZSKVGTPCRGIANV-ZXFLCMHBSA-N D0H3TD DRUGSMIL CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O D0H3TD HIGHSTAT Approved D0H3WI DRUG__ID D0H3WI D0H3WI DRUGCOMP Hoffmann-La Roche pharmaceutical company D0H3WI THERCLAS Antiviral Agents D0H3WI DRUGTYPE Small molecular drug D0H3WI DRUGINCH 1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1 D0H3WI DRUGINKE IWUCXVSUMQZMFG-AFCXAGJDSA-N D0H3WI DRUGSMIL C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N D0H3WI HIGHSTAT Approved D0H4JM DRUG__ID D0H4JM D0H4JM DRUGCOMP Palisades Pharmaceuticals Inc D0H4JM THERCLAS Mydriatics D0H4JM DRUGTYPE Small molecular drug D0H4JM DRUGINCH 1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 D0H4JM DRUGINKE BLGXFZZNTVWLAY-SCYLSFHTSA-N D0H4JM DRUGSMIL COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O D0H4JM HIGHSTAT Approved D0H5DU DRUG__ID D0H5DU D0H5DU DRUGCOMP Pfizer Laboratories Div Pfizer Inc D0H5DU THERCLAS Anticholinergic Agents D0H5DU DRUGTYPE Small molecular drug D0H5DU DRUGINCH 1S/C20H28N2O3/c1-22-14-8-13-21-18(22)15-25-19(23)20(24,16-9-4-2-5-10-16)17-11-6-3-7-12-17/h2,4-5,9-10,17,24H,3,6-8,11-15H2,1H3 D0H5DU DRUGINKE DUDKAZCAISNGQN-UHFFFAOYSA-N D0H5DU DRUGSMIL CN1CCCN=C1COC(=O)C(C2CCCCC2)(C3=CC=CC=C3)O D0H5DU HIGHSTAT Approved D0H7KF DRUG__ID D0H7KF D0H7KF DRUGCOMP AstraZeneca D0H7KF THERCLAS Antipsychotic Agents D0H7KF DRUGTYPE Small molecular drug D0H7KF DRUGINCH 1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2 D0H7KF DRUGINKE URKOMYMAXPYINW-UHFFFAOYSA-N D0H7KF DRUGSMIL C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42 D0H7KF HIGHSTAT Approved D0H8FH DRUG__ID D0H8FH D0H8FH DRUGCOMP Servier Laboratories D0H8FH THERCLAS Antihypertensive Agents D0H8FH DRUGTYPE Small molecular drug D0H8FH DRUGINCH 1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23) D0H8FH DRUGINKE NDDAHWYSQHTHNT-UHFFFAOYSA-N D0H8FH DRUGSMIL CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N D0H8FH HIGHSTAT Approved D0H8OH DRUG__ID D0H8OH D0H8OH TRADNAME Sohonos D0H8OH DRUGCOMP Ipsen; Roche D0H8OH DRUGTYPE Small molecular drug D0H8OH DRUGINCH 1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+ D0H8OH DRUGINKE YTFHCXIPDIHOIA-DHZHZOJOSA-N D0H8OH DRUGSMIL CC1(CCC(C2=C1C=C(C(=C2)C=CC3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C D0H8OH HIGHSTAT Approved D0HD9K DRUG__ID D0HD9K D0HD9K DRUGCOMP Promius Pharma Llc D0HD9K THERCLAS Antihypertensive Agents D0HD9K DRUGTYPE Small molecular drug D0HD9K DRUGINCH 1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23) D0HD9K DRUGINKE GOEMGAFJFRBGGG-UHFFFAOYSA-N D0HD9K DRUGSMIL CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C D0HD9K HIGHSTAT Approved D0HQ6N DRUG__ID D0HQ6N D0HQ6N DRUGCOMP Oak Pharmaceuticals Inc Sub Akorn Inc D0HQ6N THERCLAS Antiparkinson Agents D0HQ6N DRUGTYPE Small molecular drug D0HQ6N DRUGINCH 1S/C21H25NO/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-21H,12-15H2,1H3/t18-,19+,20? D0HQ6N DRUGINKE GIJXKZJWITVLHI-YOFSQIOKSA-N D0HQ6N DRUGSMIL CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4 D0HQ6N HIGHSTAT Approved D0I0EG DRUG__ID D0I0EG D0I0EG DRUGCOMP Bristol-Myers Squibb D0I0EG THERCLAS Antihypertensive Agents D0I0EG DRUGTYPE Small molecular drug D0I0EG DRUGINCH 1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1 D0I0EG DRUGINKE FAKRSMQSSFJEIM-RQJHMYQMSA-N D0I0EG DRUGSMIL CC(CS)C(=O)N1CCCC1C(=O)O D0I0EG HIGHSTAT Approved D0I0RJ DRUG__ID D0I0RJ D0I0RJ DRUGCOMP Tornett pharmaceutical D0I0RJ THERCLAS Diuretics D0I0RJ DRUGTYPE Small molecular drug D0I0RJ DRUGINCH 1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15) D0I0RJ DRUGINKE XSDQTOBWRPYKKA-UHFFFAOYSA-N D0I0RJ DRUGSMIL C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N D0I0RJ HIGHSTAT Approved D0I1SK DRUG__ID D0I1SK D0I1SK DRUGCOMP Biovail Corporation D0I1SK THERCLAS Vasodilator Agents D0I1SK DRUGTYPE Small molecular drug D0I1SK DRUGINCH 1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1 D0I1SK DRUGINKE MOYKHGMNXAOIAT-JGWLITMVSA-N D0I1SK DRUGSMIL C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-] D0I1SK HIGHSTAT Approved D0I2MK DRUG__ID D0I2MK D0I2MK DRUGCOMP AstraZeneca D0I2MK THERCLAS Antihypertensive Agents D0I2MK DRUGTYPE Small molecular drug D0I2MK DRUGINCH 1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 D0I2MK DRUGINKE IUBSYMUCCVWXPE-UHFFFAOYSA-N D0I2MK DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CCOC)O D0I2MK HIGHSTAT Approved D0I2SD DRUG__ID D0I2SD D0I2SD DRUGCOMP Pharmacia And Upjohn Co D0I2SD THERCLAS Contraceptive Agents D0I2SD DRUGTYPE Small molecular drug D0I2SD DRUGINCH 1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1 D0I2SD DRUGINKE FRQMUZJSZHZSGN-HBNHAYAOSA-N D0I2SD DRUGSMIL CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C D0I2SD HIGHSTAT Approved D0I2VK DRUG__ID D0I2VK D0I2VK DRUGCOMP Hoffmann-La Roche pharmaceutical company D0I2VK THERCLAS Antidepressants D0I2VK DRUGTYPE Small molecular drug D0I2VK DRUGINCH 1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16) D0I2VK DRUGINKE XKFPYPQQHFEXRZ-UHFFFAOYSA-N D0I2VK DRUGSMIL CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2 D0I2VK HIGHSTAT Approved D0I4DQ DRUG__ID D0I4DQ D0I4DQ DRUGCOMP Pfizer Pharmaceuticals D0I4DQ THERCLAS Vasodilator Agents D0I4DQ DRUGTYPE Small molecular drug D0I4DQ DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1 D0I4DQ DRUGINKE GMVPRGQOIOIIMI-DWKJAMRDSA-N D0I4DQ DRUGSMIL CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O D0I4DQ HIGHSTAT Approved D0I6IB DRUG__ID D0I6IB D0I6IB DRUGCOMP Roche Laboratories Inc D0I6IB THERCLAS Antiinflammatory Agents D0I6IB DRUGTYPE Small molecular drug D0I6IB DRUGINCH 1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18) D0I6IB DRUGINKE LZNWYQJJBLGYLT-UHFFFAOYSA-N D0I6IB DRUGSMIL CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3 D0I6IB HIGHSTAT Approved D0I7SZ DRUG__ID D0I7SZ D0I7SZ DRUGCOMP Pfizer Pharmaceuticals D0I7SZ THERCLAS Antihypertensive Agents D0I7SZ DRUGTYPE Small molecular drug D0I7SZ DRUGINCH 1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1 D0I7SZ DRUGINKE JSDRRTOADPPCHY-HSQYWUDLSA-N D0I7SZ DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O D0I7SZ HIGHSTAT Approved D0I8DD DRUG__ID D0I8DD D0I8DD DRUGCOMP Procter & Gamble D0I8DD THERCLAS Muscle Relaxants D0I8DD DRUGTYPE Small molecular drug D0I8DD DRUGINCH 1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)/b15-7+ D0I8DD DRUGINKE OZOMQRBLCMDCEG-VIZOYTHASA-N D0I8DD DRUGSMIL C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-] D0I8DD HIGHSTAT Approved D0I8FI DRUG__ID D0I8FI D0I8FI DRUGCOMP Abbott Laboratories D0I8FI THERCLAS Cardiotonic Agents D0I8FI DRUGTYPE Small molecular drug D0I8FI DRUGINCH 1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3 D0I8FI DRUGINKE JWZZKOKVBUJMES-UHFFFAOYSA-N D0I8FI DRUGSMIL CC(C)NCC(C1=CC(=C(C=C1)O)O)O D0I8FI HIGHSTAT Approved D0I8LU DRUG__ID D0I8LU D0I8LU DRUGCOMP Lundbeck pharmaceutical company D0I8LU THERCLAS Antipsychotic Agents D0I8LU DRUGTYPE Small molecular drug D0I8LU DRUGINCH 1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5- D0I8LU DRUGINKE WFPIAZLQTJBIFN-DVZOWYKESA-N D0I8LU DRUGSMIL C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO D0I8LU HIGHSTAT Approved D0I8RR DRUG__ID D0I8RR D0I8RR DRUGCOMP Pfizer Pharmaceuticals D0I8RR THERCLAS Anticancer Agents D0I8RR DRUGTYPE Small molecular drug D0I8RR DRUGINCH 1S/C8H15N3O7/c1-11(10-17)8(16)9-4-6(14)5(13)3(2-12)18-7(4)15/h3-7,12-15H,2H2,1H3,(H,9,16)/t3-,4-,5-,6-,7+/m1/s1 D0I8RR DRUGINKE ZSJLQEPLLKMAKR-GKHCUFPYSA-N D0I8RR DRUGSMIL CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O D0I8RR HIGHSTAT Approved D0ID4Z DRUG__ID D0ID4Z D0ID4Z DRUGCOMP Novartis AG; Isis Pharmaceuticals D0ID4Z THERCLAS Antisense D0ID4Z DRUGTYPE Small molecular drug D0ID4Z DRUGINCH 1S/C204H263N63O114P20S20.20Na/c1-80-44-253(195(291)237-169(80)270)145-31-98(119(349-145)62-328-387(306,407)367-97-30-144(252-22-16-137(210)226-194(252)290)348-118(97)61-327-400(319,420)380-109-42-157(266-78-219-162-167(266)230-187(214)235-182(162)283)361-131(109)74-340-398(317,418)378-107-40-154(262-53-89(10)178(279)246-204(262)300)357-127(107)70-336-395(314,415)375-104-37-151(259-50-86(7)175(276)243-201(259)297)355-125(104)68-334-396(315,416)376-105-38-152(260-51-87(8)176(277)244-202(260)298)358-128(105)71-337-401(320,421)381-110-43-158(267-79-220-163-168(267)231-188(215)236-183(163)284)359-129(110)72-338-388(307,408)368-93-26-140(248-18-12-133(206)222-190(248)286)343-113(93)56-322-383(302,403)362-91-24-155(341-111(91)54-268)264-76-217-160-165(264)228-185(212)233-180(160)281)369-389(308,409)323-58-115-94(27-141(345-115)249-19-13-134(207)223-191(249)287)364-384(303,404)329-63-120-101(34-148(350-120)256-47-83(4)172(273)240-198(256)294)372-392(311,412)332-66-123-99(32-146(353-123)254-45-81(2)170(271)238-196(254)292)370-390(309,410)324-59-116-95(28-142(346-116)250-20-14-135(208)224-192(250)288)365-385(304,405)330-64-121-102(35-149(351-121)257-48-84(5)173(274)241-199(257)295)373-393(312,413)333-67-124-100(33-147(354-124)255-46-82(3)171(272)239-197(255)293)371-391(310,411)325-60-117-96(29-143(347-117)251-21-15-136(209)225-193(251)289)366-386(305,406)331-65-122-103(36-150(352-122)258-49-85(6)174(275)242-200(258)296)374-394(313,414)335-69-126-106(39-153(356-126)261-52-88(9)177(278)245-203(261)299)377-397(316,417)339-73-130-108(41-156(360-130)265-77-218-161-166(265)229-186(213)234-181(161)282)379-399(318,419)326-57-114-92(25-139(344-114)247-17-11-132(205)221-189(247)285)363-382(301,402)321-55-112-90(269)23-138(342-112)263-75-216-159-164(263)227-184(211)232-179(159)280;;;;;;;;;;;;;;;;;;;;/h11-22,44-53,75-79,90-131,138-158,268-269H,23-43,54-74H2,1-10H3,(H,301,402)(H,302,403)(H,303,404)(H,304,405)(H,305,406)(H,306,407)(H,307,408)(H,308,409)(H,309,410)(H,310,411)(H,311,412)(H,312,413)(H,313,414)(H,314,415)(H,315,416)(H,316,417)(H,317,418)(H,318,419)(H,319,420)(H,320,421)(H2,205,221,285)(H2,206,222,286)(H2,207,223,287)(H2,208,224,288)(H2,209,225,289)(H2,210,226,290)(H,237,270,291)(H,238,271,292)(H,239,272,293)(H,240,273,294)(H,241,274,295)(H,242,275,296)(H,243,276,297)(H,244,277,298)(H,245,278,299)(H,246,279,300)(H3,211,227,232,280)(H3,212,228,233,281)(H3,213,229,234,282)(H3,214,230,235,283)(H3,215,231,236,284);;;;;;;;;;;;;;;;;;;;/q;20*+1/p-20/t90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,138+,139+,140+,141+,142+,143+,144+,145+,146+,147+,148+,149+,150+,151+,152+,153+,154+,155+,156+,157+,158+,382?,383?,384?,385?,386?,387?,388?,389?,390?,391?,392?,393?,394?,395?,396?,397?,398?,399?,400?,401?;;;;;;;;;;;;;;;;;;;;/m0..................../s1 D0ID4Z DRUGINKE DLKYYJFLRUUGHJ-SSJCJZGYSA-A D0ID4Z DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=S)([O-])OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0ID4Z HIGHSTAT Approved D0IL7L DRUG__ID D0IL7L D0IL7L DRUGCOMP Schering-Plough D0IL7L THERCLAS Antiinflammatory Agents D0IL7L DRUGTYPE Small molecular drug D0IL7L DRUGINCH 1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1 D0IL7L DRUGINKE XOFYZVNMUHMLCC-ZPOLXVRWSA-N D0IL7L DRUGSMIL CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C D0IL7L HIGHSTAT Approved D0IT2G DRUG__ID D0IT2G D0IT2G DRUGCOMP Swiss Pharma D0IT2G THERCLAS Antiinflammatory Agents D0IT2G DRUGTYPE Small molecular drug D0IT2G DRUGINCH 1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1 D0IT2G DRUGINKE UREBDLICKHMUKA-CXSFZGCWSA-N D0IT2G DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C D0IT2G HIGHSTAT Approved D0IT2X DRUG__ID D0IT2X D0IT2X DRUGCOMP Pfizer Pharmaceuticals D0IT2X THERCLAS Analgesics D0IT2X DRUGTYPE Small molecular drug D0IT2X DRUGINCH 1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19) D0IT2X DRUGINKE PUXBGTOOZJQSKH-UHFFFAOYSA-N D0IT2X DRUGSMIL CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O D0IT2X HIGHSTAT Approved D0IX1A DRUG__ID D0IX1A D0IX1A DRUGCOMP Wyeth Ayerst Laboratories D0IX1A THERCLAS Antihypertensive Agents D0IX1A DRUGTYPE Small molecular drug D0IX1A DRUGINCH 1S/C15H32N2/c1-16(12-6-7-13-16)10-4-3-5-11-17(2)14-8-9-15-17/h3-15H2,1-2H3/q+2 D0IX1A DRUGINKE XSBSKEQEUFOSDD-UHFFFAOYSA-N D0IX1A DRUGSMIL C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C D0IX1A HIGHSTAT Approved D0J0BU DRUG__ID D0J0BU D0J0BU TRADNAME Bevyxxa D0J0BU DRUGCOMP Portola Pharmaceuticals D0J0BU DRUGTYPE Small molecular drug D0J0BU DRUGINCH 1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31) D0J0BU DRUGINKE XHOLNRLADUSQLD-UHFFFAOYSA-N D0J0BU DRUGSMIL CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl D0J0BU HIGHSTAT Approved D0J0ZS DRUG__ID D0J0ZS D0J0ZS DRUGCOMP Pfizer D0J0ZS THERCLAS Analgesics D0J0ZS DRUGTYPE Small molecular drug D0J0ZS DRUGINCH 1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12) D0J0ZS DRUGINKE UGJMXCAKCUNAIE-UHFFFAOYSA-N D0J0ZS DRUGSMIL C1CCC(CC1)(CC(=O)O)CN D0J0ZS HIGHSTAT Approved D0J1MI DRUG__ID D0J1MI D0J1MI DRUGCOMP Janssen Pharmaceutica D0J1MI THERCLAS Antinematodal Agents D0J1MI DRUGTYPE Small molecular drug D0J1MI DRUGINCH 1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21) D0J1MI DRUGINKE OPXLLQIJSORQAM-UHFFFAOYSA-N D0J1MI DRUGSMIL COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3 D0J1MI HIGHSTAT Approved D0J1VY DRUG__ID D0J1VY D0J1VY DRUGCOMP Norvatis Phamaceuticals Corporation D0J1VY THERCLAS Antiparkinson Agents D0J1VY DRUGTYPE Small molecular drug D0J1VY DRUGINCH 1S/C14H15N3O5/c1-3-16(4-2)14(20)10(8-15)5-9-6-11(17(21)22)13(19)12(18)7-9/h5-7,18-19H,3-4H2,1-2H3/b10-5+ D0J1VY DRUGINKE JRURYQJSLYLRLN-BJMVGYQFSA-N D0J1VY DRUGSMIL CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N D0J1VY HIGHSTAT Approved D0J2KV DRUG__ID D0J2KV D0J2KV DRUGCOMP Reliant Pharmaceuticals D0J2KV THERCLAS Antiarrhythmic Agents D0J2KV DRUGTYPE Small molecular drug D0J2KV DRUGINCH 1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3 D0J2KV DRUGINKE JWHAUXFOSRPERK-UHFFFAOYSA-N D0J2KV DRUGSMIL CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O D0J2KV HIGHSTAT Approved D0J2MJ DRUG__ID D0J2MJ D0J2MJ DRUGCOMP Somerset Pharmaceuticals Inc D0J2MJ THERCLAS Neurology Agents D0J2MJ DRUGTYPE Small molecular drug D0J2MJ DRUGINCH 1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1 D0J2MJ DRUGINKE IYETZZCWLLUHIJ-UTONKHPSSA-N D0J2MJ DRUGSMIL CC(CC1=CC=CC=C1)N(C)CC#C.Cl D0J2MJ HIGHSTAT Approved D0J2NK DRUG__ID D0J2NK D0J2NK DRUGCOMP Pfizer Pharmaceuticals D0J2NK THERCLAS Antibiotics D0J2NK DRUGTYPE Small molecular drug D0J2NK DRUGINCH 1S/C22H24N2O9/c1-21(32)7-5-4-6-8(25)9(7)15(26)10-12(21)17(28)13-14(24(2)3)16(27)11(20(23)31)19(30)22(13,33)18(10)29/h4-6,12-14,17,25-26,28,30,32-33H,1-3H3,(H2,23,31)/t12-,13-,14+,17+,21-,22+/m1/s1 D0J2NK DRUGINKE OWFJMIVZYSDULZ-PXOLEDIWSA-N D0J2NK DRUGSMIL CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O D0J2NK HIGHSTAT Approved D0J2TN DRUG__ID D0J2TN D0J2TN DRUGCOMP Janssen Pharmaceutica D0J2TN THERCLAS Analgesics D0J2TN DRUGTYPE Small molecular drug D0J2TN DRUGINCH 1S/C30H32N2O2/c1-2-34-28(33)29(25-12-6-3-7-13-25)18-21-32(22-19-29)23-20-30(24-31,26-14-8-4-9-15-26)27-16-10-5-11-17-27/h3-17H,2,18-23H2,1H3 D0J2TN DRUGINKE HYPPXZBJBPSRLK-UHFFFAOYSA-N D0J2TN DRUGSMIL CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4 D0J2TN HIGHSTAT Approved D0J5DC DRUG__ID D0J5DC D0J5DC DRUGCOMP Ayerst Laboratories Inc D0J5DC THERCLAS Antilipemic Agents D0J5DC DRUGTYPE Small molecular drug D0J5DC DRUGINCH 1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3 D0J5DC DRUGINKE KNHUKKLJHYUCFP-UHFFFAOYSA-N D0J5DC DRUGSMIL CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl D0J5DC HIGHSTAT Approved D0J5KF DRUG__ID D0J5KF D0J5KF DRUGCOMP Roche Pharmaceuticals D0J5KF THERCLAS Antiemetics D0J5KF DRUGTYPE Small molecular drug D0J5KF DRUGINCH 1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)/t12?,13-,14+ D0J5KF DRUGINKE MFWNKCLOYSRHCJ-AGUYFDCRSA-N D0J5KF DRUGSMIL CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C D0J5KF HIGHSTAT Approved D0J5YC DRUG__ID D0J5YC D0J5YC DRUGCOMP Pfizer Pharmaceuticals D0J5YC THERCLAS Anticonvulsants D0J5YC DRUGTYPE Small molecular drug D0J5YC DRUGINCH 1S/C16H15N2O6P/c19-14-16(12-7-3-1-4-8-12,13-9-5-2-6-10-13)17-15(20)18(14)11-24-25(21,22)23/h1-10H,11H2,(H,17,20)(H2,21,22,23) D0J5YC DRUGINKE XWLUWCNOOVRFPX-UHFFFAOYSA-N D0J5YC DRUGSMIL C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3 D0J5YC HIGHSTAT Approved D0J7RK DRUG__ID D0J7RK D0J7RK DRUGCOMP Ben Venue Laboratories D0J7RK THERCLAS Cardiotonic Agents D0J7RK DRUGTYPE Small molecular drug D0J7RK DRUGINCH 1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3 D0J7RK DRUGINKE JRWZLRBJNMZMFE-UHFFFAOYSA-N D0J7RK DRUGSMIL CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O D0J7RK HIGHSTAT Approved D0JB3H DRUG__ID D0JB3H D0JB3H TRADNAME Skyclarys D0JB3H DRUGCOMP Reata Pharmaceuticals D0JB3H DRUGTYPE Small molecular drug D0JB3H DRUGINCH 1S/C33H44F2N2O3/c1-27(2)11-13-33(37-26(40)32(8,34)35)14-12-31(7)24(20(33)17-27)21(38)15-23-29(5)16-19(18-36)25(39)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3,(H,37,40)/t20-,22-,24-,29-,30+,31+,33-/m0/s1 D0JB3H DRUGINKE RJCWBNBKOKFWNY-IDPLTSGASA-N D0JB3H DRUGSMIL CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C D0JB3H HIGHSTAT Approved D0JC9N DRUG__ID D0JC9N D0JC9N DRUGCOMP Galderma Laboratories D0JC9N THERCLAS Dermatologic Agents D0JC9N DRUGTYPE Small molecular drug D0JC9N DRUGINCH 1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30) D0JC9N DRUGINKE LZCDAPDGXCYOEH-UHFFFAOYSA-N D0JC9N DRUGSMIL COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5 D0JC9N HIGHSTAT Approved D0JE2E DRUG__ID D0JE2E D0JE2E DRUGCOMP AstraZeneca D0JE2E THERCLAS Anticholesteremic Agents D0JE2E DRUGTYPE Small molecular drug D0JE2E DRUGINCH 1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1 D0JE2E DRUGINKE BPRHUIZQVSMCRT-VEUZHWNKSA-N D0JE2E DRUGSMIL CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C D0JE2E HIGHSTAT Approved D0JJ7S DRUG__ID D0JJ7S D0JJ7S TRADNAME Ingrezza D0JJ7S DRUGCOMP Neurocrine Biosciences D0JJ7S DRUGTYPE Small molecular drug D0JJ7S DRUGINCH 1S/C24H38N2O4.2C7H8O3S/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4;2*1-6-2-4-7(5-3-6)11(8,9)10/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3;2*2-5H,1H3,(H,8,9,10)/t17-,19-,20-,23+;;/m1../s1 D0JJ7S DRUGINKE BXGKAGLZHGYAMW-TZYFFPFWSA-N D0JJ7S DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC D0JJ7S HIGHSTAT Approved D0JL2K DRUG__ID D0JL2K D0JL2K DRUGCOMP GlaxoSmithKline D0JL2K THERCLAS Antibiotics D0JL2K DRUGTYPE Small molecular drug D0JL2K DRUGINCH 1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26) D0JL2K DRUGINKE AIJTTZAVMXIJGM-UHFFFAOYSA-N D0JL2K DRUGSMIL CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F D0JL2K HIGHSTAT Approved D0JO7Y DRUG__ID D0JO7Y D0JO7Y DRUGCOMP AstraZeneca D0JO7Y THERCLAS Anticancer Agents D0JO7Y DRUGTYPE Small molecular drug D0JO7Y DRUGINCH 1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1 D0JO7Y DRUGINKE VWUXBMIQPBEWFH-WCCTWKNTSA-N D0JO7Y DRUGSMIL CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F D0JO7Y HIGHSTAT Approved D0JY5S DRUG__ID D0JY5S D0JY5S DRUGCOMP Shire Development Inc D0JY5S THERCLAS Anticholinergic Agents D0JY5S DRUGTYPE Small molecular drug D0JY5S DRUGINCH 1S/C21H26NO3/c1-4-22(3,5-2)14-15-24-21(23)20-16-10-6-8-12-18(16)25-19-13-9-7-11-17(19)20/h6-13,20H,4-5,14-15H2,1-3H3/q+1 D0JY5S DRUGINKE GZHFODJQISUKAY-UHFFFAOYSA-N D0JY5S DRUGSMIL CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13 D0JY5S HIGHSTAT Approved D0K0OZ DRUG__ID D0K0OZ D0K0OZ DRUGCOMP Astellas Pharma D0K0OZ THERCLAS Antiulcer Agents D0K0OZ DRUGTYPE Small molecular drug D0K0OZ DRUGINCH 1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14) D0K0OZ DRUGINKE XUFQPHANEAPEMJ-UHFFFAOYSA-N D0K0OZ DRUGSMIL C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N D0K0OZ HIGHSTAT Approved D0K0TC DRUG__ID D0K0TC D0K0TC DRUGCOMP Pfizer Inc D0K0TC THERCLAS Antidepressants D0K0TC DRUGTYPE Small molecular drug D0K0TC DRUGINCH 1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1 D0K0TC DRUGINKE VGKDLMBJGBXTGI-SJCJKPOMSA-N D0K0TC DRUGSMIL CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl D0K0TC HIGHSTAT Approved D0K3DQ DRUG__ID D0K3DQ D0K3DQ DRUGCOMP Takeda D0K3DQ THERCLAS Antibiotics D0K3DQ DRUGTYPE Small molecular drug D0K3DQ DRUGINCH 1S/C18H23N9O4S3/c1-25(2)3-4-26-18(22-23-24-26)34-7-9-6-32-15-12(14(29)27(15)13(9)16(30)31)21-11(28)5-10-8-33-17(19)20-10/h8,12,15H,3-7H2,1-2H3,(H2,19,20)(H,21,28)(H,30,31)/t12-,15-/m1/s1 D0K3DQ DRUGINKE QYQDKDWGWDOFFU-IUODEOHRSA-N D0K3DQ DRUGSMIL CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O D0K3DQ HIGHSTAT Approved D0K3QS DRUG__ID D0K3QS D0K3QS DRUGCOMP Novartis D0K3QS THERCLAS Anticancer Agents D0K3QS DRUGTYPE Small molecular drug D0K3QS DRUGINCH 1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 D0K3QS DRUGINKE HKVAMNSJSFKALM-GKUWKFKPSA-N D0K3QS DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC D0K3QS HIGHSTAT Approved D0K4CQ DRUG__ID D0K4CQ D0K4CQ DRUGCOMP Eli Lilly And Co D0K4CQ THERCLAS Antidysrhythmic Agents D0K4CQ DRUGTYPE Small molecular drug D0K4CQ DRUGINCH 1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23) D0K4CQ DRUGINKE UCEWGESNIULAGX-UHFFFAOYSA-N D0K4CQ DRUGSMIL CC(C)NCCCC1(C2=CC=CC=C2C3=CC=CC=C31)C(=O)N D0K4CQ HIGHSTAT Approved D0K5CB DRUG__ID D0K5CB D0K5CB DRUGCOMP GlaxoSmithKline D0K5CB THERCLAS Bronchodilator Agents D0K5CB DRUGTYPE Small molecular drug D0K5CB DRUGINCH 1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3 D0K5CB DRUGINKE NDAUXUAQIAJITI-UHFFFAOYSA-N D0K5CB DRUGSMIL CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O D0K5CB HIGHSTAT Approved D0K5OT DRUG__ID D0K5OT D0K5OT DRUGCOMP Bristol Myers Squibb Spa D0K5OT THERCLAS Antiinfective Agents D0K5OT DRUGTYPE Small molecular drug D0K5OT DRUGINCH 1S/C16H18N2O4S.Na/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);/q;+1/p-1/t11-,12+,14-;/m1./s1 D0K5OT DRUGINKE FCPVYOBCFFNJFS-LQDWTQKMSA-M D0K5OT DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+] D0K5OT HIGHSTAT Approved D0K6GZ DRUG__ID D0K6GZ D0K6GZ DRUGCOMP Square pharma D0K6GZ THERCLAS Antibiotics D0K6GZ DRUGTYPE Small molecular drug D0K6GZ DRUGINCH 1S/C19H22F2N4O3/c1-8-5-24(6-9(2)23-8)17-13(20)15(22)12-16(14(17)21)25(10-3-4-10)7-11(18(12)26)19(27)28/h7-10,23H,3-6,22H2,1-2H3,(H,27,28)/t8-,9+ D0K6GZ DRUGINKE DZZWHBIBMUVIIW-DTORHVGOSA-N D0K6GZ DRUGSMIL CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F D0K6GZ HIGHSTAT Approved D0K7HU DRUG__ID D0K7HU D0K7HU DRUGCOMP Altana Pharma D0K7HU THERCLAS Antiallergic Agents D0K7HU DRUGTYPE Small molecular drug D0K7HU DRUGINCH 1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1 D0K7HU DRUGINKE LUKZNWIVRBCLON-GXOBDPJESA-N D0K7HU DRUGSMIL CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6 D0K7HU HIGHSTAT Approved D0K7NQ DRUG__ID D0K7NQ D0K7NQ DRUGCOMP Parkdale Pharmaceuticals D0K7NQ THERCLAS Antibiotics D0K7NQ DRUGTYPE Small molecular drug D0K7NQ DRUGINCH 1S/C52H98N16O13/c1-9-29(6)11-10-12-40(71)59-32(13-19-53)47(76)68-42(31(8)70)52(81)64-35(16-22-56)44(73)63-37-18-24-58-51(80)41(30(7)69)67-48(77)36(17-23-57)61-43(72)33(14-20-54)62-49(78)38(25-27(2)3)66-50(79)39(26-28(4)5)65-45(74)34(15-21-55)60-46(37)75/h27-39,41-42,69-70H,9-26,53-57H2,1-8H3,(H,58,80)(H,59,71)(H,60,75)(H,61,72)(H,62,78)(H,63,73)(H,64,81)(H,65,74)(H,66,79)(H,67,77)(H,68,76)/t29?,30-,31-,32+,33+,34+,35+,36+,37+,38+,39-,41+,42+/m1/s1 D0K7NQ DRUGINKE YKQOSKADJPQZHB-QNPLFGSASA-N D0K7NQ DRUGSMIL CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O D0K7NQ HIGHSTAT Approved D0K7WK DRUG__ID D0K7WK D0K7WK DRUGCOMP GlaxoSmithKline D0K7WK THERCLAS Antiemetics D0K7WK DRUGTYPE Small molecular drug D0K7WK DRUGINCH 1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3 D0K7WK DRUGINKE FELGMEQIXOGIFQ-UHFFFAOYSA-N D0K7WK DRUGSMIL CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C D0K7WK HIGHSTAT Approved D0KL4J DRUG__ID D0KL4J D0KL4J DRUGCOMP Eisai; Johnson & Johnson D0KL4J THERCLAS Antiulcer Agents D0KL4J DRUGTYPE Small molecular drug D0KL4J DRUGINCH 1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21) D0KL4J DRUGINKE YREYEVIYCVEVJK-UHFFFAOYSA-N D0KL4J DRUGSMIL CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC D0KL4J HIGHSTAT Approved D0KR2J DRUG__ID D0KR2J D0KR2J DRUGCOMP Bristol-Myers Squibb D0KR2J THERCLAS Antiviral Agents D0KR2J DRUGTYPE Small molecular drug D0KR2J DRUGINCH 1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1 D0KR2J DRUGINKE QDGZDCVAUDNJFG-FXQIFTODSA-N D0KR2J DRUGSMIL C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N D0KR2J HIGHSTAT Approved D0KR5B DRUG__ID D0KR5B D0KR5B DRUGCOMP Merck And Co Inc D0KR5B THERCLAS Antiinflammatory Agents D0KR5B DRUGTYPE Small molecular drug D0KR5B DRUGINCH 1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 D0KR5B DRUGINKE JYGXADMDTFJGBT-VWUMJDOOSA-N D0KR5B DRUGSMIL CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O D0KR5B HIGHSTAT Approved D0L4HY DRUG__ID D0L4HY D0L4HY DRUGCOMP Eon Labs Manufacturing D0L4HY THERCLAS Sympatholytics D0L4HY DRUGTYPE Small molecular drug D0L4HY DRUGINCH 1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+ D0L4HY DRUGINKE WDZVGELJXXEGPV-YIXHJXPBSA-N D0L4HY DRUGSMIL C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl D0L4HY HIGHSTAT Approved D0L4YD DRUG__ID D0L4YD D0L4YD DRUGCOMP GlaxoSmithKline D0L4YD THERCLAS Antispasmodics D0L4YD DRUGTYPE Small molecular drug D0L4YD DRUGINCH 1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1 D0L4YD DRUGINKE FBOUYBDGKBSUES-VXKWHMMOSA-N D0L4YD DRUGSMIL C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5 D0L4YD HIGHSTAT Approved D0L5CZ DRUG__ID D0L5CZ D0L5CZ DRUGCOMP Gland Pharma Ltd D0L5CZ THERCLAS Neuromuscular Nondepolarizing Agents D0L5CZ DRUGTYPE Small molecular drug D0L5CZ DRUGINCH 1S/C32H53N2O4/c1-5-14-34(15-6-7-16-34)28-20-26-24-9-8-23-19-29(36)27(33-12-17-37-18-13-33)21-32(23,4)25(24)10-11-31(26,3)30(28)38-22(2)35/h5,23-30,36H,1,6-21H2,2-4H3/q+1/t23-,24+,25-,26-,27-,28-,29-,30-,31-,32-/m0/s1 D0L5CZ DRUGINKE YXRDKMPIGHSVRX-OOJCLDBCSA-N D0L5CZ DRUGSMIL CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C D0L5CZ HIGHSTAT Approved D0L5PO DRUG__ID D0L5PO D0L5PO DRUGCOMP Pharmaceutical Research Assoc Inc D0L5PO THERCLAS Antiinfective Agents D0L5PO DRUGTYPE Small molecular drug D0L5PO DRUGINCH 1S/C13H11NO3/c14-9-6-7-11(12(15)8-9)13(16)17-10-4-2-1-3-5-10/h1-8,15H,14H2 D0L5PO DRUGINKE DNVVZWSVACQWJE-UHFFFAOYSA-N D0L5PO DRUGSMIL C1=CC=C(C=C1)OC(=O)C2=C(C=C(C=C2)N)O D0L5PO HIGHSTAT Approved D0L5WM DRUG__ID D0L5WM D0L5WM DRUGCOMP Wyeth-Ayerst Laboratories D0L5WM THERCLAS Antiarrhythmic Agents D0L5WM DRUGTYPE Small molecular drug D0L5WM DRUGINCH 1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3 D0L5WM DRUGINKE IYIKLHRQXLHMJQ-UHFFFAOYSA-N D0L5WM DRUGSMIL CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I D0L5WM HIGHSTAT Approved D0L5YV DRUG__ID D0L5YV D0L5YV DRUGCOMP GlaxoSmithKline D0L5YV THERCLAS Bronchodilator Agents D0L5YV DRUGTYPE Small molecular drug D0L5YV DRUGINCH 1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2 D0L5YV DRUGINKE GIIZNNXWQWCKIB-UHFFFAOYSA-N D0L5YV DRUGSMIL C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O D0L5YV HIGHSTAT Approved D0L6JE DRUG__ID D0L6JE D0L6JE DRUGCOMP Eli Lilly D0L6JE THERCLAS Hypoglycemic Agents D0L6JE DRUGTYPE Small molecular drug D0L6JE DRUGINCH 1S/C158H234N40O42S2.C99H155N25O35S4/c1-79(2)57-104(181-131(213)86(15)173-136(218)102(50-53-125(211)212)179-152(234)127(84(11)12)194-148(230)107(60-82(7)8)184-145(227)113(67-95-70-166-78-172-95)189-150(232)115(74-199)176-123(208)73-170-134(216)116(75-241)191-140(222)105(58-80(3)4)182-144(226)112(66-94-69-165-77-171-94)188-138(220)101(48-51-119(161)204)178-146(228)114(68-120(162)205)190-153(235)126(83(9)10)193-132(214)98(160)61-89-31-21-18-22-32-89)139(221)185-110(64-92-40-44-96(202)45-41-92)142(224)183-106(59-81(5)6)147(229)195-128(85(13)14)154(236)192-117(76-242)135(217)169-71-121(206)174-100(49-52-124(209)210)137(219)177-99(38-29-55-167-158(163)164)133(215)168-72-122(207)175-108(62-90-33-23-19-24-34-90)141(223)186-109(63-91-35-25-20-26-36-91)143(225)187-111(65-93-42-46-97(203)47-43-93)149(231)196-129(87(16)200)155(237)180-103(37-27-28-54-159)156(238)198-56-30-39-118(198)151(233)197-130(88(17)201)157(239)240;1-12-46(9)77(121-73(134)36-100)97(156)122-76(45(7)8)95(154)108-56(25-29-75(137)138)80(139)105-54(23-27-70(102)131)83(142)117-66(40-161)93(152)119-68(42-163)94(153)124-79(48(11)127)98(157)116-64(38-126)90(149)123-78(47(10)13-2)96(155)120-67(41-162)92(151)115-63(37-125)89(148)110-58(31-44(5)6)85(144)111-59(32-49-14-18-51(128)19-15-49)86(145)106-53(22-26-69(101)130)81(140)109-57(30-43(3)4)84(143)107-55(24-28-74(135)136)82(141)113-61(34-71(103)132)88(147)112-60(33-50-16-20-52(129)21-17-50)87(146)118-65(39-160)91(150)114-62(99(158)159)35-72(104)133/h18-26,31-36,40-47,69-70,77-88,98-118,126-130,199-203,241-242H,27-30,37-39,48-68,71-76,159-160H2,1-17H3,(H2,161,204)(H2,162,205)(H,165,171)(H,166,172)(H,168,215)(H,169,217)(H,170,216)(H,173,218)(H,174,206)(H,175,207)(H,176,208)(H,177,219)(H,178,228)(H,179,234)(H,180,237)(H,181,213)(H,182,226)(H,183,224)(H,184,227)(H,185,221)(H,186,223)(H,187,225)(H,188,220)(H,189,232)(H,190,235)(H,191,222)(H,192,236)(H,193,214)(H,194,230)(H,195,229)(H,196,231)(H,197,233)(H,209,210)(H,211,212)(H,239,240)(H4,163,164,167);14-21,43-48,53-68,76-79,125-129,160-163H,12-13,22-42,100H2,1-11H3,(H2,101,130)(H2,102,131)(H2,103,132)(H2,104,133)(H,105,139)(H,106,145)(H,107,143)(H,108,154)(H,109,140)(H,110,148)(H,111,144)(H,112,147)(H,113,141)(H,114,150)(H,115,151)(H,116,157)(H,117,142)(H,118,146)(H,119,152)(H,120,155)(H,121,134)(H,122,156)(H,123,149)(H,124,153)(H,135,136)(H,137,138)(H,158,159)/t86-,87+,88+,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,126-,127-,128-,129-,130-;46-,47-,48+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,76-,77-,78-,79-/m00/s1 D0L6JE DRUGINKE WNRQPCUGRUFHED-DETKDSODSA-N D0L6JE DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CS)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CS)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)CN.CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CS)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)O)C(=O)O)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC6=CN=CN6)NC(=O)C(CO)NC(=O)CNC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C(CC7=CN=CN7)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC8=CC=CC=C8)N D0L6JE HIGHSTAT Approved D0L9GG DRUG__ID D0L9GG D0L9GG DRUGCOMP Pfizer Pharmaceuticals D0L9GG THERCLAS Hypnotics and Sedatives D0L9GG DRUGTYPE Small molecular drug D0L9GG DRUGINCH 1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3 D0L9GG DRUGINKE VREFGVBLTWBCJP-UHFFFAOYSA-N D0L9GG DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4 D0L9GG HIGHSTAT Approved D0L9UU DRUG__ID D0L9UU D0L9UU DRUGCOMP Sandoz D0L9UU THERCLAS Antibiotics D0L9UU DRUGTYPE Small molecular drug D0L9UU DRUGINCH 1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,22-24H2,1-4H3 D0L9UU DRUGINKE CEAZRRDELHUEMR-UHFFFAOYSA-N D0L9UU DRUGSMIL CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC D0L9UU HIGHSTAT Approved D0L9ZR DRUG__ID D0L9ZR D0L9ZR DRUGCOMP Bayer Pharmaceuticals Corporation D0L9ZR THERCLAS Anthelmintics D0L9ZR DRUGTYPE Small molecular drug D0L9ZR DRUGINCH 1S/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H2 D0L9ZR DRUGINKE FSVJFNAIGNNGKK-UHFFFAOYSA-N D0L9ZR DRUGSMIL C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2 D0L9ZR HIGHSTAT Approved D0LC6K DRUG__ID D0LC6K D0LC6K DRUGCOMP Fougera Pharmaceuticals Inc D0LC6K THERCLAS Antiinflammatory Agents D0LC6K DRUGTYPE Small molecular drug D0LC6K DRUGINCH 1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1 D0LC6K DRUGINKE MGNNYOODZCAHBA-GQKYHHCASA-N D0LC6K DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F D0LC6K HIGHSTAT Approved D0LG8E DRUG__ID D0LG8E D0LG8E DRUGCOMP Ben Venue Laboratories Inc D0LG8E THERCLAS Central Nervous System Stimulants D0LG8E DRUGTYPE Small molecular drug D0LG8E DRUGINCH 1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1 D0LG8E DRUGINKE KWGRBVOPPLSCSI-WPRPVWTQSA-N D0LG8E DRUGSMIL CC(C(C1=CC=CC=C1)O)NC D0LG8E HIGHSTAT Approved D0LZ7E DRUG__ID D0LZ7E D0LZ7E TRADNAME Xerava D0LZ7E DRUGCOMP Tetraphase Pharmaceuticals D0LZ7E DRUGTYPE Small molecular drug D0LZ7E DRUGINCH 1S/C27H31FN4O8/c1-31(2)20-13-8-11-7-12-14(28)9-15(30-16(33)10-32-5-3-4-6-32)21(34)18(12)22(35)17(11)24(37)27(13,40)25(38)19(23(20)36)26(29)39/h9,11,13,20,34-35,38,40H,3-8,10H2,1-2H3,(H2,29,39)(H,30,33)/t11-,13-,20-,27-/m0/s1 D0LZ7E DRUGINKE AKLMFDDQCHURPW-ISIOAQNYSA-N D0LZ7E DRUGSMIL CN(C)C1C2CC3CC4=C(C=C(C(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)NC(=O)CN5CCCC5)F D0LZ7E HIGHSTAT Approved D0M0AM DRUG__ID D0M0AM D0M0AM DRUGCOMP Novartis D0M0AM THERCLAS Anticholinergic Agents D0M0AM DRUGTYPE Small molecular drug D0M0AM DRUGINCH 1S/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1 D0M0AM DRUGINKE VPNYRYCIDCJBOM-UHFFFAOYSA-M D0M0AM DRUGSMIL C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-] D0M0AM HIGHSTAT Approved D0M1VC DRUG__ID D0M1VC D0M1VC DRUGCOMP Leo Pharmaceutical D0M1VC THERCLAS Antibiotics D0M1VC DRUGTYPE Small molecular drug D0M1VC DRUGINCH 1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/t10-,11+,13-/m1/s1 D0M1VC DRUGINKE BWWVAEOLVKTZFQ-NTZNESFSSA-N D0M1VC DRUGSMIL CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C D0M1VC HIGHSTAT Approved D0M2MC DRUG__ID D0M2MC D0M2MC DRUGCOMP Boehringer Ingelheim GmbH D0M2MC THERCLAS Appetite Depressants D0M2MC DRUGTYPE Small molecular drug D0M2MC DRUGINCH 1S/C11H15NO/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10/h2-6,9,11-12H,7-8H2,1H3 D0M2MC DRUGINKE OOBHFESNSZDWIU-UHFFFAOYSA-N D0M2MC DRUGSMIL CC1C(OCCN1)C2=CC=CC=C2 D0M2MC HIGHSTAT Approved D0M4YC DRUG__ID D0M4YC D0M4YC DRUGCOMP Gd Searle Llc D0M4YC THERCLAS Antiarrhythmic Agents D0M4YC DRUGTYPE Small molecular drug D0M4YC DRUGINCH 1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25) D0M4YC DRUGINKE UVTNFZQICZKOEM-UHFFFAOYSA-N D0M4YC DRUGSMIL CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C D0M4YC HIGHSTAT Approved D0M5OC DRUG__ID D0M5OC D0M5OC DRUGCOMP Abbott Laboratories D0M5OC THERCLAS Antihypertensive Agents D0M5OC DRUGTYPE Small molecular drug D0M5OC DRUGINCH 1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1 D0M5OC DRUGINKE VXFJYXUZANRPDJ-WTNASJBWSA-N D0M5OC DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O D0M5OC HIGHSTAT Approved D0M5YS DRUG__ID D0M5YS D0M5YS DRUGCOMP Hospira Inc D0M5YS THERCLAS Antiinfective Agents D0M5YS DRUGTYPE Small molecular drug D0M5YS DRUGINCH 1S/2ClH.Cu/h2*1H;/q;;+2/p-2 D0M5YS DRUGINKE ORTQZVOHEJQUHG-UHFFFAOYSA-L D0M5YS DRUGSMIL Cl[Cu]Cl D0M5YS HIGHSTAT Approved D0M6DO DRUG__ID D0M6DO D0M6DO DRUGCOMP Norvatis Phamaceuticals Corporation D0M6DO THERCLAS Anticancer Agents D0M6DO DRUGTYPE Small molecular drug D0M6DO DRUGINCH 1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17) D0M6DO DRUGINKE ROBVIMPUHSLWNV-UHFFFAOYSA-N D0M6DO DRUGSMIL CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N D0M6DO HIGHSTAT Approved D0M8PW DRUG__ID D0M8PW D0M8PW DRUGCOMP GlaxoSmithKline D0M8PW THERCLAS Antiallergic Agents D0M8PW DRUGTYPE Small molecular drug D0M8PW DRUGINCH 1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1 D0M8PW DRUGINKE PGLIUCLTXOYQMV-GHVWMZMZSA-N D0M8PW DRUGSMIL C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl D0M8PW HIGHSTAT Approved D0M8RC DRUG__ID D0M8RC D0M8RC DRUGCOMP Ben Venue Laboratories D0M8RC THERCLAS Bronchodilator Agents D0M8RC DRUGTYPE Small molecular drug D0M8RC DRUGINCH 1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3 D0M8RC DRUGINKE XWTYSIMOBUGWOL-UHFFFAOYSA-N D0M8RC DRUGSMIL CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O D0M8RC HIGHSTAT Approved D0M9DC DRUG__ID D0M9DC D0M9DC DRUGCOMP Gd Searle Llc D0M9DC THERCLAS Antiinflammatory Agents D0M9DC DRUGTYPE Small molecular drug D0M9DC DRUGINCH 1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21) D0M9DC DRUGINKE OFPXSFXSNFPTHF-UHFFFAOYSA-N D0M9DC DRUGSMIL C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3 D0M9DC HIGHSTAT Approved D0M9WM DRUG__ID D0M9WM D0M9WM DRUGCOMP Oak Pharmaceuticals Inc Sub Akorn Inc D0M9WM THERCLAS Antihypertensive Agents D0M9WM DRUGTYPE Small molecular drug D0M9WM DRUGINCH 1S/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H,10,11)(H2,9,12,13) D0M9WM DRUGINKE JBMKAUGHUNFTOL-UHFFFAOYSA-N D0M9WM DRUGSMIL C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2 D0M9WM HIGHSTAT Approved D0MB8I DRUG__ID D0MB8I D0MB8I DRUGCOMP Sandoz Inc D0MB8I THERCLAS Antibiotics D0MB8I DRUGTYPE Small molecular drug D0MB8I DRUGINCH 1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1 D0MB8I DRUGINKE UWYHMGVUTGAWSP-JKIFEVAISA-N D0MB8I DRUGSMIL CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O D0MB8I HIGHSTAT Approved D0ML1F DRUG__ID D0ML1F D0ML1F DRUGCOMP Gilead Sciences D0ML1F THERCLAS Antiviral Agents D0ML1F DRUGTYPE Small molecular drug D0ML1F DRUGINCH 1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23) D0ML1F DRUGINKE WOZSCQDILHKSGG-UHFFFAOYSA-N D0ML1F DRUGSMIL CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C D0ML1F HIGHSTAT Approved D0MT0M DRUG__ID D0MT0M D0MT0M DRUGCOMP Alcon Canada Inc D0MT0M THERCLAS Antiglaucomic Agents D0MT0M DRUGTYPE Small molecular drug D0MT0M DRUGINCH 1S/C9H10Cl2N4/c10-6-3-5(12)4-7(11)8(6)15-9-13-1-2-14-9/h3-4H,1-2,12H2,(H2,13,14,15) D0MT0M DRUGINKE IEJXVRYNEISIKR-UHFFFAOYSA-N D0MT0M DRUGSMIL C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl D0MT0M HIGHSTAT Approved D0MU9L DRUG__ID D0MU9L D0MU9L TRADNAME Galafold D0MU9L DRUGCOMP Amicus Therapeutics D0MU9L DRUGTYPE Small molecular drug D0MU9L DRUGINCH 1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5+,6-/m1/s1 D0MU9L DRUGINKE LXBIFEVIBLOUGU-DPYQTVNSSA-N D0MU9L DRUGSMIL C1C(C(C(C(N1)CO)O)O)O D0MU9L HIGHSTAT Approved D0N0EQ DRUG__ID D0N0EQ D0N0EQ DRUGCOMP Merck & Co D0N0EQ THERCLAS Antibiotics D0N0EQ DRUGTYPE Small molecular drug D0N0EQ DRUGINCH 1S/C21H39N7O12/c1-5-21(36,4-30)16(40-17-9(26-2)13(34)10(31)6(3-29)38-17)18(37-5)39-15-8(28-20(24)25)11(32)7(27-19(22)23)12(33)14(15)35/h4-18,26,29,31-36H,3H2,1-2H3,(H4,22,23,27)(H4,24,25,28)/t5-,6-,7+,8-,9-,10-,11+,12-,13-,14+,15+,16-,17-,18-,21+/m0/s1 D0N0EQ DRUGINKE UCSJYZPVAKXKNQ-HZYVHMACSA-N D0N0EQ DRUGSMIL CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O D0N0EQ HIGHSTAT Approved D0N0RU DRUG__ID D0N0RU D0N0RU DRUGCOMP Eisai Inc D0N0RU THERCLAS Anticancer Agents D0N0RU DRUGTYPE Small molecular drug D0N0RU DRUGINCH 1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26) D0N0RU DRUGINKE NAVMQTYZDKMPEU-UHFFFAOYSA-N D0N0RU DRUGSMIL CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C D0N0RU HIGHSTAT Approved D0N1TP DRUG__ID D0N1TP D0N1TP DRUGCOMP Abbott Laboratories D0N1TP THERCLAS Parasympathomimetics D0N1TP DRUGTYPE Small molecular drug D0N1TP DRUGINCH 1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1 D0N1TP DRUGINKE BPKAHTKRCLCHEA-UBFJEZKGSA-N D0N1TP DRUGSMIL CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C D0N1TP HIGHSTAT Approved D0N1WU DRUG__ID D0N1WU D0N1WU DRUGCOMP Meda Pharmaceuticals D0N1WU THERCLAS Analgesics D0N1WU DRUGTYPE Small molecular drug D0N1WU DRUGINCH 1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20) D0N1WU DRUGINKE NNYBQONXHNTVIJ-UHFFFAOYSA-N D0N1WU DRUGSMIL CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O D0N1WU HIGHSTAT Approved D0N3PE DRUG__ID D0N3PE D0N3PE DRUGCOMP Norvatis Phamaceuticals Corporation D0N3PE THERCLAS Antihypertensive Agents D0N3PE DRUGTYPE Small molecular drug D0N3PE DRUGINCH 1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13) D0N3PE DRUGINKE ACGDKVXYNVEAGU-UHFFFAOYSA-N D0N3PE DRUGSMIL C1CCCN(CCC1)CCN=C(N)N D0N3PE HIGHSTAT Approved D0N3SP DRUG__ID D0N3SP D0N3SP DRUGCOMP Roche Palo Alto Llc D0N3SP THERCLAS Antifungal Agents D0N3SP DRUGTYPE Small molecular drug D0N3SP DRUGINCH 1S/C19H17Cl3N2S/c20-15-7-4-14(5-8-15)6-9-16(12-24-11-10-23-13-24)25-19-17(21)2-1-3-18(19)22/h1-5,7-8,10-11,13,16H,6,9,12H2 D0N3SP DRUGINKE SWLMUYACZKCSHZ-UHFFFAOYSA-N D0N3SP DRUGSMIL C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl D0N3SP HIGHSTAT Approved D0N3VR DRUG__ID D0N3VR D0N3VR DRUGCOMP Pfizer D0N3VR THERCLAS Antifungal Agents D0N3VR DRUGTYPE Small molecular drug D0N3VR DRUGINCH 1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1 D0N3VR DRUGINKE BCEHBSKCWLPMDN-MGPLVRAMSA-N D0N3VR DRUGSMIL CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O D0N3VR HIGHSTAT Approved D0N4OW DRUG__ID D0N4OW D0N4OW DRUGCOMP Astellas Pharma D0N4OW THERCLAS Vasoconstrictor Agents D0N4OW DRUGTYPE Small molecular drug D0N4OW DRUGINCH 1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28-,29-,30-,31-,32-,33-,34-/m0/s1 D0N4OW DRUGINKE KBZOIRJILGZLEJ-LGYYRGKSSA-N D0N4OW DRUGSMIL C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D0N4OW HIGHSTAT Approved D0N5HJ DRUG__ID D0N5HJ D0N5HJ DRUGCOMP Merck & Co D0N5HJ THERCLAS Antihypertensive Agents D0N5HJ DRUGTYPE Small molecular drug D0N5HJ DRUGINCH 1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1 D0N5HJ DRUGINKE LZFZMUMEGBBDTC-QEJZJMRPSA-N D0N5HJ DRUGSMIL CC(C(=O)N1CCCC1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O D0N5HJ HIGHSTAT Approved D0N5YA DRUG__ID D0N5YA D0N5YA DRUGCOMP Novo Nordisk D0N5YA THERCLAS Hypoglycemic Agents D0N5YA DRUGTYPE Small molecular drug D0N5YA DRUGINCH 1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1 D0N5YA DRUGINKE FAEKWTJYAYMJKF-QHCPKHFHSA-N D0N5YA DRUGSMIL CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O D0N5YA HIGHSTAT Approved D0N6RF DRUG__ID D0N6RF D0N6RF DRUGCOMP Boehringer Ingelheim D0N6RF THERCLAS Antihypertensive Agents D0N6RF DRUGTYPE Small molecular drug D0N6RF DRUGINCH 1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39) D0N6RF DRUGINKE RMMXLENWKUUMAY-UHFFFAOYSA-N D0N6RF DRUGSMIL CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C D0N6RF HIGHSTAT Approved D0N8FQ DRUG__ID D0N8FQ D0N8FQ DRUGCOMP Pfizer Pharmaceuticals D0N8FQ THERCLAS Antidepressants D0N8FQ DRUGTYPE Small molecular drug D0N8FQ DRUGINCH 1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1 D0N8FQ DRUGINKE CBQGYUDMJHNJBX-RTBURBONSA-N D0N8FQ DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3 D0N8FQ HIGHSTAT Approved D0ND2J DRUG__ID D0ND2J D0ND2J DRUGCOMP Nippon Shinyaku D0ND2J THERCLAS Parasympatholytics D0ND2J DRUGTYPE Small molecular drug D0ND2J DRUGINCH 1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3 D0ND2J DRUGINKE SPIUTQOUKAMGCX-UHFFFAOYSA-N D0ND2J DRUGSMIL CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4 D0ND2J HIGHSTAT Approved D0NE9T DRUG__ID D0NE9T D0NE9T DRUGCOMP GSK D0NE9T THERCLAS Anticoagulants D0NE9T DRUGTYPE Small molecular drug D0NE9T DRUGINCH 1S/C31H53N3O49S8.10Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;;;;;;;;;;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;;;;;;;/q;10*+1/p-10/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+,24-,27+,28-,29-,30-,31-;;;;;;;;;;/m1........../s1 D0NE9T DRUGINKE XEKSTYNIJLDDAZ-JASSWCPGSA-D D0NE9T DRUGSMIL COC1C(C(C(C(O1)COS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])OC3C(C(C(C(O3)COS(=O)(=O)[O-])OC4C(C(C(C(O4)C(=O)[O-])OC5C(C(C(C(O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0NE9T HIGHSTAT Approved D0NF0W DRUG__ID D0NF0W D0NF0W DRUGCOMP Norvatis Phamaceuticals Corporation D0NF0W THERCLAS Antiparkinson Agents D0NF0W DRUGTYPE Small molecular drug D0NF0W DRUGINCH 1S/C20H23NS/c1-21-12-6-7-15(14-21)13-18-16-8-2-4-10-19(16)22-20-11-5-3-9-17(18)20/h2-5,8-11,15,18H,6-7,12-14H2,1H3 D0NF0W DRUGINKE MJFJKKXQDNNUJF-UHFFFAOYSA-N D0NF0W DRUGSMIL CN1CCCC(C1)CC2C3=CC=CC=C3SC4=CC=CC=C24 D0NF0W HIGHSTAT Approved D0NG7O DRUG__ID D0NG7O D0NG7O DRUGCOMP AstraZeneca D0NG7O THERCLAS Antimigraine Agents D0NG7O DRUGTYPE Small molecular drug D0NG7O DRUGINCH 1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1 D0NG7O DRUGINKE ULSDMUVEXKOYBU-ZDUSSCGKSA-N D0NG7O DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3 D0NG7O HIGHSTAT Approved D0NR6S DRUG__ID D0NR6S D0NR6S DRUGCOMP Pfizer; AstraZeneca D0NR6S THERCLAS Anti-HIV Agents D0NR6S DRUGTYPE Small molecular drug D0NR6S DRUGINCH 1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1 D0NR6S DRUGINKE GSNHKUDZZFZSJB-HLMSNRGBSA-N D0NR6S DRUGSMIL CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C D0NR6S HIGHSTAT Approved D0NS6H DRUG__ID D0NS6H D0NS6H DRUGCOMP Nitto Denko Corp D0NS6H THERCLAS Neurology Agents D0NS6H DRUGTYPE Small molecular drug D0NS6H DRUGINCH 1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3 D0NS6H DRUGINKE ADEBPBSSDYVVLD-UHFFFAOYSA-N D0NS6H DRUGSMIL COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC D0NS6H HIGHSTAT Approved D0NW3X DRUG__ID D0NW3X D0NW3X DRUGCOMP Pfizer Pharmaceuticals D0NW3X THERCLAS Antiarrhythmic Agents D0NW3X DRUGTYPE Small molecular drug D0NW3X DRUGINCH 1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3 D0NW3X DRUGINKE IXTMWRCNAAVVAI-UHFFFAOYSA-N D0NW3X DRUGSMIL CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C D0NW3X HIGHSTAT Approved D0O1UZ DRUG__ID D0O1UZ D0O1UZ TRADNAME Epidiolex D0O1UZ DRUGCOMP GW Pharmaceuticals D0O1UZ DRUGTYPE Small molecular drug D0O1UZ DRUGINCH 1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1 D0O1UZ DRUGINKE QHMBSVQNZZTUGM-ZWKOTPCHSA-N D0O1UZ DRUGSMIL CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O D0O1UZ HIGHSTAT Approved D0O2EM DRUG__ID D0O2EM D0O2EM DRUGCOMP Boehringer Ingelheim D0O2EM THERCLAS Anti-HIV Agents D0O2EM DRUGTYPE Small molecular drug D0O2EM DRUGINCH 1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20) D0O2EM DRUGINKE NQDJXKOVJZTUJA-UHFFFAOYSA-N D0O2EM DRUGSMIL CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4 D0O2EM HIGHSTAT Approved D0O2SR DRUG__ID D0O2SR D0O2SR DRUGCOMP Chugai; Roche; Sanofi-Aventis; Merk KGaA; Pfizer; 3M Pharmaceutical D0O2SR THERCLAS Vasodilator Agents D0O2SR DRUGTYPE Small molecular drug D0O2SR DRUGINCH 1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12) D0O2SR DRUGINKE LBHIOVVIQHSOQN-UHFFFAOYSA-N D0O2SR DRUGSMIL C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-] D0O2SR HIGHSTAT Approved D0O2WB DRUG__ID D0O2WB D0O2WB DRUGCOMP Valeant Pharmaceuticals D0O2WB THERCLAS Parasympathomimetics D0O2WB DRUGTYPE Small molecular drug D0O2WB DRUGINCH 1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1 D0O2WB DRUGINKE RVOLLAQWKVFTGE-UHFFFAOYSA-N D0O2WB DRUGSMIL C[N+]1=CC=CC(=C1)OC(=O)N(C)C D0O2WB HIGHSTAT Approved D0O3OS DRUG__ID D0O3OS D0O3OS DRUGCOMP Sanofi-Aventis D0O3OS THERCLAS Antiobesity Agents D0O3OS DRUGTYPE Small molecular drug D0O3OS DRUGINCH 1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D0O3OS DRUGINKE JZCPYUJPEARBJL-UHFFFAOYSA-N D0O3OS DRUGSMIL CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D0O3OS HIGHSTAT Approved D0O4EU DRUG__ID D0O4EU D0O4EU DRUGCOMP Pfizer Pharmaceuticals D0O4EU THERCLAS Antiinflammatory Agents D0O4EU DRUGTYPE Small molecular drug D0O4EU DRUGINCH 1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+ D0O4EU DRUGINKE PWACSDKDOHSSQD-IUTFFREVSA-N D0O4EU DRUGSMIL CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC(=N3)C=CC(=O)O D0O4EU HIGHSTAT Approved D0O5FY DRUG__ID D0O5FY D0O5FY DRUGCOMP AstraZeneca D0O5FY THERCLAS Antibiotics D0O5FY DRUGTYPE Small molecular drug D0O5FY DRUGINCH 1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1 D0O5FY DRUGINKE DMJNNHOOLUXYBV-PQTSNVLCSA-N D0O5FY DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O D0O5FY HIGHSTAT Approved D0O5LA DRUG__ID D0O5LA D0O5LA DRUGCOMP Sanofi-Aventis D0O5LA THERCLAS Antidepressants D0O5LA DRUGTYPE Small molecular drug D0O5LA DRUGINCH 1S/C17H16ClFN2O2/c18-12-5-3-11(4-6-12)17(21-9-1-2-16(20)23)14-10-13(19)7-8-15(14)22/h3-8,10,22H,1-2,9H2,(H2,20,23) D0O5LA DRUGINKE IBALRBWGSVJPAP-UHFFFAOYSA-N D0O5LA DRUGSMIL C1=CC(=CC=C1C(=NCCCC(=O)N)C2=C(C=CC(=C2)F)O)Cl D0O5LA HIGHSTAT Approved D0O5NK DRUG__ID D0O5NK D0O5NK DRUGCOMP Hoffmann-La Roche pharmaceutical company D0O5NK THERCLAS Antiviral Agents D0O5NK DRUGTYPE Small molecular drug D0O5NK DRUGINCH 1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1 D0O5NK DRUGINKE VSZGPKBBMSAYNT-RRFJBIMHSA-N D0O5NK DRUGSMIL CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC D0O5NK HIGHSTAT Approved D0O5WP DRUG__ID D0O5WP D0O5WP DRUGCOMP Sanofi-Aventis D0O5WP THERCLAS Anticancer Agents D0O5WP DRUGTYPE Small molecular drug D0O5WP DRUGINCH 1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1 D0O5WP DRUGINKE ZDZOTLJHXYCWBA-VCVYQWHSSA-N D0O5WP DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O D0O5WP HIGHSTAT Approved D0O6GC DRUG__ID D0O6GC D0O6GC DRUGCOMP Norvatis Phamaceuticals Corporation D0O6GC THERCLAS Vasoconstrictor Agents D0O6GC DRUGTYPE Small molecular drug D0O6GC DRUGINCH 1S/C21H27N3O2/c1-4-15(12-25)22-21(26)14-8-17-16-6-5-7-18-20(16)13(10-23(18)2)9-19(17)24(3)11-14/h5-8,10,14-15,19,25H,4,9,11-12H2,1-3H3,(H,22,26)/t14-,15+,19-/m1/s1 D0O6GC DRUGINKE KPJZHOPZRAFDTN-ZRGWGRIASA-N D0O6GC DRUGSMIL CCC(CO)NC(=O)C1CN(C2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C D0O6GC HIGHSTAT Approved D0O6IU DRUG__ID D0O6IU D0O6IU DRUGCOMP Alcon Canada Inc D0O6IU THERCLAS Ophthalmologicals D0O6IU DRUGTYPE Small molecular drug D0O6IU DRUGINCH 1S/C9H13NO2/c1-10-6-9(12)7-3-2-4-8(11)5-7/h2-5,9-12H,6H2,1H3/t9-/m0/s1 D0O6IU DRUGINKE SONNWYBIRXJNDC-VIFPVBQESA-N D0O6IU DRUGSMIL CNCC(C1=CC(=CC=C1)O)O D0O6IU HIGHSTAT Approved D0O6IZ DRUG__ID D0O6IZ D0O6IZ DRUGCOMP Allergan Inc D0O6IZ THERCLAS Anticancer Agents D0O6IZ DRUGTYPE Small molecular drug D0O6IZ DRUGINCH 1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16) D0O6IZ DRUGINKE CNIIGCLFLJGOGP-UHFFFAOYSA-N D0O6IZ DRUGSMIL C1CN=C(N1)CC2=CC=CC3=CC=CC=C32 D0O6IZ HIGHSTAT Approved D0O6SX DRUG__ID D0O6SX D0O6SX DRUGCOMP Pfizer Pharmaceuticals D0O6SX THERCLAS Hypnotics and Sedatives D0O6SX DRUGTYPE Small molecular drug D0O6SX DRUGINCH 1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2 D0O6SX DRUGINKE ZQDWXGKKHFNSQK-UHFFFAOYSA-N D0O6SX DRUGSMIL C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl D0O6SX HIGHSTAT Approved D0OB0F DRUG__ID D0OB0F D0OB0F DRUGCOMP Wyeth Research D0OB0F THERCLAS Anticancer Agents D0OB0F DRUGTYPE Small molecular drug D0OB0F DRUGINCH 1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31) D0OB0F DRUGINKE UBPYILGKFZZVDX-UHFFFAOYSA-N D0OB0F DRUGSMIL CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC D0OB0F HIGHSTAT Approved D0OB1J DRUG__ID D0OB1J D0OB1J DRUGCOMP Valeant International Barbados Srl D0OB1J THERCLAS Antihypertensive Agents D0OB1J DRUGTYPE Small molecular drug D0OB1J DRUGINCH 1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1 D0OB1J DRUGINKE HSUGRBWQSSZJOP-RTWAWAEBSA-N D0OB1J DRUGSMIL CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC D0OB1J HIGHSTAT Approved D0OJ4L DRUG__ID D0OJ4L D0OJ4L DRUGCOMP Concordia Pharmaceuticals Inc D0OJ4L THERCLAS Antimalarials D0OJ4L DRUGTYPE Small molecular drug D0OJ4L DRUGINCH 1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21) D0OJ4L DRUGINKE XXSMGPRMXLTPCZ-UHFFFAOYSA-N D0OJ4L DRUGSMIL CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO D0OJ4L HIGHSTAT Approved D0OT0O DRUG__ID D0OT0O D0OT0O DRUGCOMP AstraZeneca D0OT0O THERCLAS Antiviral Agents D0OT0O DRUGTYPE Small molecular drug D0OT0O DRUGINCH 1S/CH3O5P.3Na/c2-1(3)7(4,5)6;;;/h(H,2,3)(H2,4,5,6);;;/q;3*+1/p-3 D0OT0O DRUGINKE DFHAXXVZCFXGOQ-UHFFFAOYSA-K D0OT0O DRUGSMIL C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+] D0OT0O HIGHSTAT Approved D0P0HT DRUG__ID D0P0HT D0P0HT DRUGCOMP Alcon Laboratories D0P0HT THERCLAS Antiallergic Agents D0P0HT DRUGTYPE Small molecular drug D0P0HT DRUGINCH 1S/C22H29FO4/c1-12-9-17-15-6-8-21(27,13(2)24)20(15,4)11-18(26)22(17,23)19(3)7-5-14(25)10-16(12)19/h5,7,10,12,15,17-18,26-27H,6,8-9,11H2,1-4H3/t12-,15-,17-,18-,19-,20-,21-,22-/m0/s1 D0P0HT DRUGINKE FAOZLTXFLGPHNG-KNAQIMQKSA-N D0P0HT DRUGSMIL CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O D0P0HT HIGHSTAT Approved D0P0SM DRUG__ID D0P0SM D0P0SM DRUGCOMP Almirall Prodesfarma D0P0SM THERCLAS Antimigraine Agents D0P0SM DRUGTYPE Small molecular drug D0P0SM DRUGINCH 1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3 D0P0SM DRUGINKE WKEMJKQOLOHJLZ-UHFFFAOYSA-N D0P0SM DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3 D0P0SM HIGHSTAT Approved D0P0WV DRUG__ID D0P0WV D0P0WV DRUGCOMP Schering-plough D0P0WV THERCLAS Anticancer Agents D0P0WV DRUGTYPE Small molecular drug D0P0WV DRUGINCH 1S/C15H16Cl3N3O2.CH2I2O3S.Na/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18;2-1(3)7(4,5)6;/h3,5,8-10H,2,4,6-7H2,1H3;1H,(H,4,5,6);/q;;+1/p-1 D0P0WV DRUGINKE MIXCUJKCXRNYFM-UHFFFAOYSA-M D0P0WV DRUGSMIL CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.C(S(=O)(=O)[O-])(I)I.[Na+] D0P0WV HIGHSTAT Approved D0P1FO DRUG__ID D0P1FO D0P1FO DRUGCOMP Unimed Pharmaceuticals D0P1FO THERCLAS Analgesics D0P1FO DRUGTYPE Small molecular drug D0P1FO DRUGINCH 1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1 D0P1FO DRUGINKE CYQFCXCEBYINGO-IAGOWNOFSA-N D0P1FO DRUGSMIL CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O D0P1FO HIGHSTAT Approved D0P1UX DRUG__ID D0P1UX D0P1UX DRUGCOMP Wyeth D0P1UX THERCLAS Antidepressants D0P1UX DRUGTYPE Small molecular drug D0P1UX DRUGINCH 1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3 D0P1UX DRUGINKE PNVNVHUZROJLTJ-UHFFFAOYSA-N D0P1UX DRUGSMIL CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O D0P1UX HIGHSTAT Approved D0P1WA DRUG__ID D0P1WA D0P1WA DRUGCOMP Boehringer Ingelheim D0P1WA THERCLAS Bronchodilator Agents D0P1WA DRUGTYPE Small molecular drug D0P1WA DRUGINCH 1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11?,12-,13+,16-,17+ D0P1WA DRUGINKE LERNTVKEWCAPOY-FPISHFTHSA-N D0P1WA DRUGSMIL C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C D0P1WA HIGHSTAT Approved D0P2YU DRUG__ID D0P2YU D0P2YU DRUGCOMP Elixir Pharmaceuticals D0P2YU THERCLAS Hypoglycemic Agents D0P2YU DRUGTYPE Small molecular drug D0P2YU DRUGINCH 1S/C19H25NO3/c21-18(20-12-15-8-4-5-9-16(15)13-20)11-17(19(22)23)10-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13H2,(H,22,23)/t15-,16+,17-/m0/s1 D0P2YU DRUGINKE WPGGHFDDFPHPOB-BBWFWOEESA-N D0P2YU DRUGSMIL C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)O D0P2YU HIGHSTAT Approved D0P3JU DRUG__ID D0P3JU D0P3JU DRUGCOMP Taro Pharmaceutical Industries Ltd D0P3JU THERCLAS Hypnotics and Sedatives D0P3JU DRUGTYPE Small molecular drug D0P3JU DRUGINCH 1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22) D0P3JU DRUGINKE XDDJGVMJFWAHJX-UHFFFAOYSA-N D0P3JU DRUGSMIL C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O D0P3JU HIGHSTAT Approved D0P4MT DRUG__ID D0P4MT D0P4MT DRUGCOMP Pfizer Pharmaceuticals D0P4MT THERCLAS Schistosomicides D0P4MT DRUGTYPE Small molecular drug D0P4MT DRUGINCH 1S/C14H21N3O3/c1-9(2)15-7-12-4-3-10-5-11(8-18)14(17(19)20)6-13(10)16-12/h5-6,9,12,15-16,18H,3-4,7-8H2,1-2H3 D0P4MT DRUGINKE XCGYUJZMCCFSRP-UHFFFAOYSA-N D0P4MT DRUGSMIL CC(C)NCC1CCC2=CC(=C(C=C2N1)[N+](=O)[O-])CO D0P4MT HIGHSTAT Approved D0P4VX DRUG__ID D0P4VX D0P4VX DRUGCOMP Ferring Pharmaceuticals D0P4VX THERCLAS Vasoconstrictor Agents D0P4VX DRUGTYPE Small molecular drug D0P4VX DRUGINCH 1S/C52H74N16O15S2/c53-17-5-4-9-31(45(76)60-23-41(57)72)63-51(82)38-10-6-18-68(38)52(83)37-27-85-84-26-36(61-44(75)25-59-43(74)24-58-42(73)22-54)50(81)65-34(20-29-11-13-30(69)14-12-29)48(79)64-33(19-28-7-2-1-3-8-28)47(78)62-32(15-16-39(55)70)46(77)66-35(21-40(56)71)49(80)67-37/h1-3,7-8,11-14,31-38,69H,4-6,9-10,15-27,53-54H2,(H2,55,70)(H2,56,71)(H2,57,72)(H,58,73)(H,59,74)(H,60,76)(H,61,75)(H,62,78)(H,63,82)(H,64,79)(H,65,81)(H,66,77)(H,67,80)/t31-,32-,33-,34-,35-,36-,37-,38-/m0/s1 D0P4VX DRUGINKE BENFXAYNYRLAIU-QSVFAHTRSA-N D0P4VX DRUGSMIL C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N D0P4VX HIGHSTAT Approved D0P5GE DRUG__ID D0P5GE D0P5GE DRUGCOMP Novartis Pharmaceuticals Corp D0P5GE THERCLAS Anesthetics D0P5GE DRUGTYPE Small molecular drug D0P5GE DRUGINCH 1S/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24) D0P5GE DRUGINKE PUFQVTATUTYEAL-UHFFFAOYSA-N D0P5GE DRUGSMIL CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC D0P5GE HIGHSTAT Approved D0P5SA DRUG__ID D0P5SA D0P5SA DRUGCOMP Bristol-Myers Squibb D0P5SA THERCLAS Antipsychotic Agents D0P5SA DRUGTYPE Small molecular drug D0P5SA DRUGINCH 1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2 D0P5SA DRUGINKE PLDUPXSUYLZYBN-UHFFFAOYSA-N D0P5SA DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO D0P5SA HIGHSTAT Approved D0P6UB DRUG__ID D0P6UB D0P6UB DRUGCOMP Ovation Pharma D0P6UB THERCLAS Central Nervous System Stimulants D0P6UB DRUGTYPE Small molecular drug D0P6UB DRUGINCH 1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1 D0P6UB DRUGINKE MYWUZJCMWCOHBA-VIFPVBQESA-N D0P6UB DRUGSMIL CC(CC1=CC=CC=C1)NC D0P6UB HIGHSTAT Approved D0P6ZH DRUG__ID D0P6ZH D0P6ZH DRUGCOMP Forest Laboratories D0P6ZH THERCLAS Antihypertensive Agents D0P6ZH DRUGTYPE Small molecular drug D0P6ZH DRUGINCH 1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3 D0P6ZH DRUGINKE ZDXUKAKRHYTAKV-UHFFFAOYSA-N D0P6ZH DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC D0P6ZH HIGHSTAT Approved D0P8RS DRUG__ID D0P8RS D0P8RS DRUGCOMP AstraZeneca D0P8RS THERCLAS Antimalarials D0P8RS DRUGTYPE Small molecular drug D0P8RS DRUGINCH 1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17) D0P8RS DRUGINKE SSOLNOMRVKKSON-UHFFFAOYSA-N D0P8RS DRUGSMIL CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl D0P8RS HIGHSTAT Approved D0P9AC DRUG__ID D0P9AC D0P9AC DRUGCOMP Parke Davis Div Warner Lambert Co D0P9AC THERCLAS Antidepressants D0P9AC DRUGTYPE Small molecular drug D0P9AC DRUGINCH 1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2 D0P9AC DRUGINKE RMUCZJUITONUFY-UHFFFAOYSA-N D0P9AC DRUGSMIL C1=CC=C(C=C1)CCNN D0P9AC HIGHSTAT Approved D0P9RF DRUG__ID D0P9RF D0P9RF DRUGCOMP Abbott Laboratories D0P9RF THERCLAS Anticancer Agents D0P9RF DRUGTYPE Small molecular drug D0P9RF DRUGINCH 1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22) D0P9RF DRUGINKE VCKUSRYTPJJLNI-UHFFFAOYSA-N D0P9RF DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC D0P9RF HIGHSTAT Approved D0PA2N DRUG__ID D0PA2N D0PA2N DRUGCOMP Bayer Pharmaceuticals Corp D0PA2N THERCLAS Antibiotics D0PA2N DRUGTYPE Small molecular drug D0PA2N DRUGINCH 1S/C20H23N5O6S/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30/h3-7,11-13,16H,8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29)/t11-,12-,13+,16-/m1/s1 D0PA2N DRUGINKE JTWOMNBEOCYFNV-NFFDBFGFSA-N D0PA2N DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C D0PA2N HIGHSTAT Approved D0PA5S DRUG__ID D0PA5S D0PA5S DRUGCOMP Procter & Gamble; Sanofi-Aventis D0PA5S THERCLAS Bone Density Conservation Agents D0PA5S DRUGTYPE Small molecular drug D0PA5S DRUGINCH 1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15) D0PA5S DRUGINKE IIDJRNMFWXDHID-UHFFFAOYSA-N D0PA5S DRUGSMIL C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O D0PA5S HIGHSTAT Approved D0PH5Z DRUG__ID D0PH5Z D0PH5Z DRUGCOMP GlaxoSmithKline D0PH5Z THERCLAS Antibiotics D0PH5Z DRUGTYPE Small molecular drug D0PH5Z DRUGINCH 1S/C22H22N6O7S2/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34)/b26-13-/t14-,18-/m1/s1 D0PH5Z DRUGINKE ORFOPKXBNMVMKC-DWVKKRMSSA-N D0PH5Z DRUGSMIL CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-] D0PH5Z HIGHSTAT Approved D0PI2E DRUG__ID D0PI2E D0PI2E DRUGCOMP Abbvie Inc D0PI2E THERCLAS Antibiotics D0PI2E DRUGTYPE Small molecular drug D0PI2E DRUGINCH 1S/C14H16N2O6S3/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20) D0PI2E DRUGINKE NEDPPCHNEOMTJV-UHFFFAOYSA-N D0PI2E DRUGSMIL C1=CC(=CC=C1NCS(=O)O)S(=O)(=O)C2=CC=C(C=C2)NCS(=O)O D0PI2E HIGHSTAT Approved D0PN1F DRUG__ID D0PN1F D0PN1F DRUGCOMP Pfizer Laboratories Div Pfizer Inc D0PN1F THERCLAS Antiinfective Agents D0PN1F DRUGTYPE Small molecular drug D0PN1F DRUGINCH 1S/C26H26N2O6S.Na/c1-26(2)20(24(31)32)28-22(30)19(23(28)35-26)27-21(29)18(15-7-4-3-5-8-15)25(33)34-17-12-11-14-9-6-10-16(14)13-17;/h3-5,7-8,11-13,18-20,23H,6,9-10H2,1-2H3,(H,27,29)(H,31,32);/q;+1/p-1/t18?,19-,20+,23-;/m1./s1 D0PN1F DRUGINKE QFWPXOXWAUAYAB-XZVIDJSISA-M D0PN1F DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)OC4=CC5=C(CCC5)C=C4)C(=O)[O-])C.[Na+] D0PN1F HIGHSTAT Approved D0PN8H DRUG__ID D0PN8H D0PN8H TRADNAME Vonjo D0PN8H DRUGCOMP CTI Biopharma D0PN8H DRUGTYPE Small molecular drug D0PN8H DRUGINCH 1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+ D0PN8H DRUGINKE HWXVIOGONBBTBY-ONEGZZNKSA-N D0PN8H DRUGSMIL C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2 D0PN8H HIGHSTAT Approved D0PQ3G DRUG__ID D0PQ3G D0PQ3G DRUGCOMP Sanofi-Aventis D0PQ3G THERCLAS Diuretics D0PQ3G DRUGTYPE Small molecular drug D0PQ3G DRUGINCH 1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19) D0PQ3G DRUGINKE ZZUFCTLCJUWOSV-UHFFFAOYSA-N D0PQ3G DRUGSMIL C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl D0PQ3G HIGHSTAT Approved D0PW7C DRUG__ID D0PW7C D0PW7C DRUGCOMP Eli Lilly D0PW7C THERCLAS Antibiotics D0PW7C DRUGTYPE Small molecular drug D0PW7C DRUGINCH 1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1 D0PW7C DRUGINKE QYIYFLOTGYLRGG-GPCCPHFNSA-N D0PW7C DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl D0PW7C HIGHSTAT Approved D0Q0PR DRUG__ID D0Q0PR D0Q0PR DRUGCOMP Pfizer Pharmaceuticals D0Q0PR THERCLAS Antibiotics D0Q0PR DRUGTYPE Small molecular drug D0Q0PR DRUGINCH 1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1 D0Q0PR DRUGINKE YJQPYGGHQPGBLI-KGSXXDOSSA-N D0Q0PR DRUGSMIL CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O D0Q0PR HIGHSTAT Approved D0Q1BT DRUG__ID D0Q1BT D0Q1BT DRUGCOMP Hoffmann La Roche Inc D0Q1BT THERCLAS Analgesics D0Q1BT DRUGTYPE Small molecular drug D0Q1BT DRUGINCH 1S/C22H26NO3/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20,25H,12-16H2,1H3/q+1 D0Q1BT DRUGINKE HOOSGZJRQIVJSZ-UHFFFAOYSA-N D0Q1BT DRUGSMIL C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O D0Q1BT HIGHSTAT Approved D0Q1MS DRUG__ID D0Q1MS D0Q1MS DRUGCOMP Merck & Co D0Q1MS THERCLAS Antibiotics D0Q1MS DRUGTYPE Small molecular drug D0Q1MS DRUGINCH 1S/C22H25N3O7S/c1-9-16-15(10(2)26)20(28)25(16)17(22(31)32)18(9)33-13-7-14(23-8-13)19(27)24-12-5-3-4-11(6-12)21(29)30/h3-6,9-10,13-16,23,26H,7-8H2,1-2H3,(H,24,27)(H,29,30)(H,31,32)/t9-,10-,13+,14+,15-,16-/m1/s1 D0Q1MS DRUGINKE JUZNIMUFDBIJCM-ANEDZVCMSA-N D0Q1MS DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O D0Q1MS HIGHSTAT Approved D0Q1PR DRUG__ID D0Q1PR D0Q1PR DRUGCOMP Burroughs Wellcome Co D0Q1PR THERCLAS Neuromuscular Nondepolarizing Agents D0Q1PR DRUGTYPE Small molecular drug D0Q1PR DRUGINCH 1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2 D0Q1PR DRUGINKE YXSLJKQTIDHPOT-UHFFFAOYSA-N D0Q1PR DRUGSMIL C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C D0Q1PR HIGHSTAT Approved D0Q2AT DRUG__ID D0Q2AT D0Q2AT DRUGCOMP GlaxoSmithKline D0Q2AT THERCLAS Antibiotics D0Q2AT DRUGTYPE Small molecular drug D0Q2AT DRUGINCH 1S/C19H17ClFN3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1 D0Q2AT DRUGINKE UIOFUWFRIANQPC-JKIFEVAISA-N D0Q2AT DRUGSMIL CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O D0Q2AT HIGHSTAT Approved D0Q2HO DRUG__ID D0Q2HO D0Q2HO TRADNAME Symproic D0Q2HO DRUGCOMP Shionogi D0Q2HO DRUGTYPE Small molecular drug D0Q2HO DRUGINCH 1S/C32H34N4O6.C7H8O3S/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17;1-6-2-4-7(5-3-6)11(8,9)10/h3-7,10-11,17,22,26,37-38,40H,8-9,12-16H2,1-2H3,(H,34,39);2-5H,1H3,(H,8,9,10)/t22-,26+,31+,32-;/m1./s1 D0Q2HO DRUGINKE WCYDLROFMZJJLE-RTMHEQJQSA-N D0Q2HO DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O D0Q2HO HIGHSTAT Approved D0Q3VE DRUG__ID D0Q3VE D0Q3VE TRADNAME Steglatro D0Q3VE DRUGCOMP Merck & Co./Pfizer D0Q3VE DRUGTYPE Small molecular drug D0Q3VE DRUGINCH 1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1 D0Q3VE DRUGINKE MCIACXAZCBVDEE-CUUWFGFTSA-N D0Q3VE DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl D0Q3VE HIGHSTAT Approved D0Q3YO DRUG__ID D0Q3YO D0Q3YO DRUGCOMP Janssen Pharmaceutica D0Q3YO THERCLAS Antiallergic Agents D0Q3YO DRUGTYPE Small molecular drug D0Q3YO DRUGINCH 1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+ D0Q3YO DRUGINKE DERZBLKQOCDDDZ-JLHYYAGUSA-N D0Q3YO DRUGSMIL C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4 D0Q3YO HIGHSTAT Approved D0Q4CS DRUG__ID D0Q4CS D0Q4CS DRUGCOMP Daiichi Sankyo Pharma Development D0Q4CS THERCLAS Parasympathomimetics D0Q4CS DRUGTYPE Small molecular drug D0Q4CS DRUGINCH 1S/C10H17NOS/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11/h8-9H,2-7H2,1H3/t8-,10-/m1/s1 D0Q4CS DRUGINKE WUTYZMFRCNBCHQ-PSASIEDQSA-N D0Q4CS DRUGSMIL CC1OC2(CN3CCC2CC3)CS1 D0Q4CS HIGHSTAT Approved D0Q4SD DRUG__ID D0Q4SD D0Q4SD DRUGCOMP Pfizer Pharmaceuticals D0Q4SD THERCLAS Antihypertensive Agents D0Q4SD DRUGTYPE Small molecular drug D0Q4SD DRUGINCH 1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1 D0Q4SD DRUGINKE JUKPWJGBANNWMW-VWBFHTRKSA-N D0Q4SD DRUGSMIL CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC D0Q4SD HIGHSTAT Approved D0Q4XQ DRUG__ID D0Q4XQ D0Q4XQ DRUGCOMP Pfizer D0Q4XQ THERCLAS Analgesics D0Q4XQ DRUGTYPE Small molecular drug D0Q4XQ DRUGINCH 1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10) D0Q4XQ DRUGINKE HAPOVYFOVVWLRS-UHFFFAOYSA-N D0Q4XQ DRUGSMIL CCC1(CC(=O)NC1=O)C D0Q4XQ HIGHSTAT Approved D0Q5IN DRUG__ID D0Q5IN D0Q5IN DRUGCOMP Morton Grove Pharmaceuticals D0Q5IN THERCLAS Antiscabies Agent D0Q5IN DRUGTYPE Small molecular drug D0Q5IN DRUGINCH 1S/C6H6Cl6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H D0Q5IN DRUGINKE JLYXXMFPNIAWKQ-UHFFFAOYSA-N D0Q5IN DRUGSMIL C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl D0Q5IN HIGHSTAT Approved D0Q5NX DRUG__ID D0Q5NX D0Q5NX DRUGCOMP Celgene Corporation D0Q5NX THERCLAS Anticancer Agents D0Q5NX DRUGTYPE Small molecular drug D0Q5NX DRUGINCH 1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) D0Q5NX DRUGINKE GOTYRUGSSMKFNF-UHFFFAOYSA-N D0Q5NX DRUGSMIL C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N D0Q5NX HIGHSTAT Approved D0Q7ZQ DRUG__ID D0Q7ZQ D0Q7ZQ DRUGCOMP Sandoz Canada Inc D0Q7ZQ THERCLAS Analgesics D0Q7ZQ DRUGTYPE Small molecular drug D0Q7ZQ DRUGINCH 1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2 D0Q7ZQ DRUGINKE AXOIZCJOOAYSMI-UHFFFAOYSA-N D0Q7ZQ DRUGSMIL C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C D0Q7ZQ HIGHSTAT Approved D0Q8ZX DRUG__ID D0Q8ZX D0Q8ZX DRUGCOMP Wyeth Pharmaceuticals D0Q8ZX THERCLAS Anesthetics D0Q8ZX DRUGTYPE Small molecular drug D0Q8ZX DRUGINCH 1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3 D0Q8ZX DRUGINKE BLFLLBZGZJTVJG-UHFFFAOYSA-N D0Q8ZX DRUGSMIL CCOC(=O)C1=CC=C(C=C1)N D0Q8ZX HIGHSTAT Approved D0Q9DK DRUG__ID D0Q9DK D0Q9DK DRUGCOMP Eli Lilly D0Q9DK THERCLAS Antiulcer Agents D0Q9DK DRUGTYPE Small molecular drug D0Q9DK DRUGINCH 1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3/b11-6+ D0Q9DK DRUGINKE SGXXNSQHWDMGGP-IZZDOVSWSA-N D0Q9DK DRUGSMIL CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C D0Q9DK HIGHSTAT Approved D0Q9HF DRUG__ID D0Q9HF D0Q9HF DRUGCOMP Novartis Pharmaceuticals Corp D0Q9HF THERCLAS Cardiovascular Agents D0Q9HF DRUGTYPE Small molecular drug D0Q9HF DRUGINCH 1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1 D0Q9HF DRUGINKE OIPILFWXSMYKGL-UHFFFAOYSA-N D0Q9HF DRUGSMIL CC(=O)OCC[N+](C)(C)C D0Q9HF HIGHSTAT Approved D0Q9JT DRUG__ID D0Q9JT D0Q9JT DRUGCOMP Norvatis Phamaceuticals Corporation D0Q9JT THERCLAS Antimetabolites D0Q9JT DRUGTYPE Small molecular drug D0Q9JT DRUGINCH 1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3 D0Q9JT DRUGINKE FJLBFSROUSIWMA-UHFFFAOYSA-N D0Q9JT DRUGSMIL CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2 D0Q9JT HIGHSTAT Approved D0QL3P DRUG__ID D0QL3P D0QL3P DRUGCOMP Norvatis Phamaceuticals Corporation D0QL3P THERCLAS Anticonvulsants D0QL3P DRUGTYPE Small molecular drug D0QL3P DRUGINCH 1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19) D0QL3P DRUGINKE CTRLABGOLIVAIY-UHFFFAOYSA-N D0QL3P DRUGSMIL C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N D0QL3P HIGHSTAT Approved D0QQ7D DRUG__ID D0QQ7D D0QQ7D DRUGCOMP Gepach International D0QQ7D THERCLAS Antiinfective Agents D0QQ7D DRUGTYPE Small molecular drug D0QQ7D DRUGINCH 1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1 D0QQ7D DRUGINKE LPQZKKCYTLCDGQ-WEDXCCLWSA-N D0QQ7D DRUGSMIL CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3 D0QQ7D HIGHSTAT Approved D0R0BX DRUG__ID D0R0BX D0R0BX DRUGCOMP Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co D0R0BX THERCLAS Antiinfective Agents D0R0BX DRUGTYPE Small molecular drug D0R0BX DRUGINCH 1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+ D0R0BX DRUGINKE NXFQHRVNIOXGAQ-YCRREMRBSA-N D0R0BX DRUGSMIL C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-] D0R0BX HIGHSTAT Approved D0R0FE DRUG__ID D0R0FE D0R0FE DRUGCOMP Pfizer Inc D0R0FE THERCLAS Analgesics D0R0FE DRUGTYPE Small molecular drug D0R0FE DRUGINCH 1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3 D0R0FE DRUGINKE SGTNSNPWRIOYBX-UHFFFAOYSA-N D0R0FE DRUGSMIL CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC D0R0FE HIGHSTAT Approved D0R0MW DRUG__ID D0R0MW D0R0MW DRUGCOMP Pfizer D0R0MW THERCLAS Anticancer Agents D0R0MW DRUGTYPE Small molecular drug D0R0MW DRUGINCH 1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12- D0R0MW DRUGINKE WINHZLLDWRZWRT-ATVHPVEESA-N D0R0MW DRUGSMIL CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C D0R0MW HIGHSTAT Approved D0R0TS DRUG__ID D0R0TS D0R0TS TRADNAME Pifeltro D0R0TS DRUGCOMP Merck & Co. D0R0TS DRUGTYPE Small molecular drug D0R0TS DRUGINCH 1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28) D0R0TS DRUGINKE ZIAOVIPSKUPPQW-UHFFFAOYSA-N D0R0TS DRUGSMIL CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F D0R0TS HIGHSTAT Approved D0R0UJ DRUG__ID D0R0UJ D0R0UJ DRUGCOMP Abbott Laboratories Pharmaceutical Products Div D0R0UJ THERCLAS Antihypertensive Agents D0R0UJ DRUGTYPE Small molecular drug D0R0UJ DRUGINCH 1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3 D0R0UJ DRUGINKE DPWPWRLQFGFJFI-UHFFFAOYSA-N D0R0UJ DRUGSMIL CN(CC#C)CC1=CC=CC=C1 D0R0UJ HIGHSTAT Approved D0R0ZL DRUG__ID D0R0ZL D0R0ZL DRUGCOMP Pharmacia And Upjohn Co D0R0ZL THERCLAS Antibiotics D0R0ZL DRUGTYPE Small molecular drug D0R0ZL DRUGINCH 1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1 D0R0ZL DRUGINKE KDLRVYVGXIQJDK-AWPVFWJPSA-N D0R0ZL DRUGSMIL CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl D0R0ZL HIGHSTAT Approved D0R1JV DRUG__ID D0R1JV D0R1JV DRUGCOMP Pfizer D0R1JV THERCLAS Antipsychotic Agents D0R1JV DRUGTYPE Small molecular drug D0R1JV DRUGINCH 1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27) D0R1JV DRUGINKE MVWVFYHBGMAFLY-UHFFFAOYSA-N D0R1JV DRUGSMIL C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54 D0R1JV HIGHSTAT Approved D0R1RS DRUG__ID D0R1RS D0R1RS DRUGCOMP Recordati Rare Diseases Inc D0R1RS THERCLAS Antiinflammatory Agents D0R1RS DRUGTYPE Small molecular drug D0R1RS DRUGINCH 1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) D0R1RS DRUGINKE CGIGDMFJXJATDK-UHFFFAOYSA-N D0R1RS DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O D0R1RS HIGHSTAT Approved D0R2KJ DRUG__ID D0R2KJ D0R2KJ DRUGCOMP Sandoz Inc D0R2KJ THERCLAS Antibiotics D0R2KJ DRUGTYPE Small molecular drug D0R2KJ DRUGINCH 1S/C19H17Cl2N3O5S/c1-7-10(12(23-29-7)11-8(20)5-4-6-9(11)21)15(25)22-13-16(26)24-14(18(27)28)19(2,3)30-17(13)24/h4-6,13-14,17H,1-3H3,(H,22,25)(H,27,28)/t13-,14+,17-/m1/s1 D0R2KJ DRUGINKE YFAGHNZHGGCZAX-JKIFEVAISA-N D0R2KJ DRUGSMIL CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O D0R2KJ HIGHSTAT Approved D0R3JB DRUG__ID D0R3JB D0R3JB DRUGCOMP Serono D0R3JB THERCLAS Analgesics D0R3JB DRUGTYPE Small molecular drug D0R3JB DRUGINCH 1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2 D0R3JB DRUGINKE KKZJGLLVHKMTCM-UHFFFAOYSA-N D0R3JB DRUGSMIL C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO D0R3JB HIGHSTAT Approved D0R3QY DRUG__ID D0R3QY D0R3QY DRUGCOMP Ovation Pharma; Lundbeck D0R3QY THERCLAS Anticonvulsants D0R3QY DRUGTYPE Small molecular drug D0R3QY DRUGINCH 1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9) D0R3QY DRUGINKE PJDFLNIOAUIZSL-UHFFFAOYSA-N D0R3QY DRUGSMIL C=CC(CCC(=O)O)N D0R3QY HIGHSTAT Approved D0R4OM DRUG__ID D0R4OM D0R4OM DRUGCOMP GlaxoSmithKline plc D0R4OM THERCLAS Antipsychotic Agents D0R4OM DRUGTYPE Small molecular drug D0R4OM DRUGINCH 1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3 D0R4OM DRUGINKE ZEWQUBUPAILYHI-UHFFFAOYSA-N D0R4OM DRUGSMIL CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F D0R4OM HIGHSTAT Approved D0R5GS DRUG__ID D0R5GS D0R5GS TRADNAME Exxua D0R5GS DRUGCOMP Fabre-Kramer; GSK D0R5GS DRUGTYPE Small molecular drug D0R5GS DRUGINCH 1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3 D0R5GS DRUGINKE QOIGKGMMAGJZNZ-UHFFFAOYSA-N D0R5GS DRUGSMIL CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=NC=CC=N3)C D0R5GS HIGHSTAT Approved D0R6BI DRUG__ID D0R6BI D0R6BI DRUGCOMP Ben Venue Laboratories D0R6BI THERCLAS Antihypertensive Agents D0R6BI DRUGTYPE Small molecular drug D0R6BI DRUGINCH 1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2 D0R6BI DRUGINKE TVURRHSHRRELCG-UHFFFAOYSA-N D0R6BI DRUGSMIL C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O D0R6BI HIGHSTAT Approved D0R6HN DRUG__ID D0R6HN D0R6HN DRUGCOMP Ge Healthcare D0R6HN THERCLAS Neurology Agents D0R6HN DRUGTYPE Small molecular drug D0R6HN DRUGINCH 1S/2ClH.Sr/h2*1H;/q;;+2/p-2/i;;1+1 D0R6HN DRUGINKE AHBGXTDRMVNFER-FCHARDOESA-L D0R6HN DRUGSMIL [Cl-].[Cl-].[Sr+2] D0R6HN HIGHSTAT Approved D0R6RC DRUG__ID D0R6RC D0R6RC DRUGCOMP Lederle Laboratories Div American Cyanamid Co D0R6RC THERCLAS Antiinfective Agents D0R6RC DRUGTYPE Small molecular drug D0R6RC DRUGINCH 1S/C22H23ClN2O8/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21/h4-5,7-8,15,26-27,30,32-33H,6H2,1-3H3,(H2,24,31)/t7-,8-,15-,21-,22-/m0/s1 D0R6RC DRUGINKE DHPRQBPJLMKORJ-XRNKAMNCSA-N D0R6RC DRUGSMIL CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O D0R6RC HIGHSTAT Approved D0R6RO DRUG__ID D0R6RO D0R6RO DRUGCOMP GlaxoSmithKline D0R6RO THERCLAS Antidepressants D0R6RO DRUGTYPE Small molecular drug D0R6RO DRUGINCH 1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3 D0R6RO DRUGINKE UEQUQVLFIPOEMF-UHFFFAOYSA-N D0R6RO DRUGSMIL CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42 D0R6RO HIGHSTAT Approved D0R6TI DRUG__ID D0R6TI D0R6TI DRUGCOMP Sanofi Aventis Us Llc D0R6TI THERCLAS Cardiovascular Agents D0R6TI DRUGTYPE Small molecular drug D0R6TI DRUGINCH 1S/C10H9N3O.C3H6O3/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7;1-2(4)3(5)6/h1-6H,11H2,(H,13,14);2,4H,1H3,(H,5,6) D0R6TI DRUGINKE DOSIONJFGDSKCQ-UHFFFAOYSA-N D0R6TI DRUGSMIL CC(C(=O)O)O.C1=CN=CC=C1C2=CNC(=O)C(=C2)N D0R6TI HIGHSTAT Approved D0R7HO DRUG__ID D0R7HO D0R7HO DRUGCOMP Hoffmann-La Roche pharmaceutical company D0R7HO THERCLAS Diuretics D0R7HO DRUGTYPE Small molecular drug D0R7HO DRUGINCH 1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23) D0R7HO DRUGINKE MAEIEVLCKWDQJH-UHFFFAOYSA-N D0R7HO DRUGSMIL CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2 D0R7HO HIGHSTAT Approved D0R7LD DRUG__ID D0R7LD D0R7LD TRADNAME Lumakras D0R7LD DRUGCOMP Amgen D0R7LD DRUGTYPE Small molecular drug D0R7LD DRUGINCH 1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1 D0R7LD DRUGINKE NXQKSXLFSAEQCZ-SFHVURJKSA-N D0R7LD DRUGSMIL CC1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C D0R7LD HIGHSTAT Approved D0R9EQ DRUG__ID D0R9EQ D0R9EQ DRUGCOMP GlaxoSmithKline plc D0R9EQ THERCLAS Antiparkinson Agents D0R9EQ DRUGTYPE Small molecular drug D0R9EQ DRUGINCH 1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19) D0R9EQ DRUGINKE UHSKFQJFRQCDBE-UHFFFAOYSA-N D0R9EQ DRUGSMIL CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1 D0R9EQ HIGHSTAT Approved D0R9VR DRUG__ID D0R9VR D0R9VR DRUGCOMP Janssen Pharmaceutica D0R9VR THERCLAS Parasympathomimetics D0R9VR DRUGTYPE Small molecular drug D0R9VR DRUGINCH 1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1 D0R9VR DRUGINKE ASUTZQLVASHGKV-JDFRZJQESA-N D0R9VR DRUGSMIL CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O D0R9VR HIGHSTAT Approved D0R9WP DRUG__ID D0R9WP D0R9WP DRUGCOMP Patheon Pharmaceuticals Inc D0R9WP THERCLAS Antibiotics D0R9WP DRUGTYPE Small molecular drug D0R9WP DRUGINCH 1S/C21H21ClN2O8/c1-24(2)14-7-5-6-10(16(27)12-9(25)4-3-8(22)11(12)15(6)26)18(29)21(7,32)19(30)13(17(14)28)20(23)31/h3-4,6-7,14-15,25-27,30,32H,5H2,1-2H3,(H2,23,31)/t6-,7-,14-,15-,21-/m0/s1 D0R9WP DRUGINKE GUXHBMASAHGULD-SEYHBJAFSA-N D0R9WP DRUGSMIL CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O D0R9WP HIGHSTAT Approved D0R9ZB DRUG__ID D0R9ZB D0R9ZB DRUGCOMP Hikma Maple Ltd D0R9ZB THERCLAS Sedatives and Hypnotics D0R9ZB DRUGTYPE Small molecular drug D0R9ZB DRUGINCH 1S/C20H24N2OS/c1-5-18(23)15-10-11-20-17(12-15)22(13-14(2)21(3)4)16-8-6-7-9-19(16)24-20/h6-12,14H,5,13H2,1-4H3 D0R9ZB DRUGINKE UVOIBTBFPOZKGP-UHFFFAOYSA-N D0R9ZB DRUGSMIL CCC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CC(C)N(C)C D0R9ZB HIGHSTAT Approved D0RE6T DRUG__ID D0RE6T D0RE6T TRADNAME Xermelo D0RE6T DRUGCOMP Lexicon Pharmaceuticals D0RE6T DRUGTYPE Small molecular drug D0RE6T DRUGINCH 1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1 D0RE6T DRUGINKE MDSQOJYHHZBZKA-GBXCKJPGSA-N D0RE6T DRUGSMIL CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N D0RE6T HIGHSTAT Approved D0RG3O DRUG__ID D0RG3O D0RG3O DRUGCOMP Pfizer Pharmaceuticals D0RG3O THERCLAS Antiarrhythmic Agents D0RG3O DRUGTYPE Small molecular drug D0RG3O DRUGINCH 1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16? D0RG3O DRUGINKE RKUNBYITZUJHSG-PJPHBNEVSA-N D0RG3O DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 D0RG3O HIGHSTAT Approved D0RU0O DRUG__ID D0RU0O D0RU0O TRADNAME Copiktra D0RU0O DRUGCOMP Verastem D0RU0O DRUGTYPE Small molecular drug D0RU0O DRUGINCH 1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1 D0RU0O DRUGINKE SJVQHLPISAIATJ-ZDUSSCGKSA-N D0RU0O DRUGSMIL CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 D0RU0O HIGHSTAT Approved D0S0LZ DRUG__ID D0S0LZ D0S0LZ DRUGCOMP Collagenex D0S0LZ THERCLAS Antiinflammatory Agents D0S0LZ DRUGTYPE Small molecular drug D0S0LZ DRUGINCH 1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25-27,30,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1 D0S0LZ DRUGINKE SGKRLCUYIXIAHR-AKNGSSGZSA-N D0S0LZ DRUGSMIL CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O D0S0LZ HIGHSTAT Approved D0S2BT DRUG__ID D0S2BT D0S2BT DRUGCOMP Glenwood Inc D0S2BT THERCLAS Antiinfective Agents D0S2BT DRUGTYPE Small molecular drug D0S2BT DRUGINCH 1S/C7H7NO3.K/c8-4-1-2-5(7(10)11)6(9)3-4;/h1-3,9H,8H2,(H,10,11);/q;+1/p-1 D0S2BT DRUGINKE PRZJIMSXCLZGLT-UHFFFAOYSA-M D0S2BT DRUGSMIL C1=CC(=C(C=C1N)O)C(=O)[O-].[K+] D0S2BT HIGHSTAT Approved D0S5LO DRUG__ID D0S5LO D0S5LO TRADNAME Daurismo D0S5LO DRUGCOMP Pfizer D0S5LO DRUGTYPE Small molecular drug D0S5LO DRUGINCH 1S/C21H22N6O/c1-27-11-10-16(24-21(28)23-15-8-6-14(13-22)7-9-15)12-19(27)20-25-17-4-2-3-5-18(17)26-20/h2-9,16,19H,10-12H2,1H3,(H,25,26)(H2,23,24,28)/t16-,19-/m1/s1 D0S5LO DRUGINKE SFNSLLSYNZWZQG-VQIMIIECSA-N D0S5LO DRUGSMIL CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N D0S5LO HIGHSTAT Approved D0S5UH DRUG__ID D0S5UH D0S5UH DRUGCOMP Norvatis Phamaceuticals Corporation D0S5UH THERCLAS Antiinflammatory Agents D0S5UH DRUGTYPE Small molecular drug D0S5UH DRUGINCH 1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3 D0S5UH DRUGINKE WDQPAMHFFCXSNU-UHFFFAOYSA-N D0S5UH DRUGSMIL CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl D0S5UH HIGHSTAT Approved D0S6JG DRUG__ID D0S6JG D0S6JG DRUGCOMP King Pharmaceuticals, Inc D0S6JG THERCLAS Hormone Replacement Agents D0S6JG DRUGTYPE Small molecular drug D0S6JG DRUGINCH 1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1 D0S6JG DRUGINKE AUYYCJSJGJYCDS-LBPRGKRZSA-N D0S6JG DRUGSMIL C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O D0S6JG HIGHSTAT Approved D0S7LG DRUG__ID D0S7LG D0S7LG TRADNAME Erleada D0S7LG DRUGCOMP Johnson & Johnson D0S7LG DRUGTYPE Small molecular drug D0S7LG DRUGINCH 1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31) D0S7LG DRUGINKE HJBWBFZLDZWPHF-UHFFFAOYSA-N D0S7LG DRUGSMIL CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F D0S7LG HIGHSTAT Approved D0S8TD DRUG__ID D0S8TD D0S8TD DRUGCOMP Par Sterile Products Llc D0S8TD THERCLAS Anesthetics D0S8TD DRUGTYPE Small molecular drug D0S8TD DRUGINCH 1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19) D0S8TD DRUGINKE NZXKDOXHBHYTKP-UHFFFAOYSA-N D0S8TD DRUGSMIL CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C D0S8TD HIGHSTAT Approved D0S9MU DRUG__ID D0S9MU D0S9MU DRUGCOMP Merck & Co D0S9MU THERCLAS Antiinflammatory Agents D0S9MU DRUGTYPE Small molecular drug D0S9MU DRUGINCH 1S/C15H19N5/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3 D0S9MU DRUGINKE ULFRLSNUDGIQQP-UHFFFAOYSA-N D0S9MU DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3 D0S9MU HIGHSTAT Approved D0S9SD DRUG__ID D0S9SD D0S9SD DRUGCOMP Gilead; Bristol-Myers Squibb D0S9SD THERCLAS Anti-HIV Agents D0S9SD DRUGTYPE Small molecular drug D0S9SD DRUGINCH 1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1 D0S9SD DRUGINKE XQSPYNMVSIKCOC-NTSWFWBYSA-N D0S9SD DRUGSMIL C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F D0S9SD HIGHSTAT Approved D0SH3I DRUG__ID D0SH3I D0SH3I DRUGCOMP Takeda D0SH3I THERCLAS Anticancer Agents D0SH3I DRUGTYPE Small molecular drug D0SH3I DRUGINCH 1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1 D0SH3I DRUGINKE GXJABQQUPOEUTA-RDJZCZTQSA-N D0SH3I DRUGSMIL B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O D0SH3I HIGHSTAT Approved D0SN9T DRUG__ID D0SN9T D0SN9T DRUGCOMP Aventis Pharmaceuticals Inc. D0SN9T THERCLAS Anticancer Agents D0SN9T DRUGTYPE Small molecular drug D0SN9T DRUGINCH 1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20) D0SN9T DRUGINKE XWXYUMMDTVBTOU-UHFFFAOYSA-N D0SN9T DRUGSMIL CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C D0SN9T HIGHSTAT Approved D0SQ1W DRUG__ID D0SQ1W D0SQ1W DRUGCOMP Hospira Inc D0SQ1W THERCLAS Anticancer Agents D0SQ1W DRUGTYPE Small molecular drug D0SQ1W DRUGINCH 1S/H2O/h1H2 D0SQ1W DRUGINKE XLYOFNOQVPJJNP-UHFFFAOYSA-N D0SQ1W DRUGSMIL O D0SQ1W HIGHSTAT Approved D0SS4P DRUG__ID D0SS4P D0SS4P DRUGCOMP 3M Pharmaceuticals D0SS4P THERCLAS Bronchodilator Agents D0SS4P DRUGTYPE Small molecular drug D0SS4P DRUGINCH 1S/C12H20N2O3/c1-12(2,3)13-6-11(17)8-4-5-10(16)9(7-15)14-8/h4-5,11,13,15-17H,6-7H2,1-3H3 D0SS4P DRUGINKE VQDBNKDJNJQRDG-UHFFFAOYSA-N D0SS4P DRUGSMIL CC(C)(C)NCC(C1=NC(=C(C=C1)O)CO)O D0SS4P HIGHSTAT Approved D0T0KA DRUG__ID D0T0KA D0T0KA DRUGCOMP Chiesi Usa Inc D0T0KA THERCLAS Antihypertensive Agents D0T0KA DRUGTYPE Small molecular drug D0T0KA DRUGINCH 1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3 D0T0KA DRUGINKE ZBBHBTPTTSWHBA-UHFFFAOYSA-N D0T0KA DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC D0T0KA HIGHSTAT Approved D0T0LM DRUG__ID D0T0LM D0T0LM DRUGCOMP Boehringer Ingelheim D0T0LM THERCLAS Antiulcer Agents D0T0LM DRUGTYPE Small molecular drug D0T0LM DRUGINCH 1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26) D0T0LM DRUGINKE RMHMFHUVIITRHF-UHFFFAOYSA-N D0T0LM DRUGSMIL CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 D0T0LM HIGHSTAT Approved D0T0LU DRUG__ID D0T0LU D0T0LU DRUGCOMP Wyeth Pharmaceuticals D0T0LU THERCLAS Estrogens D0T0LU DRUGTYPE Small molecular drug D0T0LU DRUGINCH 1S/C18H22O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);/q;+1/p-1/t14?,15?,16?,18-;/m0./s1 D0T0LU DRUGINKE VUCAHVBMSFIGAI-TWCWWGPMSA-M D0T0LU DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+] D0T0LU HIGHSTAT Approved D0T1LK DRUG__ID D0T1LK D0T1LK DRUGCOMP Sanofi-Aventis D0T1LK THERCLAS Antimalarials D0T1LK DRUGTYPE Small molecular drug D0T1LK DRUGINCH 1S/C15H21N3O/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14/h4,6,8-11,18H,3,5,7,16H2,1-2H3 D0T1LK DRUGINKE INDBQLZJXZLFIT-UHFFFAOYSA-N D0T1LK DRUGSMIL CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2 D0T1LK HIGHSTAT Approved D0T1XW DRUG__ID D0T1XW D0T1XW DRUGCOMP Citron Pharma Llc D0T1XW THERCLAS Antiallergic Agents D0T1XW DRUGTYPE Small molecular drug D0T1XW DRUGINCH 1S/C25H27ClN2/c1-20-6-5-7-21(18-20)19-27-14-16-28(17-15-27)25(22-8-3-2-4-9-22)23-10-12-24(26)13-11-23/h2-13,18,25H,14-17,19H2,1H3 D0T1XW DRUGINKE OCJYIGYOJCODJL-UHFFFAOYSA-N D0T1XW DRUGSMIL CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl D0T1XW HIGHSTAT Approved D0T2IA DRUG__ID D0T2IA D0T2IA DRUGCOMP Abbott Laboratories D0T2IA THERCLAS Ophthalmologicals D0T2IA DRUGTYPE Small molecular drug D0T2IA DRUGINCH 1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3 D0T2IA DRUGINKE RFWZESUMWJKKRN-UHFFFAOYSA-N D0T2IA DRUGSMIL CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4 D0T2IA HIGHSTAT Approved D0T2XU DRUG__ID D0T2XU D0T2XU DRUGCOMP Wyeth Pharmaceuticals D0T2XU THERCLAS Antiallergic Agents D0T2XU DRUGTYPE Small molecular drug D0T2XU DRUGINCH 1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3 D0T2XU DRUGINKE PWWVAXIEGOYWEE-UHFFFAOYSA-N D0T2XU DRUGSMIL CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C D0T2XU HIGHSTAT Approved D0T3HY DRUG__ID D0T3HY D0T3HY DRUGCOMP Roxane Laboratories D0T3HY THERCLAS Analgesics D0T3HY DRUGTYPE Small molecular drug D0T3HY DRUGINCH 1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1 D0T3HY DRUGINKE JAQUASYNZVUNQP-USXIJHARSA-N D0T3HY DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O D0T3HY HIGHSTAT Approved D0T3KI DRUG__ID D0T3KI D0T3KI DRUGCOMP GlaxoSmithKline D0T3KI THERCLAS Vasoconstrictor Agents D0T3KI DRUGTYPE Small molecular drug D0T3KI DRUGINCH 1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3 D0T3KI DRUGINKE AMKVXSZCKVJAGH-UHFFFAOYSA-N D0T3KI DRUGSMIL CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C D0T3KI HIGHSTAT Approved D0T3LF DRUG__ID D0T3LF D0T3LF DRUGCOMP GlaxoSmithKline D0T3LF THERCLAS Central Nervous System Stimulants D0T3LF DRUGTYPE Small molecular drug D0T3LF DRUGINCH 1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1 D0T3LF DRUGINKE KWTSXDURSIMDCE-QMMMGPOBSA-N D0T3LF DRUGSMIL CC(CC1=CC=CC=C1)N D0T3LF HIGHSTAT Approved D0T5OX DRUG__ID D0T5OX D0T5OX DRUGCOMP Abbott Laboratories D0T5OX THERCLAS Hypnotics and Sedatives D0T5OX DRUGTYPE Small molecular drug D0T5OX DRUGINCH 1S/C20H28N2O5/c1-4-17(23)22(16-8-6-5-7-9-16)20(19(25)27-3)11-14-21(15-12-20)13-10-18(24)26-2/h5-9H,4,10-15H2,1-3H3 D0T5OX DRUGINKE ZTVQQQVZCWLTDF-UHFFFAOYSA-N D0T5OX DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC D0T5OX HIGHSTAT Approved D0T6CN DRUG__ID D0T6CN D0T6CN TRADNAME Aphexda D0T6CN DRUGCOMP BioLineRx D0T6CN DRUGTYPE Peptide D0T6CN DRUGINCH 1S/C97H144FN33O19S2/c98-60-33-31-58(32-34-60)78(135)119-65(19-8-42-113-93(104)105)79(136)121-68(21-10-44-115-95(108)109)83(140)126-73(51-56-25-30-57-14-1-2-15-59(57)48-56)87(144)130-75-53-152-151-52-74(88(145)118-63(77(101)134)18-7-41-112-92(102)103)129-84(141)69(23-12-46-117-97(111)150)122-81(138)66(20-9-43-114-94(106)107)124-86(143)72(50-55-28-37-62(133)38-29-55)128-90(147)76-24-13-47-131(76)91(148)70(17-4-6-40-100)125-82(139)64(16-3-5-39-99)120-80(137)67(22-11-45-116-96(110)149)123-85(142)71(127-89(75)146)49-54-26-35-61(132)36-27-54/h1-2,14-15,25-38,48,63-76,132-133H,3-13,16-24,39-47,49-53,99-100H2,(H2,101,134)(H,118,145)(H,119,135)(H,120,137)(H,121,136)(H,122,138)(H,123,142)(H,124,143)(H,125,139)(H,126,140)(H,127,146)(H,128,147)(H,129,141)(H,130,144)(H4,102,103,112)(H4,104,105,113)(H4,106,107,114)(H4,108,109,115)(H3,110,116,149)(H3,111,117,150)/t63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-/m0/s1 D0T6CN DRUGINKE JJVZSYKFCOBILL-MKMRYRNGSA-N D0T6CN DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CCCCN)CCCCN)CCCNC(=O)N)CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C6=CC=C(C=C6)F)C(=O)NC(CCCNC(=N)N)C(=O)N)CCCNC(=O)N)CCCNC(=N)N)CC7=CC=C(C=C7)O D0T6CN HIGHSTAT Approved D0T6SU DRUG__ID D0T6SU D0T6SU DRUGCOMP Sandoz Inc D0T6SU THERCLAS Anorexigenic Agents D0T6SU DRUGTYPE Small molecular drug D0T6SU DRUGINCH 1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1 D0T6SU DRUGINKE MFOCDFTXLCYLKU-CMPLNLGQSA-N D0T6SU DRUGSMIL CC1C(OCCN1C)C2=CC=CC=C2 D0T6SU HIGHSTAT Approved D0T6XX DRUG__ID D0T6XX D0T6XX DRUGCOMP Wyeth; Altana; Solvay D0T6XX THERCLAS Antiulcer Agents D0T6XX DRUGTYPE Small molecular drug D0T6XX DRUGINCH 1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21) D0T6XX DRUGINKE IQPSEEYGBUAQFF-UHFFFAOYSA-N D0T6XX DRUGSMIL COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC D0T6XX HIGHSTAT Approved D0T7OW DRUG__ID D0T7OW D0T7OW DRUGCOMP Baxter Healthcare Corp Anesthesia And Critical Care D0T7OW THERCLAS Cardiotonic Agents D0T7OW DRUGTYPE Small molecular drug D0T7OW DRUGINCH 1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2 D0T7OW DRUGINKE VYFYYTLLBUKUHU-UHFFFAOYSA-N D0T7OW DRUGSMIL C1=CC(=C(C=C1CCN)O)O D0T7OW HIGHSTAT Approved D0T7US DRUG__ID D0T7US D0T7US DRUGCOMP Abbott Laboratories D0T7US THERCLAS Antihypertensive Agents D0T7US DRUGTYPE Small molecular drug D0T7US DRUGINCH 1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+ D0T7US DRUGINKE OROAFUQRIXKEMV-LDADJPATSA-N D0T7US DRUGSMIL CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O D0T7US HIGHSTAT Approved D0T9TJ DRUG__ID D0T9TJ D0T9TJ DRUGCOMP GlaxoSmithKline plc D0T9TJ THERCLAS Antiobesity Agents D0T9TJ DRUGTYPE Small molecular drug D0T9TJ DRUGINCH 1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1 D0T9TJ DRUGINKE AHLBNYSZXLDEJQ-FWEHEUNISA-N D0T9TJ DRUGSMIL CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O D0T9TJ HIGHSTAT Approved D0TG1H DRUG__ID D0TG1H D0TG1H DRUGCOMP Novartis Pharmaceuticals Corp D0TG1H THERCLAS Neurology Agents D0TG1H DRUGTYPE Small molecular drug D0TG1H DRUGINCH 1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19) D0TG1H DRUGINKE DCOPUUMXTXDBNB-UHFFFAOYSA-N D0TG1H DRUGSMIL C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl D0TG1H HIGHSTAT Approved D0TK7R DRUG__ID D0TK7R D0TK7R TRADNAME Braftovi D0TK7R DRUGCOMP Array BioPharma D0TK7R DRUGTYPE Small molecular drug D0TK7R DRUGINCH 1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1 D0TK7R DRUGINKE CMJCXYNUCSMDBY-ZDUSSCGKSA-N D0TK7R DRUGSMIL CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC D0TK7R HIGHSTAT Approved D0TQ1G DRUG__ID D0TQ1G D0TQ1G DRUGCOMP Forest Laboratories Inc D0TQ1G THERCLAS Antiviral Agents D0TQ1G DRUGTYPE Small molecular drug D0TQ1G DRUGINCH 1S/C12H21N/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12/h8-11H,2-7,13H2,1H3 D0TQ1G DRUGINKE UBCHPRBFMUDMNC-UHFFFAOYSA-N D0TQ1G DRUGSMIL CC(C12CC3CC(C1)CC(C3)C2)N D0TQ1G HIGHSTAT Approved D0TR5X DRUG__ID D0TR5X D0TR5X DRUGCOMP Eli Lilly D0TR5X THERCLAS Antidepressants D0TR5X DRUGTYPE Small molecular drug D0TR5X DRUGINCH 1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 D0TR5X DRUGINKE RTHCYVBBDHJXIQ-UHFFFAOYSA-N D0TR5X DRUGSMIL CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F D0TR5X HIGHSTAT Approved D0TZ1G DRUG__ID D0TZ1G D0TZ1G DRUGCOMP Wyeth Pharmaceuticals D0TZ1G THERCLAS Anesthetics D0TZ1G DRUGTYPE Small molecular drug D0TZ1G DRUGINCH 1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3 D0TZ1G DRUGINKE MFDFERRIHVXMIY-UHFFFAOYSA-N D0TZ1G DRUGSMIL CCN(CC)CCOC(=O)C1=CC=C(C=C1)N D0TZ1G HIGHSTAT Approved D0U0KW DRUG__ID D0U0KW D0U0KW DRUGCOMP Takeda D0U0KW THERCLAS Hypnotics and Sedatives D0U0KW DRUGTYPE Small molecular drug D0U0KW DRUGINCH 1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1 D0U0KW DRUGINKE YLXDSYKOBKBWJQ-LBPRGKRZSA-N D0U0KW DRUGSMIL CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3 D0U0KW HIGHSTAT Approved D0U0RZ DRUG__ID D0U0RZ D0U0RZ DRUGCOMP Medeva Pharmaceuticals D0U0RZ THERCLAS Appetite Depressants D0U0RZ DRUGTYPE Small molecular drug D0U0RZ DRUGINCH 1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3 D0U0RZ DRUGINKE DHHVAGZRUROJKS-UHFFFAOYSA-N D0U0RZ DRUGSMIL CC(C)(CC1=CC=CC=C1)N D0U0RZ HIGHSTAT Approved D0U1OE DRUG__ID D0U1OE D0U1OE DRUGCOMP Norvatis Phamaceuticals Corporation D0U1OE THERCLAS Antipsychotic Agents D0U1OE DRUGTYPE Small molecular drug D0U1OE DRUGINCH 1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3 D0U1OE DRUGINKE KLBQZWRITKRQQV-UHFFFAOYSA-N D0U1OE DRUGSMIL CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC D0U1OE HIGHSTAT Approved D0U2JP DRUG__ID D0U2JP D0U2JP DRUGCOMP Merck & Co D0U2JP THERCLAS Hypoglycemic Agents D0U2JP DRUGTYPE Small molecular drug D0U2JP DRUGINCH 1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1 D0U2JP DRUGINKE MFFMDFFZMYYVKS-SECBINFHSA-N D0U2JP DRUGSMIL C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N D0U2JP HIGHSTAT Approved D0U2OO DRUG__ID D0U2OO D0U2OO DRUGCOMP Bristol-Myers Squibb D0U2OO THERCLAS Antianxiety Agents D0U2OO DRUGTYPE Small molecular drug D0U2OO DRUGINCH 1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2 D0U2OO DRUGINKE QWCRAEMEVRGPNT-UHFFFAOYSA-N D0U2OO DRUGSMIL C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4 D0U2OO HIGHSTAT Approved D0U3DU DRUG__ID D0U3DU D0U3DU DRUGCOMP Hospira D0U3DU THERCLAS Hypnotics and Sedatives D0U3DU DRUGTYPE Small molecular drug D0U3DU DRUGINCH 1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1 D0U3DU DRUGINKE CUHVIMMYOGQXCV-NSHDSACASA-N D0U3DU DRUGSMIL CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C D0U3DU HIGHSTAT Approved D0U3EC DRUG__ID D0U3EC D0U3EC DRUGCOMP Norvatis Phamaceuticals Corporation D0U3EC THERCLAS Antihypertensive Agents D0U3EC DRUGTYPE Small molecular drug D0U3EC DRUGINCH 1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1 D0U3EC DRUGINKE XPCFTKFZXHTYIP-PMACEKPBSA-N D0U3EC DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O D0U3EC HIGHSTAT Approved D0U3LS DRUG__ID D0U3LS D0U3LS DRUGCOMP Upjohn Corporation D0U3LS THERCLAS Hypnotics and Sedatives D0U3LS DRUGTYPE Small molecular drug D0U3LS DRUGINCH 1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3 D0U3LS DRUGINKE JOFWLTCLBGQGBO-UHFFFAOYSA-N D0U3LS DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl D0U3LS HIGHSTAT Approved D0U4CE DRUG__ID D0U4CE D0U4CE DRUGCOMP Actelion Pharmaceuticals D0U4CE THERCLAS Antihypertensive Agents D0U4CE DRUGTYPE Small molecular drug D0U4CE DRUGINCH 1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32) D0U4CE DRUGINKE GJPICJJJRGTNOD-UHFFFAOYSA-N D0U4CE DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC D0U4CE HIGHSTAT Approved D0U4YG DRUG__ID D0U4YG D0U4YG DRUGCOMP King Pharmaceuticals Inc D0U4YG THERCLAS Antiinfective Agents D0U4YG DRUGTYPE Small molecular drug D0U4YG DRUGINCH 1S/2C16H18N2O4S.C16H20N2.4H2O/c2*1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9;1-3-7-15(8-4-1)13-17-11-12-18-14-16-9-5-2-6-10-16;;;;/h2*3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22);1-10,17-18H,11-14H2;4*1H2/t2*11-,12+,14-;;;;;/m11...../s1 D0U4YG DRUGINKE WIDKTXGNSOORHA-CJHXQPGBSA-N D0U4YG DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C.C1=CC=C(C=C1)CNCCNCC2=CC=CC=C2.O.O.O.O D0U4YG HIGHSTAT Approved D0U5FF DRUG__ID D0U5FF D0U5FF DRUGCOMP Abbott Laboratories D0U5FF THERCLAS Anticancer Agents D0U5FF DRUGTYPE Small molecular drug D0U5FF DRUGINCH 1S/C59H84N16O12/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64)/t40-,41-,42-,43+,44-,45-,46-,47-,48-/m0/s1 D0U5FF DRUGINKE GFIJNRVAKGFPGQ-LIJARHBVSA-N D0U5FF DRUGSMIL CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6 D0U5FF HIGHSTAT Approved D0U5FS DRUG__ID D0U5FS D0U5FS DRUGCOMP Janssen Pharmaceutica D0U5FS THERCLAS Antipsychotic Agents D0U5FS DRUGTYPE Small molecular drug D0U5FS DRUGINCH 1S/C29H31F2N3O/c30-24-12-8-22(9-13-24)27(23-10-14-25(31)15-11-23)7-4-18-33-19-16-29(17-20-33)28(35)32-21-34(29)26-5-2-1-3-6-26/h1-3,5-6,8-15,27H,4,7,16-21H2,(H,32,35) D0U5FS DRUGINKE QOYHHIBFXOOADH-UHFFFAOYSA-N D0U5FS DRUGSMIL C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F D0U5FS HIGHSTAT Approved D0U5GB DRUG__ID D0U5GB D0U5GB DRUGCOMP Abbott Laboratories D0U5GB THERCLAS Anti-HIV Agents D0U5GB DRUGTYPE Small molecular drug D0U5GB DRUGINCH 1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 D0U5GB DRUGINKE KJHKTHWMRKYKJE-SUGCFTRWSA-N D0U5GB DRUGSMIL CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O D0U5GB HIGHSTAT Approved D0U5HU DRUG__ID D0U5HU D0U5HU DRUGCOMP Bristol-Myers Squibb D0U5HU THERCLAS Anticancer Agents D0U5HU DRUGTYPE Small molecular drug D0U5HU DRUGINCH 1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2 D0U5HU DRUGINKE LXZZYRPGZAFOLE-UHFFFAOYSA-L D0U5HU DRUGSMIL N.N.Cl[Pt]Cl D0U5HU HIGHSTAT Approved D0U5OE DRUG__ID D0U5OE D0U5OE DRUGCOMP Watson Laboratories D0U5OE THERCLAS Antipsychotic Agents D0U5OE DRUGTYPE Small molecular drug D0U5OE DRUGINCH 1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3 D0U5OE DRUGINKE XJGVXQDUIWGIRW-UHFFFAOYSA-N D0U5OE DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl D0U5OE HIGHSTAT Approved D0U5RT DRUG__ID D0U5RT D0U5RT DRUGCOMP Rekah Pharmaceutical D0U5RT THERCLAS Anticonvulsants D0U5RT DRUGTYPE Small molecular drug D0U5RT DRUGINCH 1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) D0U5RT DRUGINKE DQMZLTXERSFNPB-UHFFFAOYSA-N D0U5RT DRUGSMIL CCC1(C(=O)NCNC1=O)C2=CC=CC=C2 D0U5RT HIGHSTAT Approved D0U5VZ DRUG__ID D0U5VZ D0U5VZ DRUGCOMP Tanabe Seiyaku Co D0U5VZ THERCLAS Antiallergic Agents D0U5VZ DRUGTYPE Small molecular drug D0U5VZ DRUGINCH 1S/C21H25ClN2O3/c22-17-8-6-16(7-9-17)21(19-4-1-2-12-23-19)27-18-10-14-24(15-11-18)13-3-5-20(25)26/h1-2,4,6-9,12,18,21H,3,5,10-11,13-15H2,(H,25,26)/t21-/m0/s1 D0U5VZ DRUGINKE YWGDOWXRIALTES-NRFANRHFSA-N D0U5VZ DRUGSMIL C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O D0U5VZ HIGHSTAT Approved D0U6LM DRUG__ID D0U6LM D0U6LM DRUGCOMP Roche Pharmaceuticals D0U6LM THERCLAS Hypnotics and Sedatives D0U6LM DRUGTYPE Small molecular drug D0U6LM DRUGINCH 1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3 D0U6LM DRUGINKE DDLIGBOFAVUZHB-UHFFFAOYSA-N D0U6LM DRUGSMIL CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F D0U6LM HIGHSTAT Approved D0U7BW DRUG__ID D0U7BW D0U7BW DRUGCOMP Norvatis Phamaceuticals Corporation D0U7BW THERCLAS Cardiotonic Agents D0U7BW DRUGTYPE Small molecular drug D0U7BW DRUGINCH 1S/C6H14N2O2.ClH/c1-8(2,3)4-5-10-6(7)9;/h4-5H2,1-3H3,(H-,7,9);1H D0U7BW DRUGINKE AIXAANGOTKPUOY-UHFFFAOYSA-N D0U7BW DRUGSMIL C[N+](C)(C)CCOC(=O)N.[Cl-] D0U7BW HIGHSTAT Approved D0U7IL DRUG__ID D0U7IL D0U7IL TRADNAME Inpefa D0U7IL DRUGCOMP Lexicon Pharmaceuticals D0U7IL DRUGTYPE Small molecular drug D0U7IL DRUGINCH 1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1 D0U7IL DRUGINKE QKDRXGFQVGOQKS-CRSSMBPESA-N D0U7IL DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl D0U7IL HIGHSTAT Approved D0U8AT DRUG__ID D0U8AT D0U8AT DRUGCOMP Wyeth Pharmaceuticals D0U8AT THERCLAS Parasympathomimetics D0U8AT DRUGTYPE Small molecular drug D0U8AT DRUGINCH 1S/C9H23NO3PS.HI/c1-6-12-14(11,13-7-2)15-9-8-10(3,4)5;/h6-9H2,1-5H3;1H/q+1;/p-1 D0U8AT DRUGINKE OVXQHPWHMXOFRD-UHFFFAOYSA-M D0U8AT DRUGSMIL CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-] D0U8AT HIGHSTAT Approved D0U8UV DRUG__ID D0U8UV D0U8UV DRUGCOMP Carter-Horner Corp. D0U8UV THERCLAS Antiemetics D0U8UV DRUGTYPE Small molecular drug D0U8UV DRUGINCH 1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10) D0U8UV DRUGINKE NFLLKCVHYJRNRH-UHFFFAOYSA-N D0U8UV DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2 D0U8UV HIGHSTAT Approved D0UM7O DRUG__ID D0UM7O D0UM7O DRUGCOMP Pfizer Pharmaceuticals D0UM7O THERCLAS Analgesics D0UM7O DRUGTYPE Small molecular drug D0UM7O DRUGINCH 1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3 D0UM7O DRUGINKE YQEZLKZALYSWHR-UHFFFAOYSA-N D0UM7O DRUGSMIL CNC1(CCCCC1=O)C2=CC=CC=C2Cl D0UM7O HIGHSTAT Approved D0V0LB DRUG__ID D0V0LB D0V0LB DRUGCOMP Mylan Pharmaceuticals Inc D0V0LB THERCLAS Nephropathic cystinosis therapy D0V0LB DRUGTYPE Small molecular drug D0V0LB DRUGINCH 1S/C2H7NS/c3-1-2-4/h4H,1-3H2 D0V0LB DRUGINKE UFULAYFCSOUIOV-UHFFFAOYSA-N D0V0LB DRUGSMIL C(CS)N D0V0LB HIGHSTAT Approved D0V3GA DRUG__ID D0V3GA D0V3GA DRUGCOMP Norvatis Phamaceuticals Corporation D0V3GA THERCLAS Cardiotonic Agents D0V3GA DRUGTYPE Small molecular drug D0V3GA DRUGINCH 1S/C43H66O14/c1-21-38(48)33(54-24(4)44)19-37(51-21)57-40-23(3)53-36(18-32(40)46)56-39-22(2)52-35(17-31(39)45)55-27-9-12-41(5)26(16-27)7-8-30-29(41)10-13-42(6)28(11-14-43(30,42)49)25-15-34(47)50-20-25/h15,21-23,26-33,35-40,45-46,48-49H,7-14,16-20H2,1-6H3/t21-,22-,23-,26-,27+,28-,29+,30-,31+,32+,33+,35+,36+,37+,38-,39-,40-,41+,42-,43+/m1/s1 D0V3GA DRUGINKE HPMZBILYSWLILX-UMDUKNJSSA-N D0V3GA DRUGSMIL CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)OC(=O)C)O D0V3GA HIGHSTAT Approved D0V3ZA DRUG__ID D0V3ZA D0V3ZA DRUGCOMP Pfizer Pharmaceuticals D0V3ZA THERCLAS Antimigraine Agents D0V3ZA DRUGTYPE Small molecular drug D0V3ZA DRUGINCH 1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1 D0V3ZA DRUGINKE LUZRJRNZXALNLM-JGRZULCMSA-N D0V3ZA DRUGSMIL CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C D0V3ZA HIGHSTAT Approved D0V4GY DRUG__ID D0V4GY D0V4GY DRUGCOMP G. D. Pharmaceuticals D0V4GY THERCLAS Antibiotics D0V4GY DRUGTYPE Small molecular drug D0V4GY DRUGINCH 1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34) D0V4GY DRUGINKE GHXZTYHSJHQHIJ-UHFFFAOYSA-N D0V4GY DRUGSMIL C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl D0V4GY HIGHSTAT Approved D0V4IB DRUG__ID D0V4IB D0V4IB DRUGCOMP Janssen Pharmaceutica D0V4IB THERCLAS Antifungal Agents D0V4IB DRUGTYPE Small molecular drug D0V4IB DRUGINCH 1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1 D0V4IB DRUGINKE VHVPQPYKVGDNFY-ZPGVKDDISA-N D0V4IB DRUGSMIL CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl D0V4IB HIGHSTAT Approved D0V4QS DRUG__ID D0V4QS D0V4QS DRUGCOMP Eli Lilly D0V4QS THERCLAS Antipsychotic Agents D0V4QS DRUGTYPE Small molecular drug D0V4QS DRUGINCH 1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 D0V4QS DRUGINKE KVWDHTXUZHCGIO-UHFFFAOYSA-N D0V4QS DRUGSMIL CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C D0V4QS HIGHSTAT Approved D0V5IW DRUG__ID D0V5IW D0V5IW TRADNAME Solosec D0V5IW DRUGCOMP Lupin D0V5IW DRUGTYPE Small molecular drug D0V5IW DRUGINCH 1S/C7H11N3O3/c1-5(11)4-9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3 D0V5IW DRUGINKE KPQZUUQMTUIKBP-UHFFFAOYSA-N D0V5IW DRUGSMIL CC1=NC=C(N1CC(C)O)[N+](=O)[O-] D0V5IW HIGHSTAT Approved D0V7CF DRUG__ID D0V7CF D0V7CF DRUGCOMP Merck & Co D0V7CF THERCLAS Anti-HIV Agents D0V7CF DRUGTYPE Small molecular drug D0V7CF DRUGINCH 1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1 D0V7CF DRUGINKE CBVCZFGXHXORBI-PXQQMZJSSA-N D0V7CF DRUGSMIL CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5 D0V7CF HIGHSTAT Approved D0V8HA DRUG__ID D0V8HA D0V8HA DRUGCOMP Mecamylamine D0V8HA THERCLAS Antihypertensive Agents D0V8HA DRUGTYPE Small molecular drug D0V8HA DRUGINCH 1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3 D0V8HA DRUGINKE IMYZQPCYWPFTAG-UHFFFAOYSA-N D0V8HA DRUGSMIL CC1(C2CCC(C2)C1(C)NC)C D0V8HA HIGHSTAT Approved D0V8HJ DRUG__ID D0V8HJ D0V8HJ TRADNAME Tavalisse D0V8HJ DRUGCOMP Rigel Pharmaceuticals D0V8HJ DRUGTYPE Small molecular drug D0V8HJ DRUGINCH 1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29) D0V8HJ DRUGINKE GKDRMWXFWHEQQT-UHFFFAOYSA-N D0V8HJ DRUGSMIL CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C D0V8HJ HIGHSTAT Approved D0V8QT DRUG__ID D0V8QT D0V8QT DRUGCOMP GlaxoSmithKline D0V8QT THERCLAS Anticancer Agents D0V8QT DRUGTYPE Small molecular drug D0V8QT DRUGINCH 1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19) D0V8QT DRUGINKE JCKYGMPEJWAADB-UHFFFAOYSA-N D0V8QT DRUGSMIL C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl D0V8QT HIGHSTAT Approved D0V9BD DRUG__ID D0V9BD D0V9BD DRUGCOMP AstraZeneca plc D0V9BD THERCLAS Anticancer Agents D0V9BD DRUGTYPE Small molecular drug D0V9BD DRUGINCH 1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25) D0V9BD DRUGINKE LKJPYSCBVHEWIU-UHFFFAOYSA-N D0V9BD DRUGSMIL CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O D0V9BD HIGHSTAT Approved D0V9WF DRUG__ID D0V9WF D0V9WF DRUGCOMP Cephalon; Kyowa Hakko Kogyo D0V9WF THERCLAS Anticancer Agents D0V9WF DRUGTYPE Small molecular drug D0V9WF DRUGINCH 1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1 D0V9WF DRUGINKE UIARLYUEJFELEN-LROUJFHJSA-N D0V9WF DRUGSMIL CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O D0V9WF HIGHSTAT Approved (orphan drug) D0VB0U DRUG__ID D0VB0U D0VB0U DRUGCOMP Pharmacia And Upjohn Co D0VB0U THERCLAS Neurology Agents D0VB0U DRUGTYPE Small molecular drug D0VB0U DRUGINCH 1S/C9H11ClO3/c10-7-1-3-9(4-2-7)13-6-8(12)5-11/h1-4,8,11-12H,5-6H2 D0VB0U DRUGINKE MXOAEAUPQDYUQM-UHFFFAOYSA-N D0VB0U DRUGSMIL C1=CC(=CC=C1OCC(CO)O)Cl D0VB0U HIGHSTAT Approved D0VM2L DRUG__ID D0VM2L D0VM2L DRUGCOMP Norvatis Phamaceuticals Corporation D0VM2L THERCLAS Bone Density Conservation Agents D0VM2L DRUGTYPE Small molecular drug D0VM2L DRUGINCH 1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14) D0VM2L DRUGINKE XRASPMIURGNCCH-UHFFFAOYSA-N D0VM2L DRUGSMIL C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O D0VM2L HIGHSTAT Approved D0VR7W DRUG__ID D0VR7W D0VR7W DRUGCOMP Oscient Pharmaceuticals D0VR7W THERCLAS Antibiotics D0VR7W DRUGTYPE Small molecular drug D0VR7W DRUGINCH 1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+ D0VR7W DRUGINKE ZRCVYEYHRGVLOC-HYARGMPZSA-N D0VR7W DRUGSMIL CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F D0VR7W HIGHSTAT Approved D0VT8P DRUG__ID D0VT8P D0VT8P DRUGCOMP Schering-Plough D0VT8P THERCLAS Antiviral Agents D0VT8P DRUGTYPE Small molecular drug D0VT8P DRUGINCH 1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18) D0VT8P DRUGINKE GGXKWVWZWMLJEH-UHFFFAOYSA-N D0VT8P DRUGSMIL CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C D0VT8P HIGHSTAT Approved D0W0BF DRUG__ID D0W0BF D0W0BF DRUGCOMP AstraZeneca D0W0BF THERCLAS Anticancer Agents D0W0BF DRUGTYPE Small molecular drug D0W0BF DRUGINCH 1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3 D0W0BF DRUGINKE YBBLVLTVTVSKRW-UHFFFAOYSA-N D0W0BF DRUGSMIL CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N D0W0BF HIGHSTAT Approved D0W1DI DRUG__ID D0W1DI D0W1DI TRADNAME Doptelet D0W1DI DRUGCOMP Dova Pharmaceuticals D0W1DI DRUGTYPE Small molecular drug D0W1DI DRUGINCH 1S/C29H34Cl2N6O3S2/c30-20-15-23(41-17-20)24-27(37-12-10-35(11-13-37)21-4-2-1-3-5-21)42-29(33-24)34-26(38)19-14-22(31)25(32-16-19)36-8-6-18(7-9-36)28(39)40/h14-18,21H,1-13H2,(H,39,40)(H,33,34,38) D0W1DI DRUGINKE OFZJKCQENFPZBH-UHFFFAOYSA-N D0W1DI DRUGSMIL C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl D0W1DI HIGHSTAT Approved D0W2NM DRUG__ID D0W2NM D0W2NM DRUGCOMP Roche Laboratories Inc D0W2NM THERCLAS Hypnotics and Sedatives D0W2NM DRUGTYPE Small molecular drug D0W2NM DRUGINCH 1S/C16H12FN3O3/c1-19-14-7-6-10(20(22)23)8-12(14)16(18-9-15(19)21)11-4-2-3-5-13(11)17/h2-8H,9H2,1H3 D0W2NM DRUGINKE PPTYJKAXVCCBDU-UHFFFAOYSA-N D0W2NM DRUGSMIL CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3F D0W2NM HIGHSTAT Approved D0W4HZ DRUG__ID D0W4HZ D0W4HZ DRUGCOMP Schering-Plough D0W4HZ THERCLAS Anticancer Agents D0W4HZ DRUGTYPE Small molecular drug D0W4HZ DRUGINCH 1S/C27H31Br2ClN4O2/c28-20-12-19-2-1-18-13-21(30)14-22(29)24(18)25(26(19)32-15-20)17-5-9-33(10-6-17)23(35)11-16-3-7-34(8-4-16)27(31)36/h12-17,25H,1-11H2,(H2,31,36)/t25-/m1/s1 D0W4HZ DRUGINKE DHMTURDWPRKSOA-RUZDIDTESA-N D0W4HZ DRUGSMIL C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N D0W4HZ HIGHSTAT Approved D0W5HK DRUG__ID D0W5HK D0W5HK DRUGCOMP Bayer AG; Onyx Pharmaceuticals D0W5HK THERCLAS Anticancer Agents D0W5HK DRUGTYPE Small molecular drug D0W5HK DRUGINCH 1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) D0W5HK DRUGINKE MLDQJTXFUGDVEO-UHFFFAOYSA-N D0W5HK DRUGSMIL CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F D0W5HK HIGHSTAT Approved D0W5UV DRUG__ID D0W5UV D0W5UV DRUGCOMP Aton Pharma Inc D0W5UV THERCLAS Cardiovascular Agents D0W5UV DRUGTYPE Small molecular drug D0W5UV DRUGINCH 1S/C13H12Cl2O4.Na/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17;/h4-5H,2-3,6H2,1H3,(H,16,17);/q;+1/p-1 D0W5UV DRUGINKE CWCSCNSKBSCYCS-UHFFFAOYSA-M D0W5UV DRUGSMIL CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)[O-])Cl)Cl.[Na+] D0W5UV HIGHSTAT Approved D0W6CA DRUG__ID D0W6CA D0W6CA DRUGCOMP Pfizer Pharmaceuticals D0W6CA THERCLAS Antibiotics D0W6CA DRUGTYPE Small molecular drug D0W6CA DRUGINCH 1S/C15H17N5O6S2/c1-25-3-6-4-27-13-9(12(22)20(13)10(6)14(23)24)18-11(21)8(19-26-2)7-5-28-15(16)17-7/h5,9,13H,3-4H2,1-2H3,(H2,16,17)(H,18,21)(H,23,24)/b19-8-/t9-,13-/m1/s1 D0W6CA DRUGINKE WYUSVOMTXWRGEK-HBWVYFAYSA-N D0W6CA DRUGSMIL COCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O D0W6CA HIGHSTAT Approved D0W6DG DRUG__ID D0W6DG D0W6DG DRUGCOMP Sterling Drug Company D0W6DG THERCLAS Anesthetics D0W6DG DRUGTYPE Small molecular drug D0W6DG DRUGINCH 1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m0/s1 D0W6DG DRUGINKE VOKSWYLNZZRQPF-GDIGMMSISA-N D0W6DG DRUGSMIL CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O D0W6DG HIGHSTAT Approved D0W6ZF DRUG__ID D0W6ZF D0W6ZF DRUGCOMP Abbott Laboratories D0W6ZF THERCLAS Anesthetics D0W6ZF DRUGTYPE Small molecular drug D0W6ZF DRUGINCH 1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2 D0W6ZF DRUGINKE DFEYYRMXOJXZRJ-UHFFFAOYSA-N D0W6ZF DRUGSMIL C(OC(C(F)(F)F)C(F)(F)F)F D0W6ZF HIGHSTAT Approved D0W7RJ DRUG__ID D0W7RJ D0W7RJ DRUGCOMP Bristol Laboratories Inc Div Bristol Myers Co D0W7RJ THERCLAS Antibiotics D0W7RJ DRUGTYPE Small molecular drug D0W7RJ DRUGINCH 1S/C19H23N3O4S/c1-18(2)13(17(25)26)21-15(24)12(16(21)27-18)22-14(23)11(20-19(22,3)4)10-8-6-5-7-9-10/h5-9,11-13,16,20H,1-4H3,(H,25,26)/t11-,12-,13+,16-/m1/s1 D0W7RJ DRUGINKE DXVUYOAEDJXBPY-NFFDBFGFSA-N D0W7RJ DRUGSMIL CC1(C(N2C(S1)C(C2=O)N3C(=O)C(NC3(C)C)C4=CC=CC=C4)C(=O)O)C D0W7RJ HIGHSTAT Approved D0W9LX DRUG__ID D0W9LX D0W9LX DRUGCOMP GlaxoSmithKline plc D0W9LX THERCLAS Vasodilator Agents D0W9LX DRUGTYPE Small molecular drug D0W9LX DRUGINCH 1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3 D0W9LX DRUGINKE OGHNVEJMJSYVRP-UHFFFAOYSA-N D0W9LX DRUGSMIL COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O D0W9LX HIGHSTAT Approved D0W9MM DRUG__ID D0W9MM D0W9MM DRUGCOMP Eli Lilly And Co D0W9MM THERCLAS Anticancer Agents D0W9MM DRUGTYPE Small molecular drug D0W9MM DRUGINCH 1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1 D0W9MM DRUGINKE JXLYSJRDGCGARV-CFWMRBGOSA-N D0W9MM DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O D0W9MM HIGHSTAT Approved D0W9WF DRUG__ID D0W9WF D0W9WF DRUGCOMP ProEthic Pharmaceuticals D0W9WF THERCLAS Analgesics D0W9WF DRUGTYPE Small molecular drug D0W9WF DRUGINCH 1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19) D0W9WF DRUGINKE DKYWVDODHFEZIM-UHFFFAOYSA-N D0W9WF DRUGSMIL CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O D0W9WF HIGHSTAT Approved D0W9ZF DRUG__ID D0W9ZF D0W9ZF DRUGCOMP Ferring Pharmaceuticals D0W9ZF THERCLAS Fertility Agents D0W9ZF DRUGTYPE Small molecular drug D0W9ZF DRUGINCH 1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3/t16-,17+,19-/m1/s1 D0W9ZF DRUGINKE GDFGTRDCCWFXTG-ZIFCJYIRSA-N D0W9ZF DRUGSMIL CCCN1CC(CC2C1CC3=C(C2)C(=CC=C3)O)NS(=O)(=O)N(CC)CC D0W9ZF HIGHSTAT Approved D0WE3O DRUG__ID D0WE3O D0WE3O DRUGCOMP Eurohealth International Sarl D0WE3O THERCLAS Analgesics D0WE3O DRUGTYPE Small molecular drug D0WE3O DRUGINCH 1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1 D0WE3O DRUGINKE BQJCRHHNABKAKU-KBQPJGBKSA-N D0WE3O DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O D0WE3O HIGHSTAT Approved D0WI3T DRUG__ID D0WI3T D0WI3T DRUGCOMP Hoffmann-La Roche pharmaceutical company D0WI3T THERCLAS Anti-HIV Agents D0WI3T DRUGTYPE Small molecular drug D0WI3T DRUGINCH 1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1 D0WI3T DRUGINKE QWAXKHKRTORLEM-UGJKXSETSA-N D0WI3T DRUGSMIL CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O D0WI3T HIGHSTAT Approved D0WN0U DRUG__ID D0WN0U D0WN0U DRUGCOMP AstraZeneca D0WN0U THERCLAS Antihypertensive Agents D0WN0U DRUGTYPE Small molecular drug D0WN0U DRUGINCH 1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3 D0WN0U DRUGINKE RZTAMFZIAATZDJ-UHFFFAOYSA-N D0WN0U DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C D0WN0U HIGHSTAT Approved D0WO8W DRUG__ID D0WO8W D0WO8W DRUGCOMP Eastman Kodak Co D0WO8W THERCLAS Anesthetics D0WO8W DRUGTYPE Small molecular drug D0WO8W DRUGINCH 1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18) D0WO8W DRUGINKE INWLQCZOYSRPNW-UHFFFAOYSA-N D0WO8W DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C D0WO8W HIGHSTAT Approved D0WS1X DRUG__ID D0WS1X D0WS1X DRUGCOMP Abbott Laboratories D0WS1X THERCLAS Antibiotics D0WS1X DRUGTYPE Small molecular drug D0WS1X DRUGINCH 1S/C14H13N5O5S2/c1-2-5-3-25-12-8(11(21)19(12)9(5)13(22)23)17-10(20)7(18-24)6-4-26-14(15)16-6/h2,4,8,12,24H,1,3H2,(H2,15,16)(H,17,20)(H,22,23)/b18-7-/t8-,12-/m1/s1 D0WS1X DRUGINKE RTXOFQZKPXMALH-GHXIOONMSA-N D0WS1X DRUGSMIL C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O D0WS1X HIGHSTAT Approved D0WV3U DRUG__ID D0WV3U D0WV3U DRUGCOMP Pfizer Pharmaceuticals D0WV3U THERCLAS Antihypertensive Agents D0WV3U DRUGTYPE Small molecular drug D0WV3U DRUGINCH 1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22) D0WV3U DRUGINKE IENZQIKPVFGBNW-UHFFFAOYSA-N D0WV3U DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC D0WV3U HIGHSTAT Approved D0X0CH DRUG__ID D0X0CH D0X0CH TRADNAME Ztalmy D0X0CH DRUGCOMP Marinus D0X0CH DRUGTYPE Small molecular drug D0X0CH DRUGINCH 1S/C22H36O2/c1-14(23)17-7-8-18-16-6-5-15-13-20(2,24)11-12-21(15,3)19(16)9-10-22(17,18)4/h15-19,24H,5-13H2,1-4H3/t15-,16-,17+,18-,19-,20+,21-,22+/m0/s1 D0X0CH DRUGINKE PGTVWKLGGCQMBR-FLBATMFCSA-N D0X0CH DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C D0X0CH HIGHSTAT Approved D0X0RI DRUG__ID D0X0RI D0X0RI DRUGCOMP Boehringer Ingelheim D0X0RI THERCLAS Antiarrhythmic Agents D0X0RI DRUGTYPE Small molecular drug D0X0RI DRUGINCH 1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3 D0X0RI DRUGINKE VLPIATFUUWWMKC-UHFFFAOYSA-N D0X0RI DRUGSMIL CC1=C(C(=CC=C1)C)OCC(C)N D0X0RI HIGHSTAT Approved D0X2DK DRUG__ID D0X2DK D0X2DK DRUGCOMP Concordia Pharmaceuticals Inc D0X2DK THERCLAS Antihypertensive Agents D0X2DK DRUGTYPE Small molecular drug D0X2DK DRUGINCH 1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3 D0X2DK DRUGINKE QZVCTJOXCFMACW-UHFFFAOYSA-N D0X2DK DRUGSMIL CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2 D0X2DK HIGHSTAT Approved D0X3FX DRUG__ID D0X3FX D0X3FX DRUGCOMP Bristol Meyers Squibb D0X3FX THERCLAS Antinarcotic Agents D0X3FX DRUGTYPE Small molecular drug D0X3FX DRUGINCH 1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1 D0X3FX DRUGINKE UZHSEJADLWPNLE-GRGSLBFTSA-N D0X3FX DRUGSMIL C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O D0X3FX HIGHSTAT Approved D0X4RN DRUG__ID D0X4RN D0X4RN DRUGCOMP Endo Pharmaceuticals D0X4RN THERCLAS Anesthetics D0X4RN DRUGTYPE Small molecular drug D0X4RN DRUGINCH 1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17) D0X4RN DRUGINKE NNJVILVZKWQKPM-UHFFFAOYSA-N D0X4RN DRUGSMIL CCN(CC)CC(=O)NC1=C(C=CC=C1C)C D0X4RN HIGHSTAT Approved D0X4RS DRUG__ID D0X4RS D0X4RS DRUGCOMP Pharmacia And Upjohn Co D0X4RS THERCLAS Anticancer Agents D0X4RS DRUGTYPE Small molecular drug D0X4RS DRUGINCH 1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1 D0X4RS DRUGINKE ITRJWOMZKQRYTA-RFZYENFJSA-N D0X4RS DRUGSMIL CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O D0X4RS HIGHSTAT Approved D0X5KF DRUG__ID D0X5KF D0X5KF DRUGCOMP Abbott Laboratories D0X5KF THERCLAS Analgesics D0X5KF DRUGTYPE Small molecular drug D0X5KF DRUGINCH 1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1 D0X5KF DRUGINKE LLPOLZWFYMWNKH-CMKMFDCUSA-N D0X5KF DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4 D0X5KF HIGHSTAT Approved D0X5SD DRUG__ID D0X5SD D0X5SD DRUGCOMP Odyssey Pharmaceuticals D0X5SD THERCLAS Alcohol Deterrents D0X5SD DRUGTYPE Small molecular drug D0X5SD DRUGINCH 1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3 D0X5SD DRUGINKE AUZONCFQVSMFAP-UHFFFAOYSA-N D0X5SD DRUGSMIL CCN(CC)C(=S)SSC(=S)N(CC)CC D0X5SD HIGHSTAT Approved D0X6GN DRUG__ID D0X6GN D0X6GN DRUGCOMP Bausch & Lomb Pharmaceuticals, Inc. D0X6GN THERCLAS Antiallergic Agents D0X6GN DRUGTYPE Small molecular drug D0X6GN DRUGINCH 1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1 D0X6GN DRUGINKE DMKSVUSAATWOCU-HROMYWEYSA-N D0X6GN DRUGSMIL CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl D0X6GN HIGHSTAT Approved D0X6IU DRUG__ID D0X6IU D0X6IU DRUGCOMP Aventis Pharmaceuticals Inc. D0X6IU THERCLAS Antibiotics D0X6IU DRUGTYPE Small molecular drug D0X6IU DRUGINCH 1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1 D0X6IU DRUGINKE WIIZWVCIJKGZOK-RKDXNWHRSA-N D0X6IU DRUGSMIL C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-] D0X6IU HIGHSTAT Approved D0X7DE DRUG__ID D0X7DE D0X7DE DRUGCOMP Bristol-Myers Squibb D0X7DE THERCLAS Antidepressants D0X7DE DRUGTYPE Small molecular drug D0X7DE DRUGINCH 1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3 D0X7DE DRUGINKE VRBKIVRKKCLPHA-UHFFFAOYSA-N D0X7DE DRUGSMIL CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl D0X7DE HIGHSTAT Approved D0X7GL DRUG__ID D0X7GL D0X7GL DRUGCOMP GSK D0X7GL THERCLAS Anticonvulsants D0X7GL DRUGTYPE Small molecular drug D0X7GL DRUGINCH 1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21) D0X7GL DRUGINKE PCOBBVZJEWWZFR-UHFFFAOYSA-N D0X7GL DRUGSMIL CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N D0X7GL HIGHSTAT Approved D0X7HM DRUG__ID D0X7HM D0X7HM DRUGCOMP Bristol-Myers Squibb D0X7HM THERCLAS Anticancer Agents D0X7HM DRUGTYPE Small molecular drug D0X7HM DRUGINCH 1S/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6;;;/h1-3H2,(H,7,8)(H,9,10);2*1H2;/q;2*-1;+2 D0X7HM DRUGINKE VSRXQHXAPYXROS-UHFFFAOYSA-N D0X7HM DRUGSMIL C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2] D0X7HM HIGHSTAT Approved D0X7JN DRUG__ID D0X7JN D0X7JN DRUGCOMP GlaxoSmithKline D0X7JN THERCLAS Antibiotics D0X7JN DRUGTYPE Small molecular drug D0X7JN DRUGINCH 1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1 D0X7JN DRUGINKE HZZVJAQRINQKSD-PBFISZAISA-N D0X7JN DRUGSMIL C1C2N(C1=O)C(C(=CCO)O2)C(=O)O D0X7JN HIGHSTAT Approved D0X7JR DRUG__ID D0X7JR D0X7JR DRUGCOMP Sanofi-Aventis D0X7JR THERCLAS Anticancer Agents D0X7JR DRUGTYPE Small molecular drug D0X7JR DRUGINCH 1S/C6H12F2N2O2/c7-4(8)6(10,5(11)12)2-1-3-9/h4H,1-3,9-10H2,(H,11,12) D0X7JR DRUGINKE VLCYCQAOQCDTCN-UHFFFAOYSA-N D0X7JR DRUGSMIL C(CC(C(F)F)(C(=O)O)N)CN D0X7JR HIGHSTAT Approved D0X7KB DRUG__ID D0X7KB D0X7KB DRUGCOMP IVAX Pharmaceuticals D0X7KB THERCLAS Antiparkinson Agents D0X7KB DRUGTYPE Small molecular drug D0X7KB DRUGINCH 1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18+/m0/s1 D0X7KB DRUGINKE BKRGVLQUQGGVSM-KBXCAEBGSA-N D0X7KB DRUGSMIL CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C D0X7KB HIGHSTAT Approved D0X7XG DRUG__ID D0X7XG D0X7XG DRUGCOMP Leo Laboratories D0X7XG THERCLAS Antibiotics D0X7XG DRUGTYPE Small molecular drug D0X7XG DRUGINCH 1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1 D0X7XG DRUGINKE IECPWNUMDGFDKC-MZJAQBGESA-N D0X7XG DRUGSMIL CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4=C(CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C D0X7XG HIGHSTAT Approved D0X8KY DRUG__ID D0X8KY D0X8KY DRUGCOMP Bristol-Myers Squibb D0X8KY THERCLAS Antihypertensive Agents D0X8KY DRUGTYPE Small molecular drug D0X8KY DRUGINCH 1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39?/m1/s1 D0X8KY DRUGINKE BIDNLKIUORFRQP-FKDWWROVSA-N D0X8KY DRUGSMIL CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3 D0X8KY HIGHSTAT Approved D0X8XA DRUG__ID D0X8XA D0X8XA DRUGCOMP Ranbaxy Laboratories Inc D0X8XA THERCLAS Antiinfective Agents D0X8XA DRUGTYPE Small molecular drug D0X8XA DRUGINCH 1S/C18H15Cl3N2S/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2 D0X8XA DRUGINKE AFNXATANNDIXLG-UHFFFAOYSA-N D0X8XA DRUGSMIL C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl D0X8XA HIGHSTAT Approved D0X9RG DRUG__ID D0X9RG D0X9RG DRUGCOMP Apotex Inc D0X9RG THERCLAS Analgesics D0X9RG DRUGTYPE Small molecular drug D0X9RG DRUGINCH 1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21-/m1/s1 D0X9RG DRUGINKE IFKLAQQSCNILHL-QHAWAJNXSA-N D0X9RG DRUGSMIL C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O D0X9RG HIGHSTAT Approved D0X9ZC DRUG__ID D0X9ZC D0X9ZC DRUGCOMP Pharco B international D0X9ZC THERCLAS Antibiotics D0X9ZC DRUGTYPE Small molecular drug D0X9ZC DRUGINCH 1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1 D0X9ZC DRUGINKE BOEGTKLJZSQCCD-UEKVPHQBSA-N D0X9ZC DRUGSMIL CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O D0X9ZC HIGHSTAT Approved D0XN1F DRUG__ID D0XN1F D0XN1F DRUGCOMP Bayer Pharmaceuticals Corporation D0XN1F THERCLAS Vasodilator Agents D0XN1F DRUGTYPE Small molecular drug D0XN1F DRUGINCH 1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3 D0XN1F DRUGINKE UIAGMCDKSXEBJQ-UHFFFAOYSA-N D0XN1F DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC D0XN1F HIGHSTAT Approved D0Y0ER DRUG__ID D0Y0ER D0Y0ER DRUGCOMP Norvatis Phamaceuticals Corporation D0Y0ER THERCLAS Antiemetics D0Y0ER DRUGTYPE Small molecular drug D0Y0ER DRUGINCH 1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3 D0Y0ER DRUGINKE XCTYLCDETUVOIP-UHFFFAOYSA-N D0Y0ER DRUGSMIL CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C D0Y0ER HIGHSTAT Approved D0Y0SW DRUG__ID D0Y0SW D0Y0SW DRUGCOMP Schering-Plough Corporation D0Y0SW THERCLAS Anticancer Agents D0Y0SW DRUGTYPE Small molecular drug D0Y0SW DRUGINCH 1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17) D0Y0SW DRUGINKE MKXKFYHWDHIYRV-UHFFFAOYSA-N D0Y0SW DRUGSMIL CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F D0Y0SW HIGHSTAT Approved D0Y2CJ DRUG__ID D0Y2CJ D0Y2CJ DRUGCOMP Upjohn Corporation D0Y2CJ THERCLAS Antihypertensive Agents D0Y2CJ DRUGTYPE Small molecular drug D0Y2CJ DRUGINCH 1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2 D0Y2CJ DRUGINKE ZIMGGGWCDYVHOY-UHFFFAOYSA-N D0Y2CJ DRUGSMIL C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O D0Y2CJ HIGHSTAT Approved D0Y2IE DRUG__ID D0Y2IE D0Y2IE DRUGCOMP GlaxoSmithKline D0Y2IE THERCLAS Antibiotics D0Y2IE DRUGTYPE Small molecular drug D0Y2IE DRUGINCH 1S/C16H16N4O8S/c1-26-19-9(8-3-2-4-27-8)12(21)18-10-13(22)20-11(15(23)24)7(5-28-16(17)25)6-29-14(10)20/h2-4,10,14H,5-6H2,1H3,(H2,17,25)(H,18,21)(H,23,24)/b19-9-/t10-,14-/m1/s1 D0Y2IE DRUGINKE JFPVXVDWJQMJEE-IZRZKJBUSA-N D0Y2IE DRUGSMIL CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O D0Y2IE HIGHSTAT Approved D0Y2IZ DRUG__ID D0Y2IZ D0Y2IZ DRUGCOMP Hoechst Marion Roussel D0Y2IZ THERCLAS Antihypertensive Agents D0Y2IZ DRUGTYPE Small molecular drug D0Y2IZ DRUGINCH 1S/C8H8Cl3N3O4S2/c9-3-1-4-6(2-5(3)19(12,15)16)20(17,18)14-8(13-4)7(10)11/h1-2,7-8,13-14H,(H2,12,15,16) D0Y2IZ DRUGINKE LMJSLTNSBFUCMU-UHFFFAOYSA-N D0Y2IZ DRUGSMIL C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl D0Y2IZ HIGHSTAT Approved D0Y2LR DRUG__ID D0Y2LR D0Y2LR DRUGCOMP Ion Healthcare D0Y2LR THERCLAS Hypnotics and Sedatives D0Y2LR DRUGTYPE Small molecular drug D0Y2LR DRUGINCH 1S/C17H22N2O/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16/h4-12H,13-14H2,1-3H3 D0Y2LR DRUGINKE HCFDWZZGGLSKEP-UHFFFAOYSA-N D0Y2LR DRUGSMIL CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C D0Y2LR HIGHSTAT Approved D0Y2NE DRUG__ID D0Y2NE D0Y2NE DRUGCOMP Bayer Pharmaceuticals Corp D0Y2NE THERCLAS Anticancer Agents D0Y2NE DRUGTYPE Small molecular drug D0Y2NE DRUGINCH 1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+ D0Y2NE DRUGINKE RGLYKWWBQGJZGM-ISLYRVAYSA-N D0Y2NE DRUGSMIL CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O D0Y2NE HIGHSTAT Approved D0Y2YP DRUG__ID D0Y2YP D0Y2YP DRUGCOMP Watson Laboratories D0Y2YP THERCLAS Antiinflammatory Agents D0Y2YP DRUGTYPE Small molecular drug D0Y2YP DRUGINCH 1S/C24H33FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h7,13-14,16-17,19-20,26,28H,5-6,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1 D0Y2YP DRUGINKE POPFMWWJOGLOIF-XWCQMRHXSA-N D0Y2YP DRUGSMIL CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C D0Y2YP HIGHSTAT Approved D0Y3KG DRUG__ID D0Y3KG D0Y3KG DRUGCOMP Abbot Phamaceuticals D0Y3KG THERCLAS Neurology Agents D0Y3KG DRUGTYPE Small molecular drug D0Y3KG DRUGINCH 1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10) D0Y3KG DRUGINKE NIJJYAXOARWZEE-UHFFFAOYSA-N D0Y3KG DRUGSMIL CCCC(CCC)C(=O)O D0Y3KG HIGHSTAT Approved D0Y3ME DRUG__ID D0Y3ME D0Y3ME DRUGCOMP Sanofi-Aventis D0Y3ME THERCLAS Anticancer Agents D0Y3ME DRUGTYPE Small molecular drug D0Y3ME DRUGINCH 1S/C6H12N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-8H,1-4H2;(H,3,4)(H,5,6);/q-2;;+2/t5-,6-;;/m1../s1 D0Y3ME DRUGINKE DRMCATBEKSVAPL-BNTLRKBRSA-N D0Y3ME DRUGSMIL C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2] D0Y3ME HIGHSTAT Approved D0Y3MO DRUG__ID D0Y3MO D0Y3MO DRUGCOMP Abbott Laboratories D0Y3MO THERCLAS Antibiotics D0Y3MO DRUGTYPE Small molecular drug D0Y3MO DRUGINCH 1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+/m0/s1 D0Y3MO DRUGINKE LKCWBDHBTVXHDL-RMDFUYIESA-N D0Y3MO DRUGSMIL C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N D0Y3MO HIGHSTAT Approved D0Y4AW DRUG__ID D0Y4AW D0Y4AW DRUGCOMP Wyeth Pharmaceuticals D0Y4AW THERCLAS Antianxiety Agents D0Y4AW DRUGTYPE Small molecular drug D0Y4AW DRUGINCH 1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13) D0Y4AW DRUGINKE NPPQSCRMBWNHMW-UHFFFAOYSA-N D0Y4AW DRUGSMIL CCCC(C)(COC(=O)N)COC(=O)N D0Y4AW HIGHSTAT Approved D0Y4GO DRUG__ID D0Y4GO D0Y4GO DRUGCOMP Eli Lilly D0Y4GO THERCLAS Anticancer Agents D0Y4GO DRUGTYPE Small molecular drug D0Y4GO DRUGINCH 1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1 D0Y4GO DRUGINKE WBXPDJSOTKVWSJ-ZDUSSCGKSA-N D0Y4GO DRUGSMIL C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O D0Y4GO HIGHSTAT Approved D0Y5AM DRUG__ID D0Y5AM D0Y5AM DRUGCOMP Norvatis Phamaceuticals Corporation D0Y5AM THERCLAS Urinary antispasmodics D0Y5AM DRUGTYPE Small molecular drug D0Y5AM DRUGINCH 1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1 D0Y5AM DRUGINKE HXGBXQDTNZMWGS-RUZDIDTESA-N D0Y5AM DRUGSMIL C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5 D0Y5AM HIGHSTAT Approved D0Y5DO DRUG__ID D0Y5DO D0Y5DO DRUGCOMP Forest Laboratories, Inc D0Y5DO THERCLAS Antidepressants D0Y5DO DRUGTYPE Small molecular drug D0Y5DO DRUGINCH 1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3 D0Y5DO DRUGINKE WSEQXVZVJXJVFP-UHFFFAOYSA-N D0Y5DO DRUGSMIL CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F D0Y5DO HIGHSTAT Approved D0Y5UG DRUG__ID D0Y5UG D0Y5UG DRUGCOMP Hoffmann La Roche Inc D0Y5UG THERCLAS Analgesics D0Y5UG DRUGTYPE Small molecular drug D0Y5UG DRUGINCH 1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3 D0Y5UG DRUGINKE KRMDCWKBEZIMAB-UHFFFAOYSA-N D0Y5UG DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 D0Y5UG HIGHSTAT Approved D0Y6KO DRUG__ID D0Y6KO D0Y6KO DRUGCOMP Merck And Co Inc D0Y6KO THERCLAS Cardiovascular Agents D0Y6KO DRUGTYPE Small molecular drug D0Y6KO DRUGINCH 1S/C12H17NO4.ClH/c1-3-17-11(16)12(2,13)7-8-4-5-9(14)10(15)6-8;/h4-6,14-15H,3,7,13H2,1-2H3;1H/t12-;/m0./s1 D0Y6KO DRUGINKE QSRVZCCJDKYRRF-YDALLXLXSA-N D0Y6KO DRUGSMIL CCOC(=O)C(C)(CC1=CC(=C(C=C1)O)O)N.Cl D0Y6KO HIGHSTAT Approved D0Y7BD DRUG__ID D0Y7BD D0Y7BD DRUGCOMP Fujisawa Pharmaceutical Co D0Y7BD THERCLAS Antibiotics D0Y7BD DRUGTYPE Small molecular drug D0Y7BD DRUGINCH 1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1 D0Y7BD DRUGINKE NNULBSISHYWZJU-LLKWHZGFSA-N D0Y7BD DRUGSMIL CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)O D0Y7BD HIGHSTAT Approved D0Y7IC DRUG__ID D0Y7IC D0Y7IC TRADNAME Olumiant D0Y7IC DRUGCOMP Incyte/Eli Lilly D0Y7IC DRUGTYPE Small molecular drug D0Y7IC DRUGINCH 1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) D0Y7IC DRUGINKE XUZMWHLSFXCVMG-UHFFFAOYSA-N D0Y7IC DRUGSMIL CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 D0Y7IC HIGHSTAT Approved D0Y7IU DRUG__ID D0Y7IU D0Y7IU DRUGCOMP AstraZeneca D0Y7IU THERCLAS Antiinflammatory Agents D0Y7IU DRUGTYPE Small molecular drug D0Y7IU DRUGINCH 1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1 D0Y7IU DRUGINKE VOVIALXJUBGFJZ-KWVAZRHASA-N D0Y7IU DRUGSMIL CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C D0Y7IU HIGHSTAT Approved D0Y7RW DRUG__ID D0Y7RW D0Y7RW DRUGCOMP FISCHER and ROCH D0Y7RW THERCLAS Anticonvulsants D0Y7RW DRUGTYPE Small molecular drug D0Y7RW DRUGINCH 1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17) D0Y7RW DRUGINKE DDBREPKUVSBGFI-UHFFFAOYSA-N D0Y7RW DRUGSMIL CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2 D0Y7RW HIGHSTAT Approved D0Y7TO DRUG__ID D0Y7TO D0Y7TO DRUGCOMP Abbott Laboratories D0Y7TO THERCLAS Analgesics D0Y7TO DRUGTYPE Small molecular drug D0Y7TO DRUGINCH 1S/C56H78N2O16/c1-57(23-19-37-33-45(65-7)53(69-11)55(71-13)49(37)39(57)27-35-29-41(61-3)51(67-9)42(30-35)62-4)21-15-25-73-47(59)17-18-48(60)74-26-16-22-58(2)24-20-38-34-46(66-8)54(70-12)56(72-14)50(38)40(58)28-36-31-43(63-5)52(68-10)44(32-36)64-6/h29-34,39-40H,15-28H2,1-14H3/q+2 D0Y7TO DRUGINKE GBLRQXKSCRCLBZ-UHFFFAOYSA-N D0Y7TO DRUGSMIL C[N+]1(CCC2=CC(=C(C(=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)OC)CCCOC(=O)CCC(=O)OCCC[N+]4(CCC5=CC(=C(C(=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)OC)C D0Y7TO HIGHSTAT Approved D0Y7TS DRUG__ID D0Y7TS D0Y7TS DRUGCOMP Medimmune Oncology Inc D0Y7TS THERCLAS Antifungal Agents D0Y7TS DRUGTYPE Small molecular drug D0Y7TS DRUGINCH 1S/C19H23N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24) D0Y7TS DRUGINKE NOYPYLRCIDNJJB-UHFFFAOYSA-N D0Y7TS DRUGSMIL CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC D0Y7TS HIGHSTAT Approved D0Y7ZU DRUG__ID D0Y7ZU D0Y7ZU DRUGCOMP Bayer Pharmaceuticals Corporation D0Y7ZU THERCLAS Anticancer Agents D0Y7ZU DRUGTYPE Small molecular drug D0Y7ZU DRUGINCH 1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+ D0Y7ZU DRUGINKE FDKXTQMXEQVLRF-ZHACJKMWSA-N D0Y7ZU DRUGSMIL CN(C)N=NC1=C(NC=N1)C(=O)N D0Y7ZU HIGHSTAT Approved D0Y9TS DRUG__ID D0Y9TS D0Y9TS DRUGCOMP Pharmacia And Upjohn Co D0Y9TS THERCLAS Diagnostic Agents D0Y9TS DRUGTYPE Small molecular drug D0Y9TS DRUGINCH 1S/C58H73N13O21S2/c1-29(72)49(71-57(87)40(23-31-12-14-33(15-13-31)92-94(89,90)91)68-56(86)43(26-48(78)79)69-52(82)37(16-18-44(59)73)65-51(81)36-17-19-45(74)63-36)58(88)62-28-46(75)64-41(24-32-27-61-35-11-7-6-10-34(32)35)54(84)66-38(20-21-93-2)53(83)70-42(25-47(76)77)55(85)67-39(50(60)80)22-30-8-4-3-5-9-30/h3-15,27,29,36-43,49,61,72H,16-26,28H2,1-2H3,(H2,59,73)(H2,60,80)(H,62,88)(H,63,74)(H,64,75)(H,65,81)(H,66,84)(H,67,85)(H,68,86)(H,69,82)(H,70,83)(H,71,87)(H,76,77)(H,78,79)(H,89,90,91)/t29-,36+,37+,38+,39+,40+,41+,42+,43+,49+/m1/s1 D0Y9TS DRUGINKE YRALAIOMGQZKOW-HYAOXDFASA-N D0Y9TS DRUGSMIL CC(C(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C5CCC(=O)N5)O D0Y9TS HIGHSTAT Approved D0Y9ZE DRUG__ID D0Y9ZE D0Y9ZE DRUGCOMP Sanofi-Synthelabo Inc D0Y9ZE THERCLAS Cardiotonic Agents D0Y9ZE DRUGTYPE Small molecular drug D0Y9ZE DRUGINCH 1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16) D0Y9ZE DRUGINKE PZRHRDRVRGEVNW-UHFFFAOYSA-N D0Y9ZE DRUGSMIL CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2 D0Y9ZE HIGHSTAT Approved D0YA2L DRUG__ID D0YA2L D0YA2L DRUGCOMP Eli Lilly D0YA2L THERCLAS Bone Density Conservation Agents D0YA2L DRUGTYPE Peptide D0YA2L DRUGINCH 1S/C181H291N55O51S2/c1-21-96(18)146(236-160(267)114(48-53-141(250)251)212-174(281)132(84-239)232-177(284)143(93(12)13)233-147(254)103(185)82-237)178(285)216-111(45-50-134(187)241)155(262)219-119(65-90(6)7)163(270)213-116(55-62-289-20)158(265)224-124(71-100-79-196-86-203-100)167(274)226-126(73-135(188)242)169(276)217-117(63-88(2)3)148(255)201-81-138(245)205-105(39-27-30-56-182)149(256)223-123(70-99-78-195-85-202-99)166(273)221-121(67-92(10)11)164(271)225-128(75-137(190)244)171(278)231-131(83-238)173(280)214-115(54-61-288-19)157(264)210-112(46-51-139(246)247)153(260)208-109(43-34-60-199-181(193)194)159(266)234-144(94(14)15)175(282)215-113(47-52-140(248)249)156(263)222-122(69-98-77-200-104-38-26-25-37-102(98)104)165(272)220-120(66-91(8)9)161(268)209-108(42-33-59-198-180(191)192)151(258)206-106(40-28-31-57-183)150(257)207-107(41-29-32-58-184)152(259)218-118(64-89(4)5)162(269)211-110(44-49-133(186)240)154(261)228-129(76-142(252)253)172(279)235-145(95(16)17)176(283)229-125(72-101-80-197-87-204-101)168(275)227-127(74-136(189)243)170(277)230-130(179(286)287)68-97-35-23-22-24-36-97/h22-26,35-38,77-80,85-96,103,105-132,143-146,200,237-239H,21,27-34,39-76,81-84,182-185H2,1-20H3,(H2,186,240)(H2,187,241)(H2,188,242)(H2,189,243)(H2,190,244)(H,195,202)(H,196,203)(H,197,204)(H,201,255)(H,205,245)(H,206,258)(H,207,257)(H,208,260)(H,209,268)(H,210,264)(H,211,269)(H,212,281)(H,213,270)(H,214,280)(H,215,282)(H,216,285)(H,217,276)(H,218,259)(H,219,262)(H,220,272)(H,221,273)(H,222,263)(H,223,256)(H,224,265)(H,225,271)(H,226,274)(H,227,275)(H,228,261)(H,229,283)(H,230,277)(H,231,278)(H,232,284)(H,233,254)(H,234,266)(H,235,279)(H,236,267)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,286,287)(H4,191,192,198)(H4,193,194,199)/t96-,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,143-,144-,145-,146-/m0/s1 D0YA2L DRUGINKE OGBMKVWORPGQRR-UMXFMPSGSA-N D0YA2L DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N D0YA2L HIGHSTAT Approved D0YA9Z DRUG__ID D0YA9Z D0YA9Z DRUGCOMP Stadapharm GmbH D0YA9Z THERCLAS Antibiotics D0YA9Z DRUGTYPE Small molecular drug D0YA9Z DRUGINCH 1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1 D0YA9Z DRUGINKE AVKUERGKIZMTKX-NJBDSQKTSA-N D0YA9Z DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C D0YA9Z HIGHSTAT Approved D0YG7M DRUG__ID D0YG7M D0YG7M DRUGCOMP Norvatis Phamaceuticals Corporation D0YG7M THERCLAS Antiallergic Agents D0YG7M DRUGTYPE Small molecular drug D0YG7M DRUGINCH 1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3 D0YG7M DRUGINKE ZCVMWBYGMWKGHF-UHFFFAOYSA-N D0YG7M DRUGSMIL CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1 D0YG7M HIGHSTAT Approved D0YS1U DRUG__ID D0YS1U D0YS1U TRADNAME Filspari D0YS1U DRUGCOMP Travere Therapeutics D0YS1U DRUGTYPE Small molecular drug D0YS1U DRUGINCH 1S/C32H40N4O5S/c1-5-7-14-29-33-32(17-10-11-18-32)31(37)36(29)20-24-15-16-26(25(19-24)21-40-6-2)27-12-8-9-13-28(27)42(38,39)35-30-22(3)23(4)41-34-30/h8-9,12-13,15-16,19H,5-7,10-11,14,17-18,20-21H2,1-4H3,(H,34,35) D0YS1U DRUGINKE WRFHGDPIDHPWIQ-UHFFFAOYSA-N D0YS1U DRUGSMIL CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC D0YS1U HIGHSTAT Approved D0YS7D DRUG__ID D0YS7D D0YS7D DRUGCOMP AstraZeneca D0YS7D THERCLAS Vasodilator Agents D0YS7D DRUGTYPE Small molecular drug D0YS7D DRUGINCH 1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1 D0YS7D DRUGINKE YWXYYJSYQOXTPL-SLPGGIOYSA-N D0YS7D DRUGSMIL C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O D0YS7D HIGHSTAT Approved D0YV1Q DRUG__ID D0YV1Q D0YV1Q DRUGCOMP Sigma Chemical Company D0YV1Q THERCLAS Antibiotics D0YV1Q DRUGTYPE Small molecular drug D0YV1Q DRUGINCH 1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1 D0YV1Q DRUGINKE SBUJHOSQTJFQJX-NOAMYHISSA-N D0YV1Q DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N D0YV1Q HIGHSTAT Approved D0YX4S DRUG__ID D0YX4S D0YX4S DRUGCOMP Bristol-Myers Squibb D0YX4S THERCLAS Antibiotics D0YX4S DRUGTYPE Small molecular drug D0YX4S DRUGINCH 1S/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)/b3-2+/t12-,13-,17-/m1/s1 D0YX4S DRUGINKE WDLWHQDACQUCJR-ZAMMOSSLSA-N D0YX4S DRUGSMIL CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O D0YX4S HIGHSTAT Approved D0Z1FX DRUG__ID D0Z1FX D0Z1FX DRUGCOMP Pipex Pharmaceuticals D0Z1FX THERCLAS Estrogens D0Z1FX DRUGTYPE Small molecular drug D0Z1FX DRUGINCH 1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1 D0Z1FX DRUGINKE PROQIPRRNZUXQM-ZXXIGWHRSA-N D0Z1FX DRUGSMIL CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O D0Z1FX HIGHSTAT Approved D0Z1RV DRUG__ID D0Z1RV D0Z1RV DRUGCOMP Sandoz D0Z1RV THERCLAS Antipsychotic Agents D0Z1RV DRUGTYPE Small molecular drug D0Z1RV DRUGINCH 1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3 D0Z1RV DRUGINKE QZUDBNBUXVUHMW-UHFFFAOYSA-N D0Z1RV DRUGSMIL CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42 D0Z1RV HIGHSTAT Approved D0Z1UA DRUG__ID D0Z1UA D0Z1UA DRUGCOMP Forest Laboratories D0Z1UA THERCLAS Antihypertensive Agents D0Z1UA DRUGTYPE Small molecular drug D0Z1UA DRUGINCH 1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2 D0Z1UA DRUGINKE KOHIRBRYDXPAMZ-UHFFFAOYSA-N D0Z1UA DRUGSMIL C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O D0Z1UA HIGHSTAT Approved D0Z1ZM DRUG__ID D0Z1ZM D0Z1ZM DRUGCOMP Abbott Laboratories D0Z1ZM THERCLAS Antibiotics D0Z1ZM DRUGTYPE Small molecular drug D0Z1ZM DRUGINCH 1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 D0Z1ZM DRUGINKE AGOYDEPGAOXOCK-KCBOHYOISA-N D0Z1ZM DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O D0Z1ZM HIGHSTAT Approved D0Z4SB DRUG__ID D0Z4SB D0Z4SB DRUGCOMP Pfizer Pharmaceuticals D0Z4SB THERCLAS Hypoglycemic Agents D0Z4SB DRUGTYPE Small molecular drug D0Z4SB DRUGINCH 1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28) D0Z4SB DRUGINKE ZJJXGWJIGJFDTL-UHFFFAOYSA-N D0Z4SB DRUGSMIL CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 D0Z4SB HIGHSTAT Approved D0Z4UN DRUG__ID D0Z4UN D0Z4UN DRUGCOMP Norvatis Phamaceuticals Corporation D0Z4UN THERCLAS Dermatologic Agents D0Z4UN DRUGTYPE Small molecular drug D0Z4UN DRUGINCH 1S/C43H68ClNO11/c1-10-30-18-24(2)17-25(3)19-36(53-8)39-37(54-9)21-27(5)43(51,56-39)40(48)41(49)45-16-12-11-13-32(45)42(50)55-38(28(6)33(46)23-34(30)47)26(4)20-29-14-15-31(44)35(22-29)52-7/h18,20,25,27-33,35-39,46,51H,10-17,19,21-23H2,1-9H3/b24-18+,26-20+/t25-,27+,28+,29-,30+,31-,32-,33-,35+,36-,37-,38+,39+,43+/m0/s1 D0Z4UN DRUGINKE KASDHRXLYQOAKZ-XDSKOBMDSA-N D0Z4UN DRUGSMIL CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C D0Z4UN HIGHSTAT Approved D0Z5EM DRUG__ID D0Z5EM D0Z5EM DRUGCOMP Eli Lilly D0Z5EM THERCLAS Antibiotics D0Z5EM DRUGTYPE Small molecular drug D0Z5EM DRUGINCH 1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1 D0Z5EM DRUGINKE ZAIPMKNFIOOWCQ-UEKVPHQBSA-N D0Z5EM DRUGSMIL CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O D0Z5EM HIGHSTAT Approved D0Z5IU DRUG__ID D0Z5IU D0Z5IU DRUGCOMP Merck & Co D0Z5IU THERCLAS Antiinflammatory Agents D0Z5IU DRUGTYPE Small molecular drug D0Z5IU DRUGINCH 1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- D0Z5IU DRUGINKE MLKXDPUZXIRXEP-MFOYZWKCSA-N D0Z5IU DRUGSMIL CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O D0Z5IU HIGHSTAT Approved D0Z5OE DRUG__ID D0Z5OE D0Z5OE DRUGCOMP Bristol Myers Squibb D0Z5OE THERCLAS Anticancer Agents D0Z5OE DRUGTYPE Small molecular drug D0Z5OE DRUGINCH 1S/C14H10Cl4/c15-10-7-5-9(6-8-10)13(14(17)18)11-3-1-2-4-12(11)16/h1-8,13-14H D0Z5OE DRUGINKE JWBOIMRXGHLCPP-UHFFFAOYSA-N D0Z5OE DRUGSMIL C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl D0Z5OE HIGHSTAT Approved D0Z6UC DRUG__ID D0Z6UC D0Z6UC DRUGCOMP GlaxoSmithKline D0Z6UC THERCLAS Vasoconstrictor Agents D0Z6UC DRUGTYPE Small molecular drug D0Z6UC DRUGINCH 1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3 D0Z6UC DRUGINKE KQKPFRSPSRPDEB-UHFFFAOYSA-N D0Z6UC DRUGSMIL CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C D0Z6UC HIGHSTAT Approved D0Z7KE DRUG__ID D0Z7KE D0Z7KE DRUGCOMP Norvatis Phamaceuticals Corporation D0Z7KE THERCLAS Antihypertensive Agents D0Z7KE DRUGTYPE Small molecular drug D0Z7KE DRUGINCH 1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3 D0Z7KE DRUGINKE HMJIYCCIJYRONP-UHFFFAOYSA-N D0Z7KE DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC D0Z7KE HIGHSTAT Approved D0Z8AA DRUG__ID D0Z8AA D0Z8AA DRUGCOMP Forest Laboratories Inc D0Z8AA THERCLAS Antiinfective Agents D0Z8AA DRUGTYPE Small molecular drug D0Z8AA DRUGINCH 1S/C3H4O2/c4-3-1-2-5-3/h1-2H2 D0Z8AA DRUGINKE VEZXCJBBBCKRPI-UHFFFAOYSA-N D0Z8AA DRUGSMIL C1COC1=O D0Z8AA HIGHSTAT Approved D0Z8EX DRUG__ID D0Z8EX D0Z8EX DRUGCOMP Aurobindo Pharma D0Z8EX THERCLAS Anti-HIV Agents D0Z8EX DRUGTYPE Small molecular drug D0Z8EX DRUGINCH 1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1 D0Z8EX DRUGINKE XNKLLVCARDGLGL-JGVFFNPUSA-N D0Z8EX DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO D0Z8EX HIGHSTAT Approved D0Z8HG DRUG__ID D0Z8HG D0Z8HG DRUGCOMP Bedford Laboratories D0Z8HG THERCLAS Analgesics D0Z8HG DRUGTYPE Small molecular drug D0Z8HG DRUGINCH 1S/C34H57N2O4/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36/h25-32H,6-22H2,1-5H3/q+1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1 D0Z8HG DRUGINKE BGSZAXLLHYERSY-XQIGCQGXSA-N D0Z8HG DRUGSMIL CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C D0Z8HG HIGHSTAT Approved D0Z9QR DRUG__ID D0Z9QR D0Z9QR DRUGCOMP Hoffmann-La Roche pharmaceutical company D0Z9QR THERCLAS Anti-HIV Agents D0Z9QR DRUGTYPE Small molecular drug D0Z9QR DRUGINCH 1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1 D0Z9QR DRUGINKE WREGKURFCTUGRC-POYBYMJQSA-N D0Z9QR DRUGSMIL C1CC(OC1CO)N2C=CC(=NC2=O)N D0Z9QR HIGHSTAT Approved D0ZB7K DRUG__ID D0ZB7K D0ZB7K DRUGCOMP Sanofi-Aventis D0ZB7K THERCLAS Hypnotics and Sedatives D0ZB7K DRUGTYPE Small molecular drug D0ZB7K DRUGINCH 1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3 D0ZB7K DRUGINKE GBBSUAFBMRNDJC-UHFFFAOYSA-N D0ZB7K DRUGSMIL CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl D0ZB7K HIGHSTAT Approved D0ZS8P DRUG__ID D0ZS8P D0ZS8P DRUGCOMP Norvatis Phamaceuticals Corporation D0ZS8P THERCLAS Antidepressants D0ZS8P DRUGTYPE Small molecular drug D0ZS8P DRUGINCH 1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3 D0ZS8P DRUGINKE GDLIGKIOYRNHDA-UHFFFAOYSA-N D0ZS8P DRUGSMIL CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl D0ZS8P HIGHSTAT Approved D0ZU9R DRUG__ID D0ZU9R D0ZU9R DRUGCOMP Abbott Laboratories D0ZU9R THERCLAS Anti-HIV Agents D0ZU9R DRUGTYPE Small molecular drug D0ZU9R DRUGINCH 1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1 D0ZU9R DRUGINKE NCDNCNXCDXHOMX-XGKFQTDJSA-N D0ZU9R DRUGSMIL CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O D0ZU9R HIGHSTAT Approved D0ZV0Z DRUG__ID D0ZV0Z D0ZV0Z DRUGCOMP Bayer AG D0ZV0Z THERCLAS Antibiotics D0ZV0Z DRUGTYPE Small molecular drug D0ZV0Z DRUGINCH 1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1 D0ZV0Z DRUGINKE FABPRXSRWADJSP-MEDUHNTESA-N D0ZV0Z DRUGSMIL COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O D0ZV0Z HIGHSTAT Approved D24GYL DRUG__ID D24GYL D24GYL TRADNAME Sunlenca D24GYL DRUGCOMP Gilead Sciences D24GYL DRUGTYPE Small molecular drug D24GYL DRUGINCH 1S/C41H36ClF8N7O5S2/c1-40(2,63(3,59)60)11-10-22-4-7-24(25-8-9-28(42)33-36(25)56(17-30(45)46)54-39(33)55-64(61,62)23-5-6-23)34(51-22)29(14-19-12-20(43)15-21(44)13-19)52-31(58)18-57-37-32(35(53-57)38(47)48)26-16-27(26)41(37,49)50/h4,7-9,12-13,15,23,26-27,29-30,38H,5-6,14,16-18H2,1-3H3,(H,52,58)(H,54,55)/t26-,27+,29-/m1/s1 D24GYL DRUGINKE CPCUUUACFKQOHY-IUAQSZDVSA-N D24GYL DRUGSMIL CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)F)NS(=O)(=O)C4CC4)C(CC5=CC(=CC(=C5)F)F)NC(=O)CN6C7=C(C8CC8C7(F)F)C(=N6)C(F)F)S(=O)(=O)C D24GYL HIGHSTAT Approved DEWC27 DRUG__ID DEWC27 DEWC27 TRADNAME Bylvay DEWC27 DRUGCOMP Albireo Pharma DEWC27 DRUGTYPE Small molecular drug DEWC27 DRUGINCH 1S/C37H48N4O8S2/c1-5-8-19-37(20-9-6-2)24-41(26-13-11-10-12-14-26)29-21-31(50-4)30(22-32(29)51(47,48)40-37)49-23-33(43)39-34(25-15-17-27(42)18-16-25)35(44)38-28(7-3)36(45)46/h10-18,21-22,28,34,40,42H,5-9,19-20,23-24H2,1-4H3,(H,38,44)(H,39,43)(H,45,46)/t28-,34+/m0/s1 DEWC27 DRUGINKE XULSCZPZVQIMFM-IPZQJPLYSA-N DEWC27 DRUGSMIL CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)N1)OCC(=O)NC(C3=CC=C(C=C3)O)C(=O)NC(CC)C(=O)O)SC)C4=CC=CC=C4)CCCC DEWC27 HIGHSTAT Approved DGO2C1 DRUG__ID DGO2C1 DGO2C1 TRADNAME Joenja DGO2C1 DRUGCOMP Pharming DGO2C1 DRUGTYPE Small molecular drug DGO2C1 DRUGINCH 1S/C21H25F3N6O2/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28)/t13-/m0/s1 DGO2C1 DRUGINKE MWKYMZXCGYXLPL-ZDUSSCGKSA-N DGO2C1 DRUGSMIL CCC(=O)N1CCC(C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F DGO2C1 HIGHSTAT Approved DI4HA7 DRUG__ID DI4HA7 DI4HA7 TRADNAME Exkivity DI4HA7 DRUGCOMP Takeda DI4HA7 DRUGTYPE Small molecular drug DI4HA7 DRUGINCH 1S/C32H39N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h9-13,16-20H,1,14-15H2,2-8H3,(H,34,40)(H,33,35,36) DI4HA7 DRUGINKE AZSRSNUQCUDCGG-UHFFFAOYSA-N DI4HA7 DRUGSMIL CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC DI4HA7 HIGHSTAT Approved DJ48HT DRUG__ID DJ48HT DJ48HT TRADNAME Fabhalta DJ48HT DRUGCOMP Novartis DJ48HT DRUGTYPE Small molecular drug DJ48HT DRUGINCH 1S/C25H30N2O4/c1-4-31-19-10-12-27(22(14-19)17-5-7-18(8-6-17)25(28)29)15-21-20-9-11-26-24(20)16(2)13-23(21)30-3/h5-9,11,13,19,22,26H,4,10,12,14-15H2,1-3H3,(H,28,29)/t19-,22-/m0/s1 DJ48HT DRUGINKE RENRQMCACQEWFC-UGKGYDQZSA-N DJ48HT DRUGSMIL CCOC1CCN(C(C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC DJ48HT HIGHSTAT Approved DM8BN1 DRUG__ID DM8BN1 DM8BN1 TRADNAME Vivjoa DM8BN1 DRUGCOMP Mycovia Pharmaceuticals DM8BN1 DRUGTYPE Small molecular drug DM8BN1 DRUGINCH 1S/C23H16F7N5O2/c24-16-4-7-18(19(25)9-16)21(36,11-35-13-32-33-34-35)23(29,30)20-8-3-15(10-31-20)14-1-5-17(6-2-14)37-12-22(26,27)28/h1-10,13,36H,11-12H2/t21-/m0/s1 DM8BN1 DRUGINKE IDUYJRXRDSPPRC-NRFANRHFSA-N DM8BN1 DRUGSMIL C1=CC(=CC=C1C2=CN=C(C=C2)C(C(CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F DM8BN1 HIGHSTAT Approved DSHT18 DRUG__ID DSHT18 DSHT18 TRADNAME Scemblix DSHT18 DRUGCOMP Novartis DSHT18 DRUGTYPE Small molecular drug DSHT18 DRUGINCH 1S/C20H18ClF2N5O3/c21-20(22,23)31-15-3-1-13(2-4-15)26-19(30)12-9-16(17-5-7-25-27-17)18(24-10-12)28-8-6-14(29)11-28/h1-5,7,9-10,14,29H,6,8,11H2,(H,25,27)(H,26,30)/t14-/m1/s1 DSHT18 DRUGINKE VOVZXURTCKPRDQ-CQSZACIVSA-N DSHT18 DRUGSMIL C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4 DSHT18 HIGHSTAT Approved DUQV41 DRUG__ID DUQV41 DUQV41 TRADNAME Krazati DUQV41 DRUGCOMP Mirati Therapeutics DUQV41 DRUGTYPE Small molecular drug DUQV41 DRUGINCH 1S/C32H35ClFN7O2/c1-21(34)31(42)41-17-16-40(18-23(41)11-13-35)30-25-12-15-39(28-10-4-7-22-6-3-9-26(33)29(22)28)19-27(25)36-32(37-30)43-20-24-8-5-14-38(24)2/h3-4,6-7,9-10,23-24H,1,5,8,11-12,14-20H2,2H3/t23-,24-/m0/s1 DUQV41 DRUGINKE PEMUGDMSUDYLHU-ZEQRLZLVSA-N DUQV41 DRUGSMIL CN1CCCC1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN(C(C6)CC#N)C(=O)C(=C)F DUQV41 HIGHSTAT Approved DXP04H DRUG__ID DXP04H DXP04H TRADNAME Jaypirca DXP04H DRUGCOMP Eli Lilly/Innovent Biologics DXP04H DRUGTYPE Small molecular drug DXP04H DRUGINCH 1S/C22H21F4N5O3/c1-11(22(24,25)26)31-19(27)17(20(28)32)18(30-31)13-5-3-12(4-6-13)10-29-21(33)15-9-14(23)7-8-16(15)34-2/h3-9,11H,10,27H2,1-2H3,(H2,28,32)(H,29,33)/t11-/m0/s1 DXP04H DRUGINKE FWZAWAUZXYCBKZ-NSHDSACASA-N DXP04H DRUGSMIL CC(C(F)(F)F)N1C(=C(C(=N1)C2=CC=C(C=C2)CNC(=O)C3=C(C=CC(=C3)F)OC)C(=O)N)N DXP04H HIGHSTAT Approved DZB84T DRUG__ID DZB84T DZB84T TRADNAME Livmarli DZB84T DRUGCOMP Mirum Pharmaceuticals DZB84T DRUGTYPE Small molecular drug DZB84T DRUGINCH 1S/C40H56N3O4S/c1-5-7-19-40(20-8-6-2)30-48(45,46)37-18-15-34(41(3)4)27-36(37)38(39(40)44)33-13-16-35(17-14-33)47-29-32-11-9-31(10-12-32)28-43-24-21-42(22-25-43)23-26-43/h9-18,27,38-39,44H,5-8,19-26,28-30H2,1-4H3/q+1/t38-,39-/m1/s1 DZB84T DRUGINKE STPKWKPURVSAJF-LJEWAXOPSA-N DZB84T DRUGSMIL CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC DZB84T HIGHSTAT Approved D00AEQ DRUG__ID D00AEQ D00AEQ DRUGCOMP Bristol Myers Squibb D00AEQ DRUGTYPE Small molecular drug D00AEQ DRUGINCH 1S/C21H30O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h12,16-18,24H,4-11H2,1-3H3/t16-,17+,18+,19+,20+,21+/m1/s1 D00AEQ DRUGINKE DBPWSSGDRRHUNT-CEGNMAFCSA-N D00AEQ DRUGSMIL CC(=O)C1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)O D00AEQ HIGHSTAT Approved D00AMQ DRUG__ID D00AMQ D00AMQ THERCLAS Analgesics D00AMQ DRUGTYPE Small molecular drug D00AMQ DRUGINCH 1S/C2H6O/c1-2-3/h3H,2H2,1H3 D00AMQ DRUGINKE LFQSCWFLJHTTHZ-UHFFFAOYSA-N D00AMQ DRUGSMIL CCO D00AMQ HIGHSTAT Approved D00BCP DRUG__ID D00BCP D00BCP THERCLAS Hypoglycemic Agents D00BCP DRUGTYPE Small molecular drug D00BCP DRUGINCH 1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14) D00BCP DRUGINKE RKWGIWYCVPQPMF-UHFFFAOYSA-N D00BCP DRUGSMIL CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl D00BCP HIGHSTAT Approved D00BLL DRUG__ID D00BLL D00BLL DRUGCOMP Pfizer D00BLL DRUGTYPE Small molecular drug D00BLL DRUGINCH 1S/C26H37NO3.C4H4O4/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6;5-3(6)1-2-4(7)8/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-;/m1./s1 D00BLL DRUGINKE MWHXMIASLKXGBU-RNCYCKTQSA-N D00BLL DRUGSMIL CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O D00BLL HIGHSTAT Approved D00CSQ DRUG__ID D00CSQ D00CSQ THERCLAS Antibiotics D00CSQ DRUGTYPE Small molecular drug D00CSQ DRUGINCH 1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H D00CSQ DRUGINKE XEFQLINVKFYRCS-UHFFFAOYSA-N D00CSQ DRUGSMIL C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl D00CSQ HIGHSTAT Approved D00DEF DRUG__ID D00DEF D00DEF DRUGCOMP New River Pharmaceuticals D00DEF DRUGTYPE Small molecular drug D00DEF DRUGINCH 1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1 D00DEF DRUGINKE VOBHXZCDAVEXEY-JSGCOSHPSA-N D00DEF DRUGSMIL CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N D00DEF HIGHSTAT Approved D00ENY DRUG__ID D00ENY D00ENY THERCLAS Dietary supplement D00ENY DRUGTYPE Small molecular drug D00ENY DRUGINCH 1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 D00ENY DRUGINKE WHUUTDBJXJRKMK-VKHMYHEASA-N D00ENY DRUGSMIL C(CC(=O)O)C(C(=O)O)N D00ENY HIGHSTAT Approved D00EQL DRUG__ID D00EQL D00EQL DRUGCOMP Epizyme D00EQL DRUGTYPE Small molecular drug D00EQL DRUGINCH 1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40) D00EQL DRUGINKE NSQSAUGJQHDYNO-UHFFFAOYSA-N D00EQL DRUGSMIL CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5 D00EQL HIGHSTAT Approved D00ETS DRUG__ID D00ETS D00ETS THERCLAS Hypnotics and Sedatives D00ETS DRUGTYPE Small molecular drug D00ETS DRUGINCH 1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17) D00ETS DRUGINKE UYXAWHWODHRRMR-UHFFFAOYSA-N D00ETS DRUGSMIL CC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2 D00ETS HIGHSTAT Approved D00FGO DRUG__ID D00FGO D00FGO THERCLAS Anticancer Agents D00FGO DRUGTYPE Small molecular drug D00FGO DRUGINCH 1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1 D00FGO DRUGINKE SGDBTWWWUNNDEQ-LBPRGKRZSA-N D00FGO DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl D00FGO HIGHSTAT Approved D00FSV DRUG__ID D00FSV D00FSV THERCLAS Vitamins D00FSV DRUGTYPE Small molecular drug D00FSV DRUGINCH 1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1 D00FSV DRUGINKE MBWXNTAXLNYFJB-NKFFZRIASA-N D00FSV DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C D00FSV HIGHSTAT Approved D00GNJ DRUG__ID D00GNJ D00GNJ DRUGCOMP Microbia D00GNJ DRUGTYPE Small molecular drug D00GNJ DRUGINCH 1S/C59H79N15O21S6/c1-26-47(82)69-41-25-101-99-22-38-52(87)65-33(13-14-45(80)81)49(84)66-34(16-28-5-9-30(76)10-6-28)50(85)71-40(54(89)72-39(23-97-96-20-32(60)48(83)70-38)53(88)67-35(18-43(61)78)58(93)74-15-3-4-42(74)56(91)63-26)24-100-98-21-37(64-44(79)19-62-57(92)46(27(2)75)73-55(41)90)51(86)68-36(59(94)95)17-29-7-11-31(77)12-8-29/h5-12,26-27,32-42,46,75-77H,3-4,13-25,60H2,1-2H3,(H2,61,78)(H,62,92)(H,63,91)(H,64,79)(H,65,87)(H,66,84)(H,67,88)(H,68,86)(H,69,82)(H,70,83)(H,71,85)(H,72,89)(H,73,90)(H,80,81)(H,94,95)/t26-,27+,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,46-/m0/s1 D00GNJ DRUGINKE KXGCNMMJRFDFNR-WDRJZQOASA-N D00GNJ DRUGSMIL CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O D00GNJ HIGHSTAT Approved D00GOS DRUG__ID D00GOS D00GOS DRUGCOMP Promius Pharma Llc D00GOS DRUGTYPE Small molecular drug D00GOS DRUGINCH 1S/C22H28ClFO4/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-21(15,3)22(14,23)18(28)9-20(13,2)19(11)17(27)10-25/h4-5,7,11,13-14,16,18-19,25,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,18+,19-,20+,21+,22+/m1/s1 D00GOS DRUGINKE YMTMADLUXIRMGX-RFPWEZLHSA-N D00GOS DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)Cl)C)F D00GOS HIGHSTAT Approved D00HGB DRUG__ID D00HGB D00HGB THERCLAS Antiinflammatory Agents D00HGB DRUGTYPE Small molecular drug D00HGB DRUGINCH 1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20) D00HGB DRUGINKE JZFPYUNJRRFVQU-UHFFFAOYSA-N D00HGB DRUGSMIL C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F D00HGB HIGHSTAT Approved D00HHS DRUG__ID D00HHS D00HHS DRUGCOMP Pfizer Pharmaceuticals D00HHS DRUGTYPE Small molecular drug D00HHS DRUGINCH 1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10+/m0/s1 D00HHS DRUGINKE KWGRBVOPPLSCSI-WCBMZHEXSA-N D00HHS DRUGSMIL CC(C(C1=CC=CC=C1)O)NC D00HHS HIGHSTAT Approved D00HNB DRUG__ID D00HNB D00HNB THERCLAS Antihypocalcemic Agents D00HNB DRUGTYPE Small molecular drug D00HNB DRUGINCH 1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9) D00HNB DRUGINKE ACSIXWWBWUQEHA-UHFFFAOYSA-N D00HNB DRUGSMIL C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl D00HNB HIGHSTAT Approved D00HWO DRUG__ID D00HWO D00HWO THERCLAS Antibiotics D00HWO DRUGTYPE Small molecular drug D00HWO DRUGINCH 1S/C15H23N3O4S/c1-14(2)9(12(20)21)18-10(19)8(11(18)23-14)17-13(22)15(16)6-4-3-5-7-15/h8-9,11H,3-7,16H2,1-2H3,(H,17,22)(H,20,21)/t8-,9+,11-/m1/s1 D00HWO DRUGINKE HGBLNBBNRORJKI-WCABBAIRSA-N D00HWO DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C D00HWO HIGHSTAT Approved D00JRA DRUG__ID D00JRA D00JRA DRUGCOMP Organon BioSciences D00JRA DRUGTYPE Small molecular drug D00JRA DRUGINCH 1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m0/s1 D00JRA DRUGINKE VSWBSWWIRNCQIJ-GJZGRUSLSA-N D00JRA DRUGSMIL CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24 D00JRA HIGHSTAT Approved D00KRE DRUG__ID D00KRE D00KRE DRUGCOMP Pharmacia & Upjohn AB D00KRE DRUGTYPE Small molecular drug D00KRE DRUGINCH 1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22) D00KRE DRUGINKE QQBDLJCYGRGAKP-UHFFFAOYSA-N D00KRE DRUGSMIL C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O D00KRE HIGHSTAT Approved D00LFB DRUG__ID D00LFB D00LFB THERCLAS Sympathomimetics D00LFB DRUGTYPE Small molecular drug D00LFB DRUGINCH 1S/C17H21NO3/c1-12(17(21)14-4-8-16(20)9-5-14)18-11-10-13-2-6-15(19)7-3-13/h2-9,12,17-21H,10-11H2,1H3/t12-,17-/m0/s1 D00LFB DRUGINKE IOVGROKTTNBUGK-SJCJKPOMSA-N D00LFB DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O D00LFB HIGHSTAT Approved D00MIN DRUG__ID D00MIN D00MIN THERCLAS Antithyroid Agents D00MIN DRUGTYPE Small molecular drug D00MIN DRUGINCH 1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11) D00MIN DRUGINKE KNAHARQHSZJURB-UHFFFAOYSA-N D00MIN DRUGSMIL CCCC1=CC(=O)NC(=S)N1 D00MIN HIGHSTAT Approved D00MLW DRUG__ID D00MLW D00MLW DRUGCOMP Ultragenyx D00MLW DRUGTYPE Small molecular drug D00MLW DRUGINCH 1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3 D00MLW DRUGINKE PJHKBYALYHRYSK-UHFFFAOYSA-N D00MLW DRUGSMIL CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC D00MLW HIGHSTAT Approved D00NJJ DRUG__ID D00NJJ D00NJJ THERCLAS Antibiotics D00NJJ DRUGTYPE Small molecular drug D00NJJ DRUGINCH 1S/C21H25N5O8S2/c1-21(2)14(18(29)30)26-16(28)13(17(26)35-21)22-15(27)12(11-7-5-4-6-8-11)23-19(31)24-9-10-25(20(24)32)36(3,33)34/h4-8,12-14,17H,9-10H2,1-3H3,(H,22,27)(H,23,31)(H,29,30)/t12-,13-,14+,17-/m1/s1 D00NJJ DRUGINKE YPBATNHYBCGSSN-VWPFQQQWSA-N D00NJJ DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C D00NJJ HIGHSTAT Approved D00NKB DRUG__ID D00NKB D00NKB THERCLAS Diuretics D00NKB DRUGTYPE Small molecular drug D00NKB DRUGINCH 1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19) D00NKB DRUGINKE FNYLWPVRPXGIIP-UHFFFAOYSA-N D00NKB DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N D00NKB HIGHSTAT Approved D00NNC DRUG__ID D00NNC D00NNC THERCLAS Bone Density Conservation Agents D00NNC DRUGTYPE Small molecular drug D00NNC DRUGINCH 1S/C2H8O7P2/c1-2(3,10(4,5)6)11(7,8)9/h3H,1H3,(H2,4,5,6)(H2,7,8,9) D00NNC DRUGINKE DBVJJBKOTRCVKF-UHFFFAOYSA-N D00NNC DRUGSMIL CC(O)(P(=O)(O)O)P(=O)(O)O D00NNC HIGHSTAT Approved D00NVX DRUG__ID D00NVX D00NVX THERCLAS Antihypertensive Agents D00NVX DRUGTYPE Small molecular drug D00NVX DRUGINCH 1S/C23H28N8/c1-3-5-11-21-25-22(12-6-4-2)31(28-21)16-17-13-14-20(24-15-17)18-9-7-8-10-19(18)23-26-29-30-27-23/h7-10,13-15H,3-6,11-12,16H2,1-2H3,(H,26,27,29,30) D00NVX DRUGINKE YONOBYIBNBCDSJ-UHFFFAOYSA-N D00NVX DRUGSMIL CCCCC1=NN(C(=N1)CCCC)CC2=CN=C(C=C2)C3=CC=CC=C3C4=NNN=N4 D00NVX HIGHSTAT Approved D00OAY DRUG__ID D00OAY D00OAY DRUGCOMP Kanebo D00OAY DRUGTYPE Small molecular drug D00OAY DRUGINCH 1S/C21H25N3O7S.ClH/c1-10-12(31-20(28)30-10)9-29-19(27)15-21(2,3)32-18-14(17(26)24(15)18)23-16(25)13(22)11-7-5-4-6-8-11;/h4-8,10,12-15,18H,9,22H2,1-3H3,(H,23,25);1H/t10?,12?,13-,14-,15+,18-;/m1./s1 D00OAY DRUGINKE DYYWCSJCOBIQFH-XFWACAJASA-N D00OAY DRUGSMIL CC1C(OC(=O)O1)COC(=O)C2C(SC3N2C(=O)C3NC(=O)C(C4=CC=CC=C4)N)(C)C.Cl D00OAY HIGHSTAT Approved D00PBX DRUG__ID D00PBX D00PBX DRUGCOMP AbbVie D00PBX DRUGTYPE Small molecular drug D00PBX DRUGINCH 1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54) D00PBX DRUGINKE LQBVNQSMGBZMKD-UHFFFAOYSA-N D00PBX DRUGSMIL CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C D00PBX HIGHSTAT Approved D00PEH DRUG__ID D00PEH D00PEH DRUGCOMP GlaxoSmithKline D00PEH DRUGTYPE Small molecular drug D00PEH DRUGINCH 1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33) D00PEH DRUGINKE SVOQIEJWJCQGDQ-UHFFFAOYSA-N D00PEH DRUGSMIL CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C D00PEH HIGHSTAT Approved D00PLV DRUG__ID D00PLV D00PLV THERCLAS Antihypertensive Agents D00PLV DRUGTYPE Small molecular drug D00PLV DRUGINCH 1S/5CN.Fe.NO/c5*1-2;;1-2/q5*-1;+6;-1 D00PLV DRUGINKE CDLSWOALPINAJL-UHFFFAOYSA-N D00PLV DRUGSMIL [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+6] D00PLV HIGHSTAT Approved D00RCI DRUG__ID D00RCI D00RCI DRUGCOMP NPS D00RCI DRUGTYPE Small molecular drug D00RCI DRUGINCH 1S/C164H252N44O55S/c1-21-77(11)126(156(255)187-95(44-46-114(167)214)141(240)206-130(83(17)211)160(259)186-93(42-33-34-49-165)140(239)202-129(80(14)24-4)159(258)208-131(84(18)212)161(260)200-111(163(262)263)66-125(230)231)203-151(250)100(54-76(9)10)189-145(244)103(57-88-67-175-92-41-32-31-40-90(88)92)192-147(246)105(60-116(169)216)199-157(256)127(78(12)22-2)204-152(251)102(56-87-38-29-26-30-39-87)190-149(248)109(64-123(226)227)195-137(236)94(43-35-50-174-164(171)172)183-134(233)82(16)179-133(232)81(15)180-142(241)98(52-74(5)6)188-146(245)104(59-115(168)215)194-150(249)110(65-124(228)229)196-143(242)99(53-75(7)8)198-158(257)128(79(13)23-3)205-162(261)132(85(19)213)207-153(252)106(61-117(170)217)193-139(238)97(48-51-264-20)185-138(237)96(45-47-120(220)221)184-148(247)108(63-122(224)225)197-155(254)113(72-210)201-144(243)101(55-86-36-27-25-28-37-86)191-154(253)112(71-209)182-119(219)70-177-136(235)107(62-121(222)223)181-118(218)69-176-135(234)91(166)58-89-68-173-73-178-89/h25-32,36-41,67-68,73-85,91,93-113,126-132,175,209-213H,21-24,33-35,42-66,69-72,165-166H2,1-20H3,(H2,167,214)(H2,168,215)(H2,169,216)(H2,170,217)(H,173,178)(H,176,234)(H,177,235)(H,179,232)(H,180,241)(H,181,218)(H,182,219)(H,183,233)(H,184,247)(H,185,237)(H,186,259)(H,187,255)(H,188,245)(H,189,244)(H,190,248)(H,191,253)(H,192,246)(H,193,238)(H,194,249)(H,195,236)(H,196,242)(H,197,254)(H,198,257)(H,199,256)(H,200,260)(H,201,243)(H,202,239)(H,203,250)(H,204,251)(H,205,261)(H,206,240)(H,207,252)(H,208,258)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,262,263)(H4,171,172,174)/t77-,78-,79-,80-,81-,82-,83+,84+,85+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,126-,127-,128-,129-,130-,131-,132-/m0/s1 D00RCI DRUGINKE CILIXQOJUNDIDU-ASQIGDHWSA-N D00RCI DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N D00RCI HIGHSTAT Approved D00SBN DRUG__ID D00SBN D00SBN THERCLAS Vasodilator Agents D00SBN DRUGTYPE Small molecular drug D00SBN DRUGINCH 1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2 D00SBN DRUGINKE CYXKNKQEMFBLER-UHFFFAOYSA-N D00SBN DRUGSMIL C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3 D00SBN HIGHSTAT Approved D00SLY DRUG__ID D00SLY D00SLY DRUGCOMP GlaxoSmithKline D00SLY DRUGTYPE Small molecular drug D00SLY DRUGINCH 1S/C29H34NO2/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25/h1-15,31H,16-24H2/q+1 D00SLY DRUGINKE FVTWTVQXNAJTQP-UHFFFAOYSA-N D00SLY DRUGSMIL C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5 D00SLY HIGHSTAT Approved D00SOZ DRUG__ID D00SOZ D00SOZ TRADNAME Omlonti D00SOZ DRUGCOMP Santen D00SOZ DRUGINCH 1S/C26H28N6O4S/c1-20(2)36-26(33)17-28-25-8-3-6-22(30-25)19-31(37(34,35)24-7-4-13-27-16-24)18-21-9-11-23(12-10-21)32-15-5-14-29-32/h3-16,20H,17-19H2,1-2H3,(H,28,30) D00SOZ DRUGINKE VIQCWEGEHRBLAC-UHFFFAOYSA-N D00SOZ DRUGSMIL CC(C)OC(=O)CNC1=CC=CC(=N1)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4 D00SOZ HIGHSTAT Approved D00TGR DRUG__ID D00TGR D00TGR DRUGCOMP Ferring Pharmaceuticals D00TGR DRUGTYPE Small molecular drug D00TGR DRUGINCH 1S/C18H15NO8S2.2Na/c20-28(21,22)26-15-8-4-13(5-9-15)18(17-3-1-2-12-19-17)14-6-10-16(11-7-14)27-29(23,24)25;;/h1-12,18H,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2 D00TGR DRUGINKE GOZDTZWAMGHLDY-UHFFFAOYSA-L D00TGR DRUGSMIL C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+] D00TGR HIGHSTAT Approved D00TRV DRUG__ID D00TRV D00TRV DRUGCOMP Bausch & Lomb D00TRV DRUGTYPE Small molecular drug D00TRV DRUGINCH 1S/C19H21ClFN3O3/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23/h7,9-11H,1-6,8,22H2,(H,26,27)/t10-/m1/s1 D00TRV DRUGINKE QFFGVLORLPOAEC-SNVBAGLBSA-N D00TRV DRUGSMIL C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F D00TRV HIGHSTAT Approved D00UOR DRUG__ID D00UOR D00UOR DRUGCOMP Canyon Pharmaceuticals D00UOR DRUGTYPE Small molecular drug D00UOR DRUGINCH 1S/C287H440N80O110S6/c1-25-133(19)226-281(470)345-161(87-125(3)4)235(424)306-111-208(395)320-180(116-370)266(455)344-175(101-219(415)416)237(426)307-105-202(389)316-151(62-75-212(401)402)242(431)321-145(41-30-33-81-288)240(429)339-170(96-197(297)384)258(447)326-152(57-70-193(293)380)249(438)351-185(121-481-478-118-182-239(428)310-107-201(388)313-147(55-68-191(291)378)232(421)303-108-205(392)317-169(95-196(296)383)257(446)322-146(42-31-34-82-289)241(430)350-186(271(460)360-226)122-482-479-119-183(268(457)323-149(61-74-211(399)400)234(423)304-110-207(394)319-179(115-369)265(454)342-173(99-200(300)387)264(453)357-223(130(13)14)279(468)355-182)352-253(442)164(90-128(9)10)335-269(458)184-120-480-483-123-187(354-262(451)177(103-221(419)420)347-283(472)230(137(23)374)362-263(452)167(93-141-49-53-144(377)54-50-141)346-278(467)224(131(15)16)359-276(465)222(301)129(11)12)272(461)363-229(136(22)373)282(471)330-157(66-79-216(409)410)248(437)348-178(114-368)238(427)309-106-203(390)315-150(56-69-192(292)379)243(432)340-171(97-198(298)385)259(448)334-163(89-127(7)8)252(441)353-184)270(459)358-225(132(17)18)280(469)364-228(135(21)372)277(466)311-112-204(391)314-148(60-73-210(397)398)233(422)305-113-209(396)356-231(138(24)375)286(475)367-86-38-46-190(367)275(464)331-159(43-32-35-83-290)284(473)365-84-36-44-188(365)273(462)328-153(58-71-194(294)381)247(436)349-181(117-371)267(456)338-168(94-142-104-302-124-312-142)256(445)341-172(98-199(299)386)260(449)343-174(100-218(413)414)236(425)308-109-206(393)318-176(102-220(417)418)261(450)337-165(91-139-39-28-27-29-40-139)254(443)327-154(63-76-213(403)404)244(433)325-158(67-80-217(411)412)250(439)361-227(134(20)26-2)285(474)366-85-37-45-189(366)274(463)329-156(65-78-215(407)408)245(434)324-155(64-77-214(405)406)246(435)336-166(92-140-47-51-143(376)52-48-140)255(444)333-162(88-126(5)6)251(440)332-160(287(476)477)59-72-195(295)382/h27-29,39-40,47-54,104,124-138,145-190,222-231,368-377H,25-26,30-38,41-46,55-103,105-123,288-290,301H2,1-24H3,(H2,291,378)(H2,292,379)(H2,293,380)(H2,294,381)(H2,295,382)(H2,296,383)(H2,297,384)(H2,298,385)(H2,299,386)(H2,300,387)(H,302,312)(H,303,421)(H,304,423)(H,305,422)(H,306,424)(H,307,426)(H,308,425)(H,309,427)(H,310,428)(H,311,466)(H,313,388)(H,314,391)(H,315,390)(H,316,389)(H,317,392)(H,318,393)(H,319,394)(H,320,395)(H,321,431)(H,322,446)(H,323,457)(H,324,434)(H,325,433)(H,326,447)(H,327,443)(H,328,462)(H,329,463)(H,330,471)(H,331,464)(H,332,440)(H,333,444)(H,334,448)(H,335,458)(H,336,435)(H,337,450)(H,338,456)(H,339,429)(H,340,432)(H,341,445)(H,342,454)(H,343,449)(H,344,455)(H,345,470)(H,346,467)(H,347,472)(H,348,437)(H,349,436)(H,350,430)(H,351,438)(H,352,442)(H,353,441)(H,354,451)(H,355,468)(H,356,396)(H,357,453)(H,358,459)(H,359,465)(H,360,460)(H,361,439)(H,362,452)(H,363,461)(H,364,469)(H,397,398)(H,399,400)(H,401,402)(H,403,404)(H,405,406)(H,407,408)(H,409,410)(H,411,412)(H,413,414)(H,415,416)(H,417,418)(H,419,420)(H,476,477)/t133-,134-,135+,136+,137+,138+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,222-,223-,224-,225-,226-,227-,228-,229-,230-,231-/m0/s1 D00UOR DRUGINKE XYWBJDRHGNULKG-OUMQNGNKSA-N D00UOR DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C D00UOR HIGHSTAT Approved D00UTD DRUG__ID D00UTD D00UTD DRUGCOMP Shionogi & Co Ltd D00UTD DRUGTYPE Small molecular drug D00UTD DRUGINCH 1S/C2H4O3.2H3N.Pt/c3-1-2(4)5;;;/h3H,1H2,(H,4,5);2*1H3; D00UTD DRUGINKE ZAXCMPAWRCMABN-UHFFFAOYSA-N D00UTD DRUGSMIL C(C(=O)O)O.N.N.[Pt] D00UTD HIGHSTAT Approved D00UVA DRUG__ID D00UVA D00UVA DRUGCOMP Onyx Pharmaceuticals D00UVA DRUGTYPE Small molecular drug D00UVA DRUGINCH 1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1 D00UVA DRUGINKE BLMPQMFVWMYDKT-NZTKNTHTSA-N D00UVA DRUGSMIL CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 D00UVA HIGHSTAT Approved D00UXT DRUG__ID D00UXT D00UXT DRUGCOMP Ortho Mcneil Pharmaceutical Inc D00UXT DRUGTYPE Small molecular drug D00UXT DRUGINCH 1S/C9H6I3NO3.Na/c1-3(14)13-8-5(11)2-4(10)6(7(8)12)9(15)16;/h2H,1H3,(H,13,14)(H,15,16);/q;+1/p-1 D00UXT DRUGINKE UCPVOMHRDXMAIZ-UHFFFAOYSA-M D00UXT DRUGSMIL CC(=O)NC1=C(C=C(C(=C1I)C(=O)[O-])I)I.[Na+] D00UXT HIGHSTAT Approved D00VFE DRUG__ID D00VFE D00VFE DRUGCOMP Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co D00VFE DRUGTYPE Small molecular drug D00VFE DRUGINCH 1S/C42H65N13O10.C2H4O2.H2O/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65;1-2(3)4;/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47);1H3,(H,3,4);1H2/t24-,28-,29-,30-,31-,33-,34-;;/m0../s1 D00VFE DRUGINKE YBZYNINTWCLDQA-UHKVWXOHSA-N D00VFE DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)CNC.CC(=O)O.O D00VFE HIGHSTAT Approved D00WAM DRUG__ID D00WAM D00WAM THERCLAS Diuretics D00WAM DRUGTYPE Small molecular drug D00WAM DRUGINCH 1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16) D00WAM DRUGINKE DMDGGSIALPNSEE-UHFFFAOYSA-N D00WAM DRUGSMIL C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1 D00WAM HIGHSTAT Approved D00WCX DRUG__ID D00WCX D00WCX THERCLAS Antilipemic Agents D00WCX DRUGTYPE Small molecular drug D00WCX DRUGINCH 1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24) D00WCX DRUGINKE IIBYAHWJQTYFKB-UHFFFAOYSA-N D00WCX DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl D00WCX HIGHSTAT Approved D00WMK DRUG__ID D00WMK D00WMK DRUGCOMP GlaxoSmithKline D00WMK DRUGTYPE Small molecular drug D00WMK DRUGINCH 1S/C27H29F3O6S.C24H33Cl2NO5/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20;25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3;5-9,14,24,27-30H,1-4,10-13,15-17H2/t14-,16+,17?,19+,21+,24+,25+,26+,27+;24-/m10/s1 D00WMK DRUGINKE IVFHIIPWLILHCX-KVXXQBCDSA-N D00WMK DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl D00WMK HIGHSTAT Approved D00WUF DRUG__ID D00WUF D00WUF DRUGCOMP Pfizer D00WUF DRUGTYPE Small molecular drug D00WUF DRUGINCH 1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1 D00WUF DRUGINKE AYXYPKUFHZROOJ-ZETCQYMHSA-N D00WUF DRUGSMIL CC(C)CC(CC(=O)O)CN D00WUF HIGHSTAT Approved D00WVW DRUG__ID D00WVW D00WVW DRUGCOMP Astellas D00WVW DRUGTYPE Small molecular drug D00WVW DRUGINCH 1S/C21H30N4O5S.ClH.3H2O/c1-12(2)25(13(3)4)8-7-22-20(28)15-11-31-21(23-15)24-19(27)14-9-17(29-5)18(30-6)10-16(14)26;;;;/h9-13,26H,7-8H2,1-6H3,(H,22,28)(H,23,24,27);1H;3*1H2 D00WVW DRUGINKE NPTDXIXCQCFGKC-UHFFFAOYSA-N D00WVW DRUGSMIL CC(C)N(CCNC(=O)C1=CSC(=N1)NC(=O)C2=CC(=C(C=C2O)OC)OC)C(C)C.O.O.O.Cl D00WVW HIGHSTAT Approved D00XHD DRUG__ID D00XHD D00XHD DRUGCOMP Chugai D00XHD DRUGTYPE Small molecular drug D00XHD DRUGINCH 1S/C20H24FN3O4/c1-22-11-4-3-7-23(9-11)17-15(21)8-13-16(19(17)28-2)24(12-5-6-12)10-14(18(13)25)20(26)27/h8,10-12,22H,3-7,9H2,1-2H3,(H,26,27) D00XHD DRUGINKE MGQLHRYJBWGORO-UHFFFAOYSA-N D00XHD DRUGSMIL CNC1CCCN(C1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F D00XHD HIGHSTAT Approved D00XPC DRUG__ID D00XPC D00XPC THERCLAS Antiinflammatory Agents D00XPC DRUGTYPE Small molecular drug D00XPC DRUGINCH 1S/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24-,25-/m0/s1 D00XPC DRUGINKE BDSYKGHYMJNPAB-LICBFIPMSA-N D00XPC DRUGSMIL CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl D00XPC HIGHSTAT Approved D00XUN DRUG__ID D00XUN D00XUN DRUGCOMP Procter And Gamble Pharmaceuticals Inc Sub Procter And Gamble Co D00XUN DRUGTYPE Small molecular drug D00XUN DRUGINCH 1S/C2H8O7P2.2Na/c1-2(3,10(4,5)6)11(7,8)9;;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);;/q;2*+1/p-2 D00XUN DRUGINKE GWBBVOVXJZATQQ-UHFFFAOYSA-L D00XUN DRUGSMIL CC(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+] D00XUN HIGHSTAT Approved D00XWD DRUG__ID D00XWD D00XWD DRUGCOMP Novartis D00XWD DRUGTYPE Small molecular drug D00XWD DRUGINCH 1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21)/b20-11+ D00XWD DRUGINKE IKBKZGMPCYNSLU-RGVLZGJSSA-N D00XWD DRUGSMIL CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC D00XWD HIGHSTAT Approved D00YZD DRUG__ID D00YZD D00YZD DRUGCOMP GlaxoSmithKline D00YZD DRUGTYPE Small molecular drug D00YZD DRUGINCH 1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1 D00YZD DRUGINKE RHWKPHLQXYSBKR-BMIGLBTASA-N D00YZD DRUGSMIL CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O D00YZD HIGHSTAT Approved D00ZCT DRUG__ID D00ZCT D00ZCT DRUGCOMP Bristol-myers squibb D00ZCT DRUGTYPE Small molecular drug D00ZCT DRUGINCH 1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38) D00ZCT DRUGINKE SWMDAPWAQQTBOG-UHFFFAOYSA-N D00ZCT DRUGSMIL CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC D00ZCT HIGHSTAT Approved D00ZFP DRUG__ID D00ZFP D00ZFP THERCLAS Antimenopausal Agents D00ZFP DRUGTYPE Small molecular drug D00ZFP DRUGINCH 1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1 D00ZFP DRUGINKE DNXHEGUUPJUMQT-CBZIJGRNSA-N D00ZFP DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O D00ZFP HIGHSTAT Approved D01AQT DRUG__ID D01AQT D01AQT THERCLAS Antifungal Agents D01AQT DRUGTYPE Small molecular drug D01AQT DRUGINCH 1S/C26H31Cl2N5O3/c1-19(2)31-9-11-32(12-10-31)21-4-6-22(7-5-21)34-14-23-15-35-26(36-23,16-33-18-29-17-30-33)24-8-3-20(27)13-25(24)28/h3-8,13,17-19,23H,9-12,14-16H2,1-2H3/t23-,26-/m0/s1 D01AQT DRUGINKE BLSQLHNBWJLIBQ-OZXSUGGESA-N D01AQT DRUGSMIL CC(C)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl D01AQT HIGHSTAT Approved D01BYB DRUG__ID D01BYB D01BYB THERCLAS Dietary supplement D01BYB DRUGTYPE Small molecular drug D01BYB DRUGINCH 1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D01BYB DRUGINKE ZKHQWZAMYRWXGA-KQYNXXCUSA-N D01BYB DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N D01BYB HIGHSTAT Approved D01CRB DRUG__ID D01CRB D01CRB THERCLAS Dietary supplement D01CRB DRUGTYPE Small molecular drug D01CRB DRUGINCH 1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1 D01CRB DRUGINKE OUYCCCASQSFEME-QMMMGPOBSA-N D01CRB DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)O D01CRB HIGHSTAT Approved D01CYA DRUG__ID D01CYA D01CYA DRUGCOMP Cephalon D01CYA DRUGTYPE Small molecular drug D01CYA DRUGINCH 1S/C16H21Cl2N3O2.ClH/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23;/h5-6,11H,2-4,7-10H2,1H3,(H,22,23);1H D01CYA DRUGINKE ZHSKUOZOLHMKEA-UHFFFAOYSA-N D01CYA DRUGSMIL CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl D01CYA HIGHSTAT Approved D01DBQ DRUG__ID D01DBQ D01DBQ THERCLAS Anticancer Agents D01DBQ DRUGTYPE Small molecular drug D01DBQ DRUGINCH 1S/C32H32O13S/c1-37-19-6-13(7-20(38-2)25(19)33)23-14-8-17-18(42-12-41-17)9-15(14)28(16-10-39-30(36)24(16)23)44-32-27(35)26(34)29-21(43-32)11-40-31(45-29)22-4-3-5-46-22/h3-9,16,21,23-24,26-29,31-35H,10-12H2,1-2H3/t16-,21+,23+,24-,26+,27+,28+,29+,31+,32-/m0/s1 D01DBQ DRUGINKE NRUKOCRGYNPUPR-QBPJDGROSA-N D01DBQ DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O D01DBQ HIGHSTAT Approved D01DSP DRUG__ID D01DSP D01DSP THERCLAS Antibiotics D01DSP DRUGTYPE Small molecular drug D01DSP DRUGINCH 1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1 D01DSP DRUGINKE UQLLWWBDSUHNEB-CZUORRHYSA-N D01DSP DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O D01DSP HIGHSTAT Approved D01EKQ DRUG__ID D01EKQ D01EKQ DRUGCOMP Mallinckrodt Inc D01EKQ DRUGTYPE Small molecular drug D01EKQ DRUGINCH 1S/2C6H8O7.3Fe/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6/i;;3*1+3 D01EKQ DRUGINKE PFKAKHILNWLJRT-ZHVHGXCCSA-H D01EKQ DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+2].[Fe+2].[Fe+2] D01EKQ HIGHSTAT Approved D01GYT DRUG__ID D01GYT D01GYT THERCLAS Antibiotics D01GYT DRUGTYPE Small molecular drug D01GYT DRUGINCH 1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1 D01GYT DRUGINKE YMDXZJFXQJVXBF-STHAYSLISA-N D01GYT DRUGSMIL CC1C(O1)P(=O)(O)O D01GYT HIGHSTAT Approved D01HKL DRUG__ID D01HKL D01HKL DRUGCOMP Abbott Laboratories D01HKL DRUGTYPE Small molecular drug D01HKL DRUGINCH 1S/C17H15ClO4.C5H14NO/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11;1-6(2,3)4-5-7/h3-10H,1-2H3,(H,20,21);7H,4-5H2,1-3H3/q;+1/p-1 D01HKL DRUGINKE JWAZHODZSADEHB-UHFFFAOYSA-M D01HKL DRUGSMIL CC(C)(C(=O)[O-])OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl.C[N+](C)(C)CCO D01HKL HIGHSTAT Approved D01HPY DRUG__ID D01HPY D01HPY DRUGCOMP Oncopeptides AB D01HPY DRUGTYPE Small molecular drug D01HPY DRUGINCH 1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/t21-,22-/m0/s1 D01HPY DRUGINKE YQZNKYXGZSVEHI-VXKWHMMOSA-N D01HPY DRUGSMIL CCOC(=O)C(CC1=CC=C(C=C1)F)NC(=O)C(CC2=CC=C(C=C2)N(CCCl)CCCl)N D01HPY HIGHSTAT Approved D01ICI DRUG__ID D01ICI D01ICI DRUGCOMP Gilead Sciences, Foster City, CA D01ICI DRUGTYPE Small molecular drug D01ICI DRUGINCH 1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1 D01ICI DRUGINKE RWWYLEGWBNMMLJ-YSOARWBDSA-N D01ICI DRUGSMIL CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4 D01ICI HIGHSTAT Approved D01IEM DRUG__ID D01IEM D01IEM DRUGCOMP Merck & Co Inc D01IEM DRUGTYPE Small molecular drug D01IEM DRUGINCH 1S/C12H6Cl4OS/c13-7-1-3-8(4-2-7)18(17)12-6-10(15)9(14)5-11(12)16/h1-6H D01IEM DRUGINKE IEPUYXNXNXZXRP-UHFFFAOYSA-N D01IEM DRUGSMIL C1=CC(=CC=C1S(=O)C2=CC(=C(C=C2Cl)Cl)Cl)Cl D01IEM HIGHSTAT Approved D01IRG DRUG__ID D01IRG D01IRG TRADNAME Biktarvy D01IRG DRUGCOMP Gilead Sciences D01IRG DRUGINCH 1S/C21H18F3N3O5.C21H29N6O5P.C8H10FN3O3S/c22-9-3-14(23)12(15(24)4-9)6-25-20(30)13-7-26-8-16-27(10-1-2-11(5-10)32-16)21(31)17(26)19(29)18(13)28;1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h3-4,7,10-11,16,29H,1-2,5-6,8H2,(H,25,30);5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24);1,5-6,13H,2-3H2,(H2,10,11,14)/t10-,11+,16+;15-,16+,33+;5-,6+/m010/s1 D01IRG DRUGINKE GMIGIKGMWTUBHA-UKQLQXPXSA-N D01IRG DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3.C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F.C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F D01IRG HIGHSTAT Approved D01IWS DRUG__ID D01IWS D01IWS THERCLAS Hypoglycemic Agents D01IWS DRUGTYPE Small molecular drug D01IWS DRUGINCH 1S/C228H382O191/c229-1-76-114(268)152(306)153(307)191(381-76)419-228(190(344)151(305)113(38-266)418-228)75-380-227(189(343)150(304)112(37-265)417-227)74-379-226(188(342)149(303)111(36-264)416-226)73-378-225(187(341)148(302)110(35-263)415-225)72-377-224(186(340)147(301)109(34-262)414-224)71-376-223(185(339)146(300)108(33-261)413-223)70-375-222(184(338)145(299)107(32-260)412-222)69-374-221(183(337)144(298)106(31-259)411-221)68-373-220(182(336)143(297)105(30-258)410-220)67-372-219(181(335)142(296)104(29-257)409-219)66-371-218(180(334)141(295)103(28-256)408-218)65-370-217(179(333)140(294)102(27-255)407-217)64-369-216(178(332)139(293)101(26-254)406-216)63-368-215(177(331)138(292)100(25-253)405-215)62-367-214(176(330)137(291)99(24-252)404-214)61-366-213(175(329)136(290)98(23-251)403-213)60-365-212(174(328)135(289)97(22-250)402-212)59-364-211(173(327)134(288)96(21-249)401-211)58-363-210(172(326)133(287)95(20-248)400-210)57-362-209(171(325)132(286)94(19-247)399-209)56-361-208(170(324)131(285)93(18-246)398-208)55-360-207(169(323)130(284)92(17-245)397-207)54-359-206(168(322)129(283)91(16-244)396-206)53-358-205(167(321)128(282)90(15-243)395-205)52-357-204(166(320)127(281)89(14-242)394-204)51-356-203(165(319)126(280)88(13-241)393-203)50-355-202(164(318)125(279)87(12-240)392-202)49-354-201(163(317)124(278)86(11-239)391-201)48-353-200(162(316)123(277)85(10-238)390-200)47-352-199(161(315)122(276)84(9-237)389-199)46-351-198(160(314)121(275)83(8-236)388-198)45-350-197(159(313)120(274)82(7-235)387-197)44-349-196(158(312)119(273)81(6-234)386-196)43-348-195(157(311)118(272)80(5-233)385-195)42-347-194(156(310)117(271)79(4-232)384-194)41-346-193(155(309)116(270)78(3-231)383-193)40-345-192(39-267)154(308)115(269)77(2-230)382-192/h76-191,229-344H,1-75H2/t76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152+,153-,154+,155+,156+,157+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180+,181+,182+,183+,184+,185+,186+,187+,188+,189+,190+,191-,192-,193-,194-,195-,196-,197-,198-,199-,200-,201-,202-,203-,204-,205-,206-,207-,208-,209-,210-,211-,212-,213-,214-,215-,216-,217-,218-,219-,220-,221-,222-,223-,224-,225-,226-,227-,228+/m1/s1 D01IWS DRUGINKE JYJIGFIDKWBXDU-MNNPPOADSA-N D01IWS DRUGSMIL C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)COC3(C(C(C(O3)CO)O)O)COC4(C(C(C(O4)CO)O)O)COC5(C(C(C(O5)CO)O)O)COC6(C(C(C(O6)CO)O)O)COC7(C(C(C(O7)CO)O)O)COC8(C(C(C(O8)CO)O)O)COC9(C(C(C(O9)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)COC1(C(C(C(O1)CO)O)O)CO)O)O)O)O D01IWS HIGHSTAT Approved D01IXD DRUG__ID D01IXD D01IXD DRUGCOMP Alcon D01IXD DRUGTYPE Small molecular drug D01IXD DRUGINCH 1S/C20H19FN4O4/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28)/t15-,16-/m0/s1 D01IXD DRUGINKE FYMHQCNFKNMJAV-HOTGVXAUSA-N D01IXD DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O D01IXD HIGHSTAT Approved D01JEU DRUG__ID D01JEU D01JEU DRUGCOMP Merz & Co GmbH D01JEU DRUGTYPE Small molecular drug D01JEU DRUGINCH 1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3 D01JEU DRUGINKE BUGYDGFZZOZRHP-UHFFFAOYSA-N D01JEU DRUGSMIL CC12CC3CC(C1)(CC(C3)(C2)N)C D01JEU HIGHSTAT Approved D01JIA DRUG__ID D01JIA D01JIA DRUGCOMP Nutritional Restart D01JIA DRUGTYPE Small molecular drug D01JIA DRUGINCH 1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1 D01JIA DRUGINKE ZDXPYRJPNDTMRX-VKHMYHEASA-N D01JIA DRUGSMIL C(CC(=O)N)C(C(=O)O)N D01JIA HIGHSTAT Approved D01JMC DRUG__ID D01JMC D01JMC DRUGCOMP Arena Pharmaceuticals Inc. D01JMC DRUGTYPE Small molecular drug D01JMC DRUGINCH 1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1 D01JMC DRUGINKE XTTZERNUQAFMOF-QMMMGPOBSA-N D01JMC DRUGSMIL CC1CNCCC2=C1C=C(C=C2)Cl D01JMC HIGHSTAT Approved D01KTN DRUG__ID D01KTN D01KTN DRUGCOMP Shionogi D01KTN DRUGTYPE Small molecular drug D01KTN DRUGINCH 1S/C23H29N5O8S2/c1-5-6-12(13-9-38-21(24)26-13)16(29)27-14-17(30)28-15(11(7-34-22(25)33)8-37-18(14)28)19(31)35-10-36-20(32)23(2,3)4/h6,9,14,18H,5,7-8,10H2,1-4H3,(H2,24,26)(H2,25,33)(H,27,29)/b12-6-/t14-,18-/m1/s1 D01KTN DRUGINKE WVPAABNYMHNFJG-QDVBXLKVSA-N D01KTN DRUGSMIL CCC=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)OCOC(=O)C(C)(C)C D01KTN HIGHSTAT Approved D01MGA DRUG__ID D01MGA D01MGA DRUGCOMP Pfizer Inc D01MGA DRUGTYPE Small molecular drug D01MGA DRUGINCH 1S/C26H25F3N6O5.CH4O3S/c1-10(30)24(37)31-11(2)25(38)32-20-14-7-34(8-15(14)20)23-18(29)6-13-21(36)16(26(39)40)9-35(22(13)33-23)19-4-3-12(27)5-17(19)28;1-5(2,3)4/h3-6,9-11,14-15,20H,7-8,30H2,1-2H3,(H,31,37)(H,32,38)(H,39,40);1H3,(H,2,3,4)/t10-,11-,14-,15+,20?;/m0./s1 D01MGA DRUGINKE CYETUYYEVKNSHZ-RSUMCGCKSA-N D01MGA DRUGSMIL CC(C(=O)NC(C)C(=O)NC1C2C1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N.CS(=O)(=O)O D01MGA HIGHSTAT Approved D01MML DRUG__ID D01MML D01MML DRUGCOMP Millennium Pharmaceuticals D01MML DRUGTYPE Small molecular drug D01MML DRUGINCH 1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-17(29)8-20(34-21,19(31)32)7-16(27)28)25-15(26)9-24-18(30)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,30)(H,25,26)(H,27,28)(H,31,32)/t14-,20?/m0/s1 D01MML DRUGINKE YTXSYWAKVMZICI-PVCZSOGJSA-N D01MML DRUGSMIL B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl D01MML HIGHSTAT Approved D01NJI DRUG__ID D01NJI D01NJI THERCLAS Antiasthmatic Agents D01NJI DRUGTYPE Small molecular drug D01NJI DRUGINCH 1S/C17H23N3O.C4H4O4/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15;5-3(6)1-2-4(7)8/h4-11H,12-14H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D01NJI DRUGINKE JXYWFNAQESKDNC-BTJKTKAUSA-N D01NJI DRUGSMIL CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O D01NJI HIGHSTAT Approved D01NQM DRUG__ID D01NQM D01NQM DRUGCOMP Colucid pharmaceuticals D01NQM DRUGTYPE Small molecular drug D01NQM DRUGINCH 1S/C19H18F3N3O2/c1-25-7-5-11(6-8-25)18(26)15-3-2-4-16(23-15)24-19(27)17-13(21)9-12(20)10-14(17)22/h2-4,9-11H,5-8H2,1H3,(H,23,24,27) D01NQM DRUGINKE XEDHVZKDSYZQBF-UHFFFAOYSA-N D01NQM DRUGSMIL CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F D01NQM HIGHSTAT Approved D01NTX DRUG__ID D01NTX D01NTX DRUGCOMP Millennium Pharmaceuticals D01NTX DRUGTYPE Small molecular drug D01NTX DRUGINCH 1S/C59H109N6O19P/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-50(69)79-40-46(83-51(70)34-32-30-28-26-24-22-20-18-16-14-12-10-8-2)41-81-85(77,78)80-38-37-61-56(73)42(3)62-49(68)36-35-47(55(60)72)65-57(74)43(4)63-58(75)44(5)82-54-52(64-45(6)67)59(76)84-48(39-66)53(54)71/h42-44,46-48,52-54,59,66,71,76H,7-41H2,1-6H3,(H2,60,72)(H,61,73)(H,62,68)(H,63,75)(H,64,67)(H,65,74)(H,77,78)/t42-,43-,44+,46+,47+,48+,52+,53+,54+,59?/m0/s1 D01NTX DRUGINKE JMUHBNWAORSSBD-WKYWBUFDSA-N D01NTX DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)C(C)NC(=O)CCC(C(=O)N)NC(=O)C(C)NC(=O)C(C)OC1C(C(OC(C1O)CO)O)NC(=O)C)OC(=O)CCCCCCCCCCCCCCC D01NTX HIGHSTAT Approved D01OIL DRUG__ID D01OIL D01OIL THERCLAS Contrast Media D01OIL DRUGTYPE Small molecular drug D01OIL DRUGINCH 1S/C22H31N3O11.2C7H17NO5.Gd/c26-18(27)10-23(6-7-24(11-19(28)29)12-20(30)31)8-9-25(13-21(32)33)17(22(34)35)15-36-14-16-4-2-1-3-5-16;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-5,17H,6-15H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,34,35);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1 D01OIL DRUGINKE OCDAWJYGVOLXGZ-VPVMAENOSA-K D01OIL DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3] D01OIL HIGHSTAT Approved D01OPV DRUG__ID D01OPV D01OPV DRUGCOMP Ge Healthcare D01OPV DRUGTYPE Small molecular drug D01OPV DRUGINCH 1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1/i9-4 D01OPV DRUGINKE RJFAYQIBOAGBLC-ZEMBQCNESA-N D01OPV DRUGSMIL C[Se]CCC(C(=O)O)N D01OPV HIGHSTAT Approved D01OXI DRUG__ID D01OXI D01OXI DRUGCOMP Direct Therapeutics Inc D01OXI DRUGTYPE Small molecular drug D01OXI DRUGINCH 1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11) D01OXI DRUGINKE DLGOEMSEDOSKAD-UHFFFAOYSA-N D01OXI DRUGSMIL C(CCl)NC(=O)N(CCCl)N=O D01OXI HIGHSTAT Approved D01PJR DRUG__ID D01PJR D01PJR THERCLAS Antiarrhythmic Agents D01PJR DRUGTYPE Small molecular drug D01PJR DRUGINCH 1S/C11H16N2O/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12/h4-6,9H,12H2,1-3H3,(H,13,14) D01PJR DRUGINKE BUJAGSGYPOAWEI-UHFFFAOYSA-N D01PJR DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C(C)N D01PJR HIGHSTAT Approved D01PZD DRUG__ID D01PZD D01PZD DRUGCOMP Amgen D01PZD DRUGTYPE Small molecular drug D01PZD DRUGINCH 1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8- D01PZD DRUGINKE WUWDLXZGHZSWQZ-WQLSENKSSA-N D01PZD DRUGSMIL CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C D01PZD HIGHSTAT Approved D01QGX DRUG__ID D01QGX D01QGX DRUGCOMP Sumitomo D01QGX DRUGTYPE Small molecular drug D01QGX DRUGINCH 1S/C28H36N4O2S.ClH/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26;/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2;1H/t18-,19+,20-,21-,24+,25-;/m0./s1 D01QGX DRUGINKE NEKCRUIRPWNMLK-SCIYSFAVSA-N D01QGX DRUGSMIL C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O.Cl D01QGX HIGHSTAT Approved D01SAT DRUG__ID D01SAT D01SAT THERCLAS Antihypertensive Agents D01SAT DRUGTYPE Small molecular drug D01SAT DRUGINCH 1S/C20H27NO4/c1-15-5-4-6-18(11-15)25-14-17(22)13-21-10-9-16-7-8-19(23-2)20(12-16)24-3/h4-8,11-12,17,21-22H,9-10,13-14H2,1-3H3 D01SAT DRUGINKE HXLAFSUPPDYFEO-UHFFFAOYSA-N D01SAT DRUGSMIL CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O D01SAT HIGHSTAT Approved D01SHZ DRUG__ID D01SHZ D01SHZ DRUGCOMP Clovis Oncology D01SHZ DRUGTYPE Small molecular drug D01SHZ DRUGINCH 1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24) D01SHZ DRUGINKE HMABYWSNWIZPAG-UHFFFAOYSA-N D01SHZ DRUGSMIL CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2 D01SHZ HIGHSTAT Approved D01TNW DRUG__ID D01TNW D01TNW DRUGCOMP AstraZeneca D01TNW DRUGTYPE Small molecular drug D01TNW DRUGINCH 1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1 D01TNW DRUGINKE JVHXJTBJCFBINQ-ADAARDCZSA-N D01TNW DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl D01TNW HIGHSTAT Approved D01UBX DRUG__ID D01UBX D01UBX THERCLAS Anticancer Agents D01UBX DRUGTYPE Small molecular drug D01UBX DRUGINCH 1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1 D01UBX DRUGINKE USZYSDMBJDPRIF-SVEJIMAYSA-N D01UBX DRUGSMIL CCC1(CC(C2=C(C3=C(C=C2C1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CCC(=O)C(O7)C)O)N(C)C)O D01UBX HIGHSTAT Approved D01UUD DRUG__ID D01UUD D01UUD DRUGCOMP Bioprojet; Ferrer D01UUD DRUGTYPE Small molecular drug D01UUD DRUGINCH 1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2 D01UUD DRUGINKE NNACHAUCXXVJSP-UHFFFAOYSA-N D01UUD DRUGSMIL C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl D01UUD HIGHSTAT Approved D01UXC DRUG__ID D01UXC D01UXC THERCLAS Antihypertensive Agents D01UXC DRUGTYPE Small molecular drug D01UXC DRUGINCH 1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18) D01UXC DRUGINKE METKIMKYRPQLGS-UHFFFAOYSA-N D01UXC DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O D01UXC HIGHSTAT Approved D01VMO DRUG__ID D01VMO D01VMO DRUGCOMP Grupo Uriach D01VMO DRUGTYPE Small molecular drug D01VMO DRUGINCH 1S/C22H16F2N2/c23-19-12-10-18(11-13-19)22(26-15-14-25-16-26,17-6-2-1-3-7-17)20-8-4-5-9-21(20)24/h1-16H D01VMO DRUGINKE QHMWCHQXCUNUAK-UHFFFAOYSA-N D01VMO DRUGSMIL C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=CC=C3F)N4C=CN=C4 D01VMO HIGHSTAT Approved D01WJL DRUG__ID D01WJL D01WJL DRUGCOMP Panray Corp Sub Ormont Drug And Chemical Co Inc D01WJL DRUGTYPE Small molecular drug D01WJL DRUGINCH 1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11) D01WJL DRUGINKE WUBBRNOQWQTFEX-UHFFFAOYSA-N D01WJL DRUGSMIL C1=CC(=C(C=C1N)O)C(=O)O D01WJL HIGHSTAT Approved D01WLC DRUG__ID D01WLC D01WLC THERCLAS Antihypertensive Agents D01WLC DRUGTYPE Small molecular drug D01WLC DRUGINCH 1S/C16H16ClN3O3S/c1-9-5-3-4-6-14(9)20-10(2)19-13-8-12(17)15(24(18,22)23)7-11(13)16(20)21/h3-8,10,19H,1-2H3,(H2,18,22,23) D01WLC DRUGINKE AQCHWTWZEMGIFD-UHFFFAOYSA-N D01WLC DRUGSMIL CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl D01WLC HIGHSTAT Approved D01WMJ DRUG__ID D01WMJ D01WMJ DRUGCOMP Gd Searle Llc D01WMJ DRUGTYPE Small molecular drug D01WMJ DRUGINCH 1S/Cu D01WMJ DRUGINKE RYGMFSIKBFXOCR-UHFFFAOYSA-N D01WMJ DRUGSMIL [Cu] D01WMJ HIGHSTAT Approved D01WUA DRUG__ID D01WUA D01WUA THERCLAS Antihypertensive Agents D01WUA DRUGTYPE Small molecular drug D01WUA DRUGINCH 1S/C23H34O5/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27)/t16-,17-,18+,19-,21+/m0/s1 D01WUA DRUGINKE PAJMKGZZBBTTOY-ZFORQUDYSA-N D01WUA DRUGSMIL CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O D01WUA HIGHSTAT Approved D01XBA DRUG__ID D01XBA D01XBA DRUGCOMP SCOLR Pharma Inc D01XBA DRUGTYPE Small molecular drug D01XBA DRUGINCH 1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2 D01XBA DRUGINKE GZUITABIAKMVPG-UHFFFAOYSA-N D01XBA DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O D01XBA HIGHSTAT Approved D01XWG DRUG__ID D01XWG D01XWG THERCLAS Anticancer Agents D01XWG DRUGTYPE Small molecular drug D01XWG DRUGINCH 1S/C27H29NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3/t10-,14-,16-,17-,22+,27-/m0/s1 D01XWG DRUGINKE STQGQHZAVUOBTE-VGBVRHCVSA-N D01XWG DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O D01XWG HIGHSTAT Approved D01YVT DRUG__ID D01YVT D01YVT DRUGCOMP GelTex Pharmaceuticals Inc D01YVT DRUGTYPE Small molecular drug D01YVT DRUGINCH 1S/C13H27N.C12H27N2.C3H5ClO.C3H7N.2ClH/c1-3-5-6-7-8-9-10-11-13-14-12-4-2;1-5-10-13-11-8-6-7-9-12-14(2,3)4;4-1-3-2-5-3;1-2-3-4;;/h4,14H,2-3,5-13H2,1H3;5,13H,1,6-12H2,2-4H3;3H,1-2H2;2H,1,3-4H2;2*1H/q;+1;;;;/p-1 D01YVT DRUGINKE VTAKZNRDSPNOAU-UHFFFAOYSA-M D01YVT DRUGSMIL CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-] D01YVT HIGHSTAT Approved D01ZEC DRUG__ID D01ZEC D01ZEC THERCLAS Antibiotics D01ZEC DRUGTYPE Small molecular drug D01ZEC DRUGINCH 1S/C13H13N3O6S/c1-6(17)22-4-7-5-23-12-9(15-8(18)2-3-14)11(19)16(12)10(7)13(20)21/h9,12H,2,4-5H2,1H3,(H,15,18)(H,20,21)/t9-,12-/m1/s1 D01ZEC DRUGINKE RRYMAQUWDLIUPV-BXKDBHETSA-N D01ZEC DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CC#N)SC1)C(=O)O D01ZEC HIGHSTAT Approved D01ZLU DRUG__ID D01ZLU D01ZLU TRADNAME Lytgobi D01ZLU DRUGCOMP Taiho oncology D01ZLU DRUGINCH 1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1 D01ZLU DRUGINKE KEIPNCCJPRMIAX-HNNXBMFYSA-N D01ZLU DRUGSMIL COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC D01ZLU HIGHSTAT Approved D01ZOG DRUG__ID D01ZOG D01ZOG DRUGCOMP Sirion D01ZOG DRUGTYPE Small molecular drug D01ZOG DRUGINCH 1S/C27H34F2O7/c1-5-6-23(34)36-26(22(33)14-35-15(2)30)10-8-17-18-12-20(28)19-11-16(31)7-9-24(19,3)27(18,29)21(32)13-25(17,26)4/h7,9,11,17-18,20-21,32H,5-6,8,10,12-14H2,1-4H3/t17-,18-,20-,21-,24-,25-,26-,27-/m0/s1 D01ZOG DRUGINKE WYQPLTPSGFELIB-JTQPXKBDSA-N D01ZOG DRUGSMIL CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C D01ZOG HIGHSTAT Approved D02AEW DRUG__ID D02AEW D02AEW DRUGCOMP Mallinckrodt Medical Inc D02AEW DRUGTYPE Small molecular drug D02AEW DRUGINCH 1S/Xe/i1-4 D02AEW DRUGINKE FHNFHKCVQCLJFQ-AHCXROLUSA-N D02AEW DRUGSMIL [Xe] D02AEW HIGHSTAT Approved D02AQY DRUG__ID D02AQY D02AQY DRUGCOMP Nippon Shinyaku Co Ltd D02AQY DRUGTYPE Small molecular drug D02AQY DRUGINCH 1S/C10H11NO3/c1-7(12)11-9-4-2-8(3-5-9)6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14) D02AQY DRUGINKE MROJXXOCABQVEF-UHFFFAOYSA-N D02AQY DRUGSMIL CC(=O)NC1=CC=C(C=C1)CC(=O)O D02AQY HIGHSTAT Approved D02AXG DRUG__ID D02AXG D02AXG DRUGCOMP Organon Greece D02AXG DRUGTYPE Small molecular drug D02AXG DRUGINCH 1S/C30H48O3/c1-4-5-6-7-8-9-10-11-12-28(32)33-27-16-15-25-24-14-13-22-21-23(31)17-19-29(22,2)26(24)18-20-30(25,27)3/h21,24-27H,4-20H2,1-3H3/t24-,25-,26-,27-,29-,30-/m0/s1 D02AXG DRUGINKE UDSFVOAUHKGBEK-CNQKSJKFSA-N D02AXG DRUGSMIL CCCCCCCCCCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C D02AXG HIGHSTAT Approved D02CFP DRUG__ID D02CFP D02CFP DRUGCOMP Ferrer Internacional SA D02CFP DRUGTYPE Small molecular drug D02CFP DRUGINCH 1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/t9-,11-,12-,13-/m1/s1 D02CFP DRUGINKE RZZPDXZPRHQOCG-OJAKKHQRSA-N D02CFP DRUGSMIL C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O D02CFP HIGHSTAT Approved D02CJX DRUG__ID D02CJX D02CJX DRUGCOMP Organon Usa Inc D02CJX DRUGTYPE Small molecular drug D02CJX DRUGINCH 1S/C23H32O4/c1-14(24)27-13-21(26)20-7-6-18-17-5-4-15-12-16(25)8-10-22(15,2)19(17)9-11-23(18,20)3/h12,17-20H,4-11,13H2,1-3H3/t17-,18-,19-,20+,22-,23-/m0/s1 D02CJX DRUGINKE VPGRYOFKCNULNK-ACXQXYJUSA-N D02CJX DRUGSMIL CC(=O)OCC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C D02CJX HIGHSTAT Approved D02CKX DRUG__ID D02CKX D02CKX THERCLAS Antithyroid Agents D02CKX DRUGTYPE Small molecular drug D02CKX DRUGINCH 1S/C7H10N2O2S/c1-3-11-7(10)9-5-4-8(2)6(9)12/h4-5H,3H2,1-2H3 D02CKX DRUGINKE CFOYWRHIYXMDOT-UHFFFAOYSA-N D02CKX DRUGSMIL CCOC(=O)N1C=CN(C1=S)C D02CKX HIGHSTAT Approved D02CPP DRUG__ID D02CPP D02CPP DRUGCOMP Takeda D02CPP DRUGTYPE Small molecular drug D02CPP DRUGINCH 1S/C17H16FN3O2S.C4H4O4/c1-19-10-13-9-17(15-6-2-3-7-16(15)18)21(12-13)24(22,23)14-5-4-8-20-11-14;5-3(6)1-2-4(7)8/h2-9,11-12,19H,10H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D02CPP DRUGINKE ROGSHYHKHPCCJW-WLHGVMLRSA-N D02CPP DRUGSMIL CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O D02CPP HIGHSTAT Approved D02CTS DRUG__ID D02CTS D02CTS DRUGCOMP Shionogi; QuatRx D02CTS DRUGTYPE Small molecular drug D02CTS DRUGINCH 1S/C24H23ClO2/c25-16-15-23(19-7-3-1-4-8-19)24(20-9-5-2-6-10-20)21-11-13-22(14-12-21)27-18-17-26/h1-14,26H,15-18H2/b24-23- D02CTS DRUGINKE LUMKNAVTFCDUIE-VHXPQNKSSA-N D02CTS DRUGSMIL C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl D02CTS HIGHSTAT Approved D02DKD DRUG__ID D02DKD D02DKD THERCLAS Antiemetics D02DKD DRUGTYPE Small molecular drug D02DKD DRUGINCH 1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3 D02DKD DRUGINKE JSZILQVIPPROJI-UHFFFAOYSA-N D02DKD DRUGSMIL CCN(CC)C(=O)C1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C)OC)OC D02DKD HIGHSTAT Approved D02DSD DRUG__ID D02DSD D02DSD DRUGCOMP Bracco Diagnostics Inc D02DSD DRUGTYPE Small molecular drug D02DSD DRUGINCH 1S/Cr.2Na.4O/q;2*+1;;;2*-1/i1-1;;;;;; D02DSD DRUGINKE PXLIDIMHPNPGMH-PJWPDVOUSA-N D02DSD DRUGSMIL [O-][Cr](=O)(=O)[O-].[Na+].[Na+] D02DSD HIGHSTAT Approved D02DSZ DRUG__ID D02DSZ D02DSZ DRUGCOMP Sankyo D02DSZ DRUGTYPE Small molecular drug D02DSZ DRUGINCH 1S/C23H28N2O5S2.ClH/c1-2-30-23(29)17(11-10-16-7-4-3-5-8-16)24-18-15-32-20(19-9-6-12-31-19)13-25(22(18)28)14-21(26)27;/h3-9,12,17-18,20,24H,2,10-11,13-15H2,1H3,(H,26,27);1H/t17-,18-,20-;/m0./s1 D02DSZ DRUGINKE XDDQNOKKZKHBIX-ASBZXGSUSA-N D02DSZ DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC2CSC(CN(C2=O)CC(=O)O)C3=CC=CS3.Cl D02DSZ HIGHSTAT Approved D02DWM DRUG__ID D02DWM D02DWM THERCLAS Antifungal Agents D02DWM DRUGTYPE Small molecular drug D02DWM DRUGINCH 1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1 D02DWM DRUGINKE APKFDSVGJQXUKY-INPOYWNPSA-N D02DWM DRUGSMIL CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O D02DWM HIGHSTAT Approved D02EYG DRUG__ID D02EYG D02EYG DRUGCOMP Boehringer Ingelheim D02EYG DRUGTYPE Small molecular drug D02EYG DRUGINCH 1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1 D02EYG DRUGINKE LTXREWYXXSTFRX-QGZVFWFLSA-N D02EYG DRUGSMIL CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C D02EYG HIGHSTAT Approved D02EZM DRUG__ID D02EZM D02EZM DRUGCOMP Eisai D02EZM DRUGTYPE Small molecular drug D02EZM DRUGINCH 1S/C13H21O5P.2Na/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16;;/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16);;/q;2*+1/p-2 D02EZM DRUGINKE LWYLQNWMSGFCOZ-UHFFFAOYSA-L D02EZM DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)([O-])[O-].[Na+].[Na+] D02EZM HIGHSTAT Approved D02FCQ DRUG__ID D02FCQ D02FCQ DRUGCOMP Sanofi Aventis Us Llc D02FCQ DRUGTYPE Small molecular drug D02FCQ DRUGINCH 1S/C18H21NO5.ClH/c1-11(6-12-2-5-17-18(7-12)24-10-23-17)19-9-16(22)13-3-4-14(20)15(21)8-13;/h2-5,7-8,11,16,19-22H,6,9-10H2,1H3;1H D02FCQ DRUGINKE LOVXREQUMZKFCM-UHFFFAOYSA-N D02FCQ DRUGSMIL CC(CC1=CC2=C(C=C1)OCO2)NCC(C3=CC(=C(C=C3)O)O)O.Cl D02FCQ HIGHSTAT Approved D02FEM DRUG__ID D02FEM D02FEM THERCLAS Antifungal Agents D02FEM DRUGTYPE Small molecular drug D02FEM DRUGINCH 1S/C33H47NO13/c1-18-10-8-6-4-3-5-7-9-11-21(45-32-30(39)28(34)29(38)19(2)44-32)15-25-27(31(40)41)22(36)17-33(42,47-25)16-20(35)14-24-23(46-24)12-13-26(37)43-18/h3-9,11-13,18-25,27-30,32,35-36,38-39,42H,10,14-17,34H2,1-2H3,(H,40,41)/b4-3+,7-5+,8-6+,11-9+,13-12+/t18-,19-,20+,21+,22+,23-,24-,25+,27-,28+,29-,30+,32+,33-/m1/s1 D02FEM DRUGINKE NCXMLFZGDNKEPB-FFPOYIOWSA-N D02FEM DRUGSMIL CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O D02FEM HIGHSTAT Approved D02FLB DRUG__ID D02FLB D02FLB THERCLAS Antidiarrheals D02FLB DRUGTYPE Small molecular drug D02FLB DRUGINCH 1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1 D02FLB DRUGINKE UIIMBOGNXHQVGW-UHFFFAOYSA-M D02FLB DRUGSMIL C(=O)(O)[O-].[Na+] D02FLB HIGHSTAT Approved D02GAC DRUG__ID D02GAC D02GAC THERCLAS Antibiotics D02GAC DRUGTYPE Small molecular drug D02GAC DRUGINCH 1S/C23H25ClN2O9/c1-22(34)8-6-9-16(26(2)3)18(30)14(21(33)25-7-27)20(32)23(9,35)19(31)12(8)17(29)13-11(28)5-4-10(24)15(13)22/h4-5,8-9,16,27-29,32,34-35H,6-7H2,1-3H3,(H,25,33)/t8-,9-,16-,22-,23-/m0/s1 D02GAC DRUGINKE BXTHDFJCJQJHKD-KMVLDZISSA-N D02GAC DRUGSMIL CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)NCO)N(C)C)O D02GAC HIGHSTAT Approved D02GJZ DRUG__ID D02GJZ D02GJZ DRUGCOMP GE Healthcare D02GJZ DRUGTYPE Small molecular drug D02GJZ DRUGINCH 1S/C18H23FINO2/c1-23-18(22)17-15(12-3-5-13(20)6-4-12)11-14-7-8-16(17)21(14)10-2-9-19/h3-6,14-17H,2,7-11H2,1H3/t14-,15+,16+,17-/m0/s1/i20-4 D02GJZ DRUGINKE HXWLAJVUJSVENX-HFIFKADTSA-N D02GJZ DRUGSMIL COC(=O)C1C2CCC(N2CCCF)CC1C3=CC=C(C=C3)I D02GJZ HIGHSTAT Approved D02HSB DRUG__ID D02HSB D02HSB DRUGCOMP Sanofi-Aventis D02HSB DRUGTYPE Small molecular drug D02HSB DRUGINCH 1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1 D02HSB DRUGINKE BMQGVNUXMIRLCK-OAGWZNDDSA-N D02HSB DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC D02HSB HIGHSTAT Approved D02IBU DRUG__ID D02IBU D02IBU DRUGCOMP Eli Lilly D02IBU DRUGTYPE Small molecular drug D02IBU DRUGINCH 1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1 D02IBU DRUGINKE VHFGEBVPHAGQPI-LXKZPTCJSA-N D02IBU DRUGSMIL CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C(C=C1)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O D02IBU HIGHSTAT Approved D02IHW DRUG__ID D02IHW D02IHW DRUGCOMP Alcon D02IHW DRUGTYPE Small molecular drug D02IHW DRUGINCH 1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18) D02IHW DRUGINKE QEFAQIPZVLVERP-UHFFFAOYSA-N D02IHW DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N D02IHW HIGHSTAT Approved D02IUD DRUG__ID D02IUD D02IUD DRUGCOMP Ge Healthcare D02IUD DRUGTYPE Small molecular drug D02IUD DRUGINCH 1S/FH.Na/h1H;/q;+1/p-1/i1-1; D02IUD DRUGINKE PUZPDOWCWNUUKD-ULWFUOSBSA-M D02IUD DRUGSMIL [F-].[Na+] D02IUD HIGHSTAT Approved D02JIS DRUG__ID D02JIS D02JIS DRUGCOMP GE Healthcare D02JIS DRUGTYPE Small molecular drug D02JIS DRUGINCH 1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)/i9-4 D02JIS DRUGINKE PDWUPXJEEYOOTR-IUAIQHPESA-N D02JIS DRUGSMIL C1=CC(=CC(=C1)I)CN=C(N)N D02JIS HIGHSTAT Approved D02JNM DRUG__ID D02JNM D02JNM THERCLAS Antiinflammatory Agents D02JNM DRUGTYPE Small molecular drug D02JNM DRUGINCH 1S/C24H32O6/c1-21(2)29-19-10-16-15-6-5-13-9-14(26)7-8-22(13,3)20(15)17(27)11-23(16,4)24(19,30-21)18(28)12-25/h7-9,15-17,19-20,25,27H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,20+,22-,23-,24+/m0/s1 D02JNM DRUGINKE WBGKWQHBNHJJPZ-LECWWXJVSA-N D02JNM DRUGSMIL CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C D02JNM HIGHSTAT Approved D02JWA DRUG__ID D02JWA D02JWA DRUGCOMP Shionogi D02JWA DRUGTYPE Small molecular drug D02JWA DRUGINCH 1S/C15H18F2N6O7S2.Na/c1-29-15(18-8(25)6-31-13(16)17)11(28)23-9(10(26)27)7(4-30-12(15)23)5-32-14-19-20-21-22(14)2-3-24;/h12-13,24H,2-6H2,1H3,(H,18,25)(H,26,27);/q;+1/p-1/t12-,15+;/m1./s1 D02JWA DRUGINKE PPPZBOLFWGINKN-YLCXCWDSSA-M D02JWA DRUGSMIL COC1(C2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)[O-])NC(=O)CSC(F)F.[Na+] D02JWA HIGHSTAT Approved D02JYY DRUG__ID D02JYY D02JYY DRUGCOMP Ge Healthcare D02JYY DRUGTYPE Small molecular drug D02JYY DRUGINCH 1S/3C9H7NO.In/c3*11-8-5-1-3-7-4-2-6-10-9(7)8;/h3*1-6,11H;/q;;;+3/p-3/i;;;1-4 D02JYY DRUGINKE AEGSYIKLTCZUEZ-FZTWWWDYSA-K D02JYY DRUGSMIL C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[In+3] D02JYY HIGHSTAT Approved D02KBD DRUG__ID D02KBD D02KBD DRUGCOMP Medpointe Pharmaceuticals Medpointe Healthcare Inc D02KBD DRUGTYPE Small molecular drug D02KBD DRUGINCH 1S/C10H20N2O4/c1-4-7(2)10(3,5-15-8(11)13)6-16-9(12)14/h7H,4-6H2,1-3H3,(H2,11,13)(H2,12,14) D02KBD DRUGINKE LEROTMJVBFSIMP-UHFFFAOYSA-N D02KBD DRUGSMIL CCC(C)C(C)(COC(=O)N)COC(=O)N D02KBD HIGHSTAT Approved D02KIE DRUG__ID D02KIE D02KIE DRUGCOMP DeAngelini D02KIE DRUGTYPE Small molecular drug D02KIE DRUGINCH 1S/C21H28NO4.BrH/c1-22(11-13-7-8-13)17-9-15(10-18(22)20-19(17)26-20)25-21(24)16(12-23)14-5-3-2-4-6-14;/h2-6,13,15-20,23H,7-12H2,1H3;1H/q+1;/p-1/t15?,16-,17-,18+,19-,20+,22?;/m1./s1 D02KIE DRUGINKE WDURTRGFUGAJHA-HNHWXVNLSA-M D02KIE DRUGSMIL C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)CC5CC5.[Br-] D02KIE HIGHSTAT Approved D02KIU DRUG__ID D02KIU D02KIU THERCLAS Contraceptive Agents D02KIU DRUGTYPE Small molecular drug D02KIU DRUGINCH 1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1 D02KIU DRUGINKE GCKFUYQCUCGESZ-BPIQYHPVSA-N D02KIU DRUGSMIL CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34 D02KIU HIGHSTAT Approved D02KMO DRUG__ID D02KMO D02KMO THERCLAS Antihypertensive Agents D02KMO DRUGTYPE Small molecular drug D02KMO DRUGINCH 1S/C13H19N5/c1-10(13(2,3)4)17-12(16-9-14)18-11-5-7-15-8-6-11/h5-8,10H,1-4H3,(H2,15,16,17,18) D02KMO DRUGINKE IVVNZDGDKPTYHK-UHFFFAOYSA-N D02KMO DRUGSMIL CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1 D02KMO HIGHSTAT Approved D02KRS DRUG__ID D02KRS D02KRS THERCLAS Antiviral Agents D02KRS DRUGTYPE Small molecular drug D02KRS DRUGINCH 1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2 D02KRS DRUGINKE DKNWSYNQZKUICI-UHFFFAOYSA-N D02KRS DRUGSMIL C1C2CC3CC1CC(C2)(C3)N D02KRS HIGHSTAT Approved D02LJR DRUG__ID D02LJR D02LJR DRUGCOMP Sanofi Aventis Us Llc D02LJR DRUGTYPE Small molecular drug D02LJR DRUGINCH 1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2 D02LJR DRUGINKE VKYKSIONXSXAKP-UHFFFAOYSA-N D02LJR DRUGSMIL C1N2CN3CN1CN(C2)C3 D02LJR HIGHSTAT Approved D02LJW DRUG__ID D02LJW D02LJW DRUGCOMP Kinex Pharmaceuticals D02LJW DRUGTYPE Small molecular drug D02LJW DRUGINCH 1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30) D02LJW DRUGINKE HUNGUWOZPQBXGX-UHFFFAOYSA-N D02LJW DRUGSMIL C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4 D02LJW HIGHSTAT Approved D02LPF DRUG__ID D02LPF D02LPF THERCLAS Anticancer Agents D02LPF DRUGTYPE Small molecular drug D02LPF DRUGINCH 1S/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H3 D02LPF DRUGINKE UUVWYPNAQBNQJQ-UHFFFAOYSA-N D02LPF DRUGSMIL CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C D02LPF HIGHSTAT Approved D02LRQ DRUG__ID D02LRQ D02LRQ THERCLAS Antiparkinson Agents D02LRQ DRUGTYPE Small molecular drug D02LRQ DRUGINCH 1S/C19H29NO/c21-19(18-11-5-6-12-18,17-9-3-1-4-10-17)13-16-20-14-7-2-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2 D02LRQ DRUGINKE SWRUZBWLEWHWRI-UHFFFAOYSA-N D02LRQ DRUGSMIL C1CCN(CC1)CCC(C2CCCC2)(C3=CC=CC=C3)O D02LRQ HIGHSTAT Approved D02LWU DRUG__ID D02LWU D02LWU DRUGCOMP Allos Therapeutics D02LWU DRUGTYPE Small molecular drug D02LWU DRUGINCH 1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1 D02LWU DRUGINKE OGSBUKJUDHAQEA-WMCAAGNKSA-N D02LWU DRUGSMIL C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D02LWU HIGHSTAT Approved D02NEH DRUG__ID D02NEH D02NEH DRUGCOMP Merck D02NEH DRUGTYPE Small molecular drug D02NEH DRUGINCH 1S/C27H36N4O5S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27/h4-12,22H,13-19,28H2,1-3H3,(H,29,33)/t22-/m1/s1 D02NEH DRUGINKE UMUPQWIGCOZEOY-JOCHJYFZSA-N D02NEH DRUGSMIL CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=CC=CC=C34)S(=O)(=O)C)N D02NEH HIGHSTAT Approved D02NJA DRUG__ID D02NJA D02NJA THERCLAS Antidotes D02NJA DRUGTYPE Small molecular drug D02NJA DRUGINCH 1S/C4H6N2/c1-4-2-5-6-3-4/h2-3H,1H3,(H,5,6) D02NJA DRUGINKE RIKMMFOAQPJVMX-UHFFFAOYSA-N D02NJA DRUGSMIL CC1=CNN=C1 D02NJA HIGHSTAT Approved D02PWM DRUG__ID D02PWM D02PWM THERCLAS Bronchodilator Agents D02PWM DRUGTYPE Small molecular drug D02PWM DRUGINCH 1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3 D02PWM DRUGINKE KSCFJBIXMNOVSH-UHFFFAOYSA-N D02PWM DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O D02PWM HIGHSTAT Approved D02QCM DRUG__ID D02QCM D02QCM DRUGCOMP Novartis Pharmaceuticals Corp D02QCM THERCLAS Anticancer Agents D02QCM DRUGINCH 1S/C151H226N40O45S3/c1-17-75(8)118(144(229)163-67-114(205)183-117(74(6)7)143(228)162-64-112(203)165-77(10)150(235)190-50-29-38-106(190)124(158)209)185-125(210)76(9)166-145(230)120(79(12)194)186-131(216)92(45-47-109(155)200)170-142(227)107-39-30-51-191(107)151(236)103(58-85-35-25-20-26-36-85)180-148(233)122(81(14)196)188-139(224)99(59-87-63-159-71-164-87)176-133(218)96(55-83-31-21-18-22-32-83)174-128(213)90(37-27-28-49-152)168-136(221)101(61-111(157)202)177-134(219)97(56-84-33-23-19-24-34-84)175-137(222)102(62-116(207)208)178-129(214)91(44-46-108(154)199)171-147(232)121(80(13)195)187-138(223)98(57-86-40-42-88(198)43-41-86)179-146(231)119(78(11)193)184-115(206)66-161-127(212)94(53-72(2)3)172-130(215)93(48-52-237-16)169-141(226)105-70-239-238-69-89(153)126(211)160-65-113(204)167-100(60-110(156)201)135(220)173-95(54-73(4)5)132(217)181-104(68-192)140(225)189-123(82(15)197)149(234)182-105/h18-26,31-36,40-43,63,71-82,89-107,117-123,192-198H,17,27-30,37-39,44-62,64-70,152-153H2,1-16H3,(H2,154,199)(H2,155,200)(H2,156,201)(H2,157,202)(H2,158,209)(H,159,164)(H,160,211)(H,161,212)(H,162,228)(H,163,229)(H,165,203)(H,166,230)(H,167,204)(H,168,221)(H,169,226)(H,170,227)(H,171,232)(H,172,215)(H,173,220)(H,174,213)(H,175,222)(H,176,218)(H,177,219)(H,178,214)(H,179,231)(H,180,233)(H,181,217)(H,182,234)(H,183,205)(H,184,206)(H,185,210)(H,186,216)(H,187,223)(H,188,224)(H,189,225)(H,207,208)/t75-,76-,77-,78+,79+,80+,81+,82+,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,117-,118-,119-,120-,121-,122-,123-/m0/s1 D02QCM DRUGINKE LDVRMNJZLWXJPL-JKQNMTHDSA-N D02QCM DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C8CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)C(C)O)CO)CC(C)C)CC(=O)N)N D02QCM HIGHSTAT Approved D02QJH DRUG__ID D02QJH D02QJH THERCLAS Antiinflammatory Agents D02QJH DRUGTYPE Small molecular drug D02QJH DRUGINCH 1S/C24H30F2O6/c1-20(2)31-19-9-13-14-8-16(25)15-7-12(28)5-6-21(15,3)23(14,26)17(29)10-22(13,4)24(19,32-20)18(30)11-27/h5-7,13-14,16-17,19,27,29H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,21-,22-,23-,24+/m0/s1 D02QJH DRUGINKE FEBLZLNTKCEFIT-VSXGLTOVSA-N D02QJH DRUGSMIL CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C D02QJH HIGHSTAT Approved D02QPR DRUG__ID D02QPR D02QPR DRUGCOMP Hospira Inc D02QPR DRUGTYPE Small molecular drug D02QPR DRUGINCH 1S/2ClH.Mn.4H2O/h2*1H;;4*1H2/q;;+2;;;;/p-2 D02QPR DRUGINKE CNFDGXZLMLFIJV-UHFFFAOYSA-L D02QPR DRUGSMIL O.O.O.O.[Cl-].[Cl-].[Mn+2] D02QPR HIGHSTAT Approved D02RIV DRUG__ID D02RIV D02RIV THERCLAS Antifungal Agents D02RIV DRUGTYPE Small molecular drug D02RIV DRUGINCH 1S/C16H16N4O.C2H6O4S/c17-15(18)12-5-2-10(3-6-12)1-4-11-7-8-13(16(19)20)9-14(11)21;3-1-2-7(4,5)6/h1-9,21H,(H3,17,18)(H3,19,20);3H,1-2H2,(H,4,5,6)/b4-1+; D02RIV DRUGINKE HPLUMRXCPMTSQW-DYVSEJHDSA-N D02RIV DRUGSMIL C1=CC(=CC=C1C=CC2=C(C=C(C=C2)C(=N)N)O)C(=N)N.C(CS(=O)(=O)O)O D02RIV HIGHSTAT Approved D02SBQ DRUG__ID D02SBQ D02SBQ THERCLAS Fertility Agents D02SBQ DRUGTYPE Small molecular drug D02SBQ DRUGINCH 1S/C42H65N11O12S2/c1-6-21(4)33-40(63)52-34(22(5)54)41(64)49-28(16-31(44)56)37(60)50-29(19-67-66-18-25(43)35(58)47-27(38(61)51-33)15-23-9-11-24(55)12-10-23)42(65)53-13-7-8-30(53)39(62)48-26(14-20(2)3)36(59)46-17-32(45)57/h9-12,20-22,25-30,33-34,54-55H,6-8,13-19,43H2,1-5H3,(H2,44,56)(H2,45,57)(H,46,59)(H,47,58)(H,48,62)(H,49,64)(H,50,60)(H,51,61)(H,52,63) D02SBQ DRUGINKE ZDRRIRUAESZNIH-UHFFFAOYSA-N D02SBQ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O D02SBQ HIGHSTAT Approved D02TJS DRUG__ID D02TJS D02TJS THERCLAS Anticoagulants D02TJS DRUGTYPE Small molecular drug D02TJS DRUGINCH 1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2 D02TJS DRUGINKE DOBMPNYZJYQDGZ-UHFFFAOYSA-N D02TJS DRUGSMIL C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O D02TJS HIGHSTAT Approved D02TLO DRUG__ID D02TLO D02TLO THERCLAS Anticancer Agents D02TLO DRUGTYPE Small molecular drug D02TLO DRUGINCH 1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12) D02TLO DRUGINKE HOMGKSMUEGBAAB-UHFFFAOYSA-N D02TLO DRUGSMIL C1CN(P(=O)(OC1)NCCCl)CCCl D02TLO HIGHSTAT Approved D02TUL DRUG__ID D02TUL D02TUL TRADNAME Litfulo D02TUL DRUGCOMP Pfizer New York, NY D02TUL DRUGINCH 1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1 D02TUL DRUGINKE CBRJPFGIXUFMTM-WDEREUQCSA-N D02TUL DRUGSMIL CC1CCC(CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3 D02TUL HIGHSTAT Approved D02UFG DRUG__ID D02UFG D02UFG DRUGCOMP Boehringer Ingelheim Pharmaceuticals Inc D02UFG DRUGTYPE Small molecular drug D02UFG DRUGINCH 1S/2C11H17NO3.H2O4S/c2*1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8;1-5(2,3)4/h2*3-5,7,11-15H,6H2,1-2H3;(H2,1,2,3,4) D02UFG DRUGINKE MKFFGUZYVNDHIH-UHFFFAOYSA-N D02UFG DRUGSMIL CC(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O D02UFG HIGHSTAT Approved D02VIT DRUG__ID D02VIT D02VIT DRUGCOMP Good Earth Medicine D02VIT DRUGTYPE Small molecular drug D02VIT DRUGINCH 1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3 D02VIT DRUGINKE KCFYEAOKVJSACF-UHFFFAOYSA-N D02VIT DRUGSMIL CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3 D02VIT HIGHSTAT Approved D02VJP DRUG__ID D02VJP D02VJP DRUGCOMP GILEAD D02VJP DRUGTYPE Small molecular drug D02VJP DRUGINCH 1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1 D02VJP DRUGINKE ZCIGNRJZKPOIKD-CQXVEOKZSA-N D02VJP DRUGSMIL CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5 D02VJP HIGHSTAT Approved D02WCI DRUG__ID D02WCI D02WCI DRUGCOMP InterMune D02WCI DRUGTYPE Small molecular drug D02WCI DRUGINCH 1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3 D02WCI DRUGINKE ISWRGOKTTBVCFA-UHFFFAOYSA-N D02WCI DRUGSMIL CC1=CN(C(=O)C=C1)C2=CC=CC=C2 D02WCI HIGHSTAT Approved D02WFK DRUG__ID D02WFK D02WFK THERCLAS Antiinfective Agents D02WFK DRUGTYPE Small molecular drug D02WFK DRUGINCH 1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1 D02WFK DRUGINKE DYDCUQKUCUHJBH-UWTATZPHSA-N D02WFK DRUGSMIL C1C(C(=O)NO1)N D02WFK HIGHSTAT Approved D02XJI DRUG__ID D02XJI D02XJI THERCLAS Antiallergic Agents D02XJI DRUGTYPE Small molecular drug D02XJI DRUGINCH 1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3 D02XJI DRUGINKE KBUZBQVCBVDWKX-UHFFFAOYSA-N D02XJI DRUGSMIL CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C D02XJI HIGHSTAT Approved D02XOK DRUG__ID D02XOK D02XOK DRUGCOMP Forest Laboratories D02XOK DRUGTYPE Small molecular drug D02XOK DRUGINCH 1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m0/s1 D02XOK DRUGINKE GJJFMKBJSRMPLA-DZGCQCFKSA-N D02XOK DRUGSMIL CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2 D02XOK HIGHSTAT Approved D02YCH DRUG__ID D02YCH D02YCH DRUGCOMP Innovata plc D02YCH DRUGTYPE Small molecular drug D02YCH DRUGINCH 1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14) D02YCH DRUGINKE WDZVGELJXXEGPV-UHFFFAOYSA-N D02YCH DRUGSMIL C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl D02YCH HIGHSTAT Approved D02ZUG DRUG__ID D02ZUG D02ZUG TRADNAME Qulipta D02ZUG DRUGCOMP AbbVie D02ZUG DRUGINCH 1S/C29H23F6N5O3/c1-13-16(22-18(30)4-5-19(31)23(22)32)8-20(26(42)40(13)12-29(33,34)35)38-25(41)15-7-14-9-28(10-21(14)37-11-15)17-3-2-6-36-24(17)39-27(28)43/h2-7,11,13,16,20H,8-10,12H2,1H3,(H,38,41)(H,36,39,43)/t13-,16-,20+,28+/m1/s1 D02ZUG DRUGINKE QIVUCLWGARAQIO-OLIXTKCUSA-N D02ZUG DRUGSMIL CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=C(C=CC(=C6F)F)F D02ZUG HIGHSTAT Approved D03AJU DRUG__ID D03AJU D03AJU DRUGCOMP Novartis Pharmaceuticals D03AJU DRUGTYPE Small molecular drug D03AJU DRUGINCH 1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1 D03AJU DRUGINKE USUZGMWDZDXMDG-CYBMUJFWSA-N D03AJU DRUGSMIL C1CC2=CN=CN2C1C3=C(C=C(C=C3)C#N)F D03AJU HIGHSTAT Approved D03AZK DRUG__ID D03AZK D03AZK TRADNAME Lokelma D03AZK DRUGCOMP AstraZeneca D03AZK DRUGINCH 1S/2Na.H6O9Si3.Zr/c;;1-10(2)7-11(3,4)9-12(5,6)8-10;/h;;1-6H;/q2*+1;; D03AZK DRUGINKE CBTCHTJSGLCFMY-UHFFFAOYSA-N D03AZK DRUGSMIL O[Si]1(O[Si](O[Si](O1)(O)O)(O)O)O.[Na+].[Na+].[Zr] D03AZK HIGHSTAT Approved D03CAT DRUG__ID D03CAT D03CAT DRUGCOMP Toyama D03CAT DRUGTYPE Small molecular drug D03CAT DRUGINCH 1S/C22H27N9O7S2/c1-10-26-29-30(27-10)6-11-7-39-18-14(25-16(32)13(28-36-5)12-8-40-21(23)24-12)17(33)31(18)15(11)19(34)37-9-38-20(35)22(2,3)4/h8,14,18H,6-7,9H2,1-5H3,(H2,23,24)(H,25,32)/b28-13-/t14-,18-/m1/s1 D03CAT DRUGINKE UIYAXIPXULMHAI-JLGRZTKVSA-N D03CAT DRUGSMIL CC1=NN(N=N1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C D03CAT HIGHSTAT Approved D03CEF DRUG__ID D03CEF D03CEF DRUGCOMP Wyeth D03CEF DRUGTYPE Small molecular drug D03CEF DRUGINCH 1S/C16H25NO2.C4H6O4.H2O/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16;5-3(6)1-2-4(7)8;/h6-9,15,18-19H,3-5,10-12H2,1-2H3;1-2H2,(H,5,6)(H,7,8);1H2 D03CEF DRUGINKE PWPDEXVGKDEKTE-UHFFFAOYSA-N D03CEF DRUGSMIL CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O D03CEF HIGHSTAT Approved D03CNS DRUG__ID D03CNS D03CNS THERCLAS Antihypertensive Agents D03CNS DRUGTYPE Small molecular drug D03CNS DRUGINCH 1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20) D03CNS DRUGINKE BOCUKUHCLICSIY-UHFFFAOYSA-N D03CNS DRUGSMIL C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl D03CNS HIGHSTAT Approved D03DEI DRUG__ID D03DEI D03DEI THERCLAS Uricosuric Agents D03DEI DRUGTYPE Small molecular drug D03DEI DRUGINCH 1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2 D03DEI DRUGINKE MBGGBVCUIVRRBF-UHFFFAOYSA-N D03DEI DRUGSMIL C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4 D03DEI HIGHSTAT Approved D03DJL DRUG__ID D03DJL D03DJL DRUGCOMP Novartis D03DJL DRUGTYPE Small molecular drug D03DJL DRUGINCH 1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1 D03DJL DRUGINKE QZZUEBNBZAPZLX-QFIPXVFZSA-N D03DJL DRUGSMIL CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC D03DJL HIGHSTAT Approved D03DMB DRUG__ID D03DMB D03DMB TRADNAME Vtama D03DMB DRUGCOMP Dermavant D03DMB DRUGINCH 1S/C17H18O2/c1-12(2)17-15(18)10-14(11-16(17)19)9-8-13-6-4-3-5-7-13/h3-12,18-19H,1-2H3/b9-8+ D03DMB DRUGINKE ZISJNXNHJRQYJO-CMDGGOBGSA-N D03DMB DRUGSMIL CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O D03DMB HIGHSTAT Approved D03DSR DRUG__ID D03DSR D03DSR DRUGCOMP Exsar D03DSR DRUGTYPE Small molecular drug D03DSR DRUGINCH 1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2 D03DSR DRUGINKE JBDGDEWWOUBZPM-UHFFFAOYSA-N D03DSR DRUGSMIL C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O D03DSR HIGHSTAT Approved D03EDQ DRUG__ID D03EDQ D03EDQ DRUGCOMP Genentech D03EDQ DRUGTYPE Small molecular drug D03EDQ DRUGINCH 1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24) D03EDQ DRUGINKE BPQMGSKTAYIVFO-UHFFFAOYSA-N D03EDQ DRUGSMIL CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl D03EDQ HIGHSTAT Approved D03EEH DRUG__ID D03EEH D03EEH DRUGCOMP GE Healthcare D03EEH DRUGTYPE Small molecular drug D03EEH DRUGINCH 1S/C16H29N5O8.Gd/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+3/p-3 D03EEH DRUGINKE HZHFFEYYPYZMNU-UHFFFAOYSA-K D03EEH DRUGSMIL CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3] D03EEH HIGHSTAT Approved D03FNJ DRUG__ID D03FNJ D03FNJ THERCLAS Anticancer Agents D03FNJ DRUGTYPE Small molecular drug D03FNJ DRUGINCH 1S/C10H16Br2N2O2/c11-3-1-9(15)13-5-7-14(8-6-13)10(16)2-4-12/h1-8H2 D03FNJ DRUGINKE NJBFOOCLYDNZJN-UHFFFAOYSA-N D03FNJ DRUGSMIL C1CN(CCN1C(=O)CCBr)C(=O)CCBr D03FNJ HIGHSTAT Approved D03GET DRUG__ID D03GET D03GET THERCLAS Vitamins D03GET DRUGTYPE Small molecular drug D03GET DRUGINCH 1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3 D03GET DRUGINKE MJVAVZPDRWSRRC-UHFFFAOYSA-N D03GET DRUGSMIL CC1=CC(=O)C2=CC=CC=C2C1=O D03GET HIGHSTAT Approved D03GOI DRUG__ID D03GOI D03GOI DRUGCOMP Novo Nordisk Massachusetts General Hospital D03GOI DRUGTYPE Small molecular drug D03GOI DRUGINCH 1S/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-129(224)195-116(170(265)266)59-64-128(223)180-68-41-40-50-111(153(248)199-115(62-67-135(232)233)154(249)204-120(73-100-44-33-31-34-45-100)159(254)214-140(93(11)19-2)167(262)192-97(15)146(241)201-122(76-103-79-183-108-49-39-38-48-106(103)108)157(252)203-118(72-90(5)6)158(253)212-138(91(7)8)165(260)200-110(52-43-70-182-172(177)178)149(244)184-81-130(225)193-109(51-42-69-181-171(175)176)148(243)187-84-137(236)237)196-144(239)95(13)189-143(238)94(12)191-152(247)114(58-63-127(174)222)194-131(226)82-185-151(246)113(61-66-134(230)231)198-155(250)117(71-89(3)4)202-156(251)119(75-102-54-56-105(221)57-55-102)205-162(257)124(85-216)208-164(259)126(87-218)209-166(261)139(92(9)10)213-161(256)123(78-136(234)235)206-163(258)125(86-217)210-169(264)142(99(17)220)215-160(255)121(74-101-46-35-32-36-47-101)207-168(263)141(98(16)219)211-132(227)83-186-150(245)112(60-65-133(228)229)197-145(240)96(14)190-147(242)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,223)(H,184,244)(H,185,246)(H,186,245)(H,187,243)(H,189,238)(H,190,242)(H,191,247)(H,192,262)(H,193,225)(H,194,226)(H,195,224)(H,196,239)(H,197,240)(H,198,250)(H,199,248)(H,200,260)(H,201,241)(H,202,251)(H,203,252)(H,204,249)(H,205,257)(H,206,258)(H,207,263)(H,208,259)(H,209,261)(H,210,264)(H,211,227)(H,212,253)(H,213,256)(H,214,254)(H,215,255)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H,265,266)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1 D03GOI DRUGINKE YSDQQAXHVYUZIW-QCIJIYAXSA-N D03GOI DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O D03GOI HIGHSTAT Approved D03GVC DRUG__ID D03GVC D03GVC THERCLAS Antihypertensive Agents D03GVC DRUGTYPE Small molecular drug D03GVC DRUGINCH 1S/C9H11Cl2N3O4S2/c1-14-9(4-10)13-6-2-5(11)7(19(12,15)16)3-8(6)20(14,17)18/h2-3,9,13H,4H2,1H3,(H2,12,15,16) D03GVC DRUGINKE CESYKOGBSMNBPD-UHFFFAOYSA-N D03GVC DRUGSMIL CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl D03GVC HIGHSTAT Approved D03JAA DRUG__ID D03JAA D03JAA THERCLAS Hypoglycemic Agents D03JAA DRUGTYPE Small molecular drug D03JAA DRUGINCH 1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16) D03JAA DRUGINKE QFWPJPIVLCBXFJ-UHFFFAOYSA-N D03JAA DRUGSMIL COCCOC1=CN=C(N=C1)NS(=O)(=O)C2=CC=CC=C2 D03JAA HIGHSTAT Approved D03JTG DRUG__ID D03JTG D03JTG TRADNAME Fruzaqla D03JTG DRUGCOMP Takeda D03JTG DRUGINCH 1S/C21H19N3O5/c1-11-19(20(25)22-2)13-6-5-12(7-16(13)28-11)29-21-14-8-17(26-3)18(27-4)9-15(14)23-10-24-21/h5-10H,1-4H3,(H,22,25) D03JTG DRUGINKE BALLNEJQLSTPIO-UHFFFAOYSA-N D03JTG DRUGSMIL CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC D03JTG HIGHSTAT Approved D03KPZ DRUG__ID D03KPZ D03KPZ DRUGCOMP Alcon D03KPZ DRUGTYPE Small molecular drug D03KPZ DRUGINCH 1S/C22H29FO5.C17H18FN3O3/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24;18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3;7-10,19H,1-6H2,(H,23,24)/t12-,15+,16+,17+,19+,20+,21+,22+;/m1./s1 D03KPZ DRUGINKE NTRHYMXQWWPZDD-WKSAPEMMSA-N D03KPZ DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C.C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O D03KPZ HIGHSTAT Approved D03KUB DRUG__ID D03KUB D03KUB DRUGCOMP Roberts Pharmaceuticals D03KUB DRUGTYPE Small molecular drug D03KUB DRUGINCH 1S/C64H83N17O12/c1-4-68-62(92)53-16-10-24-81(53)63(93)46(15-9-23-69-64(65)66)74-56(86)47(25-35(2)3)75-58(88)49(27-37-30-70-43-13-7-5-11-41(37)43)77-57(87)48(26-36-17-19-40(83)20-18-36)76-61(91)52(33-82)80-59(89)50(28-38-31-71-44-14-8-6-12-42(38)44)78-60(90)51(29-39-32-67-34-72-39)79-55(85)45-21-22-54(84)73-45/h5-8,11-14,17-20,30-32,34-35,45-53,70-71,82-83H,4,9-10,15-16,21-29,33H2,1-3H3,(H,67,72)(H,68,92)(H,73,84)(H,74,86)(H,75,88)(H,76,91)(H,77,87)(H,78,90)(H,79,85)(H,80,89)(H4,65,66,69)/t45-,46-,47-,48-,49+,50-,51-,52-,53-/m0/s1 D03KUB DRUGINKE GJKXGJCSJWBJEZ-XRSSZCMZSA-N D03KUB DRUGSMIL CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 D03KUB HIGHSTAT Approved D03KYG DRUG__ID D03KYG D03KYG THERCLAS Antihypertensive Agents D03KYG DRUGTYPE Small molecular drug D03KYG DRUGINCH 1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15-,16-/m0/s1 D03KYG DRUGINKE IPVQLZZIHOAWMC-QXKUPLGCSA-N D03KYG DRUGSMIL CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O D03KYG HIGHSTAT Approved D03KZM DRUG__ID D03KZM D03KZM DRUGCOMP Otsuka; Winston Laboratories & Otsuka D03KZM DRUGTYPE Small molecular drug D03KZM DRUGINCH 1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31) D03KZM DRUGINKE GYHCTFXIZSNGJT-UHFFFAOYSA-N D03KZM DRUGSMIL CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C D03KZM HIGHSTAT Approved D03MGL DRUG__ID D03MGL D03MGL DRUGCOMP FoldRx Pharmaceuticals D03MGL DRUGTYPE Small molecular drug D03MGL DRUGINCH 1S/C14H7Cl2NO3.C7H17NO5/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13;1-8-2-4(10)6(12)7(13)5(11)3-9/h1-6H,(H,18,19);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1 D03MGL DRUGINKE DQJDBUPLRMRBAB-WZTVWXICSA-N D03MGL DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl D03MGL HIGHSTAT Approved D03MZQ DRUG__ID D03MZQ D03MZQ DRUGCOMP GelTex Pharmaceuticals Inc D03MZQ DRUGTYPE Small molecular drug D03MZQ DRUGINCH 1S/C3H5ClO.C3H7N.ClH/c4-1-3-2-5-3;1-2-3-4;/h3H,1-2H2;2H,1,3-4H2;1H D03MZQ DRUGINKE KHNXRSIBRKBJDI-UHFFFAOYSA-N D03MZQ DRUGSMIL C=CCN.C1C(O1)CCl.Cl D03MZQ HIGHSTAT Approved D03NTJ DRUG__ID D03NTJ D03NTJ THERCLAS Antipsychotic Agents D03NTJ DRUGTYPE Small molecular drug D03NTJ DRUGINCH 1S/C32H44F3N3O2S/c1-2-3-4-5-6-7-8-14-31(39)40-24-23-37-21-19-36(20-22-37)17-11-18-38-27-12-9-10-13-29(27)41-30-16-15-26(25-28(30)38)32(33,34)35/h9-10,12-13,15-16,25H,2-8,11,14,17-24H2,1H3 D03NTJ DRUGINKE VIQCGTZFEYDQMR-UHFFFAOYSA-N D03NTJ DRUGSMIL CCCCCCCCCC(=O)OCCN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F D03NTJ HIGHSTAT Approved D03QIP DRUG__ID D03QIP D03QIP DRUGCOMP Blue Earth D03QIP DRUGTYPE Small molecular drug D03QIP DRUGINCH 1S/C5H8FNO2/c6-3-1-5(7,2-3)4(8)9/h3H,1-2,7H2,(H,8,9)/i6-1 D03QIP DRUGINKE NTEDWGYJNHZKQW-KWCOIAHCSA-N D03QIP DRUGSMIL C1C(CC1(C(=O)O)N)F D03QIP HIGHSTAT Approved D03QJL DRUG__ID D03QJL D03QJL DRUGCOMP Avigen D03QJL DRUGTYPE Small molecular drug D03QJL DRUGINCH 1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3 D03QJL DRUGINKE ZJVFLBOZORBYFE-UHFFFAOYSA-N D03QJL DRUGSMIL CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C D03QJL HIGHSTAT Approved D03QRS DRUG__ID D03QRS D03QRS DRUGCOMP Tulane University D03QRS DRUGTYPE Small molecular drug D03QRS DRUGINCH 1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1 D03QRS DRUGINKE VXKHXGOKWPXYNA-PGBVPBMZSA-N D03QRS DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 D03QRS HIGHSTAT Approved D03QWT DRUG__ID D03QWT D03QWT DRUGCOMP Shionogi; penisula D03QWT DRUGTYPE Small molecular drug D03QWT DRUGINCH 1S/C15H24N4O6S2/c1-6-11-10(7(2)20)14(21)19(11)12(15(22)23)13(6)26-9-3-8(17-5-9)4-18-27(16,24)25/h6-11,17-18,20H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t6-,7-,8+,9+,10-,11-/m1/s1 D03QWT DRUGINKE AVAACINZEOAHHE-VFZPANTDSA-N D03QWT DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O D03QWT HIGHSTAT Approved D03RCJ DRUG__ID D03RCJ D03RCJ DRUGCOMP Elkins Sinn Div Ah Robins Co Inc D03RCJ DRUGTYPE Small molecular drug D03RCJ DRUGINCH 1S/C4H6O4.2Na/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 D03RCJ DRUGINKE ZDQYSKICYIVCPN-UHFFFAOYSA-L D03RCJ DRUGSMIL C(CC(=O)[O-])C(=O)[O-].[Na+].[Na+] D03RCJ HIGHSTAT Approved D03RTK DRUG__ID D03RTK D03RTK DRUGCOMP PharmaMar D03RTK DRUGTYPE Small molecular drug D03RTK DRUGINCH 1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1 D03RTK DRUGINKE PKVRCIRHQMSYJX-AIFWHQITSA-N D03RTK DRUGSMIL CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O D03RTK HIGHSTAT Approved D03RZV DRUG__ID D03RZV D03RZV THERCLAS Vasodilator Agents D03RZV DRUGTYPE Small molecular drug D03RZV DRUGINCH 1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12) D03RZV DRUGINKE JIVZKJJQOZQXQB-UHFFFAOYSA-N D03RZV DRUGSMIL C1CN=C(N1)CC2=CC=CC=C2 D03RZV HIGHSTAT Approved D03SXE DRUG__ID D03SXE D03SXE DRUGCOMP Schering Corp Sub Schering Plough Corp D03SXE DRUGTYPE Small molecular drug D03SXE DRUGINCH 1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19-,20-,21-,24-,25-,26-,27-/m0/s1 D03SXE DRUGINKE SNHRLVCMMWUAJD-SUYDQAKGSA-N D03SXE DRUGSMIL CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO D03SXE HIGHSTAT Approved D03TPR DRUG__ID D03TPR D03TPR DRUGCOMP Abbvie Inc D03TPR DRUGTYPE Small molecular drug D03TPR DRUGINCH 1S/C15H11I4NO4.Na/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23;/h1-2,4-5,12,21H,3,20H2,(H,22,23);/q;+1/p-1/t12-;/m1./s1 D03TPR DRUGINKE YDTFRJLNMPSCFM-UTONKHPSSA-M D03TPR DRUGSMIL C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+] D03TPR HIGHSTAT Approved D03TVW DRUG__ID D03TVW D03TVW DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D03TVW DRUGTYPE Small molecular drug D03TVW DRUGINCH 1S/C10H11NO4S2/c1-6(9(14)11-5-8(12)13)17-10(15)7-3-2-4-16-7/h2-4,6H,5H2,1H3,(H,11,14)(H,12,13) D03TVW DRUGINKE JNYSEDHQJCOWQU-UHFFFAOYSA-N D03TVW DRUGSMIL CC(C(=O)NCC(=O)O)SC(=O)C1=CC=CS1 D03TVW HIGHSTAT Approved D03TYI DRUG__ID D03TYI D03TYI THERCLAS Bronchodilator Agents D03TYI DRUGTYPE Small molecular drug D03TYI DRUGINCH 1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2 D03TYI DRUGINKE FQPFAHBPWDRTLU-UHFFFAOYSA-N D03TYI DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N D03TYI HIGHSTAT Approved D03VNJ DRUG__ID D03VNJ D03VNJ DRUGCOMP Asubio Pharmaceuticals D03VNJ DRUGTYPE Small molecular drug D03VNJ DRUGINCH 1S/C127H203N45O39S3/c1-9-64(6)99-121(209)150-52-94(182)151-65(7)100(188)155-76(34-35-91(129)179)109(197)167-85(56-174)104(192)149-53-96(184)153-78(43-62(2)3)102(190)148-54-97(185)154-89(119(207)164-82(48-92(130)180)114(202)169-86(57-175)116(204)163-81(46-67-23-14-11-15-24-67)113(201)158-73(27-18-39-143-125(135)136)107(195)166-84(122(210)211)47-68-30-32-69(178)33-31-68)60-213-214-61-90(171-118(206)88(59-177)170-117(205)87(58-176)168-108(196)74(28-19-40-144-126(137)138)156-106(194)72(26-17-38-142-124(133)134)157-112(200)79(44-63(4)5)161-101(189)70(128)55-173)120(208)162-80(45-66-21-12-10-13-22-66)103(191)147-50-93(181)146-51-95(183)152-71(25-16-37-141-123(131)132)105(193)160-77(36-42-212-8)110(198)165-83(49-98(186)187)115(203)159-75(111(199)172-99)29-20-41-145-127(139)140/h10-15,21-24,30-33,62-65,70-90,99,173-178H,9,16-20,25-29,34-61,128H2,1-8H3,(H2,129,179)(H2,130,180)(H,146,181)(H,147,191)(H,148,190)(H,149,192)(H,150,209)(H,151,182)(H,152,183)(H,153,184)(H,154,185)(H,155,188)(H,156,194)(H,157,200)(H,158,201)(H,159,203)(H,160,193)(H,161,189)(H,162,208)(H,163,204)(H,164,207)(H,165,198)(H,166,195)(H,167,197)(H,168,196)(H,169,202)(H,170,205)(H,171,206)(H,172,199)(H,186,187)(H,210,211)(H4,131,132,141)(H4,133,134,142)(H4,135,136,143)(H4,137,138,144)(H4,139,140,145)/t64-,65-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,99-/m0/s1 D03VNJ DRUGINKE NSQLIUXCMFBZME-MPVJKSABSA-N D03VNJ DRUGSMIL CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C D03VNJ HIGHSTAT Approved D03WEX DRUG__ID D03WEX D03WEX DRUGCOMP Lundbeck; Takeda Pharmaceuticals D03WEX DRUGTYPE Small molecular drug D03WEX DRUGINCH 1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3 D03WEX DRUGINKE YQNWZWMKLDQSAC-UHFFFAOYSA-N D03WEX DRUGSMIL CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C D03WEX HIGHSTAT Approved D03WLI DRUG__ID D03WLI D03WLI DRUGCOMP Ge Healthcare D03WLI DRUGTYPE Small molecular drug D03WLI DRUGINCH 1S/C14H23N3O10/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27) D03WLI DRUGINKE QPCDCPDFJACHGM-UHFFFAOYSA-N D03WLI DRUGSMIL C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O D03WLI HIGHSTAT Approved D03XOC DRUG__ID D03XOC D03XOC DRUGCOMP Dechra Pharmaceuticals D03XOC DRUGTYPE Small molecular drug D03XOC DRUGINCH 1S/C20H27NO3/c1-18-7-6-14-12(13(18)3-4-15(18)22)5-8-20-17(24-20)16(23)11(10-21)9-19(14,20)2/h12-15,17,22-23H,3-9H2,1-2H3/t12-,13-,14-,15-,17+,18-,19+,20+/m0/s1 D03XOC DRUGINKE KVJXBPDAXMEYOA-CXANFOAXSA-N D03XOC DRUGSMIL CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C D03XOC HIGHSTAT Approved D03YVO DRUG__ID D03YVO D03YVO DRUGCOMP Progenics D03YVO DRUGTYPE Small molecular drug D03YVO DRUGINCH 1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1 D03YVO DRUGINKE IFGIYSGOEZJNBE-KNLJMPJLSA-N D03YVO DRUGSMIL C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6.[Br-] D03YVO HIGHSTAT Approved D03ZBT DRUG__ID D03ZBT D03ZBT DRUGCOMP Pfizer New York, NY D03ZBT DRUGTYPE Small molecular drug D03ZBT DRUGINCH 1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1 D03ZBT DRUGINKE KTEIFNKAUNYNJU-GFCCVEGCSA-N D03ZBT DRUGSMIL CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N D03ZBT HIGHSTAT Approved D03ZFG DRUG__ID D03ZFG D03ZFG THERCLAS Antiinfective Agents D03ZFG DRUGTYPE Small molecular drug D03ZFG DRUGINCH 1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/b3-2+,6-5+/t10-,11-/m1/s1 D03ZFG DRUGINKE GVEZIHKRYBHEFX-NQQPLRFYSA-N D03ZFG DRUGSMIL CC=CCC=CCCC(=O)C1C(O1)C(=O)N D03ZFG HIGHSTAT Approved D03ZTE DRUG__ID D03ZTE D03ZTE DRUGCOMP Sigma Tau Pharmaceuticals Inc D03ZTE DRUGTYPE Small molecular drug D03ZTE DRUGINCH 1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1 D03ZTE DRUGINKE RUDATBOHQWOJDD-BSWAIDMHSA-N D03ZTE DRUGSMIL CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C D03ZTE HIGHSTAT Approved D04ACW DRUG__ID D04ACW D04ACW DRUGCOMP Takeda Pharmaceuticals U.S.A. D04ACW DRUGTYPE Small molecular drug D04ACW DRUGINCH 1S/C18H21N5O2.C4H11N5.ClH/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19;1-9(2)4(7)8-3(5)6;/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3;1-2H3,(H5,5,6,7,8);1H/t15-;;/m1../s1 D04ACW DRUGINKE QBZIUBASMTZXMT-QCUBGVIVSA-N D04ACW DRUGSMIL CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.CN(C)C(=N)N=C(N)N.Cl D04ACW HIGHSTAT Approved D04ASH DRUG__ID D04ASH D04ASH DRUGCOMP Takeda D04ASH DRUGTYPE Small molecular drug D04ASH DRUGINCH 1S/C59H84N16O12.C2H4O2/c1-6-63-57(86)48-14-10-22-75(48)58(87)41(13-9-21-64-59(60)61)68-51(80)42(23-32(2)3)69-52(81)43(24-33(4)5)70-53(82)44(25-34-15-17-37(77)18-16-34)71-56(85)47(30-76)74-54(83)45(26-35-28-65-39-12-8-7-11-38(35)39)72-55(84)46(27-36-29-62-31-66-36)73-50(79)40-19-20-49(78)67-40;1-2(3)4/h7-8,11-12,15-18,28-29,31-33,40-48,65,76-77H,6,9-10,13-14,19-27,30H2,1-5H3,(H,62,66)(H,63,86)(H,67,78)(H,68,80)(H,69,81)(H,70,82)(H,71,85)(H,72,84)(H,73,79)(H,74,83)(H4,60,61,64);1H3,(H,3,4)/t40-,41-,42-,43+,44-,45-,46-,47-,48-;/m0./s1 D04ASH DRUGINKE RGLRXNKKBLIBQS-XNHQSDQCSA-N D04ASH DRUGSMIL CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O D04ASH HIGHSTAT Approved D04ATM DRUG__ID D04ATM D04ATM DRUGCOMP Wyeth-Ayerst D04ATM DRUGTYPE Small molecular drug D04ATM DRUGINCH 1S/C22H30O3/c1-13(23)20(25)22(3)11-9-19-18-6-4-14-12-15(24)5-7-16(14)17(18)8-10-21(19,22)2/h12-13,18-19,23H,4-11H2,1-3H3/t13-,18+,19-,21-,22+/m0/s1 D04ATM DRUGINKE JUNDJWOLDSCTFK-MTZCLOFQSA-N D04ATM DRUGSMIL CC(C(=O)C1(CCC2C1(CCC3=C4CCC(=O)C=C4CCC23)C)C)O D04ATM HIGHSTAT Approved D04BCB DRUG__ID D04BCB D04BCB DRUGCOMP Chong Kun Dang Pharmaceutical Corp D04BCB DRUGTYPE Small molecular drug D04BCB DRUGINCH 1S/C24H24N4O5S/c1-28(21-14-22(26-15-25-21)33-19-9-7-17(31-2)8-10-19)11-12-32-18-5-3-16(4-6-18)13-20-23(29)27-24(30)34-20/h3-10,14-15,20H,11-13H2,1-2H3,(H,27,29,30) D04BCB DRUGINKE CHHXEZSCHQVSRE-UHFFFAOYSA-N D04BCB DRUGSMIL CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC D04BCB HIGHSTAT Approved D04BKZ DRUG__ID D04BKZ D04BKZ DRUGCOMP Ge Healthcare D04BKZ DRUGTYPE Small molecular drug D04BKZ DRUGINCH 1S/C22H32N4O14P2.Mn.3Na/c1-13-21(31)17(15(5-23-13)11-39-41(33,34)35)7-25(9-19(27)28)3-4-26(10-20(29)30)8-18-16(12-40-42(36,37)38)6-24-14(2)22(18)32;;;;/h5-6,31-32H,3-4,7-12H2,1-2H3,(H,27,28)(H,29,30)(H2,33,34,35)(H2,36,37,38);;;;/q;+2;3*+1/p-5 D04BKZ DRUGINKE BENFPBJLMUIGGD-UHFFFAOYSA-I D04BKZ DRUGSMIL [H+].[H+].[H+].CC1=NC=C(C(=C1[O-])CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)[O-])CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Mn+2] D04BKZ HIGHSTAT Approved D04CBI DRUG__ID D04CBI D04CBI DRUGCOMP Bayer D04CBI DRUGTYPE Small molecular drug D04CBI DRUGINCH 1S/C20H25NO2/c1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h12,17-18,23H,2-10H2,1H3/t17-,18+,19+,20-/m1/s1 D04CBI DRUGINKE AZFLJNIPTRTECV-FUMNGEBKSA-N D04CBI DRUGSMIL CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O D04CBI HIGHSTAT Approved D04CJL DRUG__ID D04CJL D04CJL DRUGCOMP Keryx biopharmaceuticals D04CJL DRUGTYPE Small molecular drug D04CJL DRUGINCH 1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3 D04CJL DRUGINKE NPFOYSMITVOQOS-UHFFFAOYSA-K D04CJL DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+3] D04CJL HIGHSTAT Approved D04CRN DRUG__ID D04CRN D04CRN DRUGCOMP Eli Lilly D04CRN DRUGTYPE Small molecular drug D04CRN DRUGINCH 1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1 D04CRN DRUGINKE VHGCDTVCOLNTBX-QGZVFWFLSA-N D04CRN DRUGSMIL CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2 D04CRN HIGHSTAT Approved D04CSZ DRUG__ID D04CSZ D04CSZ THERCLAS Antipruritics D04CSZ DRUGTYPE Small molecular drug D04CSZ DRUGINCH 1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3 D04CSZ DRUGINKE NOOLISFMXDJSKH-UHFFFAOYSA-N D04CSZ DRUGSMIL CC1CCC(C(C1)O)C(C)C D04CSZ HIGHSTAT Approved D04DXA DRUG__ID D04DXA D04DXA DRUGCOMP Genentech D04DXA DRUGTYPE Small molecular drug D04DXA DRUGINCH 1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1 D04DXA DRUGINKE VWVKUNOPTJGDOB-BDHVOXNPSA-N D04DXA DRUGSMIL CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2 D04DXA HIGHSTAT Approved D04GKO DRUG__ID D04GKO D04GKO THERCLAS Antihypertensive Agents D04GKO DRUGTYPE Small molecular drug D04GKO DRUGINCH 1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)/t17-,18-,19-/m0/s1 D04GKO DRUGINKE HHHKFGXWKKUNCY-FHWLQOOXSA-N D04GKO DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC2CCCN3CCCC(N3C2=O)C(=O)O D04GKO HIGHSTAT Approved D04GSY DRUG__ID D04GSY D04GSY DRUGCOMP Hoechst AG D04GSY DRUGTYPE Small molecular drug D04GSY DRUGINCH 1S/C60H86N16O13.C2H4O2/c1-7-64-57(87)48-15-11-23-76(48)58(88)41(14-10-22-65-59(61)62)69-51(81)42(24-33(2)3)70-56(86)47(31-89-60(4,5)6)75-52(82)43(25-34-16-18-37(78)19-17-34)71-55(85)46(30-77)74-53(83)44(26-35-28-66-39-13-9-8-12-38(35)39)72-54(84)45(27-36-29-63-32-67-36)73-50(80)40-20-21-49(79)68-40;1-2(3)4/h8-9,12-13,16-19,28-29,32-33,40-48,66,77-78H,7,10-11,14-15,20-27,30-31H2,1-6H3,(H,63,67)(H,64,87)(H,68,79)(H,69,81)(H,70,86)(H,71,85)(H,72,84)(H,73,80)(H,74,83)(H,75,82)(H4,61,62,65);1H3,(H,3,4)/t40-,41-,42-,43-,44-,45-,46-,47+,48-;/m0./s1 D04GSY DRUGINKE PYMDEDHDQYLBRT-DRIHCAFSSA-N D04GSY DRUGSMIL CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O D04GSY HIGHSTAT Approved D04ITO DRUG__ID D04ITO D04ITO DRUGCOMP Salix Pharmaceuticals Ltd D04ITO DRUGTYPE Small molecular drug D04ITO DRUGINCH 1S/C43H51N3O11/c1-19-14-16-46-28(18-19)44-32-29-30-37(50)25(7)40-31(29)41(52)43(9,57-40)55-17-15-27(54-10)22(4)39(56-26(8)47)24(6)36(49)23(5)35(48)20(2)12-11-13-21(3)42(53)45-33(34(32)46)38(30)51/h11-18,20,22-24,27,35-36,39,48-51H,1-10H3,(H,45,53)/b12-11+,17-15+,21-13-/t20-,22+,23+,24+,27-,35-,36+,39+,43-/m0/s1 D04ITO DRUGINKE NZCRJKRKKOLAOJ-XRCRFVBUSA-N D04ITO DRUGSMIL CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C D04ITO HIGHSTAT Approved D04JMQ DRUG__ID D04JMQ D04JMQ DRUGCOMP Pierrel D04JMQ DRUGTYPE Small molecular drug D04JMQ DRUGINCH 1S/C43H74FNO16/c1-15-28-43(11,53)35(49)25(6)34(48)40(8,44)21-41(9,52)37(23(4)32(24(5)38(51)58-28)60-31-20-42(10,54-14)36(50)26(7)57-31)61-39-33(27(45(12)13)19-22(3)56-39)59-30(47)18-17-29(46)55-16-2/h22-28,31-33,35-37,39,49-50,52-53H,15-21H2,1-14H3/t22-,23+,24-,25+,26+,27+,28-,31+,32+,33-,35-,36+,37-,39+,40+,41-,42-,43-/m1/s1 D04JMQ DRUGINKE GFIQERTUSVTTRE-HCTDEEJFSA-N D04JMQ DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)(C)F)C)O)(C)O D04JMQ HIGHSTAT Approved D04JPJ DRUG__ID D04JPJ D04JPJ THERCLAS Anticancer Agents D04JPJ DRUGTYPE Small molecular drug D04JPJ DRUGINCH 1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14) D04JPJ DRUGINKE GQYIWUVLTXOXAJ-UHFFFAOYSA-N D04JPJ DRUGSMIL C1CCC(CC1)NC(=O)N(CCCl)N=O D04JPJ HIGHSTAT Approved D04KAQ DRUG__ID D04KAQ D04KAQ THERCLAS Antibiotics D04KAQ DRUGTYPE Small molecular drug D04KAQ DRUGINCH 1S/C22H29N3O6S/c1-21(2,3)20(29)31-11-30-19(28)15-22(4,5)32-18-14(17(27)25(15)18)24-16(26)13(23)12-9-7-6-8-10-12/h6-10,13-15,18H,11,23H2,1-5H3,(H,24,26)/t13-,14-,15+,18-/m1/s1 D04KAQ DRUGINKE ZEMIJUDPLILVNQ-ZXFNITATSA-N D04KAQ DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)OCOC(=O)C(C)(C)C)C D04KAQ HIGHSTAT Approved D04KZY DRUG__ID D04KZY D04KZY TRADNAME Xospata D04KZY DRUGCOMP Astellas D04KZY DRUGINCH 1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34) D04KZY DRUGINKE GYQYAJJFPNQOOW-UHFFFAOYSA-N D04KZY DRUGSMIL CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5 D04KZY HIGHSTAT Approved D04LCQ DRUG__ID D04LCQ D04LCQ DRUGCOMP Merck D04LCQ DRUGTYPE Small molecular drug D04LCQ DRUGINCH 1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1 D04LCQ DRUGINKE WSNODXPBBALQOF-VEJSHDCNSA-N D04LCQ DRUGSMIL CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC=C2)(F)F)O)O D04LCQ HIGHSTAT Approved D04LHJ DRUG__ID D04LHJ D04LHJ DRUGCOMP Private Formulations Inc D04LHJ DRUGTYPE Small molecular drug D04LHJ DRUGINCH 1S/C18H24NO4.BrH/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11;/h3-7,12-17,20H,8-10H2,1-2H3;1H/q+1;/p-1/t12?,13-,14-,15+,16-,17+;/m1./s1 D04LHJ DRUGINKE CXYRUNPLKGGUJF-OZVSTBQFSA-M D04LHJ DRUGSMIL C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-] D04LHJ HIGHSTAT Approved D04LKS DRUG__ID D04LKS D04LKS DRUGCOMP Incyte D04LKS DRUGTYPE Small molecular drug D04LKS DRUGINCH 1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1 D04LKS DRUGINKE HFNKQEVNSGCOJV-OAHLLOKOSA-N D04LKS DRUGSMIL C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 D04LKS HIGHSTAT Approved D04MGU DRUG__ID D04MGU D04MGU DRUGCOMP E I DuPont de Nemours & Co D04MGU DRUGTYPE Small molecular drug D04MGU DRUGINCH 1S/C12H23N2O4S2.O.Tc/c1-3-17-11(15)9(7-19)13-5-6-14-10(8-20)12(16)18-4-2;;/h9-10,13,19-20H,3-8H2,1-2H3;;/q-1;;+4/p-2/t9-,10-;;/m0../s1/i;;1+1 D04MGU DRUGINKE JYXUFIBQASHILB-DLGXYJAYSA-L D04MGU DRUGSMIL CCOC(=O)C(C[S-])NCC[N-]C(C[S-])C(=O)OCC.O=[Tc+4] D04MGU HIGHSTAT Approved D04MRQ DRUG__ID D04MRQ D04MRQ DRUGCOMP Nippon Shinyaku Co Ltd D04MRQ DRUGTYPE Small molecular drug D04MRQ DRUGINCH 1S/C9H7Cl2N5/c10-4-1-2-6(11)5(3-4)7-14-8(12)16-9(13)15-7/h1-3H,(H4,12,13,14,15,16) D04MRQ DRUGINKE ATCGGEJZONJOCL-UHFFFAOYSA-N D04MRQ DRUGSMIL C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl D04MRQ HIGHSTAT Approved D04MSM DRUG__ID D04MSM D04MSM DRUGCOMP Lundbeck Inc D04MSM DRUGTYPE Small molecular drug D04MSM DRUGINCH 1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18) D04MSM DRUGINKE FFGPTBGBLSHEPO-UHFFFAOYSA-N D04MSM DRUGSMIL C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N D04MSM HIGHSTAT Approved D04MWJ DRUG__ID D04MWJ D04MWJ DRUGCOMP Methapharm Inc D04MWJ DRUGTYPE Small molecular drug D04MWJ DRUGINCH 1S/C8H18NO2.ClH/c1-7(11-8(2)10)6-9(3,4)5;/h7H,6H2,1-5H3;1H/q+1;/p-1 D04MWJ DRUGINKE JHPHVAVFUYTVCL-UHFFFAOYSA-M D04MWJ DRUGSMIL CC(C[N+](C)(C)C)OC(=O)C.[Cl-] D04MWJ HIGHSTAT Approved D04NQI DRUG__ID D04NQI D04NQI THERCLAS Antimalarials D04NQI DRUGTYPE Small molecular drug D04NQI DRUGINCH 1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23) D04NQI DRUGINKE OVCDSSHSILBFBN-UHFFFAOYSA-N D04NQI DRUGSMIL CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O D04NQI HIGHSTAT Approved D04NTJ DRUG__ID D04NTJ D04NTJ THERCLAS Hypoglycemic Agents D04NTJ DRUGTYPE Small molecular drug D04NTJ DRUGINCH 1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27) D04NTJ DRUGINKE ZKUDBRCEOBOWLF-UHFFFAOYSA-N D04NTJ DRUGSMIL CC1=CC(=NO1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NN3CCCCCC3 D04NTJ HIGHSTAT Approved D04NXQ DRUG__ID D04NXQ D04NXQ THERCLAS Antiinfective Agents D04NXQ DRUGTYPE Small molecular drug D04NXQ DRUGINCH 1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24) D04NXQ DRUGINKE FHFYDNQZQSQIAI-UHFFFAOYSA-N D04NXQ DRUGSMIL CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O D04NXQ HIGHSTAT Approved D04PAN DRUG__ID D04PAN D04PAN DRUGCOMP Alliance Pharmaceutical Corp D04PAN DRUGTYPE Small molecular drug D04PAN DRUGINCH 1S/C8BrF17/c9-7(22,23)5(18,19)3(14,15)1(10,11)2(12,13)4(16,17)6(20,21)8(24,25)26 D04PAN DRUGINKE WTWWXOGTJWMJHI-UHFFFAOYSA-N D04PAN DRUGSMIL C(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F D04PAN HIGHSTAT Approved D04PHC DRUG__ID D04PHC D04PHC THERCLAS Vasoconstrictor Agents D04PHC DRUGTYPE Small molecular drug D04PHC DRUGINCH 1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1 D04PHC DRUGINKE UCTWMZQNUQWSLP-VIFPVBQESA-N D04PHC DRUGSMIL CNCC(C1=CC(=C(C=C1)O)O)O D04PHC HIGHSTAT Approved D04QNO DRUG__ID D04QNO D04QNO DRUGCOMP AstraZeneca D04QNO DRUGTYPE Small molecular drug D04QNO DRUGINCH 1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21+,22+,23-,24-,25+/m0/s1 D04QNO DRUGINKE VOVIALXJUBGFJZ-VXKMTNQYSA-N D04QNO DRUGSMIL CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C D04QNO HIGHSTAT Approved D04QZD DRUG__ID D04QZD D04QZD THERCLAS Neurology Agents D04QZD DRUGTYPE Small molecular drug D04QZD DRUGINCH 1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1 D04QZD DRUGINKE BMPDWHIDQYTSHX-AWEZNQCLSA-N D04QZD DRUGSMIL C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O D04QZD HIGHSTAT Approved D04RGA DRUG__ID D04RGA D04RGA THERCLAS Abortifacient Agents D04RGA DRUGTYPE Small molecular drug D04RGA DRUGINCH 1S/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4-,13-12+;/t15-,16+,17+,18-,19+;/m0./s1 D04RGA DRUGINKE IYGXEHDCSOYNKY-RZHHZEQLSA-N D04RGA DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O D04RGA HIGHSTAT Approved D04RLY DRUG__ID D04RLY D04RLY THERCLAS Anticancer Agents D04RLY DRUGTYPE Small molecular drug D04RLY DRUGINCH 1S/C43H55N5O7/c1-6-39(52)21-25-22-42(38(51)55-5,33-27(13-17-47(23-25)24-39)26-11-8-9-12-30(26)45-33)29-19-28-31(20-32(29)54-4)46(3)35-41(28)15-18-48-16-10-14-40(7-2,34(41)48)36(49)43(35,53)37(44)50/h8-12,14,19-20,25,34-36,45,49,52-53H,6-7,13,15-18,21-24H2,1-5H3,(H2,44,50)/t25-,34+,35-,36-,39+,40-,41-,42+,43+/m1/s1 D04RLY DRUGINKE HHJUWIANJFBDHT-KOTLKJBCSA-N D04RLY DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O D04RLY HIGHSTAT Approved D04TDQ DRUG__ID D04TDQ D04TDQ DRUGCOMP Paris Ecole de Pharmacie; Academie Royale des Sciences D04TDQ DRUGTYPE Small molecular drug D04TDQ DRUGINCH 1S/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3 D04TDQ DRUGINKE AKNNEGZIBPJZJG-UHFFFAOYSA-N D04TDQ DRUGSMIL CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3 D04TDQ HIGHSTAT Approved D04TQO DRUG__ID D04TQO D04TQO DRUGCOMP AstraZeneca D04TQO DRUGTYPE Small molecular drug D04TQO DRUGINCH 1S/C50H66Cl4N8O10S2/c1-61-31-43(41-27-37(51)29-47(53)45(41)33-61)35-7-5-9-39(25-35)73(65,66)59-15-19-71-23-21-69-17-13-57-49(63)55-11-3-4-12-56-50(64)58-14-18-70-22-24-72-20-16-60-74(67,68)40-10-6-8-36(26-40)44-32-62(2)34-46-42(44)28-38(52)30-48(46)54/h5-10,25-30,43-44,59-60H,3-4,11-24,31-34H2,1-2H3,(H2,55,57,63)(H2,56,58,64)/t43-,44-/m0/s1 D04TQO DRUGINKE DNHPDWGIXIMXSA-CXNSMIOJSA-N D04TQO DRUGSMIL CN1CC(C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)C5CN(CC6=C5C=C(C=C6Cl)Cl)C D04TQO HIGHSTAT Approved D04UKC DRUG__ID D04UKC D04UKC DRUGCOMP Bayer HealthCare Pharmaceuticals D04UKC DRUGTYPE Small molecular drug D04UKC DRUGINCH 1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26) D04UKC DRUGINKE WXXSNCNJFUAIDG-UHFFFAOYSA-N D04UKC DRUGSMIL CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC D04UKC HIGHSTAT Approved D04USC DRUG__ID D04USC D04USC THERCLAS Antiallergic Agents D04USC DRUGTYPE Small molecular drug D04USC DRUGINCH 1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8) D04USC DRUGINKE NTYJJOPFIAHURM-UHFFFAOYSA-N D04USC DRUGSMIL C1=C(NC=N1)CCN D04USC HIGHSTAT Approved D04UTT DRUG__ID D04UTT D04UTT DRUGCOMP Boehringer Ingelheim Pharmaceuticals D04UTT DRUGTYPE Small molecular drug D04UTT DRUGINCH 1S/C21H26N2O5/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26)/t18-/m0/s1 D04UTT DRUGINKE COUYJEVMBVSIHV-SFHVURJKSA-N D04UTT DRUGSMIL CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=C3C(=CC(=C2)O)NC(=O)CO3)O D04UTT HIGHSTAT Approved D04UUH DRUG__ID D04UUH D04UUH DRUGCOMP Noven Therapeutics Llc D04UUH DRUGTYPE Small molecular drug D04UUH DRUGINCH 1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2 D04UUH DRUGINKE XGZVUEUWXADBQD-UHFFFAOYSA-L D04UUH DRUGSMIL [Li+].[Li+].C(=O)([O-])[O-] D04UUH HIGHSTAT Approved D04UZT DRUG__ID D04UZT D04UZT THERCLAS Anticancer Agents D04UZT DRUGTYPE Small molecular drug D04UZT DRUGINCH 1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1 D04UZT DRUGINKE PWZUUYSISTUNDW-VAFBSOEGSA-N D04UZT DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5 D04UZT HIGHSTAT Approved D04WFD DRUG__ID D04WFD D04WFD THERCLAS Antidepressants D04WFD DRUGTYPE Small molecular drug D04WFD DRUGINCH 1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3 D04WFD DRUGINKE PHVGLTMQBUFIQQ-UHFFFAOYSA-N D04WFD DRUGSMIL CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 D04WFD HIGHSTAT Approved D04WJO DRUG__ID D04WJO D04WJO DRUGCOMP Light Sciences Oncology D04WJO DRUGTYPE Small molecular drug D04WJO DRUGINCH 1S/C38H41N5O9/c1-7-20-16(3)24-12-26-18(5)22(9-10-32(45)46)35(42-26)23(11-31(44)41-30(37(49)50)15-33(47)48)36-34(38(51)52)19(6)27(43-36)14-29-21(8-2)17(4)25(40-29)13-28(20)39-24/h7,12-14,18,22,30,39-40H,1,8-11,15H2,2-6H3,(H,41,44)(H,45,46)(H,47,48)(H,49,50)(H,51,52)/t18-,22-,30-/m0/s1 D04WJO DRUGINKE SIEXFRDYNDREBM-BRXYURPTSA-N D04WJO DRUGSMIL CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)C(=O)O)CC(=O)NC(CC(=O)O)C(=O)O)CCC(=O)O)C)C)C=C)C D04WJO HIGHSTAT Approved D04WOM DRUG__ID D04WOM D04WOM DRUGCOMP Armour Pharmaceutical Co D04WOM THERCLAS Cardiovascular Agents D04WOM DRUGINCH 1S/C207H308N56O58S.C2H4O2/c1-108(2)89-140(186(302)241-136(70-75-163(279)280)181(297)254-149(204(320)321)94-117-43-20-15-21-44-117)250-193(309)152-54-35-86-262(152)202(318)147(92-116-41-18-14-19-42-116)252-171(287)114(11)230-174(290)134(68-73-161(275)276)235-170(286)113(10)231-191(307)150(105-265)255-182(298)133(66-71-156(213)269)240-190(306)146(98-165(283)284)249-179(295)132(67-72-160(273)274)233-157(270)101-225-169(285)112(9)229-185(301)145(97-164(281)282)251-194(310)153-55-36-87-263(153)203(319)148(93-119-60-64-123(268)65-61-119)253-199(315)167(110(5)6)257-184(300)129(49-26-30-79-210)243-198(314)168(111(7)8)259-196(312)155-57-38-85-261(155)201(317)139(53-34-83-223-207(218)219)244-177(293)130(51-32-81-221-205(214)215)237-176(292)128(48-25-29-78-209)236-175(291)127(47-24-28-77-208)232-158(271)103-227-197(313)166(109(3)4)258-195(311)154-56-37-84-260(154)200(316)138(50-27-31-80-211)234-159(272)102-226-173(289)143(95-120-99-224-126-46-23-22-45-124(120)126)247-178(294)131(52-33-82-222-206(216)217)238-187(303)142(90-115-39-16-13-17-40-115)246-189(305)144(96-121-100-220-107-228-121)248-180(296)135(69-74-162(277)278)239-183(299)137(76-88-322-12)242-192(308)151(106-266)256-188(304)141(245-172(288)125(212)104-264)91-118-58-62-122(267)63-59-118;1-2(3)4/h13-23,39-46,58-65,99-100,107-114,125,127-155,166-168,224,264-268H,24-38,47-57,66-98,101-106,208-212H2,1-12H3,(H2,213,269)(H,220,228)(H,225,285)(H,226,289)(H,227,313)(H,229,301)(H,230,290)(H,231,307)(H,232,271)(H,233,270)(H,234,272)(H,235,286)(H,236,291)(H,237,292)(H,238,303)(H,239,299)(H,240,306)(H,241,302)(H,242,308)(H,243,314)(H,244,293)(H,245,288)(H,246,305)(H,247,294)(H,248,296)(H,249,295)(H,250,309)(H,251,310)(H,252,287)(H,253,315)(H,254,297)(H,255,298)(H,256,304)(H,257,300)(H,258,311)(H,259,312)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,320,321)(H4,214,215,221)(H4,216,217,222)(H4,218,219,223);1H3,(H,3,4)/t112-,113-,114-,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,166-,167-,168-;/m0./s1 D04WOM DRUGINKE UXTMGOKKKZOAEF-ZTIPCJHQSA-N D04WOM DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N.CC(=O)O D04WOM HIGHSTAT Approved D04WYX DRUG__ID D04WYX D04WYX TRADNAME Rhopressa D04WYX DRUGCOMP Aerie Pharmaceuticals D04WYX DRUGINCH 1S/C28H27N3O3/c1-18-3-10-25(19(2)13-18)28(33)34-17-20-4-6-21(7-5-20)26(15-29)27(32)31-24-9-8-23-16-30-12-11-22(23)14-24/h3-14,16,26H,15,17,29H2,1-2H3,(H,31,32)/t26-/m1/s1 D04WYX DRUGINKE OURRXQUGYQRVML-AREMUKBSSA-N D04WYX DRUGSMIL CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C D04WYX HIGHSTAT Approved D04XPW DRUG__ID D04XPW D04XPW THERCLAS Anesthetics D04XPW DRUGTYPE Small molecular drug D04XPW DRUGINCH 1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1 D04XPW DRUGINKE ZPUCINDJVBIVPJ-LJISPDSOSA-N D04XPW DRUGSMIL CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC D04XPW HIGHSTAT Approved D04XVN DRUG__ID D04XVN D04XVN DRUGCOMP GlaxoSmithKline D04XVN DRUGTYPE Small molecular drug D04XVN DRUGINCH 1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34) D04XVN DRUGINKE LIRYPHYGHXZJBZ-UHFFFAOYSA-N D04XVN DRUGSMIL CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5 D04XVN HIGHSTAT Approved D04YPN DRUG__ID D04YPN D04YPN DRUGCOMP Medac D04YPN DRUGTYPE Small molecular drug D04YPN DRUGINCH 1S/C6H14O8S2/c1-15(9,10)13-3-5(7)6(8)4-14-16(2,11)12/h5-8H,3-4H2,1-2H3/t5-,6-/m0/s1 D04YPN DRUGINKE YCPOZVAOBBQLRI-WDSKDSINSA-N D04YPN DRUGSMIL CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O D04YPN HIGHSTAT Approved D05AFC DRUG__ID D05AFC D05AFC THERCLAS Antibiotics D05AFC DRUGTYPE Small molecular drug D05AFC DRUGINCH 1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9+,12-11+,23-18+/t24-,25-,28-,31-,32-/m1/s1 D05AFC DRUGINKE SUYRLXYYZQTJHF-VMBLUXKRSA-N D05AFC DRUGSMIL CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C D05AFC HIGHSTAT Approved D05AFR DRUG__ID D05AFR D05AFR THERCLAS Antibiotics D05AFR DRUGTYPE Small molecular drug D05AFR DRUGINCH 1S/C27H33N3O8/c1-26(37)13-7-6-8-16(31)17(13)21(32)18-14(26)11-15-20(29(2)3)22(33)19(24(35)27(15,38)23(18)34)25(36)28-12-30-9-4-5-10-30/h6-8,14-15,20,31-32,35,37-38H,4-5,9-12H2,1-3H3,(H,28,36)/t14-,15-,20-,26+,27-/m0/s1 D05AFR DRUGINKE IKQRPFTXKQQLJF-IAHYZSEUSA-N D05AFR DRUGSMIL CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCN5CCCC5)N(C)C)O D05AFR HIGHSTAT Approved D05BMG DRUG__ID D05BMG D05BMG DRUGCOMP PharmacoFore Inc D05BMG DRUGTYPE Small molecular drug D05BMG DRUGINCH 1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3 D05BMG DRUGINKE KWTSXDURSIMDCE-UHFFFAOYSA-N D05BMG DRUGSMIL CC(CC1=CC=CC=C1)N D05BMG HIGHSTAT Approved D05BQK DRUG__ID D05BQK D05BQK THERCLAS Analgesics D05BQK DRUGTYPE Small molecular drug D05BQK DRUGINCH 1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16) D05BQK DRUGINKE UZVHFVZFNXBMQJ-UHFFFAOYSA-N D05BQK DRUGSMIL CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C D05BQK HIGHSTAT Approved D05CKR DRUG__ID D05CKR D05CKR DRUGCOMP Nobex Corp D05CKR DRUGTYPE Small molecular drug D05CKR DRUGINCH 1S/C15H16O2/c1-11(16)3-4-12-5-6-14-10-15(17-2)8-7-13(14)9-12/h5-10H,3-4H2,1-2H3 D05CKR DRUGINKE BLXXJMDCKKHMKV-UHFFFAOYSA-N D05CKR DRUGSMIL CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC D05CKR HIGHSTAT Approved D05CPV DRUG__ID D05CPV D05CPV DRUGCOMP Sanofi-Synthelabo D05CPV DRUGTYPE Small molecular drug D05CPV DRUGINCH 1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3 D05CPV DRUGINKE ZQTNQVWKHCQYLQ-UHFFFAOYSA-N D05CPV DRUGSMIL CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC D05CPV HIGHSTAT Approved D05EAM DRUG__ID D05EAM D05EAM THERCLAS Antifungal Agents D05EAM DRUGTYPE Small molecular drug D05EAM DRUGINCH 1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23) D05EAM DRUGINKE XDRYMKDFEDOLFX-UHFFFAOYSA-N D05EAM DRUGSMIL C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N D05EAM HIGHSTAT Approved D05EJG DRUG__ID D05EJG D05EJG THERCLAS Antidepressants D05EJG DRUGTYPE Small molecular drug D05EJG DRUGINCH 1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1 D05EJG DRUGINKE QIVBCDIJIAJPQS-VIFPVBQESA-N D05EJG DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N D05EJG HIGHSTAT Approved D05ELO DRUG__ID D05ELO D05ELO THERCLAS Hypoglycemic Agents D05ELO DRUGTYPE Small molecular drug D05ELO DRUGINCH 1S/C256H381N65O76S6/c1-29-131(23)205(313-193(337)104-258)251(391)317-204(130(21)22)247(387)288-159(75-82-200(347)348)217(357)282-156(71-78-189(262)333)221(361)308-183-116-401-402-117-184-242(382)305-178(111-323)239(379)294-162(88-123(7)8)224(364)295-168(95-140-53-61-146(327)62-54-140)227(367)283-154(69-76-187(260)331)218(358)290-161(87-122(5)6)222(362)285-158(74-81-199(345)346)220(360)302-174(101-190(263)334)234(374)298-170(97-142-57-65-148(329)66-58-142)230(370)309-182(241(381)304-176(255(396)397)103-192(265)336)115-400-399-114-181(213(353)272-107-194(338)278-153(72-79-197(341)342)216(356)281-151(51-42-84-270-256(266)267)211(351)271-108-195(339)279-166(93-138-46-36-32-37-47-138)226(366)297-167(94-139-48-38-33-39-49-139)229(369)299-171(98-143-59-67-149(330)68-60-143)237(377)320-208(136(28)326)253(393)321-85-43-52-186(321)245(385)286-152(50-40-41-83-257)214(354)277-134(26)254(394)395)311-249(389)203(129(19)20)316-235(375)164(90-125(11)12)292-228(368)169(96-141-55-63-147(328)64-56-141)296-223(363)160(86-121(3)4)289-209(349)133(25)276-215(355)157(73-80-198(343)344)287-246(386)202(128(17)18)315-236(376)165(91-126(13)14)293-232(372)173(100-145-106-269-120-275-145)301-238(378)177(110-322)280-196(340)109-273-212(352)180(113-398-403-118-185(310-243(183)383)244(384)319-207(135(27)325)252(392)306-179(112-324)240(380)318-206(132(24)30-2)250(390)312-184)307-225(365)163(89-124(9)10)291-231(371)172(99-144-105-268-119-274-144)300-219(359)155(70-77-188(261)332)284-233(373)175(102-191(264)335)303-248(388)201(127(15)16)314-210(350)150(259)92-137-44-34-31-35-45-137/h31-39,44-49,53-68,105-106,119-136,150-186,201-208,322-330H,29-30,40-43,50-52,69-104,107-118,257-259H2,1-28H3,(H2,260,331)(H2,261,332)(H2,262,333)(H2,263,334)(H2,264,335)(H2,265,336)(H,268,274)(H,269,275)(H,271,351)(H,272,353)(H,273,352)(H,276,355)(H,277,354)(H,278,338)(H,279,339)(H,280,340)(H,281,356)(H,282,357)(H,283,367)(H,284,373)(H,285,362)(H,286,385)(H,287,386)(H,288,387)(H,289,349)(H,290,358)(H,291,371)(H,292,368)(H,293,372)(H,294,379)(H,295,364)(H,296,363)(H,297,366)(H,298,374)(H,299,369)(H,300,359)(H,301,378)(H,302,360)(H,303,388)(H,304,381)(H,305,382)(H,306,392)(H,307,365)(H,308,361)(H,309,370)(H,310,383)(H,311,389)(H,312,390)(H,313,337)(H,314,350)(H,315,376)(H,316,375)(H,317,391)(H,318,380)(H,319,384)(H,320,377)(H,341,342)(H,343,344)(H,345,346)(H,347,348)(H,394,395)(H,396,397)(H4,266,267,270)/t131-,132-,133-,134-,135+,136+,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,201-,202-,203-,204-,205-,206-,207-,208-/m0/s1 D05ELO DRUGINKE NOESYZHRGYRDHS-ZYCCASTOSA-N D05ELO DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CN=CN2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN=CN2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D05ELO HIGHSTAT Approved D05ELV DRUG__ID D05ELV D05ELV DRUGCOMP Hospira Inc D05ELV DRUGTYPE Small molecular drug D05ELV DRUGINCH 1S/2ClH.Zn/h2*1H;/q;;+2/p-2 D05ELV DRUGINKE JIAARYAFYJHUJI-UHFFFAOYSA-L D05ELV DRUGSMIL Cl[Zn]Cl D05ELV HIGHSTAT Approved D05FGG DRUG__ID D05FGG D05FGG DRUGCOMP Takeda D05FGG DRUGTYPE Small molecular drug D05FGG DRUGINCH 1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32) D05FGG DRUGINKE KGSXMPPBFPAXLY-UHFFFAOYSA-N D05FGG DRUGSMIL CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O D05FGG HIGHSTAT Approved D05FTJ DRUG__ID D05FTJ D05FTJ THERCLAS Antiinflammatory Agents D05FTJ DRUGTYPE Small molecular drug D05FTJ DRUGINCH 1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18) D05FTJ DRUGINKE HYYBABOKPJLUIN-UHFFFAOYSA-N D05FTJ DRUGSMIL CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C D05FTJ HIGHSTAT Approved D05GRY DRUG__ID D05GRY D05GRY DRUGCOMP Scios Llc D05GRY DRUGTYPE Small molecular drug D05GRY DRUGINCH 1S/C143H244N50O42S4/c1-13-76(10)112-137(232)189-99(68-199)131(226)188-98(67-198)130(225)187-97(66-197)129(224)186-96(65-196)117(212)166-59-105(202)169-90(52-72(2)3)114(209)163-61-107(204)171-100(132(227)177-83(32-19-22-44-146)124(219)190-111(75(8)9)136(231)184-91(53-73(4)5)127(222)175-84(34-24-46-159-141(151)152)121(216)174-85(35-25-47-160-142(153)154)122(217)185-94(139(234)235)55-78-57-157-71-167-78)69-238-239-70-101(172-108(205)62-165-116(211)95(64-195)170-106(203)60-162-113(208)87(38-39-103(148)200)181-135(230)110(74(6)7)191-126(221)89(41-51-237-12)179-120(215)82(31-18-21-43-145)180-134(229)102-37-27-49-193(102)138(233)79(147)63-194)133(228)182-92(54-77-28-15-14-16-29-77)115(210)164-58-104(201)168-80(33-23-45-158-140(149)150)118(213)173-81(30-17-20-42-144)119(214)178-88(40-50-236-11)123(218)183-93(56-109(206)207)128(223)176-86(125(220)192-112)36-26-48-161-143(155)156/h14-16,28-29,57,71-76,79-102,110-112,194-199H,13,17-27,30-56,58-70,144-147H2,1-12H3,(H2,148,200)(H,157,167)(H,162,208)(H,163,209)(H,164,210)(H,165,211)(H,166,212)(H,168,201)(H,169,202)(H,170,203)(H,171,204)(H,172,205)(H,173,213)(H,174,216)(H,175,222)(H,176,223)(H,177,227)(H,178,214)(H,179,215)(H,180,229)(H,181,230)(H,182,228)(H,183,218)(H,184,231)(H,185,217)(H,186,224)(H,187,225)(H,188,226)(H,189,232)(H,190,219)(H,191,221)(H,192,220)(H,206,207)(H,234,235)(H4,149,150,158)(H4,151,152,159)(H4,153,154,160)(H4,155,156,161)/t76-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,110-,111-,112-/m0/s1 D05GRY DRUGINKE HPNRHPKXQZSDFX-OAQDCNSJSA-N D05GRY DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CNC=N4)C(=O)O)CC(C)C)CO)CO)CO)CO D05GRY HIGHSTAT Approved D05HFY DRUG__ID D05HFY D05HFY THERCLAS Anticoagulants D05HFY DRUGTYPE Small molecular drug D05HFY DRUGINCH 1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3 D05HFY DRUGINKE VABCILAOYCMVPS-UHFFFAOYSA-N D05HFY DRUGSMIL CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O D05HFY HIGHSTAT Approved D05HSC DRUG__ID D05HSC D05HSC THERCLAS Neuromuscular Nondepolarizing Agents D05HSC DRUGTYPE Small molecular drug D05HSC DRUGINCH 1S/C37H40N2O6/c1-38-14-12-24-19-32(42-4)33-21-27(24)28(38)16-22-6-9-26(10-7-22)44-37-35-25(20-34(43-5)36(37)41)13-15-39(2,3)29(35)17-23-8-11-30(40)31(18-23)45-33/h6-11,18-21,28-29H,12-17H2,1-5H3,(H-,40,41)/p+1/t28-,29+/m0/s1 D05HSC DRUGINKE JFJZZMVDLULRGK-URLMMPGGSA-O D05HSC DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC D05HSC HIGHSTAT Approved D05IHU DRUG__ID D05IHU D05IHU DRUGCOMP Fougera Pharmaceuticals Inc D05IHU DRUGTYPE Small molecular drug D05IHU DRUGINCH 1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15) D05IHU DRUGINKE BYJAVTDNIXVSPW-UHFFFAOYSA-N D05IHU DRUGSMIL C1CC(C2=CC=CC=C2C1)C3=NCCN3 D05IHU HIGHSTAT Approved D05IPF DRUG__ID D05IPF D05IPF DRUGCOMP AstraZeneca D05IPF DRUGTYPE Small molecular drug D05IPF DRUGINCH 1S/C18H25N3O2.C4H11N5/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;1-9(2)4(7)8-3(5)6/h10-15,23H,1-7,9,20H2;1-2H3,(H5,5,6,7,8)/t10?,11?,12?,13-,14-,15+,17?,18?;/m1./s1 D05IPF DRUGINKE QUKZWYNGKYRRKE-RIKNOMPASA-N D05IPF DRUGSMIL CN(C)C(=N)N=C(N)N.C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N D05IPF HIGHSTAT Approved D05JNI DRUG__ID D05JNI D05JNI THERCLAS Antibiotics D05JNI DRUGTYPE Small molecular drug D05JNI DRUGINCH 1S/C23H46N6O13/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22/h5-23,30-36H,1-4,24-29H2/t5-,6+,7-,8+,9-,10-,11-,12+,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+/m1/s1 D05JNI DRUGINKE PGBHMTALBVVCIT-VCIWKGPPSA-N D05JNI DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N D05JNI HIGHSTAT Approved D05LBU DRUG__ID D05LBU D05LBU THERCLAS Fibrinolytic Agents D05LBU DRUGTYPE Small molecular drug D05LBU DRUGINCH 1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2 D05LBU DRUGINKE PHWBOXQYWZNQIN-UHFFFAOYSA-N D05LBU DRUGSMIL C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl D05LBU HIGHSTAT Approved D05MFG DRUG__ID D05MFG D05MFG THERCLAS Antihypertensive Agents D05MFG DRUGTYPE Small molecular drug D05MFG DRUGINCH 1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1 D05MFG DRUGINKE HRWCVUIFMSZDJS-SZMVWBNQSA-N D05MFG DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3(CC2C(=O)O)SCCS3 D05MFG HIGHSTAT Approved D05MKA DRUG__ID D05MKA D05MKA DRUGCOMP Sanofi D05MKA DRUGTYPE Small molecular drug D05MKA DRUGINCH 1S/C215H347N61O65S/c1-16-115(10)173(210(337)256-141(68-74-170(299)300)194(321)261-148(94-122-98-232-126-50-24-23-49-124(122)126)199(326)258-143(89-111(2)3)196(323)247-134(58-32-40-83-223)189(316)262-149(96-160(226)285)180(307)235-100-161(286)233-104-165(290)274-85-42-60-156(274)207(334)267-154(108-280)206(333)265-151(105-277)181(308)237-101-162(287)239-117(12)213(340)276-87-44-62-158(276)214(341)275-86-43-61-157(275)208(335)268-153(107-279)204(331)249-132(56-30-38-81-221)187(314)246-131(55-29-37-80-220)186(313)245-130(54-28-36-79-219)185(312)244-129(53-27-35-78-218)184(311)243-128(52-26-34-77-217)183(310)242-127(176(227)303)51-25-33-76-216)272-201(328)146(92-120-45-19-17-20-46-120)260-197(324)144(90-112(4)5)257-190(317)135(59-41-84-231-215(228)229)255-209(336)172(114(8)9)271-177(304)116(11)240-182(309)138(65-71-167(293)294)251-192(319)139(66-72-168(295)296)252-193(320)140(67-73-169(297)298)253-195(322)142(75-88-342-15)254-191(318)137(63-69-159(225)284)250-188(315)133(57-31-39-82-222)248-203(330)152(106-278)266-198(325)145(91-113(6)7)259-200(327)150(97-171(301)302)263-205(332)155(109-281)269-212(339)175(119(14)283)273-202(329)147(93-121-47-21-18-22-48-121)264-211(338)174(118(13)282)270-164(289)103-236-179(306)136(64-70-166(291)292)241-163(288)102-234-178(305)125(224)95-123-99-230-110-238-123/h17-24,45-50,98-99,110-119,125,127-158,172-175,232,277-283H,16,25-44,51-97,100-109,216-224H2,1-15H3,(H2,225,284)(H2,226,285)(H2,227,303)(H,230,238)(H,233,286)(H,234,305)(H,235,307)(H,236,306)(H,237,308)(H,239,287)(H,240,309)(H,241,288)(H,242,310)(H,243,311)(H,244,312)(H,245,313)(H,246,314)(H,247,323)(H,248,330)(H,249,331)(H,250,315)(H,251,319)(H,252,320)(H,253,322)(H,254,318)(H,255,336)(H,256,337)(H,257,317)(H,258,326)(H,259,327)(H,260,324)(H,261,321)(H,262,316)(H,263,332)(H,264,338)(H,265,333)(H,266,325)(H,267,334)(H,268,335)(H,269,339)(H,270,289)(H,271,304)(H,272,328)(H,273,329)(H,291,292)(H,293,294)(H,295,296)(H,297,298)(H,299,300)(H,301,302)(H4,228,229,231)/t115-,116-,117-,118+,119+,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,172-,173-,174-,175-/m0/s1 D05MKA DRUGINKE XVVOERDUTLJJHN-IAEQDCLQSA-N D05MKA DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N D05MKA HIGHSTAT Approved D05NFR DRUG__ID D05NFR D05NFR TRADNAME Augtyro D05NFR DRUGCOMP Bristol Myers Squibb D05NFR DRUGINCH 1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1 D05NFR DRUGINKE FIKPXCOQUIZNHB-WDEREUQCSA-N D05NFR DRUGSMIL CC1CNC(=O)C2=C3N=C(C=CN3N=C2)NC(C4=C(O1)C=CC(=C4)F)C D05NFR HIGHSTAT Approved D05OIS DRUG__ID D05OIS D05OIS DRUGCOMP Sciele Pharma D05OIS DRUGTYPE Small molecular drug D05OIS DRUGINCH 1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2 D05OIS DRUGINKE WVDDGKGOMKODPV-UHFFFAOYSA-N D05OIS DRUGSMIL C1=CC=C(C=C1)CO D05OIS HIGHSTAT Approved D05OQJ DRUG__ID D05OQJ D05OQJ THERCLAS Sedatives and Hypnotics D05OQJ DRUGTYPE Small molecular drug D05OQJ DRUGINCH 1S/C10H17NO2/c1-4-10(5-2)8(12)7(3)6-11-9(10)13/h7H,4-6H2,1-3H3,(H,11,13) D05OQJ DRUGINKE SIDLZWOQUZRBRU-UHFFFAOYSA-N D05OQJ DRUGSMIL CCC1(C(=O)C(CNC1=O)C)CC D05OQJ HIGHSTAT Approved D05PCM DRUG__ID D05PCM D05PCM TRADNAME Cibinqo D05PCM DRUGCOMP Pfizer D05PCM DRUGINCH 1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17) D05PCM DRUGINKE IUEWXNHSKRWHDY-UHFFFAOYSA-N D05PCM DRUGSMIL CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3 D05PCM HIGHSTAT Approved D05QDC DRUG__ID D05QDC D05QDC THERCLAS Keratolytic Agents D05QDC DRUGTYPE Small molecular drug D05QDC DRUGINCH 1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+ D05QDC DRUGINKE IHUNBGSDBOWDMA-AQFIFDHZSA-N D05QDC DRUGSMIL CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC D05QDC HIGHSTAT Approved D05QNO DRUG__ID D05QNO D05QNO THERCLAS Neuromuscular Depolarizing Agents D05QNO DRUGTYPE Small molecular drug D05QNO DRUGINCH 1S/C16H38N2/c1-17(2,3)15-13-11-9-7-8-10-12-14-16-18(4,5)6/h7-16H2,1-6H3/q+2 D05QNO DRUGINKE MTCUAOILFDZKCO-UHFFFAOYSA-N D05QNO DRUGSMIL C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C D05QNO HIGHSTAT Approved D05RXI DRUG__ID D05RXI D05RXI THERCLAS Antiinflammatory Agents D05RXI DRUGTYPE Small molecular drug D05RXI DRUGINCH 1S/C27H41NO6/c1-5-28(6-2)15-23(32)34-16-22(31)27(33)12-10-20-19-8-7-17-13-18(29)9-11-25(17,3)24(19)21(30)14-26(20,27)4/h13,19-21,24,30,33H,5-12,14-16H2,1-4H3/t19-,20-,21-,24+,25-,26-,27-/m0/s1 D05RXI DRUGINKE FWFVLWGEFDIZMJ-FOMYWIRZSA-N D05RXI DRUGSMIL CCN(CC)CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O D05RXI HIGHSTAT Approved D05SJW DRUG__ID D05SJW D05SJW THERCLAS Skeletal Muscle Relaxants D05SJW DRUGTYPE Small molecular drug D05SJW DRUGINCH 1S/C30H60N3O3.3HI/c1-10-31(11-2,12-3)22-25-34-28-20-19-21-29(35-26-23-32(13-4,14-5)15-6)30(28)36-27-24-33(16-7,17-8)18-9;;;/h19-21H,10-18,22-27H2,1-9H3;3*1H/q+3;;;/p-3 D05SJW DRUGINKE REEUVFCVXKWOFE-UHFFFAOYSA-K D05SJW DRUGSMIL CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-] D05SJW HIGHSTAT Approved D05TMQ DRUG__ID D05TMQ D05TMQ THERCLAS Anticonvulsants D05TMQ DRUGTYPE Small molecular drug D05TMQ DRUGINCH 1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15) D05TMQ DRUGINKE UORJNBVJVRLXMQ-UHFFFAOYSA-N D05TMQ DRUGSMIL CC(C)C1(C(=O)NC(=O)NC1=O)CC=C D05TMQ HIGHSTAT Approved D05UFG DRUG__ID D05UFG D05UFG DRUGCOMP Boehringer Ingelheim D05UFG DRUGTYPE Small molecular drug D05UFG DRUGINCH 1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/b4-3+/t16-/m0/s1 D05UFG DRUGINKE ULXXDDBFHOBEHA-CWDCEQMOSA-N D05UFG DRUGSMIL CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4 D05UFG HIGHSTAT Approved D05VGL DRUG__ID D05VGL D05VGL DRUGCOMP Anacor; Anacor Pharmaceuticals Inc D05VGL DRUGTYPE Small molecular drug D05VGL DRUGINCH 1S/C7H6BFO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2 D05VGL DRUGINKE LFQDNHWZDQTITF-UHFFFAOYSA-N D05VGL DRUGSMIL B1(C2=C(CO1)C=C(C=C2)F)O D05VGL HIGHSTAT Approved D05XGO DRUG__ID D05XGO D05XGO DRUGCOMP Forest Laboratories; Gedeon Richter D05XGO DRUGTYPE Small molecular drug D05XGO DRUGINCH 1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28) D05XGO DRUGINKE KPWSJANDNDDRMB-UHFFFAOYSA-N D05XGO DRUGSMIL CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl D05XGO HIGHSTAT Approved D05ZGQ DRUG__ID D05ZGQ D05ZGQ DRUGCOMP Schering Corp Sub Schering Plough Corp D05ZGQ DRUGTYPE Small molecular drug D05ZGQ DRUGINCH 1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m0./s1 D05ZGQ DRUGINKE DBAKFASWICGISY-DASCVMRKSA-N D05ZGQ DRUGSMIL CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O D05ZGQ HIGHSTAT Approved D05ZPL DRUG__ID D05ZPL D05ZPL DRUGCOMP Chemisch FBRK KRSSLR D05ZPL DRUGTYPE Small molecular drug D05ZPL DRUGINCH 1S/C30H62O10/c1-2-3-4-5-6-7-8-9-10-11-13-32-15-17-34-19-21-36-23-25-38-27-29-40-30-28-39-26-24-37-22-20-35-18-16-33-14-12-31/h31H,2-30H2,1H3 D05ZPL DRUGINKE ONJQDTZCDSESIW-UHFFFAOYSA-N D05ZPL DRUGSMIL CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO D05ZPL HIGHSTAT Approved D05ZYM DRUG__ID D05ZYM D05ZYM THERCLAS Antiinflammatory Agents D05ZYM DRUGTYPE Small molecular drug D05ZYM DRUGINCH 1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8?/m1/s1 D05ZYM DRUGINKE OVRNDRQMDRJTHS-RTRLPJTCSA-N D05ZYM DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)O)O D05ZYM HIGHSTAT Approved D06AAP DRUG__ID D06AAP D06AAP DRUGCOMP Bracco Diagnostics Inc D06AAP DRUGTYPE Small molecular drug D06AAP DRUGINCH 1S/C12H13I3N2O2/c1-17(2)6-16-12-9(14)5-8(13)7(11(12)15)3-4-10(18)19/h5-6H,3-4H2,1-2H3,(H,18,19) D06AAP DRUGINKE YQNFBOJPTAXAKV-UHFFFAOYSA-N D06AAP DRUGSMIL CN(C)C=NC1=C(C=C(C(=C1I)CCC(=O)O)I)I D06AAP HIGHSTAT Approved D06ACW DRUG__ID D06ACW D06ACW THERCLAS Dietary supplement D06ACW DRUGTYPE Small molecular drug D06ACW DRUGINCH 1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D06ACW DRUGINKE UDMBCSSLTHHNCD-KQYNXXCUSA-N D06ACW DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O)N D06ACW HIGHSTAT Approved D06ALD DRUG__ID D06ALD D06ALD DRUGCOMP Boehringer Ingelheim Pharmaceuticals; Eli Lilly D06ALD DRUGTYPE Small molecular drug D06ALD DRUGINCH 1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1 D06ALD DRUGINKE OBWASQILIWPZMG-QZMOQZSNSA-N D06ALD DRUGSMIL C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl D06ALD HIGHSTAT Approved D06BCB DRUG__ID D06BCB D06BCB THERCLAS Vasodilator Agents D06BCB DRUGTYPE Small molecular drug D06BCB DRUGINCH 1S/C22H26N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,14,20H,3-4,7,10-13H2,1-2H3/t20-,22+/m1/s1 D06BCB DRUGINKE DDNCQMVWWZOMLN-IRLDBZIGSA-N D06BCB DRUGSMIL CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC D06BCB HIGHSTAT Approved D06BLQ DRUG__ID D06BLQ D06BLQ DRUGCOMP Taisho D06BLQ DRUGTYPE Small molecular drug D06BLQ DRUGINCH 1S/C27H30O6/c1-19(2)13-15-31-22-8-5-21(6-9-22)7-12-25(28)24-11-10-23(32-16-14-20(3)4)17-26(24)33-18-27(29)30/h5-14,17H,15-16,18H2,1-4H3,(H,29,30)/b12-7+ D06BLQ DRUGINKE GFWRVVCDTLRWPK-KPKJPENVSA-N D06BLQ DRUGSMIL CC(=CCOC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C D06BLQ HIGHSTAT Approved D06CDO DRUG__ID D06CDO D06CDO DRUGCOMP Parke Davis Div Warner Lambert Co D06CDO DRUGTYPE Small molecular drug D06CDO DRUGINCH 1S/C10H14ClN.ClH/c1-10(2,12)7-8-3-5-9(11)6-4-8;/h3-6H,7,12H2,1-2H3;1H D06CDO DRUGINKE WEJDYJKJPUPMLH-UHFFFAOYSA-N D06CDO DRUGSMIL CC(C)(CC1=CC=C(C=C1)Cl)N.Cl D06CDO HIGHSTAT Approved D06CGB DRUG__ID D06CGB D06CGB THERCLAS Contraceptive Agents D06CGB DRUGTYPE Small molecular drug D06CGB DRUGINCH 1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1 D06CGB DRUGINKE RPLCPCMSCLEKRS-BPIQYHPVSA-N D06CGB DRUGSMIL CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CCCCC34 D06CGB HIGHSTAT Approved D06CIE DRUG__ID D06CIE D06CIE DRUGCOMP Medimmune Oncology Inc D06CIE DRUGTYPE Small molecular drug D06CIE DRUGINCH 1S/C5H15N2O3PS/c6-2-1-3-7-4-5-12-11(8,9)10/h7H,1-6H2,(H2,8,9,10) D06CIE DRUGINKE JKOQGQFVAUAYPM-UHFFFAOYSA-N D06CIE DRUGSMIL C(CN)CNCCSP(=O)(O)O D06CIE HIGHSTAT Approved D06CNP DRUG__ID D06CNP D06CNP THERCLAS Anticancer Agents D06CNP DRUGTYPE Small molecular drug D06CNP DRUGINCH 1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 D06CNP DRUGINKE UVIQSJCZCSLXRZ-UBUQANBQSA-N D06CNP DRUGSMIL CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C D06CNP HIGHSTAT Approved D06CTM DRUG__ID D06CTM D06CTM DRUGCOMP AMAG Pharmaceuticals D06CTM DRUGTYPE Small molecular drug D06CTM DRUGINCH 1S/3Fe.2H2O.2O/h;;;2*1H2;;/q;2*+1;;;;/p-2 D06CTM DRUGINKE UCNNJGDEJXIUCC-UHFFFAOYSA-L D06CTM DRUGSMIL O[Fe]=O.O[Fe]=O.[Fe] D06CTM HIGHSTAT Approved D06CWH DRUG__ID D06CWH D06CWH DRUGCOMP Parke Davis Div Warner Lambert Co D06CWH DRUGTYPE Small molecular drug D06CWH DRUGINCH 1S/C29H33FO6/c1-17-13-22-21-10-9-19-14-20(32)11-12-26(19,2)28(21,30)23(33)15-27(22,3)29(17,24(34)16-31)36-25(35)18-7-5-4-6-8-18/h4-8,11-12,14,17,21-23,31,33H,9-10,13,15-16H2,1-3H3/t17-,21-,22-,23-,26-,27-,28-,29-/m0/s1 D06CWH DRUGINKE SOQJPQZCPBDOMF-YCUXZELOSA-N D06CWH DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)OC(=O)C5=CC=CC=C5)C)O)F)C D06CWH HIGHSTAT Approved D06EEL DRUG__ID D06EEL D06EEL DRUGCOMP Meiji Seika D06EEL DRUGTYPE Small molecular drug D06EEL DRUGINCH 1S/C45H71NO17/c1-13-34(50)59-33-23-36(52)55-26(4)18-16-15-17-19-32(58-29(7)48)25(3)22-31(20-21-47)41(42(33)54-12)62-44-39(53)38(46(10)11)40(27(5)57-44)61-37-24-45(9,63-30(8)49)43(28(6)56-37)60-35(51)14-2/h15-17,19,21,25-28,31-33,37-44,53H,13-14,18,20,22-24H2,1-12H3/b16-15+,19-17+/t25-,26-,27-,28+,31+,32+,33-,37+,38-,39-,40-,41+,42+,43+,44+,45-/m1/s1 D06EEL DRUGINKE GQNZGCARKRHPOH-RQIKCTSVSA-N D06EEL DRUGSMIL CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)OC(=O)C)N(C)C)O)CC=O)C)OC(=O)C)C D06EEL HIGHSTAT Approved D06EMT DRUG__ID D06EMT D06EMT THERCLAS Diagnostic Agents D06EMT DRUGTYPE Small molecular drug D06EMT DRUGINCH 1S/C5H11N2O2.ClH.Hg/c1-4(9-2)3-7-5(6)8;;/h4H,1,3H2,2H3,(H3,6,7,8);1H;/q;;+1/p-1 D06EMT DRUGINKE BJFGVYCULWBXKF-UHFFFAOYSA-M D06EMT DRUGSMIL COC(CNC(=O)N)C[Hg]Cl D06EMT HIGHSTAT Approved D06EQP DRUG__ID D06EQP D06EQP THERCLAS Antihistamines D06EQP DRUGTYPE Small molecular drug D06EQP DRUGINCH 1S/C19H22N2OS/c1-13(20(3)4)12-21-16-7-5-6-8-18(16)23-19-10-9-15(14(2)22)11-17(19)21/h5-11,13H,12H2,1-4H3 D06EQP DRUGINKE XLOQNFNTQIRSOX-UHFFFAOYSA-N D06EQP DRUGSMIL CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(=O)C)N(C)C D06EQP HIGHSTAT Approved D06FOU DRUG__ID D06FOU D06FOU DRUGCOMP Galderma D06FOU DRUGTYPE Small molecular drug D06FOU DRUGINCH 1S/C29H33NO4/c1-29(2,3)25-19-23(10-12-26(25)30-14-4-5-15-30)24-18-22(11-13-27(24)34-17-16-31)20-6-8-21(9-7-20)28(32)33/h6-13,18-19,31H,4-5,14-17H2,1-3H3,(H,32,33) D06FOU DRUGINKE MFBCDACCJCDGBA-UHFFFAOYSA-N D06FOU DRUGSMIL CC(C)(C)C1=C(C=CC(=C1)C2=C(C=CC(=C2)C3=CC=C(C=C3)C(=O)O)OCCO)N4CCCC4 D06FOU HIGHSTAT Approved D06GAM DRUG__ID D06GAM D06GAM THERCLAS Antiinfective Agents D06GAM DRUGTYPE Small molecular drug D06GAM DRUGINCH 1S/C17H18F3N3O3/c1-21-4-6-22(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26) D06GAM DRUGINKE XBJBPGROQZJDOJ-UHFFFAOYSA-N D06GAM DRUGSMIL CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F D06GAM HIGHSTAT Approved D06GCK DRUG__ID D06GCK D06GCK DRUGCOMP Korean traditional medicine D06GCK DRUGTYPE Small molecular drug D06GCK DRUGINCH 1S/C18H16O7/c1-22-12-5-4-9(6-14(12)23-2)13-7-10(19)16-15(25-13)8-11(20)18(24-3)17(16)21/h4-8,20-21H,1-3H3 D06GCK DRUGINKE DRRWBCNQOKKKOL-UHFFFAOYSA-N D06GCK DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)OC)O)OC D06GCK HIGHSTAT Approved D06GCO DRUG__ID D06GCO D06GCO DRUGCOMP Ferring D06GCO DRUGTYPE Small molecular drug D06GCO DRUGINCH 1S/C64H82N18O13.C2H4O2/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44;1-2(3)4/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69);1H3,(H,3,4)/t44-,45-,46-,47-,48+,49-,50-,51-,52-;/m0./s1 D06GCO DRUGINKE HPPONSCISKROOD-OYLNGHKZSA-N D06GCO DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8.CC(=O)O D06GCO HIGHSTAT Approved D06IAR DRUG__ID D06IAR D06IAR THERCLAS Antiarrhythmic Agents D06IAR DRUGTYPE Small molecular drug D06IAR DRUGINCH 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 D06IAR DRUGINKE OIRDTQYFTABQOQ-KQYNXXCUSA-N D06IAR DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N D06IAR HIGHSTAT Approved D06IDT DRUG__ID D06IDT D06IDT THERCLAS Parasympathomimetics D06IDT DRUGTYPE Small molecular drug D06IDT DRUGINCH 1S/C32H52N4O4.2BrH/c1-33(31(37)39-29-21-17-19-27(25-29)35(3,4)5)23-15-13-11-9-10-12-14-16-24-34(2)32(38)40-30-22-18-20-28(26-30)36(6,7)8;;/h17-22,25-26H,9-16,23-24H2,1-8H3;2*1H/q+2;;/p-2 D06IDT DRUGINKE YHKBUDZECQDYBR-UHFFFAOYSA-L D06IDT DRUGSMIL CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-] D06IDT HIGHSTAT Approved D06IIB DRUG__ID D06IIB D06IIB DRUGCOMP Ranbaxy Laboratories Inc D06IIB DRUGTYPE Small molecular drug D06IIB DRUGINCH 1S/C24H32ClFO5/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,26)17(28)11-22(16,4)24(19,31-20)18(29)12-25/h9,15-17,19,28H,5-8,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1 D06IIB DRUGINKE MUQNGPZZQDCDFT-JNQJZLCISA-N D06IIB DRUGSMIL CC1(OC2CC3C4CCC5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CCl)C)O)F)C)C D06IIB HIGHSTAT Approved D06IZM DRUG__ID D06IZM D06IZM THERCLAS Vasodilator Agents D06IZM DRUGTYPE Small molecular drug D06IZM DRUGINCH 1S/C4H6N4O12/c9-5(10)17-1-3(19-7(13)14)4(20-8(15)16)2-18-6(11)12/h3-4H,1-2H2/t3-,4+ D06IZM DRUGINKE SNFOERUNNSHUGP-ZXZARUISSA-N D06IZM DRUGSMIL C(C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-] D06IZM HIGHSTAT Approved D06JGH DRUG__ID D06JGH D06JGH THERCLAS Dietary supplement D06JGH DRUGTYPE Small molecular drug D06JGH DRUGINCH 1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14) D06JGH DRUGINKE NGVDGCNFYWLIFO-UHFFFAOYSA-N D06JGH DRUGSMIL CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O D06JGH HIGHSTAT Approved D06KYN DRUG__ID D06KYN D06KYN THERCLAS Cardiotonic Agents D06KYN DRUGTYPE Small molecular drug D06KYN DRUGINCH 1S/C18H23NO4/c20-15-7-4-13(5-8-15)3-1-2-10-19-12-18(23)14-6-9-16(21)17(22)11-14/h4-9,11,18-23H,1-3,10,12H2/t18-/m0/s1 D06KYN DRUGINKE IIRWWTKISYTTBL-SFHVURJKSA-N D06KYN DRUGSMIL C1=CC(=CC=C1CCCCNCC(C2=CC(=C(C=C2)O)O)O)O D06KYN HIGHSTAT Approved D06LHU DRUG__ID D06LHU D06LHU DRUGCOMP Bracco Diagnostics Inc D06LHU DRUGTYPE Small molecular drug D06LHU DRUGINCH 1S/C12H11I3N2O4/c1-4(18)16-3-6-8(13)7(12(20)21)10(15)11(9(6)14)17-5(2)19/h3H2,1-2H3,(H,16,18)(H,17,19)(H,20,21) D06LHU DRUGINKE VVDGWALACJEJKG-UHFFFAOYSA-N D06LHU DRUGSMIL CC(=O)NCC1=C(C(=C(C(=C1I)NC(=O)C)I)C(=O)O)I D06LHU HIGHSTAT Approved D06LNW DRUG__ID D06LNW D06LNW DRUGCOMP Astellas D06LNW DRUGTYPE Small molecular drug D06LNW DRUGINCH 1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34+,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1 D06LNW DRUGINKE ZVGNESXIJDCBKN-UUEYKCAUSA-N D06LNW DRUGSMIL CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C D06LNW HIGHSTAT Approved D06LYS DRUG__ID D06LYS D06LYS DRUGCOMP Leo AB D06LYS DRUGTYPE Small molecular drug D06LYS DRUGINCH 1S/C35H45Cl2NO6/c1-33-14-12-26(39)20-24(33)8-11-27-28-13-15-35(43,34(28,2)21-29(40)32(27)33)30(41)22-44-31(42)5-3-4-23-6-9-25(10-7-23)38(18-16-36)19-17-37/h6-7,9-10,12,14,20,27-29,32,40,43H,3-5,8,11,13,15-19,21-22H2,1-2H3/t27-,28-,29-,32+,33-,34-,35-/m0/s1 D06LYS DRUGINKE HFVNWDWLWUCIHC-GUPDPFMOSA-N D06LYS DRUGSMIL CC12CC(C3C(C1CCC2(C(=O)COC(=O)CCCC4=CC=C(C=C4)N(CCCl)CCCl)O)CCC5=CC(=O)C=CC35C)O D06LYS HIGHSTAT Approved D06MAJ DRUG__ID D06MAJ D06MAJ THERCLAS Antiallergic Agents D06MAJ DRUGTYPE Small molecular drug D06MAJ DRUGINCH 1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32) D06MAJ DRUGINKE PVLJETXTTWAYEW-UHFFFAOYSA-N D06MAJ DRUGSMIL CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5 D06MAJ HIGHSTAT Approved D06MRT DRUG__ID D06MRT D06MRT DRUGCOMP Wakamoto Pharmaceutical Co Ltd D06MRT DRUGTYPE Small molecular drug D06MRT DRUGINCH 1S/C9H7N5O3/c15-8(9(16)17)10-6-3-1-2-5(4-6)7-11-13-14-12-7/h1-4H,(H,10,15)(H,16,17)(H,11,12,13,14) D06MRT DRUGINKE VWQZJJZGISNFOE-UHFFFAOYSA-N D06MRT DRUGSMIL C1=CC(=CC(=C1)NC(=O)C(=O)O)C2=NNN=N2 D06MRT HIGHSTAT Approved D06NSA DRUG__ID D06NSA D06NSA THERCLAS Hypnotics and Sedatives D06NSA DRUGTYPE Small molecular drug D06NSA DRUGINCH 1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17) D06NSA DRUGINKE XLOMZPUITCYLMJ-UHFFFAOYSA-N D06NSA DRUGSMIL CCCC(C)C1(C(=O)NC(=S)NC1=O)CC=C D06NSA HIGHSTAT Approved D06NVJ DRUG__ID D06NVJ D06NVJ THERCLAS Antiinflammatory Agents D06NVJ DRUGTYPE Small molecular drug D06NVJ DRUGINCH 1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9) D06NVJ DRUGINKE DFPAKSUCGFBDDF-UHFFFAOYSA-N D06NVJ DRUGSMIL C1=CC(=CN=C1)C(=O)N D06NVJ HIGHSTAT Approved D06OUL DRUG__ID D06OUL D06OUL THERCLAS Antibiotics D06OUL DRUGTYPE Small molecular drug D06OUL DRUGINCH 1S/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1 D06OUL DRUGINKE SLAYUXIURFNXPG-CRAIPNDOSA-N D06OUL DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O D06OUL HIGHSTAT Approved D06PEB DRUG__ID D06PEB D06PEB THERCLAS Antiarrhythmic Agents D06PEB DRUGTYPE Small molecular drug D06PEB DRUGINCH 1S/C23H28N2O3S/c1-3-23(4-2,22(27)28)14-20(26)24-18-10-5-7-16(13-18)11-12-21-25-19(15-29-21)17-8-6-9-17/h5,7,10-13,15,17H,3-4,6,8-9,14H2,1-2H3,(H,24,26)(H,27,28)/b12-11+ D06PEB DRUGINKE BZMKNPGKXJAIDV-VAWYXSNFSA-N D06PEB DRUGSMIL CCC(CC)(CC(=O)NC1=CC=CC(=C1)C=CC2=NC(=CS2)C3CCC3)C(=O)O D06PEB HIGHSTAT Approved D06PQT DRUG__ID D06PQT D06PQT THERCLAS Vitamins D06PQT DRUGTYPE Small molecular drug D06PQT DRUGINCH 1S/C12H17N4OS.ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);1H/q+1;/p-1 D06PQT DRUGINKE MYVIATVLJGTBFV-UHFFFAOYSA-M D06PQT DRUGSMIL CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.[Cl-] D06PQT HIGHSTAT Approved D06QAK DRUG__ID D06QAK D06QAK TRADNAME Voxzogo D06QAK DRUGCOMP Biomarin pharmaceutical D06QAK DRUGINCH 1S/C176H290N56O51S3/c1-14-95(10)143-172(280)201-84-138(245)209-125(86-234)168(276)221-113(54-65-284-13)159(267)229-124(85-233)152(260)200-81-135(242)206-114(66-91(2)3)150(258)198-83-140(247)211-128(174(282)283)89-286-285-88-127(170(278)224-118(70-98-34-16-15-17-35-98)151(259)199-80-137(244)207-115(67-92(4)5)162(270)217-108(41-23-29-60-182)155(263)223-117(69-94(8)9)164(272)226-122(75-142(250)251)167(275)219-110(160(268)231-143)44-32-63-193-176(188)189)210-139(246)82-197-149(257)105(38-20-26-57-179)215-169(277)126(87-235)230-163(271)116(68-93(6)7)208-136(243)79-196-147(255)103(36-18-24-55-177)213-153(261)106(39-21-27-58-180)218-166(274)121(74-132(185)239)222-144(252)96(11)203-133(240)77-195-148(256)104(37-19-25-56-178)214-165(273)119(71-99-46-48-101(236)49-47-99)225-156(264)107(40-22-28-59-181)216-154(262)109(43-31-62-192-175(186)187)212-145(253)97(12)204-161(269)120(73-131(184)238)227-171(279)129-45-33-64-232(129)173(281)123(72-100-76-190-90-202-100)228-158(266)112(51-53-141(248)249)220-157(265)111(50-52-130(183)237)205-134(241)78-194-146(254)102-42-30-61-191-102/h15-17,34-35,46-49,76,90-97,102-129,143,191,233-236H,14,18-33,36-45,50-75,77-89,177-182H2,1-13H3,(H2,183,237)(H2,184,238)(H2,185,239)(H,190,202)(H,194,254)(H,195,256)(H,196,255)(H,197,257)(H,198,258)(H,199,259)(H,200,260)(H,201,280)(H,203,240)(H,204,269)(H,205,241)(H,206,242)(H,207,244)(H,208,243)(H,209,245)(H,210,246)(H,211,247)(H,212,253)(H,213,261)(H,214,273)(H,215,277)(H,216,262)(H,217,270)(H,218,274)(H,219,275)(H,220,265)(H,221,276)(H,222,252)(H,223,263)(H,224,278)(H,225,264)(H,226,272)(H,227,279)(H,228,266)(H,229,267)(H,230,271)(H,231,268)(H,248,249)(H,250,251)(H,282,283)(H4,186,187,192)(H4,188,189,193)/t95-,96-,97-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,143-/m0/s1 D06QAK DRUGINKE IGYWDDBBJPSOTG-WBAGYEQSSA-N D06QAK DRUGSMIL CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CC(C)C)CCCCN)CC(C)C)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C6CCCN6)C(=O)O)CC(C)C)CO)CCSC)CO D06QAK HIGHSTAT Approved D06QCC DRUG__ID D06QCC D06QCC THERCLAS Antibiotics D06QCC DRUGTYPE Small molecular drug D06QCC DRUGINCH 1S/C16H17N9O5S3/c1-24-16(20-22-23-24)33-4-6-3-31-13-9(12(27)25(13)10(6)14(28)29)19-11(26)8(21-30-2)7-5-32-15(17)18-7/h5,9,13H,3-4H2,1-2H3,(H2,17,18)(H,19,26)(H,28,29)/b21-8-/t9-,13-/m1/s1 D06QCC DRUGINKE HJJDBAOLQAWBMH-YCRCPZNHSA-N D06QCC DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O D06QCC HIGHSTAT Approved D06QKV DRUG__ID D06QKV D06QKV DRUGCOMP Helsinn Group D06QKV DRUGTYPE Small molecular drug D06QKV DRUGINCH 1S/C13H15BrN4O2/c1-19-9-4-7(5-10(20-2)11(9)14)3-8-6-17-13(16)18-12(8)15/h4-6H,3H2,1-2H3,(H4,15,16,17,18) D06QKV DRUGINKE BFCRRLMMHNLSCP-UHFFFAOYSA-N D06QKV DRUGSMIL COC1=CC(=CC(=C1Br)OC)CC2=CN=C(N=C2N)N D06QKV HIGHSTAT Approved D06RUL DRUG__ID D06RUL D06RUL DRUGCOMP Sanofi Aventis Us Llc D06RUL DRUGTYPE Small molecular drug D06RUL DRUGINCH 1S/C28H31NO5/c1-18-6-10-20(11-7-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21/h6-16,23,29-30H,17H2,1-5H3 D06RUL DRUGINKE FZGVEKPRDOIXJY-UHFFFAOYSA-N D06RUL DRUGSMIL CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C D06RUL HIGHSTAT Approved D06SVW DRUG__ID D06SVW D06SVW THERCLAS Hypoglycemic Agents D06SVW DRUGTYPE Small molecular drug D06SVW DRUGINCH 1S/C256H381N65O77S6/c1-29-130(23)202(311-190(337)103-258)250(391)315-200(128(19)20)246(387)286-158(75-82-197(347)348)216(357)281-154(70-77-186(261)333)220(361)306-181-115-402-403-116-182-241(382)303-176(110-323)238(379)293-161(88-122(7)8)224(365)294-167(95-139-53-61-145(328)62-54-139)227(368)282-153(69-76-185(260)332)217(358)289-160(87-121(5)6)222(363)283-157(74-81-196(345)346)219(360)301-173(101-188(263)335)233(374)297-169(97-141-57-65-147(330)66-58-141)230(371)307-180(240(381)302-174(254(395)396)102-189(264)336)114-401-400-113-179(213(354)272-106-191(338)277-152(72-79-194(341)342)215(356)280-150(51-42-84-270-256(266)267)211(352)271-107-192(339)278-165(93-137-46-36-32-37-47-137)226(367)296-166(94-138-48-38-33-39-49-138)229(370)298-170(98-142-59-67-148(331)68-60-142)236(377)318-205(134(27)326)253(394)321-85-43-52-184(321)244(385)284-151(50-40-41-83-257)221(362)319-206(135(28)327)255(397)398)309-247(388)199(127(17)18)314-234(375)163(90-124(11)12)291-228(369)168(96-140-55-63-146(329)64-56-140)295-223(364)159(86-120(3)4)288-209(350)132(25)276-214(355)156(73-80-195(343)344)285-245(386)198(126(15)16)313-235(376)164(91-125(13)14)292-232(373)172(100-144-105-269-119-275-144)300-237(378)175(109-322)279-193(340)108-273-212(353)178(112-399-404-117-183(308-242(181)383)243(384)317-204(133(26)325)251(392)304-177(111-324)239(380)316-203(131(24)30-2)249(390)310-182)305-225(366)162(89-123(9)10)290-231(372)171(99-143-104-268-118-274-143)299-218(359)155(71-78-187(262)334)287-252(393)207(208(265)349)320-248(389)201(129(21)22)312-210(351)149(259)92-136-44-34-31-35-45-136/h31-39,44-49,53-68,104-105,118-135,149-184,198-207,322-331H,29-30,40-43,50-52,69-103,106-117,257-259H2,1-28H3,(H2,260,332)(H2,261,333)(H2,262,334)(H2,263,335)(H2,264,336)(H2,265,349)(H,268,274)(H,269,275)(H,271,352)(H,272,354)(H,273,353)(H,276,355)(H,277,338)(H,278,339)(H,279,340)(H,280,356)(H,281,357)(H,282,368)(H,283,363)(H,284,385)(H,285,386)(H,286,387)(H,287,393)(H,288,350)(H,289,358)(H,290,372)(H,291,369)(H,292,373)(H,293,379)(H,294,365)(H,295,364)(H,296,367)(H,297,374)(H,298,370)(H,299,359)(H,300,378)(H,301,360)(H,302,381)(H,303,382)(H,304,392)(H,305,366)(H,306,361)(H,307,371)(H,308,383)(H,309,388)(H,310,390)(H,311,337)(H,312,351)(H,313,376)(H,314,375)(H,315,391)(H,316,380)(H,317,384)(H,318,377)(H,319,362)(H,320,389)(H,341,342)(H,343,344)(H,345,346)(H,347,348)(H,395,396)(H,397,398)(H4,266,267,270)/t130-,131-,132+,133+,134+,135+,149+,150+,151+,152+,153+,154+,155+,156+,157+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180+,181+,182-,183+,184+,198+,199+,200+,201+,202+,203+,204+,205+,206+,207+/m1/s1 D06SVW DRUGINKE YAJCHEVQCOHZDC-QMMNLEPNSA-N D06SVW DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(C(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D06SVW HIGHSTAT Approved D06TNG DRUG__ID D06TNG D06TNG THERCLAS Antihypertensive Agents D06TNG DRUGTYPE Small molecular drug D06TNG DRUGINCH 1S/C11H13ClF3N3O4S3/c1-18-10(4-23-5-11(13,14)15)17-7-2-6(12)8(24(16,19)20)3-9(7)25(18,21)22/h2-3,10,17H,4-5H2,1H3,(H2,16,19,20) D06TNG DRUGINKE CYLWJCABXYDINA-UHFFFAOYSA-N D06TNG DRUGSMIL CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F D06TNG HIGHSTAT Approved D06TNL DRUG__ID D06TNL D06TNL THERCLAS Diuretics D06TNL DRUGTYPE Small molecular drug D06TNL DRUGINCH 1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17) D06TNL DRUGINKE AVOLMBLBETYQHX-UHFFFAOYSA-N D06TNL DRUGSMIL CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl D06TNL HIGHSTAT Approved D06VNK DRUG__ID D06VNK D06VNK THERCLAS Dietary supplement D06VNK DRUGTYPE Small molecular drug D06VNK DRUGINCH 1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8) D06VNK DRUGINKE KDYFGRWQOYBRFD-UHFFFAOYSA-N D06VNK DRUGSMIL C(CC(=O)O)C(=O)O D06VNK HIGHSTAT Approved D06WKA DRUG__ID D06WKA D06WKA DRUGCOMP Microbia D06WKA DRUGTYPE Small molecular drug D06WKA DRUGINCH 1S/C59H79N15O21S6.C2H4O2/c1-26-47(82)69-41-25-101-99-22-38-52(87)65-33(13-14-45(80)81)49(84)66-34(16-28-5-9-30(76)10-6-28)50(85)71-40(54(89)72-39(23-97-96-20-32(60)48(83)70-38)53(88)67-35(18-43(61)78)58(93)74-15-3-4-42(74)56(91)63-26)24-100-98-21-37(64-44(79)19-62-57(92)46(27(2)75)73-55(41)90)51(86)68-36(59(94)95)17-29-7-11-31(77)12-8-29;1-2(3)4/h5-12,26-27,32-42,46,75-77H,3-4,13-25,60H2,1-2H3,(H2,61,78)(H,62,92)(H,63,91)(H,64,79)(H,65,87)(H,66,84)(H,67,88)(H,68,86)(H,69,82)(H,70,83)(H,71,85)(H,72,89)(H,73,90)(H,80,81)(H,94,95);1H3,(H,3,4)/t26-,27+,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,46-;/m0./s1 D06WKA DRUGINKE KWFNVZFWXXEJKL-YZDVLOIKSA-N D06WKA DRUGSMIL CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O.CC(=O)O D06WKA HIGHSTAT Approved D06XGW DRUG__ID D06XGW D06XGW DRUGCOMP Cumberland Pharmaceuticals Inc; RxKinetix D06XGW DRUGTYPE Small molecular drug D06XGW DRUGINCH 1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1 D06XGW DRUGINKE PWKSKIMOESPYIA-BYPYZUCNSA-N D06XGW DRUGSMIL CC(=O)NC(CS)C(=O)O D06XGW HIGHSTAT Approved D06XHC DRUG__ID D06XHC D06XHC THERCLAS Antiinflammatory Agents D06XHC DRUGTYPE Small molecular drug D06XHC DRUGINCH 1S/C28H35FO7/c1-16(30)34-15-22(33)28-23(35-26(36-28)9-4-5-10-26)13-20-19-7-6-17-12-18(31)8-11-24(17,2)27(19,29)21(32)14-25(20,28)3/h8,11-12,19-21,23,32H,4-7,9-10,13-15H2,1-3H3/t19-,20-,21-,23+,24-,25-,27-,28+/m0/s1 D06XHC DRUGINKE ILKJAFIWWBXGDU-MOGDOJJUSA-N D06XHC DRUGSMIL CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CCC5=CC(=O)C=CC54C)F)O)C)OC6(O2)CCCC6 D06XHC HIGHSTAT Approved D06XMU DRUG__ID D06XMU D06XMU DRUGCOMP Ardana Bioscience D06XMU DRUGTYPE Small molecular drug D06XMU DRUGINCH 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1 D06XMU DRUGINKE MUMGGOZAMZWBJJ-DYKIIFRCSA-N D06XMU DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C D06XMU HIGHSTAT Approved D06YYD DRUG__ID D06YYD D06YYD DRUGCOMP Takeda D06YYD DRUGTYPE Small molecular drug D06YYD DRUGINCH 1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m1/s1 D06YYD DRUGINKE MJIHNNLFOKEZEW-RUZDIDTESA-N D06YYD DRUGSMIL CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F D06YYD HIGHSTAT Approved D06ZAY DRUG__ID D06ZAY D06ZAY THERCLAS Antifungal Agents D06ZAY DRUGTYPE Small molecular drug D06ZAY DRUGINCH 1S/C9H4Cl3IO/c10-6-4-8(12)9(5-7(6)11)14-3-1-2-13/h4-5H,3H2 D06ZAY DRUGINKE CTETYYAZBPJBHE-UHFFFAOYSA-N D06ZAY DRUGSMIL C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI D06ZAY HIGHSTAT Approved D06ZEO DRUG__ID D06ZEO D06ZEO DRUGCOMP Bayer HealthCare Pharmaceuticals D06ZEO DRUGTYPE Small molecular drug D06ZEO DRUGINCH 1S/C19H16F2N8O2/c1-31-19(30)25-14-15(22)26-17(27-16(14)23)13-11-6-10(20)7-24-18(11)29(28-13)8-9-4-2-3-5-12(9)21/h2-7H,8H2,1H3,(H,25,30)(H4,22,23,26,27) D06ZEO DRUGINKE QZFHIXARHDBPBY-UHFFFAOYSA-N D06ZEO DRUGSMIL COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N D06ZEO HIGHSTAT Approved D06ZPS DRUG__ID D06ZPS D06ZPS DRUGCOMP Novartis Pharmaceuticals Corp D06ZPS DRUGTYPE Small molecular drug D06ZPS DRUGINCH 1S/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3 D06ZPS DRUGINKE HFHZKZSRXITVMK-UHFFFAOYSA-N D06ZPS DRUGSMIL CCCCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3 D06ZPS HIGHSTAT Approved D06ZUP DRUG__ID D06ZUP D06ZUP THERCLAS Antibiotics D06ZUP DRUGTYPE Small molecular drug D06ZUP DRUGINCH 1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37-,39+,40-,41-,42-/m1/s1 D06ZUP DRUGINKE WLOHNSSYAXHWNR-DWIOZXRMSA-N D06ZUP DRUGSMIL CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O D06ZUP HIGHSTAT Approved D06ZVG DRUG__ID D06ZVG D06ZVG DRUGCOMP Kureha Corp D06ZVG DRUGTYPE Small molecular drug D06ZVG DRUGINCH 1S/CH4/h1H4 D06ZVG DRUGINKE VNWKTOKETHGBQD-UHFFFAOYSA-N D06ZVG DRUGSMIL C D06ZVG HIGHSTAT Approved D07AAN DRUG__ID D07AAN D07AAN DRUGCOMP Ge Healthcare D07AAN DRUGTYPE Small molecular drug D07AAN DRUGINCH 1S/HI.Na/h1H;/q;+1/p-1/i1-4; D07AAN DRUGINKE FVAUCKIRQBBSSJ-VVUPZWBASA-M D07AAN DRUGSMIL [Na+].[I-] D07AAN HIGHSTAT Approved D07AHW DRUG__ID D07AHW D07AHW THERCLAS Vitamins D07AHW DRUGTYPE Small molecular drug D07AHW DRUGINCH 1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1 D07AHW DRUGINKE CIWBSHSKHKDKBQ-JLAZNSOCSA-N D07AHW DRUGSMIL C(C(C1C(=C(C(=O)O1)O)O)O)O D07AHW HIGHSTAT Approved D07BPS DRUG__ID D07BPS D07BPS THERCLAS Antiinflammatory Agents D07BPS DRUGTYPE Small molecular drug D07BPS DRUGINCH 1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17) D07BPS DRUGINKE MDKGKXOCJGEUJW-UHFFFAOYSA-N D07BPS DRUGSMIL CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O D07BPS HIGHSTAT Approved D07BSQ DRUG__ID D07BSQ D07BSQ DRUGCOMP Lipocine Inc D07BSQ DRUGTYPE Small molecular drug D07BSQ DRUGINCH 1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 D07BSQ DRUGINKE RJKFOVLPORLFTN-LEKSSAKUSA-N D07BSQ DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C D07BSQ HIGHSTAT Approved D07BYK DRUG__ID D07BYK D07BYK THERCLAS Antiviral Agents D07BYK DRUGTYPE Small molecular drug D07BYK DRUGINCH 1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18) D07BYK DRUGINKE JNTOCHDNEULJHD-UHFFFAOYSA-N D07BYK DRUGSMIL C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N D07BYK HIGHSTAT Approved D07CEI DRUG__ID D07CEI D07CEI DRUGCOMP Abraxis Pharmaceutical Products D07CEI DRUGTYPE Small molecular drug D07CEI DRUGINCH 1S/H2O4S.Zn/c1-5(2,3)4;/h(H2,1,2,3,4);/q;+2/p-2 D07CEI DRUGINKE NWONKYPBYAMBJT-UHFFFAOYSA-L D07CEI DRUGSMIL [O-]S(=O)(=O)[O-].[Zn+2] D07CEI HIGHSTAT Approved D07CNL DRUG__ID D07CNL D07CNL THERCLAS Anticholinergic Agents D07CNL DRUGTYPE Small molecular drug D07CNL DRUGINCH 1S/C17H32NO2.BrH/c1-5-7-13(8-6-2)17(19)20-16-11-14-9-10-15(12-16)18(14,3)4;/h13-16H,5-12H2,1-4H3;1H/q+1;/p-1/t14-,15+,16?; D07CNL DRUGINKE QSFKGMJOKUZAJM-JXMYBXCISA-M D07CNL DRUGSMIL CCCC(CCC)C(=O)OC1CC2CCC(C1)[N+]2(C)C.[Br-] D07CNL HIGHSTAT Approved D07CWD DRUG__ID D07CWD D07CWD THERCLAS Anticancer Agents D07CWD DRUGTYPE Small molecular drug D07CWD DRUGINCH 1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4) D07CWD DRUGINKE VSNHCAURESNICA-UHFFFAOYSA-N D07CWD DRUGSMIL C(=O)(N)NO D07CWD HIGHSTAT Approved D07DCG DRUG__ID D07DCG D07DCG TRADNAME Tibsovo D07DCG DRUGCOMP Agios Pharmaceuticals D07DCG DRUGINCH 1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1 D07DCG DRUGINKE WIJZXSAJMHAVGX-DHLKQENFSA-N D07DCG DRUGSMIL C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N D07DCG HIGHSTAT Approved D07DIM DRUG__ID D07DIM D07DIM THERCLAS Anticancer Agents D07DIM DRUGTYPE Small molecular drug D07DIM DRUGINCH 1S/C30H42N2O9/c1-16-10-9-11-23(37-5)28(41-30(31)36)18(3)12-17(2)27(40-8)24(38-6)13-19(4)26(39-7)21-14-20(33)15-22(25(21)34)32-29(16)35/h9-12,14-15,17,19,23-24,26-28H,13H2,1-8H3,(H2,31,36)(H,32,35)/b11-9-,16-10+,18-12+/t17-,19-,23-,24-,26+,27+,28-/m0/s1 D07DIM DRUGINKE MCAHMSDENAOJFZ-BVXDHVRPSA-N D07DIM DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C=C(C1OC)C2=O)C)OC)OC(=O)N)C)C)OC)OC D07DIM HIGHSTAT Approved D07ESC DRUG__ID D07ESC D07ESC DRUGCOMP Celgene D07ESC DRUGTYPE Small molecular drug D07ESC DRUGINCH 1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1 D07ESC DRUGINKE IMOZEMNVLZVGJZ-QGZVFWFLSA-N D07ESC DRUGSMIL CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC D07ESC HIGHSTAT Approved D07FKQ DRUG__ID D07FKQ D07FKQ DRUGCOMP Novartis D07FKQ DRUGTYPE Small molecular drug D07FKQ DRUGINCH 1S/C29H35F3N2O3/c1-3-21-14-23(10-11-24(21)15-34-16-25(17-34)28(35)36)19(2)33-37-18-20-9-12-26(22-7-5-4-6-8-22)27(13-20)29(30,31)32/h9-14,22,25H,3-8,15-18H2,1-2H3,(H,35,36)/b33-19+ D07FKQ DRUGINKE KIHYPELVXPAIDH-HNSNBQBZSA-N D07FKQ DRUGSMIL CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O D07FKQ HIGHSTAT Approved D07FTD DRUG__ID D07FTD D07FTD DRUGCOMP Chesebrough Ponds Inc D07FTD DRUGTYPE Small molecular drug D07FTD DRUGINCH 1S/FH2O3P.2Na/c1-5(2,3)4;;/h(H2,2,3,4);;/q;2*+1/p-2 D07FTD DRUGINKE BFDWBSRJQZPEEB-UHFFFAOYSA-L D07FTD DRUGSMIL [O-]P(=O)([O-])F.[Na+].[Na+] D07FTD HIGHSTAT Approved D07FUJ DRUG__ID D07FUJ D07FUJ DRUGCOMP Novartis Pharmaceuticals Corp D07FUJ DRUGTYPE Small molecular drug D07FUJ DRUGINCH 1S/C20H12O5.2Na/c21-11-5-7-15-17(9-11)25-18-10-12(22)6-8-16(18)19(15)13-3-1-2-4-14(13)20(23)24;;/h1-10,21H,(H,23,24);;/q;2*+1/p-2 D07FUJ DRUGINKE NJDNXYGOVLYJHP-UHFFFAOYSA-L D07FUJ DRUGSMIL C1=CC=C(C(=C1)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)[O-])C(=O)[O-].[Na+].[Na+] D07FUJ HIGHSTAT Approved D07GNP DRUG__ID D07GNP D07GNP DRUGCOMP Schering AG D07GNP DRUGTYPE Small molecular drug D07GNP DRUGINCH 1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29) D07GNP DRUGINKE DGAIEPBNLOQYER-UHFFFAOYSA-N D07GNP DRUGSMIL CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I D07GNP HIGHSTAT Approved D07GRH DRUG__ID D07GRH D07GRH THERCLAS Antifungal Agents D07GRH DRUGTYPE Small molecular drug D07GRH DRUGINCH 1S/C12H17NO2/c1-9-7-11(13(15)12(14)8-9)10-5-3-2-4-6-10/h7-8,10,15H,2-6H2,1H3 D07GRH DRUGINKE SCKYRAXSEDYPSA-UHFFFAOYSA-N D07GRH DRUGSMIL CC1=CC(=O)N(C(=C1)C2CCCCC2)O D07GRH HIGHSTAT Approved D07GTW DRUG__ID D07GTW D07GTW DRUGCOMP Orphatec Pharmaceuticals GmbH D07GTW DRUGTYPE Small molecular drug D07GTW DRUGINCH 1S/C10H14N5O8P/c11-9-14-6-3(7(16)15-9)12-4-8(13-6)22-2-1-21-24(19,20)23-5(2)10(4,17)18/h2,4-5,8,12,17-18H,1H2,(H,19,20)(H4,11,13,14,15,16)/t2-,4-,5+,8-/m1/s1 D07GTW DRUGINKE CZAKJJUNKNPTTO-AJFJRRQVSA-N D07GTW DRUGSMIL C1C2C(C(C3C(O2)NC4=C(N3)C(=O)NC(=N4)N)(O)O)OP(=O)(O1)O D07GTW HIGHSTAT Approved D07GXR DRUG__ID D07GXR D07GXR DRUGCOMP Merck D07GXR DRUGTYPE Small molecular drug D07GXR DRUGINCH 1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1 D07GXR DRUGINKE DDOOFTLHJSMHLN-ZQHRPCGSSA-N D07GXR DRUGSMIL CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6 D07GXR HIGHSTAT Approved D07HBX DRUG__ID D07HBX D07HBX THERCLAS Antiinflammatory Agents D07HBX DRUGTYPE Small molecular drug D07HBX DRUGINCH 1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10) D07HBX DRUGINKE YGSDEFSMJLZEOE-UHFFFAOYSA-N D07HBX DRUGSMIL C1=CC=C(C(=C1)C(=O)O)O D07HBX HIGHSTAT Approved D07HVY DRUG__ID D07HVY D07HVY THERCLAS Anti-HIV Agents D07HVY DRUGTYPE Small molecular drug D07HVY DRUGINCH 1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1 D07HVY DRUGINKE XPOQHMRABVBWPR-ZDUSSCGKSA-N D07HVY DRUGSMIL C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F D07HVY HIGHSTAT Approved D07ILQ DRUG__ID D07ILQ D07ILQ DRUGCOMP Shire D07ILQ DRUGTYPE Small molecular drug D07ILQ DRUGINCH 1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21) D07ILQ DRUGINKE HXYVTAGFYLMHSO-UHFFFAOYSA-N D07ILQ DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCO D07ILQ HIGHSTAT Approved D07INV DRUG__ID D07INV D07INV THERCLAS Diuretics D07INV DRUGTYPE Small molecular drug D07INV DRUGINCH 1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13) D07INV DRUGINKE OUZWUKMCLIBBOG-UHFFFAOYSA-N D07INV DRUGSMIL CCOC1=CC2=C(C=C1)N=C(S2)S(=O)(=O)N D07INV HIGHSTAT Approved D07IPB DRUG__ID D07IPB D07IPB THERCLAS Anticancer Agents D07IPB DRUGTYPE Small molecular drug D07IPB DRUGINCH 1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1 D07IPB DRUGINKE ZOCKGBMQLCSHFP-KQRAQHLDSA-N D07IPB DRUGSMIL CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O D07IPB HIGHSTAT Approved D07IRF DRUG__ID D07IRF D07IRF DRUGCOMP Lilly; Daiichi Sankyo D07IRF DRUGTYPE Small molecular drug D07IRF DRUGINCH 1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3 D07IRF DRUGINKE DTGLZDAWLRGWQN-UHFFFAOYSA-N D07IRF DRUGSMIL CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4 D07IRF HIGHSTAT Approved D07JGT DRUG__ID D07JGT D07JGT THERCLAS Antibiotics D07JGT DRUGTYPE Small molecular drug D07JGT DRUGINCH 1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17) D07JGT DRUGINKE MHWLWQUZZRMNGJ-UHFFFAOYSA-N D07JGT DRUGSMIL CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O D07JGT HIGHSTAT Approved D07JJS DRUG__ID D07JJS D07JJS THERCLAS Antiinfective Agents D07JJS DRUGTYPE Small molecular drug D07JJS DRUGINCH 1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13) D07JJS DRUGINKE VACCAVUAMIDAGB-UHFFFAOYSA-N D07JJS DRUGSMIL CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N D07JJS HIGHSTAT Approved D07JPC DRUG__ID D07JPC D07JPC DRUGCOMP Meiji Seika D07JPC DRUGTYPE Small molecular drug D07JPC DRUGINCH 1S/C22H44N6O10/c23-4-3-12(30)20(34)28-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)17(33)19(11)38-22-16(32)14(27)15(31)13(7-29)36-22/h8-19,21-22,29-33H,1-7,23-27H2,(H,28,34)/t8-,9+,10-,11+,12-,13+,14-,15+,16+,17-,18+,19-,21+,22+/m0/s1 D07JPC DRUGINKE MKKYBZZTJQGVCD-XTCKQBCOSA-N D07JPC DRUGSMIL C1CC(C(OC1CN)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CO)O)N)O)NC(=O)C(CCN)O)N)N D07JPC HIGHSTAT Approved D07JVL DRUG__ID D07JVL D07JVL DRUGCOMP Archimedes Pharma Ltd D07JVL DRUGTYPE Small molecular drug D07JVL DRUGINCH 1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3 D07JVL DRUGINKE AAOVKJBEBIDNHE-UHFFFAOYSA-N D07JVL DRUGSMIL CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 D07JVL HIGHSTAT Approved D07KHH DRUG__ID D07KHH D07KHH DRUGCOMP Almirall D07KHH DRUGTYPE Small molecular drug D07KHH DRUGINCH 1S/C26H30NO4S2.BrH/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21;/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2;1H/q+1;/p-1/t20?,22-,27?;/m0./s1 D07KHH DRUGINKE XLAKJQPTOJHYDR-QTQXQZBYSA-M D07KHH DRUGSMIL C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-] D07KHH HIGHSTAT Approved D07KUN DRUG__ID D07KUN D07KUN TRADNAME Orserdu D07KUN DRUGCOMP Menarini D07KUN DRUGINCH 1S/C30H38N2O2/c1-4-31-17-16-22-6-8-23(9-7-22)21-32(5-2)30-20-28(34-3)14-15-29(30)26-11-10-25-19-27(33)13-12-24(25)18-26/h6-9,12-15,19-20,26,31,33H,4-5,10-11,16-18,21H2,1-3H3/t26-/m1/s1 D07KUN DRUGINKE SIFNOOUKXBRGGB-AREMUKBSSA-N D07KUN DRUGSMIL CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O D07KUN HIGHSTAT Approved D07LCF DRUG__ID D07LCF D07LCF DRUGCOMP AstraZeneca D07LCF DRUGTYPE Small molecular drug D07LCF DRUGINCH 1S/C34H53NO11/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2/h3-5,28-29,32,36-37H,1,6-25H2,2H3/t28-,29+,32-,33-,34+/m0/s1 D07LCF DRUGINKE XNKCCCKFOQNXKV-ZRSCBOBOSA-N D07LCF DRUGSMIL COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O D07LCF HIGHSTAT Approved D07MGA DRUG__ID D07MGA D07MGA THERCLAS Anticholesteremic Agents D07MGA DRUGTYPE Small molecular drug D07MGA DRUGINCH 1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1 D07MGA DRUGINKE AIONOLUJZLIMTK-AWEZNQCLSA-N D07MGA DRUGSMIL COC1=C(C=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O D07MGA HIGHSTAT Approved D07MUN DRUG__ID D07MUN D07MUN THERCLAS Vitamins D07MUN DRUGTYPE Small molecular drug D07MUN DRUGINCH 1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3 D07MUN DRUGINKE LXNHXLLTXMVWPM-UHFFFAOYSA-N D07MUN DRUGSMIL CC1=NC=C(C(=C1O)CO)CO D07MUN HIGHSTAT Approved D07NCN DRUG__ID D07NCN D07NCN DRUGCOMP ABC S.p.A. D07NCN DRUGTYPE Small molecular drug D07NCN DRUGINCH 1S/C11H14N4O4/c1-13-9-8(10(16)14(2)11(13)17)15(6-12-9)5-7-18-3-4-19-7/h6-7H,3-5H2,1-2H3 D07NCN DRUGINKE HWXIGFIVGWUZAO-UHFFFAOYSA-N D07NCN DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3 D07NCN HIGHSTAT Approved D07NGZ DRUG__ID D07NGZ D07NGZ THERCLAS Hypoglycemic Agents D07NGZ DRUGTYPE Small molecular drug D07NGZ DRUGINCH 1S/C267H404N72O78S6/c1-29-137(23)212(330-199(355)109-269)260(412)334-211(136(21)22)256(408)305-166(79-86-206(365)366)226(378)298-163(75-82-196(273)352)230(382)326-190-122-421-422-123-191-251(403)322-185(117-341)249(401)312-170(94-129(7)8)234(386)313-176(101-146-57-65-152(346)66-58-146)237(389)299-161(73-80-194(271)350)227(379)308-169(93-128(5)6)232(384)301-165(78-85-205(363)364)229(381)320-182(107-197(274)353)244(396)316-178(103-148-61-69-154(348)70-62-148)240(392)325-188(222(374)290-115-207(367)368)120-418-420-121-189(221(373)288-112-200(356)294-160(76-83-203(359)360)225(377)297-157(53-42-88-284-265(276)277)219(371)287-113-201(357)295-174(99-144-48-36-32-37-49-144)236(388)315-175(100-145-50-38-33-39-51-145)239(391)317-179(104-149-63-71-155(349)72-64-149)247(399)338-216(142(28)345)263(415)339-91-45-56-193(339)254(406)302-158(52-40-41-87-268)231(383)336-214(140(26)343)261(413)303-159(54-43-89-285-266(278)279)224(376)306-167(264(416)417)55-44-90-286-267(280)281)328-258(410)210(135(19)20)333-245(397)172(96-131(11)12)310-238(390)177(102-147-59-67-153(347)68-60-147)314-233(385)168(92-127(3)4)307-217(369)139(25)293-223(375)164(77-84-204(361)362)304-255(407)209(134(17)18)332-246(398)173(97-132(13)14)311-242(394)181(106-151-111-283-126-292-151)319-248(400)184(116-340)296-202(358)114-289-220(372)187(119-419-423-124-192(327-252(190)404)253(405)337-215(141(27)344)262(414)323-186(118-342)250(402)335-213(138(24)30-2)259(411)329-191)324-235(387)171(95-130(9)10)309-241(393)180(105-150-110-282-125-291-150)318-228(380)162(74-81-195(272)351)300-243(395)183(108-198(275)354)321-257(409)208(133(15)16)331-218(370)156(270)98-143-46-34-31-35-47-143/h31-39,46-51,57-72,110-111,125-142,156-193,208-216,340-349H,29-30,40-45,52-56,73-109,112-124,268-270H2,1-28H3,(H2,271,350)(H2,272,351)(H2,273,352)(H2,274,353)(H2,275,354)(H,282,291)(H,283,292)(H,287,371)(H,288,373)(H,289,372)(H,290,374)(H,293,375)(H,294,356)(H,295,357)(H,296,358)(H,297,377)(H,298,378)(H,299,389)(H,300,395)(H,301,384)(H,302,406)(H,303,413)(H,304,407)(H,305,408)(H,306,376)(H,307,369)(H,308,379)(H,309,393)(H,310,390)(H,311,394)(H,312,401)(H,313,386)(H,314,385)(H,315,388)(H,316,396)(H,317,391)(H,318,380)(H,319,400)(H,320,381)(H,321,409)(H,322,403)(H,323,414)(H,324,387)(H,325,392)(H,326,382)(H,327,404)(H,328,410)(H,329,411)(H,330,355)(H,331,370)(H,332,398)(H,333,397)(H,334,412)(H,335,402)(H,336,383)(H,337,405)(H,338,399)(H,359,360)(H,361,362)(H,363,364)(H,365,366)(H,367,368)(H,416,417)(H4,276,277,284)(H4,278,279,285)(H4,280,281,286)/t137-,138-,139-,140+,141+,142+,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,208-,209-,210-,211-,212-,213-,214-,215-,216-/m0/s1 D07NGZ DRUGINKE COCFEDIXXNGUNL-RFKWWTKHSA-N D07NGZ DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NCC(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D07NGZ HIGHSTAT Approved D07NJI DRUG__ID D07NJI D07NJI DRUGCOMP GSK D07NJI DRUGTYPE Small molecular drug D07NJI DRUGINCH 1S/C14H21N3O2S.C14H14O3.C4H6O4.Na/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;5-3(6)1-2-4(7)8;/h4-5,8-9,15-16H,6-7,10H2,1-3H3;3-9H,1-2H3,(H,15,16);1-2H2,(H,5,6)(H,7,8);/q;;;+1/p-1/t;9-;;/m.0../s1 D07NJI DRUGINKE IGRAQVLKCQVBQA-DBQHITQZSA-M D07NJI DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O.[Na+] D07NJI HIGHSTAT Approved D07NSU DRUG__ID D07NSU D07NSU THERCLAS Antiinflammatory Agents D07NSU DRUGTYPE Small molecular drug D07NSU DRUGINCH 1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1 D07NSU DRUGINKE MSWZFWKMSRAUBD-IVMDWMLBSA-N D07NSU DRUGSMIL C(C1C(C(C(C(O1)O)N)O)O)O D07NSU HIGHSTAT Approved D07OHO DRUG__ID D07OHO D07OHO DRUGCOMP Pfizer Inc D07OHO DRUGTYPE Small molecular drug D07OHO DRUGINCH 1S/C20H21N3O7S/c1-4-28-20(25)30-13(2)29-18-14-9-5-6-10-15(14)31(26,27)23(3)17(18)19(24)22-16-11-7-8-12-21-16/h5-13H,4H2,1-3H3,(H,21,22,24) D07OHO DRUGINKE LSNWBKACGXCGAJ-UHFFFAOYSA-N D07OHO DRUGSMIL CCOC(=O)OC(C)OC1=C(N(S(=O)(=O)C2=CC=CC=C21)C)C(=O)NC3=CC=CC=N3 D07OHO HIGHSTAT Approved D07OIX DRUG__ID D07OIX D07OIX THERCLAS Contrast Media D07OIX DRUGTYPE Small molecular drug D07OIX DRUGINCH 1S/C20H14I6N2O6/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34) D07OIX DRUGINKE FFINMCNLQNTKLU-UHFFFAOYSA-N D07OIX DRUGSMIL C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I D07OIX HIGHSTAT Approved D07OJZ DRUG__ID D07OJZ D07OJZ DRUGCOMP Incyte D07OJZ DRUGTYPE Small molecular drug D07OJZ DRUGINCH 1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31) D07OJZ DRUGINKE LIOLIMKSCNQPLV-UHFFFAOYSA-N D07OJZ DRUGSMIL CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F D07OJZ HIGHSTAT Approved D07ONP DRUG__ID D07ONP D07ONP THERCLAS Anticonvulsants D07ONP DRUGTYPE Small molecular drug D07ONP DRUGINCH 1S/C9H10N2O2/c10-9(13)11-8(12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,10,11,12,13) D07ONP DRUGINKE XPFRXWCVYUEORT-UHFFFAOYSA-N D07ONP DRUGSMIL C1=CC=C(C=C1)CC(=O)NC(=O)N D07ONP HIGHSTAT Approved D07PCI DRUG__ID D07PCI D07PCI THERCLAS Abortifacient Agents D07PCI DRUGTYPE Small molecular drug D07PCI DRUGINCH 1S/C21H36O5.C4H11NO3/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25;5-4(1-6,2-7)3-8/h5,7,12,14,16-19,22-23,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25);6-8H,1-3,5H2/b7-5-,14-12+;/t16-,17-,18+,19-,21+;/m1./s1 D07PCI DRUGINKE UMMADZJLZAPZAW-XOWPVRJPSA-N D07PCI DRUGSMIL CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O.C(C(CO)(CO)N)O D07PCI HIGHSTAT Approved D07QAR DRUG__ID D07QAR D07QAR DRUGCOMP Pfizer D07QAR DRUGTYPE Small molecular drug D07QAR DRUGINCH 1S/C88H100Cl2N10O28/c1-38(2)13-10-8-6-7-9-11-14-61(106)94-70-73(109)75(111)78(86(120)121)128-87(70)127-77-58-31-43-32-59(77)124-55-24-19-42(29-50(55)89)71(107)69-85(119)98-67(80(114)92-25-12-26-100(4)5)48-33-44(102)34-57(125-88-76(112)74(110)72(108)60(37-101)126-88)62(48)47-28-40(17-22-52(47)103)65(82(116)99-69)95-83(117)66(43)96-84(118)68-49-35-46(36-54(105)63(49)90)123-56-30-41(18-23-53(56)104)64(91-3)81(115)93-51(79(113)97-68)27-39-15-20-45(122-58)21-16-39/h15-24,28-36,38,51,60,64-76,78,87-88,91,101-105,107-112H,6-14,25-27,37H2,1-5H3,(H,92,114)(H,93,115)(H,94,106)(H,95,117)(H,96,118)(H,97,113)(H,98,119)(H,99,116)(H,120,121)/t51-,60-,64-,65-,66-,67+,68+,69+,70-,71-,72-,73-,74+,75+,76+,78+,87-,88+/m1/s1 D07QAR DRUGINKE KGPGQDLTDHGEGT-SZUNQUCBSA-N D07QAR DRUGSMIL CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O D07QAR HIGHSTAT Approved D07QFP DRUG__ID D07QFP D07QFP DRUGCOMP Sanofi-Aventis D07QFP DRUGTYPE Small molecular drug D07QFP DRUGINCH 1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7- D07QFP DRUGINKE UTNUDOFZCWSZMS-YFHOEESVSA-N D07QFP DRUGSMIL CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O D07QFP HIGHSTAT Approved D07QPM DRUG__ID D07QPM D07QPM DRUGCOMP Mission Pharmacal Co D07QPM DRUGTYPE Small molecular drug D07QPM DRUGINCH 1S/C6H8O7.3K/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3 D07QPM DRUGINKE QEEAPRPFLLJWCF-UHFFFAOYSA-K D07QPM DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+] D07QPM HIGHSTAT Approved D07SOO DRUG__ID D07SOO D07SOO THERCLAS Anesthetics D07SOO DRUGTYPE Small molecular drug D07SOO DRUGINCH 1S/C3H4Cl2F2O/c1-8-3(6,7)2(4)5/h2H,1H3 D07SOO DRUGINKE RFKMCNOHBTXSMU-UHFFFAOYSA-N D07SOO DRUGSMIL COC(C(Cl)Cl)(F)F D07SOO HIGHSTAT Approved D07TGN DRUG__ID D07TGN D07TGN THERCLAS Antiarrhythmic Agents D07TGN DRUGTYPE Small molecular drug D07TGN DRUGINCH 1S/C47H74O19/c1-20-41(64-36-16-30(50)42(21(2)60-36)65-37-17-31(51)43(22(3)61-37)66-44-40(56)39(55)38(54)32(18-48)63-44)29(49)15-35(59-20)62-25-8-10-45(4)24(13-25)6-7-27-28(45)14-33(52)46(5)26(9-11-47(27,46)57)23-12-34(53)58-19-23/h12,20-22,24-33,35-44,48-52,54-57H,6-11,13-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27-,28+,29+,30+,31+,32-,33-,35+,36+,37+,38-,39+,40-,41-,42-,43-,44+,45+,46+,47+/m1/s1 D07TGN DRUGINKE OBATZBGFDSVCJD-LALPQLPRSA-N D07TGN DRUGSMIL CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)O)O D07TGN HIGHSTAT Approved D07TGY DRUG__ID D07TGY D07TGY DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D07TGY DRUGTYPE Small molecular drug D07TGY DRUGINCH 1S/C14H17NO2/c1-3-11-4-2-6-14(13(11)5-1)17-10-12-9-15-7-8-16-12/h1-4,6,12,15H,5,7-10H2 D07TGY DRUGINKE MADRVGBADLFHMO-UHFFFAOYSA-N D07TGY DRUGSMIL C1COC(CN1)COC2=CC=CC3=C2CC=C3 D07TGY HIGHSTAT Approved D07TOK DRUG__ID D07TOK D07TOK TRADNAME Vitrakvi D07TOK DRUGCOMP Loxo Oncology/Bayer D07TOK DRUGINCH 1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1 D07TOK DRUGINKE NYNZQNWKBKUAII-KBXCAEBGSA-N D07TOK DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F D07TOK HIGHSTAT Approved D07UBG DRUG__ID D07UBG D07UBG THERCLAS Antihypertensive Agents D07UBG DRUGTYPE Small molecular drug D07UBG DRUGINCH 1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) D07UBG DRUGINKE UQGKUQLKSCSZGY-UHFFFAOYSA-N D07UBG DRUGSMIL CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O D07UBG HIGHSTAT Approved D07UHS DRUG__ID D07UHS D07UHS DRUGCOMP Novartis D07UHS DRUGTYPE Small molecular drug D07UHS DRUGINCH 1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3 D07UHS DRUGINKE KKGQTZUTZRNORY-UHFFFAOYSA-N D07UHS DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N D07UHS HIGHSTAT Approved D07URD DRUG__ID D07URD D07URD TRADNAME Elfabrio D07URD DRUGCOMP Protalix biotherapeutics D07URD DRUGINCH 1S/C24H44N6O9/c25-17(23(35)36)5-1-3-11-27-19(31)7-9-21(33)29-13-15-39-16-14-30-22(34)10-8-20(32)28-12-4-2-6-18(26)24(37)38/h17-18H,1-16,25-26H2,(H,27,31)(H,28,32)(H,29,33)(H,30,34)(H,35,36)(H,37,38)/t17-,18-/m0/s1 D07URD DRUGINKE CQPWQUAJPPFCDP-ROUUACIJSA-N D07URD DRUGSMIL C(CCNC(=O)CCC(=O)NCCOCCNC(=O)CCC(=O)NCCCCC(C(=O)O)N)CC(C(=O)O)N D07URD HIGHSTAT Approved D07UWV DRUG__ID D07UWV D07UWV THERCLAS Anticoagulants D07UWV DRUGTYPE Small molecular drug D07UWV DRUGINCH 1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1 D07UWV DRUGINKE KXNPVXPOPUZYGB-IOVMHBDKSA-N D07UWV DRUGSMIL CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C D07UWV HIGHSTAT Approved D07UXP DRUG__ID D07UXP D07UXP THERCLAS Antiinfective Agents D07UXP DRUGTYPE Small molecular drug D07UXP DRUGINCH 1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17) D07UXP DRUGINKE VDUWPHTZYNWKRN-UHFFFAOYSA-N D07UXP DRUGSMIL CCN1C2=CC3=C(C=C2C(=O)C(=N1)C(=O)O)OCO3 D07UXP HIGHSTAT Approved D07VBA DRUG__ID D07VBA D07VBA DRUGCOMP Par Sterile Products Llc D07VBA DRUGTYPE Small molecular drug D07VBA DRUGINCH 1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1 D07VBA DRUGINKE RSEPBGGWRJCQGY-RBRWEJTLSA-N D07VBA DRUGSMIL CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C D07VBA HIGHSTAT Approved D07VHR DRUG__ID D07VHR D07VHR THERCLAS Analgesics D07VHR DRUGTYPE Small molecular drug D07VHR DRUGINCH 1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3 D07VHR DRUGINKE VYMDGNCVAMGZFE-UHFFFAOYSA-N D07VHR DRUGSMIL CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3 D07VHR HIGHSTAT Approved D07VIK DRUG__ID D07VIK D07VIK THERCLAS Anticancer Agents D07VIK DRUGTYPE Small molecular drug D07VIK DRUGINCH 1S/2As.3O/q2*+3;3*-2 D07VIK DRUGINKE QTLQKAJBUDWPIB-UHFFFAOYSA-N D07VIK DRUGSMIL [O-2].[O-2].[O-2].[As+3].[As+3] D07VIK HIGHSTAT Approved D07VYP DRUG__ID D07VYP D07VYP TRADNAME Rezlidhia D07VYP DRUGCOMP Rigel/Forma D07VYP DRUGINCH 1S/C18H15ClN4O2/c1-10(21-16-6-4-13(9-20)23(2)18(16)25)14-8-11-7-12(19)3-5-15(11)22-17(14)24/h3-8,10,21H,1-2H3,(H,22,24)/t10-/m0/s1 D07VYP DRUGINKE NEQYWYXGTJDAKR-JTQLQIEISA-N D07VYP DRUGSMIL CC(C1=CC2=C(C=CC(=C2)Cl)NC1=O)NC3=CC=C(N(C3=O)C)C#N D07VYP HIGHSTAT Approved D07WEP DRUG__ID D07WEP D07WEP THERCLAS Antihypertensive Agents D07WEP DRUGTYPE Small molecular drug D07WEP DRUGINCH 1S/C8H7ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-4H,1H3,(H,10,11) D07WEP DRUGINKE GDLBFKVLRPITMI-UHFFFAOYSA-N D07WEP DRUGSMIL CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl D07WEP HIGHSTAT Approved D07WFK DRUG__ID D07WFK D07WFK THERCLAS Hypoglycemic Agents D07WFK DRUGTYPE Small molecular drug D07WFK DRUGINCH 1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19) D07WFK DRUGINKE VGZSUPCWNCWDAN-UHFFFAOYSA-N D07WFK DRUGSMIL CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2 D07WFK HIGHSTAT Approved D07WZH DRUG__ID D07WZH D07WZH THERCLAS Antibiotics D07WZH DRUGTYPE Small molecular drug D07WZH DRUGINCH 1S/C18H19N3O6S/c1-9(22)27-7-11-8-28-17-13(16(24)21(17)14(11)18(25)26)20-15(23)12(19)10-5-3-2-4-6-10/h2-6,12-13,17H,7-8,19H2,1H3,(H,20,23)(H,25,26)/t12-,13-,17-/m1/s1 D07WZH DRUGINKE FUBBGQLTSCSAON-PBFPGSCMSA-N D07WZH DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O D07WZH HIGHSTAT Approved D07XBE DRUG__ID D07XBE D07XBE DRUGCOMP Ajinomoto D07XBE DRUGTYPE Small molecular drug D07XBE DRUGINCH 1S/C42H72O36/c43-1-8-15(48)22(55)25(58)37(69-8)66-6-13-20(53)32(28(61)36(65)68-13)75-40-29(62)33(18(51)11(4-46)72-40)77-41-30(63)34(19(52)12(5-47)73-41)78-42-31(64)35(76-39-27(60)24(57)17(50)10(3-45)71-39)21(54)14(74-42)7-67-38-26(59)23(56)16(49)9(2-44)70-38/h8-65H,1-7H2/t8-,9-,10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22+,23+,24+,25-,26-,27-,28-,29-,30-,31-,32+,33+,34+,35+,36-,37-,38-,39+,40+,41+,42+/m1/s1 D07XBE DRUGINKE MAXBMUKIXLNXGX-DMWITZOWSA-N D07XBE DRUGSMIL C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)OC5C(C(C(C(O5)COC6C(C(C(C(O6)CO)O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)O)O)O)O D07XBE HIGHSTAT Approved D07YDE DRUG__ID D07YDE D07YDE THERCLAS Vasodilator Agents D07YDE DRUGTYPE Small molecular drug D07YDE DRUGINCH 1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2 D07YDE DRUGINKE SNIOPGDIGTZGOP-UHFFFAOYSA-N D07YDE DRUGSMIL C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-] D07YDE HIGHSTAT Approved D07ZBE DRUG__ID D07ZBE D07ZBE DRUGCOMP Guerbet D07ZBE DRUGTYPE Small molecular drug D07ZBE DRUGINCH 1S/C20H28I3N3O9/c1-25(3-10(31)7-29)19(34)12-14(21)13(20(35)26(2)4-11(32)8-30)16(23)17(15(12)22)24-18(33)9(5-27)6-28/h9-11,27-32H,3-8H2,1-2H3,(H,24,33) D07ZBE DRUGINKE YLPBXIKWXNRACS-UHFFFAOYSA-N D07ZBE DRUGSMIL CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)NC(=O)C(CO)CO)I)C(=O)N(C)CC(CO)O)I D07ZBE HIGHSTAT Approved D08ALK DRUG__ID D08ALK D08ALK DRUGCOMP Abbvie Inc D08ALK DRUGTYPE Small molecular drug D08ALK DRUGINCH 1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2/t42-,43-,54-,55-/m1/s1 D08ALK DRUGINKE YXSLJKQTIDHPOT-LJCJQEJUSA-N D08ALK DRUGSMIL C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C D08ALK HIGHSTAT Approved D08CCE DRUG__ID D08CCE D08CCE DRUGCOMP Dr Lo Zambeletti SpA D08CCE DRUGTYPE Small molecular drug D08CCE DRUGINCH 1S/C16H14O5/c1-16(20-14-10-6-5-9-13(14)18-2)19-12-8-4-3-7-11(12)15(17)21-16/h3-10H,1-2H3 D08CCE DRUGINKE PSVDIHULUCLEJE-UHFFFAOYSA-N D08CCE DRUGSMIL CC1(OC2=CC=CC=C2C(=O)O1)OC3=CC=CC=C3OC D08CCE HIGHSTAT Approved D08CTT DRUG__ID D08CTT D08CTT THERCLAS Antiallergic Agents D08CTT DRUGTYPE Small molecular drug D08CTT DRUGINCH 1S/C20H24N2/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20/h4-10,12,15H,11,13-14H2,1-3H3 D08CTT DRUGINKE MVMQESMQSYOVGV-UHFFFAOYSA-N D08CTT DRUGSMIL CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C D08CTT HIGHSTAT Approved D08DFX DRUG__ID D08DFX D08DFX DRUGCOMP Johnson & Johnson D08DFX DRUGTYPE Small molecular drug D08DFX DRUGINCH 1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1 D08DFX DRUGINKE XTNGUQKDFGDXSJ-ZXGKGEBGSA-N D08DFX DRUGSMIL CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F D08DFX HIGHSTAT Approved D08FPM DRUG__ID D08FPM D08FPM THERCLAS Anticancer Agents D08FPM DRUGTYPE Small molecular drug D08FPM DRUGINCH 1S/C22H28N4O6.2C2H4O2/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32;2*1-2(3)4/h1-4,23-30H,5-12H2;2*1H3,(H,3,4) D08FPM DRUGINKE ZWCKUVMZBKQQRG-UHFFFAOYSA-N D08FPM DRUGSMIL CC(=O)[O-].CC(=O)[O-].C1=CC(=C2C(=C1NCC[NH2+]CCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCC[NH2+]CCO D08FPM HIGHSTAT Approved D08FTG DRUG__ID D08FTG D08FTG THERCLAS Anticoagulants D08FTG DRUGTYPE Small molecular drug D08FTG DRUGINCH 1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H D08FTG DRUGINKE NFBAXHOPROOJAW-UHFFFAOYSA-N D08FTG DRUGSMIL C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O D08FTG HIGHSTAT Approved D08GHB DRUG__ID D08GHB D08GHB THERCLAS Anticholesteremic Agents D08GHB DRUGTYPE Small molecular drug D08GHB DRUGINCH 1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+/t18-,19-/m1/s1 D08GHB DRUGINKE FJLGEFLZQAZZCD-MCBHFWOFSA-N D08GHB DRUGSMIL CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F D08GHB HIGHSTAT Approved D08GSF DRUG__ID D08GSF D08GSF THERCLAS Antiinfective Agents D08GSF DRUGTYPE Small molecular drug D08GSF DRUGINCH 1S/C13H11N3/c14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10/h1-7H,14-15H2 D08GSF DRUGINKE WDVSHHCDHLJJJR-UHFFFAOYSA-N D08GSF DRUGSMIL C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N D08GSF HIGHSTAT Approved D08HDY DRUG__ID D08HDY D08HDY THERCLAS Antibiotics D08HDY DRUGTYPE Small molecular drug D08HDY DRUGINCH 1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/t14-,15+,17-/m1/s1 D08HDY DRUGINKE NPGNOVNWUSPMDP-HLLBOEOZSA-N D08HDY DRUGSMIL CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C D08HDY HIGHSTAT Approved D08HQK DRUG__ID D08HQK D08HQK THERCLAS Anesthetics D08HQK DRUGTYPE Small molecular drug D08HQK DRUGINCH 1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3 D08HQK DRUGINKE GKCBAIGFKIBETG-UHFFFAOYSA-N D08HQK DRUGSMIL CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C D08HQK HIGHSTAT Approved D08HUC DRUG__ID D08HUC D08HUC THERCLAS Bronchodilator Agents D08HUC DRUGTYPE Small molecular drug D08HUC DRUGINCH 1S/C13H21NO3/c1-4-10(14-8(2)3)13(17)9-5-6-11(15)12(16)7-9/h5-8,10,13-17H,4H2,1-3H3 D08HUC DRUGINKE HUYWAWARQUIQLE-UHFFFAOYSA-N D08HUC DRUGSMIL CCC(C(C1=CC(=C(C=C1)O)O)O)NC(C)C D08HUC HIGHSTAT Approved D08HVE DRUG__ID D08HVE D08HVE DRUGCOMP Mylan Institutional Llc D08HVE DRUGTYPE Small molecular drug D08HVE DRUGINCH 1S/C2H6OS/c1-4(2)3/h1-2H3 D08HVE DRUGINKE IAZDPXIOMUYVGZ-UHFFFAOYSA-N D08HVE DRUGSMIL CS(=O)C D08HVE HIGHSTAT Approved D08HVR DRUG__ID D08HVR D08HVR DRUGCOMP Orion Corp D08HVR DRUGTYPE Small molecular drug D08HVR DRUGINCH 1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1 D08HVR DRUGINKE WTDRDQBEARUVNC-LURJTMIESA-N D08HVR DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)O)O D08HVR HIGHSTAT Approved D08HZC DRUG__ID D08HZC D08HZC THERCLAS Antidotes D08HZC DRUGTYPE Small molecular drug D08HZC DRUGINCH 1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1 D08HZC DRUGINKE VVNCNSJFMMFHPL-VKHMYHEASA-N D08HZC DRUGSMIL CC(C)(C(C(=O)O)N)S D08HZC HIGHSTAT Approved D08IBS DRUG__ID D08IBS D08IBS THERCLAS Dietary supplement D08IBS DRUGTYPE Small molecular drug D08IBS DRUGINCH 1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10) D08IBS DRUGINKE GFFGJBXGBJISGV-UHFFFAOYSA-N D08IBS DRUGSMIL C1=NC2=NC=NC(=C2N1)N D08IBS HIGHSTAT Approved D08IFL DRUG__ID D08IFL D08IFL THERCLAS Analgesics D08IFL DRUGTYPE Small molecular drug D08IFL DRUGINCH 1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19) D08IFL DRUGINKE SBDNJUWAMKYJOX-UHFFFAOYSA-N D08IFL DRUGSMIL CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl D08IFL HIGHSTAT Approved D08JCA DRUG__ID D08JCA D08JCA THERCLAS Antiinfective Agents D08JCA DRUGTYPE Small molecular drug D08JCA DRUGINCH 1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1 D08JCA DRUGINKE UEJSSZHHYBHCEL-UHFFFAOYSA-N D08JCA DRUGSMIL C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+] D08JCA HIGHSTAT Approved D08JZS DRUG__ID D08JZS D08JZS THERCLAS Antiasthmatic Agents D08JZS DRUGTYPE Small molecular drug D08JZS DRUGINCH 1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3 D08JZS DRUGINKE YECBIJXISLIIDS-UHFFFAOYSA-N D08JZS DRUGSMIL CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2 D08JZS HIGHSTAT Approved D08KBK DRUG__ID D08KBK D08KBK DRUGCOMP Bayer HealthCare Pharmaceuticals D08KBK DRUGTYPE Small molecular drug D08KBK DRUGINCH 1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1 D08KBK DRUGINKE XFALPSLJIHVRKE-GFCCVEGCSA-N D08KBK DRUGSMIL CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F D08KBK HIGHSTAT Approved D08NLN DRUG__ID D08NLN D08NLN DRUGCOMP Biosensors International Singapore D08NLN DRUGTYPE Small molecular drug D08NLN DRUGINCH 1S/C55H87NO14/c1-12-67-26-27-68-45-24-22-41(31-48(45)65-10)30-37(5)47-33-44(57)36(4)29-39(7)50(59)51(66-11)49(58)38(6)28-34(2)18-14-13-15-19-35(3)46(64-9)32-42-23-21-40(8)55(63,70-42)52(60)53(61)56-25-17-16-20-43(56)54(62)69-47/h13-15,18-19,29,34,36-38,40-43,45-48,50-51,59,63H,12,16-17,20-28,30-33H2,1-11H3/b15-13+,18-14+,35-19+,39-29+/t34-,36-,37-,38-,40-,41+,42+,43+,45-,46+,47+,48-,50-,51+,55-/m1/s1 D08NLN DRUGINKE YYSFXUWWPNHNAZ-PKJQJFMNSA-N D08NLN DRUGSMIL CCOCCOC1CCC(CC1OC)CC(C)C2CC(=O)C(C=C(C(C(C(=O)C(CC(C=CC=CC=C(C(CC3CCC(C(O3)(C(=O)C(=O)N4CCCCC4C(=O)O2)O)C)OC)C)C)C)OC)O)C)C D08NLN HIGHSTAT Approved D08NWF DRUG__ID D08NWF D08NWF DRUGCOMP Pfizer/Anacor Pharmaceuticals D08NWF DRUGTYPE Small molecular drug D08NWF DRUGINCH 1S/C14H10BNO3/c16-8-10-1-3-12(4-2-10)19-13-5-6-14-11(7-13)9-18-15(14)17/h1-7,17H,9H2 D08NWF DRUGINKE USZAGAREISWJDP-UHFFFAOYSA-N D08NWF DRUGSMIL B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O D08NWF HIGHSTAT Approved D08OKJ DRUG__ID D08OKJ D08OKJ THERCLAS Iron Supplement D08OKJ DRUGTYPE Small molecular drug D08OKJ DRUGINCH 1S/Fe.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4) D08OKJ DRUGINKE MVZXTUSAYBWAAM-UHFFFAOYSA-N D08OKJ DRUGSMIL OS(=O)(=O)O.[Fe] D08OKJ HIGHSTAT Approved D08PCE DRUG__ID D08PCE D08PCE THERCLAS Anthelmintics D08PCE DRUGTYPE Small molecular drug D08PCE DRUGINCH 1S/C23H16O6.C13H16N2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-15-9-3-8-14-13(15)7-6-11-4-2-5-12(16)10-11/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2,4-7,10,16H,3,8-9H2,1H3/b;7-6+ D08PCE DRUGINKE CCOAINFUFGBHBA-UETGHTDLSA-N D08PCE DRUGSMIL CN1CCCN=C1C=CC2=CC(=CC=C2)O.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O D08PCE HIGHSTAT Approved D08QAC DRUG__ID D08QAC D08QAC DRUGCOMP Amag Pharmaceuticals Inc D08QAC DRUGTYPE Small molecular drug D08QAC DRUGINCH 1S/3Fe.4O/q+2;2*+3;4*-2 D08QAC DRUGINKE WTFXARWRTYJXII-UHFFFAOYSA-N D08QAC DRUGSMIL [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] D08QAC HIGHSTAT Approved D08QCJ DRUG__ID D08QCJ D08QCJ THERCLAS Antinematodal Agents D08QCJ DRUGTYPE Small molecular drug D08QCJ DRUGINCH 1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13) D08QCJ DRUGINKE WJCNZQLZVWNLKY-UHFFFAOYSA-N D08QCJ DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3 D08QCJ HIGHSTAT Approved D08QGD DRUG__ID D08QGD D08QGD DRUGCOMP Bristol-Myers Squibb Co D08QGD DRUGTYPE Small molecular drug D08QGD DRUGINCH 1S/C3H6O3.H3N/c1-2(4)3(5)6;/h2,4H,1H3,(H,5,6);1H3 D08QGD DRUGINKE RZOBLYBZQXQGFY-UHFFFAOYSA-N D08QGD DRUGSMIL CC(C(=O)[O-])O.[NH4+] D08QGD HIGHSTAT Approved D08QIP DRUG__ID D08QIP D08QIP THERCLAS Antiasthmatic Agents D08QIP DRUGTYPE Small molecular drug D08QIP DRUGINCH 1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32) D08QIP DRUGINKE NBQKINXMPLXUET-UHFFFAOYSA-N D08QIP DRUGSMIL C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5 D08QIP HIGHSTAT Approved D08QMX DRUG__ID D08QMX D08QMX THERCLAS Estrogens D08QMX DRUGTYPE Small molecular drug D08QMX DRUGINCH 1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1 D08QMX DRUGINKE VOXZDWNPVJITMN-ZBRFXRBCSA-N D08QMX DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O D08QMX HIGHSTAT Approved D08RID DRUG__ID D08RID D08RID DRUGCOMP Merck D08RID DRUGTYPE Small molecular drug D08RID DRUGINCH 1S/C72H112O48S8.8Na/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-40(87)88)112-72(56(104)48(64)96)119-63-31(23-127-15-7-39(85)86)110-70(54(102)46(63)94)117-61-29(21-125-13-5-37(81)82)108-68(52(100)44(61)92)115-59-27(19-123-11-3-35(77)78)106-66(113-57)50(98)42(59)90;;;;;;;;/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88);;;;;;;;/q;8*+1/p-8/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-;;;;;;;;/m1......../s1 D08RID DRUGINKE KMGKABOMYQLLDJ-VKHHSAQNSA-F D08RID DRUGSMIL C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])O)O)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D08RID HIGHSTAT Approved D08SKH DRUG__ID D08SKH D08SKH THERCLAS Anticancer Agents D08SKH DRUGTYPE Small molecular drug D08SKH DRUGINCH 1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3 D08SKH DRUGINKE QXKHYNVANLEOEG-UHFFFAOYSA-N D08SKH DRUGSMIL COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2 D08SKH HIGHSTAT Approved D08TEJ DRUG__ID D08TEJ D08TEJ DRUGCOMP Cosmo Pharmaceuticals SpA D08TEJ DRUGTYPE Small molecular drug D08TEJ DRUGINCH 1S/C24H34O5/c1-4-21(28)29-24(20(27)14-25)12-9-19-17-6-5-15-13-16(26)7-10-22(15,2)18(17)8-11-23(19,24)3/h13,17-19,25H,4-12,14H2,1-3H3/t17-,18+,19+,22+,23+,24+/m1/s1 D08TEJ DRUGINKE GPNHMOZDMYNCPO-PDUMRIMRSA-N D08TEJ DRUGSMIL CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO D08TEJ HIGHSTAT Approved D08USJ DRUG__ID D08USJ D08USJ THERCLAS Parasympathomimetics D08USJ DRUGTYPE Small molecular drug D08USJ DRUGINCH 1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1 D08USJ DRUGINKE ALWKGYPQUAPLQC-UHFFFAOYSA-N D08USJ DRUGSMIL CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C D08USJ HIGHSTAT Approved D08VSI DRUG__ID D08VSI D08VSI DRUGCOMP GSK D08VSI DRUGTYPE Small molecular drug D08VSI DRUGINCH 1S/C22H31Cl/c23-22-17-19(12-8-11-18-9-4-1-2-5-10-18)15-16-21(22)20-13-6-3-7-14-20/h8,12,15-18,20H,1-7,9-11,13-14H2/b12-8- D08VSI DRUGINKE NDXQJQCGBAIFER-WQLSENKSSA-N D08VSI DRUGSMIL C1CCCC(CC1)CC=CC2=CC(=C(C=C2)C3CCCCC3)Cl D08VSI HIGHSTAT Approved D08XYX DRUG__ID D08XYX D08XYX DRUGCOMP Novo Nordisk A/S D08XYX DRUGTYPE Small molecular drug D08XYX DRUGINCH 1S/C284H432N84O79S7/c1-21-144(9)222-271(439)337-174(68-46-105-309-282(300)301)239(407)340-187(120-160-77-85-164(374)86-78-160)251(419)341-185(116-156-55-29-24-30-56-156)250(418)342-188(121-161-79-87-165(375)88-80-161)252(420)346-191(123-208(291)378)246(414)322-149(14)230(398)326-168(62-35-39-98-285)234(402)319-146(11)227(395)314-132-215(385)324-181(113-141(3)4)247(415)354-199-137-452-453-138-200-263(431)336-179(97-112-448-20)242(410)331-176(70-48-107-311-284(304)305)244(412)363-226(154(19)372)274(442)358-197(233(401)316-129-212(382)312-130-213(383)318-151(16)278(446)447)135-449-451-139-201(355-253(421)186(117-157-57-31-25-32-58-157)344-256(424)195(127-220(393)394)350-267(435)204-72-50-109-366(204)275(443)167(289)61-43-102-306-279(294)295)265(433)339-182(114-142(5)6)248(416)338-180(93-96-218(389)390)276(444)368-111-52-74-206(368)277(445)367-110-51-73-205(367)268(436)349-189(122-162-81-89-166(376)90-82-162)259(427)362-224(152(17)370)269(437)317-133-216(386)365-108-49-71-203(365)266(434)357-202(264(432)333-169(63-36-40-99-286)235(403)320-148(13)229(397)328-175(69-47-106-310-283(302)303)243(411)360-223(145(10)22-2)272(440)361-222)140-454-450-136-198(325-214(384)131-313-211(381)128-315-232(400)183(119-159-75-83-163(373)84-76-159)351-270(438)221(143(7)8)359-258(426)190(118-158-59-33-26-34-60-158)352-273(441)225(153(18)371)364-245(413)177(335-262(199)430)91-94-207(290)377)261(429)334-172(66-44-103-307-280(296)297)236(404)321-147(12)228(396)327-170(64-37-41-100-287)237(405)330-173(67-45-104-308-281(298)299)238(406)345-192(124-209(292)379)255(423)347-193(125-210(293)380)254(422)343-184(115-155-53-27-23-28-54-155)249(417)332-171(65-38-42-101-288)240(408)353-196(134-369)260(428)323-150(15)231(399)329-178(92-95-217(387)388)241(409)348-194(126-219(391)392)257(425)356-200/h23-34,53-60,75-90,141-154,167-206,221-226,369-376H,21-22,35-52,61-74,91-140,285-289H2,1-20H3,(H2,290,377)(H2,291,378)(H2,292,379)(H2,293,380)(H,312,382)(H,313,381)(H,314,395)(H,315,400)(H,316,401)(H,317,437)(H,318,383)(H,319,402)(H,320,403)(H,321,404)(H,322,414)(H,323,428)(H,324,385)(H,325,384)(H,326,398)(H,327,396)(H,328,397)(H,329,399)(H,330,405)(H,331,410)(H,332,417)(H,333,432)(H,334,429)(H,335,430)(H,336,431)(H,337,439)(H,338,416)(H,339,433)(H,340,407)(H,341,419)(H,342,418)(H,343,422)(H,344,424)(H,345,406)(H,346,420)(H,347,423)(H,348,409)(H,349,436)(H,350,435)(H,351,438)(H,352,441)(H,353,408)(H,354,415)(H,355,421)(H,356,425)(H,357,434)(H,358,442)(H,359,426)(H,360,411)(H,361,440)(H,362,427)(H,363,412)(H,364,413)(H,387,388)(H,389,390)(H,391,392)(H,393,394)(H,446,447)(H4,294,295,306)(H4,296,297,307)(H4,298,299,308)(H4,300,301,309)(H4,302,303,310)(H4,304,305,311)/t144-,145-,146-,147+,148-,149-,150+,151-,152-,153+,154+,167+,168-,169+,170+,171+,172+,173+,174-,175-,176+,177-,178+,179-,180+,181-,182+,183-,184+,185+,186+,187+,188+,189+,190-,191+,192+,193+,194+,195-,196+,197+,198+,199-,200+,201+,202-,203-,204+,205+,206+,221-,222+,223+,224-,225-,226-/m1/s1 D08XYX DRUGINKE ZPNFWUPYTFPOJU-VKTQZXOTSA-N D08XYX DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC D08XYX HIGHSTAT Approved D08YIN DRUG__ID D08YIN D08YIN DRUGCOMP Acorda Therapeutics D08YIN DRUGTYPE Small molecular drug D08YIN DRUGINCH 1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7) D08YIN DRUGINKE NUKYPUAOHBNCPY-UHFFFAOYSA-N D08YIN DRUGSMIL C1=CN=CC=C1N D08YIN HIGHSTAT Approved D08ZEB DRUG__ID D08ZEB D08ZEB THERCLAS Analgesics D08ZEB DRUGTYPE Small molecular drug D08ZEB DRUGINCH 1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10) D08ZEB DRUGINKE TZFWDZFKRBELIQ-UHFFFAOYSA-N D08ZEB DRUGSMIL C1=CC2=C(C=C1Cl)NC(=O)O2 D08ZEB HIGHSTAT Approved D08ZFJ DRUG__ID D08ZFJ D08ZFJ DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D08ZFJ DRUGTYPE Small molecular drug D08ZFJ DRUGINCH 1S/C4H6N2.C3H5ClO/c1-4-5-2-3-6-4;4-1-3-2-5-3/h2-3H,1H3,(H,5,6);3H,1-2H2 D08ZFJ DRUGINKE DEMLYXMVPJAVFU-UHFFFAOYSA-N D08ZFJ DRUGSMIL CC1=NC=CN1.C1C(O1)CCl D08ZFJ HIGHSTAT Approved D09AMZ DRUG__ID D09AMZ D09AMZ THERCLAS Antiinflammatory Agents D09AMZ DRUGTYPE Small molecular drug D09AMZ DRUGINCH 1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14) D09AMZ DRUGINKE SIQPXVQCUCHWDI-UHFFFAOYSA-N D09AMZ DRUGSMIL CCCN1C2=C(C(=O)NC1=O)NC=N2 D09AMZ HIGHSTAT Approved D09BIW DRUG__ID D09BIW D09BIW DRUGCOMP Bristol-Myers Squibb Pharma Co D09BIW DRUGTYPE Small molecular drug D09BIW DRUGINCH 1S/6C6H11NO.Tc/c6*1-6(2,8-4)5-7-3;/h6*5H2,1-2,4H3;/q;;;;;;+7/i;;;;;;1+1 D09BIW DRUGINKE ZGDBEIODOXIKGQ-KTTJZPQESA-N D09BIW DRUGSMIL CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.[Tc+7] D09BIW HIGHSTAT Approved D09CGE DRUG__ID D09CGE D09CGE DRUGCOMP Avid Radiopharmaceuticals D09CGE DRUGTYPE Small molecular drug D09CGE DRUGINCH 1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+/i21-1 D09CGE DRUGINKE YNDIAUKFXKEXSV-CRYLGTRXSA-N D09CGE DRUGSMIL CNC1=CC=C(C=C1)C=CC2=CN=C(C=C2)OCCOCCOCCF D09CGE HIGHSTAT Approved D09COD DRUG__ID D09COD D09COD DRUGCOMP Daiichi Seiyaku Co Ltd D09COD DRUGTYPE Small molecular drug D09COD DRUGINCH 1S/C43H78N6O13/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23-34(52)45-26-21-20-22-32(42(58)59)48-35(53)25-24-31(39(44)55)49-40(56)28(2)46-41(57)29(3)61-38-36(47-30(4)51)43(60)62-33(27-50)37(38)54/h28-29,31-33,36-38,43,50,54,60H,5-27H2,1-4H3,(H2,44,55)(H,45,52)(H,46,57)(H,47,51)(H,48,53)(H,49,56)(H,58,59)/t28-,29+,31+,32-,33+,36+,37+,38+,43?/m0/s1 D09COD DRUGINKE FKHUGQZRBPETJR-FZKCHLSLSA-N D09COD DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)CCC(C(=O)N)NC(=O)C(C)NC(=O)C(C)OC1C(C(OC(C1O)CO)O)NC(=O)C D09COD HIGHSTAT Approved D09CPR DRUG__ID D09CPR D09CPR THERCLAS Antibiotics D09CPR DRUGTYPE Small molecular drug D09CPR DRUGINCH 1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1 D09CPR DRUGINKE BPLBGHOLXOTWMN-MBNYWOFBSA-N D09CPR DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C D09CPR HIGHSTAT Approved D09DBR DRUG__ID D09DBR D09DBR DRUGCOMP Kyowa D09DBR DRUGTYPE Small molecular drug D09DBR DRUGINCH 1S/C20H41N5O7.H2O4S/c1-20(28)8-29-19(14(27)17(20)25-3)32-16-12(23)6-11(22)15(13(16)26)31-18-10(21)5-4-9(30-18)7-24-2;1-5(2,3)4/h9-19,24-28H,4-8,21-23H2,1-3H3;(H2,1,2,3,4)/t9-,10+,11-,12+,13-,14+,15+,16-,17+,18+,19+,20-;/m0./s1 D09DBR DRUGINKE MQDGQSCLOYLSEK-SCFBDNQUSA-N D09DBR DRUGSMIL CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CNC)N)N)N)O.OS(=O)(=O)O D09DBR HIGHSTAT Approved D09DHY DRUG__ID D09DHY D09DHY THERCLAS Gout Suppressants D09DHY DRUGTYPE Small molecular drug D09DHY DRUGINCH 1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1 D09DHY DRUGINKE IAKHMKGGTNLKSZ-INIZCTEOSA-N D09DHY DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC D09DHY HIGHSTAT Approved D09ELP DRUG__ID D09ELP D09ELP DRUGCOMP The Medicines Company D09ELP DRUGTYPE Small molecular drug D09ELP DRUGINCH 1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3 D09ELP DRUGINKE KPBZROQVTHLCDU-UHFFFAOYSA-N D09ELP DRUGSMIL CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C D09ELP HIGHSTAT Approved D09FJB DRUG__ID D09FJB D09FJB THERCLAS Hypoglycemic Agents D09FJB DRUGTYPE Small molecular drug D09FJB DRUGINCH 1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18) D09FJB DRUGINKE OUDSBRTVNLOZBN-UHFFFAOYSA-N D09FJB DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2 D09FJB HIGHSTAT Approved D09GDD DRUG__ID D09GDD D09GDD DRUGCOMP Bayer HealthCare Pharmaceuticals D09GDD DRUGTYPE Small molecular drug D09GDD DRUGINCH 1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32) D09GDD DRUGINKE FNHKPVJBJVTLMP-UHFFFAOYSA-N D09GDD DRUGSMIL CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F D09GDD HIGHSTAT Approved D09GUJ DRUG__ID D09GUJ D09GUJ TRADNAME Nuzyra D09GUJ DRUGCOMP Paratek Pharmaceuticals D09GUJ DRUGINCH 1S/C29H40N4O7/c1-28(2,3)12-31-11-14-10-17(32(4)5)15-8-13-9-16-21(33(6)7)24(36)20(27(30)39)26(38)29(16,40)25(37)18(13)23(35)19(15)22(14)34/h10,13,16,21,31,34-35,38,40H,8-9,11-12H2,1-7H3,(H2,30,39)/t13-,16-,21-,29-/m0/s1 D09GUJ DRUGINKE VJYKVCURWJGLPG-IQZGDKDPSA-N D09GUJ DRUGSMIL CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C D09GUJ HIGHSTAT Approved D09HDR DRUG__ID D09HDR D09HDR THERCLAS Antihypertensive Agents D09HDR DRUGTYPE Small molecular drug D09HDR DRUGINCH 1S/C32H38N2O8/c1-37-24-12-17(13-25(38-2)29(24)39-3)31(35)42-26-14-18-16-34-11-10-20-19-8-6-7-9-22(19)33-28(20)23(34)15-21(18)27(30(26)40-4)32(36)41-5/h6-9,12-13,18,21,23,26-27,30,33H,10-11,14-16H2,1-5H3/t18-,21+,23-,26-,27+,30+/m1/s1 D09HDR DRUGINKE CVBMAZKKCSYWQR-WCGOZPBSSA-N D09HDR DRUGSMIL COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=CC=CC=C45)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC D09HDR HIGHSTAT Approved D09HKX DRUG__ID D09HKX D09HKX DRUGCOMP Fujisawa D09HKX DRUGTYPE Small molecular drug D09HKX DRUGINCH 1S/C19H22N8O6S2/c1-33-24-12(10-8-35-19(21)22-10)15(29)23-13-16(30)27-14(18(31)32)9(7-34-17(13)27)6-25-3-2-11(20)26(25)4-5-28/h2-3,8,13,17,20,28H,4-7H2,1H3,(H4,21,22,23,29,31,32)/b24-12-/t13-,17-/m1/s1 D09HKX DRUGINKE BHXLLRXDAYEMPP-SBGRAJFYSA-N D09HKX DRUGSMIL CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=C(N4CCO)N)C(=O)[O-] D09HKX HIGHSTAT Approved D09HNV DRUG__ID D09HNV D09HNV DRUGCOMP Boehringer Ingelheim Pharmaceuticals D09HNV DRUGTYPE Small molecular drug D09HNV DRUGINCH 1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3 D09HNV DRUGINKE CPMDPSXJELVGJG-UHFFFAOYSA-N D09HNV DRUGSMIL CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O D09HNV HIGHSTAT Approved D09HVL DRUG__ID D09HVL D09HVL THERCLAS Antithrombotic Agents D09HVL DRUGTYPE Small molecular drug D09HVL DRUGINCH 1S/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-37-120(69)94(151)57(99)41-53-16-8-6-9-17-53/h6-11,16-19,24-27,51-52,57-70,82,123H,5,12-15,20-23,28-50,99H2,1-4H3,(H2,100,124)(H,104,125)(H,105,127)(H,106,126)(H,107,140)(H,108,148)(H,109,128)(H,110,129)(H,111,142)(H,112,141)(H,113,145)(H,114,149)(H,115,150)(H,116,143)(H,117,147)(H,118,146)(H,119,144)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,138,139)(H,154,155)(H4,101,102,103)/t52-,57+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,82-/m0/s1 D09HVL DRUGINKE OIRCOABEOLEUMC-GEJPAHFPSA-N D09HVL DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N D09HVL HIGHSTAT Approved D09IEE DRUG__ID D09IEE D09IEE THERCLAS Antiinflammatory Agents D09IEE DRUGTYPE Small molecular drug D09IEE DRUGINCH 1S/C27H36O8/c1-5-22(31)34-15-21(30)27(35-24(32)33-6-2)12-10-19-18-8-7-16-13-17(28)9-11-25(16,3)23(18)20(29)14-26(19,27)4/h9,11,13,18-20,23,29H,5-8,10,12,14-15H2,1-4H3/t18-,19-,20-,23+,25-,26-,27-/m0/s1 D09IEE DRUGINKE FNPXMHRZILFCKX-KAJVQRHHSA-N D09IEE DRUGSMIL CCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)OCC D09IEE HIGHSTAT Approved D09IOI DRUG__ID D09IOI D09IOI THERCLAS Antidepressants D09IOI DRUGTYPE Small molecular drug D09IOI DRUGINCH 1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2 D09IOI DRUGINKE QWGDMFLQWFTERH-UHFFFAOYSA-N D09IOI DRUGSMIL C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl D09IOI HIGHSTAT Approved D09IPV DRUG__ID D09IPV D09IPV THERCLAS Fertility Agents D09IPV DRUGTYPE Small molecular drug D09IPV DRUGINCH 1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1 D09IPV DRUGINKE POZRVZJJTULAOH-LHZXLZLDSA-N D09IPV DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5 D09IPV HIGHSTAT Approved D09JBP DRUG__ID D09JBP D09JBP THERCLAS Anticonvulsants D09JBP DRUGTYPE Small molecular drug D09JBP DRUGINCH 1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3 D09JBP DRUGINKE VQASKUSHBVDKGU-UHFFFAOYSA-N D09JBP DRUGSMIL CCC1(C(=O)N(C(=O)O1)C)C D09JBP HIGHSTAT Approved D09KTS DRUG__ID D09KTS D09KTS DRUGCOMP Janssen Biotech; Pharmacyclics D09KTS DRUGTYPE Small molecular drug D09KTS DRUGINCH 1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1 D09KTS DRUGINKE XYFPWWZEPKGCCK-GOSISDBHSA-N D09KTS DRUGSMIL C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N D09KTS HIGHSTAT Approved D09LPN DRUG__ID D09LPN D09LPN THERCLAS Antithrombotic Agents D09LPN DRUGTYPE Small molecular drug D09LPN DRUGINCH 1S/C287H440N80O111S6/c1-24-132(17)225-280(470)345-162(87-126(5)6)236(426)306-111-209(396)320-181(116-370)267(457)344-176(101-220(416)417)238(428)307-105-203(390)316-152(61-74-213(402)403)243(433)321-146(40-29-32-80-288)241(431)339-171(96-198(298)385)259(449)326-153(56-69-194(294)381)250(440)351-186(121-482-479-118-183-240(430)310-107-202(389)313-148(54-67-192(292)379)233(423)303-108-206(393)317-170(95-197(297)384)258(448)322-147(41-30-33-81-289)242(432)350-187(272(462)359-225)122-483-480-119-184(269(459)323-150(60-73-212(400)401)235(425)304-110-208(395)319-180(115-369)266(456)342-174(99-201(301)388)265(455)357-223(130(13)14)278(468)355-183)352-254(444)165(90-129(11)12)335-270(460)185-120-481-484-123-188(354-263(453)178(103-222(420)421)347-283(473)230(137(22)375)362-264(454)168(93-141-48-52-144(378)53-49-141)346-282(472)228(135(20)373)361-232(422)145(291)86-125(3)4)273(463)363-229(136(21)374)281(471)330-158(65-78-217(410)411)249(439)348-179(114-368)239(429)309-106-204(391)315-151(55-68-193(293)380)244(434)340-172(97-199(299)386)260(450)334-164(89-128(9)10)253(443)353-185)271(461)358-224(131(15)16)279(469)364-227(134(19)372)277(467)311-112-205(392)314-149(59-72-211(398)399)234(424)305-113-210(397)356-231(138(23)376)286(476)367-85-37-45-191(367)276(466)331-160(42-31-34-82-290)284(474)365-83-35-43-189(365)274(464)328-154(57-70-195(295)382)248(438)349-182(117-371)268(458)338-169(94-142-104-302-124-312-142)257(447)341-173(98-200(300)387)261(451)343-175(100-219(414)415)237(427)308-109-207(394)318-177(102-221(418)419)262(452)337-166(91-139-38-27-26-28-39-139)255(445)327-155(62-75-214(404)405)245(435)325-159(66-79-218(412)413)251(441)360-226(133(18)25-2)285(475)366-84-36-44-190(366)275(465)329-157(64-77-216(408)409)246(436)324-156(63-76-215(406)407)247(437)336-167(92-140-46-50-143(377)51-47-140)256(446)333-163(88-127(7)8)252(442)332-161(287(477)478)58-71-196(296)383/h26-28,38-39,46-53,104,124-138,145-191,223-231,368-378H,24-25,29-37,40-45,54-103,105-123,288-291H2,1-23H3,(H2,292,379)(H2,293,380)(H2,294,381)(H2,295,382)(H2,296,383)(H2,297,384)(H2,298,385)(H2,299,386)(H2,300,387)(H2,301,388)(H,302,312)(H,303,423)(H,304,425)(H,305,424)(H,306,426)(H,307,428)(H,308,427)(H,309,429)(H,310,430)(H,311,467)(H,313,389)(H,314,392)(H,315,391)(H,316,390)(H,317,393)(H,318,394)(H,319,395)(H,320,396)(H,321,433)(H,322,448)(H,323,459)(H,324,436)(H,325,435)(H,326,449)(H,327,445)(H,328,464)(H,329,465)(H,330,471)(H,331,466)(H,332,442)(H,333,446)(H,334,450)(H,335,460)(H,336,437)(H,337,452)(H,338,458)(H,339,431)(H,340,434)(H,341,447)(H,342,456)(H,343,451)(H,344,457)(H,345,470)(H,346,472)(H,347,473)(H,348,439)(H,349,438)(H,350,432)(H,351,440)(H,352,444)(H,353,443)(H,354,453)(H,355,468)(H,356,397)(H,357,455)(H,358,461)(H,359,462)(H,360,441)(H,361,422)(H,362,454)(H,363,463)(H,364,469)(H,398,399)(H,400,401)(H,402,403)(H,404,405)(H,406,407)(H,408,409)(H,410,411)(H,412,413)(H,414,415)(H,416,417)(H,418,419)(H,420,421)(H,477,478)/t132-,133-,134+,135+,136+,137+,138+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,223-,224-,225-,226-,227-,228-,229-,230-,231-/m0/s1 D09LPN DRUGINKE FIBJDTSHOUXTKV-BRHMIFOHSA-N D09LPN DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CNC=N7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C D09LPN HIGHSTAT Approved D09LZT DRUG__ID D09LZT D09LZT DRUGCOMP Immunex Corp D09LZT DRUGTYPE Small molecular drug D09LZT DRUGINCH 1S/C19H24N2OS/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21/h5-11,14H,12-13H2,1-4H3/t14-/m1/s1 D09LZT DRUGINKE VRQVVMDWGGWHTJ-CQSZACIVSA-N D09LZT DRUGSMIL CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C D09LZT HIGHSTAT Approved D09MXS DRUG__ID D09MXS D09MXS DRUGCOMP Pharmaxis D09MXS DRUGTYPE Small molecular drug D09MXS DRUGINCH 1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5-,6-/m1/s1 D09MXS DRUGINKE FBPFZTCFMRRESA-JGWLITMVSA-N D09MXS DRUGSMIL C(C(C(C(C(CO)O)O)O)O)O D09MXS HIGHSTAT Approved D09NFN DRUG__ID D09NFN D09NFN DRUGCOMP Pharma Hameln GmbH D09NFN DRUGTYPE Small molecular drug D09NFN DRUGINCH 1S/C14H23N3O10.Ca.3Na/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;/q;+2;3*+1/p-5 D09NFN DRUGINKE AYFCVLSUPGCQKD-UHFFFAOYSA-I D09NFN DRUGSMIL C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Ca+2] D09NFN HIGHSTAT Approved D09NIA DRUG__ID D09NIA D09NIA THERCLAS Antihypertensive Agents D09NIA DRUGTYPE Small molecular drug D09NIA DRUGINCH 1S/C14H11ClN2O4S/c15-11-6-5-8(7-12(11)22(16,20)21)14(19)10-4-2-1-3-9(10)13(18)17-14/h1-7,19H,(H,17,18)(H2,16,20,21) D09NIA DRUGINKE JIVPVXMEBJLZRO-UHFFFAOYSA-N D09NIA DRUGSMIL C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O D09NIA HIGHSTAT Approved D09NIB DRUG__ID D09NIB D09NIB DRUGCOMP Brystol-Myers Squibb D09NIB DRUGTYPE Small molecular drug D09NIB DRUGINCH 1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20+/m0/s1 D09NIB DRUGINKE YJGVMLPVUAXIQN-LGWHJFRWSA-N D09NIB DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O D09NIB HIGHSTAT Approved D09NMD DRUG__ID D09NMD D09NMD DRUGCOMP Pfizer D09NMD DRUGTYPE Small molecular drug D09NMD DRUGINCH 1S/C28H31NO2/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2/t26-,28+/m1/s1 D09NMD DRUGINKE GXESHMAMLJKROZ-IAPPQJPRSA-N D09NMD DRUGSMIL C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5 D09NMD HIGHSTAT Approved D09NNH DRUG__ID D09NNH D09NNH DRUGCOMP Sanochemia Pharmazeutika AG D09NNH DRUGTYPE Small molecular drug D09NNH DRUGINCH 1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)/t23-,25-,27-,28+,29+,34-,35+/m1/s1 D09NNH DRUGINKE DEQITUUQPICUMR-HJPBWRTMSA-N D09NNH DRUGSMIL CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C D09NNH HIGHSTAT Approved D09OBB DRUG__ID D09OBB D09OBB THERCLAS Analgesics D09OBB DRUGTYPE Small molecular drug D09OBB DRUGINCH 1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1 D09OBB DRUGINKE MKXZASYAUGDDCJ-NJAFHUGGSA-N D09OBB DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC D09OBB HIGHSTAT Approved D09OOV DRUG__ID D09OOV D09OOV THERCLAS Antibiotics D09OOV DRUGTYPE Small molecular drug D09OOV DRUGINCH 1S/C56H98N16O13.H2O4S/c1-7-32(4)13-11-12-16-44(75)63-36(17-23-57)51(80)72-46(34(6)74)56(85)68-39(20-26-60)48(77)67-41-22-28-62-55(84)45(33(5)73)71-52(81)40(21-27-61)65-47(76)37(18-24-58)66-53(82)42(29-31(2)3)69-54(83)43(30-35-14-9-8-10-15-35)70-49(78)38(19-25-59)64-50(41)79;1-5(2,3)4/h8-10,14-15,31-34,36-43,45-46,73-74H,7,11-13,16-30,57-61H2,1-6H3,(H,62,84)(H,63,75)(H,64,79)(H,65,76)(H,66,82)(H,67,77)(H,68,85)(H,69,83)(H,70,78)(H,71,81)(H,72,80);(H2,1,2,3,4) D09OOV DRUGINKE HFMDLUQUEXNBOP-UHFFFAOYSA-N D09OOV DRUGSMIL CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O D09OOV HIGHSTAT Approved D09OQV DRUG__ID D09OQV D09OQV DRUGCOMP National Cancer Institute (NCI) D09OQV DRUGTYPE Small molecular drug D09OQV DRUGINCH 1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3 D09OQV DRUGINKE KFQYTPMOWPVWEJ-UHFFFAOYSA-N D09OQV DRUGSMIL CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O D09OQV HIGHSTAT Approved D09PEQ DRUG__ID D09PEQ D09PEQ THERCLAS Antibiotics D09PEQ DRUGTYPE Small molecular drug D09PEQ DRUGINCH 1S/C21H43N5O7.C20H41N5O7.C19H39N5O7.H2O4S/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20;1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19;1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17;1-5(2,3)4/h9-20,25-29H,5-8,22-24H2,1-4H3;8-19,25-28H,4-7,21-24H2,1-3H3;8-18,24-27H,3-7,20-23H2,1-2H3;(H2,1,2,3,4)/t9-,10-,11+,12-,13+,14+,15-,16-,17+,18-,19-,20-,21+;8-,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+;8-,9+,10-,11+,12-,13+,14+,15-,16+,17+,18+,19-;/m110./s1 D09PEQ DRUGINKE RDEIXVOBVLKYNT-HDZPSJEVSA-N D09PEQ DRUGSMIL CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)N.CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CCC(O3)CN)N)N)N)O.OS(=O)(=O)O D09PEQ HIGHSTAT Approved D09PJX DRUG__ID D09PJX D09PJX THERCLAS Nephropathic cystinosis therapy D09PJX DRUGTYPE Small molecular drug D09PJX DRUGINCH 1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3 D09PJX DRUGINKE MKJIEFSOBYUXJB-UHFFFAOYSA-N D09PJX DRUGSMIL CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC D09PJX HIGHSTAT Approved D09PQZ DRUG__ID D09PQZ D09PQZ TRADNAME Calquence D09PQZ DRUGCOMP AstraZeneca/Acerta Pharma D09PQZ DRUGINCH 1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1 D09PQZ DRUGINKE WDENQIQQYWYTPO-IBGZPJMESA-N D09PQZ DRUGSMIL CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5 D09PQZ HIGHSTAT Approved D09PUL DRUG__ID D09PUL D09PUL THERCLAS Dietary supplement D09PUL DRUGTYPE Small molecular drug D09PUL DRUGINCH 1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1 D09PUL DRUGINKE QNAYBMKLOCPYGJ-REOHCLBHSA-N D09PUL DRUGSMIL CC(C(=O)O)N D09PUL HIGHSTAT Approved D09PZO DRUG__ID D09PZO D09PZO THERCLAS Antiviral Agents D09PZO DRUGTYPE Small molecular drug D09PZO DRUGINCH 1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 D09PZO DRUGINKE XQFRJNBWHJMXHO-RRKCRQDMSA-N D09PZO DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O D09PZO HIGHSTAT Approved D09QBG DRUG__ID D09QBG D09QBG DRUGCOMP The Medicines Company D09QBG DRUGTYPE Small molecular drug D09QBG DRUGINCH 1S/C17H25Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32)/t8-,10-,11-,14-/m1/s1 D09QBG DRUGINKE PAEBIVWUMLRPSK-IDTAVKCVSA-N D09QBG DRUGSMIL CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O D09QBG HIGHSTAT Approved D09QDP DRUG__ID D09QDP D09QDP THERCLAS Antiparkinson Agents D09QDP DRUGTYPE Small molecular drug D09QDP DRUGINCH 1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3 D09QDP DRUGINKE BTFHLQRNAMSNLC-UHFFFAOYSA-N D09QDP DRUGSMIL CN(CCCOC1=C(C=C(C=C1)Cl)Cl)CC#C D09QDP HIGHSTAT Approved D09QZI DRUG__ID D09QZI D09QZI THERCLAS Contraceptive Agents D09QZI DRUGTYPE Small molecular drug D09QZI DRUGINCH 1S/C23H31NO3/c1-4-22-12-10-19-18-9-7-17(24-26)14-16(18)6-8-20(19)21(22)11-13-23(22,5-2)27-15(3)25/h2,14,18-21,26H,4,6-13H2,1,3H3/b24-17+/t18-,19+,20+,21-,22-,23-/m0/s1 D09QZI DRUGINKE KIQQMECNKUGGKA-NMYWJIRASA-N D09QZI DRUGSMIL CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34 D09QZI HIGHSTAT Approved D09RUW DRUG__ID D09RUW D09RUW DRUGCOMP Bracco SpA D09RUW DRUGTYPE Small molecular drug D09RUW DRUGINCH 1S/C17H22I3N3O8/c1-23(9(29)6-26)15-13(19)10(16(30)21-2-7(27)4-24)12(18)11(14(15)20)17(31)22-3-8(28)5-25/h7-8,24-28H,2-6H2,1H3,(H,21,30)(H,22,31) D09RUW DRUGINKE NJKDOADNQSYQEV-UHFFFAOYSA-N D09RUW DRUGSMIL CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO D09RUW HIGHSTAT Approved D09SGV DRUG__ID D09SGV D09SGV DRUGCOMP Bristol-Myers Squibb D09SGV DRUGTYPE Small molecular drug D09SGV DRUGINCH 1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1 D09SGV DRUGINKE FKRSSPOQAMALKA-CUPIEXAXSA-N D09SGV DRUGSMIL CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC D09SGV HIGHSTAT Approved D09TPF DRUG__ID D09TPF D09TPF THERCLAS Antipsychotic Agents D09TPF DRUGTYPE Small molecular drug D09TPF DRUGINCH 1S/C16H24N2O2/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18/h12,17H,3-10H2,1-2H3 D09TPF DRUGINKE KLPWJLBORRMFGK-UHFFFAOYSA-N D09TPF DRUGSMIL CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C D09TPF HIGHSTAT Approved D09UXE DRUG__ID D09UXE D09UXE THERCLAS Antimalarials D09UXE DRUGTYPE Small molecular drug D09UXE DRUGINCH 1S/C4H10NO5P/c6-4-5(7)2-1-3-11(8,9)10/h4,7H,1-3H2,(H2,8,9,10) D09UXE DRUGINKE GJXWDTUCERCKIX-UHFFFAOYSA-N D09UXE DRUGSMIL C(CN(C=O)O)CP(=O)(O)O D09UXE HIGHSTAT Approved D09VOK DRUG__ID D09VOK D09VOK DRUGCOMP Aton Pharma Inc D09VOK DRUGTYPE Small molecular drug D09VOK DRUGINCH 1S/C6H18N4.2ClH/c7-1-3-9-5-6-10-4-2-8;;/h9-10H,1-8H2;2*1H D09VOK DRUGINKE WYHIICXRPHEJKI-UHFFFAOYSA-N D09VOK DRUGSMIL C(CNCCNCCN)N.Cl.Cl D09VOK HIGHSTAT Approved D09VXM DRUG__ID D09VXM D09VXM DRUGCOMP Salix D09VXM DRUGTYPE Small molecular drug D09VXM DRUGINCH 1S/C18H16N2O3/c1-22-16-10-6-5-9-14(16)12-19-18(21)15-11-17(23-20-15)13-7-3-2-4-8-13/h2-11H,12H2,1H3,(H,19,21) D09VXM DRUGINKE JDNAIBCYTQGWFC-UHFFFAOYSA-N D09VXM DRUGSMIL COC1=CC=CC=C1CNC(=O)C2=NOC(=C2)C3=CC=CC=C3 D09VXM HIGHSTAT Approved D09WCM DRUG__ID D09WCM D09WCM DRUGCOMP ParaPRO D09WCM DRUGTYPE Small molecular drug D09WCM DRUGINCH 1S/C41H65NO10/c1-10-26-12-11-13-34(52-36-17-16-33(42(5)6)23(3)48-36)22(2)37(44)32-20-30-28(31(32)21-35(43)50-26)15-14-25-18-27(19-29(25)30)51-41-40(47-9)39(46-8)38(45-7)24(4)49-41/h14-15,20,22-31,33-34,36,38-41H,10-13,16-19,21H2,1-9H3/t22-,23-,24+,25-,26+,27-,28+,29-,30-,31?,33+,34+,36+,38+,39-,40-,41+/m1/s1 D09WCM DRUGINKE SRJQTHAZUNRMPR-MGGCLMNKSA-N D09WCM DRUGSMIL CCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C=CC3C2CC(=O)O1)OC5C(C(C(C(O5)C)OC)OC)OC)C)OC6CCC(C(O6)C)N(C)C D09WCM HIGHSTAT Approved D09WKB DRUG__ID D09WKB D09WKB THERCLAS Anticoagulants D09WKB DRUGTYPE Small molecular drug D09WKB DRUGINCH 1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3 D09WKB DRUGINKE XRCFXMGQEVUZFC-UHFFFAOYSA-N D09WKB DRUGSMIL COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O D09WKB HIGHSTAT Approved D09XWD DRUG__ID D09XWD D09XWD DRUGCOMP Eisai D09XWD DRUGTYPE Small molecular drug D09XWD DRUGINCH 1S/C23H38O/c1-19(2)11-7-12-20(3)13-8-14-21(4)15-9-16-22(5)17-10-18-23(6)24/h11,13,15,17H,7-10,12,14,16,18H2,1-6H3/b20-13+,21-15+,22-17+ D09XWD DRUGINKE HUCXKZBETONXFO-NJFMWZAGSA-N D09XWD DRUGSMIL CC(=CCCC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C)C D09XWD HIGHSTAT Approved D09ZOQ DRUG__ID D09ZOQ D09ZOQ DRUGCOMP Glaxosmithkline D09ZOQ DRUGTYPE Small molecular drug D09ZOQ DRUGINCH 1S/C29H34NO2.BrH/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25;/h1-15,31H,16-24H2;1H/q+1;/p-1 D09ZOQ DRUGINKE PEJHHXHHNGORMP-UHFFFAOYSA-M D09ZOQ DRUGSMIL C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.[Br-] D09ZOQ HIGHSTAT Approved D09ZQN DRUG__ID D09ZQN D09ZQN THERCLAS Estrogens D09ZQN DRUGTYPE Small molecular drug D09ZQN DRUGINCH 1S/C18H18O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h3-12,19-20H,1-2H3/b17-3+,18-4+ D09ZQN DRUGINKE NFDFQCUYFHCNBW-SCGPFSFSSA-N D09ZQN DRUGSMIL CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O D09ZQN HIGHSTAT Approved D09ZXR DRUG__ID D09ZXR D09ZXR DRUGCOMP Furiex pharmaceuticals D09ZXR DRUGTYPE Small molecular drug D09ZXR DRUGINCH 1S/C32H35N5O5/c1-18-12-23(29(34)38)13-19(2)24(18)15-26(33)31(39)37(17-21-10-11-28(42-4)25(14-21)32(40)41)20(3)30-35-16-27(36-30)22-8-6-5-7-9-22/h5-14,16,20,26H,15,17,33H2,1-4H3,(H2,34,38)(H,35,36)(H,40,41)/t20-,26-/m0/s1 D09ZXR DRUGINKE QFNHIDANIVGXPE-FNZWTVRRSA-N D09ZXR DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N D09ZXR HIGHSTAT Approved D0A0JH DRUG__ID D0A0JH D0A0JH THERCLAS Antibiotics D0A0JH DRUGTYPE Small molecular drug D0A0JH DRUGINCH 1S/C21H22N2O5S/c1-4-28-13-10-9-11-7-5-6-8-12(11)14(13)17(24)22-15-18(25)23-16(20(26)27)21(2,3)29-19(15)23/h5-10,15-16,19H,4H2,1-3H3,(H,22,24)(H,26,27)/t15-,16+,19-/m1/s1 D0A0JH DRUGINKE GPXLMGHLHQJAGZ-JTDSTZFVSA-N D0A0JH DRUGSMIL CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O D0A0JH HIGHSTAT Approved D0A0SP DRUG__ID D0A0SP D0A0SP DRUGCOMP Parke Davis Div Warner Lambert Co D0A0SP THERCLAS Antiinfective Agents D0A0SP DRUGINCH 1S/C26H28N3/c1-19-17-21(20(2)29(19)24-9-7-6-8-10-24)11-13-23-14-12-22-18-25(27(3)4)15-16-26(22)28(23)5/h6-18H,1-5H3/q+1 D0A0SP DRUGINKE QMHSXPLYMTVAMK-UHFFFAOYSA-N D0A0SP DRUGSMIL CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C D0A0SP HIGHSTAT Approved D0A1DH DRUG__ID D0A1DH D0A1DH THERCLAS Antihypertensive Agents D0A1DH DRUGTYPE Small molecular drug D0A1DH DRUGINCH 1S/C18H20N2O6/c1-5-26-18(22)15-11(3)19-10(2)14(17(21)25-4)16(15)12-7-6-8-13(9-12)20(23)24/h6-9,16,19H,5H2,1-4H3 D0A1DH DRUGINKE PVHUJELLJLJGLN-UHFFFAOYSA-N D0A1DH DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C D0A1DH HIGHSTAT Approved D0A1XS DRUG__ID D0A1XS D0A1XS DRUGCOMP Glaxo Wellcome plc D0A1XS DRUGTYPE Small molecular drug D0A1XS DRUGINCH 1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1 D0A1XS DRUGINKE KILNVBDSWZSGLL-KXQOOQHDSA-N D0A1XS DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC D0A1XS HIGHSTAT Approved D0A3ZU DRUG__ID D0A3ZU D0A3ZU DRUGCOMP Celgene D0A3ZU DRUGTYPE Small molecular drug D0A3ZU DRUGINCH 1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) D0A3ZU DRUGINKE UVSMNLNDYGZFPF-UHFFFAOYSA-N D0A3ZU DRUGSMIL C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N D0A3ZU HIGHSTAT Approved D0A4JK DRUG__ID D0A4JK D0A4JK THERCLAS Antianxiety Agents D0A4JK DRUGTYPE Small molecular drug D0A4JK DRUGINCH 1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15) D0A4JK DRUGINKE ZRIHAIZYIMGOAB-UHFFFAOYSA-N D0A4JK DRUGSMIL CCC(C)C1(C(=O)NC(=O)NC1=O)CC D0A4JK HIGHSTAT Approved D0A5SE DRUG__ID D0A5SE D0A5SE DRUGCOMP Takeda D0A5SE DRUGTYPE Small molecular drug D0A5SE DRUGINCH 1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20) D0A5SE DRUGINKE BQSJTQLCZDPROO-UHFFFAOYSA-N D0A5SE DRUGSMIL CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O D0A5SE HIGHSTAT Approved D0A6KR DRUG__ID D0A6KR D0A6KR THERCLAS Antiinflammatory Agents D0A6KR DRUGTYPE Small molecular drug D0A6KR DRUGINCH 1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26) D0A6KR DRUGINKE IPOKCKJONYRRHP-UHFFFAOYSA-N D0A6KR DRUGSMIL C1=CC(=CC=C1C(=O)NCCC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O D0A6KR HIGHSTAT Approved D0A7MY DRUG__ID D0A7MY D0A7MY DRUGCOMP Biogen Idec D0A7MY DRUGTYPE Small molecular drug D0A7MY DRUGINCH 1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+ D0A7MY DRUGINKE LDCRTTXIJACKKU-ONEGZZNKSA-N D0A7MY DRUGSMIL COC(=O)C=CC(=O)OC D0A7MY HIGHSTAT Approved D0A8CJ DRUG__ID D0A8CJ D0A8CJ DRUGCOMP Santeen D0A8CJ DRUGTYPE Small molecular drug D0A8CJ DRUGINCH 1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8) D0A8CJ DRUGINKE YTGJWQPHMWSCST-UHFFFAOYSA-N D0A8CJ DRUGSMIL CC(C(=O)NCC(=O)O)S D0A8CJ HIGHSTAT Approved D0A8FB DRUG__ID D0A8FB D0A8FB DRUGCOMP Par Sterile Products Llc D0A8FB DRUGTYPE Small molecular drug D0A8FB DRUGINCH 1S/C21H28N2O5/c1-23(2)10-11-28-17-8-6-15(7-9-17)14-22-21(24)16-12-18(25-3)20(27-5)19(13-16)26-4/h6-9,12-13H,10-11,14H2,1-5H3,(H,22,24) D0A8FB DRUGINKE FEZBIKUBAYAZIU-UHFFFAOYSA-N D0A8FB DRUGSMIL CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC D0A8FB HIGHSTAT Approved D0A8RX DRUG__ID D0A8RX D0A8RX DRUGCOMP Kaken D0A8RX DRUGTYPE Small molecular drug D0A8RX DRUGINCH 1S/C24H42O21/c25-1-5-9(28)13(32)15(34)22(41-5)39-4-8-12(31)20(45-23-16(35)14(33)10(29)6(2-26)42-23)18(37)24(43-8)44-19-11(30)7(3-27)40-21(38)17(19)36/h5-38H,1-4H2/t5-,6-,7-,8-,9-,10-,11-,12-,13+,14+,15-,16-,17-,18-,19+,20+,21-,22-,23+,24+/m1/s1 D0A8RX DRUGINKE WDQLRUYAYXDIFW-RWKIJVEZSA-N D0A8RX DRUGSMIL C(C1C(C(C(C(O1)O)O)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O)O D0A8RX HIGHSTAT Approved D0A8TA DRUG__ID D0A8TA D0A8TA DRUGCOMP Akcea Therapeutics Cambridge, MA, Ionis Pharmaceuticals Carlsbad, CA D0A8TA DRUGTYPE Antisense oligonucleotide D0A8TA DRUGINCH 1S/C230H320N63O125P19S19/c1-98-55-274(217(308)254-178(98)231)142-45-112(400-419(322,438)361-70-124-113(46-143(381-124)275-56-99(2)179(232)255-218(275)309)401-423(326,442)367-76-130-119(52-149(387-130)288-92-248-152-183(236)242-89-245-186(152)288)407-427(330,446)369-78-132-121(54-151(389-132)290-94-252-156-190(290)260-215(240)263-202(156)306)408-425(328,444)365-72-125-114(47-144(382-125)276-57-100(3)180(233)256-219(276)310)406-428(331,447)372-81-134-160(171(354-38-28-344-18)206(393-134)283-64-107(10)196(300)269-226(283)317)412-432(335,451)375-84-137-163(173(356-40-30-346-20)208(395-137)285-66-109(12)198(302)271-228(285)319)415-435(338,454)377-86-139-165(175(358-42-32-348-22)210(397-139)287-68-111(14)200(304)273-230(287)321)416-436(339,455)379-87-140-166(176(359-43-33-349-23)212(398-140)292-96-250-154-185(238)244-91-247-188(154)292)417-430(333,449)371-80-133-158(295)168(351-35-25-341-15)204(391-133)282-63-106(9)195(299)268-225(282)316)123(380-142)71-362-421(324,440)403-117-50-147(279-61-104(7)193(297)266-223(279)314)386-128(117)75-366-426(329,445)409-120-53-150(289-93-251-155-189(289)259-214(239)262-201(155)305)388-131(120)77-368-424(327,443)405-118-51-148(280-62-105(8)194(298)267-224(280)315)385-127(118)74-364-422(325,441)404-116-49-146(278-60-103(6)192(296)265-222(278)313)384-126(116)73-363-420(323,439)402-115-48-145(277-58-101(4)181(234)257-220(277)311)383-129(115)79-370-429(332,448)411-162-136(394-207(172(162)355-39-29-345-19)284-65-108(11)197(301)270-227(284)318)83-374-434(337,453)414-164-138(396-209(174(164)357-41-31-347-21)286-67-110(13)199(303)272-229(286)320)85-376-433(336,452)413-161-135(392-205(170(161)353-37-27-343-17)281-59-102(5)182(235)258-221(281)312)82-378-437(340,456)418-167-141(399-213(177(167)360-44-34-350-24)293-97-253-157-191(293)261-216(241)264-203(157)307)88-373-431(334,450)410-159-122(69-294)390-211(169(159)352-36-26-342-16)291-95-249-153-184(237)243-90-246-187(153)291/h55-68,89-97,112-151,158-177,204-213,294-295H,25-54,69-88H2,1-24H3,(H,322,438)(H,323,439)(H,324,440)(H,325,441)(H,326,442)(H,327,443)(H,328,444)(H,329,445)(H,330,446)(H,331,447)(H,332,448)(H,333,449)(H,334,450)(H,335,451)(H,336,452)(H,337,453)(H,338,454)(H,339,455)(H,340,456)(H2,231,254,308)(H2,232,255,309)(H2,233,256,310)(H2,234,257,311)(H2,235,258,312)(H2,236,242,245)(H2,237,243,246)(H2,238,244,247)(H,265,296,313)(H,266,297,314)(H,267,298,315)(H,268,299,316)(H,269,300,317)(H,270,301,318)(H,271,302,319)(H,272,303,320)(H,273,304,321)(H3,239,259,262,305)(H3,240,260,263,306)(H3,241,261,264,307)/t112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,135+,136+,137+,138+,139+,140+,141+,142+,143+,144+,145+,146+,147+,148+,149+,150+,151+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,204+,205+,206+,207+,208+,209+,210+,211+,212+,213+,419?,420?,421?,422?,423?,424?,425?,426?,427?,428?,429?,430?,431?,432?,433?,434?,435?,436?,437?/m0/s1 D0A8TA DRUGINKE IJUQCWMZCMFFJP-GQSLRNSLSA-N D0A8TA DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=C(C(=O)NC6=O)C)COP(=S)(O)OC7C(OC(C7OCCOC)N8C=C(C(=O)NC8=O)C)COP(=S)(O)OC9C(OC(C9OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C(N=CN=C21)N)CO)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O D0A8TA HIGHSTAT Approved D0A8XY DRUG__ID D0A8XY D0A8XY DRUGCOMP Harvard University D0A8XY DRUGTYPE Small molecular drug D0A8XY DRUGINCH 1S/C18H21FINO2/c1-23-18(22)17-15(12-3-5-13(19)6-4-12)11-14-7-8-16(17)21(14)10-2-9-20/h2-6,9,14-17H,7-8,10-11H2,1H3/b9-2+/t14-,15+,16+,17-/m0/s1 D0A8XY DRUGINKE GTQLIPQFXVKRKJ-UNSMHXHVSA-N D0A8XY DRUGSMIL COC(=O)C1C2CCC(N2CC=CI)CC1C3=CC=C(C=C3)F D0A8XY HIGHSTAT Approved D0A9ZX DRUG__ID D0A9ZX D0A9ZX DRUGCOMP Necura Pharmaceuticals AG D0A9ZX DRUGTYPE Small molecular drug D0A9ZX DRUGINCH 1S/C35H58O12/c1-4-5-11-16-29(41)32-30(42)20-26(38)18-24(36)17-25(37)19-27(39)21-31(43)34(45)33(44)22(2)14-12-9-7-6-8-10-13-15-28(40)23(3)47-35(32)46/h6-10,12-15,23-34,36-45H,4-5,11,16-21H2,1-3H3/b7-6+,10-8+,12-9+,15-13+,22-14+/t23-,24+,25-,26+,27-,28+,29-,30+,31-,32-,33-,34-/m1/s1 D0A9ZX DRUGINKE AGJUUQSLGVCRQA-SWOUQTJZSA-N D0A9ZX DRUGSMIL CCCCCC(C1C(CC(CC(CC(CC(CC(C(C(C(=CC=CC=CC=CC=CC(C(OC1=O)C)O)C)O)O)O)O)O)O)O)O)O D0A9ZX HIGHSTAT Approved D0AE3X DRUG__ID D0AE3X D0AE3X DRUGCOMP PSivida Corp D0AE3X DRUGTYPE Small molecular drug D0AE3X DRUGINCH 1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17) D0AE3X DRUGINKE XYLJNLCSTIOKRM-UHFFFAOYSA-N D0AE3X DRUGSMIL C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br D0AE3X HIGHSTAT Approved D0AF6O DRUG__ID D0AF6O D0AF6O TRADNAME Lorbrena D0AF6O DRUGCOMP Pfizer D0AF6O DRUGINCH 1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1 D0AF6O DRUGINKE IIXWYSCJSQVBQM-LLVKDONJSA-N D0AF6O DRUGSMIL CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C D0AF6O HIGHSTAT Approved D0AN7B DRUG__ID D0AN7B D0AN7B THERCLAS Central Nervous System Stimulants D0AN7B DRUGTYPE Small molecular drug D0AN7B DRUGINCH 1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16) D0AN7B DRUGINKE DRLFMBDRBRZALE-UHFFFAOYSA-N D0AN7B DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC D0AN7B HIGHSTAT Approved D0AO6B DRUG__ID D0AO6B D0AO6B DRUGCOMP Dow Pharmaceutical Corp Sub Dow Chemical Co D0AO6B DRUGTYPE Small molecular drug D0AO6B DRUGINCH 1S/C24H30N2O2S/c1-18(28)20-7-8-24-22(17-20)26(21-5-2-3-6-23(21)29-24)13-4-12-25-14-9-19(10-15-25)11-16-27/h2-3,5-8,17,19,27H,4,9-16H2,1H3 D0AO6B DRUGINKE BTFMCMVEUCGQDX-UHFFFAOYSA-N D0AO6B DRUGSMIL CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO D0AO6B HIGHSTAT Approved D0AO9S DRUG__ID D0AO9S D0AO9S THERCLAS Anesthetics D0AO9S DRUGTYPE Small molecular drug D0AO9S DRUGINCH 1S/C3H2ClF5O/c4-1(5)3(8,9)10-2(6)7/h1-2H D0AO9S DRUGINKE JPGQOUSTVILISH-UHFFFAOYSA-N D0AO9S DRUGSMIL C(C(OC(F)F)(F)F)(F)Cl D0AO9S HIGHSTAT Approved D0AR3J DRUG__ID D0AR3J D0AR3J THERCLAS Cardiotonic Agents D0AR3J DRUGTYPE Small molecular drug D0AR3J DRUGINCH 1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1 D0AR3J DRUGINKE LPMXVESGRSUGHW-HBYQJFLCSA-N D0AR3J DRUGSMIL CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O D0AR3J HIGHSTAT Approved D0B0CP DRUG__ID D0B0CP D0B0CP THERCLAS Antipsychotic Agents D0B0CP DRUGTYPE Small molecular drug D0B0CP DRUGINCH 1S/C18H18ClNS/c1-20(2)11-5-7-14-15-6-3-4-8-17(15)21-18-10-9-13(19)12-16(14)18/h3-4,6-10,12H,5,11H2,1-2H3/b14-7- D0B0CP DRUGINKE WSPOMRSOLSGNFJ-AUWJEWJLSA-N D0B0CP DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl D0B0CP HIGHSTAT Approved D0B0SH DRUG__ID D0B0SH D0B0SH THERCLAS Bronchodilator Agents D0B0SH DRUGTYPE Small molecular drug D0B0SH DRUGINCH 1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3,12H,1-2H3;7H,4-5H2,1-3H3/q;+1/p-1 D0B0SH DRUGINKE SOELXOBIIIBLRJ-UHFFFAOYSA-M D0B0SH DRUGSMIL CN1C(=C2C(=NC=N2)N(C1=O)C)[O-].C[N+](C)(C)CCO D0B0SH HIGHSTAT Approved D0B1FE DRUG__ID D0B1FE D0B1FE THERCLAS Fibrinolytic Agents D0B1FE DRUGTYPE Small molecular drug D0B1FE DRUGINCH 1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H D0B1FE DRUGINKE DYEFUKCXAQOFHX-UHFFFAOYSA-N D0B1FE DRUGSMIL C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2 D0B1FE HIGHSTAT Approved D0B1IV DRUG__ID D0B1IV D0B1IV DRUGCOMP AuricX Pharmaceuticals Inc D0B1IV THERCLAS Antiinfective Agents D0B1IV DRUGINCH 1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1 D0B1IV DRUGINKE MYPYJXKWCTUITO-LYRMYLQWSA-N D0B1IV DRUGSMIL CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O D0B1IV HIGHSTAT Approved D0B2DP DRUG__ID D0B2DP D0B2DP DRUGCOMP Sanofi Aventis Us Llc D0B2DP DRUGTYPE Small molecular drug D0B2DP DRUGINCH 1S/C2H4Cl3O4P.Na/c3-2(4,5)1-9-10(6,7)8;/h1H2,(H2,6,7,8);/q;+1/p-1 D0B2DP DRUGINKE WFKJEZKHPGDCRK-UHFFFAOYSA-M D0B2DP DRUGSMIL C(C(Cl)(Cl)Cl)OP(=O)(O)[O-].[Na+] D0B2DP HIGHSTAT Approved D0B2OT DRUG__ID D0B2OT D0B2OT THERCLAS Antiglaucomic Agents D0B2OT DRUGTYPE Small molecular drug D0B2OT DRUGINCH 1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3 D0B2OT DRUGINKE MUCZHBLJLSDCSD-UHFFFAOYSA-N D0B2OT DRUGSMIL CC(C)OP(=O)(OC(C)C)F D0B2OT HIGHSTAT Approved D0B3QM DRUG__ID D0B3QM D0B3QM THERCLAS Anticancer Agents D0B3QM DRUGTYPE Small molecular drug D0B3QM DRUGINCH 1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)/t10-/m0/s1 D0B3QM DRUGINKE NHTGHBARYWONDQ-JTQLQIEISA-N D0B3QM DRUGSMIL CC(CC1=CC=C(C=C1)O)(C(=O)O)N D0B3QM HIGHSTAT Approved D0B3UJ DRUG__ID D0B3UJ D0B3UJ DRUGCOMP Johnson & Johnson D0B3UJ DRUGTYPE Small molecular drug D0B3UJ DRUGINCH 1S/C23H27FN4O3/c1-14-17(23(30)28-9-2-3-19(29)22(28)25-14)8-12-27-10-6-15(7-11-27)21-18-5-4-16(24)13-20(18)31-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3 D0B3UJ DRUGINKE PMXMIIMHBWHSKN-UHFFFAOYSA-N D0B3UJ DRUGSMIL CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F D0B3UJ HIGHSTAT Approved D0B5FZ DRUG__ID D0B5FZ D0B5FZ DRUGCOMP Takeda D0B5FZ DRUGTYPE Small molecular drug D0B5FZ DRUGINCH 1S/C19H17N9O5S2/c1-33-24-11(14-23-19(20)35-25-14)15(29)22-12-16(30)28-13(18(31)32)9(8-34-17(12)28)7-26-5-6-27-10(26)3-2-4-21-27/h2-6,12,17H,7-8H2,1H3,(H3-,20,22,23,25,29,31,32)/b24-11-/t12-,17-/m1/s1 D0B5FZ DRUGINKE QDUIJCOKQCCXQY-WHJQOFBOSA-N D0B5FZ DRUGSMIL CON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=C5C=CC=NN5C=C4)C(=O)[O-] D0B5FZ HIGHSTAT Approved D0B5LF DRUG__ID D0B5LF D0B5LF DRUGCOMP AstraZeneca D0B5LF DRUGTYPE Small molecular drug D0B5LF DRUGINCH 1S/C14H21N3O/c1-10(15)11-2-4-12(5-3-11)14(18)17-13-6-8-16-9-7-13/h6-12H,2-5,15H2,1H3,(H,16,17,18)/t10-,11?,12?/m1/s1 D0B5LF DRUGINKE IYOZTVGMEWJPKR-VOMCLLRMSA-N D0B5LF DRUGSMIL CC(C1CCC(CC1)C(=O)NC2=CC=NC=C2)N D0B5LF HIGHSTAT Approved D0B8MZ DRUG__ID D0B8MZ D0B8MZ DRUGCOMP Eisai D0B8MZ DRUGTYPE Small molecular drug D0B8MZ DRUGINCH 1S/C17H14N2O6S/c1-26(22,23)19-13-8-15-12(17(21)14(9-24-15)18-10-20)7-16(13)25-11-5-3-2-4-6-11/h2-10,19H,1H3,(H,18,20) D0B8MZ DRUGINKE ANMATWQYLIFGOK-UHFFFAOYSA-N D0B8MZ DRUGSMIL CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3 D0B8MZ HIGHSTAT Approved D0B8QB DRUG__ID D0B8QB D0B8QB DRUGCOMP AstraZeneca D0B8QB DRUGTYPE Small molecular drug D0B8QB DRUGINCH 1S/Mg D0B8QB DRUGINKE FYYHWMGAXLPEAU-UHFFFAOYSA-N D0B8QB DRUGSMIL [Mg] D0B8QB HIGHSTAT Approved D0B8SV DRUG__ID D0B8SV D0B8SV THERCLAS Dietary supplement D0B8SV DRUGTYPE Small molecular drug D0B8SV DRUGINCH 1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 D0B8SV DRUGINKE BOPGDPNILDQYTO-NNYOXOHSSA-N D0B8SV DRUGSMIL C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O D0B8SV HIGHSTAT Approved D0B8SY DRUG__ID D0B8SY D0B8SY DRUGCOMP Abbott Laboratories Pharmaceutical Products Div D0B8SY DRUGTYPE Small molecular drug D0B8SY DRUGINCH 1S/2C7H14O8.Ca/c2*8-1-2(9)3(10)4(11)5(12)6(13)7(14)15;/h2*2-6,8-13H,1H2,(H,14,15);/q;;+2/p-2/t2*2-,3-,4+,5-,6?;/m11./s1 D0B8SY DRUGINKE FATUQANACHZLRT-KMRXSBRUSA-L D0B8SY DRUGSMIL C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2] D0B8SY HIGHSTAT Approved D0B9AO DRUG__ID D0B9AO D0B9AO THERCLAS Antihypertensive Agents D0B9AO DRUGTYPE Small molecular drug D0B9AO DRUGINCH 1S/C25H22BrF3N4O4S/c1-2-19-31-21(14-8-9-14)22(24(30)34)33(19)12-13-7-10-18-16(11-13)20(26)23(37-18)15-5-3-4-6-17(15)32-38(35,36)25(27,28)29/h3-7,10-11,14,32H,2,8-9,12H2,1H3,(H2,30,34) D0B9AO DRUGINKE DUEWVPTZCSAMNB-UHFFFAOYSA-N D0B9AO DRUGSMIL CCC1=NC(=C(N1CC2=CC3=C(C=C2)OC(=C3Br)C4=CC=CC=C4NS(=O)(=O)C(F)(F)F)C(=O)N)C5CC5 D0B9AO HIGHSTAT Approved D0B9EJ DRUG__ID D0B9EJ D0B9EJ THERCLAS Anticancer Agents D0B9EJ DRUGTYPE Small molecular drug D0B9EJ DRUGINCH 1S/C16H19N3O6/c1-6-11(20)10-9(12(21)13(6)23-2)7(5-25-15(17)22)16(24-3)14-8(18-14)4-19(10)16/h7-8,14,18H,4-5H2,1-3H3,(H2,17,22)/t7-,8+,14+,16-/m1/s1 D0B9EJ DRUGINKE HYFMSAFINFJTFH-NGSRAFSJSA-N D0B9EJ DRUGSMIL CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)OC D0B9EJ HIGHSTAT Approved D0BA9U DRUG__ID D0BA9U D0BA9U THERCLAS Contraceptive Agents D0BA9U DRUGTYPE Small molecular drug D0BA9U DRUGINCH 1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1 D0BA9U DRUGINKE WWYNJERNGUHSAO-XUDSTZEESA-N D0BA9U DRUGSMIL CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34 D0BA9U HIGHSTAT Approved D0BC2E DRUG__ID D0BC2E D0BC2E THERCLAS Anticancer Agents D0BC2E DRUGTYPE Small molecular drug D0BC2E DRUGINCH 1S/C11H11F3N2O4/c1-10(2,18)9(17)15-6-3-4-8(16(19)20)7(5-6)11(12,13)14/h3-5,18H,1-2H3,(H,15,17) D0BC2E DRUGINKE YPQLFJODEKMJEF-UHFFFAOYSA-N D0BC2E DRUGSMIL CC(C)(C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F)O D0BC2E HIGHSTAT Approved D0BF8G DRUG__ID D0BF8G D0BF8G THERCLAS Antiinflammatory Agents D0BF8G DRUGTYPE Small molecular drug D0BF8G DRUGINCH 1S/C3H11NO7P2/c4-2-1-3(5,12(6,7)8)13(9,10)11/h5H,1-2,4H2,(H2,6,7,8)(H2,9,10,11) D0BF8G DRUGINKE WRUUGTRCQOWXEG-UHFFFAOYSA-N D0BF8G DRUGSMIL C(CN)C(O)(P(=O)(O)O)P(=O)(O)O D0BF8G HIGHSTAT Approved D0C0SK DRUG__ID D0C0SK D0C0SK THERCLAS Antimalarials D0C0SK DRUGTYPE Small molecular drug D0C0SK DRUGINCH 1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17) D0C0SK DRUGINKE WKSAUQYGYAYLPV-UHFFFAOYSA-N D0C0SK DRUGSMIL CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl D0C0SK HIGHSTAT Approved D0C1BG DRUG__ID D0C1BG D0C1BG DRUGCOMP Zyma SA D0C1BG DRUGTYPE Small molecular drug D0C1BG DRUGINCH 1S/C12H24O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h4-21H,1-3H2/t4-,5+,6+,7+,8-,9-,10+,11+,12-/m0/s1 D0C1BG DRUGINKE VQHSOMBJVWLPSR-JVCRWLNRSA-N D0C1BG DRUGSMIL C(C1C(C(C(C(O1)OC(C(CO)O)C(C(CO)O)O)O)O)O)O D0C1BG HIGHSTAT Approved D0C1PY DRUG__ID D0C1PY D0C1PY DRUGCOMP Hospira Inc D0C1PY DRUGTYPE Small molecular drug D0C1PY DRUGINCH 1S/C2H4O2.K/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1 D0C1PY DRUGINKE SCVFZCLFOSHCOH-UHFFFAOYSA-M D0C1PY DRUGSMIL CC(=O)[O-].[K+] D0C1PY HIGHSTAT Approved D0C1QZ DRUG__ID D0C1QZ D0C1QZ DRUGCOMP MCPRF D0C1QZ DRUGTYPE Small molecular drug D0C1QZ DRUGINCH 1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1/i1-1 D0C1QZ DRUGINKE OEYIOHPDSNJKLS-BJUDXGSMSA-N D0C1QZ DRUGSMIL C[N+](C)(C)CCO D0C1QZ HIGHSTAT Approved D0C1SF DRUG__ID D0C1SF D0C1SF THERCLAS Antifungal Agents D0C1SF DRUGTYPE Small molecular drug D0C1SF DRUGINCH 1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1 D0C1SF DRUGINKE DDUHZTYCFQRHIY-RBHXEPJQSA-N D0C1SF DRUGSMIL CC1CC(=O)C=C(C12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC D0C1SF HIGHSTAT Approved D0C1WH DRUG__ID D0C1WH D0C1WH THERCLAS Anticancer Agents D0C1WH DRUGTYPE Small molecular drug D0C1WH DRUGINCH 1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H D0C1WH DRUGINKE HPJKCIUCZWXJDR-UHFFFAOYSA-N D0C1WH DRUGSMIL C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3 D0C1WH HIGHSTAT Approved D0C2II DRUG__ID D0C2II D0C2II DRUGCOMP Effcon Laboratories Inc D0C2II DRUGTYPE Small molecular drug D0C2II DRUGINCH 1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12) D0C2II DRUGINKE FLOSMHQXBMRNHR-UHFFFAOYSA-N D0C2II DRUGSMIL CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C D0C2II HIGHSTAT Approved D0C3BS DRUG__ID D0C3BS D0C3BS DRUGCOMP Daiichi Sankyo D0C3BS DRUGTYPE Small molecular drug D0C3BS DRUGINCH 1S/C24H30ClN7O4S.C7H8O3S.H2O/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23;1-6-2-4-7(5-3-6)11(8,9)10;/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34);2-5H,1H3,(H,8,9,10);1H2/t13-,15-,17+;;/m0../s1 D0C3BS DRUGINKE PSMMNJNZVZZNOI-SJILXJHISA-N D0C3BS DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O D0C3BS HIGHSTAT Approved D0C3SW DRUG__ID D0C3SW D0C3SW DRUGCOMP Ardea Biosciences D0C3SW DRUGTYPE Small molecular drug D0C3SW DRUGINCH 1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23) D0C3SW DRUGINKE FGQFOYHRJSUHMR-UHFFFAOYSA-N D0C3SW DRUGSMIL C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O D0C3SW HIGHSTAT Approved D0C3YQ DRUG__ID D0C3YQ D0C3YQ DRUGCOMP ASTA Medica AG D0C3YQ DRUGTYPE Small molecular drug D0C3YQ DRUGINCH 1S/C2H6O3S2.Na/c3-7(4,5)2-1-6;/h6H,1-2H2,(H,3,4,5);/q;+1/p-1 D0C3YQ DRUGINKE XOGTZOOQQBDUSI-UHFFFAOYSA-M D0C3YQ DRUGSMIL C(CS(=O)(=O)[O-])S.[Na+] D0C3YQ HIGHSTAT Approved D0C4AM DRUG__ID D0C4AM D0C4AM DRUGCOMP Amylin Pharmaceuticals D0C4AM DRUGTYPE Small molecular drug D0C4AM DRUGINCH 1S/C171H267N51O53S2/c1-21-81(12)130(163(268)207-110(56-78(6)7)169(274)222-53-33-42-118(222)170(275)221-52-32-41-117(221)160(265)219-135(89(20)230)167(272)206-109(66-125(180)238)151(256)212-128(79(8)9)161(266)186-68-126(239)192-111(70-223)154(259)203-107(64-123(178)236)152(257)218-134(88(19)229)166(271)195-98(136(181)241)57-92-43-45-94(231)46-44-92)214-159(264)116-40-31-51-220(116)127(240)69-187-141(246)101(58-90-34-24-22-25-35-90)199-148(253)105(62-121(176)234)201-149(254)106(63-122(177)235)202-155(260)112(71-224)209-156(261)113(72-225)208-146(251)103(60-93-67-184-75-188-93)205-162(267)129(80(10)11)213-150(255)100(55-77(4)5)198-145(250)102(59-91-36-26-23-27-37-91)200-147(252)104(61-120(175)233)196-137(242)82(13)189-144(249)99(54-76(2)3)197-142(247)96(39-30-50-185-171(182)183)193-143(248)97(47-48-119(174)232)194-165(270)132(86(17)227)215-138(243)83(14)190-157(262)114-73-276-277-74-115(210-140(245)95(173)38-28-29-49-172)158(263)204-108(65-124(179)237)153(258)217-131(85(16)226)164(269)191-84(15)139(244)216-133(87(18)228)168(273)211-114/h22-27,34-37,43-46,67,75-89,95-118,128-135,223-231H,21,28-33,38-42,47-66,68-74,172-173H2,1-20H3,(H2,174,232)(H2,175,233)(H2,176,234)(H2,177,235)(H2,178,236)(H2,179,237)(H2,180,238)(H2,181,241)(H,184,188)(H,186,266)(H,187,246)(H,189,249)(H,190,262)(H,191,269)(H,192,239)(H,193,248)(H,194,270)(H,195,271)(H,196,242)(H,197,247)(H,198,250)(H,199,253)(H,200,252)(H,201,254)(H,202,260)(H,203,259)(H,204,263)(H,205,267)(H,206,272)(H,207,268)(H,208,251)(H,209,261)(H,210,245)(H,211,273)(H,212,256)(H,213,255)(H,214,264)(H,215,243)(H,216,244)(H,217,258)(H,218,257)(H,219,265)(H4,182,183,185)/t81-,82-,83-,84-,85+,86+,87+,88+,89+,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,128-,129-,130-,131-,132-,133-,134-,135-/m0/s1 D0C4AM DRUGINKE TZIRZGBAFTZREM-MKAGXXMWSA-N D0C4AM DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C8CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)C(C)O)C)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N D0C4AM HIGHSTAT Approved D0C4YC DRUG__ID D0C4YC D0C4YC THERCLAS Antiinflammatory Agents D0C4YC DRUGTYPE Small molecular drug D0C4YC DRUGINCH 1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11) D0C4YC DRUGINKE KBOPZPXVLCULAV-UHFFFAOYSA-N D0C4YC DRUGSMIL C1=CC(=C(C=C1N)C(=O)O)O D0C4YC HIGHSTAT Approved D0C6QG DRUG__ID D0C6QG D0C6QG DRUGCOMP Bracco Diagnostics Inc D0C6QG DRUGTYPE Small molecular drug D0C6QG DRUGINCH 1S/2ClH.Mn.4H2O/h2*1H;;4*1H2/q;;+2;;;;/p-2 D0C6QG DRUGINKE CNFDGXZLMLFIJV-UHFFFAOYSA-L D0C6QG DRUGSMIL O.O.O.O.Cl[Mn]Cl D0C6QG HIGHSTAT Approved D0C7ET DRUG__ID D0C7ET D0C7ET THERCLAS Antibiotics D0C7ET DRUGTYPE Small molecular drug D0C7ET DRUGINCH 1S/C11H17N3O8/c12-8-13-6(17)2-4-9(19,1-15)5-3(16)10(2,14-8)7(18)11(20,21-4)22-5/h2-7,15-20H,1H2,(H3,12,13,14)/t2-,3-,4-,5+,6-,7+,9+,10-,11+/m1/s1 D0C7ET DRUGINKE CFMYXEVWODSLAX-QOZOJKKESA-N D0C7ET DRUGSMIL C(C1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O)O D0C7ET HIGHSTAT Approved D0C7JF DRUG__ID D0C7JF D0C7JF THERCLAS Anticancer Agents D0C7JF DRUGTYPE Small molecular drug D0C7JF DRUGINCH 1S/C19H24O3/c1-18-9-7-13(20)11-12(18)3-4-14-15(18)8-10-19(2)16(14)5-6-17(21)22-19/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15+,16+,18+,19+/m1/s1 D0C7JF DRUGINKE BPEWUONYVDABNZ-DZBHQSCQSA-N D0C7JF DRUGSMIL CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C D0C7JF HIGHSTAT Approved D0C8AP DRUG__ID D0C8AP D0C8AP TRADNAME Pyrukynd D0C8AP DRUGCOMP Agios D0C8AP DRUGINCH 1S/C24H26N4O3S/c29-24(28-15-13-27(14-16-28)17-18-6-7-18)20-8-10-21(11-9-20)26-32(30,31)22-5-1-3-19-4-2-12-25-23(19)22/h1-5,8-12,18,26H,6-7,13-17H2 D0C8AP DRUGINKE XAYGBKHKBBXDAK-UHFFFAOYSA-N D0C8AP DRUGSMIL C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5 D0C8AP HIGHSTAT Approved D0C8FX DRUG__ID D0C8FX D0C8FX DRUGCOMP Warner Chilcott Co Llc D0C8FX DRUGTYPE Small molecular drug D0C8FX DRUGINCH 1S/2C5H4NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4H;/q2*-1;+2 D0C8FX DRUGINKE PICXIOQBANWBIZ-UHFFFAOYSA-N D0C8FX DRUGSMIL C1=CC(=S)N(C=C1)[O-].C1=CC(=S)N(C=C1)[O-].[Zn+2] D0C8FX HIGHSTAT Approved D0C8HR DRUG__ID D0C8HR D0C8HR DRUGCOMP Ciba-Geigy D0C8HR DRUGTYPE Small molecular drug D0C8HR DRUGINCH 1S/C22H27ClF2O5/c1-10-4-11-12-5-15(24)13-6-16(27)14(23)7-19(13,2)21(12,25)17(28)8-20(11,3)22(10,30)18(29)9-26/h6-7,10-12,15,17,26,28,30H,4-5,8-9H2,1-3H3/t10-,11+,12+,15+,17+,19+,20+,21+,22+/m1/s1 D0C8HR DRUGINKE GGXMRPUKBWXVHE-MIHLVHIWSA-N D0C8HR DRUGSMIL CC1CC2C3CC(C4=CC(=O)C(=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)Cl)F D0C8HR HIGHSTAT Approved D0CA6J DRUG__ID D0CA6J D0CA6J THERCLAS Antifungal Agents D0CA6J DRUGTYPE Small molecular drug D0CA6J DRUGINCH 1S/C16H13Cl3N2OS/c17-12-1-2-13(14(18)7-12)15(8-21-5-4-20-10-21)22-9-11-3-6-23-16(11)19/h1-7,10,15H,8-9H2 D0CA6J DRUGINKE QXHHHPZILQDDPS-UHFFFAOYSA-N D0CA6J DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl D0CA6J HIGHSTAT Approved D0CF0Y DRUG__ID D0CF0Y D0CF0Y DRUGCOMP TESARO D0CF0Y DRUGTYPE Small molecular drug D0CF0Y DRUGINCH 1S/C25H26F6N2O2/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34)/t16-,22-,23-/m1/s1 D0CF0Y DRUGINKE FIVSJYGQAIEMOC-ZGNKEGEESA-N D0CF0Y DRUGSMIL CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC3(CCC(=O)N3)CN2)C4=CC=CC=C4 D0CF0Y HIGHSTAT Approved D0CK3G DRUG__ID D0CK3G D0CK3G THERCLAS Hypnotics and Sedatives D0CK3G DRUGTYPE Small molecular drug D0CK3G DRUGINCH 1S/C9H13NO2/c1-2-9(12-8(10)11)6-4-3-5-7-9/h1H,3-7H2,(H2,10,11) D0CK3G DRUGINKE GXRZIMHKGDIBEW-UHFFFAOYSA-N D0CK3G DRUGSMIL C#CC1(CCCCC1)OC(=O)N D0CK3G HIGHSTAT Approved D0CT4D DRUG__ID D0CT4D D0CT4D DRUGCOMP UCB D0CT4D DRUGTYPE Small molecular drug D0CT4D DRUGINCH 1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1 D0CT4D DRUGINKE MSYKRHVOOPPJKU-BDAKNGLRSA-N D0CT4D DRUGSMIL CCCC1CC(=O)N(C1)C(CC)C(=O)N D0CT4D HIGHSTAT Approved D0CT9Y DRUG__ID D0CT9Y D0CT9Y THERCLAS Fertility Agents D0CT9Y DRUGTYPE Small molecular drug D0CT9Y DRUGINCH 1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+ D0CT9Y DRUGINKE GKIRPKYJQBWNGO-OCEACIFDSA-N D0CT9Y DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3 D0CT9Y HIGHSTAT Approved D0CW1P DRUG__ID D0CW1P D0CW1P THERCLAS Antiinflammatory Agents D0CW1P DRUGTYPE Small molecular drug D0CW1P DRUGINCH 1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1 D0CW1P DRUGINKE UREBDLICKHMUKA-DVTGEIKXSA-N D0CW1P DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C D0CW1P HIGHSTAT Approved D0CZ1Q DRUG__ID D0CZ1Q D0CZ1Q THERCLAS Antiinflammatory Agents D0CZ1Q DRUGTYPE Small molecular drug D0CZ1Q DRUGINCH 1S/C22H29FO4/c1-12-8-16-15-5-4-13-9-14(25)6-7-21(13,3)22(15,23)18(27)10-20(16,2)19(12)17(26)11-24/h6-7,9,12,15-16,18-19,24,27H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,18+,19-,20+,21+,22+/m1/s1 D0CZ1Q DRUGINKE VWVSBHGCDBMOOT-IIEHVVJPSA-N D0CZ1Q DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C D0CZ1Q HIGHSTAT Approved D0D0SH DRUG__ID D0D0SH D0D0SH DRUGCOMP Russian Academy of Sciences D0D0SH DRUGTYPE Small molecular drug D0D0SH DRUGINCH 1S/C25H43N5O15/c1-8(21(37)30-11(23(39)40)4-5-14(26)34)28-22(38)9(2)42-20-16(29-10(3)33)24(41)43-13(7-32)19(20)45-25-15(27)18(36)17(35)12(6-31)44-25/h8-9,11-13,15-20,24-25,31-32,35-36,41H,4-7,27H2,1-3H3,(H2,26,34)(H,28,38)(H,29,33)(H,30,37)(H,39,40)/t8-,9?,11+,12+,13+,15+,16+,17+,18+,19+,20+,24-,25-/m0/s1 D0D0SH DRUGINKE MXMOFDISXOBSJM-QYRWPYKKSA-N D0D0SH DRUGSMIL CC(C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(C)OC1C(C(OC(C1OC2C(C(C(C(O2)CO)O)O)N)CO)O)NC(=O)C D0D0SH HIGHSTAT Approved D0D0YM DRUG__ID D0D0YM D0D0YM DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0D0YM DRUGTYPE Small molecular drug D0D0YM DRUGINCH 1S/C18H24N2O5S/c1-13-7-8-14(11-18(13)26(19,22)23)15(21)12-20-9-10-25-17-6-4-3-5-16(17)24-2/h3-8,11,15,20-21H,9-10,12H2,1-2H3,(H2,19,22,23) D0D0YM DRUGINKE LVEXHFZHOIWIIP-UHFFFAOYSA-N D0D0YM DRUGSMIL CC1=C(C=C(C=C1)C(CNCCOC2=CC=CC=C2OC)O)S(=O)(=O)N D0D0YM HIGHSTAT Approved D0D0ZD DRUG__ID D0D0ZD D0D0ZD THERCLAS Hypoglycemic Agents D0D0ZD DRUGTYPE Small molecular drug D0D0ZD DRUGINCH 1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1 D0D0ZD DRUGINKE IBAQFPQHRJAVAV-ULAWRXDQSA-N D0D0ZD DRUGSMIL C1C(C(C(C(N1CCO)CO)O)O)O D0D0ZD HIGHSTAT Approved D0D1BR DRUG__ID D0D1BR D0D1BR DRUGCOMP Gilead Sciences D0D1BR DRUGTYPE Small molecular drug D0D1BR DRUGINCH 1S/C21H29N6O5P/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24)/t15-,16+,33+/m1/s1 D0D1BR DRUGINKE LDEKQSIMHVQZJK-CAQYMETFSA-N D0D1BR DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3 D0D1BR HIGHSTAT Approved D0D1ZF DRUG__ID D0D1ZF D0D1ZF TRADNAME Camzyos D0D1ZF DRUGCOMP Bristol Myers Squibb D0D1ZF DRUGINCH 1S/C15H19N3O2/c1-10(2)18-14(19)9-13(17-15(18)20)16-11(3)12-7-5-4-6-8-12/h4-11,16H,1-3H3,(H,17,20)/t11-/m0/s1 D0D1ZF DRUGINKE RLCLASQCAPXVLM-NSHDSACASA-N D0D1ZF DRUGSMIL CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2 D0D1ZF HIGHSTAT Approved D0D2TN DRUG__ID D0D2TN D0D2TN DRUGCOMP Auritec Pharmaceuticals Inc D0D2TN DRUGTYPE Small molecular drug D0D2TN DRUGINCH 1S/C24H34O3/c1-6-20(27)24(5)14(2)11-18-17-8-7-15-12-16(25)9-10-22(15,3)21(17)19(26)13-23(18,24)4/h9-10,12,14,17-19,21,26H,6-8,11,13H2,1-5H3/t14-,17+,18+,19+,21-,22+,23+,24-/m1/s1 D0D2TN DRUGINKE QTTRZHGPGKRAFB-OOKHYKNYSA-N D0D2TN DRUGSMIL CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C D0D2TN HIGHSTAT Approved D0D2VS DRUG__ID D0D2VS D0D2VS THERCLAS Anticancer Agents D0D2VS DRUGTYPE Small molecular drug D0D2VS DRUGINCH 1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1 D0D2VS DRUGINKE BFYIZQONLCFLEV-DAELLWKTSA-N D0D2VS DRUGSMIL CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C D0D2VS HIGHSTAT Approved D0D4CY DRUG__ID D0D4CY D0D4CY THERCLAS Dermatologic Agents D0D4CY DRUGTYPE Small molecular drug D0D4CY DRUGINCH 1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14) D0D4CY DRUGINKE GECHUMIMRBOMGK-UHFFFAOYSA-N D0D4CY DRUGSMIL C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N D0D4CY HIGHSTAT Approved D0D4HN DRUG__ID D0D4HN D0D4HN DRUGCOMP Actavis Laboratories Ut Inc D0D4HN DRUGTYPE Small molecular drug D0D4HN DRUGINCH 1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1 D0D4HN DRUGINKE YJGVMLPVUAXIQN-XVVDYKMHSA-N D0D4HN DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O D0D4HN HIGHSTAT Approved D0D4IH DRUG__ID D0D4IH D0D4IH DRUGCOMP Dieckmann D0D4IH DRUGTYPE Small molecular drug D0D4IH DRUGINCH 1S/C19H26NO4.BrH/c1-3-20(2)15-9-13(10-16(20)18-17(15)24-18)23-19(22)14(11-21)12-7-5-4-6-8-12;/h4-8,13-18,21H,3,9-11H2,1-2H3;1H/q+1;/p-1/t13?,14-,15-,16+,17-,18+,20?;/m1./s1 D0D4IH DRUGINKE LCELQERNWLBPSY-YAYGZGPXSA-M D0D4IH DRUGSMIL CC[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C.[Br-] D0D4IH HIGHSTAT Approved D0D4PB DRUG__ID D0D4PB D0D4PB THERCLAS Analgesics D0D4PB DRUGTYPE Small molecular drug D0D4PB DRUGINCH 1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3/t18-,22+/m1/s1 D0D4PB DRUGINKE XLMALTXPSGQGBX-GCJKJVERSA-N D0D4PB DRUGSMIL CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C D0D4PB HIGHSTAT Approved D0D4YZ DRUG__ID D0D4YZ D0D4YZ DRUGCOMP Gilead Sciences D0D4YZ DRUGTYPE Small molecular drug D0D4YZ DRUGINCH 1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1 D0D4YZ DRUGINKE TTZHDVOVKQGIBA-IQWMDFIBSA-N D0D4YZ DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 D0D4YZ HIGHSTAT Approved D0D5GD DRUG__ID D0D5GD D0D5GD DRUGCOMP Coeruleus Ltd D0D5GD DRUGTYPE Small molecular drug D0D5GD DRUGINCH 1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3 D0D5GD DRUGINKE OFBIFZUFASYYRE-UHFFFAOYSA-N D0D5GD DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C D0D5GD HIGHSTAT Approved D0D8VE DRUG__ID D0D8VE D0D8VE THERCLAS Anesthetics D0D8VE DRUGTYPE Small molecular drug D0D8VE DRUGINCH 1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H D0D8VE DRUGINKE BCQZXOMGPXTTIC-UHFFFAOYSA-N D0D8VE DRUGSMIL C(C(F)(F)F)(Cl)Br D0D8VE HIGHSTAT Approved D0D9NA DRUG__ID D0D9NA D0D9NA THERCLAS Antiinflammatory Agents D0D9NA DRUGTYPE Small molecular drug D0D9NA DRUGINCH 1S/C26H29F2N7/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33) D0D9NA DRUGINKE OBDOVFRMEYHSQB-UHFFFAOYSA-N D0D9NA DRUGSMIL C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C D0D9NA HIGHSTAT Approved D0D9NY DRUG__ID D0D9NY D0D9NY DRUGCOMP Esperion Therapeutics D0D9NY DRUGTYPE Small molecular drug D0D9NY DRUGINCH 1S/C19H36O5/c1-18(2,16(21)22)13-9-5-7-11-15(20)12-8-6-10-14-19(3,4)17(23)24/h15,20H,5-14H2,1-4H3,(H,21,22)(H,23,24) D0D9NY DRUGINKE HYHMLYSLQUKXKP-UHFFFAOYSA-N D0D9NY DRUGSMIL CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)O)O)C(=O)O D0D9NY HIGHSTAT Approved D0DJ1B DRUG__ID D0DJ1B D0DJ1B DRUGCOMP Iroko pharmaceuticals; PLx Pharma; CeNeS Pharmaceuticals plc D0DJ1B DRUGTYPE Small molecular drug D0DJ1B DRUGINCH 1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1 D0DJ1B DRUGINKE CMWTZPSULFXXJA-VIFPVBQESA-N D0DJ1B DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O D0DJ1B HIGHSTAT Approved D0DK8G DRUG__ID D0DK8G D0DK8G DRUGCOMP Ge Healthcare D0DK8G DRUGTYPE Small molecular drug D0DK8G DRUGINCH 1S/C2H8O7P2.Tc/c1-2(3,10(4,5)6)11(7,8)9;/h3H,1H3,(H2,4,5,6)(H2,7,8,9);/i;1+1 D0DK8G DRUGINKE VEXMHRQGHKTMHQ-IEOVAKBOSA-N D0DK8G DRUGSMIL CC(O)(P(=O)(O)O)P(=O)(O)O.[Tc] D0DK8G HIGHSTAT Approved D0DP6L DRUG__ID D0DP6L D0DP6L THERCLAS Anesthetics D0DP6L DRUGTYPE Small molecular drug D0DP6L DRUGINCH 1S/C3H2ClF5O/c4-1(3(7,8)9)10-2(5)6/h1-2H D0DP6L DRUGINKE PIWKPBJCKXDKJR-UHFFFAOYSA-N D0DP6L DRUGSMIL C(C(F)(F)F)(OC(F)F)Cl D0DP6L HIGHSTAT Approved D0DQ7V DRUG__ID D0DQ7V D0DQ7V TRADNAME Lutathera D0DQ7V DRUGCOMP Advanced Accelerator Applications/Novartis D0DQ7V DRUGINCH 1S/C65H90N14O19S2.Lu/c1-38(80)56-64(96)73-51(63(95)75-57(39(2)81)65(97)98)37-100-99-36-50(72-59(91)47(28-40-10-4-3-5-11-40)68-52(83)32-76-20-22-77(33-53(84)85)24-26-79(35-55(88)89)27-25-78(23-21-76)34-54(86)87)62(94)70-48(29-41-15-17-43(82)18-16-41)60(92)71-49(30-42-31-67-45-13-7-6-12-44(42)45)61(93)69-46(58(90)74-56)14-8-9-19-66;/h3-7,10-13,15-18,31,38-39,46-51,56-57,67,80-82H,8-9,14,19-30,32-37,66H2,1-2H3,(H,68,83)(H,69,93)(H,70,94)(H,71,92)(H,72,91)(H,73,96)(H,74,90)(H,75,95)(H,84,85)(H,86,87)(H,88,89)(H,97,98);/q;+3/p-3/t38-,39-,46+,47-,48+,49-,50+,51+,56+,57+;/m1./s1/i;1+2 D0DQ7V DRUGINKE MXDPZUIOZWKRAA-PRDSJKGBSA-K D0DQ7V DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(C(C)O)C(=O)O)O.[Lu+3] D0DQ7V HIGHSTAT Approved D0DZ3X DRUG__ID D0DZ3X D0DZ3X THERCLAS Dietary supplement D0DZ3X DRUGTYPE Small molecular drug D0DZ3X DRUGINCH 1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1 D0DZ3X DRUGINKE ONIBWKKTOPOVIA-BYPYZUCNSA-N D0DZ3X DRUGSMIL C1CC(NC1)C(=O)O D0DZ3X HIGHSTAT Approved D0E0BD DRUG__ID D0E0BD D0E0BD DRUGCOMP Ucyclyd Pharma Inc D0E0BD DRUGTYPE Small molecular drug D0E0BD DRUGINCH 1S/C33H38O6/c34-31(22-10-19-27-13-4-1-5-14-27)37-25-30(39-33(36)24-12-21-29-17-8-3-9-18-29)26-38-32(35)23-11-20-28-15-6-2-7-16-28/h1-9,13-18,30H,10-12,19-26H2 D0E0BD DRUGINKE ZSDBFLMJVAGKOU-UHFFFAOYSA-N D0E0BD DRUGSMIL C1=CC=C(C=C1)CCCC(=O)OCC(COC(=O)CCCC2=CC=CC=C2)OC(=O)CCCC3=CC=CC=C3 D0E0BD HIGHSTAT Approved D0E0SW DRUG__ID D0E0SW D0E0SW THERCLAS Cardiotonic Agents D0E0SW DRUGTYPE Small molecular drug D0E0SW DRUGINCH 1S/C12H12N2O2S/c1-7-10(14-12(16)13-7)11(15)8-3-5-9(17-2)6-4-8/h3-6H,1-2H3,(H2,13,14,16) D0E0SW DRUGINKE ZJKNESGOIKRXQY-UHFFFAOYSA-N D0E0SW DRUGSMIL CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC D0E0SW HIGHSTAT Approved D0E1HC DRUG__ID D0E1HC D0E1HC TRADNAME Symdeko D0E1HC DRUGCOMP Vertex Pharmaceuticals D0E1HC DRUGINCH 1S/C26H27F3N2O6.C24H28N2O3/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20;1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35);7-13,27H,1-6H3,(H,25,28)(H,26,29)/t16-;/m1./s1 D0E1HC DRUGINKE NETGOEWJJZQLCO-PKLMIRHRSA-N D0E1HC DRUGSMIL CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F D0E1HC HIGHSTAT Approved D0E1OJ DRUG__ID D0E1OJ D0E1OJ DRUGCOMP Ge Healthcare D0E1OJ DRUGTYPE Small molecular drug D0E1OJ DRUGINCH 1S/Xe/i1+2 D0E1OJ DRUGINKE FHNFHKCVQCLJFQ-NJFSPNSNSA-N D0E1OJ DRUGSMIL [Xe] D0E1OJ HIGHSTAT Approved D0E1SW DRUG__ID D0E1SW D0E1SW THERCLAS Anticonvulsants D0E1SW DRUGTYPE Small molecular drug D0E1SW DRUGINCH 1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9) D0E1SW DRUGINKE BZKPWHYZMXOIDC-UHFFFAOYSA-N D0E1SW DRUGSMIL CC(=O)NC1=NN=C(S1)S(=O)(=O)N D0E1SW HIGHSTAT Approved D0E2OU DRUG__ID D0E2OU D0E2OU THERCLAS Antibiotics D0E2OU DRUGTYPE Small molecular drug D0E2OU DRUGINCH 1S/C53H67N9O10S/c1-6-37-50(68)61-23-11-14-38(61)51(69)59(5)40(26-32-16-18-36(19-17-32)58(3)4)52(70)62-28-35(30-73-43-29-60-24-20-33(43)21-25-60)42(64)27-39(62)47(65)57-45(34-12-8-7-9-13-34)53(71)72-31(2)44(48(66)55-37)56-49(67)46-41(63)15-10-22-54-46/h7-10,12-13,15-19,22,31,33,35,37-40,43-45,63H,6,11,14,20-21,23-30H2,1-5H3,(H,55,66)(H,56,67)(H,57,65)/t31-,35+,37-,38+,39+,40+,43-,44+,45+/m1/s1 D0E2OU DRUGINKE WTHRRGMBUAHGNI-LCYNINFDSA-N D0E2OU DRUGSMIL CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C D0E2OU HIGHSTAT Approved D0E3BH DRUG__ID D0E3BH D0E3BH THERCLAS Gastrointestinal Agents D0E3BH DRUGTYPE Small molecular drug D0E3BH DRUGINCH 1S/C18H17F3N2O3/c19-18(20,21)15-7-3-5-13(11-15)17(14-6-4-9-22-12-14)23-26-10-2-1-8-16(24)25/h3-7,9,11-12H,1-2,8,10H2,(H,24,25)/b23-17+ D0E3BH DRUGINKE GLLPUTYLZIKEGF-HAVVHWLPSA-N D0E3BH DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C(=NOCCCCC(=O)O)C2=CN=CC=C2 D0E3BH HIGHSTAT Approved D0E3SF DRUG__ID D0E3SF D0E3SF DRUGCOMP Biovertis D0E3SF DRUGTYPE Small molecular drug D0E3SF DRUGINCH 1S/C31H33F2N4O11P/c1-17(38)34-13-20-14-37(30(42)47-20)19-4-5-27(24(33)10-19)46-16-31(48-49(43,44)45)6-8-35(9-7-31)26-12-25-21(11-23(26)32)28(39)22(29(40)41)15-36(25)18-2-3-18/h4-5,10-12,15,18,20H,2-3,6-9,13-14,16H2,1H3,(H,34,38)(H,40,41)(H2,43,44,45)/t20-/m0/s1 D0E3SF DRUGINKE MNABRWLVTSGIMU-FQEVSTJZSA-N D0E3SF DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)OCC3(CCN(CC3)C4=C(C=C5C(=C4)N(C=C(C5=O)C(=O)O)C6CC6)F)OP(=O)(O)O)F D0E3SF HIGHSTAT Approved D0E3SH DRUG__ID D0E3SH D0E3SH DRUGCOMP Novartis D0E3SH DRUGTYPE Small molecular drug D0E3SH DRUGINCH 1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/b11-10+ D0E3SH DRUGINKE FPOHNWQLNRZRFC-ZHACJKMWSA-N D0E3SH DRUGSMIL CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO D0E3SH HIGHSTAT Approved D0E4SI DRUG__ID D0E4SI D0E4SI DRUGCOMP Pierrel D0E4SI DRUGTYPE Small molecular drug D0E4SI DRUGINCH 1S/C37H67NO13.C4H6O4S.C3H6O2/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;5-3(6)1-2(9)4(7)8;1-2-3(4)5/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2,9H,1H2,(H,5,6)(H,7,8);2H2,1H3,(H,4,5)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;;/m1../s1 D0E4SI DRUGINKE BKKRRHRHFZPQSJ-INORWZNNSA-N D0E4SI DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.CCC(=O)O.C(C(C(=O)O)S)C(=O)O D0E4SI HIGHSTAT Approved D0E4WR DRUG__ID D0E4WR D0E4WR THERCLAS Dermatologic Agents D0E4WR DRUGTYPE Small molecular drug D0E4WR DRUGINCH 1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13) D0E4WR DRUGINKE BDJRBEYXGGNYIS-UHFFFAOYSA-N D0E4WR DRUGSMIL C(CCCC(=O)O)CCCC(=O)O D0E4WR HIGHSTAT Approved D0E6OC DRUG__ID D0E6OC D0E6OC DRUGCOMP Kissei D0E6OC DRUGTYPE Small molecular drug D0E6OC DRUGINCH 1S/C18H17NO5/c1-23-15-9-7-12(11-16(15)24-2)8-10-17(20)19-14-6-4-3-5-13(14)18(21)22/h3-11H,1-2H3,(H,19,20)(H,21,22)/b10-8+ D0E6OC DRUGINKE NZHGWWWHIYHZNX-CSKARUKUSA-N D0E6OC DRUGSMIL COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC D0E6OC HIGHSTAT Approved D0E6YQ DRUG__ID D0E6YQ D0E6YQ THERCLAS Parasympathomimetics D0E6YQ DRUGTYPE Small molecular drug D0E6YQ DRUGINCH 1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15) D0E6YQ DRUGINKE YLJREFDVOIBQDA-UHFFFAOYSA-N D0E6YQ DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)N D0E6YQ HIGHSTAT Approved D0E7FS DRUG__ID D0E7FS D0E7FS THERCLAS Antidepressants D0E7FS DRUGTYPE Small molecular drug D0E7FS DRUGINCH 1S/C19H18ClN5/c1-24(2)12-18-23-22-17-11-21-19(13-6-4-3-5-7-13)15-10-14(20)8-9-16(15)25(17)18/h3-10H,11-12H2,1-2H3 D0E7FS DRUGINKE GJSLOMWRLALDCT-UHFFFAOYSA-N D0E7FS DRUGSMIL CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4 D0E7FS HIGHSTAT Approved D0E7MV DRUG__ID D0E7MV D0E7MV THERCLAS Antibiotics D0E7MV DRUGTYPE Small molecular drug D0E7MV DRUGINCH 1S/C25H44N14O8.C25H44N14O7/c26-4-1-2-11(27)6-17(41)32-8-14-20(43)35-15(9-34-25(30)47)21(44)39-18(13-3-5-31-24(29)38-13)23(46)33-7-12(28)19(42)37-16(10-40)22(45)36-14;1-11-19(41)36-15(9-32-17(40)7-12(27)3-2-5-26)21(43)37-16(10-34-25(30)46)22(44)39-18(14-4-6-31-24(29)38-14)23(45)33-8-13(28)20(42)35-11/h9,11-14,16,18,40H,1-8,10,26-28H2,(H,32,41)(H,33,46)(H,35,43)(H,36,45)(H,37,42)(H,39,44)(H3,29,31,38)(H3,30,34,47);10-15,18H,2-9,26-28H2,1H3,(H,32,40)(H,33,45)(H,35,42)(H,36,41)(H,37,43)(H,39,44)(H3,29,31,38)(H3,30,34,46)/b15-9+;16-10+/t11-,12-,13+,14-,16-,18-;11-,12-,13-,14+,15-,18-/m00/s1 D0E7MV DRUGINKE VCOPTHOUUNAYKQ-WBTCAYNUSA-N D0E7MV DRUGSMIL CC1C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)NC(C(=O)NCC(C(=O)N1)N)C2CCN=C(N2)N)CNC(=O)CC(CCCN)N.C1CN=C(NC1C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CNC(=O)CC(CCCN)N)CO)N)N D0E7MV HIGHSTAT Approved D0E7QN DRUG__ID D0E7QN D0E7QN DRUGCOMP Meiji Seika D0E7QN DRUGTYPE Small molecular drug D0E7QN DRUGINCH 1S/C15H18N4O4S/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)24-9-3-17-5-16-6-18(17)4-9/h5-11,20H,3-4H2,1-2H3/t7-,8-,10-,11-/m1/s1 D0E7QN DRUGINKE MRMBZHPJVKCOMA-YJFSRANCSA-N D0E7QN DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CN4C=NC=[N+]4C3)C(=O)[O-])C(C)O D0E7QN HIGHSTAT Approved D0E8CI DRUG__ID D0E8CI D0E8CI THERCLAS Antiallergic Agents D0E8CI DRUGTYPE Small molecular drug D0E8CI DRUGINCH 1S/C19H22N2/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21/h2-3,6-12H,4-5,13-15H2,1H3/b18-11+ D0E8CI DRUGINKE CBEQULMOCCWAQT-WOJGMQOQSA-N D0E8CI DRUGSMIL CC1=CC=C(C=C1)C(=CCN2CCCC2)C3=CC=CC=N3 D0E8CI HIGHSTAT Approved D0E9CD DRUG__ID D0E9CD D0E9CD THERCLAS Anticancer Agents D0E9CD DRUGTYPE Small molecular drug D0E9CD DRUGINCH 1S/C8H8O3/c1-11-8-3-2-6(5-9)4-7(8)10/h2-5,10H,1H3 D0E9CD DRUGINKE JVTZFYYHCGSXJV-UHFFFAOYSA-N D0E9CD DRUGSMIL COC1=C(C=C(C=C1)C=O)O D0E9CD HIGHSTAT Approved D0E9JM DRUG__ID D0E9JM D0E9JM THERCLAS Dietary supplement D0E9JM DRUGTYPE Small molecular drug D0E9JM DRUGINCH 1S/ClH.K/h1H;/q;+1/p-1 D0E9JM DRUGINKE WCUXLLCKKVVCTQ-UHFFFAOYSA-M D0E9JM DRUGSMIL [Cl-].[K+] D0E9JM HIGHSTAT Approved D0E9KA DRUG__ID D0E9KA D0E9KA DRUGCOMP LEO Pharma D0E9KA DRUGTYPE Small molecular drug D0E9KA DRUGINCH 1S/C25H34O6/c1-7-12(2)22(29)31-21-13(3)10-24-14(4)8-17-18(23(17,5)6)16(20(24)28)9-15(11-26)19(27)25(21,24)30/h7,9-10,14,16-19,21,26-27,30H,8,11H2,1-6H3/b12-7-/t14-,16+,17-,18+,19-,21+,24+,25+/m1/s1 D0E9KA DRUGINKE VDJHFHXMUKFKET-WDUFCVPESA-N D0E9KA DRUGSMIL CC=C(C)C(=O)OC1C(=CC23C1(C(C(=CC(C2=O)C4C(C4(C)C)CC3C)CO)O)O)C D0E9KA HIGHSTAT Approved D0E9WO DRUG__ID D0E9WO D0E9WO DRUGCOMP Sapos SA D0E9WO DRUGTYPE Small molecular drug D0E9WO DRUGINCH 1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27) D0E9WO DRUGINKE QHZQILHUJDRDAI-UHFFFAOYSA-N D0E9WO DRUGSMIL CCCCOCC(CN1C(=O)C(C(=O)NC1=O)(CC)C2=CC=CC=C2)OC(=O)N D0E9WO HIGHSTAT Approved D0EG1I DRUG__ID D0EG1I D0EG1I DRUGCOMP Pfizer D0EG1I DRUGTYPE Small molecular drug D0EG1I DRUGINCH 1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 D0EG1I DRUGINKE UJLAWZDWDVHWOW-YPMHNXCESA-N D0EG1I DRUGSMIL CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N D0EG1I HIGHSTAT Approved D0EJ6O DRUG__ID D0EJ6O D0EJ6O THERCLAS Anticancer Agents D0EJ6O DRUGTYPE Small molecular drug D0EJ6O DRUGINCH 1S/C13H14Cl2O3/c1-12(2,11(16)17)18-9-5-3-8(4-6-9)10-7-13(10,14)15/h3-6,10H,7H2,1-2H3,(H,16,17) D0EJ6O DRUGINKE KPSRODZRAIWAKH-UHFFFAOYSA-N D0EJ6O DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl D0EJ6O HIGHSTAT Approved D0EN0G DRUG__ID D0EN0G D0EN0G THERCLAS Diagnostic Agents D0EN0G DRUGTYPE Small molecular drug D0EN0G DRUGINCH 1S/C5H9N3.2H3O4P/c6-2-1-5-3-7-4-8-5;2*1-5(2,3)4/h3-4H,1-2,6H2,(H,7,8);2*(H3,1,2,3,4) D0EN0G DRUGINKE ZHIBQGJKHVBLJJ-UHFFFAOYSA-N D0EN0G DRUGSMIL C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O D0EN0G HIGHSTAT Approved D0ES1Q DRUG__ID D0ES1Q D0ES1Q DRUGCOMP Wyeth D0ES1Q DRUGTYPE Small molecular drug D0ES1Q DRUGINCH 1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1 D0ES1Q DRUGINKE CBPNZQVSJQDFBE-FUXHJELOSA-N D0ES1Q DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC D0ES1Q HIGHSTAT Approved D0F0ZE DRUG__ID D0F0ZE D0F0ZE DRUGCOMP GSK D0F0ZE DRUGTYPE Small molecular drug D0F0ZE DRUGINCH 1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)/t18-/m0/s1 D0F0ZE DRUGINKE JBPUGFODGPKTDW-SFHVURJKSA-N D0F0ZE DRUGSMIL COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4 D0F0ZE HIGHSTAT Approved D0F0ZY DRUG__ID D0F0ZY D0F0ZY DRUGCOMP GlaxoSmithKline D0F0ZY DRUGTYPE Small molecular drug D0F0ZY DRUGINCH 1S/C21H23N7O2S.ClH/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16;/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25);1H D0F0ZY DRUGINKE MQHIQUBXFFAOMK-UHFFFAOYSA-N D0F0ZY DRUGSMIL CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl D0F0ZY HIGHSTAT Approved D0F1GS DRUG__ID D0F1GS D0F1GS DRUGCOMP Fresenius Medical Care North America D0F1GS DRUGTYPE Small molecular drug D0F1GS DRUGINCH 1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2 D0F1GS DRUGINKE VSGNNIFQASZAOI-UHFFFAOYSA-L D0F1GS DRUGSMIL CC(=O)[O-].CC(=O)[O-].[Ca+2] D0F1GS HIGHSTAT Approved D0F2AK DRUG__ID D0F2AK D0F2AK DRUGCOMP Labs. Cassenne D0F2AK DRUGTYPE Small molecular drug D0F2AK DRUGINCH 1S/C22H30O2/c1-4-20(24)22(3)12-10-19-18-7-5-14-13-15(23)6-8-16(14)17(18)9-11-21(19,22)2/h13,18-19H,4-12H2,1-3H3/t18-,19+,21+,22-/m1/s1 D0F2AK DRUGINKE QFFCYTLOTYIJMR-XMGTWHOFSA-N D0F2AK DRUGSMIL CCC(=O)C1(CCC2C1(CCC3=C4CCC(=O)C=C4CCC23)C)C D0F2AK HIGHSTAT Approved D0F2WP DRUG__ID D0F2WP D0F2WP DRUGCOMP Takeda D0F2WP DRUGTYPE Small molecular drug D0F2WP DRUGINCH 1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40) D0F2WP DRUGINKE AOMXMOCNKJTRQP-UHFFFAOYSA-N D0F2WP DRUGSMIL CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC D0F2WP HIGHSTAT Approved D0F3IP DRUG__ID D0F3IP D0F3IP DRUGCOMP Boehringer Ingelheim Corp D0F3IP DRUGTYPE Small molecular drug D0F3IP DRUGINCH 1S/C24H40N8O4.C9H8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30;1-6(10)13-8-5-3-2-4-7(8)9(11)12/h33-36H,1-18H2;2-5H,1H3,(H,11,12) D0F3IP DRUGINKE NOHUXXDTQJPXSB-UHFFFAOYSA-N D0F3IP DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)O.C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO D0F3IP HIGHSTAT Approved D0F4ZY DRUG__ID D0F4ZY D0F4ZY DRUGCOMP Kyowa Hakko Pharmaceuticals D0F4ZY DRUGTYPE Small molecular drug D0F4ZY DRUGINCH 1S/C20H24N4O4/c1-6-23-18-17(19(25)24(7-2)20(23)26)22(3)16(21-18)11-9-13-8-10-14(27-4)15(12-13)28-5/h8-12H,6-7H2,1-5H3/b11-9+ D0F4ZY DRUGINKE IQVRBWUUXZMOPW-PKNBQFBNSA-N D0F4ZY DRUGSMIL CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C D0F4ZY HIGHSTAT Approved D0F5ZM DRUG__ID D0F5ZM D0F5ZM DRUGCOMP Italfarmaco SpA D0F5ZM DRUGTYPE Small molecular drug D0F5ZM DRUGINCH 1S/C7H6O3.C3H4N2/c8-6-4-2-1-3-5(6)7(9)10;1-2-5-3-4-1/h1-4,8H,(H,9,10);1-3H,(H,4,5) D0F5ZM DRUGINKE XCHHJFVNQPPLJK-UHFFFAOYSA-N D0F5ZM DRUGSMIL C1=CC=C(C(=C1)C(=O)O)O.C1=CN=CN1 D0F5ZM HIGHSTAT Approved D0F6GV DRUG__ID D0F6GV D0F6GV DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D0F6GV DRUGTYPE Small molecular drug D0F6GV DRUGINCH 1S/C23H30N4O2S/c28-22-17-7-1-2-8-18(17)23(29)27(22)12-6-5-11-25-13-15-26(16-14-25)21-19-9-3-4-10-20(19)30-24-21/h3-4,9-10,17-18H,1-2,5-8,11-16H2/t17-,18+ D0F6GV DRUGINKE FBVFZWUMDDXLLG-HDICACEKSA-N D0F6GV DRUGSMIL C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54 D0F6GV HIGHSTAT Approved D0F6YM DRUG__ID D0F6YM D0F6YM TRADNAME Agamree D0F6YM DRUGCOMP Santhera D0F6YM DRUGINCH 1S/C22H28O4/c1-13-10-18-16-5-4-14-11-15(24)6-8-20(14,2)17(16)7-9-21(18,3)22(13,26)19(25)12-23/h6-8,11,13,16,18,23,26H,4-5,9-10,12H2,1-3H3/t13-,16-,18+,20+,21+,22+/m1/s1 D0F6YM DRUGINKE ZYTXTXAMMDTYDQ-DGEXFFLYSA-N D0F6YM DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1(C(=O)CO)O)C)C D0F6YM HIGHSTAT Approved D0F7NQ DRUG__ID D0F7NQ D0F7NQ THERCLAS Antiinflammatory Agents D0F7NQ DRUGTYPE Small molecular drug D0F7NQ DRUGINCH 1S/C27H36F2O6/c1-14-9-16-17-11-19(28)18-10-15(30)7-8-24(18,5)26(17,29)20(31)12-25(16,6)27(14,34)21(32)13-35-22(33)23(2,3)4/h7-8,10,14,16-17,19-20,31,34H,9,11-13H2,1-6H3/t14-,16+,17+,19+,20+,24+,25+,26+,27+/m1/s1 D0F7NQ DRUGINKE JWRMHDSINXPDHB-OJAGFMMFSA-N D0F7NQ DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C)F D0F7NQ HIGHSTAT Approved D0FC1J DRUG__ID D0FC1J D0FC1J DRUGCOMP Bayer healthcare pharmaceuticals D0FC1J DRUGTYPE Small molecular drug D0FC1J DRUGINCH 1S/C10H13N3O5S/c1-8-7-19(16,17)5-4-12(8)11-6-9-2-3-10(18-9)13(14)15/h2-3,6,8H,4-5,7H2,1H3/b11-6+ D0FC1J DRUGINKE ARFHIAQFJWUCFH-IZZDOVSWSA-N D0FC1J DRUGSMIL CC1CS(=O)(=O)CCN1N=CC2=CC=C(O2)[N+](=O)[O-] D0FC1J HIGHSTAT Approved D0FG6M DRUG__ID D0FG6M D0FG6M DRUGCOMP GSK D0FG6M DRUGTYPE Small molecular drug D0FG6M DRUGINCH 1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2 D0FG6M DRUGINKE DAFYYTQWSAWIGS-UHFFFAOYSA-N D0FG6M DRUGSMIL C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl D0FG6M HIGHSTAT Approved D0FJ8A DRUG__ID D0FJ8A D0FJ8A DRUGCOMP Novartis Pharmaceuticals Corp D0FJ8A DRUGTYPE Small molecular drug D0FJ8A DRUGINCH 1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4) D0FJ8A DRUGINKE IDDIJAWJANBQLJ-UHFFFAOYSA-N D0FJ8A DRUGSMIL CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O D0FJ8A HIGHSTAT Approved D0FM2P DRUG__ID D0FM2P D0FM2P THERCLAS Antiasthmatic Agents D0FM2P DRUGTYPE Small molecular drug D0FM2P DRUGINCH 1S/C24H31FO6/c1-21(2)30-19-9-14-13-8-16(25)15-7-12(27)5-6-22(15,3)20(13)17(28)10-23(14,4)24(19,31-21)18(29)11-26/h5-7,13-14,16-17,19-20,26,28H,8-11H2,1-4H3/t13-,14-,16-,17-,19+,20+,22-,23-,24+/m0/s1 D0FM2P DRUGINKE XSFJVAJPIHIPKU-XWCQMRHXSA-N D0FM2P DRUGSMIL CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C D0FM2P HIGHSTAT Approved D0FT7Y DRUG__ID D0FT7Y D0FT7Y DRUGCOMP Feinstein D0FT7Y DRUGTYPE Small molecular drug D0FT7Y DRUGINCH 1S/H3N/h1H3 D0FT7Y DRUGINKE QGZKDVFQNNGYKY-UHFFFAOYSA-N D0FT7Y DRUGSMIL N D0FT7Y HIGHSTAT Approved D0FV3V DRUG__ID D0FV3V D0FV3V THERCLAS Parasympatholytics D0FV3V DRUGTYPE Small molecular drug D0FV3V DRUGINCH 1S/C21H26NO3/c1-22(2)15-9-14-19(16-22)25-20(23)21(24,17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19,24H,9,14-16H2,1-2H3/q+1 D0FV3V DRUGINKE GKNPSSNBBWDAGH-UHFFFAOYSA-N D0FV3V DRUGSMIL C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C D0FV3V HIGHSTAT Approved D0G2MH DRUG__ID D0G2MH D0G2MH DRUGCOMP Ge Healthcare D0G2MH DRUGTYPE Small molecular drug D0G2MH DRUGINCH 1S/C9H8INO3.Na/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13;/h1-4H,5H2,(H,11,14)(H,12,13);/q;+1/p-1 D0G2MH DRUGINKE XYITYKDGJLHYPW-UHFFFAOYSA-M D0G2MH DRUGSMIL C1=CC=C(C(=C1)C(=O)NCC(=O)[O-])I.[Na+] D0G2MH HIGHSTAT Approved D0G2MW DRUG__ID D0G2MW D0G2MW THERCLAS Dietary supplement D0G2MW DRUGTYPE Small molecular drug D0G2MW DRUGINCH 1S/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15- D0G2MW DRUGINKE JAZBEHYOTPTENJ-JLNKQSITSA-N D0G2MW DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O D0G2MW HIGHSTAT Approved D0G3AQ DRUG__ID D0G3AQ D0G3AQ THERCLAS Antianxiety Agents D0G3AQ DRUGTYPE Small molecular drug D0G3AQ DRUGINCH 1S/C19H17ClN2O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)21-11-18(23)22(17)12-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2 D0G3AQ DRUGINKE MWQCHHACWWAQLJ-UHFFFAOYSA-N D0G3AQ DRUGSMIL C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4 D0G3AQ HIGHSTAT Approved D0G4BI DRUG__ID D0G4BI D0G4BI DRUGCOMP Dow D0G4BI DRUGTYPE Small molecular drug D0G4BI DRUGINCH 1S/C18H22F2N4O/c1-13-5-7-23(8-6-13)14(2)18(25,10-24-12-21-11-22-24)16-4-3-15(19)9-17(16)20/h3-4,9,11-12,14,25H,1,5-8,10H2,2H3/t14-,18-/m1/s1 D0G4BI DRUGINKE NFEZZTICAUWDHU-RDTXWAMCSA-N D0G4BI DRUGSMIL CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3 D0G4BI HIGHSTAT Approved D0G4JI DRUG__ID D0G4JI D0G4JI THERCLAS Dietary supplement D0G4JI DRUGTYPE Small molecular drug D0G4JI DRUGINCH 1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6) D0G4JI DRUGINKE LCTONWCANYUPML-UHFFFAOYSA-N D0G4JI DRUGSMIL CC(=O)C(=O)O D0G4JI HIGHSTAT Approved D0G4YT DRUG__ID D0G4YT D0G4YT DRUGCOMP Tosoh Corp D0G4YT DRUGTYPE Small molecular drug D0G4YT DRUGINCH 1S/C18H20N2O2S/c1-20(16-8-5-9-17(19-16)21-2)18(23)22-15-11-10-13-6-3-4-7-14(13)12-15/h5,8-12H,3-4,6-7H2,1-2H3 D0G4YT DRUGINKE VPHPQNGOVQYUMG-UHFFFAOYSA-N D0G4YT DRUGSMIL CN(C1=NC(=CC=C1)OC)C(=S)OC2=CC3=C(CCCC3)C=C2 D0G4YT HIGHSTAT Approved D0G5AG DRUG__ID D0G5AG D0G5AG THERCLAS Antimetabolites D0G5AG DRUGTYPE Small molecular drug D0G5AG DRUGINCH 1S/C9H13N3O6/c10-7(16)4-8(17)12(2-11-4)9-6(15)5(14)3(1-13)18-9/h2-3,5-6,9,13-15,17H,1H2,(H2,10,16)/t3-,5-,6-,9-/m1/s1 D0G5AG DRUGINKE HZQDCMWJEBCWBR-UUOKFMHZSA-N D0G5AG DRUGSMIL C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N D0G5AG HIGHSTAT Approved D0G5CF DRUG__ID D0G5CF D0G5CF DRUGCOMP Genzyme D0G5CF DRUGTYPE Small molecular drug D0G5CF DRUGINCH 1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 D0G5CF DRUGINKE HKXBNHCUPKIYDM-CGMHZMFXSA-N D0G5CF DRUGSMIL CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D0G5CF HIGHSTAT Approved D0G6VL DRUG__ID D0G6VL D0G6VL THERCLAS Hypoglycemic Agents D0G6VL DRUGTYPE Small molecular drug D0G6VL DRUGINCH 1S/C24H31NO6/c1-25(2)16-21(31-24(28)14-13-23(26)27)17-30-22-10-5-4-8-19(22)12-11-18-7-6-9-20(15-18)29-3/h4-10,15,21H,11-14,16-17H2,1-3H3,(H,26,27) D0G6VL DRUGINKE FFYNAVGJSYHHFO-UHFFFAOYSA-N D0G6VL DRUGSMIL CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O D0G6VL HIGHSTAT Approved D0G7FJ DRUG__ID D0G7FJ D0G7FJ DRUGCOMP Iroko pharmaceuticals D0G7FJ DRUGTYPE Small molecular drug D0G7FJ DRUGINCH 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19) D0G7FJ DRUGINKE ZRVUJXDFFKFLMG-UHFFFAOYSA-N D0G7FJ DRUGSMIL CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O D0G7FJ HIGHSTAT Approved D0G7IY DRUG__ID D0G7IY D0G7IY DRUGCOMP Thornton & Ross Ltd D0G7IY DRUGTYPE Small molecular drug D0G7IY DRUGINCH 1S/C23H16O11.2Na/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30;;/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30);;/q;2*+1/p-2 D0G7IY DRUGINKE VLARUOGDXDTHEH-UHFFFAOYSA-L D0G7IY DRUGSMIL C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+] D0G7IY HIGHSTAT Approved D0G7SR DRUG__ID D0G7SR D0G7SR DRUGCOMP AstraZeneca D0G7SR DRUGTYPE Small molecular drug D0G7SR DRUGINCH 1S/C22H21N8O8PS4.C2H4O2/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10;1-2(3)4/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37);1H3,(H,3,4)/b26-13-;/t14-,19-;/m1./s1 D0G7SR DRUGINKE UGHHNQFYEVOFIV-VRDMTWHKSA-N D0G7SR DRUGSMIL CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-].CC(=O)O D0G7SR HIGHSTAT Approved D0G7WY DRUG__ID D0G7WY D0G7WY DRUGCOMP Tillotts Pharma AG D0G7WY DRUGTYPE Small molecular drug D0G7WY DRUGINCH 1S/C22H32O2.C20H30O2.C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24);3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22);3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-;4-3-,7-6-,10-9-,13-12-,16-15-;4-3-,7-6-,10-9- D0G7WY DRUGINKE QPEOIOLHJXXJFN-GNGJDXFDSA-N D0G7WY DRUGSMIL CCC=CCC=CCC=CCCCCCCCC(=O)O.CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O.CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O D0G7WY HIGHSTAT Approved D0G8BM DRUG__ID D0G8BM D0G8BM DRUGCOMP Targen D0G8BM DRUGTYPE Small molecular drug D0G8BM DRUGINCH 1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31) D0G8BM DRUGINKE JOOXLOJCABQBSG-UHFFFAOYSA-N D0G8BM DRUGSMIL CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4 D0G8BM HIGHSTAT Approved D0G8BV DRUG__ID D0G8BV D0G8BV THERCLAS Antiinflammatory Agents D0G8BV DRUGTYPE Small molecular drug D0G8BV DRUGINCH 1S/C21H28O2/c1-4-16-19(23)12-18-15-6-5-13-11-14(22)7-9-20(13,2)17(15)8-10-21(16,18)3/h4,11,15,17-18H,5-10,12H2,1-3H3/b16-4+/t15-,17+,18+,20+,21-/m1/s1 D0G8BV DRUGINKE WDXRGPWQVHZTQJ-OSJVMJFVSA-N D0G8BV DRUGSMIL CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C D0G8BV HIGHSTAT Approved D0G8NJ DRUG__ID D0G8NJ D0G8NJ THERCLAS Antihypertensive Agents D0G8NJ DRUGTYPE Small molecular drug D0G8NJ DRUGINCH 1S/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1 D0G8NJ DRUGINKE SZLZWPPUNLXJEA-QEGASFHISA-N D0G8NJ DRUGSMIL COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC D0G8NJ HIGHSTAT Approved D0G8OC DRUG__ID D0G8OC D0G8OC THERCLAS Antihypoparathyroid Agents D0G8OC DRUGTYPE Small molecular drug D0G8OC DRUGINCH 1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1 D0G8OC DRUGINKE ILYCWAKSDCYMBB-OPCMSESCSA-N D0G8OC DRUGSMIL CC1CCC(CC1=CC=C2CCCC3(C2CCC3C(C)C=CC(C)C(C)C)C)O D0G8OC HIGHSTAT Approved D0G8QW DRUG__ID D0G8QW D0G8QW DRUGCOMP Takeda D0G8QW DRUGTYPE Small molecular drug D0G8QW DRUGINCH 1S/C26H32N2O5/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30)/t18-,23-/m0/s1 D0G8QW DRUGINKE WOUOLAUOZXOLJQ-MBSDFSHPSA-N D0G8QW DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2 D0G8QW HIGHSTAT Approved D0GA5T DRUG__ID D0GA5T D0GA5T DRUGCOMP Neurocrine Biosciences D0GA5T DRUGTYPE Small molecular drug D0GA5T DRUGINCH 1S/C20H16N4O2S/c1-13(25)23(2)15-6-3-5-14(11-15)17-8-9-21-20-16(12-22-24(17)20)19(26)18-7-4-10-27-18/h3-12H,1-2H3 D0GA5T DRUGINKE CBIAWPMZSFFRGN-UHFFFAOYSA-N D0GA5T DRUGSMIL CC(=O)N(C)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C(=O)C4=CC=CS4 D0GA5T HIGHSTAT Approved D0GC2M DRUG__ID D0GC2M D0GC2M THERCLAS Alcohol Deterrents D0GC2M DRUGTYPE Small molecular drug D0GC2M DRUGINCH 1S/C5H11NO4S/c1-5(7)6-3-2-4-11(8,9)10/h2-4H2,1H3,(H,6,7)(H,8,9,10) D0GC2M DRUGINKE AFCGFAGUEYAMAO-UHFFFAOYSA-N D0GC2M DRUGSMIL CC(=O)NCCCS(=O)(=O)O D0GC2M HIGHSTAT Approved D0GJ8R DRUG__ID D0GJ8R D0GJ8R DRUGCOMP Pharmacia And Upjohn Co D0GJ8R DRUGTYPE Small molecular drug D0GJ8R DRUGINCH 1S/C8H23N5.C3H5ClO/c9-1-3-11-5-7-13-8-6-12-4-2-10;4-1-3-2-5-3/h11-13H,1-10H2;3H,1-2H2 D0GJ8R DRUGINKE GMRWGQCZJGVHKL-UHFFFAOYSA-N D0GJ8R DRUGSMIL C1C(O1)CCl.C(CNCCNCCNCCN)N D0GJ8R HIGHSTAT Approved D0GR0T DRUG__ID D0GR0T D0GR0T THERCLAS Narcotics D0GR0T DRUGTYPE Small molecular drug D0GR0T DRUGINCH 1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3 D0GR0T DRUGINKE XBMIVRRWGCYBTQ-UHFFFAOYSA-N D0GR0T DRUGSMIL CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C D0GR0T HIGHSTAT Approved D0H0EQ DRUG__ID D0H0EQ D0H0EQ DRUGCOMP ARIAD Pharmaceuticals D0H0EQ DRUGTYPE Small molecular drug D0H0EQ DRUGINCH 1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) D0H0EQ DRUGINKE PHXJVRSECIGDHY-UHFFFAOYSA-N D0H0EQ DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5 D0H0EQ HIGHSTAT Approved D0H0WK DRUG__ID D0H0WK D0H0WK DRUGCOMP Epix D0H0WK DRUGTYPE Small molecular drug D0H0WK DRUGINCH 1S/C33H44N3O14P.Gd/c37-28(38)18-34(15-16-35(19-29(39)40)20-30(41)42)17-26(36(21-31(43)44)22-32(45)46)23-49-51(47,48)50-27-11-13-33(14-12-27,24-7-3-1-4-8-24)25-9-5-2-6-10-25;/h1-10,26-27H,11-23H2,(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H,45,46)(H,47,48);/q;+3/p-3/t26-;/m1./s1 D0H0WK DRUGINKE ZSDLYSDDELEVDD-UFTMZEDQSA-K D0H0WK DRUGSMIL [H+].[H+].[H+].C1CC(CCC1OP(=O)([O-])OCC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.[Gd+3] D0H0WK HIGHSTAT Approved D0H1AR DRUG__ID D0H1AR D0H1AR THERCLAS Antibiotics D0H1AR DRUGTYPE Small molecular drug D0H1AR DRUGINCH 1S/C22H22N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-6,10,14-15,17,25-27,30,32H,1H2,2-3H3,(H2,23,31)/t10-,14-,15+,17+,22+/m1/s1 D0H1AR DRUGINKE XIYOPDCBBDCGOE-IWVLMIASSA-N D0H1AR DRUGSMIL CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O D0H1AR HIGHSTAT Approved D0H1GJ DRUG__ID D0H1GJ D0H1GJ THERCLAS Antiinfective Agents D0H1GJ DRUGTYPE Small molecular drug D0H1GJ DRUGINCH 1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15) D0H1GJ DRUGINKE QPPBRPIAZZHUNT-UHFFFAOYSA-N D0H1GJ DRUGSMIL CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N D0H1GJ HIGHSTAT Approved D0H1LO DRUG__ID D0H1LO D0H1LO DRUGCOMP Shire Pharm D0H1LO DRUGTYPE Small molecular drug D0H1LO DRUGINCH 1S/3CH2O3.2La/c3*2-1(3)4;;/h3*(H2,2,3,4);;/q;;;2*+3/p-6 D0H1LO DRUGINKE NZPIUJUFIFZSPW-UHFFFAOYSA-H D0H1LO DRUGSMIL C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].[La+3].[La+3] D0H1LO HIGHSTAT Approved D0H1YQ DRUG__ID D0H1YQ D0H1YQ DRUGCOMP Sanofi-Aventis D0H1YQ DRUGTYPE Small molecular drug D0H1YQ DRUGINCH 1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H D0H1YQ DRUGINKE YTNKWDJILNVLGX-UHFFFAOYSA-N D0H1YQ DRUGSMIL CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl D0H1YQ HIGHSTAT Approved D0H2DQ DRUG__ID D0H2DQ D0H2DQ THERCLAS Anticholesteremic Agents D0H2DQ DRUGTYPE Small molecular drug D0H2DQ DRUGINCH 1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3 D0H2DQ DRUGINKE FYPMFJGVHOHGLL-UHFFFAOYSA-N D0H2DQ DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C D0H2DQ HIGHSTAT Approved D0H2JP DRUG__ID D0H2JP D0H2JP DRUGCOMP Orexo D0H2JP DRUGTYPE Small molecular drug D0H2JP DRUGINCH 1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29?/m1/s1 D0H2JP DRUGINKE RMRJXGBAOAMLHD-MLLHIGKASA-N D0H2JP DRUGSMIL CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O D0H2JP HIGHSTAT Approved D0H2MO DRUG__ID D0H2MO D0H2MO DRUGCOMP Nippon Kayaku D0H2MO DRUGTYPE Small molecular drug D0H2MO DRUGINCH 1S/C27H43NO8.ClH/c1-10-24(5)15-18(31)27(33)25(6)17(30)11-13-23(3,4)21(25)20(35-19(32)12-14-28(8)9)22(34-16(2)29)26(27,7)36-24;/h10,17,20-22,30,33H,1,11-15H2,2-9H3;1H/t17-,20-,21-,22-,24-,25-,26+,27-;/m0./s1 D0H2MO DRUGINKE VIRRLEDAYYYTOD-YHEOSNBFSA-N D0H2MO DRUGSMIL CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)OC(=O)CCN(C)C.Cl D0H2MO HIGHSTAT Approved D0H2QO DRUG__ID D0H2QO D0H2QO THERCLAS Dietary supplement D0H2QO DRUGTYPE Small molecular drug D0H2QO DRUGINCH 1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1 D0H2QO DRUGINKE MSTNYGQPCMXVAQ-KIYNQFGBSA-N D0H2QO DRUGSMIL C1C(NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0H2QO HIGHSTAT Approved D0H3KI DRUG__ID D0H3KI D0H3KI DRUGCOMP Threshold Pharmaceuticals D0H3KI DRUGTYPE Small molecular drug D0H3KI DRUGINCH 1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1 D0H3KI DRUGINKE VRYALKFFQXWPIH-PBXRRBTRSA-N D0H3KI DRUGSMIL C(C=O)C(C(C(CO)O)O)O D0H3KI HIGHSTAT Approved D0H4GN DRUG__ID D0H4GN D0H4GN THERCLAS Anesthetics D0H4GN DRUGTYPE Small molecular drug D0H4GN DRUGINCH 1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H D0H4GN DRUGINKE DPYMFVXJLLWWEU-UHFFFAOYSA-N D0H4GN DRUGSMIL C(C(F)(F)F)(OC(F)F)F D0H4GN HIGHSTAT Approved D0H6QU DRUG__ID D0H6QU D0H6QU DRUGCOMP Archimedes Pharma Ltd D0H6QU DRUGTYPE Small molecular drug D0H6QU DRUGINCH 1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1 D0H6QU DRUGINKE VMWNQDUVQKEIOC-CYBMUJFWSA-N D0H6QU DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O D0H6QU HIGHSTAT Approved D0H6TP DRUG__ID D0H6TP D0H6TP THERCLAS Dermatologic Agents D0H6TP DRUGTYPE Small molecular drug D0H6TP DRUGINCH 1S/C13H12O2/c14-12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-9,14H,10H2 D0H6TP DRUGINKE VYQNWZOUAUKGHI-UHFFFAOYSA-N D0H6TP DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)O D0H6TP HIGHSTAT Approved D0H7AV DRUG__ID D0H7AV D0H7AV DRUGCOMP Suntory Ltd D0H7AV DRUGTYPE Small molecular drug D0H7AV DRUGINCH 1S/C17H24N2O/c1-13-6-3-7-14(2)16(13)18-15(20)12-17-8-4-10-19(17)11-5-9-17/h3,6-7H,4-5,8-12H2,1-2H3,(H,18,20) D0H7AV DRUGINKE BCQTVJKBTWGHCX-UHFFFAOYSA-N D0H7AV DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3 D0H7AV HIGHSTAT Approved D0H8QL DRUG__ID D0H8QL D0H8QL THERCLAS Central Nervous System Stimulants D0H8QL DRUGTYPE Small molecular drug D0H8QL DRUGINCH 1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2 D0H8QL DRUGINKE ZPXSCAKFGYXMGA-UHFFFAOYSA-N D0H8QL DRUGSMIL C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O D0H8QL HIGHSTAT Approved D0H8VY DRUG__ID D0H8VY D0H8VY DRUGCOMP Bristol-Myers Squibb D0H8VY DRUGTYPE Small molecular drug D0H8VY DRUGINCH 1S/C39H37F6N3O2/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49) D0H8VY DRUGINKE MBBCVAKAJPKAKM-UHFFFAOYSA-N D0H8VY DRUGSMIL C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F D0H8VY HIGHSTAT Approved D0H8WF DRUG__ID D0H8WF D0H8WF THERCLAS Antihypoglycemic Agents D0H8WF DRUGTYPE Small molecular drug D0H8WF DRUGINCH 1S/C153H225N43O49S/c1-72(2)52-97(133(226)176-96(47-51-246-11)132(225)184-104(60-115(159)209)143(236)196-123(78(10)203)151(244)245)179-137(230)103(58-83-64-167-89-29-19-18-28-87(83)89)183-131(224)95(43-46-114(158)208)177-148(241)120(74(5)6)194-141(234)101(54-79-24-14-12-15-25-79)182-138(231)105(61-117(211)212)185-130(223)94(42-45-113(157)207)171-124(217)75(7)170-127(220)91(31-22-49-165-152(160)161)172-128(221)92(32-23-50-166-153(162)163)174-146(239)110(69-199)191-140(233)107(63-119(215)216)186-134(227)98(53-73(3)4)178-135(228)99(56-81-33-37-85(204)38-34-81)180-129(222)90(30-20-21-48-154)173-145(238)109(68-198)190-136(229)100(57-82-35-39-86(205)40-36-82)181-139(232)106(62-118(213)214)187-147(240)111(70-200)192-150(243)122(77(9)202)195-142(235)102(55-80-26-16-13-17-27-80)188-149(242)121(76(8)201)193-116(210)66-168-126(219)93(41-44-112(156)206)175-144(237)108(67-197)189-125(218)88(155)59-84-65-164-71-169-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,167,197-205H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H,164,169)(H,168,219)(H,170,220)(H,171,217)(H,172,221)(H,173,238)(H,174,239)(H,175,237)(H,176,226)(H,177,241)(H,178,228)(H,179,230)(H,180,222)(H,181,232)(H,182,231)(H,183,224)(H,184,225)(H,185,223)(H,186,227)(H,187,240)(H,188,242)(H,189,218)(H,190,229)(H,191,233)(H,192,243)(H,193,210)(H,194,234)(H,195,235)(H,196,236)(H,211,212)(H,213,214)(H,215,216)(H,244,245)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1 D0H8WF DRUGINKE MASNOZXLGMXCHN-ZLPAWPGGSA-N D0H8WF DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N D0H8WF HIGHSTAT Approved D0HE0Y DRUG__ID D0HE0Y D0HE0Y TRADNAME Firdapse D0HE0Y DRUGCOMP Catalyst Pharmaceuticals D0HE0Y DRUGINCH 1S/C5H7N3/c6-4-1-2-8-3-5(4)7/h1-3H,7H2,(H2,6,8) D0HE0Y DRUGINKE OYTKINVCDFNREN-UHFFFAOYSA-N D0HE0Y DRUGSMIL C1=CN=CC(=C1N)N D0HE0Y HIGHSTAT Approved D0HF0W DRUG__ID D0HF0W D0HF0W DRUGCOMP Eli Lilly Industries Inc D0HF0W DRUGTYPE Small molecular drug D0HF0W DRUGINCH 1S/C22H29NO2.C10H8O3S/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19;11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10/h6-15,18H,5,16-17H2,1-4H3;1-7H,(H,11,12,13)/t18-,22+;/m0./s1 D0HF0W DRUGINKE VZPXFHVJUUSVLH-VNJAQMQMSA-N D0HF0W DRUGSMIL CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O D0HF0W HIGHSTAT Approved D0HR8Z DRUG__ID D0HR8Z D0HR8Z THERCLAS Anti-HIV Agents D0HR8Z DRUGTYPE Small molecular drug D0HR8Z DRUGINCH 1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1 D0HR8Z DRUGINKE UQRORFVVSGFNRO-UTINFBMNSA-N D0HR8Z DRUGSMIL CCCCN1CC(C(C(C1CO)O)O)O D0HR8Z HIGHSTAT Approved D0HU0W DRUG__ID D0HU0W D0HU0W DRUGCOMP Beecham, Eumedica Pharmaceuticals D0HU0W DRUGTYPE Small molecular drug D0HU0W DRUGINCH 1S/C16H18N2O7S2/c1-15(2)9(12(22)23)18-13(24)16(25-3,14(18)27-15)17-10(19)8(11(20)21)7-4-5-26-6-7/h4-6,8-9,14H,1-3H3,(H,17,19)(H,20,21)(H,22,23)/t8?,9-,14+,16-/m0/s1 D0HU0W DRUGINKE BVCKFLJARNKCSS-DWPRYXJFSA-N D0HU0W DRUGSMIL CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C D0HU0W HIGHSTAT Approved D0I0RB DRUG__ID D0I0RB D0I0RB DRUGCOMP Otsuka Pharmaceutical Co Ltd D0I0RB DRUGTYPE Small molecular drug D0I0RB DRUGINCH 1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26) D0I0RB DRUGINKE JYJTVFIEFKZWCJ-UHFFFAOYSA-N D0I0RB DRUGSMIL CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2N4CCC(CC4)O)F)C(=O)O D0I0RB HIGHSTAT Approved D0I1FQ DRUG__ID D0I1FQ D0I1FQ DRUGCOMP Merck D0I1FQ DRUGTYPE Small molecular drug D0I1FQ DRUGINCH 1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30) D0I1FQ DRUGINKE CZFFBEXEKNGXKS-UHFFFAOYSA-N D0I1FQ DRUGSMIL CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F D0I1FQ HIGHSTAT Approved D0I1LH DRUG__ID D0I1LH D0I1LH THERCLAS Antihypertensive Agents D0I1LH DRUGTYPE Small molecular drug D0I1LH DRUGINCH 1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1 D0I1LH DRUGINKE PQSUYGKTWSAVDQ-ZVIOFETBSA-N D0I1LH DRUGSMIL CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C=O)O D0I1LH HIGHSTAT Approved D0I1XG DRUG__ID D0I1XG D0I1XG THERCLAS Antiosteporotic Agents D0I1XG DRUGTYPE Small molecular drug D0I1XG DRUGINCH 1S/C145H240N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99-63-239-238-62-79(148)117(210)178-96(59-191)134(227)174-92(52-104(151)202)131(224)172-90(49-69(9)10)129(222)180-98(61-193)135(228)187-114(74(16)197)142(235)181-99)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157) D0I1XG DRUGINKE BBBFJLBPOGFECG-UHFFFAOYSA-N D0I1XG DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CO)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO D0I1XG HIGHSTAT Approved D0I3LE DRUG__ID D0I3LE D0I3LE THERCLAS Hypoglycemic Agents D0I3LE DRUGTYPE Small molecular drug D0I3LE DRUGINCH 1S/C256H381N65O79S6/c1-29-129(23)204(313-191(338)102-258)251(394)317-203(128(21)22)247(390)287-157(73-80-198(348)349)216(359)282-154(69-76-187(262)334)220(363)308-182-114-404-405-115-183-243(386)305-177(109-323)240(383)293-160(85-121(7)8)224(367)294-166(92-138-51-59-144(328)60-52-138)227(370)283-152(67-74-185(260)332)217(360)289-159(84-120(5)6)222(365)285-156(72-79-197(346)347)219(362)301-172(98-188(263)335)234(377)297-168(94-140-55-63-146(330)64-56-140)230(373)309-181(242(385)304-175(254(397)398)100-190(265)337)113-403-402-112-180(213(356)272-105-192(339)277-151(70-77-195(342)343)215(358)280-149(50-42-82-270-256(266)267)211(354)271-106-193(340)278-164(90-136-45-36-32-37-46-136)226(369)296-165(91-137-47-38-33-39-48-137)229(372)298-169(95-141-57-65-147(331)66-58-141)238(381)319-206(132(26)325)252(395)303-174(101-199(350)351)235(378)281-150(49-40-41-81-257)221(364)321-208(134(28)327)255(399)400)311-249(392)202(127(19)20)316-236(379)162(87-123(11)12)291-228(371)167(93-139-53-61-145(329)62-54-139)295-223(366)158(83-119(3)4)288-209(352)131(25)276-214(357)155(71-78-196(344)345)286-246(389)201(126(17)18)315-237(380)163(88-124(13)14)292-232(375)171(97-143-104-269-118-275-143)300-239(382)176(108-322)279-194(341)107-273-212(355)179(111-401-406-116-184(310-244(182)387)245(388)320-207(133(27)326)253(396)306-178(110-324)241(384)318-205(130(24)30-2)250(393)312-183)307-225(368)161(86-122(9)10)290-231(374)170(96-142-103-268-117-274-142)299-218(361)153(68-75-186(261)333)284-233(376)173(99-189(264)336)302-248(391)200(125(15)16)314-210(353)148(259)89-135-43-34-31-35-44-135/h31-39,43-48,51-66,103-104,117-134,148-184,200-208,322-331H,29-30,40-42,49-50,67-102,105-116,257-259H2,1-28H3,(H2,260,332)(H2,261,333)(H2,262,334)(H2,263,335)(H2,264,336)(H2,265,337)(H,268,274)(H,269,275)(H,271,354)(H,272,356)(H,273,355)(H,276,357)(H,277,339)(H,278,340)(H,279,341)(H,280,358)(H,281,378)(H,282,359)(H,283,370)(H,284,376)(H,285,365)(H,286,389)(H,287,390)(H,288,352)(H,289,360)(H,290,374)(H,291,371)(H,292,375)(H,293,383)(H,294,367)(H,295,366)(H,296,369)(H,297,377)(H,298,372)(H,299,361)(H,300,382)(H,301,362)(H,302,391)(H,303,395)(H,304,385)(H,305,386)(H,306,396)(H,307,368)(H,308,363)(H,309,373)(H,310,387)(H,311,392)(H,312,393)(H,313,338)(H,314,353)(H,315,380)(H,316,379)(H,317,394)(H,318,384)(H,319,381)(H,320,388)(H,321,364)(H,342,343)(H,344,345)(H,346,347)(H,348,349)(H,350,351)(H,397,398)(H,399,400)(H4,266,267,270)/t129-,130-,131-,132+,133+,134+,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,200-,201-,202-,203-,204-,205-,206-,207-,208-/m0/s1 D0I3LE DRUGINKE WEDIKSVWBUKTRA-WTKGVUNUSA-N D0I3LE DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC8=CC=C(C=C8)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC9=CNC=N9)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D0I3LE HIGHSTAT Approved D0I3RO DRUG__ID D0I3RO D0I3RO DRUGCOMP Chelsea Therapeutics D0I3RO DRUGTYPE Small molecular drug D0I3RO DRUGINCH 1S/C9H11NO5/c10-7(9(14)15)8(13)4-1-2-5(11)6(12)3-4/h1-3,7-8,11-13H,10H2,(H,14,15)/t7-,8+/m0/s1 D0I3RO DRUGINKE QXWYKJLNLSIPIN-JGVFFNPUSA-N D0I3RO DRUGSMIL C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O D0I3RO HIGHSTAT Approved D0I5DS DRUG__ID D0I5DS D0I5DS DRUGCOMP Schering Corp Sub Schering Plough Corp D0I5DS DRUGTYPE Small molecular drug D0I5DS DRUGINCH 1S/C22H28O5/c1-12-8-16-15-5-4-13-9-14(24)6-7-20(13,2)19(15)17(25)10-21(16,3)22(12,27)18(26)11-23/h6-7,9,12,15-16,19,23,27H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,19+,20-,21-,22-/m0/s1 D0I5DS DRUGINKE PIDANAQULIKBQS-RNUIGHNZSA-N D0I5DS DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C D0I5DS HIGHSTAT Approved D0I5HF DRUG__ID D0I5HF D0I5HF DRUGCOMP Pfizer D0I5HF DRUGTYPE Small molecular drug D0I5HF DRUGINCH 1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32) D0I5HF DRUGINKE QNZCBYKSOIHPEH-UHFFFAOYSA-N D0I5HF DRUGSMIL COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N D0I5HF HIGHSTAT Approved D0I5WB DRUG__ID D0I5WB D0I5WB DRUGCOMP Sanofi Aventis Us Llc D0I5WB DRUGTYPE Small molecular drug D0I5WB DRUGINCH 1S/C26H28ClNO.C6H8O7/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18H,3-4,19-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-; D0I5WB DRUGINKE PYTMYKVIJXPNBD-OQKDUQJOSA-N D0I5WB DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D0I5WB HIGHSTAT Approved D0I6IP DRUG__ID D0I6IP D0I6IP THERCLAS Antibiotics D0I6IP DRUGTYPE Small molecular drug D0I6IP DRUGINCH 1S/C59H84N2O18/c1-35-18-15-13-11-9-7-5-6-8-10-12-14-16-21-47(78-59-56(74)54(61)55(73)38(4)77-59)33-51(71)53(58(75)76)50(70)31-46(67)30-45(66)29-44(65)28-43(64)27-41(62)19-17-20-42(63)32-52(72)79-57(35)37(3)26-36(2)48(68)34-49(69)39-22-24-40(60)25-23-39/h5-16,18,21-25,35-38,43-45,47-48,50-51,53-57,59,64-66,68,70-71,73-74H,17,19-20,26-34,60-61H2,1-4H3,(H,75,76)/b6-5+,9-7+,10-8+,13-11+,14-12+,18-15+,21-16+/t35?,36?,37?,38-,43?,44?,45?,47?,48?,50?,51?,53?,54+,55-,56+,57?,59?/m1/s1 D0I6IP DRUGINKE OPGSFDUODIJJGF-JBUZINEHSA-N D0I6IP DRUGSMIL CC1C=CC=CC=CC=CC=CC=CC=CC(CC(C(C(CC(=O)CC(CC(CC(CC(=O)CCCC(=O)CC(=O)OC1C(C)CC(C)C(CC(=O)C2=CC=C(C=C2)N)O)O)O)O)O)C(=O)O)O)OC3C(C(C(C(O3)C)O)N)O D0I6IP HIGHSTAT Approved D0IN7I DRUG__ID D0IN7I D0IN7I DRUGCOMP Astellas D0IN7I DRUGTYPE Small molecular drug D0IN7I DRUGINCH 1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1 D0IN7I DRUGINKE KRVOJOCLBAAKSJ-RDTXWAMCSA-N D0IN7I DRUGSMIL CC1C(CCN1CC2=CC=CC=C2)NC(=O)C3=CC(=C(C=C3OC)NC)Cl D0IN7I HIGHSTAT Approved D0IQ6P DRUG__ID D0IQ6P D0IQ6P DRUGCOMP Exelixis D0IQ6P DRUGTYPE Small molecular drug D0IQ6P DRUGINCH 1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34) D0IQ6P DRUGINKE ONIQOQHATWINJY-UHFFFAOYSA-N D0IQ6P DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F D0IQ6P HIGHSTAT Approved D0J1ML DRUG__ID D0J1ML D0J1ML THERCLAS Estrogens D0J1ML DRUGTYPE Small molecular drug D0J1ML DRUGINCH 1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1 D0J1ML DRUGINKE IMSSROKUHAOUJS-MJCUULBUSA-N D0J1ML DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC D0J1ML HIGHSTAT Approved D0J4GO DRUG__ID D0J4GO D0J4GO THERCLAS Antiglaucomic Agents D0J4GO DRUGTYPE Small molecular drug D0J4GO DRUGINCH 1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14) D0J4GO DRUGINKE GJQPMPFPNINLKP-UHFFFAOYSA-N D0J4GO DRUGSMIL C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N D0J4GO HIGHSTAT Approved D0J4JM DRUG__ID D0J4JM D0J4JM THERCLAS Antihypertensive Agents D0J4JM DRUGTYPE Small molecular drug D0J4JM DRUGINCH 1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1 D0J4JM DRUGINKE QEVHRUUCFGRFIF-MDEJGZGSSA-N D0J4JM DRUGSMIL COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC D0J4JM HIGHSTAT Approved D0J5RN DRUG__ID D0J5RN D0J5RN DRUGCOMP Cephalon D0J5RN DRUGTYPE Small molecular drug D0J5RN DRUGINCH 1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)/t19-/m1/s1 D0J5RN DRUGINKE YFGHCGITMMYXAQ-LJQANCHMSA-N D0J5RN DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N D0J5RN HIGHSTAT Approved D0J5VR DRUG__ID D0J5VR D0J5VR DRUGCOMP Gilead Sciences D0J5VR DRUGTYPE Small molecular drug D0J5VR DRUGINCH 1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1 D0J5VR DRUGINKE IFSDAJWBUCMOAH-HNNXBMFYSA-N D0J5VR DRUGSMIL CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 D0J5VR HIGHSTAT Approved D0J7TM DRUG__ID D0J7TM D0J7TM THERCLAS Analgesics D0J7TM DRUGTYPE Small molecular drug D0J7TM DRUGINCH 1S/C22H32N4O6S.C6H14N2O2/c1-22(2)17(21(31)32)26-19(33-22)16(25-15(27)12-13-8-4-3-5-9-13)18(28)24-11-7-6-10-14(23)20(29)30;7-4-2-1-3-5(8)6(9)10/h3-5,8-9,14,16-17,19,26H,6-7,10-12,23H2,1-2H3,(H,24,28)(H,25,27)(H,29,30)(H,31,32);5H,1-4,7-8H2,(H,9,10)/t14-,16?,17+,19-;5-/m11/s1 D0J7TM DRUGINKE IMPVZRLKKKXMKQ-SGDOCVTFSA-N D0J7TM DRUGSMIL CC1(C(NC(S1)C(C(=O)NCCCCC(C(=O)O)N)NC(=O)CC2=CC=CC=C2)C(=O)O)C.C(CCN)CC(C(=O)O)N D0J7TM HIGHSTAT Approved D0J7XL DRUG__ID D0J7XL D0J7XL THERCLAS Antibiotics D0J7XL DRUGTYPE Small molecular drug D0J7XL DRUGINCH 1S/C96H135N19O16/c1-50(2)36-71(105-79(118)48-102-93(128)80(54(9)10)103-49-117)86(121)104-58(17)84(119)113-82(56(13)14)95(130)115-83(57(15)16)96(131)114-81(55(11)12)94(129)112-78(43-62-47-101-70-33-25-21-29-66(62)70)92(127)108-74(39-53(7)8)89(124)111-77(42-61-46-100-69-32-24-20-28-65(61)69)91(126)107-73(38-52(5)6)88(123)110-76(41-60-45-99-68-31-23-19-27-64(60)68)90(125)106-72(37-51(3)4)87(122)109-75(85(120)97-34-35-116)40-59-44-98-67-30-22-18-26-63(59)67/h18-33,44-47,49-58,71-78,80-83,98-101,116H,34-43,48H2,1-17H3,(H,97,120)(H,102,128)(H,103,117)(H,104,121)(H,105,118)(H,106,125)(H,107,126)(H,108,127)(H,109,122)(H,110,123)(H,111,124)(H,112,129)(H,113,119)(H,114,131)(H,115,130)/t58-,71+,72+,73+,74+,75-,76-,77-,78-,80-,81+,82+,83-/m0/s1 D0J7XL DRUGINKE NDAYQJDHGXTBJL-MWWSRJDJSA-N D0J7XL DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC(C)C)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)NCCO)NC(=O)CNC(=O)C(C(C)C)NC=O D0J7XL HIGHSTAT Approved D0J8IJ DRUG__ID D0J8IJ D0J8IJ DRUGCOMP Genzyme D0J8IJ DRUGTYPE Small molecular drug D0J8IJ DRUGINCH 1S/2C23H36N2O4.C4H6O6/c2*1-2-3-4-5-6-9-22(26)24-19(17-25-12-7-8-13-25)23(27)18-10-11-20-21(16-18)29-15-14-28-20;5-1(3(7)8)2(6)4(9)10/h2*10-11,16,19,23,27H,2-9,12-15,17H2,1H3,(H,24,26);1-2,5-6H,(H,7,8)(H,9,10)/t2*19-,23-;1-,2-/m111/s1 D0J8IJ DRUGINKE KUBARPMUNHKBIQ-VTHUDJRQSA-N D0J8IJ DRUGSMIL CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O.CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O.C(C(C(=O)O)O)(C(=O)O)O D0J8IJ HIGHSTAT Approved D0J8JP DRUG__ID D0J8JP D0J8JP DRUGCOMP Acadia Pharmaceuticals D0J8JP DRUGTYPE Small molecular drug D0J8JP DRUGINCH 1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30) D0J8JP DRUGINKE RKEWSXXUOLRFBX-UHFFFAOYSA-N D0J8JP DRUGSMIL CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C D0J8JP HIGHSTAT Approved D0J8ZA DRUG__ID D0J8ZA D0J8ZA THERCLAS Antihypertensive Agents D0J8ZA DRUGTYPE Small molecular drug D0J8ZA DRUGINCH 1S/C10H12ClN3O3S/c1-2-9-13-7-4-6(11)8(18(12,16)17)3-5(7)10(15)14-9/h3-4,9,13H,2H2,1H3,(H,14,15)(H2,12,16,17) D0J8ZA DRUGINKE AGMMTXLNIQSRCG-UHFFFAOYSA-N D0J8ZA DRUGSMIL CCC1NC2=CC(=C(C=C2C(=O)N1)S(=O)(=O)N)Cl D0J8ZA HIGHSTAT Approved D0J9HW DRUG__ID D0J9HW D0J9HW DRUGCOMP AstraZeneca D0J9HW DRUGTYPE Small molecular drug D0J9HW DRUGINCH 1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) D0J9HW DRUGINKE FDLYAMZZIXQODN-UHFFFAOYSA-N D0J9HW DRUGSMIL C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F D0J9HW HIGHSTAT Approved D0J9UN DRUG__ID D0J9UN D0J9UN THERCLAS Anticancer Agents D0J9UN DRUGTYPE Small molecular drug D0J9UN DRUGINCH 1S/C8H11Cl2N3O2/c9-1-3-13(4-2-10)6-5-11-8(15)12-7(6)14/h5H,1-4H2,(H2,11,12,14,15) D0J9UN DRUGINKE IDPUKCWIGUEADI-UHFFFAOYSA-N D0J9UN DRUGSMIL C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl D0J9UN HIGHSTAT Approved D0J9XZ DRUG__ID D0J9XZ D0J9XZ THERCLAS Diuretics D0J9XZ DRUGTYPE Small molecular drug D0J9XZ DRUGINCH 1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21) D0J9XZ DRUGINKE NGBFQHCMQULJNZ-UHFFFAOYSA-N D0J9XZ DRUGSMIL CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C D0J9XZ HIGHSTAT Approved D0JO3U DRUG__ID D0JO3U D0JO3U DRUGCOMP Sanofi D0JO3U DRUGTYPE Small molecular drug D0JO3U DRUGINCH 1S/C18H16N2O.C2H4O2/c1-10-15-9-20(3)7-6-13(15)11(2)18-17(10)14-8-12(21)4-5-16(14)19-18;1-2(3)4/h4-9,21H,1-3H3;1H3,(H,3,4) D0JO3U DRUGINKE BOMZMNZEXMAQQW-UHFFFAOYSA-N D0JO3U DRUGSMIL CC1=C2C=C[N+](=CC2=C(C3=C1NC4=C3C=C(C=C4)O)C)C.CC(=O)[O-] D0JO3U HIGHSTAT Approved D0JV4Q DRUG__ID D0JV4Q D0JV4Q DRUGCOMP Nihon Nohyaku Co Ltd D0JV4Q DRUGTYPE Small molecular drug D0JV4Q DRUGINCH 1S/C14H10ClN3S2/c15-11-4-2-1-3-10(11)13-8-19-14(20-13)12(7-16)18-6-5-17-9-18/h1-6,9,13H,8H2/b14-12+ D0JV4Q DRUGINKE ZRTQSJFIDWNVJW-WYMLVPIESA-N D0JV4Q DRUGSMIL C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=CC=CC=C3Cl D0JV4Q HIGHSTAT Approved D0JW1S DRUG__ID D0JW1S D0JW1S DRUGCOMP Guerbet D0JW1S DRUGTYPE Small molecular drug D0JW1S DRUGINCH 1S/C16H28N4O8.C7H17NO5.Gd/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26;1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28);4-13H,2-3H2,1H3;/q;;+3/p-3/t;4-,5+,6+,7+;/m.0./s1 D0JW1S DRUGINKE RYHQMKVRYNEBNJ-BMWGJIJESA-K D0JW1S DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3] D0JW1S HIGHSTAT Approved D0JY3V DRUG__ID D0JY3V D0JY3V DRUGCOMP BioProjet; Societe Civile de Recherche D0JY3V DRUGTYPE Small molecular drug D0JY3V DRUGINCH 1S/C21H23NO4S/c1-16(23)27-15-19(12-17-8-4-2-5-9-17)21(25)22-13-20(24)26-14-18-10-6-3-7-11-18/h2-11,19H,12-15H2,1H3,(H,22,25) D0JY3V DRUGINKE ODUOJXZPIYUATO-UHFFFAOYSA-N D0JY3V DRUGSMIL CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2 D0JY3V HIGHSTAT Approved D0JY8T DRUG__ID D0JY8T D0JY8T DRUGCOMP Ligand Pharmaceuticals Inc D0JY8T DRUGTYPE Small molecular drug D0JY8T DRUGINCH 1S/C30H34N2O3/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31/h6-15,20,33-34H,2-5,16-19,21H2,1H3 D0JY8T DRUGINKE UCJGJABZCDBEDK-UHFFFAOYSA-N D0JY8T DRUGSMIL CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O D0JY8T HIGHSTAT Approved D0K0KH DRUG__ID D0K0KH D0K0KH DRUGCOMP Novartis International AG D0K0KH DRUGTYPE Small molecular drug D0K0KH DRUGINCH 1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3/t11-,12+,13? D0K0KH DRUGINKE ZNRGQMMCGHDTEI-FUNVUKJBSA-N D0K0KH DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43 D0K0KH HIGHSTAT Approved D0K1QD DRUG__ID D0K1QD D0K1QD DRUGCOMP Mylan Inc D0K1QD DRUGTYPE Small molecular drug D0K1QD DRUGINCH 1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11) D0K1QD DRUGINKE TYMRLRRVMHJFTF-UHFFFAOYSA-N D0K1QD DRUGSMIL C1=CC(=CC=C1CN)S(=O)(=O)N D0K1QD HIGHSTAT Approved D0K1ST DRUG__ID D0K1ST D0K1ST TRADNAME Yupelri D0K1ST DRUGCOMP Theravance Biopharma/Mylan D0K1ST DRUGINCH 1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43) D0K1ST DRUGINKE FYDWDCIFZSGNBU-UHFFFAOYSA-N D0K1ST DRUGSMIL CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N D0K1ST HIGHSTAT Approved D0K1XK DRUG__ID D0K1XK D0K1XK THERCLAS Antihypertensive Agents D0K1XK DRUGTYPE Small molecular drug D0K1XK DRUGINCH 1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12) D0K1XK DRUGINKE RPTUSVTUFVMDQK-UHFFFAOYSA-N D0K1XK DRUGSMIL C1=CC=C2C(=C1)C=NN=C2NN D0K1XK HIGHSTAT Approved D0K3LW DRUG__ID D0K3LW D0K3LW THERCLAS Parasympathomimetics D0K3LW DRUGTYPE Small molecular drug D0K3LW DRUGINCH 1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3 D0K3LW DRUGINKE JXSJBGJIGXNWCI-UHFFFAOYSA-N D0K3LW DRUGSMIL CCOC(=O)CC(C(=O)OCC)SP(=S)(OC)OC D0K3LW HIGHSTAT Approved D0K3MC DRUG__ID D0K3MC D0K3MC DRUGCOMP Leo AB D0K3MC DRUGTYPE Small molecular drug D0K3MC DRUGINCH 1S/C26H27ClN2O/c1-28(19-26(30)22-13-15-23(27)16-14-22)17-6-18-29-24-9-4-2-7-20(24)11-12-21-8-3-5-10-25(21)29/h2-5,7-10,13-16H,6,11-12,17-19H2,1H3 D0K3MC DRUGINKE SAPNXPWPAUFAJU-UHFFFAOYSA-N D0K3MC DRUGSMIL CN(CCCN1C2=CC=CC=C2CCC3=CC=CC=C31)CC(=O)C4=CC=C(C=C4)Cl D0K3MC HIGHSTAT Approved D0K3OK DRUG__ID D0K3OK D0K3OK TRADNAME Korsuva D0K3OK DRUGCOMP Cara Therapeutics D0K3OK DRUGINCH 1S/C36H53N7O6/c1-24(2)21-29(32(45)40-28(15-9-10-18-37)34(47)43-19-16-36(39,17-20-43)35(48)49)42-33(46)30(23-26-13-7-4-8-14-26)41-31(44)27(38)22-25-11-5-3-6-12-25/h3-8,11-14,24,27-30H,9-10,15-23,37-39H2,1-2H3,(H,40,45)(H,41,44)(H,42,46)(H,48,49)/t27-,28-,29-,30-/m1/s1 D0K3OK DRUGINKE FWMNVWWHGCHHJJ-SKKKGAJSSA-N D0K3OK DRUGSMIL CC(C)CC(C(=O)NC(CCCCN)C(=O)N1CCC(CC1)(C(=O)O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)N D0K3OK HIGHSTAT Approved D0K3VA DRUG__ID D0K3VA D0K3VA DRUGCOMP Edmond Pharma D0K3VA DRUGTYPE Small molecular drug D0K3VA DRUGINCH 1S/C8H11NO4S2/c10-6(3-14-4-7(11)12)9-5-1-2-15-8(5)13/h5H,1-4H2,(H,9,10)(H,11,12) D0K3VA DRUGINKE QGFORSXNKQLDNO-UHFFFAOYSA-N D0K3VA DRUGSMIL C1CSC(=O)C1NC(=O)CSCC(=O)O D0K3VA HIGHSTAT Approved D0K3WO DRUG__ID D0K3WO D0K3WO DRUGCOMP Merck D0K3WO DRUGTYPE Small molecular drug D0K3WO DRUGINCH 1S/C27H30Cl2O6.C19H24N2O4.C4H4O4.2H2O/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20;1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-3(6)1-2-4(7)8;;/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3;3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2H,(H,5,6)(H,7,8);2*1H2/b;;2-1+;;/t15-,18?,19+,21+,24+,25+,26+,27+;13-,19+;;;/m10.../s1 D0K3WO DRUGINKE UXHWDONWSPBGOI-OZDDIZNSSA-N D0K3WO DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C.CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(=CC(=O)O)C(=O)O.O.O D0K3WO HIGHSTAT Approved D0K3ZR DRUG__ID D0K3ZR D0K3ZR THERCLAS Antihypertensive Agents D0K3ZR DRUGTYPE Small molecular drug D0K3ZR DRUGINCH 1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3 D0K3ZR DRUGINKE VHYCDWMUTMEGQY-UHFFFAOYSA-N D0K3ZR DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O D0K3ZR HIGHSTAT Approved D0K4MH DRUG__ID D0K4MH D0K4MH DRUGCOMP Ortho-McNell Pharmaceutical D0K4MH DRUGTYPE Small molecular drug D0K4MH DRUGINCH 1S/C14H23NO.ClH/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12;/h6-9,11,14,16H,5,10H2,1-4H3;1H/t11-,14+;/m0./s1 D0K4MH DRUGINKE ZELFLGGRLLOERW-YECZQDJWSA-N D0K4MH DRUGSMIL CCC(C1=CC(=CC=C1)O)C(C)CN(C)C.Cl D0K4MH HIGHSTAT Approved D0K5ER DRUG__ID D0K5ER D0K5ER DRUGCOMP GSK D0K5ER DRUGTYPE Small molecular drug D0K5ER DRUGINCH 1S/C18H19N3O3S.C4H4O4/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;5-3(6)1-2-4(7)8/h2-9,15H,10-12H2,1H3,(H,20,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1- D0K5ER DRUGINKE SUFUKZSWUHZXAV-BTJKTKAUSA-N D0K5ER DRUGSMIL CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O D0K5ER HIGHSTAT Approved D0K5LQ DRUG__ID D0K5LQ D0K5LQ THERCLAS Antiallergic Agents D0K5LQ DRUGTYPE Small molecular drug D0K5LQ DRUGINCH 1S/C10H8N6O/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8/h2-5H,1H3,(H,12,13,14,15) D0K5LQ DRUGINKE HIANJWSAHKJQTH-UHFFFAOYSA-N D0K5LQ DRUGSMIL CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3 D0K5LQ HIGHSTAT Approved D0K5WS DRUG__ID D0K5WS D0K5WS THERCLAS Vitamins D0K5WS DRUGTYPE Small molecular drug D0K5WS DRUGINCH 1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1 D0K5WS DRUGINKE QYSXJUFSXHHAJI-YRZJJWOYSA-N D0K5WS DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C D0K5WS HIGHSTAT Approved D0K6MW DRUG__ID D0K6MW D0K6MW DRUGCOMP Sanofi-Aventis D0K6MW DRUGTYPE Small molecular drug D0K6MW DRUGINCH 1S/C88H97Cl2N9O33/c1-3-4-5-6-7-8-9-10-60(108)94-68-74(113)71(110)58(32-101)129-87(68)132-78-55-26-40-27-56(78)126-52-18-14-38(24-47(52)90)77(131-86-67(92-34(2)103)73(112)70(109)57(31-100)128-86)69-84(121)98-66(85(122)123)45-29-42(105)30-54(127-88-76(115)75(114)72(111)59(33-102)130-88)61(45)44-23-37(13-15-49(44)106)63(81(118)99-69)96-83(120)65(40)97-82(119)64-39-21-41(104)28-43(22-39)124-53-25-36(12-16-50(53)107)62(91)80(117)93-48(79(116)95-64)20-35-11-17-51(125-55)46(89)19-35/h11-19,21-30,48,57-59,62-77,86-88,100-102,104-107,109-115H,3-10,20,31-33,91H2,1-2H3,(H,92,103)(H,93,117)(H,94,108)(H,95,116)(H,96,120)(H,97,119)(H,98,121)(H,99,118)(H,122,123)/t48-,57-,58-,59-,62-,63-,64+,65-,66+,67-,68-,69+,70-,71-,72-,73-,74-,75+,76+,77-,86+,87+,88?/m1/s1 D0K6MW DRUGINKE BJNLLBUOHPVGFT-CAYRISATSA-N D0K6MW DRUGSMIL CCCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)Cl)CO)O)O D0K6MW HIGHSTAT Approved D0K8CI DRUG__ID D0K8CI D0K8CI DRUGCOMP Menarini D0K8CI DRUGTYPE Small molecular drug D0K8CI DRUGINCH 1S/C29H42N2O4.BrH/c1-5-8-9-10-11-14-22-34-27-16-13-12-15-26(27)28(32)30-25-19-17-24(18-20-25)29(33)35-23-21-31(4,6-2)7-3;/h12-13,15-20H,5-11,14,21-23H2,1-4H3;1H D0K8CI DRUGINKE VWZPIJGXYWHBOW-UHFFFAOYSA-N D0K8CI DRUGSMIL CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC.[Br-] D0K8CI HIGHSTAT Approved D0K8KX DRUG__ID D0K8KX D0K8KX THERCLAS Hypoglycemic Agents D0K8KX DRUGTYPE Small molecular drug D0K8KX DRUGINCH 1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H D0K8KX DRUGINKE REFJWTPEDVJJIY-UHFFFAOYSA-N D0K8KX DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O D0K8KX HIGHSTAT Approved D0K8MP DRUG__ID D0K8MP D0K8MP THERCLAS Insecticides D0K8MP DRUGTYPE Small molecular drug D0K8MP DRUGINCH 1S/C21H20Cl2O3/c1-21(2)17(12-18(22)23)19(21)20(24)25-13-14-7-6-10-16(11-14)26-15-8-4-3-5-9-15/h3-12,17,19H,13H2,1-2H3 D0K8MP DRUGINKE RLLPVAHGXHCWKJ-UHFFFAOYSA-N D0K8MP DRUGSMIL CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C D0K8MP HIGHSTAT Approved D0K9MY DRUG__ID D0K9MY D0K9MY DRUGCOMP Bristol-Myers Squibb; AstraZeneca D0K9MY DRUGTYPE Small molecular drug D0K9MY DRUGINCH 1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1 D0K9MY DRUGINKE QGJUIPDUBHWZPV-SGTAVMJGSA-N D0K9MY DRUGSMIL C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N D0K9MY HIGHSTAT Approved D0KD1U DRUG__ID D0KD1U D0KD1U THERCLAS Antiarrhythmic Agents D0KD1U DRUGTYPE Small molecular drug D0KD1U DRUGINCH 1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17) D0KD1U DRUGINKE DURULFYMVIFBIR-UHFFFAOYSA-N D0KD1U DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O D0KD1U HIGHSTAT Approved D0KG3R DRUG__ID D0KG3R D0KG3R DRUGCOMP Bayer HealthCare Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development D0KG3R DRUGTYPE Small molecular drug D0KG3R DRUGINCH 1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1 D0KG3R DRUGINKE KGFYHTZWPPHNLQ-AWEZNQCLSA-N D0KG3R DRUGSMIL C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl D0KG3R HIGHSTAT Approved D0KG4B DRUG__ID D0KG4B D0KG4B DRUGCOMP Toyama D0KG4B DRUGTYPE Small molecular drug D0KG4B DRUGINCH 1S/C22H29N9O9S2.Na/c1-5-29-6-7-30(16(35)15(29)34)20(39)23-12(10(2)32)14(33)24-22(40-4)18(38)31-13(17(36)37)11(8-41-19(22)31)9-42-21-25-26-27-28(21)3;/h10,12,19,32H,5-9H2,1-4H3,(H,23,39)(H,24,33)(H,36,37);/q;+1/p-1/t10-,12+,19+,22-;/m0./s1 D0KG4B DRUGINKE WNJOIIXGSLBJAS-FDVIUCIPSA-M D0KG4B DRUGSMIL CCN1CCN(C(=O)C1=O)C(=O)NC(C(C)O)C(=O)NC2(C3N(C2=O)C(=C(CS3)CSC4=NN=NN4C)C(=O)[O-])OC.[Na+] D0KG4B HIGHSTAT Approved D0KK2E DRUG__ID D0KK2E D0KK2E DRUGCOMP Eisai D0KK2E DRUGTYPE Small molecular drug D0KK2E DRUGINCH 1S/C40H59NO11/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41/h19,23-39,43H,2-3,5-18,41H2,1,4H3/t19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+/m1/s1 D0KK2E DRUGINKE UFNVPOGXISZXJD-JBQZKEIOSA-N D0KK2E DRUGSMIL CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O D0KK2E HIGHSTAT Approved D0KL9X DRUG__ID D0KL9X D0KL9X DRUGCOMP Ge Healthcare D0KL9X DRUGTYPE Small molecular drug D0KL9X DRUGINCH 1S/Kr/i1-3 D0KL9X DRUGINKE DNNSSWSSYDEUBZ-OIOBTWANSA-N D0KL9X DRUGSMIL [Kr] D0KL9X HIGHSTAT Approved D0KR9U DRUG__ID D0KR9U D0KR9U THERCLAS Central Nervous System Stimulants D0KR9U DRUGTYPE Small molecular drug D0KR9U DRUGINCH 1S/C15H18O7.C15H16O6/c1-12(2,18)6-7-10(16)20-8(6)9-13(3)14(7,19)4-5-15(13,22-5)11(17)21-9;1-5(2)7-8-11(16)19-9(7)10-13(3)14(8,18)4-6-15(13,21-6)12(17)20-10/h5-9,18-19H,4H2,1-3H3;6-10,18H,1,4H2,2-3H3/t5-,6+,7?,8?,9-,13-,14-,15+;6?,7-,8?,9?,10+,13+,14+,15-/m10/s1 D0KR9U DRUGINKE VJKUPQSHOVKBCO-ZTYBEOBUSA-N D0KR9U DRUGSMIL CC(=C)C1C2C3C4(C(C1C(=O)O2)(CC5C4(O5)C(=O)O3)O)C.CC12C3C4C(C(C1(CC5C2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O D0KR9U HIGHSTAT Approved D0L0GM DRUG__ID D0L0GM D0L0GM DRUGCOMP GlaxoSmithKline D0L0GM DRUGTYPE Small molecular drug D0L0GM DRUGINCH 1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1 D0L0GM DRUGINKE DAFYYTQWSAWIGS-DEOSSOPVSA-N D0L0GM DRUGSMIL C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl D0L0GM HIGHSTAT Approved D0L0MB DRUG__ID D0L0MB D0L0MB THERCLAS Antipsychotic Agents D0L0MB DRUGTYPE Small molecular drug D0L0MB DRUGINCH 1S/C23H29N3O2S/c1-18(28)19-7-8-23-21(17-19)26(20-5-2-3-6-22(20)29-23)10-4-9-24-11-13-25(14-12-24)15-16-27/h2-3,5-8,17,27H,4,9-16H2,1H3 D0L0MB DRUGINKE WNTYBHLDCKXEOT-UHFFFAOYSA-N D0L0MB DRUGSMIL CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)CCO D0L0MB HIGHSTAT Approved D0L2LS DRUG__ID D0L2LS D0L2LS THERCLAS Anabolic Agents D0L2LS DRUGTYPE Small molecular drug D0L2LS DRUGINCH 1S/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1 D0L2LS DRUGINKE YLRFCQOZQXIBAB-RBZZARIASA-N D0L2LS DRUGSMIL CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C)O)C)O)F D0L2LS HIGHSTAT Approved D0L2MX DRUG__ID D0L2MX D0L2MX THERCLAS Antihypertensive Agents D0L2MX DRUGTYPE Small molecular drug D0L2MX DRUGINCH 1S/C15H14ClN3O4S3/c16-11-6-12-14(7-13(11)25(17,20)21)26(22,23)19-15(18-12)9-24-8-10-4-2-1-3-5-10/h1-7H,8-9H2,(H,18,19)(H2,17,20,21) D0L2MX DRUGINKE NDTSRXAMMQDVSW-UHFFFAOYSA-N D0L2MX DRUGSMIL C1=CC=C(C=C1)CSCC2=NS(=O)(=O)C3=CC(=C(C=C3N2)Cl)S(=O)(=O)N D0L2MX HIGHSTAT Approved D0L2UN DRUG__ID D0L2UN D0L2UN THERCLAS Antirheumatic Agents D0L2UN DRUGTYPE Small molecular drug D0L2UN DRUGINCH 1S/C14H20O9S.C6H15P.Au/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18;1-4-7(5-2)6-3;/h10-14,24H,5H2,1-4H3;4-6H2,1-3H3;/q;;+1/p-1 D0L2UN DRUGINKE AUJRCFUBUPVWSZ-UHFFFAOYSA-M D0L2UN DRUGSMIL CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+] D0L2UN HIGHSTAT Approved D0L3DK DRUG__ID D0L3DK D0L3DK DRUGCOMP Novartis D0L3DK DRUGTYPE Small molecular drug D0L3DK DRUGINCH 1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1 D0L3DK DRUGINKE SYOKIDBDQMKNDQ-XWTIBIIYSA-N D0L3DK DRUGSMIL C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N D0L3DK HIGHSTAT Approved D0L4JT DRUG__ID D0L4JT D0L4JT THERCLAS Antibiotics D0L4JT DRUGTYPE Small molecular drug D0L4JT DRUGINCH 1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10) D0L4JT DRUGINKE FDDDEECHVMSUSB-UHFFFAOYSA-N D0L4JT DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)N D0L4JT HIGHSTAT Approved D0L5FY DRUG__ID D0L5FY D0L5FY THERCLAS Antihypertensive Agents D0L5FY DRUGTYPE Small molecular drug D0L5FY DRUGINCH 1S/C17H27NO4/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4/h7,10,15,18,20H,8-9H2,1-6H3 D0L5FY DRUGINKE BQIPXWYNLPYNHW-UHFFFAOYSA-N D0L5FY DRUGSMIL CC1=CC(=C(C(=C1OC(=O)C)C)C)OCC(CNC(C)C)O D0L5FY HIGHSTAT Approved D0L5KU DRUG__ID D0L5KU D0L5KU DRUGCOMP GlaxoSmithKline plc D0L5KU DRUGTYPE Small molecular drug D0L5KU DRUGINCH 1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3/t17-/m0/s1 D0L5KU DRUGINKE CYHWMBVXXDIZNZ-KRWDZBQOSA-N D0L5KU DRUGSMIL CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=NC2CCC(=O)OC)C4=CC=CC=N4 D0L5KU HIGHSTAT Approved D0L5QT DRUG__ID D0L5QT D0L5QT DRUGCOMP Pharma Hameln GmbH D0L5QT DRUGTYPE Small molecular drug D0L5QT DRUGINCH 1S/C14H23N3O10.3Na.Zn/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;;;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);;;;/q;3*+1;+2/p-5 D0L5QT DRUGINKE HVASDHJNLYRZEA-UHFFFAOYSA-I D0L5QT DRUGSMIL C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Zn+2] D0L5QT HIGHSTAT Approved D0L5RW DRUG__ID D0L5RW D0L5RW DRUGCOMP Genzyme D0L5RW DRUGTYPE Small molecular drug D0L5RW DRUGINCH 1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2 D0L5RW DRUGINKE YIQPUIGJQJDJOS-UHFFFAOYSA-N D0L5RW DRUGSMIL C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3 D0L5RW HIGHSTAT Approved D0L6DA DRUG__ID D0L6DA D0L6DA THERCLAS Antiinflammatory Agents D0L6DA DRUGTYPE Small molecular drug D0L6DA DRUGINCH 1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20) D0L6DA DRUGINKE LNPDTQAFDNKSHK-UHFFFAOYSA-N D0L6DA DRUGSMIL CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N D0L6DA HIGHSTAT Approved D0L6DO DRUG__ID D0L6DO D0L6DO DRUGCOMP Pfizer Inc D0L6DO DRUGTYPE Small molecular drug D0L6DO DRUGINCH 1S/C13H13F2N6O4P/c14-10-1-2-11(12(15)3-10)13(25-26(22,23)24,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9H,4-5H2,(H2,22,23,24) D0L6DO DRUGINKE GHJWNRRCRIGGIO-UHFFFAOYSA-N D0L6DO DRUGSMIL C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)OP(=O)(O)O D0L6DO HIGHSTAT Approved D0L6QI DRUG__ID D0L6QI D0L6QI DRUGCOMP Toyo Jozo Co Ltd D0L6QI DRUGTYPE Small molecular drug D0L6QI DRUGINCH 1S/C42H69NO15/c1-11-16-32(48)55-40-27(6)53-34(23-42(40,7)58-31(47)12-2)56-37-26(5)54-41(36(50)35(37)43(8)9)57-38-28(19-20-44)21-24(3)29(45)18-15-13-14-17-25(4)52-33(49)22-30(46)39(38)51-10/h13-15,18,20,24-30,34-41,45-46,50H,11-12,16-17,19,21-23H2,1-10H3/b14-13+,18-15+/t24-,25-,26-,27+,28+,29+,30-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1 D0L6QI DRUGINKE VYWWNRMSAPEJLS-MDWYKHENSA-N D0L6QI DRUGSMIL CCCC(=O)OC1C(OC(CC1(C)OC(=O)CC)OC2C(OC(C(C2N(C)C)O)OC3C(CC(C(C=CC=CCC(OC(=O)CC(C3OC)O)C)O)C)CC=O)C)C D0L6QI HIGHSTAT Approved D0L7FM DRUG__ID D0L7FM D0L7FM THERCLAS Uricosuric Agents D0L7FM DRUGTYPE Small molecular drug D0L7FM DRUGINCH 1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16) D0L7FM DRUGINKE DBABZHXKTCFAPX-UHFFFAOYSA-N D0L7FM DRUGSMIL CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O D0L7FM HIGHSTAT Approved D0L7LC DRUG__ID D0L7LC D0L7LC DRUGCOMP Gloucester Pharmaceuticals; Fujisawa Pharmaceutical Ltd. D0L7LC DRUGTYPE Small molecular drug D0L7LC DRUGINCH 1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1 D0L7LC DRUGINKE OHRURASPPZQGQM-GCCNXGTGSA-N D0L7LC DRUGSMIL CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C D0L7LC HIGHSTAT Approved D0L7UQ DRUG__ID D0L7UQ D0L7UQ THERCLAS Antituberculosis Agents D0L7UQ DRUGTYPE Small molecular drug D0L7UQ DRUGINCH 1S/C9H12N2S/c1-2-3-8-6-7(9(10)12)4-5-11-8/h4-6H,2-3H2,1H3,(H2,10,12) D0L7UQ DRUGINKE VRDIULHPQTYCLN-UHFFFAOYSA-N D0L7UQ DRUGSMIL CCCC1=NC=CC(=C1)C(=S)N D0L7UQ HIGHSTAT Approved D0L9HX DRUG__ID D0L9HX D0L9HX DRUGCOMP Isotechnika D0L9HX DRUGTYPE Small molecular drug D0L9HX DRUGINCH 1S/C63H111N11O12/c1-25-27-28-29-41(15)53(76)52-57(80)66-44(26-2)59(82)68(18)34-49(75)69(19)45(30-35(3)4)56(79)67-50(39(11)12)62(85)70(20)46(31-36(5)6)55(78)64-42(16)54(77)65-43(17)58(81)71(21)47(32-37(7)8)60(83)72(22)48(33-38(9)10)61(84)73(23)51(40(13)14)63(86)74(52)24/h25,27-28,35-48,50-53,76H,1,26,29-34H2,2-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/b28-27+/t41-,42+,43-,44+,45+,46+,47+,48+,50+,51+,52+,53-/m1/s1 D0L9HX DRUGINKE BICRTLVBTLFLRD-PTWUADNWSA-N D0L9HX DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C D0L9HX HIGHSTAT Approved D0L9KH DRUG__ID D0L9KH D0L9KH TRADNAME Velsipity D0L9KH DRUGCOMP Pfizer D0L9KH DRUGINCH 1S/C26H26F3NO3/c27-26(28,29)22-11-15(5-8-19(22)16-3-1-2-4-16)14-33-18-7-10-23-21(13-18)20-9-6-17(12-24(31)32)25(20)30-23/h5,7-8,10-11,13,16-17,30H,1-4,6,9,12,14H2,(H,31,32)/t17-/m1/s1 D0L9KH DRUGINKE MVGWUTBTXDYMND-QGZVFWFLSA-N D0L9KH DRUGSMIL C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F D0L9KH HIGHSTAT Approved D0L9YX DRUG__ID D0L9YX D0L9YX THERCLAS Antiinflammatory Agents D0L9YX DRUGTYPE Small molecular drug D0L9YX DRUGINCH 1S/C2H5NO2.Al.2H2O/c3-1-2(4)5;;;/h1,3H2,(H,4,5);;2*1H2/q;+1;;/p-1 D0L9YX DRUGINKE RBNPZEHAODHBPZ-UHFFFAOYSA-M D0L9YX DRUGSMIL C(C(=O)O[Al])N.O.O D0L9YX HIGHSTAT Approved D0LJ8C DRUG__ID D0LJ8C D0LJ8C DRUGCOMP Novartis Pharmaceuticals D0LJ8C DRUGTYPE Small molecular drug D0LJ8C DRUGINCH 1S/C24H29N5O3.C24H29NO5.3Na.3H2O/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23;1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;;;;;;/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28);4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);;;;3*1H2/q;;3*+1;;;/t22-;17-,21+;;;;;;/m01....../s1 D0LJ8C DRUGINKE ACXLNSLRLQLEAL-HWSDWTSLSA-N D0LJ8C DRUGSMIL CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O.CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O.O.O.O.[Na+].[Na+].[Na+] D0LJ8C HIGHSTAT Approved D0LM4A DRUG__ID D0LM4A D0LM4A DRUGCOMP Pfizer Pharmaceuticals D0LM4A DRUGTYPE Small molecular drug D0LM4A DRUGINCH 1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2 D0LM4A DRUGINKE JQSHBVHOMNKWFT-UHFFFAOYSA-N D0LM4A DRUGSMIL C1C2CNCC1C3=CC4=NC=CN=C4C=C23 D0LM4A HIGHSTAT Approved D0LR0R DRUG__ID D0LR0R D0LR0R THERCLAS Antihistamines D0LR0R DRUGTYPE Small molecular drug D0LR0R DRUGINCH 1S/C18H20N2S/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20/h2-9,14H,10-13H2,1H3 D0LR0R DRUGINKE HTMIBDQKFHUPSX-UHFFFAOYSA-N D0LR0R DRUGSMIL CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42 D0LR0R HIGHSTAT Approved D0LR4B DRUG__ID D0LR4B D0LR4B DRUGCOMP Sankyo Co Ltd D0LR4B DRUGTYPE Small molecular drug D0LR4B DRUGINCH 1S/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18) D0LR4B DRUGINKE YMBXTVYHTMGZDW-UHFFFAOYSA-N D0LR4B DRUGSMIL CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O D0LR4B HIGHSTAT Approved D0M1IO DRUG__ID D0M1IO D0M1IO THERCLAS Antibiotics D0M1IO DRUGTYPE Small molecular drug D0M1IO DRUGINCH 1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52-,53-,54-/m0/s1 D0M1IO DRUGINKE CLKOFPXJLQSYAH-ABRJDSQDSA-N D0M1IO DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4 D0M1IO HIGHSTAT Approved D0M1PL DRUG__ID D0M1PL D0M1PL DRUGCOMP Bayer Schering Pharma AG D0M1PL DRUGTYPE Small molecular drug D0M1PL DRUGINCH 1S/C17H32N4O7.Gd/c1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;/h14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);/q;+3/p-3 D0M1PL DRUGINKE DPNNNPAKRZOSMO-UHFFFAOYSA-K D0M1PL DRUGSMIL CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3] D0M1PL HIGHSTAT Approved D0M2MR DRUG__ID D0M2MR D0M2MR THERCLAS Hypoglycemic Agents D0M2MR DRUGTYPE Small molecular drug D0M2MR DRUGINCH 1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19) D0M2MR DRUGINKE BOVGTQGAOIONJV-UHFFFAOYSA-N D0M2MR DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 D0M2MR HIGHSTAT Approved D0M2YE DRUG__ID D0M2YE D0M2YE DRUGCOMP Beaufour-Ipsen D0M2YE DRUGTYPE Small molecular drug D0M2YE DRUGINCH 1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74) D0M2YE DRUGINKE PUDHBTGHUJUUFI-UHFFFAOYSA-N D0M2YE DRUGSMIL CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N D0M2YE HIGHSTAT Approved D0M3FJ DRUG__ID D0M3FJ D0M3FJ DRUGCOMP Pastorus Pharma Llc D0M3FJ DRUGTYPE Small molecular drug D0M3FJ DRUGINCH 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1 D0M3FJ DRUGINKE XNOPRXBHLZRZKH-DSZYJQQASA-N D0M3FJ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0M3FJ HIGHSTAT Approved D0M3QP DRUG__ID D0M3QP D0M3QP THERCLAS Antiarrhythmic Agents D0M3QP DRUGTYPE Small molecular drug D0M3QP DRUGINCH 1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20-,21-,22-,24-,25+,26-,27+,28-,29+,30+,31+,33+,34+,35+,36-,37-,38-,39+,40-,41+/m1/s1 D0M3QP DRUGINKE WDJUZGPOPHTGOT-XUDUSOBPSA-N D0M3QP DRUGSMIL CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O D0M3QP HIGHSTAT Approved D0M3TM DRUG__ID D0M3TM D0M3TM DRUGCOMP Heyl Chemisch Pharmazeutishe Fabrik D0M3TM DRUGTYPE Small molecular drug D0M3TM DRUGINCH 1S/18CN.7Fe/c18*1-2;;;;;;;/q18*-1;3*+2;4*+3 D0M3TM DRUGINKE DCYOBGZUOMKFPA-UHFFFAOYSA-N D0M3TM DRUGSMIL [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3] D0M3TM HIGHSTAT Approved D0M4VM DRUG__ID D0M4VM D0M4VM THERCLAS Antibiotics D0M4VM DRUGTYPE Small molecular drug D0M4VM DRUGINCH 1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11) D0M4VM DRUGINKE SKIVFJLNDNKQPD-UHFFFAOYSA-N D0M4VM DRUGSMIL CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N D0M4VM HIGHSTAT Approved D0M4WA DRUG__ID D0M4WA D0M4WA DRUGCOMP Intercept D0M4WA DRUGTYPE Small molecular drug D0M4WA DRUGINCH 1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19+,20+,21+,23+,24-,25-,26-/m1/s1 D0M4WA DRUGINKE ZXERDUOLZKYMJM-ZWECCWDJSA-N D0M4WA DRUGSMIL CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O D0M4WA HIGHSTAT Approved D0M4XY DRUG__ID D0M4XY D0M4XY DRUGCOMP Ivax D0M4XY DRUGTYPE Small molecular drug D0M4XY DRUGINCH 1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1 D0M4XY DRUGINKE HYFHYPWGAURHIV-JFIAXGOJSA-N D0M4XY DRUGSMIL CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O D0M4XY HIGHSTAT Approved D0M5OG DRUG__ID D0M5OG D0M5OG DRUGCOMP Fresenius kabi D0M5OG DRUGTYPE Small molecular drug D0M5OG DRUGINCH 1S/C16H32O11.C6H12O6/c17-1-6-22-11-12-13(23-7-2-18)14(24-8-3-19)15(25-9-4-20)16(27-12)26-10-5-21;7-1-2-3(8)4(9)5(10)6(11)12-2/h12-21H,1-11H2;2-11H,1H2/t12-,13-,14+,15-,16+;2-,3-,4+,5-,6+/m11/s1 D0M5OG DRUGINKE DNZMDASEFMLYBU-RNBXVSKKSA-N D0M5OG DRUGSMIL C(COCC1C(C(C(C(O1)OCCO)OCCO)OCCO)OCCO)O.C(C1C(C(C(C(O1)O)O)O)O)O D0M5OG HIGHSTAT Approved D0M5RF DRUG__ID D0M5RF D0M5RF DRUGCOMP Sarsa D0M5RF DRUGTYPE Small molecular drug D0M5RF DRUGINCH 1S/C21H24O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,9,11,13,18-19,23H,3,5-8,10,12H2,1H3/t18-,19+,20+,21+/m1/s1 D0M5RF DRUGINKE BJJXHLWLUDYTGC-ANULTFPQSA-N D0M5RF DRUGSMIL CCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O D0M5RF HIGHSTAT Approved D0M6LN DRUG__ID D0M6LN D0M6LN DRUGCOMP Merz & Co GmbH D0M6LN DRUGTYPE Small molecular drug D0M6LN DRUGINCH 1S/C5H12N2O2.C4H7NO4/c6-3-1-2-4(7)5(8)9;5-2(4(8)9)1-3(6)7/h4H,1-3,6-7H2,(H,8,9);2H,1,5H2,(H,6,7)(H,8,9)/t4-;2-/m00/s1 D0M6LN DRUGINKE IXUZXIMQZIMPSQ-ZBRNBAAYSA-N D0M6LN DRUGSMIL C(CC(C(=O)O)N)CN.C(C(C(=O)O)N)C(=O)O D0M6LN HIGHSTAT Approved D0M6VK DRUG__ID D0M6VK D0M6VK THERCLAS Anticholinergic Agents D0M6VK DRUGTYPE Small molecular drug D0M6VK DRUGINCH 1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12?,13-,14-,15+,16-,17+/m1/s1 D0M6VK DRUGINKE LZCOQTDXKCNBEE-XJMZPCNVSA-N D0M6VK DRUGSMIL C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C D0M6VK HIGHSTAT Approved D0M7BT DRUG__ID D0M7BT D0M7BT THERCLAS Central Nervous System Stimulants D0M7BT DRUGTYPE Small molecular drug D0M7BT DRUGINCH 1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3 D0M7BT DRUGINKE XFDJYSQDBULQSI-UHFFFAOYSA-N D0M7BT DRUGSMIL CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4 D0M7BT HIGHSTAT Approved D0M7JT DRUG__ID D0M7JT D0M7JT DRUGCOMP Boehringer Ingelheim D0M7JT DRUGTYPE Small molecular drug D0M7JT DRUGINCH 1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34) D0M7JT DRUGINKE YBSJFWOBGCMAKL-UHFFFAOYSA-N D0M7JT DRUGSMIL CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N D0M7JT HIGHSTAT Approved D0M7TO DRUG__ID D0M7TO D0M7TO THERCLAS Antihypertensive Agents D0M7TO DRUGTYPE Small molecular drug D0M7TO DRUGINCH 1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29) D0M7TO DRUGINKE ADXGNEYLLLSOAR-UHFFFAOYSA-N D0M7TO DRUGSMIL CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D0M7TO HIGHSTAT Approved D0M8AB DRUG__ID D0M8AB D0M8AB THERCLAS Dietary supplement D0M8AB DRUGTYPE Small molecular drug D0M8AB DRUGINCH 1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5) D0M8AB DRUGINKE DHMQDGOQFOQNFH-UHFFFAOYSA-N D0M8AB DRUGSMIL C(C(=O)O)N D0M8AB HIGHSTAT Approved D0M8VE DRUG__ID D0M8VE D0M8VE DRUGCOMP Vanda Pharmaceuticals D0M8VE DRUGTYPE Small molecular drug D0M8VE DRUGINCH 1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3 D0M8VE DRUGINKE XMXHEBAFVSFQEX-UHFFFAOYSA-N D0M8VE DRUGSMIL CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC D0M8VE HIGHSTAT Approved D0MA7C DRUG__ID D0MA7C D0MA7C DRUGCOMP Hope Medical Enterprises Inc D0MA7C DRUGTYPE Small molecular drug D0MA7C DRUGINCH 1S/HNO2.Na/c2-1-3;/h(H,2,3);/q;+1/p-1 D0MA7C DRUGINKE LPXPTNMVRIOKMN-UHFFFAOYSA-M D0MA7C DRUGSMIL N(=O)[O-].[Na+] D0MA7C HIGHSTAT Approved D0MA9N DRUG__ID D0MA9N D0MA9N THERCLAS Antiinflammatory Agents D0MA9N DRUGTYPE Small molecular drug D0MA9N DRUGINCH 1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2 D0MA9N DRUGINKE MQJKPEGWNLWLTK-UHFFFAOYSA-N D0MA9N DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N D0MA9N HIGHSTAT Approved D0MD2L DRUG__ID D0MD2L D0MD2L DRUGCOMP Eisai D0MD2L DRUGTYPE Small molecular drug D0MD2L DRUGINCH 1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17) D0MD2L DRUGINKE POGQSBRIGCQNEG-UHFFFAOYSA-N D0MD2L DRUGSMIL C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F D0MD2L HIGHSTAT Approved D0MD8D DRUG__ID D0MD8D D0MD8D TRADNAME TPOXX D0MD8D DRUGCOMP SIGA Technologies D0MD8D DRUGINCH 1S/C19H15F3N2O3/c20-19(21,22)9-3-1-8(2-4-9)16(25)23-24-17(26)14-10-5-6-11(13-7-12(10)13)15(14)18(24)27/h1-6,10-15H,7H2,(H,23,25)/t10-,11+,12+,13-,14-,15+ D0MD8D DRUGINKE CSKDFZIMJXRJGH-VWLPUNTISA-N D0MD8D DRUGSMIL C1C2C1C3C=CC2C4C3C(=O)N(C4=O)NC(=O)C5=CC=C(C=C5)C(F)(F)F D0MD8D HIGHSTAT Approved D0MF9G DRUG__ID D0MF9G D0MF9G DRUGCOMP Mallinckrodt Medical Inc D0MF9G DRUGTYPE Small molecular drug D0MF9G DRUGINCH 1S/ClHO4.K/c2-1(3,4)5;/h(H,2,3,4,5);/q;+1/p-1 D0MF9G DRUGINKE YLMGFJXSLBMXHK-UHFFFAOYSA-M D0MF9G DRUGSMIL [O-]Cl(=O)(=O)=O.[K+] D0MF9G HIGHSTAT Approved D0MM2L DRUG__ID D0MM2L D0MM2L DRUGCOMP GILEAD D0MM2L DRUGTYPE Small molecular drug D0MM2L DRUGINCH 1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5?,6-/m1/s1 D0MM2L DRUGINKE XQSPYNMVSIKCOC-PRJDIBJQSA-N D0MM2L DRUGSMIL C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F D0MM2L HIGHSTAT Approved D0MM8N DRUG__ID D0MM8N D0MM8N DRUGCOMP Santhera Pharmaceuticals D0MM8N DRUGTYPE Small molecular drug D0MM8N DRUGINCH 1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3 D0MM8N DRUGINKE JGPMMRGNQUBGND-UHFFFAOYSA-N D0MM8N DRUGSMIL CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO D0MM8N HIGHSTAT Approved D0MN9K DRUG__ID D0MN9K D0MN9K DRUGCOMP Parke Davis Div Warner Lambert Co D0MN9K DRUGTYPE Small molecular drug D0MN9K DRUGINCH 1S/C14H11Cl2NO2.Na/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;/h2-7,17H,1H3,(H,18,19);/q;+1/p-1 D0MN9K DRUGINKE OGPIIGMUPMPMNT-UHFFFAOYSA-M D0MN9K DRUGSMIL CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+] D0MN9K HIGHSTAT Approved D0MP5H DRUG__ID D0MP5H D0MP5H THERCLAS Antihypertensive Agents D0MP5H DRUGTYPE Small molecular drug D0MP5H DRUGINCH 1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12) D0MP5H DRUGINKE JWPGJSVJDAJRLW-UHFFFAOYSA-N D0MP5H DRUGSMIL C1CN(CC2=CC=CC=C21)C(=N)N D0MP5H HIGHSTAT Approved D0MR4Q DRUG__ID D0MR4Q D0MR4Q TRADNAME Tavneos D0MR4Q DRUGCOMP ChemoCentryx D0MR4Q DRUGINCH 1S/C33H35F4N3O2/c1-20-12-15-25(19-27(20)33(35,36)37)39-31(41)26-10-6-18-40(32(42)29-21(2)7-5-11-28(29)34)30(26)22-13-16-24(17-14-22)38-23-8-3-4-9-23/h5,7,11-17,19,23,26,30,38H,3-4,6,8-10,18H2,1-2H3,(H,39,41)/t26-,30-/m0/s1 D0MR4Q DRUGINKE PUKBOVABABRILL-YZNIXAGQSA-N D0MR4Q DRUGSMIL CC1=C(C(=CC=C1)F)C(=O)N2CCCC(C2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F D0MR4Q HIGHSTAT Approved D0N0ES DRUG__ID D0N0ES D0N0ES DRUGCOMP Anmar D0N0ES DRUGTYPE Small molecular drug D0N0ES DRUGINCH 1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9) D0N0ES DRUGINKE PVNIIMVLHYAWGP-UHFFFAOYSA-N D0N0ES DRUGSMIL C1=CC(=CN=C1)C(=O)O D0N0ES HIGHSTAT Approved D0N0OU DRUG__ID D0N0OU D0N0OU DRUGCOMP ApoPharma D0N0OU DRUGTYPE Small molecular drug D0N0OU DRUGINCH 1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3 D0N0OU DRUGINKE TZXKOCQBRNJULO-UHFFFAOYSA-N D0N0OU DRUGSMIL CC1=C(C(=O)C=CN1C)O D0N0OU HIGHSTAT Approved D0N0TZ DRUG__ID D0N0TZ D0N0TZ DRUGCOMP Prism Pharmaceuticals Inc D0N0TZ DRUGTYPE Small molecular drug D0N0TZ DRUGINCH 1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1 D0N0TZ DRUGINKE GKTWGGQPFAXNFI-HNNXBMFYSA-N D0N0TZ DRUGSMIL COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3 D0N0TZ HIGHSTAT Approved D0N2SR DRUG__ID D0N2SR D0N2SR DRUGCOMP Actelion Pharmaceuticals D0N2SR DRUGTYPE Small molecular drug D0N2SR DRUGINCH 1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31) D0N2SR DRUGINKE QXWZQTURMXZVHJ-UHFFFAOYSA-N D0N2SR DRUGSMIL CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D0N2SR HIGHSTAT Approved D0N3NO DRUG__ID D0N3NO D0N3NO DRUGCOMP Ono D0N3NO DRUGTYPE Small molecular drug D0N3NO DRUGINCH 1S/C22H36O5/c1-3-4-9-16(2)14-17(23)12-13-19-18(20(24)15-21(19)25)10-7-5-6-8-11-22(26)27/h8,11-13,16-19,21,23,25H,3-7,9-10,14-15H2,1-2H3,(H,26,27)/b11-8+,13-12+/t16-,17+,18+,19+,21+/m0/s1 D0N3NO DRUGINKE OJZYRQPMEIEQFC-UAWLTFRCSA-N D0N3NO DRUGSMIL CCCCC(C)CC(C=CC1C(CC(=O)C1CCCCC=CC(=O)O)O)O D0N3NO HIGHSTAT Approved D0N5KF DRUG__ID D0N5KF D0N5KF TRADNAME Vabomere D0N5KF DRUGCOMP The Medicines Company/Rempex Pharmaceuticals D0N5KF DRUGINCH 1S/C17H25N3O5S.C12H16BNO5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4;15-11(7-9-2-1-5-20-9)14-10-4-3-8(6-12(16)17)19-13(10)18/h7-12,18,21H,5-6H2,1-4H3,(H,24,25);1-2,5,8,10,18H,3-4,6-7H2,(H,14,15)(H,16,17)/t7-,8-,9+,10+,11-,12-;8-,10-/m10/s1 D0N5KF DRUGINKE SDJYWZHQLNEXKV-SSHSFQATSA-N D0N5KF DRUGSMIL B1(C(CCC(O1)CC(=O)O)NC(=O)CC2=CC=CS2)O.CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O D0N5KF HIGHSTAT Approved D0N6YV DRUG__ID D0N6YV D0N6YV DRUGCOMP Duramed Pharmaceuticals Inc D0N6YV DRUGTYPE Small molecular drug D0N6YV DRUGINCH 1S/C18H20O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3-5,10,14,16H,2,6-9H2,1H3,(H,20,21,22);/q;+1/p-1/t14-,16+,18+;/m1./s1 D0N6YV DRUGINKE QTTMOCOWZLSYSV-QWAPEVOJSA-M D0N6YV DRUGSMIL CC12CCC3C(=CCC4=C3C=CC(=C4)OS(=O)(=O)[O-])C1CCC2=O.[Na+] D0N6YV HIGHSTAT Approved D0N7AD DRUG__ID D0N7AD D0N7AD THERCLAS Antihistamines D0N7AD DRUGTYPE Small molecular drug D0N7AD DRUGINCH 1S/C20H22N2/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19/h2-7,12H,8-11,13-14H2,1H3 D0N7AD DRUGINKE SEBMTIQKRHYNIT-UHFFFAOYSA-N D0N7AD DRUGSMIL CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1 D0N7AD HIGHSTAT Approved D0N7AU DRUG__ID D0N7AU D0N7AU DRUGCOMP Merck KGaA D0N7AU DRUGTYPE Small molecular drug D0N7AU DRUGINCH 1S/C12H8N4O6S/c17-12(9-4-6-11(23-9)16(20)21)14-13-7-1-2-8-3-5-10(22-8)15(18)19/h1-7H,(H,14,17)/b2-1+,13-7+ D0N7AU DRUGINKE IDUMOVRJNBNOTR-BIZLIJPVSA-N D0N7AU DRUGSMIL C1=C(OC(=C1)[N+](=O)[O-])C=CC=NNC(=O)C2=CC=C(S2)[N+](=O)[O-] D0N7AU HIGHSTAT Approved D0NA8U DRUG__ID D0NA8U D0NA8U DRUGCOMP Universita' Degli Studi Di Urbino D0NA8U DRUGTYPE Small molecular drug D0NA8U DRUGINCH 1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/q;2*+1/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1 D0NA8U DRUGINKE PLCQGRYPOISRTQ-FCJDYXGNSA-L D0NA8U DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+] D0NA8U HIGHSTAT Approved D0NI0C DRUG__ID D0NI0C D0NI0C THERCLAS Antiviral Agents D0NI0C DRUGTYPE Small molecular drug D0NI0C DRUGINCH 1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1 D0NI0C DRUGINKE OIRDTQYFTABQOQ-UHTZMRCNSA-N D0NI0C DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N D0NI0C HIGHSTAT Approved D0NJ3V DRUG__ID D0NJ3V D0NJ3V THERCLAS Vasodilator Agents D0NJ3V DRUGTYPE Small molecular drug D0NJ3V DRUGINCH 1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3 D0NJ3V DRUGINKE XQYZDYMELSJDRZ-UHFFFAOYSA-N D0NJ3V DRUGSMIL COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC D0NJ3V HIGHSTAT Approved D0NJ5H DRUG__ID D0NJ5H D0NJ5H DRUGCOMP Takeda D0NJ5H DRUGTYPE Small molecular drug D0NJ5H DRUGINCH 1S/C18H21N5O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t15-/m1/s1 D0NJ5H DRUGINKE ZSBOMTDTBDDKMP-OAHLLOKOSA-N D0NJ5H DRUGSMIL CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N D0NJ5H HIGHSTAT Approved D0NU8J DRUG__ID D0NU8J D0NU8J TRADNAME Welireg D0NU8J DRUGCOMP Merck & Co. D0NU8J DRUGINCH 1S/C17H12F3NO4S/c1-26(23,24)12-3-2-11(13-14(12)17(22)16(20)15(13)19)25-10-5-8(7-21)4-9(18)6-10/h2-6,15-17,22H,1H3/t15-,16-,17+/m1/s1 D0NU8J DRUGINKE LOMMPXLFBTZENJ-ZACQAIPSSA-N D0NU8J DRUGSMIL CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O D0NU8J HIGHSTAT Approved D0NV5O DRUG__ID D0NV5O D0NV5O TRADNAME Kerendia D0NV5O DRUGCOMP Bayer D0NV5O DRUGINCH 1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1 D0NV5O DRUGINKE BTBHLEZXCOBLCY-QGZVFWFLSA-N D0NV5O DRUGSMIL CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C D0NV5O HIGHSTAT Approved D0O0AF DRUG__ID D0O0AF D0O0AF DRUGCOMP Fred Hutchinson Cancer Research Center D0O0AF DRUGTYPE Small molecular drug D0O0AF DRUGINCH 1S/2Na.H2S.S/h;;1H2;/q2*+1;;-2 D0O0AF DRUGINKE LCZRCSURXPJIHA-UHFFFAOYSA-N D0O0AF DRUGSMIL [Na+].[Na+].S.[S-2] D0O0AF HIGHSTAT Approved D0O0LS DRUG__ID D0O0LS D0O0LS DRUGCOMP Ignyta D0O0LS DRUGTYPE Small molecular drug D0O0LS DRUGINCH 1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40) D0O0LS DRUGINKE HAYYBYPASCDWEQ-UHFFFAOYSA-N D0O0LS DRUGSMIL CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6 D0O0LS HIGHSTAT Approved D0O1TC DRUG__ID D0O1TC D0O1TC THERCLAS Dietary supplement D0O1TC DRUGTYPE Small molecular drug D0O1TC DRUGINCH 1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12- D0O1TC DRUGINKE HOBAELRKJCKHQD-QNEBEIHSSA-N D0O1TC DRUGSMIL CCCCCC=CCC=CCC=CCCCCCCC(=O)O D0O1TC HIGHSTAT Approved D0O1WX DRUG__ID D0O1WX D0O1WX DRUGCOMP Depomed Bayer D0O1WX DRUGTYPE Small molecular drug D0O1WX DRUGINCH 1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24) D0O1WX DRUGINKE MYSWGUAQZAJSOK-UHFFFAOYSA-N D0O1WX DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O D0O1WX HIGHSTAT Approved D0O2HQ DRUG__ID D0O2HQ D0O2HQ DRUGCOMP Bracco SpA D0O2HQ DRUGTYPE Small molecular drug D0O2HQ DRUGINCH 1S/C17H22I3N3O8/c1-6(28)15(29)23-14-12(19)9(16(30)21-7(2-24)3-25)11(18)10(13(14)20)17(31)22-8(4-26)5-27/h6-8,24-28H,2-5H2,1H3,(H,21,30)(H,22,31)(H,23,29)/t6-/m0/s1 D0O2HQ DRUGINKE XQZXYNRDCRIARQ-LURJTMIESA-N D0O2HQ DRUGSMIL CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O D0O2HQ HIGHSTAT Approved D0O3AB DRUG__ID D0O3AB D0O3AB THERCLAS Hypnotics and Sedatives D0O3AB DRUGTYPE Small molecular drug D0O3AB DRUGINCH 1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15) D0O3AB DRUGINKE STDBAQMTJLUMFW-UHFFFAOYSA-N D0O3AB DRUGSMIL CCCCC1(C(=O)NC(=O)NC1=O)CC D0O3AB HIGHSTAT Approved D0O3FG DRUG__ID D0O3FG D0O3FG DRUGCOMP Wyeth D0O3FG DRUGTYPE Small molecular drug D0O3FG DRUGINCH 1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3 D0O3FG DRUGINKE KYYIDSXMWOZKMP-UHFFFAOYSA-N D0O3FG DRUGSMIL CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O D0O3FG HIGHSTAT Approved D0O4GY DRUG__ID D0O4GY D0O4GY DRUGCOMP Dusa Pharmaceuticals Inc D0O4GY DRUGTYPE Small molecular drug D0O4GY DRUGINCH 1S/C5H9NO3.ClH/c6-3-4(7)1-2-5(8)9;/h1-3,6H2,(H,8,9);1H D0O4GY DRUGINKE ZLHFONARZHCSET-UHFFFAOYSA-N D0O4GY DRUGSMIL C(CC(=O)O)C(=O)CN.Cl D0O4GY HIGHSTAT Approved D0O4QR DRUG__ID D0O4QR D0O4QR DRUGCOMP Hoechst; Taiho D0O4QR DRUGTYPE Small molecular drug D0O4QR DRUGINCH 1S/C20H20N6O7S4.2Na/c1-7-10(3-11(27)28)37-20(22-7)36-5-8-4-34-17-13(16(30)26(17)14(8)18(31)32)24-15(29)12(25-33-2)9-6-35-19(21)23-9;;/h6,13,17H,3-5H2,1-2H3,(H2,21,23)(H,24,29)(H,27,28)(H,31,32);;/q;2*+1/p-2/b25-12-;;/t13-,17-;;/m1../s1 D0O4QR DRUGINKE WBOBLQIRACJNPA-AEKYOGSZSA-L D0O4QR DRUGSMIL CC1=C(SC(=N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-])CC(=O)[O-].[Na+].[Na+] D0O4QR HIGHSTAT Approved D0O4SE DRUG__ID D0O4SE D0O4SE DRUGCOMP Presutti Laboratories D0O4SE DRUGTYPE Small molecular drug D0O4SE DRUGINCH 1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3 D0O4SE DRUGINKE HJLSLZFTEKNLFI-UHFFFAOYSA-N D0O4SE DRUGSMIL CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C D0O4SE HIGHSTAT Approved D0O5AG DRUG__ID D0O5AG D0O5AG TRADNAME Xofluza D0O5AG DRUGCOMP Shionogi/Roche D0O5AG DRUGINCH 1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1 D0O5AG DRUGINKE RZVPBGBYGMDSBG-GGAORHGYSA-N D0O5AG DRUGSMIL COC(=O)OCOC1=C2C(=O)N3CCOCC3N(N2C=CC1=O)C4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F D0O5AG HIGHSTAT Approved D0O5LU DRUG__ID D0O5LU D0O5LU THERCLAS Antibiotics D0O5LU DRUGTYPE Small molecular drug D0O5LU DRUGINCH 1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12?,18-,20+/m1/s1 D0O5LU DRUGINKE JWCSIUVGFCSJCK-CAVRMKNVSA-N D0O5LU DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O D0O5LU HIGHSTAT Approved D0O5SZ DRUG__ID D0O5SZ D0O5SZ THERCLAS Antiulcer Agents D0O5SZ DRUGTYPE Small molecular drug D0O5SZ DRUGINCH 1S/C17H24NO3.BrH/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12;/h3-7,13-16,19H,8-11H2,1-2H3;1H/q+1;/p-1/t13-,14+,15?,16?; D0O5SZ DRUGINKE FUFVKLQESJNNAN-ZZJGABIISA-M D0O5SZ DRUGSMIL C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-] D0O5SZ HIGHSTAT Approved D0O5TQ DRUG__ID D0O5TQ D0O5TQ THERCLAS Diagnostic Agents D0O5TQ DRUGTYPE Small molecular drug D0O5TQ DRUGINCH 1S/C37H49N7O9S/c1-37(2,3)53-36(52)39-16-14-30(45)41-28(19-23-21-40-25-13-9-8-12-24(23)25)34(50)42-26(15-17-54-4)33(49)44-29(20-31(46)47)35(51)43-27(32(38)48)18-22-10-6-5-7-11-22/h5-13,21,26-29,40H,14-20H2,1-4H3,(H2,38,48)(H,39,52)(H,41,45)(H,42,50)(H,43,51)(H,44,49)(H,46,47)/t26-,27-,28-,29-/m0/s1 D0O5TQ DRUGINKE NEYNJQRKHLUJRU-DZUOILHNSA-N D0O5TQ DRUGSMIL CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N D0O5TQ HIGHSTAT Approved D0O5YZ DRUG__ID D0O5YZ D0O5YZ DRUGCOMP Pharmed Dr Liedtke GmbH D0O5YZ DRUGTYPE Small molecular drug D0O5YZ DRUGINCH 1S/C15H22N2O2/c1-10(2)16-8-12(18)9-19-15-6-4-5-14-13(15)7-11(3)17-14/h4-7,10,12,16-18H,8-9H2,1-3H3 D0O5YZ DRUGINKE NXWGWUVGUSFQJC-UHFFFAOYSA-N D0O5YZ DRUGSMIL CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)C)O D0O5YZ HIGHSTAT Approved D0O6KE DRUG__ID D0O6KE D0O6KE DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D0O6KE DRUGTYPE Small molecular drug D0O6KE DRUGINCH 1S/C20H21NO5/c1-10(2)7-8-25-20(24)15-9-14(22)16-18(26-15)13-6-5-11(3)12(4)17(13)21-19(16)23/h5-6,9-10H,7-8H2,1-4H3,(H,21,23) D0O6KE DRUGINKE NFQIAEMCQGTTIR-UHFFFAOYSA-N D0O6KE DRUGSMIL CC1=C(C2=C(C=C1)C3=C(C(=O)C=C(O3)C(=O)OCCC(C)C)C(=O)N2)C D0O6KE HIGHSTAT Approved D0O6UZ DRUG__ID D0O6UZ D0O6UZ THERCLAS Antifungal Agents D0O6UZ DRUGTYPE Small molecular drug D0O6UZ DRUGINCH 1S/C20H15Cl3N2OS/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22/h1-8,11-12,19H,9-10H2 D0O6UZ DRUGINKE JLGKQTAYUIMGRK-UHFFFAOYSA-N D0O6UZ DRUGSMIL C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl D0O6UZ HIGHSTAT Approved D0O7DG DRUG__ID D0O7DG D0O7DG DRUGCOMP Roberts D0O7DG DRUGTYPE Small molecular drug D0O7DG DRUGINCH 1S/C66H86N18O12/c1-4-70-64(95)55-17-11-25-84(55)65(96)48(16-10-24-71-66(67)68)76-58(89)49(26-38(2)3)77-62(93)53(30-43-34-83(37-74-43)33-40-12-6-5-7-13-40)81-59(90)50(27-39-18-20-44(86)21-19-39)78-63(94)54(35-85)82-60(91)51(28-41-31-72-46-15-9-8-14-45(41)46)79-61(92)52(29-42-32-69-36-73-42)80-57(88)47-22-23-56(87)75-47/h5-9,12-15,18-21,31-32,34,36-38,47-55,72,85-86H,4,10-11,16-17,22-30,33,35H2,1-3H3,(H,69,73)(H,70,95)(H,75,87)(H,76,89)(H,77,93)(H,78,94)(H,79,92)(H,80,88)(H,81,90)(H,82,91)(H4,67,68,71)/t47-,48-,49-,50-,51-,52-,53+,54-,55-/m0/s1 D0O7DG DRUGINKE HHXHVIJIIXKSOE-QILQGKCVSA-N D0O7DG DRUGSMIL CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 D0O7DG HIGHSTAT Approved D0O7JW DRUG__ID D0O7JW D0O7JW DRUGCOMP Vistakon Pharmaceuticals D0O7JW DRUGTYPE Small molecular drug D0O7JW DRUGINCH 1S/C19H21N3O/c1-21-9-6-15(7-10-21)18-17-5-3-2-4-14(17)8-11-22-16(13-23)12-20-19(18)22/h2-5,12-13H,6-11H2,1H3 D0O7JW DRUGINKE MWTBKTRZPHJQLH-UHFFFAOYSA-N D0O7JW DRUGSMIL CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1 D0O7JW HIGHSTAT Approved D0O8GK DRUG__ID D0O8GK D0O8GK DRUGCOMP Astrazeneca D0O8GK DRUGTYPE Small molecular drug D0O8GK DRUGINCH 1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32) D0O8GK DRUGINKE DUYJMQONPNNFPI-UHFFFAOYSA-N D0O8GK DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC D0O8GK HIGHSTAT Approved D0O8JB DRUG__ID D0O8JB D0O8JB THERCLAS Diagnostic Agents D0O8JB DRUGTYPE Small molecular drug D0O8JB DRUGINCH 1S/C130H219N43O42/c1-59(2)43-78(118(206)172-99(65(13)14)126(214)215)151-94(182)53-148-104(192)75(31-34-91(132)180)156-113(201)81(46-62(7)8)163-115(203)82(47-63(9)10)161-107(195)72(28-22-38-145-128(136)137)153-110(198)76(32-35-92(133)181)157-114(202)80(45-61(5)6)159-106(194)71(27-21-37-144-127(134)135)152-102(190)66(15)150-120(208)87(55-174)168-117(205)86(52-98(188)189)165-109(197)73(29-23-39-146-129(138)139)154-112(200)79(44-60(3)4)160-108(196)74(30-24-40-147-130(140)141)155-121(209)89(57-176)169-116(204)83(48-64(11)12)162-111(199)77(33-36-96(184)185)158-122(210)90(58-177)170-125(213)101(68(17)179)173-119(207)84(49-69-25-19-18-20-26-69)166-124(212)100(67(16)178)171-95(183)54-149-105(193)85(51-97(186)187)164-123(211)88(56-175)167-103(191)70(131)50-93-142-41-42-143-93/h18-20,25-26,41-42,59-68,70-90,99-101,174-179H,21-24,27-40,43-58,131H2,1-17H3,(H2,132,180)(H2,133,181)(H,142,143)(H,148,192)(H,149,193)(H,150,208)(H,151,182)(H,152,190)(H,153,198)(H,154,200)(H,155,209)(H,156,201)(H,157,202)(H,158,210)(H,159,194)(H,160,196)(H,161,195)(H,162,199)(H,163,203)(H,164,211)(H,165,197)(H,166,212)(H,167,191)(H,168,205)(H,169,204)(H,170,213)(H,171,183)(H,172,206)(H,173,207)(H,184,185)(H,186,187)(H,188,189)(H,214,215)(H4,134,135,144)(H4,136,137,145)(H4,138,139,146)(H4,140,141,147) D0O8JB DRUGINKE KKNIUBFRGPFELP-UHFFFAOYSA-N D0O8JB DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC2=NC=CN2)N D0O8JB HIGHSTAT Approved D0OB2M DRUG__ID D0OB2M D0OB2M THERCLAS Neuromuscular Nondepolarizing Agents D0OB2M DRUGTYPE Small molecular drug D0OB2M DRUGINCH 1S/C58H80N2O14/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10/h13-14,31-38,45-46H,15-30H2,1-12H3/q+2/b14-13+/t45-,46-,59?,60?/m1/s1 D0OB2M DRUGINKE ILVYCEVXHALBSC-OTBYEXOQSA-N D0OB2M DRUGSMIL C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C D0OB2M HIGHSTAT Approved D0OD2I DRUG__ID D0OD2I D0OD2I TRADNAME GAVRETO D0OD2I DRUGCOMP Blueprint Medicines Cambridge, MA D0OD2I DRUGINCH 1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1 D0OD2I DRUGINKE GBLBJPZSROAGMF-SIYOEGHHSA-N D0OD2I DRUGSMIL CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)NC(C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC D0OD2I HIGHSTAT Approved D0OG5K DRUG__ID D0OG5K D0OG5K THERCLAS Antidiarrheals D0OG5K DRUGTYPE Small molecular drug D0OG5K DRUGINCH 1S/Bi D0OG5K DRUGINKE JCXGWMGPZLAOME-UHFFFAOYSA-N D0OG5K DRUGSMIL [Bi] D0OG5K HIGHSTAT Approved D0OG8A DRUG__ID D0OG8A D0OG8A DRUGCOMP Pifzer D0OG8A DRUGTYPE Small molecular drug D0OG8A DRUGINCH 1S/C25H30N4O9S2.C7H8O3S/c1-24(2)17(29-20(32)16(21(29)39-24)27-19(31)15(26)12-8-6-5-7-9-12)22(33)37-11-38-23(34)18-25(3,4)40(35,36)14-10-13(30)28(14)18;1-6-2-4-7(5-3-6)11(8,9)10/h5-9,14-18,21H,10-11,26H2,1-4H3,(H,27,31);2-5H,1H3,(H,8,9,10)/t14-,15-,16-,17+,18+,21-;/m1./s1 D0OG8A DRUGINKE FFCSPKNZHGIDQM-CGAOXQFVSA-N D0OG8A DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)OCOC(=O)C4C(S(=O)(=O)C5N4C(=O)C5)(C)C)C D0OG8A HIGHSTAT Approved D0OK5I DRUG__ID D0OK5I D0OK5I THERCLAS Anticholinergic Agents D0OK5I DRUGTYPE Small molecular drug D0OK5I DRUGINCH 1S/C21H36NO/c1-4-22(5-2,6-3)18-17-21(23,19-13-9-7-10-14-19)20-15-11-8-12-16-20/h7,9-10,13-14,20,23H,4-6,8,11-12,15-18H2,1-3H3/q+1 D0OK5I DRUGINKE NPRHVSBSZMAEIN-UHFFFAOYSA-N D0OK5I DRUGSMIL CC[N+](CC)(CC)CCC(C1CCCCC1)(C2=CC=CC=C2)O D0OK5I HIGHSTAT Approved D0OK5Q DRUG__ID D0OK5Q D0OK5Q THERCLAS Parasympatholytics D0OK5Q DRUGTYPE Small molecular drug D0OK5Q DRUGINCH 1S/C20H24N.CH4O4S/c1-21(2)15-13-19(14-16-21)20(17-9-5-3-6-10-17)18-11-7-4-8-12-18;1-5-6(2,3)4/h3-12H,13-16H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1 D0OK5Q DRUGINKE BREMLQBSKCSNNH-UHFFFAOYSA-M D0OK5Q DRUGSMIL C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-] D0OK5Q HIGHSTAT Approved D0OL6O DRUG__ID D0OL6O D0OL6O THERCLAS Anticancer Agents D0OL6O DRUGTYPE Small molecular drug D0OL6O DRUGINCH 1S/C6H11NO3/c1-10-6(9)3-2-5(8)4-7/h2-4,7H2,1H3 D0OL6O DRUGINKE YUUAYBAIHCDHHD-UHFFFAOYSA-N D0OL6O DRUGSMIL COC(=O)CCC(=O)CN D0OL6O HIGHSTAT Approved D0OL7F DRUG__ID D0OL7F D0OL7F DRUGCOMP Wellstat Therapeutics D0OL7F DRUGTYPE Small molecular drug D0OL7F DRUGINCH 1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1 D0OL7F DRUGINKE AUFUWRKPQLGTGF-FMKGYKFTSA-N D0OL7F DRUGSMIL CC(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C D0OL7F HIGHSTAT Approved D0OR3G DRUG__ID D0OR3G D0OR3G TRADNAME Brenzavvy D0OR3G DRUGCOMP TheracosBio D0OR3G DRUGINCH 1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1 D0OR3G DRUGINKE BTCRKOKVYTVOLU-SJSRKZJXSA-N D0OR3G DRUGSMIL C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl D0OR3G HIGHSTAT Approved D0P0HB DRUG__ID D0P0HB D0P0HB THERCLAS Antituberculosis Agents D0P0HB DRUGTYPE Small molecular drug D0P0HB DRUGINCH 1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11) D0P0HB DRUGINKE AEOCXXJPGCBFJA-UHFFFAOYSA-N D0P0HB DRUGSMIL CCC1=NC=CC(=C1)C(=S)N D0P0HB HIGHSTAT Approved D0P0OE DRUG__ID D0P0OE D0P0OE DRUGCOMP Lederle; Takeda D0P0OE DRUGTYPE Small molecular drug D0P0OE DRUGINCH 1S/C16H15N7O5S4.Na/c1-28-21-9(7-5-31-16(17)19-7)12(24)20-10-13(25)23-11(15(26)27)6(4-30-14(10)23)3-29-8-2-18-22-32-8;/h2,5,10,14H,3-4H2,1H3,(H2,17,19)(H,20,24)(H,26,27);/q;+1/p-1/b21-9+;/t10-,14-;/m1./s1 D0P0OE DRUGINKE BCMSQWPLFBUUKW-MMDWUFFASA-M D0P0OE DRUGSMIL CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC4=CN=NS4)C(=O)[O-].[Na+] D0P0OE HIGHSTAT Approved D0P0OU DRUG__ID D0P0OU D0P0OU DRUGCOMP Lundbeck; Otsuka America Pharmaceutical D0P0OU DRUGTYPE Small molecular drug D0P0OU DRUGINCH 1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29) D0P0OU DRUGINKE ZKIAIYBUSXZPLP-UHFFFAOYSA-N D0P0OU DRUGSMIL C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4 D0P0OU HIGHSTAT Approved D0P0QK DRUG__ID D0P0QK D0P0QK DRUGCOMP Hospira Inc D0P0QK DRUGTYPE Small molecular drug D0P0QK DRUGINCH 1S/C3H7NO2S.ClH/c4-2(1-7)3(5)6;/h2,7H,1,4H2,(H,5,6);1H D0P0QK DRUGINKE IFQSXNOEEPCSLW-UHFFFAOYSA-N D0P0QK DRUGSMIL C(C(C(=O)O)N)S.Cl D0P0QK HIGHSTAT Approved D0P0RX DRUG__ID D0P0RX D0P0RX DRUGCOMP TaiGen Biotechnology D0P0RX DRUGTYPE Small molecular drug D0P0RX DRUGINCH 1S/C20H25N3O4/c1-11-7-12(21)9-22(8-11)16-6-5-14-17(19(16)27-2)23(13-3-4-13)10-15(18(14)24)20(25)26/h5-6,10-13H,3-4,7-9,21H2,1-2H3,(H,25,26)/t11-,12-/m0/s1 D0P0RX DRUGINKE AVPQPGFLVZTJOR-RYUDHWBXSA-N D0P0RX DRUGSMIL CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N D0P0RX HIGHSTAT Approved D0P1IZ DRUG__ID D0P1IZ D0P1IZ DRUGCOMP Bayer D0P1IZ DRUGTYPE Small molecular drug D0P1IZ DRUGINCH 1S/C18H34N4O9.Gd/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+3/p-3/t14-,15-;/m1./s1 D0P1IZ DRUGINKE ZPDFIIGFYAHNSK-CTHHTMFSSA-K D0P1IZ DRUGSMIL C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3] D0P1IZ HIGHSTAT Approved D0P1RL DRUG__ID D0P1RL D0P1RL DRUGCOMP Molecular Insight Pharmaceuticals D0P1RL DRUGTYPE Small molecular drug D0P1RL DRUGINCH 1S/C22H35IO2/c1-19(18-22(24)25)12-10-8-6-4-2-3-5-7-9-11-13-20-14-16-21(23)17-15-20/h14-17,19H,2-13,18H2,1H3,(H,24,25)/i23-4 D0P1RL DRUGINKE NPCIWINHUDIWAV-NSYCNWAXSA-N D0P1RL DRUGSMIL CC(CCCCCCCCCCCCC1=CC=C(C=C1)I)CC(=O)O D0P1RL HIGHSTAT Approved D0P2AG DRUG__ID D0P2AG D0P2AG DRUGCOMP AstraZeneca D0P2AG DRUGTYPE Small molecular drug D0P2AG DRUGINCH 1S/C25H34O6.C19H24N2O4/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26;1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3;3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t16-,17-,18-,20+,21?,22+,23-,24-,25+;13-,19+/m00/s1 D0P2AG DRUGINKE PJFHZKIDENOSJB-JIVDDGRNSA-N D0P2AG DRUGSMIL CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C.CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O D0P2AG HIGHSTAT Approved D0P2CK DRUG__ID D0P2CK D0P2CK THERCLAS Anticonvulsants D0P2CK DRUGTYPE Small molecular drug D0P2CK DRUGINCH 1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2 D0P2CK DRUGINKE CDCHDCWJMGXXRH-UHFFFAOYSA-N D0P2CK DRUGSMIL C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4 D0P2CK HIGHSTAT Approved D0P2GK DRUG__ID D0P2GK D0P2GK DRUGCOMP Ucyclyd Pharma Inc; Elan Corp plc D0P2GK DRUGTYPE Small molecular drug D0P2GK DRUGINCH 1S/C10H12O2.Na/c11-10(12)8-4-7-9-5-2-1-3-6-9;/h1-3,5-6H,4,7-8H2,(H,11,12);/q;+1/p-1 D0P2GK DRUGINKE VPZRWNZGLKXFOE-UHFFFAOYSA-M D0P2GK DRUGSMIL C1=CC=C(C=C1)CCCC(=O)[O-].[Na+] D0P2GK HIGHSTAT Approved D0P2IW DRUG__ID D0P2IW D0P2IW DRUGCOMP BioCryst Pharmaceuticals D0P2IW DRUGTYPE Small molecular drug D0P2IW DRUGINCH 1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1 D0P2IW DRUGINKE XRQDFNLINLXZLB-CKIKVBCHSA-N D0P2IW DRUGSMIL CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C D0P2IW HIGHSTAT Approved D0P4PZ DRUG__ID D0P4PZ D0P4PZ DRUGCOMP BTG International D0P4PZ DRUGTYPE Small molecular drug D0P4PZ DRUGINCH 1S/4Zn/q4*+2 D0P4PZ DRUGINKE LZQXMCNBQHANEY-UHFFFAOYSA-N D0P4PZ DRUGSMIL [Zn+2].[Zn+2].[Zn+2].[Zn+2] D0P4PZ HIGHSTAT Approved D0P5AE DRUG__ID D0P5AE D0P5AE DRUGCOMP Dyax Corp D0P5AE DRUGTYPE Small molecular drug D0P5AE DRUGINCH 1S/C305H442N88O91S8/c1-16-152(5)241-295(478)377-195(124-168-80-82-172(398)83-81-168)252(435)334-137-227(404)333-138-228(405)345-214-143-487-491-147-218-291(474)351-179(73-47-107-327-301(315)316)255(438)341-154(7)245(428)339-155(8)249(432)379-210(127-171-136-326-150-338-171)299(482)393-113-53-79-221(393)294(477)361-181(75-49-109-329-303(319)320)260(443)372-203(125-169-134-332-175-69-40-39-68-173(169)175)277(460)370-198(119-163-58-29-20-30-59-163)274(457)369-199(120-164-60-31-21-32-61-164)275(458)375-207(130-226(314)403)284(467)389-242(153(6)17-2)296(479)378-202(123-167-66-37-24-38-67-167)283(466)390-243(159(12)396)297(480)362-182(76-50-110-330-304(321)322)258(441)353-186(86-94-223(311)400)267(450)383-217(290(473)359-188(89-98-234(414)415)263(446)354-189(90-99-235(416)417)265(448)368-201(282(465)388-241)122-166-64-35-23-36-65-166)146-490-489-145-216(384-268(451)191(92-101-237(420)421)355-262(445)187(88-97-233(412)413)357-271(454)194(116-151(3)4)366-285(468)212(141-394)381-266(449)190(91-100-236(418)419)358-273(456)197(118-162-56-27-19-28-57-162)367-259(442)180(74-48-108-328-302(317)318)349-280(463)206(129-225(313)402)374-264(447)185(85-93-222(310)399)356-279(462)205(128-224(312)401)344-229(406)139-335-251(434)184(352-288(214)471)87-96-232(410)411)289(472)350-178(72-43-46-106-308)256(439)347-177(71-42-45-105-307)257(440)360-193(103-115-486-15)270(453)385-219(292(475)391-244(160(13)397)298(481)363-183(77-51-111-331-305(323)324)261(444)380-211(300(483)484)133-240(426)427)148-492-488-144-215(386-276(459)200(121-165-62-33-22-34-63-165)371-286(469)213(142-395)382-278(461)204(126-170-135-325-149-337-170)373-269(452)192(102-114-485-14)346-246(429)156(9)340-250(433)174(309)84-95-231(408)409)287(470)343-158(11)247(430)364-196(117-161-54-25-18-26-55-161)272(455)348-176(70-41-44-104-306)254(437)342-157(10)248(431)365-209(132-239(424)425)281(464)376-208(131-238(422)423)253(436)336-140-230(407)392-112-52-78-220(392)293(476)387-218/h18-40,54-69,80-83,134-136,149-160,174,176-221,241-244,332,394-398H,16-17,41-53,70-79,84-133,137-148,306-309H2,1-15H3,(H2,310,399)(H2,311,400)(H2,312,401)(H2,313,402)(H2,314,403)(H,325,337)(H,326,338)(H,333,404)(H,334,435)(H,335,434)(H,336,436)(H,339,428)(H,340,433)(H,341,438)(H,342,437)(H,343,470)(H,344,406)(H,345,405)(H,346,429)(H,347,439)(H,348,455)(H,349,463)(H,350,472)(H,351,474)(H,352,471)(H,353,441)(H,354,446)(H,355,445)(H,356,462)(H,357,454)(H,358,456)(H,359,473)(H,360,440)(H,361,477)(H,362,480)(H,363,481)(H,364,430)(H,365,431)(H,366,468)(H,367,442)(H,368,448)(H,369,457)(H,370,460)(H,371,469)(H,372,443)(H,373,452)(H,374,447)(H,375,458)(H,376,464)(H,377,478)(H,378,479)(H,379,432)(H,380,444)(H,381,449)(H,382,461)(H,383,450)(H,384,451)(H,385,453)(H,386,459)(H,387,476)(H,388,465)(H,389,467)(H,390,466)(H,391,475)(H,408,409)(H,410,411)(H,412,413)(H,414,415)(H,416,417)(H,418,419)(H,420,421)(H,422,423)(H,424,425)(H,426,427)(H,483,484)(H4,315,316,327)(H4,317,318,328)(H4,319,320,329)(H4,321,322,330)(H4,323,324,331)/t152-,153-,154-,155-,156-,157-,158-,159-,160-,174-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,198-,199-,200-,201-,202-,203-,204-,205-,206-,207-,208-,209-,210-,211-,212-,213-,214-,215-,216-,217-,218-,219-,220-,221-,241-,242-,243-,244-/m0/s1 D0P5AE DRUGINKE VBGWSQKGUZHFPS-VGMMZINCSA-N D0P5AE DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O D0P5AE HIGHSTAT Approved D0P6VV DRUG__ID D0P6VV D0P6VV THERCLAS Analgesics D0P6VV DRUGTYPE Small molecular drug D0P6VV DRUGINCH 1S/C16H23NO/c1-16-8-4-2-3-5-12(15(16)17)9-11-6-7-13(18)10-14(11)16/h6-7,10,12,15,18H,2-5,8-9,17H2,1H3/t12-,15-,16+/m0/s1 D0P6VV DRUGINKE VTMVHDZWSFQSQP-VBNZEHGJSA-N D0P6VV DRUGSMIL CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O D0P6VV HIGHSTAT Approved D0P7EK DRUG__ID D0P7EK D0P7EK THERCLAS Sweetening Agents D0P7EK DRUGTYPE Small molecular drug D0P7EK DRUGINCH 1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1 D0P7EK DRUGINKE FBPFZTCFMRRESA-KVTDHHQDSA-N D0P7EK DRUGSMIL C(C(C(C(C(CO)O)O)O)O)O D0P7EK HIGHSTAT Approved D0P7JZ DRUG__ID D0P7JZ D0P7JZ THERCLAS Antiparkinson Agents D0P7JZ DRUGTYPE Small molecular drug D0P7JZ DRUGINCH 1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1 D0P7JZ DRUGINKE TZFNLOMSOLWIDK-JTQLQIEISA-N D0P7JZ DRUGSMIL CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN D0P7JZ HIGHSTAT Approved D0P7PD DRUG__ID D0P7PD D0P7PD DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0P7PD DRUGTYPE Small molecular drug D0P7PD DRUGINCH 1S/C25H28N8O2.C23H27ClO7/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20;1-28-23-21(27)19(25)20(26)22(31-23)14-4-7-18(24)15(11-14)10-13-2-5-16(6-3-13)30-17-8-9-29-12-17/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3;2-7,11,17,19-23,25-27H,8-10,12H2,1H3/t17-;17-,19+,20+,21-,22-,23-/m10/s1 D0P7PD DRUGINKE POMOOZUJAXCEKG-QPVQWCQSSA-N D0P7PD DRUGSMIL CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C.COC1C(C(C(C(O1)C2=CC(=C(C=C2)Cl)CC3=CC=C(C=C3)OC4CCOC4)O)O)O D0P7PD HIGHSTAT Approved D0P7VJ DRUG__ID D0P7VJ D0P7VJ DRUGCOMP Warner-Lambert Co D0P7VJ DRUGTYPE Small molecular drug D0P7VJ DRUGINCH 1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18) D0P7VJ DRUGINKE ZULJGOSFKWFVRX-UHFFFAOYSA-N D0P7VJ DRUGSMIL CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C D0P7VJ HIGHSTAT Approved (orphan drug) D0P8IV DRUG__ID D0P8IV D0P8IV THERCLAS Anticancer Agents D0P8IV DRUGTYPE Small molecular drug D0P8IV DRUGINCH 1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42-,43-,44+,45+,48+,49+/m1/s1 D0P8IV DRUGINKE RJURFGZVJUQBHK-IIXSONLDSA-N D0P8IV DRUGSMIL CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C D0P8IV HIGHSTAT Approved D0P8MI DRUG__ID D0P8MI D0P8MI DRUGCOMP Taiho Pharmaceutical Co Ltd D0P8MI DRUGTYPE Small molecular drug D0P8MI DRUGINCH 1S/C16H25NO4S.C7H8O3S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3;1-6-2-4-7(5-3-6)11(8,9)10/h5-8,14,18H,4,9-12H2,1-3H3;2-5H,1H3,(H,8,9,10) D0P8MI DRUGINKE RYVJQEZJUFRANT-UHFFFAOYSA-N D0P8MI DRUGSMIL CCOCC(COC1=CC=C(C=C1)NC(=O)CC[S+](C)C)O.CC1=CC=C(C=C1)S(=O)(=O)[O-] D0P8MI HIGHSTAT Approved D0P9NT DRUG__ID D0P9NT D0P9NT DRUGCOMP Adherex technologies D0P9NT DRUGTYPE Small molecular drug D0P9NT DRUGINCH 1S/2Na.H2O3S2/c;;1-5(2,3)4/h;;(H2,1,2,3,4)/q2*+1;/p-2 D0P9NT DRUGINKE AKHNMLFCWUSKQB-UHFFFAOYSA-L D0P9NT DRUGSMIL [O-]S(=O)(=S)[O-].[Na+].[Na+] D0P9NT HIGHSTAT Approved D0PG8O DRUG__ID D0PG8O D0PG8O DRUGCOMP Tni biotech; DrugAbuse Sciences; Alkermes Inc D0PG8O DRUGTYPE Small molecular drug D0PG8O DRUGINCH 1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1 D0PG8O DRUGINKE DQCKKXVULJGBQN-XFWGSAIBSA-N D0PG8O DRUGSMIL C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O D0PG8O HIGHSTAT Approved D0PI3Z DRUG__ID D0PI3Z D0PI3Z DRUGCOMP Schering D0PI3Z DRUGTYPE Small molecular drug D0PI3Z DRUGINCH 1S/C22H43N5O12/c1-22(35)6-36-20(15(33)18(22)26-2)39-17-8(27-19(34)9(28)4-23)3-7(25)16(14(17)32)38-21-13(31)12(30)11(29)10(5-24)37-21/h7-18,20-21,26,28-33,35H,3-6,23-25H2,1-2H3,(H,27,34)/t7-,8+,9-,10+,11+,12-,13+,14-,15+,16+,17-,18+,20+,21+,22-/m0/s1 D0PI3Z DRUGINKE UDIIBEDMEYAVNG-ZKFPOVNWSA-N D0PI3Z DRUGSMIL CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(C(C(C(O3)CN)O)O)O)N)NC(=O)C(CN)O)O D0PI3Z HIGHSTAT Approved D0PS6X DRUG__ID D0PS6X D0PS6X DRUGCOMP GlaxoSmithKline D0PS6X DRUGTYPE Small molecular drug D0PS6X DRUGINCH 1S/C24H36O2.C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24(25)26-4-2;1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18,20-21H,3-4,7,10,13,16,19,22-23H2,1-2H3;5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-,21-20-;6-5-,9-8-,12-11-,15-14-,18-17- D0PS6X DRUGINKE DTMGIJFHGGCSLO-FIAQIACWSA-N D0PS6X DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC.CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)OCC D0PS6X HIGHSTAT Approved D0Q0EX DRUG__ID D0Q0EX D0Q0EX THERCLAS Antibiotics D0Q0EX DRUGTYPE Small molecular drug D0Q0EX DRUGINCH 1S/C18H34N2O6S/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25)/t9-,10-,11+,12-,13+,14-,15-,16-,18-/m1/s1 D0Q0EX DRUGINKE OJMMVQQUTAEWLP-KIDUDLJLSA-N D0Q0EX DRUGSMIL CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O D0Q0EX HIGHSTAT Approved D0Q0RC DRUG__ID D0Q0RC D0Q0RC THERCLAS Antiparkinson Agents D0Q0RC DRUGTYPE Small molecular drug D0Q0RC DRUGINCH 1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3 D0Q0RC DRUGINKE CDOZDBSBBXSXLB-UHFFFAOYSA-N D0Q0RC DRUGSMIL CCN(CC)C(C)CN1C2=CC=CC=C2SC3=CC=CC=C31 D0Q0RC HIGHSTAT Approved D0Q2ES DRUG__ID D0Q2ES D0Q2ES THERCLAS Antitussives D0Q2ES DRUGTYPE Small molecular drug D0Q2ES DRUGINCH 1S/C30H53NO11/c1-3-4-9-31-29-7-5-28(6-8-29)30(32)42-27-26-41-25-24-40-23-22-39-21-20-38-19-18-37-17-16-36-15-14-35-13-12-34-11-10-33-2/h5-8,31H,3-4,9-27H2,1-2H3 D0Q2ES DRUGINKE MAFMQEKGGFWBAB-UHFFFAOYSA-N D0Q2ES DRUGSMIL CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC D0Q2ES HIGHSTAT Approved D0Q2MH DRUG__ID D0Q2MH D0Q2MH THERCLAS Analgesics D0Q2MH DRUGTYPE Small molecular drug D0Q2MH DRUGINCH 1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;;/p-2 D0Q2MH DRUGINKE WDEFPRUEZRUYNW-UHFFFAOYSA-L D0Q2MH DRUGSMIL C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-] D0Q2MH HIGHSTAT Approved D0Q2PE DRUG__ID D0Q2PE D0Q2PE THERCLAS Antibiotics D0Q2PE DRUGTYPE Small molecular drug D0Q2PE DRUGINCH 1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23) D0Q2PE DRUGINKE OGJPXUAPXNRGGI-UHFFFAOYSA-N D0Q2PE DRUGSMIL CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O D0Q2PE HIGHSTAT Approved D0Q2XF DRUG__ID D0Q2XF D0Q2XF DRUGCOMP Allergan Inc D0Q2XF DRUGTYPE Small molecular drug D0Q2XF DRUGINCH 1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 D0Q2XF DRUGINKE AQOKCDNYWBIDND-FTOWTWDKSA-N D0Q2XF DRUGSMIL CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O D0Q2XF HIGHSTAT Approved D0Q3BV DRUG__ID D0Q3BV D0Q3BV THERCLAS Antibiotics D0Q3BV DRUGTYPE Small molecular drug D0Q3BV DRUGINCH 1S/C58H110N16O28S5.5Na/c1-9-35(6)12-10-11-13-46(77)65-38(14-20-59-28-103(88,89)90)53(82)74-48(37(8)76)58(87)70-41(17-23-62-31-106(97,98)99)50(79)68-43-19-25-64-57(86)47(36(7)75)73-54(83)42(18-24-63-32-107(100,101)102)67-49(78)39(15-21-60-29-104(91,92)93)69-55(84)44(26-33(2)3)72-56(85)45(27-34(4)5)71-52(81)40(66-51(43)80)16-22-61-30-105(94,95)96;;;;;/h33-45,47-48,59-63,75-76H,9-32H2,1-8H3,(H,64,86)(H,65,77)(H,66,80)(H,67,78)(H,68,79)(H,69,84)(H,70,87)(H,71,81)(H,72,85)(H,73,83)(H,74,82)(H,88,89,90)(H,91,92,93)(H,94,95,96)(H,97,98,99)(H,100,101,102);;;;;/q;5*+1/p-5 D0Q3BV DRUGINKE IQWHCHZFYPIVRV-UHFFFAOYSA-I D0Q3BV DRUGSMIL CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+] D0Q3BV HIGHSTAT Approved D0Q4EW DRUG__ID D0Q4EW D0Q4EW DRUGCOMP Roxane Laboratories Inc D0Q4EW DRUGTYPE Small molecular drug D0Q4EW DRUGINCH 1S/C6H8O7.3Li/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3 D0Q4EW DRUGINKE WJSIUCDMWSDDCE-UHFFFAOYSA-K D0Q4EW DRUGSMIL [Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O D0Q4EW HIGHSTAT Approved D0Q4TK DRUG__ID D0Q4TK D0Q4TK THERCLAS Anthelmintics D0Q4TK DRUGTYPE Small molecular drug D0Q4TK DRUGINCH 1S/C12H16N2S.C4H6O6/c1-10-6-9-15-11(10)4-5-12-13-7-3-8-14(12)2;5-1(3(7)8)2(6)4(9)10/h4-6,9H,3,7-8H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/b5-4+;/t;1-,2-/m.1/s1 D0Q4TK DRUGINKE GGXQONWGCAQGNA-UUSVNAAPSA-N D0Q4TK DRUGSMIL CC1=C(SC=C1)C=CC2=NCCCN2C.C(C(C(=O)O)O)(C(=O)O)O D0Q4TK HIGHSTAT Approved D0Q4YK DRUG__ID D0Q4YK D0Q4YK DRUGCOMP UCB Pharma Ltd D0Q4YK DRUGTYPE Small molecular drug D0Q4YK DRUGINCH 1S/C6H10N2O2/c7-5(9)4-8-3-1-2-6(8)10/h1-4H2,(H2,7,9) D0Q4YK DRUGINKE GMZVRMREEHBGGF-UHFFFAOYSA-N D0Q4YK DRUGSMIL C1CC(=O)N(C1)CC(=O)N D0Q4YK HIGHSTAT Approved D0Q5MQ DRUG__ID D0Q5MQ D0Q5MQ DRUGCOMP Vanda Pharmaceuticals D0Q5MQ DRUGTYPE Small molecular drug D0Q5MQ DRUGINCH 1S/C15H19NO2/c1-2-15(17)16-9-10-8-13(10)11-4-3-5-14-12(11)6-7-18-14/h3-5,10,13H,2,6-9H2,1H3,(H,16,17)/t10-,13+/m0/s1 D0Q5MQ DRUGINKE PTOIAAWZLUQTIO-GXFFZTMASA-N D0Q5MQ DRUGSMIL CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2 D0Q5MQ HIGHSTAT Approved D0Q5UQ DRUG__ID D0Q5UQ D0Q5UQ DRUGCOMP Novartis D0Q5UQ DRUGTYPE Small molecular drug D0Q5UQ DRUGINCH 1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28) D0Q5UQ DRUGINKE BOFQWVMAQOTZIW-UHFFFAOYSA-N D0Q5UQ DRUGSMIL C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O D0Q5UQ HIGHSTAT Approved D0Q5XX DRUG__ID D0Q5XX D0Q5XX DRUGCOMP Omthera Pharmaceutials D0Q5XX DRUGTYPE Small molecular drug D0Q5XX DRUGINCH 1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18- D0Q5XX DRUGINKE MBMBGCFOFBJSGT-KUBAVDMBSA-N D0Q5XX DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O D0Q5XX HIGHSTAT Approved D0Q6LA DRUG__ID D0Q6LA D0Q6LA DRUGCOMP SPECTRUM pharmaceuticals D0Q6LA DRUGTYPE Small molecular drug D0Q6LA DRUGINCH 1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1 D0Q6LA DRUGINKE VVIAGPKUTFNRDU-STQMWFEESA-N D0Q6LA DRUGSMIL C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0Q6LA HIGHSTAT Approved D0Q6NZ DRUG__ID D0Q6NZ D0Q6NZ DRUGCOMP Solvay Pharmaceuticals D0Q6NZ DRUGTYPE Small molecular drug D0Q6NZ DRUGINCH 1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1 D0Q6NZ DRUGINKE ICMWWNHDUZJFDW-DHODBPELSA-N D0Q6NZ DRUGSMIL CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C D0Q6NZ HIGHSTAT Approved D0Q7MA DRUG__ID D0Q7MA D0Q7MA DRUGCOMP Glaxosmithkline; shionogi D0Q7MA DRUGTYPE Small molecular drug D0Q7MA DRUGINCH 1S/C30H34ClN7O10S2/c1-30(2,28(46)47)48-36-19(16-13-50-29(32)34-16)24(42)35-20-25(43)37-21(27(44)45)14(12-49-26(20)37)11-38(8-3-4-9-38)10-7-33-23(41)15-5-6-17(39)22(40)18(15)31/h5-6,13,20,26H,3-4,7-12H2,1-2H3,(H7-,32,33,34,35,36,39,40,41,42,44,45,46,47)/t20-,26-/m1/s1 D0Q7MA DRUGINKE DBPPRLRVDVJOCL-FQRUVTKNSA-N D0Q7MA DRUGSMIL CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-] D0Q7MA HIGHSTAT Approved D0Q7YI DRUG__ID D0Q7YI D0Q7YI DRUGCOMP Takeda Pharmaceuticals U.S.A. D0Q7YI DRUGTYPE Small molecular drug D0Q7YI DRUGINCH 1S/C19H20N2O3S.C18H21N5O2/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t;15-/m.1/s1 D0Q7YI DRUGINKE LNTORSITGSWVNQ-DYYGGQLPSA-N D0Q7YI DRUGSMIL CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N D0Q7YI HIGHSTAT Approved D0Q7ZG DRUG__ID D0Q7ZG D0Q7ZG THERCLAS Anesthetics D0Q7ZG DRUGTYPE Small molecular drug D0Q7ZG DRUGINCH 1S/C16H26N2O3/c1-4-10-20-15-8-7-13(12-14(15)17)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3 D0Q7ZG DRUGINKE KCLANYCVBBTKTO-UHFFFAOYSA-N D0Q7ZG DRUGSMIL CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N D0Q7ZG HIGHSTAT Approved D0Q8CS DRUG__ID D0Q8CS D0Q8CS DRUGCOMP Sanofi D0Q8CS DRUGTYPE Small molecular drug D0Q8CS DRUGINCH 1S/C7H9ClO6P2S/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14/h1-4,7H,(H2,9,10,11)(H2,12,13,14) D0Q8CS DRUGINKE DKJJVAGXPKPDRL-UHFFFAOYSA-N D0Q8CS DRUGSMIL C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl D0Q8CS HIGHSTAT Approved D0Q9EV DRUG__ID D0Q9EV D0Q9EV DRUGCOMP Shire Pharmaceuticals D0Q9EV DRUGTYPE Small molecular drug D0Q9EV DRUGINCH 1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1 D0Q9EV DRUGINKE JFOZKMSJYSPYLN-QHCPKHFHSA-N D0Q9EV DRUGSMIL CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl D0Q9EV HIGHSTAT Approved D0Q9WO DRUG__ID D0Q9WO D0Q9WO THERCLAS Anticonvulsants D0Q9WO DRUGTYPE Small molecular drug D0Q9WO DRUGINCH 1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2 D0Q9WO DRUGINKE XAXMYHMKTCNRRZ-UHFFFAOYSA-N D0Q9WO DRUGSMIL C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCC#N)O)F D0Q9WO HIGHSTAT Approved D0Q9YT DRUG__ID D0Q9YT D0Q9YT THERCLAS Dietary supplement D0Q9YT DRUGTYPE Small molecular drug D0Q9YT DRUGINCH 1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17) D0Q9YT DRUGINKE FNKQXYHWGSIFBK-UHFFFAOYSA-N D0Q9YT DRUGSMIL CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O D0Q9YT HIGHSTAT Approved D0QC3M DRUG__ID D0QC3M D0QC3M DRUGCOMP F Hoffmann-La Roche Ltd D0QC3M DRUGTYPE Small molecular drug D0QC3M DRUGINCH 1S/C21H35NO/c1-7-21(5,6)20-10-8-19(9-11-20)12-16(2)13-22-14-17(3)23-18(4)15-22/h8-11,16-18H,7,12-15H2,1-6H3/t16?,17-,18+ D0QC3M DRUGINKE MQHLMHIZUIDKOO-AYHJJNSGSA-N D0QC3M DRUGSMIL CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2CC(OC(C2)C)C D0QC3M HIGHSTAT Approved D0QC5D DRUG__ID D0QC5D D0QC5D DRUGCOMP Ge Healthcare D0QC5D DRUGTYPE Small molecular drug D0QC5D DRUGINCH 1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3/i;1-3 D0QC5D DRUGINKE YEEGWNXDUZONAA-RYDPDVNUSA-K D0QC5D DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ga+3] D0QC5D HIGHSTAT Approved D0QE5U DRUG__ID D0QE5U D0QE5U THERCLAS Hypoglycemic Agents D0QE5U DRUGTYPE Small molecular drug D0QE5U DRUGINCH 1S/C267H402N64O76S6/c1-29-32-33-34-35-36-37-38-39-40-50-64-204(347)280-95-52-51-61-170(265(404)405)298-256(395)197-63-54-97-331(197)264(403)220(147(28)336)330-248(387)182(110-154-71-79-160(340)80-72-154)309-240(379)178(106-150-59-48-43-49-60-150)307-237(376)177(105-149-57-46-42-47-58-149)289-207(350)120-282-223(362)162(62-53-96-281-267(276)277)291-227(366)163(84-91-209(352)353)288-206(349)119-283-225(364)192-126-409-410-127-193(252(391)314-187(266(406)407)115-203(275)346)319-241(380)181(109-153-69-77-159(339)78-70-153)308-245(384)185(113-201(273)344)312-231(370)168(86-93-211(356)357)295-233(372)172(99-134(6)7)300-229(368)164(81-88-198(270)341)293-238(377)179(107-151-65-73-157(337)74-66-151)305-235(374)173(100-135(8)9)304-250(389)189(123-333)315-253(392)195-129-412-411-128-194(318-232(371)166(83-90-200(272)343)292-228(367)169(87-94-212(358)359)297-258(397)216(142(22)23)327-262(401)217(143(24)30-2)323-205(348)116-268)254(393)320-196(255(394)329-219(146(27)335)263(402)316-190(124-334)251(390)328-218(144(25)31-3)261(400)322-195)130-413-408-125-191(317-236(375)174(101-136(10)11)301-242(381)183(111-155-117-278-131-285-155)310-230(369)165(82-89-199(271)342)294-244(383)186(114-202(274)345)313-259(398)213(139(16)17)324-222(361)161(269)104-148-55-44-41-45-56-148)224(363)284-121-208(351)290-188(122-332)249(388)311-184(112-156-118-279-132-286-156)243(382)303-176(103-138(14)15)247(386)325-214(140(18)19)257(396)296-167(85-92-210(354)355)226(365)287-145(26)221(360)299-171(98-133(4)5)234(373)306-180(108-152-67-75-158(338)76-68-152)239(378)302-175(102-137(12)13)246(385)326-215(141(20)21)260(399)321-192/h41-49,55-60,65-80,117-118,131-147,161-197,213-220,332-340H,29-40,50-54,61-64,81-116,119-130,268-269H2,1-28H3,(H2,270,341)(H2,271,342)(H2,272,343)(H2,273,344)(H2,274,345)(H2,275,346)(H,278,285)(H,279,286)(H,280,347)(H,282,362)(H,283,364)(H,284,363)(H,287,365)(H,288,349)(H,289,350)(H,290,351)(H,291,366)(H,292,367)(H,293,377)(H,294,383)(H,295,372)(H,296,396)(H,297,397)(H,298,395)(H,299,360)(H,300,368)(H,301,381)(H,302,378)(H,303,382)(H,304,389)(H,305,374)(H,306,373)(H,307,376)(H,308,384)(H,309,379)(H,310,369)(H,311,388)(H,312,370)(H,313,398)(H,314,391)(H,315,392)(H,316,402)(H,317,375)(H,318,371)(H,319,380)(H,320,393)(H,321,399)(H,322,400)(H,323,348)(H,324,361)(H,325,386)(H,326,385)(H,327,401)(H,328,390)(H,329,394)(H,330,387)(H,352,353)(H,354,355)(H,356,357)(H,358,359)(H,404,405)(H,406,407)(H4,276,277,281)/t143-,144-,145-,146+,147+,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,213-,214-,215-,216-,217-,218-,219-,220-/m0/s1 D0QE5U DRUGINKE UGOZVNFCFYTPAZ-IOXYNQHNSA-N D0QE5U DRUGSMIL CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)C1CCCN1C(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C6CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)C)CC(C)C)CC7=CC=C(C=C7)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC8=CNC=N8)CO)NC(=O)C(CC(C)C)NC(=O)C(CC9=CNC=N9)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N6)C(C)CC)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN)CO)CC(C)C)CC1=CC=C(C=C1)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)O D0QE5U HIGHSTAT Approved D0QK5X DRUG__ID D0QK5X D0QK5X DRUGCOMP Astellas Pharma D0QK5X DRUGTYPE Small molecular drug D0QK5X DRUGINCH 1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30) D0QK5X DRUGINKE WXCXUHSOUPDCQV-UHFFFAOYSA-N D0QK5X DRUGSMIL CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C D0QK5X HIGHSTAT Approved D0QO7H DRUG__ID D0QO7H D0QO7H DRUGCOMP Bioglan Pharmaceuticals Co D0QO7H DRUGTYPE Small molecular drug D0QO7H DRUGINCH 1S/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2 D0QO7H DRUGINKE NUZWLKWWNNJHPT-UHFFFAOYSA-N D0QO7H DRUGSMIL C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O D0QO7H HIGHSTAT Approved D0QQ6Q DRUG__ID D0QQ6Q D0QQ6Q DRUGCOMP Syntex D0QQ6Q DRUGTYPE Small molecular drug D0QQ6Q DRUGINCH 1S/C23H28O6/c1-28-23(27)12-8-3-2-7-11-19-20(22(26)15-21(19)25)14-13-17(24)16-29-18-9-5-4-6-10-18/h3-7,9-10,13-14,17,19-20,22,24,26H,8,11-12,15-16H2,1H3/b14-13+/t2?,17-,19-,20-,22-/m1/s1 D0QQ6Q DRUGINKE PTOJVMZPWPAXER-VFJVYMGBSA-N D0QQ6Q DRUGSMIL COC(=O)CCC=C=CCC1C(C(CC1=O)O)C=CC(COC2=CC=CC=C2)O D0QQ6Q HIGHSTAT Approved D0QV5T DRUG__ID D0QV5T D0QV5T THERCLAS Anticoagulants D0QV5T DRUGTYPE Small molecular drug D0QV5T DRUGINCH 1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3 D0QV5T DRUGINKE DQDAYGNAKTZFIW-UHFFFAOYSA-N D0QV5T DRUGSMIL CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O D0QV5T HIGHSTAT Approved D0R0FO DRUG__ID D0R0FO D0R0FO DRUGCOMP Eisai Co. Ltd. D0R0FO DRUGTYPE Small molecular drug D0R0FO DRUGINCH 1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28) D0R0FO DRUGINKE WOSKHXYHFSIKNG-UHFFFAOYSA-N D0R0FO DRUGSMIL COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl D0R0FO HIGHSTAT Approved D0R0MB DRUG__ID D0R0MB D0R0MB TRADNAME Besremi D0R0MB DRUGCOMP PharmaEssentia D0R0MB DRUGINCH 1S/C20H37N3O8/c1-28-12-14-30-19(26)21-9-4-3-6-16(22-20(27)31-15-13-29-2)8-11-23-10-5-7-17(23)18(24)25/h16-17H,3-15H2,1-2H3,(H,21,26)(H,22,27)(H,24,25)/t16?,17-/m0/s1 D0R0MB DRUGINKE LICFWYDUJZDCLK-DJNXLDHESA-N D0R0MB DRUGSMIL COCCOC(=O)NCCCCC(CCN1CCCC1C(=O)O)NC(=O)OCCOC D0R0MB HIGHSTAT Approved D0R1CR DRUG__ID D0R1CR D0R1CR THERCLAS Dietary supplement D0R1CR DRUGTYPE Small molecular drug D0R1CR DRUGINCH 1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1 D0R1CR DRUGINKE COLNVLDHVKWLRT-QMMMGPOBSA-N D0R1CR DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)N D0R1CR HIGHSTAT Approved D0R1DH DRUG__ID D0R1DH D0R1DH DRUGCOMP Watson Pharmaceuticals D0R1DH DRUGTYPE Small molecular drug D0R1DH DRUGINCH 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H D0R1DH DRUGINKE SWIJYDAEGSIQPZ-UHFFFAOYSA-N D0R1DH DRUGSMIL CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl D0R1DH HIGHSTAT Approved D0R1QE DRUG__ID D0R1QE D0R1QE THERCLAS Analgesics D0R1QE DRUGTYPE Small molecular drug D0R1QE DRUGINCH 1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15) D0R1QE DRUGINKE HEFNNWSXXWATRW-UHFFFAOYSA-N D0R1QE DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)O D0R1QE HIGHSTAT Approved D0R1WQ DRUG__ID D0R1WQ D0R1WQ DRUGCOMP Lantheus Medical Imaging Inc D0R1WQ DRUGTYPE Small molecular drug D0R1WQ DRUGINCH 1S/ClH.Tl/h1H;/q;+1/p-1/i;1-3 D0R1WQ DRUGINKE GBECUEIQVRDUKB-RYDPDVNUSA-M D0R1WQ DRUGSMIL Cl[Tl] D0R1WQ HIGHSTAT Approved D0R1WR DRUG__ID D0R1WR D0R1WR THERCLAS Antiparkinson Agents D0R1WR DRUGTYPE Small molecular drug D0R1WR DRUGINCH 1S/C19H29NO/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2 D0R1WR DRUGINKE WYDUSKDSKCASEF-UHFFFAOYSA-N D0R1WR DRUGSMIL C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O D0R1WR HIGHSTAT Approved D0R2KY DRUG__ID D0R2KY D0R2KY THERCLAS Contraceptive Agents D0R2KY DRUGTYPE Small molecular drug D0R2KY DRUGINCH 1S/C24H32O4/c1-5-24(28-16(3)26)13-11-22-21-8-6-17-14-18(27-15(2)25)7-9-19(17)20(21)10-12-23(22,24)4/h1,14,18-22H,6-13H2,2-4H3/t18-,19-,20+,21+,22-,23-,24-/m0/s1 D0R2KY DRUGINKE ONKUMRGIYFNPJW-KIEAKMPYSA-N D0R2KY DRUGSMIL CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C D0R2KY HIGHSTAT Approved D0R3BC DRUG__ID D0R3BC D0R3BC DRUGCOMP The Dow Chemical Co D0R3BC DRUGTYPE Small molecular drug D0R3BC DRUGINCH 1S/C6H20N2O12P4.Sm/c9-21(10,11)3-7(4-22(12,13)14)1-2-8(5-23(15,16)17)6-24(18,19)20;/h1-6H2,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20);/q;+3/p-3/i;1+3 D0R3BC DRUGINKE JSTADIGKFYFAIY-GJNDDOAHSA-K D0R3BC DRUGSMIL [H+].[H+].[H+].[H+].[H+].C(CN(CP(=O)([O-])[O-])CP(=O)([O-])[O-])N(CP(=O)([O-])[O-])CP(=O)([O-])[O-].[Sm+3] D0R3BC HIGHSTAT Approved D0R3BV DRUG__ID D0R3BV D0R3BV TRADNAME Tegsedi D0R3BV DRUGCOMP Ionis Pharmaceuticals D0R3BV DRUGINCH 1S/C230H318N69O121P19S19/c1-98-53-280(219(312)262-178(98)231)140-43-110(121(382-140)66-364-425(328,444)406-114-47-144(292-90-254-150-183(236)244-85-249-188(150)292)387-126(114)71-368-423(326,442)404-112-45-142(282-59-104(7)197(303)274-225(282)318)383-122(112)67-363-421(324,440)403-111-44-141(281-58-103(6)196(302)273-224(281)317)385-124(111)69-366-427(330,446)410-119-52-149(297-95-260-156-194(297)268-217(242)271-204(156)310)391-130(119)75-372-431(334,450)419-167-139(401-215(177(167)362-42-32-352-22)299-97-261-157-195(299)269-218(243)272-205(157)311)84-381-438(341,457)418-165-136(398-213(175(165)360-40-30-350-20)291-64-109(12)202(308)279-230(291)323)82-379-437(340,456)417-163-135(397-211(173(163)358-38-28-348-18)289-62-107(10)200(306)277-228(289)321)81-378-435(338,454)414-161-132(394-209(171(161)356-36-26-346-16)286-56-101(4)181(234)265-222(286)315)78-375-433(336,452)412-159-120(65-300)392-207(169(159)354-34-24-344-14)288-61-106(9)199(305)276-227(288)320)402-422(325,441)367-70-125-115(48-145(386-125)293-91-255-151-184(237)245-86-250-189(151)293)407-426(329,445)365-68-123-113(46-143(384-123)283-60-105(8)198(304)275-226(283)319)405-424(327,443)371-74-129-118(51-148(390-129)296-94-259-155-193(296)267-216(241)270-203(155)309)409-429(332,448)370-72-127-116(49-146(388-127)294-92-256-152-185(238)246-87-251-190(152)294)408-428(331,447)369-73-128-117(50-147(389-128)295-93-257-153-186(239)247-88-252-191(153)295)411-430(333,449)374-77-138-166(176(361-41-31-351-21)214(400-138)298-96-258-154-187(240)248-89-253-192(154)298)420-439(342,458)380-83-137-164(174(359-39-29-349-19)212(399-137)290-63-108(11)201(307)278-229(290)322)416-436(339,455)377-80-134-162(172(357-37-27-347-17)210(396-134)287-57-102(5)182(235)266-223(287)316)415-434(337,453)376-79-133-160(170(355-35-25-345-15)208(395-133)285-55-100(3)180(233)264-221(285)314)413-432(335,451)373-76-131-158(301)168(353-33-23-343-13)206(393-131)284-54-99(2)179(232)263-220(284)313/h53-64,85-97,110-149,158-177,206-215,300-301H,23-52,65-84H2,1-22H3,(H,324,440)(H,325,441)(H,326,442)(H,327,443)(H,328,444)(H,329,445)(H,330,446)(H,331,447)(H,332,448)(H,333,449)(H,334,450)(H,335,451)(H,336,452)(H,337,453)(H,338,454)(H,339,455)(H,340,456)(H,341,457)(H,342,458)(H2,231,262,312)(H2,232,263,313)(H2,233,264,314)(H2,234,265,315)(H2,235,266,316)(H2,236,244,249)(H2,237,245,250)(H2,238,246,251)(H2,239,247,252)(H2,240,248,253)(H,273,302,317)(H,274,303,318)(H,275,304,319)(H,276,305,320)(H,277,306,321)(H,278,307,322)(H,279,308,323)(H3,241,267,270,309)(H3,242,268,271,310)(H3,243,269,272,311)/t110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,135+,136+,137+,138+,139+,140+,141+,142+,143+,144+,145+,146+,147+,148+,149+,158+,159+,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,206+,207+,208+,209+,210+,211+,212+,213+,214+,215+,421?,422?,423?,424?,425?,426?,427?,428?,429?,430?,431?,432?,433?,434?,435?,436?,437?,438?,439?/m0/s1 D0R3BV DRUGINKE KLEGMTRDCCDFJK-XDQSQZFTSA-N D0R3BV DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)OC8C(OC(C8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O D0R3BV HIGHSTAT Approved D0R3FP DRUG__ID D0R3FP D0R3FP THERCLAS Antiinfective Agents D0R3FP DRUGTYPE Small molecular drug D0R3FP DRUGINCH 1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1 D0R3FP DRUGINKE VCMJCVGFSROFHV-WZGZYPNHSA-N D0R3FP DRUGSMIL CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O D0R3FP HIGHSTAT Approved D0R4DP DRUG__ID D0R4DP D0R4DP THERCLAS Hypnotics and Sedatives D0R4DP DRUGTYPE Small molecular drug D0R4DP DRUGINCH 1S/C16H15ClN2OS/c1-3-10-8-12-15(11-6-4-5-7-13(11)17)18-9-14(20)19(2)16(12)21-10/h4-8H,3,9H2,1-2H3 D0R4DP DRUGINKE CHBRHODLKOZEPZ-UHFFFAOYSA-N D0R4DP DRUGSMIL CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C D0R4DP HIGHSTAT Approved D0R4UW DRUG__ID D0R4UW D0R4UW DRUGCOMP Nycomed US Inc; Altana D0R4UW DRUGTYPE Small molecular drug D0R4UW DRUGINCH 1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24) D0R4UW DRUGINKE MNDBXUUTURYVHR-UHFFFAOYSA-N D0R4UW DRUGSMIL C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F D0R4UW HIGHSTAT Approved D0R4ZT DRUG__ID D0R4ZT D0R4ZT THERCLAS Anticancer Agents D0R4ZT DRUGTYPE Small molecular drug D0R4ZT DRUGINCH 1S/Ga.3NO3/c;3*2-1(3)4/q+3;3*-1 D0R4ZT DRUGINKE CHPZKNULDCNCBW-UHFFFAOYSA-N D0R4ZT DRUGSMIL [N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Ga+3] D0R4ZT HIGHSTAT Approved D0R5RR DRUG__ID D0R5RR D0R5RR THERCLAS Anticancer Agents D0R5RR DRUGTYPE Small molecular drug D0R5RR DRUGINCH 1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1 D0R5RR DRUGINKE WDDPHFBMKLOVOX-AYQXTPAHSA-N D0R5RR DRUGSMIL C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N D0R5RR HIGHSTAT Approved D0R6BR DRUG__ID D0R6BR D0R6BR THERCLAS Hypnotics and Sedatives D0R6BR DRUGTYPE Small molecular drug D0R6BR DRUGINCH 1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16) D0R6BR DRUGINKE VIROVYVQCGLCII-UHFFFAOYSA-N D0R6BR DRUGSMIL CCC1(C(=O)NC(=O)NC1=O)CCC(C)C D0R6BR HIGHSTAT Approved D0R7JT DRUG__ID D0R7JT D0R7JT THERCLAS Antiinflammatory Agents D0R7JT DRUGTYPE Small molecular drug D0R7JT DRUGINCH 1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1 D0R7JT DRUGINKE AAXVEMMRQDVLJB-BULBTXNYSA-N D0R7JT DRUGSMIL CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F D0R7JT HIGHSTAT Approved D0R8ER DRUG__ID D0R8ER D0R8ER THERCLAS Antiinfective Agents D0R8ER DRUGTYPE Small molecular drug D0R8ER DRUGINCH 1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23) D0R8ER DRUGINKE IDYZIJYBMGIQMJ-UHFFFAOYSA-N D0R8ER DRUGSMIL CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O D0R8ER HIGHSTAT Approved D0R8QG DRUG__ID D0R8QG D0R8QG DRUGCOMP EMD Serono D0R8QG DRUGTYPE Small molecular drug D0R8QG DRUGINCH 1S/C29H28N6O2/c1-34-12-10-21(11-13-34)20-37-26-17-31-29(32-18-26)25-7-3-5-23(15-25)19-35-28(36)9-8-27(33-35)24-6-2-4-22(14-24)16-30/h2-9,14-15,17-18,21H,10-13,19-20H2,1H3 D0R8QG DRUGINKE AHYMHWXQRWRBKT-UHFFFAOYSA-N D0R8QG DRUGSMIL CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N D0R8QG HIGHSTAT Approved D0R9BG DRUG__ID D0R9BG D0R9BG THERCLAS Antiinfective Agents D0R9BG DRUGTYPE Small molecular drug D0R9BG DRUGINCH 1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4) D0R9BG DRUGINKE RRUDCFGSUDOHDG-UHFFFAOYSA-N D0R9BG DRUGSMIL CC(=O)NO D0R9BG HIGHSTAT Approved D0R9OH DRUG__ID D0R9OH D0R9OH THERCLAS Antiinfective Agents D0R9OH DRUGTYPE Small molecular drug D0R9OH DRUGINCH 1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13) D0R9OH DRUGINKE JLKIGFTWXXRPMT-UHFFFAOYSA-N D0R9OH DRUGSMIL CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N D0R9OH HIGHSTAT Approved D0RD5W DRUG__ID D0RD5W D0RD5W THERCLAS Antiarrhythmic Agents D0RD5W DRUGTYPE Small molecular drug D0RD5W DRUGINCH 1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16-/m1/s1 D0RD5W DRUGINKE RKUNBYITZUJHSG-VFSICIBPSA-N D0RD5W DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 D0RD5W HIGHSTAT Approved D0RM5Z DRUG__ID D0RM5Z D0RM5Z TRADNAME Vosevi D0RM5Z DRUGCOMP Gilead Sciences D0RM5Z DRUGINCH 1S/C49H54N8O8.C40H52F4N6O9S.C22H29FN3O9P/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29;1-7-22-27-19-50(28(22)32(51)48-39(18-23(39)31(41)42)35(53)49-60(55,56)38(5)14-15-38)34(52)30(37(2,3)4)47-36(54)59-26-16-20(26)10-8-9-13-40(43,44)29-33(58-27)46-25-17-21(57-6)11-12-24(25)45-29;1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61);11-12,17,20,22-23,26-28,30-31H,7-10,13-16,18-19H2,1-6H3,(H,47,54)(H,48,51)(H,49,53);5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t27-,28-,38-,39-,41-,42+;20-,22-,23+,26-,27+,28+,30-,39-;14-,16+,18+,20+,22+,36-/m010/s1 D0RM5Z DRUGINKE FMWRYUBVSONSCK-ZYTFCPLVSA-N D0RM5Z DRUGSMIL CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C.CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC.CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 D0RM5Z HIGHSTAT Approved D0RM9Q DRUG__ID D0RM9Q D0RM9Q DRUGCOMP ALTANA Pharma AG D0RM9Q DRUGTYPE Small molecular drug D0RM9Q DRUGINCH 1S/C21H27N/c1-20(2,3)22-16-14-21(15-17-22,18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13H,14-17H2,1-3H3 D0RM9Q DRUGINKE QIHLUZAFSSMXHQ-UHFFFAOYSA-N D0RM9Q DRUGSMIL CC(C)(C)N1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3 D0RM9Q HIGHSTAT Approved D0RP2W DRUG__ID D0RP2W D0RP2W TRADNAME Elahere D0RP2W DRUGCOMP ImmunoGen D0RP2W DRUGINCH 1S/C42H61ClN4O14S3/c1-23-12-11-13-31(58-10)42(53)22-29(59-39(52)45-42)24(2)36-41(6,61-36)32(21-34(49)47(8)27-19-26(18-23)20-28(57-9)35(27)43)60-38(51)25(3)46(7)33(48)14-16-40(4,5)63-62-17-15-30(37(44)50)64(54,55)56/h11-13,19-20,24-25,29-32,36,53H,14-18,21-22H2,1-10H3,(H2,44,50)(H,45,52)(H,54,55,56)/b13-11+,23-12+/t24-,25+,29+,30?,31-,32+,36+,41+,42+/m1/s1 D0RP2W DRUGINKE ZOHXWSHGANNQGO-DSIKUUPMSA-N D0RP2W DRUGSMIL CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)CCC(C)(C)SSCCC(C(=O)N)S(=O)(=O)O)C)C)OC)(NC(=O)O2)O D0RP2W HIGHSTAT Approved D0RQ2W DRUG__ID D0RQ2W D0RQ2W DRUGCOMP Schering AG D0RQ2W DRUGTYPE Small molecular drug D0RQ2W DRUGINCH 1S/C14H23N3O10.2C7H17NO5.Gd/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;2*1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);2*4-13H,2-3H2,1H3;/q;;;+3/p-3/t;2*4-,5+,6+,7+;/m.00./s1 D0RQ2W DRUGINKE LGMLJQFQKXPRGA-VPVMAENOSA-K D0RQ2W DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3] D0RQ2W HIGHSTAT Approved D0S0AF DRUG__ID D0S0AF D0S0AF DRUGCOMP Eisai Co Ltd D0S0AF DRUGTYPE Small molecular drug D0S0AF DRUGINCH 1S/C19H27N5O3/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19/h11-12H,4-10H2,1-3H3,(H2,20,21,22) D0S0AF DRUGINKE RHLJLALHBZGAFM-UHFFFAOYSA-N D0S0AF DRUGSMIL CCCC(=O)N1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC D0S0AF HIGHSTAT Approved D0S0AS DRUG__ID D0S0AS D0S0AS THERCLAS Bronchodilator Agents D0S0AS DRUGTYPE Small molecular drug D0S0AS DRUGINCH 1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17+,18?,19?,21? D0S0AS DRUGINKE OEXHQOGQTVQTAT-BZQJJPTISA-N D0S0AS DRUGSMIL CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C D0S0AS HIGHSTAT Approved D0S0ES DRUG__ID D0S0ES D0S0ES DRUGCOMP Tanabe D0S0ES DRUGTYPE Small molecular drug D0S0ES DRUGINCH 1S/C20H27N3O6/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28/h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26)/t13-,15-,16-/m0/s1 D0S0ES DRUGINKE KLZWOWYOHUKJIG-BPUTZDHNSA-N D0S0ES DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O D0S0ES HIGHSTAT Approved D0S1NZ DRUG__ID D0S1NZ D0S1NZ DRUGCOMP Pharmacia & Upjohn AB D0S1NZ DRUGTYPE Small molecular drug D0S1NZ DRUGINCH 1S/C6H6N2O3/c1-4-2-7-5(6(9)10)3-8(4)11/h2-3H,1H3,(H,9,10) D0S1NZ DRUGINKE DJQOOSBJCLSSEY-UHFFFAOYSA-N D0S1NZ DRUGSMIL CC1=CN=C(C=[N+]1[O-])C(=O)O D0S1NZ HIGHSTAT Approved D0S1OE DRUG__ID D0S1OE D0S1OE THERCLAS Analgesics D0S1OE DRUGTYPE Small molecular drug D0S1OE DRUGINCH 1S/C11H12ClNO3S/c1-13-10(14)6-7-17(15,16)11(13)8-2-4-9(12)5-3-8/h2-5,11H,6-7H2,1H3 D0S1OE DRUGINKE WEQAYVWKMWHEJO-UHFFFAOYSA-N D0S1OE DRUGSMIL CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl D0S1OE HIGHSTAT Approved D0S1XX DRUG__ID D0S1XX D0S1XX TRADNAME Sotyktu D0S1XX DRUGCOMP Bristol Myers Squibb D0S1XX DRUGINCH 1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3 D0S1XX DRUGINKE BZZKEPGENYLQSC-FIBGUPNXSA-N D0S1XX DRUGSMIL CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4 D0S1XX HIGHSTAT Approved D0S2UG DRUG__ID D0S2UG D0S2UG DRUGCOMP Syntropharma D0S2UG DRUGTYPE Small molecular drug D0S2UG DRUGINCH 1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1 D0S2UG DRUGINKE MEZLKOACVSPNER-GFCCVEGCSA-N D0S2UG DRUGSMIL CC(CC1=CC=CC=C1)N(C)CC#C D0S2UG HIGHSTAT Approved D0S3NU DRUG__ID D0S3NU D0S3NU DRUGCOMP Otsuka pharmaceutical D0S3NU DRUGTYPE Small molecular drug D0S3NU DRUGINCH 1S/C25H25F3N4O6/c1-24(15-31-14-22(32(33)34)29-23(31)38-24)16-35-18-4-2-17(3-5-18)30-12-10-20(11-13-30)36-19-6-8-21(9-7-19)37-25(26,27)28/h2-9,14,20H,10-13,15-16H2,1H3/t24-/m1/s1 D0S3NU DRUGINKE XDAOLTSRNUSPPH-XMMPIXPASA-N D0S3NU DRUGSMIL CC1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)N4CCC(CC4)OC5=CC=C(C=C5)OC(F)(F)F D0S3NU HIGHSTAT Approved D0S4BR DRUG__ID D0S4BR D0S4BR THERCLAS Antithyroid Agents D0S4BR DRUGTYPE Small molecular drug D0S4BR DRUGINCH 1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7) D0S4BR DRUGINKE PMRYVIKBURPHAH-UHFFFAOYSA-N D0S4BR DRUGSMIL CN1C=CNC1=S D0S4BR HIGHSTAT Approved D0S4QZ DRUG__ID D0S4QZ D0S4QZ DRUGCOMP ASTA Medica AG D0S4QZ DRUGTYPE Small molecular drug D0S4QZ DRUGINCH 1S/C6H14N2.C3H5O3.Pt/c7-3-5-1-2-6(5)4-8;1-2(4)3(5)6;/h5-6H,1-4,7-8H2;2H,1H3,(H,5,6);/q;-1;+4/p-1 D0S4QZ DRUGINKE XSMVECZRZBFTIZ-UHFFFAOYSA-M D0S4QZ DRUGSMIL CC(C(=O)[O-])[O-].C1CC(C1CN)CN.[Pt+4] D0S4QZ HIGHSTAT Approved D0S5CH DRUG__ID D0S5CH D0S5CH DRUGCOMP Elan Corp plc D0S5CH DRUGTYPE Small molecular drug D0S5CH DRUGINCH 1S/C12H15NO3/c1-8-3-9(2)5-10(4-8)15-7-11-6-13-12(14)16-11/h3-5,11H,6-7H2,1-2H3,(H,13,14) D0S5CH DRUGINKE IMWZZHHPURKASS-UHFFFAOYSA-N D0S5CH DRUGSMIL CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C D0S5CH HIGHSTAT Approved D0S5CU DRUG__ID D0S5CU D0S5CU THERCLAS Antihypertensive Agents D0S5CU DRUGTYPE Small molecular drug D0S5CU DRUGINCH 1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3 D0S5CU DRUGINKE VKQFCGNPDRICFG-UHFFFAOYSA-N D0S5CU DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC D0S5CU HIGHSTAT Approved D0S5IR DRUG__ID D0S5IR D0S5IR TRADNAME Zurzuvae D0S5IR DRUGCOMP Sage Therapeutics Cambridge, MA D0S5IR DRUGINCH 1S/C25H35N3O2/c1-24(30)9-7-18-17(11-24)3-4-20-19(18)8-10-25(2)21(20)5-6-22(25)23(29)15-28-14-16(12-26)13-27-28/h13-14,17-22,30H,3-11,15H2,1-2H3/t17-,18+,19-,20-,21+,22-,24-,25+/m1/s1 D0S5IR DRUGINKE HARRKNSQXBRBGZ-GVKWWOCJSA-N D0S5IR DRUGSMIL CC1(CCC2C(C1)CCC3C2CCC4(C3CCC4C(=O)CN5C=C(C=N5)C#N)C)O D0S5IR HIGHSTAT Approved D0S5LD DRUG__ID D0S5LD D0S5LD DRUGCOMP Bayer HealthCare Pharmaceuticals D0S5LD DRUGTYPE Small molecular drug D0S5LD DRUGINCH 1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14,25H,2,5-12H2,1H3,(H2,24,26,27) D0S5LD DRUGINKE MWYDSXOGIBMAET-UHFFFAOYSA-N D0S5LD DRUGSMIL COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5 D0S5LD HIGHSTAT Approved D0S5LH DRUG__ID D0S5LH D0S5LH THERCLAS Antidotes D0S5LH DRUGTYPE Small molecular drug D0S5LH DRUGINCH 1S/C10H15NO/c1-4-11(2,3)9-6-5-7-10(12)8-9/h5-8H,4H2,1-3H3/p+1 D0S5LH DRUGINKE VWLHWLSRQJQWRG-UHFFFAOYSA-O D0S5LH DRUGSMIL CC[N+](C)(C)C1=CC(=CC=C1)O D0S5LH HIGHSTAT Approved D0S5RZ DRUG__ID D0S5RZ D0S5RZ DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D0S5RZ DRUGTYPE Small molecular drug D0S5RZ DRUGINCH 1S/C24H24N2O5/c1-16-8-10-17(11-9-16)24(29)19-13-12-18(26(19)2)14-22(27)25-15-23(28)31-21-7-5-4-6-20(21)30-3/h4-13H,14-15H2,1-3H3,(H,25,27) D0S5RZ DRUGINKE CWJNMKKMGIAGDK-UHFFFAOYSA-N D0S5RZ DRUGSMIL CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)NCC(=O)OC3=CC=CC=C3OC D0S5RZ HIGHSTAT Approved D0S5WG DRUG__ID D0S5WG D0S5WG THERCLAS Antifungal Agents D0S5WG DRUGTYPE Small molecular drug D0S5WG DRUGINCH 1S/C4H4FN3O/c5-2-1-7-4(9)8-3(2)6/h1H,(H3,6,7,8,9) D0S5WG DRUGINKE XRECTZIEBJDKEO-UHFFFAOYSA-N D0S5WG DRUGSMIL C1=NC(=O)NC(=C1F)N D0S5WG HIGHSTAT Approved D0S7DV DRUG__ID D0S7DV D0S7DV THERCLAS Anticancer Agents D0S7DV DRUGTYPE Small molecular drug D0S7DV DRUGINCH 1S/C9H12N2O5S/c10-8(15)3-2-17-9(11-3)7-6(14)5(13)4(1-12)16-7/h2,4-7,12-14H,1H2,(H2,10,15)/t4-,5-,6-,7-/m1/s1 D0S7DV DRUGINKE FVRDYQYEVDDKCR-DBRKOABJSA-N D0S7DV DRUGSMIL C1=C(N=C(S1)C2C(C(C(O2)CO)O)O)C(=O)N D0S7DV HIGHSTAT Approved D0S7JH DRUG__ID D0S7JH D0S7JH DRUGCOMP Actelion Pharmaceuticals D0S7JH DRUGTYPE Small molecular drug D0S7JH DRUGINCH 1S/C19H20Br2N6O4S/c1-2-7-26-32(28,29)27-17-16(13-3-5-14(20)6-4-13)18(25-12-24-17)30-8-9-31-19-22-10-15(21)11-23-19/h3-6,10-12,26H,2,7-9H2,1H3,(H,24,25,27) D0S7JH DRUGINKE JGCMEBMXRHSZKX-UHFFFAOYSA-N D0S7JH DRUGSMIL CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br D0S7JH HIGHSTAT Approved D0S7VO DRUG__ID D0S7VO D0S7VO THERCLAS Analgesics D0S7VO DRUGTYPE Small molecular drug D0S7VO DRUGINCH 1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17) D0S7VO DRUGINKE GUHPRPJDBZHYCJ-UHFFFAOYSA-N D0S7VO DRUGSMIL CC(C1=CC=C(S1)C(=O)C2=CC=CC=C2)C(=O)O D0S7VO HIGHSTAT Approved D0S7WX DRUG__ID D0S7WX D0S7WX THERCLAS Vitamins D0S7WX DRUGTYPE Small molecular drug D0S7WX DRUGINCH 1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+ D0S7WX DRUGINKE FPIPGXGPPPQFEQ-OVSJKPMPSA-N D0S7WX DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C D0S7WX HIGHSTAT Approved D0S8LV DRUG__ID D0S8LV D0S8LV DRUGCOMP Sankyo D0S8LV DRUGTYPE Small molecular drug D0S8LV DRUGINCH 1S/C15H21N3O4S/c1-7(19)12-10-5-11(13(15(21)22)18(10)14(12)20)23-9-3-4-17(6-9)8(2)16/h7,9-10,12,16,19H,3-6H2,1-2H3,(H,21,22)/t7-,9+,10-,12-/m1/s1 D0S8LV DRUGINKE TYMABNNERDVXID-DLYFRVTGSA-N D0S8LV DRUGSMIL CC(C1C2CC(=C(N2C1=O)C(=O)O)SC3CCN(C3)C(=N)C)O D0S8LV HIGHSTAT Approved D0S9AW DRUG__ID D0S9AW D0S9AW DRUGCOMP Lepetit D0S9AW DRUGTYPE Small molecular drug D0S9AW DRUGINCH 1S/C39H49NO14/c1-17-11-10-12-18(2)38(49)40-24-15-26(51-16-27(42)43)28-29(34(24)47)33(46)22(6)36-30(28)37(48)39(8,54-36)52-14-13-25(50-9)19(3)35(53-23(7)41)21(5)32(45)20(4)31(17)44/h10-15,17,19-21,25,31-32,35,44-47H,16H2,1-9H3,(H,40,49)(H,42,43)/b11-10+,14-13+,18-12-/t17-,19+,20+,21+,25-,31-,32+,35+,39-/m0/s1 D0S9AW DRUGINKE SQTCRTQCPJICLD-KTQDUKAHSA-N D0S9AW DRUGSMIL CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)OCC(=O)O)C D0S9AW HIGHSTAT Approved D0S9CB DRUG__ID D0S9CB D0S9CB DRUGCOMP Boehringer Ingelheim D0S9CB DRUGTYPE Small molecular drug D0S9CB DRUGINCH 1S/C20H21F3N4O/c21-20(22,23)15-4-3-5-16(14-15)26-11-8-25(9-12-26)10-13-27-18-7-2-1-6-17(18)24-19(27)28/h1-7,14H,8-13H2,(H,24,28) D0S9CB DRUGINKE PPRRDFIXUUSXRA-UHFFFAOYSA-N D0S9CB DRUGSMIL C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F D0S9CB HIGHSTAT Approved D0S9MC DRUG__ID D0S9MC D0S9MC THERCLAS Neurology Agents D0S9MC DRUGTYPE Small molecular drug D0S9MC DRUGINCH 1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3 D0S9MC DRUGINKE CXOXHMZGEKVPMT-UHFFFAOYSA-N D0S9MC DRUGSMIL CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 D0S9MC HIGHSTAT Approved D0S9QA DRUG__ID D0S9QA D0S9QA DRUGCOMP Servier D0S9QA DRUGTYPE Small molecular drug D0S9QA DRUGINCH 1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/t21-/m1/s1 D0S9QA DRUGINKE ACRHBAYQBXXRTO-OAQYLSRUSA-N D0S9QA DRUGSMIL CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC D0S9QA HIGHSTAT Approved D0SC8F DRUG__ID D0SC8F D0SC8F DRUGCOMP Organon Usa Inc D0SC8F DRUGTYPE Small molecular drug D0SC8F DRUGINCH 1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h6,15-18,21H,3-5,7-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1 D0SC8F DRUGINKE AOXRBFRFYPMWLR-XGXHKTLJSA-N D0SC8F DRUGSMIL CCC1(CCC2C1(CCC3C2CCC4=CCCCC34)C)O D0SC8F HIGHSTAT Approved D0SL8X DRUG__ID D0SL8X D0SL8X DRUGCOMP Daiichi Sankyo D0SL8X DRUGTYPE Small molecular drug D0SL8X DRUGINCH 1S/C24H30ClN7O4S.C7H8O3S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23;1-6-2-4-7(5-3-6)11(8,9)10/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34);2-5H,1H3,(H,8,9,10)/t13-,15-,17+;/m0./s1 D0SL8X DRUGINKE ZLFZITWZOYXXAW-QXXZOGQOSA-N D0SL8X DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C D0SL8X HIGHSTAT Approved D0SP3D DRUG__ID D0SP3D D0SP3D THERCLAS Vasodilator Agents D0SP3D DRUGTYPE Small molecular drug D0SP3D DRUGINCH 1S/C33H37N5O5.CH4O3S/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;1-5(2,3)4/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1H3,(H,2,3,4)/t21-,23?,25-,26+,27+,32-,33+;/m1./s1 D0SP3D DRUGINKE ADYPXRFPBQGGAH-WVVAGBSPSA-N D0SP3D DRUGSMIL CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O D0SP3D HIGHSTAT Approved D0SZ6E DRUG__ID D0SZ6E D0SZ6E DRUGCOMP Advenchen Laboratories LLC D0SZ6E DRUGTYPE Small molecular drug D0SZ6E DRUGINCH 1S/C24H23N5O.CH4O3S/c25-17-24(11-1-2-12-24)19-5-7-20(8-6-19)29-23(30)21-4-3-13-27-22(21)28-16-18-9-14-26-15-10-18;1-5(2,3)4/h3-10,13-15H,1-2,11-12,16H2,(H,27,28)(H,29,30);1H3,(H,2,3,4) D0SZ6E DRUGINKE FYJROXRIVQPKRY-UHFFFAOYSA-N D0SZ6E DRUGSMIL CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4 D0SZ6E HIGHSTAT Approved D0T1GT DRUG__ID D0T1GT D0T1GT THERCLAS Antiinfective Agents D0T1GT DRUGTYPE Small molecular drug D0T1GT DRUGINCH 1S/C12H14N4O3S/c1-2-16-8-7-11(14-12(16)17)15-20(18,19)10-5-3-9(13)4-6-10/h3-8H,2,13H2,1H3,(H,14,15,17) D0T1GT DRUGINKE SIBQAECNSSQUOD-UHFFFAOYSA-N D0T1GT DRUGSMIL CCN1C=CC(=NC1=O)NS(=O)(=O)C2=CC=C(C=C2)N D0T1GT HIGHSTAT Approved D0T1WN DRUG__ID D0T1WN D0T1WN DRUGCOMP NovaDel Pharma Inc D0T1WN DRUGTYPE Small molecular drug D0T1WN DRUGINCH 1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3 D0T1WN DRUGINKE ZAFYATHCZYHLPB-UHFFFAOYSA-N D0T1WN DRUGSMIL CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C D0T1WN HIGHSTAT Approved D0T2PL DRUG__ID D0T2PL D0T2PL DRUGCOMP Cytotech Labs LLC D0T2PL DRUGTYPE Small molecular drug D0T2PL DRUGINCH 1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1 D0T2PL DRUGINKE GMRQFYUYWCNGIN-NKMMMXOESA-N D0T2PL DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D0T2PL HIGHSTAT Approved D0T3AD DRUG__ID D0T3AD D0T3AD THERCLAS Anticancer Agents D0T3AD DRUGTYPE Small molecular drug D0T3AD DRUGINCH 1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1 D0T3AD DRUGINKE FPVKHBSQESCIEP-JQCXWYLXSA-N D0T3AD DRUGSMIL C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O D0T3AD HIGHSTAT Approved D0T5UL DRUG__ID D0T5UL D0T5UL DRUGCOMP Pharmacia D0T5UL DRUGTYPE Small molecular drug D0T5UL DRUGINCH 1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1 D0T5UL DRUGINKE YXKTVDFXDRQTKV-HNNXBMFYSA-N D0T5UL DRUGSMIL CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2 D0T5UL HIGHSTAT Approved D0T5WK DRUG__ID D0T5WK D0T5WK THERCLAS Antianxiety Agents D0T5WK DRUGTYPE Small molecular drug D0T5WK DRUGINCH 1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19) D0T5WK DRUGINKE KJONHKAYOJNZEC-UHFFFAOYSA-N D0T5WK DRUGSMIL C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3 D0T5WK HIGHSTAT Approved D0T6EI DRUG__ID D0T6EI D0T6EI TRADNAME Seysara D0T6EI DRUGCOMP Allergan D0T6EI DRUGINCH 1S/C24H29N3O8/c1-26(2)18-13-8-11-7-12-10(9-27(3)35-4)5-6-14(28)16(12)19(29)15(11)21(31)24(13,34)22(32)17(20(18)30)23(25)33/h5-6,11,13,18,28-29,32,34H,7-9H2,1-4H3,(H2,25,33)/t11-,13-,18-,24-/m0/s1 D0T6EI DRUGINKE AYUMVPHUMFKFPJ-SBAJWEJLSA-N D0T6EI DRUGSMIL CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC D0T6EI HIGHSTAT Approved D0T6IP DRUG__ID D0T6IP D0T6IP DRUGCOMP Roche D0T6IP DRUGTYPE Small molecular drug D0T6IP DRUGINCH 1S/C20H25N5O7S2.ClH/c1-9-6-33-16-12(23-14(26)11(24-30-5)10-7-34-19(21)22-10)15(27)25(16)13(9)17(28)31-8-32-18(29)20(2,3)4;/h7,12,16H,6,8H2,1-5H3,(H2,21,22)(H,23,26);1H/b24-11+;/t12-,16-;/m1./s1 D0T6IP DRUGINKE XAAOHMIKXULDKJ-LZRHLYMTSA-N D0T6IP DRUGSMIL CC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C.Cl D0T6IP HIGHSTAT Approved D0T6WT DRUG__ID D0T6WT D0T6WT DRUGCOMP Bayer company D0T6WT DRUGTYPE Small molecular drug D0T6WT DRUGINCH 1S/C21H23NO5/c1-11(23)25-16-6-4-13-10-15-14-5-7-17(26-12(2)24)20-21(14,8-9-22(15)3)18(13)19(16)27-20/h4-7,14-15,17,20H,8-10H2,1-3H3/t14-,15+,17-,20-,21-/m0/s1 D0T6WT DRUGINKE GVGLGOZIDCSQPN-PVHGPHFFSA-N D0T6WT DRUGSMIL CC(=O)OC1C=CC2C3CC4=C5C2(C1OC5=C(C=C4)OC(=O)C)CCN3C D0T6WT HIGHSTAT Approved D0T7WL DRUG__ID D0T7WL D0T7WL DRUGCOMP Pfizer Inc D0T7WL DRUGTYPE Small molecular drug D0T7WL DRUGINCH 1S/C22H30N2O/c1-18-10-8-11-19(2)24(18)17-9-15-22(25,20-12-4-3-5-13-20)21-14-6-7-16-23-21/h3-7,12-14,16,18-19,25H,8-11,15,17H2,1-2H3/t18-,19+,22? D0T7WL DRUGINKE APUDBKTWDCXQJA-QIDMFYOTSA-N D0T7WL DRUGSMIL CC1CCCC(N1CCCC(C2=CC=CC=C2)(C3=CC=CC=N3)O)C D0T7WL HIGHSTAT Approved D0T7ZQ DRUG__ID D0T7ZQ D0T7ZQ DRUGCOMP Warner Chilcott Ireland Ltd D0T7ZQ DRUGTYPE Small molecular drug D0T7ZQ DRUGINCH 1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1 D0T7ZQ DRUGINKE FHXBMXJMKMWVRG-SLHNCBLASA-N D0T7ZQ DRUGSMIL CC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4O)C D0T7ZQ HIGHSTAT Approved D0T8EH DRUG__ID D0T8EH D0T8EH DRUGCOMP Sanraku and Meiji Seika D0T8EH DRUGTYPE Small molecular drug D0T8EH DRUGINCH 1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19-,21-,22-,31+,32-/m0/s1 D0T8EH DRUGINKE KMSKQZKKOZQFFG-HSUXVGOQSA-N D0T8EH DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6 D0T8EH HIGHSTAT Approved D0T8GD DRUG__ID D0T8GD D0T8GD DRUGCOMP Upjohn Corporation D0T8GD DRUGTYPE Small molecular drug D0T8GD DRUGINCH 1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1 D0T8GD DRUGINKE SNICXCGAKADSCV-JTQLQIEISA-N D0T8GD DRUGSMIL CN1CCCC1C2=CN=CC=C2 D0T8GD HIGHSTAT Approved D0T8HZ DRUG__ID D0T8HZ D0T8HZ TRADNAME Palynziq D0T8HZ DRUGCOMP BioMarin Pharmaceutical D0T8HZ DRUGINCH 1S/C15H30N2O5/c1-21-11-12-22-10-6-2-3-8-14(18)17-9-5-4-7-13(16)15(19)20/h13H,2-12,16H2,1H3,(H,17,18)(H,19,20)/t13-/m0/s1 D0T8HZ DRUGINKE NPOCDVAOUKODSQ-ZDUSSCGKSA-N D0T8HZ DRUGSMIL COCCOCCCCCC(=O)NCCCCC(C(=O)O)N D0T8HZ HIGHSTAT Approved D0T8KD DRUG__ID D0T8KD D0T8KD DRUGCOMP Wassermann-SEEFT SA D0T8KD DRUGTYPE Small molecular drug D0T8KD DRUGINCH 1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2 D0T8KD DRUGINKE MPTJIDOGFUQSQH-UHFFFAOYSA-N D0T8KD DRUGSMIL C1CC2=C(C(C3=CC=CC=C31)N4C=CN=C4)C(=CC(=C2)Cl)Cl D0T8KD HIGHSTAT Approved D0T8VY DRUG__ID D0T8VY D0T8VY DRUGCOMP Almirall Prodesfarma SA D0T8VY DRUGTYPE Small molecular drug D0T8VY DRUGINCH 1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21) D0T8VY DRUGINKE MNIPYSSQXLZQLJ-UHFFFAOYSA-N D0T8VY DRUGSMIL C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl D0T8VY HIGHSTAT Approved D0T8XB DRUG__ID D0T8XB D0T8XB DRUGCOMP Kowa Research Institute D0T8XB DRUGTYPE Small molecular drug D0T8XB DRUGINCH 1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1 D0T8XB DRUGINKE LDXYBEHACFJIEL-HNNXBMFYSA-N D0T8XB DRUGSMIL CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N D0T8XB HIGHSTAT Approved D0T9DT DRUG__ID D0T9DT D0T9DT DRUGCOMP Bracco Diagnostics Inc D0T9DT DRUGTYPE Small molecular drug D0T9DT DRUGINCH 1S/C11H9I3N2O4/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18/h1-2H3,(H,15,17)(H,16,18)(H,19,20) D0T9DT DRUGINKE YVPYQUNUQOZFHG-UHFFFAOYSA-N D0T9DT DRUGSMIL CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I D0T9DT HIGHSTAT Approved D0TB1L DRUG__ID D0TB1L D0TB1L DRUGCOMP Ge Healthcare D0TB1L DRUGTYPE Small molecular drug D0TB1L DRUGINCH 1S/3ClH.In/h3*1H;/q;;;+3/p-3/i;;;1-4 D0TB1L DRUGINKE PSCMQHVBLHHWTO-FZTWWWDYSA-K D0TB1L DRUGSMIL Cl[In](Cl)Cl D0TB1L HIGHSTAT Approved D0TD1R DRUG__ID D0TD1R D0TD1R TRADNAME Mulpleta D0TD1R DRUGCOMP Shionogi D0TD1R DRUGINCH 1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1 D0TD1R DRUGINKE NOZIJMHMKORZBA-KJCUYJGMSA-N D0TD1R DRUGSMIL CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)C=C(C)C(=O)O)Cl D0TD1R HIGHSTAT Approved D0TP2W DRUG__ID D0TP2W D0TP2W DRUGCOMP Italfarmaco D0TP2W DRUGTYPE Small molecular drug D0TP2W DRUGINCH 1S/C30H49N9O9/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35)/t19-,20-,21-,22-,24-/m0/s1 D0TP2W DRUGINKE PSWFFKRAVBDQEG-YGQNSOCVSA-N D0TP2W DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N D0TP2W HIGHSTAT Approved D0TP8R DRUG__ID D0TP8R D0TP8R DRUGCOMP Pharmalucence Inc D0TP8R DRUGTYPE Small molecular drug D0TP8R DRUGINCH 1S/2C8H10IN3.H2O4S/c2*9-7-3-1-2-6(4-7)5-12-8(10)11;1-5(2,3)4/h2*1-4H,5H2,(H4,10,11,12);(H2,1,2,3,4)/i2*9+4; D0TP8R DRUGINKE XNACDNPGABUBFR-GNPGNDBSSA-N D0TP8R DRUGSMIL C1=CC(=CC(=C1)I)CN=C(N)N.C1=CC(=CC(=C1)I)CN=C(N)N.OS(=O)(=O)O D0TP8R HIGHSTAT Approved D0TS1Z DRUG__ID D0TS1Z D0TS1Z DRUGCOMP Heidelberger D0TS1Z DRUGTYPE Small molecular drug D0TS1Z DRUGINCH 1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 D0TS1Z DRUGINKE ODKNJVUHOIMIIZ-RRKCRQDMSA-N D0TS1Z DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O D0TS1Z HIGHSTAT Approved D0TV0C DRUG__ID D0TV0C D0TV0C DRUGCOMP Novartis D0TV0C DRUGTYPE Small molecular drug D0TV0C DRUGINCH 1S/C58H66N10O9/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72)/t43-,46+,47+,48-,49+,50+,51+/m1/s1 D0TV0C DRUGINKE VMZMNAABQBOLAK-DBILLSOUSA-N D0TV0C DRUGSMIL C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN D0TV0C HIGHSTAT Approved D0TV6I DRUG__ID D0TV6I D0TV6I DRUGCOMP Us Worldmeds D0TV6I DRUGTYPE Small molecular drug D0TV6I DRUGINCH 1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 D0TV6I DRUGINKE NEMGRZFTLSKBAP-LBPRGKRZSA-N D0TV6I DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F D0TV6I HIGHSTAT Approved D0U0OT DRUG__ID D0U0OT D0U0OT DRUGCOMP Chiesi D0U0OT DRUGTYPE Small molecular drug D0U0OT DRUGINCH 1S/C10H13NO4/c1-15-10(14)7(11)4-6-2-3-8(12)9(13)5-6/h2-3,5,7,12-13H,4,11H2,1H3/t7-/m0/s1 D0U0OT DRUGINKE XBBDACCLCFWBSI-ZETCQYMHSA-N D0U0OT DRUGSMIL COC(=O)C(CC1=CC(=C(C=C1)O)O)N D0U0OT HIGHSTAT Approved D0U0XD DRUG__ID D0U0XD D0U0XD DRUGCOMP Pharmacia And Upjohn Co D0U0XD DRUGTYPE Small molecular drug D0U0XD DRUGINCH 1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1 D0U0XD DRUGINKE UOACKFBJUYNSLK-XRKIENNPSA-N D0U0XD DRUGSMIL CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O D0U0XD HIGHSTAT Approved D0U1OM DRUG__ID D0U1OM D0U1OM THERCLAS Antiinflammatory Agents D0U1OM DRUGTYPE Small molecular drug D0U1OM DRUGINCH 1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19) D0U1OM DRUGINKE ZBPLOVFIXSTCRZ-UHFFFAOYSA-N D0U1OM DRUGSMIL C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O D0U1OM HIGHSTAT Approved D0U1ZV DRUG__ID D0U1ZV D0U1ZV TRADNAME Nerlynx D0U1ZV DRUGCOMP Puma Biotechnology D0U1ZV DRUGINCH 1S/C30H29ClN6O3.C4H4O4/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22;5-3(6)1-2-4(7)8/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38);1-2H,(H,5,6)(H,7,8)/b9-7+;2-1- D0U1ZV DRUGINKE VXZCUHNJXSIJIM-MEBGWEOYSA-N D0U1ZV DRUGSMIL CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C.C(=CC(=O)O)C(=O)O D0U1ZV HIGHSTAT Approved D0U3CR DRUG__ID D0U3CR D0U3CR THERCLAS Antihypertensive Agents D0U3CR DRUGTYPE Small molecular drug D0U3CR DRUGINCH 1S/2C10H19N3O2.H2O4S/c2*11-9(12)13-6-8-7-14-10(15-8)4-2-1-3-5-10;1-5(2,3)4/h2*8H,1-7H2,(H4,11,12,13);(H2,1,2,3,4) D0U3CR DRUGINKE RTEVGQJRTFFMLL-UHFFFAOYSA-N D0U3CR DRUGSMIL C1CCC2(CC1)OCC(O2)CN=C(N)N.C1CCC2(CC1)OCC(O2)CN=C(N)N.OS(=O)(=O)O D0U3CR HIGHSTAT Approved D0U3ED DRUG__ID D0U3ED D0U3ED DRUGCOMP Eisai Co. Ltd. D0U3ED DRUGTYPE Small molecular drug D0U3ED DRUGINCH 1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H D0U3ED DRUGINKE PRMWGUBFXWROHD-UHFFFAOYSA-N D0U3ED DRUGSMIL C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4 D0U3ED HIGHSTAT Approved D0U3GL DRUG__ID D0U3GL D0U3GL DRUGCOMP Pfizer Pharmaceuticals D0U3GL DRUGTYPE Small molecular drug D0U3GL DRUGINCH 1S/C19H30O3/c1-17-11-22-16(20)10-12(17)4-5-13-14(17)6-8-18(2)15(13)7-9-19(18,3)21/h12-15,21H,4-11H2,1-3H3/t12-,13+,14-,15-,17-,18-,19-/m0/s1 D0U3GL DRUGINKE QSLJIVKCVHQPLV-PEMPUTJUSA-N D0U3GL DRUGSMIL CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C D0U3GL HIGHSTAT Approved D0U3YB DRUG__ID D0U3YB D0U3YB THERCLAS Anticancer Agents D0U3YB DRUGTYPE Small molecular drug D0U3YB DRUGINCH 1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3/t11-,12+ D0U3YB DRUGINKE HCZKYJDFEPMADG-TXEJJXNPSA-N D0U3YB DRUGSMIL CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O D0U3YB HIGHSTAT Approved D0U3YU DRUG__ID D0U3YU D0U3YU DRUGCOMP Bioresearch SpA D0U3YU DRUGTYPE Small molecular drug D0U3YU DRUGINCH 1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1 D0U3YU DRUGINKE MEFKEPWMEQBLKI-AIRLBKTGSA-N D0U3YU DRUGSMIL C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0U3YU HIGHSTAT Approved D0U4UQ DRUG__ID D0U4UQ D0U4UQ THERCLAS Diuretics D0U4UQ DRUGTYPE Small molecular drug D0U4UQ DRUGINCH 1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13) D0U4UQ DRUGINKE JZUFKLXOESDKRF-UHFFFAOYSA-N D0U4UQ DRUGSMIL C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl D0U4UQ HIGHSTAT Approved D0U4VT DRUG__ID D0U4VT D0U4VT THERCLAS Anticonvulsants D0U4VT DRUGTYPE Small molecular drug D0U4VT DRUGINCH 1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3 D0U4VT DRUGINKE IRYJRGCIQBGHIV-UHFFFAOYSA-N D0U4VT DRUGSMIL CC1(C(=O)N(C(=O)O1)C)C D0U4VT HIGHSTAT Approved D0U4XJ DRUG__ID D0U4XJ D0U4XJ DRUGCOMP Medicis D0U4XJ DRUGTYPE Small molecular drug D0U4XJ DRUGINCH 1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1 D0U4XJ DRUGINKE YTAOBBFIOAEMLL-REQDGWNSSA-N D0U4XJ DRUGSMIL C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=C(C=C(C=C3)Cl)Cl D0U4XJ HIGHSTAT Approved D0U5CE DRUG__ID D0U5CE D0U5CE DRUGCOMP Samyang Corp D0U5CE DRUGTYPE Small molecular drug D0U5CE DRUGINCH 1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6+ D0U5CE DRUGINKE YKPUWZUDDOIDPM-SOFGYWHQSA-N D0U5CE DRUGSMIL CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC D0U5CE HIGHSTAT Approved D0U5SI DRUG__ID D0U5SI D0U5SI THERCLAS Antiarrhythmic Agents D0U5SI DRUGTYPE Small molecular drug D0U5SI DRUGINCH 1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17) D0U5SI DRUGINKE REQCZEXYDRLIBE-UHFFFAOYSA-N D0U5SI DRUGSMIL CCN(CC)CCNC(=O)C1=CC=C(C=C1)N D0U5SI HIGHSTAT Approved D0U5UC DRUG__ID D0U5UC D0U5UC TRADNAME Rezurock D0U5UC DRUGCOMP Kadmon D0U5UC DRUGINCH 1S/C26H24N6O2/c1-16(2)28-24(33)15-34-20-7-5-6-17(13-20)25-30-23-9-4-3-8-21(23)26(31-25)29-19-10-11-22-18(12-19)14-27-32-22/h3-14,16H,15H2,1-2H3,(H,27,32)(H,28,33)(H,29,30,31) D0U5UC DRUGINKE GKHIVNAUVKXIIY-UHFFFAOYSA-N D0U5UC DRUGSMIL CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5 D0U5UC HIGHSTAT Approved D0U7GK DRUG__ID D0U7GK D0U7GK THERCLAS Immunosuppressive Agents D0U7GK DRUGTYPE Small molecular drug D0U7GK DRUGINCH 1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) D0U7GK DRUGINKE UEJJHQNACJXSKW-UHFFFAOYSA-N D0U7GK DRUGSMIL C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O D0U7GK HIGHSTAT Approved D0U7SH DRUG__ID D0U7SH D0U7SH DRUGCOMP Ferring Pharmaceuticals Inc D0U7SH DRUGTYPE Small molecular drug D0U7SH DRUGINCH 1S/C46H64N14O12S2/c47-35(62)15-14-29-40(67)58-32(22-36(48)63)43(70)59-33(45(72)60-18-5-9-34(60)44(71)56-28(8-4-17-52-46(50)51)39(66)53-23-37(49)64)24-74-73-19-16-38(65)54-30(21-26-10-12-27(61)13-11-26)41(68)57-31(42(69)55-29)20-25-6-2-1-3-7-25/h1-3,6-7,10-13,28-34,61H,4-5,8-9,14-24H2,(H2,47,62)(H2,48,63)(H2,49,64)(H,53,66)(H,54,65)(H,55,69)(H,56,71)(H,57,68)(H,58,67)(H,59,70)(H4,50,51,52)/t28-,29+,30+,31+,32+,33+,34+/m1/s1 D0U7SH DRUGINKE NFLWUMRGJYTJIN-PNIOQBSNSA-N D0U7SH DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D0U7SH HIGHSTAT Approved D0U9FD DRUG__ID D0U9FD D0U9FD THERCLAS Respiratory Agents D0U9FD DRUGTYPE Small molecular drug D0U9FD DRUGINCH 1S/C25H30NO3.ClH/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26;/h1-6,9-12,21-23,28H,7-8,13-18H2;1H/q+1;/p-1/t21-,22+,23?; D0U9FD DRUGINKE RVCSYOQWLPPAOA-DHWZJIOFSA-M D0U9FD DRUGSMIL C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-] D0U9FD HIGHSTAT Approved D0UA2Z DRUG__ID D0UA2Z D0UA2Z DRUGCOMP Sandoz D0UA2Z DRUGTYPE Small molecular drug D0UA2Z DRUGINCH 1S/C16H21N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-4,7,9-11,14H,5-6,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1 D0UA2Z DRUGINKE RPBAFSBGYDKNRG-NJBDSQKTSA-N D0UA2Z DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CCC=CC3)N)C(=O)O)C D0UA2Z HIGHSTAT Approved D0UL2L DRUG__ID D0UL2L D0UL2L DRUGCOMP Roche Holding AG D0UL2L DRUGTYPE Small molecular drug D0UL2L DRUGINCH 1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19) D0UL2L DRUGINKE WLHQHAUOOXYABV-UHFFFAOYSA-N D0UL2L DRUGSMIL CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3 D0UL2L HIGHSTAT Approved D0UL9R DRUG__ID D0UL9R D0UL9R DRUGCOMP Theratechnologies D0UL9R DRUGTYPE Small molecular drug D0UL9R DRUGINCH 1S/C221H366N72O67S/c1-25-28-30-53-163(308)260-145(92-120-54-58-122(299)59-55-120)198(343)255-116(21)179(324)276-150(96-169(316)317)199(344)256-117(22)180(325)291-172(111(16)26-2)214(359)284-147(91-119-43-31-29-32-44-119)206(351)293-174(118(23)298)215(360)285-149(95-162(230)307)205(350)289-155(104-297)210(355)280-146(93-121-56-60-123(300)61-57-121)203(348)267-130(51-41-83-248-220(240)241)186(331)266-126(46-34-36-78-223)197(342)290-171(110(14)15)212(357)283-141(87-106(6)7)183(328)252-100-166(311)258-133(63-70-157(225)302)190(335)278-144(90-109(12)13)202(347)288-152(101-294)208(353)257-115(20)178(323)262-128(49-39-81-246-218(236)237)185(330)265-125(45-33-35-77-222)189(334)277-143(89-108(10)11)201(346)279-142(88-107(8)9)200(345)272-137(66-73-160(228)305)195(340)282-151(97-170(318)319)207(352)292-173(112(17)27-3)213(358)274-139(76-85-361-24)196(341)287-153(102-295)209(354)268-131(52-42-84-249-221(242)243)187(332)270-135(64-71-158(226)303)192(337)269-132(62-69-156(224)301)182(327)251-99-165(310)259-134(67-74-167(312)313)191(336)286-154(103-296)211(356)281-148(94-161(229)306)204(349)273-136(65-72-159(227)304)193(338)271-138(68-75-168(314)315)194(339)264-124(47-37-79-244-216(232)233)181(326)250-98-164(309)253-113(18)176(321)261-127(48-38-80-245-217(234)235)184(329)254-114(19)177(322)263-129(50-40-82-247-219(238)239)188(333)275-140(175(231)320)86-105(4)5/h28-32,43-44,54-61,105-118,124-155,171-174,294-300H,25-27,33-42,45-53,62-104,222-223H2,1-24H3,(H2,224,301)(H2,225,302)(H2,226,303)(H2,227,304)(H2,228,305)(H2,229,306)(H2,230,307)(H2,231,320)(H,250,326)(H,251,327)(H,252,328)(H,253,309)(H,254,329)(H,255,343)(H,256,344)(H,257,353)(H,258,311)(H,259,310)(H,260,308)(H,261,321)(H,262,323)(H,263,322)(H,264,339)(H,265,330)(H,266,331)(H,267,348)(H,268,354)(H,269,337)(H,270,332)(H,271,338)(H,272,345)(H,273,349)(H,274,358)(H,275,333)(H,276,324)(H,277,334)(H,278,335)(H,279,346)(H,280,355)(H,281,356)(H,282,340)(H,283,357)(H,284,359)(H,285,360)(H,286,336)(H,287,341)(H,288,347)(H,289,350)(H,290,342)(H,291,325)(H,292,352)(H,293,351)(H,312,313)(H,314,315)(H,316,317)(H,318,319)(H4,232,233,244)(H4,234,235,245)(H4,236,237,246)(H4,238,239,247)(H4,240,241,248)(H4,242,243,249)/b30-28+/t111-,112-,113-,114-,115-,116-,117-,118+,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,171-,172-,173-,174-/m0/s1 D0UL9R DRUGINKE QBEPNUQJQWDYKU-BMGKTWPMSA-N D0UL9R DRUGSMIL CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N D0UL9R HIGHSTAT Approved D0UP9M DRUG__ID D0UP9M D0UP9M DRUGCOMP Bristol-Myers Squibb D0UP9M DRUGTYPE Small molecular drug D0UP9M DRUGINCH 1S/C17H37N7O3.3ClH/c18-9-7-11-21-10-5-6-12-22-15(26)16(27)24-14(25)8-3-1-2-4-13-23-17(19)20;;;/h16,21,27H,1-13,18H2,(H,22,26)(H,24,25)(H4,19,20,23);3*1H D0UP9M DRUGINKE AXSPHUWXYSZPBG-UHFFFAOYSA-N D0UP9M DRUGSMIL C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O.Cl.Cl.Cl D0UP9M HIGHSTAT Approved D0UX6Z DRUG__ID D0UX6Z D0UX6Z DRUGCOMP Hospira Inc D0UX6Z THERCLAS Cardiovascular Agents D0UX6Z DRUGINCH 1S/C26H42N2O37S5.Na/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36;/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54);/q;+1 D0UX6Z DRUGINKE JRTRSJGZMRQDHI-UHFFFAOYSA-N D0UX6Z DRUGSMIL CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O.[Na+] D0UX6Z HIGHSTAT Approved D0V0IX DRUG__ID D0V0IX D0V0IX THERCLAS Antihypertensive Agents D0V0IX DRUGTYPE Small molecular drug D0V0IX DRUGINCH 1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1 D0V0IX DRUGINKE KAQKFAOMNZTLHT-OZUDYXHBSA-N D0V0IX DRUGSMIL CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O D0V0IX HIGHSTAT Approved D0V1UW DRUG__ID D0V1UW D0V1UW THERCLAS Anticancer Agents D0V1UW DRUGTYPE Small molecular drug D0V1UW DRUGINCH 1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2 D0V1UW DRUGINKE OUBCNLGXQFSTLU-UHFFFAOYSA-N D0V1UW DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-] D0V1UW HIGHSTAT Approved D0V2GH DRUG__ID D0V2GH D0V2GH THERCLAS Vasodilator Agents D0V2GH DRUGTYPE Small molecular drug D0V2GH DRUGINCH 1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1 D0V2GH DRUGINKE YSEXMKHXIOCEJA-FVFQAYNVSA-N D0V2GH DRUGSMIL CN1CC(CC2(C1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br D0V2GH HIGHSTAT Approved D0V2JK DRUG__ID D0V2JK D0V2JK DRUGCOMP Theramex D0V2JK DRUGTYPE Small molecular drug D0V2JK DRUGINCH 1S/C23H30O4/c1-13-11-20-18(17-6-5-16(26)12-19(13)17)7-9-22(4)21(20)8-10-23(22,14(2)24)27-15(3)25/h11-12,17-18,20-21H,5-10H2,1-4H3/t17-,18-,20-,21+,22+,23+/m1/s1 D0V2JK DRUGINKE IIVBFTNIGYRNQY-YQLZSBIMSA-N D0V2JK DRUGSMIL CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4C1=CC(=O)CC4 D0V2JK HIGHSTAT Approved D0V4WD DRUG__ID D0V4WD D0V4WD DRUGCOMP HRA Pharma D0V4WD DRUGTYPE Small molecular drug D0V4WD DRUGINCH 1S/C28H35NO3/c1-17(30)28(32)14-13-25-23-11-7-19-15-21(31)10-12-22(19)26(23)24(16-27(25,28)2)18-5-8-20(9-6-18)29(3)4/h5-6,8-9,15,23-25,32H,7,10-14,16H2,1-4H3/t23-,24+,25-,27-,28-/m0/s1 D0V4WD DRUGINKE HKDLNTKNLJPAIY-WKWWZUSTSA-N D0V4WD DRUGSMIL CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O D0V4WD HIGHSTAT Approved D0V4ZN DRUG__ID D0V4ZN D0V4ZN DRUGCOMP Gilead Sciences D0V4ZN DRUGTYPE Small molecular drug D0V4ZN DRUGINCH 1S/C40H53N7O5S2.C27H37N3O7S/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35;1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49);3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t32-,33-,36+;22-,23-,24+,25-,26+/m10/s1 D0V4ZN DRUGINKE CXORHDVSJFELCV-HWDLLDTBSA-N D0V4ZN DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5 D0V4ZN HIGHSTAT Approved D0V5ZZ DRUG__ID D0V5ZZ D0V5ZZ THERCLAS Antispasmodics D0V5ZZ DRUGTYPE Small molecular drug D0V5ZZ DRUGINCH 1S/C23H30NO3/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22/h6-13,16-17,22H,14-15H2,1-5H3/q+1 D0V5ZZ DRUGINKE VVWYOYDLCMFIEM-UHFFFAOYSA-N D0V5ZZ DRUGSMIL CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C D0V5ZZ HIGHSTAT Approved D0V6OA DRUG__ID D0V6OA D0V6OA DRUGCOMP PharmaMar D0V6OA DRUGTYPE Small molecular drug D0V6OA DRUGINCH 1S/C41H44N4O10S/c1-17-11-20-12-25-39(48)45-26-14-52-40(49)41(38-22(9-10-42-41)23-13-21(50-5)7-8-24(23)43-38)15-56-37(31(45)30(44(25)4)27(20)32(47)33(17)51-6)29-28(26)36-35(53-16-54-36)18(2)34(29)55-19(3)46/h7-8,11,13,25-26,30-31,37,39,42-43,47-48H,9-10,12,14-16H2,1-6H3/t25-,26-,30+,31+,37+,39-,41+/m0/s1 D0V6OA DRUGINKE YDDMIZRDDREKEP-HWTBNCOESA-N D0V6OA DRUGSMIL CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O D0V6OA HIGHSTAT Approved D0V7OH DRUG__ID D0V7OH D0V7OH DRUGCOMP Pfizer D0V7OH DRUGTYPE Small molecular drug D0V7OH DRUGINCH 1S/C19H17N5O7S3/c1-30-23-11(9-7-34-19(20)21-9)14(25)22-12-15(26)24-13(17(27)28)8(5-32-16(12)24)6-33-18(29)10-3-2-4-31-10/h2-4,7,12,16H,5-6H2,1H3,(H2,20,21)(H,22,25)(H,27,28)/b23-11-/t12-,16-/m1/s1 D0V7OH DRUGINKE ZBHXIWJRIFEVQY-IHMPYVIRSA-N D0V7OH DRUGSMIL CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O D0V7OH HIGHSTAT Approved D0V7RH DRUG__ID D0V7RH D0V7RH DRUGCOMP Lederle Laboratories D0V7RH DRUGTYPE Small molecular drug D0V7RH DRUGINCH 1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12-,13-;/m0./s1 D0V7RH DRUGINKE KVUAALJSMIVURS-QNTKWALQSA-L D0V7RH DRUGSMIL C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2] D0V7RH HIGHSTAT Approved D0V7WS DRUG__ID D0V7WS D0V7WS DRUGCOMP Medtronic D0V7WS DRUGTYPE Small molecular drug D0V7WS DRUGINCH 1S/C52H79N5O12/c1-31-16-12-11-13-17-32(2)43(65-8)28-39-21-19-37(7)52(64,69-39)49(61)50(62)56-23-15-14-18-41(56)51(63)68-44(34(4)26-38-20-22-40(45(27-38)66-9)57-30-53-54-55-57)29-42(58)33(3)25-36(6)47(60)48(67-10)46(59)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-41,43-45,47-48,60,64H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,32-17+,36-25+/t31-,33-,34-,35-,37-,38+,39+,40+,41+,43+,44+,45-,47-,48+,52-/m1/s1 D0V7WS DRUGINKE CGTADGCBEXYWNE-JUKNQOCSSA-N D0V7WS DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)N5C=NN=N5)C)C)O)OC)C)C)C)OC D0V7WS HIGHSTAT Approved D0V8TQ DRUG__ID D0V8TQ D0V8TQ THERCLAS Antiinflammatory Agents D0V8TQ DRUGTYPE Small molecular drug D0V8TQ DRUGINCH 1S/Al D0V8TQ DRUGINKE XAGFODPZIPBFFR-UHFFFAOYSA-N D0V8TQ DRUGSMIL [Al] D0V8TQ HIGHSTAT Approved D0V9DZ DRUG__ID D0V9DZ D0V9DZ DRUGCOMP Pharmacia And Upjohn Co D0V9DZ DRUGTYPE Small molecular drug D0V9DZ DRUGINCH 1S/C21H27FO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15-16,18,23,25,27H,4,6,8-10H2,1-2H3/t12-,13-,15-,16-,18+,19-,20-,21-/m0/s1 D0V9DZ DRUGINKE MYYIMZRZXIQBGI-HVIRSNARSA-N D0V9DZ DRUGSMIL CC12CC(C3C(C1CCC2(C(=O)CO)O)CC(C4=CC(=O)C=CC34C)F)O D0V9DZ HIGHSTAT Approved D0V9VG DRUG__ID D0V9VG D0V9VG DRUGCOMP Labrys Biologics D0V9VG DRUGTYPE Small molecular drug D0V9VG DRUGINCH 1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/t18-,22+,24-/m0/s1 D0V9VG DRUGINKE KRNAOFGYEFKHPB-ANJVHQHFSA-N D0V9VG DRUGSMIL C1CC(C2=C(C=CC=N2)C(C1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6 D0V9VG HIGHSTAT Approved D0V9YR DRUG__ID D0V9YR D0V9YR THERCLAS Antiinfective Agents D0V9YR DRUGTYPE Small molecular drug D0V9YR DRUGINCH 1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16) D0V9YR DRUGINKE ASWVTGNCAZCNNR-UHFFFAOYSA-N D0V9YR DRUGSMIL CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C D0V9YR HIGHSTAT Approved D0V9ZG DRUG__ID D0V9ZG D0V9ZG DRUGCOMP Daiichi Seiyaku Co Ltd D0V9ZG DRUGTYPE Small molecular drug D0V9ZG DRUGINCH 1S/C17H23NO4/c18-11-13-1-6-14(7-2-13)17(21)22-15-8-3-12(4-9-15)5-10-16(19)20/h3-4,8-9,13-14H,1-2,5-7,10-11,18H2,(H,19,20) D0V9ZG DRUGINKE FHRSHSOEWXUORL-UHFFFAOYSA-N D0V9ZG DRUGSMIL C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O D0V9ZG HIGHSTAT Approved D0VA0I DRUG__ID D0VA0I D0VA0I DRUGCOMP Schering-Plough D0VA0I DRUGTYPE Small molecular drug D0VA0I DRUGINCH 1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1 D0VA0I DRUGINKE ZBGXUVOIWDMMJE-QHNZEKIYSA-N D0VA0I DRUGSMIL CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C D0VA0I HIGHSTAT Approved D0VB3Y DRUG__ID D0VB3Y D0VB3Y DRUGCOMP Abraxis Pharmaceutical Products D0VB3Y DRUGTYPE Small molecular drug D0VB3Y DRUGINCH 1S/Mn.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2 D0VB3Y DRUGINKE SQQMAOCOWKFBNP-UHFFFAOYSA-L D0VB3Y DRUGSMIL [O-]S(=O)(=O)[O-].[Mn+2] D0VB3Y HIGHSTAT Approved D0VF4H DRUG__ID D0VF4H D0VF4H THERCLAS Vitamins D0VF4H DRUGTYPE Small molecular drug D0VF4H DRUGINCH 1S/C62H90N13O14P.Co.H2O/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;1H2/q;+2;/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1 D0VF4H DRUGINKE DQOCFCZRZOAIBN-WZHZPDAFSA-L D0VF4H DRUGSMIL CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2] D0VF4H HIGHSTAT Approved D0VG7Y DRUG__ID D0VG7Y D0VG7Y TRADNAME Orilissa D0VG7Y DRUGCOMP AbbVie D0VG7Y DRUGINCH 1S/C32H30F5N3O5.Na/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33;/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42);/q;+1/p-1/t25-;/m0./s1 D0VG7Y DRUGINKE DQYGXRQUFSRDCH-UQIIZPHYSA-M D0VG7Y DRUGSMIL CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+] D0VG7Y HIGHSTAT Approved D0VM8K DRUG__ID D0VM8K D0VM8K DRUGCOMP Rhone-Poulenc Rorer GmbH D0VM8K DRUGTYPE Small molecular drug D0VM8K DRUGINCH 1S/C6H12O7.Fe.Na/c7-1-2(8)3(9)4(10)5(11)6(12)13;;/h2-5,7-11H,1H2,(H,12,13);;/q;+3;+1/p-1/t2-,3-,4+,5-;;/m1../s1 D0VM8K DRUGINKE PKNUOQOQWGOWBO-ZBHRUSISSA-M D0VM8K DRUGSMIL C(C(C(C(C(C(=O)[O-])O)O)O)O)O.[Na+].[Fe+3] D0VM8K HIGHSTAT Approved D0VP1V DRUG__ID D0VP1V D0VP1V DRUGCOMP Almirall D0VP1V DRUGTYPE Small molecular drug D0VP1V DRUGINCH 1S/C26H30NO4S2/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2/q+1/t20?,22-,27?/m0/s1 D0VP1V DRUGINKE ASMXXROZKSBQIH-VITNCHFBSA-N D0VP1V DRUGSMIL C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5 D0VP1V HIGHSTAT Approved D0VU2X DRUG__ID D0VU2X D0VU2X DRUGCOMP Astellas Pharma Inc D0VU2X DRUGTYPE Small molecular drug D0VU2X DRUGINCH 1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37) D0VU2X DRUGINKE IKENVDNFQMCRTR-UHFFFAOYSA-N D0VU2X DRUGSMIL CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6 D0VU2X HIGHSTAT Approved D0VU8Q DRUG__ID D0VU8Q D0VU8Q DRUGCOMP Reckitt; Colman D0VU8Q DRUGTYPE Small molecular drug D0VU8Q DRUGINCH 1S/C25H35NO5/c1-6-26(19(2)17-20-9-12-22(28-3)13-10-20)15-7-8-16-31-25(27)21-11-14-23(29-4)24(18-21)30-5/h9-14,18-19H,6-8,15-17H2,1-5H3 D0VU8Q DRUGINKE VYVKHNNGDFVQGA-UHFFFAOYSA-N D0VU8Q DRUGSMIL CCN(CCCCOC(=O)C1=CC(=C(C=C1)OC)OC)C(C)CC2=CC=C(C=C2)OC D0VU8Q HIGHSTAT Approved D0W0MF DRUG__ID D0W0MF D0W0MF THERCLAS Hypnotics and Sedatives D0W0MF DRUGTYPE Small molecular drug D0W0MF DRUGINCH 1S/C11H16N2O3/c1-4-6-11(7(3)5-2)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16) D0W0MF DRUGINKE BJVVMKUXKQHWJK-UHFFFAOYSA-N D0W0MF DRUGSMIL CCC(C)C1(C(=O)NC(=O)NC1=O)CC=C D0W0MF HIGHSTAT Approved D0W1RY DRUG__ID D0W1RY D0W1RY DRUGCOMP Pharmics Inc D0W1RY DRUGTYPE Small molecular drug D0W1RY DRUGINCH 1S/C9H13NO.BrH/c1-7(10)6-8-2-4-9(11)5-3-8;/h2-5,7,11H,6,10H2,1H3;1H D0W1RY DRUGINKE RZCJLMTXBMNRAD-UHFFFAOYSA-N D0W1RY DRUGSMIL CC(CC1=CC=C(C=C1)O)N.Br D0W1RY HIGHSTAT Approved D0W2EK DRUG__ID D0W2EK D0W2EK DRUGCOMP Bristol-Myers Squibb D0W2EK DRUGTYPE Small molecular drug D0W2EK DRUGINCH 1S/C27H42N2O5S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)29-23(31)13-21(30)26(5,6)25(33)17(3)24(15)32/h11,14-15,17,20-22,24,30,32H,8-10,12-13H2,1-7H3,(H,29,31)/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1 D0W2EK DRUGINKE FABUFPQFXZVHFB-PVYNADRNSA-N D0W2EK DRUGSMIL CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C D0W2EK HIGHSTAT Approved D0W5BS DRUG__ID D0W5BS D0W5BS DRUGCOMP Otsuka Pharmaceutical Co Ltd D0W5BS DRUGTYPE Small molecular drug D0W5BS DRUGINCH 1S/C6H8O7.Fe.H3N/c7-3(8)1-6(13,5(11)12)2-4(9)10;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;1H3/q;+3; D0W5BS DRUGINKE FRHBOQMZUOWXQL-UHFFFAOYSA-N D0W5BS DRUGSMIL C(C(=O)O)C(CC(=O)O)(C(=O)O)O.N.[Fe+3] D0W5BS HIGHSTAT Approved D0W5LS DRUG__ID D0W5LS D0W5LS THERCLAS Antiaddison Agents D0W5LS DRUGTYPE Small molecular drug D0W5LS DRUGINCH 1S/C26H38O4/c1-24(2,3)23(29)30-15-22(28)21-9-8-19-18-7-6-16-14-17(27)10-12-25(16,4)20(18)11-13-26(19,21)5/h14,18-21H,6-13,15H2,1-5H3/t18-,19-,20-,21+,25-,26-/m0/s1 D0W5LS DRUGINKE VVOIQBFMTVCINR-WWMZEODYSA-N D0W5LS DRUGSMIL CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C D0W5LS HIGHSTAT Approved D0W6DY DRUG__ID D0W6DY D0W6DY THERCLAS Antihistamines D0W6DY DRUGTYPE Small molecular drug D0W6DY DRUGINCH 1S/C19H23NO/c1-20-14-12-18(13-15-20)21-19(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-19H,12-15H2,1H3 D0W6DY DRUGINKE OWQUZNMMYNAXSL-UHFFFAOYSA-N D0W6DY DRUGSMIL CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3 D0W6DY HIGHSTAT Approved D0W6KM DRUG__ID D0W6KM D0W6KM DRUGCOMP Sunovion pharmaceuticals D0W6KM DRUGTYPE Small molecular drug D0W6KM DRUGINCH 1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1 D0W6KM DRUGINKE SRPXSILJHWNFMK-MEDUHNTESA-N D0W6KM DRUGSMIL C1CC(C2=CC=CC=C2C1C3=CC(=C(C=C3)Cl)Cl)N D0W6KM HIGHSTAT Approved D0W6LI DRUG__ID D0W6LI D0W6LI DRUGCOMP Sandoz D0W6LI THERCLAS Diagnostic Agents D0W6LI DRUGINCH 1S/C136H210N40O31S/c1-75(2)109(127(200)154-71-106(181)156-88(31-13-17-52-137)114(187)158-89(32-14-18-53-138)115(188)159-91(35-21-56-149-134(142)143)116(189)164-96(37-23-58-151-136(146)147)131(204)175-60-25-39-104(175)126(199)173-111(77(5)6)128(201)163-90(33-15-19-54-139)120(193)171-110(76(3)4)129(202)169-101(65-80-43-47-84(180)48-44-80)132(205)176-61-26-40-105(176)133(206)207)172-125(198)103-38-24-59-174(103)130(203)95(34-16-20-55-140)157-107(182)70-153-113(186)99(66-81-68-152-87-30-12-11-29-85(81)87)167-117(190)92(36-22-57-150-135(144)145)160-121(194)98(63-78-27-9-8-10-28-78)166-123(196)100(67-82-69-148-74-155-82)168-118(191)93(49-50-108(183)184)161-119(192)94(51-62-208-7)162-124(197)102(73-178)170-122(195)97(165-112(185)86(141)72-177)64-79-41-45-83(179)46-42-79/h8-12,27-30,41-48,68-69,74-77,86,88-105,109-111,152,177-180H,13-26,31-40,49-67,70-73,137-141H2,1-7H3,(H,148,155)(H,153,186)(H,154,200)(H,156,181)(H,157,182)(H,158,187)(H,159,188)(H,160,194)(H,161,192)(H,162,197)(H,163,201)(H,164,189)(H,165,185)(H,166,196)(H,167,190)(H,168,191)(H,169,202)(H,170,195)(H,171,193)(H,172,198)(H,173,199)(H,183,184)(H,206,207)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151)/t86?,88-,89-,90+,91-,92+,93+,94+,95+,96-,97+,98+,99+,100+,101+,102+,103+,104+,105+,109+,110+,111+/m1/s1 D0W6LI DRUGINKE ZOEFCCMDUURGSE-CQVUSSRSSA-N D0W6LI DRUGSMIL CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC=N8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N D0W6LI HIGHSTAT Approved D0W7HE DRUG__ID D0W7HE D0W7HE DRUGCOMP Novartis D0W7HE DRUGTYPE Small molecular drug D0W7HE DRUGINCH 1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 D0W7HE DRUGINKE STUWGJZDJHPWGZ-LBPRGKRZSA-N D0W7HE DRUGSMIL CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F D0W7HE HIGHSTAT Approved D0W7JZ DRUG__ID D0W7JZ D0W7JZ DRUGCOMP Astellas Pharma US; AVEO Pharmaceuticals D0W7JZ DRUGTYPE Small molecular drug D0W7JZ DRUGINCH 1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28) D0W7JZ DRUGINKE SPMVMDHWKHCIDT-UHFFFAOYSA-N D0W7JZ DRUGSMIL CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl D0W7JZ HIGHSTAT Approved D0W7OE DRUG__ID D0W7OE D0W7OE THERCLAS Antiarrhythmic Agents D0W7OE DRUGTYPE Small molecular drug D0W7OE DRUGINCH 1S/C22H30N2/c1-3-23(4-2)15-10-16-24(21-13-6-5-7-14-21)22-17-19-11-8-9-12-20(19)18-22/h5-9,11-14,22H,3-4,10,15-18H2,1-2H3 D0W7OE DRUGINKE NZLBHDRPUJLHCE-UHFFFAOYSA-N D0W7OE DRUGSMIL CCN(CC)CCCN(C1CC2=CC=CC=C2C1)C3=CC=CC=C3 D0W7OE HIGHSTAT Approved D0W7WC DRUG__ID D0W7WC D0W7WC DRUGCOMP Vertex D0W7WC DRUGTYPE Small molecular drug D0W7WC DRUGINCH 1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29) D0W7WC DRUGINKE PURKAOJPTOLRMP-UHFFFAOYSA-N D0W7WC DRUGSMIL CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C D0W7WC HIGHSTAT Approved D0W8BO DRUG__ID D0W8BO D0W8BO TRADNAME Zilbrysq D0W8BO DRUGCOMP UCB D0W8BO DRUGINCH 1S/C172H278N24O55/c1-9-10-11-12-13-14-15-16-17-18-19-20-27-44-146(202)182-136(170(226)227)53-56-144(200)177-64-67-229-69-71-231-73-75-233-77-79-235-81-83-237-85-87-239-89-91-241-93-95-243-97-99-245-101-103-247-105-107-249-109-111-251-113-112-250-110-108-248-106-104-246-102-100-244-98-96-242-94-92-240-90-88-238-86-84-236-82-80-234-78-76-232-74-72-230-70-68-228-66-59-145(201)175-60-31-29-41-135(169(224)225)186-165(220)152(126-37-25-22-26-38-126)193-162(217)142-43-34-65-196(142)168(223)140(116-125-47-51-129(199)52-48-125)190-157(212)133(54-57-148(204)205)184-161(216)139(117-127-120-180-154-130(127)39-32-62-178-154)188-159(214)138(115-124-45-49-128(198)50-46-124)189-166(221)153(172(5,6)7)194-163(218)143(119-150(208)209)195(8)167(222)141-118-147(203)176-61-30-28-40-131(181-122(4)197)158(213)192-151(121(2)3)164(219)185-134(55-58-149(206)207)156(211)183-132(42-33-63-179-171(173)174)155(210)187-137(160(215)191-141)114-123-35-23-21-24-36-123/h21,23-24,32,35-36,39,45-52,62,120-121,126,131-143,151-153,198-199H,9-20,22,25-31,33-34,37-38,40-44,53-61,63-119H2,1-8H3,(H,175,201)(H,176,203)(H,177,200)(H,178,180)(H,181,197)(H,182,202)(H,183,211)(H,184,216)(H,185,219)(H,186,220)(H,187,210)(H,188,214)(H,189,221)(H,190,212)(H,191,215)(H,192,213)(H,193,217)(H,194,218)(H,204,205)(H,206,207)(H,208,209)(H,224,225)(H,226,227)(H4,173,174,179)/t131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,151-,152-,153+/m0/s1 D0W8BO DRUGINKE JDXCOXKBIGBZSK-PSNKNOTQSA-N D0W8BO DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)C(C1CCCCC1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CNC5=C4C=CC=N5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC(=O)O)N(C)C(=O)C7CC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O D0W8BO HIGHSTAT Approved D0W8SB DRUG__ID D0W8SB D0W8SB THERCLAS Antihypertensive Agents D0W8SB DRUGTYPE Small molecular drug D0W8SB DRUGINCH 1S/C18H29NO2/c1-18(2,3)19-12-15(20)13-21-17-11-7-6-10-16(17)14-8-4-5-9-14/h6-7,10-11,14-15,19-20H,4-5,8-9,12-13H2,1-3H3/t15-/m0/s1 D0W8SB DRUGINKE KQXKVJAGOJTNJS-HNNXBMFYSA-N D0W8SB DRUGSMIL CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O D0W8SB HIGHSTAT Approved D0W8SJ DRUG__ID D0W8SJ D0W8SJ THERCLAS Antidepressants D0W8SJ DRUGTYPE Small molecular drug D0W8SJ DRUGINCH 1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20) D0W8SJ DRUGINKE LDMWSLGGVTVJPG-UHFFFAOYSA-N D0W8SJ DRUGSMIL CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3 D0W8SJ HIGHSTAT Approved D0W9GA DRUG__ID D0W9GA D0W9GA DRUGCOMP Novo Nordisk A/S; Central Drug Research Institute D0W9GA DRUGTYPE Small molecular drug D0W9GA DRUGINCH 1S/C30H35NO3/c1-30(2)29(23-9-5-4-6-10-23)28(26-16-15-25(32-3)21-27(26)34-30)22-11-13-24(14-12-22)33-20-19-31-17-7-8-18-31/h4-6,9-16,21,28-29H,7-8,17-20H2,1-3H3/t28-,29+/m1/s1 D0W9GA DRUGINKE XZEUAXYWNKYKPL-WDYNHAJCSA-N D0W9GA DRUGSMIL CC1(C(C(C2=C(O1)C=C(C=C2)OC)C3=CC=C(C=C3)OCCN4CCCC4)C5=CC=CC=C5)C D0W9GA HIGHSTAT Approved D0WF7L DRUG__ID D0WF7L D0WF7L DRUGCOMP AstraZeneca D0WF7L DRUGTYPE Small molecular drug D0WF7L DRUGINCH 1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1 D0WF7L DRUGINKE OEKWJQXRCDYSHL-FNOIDJSQSA-N D0WF7L DRUGSMIL CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F D0WF7L HIGHSTAT Approved D0WH4P DRUG__ID D0WH4P D0WH4P TRADNAME Idhifa D0WH4P DRUGCOMP Celgene/Agios D0WH4P DRUGINCH 1S/C19H17F6N7O.CH4O3S/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25;1-5(2,3)4/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32);1H3,(H,2,3,4) D0WH4P DRUGINKE ORZHZQZYWXEDDL-UHFFFAOYSA-N D0WH4P DRUGSMIL CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O.CS(=O)(=O)O D0WH4P HIGHSTAT Approved D0WY5Q DRUG__ID D0WY5Q D0WY5Q DRUGCOMP Samyang Corp D0WY5Q DRUGTYPE Small molecular drug D0WY5Q DRUGINCH 1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1 D0WY5Q DRUGINKE XSVMFMHYUFZWBK-NSHDSACASA-N D0WY5Q DRUGSMIL CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C D0WY5Q HIGHSTAT Approved D0X0GI DRUG__ID D0X0GI D0X0GI DRUGCOMP Mallinckrodt Inc D0X0GI DRUGTYPE Small molecular drug D0X0GI DRUGINCH 1S/C20H37N5O10.Gd/c1-34-9-3-21-16(26)11-24(14-19(30)31)7-5-23(13-18(28)29)6-8-25(15-20(32)33)12-17(27)22-4-10-35-2;/h3-15H2,1-2H3,(H,21,26)(H,22,27)(H,28,29)(H,30,31)(H,32,33);/q;+3/p-3 D0X0GI DRUGINKE HBEAOBRDTOXWRZ-UHFFFAOYSA-K D0X0GI DRUGSMIL COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3] D0X0GI HIGHSTAT Approved D0X0WU DRUG__ID D0X0WU D0X0WU DRUGCOMP Sanochemia Pharmazeutika AG D0X0WU DRUGTYPE Small molecular drug D0X0WU DRUGINCH 1S/C16H23NO/c1-13-6-8-15(9-7-13)16(18)14(2)12-17-10-4-3-5-11-17/h6-9,14H,3-5,10-12H2,1-2H3 D0X0WU DRUGINKE FSKFPVLPFLJRQB-UHFFFAOYSA-N D0X0WU DRUGSMIL CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2 D0X0WU HIGHSTAT Approved D0X1HE DRUG__ID D0X1HE D0X1HE TRADNAME Xepi D0X1HE DRUGCOMP Ferrer Internacional D0X1HE DRUGINCH 1S/C21H21N3O3/c1-11-8-13(9-23-20(11)22-3)15-6-7-16-18(12(15)2)24(14-4-5-14)10-17(19(16)25)21(26)27/h6-10,14H,4-5H2,1-3H3,(H,22,23)(H,26,27) D0X1HE DRUGINKE XPIJWUTXQAGSLK-UHFFFAOYSA-N D0X1HE DRUGSMIL CC1=CC(=CN=C1NC)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)C D0X1HE HIGHSTAT Approved D0X1WJ DRUG__ID D0X1WJ D0X1WJ THERCLAS Antibiotics D0X1WJ DRUGTYPE Small molecular drug D0X1WJ DRUGINCH 1S/C42H69NO15/c1-23(2)19-32(47)56-40-27(6)53-34(22-42(40,8)50)57-37-26(5)54-41(36(49)35(37)43(9)10)58-38-29(17-18-44)20-24(3)30(46)16-14-12-13-15-25(4)52-33(48)21-31(39(38)51-11)55-28(7)45/h12-14,16,18,23-27,29-31,34-41,46,49-50H,15,17,19-22H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27+,29+,30+,31-,34+,35-,36-,37-,38+,39+,40+,41+,42-/m1/s1 D0X1WJ DRUGINKE XJSFLOJWULLJQS-NGVXBBESSA-N D0X1WJ DRUGSMIL CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)OC(=O)C)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O D0X1WJ HIGHSTAT Approved D0X2FT DRUG__ID D0X2FT D0X2FT DRUGCOMP Bayer D0X2FT DRUGTYPE Small molecular drug D0X2FT DRUGINCH 1S/C23H33N3O11.Gd.2Na/c1-2-37-18-5-3-16(4-6-18)9-17(26(14-22(33)34)15-23(35)36)10-24(11-19(27)28)7-8-25(12-20(29)30)13-21(31)32;;;/h3-6,17H,2,7-15H2,1H3,(H,27,28)(H,29,30)(H,31,32)(H,33,34)(H,35,36);;;/q;+3;2*+1/p-5 D0X2FT DRUGINKE SLYTULCOCGSBBJ-UHFFFAOYSA-I D0X2FT DRUGSMIL CCOC1=CC=C(C=C1)CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Gd+3] D0X2FT HIGHSTAT Approved D0X2MB DRUG__ID D0X2MB D0X2MB THERCLAS Antihypertensive Agents D0X2MB DRUGTYPE Small molecular drug D0X2MB DRUGINCH 1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3 D0X2MB DRUGINKE CEMAWMOMDPGJMB-UHFFFAOYSA-N D0X2MB DRUGSMIL CC(C)NCC(COC1=CC=CC=C1OCC=C)O D0X2MB HIGHSTAT Approved D0X2UE DRUG__ID D0X2UE D0X2UE DRUGCOMP Schering D0X2UE DRUGTYPE Small molecular drug D0X2UE DRUGINCH 1S/C23H31NO7S/c1-32(29,30)24-23(28)12-8-3-2-7-11-19-20(22(27)15-21(19)26)14-13-17(25)16-31-18-9-5-4-6-10-18/h2,4-7,9-10,13-14,17,19-20,22,25,27H,3,8,11-12,15-16H2,1H3,(H,24,28)/b7-2-,14-13+/t17-,19-,20-,22-/m1/s1 D0X2UE DRUGINKE UQZVCDCIMBLVNR-TWYODKAFSA-N D0X2UE DRUGSMIL CS(=O)(=O)NC(=O)CCCC=CCC1C(C(CC1=O)O)C=CC(COC2=CC=CC=C2)O D0X2UE HIGHSTAT Approved D0X4CS DRUG__ID D0X4CS D0X4CS DRUGCOMP Samjin Pharma Co D0X4CS DRUGTYPE Small molecular drug D0X4CS DRUGINCH 1S/C16H19N3O5S/c1-24-9-7-25-15-11(14(21)19(15)12(9)16(22)23)18-13(20)10(17)8-5-3-2-4-6-8/h2-3,6,10-11,15H,4-5,7,17H2,1H3,(H,18,20)(H,22,23)/t10-,11-,15-/m1/s1 D0X4CS DRUGINKE RDMOROXKXONCAL-UEKVPHQBSA-N D0X4CS DRUGSMIL COC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O D0X4CS HIGHSTAT Approved D0X4JN DRUG__ID D0X4JN D0X4JN DRUGCOMP Sankyo Co Ltd D0X4JN DRUGTYPE Small molecular drug D0X4JN DRUGINCH 1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+ D0X4JN DRUGINKE AUZUGWXLBGZUPP-GXDHUFHOSA-N D0X4JN DRUGSMIL CC(C1=CC=C(C=C1)C=C2CCCCC2=O)C(=O)O D0X4JN HIGHSTAT Approved D0X4ZR DRUG__ID D0X4ZR D0X4ZR DRUGCOMP GlaxoSmithKline plc D0X4ZR DRUGTYPE Small molecular drug D0X4ZR DRUGINCH 1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 D0X4ZR DRUGINKE SNPPWIUOZRMYNY-UHFFFAOYSA-N D0X4ZR DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D0X4ZR HIGHSTAT Approved D0X5NX DRUG__ID D0X5NX D0X5NX THERCLAS Bronchodilator Agents D0X5NX DRUGTYPE Small molecular drug D0X5NX DRUGINCH 1S/C12H18Cl2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3 D0X5NX DRUGINKE STJMRWALKKWQGH-UHFFFAOYSA-N D0X5NX DRUGSMIL CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O D0X5NX HIGHSTAT Approved D0X5SI DRUG__ID D0X5SI D0X5SI DRUGCOMP Sopar Pharma SA D0X5SI DRUGTYPE Small molecular drug D0X5SI DRUGINCH 1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 D0X5SI DRUGINKE GBFLZEXEOZUWRN-VKHMYHEASA-N D0X5SI DRUGSMIL C(C(C(=O)O)N)SCC(=O)O D0X5SI HIGHSTAT Approved D0X5SJ DRUG__ID D0X5SJ D0X5SJ DRUGCOMP Dainippon D0X5SJ DRUGTYPE Small molecular drug D0X5SJ DRUGINCH 1S/C20H26N2O5S/c1-13(12-28-14(2)23)19(25)22-10-6-9-17(22)18(24)21-16(20(26)27)11-15-7-4-3-5-8-15/h3-5,7-8,13,16-17H,6,9-12H2,1-2H3,(H,21,24)(H,26,27)/t13-,16+,17+/m1/s1 D0X5SJ DRUGINKE FHHHOYXPRDYHEZ-COXVUDFISA-N D0X5SJ DRUGSMIL CC(CSC(=O)C)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O D0X5SJ HIGHSTAT Approved D0X5UN DRUG__ID D0X5UN D0X5UN DRUGCOMP Astellas D0X5UN DRUGTYPE Small molecular drug D0X5UN DRUGINCH 1S/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)/t19-/m0/s1 D0X5UN DRUGINKE PBAPPPCECJKMCM-IBGZPJMESA-N D0X5UN DRUGSMIL C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O D0X5UN HIGHSTAT Approved D0X5XU DRUG__ID D0X5XU D0X5XU THERCLAS Anticancer Agents D0X5XU DRUGTYPE Small molecular drug D0X5XU DRUGINCH 1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1 D0X5XU DRUGINKE XAUDJQYHKZQPEU-KVQBGUIXSA-N D0X5XU DRUGSMIL C1C(C(OC1N2C=NC(=NC2=O)N)CO)O D0X5XU HIGHSTAT Approved D0X5ZI DRUG__ID D0X5ZI D0X5ZI DRUGCOMP GSK D0X5ZI DRUGTYPE Small molecular drug D0X5ZI DRUGINCH 1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1 D0X5ZI DRUGINKE OUJTZYPIHDYQMC-LJQANCHMSA-N D0X5ZI DRUGSMIL CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C D0X5ZI HIGHSTAT Approved D0X6BV DRUG__ID D0X6BV D0X6BV DRUGCOMP Genaissance and Merck KGaA D0X6BV DRUGTYPE Small molecular drug D0X6BV DRUGINCH 1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32) D0X6BV DRUGINKE SGEGOXDYSFKCPT-UHFFFAOYSA-N D0X6BV DRUGSMIL C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N D0X6BV HIGHSTAT Approved D0X6HD DRUG__ID D0X6HD D0X6HD THERCLAS Analgesics D0X6HD DRUGTYPE Small molecular drug D0X6HD DRUGINCH 1S/C22H28N2O2/c1-2-26-21(25)22(19-6-4-3-5-7-19)13-16-24(17-14-22)15-12-18-8-10-20(23)11-9-18/h3-11H,2,12-17,23H2,1H3 D0X6HD DRUGINKE LKYQLAWMNBFNJT-UHFFFAOYSA-N D0X6HD DRUGSMIL CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3 D0X6HD HIGHSTAT Approved D0X6OW DRUG__ID D0X6OW D0X6OW DRUGCOMP Meiji Seika D0X6OW DRUGTYPE Small molecular drug D0X6OW DRUGINCH 1S/C16H21N7O7S3.Na/c1-22-15(19-20-21-22)33-4-7-3-32-14-16(30-2,13(29)23(14)10(7)12(27)28)18-9(24)6-31-5-8(17)11(25)26;/h8,14H,3-6,17H2,1-2H3,(H,18,24)(H,25,26)(H,27,28);/q;+1/p-1/t8-,14-,16+;/m1./s1 D0X6OW DRUGINKE SBIDXLKJYJVQOE-YNJMIPHHSA-M D0X6OW DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)CSCC(C(=O)O)N)OC)SC2)C(=O)[O-].[Na+] D0X6OW HIGHSTAT Approved D0X7KZ DRUG__ID D0X7KZ D0X7KZ DRUGCOMP Servier D0X7KZ DRUGTYPE Small molecular drug D0X7KZ DRUGINCH 1S/C12H10N2O8S.2Sr/c13-2-6-5(1-7(15)16)10(12(21)22)23-11(6)14(3-8(17)18)4-9(19)20;;/h1,3-4H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22);;/q;2*+2/p-4 D0X7KZ DRUGINKE XXUZFRDUEGQHOV-UHFFFAOYSA-J D0X7KZ DRUGSMIL C(C1=C(SC(=C1C#N)N(CC(=O)[O-])CC(=O)[O-])C(=O)[O-])C(=O)[O-].[Sr+2].[Sr+2] D0X7KZ HIGHSTAT Approved D0X7NU DRUG__ID D0X7NU D0X7NU DRUGCOMP Baxter Healthcare Corp Anesthesia And Critical Care D0X7NU DRUGTYPE Small molecular drug D0X7NU DRUGINCH 1S/C7H8N2O.ClH/c1-9-5-3-2-4-7(9)6-8-10;/h2-6H,1H3;1H D0X7NU DRUGINKE HIGSLXSBYYMVKI-UHFFFAOYSA-N D0X7NU DRUGSMIL C[N+]1=CC=CC=C1C=NO.[Cl-] D0X7NU HIGHSTAT Approved D0X7ZL DRUG__ID D0X7ZL D0X7ZL DRUGCOMP A H Robins Co Ltd D0X7ZL DRUGTYPE Small molecular drug D0X7ZL DRUGINCH 1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1 D0X7ZL DRUGINKE ABBQHOQBGMUPJH-UHFFFAOYSA-M D0X7ZL DRUGSMIL C1=CC=C(C(=C1)C(=O)[O-])O.[Na+] D0X7ZL HIGHSTAT Approved D0X9PF DRUG__ID D0X9PF D0X9PF DRUGCOMP Palatin Technol D0X9PF DRUGTYPE Small molecular drug D0X9PF DRUGINCH 1S/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41-/m0/s1 D0X9PF DRUGINKE FFHBJDQSGDNCIV-MFVUMRCOSA-N D0X9PF DRUGSMIL CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C D0X9PF HIGHSTAT Approved D0XB8P DRUG__ID D0XB8P D0XB8P DRUGCOMP Rare Disease Therapeutics Inc D0XB8P DRUGTYPE Small molecular drug D0XB8P DRUGINCH 1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3 D0XB8P DRUGINKE KWIUHFFTVRNATP-UHFFFAOYSA-N D0XB8P DRUGSMIL C[N+](C)(C)CC(=O)[O-] D0XB8P HIGHSTAT Approved D0XE1C DRUG__ID D0XE1C D0XE1C DRUGCOMP CV Therapeutics D0XE1C DRUGTYPE Small molecular drug D0XE1C DRUGINCH 1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1 D0XE1C DRUGINKE LZPZPHGJDAGEJZ-AKAIJSEGSA-N D0XE1C DRUGSMIL CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D0XE1C HIGHSTAT Approved D0XF8W DRUG__ID D0XF8W D0XF8W THERCLAS Antitubercular Agents D0XF8W DRUGTYPE Small molecular drug D0XF8W DRUGINCH 1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9) D0XF8W DRUGINKE IPEHBUMCGVEMRF-UHFFFAOYSA-N D0XF8W DRUGSMIL C1=CN=C(C=N1)C(=O)N D0XF8W HIGHSTAT Approved D0XM1A DRUG__ID D0XM1A D0XM1A TRADNAME Xadago D0XM1A DRUGCOMP US WorldMeds D0XM1A DRUGINCH 1S/C17H19FN2O2.CH4O3S/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14;1-5(2,3)4/h2-9,12,20H,10-11H2,1H3,(H2,19,21);1H3,(H,2,3,4)/t12-;/m0./s1 D0XM1A DRUGINKE YKOCHIUQOBQIAC-YDALLXLXSA-N D0XM1A DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O D0XM1A HIGHSTAT Approved D0XN8C DRUG__ID D0XN8C D0XN8C DRUGCOMP Instituto Biochemico Italiano D0XN8C DRUGTYPE Small molecular drug D0XN8C DRUGINCH 1S/C18H34O3/c1-2-3-4-7-10-15-13-14-17(19)16(15)11-8-5-6-9-12-18(20)21/h15-17,19H,2-14H2,1H3,(H,20,21)/t15-,16+,17?/m0/s1 D0XN8C DRUGINKE NMAOJFAMEOVURT-RTKIROINSA-N D0XN8C DRUGSMIL CCCCCCC1CCC(C1CCCCCCC(=O)O)O D0XN8C HIGHSTAT Approved D0XQ2X DRUG__ID D0XQ2X D0XQ2X DRUGCOMP Hospira Inc D0XQ2X DRUGTYPE Small molecular drug D0XQ2X DRUGINCH 1S/Ca.2ClH.2H2O/h;2*1H;2*1H2/q+2;;;;/p-2 D0XQ2X DRUGINKE LLSDKQJKOVVTOJ-UHFFFAOYSA-L D0XQ2X DRUGSMIL O.O.[Cl-].[Cl-].[Ca+2] D0XQ2X HIGHSTAT Approved D0XX6Y DRUG__ID D0XX6Y D0XX6Y THERCLAS Analgesics D0XX6Y DRUGTYPE Small molecular drug D0XX6Y DRUGINCH 1S/C35H62N4O4/c1-24(40)42-32-21-26-9-10-27-28(35(26,4)23-31(32)37-15-19-39(7,8)20-16-37)11-12-34(3)29(27)22-30(33(34)43-25(2)41)36-13-17-38(5,6)18-14-36/h26-33H,9-23H2,1-8H3/q+2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-/m0/s1 D0XX6Y DRUGINKE OWWLUIWOFHMHOQ-XGHATYIMSA-N D0XX6Y DRUGSMIL CC(=O)OC1CC2CCC3C(C2(CC1N4CC[N+](CC4)(C)C)C)CCC5(C3CC(C5OC(=O)C)N6CC[N+](CC6)(C)C)C D0XX6Y HIGHSTAT Approved D0Y0GH DRUG__ID D0Y0GH D0Y0GH THERCLAS Anticancer Agents D0Y0GH DRUGTYPE Small molecular drug D0Y0GH DRUGINCH 1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1 D0Y0GH DRUGINKE NWIBSHFKIJFRCO-WUDYKRTCSA-N D0Y0GH DRUGSMIL CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N D0Y0GH HIGHSTAT Approved D0Y0JH DRUG__ID D0Y0JH D0Y0JH THERCLAS Antiinflammatory Agents D0Y0JH DRUGTYPE Small molecular drug D0Y0JH DRUGINCH 1S/C14H10O5/c15-11-7-3-1-5-9(11)14(18)19-12-8-4-2-6-10(12)13(16)17/h1-8,15H,(H,16,17) D0Y0JH DRUGINKE WVYADZUPLLSGPU-UHFFFAOYSA-N D0Y0JH DRUGSMIL C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O D0Y0JH HIGHSTAT Approved D0Y1KF DRUG__ID D0Y1KF D0Y1KF DRUGCOMP Takeda D0Y1KF DRUGTYPE Small molecular drug D0Y1KF DRUGINCH 1S/3Fe.2H2O.2O/h;;;2*1H2;;/q;2*+1;;;;/p-2 D0Y1KF DRUGINKE UCNNJGDEJXIUCC-UHFFFAOYSA-L D0Y1KF DRUGSMIL O[Fe]=O.O[Fe]=O.[Fe] D0Y1KF HIGHSTAT Approved D0Y2SW DRUG__ID D0Y2SW D0Y2SW TRADNAME Ninlaro D0Y2SW DRUGCOMP Takeda Oncology Deerfield, IL D0Y2SW DRUGINCH 1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1 D0Y2SW DRUGINKE MXAYKZJJDUDWDS-LBPRGKRZSA-N D0Y2SW DRUGSMIL B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O D0Y2SW HIGHSTAT Approved D0Y3TM DRUG__ID D0Y3TM D0Y3TM THERCLAS Iron Supplement D0Y3TM DRUGTYPE Small molecular drug D0Y3TM DRUGINCH 1S/Fe D0Y3TM DRUGINKE XEEYBQQBJWHFJM-UHFFFAOYSA-N D0Y3TM DRUGSMIL [Fe] D0Y3TM HIGHSTAT Approved D0Y4JJ DRUG__ID D0Y4JJ D0Y4JJ THERCLAS Antiarrhythmic Agents D0Y4JJ DRUGTYPE Small molecular drug D0Y4JJ DRUGINCH 1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3 D0Y4JJ DRUGINKE UIEATEWHFDRYRU-UHFFFAOYSA-N D0Y4JJ DRUGSMIL CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3 D0Y4JJ HIGHSTAT Approved D0Y4QG DRUG__ID D0Y4QG D0Y4QG DRUGCOMP Johnson & Johnson D0Y4QG DRUGTYPE Small molecular drug D0Y4QG DRUGINCH 1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1 D0Y4QG DRUGINKE QUIJNHUBAXPXFS-XLJNKUFUSA-N D0Y4QG DRUGSMIL CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O D0Y4QG HIGHSTAT Approved D0Y4SI DRUG__ID D0Y4SI D0Y4SI DRUGCOMP Actelion Pharmaceuticals South San Francisco, CA D0Y4SI DRUGTYPE Small molecular drug D0Y4SI DRUGINCH 1S/C23H25ClN2O4S/c1-3-10-25-23-26(19-7-5-4-6-15(19)2)22(29)21(31-23)12-16-8-9-20(18(24)11-16)30-14-17(28)13-27/h4-9,11-12,17,27-28H,3,10,13-14H2,1-2H3/b21-12-,25-23?/t17-/m1/s1 D0Y4SI DRUGINKE LPAUOXUZGSBGDU-ULCCENQXSA-N D0Y4SI DRUGSMIL CCCN=C1N(C(=O)C(=CC2=CC(=C(C=C2)OCC(CO)O)Cl)S1)C3=CC=CC=C3C D0Y4SI HIGHSTAT Approved D0Y5GK DRUG__ID D0Y5GK D0Y5GK THERCLAS Antihistamines D0Y5GK DRUGTYPE Small molecular drug D0Y5GK DRUGINCH 1S/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3 D0Y5GK DRUGINKE NUNIWXHYABYXKF-UHFFFAOYSA-N D0Y5GK DRUGSMIL CN(C)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)Br D0Y5GK HIGHSTAT Approved D0Y5JC DRUG__ID D0Y5JC D0Y5JC DRUGCOMP Vivus D0Y5JC DRUGTYPE Small molecular drug D0Y5JC DRUGINCH 1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 D0Y5JC DRUGINKE WEAJZXNPAWBCOA-INIZCTEOSA-N D0Y5JC DRUGSMIL COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl D0Y5JC HIGHSTAT Approved D0Y5RZ DRUG__ID D0Y5RZ D0Y5RZ DRUGCOMP Sankyo D0Y5RZ DRUGTYPE Small molecular drug D0Y5RZ DRUGINCH 1S/C21H25BrN2O3.C4H4O4/c1-3-20-8-4-9-23-10-7-15-14-6-5-13(22)11-16(14)24(17(15)18(20)23)21(26,12-20)19(25)27-2;5-3(6)1-2-4(7)8/h5-6,11,18,26H,3-4,7-10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t18-,20+,21+;/m1./s1 D0Y5RZ DRUGINKE CKCVTPQYFOMHFD-HPJCWFBOSA-N D0Y5RZ DRUGSMIL CCC12CCCN3C1C4=C(CC3)C5=C(N4C(C2)(C(=O)OC)O)C=C(C=C5)Br.C(=CC(=O)O)C(=O)O D0Y5RZ HIGHSTAT Approved D0Y5ZA DRUG__ID D0Y5ZA D0Y5ZA DRUGCOMP Artecef BV D0Y5ZA DRUGTYPE Small molecular drug D0Y5ZA DRUGINCH 1S/C17H28O5/c1-5-18-14-11(3)13-7-6-10(2)12-8-9-16(4)20-15(19-14)17(12,13)22-21-16/h10-15H,5-9H2,1-4H3/t10-,11-,12+,13+,14+,15-,16-,17-/m1/s1 D0Y5ZA DRUGINKE NLYNIRQVMRLPIQ-XQLAAWPRSA-N D0Y5ZA DRUGSMIL CCOC1C(C2CCC(C3C24C(O1)OC(CC3)(OO4)C)C)C D0Y5ZA HIGHSTAT Approved D0Y6CE DRUG__ID D0Y6CE D0Y6CE THERCLAS Anesthetics D0Y6CE DRUGTYPE Small molecular drug D0Y6CE DRUGINCH 1S/C40H48N2O6.2HI/c1-41(2)17-15-27-22-34(44-6)36-24-30(27)31(41)19-25-9-12-29(13-10-25)47-40-38-28(23-37(45-7)39(40)46-8)16-18-42(3,4)32(38)20-26-11-14-33(43-5)35(21-26)48-36;;/h9-14,21-24,31-32H,15-20H2,1-8H3;2*1H/q+2;;/p-2/t31-,32+;;/m0../s1 D0Y6CE DRUGINKE DIGFQJFCDPKEPF-OIUSMDOTSA-L D0Y6CE DRUGSMIL C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.[I-].[I-] D0Y6CE HIGHSTAT Approved D0Y7EM DRUG__ID D0Y7EM D0Y7EM DRUGCOMP Takeda Pharmaceutical Co Ltd D0Y7EM DRUGTYPE Small molecular drug D0Y7EM DRUGINCH 1S/C14H12O2/c15-14(16)10-11-6-8-13(9-7-11)12-4-2-1-3-5-12/h1-9H,10H2,(H,15,16) D0Y7EM DRUGINKE QRZAKQDHEVVFRX-UHFFFAOYSA-N D0Y7EM DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O D0Y7EM HIGHSTAT Approved D0Y7JU DRUG__ID D0Y7JU D0Y7JU DRUGCOMP GSK D0Y7JU DRUGTYPE Small molecular drug D0Y7JU DRUGINCH 1S/C27H29F3O6S/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3/t14-,16+,17+,19+,21+,24+,25+,26+,27+/m1/s1 D0Y7JU DRUGINKE XTULMSXFIHGYFS-VLSRWLAYSA-N D0Y7JU DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F D0Y7JU HIGHSTAT Approved D0Y7PG DRUG__ID D0Y7PG D0Y7PG THERCLAS Antiparkinson Agents D0Y7PG DRUGTYPE Small molecular drug D0Y7PG DRUGINCH 1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3 D0Y7PG DRUGINKE MIQPIUSUKVNLNT-UHFFFAOYSA-N D0Y7PG DRUGSMIL CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-] D0Y7PG HIGHSTAT Approved D0Y8PT DRUG__ID D0Y8PT D0Y8PT DRUGCOMP Taiho Pharmaceutical Co Ltd D0Y8PT DRUGTYPE Small molecular drug D0Y8PT DRUGINCH 1S/C8H9FN2O3.C4H4N2O2/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12;7-3-1-2-5-4(8)6-3/h4,6H,1-3H2,(H,10,12,13);1-2H,(H2,5,6,7,8) D0Y8PT DRUGINKE DHMYGZIEILLVNR-UHFFFAOYSA-N D0Y8PT DRUGSMIL C1CC(OC1)N2C=C(C(=O)NC2=O)F.C1=CNC(=O)NC1=O D0Y8PT HIGHSTAT Approved D0Y9EW DRUG__ID D0Y9EW D0Y9EW DRUGCOMP Daiichi Sankyo group; Genentech D0Y9EW DRUGTYPE Small molecular drug D0Y9EW DRUGINCH 1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28) D0Y9EW DRUGINKE GPXBXXGIAQBQNI-UHFFFAOYSA-N D0Y9EW DRUGSMIL CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F D0Y9EW HIGHSTAT Approved D0Y9GM DRUG__ID D0Y9GM D0Y9GM DRUGCOMP Dipexium Pharmaceuticals D0Y9GM DRUGTYPE Small molecular drug D0Y9GM DRUGINCH 1S/C122H210N32O22/c1-13-77(9)102(152-98(155)71-132)120(174)135-73-100(157)139-86(50-26-35-59-125)110(164)150-96(69-82-44-20-16-21-45-82)118(172)148-93(66-74(3)4)116(170)145-90(54-30-39-63-129)113(167)142-87(51-27-36-60-126)109(163)137-79(11)105(159)141-88(52-28-37-61-127)112(166)143-91(55-31-40-64-130)114(168)149-95(68-81-42-18-15-19-43-81)107(161)134-72-99(156)138-85(49-25-34-58-124)108(162)136-80(12)106(160)147-97(70-83-46-22-17-23-47-83)119(173)153-101(76(7)8)121(175)146-92(56-32-41-65-131)115(169)154-103(78(10)14-2)122(176)151-94(67-75(5)6)117(171)144-89(53-29-38-62-128)111(165)140-84(104(133)158)48-24-33-57-123/h15-23,42-47,74-80,84-97,101-103H,13-14,24-41,48-73,123-132H2,1-12H3,(H2,133,158)(H,134,161)(H,135,174)(H,136,162)(H,137,163)(H,138,156)(H,139,157)(H,140,165)(H,141,159)(H,142,167)(H,143,166)(H,144,171)(H,145,170)(H,146,175)(H,147,160)(H,148,172)(H,149,168)(H,150,164)(H,151,176)(H,152,155)(H,153,173)(H,154,169)/t77-,78-,79-,80-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,101-,102-,103-/m0/s1 D0Y9GM DRUGINKE KGZGFSNZWHMDGZ-KAYYGGFYSA-N D0Y9GM DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)CN D0Y9GM HIGHSTAT Approved D0YH0N DRUG__ID D0YH0N D0YH0N DRUGCOMP Alcobra D0YH0N DRUGTYPE Small molecular drug D0YH0N DRUGINCH 1S/C8H11NO3.C5H7NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5;7-4-2-1-3(6-4)5(8)9/h2,10-12H,3-4H2,1H3;3H,1-2H2,(H,6,7)(H,8,9)/t;3-/m.0/s1 D0YH0N DRUGINKE RYKKQQUKJJGFMN-HVDRVSQOSA-N D0YH0N DRUGSMIL CC1=NC=C(C(=C1O)CO)CO.C1CC(=O)NC1C(=O)O D0YH0N HIGHSTAT Approved D0YQ0V DRUG__ID D0YQ0V D0YQ0V DRUGCOMP Hoechst AG and Roussel Uclaf D0YQ0V DRUGTYPE Small molecular drug D0YQ0V DRUGINCH 1S/C22H22N6O5S2.H2O4S/c1-33-26-15(13-10-35-22(23)24-13)18(29)25-16-19(30)28-17(21(31)32)12(9-34-20(16)28)8-27-7-3-5-11-4-2-6-14(11)27;1-5(2,3)4/h3,5,7,10,16,20H,2,4,6,8-9H2,1H3,(H3-,23,24,25,29,31,32);(H2,1,2,3,4)/b26-15-;/t16-,20-;/m1./s1 D0YQ0V DRUGINKE RKTNPKZEPLCLSF-QHBKFCFHSA-N D0YQ0V DRUGSMIL CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-].OS(=O)(=O)O D0YQ0V HIGHSTAT Approved D0YQ5L DRUG__ID D0YQ5L D0YQ5L DRUGCOMP Imp Inc D0YQ5L DRUGTYPE Small molecular drug D0YQ5L DRUGINCH 1S/C12H18IN.ClH/c1-9(2)14-10(3)8-11-4-6-12(13)7-5-11;/h4-7,9-10,14H,8H2,1-3H3;1H/i13-4; D0YQ5L DRUGINKE AFLDFEASYWNJGX-FOHXBPHZSA-N D0YQ5L DRUGSMIL CC(C)NC(C)CC1=CC=C(C=C1)I.Cl D0YQ5L HIGHSTAT Approved D0Z0DW DRUG__ID D0Z0DW D0Z0DW THERCLAS Vitamins D0Z0DW DRUGTYPE Small molecular drug D0Z0DW DRUGINCH 1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1 D0Z0DW DRUGINKE OVBPIULPVIDEAO-LBPRGKRZSA-N D0Z0DW DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N D0Z0DW HIGHSTAT Approved D0Z0MG DRUG__ID D0Z0MG D0Z0MG DRUGCOMP Orphan Europe D0Z0MG DRUGTYPE Small molecular drug D0Z0MG DRUGINCH 1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1 D0Z0MG DRUGINKE LCQLHJZYVOQKHU-VKHMYHEASA-N D0Z0MG DRUGSMIL C(CC(=O)O)C(C(=O)O)NC(=O)N D0Z0MG HIGHSTAT Approved D0Z1WA DRUG__ID D0Z1WA D0Z1WA THERCLAS Bronchodilator Agents D0Z1WA DRUGTYPE Small molecular drug D0Z1WA DRUGINCH 1S/C16H22N2O3/c1-4-12(17-9(2)3)16(21)11-5-7-13(19)15-10(11)6-8-14(20)18-15/h5-9,12,16-17,19,21H,4H2,1-3H3,(H,18,20) D0Z1WA DRUGINKE FKNXQNWAXFXVNW-UHFFFAOYSA-N D0Z1WA DRUGSMIL CCC(C(C1=C2C=CC(=O)NC2=C(C=C1)O)O)NC(C)C D0Z1WA HIGHSTAT Approved D0Z1XD DRUG__ID D0Z1XD D0Z1XD DRUGCOMP Valeant Pharmaceuticals D0Z1XD DRUGTYPE Small molecular drug D0Z1XD DRUGINCH 1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h12,15-17,22H,4-11H2,1-3H3/t15-,16+,17+,18+,19+,20+/m1/s1 D0Z1XD DRUGINKE GCKMFJBGXUYNAG-HLXURNFRSA-N D0Z1XD DRUGSMIL CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C D0Z1XD HIGHSTAT Approved D0Z3DY DRUG__ID D0Z3DY D0Z3DY DRUGCOMP Labaz Laboratories D0Z3DY DRUGTYPE Small molecular drug D0Z3DY DRUGINCH 1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3 D0Z3DY DRUGINKE WHQCHUCQKNIQEC-UHFFFAOYSA-N D0Z3DY DRUGSMIL CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br D0Z3DY HIGHSTAT Approved D0Z4BV DRUG__ID D0Z4BV D0Z4BV DRUGCOMP ISF Societa Per Azioni D0Z4BV DRUGTYPE Small molecular drug D0Z4BV DRUGINCH 1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10) D0Z4BV DRUGINKE IHLAQQPQKRMGSS-UHFFFAOYSA-N D0Z4BV DRUGSMIL C1C(CN(C1=O)CC(=O)N)O D0Z4BV HIGHSTAT Approved D0Z4EI DRUG__ID D0Z4EI D0Z4EI DRUGCOMP HRA Pharma D0Z4EI DRUGTYPE Small molecular drug D0Z4EI DRUGINCH 1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1 D0Z4EI DRUGINKE VKHAHZOOUSRJNA-GCNJZUOMSA-N D0Z4EI DRUGSMIL CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O D0Z4EI HIGHSTAT Approved D0Z4NI DRUG__ID D0Z4NI D0Z4NI DRUGCOMP Teva Pharmaceuticals Usa Inc D0Z4NI DRUGTYPE Small molecular drug D0Z4NI DRUGINCH 1S/2C2H4O2.Zn/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2 D0Z4NI DRUGINKE DJWUNCQRNNEAKC-UHFFFAOYSA-L D0Z4NI DRUGSMIL CC(=O)[O-].CC(=O)[O-].[Zn+2] D0Z4NI HIGHSTAT Approved D0Z4UY DRUG__ID D0Z4UY D0Z4UY DRUGCOMP Hospira Inc D0Z4UY DRUGTYPE Small molecular drug D0Z4UY DRUGINCH 1S/C2H4O2.Na/c1-2(3)4;/h1H3,(H,3,4);/q;+1/p-1 D0Z4UY DRUGINKE VMHLLURERBWHNL-UHFFFAOYSA-M D0Z4UY DRUGSMIL CC(=O)[O-].[Na+] D0Z4UY HIGHSTAT Approved D0Z4XW DRUG__ID D0Z4XW D0Z4XW DRUGCOMP GSK D0Z4XW DRUGTYPE Small molecular drug D0Z4XW DRUGINCH 1S/C23H23N3O5.ClH/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20;/h5-8,27,30H,4,9-11H2,1-3H3;1H/t23-;/m0./s1 D0Z4XW DRUGINKE DGHHQBMTXTWTJV-BQAIUKQQSA-N D0Z4XW DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O.Cl D0Z4XW HIGHSTAT Approved D0Z4ZT DRUG__ID D0Z4ZT D0Z4ZT THERCLAS Contraceptive Agents D0Z4ZT DRUGTYPE Small molecular drug D0Z4ZT DRUGINCH 1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1 D0Z4ZT DRUGINKE METQSPRSQINEEU-HXCATZOESA-N D0Z4ZT DRUGSMIL CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C D0Z4ZT HIGHSTAT Approved D0Z5SM DRUG__ID D0Z5SM D0Z5SM THERCLAS Sclerosing Agents D0Z5SM DRUGTYPE Small molecular drug D0Z5SM DRUGINCH 1S/C14H30O4S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17;/h2-14H2,1H3,(H,15,16,17);/q;+1/p-1 D0Z5SM DRUGINKE UPUIQOIQVMNQAP-UHFFFAOYSA-M D0Z5SM DRUGSMIL CCCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+] D0Z5SM HIGHSTAT Approved D0Z6ST DRUG__ID D0Z6ST D0Z6ST DRUGCOMP Laboratoire L Lafon SA D0Z6ST DRUGTYPE Small molecular drug D0Z6ST DRUGINCH 1S/C17H25NO4/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18/h11-12H,4-10H2,1-3H3 D0Z6ST DRUGINKE OWYLAEYXIQKAOL-UHFFFAOYSA-N D0Z6ST DRUGSMIL COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC D0Z6ST HIGHSTAT Approved D0Z7ZM DRUG__ID D0Z7ZM D0Z7ZM DRUGCOMP Pfizer D0Z7ZM DRUGTYPE Small molecular drug D0Z7ZM DRUGINCH 1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29) D0Z7ZM DRUGINKE BNRNXUUZRGQAQC-UHFFFAOYSA-N D0Z7ZM DRUGSMIL CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C D0Z7ZM HIGHSTAT Approved D0Z8AE DRUG__ID D0Z8AE D0Z8AE DRUGCOMP Hospira Inc D0Z8AE DRUGTYPE Small molecular drug D0Z8AE DRUGINCH 1S/3ClH.Cr/h3*1H;/q;;;+3/p-3 D0Z8AE DRUGINKE QSWDMMVNRMROPK-UHFFFAOYSA-K D0Z8AE DRUGSMIL Cl[Cr](Cl)Cl D0Z8AE HIGHSTAT Approved D0Z9NZ DRUG__ID D0Z9NZ D0Z9NZ THERCLAS Hypnotics and Sedatives D0Z9NZ DRUGTYPE Small molecular drug D0Z9NZ DRUGINCH 1S/C13H15NO2/c1-2-13(10-6-4-3-5-7-10)9-8-11(15)14-12(13)16/h3-7H,2,8-9H2,1H3,(H,14,15,16) D0Z9NZ DRUGINKE JMBQKKAJIKAWKF-UHFFFAOYSA-N D0Z9NZ DRUGSMIL CCC1(CCC(=O)NC1=O)C2=CC=CC=C2 D0Z9NZ HIGHSTAT Approved D0Z9VB DRUG__ID D0Z9VB D0Z9VB THERCLAS Antianxiety Agents D0Z9VB DRUGTYPE Small molecular drug D0Z9VB DRUGINCH 1S/C17H12ClF3N2O/c18-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)22-9-15(24)23(14)10-17(19,20)21/h1-8H,9-10H2 D0Z9VB DRUGINKE WYCLKVQLVUQKNZ-UHFFFAOYSA-N D0Z9VB DRUGSMIL C1C(=O)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3)CC(F)(F)F D0Z9VB HIGHSTAT Approved D0ZI4H DRUG__ID D0ZI4H D0ZI4H DRUGCOMP Ono D0ZI4H DRUGTYPE Small molecular drug D0ZI4H DRUGINCH 1S/C23H38O6/c1-4-5-8-16(2)13-18(25)11-12-19-20(22(27)15-21(19)26)14-17(24)9-6-7-10-23(28)29-3/h11-12,16,18-21,25-26H,4-10,13-15H2,1-3H3/b12-11+/t16-,18+,19+,20+,21+/m0/s1 D0ZI4H DRUGINKE BBRBUTFBTUFFBU-LHACABTQSA-N D0ZI4H DRUGSMIL CCCCC(C)CC(C=CC1C(CC(=O)C1CC(=O)CCCCC(=O)OC)O)O D0ZI4H HIGHSTAT Approved D0ZJ1C DRUG__ID D0ZJ1C D0ZJ1C THERCLAS Antiinflammatory Agents D0ZJ1C DRUGTYPE Small molecular drug D0ZJ1C DRUGINCH 1S/C20H24N2.C4H4O4/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20;5-3(6)1-2-4(7)8/h4-10,12,15H,11,13-14H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t15-;/m1./s1 D0ZJ1C DRUGINKE SWECWXGUJQLXJF-HFNHQGOYSA-N D0ZJ1C DRUGSMIL CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C.C(=CC(=O)O)C(=O)O D0ZJ1C HIGHSTAT Approved D0ZK8H DRUG__ID D0ZK8H D0ZK8H DRUGCOMP UniQuest Pty Ltd D0ZK8H DRUGTYPE Small molecular drug D0ZK8H DRUGINCH 1S/C6H12O2/c1-4-5(2)8-6(3)7/h5H,4H2,1-3H3 D0ZK8H DRUGINKE DCKVNWZUADLDEH-UHFFFAOYSA-N D0ZK8H DRUGSMIL CCC(C)OC(=O)C D0ZK8H HIGHSTAT Approved D0ZX2G DRUG__ID D0ZX2G D0ZX2G THERCLAS Antiinfective Agents D0ZX2G DRUGTYPE Small molecular drug D0ZX2G DRUGINCH 1S/C13H6Cl6O2/c14-6-2-8(16)12(20)4(10(6)18)1-5-11(19)7(15)3-9(17)13(5)21/h2-3,20-21H,1H2 D0ZX2G DRUGINKE ACGUYXCXAPNIKK-UHFFFAOYSA-N D0ZX2G DRUGSMIL C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl D0ZX2G HIGHSTAT Approved D40IXR DRUG__ID D40IXR D40IXR DRUGCOMP Avadel Pharmaceuticals Dublin, Ireland D40IXR DRUGTYPE Small molecule D40IXR DRUGINCH InChI=1S/C4H8O3.Na/c5-3-1-2-4(6)7;/h5H,1-3H2,(H,6,7);/q;+1/p-1 D40IXR DRUGINKE XYGBKMMCQDZQOZ-UHFFFAOYSA-M D40IXR DRUGSMIL C(CC(=O)[O-])CO.[Na+] D40IXR HIGHSTAT Approved D4LOR2 DRUG__ID D4LOR2 D4LOR2 DRUGCOMP Meiji Seika Pharma D4LOR2 DRUGTYPE Small molecular drug D4LOR2 DRUGINCH 1S/C22H31N3O6S2/c1-11-15-14(12(2)26)18(27)25(15)16(19(28)30-10-31-20(29)22(3,4)5)17(11)33-13-8-24(9-13)21-23-6-7-32-21/h11-15,26H,6-10H2,1-5H3/t11-,12-,14-,15-/m1/s1 D4LOR2 DRUGINKE SNUDIPVBUUXCDG-QHSBEEBCSA-N D4LOR2 DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O D4LOR2 HIGHSTAT Approved D7S9LP DRUG__ID D7S9LP D7S9LP DRUGCOMP Novo Nordisk D7S9LP DRUGTYPE Peptide D7S9LP DRUGINCH 1S/C54H95N13O20S2/c55-39(52(76)77)37-88-38-50(74)57-25-15-14-17-40(51(56)75)60-48(72)35-86-32-30-85-29-27-59-45(69)23-21-41(53(78)79)61-46(70)24-22-42(54(80)81)62-49(73)36-87-33-31-84-28-26-58-44(68)20-16-34-89(82,83)65-47(71)19-13-11-9-7-5-3-1-2-4-6-8-10-12-18-43-63-66-67-64-43/h39-42H,1-38,55H2,(H2,56,75)(H,57,74)(H,58,68)(H,59,69)(H,60,72)(H,61,70)(H,62,73)(H,65,71)(H,76,77)(H,78,79)(H,80,81)(H,63,64,66,67)/t39-,40-,41-,42-/m0/s1 D7S9LP DRUGINKE VTUYEWRWJTWXPQ-IWWWZYECSA-N D7S9LP DRUGSMIL C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)NC(CCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NC(CCCCNC(=O)CSCC(C(=O)O)N)C(=O)N)C(=O)O)C(=O)O D7S9LP HIGHSTAT Approved D8LAE2 DRUG__ID D8LAE2 D8LAE2 DRUGCOMP Gilead D8LAE2 DRUGTYPE Antibody drug conjugate D8LAE2 DRUGINCH InChI=1S/C76H104N12O24S/c1-3-55-56-37-54(89)16-17-61(56)83-68-57(55)43-87-63(68)38-59-58(71(87)95)45-110-74(99)76(59,4-2)112-75(100)111-44-50-10-14-52(15-11-50)81-70(94)62(7-5-6-18-77)82-66(91)47-109-46-65(90)79-19-21-101-23-25-103-27-29-105-31-33-107-35-36-108-34-32-106-30-28-104-26-24-102-22-20-86-42-53(84-85-86)40-80-69(93)51-12-8-49(9-13-51)41-88-67(92)39-64(72(88)96)113-48-60(78)73(97)98/h10-11,14-17,37-38,42,49,51,60,62,64,89H,3-9,12-13,18-36,39-41,43-48,77-78H2,1-2H3,(H,79,90)(H,80,93)(H,81,94)(H,82,91)(H,97,98)/t49?,51?,60-,62-,64?,76-/m0/s1 D8LAE2 DRUGINKE ULRUOUDIQPERIJ-PQURJYPBSA-N D8LAE2 DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)OC(=O)OCC5=CC=C(C=C5)NC(=O)C(CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN6C=C(N=N6)CNC(=O)C7CCC(CC7)CN8C(=O)CC(C8=O)SCC(C(=O)O)N)C2=NC9=C1C=C(C=C9)O D8LAE2 HIGHSTAT Approved DE5N3K DRUG__ID DE5N3K DE5N3K DRUGCOMP Zealand Pharma DE5N3K DRUGTYPE Peptide DE5N3K DRUGINCH 1S/C152H222N38O50/c1-73(2)55-99(133(222)171-98(47-51-116(206)207)132(221)183-111(71-194)144(233)189-122(80(11)197)149(238)239)174-137(226)105(61-85-65-161-91-32-21-20-31-89(85)91)178-129(218)93(34-23-25-53-154)172-146(235)119(75(5)6)187-139(228)103(57-81-27-16-14-17-28-81)176-131(220)97(46-50-115(204)205)170-130(219)96(45-49-114(202)203)167-123(212)76(7)164-127(216)94(35-26-54-160-151(157)158)166-124(213)77(8)165-150(240)152(12,13)190-145(234)107(64-118(210)211)180-134(223)100(56-74(3)4)173-135(224)101(59-83-36-40-87(198)41-37-83)175-128(217)92(33-22-24-52-153)168-142(231)109(69-192)184-136(225)102(60-84-38-42-88(199)43-39-84)177-138(227)106(63-117(208)209)179-143(232)110(70-193)185-148(237)121(79(10)196)188-140(229)104(58-82-29-18-15-19-30-82)181-147(236)120(78(9)195)186-113(201)67-162-126(215)95(44-48-112(156)200)169-141(230)108(68-191)182-125(214)90(155)62-86-66-159-72-163-86/h14-21,27-32,36-43,65-66,72-80,90,92-111,119-122,161,191-199H,22-26,33-35,44-64,67-71,153-155H2,1-13H3,(H2,156,200)(H,159,163)(H,162,215)(H,164,216)(H,165,240)(H,166,213)(H,167,212)(H,168,231)(H,169,230)(H,170,219)(H,171,222)(H,172,235)(H,173,224)(H,174,226)(H,175,217)(H,176,220)(H,177,227)(H,178,218)(H,179,232)(H,180,223)(H,181,236)(H,182,214)(H,183,221)(H,184,225)(H,185,237)(H,186,201)(H,187,228)(H,188,229)(H,189,233)(H,190,234)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H,238,239)(H4,157,158,160)/t76-,77-,78+,79+,80+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,119-,120-,121-,122-/m0/s1 DE5N3K DRUGINKE RZRMFQMNPDPAIX-AJTOSFMRSA-N DE5N3K DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N DE5N3K HIGHSTAT Approved DF36DY DRUG__ID DF36DY DF36DY DRUGCOMP Alnylam Pharmaceuticals DF36DY DRUGTYPE Small interfering RNA DF36DY DRUGINCH 1S/C78H139N11O30/c1-50-42-54(96)43-89(50)65(104)26-12-10-8-6-5-7-9-11-25-64(103)88-78(47-111-39-27-61(100)82-33-19-30-79-58(97)22-13-16-36-114-75-66(85-51(2)93)72(108)69(105)55(44-90)117-75,48-112-40-28-62(101)83-34-20-31-80-59(98)23-14-17-37-115-76-67(86-52(3)94)73(109)70(106)56(45-91)118-76)49-113-41-29-63(102)84-35-21-32-81-60(99)24-15-18-38-116-77-68(87-53(4)95)74(110)71(107)57(46-92)119-77/h50,54-57,66-77,90-92,96,105-110H,5-49H2,1-4H3,(H,79,97)(H,80,98)(H,81,99)(H,82,100)(H,83,101)(H,84,102)(H,85,93)(H,86,94)(H,87,95)(H,88,103)/t50-,54-,55-,56-,57-,66-,67-,68-,69+,70+,71+,72-,73-,74-,75-,76-,77-/m1/s1 DF36DY DRUGINKE RUPXJRIDSUCQAN-PQNNUJSWSA-N DF36DY DRUGSMIL CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O DF36DY HIGHSTAT Approved DQ1S0B DRUG__ID DQ1S0B DQ1S0B DRUGCOMP BioCryst Pharmaceuticals DQ1S0B DRUGTYPE Small molecular drug DQ1S0B DRUGINCH 1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)/t28-/m1/s1 DQ1S0B DRUGINKE UXNXMBYCBRBRFD-MUUNZHRXSA-N DQ1S0B DRUGSMIL C1CC1CNC(C2=CC(=C(C=C2)F)NC(=O)C3=CC(=NN3C4=CC=CC(=C4)CN)C(F)(F)F)C5=CC=CC(=C5)C#N DQ1S0B HIGHSTAT Approved DUS06I DRUG__ID DUS06I DUS06I DRUGCOMP Astelllas DUS06I DRUGTYPE Small molecule DUS06I DRUGINCH InChI=1S/C16H15FN6OS/c1-9-13-19-20-14(15-18-10(2)21-25-15)23(13)8-7-22(9)16(24)11-3-5-12(17)6-4-11/h3-6,9H,7-8H2,1-2H3/t9-/m1/s1 DUS06I DRUGINKE PPSNFPASKFYPMN-SECBINFHSA-N DUS06I DRUGSMIL CC1C2=NN=C(N2CCN1C(=O)C3=CC=C(C=C3)F)C4=NC(=NS4)C DUS06I HIGHSTAT Approved D00BDC DRUG__ID D00BDC D00BDC DRUGTYPE Small molecular drug D00BDC DRUGINCH 1S/C19H20F3N3O3/c20-19(21,22)14-3-1-4-15(13-14)24-17-16(5-2-6-23-17)18(26)28-12-9-25-7-10-27-11-8-25/h1-6,13H,7-12H2,(H,23,24) D00BDC DRUGINKE LDXSPUSKBDTEKA-UHFFFAOYSA-N D00BDC DRUGSMIL C1COCCN1CCOC(=O)C2=C(N=CC=C2)NC3=CC=CC(=C3)C(F)(F)F D00BDC HIGHSTAT Approved D00DPJ DRUG__ID D00DPJ D00DPJ DRUGTYPE Small molecular drug D00DPJ DRUGINCH 1S/C11H11N3O/c1-15-11-7-9(12)8-13-14(11)10-5-3-2-4-6-10/h2-8,12H,1H3/p+1 D00DPJ DRUGINKE VXROHTDSRBRJLN-UHFFFAOYSA-O D00DPJ DRUGSMIL COC1=[N+](N=CC(=C1)N)C2=CC=CC=C2 D00DPJ HIGHSTAT Approved D00DZN DRUG__ID D00DZN D00DZN DRUGTYPE Small molecular drug D00DZN DRUGINCH 1S/C10H12ClNO/c11-7-6-10(13)12-8-9-4-2-1-3-5-9/h1-5H,6-8H2,(H,12,13) D00DZN DRUGINKE JPYQFYIEOUVJDU-UHFFFAOYSA-N D00DZN DRUGSMIL C1=CC=C(C=C1)CNC(=O)CCCl D00DZN HIGHSTAT Approved D00HPD DRUG__ID D00HPD D00HPD TRADNAME Lumoxiti D00HPD DRUGCOMP AstraZeneca D00HPD THERCLAS Anticancer Agents D00HPD DRUGTYPE Monoclonal antibody D00HPD HIGHSTAT Approved D00KFB DRUG__ID D00KFB D00KFB DRUGCOMP Reckitt Benckiser Llc D00KFB DRUGINCH 1S/C18H25NO.BrH/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H/t15-,17+,18+;/m1./s1 D00KFB DRUGINKE MISZALMBODQYFT-URVXVIKDSA-N D00KFB DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.Br D00KFB HIGHSTAT Approved D00KRT DRUG__ID D00KRT D00KRT DRUGTYPE Small molecular drug D00KRT DRUGINCH 1S/C43H48N2O6S2.Na/c1-42(2)38(44(28-14-16-30-52(46,47)48)36-26-24-32-18-10-12-20-34(32)40(36)42)22-8-6-5-7-9-23-39-43(3,4)41-35-21-13-11-19-33(35)25-27-37(41)45(39)29-15-17-31-53(49,50)51;/h5-13,18-27H,14-17,28-31H2,1-4H3,(H-,46,47,48,49,50,51);/q;+1/p-1 D00KRT DRUGINKE MOFVSTNWEDAEEK-UHFFFAOYSA-M D00KRT DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+] D00KRT HIGHSTAT Approved D00NJL DRUG__ID D00NJL D00NJL DRUGTYPE Small molecular drug D00NJL DRUGINCH 1S/C21H26Cl2O/c1-20(2,3)13-21(4,5)16-7-9-19(24)15(11-16)10-14-6-8-17(22)12-18(14)23/h6-9,11-12,24H,10,13H2,1-5H3 D00NJL DRUGINKE HQVZOORKDNCGCK-UHFFFAOYSA-N D00NJL DRUGSMIL CC(C)(C)CC(C)(C)C1=CC(=C(C=C1)O)CC2=C(C=C(C=C2)Cl)Cl D00NJL HIGHSTAT Approved D00NPT DRUG__ID D00NPT D00NPT DRUGTYPE Small molecular drug D00NPT DRUGINCH 1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18) D00NPT DRUGINKE VMMKGHQPQIEGSQ-UHFFFAOYSA-N D00NPT DRUGSMIL C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O D00NPT HIGHSTAT Approved D00OVU DRUG__ID D00OVU D00OVU DRUGTYPE Small molecular drug D00OVU DRUGINCH 1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1 D00OVU DRUGINKE JYTNQNCOQXFQPK-MRXNPFEDSA-N D00OVU DRUGSMIL CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl D00OVU HIGHSTAT Approved D00PRI DRUG__ID D00PRI D00PRI DRUGTYPE Small molecular drug D00PRI DRUGINCH 1S/C10H16N2O8.Ca.2Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;;/q;+2;2*+1/p-4 D00PRI DRUGINKE SHWNNYZBHZIQQV-UHFFFAOYSA-J D00PRI DRUGSMIL C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Ca+2] D00PRI HIGHSTAT Approved D00SHQ DRUG__ID D00SHQ D00SHQ DRUGTYPE Small molecular drug D00SHQ DRUGINCH 1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 D00SHQ DRUGINKE RKLNONIVDFXQRX-UHFFFAOYSA-N D00SHQ DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Br)O)CCCC(=O)C3=CC=C(C=C3)F D00SHQ HIGHSTAT Approved D00STJ DRUG__ID D00STJ D00STJ DRUGTYPE Small molecular drug D00STJ DRUGINCH 1S/C31H55N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(36)32-26-22-23-34(31(39)33-26)30-29(38)28(37)25(24-35)40-30/h22-23,25,28-30,35,37-38H,2-21,24H2,1H3,(H,32,33,36,39)/t25-,28-,29+,30-/m1/s1 D00STJ DRUGINKE SAMRUMKYXPVKPA-VFKOLLTISA-N D00STJ DRUGSMIL CCCCCCCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O D00STJ HIGHSTAT Approved D00SVU DRUG__ID D00SVU D00SVU DRUGTYPE Small molecular drug D00SVU DRUGINCH 1S/C17H20ClN3O3/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23) D00SVU DRUGINKE WUKZPHOXUVCQOR-UHFFFAOYSA-N D00SVU DRUGSMIL CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4 D00SVU HIGHSTAT Approved D00UJF DRUG__ID D00UJF D00UJF DRUGTYPE Small molecular drug D00UJF DRUGINCH 1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h1,5-18,20-30H,2-4H2 D00UJF DRUGINKE FZWBNHMXJMCXLU-UHFFFAOYSA-N D00UJF DRUGSMIL C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O D00UJF HIGHSTAT Approved D00VUL DRUG__ID D00VUL D00VUL DRUGTYPE Small molecular drug D00VUL DRUGINCH 1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14) D00VUL DRUGINKE QPFYXYFORQJZEC-UHFFFAOYSA-N D00VUL DRUGSMIL C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N D00VUL HIGHSTAT Approved D00VZZ DRUG__ID D00VZZ D00VZZ DRUGTYPE Small molecular drug D00VZZ DRUGINCH 1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1 D00VZZ DRUGINKE AURFZBICLPNKBZ-SYBPFIFISA-N D00VZZ DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D00VZZ HIGHSTAT approved D00YZA DRUG__ID D00YZA D00YZA DRUGTYPE Small molecular drug D00YZA DRUGINCH 1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2 D00YZA DRUGINKE FOCVUCIESVLUNU-UHFFFAOYSA-N D00YZA DRUGSMIL C1CN1P(=S)(N2CC2)N3CC3 D00YZA HIGHSTAT Approved D00ZOF DRUG__ID D00ZOF D00ZOF DRUGTYPE Small molecular drug D00ZOF DRUGINCH 1S/C3H6O3.Na/c1-2(4)3(5)6;/h2,4H,1H3,(H,5,6);/q;+1/p-1 D00ZOF DRUGINKE NGSFWBMYFKHRBD-UHFFFAOYSA-M D00ZOF DRUGSMIL CC(C(=O)[O-])O.[Na+] D00ZOF HIGHSTAT Approved D00ZTD DRUG__ID D00ZTD D00ZTD DRUGTYPE Small molecular drug D00ZTD DRUGINCH 1S/C22H36N2O4/c1-20(2,23)13-24-19(25)12-14-3-5-21(6-4-14)26-22(28-27-21)17-8-15-7-16(10-17)11-18(22)9-15/h14-18H,3-13,23H2,1-2H3,(H,24,25) D00ZTD DRUGINKE VXYZBLXGCYNIHP-UHFFFAOYSA-N D00ZTD DRUGSMIL CC(C)(CNC(=O)CC1CCC2(CC1)OC3(C4CC5CC(C4)CC3C5)OO2)N D00ZTD HIGHSTAT Approved D01BQK DRUG__ID D01BQK D01BQK DRUGTYPE Small molecular drug D01BQK DRUGINCH 1S/CH4N2O.H2O2/c2-1(3)4;1-2/h(H4,2,3,4);1-2H D01BQK DRUGINKE AQLJVWUFPCUVLO-UHFFFAOYSA-N D01BQK DRUGSMIL C(=O)(N)N.OO D01BQK HIGHSTAT Approved D01CKY DRUG__ID D01CKY D01CKY DRUGTYPE Small molecular drug D01CKY DRUGINCH 1S/C20H28O5S.Na/c1-12(2)14-10-13-6-7-17-19(3,8-5-9-20(17,4)18(21)22)15(13)11-16(14)26(23,24)25;/h10-12,17H,5-9H2,1-4H3,(H,21,22)(H,23,24,25);/q;+1/p-1/t17-,19-,20-;/m1./s1 D01CKY DRUGINKE RCVIHORGZULVTN-YGJXXQMASA-M D01CKY DRUGSMIL CC(C)C1=C(C=C2C(=C1)CCC3C2(CCCC3(C)C(=O)O)C)S(=O)(=O)[O-].[Na+] D01CKY HIGHSTAT Approved D01FFA DRUG__ID D01FFA D01FFA DRUGTYPE Small molecular drug D01FFA DRUGINCH 1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s1 D01FFA DRUGINKE AEQDJSLRWYMAQI-KRWDZBQOSA-N D01FFA DRUGSMIL COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC D01FFA HIGHSTAT Approved D01FJT DRUG__ID D01FJT D01FJT DRUGTYPE Small molecular drug D01FJT DRUGINCH 1S/C7H13NO3S2/c1-7(2,13)6(11)8-4(3-12)5(9)10/h4,12-13H,3H2,1-2H3,(H,8,11)(H,9,10)/t4-/m0/s1 D01FJT DRUGINKE VUAFHZCUKUDDBC-BYPYZUCNSA-N D01FJT DRUGSMIL CC(C)(C(=O)NC(CS)C(=O)O)S D01FJT HIGHSTAT Approved D01GYK DRUG__ID D01GYK D01GYK DRUGTYPE Small molecular drug D01GYK DRUGINCH 1S/C4H6O4S2/c5-3(6)1(9)2(10)4(7)8/h1-2,9-10H,(H,5,6)(H,7,8)/t1-,2+ D01GYK DRUGINKE ACTRVOBWPAIOHC-XIXRPRMCSA-N D01GYK DRUGSMIL C(C(C(=O)O)S)(C(=O)O)S D01GYK HIGHSTAT Approved D01HNL DRUG__ID D01HNL D01HNL DRUGTYPE Small molecular drug D01HNL DRUGINCH 1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11) D01HNL DRUGINKE POJWUDADGALRAB-UHFFFAOYSA-N D01HNL DRUGSMIL C1(C(=O)NC(=O)N1)NC(=O)N D01HNL HIGHSTAT Approved D01JGV DRUG__ID D01JGV D01JGV DRUGTYPE Small molecular drug D01JGV DRUGINCH 1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16+,19-/m0/s1 D01JGV DRUGINKE GRTOGORTSDXSFK-XJTZBENFSA-N D01JGV DRUGSMIL CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 D01JGV HIGHSTAT Approved D01JQJ DRUG__ID D01JQJ D01JQJ DRUGTYPE Small molecular drug D01JQJ DRUGINCH 1S/C6H11IO3/c1-4(7)6-9-3-5(2-8)10-6/h4-6,8H,2-3H2,1H3 D01JQJ DRUGINKE LTINPJMVDKPJJI-UHFFFAOYSA-N D01JQJ DRUGSMIL CC(C1OCC(O1)CO)I D01JQJ HIGHSTAT Approved D01KOA DRUG__ID D01KOA D01KOA DRUGCOMP Loxo Oncology Stamford, CT D01KOA DRUGINCH 1S/C29H34N8O3/c1-19-9-34-37-17-23(40-18-24-11-30-5-6-39-24)8-25(29(19)37)26-12-32-27(13-31-26)35-15-21-7-22(16-35)36(21)14-20-3-4-28(38-2)33-10-20/h3-4,8-10,12-13,17,21-22,24,30H,5-7,11,14-16,18H2,1-2H3/t21?,22?,24-/m0/s1 D01KOA DRUGINKE MFOVQWYFURMVKU-IWAAJCSBSA-N D01KOA DRUGSMIL CC1=C2C(=CC(=CN2N=C1)OCC3CNCCO3)C4=CN=C(C=N4)N5CC6CC(C5)N6CC7=CN=C(C=C7)OC D01KOA HIGHSTAT Approved D01QLH DRUG__ID D01QLH D01QLH DRUGTYPE Small molecular drug D01QLH DRUGINCH 1S/C5H11NO2/c1-2-3-4-5-8-6-7/h2-5H2,1H3 D01QLH DRUGINKE CSDTZUBPSYWZDX-UHFFFAOYSA-N D01QLH DRUGSMIL CCCCCON=O D01QLH HIGHSTAT Approved D01SGK DRUG__ID D01SGK D01SGK DRUGCOMP Portela & Ca SA D01SGK DRUGINCH 1S/C15H10Cl2N4O6/c1-5-10(13(17)20(24)6(2)11(5)16)14-18-15(27-19-14)7-3-8(21(25)26)12(23)9(22)4-7/h3-4,22-23H,1-2H3 D01SGK DRUGINKE ASOADIZOVZTJSR-UHFFFAOYSA-N D01SGK DRUGSMIL CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-] D01SGK HIGHSTAT Approved D01TQR DRUG__ID D01TQR D01TQR DRUGTYPE Small molecular drug D01TQR DRUGINCH 1S/C33H60O10/c1-2-3-4-5-6-7-8-9-32-10-12-33(13-11-32)43-31-30-42-29-28-41-27-26-40-25-24-39-23-22-38-21-20-37-19-18-36-17-16-35-15-14-34/h10-13,34H,2-9,14-31H2,1H3 D01TQR DRUGINKE FBWNMEQMRUMQSO-UHFFFAOYSA-N D01TQR DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCO D01TQR HIGHSTAT Approved D01UFN DRUG__ID D01UFN D01UFN DRUGTYPE Small molecular drug D01UFN DRUGINCH 1S/C27H38F6O3/c1-16(6-4-13-25(36,26(28,29)30)27(31,32)33)21-10-11-22-18(7-5-12-24(21,22)3)8-9-19-14-20(34)15-23(35)17(19)2/h8-9,16,20-23,34-36H,2,4-7,10-15H2,1,3H3/b18-8+,19-9-/t16-,20-,21-,22+,23+,24-/m1/s1 D01UFN DRUGINKE XPYGGHVSFMUHLH-UUSULHAXSA-N D01UFN DRUGSMIL CC(CCCC(C(F)(F)F)(C(F)(F)F)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D01UFN HIGHSTAT Approved D01XOD DRUG__ID D01XOD D01XOD DRUGTYPE Small molecular drug D01XOD DRUGINCH 1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3 D01XOD DRUGINKE JRTIDHTUMYMPRU-UHFFFAOYSA-N D01XOD DRUGSMIL CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl D01XOD HIGHSTAT Approved D01XRP DRUG__ID D01XRP D01XRP DRUGTYPE Small molecular drug D01XRP DRUGINCH 1S/C6H18O2Si2.O2Si/c1-7-10(5,6)8-9(2,3)4;1-3-2/h1-6H3; D01XRP DRUGINKE AMTWCFIAVKBGOD-UHFFFAOYSA-N D01XRP DRUGSMIL CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O D01XRP HIGHSTAT Approved D02ARR DRUG__ID D02ARR D02ARR DRUGTYPE Small molecular drug D02ARR DRUGINCH 1S/C24H34O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-14,16-18,22H,4-12H2,1-3H3,(H,28,29)/t13-,14+,16-,17+,18+,22+,23+,24-/m1/s1 D02ARR DRUGINKE OHXPGWPVLFPUSM-KLRNGDHRSA-N D02ARR DRUGSMIL CC(CCC(=O)O)C1CCC2C1(C(=O)CC3C2C(=O)CC4C3(CCC(=O)C4)C)C D02ARR HIGHSTAT Approved D02AUI DRUG__ID D02AUI D02AUI DRUGCOMP Bracco Diagnostics Inc D02AUI DRUGINCH 1S/C15H19BrN2O5.Tc/c1-8-4-9(2)15(10(3)14(8)16)17-11(19)5-18(6-12(20)21)7-13(22)23;/h4H,5-7H2,1-3H3,(H,17,19)(H,20,21)(H,22,23);/i;1+1 D02AUI DRUGINKE JLJSYHOPCNWUNE-IEOVAKBOSA-N D02AUI DRUGSMIL CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C.[Tc] D02AUI HIGHSTAT Approved D02AYL DRUG__ID D02AYL D02AYL DRUGTYPE Small molecular drug D02AYL DRUGINCH 1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1 D02AYL DRUGINKE ZLHZLMOSPGACSZ-NSHDSACASA-N D02AYL DRUGSMIL C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F D02AYL HIGHSTAT Approved D02CII DRUG__ID D02CII D02CII TRADNAME Tymlos D02CII DRUGCOMP Radius Health D02CII DRUGTYPE Recombinant protein D02CII DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(C)N D02CII HIGHSTAT Approved D02CNR DRUG__ID D02CNR D02CNR DRUGTYPE Small molecular drug D02CNR DRUGINCH 1S/C23H30O5/c1-14(24)28-13-20(26)23(27)11-8-19-17-5-4-15-12-16(25)6-9-21(15,2)18(17)7-10-22(19,23)3/h7,12,17,19,27H,4-6,8-11,13H2,1-3H3/t17-,19+,21+,22+,23+/m1/s1 D02CNR DRUGINKE YUWPMEXLKGOSBF-GACAOOTBSA-N D02CNR DRUGSMIL CC(=O)OCC(=O)C1(CCC2C1(CC=C3C2CCC4=CC(=O)CCC43C)C)O D02CNR HIGHSTAT Approved D02CYR DRUG__ID D02CYR D02CYR DRUGTYPE Small molecular drug D02CYR DRUGINCH 1S/Cr.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+3;/p-3/i;5+1 D02CYR DRUGINKE IKZBVTPSNGOVRJ-ZYUMTRPDSA-K D02CYR DRUGSMIL [O-]P(=O)([O-])[O-].[Cr+3] D02CYR HIGHSTAT Approved D02DJS DRUG__ID D02DJS D02DJS DRUGCOMP Bracco Diagnostics Inc D02DJS DRUGINCH 1S/C26H26I6N2O10.2C7H17NO5/c27-13-11-15(29)23(21(31)19(13)25(37)38)33-17(35)1-3-41-5-7-43-9-10-44-8-6-42-4-2-18(36)34-24-16(30)12-14(28)20(22(24)32)26(39)40;2*1-8-2-4(10)6(12)7(13)5(11)3-9/h11-12H,1-10H2,(H,33,35)(H,34,36)(H,37,38)(H,39,40);2*4-13H,2-3H2,1H3/t;2*4-,5+,6+,7+/m.00/s1 D02DJS DRUGINKE LNBGFESBSAEKAE-VRWDCWMNSA-N D02DJS DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O.C1=C(C(=C(C(=C1I)NC(=O)CCOCCOCCOCCOCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I D02DJS HIGHSTAT Approved D02DPU DRUG__ID D02DPU D02DPU DRUGTYPE Small molecular drug D02DPU DRUGINCH 1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3 D02DPU DRUGINKE ZXNRTKGTQJPIJK-UHFFFAOYSA-N D02DPU DRUGSMIL COC1=CC=C(C=C1)C(=O)N2CCCC2=O D02DPU HIGHSTAT Approved D02EHV DRUG__ID D02EHV D02EHV DRUGTYPE Small molecular drug D02EHV DRUGINCH 1S/C257H383N65O77S6/c1-29-131(23)205(313-193(339)104-259)252(393)317-204(130(21)22)248(389)288-159(75-82-200(349)350)217(358)282-156(71-78-189(263)335)221(362)308-183-116-403-404-117-184-243(384)305-178(111-324)240(381)294-162(88-123(7)8)225(366)295-168(95-140-53-61-146(329)62-54-140)228(369)283-154(69-76-187(261)333)218(359)290-161(87-122(5)6)223(364)285-158(74-81-199(347)348)220(361)302-174(101-190(264)336)235(376)298-170(97-142-57-65-148(331)66-58-142)231(372)309-182(242(383)304-176(255(396)397)103-192(266)338)115-402-401-114-181(214(355)273-107-194(340)278-153(72-79-197(343)344)216(357)281-151(51-42-84-271-257(267)268)212(353)272-108-195(341)279-166(93-138-46-36-32-37-47-138)227(368)297-167(94-139-48-38-33-39-49-139)230(371)299-171(98-143-59-67-149(332)68-60-143)238(379)320-208(135(27)327)254(395)322-85-43-52-186(322)246(387)286-152(50-40-41-83-258)222(363)321-209(136(28)328)256(398)399)311-250(391)203(129(19)20)316-236(377)164(90-125(11)12)292-229(370)169(96-141-55-63-147(330)64-56-141)296-224(365)160(86-121(3)4)289-210(351)133(25)277-215(356)157(73-80-198(345)346)287-247(388)202(128(17)18)315-237(378)165(91-126(13)14)293-233(374)173(100-145-106-270-120-276-145)301-239(380)177(110-323)280-196(342)109-274-213(354)180(113-400-405-118-185(310-244(183)385)245(386)319-207(134(26)326)253(394)306-179(112-325)241(382)318-206(132(24)30-2)251(392)312-184)307-226(367)163(89-124(9)10)291-232(373)172(99-144-105-269-119-275-144)300-219(360)155(70-77-188(262)334)284-234(375)175(102-191(265)337)303-249(390)201(127(15)16)314-211(352)150(260)92-137-44-34-31-35-45-137/h31-39,44-49,53-68,105-106,119-136,150-186,201-209,323-332H,29-30,40-43,50-52,69-104,107-118,258-260H2,1-28H3,(H2,261,333)(H2,262,334)(H2,263,335)(H2,264,336)(H2,265,337)(H2,266,338)(H,269,275)(H,270,276)(H,272,353)(H,273,355)(H,274,354)(H,277,356)(H,278,340)(H,279,341)(H,280,342)(H,281,357)(H,282,358)(H,283,369)(H,284,375)(H,285,364)(H,286,387)(H,287,388)(H,288,389)(H,289,351)(H,290,359)(H,291,373)(H,292,370)(H,293,374)(H,294,381)(H,295,366)(H,296,365)(H,297,368)(H,298,376)(H,299,371)(H,300,360)(H,301,380)(H,302,361)(H,303,390)(H,304,383)(H,305,384)(H,306,394)(H,307,367)(H,308,362)(H,309,372)(H,310,385)(H,311,391)(H,312,392)(H,313,339)(H,314,352)(H,315,378)(H,316,377)(H,317,393)(H,318,382)(H,319,386)(H,320,379)(H,321,363)(H,343,344)(H,345,346)(H,347,348)(H,349,350)(H,396,397)(H,398,399)(H4,267,268,271)/t131-,132-,133-,134+,135+,136+,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,201-,202-,203-,204-,205-,206-,207-,208-,209-/m0/s1 D02EHV DRUGINKE PBGKTOXHQIOBKM-FHFVDXKLSA-N D02EHV DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CN=CN2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CN=CN2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D02EHV HIGHSTAT Approved D02EXZ DRUG__ID D02EXZ D02EXZ DRUGCOMP Shield therapeutics D02EXZ DRUGINCH 1S/3C6H6O3.Fe/c3*1-4-6(8)5(7)2-3-9-4;/h3*2-3,8H,1H3;/q;;;+3/p-3 D02EXZ DRUGINKE AHPWLYJHTFAWKI-UHFFFAOYSA-K D02EXZ DRUGSMIL CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].[Fe+3] D02EXZ HIGHSTAT Approved D02GUG DRUG__ID D02GUG D02GUG DRUGTYPE Small molecular drug D02GUG DRUGINCH 1S/C20H26N2O2/c1-3-10-11-8-14-17-20(12-6-4-5-7-13(12)21(17)2)9-15(16(11)18(20)23)22(14)19(10)24/h4-7,10-11,14-19,23-24H,3,8-9H2,1-2H3/t10-,11-,14-,15-,16-,17-,18+,19+,20+/m0/s1 D02GUG DRUGINKE CJDRUOGAGYHKKD-RQBLFBSQSA-N D02GUG DRUGSMIL CCC1C2CC3C4C5(CC(C2C5O)N3C1O)C6=CC=CC=C6N4C D02GUG HIGHSTAT Approved D02HFD DRUG__ID D02HFD D02HFD DRUGTYPE Small molecular drug D02HFD DRUGINCH 1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1 D02HFD DRUGINKE RWSXRVCMGQZWBV-WDSKDSINSA-N D02HFD DRUGSMIL C(CC(=O)NC(CS)C(=O)NCC(=O)O)C(C(=O)O)N D02HFD HIGHSTAT Approved D02HWP DRUG__ID D02HWP D02HWP DRUGTYPE Small molecular drug D02HWP DRUGINCH 1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H D02HWP DRUGINKE WDFKMLRRRCGAKS-UHFFFAOYSA-N D02HWP DRUGSMIL C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1 D02HWP HIGHSTAT Approved D02HXS DRUG__ID D02HXS D02HXS DRUGTYPE Small molecular drug D02HXS DRUGINCH 1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14) D02HXS DRUGINKE MXJWRABVEGLYDG-UHFFFAOYSA-N D02HXS DRUGSMIL CCCCOC1=CC=C(C=C1)CC(=O)NO D02HXS HIGHSTAT Approved D02HYK DRUG__ID D02HYK D02HYK DRUGTYPE Small molecular drug D02HYK DRUGINCH 1S/C14H21NO11/c1-4(17)15-8-11(10(20)7(3-16)24-13(8)23)26-14-9(19)5(18)2-6(25-14)12(21)22/h2,5,7-11,13-14,16,18-20,23H,3H2,1H3,(H,15,17)(H,21,22)/t5-,7-,8+,9-,10+,11-,13-,14?/m1/s1 D02HYK DRUGINKE DLGJWSVWTWEWBJ-HGGSSLSASA-N D02HYK DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)O)OC2C(C(C=C(O2)C(=O)O)O)O D02HYK HIGHSTAT Approved D02ICI DRUG__ID D02ICI D02ICI DRUGCOMP Galenica AG D02ICI DRUGINCH 1S/C24H42O22.Fe.2H2O.O/c25-1-5(29)18(11(32)14(35)21(39)40)44-23-16(37)12(33)20(7(3-27)42-23)46-24-17(38)13(34)19(8(4-28)43-24)45-22-15(36)10(31)9(30)6(2-26)41-22;;;;/h5-20,22-38H,1-4H2,(H,39,40);;2*1H2;/q;+3;;;-2/p-2/t5-,6-,7-,8-,9-,10+,11+,12-,13-,14+,15-,16-,17-,18+,19-,20-,22-,23-,24-;;;;/m1..../s1 D02ICI DRUGINKE MFBBZTDYOYZJGB-HAONTEFVSA-L D02ICI DRUGSMIL C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)OC(C(CO)O)C(C(C(=O)[O-])O)O)CO)CO)O)O)O)O.O.[OH-].[O-2].[Fe+3] D02ICI HIGHSTAT Approved D02IOH DRUG__ID D02IOH D02IOH DRUGTYPE Small molecular drug D02IOH DRUGINCH 1S/C16H23NO2/c1-4-15(18)19-16(14-8-6-5-7-9-14)10-11-17(3)12-13(16)2/h5-9,13H,4,10-12H2,1-3H3 D02IOH DRUGINKE UVAZQQHAVMNMHE-UHFFFAOYSA-N D02IOH DRUGSMIL CCC(=O)OC1(CCN(CC1C)C)C2=CC=CC=C2 D02IOH HIGHSTAT Approved D02KCV DRUG__ID D02KCV D02KCV DRUGTYPE Small molecular drug D02KCV DRUGINCH 1S/C11H9I3N2O4.Na/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18;/h1-2H3,(H,15,17)(H,16,18)(H,19,20);/q;+1/p-1 D02KCV DRUGINKE ZEYOIOAKZLALAP-UHFFFAOYSA-M D02KCV DRUGSMIL CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)NC(=O)C)I.[Na+] D02KCV HIGHSTAT Approved D02KFP DRUG__ID D02KFP D02KFP DRUGTYPE Small molecular drug D02KFP DRUGINCH 1S/2C6H12O6/c2*7-1-3(9)5(11)6(12)4(10)2-8/h3,5-9,11-12H,1-2H2;1,3-6,8-12H,2H2 D02KFP DRUGINKE PJVXUVWGSCCGHT-UHFFFAOYSA-N D02KFP DRUGSMIL C(C(C(C(C(C=O)O)O)O)O)O.C(C(C(C(C(=O)CO)O)O)O)O D02KFP HIGHSTAT Approved D02KJX DRUG__ID D02KJX D02KJX DRUGTYPE Small molecular drug D02KJX DRUGINCH 1S/C5H11NO2.ClH/c1-6(2,3)4-5(7)8;/h4H2,1-3H3;1H D02KJX DRUGINKE HOPSCVCBEOCPJZ-UHFFFAOYSA-N D02KJX DRUGSMIL C[N+](C)(C)CC(=O)O.[Cl-] D02KJX HIGHSTAT Approved D02LCR DRUG__ID D02LCR D02LCR DRUGTYPE Small molecular drug D02LCR DRUGINCH 1S/C15H24N2O4S/c1-5-17(6-2)10-9-16-15(18)13-11-12(22(4,19)20)7-8-14(13)21-3/h7-8,11H,5-6,9-10H2,1-4H3,(H,16,18) D02LCR DRUGINKE JTVPZMFULRWINT-UHFFFAOYSA-N D02LCR DRUGSMIL CCN(CC)CCNC(=O)C1=C(C=CC(=C1)S(=O)(=O)C)OC D02LCR HIGHSTAT Approved D02LTL DRUG__ID D02LTL D02LTL DRUGTYPE Small molecular drug D02LTL DRUGINCH 1S/C14H23NO15S/c1-3(17)15-5-10(9(30-31(24,25)26)4(2-16)27-13(5)23)28-14-8(20)6(18)7(19)11(29-14)12(21)22/h4-11,13-14,16,18-20,23H,2H2,1H3,(H,15,17)(H,21,22)(H,24,25,26)/p-2/t4-,5-,6+,7+,8-,9+,10-,11-,13-,14-/m1/s1 D02LTL DRUGINKE AVJBPWGFOQAPRH-FWMKGIEWSA-L D02LTL DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)OS(=O)(=O)[O-])OC2C(C(C(C(O2)C(=O)[O-])O)O)O D02LTL HIGHSTAT Approved D02LZB DRUG__ID D02LZB D02LZB DRUGTYPE Small molecular drug D02LZB DRUGINCH 1S/C21H25NO5/c1-22-15-8-6-12-10-18(25-3)20(26-4)21(27-5)19(12)13-7-9-17(24-2)16(23)11-14(13)15/h7,9-11,15,22H,6,8H2,1-5H3/t15-/m0/s1 D02LZB DRUGINKE NNJPGOLRFBJNIW-HNNXBMFYSA-N D02LZB DRUGSMIL CNC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC D02LZB HIGHSTAT Approved D02NDV DRUG__ID D02NDV D02NDV DRUGCOMP Bayer Schering Pharma AG D02NDV DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1 D02NDV DRUGINKE WQZGKKKJIJFFOK-PHYPRBDBSA-N D02NDV DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D02NDV HIGHSTAT Approved D02OAV DRUG__ID D02OAV D02OAV DRUGTYPE Small molecular drug D02OAV DRUGINCH 1S/C2H3Cl3O2/c3-2(4,5)1(6)7/h1,6-7H D02OAV DRUGINKE RNFNDJAIBTYOQL-UHFFFAOYSA-N D02OAV DRUGSMIL C(C(Cl)(Cl)Cl)(O)O D02OAV HIGHSTAT Approved D02PJA DRUG__ID D02PJA D02PJA DRUGTYPE Small molecular drug D02PJA DRUGINCH 1S/HI/h1H D02PJA DRUGINKE XMBWDFGMSWQBCA-UHFFFAOYSA-N D02PJA DRUGSMIL I D02PJA HIGHSTAT Approved D02QCD DRUG__ID D02QCD D02QCD DRUGTYPE Small molecular drug D02QCD DRUGINCH 1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H/t12-,13-;/m1./s1 D02QCD DRUGINKE JUMYIBMBTDDLNG-OJERSXHUSA-N D02QCD DRUGSMIL COC(=O)C(C1CCCCN1)C2=CC=CC=C2.Cl D02QCD HIGHSTAT Approved D02RXG DRUG__ID D02RXG D02RXG DRUGTYPE Small molecular drug D02RXG DRUGINCH 1S/C28H32N2O5.ClH/c1-29(23(32)7-4-18-9-13-34-16-18)20-8-10-28(33)22-14-19-5-6-21(31)25-24(19)27(28,26(20)35-25)11-12-30(22)15-17-2-3-17;/h4-7,9,13,16-17,20,22,26,31,33H,2-3,8,10-12,14-15H2,1H3;1H/b7-4+;/t20-,22-,26+,27+,28-;/m1./s1 D02RXG DRUGINKE DJSFYNINGIMKAG-FQJQBBMWSA-N D02RXG DRUGSMIL CN(C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O)C(=O)C=CC7=COC=C7.Cl D02RXG HIGHSTAT Approved D02STN DRUG__ID D02STN D02STN DRUGTYPE Small molecular drug D02STN DRUGINCH 1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1 D02STN DRUGINKE GZOSMCIZMLWJML-VJLLXTKPSA-N D02STN DRUGSMIL CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O D02STN HIGHSTAT Approved D02TQO DRUG__ID D02TQO D02TQO DRUGTYPE Small molecular drug D02TQO DRUGINCH 1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1 D02TQO DRUGINKE GVJHHUAWPYXKBD-IEOSBIPESA-N D02TQO DRUGSMIL CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C D02TQO HIGHSTAT Approved D02URS DRUG__ID D02URS D02URS DRUGTYPE Small molecular drug D02URS DRUGINCH 1S/HI.K/h1H;/q;+1/p-1 D02URS DRUGINKE NLKNQRATVPKPDG-UHFFFAOYSA-M D02URS DRUGSMIL [K+].[I-] D02URS HIGHSTAT Approved D02VCJ DRUG__ID D02VCJ D02VCJ DRUGTYPE Small molecular drug D02VCJ DRUGINCH 1S/C18H22I3N3O8/c1-5(26)22-12-9(19)8(10(20)14(11(12)21)24(3)6(2)27)17(30)23-13-16(29)15(28)7(4-25)32-18(13)31/h7,13,15-16,18,25,28-29,31H,4H2,1-3H3,(H,22,26)(H,23,30)/t7-,13-,15-,16-,18?/m1/s1 D02VCJ DRUGINKE BAQCROVBDNBEEB-UBYUBLNFSA-N D02VCJ DRUGSMIL CC(=O)NC1=C(C(=C(C(=C1I)C(=O)NC2C(C(C(OC2O)CO)O)O)I)N(C)C(=O)C)I D02VCJ HIGHSTAT Approved D02VMJ DRUG__ID D02VMJ D02VMJ DRUGTYPE Small molecular drug D02VMJ DRUGINCH 1S/C14H9Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19) D02VMJ DRUGINKE NQPDXQQQCQDHHW-UHFFFAOYSA-N D02VMJ DRUGSMIL CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl D02VMJ HIGHSTAT Approved D02WAB DRUG__ID D02WAB D02WAB DRUGTYPE Small molecular drug D02WAB DRUGINCH 1S/C9H9Cl2NO2/c1-12(9(14)8(10)11)6-2-4-7(13)5-3-6/h2-5,8,13H,1H3 D02WAB DRUGINKE GZZZSOOGQLOEOB-UHFFFAOYSA-N D02WAB DRUGSMIL CN(C1=CC=C(C=C1)O)C(=O)C(Cl)Cl D02WAB HIGHSTAT Approved D02WUC DRUG__ID D02WUC D02WUC DRUGTYPE Small molecular drug D02WUC DRUGINCH 1S/C14H12ClN3O3S/c15-10-7-11-9(6-12(10)22(16,20)21)14(19)18-13(17-11)8-4-2-1-3-5-8/h1-7,13,17H,(H,18,19)(H2,16,20,21) D02WUC DRUGINKE DBDTUXMDTSTPQZ-UHFFFAOYSA-N D02WUC DRUGSMIL C1=CC=C(C=C1)C2NC3=CC(=C(C=C3C(=O)N2)S(=O)(=O)N)Cl D02WUC HIGHSTAT Approved D02XBW DRUG__ID D02XBW D02XBW DRUGTYPE Small molecular drug D02XBW DRUGINCH 1S/CH4N2O/c2-1(3)4/h(H4,2,3,4) D02XBW DRUGINKE XSQUKJJJFZCRTK-UHFFFAOYSA-N D02XBW DRUGSMIL C(=O)(N)N D02XBW HIGHSTAT Approved D02ZGI DRUG__ID D02ZGI D02ZGI DRUGTYPE Small molecular drug D02ZGI DRUGINCH 1S/C27H44O3/c1-18-8-12-22(28)17-21(18)11-10-20-7-6-16-27(5)23(13-14-24(20)27)19(2)9-15-25(29)26(3,4)30/h10-11,19,22-25,28-30H,1,6-9,12-17H2,2-5H3/b20-10+,21-11-/t19-,22+,23-,24+,25-,27-/m1/s1 D02ZGI DRUGINKE FCKJYANJHNLEEP-XRWYNYHCSA-N D02ZGI DRUGSMIL CC(CCC(C(C)(C)O)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C D02ZGI HIGHSTAT Approved D02ZJI DRUG__ID D02ZJI D02ZJI DRUGTYPE Small molecular drug D02ZJI DRUGINCH 1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1 D02ZJI DRUGINKE NDAUXUAQIAJITI-LBPRGKRZSA-N D02ZJI DRUGSMIL CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O D02ZJI HIGHSTAT Approved D03CHT DRUG__ID D03CHT D03CHT DRUGTYPE Small molecular drug D03CHT DRUGINCH 1S/C6H13NO3S/c7-5(6(9)10)4-11-3-1-2-8/h5,8H,1-4,7H2,(H,9,10)/t5-/m0/s1 D03CHT DRUGINKE KINWYTAUPKOPCQ-YFKPBYRVSA-N D03CHT DRUGSMIL C(CO)CSCC(C(=O)O)N D03CHT HIGHSTAT Approved D03DVJ DRUG__ID D03DVJ D03DVJ DRUGTYPE Small molecular drug D03DVJ DRUGINCH 1S/C10H21N/c1-9(11-2)8-10-6-4-3-5-7-10/h9-11H,3-8H2,1-2H3 D03DVJ DRUGINKE JCRIVQIOJSSCQD-UHFFFAOYSA-N D03DVJ DRUGSMIL CC(CC1CCCCC1)NC D03DVJ HIGHSTAT Approved D03EXK DRUG__ID D03EXK D03EXK DRUGTYPE Small molecular drug D03EXK DRUGINCH 1S/C6H9NO.I2/c1-2-7-5-3-4-6(7)8;1-2/h2H,1,3-5H2; D03EXK DRUGINKE CPKVUHPKYQGHMW-UHFFFAOYSA-N D03EXK DRUGSMIL C=CN1CCCC1=O.II D03EXK HIGHSTAT Approved D03FCF DRUG__ID D03FCF D03FCF DRUGCOMP Elixir Medical D03FCF DRUGINCH 1S/C50H77NO13/c1-29-15-11-10-12-16-30(2)40(53)27-37-20-18-35(7)50(60,64-37)47(57)48(58)51-22-14-13-17-38(51)49(59)63-42(32(4)25-36-19-21-39(52)43(26-36)61-8)28-41(54)31(3)24-34(6)45(56)46(62-9)44(55)33(5)23-29/h10-12,15-16,24,29,31-33,35-40,42-43,45-46,52-53,56,60H,13-14,17-23,25-28H2,1-9H3/b12-10+,15-11+,30-16+,34-24+/t29-,31-,32-,33-,35-,36+,37+,38+,39-,40+,42+,43-,45-,46+,50-/m1/s1 D03FCF DRUGINKE ZHYGVVKSAGDVDY-QQQXYHJWSA-N D03FCF DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)O D03FCF HIGHSTAT Approved D03HJK DRUG__ID D03HJK D03HJK DRUGTYPE Small molecular drug D03HJK DRUGINCH 1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 D03HJK DRUGINKE MQTOSJVFKKJCRP-BICOPXKESA-N D03HJK DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O D03HJK HIGHSTAT Approved D03IDU DRUG__ID D03IDU D03IDU DRUGTYPE Small molecular drug D03IDU DRUGINCH 1S/H2O2/c1-2/h1-2H D03IDU DRUGINKE MHAJPDPJQMAIIY-UHFFFAOYSA-N D03IDU DRUGSMIL OO D03IDU HIGHSTAT Approved D03IUY DRUG__ID D03IUY D03IUY DRUGTYPE Small molecular drug D03IUY DRUGINCH 1S/C18H22O5S.C4H10N2/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;1-2-6-4-3-5-1/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);5-6H,1-4H2/t14-,15-,16+,18+;/m1./s1 D03IUY DRUGINKE HZEQBCVBILBTEP-ZFINNJDLSA-N D03IUY DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1 D03IUY HIGHSTAT Approved D03KEK DRUG__ID D03KEK D03KEK DRUGTYPE Small molecular drug D03KEK DRUGINCH 1S/C6H9NO2/c8-6(9)5-1-3-7-4-2-5/h1,7H,2-4H2,(H,8,9) D03KEK DRUGINKE KRVDMABBKYMBHG-UHFFFAOYSA-N D03KEK DRUGSMIL C1CNCC=C1C(=O)O D03KEK HIGHSTAT Approved D03KIA DRUG__ID D03KIA D03KIA DRUGTYPE Small molecular drug D03KIA DRUGINCH 1S/C26H34FNO5/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32)/b11-10+/t19-,20-/m1/s1 D03KIA DRUGINKE SEERZIQQUAZTOL-ANMDKAQQSA-N D03KIA DRUGSMIL CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)O)O)O D03KIA HIGHSTAT Approved D03KTD DRUG__ID D03KTD D03KTD DRUGTYPE Small molecular drug D03KTD DRUGINCH 1S/C57H82O26/c1-21-34(79-40-19-37(53(26(6)75-40)77-28(8)59)82-38-16-33(61)52(70-11)25(5)74-38)15-31-13-30-14-32(54(71-12)51(68)46(63)22(2)58)55(50(67)44(30)49(66)43(31)45(21)62)83-41-18-35(47(64)24(4)73-41)80-39-17-36(48(65)23(3)72-39)81-42-20-57(10,69)56(27(7)76-42)78-29(9)60/h13,15,22-27,32-33,35-42,46-48,52-56,58,61-66,69H,14,16-20H2,1-12H3/t22-,23-,24-,25-,26-,27+,32+,33-,35-,36-,37-,38-,39+,40+,41+,42+,46+,47-,48-,52+,53+,54+,55+,56+,57+/m1/s1 D03KTD DRUGINKE ZYVSOIYQKUDENJ-WKSBCEQHSA-N D03KTD DRUGSMIL CC1C(C(CC(O1)OC2C(CC3=C(C2=O)C(=C4C(=C3)C=C(C(=C4O)C)OC5CC(C(C(O5)C)OC(=O)C)OC6CC(C(C(O6)C)OC)O)O)C(C(=O)C(C(C)O)O)OC)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)OC(=O)C)(C)O)O D03KTD HIGHSTAT Approved D03KXY DRUG__ID D03KXY D03KXY DRUGTYPE Small molecular drug D03KXY DRUGINCH 1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1 D03KXY DRUGINKE ZWAOHEXOSAUJHY-ZIYNGMLESA-N D03KXY DRUGSMIL CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O D03KXY HIGHSTAT Approved D03LGG DRUG__ID D03LGG D03LGG DRUGTYPE Small molecular drug D03LGG DRUGINCH 1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)/b8-6- D03LGG DRUGINKE YKPUWZUDDOIDPM-VURMDHGXSA-N D03LGG DRUGSMIL CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC D03LGG HIGHSTAT Approved D03MNN DRUG__ID D03MNN D03MNN DRUGTYPE Small molecular drug D03MNN DRUGINCH 1S/C28H27Cl2N5O3/c1-34-4-6-35(7-5-34)15-19-8-17(16-38-19)20-9-24-21(10-26(20)36-2)28(18(13-31)14-32-24)33-25-12-27(37-3)23(30)11-22(25)29/h8-12,14,16H,4-7,15H2,1-3H3,(H,32,33) D03MNN DRUGINKE ANUHLKPVOXDYSK-UHFFFAOYSA-N D03MNN DRUGSMIL CN1CCN(CC1)CC2=CC(=CO2)C3=C(C=C4C(=C3)N=CC(=C4NC5=CC(=C(C=C5Cl)Cl)OC)C#N)OC D03MNN HIGHSTAT Approved D03NOS DRUG__ID D03NOS D03NOS DRUGTYPE Small molecular drug D03NOS DRUGINCH 1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1 D03NOS DRUGINKE IYMMESGOJVNCKV-SKDRFNHKSA-N D03NOS DRUGSMIL C1CCNC(C1)C(C2=CC(=C(C=C2)O)O)O D03NOS HIGHSTAT Approved D03OIW DRUG__ID D03OIW D03OIW DRUGTYPE Small molecular drug D03OIW DRUGINCH 1S/C10H9N5O/c1-2-7(16-3-1)4-11-9-8-10(13-5-12-8)15-6-14-9/h1-3,5-6H,4H2,(H2,11,12,13,14,15) D03OIW DRUGINKE QANMHLXAZMSUEX-UHFFFAOYSA-N D03OIW DRUGSMIL C1=COC(=C1)CNC2=NC=NC3=C2NC=N3 D03OIW HIGHSTAT Approved D03PIR DRUG__ID D03PIR D03PIR DRUGTYPE Small molecular drug D03PIR DRUGINCH 1S/C13H12N8O4S3/c22-7(1-20-4-14-18-19-20)16-8-10(23)21-9(12(24)25)6(2-26-11(8)21)3-27-13-17-15-5-28-13/h4-5,8,11H,1-3H2,(H,16,22)(H,24,25)/t8-,11-/m1/s1 D03PIR DRUGINKE DZMVCVMFETWNIU-LDYMZIIASA-N D03PIR DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)CN3C=NN=N3)C(=O)O)CSC4=NN=CS4 D03PIR HIGHSTAT Approved D03PTH DRUG__ID D03PTH D03PTH DRUGTYPE Small molecular drug D03PTH DRUGINCH 1S/C11H14N2S/c1-13-8-3-7-12-11(13)6-5-10-4-2-9-14-10/h2,4-6,9H,3,7-8H2,1H3/b6-5+ D03PTH DRUGINKE YSAUAVHXTIETRK-AATRIKPKSA-N D03PTH DRUGSMIL CN1CCCN=C1C=CC2=CC=CS2 D03PTH HIGHSTAT Approved D03SFU DRUG__ID D03SFU D03SFU DRUGTYPE Small molecular drug D03SFU DRUGINCH 1S/C16H25NO2S/c1-16(2,3)17-10-13(18)11-19-14-8-4-6-12-7-5-9-20-15(12)14/h4,6,8,13,17-18H,5,7,9-11H2,1-3H3 D03SFU DRUGINKE HTWFXPCUFWKXOP-UHFFFAOYSA-N D03SFU DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1SCCC2)O D03SFU HIGHSTAT Approved D03TGJ DRUG__ID D03TGJ D03TGJ DRUGTYPE Small molecular drug D03TGJ DRUGINCH 1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1 D03TGJ DRUGINKE GCQYYIHYQMVWLT-HQNLTJAPSA-N D03TGJ DRUGSMIL C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)C=CBr D03TGJ HIGHSTAT Approved D03TTQ DRUG__ID D03TTQ D03TTQ DRUGTYPE Small molecular drug D03TTQ DRUGINCH 1S/C34H28N6O14S4.4Na/c1-15-7-17(3-5-25(15)37-39-31-27(57(49,50)51)11-19-9-21(55(43,44)45)13-23(35)29(19)33(31)41)18-4-6-26(16(2)8-18)38-40-32-28(58(52,53)54)12-20-10-22(56(46,47)48)14-24(36)30(20)34(32)42;;;;/h3-14,41-42H,35-36H2,1-2H3,(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54);;;;/q;4*+1/p-4 D03TTQ DRUGINKE GLNADSQYFUSGOU-UHFFFAOYSA-J D03TTQ DRUGSMIL CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)C)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+].[Na+] D03TTQ HIGHSTAT Approved D03UOT DRUG__ID D03UOT D03UOT DRUGTYPE Small molecular drug D03UOT DRUGINCH 1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H D03UOT DRUGINKE QIGBRXMKCJKVMJ-UHFFFAOYSA-N D03UOT DRUGSMIL C1=CC(=CC=C1O)O D03UOT HIGHSTAT Approved D03VFL DRUG__ID D03VFL D03VFL DRUGTYPE Small molecular drug D03VFL DRUGINCH 1S/C26H38O2/c1-20(2)9-6-10-21(3)11-7-12-22(4)13-8-17-26(5)18-16-23-19-24(27)14-15-25(23)28-26/h9,11,13-15,19,27H,6-8,10,12,16-18H2,1-5H3/b21-11+,22-13+ D03VFL DRUGINKE GJJVAFUKOBZPCB-ZGRPYONQSA-N D03VFL DRUGSMIL CC(=CCCC(=CCCC(=CCCC1(CCC2=C(O1)C=CC(=C2)O)C)C)C)C D03VFL HIGHSTAT Approved D03VXJ DRUG__ID D03VXJ D03VXJ DRUGTYPE Small molecular drug D03VXJ DRUGINCH 1S/ClH/h1H D03VXJ DRUGINKE VEXZGXHMUGYJMC-UHFFFAOYSA-N D03VXJ DRUGSMIL Cl D03VXJ HIGHSTAT Approved D03WAJ DRUG__ID D03WAJ D03WAJ DRUGTYPE Small molecular drug D03WAJ DRUGINCH 1S/C13H18N2O3/c1-2-13(9-7-5-3-4-6-8-9)10(16)14-12(18)15-11(13)17/h7H,2-6,8H2,1H3,(H2,14,15,16,17,18) D03WAJ DRUGINKE PAZQYDJGLKSCSI-UHFFFAOYSA-N D03WAJ DRUGSMIL CCC1(C(=O)NC(=O)NC1=O)C2=CCCCCC2 D03WAJ HIGHSTAT Approved D03WWG DRUG__ID D03WWG D03WWG DRUGTYPE Small molecular drug D03WWG DRUGINCH 1S/C148H244N42O47/c1-69(2)52-92(178-142(231)115(75(13)14)185-128(217)87-30-21-20-22-36-113(208)237-67-84(151)122(211)172-98(59-107(154)200)136(225)176-96(56-73(9)10)134(223)182-102(66-192)139(228)188-116(77(16)193)143(232)171-87)123(212)161-63-109(202)165-85(31-23-25-47-149)124(213)173-95(55-72(7)8)133(222)181-101(65-191)138(227)169-89(41-44-105(152)198)126(215)167-91(43-46-111(204)205)127(216)175-94(54-71(5)6)132(221)177-97(58-82-61-158-68-163-82)135(224)166-86(32-24-26-48-150)125(214)174-93(53-70(3)4)131(220)168-90(42-45-106(153)199)130(219)187-118(79(18)195)145(234)180-100(57-81-37-39-83(197)40-38-81)146(235)190-51-29-35-104(190)140(229)170-88(33-27-49-159-148(156)157)129(218)186-117(78(17)194)144(233)179-99(60-112(206)207)137(226)184-114(74(11)12)141(230)162-62-108(201)164-76(15)121(210)160-64-110(203)183-119(80(19)196)147(236)189-50-28-34-103(189)120(155)209/h37-40,61,68-80,84-104,114-119,191-197H,20-36,41-60,62-67,149-151H2,1-19H3,(H2,152,198)(H2,153,199)(H2,154,200)(H2,155,209)(H,158,163)(H,160,210)(H,161,212)(H,162,230)(H,164,201)(H,165,202)(H,166,224)(H,167,215)(H,168,220)(H,169,227)(H,170,229)(H,171,232)(H,172,211)(H,173,213)(H,174,214)(H,175,216)(H,176,225)(H,177,221)(H,178,231)(H,179,233)(H,180,234)(H,181,222)(H,182,223)(H,183,203)(H,184,226)(H,185,217)(H,186,218)(H,187,219)(H,188,228)(H,204,205)(H,206,207)(H4,156,157,159) D03WWG DRUGINKE JYSJVJJVLNYRKL-UHFFFAOYSA-N D03WWG DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CCCCCC(=O)OCC(C(=O)NC(C(=O)N1)CC(=O)N)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)N)C(C)O)CO D03WWG HIGHSTAT Approved D03XES DRUG__ID D03XES D03XES DRUGTYPE Small molecular drug D03XES DRUGINCH 1S/C15H21NO.BrH/c1-15-5-6-16(2)10-11(9-15)7-12-3-4-13(17)8-14(12)15;/h3-4,8,11,17H,5-7,9-10H2,1-2H3;1H/t11-,15-;/m1./s1 D03XES DRUGINKE KMISFPIWSMSMJD-GPKQSYPGSA-N D03XES DRUGSMIL CC12CCN(CC(C1)CC3=C2C=C(C=C3)O)C.Br D03XES HIGHSTAT Approved D03YLZ DRUG__ID D03YLZ D03YLZ DRUGTYPE Small molecular drug D03YLZ DRUGINCH 1S/C12H15Cl2NO5S/c1-21(19,20)8-4-2-7(3-5-8)10(17)9(6-16)15-12(18)11(13)14/h2-5,9-11,16-17H,6H2,1H3,(H,15,18)/t9-,10-/m1/s1 D03YLZ DRUGINKE OTVAEFIXJLOWRX-NXEZZACHSA-N D03YLZ DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)NC(=O)C(Cl)Cl)O D03YLZ HIGHSTAT Approved D03ZBN DRUG__ID D03ZBN D03ZBN DRUGTYPE Small molecular drug D03ZBN DRUGINCH 1S/C14H10N4O/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10/h2-6,8H,1H3,(H,17,19) D03ZBN DRUGINKE JPAWFIIYTJQOKW-UHFFFAOYSA-N D03ZBN DRUGSMIL CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2 D03ZBN HIGHSTAT Approved D03ZFN DRUG__ID D03ZFN D03ZFN DRUGTYPE Small molecular drug D03ZFN DRUGINCH 1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2 D03ZFN DRUGINKE LENZDBCJOHFCAS-UHFFFAOYSA-N D03ZFN DRUGSMIL C(C(CO)(CO)N)O D03ZFN HIGHSTAT Approved D04AIT DRUG__ID D04AIT D04AIT DRUGTYPE Small molecular drug D04AIT DRUGINCH 1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H D04AIT DRUGINKE IQPNAANSBPBGFQ-UHFFFAOYSA-N D04AIT DRUGSMIL C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O D04AIT HIGHSTAT Approved D04APR DRUG__ID D04APR D04APR DRUGTYPE Small molecular drug D04APR DRUGINCH 1S/C38H52N6O2.CH4O3S/c1-26-22-31-29-9-8-27-23-28(45)10-12-37(27,2)30(29)11-13-38(31,3)35(26)32(46)25-41-18-20-43(21-19-41)34-24-33(42-14-4-5-15-42)39-36(40-34)44-16-6-7-17-44;1-5(2,3)4/h10-12,23-24,26,29,31,35H,4-9,13-22,25H2,1-3H3;1H3,(H,2,3,4)/t26-,29-,31+,35-,37+,38+;/m1./s1 D04APR DRUGINKE HPZOOQSXPMEJBV-ODCFVKFUSA-N D04APR DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C.CS(=O)(=O)O D04APR HIGHSTAT Approved D04BCW DRUG__ID D04BCW D04BCW DRUGTYPE Small molecular drug D04BCW DRUGINCH 1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3 D04BCW DRUGINKE ALFGKMXHOUSVAD-UHFFFAOYSA-N D04BCW DRUGSMIL CCC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)O D04BCW HIGHSTAT Approved D04DKH DRUG__ID D04DKH D04DKH DRUGTYPE Small molecular drug D04DKH DRUGINCH 1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3 D04DKH DRUGINKE HRRBJVNMSRJFHQ-UHFFFAOYSA-N D04DKH DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O D04DKH HIGHSTAT Approved D04DXN DRUG__ID D04DXN D04DXN DRUGTYPE Small molecular drug D04DXN DRUGINCH 1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H D04DXN DRUGINKE OMPJBNCRMGITSC-UHFFFAOYSA-N D04DXN DRUGSMIL C1=CC=C(C=C1)C(=O)OOC(=O)C2=CC=CC=C2 D04DXN HIGHSTAT Approved D04GZA DRUG__ID D04GZA D04GZA DRUGTYPE Small molecular drug D04GZA DRUGINCH 1S/C25H30N3.ClH/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6;/h7-18H,1-6H3;1H/q+1;/p-1 D04GZA DRUGINKE ZXJXZNDDNMQXFV-UHFFFAOYSA-M D04GZA DRUGSMIL CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-] D04GZA HIGHSTAT Approved D04LVK DRUG__ID D04LVK D04LVK DRUGTYPE Small molecular drug D04LVK DRUGINCH 1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34) D04LVK DRUGINKE VERWOWGGCGHDQE-UHFFFAOYSA-N D04LVK DRUGSMIL CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl D04LVK HIGHSTAT Approved D04LYD DRUG__ID D04LYD D04LYD DRUGTYPE Small molecular drug D04LYD DRUGINCH 1S/C12H11ClN6O2S2/c13-9-5-10(15-6-7-2-1-3-22-7)8(12-16-18-19-17-12)4-11(9)23(14,20)21/h1-5,15H,6H2,(H2,14,20,21)(H,16,17,18,19) D04LYD DRUGINKE HMEDEBAJARCKCT-UHFFFAOYSA-N D04LYD DRUGSMIL C1=CSC(=C1)CNC2=CC(=C(C=C2C3=NNN=N3)S(=O)(=O)N)Cl D04LYD HIGHSTAT Approved D04MRG DRUG__ID D04MRG D04MRG DRUGTYPE Small molecular drug D04MRG DRUGINCH 1S/C38H60O18/c1-16-11-37-9-5-20-35(2,7-4-8-36(20,3)34(50)55-32-29(49)26(46)23(43)18(13-40)52-32)21(37)6-10-38(16,15-37)56-33-30(27(47)24(44)19(14-41)53-33)54-31-28(48)25(45)22(42)17(12-39)51-31/h17-33,39-49H,1,4-15H2,2-3H3/t17-,18-,19-,20+,21+,22-,23-,24-,25+,26+,27+,28-,29-,30-,31+,32+,33+,35-,36-,37-,38+/m1/s1 D04MRG DRUGINKE UEDUENGHJMELGK-HYDKPPNVSA-N D04MRG DRUGSMIL CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)(C)C(=O)OC7C(C(C(C(O7)CO)O)O)O D04MRG HIGHSTAT Approved D04QIE DRUG__ID D04QIE D04QIE DRUGCOMP Kowa Co Ltd D04QIE DRUGINCH 1S/C28H30N2O6/c1-3-25(27(31)32)35-23-9-6-8-20(18-23)19-30(28-29-24-10-4-5-11-26(24)36-28)16-7-17-34-22-14-12-21(33-2)13-15-22/h4-6,8-15,18,25H,3,7,16-17,19H2,1-2H3,(H,31,32)/t25-/m1/s1 D04QIE DRUGINKE ZHKNLJLMDFQVHJ-RUZDIDTESA-N D04QIE DRUGSMIL CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3 D04QIE HIGHSTAT Approved D04QST DRUG__ID D04QST D04QST DRUGTYPE Small molecular drug D04QST DRUGINCH 1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1 D04QST DRUGINKE AUNGANRZJHBGPY-SCRDCRAPSA-N D04QST DRUGSMIL CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(CO)O)O)O D04QST HIGHSTAT Approved D04RYU DRUG__ID D04RYU D04RYU DRUGTYPE Small molecular drug D04RYU DRUGINCH 1S/C36H56O14/c1-16-30(50-32-28(42)27(41)26(40)23(14-37)49-32)31(45-4)29(43)33(47-16)48-19-7-9-34(2)18(12-19)5-6-21-20(34)8-10-35(3)25(17-11-24(39)46-15-17)22(38)13-36(21,35)44/h11,16,18-23,25-33,37-38,40-44H,5-10,12-15H2,1-4H3/t16-,18-,19+,20+,21-,22+,23-,25+,26-,27+,28-,29-,30+,31-,32+,33+,34+,35-,36+/m1/s1 D04RYU DRUGINKE CKNOLMVLQUPVMU-YMMLYESFSA-N D04RYU DRUGSMIL CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)O)O)C)C)O)OC)OC7C(C(C(C(O7)CO)O)O)O D04RYU HIGHSTAT Approved D04SFH DRUG__ID D04SFH D04SFH DRUGTYPE Small molecular drug D04SFH DRUGINCH 1S/C22H32O3/c1-12-9-15-17-6-5-16(13(2)23)22(17,4)11-19(25)20(15)21(3)8-7-14(24)10-18(12)21/h10,12,15-17,19-20,25H,5-9,11H2,1-4H3/t12-,15-,16+,17-,19-,20+,21-,22+/m0/s1 D04SFH DRUGINKE GZENKSODFLBBHQ-ILSZZQPISA-N D04SFH DRUGSMIL CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)CC4)C)O)C)C(=O)C D04SFH HIGHSTAT Approved D04UAL DRUG__ID D04UAL D04UAL DRUGTYPE Small molecular drug D04UAL DRUGINCH 1S/C14H21ClN2O2/c1-18-10-3-2-4-14(17-19-11-9-16)12-5-7-13(15)8-6-12/h5-8H,2-4,9-11,16H2,1H3/b17-14+ D04UAL DRUGINKE XXPVSQRPGBUFKM-SAPNQHFASA-N D04UAL DRUGSMIL COCCCCC(=NOCCN)C1=CC=C(C=C1)Cl D04UAL HIGHSTAT Approved D04UZN DRUG__ID D04UZN D04UZN DRUGTYPE Small molecular drug D04UZN DRUGINCH 1S/C12H13ClN4.C12H14N4O4S/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7;1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-6H,2H2,1H3,(H4,14,15,16,17);3-7H,13H2,1-2H3,(H,14,15,16) D04UZN DRUGINKE LUBUTTBEBGYNJN-UHFFFAOYSA-N D04UZN DRUGSMIL CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl.COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N D04UZN HIGHSTAT Approved D04VIS DRUG__ID D04VIS D04VIS DRUGTYPE Small molecular drug D04VIS DRUGINCH 1S/C20H30O5/c1-12-4-7-16-19(2,9-8-17(23)20(16,3)11-21)14(12)6-5-13-15(22)10-25-18(13)24/h5,14-17,21-23H,1,4,6-11H2,2-3H3/b13-5+/t14-,15-,16+,17-,19+,20+/m1/s1 D04VIS DRUGINKE BOJKULTULYSRAS-OTESTREVSA-N D04VIS DRUGSMIL CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)CO)O D04VIS HIGHSTAT Approved D04YZL DRUG__ID D04YZL D04YZL DRUGTYPE Small molecular drug D04YZL DRUGINCH 1S/ClH.Na/h1H;/q;+1/p-1 D04YZL DRUGINKE FAPWRFPIFSIZLT-UHFFFAOYSA-M D04YZL DRUGSMIL [Na+].[Cl-] D04YZL HIGHSTAT Approved D05AFX DRUG__ID D05AFX D05AFX DRUGTYPE Small molecular drug D05AFX DRUGINCH 1S/C17H19NO/c1-18-11-12-19-17(14-7-3-2-4-8-14)16-10-6-5-9-15(16)13-18/h2-10,17H,11-13H2,1H3 D05AFX DRUGINKE RGPDEAGGEXEMMM-UHFFFAOYSA-N D05AFX DRUGSMIL CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3 D05AFX HIGHSTAT Approved D05ATI DRUG__ID D05ATI D05ATI DRUGTYPE Small molecular drug D05ATI DRUGINCH 1S/C12H26O4S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15;/h2-12H2,1H3,(H,13,14,15);/q;+1/p-1 D05ATI DRUGINKE DBMJMQXJHONAFJ-UHFFFAOYSA-M D05ATI DRUGSMIL CCCCCCCCCCCCOS(=O)(=O)[O-].[Na+] D05ATI HIGHSTAT Approved D05AWP DRUG__ID D05AWP D05AWP DRUGCOMP Medicines Development for Global Health D05AWP DRUGINCH 1S/C37H53NO8/c1-21(2)14-25(6)33-26(7)31(38-42-8)19-36(46-33)18-29-17-28(45-36)13-12-23(4)15-22(3)10-9-11-27-20-43-34-32(39)24(5)16-30(35(40)44-29)37(27,34)41/h9-12,14,16,21-22,26,28-30,32-34,39,41H,13,15,17-20H2,1-8H3/b10-9+,23-12+,25-14+,27-11+,38-31+/t22-,26-,28+,29-,30-,32+,33+,34+,36-,37+/m0/s1 D05AWP DRUGINKE YZBLFMPOMVTDJY-LSGXYNIPSA-N D05AWP DRUGSMIL CC1CC(=CCC2CC(CC3(O2)CC(=NOC)C(C(O3)C(=CC(C)C)C)C)OC(=O)C4C=C(C(C5C4(C(=CC=C1)CO5)O)O)C)C D05AWP HIGHSTAT Approved D05BTM DRUG__ID D05BTM D05BTM DRUGTYPE Small molecular drug D05BTM DRUGINCH 1S/C26H42O4/c1-17-20(15-21(27)16-24(17)28)9-8-19-7-6-12-26(5)22(10-11-23(19)26)18(2)30-14-13-25(3,4)29/h8-9,18,21-24,27-29H,1,6-7,10-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24-,26+/m0/s1 D05BTM DRUGINKE DTXXSJZBSTYZKE-ZDQKKZTESA-N D05BTM DRUGSMIL CC(C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)OCCC(C)(C)O D05BTM HIGHSTAT Approved D05EMG DRUG__ID D05EMG D05EMG DRUGTYPE Small molecular drug D05EMG DRUGINCH 1S/C21H30NO4/c1-3-4-10-22(2)17-11-15(12-18(22)20-19(17)26-20)25-21(24)16(13-23)14-8-6-5-7-9-14/h5-9,15-20,23H,3-4,10-13H2,1-2H3/q+1/t15?,16-,17-,18+,19-,20+,22?/m1/s1 D05EMG DRUGINKE YBCNXCRZPWQOBR-MWGADRMYSA-N D05EMG DRUGSMIL CCCC[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C D05EMG HIGHSTAT Approved D05HFN DRUG__ID D05HFN D05HFN DRUGCOMP GE Healthcare D05HFN DRUGINCH 1S/2C18H40O4P2.2O.Tc/c2*1-5-19-9-13-23(14-10-20-6-2)17-18-24(15-11-21-7-3)16-12-22-8-4;;;/h2*5-18H2,1-4H3;;;/p+4/i;;;;1+1 D05HFN DRUGINKE BVIZIWVHTBDMEX-RCUQKECRSA-R D05HFN DRUGSMIL CCOCC[PH+](CCOCC)CC[PH+](CCOCC)CCOCC.CCOCC[PH+](CCOCC)CC[PH+](CCOCC)CCOCC.O=[Tc]=O D05HFN HIGHSTAT Approved D05IWE DRUG__ID D05IWE D05IWE DRUGCOMP Saint Petersburg State University D05IWE DRUGINCH 1S/C52H76N22O16/c1-25(2)43(51(89)71-35(10-30-14-58-24-67-30)48(86)63-19-42(81)82)74-41(80)18-61-47(85)34(9-29-13-57-23-66-29)70-50(88)32(5-6-37(54)76)68-38(77)15-60-46(84)33(8-28-12-56-22-65-28)69-39(78)16-62-49(87)36(20-75)72-52(90)44(26(3)4)73-40(79)17-59-45(83)31(53)7-27-11-55-21-64-27/h11-14,21-26,31-36,43-44,75H,5-10,15-20,53H2,1-4H3,(H2,54,76)(H,55,64)(H,56,65)(H,57,66)(H,58,67)(H,59,83)(H,60,84)(H,61,85)(H,62,87)(H,63,86)(H,68,77)(H,69,78)(H,70,88)(H,71,89)(H,72,90)(H,73,79)(H,74,80)(H,81,82)/t31-,32-,33-,34-,35-,36-,43-,44-/m0/s1 D05IWE DRUGINKE XCAPMVINJNSTAF-WXPUDEETSA-N D05IWE DRUGSMIL CC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)NCC(=O)O)NC(=O)CNC(=O)C(CC2=CN=CN2)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CC3=CN=CN3)NC(=O)CNC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC4=CN=CN4)N D05IWE HIGHSTAT Approved D05KEZ DRUG__ID D05KEZ D05KEZ DRUGTYPE Small molecular drug D05KEZ DRUGINCH 1S/C2H5Cl/c1-2-3/h2H2,1H3 D05KEZ DRUGINKE HRYZWHHZPQKTII-UHFFFAOYSA-N D05KEZ DRUGSMIL CCCl D05KEZ HIGHSTAT Approved D05MIL DRUG__ID D05MIL D05MIL DRUGTYPE Small molecular drug D05MIL DRUGINCH 1S/C20H28I3N3O9/c1-9(29)26(5-12(32)8-35-2)18-16(22)13(19(33)24-3-10(30)6-27)15(21)14(17(18)23)20(34)25-4-11(31)7-28/h10-12,27-28,30-32H,3-8H2,1-2H3,(H,24,33)(H,25,34) D05MIL DRUGINKE IUNJANQVIJDFTQ-UHFFFAOYSA-N D05MIL DRUGSMIL CC(=O)N(CC(COC)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I D05MIL HIGHSTAT Approved D05MNW DRUG__ID D05MNW D05MNW DRUGTYPE Small molecular drug D05MNW DRUGINCH 1S/C43H49N7O10.C28H35N3O7/c1-4-29-40(56)49-21-12-17-30(49)41(57)48(3)32(23-26-13-7-5-8-14-26)42(58)50-22-19-28(51)24-31(50)37(53)47-35(27-15-9-6-10-16-27)43(59)60-25(2)34(38(54)45-29)46-39(55)36-33(52)18-11-20-44-36;1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5-11,13-16,18,20,25,29-32,34-35,52H,4,12,17,19,21-24H2,1-3H3,(H,45,54)(H,46,55)(H,47,53);5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b;7-5+,10-9+,18-13+/t25-,29-,30+,31+,32+,34+,35+;19-,20-,26-/m11/s1 D05MNW DRUGINKE MVTQIFVKRXBCHS-SMMNFGSLSA-N D05MNW DRUGSMIL CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CCC(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=CC=C6)C.CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)OC1C(C)C)O)C D05MNW HIGHSTAT Approved D05MPX DRUG__ID D05MPX D05MPX DRUGTYPE Small molecular drug D05MPX DRUGINCH 1S/C21H31NO2/c1-3-22(4-2)13-8-14-24-20(23)21(18-9-6-5-7-10-18)16-17-11-12-19(21)15-17/h5-7,9-10,17,19H,3-4,8,11-16H2,1-2H3 D05MPX DRUGINKE BDNMABJZSXTKAQ-UHFFFAOYSA-N D05MPX DRUGSMIL CCN(CC)CCCOC(=O)C1(CC2CCC1C2)C3=CC=CC=C3 D05MPX HIGHSTAT Approved D05OEU DRUG__ID D05OEU D05OEU DRUGCOMP Ge Healthcare D05OEU DRUGINCH 1S/C4H6O4S2.Tc/c5-3(6)1(9)2(10)4(7)8;/h1-2,9-10H,(H,5,6)(H,7,8);/i;1+1 D05OEU DRUGINKE UEGHKGHBANZTIM-IEOVAKBOSA-N D05OEU DRUGSMIL C(C(C(=O)O)S)(C(=O)O)S.[Tc] D05OEU HIGHSTAT Approved D05PHH DRUG__ID D05PHH D05PHH DRUGTYPE Small molecular drug D05PHH DRUGINCH 1S/C16H23N3O4/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18/h7-10H,2-6,11H2,1H3,(H4,17,18,19) D05PHH DRUGINKE YKGYIDJEEQRWQH-UHFFFAOYSA-N D05PHH DRUGSMIL CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N D05PHH HIGHSTAT Approved D05PLH DRUG__ID D05PLH D05PLH DRUGTYPE Small molecular drug D05PLH DRUGINCH 1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16) D05PLH DRUGINKE OFZCIYFFPZCNJE-UHFFFAOYSA-N D05PLH DRUGSMIL CCCC(C)(COC(=O)N)COC(=O)NC(C)C D05PLH HIGHSTAT Approved D05QPW DRUG__ID D05QPW D05QPW DRUGTYPE Small molecular drug D05QPW DRUGINCH 1S/C7H6O3.C5H14NO/c8-6-4-2-1-3-5(6)7(9)10;1-6(2,3)4-5-7/h1-4,8H,(H,9,10);7H,4-5H2,1-3H3/q;+1/p-1 D05QPW DRUGINKE UDKCHVLMFQVBAA-UHFFFAOYSA-M D05QPW DRUGSMIL C[N+](C)(C)CCO.C1=CC=C(C(=C1)C(=O)O)[O-] D05QPW HIGHSTAT Approved D05ROI DRUG__ID D05ROI D05ROI DRUGTYPE Small molecular drug D05ROI DRUGINCH 1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29) D05ROI DRUGINKE BFSMGDJOXZAERB-UHFFFAOYSA-N D05ROI DRUGSMIL CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F D05ROI HIGHSTAT Approved D05VQI DRUG__ID D05VQI D05VQI DRUGTYPE Small molecular drug D05VQI DRUGINCH 1S/C17H24O3/c1-12-9-14(11-17(2,3)10-12)20-16(19)15(18)13-7-5-4-6-8-13/h4-8,12,14-15,18H,9-11H2,1-3H3 D05VQI DRUGINKE WZHCOOQXZCIUNC-UHFFFAOYSA-N D05VQI DRUGSMIL CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O D05VQI HIGHSTAT Approved D05XQE DRUG__ID D05XQE D05XQE DRUGTYPE Small molecular drug D05XQE DRUGINCH 1S/C20H34O2/c1-17(2)8-5-9-18(3)10-6-12-20(16-22)13-7-11-19(4)14-15-21/h8,10,13-14,21-22H,5-7,9,11-12,15-16H2,1-4H3/b18-10+,19-14+,20-13- D05XQE DRUGINKE SUWYPNNPLSRNPS-UNTSEYQFSA-N D05XQE DRUGSMIL CC(=CCCC(=CCCC(=CCCC(=CCO)C)CO)C)C D05XQE HIGHSTAT Approved D05YBZ DRUG__ID D05YBZ D05YBZ DRUGTYPE Small molecular drug D05YBZ DRUGINCH 1S/C15H15N3S.ClH/c1-9-6-13-15(8-11(9)16)19-14-7-10(18(2)3)4-5-12(14)17-13;/h4-8,16H,1-3H3;1H D05YBZ DRUGINKE GEDVVYWLPUPJJZ-UHFFFAOYSA-N D05YBZ DRUGSMIL CC1=CC2=C(C=C1N)SC3=CC(=[N+](C)C)C=CC3=N2.[Cl-] D05YBZ HIGHSTAT Approved D05ZJG DRUG__ID D05ZJG D05ZJG DRUGTYPE Small molecular drug D05ZJG DRUGINCH 1S/C17H21NO5/c1-18-12-7-11(8-13(18)15-14(12)23-15)22-16(20)17(21,9-19)10-5-3-2-4-6-10/h2-6,11-15,19,21H,7-9H2,1H3/t11?,12-,13+,14-,15+,17-/m1/s1 D05ZJG DRUGINKE JEJREKXHLFEVHN-QDXGGTILSA-N D05ZJG DRUGSMIL CN1C2CC(CC1C3C2O3)OC(=O)C(CO)(C4=CC=CC=C4)O D05ZJG HIGHSTAT Approved D05ZSB DRUG__ID D05ZSB D05ZSB DRUGTYPE Small molecular drug D05ZSB DRUGINCH 1S/C205H339N59O63S/c1-30-104(21)159(198(322)225-106(23)163(214)287)259-193(317)142(87-157(285)286)253-184(308)132(77-99(11)12)246-182(306)130(75-97(7)8)244-172(296)117(46-36-38-67-207)231-170(294)118(47-39-68-221-204(215)216)233-189(313)139(84-151(213)274)251-194(318)143(91-266)256-188(312)137(82-113-88-219-93-223-113)241-165(289)108(25)227-169(293)120(51-58-147(209)270)234-173(297)121(52-59-148(210)271)229-164(288)107(24)228-179(303)128(73-95(3)4)243-176(300)123(54-61-150(212)273)236-190(314)140(85-155(281)282)242-166(290)109(26)226-168(292)116(45-35-37-66-206)239-200(324)161(110(27)268)261-178(302)126(65-72-328-29)238-174(298)124(55-62-152(275)276)237-181(305)134(79-101(15)16)254-197(321)158(103(19)20)258-177(301)125(56-63-153(277)278)235-171(295)119(48-40-69-222-205(217)218)232-180(304)129(74-96(5)6)245-183(307)131(76-98(9)10)247-187(311)138(83-114-89-220-94-224-114)250-186(310)136(81-112-43-33-32-34-44-112)255-201(325)162(111(28)269)262-192(316)135(80-102(17)18)248-191(315)141(86-156(283)284)252-185(309)133(78-100(13)14)249-195(319)144(92-267)257-199(323)160(105(22)31-2)260-196(320)145-49-41-70-263(145)203(327)146-50-42-71-264(146)202(326)127(57-64-154(279)280)240-175(299)122(53-60-149(211)272)230-167(291)115(208)90-265/h32-34,43-44,88-89,93-111,115-146,158-162,265-269H,30-31,35-42,45-87,90-92,206-208H2,1-29H3,(H2,209,270)(H2,210,271)(H2,211,272)(H2,212,273)(H2,213,274)(H2,214,287)(H,219,223)(H,220,224)(H,225,322)(H,226,292)(H,227,293)(H,228,303)(H,229,288)(H,230,291)(H,231,294)(H,232,304)(H,233,313)(H,234,297)(H,235,295)(H,236,314)(H,237,305)(H,238,298)(H,239,324)(H,240,299)(H,241,289)(H,242,290)(H,243,300)(H,244,296)(H,245,307)(H,246,306)(H,247,311)(H,248,315)(H,249,319)(H,250,310)(H,251,318)(H,252,309)(H,253,308)(H,254,321)(H,255,325)(H,256,312)(H,257,323)(H,258,301)(H,259,317)(H,260,320)(H,261,302)(H,262,316)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H4,215,216,221)(H4,217,218,222)/t104-,105-,106-,107-,108-,109-,110+,111+,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,158-,159-,160-,161-,162-/m0/s1 D05ZSB DRUGINKE QEEJLLNYQOBRRM-KSHGRFHLSA-N D05ZSB DRUGSMIL CCC(C)C(C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCSC)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(CC3=CN=CN3)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)N)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)N D05ZSB HIGHSTAT Approved D06AEB DRUG__ID D06AEB D06AEB DRUGTYPE Small molecular drug D06AEB DRUGINCH 1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H D06AEB DRUGINKE UXZFQZANDVDGMM-UHFFFAOYSA-N D06AEB DRUGSMIL C1=CC2=C(C(=C(C=C2I)I)O)N=C1 D06AEB HIGHSTAT Approved D06BQU DRUG__ID D06BQU D06BQU DRUGTYPE Small molecular drug D06BQU DRUGINCH 1S/C13H18O7/c14-5-7-3-1-2-4-8(7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-4,9-18H,5-6H2/t9-,10-,11+,12-,13-/m1/s1 D06BQU DRUGINKE NGFMICBWJRZIBI-UJPOAAIJSA-N D06BQU DRUGSMIL C1=CC=C(C(=C1)CO)OC2C(C(C(C(O2)CO)O)O)O D06BQU HIGHSTAT Approved D06BYV DRUG__ID D06BYV D06BYV DRUGTYPE Small molecular drug D06BYV DRUGINCH 1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3 D06BYV DRUGINKE WLWFNJKHKGIJNW-UHFFFAOYSA-N D06BYV DRUGSMIL CN1C(=O)CC(C1=O)C2=CC=CC=C2 D06BYV HIGHSTAT Approved D06CVT DRUG__ID D06CVT D06CVT DRUGTYPE Small molecular drug D06CVT DRUGINCH 1S/C21H25ClN2O4S/c1-24-18-9-6-5-8-16(18)21(23-13-7-3-2-4-10-20(25)26)17-12-11-15(22)14-19(17)29(24,27)28/h5-6,8-9,11-12,14,21,23H,2-4,7,10,13H2,1H3,(H,25,26) D06CVT DRUGINKE JICJBGPOMZQUBB-UHFFFAOYSA-N D06CVT DRUGSMIL CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O D06CVT HIGHSTAT Approved D06ENM DRUG__ID D06ENM D06ENM DRUGTYPE Small molecular drug D06ENM DRUGINCH 1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/t21-/m1/s1 D06ENM DRUGINKE DMNOVGJWPASQDL-OAQYLSRUSA-N D06ENM DRUGSMIL COC1=C(SC=C1)CNCCC2(CCOC3(C2)CCCC3)C4=CC=CC=N4 D06ENM HIGHSTAT Approved D06EPF DRUG__ID D06EPF D06EPF DRUGTYPE Small molecular drug D06EPF DRUGINCH 1S/C52H76O24/c1-18-29(72-34-14-30(43(58)21(4)68-34)73-33-13-28(54)42(57)20(3)67-33)12-26-10-25-11-27(49(66-9)48(63)41(56)19(2)53)50(47(62)39(25)46(61)38(26)40(18)55)76-36-16-31(44(59)23(6)70-36)74-35-15-32(45(60)22(5)69-35)75-37-17-52(8,65)51(64)24(7)71-37/h10,12,19-24,27-28,30-37,41-45,49-51,53-61,64-65H,11,13-17H2,1-9H3/t19-,20-,21-,22-,23-,24-,27+,28-,30-,31-,32-,33+,34+,35+,36+,37+,41+,42-,43-,44-,45+,49+,50+,51-,52+/m1/s1 D06EPF DRUGINKE CFCUWKMKBJTWLW-BKHRDMLASA-N D06EPF DRUGSMIL CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O D06EPF HIGHSTAT Approved D06FVX DRUG__ID D06FVX D06FVX DRUGTYPE Small molecular drug D06FVX DRUGINCH 1S/C19H17NO7.2Na/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11;;/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26);;/q;2*+1/p-2 D06FVX DRUGINKE JQEKDNLKIVGXAU-UHFFFAOYSA-L D06FVX DRUGSMIL CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)[O-])C(=O)C=C(N2CC)C(=O)[O-].[Na+].[Na+] D06FVX HIGHSTAT Approved D06FZX DRUG__ID D06FZX D06FZX DRUGTYPE Small molecular drug D06FZX DRUGINCH 1S/C17H19N3/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16/h1-10H,11-14H2,(H,18,19) D06FZX DRUGINKE REYFJDPCWQRWAA-UHFFFAOYSA-N D06FZX DRUGSMIL C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3 D06FZX HIGHSTAT Approved D06GIP DRUG__ID D06GIP D06GIP DRUGTYPE Small molecular drug D06GIP DRUGINCH 1S/C10H14O/c1-7(2)9-5-4-8(3)6-10(9)11/h4-7,11H,1-3H3 D06GIP DRUGINKE MGSRCZKZVOBKFT-UHFFFAOYSA-N D06GIP DRUGSMIL CC1=CC(=C(C=C1)C(C)C)O D06GIP HIGHSTAT Approved D06GJT DRUG__ID D06GJT D06GJT DRUGTYPE Small molecular drug D06GJT DRUGINCH 1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20) D06GJT DRUGINKE KSEYRUGYKHXGFW-UHFFFAOYSA-N D06GJT DRUGSMIL COC1=CC2=C(C=C1C(=O)NCC3CCCN3CC=C)NN=N2 D06GJT HIGHSTAT Approved D06HCP DRUG__ID D06HCP D06HCP DRUGTYPE Small molecular drug D06HCP DRUGINCH 1S/C12H15AsN6OS2/c14-10-17-11(15)19-12(18-10)16-8-3-1-7(2-4-8)13-21-6-9(5-20)22-13/h1-4,9,20H,5-6H2,(H5,14,15,16,17,18,19) D06HCP DRUGINKE JCYZMTMYPZHVBF-UHFFFAOYSA-N D06HCP DRUGSMIL C1C(S[As](S1)C2=CC=C(C=C2)NC3=NC(=NC(=N3)N)N)CO D06HCP HIGHSTAT Approved D06HZY DRUG__ID D06HZY D06HZY DRUGTYPE Small molecular drug D06HZY DRUGINCH 1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4-,5+,6?/m1/s1 D06HZY DRUGINKE LKDRXBCSQODPBY-VRPWFDPXSA-N D06HZY DRUGSMIL C1C(C(C(C(O1)(CO)O)O)O)O D06HZY HIGHSTAT Approved D06IXT DRUG__ID D06IXT D06IXT DRUGTYPE Small molecular drug D06IXT DRUGINCH 1S/C14H18N2O/c1-10(2)13-11(3)15(4)16(14(13)17)12-8-6-5-7-9-12/h5-10H,1-4H3 D06IXT DRUGINKE PXWLVJLKJGVOKE-UHFFFAOYSA-N D06IXT DRUGSMIL CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(C)C D06IXT HIGHSTAT Approved D06KDP DRUG__ID D06KDP D06KDP DRUGTYPE Small molecular drug D06KDP DRUGINCH 1S/C73H131N3O31/c1-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-52(87)76-44(45(84)33-31-29-27-25-23-21-18-16-14-12-10-8-6-2)41-98-69-61(94)59(92)63(50(39-80)101-69)103-71-62(95)67(107-73(72(96)97)35-46(85)53(74-42(3)82)66(106-73)55(88)47(86)36-77)64(51(40-81)102-71)104-68-54(75-43(4)83)65(57(90)49(38-79)99-68)105-70-60(93)58(91)56(89)48(37-78)100-70/h31,33,44-51,53-71,77-81,84-86,88-95H,5-30,32,34-41H2,1-4H3,(H,74,82)(H,75,83)(H,76,87)(H,96,97)/b33-31+/t44-,45+,46-,47+,48+,49+,50+,51+,53+,54+,55+,56-,57-,58-,59+,60+,61+,62+,63+,64-,65+,66+,67+,68-,69+,70-,71-,73-/m0/s1 D06KDP DRUGINKE QPJBWNIQKHGLAU-IQZHVAEDSA-N D06KDP DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O)NC(=O)C)OC5(CC(C(C(O5)C(C(CO)O)O)NC(=O)C)O)C(=O)O)O)O)O)C(C=CCCCCCCCCCCCCC)O D06KDP HIGHSTAT Approved D06KGV DRUG__ID D06KGV D06KGV DRUGCOMP Celtic Pharmaceuticals; celtic pharma D06KGV DRUGINCH 1S/C208H344N60O63S2/c1-30-106(20)161(165(215)291)263-202(328)163(108(22)32-3)264-184(310)129(58-67-157(285)286)243-182(308)131(70-78-333-29)246-187(313)134(80-99(6)7)250-176(302)118(45-36-37-71-209)237-174(300)120(47-39-73-225-207(218)219)239-194(320)143(89-152(214)276)256-197(323)145(94-270)260-193(319)141(87-115-91-222-96-227-115)248-169(295)112(26)230-172(298)122(51-60-149(211)273)240-177(303)123(52-61-150(212)274)234-168(294)111(25)232-185(311)133(79-98(4)5)249-181(307)124(53-62-151(213)275)241-178(304)125(54-63-153(277)278)235-167(293)110(24)229-171(297)119(46-38-72-224-206(216)217)233-166(292)109(23)231-173(299)130(69-77-332-28)245-179(305)127(56-65-155(281)282)244-188(314)138(84-103(14)15)258-200(326)160(105(18)19)262-183(309)128(57-66-156(283)284)242-175(301)121(48-40-74-226-208(220)221)238-186(312)135(81-100(8)9)251-189(315)136(82-101(10)11)252-192(318)142(88-116-92-223-97-228-116)255-191(317)140(86-114-43-34-33-35-44-114)259-203(329)164(113(27)272)266-196(322)139(85-104(16)17)253-195(321)144(90-159(289)290)257-190(316)137(83-102(12)13)254-198(324)146(95-271)261-201(327)162(107(21)31-2)265-199(325)147-49-41-75-267(147)205(331)148-50-42-76-268(148)204(330)132(59-68-158(287)288)247-180(306)126(55-64-154(279)280)236-170(296)117(210)93-269/h33-35,43-44,91-92,96-113,117-148,160-164,269-272H,30-32,36-42,45-90,93-95,209-210H2,1-29H3,(H2,211,273)(H2,212,274)(H2,213,275)(H2,214,276)(H2,215,291)(H,222,227)(H,223,228)(H,229,297)(H,230,298)(H,231,299)(H,232,311)(H,233,292)(H,234,294)(H,235,293)(H,236,296)(H,237,300)(H,238,312)(H,239,320)(H,240,303)(H,241,304)(H,242,301)(H,243,308)(H,244,314)(H,245,305)(H,246,313)(H,247,306)(H,248,295)(H,249,307)(H,250,302)(H,251,315)(H,252,318)(H,253,321)(H,254,324)(H,255,317)(H,256,323)(H,257,316)(H,258,326)(H,259,329)(H,260,319)(H,261,327)(H,262,309)(H,263,328)(H,264,310)(H,265,325)(H,266,322)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H,289,290)(H4,216,217,224)(H4,218,219,225)(H4,220,221,226)/t106-,107-,108-,109-,110-,111-,112-,113+,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,160-,161-,162-,163-,164-/m0/s1 D06KGV DRUGINKE GBONBLHJMVUBSJ-FAUHKOHMSA-N D06KGV DRUGSMIL CCC(C)C(C(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CC1=CNC=N1)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)CC)NC(=O)C4CCCN4C(=O)C5CCCN5C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)N D06KGV HIGHSTAT Approved D06LBO DRUG__ID D06LBO D06LBO DRUGTYPE Small molecular drug D06LBO DRUGINCH 1S/C18H15ClN2O/c1-14(21-10-9-20-13-21)17-7-2-3-8-18(17)22-12-15-5-4-6-16(19)11-15/h2-11,13H,1,12H2 D06LBO DRUGINKE WHPAGCJNPTUGGD-UHFFFAOYSA-N D06LBO DRUGSMIL C=C(C1=CC=CC=C1OCC2=CC(=CC=C2)Cl)N3C=CN=C3 D06LBO HIGHSTAT Approved D06LHG DRUG__ID D06LHG D06LHG DRUGTYPE Small molecular drug D06LHG DRUGINCH 1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19) D06LHG DRUGINKE ZPAKPRAICRBAOD-UHFFFAOYSA-N D06LHG DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCC(=O)O D06LHG HIGHSTAT Approved D06LOQ DRUG__ID D06LOQ D06LOQ DRUGTYPE Small molecular drug D06LOQ DRUGINCH 1S/C28H29NO4S/c1-31-22-8-5-20(6-9-22)28-27(25-14-7-21(30)19-26(25)34-28)33-24-12-10-23(11-13-24)32-18-17-29-15-3-2-4-16-29/h5-14,19,30H,2-4,15-18H2,1H3 D06LOQ DRUGINKE MCGDSOGUHLTADD-UHFFFAOYSA-N D06LOQ DRUGSMIL COC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)OCCN5CCCCC5 D06LOQ HIGHSTAT Approved D06MQM DRUG__ID D06MQM D06MQM DRUGTYPE Small molecular drug D06MQM DRUGINCH 1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15- D06MQM DRUGINKE DYLGFOYVTXJFJP-MYYYXRDXSA-N D06MQM DRUGSMIL CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O D06MQM HIGHSTAT Approved D06NNU DRUG__ID D06NNU D06NNU DRUGCOMP Ukrainian Anti-Cancer Institute D06NNU DRUGINCH 1S/C66H72N6O15PS.H2O/c1-70(25-43-37(4-7-49-64(43)85-31-76-49)58-46(73)16-34-19-52-55(82-28-79-52)22-40(34)61(58)70)13-10-67-88(89,68-11-14-71(2)26-44-38(5-8-50-65(44)86-32-77-50)59-47(74)17-35-20-53-56(83-29-80-53)23-41(35)62(59)71)69-12-15-72(3)27-45-39(6-9-51-66(45)87-33-78-51)60-48(75)18-36-21-54-57(84-30-81-54)24-42(36)63(60)72;/h4-9,19-24,46-48,58-63,73-75H,10-18,25-33H2,1-3H3,(H3,67,68,69,89);1H2/q+3;/t46-,47-,48+,58?,59?,60?,61?,62?,63?,70?,71?,72?,88?;/m0./s1 D06NNU DRUGINKE FPORNMFLKJTCFO-GIBOVVLPSA-N D06NNU DRUGSMIL C[N+]1(CC2=C(C=CC3=C2OCO3)C4C1C5=CC6=C(C=C5CC4O)OCO6)CCNP(=S)(NCC[N+]7(CC8=C(C=CC9=C8OCO9)C1C7C2=CC3=C(C=C2CC1O)OCO3)C)NCC[N+]1(CC2=C(C=CC3=C2OCO3)C2C1C1=CC3=C(C=C1CC2O)OCO3)C.O D06NNU HIGHSTAT Approved D06OAV DRUG__ID D06OAV D06OAV DRUGTYPE Small molecular drug D06OAV DRUGINCH 1S/C9H10N2O3.Na/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13;/h1-4H,5,10H2,(H,11,14)(H,12,13);/q;+1/p-1 D06OAV DRUGINKE UNZMYCAEMNVPHX-UHFFFAOYSA-M D06OAV DRUGSMIL C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+] D06OAV HIGHSTAT Approved D06OFS DRUG__ID D06OFS D06OFS DRUGTYPE Small molecular drug D06OFS DRUGINCH 1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12) D06OFS DRUGINKE CQXADFVORZEARL-UHFFFAOYSA-N D06OFS DRUGSMIL C1CC1C(C2CC2)NC3=NCCO3 D06OFS HIGHSTAT Approved D06ORU DRUG__ID D06ORU D06ORU DRUGTYPE Small molecular drug D06ORU DRUGINCH 1S/C18H30N2O2/c1-3-5-12-20(13-6-4-2)14-7-15-22-18(21)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15,19H2,1-2H3 D06ORU DRUGINKE HQFWVSGBVLEQGA-UHFFFAOYSA-N D06ORU DRUGSMIL CCCCN(CCCC)CCCOC(=O)C1=CC=C(C=C1)N D06ORU HIGHSTAT Approved D06OSM DRUG__ID D06OSM D06OSM DRUGTYPE Small molecular drug D06OSM DRUGINCH 1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18- D06OSM DRUGINKE CEIJFEGBUDEYSX-FZDBZEDMSA-N D06OSM DRUGSMIL C1CC2CC1C3C2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5 D06OSM HIGHSTAT Approved D06QDR DRUG__ID D06QDR D06QDR DRUGTYPE Small molecular drug D06QDR DRUGINCH 1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1 D06QDR DRUGINKE SUHOQUVVVLNYQR-MRVPVSSYSA-N D06QDR DRUGSMIL C[N+](C)(C)CCOP(=O)([O-])OCC(CO)O D06QDR HIGHSTAT Approved D06REO DRUG__ID D06REO D06REO DRUGTYPE Small molecular drug D06REO DRUGINCH 1S/C16H21NO4.ClH/c1-10(2)17-8-13(19)9-20-14-6-4-5-12-7-15(11(3)18)21-16(12)14;/h4-7,10,13,17,19H,8-9H2,1-3H3;1H D06REO DRUGINKE TVVTWOGRPVJKDJ-UHFFFAOYSA-N D06REO DRUGSMIL CC(C)[NH2+]CC(COC1=CC=CC2=C1OC(=C2)C(=O)C)O.[Cl-] D06REO HIGHSTAT Approved D06RFG DRUG__ID D06RFG D06RFG DRUGTYPE Small molecular drug D06RFG DRUGINCH 1S/C23H32O3.C20H25NO2/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2;1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3;12,17-18,23H,2-10H2,1H3/t18-,19-,20+,21+,23+;17-,18+,19+,20-/m11/s1 D06RFG DRUGINKE LRHSUZNWLAJWRT-GAJBHWORSA-N D06RFG DRUGSMIL CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C.CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O D06RFG HIGHSTAT Approved D06TFE DRUG__ID D06TFE D06TFE DRUGCOMP Cis Bio International Sa D06TFE DRUGINCH 1S/C65H96N16O12S2.Tc/c1-38(2)55-64(92)76-49(26-30-95-37-54(83)72-35-44(69)57(85)74-47(20-10-13-28-67)58(86)79-52(36-94)62(90)73-46(56(70)84)19-9-12-27-66)65(93)81(3)53(32-39-15-5-4-6-16-39)63(91)78-50(31-40-22-24-42(82)25-23-40)60(88)77-51(33-41-34-71-45-18-8-7-17-43(41)45)61(89)75-48(59(87)80-55)21-11-14-29-68;/h4-8,15-18,22-25,34,38,44,46-53,55,71,82,94H,9-14,19-21,26-33,35-37,66-69H2,1-3H3,(H2,70,84)(H,72,83)(H,73,90)(H,74,85)(H,75,89)(H,76,92)(H,77,88)(H,78,91)(H,79,86)(H,80,87);/t44-,46-,47-,48-,49-,50-,51+,52-,53-,55-;/m0./s1 D06TFE DRUGINKE MCEOYGQHDKBYFT-KTABZWLNSA-N D06TFE DRUGSMIL CC(C)C1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)CC5=CC=CC=C5)C)CCSCC(=O)NCC(C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CCCCN)C(=O)N)N.[Tc] D06TFE HIGHSTAT Approved D06TJJ DRUG__ID D06TJJ D06TJJ DRUGTYPE Small molecular drug D06TJJ DRUGINCH 1S/C20H12O5/c21-11-5-7-15-17(9-11)24-18-10-12(22)6-8-16(18)20(15)14-4-2-1-3-13(14)19(23)25-20/h1-10,21-22H D06TJJ DRUGINKE GNBHRKFJIUUOQI-UHFFFAOYSA-N D06TJJ DRUGSMIL C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O D06TJJ HIGHSTAT Approved D06ULU DRUG__ID D06ULU D06ULU DRUGCOMP Scios Inc D06ULU DRUGINCH 1S/C12H22O35S8.9Al.20H2O/c13-48(14,15)37-1-4-6(43-51(22,23)24)8(45-53(28,29)30)9(46-54(31,32)33)11(40-4)42-12(3-39-50(19,20)21)10(47-55(34,35)36)7(44-52(25,26)27)5(41-12)2-38-49(16,17)18;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h4-11H,1-3H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)(H,25,26,27)(H,28,29,30)(H,31,32,33)(H,34,35,36);;;;;;;;;;20*1H2/q;;8*+1;;;;;;;;;;;;;;;;;;;;/p-8/t4-,5-,6-,7-,8+,9-,10+,11-,12+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1............................./s1 D06ULU DRUGINKE YZPQNHUVIVIUCT-JTJNLBSYSA-F D06ULU DRUGSMIL C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al] D06ULU HIGHSTAT Approved D06UNR DRUG__ID D06UNR D06UNR DRUGTYPE Small molecular drug D06UNR DRUGINCH 1S/C3H8O3S3.Na/c4-9(5,6)2-3(8)1-7;/h3,7-8H,1-2H2,(H,4,5,6);/q;+1/p-1 D06UNR DRUGINKE FGGPAWQCCGEWTJ-UHFFFAOYSA-M D06UNR DRUGSMIL C(C(CS(=O)(=O)[O-])S)S.[Na+] D06UNR HIGHSTAT Approved D06VFO DRUG__ID D06VFO D06VFO DRUGTYPE Small molecular drug D06VFO DRUGINCH 1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13-,14+,15+,16-/m0/s1 D06VFO DRUGINKE WTQYWNWRJNXDEG-RBZJEDDUSA-N D06VFO DRUGSMIL CN1C2CC(CC1C(C2)O)OC(=O)C(CO)C3=CC=CC=C3 D06VFO HIGHSTAT Approved D06WEK DRUG__ID D06WEK D06WEK DRUGTYPE Small molecular drug D06WEK DRUGINCH 1S/ClH.H3N/h1H;1H3 D06WEK DRUGINKE NLXLAEXVIDQMFP-UHFFFAOYSA-N D06WEK DRUGSMIL [NH4+].[Cl-] D06WEK HIGHSTAT Approved D06XAE DRUG__ID D06XAE D06XAE DRUGTYPE Small molecular drug D06XAE DRUGINCH 1S/C24H31NO4/c1-5-26-21-10-9-17(14-22(21)27-6-2)13-20-19-16-24(29-8-4)23(28-7-3)15-18(19)11-12-25-20/h9-10,13-16,25H,5-8,11-12H2,1-4H3/b20-13- D06XAE DRUGINKE OMFNSKIUKYOYRG-MOSHPQCFSA-N D06XAE DRUGSMIL CCOC1=C(C=C(C=C1)C=C2C3=CC(=C(C=C3CCN2)OCC)OCC)OCC D06XAE HIGHSTAT Approved D06XWB DRUG__ID D06XWB D06XWB DRUGTYPE Small molecular drug D06XWB DRUGINCH 1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18)/b11-3+/t10-,15+/m0/s1 D06XWB DRUGINKE ZRJBHWIHUMBLCN-YQEJDHNASA-N D06XWB DRUGSMIL CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 D06XWB HIGHSTAT Approved D06XZR DRUG__ID D06XZR D06XZR DRUGTYPE Small molecular drug D06XZR DRUGINCH 1S/C19H21NS/c1-20-11-8-15(9-12-20)19-16-5-3-2-4-14(16)6-7-18-17(19)10-13-21-18/h2-5,10,13H,6-9,11-12H2,1H3 D06XZR DRUGINKE FIADGNVRKBPQEU-UHFFFAOYSA-N D06XZR DRUGSMIL CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1 D06XZR HIGHSTAT Approved D06YPU DRUG__ID D06YPU D06YPU DRUGTYPE Small molecular drug D06YPU DRUGINCH 1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1 D06YPU DRUGINKE HEFNNWSXXWATRW-JTQLQIEISA-N D06YPU DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)O D06YPU HIGHSTAT Approved D07BPO DRUG__ID D07BPO D07BPO DRUGCOMP Valenta Pharmaceuticals D07BPO DRUGINCH 1S/C10H15N3O3/c14-9(2-1-3-10(15)16)12-5-4-8-6-11-7-13-8/h6-7H,1-5H2,(H,11,13)(H,12,14)(H,15,16) D07BPO DRUGINKE KZIMLUFVKJLCCH-UHFFFAOYSA-N D07BPO DRUGSMIL C1=C(NC=N1)CCNC(=O)CCCC(=O)O D07BPO HIGHSTAT Approved D07BSE DRUG__ID D07BSE D07BSE DRUGTYPE Small molecular drug D07BSE DRUGINCH 1S/C28H44N2O23.Na/c1-5(33)29-9-18(11(35)7(3-31)47-25(9)46)49-28-17(41)15(39)20(22(53-28)24(44)45)51-26-10(30-6(2)34)19(12(36)8(4-32)48-26)50-27-16(40)13(37)14(38)21(52-27)23(42)43;/h7-22,25-28,31-32,35-41,46H,3-4H2,1-2H3,(H,29,33)(H,30,34)(H,42,43)(H,44,45);/q;+1/t7-,8-,9-,10-,11-,12-,13+,14+,15-,16-,17-,18-,19-,20+,21+,22+,25-,26+,27-,28-;/m1./s1 D07BSE DRUGINKE YWIVKILSMZOHHF-QJZPQSOGSA-N D07BSE DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)C(=O)O)O)O)O)NC(=O)C)O)O.[Na+] D07BSE HIGHSTAT Approved D07DJQ DRUG__ID D07DJQ D07DJQ DRUGTYPE Small molecular drug D07DJQ DRUGINCH 1S/C29H40N2O4/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3/t18-,21-,24+,25-/m0/s1 D07DJQ DRUGINKE AUVVAXYIELKVAI-CKBKHPSWSA-N D07DJQ DRUGSMIL CCC1CN2CCC3=CC(=C(C=C3C2CC1CC4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC D07DJQ HIGHSTAT Approved D07DSQ DRUG__ID D07DSQ D07DSQ DRUGTYPE Small molecular drug D07DSQ DRUGINCH 1S/C57H70N12O9S2.C2H4O2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58;1-2(3)4/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73);1H3,(H,3,4)/t40-,43+,44+,45+,46-,47+,48+,49+;/m1./s1 D07DSQ DRUGINKE KBIZSMHYSQUHDH-NCACADTJSA-N D07DSQ DRUGSMIL CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N.CC(=O)O D07DSQ HIGHSTAT Approved D07EDB DRUG__ID D07EDB D07EDB DRUGCOMP Receptos San Diego, CA D07EDB DRUGINCH 1S/C23H24N4O3/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3/t20-/m0/s1 D07EDB DRUGINKE XRVDGNKRPOAQTN-FQEVSTJZSA-N D07EDB DRUGSMIL CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)C#N D07EDB HIGHSTAT Approved D07EXH DRUG__ID D07EXH D07EXH DRUGTYPE Small molecular drug D07EXH DRUGINCH 1S/C6H6O3/c7-4-1-5(8)3-6(9)2-4/h1-3,7-9H D07EXH DRUGINKE QCDYQQDYXPDABM-UHFFFAOYSA-N D07EXH DRUGSMIL C1=C(C=C(C=C1O)O)O D07EXH HIGHSTAT Approved D07HZY DRUG__ID D07HZY D07HZY DRUGTYPE Small molecular drug D07HZY DRUGINCH 1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5?/m1/s1 D07HZY DRUGINKE SRBFZHDQGSBBOR-IOVATXLUSA-N D07HZY DRUGSMIL C1C(C(C(C(O1)O)O)O)O D07HZY HIGHSTAT Approved D07IEF DRUG__ID D07IEF D07IEF DRUGTYPE Small molecular drug D07IEF DRUGINCH 1S/C22H19NO4/c1-15(24)26-19-10-6-17(7-11-19)22(21-5-3-4-14-23-21)18-8-12-20(13-9-18)27-16(2)25/h3-14,22H,1-2H3 D07IEF DRUGINKE KHOITXIGCFIULA-UHFFFAOYSA-N D07IEF DRUGSMIL CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3 D07IEF HIGHSTAT Approved D07JAG DRUG__ID D07JAG D07JAG DRUGCOMP Abbvie D07JAG DRUGINCH 1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1 D07JAG DRUGINKE WYQFJHHDOKWSHR-MNOVXSKESA-N D07JAG DRUGSMIL CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F D07JAG HIGHSTAT Approved D07JWT DRUG__ID D07JWT D07JWT DRUGTYPE Small molecular drug D07JWT DRUGINCH 1S/C20H25N3S/c1-21-13-15-22(16-14-21)11-6-12-23-17-7-2-4-9-19(17)24-20-10-5-3-8-18(20)23/h2-5,7-10H,6,11-16H2,1H3 D07JWT DRUGINKE WEYVCQFUGFRXOM-UHFFFAOYSA-N D07JWT DRUGSMIL CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=CC=CC=C42 D07JWT HIGHSTAT Approved D07MCK DRUG__ID D07MCK D07MCK DRUGTYPE Small molecular drug D07MCK DRUGINCH 1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10) D07MCK DRUGINKE SKZKKFZAGNVIMN-UHFFFAOYSA-N D07MCK DRUGSMIL C1=CC=C(C(=C1)C(=O)N)O D07MCK HIGHSTAT Approved D07MEH DRUG__ID D07MEH D07MEH DRUGTYPE Small molecular drug D07MEH DRUGINCH 1S/C15H20Cl2N2O3/c1-3-19-6-4-5-9(19)8-18-15(21)12-13(20)10(16)7-11(17)14(12)22-2/h7,9,20H,3-6,8H2,1-2H3,(H,18,21)/t9-/m0/s1 D07MEH DRUGINKE WAOQONBSWFLFPE-VIFPVBQESA-N D07MEH DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C(=CC(=C2OC)Cl)Cl)O D07MEH HIGHSTAT Approved D07ORO DRUG__ID D07ORO D07ORO DRUGTYPE Small molecular drug D07ORO DRUGINCH 1S/C45H73NO15/c1-19-9-14-45(46-17-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(53)34(51)32(49)22(4)56-41)37(54)38(29(18-47)58-42)59-40-35(52)33(50)31(48)21(3)55-40/h7,19-22,24-42,46-54H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43+,44+,45-/m1/s1 D07ORO DRUGINKE MBWUSSKCCUMJHO-ZGXDEBHDSA-N D07ORO DRUGSMIL CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)NC1 D07ORO HIGHSTAT Approved D07PAO DRUG__ID D07PAO D07PAO DRUGTYPE Small molecular drug D07PAO DRUGINCH 1S/C12H14N4O4S/c1-19-10-11(14-7-15-12(10)20-2)16-21(17,18)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H,14,15,16) D07PAO DRUGINKE PJSFRIWCGOHTNF-UHFFFAOYSA-N D07PAO DRUGSMIL COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N D07PAO HIGHSTAT Approved D07QKN DRUG__ID D07QKN D07QKN DRUGTYPE Small molecular drug D07QKN DRUGINCH 1S/C10H20O2.H2O/c1-9(2,11)8-4-6-10(3,12)7-5-8;/h8,11-12H,4-7H2,1-3H3;1H2 D07QKN DRUGINKE JGKJMBOJWVAMIJ-UHFFFAOYSA-N D07QKN DRUGSMIL CC1(CCC(CC1)C(C)(C)O)O.O D07QKN HIGHSTAT Approved D07QLG DRUG__ID D07QLG D07QLG DRUGTYPE Small molecular drug D07QLG DRUGINCH 1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3/t7-,10-/m0/s1 D07QLG DRUGINKE OXFGTKPPFSCSMA-XVKPBYJWSA-N D07QLG DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)NC D07QLG HIGHSTAT Approved D07QQD DRUG__ID D07QQD D07QQD DRUGTYPE Small molecular drug D07QQD DRUGINCH 1S/C55H86O24/c1-10-23(2)46(71)79-43-44(72-24(3)60)55(22-59)26(17-50(43,4)5)25-11-12-30-51(6)15-14-32(52(7,21-58)29(51)13-16-53(30,8)54(25,9)18-31(55)61)75-49-41(77-48-38(67)36(65)34(63)28(20-57)74-48)39(68)40(42(78-49)45(69)70)76-47-37(66)35(64)33(62)27(19-56)73-47/h10-11,26-44,47-49,56-59,61-68H,12-22H2,1-9H3,(H,69,70)/b23-10-/t26-,27+,28+,29+,30+,31+,32-,33+,34+,35-,36-,37+,38+,39-,40-,41+,42-,43-,44-,47-,48-,49+,51-,52+,53+,54+,55-/m0/s1 D07QQD DRUGINKE AXNVHPCVMSNXNP-OXPBSUTMSA-N D07QQD DRUGSMIL CC=C(C)C(=O)OC1C(C2(C(CC1(C)C)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)CO)OC6C(C(C(C(O6)C(=O)O)OC7C(C(C(C(O7)CO)O)O)O)O)OC8C(C(C(C(O8)CO)O)O)O)C)CO)OC(=O)C D07QQD HIGHSTAT Approved D07SJT DRUG__ID D07SJT D07SJT DRUGTYPE Small molecular drug D07SJT DRUGINCH 1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/t7-/m0/s1 D07SJT DRUGINKE GHOKWGTUZJEAQD-ZETCQYMHSA-N D07SJT DRUGSMIL CC(C)(CO)C(C(=O)NCCC(=O)O)O D07SJT HIGHSTAT Approved D07UWJ DRUG__ID D07UWJ D07UWJ DRUGTYPE Small molecular drug D07UWJ DRUGINCH 1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3 D07UWJ DRUGINKE OJGDCBLYJGHCIH-UHFFFAOYSA-N D07UWJ DRUGSMIL CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2 D07UWJ HIGHSTAT Approved D07WXE DRUG__ID D07WXE D07WXE DRUGTYPE Small molecular drug D07WXE DRUGINCH 1S/C8H15N3O4/c1-4(9)7(13)11-5(8(14)15)2-3-6(10)12/h4-5H,2-3,9H2,1H3,(H2,10,12)(H,11,13)(H,14,15)/t4-,5-/m0/s1 D07WXE DRUGINKE HJCMDXDYPOUFDY-WHFBIAKZSA-N D07WXE DRUGSMIL CC(C(=O)NC(CCC(=O)N)C(=O)O)N D07WXE HIGHSTAT Approved D07XGH DRUG__ID D07XGH D07XGH DRUGTYPE Small molecular drug D07XGH DRUGINCH 1S/C43H49N7O10.C28H35N3O7/c1-4-29-40(56)49-21-12-17-30(49)41(57)48(3)32(23-26-13-7-5-8-14-26)42(58)50-22-19-28(51)24-31(50)37(53)47-35(27-15-9-6-10-16-27)43(59)60-25(2)34(38(54)45-29)46-39(55)36-33(52)18-11-20-44-36;1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5-11,13-16,18,20,25,29-32,34-35,52H,4,12,17,19,21-24H2,1-3H3,(H,45,54)(H,46,55)(H,47,53);5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b;7-5-,10-9-,18-13- D07XGH DRUGINKE MVTQIFVKRXBCHS-FHWPYUEJSA-N D07XGH DRUGSMIL CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CCC(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=CC=C6)C.CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)OC1C(C)C)O)C D07XGH HIGHSTAT Approved D07XHO DRUG__ID D07XHO D07XHO DRUGTYPE Small molecular drug D07XHO DRUGINCH 1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24) D07XHO DRUGINKE MQQNFDZXWVTQEH-UHFFFAOYSA-N D07XHO DRUGSMIL C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N D07XHO HIGHSTAT Approved D07XVR DRUG__ID D07XVR D07XVR DRUGTYPE Small molecular drug D07XVR DRUGINCH 1S/5CN.Fe.NO.2Na.2H2O/c5*1-2;;1-2;;;;/h;;;;;;;;;2*1H2/q5*-1;+4;-1;2*+1;; D07XVR DRUGINKE XRKMNJXYOFSTBE-UHFFFAOYSA-N D07XVR DRUGSMIL [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4] D07XVR HIGHSTAT Approved D07YWY DRUG__ID D07YWY D07YWY DRUGTYPE Small molecular drug D07YWY DRUGINCH 1S/C24H33NO3/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3 D07YWY DRUGINKE KBAFPSLPKGSANY-UHFFFAOYSA-N D07YWY DRUGSMIL CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32 D07YWY HIGHSTAT Approved D07ZRI DRUG__ID D07ZRI D07ZRI DRUGCOMP Mallinckrodt Medical Inc D07ZRI DRUGINCH 1S/CH6O7P2.Tc/c2-1(9(3,4)5)10(6,7)8;/h1-2H,(H2,3,4,5)(H2,6,7,8);/i;1+1 D07ZRI DRUGINKE SIJNDWFHVBDXDY-IEOVAKBOSA-N D07ZRI DRUGSMIL C(O)(P(=O)(O)O)P(=O)(O)O.[Tc] D07ZRI HIGHSTAT Approved D08BDT DRUG__ID D08BDT D08BDT DRUGTYPE Small molecular drug D08BDT DRUGINCH 1S/C25H29BrF2O7/c1-12(29)34-11-21(33)24(35-13(2)30)6-5-14-15-7-18(27)16-8-19(31)17(26)9-23(16,4)25(15,28)20(32)10-22(14,24)3/h8-9,14-15,18,20,32H,5-7,10-11H2,1-4H3/t14-,15-,18+,20-,22-,23-,24-,25-/m0/s1 D08BDT DRUGINKE YCISZOVUHXIOFY-HKXOFBAYSA-N D08BDT DRUGSMIL CC(=O)OCC(=O)C1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C(=CC43C)Br)F)F)O)C)OC(=O)C D08BDT HIGHSTAT Approved D08CVQ DRUG__ID D08CVQ D08CVQ DRUGCOMP Isis Pharmaceuticals D08CVQ THERCLAS Antisense D08CVQ DRUGTYPE Antisense drug D08CVQ DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)([O-])SC3CC(OC3COP(=O)([O-])SC4CC(OC4COP(=O)([O-])SC5CC(OC5COP(=O)([O-])SC6CC(OC6COP(=O)([O-])SC7CC(OC7COP(=O)([O-])SC8CC(OC8COP(=O)([O-])SC9CC(OC9COP(=O)([O-])SC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])SC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)([O-])SC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])SC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])SC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)CO)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)SP(=O)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)SP(=O)([O-])OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)SP(=O)([O-])OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)SP(=O)([O-])OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)SP(=O)([O-])OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)SP(=O)([O-])OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)SP(=O)([O-])OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O D08CVQ HIGHSTAT Approved D08EVN DRUG__ID D08EVN D08EVN DRUGTYPE Small molecular drug D08EVN DRUGINCH 1S/C15H18I3NO3.Na/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22;/h7-8H,3-6H2,1-2H3,(H,19,20)(H,21,22);/q;+1/p-1 D08EVN DRUGINKE KTVKGXZZBQCBGD-UHFFFAOYSA-M D08EVN DRUGSMIL CCCC(=O)NC1=C(C=C(C(=C1I)CC(CC)C(=O)[O-])I)I.[Na+] D08EVN HIGHSTAT Approved D08GJO DRUG__ID D08GJO D08GJO DRUGTYPE Small molecular drug D08GJO DRUGINCH 1S/C17H15NO5/c1-11(19)18-13-7-9-14(10-8-13)23-17(21)15-5-3-4-6-16(15)22-12(2)20/h3-10H,1-2H3,(H,18,19) D08GJO DRUGINKE FEJKLNWAOXSSNR-UHFFFAOYSA-N D08GJO DRUGSMIL CC(=O)NC1=CC=C(C=C1)OC(=O)C2=CC=CC=C2OC(=O)C D08GJO HIGHSTAT Approved D08GUZ DRUG__ID D08GUZ D08GUZ DRUGTYPE Small molecular drug D08GUZ DRUGINCH 1S/C43H72N14O14/c1-21(2)33(44)40(69)51-23(5)36(65)55-34(22(3)4)41(70)49-19-29(58)52-25(12-14-31(60)61)37(66)54-26(13-15-32(62)63)42(71)57-18-8-10-27(57)38(67)50-20-30(59)56-17-7-11-28(56)39(68)53-24(35(45)64)9-6-16-48-43(46)47/h21-28,33-34H,6-20,44H2,1-5H3,(H2,45,64)(H,49,70)(H,50,67)(H,51,69)(H,52,58)(H,53,68)(H,54,66)(H,55,65)(H,60,61)(H,62,63)(H4,46,47,48)/t23-,24-,25-,26-,27-,28-,33-,34-/m0/s1 D08GUZ DRUGINKE BDIVMSNLPYLUFI-FYNIJPSQSA-N D08GUZ DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N1CCCC1C(=O)NCC(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)N)N D08GUZ HIGHSTAT Approved D08HJT DRUG__ID D08HJT D08HJT DRUGTYPE Small molecular drug D08HJT DRUGINCH 1S/C61H88N18O21S2/c1-24-39(76-52(79-50(24)64)31(16-37(63)83)71-17-30(62)51(65)89)56(93)78-41(47(32-18-67-23-72-32)98-60-49(45(87)43(85)35(19-80)97-60)99-59-46(88)48(100-61(66)95)44(86)36(20-81)96-59)57(94)73-27(4)42(84)25(2)53(90)77-40(28(5)82)55(92)70-15-12-38-74-34(22-101-38)58-75-33(21-102-58)54(91)69-14-9-13-68-26(3)29-10-7-6-8-11-29/h6-8,10-11,18,21-23,25-28,30-31,35-36,40-49,59-60,68,71,80-82,84-88H,9,12-17,19-20,62H2,1-5H3,(H2,63,83)(H2,65,89)(H2,66,95)(H,67,72)(H,69,91)(H,70,92)(H,73,94)(H,77,90)(H,78,93)(H2,64,76,79)/t25-,26-,27+,28+,30-,31-,35-,36+,40-,41-,42-,43+,44+,45-,46-,47-,48-,49-,59+,60-/m0/s1 D08HJT DRUGINKE QIMGFXOHTOXMQP-GFAGFCTOSA-N D08HJT DRUGSMIL CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCNC(C)C7=CC=CC=C7)O D08HJT HIGHSTAT Approved D08NNW DRUG__ID D08NNW D08NNW DRUGTYPE Small molecular drug D08NNW DRUGINCH 1S/BH3O3/c2-1(3)4/h2-4H D08NNW DRUGINKE KGBXLFKZBHKPEV-UHFFFAOYSA-N D08NNW DRUGSMIL B(O)(O)O D08NNW HIGHSTAT Approved D08PSU DRUG__ID D08PSU D08PSU DRUGTYPE Small molecular drug D08PSU DRUGINCH 1S/C12H21NO20S3/c14-4-3(13-34(20,21)22)11(19)30-2(1-29-35(23,24)25)7(4)31-12-9(33-36(26,27)28)6(16)5(15)8(32-12)10(17)18/h2-9,11-16,19H,1H2,(H,17,18)(H,20,21,22)(H,23,24,25)(H,26,27,28)/p-4/t2-,3?,4-,5?,6+,7?,8?,9?,11?,12-/m1/s1 D08PSU DRUGINKE OHJKXVLJWUPWQG-IUYNYSEKSA-J D08PSU DRUGSMIL C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-] D08PSU HIGHSTAT Approved D08QJS DRUG__ID D08QJS D08QJS DRUGTYPE Small molecular drug D08QJS DRUGINCH 1S/C10H12N4O3.C7H6O3.Na/c1-14-4-9(16)5-2-6(12-13-10(11)17)8(15)3-7(5)14;8-6-4-2-1-3-5(6)7(9)10;/h2-3,9,15-16H,4H2,1H3,(H2,11,17);1-4,8H,(H,9,10);/q;;+1/p-1 D08QJS DRUGINKE JZMQADOQZYQTFU-UHFFFAOYSA-M D08QJS DRUGSMIL CN1CC(C2=CC(=C(C=C21)O)N=NC(=O)N)O.C1=CC=C(C(=C1)C(=O)[O-])O.[Na+] D08QJS HIGHSTAT Approved D08QKJ DRUG__ID D08QKJ D08QKJ DRUGTYPE Small molecular drug D08QKJ DRUGINCH 1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 D08QKJ DRUGINKE LKAJKIOFIWVMDJ-IYRCEVNGSA-N D08QKJ DRUGSMIL CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C D08QKJ HIGHSTAT Approved D08RIB DRUG__ID D08RIB D08RIB DRUGTYPE Small molecular drug D08RIB DRUGINCH 1S/C10H16N2O8.2Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;/q;2*+1/p-2 D08RIB DRUGINKE ZGTMUACCHSMWAC-UHFFFAOYSA-L D08RIB DRUGSMIL C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].[Na+].[Na+] D08RIB HIGHSTAT Approved D08SVH DRUG__ID D08SVH D08SVH DRUGTYPE Small molecular drug D08SVH DRUGINCH 1S/C27H44O3/c1-17(2)25(29)13-8-18(3)23-11-12-24-20(7-6-14-27(23,24)5)9-10-21-15-22(28)16-26(30)19(21)4/h9-10,17-18,22-26,28-30H,4,6-8,11-16H2,1-3,5H3/b20-9+,21-10-/t18-,22-,23-,24+,25-,26+,27-/m1/s1 D08SVH DRUGINKE BJYLYJCXYAMOFT-RSFVBTMBSA-N D08SVH DRUGSMIL CC(C)C(CCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O D08SVH HIGHSTAT Approved D08TPS DRUG__ID D08TPS D08TPS DRUGTYPE Small molecular drug D08TPS DRUGINCH 1S/C257H381N73O83S7/c1-20-123(15)203(245(404)283-103-192(351)285-157(80-127-42-52-135(339)53-43-127)222(381)313-171(104-331)210(369)281-101-191(350)287-167(92-198(360)361)228(387)290-146(37-27-70-273-255(265)266)213(372)318-177(110-414)238(397)292-148(62-65-185(259)344)217(376)327-205(125(17)337)249(408)294-147(38-28-71-274-256(267)268)212(371)309-168(93-199(362)363)229(388)298-153(76-117(3)4)218(377)289-145(36-26-69-272-254(263)264)211(370)303-162(86-133-96-277-144-35-25-23-33-141(133)144)226(385)304-161(85-132-95-276-143-34-24-22-32-140(132)143)225(384)291-149(63-66-195(354)355)214(373)297-154(77-118(5)6)219(378)296-152(253(412)413)39-29-72-275-257(269)270)326-247(406)202(122(13)14)324-242(401)181(114-418)320-227(386)165(90-188(262)347)307-241(400)180(113-417)322-250(409)206(126(18)338)328-231(390)160(83-130-48-58-138(342)59-49-130)302-234(393)174(107-334)315-230(389)169(94-200(364)365)310-221(380)155(78-119(7)8)299-233(392)173(106-333)314-215(374)150(64-67-196(356)357)295-248(407)204(124(16)21-2)325-232(391)163(87-134-97-271-116-284-134)305-216(375)151(68-75-420-19)293-239(398)179(112-416)321-246(405)201(121(11)12)323-194(353)99-278-189(348)98-279-208(367)164(89-187(261)346)306-220(379)156(79-120(9)10)300-240(399)178(111-415)319-223(382)158(81-128-44-54-136(340)55-45-128)286-190(349)100-280-209(368)166(91-197(358)359)308-224(383)159(82-129-46-56-137(341)57-47-129)301-235(394)175(108-335)316-237(396)176(109-336)317-244(403)184-41-31-74-330(184)252(411)182(115-419)288-193(352)102-282-243(402)183-40-30-73-329(183)251(410)170(84-131-50-60-139(343)61-51-131)311-236(395)172(105-332)312-207(366)142(258)88-186(260)345/h22-25,32-35,42-61,95-97,116-126,142,145-184,201-206,276-277,331-343,414-419H,20-21,26-31,36-41,62-94,98-115,258H2,1-19H3,(H2,259,344)(H2,260,345)(H2,261,346)(H2,262,347)(H,271,284)(H,278,348)(H,279,367)(H,280,368)(H,281,369)(H,282,402)(H,283,404)(H,285,351)(H,286,349)(H,287,350)(H,288,352)(H,289,377)(H,290,387)(H,291,384)(H,292,397)(H,293,398)(H,294,408)(H,295,407)(H,296,378)(H,297,373)(H,298,388)(H,299,392)(H,300,399)(H,301,394)(H,302,393)(H,303,370)(H,304,385)(H,305,375)(H,306,379)(H,307,400)(H,308,383)(H,309,371)(H,310,380)(H,311,395)(H,312,366)(H,313,381)(H,314,374)(H,315,389)(H,316,396)(H,317,403)(H,318,372)(H,319,382)(H,320,386)(H,321,405)(H,322,409)(H,323,353)(H,324,401)(H,325,391)(H,326,406)(H,327,376)(H,328,390)(H,354,355)(H,356,357)(H,358,359)(H,360,361)(H,362,363)(H,364,365)(H,412,413)(H4,263,264,272)(H4,265,266,273)(H4,267,268,274)(H4,269,270,275)/t123-,124-,125+,126+,142-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,201-,202-,203-,204-,205-,206-/m0/s1 D08TPS DRUGINKE VBEQCZHXXJYVRD-GACYYNSASA-N D08TPS DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)NC(C(C)C)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CS)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC7=CN=CN7)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)CNC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CS)NC(=O)CNC(=O)C1CCCN1C(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)N D08TPS HIGHSTAT Approved D08UGJ DRUG__ID D08UGJ D08UGJ DRUGTYPE Small molecular drug D08UGJ DRUGINCH 1S/C21H26N2O3/c1-3-20-10-6-11-22-12-9-15-14-7-4-5-8-16(14)23(17(15)18(20)22)21(25,13-20)19(24)26-2/h4-5,7-8,18,25H,3,6,9-13H2,1-2H3/t18-,20+,21+/m1/s1 D08UGJ DRUGINKE RXPRRQLKFXBCSJ-GIVPXCGWSA-N D08UGJ DRUGSMIL CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(C2)(C(=O)OC)O D08UGJ HIGHSTAT Approved D08VRX DRUG__ID D08VRX D08VRX DRUGTYPE Small molecular drug D08VRX DRUGINCH 1S/C45H55N9O6/c1-27(47)41(56)52-38(24-30-19-20-31-14-6-7-15-32(31)22-30)43(58)50-28(2)42(57)53-39(25-33-26-49-35-17-9-8-16-34(33)35)45(60)54-37(23-29-12-4-3-5-13-29)44(59)51-36(40(48)55)18-10-11-21-46/h3-9,12-17,19-20,22,26-28,36-39,49H,10-11,18,21,23-25,46-47H2,1-2H3,(H2,48,55)(H,50,58)(H,51,59)(H,52,56)(H,53,57)(H,54,60)/t27-,28+,36+,37-,38-,39+/m1/s1 D08VRX DRUGINKE HRNLPPBUBKMZMT-RDRUQFPZSA-N D08VRX DRUGSMIL CC(C(=O)NC(CC1=CC2=CC=CC=C2C=C1)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)N D08VRX HIGHSTAT Approved D08VXL DRUG__ID D08VXL D08VXL DRUGTYPE Small molecular drug D08VXL DRUGINCH 1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3 D08VXL DRUGINKE XLFWDASMENKTKL-UHFFFAOYSA-N D08VXL DRUGSMIL CCOC(=NC1=C[N+](=NO1)N2CCOCC2)[O-] D08VXL HIGHSTAT Approved D08VYC DRUG__ID D08VYC D08VYC DRUGTYPE Small molecular drug D08VYC DRUGINCH 1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3 D08VYC DRUGINKE NBIIXXVUZAFLBC-UHFFFAOYSA-K D08VYC DRUGSMIL [O-]P(=O)([O-])[O-] D08VYC HIGHSTAT Approved D08YPZ DRUG__ID D08YPZ D08YPZ DRUGTYPE Small molecular drug D08YPZ DRUGINCH 1S/ClH.Hg.H2N/h1H;;1H2/q;+2;-1/p-1 D08YPZ DRUGINKE WRWRKDRWMURIBI-UHFFFAOYSA-M D08YPZ DRUGSMIL [NH2-].[Cl-].[Hg+2] D08YPZ HIGHSTAT Approved D08ZBU DRUG__ID D08ZBU D08ZBU DRUGCOMP Bracco Diagnostics Inc D08ZBU DRUGINCH 1S/C62H90N13O14P.C62H88N13O14P.2CN.2ClH.3Co/c2*1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;2*1-2;;;;;/h20-21,23,28,31,34-37,41,52-53,56-57,71,76,84H,12-19,22,24-27H2,1-11H3,(H2,63,77)(H2,64,78)(H2,65,79)(H2,66,80)(H2,67,81)(H2,68,82)(H,69,83)(H,85,86);20-21,23,28,31,34-37,41,52-53,57,76,84H,12-19,22,24-27H2,1-11H3,(H2,63,77)(H2,64,78)(H2,65,79)(H2,66,80)(H2,67,81)(H2,68,82)(H,69,83)(H,85,86);;;2*1H;;;/q;;2*-1;;;+3;2*+2/p-3/b38-23-,50-32-,55-33-;42-23-,54-32-,55-33-;;;;;;;/t31-,34+,35+,36+,37-,41+,52+,53+,56?,57-,59+,60-,61-,62-;31?,34?,35?,36?,37?,41-,52?,53?,57+,59?,60?,61?,62?;;;;;;;/m01......./s1/i;;;;;;1+1;; D08ZBU DRUGINKE PJHYEMLVIZVDIW-ACDNXVHASA-K D08ZBU DRUGSMIL CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)(O)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5=NC4=C(C6=NC(=CC7=NC(=C(C8=NC5(C(C8CCC(=O)N)(C)CC(=O)N)C)C)C(C7CCC(=O)N)(C)CC(=O)N)C(C6CCC(=O)N)(C)C)C)CC(=O)N)C)O.[C-]#N.[C-]#N.Cl[Co]Cl.[Co+2].[Co+3] D08ZBU HIGHSTAT Approved D09AAK DRUG__ID D09AAK D09AAK DRUGCOMP Deciphera Pharmaceuticals Waltham, MA D09AAK DRUGINCH 1S/C24H21BrFN5O2/c1-3-31-21-12-22(27-2)28-13-14(21)9-17(23(31)32)16-10-20(19(26)11-18(16)25)30-24(33)29-15-7-5-4-6-8-15/h4-13H,3H2,1-2H3,(H,27,28)(H2,29,30,33) D09AAK DRUGINKE CEFJVGZHQAGLHS-UHFFFAOYSA-N D09AAK DRUGSMIL CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC D09AAK HIGHSTAT Approved D09CIQ DRUG__ID D09CIQ D09CIQ DRUGTYPE Small molecular drug D09CIQ DRUGINCH 1S/C12H21N5O3/c1-4-17(8-9(3)18)11-7-6-10(13-15-11)14-16-12(19)20-5-2/h6-7,9,18H,4-5,8H2,1-3H3,(H,13,14)(H,16,19) D09CIQ DRUGINKE QLTVVOATEHFXLT-UHFFFAOYSA-N D09CIQ DRUGSMIL CCN(CC(C)O)C1=NN=C(C=C1)NNC(=O)OCC D09CIQ HIGHSTAT Approved D09GRX DRUG__ID D09GRX D09GRX DRUGCOMP Seattle Genetics Bothell, WA D09GRX DRUGINCH 1S/C26H24N8O2/c1-16-10-17(5-7-22(16)36-19-8-9-34-23(12-19)28-15-30-34)31-24-20-11-18(4-6-21(20)27-14-29-24)32-25-33-26(2,3)13-35-25/h4-12,14-15H,13H2,1-3H3,(H,32,33)(H,27,29,31) D09GRX DRUGINKE SDEAXTCZPQIFQM-UHFFFAOYSA-N D09GRX DRUGSMIL CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5 D09GRX HIGHSTAT Approved D09HTS DRUG__ID D09HTS D09HTS DRUGTYPE Small molecular drug D09HTS DRUGINCH 1S/C49H76O19/c1-22-43(66-38-18-33(53)44(23(2)61-38)67-39-19-34(63-25(4)51)45(24(3)62-39)68-46-42(57)41(56)40(55)35(20-50)65-46)32(52)17-37(60-22)64-28-9-12-47(5)27(16-28)7-8-31-30(47)10-13-48(6)29(11-14-49(31,48)58)26-15-36(54)59-21-26/h15,22-24,27-35,37-46,50,52-53,55-58H,7-14,16-21H2,1-6H3/t22-,23-,24-,27-,28+,29-,30+,31-,32+,33+,34+,35-,37+,38+,39+,40-,41+,42-,43-,44-,45-,46+,47+,48-,49+/m1/s1 D09HTS DRUGINKE YFGQJKBUXPKSAW-YSTAXILLSA-N D09HTS DRUGSMIL CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)OC(=O)C)O D09HTS HIGHSTAT Approved D09KDV DRUG__ID D09KDV D09KDV DRUGTYPE Small molecular drug D09KDV DRUGINCH 1S/C3H6O3/c4-1-3(6)2-5/h4-5H,1-2H2 D09KDV DRUGINKE RXKJFZQQPQGTFL-UHFFFAOYSA-N D09KDV DRUGSMIL C(C(=O)CO)O D09KDV HIGHSTAT Approved D09KGQ DRUG__ID D09KGQ D09KGQ DRUGTYPE Small molecular drug D09KGQ DRUGINCH 1S/C11H12O8P2.4Na/c1-7-6-10(18-20(12,13)14)8-4-2-3-5-9(8)11(7)19-21(15,16)17;;;;/h2-6H,1H3,(H2,12,13,14)(H2,15,16,17);;;;/q;4*+1/p-4 D09KGQ DRUGINKE GZBACHSOZNEZOG-UHFFFAOYSA-J D09KGQ DRUGSMIL CC1=C(C2=CC=CC=C2C(=C1)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+] D09KGQ HIGHSTAT Approved D09LBS DRUG__ID D09LBS D09LBS DRUGTYPE Small molecular drug D09LBS DRUGINCH 1S/C42H38O20/c43-11-23-31(47)35(51)37(53)41(61-23)59-21-5-1-3-15-25(17-7-13(39(55)56)9-19(45)27(17)33(49)29(15)21)26-16-4-2-6-22(60-42-38(54)36(52)32(48)24(12-44)62-42)30(16)34(50)28-18(26)8-14(40(57)58)10-20(28)46/h1-10,23-26,31-32,35-38,41-48,51-54H,11-12H2,(H,55,56)(H,57,58)/t23-,24-,25-,26+,31-,32-,35+,36+,37-,38-,41-,42-/m1/s1 D09LBS DRUGINKE IPQVTOJGNYVQEO-AIFLABODSA-N D09LBS DRUGSMIL C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)OC7C(C(C(C(O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O D09LBS HIGHSTAT Approved D09LSX DRUG__ID D09LSX D09LSX DRUGTYPE Small molecular drug D09LSX DRUGINCH 1S/C21H21FN4O2/c22-18-7-6-14(12-17(18)21(28)26-10-3-8-23-9-11-26)13-19-15-4-1-2-5-16(15)20(27)25-24-19/h1-2,4-7,12,23H,3,8-11,13H2,(H,25,27) D09LSX DRUGINKE HGEPGGJUGUMFHT-UHFFFAOYSA-N D09LSX DRUGSMIL C1CNCCN(C1)C(=O)C2=C(C=CC(=C2)CC3=NNC(=O)C4=CC=CC=C43)F D09LSX HIGHSTAT Approved D09MPU DRUG__ID D09MPU D09MPU DRUGTYPE Small molecular drug D09MPU DRUGINCH 1S/C17H35N5O6.2H2O4S/c1-7(19)9-5-4-8(20)17(27-9)28-15-11(21)13(24)16(26-3)12(14(15)25)22(2)10(23)6-18;2*1-5(2,3)4/h7-9,11-17,24-25H,4-6,18-21H2,1-3H3;2*(H2,1,2,3,4)/t7-,8+,9-,11-,12-,13-,14+,15+,16+,17+;;/m0../s1 D09MPU DRUGINKE TYNZVWXDLOJTIM-QQFWICJTSA-N D09MPU DRUGSMIL CC(C1CCC(C(O1)OC2C(C(C(C(C2O)N(C)C(=O)CN)OC)O)N)N)N.OS(=O)(=O)O.OS(=O)(=O)O D09MPU HIGHSTAT Approved D09NYU DRUG__ID D09NYU D09NYU DRUGTYPE Small molecular drug D09NYU DRUGINCH 1S/C9H14N4O3.Zn/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6;/h4-5,7H,1-3,10H2,(H3,11,12,13,14,15,16);/p-1/t7-;/m0./s1 D09NYU DRUGINKE GFWBKUDRXMQSFD-FJXQXJEOSA-M D09NYU DRUGSMIL C1=C(NC=N1)CC(C(=O)O)[N-]C(=O)CCN.[Zn] D09NYU HIGHSTAT Approved D09PZZ DRUG__ID D09PZZ D09PZZ DRUGTYPE Small molecular drug D09PZZ DRUGINCH 1S/C46H65N13O12S2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69)/t28-,29-,30-,31-,32-,33-,34-,35-/m0/s1 D09PZZ DRUGINKE BJFIDCADFRDPIO-DZCXQCEKSA-N D09PZZ DRUGSMIL C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N D09PZZ HIGHSTAT Approved D09RII DRUG__ID D09RII D09RII DRUGCOMP Global Blood Therapeutics South San Francisco, CA D09RII DRUGINCH 1S/C19H19N3O3/c1-13(2)22-16(8-10-21-22)19-14(5-4-9-20-19)12-25-18-7-3-6-17(24)15(18)11-23/h3-11,13,24H,12H2,1-2H3 D09RII DRUGINKE FWCVZAQENIZVMY-UHFFFAOYSA-N D09RII DRUGSMIL CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O D09RII HIGHSTAT Approved D09SIK DRUG__ID D09SIK D09SIK DRUGTYPE Small molecular drug D09SIK DRUGINCH 1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)/t9-,11-,12-,13-/m1/s1 D09SIK DRUGINKE QQOBRRFOVWGIMD-OJAKKHQRSA-N D09SIK DRUGSMIL CC(=O)OCC1C(C(C(O1)N2C(=O)NC(=O)C=N2)OC(=O)C)OC(=O)C D09SIK HIGHSTAT Approved D09SOA DRUG__ID D09SOA D09SOA DRUGTYPE Small molecular drug D09SOA DRUGINCH 1S/C13H11ClN2O2/c1-8-10(14)5-2-6-11(8)16-12-9(13(17)18)4-3-7-15-12/h2-7H,1H3,(H,15,16)(H,17,18) D09SOA DRUGINKE CLOMYZFHNHFSIQ-UHFFFAOYSA-N D09SOA DRUGSMIL CC1=C(C=CC=C1Cl)NC2=C(C=CC=N2)C(=O)O D09SOA HIGHSTAT Approved D09SRR DRUG__ID D09SRR D09SRR DRUGTYPE Small molecular drug D09SRR DRUGINCH 1S/C22H38O5/c1-2-3-4-5-8-11-17(23)14-15-19-18(20(24)16-21(19)25)12-9-6-7-10-13-22(26)27/h6,9,18-21,24-25H,2-5,7-8,10-16H2,1H3,(H,26,27)/b9-6-/t18-,19-,20+,21-/m1/s1 D09SRR DRUGINKE TVHAZVBUYQMHBC-SNHXEXRGSA-N D09SRR DRUGSMIL CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O D09SRR HIGHSTAT Approved D09SSC DRUG__ID D09SSC D09SSC DRUGTYPE Small molecular drug D09SSC DRUGINCH 1S/C15H22N2O6/c1-10(2)16-7-12(18)8-21-14-5-3-4-11-6-13(23-17(19)20)9-22-15(11)14/h3-5,10,12-13,16,18H,6-9H2,1-2H3 D09SSC DRUGINKE OMCPLEZZPVJJIS-UHFFFAOYSA-N D09SSC DRUGSMIL CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O[N+](=O)[O-])O D09SSC HIGHSTAT Approved D09TAB DRUG__ID D09TAB D09TAB DRUGCOMP Plexxikon Inc D09TAB DRUGINCH 1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29) D09TAB DRUGINKE JGWRKYUXBBNENE-UHFFFAOYSA-N D09TAB DRUGSMIL C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F D09TAB HIGHSTAT Approved D09VAZ DRUG__ID D09VAZ D09VAZ DRUGTYPE Small molecular drug D09VAZ DRUGINCH 1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2 D09VAZ DRUGINKE VILCJCGEZXAXTO-UHFFFAOYSA-N D09VAZ DRUGSMIL C(CNCCNCCN)N D09VAZ HIGHSTAT Approved D09VBC DRUG__ID D09VBC D09VBC DRUGTYPE Small molecular drug D09VBC DRUGINCH 1S/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3 D09VBC DRUGINKE CFJMRBQWBDQYMK-UHFFFAOYSA-N D09VBC DRUGSMIL CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2 D09VBC HIGHSTAT Approved D09WEJ DRUG__ID D09WEJ D09WEJ DRUGTYPE Small molecular drug D09WEJ DRUGINCH 1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19) D09WEJ DRUGINKE GIYAQDDTCWHPPL-UHFFFAOYSA-N D09WEJ DRUGSMIL CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Br D09WEJ HIGHSTAT Approved D09XKW DRUG__ID D09XKW D09XKW DRUGTYPE Small molecular drug D09XKW DRUGINCH 1S/C57H104O9/c1-4-7-10-31-40-51(58)43-34-25-19-13-16-22-28-37-46-55(61)64-49-54(66-57(63)48-39-30-24-18-15-21-27-36-45-53(60)42-33-12-9-6-3)50-65-56(62)47-38-29-23-17-14-20-26-35-44-52(59)41-32-11-8-5-2/h25-27,34-36,51-54,58-60H,4-24,28-33,37-50H2,1-3H3/b34-25-,35-26-,36-27- D09XKW DRUGINKE ZEMPKEQAKRGZGQ-AAKVHIHISA-N D09XKW DRUGSMIL CCCCCCC(CC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC(CCCCCC)O)OC(=O)CCCCCCCC=CCC(CCCCCC)O)O D09XKW HIGHSTAT Approved D09XOR DRUG__ID D09XOR D09XOR DRUGTYPE Small molecular drug D09XOR DRUGINCH 1S/Pd/i1-3 D09XOR DRUGINKE KDLHZDBZIXYQEI-OIOBTWANSA-N D09XOR DRUGSMIL [Pd] D09XOR HIGHSTAT Approved D09YVX DRUG__ID D09YVX D09YVX DRUGTYPE Small molecular drug D09YVX DRUGINCH 1S/C18H18F3NO4/c19-18(20,21)13-4-3-5-14(12-13)22-16-7-2-1-6-15(16)17(24)26-11-10-25-9-8-23/h1-7,12,22-23H,8-11H2 D09YVX DRUGINKE XILVEPYQJIOVNB-UHFFFAOYSA-N D09YVX DRUGSMIL C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F D09YVX HIGHSTAT Approved D09ZHZ DRUG__ID D09ZHZ D09ZHZ DRUGCOMP Eisai Co Ltd D09ZHZ DRUGINCH 1S/C62H90N13O14P.CH3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);1H3;/q;-1;+3/p-2/t31?,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1 D09ZHZ DRUGINKE ZFLASALABLFSNM-WYVZQNDMSA-L D09ZHZ DRUGSMIL [CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3] D09ZHZ HIGHSTAT Approved D0A2AJ DRUG__ID D0A2AJ D0A2AJ DRUGTYPE Small molecular drug D0A2AJ DRUGINCH 1S/C15H18O3/c1-8-4-7-15-11(8)12-10(9(2)13(16)17-12)5-6-14(15,3)18-15/h4,10-12H,2,5-7H2,1,3H3/t10-,11+,12-,14-,15+/m0/s1 D0A2AJ DRUGINKE UVJYAKBJSGRTHA-CUZKYEQNSA-N D0A2AJ DRUGSMIL CC1=CCC23C1C4C(CCC2(O3)C)C(=C)C(=O)O4 D0A2AJ HIGHSTAT Approved D0A2HR DRUG__ID D0A2HR D0A2HR DRUGTYPE Small molecular drug D0A2HR DRUGINCH 1S/Ag.NO3/c;2-1(3)4/q+1;-1 D0A2HR DRUGINKE SQGYOTSLMSWVJD-UHFFFAOYSA-N D0A2HR DRUGSMIL [N+](=O)([O-])[O-].[Ag+] D0A2HR HIGHSTAT Approved D0A5CM DRUG__ID D0A5CM D0A5CM DRUGTYPE Small molecular drug D0A5CM DRUGINCH 1S/C7H6O3.C6H15NO3/c8-6-4-2-1-3-5(6)7(9)10;8-4-1-7(2-5-9)3-6-10/h1-4,8H,(H,9,10);8-10H,1-6H2 D0A5CM DRUGINKE UEVAMYPIMMOEFW-UHFFFAOYSA-N D0A5CM DRUGSMIL C1=CC=C(C(=C1)C(=O)O)O.C(CO)N(CCO)CCO D0A5CM HIGHSTAT Approved D0A5JP DRUG__ID D0A5JP D0A5JP DRUGTYPE Small molecular drug D0A5JP DRUGINCH 1S/C11H12I3NO2/c1-2-5(11(16)17)3-6-7(12)4-8(13)10(15)9(6)14/h4-5H,2-3,15H2,1H3,(H,16,17) D0A5JP DRUGINKE OIRFJRBSRORBCM-UHFFFAOYSA-N D0A5JP DRUGSMIL CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O D0A5JP HIGHSTAT Approved D0A6AP DRUG__ID D0A6AP D0A6AP DRUGTYPE Small molecular drug D0A6AP DRUGINCH 1S/C16H10N2O8S2/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14/h1-6,17,19H,(H,21,22,23)(H,24,25,26) D0A6AP DRUGINKE JMEVHYCNAPFOAB-UHFFFAOYSA-N D0A6AP DRUGSMIL C1=CC2=C(C=C1S(=O)(=O)O)C(=C(N2)C3=NC4=C(C3=O)C=C(C=C4)S(=O)(=O)O)O D0A6AP HIGHSTAT Approved D0A7GX DRUG__ID D0A7GX D0A7GX DRUGCOMP Bayer Schering Pharma AG D0A7GX DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6?/m1/s1 D0A7GX DRUGINKE WQZGKKKJIJFFOK-SVZMEOIVSA-N D0A7GX DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D0A7GX HIGHSTAT Approved D0A7QN DRUG__ID D0A7QN D0A7QN DRUGTYPE Small molecular drug D0A7QN DRUGINCH 1S/C16H25NO3/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6/h9-11H,7-8H2,1-6H3 D0A7QN DRUGINKE VRYMTAVOXVTQEF-UHFFFAOYSA-N D0A7QN DRUGSMIL CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C D0A7QN HIGHSTAT Approved D0A9KF DRUG__ID D0A9KF D0A9KF DRUGTYPE Small molecular drug D0A9KF DRUGINCH 1S/CN2.Ca/c2-1-3;/q-2;+2 D0A9KF DRUGINKE MYFXBBAEXORJNB-UHFFFAOYSA-N D0A9KF DRUGSMIL C(=[N-])=[N-].[Ca+2] D0A9KF HIGHSTAT Approved D0AP9E DRUG__ID D0AP9E D0AP9E DRUGCOMP G1 Therapeutics Research Triangle Park, NC D0AP9E DRUGINCH 1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29) D0AP9E DRUGINKE PDGKHKMBHVFCMG-UHFFFAOYSA-N D0AP9E DRUGSMIL CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6 D0AP9E HIGHSTAT Approved D0AY7K DRUG__ID D0AY7K D0AY7K DRUGTYPE Small molecular drug D0AY7K DRUGINCH 1S/C20H33N3O4.ClH/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6;/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26);1H D0AY7K DRUGINKE VKJHTUVLJYWAEY-UHFFFAOYSA-N D0AY7K DRUGSMIL CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C.Cl D0AY7K HIGHSTAT Approved D0AY9Q DRUG__ID D0AY9Q D0AY9Q DRUGTYPE Small molecular drug D0AY9Q DRUGINCH 1S/C11H21NO3.ClH/c1-2-3-4-5-8-15-11(14)7-6-10(13)9-12;/h2-9,12H2,1H3;1H D0AY9Q DRUGINKE LZYXPFZBAZTOCH-UHFFFAOYSA-N D0AY9Q DRUGSMIL CCCCCCOC(=O)CCC(=O)CN.Cl D0AY9Q HIGHSTAT Approved D0B1IP DRUG__ID D0B1IP D0B1IP DRUGTYPE Small molecular drug D0B1IP DRUGINCH 1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+ D0B1IP DRUGINKE HQMNCQVAMBCHCO-DJRRULDNSA-N D0B1IP DRUGSMIL CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C(=C(C=C1C)OC)C)C D0B1IP HIGHSTAT Approved D0B2WJ DRUG__ID D0B2WJ D0B2WJ DRUGTYPE Small molecular drug D0B2WJ DRUGINCH 1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20) D0B2WJ DRUGINKE LPEPZBJOKDYZAD-UHFFFAOYSA-N D0B2WJ DRUGSMIL C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F D0B2WJ HIGHSTAT Approved D0B4KH DRUG__ID D0B4KH D0B4KH DRUGTYPE Small molecular drug D0B4KH DRUGINCH 1S/CH6O6P2.2H2O.Tc/c2-8(3,4)1-9(5,6)7;;;/h1H2,(H2,2,3,4)(H2,5,6,7);2*1H2;/q;;;+4/p-4/i;;;1+0 D0B4KH DRUGINKE IUPNVOAUFBLQME-LDYDCSBASA-J D0B4KH DRUGSMIL C(P(=O)([O-])[O-])P(=O)([O-])[O-].O.O.[Tc+4] D0B4KH HIGHSTAT Approved D0B7OD DRUG__ID D0B7OD D0B7OD DRUGTYPE Small molecular drug D0B7OD DRUGINCH 1S/C13H19NO/c1-4-14(5-2)11(3)13(15)12-9-7-6-8-10-12/h6-11H,4-5H2,1-3H3 D0B7OD DRUGINKE XXEPPPIWZFICOJ-UHFFFAOYSA-N D0B7OD DRUGSMIL CCN(CC)C(C)C(=O)C1=CC=CC=C1 D0B7OD HIGHSTAT Approved D0B8LN DRUG__ID D0B8LN D0B8LN DRUGCOMP Bayer Healthcare Pharmaceuticals Inc D0B8LN DRUGINCH 1S/C37H48I6N6O18/c1-48(32-28(40)22(34(64)44-12(4-50)16(58)8-54)26(38)23(29(32)41)35(65)45-13(5-51)17(59)9-55)20(62)3-21(63)49(2)33-30(42)24(36(66)46-14(6-52)18(60)10-56)27(39)25(31(33)43)37(67)47-15(7-53)19(61)11-57/h12-19,50-61H,3-11H2,1-2H3,(H,44,64)(H,45,65)(H,46,66)(H,47,67) D0B8LN DRUGINKE XUHXFSYUBXNTHU-UHFFFAOYSA-N D0B8LN DRUGSMIL CN(C1=C(C(=C(C(=C1I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I)C(=O)CC(=O)N(C)C2=C(C(=C(C(=C2I)C(=O)NC(CO)C(CO)O)I)C(=O)NC(CO)C(CO)O)I D0B8LN HIGHSTAT Approved D0B9JO DRUG__ID D0B9JO D0B9JO DRUGTYPE Small molecular drug D0B9JO DRUGINCH 1S/C80H106Cl2N11O27P/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114)/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-/m0/s1 D0B9JO DRUGINKE ONUMZHGUFYIKPM-MXNFEBESSA-N D0B9JO DRUGSMIL CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C D0B9JO HIGHSTAT Approved D0BD0Q DRUG__ID D0BD0Q D0BD0Q DRUGTYPE Small molecular drug D0BD0Q DRUGINCH 1S/C46H58ClN5O8/c1-5-21-51(22-6-2)46(57)40(48-44(55)34-11-8-7-9-12-34)18-20-42(53)59-29-10-23-49-24-26-50(27-25-49)28-30-60-43(54)32-38-33(3)52(41-19-17-37(58-4)31-39(38)41)45(56)35-13-15-36(47)16-14-35/h7-9,11-17,19,31,40H,5-6,10,18,20-30,32H2,1-4H3,(H,48,55) D0BD0Q DRUGINKE PTXGHCGBYMQQIG-UHFFFAOYSA-N D0BD0Q DRUGSMIL CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CC1)CCOC(=O)CC2=C(N(C3=C2C=C(C=C3)OC)C(=O)C4=CC=C(C=C4)Cl)C)NC(=O)C5=CC=CC=C5 D0BD0Q HIGHSTAT Approved D0BP9C DRUG__ID D0BP9C D0BP9C DRUGTYPE Small molecular drug D0BP9C DRUGINCH 1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27) D0BP9C DRUGINKE PYGWGZALEOIKDF-UHFFFAOYSA-N D0BP9C DRUGSMIL CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N D0BP9C HIGHSTAT Approved D0BQ8Y DRUG__ID D0BQ8Y D0BQ8Y DRUGTYPE Small molecular drug D0BQ8Y DRUGINCH 1S/C4H5NS/c1-2-3-5-4-6/h2H,1,3H2 D0BQ8Y DRUGINKE ZOJBYZNEUISWFT-UHFFFAOYSA-N D0BQ8Y DRUGSMIL C=CCN=C=S D0BQ8Y HIGHSTAT Approved D0BU0J DRUG__ID D0BU0J D0BU0J DRUGTYPE Small molecular drug D0BU0J DRUGINCH 1S/C10H10N6O2/c1-15-8(13-6-9(15)16(17)18)3-2-7-4-5-12-10(11)14-7/h2-6H,1H3,(H2,11,12,14)/b3-2+ D0BU0J DRUGINKE LHIALLMPKJMSIQ-NSCUHMNNSA-N D0BU0J DRUGSMIL CN1C(=CN=C1C=CC2=NC(=NC=C2)N)[N+](=O)[O-] D0BU0J HIGHSTAT Approved D0C1QS DRUG__ID D0C1QS D0C1QS DRUGTYPE Small molecular drug D0C1QS DRUGINCH 1S/C13H13Cl2N3O3/c1-7(2)16-12(20)17-6-11(19)18(13(17)21)10-4-8(14)3-9(15)5-10/h3-5,7H,6H2,1-2H3,(H,16,20) D0C1QS DRUGINKE ONUFESLQCSAYKA-UHFFFAOYSA-N D0C1QS DRUGSMIL CC(C)NC(=O)N1CC(=O)N(C1=O)C2=CC(=CC(=C2)Cl)Cl D0C1QS HIGHSTAT Approved D0C3LP DRUG__ID D0C3LP D0C3LP DRUGTYPE Small molecular drug D0C3LP DRUGINCH 1S/C14H24N6O4.C2H4O2.Cu/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9;1-2(3)4;/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24);1H3,(H,3,4);/q;;+2/t10-,11-;;/m0../s1 D0C3LP DRUGINKE PBAQNGMOINVZLP-ULEGLUPFSA-N D0C3LP DRUGSMIL CC(=O)O.C1=C(NC=N1)CC(C(=O)NC(CCCCN)C(=O)O)NC(=O)CN.[Cu+2] D0C3LP HIGHSTAT Approved D0C4DH DRUG__ID D0C4DH D0C4DH TRADNAME Mavyret D0C4DH DRUGCOMP AbbVie D0C4DH DRUGTYPE Combination drug D0C4DH DRUGSMIL failed D0C4DH HIGHSTAT Approved D0C4NY DRUG__ID D0C4NY D0C4NY DRUGTYPE Small molecular drug D0C4NY DRUGINCH 1S/C22H32O2/c1-4-13-24-16-6-8-17-15(14-16)5-7-19-18(17)11-12-22(2)20(19)9-10-21(22)23-3/h6,8,14,18-21H,4-5,7,9-13H2,1-3H3/t18-,19-,20+,21+,22+/m1/s1 D0C4NY DRUGINKE IUWKNLFTJBHTSD-AANPDWTMSA-N D0C4NY DRUGSMIL CCCOC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4OC)C D0C4NY HIGHSTAT Approved D0C4RB DRUG__ID D0C4RB D0C4RB DRUGTYPE Small molecular drug D0C4RB DRUGINCH 1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1 D0C4RB DRUGINKE RCINICONZNJXQF-MZXODVADSA-N D0C4RB DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C D0C4RB HIGHSTAT Approved D0C6OQ DRUG__ID D0C6OQ D0C6OQ DRUGTYPE Small molecular drug D0C6OQ DRUGINCH 1S/C11H11ClO3/c1-2-5-15-10-4-3-8(6-9(10)12)7-11(13)14/h2-4,6H,1,5,7H2,(H,13,14) D0C6OQ DRUGINKE ARHWPKZXBHOEEE-UHFFFAOYSA-N D0C6OQ DRUGSMIL C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl D0C6OQ HIGHSTAT Approved D0CQ0Z DRUG__ID D0CQ0Z D0CQ0Z DRUGTYPE Small molecular drug D0CQ0Z DRUGINCH 1S/C28H27ClF5NO/c29-26-12-7-21(18-25(26)28(32,33)34)27(36)13-16-35(17-14-27)15-1-2-24(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24,36H,1-2,13-17H2 D0CQ0Z DRUGINKE MDLAAYDRRZXJIF-UHFFFAOYSA-N D0CQ0Z DRUGSMIL C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0CQ0Z HIGHSTAT Approved D0D0BE DRUG__ID D0D0BE D0D0BE DRUGTYPE Small molecular drug D0D0BE DRUGINCH 1S/C7H10ClN3O3/c1-5-9-3-7(11(13)14)10(5)4-6(12)2-8/h3,6,12H,2,4H2,1H3 D0D0BE DRUGINKE IPWKIXLWTCNBKN-UHFFFAOYSA-N D0D0BE DRUGSMIL CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-] D0D0BE HIGHSTAT Approved D0D0BM DRUG__ID D0D0BM D0D0BM DRUGCOMP Organon Usa Inc D0D0BM DRUGINCH 1S/C207H308N56O58S.H2O.Zn/c1-108(2)89-140(186(302)240-135(69-74-163(279)280)182(298)254-149(204(320)321)94-117-43-20-15-21-44-117)250-193(309)152-54-35-86-262(152)202(318)147(92-116-41-18-14-19-42-116)252-171(287)114(11)230-175(291)132(66-71-160(273)274)234-170(286)113(10)231-191(307)150(105-265)255-183(299)136(70-75-164(281)282)241-190(306)146(98-165(283)284)249-180(296)133(67-72-161(275)276)235-169(285)112(9)229-157(270)101-225-174(290)145(97-156(213)269)251-194(310)153-55-36-87-263(153)203(319)148(93-119-60-64-123(268)65-61-119)253-199(315)167(110(5)6)257-185(301)129(49-26-30-79-210)243-198(314)168(111(7)8)259-196(312)155-57-38-85-261(155)201(317)139(53-34-83-223-207(218)219)244-178(294)130(51-32-81-221-205(214)215)237-177(293)128(48-25-29-78-209)236-176(292)127(47-24-28-77-208)232-158(271)103-227-197(313)166(109(3)4)258-195(311)154-56-37-84-260(154)200(316)138(50-27-31-80-211)233-159(272)102-226-173(289)143(95-120-99-224-126-46-23-22-45-124(120)126)247-179(295)131(52-33-82-222-206(216)217)238-187(303)142(90-115-39-16-13-17-40-115)246-189(305)144(96-121-100-220-107-228-121)248-181(297)134(68-73-162(277)278)239-184(300)137(76-88-322-12)242-192(308)151(106-266)256-188(304)141(245-172(288)125(212)104-264)91-118-58-62-122(267)63-59-118;;/h13-23,39-46,58-65,99-100,107-114,125,127-155,166-168,224,264-268H,24-38,47-57,66-98,101-106,208-212H2,1-12H3,(H2,213,269)(H,220,228)(H,225,290)(H,226,289)(H,227,313)(H,229,270)(H,230,291)(H,231,307)(H,232,271)(H,233,272)(H,234,286)(H,235,285)(H,236,292)(H,237,293)(H,238,303)(H,239,300)(H,240,302)(H,241,306)(H,242,308)(H,243,314)(H,244,294)(H,245,288)(H,246,305)(H,247,295)(H,248,297)(H,249,296)(H,250,309)(H,251,310)(H,252,287)(H,253,315)(H,254,298)(H,255,299)(H,256,304)(H,257,301)(H,258,311)(H,259,312)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,320,321)(H4,214,215,221)(H4,216,217,222)(H4,218,219,223);1H2;/q;;+2/p-1/t112-,113-,114-,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,166-,167-,168-;;/m0../s1 D0D0BM DRUGINKE DCANWYXFXGSVLP-GKQRBXEKSA-M D0D0BM DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N.[OH-].[Zn+2] D0D0BM HIGHSTAT Approved D0D0GV DRUG__ID D0D0GV D0D0GV DRUGTYPE Small molecular drug D0D0GV DRUGINCH 1S/C14H17Cl2NO2/c1-14(7-3-2-4-8-14)13(19)17-9-5-6-10(18)12(16)11(9)15/h5-6,18H,2-4,7-8H2,1H3,(H,17,19) D0D0GV DRUGINKE VDLGAVXLJYLFDH-UHFFFAOYSA-N D0D0GV DRUGSMIL CC1(CCCCC1)C(=O)NC2=C(C(=C(C=C2)O)Cl)Cl D0D0GV HIGHSTAT Approved D0D4JO DRUG__ID D0D4JO D0D4JO DRUGTYPE Small molecular drug D0D4JO DRUGINCH 1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1 D0D4JO DRUGINKE FIHJKUPKCHIPAT-AHIGJZGOSA-N D0D4JO DRUGSMIL CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C D0D4JO HIGHSTAT Approved D0D5GG DRUG__ID D0D5GG D0D5GG DRUGTYPE Small molecular drug D0D5GG DRUGINCH 1S/C9H8N2O2/c10-9-11-8(12)7(13-9)6-4-2-1-3-5-6/h1-5,7H,(H2,10,11,12) D0D5GG DRUGINKE NRNCYVBFPDDJNE-UHFFFAOYSA-N D0D5GG DRUGSMIL C1=CC=C(C=C1)C2C(=O)N=C(O2)N D0D5GG HIGHSTAT Approved D0D7EN DRUG__ID D0D7EN D0D7EN DRUGTYPE Small molecular drug D0D7EN DRUGINCH 1S/C8H10ClN3S/c1-5-4-13-7(9)6(5)12-8-10-2-3-11-8/h4H,2-3H2,1H3,(H2,10,11,12) D0D7EN DRUGINKE CVWILQHZFWRYPB-UHFFFAOYSA-N D0D7EN DRUGSMIL CC1=CSC(=C1NC2=NCCN2)Cl D0D7EN HIGHSTAT Approved D0D7TB DRUG__ID D0D7TB D0D7TB DRUGTYPE Small molecular drug D0D7TB DRUGINCH 1S/C23H29N3O/c27-19-18-25-16-14-24(15-17-25)12-5-13-26-22-8-3-1-6-20(22)10-11-21-7-2-4-9-23(21)26/h1-4,6-11,27H,5,12-19H2 D0D7TB DRUGINKE YNZFUWZUGRBMHL-UHFFFAOYSA-N D0D7TB DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO D0D7TB HIGHSTAT Approved D0DF9Z DRUG__ID D0DF9Z D0DF9Z DRUGTYPE Small molecular drug D0DF9Z DRUGINCH 1S/2Al.2Mg.15H2O.4Si/h;;;;15*1H2;;;;/p-1 D0DF9Z DRUGINKE DGMCGTFMFPEQLT-UHFFFAOYSA-M D0DF9Z DRUGSMIL O.O.O.O.O.O.O.O.O.O.O.O.O.O.[OH-].[Mg].[Mg].[Al].[Al].[Si].[Si].[Si].[Si] D0DF9Z HIGHSTAT Approved D0DH5X DRUG__ID D0DH5X D0DH5X DRUGCOMP Merck D0DH5X DRUGINCH 1S/C26H28N4O3/c31-24-14-15-27-23-13-12-22(30(23)24)26(33)29-19-8-6-17(7-9-19)16-20-10-11-21(28-20)25(32)18-4-2-1-3-5-18/h1-9,14-15,20-22,25,28,32H,10-13,16H2,(H,29,33)/t20-,21+,22-,25+/m0/s1 D0DH5X DRUGINKE DJXRIQMCROIRCZ-XOEOCAAJSA-N D0DH5X DRUGSMIL C1CC(NC1CC2=CC=C(C=C2)NC(=O)C3CCC4=NC=CC(=O)N34)C(C5=CC=CC=C5)O D0DH5X HIGHSTAT Approved D0DV6D DRUG__ID D0DV6D D0DV6D DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D0DV6D DRUGINCH 1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1 D0DV6D DRUGINKE BLIJXOOIHRSQRB-PXYINDEMSA-N D0DV6D DRUGSMIL CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O D0DV6D HIGHSTAT Approved D0E0CT DRUG__ID D0E0CT D0E0CT DRUGTYPE Small molecular drug D0E0CT DRUGINCH 1S/C22H29NO5/c1-7-22(23(2)3,17-11-9-8-10-12-17)15-28-21(24)16-13-18(25-4)20(27-6)19(14-16)26-5/h8-14H,7,15H2,1-6H3 D0E0CT DRUGINKE LORDFXWUHHSAQU-UHFFFAOYSA-N D0E0CT DRUGSMIL CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C D0E0CT HIGHSTAT Approved D0E0KQ DRUG__ID D0E0KQ D0E0KQ DRUGTYPE Small molecular drug D0E0KQ DRUGINCH 1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32) D0E0KQ DRUGINKE DJUFPMUQJKWIJB-UHFFFAOYSA-N D0E0KQ DRUGSMIL COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6 D0E0KQ HIGHSTAT Approved D0E0RY DRUG__ID D0E0RY D0E0RY DRUGTYPE Small molecular drug D0E0RY DRUGINCH 1S/C21H25N/c1-21(2)19-13-7-5-10-17(19)16(12-9-15-22(3)4)18-11-6-8-14-20(18)21/h5-8,10-14H,9,15H2,1-4H3 D0E0RY DRUGINKE GWWLWDURRGNSRS-UHFFFAOYSA-N D0E0RY DRUGSMIL CC1(C2=CC=CC=C2C(=CCCN(C)C)C3=CC=CC=C31)C D0E0RY HIGHSTAT Approved D0E3WQ DRUG__ID D0E3WQ D0E3WQ DRUGTYPE Small molecular drug D0E3WQ DRUGINCH 1S/C16H20N2O5/c1-4-16(12-8-6-5-7-9-12)13(19)17(10-22-2)15(21)18(11-23-3)14(16)20/h5-9H,4,10-11H2,1-3H3 D0E3WQ DRUGINKE DACOQFZGGLCXMA-UHFFFAOYSA-N D0E3WQ DRUGSMIL CCC1(C(=O)N(C(=O)N(C1=O)COC)COC)C2=CC=CC=C2 D0E3WQ HIGHSTAT Approved D0E8LA DRUG__ID D0E8LA D0E8LA DRUGCOMP Zydus Cadila Gujarat, India D0E8LA DRUGINCH 1S/C25H29NO4S/c1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20/h5-14,24H,4,15-17H2,1-3H3,(H,27,28)/t24-/m0/s1 D0E8LA DRUGINKE MRWFZSLZNUJVQW-DEOSSOPVSA-N D0E8LA DRUGSMIL CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O D0E8LA HIGHSTAT Approved D0E8LT DRUG__ID D0E8LT D0E8LT DRUGTYPE Small molecular drug D0E8LT DRUGINCH 1S/C22H28N/c1-4-23(5-2)17-16-21(18(23)3)22(19-12-8-6-9-13-19)20-14-10-7-11-15-20/h6-15,18H,4-5,16-17H2,1-3H3/q+1 D0E8LT DRUGINKE ZYEPZINLLPPBMI-UHFFFAOYSA-N D0E8LT DRUGSMIL CC[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)C1C)CC D0E8LT HIGHSTAT Approved D0E9PK DRUG__ID D0E9PK D0E9PK DRUGTYPE Small molecular drug D0E9PK DRUGINCH 1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15) D0E9PK DRUGINKE WPNJAUFVNXKLIM-UHFFFAOYSA-N D0E9PK DRUGSMIL CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC D0E9PK HIGHSTAT Approved D0E9TP DRUG__ID D0E9TP D0E9TP THERCLAS Antithrombotic Agents D0E9TP DRUGINCH 1S/C12H17N5O4/c1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(20-2)8(19)6(3-18)21-12/h4-6,8-9,12,18-19H,3H2,1-2H3,(H,13,14,15)/t6-,8-,9-,12-/m1/s1 D0E9TP DRUGINKE GRYSXUXXBDSYRT-WOUKDFQISA-N D0E9TP DRUGSMIL CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC D0E9TP HIGHSTAT Approved D0EB5N DRUG__ID D0EB5N D0EB5N DRUGCOMP Nabriva Therapeutics King of Prussia, PA D0EB5N DRUGINCH 1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16-,17+,18-,20-,21-,22-,24+,25+,26-,27+,28+/m1/s1 D0EB5N DRUGINKE KPVIXBKIJXZQJX-FCEONZPQSA-N D0EB5N DRUGSMIL CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C D0EB5N HIGHSTAT Approved D0EK1D DRUG__ID D0EK1D D0EK1D DRUGTYPE Small molecular drug D0EK1D DRUGINCH 1S/C19H18F6O3/c1-10-15(26)8-13-9-16(10)27-28-17(13,2)6-5-11-3-4-12(18(20,21)22)7-14(11)19(23,24)25/h3-7,10,13,16H,8-9H2,1-2H3/b6-5-/t10-,13+,16+,17+/m1/s1 D0EK1D DRUGINKE LRTRTVPZZJAADL-DAHZFVMQSA-N D0EK1D DRUGSMIL CC1C2CC(CC1=O)C(OO2)(C)C=CC3=C(C=C(C=C3)C(F)(F)F)C(F)(F)F D0EK1D HIGHSTAT Approved D0EL2O DRUG__ID D0EL2O D0EL2O DRUGTYPE Small molecular drug D0EL2O DRUGINCH 1S/C15H18O3S.Na/c1-4-11-9-15(19(16,17)18)14-8-12(10(2)3)6-5-7-13(11)14;/h5-10H,4H2,1-3H3,(H,16,17,18);/q;+1/p-1 D0EL2O DRUGINKE KXGWXVVNYQOMQZ-UHFFFAOYSA-M D0EL2O DRUGSMIL CCC1=CC(=C2C1=CC=CC(=C2)C(C)C)S(=O)(=O)[O-].[Na+] D0EL2O HIGHSTAT Approved D0F0EP DRUG__ID D0F0EP D0F0EP DRUGTYPE Small molecular drug D0F0EP DRUGINCH 1S/C15H16ClN3O4S2/c1-9(10-5-3-2-4-6-10)15-18-12-7-11(16)13(24(17,20)21)8-14(12)25(22,23)19-15/h2-9,15,18-19H,1H3,(H2,17,20,21) D0F0EP DRUGINKE PYVUMAGVCSQCBD-UHFFFAOYSA-N D0F0EP DRUGSMIL CC(C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl)C3=CC=CC=C3 D0F0EP HIGHSTAT Approved D0F1DY DRUG__ID D0F1DY D0F1DY DRUGCOMP GSK D0F1DY DRUGINCH 1S/C148H223N39O46/c1-16-76(10)119(144(229)165-79(13)124(209)173-103(59-85-62-157-90-35-24-23-34-88(85)90)134(219)175-99(55-73(4)5)135(220)184-117(74(6)7)142(227)172-91(36-25-27-51-149)126(211)159-66-111(197)168-97(147(232)233)38-29-53-156-148(153)154)186-136(221)101(56-82-30-19-17-20-31-82)176-131(216)96(46-50-115(203)204)171-130(215)92(37-26-28-52-150)169-123(208)78(12)163-122(207)77(11)164-129(214)95(43-47-108(152)194)167-110(196)65-160-128(213)94(45-49-114(201)202)170-132(217)98(54-72(2)3)174-133(218)100(58-84-39-41-87(193)42-40-84)177-139(224)105(68-188)180-141(226)107(70-190)181-143(228)118(75(8)9)185-138(223)104(61-116(205)206)178-140(225)106(69-189)182-146(231)121(81(15)192)187-137(222)102(57-83-32-21-18-22-33-83)179-145(230)120(80(14)191)183-112(198)67-161-127(212)93(44-48-113(199)200)166-109(195)64-158-125(210)89(151)60-86-63-155-71-162-86/h17-24,30-35,39-42,62-63,71-81,89,91-107,117-121,157,188-193H,16,25-29,36-38,43-61,64-70,149-151H2,1-15H3,(H2,152,194)(H,155,162)(H,158,210)(H,159,211)(H,160,213)(H,161,212)(H,163,207)(H,164,214)(H,165,229)(H,166,195)(H,167,196)(H,168,197)(H,169,208)(H,170,217)(H,171,215)(H,172,227)(H,173,209)(H,174,218)(H,175,219)(H,176,216)(H,177,224)(H,178,225)(H,179,230)(H,180,226)(H,181,228)(H,182,231)(H,183,198)(H,184,220)(H,185,223)(H,186,221)(H,187,222)(H,199,200)(H,201,202)(H,203,204)(H,205,206)(H,232,233)(H4,153,154,156)/t76-,77-,78-,79-,80+,81+,89-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,117-,118-,119-,120-,121-/m0/s1 D0F1DY DRUGINKE OGWAVGNOAMXIIM-VTAHJYCESA-N D0F1DY DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CNC=N6)N D0F1DY HIGHSTAT Approved D0F3SY DRUG__ID D0F3SY D0F3SY DRUGTYPE Small molecular drug D0F3SY DRUGINCH 1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13) D0F3SY DRUGINKE WFWLQNSHRPWKFK-UHFFFAOYSA-N D0F3SY DRUGSMIL C1CC(OC1)N2C=C(C(=O)NC2=O)F D0F3SY HIGHSTAT Approved D0F4HB DRUG__ID D0F4HB D0F4HB DRUGCOMP Discovery Laboratories D0F4HB DRUGINCH 1S/C126H238N26O22.C2H4O2/c1-69(2)53-90(137-106(153)85(132)43-33-38-48-127)114(161)145-98(61-77(17)18)122(169)149-99(62-78(19)20)118(165)141-91(54-70(3)4)110(157)133-86(44-34-39-49-128)107(154)138-95(58-74(11)12)115(162)146-103(66-82(27)28)123(170)150-100(63-79(21)22)119(166)142-92(55-71(5)6)111(158)134-87(45-35-40-50-129)108(155)139-96(59-75(13)14)116(163)147-104(67-83(29)30)124(171)151-101(64-80(23)24)120(167)143-93(56-72(7)8)112(159)135-88(46-36-41-51-130)109(156)140-97(60-76(15)16)117(164)148-105(68-84(31)32)125(172)152-102(65-81(25)26)121(168)144-94(57-73(9)10)113(160)136-89(126(173)174)47-37-42-52-131;1-2(3)4/h69-105H,33-68,127-132H2,1-32H3,(H,133,157)(H,134,158)(H,135,159)(H,136,160)(H,137,153)(H,138,154)(H,139,155)(H,140,156)(H,141,165)(H,142,166)(H,143,167)(H,144,168)(H,145,161)(H,146,162)(H,147,163)(H,148,164)(H,149,169)(H,150,170)(H,151,171)(H,152,172)(H,173,174);1H3,(H,3,4)/t85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-;/m0./s1 D0F4HB DRUGINKE OSPNFKYGOFXGBX-YWWKUQGPSA-N D0F4HB DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N.CC(=O)O D0F4HB HIGHSTAT Approved D0F4NS DRUG__ID D0F4NS D0F4NS DRUGTYPE Small molecular drug D0F4NS DRUGINCH 1S/C27H29N3O2/c1-19-9-4-5-10-22(19)26(31)28-21-16-14-20(15-17-21)27(32)30-18-8-13-24(29(2)3)23-11-6-7-12-25(23)30/h4-7,9-12,14-17,24H,8,13,18H2,1-3H3,(H,28,31) D0F4NS DRUGINKE WRNXUQJJCIZICJ-UHFFFAOYSA-N D0F4NS DRUGSMIL CC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)N3CCCC(C4=CC=CC=C43)N(C)C D0F4NS HIGHSTAT Approved D0F5DO DRUG__ID D0F5DO D0F5DO DRUGTYPE Small molecular drug D0F5DO DRUGINCH 1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1 D0F5DO DRUGINKE ODKSFYDXXFIFQN-BYPYZUCNSA-N D0F5DO DRUGSMIL C(CC(C(=O)O)N)CN=C(N)N D0F5DO HIGHSTAT Approved D0F5OR DRUG__ID D0F5OR D0F5OR DRUGTYPE Small molecular drug D0F5OR DRUGINCH 1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26?,27?,28?,29+,30?,31-,32+,34?,35?,36?,37?,38?,39+,40+,41?,42?,43?/m1/s1 D0F5OR DRUGINKE ACTOXUHEUCPTEW-JMRHEKERSA-N D0F5OR DRUGSMIL CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C D0F5OR HIGHSTAT Approved D0F7CS DRUG__ID D0F7CS D0F7CS DRUGTYPE Small molecular drug D0F7CS DRUGINCH 1S/C23H22O6/c1-11(2)16-8-14-15(28-16)6-5-12-22(24)21-13-7-18(25-3)19(26-4)9-17(13)27-10-20(21)29-23(12)14/h5-7,9,16,20-21H,1,8,10H2,2-4H3/t16-,20-,21+/m1/s1 D0F7CS DRUGINKE JUVIOZPCNVVQFO-HBGVWJBISA-N D0F7CS DRUGSMIL CC(=C)C1CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC D0F7CS HIGHSTAT Approved D0F9HK DRUG__ID D0F9HK D0F9HK DRUGTYPE Small molecular drug D0F9HK DRUGINCH 1S/Sr/i1+1 D0F9HK DRUGINKE CIOAGBVUUVVLOB-OUBTZVSYSA-N D0F9HK DRUGSMIL [Sr] D0F9HK HIGHSTAT Approved D0FA2O DRUG__ID D0FA2O D0FA2O DRUGTYPE Small molecular drug D0FA2O DRUGINCH 1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3 D0FA2O DRUGINKE FMHHVULEAZTJMA-UHFFFAOYSA-N D0FA2O DRUGSMIL CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C D0FA2O HIGHSTAT Approved D0FD6E DRUG__ID D0FD6E D0FD6E DRUGTYPE Small molecular drug D0FD6E DRUGINCH 1S/C21H27N5O7S/c1-21(2)15(20(32)33)26-18(31)14(19(26)34-21)25-17(30)13(9-4-6-10(27)7-5-9)24-16(29)11(22)8-12(28)23-3/h4-7,11,13-15,19,27H,8,22H2,1-3H3,(H,23,28)(H,24,29)(H,25,30)(H,32,33)/t11-,13-,14-,15+,19-/m1/s1 D0FD6E DRUGINKE BHELIUBJHYAEDK-OAIUPTLZSA-N D0FD6E DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)NC(=O)C(CC(=O)NC)N)C(=O)O)C D0FD6E HIGHSTAT Approved D0FH7C DRUG__ID D0FH7C D0FH7C DRUGTYPE Small molecular drug D0FH7C DRUGINCH 1S/C4H6O4S.Au.2Na/c5-3(6)1-2(9)4(7)8;;;/h2,9H,1H2,(H,5,6)(H,7,8);;;/q;3*+1/p-3 D0FH7C DRUGINKE VXIHRIQNJCRFQX-UHFFFAOYSA-K D0FH7C DRUGSMIL C(C(C(=O)[O-])[S-])C(=O)[O-].[Na+].[Na+].[Au+] D0FH7C HIGHSTAT Approved D0FN7J DRUG__ID D0FN7J D0FN7J DRUGTYPE Small molecular drug D0FN7J DRUGINCH 1S/C11H15NO5/c1-15-9-4-2-3-5-10(9)16-6-8(13)7-17-11(12)14/h2-5,8,13H,6-7H2,1H3,(H2,12,14) D0FN7J DRUGINKE GNXFOGHNGIVQEH-UHFFFAOYSA-N D0FN7J DRUGSMIL COC1=CC=CC=C1OCC(COC(=O)N)O D0FN7J HIGHSTAT Approved D0FR9L DRUG__ID D0FR9L D0FR9L DRUGTYPE Small molecular drug D0FR9L DRUGINCH 1S/C34H34N4O4.C6H14N4O2.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;7-4(5(11)12)2-1-3-10-6(8)9;/h7-8,13-16,36,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);4H,1-3,7H2,(H,11,12)(H4,8,9,10);/q;;+2/t;4-;/m.0./s1 D0FR9L DRUGINKE HQBGGOLLNATNQC-INZIHYEWSA-N D0FR9L DRUGSMIL CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4C)C=C)C(=C3CCC(=O)O)C)CCC(=O)O.C(CC(C(=O)O)N)CN=C(N)N.[Fe+2] D0FR9L HIGHSTAT Approved D0G1VX DRUG__ID D0G1VX D0G1VX DRUGTYPE Small molecular drug D0G1VX DRUGINCH 1S/C14H12O2/c15-14(13-9-5-2-6-10-13)16-11-12-7-3-1-4-8-12/h1-10H,11H2 D0G1VX DRUGINKE SESFRYSPDFLNCH-UHFFFAOYSA-N D0G1VX DRUGSMIL C1=CC=C(C=C1)COC(=O)C2=CC=CC=C2 D0G1VX HIGHSTAT Approved D0G1WL DRUG__ID D0G1WL D0G1WL DRUGTYPE Small molecular drug D0G1WL DRUGINCH 1S/2C25H24FNO4.Ca/c2*26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31;/h2*1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31);/q;;+2/p-2/b2*12-11+;/t2*18-,19-;/m11./s1 D0G1WL DRUGINKE RHGYHLPFVJEAOC-FFNUKLMVSA-L D0G1WL DRUGSMIL C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2] D0G1WL HIGHSTAT Approved D0G2KD DRUG__ID D0G2KD D0G2KD DRUGTYPE Small molecular drug D0G2KD DRUGINCH 1S/C19H29IO2/c1-3-22-19(21)15-9-7-5-4-6-8-12-16(2)17-13-10-11-14-18(17)20/h10-11,13-14,16H,3-9,12,15H2,1-2H3 D0G2KD DRUGINKE IWRUDYQZPTVTPA-UHFFFAOYSA-N D0G2KD DRUGSMIL CCOC(=O)CCCCCCCCC(C)C1=CC=CC=C1I D0G2KD HIGHSTAT Approved D0G4KG DRUG__ID D0G4KG D0G4KG DRUGTYPE Small molecular drug D0G4KG DRUGINCH 1S/C14H12O5/c1-7-6-9(15)10-11(16-2)8-4-5-18-12(8)14(17-3)13(10)19-7/h4-6H,1-3H3 D0G4KG DRUGINKE HSMPDPBYAYSOBC-UHFFFAOYSA-N D0G4KG DRUGSMIL CC1=CC(=O)C2=C(C3=C(C(=C2O1)OC)OC=C3)OC D0G4KG HIGHSTAT Approved D0G6AB DRUG__ID D0G6AB D0G6AB DRUGTYPE Small molecular drug D0G6AB DRUGINCH 1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1 D0G6AB DRUGINKE QVCMHGGNRFRMAD-XFGHUUIASA-N D0G6AB DRUGSMIL CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O D0G6AB HIGHSTAT Approved D0G8SQ DRUG__ID D0G8SQ D0G8SQ DRUGTYPE Small molecular drug D0G8SQ DRUGINCH 1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1 D0G8SQ DRUGINKE PHIQHXFUZVPYII-ZCFIWIBFSA-N D0G8SQ DRUGSMIL C[N+](C)(C)CC(CC(=O)[O-])O D0G8SQ HIGHSTAT Approved D0H0BG DRUG__ID D0H0BG D0H0BG DRUGTYPE Small molecular drug D0H0BG DRUGINCH 1S/C8H11NO5S.Na/c1-8(2)6(7(11)12)9-4(10)3-5(9)15(8,13)14;/h5-6H,3H2,1-2H3,(H,11,12);/q;+1/p-1/t5-,6+;/m1./s1 D0H0BG DRUGINKE NKZMPZCWBSWAOX-IBTYICNHSA-M D0H0BG DRUGSMIL CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+] D0H0BG HIGHSTAT Approved D0H0SJ DRUG__ID D0H0SJ D0H0SJ DRUGTYPE Small molecular drug D0H0SJ DRUGINCH 1S/C35H35NO12/c1-16-12-19(42-4)14-22-20(16)8-9-23(37)27(22)32(40)45-24-13-18-10-11-35(26-15-43-34(41)46-26)25(48-35)7-5-6-21(18)31(24)47-33-28(36-3)30(39)29(38)17(2)44-33/h8-9,12-14,17,21,24-26,28-31,33,36-39H,6,15H2,1-4H3/t17-,21?,24-,25-,26-,28-,29+,30-,31-,33-,35+/m1/s1 D0H0SJ DRUGINKE BLXZMHNVKCEIJX-PNKAXBHOSA-N D0H0SJ DRUGSMIL CC1C(C(C(C(O1)OC2C3CC#CC4C(O4)(C#CC3=CC2OC(=O)C5=C(C=CC6=C5C=C(C=C6C)OC)O)C7COC(=O)O7)NC)O)O D0H0SJ HIGHSTAT Approved D0H1QY DRUG__ID D0H1QY D0H1QY DRUGTYPE Small molecular drug D0H1QY DRUGINCH 1S/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3 D0H1QY DRUGINKE DSSYKIVIOFKYAU-UHFFFAOYSA-N D0H1QY DRUGSMIL CC1(C2CCC1(C(=O)C2)C)C D0H1QY HIGHSTAT Approved D0H2MA DRUG__ID D0H2MA D0H2MA DRUGTYPE Small molecular drug D0H2MA DRUGINCH 1S/C47H49N3O7S2.Na/c1-6-49(31-35-11-9-13-43(29-35)58(51,52)53)40-21-25-45(33(4)27-40)47(37-15-17-38(18-16-37)48-39-19-23-42(24-20-39)57-8-3)46-26-22-41(28-34(46)5)50(7-2)32-36-12-10-14-44(30-36)59(54,55)56;/h9-30H,6-8,31-32H2,1-5H3,(H2,51,52,53,54,55,56);/q;+1/p-1 D0H2MA DRUGINKE RWVGQQGBQSJDQV-UHFFFAOYSA-M D0H2MA DRUGSMIL CCN(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC(=C(C=C2)C(=C3C=CC(=[N+](CC)CC4=CC(=CC=C4)S(=O)(=O)[O-])C=C3C)C5=CC=C(C=C5)NC6=CC=C(C=C6)OCC)C.[Na+] D0H2MA HIGHSTAT Approved D0H2RI DRUG__ID D0H2RI D0H2RI DRUGTYPE Small molecular drug D0H2RI DRUGINCH 1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3-,4-,5-,6+/m1/s1/i7-1 D0H2RI DRUGINKE ZCXUVYAZINUVJD-AHXZWLDOSA-N D0H2RI DRUGSMIL C(C1C(C(C(C(O1)O)F)O)O)O D0H2RI HIGHSTAT Approved D0H2YX DRUG__ID D0H2YX D0H2YX DRUGTYPE Small molecular drug D0H2YX DRUGINCH 1S/C25H44O5/c1-4-5-6-7-10-13-20(26)16-17-22-21(23(27)18-24(22)28)14-11-8-9-12-15-25(29)30-19(2)3/h8,11,19,21-24,27-28H,4-7,9-10,12-18H2,1-3H3/b11-8-/t21-,22-,23+,24-/m1/s1 D0H2YX DRUGINKE XXUPXHKCPIKWLR-JHUOEJJVSA-N D0H2YX DRUGSMIL CCCCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)OC(C)C)O)O D0H2YX HIGHSTAT Approved D0H2ZW DRUG__ID D0H2ZW D0H2ZW DRUGTYPE Small molecular drug D0H2ZW DRUGINCH 1S/C15H15ClN2O4S/c1-8-4-3-5-9(2)14(8)18-15(20)10-6-13(23(17,21)22)11(16)7-12(10)19/h3-7,19H,1-2H3,(H,18,20)(H2,17,21,22) D0H2ZW DRUGINKE MTZBBNMLMNBNJL-UHFFFAOYSA-N D0H2ZW DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C2=CC(=C(C=C2O)Cl)S(=O)(=O)N D0H2ZW HIGHSTAT Approved D0H5MB DRUG__ID D0H5MB D0H5MB DRUGTYPE Small molecular drug D0H5MB DRUGINCH 1S/C23H28N2O3/c1-16-13-19-20(25-16)11-8-12-21(19)27-15-18(14-24-23(2,3)4)28-22(26)17-9-6-5-7-10-17/h5-13,18,24-25H,14-15H2,1-4H3 D0H5MB DRUGINKE UUOJIACWOAYWEZ-UHFFFAOYSA-N D0H5MB DRUGSMIL CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C3=CC=CC=C3 D0H5MB HIGHSTAT Approved D0H9ZQ DRUG__ID D0H9ZQ D0H9ZQ DRUGTYPE Small molecular drug D0H9ZQ DRUGINCH 1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1 D0H9ZQ DRUGINKE SNPLKNRPJHDVJA-ZETCQYMHSA-N D0H9ZQ DRUGSMIL CC(C)(CO)C(C(=O)NCCCO)O D0H9ZQ HIGHSTAT Approved D0I0DL DRUG__ID D0I0DL D0I0DL DRUGTYPE Small molecular drug D0I0DL DRUGINCH 1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3 D0I0DL DRUGINKE UYNVMODNBIQBMV-UHFFFAOYSA-N D0I0DL DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3 D0I0DL HIGHSTAT Approved D0I0DQ DRUG__ID D0I0DQ D0I0DQ DRUGTYPE Small molecular drug D0I0DQ DRUGINCH 1S/C20H26N4O5S/c1-14-13-18(23-29-14)19(25)21-12-11-15-7-9-17(10-8-15)30(27,28)24-20(26)22-16-5-3-2-4-6-16/h7-10,13,16H,2-6,11-12H2,1H3,(H,21,25)(H2,22,24,26) D0I0DQ DRUGINKE GZKDXUIWCNCNBJ-UHFFFAOYSA-N D0I0DQ DRUGSMIL CC1=CC(=NO1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 D0I0DQ HIGHSTAT Approved D0I0DS DRUG__ID D0I0DS D0I0DS DRUGTYPE Small molecular drug D0I0DS DRUGINCH 1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13) D0I0DS DRUGINKE YAPQBXQYLJRXSA-UHFFFAOYSA-N D0I0DS DRUGSMIL CN1C=NC2=C1C(=O)NC(=O)N2C D0I0DS HIGHSTAT Approved D0I3XG DRUG__ID D0I3XG D0I3XG DRUGTYPE Small molecular drug D0I3XG DRUGINCH 1S/2C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)24(11-14-36(46)47)32(44-30)18-33-25(12-15-37(48)51-6)21(3)28(43-33)16-31(23)42-29;1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h2*9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/t2*38-,41+/m00/s1 D0I3XG DRUGINKE NJLRKAMQPVVOIU-IDLGWYNRSA-N D0I3XG DRUGSMIL CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C D0I3XG HIGHSTAT Approved D0I5HV DRUG__ID D0I5HV D0I5HV DRUGTYPE Small molecular drug D0I5HV DRUGINCH 1S/C13H20N2O3S/c1-5-6-14-9(3)12(16)15-10-8(2)7-19-11(10)13(17)18-4/h7,9,14H,5-6H2,1-4H3,(H,15,16) D0I5HV DRUGINKE QTGIAADRBBLJGA-UHFFFAOYSA-N D0I5HV DRUGSMIL CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC D0I5HV HIGHSTAT Approved D0I5KX DRUG__ID D0I5KX D0I5KX DRUGTYPE Small molecular drug D0I5KX DRUGINCH 1S/C129H215N33O55/c1-18-59(10)98(159-114(201)76(36-42-91(181)182)146-120(207)83(53-164)154-121(208)84(54-165)155-127(214)99(63(14)166)160-118(205)80(51-94(187)188)152-123(210)95(56(4)5)156-104(191)62(13)135-102(189)60(11)137-115(202)78(49-92(183)184)151-119(206)82(52-163)138-66(17)169)125(212)161-101(65(16)168)128(215)162-100(64(15)167)126(213)147-70(30-22-26-46-133)109(196)150-79(50-93(185)186)117(204)149-77(47-55(2)3)116(203)142-69(29-21-25-45-132)108(195)144-73(33-39-88(175)176)110(197)141-67(27-19-23-43-130)106(193)140-68(28-20-24-44-131)107(194)145-75(35-41-90(179)180)113(200)157-97(58(8)9)124(211)158-96(57(6)7)122(209)148-74(34-40-89(177)178)111(198)143-71(31-37-86(171)172)105(192)136-61(12)103(190)139-72(32-38-87(173)174)112(199)153-81(129(216)217)48-85(134)170/h55-65,67-84,95-101,163-168H,18-54,130-133H2,1-17H3,(H2,134,170)(H,135,189)(H,136,192)(H,137,202)(H,138,169)(H,139,190)(H,140,193)(H,141,197)(H,142,203)(H,143,198)(H,144,195)(H,145,194)(H,146,207)(H,147,213)(H,148,209)(H,149,204)(H,150,196)(H,151,206)(H,152,210)(H,153,199)(H,154,208)(H,155,214)(H,156,191)(H,157,200)(H,158,211)(H,159,201)(H,160,205)(H,161,212)(H,162,215)(H,171,172)(H,173,174)(H,175,176)(H,177,178)(H,179,180)(H,181,182)(H,183,184)(H,185,186)(H,187,188)(H,216,217)/t59-,60-,61-,62-,63+,64+,65+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,95-,96-,97-,98-,99-,100-,101-/m0/s1 D0I5KX DRUGINKE NZVYCXVTEHPMHE-ZSUJOUNUSA-N D0I5KX DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C D0I5KX HIGHSTAT Approved D0I6JF DRUG__ID D0I6JF D0I6JF DRUGTYPE Small molecular drug D0I6JF DRUGINCH 1S/2Na.H3O4P/c;;1-5(2,3)4/h;;(H3,1,2,3,4)/q2*+1;/p-2/i;;5+1 D0I6JF DRUGINKE BNIILDVGGAEEIG-JCIGTKTHSA-L D0I6JF DRUGSMIL OP(=O)([O-])[O-].[Na+].[Na+] D0I6JF HIGHSTAT Approved D0I8CA DRUG__ID D0I8CA D0I8CA DRUGTYPE Small molecular drug D0I8CA DRUGINCH 1S/C23H32N2O2S/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28) D0I8CA DRUGINKE BWBONKHPVHMQHE-UHFFFAOYSA-N D0I8CA DRUGSMIL CC(C)CCOC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)OCCC(C)C D0I8CA HIGHSTAT Approved D0I8YO DRUG__ID D0I8YO D0I8YO DRUGCOMP Chemo-Sero-Therapeutic Research Inst D0I8YO DRUGINCH 1S/C135H199N39O38S/c1-66(2)50-87(155-104(185)62-152-112(190)80(136)29-20-45-147-134(142)143)118(196)160-89(53-75-34-36-78(179)37-35-75)121(199)166-94(54-74-26-16-13-17-27-74)131(209)173-47-22-32-97(173)126(204)154-69(7)111(189)151-61-103(184)150-63-106(188)212-133(211)107(68(5)6)169-116(194)83(31-21-46-148-135(144)145)159-127(205)98-33-23-48-174(98)132(210)95(58-105(186)187)167-115(193)85(39-42-100(139)181)157-119(197)88(51-67(3)4)164-128(206)108(70(8)176)170-117(195)86(40-43-101(140)182)158-123(201)92(56-77-60-146-65-153-77)162-120(198)90(52-73-24-14-12-15-25-73)165-129(207)109(71(9)177)172-130(208)110(72(10)178)171-125(203)96(64-175)168-124(202)93(57-102(141)183)163-122(200)91(55-76-59-149-82-30-19-18-28-79(76)82)161-114(192)84(38-41-99(138)180)156-113(191)81(137)44-49-213-11/h12-19,24-28,30,34-37,59-60,65-72,77,80-81,83-98,107-110,149,175-179H,20-23,29,31-33,38-58,61-64,136-137H2,1-11H3,(H2,138,180)(H2,139,181)(H2,140,182)(H2,141,183)(H,150,184)(H,151,189)(H,152,190)(H,154,204)(H,155,185)(H,156,191)(H,157,197)(H,158,201)(H,159,205)(H,160,196)(H,161,192)(H,162,198)(H,163,200)(H,164,206)(H,165,207)(H,166,199)(H,167,193)(H,168,202)(H,169,194)(H,170,195)(H,171,203)(H,172,208)(H,186,187)(H4,142,143,147)(H4,144,145,148)/t69-,70+,71+,72+,77?,80-,81-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,107-,108-,109-,110-/m0/s1 D0I8YO DRUGINKE SPSXSWRZQFPVTJ-ZQQKUFEYSA-N D0I8YO DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=CC=C2)C(=O)N3CCCC3C(=O)NC(C)C(=O)NCC(=O)NCC(=O)OC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C4CCCN4C(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC5C=NC=N5)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C(CCC(=O)N)NC(=O)C(CCSC)N)NC(=O)CNC(=O)C(CCCNC(=N)N)N D0I8YO HIGHSTAT Approved D0I9HF DRUG__ID D0I9HF D0I9HF DRUGTYPE Small molecular drug D0I9HF DRUGINCH 1S/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10-,17-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1 D0I9HF DRUGINKE QUQPHWDTPGMPEX-QJBIFVCTSA-N D0I9HF DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O D0I9HF HIGHSTAT Approved D0IE1E DRUG__ID D0IE1E D0IE1E DRUGTYPE Small molecular drug D0IE1E DRUGINCH 1S/C6H6N4O4/c7-6(11)9-8-3-4-1-2-5(14-4)10(12)13/h1-3H,(H3,7,9,11)/b8-3+ D0IE1E DRUGINKE IAIWVQXQOWNYOU-FPYGCLRLSA-N D0IE1E DRUGSMIL C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N D0IE1E HIGHSTAT Approved D0IG4I DRUG__ID D0IG4I D0IG4I DRUGTYPE Small molecular drug D0IG4I DRUGINCH 1S/C27H33NO10S/c1-12(30)28-16-7-5-13-9-18(37-27-24(34)23(33)22(32)19(11-29)38-27)25(35-2)26(36-3)21(13)14-6-8-20(39-4)17(31)10-15(14)16/h6,8-10,16,19,22-24,27,29,32-34H,5,7,11H2,1-4H3,(H,28,30)/t16-,19+,22+,23-,24+,27+/m0/s1 D0IG4I DRUGINKE LEQAKWQJCITZNK-AXHKHJLKSA-N D0IG4I DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)OC4C(C(C(C(O4)CO)O)O)O D0IG4I HIGHSTAT Approved D0IV3M DRUG__ID D0IV3M D0IV3M DRUGTYPE Small molecular drug D0IV3M DRUGINCH 1S/C2H6O2/c3-1-2-4/h3-4H,1-2H2 D0IV3M DRUGINKE LYCAIKOWRPUZTN-UHFFFAOYSA-N D0IV3M DRUGSMIL C(CO)O D0IV3M HIGHSTAT Approved D0IX6I DRUG__ID D0IX6I D0IX6I DRUGTYPE Small molecular drug D0IX6I DRUGINCH 1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1 D0IX6I DRUGINKE MFYSYFVPBJMHGN-ZPOLXVRWSA-N D0IX6I DRUGSMIL CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C D0IX6I HIGHSTAT Approved D0J4IX DRUG__ID D0J4IX D0J4IX DRUGTYPE Small molecular drug D0J4IX DRUGINCH 1S/C18H19NO3/c1-19-8-5-11-9-14(22-2)17(21)16-15(11)13(19)10-18(16)6-3-12(20)4-7-18/h3-4,6-7,9,13,21H,5,8,10H2,1-2H3 D0J4IX DRUGINKE PNJUPRNTSWJWAX-UHFFFAOYSA-N D0J4IX DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC34C=CC(=O)C=C4)O)OC D0J4IX HIGHSTAT Approved D0J5TS DRUG__ID D0J5TS D0J5TS DRUGTYPE Small molecular drug D0J5TS DRUGINCH 1S/C31H33N3O12/c1-14-7-6-8-18-19(14)9-17(43-5)10-20(18)26(40)32-13-30(4)24(39)28(41)45-31(46-30)25(23(38)22-11-34(22)16(3)37)44-27(33-29(31)42)21(12-35)15(2)36/h6-10,12,22-25,38-39H,11,13H2,1-5H3,(H,32,40)(H,33,42) D0J5TS DRUGINKE GNGRYODSYNVRFD-UHFFFAOYSA-N D0J5TS DRUGSMIL CC1=C2C=C(C=C(C2=CC=C1)C(=O)NCC3(C(C(=O)OC4(O3)C(OC(=C(C=O)C(=O)C)NC4=O)C(C5CN5C(=O)C)O)O)C)OC D0J5TS HIGHSTAT Approved D0J6WW DRUG__ID D0J6WW D0J6WW DRUGTYPE Small molecular drug D0J6WW DRUGINCH 1S/C18H18N2O/c1-12(2)20-16-11-13(3)9-10-15(16)17(19-18(20)21)14-7-5-4-6-8-14/h4-12H,1-3H3 D0J6WW DRUGINKE JTIGKVIOEQASGT-UHFFFAOYSA-N D0J6WW DRUGSMIL CC1=CC2=C(C=C1)C(=NC(=O)N2C(C)C)C3=CC=CC=C3 D0J6WW HIGHSTAT Approved D0J6WX DRUG__ID D0J6WX D0J6WX DRUGTYPE Small molecular drug D0J6WX DRUGINCH 1S/C24H29FNO3.BrH/c1-26(15-14-25)20-12-13-21(26)17-22(16-20)29-23(27)24(28,18-8-4-2-5-9-18)19-10-6-3-7-11-19;/h2-11,20-22,28H,12-17H2,1H3;1H/q+1;/p-1/t20-,21+,22?,26?; D0J6WX DRUGINKE FNUZASGZEHGWQM-QCERWEEGSA-M D0J6WX DRUGSMIL C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCF.[Br-] D0J6WX HIGHSTAT Approved D0J7CP DRUG__ID D0J7CP D0J7CP DRUGCOMP Sandoz AG D0J7CP DRUGINCH 1S/C63H87N13O19S2.In/c1-37(78)48(34-77)70-62(94)50-36-97-96-35-49(71-58(90)45(25-39-13-5-3-6-14-39)66-51(80)29-75(31-53(83)84)23-21-74(30-52(81)82)22-24-76(32-54(85)86)33-55(87)88)61(93)68-46(26-40-15-7-4-8-16-40)59(91)69-47(27-41-28-65-43-18-10-9-17-42(41)43)60(92)67-44(19-11-12-20-64)57(89)73-56(38(2)79)63(95)72-50;/h3-10,13-18,28,37-38,44-50,56,65,77-79H,11-12,19-27,29-36,64H2,1-2H3,(H,66,80)(H,67,92)(H,68,93)(H,69,91)(H,70,94)(H,71,90)(H,72,95)(H,73,89)(H,81,82)(H,83,84)(H,85,86)(H,87,88);/q;+3/p-3/t37-,38-,44+,45-,46+,47-,48-,49+,50+,56+;/m1./s1/i;1-4 D0J7CP DRUGINKE ONJXCGCIKIYAPL-MLRSDOHDSA-K D0J7CP DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(CO)C(C)O)O.[In+3] D0J7CP HIGHSTAT Approved D0J7OG DRUG__ID D0J7OG D0J7OG DRUGTYPE Small molecular drug D0J7OG DRUGINCH 1S/C41H67NO15/c1-11-30(45)54-29-21-32(47)51-24(4)16-14-13-15-17-28(44)23(3)20-27(18-19-43)37(38(29)50-10)57-40-35(48)34(42(8)9)36(25(5)53-40)56-33-22-41(7,49)39(26(6)52-33)55-31(46)12-2/h13-15,17,19,23-29,33-40,44,48-49H,11-12,16,18,20-22H2,1-10H3/b14-13+,17-15+/t23-,24-,25-,26+,27+,28+,29-,33+,34-,35-,36-,37+,38+,39+,40+,41-/m1/s1 D0J7OG DRUGINKE DMUAPQTXSSNEDD-QALJCMCCSA-N D0J7OG DRUGSMIL CCC(=O)OC1CC(=O)OC(CC=CC=CC(C(CC(C(C1OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C D0J7OG HIGHSTAT Approved D0J9ZR DRUG__ID D0J9ZR D0J9ZR DRUGTYPE Small molecular drug D0J9ZR DRUGINCH 1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19) D0J9ZR DRUGINKE RJMUSRYZPJIFPJ-UHFFFAOYSA-N D0J9ZR DRUGSMIL C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O D0J9ZR HIGHSTAT Approved D0JO8Z DRUG__ID D0JO8Z D0JO8Z DRUGTYPE Small molecular drug D0JO8Z DRUGINCH 1S/C18H22O8P2/c1-3-17(13-5-9-15(10-6-13)25-27(19,20)21)18(4-2)14-7-11-16(12-8-14)26-28(22,23)24/h5-12H,3-4H2,1-2H3,(H2,19,20,21)(H2,22,23,24)/b18-17+ D0JO8Z DRUGINKE NLORYLAYLIXTID-ISLYRVAYSA-N D0JO8Z DRUGSMIL CCC(=C(CC)C1=CC=C(C=C1)OP(=O)(O)O)C2=CC=C(C=C2)OP(=O)(O)O D0JO8Z HIGHSTAT Approved D0K0AT DRUG__ID D0K0AT D0K0AT DRUGTYPE Small molecular drug D0K0AT DRUGINCH 1S/C42H65N13O10/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47)/t24-,28-,29-,30-,31-,33-,34-/m0/s1 D0K0AT DRUGINKE PFGWGEPQIUAZME-NXSMLHPHSA-N D0K0AT DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D0K0AT HIGHSTAT Approved D0K0EK DRUG__ID D0K0EK D0K0EK DRUGTYPE Small molecular drug D0K0EK DRUGINCH 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1 D0K0EK DRUGINKE FMGSKLZLMKYGDP-USOAJAOKSA-N D0K0EK DRUGSMIL CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C D0K0EK HIGHSTAT Approved D0K0SB DRUG__ID D0K0SB D0K0SB DRUGCOMP NKBio Biopharmacology D0K0SB DRUGINCH 1S/C23H31N5O12/c1-37-15-14(32)21(28-7-5-12(30)27-23(28)36)39-16(15)17(18(24)33)40-22-13(31)10(29)8-11(38-22)20(35)26-9-4-2-3-6-25-19(9)34/h5,7-10,13-17,21-22,29,31-32H,2-4,6H2,1H3,(H2,24,33)(H,25,34)(H,26,35)(H,27,30,36)/t9-,10-,13-,14+,15-,16-,17+,21+,22+/m0/s1 D0K0SB DRUGINKE BISOEENGZHMDEO-RLXIHFJVSA-N D0K0SB DRUGSMIL COC1C(C(OC1C(C(=O)N)OC2C(C(C=C(O2)C(=O)NC3CCCCNC3=O)O)O)N4C=CC(=O)NC4=O)O D0K0SB HIGHSTAT Approved D0K0VO DRUG__ID D0K0VO D0K0VO DRUGTYPE Small molecular drug D0K0VO DRUGINCH 1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3 D0K0VO DRUGINKE ICMGLRUYEQNHPF-UHFFFAOYSA-N D0K0VO DRUGSMIL CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC D0K0VO HIGHSTAT Approved D0K2TB DRUG__ID D0K2TB D0K2TB DRUGTYPE Small molecular drug D0K2TB DRUGINCH 1S/C21H30N2O8S/c1-5-28-20(26)30-17-8-7-15(13-18(17)31-21(27)29-6-2)9-11-22-19(25)16(10-12-32-4)23-14(3)24/h7-8,13,16H,5-6,9-12H2,1-4H3,(H,22,25)(H,23,24)/t16-/m0/s1 D0K2TB DRUGINKE ZLVMAMIPILWYHQ-INIZCTEOSA-N D0K2TB DRUGSMIL CCOC(=O)OC1=C(C=C(C=C1)CCNC(=O)C(CCSC)NC(=O)C)OC(=O)OCC D0K2TB HIGHSTAT Approved D0K5SN DRUG__ID D0K5SN D0K5SN DRUGTYPE Small molecular drug D0K5SN DRUGINCH 1S/C28H32O39S8/c1-10-21(62-70(36,37)38)23(64-72(42,43)44)25(66-74(48,49)50)27(56-10)55-9-19-22(63-71(39,40)41)24(65-73(45,46)47)26(67-75(51,52)53)28(59-19)57-12-6-17-20(18(7-12)61-69(33,34)35)13(29)8-15(58-17)11-3-4-14(54-2)16(5-11)60-68(30,31)32/h3-8,10,19,21-28H,9H2,1-2H3,(H,30,31,32)(H,33,34,35)(H,36,37,38)(H,39,40,41)(H,42,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53) D0K5SN DRUGINKE YCGANVWZEQAZHF-UHFFFAOYSA-N D0K5SN DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC4=C(C(=C3)OS(=O)(=O)O)C(=O)C=C(O4)C5=CC(=C(C=C5)OC)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O D0K5SN HIGHSTAT Approved D0K7LU DRUG__ID D0K7LU D0K7LU DRUGTYPE Small molecular drug D0K7LU DRUGINCH 1S/C15H18O3/c1-8-10-4-6-15(3)7-5-11(16)9(2)12(15)13(10)18-14(8)17/h5,7-8,10,13H,4,6H2,1-3H3/t8-,10-,13-,15-/m0/s1 D0K7LU DRUGINKE XJHDMGJURBVLLE-BOCCBSBMSA-N D0K7LU DRUGSMIL CC1C2CCC3(C=CC(=O)C(=C3C2OC1=O)C)C D0K7LU HIGHSTAT Approved D0K8IX DRUG__ID D0K8IX D0K8IX DRUGTYPE Small molecular drug D0K8IX DRUGINCH 1S/C3H3NO2S/c5-2-1-7-3(6)4-2/h1H2,(H,4,5,6) D0K8IX DRUGINKE ZOBPZXTWZATXDG-UHFFFAOYSA-N D0K8IX DRUGSMIL C1C(=O)NC(=O)S1 D0K8IX HIGHSTAT Approved D0KD4X DRUG__ID D0KD4X D0KD4X DRUGTYPE Small molecular drug D0KD4X DRUGINCH 1S/C37H61N2O4.BrH/c1-6-20-39(21-12-9-13-22-39)32-24-30-28-15-14-27-23-33(42-26(3)40)31(38-18-10-8-11-19-38)25-37(27,5)29(28)16-17-36(30,4)35(32)43-34(41)7-2;/h6,27-33,35H,1,7-25H2,2-5H3;1H/q+1;/p-1/t27-,28+,29-,30-,31-,32-,33-,35-,36-,37-;/m0./s1 D0KD4X DRUGINKE LVQTUXZKLGXYIU-GWSNJHLMSA-M D0KD4X DRUGSMIL CCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)CC=C.[Br-] D0KD4X HIGHSTAT Approved D0KN2M DRUG__ID D0KN2M D0KN2M DRUGTYPE Small molecular drug D0KN2M DRUGINCH 1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(24(34)35,11-19(30)23(20)33)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,33H,11-12H2,(H,34,35)/b7-3+,8-4+/t19-,20-,23+,25-/m1/s1 D0KN2M DRUGINKE YDDUMTOHNYZQPO-RVXRWRFUSA-N D0KN2M DRUGSMIL C1C(C(C(CC1(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O D0KN2M HIGHSTAT Approved D0KS6W DRUG__ID D0KS6W D0KS6W DRUGTYPE Small molecular drug D0KS6W DRUGINCH 1S/C17H21NO/c1-18(2)12-13-19-17-11-7-6-10-16(17)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3 D0KS6W DRUGINKE IZRPKIZLIFYYKR-UHFFFAOYSA-N D0KS6W DRUGSMIL CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2 D0KS6W HIGHSTAT Approved D0L0MK DRUG__ID D0L0MK D0L0MK DRUGTYPE Small molecular drug D0L0MK DRUGINCH 1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m1/s1 D0L0MK DRUGINKE SLRCCWJSBJZJBV-TUVASFSCSA-N D0L0MK DRUGSMIL C1CCN2CC3CC(C2C1)CN4C3CCCC4 D0L0MK HIGHSTAT Approved D0L0SW DRUG__ID D0L0SW D0L0SW DRUGTYPE Small molecular drug D0L0SW DRUGINCH 1S/C23H20N2O5/c26-19-12-6-15(7-13-19)14-20(25-21(27)16-4-2-1-3-5-16)22(28)24-18-10-8-17(9-11-18)23(29)30/h1-13,20,26H,14H2,(H,24,28)(H,25,27)(H,29,30)/t20-/m0/s1 D0L0SW DRUGINKE SPPTWHFVYKCNNK-FQEVSTJZSA-N D0L0SW DRUGSMIL C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC3=CC=C(C=C3)C(=O)O D0L0SW HIGHSTAT Approved D0L0ZF DRUG__ID D0L0ZF D0L0ZF DRUGTYPE Small molecular drug D0L0ZF DRUGINCH 1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26) D0L0ZF DRUGINKE ZVNYJIZDIRKMBF-UHFFFAOYSA-N D0L0ZF DRUGSMIL COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC D0L0ZF HIGHSTAT Approved D0L1JW DRUG__ID D0L1JW D0L1JW DRUGTYPE Small molecular drug D0L1JW DRUGINCH 1S/C21H21NO6/c1-22-7-6-11-8-15-16(27-10-26-15)9-13(11)18(22)19-12-4-5-14(24-2)20(25-3)17(12)21(23)28-19/h4-5,8-9,18-19H,6-7,10H2,1-3H3/t18-,19+/m1/s1 D0L1JW DRUGINKE JZUTXVTYJDCMDU-MOPGFXCFSA-N D0L1JW DRUGSMIL CN1CCC2=CC3=C(C=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OCO3 D0L1JW HIGHSTAT Approved D0L1OY DRUG__ID D0L1OY D0L1OY DRUGTYPE Small molecular drug D0L1OY DRUGINCH 1S/C44H50N4O2/c1-3-17-47-19-15-43-35-9-5-7-11-37(35)45-26-34-32-24-40-44(16-20-48(40,18-4-2)28-30(32)14-22-50)36-10-6-8-12-38(36)46(42(34)44)25-33(41(43)45)31(23-39(43)47)29(27-47)13-21-49/h3-14,25-26,31-32,39-42,49-50H,1-2,15-24,27-28H2/q+2/b29-13-,30-14-,33-25-,34-26-/t31-,32-,39-,40-,41-,42-,43+,44+,47-,48-/m0/s1 D0L1OY DRUGINKE MUQUYTSLDVKIOF-CHJKCJHBSA-N D0L1OY DRUGSMIL C=CC[N+]12CCC34C1CC(C(=CCO)C2)C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CC[N+]1(CC9=CCO)CC=C)C1=CC=CC=C16 D0L1OY HIGHSTAT Approved D0L1WV DRUG__ID D0L1WV D0L1WV DRUGTYPE Small molecular drug D0L1WV DRUGINCH 1S/C14H14O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-8,10,12H,9H2,1H3/b8-7+/t12-/m0/s1 D0L1WV DRUGINKE XEAQIWGXBXCYFX-GUOLPTJISA-N D0L1WV DRUGSMIL COC1=CC(=O)OC(C1)C=CC2=CC=CC=C2 D0L1WV HIGHSTAT Approved D0L2CI DRUG__ID D0L2CI D0L2CI DRUGCOMP Novo Nordisk D0L2CI DRUGINCH 1S/C274H411N65O81S6/c1-28-146(23)223(331-210(357)119-275)268(412)335-222(145(21)22)264(408)305-172(89-97-218(369)370)234(378)300-169(84-92-204(279)351)238(382)326-198-131-424-425-132-199-259(403)323-193(126-341)256(400)312-177(103-138(7)8)241(385)313-183(110-154-66-74-160(345)75-67-154)244(388)301-167(82-90-202(277)349)235(379)308-176(102-137(5)6)239(383)303-171(88-96-217(367)368)237(381)320-189(116-205(280)352)251(395)316-185(112-156-70-78-162(347)79-71-156)247(391)327-197(258(402)322-191(273(419)420)118-207(282)354)130-423-422-129-196(231(375)290-122-211(358)295-166(86-94-215(363)364)233(377)299-165(62-53-99-288-274(283)284)229(373)289-123-212(359)297-181(108-152-57-45-41-46-58-152)243(387)315-182(109-153-59-47-42-48-60-153)246(390)317-186(113-157-72-80-163(348)81-73-157)254(398)338-226(150(27)344)270(414)339-100-54-63-201(339)262(406)306-173(271(415)416)61-51-52-98-287-208(355)93-85-174(272(417)418)296-209(356)64-49-38-36-34-32-30-31-33-35-37-39-50-65-214(361)362)329-266(410)221(144(19)20)334-252(396)179(105-140(11)12)310-245(389)184(111-155-68-76-161(346)77-69-155)314-240(384)175(101-136(3)4)307-227(371)148(25)294-232(376)170(87-95-216(365)366)304-263(407)220(143(17)18)333-253(397)180(106-141(13)14)311-249(393)188(115-159-121-286-135-293-159)319-255(399)192(125-340)298-213(360)124-291-230(374)195(128-421-426-133-200(328-260(198)404)261(405)337-225(149(26)343)269(413)324-194(127-342)257(401)336-224(147(24)29-2)267(411)330-199)325-242(386)178(104-139(9)10)309-248(392)187(114-158-120-285-134-292-158)318-236(380)168(83-91-203(278)350)302-250(394)190(117-206(281)353)321-265(409)219(142(15)16)332-228(372)164(276)107-151-55-43-40-44-56-151/h40-48,55-60,66-81,120-121,134-150,164-201,219-226,340-348H,28-39,49-54,61-65,82-119,122-133,275-276H2,1-27H3,(H2,277,349)(H2,278,350)(H2,279,351)(H2,280,352)(H2,281,353)(H2,282,354)(H,285,292)(H,286,293)(H,287,355)(H,289,373)(H,290,375)(H,291,374)(H,294,376)(H,295,358)(H,296,356)(H,297,359)(H,298,360)(H,299,377)(H,300,378)(H,301,388)(H,302,394)(H,303,383)(H,304,407)(H,305,408)(H,306,406)(H,307,371)(H,308,379)(H,309,392)(H,310,389)(H,311,393)(H,312,400)(H,313,385)(H,314,384)(H,315,387)(H,316,395)(H,317,390)(H,318,380)(H,319,399)(H,320,381)(H,321,409)(H,322,402)(H,323,403)(H,324,413)(H,325,386)(H,326,382)(H,327,391)(H,328,404)(H,329,410)(H,330,411)(H,331,357)(H,332,372)(H,333,397)(H,334,396)(H,335,412)(H,336,401)(H,337,405)(H,338,398)(H,361,362)(H,363,364)(H,365,366)(H,367,368)(H,369,370)(H,415,416)(H,417,418)(H,419,420)(H4,283,284,288)/t146-,147-,148-,149+,150+,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,198-,199-,200-,201-,219-,220-,221-,222-,223-,224-,225-,226-/m0/s1 D0L2CI DRUGINKE FYZPCMFQCNBYCY-WIWKJPBBSA-N D0L2CI DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D0L2CI HIGHSTAT Approved D0L4SD DRUG__ID D0L4SD D0L4SD DRUGTYPE Small molecular drug D0L4SD DRUGINCH 1S/C43H66O15/c1-20-38(49)32(55-23(4)44)18-37(52-20)58-40-22(3)54-36(17-31(40)46)57-39-21(2)53-35(16-30(39)45)56-26-9-11-41(5)25(14-26)7-8-28-29(41)15-33(47)42(6)27(10-12-43(28,42)50)24-13-34(48)51-19-24/h13,20-22,25-33,35-40,45-47,49-50H,7-12,14-19H2,1-6H3/t20-,21-,22-,25-,26+,27-,28-,29+,30+,31+,32+,33-,35+,36+,37+,38-,39-,40-,41+,42+,43+/m1/s1 D0L4SD DRUGINKE HWKJSYYYURVNQU-DXJNJSHLSA-N D0L4SD DRUGSMIL CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)OC(=O)C)O D0L4SD HIGHSTAT Approved D0L7AS DRUG__ID D0L7AS D0L7AS DRUGTYPE Small molecular drug D0L7AS DRUGINCH 1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3/t18-,19-/m1/s1 D0L7AS DRUGINKE GECBBEABIDMGGL-RTBURBONSA-N D0L7AS DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O D0L7AS HIGHSTAT Approved D0L7VL DRUG__ID D0L7VL D0L7VL DRUGTYPE Small molecular drug D0L7VL DRUGINCH 1S/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36) D0L7VL DRUGINKE ZBIAKUMOEKILTF-UHFFFAOYSA-N D0L7VL DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0L7VL HIGHSTAT Approved D0LJ6P DRUG__ID D0LJ6P D0LJ6P DRUGTYPE Small molecular drug D0LJ6P DRUGINCH 1S/C7H10N4O4/c12-4-2-8-6(13)5-10-3-1-9-7(10)11(14)15/h1,3,12H,2,4-5H2,(H,8,13) D0LJ6P DRUGINKE WCDWBPCFGJXFJZ-UHFFFAOYSA-N D0LJ6P DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NCCO D0LJ6P HIGHSTAT Approved D0LW9U DRUG__ID D0LW9U D0LW9U DRUGTYPE Small molecular drug D0LW9U DRUGINCH 1S/C14H30O2/c1-2-3-4-5-6-7-8-9-10-11-13-16-14-12-15/h15H,2-14H2,1H3 D0LW9U DRUGINKE SFNALCNOMXIBKG-UHFFFAOYSA-N D0LW9U DRUGSMIL CCCCCCCCCCCCOCCO D0LW9U HIGHSTAT Approved D0M1PQ DRUG__ID D0M1PQ D0M1PQ DRUGTYPE Small molecular drug D0M1PQ DRUGINCH 1S/C9H19N/c1-8(2)6-5-7-9(3)10-4/h6,9-10H,5,7H2,1-4H3 D0M1PQ DRUGINKE XVQUOJBERHHONY-UHFFFAOYSA-N D0M1PQ DRUGSMIL CC(CCC=C(C)C)NC D0M1PQ HIGHSTAT Approved D0M2QH DRUG__ID D0M2QH D0M2QH DRUGTYPE Small molecular drug D0M2QH DRUGINCH 1S/C29H42O10/c1-15-22(32)23(33)24(34)25(38-15)39-17-3-8-27(14-30)19-4-7-26(2)18(16-11-21(31)37-13-16)6-10-29(26,36)20(19)5-9-28(27,35)12-17/h11,14-15,17-20,22-25,32-36H,3-10,12-13H2,1-2H3/t15-,17-,18+,19-,20+,22-,23+,24+,25-,26+,27-,28-,29-/m0/s1 D0M2QH DRUGINKE HULMNSIAKWANQO-JQKSAQOKSA-N D0M2QH DRUGSMIL CC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)C=O)O)O)O D0M2QH HIGHSTAT Approved D0M2XE DRUG__ID D0M2XE D0M2XE THERCLAS Hypoglycemic Agents D0M2XE DRUGINCH 1S/C258H384N64O78S6/c1-29-132(23)206(313-193(338)105-260)253(394)317-205(131(21)22)250(391)289-160(75-83-200(348)349)219(360)283-157(71-79-190(264)335)223(364)308-184-117-404-405-118-185-244(385)305-179(112-324)241(382)295-164(90-124(7)8)227(368)296-170(97-141-53-61-147(329)62-54-141)230(371)284-156(70-78-189(263)334)220(361)291-163(89-123(5)6)225(366)285-159(74-82-199(346)347)222(363)303-176(103-191(265)336)236(377)299-172(99-143-57-65-149(331)66-58-143)233(374)309-183(243(384)304-177(256(397)398)104-192(266)337)116-403-402-115-182(215(356)273-108-194(339)278-154(72-80-197(342)343)218(359)281-152(51-42-86-271-258(267)268)213(354)272-109-195(340)279-168(95-139-46-36-32-37-47-139)229(370)298-169(96-140-48-38-33-39-49-140)232(373)300-173(100-144-59-67-150(332)68-60-144)239(380)320-209(136(27)327)255(396)322-87-43-52-187(322)247(388)286-161(76-84-201(350)351)224(365)321-210(137(28)328)257(399)400)311-251(392)204(130(19)20)316-237(378)166(92-126(11)12)293-231(372)171(98-142-55-63-148(330)64-56-142)297-226(367)162(88-122(3)4)290-211(352)134(25)277-216(357)158(73-81-198(344)345)288-249(390)203(129(17)18)315-238(379)167(93-127(13)14)294-235(376)175(102-146-107-270-121-276-146)302-240(381)178(111-323)280-196(341)110-274-214(355)181(114-401-406-119-186(310-245(184)386)246(387)319-208(135(26)326)254(395)306-180(113-325)242(383)318-207(133(24)30-2)252(393)312-185)307-228(369)165(91-125(9)10)292-234(375)174(101-145-106-269-120-275-145)301-221(362)155(69-77-188(262)333)282-217(358)153(50-40-41-85-259)287-248(389)202(128(15)16)314-212(353)151(261)94-138-44-34-31-35-45-138/h31-39,44-49,53-68,106-107,120-137,151-187,202-210,323-332H,29-30,40-43,50-52,69-105,108-119,259-261H2,1-28H3,(H2,262,333)(H2,263,334)(H2,264,335)(H2,265,336)(H2,266,337)(H,269,275)(H,270,276)(H,272,354)(H,273,356)(H,274,355)(H,277,357)(H,278,339)(H,279,340)(H,280,341)(H,281,359)(H,282,358)(H,283,360)(H,284,371)(H,285,366)(H,286,388)(H,287,389)(H,288,390)(H,289,391)(H,290,352)(H,291,361)(H,292,375)(H,293,372)(H,294,376)(H,295,382)(H,296,368)(H,297,367)(H,298,370)(H,299,377)(H,300,373)(H,301,362)(H,302,381)(H,303,363)(H,304,384)(H,305,385)(H,306,395)(H,307,369)(H,308,364)(H,309,374)(H,310,386)(H,311,392)(H,312,393)(H,313,338)(H,314,353)(H,315,379)(H,316,378)(H,317,394)(H,318,383)(H,319,387)(H,320,380)(H,321,365)(H,342,343)(H,344,345)(H,346,347)(H,348,349)(H,350,351)(H,397,398)(H,399,400)(H4,267,268,271)/t132-,133-,134-,135+,136+,137+,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,202-,203-,204-,205-,206-,207-,208-,209-,210-/m0/s1 D0M2XE DRUGINKE RCHHVVGSTHAVPF-ZPHPLDECSA-N D0M2XE DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D0M2XE HIGHSTAT Approved D0M3CV DRUG__ID D0M3CV D0M3CV DRUGCOMP Jazz Pharmaceuticals Dublin, Ireland D0M3CV DRUGINCH 1S/C10H14N2O2/c11-9(7-14-10(12)13)6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H2,12,13)/t9-/m1/s1 D0M3CV DRUGINKE UCTRAOBQFUDCSR-SECBINFHSA-N D0M3CV DRUGSMIL C1=CC=C(C=C1)CC(COC(=O)N)N D0M3CV HIGHSTAT Approved D0M5JI DRUG__ID D0M5JI D0M5JI DRUGTYPE Small molecular drug D0M5JI DRUGINCH 1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14+;2-1- D0M5JI DRUGINKE LFMYNZPAVPMEGP-PIDGMYBPSA-N D0M5JI DRUGSMIL COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O D0M5JI HIGHSTAT Approved D0M9BW DRUG__ID D0M9BW D0M9BW DRUGTYPE Small molecular drug D0M9BW DRUGINCH 1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1 D0M9BW DRUGINKE SXYIRMFQILZOAM-HVNFFKDJSA-N D0M9BW DRUGSMIL CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C D0M9BW HIGHSTAT Approved D0M9QK DRUG__ID D0M9QK D0M9QK DRUGTYPE Small molecular drug D0M9QK DRUGINCH 1S/C43H66O15/c1-20-38(55-23(4)44)30(45)17-36(53-20)57-40-22(3)54-37(18-32(40)47)58-39-21(2)52-35(16-31(39)46)56-26-9-11-41(5)25(14-26)7-8-28-29(41)15-33(48)42(6)27(10-12-43(28,42)50)24-13-34(49)51-19-24/h13,20-22,25-33,35-40,45-48,50H,7-12,14-19H2,1-6H3/t20-,21-,22-,25-,26+,27-,28-,29+,30+,31+,32+,33-,35+,36+,37+,38-,39-,40-,41+,42+,43+/m1/s1 D0M9QK DRUGINKE NREAGDHHMSOWKZ-DXJNJSHLSA-N D0M9QK DRUGSMIL CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC(=O)C)O)O D0M9QK HIGHSTAT Approved D0MT9X DRUG__ID D0MT9X D0MT9X DRUGTYPE Small molecular drug D0MT9X DRUGINCH 1S/2C6H6O5S.Ca/c2*7-4-1-2-5(8)6(3-4)12(9,10)11;/h2*1-3,7-8H,(H,9,10,11);/q;;+2/p-2 D0MT9X DRUGINKE QGNBTYAQAPLTMX-UHFFFAOYSA-L D0MT9X DRUGSMIL C1=CC(=C(C=C1O)S(=O)(=O)[O-])O.C1=CC(=C(C=C1O)S(=O)(=O)[O-])O.[Ca+2] D0MT9X HIGHSTAT Approved D0MY8N DRUG__ID D0MY8N D0MY8N DRUGTYPE Small molecular drug D0MY8N DRUGINCH 1S/C40H56/c1-31(19-13-21-33(3)25-27-37-35(5)23-15-29-39(37,7)8)17-11-12-18-32(2)20-14-22-34(4)26-28-38-36(6)24-16-30-40(38,9)10/h11-14,17-22,25-28H,15-16,23-24,29-30H2,1-10H3/b12-11+,19-13+,20-14+,27-25+,28-26+,31-17+,32-18+,33-21+,34-22+ D0MY8N DRUGINKE OENHQHLEOONYIE-JLTXGRSLSA-N D0MY8N DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C D0MY8N HIGHSTAT Approved D0N1MC DRUG__ID D0N1MC D0N1MC DRUGTYPE Small molecular drug D0N1MC DRUGINCH 1S/C18H18N6O5S2/c19-12(8-1-3-10(25)4-2-8)15(26)21-13-16(27)24-14(18(28)29)9(7-31-17(13)24)6-30-11-5-20-23-22-11/h1-5,12-13,17,25H,6-7,19H2,(H,21,26)(H,28,29)(H,20,22,23)/t12-,13-,17-/m1/s1 D0N1MC DRUGINKE UOCJDOLVGGIYIQ-PBFPGSCMSA-N D0N1MC DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)CSC4=NNN=C4 D0N1MC HIGHSTAT Approved D0N3UL DRUG__ID D0N3UL D0N3UL DRUGTYPE Small molecular drug D0N3UL DRUGINCH 1S/C7H7O6P/c8-7(9)5-3-1-2-4-6(5)13-14(10,11)12/h1-4H,(H,8,9)(H2,10,11,12) D0N3UL DRUGINKE FFKUDWZICMJVPA-UHFFFAOYSA-N D0N3UL DRUGSMIL C1=CC=C(C(=C1)C(=O)O)OP(=O)(O)O D0N3UL HIGHSTAT Approved D0N3ZJ DRUG__ID D0N3ZJ D0N3ZJ DRUGTYPE Small molecular drug D0N3ZJ DRUGINCH 1S/C27H30F2N2O3/c1-32-24-13-8-21(26(33-2)27(24)34-3)18-30-14-16-31(17-15-30)25(19-4-9-22(28)10-5-19)20-6-11-23(29)12-7-20/h4-13,25H,14-18H2,1-3H3 D0N3ZJ DRUGINKE JQSAYKKFZOSZGJ-UHFFFAOYSA-N D0N3ZJ DRUGSMIL COC1=C(C(=C(C=C1)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC)OC D0N3ZJ HIGHSTAT Approved D0N4EC DRUG__ID D0N4EC D0N4EC DRUGTYPE Small molecular drug D0N4EC DRUGINCH 1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1 D0N4EC DRUGINKE LQZAIAZUDWIVPM-SRVKXCTJSA-N D0N4EC DRUGSMIL CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N D0N4EC HIGHSTAT Approved D0N4PZ DRUG__ID D0N4PZ D0N4PZ DRUGTYPE Small molecular drug D0N4PZ DRUGINCH 1S/C8H19NO6P2.2Na/c10-16(11,12)8(17(13,14)15)9-7-5-3-1-2-4-6-7;;/h7-9H,1-6H2,(H2,10,11,12)(H2,13,14,15);;/q;2*+1/p-2 D0N4PZ DRUGINKE PCSJAAWOSGCAFV-UHFFFAOYSA-L D0N4PZ DRUGSMIL C1CCCC(CC1)NC(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+] D0N4PZ HIGHSTAT Approved D0N5MH DRUG__ID D0N5MH D0N5MH DRUGCOMP PTC Therapeutics South Plainfield, NJ Roche Basel, Switzerland D0N5MH DRUGINCH 1S/C22H23N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3 D0N5MH DRUGINKE ASKZRYGFUPSJPN-UHFFFAOYSA-N D0N5MH DRUGSMIL CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6 D0N5MH HIGHSTAT Approved D0N6CR DRUG__ID D0N6CR D0N6CR DRUGTYPE Small molecular drug D0N6CR DRUGINCH 1S/C16H26N2O3/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3 D0N6CR DRUGINKE CAJIGINSTLKQMM-UHFFFAOYSA-N D0N6CR DRUGSMIL CCCOC1=C(C=CC(=C1)N)C(=O)OCCN(CC)CC D0N6CR HIGHSTAT Approved D0N6FH DRUG__ID D0N6FH D0N6FH DRUGTYPE Small molecular drug D0N6FH DRUGINCH 1S/C15H24O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-13,16H,4-7H2,1-3H3/t8-,9-,10+,11+,12+,13-,14-,15-/m1/s1 D0N6FH DRUGINKE BJDCWCLMFKKGEE-ISOSDAIHSA-N D0N6FH DRUGSMIL CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C D0N6FH HIGHSTAT Approved D0N8DP DRUG__ID D0N8DP D0N8DP DRUGTYPE Small molecular drug D0N8DP DRUGINCH 1S/C17H16N2OS/c20-14-10-18-16(11-6-2-1-3-7-11)15-12-8-4-5-9-13(12)21-17(15)19-14/h1-3,6-7H,4-5,8-10H2,(H,19,20) D0N8DP DRUGINKE AIZFEOPQVZBNGH-UHFFFAOYSA-N D0N8DP DRUGSMIL C1CCC2=C(C1)C3=C(S2)NC(=O)CN=C3C4=CC=CC=C4 D0N8DP HIGHSTAT Approved D0NF1U DRUG__ID D0NF1U D0NF1U DRUGTYPE Small molecular drug D0NF1U DRUGINCH 1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21) D0NF1U DRUGINKE MQOBSOSZFYZQOK-UHFFFAOYSA-N D0NF1U DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl D0NF1U HIGHSTAT Approved D0NP1J DRUG__ID D0NP1J D0NP1J DRUGTYPE Small molecular drug D0NP1J DRUGINCH 1S/C18H24N5O8P.Na/c1-3-5-11(24)22-16-13-17(20-8-19-16)23(9-21-13)18-15(30-12(25)6-4-2)14-10(29-18)7-28-32(26,27)31-14;/h8-10,14-15,18H,3-7H2,1-2H3,(H,26,27)(H,19,20,22,24);/q;+1/p-1/t10-,14-,15-,18-;/m1./s1 D0NP1J DRUGINKE KRBZRVBLIUDQNG-JBVYASIDSA-M D0NP1J DRUGSMIL CCCC(=O)NC1=C2C(=NC=N1)N(C=N2)C3C(C4C(O3)COP(=O)(O4)[O-])OC(=O)CCC.[Na+] D0NP1J HIGHSTAT Approved D0NU2H DRUG__ID D0NU2H D0NU2H DRUGTYPE Small molecular drug D0NU2H DRUGINCH 1S/C10H11I2NO3/c1-2-3-16-9(14)6-13-4-7(11)10(15)8(12)5-13/h4-5H,2-3,6H2,1H3 D0NU2H DRUGINKE ROSXARVHJNYYDO-UHFFFAOYSA-N D0NU2H DRUGSMIL CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I D0NU2H HIGHSTAT Approved D0NW0T DRUG__ID D0NW0T D0NW0T DRUGCOMP Janssen Research & Development Raritan, NJ D0NW0T DRUGINCH 1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3 D0NW0T DRUGINKE OLAHOMJCDNXHFI-UHFFFAOYSA-N D0NW0T DRUGSMIL CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC D0NW0T HIGHSTAT Approved D0O1PH DRUG__ID D0O1PH D0O1PH DRUGTYPE Small molecular drug D0O1PH DRUGINCH 1S/C18H34O2.C2H7NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;3-1-2-4/h9-10H,2-8,11-17H2,1H3,(H,19,20);4H,1-3H2/b10-9-; D0O1PH DRUGINKE KGWDUNBJIMUFAP-KVVVOXFISA-N D0O1PH DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)O.C(CO)N D0O1PH HIGHSTAT Approved D0O2PV DRUG__ID D0O2PV D0O2PV DRUGTYPE Small molecular drug D0O2PV DRUGINCH 1S/C12H14N6O10S2/c13-11-15-4(3-29-11)7(17-28-2-6(19)20)9(21)16-8-5(1-27-12(14)23)18(10(8)22)30(24,25)26/h3,5,8H,1-2H2,(H2,13,15)(H2,14,23)(H,16,21)(H,19,20)(H,24,25,26)/b17-7-/t5-,8+/m1/s1 D0O2PV DRUGINKE UIMOJFJSJSIGLV-JNHMLNOCSA-N D0O2PV DRUGSMIL C1=C(N=C(S1)N)C(=NOCC(=O)O)C(=O)NC2C(N(C2=O)S(=O)(=O)O)COC(=O)N D0O2PV HIGHSTAT Approved D0O2YE DRUG__ID D0O2YE D0O2YE DRUGTYPE Small molecular drug D0O2YE DRUGINCH 1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,19H,3-5,8H2,1-2H3,(H3,17,18,21) D0O2YE DRUGINKE IKBKZGMPCYNSLU-UHFFFAOYSA-N D0O2YE DRUGSMIL CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC D0O2YE HIGHSTAT Approved D0O3YF DRUG__ID D0O3YF D0O3YF DRUGCOMP Sandoz D0O3YF THERCLAS Immunosuppressive Agents D0O3YF DRUGTYPE Protein/peptide drug D0O3YF DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C D0O3YF HIGHSTAT Approved D0O5WD DRUG__ID D0O5WD D0O5WD DRUGTYPE Small molecular drug D0O5WD DRUGINCH 1S/C141H226N46O29S3/c1-11-77(6)111(133(212)186-112(80(9)189)134(213)183-106(74-218)130(209)184-110(76(4)5)132(211)176-97(49-32-61-161-141(155)156)120(199)170-93(45-28-57-157-137(147)148)116(195)166-78(7)113(192)180-103(136(215)216)66-82-36-16-13-17-37-82)185-128(207)104(72-188)181-131(210)107-50-33-62-187(107)135(214)79(8)165-109(191)71-164-115(194)100(64-75(2)3)177-121(200)92(44-24-27-56-144)168-117(196)91(43-23-26-55-143)169-125(204)99(53-63-219-10)175-119(198)94(46-29-58-158-138(149)150)172-126(205)101(67-83-69-162-88-40-20-18-38-85(83)88)179-124(203)98(51-52-108(146)190)174-127(206)102(68-84-70-163-89-41-21-19-39-86(84)89)178-122(201)96(48-31-60-160-140(153)154)171-118(197)95(47-30-59-159-139(151)152)173-129(208)105(73-217)182-123(202)90(42-22-25-54-142)167-114(193)87(145)65-81-34-14-12-15-35-81/h12-21,34-41,69-70,75-80,87,90-107,110-112,162-163,188-189,217-218H,11,22-33,42-68,71-74,142-145H2,1-10H3,(H2,146,190)(H,164,194)(H,165,191)(H,166,195)(H,167,193)(H,168,196)(H,169,204)(H,170,199)(H,171,197)(H,172,205)(H,173,208)(H,174,206)(H,175,198)(H,176,211)(H,177,200)(H,178,201)(H,179,203)(H,180,192)(H,181,210)(H,182,202)(H,183,213)(H,184,209)(H,185,207)(H,186,212)(H,215,216)(H4,147,148,157)(H4,149,150,158)(H4,151,152,159)(H4,153,154,160)(H4,155,156,161)/t77-,78-,79-,80+,87-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,110-,111-,112-/m0/s1 D0O5WD DRUGINKE CSSYQJWUGATIHM-IKGCZBKSSA-N D0O5WD DRUGSMIL CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O D0O5WD HIGHSTAT Approved D0O6OZ DRUG__ID D0O6OZ D0O6OZ DRUGTYPE Small molecular drug D0O6OZ DRUGINCH 1S/HI.Na/h1H;/q;+1/p-1/i1+4; D0O6OZ DRUGINKE FVAUCKIRQBBSSJ-LAIFMVDKSA-M D0O6OZ DRUGSMIL [Na+].[I-] D0O6OZ HIGHSTAT Approved D0O6UY DRUG__ID D0O6UY D0O6UY DRUGCOMP Incyte Wilmington, DE D0O6UY DRUGINCH 1S/C24H27F2N5O4/c1-4-30-21-14(11-27-23-16(21)9-15(28-23)13-29-5-7-35-8-6-29)12-31(24(30)32)22-19(25)17(33-2)10-18(34-3)20(22)26/h9-11H,4-8,12-13H2,1-3H3,(H,27,28) D0O6UY DRUGINKE HCDMJFOHIXMBOV-UHFFFAOYSA-N D0O6UY DRUGSMIL CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5 D0O6UY HIGHSTAT Approved D0O7SP DRUG__ID D0O7SP D0O7SP DRUGTYPE Small molecular drug D0O7SP DRUGINCH 1S/C20H27N5O3/c1-4-24(12-13-26)10-11-25-16(14-15-8-6-5-7-9-15)21-18-17(25)19(27)23(3)20(28)22(18)2/h5-9,26H,4,10-14H2,1-3H3 D0O7SP DRUGINKE VVUYEFBRTFASAH-UHFFFAOYSA-N D0O7SP DRUGSMIL CCN(CCN1C(=NC2=C1C(=O)N(C(=O)N2C)C)CC3=CC=CC=C3)CCO D0O7SP HIGHSTAT Approved D0O8DI DRUG__ID D0O8DI D0O8DI DRUGTYPE Small molecular drug D0O8DI DRUGINCH 1S/N2O/c1-2-3 D0O8DI DRUGINKE GQPLMRYTRLFLPF-UHFFFAOYSA-N D0O8DI DRUGSMIL [N-]=[N+]=O D0O8DI HIGHSTAT Approved D0O8IS DRUG__ID D0O8IS D0O8IS DRUGTYPE Small molecular drug D0O8IS DRUGINCH 1S/C20H24ClNO/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22/h1,3-4,7-12,20H,2,5-6,13-16H2 D0O8IS DRUGINKE FLNXBVJLPJNOSI-UHFFFAOYSA-N D0O8IS DRUGSMIL C1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl D0O8IS HIGHSTAT Approved D0O8SJ DRUG__ID D0O8SJ D0O8SJ DRUGCOMP Tg therapeutics D0O8SJ DRUGINCH 1S/C31H24F3N5O3/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29/h4-16H,1-3H3,(H2,35,36,37)/t16-/m0/s1 D0O8SJ DRUGINKE IUVCFHHAEHNCFT-INIZCTEOSA-N D0O8SJ DRUGSMIL CC(C)OC1=C(C=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F D0O8SJ HIGHSTAT Approved D0OG3K DRUG__ID D0OG3K D0OG3K DRUGTYPE Small molecular drug D0OG3K DRUGINCH 1S/C11H6ClN3O6/c12-7-5(14-8(16)10(18)19)1-4(3-13)2-6(7)15-9(17)11(20)21/h1-2H,(H,14,16)(H,15,17)(H,18,19)(H,20,21) D0OG3K DRUGINKE RVGLGHVJXCETIO-UHFFFAOYSA-N D0OG3K DRUGSMIL C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N D0OG3K HIGHSTAT Approved D0OR2L DRUG__ID D0OR2L D0OR2L DRUGTYPE Small molecular drug D0OR2L DRUGINCH 1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1 D0OR2L DRUGINKE BHQCQFFYRZLCQQ-OELDTZBJSA-N D0OR2L DRUGSMIL CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C D0OR2L HIGHSTAT Approved D0OR6A DRUG__ID D0OR6A D0OR6A DRUGTYPE Small molecular drug D0OR6A DRUGINCH 1S/C26H41NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(28)27-24(2)25-21-18-17-19-22-25/h7-8,10-11,17-19,21-22,24H,3-6,9,12-16,20,23H2,1-2H3,(H,27,28)/b8-7-,11-10- D0OR6A DRUGINKE RWIUTHWKQHRQNP-NQLNTKRDSA-N D0OR6A DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)NC(C)C1=CC=CC=C1 D0OR6A HIGHSTAT Approved D0OT9S DRUG__ID D0OT9S D0OT9S DRUGTYPE Small molecular drug D0OT9S DRUGINCH 1S/C45H54F2N4O8/c1-8-42-14-11-16-51-17-15-43(36(42)51)30-19-31(34(56-5)20-33(30)49(4)37(43)45(55,40(54)58-7)38(42)59-25(2)52)44(39(53)57-6)21-26-18-27(41(3,46)47)23-50(22-26)24-29-28-12-9-10-13-32(28)48-35(29)44/h9-14,19-20,26-27,36-38,48,55H,8,15-18,21-24H2,1-7H3/t26-,27-,36+,37-,38-,42-,43-,44+,45+/m1/s1 D0OT9S DRUGINKE NMDYYWFGPIMTKO-HBVLKOHWSA-N D0OT9S DRUGSMIL CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)C6(CC7CC(CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C D0OT9S HIGHSTAT Approved D0OY9S DRUG__ID D0OY9S D0OY9S DRUGCOMP Bracco Diagnostics Inc D0OY9S DRUGINCH 1S/C20H4Cl4I4O5.2Na/c21-9-7-8(10(22)12(24)11(9)23)20(33-19(7)31)3-1-5(25)15(29)13(27)17(3)32-18-4(20)2-6(26)16(30)14(18)28;;/h1-2,29-30H;;/q;2*+1/p-2/i25+4,26+4,27+4,28+4;; D0OY9S DRUGINKE KCQREHTWEUECQT-SZIYIJPFSA-L D0OY9S DRUGSMIL C1=C2C(=C(C(=C1I)[O-])I)OC3=C(C(=C(C=C3C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)I)[O-])I.[Na+].[Na+] D0OY9S HIGHSTAT Approved D0P0SZ DRUG__ID D0P0SZ D0P0SZ DRUGTYPE Small molecular drug D0P0SZ DRUGINCH 1S/C29H32Cl2N6/c30-22-2-4-24-26(20-22)32-8-6-28(24)36-16-12-34(13-17-36)10-1-11-35-14-18-37(19-15-35)29-7-9-33-27-21-23(31)3-5-25(27)29/h2-9,20-21H,1,10-19H2 D0P0SZ DRUGINKE UCRHFBCYFMIWHC-UHFFFAOYSA-N D0P0SZ DRUGSMIL C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl D0P0SZ HIGHSTAT Approved D0P2CS DRUG__ID D0P2CS D0P2CS DRUGTYPE Small molecular drug D0P2CS DRUGINCH 1S/C34H28N6O14S4.4Na/c1-15-11-17(3-7-21(15)37-39-23-9-5-19-25(55(43,44)45)13-27(57(49,50)51)31(35)29(19)33(23)41)18-4-8-22(16(2)12-18)38-40-24-10-6-20-26(56(46,47)48)14-28(58(52,53)54)32(36)30(20)34(24)42;;;;/h3-14,41-42H,35-36H2,1-2H3,(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54);;;;/q;4*+1/p-4 D0P2CS DRUGINKE ATNOAWAQFYGAOY-UHFFFAOYSA-J D0P2CS DRUGSMIL CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)[O-])S(=O)(=O)[O-])O)C)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+].[Na+] D0P2CS HIGHSTAT Approved D0P2IT DRUG__ID D0P2IT D0P2IT DRUGTYPE Small molecular drug D0P2IT DRUGINCH 1S/C48H78O19/c1-20-10-13-48(15-14-46(6)23(29(48)21(20)2)8-9-28-44(4)16-24(51)39(60)45(5,19-50)27(44)11-12-47(28,46)7)43(61)67-42-36(58)33(55)31(53)26(65-42)18-62-40-37(59)34(56)38(25(17-49)64-40)66-41-35(57)32(54)30(52)22(3)63-41/h8,20-22,24-42,49-60H,9-19H2,1-7H3/t20-,21+,22+,24-,25-,26-,27-,28-,29+,30+,31-,32-,33+,34-,35-,36-,37-,38-,39+,40-,41+,42+,44+,45+,46-,47-,48+/m1/s1 D0P2IT DRUGINKE WYQVAPGDARQUBT-FGWHUCSPSA-N D0P2IT DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)O)O)O)O D0P2IT HIGHSTAT Approved D0P2YD DRUG__ID D0P2YD D0P2YD DRUGTYPE Small molecular drug D0P2YD DRUGINCH 1S/C27H32N2O6S2.Na/c1-5-28(6-2)22-13-9-20(10-14-22)27(21-11-15-23(16-12-21)29(7-3)8-4)25-19-24(36(30,31)32)17-18-26(25)37(33,34)35;/h9-19H,5-8H2,1-4H3,(H-,30,31,32,33,34,35);/q;+1/p-1 D0P2YD DRUGINKE NLUFDZBOHMOBOE-UHFFFAOYSA-M D0P2YD DRUGSMIL CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+] D0P2YD HIGHSTAT Approved D0P5CD DRUG__ID D0P5CD D0P5CD DRUGTYPE Small molecular drug D0P5CD DRUGINCH 1S/C12H13I3N2O3/c1-5(12(19)20)4-17(6(2)18)11-8(14)3-7(13)10(16)9(11)15/h3,5H,4,16H2,1-2H3,(H,19,20) D0P5CD DRUGINKE GSVQIUGOUKJHRC-UHFFFAOYSA-N D0P5CD DRUGSMIL CC(CN(C1=C(C=C(C(=C1I)N)I)I)C(=O)C)C(=O)O D0P5CD HIGHSTAT Approved D0P5DG DRUG__ID D0P5DG D0P5DG DRUGTYPE Small molecular drug D0P5DG DRUGINCH 1S/C44H32N4O4/c49-29-9-1-5-25(21-29)41-33-13-15-35(45-33)42(26-6-2-10-30(50)22-26)37-17-19-39(47-37)44(28-8-4-12-32(52)24-28)40-20-18-38(48-40)43(36-16-14-34(41)46-36)27-7-3-11-31(51)23-27/h1-17,19,21-24,46-47,49-52H,18,20H2 D0P5DG DRUGINKE LYPFDBRUNKHDGX-UHFFFAOYSA-N D0P5DG DRUGSMIL C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O D0P5DG HIGHSTAT Approved D0P6IK DRUG__ID D0P6IK D0P6IK DRUGTYPE Small molecular drug D0P6IK DRUGINCH 1S/C49H76O20/c1-21-43(67-37-16-31(53)44(22(2)62-37)68-38-17-33(64-24(4)51)45(23(3)63-38)69-46-42(58)41(57)40(56)34(19-50)66-46)30(52)15-36(61-21)65-27-9-11-47(5)26(14-27)7-8-29-28(47)10-12-48(6)39(25-13-35(55)60-20-25)32(54)18-49(29,48)59/h13,21-23,26-34,36-46,50,52-54,56-59H,7-12,14-20H2,1-6H3/t21-,22-,23-,26-,27+,28+,29-,30+,31+,32+,33+,34-,36+,37+,38+,39+,40-,41+,42-,43-,44-,45-,46+,47+,48-,49+/m1/s1 D0P6IK DRUGINKE XVAPNQFQPDAROQ-CAPSWCROSA-N D0P6IK DRUGSMIL CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)O)O)C)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)OC(=O)C)O D0P6IK HIGHSTAT Approved D0P8AY DRUG__ID D0P8AY D0P8AY DRUGTYPE Small molecular drug D0P8AY DRUGINCH 1S/C18H21N3O/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22/h4-11H,12-13H2,1-3H3 D0P8AY DRUGINKE QPGGEKPRGVJKQB-UHFFFAOYSA-N D0P8AY DRUGSMIL CN1C2=CC=CC=C2C(=O)N(C3=CC=CC=C31)CCN(C)C D0P8AY HIGHSTAT Approved D0P9EA DRUG__ID D0P9EA D0P9EA DRUGTYPE Small molecular drug D0P9EA DRUGINCH 1S/C6H12O3/c1-4-7-5(2)9-6(3)8-4/h4-6H,1-3H3 D0P9EA DRUGINKE SQYNKIJPMDEDEG-UHFFFAOYSA-N D0P9EA DRUGSMIL CC1OC(OC(O1)C)C D0P9EA HIGHSTAT Approved D0PJ4K DRUG__ID D0PJ4K D0PJ4K DRUGTYPE Small molecular drug D0PJ4K DRUGINCH 1S/Ca D0PJ4K DRUGINKE OYPRJOBELJOOCE-UHFFFAOYSA-N D0PJ4K DRUGSMIL [Ca] D0PJ4K HIGHSTAT Approved D0PX8L DRUG__ID D0PX8L D0PX8L DRUGTYPE Small molecular drug D0PX8L DRUGINCH 1S/C18H18ClN3S/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3 D0PX8L DRUGINKE KAAZGXDPUNNEFN-UHFFFAOYSA-N D0PX8L DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3SC4=C2C=C(C=C4)Cl D0PX8L HIGHSTAT Approved D0Q1SA DRUG__ID D0Q1SA D0Q1SA DRUGTYPE Small molecular drug D0Q1SA DRUGINCH 1S/C31H51NO9/c1-9-25-20(5)29-31(6,41-29)12-10-23(34)17(2)14-21(11-13-33)28(19(4)24(35)16-26(36)39-25)40-30-27(37)22(32(7)8)15-18(3)38-30/h10,12-13,17-22,24-25,27-30,35,37H,9,11,14-16H2,1-8H3/b12-10+/t17-,18-,19+,20-,21+,22+,24-,25-,27-,28-,29+,30+,31+/m1/s1 D0Q1SA DRUGINKE IUPCWCLVECYZRV-JZMZINANSA-N D0Q1SA DRUGSMIL CCC1C(C2C(O2)(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC3C(C(CC(O3)C)N(C)C)O)CC=O)C)C)C D0Q1SA HIGHSTAT Approved D0Q2AS DRUG__ID D0Q2AS D0Q2AS DRUGTYPE Small molecular drug D0Q2AS DRUGINCH 1S/C13H20N2O3S/c1-3-18-11(16)9-10-14(2)12(17)13(19-10)15-7-5-4-6-8-15/h9,13H,3-8H2,1-2H3/b10-9- D0Q2AS DRUGINKE ZCKKHYXUQFTBIK-KTKRTIGZSA-N D0Q2AS DRUGSMIL CCOC(=O)C=C1N(C(=O)C(S1)N2CCCCC2)C D0Q2AS HIGHSTAT Approved D0Q2MN DRUG__ID D0Q2MN D0Q2MN DRUGTYPE Small molecular drug D0Q2MN DRUGINCH 1S/C19H21NS/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3/b17-11- D0Q2MN DRUGINKE PHTUQLWOUWZIMZ-BOPFTXTBSA-N D0Q2MN DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2CSC3=CC=CC=C31 D0Q2MN HIGHSTAT Approved D0Q2QU DRUG__ID D0Q2QU D0Q2QU DRUGTYPE Small molecular drug D0Q2QU DRUGINCH 1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;;;/m1....../s1 D0Q2QU DRUGINKE YLDCUKJMEKGGFI-QCSRICIXSA-N D0Q2QU DRUGSMIL CC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O D0Q2QU HIGHSTAT Approved D0Q4YI DRUG__ID D0Q4YI D0Q4YI DRUGTYPE Small molecular drug D0Q4YI DRUGINCH 1S/C14H22N2O3/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16/h4-5,15H,6-10H2,1-3H3 D0Q4YI DRUGINKE UHWVSEOVJBQKBE-UHFFFAOYSA-N D0Q4YI DRUGSMIL COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC D0Q4YI HIGHSTAT Approved D0Q6DX DRUG__ID D0Q6DX D0Q6DX DRUGTYPE Small molecular drug D0Q6DX DRUGINCH 1S/C9H14O6/c1-6(10)13-4-9(15-8(3)12)5-14-7(2)11/h9H,4-5H2,1-3H3 D0Q6DX DRUGINKE URAYPUMNDPQOKB-UHFFFAOYSA-N D0Q6DX DRUGSMIL CC(=O)OCC(COC(=O)C)OC(=O)C D0Q6DX HIGHSTAT Approved D0Q6OS DRUG__ID D0Q6OS D0Q6OS DRUGTYPE Small molecular drug D0Q6OS DRUGINCH 1S/C46H77NO17/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3/b15-14+,23-18+/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-/m1/s1 D0Q6OS DRUGINKE WBPYTXDJUQJLPQ-VMXQISHHSA-N D0Q6OS DRUGSMIL CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC D0Q6OS HIGHSTAT Approved D0Q8NJ DRUG__ID D0Q8NJ D0Q8NJ DRUGTYPE Small molecular drug D0Q8NJ DRUGINCH 1S/C25H43N13O10.H2O4S/c26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43;1-5(2,3)4/h7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48);(H2,1,2,3,4)/b13-7-;/t10-,11+,12-,14-,15-,17-,18-;/m0./s1 D0Q8NJ DRUGINKE AQONYROJHRNYQQ-QMAPKBLTSA-N D0Q8NJ DRUGSMIL C1C(N=C(NC1O)N)C2C(=O)NCC(C(=O)NC(C(=O)NC(C(=O)NC(=CNC(=O)N)C(=O)N2)CO)CO)NC(=O)CC(CCCN)N.OS(=O)(=O)O D0Q8NJ HIGHSTAT Approved D0Q8XH DRUG__ID D0Q8XH D0Q8XH DRUGTYPE Small molecular drug D0Q8XH DRUGINCH 1S/C22H20N4O8S2.Na/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12;/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34);/q;+1/p-1/t15-,17-,21-;/m1./s1 D0Q8XH DRUGINKE REACMANCWHKJSM-DWBVFMGKSA-M D0Q8XH DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)[O-])C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N.[Na+] D0Q8XH HIGHSTAT Approved D0Q9ON DRUG__ID D0Q9ON D0Q9ON DRUGTYPE Small molecular drug D0Q9ON DRUGINCH 1S/C18H23NO4/c1-22-17-8-3-13(11-18(17)23-2)9-10-19-12-16(21)14-4-6-15(20)7-5-14/h3-8,11,16,19-21H,9-10,12H2,1-2H3/t16-/m0/s1 D0Q9ON DRUGINKE VHSBBVZJABQOSG-INIZCTEOSA-N D0Q9ON DRUGSMIL COC1=C(C=C(C=C1)CCNCC(C2=CC=C(C=C2)O)O)OC D0Q9ON HIGHSTAT Approved D0QD1G DRUG__ID D0QD1G D0QD1G DRUGTYPE Small molecular drug D0QD1G DRUGINCH 1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1 D0QD1G DRUGINKE JUZYLCPPVHEVSV-LJQANCHMSA-N D0QD1G DRUGSMIL CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O D0QD1G HIGHSTAT Approved D0QS1U DRUG__ID D0QS1U D0QS1U DRUGTYPE Small molecular drug D0QS1U DRUGINCH 1S/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14) D0QS1U DRUGINKE VQKLRVZQQYVIJW-UHFFFAOYSA-N D0QS1U DRUGSMIL C1=CC=C2C(=C1)C(=NN=C2NN)NN D0QS1U HIGHSTAT Approved D0R1BD DRUG__ID D0R1BD D0R1BD DRUGTYPE Small molecular drug D0R1BD DRUGINCH 1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22) D0R1BD DRUGINKE JGSARLDLIJGVTE-UHFFFAOYSA-N D0R1BD DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C D0R1BD HIGHSTAT Approved D0R2KF DRUG__ID D0R2KF D0R2KF DRUGTYPE Small molecular drug D0R2KF DRUGINCH 1S/C12H18N2O5/c1-6(2)7-4-14(12(18)13-11(7)17)10-3-8(16)9(5-15)19-10/h4,6,8-10,15-16H,3,5H2,1-2H3,(H,13,17,18)/t8-,9+,10+/m0/s1 D0R2KF DRUGINKE PHUUXVYXSRZACJ-IVZWLZJFSA-N D0R2KF DRUGSMIL CC(C)C1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O D0R2KF HIGHSTAT Approved D0R2OA DRUG__ID D0R2OA D0R2OA DRUGTYPE Small molecular drug D0R2OA DRUGINCH 1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3 D0R2OA DRUGINKE SFBODOKJTYAUCM-UHFFFAOYSA-N D0R2OA DRUGSMIL CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3 D0R2OA HIGHSTAT Approved D0R4HQ DRUG__ID D0R4HQ D0R4HQ DRUGCOMP Questcor pharmaceuticals D0R4HQ DRUGINCH 1S/C207H308N56O58S/c1-108(2)89-140(186(302)240-135(69-74-163(279)280)182(298)254-149(204(320)321)94-117-43-20-15-21-44-117)250-193(309)152-54-35-86-262(152)202(318)147(92-116-41-18-14-19-42-116)252-171(287)114(11)230-175(291)132(66-71-160(273)274)234-170(286)113(10)231-191(307)150(105-265)255-183(299)136(70-75-164(281)282)241-190(306)146(98-165(283)284)249-180(296)133(67-72-161(275)276)235-169(285)112(9)229-157(270)101-225-174(290)145(97-156(213)269)251-194(310)153-55-36-87-263(153)203(319)148(93-119-60-64-123(268)65-61-119)253-199(315)167(110(5)6)257-185(301)129(49-26-30-79-210)243-198(314)168(111(7)8)259-196(312)155-57-38-85-261(155)201(317)139(53-34-83-223-207(218)219)244-178(294)130(51-32-81-221-205(214)215)237-177(293)128(48-25-29-78-209)236-176(292)127(47-24-28-77-208)232-158(271)103-227-197(313)166(109(3)4)258-195(311)154-56-37-84-260(154)200(316)138(50-27-31-80-211)233-159(272)102-226-173(289)143(95-120-99-224-126-46-23-22-45-124(120)126)247-179(295)131(52-33-82-222-206(216)217)238-187(303)142(90-115-39-16-13-17-40-115)246-189(305)144(96-121-100-220-107-228-121)248-181(297)134(68-73-162(277)278)239-184(300)137(76-88-322-12)242-192(308)151(106-266)256-188(304)141(245-172(288)125(212)104-264)91-118-58-62-122(267)63-59-118/h13-23,39-46,58-65,99-100,107-114,125,127-155,166-168,224,264-268H,24-38,47-57,66-98,101-106,208-212H2,1-12H3,(H2,213,269)(H,220,228)(H,225,290)(H,226,289)(H,227,313)(H,229,270)(H,230,291)(H,231,307)(H,232,271)(H,233,272)(H,234,286)(H,235,285)(H,236,292)(H,237,293)(H,238,303)(H,239,300)(H,240,302)(H,241,306)(H,242,308)(H,243,314)(H,244,294)(H,245,288)(H,246,305)(H,247,295)(H,248,297)(H,249,296)(H,250,309)(H,251,310)(H,252,287)(H,253,315)(H,254,298)(H,255,299)(H,256,304)(H,257,301)(H,258,311)(H,259,312)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,320,321)(H4,214,215,221)(H4,216,217,222)(H4,218,219,223)/t112-,113-,114-,125-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,166-,167-,168-/m0/s1 D0R4HQ DRUGINKE IDLFZVILOHSSID-OVLDLUHVSA-N D0R4HQ DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N D0R4HQ HIGHSTAT Approved D0R5OS DRUG__ID D0R5OS D0R5OS DRUGTYPE Small molecular drug D0R5OS DRUGINCH 1S/C25H23N5O6S.Na/c1-25(2)19(24(35)36)30-22(34)17(23(30)37-25)29-21(33)15(12-7-4-3-5-8-12)28-20(32)13-11-27-14-9-6-10-26-16(14)18(13)31;/h3-11,15,17,19,23H,1-2H3,(H,27,31)(H,28,32)(H,29,33)(H,35,36);/q;+1/p-1/t15-,17-,19+,23-;/m1./s1 D0R5OS DRUGINKE DIGBQDMXLUJMHN-FSWJYKAZSA-M D0R5OS DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)C4=CNC5=C(C4=O)N=CC=C5)C(=O)[O-])C.[Na+] D0R5OS HIGHSTAT Approved D0R7WU DRUG__ID D0R7WU D0R7WU DRUGTYPE Small molecular drug D0R7WU DRUGINCH 1S/C9H15NO2/c1-7(11)12-9-6-10-4-2-8(9)3-5-10/h8-9H,2-6H2,1H3 D0R7WU DRUGINKE WRJPSSPFHGNBMG-UHFFFAOYSA-N D0R7WU DRUGSMIL CC(=O)OC1CN2CCC1CC2 D0R7WU HIGHSTAT Approved D0R8PX DRUG__ID D0R8PX D0R8PX DRUGTYPE Small molecular drug D0R8PX DRUGINCH 1S/C11H12N2O/c14-10-5-6-13-7-8-3-1-2-4-9(8)12-11(10)13/h1-4,10,14H,5-7H2 D0R8PX DRUGINKE YIICVSCAKJMMDJ-UHFFFAOYSA-N D0R8PX DRUGSMIL C1CN2CC3=CC=CC=C3N=C2C1O D0R8PX HIGHSTAT Approved D0RA5Q DRUG__ID D0RA5Q D0RA5Q DRUGTYPE Small molecular drug D0RA5Q DRUGINCH 1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1 D0RA5Q DRUGINKE VGGGPCQERPFHOB-RDBSUJKOSA-N D0RA5Q DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O D0RA5Q HIGHSTAT Approved D0RA9E DRUG__ID D0RA9E D0RA9E DRUGTYPE Small molecular drug D0RA9E DRUGINCH 1S/C17H17N3O/c1-20-9-13(12-4-2-3-5-16(12)20)17(21)11-6-7-14-15(8-11)19-10-18-14/h2-5,9-11H,6-8H2,1H3,(H,18,19)/t11-/m1/s1 D0RA9E DRUGINKE NTHPAPBPFQJABD-LLVKDONJSA-N D0RA9E DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4 D0RA9E HIGHSTAT Approved D0RN2W DRUG__ID D0RN2W D0RN2W DRUGTYPE Small molecular drug D0RN2W DRUGINCH 1S/K D0RN2W DRUGINKE ZLMJMSJWJFRBEC-UHFFFAOYSA-N D0RN2W DRUGSMIL [K] D0RN2W HIGHSTAT Approved D0RU6U DRUG__ID D0RU6U D0RU6U DRUGTYPE Small molecular drug D0RU6U DRUGINCH 1S/C24H33N3O2S/c1-20(18-26-12-10-25(11-13-26)14-16-29-17-15-28)19-27-21-6-2-4-8-23(21)30-24-9-5-3-7-22(24)27/h2-9,20,28H,10-19H2,1H3 D0RU6U DRUGINKE MSYUMPGNGDNTIQ-UHFFFAOYSA-N D0RU6U DRUGSMIL CC(CN1CCN(CC1)CCOCCO)CN2C3=CC=CC=C3SC4=CC=CC=C42 D0RU6U HIGHSTAT Approved D0RX3C DRUG__ID D0RX3C D0RX3C DRUGTYPE Small molecular drug D0RX3C DRUGINCH 1S/C27H34N4O/c28-22-26(23-10-4-1-5-11-23,24-12-6-2-7-13-24)14-19-30-20-15-27(16-21-30,25(29)32)31-17-8-3-9-18-31/h1-2,4-7,10-13H,3,8-9,14-21H2,(H2,29,32) D0RX3C DRUGINKE IHEHEFLXQFOQJO-UHFFFAOYSA-N D0RX3C DRUGSMIL C1CCN(CC1)C2(CCN(CC2)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)N D0RX3C HIGHSTAT Approved D0RX7Z DRUG__ID D0RX7Z D0RX7Z DRUGTYPE Small molecular drug D0RX7Z DRUGINCH 1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1 D0RX7Z DRUGINKE CKTSBUTUHBMZGZ-SHYZEUOFSA-N D0RX7Z DRUGSMIL C1C(C(OC1N2C=CC(=NC2=O)N)CO)O D0RX7Z HIGHSTAT Approved D0S0NK DRUG__ID D0S0NK D0S0NK DRUGTYPE Small molecular drug D0S0NK DRUGINCH 1S/C26H40O8/c1-15-5-8-19-25(2,14-33-24-22(30)21(29)20(28)18(13-27)34-24)10-4-11-26(19,3)17(15)7-6-16-9-12-32-23(16)31/h9,17-22,24,27-30H,1,4-8,10-14H2,2-3H3/t17-,18-,19-,20-,21+,22-,24-,25+,26+/m1/s1 D0S0NK DRUGINKE YGCYRQKJYWQXHG-RDNQFMDVSA-N D0S0NK DRUGSMIL CC1(CCCC2(C1CCC(=C)C2CCC3=CCOC3=O)C)COC4C(C(C(C(O4)CO)O)O)O D0S0NK HIGHSTAT Approved D0S1ZB DRUG__ID D0S1ZB D0S1ZB DRUGTYPE Small molecular drug D0S1ZB DRUGINCH 1S/C9H19ClN3O5P/c1-4-17-19(16,18-5-2)8(3)11-9(14)13(12-15)7-6-10/h8H,4-7H2,1-3H3,(H,11,14) D0S1ZB DRUGINKE YAKWPXVTIGTRJH-UHFFFAOYSA-N D0S1ZB DRUGSMIL CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC D0S1ZB HIGHSTAT Approved D0S2IQ DRUG__ID D0S2IQ D0S2IQ DRUGTYPE Small molecular drug D0S2IQ DRUGINCH 1S/C9H15N5O3.2ClH/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7;;/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17);2*1H/t3-,4+,6-;;/m0../s1 D0S2IQ DRUGINKE RKSUYBCOVNCALL-NTVURLEBSA-N D0S2IQ DRUGSMIL CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O.Cl.Cl D0S2IQ HIGHSTAT Approved D0S2JI DRUG__ID D0S2JI D0S2JI DRUGTYPE Small molecular drug D0S2JI DRUGINCH 1S/C14H20ClN3O3S/c1-9-4-3-5-10(2)18(9)17-14(19)11-6-7-12(15)13(8-11)22(16,20)21/h6-10H,3-5H2,1-2H3,(H,17,19)(H2,16,20,21)/t9-,10+ D0S2JI DRUGINKE LBXHRAWDUMTPSE-AOOOYVTPSA-N D0S2JI DRUGSMIL CC1CCCC(N1NC(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N)C D0S2JI HIGHSTAT Approved D0S3WH DRUG__ID D0S3WH D0S3WH DRUGTYPE Small molecular drug D0S3WH DRUGINCH 1S/C15H22O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8-11,13H,4-7H2,1-3H3/t8-,9-,10+,11+,13-,14-,15-/m1/s1 D0S3WH DRUGINKE BLUAFEHZUWYNDE-NNWCWBAJSA-N D0S3WH DRUGSMIL CC1CCC2C(C(=O)OC3C24C1CCC(O3)(OO4)C)C D0S3WH HIGHSTAT Approved D0S5NG DRUG__ID D0S5NG D0S5NG DRUGTYPE Small molecular drug D0S5NG DRUGINCH 1S/C20H31NO2S/c22-20(23-14-13-21-11-6-1-2-7-12-21)19(18-10-15-24-16-18)17-8-4-3-5-9-17/h10,15-17,19H,1-9,11-14H2 D0S5NG DRUGINKE MMNICIJVQJJHHF-UHFFFAOYSA-N D0S5NG DRUGSMIL C1CCCN(CC1)CCOC(=O)C(C2CCCCC2)C3=CSC=C3 D0S5NG HIGHSTAT Approved D0S5YC DRUG__ID D0S5YC D0S5YC DRUGTYPE Small molecular drug D0S5YC DRUGINCH 1S/C15H23NO/c1-3-15(9-4-5-10-16(2)12-15)13-7-6-8-14(17)11-13/h6-8,11,17H,3-5,9-10,12H2,1-2H3 D0S5YC DRUGINKE JLICHNCFTLFZJN-UHFFFAOYSA-N D0S5YC DRUGSMIL CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O D0S5YC HIGHSTAT Approved D0S9ET DRUG__ID D0S9ET D0S9ET DRUGTYPE Small molecular drug D0S9ET DRUGINCH 1S/C13H14ClNO2/c1-9(13(16)17)10-4-5-12(11(14)8-10)15-6-2-3-7-15/h2-5,8-9H,6-7H2,1H3,(H,16,17) D0S9ET DRUGINKE PIDSZXPFGCURGN-UHFFFAOYSA-N D0S9ET DRUGSMIL CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O D0S9ET HIGHSTAT Approved D0SL2V DRUG__ID D0SL2V D0SL2V DRUGTYPE Small molecular drug D0SL2V DRUGINCH 1S/C49H76O20/c1-21-43(67-38-17-32(53)44(22(2)62-38)68-39-18-33(64-24(4)51)45(23(3)63-39)69-46-42(58)41(57)40(56)34(19-50)66-46)31(52)16-37(61-21)65-27-9-11-47(5)26(14-27)7-8-29-30(47)15-35(54)48(6)28(10-12-49(29,48)59)25-13-36(55)60-20-25/h13,21-23,26-35,37-46,50,52-54,56-59H,7-12,14-20H2,1-6H3/t21-,22-,23-,26-,27+,28-,29-,30+,31+,32+,33+,34-,35-,37+,38+,39+,40-,41+,42-,43-,44-,45-,46+,47+,48+,49+/m1/s1 D0SL2V DRUGINKE JAYAGJDXJIDEKI-PTGWOZRBSA-N D0SL2V DRUGSMIL CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC9C(C(C(C(O9)CO)O)O)O)OC(=O)C)O D0SL2V HIGHSTAT Approved D0SV8E DRUG__ID D0SV8E D0SV8E DRUGTYPE Small molecular drug D0SV8E DRUGINCH 1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1 D0SV8E DRUGINKE FBOZXECLQNJBKD-ZDUSSCGKSA-N D0SV8E DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0SV8E HIGHSTAT Approved D0T1EO DRUG__ID D0T1EO D0T1EO DRUGTYPE Small molecular drug D0T1EO DRUGINCH 1S/C17H17NO5S/c1-2-23-17(20)12-18(16-11-7-6-8-14(16)13-19)24(21,22)15-9-4-3-5-10-15/h3-11,13H,2,12H2,1H3 D0T1EO DRUGINKE DFRPGUIKXDWHSA-UHFFFAOYSA-N D0T1EO DRUGSMIL CCOC(=O)CN(C1=CC=CC=C1C=O)S(=O)(=O)C2=CC=CC=C2 D0T1EO HIGHSTAT Approved D0T3NB DRUG__ID D0T3NB D0T3NB DRUGTYPE Small molecular drug D0T3NB DRUGINCH 1S/C20H14NO4/c1-21-8-15-12(4-5-16-20(15)25-10-22-16)13-3-2-11-6-17-18(24-9-23-17)7-14(11)19(13)21/h2-8H,9-10H2,1H3/q+1 D0T3NB DRUGINKE INVGWHRKADIJHF-UHFFFAOYSA-N D0T3NB DRUGSMIL C[N+]1=C2C(=C3C=CC4=C(C3=C1)OCO4)C=CC5=CC6=C(C=C52)OCO6 D0T3NB HIGHSTAT Approved D0T3NY DRUG__ID D0T3NY D0T3NY DRUGTYPE Small molecular drug D0T3NY DRUGINCH 1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4+ D0T3NY DRUGINKE DNTGGZPQPQTDQF-XBXARRHUSA-N D0T3NY DRUGSMIL CCN(C1=CC=CC=C1C)C(=O)C=CC D0T3NY HIGHSTAT Approved D0T4WA DRUG__ID D0T4WA D0T4WA DRUGTYPE Small molecular drug D0T4WA DRUGINCH 1S/C20H29N5O6/c1-20(2,27)11-31-19(26)25-8-6-24(7-9-25)18-22-14-12(17(21)23-18)10-13(28-3)15(29-4)16(14)30-5/h10,27H,6-9,11H2,1-5H3,(H2,21,22,23) D0T4WA DRUGINKE YNZXWQJZEDLQEG-UHFFFAOYSA-N D0T4WA DRUGSMIL CC(C)(COC(=O)N1CCN(CC1)C2=NC3=C(C(=C(C=C3C(=N2)N)OC)OC)OC)O D0T4WA HIGHSTAT Approved D0T5BC DRUG__ID D0T5BC D0T5BC DRUGTYPE Small molecular drug D0T5BC DRUGINCH 1S/C12H22O11/c13-1-4-6(16)7(17)8(18)11(21-4)22-9-5(2-14)23-12(20,3-15)10(9)19/h4-11,13-20H,1-3H2/t4-,5-,6+,7+,8-,9-,10+,11+,12-/m1/s1 D0T5BC DRUGINKE JCQLYHFGKNRPGE-FCVZTGTOSA-N D0T5BC DRUGSMIL C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O D0T5BC HIGHSTAT Approved D0T5DE DRUG__ID D0T5DE D0T5DE DRUGTYPE Small molecular drug D0T5DE DRUGINCH 1S/Ba.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2 D0T5DE DRUGINKE TZCXTZWJZNENPQ-UHFFFAOYSA-L D0T5DE DRUGSMIL [O-]S(=O)(=O)[O-].[Ba+2] D0T5DE HIGHSTAT Approved D0T5XN DRUG__ID D0T5XN D0T5XN DRUGTYPE Small molecular drug D0T5XN DRUGINCH 1S/C33H40N2O12/c1-13(2)8-17(34)32(43)35-18-9-22(46-14(3)27(18)38)47-20-11-33(44,21(37)12-36)10-16-24(20)31(42)26-25(29(16)40)28(39)15-6-5-7-19(45-4)23(15)30(26)41/h5-7,13-14,17-18,20,22,27,36,38,40,42,44H,8-12,34H2,1-4H3,(H,35,43)/t14-,17-,18-,20-,22-,27+,33-/m0/s1 D0T5XN DRUGINKE HROXIDVVXKDCBD-ZUWKMVCBSA-N D0T5XN DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C(CC(C)C)N)O D0T5XN HIGHSTAT Approved D0T6QX DRUG__ID D0T6QX D0T6QX DRUGTYPE Small molecular drug D0T6QX DRUGINCH 1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3 D0T6QX DRUGINKE HDOZVRUNCMBHFH-UHFFFAOYSA-N D0T6QX DRUGSMIL CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(C=C3)Cl D0T6QX HIGHSTAT Approved D0T6VD DRUG__ID D0T6VD D0T6VD DRUGTYPE Small molecular drug D0T6VD DRUGINCH 1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1 D0T6VD DRUGINKE XOGYVDXPYVPAAQ-SESJOKTNSA-M D0T6VD DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.O[Sb](=O)=O D0T6VD HIGHSTAT Approved D0T6WN DRUG__ID D0T6WN D0T6WN DRUGTYPE Small molecular drug D0T6WN DRUGINCH 1S/C22H18N6/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19/h3-9,11-13H,1-2H3,(H2,25,26,27,28)/b4-3+ D0T6WN DRUGINKE YIBOMRUWOWDFLG-ONEGZZNKSA-N D0T6WN DRUGSMIL CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N D0T6WN HIGHSTAT Approved D0TB8C DRUG__ID D0TB8C D0TB8C DRUGTYPE Small molecular drug D0TB8C DRUGINCH 1S/C27H34O3/c1-27-16-15-22-21-11-9-20(28)17-19(21)8-10-23(22)24(27)12-13-25(27)30-26(29)14-7-18-5-3-2-4-6-18/h2-6,17,21-25H,7-16H2,1H3/t21-,22+,23+,24-,25-,27-/m0/s1 D0TB8C DRUGINKE UBWXUGDQUBIEIZ-QNTYDACNSA-N D0TB8C DRUGSMIL CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35 D0TB8C HIGHSTAT Approved D0TC7C DRUG__ID D0TC7C D0TC7C DRUGTYPE Small molecular drug D0TC7C DRUGINCH 1S/C30H36O16/c1-12-23(34)25(36)27(38)29(43-12)42-11-21-24(35)26(37)28(39)30(46-21)44-14-8-19(41-6-5-31)22-16(33)10-18(45-20(22)9-14)13-3-4-17(40-2)15(32)7-13/h3-4,7-10,12,21,23-32,34-39H,5-6,11H2,1-2H3/t12-,21+,23-,24+,25+,26-,27+,28+,29+,30+/m0/s1 D0TC7C DRUGINKE XYFLWVOTXWXNAM-WTNNCJBMSA-N D0TC7C DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC4=C(C(=C3)OCCO)C(=O)C=C(O4)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O D0TC7C HIGHSTAT Approved D0TG7I DRUG__ID D0TG7I D0TG7I DRUGTYPE Small molecular drug D0TG7I DRUGINCH 1S/C37H67NO13.C11H13N3O3S/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;3-6,14H,12H2,1-2H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;/m1./s1 D0TG7I DRUGINKE LUDXWSVNRXAANN-YZPBMOCRSA-N D0TG7I DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N D0TG7I HIGHSTAT Approved D0TV9K DRUG__ID D0TV9K D0TV9K DRUGTYPE Small molecular drug D0TV9K DRUGINCH 1S/C23H29NO3/c1-3-18-26-23(19-10-6-4-7-11-19,20-12-8-5-9-13-20)22(25)27-21-14-16-24(2)17-15-21/h4-13,21H,3,14-18H2,1-2H3 D0TV9K DRUGINKE QPCVHQBVMYCJOM-UHFFFAOYSA-N D0TV9K DRUGSMIL CCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OC3CCN(CC3)C D0TV9K HIGHSTAT Approved D0TY5N DRUG__ID D0TY5N D0TY5N DRUGTYPE Small molecular drug D0TY5N DRUGINCH 1S/C10H12N2O/c1-12-9(4-5-10(12)13)8-3-2-6-11-7-8/h2-3,6-7,9H,4-5H2,1H3/t9-/m0/s1 D0TY5N DRUGINKE UIKROCXWUNQSPJ-VIFPVBQESA-N D0TY5N DRUGSMIL CN1C(CCC1=O)C2=CN=CC=C2 D0TY5N HIGHSTAT Approved D0U0VU DRUG__ID D0U0VU D0U0VU DRUGTYPE Small molecular drug D0U0VU DRUGINCH 1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1 D0U0VU DRUGINKE PNCPYILNMDWPEY-QGZVFWFLSA-N D0U0VU DRUGSMIL CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F D0U0VU HIGHSTAT Approved D0U1ZD DRUG__ID D0U1ZD D0U1ZD DRUGTYPE Small molecular drug D0U1ZD DRUGINCH 1S/C18H24I3N3O9/c19-13-11(17(32)22-3-8(29)5-26)14(20)16(24(1-2-25)10(31)7-28)15(21)12(13)18(33)23-4-9(30)6-27/h8-9,25-30H,1-7H2,(H,22,32)(H,23,33) D0U1ZD DRUGINKE AMDBBAQNWSUWGN-UHFFFAOYSA-N D0U1ZD DRUGSMIL C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO D0U1ZD HIGHSTAT Approved D0U3IG DRUG__ID D0U3IG D0U3IG DRUGTYPE Small molecular drug D0U3IG DRUGINCH 1S/C17H38N.BrH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18(2,3)4;/h5-17H2,1-4H3;1H/q+1;/p-1 D0U3IG DRUGINKE CXRFDZFCGOPDTD-UHFFFAOYSA-M D0U3IG DRUGSMIL CCCCCCCCCCCCCC[N+](C)(C)C.[Br-] D0U3IG HIGHSTAT Approved D0U3SY DRUG__ID D0U3SY D0U3SY DRUGTYPE Small molecular drug D0U3SY DRUGINCH 1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3 D0U3SY DRUGINKE KDGFLJKFZUIJMX-UHFFFAOYSA-N D0U3SY DRUGSMIL CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C D0U3SY HIGHSTAT Approved D0U5OB DRUG__ID D0U5OB D0U5OB DRUGTYPE Small molecular drug D0U5OB DRUGINCH 1S/C176H277N57O55S7/c1-81(2)58-106-149(263)213-110(62-91-67-191-80-197-91)152(266)215-112(64-127(183)246)156(270)231-135(85(8)240)170(284)219-114(69-234)157(271)200-95(36-25-54-192-174(185)186)138(252)196-68-130(249)199-96(32-17-21-50-177)139(253)222-120-75-291-295-79-124(226-159(273)116(71-236)218-167(281)132(82(3)4)228-155(269)113(65-128(184)247)216-169(283)134(84(7)239)230-154(268)108(59-88-28-13-12-14-29-88)210-145(259)102-44-47-129(248)198-102)166(280)232-137(87(10)242)172(286)233-136(86(9)241)171(285)220-115(70-235)158(272)204-98(34-19-23-52-179)141(255)206-104(45-48-131(250)251)147(261)225-122-77-292-290-74-119(223-143(257)99(35-20-24-53-180)201-140(254)97(33-18-22-51-178)203-153(267)111(63-126(182)245)214-148(262)105(49-57-289-11)208-162(120)276)161(275)205-101(38-27-56-194-176(189)190)144(258)224-121(164(278)211-107(60-89-39-41-92(243)42-40-89)150(264)221-118(73-238)173(287)288)76-293-294-78-123(163(277)207-103(43-46-125(181)244)146(260)202-100(142(256)209-106)37-26-55-193-175(187)188)227-168(282)133(83(5)6)229-160(274)117(72-237)217-151(265)109(212-165(122)279)61-90-66-195-94-31-16-15-30-93(90)94/h12-16,28-31,39-42,66-67,80-87,95-124,132-137,195,234-243H,17-27,32-38,43-65,68-79,177-180H2,1-11H3,(H2,181,244)(H2,182,245)(H2,183,246)(H2,184,247)(H,191,197)(H,196,252)(H,198,248)(H,199,249)(H,200,271)(H,201,254)(H,202,260)(H,203,267)(H,204,272)(H,205,275)(H,206,255)(H,207,277)(H,208,276)(H,209,256)(H,210,259)(H,211,278)(H,212,279)(H,213,263)(H,214,262)(H,215,266)(H,216,283)(H,217,265)(H,218,281)(H,219,284)(H,220,285)(H,221,264)(H,222,253)(H,223,257)(H,224,258)(H,225,261)(H,226,273)(H,227,282)(H,228,269)(H,229,274)(H,230,268)(H,231,270)(H,232,280)(H,233,286)(H,250,251)(H,287,288)(H4,185,186,192)(H4,187,188,193)(H4,189,190,194)/t84-,85-,86-,87-,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,123+,124+,132+,133+,134+,135+,136+,137+/m1/s1 D0U5OB DRUGINKE CNVQLPPZGABUCM-LIGYZCPXSA-N D0U5OB DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC3CSSCC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC3=O)CC4=CNC5=CC=CC=C54)CO)C(C)C)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)NC(CO)C(=O)O)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCSC)CC(=O)N)CCCCN)CCCCN)CCC(=O)O)CCCCN)CO)C(C)O)C(C)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C8CCC(=O)N8)CCCCN)CCCNC(=N)N)CO)C(C)O)CC(=O)N)CC9=CN=CN9 D0U5OB HIGHSTAT Approved D0U9MR DRUG__ID D0U9MR D0U9MR DRUGTYPE Small molecular drug D0U9MR DRUGINCH 1S/C17H23NO2/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3/h5-8,10-12,15H,4,9,13H2,1-3H3/t15-,17+/m1/s1 D0U9MR DRUGINKE WDEFBBTXULIOBB-WBVHZDCISA-N D0U9MR DRUGSMIL CCOC(=O)C1(CCC=CC1N(C)C)C2=CC=CC=C2 D0U9MR HIGHSTAT Approved D0U9QU DRUG__ID D0U9QU D0U9QU DRUGTYPE Small molecular drug D0U9QU DRUGINCH 1S/C17H25NO4.ClH/c1-11(2)16(19)21-14-7-6-13(8-9-18-5)10-15(14)22-17(20)12(3)4;/h6-7,10-12,18H,8-9H2,1-5H3;1H D0U9QU DRUGINKE ALIXRWKJZYLBJI-UHFFFAOYSA-N D0U9QU DRUGSMIL CC(C)C(=O)OC1=C(C=C(C=C1)CCNC)OC(=O)C(C)C.Cl D0U9QU HIGHSTAT Approved D0UA0I DRUG__ID D0UA0I D0UA0I DRUGTYPE Small molecular drug D0UA0I DRUGINCH 1S/C25H29N3O2/c1-27-14-18(13-26-25(29)30-16-17-7-4-3-5-8-17)11-21-20-9-6-10-22-24(20)19(12-23(21)27)15-28(22)2/h3-10,15,18,21,23H,11-14,16H2,1-2H3,(H,26,29)/t18-,21+,23+/m0/s1 D0UA0I DRUGINKE WZHJKEUHNJHDLS-QTGUNEKASA-N D0UA0I DRUGSMIL CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5 D0UA0I HIGHSTAT Approved D0UE9X DRUG__ID D0UE9X D0UE9X DRUGTYPE Small molecular drug D0UE9X DRUGINCH 1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12- D0UE9X DRUGINKE VZCCETWTMQHEPK-QNEBEIHSSA-N D0UE9X DRUGSMIL CCCCCC=CCC=CCC=CCCCCC(=O)O D0UE9X HIGHSTAT Approved D0UF6M DRUG__ID D0UF6M D0UF6M DRUGTYPE Small molecular drug D0UF6M DRUGINCH 1S/C10H12N4OS/c1-7(15)13-9-4-2-8(3-5-9)6-12-14-10(11)16/h2-6H,1H3,(H,13,15)(H3,11,14,16)/b12-6+ D0UF6M DRUGINKE SRVJKTDHMYAMHA-WUXMJOGZSA-N D0UF6M DRUGSMIL CC(=O)NC1=CC=C(C=C1)C=NNC(=S)N D0UF6M HIGHSTAT Approved D0UF9W DRUG__ID D0UF9W D0UF9W DRUGCOMP Eyetech pharmaceuticals and Pfizer D0UF9W THERCLAS Antiangiogenic Agents D0UF9W DRUGTYPE Aptamer D0UF9W DRUGSMIL COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC D0UF9W HIGHSTAT Approved D0UO2P DRUG__ID D0UO2P D0UO2P DRUGCOMP Blueprint Medicines Cambridge, MA D0UO2P DRUGINCH 1S/C26H27FN10/c1-26(28,20-3-5-22(27)6-4-20)21-13-29-25(30-14-21)36-9-7-35(8-10-36)24-23-11-18(16-37(23)33-17-31-24)19-12-32-34(2)15-19/h3-6,11-17H,7-10,28H2,1-2H3/t26-/m0/s1 D0UO2P DRUGINKE DWYRIWUZIJHQKQ-SANMLTNESA-N D0UO2P DRUGSMIL CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N D0UO2P HIGHSTAT Approved D0UT4W DRUG__ID D0UT4W D0UT4W DRUGCOMP BeiGene Cambridge, MA D0UT4W DRUGINCH 1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34) D0UT4W DRUGINKE RNOAOAWBMHREKO-UHFFFAOYSA-N D0UT4W DRUGSMIL C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N D0UT4W HIGHSTAT Approved D0UU9Y DRUG__ID D0UU9Y D0UU9Y DRUGTYPE Small molecular drug D0UU9Y DRUGINCH 1S/C15H22N4O3/c1-4-8-18-10-16-13-12(18)14(21)19(15(22)17(13)3)9-6-5-7-11(2)20/h10H,4-9H2,1-3H3 D0UU9Y DRUGINKE RBQOQRRFDPXAGN-UHFFFAOYSA-N D0UU9Y DRUGSMIL CCCN1C=NC2=C1C(=O)N(C(=O)N2C)CCCCC(=O)C D0UU9Y HIGHSTAT Approved D0V2OX DRUG__ID D0V2OX D0V2OX DRUGTYPE Small molecular drug D0V2OX DRUGINCH 1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 D0V2OX DRUGINKE UAHFGYDRQSXQEB-LEBBXHLNSA-N D0V2OX DRUGSMIL CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C D0V2OX HIGHSTAT Approved D0V3YT DRUG__ID D0V3YT D0V3YT DRUGTYPE Small molecular drug D0V3YT DRUGINCH 1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1 D0V3YT DRUGINKE LHHCSNFAOIFYRV-DOVBMPENSA-N D0V3YT DRUGSMIL CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C D0V3YT HIGHSTAT Approved D0V4TY DRUG__ID D0V4TY D0V4TY DRUGTYPE Small molecular drug D0V4TY DRUGINCH 1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/t9-,10-,11-,12-/m0/s1 D0V4TY DRUGINKE YPZRWBKMTBYPTK-BJDJZHNGSA-N D0V4TY DRUGSMIL C(CC(=O)NC(CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)C(=O)NCC(=O)O)C(C(=O)O)N D0V4TY HIGHSTAT Approved D0V4UF DRUG__ID D0V4UF D0V4UF DRUGTYPE Small molecular drug D0V4UF DRUGINCH 1S/C17H27NO3/c1-2-3-12-20-16-5-7-17(8-6-16)21-13-4-9-18-10-14-19-15-11-18/h5-8H,2-4,9-15H2,1H3 D0V4UF DRUGINKE DQKXQSGTHWVTAD-UHFFFAOYSA-N D0V4UF DRUGSMIL CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2 D0V4UF HIGHSTAT Approved D0V7XF DRUG__ID D0V7XF D0V7XF DRUGTYPE Small molecular drug D0V7XF DRUGINCH 1S/C22H32N2O2/c25-21-11-10-20(18-22(21)26)13-17-24-15-7-2-1-6-14-23-16-12-19-8-4-3-5-9-19/h3-5,8-11,18,23-26H,1-2,6-7,12-17H2 D0V7XF DRUGINKE RYBJORHCUPVNMB-UHFFFAOYSA-N D0V7XF DRUGSMIL C1=CC=C(C=C1)CCNCCCCCCNCCC2=CC(=C(C=C2)O)O D0V7XF HIGHSTAT Approved D0V8PA DRUG__ID D0V8PA D0V8PA DRUGTYPE Small molecular drug D0V8PA DRUGINCH 1S/C6H17NO7P2/c7-5-3-1-2-4-6(8,15(9,10)11)16(12,13)14/h8H,1-5,7H2,(H2,9,10,11)(H2,12,13,14) D0V8PA DRUGINKE PUUSSSIBPPTKTP-UHFFFAOYSA-N D0V8PA DRUGSMIL C(CCC(O)(P(=O)(O)O)P(=O)(O)O)CCN D0V8PA HIGHSTAT Approved D0V9JR DRUG__ID D0V9JR D0V9JR DRUGTYPE Small molecular drug D0V9JR DRUGINCH 1S/C13H19NO3/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11/h3-6,11,14H,2,7-10H2,1H3 D0V9JR DRUGINKE YWPHCCPCQOJSGZ-UHFFFAOYSA-N D0V9JR DRUGSMIL CCOC1=CC=CC=C1OCC2CNCCO2 D0V9JR HIGHSTAT Approved D0VL8Q DRUG__ID D0VL8Q D0VL8Q DRUGTYPE Small molecular drug D0VL8Q DRUGINCH 1S/C28H41N3O3/c1-5-18-31(19-6-2)28(33)26(29-27(32)24-12-10-9-11-13-24)22-23-14-16-25(17-15-23)34-21-20-30(7-3)8-4/h9-17,26H,5-8,18-22H2,1-4H3,(H,29,32) D0VL8Q DRUGINKE FDBWMYOFXWMGEY-UHFFFAOYSA-N D0VL8Q DRUGSMIL CCCN(CCC)C(=O)C(CC1=CC=C(C=C1)OCCN(CC)CC)NC(=O)C2=CC=CC=C2 D0VL8Q HIGHSTAT Approved D0W1QI DRUG__ID D0W1QI D0W1QI DRUGTYPE Small molecular drug D0W1QI DRUGINCH 1S/C11H16ClN3O4S2/c1-6(2)3-11-14-8-4-7(12)9(20(13,16)17)5-10(8)21(18,19)15-11/h4-6,11,14-15H,3H2,1-2H3,(H2,13,16,17) D0W1QI DRUGINKE HGBFRHCDYZJRAO-UHFFFAOYSA-N D0W1QI DRUGSMIL CC(C)CC1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl D0W1QI HIGHSTAT Approved D0W2AN DRUG__ID D0W2AN D0W2AN DRUGTYPE Small molecular drug D0W2AN DRUGINCH 1S/C20H28N/c1-5-21(3,4)17(2)16-20(18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20H,5,16H2,1-4H3/q+1 D0W2AN DRUGINKE JEJBJBKVPOWOQK-UHFFFAOYSA-N D0W2AN DRUGSMIL CC[N+](C)(C)C(C)CC(C1=CC=CC=C1)C2=CC=CC=C2 D0W2AN HIGHSTAT Approved D0W3OS DRUG__ID D0W3OS D0W3OS DRUGTYPE Small molecular drug D0W3OS DRUGINCH 1S/C21H28O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,17-19,23H,5-12H2,2-3H3/t13-,17-,18+,19-,20+,21+/m1/s1 D0W3OS DRUGINKE WZDGZWOAQTVYBX-XOINTXKNSA-N D0W3OS DRUGSMIL CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O D0W3OS HIGHSTAT Approved D0W3YL DRUG__ID D0W3YL D0W3YL DRUGTYPE Small molecular drug D0W3YL DRUGINCH 1S/2Al.O2Si.H2O.3O/c;;1-3-2;;;;/h;;;1H2;;; D0W3YL DRUGINKE SVPXDRXYRYOSEX-UHFFFAOYSA-N D0W3YL DRUGSMIL O.O=[Al]O[Al]=O.O=[Si]=O D0W3YL HIGHSTAT Approved D0W9TE DRUG__ID D0W9TE D0W9TE DRUGTYPE Small molecular drug D0W9TE DRUGINCH 1S/C5H8N4O12/c10-6(11)18-1-5(2-19-7(12)13,3-20-8(14)15)4-21-9(16)17/h1-4H2 D0W9TE DRUGINKE TZRXHJWUDPFEEY-UHFFFAOYSA-N D0W9TE DRUGSMIL C(C(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-])O[N+](=O)[O-] D0W9TE HIGHSTAT Approved D0W9VB DRUG__ID D0W9VB D0W9VB DRUGTYPE Small molecular drug D0W9VB DRUGINCH 1S/C21H27NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1-2,4-7,11-14,23H,3,8-10,15-18H2 D0W9VB DRUGINKE OGAKLTJNUQRZJU-UHFFFAOYSA-N D0W9VB DRUGSMIL C1CCN(CC1)CCCC(C2=CC=CC=C2)(C3=CC=CC=C3)O D0W9VB HIGHSTAT Approved D0WB9V DRUG__ID D0WB9V D0WB9V DRUGTYPE Small molecular drug D0WB9V DRUGINCH 1S/C4H4N2O3/c7-2-1-3(8)6-4(9)5-2/h1H2,(H2,5,6,7,8,9) D0WB9V DRUGINKE HNYOPLTXPVRDBG-UHFFFAOYSA-N D0WB9V DRUGSMIL C1C(=O)NC(=O)NC1=O D0WB9V HIGHSTAT Approved D0WD8M DRUG__ID D0WD8M D0WD8M DRUGTYPE Small molecular drug D0WD8M DRUGINCH 1S/C9H9Cl2N3O.ClH/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13;/h1-3H,4H2,(H4,12,13,14,15);1H D0WD8M DRUGINKE DGFYECXYGUIODH-UHFFFAOYSA-N D0WD8M DRUGSMIL C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl D0WD8M HIGHSTAT Approved D0WP0B DRUG__ID D0WP0B D0WP0B DRUGTYPE Small molecular drug D0WP0B DRUGINCH 1S/C66H101NO49/c1-18(75)67-33-34(83)42(26(11-68)102-59(33)110-44-29(14-71)106-63(38(87)51(44)97-21(4)78)113-46-30(15-72)107-64(39(88)53(46)99-23(6)80)111-45-28(13-70)103-60(94-10)35(84)50(45)96-20(3)77)109-61-37(86)52(98-22(5)79)48(32(17-74)105-61)114-66-41(90)55(101-25(8)82)56(57(116-66)58(91)92)115-65-40(89)54(100-24(7)81)47(31(16-73)108-65)112-62-36(85)49(95-19(2)76)43(93-9)27(12-69)104-62/h26-57,59-66,68-74,83-90H,11-17H2,1-10H3,(H,67,75)(H,91,92)/p-1/t26-,27-,28-,29-,30-,31-,32-,33+,34-,35+,36+,37+,38+,39+,40+,41+,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56+,57+,59-,60+,61-,62-,63-,64-,65-,66+/m1/s1 D0WP0B DRUGINKE XOYXESIZZFUVRD-UVSAJTFZSA-M D0WP0B DRUGSMIL CC(=O)NC1C(C(C(OC1OC2C(OC(C(C2OC(=O)C)O)OC3C(OC(C(C3OC(=O)C)O)OC4C(OC(C(C4OC(=O)C)O)OC)CO)CO)CO)CO)OC5C(C(C(C(O5)CO)OC6C(C(C(C(O6)C(=O)[O-])OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)OC)OC(=O)C)O)OC(=O)C)O)OC(=O)C)O)OC(=O)C)O)O D0WP0B HIGHSTAT Approved D0WV4M DRUG__ID D0WV4M D0WV4M DRUGTYPE Small molecular drug D0WV4M DRUGINCH 1S/C18H22N2O5S/c1-4-11(25-10-8-6-5-7-9-10)14(21)19-12-15(22)20-13(17(23)24)18(2,3)26-16(12)20/h5-9,11-13,16H,4H2,1-3H3,(H,19,21)(H,23,24)/t11?,12-,13+,16-/m1/s1 D0WV4M DRUGINKE HOCWPKXKMNXINF-XQERAMJGSA-N D0WV4M DRUGSMIL CCC(C(=O)NC1C2N(C1=O)C(C(S2)(C)C)C(=O)O)OC3=CC=CC=C3 D0WV4M HIGHSTAT Approved D0WY9N DRUG__ID D0WY9N D0WY9N DRUGTYPE Small molecular drug D0WY9N DRUGINCH 1S/C26H34O8/c1-8-10-16(27)17-22(31)15(20(29)13(4)23(17)34-7)11-26(6)24(32)14(5)21(30)18(25(26)33)19(28)12(3)9-2/h12,29-32H,8-11H2,1-7H3/t12-,26+/m1/s1 D0WY9N DRUGINKE NQGCBDWQKDAGTK-RYZVSIALSA-N D0WY9N DRUGSMIL CCCC(=O)C1=C(C(=C(C(=C1O)CC2(C(=C(C(=C(C2=O)C(=O)C(C)CC)O)C)O)C)O)C)OC D0WY9N HIGHSTAT Approved D0X1EZ DRUG__ID D0X1EZ D0X1EZ DRUGTYPE Small molecular drug D0X1EZ DRUGINCH 1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3 D0X1EZ DRUGINKE GVOUFPWUYJWQSK-UHFFFAOYSA-N D0X1EZ DRUGSMIL CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C D0X1EZ HIGHSTAT Approved D0X2IE DRUG__ID D0X2IE D0X2IE DRUGTYPE Small molecular drug D0X2IE DRUGINCH 1S/C3H8OS2/c4-1-3(6)2-5/h3-6H,1-2H2 D0X2IE DRUGINKE WQABCVAJNWAXTE-UHFFFAOYSA-N D0X2IE DRUGSMIL C(C(CS)S)O D0X2IE HIGHSTAT Approved D0X2LV DRUG__ID D0X2LV D0X2LV DRUGTYPE Small molecular drug D0X2LV DRUGINCH 1S/C29H39FO7/c1-6-8-25(35)37-29(23(33)16-36-24(34)7-2)17(3)13-21-20-10-9-18-14-19(31)11-12-26(18,4)28(20,30)22(32)15-27(21,29)5/h11-12,14,17,20-22,32H,6-10,13,15-16H2,1-5H3/t17-,20-,21-,22-,26-,27-,28-,29-/m0/s1 D0X2LV DRUGINKE VXOWJCTXWVWLLC-REGDIAEZSA-N D0X2LV DRUGSMIL CCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)COC(=O)CC D0X2LV HIGHSTAT Approved D0X4FM DRUG__ID D0X4FM D0X4FM DRUGTYPE Small molecular drug D0X4FM DRUGINCH 1S/C20H38O7S/c1-5-9-11-16(7-3)14-26-19(21)13-18(28(23,24)25)20(22)27-15-17(8-4)12-10-6-2/h16-18H,5-15H2,1-4H3,(H,23,24,25) D0X4FM DRUGINKE HNSDLXPSAYFUHK-UHFFFAOYSA-N D0X4FM DRUGSMIL CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O D0X4FM HIGHSTAT Approved D0X5WJ DRUG__ID D0X5WJ D0X5WJ DRUGTYPE Small molecular drug D0X5WJ DRUGINCH 1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1 D0X5WJ DRUGINKE PTVWPYVOOKLBCG-ZDUSSCGKSA-N D0X5WJ DRUGSMIL C1CN(CCN1CC(CO)O)C2=CC=CC=C2 D0X5WJ HIGHSTAT Approved D0X7IT DRUG__ID D0X7IT D0X7IT DRUGTYPE Small molecular drug D0X7IT DRUGINCH 1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) D0X7IT DRUGINKE TYYBFXNZMFNZJT-UHFFFAOYSA-N D0X7IT DRUGSMIL CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I D0X7IT HIGHSTAT Approved D0X7QQ DRUG__ID D0X7QQ D0X7QQ DRUGTYPE Small molecular drug D0X7QQ DRUGINCH 1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28) D0X7QQ DRUGINKE FEBOTPHFXYHVPL-UHFFFAOYSA-N D0X7QQ DRUGSMIL C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F D0X7QQ HIGHSTAT Approved D0X9CH DRUG__ID D0X9CH D0X9CH DRUGTYPE Small molecular drug D0X9CH DRUGINCH 1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1 D0X9CH DRUGINKE BBAWEDCPNXPBQM-GDEBMMAJSA-N D0X9CH DRUGSMIL CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5 D0X9CH HIGHSTAT Approved D0X9MP DRUG__ID D0X9MP D0X9MP DRUGTYPE Small molecular drug D0X9MP DRUGINCH 1S/C23H32N2O3/c1-27-22(19-9-5-3-6-10-19)18-25-15-13-24(14-16-25)17-21(26)23(28-2)20-11-7-4-8-12-20/h3-12,21-23,26H,13-18H2,1-2H3 D0X9MP DRUGINKE VSTNNAYSCJQCQI-UHFFFAOYSA-N D0X9MP DRUGSMIL COC(CN1CCN(CC1)CC(C(C2=CC=CC=C2)OC)O)C3=CC=CC=C3 D0X9MP HIGHSTAT Approved D0X9RY DRUG__ID D0X9RY D0X9RY DRUGTYPE Small molecular drug D0X9RY DRUGINCH 1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9) D0X9RY DRUGINKE WPYMKLBDIGXBTP-UHFFFAOYSA-N D0X9RY DRUGSMIL C1=CC=C(C=C1)C(=O)O D0X9RY HIGHSTAT Approved D0X9XP DRUG__ID D0X9XP D0X9XP DRUGTYPE Small molecular drug D0X9XP DRUGINCH 1S/C28H32O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-8,10,19,21-30,32-37H,9H2,1-2H3/t10-,19+,21-,22+,23+,24-,25+,26+,27+,28+/m0/s1 D0X9XP DRUGINKE GZSOSUNBTXMUFQ-YFAPSIMESA-N D0X9XP DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O D0X9XP HIGHSTAT Approved D0XM9Y DRUG__ID D0XM9Y D0XM9Y DRUGTYPE Small molecular drug D0XM9Y DRUGINCH 1S/C18H13ClN2O/c1-2-10-21-16-9-8-14(19)11-15(16)18(20-12-17(21)22)13-6-4-3-5-7-13/h1,3-9,11H,10,12H2 D0XM9Y DRUGINKE MFZOSKPPVCIFMT-UHFFFAOYSA-N D0XM9Y DRUGSMIL C#CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 D0XM9Y HIGHSTAT Approved D0XQ0Q DRUG__ID D0XQ0Q D0XQ0Q DRUGTYPE Small molecular drug D0XQ0Q DRUGINCH 1S/C22H20N4O8S2/c23-18(27)13-6-8-25(9-7-13)10-14-11-35-21-15(20(29)26(21)16(14)22(30)31)24-19(28)17(36(32,33)34)12-4-2-1-3-5-12/h1-9,15,17,21H,10-11H2,(H4-,23,24,27,28,30,31,32,33,34)/t15-,17-,21-/m1/s1 D0XQ0Q DRUGINKE SYLKGLMBLAAGSC-QLVMHMETSA-N D0XQ0Q DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N D0XQ0Q HIGHSTAT Approved D0XQ5X DRUG__ID D0XQ5X D0XQ5X DRUGCOMP Eisai Woodcliff Lake, NJ D0XQ5X DRUGINCH 1S/C40H59NO11.CH4O3S/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41;1-5(2,3)4/h19,23-39,43H,2-3,5-18,41H2,1,4H3;1H3,(H,2,3,4)/t19-,23+,24+,25-,26+,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39+,40+;/m1./s1 D0XQ5X DRUGINKE QAMYWGZHLCQOOJ-WRNBYXCMSA-N D0XQ5X DRUGSMIL CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O.CS(=O)(=O)O D0XQ5X HIGHSTAT Approved D0Y1AA DRUG__ID D0Y1AA D0Y1AA DRUGTYPE Small molecular drug D0Y1AA DRUGINCH 1S/C6H6O8S2.2Na/c7-4-1-3(15(9,10)11)2-5(6(4)8)16(12,13)14;;/h1-2,7-8H,(H,9,10,11)(H,12,13,14);;/q;2*+1/p-2 D0Y1AA DRUGINKE ISWQCIVKKSOKNN-UHFFFAOYSA-L D0Y1AA DRUGSMIL C1=C(C=C(C(=C1O)O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+] D0Y1AA HIGHSTAT Approved D0Y1UC DRUG__ID D0Y1UC D0Y1UC DRUGTYPE Small molecular drug D0Y1UC DRUGINCH 1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2 D0Y1UC DRUGINKE UMKFEPPTGMDVMI-UHFFFAOYSA-N D0Y1UC DRUGSMIL C1CN(P(=O)(OC1)N(CCCl)CCCl)CCCl D0Y1UC HIGHSTAT Approved D0Y2DI DRUG__ID D0Y2DI D0Y2DI DRUGTYPE Small molecular drug D0Y2DI DRUGINCH 1S/C11H15Cl2N5/c1-6(2)16-10(14)18-11(15)17-7-3-4-8(12)9(13)5-7/h3-6H,1-2H3,(H5,14,15,16,17,18) D0Y2DI DRUGINKE ISZNZKHCRKXXAU-UHFFFAOYSA-N D0Y2DI DRUGSMIL CC(C)N=C(N)N=C(N)NC1=CC(=C(C=C1)Cl)Cl D0Y2DI HIGHSTAT Approved D0Y4YG DRUG__ID D0Y4YG D0Y4YG DRUGCOMP GE Healthcare D0Y4YG DRUGINCH 1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62) D0Y4YG DRUGINKE NBQNWMBBSKPBAY-UHFFFAOYSA-N D0Y4YG DRUGSMIL CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I D0Y4YG HIGHSTAT Approved D0Y7DP DRUG__ID D0Y7DP D0Y7DP DRUGTYPE Small molecular drug D0Y7DP DRUGINCH 1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1 D0Y7DP DRUGINKE DRTQHJPVMGBUCF-XVFCMESISA-N D0Y7DP DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O D0Y7DP HIGHSTAT Approved D0Y7KH DRUG__ID D0Y7KH D0Y7KH DRUGTYPE Small molecular drug D0Y7KH DRUGINCH 1S/C82H103ClN18O16/c1-45(2)35-60(72(107)92-59(16-9-10-33-87-46(3)4)80(115)101-34-12-17-68(101)79(114)88-47(5)70(84)105)93-74(109)63(38-51-23-30-58(31-24-51)91-81(85)116)95-76(111)64(39-50-21-28-57(29-22-50)90-71(106)66-42-69(104)100-82(117)99-66)97-78(113)67(44-102)98-77(112)65(41-53-13-11-32-86-43-53)96-75(110)62(37-49-19-26-56(83)27-20-49)94-73(108)61(89-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52/h7-8,11,13-15,18-32,36,43,45-47,59-68,87,102H,9-10,12,16-17,33-35,37-42,44H2,1-6H3,(H2,84,105)(H,88,114)(H,89,103)(H,90,106)(H,92,107)(H,93,109)(H,94,108)(H,95,111)(H,96,110)(H,97,113)(H,98,112)(H3,85,91,116)(H2,99,100,104,117)/t47-,59+,60+,61-,62-,63-,64+,65-,66+,67+,68+/m1/s1 D0Y7KH DRUGINKE MEUCPCLKGZSHTA-XYAYPHGZSA-N D0Y7KH DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C D0Y7KH HIGHSTAT Approved D0Y7LD DRUG__ID D0Y7LD D0Y7LD DRUGTYPE Small molecular drug D0Y7LD DRUGINCH 1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h10,19-21,23-27,30H,7-9,11-18H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1 D0Y7LD DRUGINKE KZJWDPNRJALLNS-VJSFXXLFSA-N D0Y7LD DRUGSMIL CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C D0Y7LD HIGHSTAT Approved D0Y7ZD DRUG__ID D0Y7ZD D0Y7ZD DRUGTYPE Small molecular drug D0Y7ZD DRUGINCH 1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9) D0Y7ZD DRUGINKE ZGXJTSGNIOSYLO-UHFFFAOYSA-N D0Y7ZD DRUGSMIL C(CC(=O)O)C(=O)CN D0Y7ZD HIGHSTAT Approved D0Y8DP DRUG__ID D0Y8DP D0Y8DP DRUGTYPE Small molecular drug D0Y8DP DRUGINCH 1S/C11H21NO2S/c1-15(13,14)11-9-7-5-3-2-4-6-8-10-12/h2-9,11H2,1H3 D0Y8DP DRUGINKE OKNKACRVIGPQAW-UHFFFAOYSA-N D0Y8DP DRUGSMIL CS(=O)(=O)CCCCCCCCCC#N D0Y8DP HIGHSTAT Approved D0Y9LL DRUG__ID D0Y9LL D0Y9LL DRUGTYPE Small molecular drug D0Y9LL DRUGINCH 1S/C22H27ClN2O/c1-17(2)24-14-12-21(13-15-24)25(20-10-8-19(23)9-11-20)22(26)16-18-6-4-3-5-7-18/h3-11,17,21H,12-16H2,1-2H3 D0Y9LL DRUGINKE XHOJAWVAWFHGHL-UHFFFAOYSA-N D0Y9LL DRUGSMIL CC(C)N1CCC(CC1)N(C2=CC=C(C=C2)Cl)C(=O)CC3=CC=CC=C3 D0Y9LL HIGHSTAT Approved D0YB1G DRUG__ID D0YB1G D0YB1G DRUGTYPE Small molecular drug D0YB1G DRUGINCH 1S/C17H12ClNO2S/c18-13-8-6-11(7-9-13)16-14(10-15(20)21)22-17(19-16)12-4-2-1-3-5-12/h1-9H,10H2,(H,20,21) D0YB1G DRUGINKE JIEKMACRVQTPRC-UHFFFAOYSA-N D0YB1G DRUGSMIL C1=CC=C(C=C1)C2=NC(=C(S2)CC(=O)O)C3=CC=C(C=C3)Cl D0YB1G HIGHSTAT Approved D0YC7U DRUG__ID D0YC7U D0YC7U DRUGCOMP SK Pharmaceutical Co Ltd D0YC7U DRUGINCH 1S/C8H18N2O2.C3H4O4.Pt/c1-5(2)8-11-6(3-9)7(4-10)12-8;4-2(5)1-3(6)7;/h5-8H,3-4,9-10H2,1-2H3;1H2,(H,4,5)(H,6,7);/q;;+2/p-2/t6-,7-;;/m1../s1 D0YC7U DRUGINKE XJXKGUZINMNEDK-GPJOBVNKSA-L D0YC7U DRUGSMIL CC(C)C1OC(C(O1)CN)CN.C(C(=O)[O-])C(=O)[O-].[Pt+2] D0YC7U HIGHSTAT Approved D0YF3X DRUG__ID D0YF3X D0YF3X DRUGTYPE Small molecular drug D0YF3X DRUGINCH 1S/C6H6O5S.C4H11N/c7-4-1-2-5(8)6(3-4)12(9,10)11;1-3-5-4-2/h1-3,7-8H,(H,9,10,11);5H,3-4H2,1-2H3 D0YF3X DRUGINKE HBGOLJKPSFNJSD-UHFFFAOYSA-N D0YF3X DRUGSMIL CCNCC.C1=CC(=C(C=C1O)S(=O)(=O)O)O D0YF3X HIGHSTAT Approved D0YP7B DRUG__ID D0YP7B D0YP7B DRUGCOMP Rhythm Metabolics Boston, MA D0YP7B DRUGINCH 1S/C49H68N18O9S2/c1-26-41(70)63-37(20-30-22-55-25-59-30)46(75)64-35(18-28-10-4-3-5-11-28)44(73)62-34(15-9-17-57-49(53)54)43(72)65-36(19-29-21-58-32-13-7-6-12-31(29)32)45(74)66-38(40(50)69)23-77-78-24-39(47(76)60-26)67-42(71)33(61-27(2)68)14-8-16-56-48(51)52/h3-7,10-13,21-22,25-26,33-39,58H,8-9,14-20,23-24H2,1-2H3,(H2,50,69)(H,55,59)(H,60,76)(H,61,68)(H,62,73)(H,63,70)(H,64,75)(H,65,72)(H,66,74)(H,67,71)(H4,51,52,56)(H4,53,54,57)/t26-,33+,34+,35-,36+,37+,38+,39+/m1/s1 D0YP7B DRUGINKE HDHDTKMUACZDAA-PHNIDTBTSA-N D0YP7B DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5 D0YP7B HIGHSTAT Approved D0Z1QC DRUG__ID D0Z1QC D0Z1QC DRUGTYPE Small molecular drug D0Z1QC DRUGINCH 1S/C11H22O4/c1-2-3-4-5-6-7-11(14)15-9-10(13)8-12/h10,12-13H,2-9H2,1H3 D0Z1QC DRUGINKE GHBFNMLVSPCDGN-UHFFFAOYSA-N D0Z1QC DRUGSMIL CCCCCCCC(=O)OCC(CO)O D0Z1QC HIGHSTAT Approved D0Z2LG DRUG__ID D0Z2LG D0Z2LG DRUGTYPE Small molecular drug D0Z2LG DRUGINCH 1S/C42H38O20/c43-11-23-31(47)35(51)37(53)41(61-23)59-21-5-1-3-15-25(17-7-13(39(55)56)9-19(45)27(17)33(49)29(15)21)26-16-4-2-6-22(60-42-38(54)36(52)32(48)24(12-44)62-42)30(16)34(50)28-18(26)8-14(40(57)58)10-20(28)46/h1-10,23-26,31-32,35-38,41-48,51-54H,11-12H2,(H,55,56)(H,57,58)/t23-,24-,25-,26-,31-,32-,35+,36+,37-,38-,41-,42-/m1/s1 D0Z2LG DRUGINKE IPQVTOJGNYVQEO-KGFNBKMBSA-N D0Z2LG DRUGSMIL C1=CC2=C(C(=C1)OC3C(C(C(C(O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)OC7C(C(C(C(O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O D0Z2LG HIGHSTAT Approved D0Z2RA DRUG__ID D0Z2RA D0Z2RA DRUGTYPE Small molecular drug D0Z2RA DRUGINCH 1S/C10H12O4/c1-9-5-3-4-6(13-5)10(9,2)8(12)14-7(9)11/h5-6H,3-4H2,1-2H3/t5-,6+,9+,10- D0Z2RA DRUGINKE DHZBEENLJMYSHQ-XCVPVQRUSA-N D0Z2RA DRUGSMIL CC12C3CCC(C1(C(=O)OC2=O)C)O3 D0Z2RA HIGHSTAT Approved D0Z3EI DRUG__ID D0Z3EI D0Z3EI DRUGTYPE Small molecular drug D0Z3EI DRUGINCH 1S/C9H7NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H,(H,10,11) D0Z3EI DRUGINKE LISFMEBWQUVKPJ-UHFFFAOYSA-N D0Z3EI DRUGSMIL C1=CC=C2C(=C1)C=CC(=O)N2 D0Z3EI HIGHSTAT Approved D0Z4PE DRUG__ID D0Z4PE D0Z4PE DRUGTYPE Small molecular drug D0Z4PE DRUGINCH 1S/C36H35NO11/c1-17-9-10-22-18(2)13-21(42-5)15-24(22)28(17)33(40)45-25-14-20-11-12-36(27-16-43-35(41)46-27)26(48-36)8-6-7-23(20)32(25)47-34-29(37-4)31(39)30(38)19(3)44-34/h7,9-10,13-15,19,25-27,29-32,34,37-39H,16H2,1-5H3/b23-7+/t19-,25-,26-,27+,29-,30+,31-,32?,34-,36+/m1/s1 D0Z4PE DRUGINKE FYQZGCBXYVWXSP-STTFAQHVSA-N D0Z4PE DRUGSMIL CC1C(C(C(C(O1)OC2C(C=C3C2=CC#CC4C(O4)(C#C3)C5COC(=O)O5)OC(=O)C6=C(C=CC7=C6C=C(C=C7C)OC)C)NC)O)O D0Z4PE HIGHSTAT Approved D0Z5BC DRUG__ID D0Z5BC D0Z5BC DRUGTYPE Small molecular drug D0Z5BC DRUGINCH 1S/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13) D0Z5BC DRUGINKE FRPZMMHWLSIFAZ-UHFFFAOYSA-N D0Z5BC DRUGSMIL C=CCCCCCCCCC(=O)O D0Z5BC HIGHSTAT Approved D0Z5OV DRUG__ID D0Z5OV D0Z5OV DRUGTYPE Small molecular drug D0Z5OV DRUGINCH 1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20) D0Z5OV DRUGINKE CHIFCDOIPRCHCF-UHFFFAOYSA-N D0Z5OV DRUGSMIL C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3Cl D0Z5OV HIGHSTAT Approved D0Z5QI DRUG__ID D0Z5QI D0Z5QI DRUGTYPE Small molecular drug D0Z5QI DRUGINCH 1S/C22H22FN3O2.C22H28N2O.C6H8O7/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28;1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19;7-3(8)1-6(13,5(11)12)2-4(9)10/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28);3-12,21H,2,13-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D0Z5QI DRUGINKE RCFLBBHULHAKQU-UHFFFAOYSA-N D0Z5QI DRUGSMIL CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3.C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D0Z5QI HIGHSTAT Approved D0Z6QG DRUG__ID D0Z6QG D0Z6QG DRUGTYPE Small molecular drug D0Z6QG DRUGINCH 1S/C24H33N3O3S2/c1-25(2)32(29,30)20-8-9-24-22(18-20)27(21-6-3-4-7-23(21)31-24)14-5-13-26-15-10-19(11-16-26)12-17-28/h3-4,6-9,18-19,28H,5,10-17H2,1-2H3 D0Z6QG DRUGINKE JOMHSQGEWSNUKU-UHFFFAOYSA-N D0Z6QG DRUGSMIL CN(C)S(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO D0Z6QG HIGHSTAT Approved D0Z8SF DRUG__ID D0Z8SF D0Z8SF DRUGTYPE Small molecular drug D0Z8SF DRUGINCH 1S/C7H8O3/c1-4-5(7(9)10)2-3-6(4)8/h5H,1-3H2,(H,9,10)/t5-/m0/s1 D0Z8SF DRUGINKE ILFPCMXTASDZKM-YFKPBYRVSA-N D0Z8SF DRUGSMIL C=C1C(CCC1=O)C(=O)O D0Z8SF HIGHSTAT Approved D0Z9PX DRUG__ID D0Z9PX D0Z9PX DRUGTYPE Small molecular drug D0Z9PX DRUGINCH 1S/C23H32N2O.HI/c1-18(2)25(5,19(3)4)17-16-23(22(24)26,20-12-8-6-9-13-20)21-14-10-7-11-15-21;/h6-15,18-19H,16-17H2,1-5H3,(H-,24,26);1H D0Z9PX DRUGINKE BFSMWENDZZIWPW-UHFFFAOYSA-N D0Z9PX DRUGSMIL CC(C)[N+](C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)C(C)C.[I-] D0Z9PX HIGHSTAT Approved D0ZS6R DRUG__ID D0ZS6R D0ZS6R DRUGCOMP Cis Bio International Sa D0ZS6R DRUGINCH 1S/C51H77N17O19S5.Na.O.Tc/c1-26(69)60-24-91-21-33(46(82)56-12-37(72)54-14-39(74)64-32(18-88)45(53)81)66-42(77)17-58-47(83)34(22-92-25-61-27(2)70)65-40(75)15-55-38(73)13-57-49(85)36-20-90-23-43(78)63-30(10-28-4-6-29(71)7-5-28)50(86)67-35(19-89-9-3-8-52)48(84)59-16-41(76)62-31(11-44(79)80)51(87)68-36;;;/h4-7,30-36,71,88H,3,8-25,52H2,1-2H3,(H2,53,81)(H,54,72)(H,55,73)(H,56,82)(H,57,85)(H,58,83)(H,59,84)(H,60,69)(H,61,70)(H,62,76)(H,63,78)(H,64,74)(H,65,75)(H,66,77)(H,67,86)(H,68,87)(H,79,80);;;/q;+1;-2;+5/p-5/t30-,31+,32+,33+,34+,35+,36+;;;/m1.../s1/i;;;1+1 D0ZS6R DRUGINKE FKYRHOMOAIJZJC-YLXBGQBVSA-I D0ZS6R DRUGSMIL CC(=O)NCSCC(C(=O)NCC(=O)NC(CSCNC(=O)C)C(=NCC(=NCC(=NC(C[S-])C(=O)N)[O-])[O-])[O-])NC(=O)CNC(=O)CNC(=O)C1CSCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)CC(=O)[O-])CSCCCN)CC2=CC=C(C=C2)O.[O-2].[Na+].[Tc+5] D0ZS6R HIGHSTAT Approved D0ZX1P DRUG__ID D0ZX1P D0ZX1P DRUGTYPE Small molecular drug D0ZX1P DRUGINCH 1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2 D0ZX1P DRUGINKE CLPFFLWZZBQMAO-UHFFFAOYSA-N D0ZX1P DRUGSMIL C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N D0ZX1P HIGHSTAT Approved D1CWL0 DRUG__ID D1CWL0 D1CWL0 DRUGTYPE Small molecular drug D1CWL0 DRUGINCH 1S/C24H28FN3O.C7H8O3S/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17;1-6-2-4-7(5-3-6)11(8,9)10/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3;2-5H,1H3,(H,8,9,10)/t20-,21-;/m0./s1 D1CWL0 DRUGINKE LHAPOGAFBLSJJQ-GUTACTQSSA-N D1CWL0 DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2C3CCN(CC3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F D1CWL0 HIGHSTAT Approved D5IS6V DRUG__ID D5IS6V D5IS6V DRUGTYPE Small molecular drug D5IS6V DRUGINCH 1S/C12H12N2/c1-9-3-5-11(13-7-9)12-6-4-10(2)8-14-12/h3-8H,1-2H3 D5IS6V DRUGINKE PTRATZCAGVBFIQ-UHFFFAOYSA-N D5IS6V DRUGSMIL CC1=CN=C(C=C1)C2=NC=C(C=C2)C D5IS6V HIGHSTAT Approved D9E6KQ DRUG__ID D9E6KQ D9E6KQ DRUGTYPE Radioactive diagnostic agent D9E6KQ DRUGINCH 1S/C65H90N14O19S2.Cu/c1-38(80)56-64(96)73-51(63(95)75-57(39(2)81)65(97)98)37-100-99-36-50(72-59(91)47(28-40-10-4-3-5-11-40)68-52(83)32-76-20-22-77(33-53(84)85)24-26-79(35-55(88)89)27-25-78(23-21-76)34-54(86)87)62(94)70-48(29-41-15-17-43(82)18-16-41)60(92)71-49(30-42-31-67-45-13-7-6-12-44(42)45)61(93)69-46(58(90)74-56)14-8-9-19-66;/h3-7,10-13,15-18,31,38-39,46-51,56-57,67,80-82H,8-9,14,19-30,32-37,66H2,1-2H3,(H,68,83)(H,69,93)(H,70,94)(H,71,92)(H,72,91)(H,73,96)(H,74,90)(H,75,95)(H,84,85)(H,86,87)(H,88,89)(H,97,98);/q;+2/p-2/t38-,39-,46+,47-,48+,49-,50+,51+,56+,57+;/m1./s1/i;1+0 D9E6KQ DRUGINKE IJRLLVFQGCCPPI-NVGRTJHCSA-L D9E6KQ DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)[O-])CC(=O)[O-])CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O.[Cu+2] D9E6KQ HIGHSTAT Approved DBG46D DRUG__ID DBG46D DBG46D DRUGTYPE Radioactive diagnostic agent DBG46D DRUGINCH 1S/C44H62N6O17.Ga/c51-34-13-8-28(22-30(34)24-49(26-40(59)60)20-21-50(27-41(61)62)25-31-23-29(9-14-35(31)52)11-16-38(55)56)10-15-37(54)46-18-4-1-2-7-36(53)45-19-5-3-6-32(42(63)64)47-44(67)48-33(43(65)66)12-17-39(57)58;/h8-9,13-14,22-23,32-33,51-52H,1-7,10-12,15-21,24-27H2,(H,45,53)(H,46,54)(H,55,56)(H,57,58)(H,59,60)(H,61,62)(H,63,64)(H,65,66)(H2,47,48,67);/q;+3/p-3/t32-,33-;/m0./s1/i;1-2 DBG46D DRUGINKE AEBYHKKMCWUMKX-LNTZDJBBSA-K DBG46D DRUGSMIL [H+].C1=CC(=C(C=C1CCC(=O)NCCCCCC(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)CN(CCN(CC2=C(C=CC(=C2)CCC(=O)O)[O-])CC(=O)[O-])CC(=O)[O-])[O-].[Ga+3] DBG46D HIGHSTAT Approved DNF9L1 DRUG__ID DNF9L1 DNF9L1 DRUGTYPE Radioactive diagnostic agent DNF9L1 DRUGINCH 1S/C9H10FNO4/c10-5-3-8(13)7(12)2-4(5)1-6(11)9(14)15/h2-3,6,12-13H,1,11H2,(H,14,15)/t6-/m0/s1/i10-1 DNF9L1 DRUGINKE PAXWQORCRCBOCU-RPDRGXCHSA-N DNF9L1 DRUGSMIL C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N DNF9L1 HIGHSTAT Approved DR36YB DRUG__ID DR36YB DR36YB DRUGTYPE Small molecular drug DR36YB DRUGINCH 1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28) DR36YB DRUGINKE PWNMXPDKBYZCOO-UHFFFAOYSA-N DR36YB DRUGSMIL CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C DR36YB HIGHSTAT Approved DU8CF6 DRUG__ID DU8CF6 DU8CF6 DRUGTYPE Small molecular drug DU8CF6 DRUGINCH 1S/C10H10ClN5O2/c11-8-4-2-1-3-7(8)9(18-10(12)17)5-16-14-6-13-15-16/h1-4,6,9H,5H2,(H2,12,17)/t9-/m0/s1 DU8CF6 DRUGINKE GFHAXPJGXSQLPT-VIFPVBQESA-N DU8CF6 DRUGSMIL C1=CC=C(C(=C1)C(CN2N=CN=N2)OC(=O)N)Cl DU8CF6 HIGHSTAT Approved DX7M4S DRUG__ID DX7M4S DX7M4S DRUGTYPE Small molecular drug DX7M4S DRUGINCH 1S/C7H8N4S/c8-7(12)11-10-5-6-1-3-9-4-2-6/h1-5H,(H3,8,11,12)/b10-5- DX7M4S DRUGINKE QTSJJDIDTYFLFC-YHYXMXQVSA-N DX7M4S DRUGSMIL C1=CN=CC=C1C=NNC(=S)N DX7M4S HIGHSTAT Approved D00QEP DRUG__ID D00QEP D00QEP TRADNAME Besponsa D00QEP DRUGCOMP Pfizer D00QEP DRUGTYPE Antibody D00QEP HIGHSTAT Approved D01TVQ DRUG__ID D01TVQ D01TVQ DRUGCOMP Bayer Pharmaceuticals Corporation D01TVQ THERCLAS Anticancer Agents D01TVQ DRUGTYPE Antibody D01TVQ HIGHSTAT Approved D01VJN DRUG__ID D01VJN D01VJN DRUGCOMP Eli Lilly; Eli Lilly & Co D01VJN DRUGTYPE Small molecular drug D01VJN DRUGSMIL CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C.CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl D01VJN HIGHSTAT Approved D01ZYG DRUG__ID D01ZYG D01ZYG DRUGCOMP Bayer Schering Pharma D01ZYG THERCLAS Anticancer Agents D01ZYG DRUGTYPE Antibody D01ZYG HIGHSTAT Approved D02GEC DRUG__ID D02GEC D02GEC DRUGCOMP National University Hospital, Singapore|National University, Singapore D02GEC THERCLAS Antiasthmatic Agents D02GEC DRUGTYPE Monoclonal antibody D02GEC HIGHSTAT Approved D02KUO DRUG__ID D02KUO D02KUO TRADNAME Oxervate D02KUO DRUGCOMP Domp D02KUO DRUGTYPE Antibody D02KUO HIGHSTAT Approved D02PIO DRUG__ID D02PIO D02PIO TRADNAME Fasenra D02PIO DRUGCOMP AstraZeneca D02PIO DRUGTYPE Monoclonal antibody D02PIO HIGHSTAT Approved D02UYB DRUG__ID D02UYB D02UYB TRADNAME Onpattro D02UYB DRUGCOMP Alnylam Pharmaceuticals D02UYB DRUGTYPE siRNA drug D02UYB HIGHSTAT Approved D03HSN DRUG__ID D03HSN D03HSN TRADNAME Tremfya D03HSN DRUGCOMP Janssen/Johnson & Johnson D03HSN DRUGTYPE Antibody D03HSN HIGHSTAT Approved D03SGR DRUG__ID D03SGR D03SGR DRUGCOMP Roche D03SGR THERCLAS Immunomodulatory Agents D03SGR DRUGTYPE Antibody D03SGR HIGHSTAT Approved D03VDC DRUG__ID D03VDC D03VDC DRUGINCH 1S/3Mg.2HO3Si.2O3Si/c;;;4*1-4(2)3/h;;;2*1H;;/q3*+2;2*-1;2*-2 D03VDC DRUGINKE KNXVOGGZOFOROK-UHFFFAOYSA-N D03VDC DRUGSMIL O[Si](=O)[O-].O[Si](=O)[O-].[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Mg+2].[Mg+2].[Mg+2] D03VDC HIGHSTAT Approved D04IEM DRUG__ID D04IEM D04IEM DRUGINCH 1S/C30H49N9O10S/c1-15(35-25(44)19(31)10-12-50-3)24(43)39-23(16(2)41)28(47)37-21(13-17-6-8-18(42)9-7-17)27(46)36-20(5-4-11-34-30(32)33)26(45)38-22(14-40)29(48)49/h6-9,15-16,19-23,40-42H,4-5,10-14,31H2,1-3H3,(H,35,44)(H,36,46)(H,37,47)(H,38,45)(H,39,43)(H,48,49)(H4,32,33,34)/t15-,16+,19-,20-,21-,22-,23-/m0/s1 D04IEM DRUGINKE DRYGYHITZUXESB-DOZDZGCYSA-N D04IEM DRUGSMIL CC(C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)O)NC(=O)C(C)NC(=O)C(CCSC)N)O D04IEM HIGHSTAT Approved D04WFL DRUG__ID D04WFL D04WFL DRUGCOMP Roche; Genentech D04WFL THERCLAS Anticancer Agents D04WFL DRUGTYPE Antibody D04WFL HIGHSTAT Approved D05BXY DRUG__ID D05BXY D05BXY DRUGCOMP Amgen D05BXY THERCLAS Anticancer Agents D05BXY DRUGTYPE Vaccine D05BXY HIGHSTAT Approved D05CEO DRUG__ID D05CEO D05CEO TRADNAME Siliq D05CEO DRUGCOMP Valeant Pharmaceuticals D05CEO DRUGTYPE Monoclonal antibody D05CEO HIGHSTAT Approved D05JFY DRUG__ID D05JFY D05JFY DRUGCOMP NitroMed D05JFY DRUGTYPE Combination drug D05JFY DRUGSMIL failed D05JFY HIGHSTAT Approved D05NUH DRUG__ID D05NUH D05NUH DRUGINCH 1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30) D05NUH DRUGINKE FDMQDKQUTRLUBU-UHFFFAOYSA-N D05NUH DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4 D05NUH HIGHSTAT Approved D06AGH DRUG__ID D06AGH D06AGH DRUGCOMP GlaxoSmithKline D06AGH DRUGTYPE Combination drug D06AGH DRUGSMIL failed D06AGH HIGHSTAT Approved D06CAS DRUG__ID D06CAS D06CAS TRADNAME Brineura D06CAS DRUGCOMP BioMarin Pharmaceutical D06CAS DRUGTYPE Recombinant protein D06CAS HIGHSTAT Approved D06EWO DRUG__ID D06EWO D06EWO DRUGCOMP Wyeth Pharmaceuticals D06EWO THERCLAS Anticancer Agents D06EWO DRUGTYPE Antibody D06EWO HIGHSTAT Approved D06SBB DRUG__ID D06SBB D06SBB DRUGCOMP Norvatis Phamaceuticals Corporation D06SBB THERCLAS Immunomodulatory Agents D06SBB DRUGTYPE Monoclonal antibody D06SBB HIGHSTAT Approved D06ZYM DRUG__ID D06ZYM D06ZYM DRUGINCH 1S/C21H30N/c1-6-18-9-13-20(14-10-18)17(2)7-8-19-11-15-21(16-12-19)22(3,4)5/h9-17H,6-8H2,1-5H3/q+1 D06ZYM DRUGINKE HGMSJMJPXGGEBP-UHFFFAOYSA-N D06ZYM DRUGSMIL CCC1=CC=C(C=C1)C(C)CCC2=CC=C(C=C2)[N+](C)(C)C D06ZYM HIGHSTAT Approved D07DPI DRUG__ID D07DPI D07DPI DRUGCOMP AstraZeneca D07DPI DRUGTYPE Combination drug D07DPI DRUGSMIL failed D07DPI HIGHSTAT Approved D07FUP DRUG__ID D07FUP D07FUP TRADNAME Dupixent D07FUP DRUGCOMP Regeneron/Sanofi D07FUP DRUGTYPE Antibody D07FUP HIGHSTAT Approved D08PLK DRUG__ID D08PLK D08PLK TRADNAME Ajovy D08PLK DRUGCOMP Teva D08PLK DRUGTYPE Antibody D08PLK HIGHSTAT Approved D09EXD DRUG__ID D09EXD D09EXD DRUGCOMP Roche D09EXD THERCLAS Anticancer Agents D09EXD DRUGTYPE Antibody D09EXD HIGHSTAT Approved D09KKH DRUG__ID D09KKH D09KKH DRUGINCH 1S/C60H88N2O19/c1-36-19-17-15-13-11-9-7-6-8-10-12-14-16-18-20-50(79-59-55(74)53(61)54(73)38(3)78-59)57-52(58(75)77-5)49(71)35-60(76,81-57)34-47(69)31-45(67)29-43(65)27-42(64)28-44(66)30-46(68)33-51(72)80-56(36)37(2)21-26-41(63)32-48(70)39-22-24-40(62-4)25-23-39/h6-19,22-25,36-38,41-43,45-47,49-50,52-57,59,62-65,67-69,71,73-74,76H,20-21,26-35,61H2,1-5H3/b7-6-,10-8+,11-9-,14-12+,15-13+,18-16+,19-17+/t36?,37?,38-,41?,42?,43?,45?,46?,47?,49?,50?,52?,53+,54-,55+,56?,57?,59?,60?/m1/s1 D09KKH DRUGINKE GTBKZCQTNWWEIB-PBSBGHGNSA-N D09KKH DRUGSMIL CC1C=CC=CC=CC=CC=CC=CC=CCC(C2C(C(CC(O2)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC1C(C)CCC(CC(=O)C3=CC=C(C=C3)NC)O)O)O)O)O)O)O)O)C(=O)OC)OC4C(C(C(C(O4)C)O)N)O D09KKH HIGHSTAT Approved D09NLC DRUG__ID D09NLC D09NLC DRUGINCH 1S/C10H16N5O12P3.2Na/c1-23-30(22,27-29(20,21)26-28(17,18)19)25-10-5(16)2-6(24-10)15-4-14-7-8(11)12-3-13-9(7)15;;/h3-6,10,16H,2H2,1H3,(H,20,21)(H2,11,12,13)(H2,17,18,19);;/q;2*+1/p-2 D09NLC DRUGINKE LUSTYMNNBDCASM-UHFFFAOYSA-L D09NLC DRUGSMIL COP(=O)(OC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])OP(=O)(O)[O-].[Na+].[Na+] D09NLC HIGHSTAT Approved D09NYS DRUG__ID D09NYS D09NYS DRUGINCH 1S/C16H18N3S.ClH/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;/h5-10H,1-4H3;1H/q+1;/p-1 D09NYS DRUGINKE CXKWCBBOMKCUKX-UHFFFAOYSA-M D09NYS DRUGSMIL CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-] D09NYS HIGHSTAT Approved D09XTN DRUG__ID D09XTN D09XTN TRADNAME Hemlibra D09XTN DRUGCOMP Roche/Genentech D09XTN DRUGTYPE Antibody D09XTN HIGHSTAT Approved D0A1AS DRUG__ID D0A1AS D0A1AS DRUGCOMP Medlmmune D0A1AS THERCLAS Antiviral Agents D0A1AS DRUGTYPE Monoclonal antibody D0A1AS HIGHSTAT Approved D0A7ZK DRUG__ID D0A7ZK D0A7ZK DRUGINCH 1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1 D0A7ZK DRUGINKE MUGXRYIUWFITCP-PGRDOPGGSA-N D0A7ZK DRUGSMIL CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C D0A7ZK HIGHSTAT Approved D0A8GM DRUG__ID D0A8GM D0A8GM TRADNAME Briumvi D0A8GM DRUGCOMP TG Therapeutics D0A8GM DRUGTYPE Antibody D0A8GM HIGHSTAT Approved D0C8VF DRUG__ID D0C8VF D0C8VF TRADNAME Emgality D0C8VF DRUGCOMP Eli Lilly D0C8VF DRUGTYPE Antibody D0C8VF HIGHSTAT Approved D0C9DA DRUG__ID D0C9DA D0C9DA TRADNAME Asparlas D0C9DA DRUGCOMP Servier D0C9DA DRUGTYPE Antibody D0C9DA HIGHSTAT Approved D0DJ9D DRUG__ID D0DJ9D D0DJ9D TRADNAME Crysvita D0DJ9D DRUGCOMP Ultragenyx Pharmaceutical/Kyowa Hakko Kirin D0DJ9D DRUGTYPE Antibody D0DJ9D HIGHSTAT Approved D0DK5R DRUG__ID D0DK5R D0DK5R TRADNAME Yescarta D0DK5R DRUGCOMP Masonic Cancer Center, University of Minnesota D0DK5R DRUGTYPE CAR T Cell Therapy D0DK5R HIGHSTAT Approved D0DS5U DRUG__ID D0DS5U D0DS5U DRUGINCH 1S/C8H8O3S/c1-2-7-3-5-8(6-4-7)12(9,10)11/h2-6H,1H2,(H,9,10,11) D0DS5U DRUGINKE MAGFQRLKWCCTQJ-UHFFFAOYSA-N D0DS5U DRUGSMIL C=CC1=CC=C(C=C1)S(=O)(=O)O D0DS5U HIGHSTAT Approved D0E7AD DRUG__ID D0E7AD D0E7AD TRADNAME Trogarzo D0E7AD DRUGCOMP TaiMed Biologics/Theratechnologies D0E7AD DRUGTYPE Antibody D0E7AD HIGHSTAT Approved D0FR6I DRUG__ID D0FR6I D0FR6I DRUGINCH 1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;-1;+3/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;;/m1../s1 D0FR6I DRUGINKE FDJOLVPMNUYSCM-WZHZPDAFSA-L D0FR6I DRUGSMIL CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3] D0FR6I HIGHSTAT Approved D0FT3R DRUG__ID D0FT3R D0FT3R TRADNAME Ilumya D0FT3R DRUGCOMP Sun Pharma D0FT3R DRUGTYPE Antibody D0FT3R HIGHSTAT Approved D0G6WW DRUG__ID D0G6WW D0G6WW DRUGINCH 1S/C20H20N6O9S.2Na/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9;;/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32);;/q;2*+1/p-2 D0G6WW DRUGINKE GRIXGZQULWMCLU-UHFFFAOYSA-L D0G6WW DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(N=C(C(C4=CC=C(C=C4)[O-])C(=O)O)[O-])OC)OC2)C(=O)O.[Na+].[Na+] D0G6WW HIGHSTAT Approved D0H6VY DRUG__ID D0H6VY D0H6VY DRUGCOMP SuppreMol D0H6VY DRUGTYPE Small molecular drug D0H6VY DRUGSMIL CC1=C(SC(C1=O)(C)C=C(C)C=C)O D0H6VY HIGHSTAT Approved (orphan drug) D0HU9H DRUG__ID D0HU9H D0HU9H DRUGCOMP Amgen & Takeda D0HU9H THERCLAS Anticancer Agents D0HU9H DRUGTYPE Monoclonal antibody D0HU9H HIGHSTAT Approved D0I1CQ DRUG__ID D0I1CQ D0I1CQ TRADNAME Qalsody D0I1CQ DRUGCOMP Ionis Pharmaceuticals D0I1CQ DRUGTYPE Antisense oligonucleotide D0I1CQ HIGHSTAT Approved D0I1ZY DRUG__ID D0I1ZY D0I1ZY TRADNAME Adbry D0I1ZY DRUGCOMP LEO Pharma D0I1ZY DRUGTYPE Monoclonal antibody D0I1ZY HIGHSTAT Approved D0I2AV DRUG__ID D0I2AV D0I2AV DRUGCOMP GlaxoSmithKline D0I2AV THERCLAS Anticancer Agents D0I2AV DRUGTYPE Antibody D0I2AV HIGHSTAT Approved D0I2VR DRUG__ID D0I2VR D0I2VR DRUGINCH 1S/3C7H6O3.C5H14NO.Mg/c3*8-6-4-2-1-3-5(6)7(9)10;1-6(2,3)4-5-7;/h3*1-4,8H,(H,9,10);7H,4-5H2,1-3H3;/q;;;+1;+2/p-3 D0I2VR DRUGINKE FQCQGOZEWWPOKI-UHFFFAOYSA-K D0I2VR DRUGSMIL C[N+](C)(C)CCO.C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].C1=CC=C(C(=C1)C(=O)O)[O-].[Mg+2] D0I2VR HIGHSTAT Approved D0IH2I DRUG__ID D0IH2I D0IH2I DRUGINCH 1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)/i1+1 D0IH2I DRUGINKE XSQUKJJJFZCRTK-OUBTZVSYSA-N D0IH2I DRUGSMIL C(=O)(N)N D0IH2I HIGHSTAT Approved D0IM6T DRUG__ID D0IM6T D0IM6T TRADNAME Kymriah D0IM6T DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0IM6T DRUGTYPE CAR T Cell Therapy D0IM6T HIGHSTAT Approved D0J6DQ DRUG__ID D0J6DQ D0J6DQ TRADNAME Imjudo D0J6DQ DRUGCOMP AstraZeneca D0J6DQ DRUGTYPE Monoclonal antibody D0J6DQ HIGHSTAT Approved D0K0DY DRUG__ID D0K0DY D0K0DY DRUGINCH 1S/C42H82O2/c1-4-7-10-13-16-18-19-20-21-22-23-24-25-26-27-29-31-34-37-40-42(43)44-41(38-35-32-15-12-9-6-3)39-36-33-30-28-17-14-11-8-5-2/h20-21,41H,4-19,22-40H2,1-3H3/b21-20- D0K0DY DRUGINKE VJVOFLWZDWLHNR-MRCUWXFGSA-N D0K0DY DRUGSMIL CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCCC=CCCCCCCCC D0K0DY HIGHSTAT Approved D0K5IP DRUG__ID D0K5IP D0K5IP TRADNAME Akynzeo IV D0K5IP DRUGCOMP Helsinn Group D0K5IP DRUGTYPE Antibody D0K5IP HIGHSTAT Approved D0K5KS DRUG__ID D0K5KS D0K5KS DRUGCOMP Abbott Laboratories D0K5KS THERCLAS Antirheumatic Agents D0K5KS DRUGTYPE Antibody D0K5KS HIGHSTAT Approved D0K7SX DRUG__ID D0K7SX D0K7SX TRADNAME Bavencio D0K7SX DRUGCOMP Merck KGaA/Pfizer D0K7SX DRUGTYPE Monoclonal antibody D0K7SX HIGHSTAT Approved D0KG4Q DRUG__ID D0KG4Q D0KG4Q TRADNAME Libtayo D0KG4Q DRUGCOMP Regeneron/Sanofi D0KG4Q DRUGTYPE Monoclonal antibody D0KG4Q HIGHSTAT Approved D0L3MP DRUG__ID D0L3MP D0L3MP DRUGCOMP VIRxSYS Corporation D0L3MP THERCLAS Antisense D0L3MP DRUGTYPE Antisense drug D0L3MP HIGHSTAT Approved D0L5AP DRUG__ID D0L5AP D0L5AP DRUGINCH 1S/C31H56N8O10/c1-9-15(5)23(37-22(42)13-32)29(46)39-25(18(8)40)30(47)34-17(7)26(43)35-19(11-14(3)4)27(44)38-24(16(6)10-2)28(45)36-20(31(48)49)12-21(33)41/h14-20,23-25,40H,9-13,32H2,1-8H3,(H2,33,41)(H,34,47)(H,35,43)(H,36,45)(H,37,42)(H,38,44)(H,39,46)(H,48,49)/t15-,16-,17-,18+,19-,20-,23-,24-,25-/m0/s1 D0L5AP DRUGINKE APSWDBKJUOEMOA-MTEWDWANSA-N D0L5AP DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)CN D0L5AP HIGHSTAT Approved D0LS9E DRUG__ID D0LS9E D0LS9E TRADNAME Imfinzi D0LS9E DRUGCOMP AstraZeneca D0LS9E DRUGTYPE Monoclonal antibody D0LS9E HIGHSTAT Approved D0M3MN DRUG__ID D0M3MN D0M3MN THERCLAS Vitamins D0M3MN DRUGTYPE Small molecular drug D0M3MN DRUGSMIL C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0M3MN HIGHSTAT Approved D0MS1G DRUG__ID D0MS1G D0MS1G TRADNAME Omegaven D0MS1G DRUGCOMP Fresenius D0MS1G DRUGTYPE Antibody D0MS1G HIGHSTAT Approved D0N5OV DRUG__ID D0N5OV D0N5OV DRUGCOMP Bristol-Myers Squibb D0N5OV THERCLAS Anticancer Agents D0N5OV DRUGTYPE Antibody D0N5OV HIGHSTAT Approved D0NW7Y DRUG__ID D0NW7Y D0NW7Y TRADNAME Ultomiris D0NW7Y DRUGCOMP Alexion D0NW7Y DRUGTYPE Antibody D0NW7Y HIGHSTAT Approved D0O5ER DRUG__ID D0O5ER D0O5ER TRADNAME Removab D0O5ER DRUGCOMP Fresenius Biotech D0O5ER DRUGTYPE Monoclonal antibody D0O5ER HIGHSTAT Approved D0P0VD DRUG__ID D0P0VD D0P0VD DRUGINCH 1S/C14H18N4O3.C10H11N3O3S/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2-6H,11H2,1H3,(H,12,13) D0P0VD DRUGINKE WZRJTRPJURQBRM-UHFFFAOYSA-N D0P0VD DRUGSMIL CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N.COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N D0P0VD HIGHSTAT Approved D0P3TX DRUG__ID D0P3TX D0P3TX DRUGCOMP Eli Lilly D0P3TX THERCLAS Anticoagulants D0P3TX DRUGTYPE Monoclonal antibody D0P3TX HIGHSTAT Approved D0PG5G DRUG__ID D0PG5G D0PG5G DRUGCOMP Samsung Bioepsis D0PG5G THERCLAS Immunosuppressive Agents D0PG5G DRUGTYPE Antibody D0PG5G HIGHSTAT Approved D0PG5O DRUG__ID D0PG5O D0PG5O TRADNAME Zynyz D0PG5O DRUGCOMP Incyte D0PG5O DRUGTYPE Antibody D0PG5O HIGHSTAT Approved D0S0BJ DRUG__ID D0S0BJ D0S0BJ TRADNAME Kimmtrak D0S0BJ DRUGCOMP Immunocore D0S0BJ DRUGTYPE Monoclonal antibody D0S0BJ HIGHSTAT Approved D0UI7K DRUG__ID D0UI7K D0UI7K TRADNAME Gamifant D0UI7K DRUGCOMP Novimmune D0UI7K DRUGTYPE Antibody D0UI7K HIGHSTAT Approved D0VH4V DRUG__ID D0VH4V D0VH4V TRADNAME Tzield D0VH4V DRUGCOMP Provention Bio D0VH4V DRUGTYPE Antibody D0VH4V HIGHSTAT Approved D0W2HD DRUG__ID D0W2HD D0W2HD TRADNAME Poteligeo D0W2HD DRUGCOMP Kyowa Hakko Kirin D0W2HD DRUGTYPE Monoclonal antibody D0W2HD HIGHSTAT Approved D0XE0U DRUG__ID D0XE0U D0XE0U DRUGINCH 1S/CH4N2O/c2-1(3)4/h(H4,2,3,4)/i1+2 D0XE0U DRUGINKE XSQUKJJJFZCRTK-NJFSPNSNSA-N D0XE0U DRUGSMIL C(=O)(N)N D0XE0U HIGHSTAT Approved D0XW2H DRUG__ID D0XW2H D0XW2H DRUGCOMP Merck D0XW2H DRUGTYPE Combination drug D0XW2H DRUGSMIL failed D0XW2H HIGHSTAT Approved D0Y1IT DRUG__ID D0Y1IT D0Y1IT DRUGINCH 1S/C7H6O2S.Na/c8-7(9)5-3-1-2-4-6(5)10;/h1-4,10H,(H,8,9);/q;+1/p-1 D0Y1IT DRUGINKE HBAIZOJDXAXWHS-UHFFFAOYSA-M D0Y1IT DRUGSMIL C1=CC=C(C(=C1)C(=O)[O-])S.[Na+] D0Y1IT HIGHSTAT Approved D0YH5F DRUG__ID D0YH5F D0YH5F DRUGCOMP State Research Center of Virology; Biotechnology VECTOR D0YH5F DRUGTYPE Small molecular drug D0YH5F DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)OC3C(OC(C3O)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OC6C(OC(C6O)N7C=CC(=O)NC7=O)COP(=O)(O)OC8C(OC(C8O)N9C=NC1=C9NC(=NC1=O)N)CO)O)O.C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)OP(=O)(O)OCC6C(C(C(O6)N7C=CC(=O)NC7=O)O)OP(=O)(O)OCC8C(C(C(O8)N9C=NC1=C9NC(=NC1=O)N)O)O)O D0YH5F HIGHSTAT Approved D0YM2K DRUG__ID D0YM2K D0YM2K TRADNAME Tecentriq D0YM2K DRUGCOMP Genentech South San Francisco, CA D0YM2K DRUGTYPE Monoclonal antibody D0YM2K HIGHSTAT Approved D0YV4F DRUG__ID D0YV4F D0YV4F TRADNAME Ocrevus D0YV4F DRUGCOMP Roche/Genentech D0YV4F DRUGTYPE Antibody D0YV4F HIGHSTAT Approved D0Z8CQ DRUG__ID D0Z8CQ D0Z8CQ TRADNAME Kevzara D0Z8CQ DRUGCOMP Sanofi/Regeneron D0Z8CQ DRUGTYPE Monoclonal antibody D0Z8CQ HIGHSTAT Approved D2HDB8 DRUG__ID D2HDB8 D2HDB8 TRADNAME Lunsumio D2HDB8 DRUGCOMP Roche/Genentech D2HDB8 DRUGTYPE Antibody D2HDB8 HIGHSTAT Approved D34SXJ DRUG__ID D34SXJ D34SXJ TRADNAME Nexviazyme D34SXJ DRUGCOMP Sanofi D34SXJ DRUGTYPE Recombinant protein D34SXJ HIGHSTAT Approved D3KO5Y DRUG__ID D3KO5Y D3KO5Y TRADNAME Elrexfio D3KO5Y DRUGCOMP Pfzer D3KO5Y DRUGTYPE Antibody D3KO5Y HIGHSTAT Approved D4XBR9 DRUG__ID D4XBR9 D4XBR9 TRADNAME Veopoz D4XBR9 DRUGCOMP Regeneron Pharmaceuticals D4XBR9 DRUGTYPE Antibody D4XBR9 HIGHSTAT Approved D93JXG DRUG__ID D93JXG D93JXG TRADNAME Ngenla D93JXG DRUGCOMP Pfizer D93JXG DRUGTYPE Peptide D93JXG HIGHSTAT Approved D9MWL4 DRUG__ID D9MWL4 D9MWL4 TRADNAME Vabysmo D9MWL4 DRUGCOMP Roche/Genentech D9MWL4 DRUGTYPE Antibody D9MWL4 HIGHSTAT Approved DB4M9J DRUG__ID DB4M9J DB4M9J TRADNAME Epkinly DB4M9J DRUGCOMP Genmab DB4M9J DRUGTYPE Antibody DB4M9J HIGHSTAT Approved DE2CW9 DRUG__ID DE2CW9 DE2CW9 TRADNAME Wainua DE2CW9 DRUGCOMP AstraZeneca DE2CW9 DRUGTYPE Antisense oligonucleotide DE2CW9 HIGHSTAT Approved DGQW52 DRUG__ID DGQW52 DGQW52 TRADNAME Pluvicto DGQW52 DRUGCOMP Novartis DGQW52 DRUGTYPE Radiopharmaceutical therapy agent DGQW52 HIGHSTAT Approved DJ0L4K DRUG__ID DJ0L4K DJ0L4K TRADNAME Enjaymo DJ0L4K DRUGCOMP Bioverativ DJ0L4K DRUGTYPE Antibody DJ0L4K HIGHSTAT Approved DKF7G0 DRUG__ID DKF7G0 DKF7G0 TRADNAME Columvi DKF7G0 DRUGCOMP Roche/Genentech DKF7G0 DRUGTYPE Antibody DKF7G0 HIGHSTAT Approved DMOF95 DRUG__ID DMOF95 DMOF95 TRADNAME Tezspire DMOF95 DRUGCOMP Amgen; AstraZeneca DMOF95 DRUGTYPE Antibody DMOF95 HIGHSTAT Approved DNF95E DRUG__ID DNF95E DNF95E TRADNAME Beyfortus DNF95E DRUGCOMP AstraZeneca DNF95E DRUGTYPE Antibody DNF95E HIGHSTAT Approved DQ5X1Z DRUG__ID DQ5X1Z DQ5X1Z TRADNAME Rybrevant DQ5X1Z DRUGCOMP Janssen Research & Development Raritan, NJ DQ5X1Z DRUGTYPE Antibody DQ5X1Z HIGHSTAT Approved DXR1A6 DRUG__ID DXR1A6 DXR1A6 TRADNAME Talvey DXR1A6 DRUGCOMP JOHNSON & JOHNSON DXR1A6 DRUGTYPE Monoclonal antibody DXR1A6 HIGHSTAT Approved DXRP68 DRUG__ID DXRP68 DXRP68 TRADNAME Amvuttra DXRP68 DRUGCOMP Alnylam Pharmaceuticals DXRP68 DRUGTYPE Small interfering RNA DXRP68 HIGHSTAT Approved DZ8DF0 DRUG__ID DZ8DF0 DZ8DF0 TRADNAME Rivfloza DZ8DF0 DRUGCOMP Novo Nordisk; Dicerna Pharmaceuticals DZ8DF0 DRUGTYPE Small interfering RNA DZ8DF0 HIGHSTAT Approved D00BZJ DRUG__ID D00BZJ D00BZJ DRUGCOMP Wyeth; pfizer D00BZJ DRUGTYPE Vaccine D00BZJ HIGHSTAT Approved D00COJ DRUG__ID D00COJ D00COJ TRADNAME Leqvio D00COJ DRUGCOMP Novartis/Alnylam D00COJ HIGHSTAT Approved D00GNI DRUG__ID D00GNI D00GNI DRUGCOMP Sanofi; Novo Nordisk D00GNI DRUGTYPE Antibody D00GNI HIGHSTAT Approved D00GOV DRUG__ID D00GOV D00GOV DRUGCOMP Bristol-Myers Squibb D00GOV DRUGTYPE Monoclonal antibody D00GOV HIGHSTAT Approved D00OTT DRUG__ID D00OTT D00OTT DRUGCOMP Isis Pharmaceuticals D00OTT DRUGTYPE Antisense drug D00OTT HIGHSTAT Approved D00RRU DRUG__ID D00RRU D00RRU TRADNAME Aduhelm D00RRU DRUGCOMP Biogen/Eisai D00RRU HIGHSTAT Approved D01RQV DRUG__ID D01RQV D01RQV DRUGCOMP Alexion Pharmaceuticals Inc D01RQV DRUGTYPE Monoclonal antibody D01RQV HIGHSTAT Approved D01SAY DRUG__ID D01SAY D01SAY TRADNAME Provenge D01SAY DRUGCOMP Dendreon D01SAY HIGHSTAT Approved D01TWG DRUG__ID D01TWG D01TWG TRADNAME Rystiggo D01TWG DRUGCOMP UCB Smyrna, GA D01TWG HIGHSTAT Approved D01VEJ DRUG__ID D01VEJ D01VEJ TRADNAME Revcovi D01VEJ DRUGCOMP Leadiant Biosciences D01VEJ HIGHSTAT Approved D01XCL DRUG__ID D01XCL D01XCL DRUGCOMP Medpointe Pharmaceuticals Medpointe Healthcare Inc D01XCL THERCLAS Cardiovascular Agents D01XCL HIGHSTAT Approved D01YYP DRUG__ID D01YYP D01YYP DRUGCOMP Macrogenics D01YYP DRUGTYPE Antibody D01YYP HIGHSTAT Approved D02DES DRUG__ID D02DES D02DES DRUGCOMP Amgen Inc D02DES THERCLAS Antiinflammatory Agents D02DES HIGHSTAT Approved D02FXK DRUG__ID D02FXK D02FXK DRUGCOMP Allergan Inc D02FXK THERCLAS Antidystonic Agents D02FXK HIGHSTAT Approved D02JDL DRUG__ID D02JDL D02JDL DRUGCOMP Concordia Laboratories Inc D02JDL DRUGTYPE Small molecular drug D02JDL HIGHSTAT Approved D02JRT DRUG__ID D02JRT D02JRT DRUGCOMP Centocor Ortho Biotech Inc D02JRT DRUGTYPE Monoclonal antibody D02JRT HIGHSTAT Approved D02JYA DRUG__ID D02JYA D02JYA DRUGCOMP GlaxoSmithKline D02JYA DRUGTYPE Monoclonal antibody D02JYA HIGHSTAT Approved D02KSP DRUG__ID D02KSP D02KSP DRUGCOMP BeiGene D02KSP DRUGTYPE Monoclonal antibody D02KSP HIGHSTAT Approved D02LVZ DRUG__ID D02LVZ D02LVZ DRUGCOMP Amgen Inc D02LVZ THERCLAS Antianemic Agents D02LVZ HIGHSTAT Approved D02QQT DRUG__ID D02QQT D02QQT DRUGCOMP Chiron Corp D02QQT DRUGTYPE Vaccine D02QQT HIGHSTAT Approved D02YQB DRUG__ID D02YQB D02YQB DRUGCOMP Sanofi D02YQB DRUGTYPE Vaccine D02YQB HIGHSTAT Approved D03AFF DRUG__ID D03AFF D03AFF TRADNAME Tecvayli D03AFF DRUGCOMP Janssen Research & Development Raritan, NJ D03AFF HIGHSTAT Approved D03LWO DRUG__ID D03LWO D03LWO DRUGCOMP Valeant Pharmaceuticals North America Llc D03LWO THERCLAS Cardiovascular Agents D03LWO HIGHSTAT Approved D03MTN DRUG__ID D03MTN D03MTN DRUGCOMP MedImmune D03MTN DRUGTYPE Monoclonal antibody D03MTN HIGHSTAT Approved D03NPI DRUG__ID D03NPI D03NPI DRUGCOMP Celgene D03NPI DRUGTYPE CAR T Cell Therapy D03NPI HIGHSTAT Approved D03TIS DRUG__ID D03TIS D03TIS DRUGCOMP Millennium Pharmaceuticals; Seattle Genetics D03TIS DRUGTYPE Monoclonal antibody D03TIS HIGHSTAT Approved D03WPP DRUG__ID D03WPP D03WPP DRUGCOMP Lilly D03WPP DRUGTYPE Monoclonal antibody D03WPP HIGHSTAT Approved D04CKG DRUG__ID D04CKG D04CKG TRADNAME Rolvedon D04CKG DRUGCOMP Spectrum D04CKG HIGHSTAT Approved D04EYG DRUG__ID D04EYG D04EYG DRUGCOMP Genentech Inc D04EYG DRUGTYPE Antibody D04EYG HIGHSTAT Approved D04KBL DRUG__ID D04KBL D04KBL DRUGCOMP University of London D04KBL DRUGTYPE Monoclonal antibody D04KBL HIGHSTAT Approved D04RZD DRUG__ID D04RZD D04RZD DRUGCOMP Schering-Plough D04RZD THERCLAS Anticancer Agents D04RZD HIGHSTAT Approved D04SOA DRUG__ID D04SOA D04SOA DRUGCOMP Sinovac Biotech Ltd D04SOA DRUGTYPE Vaccine D04SOA HIGHSTAT Approved D05BKS DRUG__ID D05BKS D05BKS DRUGCOMP YM Biosciences D05BKS DRUGTYPE Monoclonal antibody D05BKS HIGHSTAT Approved D05DZR DRUG__ID D05DZR D05DZR DRUGCOMP Bristol-Myers Squibb D05DZR DRUGTYPE Antibody D05DZR HIGHSTAT Approved D05IQX DRUG__ID D05IQX D05IQX DRUGCOMP GSK D05IQX DRUGTYPE Antibody D05IQX HIGHSTAT Approved D05MZI DRUG__ID D05MZI D05MZI DRUGCOMP Biogen/Ionis Pharmaceuticals D05MZI DRUGTYPE Antisense drug D05MZI HIGHSTAT Approved D05NDR DRUG__ID D05NDR D05NDR DRUGCOMP AstraZeneca; MedImmune D05NDR DRUGTYPE Antibody D05NDR HIGHSTAT Approved D05PUD DRUG__ID D05PUD D05PUD DRUGCOMP Chiron D05PUD THERCLAS Anticancer Agents D05PUD HIGHSTAT Approved D05QOL DRUG__ID D05QOL D05QOL DRUGCOMP Genentech D05QOL DRUGTYPE Antibody D05QOL HIGHSTAT Approved D05TJR DRUG__ID D05TJR D05TJR DRUGCOMP Novartis Vaccines & Diagnostics D05TJR DRUGTYPE Vaccine D05TJR HIGHSTAT Approved D05UEI DRUG__ID D05UEI D05UEI DRUGCOMP CIS Bio international D05UEI DRUGTYPE Monoclonal antibody D05UEI HIGHSTAT Approved D06BHB DRUG__ID D06BHB D06BHB DRUGCOMP Daiichi Sankyo Basking Ridge, NJ D06BHB DRUGTYPE Antibody drug conjugate D06BHB HIGHSTAT Approved D06LDT DRUG__ID D06LDT D06LDT TRADNAME Annovera D06LDT DRUGCOMP TherapeuticsMD D06LDT HIGHSTAT Approved D06URS DRUG__ID D06URS D06URS THERCLAS Diagnostic Agents D06URS DRUGTYPE Antibody D06URS HIGHSTAT Approved D06XVR DRUG__ID D06XVR D06XVR TRADNAME Leqembi D06XVR DRUGCOMP Eisai/Biogen D06XVR HIGHSTAT Approved D07BQE DRUG__ID D07BQE D07BQE DRUGCOMP Boehringer Ingelheim Ltd D07BQE THERCLAS Thrombolytic Agents D07BQE HIGHSTAT Approved D07BUH DRUG__ID D07BUH D07BUH TRADNAME Ryzneuta D07BUH DRUGCOMP Evive D07BUH HIGHSTAT Approved D07BVI DRUG__ID D07BVI D07BVI DRUGCOMP Bristol-Myers Squibb D07BVI DRUGTYPE Monoclonal antibody D07BVI HIGHSTAT Approved D07DMY DRUG__ID D07DMY D07DMY DRUGCOMP Merck D07DMY DRUGTYPE Monoclonal antibody D07DMY HIGHSTAT Approved D07DUU DRUG__ID D07DUU D07DUU DRUGCOMP Genzyme Corporation D07DUU THERCLAS Enzyme Replacement Agents D07DUU HIGHSTAT Approved D07GAA DRUG__ID D07GAA D07GAA TRADNAME Skytrofa D07GAA DRUGCOMP Ascendis Pharma D07GAA HIGHSTAT Approved D07NJN DRUG__ID D07NJN D07NJN DRUGCOMP Janssen Biotech D07NJN DRUGTYPE Antibody D07NJN HIGHSTAT Approved D07PBZ DRUG__ID D07PBZ D07PBZ DRUGCOMP Amgen Inc D07PBZ THERCLAS Antianemic Agents D07PBZ HIGHSTAT Approved D07WLI DRUG__ID D07WLI D07WLI DRUGCOMP Palatin Technologies D07WLI DRUGTYPE Antibody D07WLI HIGHSTAT Approved D07WXH DRUG__ID D07WXH D07WXH DRUGCOMP GlaxoSmithKline plc D07WXH DRUGTYPE Vaccine D07WXH HIGHSTAT Approved D08ANZ DRUG__ID D08ANZ D08ANZ DRUGCOMP Merck Kenilworth, NJ D08ANZ DRUGTYPE Monoclonal antibody D08ANZ HIGHSTAT Approved D08HPZ DRUG__ID D08HPZ D08HPZ DRUGCOMP Roche; Genentech D08HPZ DRUGTYPE Monoclonal antibody D08HPZ HIGHSTAT Approved D08LEY DRUG__ID D08LEY D08LEY TRADNAME Takhzyro D08LEY DRUGCOMP Dyax/Shire D08LEY HIGHSTAT Approved D08NMV DRUG__ID D08NMV D08NMV DRUGCOMP Eli Lilly D08NMV DRUGTYPE Monoclonal antibody D08NMV HIGHSTAT Approved D08NWC DRUG__ID D08NWC D08NWC DRUGCOMP Schering-Plough D08NWC THERCLAS Antiviral Agents D08NWC HIGHSTAT Approved D08WSY DRUG__ID D08WSY D08WSY DRUGCOMP Amgen D08WSY DRUGTYPE Antibody D08WSY HIGHSTAT Approved D09AWJ DRUG__ID D09AWJ D09AWJ DRUGCOMP Glaxosmithkline; novavax; vaxart D09AWJ DRUGTYPE Vaccine D09AWJ HIGHSTAT Approved D09FSG DRUG__ID D09FSG D09FSG DRUGCOMP Takeda D09FSG DRUGTYPE Antibody D09FSG HIGHSTAT Approved D09HVD DRUG__ID D09HVD D09HVD DRUGCOMP Lilly D09HVD DRUGTYPE Monoclonal antibody D09HVD HIGHSTAT Approved D09KRE DRUG__ID D09KRE D09KRE DRUGCOMP Merck & Co. D09KRE DRUGTYPE Monoclonal antibody D09KRE HIGHSTAT Approved D09PGL DRUG__ID D09PGL D09PGL THERCLAS Imaging Agents D09PGL DRUGTYPE Antibody D09PGL HIGHSTAT Approved D09QZS DRUG__ID D09QZS D09QZS DRUGCOMP Eli Lilly D09QZS DRUGTYPE Monoclonal antibody D09QZS HIGHSTAT Approved D09VOS DRUG__ID D09VOS D09VOS DRUGCOMP Elusys Therapeutics D09VOS DRUGTYPE Antibody D09VOS HIGHSTAT Approved D0A2GM DRUG__ID D0A2GM D0A2GM DRUGCOMP Sanofi Aventis Us Llc D0A2GM THERCLAS Cardiovascular Agents D0A2GM HIGHSTAT Approved D0A2UV DRUG__ID D0A2UV D0A2UV DRUGCOMP Centocor Ortho Biotech D0A2UV DRUGTYPE Antibody D0A2UV HIGHSTAT Approved D0A4GQ DRUG__ID D0A4GQ D0A4GQ TRADNAME Tivdak D0A4GQ DRUGCOMP Seagen/Genmab D0A4GQ HIGHSTAT Approved D0AZ8Y DRUG__ID D0AZ8Y D0AZ8Y DRUGCOMP Centocor Ortho Biotech Inc D0AZ8Y DRUGTYPE Monoclonal antibody D0AZ8Y HIGHSTAT Approved D0B6GW DRUG__ID D0B6GW D0B6GW DRUGCOMP Finlay Institute D0B6GW DRUGTYPE Vaccine D0B6GW HIGHSTAT Approved D0B9FW DRUG__ID D0B9FW D0B9FW DRUGCOMP Boehringer Ingelheim D0B9FW DRUGTYPE Antibody D0B9FW HIGHSTAT Approved D0BI1C DRUG__ID D0BI1C D0BI1C DRUGCOMP St Petersburg Institute of Experimental Medicine D0BI1C DRUGTYPE Vaccine D0BI1C HIGHSTAT Approved D0C6KK DRUG__ID D0C6KK D0C6KK TRADNAME Daxxify D0C6KK DRUGCOMP Revance D0C6KK HIGHSTAT Approved D0CA0P DRUG__ID D0CA0P D0CA0P DRUGCOMP UCB D0CA0P DRUGTYPE Monoclonal antibody D0CA0P HIGHSTAT Approved D0CI4E DRUG__ID D0CI4E D0CI4E DRUGCOMP Roche; Genentech D0CI4E DRUGTYPE Monoclonal antibody D0CI4E HIGHSTAT Approved D0D6NQ DRUG__ID D0D6NQ D0D6NQ DRUGCOMP Beijing Wantai Biological Pharmacy Enterprise Co Ltd D0D6NQ DRUGTYPE Vaccine D0D6NQ HIGHSTAT Approved D0D6VE DRUG__ID D0D6VE D0D6VE DRUGCOMP Abbott Laboratories D0D6VE THERCLAS Anabolic Agents D0D6VE HIGHSTAT Approved D0E3RC DRUG__ID D0E3RC D0E3RC DRUGCOMP Immunomedics Inc D0E3RC DRUGTYPE Monoclonal antibody D0E3RC HIGHSTAT Approved D0E7QB DRUG__ID D0E7QB D0E7QB TRADNAME Omvoh D0E7QB DRUGCOMP Eli Lilly Indianapolis, IN D0E7QB HIGHSTAT Approved D0EW4L DRUG__ID D0EW4L D0EW4L DRUGCOMP Bristol-Myers Squibb D0EW4L THERCLAS Antirheumatic Agents D0EW4L HIGHSTAT Approved D0F0RR DRUG__ID D0F0RR D0F0RR DRUGCOMP GlaxoSmithKline plc D0F0RR DRUGTYPE Vaccine D0F0RR HIGHSTAT Approved D0F7AT DRUG__ID D0F7AT D0F7AT DRUGCOMP Medpointe Pharmaceuticals Medpointe Healthcare Inc D0F7AT THERCLAS Cardiovascular Agents D0F7AT HIGHSTAT Approved D0FU8R DRUG__ID D0FU8R D0FU8R TRADNAME Saphnelo D0FU8R DRUGCOMP AstraZeneca D0FU8R HIGHSTAT Approved D0GP8Q DRUG__ID D0GP8Q D0GP8Q TRADNAME Skyrizi D0GP8Q DRUGCOMP AbbVie North Chicago, IL Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D0GP8Q HIGHSTAT Approved D0I4EL DRUG__ID D0I4EL D0I4EL DRUGCOMP IMTIX-Sangstat D0I4EL DRUGTYPE Monoclonal antibody D0I4EL HIGHSTAT Approved D0I5QX DRUG__ID D0I5QX D0I5QX DRUGCOMP AstraZeneca D0I5QX DRUGTYPE Monoclonal antibody D0I5QX HIGHSTAT Approved D0J3RY DRUG__ID D0J3RY D0J3RY DRUGCOMP Louisville D0J3RY THERCLAS Anticancer Agents D0J3RY HIGHSTAT Approved D0JE4D DRUG__ID D0JE4D D0JE4D DRUGCOMP Genentech D0JE4D THERCLAS Enzyme Replacement Agents D0JE4D HIGHSTAT Approved D0K3LO DRUG__ID D0K3LO D0K3LO DRUGCOMP Amgen D0K3LO DRUGTYPE Antibody D0K3LO HIGHSTAT Approved D0K4RK DRUG__ID D0K4RK D0K4RK DRUGCOMP Amgen D0K4RK DRUGTYPE Monoclonal antibody D0K4RK HIGHSTAT Approved D0KX1Y DRUG__ID D0KX1Y D0KX1Y TRADNAME Aimovig D0KX1Y DRUGCOMP Amgen/Novartis D0KX1Y HIGHSTAT Approved D0M1PR DRUG__ID D0M1PR D0M1PR DRUGCOMP Pfizer Vaccines D0M1PR DRUGTYPE Vaccine D0M1PR HIGHSTAT Approved D0M4WU DRUG__ID D0M4WU D0M4WU DRUGCOMP Celgene D0M4WU DRUGTYPE CAR T Cell Therapy D0M4WU HIGHSTAT Approved D0M7XS DRUG__ID D0M7XS D0M7XS DRUGCOMP Pfizer Pharmaceuticals D0M7XS THERCLAS Immunomodulatory Agents D0M7XS HIGHSTAT Approved D0N5ZS DRUG__ID D0N5ZS D0N5ZS DRUGCOMP Millennium Pharmaceuticals D0N5ZS DRUGTYPE Monoclonal antibody D0N5ZS HIGHSTAT Approved D0O4FF DRUG__ID D0O4FF D0O4FF TRADNAME NexoBrid D0O4FF DRUGCOMP Mediwound D0O4FF HIGHSTAT Approved D0O4RQ DRUG__ID D0O4RQ D0O4RQ DRUGCOMP Novartis AG D0O4RQ DRUGTYPE Vaccine D0O4RQ HIGHSTAT Approved D0O8KX DRUG__ID D0O8KX D0O8KX DRUGCOMP Teva D0O8KX DRUGTYPE Monoclonal antibody D0O8KX HIGHSTAT Approved D0OY4K DRUG__ID D0OY4K D0OY4K TRADNAME Mepsevii D0OY4K DRUGCOMP Ultragenyx D0OY4K HIGHSTAT Approved D0OZ4J DRUG__ID D0OZ4J D0OZ4J DRUGCOMP Genentech D0OZ4J DRUGTYPE Monoclonal antibody D0OZ4J HIGHSTAT Approved D0P0LD DRUG__ID D0P0LD D0P0LD TRADNAME Vyvgart D0P0LD DRUGCOMP Argenx D0P0LD HIGHSTAT Approved D0P1BZ DRUG__ID D0P1BZ D0P1BZ DRUGCOMP Biogen D0P1BZ DRUGTYPE Monoclonal antibody D0P1BZ HIGHSTAT Approved D0P3SY DRUG__ID D0P3SY D0P3SY DRUGCOMP Schering-Plough D0P3SY THERCLAS Anticoagulants D0P3SY HIGHSTAT Approved D0P4DJ DRUG__ID D0P4DJ D0P4DJ DRUGCOMP Pfizer Pharmaceuticals D0P4DJ THERCLAS Hormone Replacement Agents D0P4DJ HIGHSTAT Approved D0P5LH DRUG__ID D0P5LH D0P5LH TRADNAME Empaveli D0P5LH DRUGCOMP Apellis Pharmaceuticals D0P5LH HIGHSTAT Approved D0PG0G DRUG__ID D0PG0G D0PG0G DRUGCOMP Eli Lilly D0PG0G THERCLAS Antisepsis Agents D0PG0G HIGHSTAT Approved D0Q0OD DRUG__ID D0Q0OD D0Q0OD DRUGCOMP National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) D0Q0OD DRUGTYPE Monoclonal antibody D0Q0OD HIGHSTAT Approved D0R2RR DRUG__ID D0R2RR D0R2RR DRUGCOMP Novartis Vaccines Institute for Global Health D0R2RR DRUGTYPE Vaccine D0R2RR HIGHSTAT Approved D0R3PY DRUG__ID D0R3PY D0R3PY DRUGCOMP MorphoSys; Xenvor D0R3PY DRUGTYPE Antibody D0R3PY HIGHSTAT Approved D0R7NI DRUG__ID D0R7NI D0R7NI TRADNAME Elzonris D0R7NI DRUGCOMP Stemline Therapeutics D0R7NI HIGHSTAT Approved D0RV4P DRUG__ID D0RV4P D0RV4P DRUGCOMP Genmab Princeton, NJ D0RV4P DRUGTYPE Antibody D0RV4P HIGHSTAT Approved D0S0WR DRUG__ID D0S0WR D0S0WR TRADNAME Reblozyl D0S0WR DRUGCOMP Acceleron Pharma Cambridge, MA Celgene Summit, NJ D0S0WR HIGHSTAT Approved D0S8WA DRUG__ID D0S8WA D0S8WA DRUGCOMP Biogen Idec; Genentech D0S8WA DRUGTYPE Antibody D0S8WA HIGHSTAT Approved D0S9WB DRUG__ID D0S9WB D0S9WB TRADNAME Orkambi D0S9WB DRUGCOMP Vertex D0S9WB HIGHSTAT Approved D0T1IJ DRUG__ID D0T1IJ D0T1IJ DRUGCOMP Wyeth Pharmaceuticals D0T1IJ THERCLAS Anticoagulants D0T1IJ HIGHSTAT Approved D0T5QT DRUG__ID D0T5QT D0T5QT DRUGCOMP Ortho-McNeil Pharmaceutical D0T5QT THERCLAS Antiulcer Agents D0T5QT HIGHSTAT Approved D0TD2G DRUG__ID D0TD2G D0TD2G DRUGCOMP Novartis D0TD2G DRUGTYPE Antibody D0TD2G HIGHSTAT Approved D0TL1L DRUG__ID D0TL1L D0TL1L DRUGCOMP GlaxoSmithKline Biologicals D0TL1L DRUGTYPE Vaccine D0TL1L HIGHSTAT Approved D0V4JQ DRUG__ID D0V4JQ D0V4JQ THERCLAS Immunomodulatory Agents D0V4JQ DRUGTYPE Protein/peptide drug D0V4JQ HIGHSTAT Approved D0V6RC DRUG__ID D0V6RC D0V6RC THERCLAS Imaging Agents D0V6RC DRUGTYPE Monoclonal antibody D0V6RC HIGHSTAT Approved D0W8HN DRUG__ID D0W8HN D0W8HN DRUGCOMP EMD Serono Rockland, MA Pfizer New York, NY D0W8HN DRUGTYPE Monoclonal antibody D0W8HN HIGHSTAT Approved D0W9OR DRUG__ID D0W9OR D0W9OR THERCLAS Vaccines D0W9OR DRUGTYPE Vaccine D0W9OR HIGHSTAT Approved D0W9YW DRUG__ID D0W9YW D0W9YW TRADNAME Spevigo D0W9YW DRUGCOMP Boehringer Ingelheim D0W9YW HIGHSTAT Approved D0WJ5M DRUG__ID D0WJ5M D0WJ5M TRADNAME Bimzelx D0WJ5M DRUGCOMP UCB Atlanta, GA D0WJ5M HIGHSTAT Approved D0XT5Y DRUG__ID D0XT5Y D0XT5Y DRUGCOMP Bayer Pharmaceuticals Corporation D0XT5Y THERCLAS Immunomodulatory Agents D0XT5Y HIGHSTAT Approved D0Y2FY DRUG__ID D0Y2FY D0Y2FY DRUGCOMP Glaxosmithkline D0Y2FY THERCLAS Antiinfective Agents D0Y2FY HIGHSTAT Approved D0Y2MC DRUG__ID D0Y2MC D0Y2MC DRUGCOMP 3m Pharmaceuticals Inc D0Y2MC THERCLAS Cardiovascular Agents D0Y2MC HIGHSTAT Approved D0Y6NL DRUG__ID D0Y6NL D0Y6NL DRUGCOMP GlaxoSmithKline plc D0Y6NL DRUGTYPE Vaccine D0Y6NL HIGHSTAT Approved D0Y6QC DRUG__ID D0Y6QC D0Y6QC DRUGCOMP Astrazeneca D0Y6QC DRUGTYPE Small molecular drug D0Y6QC HIGHSTAT Approved D0Y8KN DRUG__ID D0Y8KN D0Y8KN DRUGCOMP Novartis Pharmaceuticals D0Y8KN DRUGTYPE Monoclonal antibody D0Y8KN HIGHSTAT Approved D0Y8OK DRUG__ID D0Y8OK D0Y8OK DRUGCOMP Hoffmann-La Roche pharmaceutical company D0Y8OK THERCLAS Anticancer Agents D0Y8OK HIGHSTAT Approved D0Y8ZN DRUG__ID D0Y8ZN D0Y8ZN DRUGCOMP GlaxoSmithKline D0Y8ZN DRUGTYPE Antibody D0Y8ZN HIGHSTAT Approved D0YM7U DRUG__ID D0YM7U D0YM7U DRUGCOMP Genentech D0YM7U DRUGTYPE Antibody D0YM7U HIGHSTAT Approved D0YX3D DRUG__ID D0YX3D D0YX3D TRADNAME Xenpozyme D0YX3D DRUGCOMP Sanofi/Genzyme D0YX3D HIGHSTAT Approved D0Z4BH DRUG__ID D0Z4BH D0Z4BH DRUGCOMP Novartis AG D0Z4BH DRUGTYPE Vaccine D0Z4BH HIGHSTAT Approved D18SHN DRUG__ID D18SHN D18SHN DRUGCOMP Gilead Sciences; Kite Pharma D18SHN DRUGTYPE CAR T Cell Therapy D18SHN HIGHSTAT Approved D2G4HB DRUG__ID D2G4HB D2G4HB DRUGCOMP MYR Pharma D2G4HB DRUGTYPE Peptide D2G4HB HIGHSTAT Approved D3LWJ7 DRUG__ID D3LWJ7 D3LWJ7 DRUGCOMP Novartis D3LWJ7 DRUGTYPE Monoclonal antibody D3LWJ7 HIGHSTAT Approved D3UG0T DRUG__ID D3UG0T D3UG0T DRUGCOMP BTG D3UG0T DRUGTYPE Radiopharmaceutical therapy agent D3UG0T HIGHSTAT Approved D4Y0SB DRUG__ID D4Y0SB D4Y0SB DRUGCOMP Vonvendi D4Y0SB DRUGTYPE Recombinant protein D4Y0SB HIGHSTAT Approved D5DO9L DRUG__ID D5DO9L D5DO9L DRUGCOMP Alcon D5DO9L DRUGTYPE Antibody D5DO9L HIGHSTAT Approved D67KYA DRUG__ID D67KYA D67KYA TRADNAME Pombiliti D67KYA DRUGCOMP Amicus D67KYA HIGHSTAT Approved D71UXY DRUG__ID D71UXY D71UXY DRUGCOMP Pfzer D71UXY DRUGTYPE Vaccine D71UXY HIGHSTAT Approved D75AZJ DRUG__ID D75AZJ D75AZJ TRADNAME Izervay D75AZJ DRUGCOMP Iveric/Astellas D75AZJ HIGHSTAT Approved D8B9KJ DRUG__ID D8B9KJ D8B9KJ DRUGCOMP Bayer D8B9KJ DRUGTYPE Recombinant protein D8B9KJ HIGHSTAT Approved D8L5PA DRUG__ID D8L5PA D8L5PA DRUGCOMP ADC Therapeutics D8L5PA DRUGTYPE Antibody drug conjugate D8L5PA HIGHSTAT Approved D8MNH5 DRUG__ID D8MNH5 D8MNH5 DRUGCOMP Amgen D8MNH5 DRUGTYPE Monoclonal antibody D8MNH5 HIGHSTAT Approved D92OCI DRUG__ID D92OCI D92OCI DRUGCOMP Coherus Biosciences D92OCI DRUGTYPE Monoclonal antibody D92OCI HIGHSTAT Approved in China D96DLV DRUG__ID D96DLV D96DLV TRADNAME Lamzede D96DLV DRUGCOMP Chiesi D96DLV HIGHSTAT Approved D98EUL DRUG__ID D98EUL D98EUL DRUGCOMP GlaxoSmithKline D98EUL DRUGTYPE Antibody D98EUL HIGHSTAT Approved in EU D9EC0G DRUG__ID D9EC0G D9EC0G DRUGCOMP CSL Behring D9EC0G DRUGTYPE Recombinant protein D9EC0G HIGHSTAT Approved DA69JF DRUG__ID DA69JF DA69JF TRADNAME Mounjaro DA69JF DRUGCOMP Eli Lilly DA69JF HIGHSTAT Approved DAG87H DRUG__ID DAG87H DAG87H DRUGCOMP Astellas DAG87H DRUGTYPE Antibody drug conjugate DAG87H HIGHSTAT Approved DD1GK8 DRUG__ID DD1GK8 DD1GK8 DRUGCOMP Alnylam Pharmaceuticals DD1GK8 DRUGTYPE Small interfering RNA DD1GK8 HIGHSTAT Approved DD8QK9 DRUG__ID DD8QK9 DD8QK9 DRUGCOMP GlaxoSmithKline DD8QK9 DRUGTYPE Vaccine DD8QK9 HIGHSTAT Approved DDZ48Y DRUG__ID DDZ48Y DDZ48Y DRUGCOMP EQRx DDZ48Y DRUGTYPE Monoclonal antibody DDZ48Y HIGHSTAT Approved in China DF2C7K DRUG__ID DF2C7K DF2C7K DRUGCOMP GlaxoSmithKline DF2C7K DRUGTYPE Vaccine DF2C7K HIGHSTAT Approved DFLK16 DRUG__ID DFLK16 DFLK16 DRUGCOMP Innovent Biologics DFLK16 DRUGTYPE Antibody DFLK16 HIGHSTAT Approved DFN1D5 DRUG__ID DFN1D5 DFN1D5 TRADNAME Quviviq DFN1D5 DRUGCOMP Idorsia DFN1D5 HIGHSTAT Approved DGQU43 DRUG__ID DGQU43 DGQU43 DRUGCOMP AnaptysBio; GlaxoSmithKline DGQU43 DRUGTYPE Antibody DGQU43 HIGHSTAT Approved DGWE36 DRUG__ID DGWE36 DGWE36 DRUGCOMP CDH Genetech/Sirtex DGWE36 DRUGTYPE Radiopharmaceutical therapy agent DGWE36 HIGHSTAT Approved DMU9P2 DRUG__ID DMU9P2 DMU9P2 DRUGCOMP Sanofi DMU9P2 DRUGTYPE Protein DMU9P2 HIGHSTAT Approved DORB45 DRUG__ID DORB45 DORB45 DRUGCOMP Astellas Northbrook, IL Seattle Genetics Bothell, WA DORB45 DRUGTYPE Antibody drug conjugate DORB45 HIGHSTAT Approved DP07NC DRUG__ID DP07NC DP07NC DRUGCOMP AveXis DP07NC DRUGTYPE Gene therapy DP07NC HIGHSTAT Approved DP3Q0C DRUG__ID DP3Q0C DP3Q0C DRUGCOMP Seqirus DP3Q0C DRUGTYPE Vaccine DP3Q0C HIGHSTAT Approved DP4O5R DRUG__ID DP4O5R DP4O5R DRUGCOMP GlaxoSmithKline DP4O5R DRUGTYPE Vaccine DP4O5R HIGHSTAT Approved in EU DQ4TO3 DRUG__ID DQ4TO3 DQ4TO3 DRUGCOMP Orchard Therapeutics DQ4TO3 DRUGTYPE Gene therapy DQ4TO3 HIGHSTAT Approved DSD9Z8 DRUG__ID DSD9Z8 DSD9Z8 TRADNAME Miebo DSD9Z8 DRUGCOMP Bausc; Lomb DSD9Z8 HIGHSTAT Approved DU47SF DRUG__ID DU47SF DU47SF DRUGCOMP Novartis DU47SF DRUGTYPE Antibody DU47SF HIGHSTAT Approved DV87CQ DRUG__ID DV87CQ DV87CQ TRADNAME Xdemvy DV87CQ DRUGCOMP Tarsus DV87CQ HIGHSTAT Approved DW7EN6 DRUG__ID DW7EN6 DW7EN6 DRUGCOMP Amicus Therapeutics DW7EN6 DRUGTYPE Enzyme replacement DW7EN6 HIGHSTAT Approved in EU DX02MF DRUG__ID DX02MF DX02MF DRUGCOMP GlaxoSmithKline DX02MF DRUGTYPE Vaccine DX02MF HIGHSTAT Approved DY49OT DRUG__ID DY49OT DY49OT DRUGCOMP AstraZeneca DY49OT DRUGTYPE Recombinant protein DY49OT HIGHSTAT Approved DZA90G DRUG__ID DZA90G DZA90G DRUGCOMP BioNTech DZA90G DRUGTYPE Vaccine DZA90G HIGHSTAT Approved D00ALE DRUG__ID D00ALE D00ALE DRUGCOMP Sanofi Pasteur D00ALE HIGHSTAT Approved D00ASJ DRUG__ID D00ASJ D00ASJ DRUGCOMP SmithKline Beecham plc D00ASJ HIGHSTAT Approved D00CEE DRUG__ID D00CEE D00CEE DRUGCOMP Sanofi Pasteur MSD D00CEE HIGHSTAT Approved D00DCY DRUG__ID D00DCY D00DCY DRUGCOMP Zila D00DCY HIGHSTAT Approved D00FIX DRUG__ID D00FIX D00FIX DRUGCOMP Genzyme D00FIX HIGHSTAT Approved D00HEN DRUG__ID D00HEN D00HEN DRUGCOMP Lanzhou Institute of Biological Products D00HEN HIGHSTAT Approved D00IDP DRUG__ID D00IDP D00IDP DRUGCOMP Biora AB D00IDP HIGHSTAT Approved D00OGX DRUG__ID D00OGX D00OGX DRUGCOMP ASAC Pharmaceutical International AIE D00OGX HIGHSTAT Approved D00PJY DRUG__ID D00PJY D00PJY DRUGCOMP Cypress Bioscience Inc D00PJY HIGHSTAT Approved D00SGD DRUG__ID D00SGD D00SGD DRUGCOMP Sanofi Pasteur D00SGD HIGHSTAT Approved D00TCM DRUG__ID D00TCM D00TCM DRUGCOMP Berna Biotech D00TCM HIGHSTAT Approved D00USS DRUG__ID D00USS D00USS DRUGCOMP Avant Immunotherapeutics D00USS HIGHSTAT Approved D00XZY DRUG__ID D00XZY D00XZY DRUGCOMP VABIOTECH D00XZY HIGHSTAT Approved D01CZH DRUG__ID D01CZH D01CZH DRUGCOMP Wolwo Biotech Co Ltd D01CZH HIGHSTAT Approved D01EHI DRUG__ID D01EHI D01EHI DRUGCOMP Medlmmune LLC D01EHI HIGHSTAT Approved D01FWE DRUG__ID D01FWE D01FWE DRUGCOMP North American Vaccine Inc D01FWE HIGHSTAT Approved D01GPA DRUG__ID D01GPA D01GPA DRUGCOMP Immutic Group D01GPA HIGHSTAT Approved D01HRJ DRUG__ID D01HRJ D01HRJ DRUGCOMP BIKEN D01HRJ HIGHSTAT Approved D01ILJ DRUG__ID D01ILJ D01ILJ DRUGCOMP Baxter International Inc D01ILJ HIGHSTAT Approved D01NTO DRUG__ID D01NTO D01NTO DRUGCOMP Finlay Institute D01NTO HIGHSTAT Approved D01OGL DRUG__ID D01OGL D01OGL DRUGCOMP Mallinckrodt Medical Inc D01OGL HIGHSTAT Approved D01PQM DRUG__ID D01PQM D01PQM DRUGCOMP DynPort Vaccine Company LLC D01PQM HIGHSTAT Approved D01RLG DRUG__ID D01RLG D01RLG DRUGCOMP Astellas Pharma Inc D01RLG HIGHSTAT Approved D01XAJ DRUG__ID D01XAJ D01XAJ DRUGCOMP CSL Ltd D01XAJ HIGHSTAT Approved D01XTN DRUG__ID D01XTN D01XTN DRUGCOMP Berna Biotech AG D01XTN HIGHSTAT Approved D01YQH DRUG__ID D01YQH D01YQH DRUGCOMP Stem Cell Therapeutics Corp D01YQH HIGHSTAT Approved D02BLO DRUG__ID D02BLO D02BLO DRUGCOMP Cook Imaging Inc; GE Healthcare D02BLO HIGHSTAT Approved D02BTZ DRUG__ID D02BTZ D02BTZ DRUGCOMP SmithKline Beecham plc D02BTZ HIGHSTAT Approved D02CKO DRUG__ID D02CKO D02CKO DRUGCOMP GlaxoSmithKline D02CKO HIGHSTAT Approved D02DNA DRUG__ID D02DNA D02DNA DRUGCOMP S.Biomedics Co Ltd D02DNA HIGHSTAT Approved D02GDN DRUG__ID D02GDN D02GDN DRUGCOMP CSL Behring D02GDN HIGHSTAT Approved D02GOG DRUG__ID D02GOG D02GOG DRUGCOMP ALTANA Pharma AG D02GOG HIGHSTAT Approved D02GTV DRUG__ID D02GTV D02GTV DRUGCOMP Aventis SA D02GTV HIGHSTAT Approved D02HNF DRUG__ID D02HNF D02HNF DRUGCOMP Bayer HealthCare Pharmaceuticals D02HNF HIGHSTAT Approved D02KII DRUG__ID D02KII D02KII DRUGCOMP Merck & Co Inc D02KII HIGHSTAT Approved D02KOY DRUG__ID D02KOY D02KOY DRUGCOMP Merck & Co Inc D02KOY HIGHSTAT Approved D02MGH DRUG__ID D02MGH D02MGH DRUGCOMP GlaxoSmithKline D02MGH HIGHSTAT Approved D02NMJ DRUG__ID D02NMJ D02NMJ DRUGCOMP Chiron Corp D02NMJ HIGHSTAT Approved D02ORJ DRUG__ID D02ORJ D02ORJ DRUGCOMP ADImmune Corp D02ORJ HIGHSTAT Approved D02QHJ DRUG__ID D02QHJ D02QHJ DRUGCOMP Biotest AG D02QHJ HIGHSTAT Approved D02RBB DRUG__ID D02RBB D02RBB DRUGCOMP Berna Biotech AG D02RBB HIGHSTAT Approved D02VLX DRUG__ID D02VLX D02VLX DRUGCOMP Abbvie Inc D02VLX HIGHSTAT Approved D02XHV DRUG__ID D02XHV D02XHV DRUGCOMP Protein Sciences D02XHV HIGHSTAT Approved D03ALS DRUG__ID D03ALS D03ALS DRUGCOMP Finlay Institute D03ALS HIGHSTAT Approved D03BDP DRUG__ID D03BDP D03BDP DRUGCOMP Rockwell medical technologies D03BDP HIGHSTAT Approved D03EER DRUG__ID D03EER D03EER DRUGCOMP Sanofi Aventis Us Llc D03EER HIGHSTAT Approved D03FIL DRUG__ID D03FIL D03FIL DRUGCOMP Eli Lilly And Co D03FIL HIGHSTAT Approved D03FKQ DRUG__ID D03FKQ D03FKQ DRUGCOMP Axcan Pharma D03FKQ HIGHSTAT Approved D03FON DRUG__ID D03FON D03FON DRUGCOMP Bharat Biotech International Ltd D03FON HIGHSTAT Approved D03FXM DRUG__ID D03FXM D03FXM DRUGCOMP Eli Lilly And Co D03FXM HIGHSTAT Approved D03GOP DRUG__ID D03GOP D03GOP DRUGCOMP BM ImmunoTherapeutics D03GOP HIGHSTAT Approved D03JUM DRUG__ID D03JUM D03JUM DRUGCOMP Sanofi Pasteur D03JUM HIGHSTAT Approved D03LTA DRUG__ID D03LTA D03LTA DRUGCOMP Center for Genetic Engineering and Biotechnology D03LTA HIGHSTAT Approved D03NAW DRUG__ID D03NAW D03NAW DRUGCOMP Eli Lilly D03NAW HIGHSTAT Approved D03PGE DRUG__ID D03PGE D03PGE DRUGCOMP Pharmagenesis Inc D03PGE HIGHSTAT Approved D03QCW DRUG__ID D03QCW D03QCW THERCLAS Antiviral Agents D03QCW HIGHSTAT Approved D03QNW DRUG__ID D03QNW D03QNW DRUGCOMP BioTime Inc D03QNW HIGHSTAT Approved D03UFQ DRUG__ID D03UFQ D03UFQ DRUGCOMP GenVec; U.S. Naval Medical Research Center D03UFQ HIGHSTAT Approved D03VGD DRUG__ID D03VGD D03VGD DRUGCOMP Shire BioChem Inc D03VGD HIGHSTAT Approved D03VMW DRUG__ID D03VMW D03VMW DRUGCOMP Cangene Corp D03VMW HIGHSTAT Approved D03VRX DRUG__ID D03VRX D03VRX DRUGCOMP Iso Tex Diagnostics Inc D03VRX HIGHSTAT Approved D03VXG DRUG__ID D03VXG D03VXG THERCLAS Hypoglycemic Agents D03VXG HIGHSTAT Approved D03WOG DRUG__ID D03WOG D03WOG DRUGCOMP Regeneron Pharmaceuticals Tarrytown, NY D03WOG HIGHSTAT Approved D04AIV DRUG__ID D04AIV D04AIV DRUGCOMP Sarepta Therapeutics D04AIV HIGHSTAT Approved D04ELD DRUG__ID D04ELD D04ELD DRUGCOMP Baxter D04ELD HIGHSTAT Approved D04GPZ DRUG__ID D04GPZ D04GPZ DRUGCOMP PrimaPharm; Primapharm D04GPZ HIGHSTAT Approved D04GSL DRUG__ID D04GSL D04GSL DRUGCOMP Nippon Kayaku Co Ltd D04GSL HIGHSTAT Approved D04HIS DRUG__ID D04HIS D04HIS DRUGCOMP SmithKline Beecham plc D04HIS HIGHSTAT Approved D04HXB DRUG__ID D04HXB D04HXB DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D04HXB HIGHSTAT Approved D04IBG DRUG__ID D04IBG D04IBG DRUGCOMP SmithKline Beecham plc D04IBG HIGHSTAT Approved D04IUQ DRUG__ID D04IUQ D04IUQ DRUGCOMP ImaRx Therapeutics Inc D04IUQ HIGHSTAT Approved D04LCX DRUG__ID D04LCX D04LCX DRUGCOMP Finlay Institute D04LCX HIGHSTAT Approved D04RCZ DRUG__ID D04RCZ D04RCZ DRUGCOMP Immunotech Developments Inc D04RCZ HIGHSTAT Approved D04RZE DRUG__ID D04RZE D04RZE DRUGCOMP GlaxoSmithKline D04RZE HIGHSTAT Approved D04VCN DRUG__ID D04VCN D04VCN DRUGCOMP Boehringer Ingelheim Corp D04VCN HIGHSTAT Approved D04WBY DRUG__ID D04WBY D04WBY THERCLAS Fertility Agents D04WBY HIGHSTAT Approved D04WFV DRUG__ID D04WFV D04WFV DRUGCOMP Nabi Biopharmaceuticals; Cangene D04WFV HIGHSTAT Approved D04XGU DRUG__ID D04XGU D04XGU DRUGCOMP AstraZeneca D04XGU HIGHSTAT Approved D04YXL DRUG__ID D04YXL D04YXL DRUGCOMP Biogen idec D04YXL HIGHSTAT Approved D05EFR DRUG__ID D05EFR D05EFR DRUGCOMP Confluent Surgical D05EFR HIGHSTAT Approved D05EHJ DRUG__ID D05EHJ D05EHJ DRUGCOMP Aventis SA D05EHJ HIGHSTAT Approved D05EIT DRUG__ID D05EIT D05EIT DRUGCOMP CV Technologies D05EIT HIGHSTAT Approved D05GGP DRUG__ID D05GGP D05GGP DRUGCOMP Bharat Biotech D05GGP HIGHSTAT Approved D05HIP DRUG__ID D05HIP D05HIP DRUGCOMP Bharat Biotech International Ltd D05HIP HIGHSTAT Approved D05HWX DRUG__ID D05HWX D05HWX DRUGCOMP Diatide Inc D05HWX HIGHSTAT Approved D05IBA DRUG__ID D05IBA D05IBA DRUGCOMP Shantha Biotechnics PVT Ltd D05IBA HIGHSTAT Approved D05KZK DRUG__ID D05KZK D05KZK DRUGCOMP DanioLabs Ltd D05KZK HIGHSTAT Approved D05QIM DRUG__ID D05QIM D05QIM DRUGCOMP ImmuLogic Pharmaceutical Corp D05QIM HIGHSTAT Approved D05RIY DRUG__ID D05RIY D05RIY DRUGCOMP GE Healthcare; acusphere D05RIY HIGHSTAT Approved D05SPL DRUG__ID D05SPL D05SPL DRUGCOMP Pharmacosmos A/S D05SPL HIGHSTAT Approved D05TFW DRUG__ID D05TFW D05TFW DRUGCOMP BIKEN D05TFW HIGHSTAT Approved D05UHF DRUG__ID D05UHF D05UHF THERCLAS Enzyme Replacement Agents D05UHF HIGHSTAT Approved D05URO DRUG__ID D05URO D05URO DRUGCOMP Berna Biotech AG D05URO HIGHSTAT Approved D05WTS DRUG__ID D05WTS D05WTS DRUGCOMP The Centre of Modern Medicine Ltd D05WTS HIGHSTAT Approved D05XSJ DRUG__ID D05XSJ D05XSJ DRUGCOMP Enobia Pharma Inc D05XSJ HIGHSTAT Approved D05YAG DRUG__ID D05YAG D05YAG DRUGCOMP Shandong Simcere Medgenn Bio- Pharmaceutical Co Ltd D05YAG HIGHSTAT Approved D05YMT DRUG__ID D05YMT D05YMT DRUGCOMP ProCyte Corp D05YMT HIGHSTAT Approved D06ANT DRUG__ID D06ANT D06ANT DRUGCOMP Stallergenes D06ANT HIGHSTAT Approved D06AWD DRUG__ID D06AWD D06AWD DRUGCOMP Mitsubishi Tanabe Pharma Corp D06AWD HIGHSTAT Approved D06BYG DRUG__ID D06BYG D06BYG DRUGCOMP Miyarisan Pharmaceutical Co Ltd D06BYG HIGHSTAT Approved D06CDN DRUG__ID D06CDN D06CDN DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D06CDN HIGHSTAT Approved D06EZI DRUG__ID D06EZI D06EZI DRUGCOMP Akorn Inc D06EZI HIGHSTAT Approved D06HWG DRUG__ID D06HWG D06HWG DRUGCOMP Berna Biotech AG D06HWG HIGHSTAT Approved D06IJG DRUG__ID D06IJG D06IJG DRUGCOMP Hanmi Pharmaceutical Co Ltd D06IJG HIGHSTAT Approved D06JDK DRUG__ID D06JDK D06JDK DRUGCOMP Alliance Pharmaceutical Corp D06JDK HIGHSTAT Approved D06JED DRUG__ID D06JED D06JED DRUGCOMP Baxter Healthcare Ltd D06JED HIGHSTAT Approved D06JLX DRUG__ID D06JLX D06JLX DRUGCOMP State Research Center of Virology; Biotechnology VECTOR D06JLX HIGHSTAT Approved D06KPV DRUG__ID D06KPV D06KPV DRUGCOMP CreaGene Inc D06KPV HIGHSTAT Approved D06MMW DRUG__ID D06MMW D06MMW DRUGCOMP Gliatech Inc D06MMW HIGHSTAT Approved D06MRY DRUG__ID D06MRY D06MRY DRUGCOMP Novartis AG D06MRY HIGHSTAT Approved D06NBK DRUG__ID D06NBK D06NBK DRUGCOMP Draxis D06NBK HIGHSTAT Approved D06QGH DRUG__ID D06QGH D06QGH DRUGCOMP SBL Vaccin AB D06QGH HIGHSTAT Approved D06SFX DRUG__ID D06SFX D06SFX DRUGCOMP Fresenius Kabi Deutschland Gmbh D06SFX HIGHSTAT Approved D06WGK DRUG__ID D06WGK D06WGK DRUGCOMP MedImmune D06WGK HIGHSTAT Approved D06XOT DRUG__ID D06XOT D06XOT DRUGCOMP GE Healthcare D06XOT HIGHSTAT Approved D06YEG DRUG__ID D06YEG D06YEG DRUGCOMP Bharat Biotech International Ltd D06YEG HIGHSTAT Approved D06ZAS DRUG__ID D06ZAS D06ZAS DRUGCOMP Bracco Diagnostics Inc D06ZAS HIGHSTAT Approved D06ZIT DRUG__ID D06ZIT D06ZIT DRUGCOMP Savient D06ZIT HIGHSTAT Approved D07BDW DRUG__ID D07BDW D07BDW DRUGCOMP Mitsubishi Pharma Corp D07BDW HIGHSTAT Approved D07CGI DRUG__ID D07CGI D07CGI DRUGCOMP Merck & Co Inc D07CGI HIGHSTAT Approved D07CMM DRUG__ID D07CMM D07CMM DRUGCOMP Interferon Sciences Inc D07CMM HIGHSTAT Approved D07FND DRUG__ID D07FND D07FND DRUGCOMP Nabi Biologics D07FND HIGHSTAT Approved D07GNR DRUG__ID D07GNR D07GNR DRUGCOMP CSL Behring D07GNR HIGHSTAT Approved D07GTF DRUG__ID D07GTF D07GTF DRUGCOMP Zhejiang Tianyuan Bio-Pharmaceutical Co Ltd D07GTF HIGHSTAT Approved D07IRG DRUG__ID D07IRG D07IRG DRUGCOMP Hokuriku Seiyaku KK D07IRG HIGHSTAT Approved D07ISO DRUG__ID D07ISO D07ISO DRUGCOMP Cangene Corp D07ISO HIGHSTAT Approved D07JHV DRUG__ID D07JHV D07JHV DRUGCOMP CSL Behring D07JHV HIGHSTAT Approved D07JTH DRUG__ID D07JTH D07JTH DRUGCOMP Meiji Dairies Corp D07JTH HIGHSTAT Approved D07KFG DRUG__ID D07KFG D07KFG DRUGCOMP Octapharma usa D07KFG HIGHSTAT Approved D07KJH DRUG__ID D07KJH D07KJH DRUGCOMP Yale University D07KJH HIGHSTAT Approved D07KKQ DRUG__ID D07KKQ D07KKQ DRUGCOMP Chiron Vaccines Co D07KKQ HIGHSTAT Approved D07KKZ DRUG__ID D07KKZ D07KKZ DRUGCOMP Advanced Accelerator Applications D07KKZ HIGHSTAT Approved D07RRC DRUG__ID D07RRC D07RRC DRUGCOMP Bharat Biotech International Ltd D07RRC HIGHSTAT Approved D07RSI DRUG__ID D07RSI D07RSI DRUGCOMP AMI Pharm Co Ltd D07RSI HIGHSTAT Approved D07SNG DRUG__ID D07SNG D07SNG DRUGCOMP Sanofi Pasteur D07SNG HIGHSTAT Approved D07TRF DRUG__ID D07TRF D07TRF DRUGCOMP Piramal Healthcare D07TRF HIGHSTAT Approved D07WON DRUG__ID D07WON D07WON DRUGCOMP Auspharm Institute for Mucosal Immunology (AIMI) D07WON HIGHSTAT Approved D07XCG DRUG__ID D07XCG D07XCG DRUGCOMP Organogenesis Inc D07XCG HIGHSTAT Approved D07YUH DRUG__ID D07YUH D07YUH DRUGCOMP Genoa Biotecnologia SA D07YUH HIGHSTAT Approved D07ZGF DRUG__ID D07ZGF D07ZGF DRUGCOMP Emergent BioSolutions D07ZGF HIGHSTAT Approved D08CSE DRUG__ID D08CSE D08CSE DRUGCOMP Iroko Pharmaceuticals D08CSE HIGHSTAT Approved D08ENK DRUG__ID D08ENK D08ENK DRUGCOMP Eli Lilly And Co D08ENK HIGHSTAT Approved D08FWW DRUG__ID D08FWW D08FWW DRUGCOMP Bio Products Laboratory D08FWW HIGHSTAT Approved D08JMO DRUG__ID D08JMO D08JMO DRUGCOMP Italfarmaco SpA D08JMO HIGHSTAT Approved D08MEF DRUG__ID D08MEF D08MEF DRUGCOMP Bayer Schering Pharma AG D08MEF HIGHSTAT Approved D08MYF DRUG__ID D08MYF D08MYF DRUGCOMP Savient Pharmaceuticals Inc D08MYF HIGHSTAT Approved D08NAB DRUG__ID D08NAB D08NAB DRUGCOMP Sola Barnes Hind D08NAB HIGHSTAT Approved D08RHR DRUG__ID D08RHR D08RHR DRUGCOMP Chiron Corp D08RHR HIGHSTAT Approved D08WWN DRUG__ID D08WWN D08WWN DRUGCOMP Chugai; Roche D08WWN HIGHSTAT Approved D08ZVY DRUG__ID D08ZVY D08ZVY DRUGCOMP Draximage Inc D08ZVY HIGHSTAT Approved D09ADS DRUG__ID D09ADS D09ADS DRUGCOMP Innocell Corp D09ADS HIGHSTAT Approved D09DBY DRUG__ID D09DBY D09DBY DRUGCOMP Regeneron D09DBY HIGHSTAT Approved D09EBL DRUG__ID D09EBL D09EBL DRUGTYPE Antibody D09EBL HIGHSTAT Approved D09FHM DRUG__ID D09FHM D09FHM DRUGCOMP Sanofi D09FHM HIGHSTAT Approved D09GMH DRUG__ID D09GMH D09GMH DRUGCOMP Combiotech D09GMH HIGHSTAT Approved D09JJU DRUG__ID D09JJU D09JJU DRUGCOMP Protherics plc D09JJU HIGHSTAT Approved D09JNP DRUG__ID D09JNP D09JNP DRUGCOMP AVAX Technologies D09JNP HIGHSTAT Approved D09LEN DRUG__ID D09LEN D09LEN DRUGCOMP Pfizer D09LEN HIGHSTAT Approved D09LLS DRUG__ID D09LLS D09LLS DRUGCOMP SmithKline Beecham plc D09LLS HIGHSTAT Approved D09MVZ DRUG__ID D09MVZ D09MVZ DRUGTYPE Monoclonal antibody D09MVZ HIGHSTAT Approved D09NIY DRUG__ID D09NIY D09NIY DRUGCOMP Pharmaceutical Research Assoc Inc D09NIY HIGHSTAT Approved D09PLI DRUG__ID D09PLI D09PLI DRUGCOMP Efamol D09PLI HIGHSTAT Approved D09PMV DRUG__ID D09PMV D09PMV THERCLAS Anticancer Agents D09PMV HIGHSTAT Approved D09PPG DRUG__ID D09PPG D09PPG DRUGCOMP Boehringer Ingelheim Pharmaceuticals; Merck; Depomed; Janssen Research & Development; AstraZeneca; Bristol-Myers Squibb D09PPG HIGHSTAT Approved D09RBQ DRUG__ID D09RBQ D09RBQ DRUGCOMP Biotest AG D09RBQ HIGHSTAT Approved D09RED DRUG__ID D09RED D09RED DRUGCOMP Nanjing MeiRui Pharma Co Ltd D09RED HIGHSTAT Approved D09RHS DRUG__ID D09RHS D09RHS DRUGCOMP UCB Celltech D09RHS HIGHSTAT Approved D09RRG DRUG__ID D09RRG D09RRG DRUGCOMP BIKEN D09RRG HIGHSTAT Approved D09SMG DRUG__ID D09SMG D09SMG DRUGCOMP SmithKline Beecham plc D09SMG HIGHSTAT Approved D09SRZ DRUG__ID D09SRZ D09SRZ DRUGCOMP Biogen idec D09SRZ HIGHSTAT Approved D09TYX DRUG__ID D09TYX D09TYX DRUGCOMP Green Cross Corp D09TYX HIGHSTAT Approved D09WDK DRUG__ID D09WDK D09WDK DRUGCOMP Sicor Biotech D09WDK HIGHSTAT Approved D09WKH DRUG__ID D09WKH D09WKH DRUGCOMP Wyeth D09WKH HIGHSTAT Approved D09WZV DRUG__ID D09WZV D09WZV DRUGCOMP MacroGenics & Genzyme D09WZV HIGHSTAT Approved (orphan drug) D09XRD DRUG__ID D09XRD D09XRD DRUGCOMP Merck & Co Inc D09XRD HIGHSTAT Approved D09XVS DRUG__ID D09XVS D09XVS DRUGCOMP Navidea Pharmaceuticals D09XVS HIGHSTAT Approved D09ZSO DRUG__ID D09ZSO D09ZSO THERCLAS Analgesics D09ZSO HIGHSTAT Approved D0A1VS DRUG__ID D0A1VS D0A1VS DRUGCOMP Abbott Laboratories Pharmaceutical Products Div D0A1VS HIGHSTAT Approved D0A3WJ DRUG__ID D0A3WJ D0A3WJ DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0A3WJ HIGHSTAT Approved D0A4SU DRUG__ID D0A4SU D0A4SU DRUGCOMP New York Blood Center D0A4SU HIGHSTAT Approved D0A7GE DRUG__ID D0A7GE D0A7GE DRUGCOMP ALK-Abello D0A7GE HIGHSTAT Approved D0A7WT DRUG__ID D0A7WT D0A7WT DRUGCOMP Aradigm D0A7WT HIGHSTAT Approved D0A8LZ DRUG__ID D0A8LZ D0A8LZ DRUGCOMP Organon BioSciences D0A8LZ HIGHSTAT Approved D0A9ZA DRUG__ID D0A9ZA D0A9ZA DRUGCOMP Serum Institute of India D0A9ZA HIGHSTAT Approved D0AR0B DRUG__ID D0AR0B D0AR0B DRUGCOMP Acambis plc D0AR0B HIGHSTAT Approved D0AW9T DRUG__ID D0AW9T D0AW9T DRUGCOMP Revo biologics D0AW9T HIGHSTAT Approved D0B3VR DRUG__ID D0B3VR D0B3VR DRUGCOMP GlaxoSmithKline D0B3VR HIGHSTAT Approved D0B6ZI DRUG__ID D0B6ZI D0B6ZI DRUGCOMP Sinovac Biotech Ltd D0B6ZI HIGHSTAT Approved D0B7VC DRUG__ID D0B7VC D0B7VC DRUGCOMP Sanofi Pasteur D0B7VC HIGHSTAT Approved D0B8NH DRUG__ID D0B8NH D0B8NH DRUGCOMP Sanquin Blood Supply Foundation D0B8NH HIGHSTAT Approved D0B8RJ DRUG__ID D0B8RJ D0B8RJ DRUGCOMP North American Vaccine Inc D0B8RJ HIGHSTAT Approved D0B8WS DRUG__ID D0B8WS D0B8WS DRUGCOMP Merck D0B8WS HIGHSTAT Approved D0BP4Y DRUG__ID D0BP4Y D0BP4Y DRUGCOMP Mallinckrodt Medical Inc D0BP4Y HIGHSTAT Approved D0C0YG DRUG__ID D0C0YG D0C0YG DRUGCOMP Zhejiang Tianyuan Bio-Pharmaceutical Co Ltd D0C0YG HIGHSTAT Approved D0C2WV DRUG__ID D0C2WV D0C2WV DRUGCOMP CJ Corp D0C2WV HIGHSTAT Approved D0C3XN DRUG__ID D0C3XN D0C3XN DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0C3XN HIGHSTAT Approved D0C6PS DRUG__ID D0C6PS D0C6PS THERCLAS Immunomodulatory Agents D0C6PS HIGHSTAT Approved D0C8PW DRUG__ID D0C8PW D0C8PW DRUGCOMP Molecular Biosystems Inc D0C8PW HIGHSTAT Approved D0C8QS DRUG__ID D0C8QS D0C8QS DRUGCOMP Merck D0C8QS HIGHSTAT Approved D0C8TD DRUG__ID D0C8TD D0C8TD DRUGCOMP King Pharmaceuticals Inc D0C8TD HIGHSTAT Approved D0C9ET DRUG__ID D0C9ET D0C9ET DRUGCOMP Sanofi D0C9ET HIGHSTAT Approved D0CH4A DRUG__ID D0CH4A D0CH4A DRUGCOMP Synageva biopharma D0CH4A HIGHSTAT Approved D0CQ2O DRUG__ID D0CQ2O D0CQ2O THERCLAS Immunomodulatory Agents D0CQ2O HIGHSTAT Approved D0D2FZ DRUG__ID D0D2FZ D0D2FZ DRUGCOMP Greer laboratories D0D2FZ HIGHSTAT Approved D0D2IU DRUG__ID D0D2IU D0D2IU DRUGCOMP SmithKline Beecham plc D0D2IU HIGHSTAT Approved D0D3KS DRUG__ID D0D3KS D0D3KS DRUGCOMP University of Maryland D0D3KS HIGHSTAT Approved D0D6QH DRUG__ID D0D6QH D0D6QH DRUGCOMP Scitech Genetics Ltd D0D6QH HIGHSTAT Approved D0D6QU DRUG__ID D0D6QU D0D6QU DRUGCOMP Gliatech Inc D0D6QU HIGHSTAT Approved D0D6ZL DRUG__ID D0D6ZL D0D6ZL DRUGCOMP Hutchison Medipharma Enterprises Ltd D0D6ZL HIGHSTAT Approved D0D7MZ DRUG__ID D0D7MZ D0D7MZ DRUGCOMP Farma Biagini SpA D0D7MZ HIGHSTAT Approved D0D9FW DRUG__ID D0D9FW D0D9FW DRUGCOMP D-Pharm Ltd D0D9FW HIGHSTAT Approved D0DR6Q DRUG__ID D0DR6Q D0DR6Q DRUGCOMP Novartis vaccines D0DR6Q HIGHSTAT Approved D0DV4J DRUG__ID D0DV4J D0DV4J DRUGCOMP Aventis Behring LLC D0DV4J HIGHSTAT Approved D0E1DF DRUG__ID D0E1DF D0E1DF DRUGCOMP MannKind D0E1DF HIGHSTAT Approved D0E1VD DRUG__ID D0E1VD D0E1VD DRUGCOMP OM Pharma D0E1VD HIGHSTAT Approved D0E2ML DRUG__ID D0E2ML D0E2ML DRUGCOMP Indigene Pharmaceuticals Inc D0E2ML HIGHSTAT Approved D0E5TI DRUG__ID D0E5TI D0E5TI DRUGCOMP Bayer HealthCare Pharmaceuticals D0E5TI HIGHSTAT Approved D0E5UK DRUG__ID D0E5UK D0E5UK DRUGCOMP PPL Therapeutics plc D0E5UK HIGHSTAT Approved D0E6AF DRUG__ID D0E6AF D0E6AF DRUGCOMP Bayer HealthCare Pharmaceuticals D0E6AF HIGHSTAT Approved D0E6CH DRUG__ID D0E6CH D0E6CH DRUGCOMP Aton Pharma Inc D0E6CH HIGHSTAT Approved D0E8UO DRUG__ID D0E8UO D0E8UO THERCLAS Thrombolytic Agents D0E8UO HIGHSTAT Approved D0E9AZ DRUG__ID D0E9AZ D0E9AZ DRUGCOMP Finlay Institute D0E9AZ HIGHSTAT Approved D0EC5T DRUG__ID D0EC5T D0EC5T DRUGCOMP Escape Therapeutics Inc D0EC5T HIGHSTAT Approved D0EN0W DRUG__ID D0EN0W D0EN0W DRUGCOMP River vision D0EN0W HIGHSTAT Approved D0EW5Y DRUG__ID D0EW5Y D0EW5Y DRUGCOMP LifeCell Corp D0EW5Y HIGHSTAT Approved D0EZ5J DRUG__ID D0EZ5J D0EZ5J DRUGCOMP Sanofi Pasteur D0EZ5J HIGHSTAT Approved D0F0ID DRUG__ID D0F0ID D0F0ID DRUGCOMP Immutic Group D0F0ID HIGHSTAT Approved D0F2QS DRUG__ID D0F2QS D0F2QS DRUGCOMP National Academy of Sciences of Ukraine D0F2QS HIGHSTAT Approved D0F3JT DRUG__ID D0F3JT D0F3JT THERCLAS Immunomodulatory Agents D0F3JT HIGHSTAT Approved D0F4QO DRUG__ID D0F4QO D0F4QO DRUGCOMP Therabel Research SA D0F4QO HIGHSTAT Approved D0F7AJ DRUG__ID D0F7AJ D0F7AJ THERCLAS Antiinfective Agents D0F7AJ HIGHSTAT Approved D0F8HU DRUG__ID D0F8HU D0F8HU DRUGCOMP Zydus-Cadila Group D0F8HU HIGHSTAT Approved D0FM2W DRUG__ID D0FM2W D0FM2W DRUGCOMP Gentium D0FM2W HIGHSTAT Approved D0FS5O DRUG__ID D0FS5O D0FS5O DRUGCOMP Shanghai Greenvalley D0FS5O HIGHSTAT Approved in China D0FX8A DRUG__ID D0FX8A D0FX8A THERCLAS Thrombolytic Agents D0FX8A HIGHSTAT Approved D0G0AI DRUG__ID D0G0AI D0G0AI DRUGCOMP Baxter D0G0AI HIGHSTAT Approved D0G0IA DRUG__ID D0G0IA D0G0IA DRUGCOMP Baxter Healthcare D0G0IA HIGHSTAT Approved D0G0MM DRUG__ID D0G0MM D0G0MM DRUGCOMP Bharat Biotech International Ltd D0G0MM HIGHSTAT Approved D0G2ZG DRUG__ID D0G2ZG D0G2ZG DRUGCOMP GlaxoSmithKline D0G2ZG HIGHSTAT Approved D0G3EC DRUG__ID D0G3EC D0G3EC DRUGCOMP China Nuokang Bio-Pharmaceutical Inc D0G3EC HIGHSTAT Approved D0G5BK DRUG__ID D0G5BK D0G5BK DRUGCOMP Molecular Biosystems Inc; ImaRx Therapeutics Inc D0G5BK HIGHSTAT Approved D0G5ET DRUG__ID D0G5ET D0G5ET DRUGCOMP Shire D0G5ET HIGHSTAT Approved D0G6DR DRUG__ID D0G6DR D0G6DR DRUGCOMP Nippon Shinyaku Kyoto, Japan D0G6DR HIGHSTAT Approved D0G6HA DRUG__ID D0G6HA D0G6HA DRUGCOMP Pfizer D0G6HA HIGHSTAT Approved D0G7QH DRUG__ID D0G7QH D0G7QH DRUGCOMP North American Vaccine Inc D0G7QH HIGHSTAT Approved D0GA0A DRUG__ID D0GA0A D0GA0A THERCLAS Anticancer Agents D0GA0A HIGHSTAT Approved D0H0GY DRUG__ID D0H0GY D0H0GY DRUGCOMP HanAll Biopharma Co Ltd D0H0GY HIGHSTAT Approved D0H3AB DRUG__ID D0H3AB D0H3AB DRUGCOMP Merz D0H3AB HIGHSTAT Approved D0H3PC DRUG__ID D0H3PC D0H3PC DRUGCOMP Ge Healthcare D0H3PC HIGHSTAT Approved D0H3WU DRUG__ID D0H3WU D0H3WU DRUGCOMP Takeda D0H3WU HIGHSTAT Approved D0H3ZR DRUG__ID D0H3ZR D0H3ZR DRUGCOMP Medlmmune LLC D0H3ZR HIGHSTAT Approved D0H4TQ DRUG__ID D0H4TQ D0H4TQ THERCLAS Diagnostic Agents D0H4TQ HIGHSTAT Approved D0H5XB DRUG__ID D0H5XB D0H5XB DRUGCOMP EUSA Pharma D0H5XB HIGHSTAT Approved D0H6QD DRUG__ID D0H6QD D0H6QD DRUGCOMP Alder Biopharmaceuticals Bothell, WA D0H6QD HIGHSTAT Approved D0HA7E DRUG__ID D0HA7E D0HA7E DRUGCOMP Chiron D0HA7E HIGHSTAT Approved D0HI5D DRUG__ID D0HI5D D0HI5D DRUGCOMP Y-mAbs Therapeutics New York, NY D0HI5D HIGHSTAT Approved D0HV7K DRUG__ID D0HV7K D0HV7K DRUGCOMP Corixa Corp D0HV7K HIGHSTAT Approved D0I0AW DRUG__ID D0I0AW D0I0AW DRUGCOMP Merck & Co. D0I0AW HIGHSTAT Approved D0I0VI DRUG__ID D0I0VI D0I0VI DRUGCOMP Ge Healthcare D0I0VI HIGHSTAT Approved D0I1DH DRUG__ID D0I1DH D0I1DH DRUGCOMP Mallinckrodt Medical Inc D0I1DH HIGHSTAT Approved D0I1PY DRUG__ID D0I1PY D0I1PY DRUGCOMP Eli Lilly And Co D0I1PY HIGHSTAT Approved D0I2NF DRUG__ID D0I2NF D0I2NF DRUGCOMP CSL Ltd D0I2NF HIGHSTAT Approved D0I3IG DRUG__ID D0I3IG D0I3IG THERCLAS Antihypertensive Agents D0I3IG HIGHSTAT Approved D0I3JZ DRUG__ID D0I3JZ D0I3JZ DRUGCOMP Affymax D0I3JZ HIGHSTAT Approved D0I3TJ DRUG__ID D0I3TJ D0I3TJ DRUGCOMP CSL Ltd D0I3TJ HIGHSTAT Approved D0I4ZQ DRUG__ID D0I4ZQ D0I4ZQ DRUGCOMP Auxilium D0I4ZQ HIGHSTAT Approved D0I5TC DRUG__ID D0I5TC D0I5TC DRUGCOMP Bracco Diagnostics Inc D0I5TC HIGHSTAT Approved D0I5WO DRUG__ID D0I5WO D0I5WO DRUGCOMP Pharmacia & Upjohn Inc D0I5WO HIGHSTAT Approved D0I6LD DRUG__ID D0I6LD D0I6LD DRUGCOMP Sanofi Pasteur D0I6LD HIGHSTAT Approved D0I7PO DRUG__ID D0I7PO D0I7PO DRUGCOMP Boehringer-Ingelheim Pharmaceuticals D0I7PO HIGHSTAT Approved D0IL0C DRUG__ID D0IL0C D0IL0C DRUGCOMP SK Chemicals Co Ltd D0IL0C HIGHSTAT Approved D0IP2J DRUG__ID D0IP2J D0IP2J DRUGCOMP Merck & Co Inc D0IP2J HIGHSTAT Approved D0IP9E DRUG__ID D0IP9E D0IP9E DRUGCOMP Baxter D0IP9E HIGHSTAT Approved D0IY3Z DRUG__ID D0IY3Z D0IY3Z DRUGCOMP Biotest AG D0IY3Z HIGHSTAT Approved D0J0LI DRUG__ID D0J0LI D0J0LI DRUGCOMP Ferring Pharmaceuticals Inc D0J0LI HIGHSTAT Approved D0J1TU DRUG__ID D0J1TU D0J1TU DRUGCOMP Lantheus Medical Imaging Inc D0J1TU HIGHSTAT Approved D0J1UA DRUG__ID D0J1UA D0J1UA DRUGCOMP Biomarin D0J1UA HIGHSTAT Approved D0JB2J DRUG__ID D0JB2J D0JB2J DRUGCOMP SanofiBridgewater, NJ D0JB2J HIGHSTAT Approved D0JP4A DRUG__ID D0JP4A D0JP4A DRUGCOMP Osiris Therapeutics Inc D0JP4A HIGHSTAT Approved D0K0MI DRUG__ID D0K0MI D0K0MI DRUGCOMP Bracco SpA D0K0MI HIGHSTAT Approved D0K4DI DRUG__ID D0K4DI D0K4DI THERCLAS Thrombolytic Agents D0K4DI HIGHSTAT Approved D0K7OO DRUG__ID D0K7OO D0K7OO DRUGCOMP Chengdu Institute of Biological Products D0K7OO HIGHSTAT Approved D0KT3X DRUG__ID D0KT3X D0KT3X DRUGCOMP OMRIX Biopharmaceuticals SA D0KT3X HIGHSTAT Approved D0L2VV DRUG__ID D0L2VV D0L2VV DRUGCOMP Connaught Laboratories Inc D0L2VV HIGHSTAT Approved D0L2WJ DRUG__ID D0L2WJ D0L2WJ DRUGCOMP Novo Nordisk D0L2WJ HIGHSTAT Approved D0L3WJ DRUG__ID D0L3WJ D0L3WJ DRUGCOMP TNI BioTech D0L3WJ HIGHSTAT Approved D0L4EG DRUG__ID D0L4EG D0L4EG DRUGCOMP Himalaya Drug Co D0L4EG HIGHSTAT Approved D0L4ET DRUG__ID D0L4ET D0L4ET DRUGCOMP Biotest AG D0L4ET HIGHSTAT Approved D0L4XW DRUG__ID D0L4XW D0L4XW DRUGCOMP GlaxoSmithKline D0L4XW HIGHSTAT Approved D0L7QB DRUG__ID D0L7QB D0L7QB DRUGCOMP Alfa Wassermann SpA D0L7QB HIGHSTAT Approved D0L9MM DRUG__ID D0L9MM D0L9MM DRUGCOMP Hard To Treat Diseases Inc D0L9MM HIGHSTAT Approved D0L9WF DRUG__ID D0L9WF D0L9WF DRUGCOMP Lincoln Pharmaceuticals Ltd D0L9WF HIGHSTAT Approved D0LC4L DRUG__ID D0LC4L D0LC4L DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0LC4L HIGHSTAT Approved D0LP4Q DRUG__ID D0LP4Q D0LP4Q DRUGCOMP XOMA Corporation D0LP4Q HIGHSTAT Approved D0LW4O DRUG__ID D0LW4O D0LW4O DRUGCOMP Biogen Idec D0LW4O HIGHSTAT Approved D0M0AA DRUG__ID D0M0AA D0M0AA DRUGCOMP GlaxoSmithKline D0M0AA HIGHSTAT Approved D0M2WF DRUG__ID D0M2WF D0M2WF DRUGCOMP 3m Medical Products Div D0M2WF HIGHSTAT Approved D0M3AH DRUG__ID D0M3AH D0M3AH DRUGCOMP Nycomed D0M3AH HIGHSTAT Approved D0M4OC DRUG__ID D0M4OC D0M4OC DRUGCOMP Vifor (International) SA D0M4OC HIGHSTAT Approved D0M5GX DRUG__ID D0M5GX D0M5GX DRUGCOMP GlaxoSmithKline Biologicals D0M5GX HIGHSTAT Approved D0M6ER DRUG__ID D0M6ER D0M6ER DRUGCOMP Sarepta Therapeutics Cambridge, MA D0M6ER HIGHSTAT Approved D0M7IH DRUG__ID D0M7IH D0M7IH DRUGCOMP Ipsen D0M7IH HIGHSTAT Approved D0MD0T DRUG__ID D0MD0T D0MD0T DRUGCOMP Chugai Pharma USA Berkeley Heights, NJ RocheBasel, Switzerland D0MD0T HIGHSTAT Approved D0MD8O DRUG__ID D0MD8O D0MD8O DRUGCOMP Sanofi Pasteur D0MD8O HIGHSTAT Approved D0MY1U DRUG__ID D0MY1U D0MY1U DRUGCOMP Sanofi Pasteur D0MY1U HIGHSTAT Approved D0N3UG DRUG__ID D0N3UG D0N3UG DRUGCOMP Halozyme therapeutics; baxter healthcare D0N3UG HIGHSTAT Approved D0N4HB DRUG__ID D0N4HB D0N4HB DRUGCOMP Bristol-Myers Squibb D0N4HB HIGHSTAT Approved D0N6UJ DRUG__ID D0N6UJ D0N6UJ DRUGCOMP Salix Pharmaceuticals D0N6UJ HIGHSTAT Approved D0N7KV DRUG__ID D0N7KV D0N7KV DRUGCOMP LipoNova AG D0N7KV HIGHSTAT Approved D0NK7X DRUG__ID D0NK7X D0NK7X DRUGCOMP Novo Nordisk Pharmaceuticals Ltd D0NK7X HIGHSTAT Approved D0O7ES DRUG__ID D0O7ES D0O7ES DRUGCOMP Center for Genetic Engineering and Biotechnology D0O7ES HIGHSTAT Approved D0O7GU DRUG__ID D0O7GU D0O7GU THERCLAS Antimucositis Agents D0O7GU HIGHSTAT Approved D0O8YO DRUG__ID D0O8YO D0O8YO DRUGCOMP Ge Healthcare D0O8YO HIGHSTAT Approved D0O9KY DRUG__ID D0O9KY D0O9KY DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0O9KY HIGHSTAT Approved D0O9MX DRUG__ID D0O9MX D0O9MX DRUGCOMP Sinovac Biotech Ltd D0O9MX HIGHSTAT Approved D0O9RJ DRUG__ID D0O9RJ D0O9RJ DRUGCOMP Celldex Therapeutics D0O9RJ HIGHSTAT Approved D0OH4N DRUG__ID D0OH4N D0OH4N DRUGCOMP Dentsply International D0OH4N HIGHSTAT Approved D0OM3A DRUG__ID D0OM3A D0OM3A THERCLAS Fertility Agents D0OM3A HIGHSTAT Approved D0OY5X DRUG__ID D0OY5X D0OY5X DRUGCOMP Advanced Tissue Sciences Inc D0OY5X HIGHSTAT Approved D0P1AS DRUG__ID D0P1AS D0P1AS DRUGCOMP Epeius Biotechnologies D0P1AS HIGHSTAT Approved D0P1JL DRUG__ID D0P1JL D0P1JL DRUGCOMP Sanofi Pasteur D0P1JL HIGHSTAT Approved D0P2EX DRUG__ID D0P2EX D0P2EX DRUGCOMP Momenta Pharmaceuticals Inc D0P2EX HIGHSTAT Approved D0P2JH DRUG__ID D0P2JH D0P2JH DRUGCOMP Bracco D0P2JH HIGHSTAT Approved D0P2LR DRUG__ID D0P2LR D0P2LR DRUGCOMP National Institute of Immunology D0P2LR HIGHSTAT Approved D0P5AL DRUG__ID D0P5AL D0P5AL DRUGCOMP State Research Center of Virology; Biotechnology VECTOR D0P5AL HIGHSTAT Approved D0P5DW DRUG__ID D0P5DW D0P5DW DRUGCOMP Universidade Federal de Santa Catarina D0P5DW HIGHSTAT Approved D0P6NL DRUG__ID D0P6NL D0P6NL DRUGCOMP Mallinckrodt Medical Inc D0P6NL HIGHSTAT Approved D0P8QN DRUG__ID D0P8QN D0P8QN DRUGCOMP Baxter 1nternational D0P8QN HIGHSTAT Approved D0P9JE DRUG__ID D0P9JE D0P9JE DRUGCOMP Zhejiang Tianyuan Bio-Pharmaceutical Co Ltd D0P9JE HIGHSTAT Approved D0P9OU DRUG__ID D0P9OU D0P9OU DRUGCOMP Greer Laboratories D0P9OU HIGHSTAT Approved D0PK5M DRUG__ID D0PK5M D0PK5M DRUGCOMP Takeda D0PK5M HIGHSTAT Approved D0Q0JG DRUG__ID D0Q0JG D0Q0JG DRUGCOMP Reckitt; Colman D0Q0JG HIGHSTAT Approved D0Q3UQ DRUG__ID D0Q3UQ D0Q3UQ DRUGCOMP Chemo-Sero-Therapeutic Research Inst D0Q3UQ HIGHSTAT Approved D0Q5KL DRUG__ID D0Q5KL D0Q5KL THERCLAS Anticoagulants D0Q5KL HIGHSTAT Approved D0Q5SP DRUG__ID D0Q5SP D0Q5SP DRUGCOMP Ucyclyd Pharma Inc D0Q5SP HIGHSTAT Approved D0Q6BH DRUG__ID D0Q6BH D0Q6BH DRUGCOMP Novartis Vaccines & Diagnostics D0Q6BH HIGHSTAT Approved D0Q7SR DRUG__ID D0Q7SR D0Q7SR DRUGCOMP Medlmmune LLC D0Q7SR HIGHSTAT Approved D0Q9TC DRUG__ID D0Q9TC D0Q9TC DRUGCOMP Sanofi D0Q9TC HIGHSTAT Approved D0Q9VA DRUG__ID D0Q9VA D0Q9VA DRUGCOMP SmithKline Beecham Corp D0Q9VA HIGHSTAT Approved D0QB7K DRUG__ID D0QB7K D0QB7K DRUGCOMP Zhejiang Tianyuan Bio-Pharmaceutical Co Ltd D0QB7K HIGHSTAT Approved D0QE1Y DRUG__ID D0QE1Y D0QE1Y DRUGCOMP Protherics plc D0QE1Y HIGHSTAT Approved D0QF9P DRUG__ID D0QF9P D0QF9P DRUGCOMP GlaxoSmithKline plc D0QF9P HIGHSTAT Approved D0R1GJ DRUG__ID D0R1GJ D0R1GJ DRUGCOMP Sarepta Therapeutics Cambridge, MA D0R1GJ HIGHSTAT Approved D0R1JB DRUG__ID D0R1JB D0R1JB DRUGCOMP Allergy Therapeutics plc D0R1JB HIGHSTAT Approved D0R2CZ DRUG__ID D0R2CZ D0R2CZ DRUGCOMP Medimmune D0R2CZ HIGHSTAT Approved D0R4NY DRUG__ID D0R4NY D0R4NY DRUGCOMP North American Vaccine Inc D0R4NY HIGHSTAT Approved D0R5JL DRUG__ID D0R5JL D0R5JL DRUGCOMP SBL Vaccin AB D0R5JL HIGHSTAT Approved D0R6CD DRUG__ID D0R6CD D0R6CD DRUGCOMP Cense Biosciences Inc D0R6CD HIGHSTAT Approved D0R7KX DRUG__ID D0R7KX D0R7KX DRUGCOMP Celldex Therapeutics Inc D0R7KX HIGHSTAT Approved D0R9NB DRUG__ID D0R9NB D0R9NB DRUGCOMP Canyon pharmaceuticals D0R9NB HIGHSTAT Approved D0S1HE DRUG__ID D0S1HE D0S1HE DRUGCOMP Mallinckrodt Medical D0S1HE HIGHSTAT Approved D0S1UW DRUG__ID D0S1UW D0S1UW DRUGCOMP Wyeth D0S1UW HIGHSTAT Approved D0S4KI DRUG__ID D0S4KI D0S4KI DRUGCOMP SmithKline Beecham plc D0S4KI HIGHSTAT Approved D0S8FU DRUG__ID D0S8FU D0S8FU DRUGCOMP Piedmont pharmaceuticals D0S8FU HIGHSTAT Approved D0SX6O DRUG__ID D0SX6O D0SX6O DRUGCOMP Chiron SpA D0SX6O HIGHSTAT Approved D0T1QY DRUG__ID D0T1QY D0T1QY DRUGCOMP Bristol Myers Squibb Pharma Co D0T1QY HIGHSTAT Approved D0T1UJ DRUG__ID D0T1UJ D0T1UJ THERCLAS Thrombolytic Agents D0T1UJ HIGHSTAT Approved D0T4GA DRUG__ID D0T4GA D0T4GA DRUGCOMP Integra LifeSciences Holdings Corp D0T4GA HIGHSTAT Approved D0T5VQ DRUG__ID D0T5VQ D0T5VQ DRUGCOMP BIKEN D0T5VQ HIGHSTAT Approved D0T5WA DRUG__ID D0T5WA D0T5WA DRUGCOMP Sinovac Biotech Ltd D0T5WA HIGHSTAT Approved D0T6XU DRUG__ID D0T6XU D0T6XU DRUGCOMP Shemyakin Institute of Bioorganic Chemistry D0T6XU HIGHSTAT Approved D0T8ZA DRUG__ID D0T8ZA D0T8ZA DRUGCOMP Zogenix D0T8ZA HIGHSTAT Approved D0T9TE DRUG__ID D0T9TE D0T9TE THERCLAS Antiinfective Agents D0T9TE HIGHSTAT Approved D0U1TA DRUG__ID D0U1TA D0U1TA DRUGCOMP Bio-Gal Advanced Biotechnology D0U1TA HIGHSTAT Approved D0U4HZ DRUG__ID D0U4HZ D0U4HZ DRUGCOMP Sinovac Biotech Ltd D0U4HZ HIGHSTAT Approved D0U4XC DRUG__ID D0U4XC D0U4XC DRUGCOMP Genzyme Tissue Repair D0U4XC HIGHSTAT Approved D0U5SC DRUG__ID D0U5SC D0U5SC DRUGCOMP Curative Health Services D0U5SC HIGHSTAT Approved D0U6EX DRUG__ID D0U6EX D0U6EX DRUGCOMP Sanofi D0U6EX HIGHSTAT Approved D0U7GP DRUG__ID D0U7GP D0U7GP DRUGTYPE Small molecular drug D0U7GP HIGHSTAT Approved D0U7KM DRUG__ID D0U7KM D0U7KM DRUGCOMP GlaxoSmithKline Biologicals D0U7KM HIGHSTAT Approved D0U8US DRUG__ID D0U8US D0U8US THERCLAS Immunomodulatory Agents D0U8US HIGHSTAT Approved D0U9EN DRUG__ID D0U9EN D0U9EN DRUGCOMP Horizon Pharma Lake Forest, IL D0U9EN HIGHSTAT Approved D0UH0S DRUG__ID D0UH0S D0UH0S DRUGCOMP Omninvest D0UH0S HIGHSTAT Approved D0UQ1R DRUG__ID D0UQ1R D0UQ1R DRUGCOMP Biogen Idec D0UQ1R HIGHSTAT Approved D0UW7D DRUG__ID D0UW7D D0UW7D DRUGCOMP Merck D0UW7D HIGHSTAT Approved D0V0OP DRUG__ID D0V0OP D0V0OP DRUGCOMP MediGene AG and Bradley Pharmaceuticals D0V0OP HIGHSTAT Approved D0V0YH DRUG__ID D0V0YH D0V0YH DRUGCOMP GlaxoSmithKline D0V0YH HIGHSTAT Approved D0V2NJ DRUG__ID D0V2NJ D0V2NJ DRUGCOMP Lg life sciences D0V2NJ HIGHSTAT Approved D0V3SB DRUG__ID D0V3SB D0V3SB DRUGCOMP Bayer AG D0V3SB HIGHSTAT Approved D0V4AS DRUG__ID D0V4AS D0V4AS DRUGCOMP Mission Pharmacal Co D0V4AS HIGHSTAT Approved D0V4JR DRUG__ID D0V4JR D0V4JR DRUGCOMP Ge Healthcare D0V4JR HIGHSTAT Approved D0V4YE DRUG__ID D0V4YE D0V4YE DRUGCOMP Pharmalucence Inc D0V4YE HIGHSTAT Approved D0V5XJ DRUG__ID D0V5XJ D0V5XJ DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0V5XJ HIGHSTAT Approved D0V7DW DRUG__ID D0V7DW D0V7DW DRUGCOMP Novartis D0V7DW HIGHSTAT Approved D0V7QT DRUG__ID D0V7QT D0V7QT DRUGCOMP AMAG Pharmaceuticals Inc D0V7QT HIGHSTAT Approved D0V9UY DRUG__ID D0V9UY D0V9UY DRUGCOMP Bracco Diagnostics Inc D0V9UY HIGHSTAT Approved D0W0DY DRUG__ID D0W0DY D0W0DY DRUGCOMP Chiron Vaccines Co; Chiron Corp D0W0DY HIGHSTAT Approved D0W1BV DRUG__ID D0W1BV D0W1BV DRUGCOMP Takeda Pharmaceutical Co Ltd D0W1BV HIGHSTAT Approved D0W2LR DRUG__ID D0W2LR D0W2LR DRUGCOMP Dynavax D0W2LR HIGHSTAT Approved D0W3SQ DRUG__ID D0W3SQ D0W3SQ DRUGCOMP Shanghai Sunway Biotech D0W3SQ HIGHSTAT Approved D0W5MX DRUG__ID D0W5MX D0W5MX DRUGCOMP Chiron Vaccines Co D0W5MX HIGHSTAT Approved D0W6GR DRUG__ID D0W6GR D0W6GR DRUGCOMP Green Cross Corp D0W6GR HIGHSTAT Approved D0W6SS DRUG__ID D0W6SS D0W6SS THERCLAS Fertility Agents D0W6SS HIGHSTAT Approved D0W8FU DRUG__ID D0W8FU D0W8FU DRUGCOMP BioChon Biotech D0W8FU HIGHSTAT Approved D0WL5F DRUG__ID D0WL5F D0WL5F DRUGCOMP Merck D0WL5F HIGHSTAT Approved D0WY9F DRUG__ID D0WY9F D0WY9F DRUGCOMP Meningitis Vaccine Project D0WY9F HIGHSTAT Approved D0X2HE DRUG__ID D0X2HE D0X2HE DRUGCOMP Neose Technologies D0X2HE HIGHSTAT Approved D0X2RJ DRUG__ID D0X2RJ D0X2RJ DRUGTYPE Monoclonal antibody D0X2RJ HIGHSTAT Approved D0X4BZ DRUG__ID D0X4BZ D0X4BZ DRUGCOMP Lorus Therapeutics D0X4BZ HIGHSTAT Approved D0X5UL DRUG__ID D0X5UL D0X5UL DRUGCOMP Finlay Institute D0X5UL HIGHSTAT Approved D0X9KI DRUG__ID D0X9KI D0X9KI DRUGCOMP Pharmalucence Inc D0X9KI HIGHSTAT Approved D0XH3V DRUG__ID D0XH3V D0XH3V DRUGCOMP MedImmune Gaithersburg, MD D0XH3V HIGHSTAT Approved D0XL6C DRUG__ID D0XL6C D0XL6C DRUGCOMP SmithKline Beecham plc D0XL6C HIGHSTAT Approved D0Y3VQ DRUG__ID D0Y3VQ D0Y3VQ DRUGCOMP Novo nordisk D0Y3VQ HIGHSTAT Approved D0Y4KE DRUG__ID D0Y4KE D0Y4KE THERCLAS Antiulcer Agents D0Y4KE HIGHSTAT Approved D0Y5OY DRUG__ID D0Y5OY D0Y5OY DRUGCOMP ALK-Abello; merck D0Y5OY HIGHSTAT Approved D0Y7XG DRUG__ID D0Y7XG D0Y7XG DRUGCOMP ThromboGenics D0Y7XG HIGHSTAT Approved D0YP2R DRUG__ID D0YP2R D0YP2R DRUGCOMP Squibb Diagnostics D0YP2R HIGHSTAT Approved D0Z1KC DRUG__ID D0Z1KC D0Z1KC DRUGCOMP Biogen D0Z1KC HIGHSTAT Approved D0Z2CM DRUG__ID D0Z2CM D0Z2CM THERCLAS Fertility Agents D0Z2CM HIGHSTAT Approved D0Z2YQ DRUG__ID D0Z2YQ D0Z2YQ DRUGCOMP Relypsa Inc D0Z2YQ HIGHSTAT Approved D0Z3FV DRUG__ID D0Z3FV D0Z3FV DRUGCOMP Allergy Therapeutics plc D0Z3FV HIGHSTAT Approved D0Z5IP DRUG__ID D0Z5IP D0Z5IP DRUGCOMP Intercell; Novartis Vaccines & Diagnostics D0Z5IP HIGHSTAT Approved D0Z6BF DRUG__ID D0Z6BF D0Z6BF DRUGCOMP Merck D0Z6BF HIGHSTAT Approved D0Z9EO DRUG__ID D0Z9EO D0Z9EO DRUGCOMP Amylin Pharmaceuticals D0Z9EO HIGHSTAT Approved D0ZA4G DRUG__ID D0ZA4G D0ZA4G DRUGCOMP GlaxoSmithKline D0ZA4G HIGHSTAT Approved D13YOP DRUG__ID D13YOP D13YOP DRUGCOMP Tris Pharma D13YOP HIGHSTAT Approved D1HEN2 DRUG__ID D1HEN2 D1HEN2 DRUGTYPE radioactive diagnostic agent D1HEN2 HIGHSTAT Approved D52NZX DRUG__ID D52NZX D52NZX DRUGTYPE Antibody drug conjugate D52NZX HIGHSTAT Approved D8SU9N DRUG__ID D8SU9N D8SU9N DRUGCOMP Amryt Pharma Boston, MA D8SU9N HIGHSTAT Approved in EU DG9Y6S DRUG__ID DG9Y6S DG9Y6S DRUGCOMP TAKEDA DG9Y6S HIGHSTAT Approved DRM1X5 DRUG__ID DRM1X5 DRM1X5 DRUGTYPE Antibody DRM1X5 HIGHSTAT Approved DT7SN5 DRUG__ID DT7SN5 DT7SN5 DRUGTYPE Ultrasound contrast agent DT7SN5 HIGHSTAT Approved DUCA08 DRUG__ID DUCA08 DUCA08 DRUGTYPE Antibody DUCA08 HIGHSTAT Approved DY38JR DRUG__ID DY38JR DY38JR DRUGCOMP Starpharma DY38JR HIGHSTAT Approved D00AEV DRUG__ID D00AEV D00AEV HIGHSTAT Approved D00EIB DRUG__ID D00EIB D00EIB HIGHSTAT Approved D00GBG DRUG__ID D00GBG D00GBG HIGHSTAT Approved D00IAH DRUG__ID D00IAH D00IAH HIGHSTAT Approved D00NTR DRUG__ID D00NTR D00NTR HIGHSTAT Approved D00YLF DRUG__ID D00YLF D00YLF HIGHSTAT Approved D01CHI DRUG__ID D01CHI D01CHI HIGHSTAT Approved D01DGN DRUG__ID D01DGN D01DGN HIGHSTAT Approved D01ICU DRUG__ID D01ICU D01ICU HIGHSTAT Approved D01LUS DRUG__ID D01LUS D01LUS HIGHSTAT Approved D01MMB DRUG__ID D01MMB D01MMB HIGHSTAT Approved D01OWB DRUG__ID D01OWB D01OWB HIGHSTAT Approved D01PAR DRUG__ID D01PAR D01PAR HIGHSTAT Approved D01THX DRUG__ID D01THX D01THX HIGHSTAT Approved D01TMF DRUG__ID D01TMF D01TMF HIGHSTAT Approved D02EPS DRUG__ID D02EPS D02EPS HIGHSTAT Approved D02GKJ DRUG__ID D02GKJ D02GKJ HIGHSTAT Approved D02IRD DRUG__ID D02IRD D02IRD HIGHSTAT Approved D02OJN DRUG__ID D02OJN D02OJN HIGHSTAT Approved D02WHY DRUG__ID D02WHY D02WHY HIGHSTAT Approved D03EOT DRUG__ID D03EOT D03EOT HIGHSTAT Approved D03FEO DRUG__ID D03FEO D03FEO HIGHSTAT Approved D03LUN DRUG__ID D03LUN D03LUN HIGHSTAT Approved D03MUT DRUG__ID D03MUT D03MUT HIGHSTAT Approved D03QBS DRUG__ID D03QBS D03QBS HIGHSTAT Approved D03TME DRUG__ID D03TME D03TME HIGHSTAT Approved D03VNX DRUG__ID D03VNX D03VNX HIGHSTAT Approved D03YET DRUG__ID D03YET D03YET HIGHSTAT Approved D04DFJ DRUG__ID D04DFJ D04DFJ HIGHSTAT Approved D04JZD DRUG__ID D04JZD D04JZD HIGHSTAT Approved D04KUK DRUG__ID D04KUK D04KUK HIGHSTAT Approved D04VGS DRUG__ID D04VGS D04VGS HIGHSTAT Approved D04YKM DRUG__ID D04YKM D04YKM HIGHSTAT Approved D05CVH DRUG__ID D05CVH D05CVH HIGHSTAT Approved D05EVF DRUG__ID D05EVF D05EVF HIGHSTAT Approved D05GVQ DRUG__ID D05GVQ D05GVQ HIGHSTAT Approved D05HAJ DRUG__ID D05HAJ D05HAJ HIGHSTAT Approved D05ILN DRUG__ID D05ILN D05ILN HIGHSTAT Approved D05JRG DRUG__ID D05JRG D05JRG HIGHSTAT Approved D05LTY DRUG__ID D05LTY D05LTY HIGHSTAT Approved D05NMJ DRUG__ID D05NMJ D05NMJ HIGHSTAT Approved D05OSR DRUG__ID D05OSR D05OSR HIGHSTAT Approved D05RQW DRUG__ID D05RQW D05RQW HIGHSTAT Approved D05TUZ DRUG__ID D05TUZ D05TUZ HIGHSTAT Approved D05VFO DRUG__ID D05VFO D05VFO HIGHSTAT Approved D05WVU DRUG__ID D05WVU D05WVU HIGHSTAT Approved D06AJL DRUG__ID D06AJL D06AJL HIGHSTAT Approved D06CZJ DRUG__ID D06CZJ D06CZJ HIGHSTAT Approved D06IPN DRUG__ID D06IPN D06IPN HIGHSTAT Approved D06NQJ DRUG__ID D06NQJ D06NQJ HIGHSTAT Approved D06VYE DRUG__ID D06VYE D06VYE HIGHSTAT Approved D07BXQ DRUG__ID D07BXQ D07BXQ HIGHSTAT Approved D07CTM DRUG__ID D07CTM D07CTM HIGHSTAT Approved D07NPH DRUG__ID D07NPH D07NPH HIGHSTAT Approved D07VRO DRUG__ID D07VRO D07VRO HIGHSTAT Approved D08BKM DRUG__ID D08BKM D08BKM HIGHSTAT Approved D08LJP DRUG__ID D08LJP D08LJP HIGHSTAT Approved D08RHU DRUG__ID D08RHU D08RHU HIGHSTAT Approved D08SCQ DRUG__ID D08SCQ D08SCQ HIGHSTAT Approved D09ITH DRUG__ID D09ITH D09ITH HIGHSTAT Approved D09NTM DRUG__ID D09NTM D09NTM HIGHSTAT Approved D09PHB DRUG__ID D09PHB D09PHB HIGHSTAT Approved D09QRS DRUG__ID D09QRS D09QRS HIGHSTAT Approved D09YEY DRUG__ID D09YEY D09YEY HIGHSTAT Approved D0A2RG DRUG__ID D0A2RG D0A2RG HIGHSTAT Approved D0AM4P DRUG__ID D0AM4P D0AM4P HIGHSTAT Approved D0B1EM DRUG__ID D0B1EM D0B1EM HIGHSTAT Approved D0BK4X DRUG__ID D0BK4X D0BK4X HIGHSTAT Approved D0BU8L DRUG__ID D0BU8L D0BU8L HIGHSTAT Approved D0C8RW DRUG__ID D0C8RW D0C8RW HIGHSTAT Approved D0C9IW DRUG__ID D0C9IW D0C9IW HIGHSTAT Approved D0CH1U DRUG__ID D0CH1U D0CH1U HIGHSTAT Approved D0D1RM DRUG__ID D0D1RM D0D1RM HIGHSTAT Approved D0D4HM DRUG__ID D0D4HM D0D4HM HIGHSTAT Approved D0D7DH DRUG__ID D0D7DH D0D7DH HIGHSTAT Approved D0D8ZB DRUG__ID D0D8ZB D0D8ZB HIGHSTAT Approved D0D9NP DRUG__ID D0D9NP D0D9NP HIGHSTAT Approved D0DE4U DRUG__ID D0DE4U D0DE4U HIGHSTAT Approved D0DT1E DRUG__ID D0DT1E D0DT1E HIGHSTAT Approved D0E0ST DRUG__ID D0E0ST D0E0ST HIGHSTAT Approved D0E7US DRUG__ID D0E7US D0E7US HIGHSTAT Approved D0F3LS DRUG__ID D0F3LS D0F3LS HIGHSTAT Approved D0F8EM DRUG__ID D0F8EM D0F8EM HIGHSTAT Approved D0FX6P DRUG__ID D0FX6P D0FX6P HIGHSTAT Approved D0FY3O DRUG__ID D0FY3O D0FY3O HIGHSTAT Approved D0G2TA DRUG__ID D0G2TA D0G2TA HIGHSTAT Approved D0GT9I DRUG__ID D0GT9I D0GT9I HIGHSTAT Approved D0GY5T DRUG__ID D0GY5T D0GY5T HIGHSTAT Approved D0GZ5M DRUG__ID D0GZ5M D0GZ5M HIGHSTAT Approved D0H0SL DRUG__ID D0H0SL D0H0SL HIGHSTAT Approved D0H1WY DRUG__ID D0H1WY D0H1WY HIGHSTAT Approved D0I6FA DRUG__ID D0I6FA D0I6FA HIGHSTAT Approved D0I6FS DRUG__ID D0I6FS D0I6FS HIGHSTAT Approved D0J0KD DRUG__ID D0J0KD D0J0KD HIGHSTAT Approved D0J1PW DRUG__ID D0J1PW D0J1PW HIGHSTAT Approved D0J3BU DRUG__ID D0J3BU D0J3BU HIGHSTAT Approved D0J6BR DRUG__ID D0J6BR D0J6BR HIGHSTAT Approved D0J6LP DRUG__ID D0J6LP D0J6LP HIGHSTAT Approved D0JS2A DRUG__ID D0JS2A D0JS2A HIGHSTAT Approved D0K2FH DRUG__ID D0K2FH D0K2FH HIGHSTAT Approved D0K2GA DRUG__ID D0K2GA D0K2GA HIGHSTAT Approved D0K3XP DRUG__ID D0K3XP D0K3XP HIGHSTAT Approved D0K5CX DRUG__ID D0K5CX D0K5CX HIGHSTAT Approved D0K6VD DRUG__ID D0K6VD D0K6VD HIGHSTAT Approved D0K8AA DRUG__ID D0K8AA D0K8AA HIGHSTAT Approved D0L0JM DRUG__ID D0L0JM D0L0JM HIGHSTAT Approved D0L1QF DRUG__ID D0L1QF D0L1QF HIGHSTAT Approved D0L6BI DRUG__ID D0L6BI D0L6BI HIGHSTAT Approved D0L7JR DRUG__ID D0L7JR D0L7JR HIGHSTAT Approved D0L7YL DRUG__ID D0L7YL D0L7YL HIGHSTAT Approved D0M1CZ DRUG__ID D0M1CZ D0M1CZ HIGHSTAT Approved D0M2BR DRUG__ID D0M2BR D0M2BR HIGHSTAT Approved D0M3KK DRUG__ID D0M3KK D0M3KK HIGHSTAT Approved D0M8PD DRUG__ID D0M8PD D0M8PD HIGHSTAT Approved D0MG1Y DRUG__ID D0MG1Y D0MG1Y HIGHSTAT Approved D0N1NE DRUG__ID D0N1NE D0N1NE HIGHSTAT Approved D0N2BX DRUG__ID D0N2BX D0N2BX HIGHSTAT Approved D0N3NZ DRUG__ID D0N3NZ D0N3NZ HIGHSTAT Approved D0N5VL DRUG__ID D0N5VL D0N5VL HIGHSTAT Approved D0N7XI DRUG__ID D0N7XI D0N7XI HIGHSTAT Approved D0O0NY DRUG__ID D0O0NY D0O0NY HIGHSTAT Approved D0O0ZG DRUG__ID D0O0ZG D0O0ZG HIGHSTAT Approved D0O1AN DRUG__ID D0O1AN D0O1AN HIGHSTAT Approved D0OF2K DRUG__ID D0OF2K D0OF2K HIGHSTAT Approved D0P2BV DRUG__ID D0P2BV D0P2BV HIGHSTAT Approved D0P4EC DRUG__ID D0P4EC D0P4EC HIGHSTAT Approved D0P5AP DRUG__ID D0P5AP D0P5AP HIGHSTAT Approved D0P5VC DRUG__ID D0P5VC D0P5VC HIGHSTAT Approved D0P6UK DRUG__ID D0P6UK D0P6UK HIGHSTAT Approved D0Q1YZ DRUG__ID D0Q1YZ D0Q1YZ HIGHSTAT Approved D0Q2WS DRUG__ID D0Q2WS D0Q2WS HIGHSTAT Approved D0Q2ZT DRUG__ID D0Q2ZT D0Q2ZT HIGHSTAT Approved D0Q7RA DRUG__ID D0Q7RA D0Q7RA HIGHSTAT Approved D0QD6R DRUG__ID D0QD6R D0QD6R HIGHSTAT Approved D0QD9R DRUG__ID D0QD9R D0QD9R HIGHSTAT Approved D0QW9H DRUG__ID D0QW9H D0QW9H HIGHSTAT Approved D0R6RE DRUG__ID D0R6RE D0R6RE HIGHSTAT Approved D0R7US DRUG__ID D0R7US D0R7US HIGHSTAT Approved D0S2NI DRUG__ID D0S2NI D0S2NI HIGHSTAT Approved D0S5EB DRUG__ID D0S5EB D0S5EB HIGHSTAT Approved D0S7XV DRUG__ID D0S7XV D0S7XV HIGHSTAT Approved D0SZ2E DRUG__ID D0SZ2E D0SZ2E HIGHSTAT Approved D0T0YB DRUG__ID D0T0YB D0T0YB HIGHSTAT Approved D0T2RZ DRUG__ID D0T2RZ D0T2RZ HIGHSTAT Approved D0TX7T DRUG__ID D0TX7T D0TX7T HIGHSTAT Approved D0TY0G DRUG__ID D0TY0G D0TY0G HIGHSTAT Approved D0TZ1C DRUG__ID D0TZ1C D0TZ1C HIGHSTAT Approved D0U6BJ DRUG__ID D0U6BJ D0U6BJ HIGHSTAT Approved D0U7HJ DRUG__ID D0U7HJ D0U7HJ HIGHSTAT Approved D0U8JN DRUG__ID D0U8JN D0U8JN HIGHSTAT Approved D0V0RY DRUG__ID D0V0RY D0V0RY HIGHSTAT Approved D0V1QC DRUG__ID D0V1QC D0V1QC HIGHSTAT Approved D0V2DV DRUG__ID D0V2DV D0V2DV HIGHSTAT Approved D0V2KE DRUG__ID D0V2KE D0V2KE HIGHSTAT Approved D0V5AJ DRUG__ID D0V5AJ D0V5AJ HIGHSTAT Approved D0V6XJ DRUG__ID D0V6XJ D0V6XJ HIGHSTAT Approved D0V7IE DRUG__ID D0V7IE D0V7IE HIGHSTAT Approved D0W3NN DRUG__ID D0W3NN D0W3NN HIGHSTAT Approved D0X1RR DRUG__ID D0X1RR D0X1RR HIGHSTAT Approved D0X6LC DRUG__ID D0X6LC D0X6LC HIGHSTAT Approved D0XE8H DRUG__ID D0XE8H D0XE8H HIGHSTAT Approved D0XV5B DRUG__ID D0XV5B D0XV5B HIGHSTAT Approved D0Y2TK DRUG__ID D0Y2TK D0Y2TK HIGHSTAT Approved D0Y7OJ DRUG__ID D0Y7OJ D0Y7OJ HIGHSTAT Approved D0Y9FF DRUG__ID D0Y9FF D0Y9FF HIGHSTAT Approved D0YB5G DRUG__ID D0YB5G D0YB5G HIGHSTAT Approved D0YG3K DRUG__ID D0YG3K D0YG3K HIGHSTAT Approved D90GKY DRUG__ID D90GKY D90GKY HIGHSTAT Approved D00SQN DRUG__ID D00SQN D00SQN DRUGCOMP HUYA Bioscience International; Quintiles D00SQN DRUGTYPE Small molecular drug D00SQN DRUGINCH 1S/C22H19FN4O2/c23-18-8-9-20(19(24)12-18)27-22(29)17-6-3-16(4-7-17)14-26-21(28)10-5-15-2-1-11-25-13-15/h1-13H,14,24H2,(H,26,28)(H,27,29)/b10-5+ D00SQN DRUGINKE SZMJVTADHFNAIS-BJMVGYQFSA-N D00SQN DRUGSMIL C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N D00SQN HIGHSTAT Registered D06WRJ DRUG__ID D06WRJ D06WRJ DRUGCOMP Beta Pharma Inc D06WRJ DRUGTYPE Small molecular drug D06WRJ DRUGINCH 1S/C22H21N3O4.ClH/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20;/h1,3-5,12-15H,6-11H2,(H,23,24,25);1H D06WRJ DRUGINKE PNNGXMJMUUJHAV-UHFFFAOYSA-N D06WRJ DRUGSMIL C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4.Cl D06WRJ HIGHSTAT Registered D0R6IM DRUG__ID D0R6IM D0R6IM DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0R6IM DRUGTYPE Small molecular drug D0R6IM DRUGINCH 1S/C23H27ClO7.C4H11N5.ClH/c1-28-23-21(27)19(25)20(26)22(31-23)14-4-7-18(24)15(11-14)10-13-2-5-16(6-3-13)30-17-8-9-29-12-17;1-9(2)4(7)8-3(5)6;/h2-7,11,17,19-23,25-27H,8-10,12H2,1H3;1-2H3,(H5,5,6,7,8);1H/t17-,19+,20+,21-,22-,23-;;/m0../s1 D0R6IM DRUGINKE YBRWIMHXUHRVDV-ZBYKXHQASA-N D0R6IM DRUGSMIL CN(C)C(=N)N=C(N)N.COC1C(C(C(C(O1)C2=CC(=C(C=C2)Cl)CC3=CC=C(C=C3)OC4CCOC4)O)O)O.Cl D0R6IM HIGHSTAT Registered D0Y4LX DRUG__ID D0Y4LX D0Y4LX DRUGCOMP Toyama Chemical D0Y4LX DRUGTYPE Small molecular drug D0Y4LX DRUGINCH 1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11) D0Y4LX DRUGINKE ZCGNOVWYSGBHAU-UHFFFAOYSA-N D0Y4LX DRUGSMIL C1=C(N=C(C(=O)N1)C(=O)N)F D0Y4LX HIGHSTAT Registered D04ZXP DRUG__ID D04ZXP D04ZXP DRUGCOMP Peking University D04ZXP DRUGINCH 1S/2C6H8O4.2H3N.Pt/c2*7-4(8)6(5(9)10)2-1-3-6;;;/h2*1-3H2,(H,7,8)(H,9,10);2*1H3;/q;;;;+2/p-2 D04ZXP DRUGINKE IIJQICKYWPGJDT-UHFFFAOYSA-L D04ZXP DRUGSMIL C1CC(C1)(C(=O)O)C(=O)O.C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2] D04ZXP HIGHSTAT Registered D07VFD DRUG__ID D07VFD D07VFD DRUGTYPE Small molecular drug D07VFD DRUGINCH 1S/C12H19NO2/c1-2-8-3-9-5-12(7-13,6-11(14)15)10(9)4-8/h4,9-10H,2-3,5-7,13H2,1H3,(H,14,15)/t9-,10-,12-/m1/s1 D07VFD DRUGINKE FTBQORVNHOIASH-CKYFFXLPSA-N D07VFD DRUGSMIL CCC1=CC2C(C1)CC2(CC(=O)O)CN D07VFD HIGHSTAT Registered D0Q2ZV DRUG__ID D0Q2ZV D0Q2ZV DRUGTYPE Small molecular drug D0Q2ZV DRUGINCH 1S/C17H27Cl2N5.ClH/c1-2-3-4-5-6-7-10-22-16(20)24-17(21)23-12-13-8-9-14(18)15(19)11-13;/h8-9,11H,2-7,10,12H2,1H3,(H5,20,21,22,23,24);1H D0Q2ZV DRUGINKE GVBQOBUYEOFFLD-UHFFFAOYSA-N D0Q2ZV DRUGSMIL CCCCCCCCN=C(N)NC(=NCC1=CC(=C(C=C1)Cl)Cl)N.Cl D0Q2ZV HIGHSTAT Registered D0U2CV DRUG__ID D0U2CV D0U2CV DRUGTYPE Small molecular drug D0U2CV DRUGINCH 1S/C10H15N5/c1-4-14(5-2)9-6-8(3)13-10-11-7-12-15(9)10/h6-7H,4-5H2,1-3H3 D0U2CV DRUGINKE GSNOZLZNQMLSKJ-UHFFFAOYSA-N D0U2CV DRUGSMIL CCN(CC)C1=CC(=NC2=NC=NN12)C D0U2CV HIGHSTAT Phase 4 DRMX13 DRUG__ID DRMX13 DRMX13 DRUGCOMP GlaxoSmithKline DRMX13 DRUGTYPE Vaccine DRMX13 HIGHSTAT Registered D01KCE DRUG__ID D01KCE D01KCE DRUGCOMP Baxter; Takeda D01KCE HIGHSTAT Registered D02XGF DRUG__ID D02XGF D02XGF DRUGCOMP Sanofi Pasteur D02XGF HIGHSTAT Registered D0QL9W DRUG__ID D0QL9W D0QL9W DRUGCOMP Sanofi Pasteur-Daiichi Sankyo Vaccines Co Ltd D0QL9W HIGHSTAT Registered D0SR6S DRUG__ID D0SR6S D0SR6S DRUGCOMP Panacea Biotec Ltd D0SR6S HIGHSTAT Registered D0SX4D DRUG__ID D0SX4D D0SX4D DRUGCOMP Chemo-Sero-Therapeutic Research Inst D0SX4D HIGHSTAT Registered D0B0AX DRUG__ID D0B0AX D0B0AX DRUGCOMP Enzon D0B0AX THERCLAS Anticancer Agents D0B0AX DRUGTYPE Small molecular drug D0B0AX DRUGINCH 1S/C20H24N6O3/c1-20(2,3)26-19(27)25-17-15(8-12-10-22-18(21)24-16(12)23-17)11-6-13(28-4)9-14(7-11)29-5/h6-10H,1-5H3,(H4,21,22,23,24,25,26,27) D0B0AX DRUGINKE NHJSWORVNIOXIT-UHFFFAOYSA-N D0B0AX DRUGSMIL CC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=CC(=CC(=C3)OC)OC D0B0AX HIGHSTAT Phase 4 D01ZUA DRUG__ID D01ZUA D01ZUA DRUGCOMP Ryan Pharmaceuticals Inc D01ZUA DRUGTYPE Small molecular drug D01ZUA DRUGINCH 1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+ D01ZUA DRUGINKE ACTIUHUUMQJHFO-UPTCCGCDSA-N D01ZUA DRUGSMIL CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C D01ZUA HIGHSTAT Phase 4 D03IUD DRUG__ID D03IUD D03IUD DRUGCOMP Fujisawa Pharmaceutical Co Ltd; Calixa Therapeutics Inc D03IUD DRUGTYPE Small molecular drug D03IUD DRUGINCH 1S/C23H30N12O8S2.H2O4S/c1-23(2,20(40)41)43-31-11(15-30-21(26)45-32-15)16(36)29-12-17(37)35-13(19(38)39)9(8-44-18(12)35)6-34-7-10(14(25)33(34)3)28-22(42)27-5-4-24;1-5(2,3)4/h7,12,18,25H,4-6,8,24H2,1-3H3,(H7,26,27,28,29,30,32,36,38,39,40,41,42);(H2,1,2,3,4)/b31-11+;/t12-,18-;/m1./s1 D03IUD DRUGINKE UJDQGRLTPBVSFN-GZGOMJRCSA-N D03IUD DRUGSMIL CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)O.OS(=O)(=O)[O-] D03IUD HIGHSTAT Phase 4 D05QHL DRUG__ID D05QHL D05QHL DRUGCOMP ONO Pharmaceuticals D05QHL DRUGTYPE Small molecular drug D05QHL DRUGINCH 1S/C20H22N2O7S.Na.4H2O/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24;;;;;/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24);;4*1H2/q;+1;;;;/p-1 D05QHL DRUGINKE PLHREJBSQUSUCW-UHFFFAOYSA-M D05QHL DRUGSMIL CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)[O-].O.O.O.O.[Na+] D05QHL HIGHSTAT Phase 4 D06PTA DRUG__ID D06PTA D06PTA DRUGCOMP Sunovion Pharmaceuticals D06PTA DRUGTYPE Small molecular drug D06PTA DRUGINCH 1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17-,18?,19?,21?/m1/s1 D06PTA DRUGINKE OEXHQOGQTVQTAT-IPHBXJNRSA-N D06PTA DRUGSMIL CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C D06PTA HIGHSTAT Phase 4 D07HOF DRUG__ID D07HOF D07HOF DRUGCOMP Chugai Pharmaceutical Co Ltd D07HOF DRUGTYPE Small molecular drug D07HOF DRUGINCH 1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/p-1/t11-,12+,14-/m1/s1 D07HOF DRUGINKE JGSARLDLIJGVTE-MBNYWOFBSA-M D07HOF DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C D07HOF HIGHSTAT Phase 4 D0B4RU DRUG__ID D0B4RU D0B4RU DRUGCOMP Duke University D0B4RU DRUGTYPE Small molecular drug D0B4RU DRUGINCH 1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1 D0B4RU DRUGINKE ORNBQBCIOKFOEO-QGVNFLHTSA-N D0B4RU DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C D0B4RU HIGHSTAT Phase 4 D0C7AA DRUG__ID D0C7AA D0C7AA DRUGCOMP Kissei Pharmaceutical Co Ltd D0C7AA DRUGTYPE Small molecular drug D0C7AA DRUGINCH 1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+ D0C7AA DRUGINKE SHZKQBHERIJWAO-AATRIKPKSA-N D0C7AA DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O D0C7AA HIGHSTAT Phase 4 D0FW2A DRUG__ID D0FW2A D0FW2A DRUGCOMP LEO Pharma D0FW2A DRUGTYPE Small molecular drug D0FW2A DRUGINCH 1S/C28H37FO7.C27H40O3/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5;1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3;6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b;13-6+,19-7+,21-10-/t16-,19-,20-,21-,25-,26-,27-,28-;17-,22-,23-,24+,25-,26+,27-/m01/s1 D0FW2A DRUGINKE CNXNMLQATFFYLX-ICTDYHGOSA-N D0FW2A DRUGSMIL CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC.CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D0FW2A HIGHSTAT Phase 4 D0H5LK DRUG__ID D0H5LK D0H5LK DRUGCOMP Furiex pharmaceuticals D0H5LK DRUGTYPE Small molecular drug D0H5LK DRUGINCH 1S/C21H23NO/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21/h3-14,20H,15-16H2,1-2H3/t20-/m0/s1 D0H5LK DRUGINKE USRHYDPUVLEVMC-FQEVSTJZSA-N D0H5LK DRUGSMIL CN(C)C(CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3 D0H5LK HIGHSTAT Phase 4 D0I2WV DRUG__ID D0I2WV D0I2WV DRUGCOMP SK Chemicals Co Ltd D0I2WV DRUGTYPE Small molecular drug D0I2WV DRUGINCH 1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3/t17-/m0/s1 D0I2WV DRUGINKE HTIQEAQVCYTUBX-KRWDZBQOSA-N D0I2WV DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN D0I2WV HIGHSTAT Phase 4 D0Q1IT DRUG__ID D0Q1IT D0Q1IT DRUGCOMP Almirall D0Q1IT DRUGTYPE Small molecular drug D0Q1IT DRUGINCH 1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m0/s1 D0Q1IT DRUGINKE BPZSYCZIITTYBL-ORAYPTAESA-N D0Q1IT DRUGSMIL CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O D0Q1IT HIGHSTAT Phase 4 D0T6RC DRUG__ID D0T6RC D0T6RC DRUGCOMP Mundipharma AG D0T6RC DRUGTYPE Small molecular drug D0T6RC DRUGINCH 1S/C18H23NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-13,17,20H,4-5,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1 D0T6RC DRUGINKE RBOXVHNMENFORY-DNJOTXNNSA-N D0T6RC DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(CC4)O D0T6RC HIGHSTAT Phase 4 D0Y4DY DRUG__ID D0Y4DY D0Y4DY DRUGCOMP Fortune Apex Development Ltd D0Y4DY DRUGTYPE Small molecular drug D0Y4DY DRUGINCH 1S/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18) D0Y4DY DRUGINKE HUCJFAOMUPXHDK-UHFFFAOYSA-N D0Y4DY DRUGSMIL CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C D0Y4DY HIGHSTAT Phase 4 D63WMQ DRUG__ID D63WMQ D63WMQ DRUGCOMP Neurocrine Biosciences D63WMQ DRUGTYPE Small molecular drug D63WMQ DRUGINCH 1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1 D63WMQ DRUGINKE GEJDGVNQKABXKG-CFKGEZKQSA-N D63WMQ DRUGSMIL CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC D63WMQ HIGHSTAT Phase 4 D81KMY DRUG__ID D81KMY D81KMY DRUGCOMP UCB D81KMY DRUGTYPE Small molecular drug D81KMY DRUGINCH 1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1 D81KMY DRUGINKE KFQYTPMOWPVWEJ-INIZCTEOSA-N D81KMY DRUGSMIL CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O D81KMY HIGHSTAT Phase 4 DRL5Y7 DRUG__ID DRL5Y7 DRL5Y7 DRUGCOMP Supernus Pharmaceuticals DRL5Y7 DRUGTYPE Small molecular drug DRL5Y7 DRUGINCH 1S/C13H19NO3.ClH/c1-2-15-12-5-3-4-6-13(12)17-10-11-9-14-7-8-16-11;/h3-6,11,14H,2,7-10H2,1H3;1H DRL5Y7 DRUGINKE HJOCKFVCMLCPTP-UHFFFAOYSA-N DRL5Y7 DRUGSMIL CCOC1=CC=CC=C1OCC2CNCCO2.Cl DRL5Y7 HIGHSTAT Phase 4 D02UDJ DRUG__ID D02UDJ D02UDJ DRUGTYPE Small molecular drug D02UDJ DRUGINCH 1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1 D02UDJ DRUGINKE MTCFGRXMJLQNBG-UWTATZPHSA-N D02UDJ DRUGSMIL C(C(C(=O)O)N)O D02UDJ HIGHSTAT Phase 4 D03ZJE DRUG__ID D03ZJE D03ZJE DRUGTYPE Small molecular drug D03ZJE DRUGINCH 1S/C16H27NO4/c1-2-3-4-5-6-7-8-9-13(18)12-15(19)17-14-10-11-21-16(14)20/h14H,2-12H2,1H3,(H,17,19)/t14-/m0/s1 D03ZJE DRUGINKE PHSRRHGYXQCRPU-AWEZNQCLSA-N D03ZJE DRUGSMIL CCCCCCCCCC(=O)CC(=O)NC1CCOC1=O D03ZJE HIGHSTAT Phase 4 D04DJN DRUG__ID D04DJN D04DJN DRUGTYPE Small molecular drug D04DJN DRUGINCH 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1 D04DJN DRUGINKE NVKAWKQGWWIWPM-ABEVXSGRSA-N D04DJN DRUGSMIL CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4O)C D04DJN HIGHSTAT Phase 4 D05SGO DRUG__ID D05SGO D05SGO DRUGTYPE Small molecular drug D05SGO DRUGINCH 1S/C120H188N34O35S/c1-9-64(6)97(152-114(184)86-31-22-53-154(86)117(187)96(63(4)5)151-99(169)70(123)56-66-23-12-10-13-24-66)115(185)150-84(57-67-25-14-11-15-26-67)113(183)153-98(65(7)155)116(186)149-83(58-68-32-34-69(156)35-33-68)101(171)135-60-91(161)136-75(39-45-93(163)164)105(175)147-82(55-62(2)3)111(181)145-77(37-43-88(125)158)106(176)140-73(29-20-51-132-119(128)129)103(173)146-80(48-54-190-8)110(180)142-76(36-42-87(124)157)107(177)144-79(41-47-95(167)168)108(178)139-72(28-17-19-50-122)102(172)143-78(40-46-94(165)166)109(179)141-74(30-21-52-133-120(130)131)104(174)148-85(59-90(127)160)112(182)138-71(27-16-18-49-121)100(170)134-61-92(162)137-81(118(188)189)38-44-89(126)159/h10-15,23-26,32-35,62-65,70-86,96-98,155-156H,9,16-22,27-31,36-61,121-123H2,1-8H3,(H2,124,157)(H2,125,158)(H2,126,159)(H2,127,160)(H,134,170)(H,135,171)(H,136,161)(H,137,162)(H,138,182)(H,139,178)(H,140,176)(H,141,179)(H,142,180)(H,143,172)(H,144,177)(H,145,181)(H,146,173)(H,147,175)(H,148,174)(H,149,186)(H,150,185)(H,151,169)(H,152,184)(H,153,183)(H,163,164)(H,165,166)(H,167,168)(H,188,189)(H4,128,129,132)(H4,130,131,133)/t64-,65+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,96-,97-,98-/m0/s1 D05SGO DRUGINKE LVRVABPNVHYXRT-BQWXUCBYSA-N D05SGO DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCSC)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C3CCCN3C(=O)C(C(C)C)NC(=O)C(CC4=CC=CC=C4)N D05SGO HIGHSTAT Phase 4 D05UWI DRUG__ID D05UWI D05UWI DRUGTYPE Small molecular drug D05UWI DRUGINCH 1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22) D05UWI DRUGINKE TZRHLKRLEZJVIJ-UHFFFAOYSA-N D05UWI DRUGSMIL CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C D05UWI HIGHSTAT Phase 4 D06PZN DRUG__ID D06PZN D06PZN DRUGTYPE Small molecular drug D06PZN DRUGINCH 1S/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27) D06PZN DRUGINKE YPELFRMCRYSPKZ-UHFFFAOYSA-N D06PZN DRUGSMIL CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N D06PZN HIGHSTAT Phase 4 D08BYK DRUG__ID D08BYK D08BYK DRUGTYPE Small molecular drug D08BYK DRUGINCH 1S/C9H12N2O4S/c1-9(2)5(8(14)15)11-6(13)4(10-3-12)7(11)16-9/h3-5,7H,1-2H3,(H,10,12)(H,14,15)/t4-,5+,7-/m1/s1 D08BYK DRUGINKE MDQGTDMBVJCTBN-JCGDXUMPSA-N D08BYK DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC=O)C(=O)O)C D08BYK HIGHSTAT Phase 4 D0AL8M DRUG__ID D0AL8M D0AL8M DRUGTYPE Small molecular drug D0AL8M DRUGINCH 1S/C21H23NO3S/c1-4-13-22-14-19(16-9-11-18(12-10-16)26(3,24)25)20(21(22)23)17-7-5-15(2)6-8-17/h5-12H,4,13-14H2,1-3H3 D0AL8M DRUGINKE AXMZZGKKZDJGAZ-UHFFFAOYSA-N D0AL8M DRUGSMIL CCCN1CC(=C(C1=O)C2=CC=C(C=C2)C)C3=CC=C(C=C3)S(=O)(=O)C D0AL8M HIGHSTAT Phase 4 D0AZ8C DRUG__ID D0AZ8C D0AZ8C DRUGTYPE Small molecular drug D0AZ8C DRUGINCH 1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3 D0AZ8C DRUGINKE SEBFKMXJBCUCAI-UHFFFAOYSA-N D0AZ8C DRUGSMIL COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O D0AZ8C HIGHSTAT Phase 4 D0D8XY DRUG__ID D0D8XY D0D8XY DRUGTYPE Small molecular drug D0D8XY DRUGINCH 1S/C43H67N11O12S2/c1-5-23(3)35-41(63)53-36(24(4)55)42(64)50-29(20-32(45)56)38(60)51-30(43(65)54-17-8-10-31(54)40(62)49-27(9-7-16-44)37(59)47-21-33(46)57)22-68-67-18-15-34(58)48-28(39(61)52-35)19-25-11-13-26(14-12-25)66-6-2/h11-14,23-24,27-31,35-36,55H,5-10,15-22,44H2,1-4H3,(H2,45,56)(H2,46,57)(H,47,59)(H,48,58)(H,49,62)(H,50,64)(H,51,60)(H,52,61)(H,53,63)/t23-,24+,27-,28+,29-,30-,31-,35-,36-/m0/s1 D0D8XY DRUGINKE VWXRQYYUEIYXCZ-OBIMUBPZSA-N D0D8XY DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCC3C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N)C(C)O D0D8XY HIGHSTAT Phase 4 D0F3SZ DRUG__ID D0F3SZ D0F3SZ DRUGTYPE Small molecular drug D0F3SZ DRUGINCH 1S/C287H440N80O113S7/c1-25-133(19)226-281(469)345-161(87-125(3)4)235(423)306-111-208(394)320-180(116-370)266(454)344-175(101-219(414)415)237(425)307-105-202(388)316-151(62-75-212(400)401)242(430)321-145(41-30-33-81-288)240(428)339-170(96-197(297)383)258(446)326-152(57-70-193(293)379)249(437)351-185(121-484-481-118-182-239(427)310-107-201(387)313-147(55-68-191(291)377)232(420)303-108-205(391)317-169(95-196(296)382)257(445)322-146(42-31-34-82-289)241(429)350-186(271(459)360-226)122-485-482-119-183(268(456)323-149(61-74-211(398)399)234(422)304-110-207(393)319-179(115-369)265(453)342-173(99-200(300)386)264(452)357-223(130(13)14)279(467)355-182)352-253(441)164(90-128(9)10)335-269(457)184-120-483-486-123-187(354-262(450)177(103-221(418)419)347-283(471)230(137(23)374)362-263(451)167(92-140-47-51-143(376)52-48-140)346-278(466)224(131(15)16)359-276(464)222(301)129(11)12)272(460)363-229(136(22)373)282(470)330-157(66-79-216(408)409)248(436)348-178(114-368)238(426)309-106-203(389)315-150(56-69-192(292)378)243(431)340-171(97-198(298)384)259(447)334-163(89-127(7)8)252(440)353-184)270(458)358-225(132(17)18)280(468)364-228(135(21)372)277(465)311-112-204(390)314-148(60-73-210(396)397)233(421)305-113-209(395)356-231(138(24)375)286(474)367-86-38-46-190(367)275(463)331-159(43-32-35-83-290)284(472)365-84-36-44-188(365)273(461)328-153(58-71-194(294)380)247(435)349-181(117-371)267(455)338-168(94-142-104-302-124-312-142)256(444)341-172(98-199(299)385)260(448)343-174(100-218(412)413)236(424)308-109-206(392)318-176(102-220(416)417)261(449)337-165(91-139-39-28-27-29-40-139)254(442)327-154(63-76-213(402)403)244(432)325-158(67-80-217(410)411)250(438)361-227(134(20)26-2)285(473)366-85-37-45-189(366)274(462)329-156(65-78-215(406)407)245(433)324-155(64-77-214(404)405)246(434)336-166(93-141-49-53-144(54-50-141)480-487(477,478)479)255(443)333-162(88-126(5)6)251(439)332-160(287(475)476)59-72-195(295)381/h27-29,39-40,47-54,104,124-138,145-190,222-231,368-376H,25-26,30-38,41-46,55-103,105-123,288-290,301H2,1-24H3,(H2,291,377)(H2,292,378)(H2,293,379)(H2,294,380)(H2,295,381)(H2,296,382)(H2,297,383)(H2,298,384)(H2,299,385)(H2,300,386)(H,302,312)(H,303,420)(H,304,422)(H,305,421)(H,306,423)(H,307,425)(H,308,424)(H,309,426)(H,310,427)(H,311,465)(H,313,387)(H,314,390)(H,315,389)(H,316,388)(H,317,391)(H,318,392)(H,319,393)(H,320,394)(H,321,430)(H,322,445)(H,323,456)(H,324,433)(H,325,432)(H,326,446)(H,327,442)(H,328,461)(H,329,462)(H,330,470)(H,331,463)(H,332,439)(H,333,443)(H,334,447)(H,335,457)(H,336,434)(H,337,449)(H,338,455)(H,339,428)(H,340,431)(H,341,444)(H,342,453)(H,343,448)(H,344,454)(H,345,469)(H,346,466)(H,347,471)(H,348,436)(H,349,435)(H,350,429)(H,351,437)(H,352,441)(H,353,440)(H,354,450)(H,355,467)(H,356,395)(H,357,452)(H,358,458)(H,359,464)(H,360,459)(H,361,438)(H,362,451)(H,363,460)(H,364,468)(H,396,397)(H,398,399)(H,400,401)(H,402,403)(H,404,405)(H,406,407)(H,408,409)(H,410,411)(H,412,413)(H,414,415)(H,416,417)(H,418,419)(H,475,476)(H,477,478,479)/t133-,134-,135+,136+,137+,138+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,222-,223-,224-,225-,226-,227-,228-,229-,230-,231-/m0/s1 D0F3SZ DRUGINKE WQPDUTSPKFMPDP-OUMQNGNKSA-N D0F3SZ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)OS(=O)(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C D0F3SZ HIGHSTAT Phase 4 D0F4CG DRUG__ID D0F4CG D0F4CG DRUGCOMP Avid radiopharmaceuticals; eli lilly; sgc pharma D0F4CG DRUGINCH 1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H/i17-1 D0F4CG DRUGINKE GETAAWDSFUCLBS-SJPDSGJFSA-N D0F4CG DRUGSMIL C1=CC2=C(C=C1C3=CN=C(C=C3)F)NC4=C2C=NC=C4 D0F4CG HIGHSTAT Phase 4 D0N1FS DRUG__ID D0N1FS D0N1FS DRUGTYPE Small molecular drug D0N1FS DRUGINCH 1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25) D0N1FS DRUGINKE TYNLGDBUJLVSMA-UHFFFAOYSA-N D0N1FS DRUGSMIL CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O D0N1FS HIGHSTAT Phase 4 D0PI8W DRUG__ID D0PI8W D0PI8W DRUGTYPE Small molecular drug D0PI8W DRUGINCH 1S/C165H261N51O55S2/c1-22-75(12)124(159(266)200-95(47-71(4)5)140(247)203-108(64-219)153(260)206-110(66-221)154(261)216-129(84(21)226)163(270)202-105(58-119(174)234)147(254)209-122(73(8)9)157(264)181-61-121(236)187-106(62-217)150(257)198-103(56-117(172)232)148(255)215-128(83(20)225)162(269)190-93(130(175)237)49-87-38-40-89(227)41-39-87)211-132(239)76(13)183-120(235)60-180-136(243)97(50-85-32-25-23-26-33-85)194-144(251)101(54-115(170)230)196-145(252)102(55-116(171)231)197-151(258)107(63-218)205-152(259)109(65-220)204-142(249)99(52-88-59-178-69-182-88)201-158(265)123(74(10)11)210-146(253)96(48-72(6)7)193-141(248)98(51-86-34-27-24-28-35-86)195-143(250)100(53-114(169)229)191-131(238)77(14)184-139(246)94(46-70(2)3)192-137(244)91(37-31-45-179-165(176)177)188-138(245)92(42-43-113(168)228)189-161(268)126(81(18)223)212-133(240)78(15)185-155(262)111-67-272-273-68-112(207-135(242)90(167)36-29-30-44-166)156(263)199-104(57-118(173)233)149(256)214-125(80(17)222)160(267)186-79(16)134(241)213-127(82(19)224)164(271)208-111/h23-28,32-35,38-41,59,69-84,90-112,122-129,217-227H,22,29-31,36-37,42-58,60-68,166-167H2,1-21H3,(H2,168,228)(H2,169,229)(H2,170,230)(H2,171,231)(H2,172,232)(H2,173,233)(H2,174,234)(H2,175,237)(H,178,182)(H,180,243)(H,181,264)(H,183,235)(H,184,246)(H,185,262)(H,186,267)(H,187,236)(H,188,245)(H,189,268)(H,190,269)(H,191,238)(H,192,244)(H,193,248)(H,194,251)(H,195,250)(H,196,252)(H,197,258)(H,198,257)(H,199,263)(H,200,266)(H,201,265)(H,202,270)(H,203,247)(H,204,249)(H,205,259)(H,206,260)(H,207,242)(H,208,271)(H,209,254)(H,210,253)(H,211,239)(H,212,240)(H,213,241)(H,214,256)(H,215,255)(H,216,261)(H4,176,177,179)/t75-,76-,77-,78-,79-,80+,81+,82+,83+,84+,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,122-,123-,124-,125-,126-,127-,128-,129-/m0/s1 D0PI8W DRUGINKE PLOPBXQQPZYQFA-AXPWDRQUSA-N D0PI8W DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(C)NC(=O)CNC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC3=CN=CN3)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)O)C)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N D0PI8W HIGHSTAT Phase 4 D0S1CQ DRUG__ID D0S1CQ D0S1CQ DRUGTYPE Small molecular drug D0S1CQ DRUGINCH 1S/C26H26ClN3/c1-18-13-19(16-28-15-18)17-30-11-8-20(9-12-30)25-24-7-6-23(27)14-22(24)5-4-21-3-2-10-29-26(21)25/h2-3,6-7,10,13-16H,4-5,8-9,11-12,17H2,1H3 D0S1CQ DRUGINKE WUZYKBABMWJHDL-UHFFFAOYSA-N D0S1CQ DRUGSMIL CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2 D0S1CQ HIGHSTAT Phase 4 D0S2BV DRUG__ID D0S2BV D0S2BV DRUGTYPE Small molecular drug D0S2BV DRUGINCH 1S/C10H9NO3S/c12-7-3-1-6(2-4-7)5-8-9(13)11-10(14)15-8/h1-4,8,12H,5H2,(H,11,13,14) D0S2BV DRUGINKE NKOHRVBBQISBSB-UHFFFAOYSA-N D0S2BV DRUGSMIL C1=CC(=CC=C1CC2C(=O)NC(=O)S2)O D0S2BV HIGHSTAT Phase 4 D0T8LY DRUG__ID D0T8LY D0T8LY DRUGTYPE Small molecular drug D0T8LY DRUGINCH 1S/C5H5N/c1-2-4-6-5-3-1/h1-5H D0T8LY DRUGINKE JUJWROOIHBZHMG-UHFFFAOYSA-N D0T8LY DRUGSMIL C1=CC=NC=C1 D0T8LY HIGHSTAT Phase 4 D0V9EN DRUG__ID D0V9EN D0V9EN DRUGTYPE Small molecular drug D0V9EN DRUGINCH 1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2+ D0V9EN DRUGINKE QAIPRVGONGVQAS-DUXPYHPUSA-N D0V9EN DRUGSMIL C1=CC(=C(C=C1C=CC(=O)O)O)O D0V9EN HIGHSTAT Phase 4 D0W8WB DRUG__ID D0W8WB D0W8WB DRUGTYPE Small molecular drug D0W8WB DRUGINCH 1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1 D0W8WB DRUGINKE YBHILYKTIRIUTE-UHFFFAOYSA-N D0W8WB DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC D0W8WB HIGHSTAT Phase 4 D0WL5V DRUG__ID D0WL5V D0WL5V DRUGTYPE Small molecular drug D0WL5V DRUGINCH 1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1 D0WL5V DRUGINKE NXFFJDQHYLNEJK-CYBMUJFWSA-N D0WL5V DRUGSMIL CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F D0WL5V HIGHSTAT Phase 4 D0Y7XC DRUG__ID D0Y7XC D0Y7XC DRUGTYPE Small molecular drug D0Y7XC DRUGINCH 1S/C10H15N3S/c1-2-5-13-6-3-8-9(4-7-13)14-10(11)12-8/h2H,1,3-7H2,(H2,11,12) D0Y7XC DRUGINKE DHSSDEDRBUKTQY-UHFFFAOYSA-N D0Y7XC DRUGSMIL C=CCN1CCC2=C(CC1)SC(=N2)N D0Y7XC HIGHSTAT Phase 4 D4Q5AW DRUG__ID D4Q5AW D4Q5AW DRUGTYPE Small molecular drug D4Q5AW DRUGINCH 1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+ D4Q5AW DRUGINKE CTPOHARTNNSRSR-OUKQBFOZSA-N D4Q5AW DRUGSMIL CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O D4Q5AW HIGHSTAT Phase 4 D7I9JH DRUG__ID D7I9JH D7I9JH DRUGTYPE Small molecular drug D7I9JH DRUGINCH 1S/C2H2Cl2O2/c3-1(4)2(5)6/h1H,(H,5,6)/p-1 D7I9JH DRUGINKE JXTHNDFMNIQAHM-UHFFFAOYSA-M D7I9JH DRUGSMIL C(C(=O)[O-])(Cl)Cl D7I9JH HIGHSTAT Phase 4 D02DPP DRUG__ID D02DPP D02DPP DRUGTYPE Small molecular drug D02DPP DRUGSMIL C1C2CN(CN2C3=C(N1)NC(=NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O D02DPP HIGHSTAT Phase 4 D04VOZ DRUG__ID D04VOZ D04VOZ DRUGCOMP Tekmira Pharmaceuticals D04VOZ DRUGTYPE siRNA drug D04VOZ HIGHSTAT Phase 4 D04FIP DRUG__ID D04FIP D04FIP DRUGCOMP Arcarios D04FIP HIGHSTAT Phase 4 D05GGD DRUG__ID D05GGD D05GGD DRUGCOMP Sanofi D05GGD HIGHSTAT Phase 4 D05LCN DRUG__ID D05LCN D05LCN DRUGCOMP Curis Inc; Adocia SAS D05LCN HIGHSTAT Phase 4 D06GYJ DRUG__ID D06GYJ D06GYJ DRUGCOMP AFFiRiS AG D06GYJ HIGHSTAT Phase 4 D07NLI DRUG__ID D07NLI D07NLI DRUGCOMP Lantibio D07NLI HIGHSTAT Phase 4 D0D6GT DRUG__ID D0D6GT D0D6GT DRUGCOMP Marinomed Biotechnologie GmbH D0D6GT HIGHSTAT Phase 4 D0E8IT DRUG__ID D0E8IT D0E8IT DRUGCOMP Genecure LLC D0E8IT HIGHSTAT Phase 4 D0LJ5Q DRUG__ID D0LJ5Q D0LJ5Q DRUGCOMP GlaxoSmithKline D0LJ5Q HIGHSTAT Phase 4 D0N6FI DRUG__ID D0N6FI D0N6FI DRUGCOMP St Louis University D0N6FI HIGHSTAT Phase 4 D0O7IZ DRUG__ID D0O7IZ D0O7IZ DRUGCOMP Baxter healthcare D0O7IZ HIGHSTAT Phase 4 D0Q9PT DRUG__ID D0Q9PT D0Q9PT DRUGCOMP SmithKline Beecham plc D0Q9PT HIGHSTAT Phase 4 D0S0ST DRUG__ID D0S0ST D0S0ST DRUGCOMP Piramal Healthcare Ltd D0S0ST HIGHSTAT Phase 4 D0X3AK DRUG__ID D0X3AK D0X3AK DRUGCOMP National Institutes of Health D0X3AK HIGHSTAT Phase 4 D0XZ9H DRUG__ID D0XZ9H D0XZ9H DRUGCOMP Lilly D0XZ9H HIGHSTAT Phase 4 D0Y5LR DRUG__ID D0Y5LR D0Y5LR DRUGCOMP Adeona Pharmaceuticals Inc; Teva Pharmaceutical Industries Ltd D0Y5LR HIGHSTAT Phase 4 D05HUQ DRUG__ID D05HUQ D05HUQ HIGHSTAT Phase 4 D0T3FN DRUG__ID D0T3FN D0T3FN DRUGCOMP Novartis D0T3FN DRUGTYPE Small molecular drug D0T3FN DRUGINCH 1S/C256H408N74O74S8/c1-32-128(20)198-246(396)286-135(27)207(357)326-199(129(21)33-2)248(398)321-180(210(360)279-106-189(343)289-161(79-88-405-30)221(371)315-177(111-334)239(389)329-202(137(29)337)250(400)312-171(232(382)317-178(112-335)251(401)402)98-141-103-277-148-57-41-39-55-145(141)148)114-408-412-118-184(252(403)404)322-230(380)168(95-138-52-36-35-37-53-138)308-215(365)154(63-50-86-274-255(267)268)291-203(353)132(24)283-226(376)164(91-121(6)7)307-238(388)176(110-333)314-216(366)155(64-51-87-275-256(269)270)293-213(363)151(59-43-46-82-258)301-249(399)201(136(28)336)330-242(392)181-115-409-411-117-183(319-217(367)150(58-42-45-81-257)294-233(383)173(101-186(262)340)303-206(356)133(25)284-225(375)163(90-120(4)5)302-205(355)134(26)285-236(386)174(108-331)316-229(379)169(96-139-65-67-143(338)68-66-139)309-227(377)165(92-122(8)9)305-218(368)156-70-75-187(341)287-156)241(391)320-182(240(390)311-172(99-142-104-271-119-281-142)235(385)323-195(125(14)15)243(393)280-107-190(344)290-181)116-410-407-113-179(209(359)278-105-188(342)288-149(61-48-84-272-253(263)264)212(362)295-159(72-77-192(347)348)220(370)306-167(94-124(12)13)234(384)325-196(126(16)17)244(394)299-153(62-49-85-273-254(265)266)211(361)282-131(23)204(354)292-157(224(374)327-198)69-74-185(261)339)318-228(378)166(93-123(10)11)304-214(364)152(60-44-47-83-259)300-247(397)200(130(22)34-3)328-245(395)197(127(18)19)324-223(373)160(73-78-193(349)350)297-219(369)158(71-76-191(345)346)296-222(372)162(80-89-406-31)298-231(381)170(97-140-102-276-147-56-40-38-54-144(140)147)310-237(387)175(109-332)313-208(358)146(260)100-194(351)352/h35-41,52-57,65-68,102-104,119-137,146,149-184,195-202,276-277,331-338H,32-34,42-51,58-64,69-101,105-118,257-260H2,1-31H3,(H2,261,339)(H2,262,340)(H,271,281)(H,278,359)(H,279,360)(H,280,393)(H,282,361)(H,283,376)(H,284,375)(H,285,386)(H,286,396)(H,287,341)(H,288,342)(H,289,343)(H,290,344)(H,291,353)(H,292,354)(H,293,363)(H,294,383)(H,295,362)(H,296,372)(H,297,369)(H,298,381)(H,299,394)(H,300,397)(H,301,399)(H,302,355)(H,303,356)(H,304,364)(H,305,368)(H,306,370)(H,307,388)(H,308,365)(H,309,377)(H,310,387)(H,311,390)(H,312,400)(H,313,358)(H,314,366)(H,315,371)(H,316,379)(H,317,382)(H,318,378)(H,319,367)(H,320,391)(H,321,398)(H,322,380)(H,323,385)(H,324,373)(H,325,384)(H,326,357)(H,327,374)(H,328,395)(H,329,389)(H,330,392)(H,345,346)(H,347,348)(H,349,350)(H,351,352)(H,401,402)(H,403,404)(H4,263,264,272)(H4,265,266,273)(H4,267,268,274)(H4,269,270,275)/t128-,129-,130-,131-,132-,133-,134-,135-,136+,137+,146-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,195-,196-,197-,198-,199-,200-,201-,202-/m0/s1 D0T3FN DRUGINKE DTLOVISJEFBXLX-REAFJZEQSA-N D0T3FN DRUGSMIL CCC(C)C1C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)C(C)CC)CCC(=O)N)C)CCCNC(=N)N)C(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC(=O)O)N)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2)C(C)C)CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(C)C)NC(=O)C7CCC(=O)N7)C(C)O)CCCCN)CCCNC(=N)N)CO)CC(C)C)C)CCCNC(=N)N)CC8=CC=CC=C8)C(=O)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CO)C(=O)O D0T3FN HIGHSTAT Approval submitted D0G9FL DRUG__ID D0G9FL D0G9FL DRUGCOMP Taisho Pharmaceutical; Chugai Pharmaceutical D0G9FL DRUGTYPE Small molecular drug D0G9FL DRUGINCH 1S/C9H23NO7P2.Na.H2O/c1-3-4-5-7-10(2)8-6-9(11,18(12,13)14)19(15,16)17;;/h11H,3-8H2,1-2H3,(H2,12,13,14)(H2,15,16,17);;1H2/q;+1;/p-1 D0G9FL DRUGINKE VBDRTGFACFYFCT-UHFFFAOYSA-M D0G9FL DRUGSMIL CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+] D0G9FL HIGHSTAT NDA filed D0IJ0U DRUG__ID D0IJ0U D0IJ0U DRUGCOMP Taisho Pharmaceutical D0IJ0U DRUGTYPE Small molecular drug D0IJ0U DRUGINCH 1S/C23H30O6S/c1-4-29-16-7-5-14(6-8-16)10-15-11-17(18(28-3)9-13(15)2)23-22(27)21(26)20(25)19(12-24)30-23/h5-9,11,19-27H,4,10,12H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1 D0IJ0U DRUGINKE WHSOLWOTCHFFBK-ZQGJOIPISA-N D0IJ0U DRUGSMIL CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2C)OC)C3C(C(C(C(S3)CO)O)O)O D0IJ0U HIGHSTAT NDA filed D09RJA DRUG__ID D09RJA D09RJA DRUGCOMP Theravance D09RJA HIGHSTAT NDA filed D0A5DJ DRUG__ID D0A5DJ D0A5DJ DRUGCOMP Digestive Care Inc D0A5DJ HIGHSTAT NDA filed D00TIG DRUG__ID D00TIG D00TIG DRUGCOMP Roche D00TIG DRUGTYPE Small molecular drug D00TIG DRUGINCH 1S/C49H66N10O10S2.C2H4O2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41;1-2(3)4/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64);1H3,(H,3,4)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+;/m1./s1 D00TIG DRUGINKE XQEJFZYLWPSJOV-XJQYZYIXSA-N D00TIG DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O.CC(=O)O D00TIG HIGHSTAT Preregistration D0G2IC DRUG__ID D0G2IC D0G2IC DRUGCOMP Taisho Pharmaceutical; TOKUHON D0G2IC DRUGTYPE Small molecular drug D0G2IC DRUGINCH 1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m0/s1 D0G2IC DRUGINKE SYTBZMRGLBWNTM-JTQLQIEISA-N D0G2IC DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O D0G2IC HIGHSTAT Preregistration D01VNT DRUG__ID D01VNT D01VNT DRUGCOMP Collegium pharmaceuticals D01VNT DRUGINCH 1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3 D01VNT DRUGINKE BRUQQQPBMZOVGD-UHFFFAOYSA-N D01VNT DRUGSMIL CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O D01VNT HIGHSTAT Preregistration D08KNK DRUG__ID D08KNK D08KNK DRUGCOMP Allergy therapeutics D08KNK DRUGTYPE Vaccine D08KNK HIGHSTAT Preregistration D0A5SJ DRUG__ID D0A5SJ D0A5SJ DRUGCOMP BioVest International D0A5SJ DRUGTYPE Vaccine D0A5SJ HIGHSTAT Preregistration D0FC7P DRUG__ID D0FC7P D0FC7P DRUGCOMP Dynavax D0FC7P DRUGTYPE Vaccine D0FC7P HIGHSTAT Preregistration D01FWR DRUG__ID D01FWR D01FWR DRUGCOMP Allergy therapeutics D01FWR HIGHSTAT Preregistration D01KPS DRUG__ID D01KPS D01KPS DRUGCOMP Innopharma D01KPS HIGHSTAT Preregistration D02DJF DRUG__ID D02DJF D02DJF DRUGCOMP Baxter international D02DJF HIGHSTAT Preregistration D02MBM DRUG__ID D02MBM D02MBM DRUGCOMP GlaxoSmithKline D02MBM HIGHSTAT Preregistration D03EWD DRUG__ID D03EWD D03EWD DRUGCOMP Cytochroma D03EWD HIGHSTAT Preregistration D08AMJ DRUG__ID D08AMJ D08AMJ DRUGCOMP Molmed D08AMJ HIGHSTAT Preregistration D0B0BE DRUG__ID D0B0BE D0B0BE DRUGCOMP Merck; sanofi pasteur; Sanofi D0B0BE HIGHSTAT Preregistration D0BU5G DRUG__ID D0BU5G D0BU5G DRUGCOMP Biovest international D0BU5G HIGHSTAT Preregistration D0F4QV DRUG__ID D0F4QV D0F4QV DRUGCOMP Glaxosmithkline; molmed D0F4QV HIGHSTAT Preregistration D0FP8S DRUG__ID D0FP8S D0FP8S DRUGCOMP Aventis Behring LLC D0FP8S HIGHSTAT Preregistration D0UR1Z DRUG__ID D0UR1Z D0UR1Z DRUGCOMP Intracel Corp D0UR1Z HIGHSTAT Preregistration D0V6RL DRUG__ID D0V6RL D0V6RL DRUGCOMP Stempeutics Research Pte Ltd D0V6RL HIGHSTAT Preregistration D0ZL1T DRUG__ID D0ZL1T D0ZL1T DRUGCOMP SK Chemicals Co Ltd D0ZL1T HIGHSTAT Preregistration D07JEW DRUG__ID D07JEW D07JEW DRUGCOMP Bio products laboratory D07JEW HIGHSTAT BLA submitted D14VOX DRUG__ID D14VOX D14VOX DRUGCOMP Klus Pharma D14VOX DRUGTYPE Fusion protein D14VOX HIGHSTAT IND submitted D39PWR DRUG__ID D39PWR D39PWR DRUGCOMP Klus Pharma D39PWR DRUGTYPE Small molecule D39PWR HIGHSTAT IND submitted D8UKA4 DRUG__ID D8UKA4 D8UKA4 DRUGCOMP Klus Pharma D8UKA4 DRUGTYPE Small molecule D8UKA4 HIGHSTAT IND submitted DHJ64U DRUG__ID DHJ64U DHJ64U DRUGCOMP Klus Pharma DHJ64U DRUGTYPE Small molecule DHJ64U HIGHSTAT IND submitted DJC4L7 DRUG__ID DJC4L7 DJC4L7 DRUGCOMP Klus Pharma DJC4L7 DRUGTYPE Small molecule DJC4L7 HIGHSTAT IND submitted DX8M3T DRUG__ID DX8M3T DX8M3T DRUGCOMP Klus Pharma DX8M3T DRUGTYPE Monoclonal antibody DX8M3T HIGHSTAT IND submitted D0B4VH DRUG__ID D0B4VH D0B4VH DRUGCOMP Central Drug Research Institute D0B4VH HIGHSTAT IND submitted D0D5FU DRUG__ID D0D5FU D0D5FU TRADNAME Olumiant D0D5FU DRUGCOMP Incyte/Eli Lilly D0D5FU THERCLAS Antiviral Agents D0D5FU DRUGTYPE Small molecular drug D0D5FU DRUGINCH 1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20) D0D5FU DRUGINKE XUZMWHLSFXCVMG-UHFFFAOYSA-N D0D5FU DRUGSMIL CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 D0D5FU HIGHSTAT Phase 3 Trial D00GEG DRUG__ID D00GEG D00GEG DRUGCOMP Newron D00GEG THERCLAS Analgesics D00GEG DRUGTYPE Small molecular drug D00GEG DRUGINCH 1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-6-8-15(9-7-13)22-11-14-4-2-3-5-16(14)18/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 D00GEG DRUGINKE BHJIBOFHEFDSAU-LBPRGKRZSA-N D00GEG DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F D00GEG HIGHSTAT Phase 3 D01VHJ DRUG__ID D01VHJ D01VHJ DRUGCOMP Unimed Pharmaceuticals D01VHJ THERCLAS Antiviral Agents D01VHJ DRUGTYPE Small molecular drug D01VHJ DRUGINCH 1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17) D01VHJ DRUGINKE YQNQNVDNTFHQSW-UHFFFAOYSA-N D01VHJ DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-] D01VHJ HIGHSTAT Phase 3 Trial D03QIE DRUG__ID D03QIE D03QIE DRUGCOMP Dov Pharmaceutical D03QIE THERCLAS Analgesics D03QIE DRUGTYPE Small molecular drug D03QIE DRUGINCH 1S/C12H15N/c1-9-2-4-10(5-3-9)12-6-11(12)7-13-8-12/h2-5,11,13H,6-8H2,1H3 D03QIE DRUGINKE OFYVIGTWSQPCLF-UHFFFAOYSA-N D03QIE DRUGSMIL CC1=CC=C(C=C1)C23CC2CNC3 D03QIE HIGHSTAT Phase 3 D03WQS DRUG__ID D03WQS D03WQS DRUGCOMP Bristol Myers Squibb D03WQS THERCLAS Anticancer Agents D03WQS DRUGTYPE Small molecular drug D03WQS DRUGINCH 1S/C22H24FN5O4/c1-11-7-15-16(27-11)5-6-17(19(15)23)32-21-20-13(3)18(8-28(20)26-10-25-21)30-9-12(2)31-22(29)14(4)24/h5-8,10,12,14,27H,9,24H2,1-4H3/t12-,14+/m1/s1 D03WQS DRUGINKE LTEJRLHKIYCEOX-OCCSQVGLSA-N D03WQS DRUGSMIL CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)OC(=O)C(C)N)C D03WQS HIGHSTAT Phase 3 D04AGG DRUG__ID D04AGG D04AGG DRUGCOMP Toyama Chemical D04AGG THERCLAS Antiviral Agents D04AGG DRUGTYPE Small molecular drug D04AGG DRUGINCH 1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11) D04AGG DRUGINKE ZCGNOVWYSGBHAU-UHFFFAOYSA-N D04AGG DRUGSMIL C1=C(N=C(C(=O)N1)C(=O)N)F D04AGG HIGHSTAT Phase 3 Trial D04ZJG DRUG__ID D04ZJG D04ZJG DRUGCOMP Progen Industries D04ZJG THERCLAS Anticancer Agents D04ZJG DRUGTYPE Small molecular drug D04ZJG DRUGINCH 1S/C30H53O77PS16.15Na/c31-108(32,33)82-1-6-14(99-116(55,56)57)20(102-119(64,65)66)25(106-123(76,77)78)29(87-6)94-17-12(97-114(49,50)51)8(3-84-110(37,38)39)89-27(23(17)104-121(70,71)72)92-16-11(96-113(46,47)48)7(2-83-109(34,35)36)88-26(22(16)103-120(67,68)69)93-18-13(98-115(52,53)54)9(4-85-111(40,41)42)90-28(24(18)105-122(73,74)75)95-21-19(101-118(61,62)63)15(100-117(58,59)60)10(5-86-112(43,44)45)91-30(21)107-124(79,80)81;;;;;;;;;;;;;;;/h6-30H,1-5H2,(H2,31,32,33)(H,34,35,36)(H,37,38,39)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)(H,55,56,57)(H,58,59,60)(H,61,62,63)(H,64,65,66)(H,67,68,69)(H,70,71,72)(H,73,74,75)(H,76,77,78)(H,79,80,81);;;;;;;;;;;;;;;/q;15*+1/p-18/t6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17+,18+,19+,20+,21+,22+,23+,24+,25+,26-,27-,28-,29-,30-;;;;;;;;;;;;;;;/m1.............../s1 D04ZJG DRUGINKE FIYNUMVQYZZZCH-JSZMYKOGSA-A D04ZJG DRUGSMIL C(C1C(C(C(C(O1)OC2C(C(OC(C2OS(=O)(=O)[O-])OC3C(C(OC(C3OS(=O)(=O)[O-])OC4C(C(OC(C4OS(=O)(=O)[O-])OC5C(C(C(OC5OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D04ZJG HIGHSTAT Phase 3 D05PZB DRUG__ID D05PZB D05PZB DRUGCOMP Astex Therape. D05PZB THERCLAS Anticancer Agents D05PZB DRUGTYPE Small molecular drug D05PZB DRUGINCH 1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27) D05PZB DRUGINKE LOLPPWBBNUVNQZ-UHFFFAOYSA-N D05PZB DRUGSMIL C1CC1NC(=O)NC2=C(NN=C2)C3=NC4=C(N3)C=C(C=C4)CN5CCOCC5 D05PZB HIGHSTAT Phase 3 D05VZE DRUG__ID D05VZE D05VZE DRUGCOMP British Biotech plc; Schering-Plough D05VZE THERCLAS Anticancer Agents D05VZE DRUGTYPE Small molecular drug D05VZE DRUGINCH 1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1 D05VZE DRUGINKE OCSMOTCMPXTDND-OUAUKWLOSA-N D05VZE DRUGSMIL CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C D05VZE HIGHSTAT Phase 3 D06BDE DRUG__ID D06BDE D06BDE DRUGCOMP Gilead Sciences, Foster City, CA D06BDE THERCLAS Antiviral Agents D06BDE DRUGTYPE Small molecular drug D06BDE DRUGINCH 1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1 D06BDE DRUGINKE RWWYLEGWBNMMLJ-YSOARWBDSA-N D06BDE DRUGSMIL CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4 D06BDE HIGHSTAT Phase 3 Trial D07NPS DRUG__ID D07NPS D07NPS DRUGCOMP Johnson & Johnson D07NPS THERCLAS Anticancer Agents D07NPS DRUGTYPE Small molecular drug D07NPS DRUGINCH 1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1 D07NPS DRUGINKE PLHJCIYEEKOWNM-HHHXNRCGSA-N D07NPS DRUGSMIL CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N D07NPS HIGHSTAT Phase 3 D07OZR DRUG__ID D07OZR D07OZR DRUGCOMP Novartis & Chiron Corp D07OZR THERCLAS Anticancer Agents D07OZR DRUGTYPE Small molecular drug D07OZR DRUGINCH 1S/C21H21FN6O.C3H6O3.H2O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29;1-2(4)3(5)6;/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29);2,4H,1H3,(H,5,6);1H2 D07OZR DRUGINKE QDPVYZNVVQQULH-UHFFFAOYSA-N D07OZR DRUGSMIL CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N.O D07OZR HIGHSTAT Phase 3 D07QYQ DRUG__ID D07QYQ D07QYQ DRUGCOMP Medreich Sterilab Ltd D07QYQ THERCLAS Antiviral Agents D07QYQ DRUGTYPE Small molecular drug D07QYQ DRUGINCH 1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21) D07QYQ DRUGINKE WHTVZRBIWZFKQO-UHFFFAOYSA-N D07QYQ DRUGSMIL CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl D07QYQ HIGHSTAT Phase 3 Trial D09VMI DRUG__ID D09VMI D09VMI DRUGCOMP AstraZeneca D09VMI THERCLAS Anticancer Agents D09VMI DRUGTYPE Small molecular drug D09VMI DRUGINCH 1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3 D09VMI DRUGINKE XXJWYDDUDKYVKI-UHFFFAOYSA-N D09VMI DRUGSMIL CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5 D09VMI HIGHSTAT Phase 3 D0E3ZC DRUG__ID D0E3ZC D0E3ZC DRUGCOMP Hoffmann-La Roche pharmaceutical company D0E3ZC THERCLAS Antiviral Agents D0E3ZC DRUGTYPE Small molecular drug D0E3ZC DRUGINCH 1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1 D0E3ZC DRUGINKE VSZGPKBBMSAYNT-RRFJBIMHSA-N D0E3ZC DRUGSMIL CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC D0E3ZC HIGHSTAT Phase 3 Trial D0F1UZ DRUG__ID D0F1UZ D0F1UZ DRUGCOMP EpiCept Pharmaceuticals D0F1UZ THERCLAS Analgesics D0F1UZ DRUGTYPE Small molecular drug D0F1UZ DRUGINCH 1S/C20H16N4O2S.ClH/c1-13(25)23(2)15-6-3-5-14(11-15)17-8-9-21-20-16(12-22-24(17)20)19(26)18-7-4-10-27-18;/h3-12H,1-2H3;1H D0F1UZ DRUGINKE HPYLZBPCIBFRAI-UHFFFAOYSA-N D0F1UZ DRUGSMIL CC(=O)N(C)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C(=O)C4=CC=CS4.Cl D0F1UZ HIGHSTAT Phase 3 D0I6VU DRUG__ID D0I6VU D0I6VU DRUGCOMP Eli Lilly D0I6VU THERCLAS Anticancer Agents D0I6VU DRUGTYPE Small molecular drug D0I6VU DRUGINCH 1S/C32H29N5O2/c1-35-19-25(23-9-2-4-11-27(23)35)29-30(32(39)34-31(29)38)26-20-37(28-12-5-3-10-24(26)28)22-13-16-36(17-14-22)18-21-8-6-7-15-33-21/h2-12,15,19-20,22H,13-14,16-18H2,1H3,(H,34,38,39) D0I6VU DRUGINKE AXRCEOKUDYDWLF-UHFFFAOYSA-N D0I6VU DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7 D0I6VU HIGHSTAT Phase 3 D0J1GR DRUG__ID D0J1GR D0J1GR DRUGCOMP Pfizer D0J1GR THERCLAS Anticancer Agents D0J1GR DRUGTYPE Small molecular drug D0J1GR DRUGINCH 1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3 D0J1GR DRUGINKE DYNHJHQFHQTFTP-UHFFFAOYSA-N D0J1GR DRUGSMIL CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4 D0J1GR HIGHSTAT Phase 3 D0KG3Y DRUG__ID D0KG3Y D0KG3Y DRUGCOMP Novartis AG D0KG3Y THERCLAS Antiviral Agents D0KG3Y DRUGTYPE Small molecular drug D0KG3Y DRUGINCH 1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) D0KG3Y DRUGINKE KTUFNOKKBVMGRW-UHFFFAOYSA-N D0KG3Y DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 D0KG3Y HIGHSTAT Phase 3 Trial D0KH8Q DRUG__ID D0KH8Q D0KH8Q DRUGCOMP Incyte D0KH8Q THERCLAS Antiviral Agents D0KH8Q DRUGTYPE Small molecular drug D0KH8Q DRUGINCH 1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1 D0KH8Q DRUGINKE HFNKQEVNSGCOJV-OAHLLOKOSA-N D0KH8Q DRUGSMIL C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 D0KH8Q HIGHSTAT Phase 3 Trial D0LN1Z DRUG__ID D0LN1Z D0LN1Z DRUGCOMP Pharmacia And Upjohn Co D0LN1Z THERCLAS Antiviral Agents D0LN1Z DRUGTYPE Small molecular drug D0LN1Z DRUGINCH 1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1 D0LN1Z DRUGINKE VHRSUDSXCMQTMA-PJHHCJLFSA-N D0LN1Z DRUGSMIL CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O D0LN1Z HIGHSTAT Phase 3 Trial D0M9QZ DRUG__ID D0M9QZ D0M9QZ DRUGCOMP Abbott Laboratories D0M9QZ THERCLAS Anticancer Agents D0M9QZ DRUGTYPE Small molecular drug D0M9QZ DRUGINCH 1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28) D0M9QZ DRUGINKE MPVGZUGXCQEXTM-UHFFFAOYSA-N D0M9QZ DRUGSMIL CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N D0M9QZ HIGHSTAT Phase 3 D0O2WJ DRUG__ID D0O2WJ D0O2WJ DRUGCOMP Merck & Co D0O2WJ THERCLAS Antiviral Agents D0O2WJ DRUGTYPE Small molecular drug D0O2WJ DRUGINCH 1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28) D0O2WJ DRUGINKE PSIFNNKUMBGKDQ-UHFFFAOYSA-N D0O2WJ DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl D0O2WJ HIGHSTAT Phase 3 Trial D0Q9CY DRUG__ID D0Q9CY D0Q9CY DRUGCOMP Wyeth Research D0Q9CY THERCLAS Anticancer Agents D0Q9CY DRUGTYPE Small molecular drug D0Q9CY DRUGINCH 1S/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+ D0Q9CY DRUGINKE JWNPDZNEKVCWMY-VQHVLOKHSA-N D0Q9CY DRUGSMIL CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C D0Q9CY HIGHSTAT Phase 3 D0UK3A DRUG__ID D0UK3A D0UK3A DRUGCOMP Concordia Pharmaceuticals Inc D0UK3A THERCLAS Antiviral Agents D0UK3A DRUGTYPE Small molecular drug D0UK3A DRUGINCH 1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21) D0UK3A DRUGINKE XXSMGPRMXLTPCZ-UHFFFAOYSA-N D0UK3A DRUGSMIL CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO D0UK3A HIGHSTAT Phase 3 Trial D0V6GN DRUG__ID D0V6GN D0V6GN DRUGCOMP GlaxoSmithKline D0V6GN THERCLAS Antiviral Agents D0V6GN DRUGTYPE Small molecular drug D0V6GN DRUGINCH 1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3 D0V6GN DRUGINKE ZPEIMTDSQAKGNT-UHFFFAOYSA-N D0V6GN DRUGSMIL CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl D0V6GN HIGHSTAT Phase 3 Trial D00BHL DRUG__ID D00BHL D00BHL DRUGCOMP Endocyte D00BHL DRUGTYPE Small molecular drug D00BHL DRUGINCH 1S/C29H35N11O11S/c30-15(24(45)37-17(7-20(42)43)25(46)38-18(11-52)28(50)51)10-33-19(41)6-5-16(27(48)49)36-23(44)12-1-3-13(4-2-12)32-8-14-9-34-22-21(35-14)26(47)40-29(31)39-22/h1-4,9,15-18,32,52H,5-8,10-11,30H2,(H,33,41)(H,36,44)(H,37,45)(H,38,46)(H,42,43)(H,48,49)(H,50,51)(H3,31,34,39,40,47)/t15-,16+,17-,18-/m0/s1 D00BHL DRUGINKE RKGPQAGUQDVJHG-MHORFTMASA-N D00BHL DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)NCC(C(=O)NC(CC(=O)O)C(=O)NC(CS)C(=O)O)N)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N D00BHL HIGHSTAT Phase 3 D00BMF DRUG__ID D00BMF D00BMF DRUGCOMP Merck D00BMF DRUGTYPE Small molecular drug D00BMF DRUGINCH 1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1 D00BMF DRUGINKE PCHKPVIQAHNQLW-CQSZACIVSA-N D00BMF DRUGSMIL C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N D00BMF HIGHSTAT Phase 3 D00BYM DRUG__ID D00BYM D00BYM DRUGCOMP Boehringer Ingelheim D00BYM DRUGTYPE Small molecular drug D00BYM DRUGINCH 1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1 D00BYM DRUGINKE SXNJFOWDRLKDSF-XKHVUIRMSA-N D00BYM DRUGSMIL CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C D00BYM HIGHSTAT Phase 3 D00EWR DRUG__ID D00EWR D00EWR DRUGCOMP Sanwa Kagaku D00EWR DRUGTYPE Small molecular drug D00EWR DRUGINCH 1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12-/m0/s1 D00EWR DRUGINKE WAAPEIZFCHNLKK-UFBFGSQYSA-N D00EWR DRUGSMIL C1C(OC2=C(C13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N D00EWR HIGHSTAT Phase 3 D00HAP DRUG__ID D00HAP D00HAP DRUGCOMP AstraZeneca; Bristol-Myers Squibb D00HAP DRUGTYPE Small molecular drug D00HAP DRUGINCH 1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21?/m1/s1 D00HAP DRUGINKE JVHXJTBJCFBINQ-AWGDKMGJSA-N D00HAP DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl D00HAP HIGHSTAT Phase 3 D00LNW DRUG__ID D00LNW D00LNW DRUGCOMP Karyopharm therapeutics D00LNW DRUGTYPE Small molecular drug D00LNW DRUGINCH 1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1- D00LNW DRUGINKE DEVSOMFAQLZNKR-RJRFIUFISA-N D00LNW DRUGSMIL C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D00LNW HIGHSTAT Phase 3 D00MLX DRUG__ID D00MLX D00MLX DRUGCOMP ViiV Healthcare D00MLX DRUGTYPE Small molecular drug D00MLX DRUGINCH 1S/C20H19F2N3O5.C14H18N6O.C8H11N3O3S/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22;15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21;9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28);1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19);1-2,6-7,12H,3-4H2,(H2,9,10,13)/t10-,15+;8-,10+;6-,7+/m110/s1 D00MLX DRUGINKE SRMOJRAUYXTFJA-RAKRLELNSA-N D00MLX DRUGSMIL CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O.C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO.C1C(OC(S1)CO)N2C=CC(=NC2=O)N D00MLX HIGHSTAT Phase 3 D00NVM DRUG__ID D00NVM D00NVM DRUGCOMP Sunesis Pharmaceuticals Inc D00NVM DRUGTYPE Small molecular drug D00NVM DRUGINCH 1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1 D00NVM DRUGINKE XZAFZXJXZHRNAQ-STQMWFEESA-N D00NVM DRUGSMIL CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O D00NVM HIGHSTAT Phase 3 D00OTL DRUG__ID D00OTL D00OTL DRUGCOMP Cardiome Pharma; Merck D00OTL DRUGTYPE Small molecular drug D00OTL DRUGINCH 1S/C20H31NO4/c1-23-19-8-7-15(13-20(19)24-2)10-12-25-18-6-4-3-5-17(18)21-11-9-16(22)14-21/h7-8,13,16-18,22H,3-6,9-12,14H2,1-2H3/t16-,17-,18-/m1/s1 D00OTL DRUGINKE VBHQKCBVWWUUKN-KZNAEPCWSA-N D00OTL DRUGSMIL COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC D00OTL HIGHSTAT Phase 3 D00RJE DRUG__ID D00RJE D00RJE DRUGCOMP Almirall Prodesfarma SA D00RJE DRUGTYPE Small molecular drug D00RJE DRUGINCH 1S/C18H24ClN3O2/c19-14-7-13(17(8-15(14)20)24-10-11-1-2-11)18(23)21-16-9-22-5-3-12(16)4-6-22/h7-8,11-12,16H,1-6,9-10,20H2,(H,21,23) D00RJE DRUGINKE DBQMQBCSKXTCIJ-UHFFFAOYSA-N D00RJE DRUGSMIL C1CC1COC2=CC(=C(C=C2C(=O)NC3CN4CCC3CC4)Cl)N D00RJE HIGHSTAT Phase 3 D01FDL DRUG__ID D01FDL D01FDL DRUGCOMP Servier D01FDL DRUGTYPE Small molecular drug D01FDL DRUGINCH 1S/C15H22N2O2/c1-17-8-3-5-12-4-2-6-14(15(12)17)19-11-13-10-16-7-9-18-13/h2,4,6,13,16H,3,5,7-11H2,1H3 D01FDL DRUGINKE VXQWMLATWQSCBE-UHFFFAOYSA-N D01FDL DRUGSMIL CN1CCCC2=C1C(=CC=C2)OCC3CNCCO3 D01FDL HIGHSTAT Phase 3 D01FUC DRUG__ID D01FUC D01FUC DRUGCOMP Daiichi Seiyaku Co Ltd D01FUC DRUGTYPE Small molecular drug D01FUC DRUGINCH 1S/C24H22FN3O4/c1-3-24(31)14-6-18-21-12(8-28(18)22(29)13(14)9-32-23(24)30)19-16(26)5-4-11-10(2)15(25)7-17(27-21)20(11)19/h6-7,16,31H,3-5,8-9,26H2,1-2H3/t16-,24-/m0/s1 D01FUC DRUGINKE ZVYVPGLRVWUPMP-FYSMJZIKSA-N D01FUC DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O D01FUC HIGHSTAT Phase 3 D01IUS DRUG__ID D01IUS D01IUS DRUGCOMP Bayer Schering Pharma AG D01IUS DRUGTYPE Small molecular drug D01IUS DRUGINCH 1S/C25H26F4N2O2/c1-15-7-8-18-20(5-4-6-21(18)31-15)30-14-24(32,25(27,28)29)13-23(2,3)19-12-17(26)11-16-9-10-33-22(16)19/h4-8,11-12,30,32H,9-10,13-14H2,1-3H3/t24-/m1/s1 D01IUS DRUGINKE VJGFOYBQOIPQFY-XMMPIXPASA-N D01IUS DRUGSMIL CC1=NC2=C(C=C1)C(=CC=C2)NCC(CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O D01IUS HIGHSTAT Phase 3 D01JFM DRUG__ID D01JFM D01JFM DRUGCOMP Aciex Therapeutics Inc D01JFM DRUGTYPE Small molecular drug D01JFM DRUGINCH 1S/C6H6BrNO/c7-5-1-2-6(4-9)8-3-5/h1-3,9H,4H2 D01JFM DRUGINKE RUCZFWMEACWFER-UHFFFAOYSA-N D01JFM DRUGSMIL C1=CC(=NC=C1Br)CO D01JFM HIGHSTAT Phase 3 D01JGE DRUG__ID D01JGE D01JGE DRUGCOMP Helsinn Therapeutics D01JGE DRUGTYPE Small molecular drug D01JGE DRUGINCH 1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17+/m0/s1 D01JGE DRUGINKE CPZBLNMUGSZIPR-DOTOQJQBSA-N D01JGE DRUGSMIL C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5 D01JGE HIGHSTAT Phase 3 D01JLO DRUG__ID D01JLO D01JLO DRUGCOMP Nono inc D01JLO DRUGTYPE Peptide D01JLO DRUGINCH 1S/C105H188N42O30/c1-7-55(6)80(98(175)140-69(34-36-77(154)155)92(169)143-72(50-148)95(172)142-71(48-78(156)157)94(171)146-79(54(4)5)99(176)177)147-97(174)74(52-150)145-96(173)73(51-149)144-93(170)70(46-53(2)3)141-90(167)62(22-10-13-39-108)133-85(162)63(24-15-41-124-101(113)114)135-87(164)65(26-17-43-126-103(117)118)136-88(165)66(27-18-44-127-104(119)120)138-91(168)68(33-35-75(110)152)139-89(166)67(28-19-45-128-105(121)122)137-86(163)64(25-16-42-125-102(115)116)134-84(161)61(21-9-12-38-107)132-83(160)60(20-8-11-37-106)131-82(159)59(23-14-40-123-100(111)112)130-76(153)49-129-81(158)58(109)47-56-29-31-57(151)32-30-56/h29-32,53-55,58-74,79-80,148-151H,7-28,33-52,106-109H2,1-6H3,(H2,110,152)(H,129,158)(H,130,153)(H,131,159)(H,132,160)(H,133,162)(H,134,161)(H,135,164)(H,136,165)(H,137,163)(H,138,168)(H,139,166)(H,140,175)(H,141,167)(H,142,172)(H,143,169)(H,144,170)(H,145,173)(H,146,171)(H,147,174)(H,154,155)(H,156,157)(H,176,177)(H4,111,112,123)(H4,113,114,124)(H4,115,116,125)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)/t55-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,79-,80-/m0/s1 D01JLO DRUGINKE XWQVQFBTSBCKLI-FKXNDIMNSA-N D01JLO DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)N D01JLO HIGHSTAT Phase 3 D01LXD DRUG__ID D01LXD D01LXD DRUGCOMP Eli Lilly & Co D01LXD DRUGTYPE Small molecular drug D01LXD DRUGINCH 1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1 D01LXD DRUGINKE PKXWXXPNHIWQHW-RCBQFDQVSA-N D01LXD DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O D01LXD HIGHSTAT Phase 3 D01LYX DRUG__ID D01LYX D01LYX DRUGCOMP Consiglio Nazionale delle Ricerche D01LYX DRUGTYPE Small molecular drug D01LYX DRUGINCH 1S/C21H33N3O2/c1-5-6-7-8-9-13-22-20(25)26-16-10-11-18-17(15-16)21(2)12-14-23(3)19(21)24(18)4/h10-11,15,19H,5-9,12-14H2,1-4H3,(H,22,25)/t19-,21+/m1/s1 D01LYX DRUGINKE RRGMXBQMCUKRLH-CTNGQTDRSA-N D01LYX DRUGSMIL CCCCCCCNC(=O)OC1=CC2=C(C=C1)N(C3C2(CCN3C)C)C D01LYX HIGHSTAT Phase 3 D01MXK DRUG__ID D01MXK D01MXK DRUGCOMP SantoSolve AS D01MXK DRUGTYPE Small molecular drug D01MXK DRUGINCH 1S/C26H31N5O/c1-17-6-7-25-22(12-17)19(15-29-25)16-31-10-8-20(9-11-31)30-26(32)23(27)13-18-14-28-24-5-3-2-4-21(18)24/h2-7,12,14-15,20,23,28-29H,8-11,13,16,27H2,1H3,(H,30,32)/t23-/m0/s1 D01MXK DRUGINKE HAGXHOXTZOWANA-QHCPKHFHSA-N D01MXK DRUGSMIL CC1=CC2=C(C=C1)NC=C2CN3CCC(CC3)NC(=O)C(CC4=CNC5=CC=CC=C54)N D01MXK HIGHSTAT Phase 3 D01NIR DRUG__ID D01NIR D01NIR DRUGCOMP Il-Yang Pharmaceutical Co D01NIR DRUGTYPE Small molecular drug D01NIR DRUGINCH 1S/C27H21F3N8O/c1-16-3-4-18(9-23(16)37-26-33-6-5-22(36-26)24-13-31-7-8-32-24)25(39)35-20-10-19(27(28,29)30)11-21(12-20)38-14-17(2)34-15-38/h3-15H,1-2H3,(H,35,39)(H,33,36,37) D01NIR DRUGINKE DUPWHXBITIZIKZ-UHFFFAOYSA-N D01NIR DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5 D01NIR HIGHSTAT Phase 3 D01ODU DRUG__ID D01ODU D01ODU DRUGCOMP Bayer AG D01ODU DRUGTYPE Small molecular drug D01ODU DRUGINCH 1S/C20H19FN4O4.ClH/c21-14-5-11-17(25(10-1-2-10)7-13(19(11)26)20(27)28)12(6-22)18(14)24-8-15-16(9-24)29-4-3-23-15;/h5,7,10,15-16,23H,1-4,8-9H2,(H,27,28);1H/t15-,16-;/m0./s1 D01ODU DRUGINKE CQMSQUOHWYYEKM-MOGJOVFKSA-N D01ODU DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O.Cl D01ODU HIGHSTAT Phase 3 D01QSO DRUG__ID D01QSO D01QSO DRUGCOMP Novartis D01QSO DRUGTYPE Small molecular drug D01QSO DRUGINCH 1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23) D01QSO DRUGINKE CWHUFRVAEUJCEF-UHFFFAOYSA-N D01QSO DRUGSMIL C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4 D01QSO HIGHSTAT Phase 3 D01REE DRUG__ID D01REE D01REE DRUGCOMP Dong-A Pharmaceutical Co Ltd D01REE DRUGTYPE Small molecular drug D01REE DRUGINCH 1S/C8H15NO2.C2H4/c1-7(2)8(10)11-6-5-9(3)4;1-2/h1,5-6H2,2-4H3;1-2H2 D01REE DRUGINKE PNMYDOBPCBCQIA-UHFFFAOYSA-N D01REE DRUGSMIL CC(=C)C(=O)OCCN(C)C.C=C D01REE HIGHSTAT Phase 3 D01SNZ DRUG__ID D01SNZ D01SNZ DRUGCOMP Mallinckrodt Pharma D01SNZ DRUGTYPE Small molecular drug D01SNZ DRUGINCH 1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3 D01SNZ DRUGINKE ODLHGICHYURWBS-UHFFFAOYSA-N D01SNZ DRUGSMIL CC(COCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)O)O)O D01SNZ HIGHSTAT Phase 3 D01TEA DRUG__ID D01TEA D01TEA DRUGCOMP Derma Sciences D01TEA DRUGTYPE Small molecular drug D01TEA DRUGINCH 1S/C42H64N12O11/c1-4-6-9-28(50-36(59)29(10-7-16-47-42(44)45)49-35(58)27(43)20-33(56)57)37(60)51-30(18-24-12-14-26(55)15-13-24)38(61)53-34(23(3)5-2)39(62)52-31(19-25-21-46-22-48-25)40(63)54-17-8-11-32(54)41(64)65/h12-15,21-23,27-32,34,55H,4-11,16-20,43H2,1-3H3,(H,46,48)(H,49,58)(H,50,59)(H,51,60)(H,52,62)(H,53,61)(H,56,57)(H,64,65)(H4,44,45,47)/t23-,27-,28-,29-,30-,31-,32-,34-/m0/s1 D01TEA DRUGINKE RUBMHAHMIJSMHA-LBWFYSSPSA-N D01TEA DRUGSMIL CCCCC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)CC)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N D01TEA HIGHSTAT Phase 3 D01TMQ DRUG__ID D01TMQ D01TMQ DRUGCOMP Orexigen Therapeutics D01TMQ DRUGTYPE Small molecular drug D01TMQ DRUGINCH 1S/C20H23NO4.C13H18ClNO/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h3-4,11,15,18,22,24H,1-2,5-10H2;5-9,15H,1-4H3/t15-,18+,19+,20-;/m1./s1 D01TMQ DRUGINKE KVNBDVQGENTICK-ITLPAZOVSA-N D01TMQ DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O D01TMQ HIGHSTAT Phase 3 D01UXW DRUG__ID D01UXW D01UXW THERCLAS Analgesics D01UXW DRUGTYPE Small molecular drug D01UXW DRUGINCH 1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1 D01UXW DRUGINKE GNJCUHZOSOYIEC-GAROZEBRSA-N D01UXW DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)OC6C(C(C(C(O6)C(=O)O)O)O)O D01UXW HIGHSTAT Phase 3 D01WYT DRUG__ID D01WYT D01WYT DRUGCOMP Astellas D01WYT DRUGTYPE Small molecular drug D01WYT DRUGINCH 1S/C82H103ClN18O16.C2H4O2/c1-45(2)35-60(72(107)92-59(16-9-10-33-87-46(3)4)80(115)101-34-12-17-68(101)79(114)88-47(5)70(84)105)93-74(109)63(38-51-23-30-58(31-24-51)91-81(85)116)95-76(111)64(39-50-21-28-57(29-22-50)90-71(106)66-42-69(104)100-82(117)99-66)97-78(113)67(44-102)98-77(112)65(41-53-13-11-32-86-43-53)96-75(110)62(37-49-19-26-56(83)27-20-49)94-73(108)61(89-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52;1-2(3)4/h7-8,11,13-15,18-32,36,43,45-47,59-68,87,102H,9-10,12,16-17,33-35,37-42,44H2,1-6H3,(H2,84,105)(H,88,114)(H,89,103)(H,90,106)(H,92,107)(H,93,109)(H,94,108)(H,95,111)(H,96,110)(H,97,113)(H,98,112)(H3,85,91,116)(H2,99,100,104,117);1H3,(H,3,4)/t47-,59+,60+,61-,62-,63-,64+,65-,66+,67+,68+;/m1./s1 D01WYT DRUGINKE AUTFSFUMNFDPLH-KYMMNHPFSA-N D01WYT DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C.CC(=O)O D01WYT HIGHSTAT Phase 3 D01WZG DRUG__ID D01WZG D01WZG DRUGCOMP Avicena Group Inc; Avicena D01WZG DRUGTYPE Small molecular drug D01WZG DRUGINCH 1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9) D01WZG DRUGINKE CVSVTCORWBXHQV-UHFFFAOYSA-N D01WZG DRUGSMIL CN(CC(=O)O)C(=N)N D01WZG HIGHSTAT Phase 3 D01YKI DRUG__ID D01YKI D01YKI DRUGCOMP ADVENTRX Pharmaceuticals D01YKI DRUGTYPE Small molecular drug D01YKI DRUGINCH 1S/C20H23N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/t12?,13-/m0/s1 D01YKI DRUGINKE QYNUQALWYRSVHF-ABLWVSNPSA-N D01YKI DRUGSMIL C1C2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O D01YKI HIGHSTAT Phase 3 D01YVZ DRUG__ID D01YVZ D01YVZ DRUGCOMP Naurex D01YVZ DRUGTYPE Small molecular drug D01YVZ DRUGINCH 1S/C18H31N5O6/c1-9(24)13(19)18(29)23-8-4-6-12(23)17(28)22-7-3-5-11(22)16(27)21-14(10(2)25)15(20)26/h9-14,24-25H,3-8,19H2,1-2H3,(H2,20,26)(H,21,27)/t9-,10-,11+,12+,13+,14+/m1/s1 D01YVZ DRUGINKE GIBQQARAXHVEGD-BSOLPCOYSA-N D01YVZ DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O D01YVZ HIGHSTAT Phase 3 D02CZK DRUG__ID D02CZK D02CZK DRUGCOMP BioNumerik Pharmaceuticals D02CZK DRUGTYPE Small molecular drug D02CZK DRUGINCH 1S/C25H28N2O4Si/c1-5-25(30)19-12-21-22-17(13-27(21)23(28)18(19)14-31-24(25)29)15(10-11-32(2,3)4)16-8-6-7-9-20(16)26-22/h6-9,12,30H,5,10-11,13-14H2,1-4H3/t25-/m0/s1 D02CZK DRUGINKE POADTFBBIXOWFJ-VWLOTQADSA-N D02CZK DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O D02CZK HIGHSTAT Phase 3 D02EOZ DRUG__ID D02EOZ D02EOZ DRUGCOMP boehringer-ingelheim D02EOZ DRUGTYPE Small molecule D02EOZ DRUGINCH InChI=1S/C20H25ClN6O2S/c21-14-10-22-17(23-11-14)13-2-7-27(8-3-13)19-24-15-4-9-30(29)16(15)18(25-19)26-20(12-28)5-1-6-20/h10-11,13,28H,1-9,12H2,(H,24,25,26)/t30-/m1/s1 D02EOZ DRUGINKE UHYCLWAANUGUMN-SSEXGKCCSA-N D02EOZ DRUGSMIL C1CC(C1)(CO)NC2=NC(=NC3=C2S(=O)CC3)N4CCC(CC4)C5=NC=C(C=N5)Cl D02EOZ HIGHSTAT Phase 3 D02GTY DRUG__ID D02GTY D02GTY DRUGCOMP Research Foundation Itsuu Laboratory D02GTY DRUGTYPE Small molecular drug D02GTY DRUGINCH 1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26) D02GTY DRUGINKE MUTNCGKQJGXKEM-UHFFFAOYSA-N D02GTY DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C D02GTY HIGHSTAT Phase 3 D02HBB DRUG__ID D02HBB D02HBB DRUGCOMP AEterna Zentaris D02HBB DRUGTYPE Small molecular drug D02HBB DRUGINCH 1S/C91H117N19O26/c1-44(2)31-58(83(125)104-57(17-11-29-98-90(94)95)89(131)110-30-12-18-63(110)88(130)100-40-67(93)114)105-81(123)55(16-7-8-28-97-68(115)20-10-21-70(117)134-42-66(113)91(132)36-52-73(65(37-91)136-71-35-53(92)76(118)45(3)135-71)80(122)75-74(78(52)120)77(119)51-14-9-19-64(133-4)72(51)79(75)121)103-84(126)59(32-46-22-24-49(112)25-23-46)106-87(129)62(41-111)109-85(127)60(33-47-38-99-54-15-6-5-13-50(47)54)107-86(128)61(34-48-39-96-43-101-48)108-82(124)56-26-27-69(116)102-56/h5-6,9,13-15,19,22-25,38-39,43-45,53,55-63,65,71,76,99,111-112,118,120,122,132H,7-8,10-12,16-18,20-21,26-37,40-42,92H2,1-4H3,(H2,93,114)(H,96,101)(H,97,115)(H,100,130)(H,102,116)(H,103,126)(H,104,125)(H,105,123)(H,106,129)(H,107,128)(H,108,124)(H,109,127)(H4,94,95,98)/t45-,53-,55+,56-,57-,58-,59-,60-,61-,62-,63-,65-,71-,76+,91-/m0/s1 D02HBB DRUGINKE OOUACICUAVTCEC-LZHWUUGESA-N D02HBB DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CCCC(=O)NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)N6CCCC6C(=O)NCC(=O)N)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(CO)NC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)O)N)O D02HBB HIGHSTAT Phase 3 D02HUB DRUG__ID D02HUB D02HUB DRUGCOMP Population Council; Population Council Center for Biomedical Research D02HUB DRUGTYPE Small molecular drug D02HUB DRUGINCH 1S/C23H30O4/c1-13-11-21-20-7-5-16-12-17(26)6-8-18(16)19(20)9-10-22(21,4)23(13,14(2)24)27-15(3)25/h12,18-21H,1,5-11H2,2-4H3/t18-,19+,20+,21-,22-,23-/m0/s1 D02HUB DRUGINKE CKFBRGLGTWAVLG-GOMYTPFNSA-N D02HUB DRUGSMIL CC(=O)C1(C(=C)CC2C1(CCC3C2CCC4=CC(=O)CCC34)C)OC(=O)C D02HUB HIGHSTAT Phase 3 D02JMU DRUG__ID D02JMU D02JMU DRUGCOMP Active Biotech D02JMU DRUGTYPE Small molecular drug D02JMU DRUGINCH 1S/C20H17F3N2O4/c1-24(12-9-7-11(8-10-12)20(21,22)23)18(27)16-17(26)15-13(25(2)19(16)28)5-4-6-14(15)29-3/h4-10,26H,1-3H3 D02JMU DRUGINKE ONDYALNGTUAJDX-UHFFFAOYSA-N D02JMU DRUGSMIL CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O D02JMU HIGHSTAT Phase 3 D02KRI DRUG__ID D02KRI D02KRI DRUGCOMP SmithKline Beecham plc D02KRI DRUGTYPE Small molecular drug D02KRI DRUGINCH 1S/C25H37NO3/c1-23(2,3)26-21(27)20-9-8-18-17-7-6-16-14-15(22(28)29)10-12-24(16,4)19(17)11-13-25(18,20)5/h6,14,17-20H,7-13H2,1-5H3,(H,26,27)(H,28,29)/t17-,18-,19-,20+,24-,25-/m0/s1 D02KRI DRUGINKE VAPSMQAHNAZRKC-PQWRYPMOSA-N D02KRI DRUGSMIL CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CC=C4C3(CCC(=C4)C(=O)O)C D02KRI HIGHSTAT Phase 3 D02KXW DRUG__ID D02KXW D02KXW DRUGCOMP Hollis-Eden Pharmaceuticals D02KXW DRUGTYPE Small molecular drug D02KXW DRUGINCH 1S/C21H30O3/c1-4-21(24)10-7-16-18-15(6-9-20(16,21)3)19(2)8-5-14(22)11-13(19)12-17(18)23/h1,12,14-18,22-24H,5-11H2,2-3H3/t14-,15-,16-,17-,18+,19-,20-,21-/m0/s1 D02KXW DRUGINKE JJKOQZHWYLMASZ-FJWDNACWSA-N D02KXW DRUGSMIL CC12CCC(CC1=CC(C3C2CCC4(C3CCC4(C#C)O)C)O)O D02KXW HIGHSTAT Phase 3 D02OJC DRUG__ID D02OJC D02OJC DRUGCOMP Sanofi-Aventis D02OJC DRUGTYPE Small molecular drug D02OJC DRUGINCH 1S/C24H22F3N/c25-24(26,27)23-7-3-6-22(17-23)20-11-14-28(15-12-20)13-10-18-8-9-19-4-1-2-5-21(19)16-18/h1-9,11,16-17H,10,12-15H2 D02OJC DRUGINKE WJJYZXPHLSLMGE-UHFFFAOYSA-N D02OJC DRUGSMIL C1CN(CC=C1C2=CC(=CC=C2)C(F)(F)F)CCC3=CC4=CC=CC=C4C=C3 D02OJC HIGHSTAT Phase 3 D02RNS DRUG__ID D02RNS D02RNS DRUGCOMP Cytran Inc D02RNS DRUGTYPE Small molecular drug D02RNS DRUGINCH 1S/C16H19N3O5/c17-11(5-6-14(20)21)15(22)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,22)(H,20,21)(H,23,24)/t11-,13-/m0/s1 D02RNS DRUGINKE LLEUXCDZPQOJMY-AAEUAGOBSA-N D02RNS DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)C(CCC(=O)O)N D02RNS HIGHSTAT Phase 3 D02UOZ DRUG__ID D02UOZ D02UOZ DRUGCOMP Nanobio D02UOZ DRUGTYPE Small molecular drug D02UOZ DRUGINCH 1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16) D02UOZ DRUGINKE CVPTTZZCRDVGSU-UHFFFAOYSA-N D02UOZ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CCNCCCCCO)N D02UOZ HIGHSTAT Phase 3 D02WVT DRUG__ID D02WVT D02WVT DRUGCOMP Clovis oncology D02WVT DRUGTYPE Small molecular drug D02WVT DRUGINCH 1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30) D02WVT DRUGINKE CUDVHEFYRIWYQD-UHFFFAOYSA-N D02WVT DRUGSMIL CNC(=O)C1=CC=CC2=C1C=CC(=C2)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC D02WVT HIGHSTAT Phase 3 D02XXN DRUG__ID D02XXN D02XXN DRUGCOMP Lilly D02XXN DRUGTYPE Small molecular drug D02XXN DRUGINCH 1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3,(H,44,45)/t20?,22?,26-/m0/s1 D02XXN DRUGINKE IHIUGIVXARLYHP-UXNJHFGPSA-N D02XXN DRUGSMIL CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C D02XXN HIGHSTAT Phase 3 D02YPU DRUG__ID D02YPU D02YPU DRUGCOMP Nephrogenex D02YPU DRUGTYPE Small molecular drug D02YPU DRUGINCH 1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3 D02YPU DRUGINKE NHZMQXZHNVQTQA-UHFFFAOYSA-N D02YPU DRUGSMIL CC1=NC=C(C(=C1O)CN)CO D02YPU HIGHSTAT Phase 3 D02YVM DRUG__ID D02YVM D02YVM DRUGCOMP Lundbeck D02YVM DRUGTYPE Small molecular drug D02YVM DRUGINCH 1S/C22H27ClN2/c1-22(2)15-25(12-11-24(22)3)21-14-19(16-7-5-4-6-8-16)18-10-9-17(23)13-20(18)21/h4-10,13,19,21H,11-12,14-15H2,1-3H3/t19-,21+/m0/s1 D02YVM DRUGINKE BYPMJBXPNZMNQD-PZJWPPBQSA-N D02YVM DRUGSMIL CC1(CN(CCN1C)C2CC(C3=C2C=C(C=C3)Cl)C4=CC=CC=C4)C D02YVM HIGHSTAT Phase 3 D03GOO DRUG__ID D03GOO D03GOO DRUGCOMP Biogen Idec D03GOO DRUGTYPE Small molecular drug D03GOO DRUGINCH 1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+ D03GOO DRUGINKE VZCYOOQTPOCHFL-OWOJBTEDSA-N D03GOO DRUGSMIL C(=CC(=O)O)C(=O)O D03GOO HIGHSTAT Phase 3 D03HVV DRUG__ID D03HVV D03HVV DRUGCOMP Allos Therapeutics D03HVV DRUGTYPE Small molecular drug D03HVV DRUGINCH 1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24) D03HVV DRUGINKE BNFRJXLZYUTIII-UHFFFAOYSA-N D03HVV DRUGSMIL CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C D03HVV HIGHSTAT Phase 3 D03MXK DRUG__ID D03MXK D03MXK DRUGCOMP Ascenta Therapeutics; Debiopharm D03MXK DRUGTYPE Small molecular drug D03MXK DRUGINCH 1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1 D03MXK DRUGINKE LSXUTRRVVSPWDZ-MKKUMYSQSA-N D03MXK DRUGSMIL CC(C)CC(=O)N1CCC2CCC(N2C(=O)C(C1)NC(=O)C(C)NC)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4 D03MXK HIGHSTAT Phase 3 D03OQI DRUG__ID D03OQI D03OQI DRUGCOMP Biotie therapies D03OQI DRUGTYPE Small molecular drug D03OQI DRUGINCH 1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24) D03OQI DRUGINKE XNBRWUQWSKXMPW-UHFFFAOYSA-N D03OQI DRUGSMIL CC1(CCN(CC1)C(=O)NC2=NC3=C(C=CC(=C3S2)N4CCOCC4)OC)O D03OQI HIGHSTAT Phase 3 D03RQW DRUG__ID D03RQW D03RQW DRUGCOMP Miravant Medical Technologies D03RQW DRUGTYPE Small molecular drug D03RQW DRUGINCH 1S/C37H43N4O2.2ClH.Sn/c1-10-23-19(6)29-17-33-25(12-3)21(8)34(40-33)26-15-27(36(42)43-14-5)37(13-4)22(9)30(41-35(26)37)18-32-24(11-2)20(7)28(39-32)16-31(23)38-29;;;/h15-18,22H,10-14H2,1-9H3,(H-,38,39,40,41,42);2*1H;/q-1;;;+4/p-3/t22-,37+;;;/m0.../s1 D03RQW DRUGINKE MCTOGTBIQBEIBZ-RHJKTMSGSA-K D03RQW DRUGSMIL CCC1=C(C2=CC3=C(C(=C4N3[Sn](N5C(=CC1=N2)C(C6(C5=C(C=C6C(=O)OCC)C7=NC(=C4)C(=C7C)CC)CC)C)(Cl)Cl)C)CC)C D03RQW HIGHSTAT Phase 3 D03SKL DRUG__ID D03SKL D03SKL DRUGCOMP Ardea Biosciences D03SKL DRUGTYPE Small molecular drug D03SKL DRUGINCH 1S/C19H20F3IN2O5S/c1-30-15-7-13(21)16(22)18(24-14-3-2-10(23)6-12(14)20)17(15)25-31(28,29)19(4-5-19)8-11(27)9-26/h2-3,6-7,11,24-27H,4-5,8-9H2,1H3/t11-/m0/s1 D03SKL DRUGINKE RDSACQWTXKSHJT-NSHDSACASA-N D03SKL DRUGSMIL COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F D03SKL HIGHSTAT Phase 3 D03TBJ DRUG__ID D03TBJ D03TBJ DRUGCOMP Forest laboratories D03TBJ DRUGTYPE Small molecular drug D03TBJ DRUGINCH 1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3 D03TBJ DRUGINKE CSMVOZKEWSOFER-UHFFFAOYSA-N D03TBJ DRUGSMIL CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5 D03TBJ HIGHSTAT Phase 3 D03WAU DRUG__ID D03WAU D03WAU DRUGCOMP Sapphire Therape. D03WAU DRUGTYPE Small molecular drug D03WAU DRUGINCH 1S/C31H42N6O3/c1-30(2,32)28(39)34-26(18-23-20-33-25-15-10-9-14-24(23)25)27(38)37-17-11-16-31(21-37,29(40)36(5)35(3)4)19-22-12-7-6-8-13-22/h6-10,12-15,20,26,33H,11,16-19,21,32H2,1-5H3,(H,34,39)/t26-,31-/m1/s1 D03WAU DRUGINKE VQPFSIRUEPQQPP-MXBOTTGLSA-N D03WAU DRUGSMIL CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N D03WAU HIGHSTAT Phase 3 D03YKE DRUG__ID D03YKE D03YKE DRUGCOMP FibroGen D03YKE DRUGTYPE Small molecular drug D03YKE DRUGINCH 1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23) D03YKE DRUGINKE YOZBGTLTNGAVFU-UHFFFAOYSA-N D03YKE DRUGSMIL CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3 D03YKE HIGHSTAT Phase 3 D03ZKM DRUG__ID D03ZKM D03ZKM DRUGCOMP Ultragenyx Pharmaceutical D03ZKM DRUGTYPE Small molecular drug D03ZKM DRUGINCH 1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6-,7+,8-,9+,11+/m0/s1 D03ZKM DRUGINKE SQVRNKJHWKZAKO-USOVHJGOSA-N D03ZKM DRUGSMIL CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)O)O D03ZKM HIGHSTAT Phase 3 D04BEN DRUG__ID D04BEN D04BEN DRUGCOMP Celgene D04BEN DRUGTYPE Small molecular drug D04BEN DRUGINCH 1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1 D04BEN DRUGINKE VJZITPJGSQKZMX-XDPRQOKASA-N D04BEN DRUGSMIL CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N D04BEN HIGHSTAT Phase 3 D04CDO DRUG__ID D04CDO D04CDO DRUGCOMP Taiho Pharma U.S.A. D04CDO DRUGTYPE Small molecular drug D04CDO DRUGINCH 1S/C10H11F3N2O5.C9H11ClN4O2.ClH/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7;10-7-5(12-9(16)13-8(7)15)4-14-3-1-2-6(14)11;/h2,5-7,16-17H,1,3H2,(H,14,18,19);11H,1-4H2,(H2,12,13,15,16);1H/t5-,6+,7+;;/m0../s1 D04CDO DRUGINKE PLIXOHWIPDGJEI-OJSHLMAWSA-N D04CDO DRUGSMIL C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl.C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O.Cl D04CDO HIGHSTAT Phase 3 D04HQJ DRUG__ID D04HQJ D04HQJ DRUGCOMP Atoxbio; fast-track drugs & biologics D04HQJ DRUGTYPE Small molecular drug D04HQJ DRUGINCH 1S/C12H16N3O3P/c16-12(18-10-11-4-2-1-3-5-11)13-19(17,14-6-7-14)15-8-9-15/h1-5H,6-10H2,(H,13,16,17) D04HQJ DRUGINKE VFIUCBTYGKMLCM-UHFFFAOYSA-N D04HQJ DRUGSMIL C1CN1P(=O)(NC(=O)OCC2=CC=CC=C2)N3CC3 D04HQJ HIGHSTAT Phase 3 D04LBC DRUG__ID D04LBC D04LBC DRUGCOMP Arpida D04LBC DRUGTYPE Small molecular drug D04LBC DRUGINCH 1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23) D04LBC DRUGINKE HWJPWWYTGBZDEG-UHFFFAOYSA-N D04LBC DRUGSMIL COC1=C(C2=C(C=CC(O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC D04LBC HIGHSTAT Phase 3 D04MKJ DRUG__ID D04MKJ D04MKJ DRUGCOMP Alizyme D04MKJ DRUGTYPE Small molecular drug D04MKJ DRUGINCH 1S/C16H22ClN3O2/c1-22-15-8-13(18)12(17)7-11(15)16(21)19-14-4-6-20-5-2-3-10(14)9-20/h7-8,10,14H,2-6,9,18H2,1H3,(H,19,21)/t10-,14+/m0/s1 D04MKJ DRUGINKE GZSKEXSLDPEFPT-IINYFYTJSA-N D04MKJ DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CCN3CCCC2C3)Cl)N D04MKJ HIGHSTAT Phase 3 D04NRB DRUG__ID D04NRB D04NRB DRUGCOMP Alizyme; Takeda; Norgine B.V. D04NRB DRUGTYPE Small molecular drug D04NRB DRUGINCH 1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3 D04NRB DRUGINKE MVCQKIKWYUURMU-UHFFFAOYSA-N D04NRB DRUGSMIL CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C=C2)C)C(=O)O1 D04NRB HIGHSTAT Phase 3 D04OXD DRUG__ID D04OXD D04OXD DRUGCOMP Burroughs Wellcome Inc D04OXD DRUGTYPE Small molecular drug D04OXD DRUGINCH 1S/C12H14N2O6/c1-2-3-6-4-14(12(19)13-10(6)18)11-9(17)8(16)7(5-15)20-11/h4,7-9,11,15-17H,5H2,1H3,(H,13,18,19)/t7-,8-,9+,11-/m1/s1 D04OXD DRUGINKE QLOCVMVCRJOTTM-SDNRWEOFSA-N D04OXD DRUGSMIL CC#CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O D04OXD HIGHSTAT Phase 3 D04PLI DRUG__ID D04PLI D04PLI DRUGCOMP Sanofi-Aventis D04PLI DRUGTYPE Small molecular drug D04PLI DRUGINCH 1S/2C19H21FN2O2.C4H4O4/c2*1-22(2)13-14-24-21-19(17-5-3-4-6-18(17)20)12-9-15-7-10-16(23)11-8-15;5-3(6)1-2-4(7)8/h2*3-12,23H,13-14H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b2*12-9+,21-19-;2-1+ D04PLI DRUGINKE RNLKLYQQDLHHBH-ABDBJYMXSA-N D04PLI DRUGSMIL CN(C)CCON=C(C=CC1=CC=C(C=C1)O)C2=CC=CC=C2F.CN(C)CCON=C(C=CC1=CC=C(C=C1)O)C2=CC=CC=C2F.C(=CC(=O)O)C(=O)O D04PLI HIGHSTAT Phase 3 D04PWT DRUG__ID D04PWT D04PWT DRUGCOMP D-Pharm D04PWT DRUGTYPE Small molecular drug D04PWT DRUGINCH 1S/C42H64N2O12/c1-3-5-7-9-11-17-23-51-25-27-55-41(49)33-43(31-39(45)46)35-19-13-15-21-37(35)53-29-30-54-38-22-16-14-20-36(38)44(32-40(47)48)34-42(50)56-28-26-52-24-18-12-10-8-6-4-2/h13-16,19-22H,3-12,17-18,23-34H2,1-2H3,(H,45,46)(H,47,48) D04PWT DRUGINKE FTGBVHPWUIHWRH-UHFFFAOYSA-N D04PWT DRUGSMIL CCCCCCCCOCCOC(=O)CN(CC(=O)O)C1=CC=CC=C1OCCOC2=CC=CC=C2N(CC(=O)O)CC(=O)OCCOCCCCCCCC D04PWT HIGHSTAT Phase 3 D04PXS DRUG__ID D04PXS D04PXS DRUGCOMP Euthymics Bioscience D04PXS DRUGTYPE Small molecular drug D04PXS DRUGINCH 1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2/t8-,11+/m1/s1 D04PXS DRUGINKE BSMNRYCSBFHEMQ-KCJUWKMLSA-N D04PXS DRUGSMIL C1C2C1(CNC2)C3=CC(=C(C=C3)Cl)Cl D04PXS HIGHSTAT Phase 3 D04QPD DRUG__ID D04QPD D04QPD DRUGCOMP Welsh School of Pharmacy D04QPD DRUGTYPE Small molecular drug D04QPD DRUGINCH 1S/C27H35N3O6.ClH/c1-4-5-6-7-17-8-10-18(11-9-17)21-12-19-14-30(27(33)29-25(19)36-21)23-13-20(31)22(35-23)15-34-26(32)24(28)16(2)3;/h8-12,14,16,20,22-24,31H,4-7,13,15,28H2,1-3H3;1H/t20-,22+,23+,24-;/m0./s1 D04QPD DRUGINKE CAHTYTZOAVUCIU-ZMQZINMSSA-N D04QPD DRUGSMIL CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)C4CC(C(O4)COC(=O)C(C(C)C)N)O.Cl D04QPD HIGHSTAT Phase 3 D04QZI DRUG__ID D04QZI D04QZI DRUGCOMP GlaxoSmithKline D04QZI DRUGTYPE Small molecular drug D04QZI DRUGINCH 1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1 D04QZI DRUGINKE PLVGDGRBPMVYPB-FDUHJNRSSA-N D04QZI DRUGSMIL CCC(C)C1C(=O)NC(C(=O)N1C(C2=COC(=N2)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4 D04QZI HIGHSTAT Phase 3 D04SLF DRUG__ID D04SLF D04SLF DRUGCOMP Roche D04SLF DRUGTYPE Combination drug (Antibody) D04SLF DRUGINCH 1S/C24H40O3/c1-15(4-9-22(26)27)19-7-8-20-18-6-5-16-14-17(25)10-12-23(16,2)21(18)11-13-24(19,20)3/h15-21,25H,4-14H2,1-3H3,(H,26,27)/t15-,16-,17-,18+,19-,20+,21+,23+,24-/m1/s1 D04SLF DRUGINKE SMEROWZSTRWXGI-HVATVPOCSA-N D04SLF DRUGSMIL CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D04SLF HIGHSTAT Phase 3 D04VSM DRUG__ID D04VSM D04VSM DRUGCOMP Biota D04VSM DRUGTYPE Small molecular drug D04VSM DRUGINCH 1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1 D04VSM DRUGINKE UKTIJASCFRNWCB-RMIBSVFLSA-N D04VSM DRUGSMIL CCCCCCCC(=O)OCC(C(C1C(C(C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)OC)O D04VSM HIGHSTAT Phase 3 D05DBY DRUG__ID D05DBY D05DBY DRUGCOMP Pfizer Inc D05DBY DRUGTYPE Small molecular drug D05DBY DRUGINCH 1S/C9H19NO2/c1-3-4-7(2)5-8(10)6-9(11)12/h7-8H,3-6,10H2,1-2H3,(H,11,12)/t7-,8+/m1/s1 D05DBY DRUGINKE JXEHXYFSIOYTAH-SFYZADRCSA-N D05DBY DRUGSMIL CCCC(C)CC(CC(=O)O)N D05DBY HIGHSTAT Phase 3 D05FUU DRUG__ID D05FUU D05FUU DRUGCOMP Kotobuki Pharmaceutical Co Ltd D05FUU DRUGTYPE Small molecular drug D05FUU DRUGINCH 1S/C25H26N6O/c1-2-7-23-26-21-10-5-6-11-22(32)24(21)31(23)16-17-12-14-18(15-13-17)19-8-3-4-9-20(19)25-27-29-30-28-25/h3-4,8-9,12-15H,2,5-7,10-11,16H2,1H3,(H,27,28,29,30) D05FUU DRUGINKE KCTFTBCZZUBAKN-UHFFFAOYSA-N D05FUU DRUGSMIL CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)CCCC2 D05FUU HIGHSTAT Phase 3 D05IIP DRUG__ID D05IIP D05IIP DRUGCOMP National Cancer Institute D05IIP DRUGTYPE Small molecular drug D05IIP DRUGINCH 1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6H,7,21H2,(H2,22,27) D05IIP DRUGINKE WNRZHQBJSXRYJK-UHFFFAOYSA-N D05IIP DRUGSMIL C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)CN3C(=C(N=N3)C(=O)N)N)Cl)Cl D05IIP HIGHSTAT Phase 3 D05IRV DRUG__ID D05IRV D05IRV DRUGCOMP Synta Pharmaceuticals D05IRV DRUGTYPE Small molecular drug D05IRV DRUGINCH 1S/C19H20N4O2S2/c1-22(18(26)14-9-5-3-6-10-14)20-16(24)13-17(25)21-23(2)19(27)15-11-7-4-8-12-15/h3-12H,13H2,1-2H3,(H,20,24)(H,21,25) D05IRV DRUGINKE BKJIXTWSNXCKJH-UHFFFAOYSA-N D05IRV DRUGSMIL CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2 D05IRV HIGHSTAT Phase 3 D05JAC DRUG__ID D05JAC D05JAC THERCLAS Antiviral Agents D05JAC DRUGTYPE Small molecular drug D05JAC DRUGINCH 1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1 D05JAC DRUGINKE LTXREWYXXSTFRX-QGZVFWFLSA-N D05JAC DRUGSMIL CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C D05JAC HIGHSTAT Phase 3 Trial D05JET DRUG__ID D05JET D05JET DRUGCOMP Astra Zeneca D05JET DRUGTYPE Small molecular drug D05JET DRUGINCH 1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20) D05JET DRUGINKE YSGASDXSLKIKOD-UHFFFAOYSA-N D05JET DRUGSMIL CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN D05JET HIGHSTAT Phase 3 D05JSU DRUG__ID D05JSU D05JSU DRUGCOMP Eli Lilly D05JSU DRUGTYPE Small molecular drug D05JSU DRUGINCH 1S/C18H26FNO4/c1-22-16-3-2-15(19)10-13(16)11-18(21,14-4-7-23-8-5-14)17-12-20-6-9-24-17/h2-3,10,14,17,20-21H,4-9,11-12H2,1H3/t17-,18+/m0/s1 D05JSU DRUGINKE CPBHSHYQQLFAPW-ZWKOTPCHSA-N D05JSU DRUGSMIL COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O D05JSU HIGHSTAT Phase 3 D05KZM DRUG__ID D05KZM D05KZM DRUGCOMP BioNumerik Pharmaceuticals D05KZM DRUGTYPE Small molecular drug D05KZM DRUGINCH 1S/C4H10O6S4.2Na/c5-13(6,7)3-1-11-12-2-4-14(8,9)10;;/h1-4H2,(H,5,6,7)(H,8,9,10);;/q;2*+1/p-2 D05KZM DRUGINKE KQYGMURBTJPBPQ-UHFFFAOYSA-L D05KZM DRUGSMIL C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+] D05KZM HIGHSTAT Phase 3 D05NEK DRUG__ID D05NEK D05NEK THERCLAS Antiviral Agents D05NEK DRUGTYPE Small molecular drug D05NEK DRUGINCH 1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1 D05NEK DRUGINKE PWKSKIMOESPYIA-BYPYZUCNSA-N D05NEK DRUGSMIL CC(=O)NC(CS)C(=O)O D05NEK HIGHSTAT Phase 3 Trial D05SSC DRUG__ID D05SSC D05SSC DRUGCOMP Roche D05SSC DRUGTYPE Small molecular drug D05SSC DRUGINCH 1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26) D05SSC DRUGINKE YZQLWPMZQVHJED-UHFFFAOYSA-N D05SSC DRUGSMIL CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C D05SSC HIGHSTAT Phase 3 D05TOJ DRUG__ID D05TOJ D05TOJ DRUGCOMP Kowa Pharmaceutical Co Ltd; Eisai Co Ltd D05TOJ DRUGTYPE Small molecular drug D05TOJ DRUGINCH 1S/C20H30O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h8-9,11,13-15H,6-7,10,12H2,1-5H3,(H,21,22)/b14-8+,17-11+,18-13+,19-15+ D05TOJ DRUGINKE UUBHZHZSIKRVIV-KCXSXWJSSA-N D05TOJ DRUGSMIL CC(=CCCC(=CCCC(=CC=CC(=CC(=O)O)C)C)C)C D05TOJ HIGHSTAT Phase 3 D05ULR DRUG__ID D05ULR D05ULR THERCLAS Antiviral Agents D05ULR DRUGTYPE Small molecular drug D05ULR DRUGINCH 1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29) D05ULR DRUGINKE BNRNXUUZRGQAQC-UHFFFAOYSA-N D05ULR DRUGSMIL CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C D05ULR HIGHSTAT Phase 3 Trial D05ZHA DRUG__ID D05ZHA D05ZHA DRUGCOMP Mochida Pharmaceutical Co Ltd D05ZHA DRUGTYPE Small molecular drug D05ZHA DRUGINCH 1S/C17H15ClN2O5S/c1-11-4-2-3-5-13(11)17(21)20-9-8-15(19-25-26(22,23)24)14-7-6-12(18)10-16(14)20/h2-7,10H,8-9H2,1H3,(H,22,23,24)/b19-15+ D05ZHA DRUGINKE QQCSUWGQBREWRO-XDJHFCHBSA-N D05ZHA DRUGSMIL CC1=CC=CC=C1C(=O)N2CCC(=NOS(=O)(=O)O)C3=C2C=C(C=C3)Cl D05ZHA HIGHSTAT Phase 3 D06CIR DRUG__ID D06CIR D06CIR DRUGCOMP ReGeneRx Biopharmaceuticals D06CIR DRUGTYPE Small molecular drug D06CIR DRUGINCH 1S/C212H350N56O78S/c1-16-106(7)166(261-190(323)131(64-75-160(292)293)231-172(305)109(10)228-174(307)134(78-91-347-15)245-196(329)140(98-165(302)303)255-201(334)147-53-39-88-266(147)209(342)135(52-29-38-87-221)250-197(330)139(97-164(300)301)254-198(331)143(100-269)229-113(14)276)204(337)246-129(62-73-158(288)289)187(320)233-118(47-24-33-82-216)179(312)252-137(94-114-42-19-18-20-43-114)194(327)253-138(96-163(298)299)195(328)237-121(50-27-36-85-219)181(314)258-144(101-270)199(332)239-119(48-25-34-83-217)178(311)251-136(92-104(3)4)193(326)236-116(45-22-31-80-214)175(308)235-122(51-28-37-86-220)189(322)263-168(110(11)273)207(340)249-133(66-77-162(296)297)192(325)264-169(111(12)274)206(339)248-126(58-69-152(224)279)184(317)243-128(61-72-157(286)287)186(319)234-120(49-26-35-84-218)180(313)256-142(95-153(225)280)211(344)268-90-40-54-148(268)202(335)257-141(93-105(5)6)210(343)267-89-41-55-149(267)203(336)259-145(102-271)200(333)238-117(46-23-32-81-215)177(310)244-132(65-76-161(294)295)191(324)265-170(112(13)275)208(341)262-167(107(8)17-2)205(338)247-130(63-74-159(290)291)188(321)241-125(57-68-151(223)278)183(316)242-127(60-71-156(284)285)185(318)232-115(44-21-30-79-213)176(309)240-124(56-67-150(222)277)173(306)227-108(9)171(304)226-99-154(281)230-123(59-70-155(282)283)182(315)260-146(103-272)212(345)346/h18-20,42-43,104-112,115-149,166-170,269-275H,16-17,21-41,44-103,213-221H2,1-15H3,(H2,222,277)(H2,223,278)(H2,224,279)(H2,225,280)(H,226,304)(H,227,306)(H,228,307)(H,229,276)(H,230,281)(H,231,305)(H,232,318)(H,233,320)(H,234,319)(H,235,308)(H,236,326)(H,237,328)(H,238,333)(H,239,332)(H,240,309)(H,241,321)(H,242,316)(H,243,317)(H,244,310)(H,245,329)(H,246,337)(H,247,338)(H,248,339)(H,249,340)(H,250,330)(H,251,311)(H,252,312)(H,253,327)(H,254,331)(H,255,334)(H,256,313)(H,257,335)(H,258,314)(H,259,336)(H,260,315)(H,261,323)(H,262,341)(H,263,322)(H,264,325)(H,265,324)(H,282,283)(H,284,285)(H,286,287)(H,288,289)(H,290,291)(H,292,293)(H,294,295)(H,296,297)(H,298,299)(H,300,301)(H,302,303)(H,345,346)/t106-,107-,108-,109-,110+,111+,112+,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,166-,167-,168-,169-,170-/m0/s1 D06CIR DRUGINKE UGPMCIBIHRSCBV-XNBOLLIBSA-N D06CIR DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CC(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C D06CIR HIGHSTAT Phase 3 D06EIC DRUG__ID D06EIC D06EIC DRUGCOMP Astellas Pharma Inc D06EIC DRUGTYPE Small molecular drug D06EIC DRUGINCH 1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14?,18? D06EIC DRUGINKE DREIJXJRTLTGJC-JQCLMNFQSA-N D06EIC DRUGSMIL C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O D06EIC HIGHSTAT Phase 3 D06ETI DRUG__ID D06ETI D06ETI DRUGCOMP Roche; Genentech D06ETI DRUGTYPE Small molecular drug D06ETI DRUGINCH 1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1 D06ETI DRUGINKE JLYAXFNOILIKPP-KXQOOQHDSA-N D06ETI DRUGSMIL CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C D06ETI HIGHSTAT Phase 3 D06FKC DRUG__ID D06FKC D06FKC DRUGCOMP Amarantus bioscience; psychogenics D06FKC DRUGTYPE Small molecular drug D06FKC DRUGINCH 1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2 D06FKC DRUGINKE WVLHGCRWEHCIOT-UHFFFAOYSA-N D06FKC DRUGSMIL C1CN(CCN1)C2=C3C(=CC=C2)OCCO3 D06FKC HIGHSTAT Phase 3 D06GRK DRUG__ID D06GRK D06GRK DRUGCOMP Archer Pharmaceuticals D06GRK DRUGTYPE Small molecular drug D06GRK DRUGINCH 1S/C19H19N3O6/c1-10(2)28-19(24)15-11(3)21-14(9-20)17(18(23)27-4)16(15)12-6-5-7-13(8-12)22(25)26/h5-8,10,16,21H,1-4H3 D06GRK DRUGINKE FAIIFDPAEUKBEP-UHFFFAOYSA-N D06GRK DRUGSMIL CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C D06GRK HIGHSTAT Phase 3 D06KJQ DRUG__ID D06KJQ D06KJQ DRUGCOMP Boehringer Ingelheim Pharma D06KJQ DRUGTYPE Small molecular drug D06KJQ DRUGINCH 1S/C40H49BrN6O9S/c1-8-21-17-40(21,36(51)52)46-34(49)27-15-23(18-47(27)35(50)32(39(4,5)6)44-38(53)56-22-11-9-10-12-22)55-29-16-25(26-19-57-37(43-26)45-33(48)20(2)3)42-31-24(29)13-14-28(54-7)30(31)41/h8,13-14,16,19-23,27,32H,1,9-12,15,17-18H2,2-7H3,(H,44,53)(H,46,49)(H,51,52)(H,43,45,48)/t21-,23-,27+,32-,40-/m1/s1 D06KJQ DRUGINKE LLGDPTDZOVKFDU-XUHJSTDZSA-N D06KJQ DRUGSMIL CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)OC4CC(N(C4)C(=O)C(C(C)(C)C)NC(=O)OC5CCCC5)C(=O)NC6(CC6C=C)C(=O)O D06KJQ HIGHSTAT Phase 3 D06KNJ DRUG__ID D06KNJ D06KNJ DRUGCOMP Point Biomedical D06KNJ DRUGTYPE Small molecular drug D06KNJ DRUGINCH 1S/C29H36N8O3S/c1-33(2)29(38)35-12-9-22(10-13-35)18-37(41(39,40)28-6-4-5-11-32-28)25-15-24-14-23(16-30)7-8-27(24)36(19-25)20-26-17-31-21-34(26)3/h4-8,11,14,17,21-22,25H,9-10,12-13,15,18-20H2,1-3H3 D06KNJ DRUGINKE BJRVIVQYGUKETA-UHFFFAOYSA-N D06KNJ DRUGSMIL CN1C=NC=C1CN2CC(CC3=C2C=CC(=C3)C#N)N(CC4CCN(CC4)C(=O)N(C)C)S(=O)(=O)C5=CC=CC=N5 D06KNJ HIGHSTAT Phase 3 D06LFV DRUG__ID D06LFV D06LFV DRUGCOMP Nissan Chemical America D06LFV DRUGTYPE Small molecular drug D06LFV DRUGINCH 1S/C19H18BrClN4O2.ClH/c20-16-17(23-12-14-3-1-9-22-11-14)19(25-24-18(16)26)27-10-2-4-13-5-7-15(21)8-6-13;/h1,3,5-9,11H,2,4,10,12H2,(H2,23,24,26);1H D06LFV DRUGINKE QWGUGDYWUADMGB-UHFFFAOYSA-N D06LFV DRUGSMIL C1=CC(=CN=C1)CNC2=C(C(=O)NN=C2OCCCC3=CC=C(C=C3)Cl)Br.Cl D06LFV HIGHSTAT Phase 3 D06OQI DRUG__ID D06OQI D06OQI DRUGCOMP ArgiNOx D06OQI DRUGTYPE Small molecular drug D06OQI DRUGINCH 1S/C7H16N4O2.C2H4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13;1-2(3)4/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11);1H3,(H,3,4)/t5-;/m0./s1 D06OQI DRUGINKE IKPNWIGTWUZCKM-JEDNCBNOSA-N D06OQI DRUGSMIL CC(=O)O.CN=C(N)NCCCC(C(=O)O)N D06OQI HIGHSTAT Phase 3 D06QZL DRUG__ID D06QZL D06QZL DRUGCOMP FAES Farma D06QZL DRUGTYPE Small molecular drug D06QZL DRUGINCH 1S/C18H20N4/c1-2-6-15(7-3-1)14-22-17-9-5-4-8-16(17)20-18(22)21-12-10-19-11-13-21/h1-9,19H,10-14H2 D06QZL DRUGINKE PWWDCRQZITYKDV-UHFFFAOYSA-N D06QZL DRUGSMIL C1CN(CCN1)C2=NC3=CC=CC=C3N2CC4=CC=CC=C4 D06QZL HIGHSTAT Phase 3 D06VSD DRUG__ID D06VSD D06VSD THERCLAS Antiviral Agents D06VSD DRUGTYPE Small molecular drug D06VSD DRUGINCH 1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1 D06VSD DRUGINKE FAKRSMQSSFJEIM-RQJHMYQMSA-N D06VSD DRUGSMIL CC(CS)C(=O)N1CCCC1C(=O)O D06VSD HIGHSTAT Phase 3 Trial D06VYK DRUG__ID D06VYK D06VYK THERCLAS Antiviral Agents D06VYK DRUGTYPE Small molecular drug D06VYK DRUGINCH 1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 D06VYK DRUGINKE MQTOSJVFKKJCRP-BICOPXKESA-N D06VYK DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O D06VYK HIGHSTAT Phase 3 Trial D06WPM DRUG__ID D06WPM D06WPM DRUGCOMP Pipex Pharmaceuticals D06WPM DRUGTYPE Small molecular drug D06WPM DRUGINCH 1S/Mo.2H2S.2S/h;2*1H2;;/p-2 D06WPM DRUGINKE VVRHUOPINLMZBL-UHFFFAOYSA-L D06WPM DRUGSMIL [SH-].[SH-].S=[Mo]=S D06WPM HIGHSTAT Phase 3 D06WQT DRUG__ID D06WQT D06WQT DRUGCOMP Agouron Pharmaceuticals Inc D06WQT DRUGTYPE Small molecular drug D06WQT DRUGINCH 1S/C14H12N4OS/c1-8-2-3-10-11(13(19)18-14(15)17-10)12(8)20-9-4-6-16-7-5-9/h2-7H,1H3,(H3,15,17,18,19) D06WQT DRUGINKE XHWRWCSCBDLOLM-UHFFFAOYSA-N D06WQT DRUGSMIL CC1=C(C2=C(C=C1)N=C(NC2=O)N)SC3=CC=NC=C3 D06WQT HIGHSTAT Phase 3 D07AEO DRUG__ID D07AEO D07AEO THERCLAS Antiviral Agents D07AEO DRUGTYPE Small molecular drug D07AEO DRUGINCH 1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14- D07AEO DRUGINKE SHGAZHPCJJPHSC-XFYACQKRSA-N D07AEO DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D07AEO HIGHSTAT Phase 3 Trial D07EBF DRUG__ID D07EBF D07EBF DRUGCOMP Cytokinetics D07EBF DRUGTYPE Small molecular drug D07EBF DRUGINCH 1S/C12H14N4O/c1-4-8-7-13-10-11(14-8)16(12(17)15-10)9(5-2)6-3/h1,7,9H,5-6H2,2-3H3,(H,13,15,17) D07EBF DRUGINKE RSQGZEAXODVTOL-UHFFFAOYSA-N D07EBF DRUGSMIL CCC(CC)N1C2=NC(=CN=C2NC1=O)C#C D07EBF HIGHSTAT Phase 3 D07EEN DRUG__ID D07EEN D07EEN DRUGCOMP Wyeth-Ayerst; Cardiokine D07EEN DRUGTYPE Small molecular drug D07EEN DRUGINCH 1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33) D07EEN DRUGINKE PPHTXRNHTVLQED-UHFFFAOYSA-N D07EEN DRUGSMIL CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl D07EEN HIGHSTAT Phase 3 D07FBM DRUG__ID D07FBM D07FBM DRUGCOMP Astellas Pharma US D07FBM DRUGTYPE Small molecular drug D07FBM DRUGINCH 1S/C21H21FO5S/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14/h1-8,16,18-21,23-26H,9-10H2/t16-,18-,19+,20-,21+/m1/s1 D07FBM DRUGINKE AHFWIQIYAXSLBA-RQXATKFSSA-N D07FBM DRUGSMIL C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)F D07FBM HIGHSTAT Phase 3 D07HLS DRUG__ID D07HLS D07HLS DRUGCOMP Merck D07HLS DRUGTYPE Small molecular drug D07HLS DRUGINCH 1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1 D07HLS DRUGINKE MZZLGJHLQGUVPN-HAWMADMCSA-N D07HLS DRUGSMIL CC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D07HLS HIGHSTAT Phase 3 D07KFB DRUG__ID D07KFB D07KFB DRUGCOMP Shionogi & Co Ltd D07KFB DRUGTYPE Small molecular drug D07KFB DRUGINCH 1S/C22H22N2O5/c1-3-15-20(21(26)22(23)27)19-16(24(15)12-14-8-5-4-6-9-14)10-7-11-17(19)29-13-18(25)28-2/h4-11H,3,12-13H2,1-2H3,(H2,23,27) D07KFB DRUGINKE VJYDOJXJUCJUHL-UHFFFAOYSA-N D07KFB DRUGSMIL CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)OC)C(=O)C(=O)N D07KFB HIGHSTAT Phase 3 D07MXF DRUG__ID D07MXF D07MXF DRUGCOMP Dong Wha Pharmaceutical Co Ltd D07MXF DRUGTYPE Small molecular drug D07MXF DRUGINCH 1S/C19H20FN5O4/c1-29-23-14-6-24(9-19(14)7-21-8-19)17-13(20)4-11-15(26)12(18(27)28)5-25(10-2-3-10)16(11)22-17/h4-5,10,21H,2-3,6-9H2,1H3,(H,27,28)/b23-14+ D07MXF DRUGINKE ZNPOCLHDJCAZAH-OEAKJJBVSA-N D07MXF DRUGSMIL CON=C1CN(CC12CNC2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5CC5)C(=O)O)F D07MXF HIGHSTAT Phase 3 D07NVI DRUG__ID D07NVI D07NVI DRUGCOMP Cornerstone Pharmaceuticals D07NVI DRUGTYPE Small molecular drug D07NVI DRUGINCH 1S/C22H28O2S2/c23-22(24)14-8-7-13-21(26-18-20-11-5-2-6-12-20)15-16-25-17-19-9-3-1-4-10-19/h1-6,9-12,21H,7-8,13-18H2,(H,23,24) D07NVI DRUGINKE ZYRLHJIMTROTBO-UHFFFAOYSA-N D07NVI DRUGSMIL C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2 D07NVI HIGHSTAT Phase 3 D07PVB DRUG__ID D07PVB D07PVB DRUGCOMP OHR Pharmaceutical D07PVB DRUGTYPE Small molecular drug D07PVB DRUGINCH 1S/C34H65N3O5S/c1-23(2)31(42-43(39,40)41)12-9-24(3)27-10-11-28-32-29(14-16-34(27,28)5)33(4)15-13-26(21-25(33)22-30(32)38)37-20-8-19-36-18-7-6-17-35/h23-32,36-38H,6-22,35H2,1-5H3,(H,39,40,41)/t24-,25-,26+,27-,28+,29+,30-,31-,32+,33+,34-/m1/s1 D07PVB DRUGINKE UIRKNQLZZXALBI-MSVGPLKSSA-N D07PVB DRUGSMIL CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCN)C)O)C)OS(=O)(=O)O D07PVB HIGHSTAT Phase 3 D07PXQ DRUG__ID D07PXQ D07PXQ DRUGCOMP Astellas Pharma Inc D07PXQ DRUGTYPE Small molecular drug D07PXQ DRUGINCH 1S/C24H26N4O5S/c1-16-4-3-5-17(2)22(16)28(24(30)19-10-12-34(31,32)13-11-19)14-21(29)26-20-8-6-18(7-9-20)23-25-15-33-27-23/h3-9,15,19H,10-14H2,1-2H3,(H,26,29) D07PXQ DRUGINKE MNHNIVNAFBSLLX-UHFFFAOYSA-N D07PXQ DRUGSMIL CC1=C(C(=CC=C1)C)N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CCS(=O)(=O)CC4 D07PXQ HIGHSTAT Phase 3 D07QJK DRUG__ID D07QJK D07QJK DRUGCOMP PharmaMar D07QJK DRUGTYPE Small molecular drug D07QJK DRUGINCH 1S/C57H87N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-34,36,39-44,46-47,49,66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1 D07QJK DRUGINKE UUSZLLQJYRSZIS-LXNNNBEUSA-N D07QJK DRUGSMIL CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O D07QJK HIGHSTAT Phase 3 D07TQN DRUG__ID D07TQN D07TQN DRUGCOMP Merck D07TQN DRUGTYPE Small molecular drug D07TQN DRUGINCH 1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1 D07TQN DRUGINKE JHLHNYVMZCADTC-LOSJGSFVSA-N D07TQN DRUGSMIL CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4 D07TQN HIGHSTAT Phase 3 D07TSV DRUG__ID D07TSV D07TSV THERCLAS Antiviral Agents D07TSV DRUGTYPE Small molecular drug D07TSV DRUGINCH 1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 D07TSV DRUGINKE XUKUURHRXDUEBC-KAYWLYCHSA-N D07TSV DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 D07TSV HIGHSTAT Phase 3 Trial D07VHS DRUG__ID D07VHS D07VHS DRUGCOMP Astellas D07VHS DRUGTYPE Small molecular drug D07VHS DRUGINCH 1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-8-17(23)6-7-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1 D07VHS DRUGINKE DDFOUSQFMYRUQK-RCDICMHDSA-N D07VHS DRUGSMIL CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O D07VHS HIGHSTAT Phase 3 D07VIB DRUG__ID D07VIB D07VIB DRUGCOMP ARYx Therapeutics D07VIB DRUGTYPE Small molecular drug D07VIB DRUGINCH 1S/C21H14F6O5/c1-19(20(22,23)24,21(25,26)27)32-17(29)12-8-6-11(7-9-12)10-14-16(28)13-4-2-3-5-15(13)31-18(14)30/h2-9,28H,10H2,1H3 D07VIB DRUGINKE QFLNTQDOVCLQKW-UHFFFAOYSA-N D07VIB DRUGSMIL CC(C(F)(F)F)(C(F)(F)F)OC(=O)C1=CC=C(C=C1)CC2=C(C3=CC=CC=C3OC2=O)O D07VIB HIGHSTAT Phase 3 D07WCB DRUG__ID D07WCB D07WCB THERCLAS Antiviral Agents D07WCB DRUGTYPE Small molecular drug D07WCB DRUGINCH 1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1 D07WCB DRUGINKE IAKHMKGGTNLKSZ-INIZCTEOSA-N D07WCB DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC D07WCB HIGHSTAT Phase 3 Trial D07XRU DRUG__ID D07XRU D07XRU THERCLAS Antiviral Agents D07XRU DRUGTYPE Small molecular drug D07XRU DRUGINCH 1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39) D07XRU DRUGINKE RMMXLENWKUUMAY-UHFFFAOYSA-N D07XRU DRUGSMIL CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C D07XRU HIGHSTAT Phase 3 Trial D07YAR DRUG__ID D07YAR D07YAR DRUGCOMP Nymox Pharmaceutical D07YAR DRUGTYPE Small molecular drug D07YAR DRUGINCH 1S/C90H163N27O25S/c1-15-48(12)68(95)84(137)110-60(41-67(123)124)81(134)105-55(28-31-64(93)119)75(128)104-56(29-32-65(94)120)77(130)115-69(47(10)11)85(138)111-59(39-45(6)7)80(133)113-62(42-118)82(135)103-54(27-23-37-101-90(98)99)76(129)116-70(49(13)16-2)86(139)108-52(25-19-21-35-92)73(126)109-58(38-44(4)5)79(132)106-57(30-33-66(121)122)78(131)117-71(50(14)17-3)87(140)107-51(24-18-20-34-91)72(125)102-53(26-22-36-100-89(96)97)74(127)114-63(43-143)83(136)112-61(88(141)142)40-46(8)9/h44-63,68-71,118,143H,15-43,91-92,95H2,1-14H3,(H2,93,119)(H2,94,120)(H,102,125)(H,103,135)(H,104,128)(H,105,134)(H,106,132)(H,107,140)(H,108,139)(H,109,126)(H,110,137)(H,111,138)(H,112,136)(H,113,133)(H,114,127)(H,115,130)(H,116,129)(H,117,131)(H,121,122)(H,123,124)(H,141,142)(H4,96,97,100)(H4,98,99,101)/t48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,68-,69-,70-,71-/m0/s1 D07YAR DRUGINKE BROGCIMRGWLMOO-SJPGHYFNSA-N D07YAR DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CS)C(=O)NC(CC(C)C)C(=O)O)N D07YAR HIGHSTAT Phase 3 D07YLV DRUG__ID D07YLV D07YLV THERCLAS Antiviral Agents D07YLV DRUGTYPE Small molecular drug D07YLV DRUGINCH 1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1 D07YLV DRUGINKE LUKZNWIVRBCLON-GXOBDPJESA-N D07YLV DRUGSMIL CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6 D07YLV HIGHSTAT Phase 3 Trial D07YVK DRUG__ID D07YVK D07YVK DRUGCOMP Pfizer D07YVK DRUGTYPE Small molecular drug D07YVK DRUGINCH 1S/C11H13N3O/c1-12-8-5-7-3-2-4-9-10(7)14(6-8)11(15)13-9/h2-4,8,12H,5-6H2,1H3,(H,13,15)/t8-/m1/s1 D07YVK DRUGINKE RKZSNTNMEFVBDT-MRVPVSSYSA-N D07YVK DRUGSMIL CNC1CC2=C3C(=CC=C2)NC(=O)N3C1 D07YVK HIGHSTAT Phase 3 D08CGU DRUG__ID D08CGU D08CGU DRUGCOMP Roche D08CGU DRUGTYPE Combination drug (Antibody) D08CGU DRUGINCH 1S/C14H19IN2O3.Li/c1-3-17(4-2)8-7-16-13(18)10-5-6-11(14(19)20)12(15)9-10;/h5-6,9H,3-4,7-8H2,1-2H3,(H,16,18)(H,19,20);/q;+1/p-1 D08CGU DRUGINKE CNMYRBKJCDLCHB-UHFFFAOYSA-M D08CGU DRUGSMIL [Li+].CCN(CC)CCNC(=O)C1=CC(=C(C=C1)C(=O)[O-])I D08CGU HIGHSTAT Phase 3 D08CVC DRUG__ID D08CVC D08CVC DRUGCOMP Orphan Europe SARL D08CVC DRUGTYPE Small molecular drug D08CVC DRUGINCH 1S/C35H58O6/c1-24(2)12-9-13-25(3)14-10-15-26(4)16-11-20-35(8)21-19-30-29(7)33(27(5)28(6)34(30)41-35)40-32(38)18-17-31(37)39-23-22-36/h24-26,36H,9-23H2,1-8H3/t25-,26-,35+/m1/s1 D08CVC DRUGINKE AOBORMOPSGHCAX-DGHZZKTQSA-N D08CVC DRUGSMIL CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C D08CVC HIGHSTAT Phase 3 D08DGC DRUG__ID D08DGC D08DGC DRUGCOMP Cervelo Pharmaceuticals Ltd D08DGC DRUGTYPE Small molecular drug D08DGC DRUGINCH 1S/C25H36O4/c1-6-7-8-9-12-24(2,3)17-14-20(26)22-18-13-16(23(27)28)10-11-19(18)25(4,5)29-21(22)15-17/h10,14-15,18-19,26H,6-9,11-13H2,1-5H3,(H,27,28)/t18-,19-/m1/s1 D08DGC DRUGINKE YCHYFHOSGQABSW-RTBURBONSA-N D08DGC DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)C(=O)O)O D08DGC HIGHSTAT Phase 3 D08DHN DRUG__ID D08DHN D08DHN DRUGCOMP Vertex pharmaceuticals D08DHN DRUGTYPE Small molecular drug D08DHN DRUGINCH 1S/C20H19F2N5O2/c21-11-5-12-13(7-24-17(12)23-6-11)18-25-8-14(22)19(27-18)26-16-10-3-1-9(2-4-10)15(16)20(28)29/h5-10,15-16H,1-4H2,(H,23,24)(H,28,29)(H,25,26,27)/t9?,10?,15-,16-/m0/s1 D08DHN DRUGINKE JGPXDNKSIXAZEQ-SBBZOCNPSA-N D08DHN DRUGSMIL C1CC2CCC1C(C2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O D08DHN HIGHSTAT Phase 3 D08GJH DRUG__ID D08GJH D08GJH DRUGCOMP Dainippon D08GJH DRUGTYPE Small molecular drug D08GJH DRUGINCH 1S/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3 D08GJH DRUGINKE XVGOZDAJGBALKS-UHFFFAOYSA-N D08GJH DRUGSMIL CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F D08GJH HIGHSTAT Phase 3 D08GOD DRUG__ID D08GOD D08GOD THERCLAS Antiviral Agents D08GOD DRUGTYPE Small molecular drug D08GOD DRUGINCH 1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2 D08GOD DRUGINKE CAVRKWRKTNINFF-UHFFFAOYSA-N D08GOD DRUGSMIL C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl D08GOD HIGHSTAT Phase 3 Trial D08JAC DRUG__ID D08JAC D08JAC DRUGCOMP Sirion Therapeutics; cerrx; Sytera Inc D08JAC DRUGTYPE Small molecular drug D08JAC DRUGINCH 1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+ D08JAC DRUGINKE AKJHMTWEGVYYSE-FXILSDISSA-N D08JAC DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C D08JAC HIGHSTAT Phase 3 D08JWJ DRUG__ID D08JWJ D08JWJ DRUGCOMP Pfizer D08JWJ DRUGTYPE Small molecular drug D08JWJ DRUGINCH 1S/C18H14ClN2O6S2.Na/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18;/h3-5,7H,6,8H2,1-2H3;/q-1;+1 D08JWJ DRUGINKE MDTNUYUCUYPIHE-UHFFFAOYSA-N D08JWJ DRUGSMIL CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)[N-]C4=C(C(=NO4)C)Cl)OCO2.[Na+] D08JWJ HIGHSTAT Phase 3 D08KYQ DRUG__ID D08KYQ D08KYQ THERCLAS Antiinfective Agents D08KYQ DRUGTYPE Small molecular drug D08KYQ DRUGINCH 1S/C12H15NO5S3/c1-5(14)7-9(15)13-8(11(16)17)12(20-10(7)13)19-6-2-3-21(18)4-6/h5-7,10,14H,2-4H2,1H3,(H,16,17)/t5-,6+,7+,10-,21-/m1/s1 D08KYQ DRUGINKE FLSUCZWOEMTFAQ-PRBGKLEPSA-N D08KYQ DRUGSMIL CC(C1C2N(C1=O)C(=C(S2)SC3CCS(=O)C3)C(=O)O)O D08KYQ HIGHSTAT Phase 3 D08LDB DRUG__ID D08LDB D08LDB DRUGCOMP GSK D08LDB DRUGTYPE Small molecular drug D08LDB DRUGINCH 1S/C19H17F2N3O5/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27)/t9-,14+/m0/s1 D08LDB DRUGINKE WCWSTNLSLKSJPK-LKFCYVNXSA-N D08LDB DRUGSMIL CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O D08LDB HIGHSTAT Phase 3 D08MXP DRUG__ID D08MXP D08MXP DRUGCOMP Novartis AG D08MXP DRUGTYPE Small molecular drug D08MXP DRUGINCH 1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28) D08MXP DRUGINKE RHXHGRAEPCAFML-UHFFFAOYSA-N D08MXP DRUGSMIL CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5 D08MXP HIGHSTAT Phase 3 D08PFA DRUG__ID D08PFA D08PFA DRUGCOMP Sankyo Co Ltd D08PFA DRUGTYPE Small molecular drug D08PFA DRUGINCH 1S/C20H19N3O4S/c1-23-16-10-14(26-2)7-8-15(16)21-18(23)11-27-13-5-3-12(4-6-13)9-17-19(24)22-20(25)28-17/h3-8,10,17H,9,11H2,1-2H3,(H,22,24,25) D08PFA DRUGINKE XMSXOLDPMGMWTH-UHFFFAOYSA-N D08PFA DRUGSMIL CN1C2=C(C=CC(=C2)OC)N=C1COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4 D08PFA HIGHSTAT Phase 3 D08PGC DRUG__ID D08PGC D08PGC DRUGCOMP Rottapharm Madaus D08PGC DRUGTYPE Small molecular drug D08PGC DRUGINCH 1S/C15H11N9O/c25-15(11-3-1-9(2-4-11)13-17-21-22-18-13)16-12-7-5-10(6-8-12)14-19-23-24-20-14/h1-8H,(H,16,25)(H,17,18,21,22)(H,19,20,23,24) D08PGC DRUGINKE VXEBMQZDPONDFB-UHFFFAOYSA-N D08PGC DRUGSMIL C1=CC(=CC=C1C2=NNN=N2)C(=O)NC3=CC=C(C=C3)C4=NNN=N4 D08PGC HIGHSTAT Phase 3 D08PXR DRUG__ID D08PXR D08PXR DRUGCOMP Abbott Laboratories D08PXR DRUGTYPE Small molecular drug D08PXR DRUGINCH 1S/C16H15FN2O2S/c1-11(19(21)16(18)20)2-7-14-8-9-15(22-14)10-12-3-5-13(17)6-4-12/h3-6,8-9,11,21H,10H2,1H3,(H2,18,20)/t11-/m1/s1 D08PXR DRUGINKE MMSNEKOTSJRTRI-LLVKDONJSA-N D08PXR DRUGSMIL CC(C#CC1=CC=C(S1)CC2=CC=C(C=C2)F)N(C(=O)N)O D08PXR HIGHSTAT Phase 3 D08TJM DRUG__ID D08TJM D08TJM DRUGCOMP Aderis Pharmaceuticals Inc D08TJM DRUGTYPE Small molecular drug D08TJM DRUGINCH 1S/C17H25N7O4/c18-14-11-15(22-17(21-14)23-20-6-9-4-2-1-3-5-9)24(8-19-11)16-13(27)12(26)10(7-25)28-16/h6,8-10,12-13,16,25-27H,1-5,7H2,(H3,18,21,22,23)/b20-6+/t10-,12-,13-,16-/m1/s1 D08TJM DRUGINKE XJFMHMFFBSOEPR-DNZQAUTHSA-N D08TJM DRUGSMIL C1CCC(CC1)C=NNC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D08TJM HIGHSTAT Phase 3 D08YHS DRUG__ID D08YHS D08YHS DRUGCOMP Bristol-Myers Squibb Pharma Co D08YHS DRUGTYPE Small molecular drug D08YHS DRUGINCH 1S/C26H21N3O/c30-25-26(18-20-10-14-27-15-11-20,19-21-12-16-28-17-13-21)23-8-4-5-9-24(23)29(25)22-6-2-1-3-7-22/h1-17H,18-19H2 D08YHS DRUGINKE YEJCDKJIEMIWRQ-UHFFFAOYSA-N D08YHS DRUGSMIL C1=CC=C(C=C1)N2C3=CC=CC=C3C(C2=O)(CC4=CC=NC=C4)CC5=CC=NC=C5 D08YHS HIGHSTAT Phase 3 D09CUR DRUG__ID D09CUR D09CUR DRUGCOMP Diffusion Pharmaceuticals D09CUR DRUGTYPE Small molecular drug D09CUR DRUGINCH 1S/C20H24O4.2Na/c1-15(11-7-13-17(3)19(21)22)9-5-6-10-16(2)12-8-14-18(4)20(23)24;;/h5-14H,1-4H3,(H,21,22)(H,23,24);;/q;2*+1/p-2/b6-5+,11-7+,12-8+,15-9+,16-10+,17-13+,18-14+;; D09CUR DRUGINKE RMDMBHQVNHQDDD-VFWKRBOSSA-L D09CUR DRUGSMIL CC(=CC=CC=C(C)C=CC=C(C)C(=O)[O-])C=CC=C(C)C(=O)[O-].[Na+].[Na+] D09CUR HIGHSTAT Phase 3 D09DJO DRUG__ID D09DJO D09DJO DRUGCOMP Immtech International; University of North Carolina D09DJO DRUGTYPE Small molecular drug D09DJO DRUGINCH 1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24) D09DJO DRUGINKE UKOQVLAXCBRRGH-UHFFFAOYSA-N D09DJO DRUGSMIL CON=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=NOC)N)N D09DJO HIGHSTAT Phase 3 D09DLP DRUG__ID D09DLP D09DLP DRUGCOMP Neurochem D09DLP DRUGTYPE Small molecular drug D09DLP DRUGINCH 1S/C3H9NO3S/c4-2-1-3-8(5,6)7/h1-4H2,(H,5,6,7) D09DLP DRUGINKE SNKZJIOFVMKAOJ-UHFFFAOYSA-N D09DLP DRUGSMIL C(CN)CS(=O)(=O)O D09DLP HIGHSTAT Phase 3 D09INF DRUG__ID D09INF D09INF DRUGCOMP Active Biotech; Teva D09INF DRUGTYPE Small molecular drug D09INF DRUGINCH 1S/C19H17ClN2O3.Na/c1-3-22(12-8-5-4-6-9-12)19(25)16-17(23)15-13(20)10-7-11-14(15)21(2)18(16)24;/h4-11,23H,3H2,1-2H3;/q;+1/p-1 D09INF DRUGINKE JWHPPWBIIQMBQC-UHFFFAOYSA-M D09INF DRUGSMIL CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)[O-].[Na+] D09INF HIGHSTAT Phase 3 D09IRN DRUG__ID D09IRN D09IRN DRUGCOMP Lundbeck D09IRN DRUGTYPE Small molecular drug D09IRN DRUGINCH 1S/C20H19F5N2O/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23/h1-5,8-9,11,19,26-27H,6-7,10,12H2 D09IRN DRUGINKE YBAWYTYNMZWMMJ-UHFFFAOYSA-N D09IRN DRUGSMIL C1=CC(=CC(=C1)OCC(C(F)F)(F)F)CNCCC2=CNC3=C2C=CC(=C3)F D09IRN HIGHSTAT Phase 3 D09IRQ DRUG__ID D09IRQ D09IRQ DRUGCOMP Genzyme; PTC Therapeutics D09IRQ DRUGTYPE Small molecular drug D09IRQ DRUGINCH 1S/C15H9FN2O3/c16-12-7-2-1-6-11(12)14-17-13(18-21-14)9-4-3-5-10(8-9)15(19)20/h1-8H,(H,19,20) D09IRQ DRUGINKE OOUGLTULBSNHNF-UHFFFAOYSA-N D09IRQ DRUGSMIL C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F D09IRQ HIGHSTAT Phase 3 D09JFY DRUG__ID D09JFY D09JFY DRUGCOMP GSK D09JFY DRUGTYPE Combination drug (small molecular drug) D09JFY DRUGINCH 1S/C27H30F6N2O2.C20H28N2O5S/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33;1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36);5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-,16-,17-,19+,21+,24-,25+;15-/m01/s1 D09JFY DRUGINKE SHHCJPKACHSWFP-NMXGMQNUSA-N D09JFY DRUGSMIL CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C D09JFY HIGHSTAT Phase 3 D09JLI DRUG__ID D09JLI D09JLI DRUGCOMP Schering-Plough D09JLI DRUGTYPE Small molecular drug D09JLI DRUGINCH 1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1 D09JLI DRUGINKE CNPVJJQCETWNEU-CYFREDJKSA-N D09JLI DRUGSMIL CC1CN(CCN1C(COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C D09JLI HIGHSTAT Phase 3 D09NTC DRUG__ID D09NTC D09NTC DRUGCOMP Celgene D09NTC DRUGTYPE Small molecular drug D09NTC DRUGINCH 1S/C19H20N4O/c1-22(2)12-13-6-8-14(9-7-13)18-21-16-5-3-4-15-17(16)23(18)11-10-20-19(15)24/h3-9H,10-12H2,1-2H3,(H,20,24) D09NTC DRUGINKE SEKJSSBJKFLZIT-UHFFFAOYSA-N D09NTC DRUGSMIL CN(C)CC1=CC=C(C=C1)C2=NC3=CC=CC4=C3N2CCNC4=O D09NTC HIGHSTAT Phase 3 D09WNK DRUG__ID D09WNK D09WNK DRUGCOMP Zogenix Emeryville, CA D09WNK DRUGTYPE Small molecular drug D09WNK DRUGINCH 1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3 D09WNK DRUGINKE DBGIVFWFUFKIQN-UHFFFAOYSA-N D09WNK DRUGSMIL CCNC(C)CC1=CC(=CC=C1)C(F)(F)F D09WNK HIGHSTAT Phase 3 D09XQU DRUG__ID D09XQU D09XQU DRUGCOMP Sri international D09XQU DRUGTYPE Small molecular drug D09XQU DRUGINCH 1S/C7H6N4O2/c8-7-9-11(13)6-4-2-1-3-5(6)10(7)12/h1-4H,(H2,8,9) D09XQU DRUGINKE ORYDPOVDJJZGHQ-UHFFFAOYSA-N D09XQU DRUGSMIL C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-] D09XQU HIGHSTAT Phase 3 D09XUB DRUG__ID D09XUB D09XUB DRUGCOMP Valeant Pharmaceuticals International D09XUB DRUGTYPE Small molecular drug D09XUB DRUGINCH 1S/C8H13N5O4/c9-6(10)7-11-2-13(12-7)8-5(16)4(15)3(1-14)17-8/h2-5,8,14-16H,1H2,(H3,9,10)/t3-,4-,5-,8-/m1/s1 D09XUB DRUGINKE NHKZSTHOYNWEEZ-AFCXAGJDSA-N D09XUB DRUGSMIL C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=N)N D09XUB HIGHSTAT Phase 3 D09YDO DRUG__ID D09YDO D09YDO DRUGCOMP Fujisawa Pharmaceutical Co Ltd D09YDO DRUGTYPE Small molecular drug D09YDO DRUGINCH 1S/C17H12N6O3/c24-15(18-17-19-21-22-20-17)12-10-14(26-11-6-2-1-3-7-11)13-8-4-5-9-23(13)16(12)25/h1-10H,(H2,18,19,20,21,22,24) D09YDO DRUGINKE ZUPLNRDTYQWUHP-UHFFFAOYSA-N D09YDO DRUGSMIL C1=CC=C(C=C1)OC2=C3C=CC=CN3C(=O)C(=C2)C(=O)NC4=NNN=N4 D09YDO HIGHSTAT Phase 3 D0A1AQ DRUG__ID D0A1AQ D0A1AQ DRUGCOMP GSK D0A1AQ DRUGTYPE Combination drug (small molecular drug) D0A1AQ DRUGINCH 1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9- D0A1AQ DRUGINKE NHFDRBXTEDBWCZ-ZROIWOOFSA-N D0A1AQ DRUGSMIL CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O D0A1AQ HIGHSTAT Phase 3 D0A1IL DRUG__ID D0A1IL D0A1IL DRUGCOMP Del Mar Pharmaceuticals D0A1IL DRUGTYPE Small molecular drug D0A1IL DRUGINCH 1S/C6H10O4/c7-5(3-1-9-3)6(8)4-2-10-4/h3-8H,1-2H2/t3-,4+,5+,6- D0A1IL DRUGINKE AAFJXZWCNVJTMK-GUCUJZIJSA-N D0A1IL DRUGSMIL C1C(O1)C(C(C2CO2)O)O D0A1IL HIGHSTAT Phase 3 D0A2RA DRUG__ID D0A2RA D0A2RA DRUGCOMP Takeda D0A2RA DRUGTYPE Small molecular drug D0A2RA DRUGINCH 1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36) D0A2RA DRUGINKE QJFSABGVXDWMIW-UHFFFAOYSA-N D0A2RA DRUGSMIL CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C D0A2RA HIGHSTAT Phase 3 D0A4UC DRUG__ID D0A4UC D0A4UC DRUGCOMP GILEAD D0A4UC DRUGTYPE Small molecular drug D0A4UC DRUGINCH 1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2 D0A4UC DRUGINKE YNUAEEJQYHYLMS-UHFFFAOYSA-N D0A4UC DRUGSMIL C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4 D0A4UC HIGHSTAT Phase 3 D0A9SA DRUG__ID D0A9SA D0A9SA DRUGCOMP Telik D0A9SA DRUGTYPE Small molecular drug D0A9SA DRUGINCH 1S/C26H40Cl4N5O10PS/c27-8-12-34(13-9-28)46(42,35(14-10-29)15-11-30)45-16-17-47(43,44)18-21(32-22(36)7-6-20(31)25(38)39)24(37)33-23(26(40)41)19-4-2-1-3-5-19/h1-5,20-21,23H,6-18,31H2,(H,32,36)(H,33,37)(H,38,39)(H,40,41)/t20-,21-,23+/m0/s1 D0A9SA DRUGINKE OJLHWPALWODJPQ-QNWVGRARSA-N D0A9SA DRUGSMIL C1=CC=C(C=C1)C(C(=O)O)NC(=O)C(CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)NC(=O)CCC(C(=O)O)N D0A9SA HIGHSTAT Phase 3 D0AW8E DRUG__ID D0AW8E D0AW8E DRUGCOMP Actelion Pharmaceuticals D0AW8E DRUGTYPE Small molecular drug D0AW8E DRUGINCH 1S/C27H27N9O6S/c1-16(2)18-8-9-22(29-15-18)43(38,39)34-26-23(42-21-7-5-4-6-20(21)40-3)27(41-13-12-37)31-24(30-26)17-10-11-28-19(14-17)25-32-35-36-33-25/h4-11,14-16,37H,12-13H2,1-3H3,(H,30,31,34)(H,32,33,35,36) D0AW8E DRUGINKE TUYWTLTWNJOZNY-UHFFFAOYSA-N D0AW8E DRUGSMIL CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC D0AW8E HIGHSTAT Phase 3 D0B3FV DRUG__ID D0B3FV D0B3FV DRUGCOMP Corcept Therapeutics D0B3FV DRUGTYPE Small molecular drug D0B3FV DRUGINCH 1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+ D0B3FV DRUGINKE BWDQBBCUWLSASG-MDZDMXLPSA-N D0B3FV DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO D0B3FV HIGHSTAT Phase 3 D0B6IZ DRUG__ID D0B6IZ D0B6IZ DRUGCOMP Roche D0B6IZ DRUGTYPE Small molecular drug D0B6IZ DRUGINCH 1S/C22H14O4/c23-19(15-7-3-1-4-8-15)21(25)17-11-13-18(14-12-17)22(26)20(24)16-9-5-2-6-10-16/h1-14H D0B6IZ DRUGINKE FUEGWHHUYNHBNI-UHFFFAOYSA-N D0B6IZ DRUGSMIL C1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)C(=O)C(=O)C3=CC=CC=C3 D0B6IZ HIGHSTAT Phase 3 D0B6RA DRUG__ID D0B6RA D0B6RA DRUGCOMP Eli Lilly D0B6RA DRUGTYPE Small molecular drug D0B6RA DRUGINCH 1S/C7H9NO6S/c8-7(6(11)12)1-15(13,14)4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3-,4+,7+/m1/s1 D0B6RA DRUGINKE AVDUGNCTZRCAHH-MDASVERJSA-N D0B6RA DRUGSMIL C1C(C2C(C2S1(=O)=O)C(=O)O)(C(=O)O)N D0B6RA HIGHSTAT Phase 3 D0B7VK DRUG__ID D0B7VK D0B7VK DRUGCOMP GD Searle & Co; Chiron D0B7VK DRUGTYPE Small molecular drug D0B7VK DRUGINCH 1S/C12H13NS/c1-2-5-11(6-3-1)9-13-10-12-7-4-8-14-12/h1-8,13H,9-10H2 D0B7VK DRUGINKE GEWKIDGKZRKUFB-UHFFFAOYSA-N D0B7VK DRUGSMIL C1=CC=C(C=C1)CNCC2=CC=CS2 D0B7VK HIGHSTAT Phase 3 D0C0NH DRUG__ID D0C0NH D0C0NH DRUGCOMP Genentech D0C0NH DRUGTYPE Small molecular drug D0C0NH DRUGINCH 1S/C10H6O3/c11-7-4-5-9(13)10-6(7)2-1-3-8(10)12/h1-5,12H D0C0NH DRUGINKE KQPYUDDGWXQXHS-UHFFFAOYSA-N D0C0NH DRUGSMIL C1=CC2=C(C(=O)C=CC2=O)C(=C1)O D0C0NH HIGHSTAT Phase 3 D0C2OR DRUG__ID D0C2OR D0C2OR DRUGCOMP Mimetogen Pharmaceuticals Inc D0C2OR DRUGTYPE Small molecular drug D0C2OR DRUGINCH 1S/C24H32N6O11/c25-9-2-1-3-15-23(37)29-17(22(36)26-12-20(33)34)8-10-41-18-6-4-13(30(39)40)11-14(18)21(35)27-16(24(38)28-15)5-7-19(31)32/h4,6,11,15-17H,1-3,5,7-10,12,25H2,(H,26,36)(H,27,35)(H,28,38)(H,29,37)(H,31,32)(H,33,34)/t15-,16-,17-/m0/s1 D0C2OR DRUGINKE DVJXNXPFYJIACK-ULQDDVLXSA-N D0C2OR DRUGSMIL C1COC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)NC(C(=O)NC(C(=O)NC1C(=O)NCC(=O)O)CCCCN)CCC(=O)O D0C2OR HIGHSTAT Phase 3 D0C5CE DRUG__ID D0C5CE D0C5CE DRUGCOMP Otsuka America Pharmaceutical D0C5CE DRUGTYPE Small molecular drug D0C5CE DRUGINCH 1S/2C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15;1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,16-17,22H,5-10H2,1-4H3;11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t16-,17-;17-,18?/m10/s1 D0C5CE DRUGINKE SSNHGLKFJISNTR-FWUPRJFYSA-N D0C5CE DRUGSMIL CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O.CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O D0C5CE HIGHSTAT Phase 3 D0C6QQ DRUG__ID D0C6QQ D0C6QQ DRUGCOMP Hoechst Marion Roussel Inc D0C6QQ DRUGTYPE Small molecular drug D0C6QQ DRUGINCH 1S/C16H17N3/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19/h3-11,13H,2,12H2,1H3 D0C6QQ DRUGINKE OTPPJICEBWOCKD-UHFFFAOYSA-N D0C6QQ DRUGSMIL CCCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32 D0C6QQ HIGHSTAT Phase 3 D0C8DD DRUG__ID D0C8DD D0C8DD DRUGCOMP GSK D0C8DD DRUGTYPE Small molecular drug D0C8DD DRUGINCH 1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28) D0C8DD DRUGINKE KKYABQBFGDZVNQ-UHFFFAOYSA-N D0C8DD DRUGSMIL CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C D0C8DD HIGHSTAT Phase 3 D0CI9T DRUG__ID D0CI9T D0CI9T DRUGCOMP Johnson & Johnson D0CI9T DRUGTYPE Small molecular drug D0CI9T DRUGINCH 1S/C20H22N8O6S2/c21-20-24-14(26-36-20)11(25-34)15(29)23-12-17(31)28-13(19(32)33)9(7-35-18(12)28)5-8-2-4-27(16(8)30)10-1-3-22-6-10/h5,10,12,18,22,34H,1-4,6-7H2,(H,23,29)(H,32,33)(H2,21,24,26)/b8-5+,25-11-/t10-,12-,18-/m1/s1 D0CI9T DRUGINKE VOAZJEPQLGBXGO-SDAWRPRTSA-N D0CI9T DRUGSMIL C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=NO)C5=NSC(=N5)N)SC3)C(=O)O)C2=O D0CI9T HIGHSTAT Phase 3 D0D1JP DRUG__ID D0D1JP D0D1JP DRUGCOMP Walter Reed Army Institute of Research D0D1JP DRUGTYPE Small molecular drug D0D1JP DRUGINCH 1S/C23H45N5O14.C21H43N5O7.2H2O4S/c24-2-7-13(32)15(34)10(27)21(37-7)41-19-9(4-30)39-23(17(19)36)42-20-12(31)5(25)1-6(26)18(20)40-22-11(28)16(35)14(33)8(3-29)38-22;1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20;2*1-5(2,3)4/h5-23,29-36H,1-4,24-28H2;9-20,25-29H,5-8,22-24H2,1-4H3;2*(H2,1,2,3,4)/t5-,6+,7+,8-,9-,10-,11-,12+,13-,14-,15-,16-,17-,18?,19-,20-,21-,22-,23?;;;/m1.../s1 D0D1JP DRUGINKE AENMFAVRQFFUDK-OOVPIQBXSA-N D0D1JP DRUGSMIL CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC.C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O D0D1JP HIGHSTAT Phase 3 D0D3TX DRUG__ID D0D3TX D0D3TX DRUGCOMP EnVivo Pharmaceuticals D0D3TX DRUGTYPE Small molecular drug D0D3TX DRUGINCH 1S/C16H17ClN2OS/c17-12-3-1-2-11-8-14(21-15(11)12)16(20)18-13-9-19-6-4-10(13)5-7-19/h1-3,8,10,13H,4-7,9H2,(H,18,20)/t13-/m0/s1 D0D3TX DRUGINKE SSRDSYXGYPJKRR-ZDUSSCGKSA-N D0D3TX DRUGSMIL C1CN2CCC1C(C2)NC(=O)C3=CC4=C(S3)C(=CC=C4)Cl D0D3TX HIGHSTAT Phase 3 D0D4RF DRUG__ID D0D4RF D0D4RF DRUGCOMP Cyclacel Pharmaceuticals D0D4RF DRUGTYPE Small molecular drug D0D4RF DRUGINCH 1S/C26H42N4O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-23(32)28-22-16-17-30(26(34)29-22)25-20(18-27)24(33)21(19-31)35-25/h16-17,20-21,24-25,31,33H,2-15,19H2,1H3,(H,28,29,32,34)/t20-,21+,24-,25+/m0/s1 D0D4RF DRUGINKE LBGFKUUHOPIEMA-PEARBKPGSA-N D0D4RF DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N D0D4RF HIGHSTAT Phase 3 D0D7TD DRUG__ID D0D7TD D0D7TD DRUGCOMP Advanced life sciences D0D7TD DRUGTYPE Small molecular drug D0D7TD DRUGINCH 1S/C42H59N3O10/c1-11-32-42(8)36(44-40(50)55-42)25(4)33(46)23(2)21-41(7,51-18-14-15-28-20-29-16-12-13-17-30(29)43-22-28)37(26(5)34(47)27(6)38(49)53-32)54-39-35(48)31(45(9)10)19-24(3)52-39/h12-17,20,22-27,31-32,35-37,39,48H,11,18-19,21H2,1-10H3,(H,44,50)/b15-14+/t23-,24-,25+,26+,27-,31+,32-,35-,36-,37-,39+,41-,42-/m1/s1 D0D7TD DRUGINKE PENDGIOBPJLVBT-ONLVEXIXSA-N D0D7TD DRUGSMIL CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OCC=CC4=CC5=CC=CC=C5N=C4)C)C)NC(=O)O2)C D0D7TD HIGHSTAT Phase 3 D0D7UD DRUG__ID D0D7UD D0D7UD DRUGCOMP Taisho Pharmaceutical Co Ltd D0D7UD DRUGTYPE Small molecular drug D0D7UD DRUGINCH 1S/C28H48O6/c1-4-7-11-15-22(29)18-19-23-24(26(21-25(23)30)34-28(32)14-6-3)16-12-9-10-13-17-27(31)33-20-8-5-2/h18-19,22-23,25,29-30H,4-17,20-21H2,1-3H3/b19-18+/t22-,23+,25+/m0/s1 D0D7UD DRUGINKE HITYEEHTEOQBAC-OSIGYOHNSA-N D0D7UD DRUGSMIL CCCCCC(C=CC1C(CC(=C1CCCCCCC(=O)OCCCC)OC(=O)CCC)O)O D0D7UD HIGHSTAT Phase 3 D0DN1V DRUG__ID D0DN1V D0DN1V THERCLAS Antiviral Agents D0DN1V DRUGTYPE Small molecular drug D0DN1V DRUGINCH 1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1 D0DN1V DRUGINKE JVHXJTBJCFBINQ-ADAARDCZSA-N D0DN1V DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl D0DN1V HIGHSTAT Phase 3 Trial D0DV8K DRUG__ID D0DV8K D0DV8K THERCLAS Antiviral Agents D0DV8K DRUGTYPE Small molecular drug D0DV8K DRUGINCH 1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1 D0DV8K DRUGINKE UREBDLICKHMUKA-CXSFZGCWSA-N D0DV8K DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C D0DV8K HIGHSTAT Phase 3 Trial D0DY7W DRUG__ID D0DY7W D0DY7W DRUGCOMP Boehringer Ingelheim Corp D0DY7W DRUGTYPE Small molecular drug D0DY7W DRUGINCH 1S/C12H16N2O/c13-7-11-6-12(15)14(9-11)8-10-4-2-1-3-5-10/h1-5,11H,6-9,13H2 D0DY7W DRUGINKE LCAFGJGYCUMTGS-UHFFFAOYSA-N D0DY7W DRUGSMIL C1C(CN(C1=O)CC2=CC=CC=C2)CN D0DY7W HIGHSTAT Phase 3 D0E0HE DRUG__ID D0E0HE D0E0HE DRUGCOMP Aeolus Pharmaceuticals Inc D0E0HE DRUGTYPE Small molecular drug D0E0HE DRUGINCH 1S/C12H5N7O12/c20-14(21)5-1-7(16(24)25)11(8(2-5)17(26)27)13-12-9(18(28)29)3-6(15(22)23)4-10(12)19(30)31/h1-4,13H D0E0HE DRUGINKE CBCIHIVRDWLAME-UHFFFAOYSA-N D0E0HE DRUGSMIL C1=C(C=C(C(=C1[N+](=O)[O-])NC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-] D0E0HE HIGHSTAT Phase 3 D0E1JP DRUG__ID D0E1JP D0E1JP THERCLAS Antiviral Agents D0E1JP DRUGTYPE Small molecular drug D0E1JP DRUGINCH 1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1 D0E1JP DRUGINKE UCHDWCPVSPXUMX-TZIWLTJVSA-N D0E1JP DRUGSMIL CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O D0E1JP HIGHSTAT Phase 3 Trial D0E3JP DRUG__ID D0E3JP D0E3JP THERCLAS Antiviral Agents D0E3JP DRUGTYPE Small molecular drug D0E3JP DRUGINCH 1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1 D0E3JP DRUGINKE XOFYZVNMUHMLCC-ZPOLXVRWSA-N D0E3JP DRUGSMIL CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C D0E3JP HIGHSTAT Phase 3 Trial D0E4GG DRUG__ID D0E4GG D0E4GG DRUGCOMP Takeda D0E4GG DRUGTYPE Small molecular drug D0E4GG DRUGINCH 1S/C15H17ClFNO4S/c1-2-22-15(19)11-5-3-4-6-14(11)23(20,21)18-13-8-7-10(17)9-12(13)16/h5,7-9,14,18H,2-4,6H2,1H3/t14-/m1/s1 D0E4GG DRUGINKE LEEIJTHMHDMWLJ-CQSZACIVSA-N D0E4GG DRUGSMIL CCOC(=O)C1=CCCCC1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl D0E4GG HIGHSTAT Phase 3 D0E4VQ DRUG__ID D0E4VQ D0E4VQ DRUGCOMP Zafgen D0E4VQ DRUGTYPE Small molecular drug D0E4VQ DRUGINCH 1S/C29H41NO6/c1-20(2)7-13-24-28(3,36-24)27-26(32-6)23(15-16-29(27)19-34-29)35-25(31)14-10-21-8-11-22(12-9-21)33-18-17-30(4)5/h7-12,14,23-24,26-27H,13,15-19H2,1-6H3/b14-10+/t23-,24-,26-,27-,28+,29+/m1/s1 D0E4VQ DRUGINKE ZEZFKUBILQRZCK-MJSCXXSSSA-N D0E4VQ DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC4=CC=C(C=C4)OCCN(C)C)OC)C D0E4VQ HIGHSTAT Phase 3 D0E5DB DRUG__ID D0E5DB D0E5DB DRUGCOMP Vion Pharmaceuticals Inc D0E5DB DRUGTYPE Small molecular drug D0E5DB DRUGINCH 1S/C6H14ClN3O5S2/c1-8-6(11)10(17(3,14)15)9(5-4-7)16(2,12)13/h4-5H2,1-3H3,(H,8,11) D0E5DB DRUGINKE PVCULFYROUOVGJ-UHFFFAOYSA-N D0E5DB DRUGSMIL CNC(=O)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C D0E5DB HIGHSTAT Phase 3 D0E6FS DRUG__ID D0E6FS D0E6FS THERCLAS Antiviral Agents D0E6FS DRUGTYPE Small molecular drug D0E6FS DRUGINCH 1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1 D0E6FS DRUGINKE KGFYHTZWPPHNLQ-AWEZNQCLSA-N D0E6FS DRUGSMIL C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl D0E6FS HIGHSTAT Phase 3 Trial D0E6OJ DRUG__ID D0E6OJ D0E6OJ THERCLAS Antiviral Agents D0E6OJ DRUGTYPE Small molecular drug D0E6OJ DRUGINCH 1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/p-1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1 D0E6OJ DRUGINKE FQISKWAFAHGMGT-SGJOWKDISA-M D0E6OJ DRUGSMIL CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O.[Na+] D0E6OJ HIGHSTAT Phase 3 Trial D0E9CC DRUG__ID D0E9CC D0E9CC DRUGCOMP Sanofi D0E9CC DRUGTYPE Small molecular drug D0E9CC DRUGINCH 1S/C21H26N2O6/c1-26-17-8-7-13(9-16(17)23-21(25)15(22)12-24)5-6-14-10-18(27-2)20(29-4)19(11-14)28-3/h5-11,15,24H,12,22H2,1-4H3,(H,23,25)/b6-5-/t15-/m0/s1 D0E9CC DRUGINKE IXWNTLSTOZFSCM-YVACAVLKSA-N D0E9CC DRUGSMIL COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)NC(=O)C(CO)N D0E9CC HIGHSTAT Phase 3 D0E9SZ DRUG__ID D0E9SZ D0E9SZ DRUGCOMP SEIKAGAKU CORPORATION D0E9SZ DRUGTYPE Small molecular drug D0E9SZ DRUGINCH 1S/C28H44N2O23/c1-5(33)29-9-18(11(35)7(3-31)47-25(9)46)49-28-17(41)15(39)20(22(53-28)24(44)45)51-26-10(30-6(2)34)19(12(36)8(4-32)48-26)50-27-16(40)13(37)14(38)21(52-27)23(42)43/h7-22,25-28,31-32,35-41,46H,3-4H2,1-2H3,(H,29,33)(H,30,34)(H,42,43)(H,44,45) D0E9SZ DRUGINKE KIUKXJAPPMFGSW-UHFFFAOYSA-N D0E9SZ DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)C(=O)O)O)O)O)NC(=O)C)O)O D0E9SZ HIGHSTAT Phase 3 D0EO8K DRUG__ID D0EO8K D0EO8K THERCLAS Antiviral Agents D0EO8K DRUGTYPE Small molecular drug D0EO8K DRUGINCH 1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1 D0EO8K DRUGINKE ACWBQPMHZXGDFX-QFIPXVFZSA-N D0EO8K DRUGSMIL CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O D0EO8K HIGHSTAT Phase 3 Trial D0ER8I DRUG__ID D0ER8I D0ER8I DRUGCOMP Polydex Pharmaceuticals Ltd D0ER8I DRUGTYPE Small molecular drug D0ER8I DRUGINCH 1S/C30H35NO3/c1-30(2)29(23-9-5-4-6-10-23)28(26-16-15-25(32-3)21-27(26)34-30)22-11-13-24(14-12-22)33-20-19-31-17-7-8-18-31/h4-6,9-16,21,28-29H,7-8,17-20H2,1-3H3/t28-,29+/m0/s1 D0ER8I DRUGINKE XZEUAXYWNKYKPL-URLMMPGGSA-N D0ER8I DRUGSMIL CC1(C(C(C2=C(O1)C=C(C=C2)OC)C3=CC=C(C=C3)OCCN4CCCC4)C5=CC=CC=C5)C D0ER8I HIGHSTAT Phase 3 D0F0TO DRUG__ID D0F0TO D0F0TO THERCLAS Antiviral Agents D0F0TO DRUGTYPE Small molecular drug D0F0TO DRUGINCH 1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2 D0F0TO DRUGINKE DFEYYRMXOJXZRJ-UHFFFAOYSA-N D0F0TO DRUGSMIL C(OC(C(F)(F)F)C(F)(F)F)F D0F0TO HIGHSTAT Phase 3 Trial D0F1CE DRUG__ID D0F1CE D0F1CE DRUGCOMP Novartis D0F1CE DRUGTYPE Small molecular drug D0F1CE DRUGINCH 1S/C25H24F3N3O2/c26-25(27,28)23-12-10-21(15-30-23)31-20-9-11-22(29-14-20)19-7-5-18(6-8-19)17-3-1-16(2-4-17)13-24(32)33/h5-12,14-17,31H,1-4,13H2,(H,32,33) D0F1CE DRUGINKE GXALXAKNHIROPE-UHFFFAOYSA-N D0F1CE DRUGSMIL C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)NC4=CN=C(C=C4)C(F)(F)F D0F1CE HIGHSTAT Phase 3 D0F2CW DRUG__ID D0F2CW D0F2CW THERCLAS Antiviral Agents D0F2CW DRUGTYPE Small molecular drug D0F2CW DRUGINCH 1S/C26H29F2N7/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33) D0F2CW DRUGINKE OBDOVFRMEYHSQB-UHFFFAOYSA-N D0F2CW DRUGSMIL C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C D0F2CW HIGHSTAT Phase 3 Trial D0F3NH DRUG__ID D0F3NH D0F3NH DRUGCOMP Dr Reddy's Research Foundation D0F3NH DRUGTYPE Small molecular drug D0F3NH DRUGINCH 1S/C20H17N3O4S/c1-23-17(21-15-5-3-2-4-14(15)19(23)25)11-27-13-8-6-12(7-9-13)10-16-18(24)22-20(26)28-16/h2-9,16H,10-11H2,1H3,(H,22,24,26) D0F3NH DRUGINKE IETKPTYAGKZLKY-UHFFFAOYSA-N D0F3NH DRUGSMIL CN1C(=NC2=CC=CC=C2C1=O)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4 D0F3NH HIGHSTAT Phase 3 D0F3WG DRUG__ID D0F3WG D0F3WG DRUGCOMP AstraZeneca D0F3WG DRUGTYPE Small molecular drug D0F3WG DRUGINCH 1S/C11H15NO7S2.2Na/c1-11(2,3)12(13)7-8-4-5-9(20(14,15)16)6-10(8)21(17,18)19;;/h4-7H,1-3H3,(H,14,15,16)(H,17,18,19);;/q;2*+1/p-2/b12-7-;; D0F3WG DRUGINKE XLZOVRYBVCMCGL-BPNVQINPSA-L D0F3WG DRUGSMIL CC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+] D0F3WG HIGHSTAT Phase 3 D0F4SY DRUG__ID D0F4SY D0F4SY DRUGCOMP Teva pharmaceutical D0F4SY DRUGTYPE Small molecular drug D0F4SY DRUGINCH 1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3 D0F4SY DRUGINKE YGKUEOZJFIXDGI-UHFFFAOYSA-N D0F4SY DRUGSMIL CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C D0F4SY HIGHSTAT Phase 3 D0F5JH DRUG__ID D0F5JH D0F5JH DRUGCOMP Shenzhen Chipscreen Biosciences Ltd D0F5JH DRUGTYPE Small molecular drug D0F5JH DRUGINCH 1S/C36H29FN2O4/c37-26-17-15-25(16-18-26)35(40)30-9-1-4-10-31(30)38-32(36(41)42)23-24-13-19-27(20-14-24)43-22-21-39-33-11-5-2-7-28(33)29-8-3-6-12-34(29)39/h1-20,32,38H,21-23H2,(H,41,42)/t32-/m0/s1 D0F5JH DRUGINKE QNLWMPLUWMWDMQ-YTTGMZPUSA-N D0F5JH DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CCOC4=CC=C(C=C4)CC(C(=O)O)NC5=CC=CC=C5C(=O)C6=CC=C(C=C6)F D0F5JH HIGHSTAT Phase 3 D0F7XT DRUG__ID D0F7XT D0F7XT THERCLAS Antiviral Agents D0F7XT DRUGTYPE Small molecular drug D0F7XT DRUGINCH 1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3 D0F7XT DRUGINKE RTHCYVBBDHJXIQ-UHFFFAOYSA-N D0F7XT DRUGSMIL CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F D0F7XT HIGHSTAT Phase 3 Trial D0F8JR DRUG__ID D0F8JR D0F8JR THERCLAS Antiviral Agents D0F8JR DRUGTYPE Small molecular drug D0F8JR DRUGINCH 1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1 D0F8JR DRUGINKE QYSXJUFSXHHAJI-YRZJJWOYSA-N D0F8JR DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C D0F8JR HIGHSTAT Phase 3 Trial D0F8UV DRUG__ID D0F8UV D0F8UV DRUGCOMP Galena biopharma D0F8UV DRUGTYPE Small molecular drug D0F8UV DRUGINCH 1S/C50H78N10O11/c1-8-31(6)42(60-44(64)35(52)21-15-16-22-51)49(69)58-37(25-33-17-11-9-12-18-33)45(65)53-27-41(62)55-40(28-61)48(68)57-36(23-29(2)3)46(66)54-32(7)43(63)56-38(26-34-19-13-10-14-20-34)47(67)59-39(50(70)71)24-30(4)5/h9-14,17-20,29-32,35-40,42,61H,8,15-16,21-28,51-52H2,1-7H3,(H,53,65)(H,54,66)(H,55,62)(H,56,63)(H,57,68)(H,58,69)(H,59,67)(H,60,64)(H,70,71)/t31-,32-,35-,36-,37-,38-,39-,40-,42-/m0/s1 D0F8UV DRUGINKE AHOKKYCUWBLDST-QYULHYBRSA-N D0F8UV DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCCCN)N D0F8UV HIGHSTAT Phase 3 D0F9VH DRUG__ID D0F9VH D0F9VH DRUGCOMP Genta D0F9VH DRUGTYPE Small molecular drug D0F9VH DRUGINCH 1S/C46H60FN3O13/c1-24-28(58-40(54)34(52)33(32-27(47)17-14-20-48-32)49-41(55)63-42(3,4)5)21-46(56)38(61-39(53)26-15-12-11-13-16-26)36-44(8,19-18-29-45(36,23-57-29)62-25(2)51)37-35(31(24)43(46,6)7)59-30(60-37)22-50(9)10/h11-17,20,28-30,33-38,52,56H,18-19,21-23H2,1-10H3,(H,49,55)/t28-,29+,30+,33-,34+,35+,36-,37+,38-,44+,45-,46+/m0/s1 D0F9VH DRUGINKE MODVSQKJJIBWPZ-VLLPJHQWSA-N D0F9VH DRUGSMIL CC1=C2C3C(C4(CCC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=C(C=CC=N6)F)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)C)OC(O3)CN(C)C D0F9VH HIGHSTAT Phase 3 D0F9ZO DRUG__ID D0F9ZO D0F9ZO THERCLAS Antiviral Agents D0F9ZO DRUGTYPE Small molecular drug D0F9ZO DRUGINCH 1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1 D0F9ZO DRUGINKE LXMSZDCAJNLERA-ZHYRCANASA-N D0F9ZO DRUGSMIL CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C D0F9ZO HIGHSTAT Phase 3 Trial D0FA3O DRUG__ID D0FA3O D0FA3O THERCLAS Antiviral Agents D0FA3O DRUGTYPE Small molecular drug D0FA3O DRUGINCH 1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 D0FA3O DRUGINKE JYGXADMDTFJGBT-VWUMJDOOSA-N D0FA3O DRUGSMIL CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O D0FA3O HIGHSTAT Phase 3 Trial D0FJ9I DRUG__ID D0FJ9I D0FJ9I DRUGCOMP Genentech South San Francisco, CA D0FJ9I DRUGTYPE Small molecular drug D0FJ9I DRUGINCH 1S/C21H21F3IN3O2/c22-14-6-5-13(19(18(14)24)27-16-7-4-12(25)9-15(16)23)20(29)28-10-21(30,11-28)17-3-1-2-8-26-17/h4-7,9,17,26-27,30H,1-3,8,10-11H2/t17-/m0/s1 D0FJ9I DRUGINKE BSMCAPRUBJMWDF-KRWDZBQOSA-N D0FJ9I DRUGSMIL C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O D0FJ9I HIGHSTAT Phase 3 D0FP0R DRUG__ID D0FP0R D0FP0R DRUGCOMP Spectrum D0FP0R DRUGTYPE Small molecular drug D0FP0R DRUGINCH 1S/C15H16N2O4/c1-16-10(3-2-6-18)9(8-19)13-14(16)12(20)7-11(15(13)21)17-4-5-17/h2-3,7,18-19H,4-6,8H2,1H3/b3-2+ D0FP0R DRUGINKE MXPOCMVWFLDDLZ-NSCUHMNNSA-N D0FP0R DRUGSMIL CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO D0FP0R HIGHSTAT Phase 3 D0FQ2U DRUG__ID D0FQ2U D0FQ2U DRUGCOMP Point Therapeutics; Tufts University School of Medicine D0FQ2U DRUGTYPE Small molecular drug D0FQ2U DRUGINCH 1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/t7-,8-/m0/s1 D0FQ2U DRUGINKE FKCMADOPPWWGNZ-YUMQZZPRSA-N D0FQ2U DRUGSMIL B(C1CCCN1C(=O)C(C(C)C)N)(O)O D0FQ2U HIGHSTAT Phase 3 D0G1EC DRUG__ID D0G1EC D0G1EC THERCLAS Antiviral Agents D0G1EC DRUGTYPE Small molecular drug D0G1EC DRUGINCH 1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12) D0G1EC DRUGINKE BSYNRYMUTXBXSQ-UHFFFAOYSA-N D0G1EC DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)O D0G1EC HIGHSTAT Phase 3 Trial D0G3YC DRUG__ID D0G3YC D0G3YC DRUGCOMP Helsinn Therapeutics D0G3YC DRUGTYPE Small molecular drug D0G3YC DRUGINCH 1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3 D0G3YC DRUGINKE WAXQNWCZJDTGBU-UHFFFAOYSA-N D0G3YC DRUGSMIL CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C D0G3YC HIGHSTAT Phase 3 D0G5JL DRUG__ID D0G5JL D0G5JL THERCLAS Antiviral Agents D0G5JL DRUGTYPE Small molecular drug D0G5JL DRUGINCH 1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14) D0G5JL DRUGINKE XUFQPHANEAPEMJ-UHFFFAOYSA-N D0G5JL DRUGSMIL C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N D0G5JL HIGHSTAT Phase 3 Trial D0G6TL DRUG__ID D0G6TL D0G6TL DRUGCOMP Andromeda biotech D0G6TL DRUGTYPE Small molecular drug D0G6TL DRUGINCH 1S/C106H180N28O34/c1-23-55(18)83(131-102(164)82(54(16)17)130-90(152)60(27-24-32-111-106(109)110)118-91(153)65(38-50(8)9)123-92(154)63(36-48(4)5)121-87(149)58(21)117-101(163)81(53(14)15)129-76(140)45-113-74(138)43-112-75(139)44-114-88(150)62(35-47(2)3)126-100(162)80(108)52(12)13)103(165)133-33-25-28-71(133)98(160)115-56(19)85(147)120-64(37-49(6)7)93(155)125-68(41-78(143)144)95(157)128-70(46-135)97(159)124-66(39-51(10)11)96(158)132-84(59(22)136)104(166)134-34-26-29-72(134)99(161)116-57(20)86(148)122-67(40-73(107)137)94(156)119-61(30-31-77(141)142)89(151)127-69(105(167)168)42-79(145)146/h47-72,80-84,135-136H,23-46,108H2,1-22H3,(H2,107,137)(H,112,139)(H,113,138)(H,114,150)(H,115,160)(H,116,161)(H,117,163)(H,118,153)(H,119,156)(H,120,147)(H,121,149)(H,122,148)(H,123,154)(H,124,159)(H,125,155)(H,126,162)(H,127,151)(H,128,157)(H,129,140)(H,130,152)(H,131,164)(H,132,158)(H,141,142)(H,143,144)(H,145,146)(H,167,168)(H4,109,110,111)/t55-,56-,57-,58-,59+,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,80-,81-,82-,83-,84-/m0/s1 D0G6TL DRUGINKE VGGRNGOEDNBLPH-YJHCMWSWSA-N D0G6TL DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)N2CCCC2C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)N D0G6TL HIGHSTAT Phase 3 D0G6ZG DRUG__ID D0G6ZG D0G6ZG DRUGCOMP Menarini D0G6ZG DRUGTYPE Small molecular drug D0G6ZG DRUGINCH 1S/C22H18O4/c23-19-8-7-13-15(20(19)24)6-5-11-9-17-12-3-1-2-4-14(12)21(25)22(26)18(17)10-16(11)13/h1-10,19-26H/t19-,20-,21-,22-/m0/s1 D0G6ZG DRUGINKE YQINXCSNGCDFCQ-CMOCDZPBSA-N D0G6ZG DRUGSMIL C1=CC=C2C(=C1)C(C(C3=C2C=C4C=CC5=C(C4=C3)C=CC(C5O)O)O)O D0G6ZG HIGHSTAT Phase 3 D0G7MV DRUG__ID D0G7MV D0G7MV DRUGCOMP Incyte D0G7MV DRUGTYPE Small molecular drug D0G7MV DRUGINCH 1S/C11H13BrFN7O4S/c12-7-5-6(1-2-8(7)13)17-11(18-21)9-10(20-24-19-9)15-3-4-16-25(14,22)23/h1-2,5,16,21H,3-4H2,(H,15,20)(H,17,18)(H2,14,22,23) D0G7MV DRUGINKE FBKMWOJEPMPVTQ-UHFFFAOYSA-N D0G7MV DRUGSMIL C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F D0G7MV HIGHSTAT Phase 3 D0GG9P DRUG__ID D0GG9P D0GG9P DRUGCOMP Polyphor D0GG9P DRUGTYPE Peptide D0GG9P DRUGINCH 1S/C80H112N22O21S2/c1-42(82)65(108)98-59-39-124-125-40-60(99-70(113)55(34-45-16-22-49(105)23-17-45)93-66(109)51(10-5-29-87-80(84)85)91-74(117)61-11-6-30-100(61)76(119)43(2)89-71(114)58(38-103)97-73(59)116)72(115)94-54(33-44-14-20-48(104)21-15-44)68(111)90-52(26-27-64(83)107)67(110)92-53(9-3-4-28-81)77(120)102-32-8-13-63(102)78(121)101-31-7-12-62(101)75(118)95-56(35-46-18-24-50(106)25-19-46)69(112)96-57(79(122)123)36-47-37-86-41-88-47/h14-25,37,41-43,51-63,103-106H,3-13,26-36,38-40,81-82H2,1-2H3,(H2,83,107)(H,86,88)(H,89,114)(H,90,111)(H,91,117)(H,92,110)(H,93,109)(H,94,115)(H,95,118)(H,96,112)(H,97,116)(H,98,108)(H,99,113)(H,122,123)(H4,84,85,87)/t42-,43-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-/m0/s1 D0GG9P DRUGINKE UUTLJGUXRVWOSI-YYXAXUJHSA-N D0GG9P DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CO)NC(=O)C(C)N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CC6=CC=C(C=C6)O)C(=O)NC(CC7=CNC=N7)C(=O)O)CC8=CC=C(C=C8)O)CCCNC(=N)N D0GG9P HIGHSTAT Phase 3 D0GH3Q DRUG__ID D0GH3Q D0GH3Q DRUGCOMP Italfarmaco D0GH3Q DRUGTYPE Small molecular drug D0GH3Q DRUGINCH 1S/C24H27N3O4/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28) D0GH3Q DRUGINKE YALNUENQHAQXEA-UHFFFAOYSA-N D0GH3Q DRUGSMIL CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO D0GH3Q HIGHSTAT Phase 3 D0GX3L DRUG__ID D0GX3L D0GX3L DRUGCOMP Genentech D0GX3L DRUGTYPE Small molecular drug D0GX3L DRUGINCH 1S/C19H26ClNO6/c1-11(2)17(24)26-18(12(3)4)27-19(25)21-10-14(9-16(22)23)13-5-7-15(20)8-6-13/h5-8,11-12,14,18H,9-10H2,1-4H3,(H,21,25)(H,22,23)/t14-,18-/m0/s1 D0GX3L DRUGINKE JXTAALBWJQJLGN-KSSFIOAISA-N D0GX3L DRUGSMIL CC(C)C(OC(=O)C(C)C)OC(=O)NCC(CC(=O)O)C1=CC=C(C=C1)Cl D0GX3L HIGHSTAT Phase 3 D0H2RJ DRUG__ID D0H2RJ D0H2RJ DRUGCOMP Actelion Pharmaceuticals D0H2RJ DRUGTYPE Small molecular drug D0H2RJ DRUGINCH 1S/C25H23N9O6S/c1-15-7-8-20(27-14-15)41(36,37)32-24-21(40-19-6-4-3-5-18(19)38-2)25(39-12-11-35)29-22(28-24)16-9-10-26-17(13-16)23-30-33-34-31-23/h3-10,13-14,35H,11-12H2,1-2H3,(H,28,29,32)(H,30,31,33,34) D0H2RJ DRUGINKE LFWCJABOXHSRGC-UHFFFAOYSA-N D0H2RJ DRUGSMIL CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC D0H2RJ HIGHSTAT Phase 3 D0H5IZ DRUG__ID D0H5IZ D0H5IZ DRUGCOMP Nektar Therapeutics D0H5IZ DRUGTYPE Small molecular drug D0H5IZ DRUGINCH 1S/C161H192N20O40/c1-9-105-109-69-101(214-153(198)174-53-37-97(38-54-174)170-45-21-17-22-46-170)29-33-125(109)166-141-113(105)81-178-129(141)73-121-117(145(178)190)85-210-149(194)158(121,13-5)218-137(186)77-162-133(182)89-202-61-65-206-93-157(94-207-66-62-203-90-134(183)163-78-138(187)219-159(14-6)122-74-130-142-114(82-179(130)146(191)118(122)86-211-150(159)195)106(10-2)110-70-102(30-34-126(110)167-142)215-154(199)175-55-39-98(40-56-175)171-47-23-18-24-48-171,95-208-67-63-204-91-135(184)164-79-139(188)220-160(15-7)123-75-131-143-115(83-180(131)147(192)119(123)87-212-151(160)196)107(11-3)111-71-103(31-35-127(111)168-143)216-155(200)176-57-41-99(42-58-176)172-49-25-19-26-50-172)96-209-68-64-205-92-136(185)165-80-140(189)221-161(16-8)124-76-132-144-116(84-181(132)148(193)120(124)88-213-152(161)197)108(12-4)112-72-104(32-36-128(112)169-144)217-156(201)177-59-43-100(44-60-177)173-51-27-20-28-52-173/h29-36,69-76,97-100H,9-28,37-68,77-96H2,1-8H3,(H,162,182)(H,163,183)(H,164,184)(H,165,185)/t158-,159-,160-,161-/m0/s1 D0H5IZ DRUGINKE SELCJVNOEBVTAC-HLDPIHRNSA-N D0H5IZ DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)OC(=O)CNC(=O)COCCOCC(COCCOCC(=O)NCC(=O)OC5(C6=C(COC5=O)C(=O)N7CC8=C(C9=C(C=CC(=C9)OC(=O)N3CCC(CC3)N3CCCCC3)N=C8C7=C6)CC)CC)(COCCOCC(=O)NCC(=O)OC3(C4=C(COC3=O)C(=O)N3CC5=C(C6=C(C=CC(=C6)OC(=O)N6CCC(CC6)N6CCCCC6)N=C5C3=C4)CC)CC)COCCOCC(=O)NCC(=O)OC3(C4=C(COC3=O)C(=O)N3CC5=C(C6=C(C=CC(=C6)OC(=O)N6CCC(CC6)N6CCCCC6)N=C5C3=C4)CC)CC)C2=NC2=C1C=C(C=C2)OC(=O)N1CCC(CC1)N1CCCCC1 D0H5IZ HIGHSTAT Phase 3 D0HR7P DRUG__ID D0HR7P D0HR7P DRUGCOMP Cephalon D0HR7P DRUGTYPE Small molecular drug D0HR7P DRUGINCH 1S/C16H17N3O2/c1-18(2)6-7-19-15(20)12-5-3-4-10-8-11(17)9-13(14(10)12)16(19)21/h3-5,8-9H,6-7,17H2,1-2H3 D0HR7P DRUGINKE UPALIKSFLSVKIS-UHFFFAOYSA-N D0HR7P DRUGSMIL CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N D0HR7P HIGHSTAT Phase 3 D0HS5V DRUG__ID D0HS5V D0HS5V DRUGCOMP Bristol-Myers Squibb D0HS5V DRUGTYPE Small molecular drug D0HS5V DRUGINCH 1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1 D0HS5V DRUGINKE WCWUXEGQKLTGDX-LLVKDONJSA-N D0HS5V DRUGSMIL CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C D0HS5V HIGHSTAT Phase 3 D0I0ZP DRUG__ID D0I0ZP D0I0ZP DRUGCOMP Biosyn Inc D0I0ZP DRUGTYPE Small molecular drug D0I0ZP DRUGINCH 1S/C20H39NO3.C16H35NO/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(22)21(2,3)18-20(23)24;1-4-5-6-7-8-9-10-11-12-13-14-15-16-17(2,3)18/h4-18H2,1-3H3;4-16H2,1-3H3 D0I0ZP DRUGINKE KALYGJOYPFFBRF-UHFFFAOYSA-N D0I0ZP DRUGSMIL CCCCCCCCCCCCCCCC(=O)[N+](C)(C)CC(=O)[O-].CCCCCCCCCCCCCC[N+](C)(C)[O-] D0I0ZP HIGHSTAT Phase 3 D0I1DW DRUG__ID D0I1DW D0I1DW DRUGCOMP Pfizer D0I1DW DRUGTYPE Small molecular drug D0I1DW DRUGINCH 1S/C29H28N4O11/c34-7-10(8-35)31-33-27(42)20-18-13-3-1-11(37)5-15(13)30-22(18)23-19(21(20)28(33)43)14-4-2-12(38)6-16(14)32(23)29-26(41)25(40)24(39)17(9-36)44-29/h1-6,10,17,24-26,29-31,34-41H,7-9H2/t17-,24-,25+,26-,29-/m1/s1 D0I1DW DRUGINKE QMVPQBFHUJZJCS-NTKFZFFISA-N D0I1DW DRUGSMIL C1=CC2=C(C=C1O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC(CO)CO)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C=C(C=C6)O D0I1DW HIGHSTAT Phase 3 D0I1QI DRUG__ID D0I1QI D0I1QI DRUGCOMP Synta Pharmaceuticals D0I1QI DRUGTYPE Small molecular drug D0I1QI DRUGINCH 1S/C20H20N4O3/c1-11(2)14-9-15(18(26)10-17(14)25)19-21-22-20(27)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25-26H,1-3H3,(H,22,27) D0I1QI DRUGINKE RVAQIUULWULRNW-UHFFFAOYSA-N D0I1QI DRUGSMIL CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O D0I1QI HIGHSTAT Phase 3 D0I4TH DRUG__ID D0I4TH D0I4TH DRUGCOMP Genentech D0I4TH DRUGTYPE Small molecular drug D0I4TH DRUGINCH 1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1 D0I4TH DRUGINKE GRZXWCHAXNAUHY-NSISKUIASA-N D0I4TH DRUGSMIL CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O D0I4TH HIGHSTAT Phase 3 D0IK5F DRUG__ID D0IK5F D0IK5F DRUGCOMP Sanofi-Aventis D0IK5F DRUGTYPE Small molecular drug D0IK5F DRUGINCH 1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11) D0IK5F DRUGINKE MDOJTZQKHMAPBK-UHFFFAOYSA-N D0IK5F DRUGSMIL C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I D0IK5F HIGHSTAT Phase 3 D0IX1I DRUG__ID D0IX1I D0IX1I DRUGCOMP Neurocrine biosciences D0IX1I DRUGTYPE Small molecular drug D0IX1I DRUGINCH 1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3 D0IX1I DRUGINKE WEQLWGNDNRARGE-UHFFFAOYSA-N D0IX1I DRUGSMIL CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1O)OC)OC D0IX1I HIGHSTAT Phase 3 D0J1NQ DRUG__ID D0J1NQ D0J1NQ DRUGCOMP Solvay D0J1NQ DRUGTYPE Small molecular drug D0J1NQ DRUGINCH 1S/C26H41BrNO4.BrH/c1-26(2)21-6-5-19(22(26)16-21)7-11-31-12-8-28(9-13-32-14-10-28)18-20-15-24(29-3)25(30-4)17-23(20)27;/h15,17,19,21-22H,5-14,16,18H2,1-4H3;1H/q+1;/p-1 D0J1NQ DRUGINKE IKGXLCMLVINENI-UHFFFAOYSA-M D0J1NQ DRUGSMIL CC1(C2CCC(C1C2)CCOCC[N+]3(CCOCC3)CC4=CC(=C(C=C4Br)OC)OC)C.[Br-] D0J1NQ HIGHSTAT Phase 3 D0J6AU DRUG__ID D0J6AU D0J6AU DRUGCOMP Merck D0J6AU DRUGTYPE Small molecular drug D0J6AU DRUGINCH 1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1 D0J6AU DRUGINKE FWIVDMJALNEADT-SFTDATJTSA-N D0J6AU DRUGSMIL CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F D0J6AU HIGHSTAT Phase 3 D0J6II DRUG__ID D0J6II D0J6II DRUGCOMP Procter & Gamble D0J6II DRUGTYPE Small molecular drug D0J6II DRUGINCH 1S/C23H28ClN5O3/c1-26-12-14-27(15-13-26)10-2-3-11-28-22(30)17-29(23(28)31)25-16-20-8-9-21(32-20)18-4-6-19(24)7-5-18/h4-9,16H,2-3,10-15,17H2,1H3/b25-16+ D0J6II DRUGINKE MREBEPTUUMTTIA-PCLIKHOPSA-N D0J6II DRUGSMIL CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl D0J6II HIGHSTAT Phase 3 D0J7KR DRUG__ID D0J7KR D0J7KR THERCLAS Antiviral Agents D0J7KR DRUGTYPE Small molecular drug D0J7KR DRUGINCH 1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18) D0J7KR DRUGINKE GOTYRUGSSMKFNF-UHFFFAOYSA-N D0J7KR DRUGSMIL C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N D0J7KR HIGHSTAT Phase 3 Trial D0J9EI DRUG__ID D0J9EI D0J9EI THERCLAS Antiviral Agents D0J9EI DRUGTYPE Combination drug D0J9EI DRUGINCH 1S/C37H48N6O5S2.C37H48N4O5/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30;1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46);5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t28-,31-,32-,33-;30-,31-,32-,34-/m00/s1 D0J9EI DRUGINKE OFFWOVJBSQMVPI-RMLGOCCBSA-N D0J9EI DRUGSMIL CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O.CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O D0J9EI HIGHSTAT Phase 3 Trial D0JN5N DRUG__ID D0JN5N D0JN5N DRUGCOMP Teva Neuroscience D0JN5N DRUGTYPE Small molecular drug D0JN5N DRUGINCH 1S/C19H17ClN2O3/c1-3-22(12-8-5-4-6-9-12)19(25)16-17(23)15-13(20)10-7-11-14(15)21(2)18(16)24/h4-11,23H,3H2,1-2H3 D0JN5N DRUGINKE GKWPCEFFIHSJOE-UHFFFAOYSA-N D0JN5N DRUGSMIL CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O D0JN5N HIGHSTAT Phase 3 D0JU5X DRUG__ID D0JU5X D0JU5X DRUGCOMP Reata Pharmaceuticals Irving, TX D0JU5X DRUGTYPE Small molecular drug D0JU5X DRUGINCH 1S/C32H43NO4/c1-27(2)11-13-32(26(36)37-8)14-12-31(7)24(20(32)17-27)21(34)15-23-29(5)16-19(18-33)25(35)28(3,4)22(29)9-10-30(23,31)6/h15-16,20,22,24H,9-14,17H2,1-8H3/t20-,22-,24-,29-,30+,31+,32-/m0/s1 D0JU5X DRUGINKE WPTTVJLTNAWYAO-KPOXMGGZSA-N D0JU5X DRUGSMIL CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C D0JU5X HIGHSTAT Phase 3 D0K3UQ DRUG__ID D0K3UQ D0K3UQ DRUGCOMP GlaxoSmithKline D0K3UQ DRUGTYPE Small molecular drug D0K3UQ DRUGINCH 1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3 D0K3UQ DRUGINKE JRWROCIMSDXGOZ-UHFFFAOYSA-N D0K3UQ DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C=C(C=C2)Cl)C(=O)C3=CC=[N+](C=C3)[O-] D0K3UQ HIGHSTAT Phase 3 D0K3XS DRUG__ID D0K3XS D0K3XS DRUGCOMP OncoGenex Pharmaceuticals D0K3XS DRUGTYPE Small molecular drug D0K3XS DRUGINCH 1S/C231H312N78O119P20S20/c1-97-52-295(224(324)273-181(97)235)210-174(361-32-24-353-10)166(118(60-310)401-210)422-444(347,464)383-78-136-171(179(366-37-29-358-15)215(406-136)308-95-265-160-189(243)253-86-259-195(160)308)427-448(351,468)387-80-138-172(180(367-38-30-359-16)216(408-138)309-96-269-164-199(309)279-220(247)283-208(164)320)428-447(350,467)385-76-134-168(175(362-33-25-354-11)211(403-134)296-53-98(2)182(236)274-225(296)325)423-442(345,462)380-73-131-114(48-151(397-131)303-90-263-158-187(241)251-84-257-193(158)303)417-439(342,459)379-72-128-115(49-152(398-128)304-91-266-161-196(304)276-217(244)280-205(161)317)418-435(338,455)370-63-121-107(41-144(390-121)291-22-19-141(234)272-223(291)323)411-430(333,450)374-67-125-111(45-148(394-125)300-87-260-155-184(238)248-81-254-190(155)300)415-437(340,457)378-71-130-117(51-154(400-130)306-93-268-163-198(306)278-219(246)282-207(163)319)420-440(343,460)376-68-126-112(46-149(395-126)301-88-261-156-185(239)249-82-255-191(156)301)416-438(341,458)377-70-129-116(50-153(399-129)305-92-267-162-197(305)277-218(245)281-206(162)318)419-436(339,456)373-66-124-109(43-146(393-124)293-56-101(5)201(313)285-228(293)328)413-433(336,453)368-61-119-105(39-142(388-119)289-20-17-139(232)270-221(289)321)409-429(332,449)371-64-122-110(44-147(391-122)294-57-102(6)202(314)286-229(294)329)414-434(337,454)372-65-123-108(42-145(392-123)292-55-100(4)200(312)284-227(292)327)412-432(335,452)369-62-120-106(40-143(389-120)290-21-18-140(233)271-222(290)322)410-431(334,451)375-69-127-113(47-150(396-127)302-89-262-157-186(240)250-83-256-192(157)302)421-441(344,461)382-75-133-167(177(364-35-27-356-13)213(405-133)299-59-104(8)204(316)288-231(299)331)424-445(348,465)384-77-135-169(176(363-34-26-355-12)212(404-135)297-54-99(3)183(237)275-226(297)326)425-446(349,466)386-79-137-170(178(365-36-28-357-14)214(407-137)307-94-264-159-188(242)252-85-258-194(159)307)426-443(346,463)381-74-132-165(311)173(360-31-23-352-9)209(402-132)298-58-103(7)203(315)287-230(298)330/h17-22,52-59,81-96,105-138,142-154,165-180,209-216,310-311H,23-51,60-80H2,1-16H3,(H,332,449)(H,333,450)(H,334,451)(H,335,452)(H,336,453)(H,337,454)(H,338,455)(H,339,456)(H,340,457)(H,341,458)(H,342,459)(H,343,460)(H,344,461)(H,345,462)(H,346,463)(H,347,464)(H,348,465)(H,349,466)(H,350,467)(H,351,468)(H2,232,270,321)(H2,233,271,322)(H2,234,272,323)(H2,235,273,324)(H2,236,274,325)(H2,237,275,326)(H2,238,248,254)(H2,239,249,255)(H2,240,250,256)(H2,241,251,257)(H2,242,252,258)(H2,243,253,259)(H,284,312,327)(H,285,313,328)(H,286,314,329)(H,287,315,330)(H,288,316,331)(H3,244,276,280,317)(H3,245,277,281,318)(H3,246,278,282,319)(H3,247,279,283,320)/t105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,135+,136+,137+,138+,142+,143+,144+,145+,146+,147+,148+,149+,150+,151+,152+,153+,154+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180+,209+,210+,211+,212+,213+,214+,215+,216+,429?,430?,431?,432?,433?,434?,435?,436?,437?,438?,439?,440?,441?,442?,443?,444?,445?,446?,447?,448?/m0/s1 D0K3XS DRUGINKE RCFZILUHCNXXFY-DEDWCYLFSA-N D0K3XS DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)CO)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=O)(OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O)S D0K3XS HIGHSTAT Phase 3 D0K7WQ DRUG__ID D0K7WQ D0K7WQ THERCLAS Antiviral Agents D0K7WQ DRUGTYPE Small molecular drug D0K7WQ DRUGINCH 1S/C12H13N5O4/c13-4-12(10(20)9(19)7(3-18)21-12)8-2-1-6-11(14)15-5-16-17(6)8/h1-2,5,7,9-10,18-20H,3H2,(H2,14,15,16)/t7-,9-,10-,12+/m1/s1 D0K7WQ DRUGINKE BRDWIEOJOWJCLU-LTGWCKQJSA-N D0K7WQ DRUGSMIL C1=C2C(=NC=NN2C(=C1)C3(C(C(C(O3)CO)O)O)C#N)N D0K7WQ HIGHSTAT Phase 3 Trial D0K8NR DRUG__ID D0K8NR D0K8NR DRUGCOMP Amgen D0K8NR DRUGTYPE Small molecular drug D0K8NR DRUGINCH 1S/Na D0K8NR DRUGINKE KEAYESYHFKHZAL-UHFFFAOYSA-N D0K8NR DRUGSMIL [Na] D0K8NR HIGHSTAT Phase 3 D0K8TI DRUG__ID D0K8TI D0K8TI DRUGCOMP Eisai D0K8TI DRUGTYPE Small molecular drug D0K8TI DRUGINCH 1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)/t17-/m1/s1 D0K8TI DRUGINKE QCVNMNYRNIMDKV-QGZVFWFLSA-N D0K8TI DRUGSMIL C1C(=O)NC(=O)C12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F D0K8TI HIGHSTAT Phase 3 D0KE1F DRUG__ID D0KE1F D0KE1F DRUGCOMP Delta-Fly Pharma D0KE1F DRUGTYPE Small molecular drug D0KE1F DRUGINCH 1S/C10H12N4O4/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17/h1-2,5-6,8-9,15-16H,4H2,(H2,12,13,17)/t5-,6+,8-,9+/m0/s1 D0KE1F DRUGINKE DCYBPMFXJCWXNB-JWIUVKOKSA-N D0KE1F DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)C#N D0KE1F HIGHSTAT Phase 3 D0KF9Q DRUG__ID D0KF9Q D0KF9Q DRUGCOMP Onconova Therapeutics D0KF9Q DRUGTYPE Small molecular drug D0KF9Q DRUGINCH 1S/C21H25NO8S/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24/h5-11,22H,12-13H2,1-4H3,(H,23,24)/b8-7+ D0KF9Q DRUGINKE OWBFCJROIKNMGD-BQYQJAHWSA-N D0KF9Q DRUGSMIL COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)O D0KF9Q HIGHSTAT Phase 3 D0L2JM DRUG__ID D0L2JM D0L2JM DRUGCOMP Pierre Fabre SA D0L2JM DRUGTYPE Small molecular drug D0L2JM DRUGINCH 1S/C20H22N2S/c1-3-7-19-17(5-1)22(18-6-2-4-8-20(18)23-19)14-16-13-21-11-9-15(16)10-12-21/h1-8,15-16H,9-14H2/t16-/m0/s1 D0L2JM DRUGINKE HOKDBMAJZXIPGC-INIZCTEOSA-N D0L2JM DRUGSMIL C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53 D0L2JM HIGHSTAT Phase 3 D0L2UQ DRUG__ID D0L2UQ D0L2UQ DRUGCOMP MEI Pharma D0L2UQ DRUGTYPE Small molecular drug D0L2UQ DRUGINCH 1S/C20H30N4O2/c1-4-7-8-19-21-17-15-16(10-12-20(25)22-26)9-11-18(17)24(19)14-13-23(5-2)6-3/h9-12,15,26H,4-8,13-14H2,1-3H3,(H,22,25)/b12-10+ D0L2UQ DRUGINKE JHDKZFFAIZKUCU-ZRDIBKRKSA-N D0L2UQ DRUGSMIL CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)C=CC(=O)NO D0L2UQ HIGHSTAT Phase 3 D0L2VT DRUG__ID D0L2VT D0L2VT DRUGCOMP Provectus Pharmaceuticals D0L2VT DRUGTYPE Small molecular drug D0L2VT DRUGINCH 1S/C20H4Cl4I4O5.2Na/c21-9-7-8(10(22)12(24)11(9)23)20(33-19(7)31)3-1-5(25)15(29)13(27)17(3)32-18-4(20)2-6(26)16(30)14(18)28;;/h1-2,29-30H;;/q;2*+1/p-2 D0L2VT DRUGINKE KCQREHTWEUECQT-UHFFFAOYSA-L D0L2VT DRUGSMIL C1=C2C(=C(C(=C1I)[O-])I)OC3=C(C(=C(C=C3C24C5=C(C(=C(C(=C5Cl)Cl)Cl)Cl)C(=O)O4)I)[O-])I.[Na+].[Na+] D0L2VT HIGHSTAT Phase 3 D0L3EO DRUG__ID D0L3EO D0L3EO DRUGCOMP Eisai D0L3EO DRUGTYPE Small molecular drug D0L3EO DRUGINCH 1S/C21H30N4O4/c1-2-29-20-13-18(22)19(25(27)28)12-17(20)21(26)23-16-8-10-24(11-9-16)14-15-6-4-3-5-7-15/h3-4,12-13,15-16H,2,5-11,14,22H2,1H3,(H,23,26) D0L3EO DRUGINKE ZDLBNXXKDMLZMF-UHFFFAOYSA-N D0L3EO DRUGSMIL CCOC1=CC(=C(C=C1C(=O)NC2CCN(CC2)CC3CCC=CC3)[N+](=O)[O-])N D0L3EO HIGHSTAT Phase 3 D0L5WD DRUG__ID D0L5WD D0L5WD DRUGCOMP EKR Therapeutics D0L5WD DRUGTYPE Small molecular drug D0L5WD DRUGINCH 1S/C145H234N52O44S3/c1-11-72(6)112-137(238)171-60-106(208)172-73(7)113(214)177-86(40-41-103(146)205)122(223)190-95(63-198)116(217)170-61-108(210)175-88(51-70(2)3)114(215)169-62-109(211)176-100(133(234)187-92(56-104(147)206)127(228)193-97(65-200)130(231)186-91(54-77-27-16-13-17-28-77)126(227)180-82(31-20-45-163-142(153)154)119(220)189-94(139(240)241)55-78-36-38-79(204)39-37-78)68-243-244-69-101(134(235)185-90(53-76-25-14-12-15-26-76)115(216)168-58-105(207)167-59-107(209)174-80(29-18-43-161-140(149)150)117(218)182-87(42-50-242-10)123(224)188-93(57-110(212)213)128(229)181-85(124(225)196-112)34-23-48-166-145(159)160)195-132(233)99(67-202)194-131(232)98(66-201)192-120(221)83(32-21-46-164-143(155)156)178-118(219)81(30-19-44-162-141(151)152)179-125(226)89(52-71(4)5)184-129(230)96(64-199)191-121(222)84(33-22-47-165-144(157)158)183-135(236)102-35-24-49-197(102)138(239)74(8)173-136(237)111(148)75(9)203/h12-17,25-28,36-39,70-75,80-102,111-112,198-204H,11,18-24,29-35,40-69,148H2,1-10H3,(H2,146,205)(H2,147,206)(H,167,207)(H,168,216)(H,169,215)(H,170,217)(H,171,238)(H,172,208)(H,173,237)(H,174,209)(H,175,210)(H,176,211)(H,177,214)(H,178,219)(H,179,226)(H,180,227)(H,181,229)(H,182,218)(H,183,236)(H,184,230)(H,185,235)(H,186,231)(H,187,234)(H,188,224)(H,189,220)(H,190,223)(H,191,222)(H,192,221)(H,193,228)(H,194,232)(H,195,233)(H,196,225)(H,212,213)(H,240,241)(H4,149,150,161)(H4,151,152,162)(H4,153,154,163)(H4,155,156,164)(H4,157,158,165)(H4,159,160,166)/t72-,73-,74-,75+,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,111-,112-/m0/s1 D0L5WD DRUGINKE IUCCYQIEZNQWRS-DWWHXVEHSA-N D0L5WD DRUGSMIL CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(C(C)O)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C D0L5WD HIGHSTAT Phase 3 D0L6NW DRUG__ID D0L6NW D0L6NW DRUGCOMP Boehringer Ingelheim Pharmaceuticals; Eli Lilly D0L6NW DRUGTYPE Small molecular drug D0L6NW DRUGINCH 1S/C261H387N65O79S6/c1-30-134(23)208(317-196(343)107-262)255(397)321-207(133(21)22)251(393)290-160(76-83-203(353)354)219(361)285-157(72-79-192(265)339)223(365)312-186-119-409-410-120-187-246(388)309-181(114-328)243(385)297-164(91-126(7)8)226(368)298-170(98-143-54-62-149(333)63-55-143)229(371)286-155(70-77-190(263)337)220(362)293-163(90-125(5)6)224(366)288-159(75-82-202(351)352)222(364)306-177(104-193(266)340)236(378)301-172(100-145-58-66-151(335)67-59-145)232(374)313-185-118-408-407-117-184(216(358)276-110-197(344)281-154(73-80-200(347)348)218(360)284-153(52-43-85-273-260(269)270)214(356)275-111-198(345)282-168(95-140-45-35-32-36-46-140)228(370)300-169(96-141-47-37-33-38-48-141)231(373)302-174(101-146-60-68-152(336)69-61-146)241(383)323-210(137(26)330)256(398)291-161(51-41-42-84-274-261(403)405-88-87-404-29)258(400)326-86-44-53-189(326)249(391)325-212(139(28)332)259(401)402)315-253(395)206(132(19)20)319-238(380)166(93-128(11)12)295-230(372)171(99-144-56-64-150(334)65-57-144)299-225(367)162(89-124(3)4)292-213(355)136(25)280-217(359)158(74-81-201(349)350)289-250(392)204(130(15)16)318-239(381)167(94-129(13)14)296-234(376)176(103-148-109-272-123-279-148)305-242(384)180(113-327)283-199(346)112-277-215(357)183(116-406-411-121-188(314-247(186)389)248(390)324-211(138(27)331)257(399)310-182(115-329)244(386)322-209(135(24)31-2)254(396)316-187)311-227(369)165(92-127(9)10)294-233(375)175(102-147-108-271-122-278-147)304-221(363)156(71-78-191(264)338)287-235(377)179(106-195(268)342)308-252(394)205(131(17)18)320-240(382)173(97-142-49-39-34-40-50-142)303-237(379)178(105-194(267)341)307-245(185)387/h32-40,45-50,54-69,108-109,122-139,153-189,204-212,327-336H,30-31,41-44,51-53,70-107,110-121,262H2,1-29H3,(H2,263,337)(H2,264,338)(H2,265,339)(H2,266,340)(H2,267,341)(H2,268,342)(H,271,278)(H,272,279)(H,274,403)(H,275,356)(H,276,358)(H,277,357)(H,280,359)(H,281,344)(H,282,345)(H,283,346)(H,284,360)(H,285,361)(H,286,371)(H,287,377)(H,288,366)(H,289,392)(H,290,393)(H,291,398)(H,292,355)(H,293,362)(H,294,375)(H,295,372)(H,296,376)(H,297,385)(H,298,368)(H,299,367)(H,300,370)(H,301,378)(H,302,373)(H,303,379)(H,304,363)(H,305,384)(H,306,364)(H,307,387)(H,308,394)(H,309,388)(H,310,399)(H,311,369)(H,312,365)(H,313,374)(H,314,389)(H,315,395)(H,316,396)(H,317,343)(H,318,381)(H,319,380)(H,320,382)(H,321,397)(H,322,386)(H,323,383)(H,324,390)(H,325,391)(H,347,348)(H,349,350)(H,351,352)(H,353,354)(H,401,402)(H4,269,270,273)/t134-,135-,136-,137+,138+,139+,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,204-,205-,206-,207-,208-,209-,210-,211-,212-/m0/s1 D0L6NW DRUGINKE UFIPGFMPJACHTH-HXDLXPBZSA-N D0L6NW DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC3C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC4=CN=CN4)CCC(=O)N)CC(=O)N)C(C)C)CC5=CC=CC=C5)CC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC6=CC=C(C=C6)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC7=CC=C(C=C7)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC8=CC=CC=C8)C(=O)NC(CC9=CC=CC=C9)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C(C)O)C(=O)NC(CCCCNC(=O)OCCOC)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC2=CC=C(C=C2)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CN=CN2)CO)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D0L6NW HIGHSTAT Phase 3 D0L9IA DRUG__ID D0L9IA D0L9IA DRUGCOMP Threshold Pharmaceuticals D0L9IA DRUGTYPE Small molecular drug D0L9IA DRUGINCH 1S/C10H21Cl2N2O7P/c11-1-3-13-22(19,14-4-2-12)21-10-9(18)8(17)7(16)6(5-15)20-10/h6-10,15-18H,1-5H2,(H2,13,14,19)/t6-,7-,8+,9-,10+/m1/s1 D0L9IA DRUGINKE PSVUJBVBCOISSP-SPFKKGSWSA-N D0L9IA DRUGSMIL C(CCl)NP(=O)(NCCCl)OC1C(C(C(C(O1)CO)O)O)O D0L9IA HIGHSTAT Phase 3 D0L9NX DRUG__ID D0L9NX D0L9NX DRUGCOMP Sanofi-Aventis D0L9NX DRUGTYPE Small molecular drug D0L9NX DRUGINCH 1S/C33H45N3O8S/c1-6-43-25-8-9-27-26(22-25)33(13-11-24(12-14-33)44-20-17-35-15-18-42-19-16-35)31(38)36(27)45(39,40)29-10-7-23(21-28(29)41-5)30(37)34-32(2,3)4/h7-10,21-22,24H,6,11-20H2,1-5H3,(H,34,37) D0L9NX DRUGINKE QKXJWFOKVQWEDZ-UHFFFAOYSA-N D0L9NX DRUGSMIL CCOC1=CC2=C(C=C1)N(C(=O)C23CCC(CC3)OCCN4CCOCC4)S(=O)(=O)C5=C(C=C(C=C5)C(=O)NC(C)(C)C)OC D0L9NX HIGHSTAT Phase 3 D0LF5Q DRUG__ID D0LF5Q D0LF5Q DRUGCOMP Abbott Laboratories D0LF5Q DRUGTYPE Small molecular drug D0LF5Q DRUGINCH 1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1 D0LF5Q DRUGINKE PIDFDZJZLOTZTM-KHVQSSSXSA-N D0LF5Q DRUGSMIL CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC D0LF5Q HIGHSTAT Phase 3 D0LG6A DRUG__ID D0LG6A D0LG6A THERCLAS Antiviral Agents D0LG6A DRUGTYPE Small molecular drug D0LG6A DRUGINCH 1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1 D0LG6A DRUGINKE VOVIALXJUBGFJZ-KWVAZRHASA-N D0LG6A DRUGSMIL CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C D0LG6A HIGHSTAT Phase 3 Trial D0LJ1B DRUG__ID D0LJ1B D0LJ1B DRUGCOMP Dompe s.p.a. D0LJ1B DRUGTYPE Small molecular drug D0LJ1B DRUGINCH 1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1 D0LJ1B DRUGINKE KQDRVXQXKZXMHP-LLVKDONJSA-N D0LJ1B DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C D0LJ1B HIGHSTAT Phase 3 D0LK4X DRUG__ID D0LK4X D0LK4X DRUGCOMP Almirall Prodesfarma D0LK4X DRUGTYPE Small molecular drug D0LK4X DRUGINCH 1S/C32H37NO4/c1-32(2,31(35)36)27-17-15-24(16-18-27)29(34)14-9-21-33-22-19-28(20-23-33)37-30(25-10-5-3-6-11-25)26-12-7-4-8-13-26/h3-8,10-13,15-18,28,30H,9,14,19-23H2,1-2H3,(H,35,36) D0LK4X DRUGINKE XGHOVGYJHWQGCC-UHFFFAOYSA-N D0LK4X DRUGSMIL CC(C)(C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)O D0LK4X HIGHSTAT Phase 3 D0M0WV DRUG__ID D0M0WV D0M0WV DRUGCOMP Apollo Scientific D0M0WV DRUGTYPE Small molecular drug D0M0WV DRUGINCH 1S/2C29H32O7S.H2O/c2*1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24;/h2*4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31);1H2/t2*23-;/m11./s1 D0M0WV DRUGINKE OJXYMYYDAVXPIK-IWKNALKQSA-N D0M0WV DRUGSMIL CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C.CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C.O D0M0WV HIGHSTAT Phase 3 D0M3XR DRUG__ID D0M3XR D0M3XR DRUGCOMP Merck D0M3XR DRUGTYPE Small molecular drug D0M3XR DRUGINCH 1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1 D0M3XR DRUGINKE MKMPWKUAHLTIBJ-ISTRZQFTSA-N D0M3XR DRUGSMIL CS(=O)(=O)N1C=C2CN(CC2=N1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N D0M3XR HIGHSTAT Phase 3 D0M4AV DRUG__ID D0M4AV D0M4AV DRUGCOMP Clovis Oncology D0M4AV DRUGTYPE Small molecular drug D0M4AV DRUGINCH 1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35) D0M4AV DRUGINKE HUFOZJXAKZVRNJ-UHFFFAOYSA-N D0M4AV DRUGSMIL CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC D0M4AV HIGHSTAT Phase 3 D0M8FD DRUG__ID D0M8FD D0M8FD DRUGCOMP Bayer Schering D0M8FD DRUGTYPE Small molecular drug D0M8FD DRUGINCH 1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26) D0M8FD DRUGINKE INVTYAOGFAGBOE-UHFFFAOYSA-N D0M8FD DRUGSMIL C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3 D0M8FD HIGHSTAT Phase 3 D0M9VE DRUG__ID D0M9VE D0M9VE DRUGCOMP OSI Pharmaceuticals D0M9VE DRUGTYPE Small molecular drug D0M9VE DRUGINCH 1S/C20H17FO4S/c1-12-17(9-13-3-6-15(7-4-13)26(2,24)25)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9- D0M9VE DRUGINKE MVGSNCBCUWPVDA-MFOYZWKCSA-N D0M9VE DRUGSMIL CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O D0M9VE HIGHSTAT Phase 3 D0MH8O DRUG__ID D0MH8O D0MH8O DRUGCOMP Tarix pharmaceuticals D0MH8O DRUGTYPE Small molecular drug D0MH8O DRUGINCH 1S/C41H62N12O11/c1-5-22(4)33(38(61)50-29(17-24-19-45-20-47-24)39(62)53-15-7-9-30(53)40(63)64)52-36(59)28(16-23-10-12-25(54)13-11-23)49-37(60)32(21(2)3)51-35(58)27(8-6-14-46-41(43)44)48-34(57)26(42)18-31(55)56/h10-13,19-22,26-30,32-33,54H,5-9,14-18,42H2,1-4H3,(H,45,47)(H,48,57)(H,49,60)(H,50,61)(H,51,58)(H,52,59)(H,55,56)(H,63,64)(H4,43,44,46)/t22-,26-,27-,28-,29-,30-,32-,33-/m0/s1 D0MH8O DRUGINKE PVHLMTREZMEJCG-GDTLVBQBSA-N D0MH8O DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N D0MH8O HIGHSTAT Phase 3 D0MW0N DRUG__ID D0MW0N D0MW0N DRUGCOMP AB Science D0MW0N DRUGTYPE Small molecular drug D0MW0N DRUGINCH 1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32) D0MW0N DRUGINKE WJEOLQLKVOPQFV-UHFFFAOYSA-N D0MW0N DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5 D0MW0N HIGHSTAT Phase 3 D0MW7B DRUG__ID D0MW7B D0MW7B DRUGCOMP Transtech pharma D0MW7B DRUGTYPE Small molecular drug D0MW7B DRUGINCH 1S/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3 D0MW7B DRUGINKE KJNNWYBAOPXVJY-UHFFFAOYSA-N D0MW7B DRUGSMIL CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC D0MW7B HIGHSTAT Phase 3 D0MY7F DRUG__ID D0MY7F D0MY7F DRUGCOMP Angion Therapeutics D0MY7F DRUGTYPE Small molecular drug D0MY7F DRUGINCH 1S/C19H17Br2NO5S/c1-4-15-17(18(23)10-7-13(20)19(24)14(21)8-10)12-6-5-11(9-16(12)27-15)28(25,26)22(2)3/h5-9,24H,4H2,1-3H3 D0MY7F DRUGINKE FEYGJZKVMASWJB-UHFFFAOYSA-N D0MY7F DRUGSMIL CCC1=C(C2=C(O1)C=C(C=C2)S(=O)(=O)N(C)C)C(=O)C3=CC(=C(C(=C3)Br)O)Br D0MY7F HIGHSTAT Phase 3 D0MY7X DRUG__ID D0MY7X D0MY7X DRUGCOMP Taisho Pharmaceutical Co Ltd D0MY7X DRUGTYPE Small molecular drug D0MY7X DRUGINCH 1S/C14H16O4S/c1-9-3-5-11(6-4-9)13(16)7-12(14(17)18)8-19-10(2)15/h3-6,12H,7-8H2,1-2H3,(H,17,18) D0MY7X DRUGINKE YRSSFEUQNAXQMX-UHFFFAOYSA-N D0MY7X DRUGSMIL CC1=CC=C(C=C1)C(=O)CC(CSC(=O)C)C(=O)O D0MY7X HIGHSTAT Phase 3 D0N0RN DRUG__ID D0N0RN D0N0RN DRUGCOMP Nereus Pharmaceuticals D0N0RN DRUGTYPE Small molecular drug D0N0RN DRUGINCH 1S/C15H20ClNO4/c1-14-10(7-8-16)12(19)17-15(14,13(20)21-14)11(18)9-5-3-2-4-6-9/h3,5,9-11,18H,2,4,6-8H2,1H3,(H,17,19)/t9-,10+,11+,14+,15+/m1/s1 D0N0RN DRUGINKE NGWSFRIPKNWYAO-SHTIJGAHSA-N D0N0RN DRUGSMIL CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl D0N0RN HIGHSTAT Phase 3 D0N3SR DRUG__ID D0N3SR D0N3SR DRUGCOMP Fuji Viscera Pharmaceutical D0N3SR DRUGTYPE Small molecular drug D0N3SR DRUGINCH 1S/C27H28N2O7/c1-18-23(26(30)35-14-8-11-20-9-5-4-6-10-20)25(21-12-7-13-22(17-21)29(32)33)24(19(2)28-18)27(31)36-16-15-34-3/h4-13,17,25,28H,14-16H2,1-3H3/b11-8+ D0N3SR DRUGINKE KJEBULYHNRNJTE-DHZHZOJOSA-N D0N3SR DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC D0N3SR HIGHSTAT Phase 3 D0N4EO DRUG__ID D0N4EO D0N4EO DRUGCOMP Glycomimetics; pfizer D0N4EO DRUGTYPE Small molecular drug D0N4EO DRUGINCH 1S/C58H74N6O31S3/c1-27-45(69)47(71)48(72)56(90-27)95-49-35(62-53(74)36-23-41(66)64-58(78)63-36)19-31(20-37(49)92-57-51(94-55(77)29-10-6-3-7-11-29)50(46(70)39(24-65)93-57)91-38(54(75)76)16-28-8-4-2-5-9-28)52(73)60-13-12-59-42(67)25-88-14-15-89-26-43(68)61-34-21-32(96(79,80)81)17-30-18-33(97(82,83)84)22-40(44(30)34)98(85,86)87/h3,6-7,10-11,17-18,21-23,27-28,31,35,37-39,45-51,56-57,65,69-72H,2,4-5,8-9,12-16,19-20,24-26H2,1H3,(H,59,67)(H,60,73)(H,61,68)(H,62,74)(H,75,76)(H,79,80,81)(H,82,83,84)(H,85,86,87)(H2,63,64,66,78)/t27-,31+,35-,37+,38-,39+,45+,46-,47+,48-,49+,50-,51+,56-,57+/m0/s1 D0N4EO DRUGINKE VXBNTHRZPJLRSS-PTCSXESPSA-N D0N4EO DRUGSMIL CC1C(C(C(C(O1)OC2C(CC(CC2OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O D0N4EO HIGHSTAT Phase 3 D0N6SO DRUG__ID D0N6SO D0N6SO DRUGCOMP Takeda D0N6SO DRUGTYPE Small molecular drug D0N6SO DRUGINCH 1S/C18H20FN5O2/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3/t15-/m1/s1 D0N6SO DRUGINKE IWYJYHUNXVAVAA-OAHLLOKOSA-N D0N6SO DRUGSMIL CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N D0N6SO HIGHSTAT Phase 3 D0N8UY DRUG__ID D0N8UY D0N8UY DRUGCOMP Eli Lilly & Co D0N8UY DRUGTYPE Small molecular drug D0N8UY DRUGINCH 1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2 D0N8UY DRUGINKE CAVRKWRKTNINFF-UHFFFAOYSA-N D0N8UY DRUGSMIL C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl D0N8UY HIGHSTAT Phase 3 D0NE3W DRUG__ID D0NE3W D0NE3W DRUGCOMP GTx D0NE3W DRUGTYPE Small molecular drug D0NE3W DRUGINCH 1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1 D0NE3W DRUGINKE JNGVJMBLXIUVRD-SFHVURJKSA-N D0NE3W DRUGSMIL CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O D0NE3W HIGHSTAT Phase 3 D0NL5M DRUG__ID D0NL5M D0NL5M DRUGCOMP Bioniche Life Sciences Inc D0NL5M DRUGTYPE Small molecular drug D0NL5M DRUGINCH 1S/C8H7Cl2NO2/c1-13-8(12)11-5-2-3-6(9)7(10)4-5/h2-4H,1H3,(H,11,12) D0NL5M DRUGINKE WOZQBERUBLYCEG-UHFFFAOYSA-N D0NL5M DRUGSMIL COC(=O)NC1=CC(=C(C=C1)Cl)Cl D0NL5M HIGHSTAT Phase 3 D0NN8N DRUG__ID D0NN8N D0NN8N DRUGCOMP TONIX Pharmaceuticals D0NN8N DRUGTYPE Small molecular drug D0NN8N DRUGINCH 1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H D0NN8N DRUGINKE VXEAYBOGHINOKW-UHFFFAOYSA-N D0NN8N DRUGSMIL CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl D0NN8N HIGHSTAT Phase 3 D0O2XQ DRUG__ID D0O2XQ D0O2XQ DRUGCOMP Genzyme D0O2XQ DRUGTYPE Small molecular drug D0O2XQ DRUGINCH 1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1 D0O2XQ DRUGINKE WVLHHLRVNDMIAR-IBGZPJMESA-N D0O2XQ DRUGSMIL C1CC(C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3 D0O2XQ HIGHSTAT Phase 3 D0O3CV DRUG__ID D0O3CV D0O3CV DRUGCOMP Merck D0O3CV DRUGTYPE Small molecular drug D0O3CV DRUGINCH 1S/C53H84NO14P/c1-32-18-14-13-15-19-33(2)44(63-8)30-40-23-21-38(7)53(61,67-40)50(58)51(59)54-25-17-16-20-41(54)52(60)66-45(35(4)28-39-22-24-43(46(29-39)64-9)68-69(11,12)62)31-42(55)34(3)27-37(6)48(57)49(65-10)47(56)36(5)26-32/h13-15,18-19,27,32,34-36,38-41,43-46,48-49,57,61H,16-17,20-26,28-31H2,1-12H3/b15-13+,18-14+,33-19+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 D0O3CV DRUGINKE BUROJSBIWGDYCN-GAUTUEMISA-N D0O3CV DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC D0O3CV HIGHSTAT Phase 3 D0O9VW DRUG__ID D0O9VW D0O9VW DRUGCOMP Nippon Kayaku Co Ltd D0O9VW DRUGTYPE Small molecular drug D0O9VW DRUGINCH 1S/C15H18F3NO/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18/h4-7,11H,2-3,8-10H2,1H3/t11-/m1/s1 D0O9VW DRUGINKE RYZCWZZJFAKYHX-LLVKDONJSA-N D0O9VW DRUGSMIL CC(CN1CCCC1)C(=O)C2=CC=C(C=C2)C(F)(F)F D0O9VW HIGHSTAT Phase 3 D0OC4O DRUG__ID D0OC4O D0OC4O DRUGCOMP Roche D0OC4O DRUGTYPE Small molecular drug D0OC4O DRUGINCH 1S/C31H29Cl2F2N3O4/c1-30(2,3)14-24-31(15-36,19-10-9-17(32)13-21(19)34)25(18-6-5-7-20(33)26(18)35)27(38-24)28(39)37-22-11-8-16(29(40)41)12-23(22)42-4/h5-13,24-25,27,38H,14H2,1-4H3,(H,37,39)(H,40,41)/t24-,25-,27+,31-/m0/s1 D0OC4O DRUGINKE TVTXCJFHQKSQQM-LJQIRTBHSA-N D0OC4O DRUGSMIL CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F D0OC4O HIGHSTAT Phase 3 D0P6GT DRUG__ID D0P6GT D0P6GT DRUGCOMP Bayer HealthCare Pharmaceuticals D0P6GT DRUGTYPE Small molecular drug D0P6GT DRUGINCH 1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2 D0P6GT DRUGINKE ARPUHYJMCVWYCZ-UHFFFAOYSA-N D0P6GT DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O.O.Cl D0P6GT HIGHSTAT Phase 3 D0P8TS DRUG__ID D0P8TS D0P8TS DRUGCOMP Eisai Co Ltd D0P8TS DRUGTYPE Small molecular drug D0P8TS DRUGINCH 1S/C17H25NO/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18/h7-10,14H,3-6,11-13H2,1-2H3 D0P8TS DRUGINKE SQUNAWUMZGQQJD-UHFFFAOYSA-N D0P8TS DRUGSMIL CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2 D0P8TS HIGHSTAT Phase 3 D0PM9D DRUG__ID D0PM9D D0PM9D DRUGCOMP Vion Pharmaceuticals Inc D0PM9D DRUGTYPE Small molecular drug D0PM9D DRUGINCH 1S/C16H20N4O5/c1-6-10(17)13(22)9-7(5-25-15(18)23)16(24-3)14-8(19(14)2)4-20(16)11(9)12(6)21/h7-8,14H,4-5,17H2,1-3H3,(H2,18,23)/t7-,8+,14+,16-,19?/m1/s1 D0PM9D DRUGINKE HRHKSTOGXBBQCB-VFWICMBZSA-N D0PM9D DRUGSMIL CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4C)N D0PM9D HIGHSTAT Phase 3 D0PY5D DRUG__ID D0PY5D D0PY5D DRUGCOMP Clavis Pharma D0PY5D DRUGTYPE Small molecular drug D0PY5D DRUGINCH 1S/C27H45N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(31)35-20-21-24(32)25(33)26(36-21)30-19-18-22(28)29-27(30)34/h9-10,18-19,21,24-26,32-33H,2-8,11-17,20H2,1H3,(H2,28,29,34)/b10-9+/t21-,24-,25+,26-/m1/s1 D0PY5D DRUGINKE FLFGNMFWNBOBGE-FNNZEKJRSA-N D0PY5D DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O D0PY5D HIGHSTAT Phase 3 D0Q0EF DRUG__ID D0Q0EF D0Q0EF DRUGCOMP Intra-Cellular Therapies D0Q0EF DRUGTYPE Small molecular drug D0Q0EF DRUGINCH 1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1 D0Q0EF DRUGINKE HOIIHACBCFLJET-SFTDATJTSA-N D0Q0EF DRUGSMIL CN1CCN2C3CCN(CC3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F D0Q0EF HIGHSTAT Phase 3 D0Q4OW DRUG__ID D0Q4OW D0Q4OW DRUGCOMP Cell Therapeutics D0Q4OW DRUGTYPE Small molecular drug D0Q4OW DRUGINCH 1S/C17H19N5O2/c18-4-7-21-12-1-2-13(22-8-5-19)15-14(12)16(23)10-3-6-20-9-11(10)17(15)24/h1-3,6,9,21-22H,4-5,7-8,18-19H2 D0Q4OW DRUGINKE PEZPMAYDXJQYRV-UHFFFAOYSA-N D0Q4OW DRUGSMIL C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN D0Q4OW HIGHSTAT Phase 3 D0Q5AT DRUG__ID D0Q5AT D0Q5AT DRUGCOMP Sosei; Vectura; Novartis D0Q5AT DRUGTYPE Small molecular drug D0Q5AT DRUGINCH 1S/C24H28N2O3.C19H28NO3.BrH/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24;1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29);3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q;+1;/p-1/t22-;;/m0../s1 D0Q5AT DRUGINKE GCUZFFAPBPDIFM-IKXQUJFKSA-M D0Q5AT DRUGSMIL CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-] D0Q5AT HIGHSTAT Phase 3 D0Q6IW DRUG__ID D0Q6IW D0Q6IW DRUGCOMP GSK D0Q6IW DRUGTYPE Combination drug (small molecular drug) D0Q6IW DRUGINCH 1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-8H,1H3,(H,16,17)/b11-4- D0Q6IW DRUGINKE KKGJVFQBVRACGR-WCIBSUBMSA-N D0Q6IW DRUGSMIL COC1=CC2=C(C=C1)NC(=O)C2=CC3C=NC=N3 D0Q6IW HIGHSTAT Phase 3 D0Q6RG DRUG__ID D0Q6RG D0Q6RG DRUGCOMP Theravance D0Q6RG DRUGTYPE Small molecular drug D0Q6RG DRUGINCH 1S/C87H95Cl3N16O28S2/c1-33(2)20-45(94-5)74(117)100-62-66(112)36-11-14-49(43(88)22-36)130-51-24-38-25-52(70(51)134-85-71(69(115)68(114)53(31-107)132-85)133-55-29-87(4,93)72(116)34(3)129-55)131-50-15-12-37(23-44(50)89)67(113)63-81(124)99-59(42-26-40(108)27-48(110)56(42)41-21-35(10-13-47(41)109)57(77(120)101-63)98-78(121)58(38)97-75(118)46(28-54(91)111)96-80(62)123)76(119)95-16-9-19-128-104-61(60-73(90)136-86(92)103-60)79(122)102-64-82(125)106-65(84(126)127)39(32-135-83(64)106)30-105-17-7-6-8-18-105/h6-8,10-15,17-18,21-27,33-34,45-46,53,55,57-59,62-64,66-69,71-72,83,85,94,107,112-116H,9,16,19-20,28-32,93H2,1-5H3,(H15-,91,92,95,96,97,98,99,100,101,102,103,104,108,109,110,111,117,118,119,120,121,122,123,124,126,127)/t34-,45+,46-,53+,55-,57+,58+,59-,62+,63-,64+,66+,67+,68+,69-,71+,72+,83+,85-,87-/m0/s1 D0Q6RG DRUGINKE OGUAFUAJSPORAH-KHCCTVBNSA-N D0Q6RG DRUGSMIL CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)NCCCON=C(C1=C(SC(=N1)N)Cl)C(=O)NC1C2N(C1=O)C(=C(CS2)C[N+]1=CC=CC=C1)C(=O)[O-])CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O D0Q6RG HIGHSTAT Phase 3 D0QG9A DRUG__ID D0QG9A D0QG9A DRUGCOMP PGx Health D0QG9A DRUGTYPE Small molecular drug D0QG9A DRUGINCH 1S/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12?,13?,16-,17+,18-,22+/m0/s1 D0QG9A DRUGINKE FLEVIENZILQUKB-DMJMAAGCSA-N D0QG9A DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)C#CCC4CCC(CC4)C(=O)OC)N)O)O D0QG9A HIGHSTAT Phase 3 D0QNS3 DRUG__ID D0QNS3 D0QNS3 DRUGCOMP Relmada Therapeutics D0QNS3 DRUGTYPE Small molecular drug D0QNS3 DRUGINCH 1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3/t17-/m0/s1 D0QNS3 DRUGINKE USSIQXCVUWKGNF-KRWDZBQOSA-N D0QNS3 DRUGSMIL CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2 D0QNS3 HIGHSTAT Phase 3 D0QR5G DRUG__ID D0QR5G D0QR5G DRUGCOMP Oclassen Pharmaceuticals Inc D0QR5G DRUGTYPE Small molecular drug D0QR5G DRUGINCH 1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3 D0QR5G DRUGINKE BGEBZHIAGXMEMV-UHFFFAOYSA-N D0QR5G DRUGSMIL COC1=C2C=CC(=O)OC2=CC3=C1C=CO3 D0QR5G HIGHSTAT Phase 3 D0R3MT DRUG__ID D0R3MT D0R3MT DRUGCOMP Schering-Plough D0R3MT DRUGTYPE Small molecular drug D0R3MT DRUGINCH 1S/C9H14N4O5/c10-7-4(8(11)17)12-2-13(7)9-6(16)5(15)3(1-14)18-9/h2-3,5-6,9,14-16H,1,10H2,(H2,11,17)/t3-,5-,6-,9-/m1/s1 D0R3MT DRUGINKE RTRQQBHATOEIAF-UUOKFMHZSA-N D0R3MT DRUGSMIL C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N D0R3MT HIGHSTAT Phase 3 D0R7YY DRUG__ID D0R7YY D0R7YY DRUGCOMP Gilead Sciences; Knoll GmbH D0R7YY DRUGTYPE Small molecular drug D0R7YY DRUGINCH 1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1 D0R7YY DRUGINKE FEJVSJIALLTFRP-LJQANCHMSA-N D0R7YY DRUGSMIL COC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)OC D0R7YY HIGHSTAT Phase 3 D0R9HI DRUG__ID D0R9HI D0R9HI DRUGCOMP GlaxoSmithKline D0R9HI DRUGTYPE Small molecular drug D0R9HI DRUGINCH 1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2 D0R9HI DRUGINKE JJZFWROHYSMCMU-UHFFFAOYSA-N D0R9HI DRUGSMIL C1CN(CCN1)C2=CC=CC3=CC(=CN=C32)S(=O)(=O)C4=CC=CC=C4 D0R9HI HIGHSTAT Phase 3 D0R9HL DRUG__ID D0R9HL D0R9HL DRUGCOMP Novartis D0R9HL DRUGTYPE Small molecular drug D0R9HL DRUGINCH 1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12-,13+,14-,16?,17?/m0/s1 D0R9HL DRUGINKE SYOKIDBDQMKNDQ-HHUWHTLVSA-N D0R9HL DRUGSMIL C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N D0R9HL HIGHSTAT Phase 3 D0RC2V DRUG__ID D0RC2V D0RC2V DRUGCOMP Frontier Biotechnologies Co Ltd D0RC2V DRUGTYPE Small molecular drug D0RC2V DRUGINCH 1S/C202H303N53O72/c1-16-99(12)164(197(320)237-127(50-65-161(285)286)178(301)230-126(49-64-160(283)284)183(306)250-141(92-256)196(319)235-119(42-55-145(208)262)179(302)244-136(85-147(210)264)188(311)232-118(41-54-144(207)261)174(297)225-116(39-52-142(205)259)172(295)227-121(44-59-155(273)274)176(299)223-113(32-23-25-68-203)170(293)243-135(84-146(209)263)189(312)234-122(45-60-156(275)276)177(300)226-117(40-53-143(206)260)173(296)228-123(46-61-157(277)278)180(303)238-129(76-95(4)5)185(308)249-140(201(324)325)79-98(10)11)252-194(317)131(78-97(8)9)240-181(304)125(48-63-159(281)282)233-187(310)134(83-106-91-215-94-221-106)247-198(321)166(101(14)18-3)253-193(316)130(77-96(6)7)239-171(294)114(33-24-26-69-216-151(268)93-327-75-74-326-73-71-217-150(267)67-72-255-152(269)56-57-153(255)270)236-200(323)167(102(15)257)254-195(318)132(80-103-35-37-107(258)38-36-103)241-190(313)137(86-148(211)265)245-191(314)138(87-149(212)266)248-199(322)165(100(13)17-2)251-184(307)128(51-66-162(287)288)231-169(292)115(34-27-70-218-202(213)214)224-192(315)139(88-163(289)290)246-186(309)133(82-105-90-220-112-31-22-20-29-109(105)112)242-182(305)124(47-62-158(279)280)229-175(298)120(43-58-154(271)272)222-168(291)110(204)81-104-89-219-111-30-21-19-28-108(104)111/h19-22,28-31,35-38,56-57,89-91,94-102,110,113-141,164-167,219-220,256-258H,16-18,23-27,32-34,39-55,58-88,92-93,203-204H2,1-15H3,(H2,205,259)(H2,206,260)(H2,207,261)(H2,208,262)(H2,209,263)(H2,210,264)(H2,211,265)(H2,212,266)(H,215,221)(H,216,268)(H,217,267)(H,222,291)(H,223,299)(H,224,315)(H,225,297)(H,226,300)(H,227,295)(H,228,296)(H,229,298)(H,230,301)(H,231,292)(H,232,311)(H,233,310)(H,234,312)(H,235,319)(H,236,323)(H,237,320)(H,238,303)(H,239,294)(H,240,304)(H,241,313)(H,242,305)(H,243,293)(H,244,302)(H,245,314)(H,246,309)(H,247,321)(H,248,322)(H,249,308)(H,250,306)(H,251,307)(H,252,317)(H,253,316)(H,254,318)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H,289,290)(H,324,325)(H4,213,214,218)/t99-,100-,101-,102+,110-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,164-,165-,166-,167-/m0/s1 D0RC2V DRUGINKE QNWVQSLLLTZQPH-VIIPOJRNSA-N D0RC2V DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)CCN2C(=O)C=CC2=O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CC3=CN=CN3)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC6=CNC7=CC=CC=C76)N D0RC2V HIGHSTAT Phase 3 D0S0FZ DRUG__ID D0S0FZ D0S0FZ DRUGCOMP Johnson & Johnson D0S0FZ DRUGTYPE Small molecular drug D0S0FZ DRUGINCH 1S/C9H10ClNO3/c10-7-4-2-1-3-6(7)8(12)5-14-9(11)13/h1-4,8,12H,5H2,(H2,11,13)/t8-/m1/s1 D0S0FZ DRUGINKE OLBWFRRUHYQABZ-MRVPVSSYSA-N D0S0FZ DRUGSMIL C1=CC=C(C(=C1)C(COC(=O)N)O)Cl D0S0FZ HIGHSTAT Phase 3 D0S4JK DRUG__ID D0S4JK D0S4JK THERCLAS Anticancer Agents D0S4JK DRUGTYPE Small molecular drug D0S4JK DRUGINCH 1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33) D0S4JK DRUGINKE ZLHFILGSQDJULK-UHFFFAOYSA-N D0S4JK DRUGSMIL COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC D0S4JK HIGHSTAT Phase 3 D0S6AE DRUG__ID D0S6AE D0S6AE DRUGCOMP Santen Pharmaceutical D0S6AE DRUGTYPE Small molecular drug D0S6AE DRUGINCH 1S/C18H26N4O23P4/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(41-15)5-39-46(31,32)43-48(35,36)45-49(37,38)44-47(33,34)40-6-8-12(26)14(28)16(42-8)22-4-2-10(24)20-18(22)30/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,37,38)(H,19,23,29)(H,20,24,30)/t7-,8-,11-,12-,13-,14-,15-,16-/m1/s1 D0S6AE DRUGINKE NMLMACJWHPHKGR-NCOIDOBVSA-N D0S6AE DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O D0S6AE HIGHSTAT Phase 3 D0S8LJ DRUG__ID D0S8LJ D0S8LJ DRUGCOMP Taiho Pharma U.S.A. D0S8LJ DRUGTYPE Small molecular drug D0S8LJ DRUGINCH 1S/C34H48Cl2N7O18P3S/c1-32(2,26(46)29(47)39-10-9-22(44)38-11-12-65-31(48)33(3,4)59-19-7-5-18(6-8-19)20-13-34(20,35)36)15-57-64(54,55)61-63(52,53)56-14-21-25(60-62(49,50)51)24(45)30(58-21)43-17-42-23-27(37)40-16-41-28(23)43/h5-8,16-17,20-21,24-26,30,45-46H,9-15H2,1-4H3,(H,38,44)(H,39,47)(H,52,53)(H,54,55)(H2,37,40,41)(H2,49,50,51)/t20?,21-,24-,25-,26?,30-/m1/s1 D0S8LJ DRUGINKE AAHIMGZVACZGCQ-NKXYKTLRSA-N D0S8LJ DRUGSMIL CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)C(C)(C)OC4=CC=C(C=C4)C5CC5(Cl)Cl)O D0S8LJ HIGHSTAT Phase 3 D0SH2X DRUG__ID D0SH2X D0SH2X DRUGCOMP Novartis AG D0SH2X DRUGTYPE Small molecular drug D0SH2X DRUGINCH 1S/C18H21N5O2S/c1-21-10-12-22(13-11-21)18(26)20-16-4-2-14(3-5-16)19-15-6-8-17(9-7-15)23(24)25/h2-9,19H,10-13H2,1H3,(H,20,26) D0SH2X DRUGINKE UFLRJROFPAGRPN-UHFFFAOYSA-N D0SH2X DRUGSMIL CN1CCN(CC1)C(=S)NC2=CC=C(C=C2)NC3=CC=C(C=C3)[N+](=O)[O-] D0SH2X HIGHSTAT Phase 3 D0SO4Z DRUG__ID D0SO4Z D0SO4Z DRUGCOMP Astellas D0SO4Z DRUGTYPE Small molecular drug D0SO4Z DRUGINCH 1S/C16H40N6.C3H5ClO/c17-7-3-13-21(14-4-8-18)11-1-2-12-22(15-5-9-19)16-6-10-20;4-1-3-2-5-3/h1-20H2;3H,1-2H2 D0SO4Z DRUGINKE UHTZABZWCSJMDY-UHFFFAOYSA-N D0SO4Z DRUGSMIL C1C(O1)CCl.C(CCN(CCCN)CCCN)CN(CCCN)CCCN D0SO4Z HIGHSTAT Phase 3 D0SP5V DRUG__ID D0SP5V D0SP5V DRUGCOMP Actelion Pharmaceuticals D0SP5V DRUGTYPE Small molecular drug D0SP5V DRUGINCH 1S/C24H19FN2O3/c25-16-8-9-21-19(12-16)20-13-26(11-10-22(20)27(21)14-23(28)29)24(30)18-7-3-5-15-4-1-2-6-17(15)18/h1-9,12H,10-11,13-14H2,(H,28,29) D0SP5V DRUGINKE IHAXLPDVOWLUOS-UHFFFAOYSA-N D0SP5V DRUGSMIL C1CN(CC2=C1N(C3=C2C=C(C=C3)F)CC(=O)O)C(=O)C4=CC=CC5=CC=CC=C54 D0SP5V HIGHSTAT Phase 3 D0T0NG DRUG__ID D0T0NG D0T0NG DRUGCOMP Almiral Prodesfarma D0T0NG DRUGTYPE Small molecular drug D0T0NG DRUGINCH 1S/C14H13ClN4O2/c1-2-7-18-13(20)11-12(17-8-16-11)19(14(18)21)10-5-3-9(15)4-6-10/h3-6,8H,2,7H2,1H3,(H,16,17) D0T0NG DRUGINKE GVTLDPJNRVMCAL-UHFFFAOYSA-N D0T0NG DRUGSMIL CCCN1C(=O)C2=C(N=CN2)N(C1=O)C3=CC=C(C=C3)Cl D0T0NG HIGHSTAT Phase 3 D0T1WY DRUG__ID D0T1WY D0T1WY DRUGCOMP Bukwang; Eisai D0T1WY DRUGTYPE Small molecular drug D0T1WY DRUGINCH 1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m0/s1 D0T1WY DRUGINKE GBBJCSTXCAQSSJ-XQXXSGGOSA-N D0T1WY DRUGSMIL CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F D0T1WY HIGHSTAT Phase 3 D0T5DP DRUG__ID D0T5DP D0T5DP DRUGCOMP AstraZeneca D0T5DP DRUGTYPE Small molecular drug D0T5DP DRUGINCH 1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) D0T5DP DRUGINKE CYOHGALHFOKKQC-UHFFFAOYSA-N D0T5DP DRUGSMIL CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO D0T5DP HIGHSTAT Phase 3 D0T6TW DRUG__ID D0T6TW D0T6TW DRUGCOMP Theravance; GlaxoSmithKline D0T6TW DRUGTYPE Small molecular drug D0T6TW DRUGINCH 1S/C9H18N2OS/c1-3-7(2)8(10)9(12)11-4-5-13-6-11/h7-8H,3-6,10H2,1-2H3/p+1/t7-,8-/m0/s1 D0T6TW DRUGINKE WCRLBFHWFPELKW-YUMQZZPRSA-O D0T6TW DRUGSMIL CCC(C)C(C(=O)N1CCSC1)[NH3+] D0T6TW HIGHSTAT Phase 3 D0T7GV DRUG__ID D0T7GV D0T7GV DRUGCOMP Ponaird Pharmaceuticals D0T7GV DRUGTYPE Small molecular drug D0T7GV DRUGINCH 1S/C6H7N.2ClH.H3N.Pt/c1-6-4-2-3-5-7-6;;;;/h2-5H,1H3;2*1H;1H3;/q;;;;+2/p-2 D0T7GV DRUGINKE IIMIOEBMYPRQGU-UHFFFAOYSA-L D0T7GV DRUGSMIL CC1=CC=CC=N1.N.[Cl-].[Cl-].[Pt+2] D0T7GV HIGHSTAT Phase 3 D0U1VZ DRUG__ID D0U1VZ D0U1VZ DRUGCOMP Lantheus medical imaging D0U1VZ DRUGTYPE Small molecular drug D0U1VZ DRUGINCH 1S/C18H22ClFN2O3/c1-18(2,3)22-17(23)16(19)15(10-21-22)25-12-14-6-4-13(5-7-14)11-24-9-8-20/h4-7,10H,8-9,11-12H2,1-3H3/i20-1 D0U1VZ DRUGINKE RMXZKEPDYBTFOS-LRFGSCOBSA-N D0U1VZ DRUGSMIL CC(C)(C)N1C(=O)C(=C(C=N1)OCC2=CC=C(C=C2)COCCF)Cl D0U1VZ HIGHSTAT Phase 3 D0U2BH DRUG__ID D0U2BH D0U2BH DRUGCOMP Anagen Therapeutics Inc; Enzo Life Sciences D0U2BH DRUGTYPE Small molecular drug D0U2BH DRUGINCH 1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1 D0U2BH DRUGINKE WMBWREPUVVBILR-WIYYLYMNSA-N D0U2BH DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O D0U2BH HIGHSTAT Phase 3 D0U3EP DRUG__ID D0U3EP D0U3EP DRUGCOMP Sirtris Pharma D0U3EP DRUGTYPE Small molecular drug D0U3EP DRUGINCH 1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ D0U3EP DRUGINKE LUKBXSAWLPMMSZ-OWOJBTEDSA-N D0U3EP DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O D0U3EP HIGHSTAT Phase 3 D0U3RV DRUG__ID D0U3RV D0U3RV DRUGCOMP Pharmacyclics D0U3RV DRUGTYPE Small molecular drug D0U3RV DRUGINCH 1S/C48H66N5O10.2C2H4O2.Lu.H2O/c1-7-35-36(8-2)40-28-42-38(12-10-14-55)34(4)46(53-42)32-50-44-30-48(63-26-24-61-22-20-59-18-16-57-6)47(62-25-23-60-21-19-58-17-15-56-5)29-43(44)49-31-45-33(3)37(11-9-13-54)41(52-45)27-39(35)51-40;2*1-2(3)4;;/h27-32,54-55H,7-26H2,1-6H3;2*1H3,(H,3,4);;1H2/q-1;;;+3;/p-2 D0U3RV DRUGINKE WIQKYZYFTAEWBF-UHFFFAOYSA-L D0U3RV DRUGSMIL CCC1=C(C2=CC3=NC(=CN=C4C=C(C(=CC4=NC=C5C(=C(C(=N5)C=C1[N-]2)CCCO)C)OCCOCCOCCOC)OCCOCCOCCOC)C(=C3CCCO)C)CC.CC(=O)[O-].CC(=O)[O-].O.[Lu+3] D0U3RV HIGHSTAT Phase 3 D0U5OU DRUG__ID D0U5OU D0U5OU DRUGCOMP NicOx SA D0U5OU DRUGTYPE Small molecular drug D0U5OU DRUGINCH 1S/C18H21NO6/c1-13(18(20)24-9-3-4-10-25-19(21)22)14-5-6-16-12-17(23-2)8-7-15(16)11-14/h5-8,11-13H,3-4,9-10H2,1-2H3/t13-/m0/s1 D0U5OU DRUGINKE AKFJWRDCWYYTIG-ZDUSSCGKSA-N D0U5OU DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OCCCCO[N+](=O)[O-] D0U5OU HIGHSTAT Phase 3 D0UI3T DRUG__ID D0UI3T D0UI3T DRUGCOMP Abbott Laboratories Abbott; Neurocrine Biosciences D0UI3T DRUGTYPE Small molecular drug D0UI3T DRUGINCH 1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1 D0UI3T DRUGINKE HEAUOKZIVMZVQL-VWLOTQADSA-N D0UI3T DRUGSMIL CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F D0UI3T HIGHSTAT Phase 3 D0UP1Z DRUG__ID D0UP1Z D0UP1Z DRUGCOMP Genentech D0UP1Z DRUGTYPE Small molecular drug D0UP1Z DRUGINCH 1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33) D0UP1Z DRUGINKE BEUQXVWXFDOSAQ-UHFFFAOYSA-N D0UP1Z DRUGSMIL CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C D0UP1Z HIGHSTAT Phase 3 D0V0DI DRUG__ID D0V0DI D0V0DI DRUGCOMP Cell Therapeutics D0V0DI DRUGTYPE Small molecular drug D0V0DI DRUGINCH 1S/C30H55N5O3/c1-4-5-6-7-8-9-10-13-16-19-22-31-24-26(36)21-18-15-12-11-14-17-20-23-35-29(37)27-28(32-25-33(27)2)34(3)30(35)38/h25-26,31,36H,4-24H2,1-3H3 D0V0DI DRUGINKE MZNMZWZGUGFQJP-UHFFFAOYSA-N D0V0DI DRUGSMIL CCCCCCCCCCCCNCC(CCCCCCCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O D0V0DI HIGHSTAT Phase 3 D0V0SL DRUG__ID D0V0SL D0V0SL DRUGCOMP Pharmacyclics D0V0SL DRUGTYPE Small molecular drug D0V0SL DRUGINCH 1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25) D0V0SL DRUGINKE MAUCONCHVWBMHK-UHFFFAOYSA-N D0V0SL DRUGSMIL CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO D0V0SL HIGHSTAT Phase 3 D0V1WQ DRUG__ID D0V1WQ D0V1WQ DRUGCOMP Takeda Pharmaceuticals U.S.A. D0V1WQ DRUGTYPE Small molecular drug D0V1WQ DRUGINCH 1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1 D0V1WQ DRUGINKE BZCALJIHZVNMGJ-HSZRJFAPSA-N D0V1WQ DRUGSMIL CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C D0V1WQ HIGHSTAT Phase 3 D0VA4Y DRUG__ID D0VA4Y D0VA4Y DRUGCOMP Vivus D0VA4Y DRUGTYPE Small molecular drug D0VA4Y DRUGINCH 1S/C12H21NO8S.C10H15N/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12;1-10(2,11)8-9-6-4-3-5-7-9/h7-9H,5-6H2,1-4H3,(H2,13,14,15);3-7H,8,11H2,1-2H3/t7-,8-,9?,12+;/m1./s1 D0VA4Y DRUGINKE PWDLDBWXTVILPC-QGGVPXFVSA-N D0VA4Y DRUGSMIL CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C.CC(C)(CC1=CC=CC=C1)N D0VA4Y HIGHSTAT Phase 3 D0VU5M DRUG__ID D0VU5M D0VU5M DRUGCOMP Takeda Pharmaceutical Co Ltd D0VU5M DRUGTYPE Small molecular drug D0VU5M DRUGINCH 1S/C28H26N2O5/c1-20-26(29-28(35-20)23-10-6-3-7-11-23)19-33-24-14-12-21(13-15-24)18-34-30-25(16-17-27(31)32)22-8-4-2-5-9-22/h2-15H,16-19H2,1H3,(H,31,32)/b30-25+ D0VU5M DRUGINKE ULVDFHLHKNJICZ-QCWLDUFUSA-N D0VU5M DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)COC3=CC=C(C=C3)CON=C(CCC(=O)O)C4=CC=CC=C4 D0VU5M HIGHSTAT Phase 3 D0W0SM DRUG__ID D0W0SM D0W0SM DRUGCOMP CytRx Corp D0W0SM DRUGTYPE Small molecular drug D0W0SM DRUGINCH 1S/C3H6O.C2H4O/c1-3-2-4-3;1-2-3-1/h3H,2H2,1H3;1-2H2 D0W0SM DRUGINKE RVGRUAULSDPKGF-UHFFFAOYSA-N D0W0SM DRUGSMIL CC1CO1.C1CO1 D0W0SM HIGHSTAT Phase 3 D0W2CX DRUG__ID D0W2CX D0W2CX DRUGCOMP CG Pharmaceuticals D0W2CX DRUGTYPE Small molecular drug D0W2CX DRUGINCH 1S/C18H16FNO4S/c1-18(2)17(21)15(12-4-3-5-13(19)10-12)16(24-18)11-6-8-14(9-7-11)25(20,22)23/h3-10H,1-2H3,(H2,20,22,23) D0W2CX DRUGINKE IJWPAFMIFNSIGD-UHFFFAOYSA-N D0W2CX DRUGSMIL CC1(C(=O)C(=C(O1)C2=CC=C(C=C2)S(=O)(=O)N)C3=CC(=CC=C3)F)C D0W2CX HIGHSTAT Phase 3 D0W2FZ DRUG__ID D0W2FZ D0W2FZ DRUGCOMP Cempra pharmaceuticals D0W2FZ DRUGTYPE Small molecular drug D0W2FZ DRUGINCH 1S/C43H65FN6O10/c1-12-32-43(8)35(50(40(55)60-43)19-14-13-18-49-23-30(46-47-49)28-16-15-17-29(45)21-28)26(4)33(51)24(2)22-41(6,56-11)37(27(5)36(53)42(7,44)39(54)58-32)59-38-34(52)31(48(9)10)20-25(3)57-38/h15-17,21,23-27,31-32,34-35,37-38,52H,12-14,18-20,22,45H2,1-11H3/t24-,25-,26+,27+,31+,32-,34-,35-,37-,38+,41-,42+,43-/m1/s1 D0W2FZ DRUGINKE IXXFZUPTQVDPPK-ZAWHAJPISA-N D0W2FZ DRUGSMIL CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)(C)F)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=N4)C5=CC(=CC=C5)N)C D0W2FZ HIGHSTAT Phase 3 D0W4NM DRUG__ID D0W4NM D0W4NM DRUGCOMP Canopus BioPharma Inc D0W4NM DRUGTYPE Small molecular drug D0W4NM DRUGINCH 1S/C8H6N2S3/c1-5-7(12-13-8(5)11)6-4-9-2-3-10-6/h2-4H,1H3 D0W4NM DRUGINKE CKNAQFVBEHDJQV-UHFFFAOYSA-N D0W4NM DRUGSMIL CC1=C(SSC1=S)C2=NC=CN=C2 D0W4NM HIGHSTAT Phase 3 D0W5LC DRUG__ID D0W5LC D0W5LC DRUGCOMP Cephalon D0W5LC DRUGTYPE Small molecular drug D0W5LC DRUGINCH 1S/C117H181N34O32PS/c1-9-64(5)94(148-99(163)75(120)24-18-47-128-115(121)122)112(176)144-85(56-71-57-127-62-132-71)106(170)139-80(44-51-185-8)103(167)147-93(63(3)4)110(174)143-83(54-69-32-38-73(154)39-33-69)105(169)146-87(60-152)108(172)138-78(25-14-16-45-118)101(165)137-76(27-19-48-129-116(123)124)96(160)97(161)88(150-184(180,181)182)61-183-133-59-91(157)135-81(26-15-17-46-119)113(177)151-50-21-29-89(151)109(173)140-77(28-20-49-130-117(125)126)100(164)131-58-90(156)136-82(53-68-30-36-72(153)37-31-68)104(168)134-66(7)98(162)142-84(52-67-22-12-11-13-23-67)107(171)149-95(65(6)10-2)111(175)141-79(42-43-92(158)159)102(166)145-86(114(178)179)55-70-34-40-74(155)41-35-70/h11-13,22-23,30-41,57,62-66,75-89,93-95,133,152-155H,9-10,14-21,24-29,42-56,58-61,118-120H2,1-8H3,(H,127,132)(H,131,164)(H,134,168)(H,135,157)(H,136,156)(H,137,165)(H,138,172)(H,139,170)(H,140,173)(H,141,175)(H,142,162)(H,143,174)(H,144,176)(H,145,166)(H,146,169)(H,147,167)(H,148,163)(H,149,171)(H,158,159)(H,178,179)(H4,121,122,128)(H4,123,124,129)(H4,125,126,130)(H3,150,180,181,182)/t64-,65-,66-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,93-,94-,95-/m0/s1 D0W5LC DRUGINKE LSLBZWAEEUGETG-GGVFYUGVSA-N D0W5LC DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)NC(CCSC)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)C(=O)C(CONCC(=O)NC(CCCCN)C(=O)N3CCCC3C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)O)NP(=O)(O)O)NC(=O)C(CCCNC(=N)N)N D0W5LC HIGHSTAT Phase 3 D0W5NW DRUG__ID D0W5NW D0W5NW DRUGCOMP Chimerix D0W5NW DRUGTYPE Small molecular drug D0W5NW DRUGINCH 1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1 D0W5NW DRUGINKE WXJFKKQWPMNTIM-VWLOTQADSA-N D0W5NW DRUGSMIL CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O D0W5NW HIGHSTAT Phase 3 D0W6BS DRUG__ID D0W6BS D0W6BS DRUGCOMP Paligent Inc D0W6BS DRUGTYPE Small molecular drug D0W6BS DRUGINCH 1S/C10H8O3S.CH2O/c11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10;1-2/h1-7H,(H,11,12,13);1H2 D0W6BS DRUGINKE RRDQTXGFURAKDI-UHFFFAOYSA-N D0W6BS DRUGSMIL C=O.C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O D0W6BS HIGHSTAT Phase 3 D0WF7K DRUG__ID D0WF7K D0WF7K THERCLAS Antihypertensive Agents D0WF7K DRUGTYPE Small molecular drug D0WF7K DRUGINCH 1S/C29H41NO7/c1-35-15-16-36-19-23(27(33)37-25-12-9-20-5-4-6-22(20)17-25)18-29(13-2-3-14-29)28(34)30-24-10-7-21(8-11-24)26(31)32/h9,12,17,21,23-24H,2-8,10-11,13-16,18-19H2,1H3,(H,30,34)(H,31,32)/t21?,23-,24?/m0/s1 D0WF7K DRUGINKE ZTWZVMIYIIVABD-RZMWZJFBSA-N D0WF7K DRUGSMIL COCCOCC(CC1(CCCC1)C(=O)NC2CCC(CC2)C(=O)O)C(=O)OC3=CC4=C(CCC4)C=C3 D0WF7K HIGHSTAT Phase 3 D0X0IY DRUG__ID D0X0IY D0X0IY DRUGCOMP Merck D0X0IY DRUGTYPE Small molecular drug D0X0IY DRUGINCH 1S/C20H28N4O2/c1-3-5-23-16-15(17(25)24(6-4-2)19(23)26)21-18(22-16)20-10-12-7-13(11-20)9-14(20)8-12/h12-14H,3-11H2,1-2H3,(H,21,22) D0X0IY DRUGINKE PJBFVWGQFLYWCB-UHFFFAOYSA-N D0X0IY DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5 D0X0IY HIGHSTAT Phase 3 D0X0KM DRUG__ID D0X0KM D0X0KM DRUGCOMP Eli Lilly & Co D0X0KM DRUGTYPE Small molecular drug D0X0KM DRUGINCH 1S/C11H6BrCl2NO3S2/c12-9-3-4-10(19-9)20(17,18)15-11(16)7-2-1-6(13)5-8(7)14/h1-5H,(H,15,16) D0X0KM DRUGINKE WWONFUQGBVOKOF-UHFFFAOYSA-N D0X0KM DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br D0X0KM HIGHSTAT Phase 3 D0X1VJ DRUG__ID D0X1VJ D0X1VJ DRUGCOMP AtheroGenics D0X1VJ DRUGTYPE Small molecular drug D0X1VJ DRUGINCH 1S/C35H52O5S2/c1-31(2,3)23-17-21(18-24(29(23)39)32(4,5)6)41-35(13,14)42-22-19-25(33(7,8)9)30(26(20-22)34(10,11)12)40-28(38)16-15-27(36)37/h17-20,39H,15-16H2,1-14H3,(H,36,37) D0X1VJ DRUGINKE RKSMVPNZHBRNNS-UHFFFAOYSA-N D0X1VJ DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)OC(=O)CCC(=O)O)C(C)(C)C D0X1VJ HIGHSTAT Phase 3 D0X3OI DRUG__ID D0X3OI D0X3OI DRUGCOMP Millennium Pharmaceuticals D0X3OI DRUGTYPE Small molecular drug D0X3OI DRUGINCH 1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22) D0X3OI DRUGINKE OZPFIJIOIVJZMN-UHFFFAOYSA-N D0X3OI DRUGSMIL CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O D0X3OI HIGHSTAT Phase 3 D0X4DB DRUG__ID D0X4DB D0X4DB DRUGCOMP GlaxoSmithKline D0X4DB DRUGTYPE Antisense drug D0X4DB DRUGINCH 1S/C211H275N76O119P19S19/c1-329-136-116(295)77(369-178(136)271-33-24-99(289)252-206(271)304)40-349-407(310,426)389-118-79(371-180(138(118)331-3)268-30-21-96(212)249-203(268)301)42-351-409(312,428)392-121-81(373-183(141(121)334-6)273-35-26-101(291)254-208(273)306)44-352-410(313,429)393-122-82(374-184(142(122)335-7)274-36-27-102(292)255-209(274)307)45-353-411(314,430)394-123-83(375-185(143(123)336-8)275-37-28-103(293)256-210(275)308)46-355-415(318,434)396-125-85(377-187(145(125)338-10)277-65-238-105-156(215)226-59-232-162(105)277)48-358-413(316,432)391-120-80(372-182(140(120)333-5)270-32-23-98(214)251-205(270)303)43-354-417(320,436)402-131-94(386-193(151(131)344-16)283-71-244-111-168(283)258-198(221)263-173(111)296)57-366-424(327,443)405-132-91(383-194(152(132)345-17)284-72-245-112-169(284)259-199(222)264-174(112)297)54-363-414(317,433)395-124-84(376-186(144(124)337-9)276-38-29-104(294)257-211(276)309)47-356-416(319,435)397-126-89(381-188(146(126)339-11)278-66-239-106-157(216)227-60-233-163(106)278)52-361-422(325,441)403-133-92(384-195(153(133)346-18)285-73-246-113-170(285)260-200(223)265-175(113)298)55-364-420(323,439)400-130-88(380-192(150(130)343-15)282-70-243-110-161(220)231-64-237-167(110)282)51-360-419(322,438)399-128-90(382-190(148(128)341-13)280-68-241-108-159(218)229-62-235-165(108)280)53-362-423(326,442)404-134-95(387-196(154(134)347-19)286-74-247-114-171(286)261-201(224)266-176(114)299)58-367-425(328,444)406-135-93(385-197(155(135)348-20)287-75-248-115-172(287)262-202(225)267-177(115)300)56-365-421(324,440)401-129-87(379-191(149(129)342-14)281-69-242-109-160(219)230-63-236-166(109)281)50-359-418(321,437)398-127-86(378-189(147(127)340-12)279-67-240-107-158(217)228-61-234-164(107)279)49-357-412(315,431)390-119-78(370-181(139(119)332-4)269-31-22-97(213)250-204(269)302)41-350-408(311,427)388-117-76(39-288)368-179(137(117)330-2)272-34-25-100(290)253-207(272)305/h21-38,59-95,116-155,178-197,288,295H,39-58H2,1-20H3,(H,310,426)(H,311,427)(H,312,428)(H,313,429)(H,314,430)(H,315,431)(H,316,432)(H,317,433)(H,318,434)(H,319,435)(H,320,436)(H,321,437)(H,322,438)(H,323,439)(H,324,440)(H,325,441)(H,326,442)(H,327,443)(H,328,444)(H2,212,249,301)(H2,213,250,302)(H2,214,251,303)(H2,215,226,232)(H2,216,227,233)(H2,217,228,234)(H2,218,229,235)(H2,219,230,236)(H2,220,231,237)(H,252,289,304)(H,253,290,305)(H,254,291,306)(H,255,292,307)(H,256,293,308)(H,257,294,309)(H3,221,258,263,296)(H3,222,259,264,297)(H3,223,260,265,298)(H3,224,261,266,299)(H3,225,262,267,300)/t76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,407?,408?,409?,410?,411?,412?,413?,414?,415?,416?,417?,418?,419?,420?,421?,422?,423?,424?,425?/m1/s1 D0X4DB DRUGINKE HUGILZFVSVLCAO-XVKRXUDYSA-N D0X4DB DRUGSMIL COC1C(C(OC1N2C=CC(=O)NC2=O)COP(=S)(O)OC3C(OC(C3OC)N4C=CC(=NC4=O)N)COP(=S)(O)OC5C(OC(C5OC)N6C=CC(=O)NC6=O)COP(=S)(O)OC7C(OC(C7OC)N8C=CC(=O)NC8=O)COP(=S)(O)OC9C(OC(C9OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=O)(OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)CO)S)O D0X4DB HIGHSTAT Phase 3 D0X5AN DRUG__ID D0X5AN D0X5AN DRUGCOMP Sanofi us D0X5AN DRUGTYPE Small molecular drug D0X5AN DRUGINCH 1S/C8H6N2O6/c1-16-8(11)5-2-6(9(12)13)4-7(3-5)10(14)15/h2-4H,1H3 D0X5AN DRUGINKE POGCCFLNFPIIGW-UHFFFAOYSA-N D0X5AN DRUGSMIL COC(=O)C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-] D0X5AN HIGHSTAT Phase 3 D0X6BX DRUG__ID D0X6BX D0X6BX DRUGCOMP Apogee Biotechnology D0X6BX DRUGTYPE Small molecular drug D0X6BX DRUGINCH 1S/C23H25ClN2O/c24-20-3-1-19(2-4-20)22-10-17-9-18(11-22)13-23(12-17,15-22)21(27)26-14-16-5-7-25-8-6-16/h1-8,17-18H,9-15H2,(H,26,27) D0X6BX DRUGINKE CAOTVXGYTWCKQE-UHFFFAOYSA-N D0X6BX DRUGSMIL C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl D0X6BX HIGHSTAT Phase 3 D0X8TS DRUG__ID D0X8TS D0X8TS DRUGCOMP RadioRx D0X8TS DRUGTYPE Small molecular drug D0X8TS DRUGINCH 1S/C5H6BrN3O5/c6-1-4(10)7-2-5(3-7,8(11)12)9(13)14/h1-3H2 D0X8TS DRUGINKE JODKFOVZURLVTG-UHFFFAOYSA-N D0X8TS DRUGSMIL C1C(CN1C(=O)CBr)([N+](=O)[O-])[N+](=O)[O-] D0X8TS HIGHSTAT Phase 3 D0X8VV DRUG__ID D0X8VV D0X8VV DRUGCOMP VUFB D0X8VV DRUGTYPE Small molecular drug D0X8VV DRUGINCH 1S/C17H14F2O3/c1-10(17(21)22)8-16(20)12-4-2-11(3-5-12)14-7-6-13(18)9-15(14)19/h2-7,9-10H,8H2,1H3,(H,21,22) D0X8VV DRUGINKE FIKVYIRIUOFLLR-UHFFFAOYSA-N D0X8VV DRUGSMIL CC(CC(=O)C1=CC=C(C=C1)C2=C(C=C(C=C2)F)F)C(=O)O D0X8VV HIGHSTAT Phase 3 D0XB0T DRUG__ID D0XB0T D0XB0T DRUGCOMP EndoCeutics D0XB0T DRUGTYPE Small molecular drug D0XB0T DRUGINCH 1S/C29H31NO4/c1-20-26-14-11-24(32)19-27(26)34-29(28(20)21-5-9-23(31)10-6-21)22-7-12-25(13-8-22)33-18-17-30-15-3-2-4-16-30/h5-14,19,29,31-32H,2-4,15-18H2,1H3/t29-/m0/s1 D0XB0T DRUGINKE DUYNJNWVGIWJRI-LJAQVGFWSA-N D0XB0T DRUGSMIL CC1=C(C(OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O D0XB0T HIGHSTAT Phase 3 D0XD5A DRUG__ID D0XD5A D0XD5A DRUGCOMP Exoxemis D0XD5A DRUGTYPE Small molecular drug D0XD5A DRUGINCH 1S/C17H25ClN2O3.ClH/c1-4-12-8-13(18)16(23-3)14(15(12)21)17(22)19-9-11-6-7-20(5-2)10-11;/h8,11,21H,4-7,9-10H2,1-3H3,(H,19,22);1H/t11-;/m0./s1 D0XD5A DRUGINKE RDZXYWICCLALQM-MERQFXBCSA-N D0XD5A DRUGSMIL CCC1=CC(=C(C(=C1O)C(=O)NCC2CCN(C2)CC)OC)Cl.Cl D0XD5A HIGHSTAT Phase 3 D0XM4G DRUG__ID D0XM4G D0XM4G DRUGCOMP Angelini Pharmaceuticals SpA D0XM4G DRUGTYPE Small molecular drug D0XM4G DRUGINCH 1S/C19H20N2O3/c1-19(2,18(22)23)24-13-16-15-10-6-7-11-17(15)21(20-16)12-14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3,(H,22,23) D0XM4G DRUGINKE MTHORRSSURHQPZ-UHFFFAOYSA-N D0XM4G DRUGSMIL CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3 D0XM4G HIGHSTAT Phase 3 D0XS4X DRUG__ID D0XS4X D0XS4X DRUGCOMP The Menarini Group D0XS4X DRUGTYPE Small molecular drug D0XS4X DRUGINCH 1S/C37H48N4O4S/c1-26-9-10-30-23-33(46-32(30)21-26)35(43)40-37(15-5-6-16-37)36(44)39-31(22-27-7-3-2-4-8-27)34(42)38-24-28-11-17-41(18-12-28)25-29-13-19-45-20-14-29/h2-4,7-10,21,23,28-29,31H,5-6,11-20,22,24-25H2,1H3,(H,38,42)(H,39,44)(H,40,43)/t31-/m1/s1 D0XS4X DRUGINKE YQYSVMKCMIUCHY-WJOKGBTCSA-N D0XS4X DRUGSMIL CC1=CC2=C(C=C1)C=C(S2)C(=O)NC3(CCCC3)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC5CCN(CC5)CC6CCOCC6 D0XS4X HIGHSTAT Phase 3 D0Y1FO DRUG__ID D0Y1FO D0Y1FO DRUGCOMP SuperGen; Clayton Foundation For Research; MD Anderson Cancer Center D0Y1FO DRUGTYPE Small molecular drug D0Y1FO DRUGINCH 1S/C20H15N3O6/c1-2-20(26)13-7-16-17-10(8-22(16)18(24)12(13)9-29-19(20)25)6-11-14(21-17)4-3-5-15(11)23(27)28/h3-7,26H,2,8-9H2,1H3/t20-/m0/s1 D0Y1FO DRUGINKE VHXNKPBCCMUMSW-FQEVSTJZSA-N D0Y1FO DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O D0Y1FO HIGHSTAT Phase 3 D0Y1RN DRUG__ID D0Y1RN D0Y1RN DRUGCOMP Accera D0Y1RN DRUGTYPE Small molecular drug D0Y1RN DRUGINCH 1S/C8H9N.ClH/c1-2-4-8-6-9-5-7(8)3-1;/h1-4,9H,5-6H2;1H D0Y1RN DRUGINKE NOVIRODZMIZUPA-UHFFFAOYSA-N D0Y1RN DRUGSMIL C1C2=CC=CC=C2CN1.Cl D0Y1RN HIGHSTAT Phase 3 D0Y2JM DRUG__ID D0Y2JM D0Y2JM DRUGCOMP Rockwell Medical Inc D0Y2JM DRUGTYPE Small molecular drug D0Y2JM DRUGINCH 1S/4Fe.3H4O7P2/c;;;;3*1-8(2,3)7-9(4,5)6/h;;;;3*(H2,1,2,3)(H2,4,5,6)/q4*+3;;;/p-12 D0Y2JM DRUGINKE CADNYOZXMIKYPR-UHFFFAOYSA-B D0Y2JM DRUGSMIL [O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[O-]P(=O)([O-])OP(=O)([O-])[O-].[Fe+3].[Fe+3].[Fe+3].[Fe+3] D0Y2JM HIGHSTAT Phase 3 D0Y3ZP DRUG__ID D0Y3ZP D0Y3ZP DRUGCOMP Pharmacia & Upjohn AB D0Y3ZP DRUGTYPE Small molecular drug D0Y3ZP DRUGINCH 1S/C20H27N/c1-16(21-20(2,3)4)15-19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,16,19,21H,15H2,1-4H3 D0Y3ZP DRUGINKE UISARWKNNNHPGI-UHFFFAOYSA-N D0Y3ZP DRUGSMIL CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C D0Y3ZP HIGHSTAT Phase 3 D0Y6MH DRUG__ID D0Y6MH D0Y6MH DRUGCOMP Sanofi-Aventis D0Y6MH DRUGTYPE Small molecular drug D0Y6MH DRUGINCH 1S/C16H21N3O4S2/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)25-9-5-18(6-9)16-17-3-4-24-16/h7-11,20H,3-6H2,1-2H3,(H,22,23)/t7-,8-,10-,11-/m1/s1 D0Y6MH DRUGINKE GXXLUDOKHXEFBQ-YJFSRANCSA-N D0Y6MH DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)C(C)O D0Y6MH HIGHSTAT Phase 3 D0Y6UU DRUG__ID D0Y6UU D0Y6UU DRUGCOMP Abbott D0Y6UU DRUGTYPE Small molecular drug D0Y6UU DRUGINCH 1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1 D0Y6UU DRUGINKE MOTJMGVDPWRKOC-QPVYNBJUSA-N D0Y6UU DRUGSMIL CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4 D0Y6UU HIGHSTAT Phase 3 D0Y9RO DRUG__ID D0Y9RO D0Y9RO DRUGCOMP Pharmos D0Y9RO DRUGTYPE Small molecular drug D0Y9RO DRUGINCH 1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m0/s1 D0Y9RO DRUGINKE SSQJFGMEZBFMNV-PMACEKPBSA-N D0Y9RO DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O D0Y9RO HIGHSTAT Phase 3 D0YL8U DRUG__ID D0YL8U D0YL8U DRUGCOMP Amgen D0YL8U DRUGTYPE Small molecular drug D0YL8U DRUGINCH 1S/C20H24FN5O3/c1-14-6-7-16(12-22-14)23-19(27)24-17-5-3-4-15(18(17)21)13-25-8-10-26(11-9-25)20(28)29-2/h3-7,12H,8-11,13H2,1-2H3,(H2,23,24,27) D0YL8U DRUGINKE RFUBTTPMWSKEIW-UHFFFAOYSA-N D0YL8U DRUGSMIL CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC D0YL8U HIGHSTAT Phase 3 D0YS2W DRUG__ID D0YS2W D0YS2W DRUGCOMP Pearl Therapeutics D0YS2W DRUGTYPE Small molecular drug D0YS2W DRUGINCH 1S/2C19H24N2O4.C4H4O4.H2O/c2*1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-3(6)1-2-4(7)8;/h2*3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2H,(H,5,6)(H,7,8);1H2/b;;2-1+;/t2*13-,19+;;/m11../s1 D0YS2W DRUGINKE BPXZSHHCUKRDHD-HTLUESNNSA-N D0YS2W DRUGSMIL CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(=CC(=O)O)C(=O)O.O D0YS2W HIGHSTAT Phase 3 D0Z1BQ DRUG__ID D0Z1BQ D0Z1BQ DRUGCOMP Eisai Co Ltd D0Z1BQ DRUGTYPE Small molecular drug D0Z1BQ DRUGINCH 1S/C20H25FN8O6S2/c1-3-29(2,7-11(22)30)6-4-5-10-8-36-18-13(17(32)28(18)14(10)19(33)34)24-16(31)12(26-35-9-21)15-25-20(23)37-27-15/h4-5,13,18H,3,6-9H2,1-2H3,(H5-,22,23,24,25,27,30,31,33,34)/b5-4+,26-12-/t13-,18-,29?/m1/s1 D0Z1BQ DRUGINKE XAKKNLNAJBNLPC-MAYKBZFQSA-N D0Z1BQ DRUGSMIL CC[N+](C)(CC=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCF)C3=NSC(=N3)N)SC1)C(=O)[O-])CC(=O)N D0Z1BQ HIGHSTAT Phase 3 D0Z1VU DRUG__ID D0Z1VU D0Z1VU DRUGCOMP Zafgen Inc D0Z1VU DRUGTYPE Small molecular drug D0Z1VU DRUGINCH 1S/2C29H41NO6.C2H2O4/c2*1-20(2)7-13-24-28(3,36-24)27-26(32-6)23(15-16-29(27)19-34-29)35-25(31)14-10-21-8-11-22(12-9-21)33-18-17-30(4)5;3-1(4)2(5)6/h2*7-12,14,23-24,26-27H,13,15-19H2,1-6H3;(H,3,4)(H,5,6)/b2*14-10+;/t2*23-,24-,26-,27-,28+,29+;/m11./s1 D0Z1VU DRUGINKE ZKEMUPZLDSXZCX-CEVDDVLHSA-N D0Z1VU DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC4=CC=C(C=C4)OCCN(C)C)OC)C.CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC4=CC=C(C=C4)OCCN(C)C)OC)C.C(=O)(C(=O)O)O D0Z1VU HIGHSTAT Phase 3 D0Z2MB DRUG__ID D0Z2MB D0Z2MB DRUGCOMP Solvay Pharma D0Z2MB DRUGTYPE Small molecular drug D0Z2MB DRUGINCH 1S/C20H21N3O/c1-13-21-9-11-22(13)12-15-7-8-17-18(20(15)24)16-6-2-4-14-5-3-10-23(17)19(14)16/h2,4,6,9,11,15H,3,5,7-8,10,12H2,1H3/t15-/m1/s1 D0Z2MB DRUGINKE NCNFDKWULDWJDS-OAHLLOKOSA-N D0Z2MB DRUGSMIL CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC5=C4N3CCC5 D0Z2MB HIGHSTAT Phase 3 D0Z2UW DRUG__ID D0Z2UW D0Z2UW DRUGCOMP Chugai Pharmaceutical D0Z2UW DRUGTYPE Small molecular drug D0Z2UW DRUGINCH 1S/C15H16N4O2/c1-11(19-15(21)13-5-3-7-17-10-13)8-18-14(20)12-4-2-6-16-9-12/h2-7,9-11H,8H2,1H3,(H,18,20)(H,19,21) D0Z2UW DRUGINKE KTXBOOWDLPUROC-UHFFFAOYSA-N D0Z2UW DRUGSMIL CC(CNC(=O)C1=CN=CC=C1)NC(=O)C2=CN=CC=C2 D0Z2UW HIGHSTAT Phase 3 D0Z5HR DRUG__ID D0Z5HR D0Z5HR DRUGCOMP Vertex Pharmaceuticals Inc D0Z5HR DRUGTYPE Small molecular drug D0Z5HR DRUGINCH 1S/C26H27F3N2O6/c1-24(2,13-33)22-8-14-7-18(17(27)10-19(14)31(22)11-16(34)12-32)30-23(35)25(5-6-25)15-3-4-20-21(9-15)37-26(28,29)36-20/h3-4,7-10,16,32-34H,5-6,11-13H2,1-2H3,(H,30,35)/t16-/m1/s1 D0Z5HR DRUGINKE MJUVRTYWUMPBTR-MRXNPFEDSA-N D0Z5HR DRUGSMIL CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F D0Z5HR HIGHSTAT Phase 3 D0Z7AB DRUG__ID D0Z7AB D0Z7AB DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0Z7AB DRUGTYPE Small molecular drug D0Z7AB DRUGINCH 1S/C19H22NO4S2.BrH/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15;/h3-8,11-13,16-17,22H,9-10H2,1-2H3;1H/q+1;/p-1/t11?,12-,13+,16-,17+; D0Z7AB DRUGINKE DQHNAVOVODVIMG-RGECMCKFSA-M D0Z7AB DRUGSMIL C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-] D0Z7AB HIGHSTAT Phase 3 D0ZD2M DRUG__ID D0ZD2M D0ZD2M DRUGCOMP Takeda D0ZD2M DRUGTYPE Small molecular drug D0ZD2M DRUGINCH 1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1 D0ZD2M DRUGINKE MPUQHZXIXSTTDU-QXGSTGNESA-N D0ZD2M DRUGSMIL C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N D0ZD2M HIGHSTAT Phase 3 D0ZD3C DRUG__ID D0ZD3C D0ZD3C DRUGCOMP LG Life Sciences Ltd D0ZD3C DRUGTYPE Small molecular drug D0ZD3C DRUGINCH 1S/C18H19F8N5O2/c19-16(20)3-1-12(32)31(8-16)6-9(27)5-13(33)30-4-2-10-11(7-30)28-15(18(24,25)26)29-14(10)17(21,22)23/h9H,1-8,27H2/t9-/m0/s1 D0ZD3C DRUGINKE ZWPRRQZNBDYKLH-VIFPVBQESA-N D0ZD3C DRUGSMIL C1CC(CN(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F D0ZD3C HIGHSTAT Phase 3 D0ZE1O DRUG__ID D0ZE1O D0ZE1O DRUGCOMP Nereus Pharmaceuticals D0ZE1O DRUGTYPE Small molecular drug D0ZE1O DRUGINCH 1S/C19H20N4O2/c1-19(2,3)16-13(20-11-21-16)10-15-18(25)22-14(17(24)23-15)9-12-7-5-4-6-8-12/h4-11H,1-3H3,(H,20,21)(H,22,25)(H,23,24)/b14-9-,15-10- D0ZE1O DRUGINKE UNRCMCRRFYFGFX-TYPNBTCFSA-N D0ZE1O DRUGSMIL CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2 D0ZE1O HIGHSTAT Phase 3 D0ZI1F DRUG__ID D0ZI1F D0ZI1F DRUGCOMP ArQule; Daiichi Sankyo D0ZI1F DRUGTYPE Small molecular drug D0ZI1F DRUGINCH 1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1 D0ZI1F DRUGINKE UCEQXRCJXIVODC-PMACEKPBSA-N D0ZI1F DRUGSMIL C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65 D0ZI1F HIGHSTAT Phase 3 D1MEH5 DRUG__ID D1MEH5 D1MEH5 DRUGCOMP Allecra Therapeutics D1MEH5 DRUGTYPE Small molecular drug D1MEH5 DRUGINCH 1S/C11H14N4O5S/c1-11(6-14-4-3-13(2)12-14)9(10(17)18)15-7(16)5-8(15)21(11,19)20/h3-4,8-9H,5-6H2,1-2H3/t8-,9+,11+/m1/s1 D1MEH5 DRUGINKE HFZITXBUTWITPT-YWVKMMECSA-N D1MEH5 DRUGSMIL CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])CN3C=C[N+](=N3)C D1MEH5 HIGHSTAT Phase 3 D1OM8E DRUG__ID D1OM8E D1OM8E DRUGCOMP AriBio D1OM8E DRUGTYPE Small molecule D1OM8E DRUGINCH InChI=1S/C8H11N/c1-9-7-8-5-3-2-4-6-8/h2-6,9H,7H2,1H3 D1OM8E DRUGINKE RIWRFSMVIUAEBX-UHFFFAOYSA-N D1OM8E DRUGSMIL CNCC1=CC=CC=C1 D1OM8E HIGHSTAT Phase 3 D2HD0V DRUG__ID D2HD0V D2HD0V DRUGCOMP Bayer D2HD0V DRUGTYPE Small molecule D2HD0V DRUGINCH InChI=1S/C26H21ClF4N6O4/c1-3-19(25(40)33-14-5-6-15(24(32)39)18(28)9-14)36-11-21(41-2)17(10-23(36)38)16-8-13(27)4-7-20(16)37-12-22(34-35-37)26(29,30)31/h4-12,19H,3H2,1-2H3,(H2,32,39)(H,33,40)/t19-/m0/s1 D2HD0V DRUGINKE XYWIPYBIIRTJMM-IBGZPJMESA-N D2HD0V DRUGSMIL CCC(C(=O)NC1=CC(=C(C=C1)C(=O)N)F)N2C=C(C(=CC2=O)C3=C(C=CC(=C3)Cl)N4C=C(N=N4)C(F)(F)F)OC D2HD0V HIGHSTAT Phase 3 D32XRQ DRUG__ID D32XRQ D32XRQ DRUGCOMP Bayer D32XRQ DRUGTYPE Small molecular drug D32XRQ DRUGINCH 1S/C13H14N8O2/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19/h1-2,7-9,17H,3-6H2 D32XRQ DRUGINKE IJMBOKOTALXLKS-UHFFFAOYSA-N D32XRQ DRUGSMIL C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4 D32XRQ HIGHSTAT Phase 3 D37IQM DRUG__ID D37IQM D37IQM DRUGCOMP Novartis D37IQM DRUGTYPE Small molecule D37IQM DRUGINCH InChI=1S/C29H28ClN7O/c1-5-24(38)36-14-29(15-36)10-20(11-29)37-17(3)25(26-21-13-31-33-22(21)8-16(2)27(26)30)28(34-37)18-6-7-23-19(9-18)12-32-35(23)4/h5-9,12-13,20H,1,10-11,14-15H2,2-4H3,(H,31,33) D37IQM DRUGINKE AZUYLZMQTIKGSC-UHFFFAOYSA-N D37IQM DRUGSMIL CC1=CC2=C(C=NN2)C(=C1Cl)C3=C(N(N=C3C4=CC5=C(C=C4)N(N=C5)C)C6CC7(C6)CN(C7)C(=O)C=C)C D37IQM HIGHSTAT Phase 3 D3NLJ9 DRUG__ID D3NLJ9 D3NLJ9 DRUGCOMP Soligenix D3NLJ9 DRUGTYPE Peptide D3NLJ9 DRUGINCH 1S/C25H47N9O5/c1-6-14(4)19(33-21(36)16(26)9-7-11-30-25(28)29)23(38)32-18(13(2)3)24(39)34-12-8-10-17(34)22(37)31-15(5)20(27)35/h13-19H,6-12,26H2,1-5H3,(H2,27,35)(H,31,37)(H,32,38)(H,33,36)(H4,28,29,30)/t14-,15-,16-,17-,18-,19-/m0/s1 D3NLJ9 DRUGINKE ZUJBBVJXXYRPFS-DYKIIFRCSA-N D3NLJ9 DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCN=C(N)N)N D3NLJ9 HIGHSTAT Phase 3 D3TW7I DRUG__ID D3TW7I D3TW7I DRUGCOMP TB D3TW7I DRUGTYPE Small molecule D3TW7I DRUGINCH InChI=1S/C34H33ClN2O2/c1-37(2)21-20-34(38,31-15-9-13-25-10-7-8-14-29(25)31)32(26-11-5-4-6-12-26)30-22-27(23-36-33(30)39-3)24-16-18-28(35)19-17-24/h4-19,22-23,32,38H,20-21H2,1-3H3/t32-,34-/m1/s1 D3TW7I DRUGINKE MMUCHWPQRGEHDV-ZFEZZJPFSA-N D3TW7I DRUGSMIL CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=CC(=C4)C5=CC=C(C=C5)Cl)OC)O D3TW7I HIGHSTAT Phase 3 D4H2CP DRUG__ID D4H2CP D4H2CP DRUGCOMP Basilea Pharmaceutica D4H2CP DRUGTYPE Small molecular drug D4H2CP DRUGINCH 1S/C26H26N8O11S2/c1-10-14(45-26(41)44-10)8-43-25(40)32-4-3-13(7-32)33-5-2-11(20(33)36)6-12-9-46-22-16(21(37)34(22)17(12)23(38)39)28-19(35)15(30-42)18-29-24(27)47-31-18/h6,13,16,22,42H,2-5,7-9H2,1H3,(H,28,35)(H,38,39)(H2,27,29,31)/b11-6+,30-15-/t13-,16-,22-/m1/s1 D4H2CP DRUGINKE HFTSMHTWUFCYMJ-YIOMYIDASA-N D4H2CP DRUGSMIL CC1=C(OC(=O)O1)COC(=O)N2CCC(C2)N3CCC(=CC4=C(N5C(C(C5=O)NC(=O)C(=NO)C6=NSC(=N6)N)SC4)C(=O)O)C3=O D4H2CP HIGHSTAT Phase 3 D4Z5CU DRUG__ID D4Z5CU D4Z5CU DRUGCOMP Momenta Pharmaceuticals; Mylan D4Z5CU DRUGTYPE Small molecular drug D4Z5CU DRUGINCH 1S/C10H16N2.2ClH/c1-11(2)9-5-7-10(8-6-9)12(3)4;;/h5-8H,1-4H3;2*1H D4Z5CU DRUGINKE FBHKTSXMTASXFJ-UHFFFAOYSA-N D4Z5CU DRUGSMIL CN(C)C1=CC=C(C=C1)N(C)C.Cl.Cl D4Z5CU HIGHSTAT Phase 3 D5E2KR DRUG__ID D5E2KR D5E2KR DRUGCOMP Angion Biomedica D5E2KR DRUGTYPE Small molecule D5E2KR DRUGINCH InChI=1S/C9H8N2S/c1-2-9(12-7-1)4-3-8-5-6-10-11-8/h1-7H,(H,10,11)/b4-3+ D5E2KR DRUGINKE FOHWAQGURRYJFK-ONEGZZNKSA-N D5E2KR DRUGSMIL C1=CSC(=C1)C=CC2=CC=NN2 D5E2KR HIGHSTAT Phase 3 D5EHL4 DRUG__ID D5EHL4 D5EHL4 DRUGCOMP AstraZeneca D5EHL4 DRUGTYPE Small molecule D5EHL4 DRUGINCH InChI=1S/C15H17FN2O3/c1-9-12(10(2)18-17-9)4-3-7-21-14-8-11(15(19)20)5-6-13(14)16/h5-6,8H,3-4,7H2,1-2H3,(H,17,18)(H,19,20) D5EHL4 DRUGINKE WBFUHHBPNXWNCC-UHFFFAOYSA-N D5EHL4 DRUGSMIL CC1=C(C(=NN1)C)CCCOC2=C(C=CC(=C2)C(=O)O)F D5EHL4 HIGHSTAT Phase 3 D5FSV8 DRUG__ID D5FSV8 D5FSV8 DRUGCOMP TauRx Therapeutics D5FSV8 DRUGTYPE Small molecular drug D5FSV8 DRUGINCH 1S/C16H19N3S.2BrH/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;;/h5-10,17H,1-4H3;2*1H D5FSV8 DRUGINKE JAUPSVVTGFBHTN-UHFFFAOYSA-N D5FSV8 DRUGSMIL CN(C)C1=CC2=C(C=C1)NC3=C(S2)C=C(C=C3)N(C)C.Br.Br D5FSV8 HIGHSTAT Phase 3 D5LZO9 DRUG__ID D5LZO9 D5LZO9 DRUGCOMP ML BioSolutions D5LZO9 DRUGTYPE Small molecule D5LZO9 DRUGINCH InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5? D5LZO9 DRUGINKE HEBKCHPVOIAQTA-NGQZWQHPSA-N D5LZO9 DRUGSMIL C(C(C(C(CO)O)O)O)O D5LZO9 HIGHSTAT Phase 3 D6SY9X DRUG__ID D6SY9X D6SY9X DRUGCOMP Cytokinetics D6SY9X DRUGTYPE Small molecule D6SY9X DRUGINCH InChI=1S/C18H19N5O2/c1-3-16-21-17(22-25-16)12-4-6-14-11(8-12)5-7-15(14)20-18(24)13-9-19-23(2)10-13/h4,6,8-10,15H,3,5,7H2,1-2H3,(H,20,24)/t15-/m1/s1 D6SY9X DRUGINKE IOVAZWDIRCRMTM-OAHLLOKOSA-N D6SY9X DRUGSMIL CCC1=NC(=NO1)C2=CC3=C(C=C2)C(CC3)NC(=O)C4=CN(N=C4)C D6SY9X HIGHSTAT Phase 3 D7M3WV DRUG__ID D7M3WV D7M3WV DRUGCOMP Mitsubishi Tanabe Pharma D7M3WV DRUGTYPE Small molecule D7M3WV DRUGINCH InChI=1S/C36H45F4N3O5/c1-47-21-25-18-42(19-30(25)29-12-9-26(36(38,39)40)17-32(29)41-15-13-24(14-16-41)33(44)45)34(46)35(37)22-43(27-5-3-4-6-27)20-31(35)23-7-10-28(48-2)11-8-23/h7-12,17,24-25,27,30-31H,3-6,13-16,18-22H2,1-2H3,(H,44,45)/t25-,30+,31+,35+/m1/s1 D7M3WV DRUGINKE MUNWOYRHJPWQNE-GMFUQMJFSA-N D7M3WV DRUGSMIL COCC1CN(CC1C2=C(C=C(C=C2)C(F)(F)F)N3CCC(CC3)C(=O)O)C(=O)C4(CN(CC4C5=CC=C(C=C5)OC)C6CCCC6)F D7M3WV HIGHSTAT Phase 3 D8NY3J DRUG__ID D8NY3J D8NY3J DRUGCOMP Imperial College London, UK National Institute of Health Research D8NY3J DRUGTYPE Small molecule D8NY3J DRUGINCH InChI=1S/C9H9Cl2N3O/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13/h1-3H,4H2,(H4,12,13,14,15) D8NY3J DRUGINKE INJOMKTZOLKMBF-UHFFFAOYSA-N D8NY3J DRUGSMIL C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl D8NY3J HIGHSTAT Phase 3 D9HYU8 DRUG__ID D9HYU8 D9HYU8 DRUGCOMP Atox Bio D9HYU8 DRUGTYPE Peptide D9HYU8 DRUGINCH 1S/C46H72N10O15S/c1-22(2)18-30(52-39(63)29(15-17-72-8)50-43(67)34-10-9-16-56(34)45(69)33(21-57)54-37(61)24(5)47)42(66)55-36(23(3)4)44(68)48-25(6)38(62)51-31(19-27-11-13-28(58)14-12-27)41(65)53-32(20-35(59)60)40(64)49-26(7)46(70)71/h11-14,22-26,29-34,36,57-58H,9-10,15-21,47H2,1-8H3,(H,48,68)(H,49,64)(H,50,67)(H,51,62)(H,52,63)(H,53,65)(H,54,61)(H,55,66)(H,59,60)(H,70,71)/t24-,25+,26-,29+,30+,31+,32+,33+,34+,36+/m1/s1 D9HYU8 DRUGINKE VRNHFZYMPDKTBS-WYUJEMNCSA-N D9HYU8 DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)O)NC(=O)C(CCSC)NC(=O)C2CCCN2C(=O)C(CO)NC(=O)C(C)N D9HYU8 HIGHSTAT Phase 3 DA29IM DRUG__ID DA29IM DA29IM DRUGCOMP UR-1 Therapeutics Miami, FL DA29IM DRUGTYPE Small molecule DA29IM DRUGINCH InChI=1S/C14H9Cl2NO4S/c15-9-5-8(6-10(16)13(9)18)14(19)17-7-22(20,21)12-4-2-1-3-11(12)17/h1-6,18H,7H2 DA29IM DRUGINKE VOFLAIHEELWYGO-UHFFFAOYSA-N DA29IM DRUGSMIL C1N(C2=CC=CC=C2S1(=O)=O)C(=O)C3=CC(=C(C(=C3)Cl)O)Cl DA29IM HIGHSTAT Phase 3 DA74SC DRUG__ID DA74SC DA74SC DRUGCOMP PharmaEssentia DA74SC DRUGTYPE Small molecular drug DA74SC DRUGINCH 1S/C8H12N2/c9-6-7-10-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2 DA74SC DRUGINKE OCIDXARMXNJACB-UHFFFAOYSA-N DA74SC DRUGSMIL C1=CC=C(C=C1)NCCN DA74SC HIGHSTAT Phase 3 DB6IM8 DRUG__ID DB6IM8 DB6IM8 DRUGCOMP Sunovion Pharmaceuticals Marlborough, MA DB6IM8 DRUGTYPE Small molecule DB6IM8 DRUGINCH InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m0/s1 DB6IM8 DRUGINKE NTJOBXMMWNYJFB-LBPRGKRZSA-N DB6IM8 DRUGSMIL CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC DB6IM8 HIGHSTAT Phase 3 DCA13V DRUG__ID DCA13V DCA13V DRUGCOMP Minoryx Therapeutics DCA13V DRUGTYPE Small molecule DCA13V DRUGINCH InChI=1S/C19H20N2O4S/c1-12(22)14-4-5-15(20-11-14)8-9-25-16-6-2-13(3-7-16)10-17-18(23)21-19(24)26-17/h2-7,11-12,17,22H,8-10H2,1H3,(H,21,23,24) DCA13V DRUGINKE OXVFDZYQLGRLCD-UHFFFAOYSA-N DCA13V DRUGSMIL CC(C1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3)O DCA13V HIGHSTAT Phase 3 DCD0M4 DRUG__ID DCD0M4 DCD0M4 DRUGCOMP Belite Bio DCD0M4 DRUGTYPE Small molecule DCD0M4 DRUGINCH InChI=1S/C21H21F5N4O2/c1-11(31)30-9-6-14-16(10-30)27-28-19(14)20(32)29-7-4-12(5-8-29)13-2-3-15(22)18(23)17(13)21(24,25)26/h2-3,12H,4-10H2,1H3,(H,27,28) DCD0M4 DRUGINKE HAGSLCBZFRRBLS-UHFFFAOYSA-N DCD0M4 DRUGSMIL CC(=O)N1CCC2=C(C1)NN=C2C(=O)N3CCC(CC3)C4=C(C(=C(C=C4)F)F)C(F)(F)F DCD0M4 HIGHSTAT Phase 3 DCJ75Y DRUG__ID DCJ75Y DCJ75Y DRUGCOMP Cyprium Therapeutics DCJ75Y DRUGTYPE Small molecular drug DCJ75Y DRUGINCH 1S/2C6H9N3O2.Cu/c2*7-5(6(10)11)1-4-2-8-3-9-4;/h2*2-3,5H,1,7H2,(H,8,9)(H,10,11);/q;;+2/p-2/t2*5-;/m00./s1 DCJ75Y DRUGINKE UUYDYUZBCIHUFZ-MDTVQASCSA-L DCJ75Y DRUGSMIL C1=C(NC=N1)CC(C(=O)[O-])N.C1=C(NC=N1)CC(C(=O)[O-])N.[Cu+2] DCJ75Y HIGHSTAT Phase 3 DD76HZ DRUG__ID DD76HZ DD76HZ DRUGCOMP Sanifit DD76HZ DRUGTYPE Small molecular drug DD76HZ DRUGINCH 1S/C6H18O24P6.6Na/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15;;;;;;/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24);;;;;;/q;6*+1/p-6 DD76HZ DRUGINKE DHZIAGCFFSRULK-UHFFFAOYSA-H DD76HZ DRUGSMIL C1(C(C(C(C(C1OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] DD76HZ HIGHSTAT Phase 3 DDH8L6 DRUG__ID DDH8L6 DDH8L6 DRUGCOMP EQRx DDH8L6 DRUGTYPE Small molecular drug DDH8L6 DRUGINCH 1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34) DDH8L6 DRUGINKE DOEOECWDNSEFDN-UHFFFAOYSA-N DDH8L6 DRUGSMIL CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC DDH8L6 HIGHSTAT Phase 3 DDU0O9 DRUG__ID DDU0O9 DDU0O9 DRUGCOMP PTC Therapeutics DDU0O9 DRUGTYPE Small molecule DDU0O9 DRUGINCH InChI=1S/C9H11N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3,15H,2H2,1H3,(H4,10,11,13,14,17)/t3-/m0/s1 DDU0O9 DRUGINKE VPVOXUSPXFPWBN-VKHMYHEASA-N DDU0O9 DRUGSMIL CC(C(=O)C1=NC2=C(NC1)N=C(NC2=O)N)O DDU0O9 HIGHSTAT Phase 3 DE4AO8 DRUG__ID DE4AO8 DE4AO8 DRUGCOMP Hinova Pharmaceuticals DE4AO8 DRUGTYPE Small molecular drug DE4AO8 DRUGINCH 1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)/i3D3 DE4AO8 DRUGINKE WXCXUHSOUPDCQV-HPRDVNIFSA-N DE4AO8 DRUGSMIL CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C DE4AO8 HIGHSTAT Phase 3 DFK8Z5 DRUG__ID DFK8Z5 DFK8Z5 DRUGCOMP Reistone Biopharma DFK8Z5 DRUGTYPE Small molecule DFK8Z5 DRUGINCH InChI=1S/C18H22N8O2S/c1-25(15-13-3-4-19-14(13)20-9-21-15)12-5-10-7-26(8-11(10)6-12)18(27)23-17-22-16(28-2)24-29-17/h3-4,9-12H,5-8H2,1-2H3,(H,19,20,21)(H,22,23,24,27)/t10-,11+,12? DFK8Z5 DRUGINKE DNBCBAXDWNDRNO-FOSCPWQOSA-N DFK8Z5 DRUGSMIL CN(C1CC2CN(CC2C1)C(=O)NC3=NC(=NS3)OC)C4=NC=NC5=C4C=CN5 DFK8Z5 HIGHSTAT Phase 3 DG4A0Y DRUG__ID DG4A0Y DG4A0Y DRUGCOMP R-Pharm DG4A0Y DRUGTYPE Small molecular drug DG4A0Y DRUGINCH 1S/C87H95Cl3N16O28S2/c1-33(2)20-45(94-5)74(117)100-62-66(112)36-11-14-49(43(88)22-36)130-51-24-38-25-52(70(51)134-85-71(69(115)68(114)53(31-107)132-85)133-55-29-87(4,93)72(116)34(3)129-55)131-50-15-12-37(23-44(50)89)67(113)63-81(124)99-59(42-26-40(108)27-48(110)56(42)41-21-35(10-13-47(41)109)57(77(120)101-63)98-78(121)58(38)97-75(118)46(28-54(91)111)96-80(62)123)76(119)95-16-9-19-128-104-61(60-73(90)136-86(92)103-60)79(122)102-64-82(125)106-65(84(126)127)39(32-135-83(64)106)30-105-17-7-6-8-18-105/h6-8,10-15,17-18,21-27,33-34,45-46,53,55,57-59,62-64,66-69,71-72,83,85,94,107,112-116H,9,16,19-20,28-32,93H2,1-5H3,(H15-,91,92,95,96,97,98,99,100,101,102,103,104,108,109,110,111,117,118,119,120,121,122,123,124,126,127)/t34-,45+,46-,53+,55-,57+,58+,59-,62+,63-,64+,66+,67+,68+,69-,71+,72+,83+,85-,87-/m0/s1 DG4A0Y DRUGINKE OGUAFUAJSPORAH-KHCCTVBNSA-N DG4A0Y DRUGSMIL CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)NCCCON=C(C1=C(SC(=N1)N)Cl)C(=O)NC1C2N(C1=O)C(=C(CS2)C[N+]1=CC=CC=C1)C(=O)[O-])CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O DG4A0Y HIGHSTAT Phase 3 DGB7W9 DRUG__ID DGB7W9 DGB7W9 DRUGCOMP Rain Therapeutics Newark, CA DGB7W9 DRUGTYPE Small molecule DGB7W9 DRUGINCH InChI=1S/C30H34Cl2FN5O4/c1-28(2)8-10-29(11-9-28)30(18-5-3-15(31)13-19(18)37-27(30)41)21(17-7-12-35-24(32)22(17)33)23(38-29)26(40)36-16-4-6-20(25(34)39)42-14-16/h3,5,7,12-13,16,20-21,23,38H,4,6,8-11,14H2,1-2H3,(H2,34,39)(H,36,40)(H,37,41)/t16-,20+,21+,23-,30-/m1/s1 DGB7W9 DRUGINKE RYAYYVTWKAOAJF-QISPRATLSA-N DGB7W9 DRUGSMIL CC1(CCC2(CC1)C3(C(C(N2)C(=O)NC4CCC(OC4)C(=O)N)C5=C(C(=NC=C5)Cl)F)C6=C(C=C(C=C6)Cl)NC3=O)C DGB7W9 HIGHSTAT Phase 3 DGW9U7 DRUG__ID DGW9U7 DGW9U7 DRUGCOMP Roche/Genentech DGW9U7 DRUGTYPE Small molecule DGW9U7 DRUGINCH InChI=1S/C27H31F5N4O/c1-16-9-20-19-5-2-3-6-23(19)34-25(20)26(36(16)14-27(31,32)15-37)24-21(29)10-17(11-22(24)30)33-18-12-35(13-18)8-4-7-28/h2-3,5-6,10-11,16,18,26,33-34,37H,4,7-9,12-15H2,1H3/t16-,26-/m1/s1 DGW9U7 DRUGINKE GQCXHIKRWBIQMD-AKJBCIBTSA-N DGW9U7 DRUGSMIL CC1CC2=C(C(N1CC(CO)(F)F)C3=C(C=C(C=C3F)NC4CN(C4)CCCF)F)NC5=CC=CC=C25 DGW9U7 HIGHSTAT Phase 3 DH7F9S DRUG__ID DH7F9S DH7F9S DRUGCOMP Novartis DH7F9S DRUGTYPE Small molecular drug DH7F9S DRUGINCH 1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26) DH7F9S DRUGINKE GFPPXZDRVCSVNR-UHFFFAOYSA-N DH7F9S DRUGSMIL CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O DH7F9S HIGHSTAT Phase 3 DHTL97 DRUG__ID DHTL97 DHTL97 DRUGCOMP Crinetics Pharmaceuticals San Diego, CA DHTL97 DRUGTYPE Small molecule DHTL97 DRUGINCH InChI=1S/C27H22F2N4O/c28-19-10-18(11-20(29)13-19)24-15-32-25-5-4-16(22-3-1-2-17(14-30)27(22)34)12-23(25)26(24)33-8-6-21(31)7-9-33/h1-5,10-13,15,21,34H,6-9,31H2 DHTL97 DRUGINKE GHILNKWBALQPDP-UHFFFAOYSA-N DHTL97 DRUGSMIL C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N DHTL97 HIGHSTAT Phase 3 DHY6S0 DRUG__ID DHY6S0 DHY6S0 DRUGCOMP Isofol Medical DHY6S0 DRUGTYPE Small molecular drug DHY6S0 DRUGINCH 1S/C20H23N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/t12-,13+/m1/s1 DHY6S0 DRUGINKE QYNUQALWYRSVHF-OLZOCXBDSA-N DHY6S0 DRUGSMIL C1C2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O DHY6S0 HIGHSTAT Phase 3 DI9P5G DRUG__ID DI9P5G DI9P5G DRUGCOMP Lilly DI9P5G DRUGTYPE Small molecule DI9P5G DRUGINCH InChI=1S/C48H48F2N10O5/c1-25-18-32(19-26(2)40(25)49)60-42(58-16-15-57(46(58)63)37-11-10-36-33(41(37)50)24-51-55(36)7)39-28(4)56(14-12-34(39)53-60)43(61)38-21-31-20-29(30-13-17-64-47(5,6)23-30)8-9-35(31)59(38)48(22-27(48)3)44-52-45(62)65-54-44/h8-11,15-16,18-21,24,27-28,30H,12-14,17,22-23H2,1-7H3,(H,52,54,62)/t27-,28-,30-,48-/m0/s1 DI9P5G DRUGINKE USUWIEBBBWHKNI-KHIFEHGGSA-N DI9P5G DRUGSMIL CC1CC1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)C5CCOC(C5)(C)C)C=C3C(=O)N6CCC7=NN(C(=C7C6C)N8C=CN(C8=O)C9=C(C1=C(C=C9)N(N=C1)C)F)C1=CC(=C(C(=C1)C)F)C DI9P5G HIGHSTAT Phase 3 DJOU19 DRUG__ID DJOU19 DJOU19 DRUGCOMP boehringer-ingelheim DJOU19 DRUGTYPE Small molecule DJOU19 DRUGINCH InChI=1S/C20H18F6N2O5S/c1-10(19(21,22)23)32-14-4-3-12(34(2,30)31)5-13(14)17(29)28-8-11-7-18(11,9-28)15-6-16(33-27-15)20(24,25)26/h3-6,10-11H,7-9H2,1-2H3/t10-,11+,18+/m1/s1 DJOU19 DRUGINKE MYHDQTVHHMSLEF-DDBGAENHSA-N DJOU19 DRUGSMIL CC(C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CC3CC3(C2)C4=NOC(=C4)C(F)(F)F DJOU19 HIGHSTAT Phase 3 DKF9I3 DRUG__ID DKF9I3 DKF9I3 DRUGCOMP Gritstone Oncology DKF9I3 DRUGTYPE Small molecular drug DKF9I3 DRUGINCH 1S/C16H14F5N5O5S/c1-29-10-6-22-15(30-2)26-13(10)23-14(24-26)25-32(27,28)12-8(16(19,20)21)4-3-5-9(12)31-7-11(17)18/h3-6,11H,7H2,1-2H3,(H,24,25) DKF9I3 DRUGINKE SYJGKVOENHZYMQ-UHFFFAOYSA-N DKF9I3 DRUGSMIL COC1=CN=C(N2C1=NC(=N2)NS(=O)(=O)C3=C(C=CC=C3OCC(F)F)C(F)(F)F)OC DKF9I3 HIGHSTAT Phase 3 DKP2I0 DRUG__ID DKP2I0 DKP2I0 DRUGCOMP Calcilytix Therapeutics DKP2I0 DRUGTYPE Small molecule DKP2I0 DRUGINCH InChI=1S/C29H33ClFNO4/c1-18-13-21(10-11-23(18)28(34)35)25-8-6-5-7-24(25)19(2)36-17-22(33)16-32-29(3,4)15-20-9-12-26(30)27(31)14-20/h5-14,19,22,32-33H,15-17H2,1-4H3,(H,34,35)/t19-,22-/m1/s1 DKP2I0 DRUGINKE UNFHDRVFEQPUEL-DENIHFKCSA-N DKP2I0 DRUGSMIL CC1=C(C=CC(=C1)C2=CC=CC=C2C(C)OCC(CNC(C)(C)CC3=CC(=C(C=C3)Cl)F)O)C(=O)O DKP2I0 HIGHSTAT Phase 3 DKZ07O DRUG__ID DKZ07O DKZ07O DRUGCOMP Bayer DKZ07O DRUGTYPE Small molecule DKZ07O DRUGINCH InChI=1S/C33H35F7N4O3/c1-19-9-23(34)5-6-26(19)27-13-29(44-16-25-18-47-8-7-43(25)15-24(44)17-45)41-14-28(27)42(4)30(46)31(2,3)20-10-21(32(35,36)37)12-22(11-20)33(38,39)40/h5-6,9-14,24-25,45H,7-8,15-18H2,1-4H3/t24-,25-/m0/s1 DKZ07O DRUGINKE DWRIJNIPBUFCQS-DQEYMECFSA-N DKZ07O DRUGSMIL CC1=C(C=CC(=C1)F)C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CC5COCCN5CC4CO DKZ07O HIGHSTAT Phase 3 DLC7Y9 DRUG__ID DLC7Y9 DLC7Y9 DRUGCOMP Cogent Biosciences DLC7Y9 DRUGTYPE Small molecule DLC7Y9 DRUGINCH InChI=1S/C19H17N5O/c1-11-12(2)23-24-17(11)19(25)21-15-8-14-9-16(22-18(14)20-10-15)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,20,22)(H,21,25)(H,23,24) DLC7Y9 DRUGINKE NVSHVYGIYPBTEZ-UHFFFAOYSA-N DLC7Y9 DRUGSMIL CC1=C(NN=C1C(=O)NC2=CN=C3C(=C2)C=C(N3)C4=CC=CC=C4)C DLC7Y9 HIGHSTAT Phase 3 DMF82G DRUG__ID DMF82G DMF82G DRUGCOMP Zealand pharma DMF82G DRUGTYPE Peptide DMF82G DRUGINCH 1S/C197H325N53O55/c1-27-102(13)152(190(299)220-111(22)166(275)248-157(113(24)254)194(303)230-129(66-45-52-78-204)176(285)244-155(105(16)30-4)192(301)250-158(114(25)255)195(304)240-142(90-151(267)268)183(292)228-128(65-44-51-77-203)173(282)227-127(64-43-50-76-202)172(281)226-126(63-42-49-75-201)171(280)225-125(62-41-48-74-200)170(279)224-124(61-40-47-73-199)169(278)222-123(160(206)269)60-39-46-72-198)245-185(294)136(83-101(11)12)234-182(291)139(86-118-91-211-122-59-38-37-58-120(118)122)232-164(273)109(20)219-189(298)153(103(14)28-2)246-186(295)138(85-117-56-35-32-36-57-117)235-184(293)141(89-150(265)266)236-174(283)130(67-53-79-210-197(207)208)223-162(271)107(18)215-161(270)106(17)216-177(286)133(80-98(5)6)231-163(272)108(19)217-179(288)140(88-149(263)264)237-180(289)135(82-100(9)10)238-191(300)154(104(15)29-3)247-196(305)159(115(26)256)249-165(274)110(21)218-178(287)134(81-99(7)8)233-175(284)132(69-71-148(261)262)229-187(296)143(95-251)242-188(297)144(96-252)241-181(290)137(84-116-54-33-31-34-55-116)239-193(302)156(112(23)253)243-146(258)94-213-168(277)131(68-70-147(259)260)221-145(257)93-212-167(276)121(205)87-119-92-209-97-214-119/h31-38,54-59,91-92,97-115,121,123-144,152-159,211,251-256H,27-30,39-53,60-90,93-96,198-205H2,1-26H3,(H2,206,269)(H,209,214)(H,212,276)(H,213,277)(H,215,270)(H,216,286)(H,217,288)(H,218,287)(H,219,298)(H,220,299)(H,221,257)(H,222,278)(H,223,271)(H,224,279)(H,225,280)(H,226,281)(H,227,282)(H,228,292)(H,229,296)(H,230,303)(H,231,272)(H,232,273)(H,233,284)(H,234,291)(H,235,293)(H,236,283)(H,237,289)(H,238,300)(H,239,302)(H,240,304)(H,241,290)(H,242,297)(H,243,258)(H,244,285)(H,245,294)(H,246,295)(H,247,305)(H,248,275)(H,249,274)(H,250,301)(H,259,260)(H,261,262)(H,263,264)(H,265,266)(H,267,268)(H4,207,208,210)/t102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112+,113+,114+,115+,121-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,152-,153-,154-,155-,156-,157-,158-,159-/m0/s1 DMF82G DRUGINKE DOAUQKRTILFGHV-PDCMDPCFSA-N DMF82G DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC5=CNC=N5)N DMF82G HIGHSTAT Phase 3 DON71B DRUG__ID DON71B DON71B DRUGCOMP Lilly DON71B DRUGTYPE Small molecule DON71B DRUGINCH InChI=1S/C29H24F4N2O3/c30-13-17-15-35(16-17)9-10-37-21-5-1-18(2-6-21)28-27-23-8-4-20(36)12-25(23)34-14-24(27)22-7-3-19(29(31,32)33)11-26(22)38-28/h1-8,11-12,14,17,28,36H,9-10,13,15-16H2/t28-/m1/s1 DON71B DRUGINKE UVBQMXOKKDCBJN-MUUNZHRXSA-N DON71B DRUGSMIL C1C(CN1CCOC2=CC=C(C=C2)C3C4=C5C=CC(=CC5=NC=C4C6=C(O3)C=C(C=C6)C(F)(F)F)O)CF DON71B HIGHSTAT Phase 3 DP2UR8 DRUG__ID DP2UR8 DP2UR8 DRUGCOMP Knopp Biosciences DP2UR8 DRUGTYPE Small molecule DP2UR8 DRUGINCH InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m1/s1 DP2UR8 DRUGINKE FASDKYOPVNHBLU-SSDOTTSWSA-N DP2UR8 DRUGSMIL CCCNC1CCC2=C(C1)SC(=N2)N DP2UR8 HIGHSTAT Phase 3 DP7GK8 DRUG__ID DP7GK8 DP7GK8 DRUGCOMP AbbVie DP7GK8 DRUGTYPE Small molecular drug DP7GK8 DRUGINCH 1S/C9H12NO7P/c10-6(9(12)13)3-5-1-2-8(7(11)4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1 DP7GK8 DRUGINKE YNDMEEULGSTYJT-LURJTMIESA-N DP7GK8 DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)O)OP(=O)(O)O DP7GK8 HIGHSTAT Phase 3 DQ84IT DRUG__ID DQ84IT DQ84IT DRUGCOMP Takeda DQ84IT DRUGTYPE Small molecule DQ84IT DRUGINCH InChI=1S/C29H27F3N6O.ClH/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37;/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39);1H DQ84IT DRUGINKE BWTNNZPNKQIADY-UHFFFAOYSA-N DQ84IT DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5.Cl DQ84IT HIGHSTAT Phase 3 DUTJ12 DRUG__ID DUTJ12 DUTJ12 DRUGCOMP InnoCare Pharma DUTJ12 DRUGTYPE Small molecular drug DUTJ12 DRUGINCH 1S/C26H25N3O3/c1-2-24(30)29-16-14-18(15-17-29)23-13-12-22(26(27)31)25(28-23)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-13,18H,1,14-17H2,(H2,27,31) DUTJ12 DRUGINKE MZPVEMOYADUARK-UHFFFAOYSA-N DUTJ12 DRUGSMIL C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4 DUTJ12 HIGHSTAT Phase 3 DV25QN DRUG__ID DV25QN DV25QN DRUGCOMP Actelion Pharmaceuticals DV25QN DRUGTYPE Small molecular drug DV25QN DRUGINCH 1S/C29H29F2N3O8/c30-21-10-19-23(33(16-1-2-16)13-20(26(19)36)27(37)38)11-24(21)32-7-5-29(40,6-8-32)15-41-25-4-3-17(9-22(25)31)34-12-18(14-35)42-28(34)39/h3-4,9-11,13,16,18,35,40H,1-2,5-8,12,14-15H2,(H,37,38)/t18-/m1/s1 DV25QN DRUGINKE XWFCFMXQTBGXQW-GOSISDBHSA-N DV25QN DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCC(CC4)(COC5=C(C=C(C=C5)N6CC(OC6=O)CO)F)O)F)C(=O)O DV25QN HIGHSTAT Phase 3 DY7MH5 DRUG__ID DY7MH5 DY7MH5 DRUGCOMP Genentech DY7MH5 DRUGTYPE Small molecular drug DY7MH5 DRUGINCH 1S/C22H24ClN5O/c1-27-13-16-12-17(23)7-10-19(16)28-20(14-27)25-26-22(28)15-5-8-18(9-6-15)29-21-4-2-3-11-24-21/h2-4,7,10-12,15,18H,5-6,8-9,13-14H2,1H3 DY7MH5 DRUGINKE GMPZPHGHNDMRKL-UHFFFAOYSA-N DY7MH5 DRUGSMIL CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1 DY7MH5 HIGHSTAT Phase 3 D00GZY DRUG__ID D00GZY D00GZY DRUGTYPE Small molecular drug D00GZY DRUGINCH 1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1 D00GZY DRUGINKE NYGCNONRVCGHAT-UFIKZEAMSA-N D00GZY DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN.CC(=O)O D00GZY HIGHSTAT Phase 3 D00HBE DRUG__ID D00HBE D00HBE DRUGCOMP Astrazeneca D00HBE DRUGINCH 1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1 D00HBE DRUGINKE ZSWMIFNWDQEXDT-ZESJGQACSA-N D00HBE DRUGSMIL CC1CN2C(C(O1)C)C3(CC4=CC5=C(C(=C42)F)ON=C5N6C(COC6=O)C)C(=O)NC(=O)NC3=O D00HBE HIGHSTAT Phase 3 D00IJQ DRUG__ID D00IJQ D00IJQ DRUGTYPE Small molecular drug D00IJQ DRUGINCH 1S/C19H25ClN2O2.C4H4O4/c1-19(2)10-11-6-12(20)7-16(17(11)24-19)18(23)21-13-8-14-4-5-15(9-13)22(14)3;5-3(6)1-2-4(7)8/h6-7,13-15H,4-5,8-10H2,1-3H3,(H,21,23);1-2H,(H,5,6)(H,7,8)/b;2-1-/t13?,14-,15+; D00IJQ DRUGINKE HAFQATMFFHYNPN-BSLJCGBVSA-N D00IJQ DRUGSMIL CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C.C(=CC(=O)O)C(=O)O D00IJQ HIGHSTAT Phase 3 D00IVF DRUG__ID D00IVF D00IVF DRUGCOMP Polyphor D00IVF DRUGINCH 1S/C73H112N22O16/c1-5-38(2)58-70(108)88-52(24-30-79)65(103)83-47(17-10-25-74)62(100)85-49(21-27-76)63(101)86-51(23-29-78)66(104)89-53(33-41-35-80-45-15-8-6-13-43(41)45)67(105)87-50(22-28-77)64(102)84-48(20-26-75)61(99)82-39(3)60(98)91-55(37-96)72(110)95-32-12-19-57(95)73(111)94-31-11-18-56(94)69(107)93-59(40(4)97)71(109)90-54(68(106)92-58)34-42-36-81-46-16-9-7-14-44(42)46/h6-9,13-16,35-36,38-40,47-59,80-81,96-97H,5,10-12,17-34,37,74-79H2,1-4H3,(H,82,99)(H,83,103)(H,84,102)(H,85,100)(H,86,101)(H,87,105)(H,88,108)(H,89,104)(H,90,109)(H,91,98)(H,92,106)(H,93,107)/t38-,39-,40+,47-,48-,49+,50-,51-,52-,53-,54-,55-,56-,57+,58-,59-/m0/s1 D00IVF DRUGINKE RIDRXGOBXZLKHZ-NZUANIILSA-N D00IVF DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N1)CC4=CNC5=CC=CC=C54)C(C)O)CO)C)CCN)CCN)CC6=CNC7=CC=CC=C76)CCN)CCN)CCCN)CCN D00IVF HIGHSTAT Phase 3 D00IWL DRUG__ID D00IWL D00IWL DRUGCOMP Northfield Laboratories D00IWL DRUGINCH 1S/C8H10NO6P.C5H8O2/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14;6-4-2-1-3-5-7/h2-3,11H,4H2,1H3,(H2,12,13,14);4-5H,1-3H2 D00IWL DRUGINKE SKKYPUWZZNPUMG-UHFFFAOYSA-N D00IWL DRUGSMIL CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O.C(CC=O)CC=O D00IWL HIGHSTAT Phase 3 D00JRD DRUG__ID D00JRD D00JRD DRUGTYPE Small molecular drug D00JRD DRUGINCH 1S/C23H40O5/c1-4-5-8-11-18(24)14-15-20-19(21(25)16-22(20)26)12-9-6-7-10-13-23(27)28-17(2)3/h6,9,14-15,17-22,24-26H,4-5,7-8,10-13,16H2,1-3H3/b9-6-,15-14+/t18-,19+,20+,21-,22+/m0/s1 D00JRD DRUGINKE FPABVZYYTCHNMK-YNRDDPJXSA-N D00JRD DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)OC(C)C)O)O)O D00JRD HIGHSTAT Phase 3 D00OPX DRUG__ID D00OPX D00OPX DRUGCOMP Rigel Pharmaceuticals South San Francisco, CA D00OPX DRUGINCH 1S/C23H26FN6O9P.2Na/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4;;/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29);;/q;2*+1/p-2 D00OPX DRUGINKE HSYBQXDGYCYSGA-UHFFFAOYSA-L D00OPX DRUGSMIL CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.[Na+].[Na+] D00OPX HIGHSTAT Phase 3 D00QAR DRUG__ID D00QAR D00QAR DRUGTYPE Small molecular drug D00QAR DRUGINCH 1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1 D00QAR DRUGINKE JGSARLDLIJGVTE-MBNYWOFBSA-N D00QAR DRUGSMIL CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C D00QAR HIGHSTAT Phase 3 D00VQT DRUG__ID D00VQT D00VQT DRUGCOMP Cell>Point LLC D00VQT DRUGINCH 1S/C20H36N4O12S2.O.Tc/c25-3-9-13(27)15(29)11(19(33)35-9)23-17(31)7(5-37)21-1-2-22-8(6-38)18(32)24-12-16(30)14(28)10(4-26)36-20(12)34;;/h7-16,19-20,25-30,33-34,37-38H,1-6H2,(H,23,31)(H,24,32);;/q-2;;+4/p-2 D00VQT DRUGINKE XUWZVUPFDWQUTO-UHFFFAOYSA-L D00VQT DRUGSMIL C(C[N-]C(C[S-])C(=O)NC1C(C(C(OC1O)CO)O)O)[N-]C(C[S-])C(=O)NC2C(C(C(OC2O)CO)O)O.O=[Tc+4] D00VQT HIGHSTAT Phase 3 D00VUI DRUG__ID D00VUI D00VUI DRUGTYPE Small molecular drug D00VUI DRUGINCH 1S/C11H6O3/c12-11-2-1-7-5-8-3-4-13-9(8)6-10(7)14-11/h1-6H D00VUI DRUGINKE ZCCUUQDIBDJBTK-UHFFFAOYSA-N D00VUI DRUGSMIL C1=CC(=O)OC2=CC3=C(C=CO3)C=C21 D00VUI HIGHSTAT Phase 3 D01GFX DRUG__ID D01GFX D01GFX DRUGTYPE Small molecular drug D01GFX DRUGINCH 1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28) D01GFX DRUGINKE PKCDDUHJAFVJJB-UHFFFAOYSA-N D01GFX DRUGSMIL CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O D01GFX HIGHSTAT Phase 3 D01IGZ DRUG__ID D01IGZ D01IGZ DRUGCOMP Boston Biomedical Cambridge, MA D01IGZ DRUGINCH 1S/C14H8O4/c1-7(15)11-6-10-12(16)8-4-2-3-5-9(8)13(17)14(10)18-11/h2-6H,1H3 D01IGZ DRUGINKE DPHUWDIXHNQOSY-UHFFFAOYSA-N D01IGZ DRUGSMIL CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O D01IGZ HIGHSTAT Phase 3 D01KYP DRUG__ID D01KYP D01KYP DRUGCOMP Aquestive Therapeutics Warren, NJ Sunovion Pharmaceuticals Marlborough, MA D01KYP DRUGINCH 1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1 D01KYP DRUGINKE CXWQXGNFZLHLHQ-DPFCLETOSA-N D01KYP DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.O.Cl.Cl D01KYP HIGHSTAT Phase 3 D01LVE DRUG__ID D01LVE D01LVE DRUGCOMP Constellation pharmaceuticals D01LVE DRUGINCH 1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9,16H,10H2,1H3,(H2,22,25)/t16-/m0/s1 D01LVE DRUGINKE GCWIQUVXWZWCLE-INIZCTEOSA-N D01LVE DRUGSMIL CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl D01LVE HIGHSTAT Phase 3 D01MUU DRUG__ID D01MUU D01MUU DRUGTYPE Small molecular drug D01MUU DRUGINCH 1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1 D01MUU DRUGINKE DKWNMCUOEDMMIN-PKOBYXMFSA-N D01MUU DRUGSMIL C1CCC(CC1)C(C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=N)N)NCC(=O)O D01MUU HIGHSTAT Phase 3 D01RBP DRUG__ID D01RBP D01RBP DRUGCOMP Retrophin San Diego, CA D01RBP DRUGINCH 1S/C20H31N2O9P/c1-14(19(26)29-5)22-32(27,31-15-9-7-6-8-10-15)30-13-20(2,3)17(24)18(25)21-12-11-16(23)28-4/h6-10,14,17,24H,11-13H2,1-5H3,(H,21,25)(H,22,27)/t14-,17-,32?/m0/s1 D01RBP DRUGINKE HUWUHKIPYXWUPN-YVRVQSMLSA-N D01RBP DRUGSMIL CC(C(=O)OC)NP(=O)(OCC(C)(C)C(C(=O)NCCC(=O)OC)O)OC1=CC=CC=C1 D01RBP HIGHSTAT Phase 3 D01XHG DRUG__ID D01XHG D01XHG DRUGTYPE Small molecular drug D01XHG DRUGINCH 1S/C16H24N4O3/c1-4-6-8-19-14-13(18(11-17-14)10-12(3)21)15(22)20(16(19)23)9-7-5-2/h11H,4-10H2,1-3H3 D01XHG DRUGINKE HJPRDDKCXVCFOH-UHFFFAOYSA-N D01XHG DRUGSMIL CCCCN1C2=C(C(=O)N(C1=O)CCCC)N(C=N2)CC(=O)C D01XHG HIGHSTAT Phase 3 D01XPY DRUG__ID D01XPY D01XPY DRUGTYPE Small molecular drug D01XPY DRUGINCH 1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1 D01XPY DRUGINKE RHGKLRLOHDJJDR-BYPYZUCNSA-N D01XPY DRUGSMIL C(CC(C(=O)O)N)CNC(=O)N D01XPY HIGHSTAT Phase 3 D01ZNH DRUG__ID D01ZNH D01ZNH DRUGTYPE Small molecular drug D01ZNH DRUGINCH 1S/C11H12N2O2.ClH/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11;/h1-4,10H,5-7H2,(H,12,13);1H D01ZNH DRUGINKE MYUBYOVCLMEAOH-UHFFFAOYSA-N D01ZNH DRUGSMIL C1CN=C(N1)C2COC3=CC=CC=C3O2.Cl D01ZNH HIGHSTAT Phase 3 D02ENG DRUG__ID D02ENG D02ENG DRUGTYPE Small molecular drug D02ENG DRUGINCH 1S/C17H21ClN4O3S2/c1-12-14(18)4-3-5-15(12)27(24,25)20-17-19-13(11-26-17)10-16(23)22-8-6-21(2)7-9-22/h3-5,11H,6-10H2,1-2H3,(H,19,20) D02ENG DRUGINKE YDPRNGAPPNPYQQ-UHFFFAOYSA-N D02ENG DRUGSMIL CC1=C(C=CC=C1Cl)S(=O)(=O)NC2=NC(=CS2)CC(=O)N3CCN(CC3)C D02ENG HIGHSTAT Phase 3 D02JUW DRUG__ID D02JUW D02JUW DRUGTYPE Small molecular drug D02JUW DRUGINCH 1S/C7H8O2/c1-9-7-5-3-2-4-6(7)8/h2-5,8H,1H3 D02JUW DRUGINKE LHGVFZTZFXWLCP-UHFFFAOYSA-N D02JUW DRUGSMIL COC1=CC=CC=C1O D02JUW HIGHSTAT Phase 3 D02NHD DRUG__ID D02NHD D02NHD DRUGTYPE Small molecular drug D02NHD DRUGINCH 1S/C25H25NO5/c1-2-29-24(25(27)28)17-18-11-13-19(14-12-18)30-16-15-26-20-7-3-5-9-22(20)31-23-10-6-4-8-21(23)26/h3-14,24H,2,15-17H2,1H3,(H,27,28)/t24-/m0/s1 D02NHD DRUGINKE WMUIIGVAWPWQAW-DEOSSOPVSA-N D02NHD DRUGSMIL CCOC(CC1=CC=C(C=C1)OCCN2C3=CC=CC=C3OC4=CC=CC=C42)C(=O)O D02NHD HIGHSTAT Phase 3 D02PQB DRUG__ID D02PQB D02PQB DRUGCOMP Bayer HealthCare Pharmaceuticals D02PQB DRUGINCH 1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1 D02PQB DRUGINKE KXGVEGMKQFWNSR-LLQZFEROSA-N D02PQB DRUGSMIL CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C D02PQB HIGHSTAT Phase 3 D02QBT DRUG__ID D02QBT D02QBT DRUGTYPE Small molecular drug D02QBT DRUGINCH 1S/C15H20N6O4/c16-13(23)11-2-1-3-21(11)15(25)10(4-8-6-17-7-18-8)20-14(24)9-5-12(22)19-9/h6-7,9-11H,1-5H2,(H2,16,23)(H,17,18)(H,19,22)(H,20,24)/t9-,10-,11-/m0/s1 D02QBT DRUGINKE WBGUMUGCONUXFK-DCAQKATOSA-N D02QBT DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CN=CN2)NC(=O)C3CC(=O)N3)C(=O)N D02QBT HIGHSTAT Phase 3 D02RQT DRUG__ID D02RQT D02RQT DRUGTYPE Small molecular drug D02RQT DRUGINCH 1S/C14H9ClN2O3S/c15-7-3-4-9-8(6-7)11(13(19)17(9)14(16)20)12(18)10-2-1-5-21-10/h1-6,19H,(H2,16,20) D02RQT DRUGINKE IZSFDUMVCVVWKW-UHFFFAOYSA-N D02RQT DRUGSMIL C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O D02RQT HIGHSTAT Phase 3 D02YEY DRUG__ID D02YEY D02YEY DRUGTYPE Small molecular drug D02YEY DRUGINCH 1S/C16H15N3O/c1-20-15-9-7-13(8-10-15)17-16-11-12-19(18-16)14-5-3-2-4-6-14/h2-12H,1H3,(H,17,18) D02YEY DRUGINKE WKLGNFJHVJIZPK-UHFFFAOYSA-N D02YEY DRUGSMIL COC1=CC=C(C=C1)NC2=NN(C=C2)C3=CC=CC=C3 D02YEY HIGHSTAT Phase 3 D02ZZG DRUG__ID D02ZZG D02ZZG DRUGCOMP LEO Pharma Madison, NJ D02ZZG DRUGINCH 1S/C28H37NO7/c1-7-18-20(19(8-2)36-29-18)25(33)35-24-13(3)11-27-14(4)9-17-21(26(17,5)6)16(23(27)32)10-15(12-30)22(31)28(24,27)34/h10-11,14,16-17,21-22,24,30-31,34H,7-9,12H2,1-6H3/t14-,16+,17-,21+,22-,24+,27+,28+/m1/s1 D02ZZG DRUGINKE GLIUZQUNUNICGS-XUBYYPQFSA-N D02ZZG DRUGSMIL CCC1=C(C(=NO1)CC)C(=O)OC2C(=CC34C2(C(C(=CC(C3=O)C5C(C5(C)C)CC4C)CO)O)O)C D02ZZG HIGHSTAT Phase 3 D03AJF DRUG__ID D03AJF D03AJF DRUGCOMP Supernus Pharmaceuticals Rockville, MD D03AJF DRUGINCH 1S/C16H24N2O2.ClH/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18;/h12,17H,3-10H2,1-2H3;1H D03AJF DRUGINKE GQWNECFJGBQMBO-UHFFFAOYSA-N D03AJF DRUGSMIL CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C.Cl D03AJF HIGHSTAT Phase 3 D03BFU DRUG__ID D03BFU D03BFU DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D03BFU DRUGINCH 1S/C34H41N7O5.CH4O3S/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29;1-5(2,3)4/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44);1H3,(H,2,3,4) D03BFU DRUGINKE XETBXHPXHHOLOE-UHFFFAOYSA-N D03BFU DRUGSMIL CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N.CS(=O)(=O)O D03BFU HIGHSTAT Phase 3 D03BQP DRUG__ID D03BQP D03BQP DRUGTYPE Small molecular drug D03BQP DRUGINCH 1S/C19H15ClN2O4/c20-13-7-5-11(6-8-13)18(24)22-16(19(25)26)9-12-10-17(23)21-15-4-2-1-3-14(12)15/h1-8,10,16H,9H2,(H,21,23)(H,22,24)(H,25,26) D03BQP DRUGINKE ALLWOAVDORUJLA-UHFFFAOYSA-N D03BQP DRUGSMIL C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl D03BQP HIGHSTAT Phase 3 D03NGH DRUG__ID D03NGH D03NGH DRUGCOMP Biosearch Italia SpA; Oscient Pharmaceuticals D03NGH DRUGINCH 1S/C106H170ClN21O30/c1-8-9-10-11-15-22-80(140)114-75(50-78(110)138)96(147)118-76(51-79(111)139)97(148)124-86(60-25-36-66(133)37-26-60)102(153)117-72(21-17-46-109)92(143)120-83(56(6)130)100(151)126-89(63-31-42-69(136)43-32-63)105(156)127-88(62-29-40-68(135)41-30-62)104(155)121-82(55(5)129)99(150)119-74(48-58-18-13-12-14-19-58)95(146)116-71(20-16-45-108)93(144)123-87(61-27-38-67(134)39-28-61)103(154)122-84(57(7)131)101(152)125-85(59-23-34-65(132)35-24-59)98(149)112-52-81(141)115-73(47-53(2)3)94(145)113-54(4)91(142)128-90(106(157)158)64-33-44-77(137)70(107)49-64/h10-15,18-19,22,53-57,59-77,82-90,129-137H,8-9,16-17,20-21,23-52,108-109H2,1-7H3,(H2,110,138)(H2,111,139)(H,112,149)(H,113,145)(H,114,140)(H,115,141)(H,116,146)(H,117,153)(H,118,147)(H,119,150)(H,120,143)(H,121,155)(H,122,154)(H,123,144)(H,124,148)(H,125,152)(H,126,151)(H,127,156)(H,128,142)(H,157,158)/b11-10-,22-15-/t54-,55+,56+,57+,59?,60?,61?,62?,63?,64?,65?,66?,67?,68?,69?,70?,71-,72-,73+,74+,75+,76?,77?,82+,83-,84+,85?,86-,87?,88-,89-,90?/m1/s1 D03NGH DRUGINKE FSBZBQUUCNYWOK-YIOPJBSBSA-N D03NGH DRUGSMIL CCCC=CC=CC(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(C1CCC(CC1)O)C(=O)NC(CCCN)C(=O)NC(C(C)O)C(=O)NC(C2CCC(CC2)O)C(=O)NC(C3CCC(CC3)O)C(=O)NC(C(C)O)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCN)C(=O)NC(C5CCC(CC5)O)C(=O)NC(C(C)O)C(=O)NC(C6CCC(CC6)O)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C7CCC(C(C7)Cl)O)C(=O)O D03NGH HIGHSTAT Phase 3 D03PIA DRUG__ID D03PIA D03PIA DRUGCOMP Cubist pharmaceuticals D03PIA DRUGINCH 1S/C77H101N17O26/c1-6-7-8-14-41-20-22-42(23-21-41)37(2)25-58(98)86-49(27-43-33-81-47-18-12-10-15-44(43)47)71(113)89-50(29-57(80)97)72(114)91-53(32-64(107)108)73(115)94-66-40(5)120-77(119)54(28-56(96)45-16-9-11-17-46(45)79)92-76(118)65(38(3)26-61(101)102)93-74(116)55(36-95)87-60(100)34-82-68(110)51(30-62(103)104)88-67(109)39(4)84-70(112)52(31-63(105)106)90-69(111)48(19-13-24-78)85-59(99)35-83-75(66)117/h9-12,15-18,20-23,25,33,38-40,48-55,65-66,81,95H,6-8,13-14,19,24,26-32,34-36,78-79H2,1-5H3,(H2,80,97)(H,82,110)(H,83,117)(H,84,112)(H,85,99)(H,86,98)(H,87,100)(H,88,109)(H,89,113)(H,90,111)(H,91,114)(H,92,118)(H,93,116)(H,94,115)(H,101,102)(H,103,104)(H,105,106)(H,107,108)/b37-25+/t38-,39-,40-,48+,49+,50-,51+,52+,53+,54+,55-,65+,66+/m1/s1 D03PIA DRUGINKE DYNMYYRPPFVAKR-CWXHRMTKSA-N D03PIA DRUGSMIL CCCCCC1=CC=C(C=C1)C(=CC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC4C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC4=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C5=CC=CC=C5N)C)C D03PIA HIGHSTAT Phase 3 D03PWD DRUG__ID D03PWD D03PWD DRUGCOMP Glycomimetics D03PWD DRUGINCH 1S/C60H109N3O27/c1-5-44-38-45(39-46(55(44)90-60-54(70)53(69)51(67)41(2)86-60)88-59-50(63-42(3)65)56(52(68)48(40-64)89-59)87-47(58(72)73)37-43-9-7-6-8-10-43)57(71)62-13-12-61-49(66)11-14-75-17-18-77-21-22-79-25-26-81-29-30-83-33-34-85-36-35-84-32-31-82-28-27-80-24-23-78-20-19-76-16-15-74-4/h41,43-48,50-56,59-60,64,67-70H,5-40H2,1-4H3,(H,61,66)(H,62,71)(H,63,65)(H,72,73)/t41-,44-,45+,46+,47-,48+,50+,51+,52-,53+,54-,55+,56+,59+,60-/m0/s1 D03PWD DRUGINKE LYSYOXNOOPBOSC-NGSKMYNLSA-N D03PWD DRUGSMIL CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC D03PWD HIGHSTAT Phase 3 D03WNG DRUG__ID D03WNG D03WNG DRUGCOMP Corcept TherapeuticsMenlo Park, CA D03WNG DRUGINCH 1S/C27H22F4N6O3S/c1-35-15-22(14-33-35)41(39,40)36-9-7-18-11-24-17(13-34-37(24)21-4-2-20(28)3-5-21)12-26(18,16-36)25(38)23-10-19(6-8-32-23)27(29,30)31/h2-6,8,10-11,13-15H,7,9,12,16H2,1H3/t26-/m0/s1 D03WNG DRUGINKE WANIDIGFXJFFEL-SANMLTNESA-N D03WNG DRUGSMIL CN1C=C(C=N1)S(=O)(=O)N2CCC3=CC4=C(CC3(C2)C(=O)C5=NC=CC(=C5)C(F)(F)F)C=NN4C6=CC=C(C=C6)F D03WNG HIGHSTAT Phase 3 D03WOW DRUG__ID D03WOW D03WOW DRUGCOMP Antigenics D03WOW DRUGINCH 1S/C92H148O46/c1-13-36(3)45(126-54(101)25-41(98)24-46(37(4)14-2)127-80-64(111)58(105)48(30-94)128-80)23-40(97)26-55(102)132-70-39(6)125-82(73(67(70)114)136-79-66(113)61(108)69(38(5)124-79)133-78-63(110)59(106)49(32-122-78)130-84-75(116)91(120,34-96)35-123-84)138-85(119)92-22-21-86(7,8)27-43(92)42-15-16-51-87(9)19-18-53(88(10,33-95)50(87)17-20-89(51,11)90(42,12)28-52(92)100)131-83-74(137-81-65(112)60(107)57(104)47(29-93)129-81)71(68(115)72(135-83)76(117)118)134-77-62(109)56(103)44(99)31-121-77/h15,33,36-41,43-53,56-75,77-84,93-94,96-100,103-116,120H,13-14,16-32,34-35H2,1-12H3,(H,117,118)/t36?,37?,38-,39+,40?,41?,43-,44+,45?,46?,47+,48-,49+,50+,51+,52+,53-,56-,57-,58-,59-,60-,61-,62+,63+,64+,65+,66+,67-,68-,69-,70-,71-,72-,73+,74+,75-,77-,78-,79-,80+,81+,82-,83+,84-,87-,88-,89+,90+,91+,92+/m0/s1 D03WOW DRUGINKE XYVMMKXMQBIPIQ-JOMHPNDBSA-N D03WOW DRUGSMIL CCC(C)C(CC(CC(=O)OC(CC(CC(=O)OC1C(OC(C(C1O)OC2C(C(C(C(O2)C)OC3C(C(C(CO3)OC4C(C(CO4)(CO)O)O)O)O)O)O)OC(=O)C56CCC(CC5C7=CCC8C9(CCC(C(C9CCC8(C7(CC6O)C)C)(C)C=O)OC1C(C(C(C(O1)C(=O)O)O)OC1C(C(C(CO1)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)C)(C)C)C)O)C(C)CC)O)OC1C(C(C(O1)CO)O)O D03WOW HIGHSTAT Phase 3 D04DJS DRUG__ID D04DJS D04DJS DRUGTYPE Small molecular drug D04DJS DRUGINCH 1S/C17H27NO2/c1-11(2)18-13(4)16(19)10-20-17-9-8-12(3)14-6-5-7-15(14)17/h8-9,11,13,16,18-19H,5-7,10H2,1-4H3 D04DJS DRUGINKE VFIDUCMKNJIJTO-UHFFFAOYSA-N D04DJS DRUGSMIL CC1=C2CCCC2=C(C=C1)OCC(C(C)NC(C)C)O D04DJS HIGHSTAT Phase 3 D04FXY DRUG__ID D04FXY D04FXY DRUGCOMP Summit Corp plc D04FXY DRUGINCH 1S/C24H16N6/c1-3-19-21(29-23(27-19)15-5-9-25-10-6-15)13-17(1)18-2-4-20-22(14-18)30-24(28-20)16-7-11-26-12-8-16/h1-14H,(H,27,29)(H,28,30) D04FXY DRUGINKE UHQFBTAJFNVZIV-UHFFFAOYSA-N D04FXY DRUGSMIL C1=CC2=C(C=C1C3=CC4=C(C=C3)N=C(N4)C5=CC=NC=C5)NC(=N2)C6=CC=NC=C6 D04FXY HIGHSTAT Phase 3 D04KMP DRUG__ID D04KMP D04KMP DRUGCOMP Suven Life Sciences Hyderabad, India D04KMP DRUGINCH 1S/C21H31N3O3/c25-21(16-23-12-14-26-15-13-23)22-17-4-6-19(7-5-17)27-20-8-10-24(11-9-20)18-2-1-3-18/h4-7,18,20H,1-3,8-16H2,(H,22,25) D04KMP DRUGINKE LNXDUSQEXVQFGP-UHFFFAOYSA-N D04KMP DRUGSMIL C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4 D04KMP HIGHSTAT Phase 3 D04NNJ DRUG__ID D04NNJ D04NNJ DRUGTYPE Small molecular drug D04NNJ DRUGINCH 1S/C23H32N2O3S/c1-5-23(26)11-9-19-17-7-6-16-12-20-15(14-25(24-20)29(4,27)28)13-21(16,2)18(17)8-10-22(19,23)3/h1,14,16-19,26H,6-13H2,2-4H3/t16-,17+,18-,19-,21-,22-,23-/m0/s1 D04NNJ DRUGINKE MHDDZDPNIDVLNK-ZGIWMXSJSA-N D04NNJ DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4C3(CC5=CN(N=C5C4)S(=O)(=O)C)C D04NNJ HIGHSTAT Phase 3 D04ORP DRUG__ID D04ORP D04ORP DRUGTYPE Small molecular drug D04ORP DRUGINCH 1S/C28H36N2O15S2/c1-41-15-7-3-5-13(9-15)25(36)29-19-21(33)17(11-31)43-27(23(19)35)46-28-24(45-47(38,39)40)20(22(34)18(12-32)44-28)30-26(37)14-6-4-8-16(10-14)42-2/h3-10,17-24,27-28,31-35H,11-12H2,1-2H3,(H,29,36)(H,30,37)(H,38,39,40)/t17-,18-,19+,20+,21+,22+,23-,24-,27+,28+/m1/s1 D04ORP DRUGINKE CNUFQRWWCPUUQG-CWKIZLMASA-N D04ORP DRUGSMIL COC1=CC=CC(=C1)C(=O)NC2C(C(OC(C2O)SC3C(C(C(C(O3)CO)O)NC(=O)C4=CC(=CC=C4)OC)OS(=O)(=O)O)CO)O D04ORP HIGHSTAT Phase 3 D04VRN DRUG__ID D04VRN D04VRN DRUGCOMP GlaxoSmithKline D04VRN DRUGINCH 1S/C16H32N6O4S2/c1-27-8-5-10(17)13(23)21-11(6-9-28-2)14(24)22-12(15(25)26)4-3-7-20-16(18)19/h10-12H,3-9,17H2,1-2H3,(H,21,23)(H,22,24)(H,25,26)(H4,18,19,20) D04VRN DRUGINKE OXIWIYOJVNOKOV-UHFFFAOYSA-N D04VRN DRUGSMIL CSCCC(C(=O)NC(CCSC)C(=O)NC(CCCN=C(N)N)C(=O)O)N D04VRN HIGHSTAT Phase 3 D04XIO DRUG__ID D04XIO D04XIO DRUGCOMP Phenomix Corp D04XIO DRUGINCH 1S/C10H20BN3O3/c15-10(7-13-8-3-4-12-6-8)14-5-1-2-9(14)11(16)17/h8-9,12-13,16-17H,1-7H2/t8-,9+/m1/s1 D04XIO DRUGINKE DVJAMEIQRSHVKC-BDAKNGLRSA-N D04XIO DRUGSMIL B(C1CCCN1C(=O)CNC2CCNC2)(O)O D04XIO HIGHSTAT Phase 3 D04ZKY DRUG__ID D04ZKY D04ZKY DRUGCOMP Sunovion D04ZKY DRUGINCH 1S/C9H13NOS/c1-10-6-8-9-7(2-4-11-8)3-5-12-9/h3,5,8,10H,2,4,6H2,1H3/t8-/m0/s1 D04ZKY DRUGINKE ABDDQTDRAHXHOC-QMMMGPOBSA-N D04ZKY DRUGSMIL CNCC1C2=C(CCO1)C=CS2 D04ZKY HIGHSTAT Phase 3 D05AJT DRUG__ID D05AJT D05AJT DRUGTYPE Small molecular drug D05AJT DRUGINCH 1S/C25H28N6O2/c32-24(23-2-1-12-26-23)28-19-5-3-18(4-6-19)22-11-13-27-25(30-22)29-20-7-9-21(10-8-20)31-14-16-33-17-15-31/h3-11,13,23,26H,1-2,12,14-17H2,(H,28,32)(H,27,29,30)/t23-/m0/s1 D05AJT DRUGINKE ISOCDPQFIXDIMS-QHCPKHFHSA-N D05AJT DRUGSMIL C1CC(NC1)C(=O)NC2=CC=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5 D05AJT HIGHSTAT Phase 3 D05ALP DRUG__ID D05ALP D05ALP DRUGCOMP Regado Biosciences D05ALP DRUGINCH 1S/C20H40N3O11P/c1-30-13-15-32-19(25)22-11-7-5-9-17(23-20(26)33-16-14-31-2)18(24)21-10-6-3-4-8-12-34-35(27,28)29/h17H,3-16H2,1-2H3,(H,21,24)(H,22,25)(H,23,26)(H2,27,28,29) D05ALP DRUGINKE QGVYYLZOAMMKAH-UHFFFAOYSA-N D05ALP DRUGSMIL COCCOC(=O)NCCCCC(C(=O)NCCCCCCOP(=O)(O)O)NC(=O)OCCOC D05ALP HIGHSTAT Phase 3 D05BDY DRUG__ID D05BDY D05BDY DRUGCOMP Pharnext SAS D05BDY DRUGINCH 1S/C21H27N3O2/c1-2-26-21(25)17-13-19(22-14-16-9-5-3-6-10-16)20(23-15-17)24-18-11-7-4-8-12-18/h3,5-6,9-10,13,15,18,22H,2,4,7-8,11-12,14H2,1H3,(H,23,24) D05BDY DRUGINKE WRUIDZKNUAHKTR-UHFFFAOYSA-N D05BDY DRUGSMIL CCOC(=O)C1=CC(=C(N=C1)NC2CCCCC2)NCC3=CC=CC=C3 D05BDY HIGHSTAT Phase 3 D05DPU DRUG__ID D05DPU D05DPU DRUGCOMP Semnur Pharmaceuticals Mountain View, CA D05DPU DRUGINCH 1S/C14H19NO4/c1-17-13-4-2-3-12(11-16)14(13)19-10-7-15-5-8-18-9-6-15/h2-4,11H,5-10H2,1H3 D05DPU DRUGINKE WWOLOKZLMZZKJY-UHFFFAOYSA-N D05DPU DRUGSMIL COC1=CC=CC(=C1OCCN2CCOCC2)C=O D05DPU HIGHSTAT Phase 3 D05FCR DRUG__ID D05FCR D05FCR DRUGCOMP Suzhou Kintor Pharmaceuticals Suzhou, China D05FCR DRUGINCH 1S/C24H19F4N5O2S/c1-23(2)21(34)32(17-9-6-14(12-29)19(20(17)25)24(26,27)28)22(36)33(23)16-8-7-15(31-13-16)4-3-5-18-30-10-11-35-18/h6-11,13H,3-5H2,1-2H3 D05FCR DRUGINKE KCBJGVDOSBKVKP-UHFFFAOYSA-N D05FCR DRUGSMIL CC1(C(=O)N(C(=S)N1C2=CN=C(C=C2)CCCC3=NC=CO3)C4=C(C(=C(C=C4)C#N)C(F)(F)F)F)C D05FCR HIGHSTAT Phase 3 D05OQG DRUG__ID D05OQG D05OQG DRUGTYPE Small molecular drug D05OQG DRUGINCH 1S/C33H40O15/c1-13(2)5-10-17-19(45-33-28(42)26(40)23(37)20(12-34)46-33)11-18(35)21-24(38)31(48-32-27(41)25(39)22(36)14(3)44-32)29(47-30(17)21)15-6-8-16(43-4)9-7-15/h5-9,11,14,20,22-23,25-28,32-37,39-42H,10,12H2,1-4H3/t14-,20+,22-,23+,25+,26-,27+,28+,32-,33+/m0/s1 D05OQG DRUGINKE TZJALUIVHRYQQB-XLRXWWTNSA-N D05OQG DRUGSMIL CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OC4C(C(C(C(O4)CO)O)O)O)O)C5=CC=C(C=C5)OC)O)O)O D05OQG HIGHSTAT Phase 3 D05OZQ DRUG__ID D05OZQ D05OZQ DRUGCOMP Sanofi US Bridgewater, NJ D05OZQ DRUGINCH 1S/C19H37N3O6/c20-16(18(23)24)6-1-2-8-21-9-4-12-27-14-15-28-13-5-11-22-10-3-7-17(22)19(25)26/h16-17,21H,1-15,20H2,(H,23,24)(H,25,26)/t16-,17-/m0/s1 D05OZQ DRUGINKE OJQLGILETRTDGQ-IRXDYDNUSA-N D05OZQ DRUGSMIL C1CC(N(C1)CCCOCCOCCCNCCCCC(C(=O)O)N)C(=O)O D05OZQ HIGHSTAT Phase 3 D05PWX DRUG__ID D05PWX D05PWX DRUGCOMP Hutchison Medipharma Enterprises Ltd D05PWX DRUGINCH 1S/C24H28N6O3S/c1-17-13-19-15-21(7-8-22(19)27-17)33-23-9-10-25-24(29-23)28-20-6-4-5-18(14-20)16-34(31,32)26-11-12-30(2)3/h4-10,13-15,26-27H,11-12,16H2,1-3H3,(H,25,28,29) D05PWX DRUGINKE TTZSNFLLYPYKIL-UHFFFAOYSA-N D05PWX DRUGSMIL CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C D05PWX HIGHSTAT Phase 3 D05QUL DRUG__ID D05QUL D05QUL DRUGTYPE Small molecular drug D05QUL DRUGINCH 1S/C4H5N5O3/c1-3(10)2-8-6-4(5-7-8)9(11)12/h2H2,1H3 D05QUL DRUGINKE RNOFFEQSFLGZHK-UHFFFAOYSA-N D05QUL DRUGSMIL CC(=O)CN1N=C(N=N1)[N+](=O)[O-] D05QUL HIGHSTAT Phase 3 D05RJP DRUG__ID D05RJP D05RJP DRUGCOMP Genta Incorp D05RJP DRUGINCH 1S/C172H221N62O91P17S17.17Na/c1-69-39-225(169(253)213-149(69)237)117-21-73(236)92(292-117)44-274-326(257,343)320-85-33-129(229-63-191-135-141(181)187-61-189-143(135)229)303-103(85)55-285-332(263,349)314-79-27-122(221-17-9-113(177)201-165(221)249)295-95(79)47-278-330(261,347)312-78-26-121(220-16-8-112(176)200-164(220)248)298-98(78)50-280-338(269,355)322-87-35-131(231-65-193-137-145(231)205-157(183)209-153(137)241)305-105(87)57-287-334(265,351)316-81-29-124(223-19-11-115(179)203-167(223)251)299-99(81)51-281-339(270,356)323-88-36-132(232-66-194-138-146(232)206-158(184)210-154(138)242)307-107(88)59-289-337(268,354)319-84-32-128(228-42-72(4)152(240)216-172(228)256)302-102(84)54-284-341(272,358)325-90-38-134(234-68-196-140-148(234)208-160(186)212-156(140)244)306-106(90)58-288-335(266,352)317-82-30-125(224-20-12-116(180)204-168(224)252)300-100(82)52-282-340(271,357)324-89-37-133(233-67-195-139-147(233)207-159(185)211-155(139)243)308-108(89)60-290-342(273,359)321-86-34-130(230-64-192-136-142(182)188-62-190-144(136)230)304-104(86)56-286-333(264,350)315-80-28-123(222-18-10-114(178)202-166(222)250)296-96(80)48-277-328(259,345)310-76-24-119(218-14-6-110(174)198-162(218)246)294-94(76)46-276-329(260,346)311-77-25-120(219-15-7-111(175)199-163(219)247)297-97(77)49-279-336(267,353)318-83-31-127(227-41-71(3)151(239)215-171(227)255)301-101(83)53-283-331(262,348)313-75-23-118(217-13-5-109(173)197-161(217)245)293-93(75)45-275-327(258,344)309-74-22-126(291-91(74)43-235)226-40-70(2)150(238)214-170(226)254;;;;;;;;;;;;;;;;;/h5-20,39-42,61-68,73-108,117-134,235-236H,21-38,43-60H2,1-4H3,(H,257,343)(H,258,344)(H,259,345)(H,260,346)(H,261,347)(H,262,348)(H,263,349)(H,264,350)(H,265,351)(H,266,352)(H,267,353)(H,268,354)(H,269,355)(H,270,356)(H,271,357)(H,272,358)(H,273,359)(H2,173,197,245)(H2,174,198,246)(H2,175,199,247)(H2,176,200,248)(H2,177,201,249)(H2,178,202,250)(H2,179,203,251)(H2,180,204,252)(H2,181,187,189)(H2,182,188,190)(H,213,237,253)(H,214,238,254)(H,215,239,255)(H,216,240,256)(H3,183,205,209,241)(H3,184,206,210,242)(H3,185,207,211,243)(H3,186,208,212,244);;;;;;;;;;;;;;;;;/q;17*+1/p-17/t73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,117+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,326?,327?,328?,329?,330?,331?,332?,333?,334?,335?,336?,337?,338?,339?,340?,341?,342?;;;;;;;;;;;;;;;;;/m0................./s1 D05RJP DRUGINKE IBXPAFBDJCXCDW-MHFPCNPESA-A D05RJP DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=S)([O-])OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D05RJP HIGHSTAT Phase 3 D05STQ DRUG__ID D05STQ D05STQ DRUGTYPE Small molecular drug D05STQ DRUGINCH 1S/C16H15FN2O4/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)22/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)/t7-/m0/s1 D05STQ DRUGINKE XAGMUUZPGZWTRP-ZETCQYMHSA-N D05STQ DRUGSMIL CC1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O D05STQ HIGHSTAT Phase 3 D05WDG DRUG__ID D05WDG D05WDG DRUGCOMP ParaPRO Carmel, IN D05WDG DRUGINCH 1S/C42H67NO10.C41H65NO10/c1-11-26-13-12-14-35(53-37-16-15-34(43(6)7)24(4)49-37)23(3)38(45)33-20-31-29(32(33)21-36(44)51-26)17-22(2)28-18-27(19-30(28)31)52-42-41(48-10)40(47-9)39(46-8)25(5)50-42;1-10-26-12-11-13-34(52-36-17-16-33(42(5)6)23(3)48-36)22(2)37(44)32-20-30-28(31(32)21-35(43)50-26)15-14-25-18-27(19-29(25)30)51-41-40(47-9)39(46-8)38(45-7)24(4)49-41/h17,20,23-32,34-35,37,39-42H,11-16,18-19,21H2,1-10H3;14-15,20,22-31,33-34,36,38-41H,10-13,16-19,21H2,1-9H3/t23-,24-,25+,26+,27-,28+,29-,30-,31-,32+,34+,35?,37+,39+,40-,41-,42+;22-,23-,24+,25-,26+,27-,28-,29-,30-,31+,33+,34?,36+,38+,39-,40-,41+/m11/s1 D05WDG DRUGINKE JFLRKDZMHNBDQS-GQHNJWLYSA-N D05WDG DRUGSMIL CCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C=CC3C2CC(=O)O1)OC5C(C(C(C(O5)C)OC)OC)OC)C)OC6CCC(C(O6)C)N(C)C.CCC1CCCC(C(C(=O)C2=CC3C4CC(CC4C(=CC3C2CC(=O)O1)C)OC5C(C(C(C(O5)C)OC)OC)OC)C)OC6CCC(C(O6)C)N(C)C D05WDG HIGHSTAT Phase 3 D06ICW DRUG__ID D06ICW D06ICW DRUGTYPE Small molecular drug D06ICW DRUGINCH 1S/C13H19NO2/c1-9(2)14-10(3)6-11-4-5-12-13(7-11)16-8-15-12/h4-5,7,9-10,14H,6,8H2,1-3H3 D06ICW DRUGINKE XKEVWMVUIDDRMC-UHFFFAOYSA-N D06ICW DRUGSMIL CC(C)NC(C)CC1=CC2=C(C=C1)OCO2 D06ICW HIGHSTAT Phase 3 D06PII DRUG__ID D06PII D06PII DRUGTYPE Small molecular drug D06PII DRUGINCH 1S/C10H14N2O4S2/c11-18(15,16)10-5-3-9(4-6-10)12-7-1-2-8-17(12,13)14/h3-6H,1-2,7-8H2,(H2,11,15,16) D06PII DRUGINKE HMHVCUVYZFYAJI-UHFFFAOYSA-N D06PII DRUGSMIL C1CCS(=O)(=O)N(C1)C2=CC=C(C=C2)S(=O)(=O)N D06PII HIGHSTAT Phase 3 D06RBJ DRUG__ID D06RBJ D06RBJ DRUGTYPE Small molecular drug D06RBJ DRUGINCH 1S/C26H35NO4.ClH/c1-7-28-23-10-9-19(14-24(23)29-8-2)13-22-21-16-26(31-18(5)6)25(30-17(3)4)15-20(21)11-12-27-22;/h9-10,14-18H,7-8,11-13H2,1-6H3;1H D06RBJ DRUGINKE AWQPJKUSDUHYIX-UHFFFAOYSA-N D06RBJ DRUGSMIL CCOC1=C(C=C(C=C1)CC2=NCCC3=CC(=C(C=C32)OC(C)C)OC(C)C)OCC.Cl D06RBJ HIGHSTAT Phase 3 D06RVQ DRUG__ID D06RVQ D06RVQ DRUGCOMP Mallinckrodt St. Louis, MO NeuroproteXeon Orchard Park, NY D06RVQ DRUGINCH 1S/Xe D06RVQ DRUGINKE FHNFHKCVQCLJFQ-UHFFFAOYSA-N D06RVQ DRUGSMIL [Xe] D06RVQ HIGHSTAT Phase 3 D06VZN DRUG__ID D06VZN D06VZN DRUGCOMP SPA Societa Prodotti Antibiotici SpA D06VZN DRUGINCH 1S/C67H103N5O19.2C6H8O6/c1-42-21-19-17-15-13-11-9-10-12-14-16-18-20-22-54(89-66-63(85)61(62(84)44(3)88-66)70-58(82)41-72(7)8)38-57-60(65(86)69-29-30-71(5)6)56(81)40-67(87,91-57)39-53(79)35-51(77)33-49(75)31-48(74)32-50(76)34-52(78)37-59(83)90-64(42)43(2)23-28-47(73)36-55(80)45-24-26-46(68-4)27-25-45;2*7-1-2(8)5-3(9)4(10)6(11)12-5/h9-22,24-27,42-44,47-49,51-54,56-57,60-64,66,68,73-75,77-79,81,84-85,87H,23,28-41H2,1-8H3,(H,69,86)(H,70,82);2*2,5,7-10H,1H2/b10-9+,13-11+,14-12+,17-15+,18-16+,21-19+,22-20+;;/t42-,43-,44+,47?,48+,49-,51-,52+,53-,54-,56-,57-,60+,61-,62+,63-,64-,66-,67+;2*2-,5+/m000/s1 D06VZN DRUGINKE VUJFLULIGNDMNL-VJVWVGQESA-N D06VZN DRUGSMIL CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(CC(CC(CC(=O)CC(CC(=O)OC1C(C)CCC(CC(=O)C3=CC=C(C=C3)NC)O)O)O)O)O)O)O)O)C(=O)NCCN(C)C)OC4C(C(C(C(O4)C)O)NC(=O)CN(C)C)O.C(C(C1C(=C(C(=O)O1)O)O)O)O.C(C(C1C(=C(C(=O)O1)O)O)O)O D06VZN HIGHSTAT Phase 3 D06WOF DRUG__ID D06WOF D06WOF DRUGCOMP StemcentRx South San Francisco, CA D06WOF DRUGINCH 1S/C78H108N10O25S/c1-49(2)70(84-68(90)16-21-103-23-25-105-27-29-107-31-33-109-35-36-110-34-32-108-30-28-106-26-24-104-22-17-80-67(89)15-18-85-69(91)43-66(76(85)97)114-48-58(79)77(98)99)72(93)82-52(5)71(92)83-54-13-11-53(12-14-54)47-113-78(100)88-60-42-65(63(102-7)40-57(60)74(95)87-46-51(4)38-61(87)75(88)96)112-20-10-8-9-19-111-64-41-59-56(39-62(64)101-6)73(94)86-45-50(3)37-55(86)44-81-59/h11-14,39-42,44-46,49,52,55,58,61,66,70,75,96H,8-10,15-38,43,47-48,79H2,1-7H3,(H,80,89)(H,82,93)(H,83,92)(H,84,90)(H,98,99)/t52-,55-,58-,61-,66+,70-,75-/m0/s1 D06WOF DRUGINKE NQUUPTGRJYIXSL-YPDXTJLXSA-N D06WOF DRUGSMIL CC1=CN2C(C1)C=NC3=CC(=C(C=C3C2=O)OC)OCCCCCOC4=C(C=C5C(=C4)N(C(C6CC(=CN6C5=O)C)O)C(=O)OCC7=CC=C(C=C7)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)CCN8C(=O)CC(C8=O)SCC(C(=O)O)N)OC D06WOF HIGHSTAT Phase 3 D07AHC DRUG__ID D07AHC D07AHC DRUGTYPE Small molecular drug D07AHC DRUGINCH 1S/C16H19NO/c1-2-4-15-11-13(5-6-14(15)3-1)12-18-16-7-9-17-10-8-16/h1-6,11,16-17H,7-10,12H2 D07AHC DRUGINKE MJJDYOLPMGIWND-UHFFFAOYSA-N D07AHC DRUGSMIL C1CNCCC1OCC2=CC3=CC=CC=C3C=C2 D07AHC HIGHSTAT Phase 3 D07CIN DRUG__ID D07CIN D07CIN DRUGTYPE Small molecular drug D07CIN DRUGINCH 1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m1/s1 D07CIN DRUGINKE PBHFNBQPZCRWQP-QUCCMNQESA-N D07CIN DRUGSMIL CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C D07CIN HIGHSTAT Phase 3 D07GJZ DRUG__ID D07GJZ D07GJZ DRUGTYPE Small molecular drug D07GJZ DRUGINCH 1S/C21H32N4O2S/c1-5-24-13-15-11-20-18(17-9-8-10-19(24)21(15)17)12-16(14-23(20)4)22-28(26,27)25(6-2)7-3/h8-10,13,16,18,20,22H,5-7,11-12,14H2,1-4H3/t16-,18+,20+/m0/s1 D07GJZ DRUGINKE ARTRTLXKTHJPRW-ILZDJORESA-N D07GJZ DRUGSMIL CCN1C=C2CC3C(CC(CN3C)NS(=O)(=O)N(CC)CC)C4=C2C1=CC=C4 D07GJZ HIGHSTAT Phase 3 D07HOH DRUG__ID D07HOH D07HOH DRUGCOMP Merrimack Pharmaceuticals D07HOH DRUGINCH 1S/C33H38N4O6.C12H22O35S8/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;13-48(14,15)37-1-4-6(43-51(22,23)24)8(45-53(28,29)30)9(46-54(31,32)33)11(40-4)42-12(3-39-50(19,20)21)10(47-55(34,35)36)7(44-52(25,26)27)5(41-12)2-38-49(16,17)18/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;4-11H,1-3H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)(H,25,26,27)(H,28,29,30)(H,31,32,33)(H,34,35,36)/t33-;4-,5-,6-,7+,8+,9-,10+,11-,12+/m01/s1 D07HOH DRUGINKE PMZSPINGJVBHAT-DJBCQDJXSA-N D07HOH DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O D07HOH HIGHSTAT Phase 3 D07KEH DRUG__ID D07KEH D07KEH DRUGCOMP Akebia therapeutics D07KEH DRUGINCH 1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20) D07KEH DRUGINKE JGRXMPYUTJLTKT-UHFFFAOYSA-N D07KEH DRUGSMIL C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O D07KEH HIGHSTAT Phase 3 D07MED DRUG__ID D07MED D07MED DRUGTYPE Small molecular drug D07MED DRUGINCH 1S/C25H30ClN3O2/c1-27(2)13-14-29-16-21(20-8-7-19(26)15-23(20)29)24(30)28-11-9-25(10-12-28)22-6-4-3-5-18(22)17-31-25/h3-8,15,21H,9-14,16-17H2,1-2H3 D07MED DRUGINKE DRMVDBATNZBNEB-UHFFFAOYSA-N D07MED DRUGSMIL CN(C)CCN1CC(C2=C1C=C(C=C2)Cl)C(=O)N3CCC4(CC3)C5=CC=CC=C5CO4 D07MED HIGHSTAT Phase 3 D07PQJ DRUG__ID D07PQJ D07PQJ DRUGCOMP ArQule Inc D07PQJ DRUGINCH 1S/C29H29FN4O/c1-35-16-15-31-14-13-20-7-6-8-22(17-20)33-29-32-19-21-18-26(24-10-4-5-12-27(24)30)23-9-2-3-11-25(23)28(21)34-29/h2-12,17,19,26,31H,13-16,18H2,1H3,(H,32,33,34)/t26-/m1/s1 D07PQJ DRUGINKE KPJDVVCDVBFRMU-AREMUKBSSA-N D07PQJ DRUGSMIL COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F D07PQJ HIGHSTAT Phase 3 D07QKK DRUG__ID D07QKK D07QKK DRUGTYPE Small molecular drug D07QKK DRUGINCH 1S/ClH/h1H/p-1 D07QKK DRUGINKE VEXZGXHMUGYJMC-UHFFFAOYSA-M D07QKK DRUGSMIL [Cl-] D07QKK HIGHSTAT Phase 3 D07SDQ DRUG__ID D07SDQ D07SDQ DRUGTYPE Small molecular drug D07SDQ DRUGINCH 1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+ D07SDQ DRUGINKE VFLDPWHFBUODDF-FCXRPNKRSA-N D07SDQ DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O D07SDQ HIGHSTAT Phase 3 D07TDV DRUG__ID D07TDV D07TDV DRUGCOMP Stealth Peptides D07TDV DRUGINCH 1S/C32H49N9O5/c1-19-15-22(42)16-20(2)23(19)18-27(41-29(44)24(34)11-8-14-38-32(36)37)31(46)39-25(12-6-7-13-33)30(45)40-26(28(35)43)17-21-9-4-3-5-10-21/h3-5,9-10,15-16,24-27,42H,6-8,11-14,17-18,33-34H2,1-2H3,(H2,35,43)(H,39,46)(H,40,45)(H,41,44)(H4,36,37,38)/t24-,25+,26+,27+/m1/s1 D07TDV DRUGINKE SFVLTCAESLKEHH-WKAQUBQDSA-N D07TDV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O D07TDV HIGHSTAT Phase 3 D07UXF DRUG__ID D07UXF D07UXF DRUGCOMP Arbor Pharmaceuticals Atlanta, GA D07UXF DRUGINCH 1S/C12H16N2O2.ClH/c1-4-8-13-12(15)16-11-7-5-6-10(9-11)14(2)3;/h4-7,9H,1,8H2,2-3H3,(H,13,15);1H D07UXF DRUGINKE LJKIRELMTXZWIT-UHFFFAOYSA-N D07UXF DRUGSMIL C[NH+](C)C1=CC(=CC=C1)OC(=O)NCC=C.[Cl-] D07UXF HIGHSTAT Phase 3 D07WHN DRUG__ID D07WHN D07WHN DRUGTYPE Small molecular drug D07WHN DRUGINCH 1S/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1 D07WHN DRUGINKE GOWRRBABHQUJMX-MRVPVSSYSA-N D07WHN DRUGSMIL C1CCN(CC1)C(=O)C2CCC(=O)N2 D07WHN HIGHSTAT Phase 3 D07ZCK DRUG__ID D07ZCK D07ZCK DRUGTYPE Small molecular drug D07ZCK DRUGINCH 1S/C23H22N2O4/c1-3-28-23(26)22-18(14-27-2)21-17-11-16(29-13-15-7-5-4-6-8-15)9-10-19(17)25-20(21)12-24-22/h4-12,25H,3,13-14H2,1-2H3 D07ZCK DRUGINKE ALBKMJDFBZVHAK-UHFFFAOYSA-N D07ZCK DRUGSMIL CCOC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4 D07ZCK HIGHSTAT Phase 3 D08BXT DRUG__ID D08BXT D08BXT DRUGTYPE Small molecular drug D08BXT DRUGINCH 1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2 D08BXT DRUGINKE ATHGHQPFGPMSJY-UHFFFAOYSA-N D08BXT DRUGSMIL C(CCNCCCN)CN D08BXT HIGHSTAT Phase 3 D08CJK DRUG__ID D08CJK D08CJK DRUGTYPE Small molecular drug D08CJK DRUGINCH 1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2 D08CJK DRUGINKE APJYDQYYACXCRM-UHFFFAOYSA-N D08CJK DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCN D08CJK HIGHSTAT Phase 3 D08HVG DRUG__ID D08HVG D08HVG DRUGTYPE Small molecular drug D08HVG DRUGINCH 1S/C35H35F2N8O5S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3/q+1/t22-,23?,35+/m0/s1 D08HVG DRUGINKE RSWOJTICKMKTER-QXLBVTBOSA-N D08HVG DRUGSMIL CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O D08HVG HIGHSTAT Phase 3 D08IXA DRUG__ID D08IXA D08IXA DRUGTYPE Small molecular drug D08IXA DRUGINCH 1S/C34H51N5O7.Na/c1-8-9-16-25(31(42)43)35-29(40)26(18-23-20-38(33(45)46-7)28-17-11-10-15-24(23)28)36-30(41)27(19-34(4,5)6)37-32(44)39-21(2)13-12-14-22(39)3;/h10-11,15,17,20-22,25-27H,8-9,12-14,16,18-19H2,1-7H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43);/q;+1/p-1/t21-,22+,25-,26-,27+;/m1./s1 D08IXA DRUGINKE QCVIFBRTTLMEOV-FUKQNADPSA-M D08IXA DRUGSMIL CCCCC(C(=O)[O-])NC(=O)C(CC1=CN(C2=CC=CC=C21)C(=O)OC)NC(=O)C(CC(C)(C)C)NC(=O)N3C(CCCC3C)C.[Na+] D08IXA HIGHSTAT Phase 3 D08MCS DRUG__ID D08MCS D08MCS DRUGCOMP Adamas Pharmaceuticals Emeryville, CA D08MCS DRUGINCH 1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H D08MCS DRUGINKE WOLHOYHSEKDWQH-UHFFFAOYSA-N D08MCS DRUGSMIL C1C2CC3CC1CC(C2)(C3)N.Cl D08MCS HIGHSTAT Phase 3 D08MHD DRUG__ID D08MHD D08MHD DRUGCOMP Eisai Co Ltd D08MHD DRUGINCH 1S/C19H18F3N5O2S/c1-9-12-7-30-18(23)27-19(12,8-29-9)11-4-10(2-3-13(11)20)26-17(28)15-6-24-14(5-25-15)16(21)22/h2-6,9,12,16H,7-8H2,1H3,(H2,23,27)(H,26,28)/t9-,12-,19-/m1/s1 D08MHD DRUGINKE AACUJFVOHGRMTR-DPXNYUHVSA-N D08MHD DRUGSMIL CC1C2CSC(=NC2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(N=C4)C(F)F)F)N D08MHD HIGHSTAT Phase 3 D08NCO DRUG__ID D08NCO D08NCO DRUGTYPE Small molecular drug D08NCO DRUGINCH 1S/H3N.3O.V/h1H3;;;;/q;;;-1;/p+1 D08NCO DRUGINKE UNTBPXHCXVWYOI-UHFFFAOYSA-O D08NCO DRUGSMIL [NH4+].[O-][V](=O)=O D08NCO HIGHSTAT Phase 3 D08NKJ DRUG__ID D08NKJ D08NKJ DRUGTYPE Small molecular drug D08NKJ DRUGINCH 1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11) D08NKJ DRUGINKE UYTPUPDQBNUYGX-UHFFFAOYSA-N D08NKJ DRUGSMIL C1=NC2=C(N1)C(=O)NC(=N2)N D08NKJ HIGHSTAT Phase 3 D08NXW DRUG__ID D08NXW D08NXW DRUGCOMP Emisphere Technologies Inc D08NXW DRUGINCH 1S/C149H226N40O45/c1-17-76(10)119(146(232)167-80(14)126(212)175-104(60-86-63-159-91-36-25-24-35-89(86)91)136(222)177-100(56-73(4)5)137(223)186-117(74(6)7)144(230)174-93(37-26-28-52-150)128(214)160-65-110(197)168-92(122(154)208)39-30-54-158-149(155)156)188-138(224)102(57-83-31-20-18-21-32-83)178-133(219)98(47-51-115(204)205)173-132(218)94(38-27-29-53-151)170-124(210)78(12)164-123(209)77(11)166-131(217)97(44-48-109(153)196)169-111(198)66-161-130(216)96(46-50-114(202)203)172-134(220)99(55-72(2)3)176-135(221)101(59-85-40-42-88(195)43-41-85)179-141(227)106(68-190)182-143(229)108(70-192)183-145(231)118(75(8)9)187-140(226)105(62-116(206)207)180-142(228)107(69-191)184-148(234)121(82(16)194)189-139(225)103(58-84-33-22-19-23-34-84)181-147(233)120(81(15)193)185-112(199)67-162-129(215)95(45-49-113(200)201)171-125(211)79(13)165-127(213)90(152)61-87-64-157-71-163-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,159,190-195H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,196)(H2,154,208)(H,157,163)(H,160,214)(H,161,216)(H,162,215)(H,164,209)(H,165,213)(H,166,217)(H,167,232)(H,168,197)(H,169,198)(H,170,210)(H,171,211)(H,172,220)(H,173,218)(H,174,230)(H,175,212)(H,176,221)(H,177,222)(H,178,219)(H,179,227)(H,180,228)(H,181,233)(H,182,229)(H,183,231)(H,184,234)(H,185,199)(H,186,223)(H,187,226)(H,188,224)(H,189,225)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,158)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1 D08NXW DRUGINKE DTHNMHAUYICORS-KTKZVXAJSA-N D08NXW DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N D08NXW HIGHSTAT Phase 3 D08PCH DRUG__ID D08PCH D08PCH DRUGCOMP Antigenics D08PCH DRUGINCH 1S/C19H11F5N2O2.C12H18N2O/c20-12-6-7-16(15(21)10-12)26-17(27)14-5-2-8-25-18(14)28-13-4-1-3-11(9-13)19(22,23)24;1-9(2)10-5-7-11(8-6-10)13-12(15)14(3)4/h1-10H,(H,26,27);5-9H,1-4H3,(H,13,15) D08PCH DRUGINKE RZSCFTDHFNHMOR-UHFFFAOYSA-N D08PCH DRUGSMIL CC(C)C1=CC=C(C=C1)NC(=O)N(C)C.C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=C(C=C(C=C3)F)F)C(F)(F)F D08PCH HIGHSTAT Phase 3 D08SJT DRUG__ID D08SJT D08SJT TRADNAME Kevzara D08SJT DRUGCOMP Sanofi/Regeneron D08SJT THERCLAS Antiviral Agents D08SJT DRUGTYPE Monoclonal antibody D08SJT HIGHSTAT Phase 3 Trial D08TVA DRUG__ID D08TVA D08TVA DRUGTYPE Small molecular drug D08TVA DRUGINCH 1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3 D08TVA DRUGINKE ANEBWFXPVPTEET-UHFFFAOYSA-N D08TVA DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC D08TVA HIGHSTAT Phase 3 D08UVZ DRUG__ID D08UVZ D08UVZ DRUGCOMP Amphastar Pharmaceuticals D08UVZ DRUGINCH 1S/CH2BrNO2/c2-1-3(4)5/h1H2 D08UVZ DRUGINKE DNPRVXJGNANVCZ-UHFFFAOYSA-N D08UVZ DRUGSMIL C([N+](=O)[O-])Br D08UVZ HIGHSTAT Phase 3 D08XPW DRUG__ID D08XPW D08XPW DRUGTYPE Small molecular drug D08XPW DRUGINCH 1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1 D08XPW DRUGINKE ANJTVLIZGCUXLD-DTWKUNHWSA-N D08XPW DRUGSMIL C1C2CNCC1C3=CC=CC(=O)N3C2 D08XPW HIGHSTAT Phase 3 D09MHC DRUG__ID D09MHC D09MHC DRUGCOMP ConjuChem D09MHC DRUGINCH 1S/C26H47N7O9S/c27-18(24(29)37)5-1-2-7-30-8-3-4-9-31-22(35)16-42-14-13-41-12-10-32-21(34)6-11-33-23(36)15-20(25(33)38)43-17-19(28)26(39)40/h18-20,30H,1-17,27-28H2,(H2,29,37)(H,31,35)(H,32,34)(H,39,40)/t18-,19-,20?/m0/s1 D09MHC DRUGINKE MSFZPBXAGPYVFD-NFBCFJMWSA-N D09MHC DRUGSMIL C1C(C(=O)N(C1=O)CCC(=O)NCCOCCOCC(=O)NCCCCNCCCCC(C(=O)N)N)SCC(C(=O)O)N D09MHC HIGHSTAT Phase 3 D09OOC DRUG__ID D09OOC D09OOC DRUGCOMP National Cancer Institute D09OOC DRUGINCH 1S/C14H10ClF2N3S/c15-12-5-4-11-13(19-12)20(14(21)18-11)7-6-8-9(16)2-1-3-10(8)17/h1-5H,6-7H2,(H,18,21) D09OOC DRUGINKE RTZACTFZGJNCLF-UHFFFAOYSA-N D09OOC DRUGSMIL C1=CC(=C(C(=C1)F)CCN2C3=C(C=CC(=N3)Cl)NC2=S)F D09OOC HIGHSTAT Phase 3 D09TLJ DRUG__ID D09TLJ D09TLJ DRUGTYPE Small molecular drug D09TLJ DRUGINCH 1S/C14H11FN2O4/c1-8-5-3-4-6-10(8)12(19)17-13(20)11(15)7-16(9(2)18)14(17)21/h3-7H,1-2H3 D09TLJ DRUGINKE DRXHAKVGNKHFMB-UHFFFAOYSA-N D09TLJ DRUGSMIL CC1=CC=CC=C1C(=O)N2C(=O)C(=CN(C2=O)C(=O)C)F D09TLJ HIGHSTAT Phase 3 D09XUH DRUG__ID D09XUH D09XUH DRUGTYPE Small molecular drug D09XUH DRUGINCH 1S/C34H34FN5O7.2Na/c35-26-10-6-5-9-20(26)14-29(32(43)39-23-12-21(33(44)45)11-22(13-23)34(46)47)40-31(42)25-16-28-27(37-18-38-28)15-24(25)30(41)36-17-19-7-3-1-2-4-8-19;;/h5-6,9-13,15-16,18-19,29H,1-4,7-8,14,17H2,(H,36,41)(H,37,38)(H,39,43)(H,40,42)(H,44,45)(H,46,47);;/q;2*+1/p-2/t29-;;/m0../s1 D09XUH DRUGINKE VHAXHRARUCKASM-UJXPALLWSA-L D09XUH DRUGSMIL C1CCCC(CC1)CNC(=O)C2=CC3=C(C=C2C(=O)NC(CC4=CC=CC=C4F)C(=O)NC5=CC(=CC(=C5)C(=O)[O-])C(=O)[O-])N=CN3.[Na+].[Na+] D09XUH HIGHSTAT Phase 3 D09YDM DRUG__ID D09YDM D09YDM DRUGTYPE Small molecular drug D09YDM DRUGINCH 1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1 D09YDM DRUGINKE VSJKWCGYPAHWDS-FQEVSTJZSA-N D09YDM DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O D09YDM HIGHSTAT Phase 3 D09ZJQ DRUG__ID D09ZJQ D09ZJQ DRUGTYPE Small molecular drug D09ZJQ DRUGINCH 1S/C30H46O3/c1-6-30(33,7-2)18-9-8-11-21(3)26-15-16-27-23(12-10-17-29(26,27)5)13-14-24-19-25(31)20-28(32)22(24)4/h8-9,11,13-14,18,21,25-28,31-33H,4,6-7,10,12,15-17,19-20H2,1-3,5H3/b11-8+,18-9+,23-13+,24-14-/t21-,25-,26-,27+,28+,29-/m1/s1 D09ZJQ DRUGINKE LVLLALCJVJNGQQ-SEODYNFXSA-N D09ZJQ DRUGSMIL CCC(CC)(C=CC=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O D09ZJQ HIGHSTAT Phase 3 D09ZXO DRUG__ID D09ZXO D09ZXO DRUGTYPE Small molecular drug D09ZXO DRUGINCH 1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1 D09ZXO DRUGINKE AMLYAMJWYAIXIA-VWNVYAMZSA-N D09ZXO DRUGSMIL CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N D09ZXO HIGHSTAT Phase 3 D0A2CP DRUG__ID D0A2CP D0A2CP DRUGCOMP Gilead Sciences Foster City, CA D0A2CP DRUGINCH 1S/C21H29N6O5P.C8H10FN3O3S/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24);1,5-6,13H,2-3H2,(H2,10,11,14)/t15-,16+,33+;5-,6+/m10/s1 D0A2CP DRUGINKE NEPFAYPIICYVCG-CFISUTRVSA-N D0A2CP DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OC3=CC=CC=C3.C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F D0A2CP HIGHSTAT Phase 3 D0A9PN DRUG__ID D0A9PN D0A9PN DRUGCOMP GenentechSouth San Francisco, CA D0A9PN DRUGINCH 1S/C37H44N8O4/c1-23-18-42(27-21-49-22-27)9-10-43(23)26-5-6-33(39-17-26)40-30-13-25(19-41(4)35(30)47)28-7-8-38-34(29(28)20-46)45-12-11-44-31(36(45)48)14-24-15-37(2,3)16-32(24)44/h5-8,13-14,17,19,23,27,46H,9-12,15-16,18,20-22H2,1-4H3,(H,39,40)/t23-/m0/s1 D0A9PN DRUGINKE WNEODWDFDXWOLU-QHCPKHFHSA-N D0A9PN DRUGSMIL CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8 D0A9PN HIGHSTAT Phase 3 D0B1EQ DRUG__ID D0B1EQ D0B1EQ DRUGCOMP Ipsen D0B1EQ DRUGINCH 1S/C152H232N40O45/c1-20-78(10)119(145(233)168-81(13)125(213)174-105(63-87-66-162-92-39-28-27-38-90(87)92)134(222)176-101(59-75(4)5)135(223)187-117(76(6)7)143(231)173-95(41-30-32-56-154)142(230)192-152(18,19)148(236)184-93(122(157)210)42-33-57-161-150(158)159)189-136(224)103(60-84-34-23-21-24-35-84)177-131(219)99(50-54-115(206)207)172-130(218)94(40-29-31-55-153)170-124(212)80(12)166-123(211)79(11)167-129(217)98(47-51-110(156)199)169-111(200)68-163-127(215)96(48-52-113(202)203)171-132(220)100(58-74(2)3)175-133(221)102(62-86-43-45-89(198)46-44-86)178-139(227)107(70-193)181-141(229)109(72-195)182-144(232)118(77(8)9)188-138(226)106(65-116(208)209)179-140(228)108(71-194)183-147(235)121(83(15)197)190-137(225)104(61-85-36-25-22-26-37-85)180-146(234)120(82(14)196)186-112(201)69-164-128(216)97(49-53-114(204)205)185-149(237)151(16,17)191-126(214)91(155)64-88-67-160-73-165-88/h21-28,34-39,43-46,66-67,73-83,91,93-109,117-121,162,193-198H,20,29-33,40-42,47-65,68-72,153-155H2,1-19H3,(H2,156,199)(H2,157,210)(H,160,165)(H,163,215)(H,164,216)(H,166,211)(H,167,217)(H,168,233)(H,169,200)(H,170,212)(H,171,220)(H,172,218)(H,173,231)(H,174,213)(H,175,221)(H,176,222)(H,177,219)(H,178,227)(H,179,228)(H,180,234)(H,181,229)(H,182,232)(H,183,235)(H,184,236)(H,185,237)(H,186,201)(H,187,223)(H,188,226)(H,189,224)(H,190,225)(H,191,214)(H,192,230)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H4,158,159,161)/t78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,117-,118-,119-,120-,121-/m0/s1 D0B1EQ DRUGINKE WRGVLTAWMNZWGT-VQSPYGJZSA-N D0B1EQ DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C)(C)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N D0B1EQ HIGHSTAT Phase 3 D0B5GS DRUG__ID D0B5GS D0B5GS DRUGCOMP Savara Pharmaceuticals Austin, TX D0B5GS DRUGINCH 1S/C66H75Cl2N9O24.ClH/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92;/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95);1H/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-;/m0./s1 D0B5GS DRUGINKE LCTORFDMHNKUSG-XTTLPDOESA-N D0B5GS DRUGSMIL CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O.Cl D0B5GS HIGHSTAT Phase 3 D0BD9K DRUG__ID D0BD9K D0BD9K DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D0BD9K DRUGINCH 1S/C24H25ClFN5O3.2C4H4O4/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15;2*5-3(6)1-2-4(7)8/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29);2*1-2H,(H,5,6)(H,7,8)/b4-3+;2*2-1-/t16-;;/m0../s1 D0BD9K DRUGINKE USNRYVNRPYXCSP-JUGPPOIOSA-N D0BD9K DRUGSMIL CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O D0BD9K HIGHSTAT Phase 3 D0BN7W DRUG__ID D0BN7W D0BN7W DRUGCOMP Aerie pharmaceuticals D0BN7W DRUGINCH 1S/C28H27N3O3.C26H40O5/c1-18-3-10-25(19(2)13-18)28(33)34-17-20-4-6-21(7-5-20)26(15-29)27(32)31-24-9-8-23-16-30-12-11-22(23)14-24;1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3-14,16,26H,15,17,29H2,1-2H3,(H,31,32);3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b;8-3-/t26-;21-,22+,23+,24-,25+/m10/s1 D0BN7W DRUGINKE QILUCPOIAVKEBG-GCBPXYGZSA-N D0BN7W DRUGSMIL CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C.CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O D0BN7W HIGHSTAT Phase 3 D0C3CZ DRUG__ID D0C3CZ D0C3CZ DRUGCOMP CytRx, Los Angeles, CA D0C3CZ DRUGINCH 1S/C37H42N4O13/c1-17-32(46)20(38)13-27(53-17)54-22-15-37(51,23(16-42)39-40-24(43)9-4-3-5-12-41-25(44)10-11-26(41)45)14-19-29(22)36(50)31-30(34(19)48)33(47)18-7-6-8-21(52-2)28(18)35(31)49/h6-8,10-11,17,20,22,27,32,42,46,48,50-51H,3-5,9,12-16,38H2,1-2H3,(H,40,43)/b39-23+/t17-,20-,22-,27-,32+,37-/m0/s1 D0C3CZ DRUGINKE OBMJQRLIQQTJLR-USGQOSEYSA-N D0C3CZ DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)CCCCCN6C(=O)C=CC6=O)CO)O)N)O D0C3CZ HIGHSTAT Phase 3 D0C8PI DRUG__ID D0C8PI D0C8PI DRUGTYPE Small molecular drug D0C8PI DRUGINCH 1S/C17H16N6O.ClH/c18-17(19)22-16(24)12-9-21-23(15(12)10-6-7-10)14-5-1-4-13-11(14)3-2-8-20-13;/h1-5,8-10H,6-7H2,(H4,18,19,22,24);1H D0C8PI DRUGINKE JTEXNYIOROVPIR-UHFFFAOYSA-N D0C8PI DRUGSMIL C1CC1C2=C(C=NN2C3=CC=CC4=C3C=CC=N4)C(=O)N=C(N)N.Cl D0C8PI HIGHSTAT Phase 3 D0CB2B DRUG__ID D0CB2B D0CB2B DRUGCOMP Menlo Therapeutics Redwood City, CA D0CB2B DRUGINCH 1S/C29H28F7NO2/c1-16(19-10-20(28(31,32)33)12-21(11-19)29(34,35)36)39-26-9-4-18-14-37(23-7-8-24(38)13-23)15-25(18)27(26)17-2-5-22(30)6-3-17/h2-3,5-6,10-13,16,18,25-27H,4,7-9,14-15H2,1H3/t16-,18-,25-,26+,27+/m1/s1 D0CB2B DRUGINKE FLNYCRJBCNNHRH-OIYLJQICSA-N D0CB2B DRUGSMIL CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2CCC3CN(CC3C2C4=CC=C(C=C4)F)C5=CC(=O)CC5 D0CB2B HIGHSTAT Phase 3 D0CE6C DRUG__ID D0CE6C D0CE6C DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0CE6C DRUGINCH 1S/C22H27N5O2/c1-21(2)10-16(11-22(3,4)27-21)29-20-8-7-18(25-26-20)17-6-5-14(9-19(17)28)15-12-23-24-13-15/h5-9,12-13,16,27-28H,10-11H2,1-4H3,(H,23,24) D0CE6C DRUGINKE STWTUEAWRAIWJG-UHFFFAOYSA-N D0CE6C DRUGSMIL CC1(CC(CC(N1)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C D0CE6C HIGHSTAT Phase 3 D0CF3M DRUG__ID D0CF3M D0CF3M DRUGCOMP FusoGen Pharmaceuticals Inc D0CF3M DRUGINCH 1S/C201H307N59O71/c1-15-93(10)156(257-177(311)124(54-67-151(285)286)235-162(296)109(31-22-70-219-197(209)210)226-168(302)119(49-62-146(275)276)237-184(318)133(81-101-87-225-108-30-21-19-28-105(101)108)254-195(329)160(97(14)264)259-178(312)125(55-68-152(287)288)239-183(317)132(244-161(295)106(202)88-261)80-100-86-224-107-29-20-18-27-104(100)107)191(325)242-123(53-66-150(283)284)173(307)249-135(83-144(208)272)186(320)247-131(79-99-38-42-103(266)43-39-99)189(323)260-159(96(13)263)194(328)241-112(34-25-73-222-200(215)216)163(297)232-117(47-60-142(206)270)176(310)258-158(95(12)17-3)193(327)253-130(78-98-36-40-102(265)41-37-98)182(316)229-113(35-26-74-223-201(217)218)175(309)256-157(94(11)16-2)192(326)252-129(77-92(8)9)179(313)236-121(51-64-148(279)280)171(305)234-122(52-65-149(281)282)174(308)255-138(89-262)190(324)240-115(45-58-140(204)268)167(301)233-118(48-61-145(273)274)170(304)230-114(44-57-139(203)267)166(300)231-116(46-59-141(205)269)172(306)251-136(84-154(291)292)187(321)228-111(33-24-72-221-199(213)214)164(298)248-134(82-143(207)271)185(319)238-120(50-63-147(277)278)169(303)227-110(32-23-71-220-198(211)212)165(299)250-137(85-155(293)294)188(322)246-128(76-91(6)7)181(315)245-127(75-90(4)5)180(314)243-126(196(330)331)56-69-153(289)290/h18-21,27-30,36-43,86-87,90-97,106,109-138,156-160,224-225,261-266H,15-17,22-26,31-35,44-85,88-89,202H2,1-14H3,(H2,203,267)(H2,204,268)(H2,205,269)(H2,206,270)(H2,207,271)(H2,208,272)(H,226,302)(H,227,303)(H,228,321)(H,229,316)(H,230,304)(H,231,300)(H,232,297)(H,233,301)(H,234,305)(H,235,296)(H,236,313)(H,237,318)(H,238,319)(H,239,317)(H,240,324)(H,241,328)(H,242,325)(H,243,314)(H,244,295)(H,245,315)(H,246,322)(H,247,320)(H,248,298)(H,249,307)(H,250,299)(H,251,306)(H,252,326)(H,253,327)(H,254,329)(H,255,308)(H,256,309)(H,257,311)(H,258,310)(H,259,312)(H,260,323)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H,289,290)(H,291,292)(H,293,294)(H,330,331)(H4,209,210,219)(H4,211,212,220)(H4,213,214,221)(H4,215,216,222)(H4,217,218,223)/t93-,94-,95-,96+,97+,106-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,156-,157-,158-,159-,160-/m0/s1 D0CF3M DRUGINKE WIOOVJJJJQAZGJ-ISHQQBGZSA-N D0CF3M DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CO)N D0CF3M HIGHSTAT Phase 3 D0CO3N DRUG__ID D0CO3N D0CO3N DRUGTYPE Small molecular drug D0CO3N DRUGINCH 1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15-,17-,19+,20+,21-,23-/m0/s1 D0CO3N DRUGINKE CTPOHARTNNSRSR-NOQAJONNSA-N D0CO3N DRUGSMIL CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O D0CO3N HIGHSTAT Phase 3 D0CU1T DRUG__ID D0CU1T D0CU1T DRUGCOMP MerckKenilworth, NJSamsung BioepisIncheon, South Korea D0CU1T DRUGINCH 1S/Sb D0CU1T DRUGINKE WATWJIUSRGPENY-UHFFFAOYSA-N D0CU1T DRUGSMIL [Sb] D0CU1T HIGHSTAT Phase 3 D0CZ1A DRUG__ID D0CZ1A D0CZ1A DRUGTYPE Small molecular drug D0CZ1A DRUGINCH 1S/C24H38O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21-19-22(25)20-23(27-2)24(21)26/h8-9,19-20H,3-7,10-18H2,1-2H3/b9-8- D0CZ1A DRUGINKE YYCCUFKHCNSRIA-HJWRWDBZSA-N D0CZ1A DRUGSMIL CCCCCCC=CCCCCCCCCCC1=CC(=O)C=C(C1=O)OC D0CZ1A HIGHSTAT Phase 3 D0D0LH DRUG__ID D0D0LH D0D0LH DRUGCOMP Nuron biotech D0D0LH DRUGINCH 1S/C24H30N2O2/c27-23(25-21-7-3-1-4-8-21)19-13-11-18-16-20(14-12-17(18)15-19)24(28)26-22-9-5-2-6-10-22/h11-16,21-22H,1-10H2,(H,25,27)(H,26,28) D0D0LH DRUGINKE MBSRTKPGZKQXQR-UHFFFAOYSA-N D0D0LH DRUGSMIL C1CCC(CC1)NC(=O)C2=CC3=C(C=C2)C=C(C=C3)C(=O)NC4CCCCC4 D0D0LH HIGHSTAT Phase 3 D0D2TZ DRUG__ID D0D2TZ D0D2TZ DRUGCOMP Shenzhen Kangzhe Pharmaceutical Co Ltd D0D2TZ DRUGINCH 1S/C17H25N3O6/c1-9(2)14(17(25)26)20-16(24)13(8-21)19-15(23)12(18)7-10-3-5-11(22)6-4-10/h3-6,9,12-14,21-22H,7-8,18H2,1-2H3,(H,19,23)(H,20,24)(H,25,26)/t12-,13-,14-/m0/s1 D0D2TZ DRUGINKE TYFLVOUZHQUBGM-IHRRRGAJSA-N D0D2TZ DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)N D0D2TZ HIGHSTAT Phase 3 D0D4ZM DRUG__ID D0D4ZM D0D4ZM DRUGTYPE Small molecular drug D0D4ZM DRUGINCH 1S/C28H29ClN4S/c1-17(2)15-21-11-9-20(10-12-21)13-14-22-16-24-26(23-7-5-6-8-25(23)29)30-18(3)27-32-31-19(4)33(27)28(24)34-22/h5-12,16-18H,13-15H2,1-4H3 D0D4ZM DRUGINKE RMSWMRJVUJSDGN-UHFFFAOYSA-N D0D4ZM DRUGSMIL CC1C2=NN=C(N2C3=C(C=C(S3)CCC4=CC=C(C=C4)CC(C)C)C(=N1)C5=CC=CC=C5Cl)C D0D4ZM HIGHSTAT Phase 3 D0D8KQ DRUG__ID D0D8KQ D0D8KQ DRUGCOMP Incyte, Wilmington, DE D0D8KQ DRUGINCH 1S/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/m1./s1 D0D8KQ DRUGINKE JFMWPOCYMYGEDM-XFULWGLBSA-N D0D8KQ DRUGSMIL C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O D0D8KQ HIGHSTAT Phase 3 D0D9VE DRUG__ID D0D9VE D0D9VE DRUGCOMP Essentials D0D9VE DRUGINCH 1S/C8H7ClN2O2S.C5H14NO/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5;1-6(2,3)4-5-7/h2-4H,1H3,(H,10,11);7H,4-5H2,1-3H3/q;+1 D0D9VE DRUGINKE HDPYPMDYNYTKHI-UHFFFAOYSA-N D0D9VE DRUGSMIL CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl.C[N+](C)(C)CCO D0D9VE HIGHSTAT Phase 3 D0DD4P DRUG__ID D0DD4P D0DD4P DRUGCOMP AstellasNorthbrook, ILBasilea Pharmaceutica Basel, Switzerland D0DD4P DRUGINCH 1S/C35H35F2N8O5S.H2O4S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3;1-5(2,3)4/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3;(H2,1,2,3,4)/q+1;/p-1/t22-,23?,35+;/m0./s1 D0DD4P DRUGINKE LWXUIUUOMSMZKJ-KLFWAVJMSA-M D0DD4P DRUGSMIL CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O.OS(=O)(=O)[O-] D0DD4P HIGHSTAT Phase 3 D0DF1R DRUG__ID D0DF1R D0DF1R DRUGTYPE Small molecular drug D0DF1R DRUGINCH 1S/C13H16O3/c1-2-6-13(7-3-1)9-15-12(16-10-13)11-5-4-8-14-11/h1-2,4-5,8,12H,3,6-7,9-10H2 D0DF1R DRUGINKE ODVKSTFPQDVPJZ-UHFFFAOYSA-N D0DF1R DRUGSMIL C1CC2(CC=C1)COC(OC2)C3=CC=CO3 D0DF1R HIGHSTAT Phase 3 D0DI6L DRUG__ID D0DI6L D0DI6L DRUGCOMP Merck Kenilworth, NJ D0DI6L DRUGINCH 1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1 D0DI6L DRUGINKE QCGUSIANLFXSGE-GFCCVEGCSA-N D0DI6L DRUGSMIL CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)COP(=O)(O)O)F D0DI6L HIGHSTAT Phase 3 D0DP3V DRUG__ID D0DP3V D0DP3V DRUGTYPE Small molecular drug D0DP3V DRUGINCH 1S/C25H40N7O19P3S2/c1-25(2,20(38)23(39)28-4-3-14(33)27-5-6-56-16(36)9-55-8-15(34)35)10-48-54(45,46)51-53(43,44)47-7-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t13-,18-,19-,20+,24-/m1/s1 D0DP3V DRUGINKE GKSSRSUPHZUOQO-ITIYDSSPSA-N D0DP3V DRUGSMIL CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CSCC(=O)O)O D0DP3V HIGHSTAT Phase 3 D0DP5I DRUG__ID D0DP5I D0DP5I DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0DP5I DRUGINCH 1S/C24H24ClFN2O/c1-15(24(29)28-20-9-6-18(25)7-10-20)16-2-4-17(5-3-16)21-12-13-27-23-11-8-19(26)14-22(21)23/h6-17H,2-5H2,1H3,(H,28,29)/t15-,16?,17?/m1/s1 D0DP5I DRUGINKE KRTIYQIPSAGSBP-KLAILNCOSA-N D0DP5I DRUGSMIL CC(C1CCC(CC1)C2=C3C=C(C=CC3=NC=C2)F)C(=O)NC4=CC=C(C=C4)Cl D0DP5I HIGHSTAT Phase 3 D0ES9U DRUG__ID D0ES9U D0ES9U DRUGCOMP Stonebridge Biopharma Trevose, PA D0ES9U DRUGINCH 1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1 D0ES9U DRUGINKE XMAYWYJOQHXEEK-ZEQKJWHPSA-N D0ES9U DRUGSMIL CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl D0ES9U HIGHSTAT Phase 3 D0F1JD DRUG__ID D0F1JD D0F1JD DRUGCOMP Resverlogix San Francisco, CA D0F1JD DRUGINCH 1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24) D0F1JD DRUGINKE NETXMUIMUZJUTB-UHFFFAOYSA-N D0F1JD DRUGSMIL CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2 D0F1JD HIGHSTAT Phase 3 D0F4ZN DRUG__ID D0F4ZN D0F4ZN DRUGTYPE Small molecular drug D0F4ZN DRUGINCH 1S/C39H62O14/c1-17-7-10-39(48-16-17)18(2)27-24(53-39)12-22-21-6-5-19-11-20(8-9-37(19,3)28(21)23(42)13-38(22,27)4)49-35-33(47)31(45)34(26(15-41)51-35)52-36-32(46)30(44)29(43)25(14-40)50-36/h17-22,24-36,40-41,43-47H,5-16H2,1-4H3/t17-,18+,19+,20+,21+,22+,24+,25-,26-,27+,28-,29-,30+,31-,32-,33-,34-,35-,36+,37+,38+,39-/m1/s1 D0F4ZN DRUGINKE VWMZIGBYZQUQOA-QEEMJVPDSA-N D0F4ZN DRUGSMIL CC1CCC2(C(C3C(O2)CC4C3(CC(=O)C5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)O)O)O)C)C)C)OC1 D0F4ZN HIGHSTAT Phase 3 D0F7ZJ DRUG__ID D0F7ZJ D0F7ZJ DRUGCOMP University of California Los Angeles; Ardea Biosciences Inc D0F7ZJ DRUGINCH 1S/C78H126N30O18S4/c1-39(2)28-49(99-57(111)32-93-56(110)31-94-63(115)45(79)16-10-24-89-75(81)82)66(118)103-53-36-128-130-38-55(72(124)107-60(40(3)4)73(125)96-34-58(112)97-46(62(80)114)17-11-25-90-76(83)84)106-74(126)61(41(5)6)108-71(123)54-37-129-127-35-52(104-68(120)51(102-70(53)122)30-43-20-22-44(109)23-21-43)69(121)100-47(18-12-26-91-77(85)86)64(116)95-33-59(113)98-48(19-13-27-92-78(87)88)65(117)101-50(67(119)105-54)29-42-14-8-7-9-15-42/h7-9,14-15,20-23,39-41,45-55,60-61,109H,10-13,16-19,24-38,79H2,1-6H3,(H2,80,114)(H,93,110)(H,94,115)(H,95,116)(H,96,125)(H,97,112)(H,98,113)(H,99,111)(H,100,121)(H,101,117)(H,102,122)(H,103,118)(H,104,120)(H,105,119)(H,106,126)(H,107,124)(H,108,123)(H4,81,82,89)(H4,83,84,90)(H4,85,86,91)(H4,87,88,92)/t45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-,61-/m0/s1 D0F7ZJ DRUGINKE GUCYBPFJNGVFEB-XELKFLSISA-N D0F7ZJ DRUGSMIL CC(C)CC(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=CC=C3)CCCNC(=N)N)CCCNC(=N)N)NC(=O)C(NC1=O)CC4=CC=C(C=C4)O)C(C)C)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)CNC(=O)CNC(=O)C(CCCNC(=N)N)N D0F7ZJ HIGHSTAT Phase 3 D0FT4R DRUG__ID D0FT4R D0FT4R DRUGTYPE Small molecular drug D0FT4R DRUGINCH 1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24) D0FT4R DRUGINKE BTGNGJJLZOIYID-UHFFFAOYSA-N D0FT4R DRUGSMIL CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O D0FT4R HIGHSTAT Phase 3 D0FV3K DRUG__ID D0FV3K D0FV3K DRUGCOMP ACEA BiosciencesSan Diego, CA D0FV3K DRUGINCH 1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32) D0FV3K DRUGINKE UOFYSRZSLXWIQB-UHFFFAOYSA-N D0FV3K DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F D0FV3K HIGHSTAT Phase 3 D0G1WV DRUG__ID D0G1WV D0G1WV DRUGTYPE Small molecular drug D0G1WV DRUGINCH 1S/C12H14N4O4S2/c1-19-11(17)15-9(21)13-7-5-3-4-6-8(7)14-10(22)16-12(18)20-2/h3-6H,1-2H3,(H2,13,15,17,21)(H2,14,16,18,22) D0G1WV DRUGINKE QGHREAKMXXNCOA-UHFFFAOYSA-N D0G1WV DRUGSMIL COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC D0G1WV HIGHSTAT Phase 3 D0G2CG DRUG__ID D0G2CG D0G2CG DRUGCOMP Advenchen Laboratories Moorpark, CA D0G2CG DRUGINCH 1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3 D0G2CG DRUGINKE KSMZEXLVHXZPEF-UHFFFAOYSA-N D0G2CG DRUGSMIL CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC D0G2CG HIGHSTAT Phase 3 D0G3LM DRUG__ID D0G3LM D0G3LM DRUGTYPE Small molecular drug D0G3LM DRUGINCH 1S/C6H8ClNS/c1-5-6(2-3-7)9-4-8-5/h4H,2-3H2,1H3 D0G3LM DRUGINKE PCLITLDOTJTVDJ-UHFFFAOYSA-N D0G3LM DRUGSMIL CC1=C(SC=N1)CCCl D0G3LM HIGHSTAT Phase 3 D0H1NL DRUG__ID D0H1NL D0H1NL DRUGTYPE Small molecular drug D0H1NL DRUGINCH 1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1 D0H1NL DRUGINKE CXGTZJYQWSUFET-IBGZPJMESA-N D0H1NL DRUGSMIL CCOC(CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O D0H1NL HIGHSTAT Phase 3 D0H1UK DRUG__ID D0H1UK D0H1UK DRUGCOMP Merck Kenilworth, NJ D0H1UK DRUGINCH 1S/C12H12FN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1 D0H1UK DRUGINKE IKKXOSBHLYMWAE-QRPMWFLTSA-N D0H1UK DRUGSMIL C#CC1(C(CC(O1)N2C=NC3=C(N=C(N=C32)F)N)O)CO D0H1UK HIGHSTAT Phase 3 D0H5HO DRUG__ID D0H5HO D0H5HO DRUGTYPE Small molecular drug D0H5HO DRUGINCH 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,18-,19-/m0/s1 D0H5HO DRUGINKE QGXBDMJGAMFCBF-HLUDHZFRSA-N D0H5HO DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O D0H5HO HIGHSTAT Phase 3 D0H5JW DRUG__ID D0H5JW D0H5JW DRUGTYPE Small molecular drug D0H5JW DRUGINCH 1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)/t8-/m0/s1 D0H5JW DRUGINKE KPYSYYIEGFHWSV-QMMMGPOBSA-N D0H5JW DRUGSMIL C1=CC(=CC=C1C(CC(=O)O)CN)Cl D0H5JW HIGHSTAT Phase 3 D0HM6B DRUG__ID D0HM6B D0HM6B DRUGCOMP Grnenthal USA Morristown, NJ D0HM6B DRUGINCH 1S/C85H137N33O17S2/c86-32-6-3-17-55-69(123)106-44-67(121)107-62(40-47-24-28-50(119)29-25-47)75(129)112-59(21-11-37-102-83(94)95)71(125)111-57(19-5-8-34-88)74(128)117-65(78(132)114-61(80(134)135)23-13-39-104-85(98)99)45-136-137-46-66(79(133)115-63(41-48-26-30-51(120)31-27-48)76(130)113-60(22-12-38-103-84(96)97)72(126)110-56(70(124)109-55)18-4-7-33-87)118-77(131)64(42-49-43-105-54-16-2-1-14-52(49)54)116-73(127)58(20-10-36-101-82(92)93)108-68(122)53(89)15-9-35-100-81(90)91/h1-2,14,16,24-31,43,53,55-66,105,119-120H,3-13,15,17-23,32-42,44-46,86-89H2,(H,106,123)(H,107,121)(H,108,122)(H,109,124)(H,110,126)(H,111,125)(H,112,129)(H,113,130)(H,114,132)(H,115,133)(H,116,127)(H,117,128)(H,118,131)(H,134,135)(H4,90,91,100)(H4,92,93,101)(H4,94,95,102)(H4,96,97,103)(H4,98,99,104)/t53-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-/m0/s1 D0HM6B DRUGINKE DHLNQBGKTBJPSZ-SKPGKBGKSA-N D0HM6B DRUGSMIL C1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)NC(CCCNC(=N)N)C(=O)O)CCCCN)CCCNC(=N)N)CC2=CC=C(C=C2)O)CCCCN)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N D0HM6B HIGHSTAT Phase 3 D0HZ2E DRUG__ID D0HZ2E D0HZ2E DRUGTYPE Small molecular drug D0HZ2E DRUGINCH 1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1 D0HZ2E DRUGINKE HXTGXYRHXAGCFP-OAQYLSRUSA-N D0HZ2E DRUGSMIL COC1=CC=CC(=C1OC)C(C2CCN(CC2)CCC3=CC=C(C=C3)F)O D0HZ2E HIGHSTAT Phase 3 D0I6LH DRUG__ID D0I6LH D0I6LH DRUGTYPE Small molecular drug D0I6LH DRUGINCH 1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14,16,22H,4-7H2,1-3H3/t11-,12-,13-,14-,16+,17-,18-,19+,20+/m0/s1 D0I6LH DRUGINKE DFBIRQPKNDILPW-CIVMWXNOSA-N D0I6LH DRUGSMIL CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C D0I6LH HIGHSTAT Phase 3 D0IQ1V DRUG__ID D0IQ1V D0IQ1V DRUGCOMP Center for Genetic Engineering and Biotechnology D0IQ1V DRUGINCH 1S/C127H215N53O30S3/c1-66(2)55-84-100(189)157-61-97(187)177-98(67(3)182)116(205)176-89(120(209)210)64-213-212-63-88(113(202)173-85(56-68-59-156-71-22-6-5-21-70(68)71)111(200)168-82(40-54-211-4)110(199)175-87(62-181)118(207)178-51-18-32-90(178)114(203)169-79(30-16-48-154-126(143)144)108(197)174-86(112(201)172-84)57-69-60-147-65-158-69)160-95(185)39-50-148-99(188)80(35-37-93(131)183)170-115(204)91-33-19-52-179(91)119(208)92-34-20-53-180(92)117(206)83(31-17-49-155-127(145)146)171-107(196)78(29-15-47-153-125(141)142)165-105(194)76(27-13-45-151-123(137)138)166-109(198)81(36-38-94(132)184)167-106(195)77(28-14-46-152-124(139)140)164-104(193)75(26-12-44-150-122(135)136)163-103(192)74(24-8-10-42-129)162-102(191)73(23-7-9-41-128)161-101(190)72(159-96(186)58-130)25-11-43-149-121(133)134/h5-6,21-22,59-60,65-67,72-92,98,156,181-182H,7-20,23-58,61-64,128-130H2,1-4H3,(H2,131,183)(H2,132,184)(H,147,158)(H,148,188)(H,157,189)(H,159,186)(H,160,185)(H,161,190)(H,162,191)(H,163,192)(H,164,193)(H,165,194)(H,166,198)(H,167,195)(H,168,200)(H,169,203)(H,170,204)(H,171,196)(H,172,201)(H,173,202)(H,174,197)(H,175,199)(H,176,205)(H,177,187)(H,209,210)(H4,133,134,149)(H4,135,136,150)(H4,137,138,151)(H4,139,140,152)(H4,141,142,153)(H4,143,144,154)(H4,145,146,155)/t67-,72+,73+,74+,75+,76+,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,98+/m1/s1 D0IQ1V DRUGINKE RNELHWXSRSKXRD-QNKYCTLBSA-N D0IQ1V DRUGSMIL CC(C)CC1C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CNC=N3)CCCNC(=N)N)CO)CCSC)CC4=CNC5=CC=CC=C54)NC(=O)CCNC(=O)C(CCC(=O)N)NC(=O)C6CCCN6C(=O)C7CCCN7C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)CN)C(=O)O)C(C)O D0IQ1V HIGHSTAT Phase 3 D0IT7F DRUG__ID D0IT7F D0IT7F DRUGCOMP Merck Kenilworth, NJ D0IT7F DRUGINCH 1S/C16H15F6N5O.C4H11N5.ClH.H3O4P/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22;1-9(2)4(7)8-3(5)6;;1-5(2,3)4/h4,6,9H,1-3,5,7,23H2;1-2H3,(H5,5,6,7,8);1H;(H3,1,2,3,4)/t9-;;;/m1.../s1 D0IT7F DRUGINKE GCERFBKFVDLDKD-NRYJBHHQSA-N D0IT7F DRUGSMIL CN(C)C(=N)N=C(N)N.C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.OP(=O)(O)O.Cl D0IT7F HIGHSTAT Phase 3 D0J7QU DRUG__ID D0J7QU D0J7QU DRUGTYPE Small molecular drug D0J7QU DRUGINCH 1S/C28H41N3O4/c1-2-3-13-31-26(32)23(18-21-7-5-4-6-8-21)29-27(33)28(31)11-14-30(15-12-28)20-22-9-10-24-25(19-22)35-17-16-34-24/h9-10,19,21,23H,2-8,11-18,20H2,1H3,(H,29,33) D0J7QU DRUGINKE VBONNDPACFTZMX-UHFFFAOYSA-N D0J7QU DRUGSMIL CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC4=C(C=C3)OCCO4)CC5CCCCC5 D0J7QU HIGHSTAT Phase 3 D0JW7D DRUG__ID D0JW7D D0JW7D DRUGCOMP Biowest Therapeutics Inc; Migenix D0JW7D DRUGINCH 1S/C90H127N27O12/c1-5-51(4)75(92)85(127)113-68(41-50(2)3)80(122)109-67(32-18-38-102-90(98)99)79(121)114-71(44-54-48-105-62-27-12-8-23-58(54)62)86(128)116-39-19-34-74(116)84(126)112-70(43-53-47-104-61-26-11-7-22-57(53)61)82(124)115-72(45-55-49-106-63-28-13-9-24-59(55)63)87(129)117-40-20-33-73(117)83(125)111-69(42-52-46-103-60-25-10-6-21-56(52)60)81(123)110-66(31-17-37-101-89(96)97)78(120)108-65(30-16-36-100-88(94)95)77(119)107-64(76(93)118)29-14-15-35-91/h6-13,21-28,46-51,64-75,103-106H,5,14-20,29-45,91-92H2,1-4H3,(H2,93,118)(H,107,119)(H,108,120)(H,109,122)(H,110,123)(H,111,125)(H,112,126)(H,113,127)(H,114,121)(H,115,124)(H4,94,95,100)(H4,96,97,101)(H4,98,99,102)/t51-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-/m0/s1 D0JW7D DRUGINKE MVPAMLBUDIFYGK-BHDRXCTLSA-N D0JW7D DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N8CCCC8C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)N)N D0JW7D HIGHSTAT Phase 3 D0K2ID DRUG__ID D0K2ID D0K2ID DRUGCOMP Nektar therapeutics D0K2ID DRUGINCH 1S/C31H49NO10/c1-32-9-8-30-27-23-4-5-24(35-3)28(27)42-29(30)25(6-7-31(30,33)26(32)22-23)41-21-20-40-19-18-39-17-16-38-15-14-37-13-12-36-11-10-34-2/h4-5,25-26,29,33H,6-22H2,1-3H3/t25-,26+,29-,30-,31+/m0/s1 D0K2ID DRUGINKE RQHILGKAOIGUHU-XPLSERNMSA-N D0K2ID DRUGSMIL CN1CCC23C4C(CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O)OCCOCCOCCOCCOCCOCCOC D0K2ID HIGHSTAT Phase 3 D0K7FT DRUG__ID D0K7FT D0K7FT DRUGCOMP Agios pharmaceuticals; celgene D0K7FT DRUGINCH 1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32) D0K7FT DRUGINKE DYLUUSLLRIQKOE-UHFFFAOYSA-N D0K7FT DRUGSMIL CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O D0K7FT HIGHSTAT Phase 3 D0K7FY DRUG__ID D0K7FY D0K7FY DRUGCOMP Novartis pharmaceuticals D0K7FY DRUGINCH 1S/C26H31ClN6O2/c1-18-16-19(12-13-28-18)25(35)30-26-29-22-10-6-9-21(27)24(22)33(26)20-8-4-5-15-32(17-20)23(34)11-7-14-31(2)3/h6-7,9-13,16,20H,4-5,8,14-15,17H2,1-3H3,(H,29,30,35)/b11-7+/t20-/m1/s1 D0K7FY DRUGINKE IOMMMLWIABWRKL-WUTDNEBXSA-N D0K7FY DRUGSMIL CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2C4CCCCN(C4)C(=O)C=CCN(C)C)C(=CC=C3)Cl D0K7FY HIGHSTAT Phase 3 D0K8GD DRUG__ID D0K8GD D0K8GD DRUGCOMP Arbor Pharmaceuticals Atlanta, GA D0K8GD DRUGINCH 1S/C13H18N2O2.CH4O4S/c1-5-9-14-13(16)17-12-8-6-7-11(10-12)15(2,3)4;1-5-6(2,3)4/h5-8,10H,1,9H2,2-4H3;1H3,(H,2,3,4) D0K8GD DRUGINKE CZCVYRBGBQAORP-UHFFFAOYSA-N D0K8GD DRUGSMIL C[N+](C)(C)C1=CC(=CC=C1)OC(=O)NCC=C.COS(=O)(=O)[O-] D0K8GD HIGHSTAT Phase 3 D0K9PC DRUG__ID D0K9PC D0K9PC DRUGCOMP Agios Pharmaceuticals Cambridge, MA Celgene Summit, NJ D0K9PC DRUGINCH 1S/C14H13ClF6N6/c1-6(13(16,17)18)22-11-25-10(8-4-3-5-9(15)24-8)26-12(27-11)23-7(2)14(19,20)21/h3-7H,1-2H3,(H2,22,23,25,26,27)/t6-,7-/m1/s1 D0K9PC DRUGINKE QCZAWDGAVJMPTA-RNFRBKRXSA-N D0K9PC DRUGSMIL CC(C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)NC(C)C(F)(F)F D0K9PC HIGHSTAT Phase 3 D0KI5R DRUG__ID D0KI5R D0KI5R DRUGCOMP Boehringer Ingelheim Ridgefield, CT D0KI5R DRUGINCH 1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44) D0KI5R DRUGINKE KSGXQBZTULBEEQ-UHFFFAOYSA-N D0KI5R DRUGSMIL CCCCCCOC(=O)NC(=N)C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4 D0KI5R HIGHSTAT Phase 3 D0KQ8X DRUG__ID D0KQ8X D0KQ8X DRUGCOMP Novartis East Hanover, NJ D0KQ8X DRUGINCH 1S/2C24H29N5O3.2C24H29NO5.6Na.5H2O/c2*1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23;2*1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;;;;;;;;;;;/h2*6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H2,25,26,27,28,31,32);2*4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);;;;;;;5*1H2/q;;;;6*+1;;;;;/p-6/t2*22-;2*17-,21+;;;;;;;;;;;/m0011.........../s1 D0KQ8X DRUGINKE ZASXKEGREHRXDL-CAWNUZPDSA-H D0KQ8X DRUGSMIL CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)C(C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)C(C(C)C)C(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0KQ8X HIGHSTAT Phase 3 D0KX7I DRUG__ID D0KX7I D0KX7I DRUGCOMP Xcovery Palm Beach Gardens, FL D0KX7I DRUGINCH 1S/C26H27Cl2FN6O3/c1-13-11-35(12-14(2)31-13)26(37)16-4-6-17(7-5-16)32-25(36)20-10-21(24(30)34-33-20)38-15(3)22-18(27)8-9-19(29)23(22)28/h4-10,13-15,31H,11-12H2,1-3H3,(H2,30,34)(H,32,36)/t13-,14+,15-/m1/s1 D0KX7I DRUGINKE GLYMPHUVMRFTFV-QLFBSQMISA-N D0KX7I DRUGSMIL CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N D0KX7I HIGHSTAT Phase 3 D0L7TA DRUG__ID D0L7TA D0L7TA DRUGCOMP Minerva neurosciences D0L7TA DRUGINCH 1S/C22H23FN2O2/c23-19-7-5-17(6-8-19)21(26)15-24-11-9-16(10-12-24)13-25-14-18-3-1-2-4-20(18)22(25)27/h1-8,16H,9-15H2 D0L7TA DRUGINKE RNRYULFRLCBRQS-UHFFFAOYSA-N D0L7TA DRUGSMIL C1CN(CCC1CN2CC3=CC=CC=C3C2=O)CC(=O)C4=CC=C(C=C4)F D0L7TA HIGHSTAT Phase 3 D0LW0T DRUG__ID D0LW0T D0LW0T DRUGCOMP AstraZeneca Wilmington, DE D0LW0T DRUGINCH 1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1 D0LW0T DRUGINKE XYDNMOZJKOGZLS-NSHDSACASA-N D0LW0T DRUGSMIL CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C D0LW0T HIGHSTAT Phase 3 D0LW1Y DRUG__ID D0LW1Y D0LW1Y DRUGCOMP Genfit SA D0LW1Y DRUGINCH 1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+ D0LW1Y DRUGINKE AFLFKFHDSCQHOL-IZZDOVSWSA-N D0LW1Y DRUGSMIL CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC D0LW1Y HIGHSTAT Phase 3 D0M0SS DRUG__ID D0M0SS D0M0SS DRUGTYPE Small molecular drug D0M0SS DRUGINCH 1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1 D0M0SS DRUGINKE ZZCHHVUQYRMYLW-HKBQPEDESA-N D0M0SS DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC(C(=O)O)NC4=CC=CC=C4C(=O)C5=CC=CC=C5 D0M0SS HIGHSTAT Phase 3 D0M1IN DRUG__ID D0M1IN D0M1IN DRUGTYPE Small molecular drug D0M1IN DRUGINCH 1S/C25H27F2N4O8P/c1-16(22(33)36-14-17-8-4-2-5-9-17)30-40(35,39-18-10-6-3-7-11-18)37-15-19-21(32)25(26,27)23(38-19)31-13-12-20(28)29-24(31)34/h2-13,16,19,21,23,32H,14-15H2,1H3,(H,30,35)(H2,28,29,34)/t16-,19+,21+,23+,40?/m0/s1 D0M1IN DRUGINKE NHTKGYOMICWFQZ-KKQYNPQSSA-N D0M1IN DRUGSMIL CC(C(=O)OCC1=CC=CC=C1)NP(=O)(OCC2C(C(C(O2)N3C=CC(=NC3=O)N)(F)F)O)OC4=CC=CC=C4 D0M1IN HIGHSTAT Phase 3 D0M3UT DRUG__ID D0M3UT D0M3UT DRUGTYPE Small molecular drug D0M3UT DRUGINCH 1S/C29H28N2O7/c1-20-26(30-28(37-20)22-6-4-3-5-7-22)16-17-36-24-10-8-21(9-11-24)18-31(19-27(32)33)29(34)38-25-14-12-23(35-2)13-15-25/h3-15H,16-19H2,1-2H3,(H,32,33) D0M3UT DRUGINKE IRLWJILLXJGJTD-UHFFFAOYSA-N D0M3UT DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CN(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC D0M3UT HIGHSTAT Phase 3 D0M5BI DRUG__ID D0M5BI D0M5BI DRUGCOMP Ampio Pharmaceuticals D0M5BI DRUGINCH 1S/C7H10N2O4/c1-3-6(12)9-4(2-5(10)11)7(13)8-3/h3-4H,2H2,1H3,(H,8,13)(H,9,12)(H,10,11)/t3-,4-/m0/s1 D0M5BI DRUGINKE RVLCUCVJZVRNDC-IMJSIDKUSA-N D0M5BI DRUGSMIL CC1C(=O)NC(C(=O)N1)CC(=O)O D0M5BI HIGHSTAT Phase 3 D0M5EN DRUG__ID D0M5EN D0M5EN DRUGCOMP Biohaven Pharmaceuticals New Haven, CT D0M5EN DRUGINCH 1S/C15H16F3N5O4S/c1-23(13(26)6-20-11(24)5-19)7-12(25)22-14-21-9-3-2-8(4-10(9)28-14)27-15(16,17)18/h2-4H,5-7,19H2,1H3,(H,20,24)(H,21,22,25) D0M5EN DRUGINKE YBZSGIWIPOUSHY-UHFFFAOYSA-N D0M5EN DRUGSMIL CN(CC(=O)NC1=NC2=C(S1)C=C(C=C2)OC(F)(F)F)C(=O)CNC(=O)CN D0M5EN HIGHSTAT Phase 3 D0M9JJ DRUG__ID D0M9JJ D0M9JJ DRUGCOMP DOV Pharmaceutical Inc D0M9JJ DRUGINCH 1S/C15H15N/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15/h1-7,14,16H,8-10H2/t14-,15+/m1/s1 D0M9JJ DRUGINKE HKHCSWPSUSWGLI-CABCVRRESA-N D0M9JJ DRUGSMIL C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3 D0M9JJ HIGHSTAT Phase 3 D0MD6C DRUG__ID D0MD6C D0MD6C DRUGCOMP Promius Pharma Princeton, NJ D0MD6C DRUGINCH 1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19-,20-,21-,25-,26-,27-,28-/m0/s1 D0MD6C DRUGINKE CIWBQSYVNNPZIQ-XYWKZLDCSA-N D0MD6C DRUGSMIL CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC D0MD6C HIGHSTAT Phase 3 D0MW3H DRUG__ID D0MW3H D0MW3H DRUGTYPE Small molecular drug D0MW3H DRUGINCH 1S/C22H36N4O5/c1-22(2)20(29)26(21(30)24(22)3)14-17(18(27)23-31)16(13-15-9-5-6-10-15)19(28)25-11-7-4-8-12-25/h15-17,31H,4-14H2,1-3H3,(H,23,27)/t16-,17+/m1/s1 D0MW3H DRUGINKE GFUITADOEPNRML-SJORKVTESA-N D0MW3H DRUGSMIL CC1(C(=O)N(C(=O)N1C)CC(C(CC2CCCC2)C(=O)N3CCCCC3)C(=O)NO)C D0MW3H HIGHSTAT Phase 3 D0MZ9A DRUG__ID D0MZ9A D0MZ9A DRUGTYPE Small molecular drug D0MZ9A DRUGINCH 1S/C20H20N2O.C4H4O4/c23-18-12-6-11-17-19(18)20(15-9-4-5-10-16(15)22-17)21-13-14-7-2-1-3-8-14;5-3(6)1-2-4(7)8/h1-5,7-10,18,23H,6,11-13H2,(H,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1- D0MZ9A DRUGINKE JRQSVNSUJOFXHC-BTJKTKAUSA-N D0MZ9A DRUGSMIL C1CC(C2=C(C3=CC=CC=C3N=C2C1)NCC4=CC=CC=C4)O.C(=CC(=O)O)C(=O)O D0MZ9A HIGHSTAT Phase 3 D0N0KW DRUG__ID D0N0KW D0N0KW DRUGTYPE Small molecular drug D0N0KW DRUGINCH 1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1 D0N0KW DRUGINKE FFEARJCKVFRZRR-SCSAIBSYSA-N D0N0KW DRUGSMIL CSCCC(C(=O)O)N D0N0KW HIGHSTAT Phase 3 D0N6UP DRUG__ID D0N6UP D0N6UP DRUGTYPE Small molecular drug D0N6UP DRUGINCH 1S/C9H14N4O2/c1-4-13-5-12-6(8(14)10-2)7(13)9(15)11-3/h5H,4H2,1-3H3,(H,10,14)(H,11,15) D0N6UP DRUGINKE RYRFAMRQBZNEPX-UHFFFAOYSA-N D0N6UP DRUGSMIL CCN1C=NC(=C1C(=O)NC)C(=O)NC D0N6UP HIGHSTAT Phase 3 D0N7WG DRUG__ID D0N7WG D0N7WG DRUGCOMP Auris Medical D0N7WG DRUGINCH 1S/C164H285N65O41/c1-84(2)77-106(216-139(254)108(79-89-33-10-9-11-34-89)219-146(261)112-48-28-72-225(112)153(268)105(55-58-119(171)235)215-148(263)123(86(5)6)221-147(262)115-51-29-73-226(115)151(266)103(45-25-69-198-163(187)188)213-142(257)110(83-230)220-137(252)100(53-56-117(169)233)201-126(241)90(168)80-121(237)238)138(253)218-109(81-120(172)236)140(255)217-107(78-85(3)4)141(256)222-124(87(7)231)149(264)223-125(88(8)232)155(270)228-75-31-50-114(228)144(259)211-99(44-24-68-197-162(185)186)135(250)212-102(37-14-17-61-167)150(265)224-71-27-47-111(224)145(260)214-104(46-26-70-199-164(189)190)152(267)229-76-32-52-116(229)154(269)227-74-30-49-113(227)143(258)210-98(43-23-67-196-161(183)184)134(249)207-95(40-20-64-193-158(177)178)131(246)206-97(42-22-66-195-160(181)182)133(248)209-101(54-57-118(170)234)136(251)208-96(41-21-65-194-159(179)180)132(247)205-94(39-19-63-192-157(175)176)130(245)204-93(36-13-16-60-166)129(244)203-92(35-12-15-59-165)128(243)202-91(38-18-62-191-156(173)174)127(242)200-82-122(239)240/h9-11,33-34,84-88,90-116,123-125,230-232H,12-32,35-83,165-168H2,1-8H3,(H2,169,233)(H2,170,234)(H2,171,235)(H2,172,236)(H,200,242)(H,201,241)(H,202,243)(H,203,244)(H,204,245)(H,205,247)(H,206,246)(H,207,249)(H,208,251)(H,209,248)(H,210,258)(H,211,259)(H,212,250)(H,213,257)(H,214,260)(H,215,263)(H,216,254)(H,217,255)(H,218,253)(H,219,261)(H,220,252)(H,221,262)(H,222,256)(H,223,264)(H,237,238)(H,239,240)(H4,173,174,191)(H4,175,176,192)(H4,177,178,193)(H4,179,180,194)(H4,181,182,195)(H4,183,184,196)(H4,185,186,197)(H4,187,188,198)(H4,189,190,199)/t87-,88-,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,123+,124+,125+/m0/s1 D0N7WG DRUGINKE HRMVIAFZYCCHGF-BMCUWHFPSA-N D0N7WG DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)N2CCCC2C(=O)NC(CCCNC(=N)N)C(=O)N3CCCC3C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCCN6C(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)N D0N7WG HIGHSTAT Phase 3 D0NS3O DRUG__ID D0NS3O D0NS3O DRUGCOMP Tessa Therapeutics Singapore D0NS3O DRUGINCH 1S/C11H10FN3OS2/c1-2-5-14-11-15-10(13)9(18-11)8(16)6-3-4-7(12)17-6/h2-4H,1,5,13H2,(H,14,15) D0NS3O DRUGINKE GVYPHJQPOHDZEI-UHFFFAOYSA-N D0NS3O DRUGSMIL C=CCNC1=NC(=C(S1)C(=O)C2=CC=C(S2)F)N D0NS3O HIGHSTAT Phase 3 D0O8FW DRUG__ID D0O8FW D0O8FW DRUGTYPE Small molecular drug D0O8FW DRUGINCH 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14-,15-,16-,18-,19-/m0/s1 D0O8FW DRUGINKE QGXBDMJGAMFCBF-LUJOEAJASA-N D0O8FW DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O D0O8FW HIGHSTAT Phase 3 D0O8TJ DRUG__ID D0O8TJ D0O8TJ DRUGCOMP Aimmune Therapeutics Brisbane, CA D0O8TJ DRUGINCH 1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23)/t14-/m0/s1 D0O8TJ DRUGINKE HWJPWWYTGBZDEG-AWEZNQCLSA-N D0O8TJ DRUGSMIL COC1=C(C2=C(C=CC(O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC D0O8TJ HIGHSTAT Phase 3 D0P9BT DRUG__ID D0P9BT D0P9BT DRUGCOMP ISIS & Atlantic Healthcare D0P9BT THERCLAS Antisense D0P9BT DRUGTYPE Antisense drug D0P9BT DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=S)([O-])OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O D0P9BT HIGHSTAT Phase 3 D0PL3N DRUG__ID D0PL3N D0PL3N DRUGCOMP Merck, Roche D0PL3N DRUGINCH 1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19) D0PL3N DRUGINKE HLWURFKMDLAKOD-UHFFFAOYSA-N D0PL3N DRUGSMIL CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC D0PL3N HIGHSTAT Phase 3 D0Q5KZ DRUG__ID D0Q5KZ D0Q5KZ DRUGCOMP Astex Pharmaceuticals D0Q5KZ DRUGINCH 1S/C18H24N9O10P.Na.H/c19-16-22-6-27(18(31)25-16)12-2-8(9(3-28)35-12)37-38(32,33)34-4-10-7(29)1-11(36-10)26-5-21-13-14(26)23-17(20)24-15(13)30;;/h5-12,28-29H,1-4H2,(H,32,33)(H2,19,25,31)(H3,20,23,24,30);;/q;+1;-1/t7?,8-,9+,10+,11?,12+;;/m0../s1 D0Q5KZ DRUGINKE AYXRQJHOBFJIHP-ZWBDGAAVSA-N D0Q5KZ DRUGSMIL [H-].C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OC4CC(OC4CO)N5C=NC(=NC5=O)N)O.[Na+] D0Q5KZ HIGHSTAT Phase 3 D0Q7UD DRUG__ID D0Q7UD D0Q7UD DRUGTYPE Small molecular drug D0Q7UD DRUGINCH 1S/C13H16N4O.2ClH/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12;;/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17);2*1H/t13-;;/m1../s1 D0Q7UD DRUGINKE DSBSVDCHFMEYBX-FFXKMJQXSA-N D0Q7UD DRUGSMIL CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N.Cl.Cl D0Q7UD HIGHSTAT Phase 3 D0Q8WX DRUG__ID D0Q8WX D0Q8WX DRUGCOMP Auris Medical AG D0Q8WX DRUGINCH 1S/C13H16ClNO.ClH/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14;/h2-3,6-7,15H,4-5,8-9H2,1H3;1H/t13-;/m0./s1 D0Q8WX DRUGINKE VCMGMSHEPQENPE-ZOWNYOTGSA-N D0Q8WX DRUGSMIL CNC1(CCCCC1=O)C2=CC=CC=C2Cl.Cl D0Q8WX HIGHSTAT Phase 3 D0QR3X DRUG__ID D0QR3X D0QR3X DRUGCOMP Catabasis Pharmaceuticals Cambridge, MA D0QR3X DRUGINCH 1S/C31H42N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-25-30(35)32-26-27-33-31(36)28-23-21-22-24-29(28)34/h3-4,6-7,9-10,12-13,15-16,18-19,21-24,34H,2,5,8,11,14,17,20,25-27H2,1H3,(H,32,35)(H,33,36)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18- D0QR3X DRUGINKE JQLBBYLGWHUHRW-KUBAVDMBSA-N D0QR3X DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)NCCNC(=O)C1=CC=CC=C1O D0QR3X HIGHSTAT Phase 3 D0R4KK DRUG__ID D0R4KK D0R4KK DRUGTYPE Small molecular drug D0R4KK DRUGINCH 1S/C17H17F2N5O3S/c1-17(9-28(26,27)24(2)16(20)23-17)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)/t17-/m0/s1 D0R4KK DRUGINKE YHYKUSGACIYRML-KRWDZBQOSA-N D0R4KK DRUGSMIL CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F D0R4KK HIGHSTAT Phase 3 D0R9US DRUG__ID D0R9US D0R9US DRUGCOMP Glaxosmithkline D0R9US DRUGINCH 1S/C24H28N6O3/c31-22-4-3-20-24-29(22)15-19(30(24)23(32)13-27-20)14-28-7-5-17(6-8-28)25-11-18-10-16-2-1-9-33-21(16)12-26-18/h3-4,10,12-13,17,19,25H,1-2,5-9,11,14-15H2/t19-/m1/s1 D0R9US DRUGINKE PZFAZQUREQIODZ-LJQANCHMSA-N D0R9US DRUGSMIL C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)CC4CN5C(=O)C=CC6=C5N4C(=O)C=N6 D0R9US HIGHSTAT Phase 3 D0R9VC DRUG__ID D0R9VC D0R9VC DRUGCOMP Ferring Pharmaceuticals Inc D0R9VC DRUGINCH 1S/C60H73N15O13/c1-32(2)20-47(60(88)75-19-7-12-49(75)59(87)65-28-50(61)78)73-55(83)44(22-34-25-63-40-10-5-3-8-38(34)40)69-52(80)29-66-53(81)43(21-33-13-15-37(77)16-14-33)70-58(86)48(30-76)74-56(84)45(23-35-26-64-41-11-6-4-9-39(35)41)71-57(85)46(24-36-27-62-31-67-36)72-54(82)42-17-18-51(79)68-42/h3-6,8-11,13-16,25-27,31-32,42-49,63-64,76-77H,7,12,17-24,28-30H2,1-2H3,(H2,61,78)(H,62,67)(H,65,87)(H,66,81)(H,68,79)(H,69,80)(H,70,86)(H,71,85)(H,72,82)(H,73,83)(H,74,84) D0R9VC DRUGINKE NMJREATYWWNIKX-UHFFFAOYSA-N D0R9VC DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8 D0R9VC HIGHSTAT Phase 3 D0RE9C DRUG__ID D0RE9C D0RE9C DRUGCOMP Actelion Pharmaceuticals South San Francisco, CA D0RE9C DRUGINCH 1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9+,10-/m1/s1 D0RE9C DRUGINKE UQRORFVVSGFNRO-XFWSIPNHSA-N D0RE9C DRUGSMIL CCCCN1CC(C(C(C1CO)O)O)O D0RE9C HIGHSTAT Phase 3 D0S5LT DRUG__ID D0S5LT D0S5LT DRUGTYPE Small molecular drug D0S5LT DRUGINCH 1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6-/m1/s1 D0S5LT DRUGINKE LXBIFEVIBLOUGU-JGWLITMVSA-N D0S5LT DRUGSMIL C1C(C(C(C(N1)CO)O)O)O D0S5LT HIGHSTAT Phase 3 D0SB1B DRUG__ID D0SB1B D0SB1B DRUGCOMP Celator Pharmaceuticals Ewing, NJ D0SB1B DRUGINCH 1S/C27H29NO10.C9H13N3O5/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t10-,14-,16-,17-,22+,27-;4-,6-,7+,8-/m01/s1 D0SB1B DRUGINKE HBQCEICSYDCGJG-SZXLQUARSA-N D0SB1B DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O D0SB1B HIGHSTAT Phase 3 D0SJ8Q DRUG__ID D0SJ8Q D0SJ8Q DRUGTYPE Small molecular drug D0SJ8Q DRUGINCH 1S/C66H126N2O19P2/c1-7-11-15-19-22-25-26-27-28-29-30-32-34-38-42-46-57(70)67-60-64(82-49-47-54(80-6)45-41-36-18-14-10-4)62(86-88(73,74)75)56(51-79-5)85-65(60)83-52-55-61(72)63(81-48-43-39-35-24-21-17-13-9-3)59(66(84-55)87-89(76,77)78)68-58(71)50-53(69)44-40-37-33-31-23-20-16-12-8-2/h25-26,54-56,59-66,72H,7-24,27-52H2,1-6H3,(H,67,70)(H,68,71)(H2,73,74,75)(H2,76,77,78)/b26-25-/t54-,55-,56-,59-,60-,61-,62-,63-,64-,65-,66-/m1/s1 D0SJ8Q DRUGINKE BPSMYQFMCXXNPC-MFCPCZTFSA-N D0SJ8Q DRUGSMIL CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC D0SJ8Q HIGHSTAT Phase 3 D0T8QB DRUG__ID D0T8QB D0T8QB DRUGTYPE Small molecular drug D0T8QB DRUGINCH 1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1 D0T8QB DRUGINKE LPLVUJXQOOQHMX-QWBHMCJMSA-N D0T8QB DRUGSMIL CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C D0T8QB HIGHSTAT Phase 3 D0TD7J DRUG__ID D0TD7J D0TD7J DRUGCOMP Alkermes, Waltham, MA D0TD7J DRUGINCH 1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+ D0TD7J DRUGINKE YIMYDTCOUQIDMT-SNAWJCMRSA-N D0TD7J DRUGSMIL COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O D0TD7J HIGHSTAT Phase 3 D0TP5H DRUG__ID D0TP5H D0TP5H DRUGCOMP Janssen Research & Development Raritan, NJ D0TP5H DRUGINCH 1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1 D0TP5H DRUGINKE YQEZLKZALYSWHR-ZDUSSCGKSA-N D0TP5H DRUGSMIL CNC1(CCCCC1=O)C2=CC=CC=C2Cl D0TP5H HIGHSTAT Phase 3 D0U2CE DRUG__ID D0U2CE D0U2CE DRUGCOMP Rhythm Pharmaceuticals D0U2CE DRUGINCH 1S/C43H50N8O5S/c44-42(56)43(16-19-45-20-17-43)51-41(55)34(21-27-9-2-1-3-10-27)49-39(53)35(22-29-25-47-33-14-6-4-12-31(29)33)50-40(54)36(48-38(52)28-11-8-18-46-24-28)23-30-26-57-37-15-7-5-13-32(30)37/h1-7,9-10,12-15,25-26,28,34-36,45-47H,8,11,16-24H2,(H2,44,56)(H,48,52)(H,49,53)(H,50,54)(H,51,55)/t28?,34-,35+,36+/m0/s1 D0U2CE DRUGINKE IPMQOGDSJZQLFX-BIBZJUPHSA-N D0U2CE DRUGSMIL C1CC(CNC1)C(=O)NC(CC2=CSC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N D0U2CE HIGHSTAT Phase 3 D0V9BU DRUG__ID D0V9BU D0V9BU DRUGTYPE Small molecular drug D0V9BU DRUGINCH 1S/C18H12ClF3N4O4/c19-12-13-7(1-9(20)14(12)25-3-6(27)4-25)15(28)8(18(29)30)5-26(13)17-11(22)2-10(21)16(23)24-17/h1-2,5-6,27H,3-4H2,(H2,23,24)(H,29,30) D0V9BU DRUGINKE DYDCPNMLZGFQTM-UHFFFAOYSA-N D0V9BU DRUGSMIL C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O D0V9BU HIGHSTAT Phase 3 D0V9QR DRUG__ID D0V9QR D0V9QR DRUGTYPE Small molecular drug D0V9QR DRUGINCH 1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m1/s1 D0V9QR DRUGINKE RYMCFYKJDVMSIR-RNFRBKRXSA-N D0V9QR DRUGSMIL C1C(SC(O1)CO)N2C=CC(=NC2=O)N D0V9QR HIGHSTAT Phase 3 D0VD8S DRUG__ID D0VD8S D0VD8S DRUGCOMP Generex Biotechnology D0VD8S DRUGINCH 1S/C257H383N65O77S6/c1-29-131(23)205(313-193(339)104-259)252(393)317-204(130(21)22)248(389)288-159(75-82-200(349)350)217(358)282-156(71-78-189(263)335)221(362)308-183-116-403-404-117-184-243(384)305-178(111-324)240(381)294-162(88-123(7)8)225(366)295-168(95-140-53-61-146(329)62-54-140)228(369)283-154(69-76-187(261)333)218(359)290-161(87-122(5)6)223(364)285-158(74-81-199(347)348)220(361)302-174(101-190(264)336)235(376)298-170(97-142-57-65-148(331)66-58-142)231(372)309-182(242(383)304-176(255(396)397)103-192(266)338)115-402-401-114-181(214(355)273-107-194(340)278-153(72-79-197(343)344)216(357)281-151(51-42-84-271-257(267)268)212(353)272-108-195(341)279-166(93-138-46-36-32-37-47-138)227(368)297-167(94-139-48-38-33-39-49-139)230(371)299-171(98-143-59-67-149(332)68-60-143)238(379)320-208(135(27)327)254(395)322-85-43-52-186(322)246(387)286-152(50-40-41-83-258)222(363)321-209(136(28)328)256(398)399)311-250(391)203(129(19)20)316-236(377)164(90-125(11)12)292-229(370)169(96-141-55-63-147(330)64-56-141)296-224(365)160(86-121(3)4)289-210(351)133(25)277-215(356)157(73-80-198(345)346)287-247(388)202(128(17)18)315-237(378)165(91-126(13)14)293-233(374)173(100-145-106-270-120-276-145)301-239(380)177(110-323)280-196(342)109-274-213(354)180(113-400-405-118-185(310-244(183)385)245(386)319-207(134(26)326)253(394)306-179(112-325)241(382)318-206(132(24)30-2)251(392)312-184)307-226(367)163(89-124(9)10)291-232(373)172(99-144-105-269-119-275-144)300-219(360)155(70-77-188(262)334)284-234(375)175(102-191(265)337)303-249(390)201(127(15)16)314-211(352)150(260)92-137-44-34-31-35-45-137/h31-39,44-49,53-68,105-106,119-136,150-186,201-209,323-332H,29-30,40-43,50-52,69-104,107-118,258-260H2,1-28H3,(H2,261,333)(H2,262,334)(H2,263,335)(H2,264,336)(H2,265,337)(H2,266,338)(H,269,275)(H,270,276)(H,272,353)(H,273,355)(H,274,354)(H,277,356)(H,278,340)(H,279,341)(H,280,342)(H,281,357)(H,282,358)(H,283,369)(H,284,375)(H,285,364)(H,286,387)(H,287,388)(H,288,389)(H,289,351)(H,290,359)(H,291,373)(H,292,370)(H,293,374)(H,294,381)(H,295,366)(H,296,365)(H,297,368)(H,298,376)(H,299,371)(H,300,360)(H,301,380)(H,302,361)(H,303,390)(H,304,383)(H,305,384)(H,306,394)(H,307,367)(H,308,362)(H,309,372)(H,310,385)(H,311,391)(H,312,392)(H,313,339)(H,314,352)(H,315,378)(H,316,377)(H,317,393)(H,318,382)(H,319,386)(H,320,379)(H,321,363)(H,343,344)(H,345,346)(H,347,348)(H,349,350)(H,396,397)(H,398,399)(H4,267,268,271)/t131-,132-,133-,134+,135+,136+,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,201-,202-,203-,204-,205-,206-,207-,208-,209-/m0/s1 D0VD8S DRUGINKE PBGKTOXHQIOBKM-FHFVDXKLSA-N D0VD8S DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN D0VD8S HIGHSTAT Phase 3 D0VK9O DRUG__ID D0VK9O D0VK9O DRUGCOMP Brickell Biotech Boulder, CO D0VK9O DRUGINCH 1S/C22H32NO5.BrH/c1-3-27-20(24)16-23(2)14-13-19(15-23)28-21(25)22(26,18-11-7-8-12-18)17-9-5-4-6-10-17;/h4-6,9-10,18-19,26H,3,7-8,11-16H2,1-2H3;1H/q+1;/p-1/t19-,22+,23?;/m1./s1 D0VK9O DRUGINKE FIAFMTCUJCWADZ-JOFREBOKSA-M D0VK9O DRUGSMIL CCOC(=O)C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-] D0VK9O HIGHSTAT Phase 3 D0VP9E DRUG__ID D0VP9E D0VP9E DRUGTYPE Small molecular drug D0VP9E DRUGINCH 1S/C17H16O6/c1-7-15(21)8(2)17-14(16(7)22)12(20)6-13(23-17)9-3-4-10(18)11(19)5-9/h3-5,13,18-19,21-22H,6H2,1-2H3 D0VP9E DRUGINKE AESMRHCYHARBLU-UHFFFAOYSA-N D0VP9E DRUGSMIL CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC(=C(C=C3)O)O)C)O D0VP9E HIGHSTAT Phase 3 D0VZ4N DRUG__ID D0VZ4N D0VZ4N DRUGCOMP Astex Pharmaceuticals Pleasanton, CA D0VZ4N DRUGINCH 1S/C18H24N9O10P/c19-16-22-6-27(18(31)25-16)12-2-8(9(3-28)35-12)37-38(32,33)34-4-10-7(29)1-11(36-10)26-5-21-13-14(26)23-17(20)24-15(13)30/h5-12,28-29H,1-4H2,(H,32,33)(H2,19,25,31)(H3,20,23,24,30)/t7-,8-,9+,10+,11+,12+/m0/s1 D0VZ4N DRUGINKE GUWXKKAWLCENJA-WGWHJZDNSA-N D0VZ4N DRUGSMIL C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OC4CC(OC4CO)N5C=NC(=NC5=O)N)O D0VZ4N HIGHSTAT Phase 3 D0W2BF DRUG__ID D0W2BF D0W2BF DRUGCOMP Seattle Genetics Bothell, WA D0W2BF DRUGINCH 1S/C63H71N9O14S/c1-35(2)57(69-55(73)11-8-7-9-20-70-56(74)29-54(62(70)79)87-34-47(64)63(80)81)59(76)67-36(3)58(75)68-41-16-12-37(13-17-41)39-23-42-30-65-48-27-52(50(83-5)25-45(48)60(77)71(42)32-39)85-21-10-22-86-53-28-49-46(26-51(53)84-6)61(78)72-33-40(24-43(72)31-66-49)38-14-18-44(82-4)19-15-38/h12-19,25-28,30-33,35-36,42-43,47,54,57H,7-11,20-24,29,34,64H2,1-6H3,(H,67,76)(H,68,75)(H,69,73)(H,80,81)/t36-,42-,43-,47-,54+,57-/m0/s1 D0W2BF DRUGINKE BNJNAEJASPUJTO-DUOHOMBCSA-N D0W2BF DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC1=CC=C(C=C1)C2=CN3C(C2)C=NC4=CC(=C(C=C4C3=O)OC)OCCCOC5=C(C=C6C(=C5)N=CC7CC(=CN7C6=O)C8=CC=C(C=C8)OC)OC)NC(=O)CCCCCN9C(=O)CC(C9=O)SCC(C(=O)O)N D0W2BF HIGHSTAT Phase 3 D0WL0Q DRUG__ID D0WL0Q D0WL0Q DRUGCOMP GILEAD D0WL0Q DRUGINCH 1S/C7H5BrFNO3/c1-13-5-3-2-4(8)6(9)7(5)10(11)12/h2-3H,1H3 D0WL0Q DRUGINKE LJJAOMRFFXQENV-UHFFFAOYSA-N D0WL0Q DRUGSMIL COC1=C(C(=C(C=C1)Br)F)[N+](=O)[O-] D0WL0Q HIGHSTAT Phase 3 D0WL3H DRUG__ID D0WL3H D0WL3H DRUGCOMP Luye america pharmaceuticals D0WL3H DRUGINCH 1S/C24H31NO3/c1-18-7-9-20(10-8-18)23(26)28-21-13-11-19(12-14-21)22(17-25(2)3)24(27)15-5-4-6-16-24/h7-14,22,27H,4-6,15-17H2,1-3H3 D0WL3H DRUGINKE QKYBZJLEMOZFFU-UHFFFAOYSA-N D0WL3H DRUGSMIL CC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(CN(C)C)C3(CCCCC3)O D0WL3H HIGHSTAT Phase 3 D0X4UP DRUG__ID D0X4UP D0X4UP DRUGCOMP Insmed, Bridgewater, NJ D0X4UP DRUGINCH 1S/C22H43N5O13/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36)/t6-,7+,8?,9+,10+,11-,12+,13+,14+,15-,16+,17-,18?,19-,21+,22+/m0/s1 D0X4UP DRUGINKE LKCWBDHBTVXHDL-CAIQVSFASA-N D0X4UP DRUGSMIL C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N D0X4UP HIGHSTAT Phase 3 D0X8ED DRUG__ID D0X8ED D0X8ED DRUGTYPE Small molecular drug D0X8ED DRUGINCH 1S/C10H15N3O5/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16/h1-2,6,12,14-17H,3-4,11H2,(H,13,18) D0X8ED DRUGINKE BNQDCRGUHNALGH-UHFFFAOYSA-N D0X8ED DRUGSMIL C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O D0X8ED HIGHSTAT Phase 3 D0XW9L DRUG__ID D0XW9L D0XW9L DRUGTYPE Small molecular drug D0XW9L DRUGINCH 1S/C51H64N4O13/c1-24(2)23-54-16-18-55(19-17-54)32-21-33(57)39-35(22-32)67-48-40(52-39)36-37-44(60)30(8)47-38(36)49(62)51(10,68-47)65-20-15-34(64-11)27(5)46(66-31(9)56)29(7)43(59)28(6)42(58)25(3)13-12-14-26(4)50(63)53-41(48)45(37)61/h12-15,20-22,24-25,27-29,34,42-43,46,58-60,62H,16-19,23H2,1-11H3,(H,53,63)/b13-12+,20-15+,26-14-/t25-,27+,28+,29+,34-,42-,43+,46+,51-/m0/s1 D0XW9L DRUGINKE IXSVOCGZBUJEPI-HTQYORAHSA-N D0XW9L DRUGSMIL CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)CC(C)C)O3)C D0XW9L HIGHSTAT Phase 3 D0Y0EP DRUG__ID D0Y0EP D0Y0EP DRUGCOMP AstraZeneca Wilmington, DE; Eli Lilly Indianapolis, IN D0Y0EP DRUGINCH 1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30)/t22?,25?,26-/m0/s1 D0Y0EP DRUGINKE WKDNQONLGXOZRG-BOPKNSRXSA-N D0Y0EP DRUGSMIL CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2 D0Y0EP HIGHSTAT Phase 3 D0Y2IN DRUG__ID D0Y2IN D0Y2IN DRUGTYPE Small molecular drug D0Y2IN DRUGINCH 1S/C8H13N3O6/c12-3-6(14)7(4-13)17-5-10-2-1-9-8(10)11(15)16/h1-2,6-7,12-14H,3-5H2/t6-,7+/m1/s1 D0Y2IN DRUGINKE FIITXXIVUIXYMI-RQJHMYQMSA-N D0Y2IN DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])COC(CO)C(CO)O D0Y2IN HIGHSTAT Phase 3 D0Y6HW DRUG__ID D0Y6HW D0Y6HW DRUGTYPE Small molecular drug D0Y6HW DRUGINCH 1S/C19H20ClNO/c1-21-9-8-13-10-16(20)18(22)11-15(13)19-14-5-3-2-4-12(14)6-7-17(19)21/h2-5,10-11,17,19,22H,6-9H2,1H3/t17-,19+/m0/s1 D0Y6HW DRUGINKE DMJWENQHWZZWDF-PKOBYXMFSA-N D0Y6HW DRUGSMIL CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl D0Y6HW HIGHSTAT Phase 3 D0Y6ZK DRUG__ID D0Y6ZK D0Y6ZK DRUGTYPE Small molecular drug D0Y6ZK DRUGINCH 1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1 D0Y6ZK DRUGINKE HUJXGQILHAUCCV-MOROJQBDSA-N D0Y6ZK DRUGSMIL CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)O)O D0Y6ZK HIGHSTAT Phase 3 D0Z6IB DRUG__ID D0Z6IB D0Z6IB DRUGCOMP Avanir pharmaceuticals D0Z6IB DRUGINCH 1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1/i1D3,2D3 D0Z6IB DRUGINKE MKXZASYAUGDDCJ-QNNIAVNKSA-N D0Z6IB DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC D0Z6IB HIGHSTAT Phase 3 D0ZG3S DRUG__ID D0ZG3S D0ZG3S DRUGCOMP Aldeyra Therapeutics Lexington, MA D0ZG3S DRUGINCH 1S/C12H13ClN2O/c1-12(2,16)11-9(14)6-7-5-8(13)3-4-10(7)15-11/h3-6,16H,14H2,1-2H3 D0ZG3S DRUGINKE GUHFUVLKYSQIOQ-UHFFFAOYSA-N D0ZG3S DRUGSMIL CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O D0ZG3S HIGHSTAT Phase 3 D0ZG5K DRUG__ID D0ZG5K D0ZG5K DRUGCOMP Auven Therapeutics New York, NY D0ZG5K DRUGINCH 1S/C3H8O6S2.2Na/c4-10(5,6)2-1-3-11(7,8)9;;/h1-3H2,(H,4,5,6)(H,7,8,9);;/q;2*+1/p-2 D0ZG5K DRUGINKE DKGJFKPIUSHDIT-UHFFFAOYSA-L D0ZG5K DRUGSMIL C(CS(=O)(=O)[O-])CS(=O)(=O)[O-].[Na+].[Na+] D0ZG5K HIGHSTAT Phase 3 D0ZL0Z DRUG__ID D0ZL0Z D0ZL0Z DRUGTYPE Small molecular drug D0ZL0Z DRUGINCH 1S/C12H12FN3S2/c13-10-3-1-2-9(8-10)4-5-14-11(17)16-12-15-6-7-18-12/h1-3,6-8H,4-5H2,(H2,14,15,16,17) D0ZL0Z DRUGINKE NDHSDDFIIZKISX-UHFFFAOYSA-N D0ZL0Z DRUGSMIL C1=CC(=CC(=C1)F)CCNC(=S)NC2=NC=CS2 D0ZL0Z HIGHSTAT Phase 3 D0ZY3E DRUG__ID D0ZY3E D0ZY3E DRUGCOMP Inotek Pharma. D0ZY3E THERCLAS Anticancer Agents D0ZY3E DRUGTYPE Small molecular drug D0ZY3E DRUGSMIL C1=NC(=O)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O D0ZY3E HIGHSTAT Phase 3 D7OZC3 DRUG__ID D7OZC3 D7OZC3 DRUGTYPE Small molecule D7OZC3 DRUGINCH InChI=1S/C26H25N5O3/c1-2-23(32)29-16-6-7-19(17-29)30-22-14-15-28-25(27)24(22)31(26(30)33)18-10-12-21(13-11-18)34-20-8-4-3-5-9-20/h2-5,8-15,19H,1,6-7,16-17H2,(H2,27,28)/t19-/m1/s1 D7OZC3 DRUGINKE KOEUOFPEZFUWRF-LJQANCHMSA-N D7OZC3 DRUGSMIL C=CC(=O)N1CCCC(C1)N2C3=C(C(=NC=C3)N)N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5 D7OZC3 HIGHSTAT Phase 3 DBND71 DRUG__ID DBND71 DBND71 DRUGTYPE Small molecular drug DBND71 DRUGINCH 1S/C28H22Cl3N3O5/c29-20-2-1-3-21(30)24(20)25-18(26(39-33-25)15-4-5-15)12-38-17-6-7-19(22(31)11-17)28(37)13-34(14-28)23-10-16(27(35)36)8-9-32-23/h1-3,6-11,15,37H,4-5,12-14H2,(H,35,36) DBND71 DRUGINKE KZSKGLFYQAYZCO-UHFFFAOYSA-N DBND71 DRUGSMIL C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl DBND71 HIGHSTAT Phase 3 DN62DG DRUG__ID DN62DG DN62DG DRUGTYPE Small molecular drug DN62DG DRUGINCH 1S/C9H9NO/c11-6-7-5-10-9-4-2-1-3-8(7)9/h1-5,10-11H,6H2 DN62DG DRUGINKE IVYPNXXAYMYVSP-UHFFFAOYSA-N DN62DG DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CO DN62DG HIGHSTAT Phase 3 DR6BU1 DRUG__ID DR6BU1 DR6BU1 DRUGTYPE Small molecular drug DR6BU1 DRUGINCH 1S/C12H16BNO5S/c15-11(7-9-2-1-5-20-9)14-10-4-3-8(6-12(16)17)19-13(10)18/h1-2,5,8,10,18H,3-4,6-7H2,(H,14,15)(H,16,17)/t8-,10-/m0/s1 DR6BU1 DRUGINKE IOOWNWLVCOUUEX-WPRPVWTQSA-N DR6BU1 DRUGSMIL B1(C(CCC(O1)CC(=O)O)NC(=O)CC2=CC=CS2)O DR6BU1 HIGHSTAT Phase 3 D00QNW DRUG__ID D00QNW D00QNW DRUGCOMP Merck D00QNW DRUGTYPE Combination drug D00QNW DRUGSMIL failed D00QNW HIGHSTAT Phase 3 D01IWJ DRUG__ID D01IWJ D01IWJ DRUGCOMP GlaxoSmithKline D01IWJ DRUGTYPE Combination drug D01IWJ DRUGSMIL failed D01IWJ HIGHSTAT Phase 3 D01PKG DRUG__ID D01PKG D01PKG DRUGCOMP Abbott Laboratories Abbott D01PKG DRUGTYPE Combination drug D01PKG DRUGSMIL failed D01PKG HIGHSTAT Phase 3 D02NZO DRUG__ID D02NZO D02NZO DRUGCOMP Sanofi-aventis D02NZO DRUGTYPE Combination drug D02NZO DRUGSMIL failed D02NZO HIGHSTAT Phase 3 D02UVT DRUG__ID D02UVT D02UVT DRUGCOMP GlaxoSmithKline D02UVT DRUGTYPE Combination drug D02UVT DRUGSMIL failed D02UVT HIGHSTAT Phase 3 D03RCV DRUG__ID D03RCV D03RCV DRUGINCH 1S/C144H212N32O24/c1-91(155-128(183)105(154)83-97-49-15-7-16-50-97)122(177)161-106(65-31-40-74-145)129(184)165-111(70-36-45-79-150)134(189)172-117(86-100-55-21-10-22-56-100)139(194)156-93(3)124(179)163-108(67-33-42-76-147)131(186)167-114(73-39-48-82-153)137(192)175-120(89-103-61-27-13-28-62-103)143(198)169-110(69-35-44-78-149)132(187)168-113(72-38-47-81-152)136(191)174-119(88-102-59-25-12-26-60-102)140(195)157-92(2)123(178)162-107(66-32-41-75-146)130(185)166-112(71-37-46-80-151)135(190)173-118(87-101-57-23-11-24-58-101)141(196)158-94(4)125(180)164-109(68-34-43-77-148)133(188)171-116(85-99-53-19-9-20-54-99)142(197)159-95(5)126(181)170-115(84-98-51-17-8-18-52-98)138(193)160-96(6)127(182)176-121(144(199)200)90-104-63-29-14-30-64-104/h7-30,49-64,91-96,105-121H,31-48,65-90,145-154H2,1-6H3,(H,155,183)(H,156,194)(H,157,195)(H,158,196)(H,159,197)(H,160,193)(H,161,177)(H,162,178)(H,163,179)(H,164,180)(H,165,184)(H,166,185)(H,167,186)(H,168,187)(H,169,198)(H,170,181)(H,171,188)(H,172,189)(H,173,190)(H,174,191)(H,175,192)(H,176,182)(H,199,200)/t91-,92-,93-,94-,95-,96-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-/m0/s1 D03RCV DRUGINKE WVRNJUBRGDUHNI-CPOCOYSOSA-N D03RCV DRUGSMIL CC(C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(C)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(C)C(=O)NC(CC7=CC=CC=C7)C(=O)O)NC(=O)C(CC8=CC=CC=C8)N D03RCV HIGHSTAT Phase 3 D06JFI DRUG__ID D06JFI D06JFI DRUGINCH 1S/C54H66N10O10S2/c1-32(65)46-53(72)62-43(27-35-19-9-4-10-20-35)51(70)63-45(54(73)74)31-76-75-30-38(56)47(66)59-41(25-33-15-5-2-6-16-33)49(68)60-42(26-34-17-7-3-8-18-34)50(69)61-44(28-36-29-57-39-22-12-11-21-37(36)39)52(71)58-40(48(67)64-46)23-13-14-24-55/h2-12,15-22,29,32,38,40-46,57,65H,13-14,23-28,30-31,55-56H2,1H3,(H,58,71)(H,59,66)(H,60,68)(H,61,69)(H,62,72)(H,63,70)(H,64,67)(H,73,74)/t32-,38+,40+,41+,42+,43+,44-,45+,46+/m1/s1 D06JFI DRUGINKE PJRZZHKHLDKTKL-OCZUONHDSA-N D06JFI DRUGSMIL CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)N)C(=O)O)CC6=CC=CC=C6)O D06JFI HIGHSTAT Phase 3 D08KSU DRUG__ID D08KSU D08KSU DRUGCOMP Antisense therapeutics D08KSU THERCLAS Antisense D08KSU DRUGTYPE Antisense drug D08KSU HIGHSTAT Phase 3 D08YWK DRUG__ID D08YWK D08YWK DRUGINCH 1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1 D08YWK DRUGINKE YNDXUCZADRHECN-JNQJZLCISA-N D08YWK DRUGSMIL CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C D08YWK HIGHSTAT Phase 3 D0B8WU DRUG__ID D0B8WU D0B8WU DRUGINCH 1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10H,6-7,9H2,(H,18,25)(H,19,20)(H,23,24) D0B8WU DRUGINKE FJYRBJKWDXVHHO-UHFFFAOYSA-N D0B8WU DRUGSMIL C1=CC=C(C=C1)CCC2=CC(=O)C(=C3N2NC=N3)C(=O)NCC(=O)O D0B8WU HIGHSTAT Phase 3 D0C0MN DRUG__ID D0C0MN D0C0MN DRUGCOMP Shionogi Florham D0C0MN DRUGTYPE Combination drug D0C0MN DRUGSMIL failed D0C0MN HIGHSTAT Phase 3 D0CE0O DRUG__ID D0CE0O D0CE0O DRUGCOMP Novartis pharmaceuticals D0CE0O DRUGTYPE Protein/peptide drug D0CE0O DRUGSMIL CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C D0CE0O HIGHSTAT Phase 3 D0D5ZU DRUG__ID D0D5ZU D0D5ZU DRUGCOMP Quark Pharmaceuticals D0D5ZU THERCLAS siRNA D0D5ZU DRUGTYPE siRNA drug D0D5ZU HIGHSTAT Phase 3 D0F3HC DRUG__ID D0F3HC D0F3HC DRUGCOMP GILEAD D0F3HC DRUGTYPE Small molecular drug D0F3HC DRUGSMIL CC1C(C(=O)N1S(=O)(=O)[O-])NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)[NH3+].C(CCN)CC(C(=O)O)N D0F3HC HIGHSTAT Phase 3 D0H0UB DRUG__ID D0H0UB D0H0UB DRUGCOMP GSK D0H0UB DRUGTYPE Combination drug D0H0UB DRUGSMIL failed D0H0UB HIGHSTAT Phase 3 D0JZ7P DRUG__ID D0JZ7P D0JZ7P THERCLAS Antiviral Agents D0JZ7P DRUGTYPE Protein/peptide drug D0JZ7P DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C D0JZ7P HIGHSTAT Phase 3 Trial D0L4LX DRUG__ID D0L4LX D0L4LX DRUGCOMP Merck D0L4LX DRUGTYPE Combination drug D0L4LX DRUGSMIL failed D0L4LX HIGHSTAT Phase 3 D0MV4W DRUG__ID D0MV4W D0MV4W DRUGINCH 1S/C28H28N4O3.ClH/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24;/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34);1H/t18-;/m0./s1 D0MV4W DRUGINKE NYQIEYDJYFVLPO-FERBBOLQSA-N D0MV4W DRUGSMIL CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O.Cl D0MV4W HIGHSTAT Phase 3 D0QJ8J DRUG__ID D0QJ8J D0QJ8J DRUGCOMP Moderna D0QJ8J THERCLAS Antiviral Agents D0QJ8J DRUGTYPE Vaccine D0QJ8J HIGHSTAT Phase 3 Trial D0R8WT DRUG__ID D0R8WT D0R8WT DRUGCOMP Roche; Genentech D0R8WT THERCLAS Antiviral Agents D0R8WT DRUGTYPE Monoclonal antibody D0R8WT HIGHSTAT Phase 3 Trial D0Z0HL DRUG__ID D0Z0HL D0Z0HL DRUGCOMP Sanofi D0Z0HL DRUGTYPE Combination drug D0Z0HL DRUGSMIL failed D0Z0HL HIGHSTAT Phase 3 D0Z1SL DRUG__ID D0Z1SL D0Z1SL DRUGCOMP Ligand Pharmaceuticals; Pfizer D0Z1SL DRUGTYPE Combination drug D0Z1SL DRUGSMIL failed D0Z1SL HIGHSTAT Phase 3 D00BVS DRUG__ID D00BVS D00BVS DRUGCOMP Pfizer New York, NY D00BVS DRUGTYPE Monoclonal antibody D00BVS HIGHSTAT Phase 3 D00CZT DRUG__ID D00CZT D00CZT DRUGCOMP Eli Lilly D00CZT DRUGTYPE Monoclonal antibody D00CZT HIGHSTAT Phase 3 D00HSK DRUG__ID D00HSK D00HSK DRUGCOMP NewLink Genetics D00HSK DRUGTYPE Vaccine D00HSK HIGHSTAT Phase 3 D00NUG DRUG__ID D00NUG D00NUG DRUGCOMP UCB D00NUG DRUGTYPE Monoclonal antibody D00NUG HIGHSTAT Phase 3 D00UAE DRUG__ID D00UAE D00UAE DRUGCOMP Peregrine Pharmaceuticals D00UAE DRUGTYPE Monoclonal antibody D00UAE HIGHSTAT Phase 3 D01XIF DRUG__ID D01XIF D01XIF THERCLAS Antiviral Agents D01XIF DRUGTYPE Combination drug D01XIF HIGHSTAT Phase 3 Trial D01XVF DRUG__ID D01XVF D01XVF DRUGCOMP GlaxoSmithKline D01XVF DRUGTYPE Monoclonal antibody D01XVF HIGHSTAT Phase 3 D01ZJP DRUG__ID D01ZJP D01ZJP THERCLAS Antiviral Agents D01ZJP DRUGTYPE Combination drug D01ZJP HIGHSTAT Phase 3 Trial D02CKG DRUG__ID D02CKG D02CKG THERCLAS Antiviral Agents D02CKG DRUGTYPE Combination drug D02CKG HIGHSTAT Phase 3 Trial D02EKI DRUG__ID D02EKI D02EKI THERCLAS Antiviral Agents D02EKI DRUGTYPE Combination drug D02EKI HIGHSTAT Phase 3 Trial D02EPW DRUG__ID D02EPW D02EPW THERCLAS Antiviral Agents D02EPW DRUGTYPE Combination drug D02EPW HIGHSTAT Phase 3 Trial D02EQX DRUG__ID D02EQX D02EQX THERCLAS Antiviral Agents D02EQX DRUGTYPE Combination drug D02EQX HIGHSTAT Phase 3 Trial D02KEW DRUG__ID D02KEW D02KEW THERCLAS Antiviral Agents D02KEW DRUGTYPE Combination drug D02KEW HIGHSTAT Phase 3 Trial D02MUA DRUG__ID D02MUA D02MUA DRUGCOMP Pfizer D02MUA DRUGTYPE Antibody D02MUA HIGHSTAT Phase 3 D02RBR DRUG__ID D02RBR D02RBR THERCLAS Antiviral Agents D02RBR DRUGTYPE Combination drug D02RBR HIGHSTAT Phase 3 Trial D02RSY DRUG__ID D02RSY D02RSY DRUGCOMP Adverum Biotechnologies D02RSY DRUGTYPE Gene therapy D02RSY HIGHSTAT Phase 3 D02XPI DRUG__ID D02XPI D02XPI THERCLAS Antiviral Agents D02XPI DRUGTYPE Combination drug D02XPI HIGHSTAT Phase 3 Trial D03AKW DRUG__ID D03AKW D03AKW DRUGCOMP Amgen D03AKW DRUGTYPE Monoclonal antibody D03AKW HIGHSTAT Phase 3 D03DJT DRUG__ID D03DJT D03DJT DRUGCOMP Pfizer D03DJT DRUGTYPE Antibody D03DJT HIGHSTAT Phase 3 D03FBV DRUG__ID D03FBV D03FBV DRUGCOMP Pfizer New York, NY D03FBV DRUGTYPE Antibody D03FBV HIGHSTAT Phase 3 D03FFA DRUG__ID D03FFA D03FFA DRUGCOMP Henogen SA D03FFA DRUGTYPE Vaccine D03FFA HIGHSTAT Phase 3 D03KAY DRUG__ID D03KAY D03KAY THERCLAS Antiviral Agents D03KAY DRUGTYPE Combination drug D03KAY HIGHSTAT Phase 3 Trial D03OTH DRUG__ID D03OTH D03OTH DRUGCOMP NovaRx D03OTH DRUGTYPE Vaccine D03OTH HIGHSTAT Phase 3 D03PUA DRUG__ID D03PUA D03PUA THERCLAS Antiviral Agents D03PUA DRUGTYPE Monoclonal antibody D03PUA HIGHSTAT Phase 3 Trial D04BNB DRUG__ID D04BNB D04BNB THERCLAS Antiviral Agents D04BNB DRUGTYPE Monoclonal antibody D04BNB HIGHSTAT Phase 3 Trial D04FNR DRUG__ID D04FNR D04FNR DRUGCOMP Memorial Sloan-Kettering Cancer Center D04FNR DRUGTYPE Monoclonal antibody D04FNR HIGHSTAT Phase 3 D04FOP DRUG__ID D04FOP D04FOP THERCLAS Antiviral Agents D04FOP DRUGTYPE Monoclonal antibody D04FOP HIGHSTAT Phase 3 Trial D04QVZ DRUG__ID D04QVZ D04QVZ THERCLAS Antiviral Agents D04QVZ DRUGTYPE Protein/peptide drug D04QVZ HIGHSTAT Phase 3 Trial D04RRZ DRUG__ID D04RRZ D04RRZ DRUGCOMP AstraZeneca D04RRZ DRUGTYPE Monoclonal antibody D04RRZ HIGHSTAT Phase 3 D04SNL DRUG__ID D04SNL D04SNL DRUGCOMP Solvay SA D04SNL DRUGTYPE Vaccine D04SNL HIGHSTAT Phase 3 D04UKP DRUG__ID D04UKP D04UKP DRUGCOMP Sigma-Tau SpA D04UKP DRUGTYPE Monoclonal antibody D04UKP HIGHSTAT Phase 3 D04VRB DRUG__ID D04VRB D04VRB DRUGCOMP Galena Biopharma D04VRB DRUGTYPE Vaccine D04VRB HIGHSTAT Phase 3 D04XQW DRUG__ID D04XQW D04XQW THERCLAS Antiviral Agents D04XQW DRUGTYPE Protein/peptide drug D04XQW HIGHSTAT Phase 3 Trial D05BAJ DRUG__ID D05BAJ D05BAJ DRUGCOMP Novartis Oncology East Hanover, NJ D05BAJ DRUGTYPE Antibody D05BAJ HIGHSTAT Phase 3 D05TBQ DRUG__ID D05TBQ D05TBQ DRUGCOMP Sanofi D05TBQ DRUGTYPE Antibody drug conjugate D05TBQ HIGHSTAT Phase 3 D05ZAI DRUG__ID D05ZAI D05ZAI DRUGCOMP Solvay SA D05ZAI DRUGTYPE Vaccine D05ZAI HIGHSTAT Phase 3 D06ARV DRUG__ID D06ARV D06ARV DRUGCOMP Schering-Plough Corp D06ARV DRUGTYPE Antibody D06ARV HIGHSTAT Phase 3 D06BGS DRUG__ID D06BGS D06BGS DRUGCOMP DiaDexus Inc D06BGS DRUGTYPE Vaccine D06BGS HIGHSTAT Phase 3 D06CXL DRUG__ID D06CXL D06CXL THERCLAS Antiviral Agents D06CXL DRUGTYPE Protein/peptide drug D06CXL HIGHSTAT Phase 3 Trial D06FMO DRUG__ID D06FMO D06FMO DRUGCOMP Amgen D06FMO DRUGTYPE Antibody D06FMO HIGHSTAT Phase 3 D06IBG DRUG__ID D06IBG D06IBG DRUGCOMP Merck D06IBG DRUGTYPE Antibody D06IBG HIGHSTAT Phase 3 D06PFT DRUG__ID D06PFT D06PFT DRUGCOMP Roche; Genentech D06PFT DRUGTYPE Antibody D06PFT HIGHSTAT Phase 3 D06QSN DRUG__ID D06QSN D06QSN DRUGCOMP Dermatology; The Center of Molecular Immunology D06QSN DRUGTYPE Antibody D06QSN HIGHSTAT Phase 3 D06XVN DRUG__ID D06XVN D06XVN DRUGCOMP Morphotek D06XVN DRUGTYPE Monoclonal antibody D06XVN HIGHSTAT Phase 3 D06ZFV DRUG__ID D06ZFV D06ZFV DRUGCOMP Quark pharmaceuticals D06ZFV DRUGTYPE siRNA drug D06ZFV HIGHSTAT Phase 3 D07HUW DRUG__ID D07HUW D07HUW DRUGCOMP Quest PharmaTech D07HUW DRUGTYPE Monoclonal antibody D07HUW HIGHSTAT Phase 3 D07VKT DRUG__ID D07VKT D07VKT DRUGCOMP United Therapeutics D07VKT DRUGTYPE Monoclonal antibody D07VKT HIGHSTAT Phase 3 D07YPW DRUG__ID D07YPW D07YPW DRUGCOMP Bellus Health D07YPW DRUGTYPE Monoclonal antibody D07YPW HIGHSTAT Phase 3 D08BBL DRUG__ID D08BBL D08BBL DRUGCOMP Actinium Pharmaceuticals D08BBL DRUGTYPE Antibody D08BBL HIGHSTAT Phase 3 D08JIP DRUG__ID D08JIP D08JIP DRUGCOMP Hemispherx Biopharma D08JIP DRUGTYPE siRNA drug D08JIP HIGHSTAT Phase 3 D08JLH DRUG__ID D08JLH D08JLH DRUGCOMP Novartis D08JLH DRUGTYPE Monoclonal antibody D08JLH HIGHSTAT Phase 3 D08RJM DRUG__ID D08RJM D08RJM DRUGCOMP Scioderm D08RJM DRUGTYPE Oligonucleotide D08RJM HIGHSTAT Phase 3 D09JKS DRUG__ID D09JKS D09JKS DRUGCOMP Erytech Pharma D09JKS DRUGTYPE Protein D09JKS HIGHSTAT Phase 3 D0A0MS DRUG__ID D0A0MS D0A0MS DRUGCOMP Boehringer ingelheim pharmaceuticals D0A0MS DRUGTYPE Antibody D0A0MS HIGHSTAT Phase 3 D0A1MX DRUG__ID D0A1MX D0A1MX DRUGCOMP Elan Corp plc D0A1MX DRUGTYPE Antibody D0A1MX HIGHSTAT Phase 3 D0AM4W DRUG__ID D0AM4W D0AM4W THERCLAS Antiviral Agents D0AM4W DRUGTYPE Combination drug D0AM4W HIGHSTAT Phase 3 Trial D0B0UF DRUG__ID D0B0UF D0B0UF DRUGCOMP Innovent Biologics D0B0UF DRUGTYPE Monoclonal antibody D0B0UF HIGHSTAT Phase 3 D0B3SV DRUG__ID D0B3SV D0B3SV DRUGCOMP Novartis Vaccines & Diagnostics D0B3SV DRUGTYPE Vaccine D0B3SV HIGHSTAT Phase 3 D0B3ZC DRUG__ID D0B3ZC D0B3ZC DRUGCOMP Ganymed Pharmaceuticals AG D0B3ZC DRUGTYPE Antibody D0B3ZC HIGHSTAT Phase 3 D0BF0X DRUG__ID D0BF0X D0BF0X THERCLAS Antiviral Agents D0BF0X DRUGTYPE Protein/peptide drug D0BF0X HIGHSTAT Phase 3 Trial D0BO0K DRUG__ID D0BO0K D0BO0K DRUGCOMP Incyte Wilmington, DE D0BO0K DRUGTYPE Monoclonal antibody D0BO0K HIGHSTAT Phase 3 D0C3LQ DRUG__ID D0C3LQ D0C3LQ DRUGCOMP Bristol-myers squibb D0C3LQ DRUGTYPE Monoclonal antibody D0C3LQ HIGHSTAT Phase 3 D0C4KT DRUG__ID D0C4KT D0C4KT DRUGCOMP XOMA D0C4KT DRUGTYPE Antibody D0C4KT HIGHSTAT Phase 3 D0CR8H DRUG__ID D0CR8H D0CR8H DRUGCOMP Symphogen A/S D0CR8H DRUGTYPE Antibody D0CR8H HIGHSTAT Phase 3 D0D7BX DRUG__ID D0D7BX D0D7BX DRUGCOMP Elevar Therapeutics D0D7BX DRUGTYPE Small molecular drug D0D7BX HIGHSTAT Phase 3 D0G2MR DRUG__ID D0G2MR D0G2MR DRUGCOMP AmVac AG D0G2MR DRUGTYPE Vaccine D0G2MR HIGHSTAT Phase 3 D0G8ZQ DRUG__ID D0G8ZQ D0G8ZQ DRUGCOMP Receptor Biologix D0G8ZQ DRUGTYPE Antibody D0G8ZQ HIGHSTAT Phase 3 D0HE7I DRUG__ID D0HE7I D0HE7I DRUGCOMP Sanofi Pasteur D0HE7I DRUGTYPE Vaccine D0HE7I HIGHSTAT Phase 3 D0HL5N DRUG__ID D0HL5N D0HL5N DRUGCOMP Synthon Pharmaceuticals Durham, NC D0HL5N DRUGTYPE Antibody drug conjugate D0HL5N HIGHSTAT Phase 3 D0I1ML DRUG__ID D0I1ML D0I1ML THERCLAS Antiviral Agents D0I1ML DRUGTYPE vaccine D0I1ML HIGHSTAT Phase 3 Trial D0I5PQ DRUG__ID D0I5PQ D0I5PQ THERCLAS Antiviral Agents D0I5PQ DRUGTYPE Protein/peptide drug D0I5PQ HIGHSTAT Phase 3 Trial D0I9VO DRUG__ID D0I9VO D0I9VO DRUGCOMP Immunomedics D0I9VO DRUGTYPE Antibody D0I9VO HIGHSTAT Phase 3 D0IV4E DRUG__ID D0IV4E D0IV4E THERCLAS Antiviral Agents D0IV4E DRUGTYPE Combination drug D0IV4E HIGHSTAT Phase 3 Trial D0KB0Y DRUG__ID D0KB0Y D0KB0Y DRUGCOMP Polaris Pharmaceuticals D0KB0Y DRUGTYPE Recombinant protein D0KB0Y HIGHSTAT Phase 3 D0L1OT DRUG__ID D0L1OT D0L1OT DRUGCOMP Oxford BioMedica D0L1OT DRUGTYPE Vaccine D0L1OT HIGHSTAT Phase 3 D0L4VD DRUG__ID D0L4VD D0L4VD DRUGCOMP Roche/Genentech D0L4VD DRUGTYPE Antibody D0L4VD HIGHSTAT Phase 3 D0L6GO DRUG__ID D0L6GO D0L6GO THERCLAS Antiviral Agents D0L6GO DRUGTYPE Combination drug D0L6GO HIGHSTAT Phase 3 Trial D0LI9I DRUG__ID D0LI9I D0LI9I THERCLAS Antiviral Agents D0LI9I DRUGTYPE Vaccine D0LI9I HIGHSTAT Phase 3 Trial D0LK9L DRUG__ID D0LK9L D0LK9L THERCLAS Antiviral Agents D0LK9L DRUGTYPE Vaccine D0LK9L HIGHSTAT Phase 3 Trial D0LM6O DRUG__ID D0LM6O D0LM6O THERCLAS Antiviral Agents D0LM6O DRUGTYPE Vaccine D0LM6O HIGHSTAT Phase 3 Trial D0LY3A DRUG__ID D0LY3A D0LY3A THERCLAS Antiviral Agents D0LY3A DRUGTYPE Combination drug D0LY3A HIGHSTAT Phase 3 Trial D0M1RD DRUG__ID D0M1RD D0M1RD DRUGCOMP ImmunoCellular Therapeutics D0M1RD DRUGTYPE Vaccine D0M1RD HIGHSTAT Phase 3 D0M2GE DRUG__ID D0M2GE D0M2GE THERCLAS Antiviral Agents D0M2GE DRUGTYPE Vaccine D0M2GE HIGHSTAT Phase 3 Trial D0M3ZB DRUG__ID D0M3ZB D0M3ZB THERCLAS Antiviral Agents D0M3ZB DRUGTYPE Vaccine D0M3ZB HIGHSTAT Phase 3 Trial D0N0QC DRUG__ID D0N0QC D0N0QC DRUGCOMP KAEL-GemVax D0N0QC DRUGTYPE Vaccine D0N0QC HIGHSTAT Phase 3 D0N7JZ DRUG__ID D0N7JZ D0N7JZ DRUGCOMP ADIENNE Pharma & Biotech D0N7JZ DRUGTYPE Antibody D0N7JZ HIGHSTAT Phase 3 D0O0QB DRUG__ID D0O0QB D0O0QB DRUGCOMP Enzon D0O0QB DRUGTYPE Antibody D0O0QB HIGHSTAT Phase 3 D0O1GS DRUG__ID D0O1GS D0O1GS DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D0O1GS DRUGTYPE Monoclonal antibody D0O1GS HIGHSTAT Phase 3 D0O3OK DRUG__ID D0O3OK D0O3OK DRUGCOMP AstraZeneca D0O3OK DRUGTYPE Monoclonal antibody D0O3OK HIGHSTAT Phase 3 D0OH8W DRUG__ID D0OH8W D0OH8W DRUGCOMP PDL BioPharma Inc; PDL BioPharma D0OH8W DRUGTYPE Antibody D0OH8W HIGHSTAT Phase 3 D0OX9W DRUG__ID D0OX9W D0OX9W DRUGCOMP EUSA Pharma D0OX9W DRUGTYPE Monoclonal antibody D0OX9W HIGHSTAT Phase 3 D0P1ME DRUG__ID D0P1ME D0P1ME DRUGCOMP Merck D0P1ME DRUGTYPE Antibody D0P1ME HIGHSTAT Phase 3 D0P4TH DRUG__ID D0P4TH D0P4TH DRUGCOMP Genentech D0P4TH DRUGTYPE Antibody drug conjugate D0P4TH HIGHSTAT Phase 3 D0P5TG DRUG__ID D0P5TG D0P5TG DRUGCOMP University of Pittsburgh D0P5TG DRUGTYPE Vaccine D0P5TG HIGHSTAT Phase 3 D0Q7YZ DRUG__ID D0Q7YZ D0Q7YZ DRUGCOMP Roche D0Q7YZ DRUGTYPE Monoclonal antibody D0Q7YZ HIGHSTAT Phase 3 D0QFD2 DRUG__ID D0QFD2 D0QFD2 DRUGCOMP Mersana Therapeutics Cambridge, MA D0QFD2 DRUGTYPE Antibody drug conjugate D0QFD2 HIGHSTAT Phase 3 D0QI4Z DRUG__ID D0QI4Z D0QI4Z DRUGCOMP KemPharm D0QI4Z DRUGTYPE Small molecular drug D0QI4Z HIGHSTAT Phase 3 D0QL4N DRUG__ID D0QL4N D0QL4N THERCLAS Antiviral Agents D0QL4N DRUGTYPE Combination drug D0QL4N HIGHSTAT Phase 3 Trial D0QO0D DRUG__ID D0QO0D D0QO0D DRUGCOMP Kitasato Institute D0QO0D DRUGTYPE Vaccine D0QO0D HIGHSTAT Phase 3 D0R4PW DRUG__ID D0R4PW D0R4PW DRUGCOMP Genmab D0R4PW DRUGTYPE Antibody D0R4PW HIGHSTAT Phase 3 D0R7EQ DRUG__ID D0R7EQ D0R7EQ DRUGCOMP Genentech D0R7EQ DRUGTYPE Monoclonal antibody D0R7EQ HIGHSTAT Phase 3 D0RP2X DRUG__ID D0RP2X D0RP2X DRUGCOMP Philogen D0RP2X DRUGTYPE Fusion protein D0RP2X HIGHSTAT Phase 3 D0S4WA DRUG__ID D0S4WA D0S4WA DRUGCOMP Astellas D0S4WA DRUGTYPE Vaccine D0S4WA HIGHSTAT Phase 3 D0SG0J DRUG__ID D0SG0J D0SG0J THERCLAS Antiviral Agents D0SG0J DRUGTYPE Combination drug D0SG0J HIGHSTAT Phase 3 Trial D0SM8S DRUG__ID D0SM8S D0SM8S DRUGCOMP Aerovance D0SM8S DRUGTYPE Monoclonal antibody D0SM8S HIGHSTAT Phase 3 D0SY0W DRUG__ID D0SY0W D0SY0W THERCLAS Antiviral Agents D0SY0W DRUGTYPE Combination drug D0SY0W HIGHSTAT Phase 3 Trial D0T8AI DRUG__ID D0T8AI D0T8AI DRUGCOMP Immunomedics D0T8AI DRUGTYPE Monoclonal antibody D0T8AI HIGHSTAT Phase 3 D0T8IW DRUG__ID D0T8IW D0T8IW DRUGCOMP ImClone Systems D0T8IW DRUGTYPE Monoclonal antibody D0T8IW HIGHSTAT Phase 3 D0TM7Q DRUG__ID D0TM7Q D0TM7Q THERCLAS Antiviral Agents D0TM7Q DRUGTYPE Combination drug D0TM7Q HIGHSTAT Phase 3 Trial D0U1HX DRUG__ID D0U1HX D0U1HX DRUGCOMP Karolinska Institute D0U1HX DRUGTYPE Antisense drug D0U1HX HIGHSTAT Phase 3 D0U4SM DRUG__ID D0U4SM D0U4SM DRUGCOMP Center for Genetic Engineering and Biotechnology D0U4SM DRUGTYPE Vaccine D0U4SM HIGHSTAT Phase 3 D0U6UK DRUG__ID D0U6UK D0U6UK DRUGCOMP Lilly D0U6UK DRUGTYPE Monoclonal antibody D0U6UK HIGHSTAT Phase 3 D0U9MJ DRUG__ID D0U9MJ D0U9MJ DRUGCOMP Institut Curie D0U9MJ DRUGTYPE Vaccine D0U9MJ HIGHSTAT Phase 3 D0UT7E DRUG__ID D0UT7E D0UT7E THERCLAS Antiviral Agents D0UT7E DRUGTYPE Combination drug D0UT7E HIGHSTAT Phase 3 Trial D0UXJ2 DRUG__ID D0UXJ2 D0UXJ2 DRUGCOMP Gamida Cell D0UXJ2 DRUGTYPE Cell therapy D0UXJ2 HIGHSTAT Phase 3 D0V0JR DRUG__ID D0V0JR D0V0JR DRUGCOMP Cadila Pharmaceuticals Ltd D0V0JR DRUGTYPE Vaccine D0V0JR HIGHSTAT Phase 3 D0V2KR DRUG__ID D0V2KR D0V2KR DRUGCOMP Immunomedics; Garden State Cancer Center; Immunomedics D0V2KR DRUGTYPE Antibody D0V2KR HIGHSTAT Phase 3 D0V2WO DRUG__ID D0V2WO D0V2WO TRADNAME PassPort (insulin), Altea; Insulin (controlled release, Biosphere), Bioglan; Insulin (hyaluronidase delivery, diabetes), Halozyme; Insulin (inhaled microspheres, ProMaxx), Baxter; Insulin (inhaled microspheres, ProMaxx), Epic; Insulin (inhaled), QDose/BMS; Insulin (inhaled, AERx), Novo Nordisk; Insulin (oral), Nobex/GSK; Insulin (oral), Nobex/GlaxoSmithKline; Insulin (oral, CADDYS), Emisphere; Insulin (oral, eligen), Emisphere; Insulin (oral/ Macrosol), Cortecs; Insulin (oral/ Macrosol), Provalis; Insulin(prefromed conjugate-drug affinity complex), ConjuChem; Insulin (rHuPH20, diabetes), Halozyme; DTY-001 (Axcess oral, type 2 diabetes), Diabetology; Insulin (Axcess, oral, type 1 diabetes), Diabetology; Insulin (Axcess, oral, type 2 diabetes), Diabetology; Insulin (inhaled, AERx), Aradigm/Novo Nordisk; Insulin (long-acting, PolyXen), Lipoxen; Insulin (oral, NOD, diabetes), Shanghai; Insulin (patch, PassPort, diabetes), Altea; Insulin (oral/capsule, type 1/2 diabetes), Hadasit; Nsulin (inhlaed), Bristol-Myers Squibb/Elan/MicroDose; 843362 D0V2WO DRUGCOMP Lipoxen plc; Aradigm; Translational Research Ltd; Diabetology Ltd; Coremed Inc; Nobex Corp; Altea Therapeutics; ConjuChem Biotechnologies Inc; Bioglan Pharmaceuticals Co; Epic Therapeutics Inc; NOD Pharmaceuticals Inc; Andaris Group Ltd; Emisphere Technologies Inc; halozyme therapeutics D0V2WO HIGHSTAT Phase 3 D0V9HC DRUG__ID D0V9HC D0V9HC THERCLAS Antiviral Agents D0V9HC DRUGTYPE Combination drug D0V9HC HIGHSTAT Phase 3 Trial D0Y5IH DRUG__ID D0Y5IH D0Y5IH DRUGCOMP Genentech D0Y5IH DRUGTYPE Monoclonal antibody D0Y5IH HIGHSTAT Phase 3 D0Y8TZ DRUG__ID D0Y8TZ D0Y8TZ DRUGCOMP Pfizer D0Y8TZ DRUGTYPE Antibody D0Y8TZ HIGHSTAT Phase 3 D0Y9HW DRUG__ID D0Y9HW D0Y9HW DRUGCOMP ISIS Pharm D0Y9HW DRUGTYPE Antisense drug D0Y9HW HIGHSTAT Phase 3 D0YFN1 DRUG__ID D0YFN1 D0YFN1 DRUGCOMP AstraZeneca D0YFN1 DRUGTYPE Monoclonal antibody D0YFN1 HIGHSTAT Phase 3 D0Z2GF DRUG__ID D0Z2GF D0Z2GF DRUGCOMP Neurimmune Therapeutics AG D0Z2GF DRUGTYPE Antibody D0Z2GF HIGHSTAT Phase 3 D0Z8KS DRUG__ID D0Z8KS D0Z8KS DRUGCOMP Emergent BioSolutions D0Z8KS DRUGTYPE Antibody D0Z8KS HIGHSTAT Phase 3 D0ZB9U DRUG__ID D0ZB9U D0ZB9U THERCLAS Antiviral Agents D0ZB9U DRUGTYPE Combination drug D0ZB9U HIGHSTAT Phase 3 Trial D19OMU DRUG__ID D19OMU D19OMU DRUGCOMP Pfizer D19OMU DRUGTYPE Antibody D19OMU HIGHSTAT Phase 3 D19RKX DRUG__ID D19RKX D19RKX DRUGCOMP Roche/Genentech D19RKX DRUGTYPE Protein D19RKX HIGHSTAT Phase 3 D1I0LQ DRUG__ID D1I0LQ D1I0LQ DRUGCOMP Alkermes Waltham, MA D1I0LQ DRUGTYPE Fusion protein D1I0LQ HIGHSTAT Phase 3 D1J4GS DRUG__ID D1J4GS D1J4GS DRUGCOMP Biotest Pharmaceuticals D1J4GS DRUGTYPE Protein D1J4GS HIGHSTAT Phase 3 D1M5NW DRUG__ID D1M5NW D1M5NW DRUGCOMP ContraFect D1M5NW DRUGTYPE Recombinant protein D1M5NW HIGHSTAT Phase 3 D1O9XQ DRUG__ID D1O9XQ D1O9XQ DRUGCOMP Roche D1O9XQ DRUGTYPE Antibody D1O9XQ HIGHSTAT Phase 3 D1S2OX DRUG__ID D1S2OX D1S2OX DRUGCOMP Prothena Biosciences D1S2OX DRUGTYPE Monoclonal antibody D1S2OX HIGHSTAT Phase 3 D1T2SQ DRUG__ID D1T2SQ D1T2SQ DRUGCOMP JOHNSON & JOHNSON D1T2SQ DRUGTYPE Vaccine D1T2SQ HIGHSTAT Phase 3 D1TED8 DRUG__ID D1TED8 D1TED8 DRUGCOMP Allena Pharmaceuticals D1TED8 DRUGTYPE Protein D1TED8 HIGHSTAT Phase 3 D1U5BA DRUG__ID D1U5BA D1U5BA DRUGCOMP Mesoblast D1U5BA DRUGTYPE Cell therapy D1U5BA HIGHSTAT Phase 3 D29XIA DRUG__ID D29XIA D29XIA DRUGCOMP ITM Solucin Munich, Germany D29XIA DRUGTYPE Somatostatin analogue D29XIA HIGHSTAT Phase 3 D2AK6X DRUG__ID D2AK6X D2AK6X DRUGCOMP Novo Nordisk Plainsboro, NJ D2AK6X DRUGTYPE Antibody D2AK6X HIGHSTAT Phase 3 D2D6NJ DRUG__ID D2D6NJ D2D6NJ DRUGCOMP Sanofi D2D6NJ DRUGTYPE Antibody drug conjugate D2D6NJ HIGHSTAT Phase 3 D2ELZ3 DRUG__ID D2ELZ3 D2ELZ3 DRUGCOMP Akeso Biopharma D2ELZ3 DRUGTYPE Bispecific antibody D2ELZ3 HIGHSTAT Phase 3 D2FE7T DRUG__ID D2FE7T D2FE7T DRUGCOMP Novo Nordisk Plainsboro, NJ D2FE7T DRUGTYPE Monoclonal antibody D2FE7T HIGHSTAT Phase 3 D2KVG4 DRUG__ID D2KVG4 D2KVG4 DRUGCOMP Teruisi D2KVG4 DRUGTYPE Antibody D2KVG4 HIGHSTAT Phase 3 D2QVG7 DRUG__ID D2QVG7 D2QVG7 DRUGCOMP ProKidney D2QVG7 DRUGTYPE Cell therapy D2QVG7 HIGHSTAT Phase 3 D2R3ZX DRUG__ID D2R3ZX D2R3ZX DRUGCOMP Bristol-Myers Squibb D2R3ZX DRUGTYPE Monoclonal antibody D2R3ZX HIGHSTAT Phase 3 D2RTQ0 DRUG__ID D2RTQ0 D2RTQ0 DRUGCOMP Samsung Bioepis D2RTQ0 DRUGTYPE Antibody D2RTQ0 HIGHSTAT Phase 3 D2SL5H DRUG__ID D2SL5H D2SL5H DRUGCOMP AstraZeneca D2SL5H DRUGTYPE Vaccine D2SL5H HIGHSTAT Phase 3 D2WT8Y DRUG__ID D2WT8Y D2WT8Y DRUGCOMP Merck D2WT8Y DRUGTYPE Vaccine D2WT8Y HIGHSTAT Phase 3 D2ZP0A DRUG__ID D2ZP0A D2ZP0A DRUGCOMP Eli Lilly D2ZP0A DRUGTYPE Monoclonal antibody D2ZP0A HIGHSTAT Phase 3 D32ZQU DRUG__ID D32ZQU D32ZQU DRUGCOMP Agenus Lexington, MA D32ZQU DRUGTYPE Antibody D32ZQU HIGHSTAT Phase 3 D34FRG DRUG__ID D34FRG D34FRG DRUGCOMP Lilly D34FRG DRUGTYPE Antibody D34FRG HIGHSTAT Phase 3 D34VAB DRUG__ID D34VAB D34VAB DRUGCOMP Pfizer D34VAB DRUGTYPE Gene therapy D34VAB HIGHSTAT Phase 3 D3MG8L DRUG__ID D3MG8L D3MG8L DRUGCOMP Pluristem Therapeutics D3MG8L DRUGTYPE Cell therapy D3MG8L HIGHSTAT Phase 3 D3MP1S DRUG__ID D3MP1S D3MP1S DRUGCOMP CStone Pharmaceuticals D3MP1S DRUGTYPE Antibody D3MP1S HIGHSTAT Phase 3 D3PD8C DRUG__ID D3PD8C D3PD8C DRUGCOMP Axsome Therapeutics D3PD8C DRUGTYPE Small molecular drug D3PD8C HIGHSTAT Phase 3 D3SJB9 DRUG__ID D3SJB9 D3SJB9 DRUGCOMP Eisai D3SJB9 DRUGTYPE Small molecule D3SJB9 HIGHSTAT Phase 3 D3XYK2 DRUG__ID D3XYK2 D3XYK2 DRUGCOMP Janssen D3XYK2 DRUGTYPE Vaccine D3XYK2 HIGHSTAT Phase 3 D46RKC DRUG__ID D46RKC D46RKC DRUGCOMP Sanofi D46RKC DRUGTYPE Small interfering RNA D46RKC HIGHSTAT Phase 3 D47RIS DRUG__ID D47RIS D47RIS DRUGCOMP Orchard Therapeutics D47RIS DRUGTYPE Gene therapy D47RIS HIGHSTAT Phase 3 D4HQ1F DRUG__ID D4HQ1F D4HQ1F DRUGCOMP Astellas Pharma D4HQ1F DRUGTYPE Antibody D4HQ1F HIGHSTAT Phase 3 D4I3HU DRUG__ID D4I3HU D4I3HU DRUGCOMP Xencor Monrovia, CA D4I3HU DRUGTYPE Antibody D4I3HU HIGHSTAT Phase 3 D4L5NW DRUG__ID D4L5NW D4L5NW DRUGCOMP CStone Pharmaceuticals D4L5NW DRUGTYPE Monoclonal antibody D4L5NW HIGHSTAT Phase 3 D4LD9G DRUG__ID D4LD9G D4LD9G DRUGCOMP Pfzer D4LD9G DRUGTYPE Vaccine D4LD9G HIGHSTAT Phase 3 D57OZX DRUG__ID D57OZX D57OZX DRUGCOMP Coya Therapeutics D57OZX DRUGTYPE Cell therapy D57OZX HIGHSTAT Phase 3 D58JRA DRUG__ID D58JRA D58JRA DRUGCOMP Amgen D58JRA DRUGTYPE Fusion protein D58JRA HIGHSTAT Phase 3 D5ISZ1 DRUG__ID D5ISZ1 D5ISZ1 DRUGCOMP Nektar Therapeutics D5ISZ1 DRUGTYPE Recombinant protein D5ISZ1 HIGHSTAT Phase 3 D5JVD6 DRUG__ID D5JVD6 D5JVD6 DRUGCOMP Anterogen D5JVD6 DRUGTYPE Cell therapy D5JVD6 HIGHSTAT Phase 3 D5Y3NP DRUG__ID D5Y3NP D5Y3NP DRUGCOMP CellTrans D5Y3NP DRUGTYPE Cell therapy D5Y3NP HIGHSTAT Phase 3 D60SWR DRUG__ID D60SWR D60SWR DRUGCOMP Janssen D60SWR DRUGTYPE Vaccine D60SWR HIGHSTAT Phase 3 D6O2PN DRUG__ID D6O2PN D6O2PN DRUGCOMP Kiadis Pharma D6O2PN DRUGTYPE Cell therapy D6O2PN HIGHSTAT Phase 3 D6PMR7 DRUG__ID D6PMR7 D6PMR7 DRUGCOMP Takeda D6PMR7 DRUGTYPE Enzyme replacement D6PMR7 HIGHSTAT Phase 3 D6STZ1 DRUG__ID D6STZ1 D6STZ1 DRUGCOMP AstraZeneca D6STZ1 DRUGTYPE Monoclonal antibody D6STZ1 HIGHSTAT Phase 3 D6V9FN DRUG__ID D6V9FN D6V9FN DRUGCOMP Ultragenyx Pharmaceutical D6V9FN DRUGTYPE Gene therapy D6V9FN HIGHSTAT Phase 3 D6YD0X DRUG__ID D6YD0X D6YD0X DRUGCOMP Idera Pharmaceuticals D6YD0X DRUGTYPE Oligonucleotide D6YD0X HIGHSTAT Phase 3 D6ZM5N DRUG__ID D6ZM5N D6ZM5N DRUGCOMP RHEACELL D6ZM5N DRUGTYPE Cell therapy D6ZM5N HIGHSTAT Phase 3 D73TKN DRUG__ID D73TKN D73TKN DRUGCOMP POINT Biopharma D73TKN DRUGTYPE Radiopharmaceutical D73TKN HIGHSTAT Phase 3 D75GUN DRUG__ID D75GUN D75GUN DRUGCOMP Polaryx Therapeutics D75GUN DRUGTYPE Small molecule D75GUN HIGHSTAT Phase 3 D76PDV DRUG__ID D76PDV D76PDV DRUGCOMP Boehringer Ingelheim D76PDV DRUGTYPE Small molecular drug D76PDV HIGHSTAT Phase 3 D7EZ0H DRUG__ID D7EZ0H D7EZ0H DRUGCOMP Cold Genesys D7EZ0H DRUGTYPE Oncolytic virus therapy D7EZ0H HIGHSTAT Phase 3 D7GYE9 DRUG__ID D7GYE9 D7GYE9 DRUGCOMP Biogen D7GYE9 DRUGTYPE Monoclonal antibody D7GYE9 HIGHSTAT Phase 3 D7HLI1 DRUG__ID D7HLI1 D7HLI1 DRUGCOMP BioMarin Pharmaceutical D7HLI1 DRUGTYPE Gene therapy D7HLI1 HIGHSTAT Phase 3 D7IO6J DRUG__ID D7IO6J D7IO6J DRUGCOMP Pharmicell D7IO6J DRUGTYPE Cell therapy D7IO6J HIGHSTAT Phase 3 D8CW9E DRUG__ID D8CW9E D8CW9E DRUGCOMP Krystal Biotech Pittsburgh, PA D8CW9E DRUGTYPE Gene therapy D8CW9E HIGHSTAT Phase 3 D8D1MI DRUG__ID D8D1MI D8D1MI DRUGCOMP Medeor Therapeutics D8D1MI DRUGTYPE Cell therapy D8D1MI HIGHSTAT Phase 3 D8F6PB DRUG__ID D8F6PB D8F6PB DRUGCOMP Fujifilm; Centus Biotherapeutics D8F6PB DRUGTYPE Antibody D8F6PB HIGHSTAT Phase 3 D8KB1Q DRUG__ID D8KB1Q D8KB1Q DRUGCOMP Moderna D8KB1Q DRUGTYPE Vaccine D8KB1Q HIGHSTAT Phase 3 D8U1EX DRUG__ID D8U1EX D8U1EX DRUGCOMP Regeneron Pharmaceuticals D8U1EX DRUGTYPE Antibody D8U1EX HIGHSTAT Phase 3 D8YWA4 DRUG__ID D8YWA4 D8YWA4 DRUGCOMP Pluristem Therapeutics D8YWA4 DRUGTYPE Cell therapy D8YWA4 HIGHSTAT Phase 3 D93UYR DRUG__ID D93UYR D93UYR DRUGCOMP LIB Therapeutics Cincinnati, OH D93UYR DRUGTYPE Fusion protein D93UYR HIGHSTAT Phase 3 D94FLC DRUG__ID D94FLC D94FLC DRUGCOMP TAKEDA D94FLC DRUGTYPE Vaccine D94FLC HIGHSTAT Phase 3 D9BVM6 DRUG__ID D9BVM6 D9BVM6 DRUGCOMP Takeda D9BVM6 DRUGTYPE RNAi D9BVM6 HIGHSTAT Phase 3 D9CI7V DRUG__ID D9CI7V D9CI7V DRUGCOMP ViroMed D9CI7V DRUGTYPE Gene therapy D9CI7V HIGHSTAT Phase 3 D9I6QG DRUG__ID D9I6QG D9I6QG DRUGCOMP BioVie D9I6QG DRUGTYPE Small molecule D9I6QG HIGHSTAT Phase 3 D9NL3R DRUG__ID D9NL3R D9NL3R DRUGCOMP Amgen D9NL3R DRUGTYPE Recombinant protein D9NL3R HIGHSTAT Phase 3 D9WQD2 DRUG__ID D9WQD2 D9WQD2 DRUGCOMP Merck D9WQD2 DRUGTYPE Vaccine D9WQD2 HIGHSTAT Phase 3 DA37BQ DRUG__ID DA37BQ DA37BQ DRUGCOMP Bavarian Nordic DA37BQ DRUGTYPE Vaccine DA37BQ HIGHSTAT Phase 3 DA6T3R DRUG__ID DA6T3R DA6T3R DRUGCOMP Valneva DA6T3R DRUGTYPE Vaccine DA6T3R HIGHSTAT Phase 3 DAW86K DRUG__ID DAW86K DAW86K DRUGCOMP Emergent BioSolutions DAW86K DRUGTYPE Vaccine DAW86K HIGHSTAT Phase 3 DBAL18 DRUG__ID DBAL18 DBAL18 DRUGCOMP Genentech DBAL18 DRUGTYPE Monoclonal antibody DBAL18 HIGHSTAT Phase 3 DBGL46 DRUG__ID DBGL46 DBGL46 DRUGCOMP Moderna DBGL46 DRUGTYPE Vaccine DBGL46 HIGHSTAT Phase 3 DBHO19 DRUG__ID DBHO19 DBHO19 DRUGCOMP uniQure DBHO19 DRUGTYPE Gene therapy DBHO19 HIGHSTAT Phase 3 DC8EN0 DRUG__ID DC8EN0 DC8EN0 DRUGCOMP Actinium Pharmaceuticals DC8EN0 DRUGTYPE Radiopharmaceutical therapy agent DC8EN0 HIGHSTAT Phase 3 DCA7F8 DRUG__ID DCA7F8 DCA7F8 DRUGCOMP Curium US DCA7F8 DRUGTYPE Radioligand therapy DCA7F8 HIGHSTAT Phase 3 DCOP72 DRUG__ID DCOP72 DCOP72 DRUGCOMP Akari Therapeutics DCOP72 DRUGTYPE Recombinant protein DCOP72 HIGHSTAT Phase 3 DCRJ78 DRUG__ID DCRJ78 DCRJ78 DRUGCOMP Ionis DCRJ78 DRUGTYPE Antisense oligonucleotide DCRJ78 HIGHSTAT Phase 3 DD39ET DRUG__ID DD39ET DD39ET DRUGCOMP Novavax DD39ET DRUGTYPE Vaccine DD39ET HIGHSTAT Phase 3 DDK1I4 DRUG__ID DDK1I4 DDK1I4 DRUGCOMP Amicus Therapeutics DDK1I4 DRUGTYPE Protein/peptide DDK1I4 HIGHSTAT Phase 3 DDV9M0 DRUG__ID DDV9M0 DDV9M0 DRUGCOMP GlaxoSmithKline DDV9M0 DRUGTYPE Vaccine DDV9M0 HIGHSTAT Phase 3 DE5L6B DRUG__ID DE5L6B DE5L6B DRUGCOMP Sumitomo Dainippon Pharma DE5L6B DRUGTYPE Vaccine DE5L6B HIGHSTAT Phase 3 DE8H1W DRUG__ID DE8H1W DE8H1W DRUGCOMP Advantagene DE8H1W DRUGTYPE Gene therapy DE8H1W HIGHSTAT Phase 3 DENA17 DRUG__ID DENA17 DENA17 DRUGCOMP OncoImmune DENA17 DRUGTYPE Recombinant protein DENA17 HIGHSTAT Phase 3 DENO78 DRUG__ID DENO78 DENO78 DRUGCOMP Progenics Pharmaceuticals New York, NY DENO78 DRUGTYPE Antibody drug conjugate DENO78 HIGHSTAT Phase 3 DF6UP7 DRUG__ID DF6UP7 DF6UP7 DRUGCOMP AB2 Bio DF6UP7 DRUGTYPE Recombinant protein DF6UP7 HIGHSTAT Phase 3 DF7Y9S DRUG__ID DF7Y9S DF7Y9S DRUGCOMP Connect Biopharma DF7Y9S DRUGTYPE Antibody DF7Y9S HIGHSTAT Phase 3 DFY58O DRUG__ID DFY58O DFY58O DRUGCOMP ResTORbio DFY58O DRUGTYPE Small molecular drug DFY58O HIGHSTAT Phase 3 DFYL51 DRUG__ID DFYL51 DFYL51 DRUGCOMP BeiGene DFYL51 DRUGTYPE Antibody DFYL51 HIGHSTAT Phase 3 DG7N3W DRUG__ID DG7N3W DG7N3W DRUGCOMP Lilly DG7N3W DRUGTYPE Peptide DG7N3W HIGHSTAT Phase 3 DG8VN2 DRUG__ID DG8VN2 DG8VN2 DRUGCOMP Ultragenyx Pharmaceutical Novato, CA DG8VN2 DRUGTYPE Antibody DG8VN2 HIGHSTAT Phase 3 DH3YK4 DRUG__ID DH3YK4 DH3YK4 DRUGCOMP Ophthotech Corp DH3YK4 DRUGTYPE Oligonucleotide DH3YK4 HIGHSTAT Phase 3 DHV2L8 DRUG__ID DHV2L8 DHV2L8 DRUGCOMP Mesoblast DHV2L8 DRUGTYPE Cell therapy DHV2L8 HIGHSTAT Phase 3 DI0CX8 DRUG__ID DI0CX8 DI0CX8 DRUGCOMP Alvotech DI0CX8 DRUGTYPE Antibody DI0CX8 HIGHSTAT Phase 3 DI0ED3 DRUG__ID DI0ED3 DI0ED3 DRUGCOMP Byondis DI0ED3 DRUGTYPE Antibody drug conjugate DI0ED3 HIGHSTAT Phase 3 DI4SM3 DRUG__ID DI4SM3 DI4SM3 DRUGCOMP Modis Therapeutics DI4SM3 DRUGTYPE Deoxynucleoside DI4SM3 HIGHSTAT Phase 3 DI6C5V DRUG__ID DI6C5V DI6C5V DRUGCOMP Merck DI6C5V DRUGTYPE Vaccine DI6C5V HIGHSTAT Phase 3 DI89WD DRUG__ID DI89WD DI89WD DRUGCOMP Klus Pharma DI89WD DRUGTYPE Monoclonal antibody DI89WD HIGHSTAT Phase 3 DIA56C DRUG__ID DIA56C DIA56C DRUGCOMP JOHNSON & JOHNSON DIA56C DRUGTYPE Vaccine DIA56C HIGHSTAT Phase 3 DJ5D4G DRUG__ID DJ5D4G DJ5D4G DRUGCOMP NeuroActiva DJ5D4G DRUGTYPE Small molecular drug DJ5D4G HIGHSTAT Phase 3 DJ5E7O DRUG__ID DJ5E7O DJ5E7O DRUGCOMP Archigen Biotech DJ5E7O DRUGTYPE Antibody DJ5E7O HIGHSTAT Phase 3 DJH9P4 DRUG__ID DJH9P4 DJH9P4 DRUGCOMP Boehringer Ingelheim DJH9P4 DRUGTYPE Antibody DJH9P4 HIGHSTAT Phase 3 DK1MX0 DRUG__ID DK1MX0 DK1MX0 DRUGCOMP Gmax Biopharm DK1MX0 DRUGTYPE Antibody DK1MX0 HIGHSTAT Phase 3 DKN63V DRUG__ID DKN63V DKN63V DRUGCOMP Ionis; Novartis DKN63V DRUGTYPE Antisense oligonucleotide DKN63V HIGHSTAT Phase 3 DKP80T DRUG__ID DKP80T DKP80T DRUGCOMP Regeneron Pharmaceuticals Tarrytown, NY DKP80T DRUGTYPE Antibody DKP80T HIGHSTAT Phase 3 DL14SU DRUG__ID DL14SU DL14SU DRUGCOMP Pfizer DL14SU DRUGTYPE Small molecule DL14SU HIGHSTAT Phase 3 DLOQ25 DRUG__ID DLOQ25 DLOQ25 DRUGCOMP Alphamab Oncology DLOQ25 DRUGTYPE Antibody DLOQ25 HIGHSTAT Phase 3 DM7Z6Y DRUG__ID DM7Z6Y DM7Z6Y DRUGCOMP Genentech DM7Z6Y DRUGTYPE Antibody DM7Z6Y HIGHSTAT Phase 3 DMS12U DRUG__ID DMS12U DMS12U DRUGCOMP AstraZeneca DMS12U DRUGTYPE Monoclonal antibody DMS12U HIGHSTAT Phase 3 DMS5N4 DRUG__ID DMS5N4 DMS5N4 DRUGCOMP OBI Pharma DMS5N4 DRUGTYPE Vaccine DMS5N4 HIGHSTAT Phase 3 DMT2F4 DRUG__ID DMT2F4 DMT2F4 DRUGCOMP Biogen DMT2F4 DRUGTYPE Monoclonal antibody DMT2F4 HIGHSTAT Phase 3 DMV0H7 DRUG__ID DMV0H7 DMV0H7 DRUGCOMP GlaxoSmithKline DMV0H7 DRUGTYPE Vaccine DMV0H7 HIGHSTAT Phase 3 DMWA10 DRUG__ID DMWA10 DMWA10 DRUGCOMP Immunovant New York, NY DMWA10 DRUGTYPE Monoclonal antibody DMWA10 HIGHSTAT Phase 3 DN2W9I DRUG__ID DN2W9I DN2W9I DRUGCOMP ATyr Pharma DN2W9I DRUGTYPE Fusion protein DN2W9I HIGHSTAT Phase 3 DN3U0I DRUG__ID DN3U0I DN3U0I DRUGCOMP Merck DN3U0I DRUGTYPE Vaccine DN3U0I HIGHSTAT Phase 3 DN5CM6 DRUG__ID DN5CM6 DN5CM6 DRUGCOMP Gilead Sciences DN5CM6 DRUGTYPE Antibody DN5CM6 HIGHSTAT Phase 3 DN87BL DRUG__ID DN87BL DN87BL DRUGCOMP Pfizer DN87BL DRUGTYPE Gene therapy DN87BL HIGHSTAT Phase 3 DN8F1Z DRUG__ID DN8F1Z DN8F1Z DRUGCOMP Aridis Pharmaceuticals DN8F1Z DRUGTYPE Antibody DN8F1Z HIGHSTAT Phase 3 DNF8Z1 DRUG__ID DNF8Z1 DNF8Z1 DRUGCOMP Arrowhead Pharmaceuticals Pasadena, CA DNF8Z1 DRUGTYPE RNA interference DNF8Z1 HIGHSTAT Phase 3 DO57XC DRUG__ID DO57XC DO57XC DRUGCOMP Alector DO57XC DRUGTYPE Antibody DO57XC HIGHSTAT Phase 3 DO78YZ DRUG__ID DO78YZ DO78YZ DRUGCOMP Gmax Biopharm DO78YZ DRUGTYPE Antibody DO78YZ HIGHSTAT Phase 3 DO7PX4 DRUG__ID DO7PX4 DO7PX4 DRUGCOMP Sanofi DO7PX4 DRUGTYPE Vaccine DO7PX4 HIGHSTAT Phase 3 DO7QK1 DRUG__ID DO7QK1 DO7QK1 DRUGCOMP Kodiak Sciences DO7QK1 DRUGTYPE Antibody biopolymer conjugate DO7QK1 HIGHSTAT Phase 3 DOTF14 DRUG__ID DOTF14 DOTF14 DRUGCOMP MedImmune DOTF14 DRUGTYPE Antibody DOTF14 HIGHSTAT Phase 3 DP2Z0X DRUG__ID DP2Z0X DP2Z0X DRUGCOMP Pfizer DP2Z0X DRUGTYPE Antibody DP2Z0X HIGHSTAT Phase 3 DP41HV DRUG__ID DP41HV DP41HV DRUGCOMP AstraZeneca DP41HV DRUGTYPE Antibody drug conjugate DP41HV HIGHSTAT Phase 3 DP8AS7 DRUG__ID DP8AS7 DP8AS7 DRUGCOMP GlaxoSmithKline DP8AS7 DRUGTYPE Monoclonal antibody DP8AS7 HIGHSTAT Phase 3 DPCM29 DRUG__ID DPCM29 DPCM29 DRUGCOMP Alexion AstraZeneca Gene Therapy Cambridge, MA DPCM29 DRUGTYPE Antibody DPCM29 HIGHSTAT Phase 3 DQ4FR9 DRUG__ID DQ4FR9 DQ4FR9 DRUGCOMP TAKEDA DQ4FR9 DRUGTYPE RNA interference DQ4FR9 HIGHSTAT Phase 3 DQN76R DRUG__ID DQN76R DQN76R DRUGCOMP BioCardia DQN76R DRUGTYPE Cell therapy DQN76R HIGHSTAT Phase 3 DQO3J7 DRUG__ID DQO3J7 DQO3J7 DRUGCOMP AGC Biologics DQO3J7 DRUGTYPE Fusion protein DQO3J7 HIGHSTAT Phase 3 DQP87H DRUG__ID DQP87H DQP87H DRUGCOMP Millburn DQP87H DRUGTYPE Small molecular drug DQP87H HIGHSTAT Phase 3 DR0B6F DRUG__ID DR0B6F DR0B6F DRUGCOMP Ionis DR0B6F DRUGTYPE Ligand-conjugated antisense DR0B6F HIGHSTAT Phase 3 DR49KB DRUG__ID DR49KB DR49KB DRUGCOMP CSL Behring DR49KB DRUGTYPE Antibody DR49KB HIGHSTAT Phase 3 DR5V8I DRUG__ID DR5V8I DR5V8I DRUGCOMP JOHNSON & JOHNSON DR5V8I DRUGTYPE Monoclonal antibody DR5V8I HIGHSTAT Phase 3 DRA84P DRUG__ID DRA84P DRA84P DRUGCOMP Sylentis DRA84P DRUGTYPE Small interfering RNA DRA84P HIGHSTAT Phase 3 DRP4Q9 DRUG__ID DRP4Q9 DRP4Q9 DRUGCOMP Sesen Bio DRP4Q9 DRUGTYPE Recombinant protein DRP4Q9 HIGHSTAT Phase 3 DRQ18X DRUG__ID DRQ18X DRQ18X DRUGCOMP Amgen DRQ18X DRUGTYPE Small molecular drug DRQ18X HIGHSTAT Phase 3 DS4U1W DRUG__ID DS4U1W DS4U1W DRUGCOMP Novartis DS4U1W DRUGTYPE Antibody DS4U1W HIGHSTAT Phase 3 DS69NO DRUG__ID DS69NO DS69NO DRUGCOMP Janssen Research & Development Raritan, NJ DS69NO DRUGTYPE Monoclonal antibody DS69NO HIGHSTAT Phase 3 DS9J7L DRUG__ID DS9J7L DS9J7L DRUGCOMP GlaxoSmithKline DS9J7L DRUGTYPE Monoclonal antibody DS9J7L HIGHSTAT Phase 3 DSC90Z DRUG__ID DSC90Z DSC90Z DRUGCOMP AstraZeneca DSC90Z DRUGTYPE Vaccine DSC90Z HIGHSTAT Phase 3 DSK96I DRUG__ID DSK96I DSK96I DRUGCOMP Infant Bacterial Therapeutics DSK96I DRUGTYPE Live biotherapeutic product DSK96I HIGHSTAT Phase 3 DSM5X9 DRUG__ID DSM5X9 DSM5X9 DRUGCOMP Advanced Accelerator Applications DSM5X9 DRUGTYPE Small molecular drug DSM5X9 HIGHSTAT Phase 3 DSNA01 DRUG__ID DSNA01 DSNA01 DRUGCOMP Janssen Research & Development DSNA01 DRUGTYPE Small molecule DSNA01 HIGHSTAT Phase 3 DST04F DRUG__ID DST04F DST04F DRUGCOMP Arcutis Biotherapeutics DST04F DRUGTYPE Small molecular drug DST04F HIGHSTAT Phase 3 DT1FS0 DRUG__ID DT1FS0 DT1FS0 DRUGCOMP Arcus Biosciences; Gilead Sciences DT1FS0 DRUGTYPE Antibody DT1FS0 HIGHSTAT Phase 3 DTB64R DRUG__ID DTB64R DTB64R DRUGCOMP Omeros DTB64R DRUGTYPE Monoclonal antibody DTB64R HIGHSTAT Phase 3 DTD9Q4 DRUG__ID DTD9Q4 DTD9Q4 DRUGCOMP Advicenne Pharma Nimes, France DTD9Q4 DRUGTYPE Small molecule DTD9Q4 HIGHSTAT Phase 3 DTV6Q7 DRUG__ID DTV6Q7 DTV6Q7 DRUGCOMP Kolon TissueGene DTV6Q7 DRUGTYPE Cell therapy DTV6Q7 HIGHSTAT Phase 3 DU4S5D DRUG__ID DU4S5D DU4S5D DRUGCOMP AlloVir Waltham, MA DU4S5D DRUGTYPE Cell therapy DU4S5D HIGHSTAT Phase 3 DU60ND DRUG__ID DU60ND DU60ND DRUGCOMP VBL Therapeutics DU60ND DRUGTYPE Gene therapy DU60ND HIGHSTAT Phase 3 DU7XQ3 DRUG__ID DU7XQ3 DU7XQ3 DRUGCOMP Biogen DU7XQ3 DRUGTYPE Gene therapy DU7XQ3 HIGHSTAT Phase 3 DV14TX DRUG__ID DV14TX DV14TX DRUGCOMP Novavax DV14TX DRUGTYPE Vaccine DV14TX HIGHSTAT Phase 3 DV29RW DRUG__ID DV29RW DV29RW DRUGCOMP Takeda DV29RW DRUGTYPE Cell therapy DV29RW HIGHSTAT Phase 3 DVA7X9 DRUG__ID DVA7X9 DVA7X9 DRUGCOMP Dare Bioscience DVA7X9 DRUGTYPE Small molecular drug DVA7X9 HIGHSTAT Phase 3 DVA8R9 DRUG__ID DVA8R9 DVA8R9 DRUGCOMP Ionis DVA8R9 DRUGTYPE Antisense oligonucleotide DVA8R9 HIGHSTAT Phase 3 DVJW15 DRUG__ID DVJW15 DVJW15 DRUGCOMP BioCardia DVJW15 DRUGTYPE Cell therapy DVJW15 HIGHSTAT Phase 3 DVT8O0 DRUG__ID DVT8O0 DVT8O0 DRUGCOMP Amgen DVT8O0 DRUGTYPE Monoclonal antibody DVT8O0 HIGHSTAT Phase 3 DW0E3K DRUG__ID DW0E3K DW0E3K DRUGCOMP GlaxoSmithKline DW0E3K DRUGTYPE Antibody DW0E3K HIGHSTAT Phase 3 DW1OK0 DRUG__ID DW1OK0 DW1OK0 DRUGCOMP Biogen DW1OK0 DRUGTYPE Gene therapy DW1OK0 HIGHSTAT Phase 3 DWH79Q DRUG__ID DWH79Q DWH79Q DRUGCOMP Lilly; AbCellera DWH79Q DRUGTYPE Antibody DWH79Q HIGHSTAT Phase 3 DWJM12 DRUG__ID DWJM12 DWJM12 DRUGCOMP Roche DWJM12 DRUGTYPE Monoclonal antibody DWJM12 HIGHSTAT Phase 3 DWK96T DRUG__ID DWK96T DWK96T DRUGCOMP Rakuten Medical DWK96T DRUGTYPE Antibody DWK96T HIGHSTAT Phase 3 DWKI46 DRUG__ID DWKI46 DWKI46 DRUGCOMP Polpharma Biologics DWKI46 DRUGTYPE Antibody DWKI46 HIGHSTAT Phase 3 DWY87T DRUG__ID DWY87T DWY87T DRUGCOMP Pfzer DWY87T DRUGTYPE Monoclonal antibody DWY87T HIGHSTAT Phase 3 DX2H9P DRUG__ID DX2H9P DX2H9P DRUGCOMP Aeglea Biotherapeutics DX2H9P DRUGTYPE Enzyme replacement DX2H9P HIGHSTAT Phase 3 DX9GT7 DRUG__ID DX9GT7 DX9GT7 DRUGCOMP EQRx DX9GT7 DRUGTYPE Antibody DX9GT7 HIGHSTAT Phase 3 DXV06E DRUG__ID DXV06E DXV06E DRUGCOMP Janssen DXV06E DRUGTYPE CAR T Cell Therapy DXV06E HIGHSTAT Phase 3 DXZ31K DRUG__ID DXZ31K DXZ31K DRUGCOMP Klus Pharma DXZ31K DRUGTYPE Monoclonal antibody DXZ31K HIGHSTAT Phase 3 DY14KR DRUG__ID DY14KR DY14KR DRUGCOMP AstraZeneca DY14KR DRUGTYPE Monoclonal antibody DY14KR HIGHSTAT Phase 3 DY2WH5 DRUG__ID DY2WH5 DY2WH5 DRUGCOMP Orchard Therapeutics DY2WH5 DRUGTYPE Gene therapy DY2WH5 HIGHSTAT Phase 3 DY4Q6M DRUG__ID DY4Q6M DY4Q6M DRUGCOMP Atara Biotherapeutics DY4Q6M DRUGTYPE Cell therapy DY4Q6M HIGHSTAT Phase 3 DYG0W5 DRUG__ID DYG0W5 DYG0W5 DRUGCOMP Akari Therapeutics DYG0W5 DRUGTYPE Recombinant?protein DYG0W5 HIGHSTAT Phase 3 DYH3Q6 DRUG__ID DYH3Q6 DYH3Q6 DRUGCOMP Mylan DYH3Q6 DRUGTYPE Antibody DYH3Q6 HIGHSTAT Phase 3 DYM5E4 DRUG__ID DYM5E4 DYM5E4 DRUGCOMP Moderna DYM5E4 DRUGTYPE Vaccine DYM5E4 HIGHSTAT Phase 3 DYR8T5 DRUG__ID DYR8T5 DYR8T5 DRUGCOMP Ionis Pharmaceuticals DYR8T5 DRUGTYPE Antisense oligonucleotide DYR8T5 HIGHSTAT Phase 3 DZ0DT2 DRUG__ID DZ0DT2 DZ0DT2 DRUGCOMP Angionetics DZ0DT2 DRUGTYPE Gene therapy DZ0DT2 HIGHSTAT Phase 3 DZ49IJ DRUG__ID DZ49IJ DZ49IJ DRUGCOMP AnaptysBio San Diego, CA DZ49IJ DRUGTYPE Monoclonal antibody DZ49IJ HIGHSTAT Phase 3 DZ9AJ3 DRUG__ID DZ9AJ3 DZ9AJ3 DRUGCOMP Pfizer DZ9AJ3 DRUGTYPE Gene therapy DZ9AJ3 HIGHSTAT Phase 3 DZA98D DRUG__ID DZA98D DZA98D DRUGCOMP Argenx DZA98D DRUGTYPE Small molecular drug DZA98D HIGHSTAT Phase 3 DZT5S9 DRUG__ID DZT5S9 DZT5S9 DRUGCOMP Moderna DZT5S9 DRUGTYPE Vaccine DZT5S9 HIGHSTAT Phase 3 D00BVB DRUG__ID D00BVB D00BVB DRUGCOMP Sanofi Pasteur Swiftwater, PA D00BVB HIGHSTAT Phase 3 D00CBP DRUG__ID D00CBP D00CBP DRUGCOMP SmithKline Beecham plc D00CBP HIGHSTAT Phase 3 D00HYF DRUG__ID D00HYF D00HYF DRUGCOMP Denka Seiken Co Ltd D00HYF HIGHSTAT Phase 3 D00ITC DRUG__ID D00ITC D00ITC DRUGCOMP Portola pharmaceuticals D00ITC HIGHSTAT Phase 3 D00IXM DRUG__ID D00IXM D00IXM DRUGCOMP Barr Laboratories D00IXM HIGHSTAT Phase 3 D00JCA DRUG__ID D00JCA D00JCA DRUGCOMP Octapharma AG D00JCA HIGHSTAT Phase 3 D00JJZ DRUG__ID D00JJZ D00JJZ DRUGCOMP Fibrocell science D00JJZ HIGHSTAT Phase 3 D00JZD DRUG__ID D00JZD D00JZD DRUGCOMP GlaxoSmithKline D00JZD HIGHSTAT Phase 3 D00KLP DRUG__ID D00KLP D00KLP DRUGCOMP Grifols USA Los Angeles, CA D00KLP HIGHSTAT Phase 3 D00NPO DRUG__ID D00NPO D00NPO DRUGCOMP Abbott Laboratories; Genentech D00NPO HIGHSTAT Phase 3 D00NWV DRUG__ID D00NWV D00NWV DRUGCOMP Xiamen Amoytop Biotech Co Ltd D00NWV HIGHSTAT Phase 3 D00OZC DRUG__ID D00OZC D00OZC DRUGCOMP Therapix Biosciences Givatayim, Israel D00OZC HIGHSTAT Phase 3 D00PMB DRUG__ID D00PMB D00PMB DRUGCOMP Inovio Pharmaceuticals D00PMB HIGHSTAT Phase 3 D00PTZ DRUG__ID D00PTZ D00PTZ DRUGCOMP Tampa D00PTZ HIGHSTAT Phase 3 D00QJL DRUG__ID D00QJL D00QJL DRUGCOMP Solvay SA D00QJL HIGHSTAT Phase 3 D00RTC DRUG__ID D00RTC D00RTC DRUGCOMP Eleven Biotherapeutics Cambridge, MA D00RTC HIGHSTAT Phase 3 D00SHS DRUG__ID D00SHS D00SHS DRUGCOMP Sangart D00SHS HIGHSTAT Phase 3 D00SMU DRUG__ID D00SMU D00SMU DRUGCOMP Bluebird bio D00SMU HIGHSTAT Phase 3 D00TJX DRUG__ID D00TJX D00TJX DRUGCOMP Human Genome Sciences D00TJX HIGHSTAT Phase 3 D00TPW DRUG__ID D00TPW D00TPW DRUGCOMP Foresight Biotherapeutics Inc D00TPW HIGHSTAT Phase 3 D00TUP DRUG__ID D00TUP D00TUP DRUGCOMP VRT D00TUP HIGHSTAT Phase 3 D00UBX DRUG__ID D00UBX D00UBX DRUGCOMP Tanox; Biogen D00UBX HIGHSTAT Phase 3 D00UUL DRUG__ID D00UUL D00UUL DRUGCOMP Novo Nordisk D00UUL HIGHSTAT Phase 3 D00VMA DRUG__ID D00VMA D00VMA DRUGCOMP Novo Nordisk A/S D00VMA HIGHSTAT Phase 3 D00XWF DRUG__ID D00XWF D00XWF DRUGCOMP Rebiotix D00XWF HIGHSTAT Phase 3 D00YQI DRUG__ID D00YQI D00YQI DRUGTYPE Monoclonal antibody D00YQI HIGHSTAT Phase 3 D00ZEN DRUG__ID D00ZEN D00ZEN DRUGCOMP Sanofi Pasteur D00ZEN HIGHSTAT Phase 3 D00ZGT DRUG__ID D00ZGT D00ZGT DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D00ZGT HIGHSTAT Phase 3 D00ZPR DRUG__ID D00ZPR D00ZPR DRUGCOMP Zensun (Shanghai) Sci-Tech Co Ltd D00ZPR HIGHSTAT Phase 3 D00ZVS DRUG__ID D00ZVS D00ZVS DRUGCOMP SEIKAGAKU CORPORATION D00ZVS HIGHSTAT Phase 3 D01AET DRUG__ID D01AET D01AET DRUGCOMP Mesoblast New York, NY D01AET HIGHSTAT Phase 3 D01AIM DRUG__ID D01AIM D01AIM DRUGCOMP Shanghai Medical University D01AIM HIGHSTAT Phase 3 D01CBK DRUG__ID D01CBK D01CBK DRUGCOMP Ose pharma D01CBK HIGHSTAT Phase 3 D01CON DRUG__ID D01CON D01CON DRUGCOMP Adma biologics D01CON HIGHSTAT Phase 3 D01EDJ DRUG__ID D01EDJ D01EDJ DRUGCOMP Venus remedies D01EDJ HIGHSTAT Phase 3 D01EUO DRUG__ID D01EUO D01EUO DRUGCOMP Greer Laboratories Inc D01EUO HIGHSTAT Phase 3 D01HHD DRUG__ID D01HHD D01HHD DRUGCOMP Biotest AG D01HHD HIGHSTAT Phase 3 D01HRU DRUG__ID D01HRU D01HRU DRUGCOMP Sebo GmbH D01HRU HIGHSTAT Phase 3 D01HZQ DRUG__ID D01HZQ D01HZQ DRUGCOMP Verrica Pharmaceuticals West Chester, PA D01HZQ HIGHSTAT Phase 3 D01KIC DRUG__ID D01KIC D01KIC DRUGCOMP Bharat Biotech International Ltd D01KIC HIGHSTAT Phase 3 D01KNA DRUG__ID D01KNA D01KNA DRUGCOMP Diamyd medical D01KNA HIGHSTAT Phase 3 D01LOE DRUG__ID D01LOE D01LOE DRUGCOMP Boehringer Ingelheim Pharmaceuticals; Eli Lilly D01LOE HIGHSTAT Phase 3 D01MGV DRUG__ID D01MGV D01MGV DRUGCOMP Warner Chilcott plc D01MGV HIGHSTAT Phase 3 D01NKW DRUG__ID D01NKW D01NKW DRUGCOMP Pharma Two B Ltd D01NKW HIGHSTAT Phase 3 D01NWV DRUG__ID D01NWV D01NWV DRUGCOMP FirstString Research D01NWV HIGHSTAT Phase 3 D01QWT DRUG__ID D01QWT D01QWT DRUGCOMP Eli LillyIndianapolis, IN D01QWT HIGHSTAT Phase 3 D01RNV DRUG__ID D01RNV D01RNV DRUGCOMP Amsterdam Molecular Therapeutics D01RNV HIGHSTAT Phase 3 D01SRB DRUG__ID D01SRB D01SRB DRUGCOMP Childrens Hospital of Philadelphia D01SRB HIGHSTAT Phase 3 D01VQA DRUG__ID D01VQA D01VQA DRUGCOMP Valeant Pharmaceuticals Bridgewater, NJ D01VQA HIGHSTAT Phase 3 D01VSR DRUG__ID D01VSR D01VSR DRUGCOMP Biotest pharmaceuticals D01VSR HIGHSTAT Phase 3 D01WTV DRUG__ID D01WTV D01WTV DRUGCOMP Highland therapeutics D01WTV HIGHSTAT Phase 3 D01WWD DRUG__ID D01WWD D01WWD DRUGCOMP Shionogi & Co Ltd D01WWD HIGHSTAT Phase 3 D01ZHB DRUG__ID D01ZHB D01ZHB DRUGTYPE siRNA drug D01ZHB HIGHSTAT Phase 3 D02BAE DRUG__ID D02BAE D02BAE DRUGCOMP Duramed Pharmaceuticals Inc D02BAE HIGHSTAT Phase 3 D02DOZ DRUG__ID D02DOZ D02DOZ DRUGCOMP Alkermes Waltham, MA D02DOZ HIGHSTAT Phase 3 D02EXB DRUG__ID D02EXB D02EXB DRUGCOMP Baxter D02EXB HIGHSTAT Phase 3 D02GDK DRUG__ID D02GDK D02GDK DRUGCOMP Cellerix SL D02GDK HIGHSTAT Phase 3 D02GLD DRUG__ID D02GLD D02GLD DRUGCOMP Bionovo Inc; Daewon Pharm Co Ltd D02GLD HIGHSTAT Phase 3 D02MBN DRUG__ID D02MBN D02MBN DRUGCOMP Pfizer New York, NY D02MBN HIGHSTAT Phase 3 D02MPT DRUG__ID D02MPT D02MPT DRUGCOMP GlaxoSmithKline D02MPT HIGHSTAT Phase 3 D02QQE DRUG__ID D02QQE D02QQE DRUGCOMP Nektar Therapeutics San Francisco, CA D02QQE HIGHSTAT Phase 3 D02QQV DRUG__ID D02QQV D02QQV DRUGCOMP Acambis Inc D02QQV HIGHSTAT Phase 3 D02QWK DRUG__ID D02QWK D02QWK DRUGCOMP inhibitor, Lexington, MA D02QWK HIGHSTAT Phase 3 D02RED DRUG__ID D02RED D02RED DRUGCOMP Northwest Biotherapeutics D02RED HIGHSTAT Phase 3 D02TAB DRUG__ID D02TAB D02TAB DRUGCOMP CJ Corp D02TAB HIGHSTAT Phase 3 D02TJT DRUG__ID D02TJT D02TJT DRUGCOMP Merck D02TJT HIGHSTAT Phase 3 D02UNP DRUG__ID D02UNP D02UNP DRUGCOMP Immatics biotechnologies GmbH D02UNP HIGHSTAT Phase 3 D02WST DRUG__ID D02WST D02WST DRUGCOMP Emisphere Technologies Inc D02WST HIGHSTAT Phase 3 D02XEI DRUG__ID D02XEI D02XEI DRUGCOMP Northwest biotherapeutics D02XEI HIGHSTAT Phase 3 D02XYA DRUG__ID D02XYA D02XYA DRUGCOMP GlaxoSmithKline D02XYA HIGHSTAT Phase 3 D02ZBW DRUG__ID D02ZBW D02ZBW DRUGCOMP LG Life Sciences Ltd D02ZBW HIGHSTAT Phase 3 D02ZHW DRUG__ID D02ZHW D02ZHW DRUGCOMP Advanced accelerator applications D02ZHW HIGHSTAT Phase 3 D03BIH DRUG__ID D03BIH D03BIH DRUGCOMP Promius Pharma Princeton, NJ D03BIH HIGHSTAT Phase 3 D03BVW DRUG__ID D03BVW D03BVW DRUGCOMP Merck; sanofi pasteur D03BVW HIGHSTAT Phase 3 D03EBV DRUG__ID D03EBV D03EBV DRUGCOMP Janssen Pharmaceutical KK D03EBV HIGHSTAT Phase 3 D03ERR DRUG__ID D03ERR D03ERR DRUGCOMP Kitasato Institute D03ERR HIGHSTAT Phase 3 D03GCR DRUG__ID D03GCR D03GCR DRUGCOMP Merck D03GCR HIGHSTAT Phase 3 D03GHV DRUG__ID D03GHV D03GHV DRUGCOMP MD Anderson Cancer Center D03GHV HIGHSTAT Phase 3 D03HDV DRUG__ID D03HDV D03HDV DRUGCOMP Daewoong Pharmaceutical Co Ltd D03HDV HIGHSTAT Phase 3 D03KDO DRUG__ID D03KDO D03KDO DRUGCOMP Osiris Therapeutics D03KDO HIGHSTAT Phase 3 D03MYX DRUG__ID D03MYX D03MYX DRUGCOMP Armo biosciences D03MYX HIGHSTAT Phase 3 D03PGS DRUG__ID D03PGS D03PGS DRUGCOMP GlaxoSmithKline Research Triangle Park, NC Ionis Pharmaceuticals, Carlsbad, CA D03PGS HIGHSTAT Phase 3 D03PLR DRUG__ID D03PLR D03PLR DRUGCOMP Immune response biopharma D03PLR HIGHSTAT Phase 3 D03QBT DRUG__ID D03QBT D03QBT DRUGCOMP GenVec D03QBT HIGHSTAT Phase 3 D03QBY DRUG__ID D03QBY D03QBY DRUGCOMP Instituto Bioclon Sa De CV D03QBY HIGHSTAT Phase 3 D03QFN DRUG__ID D03QFN D03QFN DRUGCOMP GlaxoSmithKline D03QFN HIGHSTAT Phase 3 D03QTM DRUG__ID D03QTM D03QTM DRUGCOMP Agenus D03QTM HIGHSTAT Phase 3 D03RLP DRUG__ID D03RLP D03RLP DRUGCOMP Genzyme D03RLP HIGHSTAT Phase 3 D03SIA DRUG__ID D03SIA D03SIA DRUGCOMP Baxter international; inspiration biopharmaceuticals D03SIA HIGHSTAT Phase 3 D03TSR DRUG__ID D03TSR D03TSR DRUGCOMP ALK-Abello D03TSR HIGHSTAT Phase 3 D03YZJ DRUG__ID D03YZJ D03YZJ DRUGCOMP Elite Pharmaceuticals; pfizer D03YZJ HIGHSTAT Phase 3 D03ZAE DRUG__ID D03ZAE D03ZAE DRUGCOMP Phage Biotechnology Corp D03ZAE HIGHSTAT Phase 3 D04AYZ DRUG__ID D04AYZ D04AYZ DRUGCOMP Csl behring D04AYZ HIGHSTAT Phase 3 D04BLE DRUG__ID D04BLE D04BLE DRUGCOMP AstraZeneca plc D04BLE HIGHSTAT Phase 3 D04BVN DRUG__ID D04BVN D04BVN DRUGCOMP Adocia SAS D04BVN HIGHSTAT Phase 3 D04DMZ DRUG__ID D04DMZ D04DMZ DRUGCOMP AveXis Bannockburn, IL D04DMZ HIGHSTAT Phase 3 D04EQX DRUG__ID D04EQX D04EQX DRUGCOMP Biogen Cambridge, MA D04EQX HIGHSTAT Phase 3 D04ETV DRUG__ID D04ETV D04ETV DRUGCOMP Warner Chilcott plc D04ETV HIGHSTAT Phase 3 D04FQD DRUG__ID D04FQD D04FQD DRUGCOMP Pherin Corp D04FQD HIGHSTAT Phase 3 D04FYL DRUG__ID D04FYL D04FYL DRUGCOMP Introgen Therapeutics D04FYL HIGHSTAT Phase 3 D04FYU DRUG__ID D04FYU D04FYU DRUGCOMP Bristol-Myers Squibb Pharma Co D04FYU HIGHSTAT Phase 3 D04IJZ DRUG__ID D04IJZ D04IJZ DRUGCOMP Thrombogenics D04IJZ HIGHSTAT Phase 3 D04INP DRUG__ID D04INP D04INP DRUGCOMP Immunex Corp D04INP HIGHSTAT Phase 3 D04IUB DRUG__ID D04IUB D04IUB DRUGCOMP Neos therapeutics D04IUB HIGHSTAT Phase 3 D04JYK DRUG__ID D04JYK D04JYK DRUGCOMP Green Cross Corp D04JYK HIGHSTAT Phase 3 D04LQN DRUG__ID D04LQN D04LQN DRUGCOMP Vital therapies D04LQN HIGHSTAT Phase 3 D04MZR DRUG__ID D04MZR D04MZR DRUGCOMP Astra Hassle AB D04MZR HIGHSTAT Phase 3 D04NPR DRUG__ID D04NPR D04NPR DRUGCOMP Lundbeck Deerfield, IL D04NPR HIGHSTAT Phase 3 D04OGP DRUG__ID D04OGP D04OGP DRUGCOMP LEO Pharma A/S D04OGP HIGHSTAT Phase 3 D04QXF DRUG__ID D04QXF D04QXF DRUGCOMP Harvard Medical School D04QXF HIGHSTAT Phase 3 D04RNN DRUG__ID D04RNN D04RNN DRUGCOMP Sunovion D04RNN HIGHSTAT Phase 3 D04TFE DRUG__ID D04TFE D04TFE DRUGCOMP CreaGene Inc D04TFE HIGHSTAT Phase 3 D04UFY DRUG__ID D04UFY D04UFY DRUGCOMP Ultragenyx Pharmaceutical D04UFY HIGHSTAT Phase 3 D04UWU DRUG__ID D04UWU D04UWU DRUGCOMP Kinex Pharmaceuticals D04UWU HIGHSTAT Phase 3 D04VCS DRUG__ID D04VCS D04VCS DRUGCOMP ISTO Technologies D04VCS HIGHSTAT Phase 3 D04WBT DRUG__ID D04WBT D04WBT DRUGTYPE Small molecular drug D04WBT HIGHSTAT Phase 3 D04WQT DRUG__ID D04WQT D04WQT DRUGCOMP Roche D04WQT HIGHSTAT Phase 3 D04WTN DRUG__ID D04WTN D04WTN DRUGCOMP University of Florida D04WTN HIGHSTAT Phase 3 D04WVI DRUG__ID D04WVI D04WVI DRUGCOMP BioBalance Corporation D04WVI HIGHSTAT Phase 3 D04YHG DRUG__ID D04YHG D04YHG DRUGCOMP Lipoxen plc D04YHG HIGHSTAT Phase 3 D04YWM DRUG__ID D04YWM D04YWM DRUGCOMP ZymoGenetics; Serono D04YWM HIGHSTAT Phase 3 D04ZYP DRUG__ID D04ZYP D04ZYP DRUGCOMP Circassia D04ZYP HIGHSTAT Phase 3 D05BCU DRUG__ID D05BCU D05BCU DRUGCOMP Pfizer Inc D05BCU HIGHSTAT Phase 3 D05BII DRUG__ID D05BII D05BII DRUGCOMP Knoll GmbH; Neurobiological Technologies D05BII HIGHSTAT Phase 3 D05CGO DRUG__ID D05CGO D05CGO DRUGCOMP Pharmalink AB D05CGO HIGHSTAT Phase 3 D05DZK DRUG__ID D05DZK D05DZK DRUGCOMP LG Life Sciences Ltd D05DZK HIGHSTAT Phase 3 D05FIP DRUG__ID D05FIP D05FIP DRUGCOMP BioNumerik Pharmaceuticals San Antonio, TX D05FIP HIGHSTAT Phase 3 D05FOF DRUG__ID D05FOF D05FOF DRUGCOMP Coherus biosciences D05FOF HIGHSTAT Phase 3 D05FRP DRUG__ID D05FRP D05FRP DRUGCOMP Celldex Therapeutics D05FRP HIGHSTAT Phase 3 D05GJP DRUG__ID D05GJP D05GJP DRUGCOMP LG Life Sciences Ltd D05GJP HIGHSTAT Phase 3 D05GZB DRUG__ID D05GZB D05GZB DRUGCOMP Regeneron Tarrytown, NY Sanofi Genzyme Cambridge, MA D05GZB HIGHSTAT Phase 3 D05JEG DRUG__ID D05JEG D05JEG DRUGCOMP Biomarin pharmaceutical D05JEG HIGHSTAT Phase 3 D05JEL DRUG__ID D05JEL D05JEL DRUGCOMP Nektar San Francisco, CA D05JEL HIGHSTAT Phase 3 D05LDQ DRUG__ID D05LDQ D05LDQ DRUGCOMP Bayer HealthCare Pharmaceuticals D05LDQ HIGHSTAT Phase 3 D05LOB DRUG__ID D05LOB D05LOB DRUGCOMP Faron Pharmaceuticals Ltd D05LOB HIGHSTAT Phase 3 D05LPP DRUG__ID D05LPP D05LPP DRUGCOMP Shire D05LPP HIGHSTAT Phase 3 D05MNV DRUG__ID D05MNV D05MNV DRUGCOMP Jomaa Pharma GmbH D05MNV HIGHSTAT Phase 3 D05PGG DRUG__ID D05PGG D05PGG DRUGCOMP Bavarian NordicMorrisville, NCBristol-Myers Squibb Princeton, NJ D05PGG HIGHSTAT Phase 3 D05PGU DRUG__ID D05PGU D05PGU DRUGCOMP Sanofi Pasteur Swiftwater, PA D05PGU HIGHSTAT Phase 3 D05PWU DRUG__ID D05PWU D05PWU DRUGCOMP BN ImmunoTherapeutics D05PWU HIGHSTAT Phase 3 D05QKZ DRUG__ID D05QKZ D05QKZ DRUGCOMP Cytori therapeutics D05QKZ HIGHSTAT Phase 3 D05RUH DRUG__ID D05RUH D05RUH DRUGCOMP Foamix Bridgewater, NJ D05RUH HIGHSTAT Phase 3 D05SNX DRUG__ID D05SNX D05SNX DRUGCOMP Inflazyme Pharmaceuticals D05SNX HIGHSTAT Phase 3 D05UXU DRUG__ID D05UXU D05UXU DRUGCOMP Scigenic & Scigen Harvest Co Ltd D05UXU HIGHSTAT Phase 3 D05WKQ DRUG__ID D05WKQ D05WKQ DRUGCOMP Novo Nordisk D05WKQ HIGHSTAT Phase 3 D05WTT DRUG__ID D05WTT D05WTT DRUGCOMP Immune response biopharma D05WTT HIGHSTAT Phase 3 D05WUN DRUG__ID D05WUN D05WUN DRUGCOMP Osiris Therapeutics Inc D05WUN HIGHSTAT Phase 3 D05XDZ DRUG__ID D05XDZ D05XDZ DRUGCOMP TauRx Therapeutics Pte Ltd D05XDZ HIGHSTAT Phase 3 D05XKW DRUG__ID D05XKW D05XKW DRUGCOMP ViroMed Co Ltd D05XKW HIGHSTAT Phase 3 D05YES DRUG__ID D05YES D05YES DRUGCOMP Nabi Biopharmaceuticals D05YES HIGHSTAT Phase 3 D05ZIF DRUG__ID D05ZIF D05ZIF DRUGCOMP Promius Pharma Princeton, NJ D05ZIF HIGHSTAT Phase 3 D06BBO DRUG__ID D06BBO D06BBO DRUGCOMP Dr Beckmann Pharma GmbH D06BBO HIGHSTAT Phase 3 D06BGO DRUG__ID D06BGO D06BGO DRUGCOMP Telik D06BGO HIGHSTAT Phase 3 D06GGL DRUG__ID D06GGL D06GGL DRUGCOMP Fresenius Kabi Bad Homburg, Germany D06GGL HIGHSTAT Phase 3 D06GOF DRUG__ID D06GOF D06GOF DRUGCOMP Ortho Dermatologics Raleigh, NC D06GOF HIGHSTAT Phase 3 D06KLJ DRUG__ID D06KLJ D06KLJ DRUGCOMP C3 Jian Inc D06KLJ HIGHSTAT Phase 3 D06LEG DRUG__ID D06LEG D06LEG DRUGCOMP Seqirus Cambridge, MA D06LEG HIGHSTAT Phase 3 D06OIG DRUG__ID D06OIG D06OIG DRUGCOMP GlaxoSmithKline D06OIG HIGHSTAT Phase 3 D06PBH DRUG__ID D06PBH D06PBH DRUGCOMP Novo Nordisk D06PBH HIGHSTAT Phase 3 D06PEW DRUG__ID D06PEW D06PEW DRUGCOMP Insert Therapeutics D06PEW HIGHSTAT Phase 3 D06SJO DRUG__ID D06SJO D06SJO DRUGCOMP GlaxoSmithKline Biologicals D06SJO HIGHSTAT Phase 3 D06SVC DRUG__ID D06SVC D06SVC DRUGCOMP Zymenex A/S D06SVC HIGHSTAT Phase 3 D06UNY DRUG__ID D06UNY D06UNY DRUGCOMP Novan Morrisville, NC D06UNY HIGHSTAT Phase 3 D06XMF DRUG__ID D06XMF D06XMF DRUGCOMP KT&G Corp D06XMF HIGHSTAT Phase 3 D06ZJD DRUG__ID D06ZJD D06ZJD DRUGCOMP Neostem oncology; california stem cell D06ZJD HIGHSTAT Phase 3 D07BCU DRUG__ID D07BCU D07BCU DRUGCOMP Cancer Prevention Pharmaceuticals Tucson, AZ D07BCU HIGHSTAT Phase 3 D07CCV DRUG__ID D07CCV D07CCV DRUGCOMP Merck D07CCV HIGHSTAT Phase 3 D07CPM DRUG__ID D07CPM D07CPM DRUGCOMP SandozHolzkirchen, Germany D07CPM HIGHSTAT Phase 3 D07DTM DRUG__ID D07DTM D07DTM DRUGCOMP Salvat Laboratories D07DTM HIGHSTAT Phase 3 D07EUY DRUG__ID D07EUY D07EUY DRUGCOMP Glaxosmithkline; novavax; vaxart D07EUY HIGHSTAT Phase 3 D07FPJ DRUG__ID D07FPJ D07FPJ DRUGCOMP Insmed Inc D07FPJ HIGHSTAT Phase 3 D07GNL DRUG__ID D07GNL D07GNL DRUGCOMP GlaxoSmithKline plc D07GNL HIGHSTAT Phase 3 D07HAR DRUG__ID D07HAR D07HAR DRUGCOMP Omeros Corp D07HAR HIGHSTAT Phase 3 D07JIN DRUG__ID D07JIN D07JIN DRUGCOMP Foamix Bridgewater, NJ D07JIN HIGHSTAT Phase 3 D07JRF DRUG__ID D07JRF D07JRF DRUGCOMP CEL-SCI D07JRF HIGHSTAT Phase 3 D07JZT DRUG__ID D07JZT D07JZT DRUGCOMP Sandoz D07JZT HIGHSTAT Phase 3 D07OAO DRUG__ID D07OAO D07OAO DRUGCOMP Ionis Pharmaceuticals Carlsbad, CA Roche Basel, Switzerland D07OAO HIGHSTAT Phase 3 D07PML DRUG__ID D07PML D07PML DRUGCOMP TG Therapeutics New York, NY D07PML HIGHSTAT Phase 3 D07PTH DRUG__ID D07PTH D07PTH DRUGCOMP University of California San Diego D07PTH HIGHSTAT Phase 3 D07RHF DRUG__ID D07RHF D07RHF DRUGCOMP Gage Development Rosemont, IL D07RHF HIGHSTAT Phase 3 D07STB DRUG__ID D07STB D07STB DRUGCOMP Edge Therapeutics Berkeley Heights, NJ D07STB HIGHSTAT Phase 3 D07TMR DRUG__ID D07TMR D07TMR DRUGCOMP Isis Pharmaceuticals D07TMR HIGHSTAT Phase 3 D07TSS DRUG__ID D07TSS D07TSS DRUGCOMP MesoblastNew York, NY D07TSS HIGHSTAT Phase 3 D07UAS DRUG__ID D07UAS D07UAS DRUGCOMP Polaris Pharmaceuticals D07UAS HIGHSTAT Phase 3 D07VAQ DRUG__ID D07VAQ D07VAQ DRUGCOMP Mogam Biotechnology Research Institute D07VAQ HIGHSTAT Phase 3 D07WPE DRUG__ID D07WPE D07WPE DRUGCOMP Bayer AG D07WPE HIGHSTAT Phase 3 D07WTG DRUG__ID D07WTG D07WTG DRUGCOMP SinoBiomed Inc D07WTG HIGHSTAT Phase 3 D07ZSU DRUG__ID D07ZSU D07ZSU DRUGCOMP Apimeds Gyeonggi-do, South Korea D07ZSU HIGHSTAT Phase 3 D08BMC DRUG__ID D08BMC D08BMC DRUGCOMP Laboratorios Leti SL D08BMC HIGHSTAT Phase 3 D08BNJ DRUG__ID D08BNJ D08BNJ DRUGCOMP Merck; sanofi pasteur D08BNJ HIGHSTAT Phase 3 D08CEA DRUG__ID D08CEA D08CEA DRUGCOMP Therapeutics, San Diego, CA D08CEA HIGHSTAT Phase 3 D08GIH DRUG__ID D08GIH D08GIH DRUGCOMP Molmed D08GIH HIGHSTAT Phase 3 D08HWV DRUG__ID D08HWV D08HWV DRUGCOMP BeiGene Cambridge, MA D08HWV HIGHSTAT Phase 3 D08KGY DRUG__ID D08KGY D08KGY DRUGCOMP Sophiris D08KGY HIGHSTAT Phase 3 D08KXO DRUG__ID D08KXO D08KXO DRUGCOMP Castle Creek Pharmaceuticals Parsippany, NJ D08KXO HIGHSTAT Phase 3 D08NAI DRUG__ID D08NAI D08NAI DRUGTYPE Antibody D08NAI HIGHSTAT Phase 3 D08OES DRUG__ID D08OES D08OES DRUGCOMP Gamida Cell D08OES HIGHSTAT Phase 3 D08OGB DRUG__ID D08OGB D08OGB DRUGCOMP MediGene Ltd D08OGB HIGHSTAT Phase 3 D08PBQ DRUG__ID D08PBQ D08PBQ DRUGCOMP NewLink Genetics Ames, IA D08PBQ HIGHSTAT Phase 3 D08PHD DRUG__ID D08PHD D08PHD DRUGCOMP Duramed Research Inc D08PHD HIGHSTAT Phase 3 D08POF DRUG__ID D08POF D08POF DRUGCOMP Ablynx D08POF HIGHSTAT Phase 3 D08RBW DRUG__ID D08RBW D08RBW DRUGCOMP Eli Lilly Indianapolis, IN D08RBW HIGHSTAT Phase 3 D08TBK DRUG__ID D08TBK D08TBK DRUGCOMP Bristol-Myers Squibb Princeton, NJ D08TBK HIGHSTAT Phase 3 D08UZP DRUG__ID D08UZP D08UZP DRUGCOMP Allergy therapeutics D08UZP HIGHSTAT Phase 3 D08VWK DRUG__ID D08VWK D08VWK DRUGCOMP PaxVax Redwood City, CA D08VWK HIGHSTAT Phase 3 D08XMM DRUG__ID D08XMM D08XMM DRUGCOMP GlaxoSmithKline; Nabi Biopharmaceuticals D08XMM HIGHSTAT Phase 3 D08YTF DRUG__ID D08YTF D08YTF DRUGTYPE Antibody D08YTF HIGHSTAT Phase 3 D08ZJJ DRUG__ID D08ZJJ D08ZJJ DRUGCOMP GlaxoSmithKline plc D08ZJJ HIGHSTAT Phase 3 D09APA DRUG__ID D09APA D09APA DRUGCOMP Recoly NV D09APA HIGHSTAT Phase 3 D09AYM DRUG__ID D09AYM D09AYM DRUGCOMP Xbiotech Austin, TX D09AYM HIGHSTAT Phase 3 D09BKY DRUG__ID D09BKY D09BKY DRUGCOMP Roche D09BKY HIGHSTAT Phase 3 D09EYN DRUG__ID D09EYN D09EYN DRUGCOMP NovavaxGaithersburg, MD D09EYN HIGHSTAT Phase 3 D09FKY DRUG__ID D09FKY D09FKY DRUGCOMP Giuliani SpA D09FKY HIGHSTAT Phase 3 D09FNI DRUG__ID D09FNI D09FNI DRUGCOMP Novo Nordisk, Princeton, NJ D09FNI HIGHSTAT Phase 3 D09FQW DRUG__ID D09FQW D09FQW DRUGCOMP TheraVida Inc D09FQW HIGHSTAT Phase 3 D09HOJ DRUG__ID D09HOJ D09HOJ DRUGCOMP Nihon Pharmaceutical Industry Co Ltd D09HOJ HIGHSTAT Phase 3 D09HTB DRUG__ID D09HTB D09HTB DRUGCOMP Sanofi-Aventis D09HTB HIGHSTAT Phase 3 D09JYL DRUG__ID D09JYL D09JYL DRUGCOMP Forty Seven Menlo Park, CA D09JYL HIGHSTAT Phase 3 D09KHE DRUG__ID D09KHE D09KHE DRUGCOMP Endo Pharmaceuticals D09KHE HIGHSTAT Phase 3 D09KRV DRUG__ID D09KRV D09KRV DRUGCOMP OMRIX Biopharmaceuticals SA D09KRV HIGHSTAT Phase 3 D09LHG DRUG__ID D09LHG D09LHG DRUGCOMP Yuyu Inc D09LHG HIGHSTAT Phase 3 D09MED DRUG__ID D09MED D09MED DRUGCOMP Tocagen D09MED HIGHSTAT Phase 3 D09MHN DRUG__ID D09MHN D09MHN DRUGCOMP Aastrom biosciences D09MHN HIGHSTAT Phase 3 D09MKH DRUG__ID D09MKH D09MKH DRUGCOMP Tris pharma D09MKH HIGHSTAT Phase 3 D09NAF DRUG__ID D09NAF D09NAF DRUGCOMP Avid Radiopharmaceuticals D09NAF HIGHSTAT Phase 3 D09NDM DRUG__ID D09NDM D09NDM DRUGCOMP Inpharma SA D09NDM HIGHSTAT Phase 3 D09OHH DRUG__ID D09OHH D09OHH DRUGCOMP Osmotica pharmaceutical D09OHH HIGHSTAT Phase 3 D09OHW DRUG__ID D09OHW D09OHW DRUGCOMP Binex Co Ltd D09OHW HIGHSTAT Phase 3 D09PTY DRUG__ID D09PTY D09PTY DRUGCOMP Merck & Co Inc D09PTY HIGHSTAT Phase 3 D09RPB DRUG__ID D09RPB D09RPB DRUGCOMP Promius Pharma Princeton, NJ D09RPB HIGHSTAT Phase 3 D09SHH DRUG__ID D09SHH D09SHH DRUGCOMP Baxter International Inc D09SHH HIGHSTAT Phase 3 D09TJJ DRUG__ID D09TJJ D09TJJ DRUGCOMP FibroGenSan Francisco, CA D09TJJ HIGHSTAT Phase 3 D09UVK DRUG__ID D09UVK D09UVK DRUGCOMP Merck Kenilworth, NJ, Pfizer New York, NY D09UVK HIGHSTAT Phase 3 D09VSV DRUG__ID D09VSV D09VSV DRUGCOMP Pherin pharmaceuticals D09VSV HIGHSTAT Phase 3 D09WRG DRUG__ID D09WRG D09WRG DRUGCOMP Teva pharmaceutical; mesoblast D09WRG HIGHSTAT Phase 3 D09WZG DRUG__ID D09WZG D09WZG DRUGCOMP Instituto Bioclon Sa De CV D09WZG HIGHSTAT Phase 3 D09XMX DRUG__ID D09XMX D09XMX DRUGCOMP AstraZeneca D09XMX HIGHSTAT Phase 3 D0A0NZ DRUG__ID D0A0NZ D0A0NZ DRUGCOMP University of Heidelberg D0A0NZ HIGHSTAT Phase 3 D0A0QH DRUG__ID D0A0QH D0A0QH DRUGCOMP SOTIOPrague, Czech Republic D0A0QH HIGHSTAT Phase 3 D0A2BO DRUG__ID D0A2BO D0A2BO DRUGCOMP SuperGen Inc D0A2BO HIGHSTAT Phase 3 D0A3FQ DRUG__ID D0A3FQ D0A3FQ DRUGCOMP Sanofi Pasteur D0A3FQ HIGHSTAT Phase 3 D0A3FZ DRUG__ID D0A3FZ D0A3FZ DRUGCOMP BM ImmunoTherapeutics D0A3FZ HIGHSTAT Phase 3 D0A4DP DRUG__ID D0A4DP D0A4DP DRUGCOMP Bayer HealthCare Pharmaceuticals D0A4DP HIGHSTAT Phase 3 D0A4FE DRUG__ID D0A4FE D0A4FE DRUGCOMP Osmotica Pharmaceutical Corp D0A4FE HIGHSTAT Phase 3 D0A8KX DRUG__ID D0A8KX D0A8KX DRUGCOMP Maruho Co Ltd D0A8KX HIGHSTAT Phase 3 D0A8PC DRUG__ID D0A8PC D0A8PC DRUGCOMP Chiron D0A8PC HIGHSTAT Phase 3 D0AD4Z DRUG__ID D0AD4Z D0AD4Z DRUGCOMP Regeneron Pharmaceuticals Tarrytown, NY Teva Pharmaceuticals USA North Wales, PA D0AD4Z HIGHSTAT Phase 3 D0AE6Q DRUG__ID D0AE6Q D0AE6Q DRUGCOMP Novartis Oncology East Hanover, NJ D0AE6Q HIGHSTAT Phase 3 D0AJ5E DRUG__ID D0AJ5E D0AJ5E DRUGCOMP Salix Pharmaceuticals Raleigh, NC D0AJ5E HIGHSTAT Phase 3 D0AR8G DRUG__ID D0AR8G D0AR8G DRUGCOMP Cytori Therapeutics San Diego, CA D0AR8G HIGHSTAT Phase 3 D0AY0U DRUG__ID D0AY0U D0AY0U DRUGCOMP GenentechSouth San Francisco, CA D0AY0U HIGHSTAT Phase 3 D0B2IR DRUG__ID D0B2IR D0B2IR DRUGCOMP Galderma Fort Worth, TX D0B2IR HIGHSTAT Phase 3 D0B2LC DRUG__ID D0B2LC D0B2LC DRUGCOMP Noven Pharmaceuticals Miami, FL D0B2LC HIGHSTAT Phase 3 D0B2ZZ DRUG__ID D0B2ZZ D0B2ZZ DRUGCOMP AstraZeneca D0B2ZZ HIGHSTAT Phase 3 D0B3XG DRUG__ID D0B3XG D0B3XG DRUGCOMP Csl behring D0B3XG HIGHSTAT Phase 3 D0B4ES DRUG__ID D0B4ES D0B4ES DRUGCOMP Intarcia Therapeutics D0B4ES HIGHSTAT Phase 3 D0B4OF DRUG__ID D0B4OF D0B4OF DRUGCOMP Research Triangle Institute D0B4OF HIGHSTAT Phase 3 D0B5VV DRUG__ID D0B5VV D0B5VV DRUGCOMP Novo Nordisk D0B5VV HIGHSTAT Phase 3 D0B6WP DRUG__ID D0B6WP D0B6WP DRUGCOMP GlaxoSmithKline plc D0B6WP HIGHSTAT Phase 3 D0B7AB DRUG__ID D0B7AB D0B7AB DRUGCOMP Reliance Life Sciences Group D0B7AB HIGHSTAT Phase 3 D0B7DW DRUG__ID D0B7DW D0B7DW DRUGCOMP Shire, Lexington, MA D0B7DW HIGHSTAT Phase 3 D0B7MO DRUG__ID D0B7MO D0B7MO DRUGCOMP Pfizer New York, NY D0B7MO HIGHSTAT Phase 3 D0B9RG DRUG__ID D0B9RG D0B9RG DRUGCOMP Janssen Research & Development Raritan, NJ; ViiV Healthcare Research Triangle Park, NC D0B9RG HIGHSTAT Phase 3 D0BC0F DRUG__ID D0BC0F D0BC0F DRUGCOMP Osmotica Pharmaceutical Corp D0BC0F HIGHSTAT Phase 3 D0BF8Y DRUG__ID D0BF8Y D0BF8Y DRUGCOMP Oncolytics biotech D0BF8Y HIGHSTAT Phase 3 D0BO7P DRUG__ID D0BO7P D0BO7P DRUGCOMP Gilead Sciences Foster City, CA D0BO7P HIGHSTAT Phase 3 D0C2XI DRUG__ID D0C2XI D0C2XI DRUGCOMP Schering-Plough D0C2XI HIGHSTAT Phase 3 D0C3YN DRUG__ID D0C3YN D0C3YN DRUGCOMP Watson Laboratories Inc D0C3YN HIGHSTAT Phase 3 D0C4DZ DRUG__ID D0C4DZ D0C4DZ DRUGCOMP ZARS Pharma D0C4DZ HIGHSTAT Phase 3 D0C4FA DRUG__ID D0C4FA D0C4FA DRUGCOMP Baxter 1nternational D0C4FA HIGHSTAT Phase 3 D0C4VN DRUG__ID D0C4VN D0C4VN DRUGCOMP The Center of Molecular Immunology D0C4VN HIGHSTAT Phase 3 D0C6ND DRUG__ID D0C6ND D0C6ND DRUGCOMP Alkermes D0C6ND HIGHSTAT Phase 3 D0C6XR DRUG__ID D0C6XR D0C6XR DRUGCOMP Wyeth D0C6XR HIGHSTAT Phase 3 D0C6ZX DRUG__ID D0C6ZX D0C6ZX DRUGCOMP Kyowa Hakko Kogyo Co Ltd D0C6ZX HIGHSTAT Phase 3 D0C9LQ DRUG__ID D0C9LQ D0C9LQ DRUGCOMP Bluebird bio D0C9LQ HIGHSTAT Phase 3 D0CF8T DRUG__ID D0CF8T D0CF8T DRUGCOMP Zeria Pharmaceutical Co Ltd D0CF8T HIGHSTAT Phase 3 D0CG0N DRUG__ID D0CG0N D0CG0N DRUGCOMP Progenics Pharmaceuticals Inc D0CG0N HIGHSTAT Phase 3 D0CH6B DRUG__ID D0CH6B D0CH6B DRUGCOMP AZTherapies Boston, MA D0CH6B HIGHSTAT Phase 3 D0CR9L DRUG__ID D0CR9L D0CR9L DRUGCOMP Philogen Sovicille, Italy D0CR9L HIGHSTAT Phase 3 D0CW2B DRUG__ID D0CW2B D0CW2B DRUGCOMP ETX Pharma, Oakland, MD D0CW2B HIGHSTAT Phase 3 D0CZ5Z DRUG__ID D0CZ5Z D0CZ5Z DRUGCOMP Shire plc D0CZ5Z HIGHSTAT Phase 3 D0D0HB DRUG__ID D0D0HB D0D0HB DRUGCOMP Northwest Biotherapeutics D0D0HB HIGHSTAT Phase 3 D0D0QQ DRUG__ID D0D0QQ D0D0QQ DRUGCOMP Stiefel Laboratories D0D0QQ HIGHSTAT Phase 3 D0D0RW DRUG__ID D0D0RW D0D0RW DRUGCOMP Chinese Academy of Medical Science D0D0RW HIGHSTAT Phase 3 D0D1UD DRUG__ID D0D1UD D0D1UD DRUGCOMP Sorrento Therapeutics Inc D0D1UD HIGHSTAT Phase 3 D0D2TT DRUG__ID D0D2TT D0D2TT DRUGCOMP Teva Pharmaceuticals North Wales, PA D0D2TT HIGHSTAT Phase 3 D0D4OS DRUG__ID D0D4OS D0D4OS DRUGCOMP ViroMed D0D4OS HIGHSTAT Phase 3 D0D5AV DRUG__ID D0D5AV D0D5AV DRUGCOMP Xiamen Innovax Biotech Co Ltd D0D5AV HIGHSTAT Phase 3 D0D5IS DRUG__ID D0D5IS D0D5IS DRUGCOMP Alberta Research Council D0D5IS HIGHSTAT Phase 3 D0D5NZ DRUG__ID D0D5NZ D0D5NZ DRUGCOMP CSL Ltd D0D5NZ HIGHSTAT Phase 3 D0D7GS DRUG__ID D0D7GS D0D7GS DRUGCOMP Athersys D0D7GS HIGHSTAT Phase 3 D0D7KU DRUG__ID D0D7KU D0D7KU DRUGCOMP Sienna Biopharmaceuticals Westlake Village, CA D0D7KU HIGHSTAT Phase 3 D0D8QV DRUG__ID D0D8QV D0D8QV DRUGCOMP Axsome Therapeutics New York, NY D0D8QV HIGHSTAT Phase 3 D0D8RT DRUG__ID D0D8RT D0D8RT DRUGCOMP Allergy Therapeutics D0D8RT HIGHSTAT Phase 3 D0D9HZ DRUG__ID D0D9HZ D0D9HZ DRUGCOMP Pfizer D0D9HZ HIGHSTAT Phase 3 D0DA3T DRUG__ID D0DA3T D0DA3T DRUGCOMP Northwest BioTherapeutics D0DA3T HIGHSTAT Phase 3 D0DD9F DRUG__ID D0DD9F D0DD9F DRUGCOMP Akzo Nobel NV D0DD9F HIGHSTAT Phase 3 D0DP9O DRUG__ID D0DP9O D0DP9O DRUGCOMP Histogenics Waltham, MA D0DP9O HIGHSTAT Phase 3 D0DR4W DRUG__ID D0DR4W D0DR4W DRUGCOMP Bioheart D0DR4W HIGHSTAT Phase 3 D0DU9I DRUG__ID D0DU9I D0DU9I DRUGCOMP Renova Therapeutics San Diego, CA D0DU9I HIGHSTAT Phase 3 D0DV3T DRUG__ID D0DV3T D0DV3T DRUGCOMP Hospira D0DV3T HIGHSTAT Phase 3 D0E0XL DRUG__ID D0E0XL D0E0XL DRUGCOMP Novartis D0E0XL HIGHSTAT Phase 3 D0E2YL DRUG__ID D0E2YL D0E2YL DRUGCOMP Uni-Bio Science Group Limited D0E2YL HIGHSTAT Phase 3 D0E4PQ DRUG__ID D0E4PQ D0E4PQ DRUGCOMP Innocell Corp D0E4PQ HIGHSTAT Phase 3 D0E5VO DRUG__ID D0E5VO D0E5VO DRUGCOMP GlaxoSmithKline; Theravance D0E5VO HIGHSTAT Phase 3 D0E6ES DRUG__ID D0E6ES D0E6ES DRUGCOMP Eunice Kennedy Shriver National Institutes of Child Health and Human Development D0E6ES HIGHSTAT Phase 3 D0E6UU DRUG__ID D0E6UU D0E6UU DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0E6UU HIGHSTAT Phase 3 D0E6XN DRUG__ID D0E6XN D0E6XN DRUGCOMP Torii Pharmaceutical Co Ltd D0E6XN HIGHSTAT Phase 3 D0E7OC DRUG__ID D0E7OC D0E7OC DRUGCOMP Autism therapeutics D0E7OC HIGHSTAT Phase 3 D0E8NJ DRUG__ID D0E8NJ D0E8NJ DRUGCOMP AmgenThousand Oaks, CA D0E8NJ HIGHSTAT Phase 3 D0E9AF DRUG__ID D0E9AF D0E9AF DRUGCOMP Alnylam pharmaceuticals D0E9AF HIGHSTAT Phase 3 D0E9NU DRUG__ID D0E9NU D0E9NU DRUGCOMP Kyowa Hakko Kirin Co Ltd D0E9NU HIGHSTAT Phase 3 D0EF2H DRUG__ID D0EF2H D0EF2H DRUGCOMP Foresee Pharmaceuticals Newark, DE D0EF2H HIGHSTAT Phase 3 D0EH2Q DRUG__ID D0EH2Q D0EH2Q DRUGCOMP Pfizer D0EH2Q HIGHSTAT Phase 3 D0EO5G DRUG__ID D0EO5G D0EO5G DRUGCOMP Alkermes Waltham, MA D0EO5G HIGHSTAT Phase 3 D0EQ5W DRUG__ID D0EQ5W D0EQ5W DRUGCOMP INSERM D0EQ5W HIGHSTAT Phase 3 D0ET9N DRUG__ID D0ET9N D0ET9N DRUGCOMP Warner Chilcott plc D0ET9N HIGHSTAT Phase 3 D0F4IM DRUG__ID D0F4IM D0F4IM DRUGCOMP Seattle Genetics Bothell, WA D0F4IM HIGHSTAT Phase 3 D0F7YW DRUG__ID D0F7YW D0F7YW DRUGCOMP Mologen Holding AG D0F7YW HIGHSTAT Phase 3 D0F8VM DRUG__ID D0F8VM D0F8VM DRUGCOMP Glaxosmithkline; jn-lnternational medical D0F8VM HIGHSTAT Phase 3 D0FJ1W DRUG__ID D0FJ1W D0FJ1W DRUGCOMP Daiichi Sankyo D0FJ1W HIGHSTAT Phase 3 D0FL0R DRUG__ID D0FL0R D0FL0R DRUGCOMP Angiolab Inc D0FL0R HIGHSTAT Phase 3 D0FM5M DRUG__ID D0FM5M D0FM5M DRUGCOMP Idera Pharmaceuticals D0FM5M HIGHSTAT Phase 3 D0FP5B DRUG__ID D0FP5B D0FP5B DRUGCOMP Merck D0FP5B HIGHSTAT Phase 3 D0G2ZX DRUG__ID D0G2ZX D0G2ZX DRUGCOMP Cardiome Pharma Vancouver, Canada D0G2ZX HIGHSTAT Phase 3 D0G3OI DRUG__ID D0G3OI D0G3OI DRUGCOMP ALK-Abello; Merck D0G3OI HIGHSTAT Phase 3 D0G4BF DRUG__ID D0G4BF D0G4BF DRUGCOMP LG Life Sciences Ltd D0G4BF HIGHSTAT Phase 3 D0G6DF DRUG__ID D0G6DF D0G6DF DRUGCOMP Hutchison Medipharma Enterprises Ltd D0G6DF HIGHSTAT Phase 3 D0G6RB DRUG__ID D0G6RB D0G6RB DRUGCOMP INSYS Therapeutics D0G6RB HIGHSTAT Phase 3 D0G6ZS DRUG__ID D0G6ZS D0G6ZS DRUGCOMP LG Life Sciences Ltd D0G6ZS HIGHSTAT Phase 3 D0G7IV DRUG__ID D0G7IV D0G7IV DRUGCOMP Bristol-Myers Squibb D0G7IV HIGHSTAT Phase 3 D0G8NK DRUG__ID D0G8NK D0G8NK DRUGCOMP AstraZeneca D0G8NK HIGHSTAT Phase 3 D0G8UL DRUG__ID D0G8UL D0G8UL DRUGCOMP Cardium Therapeutics D0G8UL HIGHSTAT Phase 3 D0GP8N DRUG__ID D0GP8N D0GP8N DRUGCOMP Merck D0GP8N HIGHSTAT Phase 3 D0GW1P DRUG__ID D0GW1P D0GW1P DRUGCOMP Sanofi Pasteur D0GW1P HIGHSTAT Phase 3 D0GW6K DRUG__ID D0GW6K D0GW6K DRUGCOMP Aerial BioPharma D0GW6K HIGHSTAT Phase 3 D0GY4H DRUG__ID D0GY4H D0GY4H DRUGCOMP Ark Therapeutics D0GY4H HIGHSTAT Phase 3 D0H1FN DRUG__ID D0H1FN D0H1FN DRUGCOMP Avicena D0H1FN HIGHSTAT Phase 3 D0H1PK DRUG__ID D0H1PK D0H1PK DRUGCOMP Bavarian Nordic A/S D0H1PK HIGHSTAT Phase 3 D0H1TL DRUG__ID D0H1TL D0H1TL DRUGCOMP Abbott; Astra Zeneca D0H1TL HIGHSTAT Phase 3 D0H1UW DRUG__ID D0H1UW D0H1UW DRUGCOMP Novo Nordisk D0H1UW HIGHSTAT Phase 3 D0H2AP DRUG__ID D0H2AP D0H2AP DRUGCOMP Edgemont Pharmaceuticals LLC D0H2AP HIGHSTAT Phase 3 D0H3NN DRUG__ID D0H3NN D0H3NN DRUGCOMP ISTO Technologies D0H3NN HIGHSTAT Phase 3 D0H4YL DRUG__ID D0H4YL D0H4YL DRUGCOMP SeqirusCambridge, MA D0H4YL HIGHSTAT Phase 3 D0H6BS DRUG__ID D0H6BS D0H6BS DRUGCOMP Novartis OncologyEast Hanover, NJ D0H6BS HIGHSTAT Phase 3 D0H8MH DRUG__ID D0H8MH D0H8MH DRUGCOMP Prolor biotech; chiasma D0H8MH HIGHSTAT Phase 3 D0H9PT DRUG__ID D0H9PT D0H9PT DRUGCOMP Roche D0H9PT HIGHSTAT Phase 3 D0H9QC DRUG__ID D0H9QC D0H9QC DRUGCOMP Shionogi D0H9QC HIGHSTAT Phase 3 D0HB0V DRUG__ID D0HB0V D0HB0V DRUGCOMP Jennerex Biotherapeutics D0HB0V HIGHSTAT Phase 3 D0HK3X DRUG__ID D0HK3X D0HK3X DRUGCOMP Astion Pharma A/S D0HK3X HIGHSTAT Phase 3 D0HL1X DRUG__ID D0HL1X D0HL1X DRUGTYPE Antisense drug D0HL1X HIGHSTAT Phase 3 D0HR7Z DRUG__ID D0HR7Z D0HR7Z DRUGCOMP Pfizer D0HR7Z HIGHSTAT Phase 3 D0I1KL DRUG__ID D0I1KL D0I1KL DRUGCOMP FirstString Research Inc D0I1KL HIGHSTAT Phase 3 D0I2KE DRUG__ID D0I2KE D0I2KE DRUGCOMP Merck Kenilworth, NJ D0I2KE HIGHSTAT Phase 3 D0I3NA DRUG__ID D0I3NA D0I3NA DRUGCOMP Octapharma usa D0I3NA HIGHSTAT Phase 3 D0I4XF DRUG__ID D0I4XF D0I4XF DRUGCOMP Altacor D0I4XF HIGHSTAT Phase 3 D0I5EU DRUG__ID D0I5EU D0I5EU DRUGCOMP Exelixis; Roche D0I5EU HIGHSTAT Phase 3 D0I5RR DRUG__ID D0I5RR D0I5RR DRUGCOMP Merck & Co Inc D0I5RR HIGHSTAT Phase 3 D0I5WJ DRUG__ID D0I5WJ D0I5WJ DRUGCOMP Anthera Pharmaceuticals Hayward, CA D0I5WJ HIGHSTAT Phase 3 D0I6OI DRUG__ID D0I6OI D0I6OI DRUGCOMP Abbott; Roche D0I6OI HIGHSTAT Phase 3 D0I6PP DRUG__ID D0I6PP D0I6PP DRUGCOMP Sanofi D0I6PP HIGHSTAT Phase 3 D0I6UE DRUG__ID D0I6UE D0I6UE DRUGCOMP MabtechShanghai, China Sorrento Therapeutics San Diego, CA D0I6UE HIGHSTAT Phase 3 D0IA0N DRUG__ID D0IA0N D0IA0N DRUGCOMP Neurelis Pharmaceuticals San Diego, CA D0IA0N HIGHSTAT Phase 3 D0IC7A DRUG__ID D0IC7A D0IC7A DRUGCOMP Ardana Bioscience D0IC7A HIGHSTAT Phase 3 D0IM6O DRUG__ID D0IM6O D0IM6O DRUGCOMP Agennix AG D0IM6O HIGHSTAT Phase 3 D0J0GR DRUG__ID D0J0GR D0J0GR DRUGCOMP Argos Therapeutics Durham, NC D0J0GR HIGHSTAT Phase 3 D0J1ZH DRUG__ID D0J1ZH D0J1ZH DRUGCOMP Pherin Pharmaceuticals Los Altos, CA D0J1ZH HIGHSTAT Phase 3 D0J3ZT DRUG__ID D0J3ZT D0J3ZT DRUGCOMP Proteon Therapeutics D0J3ZT HIGHSTAT Phase 3 D0J4IT DRUG__ID D0J4IT D0J4IT DRUGCOMP Circassia Ltd D0J4IT HIGHSTAT Phase 3 D0J6PY DRUG__ID D0J6PY D0J6PY DRUGCOMP Bristol-Myers Squibb D0J6PY HIGHSTAT Phase 3 D0J7CH DRUG__ID D0J7CH D0J7CH DRUGCOMP Novartis pharmaceuticals D0J7CH HIGHSTAT Phase 3 D0J9HO DRUG__ID D0J9HO D0J9HO DRUGCOMP GILEAD D0J9HO HIGHSTAT Phase 3 D0J9VL DRUG__ID D0J9VL D0J9VL DRUGCOMP MC2 Therapeutics Copenhagen, Denmark D0J9VL HIGHSTAT Phase 3 D0K1XV DRUG__ID D0K1XV D0K1XV DRUGCOMP United Therapeutics Silver Spring, MD D0K1XV HIGHSTAT Phase 3 D0K4GW DRUG__ID D0K4GW D0K4GW DRUGCOMP Innocoll Newtown Square, PA D0K4GW HIGHSTAT Phase 3 D0K5ET DRUG__ID D0K5ET D0K5ET DRUGCOMP Zosano Pharma Fremont, CA D0K5ET HIGHSTAT Phase 3 D0K6AL DRUG__ID D0K6AL D0K6AL DRUGCOMP PharmaMar USA New York, NY D0K6AL HIGHSTAT Phase 3 D0K6PP DRUG__ID D0K6PP D0K6PP DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0K6PP HIGHSTAT Phase 3 D0K9FA DRUG__ID D0K9FA D0K9FA DRUGCOMP ViiV Healthcare Research Triangle Park, NC D0K9FA HIGHSTAT Phase 3 D0K9IB DRUG__ID D0K9IB D0K9IB DRUGCOMP Proteon Therapeutics Waltham, MA D0K9IB HIGHSTAT Phase 3 D0KN2C DRUG__ID D0KN2C D0KN2C DRUGCOMP Diasome Pharmaceuticals D0KN2C HIGHSTAT Phase 3 D0KV1Q DRUG__ID D0KV1Q D0KV1Q DRUGCOMP Johnson & Johnson Licensee; Kaken Pharmaceutical D0KV1Q HIGHSTAT Phase 3 D0L1DR DRUG__ID D0L1DR D0L1DR DRUGCOMP Green Cross Corp D0L1DR HIGHSTAT Phase 3 D0L1LV DRUG__ID D0L1LV D0L1LV DRUGCOMP Fabre Kramer Pharmaceuticals Inc D0L1LV HIGHSTAT Phase 3 D0L3SP DRUG__ID D0L3SP D0L3SP DRUGCOMP Bavarian NordicMorrisville, NCJanssen Vaccines and Prevention Leiden, Netherlands D0L3SP HIGHSTAT Phase 3 D0L3UI DRUG__ID D0L3UI D0L3UI DRUGCOMP Sanofi pasteur D0L3UI HIGHSTAT Phase 3 D0L3VU DRUG__ID D0L3VU D0L3VU DRUGCOMP Britannia Pharmaceuticals Ltd D0L3VU HIGHSTAT Phase 3 D0L5WF DRUG__ID D0L5WF D0L5WF DRUGCOMP Versartis, Menlo Park, CA D0L5WF HIGHSTAT Phase 3 D0L6BH DRUG__ID D0L6BH D0L6BH DRUGCOMP Novo Nordisk D0L6BH HIGHSTAT Phase 3 D0L8PH DRUG__ID D0L8PH D0L8PH DRUGCOMP Dr Rentschler Biotechnologie GmbH D0L8PH HIGHSTAT Phase 3 D0L9HG DRUG__ID D0L9HG D0L9HG DRUGCOMP Bharat Biotech D0L9HG HIGHSTAT Phase 3 D0LA6Z DRUG__ID D0LA6Z D0LA6Z DRUGCOMP Lung Biotechnology Silver Spring, MD D0LA6Z HIGHSTAT Phase 3 D0LB3Z DRUG__ID D0LB3Z D0LB3Z DRUGCOMP Novartis pharmaceuticals D0LB3Z HIGHSTAT Phase 3 D0LC3C DRUG__ID D0LC3C D0LC3C DRUGCOMP Aradigm Hayward, CA D0LC3C HIGHSTAT Phase 3 D0LF1E DRUG__ID D0LF1E D0LF1E DRUGCOMP Aquestive Therapeutics Warren, NJ D0LF1E HIGHSTAT Phase 3 D0LF8Z DRUG__ID D0LF8Z D0LF8Z DRUGCOMP Ferring Pharmaceuticals Saint-Prex, Switzerland D0LF8Z HIGHSTAT Phase 3 D0LG3Q DRUG__ID D0LG3Q D0LG3Q DRUGCOMP Pluristem Therapeutics Haifa, Israel D0LG3Q HIGHSTAT Phase 3 D0LR1W DRUG__ID D0LR1W D0LR1W DRUGCOMP Medicago Durham, NC D0LR1W HIGHSTAT Phase 3 D0LX9H DRUG__ID D0LX9H D0LX9H DRUGCOMP United Therapeutics Silver Spring, MD D0LX9H HIGHSTAT Phase 3 D0M1WU DRUG__ID D0M1WU D0M1WU DRUGCOMP Ajinomoto Co Inc D0M1WU HIGHSTAT Phase 3 D0M2EG DRUG__ID D0M2EG D0M2EG DRUGCOMP Eli Lilly Indianapolis, IN D0M2EG HIGHSTAT Phase 3 D0M2GQ DRUG__ID D0M2GQ D0M2GQ DRUGCOMP Dynavax Technologies D0M2GQ HIGHSTAT Phase 3 D0M2IS DRUG__ID D0M2IS D0M2IS DRUGCOMP Center for Genetic Engineering and Biotechnology D0M2IS HIGHSTAT Phase 3 D0M3BB DRUG__ID D0M3BB D0M3BB DRUGCOMP Nexell Therapeutics Inc D0M3BB HIGHSTAT Phase 3 D0M4TF DRUG__ID D0M4TF D0M4TF DRUGCOMP John Wayne Cancer Institute D0M4TF HIGHSTAT Phase 3 D0M6HE DRUG__ID D0M6HE D0M6HE DRUGCOMP GlaxoSmithKline D0M6HE HIGHSTAT Phase 3 D0M7HZ DRUG__ID D0M7HZ D0M7HZ DRUGCOMP Biogen Idec; ISIS pharmaceuticals D0M7HZ HIGHSTAT Phase 3 D0M9OO DRUG__ID D0M9OO D0M9OO DRUGCOMP Sellas Life Sciences New York, NY D0M9OO HIGHSTAT Phase 3 D0ML8G DRUG__ID D0ML8G D0ML8G DRUGCOMP Novo Nordisk D0ML8G HIGHSTAT Phase 3 D0N1YF DRUG__ID D0N1YF D0N1YF DRUGCOMP AnGes; Daiichi D0N1YF HIGHSTAT Phase 3 D0N1YG DRUG__ID D0N1YG D0N1YG DRUGCOMP Macrocure D0N1YG HIGHSTAT Phase 3 D0N3ZN DRUG__ID D0N3ZN D0N3ZN DRUGCOMP Medlmmune LLC D0N3ZN HIGHSTAT Phase 3 D0N5GV DRUG__ID D0N5GV D0N5GV DRUGCOMP Bristol-Myers Squib Princeton, NJ D0N5GV HIGHSTAT Phase 3 D0N6IY DRUG__ID D0N6IY D0N6IY DRUGCOMP Targazyme D0N6IY HIGHSTAT Phase 3 D0N8IL DRUG__ID D0N8IL D0N8IL DRUGCOMP Pfizer D0N8IL HIGHSTAT Phase 3 D0NA8B DRUG__ID D0NA8B D0NA8B DRUGCOMP Clovis Oncology Boulder, CO D0NA8B HIGHSTAT Phase 3 D0NC9E DRUG__ID D0NC9E D0NC9E DRUGCOMP Soligenix, Princeton, NJ D0NC9E HIGHSTAT Phase 3 D0NE8F DRUG__ID D0NE8F D0NE8F DRUGCOMP EryDel Urbino, Italy D0NE8F HIGHSTAT Phase 3 D0NH3R DRUG__ID D0NH3R D0NH3R DRUGCOMP Astex Pharmaceuticals Pleasanton, CA D0NH3R HIGHSTAT Phase 3 D0NI9X DRUG__ID D0NI9X D0NI9X DRUGCOMP California Stem Cells D0NI9X HIGHSTAT Phase 3 D0NN7Q DRUG__ID D0NN7Q D0NN7Q DRUGCOMP Healthpoint biotherapeutics D0NN7Q HIGHSTAT Phase 3 D0NO0K DRUG__ID D0NO0K D0NO0K DRUGCOMP Redbiotec AG D0NO0K HIGHSTAT Phase 3 D0O0HU DRUG__ID D0O0HU D0O0HU DRUGCOMP Almirall Prodesfarma SA D0O0HU HIGHSTAT Phase 3 D0O1EH DRUG__ID D0O1EH D0O1EH DRUGCOMP KemPharmaCelebration, FL D0O1EH HIGHSTAT Phase 3 D0O1UT DRUG__ID D0O1UT D0O1UT DRUGCOMP Intercytex Ltd D0O1UT HIGHSTAT Phase 3 D0O1UX DRUG__ID D0O1UX D0O1UX DRUGCOMP Dbv technologies D0O1UX HIGHSTAT Phase 3 D0O2NQ DRUG__ID D0O2NQ D0O2NQ DRUGCOMP Pfizer D0O2NQ HIGHSTAT Phase 3 D0O3EX DRUG__ID D0O3EX D0O3EX DRUGCOMP Liquidia Technologies Morrisville, NC D0O3EX HIGHSTAT Phase 3 D0O5KY DRUG__ID D0O5KY D0O5KY DRUGCOMP Zensun D0O5KY HIGHSTAT Phase 3 D0O5TR DRUG__ID D0O5TR D0O5TR DRUGCOMP Reckitt benckiser pharmaceutical D0O5TR HIGHSTAT Phase 3 D0O5XQ DRUG__ID D0O5XQ D0O5XQ DRUGCOMP Alcon D0O5XQ HIGHSTAT Phase 3 D0O6BW DRUG__ID D0O6BW D0O6BW DRUGCOMP Chiron D0O6BW HIGHSTAT Phase 3 D0O7GB DRUG__ID D0O7GB D0O7GB DRUGCOMP Spark Therapeutics Philadelphia, PA D0O7GB HIGHSTAT Phase 3 D0O9DK DRUG__ID D0O9DK D0O9DK DRUGCOMP Pfizer D0O9DK HIGHSTAT Phase 3 D0O9UN DRUG__ID D0O9UN D0O9UN DRUGCOMP Sanofi D0O9UN HIGHSTAT Phase 3 D0O9UZ DRUG__ID D0O9UZ D0O9UZ DRUGCOMP Nuvelo D0O9UZ HIGHSTAT Phase 3 D0O9XO DRUG__ID D0O9XO D0O9XO DRUGCOMP Chengdu Kanghong Biotechnologies Co Ltd D0O9XO HIGHSTAT Phase 3 D0OD3T DRUG__ID D0OD3T D0OD3T DRUGCOMP Sanofi Pasteur D0OD3T HIGHSTAT Phase 3 D0OF1R DRUG__ID D0OF1R D0OF1R DRUGCOMP Eleven Biotherapeutics Cambridge, MA D0OF1R HIGHSTAT Phase 3 D0OG1V DRUG__ID D0OG1V D0OG1V DRUGCOMP Medarex D0OG1V HIGHSTAT Phase 3 D0OH5E DRUG__ID D0OH5E D0OH5E DRUGCOMP Medipost Co Ltd D0OH5E HIGHSTAT Phase 3 D0OQ9V DRUG__ID D0OQ9V D0OQ9V DRUGCOMP Biomarin pharmaceutical D0OQ9V HIGHSTAT Phase 3 D0OT1Q DRUG__ID D0OT1Q D0OT1Q DRUGCOMP Advaxis, Princeton, NJ D0OT1Q HIGHSTAT Phase 3 D0OW2S DRUG__ID D0OW2S D0OW2S DRUGCOMP Amgen Thousand D0OW2S HIGHSTAT Phase 3 D0OZ6W DRUG__ID D0OZ6W D0OZ6W DRUGCOMP Stallergenes Greer London, United Kingdom D0OZ6W HIGHSTAT Phase 3 D0P0FQ DRUG__ID D0P0FQ D0P0FQ DRUGCOMP Glaxosmithkline D0P0FQ HIGHSTAT Phase 3 D0P2RO DRUG__ID D0P2RO D0P2RO DRUGCOMP Sanofi-aventis D0P2RO HIGHSTAT Phase 3 D0P4XW DRUG__ID D0P4XW D0P4XW DRUGCOMP Janssen Biotech Titusville, NJ D0P4XW HIGHSTAT Phase 3 D0P5DZ DRUG__ID D0P5DZ D0P5DZ DRUGCOMP Merck Kenilworth, NJ D0P5DZ HIGHSTAT Phase 3 D0P9UP DRUG__ID D0P9UP D0P9UP DRUGCOMP Biotest pharmaceuticals D0P9UP HIGHSTAT Phase 3 D0P9YQ DRUG__ID D0P9YQ D0P9YQ DRUGCOMP Renovo, UK (Shire, UK) D0P9YQ HIGHSTAT Phase 3 D0PE2L DRUG__ID D0PE2L D0PE2L DRUGCOMP GlaxoSmithKline; Prosensa D0PE2L HIGHSTAT Phase 3 D0PM0Y DRUG__ID D0PM0Y D0PM0Y DRUGCOMP Taiho Oncology Princeton, NJ D0PM0Y HIGHSTAT Phase 3 D0Q0LI DRUG__ID D0Q0LI D0Q0LI DRUGCOMP Seres Health, Cambridge, MA D0Q0LI HIGHSTAT Phase 3 D0Q1VD DRUG__ID D0Q1VD D0Q1VD DRUGCOMP Novan Morrisville, NC D0Q1VD HIGHSTAT Phase 3 D0Q3WB DRUG__ID D0Q3WB D0Q3WB DRUGCOMP BIKEN D0Q3WB HIGHSTAT Phase 3 D0Q9TB DRUG__ID D0Q9TB D0Q9TB DRUGCOMP Macrocure D0Q9TB HIGHSTAT Phase 3 D0QL4X DRUG__ID D0QL4X D0QL4X DRUGCOMP Celtic Pharma D0QL4X HIGHSTAT Phase 3 D0QM1T DRUG__ID D0QM1T D0QM1T DRUGCOMP Shin Poong Pharmaceutical Co Ltd D0QM1T HIGHSTAT Phase 3 D0QP9A DRUG__ID D0QP9A D0QP9A DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0QP9A HIGHSTAT Phase 3 D0QR4F DRUG__ID D0QR4F D0QR4F DRUGCOMP Santen, Emeryville, CA D0QR4F HIGHSTAT Phase 3 D0QU0H DRUG__ID D0QU0H D0QU0H DRUGCOMP Omeros, Seattle, WA D0QU0H HIGHSTAT Phase 3 D0QU8I DRUG__ID D0QU8I D0QU8I DRUGCOMP Pfizer New York, NY D0QU8I HIGHSTAT Phase 3 D0R2NE DRUG__ID D0R2NE D0R2NE DRUGCOMP Orion; Novartis D0R2NE HIGHSTAT Phase 3 D0R3ML DRUG__ID D0R3ML D0R3ML DRUGCOMP Population Council D0R3ML HIGHSTAT Phase 3 D0R7UL DRUG__ID D0R7UL D0R7UL DRUGCOMP MedDay Pharmaceuticals Paris, France D0R7UL HIGHSTAT Phase 3 D0R8FL DRUG__ID D0R8FL D0R8FL DRUGCOMP Egalet Wayne, PA D0R8FL HIGHSTAT Phase 3 D0R8LQ DRUG__ID D0R8LQ D0R8LQ DRUGCOMP Aquestive Therapeutics Warren, NJ D0R8LQ HIGHSTAT Phase 3 D0R8QX DRUG__ID D0R8QX D0R8QX DRUGCOMP Bio3 Research Srl D0R8QX HIGHSTAT Phase 3 D0RA5E DRUG__ID D0RA5E D0RA5E DRUGCOMP Merck Kenilworth, NJ, Pfizer New York, NY D0RA5E HIGHSTAT Phase 3 D0RL5B DRUG__ID D0RL5B D0RL5B DRUGCOMP Marco Polo Pharmaceuticals SA D0RL5B HIGHSTAT Phase 3 D0RM2O DRUG__ID D0RM2O D0RM2O DRUGCOMP Eunice Kennedy Shriver National Institutes of Child Health and Human Development D0RM2O HIGHSTAT Phase 3 D0RQ5Z DRUG__ID D0RQ5Z D0RQ5Z DRUGCOMP Sanofi Pasteur Swiftwater, PA D0RQ5Z HIGHSTAT Phase 3 D0RR2E DRUG__ID D0RR2E D0RR2E DRUGCOMP Valeant Pharmaceuticals Bridgewater, NJ D0RR2E HIGHSTAT Phase 3 D0S0HA DRUG__ID D0S0HA D0S0HA DRUGCOMP Wiley-Liss; Keryx Biopharmaceuticals D0S0HA HIGHSTAT Phase 3 D0S0LD DRUG__ID D0S0LD D0S0LD DRUGCOMP Biological E Ltd D0S0LD HIGHSTAT Phase 3 D0S1KP DRUG__ID D0S1KP D0S1KP DRUGCOMP Pearl Therapeutics D0S1KP HIGHSTAT Phase 3 D0S1QY DRUG__ID D0S1QY D0S1QY DRUGCOMP Takeda D0S1QY HIGHSTAT Phase 3 D0S2BU DRUG__ID D0S2BU D0S2BU DRUGCOMP Radius Health Inc D0S2BU HIGHSTAT Phase 3 D0S3BK DRUG__ID D0S3BK D0S3BK DRUGCOMP Gen Sight Biologics Paris, France D0S3BK HIGHSTAT Phase 3 D0S3EM DRUG__ID D0S3EM D0S3EM DRUGCOMP AstraZeneca D0S3EM HIGHSTAT Phase 3 D0S3QH DRUG__ID D0S3QH D0S3QH DRUGCOMP Intec Pharma Jerusalem, Israel D0S3QH HIGHSTAT Phase 3 D0S4FQ DRUG__ID D0S4FQ D0S4FQ DRUGCOMP Gan & Lee PharmaceuticalsBeijing, China D0S4FQ HIGHSTAT Phase 3 D0S4LV DRUG__ID D0S4LV D0S4LV DRUGCOMP VBL Therapeutics D0S4LV HIGHSTAT Phase 3 D0S4RK DRUG__ID D0S4RK D0S4RK DRUGCOMP Biogen idec D0S4RK HIGHSTAT Phase 3 D0S5FF DRUG__ID D0S5FF D0S5FF DRUGCOMP Novartis D0S5FF HIGHSTAT Phase 3 D0S6HR DRUG__ID D0S6HR D0S6HR DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0S6HR HIGHSTAT Phase 3 D0S6OH DRUG__ID D0S6OH D0S6OH DRUGCOMP Ambrx Inc D0S6OH HIGHSTAT Phase 3 D0S7JN DRUG__ID D0S7JN D0S7JN DRUGCOMP Sandoz Princeton, NJ D0S7JN HIGHSTAT Phase 3 D0S7KQ DRUG__ID D0S7KQ D0S7KQ DRUGCOMP Affymax Inc; Takeda Pharmaceutical Co Ltd. D0S7KQ HIGHSTAT Phase 3 D0SB8X DRUG__ID D0SB8X D0SB8X DRUGCOMP Protein sciences D0SB8X HIGHSTAT Phase 3 D0SQ2Z DRUG__ID D0SQ2Z D0SQ2Z DRUGCOMP Medinol Tel Aviv, Israel D0SQ2Z HIGHSTAT Phase 3 D0SS1J DRUG__ID D0SS1J D0SS1J DRUGCOMP Sanofi D0SS1J HIGHSTAT Phase 3 D0T0JF DRUG__ID D0T0JF D0T0JF DRUGCOMP Immunsystem IMS AB D0T0JF HIGHSTAT Phase 3 D0T0YG DRUG__ID D0T0YG D0T0YG DRUGCOMP CTI BioPharma Seattle, WA D0T0YG HIGHSTAT Phase 3 D0T1VK DRUG__ID D0T1VK D0T1VK DRUGCOMP CJ Corp D0T1VK HIGHSTAT Phase 3 D0T2MS DRUG__ID D0T2MS D0T2MS DRUGCOMP Zogenix D0T2MS HIGHSTAT Phase 3 D0T3JF DRUG__ID D0T3JF D0T3JF DRUGCOMP Advantagene D0T3JF HIGHSTAT Phase 3 D0T4GZ DRUG__ID D0T4GZ D0T4GZ DRUGCOMP Ribi ImmunoChem Research Inc D0T4GZ HIGHSTAT Phase 3 D0T5VD DRUG__ID D0T5VD D0T5VD DRUGCOMP Evoke Pharma D0T5VD HIGHSTAT Phase 3 D0T6IN DRUG__ID D0T6IN D0T6IN DRUGCOMP Bristol-myers squibb D0T6IN HIGHSTAT Phase 3 D0T7MN DRUG__ID D0T7MN D0T7MN DRUGCOMP Zydus-Cadila Group D0T7MN HIGHSTAT Phase 3 D0T8LF DRUG__ID D0T8LF D0T8LF DRUGCOMP Curalogic D0T8LF HIGHSTAT Phase 3 D0T9DA DRUG__ID D0T9DA D0T9DA DRUGCOMP Molmed D0T9DA HIGHSTAT Phase 3 D0T9FD DRUG__ID D0T9FD D0T9FD DRUGCOMP SK Life Science D0T9FD HIGHSTAT Phase 3 D0T9GM DRUG__ID D0T9GM D0T9GM DRUGCOMP NovavaxGaithersburg, MD D0T9GM HIGHSTAT Phase 3 D0T9LR DRUG__ID D0T9LR D0T9LR DRUGCOMP Lilly D0T9LR HIGHSTAT Phase 3 D0TC4R DRUG__ID D0TC4R D0TC4R DRUGCOMP Lundbeck Research D0TC4R HIGHSTAT Phase 3 D0TY3L DRUG__ID D0TY3L D0TY3L DRUGCOMP Athenex Buffalo, NY D0TY3L HIGHSTAT Phase 3 D0TY5K DRUG__ID D0TY5K D0TY5K DRUGCOMP NextWave Pharmaceuticals Inc D0TY5K HIGHSTAT Phase 3 D0U0HX DRUG__ID D0U0HX D0U0HX DRUGCOMP GeneScience Pharmaceuticals Co Ltd D0U0HX HIGHSTAT Phase 3 D0U1LQ DRUG__ID D0U1LQ D0U1LQ DRUGCOMP Sanofi pasteur D0U1LQ HIGHSTAT Phase 3 D0U5GZ DRUG__ID D0U5GZ D0U5GZ DRUGCOMP SciClone Pharmaceuticals D0U5GZ HIGHSTAT Phase 3 D0U7AH DRUG__ID D0U7AH D0U7AH DRUGCOMP Brainstorm Cell Therapeutics Hackensack, NJ D0U7AH HIGHSTAT Phase 3 D0U8CR DRUG__ID D0U8CR D0U8CR DRUGCOMP Servier D0U8CR HIGHSTAT Phase 3 D0U8YK DRUG__ID D0U8YK D0U8YK DRUGCOMP Novo Nordisk D0U8YK HIGHSTAT Phase 3 D0U8ZD DRUG__ID D0U8ZD D0U8ZD DRUGCOMP Optimer Biotechnology D0U8ZD HIGHSTAT Phase 3 D0UE8P DRUG__ID D0UE8P D0UE8P DRUGCOMP Biomay AG D0UE8P HIGHSTAT Phase 3 D0UH7R DRUG__ID D0UH7R D0UH7R DRUGCOMP GenentechSouth San Francisco, CA D0UH7R HIGHSTAT Phase 3 D0UI3Z DRUG__ID D0UI3Z D0UI3Z DRUGCOMP Hualan Biological Engineering Inc D0UI3Z HIGHSTAT Phase 3 D0UK2N DRUG__ID D0UK2N D0UK2N DRUGCOMP Avicena Group Inc D0UK2N HIGHSTAT Phase 3 D0UK2Z DRUG__ID D0UK2Z D0UK2Z DRUGCOMP Agenus D0UK2Z HIGHSTAT Phase 3 D0UL0R DRUG__ID D0UL0R D0UL0R DRUGCOMP Bukwang Pharmaceutical Co Ltd D0UL0R HIGHSTAT Phase 3 D0UQ5B DRUG__ID D0UQ5B D0UQ5B DRUGCOMP Glaxosmithkline D0UQ5B HIGHSTAT Phase 3 D0UU4B DRUG__ID D0UU4B D0UU4B DRUGCOMP Cutanea Wayne, PA D0UU4B HIGHSTAT Phase 3 D0V0AF DRUG__ID D0V0AF D0V0AF DRUGCOMP Polynoma, San Diego, CA D0V0AF HIGHSTAT Phase 3 D0V0KJ DRUG__ID D0V0KJ D0V0KJ DRUGCOMP Mitsubishi Tanabe D0V0KJ HIGHSTAT Phase 3 D0V1FF DRUG__ID D0V1FF D0V1FF DRUGCOMP Allon Therapeutics Inc D0V1FF HIGHSTAT Phase 3 D0V1FP DRUG__ID D0V1FP D0V1FP DRUGCOMP RedHill Biopharma Tel-Aviv, Israel D0V1FP HIGHSTAT Phase 3 D0V2OL DRUG__ID D0V2OL D0V2OL DRUGCOMP Novo Nordisk D0V2OL HIGHSTAT Phase 3 D0V3LF DRUG__ID D0V3LF D0V3LF DRUGCOMP Cytori Therapeutics San Diego, CA D0V3LF HIGHSTAT Phase 3 D0V3WE DRUG__ID D0V3WE D0V3WE DRUGCOMP CJ Corp D0V3WE HIGHSTAT Phase 3 D0V3ZN DRUG__ID D0V3ZN D0V3ZN DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0V3ZN HIGHSTAT Phase 3 D0V6EC DRUG__ID D0V6EC D0V6EC DRUGCOMP Ikaria D0V6EC HIGHSTAT Phase 3 D0V6IM DRUG__ID D0V6IM D0V6IM DRUGCOMP Biotec Pharmacon D0V6IM HIGHSTAT Phase 3 D0V6SV DRUG__ID D0V6SV D0V6SV DRUGCOMP ViroMed Co Ltd D0V6SV HIGHSTAT Phase 3 D0V6ZC DRUG__ID D0V6ZC D0V6ZC DRUGCOMP NeuTec Pharma plc D0V6ZC HIGHSTAT Phase 3 D0V8GT DRUG__ID D0V8GT D0V8GT DRUGCOMP Elorac Inc D0V8GT HIGHSTAT Phase 3 D0V8KD DRUG__ID D0V8KD D0V8KD DRUGCOMP Hanall biopharma; medtronic D0V8KD HIGHSTAT Phase 3 D0V9WX DRUG__ID D0V9WX D0V9WX DRUGCOMP Karuna Pharmaceuticals Boston, MA D0V9WX HIGHSTAT Phase 3 D0VF3C DRUG__ID D0VF3C D0VF3C DRUGCOMP Nobelpharma Co Ltd D0VF3C HIGHSTAT Phase 3 D0VL3L DRUG__ID D0VL3L D0VL3L DRUGCOMP Promius Pharma Princeton, NJ D0VL3L HIGHSTAT Phase 3 D0VN3O DRUG__ID D0VN3O D0VN3O DRUGCOMP Biothera D0VN3O HIGHSTAT Phase 3 D0VW4J DRUG__ID D0VW4J D0VW4J DRUGCOMP Neos therapeutics D0VW4J HIGHSTAT Phase 3 D0VZ5B DRUG__ID D0VZ5B D0VZ5B DRUGCOMP Esperion Therapeutics Ann Arbor, MI D0VZ5B HIGHSTAT Phase 3 D0W4TG DRUG__ID D0W4TG D0W4TG DRUGCOMP Dynport vaccine company; u.s. department of defense D0W4TG HIGHSTAT Phase 3 D0W7PQ DRUG__ID D0W7PQ D0W7PQ DRUGCOMP Eleison Pharmaceuticals St. Petersburg, FL D0W7PQ HIGHSTAT Phase 3 D0W8MS DRUG__ID D0W8MS D0W8MS DRUGCOMP Allergy TherapeuticsWest Sussex, United Kingdom D0W8MS HIGHSTAT Phase 3 D0WG2R DRUG__ID D0WG2R D0WG2R DRUGCOMP Merck Kenilworth, NJ D0WG2R HIGHSTAT Phase 3 D0WL8I DRUG__ID D0WL8I D0WL8I DRUGCOMP CJ Corp D0WL8I HIGHSTAT Phase 3 D0WM6I DRUG__ID D0WM6I D0WM6I DRUGCOMP Instituto Bioclon Sa De CV D0WM6I HIGHSTAT Phase 3 D0WQ0R DRUG__ID D0WQ0R D0WQ0R DRUGCOMP Neovii Biotech Munich, Germany D0WQ0R HIGHSTAT Phase 3 D0WV4H DRUG__ID D0WV4H D0WV4H DRUGCOMP Panagin Pharmaceuticals Inc D0WV4H HIGHSTAT Phase 3 D0WZ0X DRUG__ID D0WZ0X D0WZ0X DRUGCOMP AllerganParsippany, NJAmgenThousand Oaks, CA D0WZ0X HIGHSTAT Phase 3 D0X0GB DRUG__ID D0X0GB D0X0GB DRUGCOMP Croma Pharma Leobendorf, Austria D0X0GB HIGHSTAT Phase 3 D0X2LQ DRUG__ID D0X2LQ D0X2LQ DRUGCOMP Luye america pharmaceuticals D0X2LQ HIGHSTAT Phase 3 D0X2LW DRUG__ID D0X2LW D0X2LW DRUGCOMP Chiron D0X2LW HIGHSTAT Phase 3 D0X3GA DRUG__ID D0X3GA D0X3GA DRUGCOMP Novo Nordisk D0X3GA HIGHSTAT Phase 3 D0X3HV DRUG__ID D0X3HV D0X3HV DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0X3HV HIGHSTAT Phase 3 D0X4NF DRUG__ID D0X4NF D0X4NF DRUGCOMP Advantagene D0X4NF HIGHSTAT Phase 3 D0X4TK DRUG__ID D0X4TK D0X4TK DRUGCOMP FKD Therapies Kuopio, Finland D0X4TK HIGHSTAT Phase 3 D0X5YN DRUG__ID D0X5YN D0X5YN DRUGCOMP Coherus Biosciences Redwood City, CA D0X5YN HIGHSTAT Phase 3 D0X6DE DRUG__ID D0X6DE D0X6DE DRUGCOMP AmVac AG D0X6DE HIGHSTAT Phase 3 D0X6XH DRUG__ID D0X6XH D0X6XH DRUGCOMP Cenomed BioSciences D0X6XH HIGHSTAT Phase 3 D0X8HB DRUG__ID D0X8HB D0X8HB DRUGCOMP Navidea biopharmaceuticals D0X8HB HIGHSTAT Phase 3 D0X9KB DRUG__ID D0X9KB D0X9KB DRUGCOMP Acer Therapeutics Cambridge, MA D0X9KB HIGHSTAT Phase 3 D0XF4B DRUG__ID D0XF4B D0XF4B DRUGCOMP Neoprobe Corp D0XF4B HIGHSTAT Phase 3 D0XK2N DRUG__ID D0XK2N D0XK2N DRUGCOMP Green Cross Corp D0XK2N HIGHSTAT Phase 3 D0XN5L DRUG__ID D0XN5L D0XN5L DRUGCOMP Aventis Behring LLC D0XN5L HIGHSTAT Phase 3 D0XP7T DRUG__ID D0XP7T D0XP7T DRUGCOMP Prothena Therapeutics South San Francisco, CA D0XP7T HIGHSTAT Phase 3 D0XR1B DRUG__ID D0XR1B D0XR1B DRUGCOMP Pfizer New York, NY D0XR1B HIGHSTAT Phase 3 D0XU3D DRUG__ID D0XU3D D0XU3D DRUGCOMP Ortho Dermatologics Raleigh, NC D0XU3D HIGHSTAT Phase 3 D0XV2U DRUG__ID D0XV2U D0XV2U DRUGCOMP Biogen Cambridge, MA D0XV2U HIGHSTAT Phase 3 D0XW8Y DRUG__ID D0XW8Y D0XW8Y DRUGCOMP Centrexion Therapeutics Boston, MA D0XW8Y HIGHSTAT Phase 3 D0Y1FG DRUG__ID D0Y1FG D0Y1FG DRUGCOMP MolMedMilan, Italy D0Y1FG HIGHSTAT Phase 3 D0Y1ZU DRUG__ID D0Y1ZU D0Y1ZU DRUGCOMP Chugai Pharmaceutical Co Ltd D0Y1ZU HIGHSTAT Phase 3 D0Y2RF DRUG__ID D0Y2RF D0Y2RF DRUGCOMP Abbvie D0Y2RF HIGHSTAT Phase 3 D0Y2SE DRUG__ID D0Y2SE D0Y2SE DRUGCOMP Pharming Group NV D0Y2SE HIGHSTAT Phase 3 D0Y3TY DRUG__ID D0Y3TY D0Y3TY DRUGCOMP Promius Pharma LLC D0Y3TY HIGHSTAT Phase 3 D0Y6DO DRUG__ID D0Y6DO D0Y6DO DRUGCOMP Center for Genetic Engineering and Biotechnology D0Y6DO HIGHSTAT Phase 3 D0Y7VP DRUG__ID D0Y7VP D0Y7VP DRUGCOMP Versartis D0Y7VP HIGHSTAT Phase 3 D0Y8IE DRUG__ID D0Y8IE D0Y8IE DRUGCOMP Aerie Pharmaceuticals Inc D0Y8IE HIGHSTAT Phase 3 D0Y8ND DRUG__ID D0Y8ND D0Y8ND DRUGCOMP Sol-Gel Technologies Ness Ziona, Israel D0Y8ND HIGHSTAT Phase 3 D0Y9BX DRUG__ID D0Y9BX D0Y9BX DRUGCOMP Andromeda Biotech D0Y9BX HIGHSTAT Phase 3 D0Y9GF DRUG__ID D0Y9GF D0Y9GF DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D0Y9GF HIGHSTAT Phase 3 D0Y9TQ DRUG__ID D0Y9TQ D0Y9TQ DRUGCOMP Biotest AG D0Y9TQ HIGHSTAT Phase 3 D0Y9YN DRUG__ID D0Y9YN D0Y9YN DRUGCOMP Vical D0Y9YN HIGHSTAT Phase 3 D0YO4C DRUG__ID D0YO4C D0YO4C DRUGCOMP Xbiotech D0YO4C HIGHSTAT Phase 3 D0YO6R DRUG__ID D0YO6R D0YO6R DRUGCOMP AdvaxisPrinceton, NJBristol Myers-Squibb Princeton, NJ D0YO6R HIGHSTAT Phase 3 D0Z0MI DRUG__ID D0Z0MI D0Z0MI DRUGCOMP Actinium Pharmaceuticals New York, NY D0Z0MI HIGHSTAT Phase 3 D0Z0NX DRUG__ID D0Z0NX D0Z0NX DRUGCOMP Arbor Pharmaceuticals Atlanta, GA D0Z0NX HIGHSTAT Phase 3 D0Z3ES DRUG__ID D0Z3ES D0Z3ES DRUGCOMP University of Virginia D0Z3ES HIGHSTAT Phase 3 D0Z4VX DRUG__ID D0Z4VX D0Z4VX DRUGCOMP Boehringer ingelheim pharmaceuticals D0Z4VX HIGHSTAT Phase 3 D0Z5SC DRUG__ID D0Z5SC D0Z5SC DRUGCOMP Sanofi pasteur D0Z5SC HIGHSTAT Phase 3 D0Z5TW DRUG__ID D0Z5TW D0Z5TW DRUGCOMP Laboratorios Leti SL D0Z5TW HIGHSTAT Phase 3 D0Z5UT DRUG__ID D0Z5UT D0Z5UT DRUGCOMP Bellerophon Therapeutics Warren, NJ D0Z5UT HIGHSTAT Phase 3 D0Z6SP DRUG__ID D0Z6SP D0Z6SP DRUGCOMP Gilead Sciences Foster City, CA D0Z6SP HIGHSTAT Phase 3 D0Z7UN DRUG__ID D0Z7UN D0Z7UN DRUGCOMP Omninvest D0Z7UN HIGHSTAT Phase 3 D0Z8LN DRUG__ID D0Z8LN D0Z8LN DRUGCOMP Janssen Vaccines & Prevention Leiden, Netherlands D0Z8LN HIGHSTAT Phase 3 D0Z8MC DRUG__ID D0Z8MC D0Z8MC DRUGCOMP Revance Therapeutics D0Z8MC HIGHSTAT Phase 3 D0ZH4J DRUG__ID D0ZH4J D0ZH4J DRUGCOMP Moberg Pharma Bromma, Sweden D0ZH4J HIGHSTAT Phase 3 D0ZM8F DRUG__ID D0ZM8F D0ZM8F DRUGCOMP Astellas D0ZM8F HIGHSTAT Phase 3 D0ZO2Z DRUG__ID D0ZO2Z D0ZO2Z DRUGCOMP Boehringer-Ingelheim Pharmaceuticals Ridgefield, CT Eli Lilly Indianapolis, IN D0ZO2Z HIGHSTAT Phase 3 D0ZP3Q DRUG__ID D0ZP3Q D0ZP3Q DRUGCOMP CEL-SCI Vienna, VA D0ZP3Q HIGHSTAT Phase 3 D0ZR8T DRUG__ID D0ZR8T D0ZR8T DRUGCOMP EMD Serono, Rockland, MA D0ZR8T HIGHSTAT Phase 3 D1KR3N DRUG__ID D1KR3N D1KR3N DRUGCOMP Green Valley Pharmaceuticals Shanghai, China D1KR3N HIGHSTAT Phase 3 D2GZM3 DRUG__ID D2GZM3 D2GZM3 DRUGCOMP EirGenix Taipei, Taiwan Sandoz Princeton, NJ D2GZM3 HIGHSTAT Phase 3 D2TH9K DRUG__ID D2TH9K D2TH9K DRUGCOMP TB D2TH9K HIGHSTAT Phase 3 D3G8YH DRUG__ID D3G8YH D3G8YH DRUGCOMP Noven Pharmaceuticals Tokyo, Japan D3G8YH HIGHSTAT Phase 3 D3N5TB DRUG__ID D3N5TB D3N5TB DRUGTYPE Peptide D3N5TB HIGHSTAT Phase 3 D4MO2K DRUG__ID D4MO2K D4MO2K DRUGCOMP FirstString Research D4MO2K HIGHSTAT Phase 3 D4R1JE DRUG__ID D4R1JE D4R1JE DRUGCOMP Taiwan Liposome Company Taipei, Taiwan D4R1JE HIGHSTAT Phase 3 D5VRX2 DRUG__ID D5VRX2 D5VRX2 DRUGCOMP Chimerix D5VRX2 HIGHSTAT Phase 3 D6X7KR DRUG__ID D6X7KR D6X7KR DRUGCOMP G&E Herbal Biotechnology D6X7KR HIGHSTAT Phase 3 D71LNO DRUG__ID D71LNO D71LNO DRUGCOMP Hyundai Pharmaceutical D71LNO HIGHSTAT Phase 3 D78CME DRUG__ID D78CME D78CME DRUGCOMP Tavanta Therapeutics King of Prussia, PA D78CME HIGHSTAT Phase 3 D7H3AQ DRUG__ID D7H3AQ D7H3AQ DRUGCOMP PRM Pharma D7H3AQ HIGHSTAT Phase 3 D9YW6X DRUG__ID D9YW6X D9YW6X DRUGCOMP Biospherics.net D9YW6X HIGHSTAT Phase 3 DAN2C4 DRUG__ID DAN2C4 DAN2C4 DRUGCOMP Synlogic Cambridge, MA DAN2C4 HIGHSTAT Phase 3 DB58KR DRUG__ID DB58KR DB58KR DRUGCOMP Retrotope DB58KR HIGHSTAT Phase 3 DC9MH1 DRUG__ID DC9MH1 DC9MH1 DRUGCOMP Xuanwu Hospital, Beijing DC9MH1 HIGHSTAT Phase 3 DDRX30 DRUG__ID DDRX30 DDRX30 DRUGCOMP Aravive DDRX30 HIGHSTAT Phase 3 DF86OC DRUG__ID DF86OC DF86OC DRUGCOMP Novo Nordisk DF86OC HIGHSTAT Phase 3 DFB62M DRUG__ID DFB62M DFB62M DRUGCOMP Delcath Systems DFB62M HIGHSTAT Phase 3 DH5T8D DRUG__ID DH5T8D DH5T8D DRUGCOMP Ionis DH5T8D HIGHSTAT Phase 3 DIN27R DRUG__ID DIN27R DIN27R DRUGCOMP CEL-SCI DIN27R HIGHSTAT Phase 3 DJ43UK DRUG__ID DJ43UK DJ43UK DRUGCOMP Alexion AstraZeneca Rare Disease DJ43UK HIGHSTAT Phase 3 DKI03V DRUG__ID DKI03V DKI03V DRUGCOMP Ovid Therapeutics DKI03V HIGHSTAT Phase 3 DM6KV2 DRUG__ID DM6KV2 DM6KV2 DRUGTYPE Antibody DM6KV2 HIGHSTAT Phase 3 DMOV12 DRUG__ID DMOV12 DMOV12 DRUGCOMP Ionis DMOV12 HIGHSTAT Phase 3 DPT90B DRUG__ID DPT90B DPT90B DRUGTYPE Antibody DPT90B HIGHSTAT Phase 3 DRZ84W DRUG__ID DRZ84W DRZ84W DRUGCOMP Novartis DRZ84W HIGHSTAT Phase 3 DULR78 DRUG__ID DULR78 DULR78 DRUGCOMP PegBio DULR78 HIGHSTAT Phase 3 DV3H6T DRUG__ID DV3H6T DV3H6T DRUGTYPE Small molecular drug DV3H6T HIGHSTAT Phase 3 DZ2B3I DRUG__ID DZ2B3I DZ2B3I DRUGCOMP 89bio DZ2B3I HIGHSTAT Phase 3 DZBJ64 DRUG__ID DZBJ64 DZBJ64 DRUGCOMP Xenikos DZBJ64 HIGHSTAT Phase 3 D01CGX DRUG__ID D01CGX D01CGX HIGHSTAT Phase 3 D01SPW DRUG__ID D01SPW D01SPW HIGHSTAT Phase 3 D02HJR DRUG__ID D02HJR D02HJR HIGHSTAT Phase 3 D04EVE DRUG__ID D04EVE D04EVE HIGHSTAT Phase 3 D05KKC DRUG__ID D05KKC D05KKC HIGHSTAT Phase 3 D05UAV DRUG__ID D05UAV D05UAV HIGHSTAT Phase 3 D06VFP DRUG__ID D06VFP D06VFP HIGHSTAT Phase 3 D06XDI DRUG__ID D06XDI D06XDI HIGHSTAT Phase 3 D07UQQ DRUG__ID D07UQQ D07UQQ HIGHSTAT Phase 3 D09LIZ DRUG__ID D09LIZ D09LIZ HIGHSTAT Phase 3 D09VFX DRUG__ID D09VFX D09VFX HIGHSTAT Phase 3 D0A8JP DRUG__ID D0A8JP D0A8JP HIGHSTAT Phase 3 D0E1AW DRUG__ID D0E1AW D0E1AW HIGHSTAT Phase 3 D0ER5F DRUG__ID D0ER5F D0ER5F HIGHSTAT Phase 3 D0I3GZ DRUG__ID D0I3GZ D0I3GZ HIGHSTAT Phase 3 D0J0FD DRUG__ID D0J0FD D0J0FD HIGHSTAT Phase 3 D0K8WJ DRUG__ID D0K8WJ D0K8WJ HIGHSTAT Phase 3 D0M0TV DRUG__ID D0M0TV D0M0TV HIGHSTAT Phase 3 D0N3SA DRUG__ID D0N3SA D0N3SA HIGHSTAT Phase 3 D0Q4GL DRUG__ID D0Q4GL D0Q4GL HIGHSTAT Phase 3 D0Q7QA DRUG__ID D0Q7QA D0Q7QA HIGHSTAT Phase 3 D0Q9HM DRUG__ID D0Q9HM D0Q9HM HIGHSTAT Phase 3 D0R4OI DRUG__ID D0R4OI D0R4OI HIGHSTAT Phase 3 D0V6AB DRUG__ID D0V6AB D0V6AB HIGHSTAT Phase 3 D0W8CW DRUG__ID D0W8CW D0W8CW HIGHSTAT Phase 3 D0G0TS DRUG__ID D0G0TS D0G0TS DRUGCOMP Sanofi-aventis D0G0TS THERCLAS Anticancer Agents D0G0TS DRUGTYPE Small molecular drug D0G0TS DRUGINCH 1S/C32H31ClN4O5/c1-41-27-4-3-5-28(42-2)29(27)26-16-24(36-37(26)25-8-9-34-23-15-21(33)6-7-22(23)25)30(38)35-32(31(39)40)19-11-17-10-18(13-19)14-20(32)12-17/h3-9,15-20H,10-14H2,1-2H3,(H,35,38)(H,39,40) D0G0TS DRUGINKE DYLJVOXRWLXDIG-UHFFFAOYSA-N D0G0TS DRUGSMIL COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O D0G0TS HIGHSTAT Phase 2/3 D0M3TZ DRUG__ID D0M3TZ D0M3TZ DRUGCOMP Hoffmann-La Roche pharmaceutical company D0M3TZ THERCLAS Antiviral Agents D0M3TZ DRUGTYPE Small molecular drug D0M3TZ DRUGINCH 1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2 D0M3TZ DRUGINKE XEEQGYMUWCZPDN-UHFFFAOYSA-N D0M3TZ DRUGSMIL C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O D0M3TZ HIGHSTAT Phase 2/3 Trial D00GZW DRUG__ID D00GZW D00GZW DRUGCOMP Ono Pharmaceuticals D00GZW DRUGTYPE Small molecular drug D00GZW DRUGINCH 1S/C11H22O2/c1-3-5-6-7-9-10(8-4-2)11(12)13/h10H,3-9H2,1-2H3,(H,12,13)/t10-/m1/s1 D00GZW DRUGINKE YCYMCMYLORLIJX-SNVBAGLBSA-N D00GZW DRUGSMIL CCCCCCC(CCC)C(=O)O D00GZW HIGHSTAT Phase 2/3 D00NYJ DRUG__ID D00NYJ D00NYJ DRUGCOMP ASLAN Pharmaceuticals D00NYJ DRUGTYPE Small molecular drug D00NYJ DRUGINCH 1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1 D00NYJ DRUGINKE UWXSAYUXVSFDBQ-CYBMUJFWSA-N D00NYJ DRUGSMIL CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl D00NYJ HIGHSTAT Phase 2/3 D01AYX DRUG__ID D01AYX D01AYX DRUGCOMP AstraZeneca D01AYX DRUGTYPE Small molecular drug D01AYX DRUGINCH 1S/C26H28N4O/c1-4-5-18-12-21(16-28-15-18)19-6-7-20-14-25(10-8-22(31-3)9-11-25)26(23(20)13-19)29-17(2)24(27)30-26/h6-7,12-13,15-16,22H,8-11,14H2,1-3H3,(H2,27,30) D01AYX DRUGINKE WKDNQONLGXOZRG-UHFFFAOYSA-N D01AYX DRUGSMIL CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2 D01AYX HIGHSTAT Phase 2/3 D02LPY DRUG__ID D02LPY D02LPY DRUGCOMP Anthera Pharmaceuticals D02LPY DRUGTYPE Small molecular drug D02LPY DRUGINCH 1S/C16H15N3OS2/c1-11-14(22-16(18-11)19-15(17)21)13(20)10-6-5-9-12-7-3-2-4-8-12/h2-10H,1H3,(H3,17,18,19,21)/b9-5+,10-6+ D02LPY DRUGINKE BOEHSSIGBYYFMA-NXZHAISVSA-N D02LPY DRUGSMIL CC1=C(SC(=N1)NC(=S)N)C(=O)C=CC=CC2=CC=CC=C2 D02LPY HIGHSTAT Phase 2/3 D03DHQ DRUG__ID D03DHQ D03DHQ DRUGCOMP Cortex D03DHQ DRUGTYPE Small molecular drug D03DHQ DRUGINCH 1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2 D03DHQ DRUGINKE ANDGGVOPIJEHOF-UHFFFAOYSA-N D03DHQ DRUGSMIL C1CCN(CC1)C(=O)C2=CC3=NC=CN=C3C=C2 D03DHQ HIGHSTAT Phase 2/3 D03OSG DRUG__ID D03OSG D03OSG DRUGCOMP Metabolex D03OSG DRUGTYPE Small molecular drug D03OSG DRUGINCH 1S/C21H23F3O5S/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26/h4-10,17H,3,11-13H2,1-2H3,(H,25,26)/t17-/m1/s1 D03OSG DRUGINKE JWHYSEDOYMYMNM-QGZVFWFLSA-N D03OSG DRUGSMIL CCOC(COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C D03OSG HIGHSTAT Phase 2/3 D04DFR DRUG__ID D04DFR D04DFR DRUGCOMP Flexion Therapeutics D04DFR DRUGTYPE Small molecular drug D04DFR DRUGINCH 1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19) D04DFR DRUGINKE TXEIIPDJKFWEEC-UHFFFAOYSA-N D04DFR DRUGSMIL C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl D04DFR HIGHSTAT Phase 2/3 D04FUG DRUG__ID D04FUG D04FUG DRUGCOMP Insmed Bridgewater, NJ D04FUG DRUGTYPE Small molecule D04FUG DRUGINCH InChI=1S/C39H66O5/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-19-26-43-39(42)30-44-38-23-20-21-31-27-35-32(28-36(31)38)29-37(41)34(35)25-24-33(40)22-18-6-4-2/h20-21,23,32-35,37,40-41H,3-19,22,24-30H2,1-2H3/t32-,33-,34+,35-,37+/m0/s1 D04FUG DRUGINKE XOKCXRVJBBLBSX-HDMCCQRMSA-N D04FUG DRUGSMIL CCCCCCCCCCCCCCCCOC(=O)COC1=CC=CC2=C1CC3CC(C(C3C2)CCC(CCCCC)O)O D04FUG HIGHSTAT Phase 2/3 D04QWQ DRUG__ID D04QWQ D04QWQ DRUGCOMP Vertex Pharmaceuticals D04QWQ DRUGTYPE Small molecular drug D04QWQ DRUGINCH 1S/C18H19F3N6O/c1-3-17(2,16(28)25-10-18(19,20)21)27-13-6-8-23-15(26-13)12-9-24-14-11(12)5-4-7-22-14/h4-9H,3,10H2,1-2H3,(H,22,24)(H,25,28)(H,23,26,27)/t17-/m1/s1 D04QWQ DRUGINKE ASUGUQWIHMTFJL-QGZVFWFLSA-N D04QWQ DRUGSMIL CCC(C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3 D04QWQ HIGHSTAT Phase 2/3 D04XEQ DRUG__ID D04XEQ D04XEQ DRUGCOMP Geron D04XEQ DRUGTYPE Small molecular drug D04XEQ DRUGINCH 1S/C148H211N68O53P13S13/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-97(218)160-34-69(217)38-255-282(242,295)256-51-95-74(25-102(261-95)207-37-68(4)136(221)191-148(207)229)195-274(234,287)249-45-89-78(29-106(264-89)212-61-175-115-124(155)165-56-170-129(115)212)199-277(237,290)252-48-92-81(32-109(267-92)215-64-178-118-132(215)183-143(158)187-139(118)224)202-280(240,293)254-50-94-82(33-110(269-94)216-65-179-119-133(216)184-144(159)188-140(119)225)203-281(241,294)253-49-93-79(30-107(268-93)213-62-176-116-130(213)181-141(156)185-137(116)222)200-278(238,291)246-42-86-72(23-100(260-86)205-35-66(2)134(219)189-146(205)227)193-272(232,285)245-41-85-73(24-101(259-85)206-36-67(3)135(220)190-147(206)228)194-273(233,286)248-44-88-77(28-105(263-88)211-60-174-114-123(154)164-55-169-128(114)211)198-276(236,289)251-47-91-80(31-108(266-91)214-63-177-117-131(214)182-142(157)186-138(117)223)201-279(239,292)250-46-90-76(27-104(265-90)210-59-173-113-122(153)163-54-168-127(113)210)197-275(235,288)244-40-84-71(22-99(258-84)204-20-19-96(150)180-145(204)226)192-271(231,284)247-43-87-75(26-103(262-87)209-58-172-112-121(152)162-53-167-126(112)209)196-270(230,283)243-39-83-70(149)21-98(257-83)208-57-171-111-120(151)161-52-166-125(111)208/h19-20,35-37,52-65,69-95,98-110,217H,5-18,21-34,38-51,149H2,1-4H3,(H,160,218)(H,242,295)(H2,150,180,226)(H2,151,161,166)(H2,152,162,167)(H2,153,163,168)(H2,154,164,169)(H2,155,165,170)(H,189,219,227)(H,190,220,228)(H,191,221,229)(H2,192,231,284)(H2,193,232,285)(H2,194,233,286)(H2,195,234,287)(H2,196,230,283)(H2,197,235,288)(H2,198,236,289)(H2,199,237,290)(H2,200,238,291)(H2,201,239,292)(H2,202,240,293)(H2,203,241,294)(H3,156,181,185,222)(H3,157,182,186,223)(H3,158,183,187,224)(H3,159,184,188,225)/t69?,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,270?,271?,272?,273?,274?,275?,276?,277?,278?,279?,280?,281?,282?/m0/s1 D04XEQ DRUGINKE LVZYXEALRXBLJZ-ISQYCPACSA-N D04XEQ DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)N)S)O D04XEQ HIGHSTAT Phase 2/3 D06CYI DRUG__ID D06CYI D06CYI THERCLAS Antiviral Agents D06CYI DRUGTYPE Small molecular drug D06CYI DRUGINCH 1S/NO/c1-2 D06CYI DRUGINKE MWUXSHHQAYIFBG-UHFFFAOYSA-N D06CYI DRUGSMIL [N]=O D06CYI HIGHSTAT Phase 2/3 Trial D06DKU DRUG__ID D06DKU D06DKU THERCLAS Antiviral Agents D06DKU DRUGTYPE Small molecular drug D06DKU DRUGINCH 1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3 D06DKU DRUGINKE IYIKLHRQXLHMJQ-UHFFFAOYSA-N D06DKU DRUGSMIL CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I D06DKU HIGHSTAT Phase 2/3 Trial D06ECJ DRUG__ID D06ECJ D06ECJ THERCLAS Antiviral Agents D06ECJ DRUGTYPE Small molecular drug D06ECJ DRUGINCH 1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3 D06ECJ DRUGINKE SGTNSNPWRIOYBX-UHFFFAOYSA-N D06ECJ DRUGSMIL CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC D06ECJ HIGHSTAT Phase 2/3 Trial D06GYY DRUG__ID D06GYY D06GYY THERCLAS Antiviral Agents D06GYY DRUGTYPE Small molecular drug D06GYY DRUGINCH 1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3 D06GYY DRUGINKE UYNVMODNBIQBMV-UHFFFAOYSA-N D06GYY DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3 D06GYY HIGHSTAT Phase 2/3 Trial D06OZW DRUG__ID D06OZW D06OZW DRUGCOMP Hong Kong University of Science & Technology D06OZW DRUGTYPE Small molecular drug D06OZW DRUGINCH 1S/C19H31NO6S/c1-12-4-5-15-13(2)16(20-8-10-27(21,22)11-9-20)23-17-19(15)14(12)6-7-18(3,24-17)25-26-19/h12-17H,4-11H2,1-3H3/t12-,13-,14+,15+,16-,17-,18-,19-/m1/s1 D06OZW DRUGINKE FDMUNKXWYMSZIR-NQWKWHCYSA-N D06OZW DRUGSMIL CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)N5CCS(=O)(=O)CC5)C D06OZW HIGHSTAT Phase 2/3 D06TFI DRUG__ID D06TFI D06TFI DRUGCOMP Eli Lilly D06TFI DRUGTYPE Small molecular drug D06TFI DRUGINCH 1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28) D06TFI DRUGINKE IVRXNBXKWIJUQB-UHFFFAOYSA-N D06TFI DRUGSMIL CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N D06TFI HIGHSTAT Phase 2/3 D06VCN DRUG__ID D06VCN D06VCN DRUGCOMP Glaxo Smithkline D06VCN DRUGTYPE Small molecular drug D06VCN DRUGINCH 1S/C20H18F3N3O/c21-14-5-1-12(2-6-14)18(13-3-7-15(22)8-4-13)19(25)20(27)26-11-16(23)9-17(26)10-24/h1-8,16-19H,9,11,25H2/t16-,17-,19-/m0/s1 D06VCN DRUGINKE URRAHSMDPCMOTH-LNLFQRSKSA-N D06VCN DRUGSMIL C1C(CN(C1C#N)C(=O)C(C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)N)F D06VCN HIGHSTAT Phase 2/3 D06ZXH DRUG__ID D06ZXH D06ZXH DRUGCOMP PhytoHealth Corp D06ZXH DRUGTYPE Small molecular drug D06ZXH DRUGINCH 1S/C21H27NO4.ClH/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12;/h4-5,12,15-16,19,23-25H,1-3,6-11H2;1H/t15-,16+,19-,20-,21+;/m0./s1 D06ZXH DRUGINKE YZLZPSJXMWGIFH-BCXQGASESA-N D06ZXH DRUGSMIL C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O.Cl D06ZXH HIGHSTAT Phase 2/3 D07JLM DRUG__ID D07JLM D07JLM DRUGCOMP Synvista Therapeutics Inc D07JLM DRUGTYPE Small molecular drug D07JLM DRUGINCH 1S/C13H14NOS.ClH/c1-10-11(2)16-9-14(10)8-13(15)12-6-4-3-5-7-12;/h3-7,9H,8H2,1-2H3;1H/q+1;/p-1 D07JLM DRUGINKE MKOMESMZHZNBIZ-UHFFFAOYSA-M D07JLM DRUGSMIL CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C.[Cl-] D07JLM HIGHSTAT Phase 2/3 D07WQT DRUG__ID D07WQT D07WQT THERCLAS Antiviral Agents D07WQT DRUGTYPE Small molecular drug D07WQT DRUGINCH 1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 D07WQT DRUGINKE AZSNMRSAGSSBNP-XPNPUAGNSA-N D07WQT DRUGSMIL CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C D07WQT HIGHSTAT Phase 2/3 Trial D08FUR DRUG__ID D08FUR D08FUR THERCLAS Antiviral Agents D08FUR DRUGTYPE Small molecular drug D08FUR DRUGINCH 1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25) D08FUR DRUGINKE XPRDUGXOWVXZLL-UHFFFAOYSA-N D08FUR DRUGSMIL COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F D08FUR HIGHSTAT Phase 2/3 Trial D08FWK DRUG__ID D08FWK D08FWK DRUGCOMP Johns Hopkins University D08FWK DRUGTYPE Small molecular drug D08FWK DRUGINCH 1S/C5H4N4O2/c10-4-2-1-6-9-3(2)7-5(11)8-4/h1H,(H3,6,7,8,9,10,11) D08FWK DRUGINKE HXNFUBHNUDHIGC-UHFFFAOYSA-N D08FWK DRUGSMIL C1=NNC2=C1C(=O)NC(=O)N2 D08FWK HIGHSTAT Phase 2/3 D08NAD DRUG__ID D08NAD D08NAD DRUGCOMP Tularik Inc D08NAD DRUGTYPE Small molecular drug D08NAD DRUGINCH 1S/C13H7F6NO3S/c1-23-7-3-2-5(4-6(7)14)20-24(21,22)13-11(18)9(16)8(15)10(17)12(13)19/h2-4,20H,1H3 D08NAD DRUGINKE ROZCIVXTLACYNY-UHFFFAOYSA-N D08NAD DRUGSMIL COC1=C(C=C(C=C1)NS(=O)(=O)C2=C(C(=C(C(=C2F)F)F)F)F)F D08NAD HIGHSTAT Phase 2/3 D09AHZ DRUG__ID D09AHZ D09AHZ DRUGCOMP Sanofi-aventis D09AHZ DRUGTYPE Small molecular drug D09AHZ DRUGINCH 1S/C34H47NO4/c1-6-9-14-31-32(29-24-28(19-20-30(29)39-31)34(37)38-25(4)5)33(36)27-17-15-26(16-18-27)13-12-23-35(21-10-7-2)22-11-8-3/h15-20,24-25H,6-14,21-23H2,1-5H3 D09AHZ DRUGINKE ZCENNVQCOZQSGH-UHFFFAOYSA-N D09AHZ DRUGSMIL CCCCC1=C(C2=C(O1)C=CC(=C2)C(=O)OC(C)C)C(=O)C3=CC=C(C=C3)CCCN(CCCC)CCCC D09AHZ HIGHSTAT Phase 2/3 D09PVO DRUG__ID D09PVO D09PVO DRUGCOMP Galmed Medical Research Ltd D09PVO DRUGTYPE Small molecular drug D09PVO DRUGINCH 1S/C44H79NO5/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-40(48)45-34-27-28-43(3)33(29-34)30-38(46)42-36-25-24-35(32(2)23-26-41(49)50)44(36,4)39(47)31-37(42)43/h32-39,42,46-47H,5-31H2,1-4H3,(H,45,48)(H,49,50)/t32-,33+,34+,35-,36+,37+,38-,39+,42+,43+,44-/m1/s1 D09PVO DRUGINKE SHKXZIQNFMOPBS-OOMQYRRCSA-N D09PVO DRUGSMIL CCCCCCCCCCCCCCCCCCCC(=O)NC1CCC2(C(C1)CC(C3C2CC(C4(C3CCC4C(C)CCC(=O)O)C)O)O)C D09PVO HIGHSTAT Phase 2/3 D0A5BT DRUG__ID D0A5BT D0A5BT THERCLAS Antiviral Agents D0A5BT DRUGTYPE Small molecular drug D0A5BT DRUGINCH 1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4) D0A5BT DRUGINKE FSEKIHNIDBATFG-UHFFFAOYSA-N D0A5BT DRUGSMIL CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O D0A5BT HIGHSTAT Phase 2/3 Trial D0A7CO DRUG__ID D0A7CO D0A7CO THERCLAS Antiviral Agents D0A7CO DRUGTYPE Small molecular drug D0A7CO DRUGINCH 1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54) D0A7CO DRUGINKE HTTJABKRGRZYRN-UHFFFAOYSA-N D0A7CO DRUGSMIL CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O D0A7CO HIGHSTAT Phase 2/3 Trial D0AL8T DRUG__ID D0AL8T D0AL8T DRUGCOMP Parke-Davis & Co D0AL8T DRUGTYPE Small molecular drug D0AL8T DRUGINCH 1S/C18H24N2O2S/c1-17(2,3)11-7-10(8-12(14(11)21)18(4,5)6)9-13-15(22)20-16(19)23-13/h7-9,21H,1-6H3,(H2,19,20,22)/b13-9- D0AL8T DRUGINKE AKTXOQVMWSFEBQ-LCYFTJDESA-N D0AL8T DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N=C(S2)N D0AL8T HIGHSTAT Phase 2/3 D0B5HS DRUG__ID D0B5HS D0B5HS DRUGCOMP NewLink Genetics D0B5HS DRUGTYPE Small molecular drug D0B5HS DRUGINCH 1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16)/t10-/m1/s1 D0B5HS DRUGINKE ZADWXFSZEAPBJS-SNVBAGLBSA-N D0B5HS DRUGSMIL CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N D0B5HS HIGHSTAT Phase 2/3 D0E3MA DRUG__ID D0E3MA D0E3MA DRUGCOMP ReProtect D0E3MA DRUGTYPE Small molecular drug D0E3MA DRUGINCH 1S/C3H4O2/c1-2-3(4)5/h2H,1H2,(H,4,5) D0E3MA DRUGINKE NIXOWILDQLNWCW-UHFFFAOYSA-N D0E3MA DRUGSMIL C=CC(=O)O D0E3MA HIGHSTAT Phase 2/3 D0F2PD DRUG__ID D0F2PD D0F2PD DRUGCOMP Biorex Research and Development Co D0F2PD DRUGTYPE Small molecular drug D0F2PD DRUGINCH 1S/C14H20ClN3O3/c15-14(12-5-4-8-18(20)9-12)16-21-11-13(19)10-17-6-2-1-3-7-17/h4-5,8-9,13,19H,1-3,6-7,10-11H2/b16-14-/t13-/m1/s1 D0F2PD DRUGINKE SGEIEGAXKLMUIZ-XUVDNFPMSA-N D0F2PD DRUGSMIL C1CCN(CC1)CC(CON=C(C2=C[N+](=CC=C2)[O-])Cl)O D0F2PD HIGHSTAT Phase 2/3 D0F4JK DRUG__ID D0F4JK D0F4JK DRUGCOMP Pfizer Inc D0F4JK DRUGTYPE Small molecular drug D0F4JK DRUGINCH 1S/C22H29ClN4O6/c1-33-13-16(28)12-26-19(29)11-25-27(21(26)31)15-6-7-18(23)17(10-15)20(30)24-14-22(32)8-4-2-3-5-9-22/h6-7,10-11,16,28,32H,2-5,8-9,12-14H2,1H3,(H,24,30)/t16-/m1/s1 D0F4JK DRUGINKE FUCKCIVGBCBZNP-MRXNPFEDSA-N D0F4JK DRUGSMIL COCC(CN1C(=O)C=NN(C1=O)C2=CC(=C(C=C2)Cl)C(=O)NCC3(CCCCCC3)O)O D0F4JK HIGHSTAT Phase 2/3 D0FE8F DRUG__ID D0FE8F D0FE8F THERCLAS Antiviral Agents D0FE8F DRUGTYPE Small molecular drug D0FE8F DRUGINCH 1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1 D0FE8F DRUGINKE OVBPIULPVIDEAO-LBPRGKRZSA-N D0FE8F DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N D0FE8F HIGHSTAT Phase 2/3 Trial D0G0YL DRUG__ID D0G0YL D0G0YL DRUGCOMP Logical Therapeutics D0G0YL DRUGTYPE Small molecular drug D0G0YL DRUGINCH 1S/C17H20O5S/c1-12(17(18)22-8-9-23(3,19)20)13-4-5-15-11-16(21-2)7-6-14(15)10-13/h4-7,10-12H,8-9H2,1-3H3/t12-/m0/s1 D0G0YL DRUGINKE JGBUBSOKFSVXKS-LBPRGKRZSA-N D0G0YL DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OCCS(=O)(=O)C D0G0YL HIGHSTAT Phase 2/3 D0G5GY DRUG__ID D0G5GY D0G5GY THERCLAS Antiviral Agents D0G5GY DRUGTYPE Small molecular drug D0G5GY DRUGINCH 1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 D0G5GY DRUGINKE JWUBBDSIWDLEOM-DTOXIADCSA-N D0G5GY DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C D0G5GY HIGHSTAT Phase 2/3 Trial D0G5PF DRUG__ID D0G5PF D0G5PF DRUGCOMP Novartis D0G5PF DRUGTYPE Small molecular drug D0G5PF DRUGINCH 1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1 D0G5PF DRUGINKE ZFPZEYHRWGMJCV-ZHALLVOQSA-N D0G5PF DRUGSMIL CC1=CC(=CC=C1)C#CC2(CCCC3C2CCN3C(=O)OC)O D0G5PF HIGHSTAT Phase 2/3 D0G6XU DRUG__ID D0G6XU D0G6XU THERCLAS Antiviral Agents D0G6XU DRUGTYPE Small molecular drug D0G6XU DRUGINCH 1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16) D0G6XU DRUGINKE DRLFMBDRBRZALE-UHFFFAOYSA-N D0G6XU DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC D0G6XU HIGHSTAT Phase 2/3 Trial D0GC5H DRUG__ID D0GC5H D0GC5H DRUGCOMP Bayer Yakuhin D0GC5H DRUGTYPE Small molecular drug D0GC5H DRUGINCH 1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1 D0GC5H DRUGINKE LDXDSHIEDAPSSA-OAHLLOKOSA-N D0GC5H DRUGSMIL C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O D0GC5H HIGHSTAT Phase 2/3 D0GP1O DRUG__ID D0GP1O D0GP1O DRUGCOMP Acucela Seattle, WA D0GP1O DRUGTYPE Small molecular drug D0GP1O DRUGINCH 1S/C16H25NO2/c17-10-9-16(18)14-7-4-8-15(11-14)19-12-13-5-2-1-3-6-13/h4,7-8,11,13,16,18H,1-3,5-6,9-10,12,17H2/t16-/m1/s1 D0GP1O DRUGINKE WJIGGYYSZBWCGC-MRXNPFEDSA-N D0GP1O DRUGSMIL C1CCC(CC1)COC2=CC=CC(=C2)C(CCN)O D0GP1O HIGHSTAT Phase 2/3 D0I5TL DRUG__ID D0I5TL D0I5TL DRUGCOMP Addex Pharma. D0I5TL DRUGTYPE Small molecular drug D0I5TL DRUGINCH 1S/C16H12FN3/c17-13-8-9-16-19-15(12-20(16)11-13)7-2-1-5-14-6-3-4-10-18-14/h3-4,6,8-12H,2,7H2 D0I5TL DRUGINKE LZXMUJCJAWVHPZ-UHFFFAOYSA-N D0I5TL DRUGSMIL C1=CC=NC(=C1)C#CCCC2=CN3C=C(C=CC3=N2)F D0I5TL HIGHSTAT Phase 2/3 D0I8QT DRUG__ID D0I8QT D0I8QT THERCLAS Antiviral Agents D0I8QT DRUGTYPE Small molecular drug D0I8QT DRUGINCH 1S/C9H13N2O2/c1-10(2)9(12)13-8-5-4-6-11(3)7-8/h4-7H,1-3H3/q+1 D0I8QT DRUGINKE RVOLLAQWKVFTGE-UHFFFAOYSA-N D0I8QT DRUGSMIL C[N+]1=CC=CC(=C1)OC(=O)N(C)C D0I8QT HIGHSTAT Phase 2/3 Trial D0J3BY DRUG__ID D0J3BY D0J3BY DRUGCOMP Synvista Therapeutics D0J3BY DRUGTYPE Small molecular drug D0J3BY DRUGINCH 1S/CH6N4.ClH/c2-1(3)5-4;/h4H2,(H4,2,3,5);1H D0J3BY DRUGINKE UBDZFAGVPPMTIT-UHFFFAOYSA-N D0J3BY DRUGSMIL C(=[NH+]N)(N)N.[Cl-] D0J3BY HIGHSTAT Phase 2/3 D0KN1U DRUG__ID D0KN1U D0KN1U DRUGCOMP Sanifit Laboratoris SL D0KN1U DRUGTYPE Small molecular drug D0KN1U DRUGINCH 1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24) D0KN1U DRUGINKE IMQLKJBTEOYOSI-UHFFFAOYSA-N D0KN1U DRUGSMIL C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O D0KN1U HIGHSTAT Phase 2/3 D0L4FS DRUG__ID D0L4FS D0L4FS DRUGCOMP DSM Nutritional Products D0L4FS DRUGTYPE Small molecular drug D0L4FS DRUGINCH 1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H D0L4FS DRUGINKE TZBJGXHYKVUXJN-UHFFFAOYSA-N D0L4FS DRUGSMIL C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O D0L4FS HIGHSTAT Phase 2/3 D0NU0U DRUG__ID D0NU0U D0NU0U DRUGCOMP AstraZeneca D0NU0U DRUGTYPE Small molecular drug D0NU0U DRUGINCH 1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+ D0NU0U DRUGINKE VRQMAABPASPXMW-HDICACEKSA-N D0NU0U DRUGSMIL CC1CN(CC(N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC D0NU0U HIGHSTAT Phase 2/3 D0O0PY DRUG__ID D0O0PY D0O0PY DRUGCOMP Rhone-Poulenc SA D0O0PY DRUGTYPE Small molecular drug D0O0PY DRUGINCH 1S/C23H22ClN3O2/c1-14(2)7-10-16(28)13-19-17-5-3-4-6-18(17)23(29)27(19)21-12-9-15-8-11-20(24)25-22(15)26-21/h3-6,8-9,11-12,14,19H,7,10,13H2,1-2H3 D0O0PY DRUGINKE HIUPRQPBWVEQJJ-UHFFFAOYSA-N D0O0PY DRUGSMIL CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl D0O0PY HIGHSTAT Phase 2/3 D0PY5G DRUG__ID D0PY5G D0PY5G DRUGCOMP Seachaid Pharmaceuticals Inc D0PY5G DRUGTYPE Small molecular drug D0PY5G DRUGINCH 1S/C36H64N8O17/c1-6-39-25-29(28(22(14-46)59-35(25)57)61-36-24(42-18(5)47)27(50)26(49)21(13-45)60-36)58-17(4)32(53)40-15(2)31(52)44-19(30(38)51)10-11-23(48)43-20(9-7-8-12-37)33(54)41-16(3)34(55)56/h15-17,19-22,24-29,35-36,39,45-46,49-50,57H,6-14,37H2,1-5H3,(H2,38,51)(H,40,53)(H,41,54)(H,42,47)(H,43,48)(H,44,52)(H,55,56)/t15-,16+,17?,19-,20-,21-,22-,24-,25-,26-,27-,28-,29-,35?,36+/m1/s1 D0PY5G DRUGINKE DQJCDTNMLBYVAY-ZXXIYAEKSA-N D0PY5G DRUGSMIL CCNC1C(C(C(OC1O)CO)OC2C(C(C(C(O2)CO)O)O)NC(=O)C)OC(C)C(=O)NC(C)C(=O)NC(CCC(=O)NC(CCCCN)C(=O)NC(C)C(=O)O)C(=O)N D0PY5G HIGHSTAT Phase 2/3 D0Q6MY DRUG__ID D0Q6MY D0Q6MY THERCLAS Antiviral Agents D0Q6MY DRUGTYPE Small molecular drug D0Q6MY DRUGINCH 1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24) D0Q6MY DRUGINKE MQQNFDZXWVTQEH-UHFFFAOYSA-N D0Q6MY DRUGSMIL C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N D0Q6MY HIGHSTAT Phase 2/3 Trial D0U3LK DRUG__ID D0U3LK D0U3LK DRUGCOMP Laboratorios Silanes SA De CV D0U3LK DRUGTYPE Small molecular drug D0U3LK DRUGINCH 1S/C4H11N5.C2H5NO2/c1-9(2)4(7)8-3(5)6;3-1-2(4)5/h1-2H3,(H5,5,6,7,8);1,3H2,(H,4,5) D0U3LK DRUGINKE KOFRCHIVYXPUNL-UHFFFAOYSA-N D0U3LK DRUGSMIL CN(C)C(=N)N=C(N)N.C(C(=O)O)N D0U3LK HIGHSTAT Phase 2/3 D0W5EH DRUG__ID D0W5EH D0W5EH DRUGCOMP EMD Serono D0W5EH DRUGTYPE Small molecular drug D0W5EH DRUGINCH 1S/C22H21FN2O/c23-20-8-5-17(6-9-20)19-11-16(12-24-14-19)13-25-15-21-10-7-18-3-1-2-4-22(18)26-21/h1-6,8-9,11-12,14,21,25H,7,10,13,15H2/t21-/m1/s1 D0W5EH DRUGINKE HKFMQJUJWSFOLY-OAQYLSRUSA-N D0W5EH DRUGSMIL C1CC2=CC=CC=C2OC1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F D0W5EH HIGHSTAT Phase 2/3 D0X7VB DRUG__ID D0X7VB D0X7VB DRUGCOMP Metabolex D0X7VB DRUGTYPE Small molecular drug D0X7VB DRUGINCH 1S/C19H17ClF3NO4/c1-12(25)24-9-10-27-18(26)17(13-5-7-15(20)8-6-13)28-16-4-2-3-14(11-16)19(21,22)23/h2-8,11,17H,9-10H2,1H3,(H,24,25)/t17-/m1/s1 D0X7VB DRUGINKE BJBCSGQLZQGGIQ-QGZVFWFLSA-N D0X7VB DRUGSMIL CC(=O)NCCOC(=O)C(C1=CC=C(C=C1)Cl)OC2=CC=CC(=C2)C(F)(F)F D0X7VB HIGHSTAT Phase 2/3 D0Z9LP DRUG__ID D0Z9LP D0Z9LP DRUGCOMP RESprotect D0Z9LP DRUGTYPE Small molecular drug D0Z9LP DRUGINCH 1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1 D0Z9LP DRUGINKE ODZBBRURCPAEIQ-PIXDULNESA-N D0Z9LP DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)C=CBr)CO)O D0Z9LP HIGHSTAT Phase 2/3 D0ZM5O DRUG__ID D0ZM5O D0ZM5O DRUGCOMP Bristol-Myers Squibb D0ZM5O DRUGTYPE Small molecular drug D0ZM5O DRUGINCH 1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1 D0ZM5O DRUGINKE LBWQSAZEYIZZCE-SNVBAGLBSA-N D0ZM5O DRUGSMIL CCC(C)NC1=NC(=NC2=C(C(=NN21)C)C3=C(N=C(C=C3)OC)C)C D0ZM5O HIGHSTAT Phase 2/3 D4PL6G DRUG__ID D4PL6G D4PL6G DRUGCOMP BioNevia Pharmaceuticals D4PL6G DRUGTYPE Small molecular drug D4PL6G DRUGINCH 1S/2C15H13NO3S2.C5H14NO/c2*1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12;1-6(2,3)4-5-7/h2*2-8H,9H2,1H3,(H,17,18);7H,4-5H2,1-3H3/q;;+1/p-1/b2*10-7+,12-8-; D4PL6G DRUGINKE WKSNHZZSMLFYFI-UROVXFGGSA-M D4PL6G DRUGSMIL CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O.CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)[O-].C[N+](C)(C)CCO D4PL6G HIGHSTAT Phase 2/3 D58BFC DRUG__ID D58BFC D58BFC DRUGCOMP Cortexyme D58BFC DRUGTYPE Small molecule D58BFC DRUGINCH InChI=1S/C19H25F3N2O3/c20-13-8-9-14(21)18(17(13)22)27-11-16(25)15(7-3-4-10-23)24-19(26)12-5-1-2-6-12/h8-9,12,15H,1-7,10-11,23H2,(H,24,26)/t15-/m0/s1 D58BFC DRUGINKE OLIMBXKACVCIMM-HNNXBMFYSA-N D58BFC DRUGSMIL C1CCC(C1)C(=O)NC(CCCCN)C(=O)COC2=C(C=CC(=C2F)F)F D58BFC HIGHSTAT Phase 2/3 D5U4MY DRUG__ID D5U4MY D5U4MY DRUGCOMP Forma Therapeutics D5U4MY DRUGTYPE Small molecule D5U4MY DRUGINCH InChI=1S/C22H23N3O6S/c26-14-19(15-4-2-1-3-5-15)22(27)24-10-16-12-25(13-17(16)11-24)32(28,29)18-8-20-21(23-9-18)31-7-6-30-20/h1-5,8-9,19,26H,6-7,10-14H2/t19-/m1/s1 D5U4MY DRUGINKE KZFFYEPYCVDOGE-LJQANCHMSA-N D5U4MY DRUGSMIL C1COC2=C(O1)C=C(C=N2)S(=O)(=O)N3CC4=C(C3)CN(C4)C(=O)C(CO)C5=CC=CC=C5 D5U4MY HIGHSTAT Phase 2/3 D87IQS DRUG__ID D87IQS D87IQS DRUGCOMP AstraZeneca D87IQS DRUGTYPE Small molecule D87IQS DRUGINCH InChI=1S/C15H15ClN4OS/c1-8(17)11-6-10(16)3-2-9(11)7-20-12-4-5-18-13(12)14(21)19-15(20)22/h2-6,8,18H,7,17H2,1H3,(H,19,21,22)/t8-/m1/s1 D87IQS DRUGINKE BHKKSKOHRFHHIN-MRVPVSSYSA-N D87IQS DRUGSMIL CC(C1=C(C=CC(=C1)Cl)CN2C3=C(C(=O)NC2=S)NC=C3)N D87IQS HIGHSTAT Phase 2/3 DCA5M2 DRUG__ID DCA5M2 DCA5M2 DRUGCOMP UCB DCA5M2 DRUGTYPE Small molecular drug DCA5M2 DRUGINCH 1S/C14H14ClF5N4O2S/c1-26-6-9-22-24-8(11(14(18,19)20)21-12(24)27-9)5-23-4-7(2-10(23)25)3-13(15,16)17/h7H,2-6H2,1H3/t7-/m1/s1 DCA5M2 DRUGINKE DCXFIOLWWRXEQH-SSDOTTSWSA-N DCA5M2 DRUGSMIL COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3CC(CC3=O)CC(F)(F)Cl DCA5M2 HIGHSTAT Phase 2/3 DDBY18 DRUG__ID DDBY18 DDBY18 DRUGCOMP Athira Pharma DDBY18 DRUGTYPE Small molecule DDBY18 DRUGINCH InChI=1S/C27H45N4O8P/c1-4-6-8-12-24(33)30-22(18-20-13-15-21(16-14-20)39-40(36,37)38)26(34)31-25(19(3)5-2)27(35)29-17-10-7-9-11-23(28)32/h13-16,19,22,25H,4-12,17-18H2,1-3H3,(H2,28,32)(H,29,35)(H,30,33)(H,31,34)(H2,36,37,38)/t19-,22-,25-/m0/s1 DDBY18 DRUGINKE MBYDCPOKVKDSFD-JTJYXVOQSA-N DDBY18 DRUGSMIL CCCCCC(=O)NC(CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NC(C(C)CC)C(=O)NCCCCCC(=O)N DDBY18 HIGHSTAT Phase 2/3 DF29AZ DRUG__ID DF29AZ DF29AZ DRUGCOMP VA Office of Research and Development, University of Wisconsin, Madison DF29AZ DRUGTYPE Small molecule DF29AZ DRUGINCH InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17- DF29AZ DRUGINKE SSQPWTVBQMWLSZ-AAQCHOMXSA-N DF29AZ DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC DF29AZ HIGHSTAT Phase 2/3 DGJD82 DRUG__ID DGJD82 DGJD82 DRUGCOMP Presidio Pharmaceuticals DGJD82 DRUGTYPE Small molecular drug DGJD82 DRUGINCH 1S/C42H50N8O6/c1-23(2)35(47-41(53)55-5)39(51)49-17-7-9-33(49)37-43-22-32(46-37)29-14-13-25-19-26(11-12-27(25)20-29)28-15-16-30-31(21-28)45-38(44-30)34-10-8-18-50(34)40(52)36(24(3)4)48-42(54)56-6/h11-16,19-24,33-36H,7-10,17-18H2,1-6H3,(H,43,46)(H,44,45)(H,47,53)(H,48,54)/t33-,34-,35-,36-/m0/s1 DGJD82 DRUGINKE LCHMHYPWGWYXEL-ZYADHFCISA-N DGJD82 DRUGSMIL CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC DGJD82 HIGHSTAT Phase 2/3 DK5VM1 DRUG__ID DK5VM1 DK5VM1 DRUGCOMP Viriom DK5VM1 DRUGTYPE Small molecule DK5VM1 DRUGINCH InChI=1S/C21H13BrCl2FN3O4S/c22-16-3-1-12(20(25)21(16)32-14-6-11(10-26)5-13(23)8-14)7-19(29)28-18-4-2-15(9-17(18)24)33(27,30)31/h1-6,8-9H,7H2,(H,28,29)(H2,27,30,31) DK5VM1 DRUGINKE SBUUICLVCQQMFP-UHFFFAOYSA-N DK5VM1 DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)Cl)NC(=O)CC2=C(C(=C(C=C2)Br)OC3=CC(=CC(=C3)C#N)Cl)F DK5VM1 HIGHSTAT Phase 2/3 DU0K2R DRUG__ID DU0K2R DU0K2R DRUGCOMP Millendo Therapeutics DU0K2R DRUGTYPE Peptide DU0K2R DRUGINCH 1S/C40H63N15O13/c1-19(2)31-38(67)51-23(8-11-29(42)58)34(63)53-26(17-56)39(68)55-14-4-6-27(55)37(66)50-24(9-12-30(59)60)33(62)52-25(15-20-16-45-18-47-20)36(65)49-22(7-10-28(41)57)32(61)48-21(35(64)54-31)5-3-13-46-40(43)44/h16,18-19,21-27,31,56H,3-15,17H2,1-2H3,(H2,41,57)(H2,42,58)(H,45,47)(H,48,61)(H,49,65)(H,50,66)(H,51,67)(H,52,62)(H,53,63)(H,54,64)(H,59,60)(H4,43,44,46)/t21-,22-,23-,24-,25-,26-,27-,31-/m0/s1 DU0K2R DRUGINKE JXPWLIYXIWGWSA-CLBRJLNISA-N DU0K2R DRUGSMIL CC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N DU0K2R HIGHSTAT Phase 2/3 DUH2E6 DRUG__ID DUH2E6 DUH2E6 DRUGCOMP PTC Therapeutics South Plainfield, NJ DUH2E6 DRUGTYPE Small molecule DUH2E6 DRUGINCH InChI=1S/C19H13F5N6/c1-9-26-13-7-4-11(20)8-14(13)30(9)18-28-16(25)15(21)17(29-18)27-12-5-2-10(3-6-12)19(22,23)24/h2-8H,1H3,(H3,25,27,28,29) DUH2E6 DRUGINKE TWLWOOPCEXYVBE-UHFFFAOYSA-N DUH2E6 DRUGSMIL CC1=NC2=C(N1C3=NC(=C(C(=N3)NC4=CC=C(C=C4)C(F)(F)F)F)N)C=C(C=C2)F DUH2E6 HIGHSTAT Phase 2/3 DWR4I7 DRUG__ID DWR4I7 DWR4I7 DRUGCOMP Pfzer DWR4I7 DRUGTYPE Small molecule DWR4I7 DRUGINCH InChI=1S/C20H22N2O6/c23-9-6-17-15(3-2-7-21-17)20(26)22-8-10-27-12-14(22)13-28-19-5-1-4-18(25)16(19)11-24/h1-5,7,11,14,23,25H,6,8-10,12-13H2/t14-/m0/s1 DWR4I7 DRUGINKE NIWBSQAKKNNWBT-AWEZNQCLSA-N DWR4I7 DRUGSMIL C1COCC(N1C(=O)C2=C(N=CC=C2)CCO)COC3=CC=CC(=C3C=O)O DWR4I7 HIGHSTAT Phase 2/3 D00HGF DRUG__ID D00HGF D00HGF DRUGTYPE Small molecular drug D00HGF DRUGINCH 1S/C4H10O4/c5-1-3(7)4(8)2-6/h3-8H,1-2H2/t3-,4+ D00HGF DRUGINKE UNXHWFMMPAWVPI-ZXZARUISSA-N D00HGF DRUGSMIL C(C(C(CO)O)O)O D00HGF HIGHSTAT Phase 2/3 D02ADM DRUG__ID D02ADM D02ADM DRUGCOMP Meda Pharmaceuticals Somerset, NJ D02ADM DRUGINCH 1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23+,24-,25-/m1/s1 D02ADM DRUGINKE SEBFKMXJBCUCAI-HKTJVKLFSA-N D02ADM DRUGSMIL COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O D02ADM HIGHSTAT Phase 2/3 D02GWF DRUG__ID D02GWF D02GWF DRUGTYPE Small molecular drug D02GWF DRUGINCH 1S/C25H40N2O3/c1-7-8-9-10-11-12-14-27-15-13-19-17(2)20(16-21(28)29)18(3)22(23(19)27)26-24(30)25(4,5)6/h7-16H2,1-6H3,(H,26,30)(H,28,29) D02GWF DRUGINKE TXIIZHHIOHVWJD-UHFFFAOYSA-N D02GWF DRUGSMIL CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C D02GWF HIGHSTAT Phase 2/3 D03MZJ DRUG__ID D03MZJ D03MZJ DRUGTYPE Small molecular drug D03MZJ DRUGINCH 1S/C22H25N3O2/c1-22(2,11-17-13-24-20-9-5-4-8-19(17)20)25-14-18(26)15-27-21-10-6-3-7-16(21)12-23/h3-10,13,18,24-26H,11,14-15H2,1-2H3 D03MZJ DRUGINKE FBMYKMYQHCBIGU-UHFFFAOYSA-N D03MZJ DRUGSMIL CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O D03MZJ HIGHSTAT Phase 2/3 D03QLG DRUG__ID D03QLG D03QLG DRUGTYPE Small molecular drug D03QLG DRUGINCH 1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1 D03QLG DRUGINKE SCMLRESZJCKCTC-KMYQRJGFSA-N D03QLG DRUGSMIL CCSCC1=CC2=C(C=C1)N3C4CC(C(O4)(N5C6=C(C=C(C=C6)CSCC)C7=C8CNC(=O)C8=C2C3=C75)C)(C(=O)OC)O D03QLG HIGHSTAT Phase 2/3 D03ZDX DRUG__ID D03ZDX D03ZDX DRUGCOMP Tyme Technologies New York, NY D03ZDX DRUGINCH 1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14) D03ZDX DRUGINKE NHTGHBARYWONDQ-UHFFFAOYSA-N D03ZDX DRUGSMIL CC(CC1=CC=C(C=C1)O)(C(=O)O)N D03ZDX HIGHSTAT Phase 2/3 D04PBH DRUG__ID D04PBH D04PBH DRUGTYPE Small molecular drug D04PBH DRUGINCH 1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1 D04PBH DRUGINKE OVSQVDMCBVZWGM-QSOFNFLRSA-N D04PBH DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O D04PBH HIGHSTAT Phase 2/3 D05BLN DRUG__ID D05BLN D05BLN DRUGCOMP Mirati therapeutics D05BLN DRUGINCH 1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42) D05BLN DRUGINKE WLAVZAAODLTUSW-UHFFFAOYSA-N D05BLN DRUGSMIL COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F D05BLN HIGHSTAT Phase 2/3 D08UGX DRUG__ID D08UGX D08UGX DRUGTYPE Small molecular drug D08UGX DRUGINCH 1S/C17H13ClN4/c18-14-3-1-2-12(8-14)17(22-7-6-19-11-22)13-4-5-15-16(9-13)21-10-20-15/h1-11,17H,(H,20,21) D08UGX DRUGINKE UGFHIPBXIWJXNA-UHFFFAOYSA-N D08UGX DRUGSMIL C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4 D08UGX HIGHSTAT Phase 2/3 D0E2IN DRUG__ID D0E2IN D0E2IN DRUGTYPE Small molecular drug D0E2IN DRUGINCH 1S/C28H29N5O3.ClH/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23;/h2-12,21H,13-18,20H2,1H3;1H/t21-;/m1./s1 D0E2IN DRUGINKE GXYZREDEYDFJPT-ZMBIFBSDSA-N D0E2IN DRUGSMIL CC(CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5.Cl D0E2IN HIGHSTAT Phase 2/3 D0KL7C DRUG__ID D0KL7C D0KL7C DRUGCOMP MondoBIOTECH Holding AG D0KL7C DRUGINCH 1S/C147H237N43O43S/c1-18-75(12)115(142(229)180-96(56-72(6)7)131(218)183-104(145(232)233)63-110(155)200)188-139(226)106(68-192)185-134(221)101(62-109(154)199)177-130(217)95(55-71(4)5)174-132(219)97(58-81-37-41-84(195)42-38-81)175-125(212)88(33-23-26-49-149)167-123(210)89(34-24-27-50-150)171-140(227)113(73(8)9)186-118(205)76(13)164-121(208)93(47-53-234-17)170-127(214)92(45-46-107(152)197)169-122(209)87(32-22-25-48-148)166-124(211)90(35-28-51-161-146(156)157)168-129(216)94(54-70(2)3)173-126(213)91(36-29-52-162-147(158)159)172-143(230)116(78(15)193)189-136(223)98(59-82-39-43-85(196)44-40-82)176-133(220)100(61-108(153)198)178-135(222)103(65-112(203)204)182-144(231)117(79(16)194)190-137(224)99(57-80-30-20-19-21-31-80)181-141(228)114(74(10)11)187-119(206)77(14)165-128(215)102(64-111(201)202)179-138(225)105(67-191)184-120(207)86(151)60-83-66-160-69-163-83/h19-21,30-31,37-44,66,69-79,86-106,113-117,191-196H,18,22-29,32-36,45-65,67-68,148-151H2,1-17H3,(H2,152,197)(H2,153,198)(H2,154,199)(H2,155,200)(H,160,163)(H,164,208)(H,165,215)(H,166,211)(H,167,210)(H,168,216)(H,169,209)(H,170,214)(H,171,227)(H,172,230)(H,173,213)(H,174,219)(H,175,212)(H,176,220)(H,177,217)(H,178,222)(H,179,225)(H,180,229)(H,181,228)(H,182,231)(H,183,218)(H,184,207)(H,185,221)(H,186,205)(H,187,206)(H,188,226)(H,189,223)(H,190,224)(H,201,202)(H,203,204)(H,232,233)(H4,156,157,161)(H4,158,159,162)/t75-,76-,77-,78+,79+,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,113-,114-,115-,116-,117-/m0/s1 D0KL7C DRUGINKE VBUWHHLIZKOSMS-RIWXPGAOSA-N D0KL7C DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CN=CN4)N D0KL7C HIGHSTAT Phase 2/3 D0L6HN DRUG__ID D0L6HN D0L6HN DRUGTYPE Small molecular drug D0L6HN DRUGINCH 1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H D0L6HN DRUGINKE ISWSIDIOOBJBQZ-UHFFFAOYSA-N D0L6HN DRUGSMIL C1=CC=C(C=C1)O D0L6HN HIGHSTAT Phase 2/3 D0Q0FW DRUG__ID D0Q0FW D0Q0FW DRUGTYPE Small molecular drug D0Q0FW DRUGINCH 1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 D0Q0FW DRUGINKE LDHMAVIPBRSVRG-UHFFFAOYSA-O D0Q0FW DRUGSMIL C[N+]1=CC=CC(=C1)C(=O)N D0Q0FW HIGHSTAT Phase 2/3 D0R9DP DRUG__ID D0R9DP D0R9DP DRUGCOMP Cempra Pharmaceuticals Chapel Hill, NC D0R9DP DRUGINCH 1S/C31H48O6.Na/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32;/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36);/q;+1/p-1/b26-20-;/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-;/m0./s1 D0R9DP DRUGINKE HJHVQCXHVMGZNC-JCJNLNMISA-M D0R9DP DRUGSMIL CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4=C(CCC=C(C)C)C(=O)[O-])OC(=O)C)C)O)C.[Na+] D0R9DP HIGHSTAT Phase 2/3 D0SC6I DRUG__ID D0SC6I D0SC6I DRUGCOMP SyneuRx Taipei, Taiwan D0SC6I DRUGINCH 1S/C7H6O2.Na/c8-7(9)6-4-2-1-3-5-6;/h1-5H,(H,8,9);/q;+1/p-1 D0SC6I DRUGINKE WXMKPNITSTVMEF-UHFFFAOYSA-M D0SC6I DRUGSMIL C1=CC=C(C=C1)C(=O)[O-].[Na+] D0SC6I HIGHSTAT Phase 2/3 D0T2FP DRUG__ID D0T2FP D0T2FP DRUGCOMP Janssen research & development D0T2FP DRUGINCH 1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8,10H,1H3,(H2,21,24)(H,23,25)/t18-/m0/s1 D0T2FP DRUGINKE VLLFGVHGKLDDLW-SFHVURJKSA-N D0T2FP DRUGSMIL CC1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F D0T2FP HIGHSTAT Phase 2/3 D0V4HO DRUG__ID D0V4HO D0V4HO DRUGCOMP BioCryst Pharmaceuticals Durham, NC D0V4HO DRUGINCH 1S/C28H27N5O5/c1-3-16-12-21(26(34)32-18-8-6-17(7-9-18)25(29)30)20(13-23(16)38-2)19-10-11-22(33-24(19)28(36)37)27(35)31-14-15-4-5-15/h3,6-13,15H,1,4-5,14H2,2H3,(H3,29,30)(H,31,35)(H,32,34)(H,36,37) D0V4HO DRUGINKE TUWMKPVJGGWGNL-UHFFFAOYSA-N D0V4HO DRUGSMIL COC1=CC(=C(C=C1C=C)C(=O)NC2=CC=C(C=C2)C(=N)N)C3=C(N=C(C=C3)C(=O)NCC4CC4)C(=O)O D0V4HO HIGHSTAT Phase 2/3 D0VD6Q DRUG__ID D0VD6Q D0VD6Q DRUGCOMP Raptor Therapeutics Novato, CA D0VD6Q DRUGINCH 1S/C4H6O6.C2H7NS/c5-1(3(7)8)2(6)4(9)10;3-1-2-4/h1-2,5-6H,(H,7,8)(H,9,10);4H,1-3H2/t1-,2-;/m1./s1 D0VD6Q DRUGINKE NSKJTUFFDRENDM-ZVGUSBNCSA-N D0VD6Q DRUGSMIL C(CS)N.C(C(C(=O)O)O)(C(=O)O)O D0VD6Q HIGHSTAT Phase 2/3 D0VL4V DRUG__ID D0VL4V D0VL4V DRUGCOMP Sanofi-aventis D0VL4V DRUGINCH 1S/C127H220O134S17.19Na/c1-183-32-46-60(235-114-95(203-21)76(192-10)62(48(223-114)34-185-3)237-116-97(205-23)78(194-12)64(50(225-116)36-187-5)239-118-99(207-25)80(196-14)66(52(227-118)38-189-7)241-120-101(209-27)82(198-16)68(55(229-120)41-216-264(138,139)140)244-124-106(258-275(171,172)173)89(254-271(159,160)161)71(57(231-124)43-218-266(144,145)146)246-125-107(259-276(174,175)176)90(255-272(162,163)164)72(58(232-125)44-219-267(147,148)149)247-126-109(261-278(180,181)182)91(256-273(165,166)167)73(252-269(153,154)155)59(234-126)45-220-268(150,151)152)74(190-8)94(202-20)113(222-46)236-61-47(33-184-2)224-115(96(204-22)75(61)191-9)238-63-49(35-186-4)226-117(98(206-24)77(63)193-11)240-65-51(37-188-6)228-119(100(208-26)79(65)195-13)242-67-54(40-215-263(135,136)137)230-121(102(210-28)81(67)197-15)248-86-84(200-18)104(212-30)123(251-92(86)110(128)129)245-70-56(42-217-265(141,142)143)233-127(108(260-277(177,178)179)88(70)253-270(156,157)158)249-87-85(201-19)103(211-29)122(250-93(87)111(130)131)243-69-53(39-214-262(132,133)134)221-112(213-31)105(83(69)199-17)257-274(168,169)170;;;;;;;;;;;;;;;;;;;/h46-109,112-127H,32-45H2,1-31H3,(H,128,129)(H,130,131)(H,132,133,134)(H,135,136,137)(H,138,139,140)(H,141,142,143)(H,144,145,146)(H,147,148,149)(H,150,151,152)(H,153,154,155)(H,156,157,158)(H,159,160,161)(H,162,163,164)(H,165,166,167)(H,168,169,170)(H,171,172,173)(H,174,175,176)(H,177,178,179)(H,180,181,182);;;;;;;;;;;;;;;;;;;/q;19*+1/p-19/t46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67+,68-,69-,70-,71-,72-,73-,74+,75+,76+,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103+,104-,105+,106-,107-,108-,109-,112+,113-,114+,115+,116+,117-,118+,119+,120-,121-,122-,123-,124+,125-,126-,127-;;;;;;;;;;;;;;;;;;;/m1.................../s1 D0VL4V DRUGINKE RRHHPXJSGSYSHW-ZURHXDBDSA-A D0VL4V DRUGSMIL COCC1C(C(C(C(O1)OC2C(OC(C(C2OC)OC)OC3C(OC(C(C3OC)OC)OC4C(OC(C(C4OC)OC)OC5C(C(C(OC5C(=O)[O-])OC6C(OC(C(C6OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC7C(C(C(OC7C(=O)[O-])OC8C(OC(C(C8OC)OS(=O)(=O)[O-])OC)COS(=O)(=O)[O-])OC)OC)COS(=O)(=O)[O-])OC)OC)COS(=O)(=O)[O-])COC)COC)OC)OC)OC9C(C(C(C(O9)COC)OC1C(C(C(C(O1)COC)OC1C(C(C(C(O1)COC)OC1C(C(C(C(O1)COC)OC1C(C(C(C(O1)COS(=O)(=O)[O-])OC1C(C(C(C(O1)COS(=O)(=O)[O-])OC1C(C(C(C(O1)COS(=O)(=O)[O-])OC1C(C(C(C(O1)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OC)OC)OC)OC)OC)OC)OC)OC)OC)OC.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0VL4V HIGHSTAT Phase 2/3 DY4OZ6 DRUG__ID DY4OZ6 DY4OZ6 DRUGTYPE Small molecular drug DY4OZ6 DRUGINCH 1S/C10H12O2/c1-6(2)8-5-9(11)7(3)4-10(8)12/h4-6H,1-3H3 DY4OZ6 DRUGINKE KEQHJBNSCLWCAE-UHFFFAOYSA-N DY4OZ6 DRUGSMIL CC1=CC(=O)C(=CC1=O)C(C)C DY4OZ6 HIGHSTAT Phase 2/3 D01FDN DRUG__ID D01FDN D01FDN DRUGINCH 1S/C18H21N3O4/c19-14(17(23)21-15(18(24)25)7-8-16(20)22)10-11-5-6-12-3-1-2-4-13(12)9-11/h1-6,9,14-15H,7-8,10,19H2,(H2,20,22)(H,21,23)(H,24,25)/t14-,15-/m0/s1 D01FDN DRUGINKE VSZVSSYQFUFEQG-GJZGRUSLSA-N D01FDN DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC(C(=O)NC(CCC(=O)N)C(=O)O)N D01FDN HIGHSTAT Phase 2/3 D04NVG DRUG__ID D04NVG D04NVG THERCLAS Antiviral Agents D04NVG DRUGTYPE Protein/peptide drug D04NVG DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N D04NVG HIGHSTAT Phase 2/3 Trial D04PKR DRUG__ID D04PKR D04PKR THERCLAS Antiviral Agents D04PKR DRUGTYPE Protein/peptide drug D04PKR DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CN=CN4)N D04PKR HIGHSTAT Phase 2/3 Trial D00KGB DRUG__ID D00KGB D00KGB DRUGCOMP Menarini D00KGB DRUGTYPE Monoclonal antibody D00KGB HIGHSTAT Phase 2/3 D01ADL DRUG__ID D01ADL D01ADL DRUGCOMP LFB Biotechnologies D01ADL DRUGTYPE Antibody D01ADL HIGHSTAT Phase 2/3 D01CAH DRUG__ID D01CAH D01CAH THERCLAS Antiviral Agents D01CAH DRUGTYPE Cell therapy D01CAH HIGHSTAT Phase 2/3 Trial D01MSB DRUG__ID D01MSB D01MSB THERCLAS Antiviral Agents D01MSB DRUGTYPE Combination drug D01MSB HIGHSTAT Phase 2/3 Trial D01MTY DRUG__ID D01MTY D01MTY THERCLAS Antiviral Agents D01MTY DRUGTYPE Combination drug D01MTY HIGHSTAT Phase 2/3 Trial D01NKS DRUG__ID D01NKS D01NKS THERCLAS Antiviral Agents D01NKS DRUGTYPE Combination drug D01NKS HIGHSTAT Phase 2/3 Trial D01WYO DRUG__ID D01WYO D01WYO THERCLAS Antiviral Agents D01WYO DRUGTYPE Combination drug D01WYO HIGHSTAT Phase 2/3 Trial D01YQN DRUG__ID D01YQN D01YQN THERCLAS Antiviral Agents D01YQN DRUGTYPE Combination drug D01YQN HIGHSTAT Phase 2/3 Trial D01ZQE DRUG__ID D01ZQE D01ZQE THERCLAS Antiviral Agents D01ZQE DRUGTYPE Combination drug D01ZQE HIGHSTAT Phase 2/3 Trial D01ZWC DRUG__ID D01ZWC D01ZWC THERCLAS Antiviral Agents D01ZWC DRUGTYPE Combination drug D01ZWC HIGHSTAT Phase 2/3 Trial D02CYL DRUG__ID D02CYL D02CYL DRUGCOMP Morphosys D02CYL DRUGTYPE Antibody D02CYL HIGHSTAT Phase 2/3 D02MLN DRUG__ID D02MLN D02MLN THERCLAS Antiviral Agents D02MLN DRUGTYPE Vaccine D02MLN HIGHSTAT Phase 2/3 Trial D03IOM DRUG__ID D03IOM D03IOM DRUGCOMP Fujian Medical University D03IOM DRUGTYPE CAR T Cell Therapy D03IOM HIGHSTAT Phase 2/3 D03RDQ DRUG__ID D03RDQ D03RDQ DRUGCOMP Abgenix Inc D03RDQ DRUGTYPE Antibody D03RDQ HIGHSTAT Phase 2/3 D03ZYQ DRUG__ID D03ZYQ D03ZYQ THERCLAS Antiviral Agents D03ZYQ DRUGTYPE Monoclonal antibody D03ZYQ HIGHSTAT Phase 2/3 Trial D04DTH DRUG__ID D04DTH D04DTH THERCLAS Antiviral Agents D04DTH DRUGTYPE Monoclonal antibody D04DTH HIGHSTAT Phase 2/3 Trial D04GGG DRUG__ID D04GGG D04GGG DRUGCOMP Fujian Medical University D04GGG DRUGTYPE CAR T Cell Therapy (Dual specific) D04GGG HIGHSTAT Phase 2/3 D04VHZ DRUG__ID D04VHZ D04VHZ THERCLAS Antiviral Agents D04VHZ DRUGTYPE Protein/peptide drug D04VHZ HIGHSTAT Phase 2/3 Trial D04YSC DRUG__ID D04YSC D04YSC DRUGCOMP Fujian Medical University D04YSC DRUGTYPE CAR T Cell Therapy D04YSC HIGHSTAT Phase 2/3 D04YSK DRUG__ID D04YSK D04YSK DRUGCOMP Biosynexus Inc D04YSK DRUGTYPE Monoclonal antibody D04YSK HIGHSTAT Phase 2/3 D06ALE DRUG__ID D06ALE D06ALE THERCLAS Antiviral Agents D06ALE DRUGTYPE Monoclonal antibody D06ALE HIGHSTAT Phase 2/3 Trial D09JVK DRUG__ID D09JVK D09JVK DRUGCOMP Eli lilly D09JVK DRUGTYPE Antibody D09JVK HIGHSTAT Phase 2/3 D0F3KC DRUG__ID D0F3KC D0F3KC DRUGCOMP Abbott Laboratories Abbott D0F3KC DRUGTYPE Antibody D0F3KC HIGHSTAT Phase 2/3 D0FX3U DRUG__ID D0FX3U D0FX3U THERCLAS Antiviral Agents D0FX3U DRUGTYPE Monoclonal antibody D0FX3U HIGHSTAT Phase 2/3 Trial D0I3VT DRUG__ID D0I3VT D0I3VT DRUGCOMP Cytos Biotechnology AG D0I3VT DRUGTYPE Vaccine D0I3VT HIGHSTAT Phase 2/3 D0I9AC DRUG__ID D0I9AC D0I9AC DRUGCOMP Samumed San Diego,CA D0I9AC DRUGTYPE Small molecular drug D0I9AC HIGHSTAT Phase 2/3 D0J8OV DRUG__ID D0J8OV D0J8OV THERCLAS Antiviral Agents D0J8OV DRUGTYPE Vaccine D0J8OV HIGHSTAT Phase 2/3 Trial D0JE8O DRUG__ID D0JE8O D0JE8O THERCLAS Antiviral Agents D0JE8O DRUGTYPE Vaccine D0JE8O HIGHSTAT Phase 2/3 Trial D0Q3IS DRUG__ID D0Q3IS D0Q3IS DRUGCOMP Viventia Biotechnologies D0Q3IS DRUGTYPE Antibody D0Q3IS HIGHSTAT Phase 2/3 D0R7BB DRUG__ID D0R7BB D0R7BB DRUGCOMP GlaxoSmithKline D0R7BB DRUGTYPE Antibody D0R7BB HIGHSTAT Phase 2/3 D0RF4J DRUG__ID D0RF4J D0RF4J DRUGCOMP Fujian Medical University D0RF4J DRUGTYPE CAR T Cell Therapy (Dual specific) D0RF4J HIGHSTAT Phase 2/3 D0SB5K DRUG__ID D0SB5K D0SB5K DRUGCOMP Sanofi-Aventis D0SB5K THERCLAS Analgesics D0SB5K HIGHSTAT Phase 2/3 D0SQ8R DRUG__ID D0SQ8R D0SQ8R DRUGCOMP Intercell AG D0SQ8R DRUGTYPE Vaccine D0SQ8R HIGHSTAT Phase 2/3 D0U8VO DRUG__ID D0U8VO D0U8VO THERCLAS Antiviral Agents D0U8VO DRUGTYPE Combination drug D0U8VO HIGHSTAT Phase 2/3 Trial D1M8GC DRUG__ID D1M8GC D1M8GC DRUGCOMP CytoDyn D1M8GC DRUGTYPE Antibody D1M8GC HIGHSTAT Phase 2/3 D1U3EG DRUG__ID D1U3EG D1U3EG DRUGCOMP Ridgeback Biotherapeutics D1U3EG DRUGTYPE Antibody D1U3EG HIGHSTAT Phase 2/3 D21URW DRUG__ID D21URW D21URW DRUGCOMP ProQR Therapeutics D21URW DRUGTYPE Antisense oligonucleotide D21URW HIGHSTAT Phase 2/3 D23CDU DRUG__ID D23CDU D23CDU DRUGCOMP AVROBIO D23CDU DRUGTYPE Gene therapy D23CDU HIGHSTAT Phase 2/3 D3WA2V DRUG__ID D3WA2V D3WA2V DRUGCOMP Abcuro D3WA2V DRUGTYPE Monoclonal antibody D3WA2V HIGHSTAT Phase 2/3 D3YJZ7 DRUG__ID D3YJZ7 D3YJZ7 DRUGCOMP Merck D3YJZ7 DRUGTYPE Antibody drug conjugate D3YJZ7 HIGHSTAT Phase 2/3 D3YKX2 DRUG__ID D3YKX2 D3YKX2 DRUGCOMP Kibow Biotech Newtown Square, PA D3YKX2 DRUGTYPE Live biotherapeutic D3YKX2 HIGHSTAT Phase 2/3 D4OU6H DRUG__ID D4OU6H D4OU6H DRUGCOMP Bellicum Pharmaceuticals D4OU6H DRUGTYPE Cell therapy D4OU6H HIGHSTAT Phase 2/3 D4OZC7 DRUG__ID D4OZC7 D4OZC7 DRUGCOMP Wave Life Sciences D4OZC7 DRUGTYPE Antisense oligonucleotide D4OZC7 HIGHSTAT Phase 2/3 D5A6JN DRUG__ID D5A6JN D5A6JN DRUGCOMP TVAX Biomedical Olathe, KS D5A6JN DRUGTYPE Vaccine D5A6JN HIGHSTAT Phase 2/3 D5DAR1 DRUG__ID D5DAR1 D5DAR1 DRUGCOMP Lysogene; Sarepta Therapeutics D5DAR1 DRUGTYPE Gene therapy D5DAR1 HIGHSTAT Phase 2/3 D7HKM2 DRUG__ID D7HKM2 D7HKM2 DRUGCOMP Moderna D7HKM2 DRUGTYPE Vaccine D7HKM2 HIGHSTAT Phase 2/3 DCRU72 DRUG__ID DCRU72 DCRU72 DRUGCOMP Moderna DCRU72 DRUGTYPE Vaccine DCRU72 HIGHSTAT Phase 2/3 DF3UN2 DRUG__ID DF3UN2 DF3UN2 DRUGCOMP Novartis DF3UN2 DRUGTYPE Vaccine DF3UN2 HIGHSTAT Phase 2/3 DGU51Y DRUG__ID DGU51Y DGU51Y DRUGCOMP Sihuan Pharmaceutical DGU51Y DRUGTYPE Small molecular drug DGU51Y HIGHSTAT Phase 2/3 DJAW98 DRUG__ID DJAW98 DJAW98 DRUGCOMP Nature Cell DJAW98 DRUGTYPE Cell therapy DJAW98 HIGHSTAT Phase 2/3 DKFP51 DRUG__ID DKFP51 DKFP51 DRUGCOMP PCR Pharmaceuticals Hyogo, Japan Takeda DKFP51 DRUGTYPE Fusion protein DKFP51 HIGHSTAT Phase 2/3 DKH94Z DRUG__ID DKH94Z DKH94Z DRUGCOMP Applied Genetic Technologies DKH94Z DRUGTYPE Gene therapy DKH94Z HIGHSTAT Phase 2/3 DKJ93L DRUG__ID DKJ93L DKJ93L DRUGCOMP Y-mAbs Therapeutics DKJ93L DRUGTYPE Antibody DKJ93L HIGHSTAT Phase 2/3 DL4WG9 DRUG__ID DL4WG9 DL4WG9 DRUGCOMP Sanofi DL4WG9 DRUGTYPE Vaccine DL4WG9 HIGHSTAT Phase 2/3 DO5H6K DRUG__ID DO5H6K DO5H6K DRUGCOMP Mateon/Oncotelic DO5H6K DRUGTYPE Antisense oligonucleotide DO5H6K HIGHSTAT Phase 2/3 DOST52 DRUG__ID DOST52 DOST52 DRUGCOMP Merck DOST52 DRUGTYPE Antibody DOST52 HIGHSTAT Phase 2/3 DQ02VJ DRUG__ID DQ02VJ DQ02VJ DRUGCOMP Eisai DQ02VJ DRUGTYPE Monoclonal antibody DQ02VJ HIGHSTAT Phase 2/3 DS14FO DRUG__ID DS14FO DS14FO DRUGCOMP ProQR Therapeutics DS14FO DRUGTYPE Oligonucleotide DS14FO HIGHSTAT Phase 2/3 DTV58L DRUG__ID DTV58L DTV58L DRUGCOMP Denali Therapeutics DTV58L DRUGTYPE Enzyme replacement DTV58L HIGHSTAT Phase 2/3 DUBW95 DRUG__ID DUBW95 DUBW95 DRUGCOMP Y-mAbs Therapeutics DUBW95 DRUGTYPE Antibody DUBW95 HIGHSTAT Phase 2/3 DWS08I DRUG__ID DWS08I DWS08I DRUGCOMP Bio Products Laboratory DWS08I DRUGTYPE Vaccine DWS08I HIGHSTAT Phase 2/3 DX2B8E DRUG__ID DX2B8E DX2B8E DRUGCOMP Transgene; Bristol-Myers Squibb DX2B8E DRUGTYPE Vaccine DX2B8E HIGHSTAT Phase 2/3 D01AKK DRUG__ID D01AKK D01AKK DRUGCOMP Alexion pharmaceuticals D01AKK HIGHSTAT Phase 2/3 D01BBB DRUG__ID D01BBB D01BBB DRUGCOMP Viriom Ltd D01BBB HIGHSTAT Phase 2/3 D01CTR DRUG__ID D01CTR D01CTR DRUGCOMP ProMetic Biotherapeutics Quebec, Canada D01CTR HIGHSTAT Phase 2/3 D01WLE DRUG__ID D01WLE D01WLE DRUGCOMP Texas A&M University System D01WLE HIGHSTAT Phase 2/3 D01WXU DRUG__ID D01WXU D01WXU DRUGCOMP Collateral Therapeutics Inc; Bayer HealthCare Pharmaceuticals D01WXU HIGHSTAT Phase 2/3 D02FDZ DRUG__ID D02FDZ D02FDZ DRUGCOMP Veloxis Pharmaceuticals D02FDZ HIGHSTAT Phase 2/3 D02NBY DRUG__ID D02NBY D02NBY DRUGCOMP Osel D02NBY HIGHSTAT Phase 2/3 D02SDY DRUG__ID D02SDY D02SDY DRUGCOMP SyneuRx Taipei City, Taiwan D02SDY HIGHSTAT Phase 2/3 D02URX DRUG__ID D02URX D02URX DRUGCOMP Kamada; kedrion biopharma D02URX HIGHSTAT Phase 2/3 D04EGR DRUG__ID D04EGR D04EGR DRUGCOMP Pharmena North America Boston D04EGR HIGHSTAT Phase 2/3 D04QSH DRUG__ID D04QSH D04QSH DRUGCOMP Dong Wha Pharmaceutical Co Ltd D04QSH HIGHSTAT Phase 2/3 D05ZDD DRUG__ID D05ZDD D05ZDD DRUGCOMP Scil Technology GmbH D05ZDD HIGHSTAT Phase 2/3 D06APK DRUG__ID D06APK D06APK DRUGCOMP Insmed Inc D06APK HIGHSTAT Phase 2/3 D06GKE DRUG__ID D06GKE D06GKE DRUGCOMP Sanofi D06GKE HIGHSTAT Phase 2/3 D06SZU DRUG__ID D06SZU D06SZU DRUGCOMP WaVe Life Sciences Cambridge, MA D06SZU HIGHSTAT Phase 2/3 D06XPL DRUG__ID D06XPL D06XPL DRUGCOMP Tocagen Inc D06XPL HIGHSTAT Phase 2/3 D07DBE DRUG__ID D07DBE D07DBE DRUGCOMP Eisai D07DBE HIGHSTAT Phase 2/3 D07FGA DRUG__ID D07FGA D07FGA DRUGCOMP MGI Pharma D07FGA HIGHSTAT Phase 2/3 D07WJE DRUG__ID D07WJE D07WJE DRUGCOMP NovaBay Pharmaceuticals Inc D07WJE HIGHSTAT Phase 2/3 D07ZUW DRUG__ID D07ZUW D07ZUW DRUGCOMP NanoBio Corp D07ZUW HIGHSTAT Phase 2/3 D08BZZ DRUG__ID D08BZZ D08BZZ DRUGCOMP Y-mAbs Therapeutics New York, NY D08BZZ HIGHSTAT Phase 2/3 D08NJE DRUG__ID D08NJE D08NJE DRUGCOMP Cara Therapeutics Inc; cara therapeutics D08NJE HIGHSTAT Phase 2/3 D08QGE DRUG__ID D08QGE D08QGE DRUGCOMP SEIKAGAKU CORPORATION D08QGE HIGHSTAT Phase 2/3 D08RFZ DRUG__ID D08RFZ D08RFZ DRUGCOMP MedImmune Gaithersburg, MDSanofi Pasteur Swiftwater, PA D08RFZ HIGHSTAT Phase 2/3 D09CNO DRUG__ID D09CNO D09CNO DRUGCOMP ALK Abello; Merck D09CNO HIGHSTAT Phase 2/3 D09OWI DRUG__ID D09OWI D09OWI DRUGCOMP Diasome Pharmaceuticals D09OWI HIGHSTAT Phase 2/3 D09VKP DRUG__ID D09VKP D09VKP DRUGCOMP Cardio3 biosciences D09VKP HIGHSTAT Phase 2/3 D0A6LT DRUG__ID D0A6LT D0A6LT DRUGCOMP Prolong Pharmaceuticals Inc D0A6LT HIGHSTAT Phase 2/3 D0A7GA DRUG__ID D0A7GA D0A7GA DRUGCOMP Auron Healthcare GmbH D0A7GA HIGHSTAT Phase 2/3 D0A7WO DRUG__ID D0A7WO D0A7WO DRUGCOMP Amgen Inc D0A7WO HIGHSTAT Phase 2/3 D0B3CC DRUG__ID D0B3CC D0B3CC DRUGCOMP Immunovative Therapies D0B3CC HIGHSTAT Phase 2/3 D0B7LK DRUG__ID D0B7LK D0B7LK DRUGCOMP Epimmune Inc D0B7LK HIGHSTAT Phase 2/3 D0BS5E DRUG__ID D0BS5E D0BS5E DRUGCOMP AMO Pharma Berwyn, PA D0BS5E HIGHSTAT Phase 2/3 D0C0CE DRUG__ID D0C0CE D0C0CE DRUGCOMP Csl behring D0C0CE HIGHSTAT Phase 2/3 D0D9ZB DRUG__ID D0D9ZB D0D9ZB DRUGCOMP Takeda Pharmaceutical Co Ltd D0D9ZB HIGHSTAT Phase 2/3 D0EP9A DRUG__ID D0EP9A D0EP9A DRUGCOMP United Therapeutics Silver Spring, MD D0EP9A HIGHSTAT Phase 2/3 D0F7TR DRUG__ID D0F7TR D0F7TR DRUGCOMP Mytogen Inc D0F7TR HIGHSTAT Phase 2/3 D0G3DC DRUG__ID D0G3DC D0G3DC DRUGCOMP Asphelia Pharmaceuticals Inc D0G3DC HIGHSTAT Phase 2/3 D0H4CB DRUG__ID D0H4CB D0H4CB DRUGCOMP Ontario Inc D0H4CB HIGHSTAT Phase 2/3 D0H4YD DRUG__ID D0H4YD D0H4YD DRUGCOMP Amgen Thousand Oaks, CA Novartis East Hanover, NJ D0H4YD HIGHSTAT Phase 2/3 D0IJ0F DRUG__ID D0IJ0F D0IJ0F DRUGCOMP Flanders Interuniversity Institute for Biotechnology (VIB) D0IJ0F HIGHSTAT Phase 2/3 D0J8SE DRUG__ID D0J8SE D0J8SE DRUGCOMP Promius Pharma Princeton, NJ D0J8SE HIGHSTAT Phase 2/3 D0M4GX DRUG__ID D0M4GX D0M4GX DRUGCOMP AMAG Pharmaceuticals Waltham, MA D0M4GX HIGHSTAT Phase 2/3 D0M9EV DRUG__ID D0M9EV D0M9EV DRUGCOMP Nobilis Therapeutics Portland, OR D0M9EV HIGHSTAT Phase 2/3 D0MM5P DRUG__ID D0MM5P D0MM5P DRUGCOMP scPharmaceuticals Burlington, MA D0MM5P HIGHSTAT Phase 2/3 D0N2CG DRUG__ID D0N2CG D0N2CG DRUGCOMP Gamida Cell; Teva North America D0N2CG HIGHSTAT Phase 2/3 D0O7CO DRUG__ID D0O7CO D0O7CO DRUGCOMP Bioheart D0O7CO HIGHSTAT Phase 2/3 D0O9EQ DRUG__ID D0O9EQ D0O9EQ DRUGCOMP Vertex Pharmaceuticals Boston, MA D0O9EQ HIGHSTAT Phase 2/3 D0P1SA DRUG__ID D0P1SA D0P1SA DRUGCOMP Kobe Institute of Biomedical Research and Innovation D0P1SA HIGHSTAT Phase 2/3 D0P2OW DRUG__ID D0P2OW D0P2OW DRUGCOMP Immune response biopharma D0P2OW HIGHSTAT Phase 2/3 D0P6MW DRUG__ID D0P6MW D0P6MW DRUGCOMP Biothera D0P6MW HIGHSTAT Phase 2/3 D0PV4H DRUG__ID D0PV4H D0PV4H DRUGCOMP Scripps Research Institute D0PV4H HIGHSTAT Phase 2/3 D0Q8DZ DRUG__ID D0Q8DZ D0Q8DZ DRUGCOMP EffRx Pharmaceuticals Freienbark, Switzerland D0Q8DZ HIGHSTAT Phase 2/3 D0R1QH DRUG__ID D0R1QH D0R1QH DRUGCOMP University of Pennsylvania D0R1QH HIGHSTAT Phase 2/3 D0R5TV DRUG__ID D0R5TV D0R5TV DRUGCOMP Handok Pharmaceuticals D0R5TV HIGHSTAT Phase 2/3 D0RP5T DRUG__ID D0RP5T D0RP5T DRUGCOMP Roche Basel, Switzerland D0RP5T HIGHSTAT Phase 2/3 D0S4YT DRUG__ID D0S4YT D0S4YT DRUGCOMP Kedrion D0S4YT HIGHSTAT Phase 2/3 D0T8HR DRUG__ID D0T8HR D0T8HR DRUGCOMP Active Biotech D0T8HR HIGHSTAT Phase 2/3 D0T9CO DRUG__ID D0T9CO D0T9CO DRUGCOMP DanDrit Biotech AS D0T9CO HIGHSTAT Phase 2/3 D0U1XQ DRUG__ID D0U1XQ D0U1XQ DRUGCOMP Origin Biosciences D0U1XQ HIGHSTAT Phase 2/3 D0W9AI DRUG__ID D0W9AI D0W9AI DRUGCOMP FeRx D0W9AI HIGHSTAT Phase 2/3 D0WH4L DRUG__ID D0WH4L D0WH4L DRUGCOMP Avineuro Pharmaceuticals D0WH4L HIGHSTAT Phase 2/3 D0XM9E DRUG__ID D0XM9E D0XM9E DRUGCOMP Kedrion, Barga, Italy D0XM9E HIGHSTAT Phase 2/3 D0Y9XU DRUG__ID D0Y9XU D0Y9XU DRUGCOMP NewLink Genetics Ames, IA D0Y9XU HIGHSTAT Phase 2/3 D0YX4Z DRUG__ID D0YX4Z D0YX4Z DRUGCOMP Novartis vaccines D0YX4Z HIGHSTAT Phase 2/3 D0Z6OW DRUG__ID D0Z6OW D0Z6OW DRUGCOMP Novartis Vaccines & Diagnostics D0Z6OW HIGHSTAT Phase 2/3 D0Z9YF DRUG__ID D0Z9YF D0Z9YF DRUGCOMP Stallergenes SA D0Z9YF HIGHSTAT Phase 2/3 D0ZW3R DRUG__ID D0ZW3R D0ZW3R DRUGCOMP Transgene D0ZW3R HIGHSTAT Phase 2/3 D6S9AH DRUG__ID D6S9AH D6S9AH DRUGCOMP Nanjing Medical University D6S9AH HIGHSTAT Phase 2/3 DA97XT DRUG__ID DA97XT DA97XT DRUGCOMP Ascendis Pharma North Brunswick, NJ DA97XT HIGHSTAT Phase 2/3 DK6U4E DRUG__ID DK6U4E DK6U4E DRUGCOMP Mapp Biopharmaceutical San Diego, CA DK6U4E HIGHSTAT Phase 2/3 DRP8H0 DRUG__ID DRP8H0 DRP8H0 DRUGCOMP ALX Oncology DRP8H0 HIGHSTAT Phase 2/3 D04OFR DRUG__ID D04OFR D04OFR HIGHSTAT Phase 2/3 D0H0VI DRUG__ID D0H0VI D0H0VI HIGHSTAT Phase 2/3 D0G9XP DRUG__ID D0G9XP D0G9XP DRUGCOMP LG Life Sciences D0G9XP DRUGTYPE Small molecular drug D0G9XP DRUGINCH 1S/C22H34N5O8P/c1-20(2,3)17(28)31-12-34-36(30,35-13-32-18(29)21(4,5)6)14-33-22(7-8-22)10-27-11-25-15-9-24-19(23)26-16(15)27/h9,11H,7-8,10,12-14H2,1-6H3,(H2,23,24,26) D0G9XP DRUGINKE JLKJXDOWBVVABZ-UHFFFAOYSA-N D0G9XP DRUGSMIL CC(C)(C)C(=O)OCOP(=O)(COC1(CC1)CN2C=NC3=CN=C(N=C32)N)OCOC(=O)C(C)(C)C D0G9XP HIGHSTAT Phase 2b D0W9VW DRUG__ID D0W9VW D0W9VW DRUGCOMP Tranzyme D0W9VW DRUGTYPE Small molecular drug D0W9VW DRUGINCH 1S/C30H39FN4O4/c1-19-18-33-27(23-12-13-23)30(38)35(3)20(2)28(36)34-25(17-21-10-14-24(31)15-11-21)29(37)32-16-6-8-22-7-4-5-9-26(22)39-19/h4-5,7,9-11,14-15,19-20,23,25,27,33H,6,8,12-13,16-18H2,1-3H3,(H,32,37)(H,34,36)/t19-,20-,25-,27+/m1/s1 D0W9VW DRUGINKE WGYPAJVJMXQXTR-ABNZCKJZSA-N D0W9VW DRUGSMIL CC1CNC(C(=O)N(C(C(=O)NC(C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4 D0W9VW HIGHSTAT Phase 2b D0Q9XE DRUG__ID D0Q9XE D0Q9XE DRUGCOMP AstraZeneca D0Q9XE DRUGTYPE Antibody D0Q9XE HIGHSTAT Phase 2b D06CVO DRUG__ID D06CVO D06CVO DRUGCOMP Merck Research Laboratories D06CVO HIGHSTAT Phase 2b D0C0KP DRUG__ID D0C0KP D0C0KP DRUGCOMP Anergis SA D0C0KP HIGHSTAT Phase 2b D0ME1L DRUG__ID D0ME1L D0ME1L DRUGCOMP Glenveigh pharmaceuticals D0ME1L HIGHSTAT Phase 2b D02AUB DRUG__ID D02AUB D02AUB DRUGCOMP Encysive Pharma D02AUB DRUGTYPE Small molecular drug D02AUB DRUGINCH 1S/C46H54O16/c47-23-35-39(53)41(55)43(57)45(61-35)59-33-15-13-25(19-31(33)29-11-5-9-27(17-29)21-37(49)50)7-3-1-2-4-8-26-14-16-34(60-46-44(58)42(56)40(54)36(24-48)62-46)32(20-26)30-12-6-10-28(18-30)22-38(51)52/h5-6,9-20,35-36,39-48,53-58H,1-4,7-8,21-24H2,(H,49,50)(H,51,52)/t35-,36-,39-,40-,41+,42+,43+,44+,45+,46+/m1/s1 D02AUB DRUGINKE RYWCQJDEHXJHRI-XJMXIVSISA-N D02AUB DRUGSMIL C1=CC(=CC(=C1)C2=C(C=CC(=C2)CCCCCCC3=CC(=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)C5=CC=CC(=C5)CC(=O)O)OC6C(C(C(C(O6)CO)O)O)O)CC(=O)O D02AUB HIGHSTAT Phase 2a D05XLO DRUG__ID D05XLO D05XLO DRUGCOMP Incyte D05XLO DRUGTYPE Small molecular drug D05XLO DRUGINCH 1S/C19H27ClN2O3S/c1-14-17(20)10-5-11-18(14)26(24,25)22-12-6-7-15(13-22)19(23)21-16-8-3-2-4-9-16/h5,10-11,15-16H,2-4,6-9,12-13H2,1H3,(H,21,23) D05XLO DRUGINKE ODRPEKCTTLECBX-UHFFFAOYSA-N D05XLO DRUGSMIL CC1=C(C=CC=C1Cl)S(=O)(=O)N2CCCC(C2)C(=O)NC3CCCCC3 D05XLO HIGHSTAT Phase 2a D08UQS DRUG__ID D08UQS D08UQS DRUGCOMP Bayer D08UQS DRUGTYPE Small molecular drug D08UQS DRUGINCH 1S/C22H25ClN2O5/c1-12(2)30-22(27)18-14(4)25-13(3)17(21(26)29-10-9-28-5)19(18)16-8-6-7-15(11-24)20(16)23/h6-8,12,19,25H,9-10H2,1-5H3 D08UQS DRUGINKE GTIKSQYSAKETQA-UHFFFAOYSA-N D08UQS DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC(=C2Cl)C#N)C(=O)OCCOC D08UQS HIGHSTAT Phase 2a D09EFC DRUG__ID D09EFC D09EFC THERCLAS Anticancer Agents D09EFC DRUGTYPE Small molecular drug D09EFC DRUGINCH 1S/C45H58N10O9S2/c1-25(56)38(39(48)58)55-45(64)37-24-66-65-23-36(53-40(59)31(47)19-26-9-3-2-4-10-26)44(63)51-34(20-27-14-16-29(57)17-15-27)42(61)52-35(21-28-22-49-32-12-6-5-11-30(28)32)43(62)50-33(41(60)54-37)13-7-8-18-46/h2-6,9-12,14-17,22,25,31,33-38,49,56-57H,7-8,13,18-21,23-24,46-47H2,1H3,(H2,48,58)(H,50,62)(H,51,63)(H,52,61)(H,53,59)(H,54,60)(H,55,64)/t25-,31-,33+,34+,35-,36+,37+,38+/m1/s1 D09EFC DRUGINKE SNAJPQVDGYDQSW-DYCFWDQMSA-N D09EFC DRUGSMIL CC(C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)O D09EFC HIGHSTAT Phase 2a D0D9AH DRUG__ID D0D9AH D0D9AH DRUGCOMP Vertex Pharma D0D9AH DRUGTYPE Small molecular drug D0D9AH DRUGINCH 1S/C19H12F4N4O2/c20-9-4-5-10(14(23)8-9)16-11(18(24)28)6-7-15(26-16)27(19(25)29)17-12(21)2-1-3-13(17)22/h1-8H,(H2,24,28)(H2,25,29) D0D9AH DRUGINKE FYSRKRZDBHOFAY-UHFFFAOYSA-N D0D9AH DRUGSMIL C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F D0D9AH HIGHSTAT Phase 2a D0Y7NA DRUG__ID D0Y7NA D0Y7NA DRUGCOMP Incyte D0Y7NA DRUGTYPE Small molecular drug D0Y7NA DRUGINCH 1S/C30H40F3N5O2/c1-6-40-25-16-22-15-23(30(31,32)33)7-8-24(22)27(25)38-14-13-37(17-19(38)2)29(5)9-11-36(12-10-29)28(39)26-20(3)34-18-35-21(26)4/h7-8,15,18-19,25,27H,6,9-14,16-17H2,1-5H3/t19-,25+,27+/m0/s1 D0Y7NA DRUGINKE ZMCJFJZOSKEMOM-DNKZPPIMSA-N D0Y7NA DRUGSMIL CCOC1CC2=C(C1N3CCN(CC3C)C4(CCN(CC4)C(=O)C5=C(N=CN=C5C)C)C)C=CC(=C2)C(F)(F)F D0Y7NA HIGHSTAT Phase 2a D04TIL DRUG__ID D04TIL D04TIL DRUGCOMP Anadys Pharmaceuticals D04TIL HIGHSTAT Phase 2a D06GDR DRUG__ID D06GDR D06GDR DRUGCOMP Biotie D06GDR HIGHSTAT Phase 2a D0BW3P DRUG__ID D0BW3P D0BW3P DRUGCOMP Aerovance D0BW3P HIGHSTAT Phase 2a D0J0KT DRUG__ID D0J0KT D0J0KT DRUGCOMP MediGene AG D0J0KT HIGHSTAT Phase 2a D0MM3A DRUG__ID D0MM3A D0MM3A DRUGCOMP Biogen D0MM3A HIGHSTAT Phase 2a D0U9OD DRUG__ID D0U9OD D0U9OD DRUGCOMP CreaGene Inc D0U9OD HIGHSTAT Phase 2a D00FHR DRUG__ID D00FHR D00FHR DRUGCOMP MethylGene Inc D00FHR THERCLAS Anticancer Agents D00FHR DRUGTYPE Small molecular drug D00FHR DRUGINCH 1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29) D00FHR DRUGINKE HRNLUBSXIHFDHP-UHFFFAOYSA-N D00FHR DRUGSMIL C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4 D00FHR HIGHSTAT Phase 2 D00YPR DRUG__ID D00YPR D00YPR DRUGCOMP OSI Pharmaceuticals D00YPR THERCLAS Anticancer Agents D00YPR DRUGTYPE Small molecular drug D00YPR DRUGINCH 1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30) D00YPR DRUGINKE HXHAJRMTJXHJJZ-UHFFFAOYSA-N D00YPR DRUGSMIL C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N D00YPR HIGHSTAT Phase 2 D01KMR DRUG__ID D01KMR D01KMR DRUGCOMP Merz Pharmaceuticals GmbH D01KMR THERCLAS Analgesics D01KMR DRUGTYPE Small molecular drug D01KMR DRUGINCH 1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3 D01KMR DRUGINKE OGZQTTHDGQBLBT-UHFFFAOYSA-N D01KMR DRUGSMIL CC1(CC(CC(C1)(C)N)(C)C)C D01KMR HIGHSTAT Phase 2 D01UMT DRUG__ID D01UMT D01UMT DRUGCOMP Hoffmann La Roche D01UMT THERCLAS Anticancer Agents D01UMT DRUGTYPE Small molecular drug D01UMT DRUGINCH 1S/C22H16N4O4/c1-24-10-15(13-5-3-4-6-17(13)24)19-20(22(28)23-21(19)27)16-11-25(2)18-9-12(26(29)30)7-8-14(16)18/h3-11H,1-2H3,(H,23,27,28) D01UMT DRUGINKE OVSKGTONMLKNPZ-UHFFFAOYSA-N D01UMT DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=C4C=CC(=C5)[N+](=O)[O-])C D01UMT HIGHSTAT Phase 2 D02LBK DRUG__ID D02LBK D02LBK DRUGCOMP Array BioPharma. D02LBK THERCLAS Analgesics D02LBK DRUGTYPE Small molecular drug D02LBK DRUGINCH 1S/C22H26F2N4O2/c1-14(2)13-28-19-11-17(22(29)25-7-8-27(3)4)21(9-15(19)12-26-28)30-20-6-5-16(23)10-18(20)24/h5-6,9-12,14H,7-8,13H2,1-4H3,(H,25,29) D02LBK DRUGINKE IFGWYHGYNVGVRB-UHFFFAOYSA-N D02LBK DRUGSMIL CC(C)CN1C2=CC(=C(C=C2C=N1)OC3=C(C=C(C=C3)F)F)C(=O)NCCN(C)C D02LBK HIGHSTAT Phase 2 D02XNW DRUG__ID D02XNW D02XNW DRUGCOMP Vertex; Merck D02XNW THERCLAS Anticancer Agents D02XNW DRUGTYPE Small molecular drug D02XNW DRUGINCH 1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29) D02XNW DRUGINKE GCIKSSRWRFVXBI-UHFFFAOYSA-N D02XNW DRUGSMIL CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C D02XNW HIGHSTAT Phase 2 D03KAC DRUG__ID D03KAC D03KAC DRUGCOMP Exelixis D03KAC THERCLAS Anticancer Agents D03KAC DRUGTYPE Small molecular drug D03KAC DRUGINCH 1S/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27) D03KAC DRUGINKE MQMKRQLTIWPEDM-UHFFFAOYSA-N D03KAC DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4 D03KAC HIGHSTAT Phase 2 D03NJY DRUG__ID D03NJY D03NJY DRUGCOMP Semafore Pharma D03NJY THERCLAS Anticancer Agents D03NJY DRUGTYPE Small molecular drug D03NJY DRUGINCH 1S/C39H48N8O14/c40-39(41)42-13-5-10-26(36(55)43-20-31(51)45-27(18-33(52)53)37(56)46-28(21-48)38(57)58)44-30(50)11-12-34(54)60-22-47(14-16-59-17-15-47)32-19-29(49)25-9-4-8-24(35(25)61-32)23-6-2-1-3-7-23/h1-4,6-9,19,26-28,48H,5,10-18,20-22H2,(H9-,40,41,42,43,44,45,46,50,51,52,53,55,56,57,58)/t26-,27-,28-/m0/s1 D03NJY DRUGINKE SVNJBEMPMKWDCO-KCHLEUMXSA-N D03NJY DRUGSMIL C1COCC[N+]1(COC(=O)CCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)[O-])C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4 D03NJY HIGHSTAT Phase 2 D04BUH DRUG__ID D04BUH D04BUH DRUGCOMP Esteve Laboratories D04BUH THERCLAS Analgesics D04BUH DRUGTYPE Small molecular drug D04BUH DRUGINCH 1S/C15H21N3O/c1-17(2)11-12-19-15(13-7-5-4-6-8-13)14-9-10-16-18(14)3/h4-10,15H,11-12H2,1-3H3 D04BUH DRUGINKE DCMJBKFKXGPPMT-UHFFFAOYSA-N D04BUH DRUGSMIL CN1C(=CC=N1)C(C2=CC=CC=C2)OCCN(C)C D04BUH HIGHSTAT Phase 2 D04JTD DRUG__ID D04JTD D04JTD DRUGCOMP Biomira D04JTD THERCLAS Anticancer Agents D04JTD DRUGTYPE Small molecular drug D04JTD DRUGINCH 1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9) D04JTD DRUGINKE BPBPYQWMFCTCNG-UHFFFAOYSA-N D04JTD DRUGSMIL CCC(C)SSC1=NC=CN1 D04JTD HIGHSTAT Phase 2 D04RCT DRUG__ID D04RCT D04RCT DRUGCOMP Chiesi D04RCT THERCLAS Analgesics D04RCT DRUGTYPE Small molecular drug D04RCT DRUGINCH 1S/C11H14N2O.ClH/c12-11(14)7-13-10-5-8-3-1-2-4-9(8)6-10;/h1-4,10,13H,5-7H2,(H2,12,14);1H D04RCT DRUGINKE JPNNIRXUJSPGRM-UHFFFAOYSA-N D04RCT DRUGSMIL C1C(CC2=CC=CC=C21)NCC(=O)N.Cl D04RCT HIGHSTAT Phase 2 D04VSI DRUG__ID D04VSI D04VSI DRUGCOMP Good Earth Medicine D04VSI THERCLAS Antiviral Agents D04VSI DRUGTYPE Small molecular drug D04VSI DRUGINCH 1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3 D04VSI DRUGINKE KCFYEAOKVJSACF-UHFFFAOYSA-N D04VSI DRUGSMIL CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3 D04VSI HIGHSTAT Phase 2 Trial D04VWJ DRUG__ID D04VWJ D04VWJ DRUGCOMP Array BioPharma. D04VWJ THERCLAS Anticancer Agents D04VWJ DRUGTYPE Small molecular drug D04VWJ DRUGINCH 1S/C20H22F2N4O2S/c1-25(28-2)19(27)26-20(11-6-12-23,14-7-4-3-5-8-14)29-18(24-26)16-13-15(21)9-10-17(16)22/h3-5,7-10,13H,6,11-12,23H2,1-2H3/t20-/m0/s1 D04VWJ DRUGINKE LLXISKGBWFTGEI-FQEVSTJZSA-N D04VWJ DRUGSMIL CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC D04VWJ HIGHSTAT Phase 2 D05BYA DRUG__ID D05BYA D05BYA DRUGCOMP Vernalis; Novartis D05BYA THERCLAS Anticancer Agents D05BYA DRUGTYPE Small molecular drug D05BYA DRUGINCH 1S/C26H31N3O5/c1-4-27-26(32)24-23(18-7-5-17(6-8-18)15-29-9-11-33-12-10-29)25(34-28-24)20-13-19(16(2)3)21(30)14-22(20)31/h5-8,13-14,16,30-31H,4,9-12,15H2,1-3H3,(H,27,32) D05BYA DRUGINKE NDAZATDQFDPQBD-UHFFFAOYSA-N D05BYA DRUGSMIL CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C D05BYA HIGHSTAT Phase 2 D05OQX DRUG__ID D05OQX D05OQX DRUGCOMP NiCox SA D05OQX THERCLAS Analgesics D05OQX DRUGTYPE Small molecular drug D05OQX DRUGINCH 1S/C16H13NO7/c1-11(18)23-15-8-3-2-7-14(15)16(19)24-13-6-4-5-12(9-13)10-22-17(20)21/h2-9H,10H2,1H3 D05OQX DRUGINKE IOJUJUOXKXMJNF-UHFFFAOYSA-N D05OQX DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)OC2=CC=CC(=C2)CO[N+](=O)[O-] D05OQX HIGHSTAT Phase 2 D05VVX DRUG__ID D05VVX D05VVX DRUGCOMP PTC Therape D05VVX THERCLAS Anticancer Agents D05VVX DRUGTYPE Small molecular drug D05VVX DRUGINCH 1S/C25H20Cl2N2O3/c1-31-18-7-2-15(3-8-18)24-23-20(21-14-17(27)6-11-22(21)28-23)12-13-29(24)25(30)32-19-9-4-16(26)5-10-19/h2-11,14,24,28H,12-13H2,1H3/t24-/m0/s1 D05VVX DRUGINKE SRSHBZRURUNOSM-DEOSSOPVSA-N D05VVX DRUGSMIL COC1=CC=C(C=C1)C2C3=C(CCN2C(=O)OC4=CC=C(C=C4)Cl)C5=C(N3)C=CC(=C5)Cl D05VVX HIGHSTAT Phase 2 D05XJW DRUG__ID D05XJW D05XJW DRUGCOMP Afferon D05XJW THERCLAS Analgesics D05XJW DRUGTYPE Small molecular drug D05XJW DRUGINCH 1S/C37H40O9/c1-21(2)35-17-23(4)37-27(33(35)44-36(45-35,46-37)19-24-9-7-6-8-10-24)14-26(18-34(41)30(37)13-22(3)32(34)40)20-43-31(39)16-25-11-12-28(38)29(15-25)42-5/h6-15,23,27,30,33,38,41H,1,16-20H2,2-5H3/t23-,27+,30-,33-,34-,35-,36-,37-/m1/s1 D05XJW DRUGINKE DSDNAKHZNJAGHN-MXTYGGKSSA-N D05XJW DRUGSMIL CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C D05XJW HIGHSTAT Phase 2 D07KVV DRUG__ID D07KVV D07KVV DRUGCOMP Karyopharm therapeutics D07KVV THERCLAS Antiviral Agents D07KVV DRUGTYPE Small molecular drug D07KVV DRUGINCH 1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1- D07KVV DRUGINKE DEVSOMFAQLZNKR-RJRFIUFISA-N D07KVV DRUGSMIL C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D07KVV HIGHSTAT Phase 2 Trial D07NOI DRUG__ID D07NOI D07NOI DRUGCOMP Bayer AG D07NOI THERCLAS Anticancer Agents D07NOI DRUGTYPE Small molecular drug D07NOI DRUGINCH 1S/C20H16ClN5O3/c1-22-19(27)16-10-12(6-8-23-16)11-29-20-17-15(7-9-28-17)18(25-26-20)24-14-4-2-13(21)3-5-14/h2-10H,11H2,1H3,(H,22,27)(H,24,25) D07NOI DRUGINKE QFCXANHHBCGMAS-UHFFFAOYSA-N D07NOI DRUGSMIL CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl D07NOI HIGHSTAT Phase 2 D09BEG DRUG__ID D09BEG D09BEG DRUGCOMP CeNeS D09BEG THERCLAS Analgesics D09BEG DRUGTYPE Small molecular drug D09BEG DRUGINCH 1S/C16H18ClN3S2/c1-20(11-5-4-6-12(9-11)21-2)16(18)19-15-10-13(22-3)7-8-14(15)17/h4-10H,1-3H3,(H2,18,19) D09BEG DRUGINKE JHVHEDNLONERHY-UHFFFAOYSA-N D09BEG DRUGSMIL CN(C1=CC(=CC=C1)SC)C(=NC2=C(C=CC(=C2)SC)Cl)N D09BEG HIGHSTAT Phase 2 D0B0NQ DRUG__ID D0B0NQ D0B0NQ DRUGCOMP Eli Lilly D0B0NQ THERCLAS Analgesics D0B0NQ DRUGTYPE Small molecular drug D0B0NQ DRUGINCH 1S/C13H21N5O2/c19-13(20)11-6-10-5-8(1-3-9(10)7-14-11)2-4-12-15-17-18-16-12/h8-11,14H,1-7H2,(H,19,20)(H,15,16,17,18)/t8-,9+,10-,11+/m1/s1 D0B0NQ DRUGINKE ZXFRFPSZAKNPQQ-YTWAJWBKSA-N D0B0NQ DRUGSMIL C1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O D0B0NQ HIGHSTAT Phase 2 D0C2ZL DRUG__ID D0C2ZL D0C2ZL DRUGCOMP Sanofi-Aventis D0C2ZL THERCLAS Analgesics D0C2ZL DRUGTYPE Small molecular drug D0C2ZL DRUGINCH 1S/C21H19Cl2N3O6S3/c22-14-1-6-18(25-34(28,29)20-8-7-19(23)33-20)17(13-14)21(27)24-15-2-4-16(5-3-15)35(30,31)26-9-11-32-12-10-26/h1-8,13,25H,9-12H2,(H,24,27) D0C2ZL DRUGINKE PQHLRGARXNPFCF-UHFFFAOYSA-N D0C2ZL DRUGSMIL C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl D0C2ZL HIGHSTAT Phase 2 D0C6VV DRUG__ID D0C6VV D0C6VV DRUGCOMP Protherics D0C6VV THERCLAS Anticancer Agents D0C6VV DRUGTYPE Small molecular drug D0C6VV DRUGINCH 1S/C8H11N3O2/c9-7(12)5-11-3-1-2-6(4-11)8(10)13/h1,3-4H,2,5H2,(H2,9,12)(H2,10,13) D0C6VV DRUGINKE WEJRSYKFMCUCRQ-UHFFFAOYSA-N D0C6VV DRUGSMIL C1C=CN(C=C1C(=O)N)CC(=O)N D0C6VV HIGHSTAT Phase 2 D0CN9Q DRUG__ID D0CN9Q D0CN9Q DRUGCOMP Pfizer D0CN9Q THERCLAS Anticancer Agents D0CN9Q DRUGTYPE Small molecular drug D0CN9Q DRUGINCH 1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+ D0CN9Q DRUGINKE LLVZBTWPGQVVLW-SNAWJCMRSA-N D0CN9Q DRUGSMIL CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)C=CCNC(=O)COC)C D0CN9Q HIGHSTAT Phase 2 D0D1GF DRUG__ID D0D1GF D0D1GF DRUGCOMP Exelixis; GlaxoSmithKline D0D1GF THERCLAS Anticancer Agents D0D1GF DRUGTYPE Small molecular drug D0D1GF DRUGINCH 1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42) D0D1GF DRUGINKE CXQHYVUVSFXTMY-UHFFFAOYSA-N D0D1GF DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F D0D1GF HIGHSTAT Phase 2 D0F2JS DRUG__ID D0F2JS D0F2JS DRUGCOMP Chroma Therape. D0F2JS THERCLAS Anticancer Agents D0F2JS DRUGTYPE Small molecular drug D0F2JS DRUGINCH 1S/C21H30N2O6/c1-13(2)12-16(18(24)20(26)23-28)19(25)22-17(14-8-4-3-5-9-14)21(27)29-15-10-6-7-11-15/h3-5,8-9,13,15-18,24,28H,6-7,10-12H2,1-2H3,(H,22,25)(H,23,26)/t16-,17+,18+/m1/s1 D0F2JS DRUGINKE FWFGIHPGRQZWIW-SQNIBIBYSA-N D0F2JS DRUGSMIL CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2 D0F2JS HIGHSTAT Phase 2 D0H7GQ DRUG__ID D0H7GQ D0H7GQ DRUGCOMP NeuroSearch D0H7GQ THERCLAS Analgesics D0H7GQ DRUGTYPE Small molecular drug D0H7GQ DRUGINCH 1S/C24H28N4O7S/c1-27(2)36(33,34)15-6-4-14(5-7-15)17-12-18-21(19-13-28(3)10-8-16(17)19)25-23(30)22(18)26-35-20(9-11-29)24(31)32/h4-7,12,20,29H,8-11,13H2,1-3H3,(H,31,32)(H,25,26,30) D0H7GQ DRUGINKE CFJRSKULEDUDKL-UHFFFAOYSA-N D0H7GQ DRUGSMIL CN1CCC2=C(C1)C3=C(C=C2C4=CC=C(C=C4)S(=O)(=O)N(C)C)C(=NOC(CCO)C(=O)O)C(=O)N3 D0H7GQ HIGHSTAT Phase 2 D0K0JQ DRUG__ID D0K0JQ D0K0JQ DRUGCOMP GSK D0K0JQ THERCLAS Analgesics D0K0JQ DRUGTYPE Small molecular drug D0K0JQ DRUGINCH 1S/C23H19F3N4O3/c1-12-9-13(24)5-6-15(12)20-16-7-8-19(33)30(21-17(25)3-2-4-18(21)26)22(16)29-23(28-20)27-14(10-31)11-32/h2-9,14,31-32H,10-11H2,1H3,(H,27,28,29) D0K0JQ DRUGINKE ORVNHOYNEHYKJG-UHFFFAOYSA-N D0K0JQ DRUGSMIL CC1=C(C=CC(=C1)F)C2=C3C=CC(=O)N(C3=NC(=N2)NC(CO)CO)C4=C(C=CC=C4F)F D0K0JQ HIGHSTAT Phase 2 D0K0YC DRUG__ID D0K0YC D0K0YC DRUGCOMP Pfizer D0K0YC THERCLAS Anticancer Agents D0K0YC DRUGTYPE Small molecular drug D0K0YC DRUGINCH 1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1 D0K0YC DRUGINKE SUDAHWBOROXANE-SECBINFHSA-N D0K0YC DRUGSMIL C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O D0K0YC HIGHSTAT Phase 2 D0KK9E DRUG__ID D0KK9E D0KK9E DRUGCOMP Adherex Technol. D0KK9E THERCLAS Anticancer Agents D0KK9E DRUGTYPE Small molecular drug D0KK9E DRUGINCH 1S/C22H34N8O6S2/c1-10(2)17-22(36)29-15(18(23)32)7-37-38-8-16(27-12(4)31)21(35)28-14(5-13-6-24-9-25-13)20(34)26-11(3)19(33)30-17/h6,9-11,14-17H,5,7-8H2,1-4H3,(H2,23,32)(H,24,25)(H,26,34)(H,27,31)(H,28,35)(H,29,36)(H,30,33)/t11-,14-,15-,16-,17-/m0/s1 D0KK9E DRUGINKE FQVLRGLGWNWPSS-BXBUPLCLSA-N D0KK9E DRUGSMIL CC1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CN=CN2)NC(=O)C)C(=O)N)C(C)C D0KK9E HIGHSTAT Phase 2 D0M0XB DRUG__ID D0M0XB D0M0XB DRUGCOMP AstraZeneca D0M0XB THERCLAS Anticancer Agents D0M0XB DRUGTYPE Small molecular drug D0M0XB DRUGINCH 1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31) D0M0XB DRUGINKE OUKYUETWWIPKQR-UHFFFAOYSA-N D0M0XB DRUGSMIL CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl D0M0XB HIGHSTAT Phase 2 D0N3EJ DRUG__ID D0N3EJ D0N3EJ DRUGCOMP Gedeon Richter D0N3EJ THERCLAS Analgesics D0N3EJ DRUGTYPE Small molecular drug D0N3EJ DRUGINCH 1S/C21H20FN3O4/c22-15-3-1-13(2-4-15)11-14-7-9-25(10-8-14)20(27)19(26)23-16-5-6-17-18(12-16)29-21(28)24-17/h1-6,12,14H,7-11H2,(H,23,26)(H,24,28) D0N3EJ DRUGINKE GKGRZLGAQZPEHO-UHFFFAOYSA-N D0N3EJ DRUGSMIL C1CN(CCC1CC2=CC=C(C=C2)F)C(=O)C(=O)NC3=CC4=C(C=C3)NC(=O)O4 D0N3EJ HIGHSTAT Phase 2 D0O0LQ DRUG__ID D0O0LQ D0O0LQ DRUGCOMP Boehringer Ingelheim D0O0LQ THERCLAS Anticancer Agents D0O0LQ DRUGTYPE Small molecular drug D0O0LQ DRUGINCH 1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1 D0O0LQ DRUGINKE XQVVPGYIWAGRNI-JOCHJYFZSA-N D0O0LQ DRUGSMIL CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C D0O0LQ HIGHSTAT Phase 2 D0P4BC DRUG__ID D0P4BC D0P4BC DRUGCOMP Odyssey Pharmaceuticals D0P4BC THERCLAS Antiviral Agents D0P4BC DRUGTYPE Small molecular drug D0P4BC DRUGINCH 1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3 D0P4BC DRUGINKE AUZONCFQVSMFAP-UHFFFAOYSA-N D0P4BC DRUGSMIL CCN(CC)C(=S)SSC(=S)N(CC)CC D0P4BC HIGHSTAT Phase 2 Trial D0PW4N DRUG__ID D0PW4N D0PW4N DRUGCOMP Cytokinetics D0PW4N THERCLAS Anticancer Agents D0PW4N DRUGTYPE Small molecular drug D0PW4N DRUGINCH 1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1 D0PW4N DRUGINKE QJZRFPJCWMNVAV-HHHXNRCGSA-N D0PW4N DRUGSMIL CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C D0PW4N HIGHSTAT Phase 2 D0SC2J DRUG__ID D0SC2J D0SC2J DRUGCOMP Bristol-Myers Squibb; Infinity Pharmaceuticals D0SC2J THERCLAS Anticancer Agents D0SC2J DRUGTYPE Small molecular drug D0SC2J DRUGINCH 1S/C31H43N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,36H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1 D0SC2J DRUGINKE AYUNIORJHRXIBJ-TXHRRWQRSA-N D0SC2J DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC D0SC2J HIGHSTAT Phase 2 D0T1GF DRUG__ID D0T1GF D0T1GF DRUGCOMP SuperGen D0T1GF THERCLAS Anticancer Agents D0T1GF DRUGTYPE Small molecular drug D0T1GF DRUGINCH 1S/C23H21N5O3S/c32-23(24-12-15-5-6-18-19(11-15)30-14-29-18)28-9-7-27(8-10-28)22-21-20(25-13-26-22)16-3-1-2-4-17(16)31-21/h1-6,11,13H,7-10,12,14H2,(H,24,32) D0T1GF DRUGINKE FOFDIMHVKGYHRU-UHFFFAOYSA-N D0T1GF DRUGSMIL C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6 D0T1GF HIGHSTAT Phase 2 D0U4EU DRUG__ID D0U4EU D0U4EU DRUGCOMP GlaxoSmithKline D0U4EU THERCLAS Anticancer Agents D0U4EU DRUGTYPE Small molecular drug D0U4EU DRUGINCH 1S/C31H33ClN2O3.ClH/c1-20(2)28(34(17-7-16-33)31(36)23-12-10-21(3)11-13-23)30-26(18-22-8-5-4-6-9-22)29(35)25-15-14-24(32)19-27(25)37-30;/h4-6,8-15,19-20,28H,7,16-18,33H2,1-3H3;1H/t28-;/m1./s1 D0U4EU DRUGINKE MLMZVWABFOLFGV-LNLSOMNWSA-N D0U4EU DRUGSMIL CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=C(C(=O)C3=C(O2)C=C(C=C3)Cl)CC4=CC=CC=C4)C(C)C.Cl D0U4EU HIGHSTAT Phase 2 D0U4FF DRUG__ID D0U4FF D0U4FF DRUGCOMP Bristol Myers Squibb D0U4FF THERCLAS Anticancer Agents D0U4FF DRUGTYPE Small molecular drug D0U4FF DRUGINCH 1S/C27H27FN8O3/c1-17-23(34-27(37)39-15-22-14-38-8-7-29-22)13-36-25(17)26(30-16-32-36)33-21-5-6-24-19(10-21)11-31-35(24)12-18-3-2-4-20(28)9-18/h2-6,9-11,13,16,22,29H,7-8,12,14-15H2,1H3,(H,34,37)(H,30,32,33)/t22-/m0/s1 D0U4FF DRUGINKE LUJZZYWHBDHDQX-QFIPXVFZSA-N D0U4FF DRUGSMIL CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F D0U4FF HIGHSTAT Phase 2 D0VE1W DRUG__ID D0VE1W D0VE1W DRUGCOMP GlaxoSmithKline D0VE1W THERCLAS Anticancer Agents D0VE1W DRUGTYPE Small molecular drug D0VE1W DRUGINCH 1S/C24H30N4O2/c1-3-27(4-2)16-17-28-22-13-10-20(12-15-24(29)26-30)18-21(22)25-23(28)14-11-19-8-6-5-7-9-19/h5-10,12-13,15,18,30H,3-4,11,14,16-17H2,1-2H3,(H,26,29)/b15-12+ D0VE1W DRUGINKE FFXUDLUXUIJFSS-NTCAYCPXSA-N D0VE1W DRUGSMIL CCN(CC)CCN1C2=C(C=C(C=C2)C=CC(=O)NO)N=C1CCC3=CC=CC=C3 D0VE1W HIGHSTAT Phase 2 D0XT6W DRUG__ID D0XT6W D0XT6W DRUGCOMP National Cancer Institute (NCI) D0XT6W THERCLAS Anticancer Agents D0XT6W DRUGTYPE Small molecular drug D0XT6W DRUGINCH 1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+ D0XT6W DRUGINKE NCNRHFGMJRPRSK-MDZDMXLPSA-N D0XT6W DRUGSMIL C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO D0XT6W HIGHSTAT Phase 2 D0YB3W DRUG__ID D0YB3W D0YB3W DRUGCOMP Pfizer D0YB3W THERCLAS Anticancer Agents D0YB3W DRUGTYPE Small molecular drug D0YB3W DRUGINCH 1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29) D0YB3W DRUGINKE OMZCMEYTWSXEPZ-UHFFFAOYSA-N D0YB3W DRUGSMIL C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 D0YB3W HIGHSTAT Phase 2 D0Z9VY DRUG__ID D0Z9VY D0Z9VY DRUGCOMP Keryx BioPharma. D0Z9VY THERCLAS Anticancer Agents D0Z9VY DRUGTYPE Small molecular drug D0Z9VY DRUGINCH 1S/C28H26N4O4/c1-28-25(35-3)15(29-2)12-18(36-28)31-16-10-6-4-8-13(16)19-21-22(27(34)30-26(21)33)20-14-9-5-7-11-17(14)32(28)24(20)23(19)31/h4-11,15,18,25,27,29,34H,12H2,1-3H3,(H,30,33)/t15-,18-,25-,27-,28+/m1/s1 D0Z9VY DRUGINKE PBCZSGKMGDDXIJ-HQCWYSJUSA-N D0Z9VY DRUGSMIL CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(NC6=O)O)NC)OC D0Z9VY HIGHSTAT Phase 2 D00AKV DRUG__ID D00AKV D00AKV DRUGCOMP GNI Ltd D00AKV DRUGTYPE Small molecular drug D00AKV DRUGINCH 1S/C12H11NO2/c1-9-2-7-12(15)13(8-9)10-3-5-11(14)6-4-10/h2-8,14H,1H3 D00AKV DRUGINKE NETTXQJYJRFTFS-UHFFFAOYSA-N D00AKV DRUGSMIL CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O D00AKV HIGHSTAT Phase 2 D00AUX DRUG__ID D00AUX D00AUX DRUGCOMP Metabolic Solutions Development D00AUX DRUGTYPE Small molecular drug D00AUX DRUGINCH 1S/C19H17NO5S/c1-24-15-4-2-3-13(10-15)16(21)11-25-14-7-5-12(6-8-14)9-17-18(22)20-19(23)26-17/h2-8,10,17H,9,11H2,1H3,(H,20,22,23) D00AUX DRUGINKE YAUMOGALQJYOJQ-UHFFFAOYSA-N D00AUX DRUGSMIL COC1=CC=CC(=C1)C(=O)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D00AUX HIGHSTAT Phase 2 D00BOY DRUG__ID D00BOY D00BOY DRUGCOMP Cephalon D00BOY DRUGTYPE Small molecular drug D00BOY DRUGINCH 1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14?,18-,19-/m0/s1 D00BOY DRUGINKE SJFBTAPEPRWNKH-SQJZIBIZSA-N D00BOY DRUGSMIL B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O D00BOY HIGHSTAT Phase 2 D00BUR DRUG__ID D00BUR D00BUR DRUGCOMP Icagen D00BUR DRUGTYPE Small molecular drug D00BUR DRUGINCH 1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24) D00BUR DRUGINKE SCTZUZTYRMOMKT-UHFFFAOYSA-N D00BUR DRUGSMIL C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N D00BUR HIGHSTAT Phase 2 D00BWF DRUG__ID D00BWF D00BWF DRUGCOMP ACADIA Pharmaceuticals D00BWF DRUGTYPE Small molecular drug D00BWF DRUGINCH 1S/C13H16N2S/c1-8-5-4-6-11(9(8)2)10(3)12-7-14-13(16)15-12/h4-7,10H,1-3H3,(H2,14,15,16)/t10-/m0/s1 D00BWF DRUGINKE WQXVKEDUCPMRRI-JTQLQIEISA-N D00BWF DRUGSMIL CC1=C(C(=CC=C1)C(C)C2=CNC(=S)N2)C D00BWF HIGHSTAT Phase 2 D00BZS DRUG__ID D00BZS D00BZS DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D00BZS DRUGTYPE Small molecular drug D00BZS DRUGINCH 1S/C25H25N3O5/c1-5-25(31)18-10-20-21-16(12-28(20)22(29)17(18)13-32-23(25)30)15(11-26-33-24(2,3)4)14-8-6-7-9-19(14)27-21/h6-11,31H,5,12-13H2,1-4H3/b26-11+/t25-/m0/s1 D00BZS DRUGINKE UIVFUQKYVFCEKJ-OPTOVBNMSA-N D00BZS DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)C=NOC(C)(C)C)O D00BZS HIGHSTAT Phase 2 D00CVJ DRUG__ID D00CVJ D00CVJ DRUGCOMP Neurim Pharmaceuticals D00CVJ DRUGTYPE Small molecular drug D00CVJ DRUGINCH 1S/C17H16N2O4/c1-22-13-2-3-15-14(9-13)11(10-19-15)4-6-18-17(21)16-8-12(20)5-7-23-16/h2-3,5,7-10,19H,4,6H2,1H3,(H,18,21) D00CVJ DRUGINKE PNTNBIHOAPJYDB-UHFFFAOYSA-N D00CVJ DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCNC(=O)C3=CC(=O)C=CO3 D00CVJ HIGHSTAT Phase 2 D00DYK DRUG__ID D00DYK D00DYK DRUGCOMP Johns Hopkins University D00DYK DRUGTYPE Small molecular drug D00DYK DRUGINCH 1S/C28H42O4S/c1-19(9-8-16-33(31,32)27(3,4)5)24-13-14-25-21(10-7-15-28(24,25)6)11-12-22-17-23(29)18-26(30)20(22)2/h8,11-13,16,19,23,25-26,29-30H,2,7,9-10,14-15,17-18H2,1,3-6H3/b16-8+,21-11+,22-12-/t19-,23-,25+,26+,28-/m1/s1 D00DYK DRUGINKE RFQHCLMGLJGZNV-UXXOMSPDSA-N D00DYK DRUGSMIL CC(CC=CS(=O)(=O)C(C)(C)C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D00DYK HIGHSTAT Phase 2 D00EPT DRUG__ID D00EPT D00EPT DRUGCOMP Eisai D00EPT DRUGTYPE Small molecular drug D00EPT DRUGINCH 1S/C15H18O3/c1-8-6-10-12(11(8)7-16)9(2)15(4-5-15)14(3,18)13(10)17/h6,16,18H,4-5,7H2,1-3H3/t14-/m0/s1 D00EPT DRUGINKE NICJCIQSJJKZAH-AWEZNQCLSA-N D00EPT DRUGSMIL CC1=C(C2=C(C3(CC3)C(C(=O)C2=C1)(C)O)C)CO D00EPT HIGHSTAT Phase 2 D00EVP DRUG__ID D00EVP D00EVP DRUGCOMP Allergan Inc D00EVP DRUGTYPE Small molecular drug D00EVP DRUGINCH 1S/C26H35NO5S/c1-4-5-6-7-23(28)19-8-10-20(11-9-19)27-21(12-15-25(27)29)16-31-17-22-13-14-24(33-22)26(30)32-18(2)3/h8-11,13-14,18,21,23,28H,4-7,12,15-17H2,1-3H3/t21-,23+/m1/s1 D00EVP DRUGINKE MSIIJNOQQWRTFC-GGAORHGYSA-N D00EVP DRUGSMIL CCCCCC(C1=CC=C(C=C1)N2C(CCC2=O)COCC3=CC=C(S3)C(=O)OC(C)C)O D00EVP HIGHSTAT Phase 2 D00GXL DRUG__ID D00GXL D00GXL DRUGCOMP Prana biotechnology D00GXL DRUGTYPE Small molecular drug D00GXL DRUGINCH 1S/C12H12Cl2N2O/c1-16(2)6-7-3-4-8-9(13)5-10(14)12(17)11(8)15-7/h3-5,17H,6H2,1-2H3 D00GXL DRUGINKE YZPOQCQXOSEMAZ-UHFFFAOYSA-N D00GXL DRUGSMIL CN(C)CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl D00GXL HIGHSTAT Phase 2 D00HTO DRUG__ID D00HTO D00HTO DRUGCOMP Genzyme D00HTO DRUGTYPE Small molecular drug D00HTO DRUGINCH 1S/C28H52O7P2/c1-18(2)32-36(30,33-19(3)4)25(37(31,34-20(5)6)35-21(7)8)17-22-15-23(27(9,10)11)26(29)24(16-22)28(12,13)14/h15-16,18-21,25,29H,17H2,1-14H3 D00HTO DRUGINKE YLJOVCWVJCDPLN-UHFFFAOYSA-N D00HTO DRUGSMIL CC(C)OP(=O)(C(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)P(=O)(OC(C)C)OC(C)C)OC(C)C D00HTO HIGHSTAT Phase 2 D00HYK DRUG__ID D00HYK D00HYK DRUGCOMP Affinium pharmaceuticals D00HYK DRUGTYPE Small molecular drug D00HYK DRUGINCH 1S/C22H21N3O3/c1-14-17-5-3-4-6-18(17)28-19(14)13-25(2)21(27)10-7-15-11-16-8-9-20(26)24-22(16)23-12-15/h3-7,10-12H,8-9,13H2,1-2H3,(H,23,24,26)/b10-7+ D00HYK DRUGINKE QXTWSUQCXCWEHF-JXMROGBWSA-N D00HYK DRUGSMIL CC1=C(OC2=CC=CC=C12)CN(C)C(=O)C=CC3=CC4=C(NC(=O)CC4)N=C3 D00HYK HIGHSTAT Phase 2 D00IQH DRUG__ID D00IQH D00IQH DRUGCOMP Pfizer Inc; RaQualia Pharma Inc D00IQH DRUGTYPE Small molecular drug D00IQH DRUGINCH 1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32) D00IQH DRUGINKE HZVLFTCYCLXTGV-UHFFFAOYSA-N D00IQH DRUGSMIL CCC1=NC2=C(N1C3=CC=C(C=C3)CCNC(=O)NS(=O)(=O)C4=CC=C(C=C4)C)C=C(N=C2C)C D00IQH HIGHSTAT Phase 2 D00ISN DRUG__ID D00ISN D00ISN DRUGCOMP Mitsubishi Tanabe Pharma Corp D00ISN DRUGTYPE Small molecular drug D00ISN DRUGINCH 1S/C19H30F3NO3.ClH/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25;/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3;1H D00ISN DRUGINKE GEDVJGOVRLHFQG-UHFFFAOYSA-N D00ISN DRUGSMIL CCCCCCCOC1=C(C=C(C=C1)CCC(CO)(CO)N)C(F)(F)F.Cl D00ISN HIGHSTAT Phase 2 D00IUD DRUG__ID D00IUD D00IUD DRUGCOMP Kowa D00IUD DRUGTYPE Small molecular drug D00IUD DRUGINCH 1S/C24H19ClN2OS/c1-29-21-13-9-19(10-14-21)24-22(18-7-11-20(25)12-8-18)15-23(28)27(26-24)16-17-5-3-2-4-6-17/h2-15H,16H2,1H3 D00IUD DRUGINKE HEUAVAATAFEENP-UHFFFAOYSA-N D00IUD DRUGSMIL CSC1=CC=C(C=C1)C2=NN(C(=O)C=C2C3=CC=C(C=C3)Cl)CC4=CC=CC=C4 D00IUD HIGHSTAT Phase 2 D00IYB DRUG__ID D00IYB D00IYB DRUGCOMP GE Healthcare D00IYB DRUGTYPE Small molecular drug D00IYB DRUGINCH 1S/C72H120N20O21S3/c1-45(91-108)71(3,4)82-26-21-47(22-27-83-72(5,6)46(2)92-109)20-25-77-58(95)19-12-18-57(94)76-23-11-10-16-50-65(103)89-54-42-115-116-43-55(90-67(105)52(37-62(99)100)85-59(96)38-81-63(101)49(86-68(54)106)17-13-24-80-70(74)75)69(107)87-51(36-48-14-8-7-9-15-48)66(104)88-53(41-114-44-61(98)84-50)64(102)79-29-31-111-33-35-112-34-32-110-30-28-78-60(97)40-113-39-56(73)93/h7-9,14-15,47,49-55,82-83,108-109H,10-13,16-44H2,1-6H3,(H2,73,93)(H,76,94)(H,77,95)(H,78,97)(H,79,102)(H,81,101)(H,84,98)(H,85,96)(H,86,106)(H,87,107)(H,88,104)(H,89,103)(H,90,105)(H,99,100)(H4,74,75,80)/t47?,49-,50-,51-,52-,53-,54-,55-/m0/s1 D00IYB DRUGINKE OTOMOKKNHNZSBB-CQSZQERZSA-N D00IYB DRUGSMIL CC(=NO)C(C)(C)NCCC(CCNC(=O)CCCC(=O)NCCCCC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(CSCC(=O)N1)C(=O)NCCOCCOCCOCCNC(=O)COCC(=O)N)CC3=CC=CC=C3)NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)CCNC(C)(C)C(=NO)C D00IYB HIGHSTAT Phase 2 D00KTV DRUG__ID D00KTV D00KTV DRUGCOMP Kadmon D00KTV DRUGTYPE Small molecular drug D00KTV DRUGINCH 1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+ D00KTV DRUGINKE WUILNKCFCLNXOK-CFBAGHHKSA-N D00KTV DRUGSMIL CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C D00KTV HIGHSTAT Phase 2 D00LSI DRUG__ID D00LSI D00LSI DRUGCOMP 4SC AG D00LSI DRUGTYPE Small molecular drug D00LSI DRUGINCH 1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25) D00LSI DRUGINKE XPRDUGXOWVXZLL-UHFFFAOYSA-N D00LSI DRUGSMIL COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F D00LSI HIGHSTAT Phase 2 D00LSW DRUG__ID D00LSW D00LSW DRUGCOMP Ferring Pharmaceuticals Inc D00LSW DRUGTYPE Small molecular drug D00LSW DRUGINCH 1S/C23H21ClFN5O2/c1-29-21-16(11-27-29)12-30(20-7-6-17(24)9-19(20)28-21)23(32)14-4-5-15(18(25)8-14)10-26-22(31)13-2-3-13/h4-9,11,13,28H,2-3,10,12H2,1H3,(H,26,31) D00LSW DRUGINKE VOEZSPDOPDPGSY-UHFFFAOYSA-N D00LSW DRUGSMIL CN1C2=C(CN(C3=C(N2)C=C(C=C3)Cl)C(=O)C4=CC(=C(C=C4)CNC(=O)C5CC5)F)C=N1 D00LSW HIGHSTAT Phase 2 D00MXN DRUG__ID D00MXN D00MXN DRUGCOMP Merck & Co Inc D00MXN DRUGTYPE Small molecular drug D00MXN DRUGINCH 1S/C31H29F2N5O3/c32-21-10-19(11-22(33)13-21)25-16-35-31(7-1-2-8-31)29(41)38(25)17-26(39)36-23-6-5-18-14-30(15-20(18)12-23)24-4-3-9-34-27(24)37-28(30)40/h3-6,9-13,25,35H,1-2,7-8,14-17H2,(H,36,39)(H,34,37,40)/t25-,30+/m0/s1 D00MXN DRUGINKE AZAANWYREOQRFB-SETSBSEESA-N D00MXN DRUGSMIL C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4 D00MXN HIGHSTAT Phase 2 D00NVO DRUG__ID D00NVO D00NVO DRUGCOMP ASTA Medica AG D00NVO DRUGTYPE Small molecular drug D00NVO DRUGINCH 1S/C29H30FN3O/c30-24-14-12-23(13-15-24)21-28-26-10-4-5-11-27(26)29(34)33(31-28)25-9-6-18-32(20-17-25)19-16-22-7-2-1-3-8-22/h1-5,7-8,10-15,25H,6,9,16-21H2 D00NVO DRUGINKE HQFSNUYUXXPVKL-UHFFFAOYSA-N D00NVO DRUGSMIL C1CC(CCN(C1)CCC2=CC=CC=C2)N3C(=O)C4=CC=CC=C4C(=N3)CC5=CC=C(C=C5)F D00NVO HIGHSTAT Phase 2 D00NXM DRUG__ID D00NXM D00NXM DRUGCOMP Anacor Pharmaceuticals Inc D00NXM DRUGTYPE Small molecular drug D00NXM DRUGINCH 1S/C11H16BNO4/c13-7-10-8-3-1-4-9(16-6-2-5-14)11(8)12(15)17-10/h1,3-4,10,14-15H,2,5-7,13H2/t10-/m1/s1 D00NXM DRUGINKE FXQIIDINBDJDKL-SNVBAGLBSA-N D00NXM DRUGSMIL B1(C2=C(C=CC=C2OCCCO)C(O1)CN)O D00NXM HIGHSTAT Phase 2 D00NZL DRUG__ID D00NZL D00NZL DRUGCOMP Eli Lilly D00NZL DRUGTYPE Small molecular drug D00NZL DRUGINCH 1S/C18H22BrN5O3/c1-11-5-16(27-10-13-8-20-3-4-26-13)15(6-14(11)19)23-18(25)24-17-9-21-12(2)7-22-17/h5-7,9,13,20H,3-4,8,10H2,1-2H3,(H2,22,23,24,25)/t13-/m0/s1 D00NZL DRUGINKE SYYBDNPGDKKJDU-ZDUSSCGKSA-N D00NZL DRUGSMIL CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3 D00NZL HIGHSTAT Phase 2 D00OYQ DRUG__ID D00OYQ D00OYQ DRUGCOMP MetaPhore Pharmaceuticals D00OYQ DRUGTYPE Small molecular drug D00OYQ DRUGINCH 1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m1.../s1 D00OYQ DRUGINKE WXEMWBBXVXHEPU-XNPJUPKFSA-L D00OYQ DRUGSMIL C1CCC2C(C1)NCCNC3CCCCC3NCC4=CC=CC(=N4)CN2.Cl[Mn]Cl D00OYQ HIGHSTAT Phase 2 D00PJJ DRUG__ID D00PJJ D00PJJ DRUGCOMP Fujisawa Pharmaceutical Co Ltd; aestus therapeutics D00PJJ DRUGTYPE Small molecular drug D00PJJ DRUGINCH 1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)15-7-9-19-20(11-15)26(14(2)24-19)13-16-6-8-17(22)12-18(16)23/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27) D00PJJ DRUGINKE UYGZODVVDUIDDQ-UHFFFAOYSA-N D00PJJ DRUGSMIL CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=C(C=C(C=C3)Cl)Cl)C D00PJJ HIGHSTAT Phase 2 D00QKI DRUG__ID D00QKI D00QKI DRUGCOMP Pharmacopeia; Schering-Plough D00QKI DRUGTYPE Small molecular drug D00QKI DRUGINCH 1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1 D00QKI DRUGINKE RXIUEIPPLAFSDF-CYBMUJFWSA-N D00QKI DRUGSMIL CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C D00QKI HIGHSTAT Phase 2 D00QVT DRUG__ID D00QVT D00QVT DRUGCOMP University of Michigan D00QVT DRUGTYPE Small molecular drug D00QVT DRUGINCH 1S/C23H35N9O8S/c1-11(34)32-4-2-3-17(32)23(40)29-14(5-12-7-26-10-27-12)20(37)30-15(8-33)21(38)31-16(9-41)22(39)28-13(19(25)36)6-18(24)35/h7,10,13-17,33,41H,2-6,8-9H2,1H3,(H2,24,35)(H2,25,36)(H,26,27)(H,28,39)(H,29,40)(H,30,37)(H,31,38)/t13-,14-,15-,16-,17-/m0/s1 D00QVT DRUGINKE MMHDBUJXLOFTLC-WOYTXXSLSA-N D00QVT DRUGSMIL CC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)N D00QVT HIGHSTAT Phase 2 D00RJB DRUG__ID D00RJB D00RJB DRUGCOMP Hoechst AG D00RJB DRUGTYPE Small molecular drug D00RJB DRUGINCH 1S/C19H16ClNO4/c1-13-10-15(21(23)19(22)11-13)12-24-16-6-8-18(9-7-16)25-17-4-2-14(20)3-5-17/h2-11,23H,12H2,1H3 D00RJB DRUGINKE UDYUIWXQUBNDHC-UHFFFAOYSA-N D00RJB DRUGSMIL CC1=CC(=O)N(C(=C1)COC2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)O D00RJB HIGHSTAT Phase 2 D00RWQ DRUG__ID D00RWQ D00RWQ DRUGCOMP CeNeRx Pharma D00RWQ DRUGTYPE Small molecular drug D00RWQ DRUGINCH 1S/C14H8F4O4S/c15-8-1-3-12-10(5-8)22-11-6-9(21-7-14(16,17)18)2-4-13(11)23(12,19)20/h1-6H,7H2 D00RWQ DRUGINKE PDIMOTRDGUQMNY-UHFFFAOYSA-N D00RWQ DRUGSMIL C1=CC2=C(C=C1OCC(F)(F)F)OC3=C(S2(=O)=O)C=CC(=C3)F D00RWQ HIGHSTAT Phase 2 D00SBD DRUG__ID D00SBD D00SBD DRUGCOMP Dong-A Pharmaceutical Co Ltd D00SBD DRUGTYPE Small molecular drug D00SBD DRUGINCH 1S/C20H18O8/c1-24-14-5-4-11(6-16(14)25-2)15-9-13(21)20-17(26-3)7-12(8-18(20)28-15)27-10-19(22)23/h4-9H,10H2,1-3H3,(H,22,23) D00SBD DRUGINKE BCPQOBQIVJZOFL-UHFFFAOYSA-N D00SBD DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3OC)OCC(=O)O)OC D00SBD HIGHSTAT Phase 2 D00SWQ DRUG__ID D00SWQ D00SWQ DRUGCOMP Metabolic Solutions Development D00SWQ DRUGTYPE Small molecular drug D00SWQ DRUGINCH 1S/C19H18N2O4S/c1-2-12-5-8-15(20-10-12)16(22)11-25-14-6-3-13(4-7-14)9-17-18(23)21-19(24)26-17/h3-8,10,17H,2,9,11H2,1H3,(H,21,23,24) D00SWQ DRUGINKE IRNJSRAGRIZIHD-UHFFFAOYSA-N D00SWQ DRUGSMIL CCC1=CN=C(C=C1)C(=O)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D00SWQ HIGHSTAT Phase 2 D00THA DRUG__ID D00THA D00THA DRUGCOMP Qlt D00THA DRUGTYPE Small molecular drug D00THA DRUGINCH 1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9-,18-14+ D00THA DRUGINKE QGNJRVVDBSJHIZ-AQDFTDIISA-N D00THA DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C D00THA HIGHSTAT Phase 2 D00UDP DRUG__ID D00UDP D00UDP DRUGCOMP Erimos D00UDP DRUGTYPE Small molecular drug D00UDP DRUGINCH 1S/C22H30O4/c1-15(11-17-7-9-19(23-3)21(13-17)25-5)16(2)12-18-8-10-20(24-4)22(14-18)26-6/h7-10,13-16H,11-12H2,1-6H3/t15-,16+ D00UDP DRUGINKE ORQFDHFZSMXRLM-IYBDPMFKSA-N D00UDP DRUGSMIL CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC D00UDP HIGHSTAT Phase 2 D00UWY DRUG__ID D00UWY D00UWY DRUGCOMP Revance Therapeutics Inc D00UWY DRUGTYPE Small molecular drug D00UWY DRUGINCH 1S/C20H36O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-4-2/h8-9,11-12H,3-7,10,13-19H2,1-2H3/b9-8-,12-11-/i10D2 D00UWY DRUGINKE FMMOOAYVCKXGMF-XMCVDNGOSA-N D00UWY DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)OCC D00UWY HIGHSTAT Phase 2 D00WZK DRUG__ID D00WZK D00WZK DRUGCOMP Nabriva therapeutics D00WZK DRUGTYPE Small molecular drug D00WZK DRUGINCH 1S/C28H45NO5S/c1-6-26(4)14-22(34-23(32)15-35-21-8-7-18(29)13-20(21)31)27(5)16(2)9-11-28(17(3)25(26)33)12-10-19(30)24(27)28/h6,16-18,20-22,24-25,31,33H,1,7-15,29H2,2-5H3/t16-,17+,18?,20?,21?,22-,24+,25+,26-,27+,28+/m1/s1 D00WZK DRUGINKE KPVIXBKIJXZQJX-IJUBVZAWSA-N D00WZK DRUGSMIL CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C D00WZK HIGHSTAT Phase 2 D00YER DRUG__ID D00YER D00YER DRUGCOMP Hanmi Pharmaceutical Co Ltd D00YER DRUGTYPE Small molecular drug D00YER DRUGINCH 1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29) D00YER DRUGINKE LPFWVDIFUFFKJU-UHFFFAOYSA-N D00YER DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C D00YER HIGHSTAT Phase 2 D01ASM DRUG__ID D01ASM D01ASM DRUGCOMP Scios Inc D01ASM DRUGTYPE Small molecular drug D01ASM DRUGINCH 1S/C21H23NO4/c1-13(2)11-19(20(23)24)22-21(25)26-12-18-16-9-5-3-7-14(16)15-8-4-6-10-17(15)18/h3-10,13,18-19H,11-12H2,1-2H3,(H,22,25)(H,23,24)/t19-/m0/s1 D01ASM DRUGINKE CBPJQFCAFFNICX-IBGZPJMESA-N D01ASM DRUGSMIL CC(C)CC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 D01ASM HIGHSTAT Phase 2 D01AZP DRUG__ID D01AZP D01AZP DRUGCOMP Iliad Chemicals Pty Ltd D01AZP DRUGTYPE Small molecular drug D01AZP DRUGINCH 1S/C20H20O7/c1-10-16(12-6-7-13(23-2)18(22)19(12)27-10)17(21)11-8-14(24-3)20(26-5)15(9-11)25-4/h6-9,22H,1-5H3 D01AZP DRUGINKE RADMJHVVIZTENA-UHFFFAOYSA-N D01AZP DRUGSMIL CC1=C(C2=C(O1)C(=C(C=C2)OC)O)C(=O)C3=CC(=C(C(=C3)OC)OC)OC D01AZP HIGHSTAT Phase 2 D01BDY DRUG__ID D01BDY D01BDY DRUGCOMP Grunenthal GmbH D01BDY DRUGTYPE Small molecular drug D01BDY DRUGINCH 1S/C16H25NO3/c1-17(2)11-13-7-8-14(18)10-16(13,19)12-5-4-6-15(9-12)20-3/h4-6,9,13-14,18-19H,7-8,10-11H2,1-3H3/t13-,14-,16+/m1/s1 D01BDY DRUGINKE LQJLLAOISDVBJM-FMKPAKJESA-N D01BDY DRUGSMIL CN(C)CC1CCC(CC1(C2=CC(=CC=C2)OC)O)O D01BDY HIGHSTAT Phase 2 D01BVI DRUG__ID D01BVI D01BVI DRUGCOMP Vicept Therapeutics Inc D01BVI DRUGTYPE Small molecular drug D01BVI DRUGINCH 1S/C12H6Cl4S/c13-7-1-3-8(4-2-7)17-12-6-10(15)9(14)5-11(12)16/h1-6H D01BVI DRUGINKE QUWSDLYBOVGOCW-UHFFFAOYSA-N D01BVI DRUGSMIL C1=CC(=CC=C1SC2=CC(=C(C=C2Cl)Cl)Cl)Cl D01BVI HIGHSTAT Phase 2 D01CNB DRUG__ID D01CNB D01CNB DRUGCOMP Eisai Ltd. D01CNB DRUGTYPE Small molecular drug D01CNB DRUGINCH 1S/C21H27NO6/c1-4-22-15-10-14-6-5-7-16(23)20(26)17(24)9-8-12(2)13(3)28-21(27)19(14)18(25)11-15/h5-6,8-13,16,20,22-23,25-26H,4,7H2,1-3H3/b6-5+,9-8-/t12-,13+,16+,20+/m1/s1 D01CNB DRUGINKE MWUFVYLAWAXDHQ-HMNLTAHHSA-N D01CNB DRUGSMIL CCNC1=CC2=C(C(=C1)O)C(=O)OC(C(C=CC(=O)C(C(CC=C2)O)O)C)C D01CNB HIGHSTAT Phase 2 D01DDN DRUG__ID D01DDN D01DDN DRUGCOMP Merck D01DDN DRUGTYPE Small molecular drug D01DDN DRUGINCH 1S/C14H16N2O4/c1-14(5-6-14)4-2-3-8-7-9(17)20-12-10(8)11(18)15-13(19)16-12/h7H,2-6H2,1H3,(H2,15,16,18,19) D01DDN DRUGINKE ARJKMWXLIHZLQZ-UHFFFAOYSA-N D01DDN DRUGSMIL CC1(CC1)CCCC2=CC(=O)OC3=C2C(=O)NC(=O)N3 D01DDN HIGHSTAT Phase 2 D01ELU DRUG__ID D01ELU D01ELU DRUGCOMP Canbex Therapeutics Ltd D01ELU DRUGTYPE Small molecular drug D01ELU DRUGINCH 1S/C18H26N2O3/c1-14(13-21)19-18(23)16-10-7-9-15(12-16)8-5-4-6-11-17(22)20(2)3/h5,7-10,12,14,21H,4,6,11,13H2,1-3H3,(H,19,23)/b8-5-/t14-/m1/s1 D01ELU DRUGINKE SVYRYFAUQHVGAI-BMWLXYDHSA-N D01ELU DRUGSMIL CC(CO)NC(=O)C1=CC=CC(=C1)C=CCCCC(=O)N(C)C D01ELU HIGHSTAT Phase 2 D01FQR DRUG__ID D01FQR D01FQR DRUGCOMP Johnson & Johnson D01FQR DRUGTYPE Small molecular drug D01FQR DRUGINCH 1S/C24H25FN4O2/c1-15-4-3-10-29-23(15)26-16(2)19(24(29)30)9-13-28-11-7-17(8-12-28)22-20-6-5-18(25)14-21(20)31-27-22/h3-6,10,14,17H,7-9,11-13H2,1-2H3 D01FQR DRUGINKE ZZQNEJILGNNOEP-UHFFFAOYSA-N D01FQR DRUGSMIL CC1=CC=CN2C1=NC(=C(C2=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F)C D01FQR HIGHSTAT Phase 2 D01HBG DRUG__ID D01HBG D01HBG DRUGCOMP Rhone-Poulenc SA D01HBG DRUGTYPE Small molecular drug D01HBG DRUGINCH 1S/C23H29N3OS/c1-3-12-24-23(27)18-10-11-22-20(15-18)26(17(2)16-25-13-6-7-14-25)19-8-4-5-9-21(19)28-22/h4-5,8-11,15,17H,3,6-7,12-14,16H2,1-2H3,(H,24,27)/t17-/m1/s1 D01HBG DRUGINKE KXMAIWXPZGQNCR-QGZVFWFLSA-N D01HBG DRUGSMIL CCCNC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2C(C)CN4CCCC4 D01HBG HIGHSTAT Phase 2 D01HDP DRUG__ID D01HDP D01HDP DRUGCOMP Solvay Pharma D01HDP DRUGTYPE Small molecular drug D01HDP DRUGINCH 1S/C31H38N2O6/c1-2-39-29(37)24(15-14-22-10-4-3-5-11-22)20-31(18-8-9-19-31)30(38)32-25-17-16-23-12-6-7-13-26(23)33(28(25)36)21-27(34)35/h3-7,10-13,24-25H,2,8-9,14-21H2,1H3,(H,32,38)(H,34,35)/t24-,25+/m1/s1 D01HDP DRUGINKE XMQODGUTLZXUGZ-RPBOFIJWSA-N D01HDP DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)CC2(CCCC2)C(=O)NC3CCC4=CC=CC=C4N(C3=O)CC(=O)O D01HDP HIGHSTAT Phase 2 D01HVM DRUG__ID D01HVM D01HVM DRUGCOMP Agen biomedical (agenix) D01HVM DRUGTYPE Small molecular drug D01HVM DRUGINCH 1S/C18H14IN3O3/c1-18(24,11-25-15-6-2-12(9-20)3-7-15)17(23)22-14-5-4-13(10-21)16(19)8-14/h2-8,24H,11H2,1H3,(H,22,23)/t18-/m0/s1 D01HVM DRUGINKE RXSZCFAPSDTELY-SFHVURJKSA-N D01HVM DRUGSMIL CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)I)O D01HVM HIGHSTAT Phase 2 D01HVZ DRUG__ID D01HVZ D01HVZ DRUGCOMP Theravance D01HVZ DRUGTYPE Small molecular drug D01HVZ DRUGINCH 1S/C25H37N5O3/c1-17(2)23-27-21-6-4-5-20(22(21)28-23)24(31)26-15-18-7-11-29(12-8-18)16-19-9-13-30(14-10-19)25(32)33-3/h4-6,17-19H,7-16H2,1-3H3,(H,26,31)(H,27,28) D01HVZ DRUGINKE MZOITCJKGUIQEI-UHFFFAOYSA-N D01HVZ DRUGSMIL CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)C(=O)OC D01HVZ HIGHSTAT Phase 2 D01IHR DRUG__ID D01IHR D01IHR DRUGCOMP Accera D01IHR DRUGTYPE Small molecular drug D01IHR DRUGINCH 1S/C27H50O6/c1-4-7-10-13-16-19-25(28)31-22-24(33-27(30)21-18-15-12-9-6-3)23-32-26(29)20-17-14-11-8-5-2/h24H,4-23H2,1-3H3 D01IHR DRUGINKE VLPFTAMPNXLGLX-UHFFFAOYSA-N D01IHR DRUGSMIL CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC D01IHR HIGHSTAT Phase 2 D01ISE DRUG__ID D01ISE D01ISE DRUGCOMP Merck KGaA D01ISE DRUGTYPE Small molecular drug D01ISE DRUGINCH 1S/C17H14N2O2/c1-17(2)10-14(19-8-4-3-5-16(19)20)13-9-12(11-18)6-7-15(13)21-17/h3-10H,1-2H3 D01ISE DRUGINKE JTVSKASWNROQQF-UHFFFAOYSA-N D01ISE DRUGSMIL CC1(C=C(C2=C(O1)C=CC(=C2)C#N)N3C=CC=CC3=O)C D01ISE HIGHSTAT Phase 2 D01MAU DRUG__ID D01MAU D01MAU DRUGCOMP Targacept Inc D01MAU DRUGTYPE Small molecular drug D01MAU DRUGINCH 1S/C11H13ClN2O2/c12-10-2-1-9(16-10)11(15)14-5-7-3-13-4-8(7)6-14/h1-2,7-8,13H,3-6H2/t7-,8+ D01MAU DRUGINKE GTUIQNHJSXQMKW-OCAPTIKFSA-N D01MAU DRUGSMIL C1C2CN(CC2CN1)C(=O)C3=CC=C(O3)Cl D01MAU HIGHSTAT Phase 2 D01MHI DRUG__ID D01MHI D01MHI DRUGCOMP Mitsubishi Pharma Corp D01MHI DRUGTYPE Small molecular drug D01MHI DRUGINCH 1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23) D01MHI DRUGINKE PSPGQHXMUKWNDI-UHFFFAOYSA-N D01MHI DRUGSMIL CC1=C(OC2=NC3=C(CCCC3)C(=C12)NC(=O)CN4CCCC4=O)C D01MHI HIGHSTAT Phase 2 D01NCH DRUG__ID D01NCH D01NCH DRUGCOMP Hoechst AG D01NCH DRUGTYPE Small molecular drug D01NCH DRUGINCH 1S/C13H19N3O4/c1-19-7-5-15-12(17)10-3-4-14-11(9-10)13(18)16-6-8-20-2/h3-4,9H,5-8H2,1-2H3,(H,15,17)(H,16,18) D01NCH DRUGINKE JUCNGMPTCXPMNB-UHFFFAOYSA-N D01NCH DRUGSMIL COCCNC(=O)C1=CC(=NC=C1)C(=O)NCCOC D01NCH HIGHSTAT Phase 2 D01NEC DRUG__ID D01NEC D01NEC DRUGCOMP GlaxoSmithKline D01NEC DRUGTYPE Small molecular drug D01NEC DRUGINCH 1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1 D01NEC DRUGINKE AXTAPYRUEKNRBA-JTQLQIEISA-N D01NEC DRUGSMIL CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl D01NEC HIGHSTAT Phase 2 D01PGR DRUG__ID D01PGR D01PGR DRUGCOMP Sanofi; Exelixis D01PGR DRUGTYPE Small molecular drug D01PGR DRUGINCH 1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17) D01PGR DRUGINKE RGHYDLZMTYDBDT-UHFFFAOYSA-N D01PGR DRUGSMIL CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N D01PGR HIGHSTAT Phase 2 D01PLR DRUG__ID D01PLR D01PLR DRUGCOMP Pfizer New York, NY D01PLR DRUGTYPE Small molecular drug D01PLR DRUGINCH 1S/C29H30F3N2O5P/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(29(30,31)32,39-40(36,37)38)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23H,9,11,13-14,17-18H2,1H3,(H,34,35)(H2,36,37,38)/t23-,27+,28-/m1/s1 D01PLR DRUGINKE BVXLAHSJXXSWFF-KEKPKEOLSA-N D01PLR DRUGSMIL CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)C4(CCC(CC4CC3)(C(F)(F)F)OP(=O)(O)O)CC5=CC=CC=C5 D01PLR HIGHSTAT Phase 2 D01RAN DRUG__ID D01RAN D01RAN DRUGCOMP Lacer SA D01RAN DRUGTYPE Small molecular drug D01RAN DRUGINCH 1S/C8H11NO6S/c1-4(10)16-6-3-14-7-5(15-9(11)12)2-13-8(6)7/h5-8H,2-3H2,1H3/t5-,6+,7-,8-/m1/s1 D01RAN DRUGINKE BXZDULYKEZVEEK-ULAWRXDQSA-N D01RAN DRUGSMIL CC(=O)SC1COC2C1OCC2O[N+](=O)[O-] D01RAN HIGHSTAT Phase 2 D01RBR DRUG__ID D01RBR D01RBR DRUGCOMP Saegis Pharmaceuticals D01RBR DRUGTYPE Small molecular drug D01RBR DRUGINCH 1S/C7H18NO2P/c1-2-3-6-11(9,10)7-4-5-8/h2-8H2,1H3,(H,9,10) D01RBR DRUGINKE ONNMDRQRSGKZCN-UHFFFAOYSA-N D01RBR DRUGSMIL CCCCP(=O)(CCCN)O D01RBR HIGHSTAT Phase 2 D01RXW DRUG__ID D01RXW D01RXW DRUGCOMP Merck D01RXW DRUGTYPE Small molecular drug D01RXW DRUGINCH 1S/C38H55N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h10,12-13,25-27,29-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,26-,29+,30-,38-/m1/s1 D01RXW DRUGINKE KUQWGLQLLVFLSM-ONAXAZCASA-N D01RXW DRUGSMIL CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C D01RXW HIGHSTAT Phase 2 D01SJS DRUG__ID D01SJS D01SJS DRUGCOMP Axelar AB D01SJS DRUGTYPE Small molecular drug D01SJS DRUGINCH 1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1 D01SJS DRUGINKE YJGVMLPVUAXIQN-HAEOHBJNSA-N D01SJS DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O D01SJS HIGHSTAT Phase 2 D01SPD DRUG__ID D01SPD D01SPD DRUGCOMP Bayer HealthCare Pharmaceuticals D01SPD DRUGTYPE Small molecular drug D01SPD DRUGINCH 1S/C13H14N8O2.Na/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19;/h1-2,7-9,22H,3-6H2;/q;+1/p-1 D01SPD DRUGINKE VYRQLKYGGSWDNH-UHFFFAOYSA-M D01SPD DRUGSMIL C1COCCN1C2=NC=NC(=C2)N3C(=C(C=N3)N4C=CN=N4)[O-].[Na+] D01SPD HIGHSTAT Phase 2 D01UBY DRUG__ID D01UBY D01UBY DRUGCOMP Janssen Research & Development D01UBY DRUGTYPE Small molecular drug D01UBY DRUGINCH 1S/C22H25F3N4O3S/c23-22(24,25)15-3-1-2-14(8-15)20(31)27-10-19(30)28-16-11-29(12-16)17-4-6-21(32,7-5-17)18-9-26-13-33-18/h1-3,8-9,13,16-17,32H,4-7,10-12H2,(H,27,31)(H,28,30) D01UBY DRUGINKE CFKBNYUHQSQBSX-UHFFFAOYSA-N D01UBY DRUGSMIL C1CC(CCC1N2CC(C2)NC(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)(C4=CN=CS4)O D01UBY HIGHSTAT Phase 2 D01UGG DRUG__ID D01UGG D01UGG DRUGCOMP The Menarini Group D01UGG DRUGTYPE Small molecular drug D01UGG DRUGINCH 1S/C32H37NO13/c1-12-26(37)17(33)7-21(43-12)46-31-13(2)44-22(8-18(31)35)45-19-10-32(42,20(36)11-34)9-16-23(19)30(41)25-24(29(16)40)27(38)14-5-3-4-6-15(14)28(25)39/h3-6,12-13,17-19,21-22,26,31,34-35,37,40-42H,7-11,33H2,1-2H3/t12-,13-,17-,18-,19-,21-,22-,26+,31+,32-/m0/s1 D01UGG DRUGINKE VQHRZZISQVWPLK-UIRGBLDSSA-N D01UGG DRUGSMIL CC1C(C(CC(O1)OC2C(OC(CC2O)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=CC=CC=C6C5=O)O)(C(=O)CO)O)C)N)O D01UGG HIGHSTAT Phase 2 D01UXJ DRUG__ID D01UXJ D01UXJ DRUGCOMP 4SC AG D01UXJ DRUGTYPE Small molecular drug D01UXJ DRUGINCH 1S/C16H19N3O4S/c1-18(2)11-13-3-6-15(7-4-13)24(22,23)19-10-9-14(12-19)5-8-16(20)17-21/h3-10,12,21H,11H2,1-2H3,(H,17,20)/b8-5+ D01UXJ DRUGINKE FECGNJPYVFEKOD-VMPITWQZSA-N D01UXJ DRUGSMIL CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO D01UXJ HIGHSTAT Phase 2 D01WBD DRUG__ID D01WBD D01WBD DRUGCOMP Eli Lilly & Co D01WBD DRUGTYPE Small molecular drug D01WBD DRUGINCH 1S/C21H30N2O4S2/c1-16(2)29(26,27)23-15-17(3)19-9-11-21(12-10-19)20-7-5-18(6-8-20)13-14-22-28(4,24)25/h5-12,16-17,22-23H,13-15H2,1-4H3/t17-/m0/s1 D01WBD DRUGINKE ULRDYYKSPCRXAJ-KRWDZBQOSA-N D01WBD DRUGSMIL CC(C)S(=O)(=O)NCC(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CCNS(=O)(=O)C D01WBD HIGHSTAT Phase 2 D01WKE DRUG__ID D01WKE D01WKE DRUGCOMP Cytokine PharmaSciences Inc D01WKE DRUGTYPE Small molecular drug D01WKE DRUGINCH 1S/C34H52N18O2/c1-19(45-49-31(35)36)23-13-24(20(2)46-50-32(37)38)16-27(15-23)43-29(53)11-9-7-5-6-8-10-12-30(54)44-28-17-25(21(3)47-51-33(39)40)14-26(18-28)22(4)48-52-34(41)42/h13-18H,5-12H2,1-4H3,(H,43,53)(H,44,54)(H4,35,36,49)(H4,37,38,50)(H4,39,40,51)(H4,41,42,52)/b45-19+,46-20+,47-21+,48-22+ D01WKE DRUGINKE PWDYHMBTPGXCSN-VCBMUGGBSA-N D01WKE DRUGSMIL CC(=NN=C(N)N)C1=CC(=CC(=C1)NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(=NN=C(N)N)C)C(=NN=C(N)N)C)C(=NN=C(N)N)C D01WKE HIGHSTAT Phase 2 D01ZBF DRUG__ID D01ZBF D01ZBF DRUGCOMP Bristol-Myers Squibb Co D01ZBF DRUGTYPE Small molecular drug D01ZBF DRUGINCH 1S/C15H20BNO3/c1-11(18)13-12(7-6-10-17-13)8-9-16-19-14(2,3)15(4,5)20-16/h6-10H,1-5H3/b9-8+ D01ZBF DRUGINKE DAQLKAUMCVWOCH-CMDGGOBGSA-N D01ZBF DRUGSMIL B1(OC(C(O1)(C)C)(C)C)C=CC2=C(N=CC=C2)C(=O)C D01ZBF HIGHSTAT Phase 2 D01ZOB DRUG__ID D01ZOB D01ZOB DRUGCOMP ErgoNex Pharma; Pfizer D01ZOB DRUGTYPE Small molecular drug D01ZOB DRUGINCH 1S/C20H28N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,11,14,16,18,21H,4-5,9-10,12H2,1-3H3,(H,22,25)/t14-,16+,18+/m0/s1 D01ZOB DRUGINKE JOAHPSVPXZTVEP-YXJHDRRASA-N D01ZOB DRUGSMIL CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C D01ZOB HIGHSTAT Phase 2 D02AAO DRUG__ID D02AAO D02AAO DRUGCOMP AstraZeneca plc D02AAO DRUGTYPE Small molecular drug D02AAO DRUGINCH 1S/C28H33N5O2S/c1-18(2)24(32(16-8-15-29)27(34)22-13-11-19(3)12-14-22)25-30-26-23(20(4)31-36-26)28(35)33(25)17-21-9-6-5-7-10-21/h5-7,9-14,18,24H,8,15-17,29H2,1-4H3 D02AAO DRUGINKE SMFXSYMLJDHGIE-UHFFFAOYSA-N D02AAO DRUGSMIL CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C(=NS3)C)C(=O)N2CC4=CC=CC=C4)C(C)C D02AAO HIGHSTAT Phase 2 D02AIM DRUG__ID D02AIM D02AIM DRUGCOMP Werkheiser D02AIM DRUGTYPE Small molecular drug D02AIM DRUGINCH 1S/C11H10Cl2N4/c1-5-9(10(14)17-11(15)16-5)6-2-3-7(12)8(13)4-6/h2-4H,1H3,(H4,14,15,16,17) D02AIM DRUGINKE VQJHOPSWBGJHQS-UHFFFAOYSA-N D02AIM DRUGSMIL CC1=C(C(=NC(=N1)N)N)C2=CC(=C(C=C2)Cl)Cl D02AIM HIGHSTAT Phase 2 D02BLD DRUG__ID D02BLD D02BLD DRUGCOMP Onyx Pharmaceuticals D02BLD DRUGTYPE Small molecular drug D02BLD DRUGINCH 1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1 D02BLD DRUGINKE SWZXEVABPLUDIO-WSZYKNRRSA-N D02BLD DRUGSMIL CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C D02BLD HIGHSTAT Phase 2 D02BQE DRUG__ID D02BQE D02BQE DRUGCOMP Eisai D02BQE DRUGTYPE Small molecular drug D02BQE DRUGINCH 1S/C17H12N4O2S/c1-11-5-6-15(17-16(11)13(9-19)10-20-17)21-24(22,23)14-4-2-3-12(7-14)8-18/h2-7,10,20-21H,1H3 D02BQE DRUGINKE LWGUASZLXHYWIV-UHFFFAOYSA-N D02BQE DRUGSMIL CC1=C2C(=CNC2=C(C=C1)NS(=O)(=O)C3=CC=CC(=C3)C#N)C#N D02BQE HIGHSTAT Phase 2 D02BRJ DRUG__ID D02BRJ D02BRJ DRUGCOMP Wyeth D02BRJ DRUGTYPE Small molecular drug D02BRJ DRUGINCH 1S/C15H20N2/c1-3-11-9-16-7-8-17-10-12-4-2-5-13(12)14(6-1)15(11)17/h1,3,6,12-13,16H,2,4-5,7-10H2/t12-,13-/m0/s1 D02BRJ DRUGINKE NPTIPEQJIDTVKR-STQMWFEESA-N D02BRJ DRUGSMIL C1CC2CN3CCNCC4=C3C(=CC=C4)C2C1 D02BRJ HIGHSTAT Phase 2 D02DMW DRUG__ID D02DMW D02DMW DRUGCOMP Shionogi & Co Ltd D02DMW DRUGTYPE Small molecular drug D02DMW DRUGINCH 1S/C16H12FN3O3/c17-11-3-1-10(2-4-11)7-12-5-6-15(23-12)13(21)8-14(22)16-18-9-19-20-16/h1-6,8-9,22H,7H2,(H,18,19,20)/b14-8- D02DMW DRUGINKE HFHDGHOGHWXXDT-ZSOIEALJSA-N D02DMW DRUGSMIL C1=CC(=CC=C1CC2=CC=C(O2)C(=O)C=C(C3=NC=NN3)O)F D02DMW HIGHSTAT Phase 2 D02DTQ DRUG__ID D02DTQ D02DTQ DRUGCOMP Pfizer Inc D02DTQ DRUGTYPE Small molecular drug D02DTQ DRUGINCH 1S/C13H22N6/c1-15-10-4-5-19(8-10)12-6-11(17-13(14)18-12)16-7-9-2-3-9/h6,9-10,15H,2-5,7-8H2,1H3,(H3,14,16,17,18)/t10-/m1/s1 D02DTQ DRUGINKE ISBHYKVAFKTATD-SNVBAGLBSA-N D02DTQ DRUGSMIL CNC1CCN(C1)C2=NC(=NC(=C2)NCC3CC3)N D02DTQ HIGHSTAT Phase 2 D02EEJ DRUG__ID D02EEJ D02EEJ DRUGCOMP SCYNEXIS D02EEJ DRUGTYPE Small molecular drug D02EEJ DRUGINCH 1S/C66H120N12O13S/c1-27-29-30-42(13)53(79)52-57(83)69-45(28-2)59(85)78(26)65(92-32-31-71(18)19)64(90)75(23)49(36-66(16,17)91)56(82)70-50(40(9)10)62(88)72(20)46(33-37(3)4)55(81)67-43(14)54(80)68-44(15)58(84)73(21)47(34-38(5)6)60(86)74(22)48(35-39(7)8)61(87)76(24)51(41(11)12)63(89)77(52)25/h27,29,37-53,65,79,91H,28,30-36H2,1-26H3,(H,67,81)(H,68,80)(H,69,83)(H,70,82)/b29-27+/t42-,43+,44-,45+,46+,47+,48+,49+,50+,51+,52+,53-,65-/m1/s1 D02EEJ DRUGINKE AQHMBDAHQGYLIU-XNFHFXFQSA-N D02EEJ DRUGSMIL CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)(C)O)C)SCCN(C)C)C D02EEJ HIGHSTAT Phase 2 D02ELS DRUG__ID D02ELS D02ELS DRUGCOMP Salmedix D02ELS DRUGTYPE Small molecular drug D02ELS DRUGINCH 1S/C3H7N3O4/c4-2(3(7)8)1-6(10)5-9/h2,9H,1,4H2,(H,7,8)/b6-5-/t2-/m0/s1 D02ELS DRUGINKE ZGNLFUXWZJGETL-YUSKDDKASA-N D02ELS DRUGSMIL C(C(C(=O)O)N)[N+](=NO)[O-] D02ELS HIGHSTAT Phase 2 D02ETY DRUG__ID D02ETY D02ETY DRUGCOMP Sanofi D02ETY DRUGTYPE Small molecular drug D02ETY DRUGINCH 1S/C24H42N2O2S2/c1-21-23(13-17-27)29-19-25(21)15-11-9-7-5-3-4-6-8-10-12-16-26-20-30-24(14-18-28)22(26)2/h19-20,27-28H,3-18H2,1-2H3/q+2 D02ETY DRUGINKE UZPXHZIQHWKNPF-UHFFFAOYSA-N D02ETY DRUGSMIL CC1=C(SC=[N+]1CCCCCCCCCCCC[N+]2=CSC(=C2C)CCO)CCO D02ETY HIGHSTAT Phase 2 D02EVF DRUG__ID D02EVF D02EVF DRUGCOMP InVasc Therapeutics D02EVF DRUGTYPE Small molecular drug D02EVF DRUGINCH 1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1 D02EVF DRUGINKE AGBQKNBQESQNJD-SSDOTTSWSA-N D02EVF DRUGSMIL C1CSSC1CCCCC(=O)O D02EVF HIGHSTAT Phase 2 D02FCU DRUG__ID D02FCU D02FCU DRUGCOMP Medivir; Daewoong D02FCU DRUGTYPE Small molecular drug D02FCU DRUGINCH 1S/C10H12FN5O3/c11-4-1-6(19-5(4)2-17)16-3-13-7-8(16)14-10(12)15-9(7)18/h3-6,17H,1-2H2,(H3,12,14,15,18)/t4-,5+,6+/m0/s1 D02FCU DRUGINKE RTJUXLYUUDBAJN-KVQBGUIXSA-N D02FCU DRUGSMIL C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)CO)F D02FCU HIGHSTAT Phase 2 D02FEV DRUG__ID D02FEV D02FEV DRUGCOMP Shionogi & Co Ltd D02FEV DRUGTYPE Small molecular drug D02FEV DRUGINCH 1S/C30H36O9/c1-9-16(10-2)13-19(31)25-26(30(33)39-8)23(17-11-12-20(34-3)21(14-17)35-4)24-18(27(25)32)15-22(36-5)28(37-6)29(24)38-7/h11-12,14-16,32H,9-10,13H2,1-8H3 D02FEV DRUGINKE QEJQEIIPZKQCNP-UHFFFAOYSA-N D02FEV DRUGSMIL CCC(CC)CC(=O)C1=C(C2=CC(=C(C(=C2C(=C1C(=O)OC)C3=CC(=C(C=C3)OC)OC)OC)OC)OC)O D02FEV HIGHSTAT Phase 2 D02GIA DRUG__ID D02GIA D02GIA DRUGCOMP Yissum Research Development Co D02GIA DRUGTYPE Small molecular drug D02GIA DRUGINCH 1S/C194H253N64O106P19S19/c1-78-45-248(189(279)233-165(78)261)137-35-91(108(333-137)58-307-365(285,384)346-84-28-130(326-101(84)51-259)239-19-10-121(195)218-180(239)270)357-375(295,394)321-66-116-98(42-144(341-116)255-74-215-149-162(255)227-177(206)230-171(149)267)360-378(298,397)312-56-106-85(29-131(331-106)240-20-11-122(196)219-181(240)271)347-366(286,385)308-52-102-88(32-134(327-102)243-23-14-125(199)222-184(243)274)350-369(289,388)319-64-114-97(41-143(339-114)254-73-213-147-158(204)209-71-211-160(147)254)359-377(297,396)311-55-105-89(33-135(330-105)244-24-15-126(200)223-185(244)275)351-370(290,389)320-65-115-100(44-146(340-115)257-76-217-151-164(257)229-179(208)232-173(151)269)362-380(300,399)318-63-113-95(39-141(338-113)252-49-82(5)169(265)237-193(252)283)356-374(294,393)316-61-111-93(37-139(336-111)250-47-80(3)167(263)235-191(250)281)354-372(292,391)310-54-104-86(30-132(329-104)241-21-12-123(197)220-182(241)272)348-367(287,386)314-59-109-92(36-138(334-109)249-46-79(2)166(262)234-190(249)280)353-371(291,390)309-53-103-87(31-133(328-103)242-22-13-124(198)221-183(242)273)349-368(288,387)315-60-110-94(38-140(335-110)251-48-81(4)168(264)236-192(251)282)355-373(293,392)317-62-112-96(40-142(337-112)253-50-83(6)170(266)238-194(253)284)358-376(296,395)322-67-117-99(43-145(342-117)256-75-216-150-163(256)228-178(207)231-172(150)268)361-379(299,398)313-57-107-90(34-136(332-107)245-25-16-127(201)224-186(245)276)352-381(301,400)324-69-120-154(157(306-9)176(345-120)258-77-214-148-159(205)210-72-212-161(148)258)364-383(303,402)325-70-119-153(156(305-8)175(344-119)247-27-18-129(203)226-188(247)278)363-382(302,401)323-68-118-152(260)155(304-7)174(343-118)246-26-17-128(202)225-187(246)277/h10-27,45-50,71-77,84-120,130-146,152-157,174-176,259-260H,28-44,51-70H2,1-9H3,(H,285,384)(H,286,385)(H,287,386)(H,288,387)(H,289,388)(H,290,389)(H,291,390)(H,292,391)(H,293,392)(H,294,393)(H,295,394)(H,296,395)(H,297,396)(H,298,397)(H,299,398)(H,300,399)(H,301,400)(H,302,401)(H,303,402)(H2,195,218,270)(H2,196,219,271)(H2,197,220,272)(H2,198,221,273)(H2,199,222,274)(H2,200,223,275)(H2,201,224,276)(H2,202,225,277)(H2,203,226,278)(H2,204,209,211)(H2,205,210,212)(H,233,261,279)(H,234,262,280)(H,235,263,281)(H,236,264,282)(H,237,265,283)(H,238,266,284)(H3,206,227,230,267)(H3,207,228,231,268)(H3,208,229,232,269) D02GIA DRUGINKE QJYMZHMIZZYHBI-UHFFFAOYSA-N D02GIA DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3CO)N4C=CC(=NC4=O)N)OP(=S)(O)OCC5C(CC(O5)N6C=NC7=C6N=C(NC7=O)N)OP(=S)(O)OCC8C(CC(O8)N9C=CC(=NC9=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OC)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)O D02GIA HIGHSTAT Phase 2 D02HDG DRUG__ID D02HDG D02HDG DRUGCOMP Aquinox Pharmaceuticals Inc D02HDG DRUGTYPE Small molecular drug D02HDG DRUGINCH 1S/C20H35NO2/c1-13-4-5-17-16(11-21)18(7-9-19(13,17)2)20(3)8-6-15(23)10-14(20)12-22/h14-18,22-23H,1,4-12,21H2,2-3H3/t14-,15+,16+,17+,18+,19-,20+/m1/s1 D02HDG DRUGINKE MDEJTPWQNNMAQF-BVMLLJBZSA-N D02HDG DRUGSMIL CC1(CCC(CC1CO)O)C2CCC3(C(C2CN)CCC3=C)C D02HDG HIGHSTAT Phase 2 D02HNG DRUG__ID D02HNG D02HNG DRUGCOMP Merck D02HNG DRUGTYPE Small molecular drug D02HNG DRUGINCH 1S/C21H21ClF2O4S/c22-15-2-5-17(6-3-15)29(27,28)21(18-13-16(23)4-7-19(18)24)11-9-14(10-12-21)1-8-20(25)26/h2-7,13-14H,1,8-12H2,(H,25,26) D02HNG DRUGINKE XCGJIFAKUZNNOR-UHFFFAOYSA-N D02HNG DRUGSMIL C1CC(CCC1CCC(=O)O)(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl D02HNG HIGHSTAT Phase 2 D02HTD DRUG__ID D02HTD D02HTD DRUGCOMP GILEAD D02HTD DRUGTYPE Small molecular drug D02HTD DRUGINCH 1S/C45H60ClN7O9S/c1-7-27-21-45(27,41(56)57)51-39(54)33-19-29(22-53(33)40(55)38(44(4,5)6)50-43(58)62-28-17-25-16-26(25)18-28)61-35-20-31(32-23-63-42(49-32)47-24(2)3)48-37-30(35)8-9-34(36(37)46)60-15-12-52-10-13-59-14-11-52/h8-9,20,23-29,33,38H,7,10-19,21-22H2,1-6H3,(H,47,49)(H,50,58)(H,51,54)(H,56,57)/t25-,26+,27-,28?,29-,33+,38-,45-/m1/s1 D02HTD DRUGINKE OTXAMWFYPMNDME-OPUYQWCOSA-N D02HTD DRUGSMIL CCC1CC1(C(=O)O)NC(=O)C2CC(CN2C(=O)C(C(C)(C)C)NC(=O)OC3CC4CC4C3)OC5=CC(=NC6=C5C=CC(=C6Cl)OCCN7CCOCC7)C8=CSC(=N8)NC(C)C D02HTD HIGHSTAT Phase 2 D02IJA DRUG__ID D02IJA D02IJA DRUGCOMP Siemens Medical Solutions Molecular Imaging D02IJA DRUGTYPE Small molecular drug D02IJA DRUGINCH 1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H D02IJA DRUGINKE GETAAWDSFUCLBS-UHFFFAOYSA-N D02IJA DRUGSMIL C1=CC2=C(C=C1C3=CN=C(C=C3)F)NC4=C2C=NC=C4 D02IJA HIGHSTAT Phase 2 D02INX DRUG__ID D02INX D02INX DRUGCOMP Theravance D02INX DRUGTYPE Small molecular drug D02INX DRUGINCH 1S/C26H39N3O4/c27-25(32)20-8-4-7-19(13-20)21-14-22-9-10-23(15-21)29(22)12-11-28(26(33)24(31)17-30)16-18-5-2-1-3-6-18/h4,7-8,13,18,21-24,30-31H,1-3,5-6,9-12,14-17H2,(H2,27,32)/t21?,22-,23+,24-/m0/s1 D02INX DRUGINKE ATLYLVPZNWDJBW-NHYNNZIHSA-N D02INX DRUGSMIL C1CCC(CC1)CN(CCN2C3CCC2CC(C3)C4=CC(=CC=C4)C(=O)N)C(=O)C(CO)O D02INX HIGHSTAT Phase 2 D02IWC DRUG__ID D02IWC D02IWC DRUGCOMP AstraZeneca D02IWC DRUGTYPE Small molecular drug D02IWC DRUGINCH 1S/C26H25N3O3S/c1-3-21(18-12-6-4-7-13-18)28-26(30)23-20-16-10-11-17-22(20)27-24(19-14-8-5-9-15-19)25(23)29-33(2,31)32/h4-17,21,29H,3H2,1-2H3,(H,28,30)/t21-/m0/s1 D02IWC DRUGINKE QYTBBBAHNIWFOD-NRFANRHFSA-N D02IWC DRUGSMIL CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)NS(=O)(=O)C D02IWC HIGHSTAT Phase 2 D02JAY DRUG__ID D02JAY D02JAY DRUGCOMP InfaCare Pharma. D02JAY DRUGTYPE Small molecular drug D02JAY DRUGINCH 1S/C34H38N4O4.2ClH.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;;/h13-16H,7-12H2,1-6H3,(H4,35,36,37,38,39,40,41,42);2*1H;/q;;;+4/p-4 D02JAY DRUGINKE LLDZJTIZVZFNCM-UHFFFAOYSA-J D02JAY DRUGSMIL [H+].[H+].CCC1=C(C2=NC1=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=NC(=C2)C(=C5C)CC)[N-]4)C)CCC(=O)[O-])CCC(=O)[O-])C)C.[Cl-].[Cl-].[Sn+4] D02JAY HIGHSTAT Phase 2 D02JIN DRUG__ID D02JIN D02JIN DRUGCOMP Glaxo Wellcome plc D02JIN DRUGTYPE Small molecular drug D02JIN DRUGINCH 1S/C23H31NO4S/c1-5-7-13-23(6-2)16-29(25,26)21-15-20(28-4)19(27-3)14-18(21)22(24-23)17-11-9-8-10-12-17/h8-12,14-15,22,24H,5-7,13,16H2,1-4H3/t22-,23-/m1/s1 D02JIN DRUGINKE CKFWDLFFXXVSBJ-DHIUTWEWSA-N D02JIN DRUGSMIL CCCCC1(CS(=O)(=O)C2=CC(=C(C=C2C(N1)C3=CC=CC=C3)OC)OC)CC D02JIN HIGHSTAT Phase 2 D02JOH DRUG__ID D02JOH D02JOH DRUGCOMP Bristol-Myers Squibb D02JOH DRUGTYPE Small molecular drug D02JOH DRUGINCH 1S/C20H17ClF4N4O4S/c21-14-3-5-15(6-4-14)34(31,32)29(17(18(26)30)7-8-20(23,24)25)10-13-2-1-12(9-16(13)22)19-27-11-33-28-19/h1-6,9,11,17H,7-8,10H2,(H2,26,30)/t17-/m1/s1 D02JOH DRUGINKE XEAOPVUAMONVLA-QGZVFWFLSA-N D02JOH DRUGSMIL C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl D02JOH HIGHSTAT Phase 2 D02JXG DRUG__ID D02JXG D02JXG DRUGCOMP GlaxoSmithKline D02JXG DRUGTYPE Small molecular drug D02JXG DRUGINCH 1S/C14H9BrN6O/c15-9-3-1-2-4-10(9)17-14(22)18-11-6-5-8(7-16)12-13(11)20-21-19-12/h1-6H,(H2,17,18,22)(H,19,20,21) D02JXG DRUGINKE SEDUMQWZEOMXSO-UHFFFAOYSA-N D02JXG DRUGSMIL C1=CC=C(C(=C1)NC(=O)NC2=CC=C(C3=NNN=C23)C#N)Br D02JXG HIGHSTAT Phase 2 D02KKA DRUG__ID D02KKA D02KKA DRUGCOMP Merck D02KKA DRUGTYPE Small molecular drug D02KKA DRUGINCH 1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31) D02KKA DRUGINKE BKWJAKQVGHWELA-UHFFFAOYSA-N D02KKA DRUGSMIL CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O D02KKA HIGHSTAT Phase 2 D02MRN DRUG__ID D02MRN D02MRN DRUGCOMP Verta Ltd; SciClone Pharmaceuticals D02MRN DRUGTYPE Small molecular drug D02MRN DRUGINCH 1S/C16H19N3O5/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24)/t11-,13+/m1/s1 D02MRN DRUGINKE CATMPQFFVNKDEY-YPMHNXCESA-N D02MRN DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CCC(C(=O)O)N D02MRN HIGHSTAT Phase 2 D02NNV DRUG__ID D02NNV D02NNV DRUGCOMP Vertex Pharma D02NNV DRUGTYPE Small molecular drug D02NNV DRUGINCH 1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H D02NNV DRUGINKE VEPKQEUBKLEPRA-UHFFFAOYSA-N D02NNV DRUGSMIL C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl D02NNV HIGHSTAT Phase 2 D02NTS DRUG__ID D02NTS D02NTS DRUGCOMP Janssen Pharmaceutica NV D02NTS DRUGTYPE Small molecular drug D02NTS DRUGINCH 1S/C19H18F2N6O3/c1-26(2)16(28)7-10-27-17(12-5-8-22-9-6-12)24-18(25-27)23-13-3-4-14-15(11-13)30-19(20,21)29-14/h3-6,8-9,11H,7,10H2,1-2H3,(H,23,25) D02NTS DRUGINKE IURMHZBQEYNQOH-UHFFFAOYSA-N D02NTS DRUGSMIL CN(C)C(=O)CCN1C(=NC(=N1)NC2=CC3=C(C=C2)OC(O3)(F)F)C4=CC=NC=C4 D02NTS HIGHSTAT Phase 2 D02NXM DRUG__ID D02NXM D02NXM DRUGCOMP GlaxoSmithKline D02NXM DRUGTYPE Small molecular drug D02NXM DRUGINCH 1S/C18H17Cl2FN4OS/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26)/t12-/m0/s1 D02NXM DRUGINKE AFJRDFWMXUECEW-LBPRGKRZSA-N D02NXM DRUGSMIL CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl D02NXM HIGHSTAT Phase 2 D02ORS DRUG__ID D02ORS D02ORS DRUGCOMP SK Life Science D02ORS DRUGTYPE Small molecular drug D02ORS DRUGINCH 1S/C24H30ClFN4O4/c1-33-22-13-20(27)19(25)12-18(22)23(31)29-14-15-6-9-30(10-7-15)11-8-21(34-24(28)32)16-2-4-17(26)5-3-16/h2-5,12-13,15,21H,6-11,14,27H2,1H3,(H2,28,32)(H,29,31)/t21-/m0/s1 D02ORS DRUGINKE KGMMSPVVHZGPHL-NRFANRHFSA-N D02ORS DRUGSMIL COC1=CC(=C(C=C1C(=O)NCC2CCN(CC2)CCC(C3=CC=C(C=C3)F)OC(=O)N)Cl)N D02ORS HIGHSTAT Phase 2 D02OZK DRUG__ID D02OZK D02OZK DRUGCOMP Cephalon D02OZK DRUGTYPE Small molecular drug D02OZK DRUGINCH 1S/C20H19N3O/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17/h4-11,21,23H,1-3H3/b18-17-,19-10- D02OZK DRUGINKE CVCLJVVBHYOXDC-IAZSKANUSA-N D02OZK DRUGSMIL CC1=CC(=C(N1)C=C2C(=CC(=C3C=C4C=CC=CC4=N3)N2)OC)C D02OZK HIGHSTAT Phase 2 D02PHE DRUG__ID D02PHE D02PHE DRUGCOMP AstraZeneca D02PHE DRUGTYPE Small molecular drug D02PHE DRUGINCH 1S/C25H22F3N5O4S/c1-15-20(22-9-10-31-32(22)2)12-21(23(34)30-13-17-7-8-19(14-29-17)38(3,36)37)24(35)33(15)18-6-4-5-16(11-18)25(26,27)28/h4-12,14H,13H2,1-3H3,(H,30,34) D02PHE DRUGINKE QNQZWEGMKJBHEM-UHFFFAOYSA-N D02PHE DRUGSMIL CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C D02PHE HIGHSTAT Phase 2 D02PYN DRUG__ID D02PYN D02PYN DRUGCOMP SRI International D02PYN DRUGTYPE Small molecular drug D02PYN DRUGINCH 1S/C33H47NO3.C6H8O7/c1-6-34(7-2)21-23-8-13-30(31(19-23)36-5)37-17-15-25-9-12-29-32-22(3)18-24-20-26(35)10-11-27(24)28(32)14-16-33(25,29)4;7-3(8)1-6(13,5(11)12)2-4(9)10/h8,10-11,13,19-20,22,25,28-29,32,35H,6-7,9,12,14-18,21H2,1-5H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t22-,25-,28-,29+,32-,33-;/m1./s1 D02PYN DRUGINKE VOHOCSJONOJOSD-SCIDSJFVSA-N D02PYN DRUGSMIL CCN(CC)CC1=CC(=C(C=C1)OCCC2CCC3C2(CCC4C3C(CC5=C4C=CC(=C5)O)C)C)OC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D02PYN HIGHSTAT Phase 2 D02RJY DRUG__ID D02RJY D02RJY DRUGCOMP Pfizer; Nerviano D02RJY DRUGTYPE Small molecular drug D02RJY DRUGINCH 1S/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1 D02RJY DRUGINKE XKFTZKGMDDZMJI-HSZRJFAPSA-N D02RJY DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC D02RJY HIGHSTAT Phase 2 D02RPK DRUG__ID D02RPK D02RPK THERCLAS Anticancer Agents D02RPK DRUGTYPE Small molecular drug D02RPK DRUGINCH 1S/C29H36N4O5/c1-29(2,3)25(34)18-33-24-15-8-7-14-23(24)32(21-12-5-4-6-13-21)17-22(26(33)35)31-28(38)30-20-11-9-10-19(16-20)27(36)37/h7-11,14-16,21-22H,4-6,12-13,17-18H2,1-3H3,(H,36,37)(H2,30,31,38)/t22-/m1/s1 D02RPK DRUGINKE VIJCCFFEBCOOIE-JOCHJYFZSA-N D02RPK DRUGSMIL CC(C)(C)C(=O)CN1C2=CC=CC=C2N(CC(C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4 D02RPK HIGHSTAT Phase 2 D02RVN DRUG__ID D02RVN D02RVN DRUGCOMP Novartis pharmaceuticals D02RVN DRUGTYPE Small molecular drug D02RVN DRUGINCH 1S/C16H19N5O4S/c1-9(2)10-8-13-12(7-11(10)14-5-6-17-20(14)3)15(22)21(16(23)18-13)19-26(4,24)25/h5-9,19H,1-4H3,(H,18,23) D02RVN DRUGINKE MCECSFFXUPEPDB-UHFFFAOYSA-N D02RVN DRUGSMIL CC(C)C1=C(C=C2C(=C1)NC(=O)N(C2=O)NS(=O)(=O)C)C3=CC=NN3C D02RVN HIGHSTAT Phase 2 D02SNY DRUG__ID D02SNY D02SNY DRUGCOMP Dimethaid AG D02SNY DRUGTYPE Small molecular drug D02SNY DRUGINCH 1S/4ClHO2.O2.H2O/c4*2-1-3;1-2;/h4*(H,2,3);;1H2/p-4 D02SNY DRUGINKE VOWOEBADKMXUBU-UHFFFAOYSA-J D02SNY DRUGSMIL O.[O-]Cl=O.[O-]Cl=O.[O-]Cl=O.[O-]Cl=O.O=O D02SNY HIGHSTAT Phase 2 D02SPX DRUG__ID D02SPX D02SPX DRUGCOMP GSK D02SPX DRUGTYPE Small molecular drug D02SPX DRUGINCH 1S/C20H17ClN3O3P/c1-12-8-13(4-3-7-22)10-15(9-12)28(26,27-2)19-16-11-14(21)5-6-17(16)24-18(19)20(23)25/h3-6,8-11,24H,1-2H3,(H2,23,25)/b4-3+ D02SPX DRUGINKE CGBYTKOSZYQOPV-ONEGZZNKSA-N D02SPX DRUGSMIL CC1=CC(=CC(=C1)P(=O)(C2=C(NC3=C2C=C(C=C3)Cl)C(=O)N)OC)C=CC#N D02SPX HIGHSTAT Phase 2 D02TGD DRUG__ID D02TGD D02TGD DRUGCOMP Mitsubishi Pharma D02TGD DRUGTYPE Small molecular drug D02TGD DRUGINCH 1S/C21H16FNO3S/c22-18-4-2-1-3-16(18)12-26-17-8-7-14-9-13(5-6-15(14)11-17)10-19-20(24)23-21(25)27-19/h1-9,11,19H,10,12H2,(H,23,24,25) D02TGD DRUGINKE PKWDZWYVIHVNKS-UHFFFAOYSA-N D02TGD DRUGSMIL C1=CC=C(C(=C1)COC2=CC3=C(C=C2)C=C(C=C3)CC4C(=O)NC(=O)S4)F D02TGD HIGHSTAT Phase 2 D02TIK DRUG__ID D02TIK D02TIK DRUGCOMP Sanofi-Aventis D02TIK DRUGTYPE Small molecular drug D02TIK DRUGINCH 1S/C17H18FN3/c1-3-10-20(17-8-9-19-11-15(17)18)21-12-13(2)14-6-4-5-7-16(14)21/h4-9,11-12H,3,10H2,1-2H3 D02TIK DRUGINKE BTDHTARYCBHHPJ-UHFFFAOYSA-N D02TIK DRUGSMIL CCCN(C1=C(C=NC=C1)F)N2C=C(C3=CC=CC=C32)C D02TIK HIGHSTAT Phase 2 D02UJD DRUG__ID D02UJD D02UJD DRUGCOMP Parke-Davis & Co D02UJD DRUGTYPE Small molecular drug D02UJD DRUGINCH 1S/C24H27N/c1-3-9-21(10-4-1)23-14-16-25(17-15-23)19-20-8-7-13-24(18-20)22-11-5-2-6-12-22/h1-7,9-14,20,24H,8,15-19H2/t20-,24?/m1/s1 D02UJD DRUGINKE SDOHTVBFDDPWNE-CGHJUBPDSA-N D02UJD DRUGSMIL C1CN(CC=C1C2=CC=CC=C2)CC3CC=CC(C3)C4=CC=CC=C4 D02UJD HIGHSTAT Phase 2 D02UKX DRUG__ID D02UKX D02UKX DRUGCOMP University of Chicago D02UKX DRUGTYPE Small molecular drug D02UKX DRUGINCH 1S/C43H68N10O15/c1-20(2)12-27(49-37(61)26(44)15-24-8-10-25(55)11-9-24)40(64)53-32(19-54)38(62)46-18-34(57)47-23(7)36(60)48-30(17-35(58)59)42(66)50-28(13-21(3)4)39(63)51-29(16-33(45)56)41(65)52-31(43(67)68)14-22(5)6/h8-11,20-23,26-32,54-55H,12-19,44H2,1-7H3,(H2,45,56)(H,46,62)(H,47,57)(H,48,60)(H,49,61)(H,50,66)(H,51,63)(H,52,65)(H,53,64)(H,58,59)(H,67,68) D02UKX DRUGINKE SNKUSVNHTCUELQ-UHFFFAOYSA-N D02UKX DRUGSMIL CC(C)CC(C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N D02UKX HIGHSTAT Phase 2 D02VSP DRUG__ID D02VSP D02VSP DRUGCOMP Merck D02VSP DRUGTYPE Small molecular drug D02VSP DRUGINCH 1S/C12H20N4O6S/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21)/t9-,10+/m1/s1 D02VSP DRUGINKE SMOBCLHAZXOKDQ-ZJUUUORDSA-N D02VSP DRUGSMIL C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3 D02VSP HIGHSTAT Phase 2 D02WFN DRUG__ID D02WFN D02WFN DRUGCOMP Merck D02WFN DRUGTYPE Small molecular drug D02WFN DRUGINCH 1S/C25H25N3O2/c1-16-10-11-17(14-26-16)12-18-13-21-24(20-7-3-2-6-19(18)20)27-15-28(25(21)30)22-8-4-5-9-23(22)29/h2-3,6-7,10-11,13-15,22-23,29H,4-5,8-9,12H2,1H3/t22-,23-/m0/s1 D02WFN DRUGINKE JUVQLZBJFOGEEO-GOTSBHOMSA-N D02WFN DRUGSMIL CC1=NC=C(C=C1)CC2=CC3=C(C4=CC=CC=C42)N=CN(C3=O)C5CCCCC5O D02WFN HIGHSTAT Phase 2 D02WRV DRUG__ID D02WRV D02WRV DRUGCOMP Cure Therapeutics D02WRV DRUGTYPE Small molecular drug D02WRV DRUGINCH 1S/C8H9NO3/c1-12-8(11)5-2-3-7(10)6(9)4-5/h2-4,10H,9H2,1H3 D02WRV DRUGINKE VNQABZCSYCTZMS-UHFFFAOYSA-N D02WRV DRUGSMIL COC(=O)C1=CC(=C(C=C1)O)N D02WRV HIGHSTAT Phase 2 D03AND DRUG__ID D03AND D03AND DRUGCOMP Novartis Pharmaceuticals D03AND DRUGTYPE Small molecular drug D03AND DRUGINCH 1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34) D03AND DRUGINKE YABJJWZLRMPFSI-UHFFFAOYSA-N D03AND DRUGSMIL CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F D03AND HIGHSTAT Phase 2 D03AZR DRUG__ID D03AZR D03AZR DRUGCOMP MD Anderson Cancer Center D03AZR DRUGTYPE Small molecular drug D03AZR DRUGINCH 1S/C34H35NO11/c1-16-33(44-15-17-7-4-3-5-8-17)20(35)11-24(45-16)46-22-13-34(42,23(37)14-36)12-19-26(22)32(41)28-27(30(19)39)29(38)18-9-6-10-21(43-2)25(18)31(28)40/h3-10,16,20,22,24,33,36,39,41-42H,11-15,35H2,1-2H3/t16-,20-,22-,24-,33+,34-/m0/s1 D03AZR DRUGINKE FIGNGSHKNAHTSH-JJMFXPFOSA-N D03AZR DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OCC6=CC=CC=C6 D03AZR HIGHSTAT Phase 2 D03CHM DRUG__ID D03CHM D03CHM DRUGCOMP EMD Serono D03CHM DRUGTYPE Small molecular drug D03CHM DRUGINCH 1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1 D03CHM DRUGINKE VIUAUNHCRHHYNE-JTQLQIEISA-N D03CHM DRUGSMIL C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O D03CHM HIGHSTAT Phase 2 D03DPZ DRUG__ID D03DPZ D03DPZ DRUGCOMP Intellikine; MMRC D03DPZ DRUGTYPE Small molecular drug D03DPZ DRUGINCH 1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19) D03DPZ DRUGINKE GYLDXIAOMVERTK-UHFFFAOYSA-N D03DPZ DRUGSMIL CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N D03DPZ HIGHSTAT Phase 2 D03DRR DRUG__ID D03DRR D03DRR DRUGCOMP Janssen Pharmaceutica NV D03DRR DRUGTYPE Small molecular drug D03DRR DRUGINCH 1S/C17H21N5O/c1-12-4-5-14(23-12)11-22-16-15(3-2-8-19-16)21-17(22)20-13-6-9-18-10-7-13/h2-5,8,13,18H,6-7,9-11H2,1H3,(H,20,21) D03DRR DRUGINKE VNIOQSAWKLOGLY-UHFFFAOYSA-N D03DRR DRUGSMIL CC1=CC=C(O1)CN2C3=C(C=CC=N3)N=C2NC4CCNCC4 D03DRR HIGHSTAT Phase 2 D03FVS DRUG__ID D03FVS D03FVS DRUGCOMP Shanghai Institute of Materia Medica (SIMM) D03FVS DRUGTYPE Small molecular drug D03FVS DRUGINCH 1S/C20H26O4/c1-11(2)15-10-13-7-6-12(3)14(17(13)19(23)18(15)22)8-9-16(21)20(4,5)24/h6-7,10-11,16,21,24H,8-9H2,1-5H3 D03FVS DRUGINKE NZIUPDOWWMGNCV-UHFFFAOYSA-N D03FVS DRUGSMIL CC1=C(C2=C(C=C1)C=C(C(=O)C2=O)C(C)C)CCC(C(C)(C)O)O D03FVS HIGHSTAT Phase 2 D03GVG DRUG__ID D03GVG D03GVG DRUGCOMP Periphagen holdings D03GVG DRUGTYPE Small molecular drug D03GVG DRUGINCH 1S/C161H282N62O36S6/c1-20-84(15)120(148(254)206-91(38-25-51-182-153(163)164)125(231)192-70-115(224)197-92(39-26-52-183-154(165)166)132(238)220-121(85(16)21-2)149(255)212-106(67-90-68-181-77-193-90)151(257)223-61-35-48-114(223)145(251)210-103(64-80(7)8)136(242)215-112(76-265)143(249)217-110(74-263)141(247)203-97(44-31-57-188-159(175)176)130(236)207-100(152(258)259)46-33-59-190-161(179)180)221-133(239)98(45-32-58-189-160(177)178)204-140(246)109(73-262)216-137(243)104(66-89-36-23-22-24-37-89)198-116(225)69-191-122(228)86(17)194-126(232)93(40-27-53-184-155(167)168)199-128(234)95(42-29-55-186-157(171)172)201-131(237)99(49-50-117(226)227)205-134(240)102(63-79(5)6)209-144(250)113-47-34-60-222(113)150(256)105(65-81(9)10)211-142(248)111(75-264)214-135(241)101(62-78(3)4)208-123(229)87(18)195-127(233)94(41-28-54-185-156(169)170)200-129(235)96(43-30-56-187-158(173)174)202-139(245)108(72-261)213-124(230)88(19)196-138(244)107(71-260)218-147(253)119(83(13)14)219-146(252)118(162)82(11)12/h22-24,36-37,68,77-88,91-114,118-121,260-265H,20-21,25-35,38-67,69-76,162H2,1-19H3,(H,181,193)(H,191,228)(H,192,231)(H,194,232)(H,195,233)(H,196,244)(H,197,224)(H,198,225)(H,199,234)(H,200,235)(H,201,237)(H,202,245)(H,203,247)(H,204,246)(H,205,240)(H,206,254)(H,207,236)(H,208,229)(H,209,250)(H,210,251)(H,211,248)(H,212,255)(H,213,230)(H,214,241)(H,215,242)(H,216,243)(H,217,249)(H,218,253)(H,219,252)(H,220,238)(H,221,239)(H,226,227)(H,258,259)(H4,163,164,182)(H4,165,166,183)(H4,167,168,184)(H4,169,170,185)(H4,171,172,186)(H4,173,174,187)(H4,175,176,188)(H4,177,178,189)(H4,179,180,190)/t84-,85-,86-,87-,88-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,118-,119-,120-,121-/m0/s1 D03GVG DRUGINKE AEUKDPKXTPNBNY-XEYRWQBLSA-N D03GVG DRUGSMIL CCC(C)C(C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)NC(CS)C(=O)NC(CS)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CS)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C4CCCN4C(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CS)NC(=O)C(C)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N D03GVG HIGHSTAT Phase 2 D03IBI DRUG__ID D03IBI D03IBI DRUGCOMP Vela Pharmaceuticals Inc D03IBI DRUGTYPE Small molecular drug D03IBI DRUGINCH 1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3/t15-/m1/s1 D03IBI DRUGINKE RUJBDQSFYCKFAA-OAHLLOKOSA-N D03IBI DRUGSMIL CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C D03IBI HIGHSTAT Phase 2 D03KGH DRUG__ID D03KGH D03KGH DRUGCOMP Wilex D03KGH DRUGTYPE Small molecular drug D03KGH DRUGINCH 1S/C32H47N5O6S/c1-8-43-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34-40)35-44(41,42)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35,40H,8,12-15,17H2,1-7H3,(H2,33,34)/t28-/m0/s1 D03KGH DRUGINKE HUASEDVYRABWCV-NDEPHWFRSA-N D03KGH DRUGSMIL CCOC(=O)N1CCN(CC1)C(=O)C(CC2=CC(=CC=C2)C(=NO)N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C D03KGH HIGHSTAT Phase 2 D03LAB DRUG__ID D03LAB D03LAB DRUGCOMP Encysive Pharmaceuticals D03LAB DRUGTYPE Small molecular drug D03LAB DRUGINCH 1S/C20H21N3O5S2/c1-10-8-11(2)17(15(9-10)14(5)24)21-19(25)18-16(6-7-29-18)30(26,27)23-20-12(3)13(4)22-28-20/h6-9,23H,1-5H3,(H,21,25) D03LAB DRUGINKE IAYNHDZSSDUYHY-UHFFFAOYSA-N D03LAB DRUGSMIL CC1=CC(=C(C(=C1)C(=O)C)NC(=O)C2=C(C=CS2)S(=O)(=O)NC3=C(C(=NO3)C)C)C D03LAB HIGHSTAT Phase 2 D03MFQ DRUG__ID D03MFQ D03MFQ DRUGCOMP Chiesi Pharmaceuticals D03MFQ DRUGTYPE Small molecular drug D03MFQ DRUGINCH 1S/C16H11Cl2FO2/c17-12-4-1-9(7-13(12)18)11-3-2-10(8-14(11)19)16(5-6-16)15(20)21/h1-4,7-8H,5-6H2,(H,20,21) D03MFQ DRUGINKE LIYLTQQDABRNRX-UHFFFAOYSA-N D03MFQ DRUGSMIL C1CC1(C2=CC(=C(C=C2)C3=CC(=C(C=C3)Cl)Cl)F)C(=O)O D03MFQ HIGHSTAT Phase 2 D03NLV DRUG__ID D03NLV D03NLV DRUGCOMP KinDEx Therapeutics D03NLV DRUGTYPE Small molecular drug D03NLV DRUGINCH 1S/C21H33O5.K/c1-12(2)7-9-15-19(24)18(16(22)11-14(5)6)20(25)21(15,26)17(23)10-8-13(3)4;/h12-15,25H,7-11H2,1-6H3;/q-1;+1/t15-,21+;/m1./s1 D03NLV DRUGINKE OBRIOHODJVKWGS-WSZABJOTSA-N D03NLV DRUGSMIL CC(C)CCC1C(=O)C(=C(C1(C(=O)CCC(C)C)[O-])O)C(=O)CC(C)C.[K+] D03NLV HIGHSTAT Phase 2 D03OGQ DRUG__ID D03OGQ D03OGQ DRUGCOMP AstraZeneca plc D03OGQ DRUGTYPE Small molecular drug D03OGQ DRUGINCH 1S/C22H23ClF2N4O5/c1-33-28-19(26)13-4-2-12(3-5-13)11-27-20(31)17-6-7-29(17)21(32)18(30)14-8-15(23)10-16(9-14)34-22(24)25/h2-5,8-10,17-18,22,30H,6-7,11H2,1H3,(H2,26,28)(H,27,31) D03OGQ DRUGINKE XSNMGLZVFNDDPW-UHFFFAOYSA-N D03OGQ DRUGSMIL CON=C(C1=CC=C(C=C1)CNC(=O)C2CCN2C(=O)C(C3=CC(=CC(=C3)Cl)OC(F)F)O)N D03OGQ HIGHSTAT Phase 2 D03PVQ DRUG__ID D03PVQ D03PVQ DRUGCOMP Enanta D03PVQ DRUGTYPE Small molecular drug D03PVQ DRUGINCH 1S/C43H64N6O11/c1-12-33-43(9,54)39-26(4)35(46-29(7)50)24(2)19-42(8,56-23-31(22-55-39)47-57-21-30-14-15-34(44-20-30)49-17-13-16-45-49)38(27(5)36(51)28(6)40(53)59-33)60-41-37(52)32(48(10)11)18-25(3)58-41/h13-17,20,24-28,32-33,37-39,41,52,54H,12,18-19,21-23H2,1-11H3/b46-35?,47-31+/t24-,25-,26+,27+,28-,32+,33-,37-,38-,39-,41+,42-,43-/m1/s1 D03PVQ DRUGINKE WLGSYOKBEDVHQB-ZIJNRMRWSA-N D03PVQ DRUGSMIL CCC1C(C2C(C(=NC(=O)C)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(OCC(=NOCC4=CN=C(C=C4)N5C=CC=N5)CO2)C)C)C)(C)O D03PVQ HIGHSTAT Phase 2 D03PYD DRUG__ID D03PYD D03PYD DRUGCOMP Kowa Pharmaceuticals America D03PYD DRUGTYPE Small molecular drug D03PYD DRUGINCH 1S/C23H30N6OS3/c1-16-14-19(31-2)21(22(24-16)32-3)27-20(30)15-29-10-8-28(9-11-29)12-13-33-23-25-17-6-4-5-7-18(17)26-23/h4-7,14H,8-13,15H2,1-3H3,(H,25,26)(H,27,30) D03PYD DRUGINKE VGGMTOYKEDKFLN-UHFFFAOYSA-N D03PYD DRUGSMIL CC1=CC(=C(C(=N1)SC)NC(=O)CN2CCN(CC2)CCSC3=NC4=CC=CC=C4N3)SC D03PYD HIGHSTAT Phase 2 D03QWO DRUG__ID D03QWO D03QWO DRUGCOMP Pierre Fabre D03QWO DRUGTYPE Small molecular drug D03QWO DRUGINCH 1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15)/t13-/m1/s1 D03QWO DRUGINKE RATZLMXRALDSJW-CYBMUJFWSA-N D03QWO DRUGSMIL CCC1(CC2=CC=CC=C2O1)C3=NCCN3 D03QWO HIGHSTAT Phase 2 D03QWZ DRUG__ID D03QWZ D03QWZ DRUGCOMP PledPharma AB D03QWZ DRUGTYPE Small molecular drug D03QWZ DRUGINCH 1S/C22H32N4O14P2.Mn.3Na/c1-13-21(31)17(15(5-23-13)11-39-41(33,34)35)7-25(9-19(27)28)3-4-26(10-20(29)30)8-18-16(12-40-42(36,37)38)6-24-14(2)22(18)32;;;;/h5-6,31-32H,3-4,7-12H2,1-2H3,(H,27,28)(H,29,30)(H2,33,34,35)(H2,36,37,38);;;;/q;;3*+1/p-3 D03QWZ DRUGINKE NBHBBGSKOXRZSD-UHFFFAOYSA-K D03QWZ DRUGSMIL CC1=[NH+]C=C(C(=C1O)CN(CCN(CC2=C(C(=[NH+]C=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)(O)[O-].[Na+].[Na+].[Na+].[Mn] D03QWZ HIGHSTAT Phase 2 D03UIB DRUG__ID D03UIB D03UIB DRUGCOMP Toyo Jozo Co Ltd D03UIB DRUGTYPE Small molecular drug D03UIB DRUGINCH 1S/C17H21N3OS/c1-12-14(22-16-19-17(2,3)11-20(12)16)15(21)18-10-9-13-7-5-4-6-8-13/h4-8H,9-11H2,1-3H3,(H,18,21) D03UIB DRUGINKE RJPFPRVTDMWNTH-UHFFFAOYSA-N D03UIB DRUGSMIL CC1=C(SC2=NC(CN12)(C)C)C(=O)NCCC3=CC=CC=C3 D03UIB HIGHSTAT Phase 2 D03VPJ DRUG__ID D03VPJ D03VPJ DRUGCOMP Anacor Pharma. D03VPJ DRUGTYPE Small molecular drug D03VPJ DRUGINCH 1S/C20H16BCl2NO3/c1-12-5-7-14(10-16(12)22)21(15-8-6-13(2)17(23)11-15)27-20(26)19-18(25)4-3-9-24-19/h3-11,25H,1-2H3 D03VPJ DRUGINKE ZTLSOLUCMQEGEA-UHFFFAOYSA-N D03VPJ DRUGSMIL B(C1=CC(=C(C=C1)C)Cl)(C2=CC(=C(C=C2)C)Cl)OC(=O)C3=C(C=CC=N3)O D03VPJ HIGHSTAT Phase 2 D03WRJ DRUG__ID D03WRJ D03WRJ DRUGCOMP DiaKine Therapeutics D03WRJ DRUGTYPE Small molecular drug D03WRJ DRUGINCH 1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1 D03WRJ DRUGINKE NSMXQKNUPPXBRG-SECBINFHSA-N D03WRJ DRUGSMIL CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O D03WRJ HIGHSTAT Phase 2 D03XTY DRUG__ID D03XTY D03XTY DRUGCOMP Aprea Therapeutics D03XTY DRUGTYPE Small molecular drug D03XTY DRUGINCH 1S/C10H17NO3/c1-14-7-10(6-12)9(13)8-2-4-11(10)5-3-8/h8,12H,2-7H2,1H3 D03XTY DRUGINKE BGBNULCRKBVAKL-UHFFFAOYSA-N D03XTY DRUGSMIL COCC1(C(=O)C2CCN1CC2)CO D03XTY HIGHSTAT Phase 2 D03ZME DRUG__ID D03ZME D03ZME DRUGCOMP ZIOPHARM Oncology D03ZME DRUGTYPE Small molecular drug D03ZME DRUGINCH 1S/C12H22AsN3O6S/c1-13(2)23-6-8(11(20)15-5-10(18)19)16-9(17)4-3-7(14)12(21)22/h7-8H,3-6,14H2,1-2H3,(H,15,20)(H,16,17)(H,18,19)(H,21,22)/t7-,8-/m0/s1 D03ZME DRUGINKE JGDXFQORBMPJGR-YUMQZZPRSA-N D03ZME DRUGSMIL C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N D03ZME HIGHSTAT Phase 2 D04AMD DRUG__ID D04AMD D04AMD DRUGCOMP Angiogene Pharmaceuticals Ltd; Angiogene D04AMD DRUGTYPE Small molecular drug D04AMD DRUGINCH 1S/C20H24NO8P/c1-11(22)21-16-8-5-12-9-17(26-2)19(27-3)20(28-4)18(12)14-7-6-13(10-15(14)16)29-30(23,24)25/h6-7,9-10,16H,5,8H2,1-4H3,(H,21,22)(H2,23,24,25)/t16-/m0/s1 D04AMD DRUGINKE UGBMEXLBFDAOGL-INIZCTEOSA-N D04AMD DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=C1C=C(C=C3)OP(=O)(O)O)OC)OC)OC D04AMD HIGHSTAT Phase 2 D04BFC DRUG__ID D04BFC D04BFC DRUGCOMP Celgene D04BFC DRUGTYPE Small molecular drug D04BFC DRUGINCH 1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28) D04BFC DRUGINKE KXBDTLQSDKGAEB-UHFFFAOYSA-N D04BFC DRUGSMIL COCCOC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)NC(=O)C=C)F D04BFC HIGHSTAT Phase 2 D04BPS DRUG__ID D04BPS D04BPS DRUGCOMP Ligand Pharmaceuticals D04BPS DRUGTYPE Small molecular drug D04BPS DRUGINCH 1S/C25H26O6/c1-28-24(25(26)27)18-19-8-10-20(11-9-19)29-16-5-17-30-21-12-14-23(15-13-21)31-22-6-3-2-4-7-22/h2-4,6-15,24H,5,16-18H2,1H3,(H,26,27)/t24-/m0/s1 D04BPS DRUGINKE OKJHGOPITGTTIM-DEOSSOPVSA-N D04BPS DRUGSMIL COC(CC1=CC=C(C=C1)OCCCOC2=CC=C(C=C2)OC3=CC=CC=C3)C(=O)O D04BPS HIGHSTAT Phase 2 D04BQV DRUG__ID D04BQV D04BQV DRUGCOMP Amicus Therape. D04BQV DRUGTYPE Small molecular drug D04BQV DRUGINCH 1S/C6H13NO3.C4H6O6/c8-3-4-1-7-2-5(9)6(4)10;5-1(3(7)8)2(6)4(9)10/h4-10H,1-3H2;1-2,5-6H,(H,7,8)(H,9,10)/t4-,5-,6-;1-,2-/m11/s1 D04BQV DRUGINKE ULBPPCHRAVUQMC-MUMXBIPUSA-N D04BQV DRUGSMIL C1C(C(C(CN1)O)O)CO.C(C(C(=O)O)O)(C(=O)O)O D04BQV HIGHSTAT Phase 2 D04CQV DRUG__ID D04CQV D04CQV DRUGCOMP BioCis Pharma Ltd D04CQV DRUGTYPE Small molecular drug D04CQV DRUGINCH 1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/b2-1- D04CQV DRUGINKE LOIYMIARKYCTBW-UPHRSURJSA-N D04CQV DRUGSMIL C1=C(NC=N1)C=CC(=O)O D04CQV HIGHSTAT Phase 2 D04DQZ DRUG__ID D04DQZ D04DQZ DRUGCOMP AstraZeneca plc D04DQZ DRUGTYPE Small molecular drug D04DQZ DRUGINCH 1S/C29H35FN4O/c1-3-33(4-2)29(35)24-12-10-23(11-13-24)28(25-6-5-7-27(31)20-25)34-18-16-32(17-19-34)21-22-8-14-26(30)15-9-22/h5-15,20,28H,3-4,16-19,21,31H2,1-2H3/t28-/m1/s1 D04DQZ DRUGINKE XGFLMBBZEPJGHY-MUUNZHRXSA-N D04DQZ DRUGSMIL CCN(CC)C(=O)C1=CC=C(C=C1)C(C2=CC(=CC=C2)N)N3CCN(CC3)CC4=CC=C(C=C4)F D04DQZ HIGHSTAT Phase 2 D04DYC DRUG__ID D04DYC D04DYC DRUGCOMP Pfizer D04DYC DRUGTYPE Small molecular drug D04DYC DRUGINCH 1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1 D04DYC DRUGINKE IIXWYSCJSQVBQM-LLVKDONJSA-N D04DYC DRUGSMIL CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C D04DYC HIGHSTAT Phase 2 D04EFK DRUG__ID D04EFK D04EFK DRUGCOMP Dynogen D04EFK DRUGTYPE Small molecular drug D04EFK DRUGINCH 1S/C17H17FN4S.ClH.H2O/c1-11-10-13-15(12-4-2-3-5-14(12)18)20-17(21-16(13)23-11)22-8-6-19-7-9-22;;/h2-5,10,19H,6-9H2,1H3;1H;1H2 D04EFK DRUGINKE SAURKKOJWIFYSR-UHFFFAOYSA-N D04EFK DRUGSMIL CC1=CC2=C(N=C(N=C2S1)N3CCNCC3)C4=CC=CC=C4F.O.Cl D04EFK HIGHSTAT Phase 2 D04FDN DRUG__ID D04FDN D04FDN DRUGCOMP ZIOPHARM Oncology D04FDN DRUGTYPE Small molecular drug D04FDN DRUGINCH 1S/C4H11Cl2N2O2P/c5-1-3-7-11(9,10)8-4-2-6/h1-4H2,(H3,7,8,9,10) D04FDN DRUGINKE BKCJZNIZRWYHBN-UHFFFAOYSA-N D04FDN DRUGSMIL C(CCl)NP(=O)(NCCCl)O D04FDN HIGHSTAT Phase 2 D04FGX DRUG__ID D04FGX D04FGX DRUGCOMP Esperance Pharmaceuticals Inc D04FGX DRUGTYPE Small molecular drug D04FGX DRUGINCH 1S/C15H16O2.C3H5ClO/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12;4-1-3-2-5-3/h3-10,16-17H,1-2H3;3H,1-2H2 D04FGX DRUGINKE KUBDPQJOLOUJRM-UHFFFAOYSA-N D04FGX DRUGSMIL CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O.C1C(O1)CCl D04FGX HIGHSTAT Phase 2 D04FNQ DRUG__ID D04FNQ D04FNQ DRUGCOMP Ipsen D04FNQ DRUGTYPE Small molecular drug D04FNQ DRUGINCH 1S/C16H15ClO6/c1-8(18)22-13-11-6-5-10(17)7-12(11)14(23-9(2)19)16(21-4)15(13)20-3/h5-7H,1-4H3 D04FNQ DRUGINKE IFWMVQUGSGWCRP-UHFFFAOYSA-N D04FNQ DRUGSMIL CC(=O)OC1=C(C(=C(C2=C1C=CC(=C2)Cl)OC(=O)C)OC)OC D04FNQ HIGHSTAT Phase 2 D04FVD DRUG__ID D04FVD D04FVD DRUGCOMP Fabre-Kramer D04FVD DRUGTYPE Small molecular drug D04FVD DRUGINCH 1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16) D04FVD DRUGINKE DRTQHJPVMGBUCF-UHFFFAOYSA-N D04FVD DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O D04FVD HIGHSTAT Phase 2 D04GZS DRUG__ID D04GZS D04GZS DRUGCOMP Georgetown University; Mitos Pharmaceuticals Inc D04GZS DRUGTYPE Small molecular drug D04GZS DRUGINCH 1S/C9H18NO2/c1-8(2)5-7(11)6-9(3,4)10(8)12/h7,11H,5-6H2,1-4H3 D04GZS DRUGINKE UZFMOKQJFYMBGY-UHFFFAOYSA-N D04GZS DRUGSMIL CC1(CC(CC(N1[O])(C)C)O)C D04GZS HIGHSTAT Phase 2 D04JNI DRUG__ID D04JNI D04JNI DRUGCOMP GSK D04JNI DRUGTYPE Small molecular drug D04JNI DRUGINCH 1S/C26H24N6O2S2/c1-17-23(36-25(28-17)18-5-4-8-27-13-18)24(33)29-21-7-3-2-6-20(21)22-15-32-19(16-35-26(32)30-22)14-31-9-11-34-12-10-31/h2-8,13,15-16H,9-12,14H2,1H3,(H,29,33) D04JNI DRUGINKE LAMQVIQMVKWXOC-UHFFFAOYSA-N D04JNI DRUGSMIL CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6 D04JNI HIGHSTAT Phase 2 D04JZP DRUG__ID D04JZP D04JZP DRUGCOMP RW Johnson Pharmaceutical Research Institute D04JZP DRUGTYPE Small molecular drug D04JZP DRUGINCH 1S/C26H35N3O2.C4H6O4/c1-21(2)31-25-12-5-4-11-24(25)28-17-15-27(16-18-28)20-22-9-8-10-23(19-22)26(30)29-13-6-3-7-14-29;5-3(6)1-2-4(7)8/h4-5,8-12,19,21H,3,6-7,13-18,20H2,1-2H3;1-2H2,(H,5,6)(H,7,8) D04JZP DRUGINKE WAHFGTZTVZRLEY-UHFFFAOYSA-N D04JZP DRUGSMIL CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CC=C3)C(=O)N4CCCCC4.C(CC(=O)O)C(=O)O D04JZP HIGHSTAT Phase 2 D04MCY DRUG__ID D04MCY D04MCY DRUGCOMP Bristol-Myers Squibb D04MCY DRUGTYPE Small molecular drug D04MCY DRUGINCH 1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1 D04MCY DRUGINKE XRWSZZJLZRKHHD-WVWIJVSJSA-N D04MCY DRUGSMIL CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C D04MCY HIGHSTAT Phase 2 D04MPB DRUG__ID D04MPB D04MPB DRUGCOMP Panacos D04MPB DRUGTYPE Small molecular drug D04MPB DRUGINCH 1S/C36H56O6/c1-21(2)22-12-17-36(30(40)41)19-18-34(8)23(28(22)36)10-11-25-33(7)15-14-26(42-27(37)20-31(3,4)29(38)39)32(5,6)24(33)13-16-35(25,34)9/h22-26,28H,1,10-20H2,2-9H3,(H,38,39)(H,40,41)/t22-,23+,24-,25+,26-,28+,33-,34+,35+,36-/m0/s1 D04MPB DRUGINKE YJEJKUQEXFSVCJ-WRFMNRASSA-N D04MPB DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C)C(=O)O D04MPB HIGHSTAT Phase 2 D04NAQ DRUG__ID D04NAQ D04NAQ DRUGCOMP Conatus Pharmaceuticals D04NAQ DRUGTYPE Small molecular drug D04NAQ DRUGINCH 1S/C26H27F4N3O7/c1-12(31-24(38)25(39)32-16-8-6-5-7-13(16)26(2,3)4)23(37)33-17(10-19(35)36)18(34)11-40-22-20(29)14(27)9-15(28)21(22)30/h5-9,12,17H,10-11H2,1-4H3,(H,31,38)(H,32,39)(H,33,37)(H,35,36)/t12-,17-/m0/s1 D04NAQ DRUGINKE SCVHJVCATBPIHN-SJCJKPOMSA-N D04NAQ DRUGSMIL CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C D04NAQ HIGHSTAT Phase 2 D04NXL DRUG__ID D04NXL D04NXL DRUGCOMP ZioPharm D04NXL DRUGTYPE Small molecular drug D04NXL DRUGINCH 1S/C22H16ClN3O2/c23-16-7-5-15(6-8-16)13-26-14-19(18-3-1-2-4-20(18)26)21(27)22(28)25-17-9-11-24-12-10-17/h1-12,14H,13H2,(H,24,25,28) D04NXL DRUGINKE SOLIIYNRSAWTSQ-UHFFFAOYSA-N D04NXL DRUGSMIL C1=CC=C2C(=C1)C(=CN2CC3=CC=C(C=C3)Cl)C(=O)C(=O)NC4=CC=NC=C4 D04NXL HIGHSTAT Phase 2 D04ODO DRUG__ID D04ODO D04ODO DRUGCOMP GlaxoSmithKline plc D04ODO DRUGTYPE Small molecular drug D04ODO DRUGINCH 1S/C10H13ClN4O2/c1-2-3-4-5-15-7-6(12-9(11)13-7)8(16)14-10(15)17/h2-5H2,1H3,(H,12,13)(H,14,16,17) D04ODO DRUGINKE CGAMDQCXAAOFSR-UHFFFAOYSA-N D04ODO DRUGSMIL CCCCCN1C2=C(C(=O)NC1=O)NC(=N2)Cl D04ODO HIGHSTAT Phase 2 D04PAU DRUG__ID D04PAU D04PAU DRUGCOMP GlaxoSmithKline D04PAU DRUGTYPE Small molecular drug D04PAU DRUGINCH 1S/C20H34N6O2/c1-3-10-15(2)28-19-23-17(21)16-18(24-19)26(20(27)22-16)14-9-5-8-13-25-11-6-4-7-12-25/h15H,3-14H2,1-2H3,(H,22,27)(H2,21,23,24)/t15-/m0/s1 D04PAU DRUGINKE LFMPVTVPXHNXOT-HNNXBMFYSA-N D04PAU DRUGSMIL CCCC(C)OC1=NC(=C2C(=N1)N(C(=O)N2)CCCCCN3CCCCC3)N D04PAU HIGHSTAT Phase 2 D04PER DRUG__ID D04PER D04PER DRUGCOMP Xenon Pharmaceuticals Inc D04PER DRUGTYPE Small molecular drug D04PER DRUGINCH 1S/C22H14F3NO5/c23-22(24,25)19-6-5-12(31-19)9-26-15-4-2-1-3-13(15)21(20(26)27)10-28-16-8-18-17(7-14(16)21)29-11-30-18/h1-8H,9-11H2/t21-/m0/s1 D04PER DRUGINKE NEBUOXBYNAHKFV-NRFANRHFSA-N D04PER DRUGSMIL C1C2(C3=CC=CC=C3N(C2=O)CC4=CC=C(O4)C(F)(F)F)C5=CC6=C(C=C5O1)OCO6 D04PER HIGHSTAT Phase 2 D04QKU DRUG__ID D04QKU D04QKU DRUGCOMP F Hoffmann-La Roche Ltd D04QKU DRUGTYPE Small molecular drug D04QKU DRUGINCH 1S/C18H13ClFN3/c1-12-17(8-3-14-9-10-21-18(19)11-14)22-13(2)23(12)16-6-4-15(20)5-7-16/h4-7,9-11H,1-2H3 D04QKU DRUGINKE UPZWINBEAHDTLA-UHFFFAOYSA-N D04QKU DRUGSMIL CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl D04QKU HIGHSTAT Phase 2 D04QRG DRUG__ID D04QRG D04QRG DRUGCOMP Burzynski research institute D04QRG DRUGTYPE Small molecular drug D04QRG DRUGINCH 1S/C13H14N2O3/c16-11-7-6-10(13(18)15-11)14-12(17)8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,14,17)(H,15,16,18)/t10-/m0/s1 D04QRG DRUGINKE OQGRFQCUGLKSAV-JTQLQIEISA-N D04QRG DRUGSMIL C1CC(=O)NC(=O)C1NC(=O)CC2=CC=CC=C2 D04QRG HIGHSTAT Phase 2 D04QUG DRUG__ID D04QUG D04QUG DRUGCOMP Anthera Pharmaceuticals Inc D04QUG DRUGTYPE Small molecular drug D04QUG DRUGINCH 1S/C18H19N3O5/c22-17(11-13-4-2-1-3-5-13)20-12-19-16(18(23)24)10-14-6-8-15(9-7-14)21(25)26/h1-9,16,19H,10-12H2,(H,20,22)(H,23,24)/t16-/m0/s1 D04QUG DRUGINKE MALANEHOOMRDSZ-INIZCTEOSA-N D04QUG DRUGSMIL C1=CC=C(C=C1)CC(=O)NCNC(CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)O D04QUG HIGHSTAT Phase 2 D04RKW DRUG__ID D04RKW D04RKW DRUGCOMP Trier Research Laboratories D04RKW DRUGTYPE Small molecular drug D04RKW DRUGINCH 1S/C6H6N4O2/c1-10-2-7-4-3(10)5(11)9-6(12)8-4/h2H,1H3,(H2,8,9,11,12) D04RKW DRUGINKE PFWLFWPASULGAN-UHFFFAOYSA-N D04RKW DRUGSMIL CN1C=NC2=C1C(=O)NC(=O)N2 D04RKW HIGHSTAT Phase 2 D04TGF DRUG__ID D04TGF D04TGF DRUGCOMP AstraZenec, UK D04TGF DRUGTYPE Small molecular drug D04TGF DRUGINCH 1S/C17H25FN2O2/c1-11(2)16(10-20-8-14(21)9-20)19(4)17(22)13-5-6-15(18)12(3)7-13/h5-7,11,14,16,21H,8-10H2,1-4H3/t16-/m1/s1 D04TGF DRUGINKE GAHPWXLXWUVMIV-MRXNPFEDSA-N D04TGF DRUGSMIL CC1=C(C=CC(=C1)C(=O)N(C)C(CN2CC(C2)O)C(C)C)F D04TGF HIGHSTAT Phase 2 D04TLJ DRUG__ID D04TLJ D04TLJ DRUGCOMP Teikoku Hormone Manufacturing Co Ltd D04TLJ DRUGTYPE Small molecular drug D04TLJ DRUGINCH 1S/C39H67N5O6/c1-13-27(6)35(43(10)39(48)33(25(2)3)41-38(47)34(26(4)5)42(8)9)31(49-11)24-32(45)44-23-17-20-30(44)36(50-12)28(7)37(46)40-22-21-29-18-15-14-16-19-29/h14-16,18-19,25-28,30-31,33-36H,13,17,20-24H2,1-12H3,(H,40,46)(H,41,47)/t27-,28+,30-,31+,33-,34-,35-,36+/m0/s1 D04TLJ DRUGINKE DZMVCVHATYROOS-ZBFGKEHZSA-N D04TLJ DRUGSMIL CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NCCC2=CC=CC=C2)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C D04TLJ HIGHSTAT Phase 2 D04TPQ DRUG__ID D04TPQ D04TPQ DRUGCOMP Allergan Inc D04TPQ DRUGTYPE Small molecular drug D04TPQ DRUGINCH 1S/C27H37NO4S/c1-4-5-6-10-24(29)20-11-13-22(14-12-20)28-21(15-18-26(28)30)8-7-9-23-16-17-25(33-23)27(31)32-19(2)3/h11-14,16-17,19,21,24,29H,4-10,15,18H2,1-3H3/t21-,24-/m0/s1 D04TPQ DRUGINKE GKRBCKDGBDUAIQ-URXFXBBRSA-N D04TPQ DRUGSMIL CCCCCC(C1=CC=C(C=C1)N2C(CCC2=O)CCCC3=CC=C(S3)C(=O)OC(C)C)O D04TPQ HIGHSTAT Phase 2 D04TQT DRUG__ID D04TQT D04TQT DRUGCOMP Ferring Pharmaceuticals Inc D04TQT DRUGTYPE Small molecular drug D04TQT DRUGINCH 1S/C40H63N9O8S/c1-6-23(3)34-38(55)46-31(20-32(42)51)36(53)45-29(40(57)49(5)26(22-50)11-10-16-41)14-17-58-18-15-33(52)44-30(19-25-21-43-28-13-9-8-12-27(25)28)37(54)47-35(24(4)7-2)39(56)48-34/h8-9,12-13,21,23-24,26,29-31,34-35,43,50H,6-7,10-11,14-20,22,41H2,1-5H3,(H2,42,51)(H,44,52)(H,45,53)(H,46,55)(H,47,54)(H,48,56)/t23-,24+,26+,29+,30-,31+,34+,35+/m1/s1 D04TQT DRUGINKE UGNGRKKDUVKQDF-IHOMMZCZSA-N D04TQT DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CCSCCC(=O)NC(C(=O)N1)CC2=CNC3=CC=CC=C32)C(=O)N(C)C(CCCN)CO)CC(=O)N)C(C)CC D04TQT HIGHSTAT Phase 2 D04UUD DRUG__ID D04UUD D04UUD THERCLAS Anticancer Agents D04UUD DRUGTYPE Small molecular drug D04UUD DRUGINCH 1S/C22H24N6O/c1-2-9-28(10-3-1)11-12-29-18-6-4-5-16(13-18)21-19-14-17(22-23-15-24-27-22)7-8-20(19)25-26-21/h4-8,13-15H,1-3,9-12H2,(H,25,26)(H,23,24,27) D04UUD DRUGINKE XDJCLCLBSGGNKS-UHFFFAOYSA-N D04UUD DRUGSMIL C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5 D04UUD HIGHSTAT Phase 2 D04WUA DRUG__ID D04WUA D04WUA THERCLAS Analgesics D04WUA DRUGTYPE Small molecular drug D04WUA DRUGINCH 1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1 D04WUA DRUGINKE QEMSVZNTSXPFJA-HNAYVOBHSA-N D04WUA DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)(C3=CC=CC=C3)O D04WUA HIGHSTAT Phase 2 D04XVU DRUG__ID D04XVU D04XVU DRUGCOMP Genkyotex innovation D04XVU DRUGTYPE Small molecular drug D04XVU DRUGINCH 1S/C21H19ClN4O2/c1-24(2)14-8-6-7-13(11-14)20-19-16(12-18(27)25(20)3)23-26(21(19)28)17-10-5-4-9-15(17)22/h4-12,23H,1-3H3 D04XVU DRUGINKE RGYQPQARIQKJKH-UHFFFAOYSA-N D04XVU DRUGSMIL CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl D04XVU HIGHSTAT Phase 2 D04XZE DRUG__ID D04XZE D04XZE THERCLAS Analgesics D04XZE DRUGTYPE Small molecular drug D04XZE DRUGINCH 1S/C21H28FN3O.ClH/c1-17-23-20(18-8-10-19(22)11-9-18)16-21(24-17)26-15-7-3-6-14-25-12-4-2-5-13-25;/h8-11,16H,2-7,12-15H2,1H3;1H D04XZE DRUGINKE VLYZLIWXMLUPLD-UHFFFAOYSA-N D04XZE DRUGSMIL CC1=NC(=CC(=N1)OCCCCCN2CCCCC2)C3=CC=C(C=C3)F.Cl D04XZE HIGHSTAT Phase 2 D04YEW DRUG__ID D04YEW D04YEW DRUGCOMP Laboratorios SALVAT SA D04YEW DRUGTYPE Small molecular drug D04YEW DRUGINCH 1S/C21H20F4N2O2/c22-15-2-1-3-16(10-15)27(11-13-8-17(23)20(25)18(24)9-13)21(28)29-19-12-26-6-4-14(19)5-7-26/h1-3,8-10,14,19H,4-7,11-12H2/t19-/m0/s1 D04YEW DRUGINKE UXZDMXYRRQJIBJ-IBGZPJMESA-N D04YEW DRUGSMIL C1CN2CCC1C(C2)OC(=O)N(CC3=CC(=C(C(=C3)F)F)F)C4=CC(=CC=C4)F D04YEW HIGHSTAT Phase 2 D04YJN DRUG__ID D04YJN D04YJN DRUGCOMP Roche D04YJN DRUGTYPE Small molecular drug D04YJN DRUGINCH 1S/C12H18O/c1-3-12(2,13)10-9-11-7-5-4-6-8-11/h4-8,13H,3,9-10H2,1-2H3 D04YJN DRUGINKE AEJRTNBCFUOSEM-UHFFFAOYSA-N D04YJN DRUGSMIL CCC(C)(CCC1=CC=CC=C1)O D04YJN HIGHSTAT Phase 2 D05AAD DRUG__ID D05AAD D05AAD DRUGCOMP Anadys Pharmaceuticals D05AAD DRUGTYPE Small molecular drug D05AAD DRUGINCH 1S/C10H12N4O6S/c11-9-12-6-5(7(18)13-9)21-10(19)14(6)8-4(17)3(16)2(1-15)20-8/h2-4,8,15-17H,1H2,(H3,11,12,13,18)/t2-,3-,4-,8-/m1/s1 D05AAD DRUGINKE TZYVRXZQAWPIAB-FCLHUMLKSA-N D05AAD DRUGSMIL C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)SC2=O)O)O)O D05AAD HIGHSTAT Phase 2 D05ADP DRUG__ID D05ADP D05ADP DRUGCOMP Cyclacel D05ADP DRUGTYPE Small molecular drug D05ADP DRUGINCH 1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 D05ADP DRUGINKE BTIHMVBBUGXLCJ-OAHLLOKOSA-N D05ADP DRUGSMIL CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3 D05ADP HIGHSTAT Phase 2 D05BHF DRUG__ID D05BHF D05BHF DRUGCOMP Zeneca Group plc D05BHF DRUGTYPE Small molecular drug D05BHF DRUGINCH 1S/C31H32F3N3O5S/c1-19(16-31(32,33)34)17-35-29(38)22-11-12-26-25(14-22)24(18-37(26)3)13-21-9-10-23(15-27(21)42-4)30(39)36-43(40,41)28-8-6-5-7-20(28)2/h5-12,14-15,18-19H,13,16-17H2,1-4H3,(H,35,38)(H,36,39)/t19-/m1/s1 D05BHF DRUGINKE ULMFXAMQUGLVGA-LJQANCHMSA-N D05BHF DRUGSMIL CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)C(=O)NCC(C)CC(F)(F)F)C)OC D05BHF HIGHSTAT Phase 2 D05BXO DRUG__ID D05BXO D05BXO DRUGCOMP Lundbeck D05BXO DRUGTYPE Small molecular drug D05BXO DRUGINCH 1S/C16H20Cl2N2O/c1-20-11-4-6-16(20)13(9-19-21-2)12(8-11)10-3-5-14(17)15(18)7-10/h3,5,7,9,11-13,16H,4,6,8H2,1-2H3/b19-9+/t11?,12-,13-,16?/m1/s1 D05BXO DRUGINKE NRLIFEGHTNUYFL-MTKJPOGLSA-N D05BXO DRUGSMIL CN1C2CCC1C(C(C2)C3=CC(=C(C=C3)Cl)Cl)C=NOC D05BXO HIGHSTAT Phase 2 D05CFG DRUG__ID D05CFG D05CFG DRUGCOMP Proacta D05CFG DRUGTYPE Small molecular drug D05CFG DRUGINCH 1S/C14H20BrN4O12PS/c1-33(28,29)31-7-5-17(4-2-15)13-11(14(20)16-3-6-30-32(25,26)27)8-10(18(21)22)9-12(13)19(23)24/h8-9H,2-7H2,1H3,(H,16,20)(H2,25,26,27) D05CFG DRUGINKE GZSOKPMDWVRVMG-UHFFFAOYSA-N D05CFG DRUGSMIL CS(=O)(=O)OCCN(CCBr)C1=C(C=C(C=C1[N+](=O)[O-])[N+](=O)[O-])C(=O)NCCOP(=O)(O)O D05CFG HIGHSTAT Phase 2 D05ECK DRUG__ID D05ECK D05ECK DRUGCOMP SmithKline Beecham plc D05ECK DRUGTYPE Small molecular drug D05ECK DRUGINCH 1S/C46H56N12O6/c1-27(54-44(62)39(20-29-23-51-35-15-7-5-13-32(29)35)57-43(61)34(48)22-31-25-50-26-53-31)42(60)56-40(21-30-24-52-36-16-8-6-14-33(30)36)46(64)58-38(19-28-11-3-2-4-12-28)45(63)55-37(41(49)59)17-9-10-18-47/h2-8,11-16,23-27,34,37-40,51-52H,9-10,17-22,47-48H2,1H3,(H2,49,59)(H,50,53)(H,54,62)(H,55,63)(H,56,60)(H,57,61)(H,58,64) D05ECK DRUGINKE WZHKXNSOCOQYQX-UHFFFAOYSA-N D05ECK DRUGSMIL CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N D05ECK HIGHSTAT Phase 2 D05ELM DRUG__ID D05ELM D05ELM DRUGCOMP Aciex Therapeutics Inc D05ELM DRUGTYPE Small molecular drug D05ELM DRUGINCH 1S/C3H8BrN.BrH/c4-2-1-3-5;/h1-3,5H2;1H D05ELM DRUGINKE PQIYSSSTRHVOBW-UHFFFAOYSA-N D05ELM DRUGSMIL C(CN)CBr.Br D05ELM HIGHSTAT Phase 2 D05ENJ DRUG__ID D05ENJ D05ENJ DRUGCOMP The Menarini Group D05ENJ DRUGTYPE Small molecular drug D05ENJ DRUGINCH 1S/C36H49Cl2N6O6S.ClH/c1-24-22-25(2)40-33-26(24)8-6-10-30(33)50-23-27-28(37)11-12-31(32(27)38)51(47,48)41-36(13-20-49-21-14-36)35(46)43-17-15-42(16-18-43)34(45)29(39)9-7-19-44(3,4)5;/h6,8,10-12,22,29,41H,7,9,13-21,23,39H2,1-5H3;1H/q+1;/p-1/t29-;/m0./s1 D05ENJ DRUGINKE ZNHJDJYKDVGQSH-JMAPEOGHSA-M D05ENJ DRUGSMIL CC1=CC(=NC2=C1C=CC=C2OCC3=C(C=CC(=C3Cl)S(=O)(=O)NC4(CCOCC4)C(=O)N5CCN(CC5)C(=O)C(CCC[N+](C)(C)C)N)Cl)C.[Cl-] D05ENJ HIGHSTAT Phase 2 D05FQD DRUG__ID D05FQD D05FQD DRUGCOMP Molecular Insights Pharmaceuticals D05FQD DRUGTYPE Small molecular drug D05FQD DRUGINCH 1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)/i9+4 D05FQD DRUGINKE PDWUPXJEEYOOTR-JRGAVVOBSA-N D05FQD DRUGSMIL C1=CC(=CC(=C1)I)CN=C(N)N D05FQD HIGHSTAT Phase 2 D05FWH DRUG__ID D05FWH D05FWH DRUGCOMP Merck D05FWH DRUGTYPE Small molecular drug D05FWH DRUGINCH 1S/C15H18BrN7/c1-22-8-10(6-19-22)11-7-20-23-14(17)12(16)13(21-15(11)23)9-3-2-4-18-5-9/h6-9,18H,2-5,17H2,1H3/t9-/m1/s1 D05FWH DRUGINKE GMIZZEXBPRLVIV-SECBINFHSA-N D05FWH DRUGSMIL CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4 D05FWH HIGHSTAT Phase 2 D05GEF DRUG__ID D05GEF D05GEF DRUGCOMP Dara biosciences D05GEF DRUGTYPE Small molecular drug D05GEF DRUGINCH 1S/C28H43N7O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-19(38)29-14-20(39)34-21-23(40)24(41)28(42-25(21)18(37)15-36)35-27-22-26(31-16-30-22)32-17-33-27/h10-13,16-18,21,23-25,28,36-37,40-41H,2-9,14-15H2,1H3,(H,29,38)(H,34,39)(H2,30,31,32,33,35)/b11-10+,13-12+/t18-,21+,23+,24+,25-,28-/m0/s1 D05GEF DRUGINKE LQIPDFIUPOYMPR-BKYURJJWSA-N D05GEF DRUGSMIL CCCCCCCCCC=CC=CC(=O)NCC(=O)NC1C(C(C(OC1C(CO)O)NC2=NC=NC3=C2NC=N3)O)O D05GEF HIGHSTAT Phase 2 D05HWN DRUG__ID D05HWN D05HWN DRUGCOMP Conforma Therapeutics Corp D05HWN DRUGTYPE Small molecular drug D05HWN DRUGINCH 1S/C14H15ClN6O/c1-7-4-17-9(8(2)11(7)22-3)5-21-6-18-10-12(15)19-14(16)20-13(10)21/h4,6H,5H2,1-3H3,(H2,16,19,20) D05HWN DRUGINKE QULDDKSCVCJTPV-UHFFFAOYSA-N D05HWN DRUGSMIL CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N D05HWN HIGHSTAT Phase 2 D05IIN DRUG__ID D05IIN D05IIN DRUGCOMP Sanofi-Aventis D05IIN DRUGTYPE Small molecular drug D05IIN DRUGINCH 1S/C27H28ClFN2OS/c1-6-11-31(24(13-19-8-9-19)20-10-7-16(2)23(29)14-20)27-30-26(18(4)33-27)21-12-17(3)25(32-5)15-22(21)28/h1,7,10,12,14-15,19,24H,8-9,11,13H2,2-5H3/t24-/m0/s1 D05IIN DRUGINKE IEAKXXNRGSLYTQ-DEOSSOPVSA-N D05IIN DRUGSMIL CC1=C(C=C(C=C1)C(CC2CC2)N(CC#C)C3=NC(=C(S3)C)C4=C(C=C(C(=C4)C)OC)Cl)F D05IIN HIGHSTAT Phase 2 D05IRT DRUG__ID D05IRT D05IRT DRUGCOMP Nicholas Piramal D05IRT DRUGTYPE Small molecular drug D05IRT DRUGINCH 1S/C21H20ClNO5.ClH/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22;/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3;1H/t12-,14+;/m1./s1 D05IRT DRUGINKE OOVTUOCTLAERQD-OJMBIDBESA-N D05IRT DRUGSMIL CN1CCC(C1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O.Cl D05IRT HIGHSTAT Phase 2 D05JHB DRUG__ID D05JHB D05JHB THERCLAS Antiviral Agents D05JHB DRUGTYPE Small molecular drug D05JHB DRUGINCH 1S/C10H6O5/c11-6-3-5-1-2-7(12)15-8(5)10-9(6)13-4-14-10/h1-3,11H,4H2 D05JHB DRUGINKE BKFIQORTLXDLHQ-UHFFFAOYSA-N D05JHB DRUGSMIL C1OC2=C(C=C3C=CC(=O)OC3=C2O1)O D05JHB HIGHSTAT Phase 2 Trial D05KBU DRUG__ID D05KBU D05KBU THERCLAS Neurology Agents D05KBU DRUGTYPE Small molecular drug D05KBU DRUGINCH 1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19) D05KBU DRUGINKE TZDUHAJSIBHXDL-UHFFFAOYSA-N D05KBU DRUGSMIL CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O D05KBU HIGHSTAT Phase 2 D05KED DRUG__ID D05KED D05KED DRUGCOMP Acetylon pharmaceuticals D05KED DRUGTYPE Small molecular drug D05KED DRUGINCH 1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30) D05KED DRUGINKE QGZYDVAGYRLSKP-UHFFFAOYSA-N D05KED DRUGSMIL C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO D05KED HIGHSTAT Phase 2 D05KVC DRUG__ID D05KVC D05KVC DRUGCOMP Sanofi-aventis D05KVC DRUGTYPE Small molecular drug D05KVC DRUGINCH 1S/C26H24F3N/c27-26(28,29)25-8-4-7-24(19-25)23-14-17-30(18-15-23)16-13-20-9-11-22(12-10-20)21-5-2-1-3-6-21/h1-12,14,19H,13,15-18H2 D05KVC DRUGINKE CNEWKIDCGDXBDE-UHFFFAOYSA-N D05KVC DRUGSMIL C1CN(CC=C1C2=CC(=CC=C2)C(F)(F)F)CCC3=CC=C(C=C3)C4=CC=CC=C4 D05KVC HIGHSTAT Phase 2 D05MDJ DRUG__ID D05MDJ D05MDJ DRUGCOMP Organon D05MDJ DRUGTYPE Small molecular drug D05MDJ DRUGINCH 1S/C28H30O4/c1-3-11-28(30)12-10-23-21-7-4-17-13-19(29)6-8-20(17)26(21)22(15-27(23,28)2)18-5-9-24-25(14-18)32-16-31-24/h5,9,13-14,21-23,30H,4,6-8,10,12,15-16H2,1-2H3/t21-,22+,23-,27-,28-/m0/s1 D05MDJ DRUGINKE DFELGYQKEOCHOA-BZAFBGKRSA-N D05MDJ DRUGSMIL CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC6=C(C=C5)OCO6)C)O D05MDJ HIGHSTAT Phase 2 D05MHI DRUG__ID D05MHI D05MHI DRUGCOMP Biocardia; allocure D05MHI DRUGTYPE Small molecular drug D05MHI DRUGINCH 1S/C11H10O3S2/c1-14-10(12)11(13,8-4-2-6-15-8)9-5-3-7-16-9/h2-7,13H,1H3 D05MHI DRUGINKE SYHWYWHVEQQDMO-UHFFFAOYSA-N D05MHI DRUGSMIL COC(=O)C(C1=CC=CS1)(C2=CC=CS2)O D05MHI HIGHSTAT Phase 2 D05OTZ DRUG__ID D05OTZ D05OTZ DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D05OTZ DRUGTYPE Small molecular drug D05OTZ DRUGINCH 1S/C27H26F3N3O2/c28-27(29,30)35-22-10-6-7-19(17-22)18-32-15-13-21(14-16-32)33-25(20-8-2-1-3-9-20)23-11-4-5-12-24(23)31-26(33)34/h1-12,17,21,25H,13-16,18H2,(H,31,34) D05OTZ DRUGINKE IJUMFEAYOMCXAQ-UHFFFAOYSA-N D05OTZ DRUGSMIL C1CN(CCC1N2C(C3=CC=CC=C3NC2=O)C4=CC=CC=C4)CC5=CC(=CC=C5)OC(F)(F)F D05OTZ HIGHSTAT Phase 2 D05PIX DRUG__ID D05PIX D05PIX DRUGCOMP Cg pharmaceuticals D05PIX DRUGTYPE Small molecular drug D05PIX DRUGINCH 1S/C19H20N2O2S/c1-14-15(4-2-6-18(14)20)13-21-9-7-16(12-19(21)22)23-10-8-17-5-3-11-24-17/h2-7,9,11-12H,8,10,13,20H2,1H3 D05PIX DRUGINKE YCLREGRRHGLOAK-UHFFFAOYSA-N D05PIX DRUGSMIL CC1=C(C=CC=C1N)CN2C=CC(=CC2=O)OCCC3=CC=CS3 D05PIX HIGHSTAT Phase 2 D05PZN DRUG__ID D05PZN D05PZN DRUGCOMP Trophos D05PZN DRUGTYPE Small molecular drug D05PZN DRUGINCH 1S/C27H45NO/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28-29)13-15-26(20,4)25(22)14-16-27(23,24)5/h17-19,22-25,29H,6-16H2,1-5H3/b28-21+/t19-,22+,23-,24+,25+,26+,27-/m1/s1 D05PZN DRUGINKE QNTASHOAVRSLMD-SIWSWZRQSA-N D05PZN DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4=CC(=NO)CCC34C)C D05PZN HIGHSTAT Phase 2 D05QIK DRUG__ID D05QIK D05QIK THERCLAS Antiviral Agents D05QIK DRUGTYPE Small molecular drug D05QIK DRUGINCH 1S/C19H11ClF3N3O3/c1-9-3-2-4-12(21)17(9)18(27)26-16-8-24-13(7-25-16)10-5-14-15(6-11(10)20)29-19(22,23)28-14/h2-8H,1H3,(H,25,26,27) D05QIK DRUGINKE QQMKTHUGOQDEIL-UHFFFAOYSA-N D05QIK DRUGSMIL CC1=C(C(=CC=C1)F)C(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3Cl)OC(O4)(F)F D05QIK HIGHSTAT Phase 2 Trial D05QIS DRUG__ID D05QIS D05QIS DRUGCOMP Avalon Pharmaceuticals D05QIS DRUGTYPE Small molecular drug D05QIS DRUGINCH 1S/C25H27N5O5/c1-4-20(10-11-26)35-25(32)28-16(2)17-6-5-7-18(12-17)29-24(31)30-19-8-9-21(22(13-19)33-3)23-14-27-15-34-23/h5-9,12-16,20H,4,10H2,1-3H3,(H,28,32)(H2,29,30,31)/t16-,20+/m0/s1 D05QIS DRUGINKE GYCPCOJTCINIFZ-OXJNMPFZSA-N D05QIS DRUGSMIL CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC D05QIS HIGHSTAT Phase 2 D05RSC DRUG__ID D05RSC D05RSC DRUGCOMP Abbott Laboratories; NeuroSearch D05RSC DRUGTYPE Small molecular drug D05RSC DRUGINCH 1S/C10H11Cl2N3/c11-8-1-7(3-14-10(8)12)15-4-6-2-13-9(6)5-15/h1,3,6,9,13H,2,4-5H2/t6-,9+/m0/s1 D05RSC DRUGINKE MBQYQLWSBRANKQ-IMTBSYHQSA-N D05RSC DRUGSMIL C1C2CN(CC2N1)C3=CC(=C(N=C3)Cl)Cl D05RSC HIGHSTAT Phase 2 D05SBR DRUG__ID D05SBR D05SBR THERCLAS Antiviral Agents D05SBR DRUGTYPE Small molecular drug D05SBR DRUGINCH 1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1 D05SBR DRUGINKE HUJXGQILHAUCCV-MOROJQBDSA-N D05SBR DRUGSMIL CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)O)O D05SBR HIGHSTAT Phase 2 Trial D05TKB DRUG__ID D05TKB D05TKB DRUGCOMP Gilead D05TKB DRUGTYPE Small molecular drug D05TKB DRUGINCH 1S/C46H56ClF2N6O8PS/c1-26(2)50-44-52-36(25-65-44)35-21-39(30-18-19-38(61-3)40(47)41(30)51-35)62-29-20-37-42(56)54-46(64(59,60)24-31-32(48)15-11-16-33(31)49)22-27(46)12-7-5-4-6-8-17-34(43(57)55(37)23-29)53-45(58)63-28-13-9-10-14-28/h11,15-16,18-19,21,25-29,34,37H,4-10,12-14,17,20,22-24H2,1-3H3,(H,50,52)(H,53,58)(H,54,56)(H,59,60)/t27-,29-,34+,37+,46+/m1/s1 D05TKB DRUGINKE RFGUWOCFYCYEDM-ZOMNBDOOSA-N D05TKB DRUGSMIL CC(C)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Cl)OC)C(=C2)OC4CC5C(=O)NC6(CC6CCCCCCCC(C(=O)N5C4)NC(=O)OC7CCCC7)P(=O)(CC8=C(C=CC=C8F)F)O D05TKB HIGHSTAT Phase 2 D05TLP DRUG__ID D05TLP D05TLP DRUGCOMP SmithKline Beecham plc D05TLP DRUGTYPE Small molecular drug D05TLP DRUGINCH 1S/C20H20FNO4/c1-11(23)13-6-9-16-15(10-13)17(18(24)20(2,3)26-16)22-19(25)12-4-7-14(21)8-5-12/h4-10,17-18,24H,1-3H3,(H,22,25)/t17-,18+/m0/s1 D05TLP DRUGINKE RCLXAPJEFHPYEG-ZWKOTPCHSA-N D05TLP DRUGSMIL CC(=O)C1=CC2=C(C=C1)OC(C(C2NC(=O)C3=CC=C(C=C3)F)O)(C)C D05TLP HIGHSTAT Phase 2 D05TSJ DRUG__ID D05TSJ D05TSJ DRUGCOMP Eli Lilly D05TSJ DRUGTYPE Small molecular drug D05TSJ DRUGINCH 1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30) D05TSJ DRUGINKE SQSZANZGUXWJEA-UHFFFAOYSA-N D05TSJ DRUGSMIL CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F D05TSJ HIGHSTAT Phase 2 D05UFP DRUG__ID D05UFP D05UFP DRUGCOMP Enzon pharmaceuticals D05UFP DRUGTYPE Small molecular drug D05UFP DRUGINCH 1S/C118H122N12O37/c1-9-67-71-33-61(131)17-21-87(71)123-103-75(67)45-127-91(103)37-83-79(107(127)143)53-160-111(147)115(83,13-5)164-99(139)41-119-95(135)57-153-27-25-151-49-65(158-31-29-155-59-97(137)121-43-101(141)166-117(15-7)85-39-93-105-77(47-129(93)109(145)81(85)55-162-113(117)149)69(11-3)73-35-63(133)19-23-89(73)125-105)51-157-52-66(159-32-30-156-60-98(138)122-44-102(142)167-118(16-8)86-40-94-106-78(48-130(94)110(146)82(86)56-163-114(118)150)70(12-4)74-36-64(134)20-24-90(74)126-106)50-152-26-28-154-58-96(136)120-42-100(140)165-116(14-6)84-38-92-104-76(46-128(92)108(144)80(84)54-161-112(116)148)68(10-2)72-34-62(132)18-22-88(72)124-104/h17-24,33-40,65-66,131-134H,9-16,25-32,41-60H2,1-8H3,(H,119,135)(H,120,136)(H,121,137)(H,122,138)/t65?,66?,115-,116-,117-,118-/m0/s1 D05UFP DRUGINKE CXWRXYDTWCBSJF-DPTNTHPESA-N D05UFP DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)OC(=O)CNC(=O)COCCOCC(COCC(COCCOCC(=O)NCC(=O)OC5(C6=C(COC5=O)C(=O)N7CC8=C(C9=C(C=CC(=C9)O)N=C8C7=C6)CC)CC)OCCOCC(=O)NCC(=O)OC3(C4=C(COC3=O)C(=O)N3CC5=C(C6=C(C=CC(=C6)O)N=C5C3=C4)CC)CC)OCCOCC(=O)NCC(=O)OC3(C4=C(COC3=O)C(=O)N3CC5=C(C6=C(C=CC(=C6)O)N=C5C3=C4)CC)CC)C2=NC2=C1C=C(C=C2)O D05UFP HIGHSTAT Phase 2 D05USQ DRUG__ID D05USQ D05USQ THERCLAS Antiviral Agents D05USQ DRUGTYPE Small molecular drug D05USQ DRUGINCH 1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3 D05USQ DRUGINKE CPMDPSXJELVGJG-UHFFFAOYSA-N D05USQ DRUGSMIL CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O D05USQ HIGHSTAT Phase 2 Trial D05UYQ DRUG__ID D05UYQ D05UYQ DRUGCOMP GlaxoSmithKline D05UYQ DRUGTYPE Small molecular drug D05UYQ DRUGINCH 1S/C25H33FN4O/c1-19-17-29(14-11-27-19)18-21-7-5-20(6-8-21)15-25(31)30-12-9-23(10-13-30)28-24-4-2-3-22(26)16-24/h2-8,16,19,23,27-28H,9-15,17-18H2,1H3/t19-/m0/s1 D05UYQ DRUGINKE RZKDEGZIFSJVNA-IBGZPJMESA-N D05UYQ DRUGSMIL CC1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F D05UYQ HIGHSTAT Phase 2 D05WCI DRUG__ID D05WCI D05WCI DRUGCOMP Abbott Laboratories D05WCI DRUGTYPE Small molecular drug D05WCI DRUGINCH 1S/C25H34F3N5O2/c1-23(2,33-7-5-32(6-8-33)19-4-3-18(14-30-19)25(26,27)28)22(35)31-20-16-9-15-10-17(20)13-24(11-15,12-16)21(29)34/h3-4,14-17,20H,5-13H2,1-2H3,(H2,29,34)(H,31,35) D05WCI DRUGINKE CLHMYBJIOZXCEX-UHFFFAOYSA-N D05WCI DRUGSMIL CC(C)(C(=O)NC1C2CC3CC1CC(C3)(C2)C(=O)N)N4CCN(CC4)C5=NC=C(C=C5)C(F)(F)F D05WCI HIGHSTAT Phase 2 D05WJF DRUG__ID D05WJF D05WJF THERCLAS Antiviral Agents D05WJF DRUGTYPE Small molecular drug D05WJF DRUGINCH 1S/C20H21N4O6P/c1-11(2)14-9-15(17(25)10-18(14)30-31(27,28)29)19-21-22-20(26)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25H,1-3H3,(H,22,26)(H2,27,28,29) D05WJF DRUGINKE JNWFIPVDEINBAI-UHFFFAOYSA-N D05WJF DRUGSMIL CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O D05WJF HIGHSTAT Phase 2 Trial D05YTG DRUG__ID D05YTG D05YTG DRUGCOMP Surface D05YTG DRUGTYPE Small molecular drug D05YTG DRUGINCH 1S/C31H25F3N2O4/c1-39-27-9-5-8-26(28(27)20-10-13-23(14-11-20)31(32,33)34)29(37)35-24-15-12-22-19-36(17-16-21(22)18-24)30(38)40-25-6-3-2-4-7-25/h2-15,18H,16-17,19H2,1H3,(H,35,37) D05YTG DRUGINKE AZUIUVJESCFSLJ-UHFFFAOYSA-N D05YTG DRUGSMIL COC1=CC=CC(=C1C2=CC=C(C=C2)C(F)(F)F)C(=O)NC3=CC4=C(CN(CC4)C(=O)OC5=CC=CC=C5)C=C3 D05YTG HIGHSTAT Phase 2 D06BHG DRUG__ID D06BHG D06BHG DRUGCOMP Sanofi D06BHG DRUGTYPE Small molecular drug D06BHG DRUGINCH 1S/C25H34N4O5S/c1-18-14-22(33-5)15-19(2)24(18)35(31,32)29(4)12-13-34-17-23(30)28(3)16-20-6-8-21(9-7-20)25-26-10-11-27-25/h6-9,14-15H,10-13,16-17H2,1-5H3,(H,26,27) D06BHG DRUGINKE AMTQCENHQIDBHQ-UHFFFAOYSA-N D06BHG DRUGSMIL CC1=CC(=CC(=C1S(=O)(=O)N(C)CCOCC(=O)N(C)CC2=CC=C(C=C2)C3=NCCN3)C)OC D06BHG HIGHSTAT Phase 2 D06BUA DRUG__ID D06BUA D06BUA DRUGCOMP BASF AG D06BUA DRUGTYPE Small molecular drug D06BUA DRUGINCH 1S/C24H40N2O3/c1-8-9-10-11-14-26(4)15-12-13-24(18-25,19(2)3)20-16-21(27-5)23(29-7)22(17-20)28-6/h16-17,19H,8-15H2,1-7H3/t24-/m0/s1 D06BUA DRUGINKE SKDZEFVVFACNLS-DEOSSOPVSA-N D06BUA DRUGSMIL CCCCCCN(C)CCCC(C#N)(C1=CC(=C(C(=C1)OC)OC)OC)C(C)C D06BUA HIGHSTAT Phase 2 D06CCR DRUG__ID D06CCR D06CCR DRUGCOMP Oclassen Pharmaceuticals Inc D06CCR DRUGTYPE Small molecular drug D06CCR DRUGINCH 1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1 D06CCR DRUGINKE IPVFGAYTKQKGBM-BYPJNBLXSA-N D06CCR DRUGSMIL C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I D06CCR HIGHSTAT Phase 2 D06CKX DRUG__ID D06CKX D06CKX DRUGCOMP GlaxoSmithKline D06CKX DRUGTYPE Small molecular drug D06CKX DRUGINCH 1S/C26H24FN3O3S/c1-16-29-23(24(34-16)17-8-10-18(27)11-9-17)26(32)30-13-3-2-5-19(30)15-28-25(31)21-6-4-7-22-20(21)12-14-33-22/h4,6-12,14,19H,2-3,5,13,15H2,1H3,(H,28,31)/t19-/m0/s1 D06CKX DRUGINKE ZJXIUGNEAIHSBI-IBGZPJMESA-N D06CKX DRUGSMIL CC1=NC(=C(S1)C2=CC=C(C=C2)F)C(=O)N3CCCCC3CNC(=O)C4=C5C=COC5=CC=C4 D06CKX HIGHSTAT Phase 2 D06DHB DRUG__ID D06DHB D06DHB DRUGCOMP Eisai D06DHB DRUGTYPE Small molecular drug D06DHB DRUGINCH 1S/C20H19N3O3/c24-13-6-8-23(9-7-13)11-12-4-5-16-15(10-12)19-18-14(20(25)22-21-19)2-1-3-17(18)26-16/h1-5,10,13,24H,6-9,11H2,(H,22,25) D06DHB DRUGINKE HAVFFEMDLROBGI-UHFFFAOYSA-N D06DHB DRUGSMIL C1CN(CCC1O)CC2=CC3=C(C=C2)OC4=CC=CC5=C4C3=NNC5=O D06DHB HIGHSTAT Phase 2 D06EGV DRUG__ID D06EGV D06EGV DRUGCOMP Lilly D06EGV DRUGTYPE Small molecular drug D06EGV DRUGINCH 1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39) D06EGV DRUGINKE QHADVLVFMKEIIP-UHFFFAOYSA-N D06EGV DRUGSMIL CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F D06EGV HIGHSTAT Phase 2 D06EPO DRUG__ID D06EPO D06EPO DRUGCOMP Pfizer D06EPO DRUGTYPE Small molecular drug D06EPO DRUGINCH 1S/C29H31F3N6O3/c30-29(31,32)21-4-1-3-19(15-21)27(40)36-17-25(39)38-14-9-23(18-38)37-22-7-10-28(41,11-8-22)24-6-5-20(16-35-24)26-33-12-2-13-34-26/h1-6,12-13,15-16,22-23,37,41H,7-11,14,17-18H2,(H,36,40)/t22?,23-,28?/m0/s1 D06EPO DRUGINKE ZNSVOHSYDRPBGI-CBQRAPNFSA-N D06EPO DRUGSMIL C1CC(CCC1NC2CCN(C2)C(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)(C4=NC=C(C=C4)C5=NC=CC=N5)O D06EPO HIGHSTAT Phase 2 D06FOL DRUG__ID D06FOL D06FOL DRUGCOMP Mitsubishi Pharma D06FOL DRUGTYPE Small molecular drug D06FOL DRUGINCH 1S/C11H16N2O3S.H2O/c1-9-2-3-10(11(8-9)17(14,15)16)13-6-4-12-5-7-13;/h2-3,8,12H,4-7H2,1H3,(H,14,15,16);1H2 D06FOL DRUGINKE ZRQKZWAOIRVBFD-UHFFFAOYSA-N D06FOL DRUGSMIL CC1=CC(=C(C=C1)N2CCNCC2)S(=O)(=O)O.O D06FOL HIGHSTAT Phase 2 D06GMG DRUG__ID D06GMG D06GMG THERCLAS Antiviral Agents D06GMG DRUGTYPE Small molecular drug D06GMG DRUGINCH 1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1 D06GMG DRUGINKE VJJPUSNTGOMMGY-MRVIYFEKSA-N D06GMG DRUGSMIL CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O D06GMG HIGHSTAT Phase 2 Trial D06HFI DRUG__ID D06HFI D06HFI DRUGCOMP Ocera therapeutics D06HFI DRUGTYPE Small molecular drug D06HFI DRUGINCH 1S/C8H8O2.C5H12N2O2/c9-8(10)6-7-4-2-1-3-5-7;6-3-1-2-4(7)5(8)9/h1-5H,6H2,(H,9,10);4H,1-3,6-7H2,(H,8,9)/t;4-/m.0/s1 D06HFI DRUGINKE LRSYFEZBIMVWRY-VWMHFEHESA-N D06HFI DRUGSMIL C1=CC=C(C=C1)CC(=O)O.C(CC(C(=O)O)N)CN D06HFI HIGHSTAT Phase 2 D06JHV DRUG__ID D06JHV D06JHV DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D06JHV DRUGTYPE Small molecular drug D06JHV DRUGINCH 1S/C29H29F3N8O/c1-19-26(38-28-34-9-7-25(37-28)21-4-3-8-33-16-21)15-23(17-35-19)36-27(41)20-5-6-22(24(14-20)29(30,31)32)18-40-12-10-39(2)11-13-40/h3-9,14-17H,10-13,18H2,1-2H3,(H,36,41)(H,34,37,38) D06JHV DRUGINKE BJCJYEYYYGBROF-UHFFFAOYSA-N D06JHV DRUGSMIL CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 D06JHV HIGHSTAT Phase 2 D06KCU DRUG__ID D06KCU D06KCU DRUGCOMP Novartis & Millenium D06KCU DRUGTYPE Small molecular drug D06KCU DRUGINCH 1S/C58H62N24O22S6.2Na/c59-45(83)23-79(24-46(60)84)105(91,92)37-9-1-5-31(17-37)67-53-73-54(68-32-6-2-10-38(18-32)106(93,94)80(25-47(61)85)26-48(62)86)76-57(75-53)71-35-13-15-41(43(21-35)109(99,100)101)42-16-14-36(22-44(42)110(102,103)104)72-58-77-55(69-33-7-3-11-39(19-33)107(95,96)81(27-49(63)87)28-50(64)88)74-56(78-58)70-34-8-4-12-40(20-34)108(97,98)82(29-51(65)89)30-52(66)90;;/h1-22H,23-30H2,(H2,59,83)(H2,60,84)(H2,61,85)(H2,62,86)(H2,63,87)(H2,64,88)(H2,65,89)(H2,66,90)(H,99,100,101)(H,102,103,104)(H3,67,68,71,73,75,76)(H3,69,70,72,74,77,78);;/q;2*+1/p-2 D06KCU DRUGINKE UNNCHYARSNZOPF-UHFFFAOYSA-L D06KCU DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N(CC(=O)N)CC(=O)N)NC2=NC(=NC(=N2)NC3=CC(=C(C=C3)C4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)N(CC(=O)N)CC(=O)N)NC7=CC(=CC=C7)S(=O)(=O)N(CC(=O)N)CC(=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])NC8=CC(=CC=C8)S(=O)(=O)N(CC(=O)N)CC(=O)N.[Na+].[Na+] D06KCU HIGHSTAT Phase 2 D06KSV DRUG__ID D06KSV D06KSV DRUGCOMP Novartis AG D06KSV DRUGTYPE Small molecular drug D06KSV DRUGINCH 1S/C19H17NO/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19/h1,4-11,13H,12,14H2,2H3 D06KSV DRUGINKE QLMMOGWZCFQAPU-UHFFFAOYSA-N D06KSV DRUGSMIL CN(CC#C)CC1=CC2=CC=CC=C2OC3=CC=CC=C31 D06KSV HIGHSTAT Phase 2 D06LUZ DRUG__ID D06LUZ D06LUZ DRUGCOMP Gilead Sciences Inc D06LUZ DRUGTYPE Small molecular drug D06LUZ DRUGINCH 1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1 D06LUZ DRUGINKE VRTWBAAJJOHBQU-KMWAZVGDSA-N D06LUZ DRUGSMIL CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC D06LUZ HIGHSTAT Phase 2 D06MIQ DRUG__ID D06MIQ D06MIQ DRUGCOMP Aderis Pharmaceuticals Licensee; King Pharmaceuticals D06MIQ DRUGTYPE Small molecular drug D06MIQ DRUGINCH 1S/C18H20ClN5O5/c19-10-3-1-9(2-4-10)5-6-28-18-22-15(20)12-16(23-18)24(8-21-12)17-14(27)13(26)11(7-25)29-17/h1-4,8,11,13-14,17,25-27H,5-7H2,(H2,20,22,23)/t11-,13-,14-,17-/m1/s1 D06MIQ DRUGINKE WUCQGGOGHZRELS-LSCFUAHRSA-N D06MIQ DRUGSMIL C1=CC(=CC=C1CCOC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N)Cl D06MIQ HIGHSTAT Phase 2 D06MNF DRUG__ID D06MNF D06MNF DRUGCOMP Solvay D06MNF DRUGTYPE Small molecular drug D06MNF DRUGINCH 1S/C12H15N3O2/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9/h2-4H,5-8H2,1H3,(H,13,16) D06MNF DRUGINKE YVPUUUDAZYFFQT-UHFFFAOYSA-N D06MNF DRUGSMIL CN1CCN(CC1)C2=CC=CC3=C2OC(=O)N3 D06MNF HIGHSTAT Phase 2 D06NYA DRUG__ID D06NYA D06NYA DRUGCOMP EntreMed D06NYA DRUGTYPE Small molecular drug D06NYA DRUGINCH 1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1 D06NYA DRUGINKE CQOQDQWUFQDJMK-SSTWWWIQSA-N D06NYA DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O D06NYA HIGHSTAT Phase 2 D06ORI DRUG__ID D06ORI D06ORI THERCLAS Antiviral Agents D06ORI DRUGTYPE Small molecular drug D06ORI DRUGINCH 1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3 D06ORI DRUGINKE YQEZLKZALYSWHR-UHFFFAOYSA-N D06ORI DRUGSMIL CNC1(CCCCC1=O)C2=CC=CC=C2Cl D06ORI HIGHSTAT Phase 2 Trial D06PGZ DRUG__ID D06PGZ D06PGZ DRUGCOMP Anadys Pharmaceuticals D06PGZ DRUGTYPE Small molecular drug D06PGZ DRUGINCH 1S/C25H25FN4O6S2/c1-37(33,34)28-17-8-9-18-19(11-17)38(35,36)29-24(27-18)21-23(31)20-14-4-5-15(10-14)22(20)30(25(21)32)12-13-2-6-16(26)7-3-13/h2-3,6-9,11,14-15,20,22,28,31H,4-5,10,12H2,1H3,(H,27,29)/t14-,15+,20+,22-/m0/s1 D06PGZ DRUGINKE DEKOYVOWOVJMPM-RLHIPHHXSA-N D06PGZ DRUGSMIL CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C3=C(C4C5CCC(C5)C4N(C3=O)CC6=CC=C(C=C6)F)O D06PGZ HIGHSTAT Phase 2 D06PHH DRUG__ID D06PHH D06PHH DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D06PHH DRUGTYPE Small molecular drug D06PHH DRUGINCH 1S/C22H23FN4O2/c1-15(17-7-8-18(19(23)13-17)16-5-3-2-4-6-16)20-14-21(29-26-20)25-22(24)27-9-11-28-12-10-27/h2-8,13-15H,9-12H2,1H3,(H2,24,25)/t15-/m0/s1 D06PHH DRUGINKE MYTIJGWONQOOLC-HNNXBMFYSA-N D06PHH DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C3=NOC(=C3)N=C(N)N4CCOCC4 D06PHH HIGHSTAT Phase 2 D06QBY DRUG__ID D06QBY D06QBY DRUGCOMP InteKrin Therapeutics D06QBY DRUGTYPE Small molecular drug D06QBY DRUGINCH 1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H D06QBY DRUGINKE NMRWDFUZLLQSBN-UHFFFAOYSA-N D06QBY DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)OC3=C(C=C(C=C3Cl)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl)Cl D06QBY HIGHSTAT Phase 2 D06QXI DRUG__ID D06QXI D06QXI DRUGCOMP Allergan Ligand Retinoid Therapeutics Inc D06QXI DRUGTYPE Small molecular drug D06QXI DRUGINCH 1S/C24H32O2/c1-16(13-21(25)26)7-8-18-15-24(18,6)17-9-10-19-20(14-17)23(4,5)12-11-22(19,2)3/h7-10,13-14,18H,11-12,15H2,1-6H3,(H,25,26)/b8-7+,16-13+ D06QXI DRUGINKE BOOOLEGQBVUTKC-YWRSBGDESA-N D06QXI DRUGSMIL CC(=CC(=O)O)C=CC1CC1(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C D06QXI HIGHSTAT Phase 2 D06TKE DRUG__ID D06TKE D06TKE DRUGCOMP Zeneca Group plc D06TKE DRUGTYPE Small molecular drug D06TKE DRUGINCH 1S/C15H20N4.ClH/c1-5-19(13-9-7-6-8-10-13)15-11-14(16-3)18(4)12(2)17-15;/h6-11H,5H2,1-4H3;1H D06TKE DRUGINKE DUWKUHWHTPRMAP-UHFFFAOYSA-N D06TKE DRUGSMIL CCN(C1=CC=CC=C1)C2=CC(=[N+](C(=N2)C)C)NC.[Cl-] D06TKE HIGHSTAT Phase 2 D06UKG DRUG__ID D06UKG D06UKG DRUGCOMP Eli Lilly & Co D06UKG DRUGTYPE Small molecular drug D06UKG DRUGINCH 1S/C31H32N4O4/c1-31(2,16-20-10-13-23(14-11-20)39-28-15-12-21(17-33-28)30(32)37)34-18-22(36)19-38-27-9-5-8-26-29(27)24-6-3-4-7-25(24)35-26/h3-15,17,22,34-36H,16,18-19H2,1-2H3,(H2,32,37)/t22-/m0/s1 D06UKG DRUGINKE RBSGUQYXRDKPAE-QFIPXVFZSA-N D06UKG DRUGSMIL CC(C)(CC1=CC=C(C=C1)OC2=NC=C(C=C2)C(=O)N)NCC(COC3=CC=CC4=C3C5=CC=CC=C5N4)O D06UKG HIGHSTAT Phase 2 D06VHG DRUG__ID D06VHG D06VHG DRUGCOMP Neuralstem D06VHG DRUGTYPE Small molecular drug D06VHG DRUGINCH 1S/C22H30N4O/c1-18(2)10-12-24-21-20(9-6-11-23-21)22(27)26-15-13-25(14-16-26)17-19-7-4-3-5-8-19/h3-9,11,18H,10,12-17H2,1-2H3,(H,23,24) D06VHG DRUGINKE DYTOQURYRYYNOR-UHFFFAOYSA-N D06VHG DRUGSMIL CC(C)CCNC1=C(C=CC=N1)C(=O)N2CCN(CC2)CC3=CC=CC=C3 D06VHG HIGHSTAT Phase 2 D06WRF DRUG__ID D06WRF D06WRF DRUGCOMP Kadmon Pharmaceuticals D06WRF DRUGTYPE Small molecular drug D06WRF DRUGINCH 1S/C24H25Cl2FN4O2/c1-31-9-14-5-13(6-15(14)10-31)11-33-21-8-19-16(7-20(21)32-2)24(29-12-28-19)30-18-4-3-17(25)22(26)23(18)27/h3-4,7-8,12-15H,5-6,9-11H2,1-2H3,(H,28,29,30)/t13?,14-,15+ D06WRF DRUGINKE HVXKQKFEHMGHSL-GOOCMWNKSA-N D06WRF DRUGSMIL CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC D06WRF HIGHSTAT Phase 2 D06XES DRUG__ID D06XES D06XES THERCLAS Antiviral Agents D06XES DRUGTYPE Small molecular drug D06XES DRUGINCH 1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1 D06XES DRUGINKE SGDBTWWWUNNDEQ-LBPRGKRZSA-N D06XES DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl D06XES HIGHSTAT Phase 2 Trial D06YWH DRUG__ID D06YWH D06YWH DRUGCOMP Astellas Pharma D06YWH DRUGTYPE Small molecular drug D06YWH DRUGINCH 1S/C20H19N4O3.BrH/c1-13-23(9-10-27-2)17-18(24(13)12-14-11-21-7-8-22-14)20(26)16-6-4-3-5-15(16)19(17)25;/h3-8,11H,9-10,12H2,1-2H3;1H/q+1;/p-1 D06YWH DRUGINKE QBIYUDDJPRGKNJ-UHFFFAOYSA-M D06YWH DRUGSMIL CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-] D06YWH HIGHSTAT Phase 2 D06ZVZ DRUG__ID D06ZVZ D06ZVZ THERCLAS Antiviral Agents D06ZVZ DRUGTYPE Small molecular drug D06ZVZ DRUGINCH 1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1 D06ZVZ DRUGINKE SJVQHLPISAIATJ-ZDUSSCGKSA-N D06ZVZ DRUGSMIL CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 D06ZVZ HIGHSTAT Phase 2 Trial D07ALX DRUG__ID D07ALX D07ALX THERCLAS Antiviral Agents D07ALX DRUGTYPE Small molecular drug D07ALX DRUGINCH 1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1 D07ALX DRUGINKE QFJCIRLUMZQUOT-HPLJOQBZSA-N D07ALX DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC D07ALX HIGHSTAT Phase 2 Trial D07AOL DRUG__ID D07AOL D07AOL DRUGCOMP New York University D07AOL DRUGTYPE Small molecular drug D07AOL DRUGINCH 1S/C9H9NS/c11-8-10-7-6-9-4-2-1-3-5-9/h1-5H,6-7H2 D07AOL DRUGINKE IZJDOKYDEWTZSO-UHFFFAOYSA-N D07AOL DRUGSMIL C1=CC=C(C=C1)CCN=C=S D07AOL HIGHSTAT Phase 2 D07BRZ DRUG__ID D07BRZ D07BRZ DRUGCOMP Eli Lilly D07BRZ DRUGTYPE Small molecular drug D07BRZ DRUGINCH 1S/C27H33N5O2/c1-30-13-10-23(11-14-30)31-15-17-32(18-16-31)27(34)25(21-5-3-2-4-6-21)29-26(33)22-8-7-20-9-12-28-24(20)19-22/h2-9,12,19,23,25,28H,10-11,13-18H2,1H3,(H,29,33)/t25-/m1/s1 D07BRZ DRUGINKE VYNKVNDKAOGAAQ-RUZDIDTESA-N D07BRZ DRUGSMIL CN1CCC(CC1)N2CCN(CC2)C(=O)C(C3=CC=CC=C3)NC(=O)C4=CC5=C(C=C4)C=CN5 D07BRZ HIGHSTAT Phase 2 D07CJN DRUG__ID D07CJN D07CJN DRUGCOMP Sonexa Therapeutics D07CJN DRUGTYPE Small molecular drug D07CJN DRUGINCH 1S/C15H12N2O/c18-14-15(17-8-4-3-7-13(17)16-14)9-11-5-1-2-6-12(11)10-15/h1-8H,9-10H2 D07CJN DRUGINKE QZWYXEBIQWJXAR-UHFFFAOYSA-N D07CJN DRUGSMIL C1C2=CC=CC=C2CC13C(=O)N=C4N3C=CC=C4 D07CJN HIGHSTAT Phase 2 D07CMN DRUG__ID D07CMN D07CMN DRUGCOMP Pfizer D07CMN DRUGTYPE Small molecular drug D07CMN DRUGINCH 1S/C25H36N2O2S/c1-24(2,3)20-16-19(17-21(23(20)29)25(4,5)6)30-15-12-22(28)27(7)14-11-18-10-8-9-13-26-18/h8-10,13,16-17,29H,11-12,14-15H2,1-7H3 D07CMN DRUGINKE YPPRSIHNTQEZCJ-UHFFFAOYSA-N D07CMN DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCCC(=O)N(C)CCC2=CC=CC=N2 D07CMN HIGHSTAT Phase 2 D07EIQ DRUG__ID D07EIQ D07EIQ THERCLAS Antiviral Agents D07EIQ DRUGTYPE Small molecular drug D07EIQ DRUGINCH 1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+ D07EIQ DRUGINKE CJOFXWAVKWHTFT-XSFVSMFZSA-N D07EIQ DRUGSMIL COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F D07EIQ HIGHSTAT Phase 2 Trial D07EUO DRUG__ID D07EUO D07EUO THERCLAS Antiviral Agents D07EUO DRUGTYPE Small molecular drug D07EUO DRUGINCH 1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1 D07EUO DRUGINKE DQCKKXVULJGBQN-XFWGSAIBSA-N D07EUO DRUGSMIL C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O D07EUO HIGHSTAT Phase 2 Trial D07FRV DRUG__ID D07FRV D07FRV THERCLAS Antiviral Agents D07FRV DRUGTYPE Small molecular drug D07FRV DRUGINCH 1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1 D07FRV DRUGINKE HDACQVRGBOVJII-JBDAPHQKSA-N D07FRV DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O D07FRV HIGHSTAT Phase 2 Trial D07GCK DRUG__ID D07GCK D07GCK DRUGCOMP Archer Biosciences D07GCK DRUGTYPE Small molecular drug D07GCK DRUGINCH 1S/C46H63NO15/c1-13-32-58-30-20-31-45(22-55-31,61-26(6)49)36-38(60-39(51)27-17-15-14-16-18-27)46(54)21-29(57-40(52)34(50)28(19-23(2)3)47-41(53)62-42(7,8)9)24(4)33(43(46,10)11)35(56-25(5)48)37(59-32)44(30,36)12/h13-18,23,28-32,34-38,50,54H,1,19-22H2,2-12H3,(H,47,53)/t28-,29-,30-,31+,32?,34?,35-,36-,37-,38-,44+,45-,46+/m0/s1 D07GCK DRUGINKE FDTAUJJRHBRHIJ-MUVVMLKJSA-N D07GCK DRUGSMIL CC1=C2C(C3C4(C(CC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(CC(C)C)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO5)OC(=O)C)OC(O3)C=C)C)OC(=O)C D07GCK HIGHSTAT Phase 2 D07IEU DRUG__ID D07IEU D07IEU DRUGCOMP Millennium Pharmaceuticals D07IEU DRUGTYPE Small molecular drug D07IEU DRUGINCH 1S/C17H12Cl2F3N7O2S/c1-6(28-15(31)12-11(19)13(23)27-5-26-12)16-25-4-9(32-16)14(30)29-10-2-7(17(20,21)22)8(18)3-24-10/h2-6H,1H3,(H,28,31)(H2,23,26,27)(H,24,29,30)/t6-/m1/s1 D07IEU DRUGINKE VWMJHAFYPMOMGF-ZCFIWIBFSA-N D07IEU DRUGSMIL CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl D07IEU HIGHSTAT Phase 2 D07ISX DRUG__ID D07ISX D07ISX THERCLAS Antiviral Agents D07ISX DRUGTYPE Small molecular drug D07ISX DRUGINCH 1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) D07ISX DRUGINKE UEJJHQNACJXSKW-UHFFFAOYSA-N D07ISX DRUGSMIL C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O D07ISX HIGHSTAT Phase 2 Trial D07JVO DRUG__ID D07JVO D07JVO DRUGCOMP OXiGENE South D07JVO DRUGTYPE Small molecular drug D07JVO DRUGINCH 1S/C18H21O8P/c1-22-14-8-7-12(9-15(14)26-27(19,20)21)5-6-13-10-16(23-2)18(25-4)17(11-13)24-3/h5-11H,1-4H3,(H2,19,20,21)/b6-5- D07JVO DRUGINKE WDOGQTQEKVLZIJ-WAYWQWQTSA-N D07JVO DRUGSMIL COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)O D07JVO HIGHSTAT Phase 2 D07KWN DRUG__ID D07KWN D07KWN DRUGCOMP Aarhus University Hospital D07KWN DRUGTYPE Small molecular drug D07KWN DRUGINCH 1S/C20H30O3/c1-17-9-5-14-18(2)7-4-8-19(3,16(22)23)13(18)6-10-20(14,12-17)11-15(17)21/h13-14H,4-12H2,1-3H3,(H,22,23)/t13-,14-,17-,18+,19+,20-/m0/s1 D07KWN DRUGINKE KFVUFODCZDRVSS-XGBBNYNSSA-N D07KWN DRUGSMIL CC12CCC3C4(CCCC(C4CCC3(C1)CC2=O)(C)C(=O)O)C D07KWN HIGHSTAT Phase 2 D07MON DRUG__ID D07MON D07MON DRUGCOMP Context Therapeutics D07MON DRUGTYPE Small molecular drug D07MON DRUGINCH 1S/C29H39NO3/c1-28-18-25(19-5-8-21(9-6-19)30(2)3)27-23-12-10-22(32)17-20(23)7-11-24(27)26(28)13-15-29(28,33)14-4-16-31/h5-6,8-9,17,24-26,31,33H,4,7,10-16,18H2,1-3H3/t24-,25+,26-,28+,29+/m0/s1 D07MON DRUGINKE IEXUMDBQLIVNHZ-YOUGDJEHSA-N D07MON DRUGSMIL CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C D07MON HIGHSTAT Phase 2 D07NCV DRUG__ID D07NCV D07NCV DRUGCOMP Synvista Therapeutics D07NCV DRUGTYPE Small molecular drug D07NCV DRUGINCH 1S/C10H13NSe/c1-10(2)7-11-12-9-6-4-3-5-8(9)10/h3-6,11H,7H2,1-2H3 D07NCV DRUGINKE FXRYWOJYVGJZLE-UHFFFAOYSA-N D07NCV DRUGSMIL CC1(CN[Se]C2=CC=CC=C21)C D07NCV HIGHSTAT Phase 2 D07NKJ DRUG__ID D07NKJ D07NKJ THERCLAS Antiviral Agents D07NKJ DRUGTYPE Small molecular drug D07NKJ DRUGINCH 1S/C17H10F3N5O3S/c18-17(19,20)8-1-2-11-9(5-8)23-12(29-11)7-25-16(28)15-14(21-3-4-22-15)10(24-25)6-13(26)27/h1-5H,6-7H2,(H,26,27) D07NKJ DRUGINKE YRGPAXAVTDMKDK-UHFFFAOYSA-N D07NKJ DRUGSMIL C1=CC2=C(C=C1C(F)(F)F)N=C(S2)CN3C(=O)C4=NC=CN=C4C(=N3)CC(=O)O D07NKJ HIGHSTAT Phase 2 Trial D07NPX DRUG__ID D07NPX D07NPX THERCLAS Antiviral Agents D07NPX DRUGTYPE Small molecular drug D07NPX DRUGINCH 1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1 D07NPX DRUGINKE AUYYCJSJGJYCDS-LBPRGKRZSA-N D07NPX DRUGSMIL C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O D07NPX HIGHSTAT Phase 2 Trial D07NTC DRUG__ID D07NTC D07NTC DRUGCOMP Wockhardt Ltd D07NTC DRUGTYPE Small molecular drug D07NTC DRUGINCH 1S/C19H21FN2O4.C6H14N4O2/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21;7-4(5(11)12)2-1-3-10-6(8)9/h8-11,23H,2-7H2,1H3,(H,25,26);4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t10-;4-/m00/s1 D07NTC DRUGINKE WIFOPRFVQIVWTB-YBVIJTQESA-N D07NTC DRUGSMIL CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2N4CCC(CC4)O)F)C(=O)O.C(CC(C(=O)O)N)CN=C(N)N D07NTC HIGHSTAT Phase 2 D07OCV DRUG__ID D07OCV D07OCV DRUGCOMP Dart neuroscience D07OCV DRUGTYPE Small molecular drug D07OCV DRUGINCH 1S/C25H31NO3/c1-17-6-5-7-18(12-17)13-20-14-21(16-26-25(20)27)19-10-11-23(28-2)24(15-19)29-22-8-3-4-9-22/h5-7,10-12,15,20-22H,3-4,8-9,13-14,16H2,1-2H3,(H,26,27)/t20-,21-/m1/s1 D07OCV DRUGINKE ABEJDMOBAFLQNJ-NHCUHLMSSA-N D07OCV DRUGSMIL CC1=CC(=CC=C1)CC2CC(CNC2=O)C3=CC(=C(C=C3)OC)OC4CCCC4 D07OCV HIGHSTAT Phase 2 D07QAF DRUG__ID D07QAF D07QAF DRUGCOMP Boehringer Ingelheim Pharma D07QAF DRUGTYPE Small molecular drug D07QAF DRUGINCH 1S/C34H33BrN6O3/c1-40-26-17-22(10-11-24(26)29(21-6-3-4-7-21)30(40)31-36-18-23(35)19-37-31)32(44)39-34(14-5-15-34)33-38-25-12-8-20(9-13-28(42)43)16-27(25)41(33)2/h8-13,16-19,21H,3-7,14-15H2,1-2H3,(H,39,44)(H,42,43)/b13-9+ D07QAF DRUGINKE BMAIGAHXAJEULY-UKTHLTGXSA-N D07QAF DRUGSMIL CN1C2=C(C=CC(=C2)C(=O)NC3(CCC3)C4=NC5=C(N4C)C=C(C=C5)C=CC(=O)O)C(=C1C6=NC=C(C=N6)Br)C7CCCC7 D07QAF HIGHSTAT Phase 2 D07QAK DRUG__ID D07QAK D07QAK DRUGCOMP Sauerberg D07QAK DRUGTYPE Small molecular drug D07QAK DRUGINCH 1S/C14H23N3OS.C4H6O6/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12;5-1(3(7)8)2(6)4(9)10/h8H,3-7,9-11H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 D07QAK DRUGINKE SJSVWTMVMBGIHQ-LREBCSMRSA-N D07QAK DRUGSMIL CCCCCCOC1=NSN=C1C2=CCCN(C2)C.C(C(C(=O)O)O)(C(=O)O)O D07QAK HIGHSTAT Phase 2 D07QFU DRUG__ID D07QFU D07QFU DRUGCOMP Tularik Inc D07QFU DRUGTYPE Small molecular drug D07QFU DRUGINCH 1S/C5H11NOS3/c1-3-9-10-5(8-2)4(6)7/h5H,3H2,1-2H3,(H2,6,7) D07QFU DRUGINKE OKTRVIBXCNRKHI-UHFFFAOYSA-N D07QFU DRUGSMIL CCSSC(C(=O)N)SC D07QFU HIGHSTAT Phase 2 D07QQP DRUG__ID D07QQP D07QQP DRUGCOMP Inspire Pharmaceuticals D07QQP DRUGTYPE Small molecular drug D07QQP DRUGINCH 1S/C18H27N5O21P4.4Na/c19-11-1-3-22(17(28)20-11)13-5-8(24)9(40-13)6-38-45(30,31)42-47(34,35)44-48(36,37)43-46(32,33)39-7-10-14(26)15(27)16(41-10)23-4-2-12(25)21-18(23)29;;;;/h1-4,8-10,13-16,24,26-27H,5-7H2,(H,30,31)(H,32,33)(H,34,35)(H,36,37)(H2,19,20,28)(H,21,25,29);;;;/q;4*+1/p-4/t8-,9+,10+,13+,14+,15+,16+;;;;/m0..../s1 D07QQP DRUGINKE PASYJVRFGUDDEW-WMUGRWSXSA-J D07QQP DRUGSMIL C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O.[Na+].[Na+].[Na+].[Na+] D07QQP HIGHSTAT Phase 2 D07QXU DRUG__ID D07QXU D07QXU DRUGCOMP GlaxoSmithKline D07QXU DRUGTYPE Small molecular drug D07QXU DRUGINCH 1S/C16H21Cl2NO/c1-19-11-4-6-16(19)13(9-20-2)12(8-11)10-3-5-14(17)15(18)7-10/h3,5,7,11-13,16H,4,6,8-9H2,1-2H3/t11-,12+,13+,16+/m0/s1 D07QXU DRUGINKE PGYDXVBZYKQYCS-VPWBDBDCSA-N D07QXU DRUGSMIL CN1C2CCC1C(C(C2)C3=CC(=C(C=C3)Cl)Cl)COC D07QXU HIGHSTAT Phase 2 D07SMH DRUG__ID D07SMH D07SMH DRUGCOMP Merck D07SMH DRUGTYPE Small molecular drug D07SMH DRUGINCH 1S/C29H38N4O7/c1-29(2,3)24-26(34)33-15-18(14-22(33)27(35)36)39-25-20(30-19-11-10-17(38-4)13-21(19)31-25)9-7-5-6-8-16-12-23(16)40-28(37)32-24/h10-11,13,16,18,22-24H,5-9,12,14-15H2,1-4H3,(H,32,37)(H,35,36)/t16-,18-,22+,23-,24-/m1/s1 D07SMH DRUGINKE IVROMYPOGKZNLP-FDOFPDFBSA-N D07SMH DRUGSMIL CC(C)(C)C1C(=O)N2CC(CC2C(=O)O)OC3=NC4=C(C=CC(=C4)OC)N=C3CCCCCC5CC5OC(=O)N1 D07SMH HIGHSTAT Phase 2 D07TEP DRUG__ID D07TEP D07TEP DRUGCOMP Schering-Plough D07TEP DRUGTYPE Small molecular drug D07TEP DRUGINCH 1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7,14,17H,8-13,15-16H2,1H3,(H2,26,29) D07TEP DRUGINKE DTYWJKSSUANMHD-UHFFFAOYSA-N D07TEP DRUGSMIL COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6 D07TEP HIGHSTAT Phase 2 D07TXJ DRUG__ID D07TXJ D07TXJ DRUGCOMP Vela Pharmaceuticals D07TXJ DRUGTYPE Small molecular drug D07TXJ DRUGINCH 1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3/t15-/m0/s1 D07TXJ DRUGINKE RUJBDQSFYCKFAA-HNNXBMFYSA-N D07TXJ DRUGSMIL CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C D07TXJ HIGHSTAT Phase 2 D07TZT DRUG__ID D07TZT D07TZT DRUGCOMP Tigris Pharmaceuticals D07TZT DRUGTYPE Small molecular drug D07TZT DRUGINCH 1S/C19H14N4O6/c24-15-6-1-12(2-7-15)19(13-3-8-16(25)9-4-13)21-20-17-10-5-14(22(26)27)11-18(17)23(28)29/h1-11,20,24-25H D07TZT DRUGINKE YOQPCWIXYUNEET-UHFFFAOYSA-N D07TZT DRUGSMIL C1=CC(=CC=C1C(=NNC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C3=CC=C(C=C3)O)O D07TZT HIGHSTAT Phase 2 D07WYI DRUG__ID D07WYI D07WYI DRUGCOMP Spectrum D07WYI DRUGTYPE Small molecular drug D07WYI DRUGINCH 1S/C86H117N17O27/c1-11-44(7)71(84(127)100-63(86(129)130)35-50-39-88-54-21-17-16-20-53(50)54)103-85(128)72(45(8)12-2)102-82(125)62(38-69(114)115)98-78(121)57(32-42(3)4)96-80(123)60(36-51-40-87-41-89-51)95-73(116)46(9)91-77(120)58(33-48-18-14-13-15-19-48)97-79(122)59(34-49-22-24-52(104)25-23-49)99-83(126)70(43(5)6)101-74(117)47(10)90-75(118)55(26-29-65(106)107)93-76(119)56(27-30-66(108)109)94-81(124)61(37-68(112)113)92-64(105)28-31-67(110)111/h13-25,39-47,55-63,70-72,88,104H,11-12,26-38H2,1-10H3,(H,87,89)(H,90,118)(H,91,120)(H,92,105)(H,93,119)(H,94,124)(H,95,116)(H,96,123)(H,97,122)(H,98,121)(H,99,126)(H,100,127)(H,101,117)(H,102,125)(H,103,128)(H,106,107)(H,108,109)(H,110,111)(H,112,113)(H,114,115)(H,129,130)/t44-,45-,46-,47-,55-,56-,57-,58-,59-,60-,61-,62-,63-,70-,71-,72-/m0/s1 D07WYI DRUGINKE DXPHNGAMYPPTBJ-TZMIJSMNSA-N D07WYI DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CNC=N3)NC(=O)C(C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)CCC(=O)O D07WYI HIGHSTAT Phase 2 D07XJJ DRUG__ID D07XJJ D07XJJ DRUGCOMP Momenta Pharmaceuticals D07XJJ DRUGTYPE Small molecular drug D07XJJ DRUGINCH 1S/2C17H20N4O.4ClH.Zn/c2*1-4-21(5-2)11-6-7-14-15(8-11)22-17-10(3)12(18)9-13(19)16(17)20-14;;;;;/h2*6-9H,4-5H2,1-3H3,(H3,18,19);4*1H;/q;;;;;;+2/p-2 D07XJJ DRUGINKE JJKNZNYHIUJGIC-UHFFFAOYSA-L D07XJJ DRUGSMIL CC[N+](=C1C=CC2=NC3=C(C=C(C(=C3OC2=C1)C)N)N)CC.CC[N+](=C1C=CC2=NC3=C(C=C(C(=C3OC2=C1)C)N)N)CC.Cl[Zn-2](Cl)(Cl)Cl D07XJJ HIGHSTAT Phase 2 D07YGH DRUG__ID D07YGH D07YGH DRUGCOMP GSK D07YGH DRUGTYPE Small molecular drug D07YGH DRUGINCH 1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2 D07YGH DRUGINKE YFRBKEVUUCQYOW-UHFFFAOYSA-N D07YGH DRUGSMIL C1CC(C1)N2CCC3=C(CC2)C=C(C=C3)OC4=NC=C(C=C4)N5CCCC5=O D07YGH HIGHSTAT Phase 2 D07YHM DRUG__ID D07YHM D07YHM DRUGCOMP Eli Lilly & Co D07YHM DRUGTYPE Small molecular drug D07YHM DRUGINCH 1S/C26H27FN2O2/c1-17-12-18(2)14-21(13-17)24-4-3-11-29(24)16-19-5-8-22(9-6-19)31-25-10-7-20(26(28)30)15-23(25)27/h5-10,12-15,24H,3-4,11,16H2,1-2H3,(H2,28,30)/t24-/m0/s1 D07YHM DRUGINKE ZHPMYDSXGRRERG-DEOSSOPVSA-N D07YHM DRUGSMIL CC1=CC(=CC(=C1)C2CCCN2CC3=CC=C(C=C3)OC4=C(C=C(C=C4)C(=O)N)F)C D07YHM HIGHSTAT Phase 2 D07ZAH DRUG__ID D07ZAH D07ZAH DRUGCOMP Achillion D07ZAH DRUGTYPE Small molecular drug D07ZAH DRUGINCH 1S/C43H53N5O8S/c1-6-28-25-43(28,41(52)46-57(53,54)31-16-17-31)45-39(50)36-22-30(26-48(36)40(51)33(42(2,3)4)23-38(49)47-19-11-8-12-20-47)56-37-24-34(27-13-9-7-10-14-27)44-35-21-29(55-5)15-18-32(35)37/h6-7,9-10,13-15,18,21,24,28,30-31,33,36H,1,8,11-12,16-17,19-20,22-23,25-26H2,2-5H3,(H,45,50)(H,46,52)/t28-,30-,33-,36+,43-/m1/s1 D07ZAH DRUGINKE MHFMTUBUVQZIRE-WINRQGAFSA-N D07ZAH DRUGSMIL CC(C)(C)C(CC(=O)N1CCCCC1)C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7 D07ZAH HIGHSTAT Phase 2 D07ZNI DRUG__ID D07ZNI D07ZNI DRUGCOMP EntreMed D07ZNI DRUGTYPE Small molecular drug D07ZNI DRUGINCH 1S/C19H28N2O7S2/c1-19-8-7-12-13(15(19)5-6-18(19)28-30(21,24)25)4-3-11-9-17(27-29(20,22)23)16(26-2)10-14(11)12/h9-10,12-13,15,18H,3-8H2,1-2H3,(H2,20,22,23)(H2,21,24,25)/t12-,13+,15-,18-,19-/m0/s1 D07ZNI DRUGINKE AQSNIXKAKUZPSI-SSTWWWIQSA-N D07ZNI DRUGSMIL CC12CCC3C(C1CCC2OS(=O)(=O)N)CCC4=CC(=C(C=C34)OC)OS(=O)(=O)N D07ZNI HIGHSTAT Phase 2 D07ZTD DRUG__ID D07ZTD D07ZTD DRUGCOMP Ligand Pharmaceuticals D07ZTD DRUGTYPE Small molecular drug D07ZTD DRUGINCH 1S/C28H32ClO5P/c1-18(2)25-14-21(8-9-27(25)30)15-26-19(3)12-24(13-20(26)4)32-17-35(31)33-11-10-28(34-35)22-6-5-7-23(29)16-22/h5-9,12-14,16,18,28,30H,10-11,15,17H2,1-4H3/t28-,35+/m0/s1 D07ZTD DRUGINKE LGGPZDRLTDGYSQ-JADSYQMUSA-N D07ZTD DRUGSMIL CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCP3(=O)OCCC(O3)C4=CC(=CC=C4)Cl D07ZTD HIGHSTAT Phase 2 D08ABQ DRUG__ID D08ABQ D08ABQ THERCLAS Antiviral Agents D08ABQ DRUGTYPE Small molecular drug D08ABQ DRUGINCH 1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1 D08ABQ DRUGINKE WDENQIQQYWYTPO-IBGZPJMESA-N D08ABQ DRUGSMIL CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5 D08ABQ HIGHSTAT Phase 2 Trial D08ADX DRUG__ID D08ADX D08ADX THERCLAS Antiviral Agents D08ADX DRUGTYPE Small molecular drug D08ADX DRUGINCH 1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m0/s1 D08ADX DRUGINKE GBBJCSTXCAQSSJ-XQXXSGGOSA-N D08ADX DRUGSMIL CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F D08ADX HIGHSTAT Phase 2 Trial D08BEO DRUG__ID D08BEO D08BEO DRUGCOMP Teva Pharmaceutical Industries D08BEO DRUGTYPE Small molecular drug D08BEO DRUGINCH 1S/C19H19N3O3/c1-11-7-14-8-17-18(25-10-24-17)9-16(14)19(21-22(11)12(2)23)13-3-5-15(20)6-4-13/h3-6,8-9,11H,7,10,20H2,1-2H3/t11-/m1/s1 D08BEO DRUGINKE JACAAXNEHGBPOQ-LLVKDONJSA-N D08BEO DRUGSMIL CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3 D08BEO HIGHSTAT Phase 2 D08CQY DRUG__ID D08CQY D08CQY DRUGCOMP Cellceutix D08CQY DRUGTYPE Small molecular drug D08CQY DRUGINCH 1S/C40H50F6N14O6/c41-39(42,43)21-13-25(57-31(61)5-1-3-9-53-37(47)48)33(65-23-7-11-51-18-23)27(15-21)59-35(63)29-17-30(56-20-55-29)36(64)60-28-16-22(40(44,45)46)14-26(34(28)66-24-8-12-52-19-24)58-32(62)6-2-4-10-54-38(49)50/h13-17,20,23-24,51-52H,1-12,18-19H2,(H,57,61)(H,58,62)(H,59,63)(H,60,64)(H4,47,48,53)(H4,49,50,54)/t23-,24-/m1/s1 D08CQY DRUGINKE QPDYBCZNGUJZDK-DNQXCXABSA-N D08CQY DRUGSMIL C1CNCC1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4OC5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N D08CQY HIGHSTAT Phase 2 D08DGW DRUG__ID D08DGW D08DGW DRUGCOMP AstraZeneca D08DGW DRUGTYPE Small molecular drug D08DGW DRUGINCH 1S/C6H12O/c7-6-4-2-1-3-5-6/h6-7H,1-5H2 D08DGW DRUGINKE HPXRVTGHNJAIIH-UHFFFAOYSA-N D08DGW DRUGSMIL C1CCC(CC1)O D08DGW HIGHSTAT Phase 2 D08DUF DRUG__ID D08DUF D08DUF DRUGCOMP Gliknik D08DUF DRUGTYPE Small molecular drug D08DUF DRUGINCH 1S/C261H449N91O56/c1-30-147(26)204(249(406)339-186(124-153-70-38-33-39-71-153)234(391)342-190(131-354)238(395)322-159(75-43-49-99-263)210(367)309-149(28)207(364)341-189(130-353)240(397)344-192(133-356)241(398)343-191(132-355)239(396)335-180(118-137(6)7)230(387)324-175(93-96-195(270)358)223(380)331-178(116-135(2)3)228(385)320-168(84-58-108-298-255(279)280)218(375)313-160(76-44-50-100-264)212(369)312-161(77-45-51-101-265)213(370)314-165(81-55-105-295-252(273)274)216(373)315-167(83-57-107-297-254(277)278)219(376)323-174(92-95-194(269)357)222(379)318-166(82-56-106-296-253(275)276)217(374)316-169(85-59-109-299-256(281)282)220(377)329-177(250(407)408)90-64-114-304-261(291)292)351-248(405)203(146(24)25)348-225(382)171(87-61-111-301-258(285)286)319-215(372)163(79-47-53-103-267)327-245(402)200(143(18)19)347-227(384)173(89-63-113-303-260(289)290)328-246(403)201(144(20)21)349-236(393)182(120-139(10)11)330-206(363)148(27)308-211(368)164(80-54-104-294-251(271)272)325-242(399)193-91-65-115-352(193)196(359)129-306-209(366)187(125-154-127-305-158-74-41-40-72-156(154)158)338-231(388)181(119-138(8)9)334-232(389)184(122-151-66-34-31-35-67-151)336-221(378)170(86-60-110-300-257(283)284)317-214(371)162(78-46-52-102-266)326-244(401)199(142(16)17)346-226(383)172(88-62-112-302-259(287)288)321-229(386)179(117-136(4)5)333-233(390)185(123-152-68-36-32-37-69-152)337-235(392)188(126-155-128-293-134-307-155)340-247(404)202(145(22)23)350-237(394)183(121-140(12)13)332-224(381)176(94-97-197(360)361)311-205(362)150(29)310-243(400)198(141(14)15)345-208(365)157(268)73-42-48-98-262/h31-41,66-72,74,127-128,134-150,157,159-193,198-204,305,353-356H,30,42-65,73,75-126,129-133,262-268H2,1-29H3,(H2,269,357)(H2,270,358)(H,293,307)(H,306,366)(H,308,368)(H,309,367)(H,310,400)(H,311,362)(H,312,369)(H,313,375)(H,314,370)(H,315,373)(H,316,374)(H,317,371)(H,318,379)(H,319,372)(H,320,385)(H,321,386)(H,322,395)(H,323,376)(H,324,387)(H,325,399)(H,326,401)(H,327,402)(H,328,403)(H,329,377)(H,330,363)(H,331,380)(H,332,381)(H,333,390)(H,334,389)(H,335,396)(H,336,378)(H,337,392)(H,338,388)(H,339,406)(H,340,404)(H,341,364)(H,342,391)(H,343,398)(H,344,397)(H,345,365)(H,346,383)(H,347,384)(H,348,382)(H,349,393)(H,350,394)(H,351,405)(H,360,361)(H,407,408)(H4,271,272,294)(H4,273,274,295)(H4,275,276,296)(H4,277,278,297)(H4,279,280,298)(H4,281,282,299)(H4,283,284,300)(H4,285,286,301)(H4,287,288,302)(H4,289,290,303)(H4,291,292,304)/t147-,148-,149-,150-,157-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,198-,199-,200-,201-,202-,203-,204-/m0/s1 D08DUF DRUGINKE SSOORFWOBGFTHL-OTEJMHTDSA-N D08DUF DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C2CCCN2C(=O)CNC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC7=CNC=N7)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(CCCCN)N D08DUF HIGHSTAT Phase 2 D08EUS DRUG__ID D08EUS D08EUS DRUGCOMP Progen Pharmaceuticals D08EUS DRUGTYPE Small molecular drug D08EUS DRUGINCH 1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5- D08EUS DRUGINKE XFWLTFZLLXVKDY-WAYWQWQTSA-N D08EUS DRUGSMIL CCNCCCNCC=CCNCCCNCC D08EUS HIGHSTAT Phase 2 D08FDX DRUG__ID D08FDX D08FDX DRUGCOMP MethylGene D08FDX DRUGTYPE Small molecular drug D08FDX DRUGINCH 1S/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35) D08FDX DRUGINKE UFICVEHDQUKCEA-UHFFFAOYSA-N D08FDX DRUGSMIL CN1C=C(N=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=CC=C5)F D08FDX HIGHSTAT Phase 2 D08FKX DRUG__ID D08FKX D08FKX DRUGCOMP Novartis D08FKX DRUGTYPE Small molecular drug D08FKX DRUGINCH 1S/C23H33N3O/c1-6-23(4,7-2)22(27)25-15-11-18-16-9-8-10-19-21(16)17(14(3)24-19)12-20(18)26(5)13-15/h8-10,15,18,20,24H,6-7,11-13H2,1-5H3,(H,25,27)/t15-,18?,20+/m0/s1 D08FKX DRUGINKE UXRWQKITDPCICD-BEHPGTHXSA-N D08FKX DRUGSMIL CCC(C)(CC)C(=O)NC1CC2C(CC3=C(NC4=CC=CC2=C34)C)N(C1)C D08FKX HIGHSTAT Phase 2 D08GBB DRUG__ID D08GBB D08GBB DRUGCOMP Idenix Pharmaceuticals Inc D08GBB DRUGTYPE Small molecular drug D08GBB DRUGINCH 1S/C15H24N4O6.2ClH/c1-7(2)10(17)12(21)25-11-8(6-20)24-13(15(11,3)23)19-5-4-9(16)18-14(19)22;;/h4-5,7-8,10-11,13,20,23H,6,17H2,1-3H3,(H2,16,18,22);2*1H/t8-,10+,11-,13-,15-;;/m1../s1 D08GBB DRUGINKE XENHXZMAOSTXGD-DSMKLBDQSA-N D08GBB DRUGSMIL CC(C)C(C(=O)OC1C(OC(C1(C)O)N2C=CC(=NC2=O)N)CO)N.Cl.Cl D08GBB HIGHSTAT Phase 2 D08HOM DRUG__ID D08HOM D08HOM DRUGCOMP Abbott Laboratories Abbott D08HOM DRUGTYPE Small molecular drug D08HOM DRUGINCH 1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34) D08HOM DRUGINKE WPHKIQPVPYJNAX-UHFFFAOYSA-N D08HOM DRUGSMIL C1=CC(=CC(=C1)F)NC(=O)NC2=CC=C(C=C2)C3=CSC4=C3C(=NC=C4C5=CN(N=C5)CCO)N D08HOM HIGHSTAT Phase 2 D08HXG DRUG__ID D08HXG D08HXG DRUGCOMP PolyMedix Inc D08HXG DRUGTYPE Small molecular drug D08HXG DRUGINCH 1S/C56H79N13O12/c1-78-45-21-17-33(29-37(45)49(62)70)64-54(75)42(14-6-10-26-58)67-51(72)39-31-35(19-23-47(39)80-3)66-56(77)44(16-8-12-28-60)69-52(73)40-32-36(20-24-48(40)81-4)65-55(76)43(15-7-11-27-59)68-50(71)38-30-34(18-22-46(38)79-2)63-53(74)41(61)13-5-9-25-57/h17-24,29-32,41-44H,5-16,25-28,57-61H2,1-4H3,(H2,62,70)(H,63,74)(H,64,75)(H,65,76)(H,66,77)(H,67,72)(H,68,71)(H,69,73)/t41-,42-,43-,44-/m0/s1 D08HXG DRUGINKE PWFIFNGOPQUNIT-ITMZJIMRSA-N D08HXG DRUGSMIL COC1=C(C=C(C=C1)NC(=O)C(CCCCN)N)C(=O)NC(CCCCN)C(=O)NC2=CC(=C(C=C2)OC)C(=O)NC(CCCCN)C(=O)NC3=CC(=C(C=C3)OC)C(=O)NC(CCCCN)C(=O)NC4=CC(=C(C=C4)OC)C(=O)N D08HXG HIGHSTAT Phase 2 D08ICX DRUG__ID D08ICX D08ICX THERCLAS Antiviral Agents D08ICX DRUGTYPE Small molecular drug D08ICX DRUGINCH 1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1 D08ICX DRUGINKE UJLAWZDWDVHWOW-YPMHNXCESA-N D08ICX DRUGSMIL CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N D08ICX HIGHSTAT Phase 2 Trial D08JWC DRUG__ID D08JWC D08JWC DRUGCOMP GILEAD D08JWC DRUGTYPE Small molecular drug D08JWC DRUGINCH 1S/C22H30N6O2/c1-2-3-11-30-22-25-20(23)19-21(26-22)28(15-18(29)24-19)14-17-8-6-7-16(12-17)13-27-9-4-5-10-27/h6-8,12H,2-5,9-11,13-15H2,1H3,(H,24,29)(H2,23,25,26) D08JWC DRUGINKE VFOKSTCIRGDTBR-UHFFFAOYSA-N D08JWC DRUGSMIL CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N D08JWC HIGHSTAT Phase 2 D08KTQ DRUG__ID D08KTQ D08KTQ DRUGCOMP ConjuChem Biotechnologies Inc D08KTQ DRUGTYPE Small molecular drug D08KTQ DRUGINCH 1S/C152H252N44O42/c1-22-79(15)118(194-125(214)84(20)171-135(224)107(68-115(206)207)181-124(213)81(17)169-126(215)91(155)65-87-41-45-89(201)46-42-87)147(236)189-106(66-86-34-25-24-26-35-86)141(230)196-120(85(21)200)149(238)180-99(51-54-114(158)205)132(221)190-111(72-199)145(234)185-105(67-88-43-47-90(202)48-44-88)140(229)178-96(40-33-59-168-152(164)165)128(217)177-94(37-28-30-56-154)133(222)193-117(78(13)14)146(235)187-100(60-73(3)4)134(223)170-82(18)123(212)175-97(49-52-112(156)203)130(219)183-103(63-76(9)10)138(227)191-109(70-197)143(232)172-83(19)122(211)174-95(39-32-58-167-151(162)163)127(216)176-93(36-27-29-55-153)129(218)182-102(62-75(7)8)137(226)184-101(61-74(5)6)136(225)179-98(50-53-113(157)204)131(220)186-108(69-116(208)209)142(231)195-119(80(16)23-2)148(237)188-104(64-77(11)12)139(228)192-110(71-198)144(233)173-92(121(159)210)38-31-57-166-150(160)161/h24-26,34-35,41-48,73-85,91-111,117-120,197-202H,22-23,27-33,36-40,49-72,153-155H2,1-21H3,(H2,156,203)(H2,157,204)(H2,158,205)(H2,159,210)(H,169,215)(H,170,223)(H,171,224)(H,172,232)(H,173,233)(H,174,211)(H,175,212)(H,176,216)(H,177,217)(H,178,229)(H,179,225)(H,180,238)(H,181,213)(H,182,218)(H,183,219)(H,184,226)(H,185,234)(H,186,220)(H,187,235)(H,188,237)(H,189,236)(H,190,221)(H,191,227)(H,192,228)(H,193,222)(H,194,214)(H,195,231)(H,196,230)(H,206,207)(H,208,209)(H4,160,161,166)(H4,162,163,167)(H4,164,165,168)/t79-,80-,81+,82-,83-,84-,85+,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,117-,118-,119-,120-/m0/s1 D08KTQ DRUGINKE XOZMWINMZMMOBR-HRDSVTNWSA-N D08KTQ DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N D08KTQ HIGHSTAT Phase 2 D08LMS DRUG__ID D08LMS D08LMS DRUGCOMP CG Therapeutics D08LMS DRUGTYPE Small molecular drug D08LMS DRUGINCH 1S/C22H28NO3.CH4O4S/c1-23(2)16-10-9-15-20(23)17-26-21(24)22(25,18-11-5-3-6-12-18)19-13-7-4-8-14-19;1-5-6(2,3)4/h3-8,11-14,20,25H,9-10,15-17H2,1-2H3;1H3,(H,2,3,4)/q+1;/p-1 D08LMS DRUGINKE AXKJGGRSAVLXTE-UHFFFAOYSA-M D08LMS DRUGSMIL C[N+]1(CCCCC1COC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.COS(=O)(=O)[O-] D08LMS HIGHSTAT Phase 2 D08LRV DRUG__ID D08LRV D08LRV DRUGCOMP N-Gene Research Laboratories D08LRV DRUGTYPE Small molecular drug D08LRV DRUGINCH 1S/C14H22N4O2.2ClH/c15-14(12-5-4-6-16-9-12)17-20-11-13(19)10-18-7-2-1-3-8-18;;/h4-6,9,13,19H,1-3,7-8,10-11H2,(H2,15,17);2*1H D08LRV DRUGINKE ISGGVCWFTPTHIX-UHFFFAOYSA-N D08LRV DRUGSMIL C1CCN(CC1)CC(CON=C(C2=CN=CC=C2)N)O.Cl.Cl D08LRV HIGHSTAT Phase 2 D08MJO DRUG__ID D08MJO D08MJO DRUGCOMP UCB; Biogen Idec D08MJO DRUGTYPE Small molecular drug D08MJO DRUGINCH 1S/C28H29BrN4O3/c1-2-36-27(35)22(33-24-23(29)25(34)28(24)12-4-3-5-13-28)16-18-6-8-20(9-7-18)32-26-21-17-30-14-10-19(21)11-15-31-26/h6-11,14-15,17,22,33H,2-5,12-13,16H2,1H3,(H,31,32)/t22-/m0/s1 D08MJO DRUGINKE QCYAXXZCQKMTMO-QFIPXVFZSA-N D08MJO DRUGSMIL CCOC(=O)C(CC1=CC=C(C=C1)NC2=NC=CC3=C2C=NC=C3)NC4=C(C(=O)C45CCCCC5)Br D08MJO HIGHSTAT Phase 2 D08NDE DRUG__ID D08NDE D08NDE DRUGCOMP Novartis Institutes for BioMedical Research Inc D08NDE DRUGTYPE Small molecular drug D08NDE DRUGINCH 1S/C20H22N4O3S/c1-21-19(26)16-10-13(8-9-22-16)27-12-6-7-15-18(11-12)28-20(24-15)23-14-4-2-3-5-17(14)25/h6-11,14,17,25H,2-5H2,1H3,(H,21,26)(H,23,24)/t14-,17-/m1/s1 D08NDE DRUGINKE ADZBMFGQQWPHMJ-RHSMWYFYSA-N D08NDE DRUGSMIL CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)NC4CCCCC4O D08NDE HIGHSTAT Phase 2 D08PMB DRUG__ID D08PMB D08PMB DRUGCOMP Merck KGaA D08PMB DRUGTYPE Small molecular drug D08PMB DRUGINCH 1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1 D08PMB DRUGINKE GFICWFZTBXUVIG-SCSAIBSYSA-N D08PMB DRUGSMIL CC1N=C(NC(=N1)N(C)C)N D08PMB HIGHSTAT Phase 2 D08PYO DRUG__ID D08PYO D08PYO DRUGCOMP Kyowa Hakko Kirin D08PYO DRUGTYPE Small molecular drug D08PYO DRUGINCH 1S/C30H42N2O9/c1-5-22-23(19-28(35)32(11-13-37-2)12-14-38-3)29(25(34)20-24(22)33)30(36)21-6-7-26(27(18-21)39-4)41-17-10-31-8-15-40-16-9-31/h6-7,18,20,33-34H,5,8-17,19H2,1-4H3 D08PYO DRUGINKE VFUXSYAXEKYYMB-UHFFFAOYSA-N D08PYO DRUGSMIL CCC1=C(C(=C(C=C1O)O)C(=O)C2=CC(=C(C=C2)OCCN3CCOCC3)OC)CC(=O)N(CCOC)CCOC D08PYO HIGHSTAT Phase 2 D08QGT DRUG__ID D08QGT D08QGT DRUGCOMP Genentech D08QGT DRUGTYPE Small molecular drug D08QGT DRUGINCH 1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) D08QGT DRUGINKE LHNIIDJUOCFXAP-UHFFFAOYSA-N D08QGT DRUGSMIL CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6 D08QGT HIGHSTAT Phase 2 D08SSP DRUG__ID D08SSP D08SSP DRUGCOMP ViiV Healthcare D08SSP DRUGTYPE Small molecular drug D08SSP DRUGINCH 1S/C17H18N4O2/c1-3-15-17(16(4-2)21(20-15)5-6-22)23-14-8-12(10-18)7-13(9-14)11-19/h7-9,22H,3-6H2,1-2H3 D08SSP DRUGINKE MCPUZZJBAHRIPO-UHFFFAOYSA-N D08SSP DRUGSMIL CCC1=C(C(=NN1CCO)CC)OC2=CC(=CC(=C2)C#N)C#N D08SSP HIGHSTAT Phase 2 D08TQP DRUG__ID D08TQP D08TQP DRUGCOMP Cardiff University D08TQP DRUGTYPE Small molecular drug D08TQP DRUGINCH 1S/C30H39N6O9P/c1-17(26(38)42-15-29(2,3)4)35-46(40,45-20-13-9-11-18-10-7-8-12-19(18)20)43-14-21-23(37)30(5,39)27(44-21)36-16-32-22-24(36)33-28(31)34-25(22)41-6/h7-13,16-17,21,23,27,37,39H,14-15H2,1-6H3,(H,35,40)(H2,31,33,34)/t17-,21+,23+,27+,30+,46?/m0/s1 D08TQP DRUGINKE YFXGICNMLCGLHJ-RSKRLRQZSA-N D08TQP DRUGSMIL CC(C(=O)OCC(C)(C)C)NP(=O)(OCC1C(C(C(O1)N2C=NC3=C2N=C(N=C3OC)N)(C)O)O)OC4=CC=CC5=CC=CC=C54 D08TQP HIGHSTAT Phase 2 D08UGB DRUG__ID D08UGB D08UGB DRUGCOMP Valeant Pharmaceuticals D08UGB DRUGTYPE Small molecular drug D08UGB DRUGINCH 1S/C24H18BrClN4O3S.K/c25-23-28-29-24(34-12-21(31)27-19-9-7-14(22(32)33)11-18(19)26)30(23)20-10-8-15(13-5-6-13)16-3-1-2-4-17(16)20;/h1-4,7-11,13H,5-6,12H2,(H,27,31)(H,32,33);/q;+1/p-1 D08UGB DRUGINKE ZVIWEYTXPYNLGB-UHFFFAOYSA-M D08UGB DRUGSMIL C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)NC5=C(C=C(C=C5)C(=O)[O-])Cl.[K+] D08UGB HIGHSTAT Phase 2 D08UOY DRUG__ID D08UOY D08UOY DRUGCOMP Antisoma; University of Auckland D08UOY DRUGTYPE Small molecular drug D08UOY DRUGINCH 1S/C17H14O4/c1-9-6-7-13-15(20)12-5-3-4-11(8-14(18)19)17(12)21-16(13)10(9)2/h3-7H,8H2,1-2H3,(H,18,19) D08UOY DRUGINKE XGOYIMQSIKSOBS-UHFFFAOYSA-N D08UOY DRUGSMIL CC1=C(C2=C(C=C1)C(=O)C3=CC=CC(=C3O2)CC(=O)O)C D08UOY HIGHSTAT Phase 2 D08UUK DRUG__ID D08UUK D08UUK DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D08UUK DRUGTYPE Small molecular drug D08UUK DRUGINCH 1S/C23H34O4/c1-20-8-5-17(24)13-15(20)3-4-19-18(20)6-9-21(2)22(25,10-11-23(19,21)26)16-7-12-27-14-16/h7,12,14-15,17-19,24-26H,3-6,8-11,13H2,1-2H3/t15-,17+,18+,19-,20+,21-,22+,23+/m1/s1 D08UUK DRUGINKE AEAPORIZZWBIEX-DTBDINHYSA-N D08UUK DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3(CCC4(C5=COC=C5)O)O)C)O D08UUK HIGHSTAT Phase 2 D08VHG DRUG__ID D08VHG D08VHG DRUGCOMP King's College London D08VHG DRUGTYPE Small molecular drug D08VHG DRUGINCH 1S/C26H31N5O4/c1-15-10-16(2)24(17(3)11-15)29-23-14-20-19-13-22(35-5)21(34-4)12-18(19)6-8-30(20)26(33)31(23)9-7-28-25(27)32/h10-14H,6-9H2,1-5H3,(H3,27,28,32) D08VHG DRUGINKE CSOBIBXVIYAXFM-UHFFFAOYSA-N D08VHG DRUGSMIL CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2CCNC(=O)N)OC)OC)C D08VHG HIGHSTAT Phase 2 D08YNI DRUG__ID D08YNI D08YNI DRUGCOMP DeveloGen D08YNI DRUGTYPE Small molecular drug D08YNI DRUGINCH 1S/C60H74N12O10/c1-37(73)54-59(81)70-50(31-39-18-6-3-7-19-39)60(82)72(36-51(62)74)29-15-26-52(75)63-28-14-25-53(76)66-47(30-38-16-4-2-5-17-38)56(78)68-49(33-41-35-65-45-23-11-9-21-43(41)45)58(80)69-48(32-40-34-64-44-22-10-8-20-42(40)44)57(79)67-46(55(77)71-54)24-12-13-27-61/h2-11,16-23,34-35,37,46-50,54,64-65,73H,12-15,24-33,36,61H2,1H3,(H2,62,74)(H,63,75)(H,66,76)(H,67,79)(H,68,78)(H,69,80)(H,70,81)(H,71,77)/t37-,46+,47+,48-,49+,50+,54+/m1/s1 D08YNI DRUGINKE ABFNTRQPWNXUHA-VEVJRHMJSA-N D08YNI DRUGSMIL CC(C1C(=O)NC(C(=O)N(CCCC(=O)NCCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CNC5=CC=CC=C54)CC6=CC=CC=C6)CC(=O)N)CC7=CC=CC=C7)O D08YNI HIGHSTAT Phase 2 D08YOM DRUG__ID D08YOM D08YOM DRUGCOMP Pfizer Inc D08YOM DRUGTYPE Small molecular drug D08YOM DRUGINCH 1S/C19H27NO7S3/c1-4-11(5-2)17(23)26-9-27-18(24)14-19(28-12-6-7-30(25)8-12)29-16-13(10(3)21)15(22)20(14)16/h10-13,16,21H,4-9H2,1-3H3/t10-,12+,13+,16-,30-/m1/s1 D08YOM DRUGINKE NBPVNGWRLGHULH-CSOWVJSESA-N D08YOM DRUGSMIL CCC(CC)C(=O)OCOC(=O)C1=C(SC2N1C(=O)C2C(C)O)SC3CCS(=O)C3 D08YOM HIGHSTAT Phase 2 D08ZKJ DRUG__ID D08ZKJ D08ZKJ DRUGCOMP Boehringer Ingelheim Corp D08ZKJ DRUGTYPE Small molecular drug D08ZKJ DRUGINCH 1S/C21H25N3O/c1-15-10-11-20-19(13-15)24-21(25-20)23-18(17-9-5-6-12-22-17)14-16-7-3-2-4-8-16/h5-6,9-13,16,18H,2-4,7-8,14H2,1H3,(H,23,24)/t18-/m0/s1 D08ZKJ DRUGINKE RVXKHAITGKBBAC-SFHVURJKSA-N D08ZKJ DRUGSMIL CC1=CC2=C(C=C1)OC(=N2)NC(CC3CCCCC3)C4=CC=CC=N4 D08ZKJ HIGHSTAT Phase 2 D08ZPO DRUG__ID D08ZPO D08ZPO DRUGCOMP CoTherix D08ZPO DRUGTYPE Small molecular drug D08ZPO DRUGINCH 1S/C16H21N3O2S/c1-12-9-18-11-14-5-3-6-15(16(12)14)22(20,21)19-8-4-7-17-10-13(19)2/h3,5-6,9,11,13,17H,4,7-8,10H2,1-2H3/t13-/m0/s1 D08ZPO DRUGINKE AWDORCFLUJZUQS-ZDUSSCGKSA-N D08ZPO DRUGSMIL CC1CNCCCN1S(=O)(=O)C2=CC=CC3=C2C(=CN=C3)C D08ZPO HIGHSTAT Phase 2 D09ALE DRUG__ID D09ALE D09ALE DRUGCOMP Parke-Davis & Co D09ALE DRUGTYPE Small molecular drug D09ALE DRUGINCH 1S/C24H32N2O3/c1-25(23(27)16-18-6-4-7-22-19(18)9-15-28-22)20-8-11-24(10-5-14-29-24)17-21(20)26-12-2-3-13-26/h4,6-7,9,15,20-21H,2-3,5,8,10-14,16-17H2,1H3/t20-,21-,24-/m0/s1 D09ALE DRUGINKE JMBYBVLCYODBJQ-HFMPRLQTSA-N D09ALE DRUGSMIL CN(C1CCC2(CCCO2)CC1N3CCCC3)C(=O)CC4=C5C=COC5=CC=C4 D09ALE HIGHSTAT Phase 2 D09ALR DRUG__ID D09ALR D09ALR DRUGCOMP Medimetriks Pharmaceuticals Fairfield, NJ D09ALR DRUGTYPE Small molecular drug D09ALR DRUGINCH 1S/C23H24F2N2O5/c1-4-29-18-8-6-5-7-17(18)21(28)26-12-16-13-30-22(27-16)15-9-10-19(32-23(24)25)20(11-15)31-14(2)3/h5-11,13-14,23H,4,12H2,1-3H3,(H,26,28) D09ALR DRUGINKE VFBILHPIHUPBPZ-UHFFFAOYSA-N D09ALR DRUGSMIL CCOC1=CC=CC=C1C(=O)NCC2=COC(=N2)C3=CC(=C(C=C3)OC(F)F)OC(C)C D09ALR HIGHSTAT Phase 2 D09BNZ DRUG__ID D09BNZ D09BNZ DRUGCOMP Novartis Pharmaceuticals D09BNZ DRUGTYPE Small molecular drug D09BNZ DRUGINCH 1S/C26H26F3N3O3/c1-16-14-32(15-17(2)34-16)24-12-9-20(13-30-24)31-25(33)23-6-4-5-22(18(23)3)19-7-10-21(11-8-19)35-26(27,28)29/h4-13,16-17H,14-15H2,1-3H3,(H,31,33)/t16-,17+ D09BNZ DRUGINKE VZZJRYRQSPEMTK-CALCHBBNSA-N D09BNZ DRUGSMIL CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F D09BNZ HIGHSTAT Phase 2 D09BOH DRUG__ID D09BOH D09BOH DRUGCOMP Maxim Pharmaceuticals Inc D09BOH DRUGTYPE Small molecular drug D09BOH DRUGINCH 1S/C17H17N3O/c1-12-18-16-7-5-4-6-15(16)17(19-12)20(2)13-8-10-14(21-3)11-9-13/h4-11H,1-3H3 D09BOH DRUGINKE SNHCRNMVYDHVDT-UHFFFAOYSA-N D09BOH DRUGSMIL CC1=NC2=CC=CC=C2C(=N1)N(C)C3=CC=C(C=C3)OC D09BOH HIGHSTAT Phase 2 D09BPN DRUG__ID D09BPN D09BPN DRUGCOMP Fournier Pharma D09BPN DRUGTYPE Small molecular drug D09BPN DRUGINCH 1S/C34H36Cl2N6O5S/c1-20-18-21(2)41-31-24(20)6-3-8-28(31)47-19-25-26(35)13-14-29(30(25)36)48(45,46)42-17-4-7-27(42)34(44)40-16-5-15-39-33(43)23-11-9-22(10-12-23)32(37)38/h3,6,8-14,18,27H,4-5,7,15-17,19H2,1-2H3,(H3,37,38)(H,39,43)(H,40,44)/t27-/m0/s1 D09BPN DRUGINKE XUHBBTKJWIBQMY-MHZLTWQESA-N D09BPN DRUGSMIL CC1=CC(=NC2=C1C=CC=C2OCC3=C(C=CC(=C3Cl)S(=O)(=O)N4CCCC4C(=O)NCCCNC(=O)C5=CC=C(C=C5)C(=N)N)Cl)C D09BPN HIGHSTAT Phase 2 D09BTK DRUG__ID D09BTK D09BTK DRUGCOMP NicOx SA D09BTK DRUGTYPE Small molecular drug D09BTK DRUGINCH 1S/C38H55NO10/c1-24(28-10-11-29-36-30(16-18-38(28,29)3)37(2)17-15-27(40)22-26(37)23-31(36)41)7-13-35(43)49-32-12-8-25(21-33(32)46-4)9-14-34(42)47-19-5-6-20-48-39(44)45/h8-9,12,14,21,24,26-31,36,40-41H,5-7,10-11,13,15-20,22-23H2,1-4H3/b14-9+/t24-,26+,27-,28-,29+,30+,31+,36+,37+,38-/m1/s1 D09BTK DRUGINKE WTAVOESJEWSDJC-OBOLPPCUSA-N D09BTK DRUGSMIL CC(CCC(=O)OC1=C(C=C(C=C1)C=CC(=O)OCCCCO[N+](=O)[O-])OC)C2CCC3C2(CCC4C3C(CC5C4(CCC(C5)O)C)O)C D09BTK HIGHSTAT Phase 2 D09CIF DRUG__ID D09CIF D09CIF DRUGCOMP Kiadis Pharma D09CIF DRUGTYPE Small molecular drug D09CIF DRUGINCH 1S/C21H14Br2N2O3.ClH/c1-27-21(26)11-5-3-2-4-10(11)16-12-6-8-14(24)17(22)19(12)28-20-13(16)7-9-15(25)18(20)23;/h2-9,24H,25H2,1H3;1H D09CIF DRUGINKE MUDCDMMNYVJLEB-UHFFFAOYSA-N D09CIF DRUGSMIL COC(=O)C1=CC=CC=C1C2=C3C=CC(=[NH2+])C(=C3OC4=C2C=CC(=C4Br)N)Br.[Cl-] D09CIF HIGHSTAT Phase 2 D09DIB DRUG__ID D09DIB D09DIB DRUGCOMP F Hoffmann-La Roche Ltd D09DIB DRUGTYPE Small molecular drug D09DIB DRUGINCH 1S/C23H26N2O2.ClH/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18;/h1-10,20H,11-17H2,(H,24,26,27);1H D09DIB DRUGINKE XSOOSXRNMDUWEM-UHFFFAOYSA-N D09DIB DRUGSMIL C1CN(CCC1C2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4.Cl D09DIB HIGHSTAT Phase 2 D09ENR DRUG__ID D09ENR D09ENR DRUGCOMP Cylene Pharmaceuticals Inc D09ENR DRUGTYPE Small molecular drug D09ENR DRUGINCH 1S/C35H33FN6O3/c1-40-13-4-7-24(40)8-10-39-35(44)26-20-42-29-15-21-5-2-3-6-22(21)16-30(29)45-34-31(42)25(33(26)43)17-27(36)32(34)41-14-9-23(19-41)28-18-37-11-12-38-28/h2-3,5-6,11-12,15-18,20,23-24H,4,7-10,13-14,19H2,1H3,(H,39,44)/t23?,24-/m0/s1 D09ENR DRUGINKE WOQIDNWTQOYDLF-CGAIIQECSA-N D09ENR DRUGSMIL CN1CCCC1CCNC(=O)C2=CN3C4=CC5=CC=CC=C5C=C4OC6=C3C(=CC(=C6N7CCC(C7)C8=NC=CN=C8)F)C2=O D09ENR HIGHSTAT Phase 2 D09HFS DRUG__ID D09HFS D09HFS DRUGCOMP Kirax D09HFS DRUGTYPE Small molecular drug D09HFS DRUGINCH 1S/C22H23F3N4O3.CH4O3S/c1-10-18(24)20(28)17-15(30)9-16(32-21(17)19(10)25)11-5-6-14(12(23)8-11)29-22(31)13(27)4-2-3-7-26;1-5(2,3)4/h5-6,8-9,13H,2-4,7,26-28H2,1H3,(H,29,31);1H3,(H,2,3,4)/t13-;/m0./s1 D09HFS DRUGINKE MJVICFBYAVBBOA-ZOWNYOTGSA-N D09HFS DRUGSMIL CC1=C(C(=C2C(=O)C=C(OC2=C1F)C3=CC(=C(C=C3)NC(=O)C(CCCCN)N)F)N)F.CS(=O)(=O)O D09HFS HIGHSTAT Phase 2 D09JEJ DRUG__ID D09JEJ D09JEJ DRUGCOMP Cylene Pharmaceuticals D09JEJ DRUGTYPE Small molecular drug D09JEJ DRUGINCH 1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25) D09JEJ DRUGINKE MUOKSQABCJCOPU-UHFFFAOYSA-N D09JEJ DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4 D09JEJ HIGHSTAT Phase 2 D09KNG DRUG__ID D09KNG D09KNG DRUGCOMP Novavax D09KNG DRUGTYPE Small molecular drug D09KNG DRUGINCH 1S/C22H17FN4O2/c23-16-11-5-7-13-18(16)25-22(29)27-20-21(28)24-17-12-6-4-10-15(17)19(26-20)14-8-2-1-3-9-14/h1-13,20H,(H,24,28)(H2,25,27,29)/t20-/m1/s1 D09KNG DRUGINKE MTPVBMVUENFFLL-HXUWFJFHSA-N D09KNG DRUGSMIL C1=CC=C(C=C1)C2=NC(C(=O)NC3=CC=CC=C32)NC(=O)NC4=CC=CC=C4F D09KNG HIGHSTAT Phase 2 D09KYR DRUG__ID D09KYR D09KYR DRUGCOMP Rhone-Poulenc SA D09KYR DRUGTYPE Small molecular drug D09KYR DRUGINCH 1S/C12H16N2OS2/c1-13-11(16)12(6-2-3-8-17(12)15)10-5-4-7-14-9-10/h4-5,7,9H,2-3,6,8H2,1H3,(H,13,16)/t12-,17?/m1/s1 D09KYR DRUGINKE GKEMHVLBZNVZOI-MTATWXBHSA-N D09KYR DRUGSMIL CNC(=S)C1(CCCCS1=O)C2=CN=CC=C2 D09KYR HIGHSTAT Phase 2 D09NST DRUG__ID D09NST D09NST DRUGCOMP ASCEND Therapeutics D09NST DRUGTYPE Small molecular drug D09NST DRUGINCH 1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25- D09NST DRUGINKE TXUZVZSFRXZGTL-QPLCGJKRSA-N D09NST DRUGSMIL CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 D09NST HIGHSTAT Phase 2 D09PLF DRUG__ID D09PLF D09PLF DRUGCOMP Organon BioSciences D09PLF DRUGTYPE Small molecular drug D09PLF DRUGINCH 1S/C11H12N2O3S.ClH/c1-15-7-3-6-4-10(11(12)13-14)17-9(6)5-8(7)16-2;/h3-5,14H,1-2H3,(H2,12,13);1H D09PLF DRUGINKE DVWBMWJOYIFITF-UHFFFAOYSA-N D09PLF DRUGSMIL COC1=C(C=C2C(=C1)C=C(S2)C(=NO)N)OC.Cl D09PLF HIGHSTAT Phase 2 D09QOR DRUG__ID D09QOR D09QOR DRUGCOMP Adherex Technologies D09QOR DRUGTYPE Small molecular drug D09QOR DRUGINCH 1S/C6H4N2O2/c1-2-4-3-7-6(10)8-5(4)9/h1,3H,(H2,7,8,9,10) D09QOR DRUGINKE JOZGNYDSEBIJDH-UHFFFAOYSA-N D09QOR DRUGSMIL C#CC1=CNC(=O)NC1=O D09QOR HIGHSTAT Phase 2 D09RMU DRUG__ID D09RMU D09RMU DRUGCOMP Avantogen D09RMU DRUGTYPE Small molecular drug D09RMU DRUGINCH 1S/C81H133NO35/c1-10-11-12-13-14-15-16-17-18-19-28-82-66(101)62-57(98)61(113-67-54(95)49(90)41(86)32-104-67)64(116-70-55(96)51(92)50(91)43(31-83)109-70)72(114-62)110-47-23-24-76(6)44(77(47,7)34-84)22-25-78(8)45(76)21-20-39-40-29-75(4,5)26-27-81(40,46(88)30-79(39,78)9)74(102)117-71-63(52(93)48(89)37(2)107-71)115-69-56(97)53(94)59(38(3)108-69)111-68-58(99)60(42(87)33-105-68)112-73-65(100)80(103,35-85)36-106-73/h20,34,37-38,40-65,67-73,83,85-100,103H,10-19,21-33,35-36H2,1-9H3,(H,82,101)/t37-,38+,40?,41-,42-,43-,44?,45?,46-,47+,48+,49+,50+,51+,52+,53+,54-,55-,56-,57+,58-,59+,60+,61+,62+,63-,64-,65+,67+,68+,69+,70+,71+,72-,73+,76+,77+,78-,79-,80-,81-/m1/s1 D09RMU DRUGINKE NKVLDFAVEWLOCX-GUSKIFEASA-N D09RMU DRUGSMIL CCCCCCCCCCCCNC(=O)C1C(C(C(C(O1)OC2CCC3(C(C2(C)C=O)CCC4(C3CC=C5C4(CC(C6(C5CC(CC6)(C)C)C(=O)OC7C(C(C(C(O7)C)O)O)OC8C(C(C(C(O8)C)OC9C(C(C(CO9)O)OC1C(C(CO1)(CO)O)O)O)O)O)O)C)C)C)OC1C(C(C(C(O1)CO)O)O)O)OC1C(C(C(CO1)O)O)O)O D09RMU HIGHSTAT Phase 2 D09RVI DRUG__ID D09RVI D09RVI DRUGCOMP Gilead D09RVI DRUGTYPE Small molecular drug D09RVI DRUGINCH 1S/C25H14F7N5/c26-19-4-2-1-3-17(19)23-33-21-9-10-37(13-22(21)34-23)12-15-6-8-20(36-35-15)16-7-5-14(24(27,28)29)11-18(16)25(30,31)32/h1-11,13H,12H2 D09RVI DRUGINKE XBEQSQDCBSKCHJ-UHFFFAOYSA-N D09RVI DRUGSMIL C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F D09RVI HIGHSTAT Phase 2 D09TGC DRUG__ID D09TGC D09TGC DRUGCOMP Arena Pharmaceuticals Inc D09TGC DRUGTYPE Small molecular drug D09TGC DRUGINCH 1S/C8H8N2O2/c11-8(12)7-5-2-3-1-4(3)6(5)9-10-7/h3-4H,1-2H2,(H,9,10)(H,11,12)/t3-,4-/m1/s1 D09TGC DRUGINKE CUTZNERBKDMLAP-QWWZWVQMSA-N D09TGC DRUGSMIL C1C2C1C3=C(C2)C(=NN3)C(=O)O D09TGC HIGHSTAT Phase 2 D09UMP DRUG__ID D09UMP D09UMP DRUGCOMP MediciNova D09UMP DRUGTYPE Small molecular drug D09UMP DRUGINCH 1S/C19H21NO5.ClH/c1-2-5-18-16(4-1)22-12-15(25-18)11-20-8-3-9-21-14-6-7-17-19(10-14)24-13-23-17;/h1-2,4-7,10,15,20H,3,8-9,11-13H2;1H/t15-;/m0./s1 D09UMP DRUGINKE GGNCUSDIUUCNKE-RSAXXLAASA-N D09UMP DRUGSMIL C1C(OC2=CC=CC=C2O1)CNCCCOC3=CC4=C(C=C3)OCO4.Cl D09UMP HIGHSTAT Phase 2 D09WFL DRUG__ID D09WFL D09WFL DRUGCOMP US Army Medical Research Institute of Infectious Diseases D09WFL DRUGTYPE Small molecular drug D09WFL DRUGINCH 1S/C16H15NO3/c1-10-6-5-7-11(2)14(10)17-15(18)12-8-3-4-9-13(12)16(19)20/h3-9H,1-2H3,(H,17,18)(H,19,20) D09WFL DRUGINKE LLECMGGNFBKPRH-UHFFFAOYSA-N D09WFL DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C2=CC=CC=C2C(=O)O D09WFL HIGHSTAT Phase 2 D09WYL DRUG__ID D09WYL D09WYL DRUGCOMP GlaxoSmithKline plc D09WYL DRUGTYPE Small molecular drug D09WYL DRUGINCH 1S/C30H38N4O4/c1-5-18(2)26-28(35)32-25(23-16-21-8-6-7-9-22(21)17-23)29(36)34(26)27(24-11-10-19(3)31-20(24)4)30(37)33-12-14-38-15-13-33/h6-11,18,23,25-27H,5,12-17H2,1-4H3,(H,32,35)/t18-,25+,26+,27+/m0/s1 D09WYL DRUGINKE UWHCWRQFNKUYCG-QUZACWSFSA-N D09WYL DRUGSMIL CCC(C)C1C(=O)NC(C(=O)N1C(C2=C(N=C(C=C2)C)C)C(=O)N3CCOCC3)C4CC5=CC=CC=C5C4 D09WYL HIGHSTAT Phase 2 D09XGB DRUG__ID D09XGB D09XGB THERCLAS Anticancer Agents D09XGB DRUGTYPE Small molecular drug D09XGB DRUGINCH 1S/C19H17ClN2O5/c1-3-21-19(25)17-16(10-4-6-11(26-2)7-5-10)18(27-22-17)12-8-13(20)15(24)9-14(12)23/h4-9,23-24H,3H2,1-2H3,(H,21,25) D09XGB DRUGINKE JXPCDMPJCKNLBY-UHFFFAOYSA-N D09XGB DRUGSMIL CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)OC)C3=CC(=C(C=C3O)O)Cl D09XGB HIGHSTAT Phase 2 D09XIZ DRUG__ID D09XIZ D09XIZ DRUGCOMP Janssen Research & Development D09XIZ DRUGTYPE Small molecular drug D09XIZ DRUGINCH 1S/C21H26N6O2/c1-26-14-17(18-4-2-3-5-19(18)26)11-22-10-15-6-8-27(9-7-15)21-23-12-16(13-24-21)20(28)25-29/h2-5,12-15,22,29H,6-11H2,1H3,(H,25,28) D09XIZ DRUGINKE PAWIYAYFNXQGAP-UHFFFAOYSA-N D09XIZ DRUGSMIL CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO D09XIZ HIGHSTAT Phase 2 D09XUY DRUG__ID D09XUY D09XUY THERCLAS Antifungal Agents D09XUY DRUGTYPE Small molecular drug D09XUY DRUGINCH 1S/C7H11NO2/c1-4-2-5(7(9)10)6(8)3-4/h5-6H,1-3,8H2,(H,9,10)/t5-,6+/m1/s1 D09XUY DRUGINKE RKOUGZGFAYMUIO-RITPCOANSA-N D09XUY DRUGSMIL C=C1CC(C(C1)N)C(=O)O D09XUY HIGHSTAT Phase 2 D09YDQ DRUG__ID D09YDQ D09YDQ DRUGCOMP Merck Research Laboratories D09YDQ DRUGTYPE Small molecular drug D09YDQ DRUGINCH 1S/C18H10FN3S/c1-12-22-17(11-23-12)4-2-13-3-5-18(21-10-13)15-6-14(9-20)7-16(19)8-15/h3,5-8,10-11H,1H3 D09YDQ DRUGINKE SYOSUEIMOYEGKU-UHFFFAOYSA-N D09YDQ DRUGSMIL CC1=NC(=CS1)C#CC2=CN=C(C=C2)C3=CC(=CC(=C3)C#N)F D09YDQ HIGHSTAT Phase 2 D09ZKS DRUG__ID D09ZKS D09ZKS DRUGCOMP LION bioscience Inc D09ZKS DRUGTYPE Small molecular drug D09ZKS DRUGINCH 1S/C47H65N15O9/c1-3-4-14-33(57-27(2)63)42(67)59-35(17-18-39(48)64)44(69)62-38(22-30-24-52-26-56-30)46(71)60-36(20-28-11-6-5-7-12-28)45(70)58-34(16-10-19-53-47(50)51)43(68)61-37(41(66)55-25-40(49)65)21-29-23-54-32-15-9-8-13-31(29)32/h5-9,11-13,15,23-24,26,33-38,54H,3-4,10,14,16-22,25H2,1-2H3,(H2,48,64)(H2,49,65)(H,52,56)(H,55,66)(H,57,63)(H,58,70)(H,59,67)(H,60,71)(H,61,68)(H,62,69)(H4,50,51,53)/t33-,34-,35-,36+,37+,38-/m0/s1 D09ZKS DRUGINKE UHKZNDVUBSEJJO-XAYNKGEHSA-N D09ZKS DRUGSMIL CCCCC(C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)N)NC(=O)C D09ZKS HIGHSTAT Phase 2 D09ZSY DRUG__ID D09ZSY D09ZSY DRUGCOMP Parke-Davis & Co Ltd D09ZSY DRUGTYPE Small molecular drug D09ZSY DRUGINCH 1S/C14H12N2O2S2/c15-13(17)9-5-1-3-7-11(9)19-20-12-8-4-2-6-10(12)14(16)18/h1-8H,(H2,15,17)(H2,16,18) D09ZSY DRUGINKE OEEHSSKRJOGQMP-UHFFFAOYSA-N D09ZSY DRUGSMIL C1=CC=C(C(=C1)C(=O)N)SSC2=CC=CC=C2C(=O)N D09ZSY HIGHSTAT Phase 2 D09ZWH DRUG__ID D09ZWH D09ZWH DRUGCOMP Lexicon Pharmaceuticals D09ZWH DRUGTYPE Small molecular drug D09ZWH DRUGINCH 1S/C9H15N3O5/c1-4(12-17)9-10-2-5(11-9)7(15)8(16)6(14)3-13/h2,6-8,13-17H,3H2,1H3,(H,10,11)/b12-4+/t6-,7-,8-/m1/s1 D09ZWH DRUGINKE AMXVYJYMZLDINS-RSWLNLDNSA-N D09ZWH DRUGSMIL CC(=NO)C1=NC=C(N1)C(C(C(CO)O)O)O D09ZWH HIGHSTAT Phase 2 D09ZZW DRUG__ID D09ZZW D09ZZW DRUGCOMP Vertex D09ZZW DRUGTYPE Small molecular drug D09ZZW DRUGINCH 1S/C22H27NO3S/c1-14(2)23(21(24)17-11-9-15(3)10-12-17)18-13-19(27-20(18)22(25)26)16-7-5-4-6-8-16/h4-8,13-15,17H,9-12H2,1-3H3,(H,25,26) D09ZZW DRUGINKE RZXQBIKGWSLVEK-UHFFFAOYSA-N D09ZZW DRUGSMIL CC1CCC(CC1)C(=O)N(C2=C(SC(=C2)C3=CC=CC=C3)C(=O)O)C(C)C D09ZZW HIGHSTAT Phase 2 D0A1RP DRUG__ID D0A1RP D0A1RP DRUGCOMP Merck D0A1RP DRUGTYPE Small molecular drug D0A1RP DRUGINCH 1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/i11-1 D0A1RP DRUGINKE UXCAQJAQSWSNPQ-KXMUYVCJSA-N D0A1RP DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F D0A1RP HIGHSTAT Phase 2 D0A1WN DRUG__ID D0A1WN D0A1WN DRUGCOMP Pfizer D0A1WN DRUGTYPE Small molecular drug D0A1WN DRUGINCH 1S/C35H34ClN7O3S2/c1-35(2,3)30-19-32(43(41-30)23-12-14-27(45)26(36)18-23)38-34(46)37-20-22-8-4-6-10-28(22)48-24-13-15-31-39-40-33(42(31)21-24)25-9-5-7-11-29(25)47-17-16-44/h4-15,18-19,21,44-45H,16-17,20H2,1-3H3,(H2,37,38,46) D0A1WN DRUGINKE VGEXRDWWPSGZDH-UHFFFAOYSA-N D0A1WN DRUGSMIL CC(C)(C)C1=NN(C(=C1)NC(=O)NCC2=CC=CC=C2SC3=CN4C(=NN=C4C5=CC=CC=C5SCCO)C=C3)C6=CC(=C(C=C6)O)Cl D0A1WN HIGHSTAT Phase 2 D0A3ES DRUG__ID D0A3ES D0A3ES DRUGCOMP Orexo AB D0A3ES DRUGTYPE Small molecular drug D0A3ES DRUGINCH 1S/C21H32N6O3.ClH/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26;/h6-10H,4-5,11-17H2,1-3H3;1H D0A3ES DRUGINKE AQORHZJDCHLLJN-UHFFFAOYSA-N D0A3ES DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC.Cl D0A3ES HIGHSTAT Phase 2 D0A5EF DRUG__ID D0A5EF D0A5EF DRUGCOMP GSK D0A5EF DRUGTYPE Small molecular drug D0A5EF DRUGINCH 1S/C23H23ClN2O3/c24-20-8-2-6-18(13-20)22(27)15-25-10-11-26-21-9-3-5-17(14-21)16-4-1-7-19(12-16)23(28)29/h1-9,12-14,22,25-27H,10-11,15H2,(H,28,29)/t22-/m0/s1 D0A5EF DRUGINKE LLDXOPKUNJTIRF-QFIPXVFZSA-N D0A5EF DRUGSMIL C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNCC(C3=CC(=CC=C3)Cl)O D0A5EF HIGHSTAT Phase 2 D0A5SA DRUG__ID D0A5SA D0A5SA DRUGCOMP Takeda D0A5SA DRUGTYPE Small molecular drug D0A5SA DRUGINCH 1S/C27H41N5O4.ClH/c1-20(2)19-32(22-16-21(17-28-18-22)26(33)30-11-14-36-15-12-30)27(34)25-29-23-8-4-5-9-24(23)31(25)10-6-7-13-35-3;/h4-5,8-9,20-22,28H,6-7,10-19H2,1-3H3;1H/t21-,22+;/m1./s1 D0A5SA DRUGINKE PUXOYQIZZIWCHH-NSLUPJTDSA-N D0A5SA DRUGSMIL CC(C)CN(C1CC(CNC1)C(=O)N2CCOCC2)C(=O)C3=NC4=CC=CC=C4N3CCCCOC.Cl D0A5SA HIGHSTAT Phase 2 D0A5SR DRUG__ID D0A5SR D0A5SR DRUGCOMP MSD Japan D0A5SR DRUGTYPE Small molecular drug D0A5SR DRUGINCH 1S/C18H29N3O5S.ClH.H2O/c1-8-14-13(9(2)22)17(24)21(14)15(18(25)26)16(8)27-10-6-11(20-7-10)12(23)4-5-19-3;;/h8-14,19-20,22-23H,4-7H2,1-3H3,(H,25,26);1H;1H2/t8-,9-,10+,11+,12-,13-,14-;;/m1../s1 D0A5SR DRUGINKE FNSICOGCVDQJPU-HCRFUVGVSA-N D0A5SR DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(CCNC)O)C(=O)O)C(C)O.O.Cl D0A5SR HIGHSTAT Phase 2 D0A7JH DRUG__ID D0A7JH D0A7JH DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D0A7JH DRUGTYPE Small molecular drug D0A7JH DRUGINCH 1S/C23H19NO3.C4H11NO3/c1-15(23(25)26)17-6-7-19-13-21(11-9-18(19)12-17)27-14-20-10-8-16-4-2-3-5-22(16)24-20;5-4(1-6,2-7)3-8/h2-13,15H,14H2,1H3,(H,25,26);6-8H,1-3,5H2/t15-;/m0./s1 D0A7JH DRUGINKE FKKBZYRUPFNJJC-RSAXXLAASA-N D0A7JH DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O.C(C(CO)(CO)N)O D0A7JH HIGHSTAT Phase 2 D0A8JM DRUG__ID D0A8JM D0A8JM DRUGCOMP Genzyme D0A8JM DRUGTYPE Small molecular drug D0A8JM DRUGINCH 1S/C59H105N17O11/c1-7-13-22-40(51(81)68-36-48(78)69-47(49(61)79)35-37-29-31-38(77)32-30-37)71-53(83)42(24-15-9-3)73-55(85)44(26-17-11-5)75-57(87)46(28-20-34-67-59(64)65)76-56(86)45(27-18-12-6)74-54(84)43(25-16-10-4)72-52(82)41(23-14-8-2)70-50(80)39(60)21-19-33-66-58(62)63/h29-32,39-47,77H,7-28,33-36,60H2,1-6H3,(H2,61,79)(H,68,81)(H,69,78)(H,70,80)(H,71,83)(H,72,82)(H,73,85)(H,74,84)(H,75,87)(H,76,86)(H4,62,63,66)(H4,64,65,67)/t39-,40-,41-,42-,43-,44-,45-,46-,47-/m1/s1 D0A8JM DRUGINKE SFGFYNXPJMOUHK-PKAFTLKUSA-N D0A8JM DRUGSMIL CCCCC(C(=O)NC(CCCC)C(=O)NC(CCCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCC)C(=O)NC(CCCC)C(=O)NC(CCCC)C(=O)NCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CCCN=C(N)N)N D0A8JM HIGHSTAT Phase 2 D0A9IY DRUG__ID D0A9IY D0A9IY DRUGCOMP Pfizer Inc D0A9IY DRUGTYPE Small molecular drug D0A9IY DRUGINCH 1S/C20H25N7O2/c1-13-10-26(12-17-21-5-2-6-22-17)11-16(13)18-24-19-15(20(28)25-18)9-23-27(19)14-3-7-29-8-4-14/h2,5-6,9,13-14,16H,3-4,7-8,10-12H2,1H3,(H,24,25,28)/t13-,16-/m1/s1 D0A9IY DRUGINKE IWXUVYOOUMLUTQ-CZUORRHYSA-N D0A9IY DRUGSMIL CC1CN(CC1C2=NC3=C(C=NN3C4CCOCC4)C(=O)N2)CC5=NC=CC=N5 D0A9IY HIGHSTAT Phase 2 D0AA6Z DRUG__ID D0AA6Z D0AA6Z DRUGCOMP Barrier D0AA6Z DRUGTYPE Small molecular drug D0AA6Z DRUGINCH 1S/C21H23N5S/c1-3-15(4-2)20(26-14-22-13-23-26)16-9-11-17(12-10-16)24-21-25-18-7-5-6-8-19(18)27-21/h5-15,20H,3-4H2,1-2H3,(H,24,25) D0AA6Z DRUGINKE SNFYYXUGUBUECJ-UHFFFAOYSA-N D0AA6Z DRUGSMIL CCC(CC)C(C1=CC=C(C=C1)NC2=NC3=CC=CC=C3S2)N4C=NC=N4 D0AA6Z HIGHSTAT Phase 2 D0AA8R DRUG__ID D0AA8R D0AA8R DRUGCOMP 3M Pharmaceuticals D0AA8R DRUGTYPE Small molecular drug D0AA8R DRUGINCH 1S/C14H17N5/c1-8(2)7-19-9(3)17-12-13(19)11-10(18-14(12)15)5-4-6-16-11/h4-6,8H,7H2,1-3H3,(H2,15,18) D0AA8R DRUGINKE ZXBCLVSLRUWISJ-UHFFFAOYSA-N D0AA8R DRUGSMIL CC1=NC2=C(N1CC(C)C)C3=C(C=CC=N3)N=C2N D0AA8R HIGHSTAT Phase 2 D0AE5K DRUG__ID D0AE5K D0AE5K DRUGCOMP Lipoxen plc D0AE5K DRUGTYPE Peptide D0AE5K DRUGINCH 1S/C192H295N59O60S/c1-15-93(8)150(185(306)218-95(10)189(310)311)249-178(299)129(77-143(202)266)238-172(293)128(76-142(201)265)236-161(282)110(39-24-27-60-193)222-171(292)127(75-141(200)264)235-162(283)115(44-32-65-213-192(208)209)221-158(279)112(41-26-29-62-195)227-187(308)152(97(12)257)251-179(300)130(78-144(203)267)237-165(286)119(59-66-312-14)226-166(287)120(67-90(2)3)230-170(291)126(73-103-82-214-109-38-23-22-37-107(103)109)234-164(285)118(55-58-140(199)263)228-184(305)149(92(6)7)248-176(297)124(69-99-33-18-16-19-34-99)233-173(294)131(79-146(269)270)239-163(284)117(54-57-139(198)262)219-154(275)94(9)217-157(278)113(42-30-63-211-190(204)205)220-159(280)114(43-31-64-212-191(206)207)224-182(303)136(87-254)245-175(296)133(81-148(273)274)240-167(288)121(68-91(4)5)229-168(289)122(71-101-45-49-105(259)50-46-101)231-160(281)111(40-25-28-61-194)223-181(302)135(86-253)244-169(290)123(72-102-47-51-106(260)52-48-102)232-174(295)132(80-147(271)272)241-183(304)137(88-255)246-188(309)153(98(13)258)250-177(298)125(70-100-35-20-17-21-36-100)242-186(307)151(96(11)256)247-145(268)84-215-156(277)116(53-56-138(197)261)225-180(301)134(85-252)243-155(276)108(196)74-104-83-210-89-216-104/h16-23,33-38,45-52,82-83,89-98,108,110-137,149-153,214,252-260H,15,24-32,39-44,53-81,84-88,193-196H2,1-14H3,(H2,197,261)(H2,198,262)(H2,199,263)(H2,200,264)(H2,201,265)(H2,202,266)(H2,203,267)(H,210,216)(H,215,277)(H,217,278)(H,218,306)(H,219,275)(H,220,280)(H,221,279)(H,222,292)(H,223,302)(H,224,303)(H,225,301)(H,226,287)(H,227,308)(H,228,305)(H,229,289)(H,230,291)(H,231,281)(H,232,295)(H,233,294)(H,234,285)(H,235,283)(H,236,282)(H,237,286)(H,238,293)(H,239,284)(H,240,288)(H,241,304)(H,242,307)(H,243,276)(H,244,290)(H,245,296)(H,246,309)(H,247,268)(H,248,297)(H,249,299)(H,250,298)(H,251,300)(H,269,270)(H,271,272)(H,273,274)(H,310,311)(H4,204,205,211)(H4,206,207,212)(H4,208,209,213)/t93-,94-,95-,96+,97+,98+,108-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,149-,150-,151-,152-,153-/m0/s1 D0AE5K DRUGINKE PXZWGQLGAKCNKD-DPNMSELWSA-N D0AE5K DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N D0AE5K HIGHSTAT Phase 2 D0AW5T DRUG__ID D0AW5T D0AW5T DRUGCOMP Oncothyreon D0AW5T DRUGTYPE Small molecular drug D0AW5T DRUGINCH 1S/C29H35NO8/c1-7-11-30(12-8-2)14-17-23-26(34)25(33)22-18-9-10-20(32)28(18,4)13-19(37-16(3)31)24(22)29(23,5)21(15-36-6)38-27(17)35/h7-8,14,18-19,21,34H,1-2,9-13,15H2,3-6H3/b17-14+/t18-,19+,21+,28-,29-/m0/s1 D0AW5T DRUGINKE QIUASFSNWYMDFS-NILGECQDSA-N D0AW5T DRUGSMIL CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C(=CN(CC=C)CC=C)C4=C(C3=O)O)COC)C)C D0AW5T HIGHSTAT Phase 2 D0B2WK DRUG__ID D0B2WK D0B2WK DRUGCOMP Bristol-Myers Squibb D0B2WK DRUGTYPE Small molecular drug D0B2WK DRUGINCH 1S/C25H32N2O5.Na/c1-2-3-6-13-26-24(30)19-15-31-25(27-19)23-18(20-10-11-21(23)32-20)14-17-8-5-4-7-16(17)9-12-22(28)29;/h4-5,7-8,15,18,20-21,23H,2-3,6,9-14H2,1H3,(H,26,30)(H,28,29);/q;+1/p-1/t18-,20-,21+,23-;/m0./s1 D0B2WK DRUGINKE WOHSQDNIXPEQAE-QBKVZTCDSA-M D0B2WK DRUGSMIL CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)[O-])O3.[Na+] D0B2WK HIGHSTAT Phase 2 D0B3ZF DRUG__ID D0B3ZF D0B3ZF DRUGCOMP Orion Corp D0B3ZF DRUGTYPE Small molecular drug D0B3ZF DRUGINCH 1S/C18H23NO2/c1-18(12-20-2)9-5-10-19-11-8-14-13-6-3-4-7-15(13)21-16(14)17(18)19/h3-4,6-7,17H,5,8-12H2,1-2H3/t17-,18-/m1/s1 D0B3ZF DRUGINKE OCUKPFWNSAAHRP-QZTJIDSGSA-N D0B3ZF DRUGSMIL CC1(CCCN2C1C3=C(CC2)C4=CC=CC=C4O3)COC D0B3ZF HIGHSTAT Phase 2 D0B5RO DRUG__ID D0B5RO D0B5RO DRUGCOMP Centaur Pharmaceuticals Inc D0B5RO DRUGTYPE Small molecular drug D0B5RO DRUGINCH 1S/C13H18N2O2/c1-9(16)14-11-7-5-10(6-8-11)12(17)15-13(2,3)4/h5-8H,1-4H3,(H,14,16)(H,15,17) D0B5RO DRUGINKE DJKNRCWSXSZACF-UHFFFAOYSA-N D0B5RO DRUGSMIL CC(=O)NC1=CC=C(C=C1)C(=O)NC(C)(C)C D0B5RO HIGHSTAT Phase 2 D0B6YB DRUG__ID D0B6YB D0B6YB DRUGCOMP NeoPharm D0B6YB DRUGTYPE Small molecular drug D0B6YB DRUGINCH 1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1 D0B6YB DRUGINKE FJHBVJOVLFPMQE-QFIPXVFZSA-N D0B6YB DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)O D0B6YB HIGHSTAT Phase 2 D0B7CH DRUG__ID D0B7CH D0B7CH DRUGCOMP Scandinavian D0B7CH DRUGTYPE Small molecular drug D0B7CH DRUGINCH 1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12) D0B7CH DRUGINKE OBKXEAXTFZPCHS-UHFFFAOYSA-N D0B7CH DRUGSMIL C1=CC=C(C=C1)CCCC(=O)O D0B7CH HIGHSTAT Phase 2 D0B9OG DRUG__ID D0B9OG D0B9OG DRUGCOMP Neurogen Corporation D0B9OG DRUGTYPE Small molecular drug D0B9OG DRUGINCH 1S/C18H18FN7/c1-3-5-13-15(22-11-26-17(13)23-12(2)24-26)10-25-9-8-21-18(25)16-14(19)6-4-7-20-16/h4,6-9,11H,3,5,10H2,1-2H3 D0B9OG DRUGINKE UAMAIHOEGLEXSV-UHFFFAOYSA-N D0B9OG DRUGSMIL CCCC1=C(N=CN2C1=NC(=N2)C)CN3C=CN=C3C4=C(C=CC=N4)F D0B9OG HIGHSTAT Phase 2 D0BA5K DRUG__ID D0BA5K D0BA5K DRUGCOMP Boehringer Ingelheim Corp D0BA5K DRUGTYPE Small molecular drug D0BA5K DRUGINCH 1S/C16H22N4O3/c1-3-7-19-14-12(15(22)20(8-4-2)16(19)23)17-13(18-14)10-5-6-11(21)9-10/h10H,3-9H2,1-2H3,(H,17,18)/t10-/m0/s1 D0BA5K DRUGINKE RUHGOZFOVBMWOO-JTQLQIEISA-N D0BA5K DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CCC(=O)C3 D0BA5K HIGHSTAT Phase 2 D0BM7M DRUG__ID D0BM7M D0BM7M DRUGCOMP AstraZeneca D0BM7M DRUGTYPE Small molecular drug D0BM7M DRUGINCH 1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29) D0BM7M DRUGINKE DFJSJLGUIXFDJP-UHFFFAOYSA-N D0BM7M DRUGSMIL CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC D0BM7M HIGHSTAT Phase 2 D0BW4W DRUG__ID D0BW4W D0BW4W DRUGCOMP Sequella D0BW4W DRUGTYPE Small molecular drug D0BW4W DRUGINCH 1S/C16H20FN3O3S/c1-11(21)18-9-13-10-20(16(22)23-13)12-2-3-15(14(17)8-12)19-4-6-24-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 D0BW4W DRUGINKE FNDDDNOJWPQCBZ-ZDUSSCGKSA-N D0BW4W DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCSCC3)F D0BW4W HIGHSTAT Phase 2 D0C2AR DRUG__ID D0C2AR D0C2AR DRUGCOMP Bracco SpA D0C2AR DRUGTYPE Small molecular drug D0C2AR DRUGINCH 1S/C41H66N4O14.Gd/c1-24(4-11-34(48)49)28-7-8-29-27-6-5-25-18-26(12-13-40(25,2)30(27)19-32(46)41(28,29)3)42-33(47)10-9-31(39(58)59)45(16-14-43(20-35(50)51)21-36(52)53)17-15-44(22-37(54)55)23-38(56)57;/h24-32,46H,4-23H2,1-3H3,(H,42,47)(H,48,49)(H,50,51)(H,52,53)(H,54,55)(H,56,57)(H,58,59);/q;+3/p-3/t24-,25-,26+,27+,28-,29+,30+,31+,32+,40+,41-;/m1./s1 D0C2AR DRUGINKE FKRQJRDGWNLYFA-CFIJWHLBSA-K D0C2AR DRUGSMIL [H+].[H+].[H+].CC(CCC(=O)[O-])C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)NC(=O)CCC(C(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-])C)O)C.[Gd+3] D0C2AR HIGHSTAT Phase 2 D0C2KF DRUG__ID D0C2KF D0C2KF DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0C2KF DRUGTYPE Small molecular drug D0C2KF DRUGINCH 1S/C9H11ClN2O4S/c10-6-1-2-8-9(3-6)15-5-7(16-8)4-12-17(11,13)14/h1-3,7,12H,4-5H2,(H2,11,13,14)/t7-/m0/s1 D0C2KF DRUGINKE KXSAIQPPGSSNKX-ZETCQYMHSA-N D0C2KF DRUGSMIL C1C(OC2=C(O1)C=C(C=C2)Cl)CNS(=O)(=O)N D0C2KF HIGHSTAT Phase 2 D0C3UC DRUG__ID D0C3UC D0C3UC DRUGCOMP Hebrew University of Jerusalem D0C3UC DRUGTYPE Small molecular drug D0C3UC DRUGINCH 1S/C16H20N2O2/c1-4-10-17-15-9-7-12-6-8-13(11-14(12)15)20-16(19)18(3)5-2/h1,6,8,11,15,17H,5,7,9-10H2,2-3H3/t15-/m1/s1 D0C3UC DRUGINKE LHXOCOHMBFOVJS-OAHLLOKOSA-N D0C3UC DRUGSMIL CCN(C)C(=O)OC1=CC2=C(CCC2NCC#C)C=C1 D0C3UC HIGHSTAT Phase 2 D0C5VQ DRUG__ID D0C5VQ D0C5VQ THERCLAS Anticancer Agents D0C5VQ DRUGTYPE Small molecular drug D0C5VQ DRUGINCH 1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23-,24-,25+/m0/s1 D0C5VQ DRUGINKE SEBFKMXJBCUCAI-WAABAYLZSA-N D0C5VQ DRUGSMIL COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O D0C5VQ HIGHSTAT Phase 2 D0C8KF DRUG__ID D0C8KF D0C8KF DRUGCOMP 3M Pharma. D0C8KF DRUGTYPE Small molecular drug D0C8KF DRUGINCH 1S/C17H22N4O2/c1-4-23-9-13-20-14-15(21(13)10-17(2,3)22)11-7-5-6-8-12(11)19-16(14)18/h5-8,22H,4,9-10H2,1-3H3,(H2,18,19) D0C8KF DRUGINKE BXNMTOQRYBFHNZ-UHFFFAOYSA-N D0C8KF DRUGSMIL CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N D0C8KF HIGHSTAT Phase 2 D0C8PE DRUG__ID D0C8PE D0C8PE DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D0C8PE DRUGTYPE Small molecular drug D0C8PE DRUGINCH 1S/C17H17F5N4/c18-13-2-1-11(9-14(13)19)10-26-7-5-12(6-8-26)23-16-4-3-15(24-25-16)17(20,21)22/h1-4,9,12H,5-8,10H2,(H,23,25) D0C8PE DRUGINKE UVUYWJWYRLJHEN-UHFFFAOYSA-N D0C8PE DRUGSMIL C1CN(CCC1NC2=NN=C(C=C2)C(F)(F)F)CC3=CC(=C(C=C3)F)F D0C8PE HIGHSTAT Phase 2 D0C9NJ DRUG__ID D0C9NJ D0C9NJ DRUGCOMP Synta Pharma D0C9NJ DRUGTYPE Small molecular drug D0C9NJ DRUGINCH 1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+ D0C9NJ DRUGINKE HSKAZIJJKRAJAV-KOEQRZSOSA-N D0C9NJ DRUGSMIL CC1=CC(=CC=C1)C=NNC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4 D0C9NJ HIGHSTAT Phase 2 D0C9XA DRUG__ID D0C9XA D0C9XA DRUGCOMP GSK; Tanabe D0C9XA DRUGTYPE Small molecular drug D0C9XA DRUGINCH 1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7) D0C9XA DRUGINKE BTCSSZJGUNDROE-UHFFFAOYSA-N D0C9XA DRUGSMIL C(CC(=O)O)CN D0C9XA HIGHSTAT Phase 2 D0CS2C DRUG__ID D0CS2C D0CS2C DRUGCOMP AstraZeneca D0CS2C DRUGTYPE Small molecular drug D0CS2C DRUGINCH 1S/C24H35ClN2O2/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29) D0CS2C DRUGINKE HSQAARMBHJCUOK-UHFFFAOYSA-N D0CS2C DRUGSMIL C1C2CC3CC1CC(C2)(C3)CNC(=O)C4=C(C=CC(=C4)CCCNCCCO)Cl D0CS2C HIGHSTAT Phase 2 D0D1EV DRUG__ID D0D1EV D0D1EV DRUGCOMP National Cancer Institute D0D1EV DRUGTYPE Small molecular drug D0D1EV DRUGINCH 1S/C6H11ClN4O3/c1-10(4-5(8)12)6(13)11(9-14)3-2-7/h2-4H2,1H3,(H2,8,12) D0D1EV DRUGINKE HYHJFNXFVPGMBI-UHFFFAOYSA-N D0D1EV DRUGSMIL CN(CC(=O)N)C(=O)N(CCCl)N=O D0D1EV HIGHSTAT Phase 2 D0D1LS DRUG__ID D0D1LS D0D1LS DRUGCOMP City of Hope D0D1LS DRUGTYPE Small molecular drug D0D1LS DRUGINCH 1S/C9H12FN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1 D0D1LS DRUGINKE IDYKCXHJJGMAEV-RRKCRQDMSA-N D0D1LS DRUGSMIL C1C(C(OC1N2C=C(C(=NC2=O)N)F)CO)O D0D1LS HIGHSTAT Phase 2 D0D3AI DRUG__ID D0D3AI D0D3AI DRUGCOMP Registry Operator D0D3AI DRUGTYPE Small molecular drug D0D3AI DRUGINCH 1S/C7H15N5O4/c1-16-6(13)5(8)3-2-4-10-7(9)11-12(14)15/h5H,2-4,8H2,1H3,(H3,9,10,11)/t5-/m0/s1 D0D3AI DRUGINKE KCWZGJVSDFYRIX-YFKPBYRVSA-N D0D3AI DRUGSMIL COC(=O)C(CCCN=C(N)N[N+](=O)[O-])N D0D3AI HIGHSTAT Phase 2 D0D4CX DRUG__ID D0D4CX D0D4CX DRUGCOMP Enzon Pharmaceuticals Inc D0D4CX DRUGTYPE Small molecular drug D0D4CX DRUGINCH 1S/C52H48N6O14/c1-5-51(35-19-39-43-31(17-29-11-7-9-13-37(29)55-43)21-57(39)45(61)33(35)23-69-49(51)65)71-47(63)27(3)53-41(59)25-67-15-16-68-26-42(60)54-28(4)48(64)72-52(6-2)36-20-40-44-32(18-30-12-8-10-14-38(30)56-44)22-58(40)46(62)34(36)24-70-50(52)66/h7-14,17-20,27-28H,5-6,15-16,21-26H2,1-4H3,(H,53,59)(H,54,60)/t27-,28-,51-,52-/m0/s1 D0D4CX DRUGINKE DZNNFZGDBUXWMV-ZUWDIFAMSA-N D0D4CX DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C(C)NC(=O)COCCOCC(=O)NC(C)C(=O)OC6(C7=C(COC6=O)C(=O)N8CC9=CC1=CC=CC=C1N=C9C8=C7)CC D0D4CX HIGHSTAT Phase 2 D0D4JI DRUG__ID D0D4JI D0D4JI DRUGCOMP Sanofi-aventis; Sanofi-Synthelabo D0D4JI DRUGTYPE Small molecular drug D0D4JI DRUGINCH 1S/C23H34ClN.ClH/c1-2-25(21-13-7-4-8-14-21)17-9-10-19-15-16-22(23(24)18-19)20-11-5-3-6-12-20;/h9-10,15-16,18,20-21H,2-8,11-14,17H2,1H3;1H/b10-9-; D0D4JI DRUGINKE HKHPCMBPASXYGP-KVVVOXFISA-N D0D4JI DRUGSMIL CCN(CC=CC1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3.Cl D0D4JI HIGHSTAT Phase 2 D0D4VV DRUG__ID D0D4VV D0D4VV DRUGCOMP Lilly D0D4VV DRUGTYPE Small molecular drug D0D4VV DRUGINCH 1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+/t13-/m1/s1 D0D4VV DRUGINKE GKJCVYLDJWTWQU-CXLRFSCWSA-N D0D4VV DRUGSMIL CC(C1=C(C=NC=C1Cl)Cl)OC2=CC3=C(C=C2)NN=C3C=CC4=CN(N=C4)CCO D0D4VV HIGHSTAT Phase 2 D0D4ZW DRUG__ID D0D4ZW D0D4ZW DRUGCOMP Enzo Biochem Inc D0D4ZW DRUGTYPE Small molecular drug D0D4ZW DRUGINCH 1S/C48H93NO8/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(40-56-48-47(55)46(54)45(53)43(39-50)57-48)42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h35,37,41-43,45-48,50-51,53-55H,3-34,36,38-40H2,1-2H3,(H,49,52)/b37-35+/t41-,42+,43+,45+,46-,47+,48+/m0/s1 D0D4ZW DRUGINKE POQRWMRXUOPCLD-GZXCKHLVSA-N D0D4ZW DRUGSMIL CCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O D0D4ZW HIGHSTAT Phase 2 D0D5CY DRUG__ID D0D5CY D0D5CY DRUGCOMP Metabasis Therapeutics Inc D0D5CY DRUGTYPE Small molecular drug D0D5CY DRUGINCH 1S/C17H19ClN5O4P/c18-13-3-1-2-12(8-13)14-4-6-26-28(24,27-14)11-25-7-5-23-10-22-15-16(19)20-9-21-17(15)23/h1-3,8-10,14H,4-7,11H2,(H2,19,20,21)/t14-,28+/m0/s1 D0D5CY DRUGINKE GWNHAOBXDGOXRR-HJFSHJIFSA-N D0D5CY DRUGSMIL C1COP(=O)(OC1C2=CC(=CC=C2)Cl)COCCN3C=NC4=C(N=CN=C43)N D0D5CY HIGHSTAT Phase 2 D0D5VJ DRUG__ID D0D5VJ D0D5VJ DRUGCOMP Pfizer Inc D0D5VJ DRUGTYPE Small molecular drug D0D5VJ DRUGINCH 1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1 D0D5VJ DRUGINKE ZOTHAEBAWXWVID-HXEFRTELSA-N D0D5VJ DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)C(=O)NCCNC(=O)NC4CCN(CC4)C5=CC=CC=N5)NCC(C6=CC=CC=C6)C7=CC=CC=C7)O)O D0D5VJ HIGHSTAT Phase 2 D0D5ZV DRUG__ID D0D5ZV D0D5ZV DRUGCOMP Millennium Pharmaceuticals D0D5ZV DRUGTYPE Small molecular drug D0D5ZV DRUGINCH 1S/C31H37ClN2O8S/c1-34(36)31(35)33-18-21-14-19(15-26(37-2)29(21)41-12-13-43-23-8-6-22(32)7-9-23)24-10-11-25(42-24)20-16-27(38-3)30(40-5)28(17-20)39-4/h6-9,14-17,24-25,36H,10-13,18H2,1-5H3,(H,33,35)/t24-,25-/m0/s1 D0D5ZV DRUGINKE LZVBMKDVEPGGFK-DQEYMECFSA-N D0D5ZV DRUGSMIL CN(C(=O)NCC1=C(C(=CC(=C1)C2CCC(O2)C3=CC(=C(C(=C3)OC)OC)OC)OC)OCCSC4=CC=C(C=C4)Cl)O D0D5ZV HIGHSTAT Phase 2 D0D6SZ DRUG__ID D0D6SZ D0D6SZ DRUGCOMP Shire Pharmaceuticals D0D6SZ DRUGTYPE Small molecular drug D0D6SZ DRUGINCH 1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1 D0D6SZ DRUGINKE RXRGZNYSEHTMHC-BQBZGAKWSA-N D0D6SZ DRUGSMIL C1C(OC(O1)CO)N2C=CC(=NC2=O)N D0D6SZ HIGHSTAT Phase 2 D0D8FN DRUG__ID D0D8FN D0D8FN DRUGCOMP Phase 2 Discovery D0D8FN DRUGTYPE Small molecular drug D0D8FN DRUGINCH 1S/C14H17ClN2O2/c1-8(6-16-9(2)18)11-7-17-13-5-12(15)14(19-3)4-10(11)13/h4-5,7-8,17H,6H2,1-3H3,(H,16,18)/t8-/m0/s1 D0D8FN DRUGINKE RKHCTAKUYDTFHE-QMMMGPOBSA-N D0D8FN DRUGSMIL CC(CNC(=O)C)C1=CNC2=CC(=C(C=C21)OC)Cl D0D8FN HIGHSTAT Phase 2 D0D8JB DRUG__ID D0D8JB D0D8JB DRUGCOMP Pfizer New York, NY D0D8JB DRUGTYPE Small molecular drug D0D8JB DRUGINCH 1S/C32H41N9O4/c1-38(2)27-11-13-39(14-12-27)29(42)24-5-9-26(10-6-24)34-32(43)33-25-7-3-23(4-8-25)28-35-30(40-15-19-44-20-16-40)37-31(36-28)41-17-21-45-22-18-41/h3-10,27H,11-22H2,1-2H3,(H2,33,34,43) D0D8JB DRUGINKE DWZAEMINVBZMHQ-UHFFFAOYSA-N D0D8JB DRUGSMIL CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6 D0D8JB HIGHSTAT Phase 2 D0D8TE DRUG__ID D0D8TE D0D8TE DRUGCOMP FerroKin BioSciences Inc D0D8TE DRUGTYPE Small molecular drug D0D8TE DRUGINCH 1S/C18H25NO7S/c1-18(17(21)22)12-27-16(19-18)13-4-3-5-14(15(13)20)26-11-10-25-9-8-24-7-6-23-2/h3-5,20H,6-12H2,1-2H3,(H,21,22)/t18-/m1/s1 D0D8TE DRUGINKE AWHIMFSHNAAMBM-GOSISDBHSA-N D0D8TE DRUGSMIL CC1(CSC(=N1)C2=C(C(=CC=C2)OCCOCCOCCOC)O)C(=O)O D0D8TE HIGHSTAT Phase 2 D0DD8T DRUG__ID D0DD8T D0DD8T THERCLAS Antiviral Agents D0DD8T DRUGTYPE Small molecular drug D0DD8T DRUGINCH 1S/C21H19N3O4/c1-26-17-8-12(9-18(27-2)20(17)28-3)19(25)16-11-23-21(24-16)14-10-22-15-7-5-4-6-13(14)15/h4-11,22H,1-3H3,(H,23,24) D0DD8T DRUGINKE WQGVHOVEXMOLOK-UHFFFAOYSA-N D0DD8T DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)C2=CN=C(N2)C3=CNC4=CC=CC=C43 D0DD8T HIGHSTAT Phase 2 Trial D0DI8J DRUG__ID D0DI8J D0DI8J DRUGCOMP Bristol-Myers Squibb Co D0DI8J DRUGTYPE Small molecular drug D0DI8J DRUGINCH 1S/C43H59NO16/c1-21-24(57-35(50)28(47)31(38(3,4)5)44-36(51)59-39(6,7)8)19-43(53)33(58-34(49)23-16-14-13-15-17-23)30-41(11,32(48)29(56-22(2)45)27(21)40(43,9)10)25(46)18-26-42(30,20-55-26)60-37(52)54-12/h13-17,24-26,28-31,33,46-47,53H,18-20H2,1-12H3,(H,44,51)/t24-,25-,26+,28+,29+,30-,31+,33-,41+,42-,43+/m0/s1 D0DI8J DRUGINKE AHXICHPPXIGCBN-GPWPDEGDSA-N D0DI8J DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C(C)(C)C)NC(=O)OC(C)(C)C)O)O)OC(=O)C5=CC=CC=C5)(CO4)OC(=O)OC)O)C)OC(=O)C D0DI8J HIGHSTAT Phase 2 D0DJ4A DRUG__ID D0DJ4A D0DJ4A DRUGCOMP Poniard Pharmaceuticals Inc D0DJ4A DRUGTYPE Small molecular drug D0DJ4A DRUGINCH 1S/C29H37NO5/c1-18-9-7-13-22(31)15-16-25(32)35-29-23(14-8-10-18)27(33)20(3)19(2)26(29)24(30-28(29)34)17-21-11-5-4-6-12-21/h4-6,8,11-12,14-16,18-19,22-24,26-27,31,33H,3,7,9-10,13,17H2,1-2H3,(H,30,34)/b14-8+,16-15+/t18-,19-,22-,23+,24+,26+,27-,29-/m1/s1 D0DJ4A DRUGINKE GBOGMAARMMDZGR-TYHYBEHESA-N D0DJ4A DRUGSMIL CC1CCCC(C=CC(=O)OC23C(C=CC1)C(C(=C)C(C2C(NC3=O)CC4=CC=CC=C4)C)O)O D0DJ4A HIGHSTAT Phase 2 D0DK8X DRUG__ID D0DK8X D0DK8X DRUGCOMP Bristol-Myers Squibb D0DK8X DRUGTYPE Small molecular drug D0DK8X DRUGINCH 1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27) D0DK8X DRUGINKE JCINBYQJBYJGDM-UHFFFAOYSA-N D0DK8X DRUGSMIL CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6 D0DK8X HIGHSTAT Phase 2 D0DL8A DRUG__ID D0DL8A D0DL8A THERCLAS Antiviral Agents D0DL8A DRUGTYPE Small molecular drug D0DL8A DRUGINCH 1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 D0DL8A DRUGINKE AGOYDEPGAOXOCK-KCBOHYOISA-N D0DL8A DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O D0DL8A HIGHSTAT Phase 2 Trial D0DZ8U DRUG__ID D0DZ8U D0DZ8U THERCLAS Antiviral Agents D0DZ8U DRUGTYPE Small molecular drug D0DZ8U DRUGINCH 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11) D0DZ8U DRUGINKE GYDJEQRTZSCIOI-UHFFFAOYSA-N D0DZ8U DRUGSMIL C1CC(CCC1CN)C(=O)O D0DZ8U HIGHSTAT Phase 2 Trial D0E1WH DRUG__ID D0E1WH D0E1WH DRUGCOMP Eli Lilly & Co D0E1WH DRUGTYPE Small molecular drug D0E1WH DRUGINCH 1S/C28H37N3O3S3/c32-26(30-27-29-19-25(36-27)35-17-16-31-14-4-5-15-31)28(18-24(28)20-6-2-1-3-7-20)21-8-10-22(11-9-21)37(33,34)23-12-13-23/h8-11,19-20,23-24H,1-7,12-18H2,(H,29,30,32)/t24-,28-/m0/s1 D0E1WH DRUGINKE QIIVJLHCZUTGSD-CUBQBAPOSA-N D0E1WH DRUGSMIL C1CCC(CC1)C2CC2(C3=CC=C(C=C3)S(=O)(=O)C4CC4)C(=O)NC5=NC=C(S5)SCCN6CCCC6 D0E1WH HIGHSTAT Phase 2 D0E2JN DRUG__ID D0E2JN D0E2JN DRUGCOMP Kanebo D0E2JN DRUGTYPE Small molecular drug D0E2JN DRUGINCH 1S/C15H22ClN5/c1-10(2)21-14-9-12(17)11(16)8-13(14)18-15(21)20-6-4-19(3)5-7-20/h8-10H,4-7,17H2,1-3H3 D0E2JN DRUGINKE QEANRFDFBNUCJR-UHFFFAOYSA-N D0E2JN DRUGSMIL CC(C)N1C2=C(C=C(C(=C2)N)Cl)N=C1N3CCN(CC3)C D0E2JN HIGHSTAT Phase 2 D0E2WF DRUG__ID D0E2WF D0E2WF DRUGCOMP Organon D0E2WF DRUGTYPE Small molecular drug D0E2WF DRUGINCH 1S/C11H14N6/c12-10(13)8-3-1-2-7-6(8)4-5-9(7)16-17-11(14)15/h1-3H,4-5H2,(H3,12,13)(H4,14,15,17)/b16-9+ D0E2WF DRUGINKE CYPGNVSXMAUSJY-CXUHLZMHSA-N D0E2WF DRUGSMIL C1CC(=NN=C(N)N)C2=C1C(=CC=C2)C(=N)N D0E2WF HIGHSTAT Phase 2 D0E3EY DRUG__ID D0E3EY D0E3EY DRUGCOMP Spectrum D0E3EY DRUGTYPE Small molecular drug D0E3EY DRUGINCH 1S/C33H35NO13/c1-11-9-10-16-19-17(11)29(38)46-25-18-14(24(36)21(20(19)25)30(39)44-16)7-6-8-15(18)45-32-28(33(4,40)27(37)13(3)43-32)47-31-22(34)26(41-5)23(35)12(2)42-31/h6-10,12-13,22-23,26-28,31-32,35-37,40H,34H2,1-5H3/t12-,13-,22-,23+,26-,27+,28+,31-,32+,33+/m1/s1 D0E3EY DRUGINKE MGQRRMONVLMKJL-KWJIQSIXSA-N D0E3EY DRUGSMIL CC1C(C(C(C(O1)OC2C(OC(C(C2(C)O)O)C)OC3=CC=CC4=C3C5=C6C7=C(C=CC(=C7C(=O)O5)C)OC(=O)C6=C4O)N)OC)O D0E3EY HIGHSTAT Phase 2 D0E3LP DRUG__ID D0E3LP D0E3LP DRUGCOMP Elixir Pharmaceuticals Inc D0E3LP DRUGTYPE Small molecular drug D0E3LP DRUGINCH 1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17) D0E3LP DRUGINKE FUZYTVDVLBBXDL-UHFFFAOYSA-N D0E3LP DRUGSMIL C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N D0E3LP HIGHSTAT Phase 2 D0E5NY DRUG__ID D0E5NY D0E5NY DRUGCOMP AstraZeneca plc D0E5NY DRUGTYPE Small molecular drug D0E5NY DRUGINCH 1S/C20H29ClFN5O2/c1-20(2,3)27-7-6-23-17(13-27)18(28)25-8-10-26(11-9-25)19(29)24-14-4-5-15(21)16(22)12-14/h4-5,12,17,23H,6-11,13H2,1-3H3,(H,24,29)/t17-/m1/s1 D0E5NY DRUGINKE SRWQVWAIVQXPJY-QGZVFWFLSA-N D0E5NY DRUGSMIL CC(C)(C)N1CCNC(C1)C(=O)N2CCN(CC2)C(=O)NC3=CC(=C(C=C3)Cl)F D0E5NY HIGHSTAT Phase 2 D0E6SB DRUG__ID D0E6SB D0E6SB DRUGCOMP Hemaquest pharmaceuticals D0E6SB DRUGTYPE Small molecular drug D0E6SB DRUGINCH 1S/C6H12O2.Na/c1-4-6(2,3)5(7)8;/h4H2,1-3H3,(H,7,8);/q;+1/p-1 D0E6SB DRUGINKE OOPXYEYPPHJHSE-UHFFFAOYSA-M D0E6SB DRUGSMIL CCC(C)(C)C(=O)[O-].[Na+] D0E6SB HIGHSTAT Phase 2 D0E8HA DRUG__ID D0E8HA D0E8HA DRUGCOMP Toyama Chemical D0E8HA DRUGTYPE Small molecular drug D0E8HA DRUGINCH 1S/C16H21NO2S.C4H4O4/c18-15-11-17(12-15)6-1-7-19-8-4-13-2-3-16-14(10-13)5-9-20-16;5-3(6)1-2-4(7)8/h2-3,5,9-10,15,18H,1,4,6-8,11-12H2;1-2H,(H,5,6)(H,7,8)/b;2-1- D0E8HA DRUGINKE RLUCYBFCLXANSO-BTJKTKAUSA-N D0E8HA DRUGSMIL C1C(CN1CCCOCCC2=CC3=C(C=C2)SC=C3)O.C(=CC(=O)O)C(=O)O D0E8HA HIGHSTAT Phase 2 D0E8IZ DRUG__ID D0E8IZ D0E8IZ DRUGCOMP Upsher-smith laboratories D0E8IZ DRUGTYPE Small molecular drug D0E8IZ DRUGINCH 1S/C20H19ClFNO4/c1-10(24)11-5-7-16-13(8-11)17(18(25)20(2,3)27-16)23-19(26)12-4-6-15(22)14(21)9-12/h4-9,17-18,25H,1-3H3,(H,23,26)/t17-,18-/m0/s1 D0E8IZ DRUGINKE XLIIRNOPGJTBJD-ROUUACIJSA-N D0E8IZ DRUGSMIL CC(=O)C1=CC2=C(C=C1)OC(C(C2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C D0E8IZ HIGHSTAT Phase 2 D0E8NP DRUG__ID D0E8NP D0E8NP DRUGCOMP TetraLogic Pharmaceuticals D0E8NP DRUGTYPE Small molecular drug D0E8NP DRUGINCH 1S/C42H56F2N8O6/c1-7-33(49-39(55)21(3)45-5)41(57)51-19-27(53)15-25(51)17-31-29-11-9-23(43)13-35(29)47-37(31)38-32(30-12-10-24(44)14-36(30)48-38)18-26-16-28(54)20-52(26)42(58)34(8-2)50-40(56)22(4)46-6/h9-14,21-22,25-28,33-34,45-48,53-54H,7-8,15-20H2,1-6H3,(H,49,55)(H,50,56)/t21-,22-,25-,26-,27-,28-,33-,34-/m0/s1 D0E8NP DRUGINKE PKWRMUKBEYJEIX-DXXQBUJASA-N D0E8NP DRUGSMIL CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC D0E8NP HIGHSTAT Phase 2 D0E8ZY DRUG__ID D0E8ZY D0E8ZY DRUGCOMP Barrier Therapeutics Inc D0E8ZY DRUGTYPE Small molecular drug D0E8ZY DRUGINCH 1S/C17H20N4O/c18-15(22)14-11-20-16-17(6-8-19-9-7-17)13-4-2-1-3-12(13)5-10-21(14)16/h1-4,11,19H,5-10H2,(H2,18,22) D0E8ZY DRUGINKE VQWGYPVNVICKFC-UHFFFAOYSA-N D0E8ZY DRUGSMIL C1CN2C(=CN=C2C3(CCNCC3)C4=CC=CC=C41)C(=O)N D0E8ZY HIGHSTAT Phase 2 D0E9BF DRUG__ID D0E9BF D0E9BF DRUGCOMP Aesrx D0E9BF DRUGTYPE Small molecular drug D0E9BF DRUGINCH 1S/C6H6O3/c7-3-5-1-2-6(4-8)9-5/h1-3,8H,4H2 D0E9BF DRUGINKE NOEGNKMFWQHSLB-UHFFFAOYSA-N D0E9BF DRUGSMIL C1=C(OC(=C1)C=O)CO D0E9BF HIGHSTAT Phase 2 D0ED3R DRUG__ID D0ED3R D0ED3R THERCLAS Antiviral Agents D0ED3R DRUGTYPE Small molecular drug D0ED3R DRUGINCH 1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1 D0ED3R DRUGINKE GKTWGGQPFAXNFI-HNNXBMFYSA-N D0ED3R DRUGSMIL COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3 D0ED3R HIGHSTAT Phase 2 Trial D0EJ7U DRUG__ID D0EJ7U D0EJ7U DRUGCOMP Catalyst pharmaceutical partners D0EJ7U DRUGTYPE Small molecular drug D0EJ7U DRUGINCH 1S/C7H9F2NO2/c8-6(9)4-1-3(7(11)12)2-5(4)10/h3,5H,1-2,10H2,(H,11,12)/t3-,5-/m0/s1 D0EJ7U DRUGINKE CBSRETZPFOBWNG-UCORVYFPSA-N D0EJ7U DRUGSMIL C1C(CC(=C(F)F)C1N)C(=O)O D0EJ7U HIGHSTAT Phase 2 D0EQ6V DRUG__ID D0EQ6V D0EQ6V DRUGCOMP Sabin Vaccine Institute D0EQ6V DRUGTYPE Small molecular drug D0EQ6V DRUGINCH 1S/Al.3H2O/h;3*1H2 D0EQ6V DRUGINKE MXRIRQGCELJRSN-UHFFFAOYSA-N D0EQ6V DRUGSMIL O.O.O.[Al] D0EQ6V HIGHSTAT Phase 2 D0EQ9T DRUG__ID D0EQ9T D0EQ9T DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0EQ9T DRUGTYPE Small molecular drug D0EQ9T DRUGINCH 1S/C21H24FN3O2/c22-17-6-8-19(9-7-17)27-20-10-5-16(15-23-20)21(26)25-12-2-11-24(13-14-25)18-3-1-4-18/h5-10,15,18H,1-4,11-14H2 D0EQ9T DRUGINKE IQOWHZHNGJXGHG-UHFFFAOYSA-N D0EQ9T DRUGSMIL C1CC(C1)N2CCCN(CC2)C(=O)C3=CN=C(C=C3)OC4=CC=C(C=C4)F D0EQ9T HIGHSTAT Phase 2 D0ET2S DRUG__ID D0ET2S D0ET2S DRUGCOMP Takeda Chemical Industries D0ET2S DRUGTYPE Small molecular drug D0ET2S DRUGINCH 1S/C13H15N5/c1-8(2)6-18-7-16-11-12(18)10-9(17-13(11)14)4-3-5-15-10/h3-5,7-8H,6H2,1-2H3,(H2,14,17) D0ET2S DRUGINKE UCPMSMNKGXUFCC-UHFFFAOYSA-N D0ET2S DRUGSMIL CC(C)CN1C=NC2=C1C3=C(C=CC=N3)N=C2N D0ET2S HIGHSTAT Phase 2 D0F2KX DRUG__ID D0F2KX D0F2KX DRUGCOMP Japan Tobacco Inc D0F2KX DRUGTYPE Small molecular drug D0F2KX DRUGINCH 1S/C39H37F3N2O8/c1-5-50-36(48)38(37(49)51-6-2,27-12-8-7-9-13-27)24-52-33(45)23-25-16-21-32(31(22-25)35(47)44(3)4)43-34(46)30-15-11-10-14-29(30)26-17-19-28(20-18-26)39(40,41)42/h7-22H,5-6,23-24H2,1-4H3,(H,43,46) D0F2KX DRUGINKE FPUQGCOBYOXAED-UHFFFAOYSA-N D0F2KX DRUGSMIL CCOC(=O)C(COC(=O)CC1=CC(=C(C=C1)NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)C(=O)N(C)C)(C4=CC=CC=C4)C(=O)OCC D0F2KX HIGHSTAT Phase 2 D0F4NH DRUG__ID D0F4NH D0F4NH DRUGCOMP Vertex D0F4NH DRUGTYPE Small molecular drug D0F4NH DRUGINCH 1S/C25H35NO4S/c1-16-5-7-17(8-6-16)23(28)26(18-9-11-19(27)12-10-18)21-15-20(13-14-25(2,3)4)31-22(21)24(29)30/h15-19,27H,5-12H2,1-4H3,(H,29,30) D0F4NH DRUGINKE WPMJNLCLKAKMLA-UHFFFAOYSA-N D0F4NH DRUGSMIL CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C#CC(C)(C)C)C(=O)O D0F4NH HIGHSTAT Phase 2 D0F4TV DRUG__ID D0F4TV D0F4TV DRUGCOMP ASTA Medica AG D0F4TV DRUGTYPE Small molecular drug D0F4TV DRUGINCH 1S/C22H14Cl2FN3O3/c23-17-8-26-9-18(24)20(17)27-22(31)21(30)16-11-28(10-12-1-3-13(25)4-2-12)19-6-5-14(29)7-15(16)19/h1-9,11,29H,10H2,(H,26,27,31) D0F4TV DRUGINKE DPHDSIQHVGSITN-UHFFFAOYSA-N D0F4TV DRUGSMIL C1=CC(=CC=C1CN2C=C(C3=C2C=CC(=C3)O)C(=O)C(=O)NC4=C(C=NC=C4Cl)Cl)F D0F4TV HIGHSTAT Phase 2 D0F4VW DRUG__ID D0F4VW D0F4VW DRUGCOMP Azevan Pharmaceuticals Inc D0F4VW DRUGTYPE Small molecular drug D0F4VW DRUGINCH 1S/C42H49N5O5/c1-30(32-16-8-3-9-17-32)43-40(49)36(28-38(48)45-26-22-34(23-27-45)44-24-12-5-13-25-44)46-35(21-20-31-14-6-2-7-15-31)39(41(46)50)47-37(29-52-42(47)51)33-18-10-4-11-19-33/h2-4,6-11,14-21,30,34-37,39H,5,12-13,22-29H2,1H3,(H,43,49)/b21-20+/t30-,35-,36-,37-,39+/m1/s1 D0F4VW DRUGINKE FJUKOXWSIGULLE-JVOQCOEYSA-N D0F4VW DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C(CC(=O)N2CCC(CC2)N3CCCCC3)N4C(C(C4=O)N5C(COC5=O)C6=CC=CC=C6)C=CC7=CC=CC=C7 D0F4VW HIGHSTAT Phase 2 D0F5HB DRUG__ID D0F5HB D0F5HB DRUGCOMP Novartis D0F5HB DRUGTYPE Small molecular drug D0F5HB DRUGINCH 1S/C25H22N6O2.C2H4O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18;1-2(3)4/h2-9,14,26H,10-13H2,1H3,(H,29,32,33);1H3,(H,3,4) D0F5HB DRUGINKE RVEUYBMXVVDLFO-UHFFFAOYSA-N D0F5HB DRUGSMIL CC(=O)O.CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65 D0F5HB HIGHSTAT Phase 2 D0F5LB DRUG__ID D0F5LB D0F5LB DRUGCOMP INO Therapeutics Inc D0F5LB DRUGTYPE Small molecular drug D0F5LB DRUGINCH 1S/CO/c1-2 D0F5LB DRUGINKE UGFAIRIUMAVXCW-UHFFFAOYSA-N D0F5LB DRUGSMIL [C-]#[O+] D0F5LB HIGHSTAT Phase 2 D0F5TD DRUG__ID D0F5TD D0F5TD DRUGCOMP EISAI INC. XU, Weizheng DELAHANTY, Greg WEI, Ling ZHANG, Jie D0F5TD DRUGTYPE Small molecular drug D0F5TD DRUGINCH 1S/C18H15N5O/c24-18-13-6-3-7-14-16(13)17(21-22-18)20-15(19-14)10-23-8-11-4-1-2-5-12(11)9-23/h1-7H,8-10H2,(H,22,24)(H,19,20,21) D0F5TD DRUGINKE JLFSBHQQXIAQEC-UHFFFAOYSA-N D0F5TD DRUGSMIL C1C2=CC=CC=C2CN1CC3=NC4=NNC(=O)C5=C4C(=CC=C5)N3 D0F5TD HIGHSTAT Phase 2 D0F5UN DRUG__ID D0F5UN D0F5UN DRUGCOMP Solvay D0F5UN DRUGTYPE Small molecular drug D0F5UN DRUGINCH 1S/C18H20N4O/c23-14-8-6-13(7-9-14)20-18-15-10-11-19-17(15)21-16(22-18)12-4-2-1-3-5-12/h1-5,10-11,13-14,23H,6-9H2,(H2,19,20,21,22) D0F5UN DRUGINKE RBZNJGHIKXAKQE-UHFFFAOYSA-N D0F5UN DRUGSMIL C1CC(CCC1NC2=NC(=NC3=C2C=CN3)C4=CC=CC=C4)O D0F5UN HIGHSTAT Phase 2 D0F5VD DRUG__ID D0F5VD D0F5VD DRUGCOMP Telik D0F5VD DRUGTYPE Small molecular drug D0F5VD DRUGINCH 1S/C27H35N3O6S/c1-3-35-26(33)21(28)15-16-23(31)29-22(18-37-17-19-11-7-5-8-12-19)25(32)30-24(27(34)36-4-2)20-13-9-6-10-14-20/h5-14,21-22,24H,3-4,15-18,28H2,1-2H3,(H,29,31)(H,30,32)/t21-,22-,24+/m0/s1 D0F5VD DRUGINKE GWEJFLVSOGNLSS-WPFOTENUSA-N D0F5VD DRUGSMIL CCOC(=O)C(CCC(=O)NC(CSCC1=CC=CC=C1)C(=O)NC(C2=CC=CC=C2)C(=O)OCC)N D0F5VD HIGHSTAT Phase 2 D0F6YK DRUG__ID D0F6YK D0F6YK DRUGCOMP MRL international D0F6YK DRUGTYPE Small molecular drug D0F6YK DRUGINCH 1S/C35H37N3O2/c1-23-19-24(2)36-34-32(23)29-17-8-9-18-31(29)38(34)21-25-11-10-16-28(20-25)33(27-14-6-7-15-27)35(40)37-30(22-39)26-12-4-3-5-13-26/h3-5,8-13,16-20,27,30,33,39H,6-7,14-15,21-22H2,1-2H3,(H,37,40)/t30-,33-/m0/s1 D0F6YK DRUGINKE AMNXBQPRODZJQR-DITALETJSA-N D0F6YK DRUGSMIL CC1=CC(=NC2=C1C3=CC=CC=C3N2CC4=CC(=CC=C4)C(C5CCCC5)C(=O)NC(CO)C6=CC=CC=C6)C D0F6YK HIGHSTAT Phase 2 D0F6YW DRUG__ID D0F6YW D0F6YW DRUGCOMP Bayer HealthCare Pharmaceuticals D0F6YW DRUGTYPE Small molecular drug D0F6YW DRUGINCH 1S/C30H41NO6S/c1-7-9-20-27(34)17(2)10-8-13-30(6)25(37-30)15-22(19-11-12-23-21(14-19)31-18(3)38-23)36-26(33)16-24(32)29(4,5)28(20)35/h7,11-12,14,17,20,22,24-25,27,32,34H,1,8-10,13,15-16H2,2-6H3/t17-,20+,22-,24-,25-,27-,30+/m0/s1 D0F6YW DRUGINKE BFZKMNSQCNVFGM-UCEYFQQTSA-N D0F6YW DRUGSMIL CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)CC=C)(C)C)O)C3=CC4=C(C=C3)SC(=N4)C)C D0F6YW HIGHSTAT Phase 2 D0F7PZ DRUG__ID D0F7PZ D0F7PZ DRUGCOMP Pfizer Inc D0F7PZ DRUGTYPE Small molecular drug D0F7PZ DRUGINCH 1S/C29H40FN5O2/c1-18(2)29(37)33-12-11-28-27(17-33)31-19(3)35(28)25-15-23-8-9-24(16-25)34(23)13-10-26(32-20(4)36)21-6-5-7-22(30)14-21/h5-7,14,18,23-26H,8-13,15-17H2,1-4H3,(H,32,36)/t23-,24+,25?,26-/m0/s1 D0F7PZ DRUGINKE QETUKYDWZIRTEI-HLMSNRGBSA-N D0F7PZ DRUGSMIL CC1=NC2=C(N1C3CC4CCC(C3)N4CCC(C5=CC(=CC=C5)F)NC(=O)C)CCN(C2)C(=O)C(C)C D0F7PZ HIGHSTAT Phase 2 D0F8GK DRUG__ID D0F8GK D0F8GK DRUGCOMP Lilly D0F8GK DRUGTYPE Small molecular drug D0F8GK DRUGINCH 1S/C18H16F2N4O2S/c19-11-1-4-15(22-6-11)16(25)23-12-2-3-14(20)13(5-12)18-9-26-7-10(18)8-27-17(21)24-18/h1-6,10H,7-9H2,(H2,21,24)(H,23,25)/t10-,18-/m0/s1 D0F8GK DRUGINKE NIDRNVHMMDAAIK-YPMLDQLKSA-N D0F8GK DRUGSMIL C1C2CSC(=NC2(CO1)C3=C(C=CC(=C3)NC(=O)C4=NC=C(C=C4)F)F)N D0F8GK HIGHSTAT Phase 2 D0G0DZ DRUG__ID D0G0DZ D0G0DZ THERCLAS Antiviral Agents D0G0DZ DRUGTYPE Small molecular drug D0G0DZ DRUGINCH 1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22) D0G0DZ DRUGINKE IENZQIKPVFGBNW-UHFFFAOYSA-N D0G0DZ DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC D0G0DZ HIGHSTAT Phase 2 Trial D0G0RT DRUG__ID D0G0RT D0G0RT DRUGCOMP Chiesi D0G0RT DRUGTYPE Small molecular drug D0G0RT DRUGINCH 1S/C21H24N2O4/c1-13(11-14-3-5-15(27-2)6-4-14)22-12-19(25)16-7-9-18(24)21-17(16)8-10-20(26)23-21/h3-10,13,19,22,24-25H,11-12H2,1-2H3,(H,23,26)/t13-,19+/m1/s1 D0G0RT DRUGINKE IHOXNOQMRZISPV-YJYMSZOUSA-N D0G0RT DRUGSMIL CC(CC1=CC=C(C=C1)OC)NCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O D0G0RT HIGHSTAT Phase 2 D0G0VV DRUG__ID D0G0VV D0G0VV DRUGCOMP CytRx D0G0VV DRUGTYPE Small molecular drug D0G0VV DRUGINCH 1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m0/s1 D0G0VV DRUGINKE ZGBAJMQHJDFTQJ-DEOSSOPVSA-N D0G0VV DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CN=C5 D0G0VV HIGHSTAT Phase 2 D0G3AR DRUG__ID D0G3AR D0G3AR DRUGCOMP University of California D0G3AR DRUGTYPE Small molecular drug D0G3AR DRUGINCH 1S/C11H11N3O3/c15-11(14-3-5-16-6-4-14)8-1-2-9-10(7-8)13-17-12-9/h1-2,7H,3-6H2 D0G3AR DRUGINKE KFRQROSRKSVROW-UHFFFAOYSA-N D0G3AR DRUGSMIL C1COCCN1C(=O)C2=CC3=NON=C3C=C2 D0G3AR HIGHSTAT Phase 2 D0G3BN DRUG__ID D0G3BN D0G3BN DRUGCOMP Antigen Express Inc D0G3BN DRUGTYPE Small molecular drug D0G3BN DRUGINCH 1S/C19H23NO/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18H,13-15H2,1-2H3 D0G3BN DRUGINKE BOTHKNZTGGXFEQ-UHFFFAOYSA-N D0G3BN DRUGSMIL CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3 D0G3BN HIGHSTAT Phase 2 D0G3GF DRUG__ID D0G3GF D0G3GF DRUGCOMP GenVec D0G3GF DRUGTYPE Small molecular drug D0G3GF DRUGINCH 1S/C20H22N8O5.C18H19IN6O4/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t13-;12-,13+,14-,18+/m00/s1 D0G3GF DRUGINKE BDNQEWFVMDIRTE-VXJTWHGRSA-N D0G3GF DRUGSMIL CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)O)O.CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0G3GF HIGHSTAT Phase 2 D0G4MB DRUG__ID D0G4MB D0G4MB DRUGCOMP Abbott Laboratories D0G4MB DRUGTYPE Small molecular drug D0G4MB DRUGINCH 1S/C46H83N13O11/c1-12-18-30(39(64)55-36(26(7)13-2)42(67)53-31(19-16-21-50-46(47)48)45(70)59-22-17-20-32(59)40(65)49-15-4)52-44(69)38(28(9)60)57-43(68)37(27(8)14-3)56-41(66)35(25(5)6)54-33(62)23-51-34(63)24-58(11)29(10)61/h25-28,30-32,35-38,60H,12-24H2,1-11H3,(H,49,65)(H,51,63)(H,52,69)(H,53,67)(H,54,62)(H,55,64)(H,56,66)(H,57,68)(H4,47,48,50)/t26-,27-,28+,30-,31-,32-,35-,36-,37+,38-/m0/s1 D0G4MB DRUGINKE RIWLPSIAFBLILR-WVNGMBSFSA-N D0G4MB DRUGSMIL CCCC(C(=O)NC(C(C)CC)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN(C)C(=O)C D0G4MB HIGHSTAT Phase 2 D0G5ME DRUG__ID D0G5ME D0G5ME DRUGCOMP Merck D0G5ME DRUGTYPE Small molecular drug D0G5ME DRUGINCH 1S/C26H27F5N6O3/c27-18-4-1-3-17(21(18)28)15-6-7-19(23(38)36(13-15)14-26(29,30)31)33-24(39)35-11-8-16(9-12-35)37-20-5-2-10-32-22(20)34-25(37)40/h1-5,10,15-16,19H,6-9,11-14H2,(H,33,39)(H,32,34,40)/t15-,19-/m1/s1 D0G5ME DRUGINKE CGDZXLJGHVKVIE-DNVCBOLYSA-N D0G5ME DRUGSMIL C1CC(C(=O)N(CC1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5 D0G5ME HIGHSTAT Phase 2 D0G5SU DRUG__ID D0G5SU D0G5SU DRUGCOMP Active Biotech AB D0G5SU DRUGTYPE Small molecular drug D0G5SU DRUGINCH 1S/C21H22N2O3/c1-4-14-10-9-13-16-17(14)19(24)18(20(25)22(16)3)21(26)23(5-2)15-11-7-6-8-12-15/h6-13,24H,4-5H2,1-3H3 D0G5SU DRUGINKE DIKSYHCCYVYKRO-UHFFFAOYSA-N D0G5SU DRUGSMIL CCC1=C2C(=CC=C1)N(C(=O)C(=C2O)C(=O)N(CC)C3=CC=CC=C3)C D0G5SU HIGHSTAT Phase 2 D0G5TF DRUG__ID D0G5TF D0G5TF THERCLAS Antiviral Agents D0G5TF DRUGTYPE Small molecular drug D0G5TF DRUGINCH 1S/C16H18N3S.ClH/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;/h5-10H,1-4H3;1H/q+1;/p-1 D0G5TF DRUGINKE CXKWCBBOMKCUKX-UHFFFAOYSA-M D0G5TF DRUGSMIL CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-] D0G5TF HIGHSTAT Phase 2 Trial D0G5XV DRUG__ID D0G5XV D0G5XV THERCLAS Antiviral Agents D0G5XV DRUGTYPE Small molecular drug D0G5XV DRUGINCH 1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1 D0G5XV DRUGINKE RNOAOAWBMHREKO-QFIPXVFZSA-N D0G5XV DRUGSMIL C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N D0G5XV HIGHSTAT Phase 2 Trial D0G6EI DRUG__ID D0G6EI D0G6EI DRUGCOMP Pfizer D0G6EI DRUGTYPE Small molecular drug D0G6EI DRUGINCH 1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29) D0G6EI DRUGINKE WOHRHWDYFNWPNG-UHFFFAOYSA-N D0G6EI DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CN(CC2=CC(=CC=C2)OCC(=O)O)S(=O)(=O)C3=CN=CC=C3 D0G6EI HIGHSTAT Phase 2 D0G6JU DRUG__ID D0G6JU D0G6JU THERCLAS Antiviral Agents D0G6JU DRUGTYPE Small molecular drug D0G6JU DRUGINCH 1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1 D0G6JU DRUGINKE XYFPWWZEPKGCCK-GOSISDBHSA-N D0G6JU DRUGSMIL C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N D0G6JU HIGHSTAT Phase 2 Trial D0G6QV DRUG__ID D0G6QV D0G6QV DRUGCOMP Actavis D0G6QV DRUGTYPE Small molecular drug D0G6QV DRUGINCH 1S/C20H16ClF2N5O2/c1-12(28-11-25-18-6-13(21)2-4-15(18)19(28)29)20(30,8-27-10-24-9-26-27)16-5-3-14(22)7-17(16)23/h2-7,9-12,30H,8H2,1H3/t12-,20-/m1/s1 D0G6QV DRUGINKE UHIXWHUVLCAJQL-MPBGBICISA-N D0G6QV DRUGSMIL CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3C=NC4=C(C3=O)C=CC(=C4)Cl D0G6QV HIGHSTAT Phase 2 D0G7UX DRUG__ID D0G7UX D0G7UX THERCLAS Antiviral Agents D0G7UX DRUGTYPE Small molecular drug D0G7UX DRUGINCH 1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1 D0G7UX DRUGINKE PMATZTZNYRCHOR-CGLBZJNRSA-N D0G7UX DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C D0G7UX HIGHSTAT Phase 2 Trial D0G9AW DRUG__ID D0G9AW D0G9AW DRUGCOMP Gilead Sciences D0G9AW DRUGTYPE Small molecular drug D0G9AW DRUGINCH 1S/C23H21N7O/c1-2-17-14-25-28-20(17)13-16(1)21-15-30-8-7-24-23(30)22(27-21)26-18-3-5-19(6-4-18)29-9-11-31-12-10-29/h1-8,13-15H,9-12H2,(H,25,28)(H,26,27) D0G9AW DRUGINKE XSMSNFMDVXXHGJ-UHFFFAOYSA-N D0G9AW DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6 D0G9AW HIGHSTAT Phase 2 D0GP8P DRUG__ID D0GP8P D0GP8P DRUGCOMP GSK D0GP8P DRUGTYPE Small molecular drug D0GP8P DRUGINCH 1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)29-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(16-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22,27,35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1 D0GP8P DRUGINKE URWYQGVSPQJGGB-DHUJRADRSA-N D0GP8P DRUGSMIL COC1=CC(=C(C=C1CNCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O)Cl)NC(=O)CCN4CCC(CC4)OC(=O)NC5=CC=CC=C5C6=CC=CC=C6 D0GP8P HIGHSTAT Phase 2 D0GP9Q DRUG__ID D0GP9Q D0GP9Q DRUGCOMP TargeGen D0GP9Q DRUGTYPE Small molecular drug D0GP9Q DRUGINCH 1S/C33H30ClN5O3/c1-22-19-24(28-21-27(13-14-29(28)34)42-32(40)23-7-3-2-4-8-23)20-30-31(22)36-33(38-37-30)35-25-9-11-26(12-10-25)41-18-17-39-15-5-6-16-39/h2-4,7-14,19-21H,5-6,15-18H2,1H3,(H,35,36,38) D0GP9Q DRUGINKE JMGXJHWTVBGOKG-UHFFFAOYSA-N D0GP9Q DRUGSMIL CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OCCN4CCCC4)C5=C(C=CC(=C5)OC(=O)C6=CC=CC=C6)Cl D0GP9Q HIGHSTAT Phase 2 D0GX2W DRUG__ID D0GX2W D0GX2W DRUGCOMP Wockhardt D0GX2W DRUGTYPE Small molecular drug D0GX2W DRUGINCH 1S/C42H62N6O11S/c1-13-28-42(9)30(29(39(53)58-42)35(43)47-59-25(7)36-45-46-37(60-36)26-16-14-15-17-44-26)22(4)31(49)20(2)19-41(8,54-12)34(23(5)32(50)24(6)38(52)56-28)57-40-33(51)27(48(10)11)18-21(3)55-40/h14-17,20-25,27-30,33-34,40,51H,13,18-19H2,1-12H3,(H2,43,47)/t20-,21-,22-,23+,24-,25+,27+,28-,29-,30+,33-,34-,40+,41-,42-/m1/s1 D0GX2W DRUGINKE RLFCSBSRGRJFRO-QAOQTAGDSA-N D0GX2W DRUGSMIL CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)C(C(=O)O2)C(=NOC(C)C4=NN=C(S4)C5=CC=CC=N5)N)C D0GX2W HIGHSTAT Phase 2 D0GY0O DRUG__ID D0GY0O D0GY0O DRUGCOMP Bayer AG D0GY0O DRUGTYPE Small molecular drug D0GY0O DRUGINCH 1S/C30H32O6S/c31-29(32)20-19-27(37-28-17-13-24(14-18-28)30(33)34)10-6-7-23-11-15-26(16-12-23)36-22-5-4-21-35-25-8-2-1-3-9-25/h1-3,6,8-18,27H,4-5,7,19-22H2,(H,31,32)(H,33,34)/b10-6-/t27-/m1/s1 D0GY0O DRUGINKE MHKAEITVUICXRN-BPGQXAFDSA-N D0GY0O DRUGSMIL C1=CC=C(C=C1)OCCCCOC2=CC=C(C=C2)CC=CC(CCC(=O)O)SC3=CC=C(C=C3)C(=O)O D0GY0O HIGHSTAT Phase 2 D0H1AY DRUG__ID D0H1AY D0H1AY DRUGCOMP Novartis AG D0H1AY DRUGTYPE Small molecular drug D0H1AY DRUGINCH 1S/C19H22N2O/c1-14-2-4-15(5-3-14)18-7-6-17(12-20-18)22-19-13-21-10-8-16(19)9-11-21/h2-7,12,16,19H,8-11,13H2,1H3/t19-/m0/s1 D0H1AY DRUGINKE NPDLTEZXGWRMLQ-IBGZPJMESA-N D0H1AY DRUGSMIL CC1=CC=C(C=C1)C2=NC=C(C=C2)OC3CN4CCC3CC4 D0H1AY HIGHSTAT Phase 2 D0H1EA DRUG__ID D0H1EA D0H1EA DRUGCOMP Threshold Pharmaceuticals D0H1EA DRUGTYPE Small molecular drug D0H1EA DRUGINCH 1S/C9H16Br2N5O4P/c1-15-8(6-12-9(15)16(17)18)7-20-21(19,13-4-2-10)14-5-3-11/h6H,2-5,7H2,1H3,(H2,13,14,19) D0H1EA DRUGINKE UGJWRPJDTDGERK-UHFFFAOYSA-N D0H1EA DRUGSMIL CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr D0H1EA HIGHSTAT Phase 2 D0H5BC DRUG__ID D0H5BC D0H5BC DRUGCOMP Organon BioSciences D0H5BC DRUGTYPE Small molecular drug D0H5BC DRUGINCH 1S/C21H24O2/c1-4-21(23)10-9-18-17-7-5-14-11-15(22)6-8-16(14)19(17)13(2)12-20(18,21)3/h1,9-11,16-19,23H,2,5-8,12H2,3H3/t16-,17-,18-,19+,20-,21-/m0/s1 D0H5BC DRUGINKE YJSTYQGZKJHXLN-OLGWUGKESA-N D0H5BC DRUGSMIL CC12CC(=C)C3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34 D0H5BC HIGHSTAT Phase 2 D0H5HZ DRUG__ID D0H5HZ D0H5HZ DRUGCOMP Portela & Ca SA D0H5HZ DRUGTYPE Small molecular drug D0H5HZ DRUGINCH 1S/C14H15F2N3OS/c15-9-3-8-4-11(7-20-13(8)12(16)5-9)19-10(1-2-17)6-18-14(19)21/h3,5-6,11H,1-2,4,7,17H2,(H,18,21)/t11-/m1/s1 D0H5HZ DRUGINKE CWWWTTYMUOYSQA-LLVKDONJSA-N D0H5HZ DRUGSMIL C1C(COC2=C1C=C(C=C2F)F)N3C(=CNC3=S)CCN D0H5HZ HIGHSTAT Phase 2 D0H7FW DRUG__ID D0H7FW D0H7FW DRUGCOMP Ferring Pharmaceuticals Inc D0H7FW DRUGTYPE Small molecular drug D0H7FW DRUGINCH 1S/C28H30N6O3/c1-28(2,3)23(35)17-34-22-14-6-5-12-20(22)24(21-13-7-8-15-30-21)32-25(26(34)36)33-27(37)31-19-11-9-10-18(16-19)29-4/h5-16,25,29H,17H2,1-4H3,(H2,31,33,37)/t25-/m0/s1 D0H7FW DRUGINKE YDZYKNJZCVIKPP-VWLOTQADSA-N D0H7FW DRUGSMIL CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC=CC(=C3)NC)C4=CC=CC=N4 D0H7FW HIGHSTAT Phase 2 D0H7HR DRUG__ID D0H7HR D0H7HR THERCLAS Antiviral Agents D0H7HR DRUGTYPE Small molecular drug D0H7HR DRUGINCH 1S/C23H26N6O2/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28)/b25-17+ D0H7HR DRUGINKE HSKAZIJJKRAJAV-KOEQRZSOSA-N D0H7HR DRUGSMIL CC1=CC(=CC=C1)C=NNC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4 D0H7HR HIGHSTAT Phase 2 Trial D0H7QU DRUG__ID D0H7QU D0H7QU DRUGCOMP Bristol-Myers Squibb D0H7QU DRUGTYPE Small molecular drug D0H7QU DRUGINCH 1S/C36H45N5O5S/c1-38(2)47(44,45)37-34(42)23-10-14-28-31(16-23)40-21-36(35(43)41-24-11-12-25(41)20-39(3)19-24)18-30(36)29-17-26(46-4)13-15-27(29)33(40)32(28)22-8-6-5-7-9-22/h10,13-17,22,24-25,30H,5-9,11-12,18-21H2,1-4H3,(H,37,42)/t24-,25+,30-,36-/m0/s1 D0H7QU DRUGINKE ZTTKEBYSXUCBSE-QDFUAKMASA-N D0H7QU DRUGSMIL CN1CC2CCC(C1)N2C(=O)C34CC3C5=C(C=CC(=C5)OC)C6=C(C7=C(N6C4)C=C(C=C7)C(=O)NS(=O)(=O)N(C)C)C8CCCCC8 D0H7QU HIGHSTAT Phase 2 D0H7XL DRUG__ID D0H7XL D0H7XL DRUGCOMP OSI D0H7XL DRUGTYPE Small molecular drug D0H7XL DRUGINCH 1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12,25H,5-8H2,1H3,(H,28,29)(H2,22,23,24) D0H7XL DRUGINKE JROFGZPOBKIAEW-UHFFFAOYSA-N D0H7XL DRUGSMIL COC1=CC=CC2=C1NC(=C2)C3=C4C(=NC=NN4C(=N3)C5CCC(CC5)C(=O)O)N D0H7XL HIGHSTAT Phase 2 D0H8FY DRUG__ID D0H8FY D0H8FY DRUGCOMP GSK D0H8FY DRUGTYPE Small molecular drug D0H8FY DRUGINCH 1S/C27H27F2NO6/c1-4-36-15-17-13-22(34-2)24(23(14-17)35-3)18-10-8-16(9-11-18)12-21(27(32)33)30-26(31)25-19(28)6-5-7-20(25)29/h5-11,13-14,21H,4,12,15H2,1-3H3,(H,30,31)(H,32,33)/t21-/m0/s1 D0H8FY DRUGINKE YLFZHHDVRSYTKT-NRFANRHFSA-N D0H8FY DRUGSMIL CCOCC1=CC(=C(C(=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3F)F)OC D0H8FY HIGHSTAT Phase 2 D0H9DA DRUG__ID D0H9DA D0H9DA DRUGCOMP Astrazeneca; eagle pharmaceuticals D0H9DA DRUGTYPE Small molecular drug D0H9DA DRUGINCH 1S/C20H24N6O2S/c1-13-12-28-10-9-26(13)17-11-16(20(5-6-20)29(2,21)27)24-19(25-17)15-4-8-23-18-14(15)3-7-22-18/h3-4,7-8,11,13,21H,5-6,9-10,12H2,1-2H3,(H,22,23)/t13-,29-/m1/s1 D0H9DA DRUGINKE OHUHVTCQTUDPIJ-JYCIKRDWSA-N D0H9DA DRUGSMIL CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4 D0H9DA HIGHSTAT Phase 2 D0H9SX DRUG__ID D0H9SX D0H9SX DRUGCOMP Astellas Pharma GmbH D0H9SX DRUGTYPE Small molecular drug D0H9SX DRUGINCH 1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+ D0H9SX DRUGINKE KPBNHDGDUADAGP-VAWYXSNFSA-N D0H9SX DRUGSMIL C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3 D0H9SX HIGHSTAT Phase 2 D0H9WR DRUG__ID D0H9WR D0H9WR DRUGCOMP Lexicon Pharmaceuticals Inc D0H9WR DRUGTYPE Small molecular drug D0H9WR DRUGINCH 1S/C28H25F3N4O4/c1-38-21-4-2-3-20(14-21)17-9-11-19(12-10-17)25(28(29,30)31)39-24-15-23(34-27(33)35-24)18-7-5-16(6-8-18)13-22(32)26(36)37/h2-12,14-15,22,25H,13,32H2,1H3,(H,36,37)(H2,33,34,35)/t22-,25+/m0/s1 D0H9WR DRUGINKE XNMUICFMGGQSMZ-WIOPSUGQSA-N D0H9WR DRUGSMIL COC1=CC=CC(=C1)C2=CC=C(C=C2)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N D0H9WR HIGHSTAT Phase 2 D0H9YO DRUG__ID D0H9YO D0H9YO DRUGCOMP Aeson Therapeutics D0H9YO DRUGTYPE Small molecular drug D0H9YO DRUGINCH 1S/C19H27FO/c1-18-9-4-3-5-12(18)6-7-13-14(18)8-10-19(2)15(13)11-16(20)17(19)21/h6,13-16H,3-5,7-11H2,1-2H3/t13-,14+,15+,16-,18+,19+/m1/s1 D0H9YO DRUGINKE VHZXNQKVFDBFIK-NBBHSKLNSA-N D0H9YO DRUGSMIL CC12CCCCC1=CCC3C2CCC4(C3CC(C4=O)F)C D0H9YO HIGHSTAT Phase 2 D0HG5M DRUG__ID D0HG5M D0HG5M DRUGCOMP Wyeth Research D0HG5M DRUGTYPE Small molecular drug D0HG5M DRUGINCH 1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)/t15-/m0/s1 D0HG5M DRUGINKE MAVDNGWEBZTACC-HNNXBMFYSA-N D0HG5M DRUGSMIL CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C D0HG5M HIGHSTAT Phase 2 D0HJ5H DRUG__ID D0HJ5H D0HJ5H DRUGCOMP Pharmagene plc D0HJ5H DRUGTYPE Small molecular drug D0HJ5H DRUGINCH 1S/C26H24N2O6S.Na/c1-17-6-4-5-7-25(17)35(30,31)28-26(29)24-14-20(18(2)34-24)16-33-21-10-8-19(9-11-21)23-13-12-22(32-3)15-27-23;/h4-15H,16H2,1-3H3,(H,28,29);/q;+1/p-1 D0HJ5H DRUGINKE TVDHMDXPKGMXRT-UHFFFAOYSA-M D0HJ5H DRUGSMIL CC1=CC=CC=C1S(=O)(=O)[N-]C(=O)C2=CC(=C(O2)C)COC3=CC=C(C=C3)C4=NC=C(C=C4)OC.[Na+] D0HJ5H HIGHSTAT Phase 2 D0HK3N DRUG__ID D0HK3N D0HK3N DRUGCOMP MedKoo Biosciences; vertex pharmaceuticals D0HK3N DRUGTYPE Small molecular drug D0HK3N DRUGINCH 1S/C24H33ClN4O6/c1-5-34-23-16(12-18(30)35-23)27-21(32)17-7-6-10-29(17)22(33)19(24(2,3)4)28-20(31)13-8-9-15(26)14(25)11-13/h8-9,11,16-17,19,23H,5-7,10,12,26H2,1-4H3,(H,27,32)(H,28,31)/t16-,17-,19+,23+/m0/s1 D0HK3N DRUGINKE SJDDOCKBXFJEJB-MOKWFATOSA-N D0HK3N DRUGSMIL CCOC1C(CC(=O)O1)NC(=O)C2CCCN2C(=O)C(C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl D0HK3N HIGHSTAT Phase 2 D0HO2T DRUG__ID D0HO2T D0HO2T DRUGCOMP AstraZeneca D0HO2T DRUGTYPE Small molecular drug D0HO2T DRUGINCH 1S/C19H19FN4O2/c1-3-10-22-19(25)18-16(21)12-7-4-6-11(17(12)23-24-18)15-13(20)8-5-9-14(15)26-2/h4-9H,3,10H2,1-2H3,(H2,21,23)(H,22,25) D0HO2T DRUGINKE KYDURMHFWXCKMW-UHFFFAOYSA-N D0HO2T DRUGSMIL CCCNC(=O)C1=NN=C2C(=C1N)C=CC=C2C3=C(C=CC=C3F)OC D0HO2T HIGHSTAT Phase 2 D0I3WC DRUG__ID D0I3WC D0I3WC DRUGCOMP Roche D0I3WC DRUGTYPE Small molecular drug D0I3WC DRUGINCH 1S/C22H20F5N3O3/c1-20(2,18(32)28-11-21(23,24)22(25,26)27)19(33)30-16-14-9-4-3-7-12(14)13-8-5-6-10-15(13)29-17(16)31/h3-10,16H,11H2,1-2H3,(H,28,32)(H,29,31)(H,30,33)/t16-/m0/s1 D0I3WC DRUGINKE OJPLJFIFUQPSJR-INIZCTEOSA-N D0I3WC DRUGSMIL CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3NC1=O D0I3WC HIGHSTAT Phase 2 D0I3YX DRUG__ID D0I3YX D0I3YX DRUGCOMP Bayer HealthCare Pharmaceuticals D0I3YX DRUGTYPE Small molecular drug D0I3YX DRUGINCH 1S/C25H18ClN5O2S2/c26-17-5-1-16(2-6-17)24-30-18(13-34-24)14-35-25-21(12-28)22(20(11-27)23(29)31-25)15-3-7-19(8-4-15)33-10-9-32/h1-8,13,32H,9-10,14H2,(H2,29,31) D0I3YX DRUGINKE CITWCLNVRIKQAF-UHFFFAOYSA-N D0I3YX DRUGSMIL C1=CC(=CC=C1C2=C(C(=NC(=C2C#N)SCC3=CSC(=N3)C4=CC=C(C=C4)Cl)N)C#N)OCCO D0I3YX HIGHSTAT Phase 2 D0I5IM DRUG__ID D0I5IM D0I5IM DRUGCOMP Eli Lilly D0I5IM DRUGTYPE Small molecular drug D0I5IM DRUGINCH 1S/C23H27N3O4/c1-16-7-9-18(10-8-16)15-26-22(29)24-20(25-26)6-4-5-17-11-13-19(14-12-17)30-23(2,3)21(27)28/h7-14H,4-6,15H2,1-3H3,(H,27,28)(H,24,25,29) D0I5IM DRUGINKE PNHFDVSKDSLUFH-UHFFFAOYSA-N D0I5IM DRUGSMIL CC1=CC=C(C=C1)CN2C(=O)NC(=N2)CCCC3=CC=C(C=C3)OC(C)(C)C(=O)O D0I5IM HIGHSTAT Phase 2 D0I5OR DRUG__ID D0I5OR D0I5OR DRUGCOMP BioVision D0I5OR DRUGTYPE Small molecular drug D0I5OR DRUGINCH 1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5?,6-,7-,8-/m1/s1 D0I5OR DRUGINKE UCKYOOZPSJFJIZ-XVKVHKPRSA-N D0I5OR DRUGSMIL C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O D0I5OR HIGHSTAT Phase 2 D0I5XU DRUG__ID D0I5XU D0I5XU DRUGCOMP Pfizer Inc D0I5XU DRUGTYPE Small molecular drug D0I5XU DRUGINCH 1S/C28H32N2O3/c1-27(2,30-19-25(20-30)33-24-15-9-14-23(31)18-24)16-17-28(26(29)32,21-10-5-3-6-11-21)22-12-7-4-8-13-22/h3-15,18,25,31H,16-17,19-20H2,1-2H3,(H2,29,32) D0I5XU DRUGINKE WGOJWDWKHJHXSV-UHFFFAOYSA-N D0I5XU DRUGSMIL CC(C)(CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)N)N3CC(C3)OC4=CC=CC(=C4)O D0I5XU HIGHSTAT Phase 2 D0I6YM DRUG__ID D0I6YM D0I6YM DRUGCOMP Sanofi D0I6YM DRUGTYPE Small molecular drug D0I6YM DRUGINCH 1S/C18H19ClN3.C5H5.Fe/c1-22(2)12-14-5-3-4-13(14)11-21-17-8-9-20-18-10-15(19)6-7-16(17)18;1-2-4-5-3-1;/h4,6-10H,5,11-12H2,1-2H3,(H,20,21);1-3H,4H2;/q2*-1;+2 D0I6YM DRUGINKE DLYPREQTTOHKSM-UHFFFAOYSA-N D0I6YM DRUGSMIL CN(C)CC1=C(C=[C-]C1)CNC2=C3C=CC(=CC3=NC=C2)Cl.C1C=CC=[C-]1.[Fe+2] D0I6YM HIGHSTAT Phase 2 D0I7IB DRUG__ID D0I7IB D0I7IB DRUGCOMP Allerderm D0I7IB DRUGTYPE Small molecular drug D0I7IB DRUGINCH 1S/C4H8O2.Na/c1-2-3-4(5)6;/h2-3H2,1H3,(H,5,6);/q;+1/p-1 D0I7IB DRUGINKE MFBOGIVSZKQAPD-UHFFFAOYSA-M D0I7IB DRUGSMIL CCCC(=O)[O-].[Na+] D0I7IB HIGHSTAT Phase 2 D0I7MT DRUG__ID D0I7MT D0I7MT DRUGCOMP Natural Pharmacia International Inc D0I7MT DRUGTYPE Small molecular drug D0I7MT DRUGINCH 1S/C21H20O9/c22-7-14-17(26)18(27)19(28)21(30-14)15-13(24)6-5-11-16(25)12(8-29-20(11)15)9-1-3-10(23)4-2-9/h1-6,8,14,17-19,21-24,26-28H,7H2/t14-,17-,18+,19-,21+/m1/s1 D0I7MT DRUGINKE HKEAFJYKMMKDOR-VPRICQMDSA-N D0I7MT DRUGSMIL C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O D0I7MT HIGHSTAT Phase 2 D0I8FV DRUG__ID D0I8FV D0I8FV DRUGCOMP Wyeth D0I8FV DRUGTYPE Small molecular drug D0I8FV DRUGINCH 1S/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2 D0I8FV DRUGINKE GPMXUUPHFNMNDH-UHFFFAOYSA-N D0I8FV DRUGSMIL C1CN(CCC1(C2=CC(=CC=C2)C(F)(F)F)O)CCCC(=O)C3=CC=C(C=C3)F D0I8FV HIGHSTAT Phase 2 D0I8QS DRUG__ID D0I8QS D0I8QS DRUGCOMP Ipsen D0I8QS DRUGTYPE Small molecular drug D0I8QS DRUGINCH 1S/C18H26N2OS.ClH/c1-17(2,3)12-7-11(14-10-22-15(9-19)20-14)8-13(16(12)21)18(4,5)6;/h7-8,10,21H,9,19H2,1-6H3;1H D0I8QS DRUGINKE WPWBWGUPSJCKKF-UHFFFAOYSA-N D0I8QS DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C2=CSC(=N2)CN.Cl D0I8QS HIGHSTAT Phase 2 D0I9GR DRUG__ID D0I9GR D0I9GR DRUGCOMP BTG D0I9GR DRUGTYPE Small molecular drug D0I9GR DRUGINCH 1S/C26H25FN8O4/c1-4-9-35(13-16-11-19-22(10-14(16)2)28-15(3)29-25(19)37)17-5-6-18(20(27)12-17)24(36)30-21(26(38)39)7-8-23-31-33-34-32-23/h1,5-6,10-12,21H,7-9,13H2,2-3H3,(H,30,36)(H,38,39)(H,28,29,37)(H,31,32,33,34)/t21-/m0/s1 D0I9GR DRUGINKE IEJSCSAMMLUINT-NRFANRHFSA-N D0I9GR DRUGSMIL CC1=CC2=C(C=C1CN(CC#C)C3=CC(=C(C=C3)C(=O)NC(CCC4=NNN=N4)C(=O)O)F)C(=O)NC(=N2)C D0I9GR HIGHSTAT Phase 2 D0I9HG DRUG__ID D0I9HG D0I9HG DRUGCOMP Taiho Pharmaceutical Co Ltd D0I9HG DRUGTYPE Small molecular drug D0I9HG DRUGINCH 1S/C20H27NO3Si2/c1-25(2,3)17-11-15(12-18(13-17)26(4,5)6)19(22)21-16-9-7-14(8-10-16)20(23)24/h7-13H,1-6H3,(H,21,22)(H,23,24) D0I9HG DRUGINKE VVTNSTLJOVCBDL-UHFFFAOYSA-N D0I9HG DRUGSMIL C[Si](C)(C)C1=CC(=CC(=C1)C(=O)NC2=CC=C(C=C2)C(=O)O)[Si](C)(C)C D0I9HG HIGHSTAT Phase 2 D0IL3O DRUG__ID D0IL3O D0IL3O DRUGCOMP Osteologix Holdings PLC D0IL3O DRUGTYPE Small molecular drug D0IL3O DRUGINCH 1S/C3H4O4.Sr/c4-2(5)1-3(6)7;/h1H2,(H,4,5)(H,6,7);/q;+2/p-2 D0IL3O DRUGINKE LVZZABGEQTZXHP-UHFFFAOYSA-L D0IL3O DRUGSMIL C(C(=O)[O-])C(=O)[O-].[Sr+2] D0IL3O HIGHSTAT Phase 2 D0J1AV DRUG__ID D0J1AV D0J1AV DRUGCOMP Almirall; Forest Laboratories D0J1AV DRUGTYPE Small molecular drug D0J1AV DRUGINCH 1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1 D0J1AV DRUGINKE SFYAXIFVXBKRPK-QFIPXVFZSA-N D0J1AV DRUGSMIL C1=CC=C(C=C1)C(COCCCCCCNCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O)(F)F D0J1AV HIGHSTAT Phase 2 D0J1CL DRUG__ID D0J1CL D0J1CL DRUGCOMP MacroChem Corporation D0J1CL DRUGTYPE Small molecular drug D0J1CL DRUGINCH 1S/C18H15Cl3N2O.HNO3/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21;2-1(3)4/h1-9,12,18H,10-11H2;(H,2,3,4) D0J1CL DRUGINKE DDXORDQKGIZAME-UHFFFAOYSA-N D0J1CL DRUGSMIL C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-] D0J1CL HIGHSTAT Phase 2 D0J4LI DRUG__ID D0J4LI D0J4LI DRUGCOMP Weizmann Institute of Science D0J4LI DRUGTYPE Small molecular drug D0J4LI DRUGINCH 1S/C43H67N9O13/c1-24(2)19-27(45)37(58)47-29(15-16-35(54)55)40(61)50-31(22-36(56)57)38(59)46-23-34(53)52-18-10-14-33(52)42(63)48-28(13-8-9-17-44)39(60)49-30(21-26-11-6-5-7-12-26)41(62)51-32(43(64)65)20-25(3)4/h5-7,11-12,24-25,27-33H,8-10,13-23,44-45H2,1-4H3,(H,46,59)(H,47,58)(H,48,63)(H,49,60)(H,50,61)(H,51,62)(H,54,55)(H,56,57)(H,64,65)/t27-,28-,29-,30-,31-,32-,33-/m0/s1 D0J4LI DRUGINKE NYJVPTKMDYSZDU-MRNVWEPHSA-N D0J4LI DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NCC(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)O)N D0J4LI HIGHSTAT Phase 2 D0J4PB DRUG__ID D0J4PB D0J4PB DRUGCOMP GlaxoSmithKline D0J4PB DRUGTYPE Small molecular drug D0J4PB DRUGINCH 1S/C23H24F7N3O.CH4O3S/c1-13-8-18(24)4-5-19(13)20-12-31-6-7-33(20)21(34)32(3)14(2)15-9-16(22(25,26)27)11-17(10-15)23(28,29)30;1-5(2,3)4/h4-5,8-11,14,20,31H,6-7,12H2,1-3H3;1H3,(H,2,3,4)/t14-,20-;/m1./s1 D0J4PB DRUGINKE BHECXGHXWKHZOY-DXPOFMJKSA-N D0J4PB DRUGSMIL CC1=C(C=CC(=C1)F)C2CNCCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F.CS(=O)(=O)O D0J4PB HIGHSTAT Phase 2 D0J4YV DRUG__ID D0J4YV D0J4YV DRUGCOMP Zealand Pharma A/S; Zengen D0J4YV DRUGTYPE Small molecular drug D0J4YV DRUGINCH 1S/C113H181N33O25S/c1-66(2)94(95(121)154)145-111(170)91-38-25-54-146(91)112(171)84(36-16-23-52-120)130-92(151)62-127-96(155)87(58-70-60-126-74-29-9-8-28-73(70)74)141-102(161)81(37-24-53-125-113(122)123)136-106(165)85(56-68-26-6-5-7-27-68)139-108(167)88(59-71-61-124-65-128-71)142-104(163)82(43-44-93(152)153)137-105(164)83(45-55-172-4)138-109(168)89(63-147)144-107(166)86(57-69-39-41-72(150)42-40-69)140-110(169)90(64-148)143-103(162)80(35-15-22-51-119)135-101(160)79(34-14-21-50-118)134-100(159)78(33-13-20-49-117)133-99(158)77(32-12-19-48-116)132-98(157)76(31-11-18-47-115)131-97(156)75(129-67(3)149)30-10-17-46-114/h5-9,26-29,39-42,60-61,65-66,75-91,94,126,147-148,150H,10-25,30-38,43-59,62-64,114-120H2,1-4H3,(H2,121,154)(H,124,128)(H,127,155)(H,129,149)(H,130,151)(H,131,156)(H,132,157)(H,133,158)(H,134,159)(H,135,160)(H,136,165)(H,137,164)(H,138,168)(H,139,167)(H,140,169)(H,141,161)(H,142,163)(H,143,162)(H,144,166)(H,145,170)(H,152,153)(H4,122,123,125)/t75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,94-/m0/s1 D0J4YV DRUGINKE WHRVKPBBRZHWTN-ZHHKRVSMSA-N D0J4YV DRUGSMIL CC(C)C(C(=O)N)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C D0J4YV HIGHSTAT Phase 2 D0J5ED DRUG__ID D0J5ED D0J5ED DRUGCOMP Lytix Biopharma AS D0J5ED DRUGTYPE Small molecular drug D0J5ED DRUGINCH 1S/C43H69N11O3/c1-41(2,3)27-23-28-29(35(43(7,8)9)54-34(28)30(24-27)42(4,5)6)25-33(53-36(55)31(44)17-13-20-50-39(45)46)38(57)52-32(18-14-21-51-40(47)48)37(56)49-22-19-26-15-11-10-12-16-26/h10-12,15-16,23-24,31-33,54H,13-14,17-22,25,44H2,1-9H3,(H,49,56)(H,52,57)(H,53,55)(H4,45,46,50)(H4,47,48,51)/t31-,32-,33-/m0/s1 D0J5ED DRUGINKE ZVOYWSKEBVVLGW-ZDCRTTOTSA-N D0J5ED DRUGSMIL CC(C)(C)C1=CC2=C(C(=C1)C(C)(C)C)NC(=C2CC(C(=O)NC(CCCN=C(N)N)C(=O)NCCC3=CC=CC=C3)NC(=O)C(CCCN=C(N)N)N)C(C)(C)C D0J5ED HIGHSTAT Phase 2 D0J5UK DRUG__ID D0J5UK D0J5UK DRUGCOMP Tni biotech D0J5UK DRUGTYPE Small molecular drug D0J5UK DRUGINCH 1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39) D0J5UK DRUGINKE YFGBQHOOROIVKG-UHFFFAOYSA-N D0J5UK DRUGSMIL CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N D0J5UK HIGHSTAT Phase 2 D0J6GJ DRUG__ID D0J6GJ D0J6GJ THERCLAS Antiviral Agents D0J6GJ DRUGTYPE Small molecular drug D0J6GJ DRUGINCH 1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H D0J6GJ DRUGINKE DYEFUKCXAQOFHX-UHFFFAOYSA-N D0J6GJ DRUGSMIL C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2 D0J6GJ HIGHSTAT Phase 2 Trial D0J6LN DRUG__ID D0J6LN D0J6LN DRUGCOMP Exonhit D0J6LN DRUGTYPE Small molecular drug D0J6LN DRUGINCH 1S/C14H19N5O2/c1-5-19-13-10(8-16-19)12(18-17-9(3)4)11(7-15-13)14(20)21-6-2/h7-8H,5-6H2,1-4H3,(H,15,18) D0J6LN DRUGINKE OPQRBXUBWHDHPQ-UHFFFAOYSA-N D0J6LN DRUGSMIL CCN1C2=NC=C(C(=C2C=N1)NN=C(C)C)C(=O)OCC D0J6LN HIGHSTAT Phase 2 D0J6UA DRUG__ID D0J6UA D0J6UA DRUGCOMP Concert Pharmaceuticals D0J6UA DRUGTYPE Small molecular drug D0J6UA DRUGINCH 1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m0/s1/i1D3,6D2 D0J6UA DRUGINKE NSMXQKNUPPXBRG-WHPHVCHMSA-N D0J6UA DRUGSMIL CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O D0J6UA HIGHSTAT Phase 2 D0J7EH DRUG__ID D0J7EH D0J7EH DRUGCOMP Angiogenix D0J7EH DRUGTYPE Small molecular drug D0J7EH DRUGINCH 1S/C18H16ClNO5/c1-3-22-17(21)11(2)23-13-5-7-14(8-6-13)24-18-20-15-9-4-12(19)10-16(15)25-18/h4-11H,3H2,1-2H3 D0J7EH DRUGINKE PQKBPHSEKWERTG-UHFFFAOYSA-N D0J7EH DRUGSMIL CCOC(=O)C(C)OC1=CC=C(C=C1)OC2=NC3=C(O2)C=C(C=C3)Cl D0J7EH HIGHSTAT Phase 2 D0J8RR DRUG__ID D0J8RR D0J8RR DRUGCOMP Avanir D0J8RR DRUGTYPE Small molecular drug D0J8RR DRUGINCH 1S/C18H25NO.BrH.H2O/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18;;/h6-7,12,15,17H,3-5,8-11H2,1-2H3;1H;1H2/t15-,17+,18+;;/m1../s1 D0J8RR DRUGINKE STTADZBLEUMJRG-IKNOHUQMSA-N D0J8RR DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC.O.Br D0J8RR HIGHSTAT Phase 2 D0J8YA DRUG__ID D0J8YA D0J8YA DRUGCOMP BioTime Inc D0J8YA DRUGTYPE Small molecular drug D0J8YA DRUGINCH 1S/2ClH.2K.Mg.3Na.2H3O4P.H2O4S/c;;;;;;;;3*1-5(2,3)4/h2*1H;;;;;;;2*(H3,1,2,3,4);(H2,1,2,3,4)/q;;2*+1;+2;3*+1;;;/p-7 D0J8YA DRUGINKE DWAYUNSAAKQFJZ-UHFFFAOYSA-G D0J8YA DRUGSMIL OP(=O)(O)[O-].OP(=O)([O-])[O-].[O-]S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Mg+2].[Cl-].[Cl-].[K+].[K+] D0J8YA HIGHSTAT Phase 2 D0J9PT DRUG__ID D0J9PT D0J9PT DRUGCOMP Bristol-Myers Squibb D0J9PT DRUGTYPE Small molecular drug D0J9PT DRUGINCH 1S/C24H22N4/c1-28-14-20-13-19(23-10-11-24(25)27-26-23)8-9-21(20)22(15-28)18-7-6-16-4-2-3-5-17(16)12-18/h2-13,22H,14-15H2,1H3,(H2,25,27)/t22-/m0/s1 D0J9PT DRUGINKE VCIBGDSRPUOBOG-QFIPXVFZSA-N D0J9PT DRUGSMIL CN1CC(C2=C(C1)C=C(C=C2)C3=NN=C(C=C3)N)C4=CC5=CC=CC=C5C=C4 D0J9PT HIGHSTAT Phase 2 D0JI8B DRUG__ID D0JI8B D0JI8B DRUGCOMP Taxolog Inc D0JI8B DRUGTYPE Small molecular drug D0JI8B DRUGINCH 1S/C44H55NO16/c1-10-29(47)58-27-19-28-43(21-56-28,60-23(3)46)34-36(59-37(51)24-15-12-11-13-16-24)44(54)20-26(22(2)30(41(44,7)8)32(48)35(50)42(27,34)9)57-38(52)33(49)31(25-17-14-18-55-25)45-39(53)61-40(4,5)6/h11-18,26-28,31-34,36,48-49,54H,10,19-21H2,1-9H3,(H,45,53)/t26-,27-,28+,31-,32+,33+,34-,36-,42+,43-,44+/m0/s1 D0JI8B DRUGINKE XIVMHSNIQAICTR-UQYHODNASA-N D0JI8B DRUGSMIL CCC(=O)OC1CC2C(CO2)(C3C1(C(=O)C(C4=C(C(CC(C3OC(=O)C5=CC=CC=C5)(C4(C)C)O)OC(=O)C(C(C6=CC=CO6)NC(=O)OC(C)(C)C)O)C)O)C)OC(=O)C D0JI8B HIGHSTAT Phase 2 D0K2RY DRUG__ID D0K2RY D0K2RY DRUGCOMP Rottapharm Madaus D0K2RY DRUGTYPE Small molecular drug D0K2RY DRUGINCH 1S/C33H38N2O4/c1-22-18-23(2)31(28(19-22)32(39)35-16-14-33(15-17-35)12-5-6-13-33)34-29(36)20-25(21-30(37)38)27-11-7-9-24-8-3-4-10-26(24)27/h3-4,7-11,18-19,25H,5-6,12-17,20-21H2,1-2H3,(H,34,36)(H,37,38)/t25-/m1/s1 D0K2RY DRUGINKE MFOOVZCXWVAWOV-RUZDIDTESA-N D0K2RY DRUGSMIL CC1=CC(=C(C(=C1)C(=O)N2CCC3(CCCC3)CC2)NC(=O)CC(CC(=O)O)C4=CC=CC5=CC=CC=C54)C D0K2RY HIGHSTAT Phase 2 D0K2WK DRUG__ID D0K2WK D0K2WK DRUGCOMP Gilead Sciences D0K2WK DRUGTYPE Small molecular drug D0K2WK DRUGINCH 1S/C14H12ClNO2/c1-8-13(17)12-7-18-14(11(12)6-16-8)9-2-4-10(15)5-3-9/h2-6,14,17H,7H2,1H3 D0K2WK DRUGINKE CVKNDPRBJVBDSS-UHFFFAOYSA-N D0K2WK DRUGSMIL CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl D0K2WK HIGHSTAT Phase 2 D0K2ZF DRUG__ID D0K2ZF D0K2ZF DRUGCOMP Pfizer D0K2ZF DRUGTYPE Small molecular drug D0K2ZF DRUGINCH 1S/C22H19BrF2N2O3/c1-12-4-5-14(21(28)26-3)9-18(12)27-13(2)8-19(20(23)22(27)29)30-11-15-6-7-16(24)10-17(15)25/h4-10H,11H2,1-3H3,(H,26,28) D0K2ZF DRUGINKE KCAJXIDMCNPGHZ-UHFFFAOYSA-N D0K2ZF DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C D0K2ZF HIGHSTAT Phase 2 D0K5HI DRUG__ID D0K5HI D0K5HI DRUGCOMP GlaxoSmithKline D0K5HI DRUGTYPE Small molecular drug D0K5HI DRUGINCH 1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1 D0K5HI DRUGINKE BIAVGWDGIJKWRM-FQEVSTJZSA-N D0K5HI DRUGSMIL CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)O D0K5HI HIGHSTAT Phase 2 D0K7DV DRUG__ID D0K7DV D0K7DV DRUGCOMP Cellceutix Corp D0K7DV DRUGTYPE Small molecular drug D0K7DV DRUGINCH 1S/C5H9N3S/c6-3-1-2-4-9-5(7)8/h1-2,4H2,(H3,7,8) D0K7DV DRUGINKE PRDJGNVQBVXXEO-UHFFFAOYSA-N D0K7DV DRUGSMIL C(CC#N)CSC(=N)N D0K7DV HIGHSTAT Phase 2 D0K8DI DRUG__ID D0K8DI D0K8DI DRUGCOMP Sequella D0K8DI DRUGTYPE Small molecular drug D0K8DI DRUGINCH 1S/C22H38N2/c1-16(2)5-4-6-17(3)7-8-23-9-10-24-22-20-12-18-11-19(14-20)15-21(22)13-18/h5,7,18-24H,4,6,8-15H2,1-3H3/b17-7+ D0K8DI DRUGINKE JFIBVDBTCDTBRH-REZTVBANSA-N D0K8DI DRUGSMIL CC(=CCCC(=CCNCCNC1C2CC3CC(C2)CC1C3)C)C D0K8DI HIGHSTAT Phase 2 D0KD5P DRUG__ID D0KD5P D0KD5P DRUGCOMP Neuren Pharmaceuticals D0KD5P DRUGTYPE Small molecular drug D0KD5P DRUGINCH 1S/C14H18N2O2/c1-10-5-3-6-11(2)14(10)15-12(17)9-16-8-4-7-13(16)18/h3,5-6H,4,7-9H2,1-2H3,(H,15,17) D0KD5P DRUGINKE NGHTXZCKLWZPGK-UHFFFAOYSA-N D0KD5P DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O D0KD5P HIGHSTAT Phase 2 D0KL3U DRUG__ID D0KL3U D0KL3U DRUGCOMP Ar te Therapeutics D0KL3U DRUGTYPE Small molecular drug D0KL3U DRUGINCH 1S/C18H29N3O2/c1-12(22)21-4-2-16(3-5-21)19-17(23)20-18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H2,19,20,23) D0KL3U DRUGINKE HUDQLWBKJOMXSZ-UHFFFAOYSA-N D0KL3U DRUGSMIL CC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D0KL3U HIGHSTAT Phase 2 D0KQ0C DRUG__ID D0KQ0C D0KQ0C DRUGCOMP Pfizer; Zealand Pharma D0KQ0C DRUGTYPE Small molecular drug D0KQ0C DRUGINCH 1S/C14H17N3O4/c15-7-12(18)17-8-10(6-11(17)14(20)21)16-13(19)9-4-2-1-3-5-9/h1-5,10-11H,6-8,15H2,(H,16,19)(H,20,21)/t10-,11+/m1/s1 D0KQ0C DRUGINKE BIZKIHUJGMSVFD-MNOVXSKESA-N D0KQ0C DRUGSMIL C1C(CN(C1C(=O)O)C(=O)CN)NC(=O)C2=CC=CC=C2 D0KQ0C HIGHSTAT Phase 2 D0KU4M DRUG__ID D0KU4M D0KU4M DRUGCOMP Metabasis Therape D0KU4M DRUGTYPE Small molecular drug D0KU4M DRUGINCH 1S/C24H37N4O7PS/c1-10-33-19(30)23(6,7)27-36(32,28-24(8,9)20(31)34-11-2)15-13-12-14(35-15)16-17(37-21(25)26-16)18(29)22(3,4)5/h12-13H,10-11H2,1-9H3,(H2,25,26)(H2,27,28,32) D0KU4M DRUGINKE CTKZZUXRWBCFEI-UHFFFAOYSA-N D0KU4M DRUGSMIL CCOC(=O)C(C)(C)NP(=O)(C1=CC=C(O1)C2=C(SC(=N2)N)C(=O)C(C)(C)C)NC(C)(C)C(=O)OCC D0KU4M HIGHSTAT Phase 2 D0KX9B DRUG__ID D0KX9B D0KX9B DRUGCOMP Elevation Pharmaceuticals D0KX9B DRUGTYPE Small molecular drug D0KX9B DRUGINCH 1S/C8H12O/c1-2-6-3-4-7-8(5-6)9-7/h2,6-8H,1,3-5H2 D0KX9B DRUGINKE SLJFKNONPLNAPF-UHFFFAOYSA-N D0KX9B DRUGSMIL C=CC1CCC2C(C1)O2 D0KX9B HIGHSTAT Phase 2 D0L1KX DRUG__ID D0L1KX D0L1KX DRUGCOMP Ferring Pharmaceuticals Inc D0L1KX DRUGTYPE Small molecular drug D0L1KX DRUGINCH 1S/C36H49N9O4/c1-2-3-15-30(34(48)43-29(16-10-19-41-36(38)39)33(47)42-24-27-17-20-40-21-18-27)44-35(49)31(23-26-13-8-5-9-14-26)45-32(46)28(37)22-25-11-6-4-7-12-25/h4-9,11-14,17-18,20-21,28-31H,2-3,10,15-16,19,22-24,37H2,1H3,(H,42,47)(H,43,48)(H,44,49)(H,45,46)(H4,38,39,41)/t28-,29-,30-,31-/m1/s1 D0L1KX DRUGINKE DBOGGOVKHSCMNB-OMRVPHBLSA-N D0L1KX DRUGSMIL CCCCC(C(=O)NC(CCCN=C(N)N)C(=O)NCC1=CC=NC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)N D0L1KX HIGHSTAT Phase 2 D0L1VI DRUG__ID D0L1VI D0L1VI DRUGCOMP Tulane University D0L1VI DRUGTYPE Small molecular drug D0L1VI DRUGINCH 1S/C16H22ClN3.2ClH/c1-3-20(4-2)11-5-9-18-15-8-10-19-16-12-13(17)6-7-14(15)16;;/h6-8,10,12H,3-5,9,11H2,1-2H3,(H,18,19);2*1H D0L1VI DRUGINKE ZNHBPWZRWNFJPN-UHFFFAOYSA-N D0L1VI DRUGSMIL CCN(CC)CCCNC1=C2C=CC(=CC2=NC=C1)Cl.Cl.Cl D0L1VI HIGHSTAT Phase 2 D0L3HU DRUG__ID D0L3HU D0L3HU DRUGCOMP Bayer HealthCare Pharmaceuticals D0L3HU DRUGTYPE Small molecular drug D0L3HU DRUGINCH 1S/C28H29F5O3/c1-15(34)16-3-5-17(6-4-16)22-14-25(2)23(11-12-26(25,36)27(29,30)28(31,32)33)21-9-7-18-13-19(35)8-10-20(18)24(21)22/h3-6,13,21-23,36H,7-12,14H2,1-2H3/t21-,22+,23-,25-,26-/m0/s1 D0L3HU DRUGINKE VHZPUDNSVGRVMB-RXDLHWJPSA-N D0L3HU DRUGSMIL CC(=O)C1=CC=C(C=C1)C2CC3(C(CCC3(C(C(F)(F)F)(F)F)O)C4C2=C5CCC(=O)C=C5CC4)C D0L3HU HIGHSTAT Phase 2 D0L3TR DRUG__ID D0L3TR D0L3TR DRUGCOMP Pantarhei Bioscience BV D0L3TR DRUGTYPE Small molecular drug D0L3TR DRUGINCH 1S/C18H24O4/c1-18-7-6-12-11-5-3-10(19)8-9(11)2-4-13(12)14(18)15(20)16(21)17(18)22/h3,5,8,12-17,19-22H,2,4,6-7H2,1H3/t12-,13-,14-,15-,16-,17+,18+/m1/s1 D0L3TR DRUGINKE AJIPIJNNOJSSQC-NYLIRDPKSA-N D0L3TR DRUGSMIL CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O D0L3TR HIGHSTAT Phase 2 D0L5GH DRUG__ID D0L5GH D0L5GH DRUGCOMP Boehringer Ingelheim D0L5GH DRUGTYPE Small molecular drug D0L5GH DRUGINCH 1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1 D0L5GH DRUGINKE ITIXDWVDFFXNEG-JHOUSYSJSA-N D0L5GH DRUGSMIL C1CN(CCC1N2CC3=CC=CC=C3NC2=O)C(=O)NC(CC4=CC(=C(C(=C4)Br)O)Br)C(=O)NC(CCCCN)C(=O)N5CCN(CC5)C6=CC=NC=C6 D0L5GH HIGHSTAT Phase 2 D0L5XG DRUG__ID D0L5XG D0L5XG DRUGCOMP Pfizer Inc D0L5XG DRUGTYPE Small molecular drug D0L5XG DRUGINCH 1S/C22H23N3O2S/c1-25-20(9-12-24-25)16-5-7-18(8-6-16)28-19-4-2-3-17(15-19)22(21(23)26)10-13-27-14-11-22/h2-9,12,15H,10-11,13-14H2,1H3,(H2,23,26) D0L5XG DRUGINKE DVNQWYLVSNPCJZ-UHFFFAOYSA-N D0L5XG DRUGSMIL CN1C(=CC=N1)C2=CC=C(C=C2)SC3=CC=CC(=C3)C4(CCOCC4)C(=O)N D0L5XG HIGHSTAT Phase 2 D0L6OA DRUG__ID D0L6OA D0L6OA DRUGCOMP BioLineRx D0L6OA DRUGTYPE Small molecular drug D0L6OA DRUGINCH 1S/C25H33ClN4O2S/c26-20-8-9-24-22(19-20)30(21-5-1-2-6-23(21)33-24)12-4-11-28-13-15-29(16-14-28)17-18-32-25(31)7-3-10-27/h1-2,5-6,8-9,19H,3-4,7,10-18,27H2 D0L6OA DRUGINKE BABFYCSPNDKXRI-UHFFFAOYSA-N D0L6OA DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCOC(=O)CCCN D0L6OA HIGHSTAT Phase 2 D0L8KJ DRUG__ID D0L8KJ D0L8KJ DRUGCOMP Glenmark Pharmaceuticals Ltd D0L8KJ DRUGTYPE Small molecular drug D0L8KJ DRUGINCH 1S/C20H13Cl2F2N3O5S/c1-33(29,30)27-9-2-4-14-11(6-9)16-10(3-5-15(18(16)31-14)32-20(23)24)19(28)26-17-12(21)7-25-8-13(17)22/h2-8,20,27H,1H3,(H,25,26,28) D0L8KJ DRUGINKE OKFDRAHPFKMAJH-UHFFFAOYSA-N D0L8KJ DRUGSMIL CS(=O)(=O)NC1=CC2=C(C=C1)OC3=C(C=CC(=C23)C(=O)NC4=C(C=NC=C4Cl)Cl)OC(F)F D0L8KJ HIGHSTAT Phase 2 D0LA1R DRUG__ID D0LA1R D0LA1R DRUGCOMP Novartis D0LA1R DRUGTYPE Small molecular drug D0LA1R DRUGINCH 1S/C27H36N4O5S.C24H31N5O4.CH4O3S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27;1-3-16-6-8-19(27-23(16)25-2)9-7-17-10-12-29(24(17)33)15-21(30)28-20(13-22(31)32)18-5-4-11-26-14-18;1-5(2,3)4/h4-12,22H,13-19,28H2,1-3H3,(H,29,33);4-6,8,11,14,17,20H,3,7,9-10,12-13,15H2,1-2H3,(H,25,27)(H,28,30)(H,31,32);1H3,(H,2,3,4)/t22-;17-,20-;/m10./s1 D0LA1R DRUGINKE XAOWMNBAVQDQSR-WQDYQDSXSA-N D0LA1R DRUGSMIL CCC1=C(N=C(C=C1)CCC2CCN(C2=O)CC(=O)NC(CC(=O)O)C3=CN=CC=C3)NC.CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=CC=CC=C34)S(=O)(=O)C)N.CS(=O)(=O)O D0LA1R HIGHSTAT Phase 2 D0LF1U DRUG__ID D0LF1U D0LF1U DRUGCOMP Sanofi-Aventis D0LF1U DRUGTYPE Small molecular drug D0LF1U DRUGINCH 1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1 D0LF1U DRUGINKE BIIVYFLTOXDAOV-YVEFUNNKSA-N D0LF1U DRUGSMIL CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O D0LF1U HIGHSTAT Phase 2 D0LH4J DRUG__ID D0LH4J D0LH4J DRUGCOMP Novartis Pharmaceuticals D0LH4J DRUGTYPE Small molecular drug D0LH4J DRUGINCH 1S/C30H53N3O6.C24H29N5O3/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-,23+,24-,25-;22-/m00/s1 D0LH4J DRUGINKE AYFQOWOITXDUOI-MTFPVJPISA-N D0LH4J DRUGSMIL CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N D0LH4J HIGHSTAT Phase 2 D0M0UT DRUG__ID D0M0UT D0M0UT DRUGCOMP Cornell University D0M0UT DRUGTYPE Small molecular drug D0M0UT DRUGINCH 1S/C4H5NO3S/c6-3(7)2-1-9-4(8)5-2/h2H,1H2,(H,5,8)(H,6,7)/t2-/m0/s1 D0M0UT DRUGINKE BMLMGCPTLHPWPY-REOHCLBHSA-N D0M0UT DRUGSMIL C1C(NC(=O)S1)C(=O)O D0M0UT HIGHSTAT Phase 2 D0M1II DRUG__ID D0M1II D0M1II DRUGCOMP Zhejiang hisun pharmaceutical D0M1II DRUGTYPE Small molecular drug D0M1II DRUGINCH 1S/C25H21F2NO3/c26-19-6-1-16(2-7-19)18(15-29)5-14-23-24(17-3-12-22(30)13-4-17)28(25(23)31)21-10-8-20(27)9-11-21/h1-13,23-24,29-30H,14-15H2/b18-5+/t23-,24-/m1/s1 D0M1II DRUGINKE HEHHPZYUXSFAPV-SMOXZEHUSA-N D0M1II DRUGSMIL C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CC=C(CO)C4=CC=C(C=C4)F)O D0M1II HIGHSTAT Phase 2 D0M1MZ DRUG__ID D0M1MZ D0M1MZ DRUGCOMP Theratechnologies Inc D0M1MZ DRUGTYPE Small molecular drug D0M1MZ DRUGINCH 1S/C21H14Br2N2O3.ClH/c1-27-21(26)11-5-3-2-4-10(11)16-12-6-8-14(24)17(22)19(12)28-20-13(16)7-9-15(25)18(20)23;/h2-9,24H,25H2,1H3;1H D0M1MZ DRUGINKE MUDCDMMNYVJLEB-UHFFFAOYSA-N D0M1MZ DRUGSMIL COC(=O)C1=CC=CC=C1C2=C3C=CC(=N)C(=C3OC4=C2C=CC(=C4Br)N)Br.Cl D0M1MZ HIGHSTAT Phase 2 D0M2WZ DRUG__ID D0M2WZ D0M2WZ DRUGCOMP NeuroSearch A/S D0M2WZ DRUGTYPE Small molecular drug D0M2WZ DRUGINCH 1S/C22H20N4O/c1-3-27-25-16(2)17-9-10-22-21(13-17)24-15-26(22)20-8-4-6-18(12-20)19-7-5-11-23-14-19/h4-15H,3H2,1-2H3/b25-16+ D0M2WZ DRUGINKE NHJFEXZXSCFYRX-PCLIKHOPSA-N D0M2WZ DRUGSMIL CCON=C(C)C1=CC2=C(C=C1)N(C=N2)C3=CC=CC(=C3)C4=CN=CC=C4 D0M2WZ HIGHSTAT Phase 2 D0M5BS DRUG__ID D0M5BS D0M5BS DRUGCOMP Ono Pharmaceuticals D0M5BS DRUGTYPE Small molecular drug D0M5BS DRUGINCH 1S/C20H27N3O4/c1-26-17-7-6-15(12-18(17)27-16-4-2-3-5-16)20(14-21)8-10-23(11-9-20)13-19(24)22-25/h6-7,12,16,25H,2-5,8-11,13H2,1H3,(H,22,24) D0M5BS DRUGINKE VXYDHPDQMSVQCU-UHFFFAOYSA-N D0M5BS DRUGSMIL COC1=C(C=C(C=C1)C2(CCN(CC2)CC(=O)NO)C#N)OC3CCCC3 D0M5BS HIGHSTAT Phase 2 D0M5HV DRUG__ID D0M5HV D0M5HV DRUGCOMP Merck D0M5HV DRUGTYPE Small molecular drug D0M5HV DRUGINCH 1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39) D0M5HV DRUGINKE UCHDWCPVSPXUMX-UHFFFAOYSA-N D0M5HV DRUGSMIL CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O D0M5HV HIGHSTAT Phase 2 D0M5WS DRUG__ID D0M5WS D0M5WS DRUGCOMP Janssen Research & Development D0M5WS DRUGTYPE Small molecular drug D0M5WS DRUGINCH 1S/C34H31F3N2O3/c1-42-33(41)31(26-7-3-2-4-8-26)39-21-19-24(20-22-39)23-13-17-28(18-14-23)38-32(40)30-10-6-5-9-29(30)25-11-15-27(16-12-25)34(35,36)37/h2-18,24,31H,19-22H2,1H3,(H,38,40)/t31-/m1/s1 D0M5WS DRUGINKE WSYALRNYQFNNGP-WJOKGBTCSA-N D0M5WS DRUGSMIL COC(=O)C(C1=CC=CC=C1)N2CCC(CC2)C3=CC=C(C=C3)NC(=O)C4=CC=CC=C4C5=CC=C(C=C5)C(F)(F)F D0M5WS HIGHSTAT Phase 2 D0M6BA DRUG__ID D0M6BA D0M6BA DRUGCOMP Arno Therapeutics D0M6BA DRUGTYPE Small molecular drug D0M6BA DRUGINCH 1S/C26H30N2O5Si/c1-7-26(32)18-11-20-21-16(12-28(20)23(30)17(18)13-33-24(26)31)22(34(5,6)25(2,3)4)15-10-14(29)8-9-19(15)27-21/h8-11,29,32H,7,12-13H2,1-6H3/t26-/m0/s1 D0M6BA DRUGINKE XUSKJHCMMWAAHV-SANMLTNESA-N D0M6BA DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=C(C=CC(=C5)O)N=C4C3=C2)[Si](C)(C)C(C)(C)C)O D0M6BA HIGHSTAT Phase 2 D0M6BD DRUG__ID D0M6BD D0M6BD DRUGCOMP Roche; Verastem Oncology D0M6BD DRUGTYPE Small molecular drug D0M6BD DRUGINCH 1S/C21H18FN5O5S/c1-12-15-5-4-14(31-21-25-7-3-8-26-21)11-17(15)32-20(28)16(12)10-13-6-9-24-19(18(13)22)27-33(29,30)23-2/h3-9,11,23H,10H2,1-2H3,(H,24,27) D0M6BD DRUGINKE LMMJFBMMJUMSJS-UHFFFAOYSA-N D0M6BD DRUGSMIL CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F D0M6BD HIGHSTAT Phase 2 D0M7CB DRUG__ID D0M7CB D0M7CB DRUGCOMP Merck & Co Inc D0M7CB DRUGTYPE Small molecular drug D0M7CB DRUGINCH 1S/C25H18N4O3/c30-23-21-7-2-12-26-24(21)29(16-22(23)25(31)27-19-10-11-19)20-6-1-4-17(14-20)8-9-18-5-3-13-28(32)15-18/h1-7,12-16,19H,10-11H2,(H,27,31) D0M7CB DRUGINKE JJWKQXNHYDJXKF-UHFFFAOYSA-N D0M7CB DRUGSMIL C1CC1NC(=O)C2=CN(C3=C(C2=O)C=CC=N3)C4=CC=CC(=C4)C#CC5=C[N+](=CC=C5)[O-] D0M7CB HIGHSTAT Phase 2 D0M7DS DRUG__ID D0M7DS D0M7DS DRUGCOMP Medivir AB D0M7DS DRUGTYPE Small molecular drug D0M7DS DRUGINCH 1S/C33H58N6O5/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27(40)44-23-26(20-21-43-32(42)28(34)25(2)3)22-39-24-36-29-30(39)37-33(35)38-31(29)41/h24-26,28H,4-23,34H2,1-3H3,(H3,35,37,38,41)/t26-,28+/m1/s1 D0M7DS DRUGINKE ACBSZTQIFTYFGH-IAPPQJPRSA-N D0M7DS DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)OCC(CCOC(=O)C(C(C)C)N)CN1C=NC2=C1N=C(NC2=O)N D0M7DS HIGHSTAT Phase 2 D0M7PU DRUG__ID D0M7PU D0M7PU DRUGCOMP PharmaMar D0M7PU DRUGTYPE Small molecular drug D0M7PU DRUGINCH 1S/C37H38F3N3O8/c1-17-11-21-13-25-36(47)43-24(30(42(25)4)28(21)31(46)32(17)48-5)14-23-29(35-34(49-16-50-35)18(2)33(23)51-19(3)44)26(43)15-41-27(45)10-9-20-7-6-8-22(12-20)37(38,39)40/h6-12,24-26,30,36,46-47H,13-16H2,1-5H3,(H,41,45)/b10-9+/t24-,25-,26-,30-,36-/m0/s1 D0M7PU DRUGINKE VPAHZSUNBOYNQY-DLVGLDQCSA-N D0M7PU DRUGSMIL CC1=CC2=C(C3C4CC5=C(C(=C6C(=C5C(N4C(C(C2)N3C)O)CNC(=O)C=CC7=CC(=CC=C7)C(F)(F)F)OCO6)C)OC(=O)C)C(=C1OC)O D0M7PU HIGHSTAT Phase 2 D0M8OC DRUG__ID D0M8OC D0M8OC DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D0M8OC DRUGTYPE Small molecular drug D0M8OC DRUGINCH 1S/C19H27N3O2/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20/h1-4,18H,5-15H2 D0M8OC DRUGINKE BGBVSGSIXIIREO-UHFFFAOYSA-N D0M8OC DRUGSMIL C1CC1N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4 D0M8OC HIGHSTAT Phase 2 D0M9FQ DRUG__ID D0M9FQ D0M9FQ DRUGCOMP Pfizer New York, NY D0M9FQ DRUGTYPE Small molecular drug D0M9FQ DRUGINCH 1S/C20H28N8O4S/c1-6-27(4)20-23-15-16(19(29)26-33(5,30)31)25-28(10-11-32-7-2)17(15)18(24-20)22-14-12-13(3)8-9-21-14/h8-9,12H,6-7,10-11H2,1-5H3,(H,26,29)(H,21,22,23,24) D0M9FQ DRUGINKE ZUHZNKJIJDAJFD-UHFFFAOYSA-N D0M9FQ DRUGSMIL CCN(C)C1=NC2=C(C(=N1)NC3=NC=CC(=C3)C)N(N=C2C(=O)NS(=O)(=O)C)CCOCC D0M9FQ HIGHSTAT Phase 2 D0MP0X DRUG__ID D0MP0X D0MP0X DRUGCOMP AstraZeneca D0MP0X DRUGTYPE Small molecular drug D0MP0X DRUGINCH 1S/C14H14ClFN8/c1-7-3-11(24-23-7)21-13-10(15)6-19-14(22-13)20-8(2)12-17-4-9(16)5-18-12/h3-6,8H,1-2H3,(H3,19,20,21,22,23,24)/t8-/m0/s1 D0MP0X DRUGINKE PDOQBOJDRPLBQU-QMMMGPOBSA-N D0MP0X DRUGSMIL CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F D0MP0X HIGHSTAT Phase 2 D0MT1Q DRUG__ID D0MT1Q D0MT1Q DRUGCOMP Moberg Derma AB D0MT1Q DRUGTYPE Small molecular drug D0MT1Q DRUGINCH 1S/C25H32N2O2S.ClH/c1-29-23-7-8-24-22(18-23)19-27(15-16-30-24)25(28)11-14-26-12-9-21(10-13-26)17-20-5-3-2-4-6-20;/h2-8,18,21H,9-17,19H2,1H3;1H D0MT1Q DRUGINKE DKKLXCRMAXNIJF-UHFFFAOYSA-N D0MT1Q DRUGSMIL COC1=CC2=C(C=C1)SCCN(C2)C(=O)CCN3CCC(CC3)CC4=CC=CC=C4.Cl D0MT1Q HIGHSTAT Phase 2 D0N0AR DRUG__ID D0N0AR D0N0AR DRUGCOMP Eisai D0N0AR DRUGTYPE Small molecular drug D0N0AR DRUGINCH 1S/C12H19NO4/c1-4-12(2,3)9(14)10(15)13-7-5-6-8(13)11(16)17/h8H,4-7H2,1-3H3,(H,16,17)/t8-/m0/s1 D0N0AR DRUGINKE FOPALECPEUVCTL-QMMMGPOBSA-N D0N0AR DRUGSMIL CCC(C)(C)C(=O)C(=O)N1CCCC1C(=O)O D0N0AR HIGHSTAT Phase 2 D0N1CH DRUG__ID D0N1CH D0N1CH DRUGCOMP AGI Therapeutics D0N1CH DRUGTYPE Small molecular drug D0N1CH DRUGINCH 1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3/t26-/m1/s1 D0N1CH DRUGINKE UPKQNCPKPOLASS-AREMUKBSSA-N D0N1CH DRUGSMIL CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC D0N1CH HIGHSTAT Phase 2 D0N1TH DRUG__ID D0N1TH D0N1TH DRUGCOMP ARYx Therapeutics D0N1TH DRUGTYPE Small molecular drug D0N1TH DRUGINCH 1S/C27H31I2NO5/c1-5-17(4)34-24(31)16-23-25(19-10-8-9-11-22(19)35-23)26(32)18-14-20(28)27(21(29)15-18)33-13-12-30(6-2)7-3/h8-11,14-15,17H,5-7,12-13,16H2,1-4H3/t17-/m0/s1 D0N1TH DRUGINKE ZXOSVKYCXLTVGS-KRWDZBQOSA-N D0N1TH DRUGSMIL CCC(C)OC(=O)CC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I D0N1TH HIGHSTAT Phase 2 D0N3IA DRUG__ID D0N3IA D0N3IA DRUGCOMP Harbor Therapeutics D0N3IA DRUGTYPE Small molecular drug D0N3IA DRUGINCH 1S/C21H32O2/c1-4-21(23)12-9-18-16-6-5-14-13-15(22)7-10-19(14,2)17(16)8-11-20(18,21)3/h1,14-18,22-23H,5-13H2,2-3H3/t14-,15+,16+,17-,18-,19-,20-,21-/m0/s1 D0N3IA DRUGINKE CKAXZOYFIHQCBN-JRRMKBMNSA-N D0N3IA DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3CCC4(C#C)O)C)O D0N3IA HIGHSTAT Phase 2 D0N5CW DRUG__ID D0N5CW D0N5CW DRUGCOMP Oleoyl-Estrone Developments D0N5CW DRUGTYPE Small molecular drug D0N5CW DRUGINCH 1S/C36H54O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-35(38)39-29-20-22-30-28(27-29)19-21-32-31(30)25-26-36(2)33(32)23-24-34(36)37/h10-11,20,22,27,31-33H,3-9,12-19,21,23-26H2,1-2H3/b11-10-/t31-,32-,33+,36+/m1/s1 D0N5CW DRUGINKE IMIPDPVHGGHVNH-YWVHRCQQSA-N D0N5CW DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4=O)C D0N5CW HIGHSTAT Phase 2 D0N5JZ DRUG__ID D0N5JZ D0N5JZ DRUGCOMP Pfizer New York, NY D0N5JZ DRUGTYPE Small molecular drug D0N5JZ DRUGINCH 1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26) D0N5JZ DRUGINKE XDLYKKIQACFMJG-UHFFFAOYSA-N D0N5JZ DRUGSMIL CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC D0N5JZ HIGHSTAT Phase 2 D0N5KS DRUG__ID D0N5KS D0N5KS DRUGCOMP Dynogen D0N5KS DRUGTYPE Small molecular drug D0N5KS DRUGINCH 1S/C15H17N3O2S/c19-13-10(7-16-11-3-6-21-14(11)13)15(20)17-12-8-18-4-1-9(12)2-5-18/h3,6-7,9,12H,1-2,4-5,8H2,(H,16,19)(H,17,20)/t12-/m0/s1 D0N5KS DRUGINKE AFUWQWYPPZFWCO-LBPRGKRZSA-N D0N5KS DRUGSMIL C1CN2CCC1C(C2)NC(=O)C3=CNC4=C(C3=O)SC=C4 D0N5KS HIGHSTAT Phase 2 D0N5XI DRUG__ID D0N5XI D0N5XI DRUGCOMP Deltanoid Pharmaceuticals D0N5XI DRUGTYPE Small molecular drug D0N5XI DRUGINCH 1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22?,23-,24+,25+,27+/m0/s1 D0N5XI DRUGINKE UHMPCVGLSKFXHR-NFZXMVPNSA-N D0N5XI DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(=C)C(C3)O)O)C D0N5XI HIGHSTAT Phase 2 D0N5YD DRUG__ID D0N5YD D0N5YD DRUGCOMP Biotie Therapies D0N5YD DRUGTYPE Small molecular drug D0N5YD DRUGINCH 1S/C14H15F2N3S.ClH/c15-9-3-8-4-10(1-2-12(8)13(16)5-9)19-11(6-17)7-18-14(19)20;/h3,5,7,10H,1-2,4,6,17H2,(H,18,20);1H/t10-;/m0./s1 D0N5YD DRUGINKE DIPDUAJWNBEVOY-PPHPATTJSA-N D0N5YD DRUGSMIL C1CC2=C(CC1N3C(=CNC3=S)CN)C=C(C=C2F)F.Cl D0N5YD HIGHSTAT Phase 2 D0N6EA DRUG__ID D0N6EA D0N6EA DRUGCOMP GlaxoSmithKline D0N6EA DRUGTYPE Small molecular drug D0N6EA DRUGINCH 1S/C15H16O6S/c1-7-4-12(17)21-11-5-8(2-3-9(7)11)20-15-14(19)13(18)10(16)6-22-15/h2-5,10,13-16,18-19H,6H2,1H3/t10-,13+,14-,15-/m1/s1 D0N6EA DRUGINKE JRHNIQQUVJOPQC-AQNFWKISSA-N D0N6EA DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O D0N6EA HIGHSTAT Phase 2 D0N7JP DRUG__ID D0N7JP D0N7JP DRUGCOMP Allergan D0N7JP DRUGTYPE Small molecular drug D0N7JP DRUGINCH 1S/C9H12N6/c1-2-13(1)7-10-8(14-3-4-14)12-9(11-7)15-5-6-15/h1-6H2 D0N7JP DRUGINKE IUCJMVBFZDHPDX-UHFFFAOYSA-N D0N7JP DRUGSMIL C1CN1C2=NC(=NC(=N2)N3CC3)N4CC4 D0N7JP HIGHSTAT Phase 2 D0N8JG DRUG__ID D0N8JG D0N8JG DRUGCOMP Endocyte Inc D0N8JG DRUGTYPE Small molecular drug D0N8JG DRUGINCH 1S/C42H36N10O10S/c43-33(55)12-11-30(38(58)59)52(37(57)20-1-3-21(4-2-20)46-18-23-19-47-35-34(48-23)36(56)51-40(44)50-35)14-13-45-41(63)49-22-5-8-27-26(15-22)39(60)62-42(27)28-9-6-24(53)16-31(28)61-32-17-25(54)7-10-29(32)42/h1-10,15-17,19,30,46,53-54H,11-14,18H2,(H2,43,55)(H,58,59)(H2,45,49,63)(H3,44,47,50,51,56)/t30-/m0/s1 D0N8JG DRUGINKE ZMTAPBHUSYTHBY-PMERELPUSA-N D0N8JG DRUGSMIL C1=CC(=CC=C1C(=O)N(CCNC(=S)NC2=CC3=C(C=C2)C4(C5=C(C=C(C=C5)O)OC6=C4C=CC(=C6)O)OC3=O)C(CCC(=O)N)C(=O)O)NCC7=CN=C8C(=N7)C(=O)NC(=N8)N D0N8JG HIGHSTAT Phase 2 D0N8QK DRUG__ID D0N8QK D0N8QK DRUGCOMP Abbott Laboratories D0N8QK DRUGTYPE Small molecular drug D0N8QK DRUGINCH 1S/C23H24N4O/c1-25-15-19-12-14-26(22(19)16-25)20-8-4-17(5-9-20)18-6-10-21(11-7-18)27-23(28)3-2-13-24-27/h2-11,13,19,22H,12,14-16H2,1H3/t19-,22+/m1/s1 D0N8QK DRUGINKE GNIRITULTPTAQW-KNQAVFIVSA-N D0N8QK DRUGSMIL CN1CC2CCN(C2C1)C3=CC=C(C=C3)C4=CC=C(C=C4)N5C(=O)C=CC=N5 D0N8QK HIGHSTAT Phase 2 D0N9VZ DRUG__ID D0N9VZ D0N9VZ DRUGCOMP Pfizer D0N9VZ DRUGTYPE Small molecular drug D0N9VZ DRUGINCH 1S/C24H28N2O3.ClH/c1-3-26(4-2)23(28)17-9-10-18(21(27)15-17)20-16-24(11-13-25-14-12-24)29-22-8-6-5-7-19(20)22;/h5-10,15-16,25,27H,3-4,11-14H2,1-2H3;1H D0N9VZ DRUGINKE XROFSGVHHSJMMG-UHFFFAOYSA-N D0N9VZ DRUGSMIL CCN(CC)C(=O)C1=CC(=C(C=C1)C2=CC3(CCNCC3)OC4=CC=CC=C42)O.Cl D0N9VZ HIGHSTAT Phase 2 D0NN5A DRUG__ID D0NN5A D0NN5A DRUGCOMP Merck D0NN5A DRUGTYPE Small molecular drug D0NN5A DRUGINCH 1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1 D0NN5A DRUGINKE NPFDWHQSDBWQLH-QZTJIDSGSA-N D0NN5A DRUGSMIL CC1CCC(CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F D0NN5A HIGHSTAT Phase 2 D0O0JP DRUG__ID D0O0JP D0O0JP DRUGCOMP Spinifex pharmaceuticals D0O0JP DRUGTYPE Small molecular drug D0O0JP DRUGINCH 1S/C32H29NO5/c1-37-28-18-17-25-20-33(31(34)29(23-13-7-3-8-14-23)24-15-9-4-10-16-24)27(32(35)36)19-26(25)30(28)38-21-22-11-5-2-6-12-22/h2-18,27,29H,19-21H2,1H3,(H,35,36)/t27-/m0/s1 D0O0JP DRUGINKE GHBCIXGRCZIPNQ-MHZLTWQESA-N D0O0JP DRUGSMIL COC1=C(C2=C(CN(C(C2)C(=O)O)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4)C=C1)OCC5=CC=CC=C5 D0O0JP HIGHSTAT Phase 2 D0O0LC DRUG__ID D0O0LC D0O0LC DRUGCOMP Merrion Pharmaceuticals D0O0LC DRUGTYPE Small molecular drug D0O0LC DRUGINCH 1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2 D0O0LC DRUGINKE FUXFIVRTGHOMSO-UHFFFAOYSA-N D0O0LC DRUGSMIL C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O D0O0LC HIGHSTAT Phase 2 D0O1HL DRUG__ID D0O1HL D0O1HL DRUGCOMP GD Searle & Co D0O1HL DRUGTYPE Small molecular drug D0O1HL DRUGINCH 1S/C26H45NO8/c1-6-11-16-27-17-20(33-22(29)13-8-3)26(35-24(31)15-10-5)25(34-23(30)14-9-4)19(27)18-32-21(28)12-7-2/h19-20,25-26H,6-18H2,1-5H3/t19-,20+,25-,26-/m1/s1 D0O1HL DRUGINKE MKGDNVHZSCXBKR-KYVQNOJUSA-N D0O1HL DRUGSMIL CCCCN1CC(C(C(C1COC(=O)CCC)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC D0O1HL HIGHSTAT Phase 2 D0O2AG DRUG__ID D0O2AG D0O2AG DRUGCOMP Hoechst Marion Roussel Inc D0O2AG DRUGTYPE Small molecular drug D0O2AG DRUGINCH 1S/C17H22N4O3/c1-12-5-4-6-13(2)21(12)20-11-16(24-19-20)18-17(22)14-7-9-15(23-3)10-8-14/h7-13H,4-6H2,1-3H3/t12-,13+ D0O2AG DRUGINKE TXPUBJSOHAMNEI-BETUJISGSA-N D0O2AG DRUGSMIL CC1CCCC(N1[N+]2=NOC(=C2)N=C(C3=CC=C(C=C3)OC)[O-])C D0O2AG HIGHSTAT Phase 2 D0O2XJ DRUG__ID D0O2XJ D0O2XJ DRUGCOMP Neuraxon D0O2XJ DRUGTYPE Small molecular drug D0O2XJ DRUGINCH 1S/C27H36N2O6/c1-27(7-6-26(32)33,22-2-4-24(30)20(16-22)18-28-8-12-34-13-9-28)23-3-5-25(31)21(17-23)19-29-10-14-35-15-11-29/h2-5,16-17,30-31H,6-15,18-19H2,1H3,(H,32,33) D0O2XJ DRUGINKE JWNUBAIGCVTLMJ-UHFFFAOYSA-N D0O2XJ DRUGSMIL CC(CCC(=O)O)(C1=CC(=C(C=C1)O)CN2CCOCC2)C3=CC(=C(C=C3)O)CN4CCOCC4 D0O2XJ HIGHSTAT Phase 2 D0O3CX DRUG__ID D0O3CX D0O3CX DRUGCOMP Bristol-Myers Squibb D0O3CX DRUGTYPE Small molecular drug D0O3CX DRUGINCH 1S/C26H26F6N4O3/c1-36-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)34-22(24(36)39)35-23(38)17(12-14-26(30,31)32)16(21(33)37)11-13-25(27,28)29/h2-10,16-17,22H,11-14H2,1H3,(H2,33,37)(H,35,38)/t16-,17+,22+/m0/s1 D0O3CX DRUGINKE AYOUDDAETNMCBW-GSHUGGBRSA-N D0O3CX DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C(CCC(F)(F)F)C(CCC(F)(F)F)C(=O)N)C3=CC=CC=C3 D0O3CX HIGHSTAT Phase 2 D0O3TC DRUG__ID D0O3TC D0O3TC DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0O3TC DRUGTYPE Small molecular drug D0O3TC DRUGINCH 1S/C15H18FNO2/c1-10(18)11-4-8-14(9-5-11)17-15(19)12-2-6-13(16)7-3-12/h2-3,6-7,11,14H,4-5,8-9H2,1H3,(H,17,19) D0O3TC DRUGINKE PYMCWQVGVQEZNO-UHFFFAOYSA-N D0O3TC DRUGSMIL CC(=O)C1CCC(CC1)NC(=O)C2=CC=C(C=C2)F D0O3TC HIGHSTAT Phase 2 D0O4NR DRUG__ID D0O4NR D0O4NR DRUGCOMP LTB4 Sweden AB D0O4NR DRUGTYPE Small molecular drug D0O4NR DRUGINCH 1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7+,9-6-,14-10+,15-11-/t18-,19-/m1/s1 D0O4NR DRUGINKE VNYSSYRCGWBHLG-AMOLWHMGSA-N D0O4NR DRUGSMIL CCCCCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O D0O4NR HIGHSTAT Phase 2 D0O4WB DRUG__ID D0O4WB D0O4WB DRUGCOMP Bristol-myers squibb D0O4WB DRUGTYPE Small molecular drug D0O4WB DRUGINCH 1S/C12H12N2O4/c1-3-12(7-15)5-4-9(18-12)14-6-8(2)10(16)13-11(14)17/h1,4-6,9,15H,7H2,2H3,(H,13,16,17)/t9-,12+/m1/s1 D0O4WB DRUGINKE OSYWBJSVKUFFSU-SKDRFNHKSA-N D0O4WB DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)(CO)C#C D0O4WB HIGHSTAT Phase 2 D0O6VZ DRUG__ID D0O6VZ D0O6VZ DRUGCOMP Genentech; Roche D0O6VZ DRUGTYPE Small molecular drug D0O6VZ DRUGINCH 1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1 D0O6VZ DRUGINKE YOVVNQKCSKSHKT-HNNXBMFYSA-N D0O6VZ DRUGSMIL CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O D0O6VZ HIGHSTAT Phase 2 D0O6ZO DRUG__ID D0O6ZO D0O6ZO DRUGCOMP Takeda Pharmaceutical Co Ltd D0O6ZO DRUGTYPE Small molecular drug D0O6ZO DRUGINCH 1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28) D0O6ZO DRUGINKE HEKAIDKUDLCBRU-UHFFFAOYSA-N D0O6ZO DRUGSMIL CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC=CC(=C4)C D0O6ZO HIGHSTAT Phase 2 D0O8BS DRUG__ID D0O8BS D0O8BS DRUGCOMP AstraZeneca D0O8BS DRUGTYPE Small molecular drug D0O8BS DRUGINCH 1S/C24H26N6O5/c1-15-10-27-21(12-25-15)29-23(31)17-7-18(34-16(2)14-33-3)9-19(8-17)35-22-13-26-20(11-28-22)24(32)30-5-4-6-30/h7-13,16H,4-6,14H2,1-3H3,(H,27,29,31)/t16-/m0/s1 D0O8BS DRUGINKE FJEJHJINOKKDCW-INIZCTEOSA-N D0O8BS DRUGSMIL CC1=CN=C(C=N1)NC(=O)C2=CC(=CC(=C2)OC(C)COC)OC3=NC=C(N=C3)C(=O)N4CCC4 D0O8BS HIGHSTAT Phase 2 D0OH2W DRUG__ID D0OH2W D0OH2W DRUGCOMP Pfizer D0OH2W DRUGTYPE Small molecular drug D0OH2W DRUGINCH 1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3 D0OH2W DRUGINKE AZEXWHKOMMASPA-UHFFFAOYSA-N D0OH2W DRUGSMIL CN1C=C(C(=N1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C5=CC=NC=C5 D0OH2W HIGHSTAT Phase 2 D0OK2N DRUG__ID D0OK2N D0OK2N DRUGCOMP Amgen Thousand D0OK2N DRUGTYPE Small molecular drug D0OK2N DRUGINCH 1S/C22H17N5O2/c1-28-16-7-8-17-19(13-16)23-12-11-20(17)29-14-22-25-24-21-10-9-18(26-27(21)22)15-5-3-2-4-6-15/h2-13H,14H2,1H3 D0OK2N DRUGINKE HEAIZQNMNCHNFD-UHFFFAOYSA-N D0OK2N DRUGSMIL COC1=CC2=NC=CC(=C2C=C1)OCC3=NN=C4N3N=C(C=C4)C5=CC=CC=C5 D0OK2N HIGHSTAT Phase 2 D0OP8W DRUG__ID D0OP8W D0OP8W DRUGCOMP Wyeth D0OP8W DRUGTYPE Small molecular drug D0OP8W DRUGINCH 1S/C24H29N5O2/c30-22-20-18-6-7-19(17-5-4-16(17)18)21(20)23(31)29(22)11-2-1-10-27-12-14-28(15-13-27)24-25-8-3-9-26-24/h3-9,16-21H,1-2,10-15H2/t16-,17+,18-,19+,20-,21+ D0OP8W DRUGINKE AERLHOTUXIJQFV-RCPZPFRWSA-N D0OP8W DRUGSMIL C1CN(CCN1CCCCN2C(=O)C3C4C=CC(C3C2=O)C5C4C=C5)C6=NC=CC=N6 D0OP8W HIGHSTAT Phase 2 D0OR5P DRUG__ID D0OR5P D0OR5P DRUGCOMP Taiho Pharma U.S.A. D0OR5P DRUGTYPE Small molecular drug D0OR5P DRUGINCH 1S/C11H13N3O5/c1-2-11(18)6(5-15)19-9(8(11)16)14-4-3-7(12)13-10(14)17/h1,3-4,6,8-9,15-16,18H,5H2,(H2,12,13,17)/t6-,8+,9-,11-/m1/s1 D0OR5P DRUGINKE JFIWEPHGRUDAJN-DYUFWOLASA-N D0OR5P DRUGSMIL C#CC1(C(OC(C1O)N2C=CC(=NC2=O)N)CO)O D0OR5P HIGHSTAT Phase 2 D0OR8W DRUG__ID D0OR8W D0OR8W DRUGCOMP Teva Pharmaceutical USA D0OR8W DRUGTYPE Small molecular drug D0OR8W DRUGINCH 1S/C24H30Cl2O6/c1-4-31-21(30)24(32-20(29)19(25)26)10-8-16-15-6-5-13-11-14(27)7-9-22(13,2)18(15)17(28)12-23(16,24)3/h7,9,11,15-19,28H,4-6,8,10,12H2,1-3H3/t15-,16-,17-,18+,22-,23-,24-/m0/s1 D0OR8W DRUGINKE QAIOVDNCIZSSSF-RFAJLIJZSA-N D0OR8W DRUGSMIL CCOC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)OC(=O)C(Cl)Cl D0OR8W HIGHSTAT Phase 2 D0OY5G DRUG__ID D0OY5G D0OY5G DRUGCOMP Cell Therapeutics D0OY5G DRUGTYPE Small molecular drug D0OY5G DRUGINCH 1S/C30H35BrN12O5/c1-16(31)25(44)36-17-9-22(41(3)12-17)27(46)38-19-11-24(43(5)14-19)29(48)39-20-10-23(42(4)15-20)28(47)37-18-8-21(40(2)13-18)26(45)34-6-7-35-30(32)33/h8-15H,1,6-7H2,2-5H3,(H,34,45)(H,36,44)(H,37,47)(H,38,46)(H,39,48)(H4,32,33,35) D0OY5G DRUGINKE RXOVOXFAAGIKDQ-UHFFFAOYSA-N D0OY5G DRUGSMIL CN1C=C(C=C1C(=O)NCCN=C(N)N)NC(=O)C2=CC(=CN2C)NC(=O)C3=CC(=CN3C)NC(=O)C4=CC(=CN4C)NC(=O)C(=C)Br D0OY5G HIGHSTAT Phase 2 D0OZ7P DRUG__ID D0OZ7P D0OZ7P THERCLAS Antiviral Agents D0OZ7P DRUGTYPE Small molecular drug D0OZ7P DRUGINCH 1S/C40H50N6O8S/c1-23(2)41-38-43-32(22-55-38)31-19-34(28-16-15-26(52-3)17-30(28)42-31)53-27-18-33-35(47)45-40(37(49)50)20-24(40)11-7-5-4-6-8-14-29(36(48)46(33)21-27)44-39(51)54-25-12-9-10-13-25/h7,11,15-17,19,22-25,27,29,33H,4-6,8-10,12-14,18,20-21H2,1-3H3,(H,41,43)(H,44,51)(H,45,47)(H,49,50)/b11-7-/t24-,27-,29+,33+,40-/m1/s1 D0OZ7P DRUGINKE PJZPDFUUXKKDNB-KNINVFKUSA-N D0OZ7P DRUGSMIL CC(C)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3)OC)C(=C2)OC4CC5C(=O)NC6(CC6C=CCCCCCC(C(=O)N5C4)NC(=O)OC7CCCC7)C(=O)O D0OZ7P HIGHSTAT Phase 2 D0P1IX DRUG__ID D0P1IX D0P1IX DRUGCOMP Othera Pharmaceuticals Inc D0P1IX DRUGTYPE Small molecular drug D0P1IX DRUGINCH 1S/C13H23NO3/c1-12(2)7-10(8-13(3,4)14(12)16)17-11(15)9-5-6-9/h9-10,16H,5-8H2,1-4H3 D0P1IX DRUGINKE ZWEXEKJLDHNLLA-UHFFFAOYSA-N D0P1IX DRUGSMIL CC1(CC(CC(N1O)(C)C)OC(=O)C2CC2)C D0P1IX HIGHSTAT Phase 2 D0P1YE DRUG__ID D0P1YE D0P1YE DRUGCOMP GSK D0P1YE DRUGTYPE Small molecular drug D0P1YE DRUGINCH 1S/C31H35F7N4O2/c1-18-12-23(32)4-6-26(18)27-16-24(40-10-11-41-25(17-40)5-7-28(41)43)8-9-42(27)29(44)39(3)19(2)20-13-21(30(33,34)35)15-22(14-20)31(36,37)38/h4,6,12-15,19,24-25,27H,5,7-11,16-17H2,1-3H3/t19-,24+,25+,27-/m1/s1 D0P1YE DRUGINKE XWNBGDJPEXZSQM-VZOBGQTKSA-N D0P1YE DRUGSMIL CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN5C(C4)CCC5=O D0P1YE HIGHSTAT Phase 2 D0P5TR DRUG__ID D0P5TR D0P5TR DRUGCOMP Novartis AG D0P5TR DRUGTYPE Small molecular drug D0P5TR DRUGINCH 1S/C12H19N3O/c1-3-8-15(9-4-2)10-13-11-6-5-7-12(16)14-11/h5-7,10H,3-4,8-9H2,1-2H3,(H,14,16) D0P5TR DRUGINKE MEYPAYJYAZKERR-UHFFFAOYSA-N D0P5TR DRUGSMIL CCCN(CCC)C=NC1=CC=CC(=O)N1 D0P5TR HIGHSTAT Phase 2 D0PO9P DRUG__ID D0PO9P D0PO9P THERCLAS Antiviral Agents D0PO9P DRUGTYPE Small molecular drug D0PO9P DRUGINCH 1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1 D0PO9P DRUGINKE HTNPEHXGEKVIHG-QCNRFFRDSA-N D0PO9P DRUGSMIL CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O D0PO9P HIGHSTAT Phase 2 Trial D0PU8T DRUG__ID D0PU8T D0PU8T DRUGCOMP Eisai D0PU8T DRUGTYPE Small molecular drug D0PU8T DRUGINCH 1S/C29H38FN3O5/c1-7-37-23-15-19-16-33(28(31)24(19)25(30)27(23)38-8-2)17-22(34)18-13-20(29(3,4)5)26(35-6)21(14-18)32-9-11-36-12-10-32/h13-15,31H,7-12,16-17H2,1-6H3 D0PU8T DRUGINKE QWKAUGRRIXBIPO-UHFFFAOYSA-N D0PU8T DRUGSMIL CCOC1=C(C(=C2C(=C1)CN(C2=N)CC(=O)C3=CC(=C(C(=C3)N4CCOCC4)OC)C(C)(C)C)F)OCC D0PU8T HIGHSTAT Phase 2 D0Q0AP DRUG__ID D0Q0AP D0Q0AP DRUGCOMP Bristol-Myers Squibb D0Q0AP DRUGTYPE Small molecular drug D0Q0AP DRUGINCH 1S/C22H26N6O2/c1-4-9-23-22(30)17-11-28-19(14(17)3)20(24-12-25-28)27-18-10-15(6-5-13(18)2)21(29)26-16-7-8-16/h5-6,10-12,16H,4,7-9H2,1-3H3,(H,23,30)(H,26,29)(H,24,25,27) D0Q0AP DRUGINKE GDTQLZHHDRRBEB-UHFFFAOYSA-N D0Q0AP DRUGSMIL CCCNC(=O)C1=CN2C(=C1C)C(=NC=N2)NC3=C(C=CC(=C3)C(=O)NC4CC4)C D0Q0AP HIGHSTAT Phase 2 D0Q1LO DRUG__ID D0Q1LO D0Q1LO DRUGCOMP GlaxoSmithKline; Walter Reed Army Institute of Research D0Q1LO DRUGTYPE Small molecular drug D0Q1LO DRUGINCH 1S/C21H33N3O/c1-5-24(6-2)14-10-8-7-9-12-22-20-16-18(25-4)15-19-17(3)11-13-23-21(19)20/h11,13,15-16,22H,5-10,12,14H2,1-4H3 D0Q1LO DRUGINKE RVAKDGYPIVSYEU-UHFFFAOYSA-N D0Q1LO DRUGSMIL CCN(CC)CCCCCCNC1=CC(=CC2=C(C=CN=C12)C)OC D0Q1LO HIGHSTAT Phase 2 D0Q3PD DRUG__ID D0Q3PD D0Q3PD DRUGCOMP Shionogi D0Q3PD DRUGTYPE Small molecular drug D0Q3PD DRUGINCH 1S/C32H34N4O6/c1-30(2,29-33-27(35-42-29)18-6-4-3-5-7-18)34-28(39)20-15-32(40)22-14-19-10-11-21(37)25-23(19)31(32,26(41-25)24(20)38)12-13-36(22)16-17-8-9-17/h3-7,10-11,17,22,26,37-38,40H,8-9,12-16H2,1-2H3,(H,34,39)/t22-,26+,31+,32-/m1/s1 D0Q3PD DRUGINKE AXQACEQYCPKDMV-RZAWKFBISA-N D0Q3PD DRUGSMIL CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O D0Q3PD HIGHSTAT Phase 2 D0Q7UG DRUG__ID D0Q7UG D0Q7UG DRUGCOMP Kyorin Pharmaceutical Co Ltd D0Q7UG DRUGTYPE Small molecular drug D0Q7UG DRUGINCH 1S/C29H38O7S/c1-5-9-23-25(14-12-22(20(4)31)29(23)36-16-7-11-27(32)33)35-17-8-18-37-26-15-13-21(19(3)30)28(34)24(26)10-6-2/h12-15,34H,5-11,16-18H2,1-4H3,(H,32,33) D0Q7UG DRUGINKE KPWYNAGOBXLMSE-UHFFFAOYSA-N D0Q7UG DRUGSMIL CCCC1=C(C=CC(=C1OCCCC(=O)O)C(=O)C)OCCCSC2=C(C(=C(C=C2)C(=O)C)O)CCC D0Q7UG HIGHSTAT Phase 2 D0Q8MI DRUG__ID D0Q8MI D0Q8MI DRUGCOMP Synthelabo D0Q8MI DRUGTYPE Small molecular drug D0Q8MI DRUGINCH 1S/C14H19ClN4O2/c1-3-19-5-4-17-13(19)8-18-14(20)9-6-10(15)11(16)7-12(9)21-2/h6-7H,3-5,8,16H2,1-2H3,(H,18,20) D0Q8MI DRUGINKE MJCKISCWHDATBN-UHFFFAOYSA-N D0Q8MI DRUGSMIL CCN1CCN=C1CNC(=O)C2=CC(=C(C=C2OC)N)Cl D0Q8MI HIGHSTAT Phase 2 D0Q9UX DRUG__ID D0Q9UX D0Q9UX DRUGCOMP Nerviano Medical Services D0Q9UX DRUGTYPE Small molecular drug D0Q9UX DRUGINCH 1S/C25H32N8O/c1-25(2)14-16-15-27-24(29-20(16)22-19(25)21(23(34)26-3)30-32(22)5)28-17-6-8-18(9-7-17)33-12-10-31(4)11-13-33/h6-9,15H,10-14H2,1-5H3,(H,26,34)(H,27,28,29) D0Q9UX DRUGINKE RXZMYLDMFYNEIM-UHFFFAOYSA-N D0Q9UX DRUGSMIL CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C D0Q9UX HIGHSTAT Phase 2 D0QG2D DRUG__ID D0QG2D D0QG2D DRUGCOMP Boehringer Ingelheim D0QG2D DRUGTYPE Small molecular drug D0QG2D DRUGINCH 1S/C33H34N2O5/c1-4-38-32(37)35-31(34)25-8-16-29(17-9-25)39-21-23-6-5-7-24(20-23)22-40-30-18-12-27(13-19-30)33(2,3)26-10-14-28(36)15-11-26/h5-20,36H,4,21-22H2,1-3H3,(H2,34,35,37) D0QG2D DRUGINKE SBVYURPQULDJTI-UHFFFAOYSA-N D0QG2D DRUGSMIL CCOC(=O)NC(=N)C1=CC=C(C=C1)OCC2=CC(=CC=C2)COC3=CC=C(C=C3)C(C)(C)C4=CC=C(C=C4)O D0QG2D HIGHSTAT Phase 2 D0QY1M DRUG__ID D0QY1M D0QY1M DRUGCOMP GILEAD D0QY1M DRUGTYPE Small molecular drug D0QY1M DRUGINCH 1S/C24H30ClN7O3S/c1-15-13-32-22(27-23(15)30-10-8-17(26)14-30)12-20(28-32)21-5-3-4-9-31(21)24(33)18-11-16(25)6-7-19(18)29-36(2,34)35/h6-7,11-13,17,21,29H,3-5,8-10,14,26H2,1-2H3/t17-,21-/m0/s1 D0QY1M DRUGINKE GOFXWTVKPWJNGD-UWJYYQICSA-N D0QY1M DRUGSMIL CC1=CN2C(=CC(=N2)C3CCCCN3C(=O)C4=C(C=CC(=C4)Cl)NS(=O)(=O)C)N=C1N5CCC(C5)N D0QY1M HIGHSTAT Phase 2 D0R0EF DRUG__ID D0R0EF D0R0EF DRUGCOMP AstraZeneca plc D0R0EF DRUGTYPE Small molecular drug D0R0EF DRUGINCH 1S/C29H30N4O2S/c1-32(16-17-34)29(35)24-9-7-21(8-10-24)27(26-6-2-4-23-5-3-13-30-28(23)26)22-11-14-33(15-12-22)18-25-19-36-20-31-25/h2-10,13,19-20,34H,11-12,14-18H2,1H3 D0R0EF DRUGINKE ZJKUETLEJYCOBO-UHFFFAOYSA-N D0R0EF DRUGSMIL CN(CCO)C(=O)C1=CC=C(C=C1)C(=C2CCN(CC2)CC3=CSC=N3)C4=CC=CC5=C4N=CC=C5 D0R0EF HIGHSTAT Phase 2 D0R2SK DRUG__ID D0R2SK D0R2SK DRUGCOMP Eli Lilly & Co D0R2SK DRUGTYPE Small molecular drug D0R2SK DRUGINCH 1S/C18H18O3/c19-12-6-4-11(5-7-12)18-15-3-1-2-14(15)16-10-13(20)8-9-17(16)21-18/h4-10,14-15,18-20H,1-3H2/t14-,15+,18+/m1/s1 D0R2SK DRUGINKE XIESSJVMWNJCGZ-VKJFTORMSA-N D0R2SK DRUGSMIL C1CC2C(C1)C3=C(C=CC(=C3)O)OC2C4=CC=C(C=C4)O D0R2SK HIGHSTAT Phase 2 D0R7AK DRUG__ID D0R7AK D0R7AK DRUGCOMP Pfizer Inc D0R7AK DRUGTYPE Small molecular drug D0R7AK DRUGINCH 1S/C12H12F3N/c13-12(14,15)9-1-2-10-7-3-8(6-16-5-7)11(10)4-9/h1-2,4,7-8,16H,3,5-6H2/t7-,8+/m0/s1 D0R7AK DRUGINKE RNOBTWYQAWEZHH-JGVFFNPUSA-N D0R7AK DRUGSMIL C1C2CNCC1C3=C2C=CC(=C3)C(F)(F)F D0R7AK HIGHSTAT Phase 2 D0R7XD DRUG__ID D0R7XD D0R7XD DRUGCOMP GlaxoSmithKline D0R7XD DRUGTYPE Small molecular drug D0R7XD DRUGINCH 1S/C19H21ClFN3O4S/c1-11-14(21)5-2-6-15(11)23-19(26)24-16-8-7-13(20)18(17(16)25)29(27,28)12-4-3-9-22-10-12/h2,5-8,12,22,25H,3-4,9-10H2,1H3,(H2,23,24,26)/t12-/m0/s1 D0R7XD DRUGINKE NGYNBSHYFOFVLS-LBPRGKRZSA-N D0R7XD DRUGSMIL CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)C3CCCNC3)O D0R7XD HIGHSTAT Phase 2 D0R8GR DRUG__ID D0R8GR D0R8GR DRUGCOMP Otsuka Pharmaceutical and Vela Pharmaceuticals; Pharmos and Otsaku D0R8GR DRUGTYPE Small molecular drug D0R8GR DRUGINCH 1S/C23H28ClN3O2/c1-29-22-8-3-7-21-20(22)9-10-23(28)27(21)12-4-11-25-13-15-26(16-14-25)19-6-2-5-18(24)17-19/h2-3,5-8,17H,4,9-16H2,1H3 D0R8GR DRUGINKE TZZGTNZBLPCBIS-UHFFFAOYSA-N D0R8GR DRUGSMIL COC1=CC=CC2=C1CCC(=O)N2CCCN3CCN(CC3)C4=CC(=CC=C4)Cl D0R8GR HIGHSTAT Phase 2 D0R8IE DRUG__ID D0R8IE D0R8IE DRUGCOMP Catholic University of Leuven; Hybrigenics D0R8IE DRUGTYPE Small molecular drug D0R8IE DRUGINCH 1S/C26H40O3/c1-18(7-5-13-25(2,3)29)23-11-12-24-20(8-6-14-26(23,24)4)10-9-19-15-21(27)17-22(28)16-19/h9-10,18,21-24,27-29H,6-8,11-12,14-17H2,1-4H3/b20-10+/t18-,21-,22-,23-,24-,26-/m1/s1 D0R8IE DRUGINKE HHGRMHMXKPQNGF-WNSNRMDMSA-N D0R8IE DRUGSMIL CC(CC#CC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C D0R8IE HIGHSTAT Phase 2 D0R8IU DRUG__ID D0R8IU D0R8IU DRUGCOMP AstraZeneca plc D0R8IU DRUGTYPE Small molecular drug D0R8IU DRUGINCH 1S/C22H33N3O3S/c1-2-13-29-22-18(21(28)23-17-8-4-3-5-9-17)10-11-19(24-22)25-12-6-7-16(15-25)14-20(26)27/h10-11,16-17H,2-9,12-15H2,1H3,(H,23,28)(H,26,27)/t16-/m0/s1 D0R8IU DRUGINKE NCDZABJPWMBMIQ-INIZCTEOSA-N D0R8IU DRUGSMIL CCCSC1=C(C=CC(=N1)N2CCCC(C2)CC(=O)O)C(=O)NC3CCCCC3 D0R8IU HIGHSTAT Phase 2 D0R9MN DRUG__ID D0R9MN D0R9MN DRUGCOMP InterMune; Genentech D0R9MN DRUGTYPE Small molecular drug D0R9MN DRUGINCH 1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7-/t22-,23-,27+,28+,35-/m1/s1 D0R9MN DRUGINKE ZVTDLPBHTSMEJZ-JSZLBQEHSA-N D0R9MN DRUGSMIL CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6 D0R9MN HIGHSTAT Phase 2 D0RF3F DRUG__ID D0RF3F D0RF3F DRUGCOMP Mirati therapeutics D0RF3F DRUGTYPE Small molecular drug D0RF3F DRUGINCH 1S/C17H25N3O2/c21-16(14-20-8-4-7-17(20)22)13-18-9-11-19(12-10-18)15-5-2-1-3-6-15/h1-3,5-6,16,21H,4,7-14H2 D0RF3F DRUGINKE AFBKGQPVUQUMRC-UHFFFAOYSA-N D0RF3F DRUGSMIL C1CC(=O)N(C1)CC(CN2CCN(CC2)C3=CC=CC=C3)O D0RF3F HIGHSTAT Phase 2 D0RL4X DRUG__ID D0RL4X D0RL4X DRUGCOMP Actimis Pharmaceuticals Inc D0RL4X DRUGTYPE Small molecular drug D0RL4X DRUGINCH 1S/C25H26F3N5O3/c1-32(2)22-19(14-21(34)35)23(33(3)4)31-20(30-22)13-15-5-11-18(12-6-15)29-24(36)16-7-9-17(10-8-16)25(26,27)28/h5-12H,13-14H2,1-4H3,(H,29,36)(H,34,35) D0RL4X DRUGINKE XEOSTBFUCNZKGS-UHFFFAOYSA-N D0RL4X DRUGSMIL CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O D0RL4X HIGHSTAT Phase 2 D0RV6F DRUG__ID D0RV6F D0RV6F DRUGCOMP Merck & Co Inc D0RV6F DRUGTYPE Small molecular drug D0RV6F DRUGINCH 1S/C27H34FN5O2/c1-26-11-10-17-15(6-9-21-27(17,2)13-19(28)25(35)33(21)3)16(26)7-8-18(26)24(34)30-14-22-31-20-5-4-12-29-23(20)32-22/h4-5,12-13,15-18,21H,6-11,14H2,1-3H3,(H,30,34)(H,29,31,32)/t15-,16-,17-,18+,21+,26-,27+/m0/s1 D0RV6F DRUGINKE GBEUKTWTUSPHEE-JWJWXJQQSA-N D0RV6F DRUGSMIL CC12CCC3C(C1CCC2C(=O)NCC4=NC5=C(N4)C=CC=N5)CCC6C3(C=C(C(=O)N6C)F)C D0RV6F HIGHSTAT Phase 2 D0S0EQ DRUG__ID D0S0EQ D0S0EQ DRUGCOMP AstraZeneca plc D0S0EQ DRUGTYPE Small molecular drug D0S0EQ DRUGINCH 1S/C21H26N4O2/c1-13-6-5-7-14(2)18(13)11-23-19-10-17(21(27)22-8-9-26)12-25-16(4)15(3)24-20(19)25/h5-7,10,12,23,26H,8-9,11H2,1-4H3,(H,22,27) D0S0EQ DRUGINKE GHVIMBCFLRTFHI-UHFFFAOYSA-N D0S0EQ DRUGSMIL CC1=C(C(=CC=C1)C)CNC2=CC(=CN3C2=NC(=C3C)C)C(=O)NCCO D0S0EQ HIGHSTAT Phase 2 D0S0SE DRUG__ID D0S0SE D0S0SE DRUGCOMP Pfizer D0S0SE DRUGTYPE Small molecular drug D0S0SE DRUGINCH 1S/C31H39FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28H,5,12-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1 D0S0SE DRUGINKE CAYJBRBGZBCZKO-BHGBQCOSSA-N D0S0SE DRUGSMIL CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(CC2=CC=C(C=C2)F)CC(=O)C(C(C)C)NC(=O)C3=NOC(=C3)C D0S0SE HIGHSTAT Phase 2 D0S3PO DRUG__ID D0S3PO D0S3PO DRUGCOMP Wyeth D0S3PO DRUGTYPE Small molecular drug D0S3PO DRUGINCH 1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+ D0S3PO DRUGINKE WVUNYSQLFKLYNI-AATRIKPKSA-N D0S3PO DRUGSMIL CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C D0S3PO HIGHSTAT Phase 2 D0S3XE DRUG__ID D0S3XE D0S3XE DRUGCOMP Pharmacia & Upjohn AB D0S3XE DRUGTYPE Small molecular drug D0S3XE DRUGINCH 1S/C27H45N3O3/c1-16(2)28-25(33)30(17(3)4)24(32)21-10-9-19-18-8-11-22-27(6,15-13-23(31)29(22)7)20(18)12-14-26(19,21)5/h16-22H,8-15H2,1-7H3,(H,28,33)/t18-,19-,20-,21+,22+,26-,27+/m0/s1 D0S3XE DRUGINKE WMPQMBUXZHMEFZ-YJPJVVPASA-N D0S3XE DRUGSMIL CC(C)NC(=O)N(C(C)C)C(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(=O)N4C)C)C D0S3XE HIGHSTAT Phase 2 D0S4II DRUG__ID D0S4II D0S4II DRUGCOMP GSK D0S4II DRUGTYPE Small molecular drug D0S4II DRUGINCH 1S/C23H28N4O4S/c1-16(2)22-25-23(31-26-22)27-12-10-17(11-13-27)15-30-19-6-9-21(24-14-19)18-4-7-20(8-5-18)32(3,28)29/h4-9,14,16-17H,10-13,15H2,1-3H3 D0S4II DRUGINKE AYJRTVVIBJSSKN-UHFFFAOYSA-N D0S4II DRUGSMIL CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(=O)(=O)C D0S4II HIGHSTAT Phase 2 D0S4SX DRUG__ID D0S4SX D0S4SX DRUGCOMP Kowa Pharmaceuticals America D0S4SX DRUGTYPE Small molecular drug D0S4SX DRUGINCH 1S/C22H29N3O4/c26-20-5-2-1-4-19(20)25(16-7-8-16)22(28)23-12-3-13-29-17-9-10-18-15(14-17)6-11-21(27)24-18/h6,9-11,14,16,19-20,26H,1-5,7-8,12-13H2,(H,23,28)(H,24,27)/t19-,20-/m1/s1 D0S4SX DRUGINKE ULGNGSQNNMKROG-WOJBJXKFSA-N D0S4SX DRUGSMIL C1CCC(C(C1)N(C2CC2)C(=O)NCCCOC3=CC4=C(C=C3)NC(=O)C=C4)O D0S4SX HIGHSTAT Phase 2 D0S6KI DRUG__ID D0S6KI D0S6KI DRUGCOMP Atumida Inc D0S6KI DRUGTYPE Small molecular drug D0S6KI DRUGINCH 1S/C6H10O4/c7-3-1-9-6-4(8)2-10-5(3)6/h3-8H,1-2H2/t3-,4+,5-,6-/m1/s1 D0S6KI DRUGINKE KLDXJTOLSGUMSJ-JGWLITMVSA-N D0S6KI DRUGSMIL C1C(C2C(O1)C(CO2)O)O D0S6KI HIGHSTAT Phase 2 D0S6SQ DRUG__ID D0S6SQ D0S6SQ DRUGCOMP Eli Lilly & Co D0S6SQ DRUGTYPE Small molecular drug D0S6SQ DRUGINCH 1S/C20H24FN3O3/c21-17-11-15(12-23-8-5-14-6-9-26-10-7-14)1-3-18(17)27-19-4-2-16(13-24-19)20(22)25/h1-4,11,13-14,23H,5-10,12H2,(H2,22,25) D0S6SQ DRUGINKE QWNDOCKIKKQJNN-UHFFFAOYSA-N D0S6SQ DRUGSMIL C1COCCC1CCNCC2=CC(=C(C=C2)OC3=NC=C(C=C3)C(=O)N)F D0S6SQ HIGHSTAT Phase 2 D0S7HM DRUG__ID D0S7HM D0S7HM DRUGCOMP Entremed D0S7HM DRUGTYPE Small molecular drug D0S7HM DRUGINCH 1S/C21H25N7/c1-16-14-20(26-25-16)23-19-15-21(28-12-10-27(2)11-13-28)24-18(22-19)9-8-17-6-4-3-5-7-17/h3-9,14-15H,10-13H2,1-2H3,(H2,22,23,24,25,26)/b9-8+ D0S7HM DRUGINKE BLQYVHBZHAISJM-CMDGGOBGSA-N D0S7HM DRUGSMIL CC1=CC(=NN1)NC2=CC(=NC(=N2)C=CC3=CC=CC=C3)N4CCN(CC4)C D0S7HM HIGHSTAT Phase 2 D0SA3J DRUG__ID D0SA3J D0SA3J DRUGCOMP TAP Pharmaceuticals D0SA3J DRUGTYPE Small molecular drug D0SA3J DRUGINCH 1S/C19H20BrN2O4P/c1-3-25-27(24,26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H,3-4,13H2,1-2H3,(H,22,23) D0SA3J DRUGINKE KPRTURMJVWXURQ-UHFFFAOYSA-N D0SA3J DRUGSMIL CCOP(=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)Br)C#N)OCC D0SA3J HIGHSTAT Phase 2 D0SD9V DRUG__ID D0SD9V D0SD9V DRUGCOMP Adeona Pharmaceuticals; MI Meda Pharmaceuticals D0SD9V DRUGTYPE Small molecular drug D0SD9V DRUGINCH 1S/C15H17FN4O2/c1-2-22-15(21)19-12-7-8-13(20-14(12)17)18-9-10-3-5-11(16)6-4-10/h3-8H,2,9H2,1H3,(H,19,21)(H3,17,18,20) D0SD9V DRUGINKE JUUFBMODXQKSTD-UHFFFAOYSA-N D0SD9V DRUGSMIL CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N D0SD9V HIGHSTAT Phase 2 D0SG7B DRUG__ID D0SG7B D0SG7B DRUGCOMP Abbvie; galapagos D0SG7B DRUGTYPE Small molecular drug D0SG7B DRUGINCH 1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27) D0SG7B DRUGINKE RIJLVEAXPNLDTC-UHFFFAOYSA-N D0SG7B DRUGSMIL C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5 D0SG7B HIGHSTAT Phase 2 D0SN7I DRUG__ID D0SN7I D0SN7I DRUGCOMP GlaxoSmithKline D0SN7I DRUGTYPE Small molecular drug D0SN7I DRUGINCH 1S/C17H17Cl2FN4O4S/c18-10-4-5-13(23-17(26)22-12-3-1-2-11(20)14(12)19)15(25)16(10)29(27,28)24-8-6-21-7-9-24/h1-5,21,25H,6-9H2,(H2,22,23,26) D0SN7I DRUGINKE YQYFEGTYCUQBEI-UHFFFAOYSA-N D0SN7I DRUGSMIL C1CN(CCN1)S(=O)(=O)C2=C(C=CC(=C2O)NC(=O)NC3=C(C(=CC=C3)F)Cl)Cl D0SN7I HIGHSTAT Phase 2 D0SQ2K DRUG__ID D0SQ2K D0SQ2K DRUGCOMP Santaris Pharma A/S D0SQ2K DRUGTYPE Small molecular drug D0SQ2K DRUGINCH 1S/C151H185N49O83P14S14/c1-60-26-193(140(215)182-119(60)203)87-21-66(74(258-87)34-245-290(225,304)281-110-102-130(199-58-171-94-114(161)165-55-168-117(94)199)268-150(110,44-239-102)50-252-291(226,305)272-65-20-86(187-13-6-79(153)174-134(187)209)256-72(65)33-243-286(221,300)277-105-97-125(262-144(105,37-201)38-234-97)189-15-8-81(155)176-136(189)211)271-285(220,299)241-30-73-67(22-88(257-73)194-27-61(2)120(204)183-141(194)216)273-293(228,307)253-51-151-45-240-103(131(269-151)200-59-172-95-118(200)180-132(162)181-123(95)207)111(151)283-297(232,311)254-52-149-43-238-101(129(267-149)196-29-63(4)122(206)185-143(196)218)109(149)280-289(224,303)244-32-71-64(19-85(255-71)186-12-5-78(152)173-133(186)208)270-284(219,298)242-31-76-69(24-90(260-76)197-56-169-92-112(159)163-53-166-115(92)197)275-294(229,308)249-47-147-41-236-99(127(265-147)191-17-10-83(157)178-138(191)213)107(147)279-288(223,302)247-36-77-70(25-91(261-77)198-57-170-93-113(160)164-54-167-116(93)198)276-295(230,309)250-48-146-40-235-98(126(264-146)190-16-9-82(156)177-137(190)212)106(146)278-287(222,301)246-35-75-68(23-89(259-75)195-28-62(3)121(205)184-142(195)217)274-292(227,306)251-49-148-42-237-100(128(266-148)192-18-11-84(158)179-139(192)214)108(148)282-296(231,310)248-46-145-39-233-96(104(145)202)124(263-145)188-14-7-80(154)175-135(188)210/h5-18,26-29,53-59,64-77,85-91,96-111,124-131,201-202H,19-25,30-52H2,1-4H3,(H,219,298)(H,220,299)(H,221,300)(H,222,301)(H,223,302)(H,224,303)(H,225,304)(H,226,305)(H,227,306)(H,228,307)(H,229,308)(H,230,309)(H,231,310)(H,232,311)(H2,152,173,208)(H2,153,174,209)(H2,154,175,210)(H2,155,176,211)(H2,156,177,212)(H2,157,178,213)(H2,158,179,214)(H2,159,163,166)(H2,160,164,167)(H2,161,165,168)(H,182,203,215)(H,183,204,216)(H,184,205,217)(H,185,206,218)(H3,162,180,181,207) D0SQ2K DRUGINKE OSOOBMBDIGGTCP-UHFFFAOYSA-N D0SQ2K DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3C4C(OC3(CO4)COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6C7C(OC6(CO7)CO)N8C=CC(=NC8=O)N)N9C=CC(=NC9=O)N)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC4=C(N=CN=C41)N)OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=NC5=C(N=CN=C51)N)OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC16COC(C1OP(=S)(O)OCC17COC(C1O)C(O7)N1C=CC(=NC1=O)N)C(O6)N1C=CC(=NC1=O)N)C(O5)N1C=CC(=NC1=O)N)C(O4)N1C=CC(=NC1=O)N)C(O3)N1C=C(C(=O)NC1=O)C)C(O2)N1C=NC2=C1N=C(NC2=O)N D0SQ2K HIGHSTAT Phase 2 D0SY9B DRUG__ID D0SY9B D0SY9B DRUGCOMP Sanofi-Aventis D0SY9B DRUGTYPE Small molecular drug D0SY9B DRUGINCH 1S/C30H32ClN3O8S/c1-32(2)28(36)24-15-19(35)17-33(24)30(21-8-6-7-9-25(21)41-4)22-14-18(31)10-12-23(22)34(29(30)37)43(38,39)27-13-11-20(40-3)16-26(27)42-5/h6-14,16,19,24,35H,15,17H2,1-5H3/t19-,24+,30+/m1/s1 D0SY9B DRUGINKE NJXZWIIMWNEOGJ-WEWKHQNJSA-N D0SY9B DRUGSMIL CN(C)C(=O)C1CC(CN1C2(C3=C(C=CC(=C3)Cl)N(C2=O)S(=O)(=O)C4=C(C=C(C=C4)OC)OC)C5=CC=CC=C5OC)O D0SY9B HIGHSTAT Phase 2 D0T0ZW DRUG__ID D0T0ZW D0T0ZW DRUGCOMP Alkermes D0T0ZW DRUGTYPE Small molecular drug D0T0ZW DRUGINCH 1S/C21H26N2O4/c22-19(26)15-4-3-13-9-16-21(27)6-5-14(24)10-20(21,17(13)18(15)25)7-8-23(16)11-12-1-2-12/h3-4,12,16,25,27H,1-2,5-11H2,(H2,22,26)/t16-,20-,21-/m1/s1 D0T0ZW DRUGINKE RYIDHLJADOKWFM-MAODMQOUSA-N D0T0ZW DRUGSMIL C1CC1CN2CCC34CC(=O)CCC3(C2CC5=C4C(=C(C=C5)C(=O)N)O)O D0T0ZW HIGHSTAT Phase 2 D0T2YQ DRUG__ID D0T2YQ D0T2YQ DRUGCOMP University of Innsbruck; Opko Corporation D0T2YQ DRUGTYPE Small molecular drug D0T2YQ DRUGINCH 1S/C2H6ClNO3S/c3-4-1-2-8(5,6)7/h4H,1-2H2,(H,5,6,7) D0T2YQ DRUGINKE NMMHHSLZJLPMEG-UHFFFAOYSA-N D0T2YQ DRUGSMIL C(CS(=O)(=O)O)NCl D0T2YQ HIGHSTAT Phase 2 D0T4TN DRUG__ID D0T4TN D0T4TN DRUGCOMP Mondo Biotech D0T4TN DRUGTYPE Small molecular drug D0T4TN DRUGINCH 1S/C147H237N43O43S/c1-18-75(12)115(142(229)180-96(56-72(6)7)131(218)183-104(145(232)233)63-110(155)200)188-139(226)106(68-192)185-134(221)101(62-109(154)199)177-130(217)95(55-71(4)5)174-132(219)97(58-81-37-41-84(195)42-38-81)175-125(212)88(33-23-26-49-149)167-123(210)89(34-24-27-50-150)171-140(227)113(73(8)9)186-118(205)76(13)164-121(208)93(47-53-234-17)170-127(214)92(45-46-107(152)197)169-122(209)87(32-22-25-48-148)166-124(211)90(35-28-51-161-146(156)157)168-129(216)94(54-70(2)3)173-126(213)91(36-29-52-162-147(158)159)172-143(230)116(78(15)193)189-136(223)98(59-82-39-43-85(196)44-40-82)176-133(220)100(61-108(153)198)178-135(222)103(65-112(203)204)182-144(231)117(79(16)194)190-137(224)99(57-80-30-20-19-21-31-80)181-141(228)114(74(10)11)187-119(206)77(14)165-128(215)102(64-111(201)202)179-138(225)105(67-191)184-120(207)86(151)60-83-66-160-69-163-83/h19-21,30-31,37-44,66,69-79,86-106,113-117,191-196H,18,22-29,32-36,45-65,67-68,148-151H2,1-17H3,(H2,152,197)(H2,153,198)(H2,154,199)(H2,155,200)(H,160,163)(H,164,208)(H,165,215)(H,166,211)(H,167,210)(H,168,216)(H,169,209)(H,170,214)(H,171,227)(H,172,230)(H,173,213)(H,174,219)(H,175,212)(H,176,220)(H,177,217)(H,178,222)(H,179,225)(H,180,229)(H,181,228)(H,182,231)(H,183,218)(H,184,207)(H,185,221)(H,186,205)(H,187,206)(H,188,226)(H,189,223)(H,190,224)(H,201,202)(H,203,204)(H,232,233)(H4,156,157,161)(H4,158,159,162)/t75-,76-,77-,78+,79+,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,113-,114-,115-,116-,117-/m0/s1 D0T4TN DRUGINKE VBUWHHLIZKOSMS-RIWXPGAOSA-N D0T4TN DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CNC=N4)N D0T4TN HIGHSTAT Phase 2 D0T6BA DRUG__ID D0T6BA D0T6BA DRUGCOMP Servier D0T6BA DRUGTYPE Small molecular drug D0T6BA DRUGINCH 1S/C22H24FNO4/c23-18-6-4-17(5-7-18)19(25)14-16-8-9-24(15-16)10-11-26-20-2-1-3-21-22(20)28-13-12-27-21/h1-7,16H,8-15H2 D0T6BA DRUGINKE DXBFVLGYPFUTEZ-UHFFFAOYSA-N D0T6BA DRUGSMIL C1CN(CC1CC(=O)C2=CC=C(C=C2)F)CCOC3=CC=CC4=C3OCCO4 D0T6BA HIGHSTAT Phase 2 D0T6IM DRUG__ID D0T6IM D0T6IM DRUGCOMP Otsuka America Pharmaceutical D0T6IM DRUGTYPE Small molecular drug D0T6IM DRUGINCH 1S/C19H18N2O4S/c1-3-24-16-9-8-12(10-17(16)25-4-2)18-21-15(11-26-18)13-6-5-7-14(20-13)19(22)23/h5-11H,3-4H2,1-2H3,(H,22,23) D0T6IM DRUGINKE XDBHURGONHZNJF-UHFFFAOYSA-N D0T6IM DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=CS2)C3=NC(=CC=C3)C(=O)O)OCC D0T6IM HIGHSTAT Phase 2 D0T8KA DRUG__ID D0T8KA D0T8KA DRUGCOMP Johnson & Johnson D0T8KA DRUGTYPE Small molecular drug D0T8KA DRUGINCH 1S/C20H20ClN3/c21-17-8-6-16(7-9-17)20-18-10-12-22-13-11-19(18)24(23-20)14-15-4-2-1-3-5-15/h1-9,22H,10-14H2 D0T8KA DRUGINKE UKJPMZGILXATGT-UHFFFAOYSA-N D0T8KA DRUGSMIL C1CNCCC2=C1C(=NN2CC3=CC=CC=C3)C4=CC=C(C=C4)Cl D0T8KA HIGHSTAT Phase 2 D0T8MA DRUG__ID D0T8MA D0T8MA DRUGCOMP University of Michigan D0T8MA DRUGTYPE Small molecular drug D0T8MA DRUGINCH 1S/2C5H14NO.Mo.2H2S.2S/c2*1-6(2,3)4-5-7;;;;;/h2*7H,4-5H2,1-3H3;;2*1H2;;/q2*+1;;;;;/p-2 D0T8MA DRUGINKE FSWNJZRQQVVVJT-UHFFFAOYSA-L D0T8MA DRUGSMIL C[N+](C)(C)CCO.C[N+](C)(C)CCO.[SH-].[SH-].S=[Mo]=S D0T8MA HIGHSTAT Phase 2 D0T9DN DRUG__ID D0T9DN D0T9DN DRUGCOMP Brane Discovery Srl D0T9DN DRUGTYPE Small molecular drug D0T9DN DRUGINCH 1S/C6H8N2O2/c9-5-3-8-4(7-5)1-2-6(8)10/h4H,1-3H2,(H,7,9) D0T9DN DRUGINKE XTXXOHPHLNROBN-UHFFFAOYSA-N D0T9DN DRUGSMIL C1CC(=O)N2C1NC(=O)C2 D0T9DN HIGHSTAT Phase 2 D0TG9Q DRUG__ID D0TG9Q D0TG9Q DRUGCOMP Merck & Co Inc D0TG9Q DRUGTYPE Small molecular drug D0TG9Q DRUGINCH 1S/C24H34F3N3O3/c1-15(2)23(7-4-18(11-23)29-20-6-9-33-14-21(20)32-3)22(31)30-8-5-19-16(13-30)10-17(12-28-19)24(25,26)27/h10,12,15,18,20-21,29H,4-9,11,13-14H2,1-3H3/t18-,20+,21-,23+/m1/s1 D0TG9Q DRUGINKE MTMDXAIUENDNDL-RJSMDTJLSA-N D0TG9Q DRUGSMIL CC(C)C1(CCC(C1)NC2CCOCC2OC)C(=O)N3CCC4=C(C3)C=C(C=N4)C(F)(F)F D0TG9Q HIGHSTAT Phase 2 D0TT4H DRUG__ID D0TT4H D0TT4H DRUGCOMP Eisai D0TT4H DRUGTYPE Small molecular drug D0TT4H DRUGINCH 1S/C26H24N4O5/c1-27-26-29-20-14-22(34-3)21(33-2)13-19(20)23(30-26)17-6-5-7-18(12-17)28-24(31)15-8-10-16(11-9-15)25(32)35-4/h5-14H,1-4H3,(H,28,31)(H,27,29,30) D0TT4H DRUGINKE BBTFKAOFCSOZMB-UHFFFAOYSA-N D0TT4H DRUGSMIL CNC1=NC2=CC(=C(C=C2C(=N1)C3=CC(=CC=C3)NC(=O)C4=CC=C(C=C4)C(=O)OC)OC)OC D0TT4H HIGHSTAT Phase 2 D0U0BU DRUG__ID D0U0BU D0U0BU DRUGCOMP Tokai Pharmaceuticals D0U0BU DRUGTYPE Small molecular drug D0U0BU DRUGINCH 1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1 D0U0BU DRUGINKE PAFKTGFSEFKSQG-PAASFTFBSA-N D0U0BU DRUGSMIL CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O D0U0BU HIGHSTAT Phase 2 D0U0GZ DRUG__ID D0U0GZ D0U0GZ DRUGCOMP Pfizer D0U0GZ DRUGTYPE Small molecular drug D0U0GZ DRUGINCH 1S/C29H37N5O3/c1-5-22-14-20(15-23(6-2)31-22)11-12-29(21-9-7-8-10-21)17-25(35)24(27(36)37-29)16-26-32-28-30-18(3)13-19(4)34(28)33-26/h13-15,21,35H,5-12,16-17H2,1-4H3/t29-/m1/s1 D0U0GZ DRUGINKE SLVAPEZTBDBAPI-GDLZYMKVSA-N D0U0GZ DRUGSMIL CCC1=CC(=CC(=N1)CC)CCC2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5 D0U0GZ HIGHSTAT Phase 2 D0U0KR DRUG__ID D0U0KR D0U0KR DRUGCOMP Can-Fite BioPharm D0U0KR DRUGTYPE Small molecular drug D0U0KR DRUGINCH 1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1 D0U0KR DRUGINKE IPSYPUKKXMNCNQ-PFHKOEEOSA-N D0U0KR DRUGSMIL CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O D0U0KR HIGHSTAT Phase 2 D0U1NA DRUG__ID D0U1NA D0U1NA DRUGCOMP Orion Corp D0U1NA DRUGTYPE Small molecular drug D0U1NA DRUGINCH 1S/C13H14N2O/c16-12-4-3-9-1-2-10(13(9)6-12)5-11-7-14-8-15-11/h3-4,6-8,10,16H,1-2,5H2,(H,14,15) D0U1NA DRUGINKE VTZPAJGVRWKMAG-UHFFFAOYSA-N D0U1NA DRUGSMIL C1CC2=C(C1CC3=CN=CN3)C=C(C=C2)O D0U1NA HIGHSTAT Phase 2 D0U3KP DRUG__ID D0U3KP D0U3KP DRUGCOMP Halo therapeutics D0U3KP DRUGTYPE Small molecular drug D0U3KP DRUGINCH 1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2 D0U3KP DRUGINKE LVASCWIMLIKXLA-UHFFFAOYSA-N D0U3KP DRUGSMIL C1CC(C(NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O D0U3KP HIGHSTAT Phase 2 D0U5JP DRUG__ID D0U5JP D0U5JP DRUGCOMP Memory Pharmaceuticals D0U5JP DRUGTYPE Small molecular drug D0U5JP DRUGINCH 1S/C15H18N4O.ClH/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19;/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18);1H/t13-;/m1./s1 D0U5JP DRUGINKE CMRLNEYJEPELSM-BTQNPOSSSA-N D0U5JP DRUGSMIL C1CN2CCC1C(C2)NC(=O)C3=NNC4=CC=CC=C43.Cl D0U5JP HIGHSTAT Phase 2 D0U7HL DRUG__ID D0U7HL D0U7HL DRUGCOMP Nisshin Kyorin D0U7HL DRUGTYPE Small molecular drug D0U7HL DRUGINCH 1S/C20H22ClNO5/c1-12(22-10-16(23)14-3-2-4-15(21)9-14)7-13-5-6-17-18(8-13)26-11-19(27-17)20(24)25/h2-6,8-9,12,16,19,22-23H,7,10-11H2,1H3,(H,24,25)/t12-,16+,19-/m1/s1 D0U7HL DRUGINKE XSOXUIXLUNBLJA-RNRVQEDPSA-N D0U7HL DRUGSMIL CC(CC1=CC2=C(C=C1)OC(CO2)C(=O)O)NCC(C3=CC(=CC=C3)Cl)O D0U7HL HIGHSTAT Phase 2 D0U8AS DRUG__ID D0U8AS D0U8AS DRUGCOMP Repros Therapeutics D0U8AS DRUGTYPE Small molecular drug D0U8AS DRUGINCH 1S/C29H37NO4/c1-28-16-24(18-5-8-20(9-6-18)30(2)3)27-22-12-10-21(31)15-19(22)7-11-23(27)25(28)13-14-29(28,33)26(32)17-34-4/h5-6,8-9,15,23-25,33H,7,10-14,16-17H2,1-4H3/t23-,24+,25-,28-,29-/m0/s1 D0U8AS DRUGINKE BHERMCLNVOVDPU-DQFOBABISA-N D0U8AS DRUGSMIL CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C(=O)COC)O)C5=CC=C(C=C5)N(C)C D0U8AS HIGHSTAT Phase 2 D0U8XE DRUG__ID D0U8XE D0U8XE DRUGCOMP Rigel Pharmaceuticals; BerGen BIO D0U8XE DRUGTYPE Small molecular drug D0U8XE DRUGINCH 1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1 D0U8XE DRUGINKE KXMZDGSRSGHMMK-VWLOTQADSA-N D0U8XE DRUGSMIL C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76 D0U8XE HIGHSTAT Phase 2 D0UO4B DRUG__ID D0UO4B D0UO4B DRUGCOMP RaQualia Pharma D0UO4B DRUGTYPE Small molecular drug D0UO4B DRUGINCH 1S/C28H35N5O4/c1-27(2,29)25(35)30-22(18-37-17-21-12-8-5-9-13-21)24(34)33-15-14-23-28(19-33,26(36)32(3)31-23)16-20-10-6-4-7-11-20/h4-13,22H,14-19,29H2,1-3H3,(H,30,35)/t22-,28-/m1/s1 D0UO4B DRUGINKE KVLLHLWBPNCVNR-SKCUWOTOSA-N D0UO4B DRUGSMIL CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3=NN(C(=O)C3(C2)CC4=CC=CC=C4)C)N D0UO4B HIGHSTAT Phase 2 D0V0CJ DRUG__ID D0V0CJ D0V0CJ DRUGCOMP Clovis Oncology D0V0CJ DRUGTYPE Small molecular drug D0V0CJ DRUGINCH 1S/C27H43F2N3O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(33)36-20-21-24(34)27(28,29)25(37-21)32-19-18-22(30)31-26(32)35/h9-10,18-19,21,24-25,34H,2-8,11-17,20H2,1H3,(H2,30,31,35)/b10-9+/t21-,24-,25-/m1/s1 D0V0CJ DRUGINKE HESSNRGIEVBPRB-QDDPNBLJSA-N D0V0CJ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)(F)F)O D0V0CJ HIGHSTAT Phase 2 D0V4MB DRUG__ID D0V4MB D0V4MB DRUGCOMP GSK D0V4MB DRUGTYPE Small molecular drug D0V4MB DRUGINCH 1S/C26H38N2O9/c1-7-33-26(32)34-13-20-21(29)22(30)23(31)25(36-20)37-24-19(16(6)28(27-24)14(2)3)12-17-8-10-18(11-9-17)35-15(4)5/h8-11,14-15,20-23,25,29-31H,7,12-13H2,1-6H3/t20-,21-,22+,23-,25+/m1/s1 D0V4MB DRUGINKE UAOCLDQAQNNEAX-ABMICEGHSA-N D0V4MB DRUGSMIL CCOC(=O)OCC1C(C(C(C(O1)OC2=NN(C(=C2CC3=CC=C(C=C3)OC(C)C)C)C(C)C)O)O)O D0V4MB HIGHSTAT Phase 2 D0V4ZQ DRUG__ID D0V4ZQ D0V4ZQ DRUGCOMP Wyeth D0V4ZQ DRUGTYPE Small molecular drug D0V4ZQ DRUGINCH 1S/C22H23N3O3S/c1-25(2)13-6-14-28-17-11-12-20-19(15-17)22(24-23-20)29(26,27)21-10-5-8-16-7-3-4-9-18(16)21/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,23,24) D0V4ZQ DRUGINKE NXQGEDVQXVTCDA-UHFFFAOYSA-N D0V4ZQ DRUGSMIL CN(C)CCCOC1=CC2=C(NN=C2C=C1)S(=O)(=O)C3=CC=CC4=CC=CC=C43 D0V4ZQ HIGHSTAT Phase 2 D0V8AG DRUG__ID D0V8AG D0V8AG DRUGCOMP Oncovir D0V8AG DRUGTYPE Small molecular drug D0V8AG DRUGINCH 1S/C10H13N4O8P.C9H14N3O8P.C5H12N2O2.C2H4O3/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17;10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18;6-3-1-2-4-7-5(8)9;3-1-2(4)5/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20);1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18);7H,1-4,6H2,(H,8,9);3H,1H2,(H,4,5) D0V8AG DRUGINKE MRYYMYCQXMFJNE-UHFFFAOYSA-N D0V8AG DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O.C(CCNC(=O)O)CN.C(C(=O)O)O D0V8AG HIGHSTAT Phase 2 D0VG0D DRUG__ID D0VG0D D0VG0D DRUGCOMP Novartis D0VG0D DRUGTYPE Small molecular drug D0VG0D DRUGINCH 1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3 D0VG0D DRUGINKE JOGKUKXHTYWRGZ-UHFFFAOYSA-N D0VG0D DRUGSMIL CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5 D0VG0D HIGHSTAT Phase 2 D0VJ5N DRUG__ID D0VJ5N D0VJ5N DRUGCOMP GlaxoSmithKline D0VJ5N DRUGTYPE Small molecular drug D0VJ5N DRUGINCH 1S/C17H16BrF3N4O/c18-13-3-1-2-4-14(13)24-16(26)23-12-7-8-25(10-12)15-6-5-11(9-22-15)17(19,20)21/h1-6,9,12H,7-8,10H2,(H2,23,24,26)/t12-/m1/s1 D0VJ5N DRUGINKE JYILLRHXRVTRSH-GFCCVEGCSA-N D0VJ5N DRUGSMIL C1CN(CC1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F D0VJ5N HIGHSTAT Phase 2 D0VO0T DRUG__ID D0VO0T D0VO0T DRUGCOMP Cephalon D0VO0T DRUGTYPE Small molecular drug D0VO0T DRUGINCH 1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14-,18+,19+/m1/s1 D0VO0T DRUGINKE SJFBTAPEPRWNKH-CCKFTAQKSA-N D0VO0T DRUGSMIL B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O D0VO0T HIGHSTAT Phase 2 D0VT1S DRUG__ID D0VT1S D0VT1S DRUGCOMP TransTech Pharma D0VT1S DRUGTYPE Small molecular drug D0VT1S DRUGINCH 1S/C25H22N10O3/c1-15-28-30-32-34(15)26-13-17-3-9-23(37)21(11-17)25(19-5-7-20(36)8-6-19)22-12-18(4-10-24(22)38)14-27-35-16(2)29-31-33-35/h3-14,25,36-38H,1-2H3/b26-13+,27-14+ D0VT1S DRUGINKE BLUJRJMLDHEMRX-BMNRKXRESA-N D0VT1S DRUGSMIL CC1=NN=NN1N=CC2=CC(=C(C=C2)O)C(C3=CC=C(C=C3)O)C4=C(C=CC(=C4)C=NN5C(=NN=N5)C)O D0VT1S HIGHSTAT Phase 2 D0VU2M DRUG__ID D0VU2M D0VU2M DRUGCOMP Chiesi D0VU2M DRUGTYPE Small molecular drug D0VU2M DRUGINCH 1S/C21H24N2O4.ClH/c1-13(11-14-3-5-15(27-2)6-4-14)22-12-19(25)16-7-9-18(24)21-17(16)8-10-20(26)23-21;/h3-10,13,19,22,24-25H,11-12H2,1-2H3,(H,23,26);1H/t13-,19+;/m1./s1 D0VU2M DRUGINKE SYCWERNQGSKYAG-QVRIGTRMSA-N D0VU2M DRUGSMIL CC(CC1=CC=C(C=C1)OC)NCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O.Cl D0VU2M HIGHSTAT Phase 2 D0VX5O DRUG__ID D0VX5O D0VX5O DRUGCOMP Rottapharm Madaus D0VX5O DRUGTYPE Small molecular drug D0VX5O DRUGINCH 1S/C13H24N2O3/c1-13(2)7-5-9(6-8-13)15-12(18)10(14)3-4-11(16)17/h9-10H,3-8,14H2,1-2H3,(H,15,18)(H,16,17)/t10-/m0/s1 D0VX5O DRUGINKE VCRGLZYPNNAVRP-JTQLQIEISA-N D0VX5O DRUGSMIL CC1(CCC(CC1)NC(=O)C(CCC(=O)O)N)C D0VX5O HIGHSTAT Phase 2 D0W0NU DRUG__ID D0W0NU D0W0NU DRUGCOMP Humanetics Minneapolis, MN D0W0NU DRUGTYPE Small molecular drug D0W0NU DRUGINCH 1S/C7H14O6/c1-13-7-5(11)3(9)2(8)4(10)6(7)12/h2-12H,1H3/t2?,3-,4-,5-,6+,7?/m0/s1 D0W0NU DRUGINKE DSCFFEYYQKSRSV-FEPQRWDDSA-N D0W0NU DRUGSMIL COC1C(C(C(C(C1O)O)O)O)O D0W0NU HIGHSTAT Phase 2 D0W0VD DRUG__ID D0W0VD D0W0VD DRUGCOMP Roche D0W0VD DRUGTYPE Small molecular drug D0W0VD DRUGINCH 1S/C15H14O3/c1-15(2)8-7-11-13(17)12(16)9-5-3-4-6-10(9)14(11)18-15/h3-6H,7-8H2,1-2H3 D0W0VD DRUGINKE QZPQTZZNNJUOLS-UHFFFAOYSA-N D0W0VD DRUGSMIL CC1(CCC2=C(O1)C3=CC=CC=C3C(=O)C2=O)C D0W0VD HIGHSTAT Phase 2 D0W0WP DRUG__ID D0W0WP D0W0WP DRUGCOMP Lupin Ltd D0W0WP DRUGTYPE Small molecular drug D0W0WP DRUGINCH 1S/C29H28F3N5O/c1-21-24(20-35-14-16-36(17-15-35)26-9-5-8-25(19-26)29(30,31)32)18-27(22-6-3-2-4-7-22)37(21)34-28(38)23-10-12-33-13-11-23/h2-13,18-19H,14-17,20H2,1H3,(H,34,38) D0W0WP DRUGINKE PRXZOPNJRFEGRH-UHFFFAOYSA-N D0W0WP DRUGSMIL CC1=C(C=C(N1NC(=O)C2=CC=NC=C2)C3=CC=CC=C3)CN4CCN(CC4)C5=CC=CC(=C5)C(F)(F)F D0W0WP HIGHSTAT Phase 2 D0W0WU DRUG__ID D0W0WU D0W0WU DRUGCOMP Genzyme D0W0WU DRUGTYPE Small molecular drug D0W0WU DRUGINCH 1S/C13H32N4/c1-3-14-8-5-10-16-12-7-13-17-11-6-9-15-4-2/h14-17H,3-13H2,1-2H3 D0W0WU DRUGINKE UMJJGDUYVQCBMC-UHFFFAOYSA-N D0W0WU DRUGSMIL CCNCCCNCCCNCCCNCC D0W0WU HIGHSTAT Phase 2 D0W1JJ DRUG__ID D0W1JJ D0W1JJ DRUGCOMP GILEAD D0W1JJ DRUGTYPE Small molecular drug D0W1JJ DRUGINCH 1S/C30H41NO6S/c1-20-5-7-21(8-6-20)27(32)31(25-17-24(11-13-29(2,3)4)38-26(25)28(33)34)22-9-14-30(35,15-10-22)19-37-23-12-16-36-18-23/h5,17,21-23,35H,6-10,12,14-16,18-19H2,1-4H3,(H,33,34)/t21-,22?,23-,30?/m0/s1 D0W1JJ DRUGINKE MUICUPWICXUNRS-UVXQUXCMSA-N D0W1JJ DRUGSMIL CC1=CCC(CC1)C(=O)N(C2CCC(CC2)(COC3CCOC3)O)C4=C(SC(=C4)C#CC(C)(C)C)C(=O)O D0W1JJ HIGHSTAT Phase 2 D0W1US DRUG__ID D0W1US D0W1US DRUGCOMP ViroPharma D0W1US DRUGTYPE Small molecular drug D0W1US DRUGINCH 1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 D0W1US DRUGINKE KQOXLKOJHVFTRN-UHFFFAOYSA-N D0W1US DRUGSMIL CC1=CC(=CC(=C1OCCCC2=CC(=NO2)C)C)C3=NOC(=N3)C(F)(F)F D0W1US HIGHSTAT Phase 2 D0W3BA DRUG__ID D0W3BA D0W3BA DRUGCOMP University of Texas D0W3BA DRUGTYPE Small molecular drug D0W3BA DRUGINCH 1S/CH3FO2S/c1-5(2,3)4/h1H3 D0W3BA DRUGINKE KNWQLFOXPQZGPX-UHFFFAOYSA-N D0W3BA DRUGSMIL CS(=O)(=O)F D0W3BA HIGHSTAT Phase 2 D0W3RW DRUG__ID D0W3RW D0W3RW DRUGCOMP Merck D0W3RW DRUGTYPE Small molecular drug D0W3RW DRUGINCH 1S/C25H21N5O/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31/h1-3,5-11,14-15H,4,12-13,26H2,(H,29,31) D0W3RW DRUGINKE ULDXWLCXEDXJGE-UHFFFAOYSA-N D0W3RW DRUGSMIL C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N D0W3RW HIGHSTAT Phase 2 D0W4EB DRUG__ID D0W4EB D0W4EB DRUGCOMP Jina Pharmaceuticals Inc D0W4EB DRUGTYPE Small molecular drug D0W4EB DRUGINCH 1S/C25H27NO2/c1-3-24(19-7-5-4-6-8-19)25(20-9-13-22(27)14-10-20)21-11-15-23(16-12-21)28-18-17-26-2/h4-16,26-27H,3,17-18H2,1-2H3/b25-24- D0W4EB DRUGINKE MHJBZVSGOZTKRH-IZHYLOQSSA-N D0W4EB DRUGSMIL CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCNC)C3=CC=CC=C3 D0W4EB HIGHSTAT Phase 2 D0W4JI DRUG__ID D0W4JI D0W4JI DRUGCOMP Inspire Pharmaceuticals D0W4JI DRUGTYPE Small molecular drug D0W4JI DRUGINCH 1S/C22H25N6O8P/c1-2-23-22(29)27-19-16-20(25-11-24-19)28(12-26-16)21-18-17(14(34-21)10-33-37(30,31)32)35-15(36-18)9-8-13-6-4-3-5-7-13/h3-9,11-12,14-15,17-18,21H,2,10H2,1H3,(H2,30,31,32)(H2,23,24,25,27,29)/b9-8+/t14-,15+,17-,18-,21-/m1/s1 D0W4JI DRUGINKE NXHAXEBZOXCDKD-XIXRRVGJSA-N D0W4JI DRUGSMIL CCNC(=O)NC1=C2C(=NC=N1)N(C=N2)C3C4C(C(O3)COP(=O)(O)O)OC(O4)C=CC5=CC=CC=C5 D0W4JI HIGHSTAT Phase 2 D0W4VH DRUG__ID D0W4VH D0W4VH DRUGCOMP Carlbiotech Ltd; Peptech (UK) Ltd D0W4VH DRUGTYPE Small molecular drug D0W4VH DRUGINCH 1S/C35H55N9O16/c1-13(36)28(52)40-22(12-45)31(55)41-25(15(3)47)33(57)43-26(16(4)48)34(58)42-24(14(2)46)32(56)39-21(11-23(37)51)29(53)38-20(10-18-6-8-19(50)9-7-18)30(54)44-27(17(5)49)35(59)60/h6-9,13-17,20-22,24-27,45-50H,10-12,36H2,1-5H3,(H2,37,51)(H,38,53)(H,39,56)(H,40,52)(H,41,55)(H,42,58)(H,43,57)(H,44,54)(H,59,60)/t13-,14+,15+,16+,17+,20-,21-,22-,24-,25-,26-,27-/m0/s1 D0W4VH DRUGINKE IWHCAJPPWOMXNW-LYKMMFCUSA-N D0W4VH DRUGSMIL CC(C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CO)NC(=O)C(C)N)O D0W4VH HIGHSTAT Phase 2 D0W4XY DRUG__ID D0W4XY D0W4XY DRUGCOMP Predix Pharmaceuticals D0W4XY DRUGTYPE Small molecular drug D0W4XY DRUGINCH 1S/C19H17ClFN5S/c20-17-8-15-18(23-11-24-19(15)27-17)25-14-3-5-26(6-4-14)10-12-1-2-16(21)13(7-12)9-22/h1-2,7-8,11,14H,3-6,10H2,(H,23,24,25) D0W4XY DRUGINKE IENZFHBNCRQMNP-UHFFFAOYSA-N D0W4XY DRUGSMIL C1CN(CCC1NC2=C3C=C(SC3=NC=N2)Cl)CC4=CC(=C(C=C4)F)C#N D0W4XY HIGHSTAT Phase 2 D0W6AF DRUG__ID D0W6AF D0W6AF DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0W6AF DRUGTYPE Small molecular drug D0W6AF DRUGINCH 1S/C24H32N4OS.C4H4O4/c1-24(2,20-8-4-3-5-9-20)10-12-27-13-15-28(16-14-27)23(29)21-18-30-22(26-21)19-7-6-11-25-17-19;5-3(6)1-2-4(7)8/h3-9,11,17,21-22,26H,10,12-16,18H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D0W6AF DRUGINKE LBPPBLYOJCIZRW-WLHGVMLRSA-N D0W6AF DRUGSMIL CC(C)(CCN1CCN(CC1)C(=O)C2CSC(N2)C3=CN=CC=C3)C4=CC=CC=C4.C(=CC(=O)O)C(=O)O D0W6AF HIGHSTAT Phase 2 D0W8IY DRUG__ID D0W8IY D0W8IY DRUGCOMP Piramal Healthcare Ltd D0W8IY DRUGTYPE Small molecular drug D0W8IY DRUGINCH 1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3/t12-,14+/m1/s1 D0W8IY DRUGINKE QLUYMIVVAYRECT-OCCSQVGLSA-N D0W8IY DRUGSMIL CN1CCC(C1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O D0W8IY HIGHSTAT Phase 2 D0W9NO DRUG__ID D0W9NO D0W9NO DRUGCOMP Yamasa Shoyu Co Ltd D0W9NO DRUGTYPE Small molecular drug D0W9NO DRUGINCH 1S/C18H25N5O4/c1-2-3-4-5-6-7-8-12-21-16(19)13-17(22-12)23(10-20-13)18-15(26)14(25)11(9-24)27-18/h10-11,14-15,18,24-26H,2-6,9H2,1H3,(H2,19,21,22)/t11-,14-,15-,18-/m1/s1 D0W9NO DRUGINKE NVGGIHKSKVAPEY-XKLVTHTNSA-N D0W9NO DRUGSMIL CCCCCCC#CC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N D0W9NO HIGHSTAT Phase 2 D0W9SL DRUG__ID D0W9SL D0W9SL DRUGCOMP Lilly D0W9SL DRUGTYPE Small molecular drug D0W9SL DRUGINCH 1S/C23H37N5O4S2/c1-8-24-14-15-34(31,32)25-16-23(17-12-10-9-11-13-17)28(19(30)22(5,6)7)27-20(33-23)26-18(29)21(2,3)4/h9-13,24-25H,8,14-16H2,1-7H3,(H,26,27,29)/t23-/m0/s1 D0W9SL DRUGINKE YVAFBXLHPINSIK-QHCPKHFHSA-N D0W9SL DRUGSMIL CCNCCS(=O)(=O)NCC1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2 D0W9SL HIGHSTAT Phase 2 D0W9ZT DRUG__ID D0W9ZT D0W9ZT DRUGCOMP Pfizer D0W9ZT DRUGTYPE Small molecular drug D0W9ZT DRUGINCH 1S/C24H28N2O3.ClH/c1-3-26(4-2)23(28)18-10-8-17(9-11-18)19-16-24(12-14-25-15-13-24)29-21-7-5-6-20(27)22(19)21;/h5-11,16,25,27H,3-4,12-15H2,1-2H3;1H D0W9ZT DRUGINKE ZFNLSWREIULTDO-UHFFFAOYSA-N D0W9ZT DRUGSMIL CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=CC=CC(=C42)O.Cl D0W9ZT HIGHSTAT Phase 2 D0WK0P DRUG__ID D0WK0P D0WK0P DRUGCOMP Fuji Yakuhin Kogyo Co Ltd D0WK0P DRUGTYPE Small molecular drug D0WK0P DRUGINCH 1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19) D0WK0P DRUGINKE UBVZQGOVTLIHLH-UHFFFAOYSA-N D0WK0P DRUGSMIL C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N D0WK0P HIGHSTAT Phase 2 D0WM6E DRUG__ID D0WM6E D0WM6E DRUGCOMP Titan Pharmaceuticals D0WM6E DRUGTYPE Small molecular drug D0WM6E DRUGINCH 1S/C15H12I2O4/c16-12-7-9(1-6-14(19)20)8-13(17)15(12)21-11-4-2-10(18)3-5-11/h2-5,7-8,18H,1,6H2,(H,19,20) D0WM6E DRUGINKE WONYMNWUJVKVII-UHFFFAOYSA-N D0WM6E DRUGSMIL C1=CC(=CC=C1O)OC2=C(C=C(C=C2I)CCC(=O)O)I D0WM6E HIGHSTAT Phase 2 D0WZC1 DRUG__ID D0WZC1 D0WZC1 DRUGCOMP Janssen D0WZC1 DRUGTYPE Small molecular drug D0WZC1 DRUGINCH 1S/C23H18F4N4O2/c24-16-4-1-3-15(20(16)21-28-7-2-8-29-21)22(32)31-12-13-9-17(31)18(10-13)33-19-6-5-14(11-30-19)23(25,26)27/h1-8,11,13,17-18H,9-10,12H2/t13-,17+,18-/m1/s1/i12D2 D0WZC1 DRUGINKE HUKWIAXQBOHZIX-USKNZQBOSA-N D0WZC1 DRUGSMIL C1C2CC(C1N(C2)C(=O)C3=C(C(=CC=C3)F)C4=NC=CC=N4)OC5=NC=C(C=C5)C(F)(F)F D0WZC1 HIGHSTAT Phase 2 D0X0CB DRUG__ID D0X0CB D0X0CB DRUGCOMP Vertex Pharmaceuticals Inc D0X0CB DRUGTYPE Small molecular drug D0X0CB DRUGINCH 1S/C24H18F2N2O5/c1-13-5-8-19(27-20(13)14-3-2-4-15(11-14)21(29)30)28-22(31)23(9-10-23)16-6-7-17-18(12-16)33-24(25,26)32-17/h2-8,11-12H,9-10H2,1H3,(H,29,30)(H,27,28,31) D0X0CB DRUGINKE UFSKUSARDNFIRC-UHFFFAOYSA-N D0X0CB DRUGSMIL CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O D0X0CB HIGHSTAT Phase 2 D0X0FU DRUG__ID D0X0FU D0X0FU DRUGCOMP Koronis Pharmaceuticals D0X0FU DRUGTYPE Small molecular drug D0X0FU DRUGINCH 1S/C16H28N4O6/c1-2-3-4-5-6-7-25-16(24)19-14-17-10-20(15(23)18-14)13-8-11(22)12(9-21)26-13/h11-13,21-22H,2-10H2,1H3,(H2,17,18,19,23,24)/t11-,12+,13+/m0/s1 D0X0FU DRUGINKE SZWIAFVYPPMZML-YNEHKIRRSA-N D0X0FU DRUGSMIL CCCCCCCOC(=O)NC1=NCN(C(=O)N1)C2CC(C(O2)CO)O D0X0FU HIGHSTAT Phase 2 D0X0PW DRUG__ID D0X0PW D0X0PW DRUGCOMP Glenmark Pharmaceuticals Ltd D0X0PW DRUGTYPE Small molecular drug D0X0PW DRUGINCH 1S/C18H9Cl2F2N3O4/c19-10-6-25(27)7-11(20)15(10)24-17(26)8-1-2-13(29-18(21)22)16-14(8)9-5-23-4-3-12(9)28-16/h1-7,18,27H D0X0PW DRUGINKE CFRXVFRHMZLQBS-UHFFFAOYSA-N D0X0PW DRUGSMIL C1=CC(=C2C(=C1C(=O)N=C3C(=CN(C=C3Cl)O)Cl)C4=C(O2)C=CN=C4)OC(F)F D0X0PW HIGHSTAT Phase 2 D0X1RQ DRUG__ID D0X1RQ D0X1RQ DRUGCOMP Meditor Pharmaceuticals D0X1RQ DRUGTYPE Small molecular drug D0X1RQ DRUGINCH 1S/C4H11O4P.C3H8N2S/c1-3-7-9(5,6)8-4-2;1-2-6-3(4)5/h3-4H2,1-2H3,(H,5,6);2H2,1H3,(H3,4,5) D0X1RQ DRUGINKE CSYSULGPHGCBQD-UHFFFAOYSA-N D0X1RQ DRUGSMIL CCOP(=O)(O)OCC.CCSC(=N)N D0X1RQ HIGHSTAT Phase 2 D0X4IH DRUG__ID D0X4IH D0X4IH DRUGCOMP GE Healthcare; National Cancer Institute D0X4IH DRUGTYPE Small molecular drug D0X4IH DRUGINCH 1S/C75H115FN18O27S3/c76-52-13-11-51(12-14-52)39-87-121-45-65(100)83-19-23-113-27-31-117-34-36-118-35-33-116-30-26-112-22-18-82-64(99)44-120-43-62(97)80-15-5-4-9-54-70(106)93-58-47-123-124-48-59(94-72(108)56(38-67(102)103)89-61(96)40-86-68(104)53(90-73(58)109)10-6-16-85-75(78)79)74(110)91-55(37-50-7-2-1-3-8-50)71(107)92-57(46-122-49-66(101)88-54)69(105)84-20-24-114-28-32-115-29-25-111-21-17-81-63(98)42-119-41-60(77)95/h1-3,7-8,11-14,39,53-59H,4-6,9-10,15-38,40-49H2,(H2,77,95)(H,80,97)(H,81,98)(H,82,99)(H,83,100)(H,84,105)(H,86,104)(H,88,101)(H,89,96)(H,90,109)(H,91,110)(H,92,107)(H,93,106)(H,94,108)(H,102,103)(H4,78,79,85)/b87-39-/t53-,54-,55-,56-,57-,58-,59-/m0/s1/i76-1 D0X4IH DRUGINKE VXFFXZSNVKXXIB-SOFHUQNMSA-N D0X4IH DRUGSMIL C1C2C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSS1)C(=O)NC(C(=O)NC(CSCC(=O)NC(C(=O)N2)CCCCNC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCNC(=O)CON=CC3=CC=C(C=C3)F)C(=O)NCCOCCOCCOCCNC(=O)COCC(=O)N)CC4=CC=CC=C4)CC(=O)O)CCCN=C(N)N D0X4IH HIGHSTAT Phase 2 D0X4MN DRUG__ID D0X4MN D0X4MN DRUGCOMP Celgene D0X4MN DRUGTYPE Small molecular drug D0X4MN DRUGINCH 1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12?,13-,14?/m0/s1 D0X4MN DRUGINKE IBGLGMOPHJQDJB-MOKVOYLWSA-N D0X4MN DRUGSMIL C1CC(CCC1NC2=NC=C3C(=N2)N(C(=N3)NC4=C(C=C(C=C4F)F)F)C5CCOC5)O D0X4MN HIGHSTAT Phase 2 D0X4ZL DRUG__ID D0X4ZL D0X4ZL DRUGCOMP Elan Pharmaceutical Research D0X4ZL DRUGTYPE Small molecular drug D0X4ZL DRUGINCH 1S/C16H25NO.ClH/c1-3-12(2)17-11-16(18)15-9-8-13-6-4-5-7-14(13)10-15;/h8-10,12,16-18H,3-7,11H2,1-2H3;1H D0X4ZL DRUGINKE KHBXORBAOCQNMC-UHFFFAOYSA-N D0X4ZL DRUGSMIL CCC(C)[NH2+]CC(C1=CC2=C(CCCC2)C=C1)O.[Cl-] D0X4ZL HIGHSTAT Phase 2 D0X7EG DRUG__ID D0X7EG D0X7EG DRUGCOMP Oxagen Ltd D0X7EG DRUGTYPE Small molecular drug D0X7EG DRUGINCH 1S/C21H17FN2O2/c1-13-17(11-16-8-6-14-4-2-3-5-19(14)23-16)18-10-15(22)7-9-20(18)24(13)12-21(25)26/h2-10H,11-12H2,1H3,(H,25,26) D0X7EG DRUGINKE FATGTHLOZSXOBC-UHFFFAOYSA-N D0X7EG DRUGSMIL CC1=C(C2=C(N1CC(=O)O)C=CC(=C2)F)CC3=NC4=CC=CC=C4C=C3 D0X7EG HIGHSTAT Phase 2 D0X9LK DRUG__ID D0X9LK D0X9LK DRUGCOMP Novartis AG D0X9LK DRUGTYPE Small molecular drug D0X9LK DRUGINCH 1S/C38H37F3O8S/c1-3-11-29-31(18-17-27(23(2)42)36(29)45)48-19-9-7-5-4-6-8-14-34(35(44)24-12-10-13-25(20-24)38(39,40)41)50-26-15-16-28-30(43)22-33(37(46)47)49-32(28)21-26/h4,6,8,10,12-18,20-22,34-35,44-45H,3,5,7,9,11,19H2,1-2H3,(H,46,47)/b6-4-,14-8+/t34-,35+/m0/s1 D0X9LK DRUGINKE IXJCHVMUTFCRBH-SDUHDBOFSA-N D0X9LK DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCC=CC=CC(C(C2=CC(=CC=C2)C(F)(F)F)O)SC3=CC4=C(C=C3)C(=O)C=C(O4)C(=O)O D0X9LK HIGHSTAT Phase 2 D0XE0X DRUG__ID D0XE0X D0XE0X DRUGCOMP Wyeth D0XE0X DRUGTYPE Small molecular drug D0XE0X DRUGINCH 1S/C18H18N2O3.C4H4O4/c21-17-8-14-15(20-17)6-7-16-18(14)23-13(11-22-16)10-19-9-12-4-2-1-3-5-12;5-3(6)1-2-4(7)8/h1-7,13,19H,8-11H2,(H,20,21);1-2H,(H,5,6)(H,7,8)/b;2-1+/t13-;/m0./s1 D0XE0X DRUGINKE GELJVTSEGKGLDF-QDSMGTAFSA-N D0XE0X DRUGSMIL C1C(OC2=C(O1)C=CC3=C2CC(=O)N3)CNCC4=CC=CC=C4.C(=CC(=O)O)C(=O)O D0XE0X HIGHSTAT Phase 2 D0XH0K DRUG__ID D0XH0K D0XH0K DRUGCOMP Roche D0XH0K DRUGTYPE Small molecular drug D0XH0K DRUGINCH 1S/2C40H69NO12.C4H4O4/c2*1-16-28-40(12,47-15)33(43)23(6)31-21(4)18-39(11,53-31)35(52-37-30(42)27(17-22(5)48-37)41(13)20(2)3)24(7)32(25(8)36(45)50-28)51-29-19-38(10,46-14)34(44)26(9)49-29;5-3(6)1-2-4(7)8/h2*20,22-30,32,34-35,37,42,44H,16-19H2,1-15H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*22-,23+,24+,25-,26+,27+,28-,29+,30-,32+,34+,35-,37+,38-,39-,40-;/m11./s1 D0XH0K DRUGINKE KQRXEQGYUDDPNW-QXRSSOOUSA-N D0XH0K DRUGSMIL CCC1C(C(=O)C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C(C)C)O)C)C)C)(C)OC.CCC1C(C(=O)C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C(C)C)O)C)C)C)(C)OC.C(=CC(=O)O)C(=O)O D0XH0K HIGHSTAT Phase 2 D0XP3W DRUG__ID D0XP3W D0XP3W DRUGCOMP Roche Holding AG D0XP3W DRUGTYPE Small molecular drug D0XP3W DRUGINCH 1S/C14H13ClN4/c1-16-13-8-18-14(12-3-2-6-17-12)10-7-9(15)4-5-11(10)19-13/h2-7,17H,8H2,1H3,(H,16,19) D0XP3W DRUGINKE LEAKQIXYSHIHCW-UHFFFAOYSA-N D0XP3W DRUGSMIL CN=C1CN=C(C2=C(N1)C=CC(=C2)Cl)C3=CC=CN3 D0XP3W HIGHSTAT Phase 2 D0Y1UO DRUG__ID D0Y1UO D0Y1UO DRUGCOMP Verastem D0Y1UO DRUGTYPE Small molecular drug D0Y1UO DRUGINCH 1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30) D0Y1UO DRUGINKE FWLMVFUGMHIOAA-UHFFFAOYSA-N D0Y1UO DRUGSMIL CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F D0Y1UO HIGHSTAT Phase 2 D0Y2HA DRUG__ID D0Y2HA D0Y2HA DRUGCOMP Barrier Therapeutics D0Y2HA DRUGTYPE Small molecular drug D0Y2HA DRUGINCH 1S/C35H39F2N7O4/c1-25(2)43-17-18-44(34(43)45)29-6-4-27(5-7-29)40-13-15-41(16-14-40)28-8-10-30(11-9-28)46-20-33-47-22-35(48-33,21-42-24-38-23-39-42)31-12-3-26(36)19-32(31)37/h3-12,19,23-25,33H,13-18,20-22H2,1-2H3/t33-,35+/m0/s1 D0Y2HA DRUGINKE AEKNYBWUEYNWMJ-QWOOXDRHSA-N D0Y2HA DRUGSMIL CC(C)N1CCN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5OCC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F D0Y2HA HIGHSTAT Phase 2 D0Y2NU DRUG__ID D0Y2NU D0Y2NU DRUGCOMP NPS Allelix Corp D0Y2NU DRUGTYPE Small molecular drug D0Y2NU DRUGINCH 1S/C56H113N37O10/c1-29(94)85-31(12-3-21-77-49(60)61)40(96)87-33(14-5-23-79-51(64)65)42(98)89-35(16-7-25-81-53(68)69)44(100)91-37(18-9-27-83-55(72)73)46(102)93-38(19-10-28-84-56(74)75)47(103)92-36(17-8-26-82-54(70)71)45(101)90-34(15-6-24-80-52(66)67)43(99)88-32(13-4-22-78-50(62)63)41(97)86-30(39(57)95)11-2-20-76-48(58)59/h30-38H,2-28H2,1H3,(H2,57,95)(H,85,94)(H,86,97)(H,87,96)(H,88,99)(H,89,98)(H,90,101)(H,91,100)(H,92,103)(H,93,102)(H4,58,59,76)(H4,60,61,77)(H4,62,63,78)(H4,64,65,79)(H4,66,67,80)(H4,68,69,81)(H4,70,71,82)(H4,72,73,83)(H4,74,75,84)/t30-,31-,32-,33-,34-,35-,36-,37-,38-/m1/s1 D0Y2NU DRUGINKE LGLVVVCSQBZONM-HCCLCSBVSA-N D0Y2NU DRUGSMIL CC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)N D0Y2NU HIGHSTAT Phase 2 D0Y3LL DRUG__ID D0Y3LL D0Y3LL DRUGCOMP Pfizer Inc D0Y3LL DRUGTYPE Small molecular drug D0Y3LL DRUGINCH 1S/C24H22N4O5S/c29-24(30)18-33-22-5-1-4-20(14-22)17-27(34(31,32)23-6-2-11-25-15-23)16-19-7-9-21(10-8-19)28-13-3-12-26-28/h1-15H,16-18H2,(H,29,30) D0Y3LL DRUGINKE MFFBXYNKZHTCEY-UHFFFAOYSA-N D0Y3LL DRUGSMIL C1=CC(=CC(=C1)OCC(=O)O)CN(CC2=CC=C(C=C2)N3C=CC=N3)S(=O)(=O)C4=CN=CC=C4 D0Y3LL HIGHSTAT Phase 2 D0Y5ZT DRUG__ID D0Y5ZT D0Y5ZT DRUGCOMP Kyorin Pharmaceutical Co Ltd D0Y5ZT DRUGTYPE Small molecular drug D0Y5ZT DRUGINCH 1S/C24H26ClNO3S.ClH/c25-23-14-22(10-9-19(23)11-12-24(26,16-27)17-28)30-21-8-4-7-20(13-21)29-15-18-5-2-1-3-6-18;/h1-10,13-14,27-28H,11-12,15-17,26H2;1H D0Y5ZT DRUGINKE MYIFLDFUXIHOCJ-UHFFFAOYSA-N D0Y5ZT DRUGSMIL C1=CC=C(C=C1)COC2=CC(=CC=C2)SC3=CC(=C(C=C3)CCC(CO)(CO)N)Cl.Cl D0Y5ZT HIGHSTAT Phase 2 D0Y6VW DRUG__ID D0Y6VW D0Y6VW THERCLAS Antiviral Agents D0Y6VW DRUGTYPE Small molecular drug D0Y6VW DRUGINCH 1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3 D0Y6VW DRUGINKE KKGQTZUTZRNORY-UHFFFAOYSA-N D0Y6VW DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N D0Y6VW HIGHSTAT Phase 2 Trial D0Y7YD DRUG__ID D0Y7YD D0Y7YD DRUGCOMP Summit Corp plc D0Y7YD DRUGTYPE Small molecular drug D0Y7YD DRUGINCH 1S/C19H15NO3S/c1-2-24(21,22)16-9-10-18-17(12-16)20-19(23-18)15-8-7-13-5-3-4-6-14(13)11-15/h3-12H,2H2,1H3 D0Y7YD DRUGINKE KSGCNXAZROJSNW-UHFFFAOYSA-N D0Y7YD DRUGSMIL CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3 D0Y7YD HIGHSTAT Phase 2 D0Y8NZ DRUG__ID D0Y8NZ D0Y8NZ DRUGCOMP Daiichi Sankyo D0Y8NZ DRUGTYPE Small molecular drug D0Y8NZ DRUGINCH 1S/C27H26N4O4S/c1-15-10-20(11-16(2)25(15)28)35-19-8-9-21-22(13-19)31(3)24(29-21)14-34-18-6-4-17(5-7-18)12-23-26(32)30-27(33)36-23/h4-11,13,23H,12,14,28H2,1-3H3,(H,30,32,33) D0Y8NZ DRUGINKE JCYNMRJCUYVDBC-UHFFFAOYSA-N D0Y8NZ DRUGSMIL CC1=CC(=CC(=C1N)C)OC2=CC3=C(C=C2)N=C(N3C)COC4=CC=C(C=C4)CC5C(=O)NC(=O)S5 D0Y8NZ HIGHSTAT Phase 2 D0YB2Y DRUG__ID D0YB2Y D0YB2Y DRUGCOMP Amgen Thousand D0YB2Y DRUGTYPE Small molecular drug D0YB2Y DRUGINCH 1S/C28H27Cl2FN2O6S/c1-28(2,3)32-27(36)17-6-8-23(39-24-14-21(31)18(11-19(24)29)13-26(34)35)22(12-17)33-40(37,38)25-9-7-16(10-20(25)30)15-4-5-15/h6-12,14-15,33H,4-5,13H2,1-3H3,(H,32,36)(H,34,35) D0YB2Y DRUGINKE PFWVGKROPKKEDW-UHFFFAOYSA-N D0YB2Y DRUGSMIL CC(C)(C)NC(=O)C1=CC(=C(C=C1)OC2=C(C=C(C(=C2)F)CC(=O)O)Cl)NS(=O)(=O)C3=C(C=C(C=C3)C4CC4)Cl D0YB2Y HIGHSTAT Phase 2 D0YB4D DRUG__ID D0YB4D D0YB4D DRUGCOMP Wyeth D0YB4D DRUGTYPE Small molecular drug D0YB4D DRUGINCH 1S/C39H58N2O5/c1-13-14-15-16-21-41(25-27-19-17-26(18-20-27)24-36(2,3)4)33(31-34(43)45-39(11,12)46-35(31)44)40-28-22-29(37(5,6)7)32(42)30(23-28)38(8,9)10/h17-20,22-23,40,42H,13-16,21,24-25H2,1-12H3 D0YB4D DRUGINKE HGLFNRGXRCKGSW-UHFFFAOYSA-N D0YB4D DRUGSMIL CCCCCCN(CC1=CC=C(C=C1)CC(C)(C)C)C(=C2C(=O)OC(OC2=O)(C)C)NC3=CC(=C(C(=C3)C(C)(C)C)O)C(C)(C)C D0YB4D HIGHSTAT Phase 2 D0YF4I DRUG__ID D0YF4I D0YF4I DRUGCOMP MediciNova D0YF4I DRUGTYPE Small molecular drug D0YF4I DRUGINCH 1S/2C24H32N2O5.H2O4S/c2*1-26(2)24(30)15-31-21-7-4-16-3-6-20(12-19(16)13-21)25-14-23(29)17-5-8-22(28)18(11-17)9-10-27;1-5(2,3)4/h2*4-5,7-8,11,13,20,23,25,27-29H,3,6,9-10,12,14-15H2,1-2H3;(H2,1,2,3,4)/t2*20-,23-;/m00./s1 D0YF4I DRUGINKE VPCOODFYDJWLHD-YMZXMBPUSA-N D0YF4I DRUGSMIL CN(C)C(=O)COC1=CC2=C(CCC(C2)NCC(C3=CC(=C(C=C3)O)CCO)O)C=C1.CN(C)C(=O)COC1=CC2=C(CCC(C2)NCC(C3=CC(=C(C=C3)O)CCO)O)C=C1.OS(=O)(=O)O D0YF4I HIGHSTAT Phase 2 D0YQ7U DRUG__ID D0YQ7U D0YQ7U DRUGCOMP Tobira Therapeutics D0YQ7U DRUGTYPE Small molecular drug D0YQ7U DRUGINCH 1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1 D0YQ7U DRUGINKE PNDKCRDVVKJPKG-WHERJAGFSA-N D0YQ7U DRUGSMIL CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C D0YQ7U HIGHSTAT Phase 2 D0YTM9 DRUG__ID D0YTM9 D0YTM9 DRUGCOMP AstraZeneca D0YTM9 DRUGTYPE Small molecule D0YTM9 DRUGINCH InChI=1S/C22H26N6O2/c1-3-16-11-19-20(26-21(16)29)10-15(12-24-19)14-27-6-8-28(9-7-27)17-4-5-18(25-13-17)22(30)23-2/h4-5,10-13H,3,6-9,14H2,1-2H3,(H,23,30)(H,26,29) D0YTM9 DRUGINKE WQAVGRAETZEADU-UHFFFAOYSA-N D0YTM9 DRUGSMIL CCC1=CC2=C(C=C(C=N2)CN3CCN(CC3)C4=CN=C(C=C4)C(=O)NC)NC1=O D0YTM9 HIGHSTAT Phase 2 D0YX7E DRUG__ID D0YX7E D0YX7E DRUGCOMP Spectrum D0YX7E DRUGTYPE Small molecular drug D0YX7E DRUGINCH 1S/C44H57NO17/c1-20(2)17-25(45-38(53)61-40(6,7)8)29(49)37(52)57-30-21(3)28-31(56-22(4)46)33(50)42(11)26(48)18-27-43(19-55-27,60-23(5)47)32(42)35(58-36(51)24-15-13-12-14-16-24)44(41(28,9)10)34(30)59-39(54)62-44/h12-16,20,25-27,29-32,34-35,48-49H,17-19H2,1-11H3,(H,45,53)/t25-,26-,27+,29+,30+,31+,32-,34-,35-,42+,43-,44+/m0/s1 D0YX7E DRUGINKE BWKDAMBGCPRVPI-ZQRPHVBESA-N D0YX7E DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C5(C2(C)C)C(C1OC(=O)C(C(CC(C)C)NC(=O)OC(C)(C)C)O)OC(=O)O5)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)OC(=O)C D0YX7E HIGHSTAT Phase 2 D0Z0GH DRUG__ID D0Z0GH D0Z0GH DRUGCOMP AstraZeneca plc D0Z0GH DRUGTYPE Small molecular drug D0Z0GH DRUGINCH 1S/C21H21F2N3O7/c22-15-7-13(26-9-14(33-21(26)30)11-31-18-3-6-32-24-18)8-16(23)19(15)12-1-4-25(5-2-12)20(29)17(28)10-27/h1,3,6-8,14,17,27-28H,2,4-5,9-11H2/t14-,17+/m1/s1 D0Z0GH DRUGINKE HBUJYEUPIIJJOS-PBHICJAKSA-N D0Z0GH DRUGSMIL C1CN(CC=C1C2=C(C=C(C=C2F)N3CC(OC3=O)COC4=NOC=C4)F)C(=O)C(CO)O D0Z0GH HIGHSTAT Phase 2 D0Z0GX DRUG__ID D0Z0GX D0Z0GX DRUGCOMP Suven Life Sciences D0Z0GX DRUGTYPE Small molecular drug D0Z0GX DRUGINCH 1S/C21H24BrN3O3S/c1-23-9-11-24(12-10-23)14-16-15-25(20-8-7-17(28-2)13-18(16)20)29(26,27)21-6-4-3-5-19(21)22/h3-8,13,15H,9-12,14H2,1-2H3 D0Z0GX DRUGINKE GWCYPEHWIZXYFZ-UHFFFAOYSA-N D0Z0GX DRUGSMIL CN1CCN(CC1)CC2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4Br D0Z0GX HIGHSTAT Phase 2 D0Z1DH DRUG__ID D0Z1DH D0Z1DH DRUGCOMP Eli Lilly D0Z1DH DRUGTYPE Small molecular drug D0Z1DH DRUGINCH 1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37) D0Z1DH DRUGINKE HRJWTAWVFDCTGO-UHFFFAOYSA-N D0Z1DH DRUGSMIL C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7 D0Z1DH HIGHSTAT Phase 2 D0Z2UQ DRUG__ID D0Z2UQ D0Z2UQ DRUGCOMP AstraZeneca D0Z2UQ DRUGTYPE Small molecular drug D0Z2UQ DRUGINCH 1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)/t16-,17-/m0/s1 D0Z2UQ DRUGINKE JUSFANSTBFGBAF-IRXDYDNUSA-N D0Z2UQ DRUGSMIL CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C D0Z2UQ HIGHSTAT Phase 2 D0Z3PO DRUG__ID D0Z3PO D0Z3PO DRUGCOMP Biogen Idec D0Z3PO DRUGTYPE Small molecular drug D0Z3PO DRUGINCH 1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20) D0Z3PO DRUGINKE HQSBCDPYXDGTCL-UHFFFAOYSA-N D0Z3PO DRUGSMIL CC1=C(C=CC(=C1)CN2C3=NC(=NC(=C3N=N2)C4=CC=CO4)N)N D0Z3PO HIGHSTAT Phase 2 D0Z3RF DRUG__ID D0Z3RF D0Z3RF DRUGCOMP UCB Pharma SA D0Z3RF DRUGTYPE Small molecular drug D0Z3RF DRUGINCH 1S/C12H21N5O2/c1-2-3-10-14-11(13-4-7-18)16-12(15-10)17-5-8-19-9-6-17/h18H,2-9H2,1H3,(H,13,14,15,16) D0Z3RF DRUGINKE NERMEVBNTXXDNG-UHFFFAOYSA-N D0Z3RF DRUGSMIL CCCC1=NC(=NC(=N1)N2CCOCC2)NCCO D0Z3RF HIGHSTAT Phase 2 D0Z5XT DRUG__ID D0Z5XT D0Z5XT DRUGCOMP AmpliMed D0Z5XT DRUGTYPE Small molecular drug D0Z5XT DRUGINCH 1S/C4H5N3O/c5-3-2-1-7(2)4(8)6-3/h2H,1H2,(H2,5,6,8) D0Z5XT DRUGINKE BIXBBIPTYBJTRY-UHFFFAOYSA-N D0Z5XT DRUGSMIL C1C2N1C(=O)N=C2N D0Z5XT HIGHSTAT Phase 2 D0Z6MT DRUG__ID D0Z6MT D0Z6MT DRUGCOMP Shanghai Hengrui Pharmaceutical Co Ltd; Jiangsu Hengrui Medicine Co Ltd D0Z6MT DRUGTYPE Small molecular drug D0Z6MT DRUGINCH 1S/C23H27FN4O2/c1-4-27(5-2)10-11-28-9-8-19-21(23(28)30)14(3)20(25-19)13-17-16-12-15(24)6-7-18(16)26-22(17)29/h6-7,12-13,25H,4-5,8-11H2,1-3H3,(H,26,29)/b17-13- D0Z6MT DRUGINKE GKEYKDOLBLYGRB-LGMDPLHJSA-N D0Z6MT DRUGSMIL CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C D0Z6MT HIGHSTAT Phase 2 D0Z7IW DRUG__ID D0Z7IW D0Z7IW DRUGCOMP Jubilant Biosys D0Z7IW DRUGTYPE Small molecular drug D0Z7IW DRUGINCH 1S/C22H20BrN5O2/c1-30-20-6-5-15(23)12-18(20)27-22(29)26-17-3-2-4-19-16(17)8-10-28(19)13-14-7-9-25-21(24)11-14/h2-12H,13H2,1H3,(H2,24,25)(H2,26,27,29) D0Z7IW DRUGINKE ZXBFYBLSJMEBEP-UHFFFAOYSA-N D0Z7IW DRUGSMIL COC1=C(C=C(C=C1)Br)NC(=O)NC2=C3C=CN(C3=CC=C2)CC4=CC(=NC=C4)N D0Z7IW HIGHSTAT Phase 2 D0Z8DO DRUG__ID D0Z8DO D0Z8DO DRUGCOMP Movetis D0Z8DO DRUGTYPE Small molecular drug D0Z8DO DRUGINCH 1S/C21H18O5S/c1-13-11-15(22)7-9-17(13)21(18-10-8-16(23)12-14(18)2)19-5-3-4-6-20(19)27(24,25)26-21/h3-12,22-23H,1-2H3 D0Z8DO DRUGINKE OLQIKGSZDTXODA-UHFFFAOYSA-N D0Z8DO DRUGSMIL CC1=C(C=CC(=C1)O)C2(C3=CC=CC=C3S(=O)(=O)O2)C4=C(C=C(C=C4)O)C D0Z8DO HIGHSTAT Phase 2 D0Z9YW DRUG__ID D0Z9YW D0Z9YW DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0Z9YW DRUGTYPE Small molecular drug D0Z9YW DRUGINCH 1S/C15H13F2NO4S/c1-9(19)10-3-5-13(18-23(2,20)21)15(7-10)22-14-6-4-11(16)8-12(14)17/h3-8,18H,1-2H3 D0Z9YW DRUGINKE DIIYLGZNZGPXRR-UHFFFAOYSA-N D0Z9YW DRUGSMIL CC(=O)C1=CC(=C(C=C1)NS(=O)(=O)C)OC2=C(C=C(C=C2)F)F D0Z9YW HIGHSTAT Phase 2 D0ZC0M DRUG__ID D0ZC0M D0ZC0M DRUGCOMP GSK D0ZC0M DRUGTYPE Small molecular drug D0ZC0M DRUGINCH 1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14(4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/s1 D0ZC0M DRUGINKE VKHVAUKFLBBZFJ-SFHVURJKSA-N D0ZC0M DRUGSMIL CCC(C1=NC(=NO1)C)NC2=CC(=NC3=C(C(=NN23)C)C4=C(C=C(C=C4)OC)C)C D0ZC0M HIGHSTAT Phase 2 D0ZI0C DRUG__ID D0ZI0C D0ZI0C DRUGCOMP Grupo Uriach D0ZI0C DRUGTYPE Small molecular drug D0ZI0C DRUGINCH 1S/C35H32N6O4/c1-23-37-31-21-36-16-13-32(31)41(23)22-24-14-17-40(18-15-24)34(43)20-29(25-5-3-2-4-6-25)26-7-9-27(10-8-26)38-39-28-11-12-33(42)30(19-28)35(44)45/h2-13,16,19-21,24,42H,14-15,17-18,22H2,1H3,(H,44,45)/b29-20-,39-38? D0ZI0C DRUGINKE AYEAMZDTWLXZIJ-JEFTWCRZSA-N D0ZI0C DRUGSMIL CC1=NC2=C(N1CC3CCN(CC3)C(=O)C=C(C4=CC=CC=C4)C5=CC=C(C=C5)N=NC6=CC(=C(C=C6)O)C(=O)O)C=CN=C2 D0ZI0C HIGHSTAT Phase 2 D0ZK7B DRUG__ID D0ZK7B D0ZK7B DRUGCOMP NeuroSearch A/S D0ZK7B DRUGTYPE Small molecular drug D0ZK7B DRUGINCH 1S/C17H23Cl2NO/c1-3-21-10-14-13(9-12-5-7-17(14)20(12)2)11-4-6-15(18)16(19)8-11/h4,6,8,12-14,17H,3,5,7,9-10H2,1-2H3/t12-,13+,14+,17+/m0/s1 D0ZK7B DRUGINKE VCVWXKKWDOJNIT-ZOMKSWQUSA-N D0ZK7B DRUGSMIL CCOCC1C2CCC(N2C)CC1C3=CC(=C(C=C3)Cl)Cl D0ZK7B HIGHSTAT Phase 2 D0ZM8B DRUG__ID D0ZM8B D0ZM8B DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0ZM8B DRUGTYPE Small molecular drug D0ZM8B DRUGINCH 1S/C8H13N3O4/c1-3-6(5(2)11(14)15)4-7(10-13)8(9)12/h4-5,13H,3H2,1-2H3,(H2,9,12)/b6-4+,10-7- D0ZM8B DRUGINKE MZAGXDHQGXUDDX-JSRXJHBZSA-N D0ZM8B DRUGSMIL CCC(=CC(=NO)C(=O)N)C(C)[N+](=O)[O-] D0ZM8B HIGHSTAT Phase 2 D0ZU4U DRUG__ID D0ZU4U D0ZU4U DRUGCOMP Melior Pharmaceuticals Inc D0ZU4U DRUGTYPE Small molecular drug D0ZU4U DRUGINCH 1S/C11H10N2O2/c1-8-3-2-4-9(5-8)15-10-6-12-11(14)13-7-10/h2-7H,1H3,(H,12,13,14) D0ZU4U DRUGINKE HJQILFPVRNHTIG-UHFFFAOYSA-N D0ZU4U DRUGSMIL CC1=CC(=CC=C1)OC2=CNC(=O)N=C2 D0ZU4U HIGHSTAT Phase 2 D18ATS DRUG__ID D18ATS D18ATS DRUGCOMP Eloxx Pharmaceuticals D18ATS DRUGTYPE Small molecule D18ATS DRUGINCH InChI=1S/C19H38N4O10/c1-4(20)14-12(28)13(29)19(30-14)33-17-9(25)6(21)3-7(22)16(17)32-18-8(23)10(26)11(27)15(31-18)5(2)24/h4-19,24-29H,3,20-23H2,1-2H3/t4-,5+,6+,7-,8+,9-,10+,11-,12-,13+,14+,15+,16+,17+,18+,19-/m0/s1 D18ATS DRUGINKE KJBRSTPUILEBDR-DBMIJKFDSA-N D18ATS DRUGSMIL CC(C1C(C(C(O1)OC2C(C(CC(C2OC3C(C(C(C(O3)C(C)O)O)O)N)N)N)O)O)O)N D18ATS HIGHSTAT Phase 2 D1UA2E DRUG__ID D1UA2E D1UA2E DRUGCOMP AmDerma Pharmaceuticals D1UA2E DRUGTYPE Small molecular drug D1UA2E DRUGINCH 1S/C19H19N3O5/c1-2-10-26-14-11-17(27-15(14)12-23)22-9-8-16(21-19(22)25)20-18(24)13-6-4-3-5-7-13/h1,3-9,14-15,17,23H,10-12H2,(H,20,21,24,25)/t14-,15-,17-/m1/s1 D1UA2E DRUGINKE VUDFTOHJBXWAGS-BFYDXBDKSA-N D1UA2E DRUGSMIL C#CCOC1CC(OC1CO)N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3 D1UA2E HIGHSTAT Phase 2 D1Z0IM DRUG__ID D1Z0IM D1Z0IM DRUGCOMP Imara D1Z0IM DRUGTYPE Small molecular drug D1Z0IM DRUGINCH 1S/C21H26N6O2/c1-14-10-26(13-19-22-5-2-6-23-19)11-16(14)17-12-27-18(21(28)25-17)9-24-20(27)15-3-7-29-8-4-15/h2,5-6,9,12,14-16H,3-4,7-8,10-11,13H2,1H3,(H,25,28)/t14-,16-/m1/s1 D1Z0IM DRUGINKE GWGNPYYVGANHRJ-GDBMZVCRSA-N D1Z0IM DRUGSMIL CC1CN(CC1C2=CN3C(=CN=C3C4CCOCC4)C(=O)N2)CC5=NC=CC=N5 D1Z0IM HIGHSTAT Phase 2 D29GPF DRUG__ID D29GPF D29GPF DRUGCOMP Daiichi Sankyo Basking Ridge, NJ D29GPF DRUGTYPE Small molecule D29GPF DRUGINCH InChI=1S/C8H15NO3/c1-5(2)4-7(8(11)12)9-6(3)10/h5,7H,4H2,1-3H3,(H,9,10)(H,11,12)/t7-/m1/s1 D29GPF DRUGINKE WXNXCEHXYPACJF-SSDOTTSWSA-N D29GPF DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C D29GPF HIGHSTAT Phase 2 D2E4CG DRUG__ID D2E4CG D2E4CG DRUGCOMP Salix Pharmaceuticals Bridgewater, NJ D2E4CG DRUGTYPE Small molecule D2E4CG DRUGINCH InChI=1S/C19H30F3NO3/c1-2-3-4-5-6-11-26-17-8-7-15(12-16(17)19(20,21)22)9-10-18(23,13-24)14-25/h7-8,12,24-25H,2-6,9-11,13-14,23H2,1H3 D2E4CG DRUGINKE JVCPIJKPAKAIIP-UHFFFAOYSA-N D2E4CG DRUGSMIL CCCCCCCOC1=C(C=C(C=C1)CCC(CO)(CO)N)C(F)(F)F D2E4CG HIGHSTAT Phase 2 D2F7JC DRUG__ID D2F7JC D2F7JC DRUGCOMP Tufts Medical Center D2F7JC DRUGTYPE Small molecular drug D2F7JC DRUGINCH 1S/C55H99N13O9/c1-5-6-7-8-9-10-11-12-13-14-15-16-20-31-47(70)63-41(28-21-23-32-56)51(74)64-42(29-22-24-33-57)52(75)68-46(37-69)54(77)65-43(30-25-34-61-55(59)60)50(73)62-39(4)49(72)67-45(35-38(2)3)53(76)66-44(48(58)71)36-40-26-18-17-19-27-40/h17-19,26-27,38-39,41-46,69H,5-16,20-25,28-37,56-57H2,1-4H3,(H2,58,71)(H,62,73)(H,63,70)(H,64,74)(H,65,77)(H,66,76)(H,67,72)(H,68,75)(H4,59,60,61)/t39-,41-,42-,43-,44-,45-,46-/m0/s1 D2F7JC DRUGINKE VZRIKWNVDCTBTF-BKGFHLQYSA-N D2F7JC DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)N D2F7JC HIGHSTAT Phase 2 D2JF0S DRUG__ID D2JF0S D2JF0S DRUGCOMP JOHNSON & JOHNSON D2JF0S DRUGTYPE Small molecule D2JF0S DRUGINCH InChI=1S/C20H25ClN2O/c1-2-3-12-23-15-11-18(19(21)20(23)24)22-13-9-17(10-14-22)16-7-5-4-6-8-16/h4-8,11,15,17H,2-3,9-10,12-14H2,1H3 D2JF0S DRUGINKE HYOGJHCDLQSAHX-UHFFFAOYSA-N D2JF0S DRUGSMIL CCCCN1C=CC(=C(C1=O)Cl)N2CCC(CC2)C3=CC=CC=C3 D2JF0S HIGHSTAT Phase 2 D2KV8B DRUG__ID D2KV8B D2KV8B DRUGCOMP AnHeart Therapeutics D2KV8B DRUGTYPE Small molecular drug D2KV8B DRUGINCH 1S/C23H24FN5O/c1-15(25)14-30-20-8-6-17(7-9-20)21-13-26-23-11-10-22(28-29(21)23)27-16(2)18-4-3-5-19(24)12-18/h3-13,15-16H,14,25H2,1-2H3,(H,27,28) D2KV8B DRUGINKE HEVHTYMYEMEBPX-UHFFFAOYSA-N D2KV8B DRUGSMIL CC(COC1=CC=C(C=C1)C2=CN=C3N2N=C(C=C3)NC(C)C4=CC(=CC=C4)F)N D2KV8B HIGHSTAT Phase 2 D2L8NT DRUG__ID D2L8NT D2L8NT DRUGCOMP Tiburio Therapeutics D2L8NT DRUGTYPE Small molecular drug D2L8NT DRUGINCH 1S/C86H116N16O12S4/c1-5-30-101-41-51(32-60-58-17-14-22-64-76(58)54(39-91-64)36-72(60)101)43-115-47-74(105)89-29-13-11-21-66(93-75(106)48-116-44-52-33-61-59-18-15-23-65-77(59)55(40-92-65)37-73(61)102(42-52)31-6-2)81(109)99-70-45-117-118-46-71(86(114)100-78(49(4)103)79(88)107)98-80(108)62(7-3)94-82(110)67(20-10-12-28-87)95-84(112)69(35-53-38-90-63-19-9-8-16-57(53)63)97-83(111)68(96-85(70)113)34-50-24-26-56(104)27-25-50/h8-9,14-19,22-27,38-40,49,51-52,60-62,66-73,78,90-92,103-104H,5-7,10-13,20-21,28-37,41-48,87H2,1-4H3,(H2,88,107)(H,89,105)(H,93,106)(H,94,110)(H,95,112)(H,96,113)(H,97,111)(H,98,108)(H,99,109)(H,100,114)/t49-,51-,52-,60-,61-,62+,66-,67+,68-,69-,70+,71+,72-,73-,78+/m1/s1 D2L8NT DRUGINKE WLBJBODHTIKYSL-SJMMWMPTSA-N D2L8NT DRUGSMIL CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSCC(=O)NCCCCC(C(=O)NC5CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CC6=CC=C(C=C6)O)CC7=CNC8=CC=CC=C87)CCCCN)CC)C(=O)NC(C(C)O)C(=O)N)NC(=O)CSCC9CC1C(CC2=CNC3=CC=CC1=C23)N(C9)CCC D2L8NT HIGHSTAT Phase 2 D2RG4D DRUG__ID D2RG4D D2RG4D DRUGCOMP Bayer D2RG4D DRUGTYPE Small molecule D2RG4D DRUGINCH InChI=1S/C23H22Cl2F3NO3/c1-12(23(26,27)28)21(14-4-7-16(24)8-5-14)22(32)29-19-10-15(6-9-18(19)25)17(11-20(30)31)13-2-3-13/h4-10,12-13,17,21H,2-3,11H2,1H3,(H,29,32)(H,30,31)/t12-,17+,21+/m1/s1 D2RG4D DRUGINKE NCRMKIWHFXSBGZ-CNBXIYLPSA-N D2RG4D DRUGSMIL CC(C(C1=CC=C(C=C1)Cl)C(=O)NC2=C(C=CC(=C2)C(CC(=O)O)C3CC3)Cl)C(F)(F)F D2RG4D HIGHSTAT Phase 2 D2SPH4 DRUG__ID D2SPH4 D2SPH4 DRUGCOMP Cyclerion Therapeutics D2SPH4 DRUGTYPE Small molecular drug D2SPH4 DRUGINCH 1S/C21H16F5N7O3/c22-12-4-2-1-3-11(12)9-33-16(14-5-6-36-32-14)7-15(31-33)18-28-8-13(23)17(30-18)29-10-20(35,19(27)34)21(24,25)26/h1-8,35H,9-10H2,(H2,27,34)(H,28,29,30)/t20-/m1/s1 D2SPH4 DRUGINKE YWQFJNWMWZMXRW-HXUWFJFHSA-N D2SPH4 DRUGSMIL C1=CC=C(C(=C1)CN2C(=CC(=N2)C3=NC=C(C(=N3)NCC(C(=O)N)(C(F)(F)F)O)F)C4=NOC=C4)F D2SPH4 HIGHSTAT Phase 2 D38LQO DRUG__ID D38LQO D38LQO DRUGCOMP Neurokine Therapeutics D38LQO DRUGTYPE Small molecule D38LQO DRUGINCH InChI=1S/C24H23N5/c1-28-12-14-29(15-13-28)23-17-22(19-8-10-25-11-9-19)24(27-26-23)21-7-6-18-4-2-3-5-20(18)16-21/h2-11,16-17H,12-15H2,1H3 D38LQO DRUGINKE CIIVUDIZZJLXCN-UHFFFAOYSA-N D38LQO DRUGSMIL CN1CCN(CC1)C2=NN=C(C(=C2)C3=CC=NC=C3)C4=CC5=CC=CC=C5C=C4 D38LQO HIGHSTAT Phase 2 D39CTA DRUG__ID D39CTA D39CTA DRUGCOMP Clarity Pharmaceuticals Eveleigh, Australia D39CTA DRUGTYPE Radiopharmaceutical D39CTA DRUGINCH InChI=1S/C69H103N17O14S2/c1-42(87)58-66(98)83-55(65(97)85-59(43(2)88)67(99)100)35-102-101-34-54(64(96)80-52(31-45-19-21-47(89)22-20-45)62(94)81-53(32-46-33-77-49-15-8-7-14-48(46)49)63(95)79-50(60(92)84-58)16-9-10-23-70)82-61(93)51(30-44-12-5-4-6-13-44)78-56(90)17-11-18-57(91)86-69-39-74-27-24-71-36-68(3,37-72-25-28-75-40-69)38-73-26-29-76-41-69/h4-8,12-15,19-22,33,42-43,50-55,58-59,71-77,87-89H,9-11,16-18,23-32,34-41,70H2,1-3H3,(H,78,90)(H,79,95)(H,80,96)(H,81,94)(H,82,93)(H,83,98)(H,84,92)(H,85,97)(H,86,91)(H,99,100)/t42-,43-,50+,51-,52+,53-,54+,55+,58+,59+,68?,69?/m1/s1 D39CTA DRUGINKE HXUFICPASZINEN-NMNXQNEXSA-N D39CTA DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CCCC(=O)NC67CNCCNCC(CNCCNC6)(CNCCNC7)C)C(=O)NC(C(C)O)C(=O)O)O D39CTA HIGHSTAT Phase 2 D3AIE0 DRUG__ID D3AIE0 D3AIE0 DRUGCOMP Bristol-Myers Squibb D3AIE0 DRUGTYPE Small molecular drug D3AIE0 DRUGINCH 1S/C27H23N5O5S2/c1-31(2)25(33)16-7-5-15(6-8-16)24-28-17(14-38-24)13-36-21-9-18(34-3)10-22-19(21)11-23(37-22)20-12-32-26(29-20)39-27(30-32)35-4/h5-12,14H,13H2,1-4H3 D3AIE0 DRUGINKE KEEBLYWBELVGPQ-UHFFFAOYSA-N D3AIE0 DRUGSMIL CN(C)C(=O)C1=CC=C(C=C1)C2=NC(=CS2)COC3=CC(=CC4=C3C=C(O4)C5=CN6C(=N5)SC(=N6)OC)OC D3AIE0 HIGHSTAT Phase 2 D3LZ2F DRUG__ID D3LZ2F D3LZ2F DRUGCOMP AstraZeneca D3LZ2F DRUGTYPE Small molecule D3LZ2F DRUGINCH InChI=1S/C29H28BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23+,29-/m0/s1 D3LZ2F DRUGINKE OCXAGXCMZACNEC-CTWZREHQSA-N D3LZ2F DRUGSMIL CC1=C(N=C(C=C1)Br)NC(=O)C2CC3(CC3N2C(=O)CN4C5=C(C=C(C=C5)C6=CN=C(N=C6)C)C(=N4)C(=O)C)C D3LZ2F HIGHSTAT Phase 2 D3MG8W DRUG__ID D3MG8W D3MG8W DRUGCOMP Pliant Therapeutics D3MG8W DRUGTYPE Small molecule D3MG8W DRUGINCH InChI=1S/C27H36N6O3/c1-36-18-17-33(15-5-4-8-21-12-11-20-7-6-14-28-25(20)31-21)16-13-24(27(34)35)32-26-22-9-2-3-10-23(22)29-19-30-26/h2-3,9-12,19,24H,4-8,13-18H2,1H3,(H,28,31)(H,34,35)(H,29,30,32)/t24-/m0/s1 D3MG8W DRUGINKE CWOFQJBATWQSHL-DEOSSOPVSA-N D3MG8W DRUGSMIL COCCN(CCCCC1=NC2=C(CCCN2)C=C1)CCC(C(=O)O)NC3=NC=NC4=CC=CC=C43 D3MG8W HIGHSTAT Phase 2 D3P8JK DRUG__ID D3P8JK D3P8JK DRUGCOMP Galera Therapeutics D3P8JK DRUGTYPE Small molecular drug D3P8JK DRUGINCH 1S/C21H35N5.2C3H6O2.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;2*1-2-3(4)5;/h5-7,18-25H,1-4,8-15H2;2*2H2,1H3,(H,4,5);/q;;;+2/p-2/t18-,19-,20-,21-;;;/m0.../s1 D3P8JK DRUGINKE AVSNGWGGPXFPQX-NDOCQCNASA-L D3P8JK DRUGSMIL CCC(=O)[O-].CCC(=O)[O-].C1CCC2C(C1)NCCNC3CCCCC3NCC4=CC=CC(=N4)CN2.[Mn+2] D3P8JK HIGHSTAT Phase 2 D3X2TH DRUG__ID D3X2TH D3X2TH DRUGCOMP Cortice Biosciences D3X2TH DRUGTYPE Small molecular drug D3X2TH DRUGINCH 1S/C46H63NO15/c1-13-32-58-30-20-31-45(22-55-31,61-26(6)49)36-38(60-39(51)27-17-15-14-16-18-27)46(54)21-29(57-40(52)34(50)28(19-23(2)3)47-41(53)62-42(7,8)9)24(4)33(43(46,10)11)35(56-25(5)48)37(59-32)44(30,36)12/h13-18,23,28-32,34-38,50,54H,1,19-22H2,2-12H3,(H,47,53)/t28-,29-,30-,31+,32?,34+,35-,36-,37-,38-,44+,45-,46+/m0/s1 D3X2TH DRUGINKE FDTAUJJRHBRHIJ-FDJAAIFISA-N D3X2TH DRUGSMIL CC1=C2C(C3C4(C(CC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(CC(C)C)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO5)OC(=O)C)OC(O3)C=C)C)OC(=O)C D3X2TH HIGHSTAT Phase 2 D4DMS3 DRUG__ID D4DMS3 D4DMS3 DRUGCOMP Merck D4DMS3 DRUGTYPE Peptide D4DMS3 DRUGINCH InChI=1S/C81H108FN15O15S2/c1-50-38-51(2)40-60(39-50)96-49-59(91-92-96)48-93-47-57(62-45-58(82)19-22-67(62)93)44-65-78(106)94-29-23-68(72(94)77(105)90-71(53(4)98)76(104)89-64(42-55-17-20-61(109-9)21-18-55)79(107)95-28-13-26-81(95,5)80(108)83-27-37-114)112-31-11-10-14-54-15-12-16-56(41-54)43-63(74(102)88-65)87-73(101)52(3)85-75(103)66(86-70(100)25-36-113)46-84-69(99)24-32-110-34-35-111-33-30-97(6,7)8/h10-12,15-22,38-41,45,47,49,52-53,63-66,68,71-72,98H,13-14,23-37,42-44,46,48H2,1-9H3,(H9-,83,84,85,86,87,88,89,90,99,100,101,102,103,104,105,108,113,114)/p+1/b11-10+/t52-,53-,63+,64+,65+,66+,68+,71+,72+,81+/m1/s1 D4DMS3 DRUGINKE WQYKXIAUKXSSIN-ZPWCAMBLSA-O D4DMS3 DRUGSMIL CC1=CC(=CC(=C1)N2C=C(N=N2)CN3C=C(C4=C3C=CC(=C4)F)CC5C(=O)N6CCC(C6C(=O)NC(C(C)O)C(=O)NC(CC7=CC=C(C=C7)OC)C(=O)N8CCCC8(C)C(=O)NCCS)OCC=CCC9=CC(=CC=C9)CC(C(=O)N5)NC(=O)C(C)NC(=O)C(CNC(=O)CCOCCOCC[N+](C)(C)C)NC(=O)CCS)C D4DMS3 HIGHSTAT Phase 2 D4M8RS DRUG__ID D4M8RS D4M8RS DRUGCOMP TenNor Therapeutics D4M8RS DRUGTYPE Small molecular drug D4M8RS DRUGINCH 1S/C65H81FN6O15/c1-31-13-12-14-32(2)61(80)68-50-44(56(77)47-48(57(50)78)55(76)37(7)59-49(47)60(79)64(9,87-59)85-26-20-46(84-11)33(3)58(86-38(8)73)36(6)54(75)35(5)53(31)74)28-67-71-24-18-41(19-25-71)69(10)65(21-22-65)40-17-23-70(29-40)52-34(4)51-42(39-15-16-39)27-43(63(82)83)62(81)72(51)30-45(52)66/h12-14,20,26-28,30-31,33,35-36,39-41,46,53-54,58,74-78H,15-19,21-25,29H2,1-11H3,(H,68,80)(H,82,83)/b13-12+,26-20+,32-14-,67-28+/t31-,33-,35+,36-,40+,46-,53-,54+,58+,64-/m0/s1 D4M8RS DRUGINKE OPZFMLLAJBIKAN-YSBZUPOXSA-N D4M8RS DRUGSMIL CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCC(CC5)N(C)C6(CC6)C7CCN(C7)C8=C(C9=C(C=C(C(=O)N9C=C8F)C(=O)O)C1CC1)C)C D4M8RS HIGHSTAT Phase 2 D4USX5 DRUG__ID D4USX5 D4USX5 DRUGCOMP Actuate Therapeutics D4USX5 DRUGTYPE Small molecular drug D4USX5 DRUGINCH 1S/C22H13FN2O5/c1-25-7-13(11-5-17-18(6-15(11)25)30-9-29-17)19-20(22(27)24-21(19)26)14-8-28-16-3-2-10(23)4-12(14)16/h2-8H,9H2,1H3,(H,24,26,27) D4USX5 DRUGINKE FARXPFGGGGLENU-UHFFFAOYSA-N D4USX5 DRUGSMIL CN1C=C(C2=CC3=C(C=C21)OCO3)C4=C(C(=O)NC4=O)C5=COC6=C5C=C(C=C6)F D4USX5 HIGHSTAT Phase 2 D4W2AC DRUG__ID D4W2AC D4W2AC DRUGCOMP Landos Biopharma D4W2AC DRUGTYPE Small molecule D4W2AC DRUGINCH InChI=1S/C24H21N3O3/c1-16-7-4-10-22(25-16)28-19-13-20(29-23-11-5-8-17(2)26-23)15-21(14-19)30-24-12-6-9-18(3)27-24/h4-15H,1-3H3 D4W2AC DRUGINKE OPUQKVNCXCWRLR-UHFFFAOYSA-N D4W2AC DRUGSMIL CC1=NC(=CC=C1)OC2=CC(=CC(=C2)OC3=CC=CC(=N3)C)OC4=CC=CC(=N4)C D4W2AC HIGHSTAT Phase 2 D5AV3Q DRUG__ID D5AV3Q D5AV3Q DRUGCOMP Atea Pharmaceuticals D5AV3Q DRUGTYPE Small molecular drug D5AV3Q DRUGINCH 1S/C24H33FN7O7P/c1-13(2)37-21(34)14(3)31-40(35,39-15-9-7-6-8-10-15)36-11-16-18(33)24(4,25)22(38-16)32-12-28-17-19(27-5)29-23(26)30-20(17)32/h6-10,12-14,16,18,22,33H,11H2,1-5H3,(H,31,35)(H3,26,27,29,30)/t14-,16?,18+,22+,24+,40-/m0/s1 D5AV3Q DRUGINKE OISLSHLAXHALQZ-ZXWZJMKMSA-N D5AV3Q DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=NC3=C(N=C(N=C32)N)NC)(C)F)O)OC4=CC=CC=C4 D5AV3Q HIGHSTAT Phase 2 D5NAL9 DRUG__ID D5NAL9 D5NAL9 DRUGCOMP Oryzon Genomics, ADDF D5NAL9 DRUGTYPE Small molecule D5NAL9 DRUGINCH InChI=1S/C19H20N4O2/c20-19-23-22-18(25-19)11-21-17-10-16(17)14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16-17,21H,10-12H2,(H2,20,23)/t16-,17+/m0/s1 D5NAL9 DRUGINKE XBBRLCXCBCZIOI-DLBZAZTESA-N D5NAL9 DRUGSMIL C1C(C1NCC2=NN=C(O2)N)C3=CC=C(C=C3)OCC4=CC=CC=C4 D5NAL9 HIGHSTAT Phase 2 D5SDZ0 DRUG__ID D5SDZ0 D5SDZ0 DRUGCOMP RAPT Therapeutics South San Francisco, CA D5SDZ0 DRUGTYPE Small molecule D5SDZ0 DRUGINCH InChI=1S/C27H34Cl3N5O2/c1-15(21-7-6-19(28)9-22(21)29)31-24-23(30)16(2)32-26(33-24)35-13-18(14-35)17-5-4-8-34(12-17)20-10-27(3,11-20)25(36)37/h6-7,9,15,17-18,20H,4-5,8,10-14H2,1-3H3,(H,36,37)(H,31,32,33)/t15-,17+,20?,27?/m1/s1 D5SDZ0 DRUGINKE ANPSFQZLPNWKHR-PRZTZBHNSA-N D5SDZ0 DRUGSMIL CC1=C(C(=NC(=N1)N2CC(C2)C3CCCN(C3)C4CC(C4)(C)C(=O)O)NC(C)C5=C(C=C(C=C5)Cl)Cl)Cl D5SDZ0 HIGHSTAT Phase 2 D5XJ7F DRUG__ID D5XJ7F D5XJ7F DRUGCOMP Nimbus Therapeutics D5XJ7F DRUGTYPE Small molecule D5XJ7F DRUGINCH InChI=1S/C23H24N8O3/c1-24-20-12-18(27-16-6-5-11-30(23(16)33)19-7-3-4-10-25-19)29-21-14(13-26-31(20)21)22(32)28-15-8-9-17(15)34-2/h3-7,10-13,15,17,24H,8-9H2,1-2H3,(H,27,29)(H,28,32)/t15-,17-/m1/s1 D5XJ7F DRUGINKE BWINBHTTZLVXGT-NVXWUHKLSA-N D5XJ7F DRUGSMIL CNC1=CC(=NC2=C(C=NN12)C(=O)NC3CCC3OC)NC4=CC=CN(C4=O)C5=CC=CC=N5 D5XJ7F HIGHSTAT Phase 2 D5XV9K DRUG__ID D5XV9K D5XV9K DRUGCOMP Pfizer D5XV9K DRUGTYPE Small molecular drug D5XV9K DRUGINCH 1S/C31H30FN5O4/c32-25-14-20(16-33)4-5-23(25)19-41-30-3-1-2-26(35-30)21-8-11-36(12-9-21)18-29-34-27-7-6-22(31(38)39)15-28(27)37(29)17-24-10-13-40-24/h1-7,14-15,21,24H,8-13,17-19H2,(H,38,39)/t24-/m0/s1 D5XV9K DRUGINKE HYBAKUMPISVZQP-DEOSSOPVSA-N D5XV9K DRUGSMIL C1CN(CCC1C2=NC(=CC=C2)OCC3=C(C=C(C=C3)C#N)F)CC4=NC5=C(N4CC6CCO6)C=C(C=C5)C(=O)O D5XV9K HIGHSTAT Phase 2 D5XVM6 DRUG__ID D5XVM6 D5XVM6 DRUGCOMP Bayer D5XVM6 DRUGTYPE Small molecule D5XVM6 DRUGINCH InChI=1S/C20H21F3N4O4S/c1-19(2,29)13-10-15-12(11-27(26-15)7-8-32(3,30)31)9-16(13)25-18(28)14-5-4-6-17(24-14)20(21,22)23/h4-6,9-11,29H,7-8H2,1-3H3,(H,25,28) D5XVM6 DRUGINKE OQAMEEFUUFJZRS-UHFFFAOYSA-N D5XVM6 DRUGSMIL CC(C)(C1=CC2=NN(C=C2C=C1NC(=O)C3=NC(=CC=C3)C(F)(F)F)CCS(=O)(=O)C)O D5XVM6 HIGHSTAT Phase 2 D67DST DRUG__ID D67DST D67DST DRUGCOMP Hisun USA Bridgewater, NJ D67DST DRUGTYPE Small molecule D67DST DRUGINCH InChI=1S/C24H27N3O3/c28-23-19-13-21-22(30-16-29-21)14-20(19)24(7-8-24)27(23)12-6-17-4-10-26(11-5-17)15-18-3-1-2-9-25-18/h1-3,9,13-14,17H,4-8,10-12,15-16H2 D67DST DRUGINKE SJXBQKLTADWYTC-UHFFFAOYSA-N D67DST DRUGSMIL C1CN(CCC1CCN2C(=O)C3=CC4=C(C=C3C25CC5)OCO4)CC6=CC=CC=N6 D67DST HIGHSTAT Phase 2 D6BY8P DRUG__ID D6BY8P D6BY8P DRUGCOMP PureTech Health D6BY8P DRUGTYPE Small molecule D6BY8P DRUGINCH InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3/i1D3 D6BY8P DRUGINKE ISWRGOKTTBVCFA-FIBGUPNXSA-N D6BY8P DRUGSMIL CC1=CN(C(=O)C=C1)C2=CC=CC=C2 D6BY8P HIGHSTAT Phase 2 D6ETD2 DRUG__ID D6ETD2 D6ETD2 DRUGCOMP Pain Therapeutics D6ETD2 DRUGTYPE Small molecular drug D6ETD2 DRUGINCH 1S/C15H21N3O/c1-17-9-7-15(8-10-17)16-11-14(19)18(15)12-13-5-3-2-4-6-13/h2-6,16H,7-12H2,1H3 D6ETD2 DRUGINKE BSQPTZYKCAULBH-UHFFFAOYSA-N D6ETD2 DRUGSMIL CN1CCC2(CC1)NCC(=O)N2CC3=CC=CC=C3 D6ETD2 HIGHSTAT Phase 2 D6N5UC DRUG__ID D6N5UC D6N5UC DRUGCOMP Aclaris Therapeutics D6N5UC DRUGTYPE Small molecular drug D6N5UC DRUGINCH 1S/C20H18FN5O3/c1-10-6-13(8-16(28-3)17(10)21)24-19-22-9-11(2)18(26-19)23-12-4-5-15-14(7-12)25-20(27)29-15/h4-9H,1-3H3,(H,25,27)(H2,22,23,24,26) D6N5UC DRUGINKE OYFMQDVLFYKOPZ-UHFFFAOYSA-N D6N5UC DRUGSMIL CC1=CC(=CC(=C1F)OC)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(=O)N4)C D6N5UC HIGHSTAT Phase 2 D6Z5NV DRUG__ID D6Z5NV D6Z5NV DRUGCOMP Emerald Health Pharmaceuticals D6Z5NV DRUGTYPE Small molecule D6Z5NV DRUGINCH InChI=1S/C28H35NO3/c1-5-6-8-13-22-25(29-17-20-11-9-7-10-12-20)27(31)24(28(32)26(22)30)23-16-19(4)14-15-21(23)18(2)3/h7,9-12,16,21,23,29,31H,2,5-6,8,13-15,17H2,1,3-4H3/t21-,23+/m0/s1 D6Z5NV DRUGINKE CGGGAXJIRQSRPH-JTHBVZDNSA-N D6Z5NV DRUGSMIL CCCCCC1=C(C(=C(C(=O)C1=O)C2C=C(CCC2C(=C)C)C)O)NCC3=CC=CC=C3 D6Z5NV HIGHSTAT Phase 2 D72HXF DRUG__ID D72HXF D72HXF DRUGCOMP Enterome Biosciences D72HXF DRUGTYPE Small molecular drug D72HXF DRUGINCH 1S/C35H39NO11/c1-18(39)36-12-10-35(11-13-36)23-14-19(4-8-25-29(40)33(44)31(42)27(16-37)46-25)2-6-21(23)22-7-3-20(15-24(22)35)5-9-26-30(41)34(45)32(43)28(17-38)47-26/h2-3,6-7,14-15,25-34,37-38,40-45H,10-13,16-17H2,1H3/t25-,26-,27-,28-,29-,30-,31-,32-,33-,34-/m1/s1 D72HXF DRUGINKE SFHMWDMKUYVSQJ-VECBPBMLSA-N D72HXF DRUGSMIL CC(=O)N1CCC2(CC1)C3=C(C=CC(=C3)C#CC4C(C(C(C(O4)CO)O)O)O)C5=C2C=C(C=C5)C#CC6C(C(C(C(O6)CO)O)O)O D72HXF HIGHSTAT Phase 2 D74PRE DRUG__ID D74PRE D74PRE DRUGCOMP Ophirex D74PRE DRUGTYPE Small molecule D74PRE DRUGINCH InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25) D74PRE DRUGINKE BHLXTPHDSZUFHR-UHFFFAOYSA-N D74PRE DRUGSMIL CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N D74PRE HIGHSTAT Phase 2 D7M3JN DRUG__ID D7M3JN D7M3JN DRUGCOMP Oblato D7M3JN DRUGTYPE Small molecular drug D7M3JN DRUGINCH 1S/C11H15NO7S2/c1-11(2,3)12(13)7-8-4-5-9(20(14,15)16)6-10(8)21(17,18)19/h4-7H,1-3H3,(H,14,15,16)(H,17,18,19) D7M3JN DRUGINKE OVTCHWSLKGENKP-UHFFFAOYSA-N D7M3JN DRUGSMIL CC(C)(C)[N+](=CC1=C(C=C(C=C1)S(=O)(=O)O)S(=O)(=O)O)[O-] D7M3JN HIGHSTAT Phase 2 D7TA4P DRUG__ID D7TA4P D7TA4P DRUGCOMP Pfizer D7TA4P DRUGTYPE Small molecular drug D7TA4P DRUGINCH 1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3 D7TA4P DRUGINKE XPLZTJWZDBFWDE-UHFFFAOYSA-N D7TA4P DRUGSMIL CN1C=C(C=N1)C2=CN3C(=CC=N3)C(=N2)C4=CN(N=C4)C5(CC(C5)C#N)CC#N D7TA4P HIGHSTAT Phase 2 D7UW0X DRUG__ID D7UW0X D7UW0X DRUGCOMP Praxis Precision Medicines Boston, MA D7UW0X DRUGTYPE Small molecule D7UW0X DRUGINCH InChI=1S/C15H11F6N5O2/c1-2-28-15(20,21)13-25-24-11-5-22-10(6-26(11)13)8-3-9(16)12(23-4-8)27-7-14(17,18)19/h3-6H,2,7H2,1H3 D7UW0X DRUGINKE BFXBSYMVTNEFRF-UHFFFAOYSA-N D7UW0X DRUGSMIL CCOC(C1=NN=C2N1C=C(N=C2)C3=CC(=C(N=C3)OCC(F)(F)F)F)(F)F D7UW0X HIGHSTAT Phase 2 D7XNQ1 DRUG__ID D7XNQ1 D7XNQ1 DRUGCOMP Destiny Pharma D7XNQ1 DRUGTYPE Small molecular drug D7XNQ1 DRUGINCH 1S/C44H50N6O2.2ClH/c1-49(2,3)25-7-27-51-37-17-9-31(10-18-37)43-39-21-13-33(45-39)29-35-15-23-41(47-35)44(42-24-16-36(48-42)30-34-14-22-40(43)46-34)32-11-19-38(20-12-32)52-28-8-26-50(4,5)6;;/h9-24,29-30,45,48H,7-8,25-28H2,1-6H3;2*1H/q+2;;/p-2 D7XNQ1 DRUGINKE KJLHJQGDBJNMPU-UHFFFAOYSA-L D7XNQ1 DRUGSMIL C[N+](C)(C)CCCOC1=CC=C(C=C1)C2=C3C=CC(=CC4=NC(=C(C5=CC=C(N5)C=C6C=CC2=N6)C7=CC=C(C=C7)OCCC[N+](C)(C)C)C=C4)N3.[Cl-].[Cl-] D7XNQ1 HIGHSTAT Phase 2 D81WBS DRUG__ID D81WBS D81WBS DRUGCOMP Pfzer D81WBS DRUGTYPE Small molecule D81WBS DRUGINCH InChI=1S/C18H22BNO4/c1-3-6-23-18-8-13(4-5-17(18)22-2)14-7-15(11-20-10-14)16-9-19(21)24-12-16/h4-5,7-8,10-11,16,21H,3,6,9,12H2,1-2H3/t16-/m0/s1 D81WBS DRUGINKE KXVKOYCGACSUPP-INIZCTEOSA-N D81WBS DRUGSMIL B1(CC(CO1)C2=CN=CC(=C2)C3=CC(=C(C=C3)OC)OCCC)O D81WBS HIGHSTAT Phase 2 D8AG3S DRUG__ID D8AG3S D8AG3S DRUGCOMP Xcovery D8AG3S DRUGTYPE Small molecular drug D8AG3S DRUGINCH 1S/C23H26FN5O3/c1-12-19(10-17-16-9-14(24)5-6-18(16)27-21(17)30)25-13(2)20(12)22(31)26-15-7-8-29(11-15)23(32)28(3)4/h5-6,9-10,15,25H,7-8,11H2,1-4H3,(H,26,31)(H,27,30)/b17-10-/t15-/m0/s1 D8AG3S DRUGINKE KMIOJWCYOHBUJS-HAKPAVFJSA-N D8AG3S DRUGSMIL CC1=C(NC(=C1C(=O)NC2CCN(C2)C(=O)N(C)C)C)C=C3C4=C(C=CC(=C4)F)NC3=O D8AG3S HIGHSTAT Phase 2 D8CJE9 DRUG__ID D8CJE9 D8CJE9 DRUGCOMP Emergo Therapeutics D8CJE9 DRUGTYPE Small molecular drug D8CJE9 DRUGINCH 1S/C18H17NOS/c20-16-11-13-3-1-2-4-14(13)17(12-5-8-19-9-6-12)15-7-10-21-18(15)16/h1-4,7,10,19H,5-6,8-9,11H2 D8CJE9 DRUGINKE IYSYPCSSDZBWHN-UHFFFAOYSA-N D8CJE9 DRUGSMIL C1CNCCC1=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3 D8CJE9 HIGHSTAT Phase 2 D8FHG5 DRUG__ID D8FHG5 D8FHG5 DRUGCOMP CinCor Pharma D8FHG5 DRUGTYPE Small molecule D8FHG5 DRUGINCH InChI=1S/C22H25N3O2/c1-3-21(26)24-19-6-4-5-16-17(12-23-13-18(16)19)14-7-9-20-15(11-14)8-10-22(27)25(20)2/h7,9,11-13,19H,3-6,8,10H2,1-2H3,(H,24,26)/t19-/m1/s1 D8FHG5 DRUGINKE VDEUDSRUMNAXJG-LJQANCHMSA-N D8FHG5 DRUGSMIL CCC(=O)NC1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C D8FHG5 HIGHSTAT Phase 2 D8IQ0D DRUG__ID D8IQ0D D8IQ0D DRUGCOMP MEI Pharma; Kyowa Kirin D8IQ0D DRUGTYPE Small molecular drug D8IQ0D DRUGINCH 1S/C31H38F2N8O/c1-31(2,20-22-8-4-5-9-23(22)21-12-14-39(3)15-13-21)38-28-35-29(40-16-18-42-19-17-40)37-30(36-28)41-25-11-7-6-10-24(25)34-27(41)26(32)33/h4-11,21,26H,12-20H2,1-3H3,(H,35,36,37,38) D8IQ0D DRUGINKE WPFUFWIHMYZXSF-UHFFFAOYSA-N D8IQ0D DRUGSMIL CC(C)(CC1=CC=CC=C1C2CCN(CC2)C)NC3=NC(=NC(=N3)N4CCOCC4)N5C6=CC=CC=C6N=C5C(F)F D8IQ0D HIGHSTAT Phase 2 D8N9VF DRUG__ID D8N9VF D8N9VF DRUGCOMP Cumberland Pharmaceuticals Nashville, TN D8N9VF DRUGTYPE Small molecule D8N9VF DRUGINCH InChI=1S/C25H32N2O5/c1-2-3-6-13-26-24(30)19-15-31-25(27-19)23-18(20-10-11-21(23)32-20)14-17-8-5-4-7-16(17)9-12-22(28)29/h4-5,7-8,15,18,20-21,23H,2-3,6,9-14H2,1H3,(H,26,30)(H,28,29)/t18-,20-,21+,23-/m0/s1 D8N9VF DRUGINKE BBPRUNPUJIUXSE-DXKRWKNPSA-N D8N9VF DRUGSMIL CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3 D8N9VF HIGHSTAT Phase 2 D8VP6R DRUG__ID D8VP6R D8VP6R DRUGCOMP Pfizer D8VP6R DRUGTYPE Small molecule D8VP6R DRUGINCH InChI=1S/C21H21N5O4/c1-2-29-18-4-3-6-23-21(18)30-17-8-14(9-22-12-17)19-24-10-15(11-25-19)20(27)26-16-5-7-28-13-16/h3-4,6,8-12,16H,2,5,7,13H2,1H3,(H,26,27)/t16-/m0/s1 D8VP6R DRUGINKE UKBQFBRPXKGJPY-INIZCTEOSA-N D8VP6R DRUGSMIL CCOC1=C(N=CC=C1)OC2=CN=CC(=C2)C3=NC=C(C=N3)C(=O)NC4CCOC4 D8VP6R HIGHSTAT Phase 2 D92IRY DRUG__ID D92IRY D92IRY DRUGCOMP YSOPIA Bioscience D92IRY DRUGTYPE Small molecule D92IRY DRUGINCH InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1 D92IRY DRUGINKE FTVWIRXFELQLPI-ZDUSSCGKSA-N D92IRY DRUGSMIL C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O D92IRY HIGHSTAT Phase 2 D9I3WE DRUG__ID D9I3WE D9I3WE DRUGCOMP Acorda Therapeutics D9I3WE DRUGTYPE Small molecular drug D9I3WE DRUGINCH 1S/C18H19FN2O3S/c19-14-5-2-6-15(10-14)25(23,24)16-7-8-17-12(9-16)3-1-4-13(17)11-21-18(20)22/h2,5-10,13H,1,3-4,11H2,(H3,20,21,22)/t13-/m0/s1 D9I3WE DRUGINKE MTTHRRVVGMPYQG-ZDUSSCGKSA-N D9I3WE DRUGSMIL C1CC(C2=C(C1)C=C(C=C2)S(=O)(=O)C3=CC=CC(=C3)F)CNC(=O)N D9I3WE HIGHSTAT Phase 2 D9OR7F DRUG__ID D9OR7F D9OR7F DRUGCOMP Lumos Pharma Ames, IA D9OR7F DRUGTYPE Small molecule D9OR7F DRUGINCH InChI=1S/C27H36N4O5S.CH4O3S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27;1-5(2,3)4/h4-12,22H,13-19,28H2,1-3H3,(H,29,33);1H3,(H,2,3,4)/t22-;/m1./s1 D9OR7F DRUGINKE DUGMCDWNXXFHDE-VZYDHVRKSA-N D9OR7F DRUGSMIL CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=CC=CC=C34)S(=O)(=O)C)N.CS(=O)(=O)O D9OR7F HIGHSTAT Phase 2 D9PC0O DRUG__ID D9PC0O D9PC0O DRUGCOMP Attenua D9PC0O DRUGTYPE Small molecule D9PC0O DRUGINCH InChI=1S/C22H23N3O2/c26-22(20-13-17-5-1-2-6-19(17)27-20)24-21-16-7-10-25(11-8-16)18(21)12-15-4-3-9-23-14-15/h1-6,9,13-14,16,18,21H,7-8,10-12H2,(H,24,26)/t18-,21+/m0/s1 D9PC0O DRUGINKE OXKRFEWMSWPKKV-GHTZIAJQSA-N D9PC0O DRUGSMIL C1CN2CCC1C(C2CC3=CN=CC=C3)NC(=O)C4=CC5=CC=CC=C5O4 D9PC0O HIGHSTAT Phase 2 D9UDT8 DRUG__ID D9UDT8 D9UDT8 DRUGCOMP Vical D9UDT8 DRUGTYPE Small molecular drug D9UDT8 DRUGINCH 1S/C40H59N10O13.Al/c1-23(2)20-31-38(58)46-32(21-27-12-7-6-8-13-27)39(59)44-29(15-10-18-49(62)25(4)52)36(56)42-28(14-9-17-48(61)24(3)51)35(55)43-30(16-11-19-50(63)26(5)53)37(57)47-33(22-34(41)54)40(60)45-31;/h6-8,12-13,23,28-33H,9-11,14-22H2,1-5H3,(H2,41,54)(H,42,56)(H,43,55)(H,44,59)(H,45,60)(H,46,58)(H,47,57);/q-3;+3/t28-,29-,30-,31-,32+,33-;/m0./s1 D9UDT8 DRUGINKE NRHTWBFQTMOOKS-FELWXBABSA-N D9UDT8 DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CCCN(C(=O)C)[O-])CCCN(C(=O)C)[O-])CCCN(C(=O)C)[O-])CC2=CC=CC=C2.[Al+3] D9UDT8 HIGHSTAT Phase 2 D9UGX7 DRUG__ID D9UGX7 D9UGX7 DRUGCOMP Athenex Oncology D9UGX7 DRUGTYPE Small molecular drug D9UGX7 DRUGINCH 1S/C38H36N6O7/c1-47-32-17-24-14-16-43(22-25(24)18-33(32)48-2)15-13-23-9-11-26(12-10-23)44-41-37(40-42-44)28-19-34(49-3)35(50-4)20-29(28)39-38(46)36-21-30(45)27-7-5-6-8-31(27)51-36/h5-12,17-21H,13-16,22H2,1-4H3,(H,39,46) D9UGX7 DRUGINKE AHJUHHDDCJQACA-UHFFFAOYSA-N D9UGX7 DRUGSMIL COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC D9UGX7 HIGHSTAT Phase 2 D9YG4P DRUG__ID D9YG4P D9YG4P DRUGCOMP Apexian Pharmaceuticals D9YG4P DRUGTYPE Small molecular drug D9YG4P DRUGINCH 1S/C21H30O6/c1-5-6-7-8-9-10-11-12-15(21(24)25)13-16-14(2)17(22)19(26-3)20(27-4)18(16)23/h13H,5-12H2,1-4H3,(H,24,25)/b15-13+ D9YG4P DRUGINKE AALSSIXXBDPENJ-FYWRMAATSA-N D9YG4P DRUGSMIL CCCCCCCCCC(=CC1=C(C(=O)C(=C(C1=O)OC)OC)C)C(=O)O D9YG4P HIGHSTAT Phase 2 DA3GL5 DRUG__ID DA3GL5 DA3GL5 DRUGCOMP Zafgen DA3GL5 DRUGTYPE Small molecular drug DA3GL5 DRUGINCH 1S/C26H42N2O6/c1-18(2)5-6-21-25(3,34-21)23-22(30-4)20(7-9-26(23)17-32-26)33-24(29)28-15-19(16-28)8-10-27-11-13-31-14-12-27/h5,19-23H,6-17H2,1-4H3/t20-,21-,22-,23-,25+,26+/m1/s1 DA3GL5 DRUGINKE QJWJPMLDQYEPPW-AUKZVGPFSA-N DA3GL5 DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)N4CC(C4)CCN5CCOCC5)OC)C DA3GL5 HIGHSTAT Phase 2 DA6C8N DRUG__ID DA6C8N DA6C8N DRUGCOMP Novartis DA6C8N DRUGTYPE Small molecular drug DA6C8N DRUGINCH 1S/C23H18FN7O2/c1-12-5-4-8-25-19(12)15-10-26-23-29-21(30-31(23)11-15)17-9-16(6-7-18(17)24)28-22(32)20-13(2)27-14(3)33-20/h4-11H,1-3H3,(H,28,32) DA6C8N DRUGINKE GNVVPYCWVLCWKV-UHFFFAOYSA-N DA6C8N DRUGSMIL CC1=C(N=CC=C1)C2=CN3C(=NC(=N3)C4=C(C=CC(=C4)NC(=O)C5=C(N=C(O5)C)C)F)N=C2 DA6C8N HIGHSTAT Phase 2 DAJI68 DRUG__ID DAJI68 DAJI68 DRUGCOMP Eiger Biopharmaceuticals Palo Alto, CA DAJI68 DRUGTYPE Peptide DAJI68 DRUGINCH InChI=1S/C149H234N40O47S/c1-14-78(10)120(185-139(227)98(62-81-29-16-15-17-30-81)177-136(224)97(61-76(6)7)175-129(217)88(35-24-53-158-149(156)157)172-144(232)119(77(8)9)184-122(210)79(11)164-126(214)90(41-46-114(199)200)168-131(219)91(42-47-115(201)202)169-132(220)92(43-48-116(203)204)170-134(222)94(50-58-237-13)171-130(218)89(40-45-109(153)194)167-127(215)86(33-20-22-51-150)166-140(228)103(72-192)182-137(225)95(59-74(2)3)174-123(211)84(152)64-118(207)208)145(233)173-93(44-49-117(205)206)133(221)178-99(63-82-66-159-85-32-19-18-31-83(82)85)138(226)176-96(60-75(4)5)135(223)165-87(34-21-23-52-151)128(216)179-100(65-110(154)195)124(212)161-67-111(196)160-69-113(198)186-54-25-36-105(186)142(230)183-104(73-193)141(229)181-102(71-191)125(213)162-68-112(197)163-80(12)146(234)188-56-27-38-107(188)148(236)189-57-28-39-108(189)147(235)187-55-26-37-106(187)143(231)180-101(70-190)121(155)209/h15-19,29-32,66,74-80,84,86-108,119-120,159,190-193H,14,20-28,33-65,67-73,150-152H2,1-13H3,(H2,153,194)(H2,154,195)(H2,155,209)(H,160,196)(H,161,212)(H,162,213)(H,163,197)(H,164,214)(H,165,223)(H,166,228)(H,167,215)(H,168,219)(H,169,220)(H,170,222)(H,171,218)(H,172,232)(H,173,233)(H,174,211)(H,175,217)(H,176,226)(H,177,224)(H,178,221)(H,179,216)(H,180,231)(H,181,229)(H,182,225)(H,183,230)(H,184,210)(H,185,227)(H,199,200)(H,201,202)(H,203,204)(H,205,206)(H,207,208)(H4,156,157,158)/t78-,79-,80-,84-,86-,87-,88-,89+,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,119-,120-/m0/s1 DAJI68 DRUGINKE WSEVKKHALHSUMB-RYVRVIGHSA-N DAJI68 DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)N DAJI68 HIGHSTAT Phase 2 DATO92 DRUG__ID DATO92 DATO92 DRUGCOMP AstraZeneca DATO92 DRUGTYPE Small molecular drug DATO92 DRUGINCH 1S/C24H28F4N6/c1-15-9-19-18(4-6-21-20(19)11-30-32-21)23(34(15)14-24(26,27)28)22-5-3-16(10-29-22)31-17-12-33(13-17)8-2-7-25/h3-6,10-11,15,17,23,31H,2,7-9,12-14H2,1H3,(H,30,32)/t15-,23+/m1/s1 DATO92 DRUGINKE WDHOIABIERMLGY-CMJOXMDJSA-N DATO92 DRUGSMIL CC1CC2=C(C=CC3=C2C=NN3)C(N1CC(F)(F)F)C4=NC=C(C=C4)NC5CN(C5)CCCF DATO92 HIGHSTAT Phase 2 DB2V8K DRUG__ID DB2V8K DB2V8K DRUGCOMP TAKEDA DB2V8K DRUGTYPE Small molecule DB2V8K DRUGINCH InChI=1S/C26H36N6O6/c1-5-18(6-2)14-28-22(33)16-32-13-9-11-20(26(32)37)30-24(35)19(10-7-8-12-23(34)38-4)29-25(36)21-15-27-17-31(21)3/h8-9,11-13,15,17-19H,5-7,10,14,16H2,1-4H3,(H,28,33)(H,29,36)(H,30,35)/b12-8+/t19-/m0/s1 DB2V8K DRUGINKE VHGWUSABWIEXKQ-BEBFYNPSSA-N DB2V8K DRUGSMIL CCC(CC)CNC(=O)CN1C=CC=C(C1=O)NC(=O)C(CCC=CC(=O)OC)NC(=O)C2=CN=CN2C DB2V8K HIGHSTAT Phase 2 DB53RG DRUG__ID DB53RG DB53RG DRUGCOMP Bristol-Myers Squibb DB53RG DRUGTYPE Small molecule DB53RG DRUGINCH InChI=1S/C22H31N5O5/c1-5-11-26(3)22(30)31-13-18-20(24-25-27(18)4)17-9-10-19(14(2)23-17)32-16-8-6-7-15(12-16)21(28)29/h9-10,15-16H,5-8,11-13H2,1-4H3,(H,28,29)/t15-,16-/m0/s1 DB53RG DRUGINKE UEUNDURNLYLSNB-HOTGVXAUSA-N DB53RG DRUGSMIL CCCN(C)C(=O)OCC1=C(N=NN1C)C2=NC(=C(C=C2)OC3CCCC(C3)C(=O)O)C DB53RG HIGHSTAT Phase 2 DB5UA2 DRUG__ID DB5UA2 DB5UA2 DRUGCOMP Bristol-Myers Squibb DB5UA2 DRUGTYPE Small molecular drug DB5UA2 DRUGINCH 1S/C24H23F2N5O2/c1-30-23(32)21(14-5-6-20(33-2)19(26)11-14)22(15-3-4-16(13-27)18(25)12-15)29-24(30)31-9-7-17(28)8-10-31/h3-6,11-12,17H,7-10,28H2,1-2H3 DB5UA2 DRUGINKE NBAIXBAUHIQQGF-UHFFFAOYSA-N DB5UA2 DRUGSMIL CN1C(=O)C(=C(N=C1N2CCC(CC2)N)C3=CC(=C(C=C3)C#N)F)C4=CC(=C(C=C4)OC)F DB5UA2 HIGHSTAT Phase 2 DB6XD8 DRUG__ID DB6XD8 DB6XD8 DRUGCOMP Bristol-Myers Squibb DB6XD8 DRUGTYPE Small molecular drug DB6XD8 DRUGINCH 1S/C28H23Cl2F2N9O2/c1-15-3-2-4-23(20-9-16(7-8-33-20)26-21(36-27(15)43)12-35-41(26)28(31)32)39-14-34-19(11-25(39)42)18-10-17(29)5-6-22(18)40-13-24(30)37-38-40/h5-15,23,28H,2-4H2,1H3,(H,36,43)/t15-,23+/m1/s1 DB6XD8 DRUGINKE FSWFYCYPTDLKON-CMJOXMDJSA-N DB6XD8 DRUGSMIL CC1CCCC(C2=NC=CC(=C2)C3=C(C=NN3C(F)F)NC1=O)N4C=NC(=CC4=O)C5=C(C=CC(=C5)Cl)N6C=C(N=N6)Cl DB6XD8 HIGHSTAT Phase 2 DB8V4Z DRUG__ID DB8V4Z DB8V4Z DRUGCOMP Aptinyx DB8V4Z DRUGTYPE Small molecule DB8V4Z DRUGINCH InChI=1S/C15H18N2O3/c1-20-12-4-2-11(3-5-12)9-17-10-15(14(17)19)6-7-16-13(18)8-15/h2-5H,6-10H2,1H3,(H,16,18)/t15-/m0/s1 DB8V4Z DRUGINKE HMFZRGIXXDQHFG-HNNXBMFYSA-N DB8V4Z DRUGSMIL COC1=CC=C(C=C1)CN2CC3(C2=O)CCNC(=O)C3 DB8V4Z HIGHSTAT Phase 2 DBU2W3 DRUG__ID DBU2W3 DBU2W3 DRUGCOMP ENYO Pharma DBU2W3 DRUGTYPE Small molecular drug DBU2W3 DRUGINCH 1S/C19H15Cl3N2O5S/c20-12-2-1-3-13(21)18(12)30(27,28)24-8-6-23(7-9-24)14-4-5-15-11(17(14)22)10-16(29-15)19(25)26/h1-5,10H,6-9H2,(H,25,26) DBU2W3 DRUGINKE XLGQSYUNOIJBNR-UHFFFAOYSA-N DBU2W3 DRUGSMIL C1CN(CCN1C2=C(C3=C(C=C2)OC(=C3)C(=O)O)Cl)S(=O)(=O)C4=C(C=CC=C4Cl)Cl DBU2W3 HIGHSTAT Phase 2 DC19UI DRUG__ID DC19UI DC19UI DRUGCOMP Squarex DC19UI DRUGTYPE Small molecular drug DC19UI DRUGINCH 1S/C12H18O4/c1-3-5-7-15-11-9(13)10(14)12(11)16-8-6-4-2/h3-8H2,1-2H3 DC19UI DRUGINKE XBRWELTXMQSEIN-UHFFFAOYSA-N DC19UI DRUGSMIL CCCCOC1=C(C(=O)C1=O)OCCCC DC19UI HIGHSTAT Phase 2 DC23ER DRUG__ID DC23ER DC23ER DRUGCOMP AstraZeneca DC23ER DRUGTYPE Small molecule DC23ER DRUGINCH InChI=1S/C21H22F2N6O2/c1-12-20(30)27-18-14(25-12)4-3-13(17(18)22)11-28-7-9-29(10-8-28)16-6-5-15(21(31)24-2)26-19(16)23/h3-6H,7-11H2,1-2H3,(H,24,31)(H,27,30) DC23ER DRUGINKE WXRCLFFPZXJCLS-UHFFFAOYSA-N DC23ER DRUGSMIL CC1=NC2=C(C(=C(C=C2)CN3CCN(CC3)C4=C(N=C(C=C4)C(=O)NC)F)F)NC1=O DC23ER HIGHSTAT Phase 2 DC51MU DRUG__ID DC51MU DC51MU DRUGCOMP Bristol-Myers Squibb DC51MU DRUGTYPE Small molecule DC51MU DRUGINCH InChI=1S/C28H30FN5O5/c29-21-12-17(14-32-15-19(16-32)33-8-10-39-11-9-33)4-5-18(21)13-30-22-3-1-2-20-25(22)28(38)34(27(20)37)23-6-7-24(35)31-26(23)36/h1-5,12,19,23,30H,6-11,13-16H2,(H,31,35,36)/t23-/m0/s1 DC51MU DRUGINKE NZYDBVQXOGPDDU-QHCPKHFHSA-N DC51MU DRUGSMIL C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCC4=C(C=C(C=C4)CN5CC(C5)N6CCOCC6)F DC51MU HIGHSTAT Phase 2 DC52UD DRUG__ID DC52UD DC52UD DRUGCOMP Concert Pharmaceuticals DC52UD DRUGTYPE Small molecular drug DC52UD DRUGINCH 1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m1/s1/i2D DC52UD DRUGINKE MTCFGRXMJLQNBG-LIIDHCAMSA-N DC52UD DRUGSMIL C(C(C(=O)O)N)O DC52UD HIGHSTAT Phase 2 DC7JQ8 DRUG__ID DC7JQ8 DC7JQ8 DRUGCOMP Landos Biopharma DC7JQ8 DRUGTYPE Small molecule DC7JQ8 DRUGINCH InChI=1S/C30H24N8O2/c39-29(25-13-5-11-23(31-25)27-33-19-7-1-2-8-20(19)34-27)37-15-17-38(18-16-37)30(40)26-14-6-12-24(32-26)28-35-21-9-3-4-10-22(21)36-28/h1-14H,15-18H2,(H,33,34)(H,35,36) DC7JQ8 DRUGINKE MVHWZNBAQIGPOQ-UHFFFAOYSA-N DC7JQ8 DRUGSMIL C1CN(CCN1C(=O)C2=CC=CC(=N2)C3=NC4=CC=CC=C4N3)C(=O)C5=CC=CC(=N5)C6=NC7=CC=CC=C7N6 DC7JQ8 HIGHSTAT Phase 2 DCYV91 DRUG__ID DCYV91 DCYV91 DRUGCOMP TB Alliance DCYV91 DRUGTYPE Small molecular drug DCYV91 DRUGINCH 1S/C18H21N5O3/c1-11-6-15-16(20-7-11)13(17(25)19-4-5-24)8-23(15)9-14-12(2)18(26-3)22-10-21-14/h6-8,10,24H,4-5,9H2,1-3H3,(H,19,25) DCYV91 DRUGINKE VDRYGTNDKXIPSK-UHFFFAOYSA-N DCYV91 DRUGSMIL CC1=CC2=C(C(=CN2CC3=C(C(=NC=N3)OC)C)C(=O)NCCO)N=C1 DCYV91 HIGHSTAT Phase 2 DCZ28G DRUG__ID DCZ28G DCZ28G DRUGCOMP Acurx Pharmaceuticals DCZ28G DRUGTYPE Small molecular drug DCZ28G DRUGINCH 1S/C18H20Cl2N6O2/c19-13-2-1-12(9-14(13)20)10-21-18-23-16-15(17(27)24-18)26(11-22-16)4-3-25-5-7-28-8-6-25/h1-2,9,11H,3-8,10H2,(H2,21,23,24,27) DCZ28G DRUGINKE DEGSGBKTODESHH-UHFFFAOYSA-N DCZ28G DRUGSMIL C1COCCN1CCN2C=NC3=C2C(=O)NC(=N3)NCC4=CC(=C(C=C4)Cl)Cl DCZ28G HIGHSTAT Phase 2 DD1E6R DRUG__ID DD1E6R DD1E6R DRUGCOMP Veralox Therapeutics Frederick, MD DD1E6R DRUGTYPE Small molecule DD1E6R DRUGINCH InChI=1S/C21H19N3O4S2/c1-28-18-7-4-5-14(20(18)25)13-22-15-9-11-16(12-10-15)30(26,27)24-21-23-17-6-2-3-8-19(17)29-21/h2-12,22,25H,13H2,1H3,(H,23,24) DD1E6R DRUGINKE OWHBVKBNNRYMIN-UHFFFAOYSA-N DD1E6R DRUGSMIL COC1=CC=CC(=C1O)CNC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4S3 DD1E6R HIGHSTAT Phase 2 DD5VO3 DRUG__ID DD5VO3 DD5VO3 DRUGCOMP Takeda DD5VO3 DRUGTYPE Small molecular drug DD5VO3 DRUGINCH 1S/C31H39N3O4/c35-28(25-10-3-1-4-11-25)15-8-18-32-19-16-31(17-20-32)30(38)33(23-34(31)27-13-5-2-6-14-27)22-24-9-7-12-26(21-24)29(36)37/h1,3-4,7,9-12,21,27H,2,5-6,8,13-20,22-23H2,(H,36,37) DD5VO3 DRUGINKE BDXJYAAYLZTLEK-UHFFFAOYSA-N DD5VO3 DRUGSMIL C1CCC(CC1)N2CN(C(=O)C23CCN(CC3)CCCC(=O)C4=CC=CC=C4)CC5=CC(=CC=C5)C(=O)O DD5VO3 HIGHSTAT Phase 2 DD8L0V DRUG__ID DD8L0V DD8L0V DRUGCOMP Neurotrope Bioscience DD8L0V DRUGTYPE Small molecule DD8L0V DRUGINCH InChI=1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5)47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16+,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1 DD8L0V DRUGINKE MJQUEDHRCUIRLF-TVIXENOKSA-N DD8L0V DRUGSMIL CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O DD8L0V HIGHSTAT Phase 2 DDI6B0 DRUG__ID DDI6B0 DDI6B0 DRUGCOMP ACADIA Pharmaceuticals DDI6B0 DRUGTYPE Small molecular drug DDI6B0 DRUGINCH 1S/2C25H34FN3O2.C4H6O6/c2*1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21;5-1(3(7)8)2(6)4(9)10/h2*4-11,19,23H,12-18H2,1-3H3,(H,27,30);1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1 DDI6B0 DRUGINKE RGSULKHNAKTFIZ-CEAXSRTFSA-N DDI6B0 DRUGSMIL CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.C(C(C(=O)O)O)(C(=O)O)O DDI6B0 HIGHSTAT Phase 2 DDK53C DRUG__ID DDK53C DDK53C DRUGCOMP BlackThorn Therapeutics DDK53C DRUGTYPE Small molecular drug DDK53C DRUGINCH 1S/C25H32FN5O2/c1-4-17-13-20-15(2)22(25-27-16(3)30-33-25)24(29-23(20)21(26)14-17)31-9-5-18(6-10-31)28-19-7-11-32-12-8-19/h13-14,18-19,28H,4-12H2,1-3H3 DDK53C DRUGINKE CQOJHAJWCDJEAT-UHFFFAOYSA-N DDK53C DRUGSMIL CCC1=CC2=C(C(=C(N=C2C(=C1)F)N3CCC(CC3)NC4CCOCC4)C5=NC(=NO5)C)C DDK53C HIGHSTAT Phase 2 DDKF39 DRUG__ID DDKF39 DDKF39 DRUGCOMP Newron Pharmaceuticals DDKF39 DRUGTYPE Small molecular drug DDKF39 DRUGINCH 1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3 DDKF39 DRUGINKE GRHBODILPPXVKN-UHFFFAOYSA-N DDKF39 DRUGSMIL CCCCOC1=CC=CC(=C1)CCNCC(=O)N(C)C DDKF39 HIGHSTAT Phase 2 DE2U5N DRUG__ID DE2U5N DE2U5N DRUGCOMP 3-V Biosciences DE2U5N DRUGTYPE Small molecular drug DE2U5N DRUGINCH 1S/C27H29N5O/c1-17-14-24(22-4-3-5-22)25(26-29-18(2)30-31-26)15-23(17)27(33)32-12-10-21(11-13-32)20-8-6-19(16-28)7-9-20/h6-9,14-15,21-22H,3-5,10-13H2,1-2H3,(H,29,30,31) DE2U5N DRUGINKE BBGOSBDSLYHMRA-UHFFFAOYSA-N DE2U5N DRUGSMIL CC1=CC(=C(C=C1C(=O)N2CCC(CC2)C3=CC=C(C=C3)C#N)C4=NNC(=N4)C)C5CCC5 DE2U5N HIGHSTAT Phase 2 DE3VU1 DRUG__ID DE3VU1 DE3VU1 DRUGCOMP Bristol-Myers Squibb Princeton, NJ DE3VU1 DRUGTYPE Small molecule DE3VU1 DRUGINCH InChI=1S/C20H23FN4O2/c1-4-6-16(26)24-13-7-5-8-25(10-13)19-15(21)9-14(20(22)27)18-17(19)11(2)12(3)23-18/h9,13,23H,5,7-8,10H2,1-3H3,(H2,22,27)(H,24,26)/t13-/m0/s1 DE3VU1 DRUGINKE VJPPLCNBDLZIFG-ZDUSSCGKSA-N DE3VU1 DRUGSMIL CC#CC(=O)NC1CCCN(C1)C2=C(C=C(C3=C2C(=C(N3)C)C)C(=O)N)F DE3VU1 HIGHSTAT Phase 2 DE53JQ DRUG__ID DE53JQ DE53JQ DRUGCOMP Monopar Therapeutics DE53JQ DRUGTYPE Small molecular drug DE53JQ DRUGINCH 1S/C27H32N2O9/c1-11-23(31)14(28)8-17(37-11)38-16-10-27(35,6-7-30)9-13-19(16)26(34)20-21(25(13)33)24(32)12-4-3-5-15(36-2)18(12)22(20)29/h3-5,11,14,16-17,23,29-31,33-35H,6-10,28H2,1-2H3/t11-,14-,16-,17-,23+,27-/m0/s1 DE53JQ DRUGINKE GNCWGPLZJLZZPI-KUIJCEFOSA-N DE53JQ DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=N)C(=CC=C5)OC)O)(CCO)O)N)O DE53JQ HIGHSTAT Phase 2 DEKM09 DRUG__ID DEKM09 DEKM09 DRUGCOMP Greenwich Biosciences DEKM09 DRUGTYPE Small molecular drug DEKM09 DRUGINCH 1S/C19H26O2/c1-5-6-14-10-17(20)19(18(21)11-14)16-9-13(4)7-8-15(16)12(2)3/h9-11,15-16,20-21H,2,5-8H2,1,3-4H3/t15-,16+/m0/s1 DEKM09 DRUGINKE REOZWEGFPHTFEI-JKSUJKDBSA-N DEKM09 DRUGSMIL CCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O DEKM09 HIGHSTAT Phase 2 DENO49 DRUG__ID DENO49 DENO49 DRUGCOMP ReViral DENO49 DRUGTYPE Small molecular drug DENO49 DRUGINCH 1S/C23H22F4N4O/c24-15-3-4-16-19(11-15)31(21(32)22(16)7-8-22)13-20-29-17-10-14(12-28)2-5-18(17)30(20)9-1-6-23(25,26)27/h2-5,10-11H,1,6-9,12-13,28H2 DENO49 DRUGINKE JOPCJJSYRPUEDS-UHFFFAOYSA-N DENO49 DRUGSMIL C1CC12C3=C(C=C(C=C3)F)N(C2=O)CC4=NC5=C(N4CCCC(F)(F)F)C=CC(=C5)CN DENO49 HIGHSTAT Phase 2 DES36M DRUG__ID DES36M DES36M DRUGCOMP Qurient DES36M DRUGTYPE Small molecular drug DES36M DRUGINCH 1S/C11H21NO4/c1-7(2)8(9(13)14)12(6)10(15)16-11(3,4)5/h7-8H,1-6H3,(H,13,14)/t8-/m0/s1 DES36M DRUGINKE XPUAXAVJMJDPDH-QMMMGPOBSA-N DES36M DRUGSMIL CC(C)C(C(=O)O)N(C)C(=O)OC(C)(C)C DES36M HIGHSTAT Phase 2 DEV2G0 DRUG__ID DEV2G0 DEV2G0 DRUGCOMP Biogen DEV2G0 DRUGTYPE Small molecule DEV2G0 DRUGINCH InChI=1S/C51H68N2O10/c1-30(2)14-9-16-32(5)18-11-21-50(7)43(56)26-36-41(54)24-34-38(45(36)62-50)28-52(47(34)58)23-13-20-40(49(60)61)53-29-39-35(48(53)59)25-42(55)37-27-44(57)51(8,63-46(37)39)22-12-19-33(6)17-10-15-31(3)4/h14-15,18-19,24-25,40,43-44,54-57H,9-13,16-17,20-23,26-29H2,1-8H3,(H,60,61)/b32-18+,33-19+/t40-,43-,44-,50-,51-/m0/s1 DEV2G0 DRUGINKE CRNDCHORWGDFGR-PXTWCNKMSA-N DEV2G0 DRUGSMIL CC(=CCCC(=CCCC1(C(CC2=C(C=C3C(=C2O1)CN(C3=O)CCCC(C(=O)O)N4CC5=C6C(=C(C=C5C4=O)O)CC(C(O6)(C)CCC=C(C)CCC=C(C)C)O)O)O)C)C)C DEV2G0 HIGHSTAT Phase 2 DF1T2W DRUG__ID DF1T2W DF1T2W DRUGCOMP Gilead DF1T2W DRUGTYPE Small molecule DF1T2W DRUGINCH InChI=1S/C11H12IN3O2/c1-11(2,3)17-10(16)15-9-7(8(12)14-15)5-4-6-13-9/h4-6H,1-3H3 DF1T2W DRUGINKE OKKLWSNHFSFXEM-UHFFFAOYSA-N DF1T2W DRUGSMIL CC(C)(C)OC(=O)N1C2=C(C=CC=N2)C(=N1)I DF1T2W HIGHSTAT Phase 2 DF91UW DRUG__ID DF91UW DF91UW DRUGCOMP Spruce Biosciences Dale City, CA DF91UW DRUGTYPE Small molecule DF91UW DRUGINCH InChI=1S/C20H26ClN5OS/c1-5-14(6-2)15-11-12(3)22-19-16(13(4)24-26(15)19)17-18(21)23-20(28-17)25-7-9-27-10-8-25/h11,14H,5-10H2,1-4H3 DF91UW DRUGINKE XVAWSBAQNIXMIO-UHFFFAOYSA-N DF91UW DRUGSMIL CCC(CC)C1=CC(=NC2=C(C(=NN12)C)C3=C(N=C(S3)N4CCOCC4)Cl)C DF91UW HIGHSTAT Phase 2 DFA0W6 DRUG__ID DFA0W6 DFA0W6 DRUGCOMP Alkahest DFA0W6 DRUGTYPE Small molecule DFA0W6 DRUGINCH InChI=1S/C27H34ClN5O3/c1-17-13-19(5-6-22(17)28)16-32-11-9-21(10-12-32)33-23(7-8-25(33)34)26(35)30-24-15-20(14-18(2)29-24)27(36)31(3)4/h5-6,13-15,21,23H,7-12,16H2,1-4H3,(H,29,30,35)/t23-/m1/s1 DFA0W6 DRUGINKE DWKNOLCXIFYNFV-HSZRJFAPSA-N DFA0W6 DRUGSMIL CC1=CC(=CC(=N1)NC(=O)C2CCC(=O)N2C3CCN(CC3)CC4=CC(=C(C=C4)Cl)C)C(=O)N(C)C DFA0W6 HIGHSTAT Phase 2 DFPS93 DRUG__ID DFPS93 DFPS93 DRUGCOMP Microbion Biosciences DFPS93 DRUGTYPE Small molecular drug DFPS93 DRUGINCH 1S/3C2H6S2.2Bi/c3*3-1-2-4;;/h3*3-4H,1-2H2;;/q;;;2*+3/p-6 DFPS93 DRUGINKE GUTNLKRPYCTIHX-UHFFFAOYSA-H DFPS93 DRUGSMIL C1CS[Bi](S1)SCCS[Bi]2SCCS2 DFPS93 HIGHSTAT Phase 2 DFS18G DRUG__ID DFS18G DFS18G DRUGCOMP Pfzer DFS18G DRUGTYPE Small molecule DFS18G DRUGINCH InChI=1S/C29H37N3O8S2/c1-3-31-18-27(28(34)25-9-4-5-10-26(25)31)42(37,38)32-13-11-29(12-14-32)16-21(19-40-29)30-17-22(33)20-39-23-7-6-8-24(15-23)41(2,35)36/h4-10,15,18,21-22,30,33H,3,11-14,16-17,19-20H2,1-2H3/t21-,22+/m1/s1 DFS18G DRUGINKE PVXLIOIISUUKOQ-YADHBBJMSA-N DFS18G DRUGSMIL CCN1C=C(C(=O)C2=CC=CC=C21)S(=O)(=O)N3CCC4(CC3)CC(CO4)NCC(COC5=CC(=CC=C5)S(=O)(=O)C)O DFS18G HIGHSTAT Phase 2 DFV1I4 DRUG__ID DFV1I4 DFV1I4 DRUGCOMP Novartis Pharmaceuticals DFV1I4 DRUGTYPE Small molecule DFV1I4 DRUGINCH InChI=1S/C12H13F6N3O3/c1-10(23,12(16,17)18)4-20-8(22)7-6(19)3-5(11(13,14)15)9(21-7)24-2/h3,23H,4,19H2,1-2H3,(H,20,22)/t10-/m0/s1 DFV1I4 DRUGINKE USHQRIKZLHNPQR-JTQLQIEISA-N DFV1I4 DRUGSMIL CC(CNC(=O)C1=C(C=C(C(=N1)OC)C(F)(F)F)N)(C(F)(F)F)O DFV1I4 HIGHSTAT Phase 2 DGD72N DRUG__ID DGD72N DGD72N DRUGCOMP Bayer DGD72N DRUGTYPE Small molecular drug DGD72N DRUGINCH 1S/C23H16F3N3O6/c1-27-17-7-5-11(9-18(17)35-22(27)34)28-10-14(20(31)32)19(30)29(21(28)33)16-8-6-12-13(16)3-2-4-15(12)23(24,25)26/h2-5,7,9-10,16H,6,8H2,1H3,(H,31,32)/t16-/m1/s1 DGD72N DRUGINKE JDARDSVOVYVQST-MRXNPFEDSA-N DGD72N DRUGSMIL CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)C4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O DGD72N HIGHSTAT Phase 2 DGK6R3 DRUG__ID DGK6R3 DGK6R3 DRUGCOMP XWPharma DGK6R3 DRUGTYPE Small molecule DGK6R3 DRUGINCH InChI=1S/C9H17NO4/c1-6(2)8(10)9(13)14-5-3-4-7(11)12/h6,8H,3-5,10H2,1-2H3,(H,11,12)/t8-/m0/s1 DGK6R3 DRUGINKE RMGPNQKZEPTAOC-QMMMGPOBSA-N DGK6R3 DRUGSMIL CC(C)C(C(=O)OCCCC(=O)O)N DGK6R3 HIGHSTAT Phase 2 DGN26L DRUG__ID DGN26L DGN26L DRUGCOMP BioSight DGN26L DRUGTYPE Small molecular drug DGN26L DRUGINCH 1S/C13H18N4O8/c14-5(12(22)23)3-8(19)15-7-1-2-17(13(24)16-7)11-10(21)9(20)6(4-18)25-11/h1-2,5-6,9-11,18,20-21H,3-4,14H2,(H,22,23)(H,15,16,19,24)/t5-,6+,9+,10-,11+/m0/s1 DGN26L DRUGINKE PVPJTBAEAQVTPN-HRAQMCAYSA-N DGN26L DRUGSMIL C1=CN(C(=O)N=C1NC(=O)CC(C(=O)O)N)C2C(C(C(O2)CO)O)O DGN26L HIGHSTAT Phase 2 DH1D5R DRUG__ID DH1D5R DH1D5R DRUGCOMP Immune System Key DH1D5R DRUGTYPE Peptide DH1D5R DRUGINCH 1S/C96H129N21O20/c1-52(2)41-71(85(126)110-74(46-59-49-103-66-31-17-14-28-62(59)66)88(129)106-69(36-37-79(121)122)84(125)105-68(34-21-39-101-96(99)100)83(124)107-70(95(136)137)33-19-20-38-97)111-92(133)81(55(6)120)116-90(131)77(51-118)114-91(132)78-35-22-40-117(78)94(135)76(42-53(3)4)113-87(128)72(43-56-23-9-7-10-24-56)109-86(127)73(44-57-25-11-8-12-26-57)112-93(134)80(54(5)119)115-89(130)75(47-60-50-104-67-32-18-15-29-63(60)67)108-82(123)64(98)45-58-48-102-65-30-16-13-27-61(58)65/h7-18,23-32,48-50,52-55,64,68-78,80-81,102-104,118-120H,19-22,33-47,51,97-98H2,1-6H3,(H,105,125)(H,106,129)(H,107,124)(H,108,123)(H,109,127)(H,110,126)(H,111,133)(H,112,134)(H,113,128)(H,114,132)(H,115,130)(H,116,131)(H,121,122)(H,136,137)(H4,99,100,101)/t54-,55-,64-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,80-,81-/m1/s1 DH1D5R DRUGINKE FNQVICDIQNFNHD-AXBBNSRTSA-N DH1D5R DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C3CCCN3C(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)C(CC8=CNC9=CC=CC=C98)N DH1D5R HIGHSTAT Phase 2 DH3S7V DRUG__ID DH3S7V DH3S7V DRUGCOMP Cerevance Beta, Inc. DH3S7V DRUGTYPE Small molecule DH3S7V DRUGINCH InChI=1S/C24H29F2N5O3/c1-15(32)31-10-6-20-21(13-31)28-23(27-17-7-11-33-14-17)24(29-20)30-8-4-18(5-9-30)34-22-3-2-16(25)12-19(22)26/h2-3,12,17-18H,4-11,13-14H2,1H3,(H,27,28)/t17-/m1/s1 DH3S7V DRUGINKE HSWVJQBEXRKOBZ-QGZVFWFLSA-N DH3S7V DRUGSMIL CC(=O)N1CCC2=C(C1)N=C(C(=N2)N3CCC(CC3)OC4=C(C=C(C=C4)F)F)NC5CCOC5 DH3S7V HIGHSTAT Phase 2 DH5RN1 DRUG__ID DH5RN1 DH5RN1 DRUGCOMP Ascentage Pharma DH5RN1 DRUGTYPE Small molecular drug DH5RN1 DRUGINCH 1S/C29H27F3N6O/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H,35,39)(H,33,34,36) DH5RN1 DRUGINKE TZKBVRDEOITLRB-UHFFFAOYSA-N DH5RN1 DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4 DH5RN1 HIGHSTAT Phase 2 DHM3X5 DRUG__ID DHM3X5 DHM3X5 DRUGCOMP NFlection Therapeutics DHM3X5 DRUGTYPE Small molecule DHM3X5 DRUGINCH InChI=1S/C17H16FIN4O3/c1-23-15-11(3-2-6-20-15)14(17(25)22-26-8-7-24)16(23)21-13-5-4-10(19)9-12(13)18/h2-6,9,21,24H,7-8H2,1H3,(H,22,25) DHM3X5 DRUGINKE SENAOZROGSYRTD-UHFFFAOYSA-N DHM3X5 DRUGSMIL CN1C2=C(C=CC=N2)C(=C1NC3=C(C=C(C=C3)I)F)C(=O)NOCCO DHM3X5 HIGHSTAT Phase 2 DHY3Q9 DRUG__ID DHY3Q9 DHY3Q9 DRUGCOMP Assembly Biosciences DHY3Q9 DRUGTYPE Small molecular drug DHY3Q9 DRUGINCH 1S/C19H12F3N3O4S2/c20-19(21,22)18-24-9-11(30-18)8-23-16(26)10-5-6-15-13(7-10)25-17(27)12-3-1-2-4-14(12)31(15,28)29/h1-7,9H,8H2,(H,23,26)(H,25,27) DHY3Q9 DRUGINKE LBJVBJYMZKEREY-UHFFFAOYSA-N DHY3Q9 DRUGSMIL C1=CC=C2C(=C1)C(=O)NC3=C(S2(=O)=O)C=CC(=C3)C(=O)NCC4=CN=C(S4)C(F)(F)F DHY3Q9 HIGHSTAT Phase 2 DI2KZ7 DRUG__ID DI2KZ7 DI2KZ7 DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ DI2KZ7 DRUGTYPE Small molecule DI2KZ7 DRUGINCH InChI=1S/C16H14ClFN6O3/c17-10-5-13(18)16(20-7-10)27-12-3-1-9(2-4-12)15-21-23-24(22-15)8-11(19)6-14(25)26/h1-5,7,11H,6,8,19H2,(H,25,26)/t11-/m0/s1 DI2KZ7 DRUGINKE ZEGMEJVULDALSH-NSHDSACASA-N DI2KZ7 DRUGSMIL C1=CC(=CC=C1C2=NN(N=N2)CC(CC(=O)O)N)OC3=C(C=C(C=N3)Cl)F DI2KZ7 HIGHSTAT Phase 2 DIK8W5 DRUG__ID DIK8W5 DIK8W5 DRUGCOMP MGB Biopharma DIK8W5 DRUGTYPE Small molecular drug DIK8W5 DRUGINCH 1S/C36H37N7O4/c1-41-24-30(20-32(41)35(45)37-13-14-43-15-17-47-18-16-43)40-36(46)33-21-29(23-42(33)2)39-34(44)27-11-9-25(10-12-27)7-8-26-19-28-5-3-4-6-31(28)38-22-26/h3-12,19-24H,13-18H2,1-2H3,(H,37,45)(H,39,44)(H,40,46)/b8-7+ DIK8W5 DRUGINKE OEKXCVYZBVOWBR-BQYQJAHWSA-N DIK8W5 DRUGSMIL CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCN3CCOCC3)C)NC(=O)C4=CC=C(C=C4)C=CC5=CC6=CC=CC=C6N=C5 DIK8W5 HIGHSTAT Phase 2 DJ8CY4 DRUG__ID DJ8CY4 DJ8CY4 DRUGCOMP F2G DJ8CY4 DRUGTYPE Small molecular drug DJ8CY4 DRUGINCH 1S/C28H27FN6O2/c1-19-16-24(20-6-4-3-5-7-20)25(33(19)2)26(36)27(37)32-22-8-10-23(11-9-22)34-12-14-35(15-13-34)28-30-17-21(29)18-31-28/h3-11,16-18H,12-15H2,1-2H3,(H,32,37) DJ8CY4 DRUGINKE SUFPWYYDCOKDLL-UHFFFAOYSA-N DJ8CY4 DRUGSMIL CC1=CC(=C(N1C)C(=O)C(=O)NC2=CC=C(C=C2)N3CCN(CC3)C4=NC=C(C=N4)F)C5=CC=CC=C5 DJ8CY4 HIGHSTAT Phase 2 DK6P5A DRUG__ID DK6P5A DK6P5A DRUGCOMP Vidac Pharma DK6P5A DRUGTYPE Small molecular drug DK6P5A DRUGINCH 1S/C21H23NO3/c1-2-3-4-9-17-16(11-12-18(17)23)14-20(24)25-19-10-5-7-15-8-6-13-22-21(15)19/h3-8,10,13,16-17H,2,9,11-12,14H2,1H3/b4-3+ DK6P5A DRUGINKE AFOGJOMDCIQZNM-ONEGZZNKSA-N DK6P5A DRUGSMIL CCC=CCC1C(CCC1=O)CC(=O)OC2=CC=CC3=C2N=CC=C3 DK6P5A HIGHSTAT Phase 2 DL50ZE DRUG__ID DL50ZE DL50ZE DRUGCOMP Oryzon Genomics Boston, MA DL50ZE DRUGTYPE Small molecule DL50ZE DRUGINCH InChI=1S/C19H20N4O2/c20-19-23-22-18(25-19)11-21-17-10-16(17)14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16-17,21H,10-12H2,(H2,20,23)/t16-,17+/m0/s1 DL50ZE DRUGINKE XBBRLCXCBCZIOI-DLBZAZTESA-N DL50ZE DRUGSMIL C1C(C1NCC2=NN=C(O2)N)C3=CC=C(C=C3)OCC4=CC=CC=C4 DL50ZE HIGHSTAT Phase 2 DL51QK DRUG__ID DL51QK DL51QK DRUGCOMP Exponential Biotherapies DL51QK DRUGTYPE Peptide DL51QK DRUGINCH 1S/C15H27N5O6/c1-7(2)12(15(25)26)20-11(22)6-18-14(24)9(4-5-10(17)21)19-13(23)8(3)16/h7-9,12H,4-6,16H2,1-3H3,(H2,17,21)(H,18,24)(H,19,23)(H,20,22)(H,25,26)/t8-,9-,12-/m0/s1 DL51QK DRUGINKE DXRXYJYFADHAPA-AUTRQRHGSA-N DL51QK DRUGSMIL CC(C)C(C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C)N DL51QK HIGHSTAT Phase 2 DL7CK2 DRUG__ID DL7CK2 DL7CK2 DRUGCOMP Burke Medical Research Institute, Columbia University, NIA, ADDF DL7CK2 DRUGTYPE Small molecule DL7CK2 DRUGINCH InChI=1S/C19H23N4O6PS/c1-13(23(12-24)11-16-10-21-14(2)22-18(16)20)17(8-9-29-30(26,27)28)31-19(25)15-6-4-3-5-7-15/h3-7,10,12H,8-9,11H2,1-2H3,(H2,20,21,22)(H2,26,27,28)/b17-13- DL7CK2 DRUGINKE BTNNPSLJPBRMLZ-LGMDPLHJSA-N DL7CK2 DRUGSMIL CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C DL7CK2 HIGHSTAT Phase 2 DL9F3C DRUG__ID DL9F3C DL9F3C DRUGCOMP Betagenon DL9F3C DRUGTYPE Small molecular drug DL9F3C DRUGINCH 1S/C16H11Cl2N3O2S/c17-12-5-1-10(2-6-12)9-21-16(23)20-15(24-21)19-14(22)11-3-7-13(18)8-4-11/h1-8H,9H2,(H,19,20,22,23) DL9F3C DRUGINKE WEDWLYRQKUTOAX-UHFFFAOYSA-N DL9F3C DRUGSMIL C1=CC(=CC=C1CN2C(=O)N=C(S2)NC(=O)C3=CC=C(C=C3)Cl)Cl DL9F3C HIGHSTAT Phase 2 DLG95A DRUG__ID DLG95A DLG95A DRUGCOMP Aptinyx DLG95A DRUGTYPE Small molecular drug DLG95A DRUGINCH 1S/C14H23N3O4/c1-8(2)12(20)17-6-4-5-14(17)7-16(13(14)21)10(9(3)18)11(15)19/h8-10,18H,4-7H2,1-3H3,(H2,15,19)/t9-,10+,14-/m0/s1 DLG95A DRUGINKE NFXPEHLDVKVVKA-RBZYPMLTSA-N DLG95A DRUGSMIL CC(C)C(=O)N1CCCC12CN(C2=O)C(C(C)O)C(=O)N DLG95A HIGHSTAT Phase 2 DLK93N DRUG__ID DLK93N DLK93N DRUGCOMP Connect Biopharma San Diego, CA DLK93N DRUGTYPE Small molecule DLK93N DRUGINCH InChI=1S/C24H26FN3O3/c1-14(2)9-15-3-5-16(6-4-15)23-27-22(28-31-23)17-7-8-18(21(25)12-17)13-26-20-10-19(11-20)24(29)30/h3-8,12,14,19-20,26H,9-11,13H2,1-2H3,(H,29,30) DLK93N DRUGINKE JNFXMFRSTYONCX-UHFFFAOYSA-N DLK93N DRUGSMIL CC(C)CC1=CC=C(C=C1)C2=NC(=NO2)C3=CC(=C(C=C3)CNC4CC(C4)C(=O)O)F DLK93N HIGHSTAT Phase 2 DLO18H DRUG__ID DLO18H DLO18H DRUGCOMP Cellestia DLO18H DRUGTYPE Small molecular drug DLO18H DRUGINCH 1S/C15H18N2O/c1-15(2,3)11-4-7-13(8-5-11)18-14-9-6-12(16)10-17-14/h4-10H,16H2,1-3H3 DLO18H DRUGINKE WHIWGRCYMQLLAO-UHFFFAOYSA-N DLO18H DRUGSMIL CC(C)(C)C1=CC=C(C=C1)OC2=NC=C(C=C2)N DLO18H HIGHSTAT Phase 2 DM04QU DRUG__ID DM04QU DM04QU DRUGCOMP Avineuro DM04QU DRUGTYPE Small molecular drug DM04QU DRUGINCH 1S/C21H24N2.ClH/c1-16-8-9-20-18(14-16)19-15-22(2)12-11-21(19)23(20)13-10-17-6-4-3-5-7-17;/h3-9,14H,10-13,15H2,1-2H3;1H DM04QU DRUGINKE RKLJJDFIWWRTEJ-UHFFFAOYSA-N DM04QU DRUGSMIL CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CC=CC=C4.Cl DM04QU HIGHSTAT Phase 2 DM5T2B DRUG__ID DM5T2B DM5T2B DRUGCOMP Crescita Therapeutics DM5T2B DRUGTYPE Small molecular drug DM5T2B DRUGINCH 1S/C19H42N.BrH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(2,3)4;/h5-19H2,1-4H3;1H/q+1;/p-1 DM5T2B DRUGINKE LZZYPRNAOMGNLH-UHFFFAOYSA-M DM5T2B DRUGSMIL CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-] DM5T2B HIGHSTAT Phase 2 DM61KY DRUG__ID DM61KY DM61KY DRUGCOMP Pfzer DM61KY DRUGTYPE Small molecule DM61KY DRUGINCH InChI=1S/C31H31ClN4O5/c1-31(27-8-6-21(32)16-33-27)40-26-4-2-3-23(29(26)41-31)19-9-12-35(13-10-19)18-28-34-24-7-5-20(30(37)38)15-25(24)36(28)17-22-11-14-39-22/h2-8,15-16,19,22H,9-14,17-18H2,1H3,(H,37,38)/t22-,31-/m0/s1 DM61KY DRUGINKE SVPYZAJTWFQTSM-UGDMGKLASA-N DM61KY DRUGSMIL CC1(OC2=CC=CC(=C2O1)C3CCN(CC3)CC4=NC5=C(N4CC6CCO6)C=C(C=C5)C(=O)O)C7=NC=C(C=C7)Cl DM61KY HIGHSTAT Phase 2 DM63YS DRUG__ID DM63YS DM63YS DRUGCOMP AstraZeneca DM63YS DRUGTYPE Small molecule DM63YS DRUGINCH InChI=1S/C38H42N6O6S2/c1-43(25-8-10-26(11-9-25)50-37(48)38(49,33-5-2-19-51-33)34-6-3-20-52-34)17-4-18-44-30-14-7-24(21-29(30)41-42-44)22-39-23-32(46)27-12-15-31(45)36-28(27)13-16-35(47)40-36/h2-3,5-7,12-16,19-21,25-26,32,39,45-46,49H,4,8-11,17-18,22-23H2,1H3,(H,40,47)/t25?,26?,32-/m0/s1 DM63YS DRUGINKE ZNKWRAKPQQZLNX-FFJARJNZSA-N DM63YS DRUGSMIL CN(CCCN1C2=C(C=C(C=C2)CNCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)N=N1)C5CCC(CC5)OC(=O)C(C6=CC=CS6)(C7=CC=CS7)O DM63YS HIGHSTAT Phase 2 DMD26W DRUG__ID DMD26W DMD26W DRUGCOMP Hepion Pharmaceuticals DMD26W DRUGTYPE Small molecular drug DMD26W DRUGINCH 1S/C67H122N12O13/c1-26-48-63(88)73(19)46(17)62(87)74(20)50(34-38(4)5)59(84)72-53(41(10)11)66(91)75(21)49(33-37(2)3)58(83)69-44(15)57(82)70-45(16)61(86)76(22)51(35-39(6)7)64(89)77(23)52(36-40(8)9)65(90)78(24)54(42(12)13)67(92)79(25)55(60(85)71-48)56(81)43(14)31-29-27-28-30-32-68-47(18)80/h37-46,48-56,81H,26-36H2,1-25H3,(H,68,80)(H,69,83)(H,70,82)(H,71,85)(H,72,84)/t43-,44+,45-,46-,48+,49+,50+,51+,52+,53+,54+,55+,56-/m1/s1 DMD26W DRUGINKE KBARHGHBFILILC-NGIJKBHDSA-N DMD26W DRUGSMIL CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CCCCCCNC(=O)C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C DMD26W HIGHSTAT Phase 2 DME75T DRUG__ID DME75T DME75T DRUGCOMP Kezar Life Sciences South San Francisco, CA DME75T DRUGTYPE Small molecule DME75T DRUGINCH InChI=1S/C30H42N4O8/c1-19(31-24(35)17-34-12-14-41-15-13-34)28(38)33-25(26(36)21-8-10-22(40-3)11-9-21)29(39)32-23(16-20-6-4-5-7-20)27(37)30(2)18-42-30/h6,8-11,19,23,25-26,36H,4-5,7,12-18H2,1-3H3,(H,31,35)(H,32,39)(H,33,38)/t19-,23-,25-,26+,30+/m0/s1 DME75T DRUGINKE GHYOCDFICYLMRF-UTIIJYGPSA-N DME75T DRUGSMIL CC(C(=O)NC(C(C1=CC=C(C=C1)OC)O)C(=O)NC(CC2=CCCC2)C(=O)C3(CO3)C)NC(=O)CN4CCOCC4 DME75T HIGHSTAT Phase 2 DMJ2N9 DRUG__ID DMJ2N9 DMJ2N9 DRUGCOMP Roche DMJ2N9 DRUGTYPE Small molecule DMJ2N9 DRUGINCH InChI=1S/C15H22N10O/c1-15(2,3)14-16-12(24-6-5-9(26)7-24)11-13(17-14)25(21-19-11)8-10-18-20-22-23(10)4/h9,26H,5-8H2,1-4H3/t9-/m0/s1 DMJ2N9 DRUGINKE MAYZWDRUFKUGGP-VIFPVBQESA-N DMJ2N9 DRUGSMIL CC(C)(C)C1=NC2=C(C(=N1)N3CCC(C3)O)N=NN2CC4=NN=NN4C DMJ2N9 HIGHSTAT Phase 2 DMT4U6 DRUG__ID DMT4U6 DMT4U6 DRUGCOMP Neurocrine Biosciences DMT4U6 DRUGTYPE Small molecule DMT4U6 DRUGINCH InChI=1S/C22H25FN4O2S2/c1-16-10-21(31(28,29)25-22-14-30-15-24-22)19(23)11-20(16)26(2)18-8-9-27(13-18)12-17-6-4-3-5-7-17/h3-7,10-11,14-15,18,25H,8-9,12-13H2,1-2H3/t18-/m0/s1 DMT4U6 DRUGINKE UCSHINHOAVARGQ-SFHVURJKSA-N DMT4U6 DRUGSMIL CC1=CC(=C(C=C1N(C)C2CCN(C2)CC3=CC=CC=C3)F)S(=O)(=O)NC4=CSC=N4 DMT4U6 HIGHSTAT Phase 2 DN9DB6 DRUG__ID DN9DB6 DN9DB6 DRUGCOMP Shanghai Pharma Biotherapeutics San Diego, CA DN9DB6 DRUGTYPE Small molecule DN9DB6 DRUGINCH InChI=1S/C22H32N6O4/c1-14-5-8-17-19(26-27(20(17)25-14)11-4-9-24-22(30)31-3)15(2)28(16-6-7-16)21(29)18-13-23-10-12-32-18/h5,8,15-16,18,23H,4,6-7,9-13H2,1-3H3,(H,24,30)/t15-,18-/m1/s1 DN9DB6 DRUGINKE GRTDDIZIUSADLD-CRAIPNDOSA-N DN9DB6 DRUGSMIL CC1=NC2=C(C=C1)C(=NN2CCCNC(=O)OC)C(C)N(C3CC3)C(=O)C4CNCCO4 DN9DB6 HIGHSTAT Phase 2 DN9V3S DRUG__ID DN9V3S DN9V3S DRUGCOMP Blade Therapeutics DN9V3S DRUGTYPE Small molecule DN9V3S DRUGINCH InChI=1S/C21H15Cl2F2N3O2S/c1-2-8-27-10-11(9-26-27)28-18-13(6-7-14(22)17(18)25)19(20(28)23)31-15-5-3-4-12(16(15)24)21(29)30/h3-7,9-10H,2,8H2,1H3,(H,29,30) DN9V3S DRUGINKE NMDFAQXLJQRHMS-UHFFFAOYSA-N DN9V3S DRUGSMIL CCCN1C=C(C=N1)N2C3=C(C=CC(=C3F)Cl)C(=C2Cl)SC4=CC=CC(=C4F)C(=O)O DN9V3S HIGHSTAT Phase 2 DNM79H DRUG__ID DNM79H DNM79H DRUGCOMP Daiichi Sankyo DNM79H DRUGTYPE Small molecular drug DNM79H DRUGINCH 1S/C26H34ClN3O4/c1-14-11-15(2)29-25(32)20(14)13-28-24(31)19-12-21(27)23-22(16(19)3)33-26(4,34-23)17-7-9-18(10-8-17)30(5)6/h11-12,17-18H,7-10,13H2,1-6H3,(H,28,31)(H,29,32)/t17?,18?,26-/m1/s1 DNM79H DRUGINKE SSDRNUPMYCFXGM-ZZHSESOFSA-N DNM79H DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)OC(O3)(C)C4CCC(CC4)N(C)C)Cl)C DNM79H HIGHSTAT Phase 2 DO37EF DRUG__ID DO37EF DO37EF DRUGCOMP Cyclerion therapeutics DO37EF DRUGTYPE Small molecule DO37EF DRUGINCH InChI=1S/C16H10F4N6/c17-10-4-2-1-3-9(10)7-11-14-21-5-6-26(14)8-12(22-11)13-23-15(25-24-13)16(18,19)20/h1-6,8H,7H2,(H,23,24,25) DO37EF DRUGINKE GTKNNCQKFKGSHR-UHFFFAOYSA-N DO37EF DRUGSMIL C1=CC=C(C(=C1)CC2=NC(=CN3C2=NC=C3)C4=NNC(=N4)C(F)(F)F)F DO37EF HIGHSTAT Phase 2 DOV7J4 DRUG__ID DOV7J4 DOV7J4 DRUGCOMP Gilead Sciences DOV7J4 DRUGTYPE Small molecular drug DOV7J4 DRUGINCH 1S/C14H20FN5O/c1-3-4-5-14(2,8-21)20-12-11-10(18-13(16)19-12)6-9(15)7-17-11/h6-7,21H,3-5,8H2,1-2H3,(H3,16,18,19,20)/t14-/m1/s1 DOV7J4 DRUGINKE HTCJUBZBSJQWBW-CQSZACIVSA-N DOV7J4 DRUGSMIL CCCCC(C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N DOV7J4 HIGHSTAT Phase 2 DP1SE6 DRUG__ID DP1SE6 DP1SE6 DRUGCOMP Incyte DP1SE6 DRUGTYPE Small molecular drug DP1SE6 DRUGINCH 1S/C20H22ClFN6O2/c1-4-30-18-12(6-13(21)17(22)16(18)11-5-14(29)24-7-11)10(3)28-20-15(9(2)27-28)19(23)25-8-26-20/h6,8,10-11H,4-5,7H2,1-3H3,(H,24,29)(H2,23,25,26)/t10-,11-/m0/s1 DP1SE6 DRUGINKE ZQPDJCIXJHUERQ-QWRGUYRKSA-N DP1SE6 DRUGSMIL CCOC1=C(C(=C(C=C1C(C)N2C3=NC=NC(=C3C(=N2)C)N)Cl)F)C4CC(=O)NC4 DP1SE6 HIGHSTAT Phase 2 DP6AO8 DRUG__ID DP6AO8 DP6AO8 DRUGCOMP AstraZeneca Wilmington, DE DP6AO8 DRUGTYPE Small molecule DP6AO8 DRUGINCH InChI=1S/C20H18FN3O5/c1-22-18(25)8-13-9-28-17-7-12(21)3-4-15(17)24(13)20(27)11-2-5-16-14(6-11)23-19(26)10-29-16/h2-7,13H,8-10H2,1H3,(H,22,25)(H,23,26)/t13-/m0/s1 DP6AO8 DRUGINKE MBKYLPOPYYLTNW-ZDUSSCGKSA-N DP6AO8 DRUGSMIL CNC(=O)CC1COC2=C(N1C(=O)C3=CC4=C(C=C3)OCC(=O)N4)C=CC(=C2)F DP6AO8 HIGHSTAT Phase 2 DQ15ZM DRUG__ID DQ15ZM DQ15ZM DRUGCOMP Aclaris Therapeutics DQ15ZM DRUGTYPE Small molecule DQ15ZM DRUGINCH InChI=1S/C25H22ClF2N5O3/c1-13-10-30-18(17-5-6-29-24(32-17)25(3,4)35)9-20(13)33-14(2)7-21(22(26)23(33)34)36-12-19-16(28)8-15(27)11-31-19/h5-11,35H,12H2,1-4H3 DQ15ZM DRUGINKE FQPQMJULRZINPV-UHFFFAOYSA-N DQ15ZM DRUGSMIL CC1=CC(=C(C(=O)N1C2=CC(=NC=C2C)C3=NC(=NC=C3)C(C)(C)O)Cl)OCC4=C(C=C(C=N4)F)F DQ15ZM HIGHSTAT Phase 2 DQ3AM0 DRUG__ID DQ3AM0 DQ3AM0 DRUGCOMP Protagonist Therapeutics DQ3AM0 DRUGTYPE Peptide DQ3AM0 DRUGINCH 1S/C114H181N27O28S2/c1-7-9-10-11-12-13-14-15-16-17-18-19-26-46-90(145)125-79(113(168)169)47-49-89(144)121-53-32-29-42-76-99(154)133-80(58-71-36-22-20-23-37-71)101(156)132-78(48-50-93(148)149)111(166)140-55-34-44-87(140)107(162)130-77(43-33-54-122-114(118)119)100(155)136-84(64-142)104(159)129-75(41-28-31-52-116)98(153)123-63-92(147)127-85(105(160)128-74(97(117)152)40-27-30-51-115)65-170-171-66-86(106(161)138-95(69(5)8-2)109(164)131-76)137-108(163)88-45-35-56-141(88)112(167)83(59-72-38-24-21-25-39-72)135-102(157)81(60-73-62-120-67-124-73)134-110(165)96(70(6)143)139-103(158)82(61-94(150)151)126-91(146)57-68(3)4/h20-25,36-39,62,67-70,74-88,95-96,142-143H,7-19,26-35,40-61,63-66,115-116H2,1-6H3,(H2,117,152)(H,120,124)(H,121,144)(H,123,153)(H,125,145)(H,126,146)(H,127,147)(H,128,160)(H,129,159)(H,130,162)(H,131,164)(H,132,156)(H,133,154)(H,134,165)(H,135,157)(H,136,155)(H,137,163)(H,138,161)(H,139,158)(H,148,149)(H,150,151)(H,168,169)(H4,118,119,122)/t69-,70+,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,95-,96-/m0/s1 DQ3AM0 DRUGINKE JRVOBXXOZFTSRF-GVIPULMVSA-N DQ3AM0 DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)N1)C(C)CC)NC(=O)C3CCCN3C(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CNC=N5)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)CC(C)C)C(=O)NC(CCCCN)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCC(=O)O)CC6=CC=CC=C6)C(=O)O DQ3AM0 HIGHSTAT Phase 2 DQ62LM DRUG__ID DQ62LM DQ62LM DRUGCOMP AstraZeneca Wilmington, DE DQ62LM DRUGTYPE Small molecule DQ62LM DRUGINCH InChI=1S/C27H29N5O4S2/c1-15-25(37-27(28-15)30-21-6-4-7-22(29-21)31-11-5-8-23(31)33)18-12-19-14-32(16(2)17-9-10-17)26(34)24(19)20(13-18)38(3,35)36/h4,6-7,12-13,16-17H,5,8-11,14H2,1-3H3,(H,28,29,30)/t16-/m0/s1 DQ62LM DRUGINKE XOMFDZJQLSPGGV-INIZCTEOSA-N DQ62LM DRUGSMIL CC1=C(SC(=N1)NC2=NC(=CC=C2)N3CCCC3=O)C4=CC5=C(C(=C4)S(=O)(=O)C)C(=O)N(C5)C(C)C6CC6 DQ62LM HIGHSTAT Phase 2 DQ9OL5 DRUG__ID DQ9OL5 DQ9OL5 DRUGCOMP OBI Pharma DQ9OL5 DRUGTYPE Small molecular drug DQ9OL5 DRUGINCH 1S/C21H25N4O6P/c1-15(31-32(29,23-9-10-23)24-11-12-24)16-7-8-19(25(27)28)20(14-16)30-18-6-4-5-17(13-18)21(26)22(2)3/h4-8,13-15H,9-12H2,1-3H3/t15-/m1/s1 DQ9OL5 DRUGINKE NWGZZGNICQFUHV-OAHLLOKOSA-N DQ9OL5 DRUGSMIL CC(C1=CC(=C(C=C1)[N+](=O)[O-])OC2=CC=CC(=C2)C(=O)N(C)C)OP(=O)(N3CC3)N4CC4 DQ9OL5 HIGHSTAT Phase 2 DQM0X1 DRUG__ID DQM0X1 DQM0X1 DRUGCOMP BioMarck Pharmaceuticals DQM0X1 DRUGTYPE Small molecular drug DQM0X1 DRUGINCH 1S/C46H75N13O15/c1-24(51-36(64)22-50-28(5)62)39(66)54-31(17-18-35(49)63)41(68)57-33(21-29-13-7-6-8-14-29)43(70)58-34(23-60)44(71)55-30(15-9-11-19-47)42(69)59-37(27(4)61)45(72)53-25(2)38(65)52-26(3)40(67)56-32(46(73)74)16-10-12-20-48/h6-8,13-14,24-27,30-34,37,60-61H,9-12,15-23,47-48H2,1-5H3,(H2,49,63)(H,50,62)(H,51,64)(H,52,65)(H,53,72)(H,54,66)(H,55,71)(H,56,67)(H,57,68)(H,58,70)(H,59,69)(H,73,74)/t24-,25-,26-,27+,30-,31-,32-,33-,34-,37-/m0/s1 DQM0X1 DRUGINKE KCSNGWMKFYVMKF-HGYIIGRXSA-N DQM0X1 DRUGSMIL CC(C(C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)CNC(=O)C)O DQM0X1 HIGHSTAT Phase 2 DQNF41 DRUG__ID DQNF41 DQNF41 DRUGCOMP Integrative Research Laboratories AB DQNF41 DRUGTYPE Small molecule DQNF41 DRUGINCH InChI=1S/C12H18FNO3S/c1-3-4-14-5-6-17-11-7-10(13)8-12(9-11)18(2,15)16/h7-9,14H,3-6H2,1-2H3 DQNF41 DRUGINKE OSBPYFBXSLJHCR-UHFFFAOYSA-N DQNF41 DRUGSMIL CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F DQNF41 HIGHSTAT Phase 2 DRH80V DRUG__ID DRH80V DRH80V DRUGCOMP Janssen DRH80V DRUGTYPE Small molecular drug DRH80V DRUGINCH 1S/C21H20ClF3N4O3S/c1-33(31,32)8-2-7-27-16(10-14-9-15(22)3-4-17(14)27)12-28-19-11-26-6-5-18(19)29(20(28)30)13-21(23,24)25/h3-6,9-11H,2,7-8,12-13H2,1H3 DRH80V DRUGINKE GTQTUABHRCWVLL-UHFFFAOYSA-N DRH80V DRUGSMIL CS(=O)(=O)CCCN1C2=C(C=C(C=C2)Cl)C=C1CN3C4=C(C=CN=C4)N(C3=O)CC(F)(F)F DRH80V HIGHSTAT Phase 2 DS5LI8 DRUG__ID DS5LI8 DS5LI8 DRUGCOMP Promore Pharma DS5LI8 DRUGTYPE Small molecular drug DS5LI8 DRUGINCH 1S/C205H340N60O53/c1-20-114(16)162(261-179(296)128(66-40-46-86-211)235-176(293)135(74-78-155(273)274)243-170(287)125(63-37-43-83-208)241-192(309)148(106-266)257-174(291)126(64-38-44-84-209)234-171(288)129(67-47-87-225-201(215)216)240-185(302)142(98-119-55-29-24-30-56-119)252-187(304)144(100-121-59-33-26-34-60-121)253-189(306)146(102-158(279)280)233-154(272)104-230-167(284)138(94-109(6)7)248-166(283)122(212)93-108(4)5)194(311)231-105-153(271)232-123(61-35-41-81-206)168(285)242-136(75-79-156(275)276)177(294)251-141(97-118-53-27-23-28-54-118)184(301)238-124(62-36-42-82-207)169(286)236-131(69-49-89-227-203(219)220)181(298)263-164(116(18)22-3)197(314)259-160(112(12)13)195(312)246-134(73-77-151(213)269)175(292)237-132(70-50-90-228-204(221)222)180(297)262-163(115(17)21-2)196(313)245-127(65-39-45-85-210)172(289)256-147(103-159(281)282)190(307)254-143(99-120-57-31-25-32-58-120)186(303)249-139(95-110(8)9)183(300)239-130(68-48-88-226-202(217)218)173(290)255-145(101-152(214)270)188(305)250-140(96-111(10)11)191(308)260-161(113(14)15)199(316)265-92-52-72-150(265)193(310)244-133(71-51-91-229-205(223)224)182(299)264-165(117(19)268)198(315)247-137(76-80-157(277)278)178(295)258-149(107-267)200(317)318/h23-34,53-60,108-117,122-150,160-165,266-268H,20-22,35-52,61-107,206-212H2,1-19H3,(H2,213,269)(H2,214,270)(H,230,284)(H,231,311)(H,232,271)(H,233,272)(H,234,288)(H,235,293)(H,236,286)(H,237,292)(H,238,301)(H,239,300)(H,240,302)(H,241,309)(H,242,285)(H,243,287)(H,244,310)(H,245,313)(H,246,312)(H,247,315)(H,248,283)(H,249,303)(H,250,305)(H,251,294)(H,252,304)(H,253,306)(H,254,307)(H,255,290)(H,256,289)(H,257,291)(H,258,295)(H,259,314)(H,260,308)(H,261,296)(H,262,297)(H,263,298)(H,264,299)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,317,318)(H4,215,216,225)(H4,217,218,226)(H4,219,220,227)(H4,221,222,228)(H4,223,224,229)/t114-,115-,116-,117+,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,160-,161-,162-,163-,164-,165-/m0/s1 DS5LI8 DRUGINKE POIUWJQBRNEFGX-XAMSXPGMSA-N DS5LI8 DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)N3CCCC3C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)N DS5LI8 HIGHSTAT Phase 2 DSI31T DRUG__ID DSI31T DSI31T DRUGCOMP Amyndas DSI31T DRUGTYPE Peptide DSI31T DRUGINCH 1S/C83H117N23O18S2/c1-11-43(5)68(103-72(114)53(84)30-46-23-25-50(107)26-24-46)80(122)100-61-39-125-126-40-62(82(124)106(10)69(70(86)112)44(6)12-2)101-73(115)55(21-17-29-90-83(87)88)94-76(118)58(33-49-36-89-41-92-49)96-71(113)45(7)93-65(109)38-105(9)81(123)60(31-47-35-91-54-20-15-13-18-51(47)54)99-77(119)59(34-66(110)111)97-74(116)56(27-28-64(85)108)95-75(117)57(98-79(121)67(42(3)4)102-78(61)120)32-48-37-104(8)63-22-16-14-19-52(48)63/h13-16,18-20,22-26,35-37,41-45,53,55-62,67-69,91,107H,11-12,17,21,27-34,38-40,84H2,1-10H3,(H2,85,108)(H2,86,112)(H,89,92)(H,93,109)(H,94,118)(H,95,117)(H,96,113)(H,97,116)(H,98,121)(H,99,119)(H,100,122)(H,101,115)(H,102,120)(H,103,114)(H,110,111)(H4,87,88,90)/t43-,44-,45-,53+,55-,56-,57-,58-,59-,60-,61-,62-,67-,68-,69-/m0/s1 DSI31T DRUGINKE MUSGYEMSJUFFHT-UWABRSFTSA-N DSI31T DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CN(C(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CN(C3=CC=CC=C32)C)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)N(C)C(C(C)CC)C(=O)N)NC(=O)C(CC7=CC=C(C=C7)O)N DSI31T HIGHSTAT Phase 2 DSJX41 DRUG__ID DSJX41 DSJX41 DRUGCOMP Enterin Inc. DSJX41 DRUGTYPE Small molecule DSJX41 DRUGINCH InChI=1S/C34H65N3O5S/c1-23(2)31(42-43(39,40)41)12-9-24(3)27-10-11-28-32-29(14-16-34(27,28)5)33(4)15-13-26(21-25(33)22-30(32)38)37-20-8-19-36-18-7-6-17-35/h23-32,36-38H,6-22,35H2,1-5H3,(H,39,40,41)/t24-,25-,26+,27-,28+,29+,30-,31-,32?,33+,34-/m1/s1 DSJX41 DRUGINKE UIRKNQLZZXALBI-XJTYUZMVSA-N DSJX41 DRUGSMIL CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCN)C)O)C)OS(=O)(=O)O DSJX41 HIGHSTAT Phase 2 DT45OV DRUG__ID DT45OV DT45OV DRUGCOMP Takeda DT45OV DRUGTYPE Small molecular drug DT45OV DRUGINCH 1S/C13H11F3N2O2/c14-13(15,16)9-4-1-8(2-5-9)3-6-10-7-11(19)12(20)18-17-10/h1-2,4-5,7H,3,6H2,(H,17,19)(H,18,20) DT45OV DRUGINKE QBQMUMMSYHUDFM-UHFFFAOYSA-N DT45OV DRUGSMIL C1=CC(=CC=C1CCC2=CC(=O)C(=O)NN2)C(F)(F)F DT45OV HIGHSTAT Phase 2 DT52FI DRUG__ID DT52FI DT52FI DRUGCOMP MyoKardia; Sanofi DT52FI DRUGTYPE Small molecular drug DT52FI DRUGINCH 1S/C16H20F3N5O4S/c1-16(19,29(26,27)11-9-23(2)21-13(11)14(17)18)10-3-6-24(7-4-10)15(25)20-12-5-8-28-22-12/h5,8-10,14H,3-4,6-7H2,1-2H3,(H,20,22,25)/t16-/m1/s1 DT52FI DRUGINKE NREKKBAMVWQRES-MRXNPFEDSA-N DT52FI DRUGSMIL CC(C1CCN(CC1)C(=O)NC2=NOC=C2)(F)S(=O)(=O)C3=CN(N=C3C(F)F)C DT52FI HIGHSTAT Phase 2 DT56YX DRUG__ID DT56YX DT56YX DRUGCOMP Liminal BioSciences DT56YX DRUGTYPE Small molecular drug DT56YX DRUGINCH 1S/C13H18O2/c1-2-3-4-6-11-7-5-8-12(9-11)10-13(14)15/h5,7-9H,2-4,6,10H2,1H3,(H,14,15) DT56YX DRUGINKE PEGQOIGYZLJMIB-UHFFFAOYSA-N DT56YX DRUGSMIL CCCCCC1=CC(=CC=C1)CC(=O)O DT56YX HIGHSTAT Phase 2 DTG28Y DRUG__ID DTG28Y DTG28Y DRUGCOMP Lilly DTG28Y DRUGTYPE Small molecule DTG28Y DRUGINCH InChI=1S/C42H54N4O6/c47-40(48)37(34-10-13-43-22-34)19-28-4-1-7-31(16-28)25-46(26-32-8-2-5-29(17-32)20-38(41(49)50)35-11-14-44-23-35)27-33-9-3-6-30(18-33)21-39(42(51)52)36-12-15-45-24-36/h1-9,16-18,34-39,43-45H,10-15,19-27H2,(H,47,48)(H,49,50)(H,51,52)/t34-,35-,36-,37-,38-,39-/m0/s1 DTG28Y DRUGINKE BRLGERLDHZRETI-BGBFCPIGSA-N DTG28Y DRUGSMIL C1CNCC1C(CC2=CC(=CC=C2)CN(CC3=CC=CC(=C3)CC(C4CCNC4)C(=O)O)CC5=CC=CC(=C5)CC(C6CCNC6)C(=O)O)C(=O)O DTG28Y HIGHSTAT Phase 2 DU10JI DRUG__ID DU10JI DU10JI DRUGCOMP Concert Pharmaceuticals DU10JI DRUGTYPE Small molecular drug DU10JI DRUGINCH 1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1/i1D2,2D2,3D2,4D2 DU10JI DRUGINKE HFNKQEVNSGCOJV-FBXGHSCESA-N DU10JI DRUGSMIL C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3 DU10JI HIGHSTAT Phase 2 DU2Q0R DRUG__ID DU2Q0R DU2Q0R DRUGCOMP TB DU2Q0R DRUGTYPE Small molecule DU2Q0R DRUGINCH InChI=1S/C32H30F3N5O3/c1-41-22-13-9-20(10-14-22)37-27-19-30-28(18-26(27)39-25-7-5-17-36-31(25)42-2)38-24-6-3-4-8-29(24)40(30)21-11-15-23(16-12-21)43-32(33,34)35/h3-8,11-12,15-20,22,39H,9-10,13-14H2,1-2H3 DU2Q0R DRUGINKE GUSGYHIQYWRCQO-UHFFFAOYSA-N DU2Q0R DRUGSMIL COC1CCC(CC1)N=C2C=C3C(=NC4=CC=CC=C4N3C5=CC=C(C=C5)OC(F)(F)F)C=C2NC6=C(N=CC=C6)OC DU2Q0R HIGHSTAT Phase 2 DU5G2B DRUG__ID DU5G2B DU5G2B DRUGCOMP Galecto DU5G2B DRUGTYPE Small molecule DU5G2B DRUGINCH InChI=1S/C28H30F2N6O8S/c29-15-5-1-3-13(7-15)17-9-35(33-31-17)21-23(39)19(11-37)43-27(25(21)41)45-28-26(42)22(24(40)20(12-38)44-28)36-10-18(32-34-36)14-4-2-6-16(30)8-14/h1-10,19-28,37-42H,11-12H2/t19-,20-,21+,22+,23+,24+,25-,26-,27+,28+/m1/s1 DU5G2B DRUGINKE YGIDGBAHDZEYMT-MQFIMZJJSA-N DU5G2B DRUGSMIL C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O DU5G2B HIGHSTAT Phase 2 DUSB35 DRUG__ID DUSB35 DUSB35 DRUGCOMP GlaxoSmithKline DUSB35 DRUGTYPE Small molecular drug DUSB35 DRUGINCH 1S/C10H13BClNO4.ClH/c12-6-1-2-7(16-4-3-14)10-9(6)8(5-13)17-11(10)15;/h1-2,8,14-15H,3-5,13H2;1H/t8-;/m1./s1 DUSB35 DRUGINKE FUOKBESTQMGROA-DDWIOCJRSA-N DUSB35 DRUGSMIL B1(C2=C(C=CC(=C2C(O1)CN)Cl)OCCO)O.Cl DUSB35 HIGHSTAT Phase 2 DUW81M DRUG__ID DUW81M DUW81M DRUGCOMP Rain Therapeutics DUW81M DRUGTYPE Small molecular drug DUW81M DRUGINCH 1S/C24H23BrClN9O3/c1-33-14-30-24(34(37)38)20(33)12-35(2,3)8-4-5-22(36)32-21-10-16-19(11-27-21)28-13-29-23(16)31-15-6-7-18(26)17(25)9-15/h4-7,9-11,13-14H,8,12H2,1-3H3,(H-,27,28,29,31,32,36)/p+1/b5-4+ DUW81M DRUGINKE MUJMYVFVAWFUJL-SNAWJCMRSA-O DUW81M DRUGSMIL CN1C=NC(=C1C[N+](C)(C)CC=CC(=O)NC2=NC=C3C(=C2)C(=NC=N3)NC4=CC(=C(C=C4)Cl)Br)[N+](=O)[O-] DUW81M HIGHSTAT Phase 2 DV3Y7F DRUG__ID DV3Y7F DV3Y7F DRUGCOMP Apollomics DV3Y7F DRUGTYPE Small molecular drug DV3Y7F DRUGINCH 1S/C20H15F3N8/c1-29-9-11-6-14(15(21)7-17(11)27-29)20(22,23)19-26-25-18-5-4-16(28-31(18)19)12-8-24-30(10-12)13-2-3-13/h4-10,13H,2-3H2,1H3 DV3Y7F DRUGINKE QHXLXUIZUCJRKV-UHFFFAOYSA-N DV3Y7F DRUGSMIL CN1C=C2C=C(C(=CC2=N1)F)C(C3=NN=C4N3N=C(C=C4)C5=CN(N=C5)C6CC6)(F)F DV3Y7F HIGHSTAT Phase 2 DV8F9L DRUG__ID DV8F9L DV8F9L DRUGCOMP Afimmune DV8F9L DRUGTYPE Small molecule DV8F9L DRUGINCH InChI=1S/C22H34O3/c1-3-5-15-18-21(23)19-16-13-11-9-7-6-8-10-12-14-17-20-22(24)25-4-2/h5-7,10-13,15-16,19,21,23H,3-4,8-9,14,17-18,20H2,1-2H3/b7-6-,12-10-,13-11-,15-5-,19-16+/t21-/m0/s1 DV8F9L DRUGINKE DJYKWMOPVZGTRJ-PILRRHKESA-N DV8F9L DRUGSMIL CCC=CCC(C=CC=CCC=CCC=CCCCC(=O)OCC)O DV8F9L HIGHSTAT Phase 2 DVK21S DRUG__ID DVK21S DVK21S DRUGCOMP TB DVK21S DRUGTYPE Small molecule DVK21S DRUGINCH InChI=1S/C17H16F3N3O5S/c1-9-8-27-16(28-9)2-4-22(5-3-16)15-21-14(24)11-6-10(17(18,19)20)7-12(23(25)26)13(11)29-15/h6-7,9H,2-5,8H2,1H3/t9-/m0/s1 DVK21S DRUGINKE GTUIRORNXIOHQR-VIFPVBQESA-N DVK21S DRUGSMIL CC1COC2(O1)CCN(CC2)C3=NC(=O)C4=C(S3)C(=CC(=C4)C(F)(F)F)[N+](=O)[O-] DVK21S HIGHSTAT Phase 2 DVY0C6 DRUG__ID DVY0C6 DVY0C6 DRUGCOMP Lilly DVY0C6 DRUGTYPE Small molecule DVY0C6 DRUGINCH InChI=1S/C16H22FN5O3S/c1-9-6-12(24-8-14-19-11(3)25-21-14)4-5-22(9)7-13-15(17)20-16(26-13)18-10(2)23/h9,12H,4-8H2,1-3H3,(H,18,20,23)/t9-,12-/m0/s1 DVY0C6 DRUGINKE FRVXHWNHGWUTQO-CABZTGNLSA-N DVY0C6 DRUGSMIL CC1CC(CCN1CC2=C(N=C(S2)NC(=O)C)F)OCC3=NOC(=N3)C DVY0C6 HIGHSTAT Phase 2 DW0ZV1 DRUG__ID DW0ZV1 DW0ZV1 DRUGCOMP Bristol-Myers Squibb DW0ZV1 DRUGTYPE Small molecule DW0ZV1 DRUGINCH InChI=1S/C26H32N6O/c1-15(2)24-20-11-19(18-7-9-31(10-8-18)13-23(27)33)5-6-22(20)30-25(24)21-12-32-26(28-14-29-32)17(4)16(21)3/h5-6,11-12,14-15,18,30H,7-10,13H2,1-4H3,(H2,27,33) DW0ZV1 DRUGINKE SNFVHLQYHFQOEP-UHFFFAOYSA-N DW0ZV1 DRUGSMIL CC1=C(C2=NC=NN2C=C1C3=C(C4=C(N3)C=CC(=C4)C5CCN(CC5)CC(=O)N)C(C)C)C DW0ZV1 HIGHSTAT Phase 2 DW7OF1 DRUG__ID DW7OF1 DW7OF1 DRUGCOMP OrphoMed DW7OF1 DRUGTYPE Small molecule DW7OF1 DRUGINCH InChI=1S/C60H84N2O8/c1-51(2,3)53(7,63)41-31-55-19-21-59(41,65-9)49-57(55)23-25-61(33-35-11-12-35)43(55)29-37-15-17-39(47(69-49)45(37)57)67-27-28-68-40-18-16-38-30-44-56-20-22-60(66-10,42(32-56)54(8,64)52(4,5)6)50-58(56,46(38)48(40)70-50)24-26-62(44)34-36-13-14-36/h15-18,35-36,41-44,49-50,63-64H,11-14,19-34H2,1-10H3/t41-,42-,43-,44-,49-,50-,53+,54+,55-,56-,57+,58+,59-,60-/m1/s1 DW7OF1 DRUGINKE LEQOVFCHMOTJKU-WJVXOHEGSA-N DW7OF1 DRUGSMIL CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)OCCOC7=C8C9=C(CC1C23C9(CCN1CC1CC1)C(O8)C(CC2)(C(C3)C(C)(C(C)(C)C)O)OC)C=C7)O4)CC1CC1)OC)O DW7OF1 HIGHSTAT Phase 2 DW8Z1M DRUG__ID DW8Z1M DW8Z1M DRUGCOMP Pfzer DW8Z1M DRUGTYPE Small molecule DW8Z1M DRUGINCH InChI=1S/C19H25FN4O5S2/c1-12-8-24(9-12)31(27,28)23-17-7-18(29-13(2)16(26)10-25)22-19(21-17)30-11-14-3-5-15(20)6-4-14/h3-7,12-13,16,25-26H,8-11H2,1-2H3,(H,21,22,23)/t13-,16+/m1/s1 DW8Z1M DRUGINKE UCCNQCNIPRKLRP-CJNGLKHVSA-N DW8Z1M DRUGSMIL CC1CN(C1)S(=O)(=O)NC2=CC(=NC(=N2)SCC3=CC=C(C=C3)F)OC(C)C(CO)O DW8Z1M HIGHSTAT Phase 2 DW9ML8 DRUG__ID DW9ML8 DW9ML8 DRUGCOMP Novartis DW9ML8 DRUGTYPE Small molecular drug DW9ML8 DRUGINCH 1S/C27H22ClN3O4/c1-30-25-21-13-20(28)11-12-23(21)35-16-22(25)24(29-30)26(32)31(14-17-5-3-2-4-6-17)15-18-7-9-19(10-8-18)27(33)34/h2-13H,14-16H2,1H3,(H,33,34) DW9ML8 DRUGINKE JYTIXGYXBIBOMN-UHFFFAOYSA-N DW9ML8 DRUGSMIL CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC=CC=C4)CC5=CC=C(C=C5)C(=O)O DW9ML8 HIGHSTAT Phase 2 DWSG41 DRUG__ID DWSG41 DWSG41 DRUGCOMP Corcept Therapeutics Menlo Park, CA DWSG41 DRUGTYPE Small molecule DWSG41 DRUGINCH InChI=1S/C29H22F4N4O3S/c30-22-6-8-23(9-7-22)37-26-15-21-12-14-36(41(39,40)24-10-4-20(5-11-24)29(31,32)33)18-28(21,16-19(26)17-35-37)27(38)25-3-1-2-13-34-25/h1-11,13,15,17H,12,14,16,18H2/t28-/m0/s1 DWSG41 DRUGINKE VXOBXKQLNWYQPQ-NDEPHWFRSA-N DWSG41 DRUGSMIL C1CN(CC2(C1=CC3=C(C2)C=NN3C4=CC=C(C=C4)F)C(=O)C5=CC=CC=N5)S(=O)(=O)C6=CC=C(C=C6)C(F)(F)F DWSG41 HIGHSTAT Phase 2 DXE53Z DRUG__ID DXE53Z DXE53Z DRUGCOMP Lilly DXE53Z DRUGTYPE Small molecule DXE53Z DRUGINCH InChI=1S/C16H23N3O2/c1-10-5-4-6-18-15(10)21-9-16(2,3)19-14(20)13-11-7-17-8-12(11)13/h4-6,11-13,17H,7-9H2,1-3H3,(H,19,20)/t11-,12+,13? DXE53Z DRUGINKE PCINBSQTEDBZDB-FUNVUKJBSA-N DXE53Z DRUGSMIL CC1=C(N=CC=C1)OCC(C)(C)NC(=O)C2C3C2CNC3 DXE53Z HIGHSTAT Phase 2 DY0OR1 DRUG__ID DY0OR1 DY0OR1 DRUGCOMP Rivus Pharmaceuticals DY0OR1 DRUGTYPE Small molecule DY0OR1 DRUGINCH InChI=1S/C14H16BrN3O/c15-10-5-12(11-8-17-18-13(11)6-10)16-7-9-3-1-2-4-14(9)19/h1,3,5-6,8-9,14,16,19H,2,4,7H2,(H,17,18)/t9-,14+/m0/s1 DY0OR1 DRUGINKE KUCFPVMNWYCZRO-LKFCYVNXSA-N DY0OR1 DRUGSMIL C1CC(C(C=C1)CNC2=CC(=CC3=C2C=NN3)Br)O DY0OR1 HIGHSTAT Phase 2 DY57LN DRUG__ID DY57LN DY57LN DRUGCOMP Genosco DY57LN DRUGTYPE Small molecule DY57LN DRUGINCH InChI=1S/C25H27N7O3/c1-15-17(10-31-12-19(33)14-35-31)11-32(29-15)23-7-8-26-25(28-23)27-18-5-6-22-20(9-18)21(13-30(22)2)24(34)16-3-4-16/h5-9,11,13,16,19,33H,3-4,10,12,14H2,1-2H3,(H,26,27,28)/t19-/m0/s1 DY57LN DRUGINKE YCZUBLQESBVOSH-IBGZPJMESA-N DY57LN DRUGSMIL CC1=NN(C=C1CN2CC(CO2)O)C3=NC(=NC=C3)NC4=CC5=C(C=C4)N(C=C5C(=O)C6CC6)C DY57LN HIGHSTAT Phase 2 DYIA63 DRUG__ID DYIA63 DYIA63 DRUGCOMP TaiRx DYIA63 DRUGTYPE Small molecular drug DYIA63 DRUGINCH 1S/C16H13FNO6P/c1-23-14-6-5-11-15(16(14)24-25(20,21)22)13(19)8-12(18-11)9-3-2-4-10(17)7-9/h2-8H,1H3,(H,18,19)(H2,20,21,22) DYIA63 DRUGINKE ZDWFMAHQGDEALT-UHFFFAOYSA-N DYIA63 DRUGSMIL COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)OP(=O)(O)O DYIA63 HIGHSTAT Phase 2 DZTX12 DRUG__ID DZTX12 DZTX12 DRUGCOMP AndroScience DZTX12 DRUGTYPE Small molecular drug DZTX12 DRUGINCH 1S/C23H24O6/c1-26-20-11-7-16(13-22(20)28-3)5-9-18(24)15-19(25)10-6-17-8-12-21(27-2)23(14-17)29-4/h5-15,24H,1-4H3/b9-5+,10-6+,18-15- DZTX12 DRUGINKE ZMGUKFHHNQMKJI-CIOHCNBKSA-N DZTX12 DRUGSMIL COC1=C(C=C(C=C1)C=CC(=CC(=O)C=CC2=CC(=C(C=C2)OC)OC)O)OC DZTX12 HIGHSTAT Phase 2 D00AUC DRUG__ID D00AUC D00AUC DRUGTYPE Small molecular drug D00AUC DRUGINCH 1S/6C6H9NO2.Tc/c6*1-6(2,7-3)5(8)9-4;/h6*1-2,4H3;/i;;;;;;1+1 D00AUC DRUGINKE JECHAWIBZCKPHF-KTTJZPQESA-N D00AUC DRUGSMIL CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].CC(C)(C(=O)OC)[N+]#[C-].[Tc] D00AUC HIGHSTAT Phase 2 D00AYA DRUG__ID D00AYA D00AYA DRUGTYPE Small molecular drug D00AYA DRUGINCH 1S/C47H51NO15/c1-25-30(61-42(55)35(51)34(27-16-10-7-11-17-27)48-40(53)28-18-12-8-13-19-28)23-47(57)39(62-41(54)29-20-14-9-15-21-29)37-45(5,38(52)36(60-26(2)49)33(25)44(47,3)4)31(50)22-32-46(37,24-59-32)63-43(56)58-6/h7-21,30-32,34-37,39,50-51,57H,22-24H2,1-6H3,(H,48,53)/t30-,31-,32+,34-,35+,36+,37-,39-,45+,46-,47+/m0/s1 D00AYA DRUGINKE GMJWGJSDPOAZTP-MIDYMNAOSA-N D00AYA DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)OC)O)C)OC(=O)C D00AYA HIGHSTAT Phase 2 D00DAE DRUG__ID D00DAE D00DAE DRUGCOMP Tactical Therapeutics D00DAE DRUGINCH 1S/C17H12Cl3N5O2.C5H4N2O4/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25;8-3-1-2(4(9)10)6-5(11)7-3/h1-6H,7H2,(H4,21,22,24,27);1H,(H,9,10)(H2,6,7,8,11) D00DAE DRUGINKE WEUITFNOCGSIHW-UHFFFAOYSA-N D00DAE DRUGSMIL C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)C[N+]3=C(C(=NN3)C(=O)N)N)Cl)Cl.C1=C(NC(=O)NC1=O)C(=O)[O-] D00DAE HIGHSTAT Phase 2 D00DPP DRUG__ID D00DPP D00DPP DRUGTYPE Small molecular drug D00DPP DRUGINCH 1S/C5H11N.C4H6O5.H3N.Pt/c6-5-3-1-2-4-5;5-2(4(8)9)1-3(6)7;;/h5H,1-4,6H2;2,5H,1H2,(H,6,7)(H,8,9);1H3;/q;;;+2/p-2 D00DPP DRUGINKE OPWOOOGFNULJAQ-UHFFFAOYSA-L D00DPP DRUGSMIL C1CCC(C1)N.C(C(C(=O)[O-])O)C(=O)[O-].N.[Pt+2] D00DPP HIGHSTAT Phase 2 D00ERV DRUG__ID D00ERV D00ERV DRUGTYPE Small molecular drug D00ERV DRUGINCH 1S/C28H40N2O5/c1-20(2)28(19-29,22-17-25(33-6)27(35-8)26(18-22)34-7)13-9-14-30(3)15-12-21-10-11-23(31-4)24(16-21)32-5/h10-11,16-18,20H,9,12-15H2,1-8H3 D00ERV DRUGINKE XQLWNAFCTODIRK-UHFFFAOYSA-N D00ERV DRUGSMIL CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC D00ERV HIGHSTAT Phase 2 D00HUZ DRUG__ID D00HUZ D00HUZ DRUGTYPE Small molecular drug D00HUZ DRUGINCH 1S/2C10H20O2.C6H12N2.Pt/c2*1-10(2,3)8-6-4-5-7-9(11)12;7-5-3-1-2-4-6(5)8;/h2*4-8H2,1-3H3,(H,11,12);5-8H,1-4H2;/q;;-2;+4/p-2 D00HUZ DRUGINKE ALPHSAWEOKVWID-UHFFFAOYSA-L D00HUZ DRUGSMIL CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)[NH-])[NH-].[Pt+4] D00HUZ HIGHSTAT Phase 2 D00JED DRUG__ID D00JED D00JED DRUGCOMP Anacor Pharmaceuticals Inc D00JED DRUGINCH 1S/C15H9BN2O3/c17-7-10-1-2-13(5-11(10)8-18)21-14-3-4-15-12(6-14)9-20-16(15)19/h1-6,19H,9H2 D00JED DRUGINKE UBMGTTRDNUKZMT-UHFFFAOYSA-N D00JED DRUGSMIL B1(C2=C(CO1)C=C(C=C2)OC3=CC(=C(C=C3)C#N)C#N)O D00JED HIGHSTAT Phase 2 D00JFE DRUG__ID D00JFE D00JFE DRUGCOMP Seragon pharmaceuticals D00JFE DRUGINCH 1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+ D00JFE DRUGINKE BURHGPHDEVGCEZ-KJGLQBJMSA-N D00JFE DRUGSMIL CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl D00JFE HIGHSTAT Phase 2 D00JJG DRUG__ID D00JJG D00JJG DRUGCOMP RAPID Pharmaceuticals D00JJG DRUGINCH 1S/C35H56N10O15/c1-13(36)29(54)41-22(12-46)32(57)43-26(16(4)49)34(59)45-27(17(5)50)35(60)44-25(15(3)48)33(58)40-21(11-23(37)52)30(55)39-20(10-18-6-8-19(51)9-7-18)31(56)42-24(14(2)47)28(38)53/h6-9,13-17,20-22,24-27,46-51H,10-12,36H2,1-5H3,(H2,37,52)(H2,38,53)(H,39,55)(H,40,58)(H,41,54)(H,42,56)(H,43,57)(H,44,60)(H,45,59)/t13-,14-,15-,16-,17-,20+,21+,22+,24+,25+,26+,27+/m1/s1 D00JJG DRUGINKE AKWRNBWMGFUAMF-ZESMOPTKSA-N D00JJG DRUGSMIL CC(C(C(=O)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(C)N)O D00JJG HIGHSTAT Phase 2 D00KIE DRUG__ID D00KIE D00KIE DRUGTYPE Small molecular drug D00KIE DRUGINCH 1S/C26H32N2O5.ClH/c1-18-19(2)26(29)33-23-17-24(31-4)25(16-20(18)23)32-15-7-10-27-11-13-28(14-12-27)21-8-5-6-9-22(21)30-3;/h5-6,8-9,16-17H,7,10-15H2,1-4H3;1H D00KIE DRUGINKE XMONKHCPLIYQCY-UHFFFAOYSA-N D00KIE DRUGSMIL CC1=C(C(=O)OC2=CC(=C(C=C12)OCCCN3CCN(CC3)C4=CC=CC=C4OC)OC)C.Cl D00KIE HIGHSTAT Phase 2 D00KXO DRUG__ID D00KXO D00KXO DRUGCOMP Perosphere Danbury, CT D00KXO DRUGINCH 1S/C22H48N12O2/c23-17(5-1-7-31-21(25)26)19(35)29-9-3-11-33-13-15-34(16-14-33)12-4-10-30-20(36)18(24)6-2-8-32-22(27)28/h17-18H,1-16,23-24H2,(H,29,35)(H,30,36)(H4,25,26,31)(H4,27,28,32)/t17-,18-/m0/s1 D00KXO DRUGINKE HRDUUSCYRPOMSO-ROUUACIJSA-N D00KXO DRUGSMIL C1CN(CCN1CCCNC(=O)C(CCCN=C(N)N)N)CCCNC(=O)C(CCCN=C(N)N)N D00KXO HIGHSTAT Phase 2 D00MHP DRUG__ID D00MHP D00MHP DRUGTYPE Small molecular drug D00MHP DRUGINCH 1S/C23H18N2O3/c26-23(27)20-9-2-4-11-22(20)24-17-7-5-8-19(14-17)28-15-18-13-12-16-6-1-3-10-21(16)25-18/h1-14,24H,15H2,(H,26,27) D00MHP DRUGINKE LMPZHLXYBWGGNT-UHFFFAOYSA-N D00MHP DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=CC(=C3)NC4=CC=CC=C4C(=O)O D00MHP HIGHSTAT Phase 2 D00MZK DRUG__ID D00MZK D00MZK DRUGTYPE Small molecular drug D00MZK DRUGINCH 1S/C26H25NO6/c28-24(29)17-32-23-13-7-8-19-16-26(31,15-14-22(19)23)18-33-25(30)27(20-9-3-1-4-10-20)21-11-5-2-6-12-21/h1-13,31H,14-18H2,(H,28,29)/t26-/m1/s1 D00MZK DRUGINKE UZJAIYJXBYWENR-AREMUKBSSA-N D00MZK DRUGSMIL C1CC(CC2=C1C(=CC=C2)OCC(=O)O)(COC(=O)N(C3=CC=CC=C3)C4=CC=CC=C4)O D00MZK HIGHSTAT Phase 2 D00NBJ DRUG__ID D00NBJ D00NBJ DRUGCOMP Medivir Huddinge, Sweden D00NBJ DRUGINCH 1S/C16H21NO6/c1-22-16(20)12-8-10-13(11-9-12)23-15(19)7-5-3-2-4-6-14(18)17-21/h8-11,21H,2-7H2,1H3,(H,17,18) D00NBJ DRUGINKE XDZAHHULFQIBFE-UHFFFAOYSA-N D00NBJ DRUGSMIL COC(=O)C1=CC=C(C=C1)OC(=O)CCCCCCC(=O)NO D00NBJ HIGHSTAT Phase 2 D00OVC DRUG__ID D00OVC D00OVC DRUGCOMP Roche Holding AG D00OVC DRUGINCH 1S/C17H17ClN6O2/c1-22(2)8-13-20-16(21-26-13)15-12-7-23(3)17(25)14-10(18)5-4-6-11(14)24(12)9-19-15/h4-6,9H,7-8H2,1-3H3 D00OVC DRUGINKE JCYLWUVDHLVGER-UHFFFAOYSA-N D00OVC DRUGSMIL CN1CC2=C(N=CN2C3=C(C1=O)C(=CC=C3)Cl)C4=NOC(=N4)CN(C)C D00OVC HIGHSTAT Phase 2 D00QOF DRUG__ID D00QOF D00QOF DRUGTYPE Small molecular drug D00QOF DRUGINCH 1S/C18H25F3N4O/c19-18(20,21)15-5-6-22-16(14-15)24-12-10-23(11-13-24)7-1-2-8-25-9-3-4-17(25)26/h5-6,14H,1-4,7-13H2 D00QOF DRUGINKE YKJJCYZZWWSBEW-UHFFFAOYSA-N D00QOF DRUGSMIL C1CC(=O)N(C1)CCCCN2CCN(CC2)C3=NC=CC(=C3)C(F)(F)F D00QOF HIGHSTAT Phase 2 D00SFN DRUG__ID D00SFN D00SFN DRUGTYPE Small molecular drug D00SFN DRUGINCH 1S/C15H12O5/c16-8-12-13(17)2-1-3-14(12)20-9-10-4-6-11(7-5-10)15(18)19/h1-8,17H,9H2,(H,18,19) D00SFN DRUGINKE XEDONBRPTABQFB-UHFFFAOYSA-N D00SFN DRUGSMIL C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O D00SFN HIGHSTAT Phase 2 D00SUK DRUG__ID D00SUK D00SUK DRUGTYPE Small molecular drug D00SUK DRUGINCH 1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28) D00SUK DRUGINKE ZWTVVWUOTJRXKM-UHFFFAOYSA-N D00SUK DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CCC(CC3)(CC4)CCC(=O)O D00SUK HIGHSTAT Phase 2 D00TLM DRUG__ID D00TLM D00TLM DRUGTYPE Small molecular drug D00TLM DRUGINCH 1S/C22H21FN4O/c23-18-6-4-16(5-7-18)8-9-26-10-12-27(13-11-26)22(28)20-3-1-2-19-17(14-24)15-25-21(19)20/h1-7,15,25H,8-13H2 D00TLM DRUGINKE AQRLDDAFYYAIJP-UHFFFAOYSA-N D00TLM DRUGSMIL C1CN(CCN1CCC2=CC=C(C=C2)F)C(=O)C3=CC=CC4=C3NC=C4C#N D00TLM HIGHSTAT Phase 2 D00UET DRUG__ID D00UET D00UET DRUGCOMP Sanofi D00UET DRUGINCH 1S/C14H16N2O2/c17-14-13-2-1-12(9-10(13)3-8-16-14)18-11-4-6-15-7-5-11/h1-3,8-9,11,15H,4-7H2,(H,16,17) D00UET DRUGINKE IPEXHQGMTHOKQV-UHFFFAOYSA-N D00UET DRUGSMIL C1CNCCC1OC2=CC3=C(C=C2)C(=O)NC=C3 D00UET HIGHSTAT Phase 2 D00WHL DRUG__ID D00WHL D00WHL DRUGCOMP Renovo Group plc D00WHL DRUGINCH 1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h1,3-6,8-11H,2H2,(H2,12,13,14)/t3-,4-,5-,6-/m1/s1 D00WHL DRUGINKE VFRROHXSMXFLSN-KVTDHHQDSA-N D00WHL DRUGSMIL C(C(C(C(C(C=O)O)O)O)O)OP(=O)(O)O D00WHL HIGHSTAT Phase 2 D00XCX DRUG__ID D00XCX D00XCX DRUGTYPE Small molecular drug D00XCX DRUGINCH 1S/C21H16F2N2O4/c1-2-21(28)7-18(26)29-9-12-13(21)5-17-19-11(8-25(17)20(12)27)3-10-4-14(22)15(23)6-16(10)24-19/h3-6,28H,2,7-9H2,1H3/t21-/m1/s1 D00XCX DRUGINKE LFQCJSBXBZRMTN-OAQYLSRUSA-N D00XCX DRUGSMIL CCC1(CC(=O)OCC2=C1C=C3C4=C(CN3C2=O)C=C5C=C(C(=CC5=N4)F)F)O D00XCX HIGHSTAT Phase 2 D00XQO DRUG__ID D00XQO D00XQO DRUGTYPE Small molecular drug D00XQO DRUGINCH 1S/C25H36O5/c1-16(10-12-20-17(2)8-6-14-25(20,3)4)7-5-9-18-11-13-21(29-23(18)27)19-15-22(26)30-24(19)28/h7,11,15,21,23-24,27-28H,5-6,8-10,12-14H2,1-4H3/b16-7+/t21-,23-,24-/m1/s1 D00XQO DRUGINKE FGJIDQWRRLDGDB-CPIXEKRISA-N D00XQO DRUGSMIL CC1=C(C(CCC1)(C)C)CCC(=CCCC2=CCC(OC2O)C3=CC(=O)OC3O)C D00XQO HIGHSTAT Phase 2 D00YEV DRUG__ID D00YEV D00YEV DRUGTYPE Small molecular drug D00YEV DRUGINCH 1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H D00YEV DRUGINKE FXNFHKRTJBSTCS-UHFFFAOYSA-N D00YEV DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O D00YEV HIGHSTAT Phase 2 D00YLM DRUG__ID D00YLM D00YLM DRUGTYPE Small molecular drug D00YLM DRUGINCH 1S/C20H25NO3.CH4O3S/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17;1-5(2,3)4/h2-10,15,19,22-24H,11-14H2,1H3;1H3,(H,2,3,4)/t15-,19+;/m0./s1 D00YLM DRUGINKE OZBWUANKVIMZIA-WRRDZZDISA-N D00YLM DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)(C3=CC=CC=C3)O.CS(=O)(=O)O D00YLM HIGHSTAT Phase 2 D01AEF DRUG__ID D01AEF D01AEF DRUGCOMP Memorial Sloan-Kettering Cancer Center D01AEF DRUGINCH 1S/C15H14N2O4/c1-4-9-7-5-10(20-2)11(21-3)6-8(7)12-13(16-9)15(19)17-14(12)18/h5-6H,4H2,1-3H3,(H,17,18,19) D01AEF DRUGINKE ULVWJFBHQIXEPE-UHFFFAOYSA-N D01AEF DRUGSMIL CCC1=NC2=C(C3=CC(=C(C=C31)OC)OC)C(=O)NC2=O D01AEF HIGHSTAT Phase 2 D01CGV DRUG__ID D01CGV D01CGV DRUGCOMP Prosidion Ltd D01CGV DRUGINCH 1S/C21H25N3O4S/c25-21(24-20-14-22-9-10-23-20)19(13-15-7-11-28-12-8-15)16-1-3-17(4-2-16)29(26,27)18-5-6-18/h1-4,9-10,14-15,18-19H,5-8,11-13H2,(H,23,24,25)/t19-/m1/s1 D01CGV DRUGINKE DQIITKNITDKAJZ-LJQANCHMSA-N D01CGV DRUGSMIL C1CC1S(=O)(=O)C2=CC=C(C=C2)C(CC3CCOCC3)C(=O)NC4=NC=CN=C4 D01CGV HIGHSTAT Phase 2 D01DGZ DRUG__ID D01DGZ D01DGZ DRUGCOMP AbbVie D01DGZ DRUGINCH 1S/C28H21F4NO7/c29-26(30)37-17-6-7-18-19(13-21(38-22(18)12-17)14-1-3-15(4-2-14)24(34)35)33-25(36)27(9-10-27)16-5-8-20-23(11-16)40-28(31,32)39-20/h1-8,11-12,19,21,26H,9-10,13H2,(H,33,36)(H,34,35)/t19-,21-/m1/s1 D01DGZ DRUGINKE QVDYQHXNAQHIKH-TZIWHRDSSA-N D01DGZ DRUGSMIL C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O D01DGZ HIGHSTAT Phase 2 D01GEB DRUG__ID D01GEB D01GEB DRUGTYPE Small molecular drug D01GEB DRUGINCH 1S/C23H26N2O/c26-21-9-10-23-22(16-21)20(17-24-23)8-4-5-13-25-14-11-19(12-15-25)18-6-2-1-3-7-18/h1-3,6-7,9-11,16-17,24,26H,4-5,8,12-15H2 D01GEB DRUGINKE HGEYJZMMUGWEOT-UHFFFAOYSA-N D01GEB DRUGSMIL C1CN(CC=C1C2=CC=CC=C2)CCCCC3=CNC4=C3C=C(C=C4)O D01GEB HIGHSTAT Phase 2 D01HXA DRUG__ID D01HXA D01HXA DRUGCOMP Ausio Pharmaceuticals D01HXA DRUGINCH 1S/C15H14O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8,12,16-17H,7,9H2/t12-/m1/s1 D01HXA DRUGINKE ADFCQWZHKCXPAJ-GFCCVEGCSA-N D01HXA DRUGSMIL C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O D01HXA HIGHSTAT Phase 2 D01IED DRUG__ID D01IED D01IED DRUGCOMP Biomed valley discoveries D01IED DRUGINCH 1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1 D01IED DRUGINKE KSERXGMCDHOLSS-LJQANCHMSA-N D01IED DRUGSMIL CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl D01IED HIGHSTAT Phase 2 D01IVE DRUG__ID D01IVE D01IVE DRUGTYPE Small molecular drug D01IVE DRUGINCH 1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1 D01IVE DRUGINKE MXYUKLILVYORSK-HBMCJLEFSA-N D01IVE DRUGSMIL CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O D01IVE HIGHSTAT Phase 2 D01JIO DRUG__ID D01JIO D01JIO DRUGTYPE Small molecular drug D01JIO DRUGINCH 1S/C25H32O5/c1-23-7-4-14(26)10-13(23)11-16(22(28)29-3)20-17(23)5-8-24(2)21(20)15-12-18(15)25(24)9-6-19(27)30-25/h10,15-18,20-21H,4-9,11-12H2,1-3H3/t15-,16-,17+,18+,20-,21+,23+,24+,25+/m1/s1 D01JIO DRUGINKE YDIQJONNFLVNGD-FPMRONRSSA-N D01JIO DRUGSMIL CC12CCC(=O)C=C1CC(C3C2CCC4(C3C5CC5C46CCC(=O)O6)C)C(=O)OC D01JIO HIGHSTAT Phase 2 D01KHW DRUG__ID D01KHW D01KHW DRUGTYPE Small molecular drug D01KHW DRUGINCH 1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1 D01KHW DRUGINKE WHNFPRLDDSXQCL-UAZQEYIDSA-N D01KHW DRUGSMIL CC(C)C(C(=O)N)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C D01KHW HIGHSTAT Phase 2 D01LWO DRUG__ID D01LWO D01LWO DRUGCOMP TransMolecular Inc D01LWO DRUGINCH 1S/C158H249N53O47S11/c1-77(2)55-96-138(241)205-105(144(247)186-86(125(165)228)28-18-47-173-156(166)167)70-264-262-68-103-131(234)177-63-115(217)176-64-116(218)183-87(25-12-15-44-159)128(231)178-65-117(219)184-88(29-19-48-174-157(168)169)129(232)179-66-118(220)185-89(26-13-16-45-160)133(236)202-107-72-267-269-75-110-149(252)195-98(56-81-23-10-9-11-24-81)143(246)208-124(80(5)213)154(257)209-123(79(4)212)153(256)199-102(61-122(226)227)141(244)196-99(58-83-62-172-76-181-83)139(242)189-92(37-39-113(163)215)136(239)190-94(42-53-260-7)132(235)182-78(3)126(229)187-91(30-20-49-175-158(170)171)134(237)188-90(27-14-17-46-161)135(238)203-108(73-266-265-71-106(146(249)193-96)204-137(240)93(38-40-114(164)216)191-151(254)111-31-21-50-210(111)119(221)67-180-130(233)97(194-147(107)250)57-82-33-35-84(214)36-34-82)148(251)198-100(59-120(222)223)140(243)197-101(60-121(224)225)142(245)206-109(150(253)201-103)74-268-263-69-104(200-127(230)85(162)41-52-259-6)145(248)192-95(43-54-261-8)155(258)211-51-22-32-112(211)152(255)207-110/h9-11,23-24,33-36,62,76-80,85-112,123-124,212-214H,12-22,25-32,37-61,63-75,159-162H2,1-8H3,(H2,163,215)(H2,164,216)(H2,165,228)(H,172,181)(H,176,217)(H,177,234)(H,178,231)(H,179,232)(H,180,233)(H,182,235)(H,183,218)(H,184,219)(H,185,220)(H,186,247)(H,187,229)(H,188,237)(H,189,242)(H,190,239)(H,191,254)(H,192,248)(H,193,249)(H,194,250)(H,195,252)(H,196,244)(H,197,243)(H,198,251)(H,199,256)(H,200,230)(H,201,253)(H,202,236)(H,203,238)(H,204,240)(H,205,241)(H,206,245)(H,207,255)(H,208,246)(H,209,257)(H,222,223)(H,224,225)(H,226,227)(H4,166,167,173)(H4,168,169,174)(H4,170,171,175)/t78-,79+,80+,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,123-,124-/m0/s1 D01LWO DRUGINKE QPAKKWCQMHUHNI-GQIQPHNSSA-N D01LWO DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(CSSCC4C(=O)NCC(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCSC)CCC(=O)N)CC5=CNC=N5)CC(=O)O)C(C)O)C(C)O)CC6=CC=CC=C6)NC(=O)C7CCCN7C(=O)C(NC(=O)C(CSSCC(C(=O)N4)NC(=O)C(NC(=O)C(NC2=O)CC(=O)O)CC(=O)O)NC(=O)C(CCSC)N)CCSC)C(=O)NC(C(=O)NCC(=O)N8CCCC8C(=O)NC(C(=O)N3)CCC(=O)N)CC9=CC=C(C=C9)O)CCCCN)CCCNC(=N)N)CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)N)CC(C)C)CCCCN)CCCNC(=N)N D01LWO HIGHSTAT Phase 2 D01MBV DRUG__ID D01MBV D01MBV DRUGTYPE Small molecular drug D01MBV DRUGINCH 1S/C22H31N3O2.ClH/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25;/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26);1H D01MBV DRUGINKE UABVCZHWRUGYSR-UHFFFAOYSA-N D01MBV DRUGSMIL CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42.Cl D01MBV HIGHSTAT Phase 2 D01NUR DRUG__ID D01NUR D01NUR DRUGCOMP Astex Pharmaceuticals Pleasanton, CA D01NUR DRUGINCH 1S/C30H42FN5O3/c1-20-14-35(25(13-32-20)15-34-9-10-39-18-21(34)2)16-28(38)36-19-30(3,4)29-27(36)12-23(26(17-37)33-29)11-22-5-7-24(31)8-6-22/h5-8,12,20-21,25,32,37H,9-11,13-19H2,1-4H3/t20-,21-,25-/m1/s1 D01NUR DRUGINKE YCXOHEXZVKOGEV-DNRQZRRGSA-N D01NUR DRUGSMIL CC1CN(C(CN1)CN2CCOCC2C)CC(=O)N3CC(C4=C3C=C(C(=N4)CO)CC5=CC=C(C=C5)F)(C)C D01NUR HIGHSTAT Phase 2 D01OXH DRUG__ID D01OXH D01OXH DRUGCOMP Astellas Pharma Inc D01OXH DRUGINCH 1S/C25H23F7N2O4/c1-14(26)13-38-16-3-4-17(20(11-16)25(30,31)32)23(37)34-8-6-24(28,29)19(12-22(36)33-7-9-35)18-10-15(27)2-5-21(18)34/h2-5,10-12,14,35H,6-9,13H2,1H3,(H,33,36)/b19-12-/t14-/m1/s1 D01OXH DRUGINKE VSXSHTIGQAUGMW-VCRXTVNUSA-N D01OXH DRUGSMIL CC(COC1=CC(=C(C=C1)C(=O)N2CCC(C(=CC(=O)NCCO)C3=C2C=CC(=C3)F)(F)F)C(F)(F)F)F D01OXH HIGHSTAT Phase 2 D01TBJ DRUG__ID D01TBJ D01TBJ DRUGCOMP Ischemix D01TBJ DRUGINCH 1S/C16H26N2O6S2/c1-10(16(23)24)17-15(22)12(6-7-14(20)21)18-13(19)5-3-2-4-11-8-9-25-26-11/h10-12H,2-9H2,1H3,(H,17,22)(H,18,19)(H,20,21)(H,23,24)/t10-,11+,12-/m0/s1 D01TBJ DRUGINKE MQXRTCVZPIHBLD-TUAOUCFPSA-N D01TBJ DRUGSMIL CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CCCCC1CCSS1 D01TBJ HIGHSTAT Phase 2 D01UDS DRUG__ID D01UDS D01UDS DRUGCOMP GlaxoSmithKline plc D01UDS DRUGINCH 1S/C19H20F3N3O3S/c1-13-12-24(10-11-25(13)18(26)17-4-3-9-23-14(17)2)29(27,28)16-7-5-15(6-8-16)19(20,21)22/h3-9,13H,10-12H2,1-2H3/t13-/m0/s1 D01UDS DRUGINKE BLFJGFDZMABYMY-ZDUSSCGKSA-N D01UDS DRUGSMIL CC1CN(CCN1C(=O)C2=C(N=CC=C2)C)S(=O)(=O)C3=CC=C(C=C3)C(F)(F)F D01UDS HIGHSTAT Phase 2 D01VAP DRUG__ID D01VAP D01VAP DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D01VAP DRUGINCH 1S/C29H35N3O8/c1-19-25(28(34)38-3)27(21-10-9-11-22(16-21)32(36)37)26(20(2)31-19)29(35)39-15-8-7-14-30-17-23(33)18-40-24-12-5-4-6-13-24/h4-6,9-13,16,23,27,30-31,33H,7-8,14-15,17-18H2,1-3H3/t23-,27-/m0/s1 D01VAP DRUGINKE HBXMSJLNXYLVTA-HOFKKMOUSA-N D01VAP DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCCCNCC(COC2=CC=CC=C2)O)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC D01VAP HIGHSTAT Phase 2 D01XVX DRUG__ID D01XVX D01XVX DRUGTYPE Small molecular drug D01XVX DRUGINCH 1S/C25H27N3O5/c29-23-9-8-21(24(30)26-23)28-15-20-19(25(28)31)2-1-3-22(20)33-16-18-6-4-17(5-7-18)14-27-10-12-32-13-11-27/h1-7,21H,8-16H2,(H,26,29,30)/t21-/m0/s1 D01XVX DRUGINKE IXZOHGPZAQLIBH-NRFANRHFSA-N D01XVX DRUGSMIL C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5 D01XVX HIGHSTAT Phase 2 D01YIO DRUG__ID D01YIO D01YIO DRUGTYPE Small molecular drug D01YIO DRUGINCH 1S/C40H35N2O6P/c1-41(32-19-21-42(22-20-32)39(44)31-18-17-26-9-2-3-11-28(26)23-31)40(45)36-25-30-13-5-4-12-29(30)24-35(36)37(43)38(49(46,47)48)34-16-8-14-27-10-6-7-15-33(27)34/h2-18,23-25,32,38H,19-22H2,1H3,(H2,46,47,48) D01YIO DRUGINKE XUJQPDQURBZEGJ-UHFFFAOYSA-N D01YIO DRUGSMIL CN(C1CCN(CC1)C(=O)C2=CC3=CC=CC=C3C=C2)C(=O)C4=CC5=CC=CC=C5C=C4C(=O)C(C6=CC=CC7=CC=CC=C76)P(=O)(O)O D01YIO HIGHSTAT Phase 2 D01ZMS DRUG__ID D01ZMS D01ZMS DRUGTYPE Small molecular drug D01ZMS DRUGINCH 1S/C17H14Cl2N2O2S/c1-17(10-3-6-12(22)7-4-10)15(23)21(16(24)20(17)2)11-5-8-13(18)14(19)9-11/h3-9,22H,1-2H3/t17-/m1/s1 D01ZMS DRUGINKE YPONBLYNQFHCLA-QGZVFWFLSA-N D01ZMS DRUGSMIL CC1(C(=O)N(C(=S)N1C)C2=CC(=C(C=C2)Cl)Cl)C3=CC=C(C=C3)O D01ZMS HIGHSTAT Phase 2 D01ZNQ DRUG__ID D01ZNQ D01ZNQ DRUGCOMP Janssen research & development D01ZNQ DRUGINCH 1S/C38H53N5O7S2/c1-25(2)22-43(23-33(44)32(20-26-8-4-3-5-9-26)41-38(45)50-34-24-49-36-30(34)16-19-48-36)52(46,47)29-12-13-31-35(21-29)51-37(40-31)39-27-14-17-42(18-15-27)28-10-6-7-11-28/h3-5,8-9,12-13,21,25,27-28,30,32-34,36,44H,6-7,10-11,14-20,22-24H2,1-2H3,(H,39,40)(H,41,45)/t30-,32-,33+,34-,36+/m0/s1 D01ZNQ DRUGINKE JQUNFHFWXCXPRK-AMMMHQJVSA-N D01ZNQ DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC5=C(C=C4)N=C(S5)NC6CCN(CC6)C7CCCC7 D01ZNQ HIGHSTAT Phase 2 D02AIN DRUG__ID D02AIN D02AIN DRUGCOMP AstraZeneca Wilmington, DE D02AIN DRUGINCH 1S/C24H26N6O3/c1-14-12-19(29-28-14)15-6-8-16(9-7-15)22(31)17-4-2-3-5-18(17)23(32)27-20-13-26-30-11-10-25-24(33)21(20)30/h6-9,12-13,17-18H,2-5,10-11H2,1H3,(H,25,33)(H,27,32)(H,28,29)/t17-,18-/m1/s1 D02AIN DRUGINKE ROTWSDMXHVGAHZ-QZTJIDSGSA-N D02AIN DRUGSMIL CC1=CC(=NN1)C2=CC=C(C=C2)C(=O)C3CCCCC3C(=O)NC4=C5C(=O)NCCN5N=C4 D02AIN HIGHSTAT Phase 2 D02ALZ DRUG__ID D02ALZ D02ALZ DRUGTYPE Small molecular drug D02ALZ DRUGINCH 1S/C14H14N4O4S/c15-14(16)18-10-3-1-9(2-4-10)13(19)22-11-5-7-12(8-6-11)23(17,20)21/h1-8H,(H4,15,16,18)(H2,17,20,21) D02ALZ DRUGINKE YFUQTMNUQVFBBS-UHFFFAOYSA-N D02ALZ DRUGSMIL C1=CC(=CC=C1C(=O)OC2=CC=C(C=C2)S(=O)(=O)N)N=C(N)N D02ALZ HIGHSTAT Phase 2 D02AOD DRUG__ID D02AOD D02AOD DRUGCOMP Hunter-Fleming Ltd D02AOD DRUGINCH 1S/C19H30O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h11-15,17,20-21H,3-10H2,1-2H3/t11-,12+,13+,14+,15+,17+,18+,19+/m1/s1 D02AOD DRUGINKE VFPMCLQMAUVEHD-UCPSWNCLSA-N D02AOD DRUGSMIL CC12CCC(CC1CC(C3C2CCC4(C3CCC4=O)C)O)O D02AOD HIGHSTAT Phase 2 D02BBC DRUG__ID D02BBC D02BBC DRUGTYPE Small molecular drug D02BBC DRUGINCH 1S/C30H32N6O2/c1-5-6-11-27-31-26-17-16-22(30(2,3)38-4)18-25(26)29(37)36(27)19-20-12-14-21(15-13-20)23-9-7-8-10-24(23)28-32-34-35-33-28/h7-10,12-18H,5-6,11,19H2,1-4H3,(H,32,33,34,35) D02BBC DRUGINKE XZCUIMYYMKTCBA-UHFFFAOYSA-N D02BBC DRUGSMIL CCCCC1=NC2=C(C=C(C=C2)C(C)(C)OC)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D02BBC HIGHSTAT Phase 2 D02BYZ DRUG__ID D02BYZ D02BYZ DRUGCOMP Astellas pharma us D02BYZ DRUGINCH 1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1 D02BYZ DRUGINKE QKDCLUARMDUUKN-XMMPIXPASA-N D02BYZ DRUGSMIL CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC5CCN(C5)C(=O)C=C D02BYZ HIGHSTAT Phase 2 D02COS DRUG__ID D02COS D02COS DRUGCOMP Inverni della Beffa SpA D02COS DRUGINCH 1S/C40H68NO8P.C25H22O10/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(49-50(44,45)48-35-34-41(3,4)5)37-47-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2;1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h10-14,16-17,19,22,24,27,29,38H,6-9,15,18,20-21,23,25-26,28,30-37H2,1-5H3;2-9,20,23-29,31H,10H2,1H3/b12-10+,13-11+,16-14+,19-17+,24-22+,29-27+;/t;20?,23-,24?,25+/m.0/s1 D02COS DRUGINKE XAEMHHAVNYDWEO-CVEVMTCXSA-N D02COS DRUGSMIL CCCC=CCC=CCCCC=CCCC(=O)OCC(COC(=O)CCCCC=CCCC=CC=CCCC)OP(=O)([O-])OCC[N+](C)(C)C.COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O D02COS HIGHSTAT Phase 2 D02DEH DRUG__ID D02DEH D02DEH DRUGCOMP Genervon biopharmaceuticals D02DEH DRUGINCH 1S/C36H54N12O9/c1-20(29(51)46-26(34(56)57)10-6-16-43-36(40)41)44-32(54)27(18-22-11-13-23(50)14-12-22)47-31(53)25(9-5-15-42-35(38)39)45-33(55)28(19-49)48-30(52)24(37)17-21-7-3-2-4-8-21/h2-4,7-8,11-14,20,24-28,49-50H,5-6,9-10,15-19,37H2,1H3,(H,44,54)(H,45,55)(H,46,51)(H,47,53)(H,48,52)(H,56,57)(H4,38,39,42)(H4,40,41,43)/t20-,24-,25-,26-,27-,28-/m0/s1 D02DEH DRUGINKE WVPOPWDCSFQEBI-HJJAOGADSA-N D02DEH DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)N D02DEH HIGHSTAT Phase 2 D02DLP DRUG__ID D02DLP D02DLP DRUGTYPE Small molecular drug D02DLP DRUGINCH 1S/C21H23F3N6O.2ClH/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14;;/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3;2*1H/t17-,19-;;/m0../s1 D02DLP DRUGINKE YVNRXILPJNISEM-FFUVTKDNSA-N D02DLP DRUGSMIL COC1=C(C=C(C=C1)N2C(=NN=N2)C(F)(F)F)CNC3CCCNC3C4=CC=CC=C4.Cl.Cl D02DLP HIGHSTAT Phase 2 D02FDJ DRUG__ID D02FDJ D02FDJ DRUGCOMP GE Healthcare D02FDJ DRUGINCH 1S/C33H40I6N6O15/c34-22-18(30(57)40-1-13(52)7-46)24(36)28(25(37)19(22)31(58)41-2-14(53)8-47)44(11-50)5-17(56)6-45(12-51)29-26(38)20(32(59)42-3-15(54)9-48)23(35)21(27(29)39)33(60)43-4-16(55)10-49/h11-17,46-49,52-56H,1-10H2,(H,40,57)(H,41,58)(H,42,59)(H,43,60) D02FDJ DRUGINKE BFVVDRUCXCIALU-UHFFFAOYSA-N D02FDJ DRUGSMIL C(C(CO)O)NC(=O)C1=C(C(=C(C(=C1I)N(CC(CN(C=O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)O)C=O)I)C(=O)NCC(CO)O)I D02FDJ HIGHSTAT Phase 2 D02GPG DRUG__ID D02GPG D02GPG DRUGCOMP Janssen research & development D02GPG DRUGINCH 1S/C18H17ClF2N4O3/c19-13-3-4-22-10-14(13)23-17(26)25-7-5-24(6-8-25)11-12-1-2-15-16(9-12)28-18(20,21)27-15/h1-4,9-10H,5-8,11H2,(H,23,26) D02GPG DRUGINKE YWGYNGCRVZLMCS-UHFFFAOYSA-N D02GPG DRUGSMIL C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl D02GPG HIGHSTAT Phase 2 D02GTN DRUG__ID D02GTN D02GTN DRUGTYPE Small molecular drug D02GTN DRUGINCH 1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7+/m0/s1 D02GTN DRUGINKE OPVPGKGADVGKTG-NKWVEPMBSA-N D02GTN DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O D02GTN HIGHSTAT Phase 2 D02LSR DRUG__ID D02LSR D02LSR DRUGTYPE Small molecular drug D02LSR DRUGINCH 1S/C14H23N3O2.ClH/c18-12(10-16-7-1-4-13(16)19)15-11-14-5-2-8-17(14)9-3-6-14;/h1-11H2,(H,15,18);1H D02LSR DRUGINKE DSRRZZDDBKFTID-UHFFFAOYSA-N D02LSR DRUGSMIL C1CC(=O)N(C1)CC(=O)NCC23CCCN2CCC3.Cl D02LSR HIGHSTAT Phase 2 D02OTK DRUG__ID D02OTK D02OTK DRUGCOMP Chelsea Therapeutics D02OTK DRUGINCH 1S/C23H23N5O5/c1-12(21(30)31)10-18(22(32)33)26-20(29)15-7-4-13(5-8-15)2-3-14-6-9-17-16(11-14)19(24)28-23(25)27-17/h4-9,11,18H,1-3,10H2,(H,26,29)(H,30,31)(H,32,33)(H4,24,25,27,28)/t18-/m0/s1 D02OTK DRUGINKE NAWXUBYGYWOOIX-SFHVURJKSA-N D02OTK DRUGSMIL C=C(CC(C(=O)O)NC(=O)C1=CC=C(C=C1)CCC2=CC3=C(C=C2)N=C(N=C3N)N)C(=O)O D02OTK HIGHSTAT Phase 2 D02PAW DRUG__ID D02PAW D02PAW DRUGCOMP TLC Biopharmaceuticals D02PAW DRUGINCH 1S/C39H30N8O15/c1-5-39(26-13-30-34-18(14-43(30)36(49)25(26)16-60-38(39)51)8-21-24(15-42(3)4)31(48)7-6-27(21)40-34)61-37(50)17(2)62-41-35-22-9-19(44(52)53)11-28(46(56)57)32(22)33-23(35)10-20(45(54)55)12-29(33)47(58)59/h6-13,17,48H,5,14-16H2,1-4H3/t17?,39-/m0/s1 D02PAW DRUGINKE JCCCLGDYMMTBPM-HXDHBHDHSA-N D02PAW DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)OC(=O)C(C)ON=C6C7=C(C(=CC(=C7)[N+](=O)[O-])[N+](=O)[O-])C8=C6C=C(C=C8[N+](=O)[O-])[N+](=O)[O-] D02PAW HIGHSTAT Phase 2 D02RDX DRUG__ID D02RDX D02RDX DRUGCOMP Xenoport D02RDX DRUGINCH 1S/C11H17NO5/c1-4-12(5-2)9(13)8-17-11(15)7-6-10(14)16-3/h6-7H,4-5,8H2,1-3H3/b7-6+ D02RDX DRUGINKE AKUGRXRLHCCENI-VOTSOKGWSA-N D02RDX DRUGSMIL CCN(CC)C(=O)COC(=O)C=CC(=O)OC D02RDX HIGHSTAT Phase 2 D02RNR DRUG__ID D02RNR D02RNR DRUGTYPE Small molecular drug D02RNR DRUGINCH 1S/C13H20N2O4/c1-14-4-6-15(7-5-14)12(16)10-8-2-3-9(19-8)11(10)13(17)18/h8-11H,2-7H2,1H3,(H,17,18) D02RNR DRUGINKE JUQMLSGOTNKJKI-UHFFFAOYSA-N D02RNR DRUGSMIL CN1CCN(CC1)C(=O)C2C3CCC(C2C(=O)O)O3 D02RNR HIGHSTAT Phase 2 D02SUR DRUG__ID D02SUR D02SUR DRUGTYPE Small molecular drug D02SUR DRUGINCH 1S/C16H15Cl2N3O2/c1-3-9-6-12(16(22)20-8(9)2)19-7-13-21-14-10(17)4-5-11(18)15(14)23-13/h4-6,19H,3,7H2,1-2H3,(H,20,22) D02SUR DRUGINKE WHFRDXVXYMGAJD-UHFFFAOYSA-N D02SUR DRUGSMIL CCC1=C(NC(=O)C(=C1)NCC2=NC3=C(C=CC(=C3O2)Cl)Cl)C D02SUR HIGHSTAT Phase 2 D02XXT DRUG__ID D02XXT D02XXT DRUGTYPE Small molecular drug D02XXT DRUGINCH 1S/C15H10O/c16-15-13(11-7-3-1-4-8-11)14(15)12-9-5-2-6-10-12/h1-10H D02XXT DRUGINKE HCIBTBXNLVOFER-UHFFFAOYSA-N D02XXT DRUGSMIL C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3 D02XXT HIGHSTAT Phase 2 D02XYB DRUG__ID D02XYB D02XYB DRUGTYPE Small molecular drug D02XYB DRUGINCH 1S/C19H20ClN3O/c1-3-6-18(24)22(2)13-16-19(14-8-10-15(20)11-9-14)21-17-7-4-5-12-23(16)17/h4-5,7-12H,3,6,13H2,1-2H3 D02XYB DRUGINKE LIFDPEORUVTOCP-UHFFFAOYSA-N D02XYB DRUGSMIL CCCC(=O)N(C)CC1=C(N=C2N1C=CC=C2)C3=CC=C(C=C3)Cl D02XYB HIGHSTAT Phase 2 D02ZKR DRUG__ID D02ZKR D02ZKR DRUGTYPE Small molecular drug D02ZKR DRUGINCH 1S/C12H16N4O3/c17-5-8-3-16(4-9(8)18)2-7-1-13-11-10(7)14-6-15-12(11)19/h1,6,8-9,13,17-18H,2-5H2,(H,14,15,19)/t8-,9+/m1/s1 D02ZKR DRUGINKE AFNHHLILYQEHKK-BDAKNGLRSA-N D02ZKR DRUGSMIL C1C(C(CN1CC2=CNC3=C2N=CNC3=O)O)CO D02ZKR HIGHSTAT Phase 2 D02ZZU DRUG__ID D02ZZU D02ZZU DRUGCOMP Dekk-Tec D02ZZU DRUGINCH 1S/C35H48Cl5NO4/c1-19(2)8-7-9-20(3)24-12-13-25-23-11-10-21-18-22(14-16-33(21,4)26(23)15-17-34(24,25)5)44-32(42)45-29-27(36)30(35(38,39)40)41-31(43-6)28(29)37/h10,19-20,22-26H,7-9,11-18H2,1-6H3/t20-,22+,23+,24-,25+,26+,33+,34-/m1/s1 D02ZZU DRUGINKE ZJUUIXYKTPSIOH-LEZJFEBPSA-N D02ZZU DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)OC5=C(C(=NC(=C5Cl)OC)C(Cl)(Cl)Cl)Cl)C)C D02ZZU HIGHSTAT Phase 2 D03AOP DRUG__ID D03AOP D03AOP DRUGCOMP Daiichi Sankyo D03AOP DRUGINCH 1S/C8H11NO2/c1-3-7-6(4-5-9-7)8(10)11-2/h4-5,9H,3H2,1-2H3 D03AOP DRUGINKE FWZOVQKKSCXOHE-UHFFFAOYSA-N D03AOP DRUGSMIL CCC1=C(C=CN1)C(=O)OC D03AOP HIGHSTAT Phase 2 D03AYQ DRUG__ID D03AYQ D03AYQ DRUGCOMP Euthymics Bioscience D03AYQ DRUGINCH 1S/C15H15N.ClH/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15;/h1-7,14,16H,8-10H2;1H/t14-,15+;/m1./s1 D03AYQ DRUGINKE ACVMJAJGCQUPKX-LIOBNPLQSA-N D03AYQ DRUGSMIL C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3.Cl D03AYQ HIGHSTAT Phase 2 D03BHM DRUG__ID D03BHM D03BHM DRUGCOMP Roche D03BHM DRUGINCH 1S/C17H12N2O2/c20-19(21)16-6-3-4-13(12-16)8-10-15-11-9-14-5-1-2-7-17(14)18-15/h1-12H/b10-8+ D03BHM DRUGINKE URIXDBULDXTIHZ-CSKARUKUSA-N D03BHM DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)C=CC3=CC(=CC=C3)[N+](=O)[O-] D03BHM HIGHSTAT Phase 2 D03CPM DRUG__ID D03CPM D03CPM DRUGCOMP Solvay SA D03CPM DRUGINCH 1S/C33H36N2O6/c36-29(37)21-35-28-13-4-2-9-24(28)16-17-27(30(35)38)34-32(41)33(18-5-6-19-33)20-25(31(39)40)15-14-23-11-7-10-22-8-1-3-12-26(22)23/h1-4,7-13,25,27H,5-6,14-21H2,(H,34,41)(H,36,37)(H,39,40)/t25-,27+/m1/s1 D03CPM DRUGINKE LOFDNSDPZTVIIO-VPUSJEBWSA-N D03CPM DRUGSMIL C1CCC(C1)(CC(CCC2=CC=CC3=CC=CC=C32)C(=O)O)C(=O)NC4CCC5=CC=CC=C5N(C4=O)CC(=O)O D03CPM HIGHSTAT Phase 2 D03EOZ DRUG__ID D03EOZ D03EOZ DRUGCOMP Imago BioSciences San Carlos, CA D03EOZ DRUGINCH 1S/C28H34FN7O2/c1-34-15-17-35(18-16-34)28(38)25(3-2-12-30-26-19-24(26)20-4-8-22(29)9-5-20)32-27(37)21-6-10-23(11-7-21)36-14-13-31-33-36/h4-11,13-14,24-26,30H,2-3,12,15-19H2,1H3,(H,32,37)/t24-,25-,26+/m0/s1 D03EOZ DRUGINKE KQKBMHGOHXOHTD-KKUQBAQOSA-N D03EOZ DRUGSMIL CN1CCN(CC1)C(=O)C(CCCNC2CC2C3=CC=C(C=C3)F)NC(=O)C4=CC=C(C=C4)N5C=CN=N5 D03EOZ HIGHSTAT Phase 2 D03FLT DRUG__ID D03FLT D03FLT DRUGTYPE Small molecular drug D03FLT DRUGINCH 1S/C17H21N3O4/c18-16-6-3-13(10-20-16)15(21)11-19-7-8-24-14-4-1-12(2-5-14)9-17(22)23/h1-6,10,15,19,21H,7-9,11H2,(H2,18,20)(H,22,23)/t15-/m0/s1 D03FLT DRUGINKE GZJZZQHTBTUBEL-HNNXBMFYSA-N D03FLT DRUGSMIL C1=CC(=CC=C1CC(=O)O)OCCNCC(C2=CN=C(C=C2)N)O D03FLT HIGHSTAT Phase 2 D03HUX DRUG__ID D03HUX D03HUX DRUGCOMP TrovaGene San Diego, CA D03HUX DRUGINCH 1S/C24H27F3N8O3/c1-33-6-8-34(9-7-33)15-3-5-18(38-24(25,26)27)17(12-15)30-23-29-13-14-2-4-16-20(22(28)37)32-35(10-11-36)21(16)19(14)31-23/h3,5,12-13,36H,2,4,6-11H2,1H3,(H2,28,37)(H,29,30,31) D03HUX DRUGINKE QHLVBNKYJGBCQJ-UHFFFAOYSA-N D03HUX DRUGSMIL CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO D03HUX HIGHSTAT Phase 2 D03KHO DRUG__ID D03KHO D03KHO DRUGCOMP Pfizer D03KHO DRUGINCH 1S/C23H27N5O2/c1-14(2)28-21-17(13-24-28)11-23(12-20(21)29)6-8-27(9-7-23)22(30)16-4-5-18-19(10-16)26-15(3)25-18/h4-5,10,13-14H,6-9,11-12H2,1-3H3,(H,25,26) D03KHO DRUGINKE BDXXSFOJPYSYOC-UHFFFAOYSA-N D03KHO DRUGSMIL CC1=NC2=C(N1)C=C(C=C2)C(=O)N3CCC4(CC3)CC5=C(C(=O)C4)N(N=C5)C(C)C D03KHO HIGHSTAT Phase 2 D03LQC DRUG__ID D03LQC D03LQC DRUGCOMP Acacia Pharma Ltd D03LQC DRUGINCH 1S/C54H95N3O16/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-25-28-48(62)56-31-34-68-36-38-70-40-42-71-41-39-69-37-35-67-33-29-49(63)55-30-26-24-27-32-72-54(53(65)66)43-46(60)50(57-45(2)59)52(73-54)51(64)47(61)44-58/h46-47,50-52,58,60-61,64H,3-13,18-44H2,1-2H3,(H,55,63)(H,56,62)(H,57,59)(H,65,66)/t46-,47+,50+,51+,52+,54+/m0/s1 D03LQC DRUGINKE VRJMVFQLUBTBKF-HBJHFNNESA-N D03LQC DRUGSMIL CCCCCCCCCCCCC#CC#CCCCCCCCCC(=O)NCCOCCOCCOCCOCCOCCC(=O)NCCCCCOC1(CC(C(C(O1)C(C(CO)O)O)NC(=O)C)O)C(=O)O D03LQC HIGHSTAT Phase 2 D03MYO DRUG__ID D03MYO D03MYO DRUGCOMP Madrigal pharmaceuticals D03MYO DRUGINCH 1S/C17H12Cl2N6O4/c1-7(2)9-5-13(22-23-15(9)26)29-14-10(18)3-8(4-11(14)19)25-17(28)21-16(27)12(6-20)24-25/h3-5,7H,1-2H3,(H,23,26)(H,21,27,28) D03MYO DRUGINKE FDBYIYFVSAHJLY-UHFFFAOYSA-N D03MYO DRUGSMIL CC(C)C1=CC(=NNC1=O)OC2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C(=N3)C#N)Cl D03MYO HIGHSTAT Phase 2 D03PJU DRUG__ID D03PJU D03PJU DRUGTYPE Small molecular drug D03PJU DRUGINCH 1S/C24H30N2O3/c1-3-22(27)26(21-12-8-5-9-13-21)24(23(28)29-2)15-18-25(19-16-24)17-14-20-10-6-4-7-11-20/h4-13H,3,14-19H2,1-2H3 D03PJU DRUGINKE YDSDEBIZUNNPOB-UHFFFAOYSA-N D03PJU DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC D03PJU HIGHSTAT Phase 2 D03QHC DRUG__ID D03QHC D03QHC DRUGCOMP Novartis pharmaceuticals D03QHC DRUGINCH 1S/C22H23F2N5O/c1-22(2)21-27-19(14-3-5-15(23)6-4-14)20(26-17-9-7-16(24)8-10-17)28(21)11-12-29(22)18(30)13-25/h3-10,26H,11-13,25H2,1-2H3 D03QHC DRUGINKE BUPRVECGWBHCQV-UHFFFAOYSA-N D03QHC DRUGSMIL CC1(C2=NC(=C(N2CCN1C(=O)CN)NC3=CC=C(C=C3)F)C4=CC=C(C=C4)F)C D03QHC HIGHSTAT Phase 2 D03QSS DRUG__ID D03QSS D03QSS DRUGCOMP Amylyx Pharmaceuticals Cambridge, MA D03QSS DRUGINCH 1S/C26H45NO6S.C10H12O2.Na/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29;11-10(12)8-4-7-9-5-2-1-3-6-9;/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33);1-3,5-6H,4,7-8H2,(H,11,12);/q;;+1/p-1/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-;;/m1../s1 D03QSS DRUGINKE ZVXSXYADBOYXRM-GUBAPICVSA-M D03QSS DRUGSMIL CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C.C1=CC=C(C=C1)CCCC(=O)[O-].[Na+] D03QSS HIGHSTAT Phase 2 D03RDS DRUG__ID D03RDS D03RDS DRUGCOMP Immunomedics Morris Plains, NJ D03RDS DRUGINCH 1S/C75H102N12O24S/c1-3-54-55-36-53(88)15-16-60(55)82-67-56(54)42-86-62(67)37-58-57(70(86)94)44-109-73(98)75(58,4-2)111-74(99)110-43-49-9-13-51(14-10-49)80-69(93)61(6-5-17-76)81-65(90)46-108-45-64(89)78-18-20-100-22-24-102-26-28-104-30-32-106-34-35-107-33-31-105-29-27-103-25-23-101-21-19-85-41-52(83-84-85)39-79-68(92)50-11-7-48(8-12-50)40-87-66(91)38-63(71(87)95)112-47-59(77)72(96)97/h9-10,13-16,36-37,41,48,50,59,61,63,88H,3-8,11-12,17-35,38-40,42-47,76-77H2,1-2H3,(H,78,89)(H,79,92)(H,80,93)(H,81,90)(H,96,97)/t48?,50?,59-,61-,63?,75-/m0/s1 D03RDS DRUGINKE CBNAAKBWBABMBY-LQCKLLCCSA-N D03RDS DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)OC(=O)OCC5=CC=C(C=C5)NC(=O)C(CCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN6C=C(N=N6)CNC(=O)C7CCC(CC7)CN8C(=O)CC(C8=O)SCC(C(=O)O)N)C2=NC9=C1C=C(C=C9)O D03RDS HIGHSTAT Phase 2 D03RIO DRUG__ID D03RIO D03RIO DRUGCOMP GSK D03RIO DRUGINCH 1S/C22H23F4N5OS/c1-13-18(32-12-27-13)19-28-29-20(30(19)2)33-7-3-6-31-10-15-9-21(15,11-31)16-5-4-14(8-17(16)23)22(24,25)26/h4-5,8,12,15H,3,6-7,9-11H2,1-2H3 D03RIO DRUGINKE ZKRWPAYTJMRKLJ-UHFFFAOYSA-N D03RIO DRUGSMIL CC1=C(OC=N1)C2=NN=C(N2C)SCCCN3CC4CC4(C3)C5=C(C=C(C=C5)C(F)(F)F)F D03RIO HIGHSTAT Phase 2 D03SHD DRUG__ID D03SHD D03SHD DRUGTYPE Small molecular drug D03SHD DRUGINCH 1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H D03SHD DRUGINKE CDAISMWEOUEBRE-UHFFFAOYSA-N D03SHD DRUGSMIL C1(C(C(C(C(C1O)O)O)O)O)O D03SHD HIGHSTAT Phase 2 D03SQT DRUG__ID D03SQT D03SQT DRUGCOMP Qurient, Gyeonggi-do, South Korea D03SQT DRUGINCH 1S/C29H28ClF3N4O2/c1-2-25-27(37-18-22(30)7-12-26(37)35-25)28(38)34-17-19-3-8-23(9-4-19)36-15-13-21(14-16-36)20-5-10-24(11-6-20)39-29(31,32)33/h3-12,18,21H,2,13-17H2,1H3,(H,34,38) D03SQT DRUGINKE OJICYBSWSZGRFB-UHFFFAOYSA-N D03SQT DRUGSMIL CCC1=C(N2C=C(C=CC2=N1)Cl)C(=O)NCC3=CC=C(C=C3)N4CCC(CC4)C5=CC=C(C=C5)OC(F)(F)F D03SQT HIGHSTAT Phase 2 D03SUQ DRUG__ID D03SUQ D03SUQ DRUGCOMP LAM Therapeutics Guilford, CT D03SUQ DRUGINCH 1S/C23H26N6O2.2CH4O3S/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20;2*1-5(2,3)4/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28);2*1H3,(H,2,3,4)/b25-17+;; D03SUQ DRUGINKE GAJWNIKZLYZYSY-OKUPSQOASA-N D03SUQ DRUGSMIL CC1=CC(=CC=C1)C=NNC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4.CS(=O)(=O)O.CS(=O)(=O)O D03SUQ HIGHSTAT Phase 2 D03UVL DRUG__ID D03UVL D03UVL DRUGTYPE Small molecular drug D03UVL DRUGINCH 1S/C42H52N4O7S.ClH/c1-27(2)45(5)42(48)38(20-30-10-12-31(13-11-30)25-46-28(3)8-7-9-29(46)4)43-41(47)24-37(34-16-19-39-40(23-34)53-26-52-39)44-54(49,50)36-18-15-32-21-35(51-6)17-14-33(32)22-36;/h10-19,21-23,27-29,37-38,44H,7-9,20,24-26H2,1-6H3,(H,43,47);1H/t28-,29+,37-,38-;/m1./s1 D03UVL DRUGINKE GLHHFOSVBQQNAW-GDYXXZBVSA-N D03UVL DRUGSMIL CC1CCCC(N1CC2=CC=C(C=C2)CC(C(=O)N(C)C(C)C)NC(=O)CC(C3=CC4=C(C=C3)OCO4)NS(=O)(=O)C5=CC6=C(C=C5)C=C(C=C6)OC)C.Cl D03UVL HIGHSTAT Phase 2 D03VYZ DRUG__ID D03VYZ D03VYZ DRUGCOMP Morria Biopharmaceuticals plc D03VYZ DRUGINCH 1S/C20H18F3N4O8P/c1-11(28)35-36(31,32)27(16-4-7-33-24-16)10-13-9-26(20(30)34-13)15-8-14(21)19(18(23)17(15)22)25-5-2-12(29)3-6-25/h2,4-5,7-8,13H,3,6,9-10H2,1H3,(H,31,32)/t13-/m1/s1 D03VYZ DRUGINKE YCRAGJLWFBGKFE-CYBMUJFWSA-N D03VYZ DRUGSMIL CC(=O)OP(=O)(N(CC1CN(C(=O)O1)C2=CC(=C(C(=C2F)F)N3CCC(=O)C=C3)F)C4=NOC=C4)O D03VYZ HIGHSTAT Phase 2 D03WAT DRUG__ID D03WAT D03WAT DRUGCOMP Pronova biopharma D03WAT DRUGINCH 1S/C24H38O3/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-27-23(4-2)24(25)26/h5-6,8-9,11-12,14-15,17-18,23H,3-4,7,10,13,16,19-22H2,1-2H3,(H,25,26)/b6-5-,9-8-,12-11-,15-14-,18-17- D03WAT DRUGINKE VOGXDRFFBBLZBT-AAQCHOMXSA-N D03WAT DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O D03WAT HIGHSTAT Phase 2 D03XAO DRUG__ID D03XAO D03XAO DRUGCOMP NuvOx Pharma Tucson, AZ D03XAO DRUGINCH 1S/C5F12/c6-1(7,2(8,9)4(12,13)14)3(10,11)5(15,16)17 D03XAO DRUGINKE NJCBUSHGCBERSK-UHFFFAOYSA-N D03XAO DRUGSMIL C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F D03XAO HIGHSTAT Phase 2 D03YAS DRUG__ID D03YAS D03YAS DRUGTYPE Small molecular drug D03YAS DRUGINCH 1S/C23H32O6S/c1-29-15-17-5-2-4-16(12-17)13-18(24)7-8-19-20(22(26)14-21(19)25)9-11-30-10-3-6-23(27)28/h2,4-5,7-8,12,18-21,24-25H,3,6,9-11,13-15H2,1H3,(H,27,28)/b8-7+/t18-,19-,20-,21-/m1/s1 D03YAS DRUGINKE ORSJUPRAHPZYRL-XHTUOEPPSA-N D03YAS DRUGSMIL COCC1=CC=CC(=C1)CC(C=CC2C(CC(=O)C2CCSCCCC(=O)O)O)O D03YAS HIGHSTAT Phase 2 D03YXI DRUG__ID D03YXI D03YXI DRUGTYPE Small molecular drug D03YXI DRUGINCH 1S/C10H12N2O3/c13-9(14)4-2-6-12-10(15)8-3-1-5-11-7-8/h1,3,5,7H,2,4,6H2,(H,12,15)(H,13,14) D03YXI DRUGINKE NAJVRARAUNYNDX-UHFFFAOYSA-N D03YXI DRUGSMIL C1=CC(=CN=C1)C(=O)NCCCC(=O)O D03YXI HIGHSTAT Phase 2 D03ZIS DRUG__ID D03ZIS D03ZIS DRUGTYPE Small molecular drug D03ZIS DRUGINCH 1S/C7H15Cl2N2O4P/c8-2-4-11(5-3-9)16(13)10-7(15-12)1-6-14-16/h7,12H,1-6H2,(H,10,13)/t7-,16-/m1/s1 D03ZIS DRUGINKE VPAWVRUHMJVRHU-VGDKGRGNSA-N D03ZIS DRUGSMIL C1COP(=O)(NC1OO)N(CCCl)CCCl D03ZIS HIGHSTAT Phase 2 D03ZLR DRUG__ID D03ZLR D03ZLR DRUGCOMP Allergan Parsippany, NJ D03ZLR DRUGINCH 1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1 D03ZLR DRUGINKE DVBUEXCIEIAXPM-PJUQSVSOSA-N D03ZLR DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)N2CCCC2(CC3=CC=CC=C3)C(=O)NC(C(C)O)C(=O)N)N)O D03ZLR HIGHSTAT Phase 2 D04BFU DRUG__ID D04BFU D04BFU DRUGTYPE Small molecular drug D04BFU DRUGINCH 1S/C18H11F3N2O2S/c19-11-6-12(20)18-17(16(11)21)22-14(26-18)5-9-7-23(8-15(24)25)13-4-2-1-3-10(9)13/h1-4,6-7H,5,8H2,(H,24,25) D04BFU DRUGINKE KYHVTMFADJNSGS-UHFFFAOYSA-N D04BFU DRUGSMIL C1=CC=C2C(=C1)C(=CN2CC(=O)O)CC3=NC4=C(C(=CC(=C4S3)F)F)F D04BFU HIGHSTAT Phase 2 D04BKO DRUG__ID D04BKO D04BKO DRUGCOMP Milestone Pharmaceuticals Quebec, Canada D04BKO DRUGINCH 1S/C27H36N2O4/c1-20(2)27(19-28,23-11-12-24(31-4)25(18-23)32-5)14-8-15-29(3)16-13-21-9-7-10-22(17-21)26(30)33-6/h7,9-12,17-18,20H,8,13-16H2,1-6H3/t27-/m0/s1 D04BKO DRUGINKE VAZNEHLGJGSQEL-MHZLTWQESA-N D04BKO DRUGSMIL CC(C)C(CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC D04BKO HIGHSTAT Phase 2 D04CLM DRUG__ID D04CLM D04CLM DRUGTYPE Small molecular drug D04CLM DRUGINCH 1S/C26H32FN3O4/c1-33-23-14-19-9-12-30(17-21(19)15-24(23)34-2)26(32)20-4-3-11-29(16-20)13-10-28-25(31)18-5-7-22(27)8-6-18/h5-8,14-15,20H,3-4,9-13,16-17H2,1-2H3,(H,28,31)/t20-/m1/s1 D04CLM DRUGINKE MWLKUSHZNSYRKK-HXUWFJFHSA-N D04CLM DRUGSMIL COC1=C(C=C2CN(CCC2=C1)C(=O)C3CCCN(C3)CCNC(=O)C4=CC=C(C=C4)F)OC D04CLM HIGHSTAT Phase 2 D04EIF DRUG__ID D04EIF D04EIF DRUGTYPE Small molecular drug D04EIF DRUGINCH 1S/C13H17N5O6/c1-2-3-17-6-9(15-12(14)16-10(6)22)18(13(17)23)11-8(21)7(20)5(4-19)24-11/h2,5,7-8,11,19-21H,1,3-4H2,(H3,14,15,16,22)/t5-,7-,8-,11-/m1/s1 D04EIF DRUGINKE VDCRFBBZFHHYGT-IOSLPCCCSA-N D04EIF DRUGSMIL C=CCN1C2=C(N=C(NC2=O)N)N(C1=O)C3C(C(C(O3)CO)O)O D04EIF HIGHSTAT Phase 2 D04EMB DRUG__ID D04EMB D04EMB DRUGCOMP Ironwood Pharmaceuticals Cambridge, MA D04EMB DRUGINCH 1S/C21H14F8N6O2/c22-12-4-2-1-3-11(12)9-35-16(14-5-6-37-34-14)7-15(33-35)18-30-8-13(23)17(32-18)31-10-19(36,20(24,25)26)21(27,28)29/h1-8,36H,9-10H2,(H,30,31,32) D04EMB DRUGINKE CYSJNTQNMDWAJV-UHFFFAOYSA-N D04EMB DRUGSMIL C1=CC=C(C(=C1)CN2C(=CC(=N2)C3=NC=C(C(=N3)NCC(C(F)(F)F)(C(F)(F)F)O)F)C4=NOC=C4)F D04EMB HIGHSTAT Phase 2 D04GEI DRUG__ID D04GEI D04GEI DRUGCOMP Takeda D04GEI DRUGINCH 1S/C58H80N16O14/c1-30(2)22-42(51(82)66-40(16-11-21-63-57(61)62-5)50(81)67-41(49(60)80)25-35-28-64-39-15-10-9-14-38(35)39)70-58(88)73-72-53(84)43(23-33-12-7-6-8-13-33)69-55(86)48(31(3)75)71-52(83)44(27-47(59)79)68-54(85)46-26-37(78)29-74(46)56(87)45(65-32(4)76)24-34-17-19-36(77)20-18-34/h6-10,12-15,17-20,28,30-31,37,40-46,48,64,75,77-78H,11,16,21-27,29H2,1-5H3,(H2,59,79)(H2,60,80)(H,65,76)(H,66,82)(H,67,81)(H,68,85)(H,69,86)(H,71,83)(H,72,84)(H3,61,62,63)(H2,70,73,88)/t31-,37-,40+,41+,42+,43+,44+,45-,46+,48+/m1/s1 D04GEI DRUGINKE MWXWMWSUUYXMRA-GRKBUMBKSA-N D04GEI DRUGSMIL CC(C)CC(C(=O)NC(CCCNC(=NC)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N)NC(=O)NNC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C4CC(CN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C)O D04GEI HIGHSTAT Phase 2 D04GKL DRUG__ID D04GKL D04GKL DRUGTYPE Small molecular drug D04GKL DRUGINCH 1S/C15H18O5/c1-7-8(2)15-12(5-11(20-15)6-13(17)18)9(3)14(7)19-10(4)16/h11H,5-6H2,1-4H3,(H,17,18) D04GKL DRUGINKE QLWBKUUORSULMI-UHFFFAOYSA-N D04GKL DRUGSMIL CC1=C(C(=C(C2=C1OC(C2)CC(=O)O)C)OC(=O)C)C D04GKL HIGHSTAT Phase 2 D04GLJ DRUG__ID D04GLJ D04GLJ DRUGTYPE Small molecular drug D04GLJ DRUGINCH 1S/C22H27FN2O2/c1-27-17-22(26)25(21-10-6-5-9-20(21)23)19-12-15-24(16-13-19)14-11-18-7-3-2-4-8-18/h2-10,19H,11-17H2,1H3 D04GLJ DRUGINKE NYISTOZKVCMVEL-UHFFFAOYSA-N D04GLJ DRUGSMIL COCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3F D04GLJ HIGHSTAT Phase 2 D04GMY DRUG__ID D04GMY D04GMY DRUGTYPE Small molecular drug D04GMY DRUGINCH 1S/C25H36N4O5S/c1-16(2)29-23-8-6-5-7-17(23)11-22(25(29)32)24(31)26-18-12-19-9-10-20(13-18)28(19)15-21(30)14-27(3)35(4,33)34/h5-8,11,16,18-21,30H,9-10,12-15H2,1-4H3,(H,26,31)/t18?,19-,20+,21-/m0/s1 D04GMY DRUGINKE HXLOHDZQBKCUCR-VTHDOGFWSA-N D04GMY DRUGSMIL CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3CC4CCC(C3)N4CC(CN(C)S(=O)(=O)C)O D04GMY HIGHSTAT Phase 2 D04HAF DRUG__ID D04HAF D04HAF DRUGCOMP Hypnion D04HAF DRUGINCH 1S/C22H25N3O3/c1-22(2,21(26)27)15-24-11-13-25(14-12-24)20-16-7-3-5-9-18(16)28-19-10-6-4-8-17(19)23-20/h3-10H,11-15H2,1-2H3,(H,26,27) D04HAF DRUGINKE UEFWDVMEDFCHGW-UHFFFAOYSA-N D04HAF DRUGSMIL CC(C)(CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=CC=CC=C42)C(=O)O D04HAF HIGHSTAT Phase 2 D04HQC DRUG__ID D04HQC D04HQC DRUGCOMP Spring bank pharmaceuticals D04HQC DRUGINCH 1S/C25H34N7O13PS/c1-12(2)42-25(37)40-11-47-46(38,45-19-14(7-33)44-23(20(19)39-3)31-5-4-16(35)30-24(31)36)41-8-15-13(34)6-17(43-15)32-10-29-18-21(26)27-9-28-22(18)32/h4-5,9-10,12-15,17,19-20,23,33-34H,6-8,11H2,1-3H3,(H2,26,27,28)(H,30,35,36)/t13-,14+,15+,17+,19+,20+,23+,46?/m0/s1 D04HQC DRUGINKE CJCYTUJOSMYXLE-JDLSZIHUSA-N D04HQC DRUGSMIL CC(C)OC(=O)OCSP(=O)(OCC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)O)OC4C(OC(C4OC)N5C=CC(=O)NC5=O)CO D04HQC HIGHSTAT Phase 2 D04HQT DRUG__ID D04HQT D04HQT DRUGTYPE Small molecular drug D04HQT DRUGINCH 1S/C18H26N2O4/c1-3-12-20(13-4-2)18(24)15(10-11-16(21)22)19-17(23)14-8-6-5-7-9-14/h5-9,15H,3-4,10-13H2,1-2H3,(H,19,23)(H,21,22) D04HQT DRUGINKE DGMKFQYCZXERLX-UHFFFAOYSA-N D04HQT DRUGSMIL CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1 D04HQT HIGHSTAT Phase 2 D04IIU DRUG__ID D04IIU D04IIU DRUGTYPE Small molecular drug D04IIU DRUGINCH 1S/C14H12ClN3O4S2/c15-12-8-17-14-11(12)2-1-3-13(14)18-24(21,22)10-6-4-9(5-7-10)23(16,19)20/h1-8,17-18H,(H2,16,19,20) D04IIU DRUGINKE SETFNECMODOHTO-UHFFFAOYSA-N D04IIU DRUGSMIL C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(C=C3)S(=O)(=O)N)NC=C2Cl D04IIU HIGHSTAT Phase 2 D04KHY DRUG__ID D04KHY D04KHY DRUGTYPE Small molecular drug D04KHY DRUGINCH 1S/C21H26Cl2N2O4/c22-15-11-14(12-16(23)13-15)19(28)24-17(3-4-18(26)27)20(29)25-9-7-21(8-10-25)5-1-2-6-21/h11-13,17H,1-10H2,(H,24,28)(H,26,27)/t17-/m1/s1 D04KHY DRUGINKE FJCZHMXAGBYXHJ-QGZVFWFLSA-N D04KHY DRUGSMIL C1CCC2(C1)CCN(CC2)C(=O)C(CCC(=O)O)NC(=O)C3=CC(=CC(=C3)Cl)Cl D04KHY HIGHSTAT Phase 2 D04LOR DRUG__ID D04LOR D04LOR DRUGCOMP Bristol-myers squibb D04LOR DRUGINCH 1S/C25H20N6O2S/c26-34(32,33)20-13-18(14-27-16-20)24-30-22-11-6-10-21(17-7-2-1-3-8-17)23(22)25(31-24)29-15-19-9-4-5-12-28-19/h1-14,16H,15H2,(H2,26,32,33)(H,29,30,31) D04LOR DRUGINKE XGKULQQVQWCASY-UHFFFAOYSA-N D04LOR DRUGSMIL C1=CC=C(C=C1)C2=C3C(=CC=C2)N=C(N=C3NCC4=CC=CC=N4)C5=CC(=CN=C5)S(=O)(=O)N D04LOR HIGHSTAT Phase 2 D04LTF DRUG__ID D04LTF D04LTF DRUGTYPE Small molecular drug D04LTF DRUGINCH 1S/C28H34N2O4/c1-18(2)8-5-9-19(3)10-6-11-20(4)14-15-30-23-16-21(31)17-25(33)27(23)29-26-22(28(30)34)12-7-13-24(26)32/h7-8,10,12-14,16-17,29,31-33H,5-6,9,11,15H2,1-4H3/b19-10+,20-14+ D04LTF DRUGINKE SALVHVNECODMJP-GNUCVDFRSA-N D04LTF DRUGSMIL CC(=CCCC(=CCCC(=CCN1C2=C(C(=CC(=C2)O)O)NC3=C(C1=O)C=CC=C3O)C)C)C D04LTF HIGHSTAT Phase 2 D04OTY DRUG__ID D04OTY D04OTY DRUGCOMP Novartis AG D04OTY DRUGINCH 1S/C23H16F3N3O3/c24-23(25,26)15-4-2-5-16(10-15)29-22(31)20-6-1-3-14-9-18(7-8-19(14)20)32-21-11-17(12-30)27-13-28-21/h1-11,13,30H,12H2,(H,29,31) D04OTY DRUGINKE JNLSTLQFDDAULK-UHFFFAOYSA-N D04OTY DRUGSMIL C1=CC(=CC(=C1)NC(=O)C2=CC=CC3=C2C=CC(=C3)OC4=NC=NC(=C4)CO)C(F)(F)F D04OTY HIGHSTAT Phase 2 D04QYS DRUG__ID D04QYS D04QYS DRUGCOMP Creabilis Therapeutics Canterbury, United Kingdom D04QYS DRUGINCH 1S/C32H28N4O7/c1-31-32(29(38)34(30(39)43-32)11-12-41-14-13-40-2)15-22(42-31)35-20-9-5-3-7-17(20)24-25-19(16-33-28(25)37)23-18-8-4-6-10-21(18)36(31)27(23)26(24)35/h3-10,22H,11-16H2,1-2H3,(H,33,37) D04QYS DRUGINKE MTDVEOMKVDOULD-UHFFFAOYSA-N D04QYS DRUGSMIL CC12C3(CC(O1)N4C5=CC=CC=C5C6=C7C(=C8C9=CC=CC=C9N2C8=C64)CNC7=O)C(=O)N(C(=O)O3)CCOCCOC D04QYS HIGHSTAT Phase 2 D04SPJ DRUG__ID D04SPJ D04SPJ DRUGCOMP Astrazeneca D04SPJ DRUGINCH 1S/C27H30FN5O3/c1-17-21(28)15-18(25(34)31-19-7-8-19)16-22(17)33-13-11-30-24(26(33)35)32-27(9-10-27)20-5-3-4-6-23(20)36-14-12-29-2/h3-6,11,13,15-16,19,29H,7-10,12,14H2,1-2H3,(H,30,32)(H,31,34) D04SPJ DRUGINKE NNKPHNTWNILINE-UHFFFAOYSA-N D04SPJ DRUGSMIL CC1=C(C=C(C=C1F)C(=O)NC2CC2)N3C=CN=C(C3=O)NC4(CC4)C5=CC=CC=C5OCCNC D04SPJ HIGHSTAT Phase 2 D04SXL DRUG__ID D04SXL D04SXL DRUGCOMP Ascentage Pharma Rockville, MD D04SXL DRUGINCH 1S/C34H38Cl2FN3O4/c1-2-40-27(28(41)39-32-16-13-31(14-17-32,15-18-32)30(43)44)25(21-7-6-8-23(36)26(21)37)34(33(40)11-4-3-5-12-33)22-10-9-20(35)19-24(22)38-29(34)42/h6-10,19,25,27H,2-5,11-18H2,1H3,(H,38,42)(H,39,41)(H,43,44)/t25-,27+,31?,32?,34+/m0/s1 D04SXL DRUGINKE YJCZPJQGFSSFOL-MNZPCBJKSA-N D04SXL DRUGSMIL CCN1C(C(C2(C13CCCCC3)C4=C(C=C(C=C4)Cl)NC2=O)C5=C(C(=CC=C5)Cl)F)C(=O)NC67CCC(CC6)(CC7)C(=O)O D04SXL HIGHSTAT Phase 2 D04TBC DRUG__ID D04TBC D04TBC DRUGCOMP Medicines for Malaria Venture D04TBC DRUGINCH 1S/C28H39NO5/c1-3-26(31-14-11-29-9-12-30-13-10-29)4-2-22(1)23-5-7-27(8-6-23)32-28(34-33-27)24-16-20-15-21(18-24)19-25(28)17-20/h1-4,20-21,23-25H,5-19H2 D04TBC DRUGINKE XLCNVWUKICLURR-UHFFFAOYSA-N D04TBC DRUGSMIL C1CC2(CCC1C3=CC=C(C=C3)OCCN4CCOCC4)OC5(C6CC7CC(C6)CC5C7)OO2 D04TBC HIGHSTAT Phase 2 D04TNT DRUG__ID D04TNT D04TNT DRUGTYPE Small molecular drug D04TNT DRUGINCH 1S/C20H20ClF2N3O3S/c21-15-11-17(23)19(30(28,29)24-18-6-2-1-5-16(18)22)10-14(15)20(27)26-9-8-25-7-3-4-13(25)12-26/h1-2,5-6,10-11,13,24H,3-4,7-9,12H2/t13-/m1/s1 D04TNT DRUGINKE AGPIHNZOZNKRGT-CYBMUJFWSA-N D04TNT DRUGSMIL C1CC2CN(CCN2C1)C(=O)C3=CC(=C(C=C3Cl)F)S(=O)(=O)NC4=CC=CC=C4F D04TNT HIGHSTAT Phase 2 D04VBF DRUG__ID D04VBF D04VBF DRUGCOMP Janssen research & development D04VBF DRUGINCH 1S/C23H32N6/c1-15-12-16(2)21-20(13-15)27-22(28-21)19-14-25-23(26-17(19)3)24-9-5-6-18-7-10-29(4)11-8-18/h12-14,18H,5-11H2,1-4H3,(H,27,28)(H,24,25,26) D04VBF DRUGINKE FCRFVPZAXGJLPW-UHFFFAOYSA-N D04VBF DRUGSMIL CC1=CC(=C2C(=C1)NC(=N2)C3=CN=C(N=C3C)NCCCC4CCN(CC4)C)C D04VBF HIGHSTAT Phase 2 D04WMR DRUG__ID D04WMR D04WMR DRUGTYPE Small molecular drug D04WMR DRUGINCH 1S/C20H20ClN3O3/c1-23(26)20(25)12-7-16-13-19(14-3-5-15(21)6-4-14)24(22-16)17-8-10-18(27-2)11-9-17/h3-6,8-11,13,26H,7,12H2,1-2H3 D04WMR DRUGINKE XYKWNRUXCOIMFZ-UHFFFAOYSA-N D04WMR DRUGSMIL CN(C(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)OC)O D04WMR HIGHSTAT Phase 2 D04XCO DRUG__ID D04XCO D04XCO DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D04XCO DRUGINCH 1S/C29H43N7O5/c1-3-4-16-41-28-32-26(30)25-27(33-28)36(29(38)31-25)13-7-12-35(11-6-10-34-14-17-40-18-15-34)21-23-9-5-8-22(19-23)20-24(37)39-2/h5,8-9,19H,3-4,6-7,10-18,20-21H2,1-2H3,(H,31,38)(H2,30,32,33) D04XCO DRUGINKE FEFIBEHSXLKJGI-UHFFFAOYSA-N D04XCO DRUGSMIL CCCCOC1=NC(=C2C(=N1)N(C(=O)N2)CCCN(CCCN3CCOCC3)CC4=CC=CC(=C4)CC(=O)OC)N D04XCO HIGHSTAT Phase 2 D04XVJ DRUG__ID D04XVJ D04XVJ DRUGCOMP LEO Pharma A/S D04XVJ DRUGINCH 1S/C20H22Cl2N2O5/c1-4-7-24-18(26)11-29-19-12(5-6-17(27-2)20(19)28-3)16(25)8-13-14(21)9-23-10-15(13)22/h5-6,9-10H,4,7-8,11H2,1-3H3,(H,24,26) D04XVJ DRUGINKE HOKIHKLKOZWCRY-UHFFFAOYSA-N D04XVJ DRUGSMIL CCCNC(=O)COC1=C(C=CC(=C1OC)OC)C(=O)CC2=C(C=NC=C2Cl)Cl D04XVJ HIGHSTAT Phase 2 D04YAJ DRUG__ID D04YAJ D04YAJ DRUGTYPE Small molecular drug D04YAJ DRUGINCH 1S/C17H24N6O4/c1-2-18-16(26)13-11(24)12(25)17(27-13)23-8-21-10-14(19-7-20-15(10)23)22-9-5-3-4-6-9/h7-9,11-13,17,24-25H,2-6H2,1H3,(H,18,26)(H,19,20,22)/t11-,12+,13-,17+/m0/s1 D04YAJ DRUGINKE GWVQGVCXFNYGFP-PFHKOEEOSA-N D04YAJ DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NC4CCCC4)O)O D04YAJ HIGHSTAT Phase 2 D04ZND DRUG__ID D04ZND D04ZND DRUGCOMP Ipsen D04ZND DRUGINCH 1S/C18H25NO4S/c1-18-9-8-14-13-5-3-12(23-24(19,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,20H,2,4,6-9H2,1H3,(H2,19,21,22)/t14-,15-,16+,17+,18+/m1/s1 D04ZND DRUGINKE YXYXCSOJKUAPJI-ZBRFXRBCSA-N D04ZND DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OS(=O)(=O)N D04ZND HIGHSTAT Phase 2 D04ZQO DRUG__ID D04ZQO D04ZQO DRUGCOMP Taigen biotechnology D04ZQO DRUGINCH 1S/C47H56N6O10S/c1-28(2)60-32-21-19-29(20-22-32)40-49-38-34-16-11-12-18-37(34)63-39(38)42(50-40)61-33-25-36-41(54)51-47(44(56)52-64(58,59)46(3)23-24-46)26-30(47)13-7-5-4-6-8-17-35(43(55)53(36)27-33)48-45(57)62-31-14-9-10-15-31/h7,11-13,16,18-22,28,30-31,33,35-36H,4-6,8-10,14-15,17,23-27H2,1-3H3,(H,48,57)(H,51,54)(H,52,56)/b13-7-/t30-,33-,35+,36+,47-/m1/s1 D04ZQO DRUGINKE GZRNOYTVBWWFLJ-NTPALUMKSA-N D04ZQO DRUGSMIL CC(C)OC1=CC=C(C=C1)C2=NC3=C(C(=N2)OC4CC5C(=O)NC6(CC6C=CCCCCCC(C(=O)N5C4)NC(=O)OC7CCCC7)C(=O)NS(=O)(=O)C8(CC8)C)OC9=CC=CC=C93 D04ZQO HIGHSTAT Phase 2 D05BPC DRUG__ID D05BPC D05BPC DRUGCOMP Proteo Biotech AG D05BPC DRUGINCH 1S/C254H416N72O75S10/c1-28-129(17)195-239(387)288-142(60-38-43-85-258)208(356)283-141(59-37-42-84-257)210(358)306-168-120-407-406-119-167-228(376)294-152(99-123(5)6)215(363)284-140(58-36-41-83-256)209(357)296-158(106-191(347)348)221(369)317-200(137(25)331)244(392)299-157(105-190(345)346)218(366)308-169(248(396)321-91-49-65-172(321)231(379)274-110-186(339)310-195)121-410-408-117-165(227(375)295-155(102-138-55-33-32-34-56-138)220(368)313-194(128(15)16)251(399)325-95-53-68-175(325)232(380)292-151(252(400)401)73-77-180(262)333)302-203(351)135(23)276-207(355)147(80-97-402-26)278-183(336)107-272-206(354)163-115-404-405-116-164(225(373)277-134(22)202(350)282-148(81-98-403-27)214(362)293-153(100-124(7)8)216(364)300-159(104-182(264)335)247(395)326-96-54-71-178(326)250(398)324-94-52-67-174(324)233(381)297-156(103-181(263)334)217(365)285-143(211(359)305-167)62-45-87-269-253(265)266)304-212(360)144(63-46-88-270-254(267)268)289-240(388)196(130(18)29-2)314-219(367)154(101-125(9)10)298-241(389)197(131(19)30-3)316-242(390)198(132(20)31-4)315-236(384)177-70-51-93-323(177)249(397)170(122-411-409-118-166(307-229(168)377)226(374)286-145(74-78-188(341)342)205(353)271-108-184(337)279-160(112-327)222(370)303-163)309-223(371)161(113-328)280-185(338)109-273-230(378)171-64-48-90-320(171)245(393)149(61-39-44-86-259)291-243(391)199(136(24)330)318-224(372)162(114-329)301-238(386)193(127(13)14)311-234(382)173-66-47-89-319(173)187(340)111-275-204(352)139(57-35-40-82-255)287-237(385)192(126(11)12)312-235(383)176-69-50-92-322(176)246(394)150(75-79-189(343)344)290-213(361)146(72-76-179(261)332)281-201(349)133(21)260/h32-34,55-56,123-137,139-178,192-200,327-331H,28-31,35-54,57-122,255-260H2,1-27H3,(H2,261,332)(H2,262,333)(H2,263,334)(H2,264,335)(H,271,353)(H,272,354)(H,273,378)(H,274,379)(H,275,352)(H,276,355)(H,277,373)(H,278,336)(H,279,337)(H,280,338)(H,281,349)(H,282,350)(H,283,356)(H,284,363)(H,285,365)(H,286,374)(H,287,385)(H,288,387)(H,289,388)(H,290,361)(H,291,391)(H,292,380)(H,293,362)(H,294,376)(H,295,375)(H,296,357)(H,297,381)(H,298,389)(H,299,392)(H,300,364)(H,301,386)(H,302,351)(H,303,370)(H,304,360)(H,305,359)(H,306,358)(H,307,377)(H,308,366)(H,309,371)(H,310,339)(H,311,382)(H,312,383)(H,313,368)(H,314,367)(H,315,384)(H,316,390)(H,317,369)(H,318,372)(H,341,342)(H,343,344)(H,345,346)(H,347,348)(H,400,401)(H4,265,266,269)(H4,267,268,270)/t129-,130-,131-,132-,133-,134-,135-,136+,137+,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,192-,193-,194-,195-,196-,197-,198-,199-,200-/m0/s1 D05BPC DRUGINKE MDCUNMLZLNGCQA-HWOAGHQOSA-N D05BPC DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C4CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(C(=O)NC(C(=O)N3)CCCNC(=N)N)CC(=O)N)CC(=O)N)CC(C)C)CCSC)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C7CCCN7C(=O)C(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N4)CO)CCC(=O)O)NC2=O)NC(=O)C(CO)NC(=O)CNC(=O)C8CCCN8C(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C9CCCN9C(=O)CNC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)N)C(C)CC)C(C)CC)CC(C)C)C(C)CC)CCCNC(=N)N)CCSC)C)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(CCC(=O)N)C(=O)O)C(=O)N2CCCC2C(=O)NCC(=O)N1)CC(=O)O)C(C)O)CC(=O)O)CCCCN)CC(C)C)CCCCN)CCCCN D05BPC HIGHSTAT Phase 2 D05CMZ DRUG__ID D05CMZ D05CMZ DRUGCOMP Ono Pharmaceutical Co Ltd D05CMZ DRUGINCH 1S/C22H20ClFN2O2/c1-12(27)26-11-22(8-9-22)19-18-15(24)4-3-5-16(18)25-20(19)21(26)14-7-6-13(23)10-17(14)28-2/h3-7,10,21,25H,8-9,11H2,1-2H3/t21-/m0/s1 D05CMZ DRUGINKE ZBQMTQGDBFZUBG-NRFANRHFSA-N D05CMZ DRUGSMIL CC(=O)N1CC2(CC2)C3=C(C1C4=C(C=C(C=C4)Cl)OC)NC5=C3C(=CC=C5)F D05CMZ HIGHSTAT Phase 2 D05EUR DRUG__ID D05EUR D05EUR DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D05EUR DRUGINCH 1S/C29H25F4N3O5S/c30-21-9-15(27(37)38)10-23-25(21)34-28(42-23)36-16-7-8-17(36)12-18(11-16)39-13-20-24(35-41-26(20)14-5-6-14)19-3-1-2-4-22(19)40-29(31,32)33/h1-4,9-10,14,16-18H,5-8,11-13H2,(H,37,38)/t16-,17+,18? D05EUR DRUGINKE VYLOOGHLKSNNEK-JWTNVVGKSA-N D05EUR DRUGSMIL C1CC1C2=C(C(=NO2)C3=CC=CC=C3OC(F)(F)F)COC4CC5CCC(C4)N5C6=NC7=C(C=C(C=C7S6)C(=O)O)F D05EUR HIGHSTAT Phase 2 D05FGR DRUG__ID D05FGR D05FGR DRUGTYPE Small molecular drug D05FGR DRUGINCH 1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)/t10-/m1/s1 D05FGR DRUGINKE SYTBZMRGLBWNTM-SNVBAGLBSA-N D05FGR DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O D05FGR HIGHSTAT Phase 2 D05GNW DRUG__ID D05GNW D05GNW DRUGCOMP AstraZeneca plc D05GNW DRUGINCH 1S/C29H38FN2O2/c1-29(25-8-4-2-5-9-25,31-17-6-3-7-18-31)28(33)34-27-22-32(20-15-24(27)16-21-32)19-14-23-10-12-26(30)13-11-23/h2,4-5,8-13,24,27H,3,6-7,14-22H2,1H3/q+1/t24?,27-,29-,32?/m0/s1 D05GNW DRUGINKE FNYFFCOCVNTJCD-NNMXADRKSA-N D05GNW DRUGSMIL CC(C1=CC=CC=C1)(C(=O)OC2C[N+]3(CCC2CC3)CCC4=CC=C(C=C4)F)N5CCCCC5 D05GNW HIGHSTAT Phase 2 D05GYL DRUG__ID D05GYL D05GYL DRUGCOMP Palau Pharma SA D05GYL DRUGINCH 1S/C13H17N5O/c1-15-7-5-18(6-7)12-11-10(16-13(14)17-12)8-3-2-4-9(8)19-11/h7,15H,2-6H2,1H3,(H2,14,16,17) D05GYL DRUGINKE WUSKTVHULHXVSO-UHFFFAOYSA-N D05GYL DRUGSMIL CNC1CN(C1)C2=NC(=NC3=C2OC4=C3CCC4)N D05GYL HIGHSTAT Phase 2 D05GYU DRUG__ID D05GYU D05GYU DRUGCOMP EpiThany Seattle, WA D05GYU DRUGINCH 1S/C16H24O4/c1-8-3-12-14(19-12)5-10(8)7-18-16(17)11-6-15-13(20-15)4-9(11)2/h8-15H,3-7H2,1-2H3 D05GYU DRUGINKE GRWFFFOEIHGUBG-UHFFFAOYSA-N D05GYU DRUGSMIL CC1CC2C(O2)CC1COC(=O)C3CC4C(O4)CC3C D05GYU HIGHSTAT Phase 2 D05HTS DRUG__ID D05HTS D05HTS DRUGCOMP Daiichi sankyo parsippany D05HTS DRUGINCH 1S/C25H21F3N6O3S/c26-16-5-6-34(12-16)38(36,37)33-20-4-3-19(27)21(22(20)28)23(35)18-11-32-25-17(18)7-14(8-31-25)15-9-29-24(30-10-15)13-1-2-13/h3-4,7-11,13,16,33H,1-2,5-6,12H2,(H,31,32)/t16-/m1/s1 D05HTS DRUGINKE YYACLQUDUDXAPA-MRXNPFEDSA-N D05HTS DRUGSMIL C1CC1C2=NC=C(C=N2)C3=CC4=C(NC=C4C(=O)C5=C(C=CC(=C5F)NS(=O)(=O)N6CCC(C6)F)F)N=C3 D05HTS HIGHSTAT Phase 2 D05HYT DRUG__ID D05HYT D05HYT DRUGTYPE Small molecular drug D05HYT DRUGINCH 1S/C24H30N4O.C4H4O4/c1-3-27(4-2)17-11-16-25-23(29)19-28-24(21-14-9-6-10-15-21)22(18-26-28)20-12-7-5-8-13-20;5-3(6)1-2-4(7)8/h5-10,12-15,18H,3-4,11,16-17,19H2,1-2H3,(H,25,29);1-2H,(H,5,6)(H,7,8)/b;2-1+ D05HYT DRUGINKE KKMOBFCMCCFTDX-WLHGVMLRSA-N D05HYT DRUGSMIL CCN(CC)CCCNC(=O)CN1C(=C(C=N1)C2=CC=CC=C2)C3=CC=CC=C3.C(=CC(=O)O)C(=O)O D05HYT HIGHSTAT Phase 2 D05KIV DRUG__ID D05KIV D05KIV DRUGCOMP Psyadon Pharmaceuticals Germantown, MD D05KIV DRUGINCH 1S/C19H20ClNO.ClH/c1-21-9-8-13-10-16(20)18(22)11-15(13)19-14-5-3-2-4-12(14)6-7-17(19)21;/h2-5,10-11,17,19,22H,6-9H2,1H3;1H/t17-,19+;/m0./s1 D05KIV DRUGINKE APFMVAHRFWBCDG-JUOYHRLASA-N D05KIV DRUGSMIL CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl.Cl D05KIV HIGHSTAT Phase 2 D05LGX DRUG__ID D05LGX D05LGX DRUGTYPE Small molecular drug D05LGX DRUGINCH 1S/C14H15FN2/c1-2-14(13-8-16-9-17-13)6-10-3-4-12(15)5-11(10)7-14/h3-5,8-9H,2,6-7H2,1H3,(H,16,17) D05LGX DRUGINKE KXSUAWAUCNFBQJ-UHFFFAOYSA-N D05LGX DRUGSMIL CCC1(CC2=C(C1)C=C(C=C2)F)C3=CN=CN3 D05LGX HIGHSTAT Phase 2 D05MOZ DRUG__ID D05MOZ D05MOZ DRUGCOMP GenSpera D05MOZ DRUGINCH 1S/C66H100N6O27/c1-8-10-11-17-20-24-51(81)96-55-53-52(37(4)54(55)97-62(91)36(3)9-2)56-66(94,65(7,93)63(92)98-56)44(35-64(53,6)99-38(5)73)95-50(80)23-21-18-15-13-12-14-16-19-22-33-68-48(77)34-39(67)57(82)72-43(61(89)90)27-31-47(76)70-41(59(85)86)25-29-45(74)69-40(58(83)84)26-30-46(75)71-42(60(87)88)28-32-49(78)79/h9,39-44,53-56,93-94H,8,10-35,67H2,1-7H3,(H,68,77)(H,69,74)(H,70,76)(H,71,75)(H,72,82)(H,78,79)(H,83,84)(H,85,86)(H,87,88)(H,89,90)/b36-9-/t39-,40-,41-,42-,43-,44-,53+,54-,55-,56-,64-,65+,66+/m0/s1 D05MOZ DRUGINKE UPYNTAIBQVNPIH-ODMLWHIESA-N D05MOZ DRUGSMIL CCCCCCCC(=O)OC1C2C(=C(C1OC(=O)C(=CC)C)C)C3C(C(CC2(C)OC(=O)C)OC(=O)CCCCCCCCCCCNC(=O)CC(C(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)N)(C(C(=O)O3)(C)O)O D05MOZ HIGHSTAT Phase 2 D05NDN DRUG__ID D05NDN D05NDN DRUGTYPE Small molecular drug D05NDN DRUGINCH 1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1 D05NDN DRUGINKE UXCAQJAQSWSNPQ-XLPZGREQSA-N D05NDN DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F D05NDN HIGHSTAT Phase 2 D05NZV DRUG__ID D05NZV D05NZV DRUGTYPE Small molecular drug D05NZV DRUGINCH 1S/C20H24ClNO4/c1-14(22-12-19(23)16-4-3-5-17(21)11-16)10-15-6-8-18(9-7-15)26-13-20(24)25-2/h3-9,11,14,19,22-23H,10,12-13H2,1-2H3 D05NZV DRUGINKE ZFLBZHXQAMUEFS-UHFFFAOYSA-N D05NZV DRUGSMIL CC(CC1=CC=C(C=C1)OCC(=O)OC)NCC(C2=CC(=CC=C2)Cl)O D05NZV HIGHSTAT Phase 2 D05PFS DRUG__ID D05PFS D05PFS DRUGCOMP Allergan Parsippany, NJ Lysomal Therapeutics Cambridge, MA D05PFS DRUGINCH 1S/C20H30N4O2/c1-4-5-6-11-26-17-9-7-16(8-10-17)23-20(25)18-13-21-24-15(3)12-14(2)22-19(18)24/h12-13,16-17H,4-11H2,1-3H3,(H,23,25) D05PFS DRUGINKE HZILSILAELSWKN-UHFFFAOYSA-N D05PFS DRUGSMIL CCCCCOC1CCC(CC1)NC(=O)C2=C3N=C(C=C(N3N=C2)C)C D05PFS HIGHSTAT Phase 2 D05QJT DRUG__ID D05QJT D05QJT DRUGTYPE Small molecular drug D05QJT DRUGINCH 1S/C8H17N3O2S/c1-6(9)11-3-5-14-4-2-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1 D05QJT DRUGINKE MOLOJNHYNHBPCW-ZETCQYMHSA-N D05QJT DRUGSMIL CC(=NCCSCCC(C(=O)O)N)N D05QJT HIGHSTAT Phase 2 D05QKO DRUG__ID D05QKO D05QKO DRUGCOMP Neurocrine Biosciences Inc D05QKO DRUGINCH 1S/C87H142N24O21/c1-15-47(10)67(82(127)105-66(46(8)9)81(126)108-69(51(14)113)84(129)110-35-23-29-60(110)77(122)97-54(28-21-33-94-87(91)92)72(117)107-68(50(13)112)85(130)111-36-24-31-62(111)86(131)132)106-76(121)59(40-63(90)114)99-71(116)49(12)96-73(118)57(38-52-25-17-16-18-26-52)101-74(119)56(37-43(2)3)100-75(120)58(39-53-41-93-42-95-53)102-79(124)64(44(4)5)104-80(125)65(45(6)7)103-78(123)61-30-22-34-109(61)83(128)55(27-19-20-32-88)98-70(115)48(11)89/h16-18,25-26,41-51,54-62,64-69,112-113H,15,19-24,27-40,88-89H2,1-14H3,(H2,90,114)(H,93,95)(H,96,118)(H,97,122)(H,98,115)(H,99,116)(H,100,120)(H,101,119)(H,102,124)(H,103,123)(H,104,125)(H,105,127)(H,106,121)(H,107,117)(H,108,126)(H,131,132)(H4,91,92,94)/t47?,48-,49+,50?,51?,54+,55+,56+,57+,58+,59+,60+,61+,62+,64+,65+,66+,67+,68+,69+/m1/s1 D05QKO DRUGINKE NITUEMISTORFON-OOMTWUQISA-N D05QKO DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(C)C)NC(=O)C(CC4=CN=CN4)NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C5CCCN5C(=O)C(CCCCN)NC(=O)C(C)N D05QKO HIGHSTAT Phase 2 D05RRA DRUG__ID D05RRA D05RRA DRUGCOMP HemaQuest Pharmaceuticals Inc; Vertex Pharmaceuticals Inc D05RRA DRUGINCH 1S/3C6H14N4O2.4C4H8O2/c3*7-4(5(11)12)2-1-3-10-6(8)9;4*1-2-3-4(5)6/h3*4H,1-3,7H2,(H,11,12)(H4,8,9,10);4*2-3H2,1H3,(H,5,6)/t3*4-;;;;/m000..../s1 D05RRA DRUGINKE ZVEMACCDKBQNGX-KALODSIISA-N D05RRA DRUGSMIL CCCC(=O)O.CCCC(=O)O.CCCC(=O)O.CCCC(=O)O.C(CC(C(=O)O)N)CN=C(N)N.C(CC(C(=O)O)N)CN=C(N)N.C(CC(C(=O)O)N)CN=C(N)N D05RRA HIGHSTAT Phase 2 D05RZE DRUG__ID D05RZE D05RZE DRUGCOMP Eli Lilly & Co D05RZE DRUGINCH 1S/C30H30FN5O3/c1-19(17-35-10-12-38-13-11-35)36-27-9-6-20(15-26(27)33-30(36)34-29(32)37)14-25-23-5-3-2-4-21(23)18-39-28-16-22(31)7-8-24(25)28/h2-9,14-16,19H,10-13,17-18H2,1H3,(H3,32,33,34,37)/b25-14+/t19-/m1/s1 D05RZE DRUGINKE YPCLDHGBEKZGEB-RUDKWAFVSA-N D05RZE DRUGSMIL CC(CN1CCOCC1)N2C3=C(C=C(C=C3)C=C4C5=C(C=C(C=C5)F)OCC6=CC=CC=C64)N=C2NC(=O)N D05RZE HIGHSTAT Phase 2 D05RZW DRUG__ID D05RZW D05RZW DRUGTYPE Small molecular drug D05RZW DRUGINCH 1S/C15H15N3O4/c1-15(2)10-16(14-5-3-4-8-17(14)19)12-9-11(18(20)21)6-7-13(12)22-15/h3-9H,10H2,1-2H3 D05RZW DRUGINKE GOTJEXSHEQBBSV-UHFFFAOYSA-N D05RZW DRUGSMIL CC1(CN(C2=C(O1)C=CC(=C2)[N+](=O)[O-])C3=CC=CC=[N+]3[O-])C D05RZW HIGHSTAT Phase 2 D05STL DRUG__ID D05STL D05STL DRUGCOMP Array BioPharma D05STL DRUGINCH 1S/C26H23Cl2NO6/c1-33-22-12-17(27)5-2-15(22)8-10-29-25(30)16-3-6-18(7-4-16)35-24-14-23-20(13-21(24)28)19(26(31)32)9-11-34-23/h2-7,12-14,19H,8-11H2,1H3,(H,29,30)(H,31,32)/t19-/m0/s1 D05STL DRUGINKE QIDYUNXQPQEJEC-IBGZPJMESA-N D05STL DRUGSMIL COC1=C(C=CC(=C1)Cl)CCNC(=O)C2=CC=C(C=C2)OC3=C(C=C4C(CCOC4=C3)C(=O)O)Cl D05STL HIGHSTAT Phase 2 D05UGH DRUG__ID D05UGH D05UGH DRUGCOMP LEO Pharma Madison, NJ D05UGH DRUGINCH 1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1 D05UGH DRUGINKE LOWWYYZBZNSPDT-ZBEGNZNMSA-N D05UGH DRUGSMIL CC1CN(C12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N D05UGH HIGHSTAT Phase 2 D05VTN DRUG__ID D05VTN D05VTN DRUGCOMP ChemoCentryx Inc D05VTN DRUGINCH 1S/C22H22ClN7O2/c1-32-18-13-15(4-5-17(18)23)28-9-11-29(12-10-28)19(31)14-30-22-16(3-2-6-26-22)20(27-30)21-24-7-8-25-21/h2-8,13H,9-12,14H2,1H3,(H,24,25) D05VTN DRUGINKE ZIMLRKWQDLVPEK-UHFFFAOYSA-N D05VTN DRUGSMIL COC1=C(C=CC(=C1)N2CCN(CC2)C(=O)CN3C4=C(C=CC=N4)C(=N3)C5=NC=CN5)Cl D05VTN HIGHSTAT Phase 2 D05XUY DRUG__ID D05XUY D05XUY DRUGTYPE Small molecular drug D05XUY DRUGINCH 1S/C6H13N.2C2H4O2.2ClH.H3N.Pt/c7-6-4-2-1-3-5-6;2*1-2(3)4;;;;/h6H,1-5,7H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+2/p-2 D05XUY DRUGINKE TWEQNPPRXJRHHM-UHFFFAOYSA-L D05XUY DRUGSMIL CC(=O)O.CC(=O)O.C1CCC(CC1)N.N.Cl[Pt]Cl D05XUY HIGHSTAT Phase 2 D05YWJ DRUG__ID D05YWJ D05YWJ DRUGCOMP InflaRx Planegg, Germany D05YWJ DRUGINCH 1S/C43H60O6/c1-30(17-14-18-31(2)19-21-39-42(9,10)27-37(49-33(4)45)28-43(39,11)48)15-12-13-16-32(3)23-35(46)24-34(29-44)20-22-38-40(5,6)25-36(47)26-41(38,7)8/h12-24,29,36-38,47-48H,25-28H2,1-11H3/b15-12?,16-13?,18-14?,22-20+,30-17?,31-19?,32-23?,34-24-,39-21?/t36?,37-,38?,43-/m1/s1 D05YWJ DRUGINKE XZAPEHKCHWMSPW-MTALQEDYSA-N D05YWJ DRUGSMIL CC(=CC=CC(=CC=C1C(CC(CC1(C)O)OC(=O)C)(C)C)C)C=CC=CC(=CC(=O)C=C(C=CC2C(CC(CC2(C)C)O)(C)C)C=O)C D05YWJ HIGHSTAT Phase 2 D05ZDJ DRUG__ID D05ZDJ D05ZDJ DRUGCOMP Thrombotech Technologies Ltd D05ZDJ DRUGINCH 1S/C103H166N28O26S2.C2HF3O2/c1-15-56(9)81(129-98(155)82(57(10)16-2)128-88(145)66(37-39-77(136)137)117-86(143)65(36-38-76(134)135)119-93(150)74-30-23-45-130(74)99(156)58(11)114-84(141)67(40-47-158-13)118-85(142)64(115-59(12)132)28-21-43-112-102(107)108)97(154)120-68(41-48-159-14)87(144)124-73(52-78(138)139)91(148)121-69(29-22-44-113-103(109)110)100(157)131-46-24-31-75(131)94(151)125-71(50-60-25-18-17-19-26-60)90(147)122-70(49-53(3)4)89(146)123-72(51-61-32-34-62(133)35-33-61)92(149)126-80(55(7)8)96(153)127-79(54(5)6)95(152)116-63(83(104)140)27-20-42-111-101(105)106;3-2(4,5)1(6)7/h17-19,25-26,32-35,53-58,63-75,79-82,133H,15-16,20-24,27-31,36-52H2,1-14H3,(H2,104,140)(H,114,141)(H,115,132)(H,116,152)(H,117,143)(H,118,142)(H,119,150)(H,120,154)(H,121,148)(H,122,147)(H,123,146)(H,124,144)(H,125,151)(H,126,149)(H,127,153)(H,128,145)(H,129,155)(H,134,135)(H,136,137)(H,138,139)(H4,105,106,111)(H4,107,108,112)(H4,109,110,113);(H,6,7)/t56-,57-,58-,63-,64-,65-,66-,67-,68-,69-,70-,71?,72-,73-,74-,75-,79?,80-,81-,82-;/m0./s1 D05ZDJ DRUGINKE UNDAPMUKULIMSY-HGKXDEPLSA-N D05ZDJ DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C4CCCN4C(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCCNC(=N)N)NC(=O)C.C(=O)(C(F)(F)F)O D05ZDJ HIGHSTAT Phase 2 D05ZIS DRUG__ID D05ZIS D05ZIS DRUGCOMP Samumed D05ZIS DRUGINCH 1S/C29H24FN7O/c1-16(2)8-26(38)33-21-10-19(12-31-13-21)17-6-7-24-22(11-17)28(37-36-24)29-34-25-15-32-14-23(27(25)35-29)18-4-3-5-20(30)9-18/h3-7,9-16H,8H2,1-2H3,(H,33,38)(H,34,35)(H,36,37) D05ZIS DRUGINKE AQDWDWAYVBQMAM-UHFFFAOYSA-N D05ZIS DRUGSMIL CC(C)CC(=O)NC1=CN=CC(=C1)C2=CC3=C(C=C2)NN=C3C4=NC5=C(N4)C=NC=C5C6=CC(=CC=C6)F D05ZIS HIGHSTAT Phase 2 D05ZWG DRUG__ID D05ZWG D05ZWG DRUGTYPE Small molecular drug D05ZWG DRUGINCH 1S/C40H55N7O11S/c1-24(2)19-28(37(55)45-27(36(41)54)17-18-59-4)44-33(49)23-42-39(57)31(21-26-13-9-6-10-14-26)47(3)40(58)30(20-25-11-7-5-8-12-25)46-38(56)29(22-35(52)53)43-32(48)15-16-34(50)51/h5-14,24,27-31H,15-23H2,1-4H3,(H2,41,54)(H,42,57)(H,43,48)(H,44,49)(H,45,55)(H,46,56)(H,50,51)(H,52,53)/t27-,28-,29-,30-,31-/m0/s1 D05ZWG DRUGINKE HMHYXLVEFVGOPM-QKUYTOGTSA-N D05ZWG DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)N(C)C(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(=O)O)NC(=O)CCC(=O)O D05ZWG HIGHSTAT Phase 2 D05ZXZ DRUG__ID D05ZXZ D05ZXZ DRUGTYPE Small molecular drug D05ZXZ DRUGINCH 1S/C18H18N4O3S2/c1-12-17(27(19,24)25)26-18(21-12)22(2)16(23)11-13-6-8-14(9-7-13)15-5-3-4-10-20-15/h3-10H,11H2,1-2H3,(H2,19,24,25) D05ZXZ DRUGINKE IVZKZONQVYTCKC-UHFFFAOYSA-N D05ZXZ DRUGSMIL CC1=C(SC(=N1)N(C)C(=O)CC2=CC=C(C=C2)C3=CC=CC=N3)S(=O)(=O)N D05ZXZ HIGHSTAT Phase 2 D06EMM DRUG__ID D06EMM D06EMM DRUGCOMP Cerecor D06EMM DRUGINCH 1S/C19H23FN4O2/c1-14-3-5-15(6-4-14)13-26-19(25)24-10-7-16(17(20)12-24)11-23-18-21-8-2-9-22-18/h2-6,8-9,16-17H,7,10-13H2,1H3,(H,21,22,23)/t16-,17-/m1/s1 D06EMM DRUGINKE RECBFDWSXWAXHY-IAGOWNOFSA-N D06EMM DRUGSMIL CC1=CC=C(C=C1)COC(=O)N2CCC(C(C2)F)CNC3=NC=CC=N3 D06EMM HIGHSTAT Phase 2 D06FER DRUG__ID D06FER D06FER DRUGCOMP BioMimetix Greenwood Village, CO D06FER DRUGINCH 1S/C48H44N8.5ClH.Mn/c1-5-53-29-13-9-17-41(53)45-33-21-23-35(49-33)46(42-18-10-14-30-54(42)6-2)37-25-27-39(51-37)48(44-20-12-16-32-56(44)8-4)40-28-26-38(52-40)47(36-24-22-34(45)50-36)43-19-11-15-31-55(43)7-3;;;;;;/h9-32H,5-8H2,1-4H3;5*1H;/q+2;;;;;;+3/p-5 D06FER DRUGINKE UGVOBAHBYOONQU-UHFFFAOYSA-I D06FER DRUGSMIL CCN1C=CC=CC1=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=CC=[N+]7CC)C8=CC=CC=[N+]8CC)C=C4)C9=CC=CC=[N+]9CC)C=C3.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3] D06FER HIGHSTAT Phase 2 D06GNF DRUG__ID D06GNF D06GNF DRUGCOMP Taisho Pharmaceutical Co Ltd D06GNF DRUGINCH 1S/C20H31ClO4S.H2O/c21-17-12-19(23)16(9-10-18(22)14-6-2-1-3-7-14)15(17)8-4-5-11-26-13-20(24)25;/h14-19,22-23H,1-8,11-13H2,(H,24,25);1H2/t15-,16-,17-,18-,19-;/m1./s1 D06GNF DRUGINKE HBBRGHQOBDRHIE-HICYURJWSA-N D06GNF DRUGSMIL C1CCC(CC1)C(C#CC2C(CC(C2CCCCSCC(=O)O)Cl)O)O.O D06GNF HIGHSTAT Phase 2 D06GUA DRUG__ID D06GUA D06GUA DRUGCOMP Glaxosmithkline D06GUA DRUGINCH 1S/C26H28N6O/c1-17(2)32-10-8-31(9-11-32)16-19-14-28-26(33-19)22-12-18(13-25-23(22)15-29-30-25)20-4-3-5-24-21(20)6-7-27-24/h3-7,12-15,17,27H,8-11,16H2,1-2H3,(H,29,30) D06GUA DRUGINKE MCIDWGZGWVSZMK-UHFFFAOYSA-N D06GUA DRUGSMIL CC(C)N1CCN(CC1)CC2=CN=C(O2)C3=C4C=NNC4=CC(=C3)C5=C6C=CNC6=CC=C5 D06GUA HIGHSTAT Phase 2 D06HCC DRUG__ID D06HCC D06HCC DRUGTYPE Small molecular drug D06HCC DRUGINCH 1S/C33H45N5O3/c1-25(39)38(22-26-10-4-7-13-32(26)41-2)23-28(20-27-21-34-31-12-6-5-11-30(27)31)35-33(40)24-36-18-14-29(15-19-36)37-16-8-3-9-17-37/h4-7,10-13,21,28-29,34H,3,8-9,14-20,22-24H2,1-2H3,(H,35,40)/t28-/m1/s1 D06HCC DRUGINKE CVXJAPZTZWLRBP-MUUNZHRXSA-N D06HCC DRUGSMIL CC(=O)N(CC1=CC=CC=C1OC)CC(CC2=CNC3=CC=CC=C32)NC(=O)CN4CCC(CC4)N5CCCCC5 D06HCC HIGHSTAT Phase 2 D06HCF DRUG__ID D06HCF D06HCF DRUGCOMP Janssen Pharmaceutica NV D06HCF DRUGINCH 1S/C21H32ClN3O4/c1-21(2)10-15-18(23)16(22)9-14(19(15)29-21)20(27)24-11-13-5-7-25(12-17(13)26)6-4-8-28-3/h9,13,17,26H,4-8,10-12,23H2,1-3H3,(H,24,27)/t13-,17+/m0/s1 D06HCF DRUGINKE FOUUNSGQVBGYQM-SUMWQHHRSA-N D06HCF DRUGSMIL CC1(CC2=C(O1)C(=CC(=C2N)Cl)C(=O)NCC3CCN(CC3O)CCCOC)C D06HCF HIGHSTAT Phase 2 D06HQM DRUG__ID D06HQM D06HQM DRUGCOMP ApoPharma D06HQM DRUGINCH 1S/C16H19N3O5.K/c17-11(15(21)22)5-6-14(20)19-13(16(23)24)7-9-8-18-12-4-2-1-3-10(9)12;/h1-4,8,11,13,18H,5-7,17H2,(H,19,20)(H,21,22)(H,23,24);/q;+1/p-1/t11-,13-;/m1./s1 D06HQM DRUGINKE JBUWHGCMOSDECA-LOCPCMAASA-M D06HQM DRUGSMIL [H+].C1=CC=C2C(=C1)C(=CN2)CC(C(=O)[O-])NC(=O)CCC(C(=O)[O-])N.[K+] D06HQM HIGHSTAT Phase 2 D06HZA DRUG__ID D06HZA D06HZA DRUGCOMP GlaxoSmithKline D06HZA DRUGINCH 1S/C22H23N5O2/c1-22(2)12-26(13-22)20(29)16-10-6-14(7-11-16)17-4-3-5-18-23-21(25-27(17)18)24-19(28)15-8-9-15/h3-7,10-11,15H,8-9,12-13H2,1-2H3,(H,24,25,28) D06HZA DRUGINKE MPYACSQFXVMWNO-UHFFFAOYSA-N D06HZA DRUGSMIL CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C D06HZA HIGHSTAT Phase 2 D06IME DRUG__ID D06IME D06IME DRUGCOMP Chemocentryx D06IME DRUGINCH 1S/C20H13ClF3N5O3S/c1-10-6-15(29-33(31,32)11-2-3-14(21)13(7-11)20(22,23)24)17(26-8-10)18(30)16-12-4-5-25-19(12)28-9-27-16/h2-9,29H,1H3,(H,25,27,28) D06IME DRUGINKE LUUMLYXKTPBTQR-UHFFFAOYSA-N D06IME DRUGSMIL CC1=CC(=C(N=C1)C(=O)C2=C3C=CNC3=NC=N2)NS(=O)(=O)C4=CC(=C(C=C4)Cl)C(F)(F)F D06IME HIGHSTAT Phase 2 D06KGI DRUG__ID D06KGI D06KGI DRUGCOMP TaiGen Biotechnology Co Ltd D06KGI DRUGINCH 1S/C27H51N8O3P/c28-25-19-26(35-15-13-34(14-16-35)17-18-39(36,37)38)33-27(32-25)31-21-23-9-7-22(8-10-23)20-29-11-4-12-30-24-5-2-1-3-6-24/h19,22-24,29-30H,1-18,20-21H2,(H2,36,37,38)(H3,28,31,32,33) D06KGI DRUGINKE QLVSJMZJSABWRX-UHFFFAOYSA-N D06KGI DRUGSMIL C1CCC(CC1)NCCCNCC2CCC(CC2)CNC3=NC(=CC(=N3)N4CCN(CC4)CCP(=O)(O)O)N D06KGI HIGHSTAT Phase 2 D06KTJ DRUG__ID D06KTJ D06KTJ DRUGCOMP Millennium pharmaceuticals D06KTJ DRUGINCH 1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1 D06KTJ DRUGINKE MJHOMTRKVMKCNE-NWDGAFQWSA-N D06KTJ DRUGSMIL CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4N D06KTJ HIGHSTAT Phase 2 D06LQY DRUG__ID D06LQY D06LQY DRUGTYPE Small molecular drug D06LQY DRUGINCH 1S/C18H30O2/c1-12(20)16-5-6-17-15-4-3-13(8-10-19)11-14(15)7-9-18(16,17)2/h13-17,19H,3-11H2,1-2H3/t13-,14+,15+,16+,17-,18+/m0/s1 D06LQY DRUGINKE OOTXTVKIKCULJJ-UIGZQWRCSA-N D06LQY DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC(C3)CCO)C D06LQY HIGHSTAT Phase 2 D06LRG DRUG__ID D06LRG D06LRG DRUGCOMP Forest laboratories; trevena D06LRG DRUGINCH 1S/C43H67N13O10/c1-7-24(4)35(40(63)53-31(19-27-20-47-22-49-27)41(64)56-17-9-11-32(56)38(61)50-25(5)42(65)66)55-37(60)30(18-26-12-14-28(57)15-13-26)52-39(62)34(23(2)3)54-36(59)29(51-33(58)21-46-6)10-8-16-48-43(44)45/h12-15,20,22-25,29-32,34-35,46,57H,7-11,16-19,21H2,1-6H3,(H,47,49)(H,50,61)(H,51,58)(H,52,62)(H,53,63)(H,54,59)(H,55,60)(H,65,66)(H4,44,45,48)/t24-,25+,29-,30-,31-,32-,34-,35-/m0/s1 D06LRG DRUGINKE XIEWFECSPPTVQN-KMIMAYJXSA-N D06LRG DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(C)C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D06LRG HIGHSTAT Phase 2 D06MLA DRUG__ID D06MLA D06MLA DRUGCOMP CT Laboratories(Laboratorio Farmaceutico CT) Sanremo, Italy D06MLA DRUGINCH 1S/C13H16F3NO2/c1-19-8-2-3-12(18)17-9-10-4-6-11(7-5-10)13(14,15)16/h4-7H,2-3,8-9H2,1H3,(H,17,18) D06MLA DRUGINKE QLZOWJNFLXSDSH-UHFFFAOYSA-N D06MLA DRUGSMIL COCCCC(=O)NCC1=CC=C(C=C1)C(F)(F)F D06MLA HIGHSTAT Phase 2 D06QEL DRUG__ID D06QEL D06QEL DRUGTYPE Small molecular drug D06QEL DRUGINCH 1S/C12H15Cl2NO3.H3O4P/c13-5-7-15(18,8-6-14)11-3-1-10(2-4-11)9-12(16)17;1-5(2,3)4/h1-4H,5-9H2,(H,16,17);(H3,1,2,3,4) D06QEL DRUGINKE DMZGCZWBSXHKNL-UHFFFAOYSA-N D06QEL DRUGSMIL C1=CC(=CC=C1CC(=O)O)[N+](CCCl)(CCCl)[O-].OP(=O)(O)O D06QEL HIGHSTAT Phase 2 D06RIM DRUG__ID D06RIM D06RIM DRUGCOMP Limerick Biopharma D06RIM DRUGINCH 1S/C15H11O10P/c16-7-4-9(18)12-11(5-7)24-15(14(20)13(12)19)6-1-2-8(17)10(3-6)25-26(21,22)23/h1-5,16-18,20H,(H2,21,22,23) D06RIM DRUGINKE UWJBYNLLMAPJMM-UHFFFAOYSA-N D06RIM DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)OP(=O)(O)O)O D06RIM HIGHSTAT Phase 2 D06VMJ DRUG__ID D06VMJ D06VMJ DRUGCOMP Glenmark pharma D06VMJ DRUGINCH 1S/C15H21FN6O/c16-12-4-14(5-17)22(8-12)15(23)6-19-13-2-1-11(3-13)7-21-10-18-9-20-21/h9-14,19H,1-4,6-8H2/t11-,12-,13+,14-/m0/s1 D06VMJ DRUGINKE JSYGLDMGERSRPC-FQUUOJAGSA-N D06VMJ DRUGSMIL C1CC(CC1CN2C=NC=N2)NCC(=O)N3CC(CC3C#N)F D06VMJ HIGHSTAT Phase 2 D06VWL DRUG__ID D06VWL D06VWL DRUGTYPE Small molecular drug D06VWL DRUGINCH 1S/C27H34N4O3/c1-19-17-21(25(32)30-15-7-6-10-20-9-4-5-11-23(20)30)13-14-22(19)18-28-27(34)31-16-8-12-24(31)26(33)29(2)3/h4-5,9,11,13-14,17,24H,6-8,10,12,15-16,18H2,1-3H3,(H,28,34)/t24-/m0/s1 D06VWL DRUGINKE RUOLFWZIFNQQGH-DEOSSOPVSA-N D06VWL DRUGSMIL CC1=C(C=CC(=C1)C(=O)N2CCCCC3=CC=CC=C32)CNC(=O)N4CCCC4C(=O)N(C)C D06VWL HIGHSTAT Phase 2 D06ZWL DRUG__ID D06ZWL D06ZWL DRUGTYPE Small molecular drug D06ZWL DRUGINCH 1S/C9H12N6O3/c10-7-6-8(14-9(11)13-7)15(3-12-6)4-2-17-5(1-16)18-4/h3-5,16H,1-2H2,(H4,10,11,13,14)/t4-,5-/m1/s1 D06ZWL DRUGINKE RLAHNGKRJJEIJL-RFZPGFLSSA-N D06ZWL DRUGSMIL C1C(OC(O1)CO)N2C=NC3=C(N=C(N=C32)N)N D06ZWL HIGHSTAT Phase 2 D07ARN DRUG__ID D07ARN D07ARN DRUGCOMP Sanofi D07ARN DRUGINCH 1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35) D07ARN DRUGINKE ODIUNTQOXRXOIV-UHFFFAOYSA-N D07ARN DRUGSMIL C1COCCN1CCNC(=O)NC2=NC3=C(S2)C=C(C=C3)SC4=NN=C5N4N=C(C=C5)C6=CC=C(C=C6)F D07ARN HIGHSTAT Phase 2 D07BGC DRUG__ID D07BGC D07BGC DRUGCOMP Genentech D07BGC DRUGINCH 1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21) D07BGC DRUGINKE LGWACEZVCMBSKW-UHFFFAOYSA-N D07BGC DRUGSMIL CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C D07BGC HIGHSTAT Phase 2 D07DWF DRUG__ID D07DWF D07DWF DRUGCOMP ArQule; Daiichi D07DWF DRUGINCH 1S/C27H24N6/c28-24-21(8-4-17-30-24)25-32-23-14-13-22(18-6-2-1-3-7-18)31-26(23)33(25)20-11-9-19(10-12-20)27(29)15-5-16-27/h1-4,6-14,17H,5,15-16,29H2,(H2,28,30) D07DWF DRUGINKE HNFMVVHMKGFCMB-UHFFFAOYSA-N D07DWF DRUGSMIL C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N D07DWF HIGHSTAT Phase 2 D07EJY DRUG__ID D07EJY D07EJY DRUGCOMP Aerie Pharmaceuticals Inc D07EJY DRUGINCH 1S/C17H17N3O2S/c1-20(2)15(12-6-8-23-10-12)17(22)19-13-3-4-14-11(9-13)5-7-18-16(14)21/h3-10,15H,1-2H3,(H,18,21)(H,19,22) D07EJY DRUGINKE VDYRZXYYQMMFJW-UHFFFAOYSA-N D07EJY DRUGSMIL CN(C)C(C1=CSC=C1)C(=O)NC2=CC3=C(C=C2)C(=O)NC=C3 D07EJY HIGHSTAT Phase 2 D07HZG DRUG__ID D07HZG D07HZG DRUGTYPE Small molecular drug D07HZG DRUGINCH 1S/C17H24F2N6O/c18-17(19)2-5-25(12-17)15(26)14-10-13(11-22-14)23-6-8-24(9-7-23)16-20-3-1-4-21-16/h1,3-4,13-14,22H,2,5-12H2/t13-,14-/m0/s1 D07HZG DRUGINKE QWEWGXUTRTXFRF-KBPBESRZSA-N D07HZG DRUGSMIL C1CN(CC1(F)F)C(=O)C2CC(CN2)N3CCN(CC3)C4=NC=CC=N4 D07HZG HIGHSTAT Phase 2 D07IOT DRUG__ID D07IOT D07IOT DRUGCOMP Andarix Pharmaceuticals Somerville, NJ D07IOT DRUGINCH 1S/C46H63NO15/c1-13-32-58-30-20-31-45(22-55-31,61-26(6)49)36-38(60-39(51)27-17-15-14-16-18-27)46(54)21-29(57-40(52)34(50)28(19-23(2)3)47-41(53)62-42(7,8)9)24(4)33(43(46,10)11)35(56-25(5)48)37(59-32)44(30,36)12/h13-18,23,28-32,34-38,50,54H,1,19-22H2,2-12H3,(H,47,53)/t28-,29-,30-,31+,32?,34+,35-,36-,37-,38-,44+,45-,46?/m0/s1 D07IOT DRUGINKE FDTAUJJRHBRHIJ-BBGIBMRQSA-N D07IOT DRUGSMIL CC1=C2C(C3C4(C(CC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(CC(C)C)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO5)OC(=O)C)OC(O3)C=C)C)OC(=O)C D07IOT HIGHSTAT Phase 2 D07JTD DRUG__ID D07JTD D07JTD DRUGTYPE Small molecular drug D07JTD DRUGINCH 1S/C20H22N4O2/c1-3-23(4-2)10-9-21-15-6-7-16-19-18(15)20(26)14-11-13(25)5-8-17(14)24(19)12-22-16/h5-8,11-12,21,25H,3-4,9-10H2,1-2H3 D07JTD DRUGINKE CUNDRHORZHFPLY-UHFFFAOYSA-N D07JTD DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=C(C=C4)O D07JTD HIGHSTAT Phase 2 D07LAP DRUG__ID D07LAP D07LAP DRUGTYPE Small molecular drug D07LAP DRUGINCH 1S/C49H55NO14S/c1-27-33(62-45(57)38(53)37(30-17-11-8-12-18-30)50-43(55)31-19-13-9-14-20-31)24-49(58)42(63-44(56)32-21-15-10-16-22-32)40-47(6,41(54)39(61-28(2)51)36(27)46(49,4)5)34(60-26-65-7)23-35-48(40,25-59-35)64-29(3)52/h8-22,33-35,37-40,42,53,58H,23-26H2,1-7H3,(H,50,55)/t33-,34-,35+,37-,38+,39+,40-,42-,47+,48-,49+/m0/s1 D07LAP DRUGINKE UBJAHGAUPNGZFF-XOVTVWCYSA-N D07LAP DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)OCSC)C)OC(=O)C D07LAP HIGHSTAT Phase 2 D07LUJ DRUG__ID D07LUJ D07LUJ DRUGTYPE Small molecular drug D07LUJ DRUGINCH 1S/C30H48O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1 D07LUJ DRUGINKE WCGUUGGRBIKTOS-GPOJBZKASA-N D07LUJ DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)O D07LUJ HIGHSTAT Phase 2 D07LWT DRUG__ID D07LWT D07LWT DRUGCOMP Ferring Pharmaceuticals Inc D07LWT DRUGINCH 1S/C48H68FN11O12S/c1-5-27(4)42-47(71)56-32(16-17-37(50)62)44(68)57-35(21-38(51)63)45(69)58-36(25-73-18-6-7-40(65)54-34(46(70)59-42)20-28-10-14-31(61)15-11-28)48(72)60(23-29-8-12-30(49)13-9-29)24-41(66)55-33(19-26(2)3)43(67)53-22-39(52)64/h8-15,26-27,32-36,42,61H,5-7,16-25H2,1-4H3,(H2,50,62)(H2,51,63)(H2,52,64)(H,53,67)(H,54,65)(H,55,66)(H,56,71)(H,57,68)(H,58,69)(H,59,70)/t27?,32-,33-,34-,35-,36-,42-/m0/s1 D07LWT DRUGINKE PVVHQWISMVJHFK-JWKDVPIGSA-N D07LWT DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSCCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N(CC3=CC=C(C=C3)F)CC(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D07LWT HIGHSTAT Phase 2 D07LZH DRUG__ID D07LZH D07LZH DRUGTYPE Small molecular drug D07LZH DRUGINCH 1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2 D07LZH DRUGINKE MQIMZDXIAHJKQP-UHFFFAOYSA-N D07LZH DRUGSMIL C=CC1=C2C(=CC(=C1)O)N=C(O2)C3=CC(=C(C=C3)O)F D07LZH HIGHSTAT Phase 2 D07MDY DRUG__ID D07MDY D07MDY DRUGCOMP Viriom San Diego, CA D07MDY DRUGINCH 1S/C24H17BrCl2FN3O5S/c1-2-21(32)31-37(34,35)17-4-6-20(19(27)11-17)30-22(33)9-14-3-5-18(25)24(23(14)28)36-16-8-13(12-29)7-15(26)10-16/h3-8,10-11H,2,9H2,1H3,(H,30,33)(H,31,32) D07MDY DRUGINKE ULTDEARCBRNRGR-UHFFFAOYSA-N D07MDY DRUGSMIL CCC(=O)NS(=O)(=O)C1=CC(=C(C=C1)NC(=O)CC2=C(C(=C(C=C2)Br)OC3=CC(=CC(=C3)C#N)Cl)F)Cl D07MDY HIGHSTAT Phase 2 D07MKL DRUG__ID D07MKL D07MKL DRUGTYPE Small molecular drug D07MKL DRUGINCH 1S/C38H67NO10/c1-14-28-23(6)30(40)24(7)32-20(3)17-38(11,49-32)34(48-36-31(41)27(39(12)15-2)16-21(4)45-36)25(8)33(26(9)35(42)46-28)47-29-19-37(10,43-13)18-22(5)44-29/h21-31,33-34,36,40-41H,14-19H2,1-13H3/t21-,22+,23+,24-,25+,26-,27+,28-,29+,30+,31-,33+,34-,36+,37+,38-/m1/s1 D07MKL DRUGINKE IWTSXJNGTTXMFK-KTQUSEMZSA-N D07MKL DRUGSMIL CCC1C(C(C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(CC(O3)C)(C)OC)C)OC4C(C(CC(O4)C)N(C)CC)O)C)C)C)O)C D07MKL HIGHSTAT Phase 2 D07OHT DRUG__ID D07OHT D07OHT DRUGCOMP Abbott; Enanta D07OHT DRUGINCH 1S/C40H43N7O7S/c1-24-21-42-33(22-41-24)35(48)43-32-16-6-4-2-3-5-11-25-20-40(25,39(51)46-55(52,53)27-17-18-27)45-36(49)34-19-26(23-47(34)38(32)50)54-37-30-14-8-7-12-28(30)29-13-9-10-15-31(29)44-37/h5,7-15,21-22,25-27,32,34H,2-4,6,16-20,23H2,1H3,(H,43,48)(H,45,49)(H,46,51)/b11-5-/t25-,26-,32+,34+,40-/m1/s1 D07OHT DRUGINKE UAUIUKWPKRJZJV-QPLHLKROSA-N D07OHT DRUGSMIL CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8 D07OHT HIGHSTAT Phase 2 D07QHF DRUG__ID D07QHF D07QHF DRUGCOMP Pharmaceuticals D07QHF DRUGINCH 1S/C22H24N8OS/c1-2-16-11-23-22(24-12-16)29-9-7-17(8-10-29)21-26-18(14-32-21)13-31-20-5-3-19(4-6-20)30-15-25-27-28-30/h3-6,11-12,14-15,17H,2,7-10,13H2,1H3 D07QHF DRUGINKE NFTMKHWBOINJGM-UHFFFAOYSA-N D07QHF DRUGSMIL CCC1=CN=C(N=C1)N2CCC(CC2)C3=NC(=CS3)COC4=CC=C(C=C4)N5C=NN=N5 D07QHF HIGHSTAT Phase 2 D07TYE DRUG__ID D07TYE D07TYE DRUGTYPE Small molecular drug D07TYE DRUGINCH 1S/C40H52F4N6O9S/c1-7-22-27-19-50(28(22)32(51)48-39(18-23(39)31(41)42)35(53)49-60(55,56)38(5)14-15-38)34(52)30(37(2,3)4)47-36(54)59-26-16-20(26)10-8-9-13-40(43,44)29-33(58-27)46-25-17-21(57-6)11-12-24(25)45-29/h11-12,17,20,22-23,26-28,30-31H,7-10,13-16,18-19H2,1-6H3,(H,47,54)(H,48,51)(H,49,53)/t20-,22-,23+,26-,27+,28+,30-,39-/m1/s1 D07TYE DRUGINKE MZBLZLWXUBZHSL-FZNJKFJKSA-N D07TYE DRUGSMIL CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C D07TYE HIGHSTAT Phase 2 D07UHX DRUG__ID D07UHX D07UHX DRUGTYPE Small molecular drug D07UHX DRUGINCH 1S/C20H17N3O4/c1-2-20(26)13-7-16-17-10(6-11-14(21)4-3-5-15(11)22-17)8-23(16)18(24)12(13)9-27-19(20)25/h3-7,26H,2,8-9,21H2,1H3/t20-/m0/s1 D07UHX DRUGINKE FUXVKZWTXQUGMW-FQEVSTJZSA-N D07UHX DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5N=C4C3=C2)N)O D07UHX HIGHSTAT Phase 2 D07UIS DRUG__ID D07UIS D07UIS DRUGCOMP Corcept Therapeutics Menlo Park, CA D07UIS DRUGINCH 1S/C26H23F4N7O3S/c1-35-32-14-23(34-35)41(39,40)36-9-7-17-11-22-16(13-33-37(22)20-4-2-19(27)3-5-20)12-25(17,15-36)24(38)21-10-18(6-8-31-21)26(28,29)30/h2-6,8,10,13-14,17H,7,9,11-12,15H2,1H3/t17-,25-/m0/s1 D07UIS DRUGINKE HWJYJKAURRIWJM-GKVSMKOHSA-N D07UIS DRUGSMIL CN1N=CC(=N1)S(=O)(=O)N2CCC3CC4=C(CC3(C2)C(=O)C5=NC=CC(=C5)C(F)(F)F)C=NN4C6=CC=C(C=C6)F D07UIS HIGHSTAT Phase 2 D07UJA DRUG__ID D07UJA D07UJA DRUGCOMP Dr Reddy's Laboratories Ltd D07UJA DRUGINCH 1S/C30H31F6N7/c1-18-4-3-5-22-12-23(27(37-26(18)22)42(14-19-6-7-19)15-20-8-9-20)17-43(28-38-40-41(2)39-28)16-21-10-24(29(31,32)33)13-25(11-21)30(34,35)36/h3-5,10-13,19-20H,6-9,14-17H2,1-2H3 D07UJA DRUGINKE OCNBSSLDAIWTKS-UHFFFAOYSA-N D07UJA DRUGSMIL CC1=C2C(=CC=C1)C=C(C(=N2)N(CC3CC3)CC4CC4)CN(CC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F)C6=NN(N=N6)C D07UJA HIGHSTAT Phase 2 D07VAI DRUG__ID D07VAI D07VAI DRUGCOMP Alzheon D07VAI DRUGINCH 1S/C8H18N2O4S/c1-6(2)7(9)8(11)10-4-3-5-15(12,13)14/h6-7H,3-5,9H2,1-2H3,(H,10,11)(H,12,13,14)/t7-/m0/s1 D07VAI DRUGINKE NRZRFNYKMSAZBI-ZETCQYMHSA-N D07VAI DRUGSMIL CC(C)C(C(=O)NCCCS(=O)(=O)O)N D07VAI HIGHSTAT Phase 2 D07WCT DRUG__ID D07WCT D07WCT DRUGCOMP Sanofi us D07WCT DRUGINCH 1S/C27H27NO5/c1-18-6-5-7-19(14-18)12-13-33-24-15-20(10-11-23(24)32-2)25(29)28-27(26(30)31)16-21-8-3-4-9-22(21)17-27/h3-11,14-15H,12-13,16-17H2,1-2H3,(H,28,29)(H,30,31) D07WCT DRUGINKE SOJDTNUCCXWTMG-UHFFFAOYSA-N D07WCT DRUGSMIL CC1=CC(=CC=C1)CCOC2=C(C=CC(=C2)C(=O)NC3(CC4=CC=CC=C4C3)C(=O)O)OC D07WCT HIGHSTAT Phase 2 D07WEN DRUG__ID D07WEN D07WEN DRUGCOMP Genzyme, Cambridge, MA D07WEN DRUGINCH 1S/C20H24FN3O2S/c1-20(2,17-12-27-18(22-17)14-3-5-15(21)6-4-14)23-19(25)26-16-11-24-9-7-13(16)8-10-24/h3-6,12-13,16H,7-11H2,1-2H3,(H,23,25)/t16-/m1/s1 D07WEN DRUGINKE YFHRCLAKZBDRHN-MRXNPFEDSA-N D07WEN DRUGSMIL CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4 D07WEN HIGHSTAT Phase 2 D07WGN DRUG__ID D07WGN D07WGN DRUGCOMP Dimera Portland, OR D07WGN DRUGINCH 1S/C11H22N8O4/c12-7(2-1-3-15-11(14)18-19(22)23)10(21)17-6-4-8(9(13)20)16-5-6/h6-8,16H,1-5,12H2,(H2,13,20)(H,17,21)(H3,14,15,18)/t6-,7+,8+/m1/s1 D07WGN DRUGINKE IUFRDGFKAVLPFZ-CSMHCCOUSA-N D07WGN DRUGSMIL C1C(CNC1C(=O)N)NC(=O)C(CCCN=C(N)N[N+](=O)[O-])N D07WGN HIGHSTAT Phase 2 D07WHS DRUG__ID D07WHS D07WHS DRUGTYPE Small molecular drug D07WHS DRUGINCH 1S/C20H20ClNO7.2Na/c1-11(22-10-15(23)13-3-2-4-14(21)9-13)7-12-5-6-16-17(8-12)29-20(28-16,18(24)25)19(26)27;;/h2-6,8-9,11,15,22-23H,7,10H2,1H3,(H,24,25)(H,26,27);;/q;2*+1/p-2/t11-,15+;;/m1../s1 D07WHS DRUGINKE FUZBPOHHSBDTJQ-CFOQQKEYSA-L D07WHS DRUGSMIL CC(CC1=CC2=C(C=C1)OC(O2)(C(=O)[O-])C(=O)[O-])NCC(C3=CC(=CC=C3)Cl)O.[Na+].[Na+] D07WHS HIGHSTAT Phase 2 D07WRW DRUG__ID D07WRW D07WRW DRUGTYPE Small molecular drug D07WRW DRUGINCH 1S/C29H31NO11S/c1-13-28(41-42(3,37)38)18(30-8-9-30)10-20(39-13)40-19-12-29(36,14(2)31)11-17-21(19)27(35)23-22(26(17)34)24(32)15-6-4-5-7-16(15)25(23)33/h4-7,13,18-20,28,34-36H,8-12H2,1-3H3/t13-,18-,19-,20-,28+,29-/m0/s1 D07WRW DRUGINKE VMDWTZZCNDEKIO-CBNJBKGYSA-N D07WRW DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N6CC6)OS(=O)(=O)C D07WRW HIGHSTAT Phase 2 D07XOV DRUG__ID D07XOV D07XOV DRUGCOMP eFFECTOR Therapeutics San Diego, CA D07XOV DRUGINCH 1S/C17H20N6O2/c1-10-7-11(21-13-8-12(18)19-9-20-13)16(25)23-14(10)15(24)22-17(23)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21) D07XOV DRUGINKE HKTBYUWLRDZAJK-UHFFFAOYSA-N D07XOV DRUGSMIL CC1=C2C(=O)NC3(N2C(=O)C(=C1)NC4=NC=NC(=C4)N)CCCCC3 D07XOV HIGHSTAT Phase 2 D07XQS DRUG__ID D07XQS D07XQS DRUGCOMP Oncoceutics Philadelphia, PA D07XQS DRUGINCH 1S/C24H26N4O/c1-18-7-5-6-10-20(18)16-28-23(29)21-17-26(15-19-8-3-2-4-9-19)13-11-22(21)27-14-12-25-24(27)28/h2-10H,11-17H2,1H3 D07XQS DRUGINKE VLULRUCCHYVXOH-UHFFFAOYSA-N D07XQS DRUGSMIL CC1=CC=CC=C1CN2C(=O)C3=C(CCN(C3)CC4=CC=CC=C4)N5C2=NCC5 D07XQS HIGHSTAT Phase 2 D07YGK DRUG__ID D07YGK D07YGK DRUGTYPE Small molecular drug D07YGK DRUGINCH 1S/C27H29F5O4S/c1-24-14-21(15-3-7-18(8-4-15)37(2,35)36)23-19-10-6-17(33)13-16(19)5-9-20(23)22(24)11-12-25(24,34)26(28,29)27(30,31)32/h3-4,7-8,13,20-22,34H,5-6,9-12,14H2,1-2H3/t20-,21+,22-,24-,25-/m0/s1 D07YGK DRUGINKE JUFWQQVHQFDUOD-ANRPBIDPSA-N D07YGK DRUGSMIL CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C(C(F)(F)F)(F)F)O)C5=CC=C(C=C5)S(=O)(=O)C D07YGK HIGHSTAT Phase 2 D07ZUZ DRUG__ID D07ZUZ D07ZUZ DRUGCOMP Cytokinetics D07ZUZ DRUGINCH 1S/C19H18F2N6O/c20-13-6-19(7-13,16-15(21)2-1-4-23-16)11-26-18-24-8-14(9-25-18)27-5-3-12(10-27)17(22)28/h1-5,8-10,13H,6-7,11H2,(H2,22,28)(H,24,25,26) D07ZUZ DRUGINKE MQXWPWOCXGARRK-UHFFFAOYSA-N D07ZUZ DRUGSMIL C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F D07ZUZ HIGHSTAT Phase 2 D08AOZ DRUG__ID D08AOZ D08AOZ DRUGCOMP Bristol-Myers SquibbPrinceton, NJ D08AOZ DRUGINCH 1S/C32H30F2N4O4/c1-15-17(7-6-10-24(15)38-30(40)19-8-5-9-21(33)28(19)37(4)31(38)41)25-22(34)14-20(29(35)39)27-26(25)18-12-11-16(32(2,3)42)13-23(18)36-27/h5-10,14,16,36,42H,11-13H2,1-4H3,(H2,35,39)/t16-/m0/s1 D08AOZ DRUGINKE ZRYMMWAJAFUANM-INIZCTEOSA-N D08AOZ DRUGSMIL CC1=C(C=CC=C1N2C(=O)C3=C(C(=CC=C3)F)N(C2=O)C)C4=C(C=C(C5=C4C6=C(N5)CC(CC6)C(C)(C)O)C(=O)N)F D08AOZ HIGHSTAT Phase 2 D08FKH DRUG__ID D08FKH D08FKH DRUGCOMP Kissei Pharmaceutical Co Ltd D08FKH DRUGINCH 1S/C22H15F3N2O7S/c1-32-14-4-3-10(23)18(25)9(14)7-34-16-6-13(11(24)5-15(16)33-2)27-20(28)17-12(26-22(27)31)8-35-19(17)21(29)30/h3-6,8H,7H2,1-2H3,(H,26,31)(H,29,30) D08FKH DRUGINKE BMAAMIIYNNPHAB-UHFFFAOYSA-N D08FKH DRUGSMIL COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC D08FKH HIGHSTAT Phase 2 D08FSD DRUG__ID D08FSD D08FSD DRUGCOMP Zealand Pharma A/S D08FSD DRUGINCH 1S/C85H141N27O15/c1-52(113)101-61(29-18-46-98-84(94)95)73(117)110-70(49-54-33-37-57(115)38-34-54)82(126)111-69(48-53-31-35-56(114)36-32-53)81(125)109-68(30-19-47-99-85(96)97)80(124)112-71(50-55-51-100-59-21-3-2-20-58(55)59)83(127)108-67(28-10-17-45-92)79(123)107-66(27-9-16-44-91)78(122)106-65(26-8-15-43-90)77(121)105-64(25-7-14-42-89)76(120)104-63(24-6-13-41-88)75(119)103-62(23-5-12-40-87)74(118)102-60(72(93)116)22-4-11-39-86/h2-3,20-21,31-38,51,60-71,100,114-115H,4-19,22-30,39-50,86-92H2,1H3,(H2,93,116)(H,101,113)(H,102,118)(H,103,119)(H,104,120)(H,105,121)(H,106,122)(H,107,123)(H,108,127)(H,109,125)(H,110,117)(H,111,126)(H,112,124)(H4,94,95,98)(H4,96,97,99)/t60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-/m0/s1 D08FSD DRUGINKE GJLXVWOMRRWCIB-MERZOTPQSA-N D08FSD DRUGSMIL CC(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N D08FSD HIGHSTAT Phase 2 D08FTP DRUG__ID D08FTP D08FTP DRUGCOMP Molecular Insight Pharmaceuticals Inc D08FTP DRUGINCH 1S/C37H50N10O20.3CHO.ClH.Tc/c48-26(6-4-22(35(63)64)41-37(67)42-23(36(65)66)5-7-29(51)52)40-21(34(61)62)3-1-2-10-43(13-24-38-8-11-44(24)15-27(49)46(17-30(53)54)18-31(55)56)14-25-39-9-12-45(25)16-28(50)47(19-32(57)58)20-33(59)60;3*1-2;;/h8-9,11-12,21-23H,1-7,10,13-20H2,(H,40,48)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)(H,61,62)(H,63,64)(H,65,66)(H2,41,42,67);3*1H;1H;/q;3*-1;;+4/p-1/t21-,22-,23-;;;;;/m0...../s1/i;;;;;1+1 D08FTP DRUGINKE XOJYSFPEJAILJZ-LCERUKBVSA-M D08FTP DRUGSMIL [CH-]=O.[CH-]=O.[CH-]=O.C1=CN(C(=N1)CN(CCCCC(C(=O)O)NC(=O)CCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)CC2=NC=CN2CC(=O)N(CC(=O)O)CC(=O)O)CC(=O)N(CC(=O)O)CC(=O)O.[Cl-].[Tc+4] D08FTP HIGHSTAT Phase 2 D08GIM DRUG__ID D08GIM D08GIM DRUGCOMP PharmaMar SA D08GIM DRUGINCH 1S/C75H124N14O16/c1-20-43(15)33-34-53(91)80-54(38(5)6)68(97)87-61(46(18)90)72(101)82-56(40(9)10)69(98)83-57(41(11)12)74(103)89-36-28-32-52(89)66(95)78-50(31-27-35-76)64(93)85-59(44(16)21-2)71(100)88-62-47(19)105-75(104)58(42(13)14)84-63(92)49(23-4)77-65(94)51(37-48-29-25-24-26-30-48)79-67(96)55(39(7)8)81-70(99)60(45(17)22-3)86-73(62)102/h23-26,29-30,38-47,50-52,54-62,90H,20-22,27-28,31-37,76H2,1-19H3,(H,77,94)(H,78,95)(H,79,96)(H,80,91)(H,81,99)(H,82,101)(H,83,98)(H,84,92)(H,85,93)(H,86,102)(H,87,97)(H,88,100)/b49-23-/t43-,44-,45-,46+,47+,50-,51-,52+,54+,55+,56-,57+,58-,59+,60+,61-,62+/m0/s1 D08GIM DRUGINKE ZNVCPJPCKSJWDH-UCTDCHLSSA-N D08GIM DRUGSMIL CCC(C)CCC(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC(CCCN)C(=O)NC(C(C)CC)C(=O)NC2C(OC(=O)C(NC(=O)C(=CC)NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)C(C)CC)C(C)C)CC3=CC=CC=C3)C(C)C)C D08GIM HIGHSTAT Phase 2 D08HKT DRUG__ID D08HKT D08HKT DRUGTYPE Small molecular drug D08HKT DRUGINCH 1S/C13H13N3O3/c1-7-4-11(17)15-16-13(7)8-2-3-9-10(5-8)19-6-12(18)14-9/h2-3,5,7H,4,6H2,1H3,(H,14,18)(H,15,17) D08HKT DRUGINKE XZPGINPFWXLYNW-UHFFFAOYSA-N D08HKT DRUGSMIL CC1CC(=O)NN=C1C2=CC3=C(C=C2)NC(=O)CO3 D08HKT HIGHSTAT Phase 2 D08JSA DRUG__ID D08JSA D08JSA DRUGCOMP Novan Morrisville, NC D08JSA DRUGINCH 1S/C10H19N5O2/c1-6(2)7-13-15(9(17)14(7)11)8(16)12-10(3,4)5/h6H,11H2,1-5H3,(H,12,16) D08JSA DRUGINKE ORFPWVRKFLOQHK-UHFFFAOYSA-N D08JSA DRUGSMIL CC(C)C1=NN(C(=O)N1N)C(=O)NC(C)(C)C D08JSA HIGHSTAT Phase 2 D08NYZ DRUG__ID D08NYZ D08NYZ DRUGCOMP Asmacure Lt |e D08NYZ DRUGINCH 1S/C15H25N2.C7H8O3S/c1-3-17(4-2)13-8-11-16(12-14-17)15-9-6-5-7-10-15;1-6-2-4-7(5-3-6)11(8,9)10/h5-7,9-10H,3-4,8,11-14H2,1-2H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1 D08NYZ DRUGINKE PXRYYARWCNIUKT-UHFFFAOYSA-M D08NYZ DRUGSMIL CC[N+]1(CCCN(CC1)C2=CC=CC=C2)CC.CC1=CC=C(C=C1)S(=O)(=O)[O-] D08NYZ HIGHSTAT Phase 2 D08OTE DRUG__ID D08OTE D08OTE DRUGCOMP F Hoffmann-La Roche Ltd D08OTE DRUGINCH 1S/C21H11F6N5/c22-20(23,24)15-6-4-13(5-7-15)16-9-17(21(25,26)27)32-19(31-16)14(11-30-32)3-1-12-2-8-18(28)29-10-12/h2,4-11H,(H2,28,29) D08OTE DRUGINKE DMJHZVARRXJSEG-UHFFFAOYSA-N D08OTE DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=NN3C(=C2)C(F)(F)F)C#CC4=CN=C(C=C4)N)C(F)(F)F D08OTE HIGHSTAT Phase 2 D08PBB DRUG__ID D08PBB D08PBB DRUGTYPE Small molecular drug D08PBB DRUGINCH 1S/C31H40N4O6/c1-5-8-24(22-11-14-25-26(19-22)40-20-39-25)32-30(38)35-28(37)31(6-2,7-3)29(35)41-23-12-9-21(10-13-23)27(36)34-17-15-33(4)16-18-34/h9-14,19,24,29H,5-8,15-18,20H2,1-4H3,(H,32,38)/t24-,29+/m1/s1 D08PBB DRUGINKE ZSDCIRYNTCVTMF-GIGWZHCTSA-N D08PBB DRUGSMIL CCCC(C1=CC2=C(C=C1)OCO2)NC(=O)N3C(C(C3=O)(CC)CC)OC4=CC=C(C=C4)C(=O)N5CCN(CC5)C D08PBB HIGHSTAT Phase 2 D08PXL DRUG__ID D08PXL D08PXL DRUGCOMP Merck D08PXL DRUGINCH 1S/C24H25F3N4O3S/c1-13-8-14(10-15(9-13)30-21-28-7-5-18(31-21)24(25,26)27)17-11-29-20(35-17)23(34)6-4-16(19(32)33)22(2,3)12-23/h5,7-11,16,34H,4,6,12H2,1-3H3,(H,32,33)(H,28,30,31)/t16-,23-/m1/s1 D08PXL DRUGINKE LDDBKIFZPGDEND-WAIKUNEKSA-N D08PXL DRUGSMIL CC1=CC(=CC(=C1)NC2=NC=CC(=N2)C(F)(F)F)C3=CN=C(S3)C4(CCC(C(C4)(C)C)C(=O)O)O D08PXL HIGHSTAT Phase 2 D08SCL DRUG__ID D08SCL D08SCL DRUGCOMP Merck D08SCL DRUGINCH 1S/C23H21N5O3S/c1-14-8-15(11-24-10-14)19-9-17(18(13-26-19)23-25-6-7-32-23)21(29)27-12-16-4-5-20(30-2)22(28-16)31-3/h4-11,13H,12H2,1-3H3,(H,27,29) D08SCL DRUGINKE VSOUDUXMPUHJEU-UHFFFAOYSA-N D08SCL DRUGSMIL CC1=CC(=CN=C1)C2=NC=C(C(=C2)C(=O)NCC3=NC(=C(C=C3)OC)OC)C4=NC=CS4 D08SCL HIGHSTAT Phase 2 D08TRG DRUG__ID D08TRG D08TRG DRUGCOMP AstraZeneca plc D08TRG DRUGINCH 1S/C11H15N3O2S/c1-7(2)16-6-5-14-8-3-4-12-9(8)10(15)13-11(14)17/h3-4,7,12H,5-6H2,1-2H3,(H,13,15,17) D08TRG DRUGINKE FVJCUZCRPIMVLB-UHFFFAOYSA-N D08TRG DRUGSMIL CC(C)OCCN1C2=C(C(=O)NC1=S)NC=C2 D08TRG HIGHSTAT Phase 2 D08UUL DRUG__ID D08UUL D08UUL DRUGCOMP Eli Lilly, Indianapolis, IN D08UUL DRUGINCH 1S/C18H19N7O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25) D08UUL DRUGINKE DOTGPNHGTYJDEP-UHFFFAOYSA-N D08UUL DRUGSMIL COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N D08UUL HIGHSTAT Phase 2 D08UYM DRUG__ID D08UYM D08UYM DRUGCOMP Ono Pharmaceutical Co Ltd D08UYM DRUGINCH 1S/C22H27ClN4O/c1-5-14(6-2)24-21-17-8-7-9-19(17)25-22-20(13(3)26-27(21)22)16-11-10-15(28-4)12-18(16)23/h10-12,14,24H,5-9H2,1-4H3 D08UYM DRUGINKE LDIOUQIXNSSOGU-UHFFFAOYSA-N D08UYM DRUGSMIL CCC(CC)NC1=C2CCCC2=NC3=C(C(=NN31)C)C4=C(C=C(C=C4)OC)Cl D08UYM HIGHSTAT Phase 2 D08VIS DRUG__ID D08VIS D08VIS DRUGCOMP Aerpio Therapeutics D08VIS DRUGINCH 1S/C26H26N4O6S3/c1-36-26(32)29-21(15-17-6-3-2-4-7-17)24(31)27-20(22-16-38-25(28-22)23-8-5-13-37-23)14-18-9-11-19(12-10-18)30-39(33,34)35/h2-13,16,20-21,30H,14-15H2,1H3,(H,27,31)(H,29,32)(H,33,34,35)/t20-,21-/m0/s1 D08VIS DRUGINKE KWJDHELCGJFUHW-SFTDATJTSA-N D08VIS DRUGSMIL COC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)NS(=O)(=O)O)C3=CSC(=N3)C4=CC=CS4 D08VIS HIGHSTAT Phase 2 D08VVR DRUG__ID D08VVR D08VVR DRUGCOMP Toa Eiyo KK D08VVR DRUGINCH 1S/C14H20N4O5S.Na/c1-8-11(13(19)18-14(15)16)6-9-4-2-3-5-10(12(9)17-8)7-23-24(20,21)22;/h6,10H,2-5,7H2,1H3,(H,20,21,22)(H4,15,16,18,19);/q;+1/p-1 D08VVR DRUGINKE ZLKLPVRVDNGUND-UHFFFAOYSA-M D08VVR DRUGSMIL CC1=C(C=C2CCCCC(C2=N1)COS(=O)(=O)O)C(=NC(=N)N)[O-].[Na+] D08VVR HIGHSTAT Phase 2 D08VWO DRUG__ID D08VWO D08VWO DRUGCOMP Novartis D08VWO DRUGINCH 1S/C60H63N13O13S6/c1-28(2)44-58-72-47(39(92-58)23-85-5)51(80)62-22-42(75)69-48(49(78)30-11-7-6-8-12-30)57-67-38(26-89-57)55-65-36(24-88-55)46-33(53-66-37(25-87-53)50(79)64-35(21-41(74)61-4)56-71-45(29(3)91-56)52(81)70-44)18-19-34(63-46)54-68-40(27-90-54)73(20-10-9-13-43(76)77)60(84)86-32-16-14-31(15-17-32)59(82)83/h6-8,11-12,18-19,24-28,31-32,35,44,48-49,78H,9-10,13-17,20-23H2,1-5H3,(H,61,74)(H,62,80)(H,64,79)(H,69,75)(H,70,81)(H,76,77)(H,82,83)/t31?,32?,35-,44-,48-,49-/m0/s1 D08VWO DRUGINKE GNLYKLDXQZHYTR-QWSGWXDSSA-N D08VWO DRUGSMIL CC1=C2C(=O)NC(C3=NC(=C(S3)COC)C(=O)NCC(=O)NC(C4=NC(=CS4)C5=NC(=CS5)C6=C(C=CC(=N6)C7=NC(=CS7)N(CCCCC(=O)O)C(=O)OC8CCC(CC8)C(=O)O)C9=NC(=CS9)C(=O)NC(C(=N2)S1)CC(=O)NC)C(C1=CC=CC=C1)O)C(C)C D08VWO HIGHSTAT Phase 2 D08XOY DRUG__ID D08XOY D08XOY DRUGCOMP Abbott Laboratories D08XOY DRUGINCH 1S/C17H19N3OS/c1-2-4-12(5-3-1)16-18-19-17(22-16)21-15-13-6-11-7-14(15)10-20(8-11)9-13/h1-5,11,13-15H,6-10H2 D08XOY DRUGINKE QZDCYUCETTWCMO-UHFFFAOYSA-N D08XOY DRUGSMIL C1C2CC3CN(C2)CC1C3OC4=NN=C(S4)C5=CC=CC=C5 D08XOY HIGHSTAT Phase 2 D09AFI DRUG__ID D09AFI D09AFI DRUGTYPE Small molecular drug D09AFI DRUGINCH 1S/C26H23F4N9O/c27-20-18(1-7-32-22(20)26(28,29)30)24(40)37-9-3-17(4-10-37)38-13-25(14-38,5-6-31)39-12-16(11-36-39)21-19-2-8-33-23(19)35-15-34-21/h1-2,7-8,11-12,15,17H,3-5,9-10,13-14H2,(H,33,34,35) D09AFI DRUGINKE KTBSXLIQKWEBRB-UHFFFAOYSA-N D09AFI DRUGSMIL C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F D09AFI HIGHSTAT Phase 2 D09AYQ DRUG__ID D09AYQ D09AYQ DRUGTYPE Small molecular drug D09AYQ DRUGINCH 1S/C17H19N5O2/c1-9-11(6-10-7-12(23-2)4-5-13(10)24-3)8-20-16-14(9)15(18)21-17(19)22-16/h4-5,7-8H,6H2,1-3H3,(H4,18,19,20,21,22) D09AYQ DRUGINKE VJXSSYDSOJBUAV-UHFFFAOYSA-N D09AYQ DRUGSMIL CC1=C2C(=NC(=NC2=NC=C1CC3=C(C=CC(=C3)OC)OC)N)N D09AYQ HIGHSTAT Phase 2 D09BDE DRUG__ID D09BDE D09BDE DRUGCOMP Pacific Pharmaceuticals Co Ltd D09BDE DRUGINCH 1S/C21H22F5N3O3S/c1-4-5-17-13(6-8-18(28-17)21(24,25)26)7-9-19(30)27-12(2)14-10-15(22)20(16(23)11-14)29-33(3,31)32/h6-12,29H,4-5H2,1-3H3,(H,27,30)/b9-7+/t12-/m1/s1 D09BDE DRUGINKE UKGJZDSUJSPAJL-YPUOHESYSA-N D09BDE DRUGSMIL CCCC1=C(C=CC(=N1)C(F)(F)F)C=CC(=O)NC(C)C2=CC(=C(C(=C2)F)NS(=O)(=O)C)F D09BDE HIGHSTAT Phase 2 D09BDH DRUG__ID D09BDH D09BDH DRUGCOMP OxyPharma AB D09BDH DRUGINCH 1S/C22H24ClN5O/c1-13-9-17-18(10-14(13)2)26-22-21(25-17)16-11-15(23)5-6-19(16)28(22)12-20(29)24-7-8-27(3)4/h5-6,9-11H,7-8,12H2,1-4H3,(H,24,29) D09BDH DRUGINKE PDNNUMNEXITLCZ-UHFFFAOYSA-N D09BDH DRUGSMIL CC1=CC2=C(C=C1C)N=C3C(=N2)C4=C(N3CC(=O)NCCN(C)C)C=CC(=C4)Cl D09BDH HIGHSTAT Phase 2 D09DFB DRUG__ID D09DFB D09DFB DRUGTYPE Small molecular drug D09DFB DRUGINCH 1S/C21H32N6O3.H2O4S.H2O/c1-24-17(13-15-7-3-2-4-8-15)20(30)27-12-6-10-18(27)19(29)26-16(14-28)9-5-11-25-21(22)23;1-5(2,3)4;/h2-4,7-8,14,16-18,24H,5-6,9-13H2,1H3,(H,26,29)(H4,22,23,25);(H2,1,2,3,4);1H2/t16-,17+,18-;;/m0../s1 D09DFB DRUGINKE JJJFZLGPEFEADH-VWRRVXQQSA-N D09DFB DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C=O.O.OS(=O)(=O)O D09DFB HIGHSTAT Phase 2 D09DHT DRUG__ID D09DHT D09DHT DRUGTYPE Small molecular drug D09DHT DRUGINCH 1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1 D09DHT DRUGINKE PHEDXBVPIONUQT-RGYGYFBISA-N D09DHT DRUGSMIL CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C)O)C D09DHT HIGHSTAT Phase 2 D09EHO DRUG__ID D09EHO D09EHO DRUGTYPE Small molecular drug D09EHO DRUGINCH 1S/C18H17N3O4S/c1-25-15-8-10-16(11-9-15)26(23,24)21-17-3-2-12-19-18(17)20-13-4-6-14(22)7-5-13/h2-12,21-22H,1H3,(H,19,20) D09EHO DRUGINKE URCVCIZFVQDVPM-UHFFFAOYSA-N D09EHO DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O D09EHO HIGHSTAT Phase 2 D09GHO DRUG__ID D09GHO D09GHO DRUGTYPE Small molecular drug D09GHO DRUGINCH 1S/C21H22FN3O/c1-25-10-8-14(9-11-25)19-13-23-20-7-6-17(12-18(19)20)24-21(26)15-2-4-16(22)5-3-15/h2-7,12-14,23H,8-11H2,1H3,(H,24,26) D09GHO DRUGINKE MDMJLMDBRQXOOI-UHFFFAOYSA-N D09GHO DRUGSMIL CN1CCC(CC1)C2=CNC3=C2C=C(C=C3)NC(=O)C4=CC=C(C=C4)F D09GHO HIGHSTAT Phase 2 D09JES DRUG__ID D09JES D09JES DRUGTYPE Small molecular drug D09JES DRUGINCH 1S/C26H40N4O9S/c1-40(38,39)30-20(6-2-5-13-27)22(32)28-16-18(23(33)34)15-26(11-3-4-12-26)25(37)29-21(24(35)36)14-17-7-9-19(31)10-8-17/h7-10,18,20-21,30-31H,2-6,11-16,27H2,1H3,(H,28,32)(H,29,37)(H,33,34)(H,35,36)/t18-,20-,21-/m0/s1 D09JES DRUGINKE LPUDGHQMOAHMMF-JBACZVJFSA-N D09JES DRUGSMIL CS(=O)(=O)NC(CCCCN)C(=O)NCC(CC1(CCCC1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)C(=O)O D09JES HIGHSTAT Phase 2 D09JGH DRUG__ID D09JGH D09JGH DRUGCOMP Endocyte; Merck D09JGH DRUGINCH 1S/C86H109N21O26S2/c1-6-82(129)35-42-36-85(78(127)132-5,64-47(21-26-106(39-42)41-82)46-12-8-9-13-50(46)95-64)49-30-48-57(34-58(49)131-4)105(3)75-84(48)23-27-107-25-11-22-83(7-2,74(84)107)76(125)86(75,130)77(126)103-104-81(128)133-28-29-134-135-40-56(73(123)124)100-70(119)55(33-62(113)114)99-69(118)54(32-61(111)112)98-67(116)51(14-10-24-90-79(87)88)96-68(117)53(31-60(109)110)94-59(108)20-19-52(72(121)122)97-66(115)43-15-17-44(18-16-43)91-37-45-38-92-65-63(93-45)71(120)102-80(89)101-65/h8-9,11-13,15-18,22,30,34,38,42,51-56,74-76,91,95,125,129-130H,6-7,10,14,19-21,23-29,31-33,35-37,39-41H2,1-5H3,(H,94,108)(H,96,117)(H,97,115)(H,98,116)(H,99,118)(H,100,119)(H,103,126)(H,104,128)(H,109,110)(H,111,112)(H,113,114)(H,121,122)(H,123,124)(H4,87,88,90)(H3,89,92,101,102,120)/t42-,51-,52-,53-,54-,55-,56-,74-,75+,76+,82-,83+,84+,85-,86-/m0/s1 D09JGH DRUGINKE KUZYSQSABONDME-QRLOMCMNSA-N D09JGH DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NNC(=O)OCCSSCC(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)CCC(C(=O)O)NC(=O)C1=CC=C(C=C1)NCC1=CN=C2C(=N1)C(=O)NC(=N2)N)O)O)CC)OC)C(=O)OC)O D09JGH HIGHSTAT Phase 2 D09JXH DRUG__ID D09JXH D09JXH DRUGCOMP Lumena pharmaceuticals D09JXH DRUGINCH 1S/C40H56N3O4S.ClH/c1-5-7-19-40(20-8-6-2)30-48(45,46)37-18-15-34(41(3)4)27-36(37)38(39(40)44)33-13-16-35(17-14-33)47-29-32-11-9-31(10-12-32)28-43-24-21-42(22-25-43)23-26-43;/h9-18,27,38-39,44H,5-8,19-26,28-30H2,1-4H3;1H/q+1;/p-1/t38-,39-;/m1./s1 D09JXH DRUGINKE POMVPJBWDDJCMP-RUKDTIIFSA-M D09JXH DRUGSMIL CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC.[Cl-] D09JXH HIGHSTAT Phase 2 D09KTI DRUG__ID D09KTI D09KTI DRUGCOMP GILEAD D09KTI DRUGINCH 1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1 D09KTI DRUGINKE FHCUMDQMBHQXKK-CDIODLITSA-N D09KTI DRUGSMIL CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC D09KTI HIGHSTAT Phase 2 D09LEP DRUG__ID D09LEP D09LEP DRUGTYPE Small molecular drug D09LEP DRUGINCH 1S/C22H26O3/c1-15(2)10-19-20(22(19,3)4)21(23)25-14-17-12-18(24-13-17)11-16-8-6-5-7-9-16/h5-10,12-13,19-20H,11,14H2,1-4H3 D09LEP DRUGINKE VEMKTZHHVJILDY-UHFFFAOYSA-N D09LEP DRUGSMIL CC(=CC1C(C1(C)C)C(=O)OCC2=COC(=C2)CC3=CC=CC=C3)C D09LEP HIGHSTAT Phase 2 D09LPV DRUG__ID D09LPV D09LPV DRUGTYPE Small molecular drug D09LPV DRUGINCH 1S/C24H22N4O3/c1-16-14-18(24(25)31)4-9-21(16)28-20(8-11-23(29)30)7-10-22(28)17-2-5-19(6-3-17)27-13-12-26-15-27/h2-7,9-10,12-15H,8,11H2,1H3,(H2,25,31)(H,29,30) D09LPV DRUGINKE YVPGZQLRPAGKLA-UHFFFAOYSA-N D09LPV DRUGSMIL CC1=C(C=CC(=C1)C(=O)N)N2C(=CC=C2C3=CC=C(C=C3)N4C=CN=C4)CCC(=O)O D09LPV HIGHSTAT Phase 2 D09LQK DRUG__ID D09LQK D09LQK DRUGTYPE Small molecular drug D09LQK DRUGINCH 1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23+,24-,26+/m0/s1 D09LQK DRUGINKE VYCMAAOURFJIHD-PJNXIOHISA-N D09LQK DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43 D09LQK HIGHSTAT Phase 2 D09MIN DRUG__ID D09MIN D09MIN DRUGCOMP Novartis D09MIN DRUGINCH 1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1 D09MIN DRUGINKE UFPFGVNKHCLJJO-SSKFGXFMSA-N D09MIN DRUGSMIL CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC D09MIN HIGHSTAT Phase 2 D09OKZ DRUG__ID D09OKZ D09OKZ DRUGCOMP OXiGENE South San Francisco, CA D09OKZ DRUGINCH 1S/C18H22O6/c1-21-15-6-5-11(8-14(15)20)7-13(19)12-9-16(22-2)18(24-4)17(10-12)23-3/h5-6,8-10,13,19-20H,7H2,1-4H3/t13-/m0/s1 D09OKZ DRUGINKE LGZKGOGODCLQHG-ZDUSSCGKSA-N D09OKZ DRUGSMIL COC1=C(C=C(C=C1)CC(C2=CC(=C(C(=C2)OC)OC)OC)O)O D09OKZ HIGHSTAT Phase 2 D09OTU DRUG__ID D09OTU D09OTU DRUGTYPE Small molecular drug D09OTU DRUGINCH 1S/C21H19ClN4O2/c1-24(2)18(27)12-16-19-15-10-9-13(22)11-17(15)25(3)20(19)21(28)26(23-16)14-7-5-4-6-8-14/h4-11H,12H2,1-3H3 D09OTU DRUGINKE HJSQVJOROCIILI-UHFFFAOYSA-N D09OTU DRUGSMIL CN1C2=C(C=CC(=C2)Cl)C3=C1C(=O)N(N=C3CC(=O)N(C)C)C4=CC=CC=C4 D09OTU HIGHSTAT Phase 2 D09OWK DRUG__ID D09OWK D09OWK DRUGTYPE Small molecular drug D09OWK DRUGINCH 1S/C19H28N2O3/c1-18(2)13-16(22)20-17(23)19(18,10-7-11-21(3)4)14-8-6-9-15(12-14)24-5/h6,8-9,12H,7,10-11,13H2,1-5H3,(H,20,22,23) D09OWK DRUGINKE UJFNSGBGJMRZKS-UHFFFAOYSA-N D09OWK DRUGSMIL CC1(CC(=O)NC(=O)C1(CCCN(C)C)C2=CC(=CC=C2)OC)C D09OWK HIGHSTAT Phase 2 D09QAD DRUG__ID D09QAD D09QAD DRUGTYPE Small molecular drug D09QAD DRUGINCH 1S/C15H21NO2.ClH/c1-2-8-16-9-4-6-11-12-5-3-7-14(17)15(12)18-10-13(11)16;/h3,5,7,11,13,17H,2,4,6,8-10H2,1H3;1H/t11-,13-;/m0./s1 D09QAD DRUGINKE CEVXGMUELSDOPY-JZKFLRDJSA-N D09QAD DRUGSMIL CCCN1CCCC2C1COC3=C2C=CC=C3O.Cl D09QAD HIGHSTAT Phase 2 D09TFB DRUG__ID D09TFB D09TFB DRUGTYPE Small molecular drug D09TFB DRUGINCH 1S/C18H21N5S/c1-2-14-13-9-10-22-17(15-8-5-11-24-15)19-20-18(22)16(13)23(21-14)12-6-3-4-7-12/h5,8,11-12H,2-4,6-7,9-10H2,1H3 D09TFB DRUGINKE DHCOPPHTVOXDKU-UHFFFAOYSA-N D09TFB DRUGSMIL CCC1=NN(C2=C1CCN3C2=NN=C3C4=CC=CS4)C5CCCC5 D09TFB HIGHSTAT Phase 2 D09TFL DRUG__ID D09TFL D09TFL DRUGCOMP Pharmacyclics Sunnyvale, CA D09TFL DRUGINCH 1S/C26H24N6O9S/c27-24(28)12-1-3-17-18(8-12)32-25(31-17)16-6-11(7-21(34)30-19(26(38)39)10-22(35)36)5-15(23(16)37)14-9-13(42(29,40)41)2-4-20(14)33/h1-6,8-9,19,33,37H,7,10H2,(H3,27,28)(H,30,34)(H,31,32)(H,35,36)(H,38,39)(H2,29,40,41)/t19-/m0/s1 D09TFL DRUGINKE WDJHHCAKBRKCLW-IBGZPJMESA-N D09TFL DRUGSMIL C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC(=CC(=C3O)C4=C(C=CC(=C4)S(=O)(=O)N)O)CC(=O)NC(CC(=O)O)C(=O)O D09TFL HIGHSTAT Phase 2 D09UZL DRUG__ID D09UZL D09UZL DRUGCOMP Takeda D09UZL DRUGINCH 1S/C23H17FN6O2/c1-32-21-15-29(19-9-8-17(14-18(19)24)28-13-5-11-25-28)27-22(23(21)31)20-10-12-26-30(20)16-6-3-2-4-7-16/h2-15H,1H3 D09UZL DRUGINKE KVHRYLNQDWXAGI-UHFFFAOYSA-N D09UZL DRUGSMIL COC1=CN(N=C(C1=O)C2=CC=NN2C3=CC=CC=C3)C4=C(C=C(C=C4)N5C=CC=N5)F D09UZL HIGHSTAT Phase 2 D09XLS DRUG__ID D09XLS D09XLS DRUGTYPE Small molecular drug D09XLS DRUGINCH 1S/C33H44N6O5/c1-22(2)18-26(37-33(44)39-16-10-4-5-11-17-39)30(40)35-27(19-23-21-38(3)29-14-7-6-13-25(23)29)31(41)36-28(32(42)43)20-24-12-8-9-15-34-24/h6-9,12-15,21-22,26-28H,4-5,10-11,16-20H2,1-3H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43)/t26-,27+,28+/m0/s1 D09XLS DRUGINKE LIOKMIQQPDDTNO-UPRLRBBYSA-N D09XLS DRUGSMIL CC(C)CC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C)C(=O)NC(CC3=CC=CC=N3)C(=O)O)NC(=O)N4CCCCCC4 D09XLS HIGHSTAT Phase 2 D0A0SI DRUG__ID D0A0SI D0A0SI DRUGCOMP Bayer HealthCare Pharmaceuticals D0A0SI DRUGINCH 1S/C22H17F3N4O3S/c1-13-18(12-27)20(17-8-7-14(11-26)9-19(17)33(3,31)32)28(2)21(30)29(13)16-6-4-5-15(10-16)22(23,24)25/h4-10,20H,1-3H3/t20-/m1/s1 D0A0SI DRUGINKE YAJWYFPMASPAMM-HXUWFJFHSA-N D0A0SI DRUGSMIL CC1=C(C(N(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C)C3=C(C=C(C=C3)C#N)S(=O)(=O)C)C#N D0A0SI HIGHSTAT Phase 2 D0A3NN DRUG__ID D0A3NN D0A3NN DRUGCOMP Antigenics D0A3NN DRUGINCH 1S/2C10H20O2.C6H14N2.Pt/c2*1-10(2,3)8-6-4-5-7-9(11)12;7-5-3-1-2-4-6(5)8;/h2*4-8H2,1-3H3,(H,11,12);5-6H,1-4,7-8H2;/q;;;+2/p-2 D0A3NN DRUGINKE PZAQDVNYNJBUTM-UHFFFAOYSA-L D0A3NN DRUGSMIL CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2] D0A3NN HIGHSTAT Phase 2 D0A4YK DRUG__ID D0A4YK D0A4YK DRUGCOMP Phoenix Biotechnology D0A4YK DRUGINCH 1S/C32H48O9/c1-17-29(35)24(37-5)14-27(39-17)41-21-8-10-30(3)20(13-21)6-7-23-22(30)9-11-31(4)28(19-12-26(34)38-16-19)25(40-18(2)33)15-32(23,31)36/h12,17,20-25,27-29,35-36H,6-11,13-16H2,1-5H3/t17-,20+,21-,22-,23+,24-,25-,27-,28-,29-,30-,31+,32-/m0/s1 D0A4YK DRUGINKE JLPDBLFIVFSOCC-XYXFTTADSA-N D0A4YK DRUGSMIL CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC(=O)C)O)C)C)OC)O D0A4YK HIGHSTAT Phase 2 D0A5FD DRUG__ID D0A5FD D0A5FD DRUGCOMP Arbor Pharmaceuticals Atlanta, GA D0A5FD DRUGINCH 1S/C14H22N2O3.HI/c1-10(16(3,4)5)11-7-8-12(18-6)13(9-11)19-14(17)15-2;/h7-10H,1-6H3;1H D0A5FD DRUGINKE WOISFDDSLXQGKE-UHFFFAOYSA-N D0A5FD DRUGSMIL CC(C1=CC(=C(C=C1)OC)OC(=O)NC)[N+](C)(C)C.[I-] D0A5FD HIGHSTAT Phase 2 D0A5MR DRUG__ID D0A5MR D0A5MR DRUGTYPE Small molecular drug D0A5MR DRUGINCH 1S/C7H8N6/c1-2-4-5(3-1)8-9-6(4)7-10-12-13-11-7/h1-3H2,(H,8,9)(H,10,11,12,13) D0A5MR DRUGINKE LTQYSJKGRPGMPO-UHFFFAOYSA-N D0A5MR DRUGSMIL C1CC2=C(C1)NN=C2C3=NNN=N3 D0A5MR HIGHSTAT Phase 2 D0AC8W DRUG__ID D0AC8W D0AC8W DRUGTYPE Small molecular drug D0AC8W DRUGINCH 1S/C56H79N15O9/c1-29(2)18-35(25-61-42(50(58)74)19-30(3)4)66-55(79)45(21-34-24-59-28-64-34)68-48(73)27-63-56(80)49(31(5)6)71-51(75)32(7)65-54(78)44(20-33-23-60-39-14-10-8-12-36(33)39)70-52(76)41(16-17-47(57)72)69-53(77)43-22-38-37-13-9-11-15-40(37)67-46(38)26-62-43/h8-15,23-24,28-32,35,41-45,49,60-62,67H,16-22,25-27H2,1-7H3,(H2,57,72)(H2,58,74)(H,59,64)(H,63,80)(H,65,78)(H,66,79)(H,68,73)(H,69,77)(H,70,76)(H,71,75)/t32-,35-,41-,42-,43+,44-,45-,49-/m0/s1 D0AC8W DRUGINKE IUYCRRDHLJIJBB-QAGBKCHLSA-N D0AC8W DRUGSMIL CC(C)CC(CNC(CC(C)C)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)C4CC5=C(CN4)NC6=CC=CC=C56 D0AC8W HIGHSTAT Phase 2 D0AD4D DRUG__ID D0AD4D D0AD4D DRUGCOMP Cardioxyl Pharmaceuticals D0AD4D DRUGINCH 1S/C7H9NO5S2/c1-14(10,11)6-4-2-3-5-7(6)15(12,13)8-9/h2-5,8-9H,1H3 D0AD4D DRUGINKE RZRWBKKAFHXNEQ-UHFFFAOYSA-N D0AD4D DRUGSMIL CS(=O)(=O)C1=CC=CC=C1S(=O)(=O)NO D0AD4D HIGHSTAT Phase 2 D0AG8L DRUG__ID D0AG8L D0AG8L DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0AG8L DRUGINCH 1S/C5H7NO4S/c1-4-2-3-5(10-4)11(8,9)6-7/h2-3,6-7H,1H3 D0AG8L DRUGINKE LIXKIXWSKOENAB-UHFFFAOYSA-N D0AG8L DRUGSMIL CC1=CC=C(O1)S(=O)(=O)NO D0AG8L HIGHSTAT Phase 2 D0AX1N DRUG__ID D0AX1N D0AX1N DRUGCOMP Isis Pharmaceuticals & OncoGenex D0AX1N THERCLAS Antisense D0AX1N DRUGTYPE Antisense drug D0AX1N DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=O)(OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)CO)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)S)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=CNC2=N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O D0AX1N HIGHSTAT Phase 2 D0B1SG DRUG__ID D0B1SG D0B1SG DRUGCOMP Bristol-myers squibb D0B1SG DRUGINCH 1S/C25H40N8O2/c1-15(34)28-18-12-16(30-25(5,6)7)8-9-19(18)32-11-10-17(22(32)35)29-23-27-14-26-21-13-20(24(2,3)4)31-33(21)23/h13-14,16-19,30H,8-12H2,1-7H3,(H,28,34)(H,26,27,29)/t16-,17+,18-,19+/m1/s1 D0B1SG DRUGINKE CMVHFGNTABZQJU-HCXYKTFWSA-N D0B1SG DRUGSMIL CC(=O)NC1CC(CCC1N2CCC(C2=O)NC3=NC=NC4=CC(=NN43)C(C)(C)C)NC(C)(C)C D0B1SG HIGHSTAT Phase 2 D0B1VZ DRUG__ID D0B1VZ D0B1VZ DRUGCOMP Allegro Ophthalmics D0B1VZ DRUGINCH 1S/C22H39N9O11S/c1-11(32)17(20(37)31-7-3-5-14(31)21(38)39)30-19(36)13(10-43(40,41)42)29-16(34)9-27-18(35)12(28-15(33)8-23)4-2-6-26-22(24)25/h11-14,17,32H,2-10,23H2,1H3,(H,27,35)(H,28,33)(H,29,34)(H,30,36)(H,38,39)(H4,24,25,26)(H,40,41,42)/t11-,12+,13+,14+,17+/m1/s1 D0B1VZ DRUGINKE MYZAXBZLEILEBR-RVFOSREFSA-N D0B1VZ DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)CN)O D0B1VZ HIGHSTAT Phase 2 D0B7QU DRUG__ID D0B7QU D0B7QU DRUGCOMP AIM Therapeutics Inc D0B7QU DRUGINCH 1S/C16H27N3O6/c17-11(8-10-4-2-1-3-5-10)15(24)19-12(6-7-13(20)21)16(25)18-9-14(22)23/h10-12H,1-9,17H2,(H,18,25)(H,19,24)(H,20,21)(H,22,23)/t11-,12-/m1/s1 D0B7QU DRUGINKE CNDMSQXUUIBFPE-VXGBXAGGSA-N D0B7QU DRUGSMIL C1CCC(CC1)CC(C(=O)NC(CCC(=O)O)C(=O)NCC(=O)O)N D0B7QU HIGHSTAT Phase 2 D0B8TK DRUG__ID D0B8TK D0B8TK DRUGCOMP Lexicon Pharmaceuticals D0B8TK DRUGINCH 1S/C22H20ClN3O/c23-20-4-1-3-19(15-20)16-5-7-17(8-6-16)21(27)18-9-13-26(14-10-18)22-24-11-2-12-25-22/h1-8,11-12,15,18H,9-10,13-14H2 D0B8TK DRUGINKE VHTIWIZIPOXSNP-UHFFFAOYSA-N D0B8TK DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)C3=CC(=CC=C3)Cl)C4=NC=CC=N4 D0B8TK HIGHSTAT Phase 2 D0B9DM DRUG__ID D0B9DM D0B9DM DRUGCOMP Shionogi D0B9DM DRUGINCH 1S/C24H27N3O7S/c1-17(2)34-19-4-6-20(7-5-19)35(30,31)27-12-10-26(11-13-27)18-3-8-21(24-25-9-14-32-24)22(15-18)33-16-23(28)29/h3-9,14-15,17H,10-13,16H2,1-2H3,(H,28,29) D0B9DM DRUGINKE ZMZNWNTZRWXTJU-UHFFFAOYSA-N D0B9DM DRUGSMIL CC(C)OC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=CC(=C(C=C3)C4=NC=CO4)OCC(=O)O D0B9DM HIGHSTAT Phase 2 D0B9RD DRUG__ID D0B9RD D0B9RD DRUGCOMP Alkeus Pharmaceuticals Inc D0B9RD DRUGINCH 1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9+,18-14+/i2D3 D0B9RD DRUGINKE QGNJRVVDBSJHIZ-QJZZLBIKSA-N D0B9RD DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C D0B9RD HIGHSTAT Phase 2 D0BA8M DRUG__ID D0BA8M D0BA8M DRUGTYPE Small molecular drug D0BA8M DRUGINCH 1S/C15H12Cl2N2O4S/c16-12-3-1-10(8-13(12)17)18-15(20)19-24(21,22)11-2-4-14-9(7-11)5-6-23-14/h1-4,7-8H,5-6H2,(H2,18,19,20) D0BA8M DRUGINKE VAMFSFIPDOODFH-UHFFFAOYSA-N D0BA8M DRUGSMIL C1COC2=C1C=C(C=C2)S(=O)(=O)NC(=O)NC3=CC(=C(C=C3)Cl)Cl D0BA8M HIGHSTAT Phase 2 D0BE0Z DRUG__ID D0BE0Z D0BE0Z DRUGCOMP MicuRx Pharmaceuticals Hayward, CA D0BE0Z DRUGINCH 1S/C20H18F3N4O8P.Na/c1-11(28)35-36(31,32)27(16-4-7-33-24-16)10-13-9-26(20(30)34-13)15-8-14(21)19(18(23)17(15)22)25-5-2-12(29)3-6-25;/h2,4-5,7-8,13H,3,6,9-10H2,1H3,(H,31,32);/q;+1/p-1/t13-;/m1./s1 D0BE0Z DRUGINKE JANNTEAGZXJITO-BTQNPOSSSA-M D0BE0Z DRUGSMIL CC(=O)OP(=O)(N(CC1CN(C(=O)O1)C2=CC(=C(C(=C2F)F)N3CCC(=O)C=C3)F)C4=NOC=C4)[O-].[Na+] D0BE0Z HIGHSTAT Phase 2 D0BF4Z DRUG__ID D0BF4Z D0BF4Z DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0BF4Z DRUGINCH 1S/C25H35NO5S/c1-4-20-5-7-23(8-6-20)26(16-19(2)3)32(28,29)24-9-10-25(22(15-24)17-27)31-18-21-11-13-30-14-12-21/h5-10,15,19,21,27H,4,11-14,16-18H2,1-3H3 D0BF4Z DRUGINKE LZLBRISQTJVZNP-UHFFFAOYSA-N D0BF4Z DRUGSMIL CCC1=CC=C(C=C1)N(CC(C)C)S(=O)(=O)C2=CC(=C(C=C2)OCC3CCOCC3)CO D0BF4Z HIGHSTAT Phase 2 D0BI3N DRUG__ID D0BI3N D0BI3N DRUGCOMP Portola Pharmaceuticals Inc; portola pharmaceuticals D0BI3N DRUGINCH 1S/C20H27N7O3S/c1-2-31(29,30)27-11-9-26(10-12-27)16-7-5-15(6-8-16)24-20-22-13-17(18(21)28)19(25-20)23-14-3-4-14/h5-8,13-14H,2-4,9-12H2,1H3,(H2,21,28)(H2,22,23,24,25) D0BI3N DRUGINKE BGLPECHZZQDNCD-UHFFFAOYSA-N D0BI3N DRUGSMIL CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N D0BI3N HIGHSTAT Phase 2 D0BO7U DRUG__ID D0BO7U D0BO7U DRUGCOMP BioMimetix Greenwood Village, CO D0BO7U DRUGINCH 1S/C64H76N8O4.5ClH.Mn/c1-5-9-41-73-45-37-69-33-17-13-21-57(69)61-49-25-27-51(65-49)62(58-22-14-18-34-70(58)38-46-74-42-10-6-2)53-29-31-55(67-53)64(60-24-16-20-36-72(60)40-48-76-44-12-8-4)56-32-30-54(68-56)63(52-28-26-50(61)66-52)59-23-15-19-35-71(59)39-47-75-43-11-7-3;;;;;;/h13-36H,5-12,37-48H2,1-4H3;5*1H;/q+2;;;;;;+3/p-5 D0BO7U DRUGINKE FVIXMTYHFFAYDY-UHFFFAOYSA-I D0BO7U DRUGSMIL CCCCOCCN1C=CC=CC1=C2C3=NC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=CC=CC=[N+]7CCOCCCC)C8=CC=CC=[N+]8CCOCCCC)C=C4)C9=CC=CC=[N+]9CCOCCCC)C=C3.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3] D0BO7U HIGHSTAT Phase 2 D0BW6F DRUG__ID D0BW6F D0BW6F DRUGCOMP Gilead Sciences Foster City, CA D0BW6F DRUGINCH 1S/C23H25N9O/c24-21-12-25-11-19(28-21)20-13-32-6-5-26-23(32)22(29-20)27-16-1-3-17(4-2-16)30-7-9-31(10-8-30)18-14-33-15-18/h1-6,11-13,18H,7-10,14-15H2,(H2,24,28)(H,27,29) D0BW6F DRUGINKE XCIGZBVOUQVIPI-UHFFFAOYSA-N D0BW6F DRUGSMIL C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N D0BW6F HIGHSTAT Phase 2 D0C0TU DRUG__ID D0C0TU D0C0TU DRUGCOMP SEIKAGAKU CORPORATION D0C0TU DRUGINCH 1S/C58H79Cl2N5O35/c1-17(69)62-29-42(32(73)24(14-66)90-53(29)88)93-58-41(82)38(79)46(49(100-58)52(86)87)97-55-31(64-19(3)71)44(34(75)26(16-68)92-55)95-57-40(81)37(78)45(48(99-57)50(83)61-11-12-89-27(72)13-20-7-4-5-10-23(20)65-28-21(59)8-6-9-22(28)60)96-54-30(63-18(2)70)43(33(74)25(15-67)91-54)94-56-39(80)35(76)36(77)47(98-56)51(84)85/h4-10,24-26,29-49,53-58,65-68,73-82,88H,11-16H2,1-3H3,(H,61,83)(H,62,69)(H,63,70)(H,64,71)(H,84,85)(H,86,87)/t24-,25-,26-,29-,30-,31-,32-,33-,34-,35+,36+,37-,38-,39-,40-,41-,42-,43-,44-,45+,46+,47+,48+,49+,53-,54+,55+,56-,57-,58-/m1/s1 D0C0TU DRUGINKE SBQKIAATAMGBFR-NOWFGEBOSA-N D0C0TU DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)C(=O)NCCOC(=O)CC5=CC=CC=C5NC6=C(C=CC=C6Cl)Cl)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)C(=O)O)O)O)O)NC(=O)C)O)O)NC(=O)C)O)O D0C0TU HIGHSTAT Phase 2 D0C1JV DRUG__ID D0C1JV D0C1JV DRUGCOMP Pfizer D0C1JV DRUGINCH 1S/C8H20N2O6S4/c9-7(1-3-19(11,12)13)5-17-18-6-8(10)2-4-20(14,15)16/h7-8H,1-6,9-10H2,(H,11,12,13)(H,14,15,16)/t7-,8-/m0/s1 D0C1JV DRUGINKE HJPXZXVKLGEMGP-YUMQZZPRSA-N D0C1JV DRUGSMIL C(CS(=O)(=O)O)C(CSSCC(CCS(=O)(=O)O)N)N D0C1JV HIGHSTAT Phase 2 D0C1WR DRUG__ID D0C1WR D0C1WR DRUGCOMP Amgen D0C1WR DRUGINCH 1S/C28H35Cl2NO5S/c1-17(2)24(16-37(35,36)18(3)4)31-26(19-9-11-21(29)12-10-19)23(20-7-6-8-22(30)13-20)14-28(5,27(31)34)15-25(32)33/h6-13,17-18,23-24,26H,14-16H2,1-5H3,(H,32,33)/t23-,24-,26-,28-/m1/s1 D0C1WR DRUGINKE DRLCSJFKKILATL-YWCVFVGNSA-N D0C1WR DRUGSMIL CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl D0C1WR HIGHSTAT Phase 2 D0C2FJ DRUG__ID D0C2FJ D0C2FJ DRUGTYPE Small molecular drug D0C2FJ DRUGINCH 1S/C27H25F3N6O/c28-27(29,30)23-8-4-7-21(15-23)24-9-10-35(26-22(16-31)17-32-36(24)26)25(37)19-34-13-11-33(12-14-34)18-20-5-2-1-3-6-20/h1-9,15,17H,10-14,18-19H2 D0C2FJ DRUGINKE KVRVFYBZHKPBDB-UHFFFAOYSA-N D0C2FJ DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)CC(=O)N3CC=C(N4C3=C(C=N4)C#N)C5=CC(=CC=C5)C(F)(F)F D0C2FJ HIGHSTAT Phase 2 D0C3BA DRUG__ID D0C3BA D0C3BA DRUGTYPE Small molecular drug D0C3BA DRUGINCH 1S/C22H22N8/c1-3-16-14-29(30-22(16)23-20(4-2)26-30)13-15-9-11-17(12-10-15)18-7-5-6-8-19(18)21-24-27-28-25-21/h5-12,14H,3-4,13H2,1-2H3,(H,24,25,27,28) D0C3BA DRUGINKE LASWNZRBIPFGHP-UHFFFAOYSA-N D0C3BA DRUGSMIL CCC1=CN(N2C1=NC(=N2)CC)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D0C3BA HIGHSTAT Phase 2 D0C3JB DRUG__ID D0C3JB D0C3JB DRUGCOMP Mustang Bio New York, NY D0C3JB DRUGINCH 1S/C12H16N6O8/c13-7-5(9(21)15-3(1-19)11(23)24)17-8(14)6(18-7)10(22)16-4(2-20)12(25)26/h3-4,19-20H,1-2H2,(H2,14,17)(H2,13,18)(H,15,21)(H,16,22)(H,23,24)(H,25,26)/t3-,4-/m1/s1 D0C3JB DRUGINKE XHNJXRDGTITISI-QWWZWVQMSA-N D0C3JB DRUGSMIL C(C(C(=O)O)NC(=O)C1=C(N=C(C(=N1)N)C(=O)NC(CO)C(=O)O)N)O D0C3JB HIGHSTAT Phase 2 D0C4QN DRUG__ID D0C4QN D0C4QN DRUGTYPE Small molecular drug D0C4QN DRUGINCH 1S/C28H39N7O9/c1-15(25(41)30-12-23(29)39)32-24(40)13-31-26(42)22-11-19(38)14-35(22)28(44)21-4-3-9-34(21)27(43)20(33-16(2)36)10-17-5-7-18(37)8-6-17/h5-8,15,19-22,37-38H,3-4,9-14H2,1-2H3,(H2,29,39)(H,30,41)(H,31,42)(H,32,40)(H,33,36)/t15-,19+,20-,21-,22-/m1/s1 D0C4QN DRUGINKE GFJRASPBQLDRRY-TWTQBQJDSA-N D0C4QN DRUGSMIL CC(C(=O)NCC(=O)N)NC(=O)CNC(=O)C1CC(CN1C(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C)O D0C4QN HIGHSTAT Phase 2 D0C4WC DRUG__ID D0C4WC D0C4WC DRUGCOMP University of Navarra D0C4WC DRUGINCH 1S/C68H109N17O22S2/c1-12-32(5)53(85-67(105)54(33(6)13-2)84-64(102)48(30-87)82-56(94)35(8)74-61(99)45(27-51(91)92)79-62(100)43(24-31(3)4)78-63(101)47(29-86)83-65(103)52(71)36(9)88)66(104)80-44(25-37-28-72-39-17-15-14-16-38(37)39)60(98)73-34(7)55(93)75-41(20-22-108-10)58(96)77-42(21-23-109-11)59(97)76-40(18-19-49(69)89)57(95)81-46(68(106)107)26-50(70)90/h14-17,28,31-36,40-48,52-54,72,86-88H,12-13,18-27,29-30,71H2,1-11H3,(H2,69,89)(H2,70,90)(H,73,98)(H,74,99)(H,75,93)(H,76,97)(H,77,96)(H,78,101)(H,79,100)(H,80,104)(H,81,95)(H,82,94)(H,83,103)(H,84,102)(H,85,105)(H,91,92)(H,106,107)/t32-,33-,34-,35-,36+,40-,41-,42-,43-,44-,45-,46-,47-,48-,52-,53-,54-/m0/s1 D0C4WC DRUGINKE IUYPEUHIWDMJLM-SWHDLQTQSA-N D0C4WC DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)N D0C4WC HIGHSTAT Phase 2 D0C5JQ DRUG__ID D0C5JQ D0C5JQ DRUGCOMP Janssen Research & Development D0C5JQ DRUGINCH 1S/C27H35N5O2/c1-25(2)11-9-17(10-12-25)22-21(32-24(33)23-29-16-19(15-28)30-23)8-7-20(31-22)18-13-26(3,4)34-27(5,6)14-18/h7-9,16,18H,10-14H2,1-6H3,(H,29,30)(H,32,33) D0C5JQ DRUGINKE BNVPFDRNGHMRJS-UHFFFAOYSA-N D0C5JQ DRUGSMIL CC1(CCC(=CC1)C2=C(C=CC(=N2)C3CC(OC(C3)(C)C)(C)C)NC(=O)C4=NC=C(N4)C#N)C D0C5JQ HIGHSTAT Phase 2 D0C6MS DRUG__ID D0C6MS D0C6MS DRUGCOMP Pfizer D0C6MS DRUGINCH 1S/C18H19F3N4O3/c19-18(20,21)14-9-25(10-23-14)13(7-11-3-1-2-4-11)16(26)24-15-6-5-12(8-22-15)17(27)28/h5-6,8-11,13H,1-4,7H2,(H,27,28)(H,22,24,26)/t13-/m0/s1 D0C6MS DRUGINKE GKMLFBRLRVQVJO-ZDUSSCGKSA-N D0C6MS DRUGSMIL C1CCC(C1)CC(C(=O)NC2=NC=C(C=C2)C(=O)O)N3C=C(N=C3)C(F)(F)F D0C6MS HIGHSTAT Phase 2 D0C9MA DRUG__ID D0C9MA D0C9MA DRUGCOMP Achillion Pharmaceuticals New Haven, CT D0C9MA DRUGINCH 1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1 D0C9MA DRUGINKE PIBARDGJJAGJAJ-NQIIRXRSSA-N D0C9MA DRUGSMIL CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4CC(CC4C(=O)NC5=NC(=CC=C5)Br)F D0C9MA HIGHSTAT Phase 2 D0C9PZ DRUG__ID D0C9PZ D0C9PZ DRUGCOMP Peloton Therapeutics Dallas, TX D0C9PZ DRUGINCH 1S/C17H12F3NO4S/c1-26(23,24)14-3-2-13(12-7-17(19,20)16(22)15(12)14)25-11-5-9(8-21)4-10(18)6-11/h2-6,16,22H,7H2,1H3/t16-/m0/s1 D0C9PZ DRUGINKE ONBSHRSJOPSEGS-INIZCTEOSA-N D0C9PZ DRUGSMIL CS(=O)(=O)C1=C2C(C(CC2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)(F)F)O D0C9PZ HIGHSTAT Phase 2 D0CC8L DRUG__ID D0CC8L D0CC8L DRUGTYPE Small molecular drug D0CC8L DRUGINCH 1S/C14H23NO3/c1-9-6-10(8-14(2,3)7-9)18-13(17)11-4-5-12(16)15-11/h9-11H,4-8H2,1-3H3,(H,15,16)/t9?,10?,11-/m0/s1 D0CC8L DRUGINKE FXAAOALUHHXBSO-ILDUYXDCSA-N D0CC8L DRUGSMIL CC1CC(CC(C1)(C)C)OC(=O)C2CCC(=O)N2 D0CC8L HIGHSTAT Phase 2 D0CH7C DRUG__ID D0CH7C D0CH7C DRUGCOMP Roche D0CH7C DRUGINCH 1S/C21H20FN3O5S/c1-14-18(20(24-30-14)15-2-5-17(22)6-3-15)13-29-19-7-4-16(12-23-19)21(26)25-8-10-31(27,28)11-9-25/h2-7,12H,8-11,13H2,1H3 D0CH7C DRUGINKE VCGRFBXVSFAGGA-UHFFFAOYSA-N D0CH7C DRUGSMIL CC1=C(C(=NO1)C2=CC=C(C=C2)F)COC3=NC=C(C=C3)C(=O)N4CCS(=O)(=O)CC4 D0CH7C HIGHSTAT Phase 2 D0CR7L DRUG__ID D0CR7L D0CR7L DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0CR7L DRUGINCH 1S/C24H32N6O3/c1-17(31)30-10-7-20(8-11-30)28-23-12-22(26-16-27-23)24(33)25-13-21(32)15-29-9-6-18-4-2-3-5-19(18)14-29/h2-5,12,16,20-21,32H,6-11,13-15H2,1H3,(H,25,33)(H,26,27,28)/t21-/m0/s1 D0CR7L DRUGINKE JLCCNYVTIWRPIZ-NRFANRHFSA-N D0CR7L DRUGSMIL CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NCC(CN3CCC4=CC=CC=C4C3)O D0CR7L HIGHSTAT Phase 2 D0CT5O DRUG__ID D0CT5O D0CT5O DRUGCOMP Ralexar Therapeutics Malvern, PA D0CT5O DRUGINCH 1S/C21H19F3N2O4S/c1-3-30-20(27)13-26-18(12-19(25-26)21(22,23)24)15-9-7-14(8-10-15)16-5-4-6-17(11-16)31(2,28)29/h4-12H,3,13H2,1-2H3 D0CT5O DRUGINKE ZUMNJDGBYXHASJ-UHFFFAOYSA-N D0CT5O DRUGSMIL CCOC(=O)CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C D0CT5O HIGHSTAT Phase 2 D0D1FC DRUG__ID D0D1FC D0D1FC DRUGCOMP Eli Lilly D0D1FC DRUGINCH 1S/C26H29N5O5/c1-26(2,29-14-18(32)15-35-21-5-3-4-20-23(21)31-25(34)30-20)12-16-6-9-19(10-7-16)36-22-11-8-17(13-28-22)24(27)33/h3-11,13,18,29,32H,12,14-15H2,1-2H3,(H2,27,33)(H2,30,31,34) D0D1FC DRUGINKE RLYDBONATWKYQX-UHFFFAOYSA-N D0D1FC DRUGSMIL CC(C)(CC1=CC=C(C=C1)OC2=NC=C(C=C2)C(=O)N)NCC(COC3=CC=CC4=C3NC(=O)N4)O D0D1FC HIGHSTAT Phase 2 D0D6MV DRUG__ID D0D6MV D0D6MV DRUGCOMP Presidio pharmaceuticals D0D6MV DRUGINCH 1S/C42H50N8O6.2ClH/c1-23(2)35(47-41(53)55-5)39(51)49-17-7-9-33(49)37-43-22-32(46-37)29-14-13-25-19-26(11-12-27(25)20-29)28-15-16-30-31(21-28)45-38(44-30)34-10-8-18-50(34)40(52)36(24(3)4)48-42(54)56-6;;/h11-16,19-24,33-36H,7-10,17-18H2,1-6H3,(H,43,46)(H,44,45)(H,47,53)(H,48,54);2*1H/t33-,34-,35-,36-;;/m0../s1 D0D6MV DRUGINKE JYLMWUZJMRNMDA-SPRBZRACSA-N D0D6MV DRUGSMIL CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl D0D6MV HIGHSTAT Phase 2 D0D6ZW DRUG__ID D0D6ZW D0D6ZW DRUGCOMP Bristol-Myers SquibbPrinceton, NJ D0D6ZW DRUGINCH 1S/C29H26N2O5/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33)/t19-/m1/s1 D0D6ZW DRUGINKE GQBRZBHEPUQRPL-LJQANCHMSA-N D0D6ZW DRUGSMIL CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O D0D6ZW HIGHSTAT Phase 2 D0D7YW DRUG__ID D0D7YW D0D7YW DRUGCOMP Atacama Therapeutics Wellesley, MA D0D7YW DRUGINCH 1S/C11H21N.ClH/c1-10(2)8-5-6-9(7-8)11(10,3)12-4;/h8-9,12H,5-7H2,1-4H3;1H/t8-,9+,11-;/m0./s1 D0D7YW DRUGINKE PKVZBNCYEICAQP-GSTSRXQZSA-N D0D7YW DRUGSMIL CC1(C2CCC(C2)C1(C)NC)C.Cl D0D7YW HIGHSTAT Phase 2 D0D8UM DRUG__ID D0D8UM D0D8UM DRUGCOMP Debiopharm Lausanne, Switzerland D0D8UM DRUGINCH 1S/C23H24N3O7P/c1-15-18-5-3-4-6-19(18)33-20(15)13-25(2)21(27)9-7-16-11-17-8-10-22(28)26(23(17)24-12-16)14-32-34(29,30)31/h3-7,9,11-12H,8,10,13-14H2,1-2H3,(H2,29,30,31)/b9-7+ D0D8UM DRUGINKE HFYMDQMXVPJNTH-VQHVLOKHSA-N D0D8UM DRUGSMIL CC1=C(OC2=CC=CC=C12)CN(C)C(=O)C=CC3=CC4=C(N=C3)N(C(=O)CC4)COP(=O)(O)O D0D8UM HIGHSTAT Phase 2 D0D8VU DRUG__ID D0D8VU D0D8VU DRUGCOMP Ligand pharmaceuticals D0D8VU DRUGINCH 1S/C43H46N2O5S/c1-28-25-29(2)40(30(3)26-28)35-17-21-38(22-18-35)45-42(47)39(27-31-7-9-36(10-8-31)41(46)44-23-24-51(48,49)50)34-13-11-32(12-14-34)33-15-19-37(20-16-33)43(4,5)6/h7-22,25-26,39H,23-24,27H2,1-6H3,(H,44,46)(H,45,47)(H,48,49,50)/t39-/m1/s1 D0D8VU DRUGINKE HKJMCBYPVCGZFB-LDLOPFEMSA-N D0D8VU DRUGSMIL CC1=CC(=C(C(=C1)C)C2=CC=C(C=C2)NC(=O)C(CC3=CC=C(C=C3)C(=O)NCCS(=O)(=O)O)C4=CC=C(C=C4)C5=CC=C(C=C5)C(C)(C)C)C D0D8VU HIGHSTAT Phase 2 D0D9HA DRUG__ID D0D9HA D0D9HA DRUGCOMP Pfizer D0D9HA DRUGINCH 1S/C25H36F3N5O3/c1-15(2)24(6-4-16(10-24)31-19-5-7-36-13-20(19)35-3)23(34)33-12-17-8-18(33)11-32(17)22-9-21(25(26,27)28)29-14-30-22/h9,14-20,31H,4-8,10-13H2,1-3H3/t16-,17+,18+,19+,20-,24+/m1/s1 D0D9HA DRUGINKE MCRWZBYTLVCCJJ-DKALBXGISA-N D0D9HA DRUGSMIL CC(C)C1(CCC(C1)NC2CCOCC2OC)C(=O)N3CC4CC3CN4C5=NC=NC(=C5)C(F)(F)F D0D9HA HIGHSTAT Phase 2 D0D9NZ DRUG__ID D0D9NZ D0D9NZ DRUGTYPE Small molecular drug D0D9NZ DRUGINCH 1S/C19H26O3/c1-19-8-7-14-13(15(19)5-6-17(19)21)4-3-11-9-12(20)10-16(22-2)18(11)14/h9-10,13-15,17,20-21H,3-8H2,1-2H3/t13-,14-,15-,17-,19-/m0/s1 D0D9NZ DRUGINKE PJCUYTOXKIUJSL-SARNLOFESA-N D0D9NZ DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=C3C(=CC(=C4)O)OC D0D9NZ HIGHSTAT Phase 2 D0DL3W DRUG__ID D0DL3W D0DL3W DRUGCOMP Epitomics Inc D0DL3W DRUGINCH 1S/C22H21N4O6P/c23-22-19(4-3-11-26(22)15-31-33(27,28)29)20-13-18(25-32-20)12-16-6-8-17(9-7-16)14-30-21-5-1-2-10-24-21/h1-11,13,23H,12,14-15H2,(H2,27,28,29) D0DL3W DRUGINKE JQONJQKKVAHONF-UHFFFAOYSA-N D0DL3W DRUGSMIL C1=CC=NC(=C1)OCC2=CC=C(C=C2)CC3=NOC(=C3)C4=C([N+](=CC=C4)COP(=O)(O)[O-])N D0DL3W HIGHSTAT Phase 2 D0DM6I DRUG__ID D0DM6I D0DM6I DRUGTYPE Small molecular drug D0DM6I DRUGINCH 1S/C37H39NO4/c1-26(29-18-10-12-20-33(29)41-2)35(39)38-24-31-32(25-38)37(40,30-19-11-13-21-34(30)42-3)23-22-36(31,27-14-6-4-7-15-27)28-16-8-5-9-17-28/h4-21,26,31-32,40H,22-25H2,1-3H3/t26-,31-,32+,37+/m0/s1 D0DM6I DRUGINKE CCIWVEMVBWEMCY-RCFOMQFPSA-N D0DM6I DRUGSMIL CC(C1=CC=CC=C1OC)C(=O)N2CC3C(C2)C(CCC3(C4=CC=CC=C4)C5=CC=CC=C5)(C6=CC=CC=C6OC)O D0DM6I HIGHSTAT Phase 2 D0DQ2D DRUG__ID D0DQ2D D0DQ2D DRUGCOMP RocheBasel, Switzerland D0DQ2D DRUGINCH 1S/C25H23F6N5O4S/c1-35-11-15(10-33-35)14-2-3-19(17(8-14)24(26,27)28)41(39,40)16-9-18(20(37)34-22(13-32)4-5-22)36(12-16)21(38)23(6-7-23)25(29,30)31/h2-3,8,10-11,16,18H,4-7,9,12H2,1H3,(H,34,37)/t16-,18+/m1/s1 D0DQ2D DRUGINKE KXAAIORSMACJSI-AEFFLSMTSA-N D0DQ2D DRUGSMIL CN1C=C(C=N1)C2=CC(=C(C=C2)S(=O)(=O)C3CC(N(C3)C(=O)C4(CC4)C(F)(F)F)C(=O)NC5(CC5)C#N)C(F)(F)F D0DQ2D HIGHSTAT Phase 2 D0DT1R DRUG__ID D0DT1R D0DT1R DRUGTYPE Small molecular drug D0DT1R DRUGINCH 1S/C7H9N5S/c8-5-2-1-3-10-6(5)4-11-12-7(9)13/h1-4H,8H2,(H3,9,12,13)/b11-4+ D0DT1R DRUGINKE XMYKNCNAZKMVQN-NYYWCZLTSA-N D0DT1R DRUGSMIL C1=CC(=C(N=C1)C=NNC(=S)N)N D0DT1R HIGHSTAT Phase 2 D0E0AS DRUG__ID D0E0AS D0E0AS DRUGCOMP Sepracor D0E0AS DRUGINCH 1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/t22-/m1/s1 D0E0AS DRUGINKE XIQVNETUBQGFHX-JOCHJYFZSA-N D0E0AS DRUGSMIL CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O D0E0AS HIGHSTAT Phase 2 D0E0JO DRUG__ID D0E0JO D0E0JO DRUGCOMP Galapagos, AbbVie D0E0JO DRUGINCH 1S/C16H20N4O3S/c1-15(2)7-8-10(12(17)21)14(24-11(8)16(3,4)23-15)19-13(22)9-5-6-18-20-9/h5-6H,7H2,1-4H3,(H2,17,21)(H,18,20)(H,19,22) D0E0JO DRUGINKE GHTGYZMBQPXTCQ-UHFFFAOYSA-N D0E0JO DRUGSMIL CC1(CC2=C(C(O1)(C)C)SC(=C2C(=O)N)NC(=O)C3=CC=NN3)C D0E0JO HIGHSTAT Phase 2 D0E6AH DRUG__ID D0E6AH D0E6AH DRUGTYPE Small molecular drug D0E6AH DRUGINCH 1S/C47H68O17/c1-10-11-12-13-14-15-39(51)62-43-31(22-41(53)58-9)21-34-25-37(28(2)48)61-42(54)24-32(50)23-35-26-38(59-29(3)49)45(6,7)46(55,63-35)27-36-19-30(20-40(52)57-8)18-33(60-36)16-17-44(4,5)47(43,56)64-34/h12-17,20,22,28,32-38,43,48,50,55-56H,10-11,18-19,21,23-27H2,1-9H3/b13-12+,15-14+,17-16+,30-20+,31-22+/t28-,32-,33+,34+,35-,36+,37-,38+,43+,46+,47-/m1/s1 D0E6AH DRUGINKE MJQUEDHRCUIRLF-TVIXENOKSA-N D0E6AH DRUGSMIL CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O D0E6AH HIGHSTAT Phase 2 D0E6ME DRUG__ID D0E6ME D0E6ME DRUGCOMP Giuliani SpA D0E6ME DRUGINCH 1S/C10H13NO3/c1-14-9(10(12)13)6-7-2-4-8(11)5-3-7/h2-5,9H,6,11H2,1H3,(H,12,13)/t9-/m0/s1 D0E6ME DRUGINKE QLJYLJGYIDIJPT-VIFPVBQESA-N D0E6ME DRUGSMIL COC(CC1=CC=C(C=C1)N)C(=O)O D0E6ME HIGHSTAT Phase 2 D0E6SX DRUG__ID D0E6SX D0E6SX DRUGCOMP AstraZeneca plc D0E6SX DRUGINCH 1S/C18H22F2N4O5S2/c1-11(14(26)9-25)29-16-8-15(23-31(27,28)24-6-3-7-24)21-18(22-16)30-10-12-4-2-5-13(19)17(12)20/h2,4-5,8,11,14,25-26H,3,6-7,9-10H2,1H3,(H,21,22,23)/t11-,14+/m1/s1 D0E6SX DRUGINKE QZECRCLSIGFCIO-RISCZKNCSA-N D0E6SX DRUGSMIL CC(C(CO)O)OC1=NC(=NC(=C1)NS(=O)(=O)N2CCC2)SCC3=C(C(=CC=C3)F)F D0E6SX HIGHSTAT Phase 2 D0E7FM DRUG__ID D0E7FM D0E7FM DRUGCOMP GTx D0E7FM DRUGINCH 1S/C19H13F2NO3/c20-13-2-4-14(5-3-13)22(15-6-8-16(23)9-7-15)19(25)12-1-10-18(24)17(21)11-12/h1-11,23-24H D0E7FM DRUGINKE FBCQEUMZZNVQKD-UHFFFAOYSA-N D0E7FM DRUGSMIL C1=CC(=CC=C1N(C2=CC=C(C=C2)F)C(=O)C3=CC(=C(C=C3)O)F)O D0E7FM HIGHSTAT Phase 2 D0E8IQ DRUG__ID D0E8IQ D0E8IQ DRUGCOMP Daiichi Sankyo Basking Ridge, NJ D0E8IQ DRUGINCH 1S/C13H11N/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13H,14H2 D0E8IQ DRUGINKE OUGMRQJTULXVDC-UHFFFAOYSA-N D0E8IQ DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C32)N D0E8IQ HIGHSTAT Phase 2 D0E8PR DRUG__ID D0E8PR D0E8PR DRUGCOMP Bayer healthcare pharmaceuticals D0E8PR DRUGINCH 1S/C23H26N6O3S/c1-13-6-14-8-18(33-22(14)17(7-13)32-3)20-15(11-31-2)16(9-28-5-4-25-19(30)10-28)29-21(20)23(24)26-12-27-29/h6-8,12H,4-5,9-11H2,1-3H3,(H,25,30)(H2,24,26,27) D0E8PR DRUGINKE HNLRRJSKGXOYNO-UHFFFAOYSA-N D0E8PR DRUGSMIL CC1=CC2=C(C(=C1)OC)SC(=C2)C3=C4C(=NC=NN4C(=C3COC)CN5CCNC(=O)C5)N D0E8PR HIGHSTAT Phase 2 D0E9RP DRUG__ID D0E9RP D0E9RP DRUGCOMP Wockhardt D0E9RP DRUGINCH 1S/C22H26FN3O5/c1-11-3-4-14-18-15(20(27)16(21(28)29)10-26(11)18)9-17(23)19(14)25-7-5-13(6-8-25)31-22(30)12(2)24/h9-13H,3-8,24H2,1-2H3,(H,28,29)/t11-,12-/m0/s1 D0E9RP DRUGINKE OUXXDXXQNWKOIF-RYUDHWBXSA-N D0E9RP DRUGSMIL CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2N4CCC(CC4)OC(=O)C(C)N)F)C(=O)O D0E9RP HIGHSTAT Phase 2 D0ED6O DRUG__ID D0ED6O D0ED6O DRUGCOMP Charsire Biotechnology Tainan, Taiwan D0ED6O DRUGINCH 1S/C6H14N2O3/c1-2-3(7)5(9)4(8)6(10)11-2/h2-6,9-10H,7-8H2,1H3/t2-,3-,4-,5+,6?/m1/s1 D0ED6O DRUGINKE LEJHBBPEPOZERQ-RSVSWTKNSA-N D0ED6O DRUGSMIL CC1C(C(C(C(O1)O)N)O)N D0ED6O HIGHSTAT Phase 2 D0ER9I DRUG__ID D0ER9I D0ER9I DRUGCOMP Janssen Research & Development D0ER9I DRUGINCH 1S/C22H24N4O2S/c1-14(27)24-16-11-17-6-7-18(12-16)26(17)13-15-4-8-19(9-5-15)28-22-25-21-20(29-22)3-2-10-23-21/h2-5,8-10,16-18H,6-7,11-13H2,1H3,(H,24,27)/t16?,17-,18+ D0ER9I DRUGINKE QZOOKXDESAXLGB-AYHJJNSGSA-N D0ER9I DRUGSMIL CC(=O)NC1CC2CCC(C1)N2CC3=CC=C(C=C3)OC4=NC5=C(S4)C=CC=N5 D0ER9I HIGHSTAT Phase 2 D0F1WX DRUG__ID D0F1WX D0F1WX DRUGTYPE Small molecular drug D0F1WX DRUGINCH 1S/C31H35Cl2F6N3O3/c1-28(2,27(40)44)20-5-8-41(9-6-20)10-7-29(21-3-4-24(32)25(33)17-21)18-42(11-12-45-29)26(43)15-19-13-22(30(34,35)36)16-23(14-19)31(37,38)39/h3-4,13-14,16-17,20H,5-12,15,18H2,1-2H3,(H2,40,44) D0F1WX DRUGINKE ZLNYUCXXSDDIFU-UHFFFAOYSA-N D0F1WX DRUGSMIL CC(C)(C1CCN(CC1)CCC2(CN(CCO2)C(=O)CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=CC(=C(C=C4)Cl)Cl)C(=O)N D0F1WX HIGHSTAT Phase 2 D0F2ML DRUG__ID D0F2ML D0F2ML DRUGTYPE Small molecular drug D0F2ML DRUGINCH 1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15) D0F2ML DRUGINKE CUHVIMMYOGQXCV-UHFFFAOYSA-N D0F2ML DRUGSMIL CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C D0F2ML HIGHSTAT Phase 2 D0F4GF DRUG__ID D0F4GF D0F4GF DRUGCOMP Merck D0F4GF DRUGINCH 1S/C20H23F3N2O2/c1-13(2)16-6-4-15(5-7-16)10-19(26)25-14(3)18-9-8-17(11-24-18)27-12-20(21,22)23/h4-9,11,13-14H,10,12H2,1-3H3,(H,25,26)/t14-/m1/s1 D0F4GF DRUGINKE IQIKXZMPPBEWAD-CQSZACIVSA-N D0F4GF DRUGSMIL CC(C)C1=CC=C(C=C1)CC(=O)NC(C)C2=NC=C(C=C2)OCC(F)(F)F D0F4GF HIGHSTAT Phase 2 D0F5AR DRUG__ID D0F5AR D0F5AR DRUGCOMP Araim Pharmaceuticals Tarrytown, NY D0F5AR DRUGINCH 1S/C51H84N16O21/c1-22(2)17-30(47(84)65-32(19-36(53)71)48(85)66-33(20-68)49(86)67-34(21-69)50(87)88)63-40(77)24(5)57-41(78)25(7-6-16-56-51(54)55)59-43(80)29(11-15-39(75)76)62-46(83)31(18-23(3)4)64-45(82)27(8-12-35(52)70)60-44(81)28(10-14-38(73)74)61-42(79)26-9-13-37(72)58-26/h22-34,68-69H,6-21H2,1-5H3,(H2,52,70)(H2,53,71)(H,57,78)(H,58,72)(H,59,80)(H,60,81)(H,61,79)(H,62,83)(H,63,77)(H,64,82)(H,65,84)(H,66,85)(H,67,86)(H,73,74)(H,75,76)(H,87,88)(H4,54,55,56)/t24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-/m0/s1 D0F5AR DRUGINKE WZTIQQBMSJTRBR-WYKNNRPVSA-N D0F5AR DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C1CCC(=O)N1 D0F5AR HIGHSTAT Phase 2 D0F5IY DRUG__ID D0F5IY D0F5IY DRUGTYPE Small molecular drug D0F5IY DRUGINCH 1S/C17H12Cl2N2O6S/c1-28(24,25)27-9-3-5-11-13(7-9)26-16(14(11)21-17(20)23)15(22)10-4-2-8(18)6-12(10)19/h2-7H,1H3,(H3,20,21,23) D0F5IY DRUGINKE YPFLFUJKZDAXRA-UHFFFAOYSA-N D0F5IY DRUGSMIL CS(=O)(=O)OC1=CC2=C(C=C1)C(=C(O2)C(=O)C3=C(C=C(C=C3)Cl)Cl)NC(=O)N D0F5IY HIGHSTAT Phase 2 D0F5JR DRUG__ID D0F5JR D0F5JR DRUGTYPE Small molecular drug D0F5JR DRUGINCH 1S/C16H19ClN2O3/c17-13-5-3-12(4-6-13)10-18-15(21)7-8-16(22)19-9-1-2-14(19)11-20/h3-6,11,14H,1-2,7-10H2,(H,18,21)/t14-/m0/s1 D0F5JR DRUGINKE KGDFDVHLEYUZLN-AWEZNQCLSA-N D0F5JR DRUGSMIL C1CC(N(C1)C(=O)CCC(=O)NCC2=CC=C(C=C2)Cl)C=O D0F5JR HIGHSTAT Phase 2 D0F6TD DRUG__ID D0F6TD D0F6TD DRUGTYPE Small molecular drug D0F6TD DRUGINCH 1S/C23H24ClN3O2/c24-22-17-29-21-9-2-1-7-19(21)23(28)27(22)14-6-5-13-26-15-10-18(11-16-26)20-8-3-4-12-25-20/h1-4,7-10,12,17H,5-6,11,13-16H2 D0F6TD DRUGINKE URMTUEWUIGOJBW-UHFFFAOYSA-N D0F6TD DRUGSMIL C1CN(CC=C1C2=CC=CC=N2)CCCCN3C(=COC4=CC=CC=C4C3=O)Cl D0F6TD HIGHSTAT Phase 2 D0F9FR DRUG__ID D0F9FR D0F9FR DRUGTYPE Small molecular drug D0F9FR DRUGINCH 1S/C3H5NO2/c5-3-4-1-2-6-3/h1-2H2,(H,4,5) D0F9FR DRUGINKE IZXIZTKNFFYFOF-UHFFFAOYSA-N D0F9FR DRUGSMIL C1COC(=O)N1 D0F9FR HIGHSTAT Phase 2 D0FK6O DRUG__ID D0FK6O D0FK6O DRUGCOMP Minerva Neurosciences Waltham, MA D0FK6O DRUGINCH 1S/C21H22FN7O/c1-13-8-14(2)26-21(25-13)28-11-15-9-27(10-16(15)12-28)20(30)19-17(22)4-3-5-18(19)29-23-6-7-24-29/h3-8,15-16H,9-12H2,1-2H3 D0FK6O DRUGINKE SQOCEMCKYDVLMM-UHFFFAOYSA-N D0FK6O DRUGSMIL CC1=CC(=NC(=N1)N2CC3CN(CC3C2)C(=O)C4=C(C=CC=C4F)N5N=CC=N5)C D0FK6O HIGHSTAT Phase 2 D0FX8N DRUG__ID D0FX8N D0FX8N DRUGCOMP Cognition Therapeutics Pittsburgh, PA D0FX8N DRUGINCH 1S/C24H33NO4S/c1-23(2,3)29-22-13-17(7-10-21(22)26)11-12-24(4,5)25-15-18-8-9-20(30(6,27)28)14-19(18)16-25/h7-10,13-14,26H,11-12,15-16H2,1-6H3 D0FX8N DRUGINKE ISQAPFMBJFZOLG-UHFFFAOYSA-N D0FX8N DRUGSMIL CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O D0FX8N HIGHSTAT Phase 2 D0G2XE DRUG__ID D0G2XE D0G2XE DRUGTYPE Small molecular drug D0G2XE DRUGINCH 1S/C47H65N11O7/c1-29(59)53-37(25-30-13-4-2-5-14-30)42(61)55-36-20-11-22-50-41(60)35(19-10-23-51-47(48)49)54-44(63)39(27-32-28-52-34-18-9-8-17-33(32)34)56-43(62)38(26-31-15-6-3-7-16-31)57-45(64)40-21-12-24-58(40)46(36)65/h2,4-5,8-9,13-14,17-18,28,31,35-40,52H,3,6-7,10-12,15-16,19-27H2,1H3,(H,50,60)(H,53,59)(H,54,63)(H,55,61)(H,56,62)(H,57,64)(H4,48,49,51)/t35-,36-,37-,38+,39-,40-/m0/s1 D0G2XE DRUGINKE YOKBGCTZYPOSQM-HPSWDUTRSA-N D0G2XE DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)NC2CCCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3CCCN3C2=O)CC4CCCCC4)CC5=CNC6=CC=CC=C65)CCCN=C(N)N D0G2XE HIGHSTAT Phase 2 D0G2ZL DRUG__ID D0G2ZL D0G2ZL DRUGCOMP Metabasis Therapeutics Inc D0G2ZL DRUGINCH 1S/C21H33N4O5PS/c1-7-28-19(26)13(5)24-31(25-14(6)20(27)29-8-2)17-10-9-15(30-17)18-16(11-12(3)4)32-21(22)23-18/h9-10,12-14,24-25H,7-8,11H2,1-6H3,(H2,22,23)/t13-,14-/m0/s1 D0G2ZL DRUGINKE JGCMEVUWRCNKKE-KBPBESRZSA-N D0G2ZL DRUGSMIL CCOC(=O)C(C)NP(C1=CC=C(O1)C2=C(SC(=N2)N)CC(C)C)NC(C)C(=O)OCC D0G2ZL HIGHSTAT Phase 2 D0G4DE DRUG__ID D0G4DE D0G4DE DRUGTYPE Small molecular drug D0G4DE DRUGINCH 1S/C14H11NO5/c16-12(6-9-4-2-1-3-5-9)10-7-11(15(19)20)14(18)13(17)8-10/h1-5,7-8,17-18H,6H2 D0G4DE DRUGINKE MRFOLGFFTUGAEB-UHFFFAOYSA-N D0G4DE DRUGSMIL C1=CC=C(C=C1)CC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-] D0G4DE HIGHSTAT Phase 2 D0G4YZ DRUG__ID D0G4YZ D0G4YZ DRUGCOMP National Institutes of Health D0G4YZ DRUGINCH 1S/C21H20N2O3/c1-16(24)23(15-17-8-6-7-11-20(17)25-2)19-14-22-13-12-21(19)26-18-9-4-3-5-10-18/h3-14H,15H2,1-2H3/i2-1 D0G4YZ DRUGINKE DHZBNHMEIOBPAE-JVVVGQRLSA-N D0G4YZ DRUGSMIL CC(=O)N(CC1=CC=CC=C1OC)C2=C(C=CN=C2)OC3=CC=CC=C3 D0G4YZ HIGHSTAT Phase 2 D0G5CS DRUG__ID D0G5CS D0G5CS DRUGTYPE Small molecular drug D0G5CS DRUGINCH 1S/C15H12O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-7,13,16-17H,8H2/t13-/m0/s1 D0G5CS DRUGINKE URFCJEUYXNAHFI-ZDUSSCGKSA-N D0G5CS DRUGSMIL C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=CC=C3 D0G5CS HIGHSTAT Phase 2 D0G6CF DRUG__ID D0G6CF D0G6CF DRUGCOMP BioClin Therapeutics San Ramon, CA D0G6CF DRUGINCH 1S/C10H22Cl3N2O3P/c11-3-1-10-18-19(17,14-6-2-9-16)15(7-4-12)8-5-13/h16H,1-10H2,(H,14,17) D0G6CF DRUGINKE VKRFJPYJBOIVPD-UHFFFAOYSA-N D0G6CF DRUGSMIL C(CNP(=O)(N(CCCl)CCCl)OCCCCl)CO D0G6CF HIGHSTAT Phase 2 D0G7MM DRUG__ID D0G7MM D0G7MM DRUGCOMP Mitsubishi Tanabe Pharma Corp D0G7MM DRUGINCH 1S/C32H31F9N4O5/c1-3-22-14-26(24-13-19(30(33,34)35)7-8-25(24)45(22)29(48)49-4-2)44(28-42-15-23(16-43-28)50-9-5-6-27(46)47)17-18-10-20(31(36,37)38)12-21(11-18)32(39,40)41/h7-8,10-13,15-16,22,26H,3-6,9,14,17H2,1-2H3,(H,46,47)/t22-,26+/m1/s1 D0G7MM DRUGINKE NRWORBQAOQVYBJ-GJZUVCINSA-N D0G7MM DRUGSMIL CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)OCCCC(=O)O D0G7MM HIGHSTAT Phase 2 D0G8UY DRUG__ID D0G8UY D0G8UY DRUGCOMP Pfizer D0G8UY DRUGINCH 1S/C18H20N2O4S2/c1-12(2)26(21,22)20-16-10-23-11-17(16)24-14-5-3-13(4-6-14)18-8-7-15(9-19)25-18/h3-8,12,16-17,20H,10-11H2,1-2H3/t16-,17+/m0/s1 D0G8UY DRUGINKE TTYKUKSFWHEBLI-DLBZAZTESA-N D0G8UY DRUGSMIL CC(C)S(=O)(=O)NC1COCC1OC2=CC=C(C=C2)C3=CC=C(S3)C#N D0G8UY HIGHSTAT Phase 2 D0GD4Q DRUG__ID D0GD4Q D0GD4Q DRUGCOMP PellePharm San Francisco, CA D0GD4Q DRUGINCH 1S/C29H48N2O3S/c1-17-12-26-27(30-16-17)19(3)29(34-26)11-9-22-23-7-6-20-13-21(31-35(5,32)33)8-10-28(20,4)25(23)14-24(22)18(2)15-29/h17,19-23,25-27,30-31H,6-16H2,1-5H3/t17-,19+,20+,21+,22-,23-,25-,26+,27-,28-,29-/m0/s1 D0GD4Q DRUGINKE HZLFFNCLTRVYJG-WWGOJCOQSA-N D0GD4Q DRUGSMIL CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5CC4=C(C3)C)C)NS(=O)(=O)C)C)NC1 D0GD4Q HIGHSTAT Phase 2 D0GH7L DRUG__ID D0GH7L D0GH7L DRUGCOMP Principia Biopharma South San Francisco, CA D0GH7L DRUGINCH 1S/C36H40FN9O3/c1-36(2,45-15-13-43(14-16-45)26-21-48-22-26)18-24(19-38)35(47)44-12-6-7-25(20-44)46-34-31(33(39)40-23-41-34)32(42-46)29-11-10-28(17-30(29)37)49-27-8-4-3-5-9-27/h3-5,8-11,17-18,23,25-26H,6-7,12-16,20-22H2,1-2H3,(H2,39,40,41)/b24-18+/t25-/m1/s1 D0GH7L DRUGINKE LCFFREMLXLZNHE-GBOLQPHISA-N D0GH7L DRUGSMIL CC(C)(C=C(C#N)C(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N)N6CCN(CC6)C7COC7 D0GH7L HIGHSTAT Phase 2 D0GJ7B DRUG__ID D0GJ7B D0GJ7B DRUGTYPE Small molecular drug D0GJ7B DRUGINCH 1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26) D0GJ7B DRUGINKE COSPVUFTLGQDQL-UHFFFAOYSA-N D0GJ7B DRUGSMIL CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)OC D0GJ7B HIGHSTAT Phase 2 D0GK4E DRUG__ID D0GK4E D0GK4E DRUGTYPE Small molecular drug D0GK4E DRUGINCH 1S/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21) D0GK4E DRUGINKE MLILORUFDVLTSP-UHFFFAOYSA-N D0GK4E DRUGSMIL CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2 D0GK4E HIGHSTAT Phase 2 D0GW8X DRUG__ID D0GW8X D0GW8X DRUGCOMP GenentechSouth San Francisco, CA D0GW8X DRUGINCH 1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1 D0GW8X DRUGINKE SGEUNORSOZVTOL-CABZTGNLSA-N D0GW8X DRUGSMIL CC(C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4C(COC4=O)C(F)F D0GW8X HIGHSTAT Phase 2 D0H0KH DRUG__ID D0H0KH D0H0KH DRUGCOMP Gilead Sciences Foster City, CA D0H0KH DRUGINCH 1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1 D0H0KH DRUGINKE SEJLPXCPMNSRAM-GOSISDBHSA-N D0H0KH DRUGSMIL CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N D0H0KH HIGHSTAT Phase 2 D0H0YD DRUG__ID D0H0YD D0H0YD DRUGCOMP Promius Pharma Princeton, NJ D0H0YD DRUGINCH 1S/C25H32ClFO5/c1-5-21(31)32-25(20(30)13-26)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,27)19(29)12-23(18,25)4/h8-9,11,14,17-19,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1 D0H0YD DRUGINKE CBGUOGMQLZIXBE-XGQKBEPLSA-N D0H0YD DRUGSMIL CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl D0H0YD HIGHSTAT Phase 2 D0H1WC DRUG__ID D0H1WC D0H1WC DRUGCOMP Lilly D0H1WC DRUGINCH 1S/C23H26N4O3/c1-14(30-5)13-27-21-18-9-15(16-8-17(11-24-10-16)23(2,3)29)6-7-19(18)25-12-20(21)26(4)22(27)28/h6-12,14,29H,13H2,1-5H3/t14-/m0/s1 D0H1WC DRUGINKE ACCFLVVUVBJNGT-AWEZNQCLSA-N D0H1WC DRUGSMIL CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC D0H1WC HIGHSTAT Phase 2 D0H2IO DRUG__ID D0H2IO D0H2IO DRUGTYPE Small molecular drug D0H2IO DRUGINCH 1S/C9H18N2OS.C4H4O4/c1-3-7(2)8(10)9(12)11-4-5-13-6-11;5-3(6)1-2-4(7)8/h7-8H,3-6,10H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t7-,8-;/m0./s1 D0H2IO DRUGINKE ZSOPWZQRZHWYFY-NUXPJIRBSA-N D0H2IO DRUGSMIL CCC(C)C(C(=O)N1CCSC1)N.C(=CC(=O)O)C(=O)O D0H2IO HIGHSTAT Phase 2 D0H2NI DRUG__ID D0H2NI D0H2NI DRUGCOMP Kotobuki Pharmaceutical Co Ltd D0H2NI DRUGINCH 1S/C23H24O6.C5H14NO/c24-12-19-20(26)21(27)22(28)23(29-19)17-11-13(6-7-18(17)25)8-14-9-15-4-2-1-3-5-16(15)10-14;1-6(2,3)4-5-7/h1-7,9-11,19-28H,8,12H2;7H,4-5H2,1-3H3/q;+1/p-1/t19-,20-,21+,22-,23+;/m1./s1 D0H2NI DRUGINKE UKOOBSDARBTSHN-NGOMLPPMSA-M D0H2NI DRUGSMIL C[N+](C)(C)CCO.C1=CC=C2C=C(C=C2C=C1)CC3=CC(=C(C=C3)[O-])C4C(C(C(C(O4)CO)O)O)O D0H2NI HIGHSTAT Phase 2 D0H8OA DRUG__ID D0H8OA D0H8OA DRUGCOMP Merck D0H8OA DRUGINCH 1S/C29H33ClFNO4/c1-18-13-21(10-11-23(18)28(34)35)25-8-6-5-7-24(25)19(2)36-17-22(33)16-32-29(3,4)15-20-9-12-26(30)27(31)14-20/h5-14,19,22,32-33H,15-17H2,1-4H3,(H,34,35)/t19-,22-/m1/s1 D0H8OA DRUGINKE UNFHDRVFEQPUEL-DENIHFKCSA-N D0H8OA DRUGSMIL CC1=C(C=CC(=C1)C2=CC=CC=C2C(C)OCC(CNC(C)(C)CC3=CC(=C(C=C3)Cl)F)O)C(=O)O D0H8OA HIGHSTAT Phase 2 D0H8WZ DRUG__ID D0H8WZ D0H8WZ DRUGTYPE Small molecular drug D0H8WZ DRUGINCH 1S/C44H64N8O8/c1-4-29(2)40(43(60)52-44(3,26-53)27-54)51-39(57)23-37(55)34(20-30-12-7-5-8-13-30)49-42(59)36(22-33-25-46-28-47-33)50-41(58)35(21-31-14-9-6-10-15-31)48-38(56)18-17-32-16-11-19-45-24-32/h6,9-11,14-16,19,24-25,28-30,34-37,40,53-55H,4-5,7-8,12-13,17-18,20-23,26-27H2,1-3H3,(H,46,47)(H,48,56)(H,49,59)(H,50,58)(H,51,57)(H,52,60) D0H8WZ DRUGINKE NZGWKVVFXREROW-UHFFFAOYSA-N D0H8WZ DRUGSMIL CCC(C)C(C(=O)NC(C)(CO)CO)NC(=O)CC(C(CC1CCCCC1)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=CC=C3)NC(=O)CCC4=CN=CC=C4)O D0H8WZ HIGHSTAT Phase 2 D0H8XB DRUG__ID D0H8XB D0H8XB DRUGCOMP Lantibio Inc D0H8XB DRUGINCH 1S/C89H125N23O25S3/c1-44(2)67-85(131)107-60-42-138-41-59-80(126)106-61-43-140-46(4)69(87(133)103-56(76(122)108-67)35-49-23-12-7-13-24-49)109-77(123)55(34-48-21-10-6-11-22-48)102-83(129)62-27-18-32-112(62)66(116)39-96-73(119)54(33-47-19-8-5-9-20-47)101-79(125)58(104-81(61)127)37-94-31-17-15-26-53(88(134)135)100-86(132)68(110-78(124)57(36-64(93)114)97-65(115)38-95-84(130)70(111-82(60)128)71(117)89(136)137)45(3)139-40-50(91)72(118)98-51(25-14-16-30-90)74(120)99-52(75(121)105-59)28-29-63(92)113/h5-13,19-24,44-46,50-62,67-71,94,117H,14-18,25-43,90-91H2,1-4H3,(H2,92,113)(H2,93,114)(H,95,130)(H,96,119)(H,97,115)(H,98,118)(H,99,120)(H,100,132)(H,101,125)(H,102,129)(H,103,133)(H,104,127)(H,105,121)(H,106,126)(H,107,131)(H,108,122)(H,109,123)(H,110,124)(H,111,128)(H,134,135)(H,136,137)/t45?,46-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59+,60-,61-,62-,67-,68+,69+,70-,71+/m0/s1 D0H8XB DRUGINKE SFWLDKQAUHFCBS-WWXQEMPQSA-N D0H8XB DRUGSMIL CC1C2C(=O)NC(C(=O)NC(C(=O)NC3CSCC4C(=O)NC(CS1)C(=O)NC(CNCCCCC(NC(=O)C(C(SCC(C(=O)NC(C(=O)NC(C(=O)N4)CCC(=O)N)CCCCN)N)C)NC(=O)C(NC(=O)CNC(=O)C(NC3=O)C(C(=O)O)O)CC(=O)N)C(=O)O)C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)NC(C(=O)N2)CC6=CC=CC=C6)CC7=CC=CC=C7)C(C)C)CC8=CC=CC=C8 D0H8XB HIGHSTAT Phase 2 D0HD7C DRUG__ID D0HD7C D0HD7C DRUGCOMP Photopharmica Ltd D0HD7C DRUGINCH 1S/C28H42N3S.BrH/c1-5-9-17-30(18-10-6-2)23-13-15-25-27(21-23)32-28-22-24(14-16-26(28)29-25)31(19-11-7-3)20-12-8-4;/h13-16,21-22H,5-12,17-20H2,1-4H3;1H/q+1;/p-1 D0HD7C DRUGINKE LLMPBOPIZQTTLB-UHFFFAOYSA-M D0HD7C DRUGSMIL CCCCN(CCCC)C1=CC2=C(C=C1)N=C3C=CC(=[N+](CCCC)CCCC)C=C3S2.[Br-] D0HD7C HIGHSTAT Phase 2 D0I0UE DRUG__ID D0I0UE D0I0UE DRUGTYPE Small molecular drug D0I0UE DRUGINCH 1S/C23H30N4O4S/c1-6-31-23(28)22(13-16(2)3)26(5)32(29,30)19-9-7-18(8-10-19)15-27-17(4)25-20-14-24-12-11-21(20)27/h7-12,14,16,22H,6,13,15H2,1-5H3/t22-/m0/s1 D0I0UE DRUGINKE AQRXDPFOYJSPMP-QFIPXVFZSA-N D0I0UE DRUGSMIL CCOC(=O)C(CC(C)C)N(C)S(=O)(=O)C1=CC=C(C=C1)CN2C(=NC3=C2C=CN=C3)C D0I0UE HIGHSTAT Phase 2 D0I0XF DRUG__ID D0I0XF D0I0XF DRUGCOMP Idera Pharmaceuticals Cambridge, MA D0I0XF DRUGINCH 1S/C179H233N52O101P17S17/c1-71-41-221(172(252)200-143(71)184)123-32-85(106(303-123)62-293-347(274,364)330-136-109(313-160(140(136)278-10)220-26-19-117(234)199-171(220)251)66-297-349(276,366)332-138-111(315-162(142(138)280-12)231-70-193-134-148(231)203-165(188)206-158(134)245)65-296-346(273,363)328-92-39-130(228-48-78(8)155(242)213-179(228)259)310-105(92)60-289-337(264,354)320-84-31-122(218-24-17-115(183)197-169(218)249)302-98(84)53-285-341(268,358)324-89-36-127(225-45-75(5)152(239)210-176(225)256)308-103(89)58-291-344(271,361)329-93-40-131(229-68-191-132-144(185)189-67-190-146(132)229)311-107(93)61-292-343(270,360)326-86-33-124(222-42-72(2)149(236)207-173(222)253)304-99(86)54-281-333(260,350)316-80-27-119(298-94(80)49-232)215-21-14-112(180)194-166(215)246)321-338(265,355)282-50-95-81(28-118(299-95)214-20-13-79-145(214)201-163(186)204-156(79)243)317-334(261,351)286-55-100-90(37-128(305-100)226-46-76(6)153(240)211-177(226)257)325-342(269,359)290-57-102-88(35-126(307-102)224-44-74(4)151(238)209-175(224)255)323-340(267,357)284-51-96-82(29-120(300-96)216-22-15-113(181)195-167(216)247)318-335(262,352)287-56-101-87(34-125(306-101)223-43-73(3)150(237)208-174(223)254)322-339(266,356)283-52-97-83(30-121(301-97)217-23-16-114(182)196-168(217)248)319-336(263,353)288-59-104-91(38-129(309-104)227-47-77(7)154(241)212-178(227)258)327-345(272,362)295-64-110-137(141(279-11)161(314-110)230-69-192-133-147(230)202-164(187)205-157(133)244)331-348(275,365)294-63-108-135(235)139(277-9)159(312-108)219-25-18-116(233)198-170(219)250/h13-26,41-48,67-70,80-111,118-131,135-142,159-162,232,235H,27-40,49-66H2,1-12H3,(H,260,350)(H,261,351)(H,262,352)(H,263,353)(H,264,354)(H,265,355)(H,266,356)(H,267,357)(H,268,358)(H,269,359)(H,270,360)(H,271,361)(H,272,362)(H,273,363)(H,274,364)(H,275,365)(H,276,366)(H2,180,194,246)(H2,181,195,247)(H2,182,196,248)(H2,183,197,249)(H2,184,200,252)(H2,185,189,190)(H,198,233,250)(H,199,234,251)(H,207,236,253)(H,208,237,254)(H,209,238,255)(H,210,239,256)(H,211,240,257)(H,212,241,258)(H,213,242,259)(H3,186,201,204,243)(H3,187,202,205,244)(H3,188,203,206,245)/t80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94+,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105+,106+,107+,108+,109+,110+,111+,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,135+,136+,137+,138+,139+,140+,141+,142+,159+,160+,161+,162+,333?,334?,335?,336?,337?,338?,339?,340?,341?,342?,343?,344?,345?,346?,347?,348?,349?/m0/s1 D0I0XF DRUGINKE HDRGJRSISASRAJ-WKPMUQCKSA-N D0I0XF DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OC)N6C=CC(=O)NC6=O)COP(=S)(O)OC7C(OC(C7OC)N8C=NC9=C8N=C(NC9=O)N)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=O)(OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)S)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=NC1=O)N)C)N1C=CC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OC)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)O D0I0XF HIGHSTAT Phase 2 D0I1KQ DRUG__ID D0I1KQ D0I1KQ DRUGTYPE Small molecular drug D0I1KQ DRUGINCH 1S/C190H287N55O57/c1-16-94(9)149(180(296)235-129(81-141(194)255)169(285)227-124(74-93(7)8)172(288)240-150(95(10)17-2)181(297)241-151(100(15)248)182(298)222-116(32-23-67-209-190(203)204)156(272)221-118(57-60-140(193)254)161(277)219-114(30-21-65-207-188(199)200)157(273)224-121(152(196)268)76-102-39-49-108(250)50-40-102)239-173(289)127(79-105-45-55-111(253)56-46-105)230-168(284)128(80-106-86-205-90-211-106)231-159(275)115(31-22-66-208-189(201)202)220-165(281)123(73-92(5)6)225-155(271)97(12)213-174(290)134(88-246)237-167(283)126(78-104-43-53-110(252)54-44-104)229-166(282)125(77-103-41-51-109(251)52-42-103)228-158(274)113(29-20-64-206-187(197)198)217-153(269)96(11)212-163(279)122(72-91(3)4)226-170(286)131(84-147(264)265)233-162(278)119(59-62-145(260)261)218-154(270)98(13)214-177(293)137-34-25-68-242(137)183(299)99(14)215-164(280)130(83-146(262)263)232-160(276)117(58-61-144(258)259)216-143(257)87-210-176(292)136-33-24-70-244(136)186(302)133(82-142(195)256)236-171(287)132(85-148(266)267)234-178(294)139-36-27-71-245(139)185(301)120(28-18-19-63-191)223-175(291)135(89-247)238-179(295)138-35-26-69-243(138)184(300)112(192)75-101-37-47-107(249)48-38-101/h37-56,86,90-100,112-139,149-151,246-253H,16-36,57-85,87-89,191-192H2,1-15H3,(H2,193,254)(H2,194,255)(H2,195,256)(H2,196,268)(H,205,211)(H,210,292)(H,212,279)(H,213,290)(H,214,293)(H,215,280)(H,216,257)(H,217,269)(H,218,270)(H,219,277)(H,220,281)(H,221,272)(H,222,298)(H,223,291)(H,224,273)(H,225,271)(H,226,286)(H,227,285)(H,228,274)(H,229,282)(H,230,284)(H,231,275)(H,232,276)(H,233,278)(H,234,294)(H,235,296)(H,236,287)(H,237,283)(H,238,295)(H,239,289)(H,240,288)(H,241,297)(H,258,259)(H,260,261)(H,262,263)(H,264,265)(H,266,267)(H4,197,198,206)(H4,199,200,207)(H4,201,202,208)(H4,203,204,209)/t94-,95-,96-,97-,98-,99-,100+,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,149-,150-,151-/m0/s1 D0I1KQ DRUGINKE URPYMXQQVHTUDU-OFGSCBOVSA-N D0I1KQ DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C6CCCN6C(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C7CCCN7C(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C8CCCN8C(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C9CCCN9C(=O)C(CC1=CC=C(C=C1)O)N D0I1KQ HIGHSTAT Phase 2 D0I2GS DRUG__ID D0I2GS D0I2GS DRUGCOMP MicuRx Pharmaceuticals Hayward, CA D0I2GS DRUGINCH 1S/C18H15F3N4O4/c19-12-7-13(15(20)16(21)17(12)24-4-1-10(26)2-5-24)25-9-11(29-18(25)27)8-22-14-3-6-28-23-14/h1,3-4,6-7,11H,2,5,8-9H2,(H,22,23)/t11-/m0/s1 D0I2GS DRUGINKE SULYVXZZUMRQAX-NSHDSACASA-N D0I2GS DRUGSMIL C1CN(C=CC1=O)C2=C(C=C(C(=C2F)F)N3CC(OC3=O)CNC4=NOC=C4)F D0I2GS HIGHSTAT Phase 2 D0I2RB DRUG__ID D0I2RB D0I2RB DRUGCOMP Emd serono D0I2RB DRUGINCH 1S/C27H33NO4/c1-4-5-19-6-7-22(26(12-19)31-3)17-32-24-10-11-25-18(2)21(9-8-20(25)13-24)14-28-15-23(16-28)27(29)30/h6-7,10-13,23H,4-5,8-9,14-17H2,1-3H3,(H,29,30) D0I2RB DRUGINKE QDDQIPUKAXBMBX-UHFFFAOYSA-N D0I2RB DRUGSMIL CCCC1=CC(=C(C=C1)COC2=CC3=C(C=C2)C(=C(CC3)CN4CC(C4)C(=O)O)C)OC D0I2RB HIGHSTAT Phase 2 D0I3LO DRUG__ID D0I3LO D0I3LO DRUGCOMP Infinity Pharmaceuticals Cambridge, MA D0I3LO DRUGINCH 1S/C30H24N8O2/c1-19(34-29(39)26-27(31)35-37-15-7-14-32-28(26)37)24-16-22-9-6-8-21(13-12-20-17-33-36(2)18-20)25(22)30(40)38(24)23-10-4-3-5-11-23/h3-11,14-19H,1-2H3,(H2,31,35)(H,34,39)/t19-/m0/s1 D0I3LO DRUGINKE XUMALORDVCFWKV-IBGZPJMESA-N D0I3LO DRUGSMIL CC(C1=CC2=C(C(=CC=C2)C#CC3=CN(N=C3)C)C(=O)N1C4=CC=CC=C4)NC(=O)C5=C6N=CC=CN6N=C5N D0I3LO HIGHSTAT Phase 2 D0I4PW DRUG__ID D0I4PW D0I4PW DRUGCOMP Arena Pharmaceuticals San Diego, CA D0I4PW DRUGINCH 1S/C18H23N5O3/c1-18(2,3)13(9-24)20-17(25)15-12-7-10-6-11(10)16(12)23(21-15)14-8-22(26)5-4-19-14/h4-5,8,10-11,13,24H,6-7,9H2,1-3H3,(H,20,25)/t10-,11-,13+/m0/s1 D0I4PW DRUGINKE ACSQLTBPYZSGBA-GMXVVIOVSA-N D0I4PW DRUGSMIL CC(C)(C)C(CO)NC(=O)C1=NN(C2=C1CC3C2C3)C4=NC=C[N+](=C4)[O-] D0I4PW HIGHSTAT Phase 2 D0I6ZO DRUG__ID D0I6ZO D0I6ZO DRUGCOMP AstraZeneca plc D0I6ZO DRUGINCH 1S/C19H25N3O2/c20-18(23)14-6-4-13(5-7-14)16-12-17(16)19(24)22-10-8-21(9-11-22)15-2-1-3-15/h4-7,15-17H,1-3,8-12H2,(H2,20,23)/t16-,17+/m1/s1 D0I6ZO DRUGINKE VCQZCDSEWSFTPO-SJORKVTESA-N D0I6ZO DRUGSMIL C1CC(C1)N2CCN(CC2)C(=O)C3CC3C4=CC=C(C=C4)C(=O)N D0I6ZO HIGHSTAT Phase 2 D0ID3W DRUG__ID D0ID3W D0ID3W DRUGCOMP GlaxoSmithKline plc D0ID3W DRUGINCH 1S/C17H22ClN3O5S2/c1-12(16(22)20-7-9-26-10-8-20)21-6-4-14(17(21)23)19-28(24,25)11-5-13-2-3-15(18)27-13/h2-3,5,11-12,14,19H,4,6-10H2,1H3/b11-5+/t12-,14-/m0/s1 D0ID3W DRUGINKE ACEFOQMQINFMRW-DYCFVMESSA-N D0ID3W DRUGSMIL CC(C(=O)N1CCOCC1)N2CCC(C2=O)NS(=O)(=O)C=CC3=CC=C(S3)Cl D0ID3W HIGHSTAT Phase 2 D0IZ8X DRUG__ID D0IZ8X D0IZ8X DRUGCOMP Tetra Discovery Partners Grand Rapids, MI D0IZ8X DRUGINCH 1S/C21H15ClF3NO2/c22-17-3-1-2-16(12-17)18-9-15(10-19(26-18)21(23,24)25)8-13-4-6-14(7-5-13)11-20(27)28/h1-7,9-10,12H,8,11H2,(H,27,28) D0IZ8X DRUGINKE LTSUMTMGJHPGFX-UHFFFAOYSA-N D0IZ8X DRUGSMIL C1=CC(=CC(=C1)Cl)C2=NC(=CC(=C2)CC3=CC=C(C=C3)CC(=O)O)C(F)(F)F D0IZ8X HIGHSTAT Phase 2 D0J3CT DRUG__ID D0J3CT D0J3CT DRUGTYPE Small molecular drug D0J3CT DRUGINCH 1S/C40H44N2O3/c1-27(2)23-29-14-18-31(19-15-29)39(32-20-16-30(17-21-32)24-28(3)4)41-34-10-7-9-33(25-34)40(45)36-26-42(22-8-13-38(43)44)37-12-6-5-11-35(36)37/h5-7,9-12,14-21,25-28,39,41H,8,13,22-24H2,1-4H3,(H,43,44) D0J3CT DRUGINKE LACIBZRFAYFTOV-UHFFFAOYSA-N D0J3CT DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C2=CC=C(C=C2)CC(C)C)NC3=CC=CC(=C3)C(=O)C4=CN(C5=CC=CC=C54)CCCC(=O)O D0J3CT HIGHSTAT Phase 2 D0J4XV DRUG__ID D0J4XV D0J4XV DRUGCOMP AstraZeneca Wilmington, DE D0J4XV DRUGINCH 1S/C15H11ClFN5/c1-8-6-10(7-12(16)19-8)14-13(20-15(18)22-21-14)9-2-4-11(17)5-3-9/h2-7H,1H3,(H2,18,20,22) D0J4XV DRUGINKE NCWQLHHDGDXIJN-UHFFFAOYSA-N D0J4XV DRUGSMIL CC1=CC(=CC(=N1)Cl)C2=C(N=C(N=N2)N)C3=CC=C(C=C3)F D0J4XV HIGHSTAT Phase 2 D0J6KZ DRUG__ID D0J6KZ D0J6KZ DRUGCOMP Shionogi USA Inc D0J6KZ DRUGINCH 1S/C23H27FN2O4/c1-3-19-15(2)13-18(20(27)25-23(22(29)30)11-5-4-6-12-23)21(28)26(19)14-16-7-9-17(24)10-8-16/h7-10,13H,3-6,11-12,14H2,1-2H3,(H,25,27)(H,29,30) D0J6KZ DRUGINKE JIYXOJFSPOFZPY-UHFFFAOYSA-N D0J6KZ DRUGSMIL CCC1=C(C=C(C(=O)N1CC2=CC=C(C=C2)F)C(=O)NC3(CCCCC3)C(=O)O)C D0J6KZ HIGHSTAT Phase 2 D0J8DD DRUG__ID D0J8DD D0J8DD DRUGCOMP Takeda D0J8DD DRUGINCH 1S/C19H23N3O3S/c1-14-13-22-11-12-26(23,24)21-19(22)18(20-14)15-7-9-17(10-8-15)25-16-5-3-2-4-6-16/h7-10,13,16H,2-6,11-12H2,1H3 D0J8DD DRUGINKE PXJBHEHFVQVDDS-UHFFFAOYSA-N D0J8DD DRUGSMIL CC1=CN2CCS(=O)(=O)N=C2C(=N1)C3=CC=C(C=C3)OC4CCCCC4 D0J8DD HIGHSTAT Phase 2 D0J8WE DRUG__ID D0J8WE D0J8WE DRUGTYPE Small molecular drug D0J8WE DRUGINCH 1S/C36H45ClN2O8/c1-21(2)17-29-34(42)45-27(22(3)31-32(47-31)24-11-8-7-9-12-24)13-10-14-30(40)39-26(19-23-15-16-28(44-6)25(37)18-23)33(41)38-20-36(4,5)35(43)46-29/h7-12,14-16,18,21-22,26-27,29,31-32H,13,17,19-20H2,1-6H3,(H,38,41)(H,39,40)/b14-10+/t22-,26+,27-,29-,31+,32+/m0/s1 D0J8WE DRUGINKE LSXOBYNBRKOTIQ-RQUBOUMQSA-N D0J8WE DRUGSMIL CC(C)CC1C(=O)OC(CC=CC(=O)NC(C(=O)NCC(C(=O)O1)(C)C)CC2=CC(=C(C=C2)OC)Cl)C(C)C3C(O3)C4=CC=CC=C4 D0J8WE HIGHSTAT Phase 2 D0J9IH DRUG__ID D0J9IH D0J9IH DRUGTYPE Small molecular drug D0J9IH DRUGINCH 1S/C20H25N5O6S/c1-9-6-14(18(29)23-12(19(30)31)3-5-15(26)27)32-13(9)4-2-10-7-11-16(22-8-10)24-20(21)25-17(11)28/h6,10,12H,2-5,7-8H2,1H3,(H,23,29)(H,26,27)(H,30,31)(H4,21,22,24,25,28)/t10-,12-/m0/s1 D0J9IH DRUGINKE QXOPTIPQEVJERB-JQWIXIFHSA-N D0J9IH DRUGSMIL CC1=C(SC(=C1)C(=O)NC(CCC(=O)O)C(=O)O)CCC2CC3=C(NC2)N=C(NC3=O)N D0J9IH HIGHSTAT Phase 2 D0JT5I DRUG__ID D0JT5I D0JT5I DRUGTYPE Small molecular drug D0JT5I DRUGINCH 1S/C23H20F3N5O2/c24-23(25,26)18-6-7-21(27-15-18)33-19-4-1-3-17(14-19)13-16-8-11-31(12-9-16)22(32)29-20-5-2-10-28-30-20/h1-7,10,13-15H,8-9,11-12H2,(H,29,30,32) D0JT5I DRUGINKE BATCTBJIJJEPHM-UHFFFAOYSA-N D0JT5I DRUGSMIL C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4 D0JT5I HIGHSTAT Phase 2 D0K1EG DRUG__ID D0K1EG D0K1EG DRUGCOMP Novartis AG D0K1EG DRUGINCH 1S/C18H18N2O4S/c1-12-16(10-17(21)22)15-4-3-9-19-18(15)20(12)11-13-5-7-14(8-6-13)25(2,23)24/h3-9H,10-11H2,1-2H3,(H,21,22) D0K1EG DRUGINKE YOPFAMROKXHVCQ-UHFFFAOYSA-N D0K1EG DRUGSMIL CC1=C(C2=C(N1CC3=CC=C(C=C3)S(=O)(=O)C)N=CC=C2)CC(=O)O D0K1EG HIGHSTAT Phase 2 D0K4HW DRUG__ID D0K4HW D0K4HW DRUGTYPE Small molecular drug D0K4HW DRUGINCH 1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2 D0K4HW DRUGINKE JNNOSTQEZICQQP-UHFFFAOYSA-N D0K4HW DRUGSMIL C1CN(CCN1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42 D0K4HW HIGHSTAT Phase 2 D0K4JQ DRUG__ID D0K4JQ D0K4JQ DRUGCOMP GlaxoSmithKline D0K4JQ DRUGINCH 1S/C42H52N8O8/c1-24(2)34(47-40(53)55-5)38(51)49-17-7-8-32(49)36-43-21-30(45-36)28-13-9-26(10-14-28)27-11-15-29(16-12-27)31-22-44-37(46-31)33-20-42(57-18-19-58-42)23-50(33)39(52)35(25(3)4)48-41(54)56-6/h9-16,21-22,24-25,32-35H,7-8,17-20,23H2,1-6H3,(H,43,45)(H,44,46)(H,47,53)(H,48,54)/t32-,33-,34-,35-/m0/s1 D0K4JQ DRUGINKE YMCAVGXTSCNFDE-BBACVFHCSA-N D0K4JQ DRUGSMIL CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CC7(CN6C(=O)C(C(C)C)NC(=O)OC)OCCO7)NC(=O)OC D0K4JQ HIGHSTAT Phase 2 D0K4MU DRUG__ID D0K4MU D0K4MU DRUGTYPE Small molecular drug D0K4MU DRUGINCH 1S/C25H33NO2/c1-18(28-17-19-9-6-5-7-10-19)16-26-14-13-25(4)21-11-8-12-22(27)20(21)15-23(26)24(25,2)3/h5-12,18,23,27H,13-17H2,1-4H3/t18-,23+,25-/m0/s1 D0K4MU DRUGINKE VCCBCXVFGHTDQN-UODBTFMRSA-N D0K4MU DRUGSMIL CC(CN1CCC2(C3=C(CC1C2(C)C)C(=CC=C3)O)C)OCC4=CC=CC=C4 D0K4MU HIGHSTAT Phase 2 D0K4OC DRUG__ID D0K4OC D0K4OC DRUGTYPE Small molecular drug D0K4OC DRUGINCH 1S/C19H31N5O6/c1-9(2)15(21)17(25)28-8-12-11(30-18(26)16(22)10(3)4)7-14(29-12)24-6-5-13(20)23-19(24)27/h5-6,9-12,14-16H,7-8,21-22H2,1-4H3,(H2,20,23,27)/t11-,12+,14+,15+,16+/m1/s1 D0K4OC DRUGINKE BPPMYUZIZUESBY-MLEONAHRSA-N D0K4OC DRUGSMIL CC(C)C(C(=O)OCC1C(CC(O1)N2C=CC(=NC2=O)N)OC(=O)C(C(C)C)N)N D0K4OC HIGHSTAT Phase 2 D0K4QT DRUG__ID D0K4QT D0K4QT DRUGCOMP Bayer AG D0K4QT DRUGINCH 1S/C26H24N4O2/c1-15(2)32-26(31)24-23(21(13-27)16(3)30-25(24)28)19-10-7-11-22-20(19)12-18(14-29-22)17-8-5-4-6-9-17/h4-12,14-15,23,30H,28H2,1-3H3/t23-/m1/s1 D0K4QT DRUGINKE PHJVBZVDUNTGNR-HSZRJFAPSA-N D0K4QT DRUGSMIL CC1=C(C(C(=C(N1)N)C(=O)OC(C)C)C2=C3C=C(C=NC3=CC=C2)C4=CC=CC=C4)C#N D0K4QT HIGHSTAT Phase 2 D0K8FI DRUG__ID D0K8FI D0K8FI DRUGCOMP Knoll GmbH D0K8FI DRUGINCH 1S/C299H462N84O115S6/c1-27-142(21)234-289(485)361-171(97-134(5)6)244(440)323-120-216(410)335-188(124-385)273(469)337-154(45-34-36-86-317-298(493)497-95-93-495-29-3)240(436)319-114-210(404)332-161(67-80-221(418)419)250(446)338-156(47-38-88-315-296(310)311)248(444)356-180(106-205(305)399)266(462)343-162(61-74-201(301)395)257(453)367-194(130-502-499-127-191-247(443)326-116-209(403)329-157(64-77-218(412)413)241(437)320-117-213(407)333-179(105-204(304)398)265(461)339-155(46-35-37-87-318-299(494)498-96-94-496-30-4)249(445)366-195(279(475)376-234)131-503-500-128-192(276(472)340-159(66-79-220(416)417)243(439)321-119-215(409)336-189(125-386)274(470)359-183(109-208(308)402)272(468)373-231(139(15)16)287(483)371-191)368-261(457)174(100-137(11)12)352-277(473)193-129-501-504-132-196(370-270(466)186(112-229(434)435)363-291(487)238(146(25)390)378-271(467)177(103-150-54-58-153(393)59-55-150)362-286(482)232(140(17)18)375-284(480)230(309)138(13)14)280(476)379-237(145(24)389)290(486)347-167(71-84-225(426)427)256(452)364-187(123-384)246(442)325-115-211(405)331-160(60-73-200(300)394)251(447)357-181(107-206(306)400)267(463)351-173(99-136(9)10)260(456)369-193)278(474)374-233(141(19)20)288(484)380-236(144(23)388)285(481)327-121-212(406)330-158(65-78-219(414)415)242(438)322-122-217(411)372-239(147(26)391)294(490)383-92-42-51-199(383)283(479)348-169(48-39-89-316-297(312)313)292(488)381-90-40-49-197(381)281(477)345-163(62-75-202(302)396)255(451)365-190(126-387)275(471)355-178(104-151-113-314-133-328-151)264(460)358-182(108-207(307)401)268(464)360-184(110-227(430)431)245(441)324-118-214(408)334-185(111-228(432)433)269(465)354-175(101-148-43-32-31-33-44-148)262(458)344-164(68-81-222(420)421)252(448)342-168(72-85-226(428)429)258(454)377-235(143(22)28-2)293(489)382-91-41-50-198(382)282(478)346-166(70-83-224(424)425)253(449)341-165(69-82-223(422)423)254(450)353-176(102-149-52-56-152(392)57-53-149)263(459)350-172(98-135(7)8)259(455)349-170(295(491)492)63-76-203(303)397/h31-33,43-44,52-59,113,133-147,154-199,230-239,384-393H,27-30,34-42,45-51,60-112,114-132,309H2,1-26H3,(H2,300,394)(H2,301,395)(H2,302,396)(H2,303,397)(H2,304,398)(H2,305,399)(H2,306,400)(H2,307,401)(H2,308,402)(H,314,328)(H,317,493)(H,318,494)(H,319,436)(H,320,437)(H,321,439)(H,322,438)(H,323,440)(H,324,441)(H,325,442)(H,326,443)(H,327,481)(H,329,403)(H,330,406)(H,331,405)(H,332,404)(H,333,407)(H,334,408)(H,335,410)(H,336,409)(H,337,469)(H,338,446)(H,339,461)(H,340,472)(H,341,449)(H,342,448)(H,343,462)(H,344,458)(H,345,477)(H,346,478)(H,347,486)(H,348,479)(H,349,455)(H,350,459)(H,351,463)(H,352,473)(H,353,450)(H,354,465)(H,355,471)(H,356,444)(H,357,447)(H,358,460)(H,359,470)(H,360,464)(H,361,485)(H,362,482)(H,363,487)(H,364,452)(H,365,451)(H,366,445)(H,367,453)(H,368,457)(H,369,456)(H,370,466)(H,371,483)(H,372,411)(H,373,468)(H,374,474)(H,375,480)(H,376,475)(H,377,454)(H,378,467)(H,379,476)(H,380,484)(H,412,413)(H,414,415)(H,416,417)(H,418,419)(H,420,421)(H,422,423)(H,424,425)(H,426,427)(H,428,429)(H,430,431)(H,432,433)(H,434,435)(H,491,492)(H4,310,311,315)(H4,312,313,316)/t142-,143-,144+,145+,146+,147+,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,198-,199-,230-,231-,232-,233-,234-,235-,236-,237-,238-,239-/m0/s1 D0K8FI DRUGINKE MFPRYDMAZLLTGM-IJDGSQHYSA-N D0K8FI DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCNC(=O)OCCOCC)CC(=O)N)CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCNC(=N)N)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CCC(=O)O)CCCCNC(=O)OCCOCC)CO)CC(C)C D0K8FI HIGHSTAT Phase 2 D0KF3O DRUG__ID D0KF3O D0KF3O DRUGCOMP Fluoropharma D0KF3O DRUGINCH 1S/C18H33FO2/c1-2-3-4-5-6-7-11-17(19)12-9-8-10-15-13-16(15)14-18(20)21/h15-17H,2-14H2,1H3,(H,20,21)/t15-,16+,17?/m1/s1/i19-1 D0KF3O DRUGINKE DDTRZLZETKPBPQ-YWWFHXEUSA-N D0KF3O DRUGSMIL CCCCCCCCC(CCCCC1CC1CC(=O)O)F D0KF3O HIGHSTAT Phase 2 D0KQ7M DRUG__ID D0KQ7M D0KQ7M DRUGCOMP ArQule Burlington, MA D0KQ7M DRUGINCH 1S/C25H23ClN4O4/c26-21-10-17(34-16-4-2-1-3-5-16)8-9-19(21)23(32)20-11-27-24-22(20)25(29-14-28-24)30-15-6-7-18(12-31)33-13-15/h1-5,8-11,14-15,18,31H,6-7,12-13H2,(H2,27,28,29,30)/t15-,18+/m1/s1 D0KQ7M DRUGINKE JSFCZQSJQXFJDS-QAPCUYQASA-N D0KQ7M DRUGSMIL C1CC(OCC1NC2=NC=NC3=C2C(=CN3)C(=O)C4=C(C=C(C=C4)OC5=CC=CC=C5)Cl)CO D0KQ7M HIGHSTAT Phase 2 D0KW3Z DRUG__ID D0KW3Z D0KW3Z DRUGTYPE Small molecular drug D0KW3Z DRUGINCH 1S/C20H33N5O9/c1-11(27)22-14(10-26)18(31)24-13(9-16(28)29)17(30)23-12(5-2-3-7-21)19(32)25-8-4-6-15(25)20(33)34/h12-15,26H,2-10,21H2,1H3,(H,22,27)(H,23,30)(H,24,31)(H,28,29)(H,33,34)/t12-,13-,14-,15-/m0/s1 D0KW3Z DRUGINKE HJDRXEQUFWLOGJ-AJNGGQMLSA-N D0KW3Z DRUGSMIL CC(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)O D0KW3Z HIGHSTAT Phase 2 D0L0BX DRUG__ID D0L0BX D0L0BX DRUGTYPE Small molecular drug D0L0BX DRUGINCH 1S/C21H20O6/c1-11(2)4-9-14-15(22)10-16(23)17-18(24)19(25)20(27-21(14)17)12-5-7-13(26-3)8-6-12/h4-8,10,22-23,25H,9H2,1-3H3 D0L0BX DRUGINKE TUUXBSASAQJECY-UHFFFAOYSA-N D0L0BX DRUGSMIL CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=C(C=C3)OC)O)C D0L0BX HIGHSTAT Phase 2 D0L1VF DRUG__ID D0L1VF D0L1VF DRUGCOMP Provectus Biopharmaceuticals Knoxville, TN D0L1VF DRUGINCH 1S/C20H4Cl4I4O5.2Na/c21-10-8(9(20(31)32)11(22)13(24)12(10)23)7-3-1-5(25)16(29)14(27)18(3)33-19-4(7)2-6(26)17(30)15(19)28;;/h1-2,29H,(H,31,32);;/q;2*+1/p-2 D0L1VF DRUGINKE UWBXIFCTIZXXLS-UHFFFAOYSA-L D0L1VF DRUGSMIL C1=C2C(=C3C=C(C(=O)C(=C3OC2=C(C(=C1I)[O-])I)I)I)C4=C(C(=C(C(=C4Cl)Cl)Cl)Cl)C(=O)[O-].[Na+].[Na+] D0L1VF HIGHSTAT Phase 2 D0L2YR DRUG__ID D0L2YR D0L2YR DRUGCOMP Domain Therapeutics SA D0L2YR DRUGINCH 1S/C23H23N3O3S/c27-25-19-13-22(20-14-23-17(15-24-20)5-11-30-23)29-21-4-3-16(12-18(19)21)2-1-6-26-7-9-28-10-8-26/h3-5,11-15,27H,1-2,6-10H2/b25-19+ D0L2YR DRUGINKE ZTEDNASHAWNBKQ-NCELDCMTSA-N D0L2YR DRUGSMIL C1COCCN1CCCC2=CC3=C(C=C2)OC(=CC3=NO)C4=NC=C5C=CSC5=C4 D0L2YR HIGHSTAT Phase 2 D0L4SL DRUG__ID D0L4SL D0L4SL DRUGCOMP DIC Corporation D0L4SL DRUGINCH 1S/C29H36N2O7/c1-5-6-7-8-9-10-15-38-28-26(33)21-13-12-20(18-22(21)31(2)29(28)35)30-25(32)14-11-19-16-23(36-3)27(34)24(17-19)37-4/h11-14,16-18,33-34H,5-10,15H2,1-4H3,(H,30,32)/b14-11+ D0L4SL DRUGINKE SZNJINHODJLULD-SDNWHVSQSA-N D0L4SL DRUGSMIL CCCCCCCCOC1=C(C2=C(C=C(C=C2)NC(=O)C=CC3=CC(=C(C(=C3)OC)O)OC)N(C1=O)C)O D0L4SL HIGHSTAT Phase 2 D0L5AH DRUG__ID D0L5AH D0L5AH DRUGTYPE Small molecular drug D0L5AH DRUGINCH 1S/C20H18F3NO4/c1-19(2)17(25)16(24-10-11-5-3-4-6-13(11)18(24)26)14-9-12(27-20(21,22)23)7-8-15(14)28-19/h3-9,16-17,25H,10H2,1-2H3/t16-,17+/m1/s1 D0L5AH DRUGINKE ZORATYFUTXFLJS-SJORKVTESA-N D0L5AH DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)OC(F)(F)F)N3CC4=CC=CC=C4C3=O)O)C D0L5AH HIGHSTAT Phase 2 D0L5MF DRUG__ID D0L5MF D0L5MF DRUGTYPE Small molecular drug D0L5MF DRUGINCH 1S/C19H21N5O3/c1-22(2)9-4-10-23-15-7-8-16(24(25)26)19-17(15)18(21-23)13-11-12(27-3)5-6-14(13)20-19/h5-8,11,20H,4,9-10H2,1-3H3 D0L5MF DRUGINKE HZCWPKGYTCJSEB-UHFFFAOYSA-N D0L5MF DRUGSMIL CN(C)CCCN1C2=C3C(=C(C=C2)[N+](=O)[O-])NC4=C(C3=N1)C=C(C=C4)OC D0L5MF HIGHSTAT Phase 2 D0L5VX DRUG__ID D0L5VX D0L5VX DRUGCOMP Mallinckrodt St. Louis, MO D0L5VX DRUGINCH 1S/C136H210N40O31S.6C2H4O2/c1-75(2)109(127(200)154-71-106(181)156-88(31-13-17-52-137)114(187)158-89(32-14-18-53-138)115(188)159-91(35-21-56-149-134(142)143)116(189)164-96(37-23-58-151-136(146)147)131(204)175-60-25-39-104(175)126(199)173-111(77(5)6)128(201)163-90(33-15-19-54-139)120(193)171-110(76(3)4)129(202)169-101(65-80-43-47-84(180)48-44-80)132(205)176-61-26-40-105(176)133(206)207)172-125(198)103-38-24-59-174(103)130(203)95(34-16-20-55-140)157-107(182)70-153-113(186)99(66-81-68-152-87-30-12-11-29-85(81)87)167-117(190)92(36-22-57-150-135(144)145)160-121(194)98(63-78-27-9-8-10-28-78)166-123(196)100(67-82-69-148-74-155-82)168-118(191)93(49-50-108(183)184)161-119(192)94(51-62-208-7)162-124(197)102(73-178)170-122(195)97(165-112(185)86(141)72-177)64-79-41-45-83(179)46-42-79;6*1-2(3)4/h8-12,27-30,41-48,68-69,74-77,86,88-105,109-111,152,177-180H,13-26,31-40,49-67,70-73,137-141H2,1-7H3,(H,148,155)(H,153,186)(H,154,200)(H,156,181)(H,157,182)(H,158,187)(H,159,188)(H,160,194)(H,161,192)(H,162,197)(H,163,201)(H,164,189)(H,165,185)(H,166,196)(H,167,190)(H,168,191)(H,169,202)(H,170,195)(H,171,193)(H,172,198)(H,173,199)(H,183,184)(H,206,207)(H4,142,143,149)(H4,144,145,150)(H4,146,147,151);6*1H3,(H,3,4)/t86-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,109-,110-,111-;;;;;;/m0....../s1 D0L5VX DRUGINKE DFABUZLKSKOWCS-WMPFGLIOSA-N D0L5VX DRUGSMIL CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC=N8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O.CC(=O)O D0L5VX HIGHSTAT Phase 2 D0L5WA DRUG__ID D0L5WA D0L5WA DRUGTYPE Small molecular drug D0L5WA DRUGINCH 1S/2C21H32N4.3C4H4O4/c2*1-6-12-18-15-19(22-16-21(4,5)25(7-2)8-3)23-24-20(18)17-13-10-9-11-14-17;3*5-3(6)1-2-4(7)8/h2*9-11,13-15H,6-8,12,16H2,1-5H3,(H,22,23);3*1-2H,(H,5,6)(H,7,8) D0L5WA DRUGINKE AEOGOPZZLSQJKM-UHFFFAOYSA-N D0L5WA DRUGSMIL CCCC1=CC(=NN=C1C2=CC=CC=C2)NCC(C)(C)N(CC)CC.CCCC1=CC(=NN=C1C2=CC=CC=C2)NCC(C)(C)N(CC)CC.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O D0L5WA HIGHSTAT Phase 2 D0L7WS DRUG__ID D0L7WS D0L7WS DRUGCOMP Rexahn D0L7WS DRUGINCH 1S/C10H12FN3O4/c11-6-4(3-15)8(16)9(17)7(6)14-2-1-5(12)13-10(14)18/h1-2,7-9,15-17H,3H2,(H2,12,13,18)/t7-,8-,9+/m1/s1 D0L7WS DRUGINKE QLLGKCJUPWYJON-HLTSFMKQSA-N D0L7WS DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(=C2F)CO)O)O D0L7WS HIGHSTAT Phase 2 D0L8MO DRUG__ID D0L8MO D0L8MO DRUGTYPE Small molecular drug D0L8MO DRUGINCH 1S/C12H14N2O3S2/c1-2-3-7-17-10(15)8-19(16)12-14-9-5-4-6-13-11(9)18-12/h4-6H,2-3,7-8H2,1H3 D0L8MO DRUGINKE BUXNKFNNJJTLOS-UHFFFAOYSA-N D0L8MO DRUGSMIL CCCCOC(=O)CS(=O)C1=NC2=C(S1)N=CC=C2 D0L8MO HIGHSTAT Phase 2 D0L9XF DRUG__ID D0L9XF D0L9XF DRUGCOMP Boston Biomedical D0L9XF DRUGINCH 1S/C31H33N5O2S/c1-5-36(6-2)15-14-32-30(38)28-19(3)26(33-20(28)4)17-24-23-16-22(12-13-25(23)34-29(24)37)27-18-39-31(35-27)21-10-8-7-9-11-21/h7-13,16-18,33H,5-6,14-15H2,1-4H3,(H,32,38)(H,34,37)/b24-17- D0L9XF DRUGINKE QDWKGEFGLQMDAM-ULJHMMPZSA-N D0L9XF DRUGSMIL CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C D0L9XF HIGHSTAT Phase 2 D0LE6F DRUG__ID D0LE6F D0LE6F DRUGCOMP Celgene D0LE6F DRUGINCH 1S/C24H28N2O6S/c1-4-32-21-12-16(10-11-20(21)31-2)19(14-33(3,29)30)26-13-17-6-5-7-18(22(17)24(26)28)25-23(27)15-8-9-15/h5-7,10-12,15,19H,4,8-9,13-14H2,1-3H3,(H,25,27)/t19-/m1/s1 D0LE6F DRUGINKE QDZOBXFRIVOQBR-LJQANCHMSA-N D0LE6F DRUGSMIL CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2CC3=C(C2=O)C(=CC=C3)NC(=O)C4CC4)OC D0LE6F HIGHSTAT Phase 2 D0LG7X DRUG__ID D0LG7X D0LG7X DRUGCOMP Rhizen PharmaceuticalsLa Chaux-de-Fonds, Switzerland D0LG7X DRUGINCH 1S/C23H18FN5O2/c1-2-16(29-23-19-22(26-11-25-19)27-12-28-23)21-18(13-6-5-7-14(24)10-13)20(30)15-8-3-4-9-17(15)31-21/h3-12,16H,2H2,1H3,(H2,25,26,27,28,29)/t16-/m0/s1 D0LG7X DRUGINKE HDXDQPRPFRKGKZ-INIZCTEOSA-N D0LG7X DRUGSMIL CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5 D0LG7X HIGHSTAT Phase 2 D0LI1C DRUG__ID D0LI1C D0LI1C DRUGTYPE Small molecular drug D0LI1C DRUGINCH 1S/C19H14Cl2FN3O/c1-8-4-11-10-6-14(22)13(21)7-16(10)23-17(11)19(25-8)12-5-9(20)2-3-15(12)24-18(19)26/h2-3,5-8,23,25H,4H2,1H3,(H,24,26)/t8-,19+/m0/s1 D0LI1C DRUGINKE CKLPLPZSUQEDRT-WPCRTTGESA-N D0LI1C DRUGSMIL CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl D0LI1C HIGHSTAT Phase 2 D0LQ3L DRUG__ID D0LQ3L D0LQ3L DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0LQ3L DRUGINCH 1S/C20H19N5O3/c1-25-15-9-5-6-10-16(15)28-12-14(20(25)27)21-19(26)18-22-17(23-24-18)11-13-7-3-2-4-8-13/h2-10,14H,11-12H2,1H3,(H,21,26)(H,22,23,24)/t14-/m0/s1 D0LQ3L DRUGINKE LYPAFUINURXJSG-AWEZNQCLSA-N D0LQ3L DRUGSMIL CN1C2=CC=CC=C2OCC(C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4 D0LQ3L HIGHSTAT Phase 2 D0LT0U DRUG__ID D0LT0U D0LT0U DRUGTYPE Small molecular drug D0LT0U DRUGINCH 1S/C21H25NO3/c1-22(14-20(23)24)13-17-9-8-16-12-18(25-2)10-11-19(16)21(17)15-6-4-3-5-7-15/h3-7,10-12,17,21H,8-9,13-14H2,1-2H3,(H,23,24)/t17-,21+/m1/s1 D0LT0U DRUGINKE UEBBYLJZCHTLEG-UTKZUKDTSA-N D0LT0U DRUGSMIL CN(CC1CCC2=C(C1C3=CC=CC=C3)C=CC(=C2)OC)CC(=O)O D0LT0U HIGHSTAT Phase 2 D0M0PY DRUG__ID D0M0PY D0M0PY DRUGCOMP Dyax Corp. D0M0PY DRUGINCH 1S/C282H412N74O75S6/c1-21-150(15)229-273(424)312-154(19)232(383)328-185(117-157-58-30-24-31-59-157)255(406)339-196(123-160-64-36-27-37-65-160)277(428)353-110-52-76-205(353)267(418)324-177(74-50-108-300-282(296)297)246(397)332-189(124-164-129-301-170-67-39-38-66-168(164)170)250(401)310-153(18)231(382)327-184(116-156-56-28-23-29-57-156)253(404)334-193(128-224(380)381)251(402)311-155(20)234(385)347-225(146(7)8)270(421)325-171(68-40-44-102-283)236(387)304-132-215(367)313-173(69-41-45-103-284)242(393)344-202-142-436-435-141-201-262(413)319-176(73-49-107-299-281(294)295)244(395)321-180(95-100-222(376)377)248(399)330-188(121-163-84-90-167(360)91-85-163)257(408)342-198(241(392)307-135-218(370)346-228(149(13)14)278(429)356-113-55-79-208(356)279(430)431)138-432-434-140-200(341-233(384)152(17)309-235(386)169(287)92-98-220(372)373)263(414)333-192(127-212(291)364)259(410)337-194(115-145(5)6)275(426)355-112-54-78-207(355)269(420)351-230(151(16)22-2)274(425)349-227(148(11)12)271(422)326-172(72-48-106-298-280(292)293)237(388)308-136-219(371)352-109-51-75-204(352)266(417)345-203(265(416)350-229)143-437-433-139-199(316-214(366)131-302-213(365)130-303-239(390)183(119-161-80-86-165(358)87-81-161)335-268(419)206-77-53-111-354(206)276(427)195(122-159-62-34-26-35-63-159)338-252(403)182(114-144(3)4)336-272(423)226(147(9)10)348-264(202)415)261(412)320-178(93-97-209(288)361)238(389)305-133-216(368)314-190(125-210(289)362)240(391)306-134-217(369)315-191(126-211(290)363)258(409)318-175(71-43-47-105-286)245(396)329-186(118-158-60-32-25-33-61-158)254(405)331-187(120-162-82-88-166(359)89-83-162)256(407)340-197(137-357)260(411)323-179(94-99-221(374)375)247(398)317-174(70-42-46-104-285)243(394)322-181(249(400)343-201)96-101-223(378)379/h23-39,56-67,80-91,129,144-155,169,171-208,225-230,301,357-360H,21-22,40-55,68-79,92-128,130-143,283-287H2,1-20H3,(H2,288,361)(H2,289,362)(H2,290,363)(H2,291,364)(H,302,365)(H,303,390)(H,304,387)(H,305,389)(H,306,391)(H,307,392)(H,308,388)(H,309,386)(H,310,401)(H,311,402)(H,312,424)(H,313,367)(H,314,368)(H,315,369)(H,316,366)(H,317,398)(H,318,409)(H,319,413)(H,320,412)(H,321,395)(H,322,394)(H,323,411)(H,324,418)(H,325,421)(H,326,422)(H,327,382)(H,328,383)(H,329,396)(H,330,399)(H,331,405)(H,332,397)(H,333,414)(H,334,404)(H,335,419)(H,336,423)(H,337,410)(H,338,403)(H,339,406)(H,340,407)(H,341,384)(H,342,408)(H,343,400)(H,344,393)(H,345,417)(H,346,370)(H,347,385)(H,348,415)(H,349,425)(H,350,416)(H,351,420)(H,372,373)(H,374,375)(H,376,377)(H,378,379)(H,380,381)(H,430,431)(H4,292,293,298)(H4,294,295,299)(H4,296,297,300)/t150-,151-,152-,153-,154-,155-,169-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,198-,199-,200-,201-,202-,203-,204-,205-,206-,207-,208-,225-,226-,227-,228-,229-,230-/m0/s1 D0M0PY DRUGINKE CARVNSROHCBVAO-BUGJESOBSA-N D0M0PY DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2CCCC2C(=O)NC3CSSCC4C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5CCCC5C(=O)NC(C(=O)NCC(=O)NCC(=O)N4)CC6=CC=C(C=C6)O)CC7=CC=CC=C7)CC(C)C)C(C)C)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C8CCCN8C(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC3=O)C(C)CC)C)CC9=CC=CC=C9)CC2=CC=CC=C2)CCCNC(=N)N)CC2=CNC3=CC=CC=C32)C)CC2=CC=CC=C2)CC(=O)O)C)C(C)C)CCCCN)CCCCN)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)N1)CC(C)C)CC(=O)N)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NCC(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)O)CC1=CC=C(C=C1)O)CCC(=O)O)CCCNC(=N)N)CCC(=O)O)CCCCN)CCC(=O)O)CO)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CCCCN)CC(=O)N)CC(=O)N)CCC(=O)N)CCCNC(=N)N)C(C)C D0M0PY HIGHSTAT Phase 2 D0M1ZH DRUG__ID D0M1ZH D0M1ZH DRUGCOMP EMD Serono Rockland, MA D0M1ZH DRUGINCH 1S/C10H12ClNO/c1-7-4-3-5-8(2)10(7)12-9(13)6-11/h3-5H,6H2,1-2H3,(H,12,13) D0M1ZH DRUGINKE FPQQSNUTBWFFLB-UHFFFAOYSA-N D0M1ZH DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CCl D0M1ZH HIGHSTAT Phase 2 D0M2WQ DRUG__ID D0M2WQ D0M2WQ DRUGCOMP CellAct Pharma GmbH D0M2WQ DRUGINCH 1S/C36H42O17/c1-15-43-13-25-32(49-15)28(37)29(38)34(50-25)51-30-19-9-22-21(46-14-47-22)8-18(19)26(27-20(30)12-44-33(27)39)16-6-23(41-4)31(24(7-16)42-5)52-35(40)45-10-17-11-48-36(2,3)53-17/h6-9,15,17,20,25-30,32,34,37-38H,10-14H2,1-5H3/t15?,17?,20-,25+,26+,27-,28+,29+,30+,32+,34-/m0/s1 D0M2WQ DRUGINKE FCWSQAKOPTZCOD-OUCIFNFRSA-N D0M2WQ DRUGSMIL CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)OC(=O)OCC8COC(O8)(C)C)OC)O)O D0M2WQ HIGHSTAT Phase 2 D0M4KE DRUG__ID D0M4KE D0M4KE DRUGTYPE Small molecular drug D0M4KE DRUGINCH 1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1 D0M4KE DRUGINKE KTEXNACQROZXEV-PVLRGYAZSA-N D0M4KE DRUGSMIL CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C D0M4KE HIGHSTAT Phase 2 D0M4TJ DRUG__ID D0M4TJ D0M4TJ DRUGCOMP Arena Pharmaceuticals San Diego, CA D0M4TJ DRUGINCH 1S/C23H26ClNO5/c24-19-10-12-21(13-11-19)25(20-4-2-1-3-5-20)23(28)30-15-18-8-6-17(7-9-18)14-29-16-22(26)27/h1-5,10-13,17-18H,6-9,14-16H2,(H,26,27) D0M4TJ DRUGINKE NPDKXVKJRHPDQT-UHFFFAOYSA-N D0M4TJ DRUGSMIL C1CC(CCC1COCC(=O)O)COC(=O)N(C2=CC=CC=C2)C3=CC=C(C=C3)Cl D0M4TJ HIGHSTAT Phase 2 D0M4UZ DRUG__ID D0M4UZ D0M4UZ DRUGCOMP Janssen Research & Development D0M4UZ DRUGINCH 1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1 D0M4UZ DRUGINKE COOGVHJHSCBOQT-MRVPVSSYSA-N D0M4UZ DRUGSMIL CC(C)C1=CC(=NC(=N1)N)N2CCC(C2)N D0M4UZ HIGHSTAT Phase 2 D0M5PH DRUG__ID D0M5PH D0M5PH DRUGCOMP Pfizer D0M5PH DRUGINCH 1S/C22H20N6O4/c1-12-8-24-19(11-23-12)27-21(29)14-6-17-16(5-13(2)31-17)18(7-14)32-15-9-25-20(26-10-15)22(30)28(3)4/h5-11H,1-4H3,(H,24,27,29) D0M5PH DRUGINKE MASKQITXHVYVFL-UHFFFAOYSA-N D0M5PH DRUGSMIL CC1=CC2=C(O1)C=C(C=C2OC3=CN=C(N=C3)C(=O)N(C)C)C(=O)NC4=NC=C(N=C4)C D0M5PH HIGHSTAT Phase 2 D0M5VV DRUG__ID D0M5VV D0M5VV DRUGCOMP Advanced accelerator applications D0M5VV DRUGINCH 1S/C65H90N14O19S2.Lu/c1-38(80)56-64(96)73-51(63(95)75-57(39(2)81)65(97)98)37-100-99-36-50(72-59(91)47(28-40-10-4-3-5-11-40)68-52(83)32-76-20-22-77(33-53(84)85)24-26-79(35-55(88)89)27-25-78(23-21-76)34-54(86)87)62(94)70-48(29-41-15-17-43(82)18-16-41)60(92)71-49(30-42-31-67-45-13-7-6-12-44(42)45)61(93)69-46(58(90)74-56)14-8-9-19-66;/h3-7,10-13,15-18,31,38-39,46-51,56-57,67,80-82H,8-9,14,19-30,32-37,66H2,1-2H3,(H,68,83)(H,69,93)(H,70,94)(H,71,92)(H,72,91)(H,73,96)(H,74,90)(H,75,95)(H,84,85)(H,86,87)(H,88,89)(H,97,98);/q;+3/p-3/t38-,39-,46+,47-,48+,49-,50+,51+,56+,57+;/m1./s1/i;1+2 D0M5VV DRUGINKE MXDPZUIOZWKRAA-PRDSJKGBSA-K D0M5VV DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(C(C)O)C(=O)O)O.[Lu+3] D0M5VV HIGHSTAT Phase 2 D0M6PA DRUG__ID D0M6PA D0M6PA DRUGCOMP Novartis AG D0M6PA DRUGINCH 1S/C22H19N5O2/c1-13-5-6-16(22(29)26-17-7-8-17)10-19(13)27-21(24)18(12-25-27)20(28)15-4-2-3-14(9-15)11-23/h2-6,9-10,12,17H,7-8,24H2,1H3,(H,26,29) D0M6PA DRUGINKE VGUSQKZDZHAAEE-UHFFFAOYSA-N D0M6PA DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2CC2)N3C(=C(C=N3)C(=O)C4=CC=CC(=C4)C#N)N D0M6PA HIGHSTAT Phase 2 D0M6XK DRUG__ID D0M6XK D0M6XK DRUGCOMP Angiochem Montreal, Canada D0M6XK DRUGINCH 1S/C257H308N32O79/c1-133-174(123-255(348)216(363-238(342)155-81-51-30-52-82-155)210-249(18,177(301)120-180-252(210,130-351-180)366-141(9)296)213(319)204(354-138(6)293)196(133)246(255,12)13)357-241(345)207(201(149-69-39-24-40-70-149)287-219(322)152-75-45-27-46-76-152)360-193(316)106-101-185(306)264-109-59-57-87-161(271-190(311)128-270-222(325)160(89-61-111-266-244(260)261)273-234(337)173(129-290)272-189(310)127-268-188(309)126-269-223(326)166(116-147-91-95-158(299)96-92-147)278-230(333)168(114-145-65-35-22-36-66-145)279-231(334)169(115-146-67-37-23-38-68-146)283-235(338)199(136(4)291)285-187(308)103-108-195(318)362-209(203(151-73-43-26-44-74-151)289-221(324)154-79-49-29-50-80-154)243(347)359-176-125-257(350)218(365-240(344)157-85-55-32-56-86-157)212-251(20,179(303)122-182-254(212,132-353-182)368-143(11)298)215(321)206(356-140(8)295)198(135(176)3)248(257,16)17)224(327)274-163(90-62-112-267-245(262)263)225(328)281-170(118-183(258)304)233(336)282-171(119-184(259)305)232(335)280-167(113-144-63-33-21-34-64-144)229(332)275-162(228(331)286-200(137(5)292)236(339)277-165(100-105-192(314)315)226(329)276-164(99-104-191(312)313)227(330)284-172(237(340)341)117-148-93-97-159(300)98-94-148)88-58-60-110-265-186(307)102-107-194(317)361-208(202(150-71-41-25-42-72-150)288-220(323)153-77-47-28-48-78-153)242(346)358-175-124-256(349)217(364-239(343)156-83-53-31-54-84-156)211-250(19,178(302)121-181-253(211,131-352-181)367-142(10)297)214(320)205(355-139(7)294)197(134(175)2)247(256,14)15/h21-56,63-86,91-98,136-137,160-182,199-212,216-218,290-292,299-303,348-350H,57-62,87-90,99-132H2,1-20H3,(H2,258,304)(H2,259,305)(H,264,306)(H,265,307)(H,268,309)(H,269,326)(H,270,325)(H,271,311)(H,272,310)(H,273,337)(H,274,327)(H,275,332)(H,276,329)(H,277,339)(H,278,333)(H,279,334)(H,280,335)(H,281,328)(H,282,336)(H,283,338)(H,284,330)(H,285,308)(H,286,331)(H,287,322)(H,288,323)(H,289,324)(H,312,313)(H,314,315)(H,340,341)(H4,260,261,266)(H4,262,263,267)/t136?,137-,160+,161+,162+,163+,164+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180-,181-,182-,199+,200+,201+,202+,203+,204-,205-,206-,207-,208-,209-,210+,211+,212+,216+,217+,218+,249-,250-,251-,252+,253+,254+,255-,256-,257-/m1/s1 D0M6XK DRUGINKE GBVKRUOMSUTVPW-AHNVSIPUSA-N D0M6XK DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)OC(=O)CCC(=O)NCCCCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC7=CC=CC=C7)C(=O)NC(CCCCNC(=O)CCC(=O)OC(C(C8=CC=CC=C8)NC(=O)C9=CC=CC=C9)C(=O)OC1CC2(C(C3C(C(CC5C3(CO5)OC(=O)C)O)(C(=O)C(C(=C1C)C2(C)C)OC(=O)C)C)OC(=O)C1=CC=CC=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)CNC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CCC(=O)OC(C(C1=CC=CC=C1)NC(=O)C1=CC=CC=C1)C(=O)OC1CC2(C(C3C(C(CC5C3(CO5)OC(=O)C)O)(C(=O)C(C(=C1C)C2(C)C)OC(=O)C)C)OC(=O)C1=CC=CC=C1)O)O)OC(=O)C1=CC=CC=C1)(CO4)OC(=O)C)O)C)OC(=O)C D0M6XK HIGHSTAT Phase 2 D0M7OU DRUG__ID D0M7OU D0M7OU DRUGTYPE Small molecular drug D0M7OU DRUGINCH 1S/C25H21FN2O.ClH/c1-17-22(13-18-9-11-27-12-10-18)21-8-7-20(26)14-24(21)23(17)15-25(29)28-16-19-5-3-2-4-6-19;/h2-14H,15-16H2,1H3,(H,28,29);1H/b22-13-; D0M7OU DRUGINKE KGXPDNOBLLACKL-BWLGBDCWSA-N D0M7OU DRUGSMIL CC1=C(C2=C(C1=CC3=CC=NC=C3)C=CC(=C2)F)CC(=O)NCC4=CC=CC=C4.Cl D0M7OU HIGHSTAT Phase 2 D0MD5M DRUG__ID D0MD5M D0MD5M DRUGCOMP Immune Design Seattle, WA D0MD5M DRUGINCH 1S/C12H19N5O3/c1-15-8-9(14-11(15)13-6-5-7-20-4)16(2)12(19)17(3)10(8)18/h5-7H2,1-4H3,(H,13,14) D0MD5M DRUGINKE ZZQHGKMTMAORFI-UHFFFAOYSA-N D0MD5M DRUGSMIL CN1C2=C(N=C1NCCCOC)N(C(=O)N(C2=O)C)C D0MD5M HIGHSTAT Phase 2 D0ML2V DRUG__ID D0ML2V D0ML2V DRUGTYPE Small molecular drug D0ML2V DRUGINCH 1S/C9H10ClFN2O4/c10-4-2-13(9(16)12-8(4)15)7-1-5(11)6(3-14)17-7/h2,5-7,14H,1,3H2,(H,12,15,16)/t5-,6+,7+/m0/s1 D0ML2V DRUGINKE WKVDSZYIGHLONN-RRKCRQDMSA-N D0ML2V DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)Cl)CO)F D0ML2V HIGHSTAT Phase 2 D0MO0J DRUG__ID D0MO0J D0MO0J DRUGCOMP MedImmune Gaithersburg, MD D0MO0J DRUGINCH 1S/C167H252N42O55/c1-13-14-15-16-17-18-19-20-21-22-23-24-31-47-125(219)186-109(165(263)264)53-58-124(218)175-62-35-34-44-102(189-153(251)116(72-131(228)229)201-161(259)122(83-213)206-164(262)137(92(12)215)209-157(255)114(68-94-40-29-26-30-41-94)202-163(261)136(91(11)214)207-127(221)78-181-142(240)105(52-57-123(169)217)190-158(256)119(80-210)203-141(239)100(168)71-97-76-174-84-182-97)146(244)204-120(81-211)159(257)193-108(56-61-130(226)227)148(246)197-112(69-95-48-50-98(216)51-49-95)151(249)195-111(66-86(4)5)150(248)200-118(74-133(232)233)155(253)205-121(82-212)160(258)192-107(55-60-129(224)225)147(245)188-103(45-36-63-176-166(170)171)143(241)184-89(9)139(237)187-104(46-37-64-177-167(172)173)145(243)199-117(73-132(230)231)154(252)198-113(67-93-38-27-25-28-39-93)156(254)208-135(87(6)7)162(260)185-90(10)140(238)194-115(70-96-75-178-101-43-33-32-42-99(96)101)152(250)196-110(65-85(2)3)149(247)191-106(54-59-128(222)223)144(242)183-88(8)138(236)180-77-126(220)179-79-134(234)235/h25-30,32-33,38-43,48-51,75-76,84-92,100,102-122,135-137,178,210-216H,13-24,31,34-37,44-47,52-74,77-83,168H2,1-12H3,(H2,169,217)(H,174,182)(H,175,218)(H,179,220)(H,180,236)(H,181,240)(H,183,242)(H,184,241)(H,185,260)(H,186,219)(H,187,237)(H,188,245)(H,189,251)(H,190,256)(H,191,247)(H,192,258)(H,193,257)(H,194,238)(H,195,249)(H,196,250)(H,197,246)(H,198,252)(H,199,243)(H,200,248)(H,201,259)(H,202,261)(H,203,239)(H,204,244)(H,205,253)(H,206,262)(H,207,221)(H,208,254)(H,209,255)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,263,264)(H4,170,171,176)(H4,172,173,177)/t88-,89-,90-,91+,92+,100-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,135-,136-,137-/m0/s1 D0MO0J DRUGINKE YEKUUBPJRPXMBM-PTCFZACGSA-N D0MO0J DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N)C(=O)O D0MO0J HIGHSTAT Phase 2 D0MR0B DRUG__ID D0MR0B D0MR0B DRUGCOMP Medpacto D0MR0B DRUGINCH 1S/C22H18FN7/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23/h2-10,12-13,24H,11H2,1H3,(H,28,29) D0MR0B DRUGINKE FJCDSQATIJKQKA-UHFFFAOYSA-N D0MR0B DRUGSMIL CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4 D0MR0B HIGHSTAT Phase 2 D0MZ2B DRUG__ID D0MZ2B D0MZ2B DRUGTYPE Small molecular drug D0MZ2B DRUGINCH 1S/C18H35IO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(19)18(20)21/h17H,2-16H2,1H3,(H,20,21) D0MZ2B DRUGINKE QNGRAOXOFVXXJP-UHFFFAOYSA-N D0MZ2B DRUGSMIL CCCCCCCCCCCCCCCCC(C(=O)O)I D0MZ2B HIGHSTAT Phase 2 D0N1HW DRUG__ID D0N1HW D0N1HW DRUGTYPE Small molecular drug D0N1HW DRUGINCH 1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21) D0N1HW DRUGINKE OGJGQVFWEPNYSB-UHFFFAOYSA-N D0N1HW DRUGSMIL C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)Cl D0N1HW HIGHSTAT Phase 2 D0N2IE DRUG__ID D0N2IE D0N2IE DRUGCOMP VBL Therapeutics D0N2IE DRUGINCH 1S/C29H60NO8P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-19-23-35-26-28(36-24-20-18-21-29(31)32)27-38-39(33,34)37-25-22-30(2,3)4/h28H,5-27H2,1-4H3,(H-,31,32,33,34)/t28-/m1/s1 D0N2IE DRUGINKE JGGNOCUEWOGWPL-MUUNZHRXSA-N D0N2IE DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OCCCCC(=O)O D0N2IE HIGHSTAT Phase 2 D0N3RK DRUG__ID D0N3RK D0N3RK DRUGTYPE Small molecular drug D0N3RK DRUGINCH 1S/C6H12ClN3O4S/c1-15(13,14)5-3-8-6(11)10(9-12)4-2-7/h2-5H2,1H3,(H,8,11) D0N3RK DRUGINKE IUOVOJHLRFQQNS-UHFFFAOYSA-N D0N3RK DRUGSMIL CS(=O)(=O)CCNC(=O)N(CCCl)N=O D0N3RK HIGHSTAT Phase 2 D0N3XT DRUG__ID D0N3XT D0N3XT DRUGTYPE Small molecular drug D0N3XT DRUGINCH 1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28) D0N3XT DRUGINKE PHEZJEYUWHETKO-UHFFFAOYSA-N D0N3XT DRUGSMIL CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O D0N3XT HIGHSTAT Phase 2 D0N4PW DRUG__ID D0N4PW D0N4PW DRUGCOMP The Institute for OneWorld Health D0N4PW DRUGINCH 1S/C22H15Br2N3O4/c23-17-10-14(11-18(24)19(17)28)20-26-22(31-27-20)21(29)25-12-13-6-8-16(9-7-13)30-15-4-2-1-3-5-15/h1-11,28H,12H2,(H,25,29) D0N4PW DRUGINKE DSFNLJXHXBIKDS-UHFFFAOYSA-N D0N4PW DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CNC(=O)C3=NC(=NO3)C4=CC(=C(C(=C4)Br)O)Br D0N4PW HIGHSTAT Phase 2 D0N5LJ DRUG__ID D0N5LJ D0N5LJ DRUGTYPE Small molecular drug D0N5LJ DRUGINCH 1S/C23H29N/c1-3-23(22-14-8-5-9-15-22,24(2)19-21-16-17-21)18-10-13-20-11-6-4-7-12-20/h4-15,21H,3,16-19H2,1-2H3/b13-10+ D0N5LJ DRUGINKE VCZSWYIFCKGTJI-JLHYYAGUSA-N D0N5LJ DRUGSMIL CCC(CC=CC1=CC=CC=C1)(C2=CC=CC=C2)N(C)CC3CC3 D0N5LJ HIGHSTAT Phase 2 D0N6VS DRUG__ID D0N6VS D0N6VS DRUGCOMP Aduro Biotech Berkeley, CANovartis Oncology East Hanover, NJ D0N6VS DRUGINCH 1S/C20H24N10O10P2S2.2Na/c21-15-9-17(25-3-23-15)29(5-27-9)19-12(32)13-8(38-19)2-36-42(34,44)40-14-11(31)7(1-35-41(33,43)39-13)37-20(14)30-6-28-10-16(22)24-4-26-18(10)30;;/h3-8,11-14,19-20,31-32H,1-2H2,(H,33,43)(H,34,44)(H2,21,23,25)(H2,22,24,26);;/q;2*+1/p-2/t7-,8-,11-,12-,13-,14-,19-,20-,41?,42?;;/m1../s1 D0N6VS DRUGINKE GDWOOOCBNOMMTL-QYUKNOIISA-L D0N6VS DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)OP(=S)(OCC5C(C(C(O5)N6C=NC7=C(N=CN=C76)N)O)OP(=S)(O1)[O-])[O-])O.[Na+].[Na+] D0N6VS HIGHSTAT Phase 2 D0ND9T DRUG__ID D0ND9T D0ND9T DRUGCOMP Cerulean Pharma D0ND9T DRUGINCH 1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m1/s1 D0ND9T DRUGINKE VSJKWCGYPAHWDS-HXUWFJFHSA-N D0ND9T DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O D0ND9T HIGHSTAT Phase 2 D0NS8T DRUG__ID D0NS8T D0NS8T DRUGCOMP Access Pharmaceuticals D0NS8T DRUGINCH 1S/C27H31NO10.ClH/c1-11-22(30)14(28)8-17(37-11)38-16-10-27(35,6-7-29)9-13-19(16)26(34)21-20(24(13)32)23(31)12-4-3-5-15(36-2)18(12)25(21)33;/h3-5,11,14,16-17,22,29-30,32,34-35H,6-10,28H2,1-2H3;1H/t11-,14-,16-,17-,22+,27-;/m0./s1 D0NS8T DRUGINKE YZSQITAPLDJGKS-RYQLBYGJSA-N D0NS8T DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(CCO)O)N)O.Cl D0NS8T HIGHSTAT Phase 2 D0O0BM DRUG__ID D0O0BM D0O0BM DRUGCOMP Pfizer Inc D0O0BM DRUGINCH 1S/C19H22ClFN4O/c1-23-7-13-14(8-23)15(13)9-25(19(26)18-10-24(2)11-22-18)6-12-3-4-17(21)16(20)5-12/h3-5,10-11,13-15H,6-9H2,1-2H3/t13-,14+,15? D0O0BM DRUGINKE KYLOBHXXQOZRKK-YIONKMFJSA-N D0O0BM DRUGSMIL CN1CC2C(C1)C2CN(CC3=CC(=C(C=C3)F)Cl)C(=O)C4=CN(C=N4)C D0O0BM HIGHSTAT Phase 2 D0O5GK DRUG__ID D0O5GK D0O5GK DRUGCOMP QR Pharma D0O5GK DRUGINCH 1S/C20H23N3O2/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14/h4-10,13,18H,11-12H2,1-3H3,(H,21,24)/t18-,20+/m0/s1 D0O5GK DRUGINKE PBHFNBQPZCRWQP-AZUAARDMSA-N D0O5GK DRUGSMIL CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C D0O5GK HIGHSTAT Phase 2 D0O6NA DRUG__ID D0O6NA D0O6NA DRUGCOMP Johnson & Johnson D0O6NA DRUGINCH 1S/C22H19N3O2S/c1-26-19-14-8-6-12-17(19)21-24-22(23-16-10-4-3-5-11-16)28-25(21)18-13-7-9-15-20(18)27-2/h3-15H,1-2H3 D0O6NA DRUGINKE XTHRTBCPBWJYRO-UHFFFAOYSA-N D0O6NA DRUGSMIL COC1=CC=CC=C1C2=NC(=NC3=CC=CC=C3)SN2C4=CC=CC=C4OC D0O6NA HIGHSTAT Phase 2 D0O6RK DRUG__ID D0O6RK D0O6RK DRUGCOMP Ironwood Pharmaceuticals D0O6RK DRUGINCH 1S/C10H11NO3/c1-3-14-10(13)9-6-4-5-8(11-9)7(2)12/h4-6H,3H2,1-2H3 D0O6RK DRUGINKE COYXIUHSZNHMAS-UHFFFAOYSA-N D0O6RK DRUGSMIL CCOC(=O)C1=CC=CC(=N1)C(=O)C D0O6RK HIGHSTAT Phase 2 D0O7QA DRUG__ID D0O7QA D0O7QA DRUGCOMP Pfizer D0O7QA DRUGINCH 1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25) D0O7QA DRUGINKE ZYSCOUXLBXGGIM-UHFFFAOYSA-N D0O7QA DRUGSMIL C1=CC(=C(C=C1Cl)C2=C(NN=C2)N)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=CSC=N4)F D0O7QA HIGHSTAT Phase 2 D0O9PQ DRUG__ID D0O9PQ D0O9PQ DRUGTYPE Small molecular drug D0O9PQ DRUGINCH 1S/C26H34ClN6O2P/c1-32(2)18-12-14-33(15-13-18)19-10-11-21(23(16-19)35-3)30-26-28-17-20(27)25(31-26)29-22-8-6-7-9-24(22)36(4,5)34/h6-11,16-18H,12-15H2,1-5H3,(H2,28,29,30,31) D0O9PQ DRUGINKE OVDSPTSBIQCAIN-UHFFFAOYSA-N D0O9PQ DRUGSMIL CN(C)C1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC=CC=C4P(=O)(C)C)Cl)OC D0O9PQ HIGHSTAT Phase 2 D0OH2H DRUG__ID D0OH2H D0OH2H DRUGCOMP Bayer HealthCare Pharmaceuticals D0OH2H DRUGINCH 1S/C22H23NO5/c1-6-27-22(26)19-13(4)23-12(3)18(14(5)24)20(19)16-9-7-8-15-17(25)10-11(2)28-21(15)16/h7-10,20,23H,6H2,1-5H3/t20-/m1/s1 D0OH2H DRUGINKE DXCPBIXBBLLGOZ-HXUWFJFHSA-N D0OH2H DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC3=C2OC(=CC3=O)C)C(=O)C)C)C D0OH2H HIGHSTAT Phase 2 D0OQ8Q DRUG__ID D0OQ8Q D0OQ8Q DRUGCOMP Edison Pharmaceuticals Mountain View, CA D0OQ8Q DRUGINCH 1S/C29H44O3/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8,32)19-17-26-25(7)27(30)23(5)24(6)28(26)31/h12,14,16,32H,9-11,13,15,17-19H2,1-8H3/b21-14+,22-16+/t29-/m1/s1 D0OQ8Q DRUGINKE LNOVHERIIMJMDG-XZXLULOTSA-N D0OQ8Q DRUGSMIL CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C D0OQ8Q HIGHSTAT Phase 2 D0OS6P DRUG__ID D0OS6P D0OS6P DRUGCOMP Xenetic Biosciences Lexington, MA D0OS6P DRUGINCH 1S/C15H11NO3/c17-14(18)9-16-12-7-3-1-5-10(12)15(19)11-6-2-4-8-13(11)16/h1-8H,9H2,(H,17,18) D0OS6P DRUGINKE UOMKBIIXHQIERR-UHFFFAOYSA-N D0OS6P DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3N2CC(=O)O D0OS6P HIGHSTAT Phase 2 D0OU0S DRUG__ID D0OU0S D0OU0S DRUGCOMP FORMAC Pharmaceuticals NV D0OU0S DRUGINCH 1S/C11H13NO2/c1-4-11(13)12-9-6-5-8(2)10(7-9)14-3/h4-7H,1H2,2-3H3,(H,12,13) D0OU0S DRUGINKE MLBARMMXRQCHNS-UHFFFAOYSA-N D0OU0S DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C=C)OC D0OU0S HIGHSTAT Phase 2 D0OW4A DRUG__ID D0OW4A D0OW4A DRUGTYPE Small molecular drug D0OW4A DRUGINCH 1S/C52H67N7O10/c1-8-29(5)44(49(65)57-41(52(68)69)25-34-27-53-38-21-15-14-18-35(34)38)59-50(66)45(30(6)9-2)58-48(64)40(26-42(61)62)55-47(63)39(24-28(3)4)56-51(67)46(54-31(7)60)43-36-19-12-10-16-32(36)22-23-33-17-11-13-20-37(33)43/h10-21,27-30,39-41,43-46,53H,8-9,22-26H2,1-7H3,(H,54,60)(H,55,63)(H,56,67)(H,57,65)(H,58,64)(H,59,66)(H,61,62)(H,68,69)/t29-,30-,39-,40-,41-,44-,45-,46+/m0/s1 D0OW4A DRUGINKE HRAQSWKGRRUBDJ-OMUAVVNCSA-N D0OW4A DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C3C4=CC=CC=C4CCC5=CC=CC=C35)NC(=O)C D0OW4A HIGHSTAT Phase 2 D0OX9F DRUG__ID D0OX9F D0OX9F DRUGCOMP Biogen D0OX9F DRUGINCH 1S/C18H19FN2O2/c19-15-4-2-1-3-13(15)11-23-14-7-5-12(6-8-14)16-9-10-17(21-16)18(20)22/h1-8,16-17,21H,9-11H2,(H2,20,22)/t16-,17+/m1/s1 D0OX9F DRUGINKE JESCETIFNOFKEU-SJORKVTESA-N D0OX9F DRUGSMIL C1CC(NC1C2=CC=C(C=C2)OCC3=CC=CC=C3F)C(=O)N D0OX9F HIGHSTAT Phase 2 D0P2MF DRUG__ID D0P2MF D0P2MF DRUGCOMP Nivalis Therapeutics Boulder, CO D0P2MF DRUGINCH 1S/C16H10ClNO3/c17-13-8-10(16(20)21)1-4-12(13)15-5-2-9-7-11(19)3-6-14(9)18-15/h1-8,19H,(H,20,21) D0P2MF DRUGINKE BXSZILNGNMDGSL-UHFFFAOYSA-N D0P2MF DRUGSMIL C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O D0P2MF HIGHSTAT Phase 2 D0P2QO DRUG__ID D0P2QO D0P2QO DRUGTYPE Small molecular drug D0P2QO DRUGINCH 1S/C21H24N2O2/c1-2-5-17-15-18(14-16(17)4-1)22-8-10-23(11-9-22)19-6-3-7-20-21(19)25-13-12-24-20/h1-7,18H,8-15H2 D0P2QO DRUGINKE QJPPEMXOOWNICQ-UHFFFAOYSA-N D0P2QO DRUGSMIL C1CN(CCN1C2CC3=CC=CC=C3C2)C4=C5C(=CC=C4)OCCO5 D0P2QO HIGHSTAT Phase 2 D0P3JF DRUG__ID D0P3JF D0P3JF DRUGCOMP OPKO Health Inc D0P3JF DRUGINCH 1S/C25H23F6N5O2/c1-16(17-9-19(24(26,27)28)11-20(10-17)25(29,30)31)38-14-23(18-5-3-2-4-6-18)8-7-22(12-32,13-33-23)36-15-34-35-21(36)37/h2-6,9-11,15-16,33H,7-8,13-14H2,1H3,(H,35,37)/t16-,22-,23-/m1/s1 D0P3JF DRUGINKE ACZWFJDLNLZWDP-ZGNKEGEESA-N D0P3JF DRUGSMIL CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OCC2(CCC(CN2)(C#N)N3C=NNC3=O)C4=CC=CC=C4 D0P3JF HIGHSTAT Phase 2 D0P3PB DRUG__ID D0P3PB D0P3PB DRUGCOMP Resolvyx Pharmaceuticals Inc D0P3PB DRUGINCH 1S/C18H24O4/c1-4-10-16(19)11-7-5-6-8-12-17(20)13-9-14-18(21)22-15(2)3/h1,5-7,11,15-17,19-20H,9-10,13-14H2,2-3H3/b6-5+,11-7+/t16-,17-/m1/s1 D0P3PB DRUGINKE ZVOCIIHCJJEFRQ-BHXBHYJPSA-N D0P3PB DRUGSMIL CC(C)OC(=O)CCCC(C#CC=CC=CC(CC#C)O)O D0P3PB HIGHSTAT Phase 2 D0P3ZN DRUG__ID D0P3ZN D0P3ZN DRUGCOMP AstraZeneca D0P3ZN DRUGINCH 1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24) D0P3ZN DRUGINKE YYBOLPLTQDKXPM-UHFFFAOYSA-N D0P3ZN DRUGSMIL CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N D0P3ZN HIGHSTAT Phase 2 D0P6DJ DRUG__ID D0P6DJ D0P6DJ DRUGTYPE Small molecular drug D0P6DJ DRUGINCH 1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25) D0P6DJ DRUGINKE YCOYDOIWSSHVCK-UHFFFAOYSA-N D0P6DJ DRUGSMIL C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4 D0P6DJ HIGHSTAT Phase 2 D0PC1V DRUG__ID D0PC1V D0PC1V DRUGTYPE Small molecular drug D0PC1V DRUGINCH 1S/C31H36ClN3O5S/c1-37-26-19-22(20-27(38-2)30(26)39-3)31(36)40-18-17-34-15-13-33(14-16-34)11-6-12-35-24-7-4-5-8-28(24)41-29-21-23(32)9-10-25(29)35/h4-5,7-10,19-21H,6,11-18H2,1-3H3 D0PC1V DRUGINKE KZAJTVRKNKAXAG-UHFFFAOYSA-N D0PC1V DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)OCCN2CCN(CC2)CCCN3C4=C(C=C(C=C4)Cl)SC5=CC=CC=C53 D0PC1V HIGHSTAT Phase 2 D0PF3J DRUG__ID D0PF3J D0PF3J DRUGTYPE Small molecular drug D0PF3J DRUGINCH 1S/C42H68N6O6S/c1-13-28(6)37(47(10)42(52)35(26(2)3)45-40(51)36(27(4)5)46(8)9)33(53-11)25-34(49)48-22-17-20-32(48)38(54-12)29(7)39(50)44-31(41-43-21-23-55-41)24-30-18-15-14-16-19-30/h14-16,18-19,21,23,26-29,31-33,35-38H,13,17,20,22,24-25H2,1-12H3,(H,44,50)(H,45,51)/t28-,29+,31-,32-,33+,35-,36-,37-,38+/m0/s1 D0PF3J DRUGINKE OFDNQWIFNXBECV-VFSYNPLYSA-N D0PF3J DRUGSMIL CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C D0PF3J HIGHSTAT Phase 2 D0PV9N DRUG__ID D0PV9N D0PV9N DRUGCOMP Galera Therapeutics Malvern, PA D0PV9N DRUGINCH 1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m0.../s1 D0PV9N DRUGINKE WXEMWBBXVXHEPU-NDOCQCNASA-L D0PV9N DRUGSMIL C1CCC2C(C1)NCCNC3CCCCC3NCC4=CC=CC(=N4)CN2.[Cl-].[Cl-].[Mn+2] D0PV9N HIGHSTAT Phase 2 D0PW4C DRUG__ID D0PW4C D0PW4C DRUGTYPE Small molecular drug D0PW4C DRUGINCH 1S/C22H25N3O3/c1-23(21(26)14-16-7-6-9-18(13-16)25(27)28)22-19-10-3-2-8-17(19)15-20(22)24-11-4-5-12-24/h2-3,6-10,13,20,22H,4-5,11-12,14-15H2,1H3/t20-,22-/m0/s1 D0PW4C DRUGINKE ZSDAQBWGAOKTSI-UNMCSNQZSA-N D0PW4C DRUGSMIL CN(C1C(CC2=CC=CC=C12)N3CCCC3)C(=O)CC4=CC(=CC=C4)[N+](=O)[O-] D0PW4C HIGHSTAT Phase 2 D0Q2GX DRUG__ID D0Q2GX D0Q2GX DRUGCOMP MSI Methylation Sciences Burnaby, Canada D0Q2GX DRUGINCH 1S/C16H20N6O6S/c1-22(2)14(23)10-6-5-7-11(8-10)20-29(25,26)21-16(24)19-15-17-12(27-3)9-13(18-15)28-4/h5-9,20H,1-4H3,(H2,17,18,19,21,24) D0Q2GX DRUGINKE ZYTDPWFEPDOYMB-UHFFFAOYSA-N D0Q2GX DRUGSMIL CN(C)C(=O)C1=CC(=CC=C1)NS(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC)OC D0Q2GX HIGHSTAT Phase 2 D0Q5BU DRUG__ID D0Q5BU D0Q5BU DRUGCOMP Danube Pharmaceuticals Inc; Korea Research Institute of Chemical Technology D0Q5BU DRUGINCH 1S/C22H27N5O4/c1-22(20(29-2)30-3)19(28)18(16-11-15(24)9-10-17(16)31-22)27-21(26-13-23)25-12-14-7-5-4-6-8-14/h4-11,18-20,28H,12,24H2,1-3H3,(H2,25,26,27)/t18-,19+,22+/m1/s1 D0Q5BU DRUGINKE OZHUPJHJQIEDFA-DXIQSLLYSA-N D0Q5BU DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)N)NC(=NCC3=CC=CC=C3)NC#N)O)C(OC)OC D0Q5BU HIGHSTAT Phase 2 D0Q5LF DRUG__ID D0Q5LF D0Q5LF DRUGTYPE Small molecular drug D0Q5LF DRUGINCH 1S/C36H48N6O9/c1-20(2)17-26(38-29(43)18-23-12-14-24(15-13-23)37-36(51)40-25-10-7-6-9-22(25)5)32(46)39-27(19-30(44)45)33(47)41-31(21(3)4)34(48)42-16-8-11-28(42)35(49)50/h6-7,9-10,12-15,20-21,26-28,31H,8,11,16-19H2,1-5H3,(H,38,43)(H,39,46)(H,41,47)(H,44,45)(H,49,50)(H2,37,40,51)/t26-,27-,28-,31-/m0/s1 D0Q5LF DRUGINKE NVVGCQABIHSJSQ-KFZSMJGVSA-N D0Q5LF DRUGSMIL CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CC(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)N3CCCC3C(=O)O D0Q5LF HIGHSTAT Phase 2 D0Q7NB DRUG__ID D0Q7NB D0Q7NB DRUGTYPE Small molecular drug D0Q7NB DRUGINCH 1S/C18H17Cl2F3N4O2/c19-11-1-2-14(13(20)7-11)26-17-25-9-12(15(27-17)18(21,22)23)16(28)24-8-10-3-5-29-6-4-10/h1-2,7,9-10H,3-6,8H2,(H,24,28)(H,25,26,27) D0Q7NB DRUGINKE TWQYWUXBZHPIIV-UHFFFAOYSA-N D0Q7NB DRUGSMIL C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl D0Q7NB HIGHSTAT Phase 2 D0Q9KR DRUG__ID D0Q9KR D0Q9KR DRUGCOMP Innocrin Pharmaceuticals Durham, NC D0Q9KR DRUGINCH 1S/C18H17F4N3O3/c1-9(2)18(26,15-8-23-25-24-15)12-4-3-10-6-13(27-16(19)20)14(28-17(21)22)7-11(10)5-12/h3-9,16-17,26H,1-2H3,(H,23,24,25)/t18-/m0/s1 D0Q9KR DRUGINKE ZBRAJOQFSNYJMF-SFHVURJKSA-N D0Q9KR DRUGSMIL CC(C)C(C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O D0Q9KR HIGHSTAT Phase 2 D0QG1B DRUG__ID D0QG1B D0QG1B DRUGCOMP Idorsia Pharmaceuticals Allschwil, Switzerland Janssen Biotech Horsham, PA D0QG1B DRUGINCH 1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24) D0QG1B DRUGINKE DKULOVKANLVDEA-UHFFFAOYSA-N D0QG1B DRUGSMIL C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br D0QG1B HIGHSTAT Phase 2 D0QG8F DRUG__ID D0QG8F D0QG8F DRUGTYPE Small molecular drug D0QG8F DRUGINCH 1S/C6H3ClN2O4/c7-5-2-1-4(8(10)11)3-6(5)9(12)13/h1-3H D0QG8F DRUGINKE VYZAHLCBVHPDDF-UHFFFAOYSA-N D0QG8F DRUGSMIL C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl D0QG8F HIGHSTAT Phase 2 D0QH7H DRUG__ID D0QH7H D0QH7H DRUGTYPE Small molecular drug D0QH7H DRUGINCH 1S/C22H28ClN5O3S/c1-3-12(9-17-15(23)6-8-32-17)27-20-13-5-7-28(21(13)26-11-25-20)16-10-14(18(29)19(16)30)22(31)24-4-2/h5-8,11-12,14,16,18-19,29-30H,3-4,9-10H2,1-2H3,(H,24,31)(H,25,26,27)/t12-,14+,16-,18-,19+/m1/s1 D0QH7H DRUGINKE CKQOOYMMAAPDKH-QODLLSGVSA-N D0QH7H DRUGSMIL CCC(CC1=C(C=CS1)Cl)NC2=C3C=CN(C3=NC=N2)C4CC(C(C4O)O)C(=O)NCC D0QH7H HIGHSTAT Phase 2 D0QX8X DRUG__ID D0QX8X D0QX8X DRUGCOMP EMD Serono Rockland, MA D0QX8X DRUGINCH 1S/C25H27N5O2/c1-2-22(31)30-14-12-18(13-15-30)16-27-25-23(24(26)28-17-29-25)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-11,17-18H,1,12-16H2,(H3,26,27,28,29) D0QX8X DRUGINKE QUIWHXQETADMGN-UHFFFAOYSA-N D0QX8X DRUGSMIL C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N D0QX8X HIGHSTAT Phase 2 D0R1YL DRUG__ID D0R1YL D0R1YL DRUGTYPE Small molecular drug D0R1YL DRUGINCH 1S/C10H18N2OS/c1-3-8-9(13)11-10(14-8)4-6-12(2)7-5-10/h8H,3-7H2,1-2H3,(H,11,13)/t8-/m0/s1 D0R1YL DRUGINKE PHOZOHFUXHPOCK-QMMMGPOBSA-N D0R1YL DRUGSMIL CCC1C(=O)NC2(S1)CCN(CC2)C D0R1YL HIGHSTAT Phase 2 D0R4MT DRUG__ID D0R4MT D0R4MT DRUGCOMP Gemphire Therapeutics Livonia, MI D0R4MT DRUGINCH 1S/C16H30O5/c1-15(2,13(17)18)9-5-7-11-21-12-8-6-10-16(3,4)14(19)20/h5-12H2,1-4H3,(H,17,18)(H,19,20) D0R4MT DRUGINKE SDMBRCRVFFHJKR-UHFFFAOYSA-N D0R4MT DRUGSMIL CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O D0R4MT HIGHSTAT Phase 2 D0R5HH DRUG__ID D0R5HH D0R5HH DRUGCOMP Acceleron Pharma Cambridge, MA D0R5HH DRUGINCH 1S/C20H31N3O2/c1-16(24)21-19-12-17(14-22-8-4-2-5-9-22)20(25)18(13-19)15-23-10-6-3-7-11-23/h12-13,25H,2-11,14-15H2,1H3,(H,21,24) D0R5HH DRUGINKE AVPLCNNLKMYJHF-UHFFFAOYSA-N D0R5HH DRUGSMIL CC(=O)NC1=CC(=C(C(=C1)CN2CCCCC2)O)CN3CCCCC3 D0R5HH HIGHSTAT Phase 2 D0R6TY DRUG__ID D0R6TY D0R6TY DRUGCOMP DemeRxFort Lauderdale, FL D0R6TY DRUGINCH 1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3/t11-,12+,16+,19+/m1/s1 D0R6TY DRUGINKE RAUCDOKTMDOIPF-RYRUWHOVSA-N D0R6TY DRUGSMIL CCC1CC2CC3C1N(C2)CCC4=C3NC5=C4C=C(C=C5)O D0R6TY HIGHSTAT Phase 2 D0R6UV DRUG__ID D0R6UV D0R6UV DRUGTYPE Small molecular drug D0R6UV DRUGINCH 1S/C19H24N6O2/c1-27-15-4-2-3-14(9-15)23-19-18-13(5-8-25(18)22-12-21-19)10-24-7-6-16(20)17(26)11-24/h2-5,8-9,12,16-17,26H,6-7,10-11,20H2,1H3,(H,21,22,23)/t16-,17-/m1/s1 D0R6UV DRUGINKE CSGQVNMSRKWUSH-IAGOWNOFSA-N D0R6UV DRUGSMIL COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N D0R6UV HIGHSTAT Phase 2 D0R7IU DRUG__ID D0R7IU D0R7IU DRUGCOMP GlaxoSmithKline plc D0R7IU DRUGINCH 1S/C26H32N2O4/c1-26(2,14-19-11-20-5-3-4-6-21(20)12-19)28-16-23(29)17-32-24-13-18(8-10-25(30)31)7-9-22(24)15-27/h3-7,9,13,19,23,28-29H,8,10-12,14,16-17H2,1-2H3,(H,30,31)/t23-/m1/s1 D0R7IU DRUGINKE NJBFJCJKWWIKRD-HSZRJFAPSA-N D0R7IU DRUGSMIL CC(C)(CC1CC2=CC=CC=C2C1)NCC(COC3=C(C=CC(=C3)CCC(=O)O)C#N)O D0R7IU HIGHSTAT Phase 2 D0S0RS DRUG__ID D0S0RS D0S0RS DRUGTYPE Small molecular drug D0S0RS DRUGINCH 1S/C17H16BrFN6O4/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27/h1-2,7-8,11H,3-6,9H2,(H,26,27) D0S0RS DRUGINKE UJEAABFSXKCSGI-UHFFFAOYSA-N D0S0RS DRUGSMIL C1CN(CCC1OC2=C(C=CC(=C2)F)Br)C3=NOC(=C3)C4=NN(N=N4)CC(=O)O D0S0RS HIGHSTAT Phase 2 D0S1TI DRUG__ID D0S1TI D0S1TI DRUGCOMP Rexahn D0S1TI DRUGINCH 1S/C22H24FN5O4/c1-30-16-11-15(12-17(13-16)31-2)27-6-8-28(9-7-27)22(29)26-20-21(32-3)25-18-5-4-14(23)10-19(18)24-20/h4-5,10-13H,6-9H2,1-3H3,(H,24,26,29) D0S1TI DRUGINKE KAKPGJJRYRYSTP-UHFFFAOYSA-N D0S1TI DRUGSMIL COC1=CC(=CC(=C1)N2CCN(CC2)C(=O)NC3=NC4=C(C=CC(=C4)F)N=C3OC)OC D0S1TI HIGHSTAT Phase 2 D0S2PD DRUG__ID D0S2PD D0S2PD DRUGCOMP Bristol-Myers Squibb D0S2PD DRUGINCH 1S/C18H18ClN3O/c1-17(2,23)14-4-3-11-22-15(14)20-21-16(22)18(9-10-18)12-5-7-13(19)8-6-12/h3-8,11,23H,9-10H2,1-2H3 D0S2PD DRUGINKE PTIFVLOBVCIMKL-UHFFFAOYSA-N D0S2PD DRUGSMIL CC(C)(C1=CC=CN2C1=NN=C2C3(CC3)C4=CC=C(C=C4)Cl)O D0S2PD HIGHSTAT Phase 2 D0S2UR DRUG__ID D0S2UR D0S2UR DRUGTYPE Small molecular drug D0S2UR DRUGINCH 1S/C18H17N3O2/c22-16-14-9-6-10-19-17(14)21(13-7-2-1-3-8-13)18(23)15(16)20-11-4-5-12-20/h1-3,6-10,22H,4-5,11-12H2 D0S2UR DRUGINKE ULGABHCZIJXUFO-UHFFFAOYSA-N D0S2UR DRUGSMIL C1CCN(C1)C2=C(C3=C(N=CC=C3)N(C2=O)C4=CC=CC=C4)O D0S2UR HIGHSTAT Phase 2 D0S3YN DRUG__ID D0S3YN D0S3YN DRUGCOMP Ferring Pharmaceuticals Inc D0S3YN DRUGINCH 1S/C46H73N13O11S2/c1-5-26(4)38-45(69)54-30(14-9-17-35(48)60)41(65)56-32(21-36(49)61)42(66)57-33(24-72-71-23-28(47)39(63)55-31(43(67)58-38)20-27-12-7-6-8-13-27)46(70)59-19-11-16-34(59)44(68)53-29(15-10-18-51-25(2)3)40(64)52-22-37(50)62/h6-8,12-13,25-26,28-34,38,51H,5,9-11,14-24,47H2,1-4H3,(H2,48,60)(H2,49,61)(H2,50,62)(H,52,64)(H,53,68)(H,54,69)(H,55,63)(H,56,65)(H,57,66)(H,58,67)/t26-,28-,29-,30-,31-,32-,33-,34-,38-/m0/s1 D0S3YN DRUGINKE JCVQBJTWWDYUFQ-MRUTUVJXSA-N D0S3YN DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)N)C(=O)N3CCCC3C(=O)NC(CCCNC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCCC(=O)N D0S3YN HIGHSTAT Phase 2 D0S7BQ DRUG__ID D0S7BQ D0S7BQ DRUGCOMP GlaxoSmithKline D0S7BQ DRUGINCH 1S/C22H34FN7O4/c1-15-24-20(19(23)21(25-15)29-7-6-28-8-9-34-13-18(28)12-29)26-27-22(32)17(11-30(33)14-31)10-16-4-2-3-5-16/h14,16-18,33H,2-13H2,1H3,(H,27,32)(H,24,25,26)/t17-,18+/m1/s1 D0S7BQ DRUGINKE SWHNZGMQMGFQGW-MSOLQXFVSA-N D0S7BQ DRUGSMIL CC1=NC(=C(C(=N1)N2CCN3CCOCC3C2)F)NNC(=O)C(CC4CCCC4)CN(C=O)O D0S7BQ HIGHSTAT Phase 2 D0S8CI DRUG__ID D0S8CI D0S8CI DRUGTYPE Small molecular drug D0S8CI DRUGINCH 1S/C20H23ClFNO/c21-18-5-3-17(4-6-18)20(24)14-23-11-9-16(10-12-23)13-15-1-7-19(22)8-2-15/h1-8,16,20,24H,9-14H2 D0S8CI DRUGINKE GGUSQTSTQSHJAH-UHFFFAOYSA-N D0S8CI DRUGSMIL C1CN(CCC1CC2=CC=C(C=C2)F)CC(C3=CC=C(C=C3)Cl)O D0S8CI HIGHSTAT Phase 2 D0S9BH DRUG__ID D0S9BH D0S9BH DRUGCOMP Spectrum D0S9BH DRUGINCH 1S/C72H96ClN17O14/c1-5-6-17-52(63(96)85-54(19-12-33-79-71(75)76)70(103)90-34-13-20-59(90)67(100)81-42(2)61(74)94)83-62(95)53(18-9-10-32-80-72(77)104)84-68(101)60(39-45-24-29-51(93)30-25-45)89(4)69(102)58(41-91)88-66(99)57(38-47-14-11-31-78-40-47)87-65(98)56(36-44-22-27-50(73)28-23-44)86-64(97)55(82-43(3)92)37-46-21-26-48-15-7-8-16-49(48)35-46/h7-8,11,14-16,21-31,35,40,42,52-60,91,93H,5-6,9-10,12-13,17-20,32-34,36-39,41H2,1-4H3,(H2,74,94)(H,81,100)(H,82,92)(H,83,95)(H,84,101)(H,85,96)(H,86,97)(H,87,98)(H,88,99)(H4,75,76,79)(H3,77,80,104)/t42-,52+,53-,54+,55-,56-,57-,58+,59+,60+/m1/s1 D0S9BH DRUGINKE KATZUZNTRINHDT-HALMFYTRSA-N D0S9BH DRUGSMIL CCCCC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D0S9BH HIGHSTAT Phase 2 D0SL8J DRUG__ID D0SL8J D0SL8J DRUGCOMP Abbott Laboratories D0SL8J DRUGINCH 1S/C44H69N5O11/c1-10-31-18-25(2)17-26(3)19-37(57-8)40-38(58-9)21-28(5)44(55,60-40)41(52)42(53)48-16-12-11-13-33(48)43(54)59-39(29(6)34(50)23-35(31)51)27(4)20-30-14-15-32(36(22-30)56-7)49-24-45-46-47-49/h18,20,24,26,28-34,36-40,50,55H,10-17,19,21-23H2,1-9H3/b25-18+,27-20+/t26-,28+,29+,30-,31+,32-,33-,34-,36+,37-,38-,39+,40+,44+/m0/s1 D0SL8J DRUGINKE HIEKJRVYXXINKH-ADVKXBNGSA-N D0SL8J DRUGSMIL CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)N5C=NN=N5)C)O)C)OC)OC)C)C D0SL8J HIGHSTAT Phase 2 D0T0PN DRUG__ID D0T0PN D0T0PN DRUGTYPE Small molecular drug D0T0PN DRUGINCH 1S/C20H23F3N2O2/c1-26-18-10-9-16(27-20(21,22)23)12-15(18)13-25-17-8-5-11-24-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,24-25H,5,8,11,13H2,1H3/t17-,19-/m0/s1 D0T0PN DRUGINKE ZIWFCOIGUNPHPM-HKUYNNGSSA-N D0T0PN DRUGSMIL COC1=C(C=C(C=C1)OC(F)(F)F)CNC2CCCNC2C3=CC=CC=C3 D0T0PN HIGHSTAT Phase 2 D0T1FC DRUG__ID D0T1FC D0T1FC DRUGCOMP Pfizer Inc D0T1FC DRUGINCH 1S/C17H23N5O2S/c1-3-14-21-15-16(12-8-4-5-9-13(12)20-17(15)18)22(14)11-7-6-10-19-25(2,23)24/h4-5,8-9,19H,3,6-7,10-11H2,1-2H3,(H2,18,20) D0T1FC DRUGINKE YZOQZEXYFLXNKA-UHFFFAOYSA-N D0T1FC DRUGSMIL CCC1=NC2=C(N1CCCCNS(=O)(=O)C)C3=CC=CC=C3N=C2N D0T1FC HIGHSTAT Phase 2 D0T3AW DRUG__ID D0T3AW D0T3AW DRUGCOMP Golden biotechnology D0T3AW DRUGINCH 1S/C24H38O4/c1-16(2)10-8-11-17(3)12-9-13-18(4)14-15-20-19(5)21(25)23(27-6)24(28-7)22(20)26/h10,12,14,19-20,22,26H,8-9,11,13,15H2,1-7H3/b17-12+,18-14+/t19-,20-,22-/m1/s1 D0T3AW DRUGINKE LJTSIMVOOOLKOL-FNRDIUJOSA-N D0T3AW DRUGSMIL CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C D0T3AW HIGHSTAT Phase 2 D0T3CH DRUG__ID D0T3CH D0T3CH DRUGCOMP REGiMMUNE D0T3CH DRUGINCH 1S/C50H99NO9/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-29-31-33-35-37-39-45(54)51-42(41-59-50-49(58)48(57)47(56)44(40-52)60-50)46(55)43(53)38-36-34-32-30-28-16-14-12-10-8-6-4-2/h42-44,46-50,52-53,55-58H,3-41H2,1-2H3,(H,51,54)/t42-,43+,44+,46-,47-,48-,49+,50-/m0/s1 D0T3CH DRUGINKE VQFKFAKEUMHBLV-BYSUZVQFSA-N D0T3CH DRUGSMIL CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C(CCCCCCCCCCCCCC)O)O D0T3CH HIGHSTAT Phase 2 D0T4SG DRUG__ID D0T4SG D0T4SG DRUGTYPE Small molecular drug D0T4SG DRUGINCH 1S/C19H17ClN2O3S/c1-11-19(26-14-8-6-13(20)7-9-14)18-15(21-12(2)23)4-3-5-16(18)22(11)10-17(24)25/h3-9H,10H2,1-2H3,(H,21,23)(H,24,25) D0T4SG DRUGINKE JWYIGNODXSRKGP-UHFFFAOYSA-N D0T4SG DRUGSMIL CC1=C(C2=C(C=CC=C2N1CC(=O)O)NC(=O)C)SC3=CC=C(C=C3)Cl D0T4SG HIGHSTAT Phase 2 D0T7YE DRUG__ID D0T7YE D0T7YE DRUGCOMP Lycera Ann Arbor, MI D0T7YE DRUGINCH 1S/C27H23F6NO6S/c1-26(2,24(35)36)13-20-14-34(41(37,38)21-5-3-4-17(11-21)27(31,32)33)22-10-15(6-7-23(22)39-20)16-8-18(28)12-19(9-16)40-25(29)30/h3-12,20,25H,13-14H2,1-2H3,(H,35,36)/t20-/m0/s1 D0T7YE DRUGINKE GULSIMHVQYBADX-FQEVSTJZSA-N D0T7YE DRUGSMIL CC(C)(CC1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O D0T7YE HIGHSTAT Phase 2 D0TA4A DRUG__ID D0TA4A D0TA4A DRUGTYPE Small molecular drug D0TA4A DRUGINCH 1S/C25H25ClN2O4S/c1-25(11-13-28(25)23(31)20-16-33-21-9-3-2-8-19(20)21)24(32)27(12-5-10-22(29)30)15-17-6-4-7-18(26)14-17/h2-4,6-9,14,16H,5,10-13,15H2,1H3,(H,29,30)/t25-/m1/s1 D0TA4A DRUGINKE MPMKMQHJHDHPBE-RUZDIDTESA-N D0TA4A DRUGSMIL CC1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl D0TA4A HIGHSTAT Phase 2 D0TG4S DRUG__ID D0TG4S D0TG4S DRUGCOMP Asana BioSciences Lawrenceville, NJ D0TG4S DRUGINCH 1S/C24H28N8O2/c25-10-5-16-6-11-32(12-7-16)24-28-20-15-26-30-23(34)21(20)22(29-24)27-17-1-3-18(4-2-17)31-13-8-19(33)9-14-31/h1-4,15-16,19,33H,5-9,11-14H2,(H,30,34)(H,27,28,29) D0TG4S DRUGINKE NLFLXLJXEIUQDL-UHFFFAOYSA-N D0TG4S DRUGSMIL C1CN(CCC1CC#N)C2=NC3=C(C(=O)NN=C3)C(=N2)NC4=CC=C(C=C4)N5CCC(CC5)O D0TG4S HIGHSTAT Phase 2 D0TH5H DRUG__ID D0TH5H D0TH5H DRUGCOMP Olatec Therapeutics New York, NY D0TH5H DRUGINCH 1S/C4H7NO2S/c1-8(6,7)4-2-3-5/h2,4H2,1H3 D0TH5H DRUGINKE LQFRYKBDZNPJSW-UHFFFAOYSA-N D0TH5H DRUGSMIL CS(=O)(=O)CCC#N D0TH5H HIGHSTAT Phase 2 D0TL7L DRUG__ID D0TL7L D0TL7L DRUGTYPE Small molecular drug D0TL7L DRUGINCH 1S/C21H30Cl2N2O5/c1-3-4-5-11-25(12-6-13-30-2)21(29)18(9-10-19(26)27)24-20(28)15-7-8-16(22)17(23)14-15/h7-8,14,18H,3-6,9-13H2,1-2H3,(H,24,28)(H,26,27)/t18-/m1/s1 D0TL7L DRUGINKE QNQZBKQEIFTHFZ-GOSISDBHSA-N D0TL7L DRUGSMIL CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl D0TL7L HIGHSTAT Phase 2 D0TU7B DRUG__ID D0TU7B D0TU7B DRUGTYPE Small molecular drug D0TU7B DRUGINCH 1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22) D0TU7B DRUGINKE ADGGYDAFIHSYFI-UHFFFAOYSA-N D0TU7B DRUGSMIL C1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4 D0TU7B HIGHSTAT Phase 2 D0TW2J DRUG__ID D0TW2J D0TW2J DRUGCOMP Cmxtwenty Wauwatosa, WI D0TW2J DRUGINCH 1S/C26H44N2O2/c1-4-5-15-19-26(30)28(23(2)3)22-17-14-12-10-8-6-7-9-11-13-16-18-25(29)27-24-20-21-24/h6,8-9,11-12,14,23-24H,4-5,7,10,13,15-22H2,1-3H3,(H,27,29)/b8-6-,11-9-,14-12- D0TW2J DRUGINKE VQHBFTSOKKCZLR-LKWBQYPOSA-N D0TW2J DRUGSMIL CCCCCC(=O)N(CCC=CCC=CCC=CCCCC(=O)NC1CC1)C(C)C D0TW2J HIGHSTAT Phase 2 D0U0AY DRUG__ID D0U0AY D0U0AY DRUGCOMP Vistagen therapeutics D0U0AY DRUGINCH 1S/C10H11ClN2O3/c11-5-1-2-6(7(12)3-5)9(14)4-8(13)10(15)16/h1-3,8H,4,12-13H2,(H,15,16)/t8-/m0/s1 D0U0AY DRUGINKE HQLHZNDJQSRKDT-QMMMGPOBSA-N D0U0AY DRUGSMIL C1=CC(=C(C=C1Cl)N)C(=O)CC(C(=O)O)N D0U0AY HIGHSTAT Phase 2 D0U2DH DRUG__ID D0U2DH D0U2DH DRUGTYPE Small molecular drug D0U2DH DRUGINCH 1S/C23H24N2O5/c1-29-19-11-10-14(12-20(19)30-15-6-2-3-7-15)18(13-21(24)26)25-22(27)16-8-4-5-9-17(16)23(25)28/h4-5,8-12,15,18H,2-3,6-7,13H2,1H3,(H2,24,26) D0U2DH DRUGINKE DDYUBCCTNHWSQM-UHFFFAOYSA-N D0U2DH DRUGSMIL COC1=C(C=C(C=C1)C(CC(=O)N)N2C(=O)C3=CC=CC=C3C2=O)OC4CCCC4 D0U2DH HIGHSTAT Phase 2 D0U2KX DRUG__ID D0U2KX D0U2KX DRUGCOMP Pherin pharmaceuticals D0U2KX DRUGINCH 1S/C19H28O/c1-18-9-3-4-16(18)15-6-5-13-12-14(20)7-11-19(13,2)17(15)8-10-18/h3,5,9,14-17,20H,4,6-8,10-12H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1 D0U2KX DRUGINKE QVHPTAJAHUONLV-DYKIIFRCSA-N D0U2KX DRUGSMIL CC12CCC3C(C1CC=C2)CC=C4C3(CCC(C4)O)C D0U2KX HIGHSTAT Phase 2 D0U5YM DRUG__ID D0U5YM D0U5YM DRUGCOMP Ono Pharma D0U5YM DRUGINCH 1S/C36H37F2NO5/c1-24-27(9-5-11-31(24)37)8-3-4-23-44-29-19-15-26(16-20-29)14-17-28-18-21-32(38)35-30(10-6-12-33(40)41)25(2)39(36(28)35)22-7-13-34(42)43/h5,9,11,15-16,18-21H,3-4,6-8,10,12-13,22-23H2,1-2H3,(H,40,41)(H,42,43) D0U5YM DRUGINKE SILHYVDKGHXGBL-UHFFFAOYSA-N D0U5YM DRUGSMIL CC1=C(C=CC=C1F)CCCCOC2=CC=C(C=C2)C#CC3=C4C(=C(C=C3)F)C(=C(N4CCCC(=O)O)C)CCCC(=O)O D0U5YM HIGHSTAT Phase 2 D0U6ML DRUG__ID D0U6ML D0U6ML DRUGTYPE Small molecular drug D0U6ML DRUGINCH 1S/C25H27N3O4/c1-4-25(31)19-11-21-22-17(12-28(21)23(29)18(19)13-32-24(25)30)15(9-10-26-14(2)3)16-7-5-6-8-20(16)27-22/h5-8,11,14,26,31H,4,9-10,12-13H2,1-3H3/t25-/m0/s1 D0U6ML DRUGINKE LNHWXBUNXOXMRL-VWLOTQADSA-N D0U6ML DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O D0U6ML HIGHSTAT Phase 2 D0U6QC DRUG__ID D0U6QC D0U6QC DRUGTYPE Small molecular drug D0U6QC DRUGINCH 1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16) D0U6QC DRUGINKE QSHWIQZFGQKFMA-UHFFFAOYSA-N D0U6QC DRUGSMIL C1=C(C(=C(N1)CN)CC(=O)O)CCC(=O)O D0U6QC HIGHSTAT Phase 2 D0U6QN DRUG__ID D0U6QN D0U6QN DRUGCOMP Achillion pharmaceuticals D0U6QN DRUGINCH 1S/C60H72N8O6/c1-33(2)53(65-59(71)73-5)57(69)67-49-13-9-7-11-41(49)31-51(67)55-61-45-25-23-39(29-47(45)63-55)43-27-35-15-19-37(43)21-17-36-16-20-38(22-18-35)44(28-36)40-24-26-46-48(30-40)64-56(62-46)52-32-42-12-8-10-14-50(42)68(52)58(70)54(34(3)4)66-60(72)74-6/h15-16,19-20,23-30,33-34,41-42,49-54H,7-14,17-18,21-22,31-32H2,1-6H3,(H,61,63)(H,62,64)(H,65,71)(H,66,72)/t41-,42-,49-,50-,51-,52-,53-,54-/m0/s1 D0U6QN DRUGINKE LSYBRGMTRKJATA-IVEWBXRVSA-N D0U6QN DRUGSMIL CC(C)C(C(=O)N1C2CCCCC2CC1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)C1CC2CCCCC2N1C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC D0U6QN HIGHSTAT Phase 2 D0U6WQ DRUG__ID D0U6WQ D0U6WQ DRUGTYPE Small molecular drug D0U6WQ DRUGINCH 1S/C26H29N5O7/c1-2-37-26-18(14-21(33)38-26)29-23(34)19-8-5-13-30-20(32)10-9-17(25(36)31(19)30)28-24(35)22-16-7-4-3-6-15(16)11-12-27-22/h3-4,6-7,11-12,17-19,26H,2,5,8-10,13-14H2,1H3,(H,28,35)(H,29,34)/t17-,18-,19-,26+/m0/s1 D0U6WQ DRUGINKE CXAGHAZMQSCAKJ-WAHHBDPQSA-N D0U6WQ DRUGSMIL CCOC1C(CC(=O)O1)NC(=O)C2CCCN3N2C(=O)C(CCC3=O)NC(=O)C4=NC=CC5=CC=CC=C54 D0U6WQ HIGHSTAT Phase 2 D0U7WF DRUG__ID D0U7WF D0U7WF DRUGTYPE Small molecular drug D0U7WF DRUGINCH 1S/C22H36O5/c1-4-5-14-22(2,3)20(25)13-12-17-16(18(23)15-19(17)24)10-8-6-7-9-11-21(26)27/h6,8,12-13,16-17,19-20,24-25H,4-5,7,9-11,14-15H2,1-3H3,(H,26,27)/b8-6-,13-12+/t16-,17-,19-,20-/m1/s1 D0U7WF DRUGINKE QAOBBBBDJSWHMU-WMBBNPMCSA-N D0U7WF DRUGSMIL CCCCC(C)(C)C(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O D0U7WF HIGHSTAT Phase 2 D0U8OD DRUG__ID D0U8OD D0U8OD DRUGTYPE Small molecular drug D0U8OD DRUGINCH 1S/C16H13ClFN3O3S/c1-24-14-7-2-10(8-13(14)18)15-16(17)20-9-21(15)11-3-5-12(6-4-11)25(19,22)23/h2-9H,1H3,(H2,19,22,23) D0U8OD DRUGINKE KYXDNECMRLFQMZ-UHFFFAOYSA-N D0U8OD DRUGSMIL COC1=C(C=C(C=C1)C2=C(N=CN2C3=CC=C(C=C3)S(=O)(=O)N)Cl)F D0U8OD HIGHSTAT Phase 2 D0U9WS DRUG__ID D0U9WS D0U9WS DRUGCOMP LEO Pharma A/S D0U9WS DRUGINCH 1S/C19H15Cl2F2NO7S/c20-12-8-24(26)9-13(21)11(12)7-14(25)10-1-2-15(29-18(22)23)17-16(10)30-19(31-17)3-5-32(27,28)6-4-19/h1-2,8-9,18H,3-7H2 D0U9WS DRUGINKE ZININGNRPUGNSL-UHFFFAOYSA-N D0U9WS DRUGSMIL C1CS(=O)(=O)CCC12OC3=C(C=CC(=C3O2)OC(F)F)C(=O)CC4=C(C=[N+](C=C4Cl)[O-])Cl D0U9WS HIGHSTAT Phase 2 D0UA9J DRUG__ID D0UA9J D0UA9J DRUGCOMP Viamet pharmaceuticals D0UA9J DRUGINCH 1S/C22H14F7N5O2/c23-15-4-7-17(18(24)9-15)20(35,11-34-12-31-32-33-34)21(25,26)19-8-3-14(10-30-19)13-1-5-16(6-2-13)36-22(27,28)29/h1-10,12,35H,11H2/t20-/m0/s1 D0UA9J DRUGINKE NCEHACHJIXJSPD-FQEVSTJZSA-N D0UA9J DRUGSMIL C1=CC(=CC=C1C2=CN=C(C=C2)C(C(CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OC(F)(F)F D0UA9J HIGHSTAT Phase 2 D0UD1Y DRUG__ID D0UD1Y D0UD1Y DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ D0UD1Y DRUGINCH 1S/C35H34ClN7O4S2/c1-21(39)32(44)40-22(2)35(45)47-16-15-46-27-11-7-23(8-12-27)30-28(17-37)31(43-13-3-4-14-43)42-34(29(30)18-38)49-20-26-19-48-33(41-26)24-5-9-25(36)10-6-24/h5-12,19,21-22H,3-4,13-16,20,39H2,1-2H3,(H,40,44)/t21-,22-/m0/s1 D0UD1Y DRUGINKE WESNEIGKOAXSGX-VXKWHMMOSA-N D0UD1Y DRUGSMIL CC(C(=O)NC(C)C(=O)OCCOC1=CC=C(C=C1)C2=C(C(=NC(=C2C#N)SCC3=CSC(=N3)C4=CC=C(C=C4)Cl)N5CCCC5)C#N)N D0UD1Y HIGHSTAT Phase 2 D0UF2N DRUG__ID D0UF2N D0UF2N DRUGTYPE Small molecular drug D0UF2N DRUGINCH 1S/C20H28N10O19P4/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(45-19)1-43-50(35,36)47-52(39,40)49-53(41,42)48-51(37,38)44-2-8-12(32)14(34)20(46-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1 D0UF2N DRUGINKE YOAHKNVSNCMZGQ-XPWFQUROSA-N D0UF2N DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)N D0UF2N HIGHSTAT Phase 2 D0UK1L DRUG__ID D0UK1L D0UK1L DRUGCOMP Organon BioSciences D0UK1L DRUGINCH 1S/C95H151N11O59S8/c1-48-41-57(138-4)49(2)50(3)83(48)167(118,119)105-54(86(111)102-55(87(112)106-32-18-13-19-33-106)42-51-25-27-52(28-26-51)84(96)97)43-64(109)99-30-20-24-63(108)101-53(21-16-17-29-98-62(107)23-15-14-22-61-65-56(47-166-61)103-95(117)104-65)85(110)100-31-34-147-35-36-148-37-38-149-39-40-150-66-58(44-151-168(120,121)122)155-91(78(143-9)69(66)139-5)159-73-71(141-7)80(145-11)93(162-76(73)88(113)114)158-68-60(46-153-170(126,127)128)156-94(82(165-173(135,136)137)75(68)163-171(129,130)131)160-74-72(142-8)79(144-10)92(161-77(74)89(115)116)157-67-59(45-152-169(123,124)125)154-90(146-12)81(70(67)140-6)164-172(132,133)134/h25-28,41,53-56,58-61,65-82,90-94,105H,13-24,29-40,42-47H2,1-12H3,(H3,96,97)(H,98,107)(H,99,109)(H,100,110)(H,101,108)(H,102,111)(H,113,114)(H,115,116)(H2,103,104,117)(H,120,121,122)(H,123,124,125)(H,126,127,128)(H,129,130,131)(H,132,133,134)(H,135,136,137)/t53-,54-,55+,56-,58+,59+,60+,61-,65-,66+,67+,68+,69-,70-,71-,72-,73-,74-,75-,76-,77+,78+,79+,80+,81+,82+,90-,91+,92+,93+,94+/m0/s1 D0UK1L DRUGINKE QIBHGITUGYXJDF-UDLCEBFESA-N D0UK1L DRUGSMIL CC1=CC(=C(C(=C1S(=O)(=O)NC(CC(=O)NCCCC(=O)NC(CCCCNC(=O)CCCCC2C3C(CS2)NC(=O)N3)C(=O)NCCOCCOCCOCCOC4C(OC(C(C4OC)OC)OC5C(C(C(OC5C(=O)O)OC6C(OC(C(C6OS(=O)(=O)O)OS(=O)(=O)O)OC7C(C(C(OC7C(=O)O)OC8C(OC(C(C8OC)OS(=O)(=O)O)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O)C(=O)NC(CC9=CC=C(C=C9)C(=N)N)C(=O)N1CCCCC1)C)C)OC D0UK1L HIGHSTAT Phase 2 D0UK1Q DRUG__ID D0UK1Q D0UK1Q DRUGCOMP Myelos Corp D0UK1Q DRUGINCH 1S/C69H110N16O26/c1-13-31(7)53(66(107)80-41(23-29(3)4)61(102)82-46(69(110)111)25-37-15-17-38(88)18-16-37)83-59(100)40(20-22-50(93)94)75-58(99)39(19-21-49(91)92)76-68(109)55(36(12)87)85-57(98)34(10)73-60(101)43(26-47(70)89)78-62(103)44(27-48(71)90)79-63(104)45(28-51(95)96)81-67(108)54(32(8)14-2)84-64(105)42(24-30(5)6)77-56(97)33(9)74-65(106)52(72)35(11)86/h15-18,29-36,39-46,52-55,86-88H,13-14,19-28,72H2,1-12H3,(H2,70,89)(H2,71,90)(H,73,101)(H,74,106)(H,75,99)(H,76,109)(H,77,97)(H,78,103)(H,79,104)(H,80,107)(H,81,108)(H,82,102)(H,83,100)(H,84,105)(H,85,98)(H,91,92)(H,93,94)(H,95,96)(H,110,111)/t31-,32-,33+,34-,35+,36+,39-,40-,41-,42-,43-,44-,45-,46-,52-,53-,54-,55-/m0/s1 D0UK1Q DRUGINKE SMUKRAODILXPSW-SRWCCNGVSA-N D0UK1Q DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C(C)O)N D0UK1Q HIGHSTAT Phase 2 D0UR4K DRUG__ID D0UR4K D0UR4K DRUGCOMP Actelion Pharmaceuticals South San Francisco, CA D0UR4K DRUGINCH 1S/C25H31N3O5/c1-4-16-10-18(9-15(2)23(16)32-14-20(30)13-29)24-27-25(33-28-24)19-11-21(17-7-5-6-8-17)26-22(12-19)31-3/h9-12,17,20,29-30H,4-8,13-14H2,1-3H3/t20-/m0/s1 D0UR4K DRUGINKE KJKKMMMRWISKRF-FQEVSTJZSA-N D0UR4K DRUGSMIL CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OCC(CO)O D0UR4K HIGHSTAT Phase 2 D0UT5A DRUG__ID D0UT5A D0UT5A DRUGCOMP Seattle Genetics D0UT5A DRUGINCH 1S/C52H83N7O13S/c1-12-32(6)45(38(71-10)27-41(61)58-25-19-22-37(58)46(72-11)33(7)47(63)54-36(52(69)70)26-34-20-15-13-16-21-34)57(9)50(66)43(30(2)3)55-48(64)44(31(4)5)56(8)40(60)23-17-14-18-24-59-42(62)28-39(49(59)65)73-29-35(53)51(67)68/h13,15-16,20-21,30-33,35-39,43-46H,12,14,17-19,22-29,53H2,1-11H3,(H,54,63)(H,55,64)(H,67,68)(H,69,70)/t32-,33+,35-,36-,37-,38+,39?,43-,44-,45-,46+/m0/s1 D0UT5A DRUGINKE BXTJCSYMGFJEID-XMTADJHZSA-N D0UT5A DRUGSMIL CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C(=O)O)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C(=O)CCCCCN3C(=O)CC(C3=O)SCC(C(=O)O)N D0UT5A HIGHSTAT Phase 2 D0UT7X DRUG__ID D0UT7X D0UT7X DRUGTYPE Small molecular drug D0UT7X DRUGINCH 1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2 D0UT7X DRUGINKE PMJIHLSCWIDGMD-UHFFFAOYSA-N D0UT7X DRUGSMIL C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43 D0UT7X HIGHSTAT Phase 2 D0UX2V DRUG__ID D0UX2V D0UX2V DRUGCOMP Bristol-Myers Squibb D0UX2V DRUGINCH 1S/C23H36ClN3O4/c1-15(2)18(26-20(29)25-13-22(5,6)30)19(28)27-12-11-23(31,21(3,4)14-27)16-7-9-17(24)10-8-16/h7-10,15,18,30-31H,11-14H2,1-6H3,(H2,25,26,29)/t18-,23+/m1/s1 D0UX2V DRUGINKE GTDPZONCGOCXOD-JPYJTQIMSA-N D0UX2V DRUGSMIL CC(C)C(C(=O)N1CCC(C(C1)(C)C)(C2=CC=C(C=C2)Cl)O)NC(=O)NCC(C)(C)O D0UX2V HIGHSTAT Phase 2 D0V3FM DRUG__ID D0V3FM D0V3FM DRUGTYPE Small molecular drug D0V3FM DRUGINCH 1S/C14H17FN4O3/c1-17-4-5-18(9-16-17)13-3-2-10(6-12(13)15)19-7-11(8-20)22-14(19)21/h2-3,6,9,11,20H,4-5,7-8H2,1H3/t11-/m1/s1 D0V3FM DRUGINKE QLUWQAFDTNAYPN-LLVKDONJSA-N D0V3FM DRUGSMIL CN1CCN(C=N1)C2=C(C=C(C=C2)N3CC(OC3=O)CO)F D0V3FM HIGHSTAT Phase 2 D0V3UN DRUG__ID D0V3UN D0V3UN DRUGTYPE Small molecular drug D0V3UN DRUGINCH 1S/C31H48N4O7S/c1-21(2)42-30(39)27(36)24(18-22-10-6-4-7-11-22)32-29(38)26(20-43-3)33-28(37)25(19-23-12-8-5-9-13-23)34-31(40)35-14-16-41-17-15-35/h5,8-9,12-13,21-22,24-27,36H,4,6-7,10-11,14-20H2,1-3H3,(H,32,38)(H,33,37)(H,34,40)/t24-,25-,26-,27+/m0/s1 D0V3UN DRUGINKE UZQBKCWYZBHBOW-YIPNQBBMSA-N D0V3UN DRUGSMIL CC(C)OC(=O)C(C(CC1CCCCC1)NC(=O)C(CSC)NC(=O)C(CC2=CC=CC=C2)NC(=O)N3CCOCC3)O D0V3UN HIGHSTAT Phase 2 D0V4DX DRUG__ID D0V4DX D0V4DX DRUGCOMP Pfizer New York, NY D0V4DX DRUGINCH 1S/C18H21F2N7O/c1-25-8-11(7-22-25)23-17-21-5-4-15(24-17)26-9-12-2-3-13(10-26)27(12)16(28)14-6-18(14,19)20/h4-5,7-8,12-14H,2-3,6,9-10H2,1H3,(H,21,23,24)/t12-,13+,14-/m0/s1 D0V4DX DRUGINKE BUWBRTXGQRBBHG-MJBXVCDLSA-N D0V4DX DRUGSMIL CN1C=C(C=N1)NC2=NC=CC(=N2)N3CC4CCC(C3)N4C(=O)C5CC5(F)F D0V4DX HIGHSTAT Phase 2 D0V4UO DRUG__ID D0V4UO D0V4UO DRUGTYPE Small molecular drug D0V4UO DRUGINCH 1S/C11H7BrN2O5S/c12-9-6-3-1-2-4-7(6)19-10(9)20(17,18)14-5-8(15)13-11(14)16/h1-4H,5H2,(H,13,15,16) D0V4UO DRUGINKE ZJSUDHQFSBHLDV-UHFFFAOYSA-N D0V4UO DRUGSMIL C1C(=O)NC(=O)N1S(=O)(=O)C2=C(C3=CC=CC=C3O2)Br D0V4UO HIGHSTAT Phase 2 D0V5WL DRUG__ID D0V5WL D0V5WL DRUGTYPE Small molecular drug D0V5WL DRUGINCH 1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1 D0V5WL DRUGINKE YFGBQHOOROIVKG-FKBYEOEOSA-N D0V5WL DRUGSMIL CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N D0V5WL HIGHSTAT Phase 2 D0V6AH DRUG__ID D0V6AH D0V6AH DRUGCOMP EntreMed D0V6AH DRUGINCH 1S/C9H10N2O2/c1-11(10-13)7-9(12)8-5-3-2-4-6-8/h2-6H,7H2,1H3 D0V6AH DRUGINKE AAFYOVPTFNNVDN-UHFFFAOYSA-N D0V6AH DRUGSMIL CN(CC(=O)C1=CC=CC=C1)N=O D0V6AH HIGHSTAT Phase 2 D0V6OZ DRUG__ID D0V6OZ D0V6OZ DRUGCOMP AegisCN Raleigh, NC D0V6OZ DRUGINCH 1S/C9H6N2O2/c12-11(13)9-3-1-2-7-6-10-5-4-8(7)9/h1-6H D0V6OZ DRUGINKE PYGMPFQCCWBTJQ-UHFFFAOYSA-N D0V6OZ DRUGSMIL C1=CC2=C(C=CN=C2)C(=C1)[N+](=O)[O-] D0V6OZ HIGHSTAT Phase 2 D0V7SO DRUG__ID D0V7SO D0V7SO DRUGCOMP Pfizer D0V7SO DRUGINCH 1S/C26H28F3N3O4/c1-4-5-22(18-6-8-19(9-7-18)25(35)30-11-10-23(33)34)36-21-12-16(2)24(17(3)13-21)32-15-20(14-31-32)26(27,28)29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,30,35)(H,33,34)/t22-/m0/s1 D0V7SO DRUGINKE IBDYYOQKQCCSDP-QFIPXVFZSA-N D0V7SO DRUGSMIL CCCC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)OC2=CC(=C(C(=C2)C)N3C=C(C=N3)C(F)(F)F)C D0V7SO HIGHSTAT Phase 2 D0V7US DRUG__ID D0V7US D0V7US DRUGCOMP Novartis; Avera Pharmaceuticals D0V7US DRUGINCH 1S/C31H24ClF6N3O2/c32-22-7-5-18(6-8-22)13-24-17-23(40-28(42)26-9-11-39-27-4-2-1-3-25(26)27)10-12-41(24)29(43)19-14-20(30(33,34)35)16-21(15-19)31(36,37)38/h1-9,11,14-16,23-24H,10,12-13,17H2,(H,40,42)/t23-,24+/m0/s1 D0V7US DRUGINKE NXLUTEDAEFXMQR-BJKOFHAPSA-N D0V7US DRUGSMIL C1CN(C(CC1NC(=O)C2=CC=NC3=CC=CC=C23)CC4=CC=C(C=C4)Cl)C(=O)C5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F D0V7US HIGHSTAT Phase 2 D0V8AP DRUG__ID D0V8AP D0V8AP DRUGCOMP Torrent Pharmaceuticals Ltd D0V8AP DRUGINCH 1S/C13H13N3O4S2.ClH/c1-22(19,20)15-14-13(18)10-4-2-6-16(8-10)9-11(17)12-5-3-7-21-12;/h2-8,15H,9H2,1H3;1H D0V8AP DRUGINKE QWXKHFBZAGOZJM-UHFFFAOYSA-N D0V8AP DRUGSMIL CS(=O)(=O)NNC(=O)C1=C[N+](=CC=C1)CC(=O)C2=CC=CS2.[Cl-] D0V8AP HIGHSTAT Phase 2 D0V9IE DRUG__ID D0V9IE D0V9IE DRUGTYPE Small molecular drug D0V9IE DRUGINCH 1S/C18H21NO4.ClH/c20-17(15-4-2-1-3-5-15)13-19-10-11-23-16-8-6-14(7-9-16)12-18(21)22;/h1-9,17,19-20H,10-13H2,(H,21,22);1H/t17-;/m0./s1 D0V9IE DRUGINKE KCEFVYIWOQSJCH-LMOVPXPDSA-N D0V9IE DRUGSMIL C1=CC=C(C=C1)C(CNCCOC2=CC=C(C=C2)CC(=O)O)O.Cl D0V9IE HIGHSTAT Phase 2 D0VA9Z DRUG__ID D0VA9Z D0VA9Z DRUGCOMP Mitsubishi Tanabe Pharma America Jersey City, NJ D0VA9Z DRUGINCH 1S/C10H14N2O4.C9H11NO4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h2-4,12-14H,5,11H2,1H3,(H,15,16);1-2,4,6,11-12H,3,10H2,(H,13,14)/t10-;6-/m00/s1 D0VA9Z DRUGINKE IVTMXOXVAHXCHI-YXLMWLKOSA-N D0VA9Z DRUGSMIL CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.C1=CC(=C(C=C1CC(C(=O)O)N)O)O D0VA9Z HIGHSTAT Phase 2 D0VB4X DRUG__ID D0VB4X D0VB4X DRUGCOMP Vitae PharmaceuticalsFort Washington, PA D0VB4X DRUGINCH 1S/C27H35F3N4O3S/c1-4-38(36,37)23-10-9-22(31-14-23)13-33-26(35)19-11-20-16-34(25(17(2)3)24(20)32-12-19)15-18-5-7-21(8-6-18)27(28,29)30/h9-12,14,17-18,21,25H,4-8,13,15-16H2,1-3H3,(H,33,35)/t18?,21?,25-/m1/s1 D0VB4X DRUGINKE XUYMIRYNRKXKOR-JBWFSBJDSA-N D0VB4X DRUGSMIL CCS(=O)(=O)C1=CN=C(C=C1)CNC(=O)C2=CC3=C(C(N(C3)CC4CCC(CC4)C(F)(F)F)C(C)C)N=C2 D0VB4X HIGHSTAT Phase 2 D0VC8Z DRUG__ID D0VC8Z D0VC8Z DRUGCOMP BioBlast Pharma New Haven, CT D0VC8Z DRUGINCH 1S/C12H22O11/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-/m1/s1 D0VC8Z DRUGINKE HDTRYLNUVZCQOY-LIZSDCNHSA-N D0VC8Z DRUGSMIL C(C1C(C(C(C(O1)OC2C(C(C(C(O2)CO)O)O)O)O)O)O)O D0VC8Z HIGHSTAT Phase 2 D0VO6J DRUG__ID D0VO6J D0VO6J DRUGTYPE Small molecular drug D0VO6J DRUGINCH 1S/C34H37FO15/c1-14-27(40)32(45)26(35)33(49-14)50-18-12-34(46,19(36)13-48-21(39)10-5-3-4-9-20(37)38)11-16-23(18)31(44)25-24(29(16)42)28(41)15-7-6-8-17(47-2)22(15)30(25)43/h6-8,14,18,26-27,32-33,40,42,44-46H,3-5,9-13H2,1-2H3,(H,37,38)/t14-,18-,26+,27+,32-,33-,34-/m0/s1 D0VO6J DRUGINKE PQMIPLRIRFVQJZ-QBYYVRQOSA-N D0VO6J DRUGSMIL CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CCCCCC(=O)O)O)F)O)O D0VO6J HIGHSTAT Phase 2 D0VT2B DRUG__ID D0VT2B D0VT2B DRUGCOMP Alios biopharma D0VT2B DRUGINCH 1S/C18H25ClFN3O6/c1-9(2)15(24)27-8-18(7-19)13(28-16(25)10(3)4)12(20)14(29-18)23-6-5-11(21)22-17(23)26/h5-6,9-10,12-14H,7-8H2,1-4H3,(H2,21,22,26)/t12-,13+,14-,18-/m1/s1 D0VT2B DRUGINKE MJVKYGMNSQJLIN-KYZVSKTDSA-N D0VT2B DRUGSMIL CC(C)C(=O)OCC1(C(C(C(O1)N2C=CC(=NC2=O)N)F)OC(=O)C(C)C)CCl D0VT2B HIGHSTAT Phase 2 D0VT2C DRUG__ID D0VT2C D0VT2C DRUGTYPE Small molecular drug D0VT2C DRUGINCH 1S/C17H11BrF2N2O4/c18-10-2-1-9(13(20)5-10)7-22-16(25)12-4-3-11(19)6-14(12)21(17(22)26)8-15(23)24/h1-6H,7-8H2,(H,23,24) D0VT2C DRUGINKE XLOHSVVOWVIPFC-UHFFFAOYSA-N D0VT2C DRUGSMIL C1=CC2=C(C=C1F)N(C(=O)N(C2=O)CC3=C(C=C(C=C3)Br)F)CC(=O)O D0VT2C HIGHSTAT Phase 2 D0VT9O DRUG__ID D0VT9O D0VT9O DRUGCOMP Arbor Pharmaceuticals Atlanta, GA D0VT9O DRUGINCH 1S/C12H18N2O2.ClH/c1-9(14(3)4)10-6-5-7-11(8-10)16-12(15)13-2;/h5-9H,1-4H3,(H,13,15);1H D0VT9O DRUGINKE SXVZMCIGRIYWTD-UHFFFAOYSA-N D0VT9O DRUGSMIL CC(C1=CC(=CC=C1)OC(=O)NC)[NH+](C)C.[Cl-] D0VT9O HIGHSTAT Phase 2 D0VZ9S DRUG__ID D0VZ9S D0VZ9S DRUGTYPE Small molecular drug D0VZ9S DRUGINCH 1S/C33H36N2O12/c1-3-41-32(39)27-15-21(36)29-23(10-7-12-25(29)46-27)43-17-19(45-31(38)20(35)9-5-6-14-34)18-44-24-11-8-13-26-30(24)22(37)16-28(47-26)33(40)42-4-2/h7-8,10-13,15-16,19-20H,3-6,9,14,17-18,34-35H2,1-2H3/t20-/m0/s1 D0VZ9S DRUGINKE NGJJDHCBOKNREV-FQEVSTJZSA-N D0VZ9S DRUGSMIL CCOC(=O)C1=CC(=O)C2=C(O1)C=CC=C2OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)OCC)OC(=O)C(CCCCN)N D0VZ9S HIGHSTAT Phase 2 D0W2HG DRUG__ID D0W2HG D0W2HG DRUGCOMP Neurocrine Biosci D0W2HG DRUGINCH 1S/C194H339N63O54S/c1-38-96(25)142(199)181(303)250-144(94(21)22)184(306)243-126(76-92(17)18)176(298)247-130(83-258)179(301)241-124(74-90(13)14)174(296)242-129(79-141(271)272)178(300)251-145(95(23)24)189(311)257-69-47-53-132(257)180(302)254-146(97(26)39-2)183(305)218-82-137(265)227-120(70-86(5)6)171(293)239-122(72-88(9)10)172(294)237-117(56-61-135(197)263)168(290)253-148(99(28)41-4)186(308)245-125(75-91(15)16)175(297)240-123(73-89(11)12)173(295)238-119(58-63-140(269)270)165(287)235-115(54-59-133(195)261)161(283)223-103(32)155(277)230-111(49-43-65-213-191(203)204)160(282)222-102(31)154(276)229-110(48-42-64-212-190(201)202)159(281)221-100(29)152(274)220-101(30)153(275)231-112(50-44-66-214-192(205)206)163(285)236-118(57-62-139(267)268)164(286)234-116(55-60-134(196)262)162(284)224-106(35)158(280)255-150(108(37)260)188(310)256-149(107(36)259)187(309)246-128(78-136(198)264)170(292)226-105(34)157(279)233-114(52-46-68-216-194(209)210)167(289)252-147(98(27)40-3)185(307)244-121(71-87(7)8)169(291)225-104(33)156(278)232-113(51-45-67-215-193(207)208)166(288)249-143(93(19)20)182(304)217-81-138(266)228-127(77-109-80-211-85-219-109)177(299)248-131(84-312)151(200)273/h80,85-108,110-132,142-150,258-260,312H,38-79,81-84,199H2,1-37H3,(H2,195,261)(H2,196,262)(H2,197,263)(H2,198,264)(H2,200,273)(H,211,219)(H,217,304)(H,218,305)(H,220,274)(H,221,281)(H,222,282)(H,223,283)(H,224,284)(H,225,291)(H,226,292)(H,227,265)(H,228,266)(H,229,276)(H,230,277)(H,231,275)(H,232,278)(H,233,279)(H,234,286)(H,235,287)(H,236,285)(H,237,294)(H,238,295)(H,239,293)(H,240,297)(H,241,301)(H,242,296)(H,243,306)(H,244,307)(H,245,308)(H,246,309)(H,247,298)(H,248,299)(H,249,288)(H,250,303)(H,251,300)(H,252,289)(H,253,290)(H,254,302)(H,255,280)(H,256,310)(H,267,268)(H,269,270)(H,271,272)(H4,201,202,212)(H4,203,204,213)(H4,205,206,214)(H4,207,208,215)(H4,209,210,216)/t96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107+,108+,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,142-,143-,144-,145-,146-,147-,148-,149-,150-/m0/s1 D0W2HG DRUGINKE ZEBBPGHOLWPSGI-KPLDDXDLSA-N D0W2HG DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)N1CCCC1C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC2=CN=CN2)C(=O)NC(CS)C(=O)N)N D0W2HG HIGHSTAT Phase 2 D0W3GL DRUG__ID D0W3GL D0W3GL DRUGTYPE Small molecular drug D0W3GL DRUGINCH 1S/C23H23BrCl2N4O/c1-2-18-21(23(31)28-29-12-4-3-5-13-29)27-30(20-11-10-17(25)14-19(20)26)22(18)15-6-8-16(24)9-7-15/h6-11,14H,2-5,12-13H2,1H3,(H,28,31) D0W3GL DRUGINKE HMXDWDSNPRNUKI-UHFFFAOYSA-N D0W3GL DRUGSMIL CCC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Br D0W3GL HIGHSTAT Phase 2 D0W3GR DRUG__ID D0W3GR D0W3GR DRUGCOMP Bio-Path Holdings Houston, TX D0W3GR DRUGINCH 1S/C177H224N63O110P17/c1-68-32-226(171(258)216-151(68)243)117-18-79(337-351(265,266)299-40-94-75(242)14-114(317-94)223-11-8-111(178)203-168(223)255)98(321-117)44-304-355(273,274)338-81-20-119(228-34-70(3)153(245)218-173(228)260)322-99(81)45-303-353(269,270)335-77-16-115(224-12-9-112(179)204-169(224)256)318-95(77)41-301-361(285,286)346-88-27-127(236-63-198-135-146(236)206-163(184)211-158(135)250)332-109(88)55-314-367(297,298)350-92-31-131(240-67-202-139-150(240)210-167(188)215-162(139)254)331-108(92)54-313-360(283,284)343-85-24-123(232-38-74(7)157(249)222-177(232)264)326-103(85)49-308-364(291,292)345-87-26-126(235-62-197-134-142(183)191-59-194-145(134)235)328-105(87)51-310-365(293,294)348-90-29-129(238-65-200-137-148(238)208-165(186)213-160(137)252)329-106(90)52-311-354(271,272)336-78-17-116(225-13-10-113(180)205-170(225)257)319-96(78)42-302-362(287,288)347-89-28-128(237-64-199-136-147(237)207-164(185)212-159(136)251)333-110(89)56-315-366(295,296)349-91-30-130(239-66-201-138-149(239)209-166(187)214-161(138)253)330-107(91)53-312-359(281,282)342-84-23-122(231-37-73(6)156(248)221-176(231)263)324-101(84)47-306-356(275,276)339-82-21-120(229-35-71(4)154(246)219-174(229)261)323-100(82)46-305-357(277,278)340-83-22-121(230-36-72(5)155(247)220-175(230)262)325-102(83)48-307-363(289,290)344-86-25-125(234-61-196-133-141(182)190-58-193-144(133)234)327-104(86)50-309-358(279,280)341-80-19-118(227-33-69(2)152(244)217-172(227)259)320-97(80)43-300-352(267,268)334-76-15-124(316-93(76)39-241)233-60-195-132-140(181)189-57-192-143(132)233/h8-13,32-38,57-67,75-110,114-131,241-242H,14-31,39-56H2,1-7H3,(H,265,266)(H,267,268)(H,269,270)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H,289,290)(H,291,292)(H,293,294)(H,295,296)(H,297,298)(H2,178,203,255)(H2,179,204,256)(H2,180,205,257)(H2,181,189,192)(H2,182,190,193)(H2,183,191,194)(H,216,243,258)(H,217,244,259)(H,218,245,260)(H,219,246,261)(H,220,247,262)(H,221,248,263)(H,222,249,264)(H3,184,206,211,250)(H3,185,207,212,251)(H3,186,208,213,252)(H3,187,209,214,253)(H3,188,210,215,254) D0W3GR DRUGINKE QAOIWVZTHIWLSW-UHFFFAOYSA-N D0W3GR DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3CO)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)OCC6C(CC(O6)N7C=NC8=C(N=CN=C87)N)OP(=O)(O)OCC9C(CC(O9)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)O D0W3GR HIGHSTAT Phase 2 D0W3LI DRUG__ID D0W3LI D0W3LI DRUGTYPE Small molecular drug D0W3LI DRUGINCH 1S/C28H28N4O3/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34)/t18-/m0/s1 D0W3LI DRUGINKE ZCBUQCWBWNUWSU-SFHVURJKSA-N D0W3LI DRUGSMIL CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O D0W3LI HIGHSTAT Phase 2 D0W7UN DRUG__ID D0W7UN D0W7UN DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0W7UN DRUGINCH 1S/C16H17N5O2/c22-16-13-10-18-21(12-4-7-23-8-5-12)15(13)19-14(20-16)9-11-3-1-2-6-17-11/h1-3,6,10,12H,4-5,7-9H2,(H,19,20,22) D0W7UN DRUGINKE BZTIJCSHNVZMES-UHFFFAOYSA-N D0W7UN DRUGSMIL C1COCCC1N2C3=C(C=N2)C(=O)NC(=N3)CC4=CC=CC=N4 D0W7UN HIGHSTAT Phase 2 D0W9JM DRUG__ID D0W9JM D0W9JM DRUGTYPE Small molecular drug D0W9JM DRUGINCH 1S/C33H41N5O6S2/c1-33(2,3)37-31(42)26-19-46-20-38(26)32(43)29(40)24(15-21-9-6-5-7-10-21)36-30(41)25(18-45-4)35-28(39)17-44-27-12-8-11-22-16-34-14-13-23(22)27/h5-14,16,24-26,29,40H,15,17-20H2,1-4H3,(H,35,39)(H,36,41)(H,37,42)/t24-,25-,26-,29-/m0/s1 D0W9JM DRUGINKE NJBBLOIWMSYVCQ-VZTVMPNDSA-N D0W9JM DRUGSMIL CC(C)(C)NC(=O)C1CSCN1C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)COC3=CC=CC4=C3C=CN=C4)O D0W9JM HIGHSTAT Phase 2 D0WH9U DRUG__ID D0WH9U D0WH9U DRUGTYPE Small molecular drug D0WH9U DRUGINCH 1S/C22H26ClN3O4S.ClH/c23-18-8-10-21(11-9-18)31(29,30)25-19-13-20(6-2-1-3-7-22(27)28)26(16-19)15-17-5-4-12-24-14-17;/h2,4-6,8-12,14,19-20,25H,1,3,7,13,15-16H2,(H,27,28);1H/b6-2-;/t19-,20-;/m1./s1 D0WH9U DRUGINKE JGCFJVFIRFTRKJ-YOLZMAEBSA-N D0WH9U DRUGSMIL C1C(CN(C1C=CCCCC(=O)O)CC2=CN=CC=C2)NS(=O)(=O)C3=CC=C(C=C3)Cl.Cl D0WH9U HIGHSTAT Phase 2 D0WU1O DRUG__ID D0WU1O D0WU1O DRUGCOMP G1 Therapeutics Research Tringle Park, NC D0WU1O DRUGINCH 1S/C26H34N8O/c1-18(2)32-10-12-33(13-11-32)20-6-7-22(27-16-20)30-25-28-15-19-14-21-24(35)29-17-26(8-4-3-5-9-26)34(21)23(19)31-25/h6-7,14-16,18H,3-5,8-13,17H2,1-2H3,(H,29,35)(H,27,28,30,31) D0WU1O DRUGINKE YPJRHEKCFKOVRT-UHFFFAOYSA-N D0WU1O DRUGSMIL CC(C)N1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6 D0WU1O HIGHSTAT Phase 2 D0X2UI DRUG__ID D0X2UI D0X2UI DRUGCOMP Novartis AG D0X2UI DRUGINCH 1S/C23H28O7/c1-2-14-4-5-15(23-22(27)21(26)20(25)19(12-24)30-23)11-16(14)9-13-3-6-17-18(10-13)29-8-7-28-17/h3-6,10-11,19-27H,2,7-9,12H2,1H3/t19-,20-,21+,22-,23+/m1/s1 D0X2UI DRUGINKE XFJAMQQAAMJFGB-ZQGJOIPISA-N D0X2UI DRUGSMIL CCC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4 D0X2UI HIGHSTAT Phase 2 D0X2XF DRUG__ID D0X2XF D0X2XF DRUGTYPE Small molecular drug D0X2XF DRUGINCH 1S/C22H31N3O2/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26) D0X2XF DRUGINKE KVCSJPATKXABRQ-UHFFFAOYSA-N D0X2XF DRUGSMIL CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42 D0X2XF HIGHSTAT Phase 2 D0X2XZ DRUG__ID D0X2XZ D0X2XZ DRUGTYPE Small molecular drug D0X2XZ DRUGINCH 1S/C33H34N4O3/c1-20-17-37(18-21(2)40-20)19-23-6-4-22(5-7-23)8-12-29-26-11-9-24(14-31(26)36-35-29)28-16-33(28)27-15-25(39-3)10-13-30(27)34-32(33)38/h4-15,20-21,28H,16-19H2,1-3H3,(H,34,38)(H,35,36)/b12-8+/t20-,21+,28-,33-/m0/s1 D0X2XZ DRUGINKE DADASRPKWOGKCU-FVTQAUBDSA-N D0X2XZ DRUGSMIL CC1CN(CC(O1)C)CC2=CC=C(C=C2)C=CC3=NNC4=C3C=CC(=C4)C5CC56C7=C(C=CC(=C7)OC)NC6=O D0X2XZ HIGHSTAT Phase 2 D0X4CE DRUG__ID D0X4CE D0X4CE DRUGCOMP Nihon Medi-Physics Co Ltd D0X4CE DRUGINCH 1S/C6H10FNO2/c1-5(7)2-6(8,3-5)4(9)10/h2-3,8H2,1H3,(H,9,10)/i7-1 D0X4CE DRUGINKE ILMJJAKSEOUEPX-JZRMKITLSA-N D0X4CE DRUGSMIL CC1(CC(C1)(C(=O)O)N)F D0X4CE HIGHSTAT Phase 2 D0X8CH DRUG__ID D0X8CH D0X8CH DRUGCOMP GlaxoSmithKline D0X8CH DRUGINCH 1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1 D0X8CH DRUGINKE CZGVOBIGEBDYTP-VSGBNLITSA-N D0X8CH DRUGSMIL CCCCC1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)C(N1)C3=CC=CC=C3)CC D0X8CH HIGHSTAT Phase 2 D0X9HB DRUG__ID D0X9HB D0X9HB DRUGTYPE Small molecular drug D0X9HB DRUGINCH 1S/C21H22N3OS2.ClH/c1-4-23-13-9-8-10-15(23)14-18-24(5-2)20(25)19(27-18)21-22(3)16-11-6-7-12-17(16)26-21;/h6-14H,4-5H2,1-3H3;1H/q+1;/p-1/b21-19+; D0X9HB DRUGINKE VSKYOTRJSLYFHX-UXJRWBAGSA-M D0X9HB DRUGSMIL CCN1C(=CC2=CC=CC=[N+]2CC)SC(=C3N(C4=CC=CC=C4S3)C)C1=O.[Cl-] D0X9HB HIGHSTAT Phase 2 D0X9YP DRUG__ID D0X9YP D0X9YP DRUGCOMP AstraZeneca D0X9YP DRUGINCH 1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-27-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26)24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,23,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23+,29-/m0/s1 D0X9YP DRUGINKE ZZWJKLGCDHYVMB-BWGXUDETSA-N D0X9YP DRUGSMIL CC(C(C1=CC2=C(C=C1)OCCO2)OC3=CC4=C(C=C3)N(N=C4)C5=CC=CC(=C5)C(=O)NC6CCOC6)NC(=O)C(C)(F)F D0X9YP HIGHSTAT Phase 2 D0XH9B DRUG__ID D0XH9B D0XH9B DRUGTYPE Small molecular drug D0XH9B DRUGINCH 1S/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1 D0XH9B DRUGINKE WURGZWOTGMLDJP-ZCYANPAGSA-N D0XH9B DRUGSMIL CC(C)(CC=CC(=O)N(C)C(CC1=CC2=CC=CC=C2C=C1)C(=O)N(C)C(CC3=CC=CC=C3)C(=O)NC)N D0XH9B HIGHSTAT Phase 2 D0XR7C DRUG__ID D0XR7C D0XR7C DRUGCOMP Astellas D0XR7C DRUGINCH 1S/C24H20N5O5S.K/c1-32-18-11-6-7-12-19(18)34-20-21(29-35(30,31)16-13-17-9-4-3-5-10-17)27-23(28-24(20)33-2)22-25-14-8-15-26-22;/h3-16H,1-2H3;/q-1;+1/b16-13+; D0XR7C DRUGINKE WOPWEXSDEXIRNG-ZUQRMPMESA-N D0XR7C DRUGSMIL COC1=CC=CC=C1OC2=C(N=C(N=C2OC)C3=NC=CC=N3)[N-]S(=O)(=O)C=CC4=CC=CC=C4.[K+] D0XR7C HIGHSTAT Phase 2 D0XT0W DRUG__ID D0XT0W D0XT0W DRUGCOMP Debiopharm D0XT0W DRUGINCH 1S/C20H16N6O/c1-11-23-16-7-6-13(9-17(16)24-11)26-20(21)14(10-22-26)19(27)18-8-12-4-2-3-5-15(12)25-18/h2-10,25H,21H2,1H3,(H,23,24) D0XT0W DRUGINKE BEMNJULZEQTDJY-UHFFFAOYSA-N D0XT0W DRUGSMIL CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)N D0XT0W HIGHSTAT Phase 2 D0XW6Y DRUG__ID D0XW6Y D0XW6Y DRUGCOMP Servier D0XW6Y DRUGINCH 1S/C17H24N2O2/c18-17(20)13-5-7-16(8-6-13)21-10-2-9-19-11-14-3-1-4-15(14)12-19/h5-8,14-15H,1-4,9-12H2,(H2,18,20) D0XW6Y DRUGINKE MRNMYWNBLVJWKG-UHFFFAOYSA-N D0XW6Y DRUGSMIL C1CC2CN(CC2C1)CCCOC3=CC=C(C=C3)C(=O)N D0XW6Y HIGHSTAT Phase 2 D0Y6OA DRUG__ID D0Y6OA D0Y6OA DRUGTYPE Small molecular drug D0Y6OA DRUGINCH 1S/C10H9NO5S/c1-6-4-10(12)15-9-5-7(2-3-8(6)9)16-17(11,13)14/h2-5H,1H3,(H2,11,13,14) D0Y6OA DRUGINKE UFGBGFMPBMEVMI-UHFFFAOYSA-N D0Y6OA DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2)OS(=O)(=O)N D0Y6OA HIGHSTAT Phase 2 D0Y6OE DRUG__ID D0Y6OE D0Y6OE DRUGTYPE Small molecular drug D0Y6OE DRUGINCH 1S/C9H12N2O/c1-2-9(6-10-4-1)12-7-8-3-5-11-8/h1-2,4,6,8,11H,3,5,7H2/t8-/m0/s1 D0Y6OE DRUGINKE XKFMBGWHHBCWCD-QMMMGPOBSA-N D0Y6OE DRUGSMIL C1CNC1COC2=CN=CC=C2 D0Y6OE HIGHSTAT Phase 2 D0Y6SQ DRUG__ID D0Y6SQ D0Y6SQ DRUGTYPE Small molecular drug D0Y6SQ DRUGINCH 1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23) D0Y6SQ DRUGINKE XASIMHXSUQUHLV-UHFFFAOYSA-N D0Y6SQ DRUGSMIL CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N D0Y6SQ HIGHSTAT Phase 2 D0Z0HH DRUG__ID D0Z0HH D0Z0HH DRUGTYPE Small molecular drug D0Z0HH DRUGINCH 1S/C30H30O8/c1-11(2)19-15-7-13(5)21(27(35)23(15)17(9-31)25(33)29(19)37)22-14(6)8-16-20(12(3)4)30(38)26(34)18(10-32)24(16)28(22)36/h7-12,33-38H,1-6H3 D0Z0HH DRUGINKE QBKSWRVVCFFDOT-UHFFFAOYSA-N D0Z0HH DRUGSMIL CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O D0Z0HH HIGHSTAT Phase 2 D0Z2FB DRUG__ID D0Z2FB D0Z2FB DRUGTYPE Small molecular drug D0Z2FB DRUGINCH 1S/C18H18Cl2N2O3/c1-24-15-7-6-11(8-16(15)25-12-4-2-3-5-12)18(23)22-17-13(19)9-21-10-14(17)20/h6-10,12H,2-5H2,1H3,(H,21,22,23) D0Z2FB DRUGINKE RRRUXBQSQLKHEL-UHFFFAOYSA-N D0Z2FB DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2=C(C=NC=C2Cl)Cl)OC3CCCC3 D0Z2FB HIGHSTAT Phase 2 D0Z2JF DRUG__ID D0Z2JF D0Z2JF DRUGCOMP LG Life Sciences Ltd D0Z2JF DRUGINCH 1S/C21H22FN3O5/c1-12(2)20(19(27)24-16-9-17(26)29-21(16,28)11-22)10-15(25-30-20)18-14-6-4-3-5-13(14)7-8-23-18/h3-8,12,16,28H,9-11H2,1-2H3,(H,24,27)/t16-,20+,21+/m0/s1 D0Z2JF DRUGINKE VYFGDLGHHBUDTQ-ZLGUVYLKSA-N D0Z2JF DRUGSMIL CC(C)C1(CC(=NO1)C2=NC=CC3=CC=CC=C32)C(=O)NC4CC(=O)OC4(CF)O D0Z2JF HIGHSTAT Phase 2 D0Z4FE DRUG__ID D0Z4FE D0Z4FE DRUGCOMP Minerva neurosciences D0Z4FE DRUGINCH 1S/C25H25Cl2N3O4.ClH/c1-15-28-29-25(33-15)24-12-19-22(3-2-4-23(19)34-24)32-14-18(31)13-30-9-7-16(8-10-30)17-5-6-20(26)21(27)11-17;/h2-6,11-12,16,18,31H,7-10,13-14H2,1H3;1H D0Z4FE DRUGINKE HRNDUKHBCUTNAL-UHFFFAOYSA-N D0Z4FE DRUGSMIL CC1=NN=C(O1)C2=CC3=C(O2)C=CC=C3OCC(CN4CCC(CC4)C5=CC(=C(C=C5)Cl)Cl)O.Cl D0Z4FE HIGHSTAT Phase 2 D0Z5EJ DRUG__ID D0Z5EJ D0Z5EJ DRUGCOMP EndocyteWest Lafayette, INRadio MedixHouston, TX D0Z5EJ DRUGINCH 1S/C49H71N9O16/c59-40(28-55-17-19-56(29-42(62)63)21-23-58(31-44(66)67)24-22-57(20-18-55)30-43(64)65)51-27-32-8-12-35(13-9-32)45(68)52-39(26-33-10-11-34-5-1-2-6-36(34)25-33)46(69)50-16-4-3-7-37(47(70)71)53-49(74)54-38(48(72)73)14-15-41(60)61/h1-2,5-6,10-11,25,32,35,37-39H,3-4,7-9,12-24,26-31H2,(H,50,69)(H,51,59)(H,52,68)(H,60,61)(H,62,63)(H,64,65)(H,66,67)(H,70,71)(H,72,73)(H2,53,54,74)/t32?,35?,37-,38-,39-/m0/s1 D0Z5EJ DRUGINKE JBHPLHATEXGMQR-VLOIPPKDSA-N D0Z5EJ DRUGSMIL C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O D0Z5EJ HIGHSTAT Phase 2 D0Z9GM DRUG__ID D0Z9GM D0Z9GM DRUGCOMP Eli Lilly & Co D0Z9GM DRUGINCH 1S/C22H23ClF2N4O2S/c1-14-16(11-29(27-14)20-15(12-30)3-2-6-26-20)10-28-7-4-21(5-8-28)19-17(9-18(23)32-19)22(24,25)13-31-21/h2-3,6,9,11,30H,4-5,7-8,10,12-13H2,1H3 D0Z9GM DRUGINKE NKQHBJNRBKHUQR-UHFFFAOYSA-N D0Z9GM DRUGSMIL CC1=NN(C=C1CN2CCC3(CC2)C4=C(C=C(S4)Cl)C(CO3)(F)F)C5=C(C=CC=N5)CO D0Z9GM HIGHSTAT Phase 2 D0ZC3C DRUG__ID D0ZC3C D0ZC3C DRUGTYPE Small molecular drug D0ZC3C DRUGINCH 1S/C19H20N2O2/c1-22-17-8-7-14(18(12-17)23-2)11-15-5-4-10-21-19(15)16-6-3-9-20-13-16/h3,6-9,11-13H,4-5,10H2,1-2H3/b15-11+ D0ZC3C DRUGINKE RPYWXZCFYPVCNQ-RVDMUPIBSA-N D0ZC3C DRUGSMIL COC1=CC(=C(C=C1)C=C2CCCN=C2C3=CN=CC=C3)OC D0ZC3C HIGHSTAT Phase 2 D0ZN1R DRUG__ID D0ZN1R D0ZN1R DRUGTYPE Small molecular drug D0ZN1R DRUGINCH 1S/C15H10O7.ClH/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6;/h1-5H,(H5-,16,17,18,19,20,21);1H D0ZN1R DRUGINKE FFNDMZIBVDSQFI-UHFFFAOYSA-N D0ZN1R DRUGSMIL C1=C(C=C(C(=C1O)O)O)C2=[O+]C3=CC(=CC(=C3C=C2O)O)O.[Cl-] D0ZN1R HIGHSTAT Phase 2 D0ZT0G DRUG__ID D0ZT0G D0ZT0G DRUGTYPE Small molecular drug D0ZT0G DRUGINCH 1S/C36H39NO5/c38-35(39)12-6-7-24-37(26-30-19-21-33(22-20-30)36(40)41)25-23-32-10-4-5-11-34(32)42-27-31-17-15-29(16-18-31)14-13-28-8-2-1-3-9-28/h1-5,8-11,15-22H,6-7,12-14,23-27H2,(H,38,39)(H,40,41) D0ZT0G DRUGINKE WPYWMXNXEZFMAK-UHFFFAOYSA-N D0ZT0G DRUGSMIL C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O D0ZT0G HIGHSTAT Phase 2 D0ZW5D DRUG__ID D0ZW5D D0ZW5D DRUGCOMP Eli Lilly & Co D0ZW5D DRUGINCH 1S/C32H36F3NO4/c1-20-18-26(19-21(2)29(20)23-10-12-25(13-11-23)31(3,4)5)40-27(14-16-32(33,34)35)22-6-8-24(9-7-22)30(39)36-17-15-28(37)38/h6-13,18-19,27H,14-17H2,1-5H3,(H,36,39)(H,37,38)/t27-/m0/s1 D0ZW5D DRUGINKE FASLTMSUPQDLIB-MHZLTWQESA-N D0ZW5D DRUGSMIL CC1=CC(=CC(=C1C2=CC=C(C=C2)C(C)(C)C)C)OC(CCC(F)(F)F)C3=CC=C(C=C3)C(=O)NCCC(=O)O D0ZW5D HIGHSTAT Phase 2 D1FR3T DRUG__ID D1FR3T D1FR3T DRUGTYPE Small molecular drug D1FR3T DRUGINCH 1S/C37H44O4P/c1-29-33(35(39)37(41-3)36(40-2)34(29)38)27-19-8-6-4-5-7-9-20-28-42(30-21-13-10-14-22-30,31-23-15-11-16-24-31)32-25-17-12-18-26-32/h10-18,21-26H,4-9,19-20,27-28H2,1-3H3/q+1 D1FR3T DRUGINKE OIIMUKXVVLRCAF-UHFFFAOYSA-N D1FR3T DRUGSMIL CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D1FR3T HIGHSTAT Phase 2 D2GV9Q DRUG__ID D2GV9Q D2GV9Q DRUGTYPE Small molecular drug D2GV9Q DRUGINCH 1S/C36H30O16/c37-20-6-1-16(11-24(20)41)13-27(34(45)46)50-29(44)10-5-18-3-9-23(40)33-30(18)31(32(52-33)19-4-8-22(39)26(43)15-19)36(49)51-28(35(47)48)14-17-2-7-21(38)25(42)12-17/h1-12,15,27-28,31-32,37-43H,13-14H2,(H,45,46)(H,47,48)/b10-5+/t27-,28-,31-,32+/m1/s1 D2GV9Q DRUGINKE SNKFFCBZYFGCQN-PDVBOLEISA-N D2GV9Q DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C3C(C(OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O D2GV9Q HIGHSTAT Phase 2 D39VXL DRUG__ID D39VXL D39VXL DRUGTYPE Small molecular drug D39VXL DRUGINCH 1S/C21H23F2N3O4.ClH/c1-30-20-17-13(19(27)14(21(28)29)10-26(17)12-4-5-12)7-15(22)18(20)25-6-2-3-11(9-25)16(23)8-24;/h7,10,12H,2-6,8-9,24H2,1H3,(H,28,29);1H/b16-11+; D39VXL DRUGINKE RDXCNSOGHLLWDV-YFMOEUEHSA-N D39VXL DRUGSMIL COC1=C2C(=CC(=C1N3CCCC(=C(CN)F)C3)F)C(=O)C(=CN2C4CC4)C(=O)O.Cl D39VXL HIGHSTAT Phase 2 D53QMP DRUG__ID D53QMP D53QMP DRUGTYPE Small molecular drug D53QMP DRUGINCH 1S/C15H24/c1-11-6-5-7-12(2)13-10-15(3,4)14(13)9-8-11/h6,13-14H,2,5,7-10H2,1,3-4H3/b11-6+/t13-,14-/m1/s1 D53QMP DRUGINKE NPNUFJAVOOONJE-GFUGXAQUSA-N D53QMP DRUGSMIL CC1=CCCC(=C)C2CC(C2CC1)(C)C D53QMP HIGHSTAT Phase 2 D5MF8Y DRUG__ID D5MF8Y D5MF8Y DRUGTYPE Small molecular drug D5MF8Y DRUGINCH 1S/Li D5MF8Y DRUGINKE WHXSMMKQMYFTQS-UHFFFAOYSA-N D5MF8Y DRUGSMIL [Li] D5MF8Y HIGHSTAT Phase 2 D6DT3X DRUG__ID D6DT3X D6DT3X DRUGTYPE Small molecular drug D6DT3X DRUGINCH 1S/C19H18ClF2N3O3/c20-14-15-8(17(26)9(18(27)28)5-25(15)12-4-10(12)21)3-11(22)16(14)24-6-13(23)19(7-24)1-2-19/h3,5,10,12-13H,1-2,4,6-7,23H2,(H,27,28)/t10-,12+,13+/m0/s1 D6DT3X DRUGINKE PNUZDKCDAWUEGK-CYZMBNFOSA-N D6DT3X DRUGSMIL C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F D6DT3X HIGHSTAT Phase 2 DB82TO DRUG__ID DB82TO DB82TO DRUGTYPE Small molecular drug DB82TO DRUGINCH 1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3 DB82TO DRUGINKE RUJBDQSFYCKFAA-UHFFFAOYSA-N DB82TO DRUGSMIL CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C DB82TO HIGHSTAT Phase 2 DEZ3D7 DRUG__ID DEZ3D7 DEZ3D7 DRUGTYPE Small molecular drug DEZ3D7 DRUGINCH 1S/C42H58O6/c1-29(18-14-19-31(3)22-23-37-38(6,7)26-35(47-33(5)43)27-40(37,10)46)16-12-13-17-30(2)20-15-21-32(4)36(45)28-42-39(8,9)24-34(44)25-41(42,11)48-42/h12-22,34-35,44,46H,24-28H2,1-11H3/b13-12+,18-14+,20-15+,29-16+,30-17+,31-19+,32-21+/t23?,34-,35-,40+,41+,42-/m0/s1 DEZ3D7 DRUGINKE SJWWTRQNNRNTPU-ABBNZJFMSA-N DEZ3D7 DRUGSMIL CC(=CC=CC=C(C)C=CC=C(C)C(=O)CC12C(CC(CC1(O2)C)O)(C)C)C=CC=C(C)C=C=C3C(CC(CC3(C)O)OC(=O)C)(C)C DEZ3D7 HIGHSTAT Phase 2 DO75VX DRUG__ID DO75VX DO75VX DRUGTYPE Small molecular drug DO75VX DRUGINCH 1S/C16H18N6O10S2/c17-14-18-7(6-33-14)9(20-32-16(1-2-16)13(25)26)11(23)19-10-8(5-21-3-4-31-15(21)27)22(12(10)24)34(28,29)30/h6,8,10H,1-5H2,(H2,17,18)(H,19,23)(H,25,26)(H,28,29,30)/b20-9+/t8-,10+/m1/s1 DO75VX DRUGINKE FWTGYTRQUBRVDW-UWGJAOEXSA-N DO75VX DRUGSMIL C1CC1(C(=O)O)ON=C(C2=CSC(=N2)N)C(=O)NC3C(N(C3=O)S(=O)(=O)O)CN4CCOC4=O DO75VX HIGHSTAT Phase 2 DS6V8H DRUG__ID DS6V8H DS6V8H DRUGTYPE Small molecule DS6V8H DRUGINCH InChI=1S/C30H30FN7O2/c1-30(2,3)15-19(16-32)29(39)37-13-7-8-20(17-37)38-28-25(27(33)34-18-35-28)26(36-38)23-12-11-22(14-24(23)31)40-21-9-5-4-6-10-21/h4-6,9-12,14-15,18,20H,7-8,13,17H2,1-3H3,(H2,33,34,35)/b19-15+/t20-/m1/s1 DS6V8H DRUGINKE KZMQPYCXSAGLTB-ZWUNQBBJSA-N DS6V8H DRUGSMIL CC(C)(C)C=C(C#N)C(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N DS6V8H HIGHSTAT Phase 2 DWM2Y5 DRUG__ID DWM2Y5 DWM2Y5 DRUGTYPE Small molecule DWM2Y5 DRUGINCH InChI=1S/C19H18N6O3/c1-25-17-14(8-5-9-20-17)28-11-13(19(25)27)21-18(26)16-22-15(23-24-16)10-12-6-3-2-4-7-12/h2-9,13H,10-11H2,1H3,(H,21,26)(H,22,23,24)/t13-/m0/s1 DWM2Y5 DRUGINKE XUZICJHIIJCKQQ-ZDUSSCGKSA-N DWM2Y5 DRUGSMIL CN1C(=O)C(COC2=C1N=CC=C2)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4 DWM2Y5 HIGHSTAT Phase 2 DX6RV3 DRUG__ID DX6RV3 DX6RV3 DRUGTYPE Small molecular drug DX6RV3 DRUGINCH 1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24) DX6RV3 DRUGINKE OQDQIFQRNZIEEJ-UHFFFAOYSA-N DX6RV3 DRUGSMIL C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2 DX6RV3 HIGHSTAT Phase 2 D00ULY DRUG__ID D00ULY D00ULY DRUGCOMP Bristol-Myers Squibb; KAI Pharmaceuticals D00ULY DRUGTYPE Combination drug D00ULY DRUGSMIL failed D00ULY HIGHSTAT Phase 2 D01KNY DRUG__ID D01KNY D01KNY DRUGINCH 1S/C9H10N4O2/c1-2-15-5-6-12-8-7(9(14)13-6)10-3-4-11-8/h3-4H,2,5H2,1H3,(H,11,12,13,14) D01KNY DRUGINKE SFWVULIFVPNTOF-UHFFFAOYSA-N D01KNY DRUGSMIL CCOCC1=NC2=NC=CN=C2C(=O)N1 D01KNY HIGHSTAT Phase 2 D01MPE DRUG__ID D01MPE D01MPE DRUGINCH 1S/C3H6N4/c1-2-5-3(4)7-6-2/h1H3,(H3,4,5,6,7) D01MPE DRUGINKE FJRZOOICEHBAED-UHFFFAOYSA-N D01MPE DRUGSMIL CC1=NC(=NN1)N D01MPE HIGHSTAT Phase 2 D01MZJ DRUG__ID D01MZJ D01MZJ DRUGCOMP Genta D01MZJ THERCLAS Anticancer Agents D01MZJ DRUGTYPE Antisense drug D01MZJ HIGHSTAT Phase 2 D01PBW DRUG__ID D01PBW D01PBW DRUGINCH 1S/C26H24F3N7O3S/c27-26(28,29)39-20-9-5-6-17(14-20)15-22(37)31-21-12-11-18(33-34-21)7-1-2-10-24-35-36-25(40-24)32-23(38)16-19-8-3-4-13-30-19/h3-6,8-9,11-14H,1-2,7,10,15-16H2,(H,31,34,37)(H,32,36,38) D01PBW DRUGINKE PRAAPINBUWJLGA-UHFFFAOYSA-N D01PBW DRUGSMIL C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F D01PBW HIGHSTAT Phase 2 D01SKR DRUG__ID D01SKR D01SKR DRUGCOMP GlaxoSmithKline D01SKR DRUGTYPE Combination drug D01SKR DRUGSMIL failed D01SKR HIGHSTAT Phase 2 D01VVL DRUG__ID D01VVL D01VVL DRUGCOMP Pfizer; Quark Pharmaceuticals D01VVL THERCLAS siRNA D01VVL DRUGTYPE siRNA drug D01VVL HIGHSTAT Phase 2 D01XFZ DRUG__ID D01XFZ D01XFZ DRUGINCH 1S/C22H16N4O/c27-22-19-18(14-15-8-3-1-4-9-15)24-25-20(19)17-12-7-13-23-21(17)26(22)16-10-5-2-6-11-16/h1-13H,14H2,(H,24,25) D01XFZ DRUGINKE NOZMPLJNURLIAQ-UHFFFAOYSA-N D01XFZ DRUGSMIL C1=CC=C(C=C1)CC2=C3C(=NN2)C4=C(N=CC=C4)N(C3=O)C5=CC=CC=C5 D01XFZ HIGHSTAT Phase 2 D02DYU DRUG__ID D02DYU D02DYU DRUGINCH 1S/C15H14ClF3O3/c1-14(2,3)9-6-11-7(5-10(9)16)4-8(13(20)21)12(22-11)15(17,18)19/h4-6,12H,1-3H3,(H,20,21)/t12-/m0/s1 D02DYU DRUGINKE QGCKNIAMHUUUDI-LBPRGKRZSA-N D02DYU DRUGSMIL CC(C)(C)C1=C(C=C2C=C(C(OC2=C1)C(F)(F)F)C(=O)O)Cl D02DYU HIGHSTAT Phase 2 D02JKY DRUG__ID D02JKY D02JKY DRUGINCH 1S/C18H18F3NO/c19-14-9-16(20)18(17(21)10-14)23-11-13-3-1-2-4-15(13)12-5-7-22-8-6-12/h1-4,9-10,12,22H,5-8,11H2 D02JKY DRUGINKE TZIALEBTHQWNAO-UHFFFAOYSA-N D02JKY DRUGSMIL C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F D02JKY HIGHSTAT Phase 2 D02RPP DRUG__ID D02RPP D02RPP DRUGCOMP Topigen Pharmaceuticals D02RPP THERCLAS Antisense D02RPP DRUGTYPE Antisense drug D02RPP HIGHSTAT Phase 2 D03RHZ DRUG__ID D03RHZ D03RHZ DRUGINCH 1S/C10H10ClN3O/c1-2-14-9(12-13-10(14)15)7-3-5-8(11)6-4-7/h3-6H,2H2,1H3,(H,13,15) D03RHZ DRUGINKE PXINDYJACXPZIN-UHFFFAOYSA-N D03RHZ DRUGSMIL CCN1C(=NNC1=O)C2=CC=C(C=C2)Cl D03RHZ HIGHSTAT Phase 2 D03TPI DRUG__ID D03TPI D03TPI DRUGCOMP Teva Pharmaceutical & Antisense Therapeutics D03TPI THERCLAS Antisense D03TPI DRUGTYPE Antisense drug D03TPI HIGHSTAT Phase 2 D03UKJ DRUG__ID D03UKJ D03UKJ DRUGCOMP GSK D03UKJ DRUGTYPE Combination drug D03UKJ DRUGSMIL failed D03UKJ HIGHSTAT Phase 2 D04FYZ DRUG__ID D04FYZ D04FYZ DRUGCOMP BTG D04FYZ DRUGTYPE Small molecular drug D04FYZ DRUGSMIL CC1=CC2=C(C=C1CN(CC#C)C3=CC(=C(C=C3)C(=O)NC(CCC4=NNN=N4)C(=O)O)F)C(=O)N=C(N2)C D04FYZ HIGHSTAT Phase 2 D04JIM DRUG__ID D04JIM D04JIM DRUGINCH 1S/C31H34ClN5O4/c32-26-12-10-25(11-13-26)29(24-7-2-1-3-8-24)36-18-16-35(17-19-36)20-21-41-28-14-9-23(22-27(28)30(33)38)6-4-5-15-37(40)31(34)39/h1-3,7-14,22,29,40H,5,15-21H2,(H2,33,38)(H2,34,39)/t29-/m1/s1 D04JIM DRUGINKE KHVLZYHEWIBDOU-GDLZYMKVSA-N D04JIM DRUGSMIL C1CN(CCN1CCOC2=C(C=C(C=C2)C#CCCN(C(=O)N)O)C(=O)N)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl D04JIM HIGHSTAT Phase 2 D04SUU DRUG__ID D04SUU D04SUU THERCLAS Antiviral Agents D04SUU DRUGTYPE Protein/peptide drug D04SUU DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CS)N D04SUU HIGHSTAT Phase 2 Trial D05XTQ DRUG__ID D05XTQ D05XTQ DRUGINCH 1S/C128H194N40O28S2/c1-71(2)55-85(105(177)155-83(121(193)194)41-25-49-147-127(139)140)157-109(181)89(59-75-33-15-9-16-34-75)159-111(183)91(161-107(179)87(57-73-29-11-7-12-30-73)151-99(171)65-149-113(185)95-61-77(169)67-167(95)117(189)93-43-27-53-163(93)115(187)81(39-23-47-145-125(135)136)153-103(175)79(129)37-21-45-143-123(131)132)69-197-97-63-101(173)165(119(97)191)51-19-5-6-20-52-166-102(174)64-98(120(166)192)198-70-92(112(184)160-90(60-76-35-17-10-18-36-76)110(182)158-86(56-72(3)4)106(178)156-84(122(195)196)42-26-50-148-128(141)142)162-108(180)88(58-74-31-13-8-14-32-74)152-100(172)66-150-114(186)96-62-78(170)68-168(96)118(190)94-44-28-54-164(94)116(188)82(40-24-48-146-126(137)138)154-104(176)80(130)38-22-46-144-124(133)134/h7-18,29-36,71-72,77-98,169-170H,5-6,19-28,37-70,129-130H2,1-4H3,(H,149,185)(H,150,186)(H,151,171)(H,152,172)(H,153,175)(H,154,176)(H,155,177)(H,156,178)(H,157,181)(H,158,182)(H,159,183)(H,160,184)(H,161,179)(H,162,180)(H,193,194)(H,195,196)(H4,131,132,143)(H4,133,134,144)(H4,135,136,145)(H4,137,138,146)(H4,139,140,147)(H4,141,142,148)/t77-,78-,79-,80-,81+,82+,83+,84+,85+,86+,87+,88+,89-,90-,91+,92+,93+,94+,95+,96+,97-,98+/m1/s1 D05XTQ DRUGINKE JKUYFMHGTOPVMR-WQVVEKGHSA-N D05XTQ DRUGSMIL CC(C)CC(C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CSC2CC(=O)N(C2=O)CCCCCCN3C(=O)CC(C3=O)SCC(C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)CNC(=O)C9CC(CN9C(=O)C1CCCN1C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N)O D05XTQ HIGHSTAT Phase 2 D06EHX DRUG__ID D06EHX D06EHX DRUGINCH 1S/C23H23N3O2/c27-22(20-7-4-12-25-21(20)19-8-13-24-14-9-19)26-15-10-23(28,11-16-26)17-18-5-2-1-3-6-18/h1-9,12-14,28H,10-11,15-17H2 D06EHX DRUGINKE XKUZMIUSBMCVPP-UHFFFAOYSA-N D06EHX DRUGSMIL C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4 D06EHX HIGHSTAT Phase 2 D06TQR DRUG__ID D06TQR D06TQR DRUGINCH 1S/C22H21FN4O3S/c1-4-27-13-24-21-18(12-25-26-22(21)27)14-6-9-19(23)17(10-14)16-8-7-15(11-20(16)30-3)31(28,29)5-2/h6-13H,4-5H2,1-3H3 D06TQR DRUGINKE PTTQXDBPTFOCMT-UHFFFAOYSA-N D06TQR DRUGSMIL CCN1C=NC2=C1N=NC=C2C3=CC(=C(C=C3)F)C4=C(C=C(C=C4)S(=O)(=O)CC)OC D06TQR HIGHSTAT Phase 2 D08EAI DRUG__ID D08EAI D08EAI DRUGCOMP Bar-Ilan University D08EAI DRUGTYPE Small molecular drug D08EAI DRUGSMIL CCCN1C2=NC(=C3C=C(NN3C)OC(=O)CNC4=CC(=C(C=C4)OC)OC)N=C2C(=O)N(C1=O)CCC D08EAI HIGHSTAT Phase 2 D08FMK DRUG__ID D08FMK D08FMK DRUGINCH 1S/C16H27N3O7S/c1-25-7-8-26-6-2-4-18-13(20)3-5-19-14(21)9-12(15(19)22)27-10-11(17)16(23)24/h11-12H,2-10,17H2,1H3,(H,18,20)(H,23,24)/t11-,12?/m0/s1 D08FMK DRUGINKE DLVAZTPQKCTPLB-PXYINDEMSA-N D08FMK DRUGSMIL COCCOCCCNC(=O)CCN1C(=O)CC(C1=O)SCC(C(=O)O)N D08FMK HIGHSTAT Phase 2 D08PMW DRUG__ID D08PMW D08PMW DRUGINCH 1S/C18H13ClF3NO3/c19-10-2-4-15(25)13(8-10)16-11(5-6-24)17(26)23-14-3-1-9(7-12(14)16)18(20,21)22/h1-4,7-8,24-25H,5-6H2,(H,23,26) D08PMW DRUGINKE QESHSZWKJULSAR-UHFFFAOYSA-N D08PMW DRUGSMIL C1=CC2=C(C=C1C(F)(F)F)C(=C(C(=O)N2)CCO)C3=C(C=CC(=C3)Cl)O D08PMW HIGHSTAT Phase 2 D08SPH DRUG__ID D08SPH D08SPH DRUGCOMP Alexion Pharmaceuticals Inc D08SPH THERCLAS Antiviral Agents D08SPH DRUGTYPE Monoclonal antibody D08SPH HIGHSTAT Phase 2 Trial D08VDM DRUG__ID D08VDM D08VDM DRUGCOMP Navidea Biopharmaceuticals D08VDM DRUGTYPE Small molecular drug D08VDM DRUGSMIL CNC1=NC(=C(CC1)C2=CC3=C(O2)C=CC(=C3)O)F D08VDM HIGHSTAT Phase 2 D09USN DRUG__ID D09USN D09USN DRUGCOMP ICOS D09USN DRUGTYPE Small molecular drug D09USN DRUGSMIL CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C.O.O.O D09USN HIGHSTAT Phase 2 D0A5HC DRUG__ID D0A5HC D0A5HC DRUGINCH 1S/C34H36N6O4/c1-22-10-12-24(13-11-22)40-31(19-29(39-40)34(2,3)4)38-33(42)36-27-14-15-28(26-9-7-6-8-25(26)27)44-20-23-16-17-35-30(18-23)37-32(41)21-43-5/h6-19H,20-21H2,1-5H3,(H,35,37,41)(H2,36,38,42) D0A5HC DRUGINKE RTDCVLCTBQDLBW-UHFFFAOYSA-N D0A5HC DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCC5=CC(=NC=C5)NC(=O)COC D0A5HC HIGHSTAT Phase 2 D0D9IQ DRUG__ID D0D9IQ D0D9IQ DRUGINCH 1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1 D0D9IQ DRUGINKE DENYZIUJOTUUNY-MRXNPFEDSA-N D0D9IQ DRUGSMIL CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F D0D9IQ HIGHSTAT Phase 2 D0F0UT DRUG__ID D0F0UT D0F0UT DRUGINCH 1S/C80H102ClN15O14/c1-46(2)37-63(72(102)89-62(18-11-12-35-84-47(3)4)80(110)96-36-14-19-70(96)79(109)85-48(5)71(82)101)90-74(104)66(40-53-23-30-60(31-24-53)86-49(6)98)92-76(106)67(41-54-25-32-61(33-26-54)87-50(7)99)94-78(108)69(45-97)95-77(107)68(43-56-15-13-34-83-44-56)93-75(105)65(39-52-21-28-59(81)29-22-52)91-73(103)64(88-51(8)100)42-55-20-27-57-16-9-10-17-58(57)38-55/h9-10,13,15-17,20-34,38,44,46-48,62-70,84,97H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,109)(H,86,98)(H,87,99)(H,88,100)(H,89,102)(H,90,104)(H,91,103)(H,92,106)(H,93,105)(H,94,108)(H,95,107)/t48-,62+,63+,64-,65-,66-,67+,68-,69+,70+/m1/s1 D0F0UT DRUGINKE ZWNUQDJANZGVFO-YHSALVGYSA-N D0F0UT DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0F0UT HIGHSTAT Phase 2 D0G0BL DRUG__ID D0G0BL D0G0BL DRUGINCH 1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1 D0G0BL DRUGINKE DWHXUGDWKAIASB-CQSZACIVSA-N D0G0BL DRUGSMIL CC(C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=C(C4=O)C=C(C=N5)OCCOC D0G0BL HIGHSTAT Phase 2 D0G4GA DRUG__ID D0G4GA D0G4GA DRUGINCH 1S/C20H21F2N3O/c21-16-9-15(10-17(22)11-16)20(26)24-19-14-3-6-25(7-4-14)18(19)8-13-2-1-5-23-12-13/h1-2,5,9-12,14,18-19H,3-4,6-8H2,(H,24,26)/t18-,19+/m0/s1 D0G4GA DRUGINKE UAKZGMMGIMKFMV-RBUKOAKNSA-N D0G4GA DRUGSMIL C1CN2CCC1C(C2CC3=CN=CC=C3)NC(=O)C4=CC(=CC(=C4)F)F D0G4GA HIGHSTAT Phase 2 D0G5BI DRUG__ID D0G5BI D0G5BI DRUGCOMP Abbott Laboratories D0G5BI DRUGTYPE Combination drug D0G5BI DRUGSMIL failed D0G5BI HIGHSTAT Phase 2 D0H5WM DRUG__ID D0H5WM D0H5WM DRUGINCH 1S/C29H29N3O7/c1-29(2,3)39-25(34)18-32(23-15-8-7-14-22(23)26(35)19-10-5-4-6-11-19)24(33)17-30-28(38)31-21-13-9-12-20(16-21)27(36)37/h4-16H,17-18H2,1-3H3,(H,36,37)(H2,30,31,38) D0H5WM DRUGINKE LROWLFSPDIVWSD-UHFFFAOYSA-N D0H5WM DRUGSMIL CC(C)(C)OC(=O)CN(C1=CC=CC=C1C(=O)C2=CC=CC=C2)C(=O)CNC(=O)NC3=CC=CC(=C3)C(=O)O D0H5WM HIGHSTAT Phase 2 D0HS4F DRUG__ID D0HS4F D0HS4F THERCLAS Antiviral Agents D0HS4F DRUGTYPE Protein/peptide drug D0HS4F DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0HS4F HIGHSTAT Phase 2 Trial D0I7MX DRUG__ID D0I7MX D0I7MX DRUGINCH 1S/C28H31N5O4S/c29-26(30)22-14-13-20(38-22)16-32-27(36)21-12-7-15-33(21)28(37)25(31-17-23(34)35)24(18-8-3-1-4-9-18)19-10-5-2-6-11-19/h1-6,8-11,13-14,21,24-25,31H,7,12,15-17H2,(H3,29,30)(H,32,36)(H,34,35)/t21-,25+/m0/s1 D0I7MX DRUGINKE BIHPYGVYKSQDLA-SQJMNOBHSA-N D0I7MX DRUGSMIL C1CC(N(C1)C(=O)C(C(C2=CC=CC=C2)C3=CC=CC=C3)NCC(=O)O)C(=O)NCC4=CC=C(S4)C(=N)N D0I7MX HIGHSTAT Phase 2 D0J1WO DRUG__ID D0J1WO D0J1WO DRUGCOMP ISIS D0J1WO THERCLAS Antisense D0J1WO DRUGTYPE Antisense drug D0J1WO HIGHSTAT Phase 2 D0J8PI DRUG__ID D0J8PI D0J8PI DRUGINCH 1S/C65H92N14O18S2/c1-39(81)51(36-80)72-64(96)53-38-99-98-37-52(73-60(92)48(28-41-10-4-3-5-11-41)68-54(84)32-76-20-22-77(33-55(85)86)24-26-79(35-57(89)90)27-25-78(23-21-76)34-56(87)88)63(95)70-49(29-42-15-17-44(83)18-16-42)61(93)71-50(30-43-31-67-46-13-7-6-12-45(43)46)62(94)69-47(14-8-9-19-66)59(91)75-58(40(2)82)65(97)74-53/h3-7,10-13,15-18,31,39-40,47-53,58,67,80-83H,8-9,14,19-30,32-38,66H2,1-2H3,(H,68,84)(H,69,94)(H,70,95)(H,71,93)(H,72,96)(H,73,92)(H,74,97)(H,75,91)(H,85,86)(H,87,88)(H,89,90)/t39-,40-,47+,48-,49+,50-,51-,52+,53+,58+/m1/s1 D0J8PI DRUGINKE RZHKDBRREKOZEW-AAXZNHDCSA-N D0J8PI DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CO)C(C)O)O D0J8PI HIGHSTAT Phase 2 D0JZ8X DRUG__ID D0JZ8X D0JZ8X DRUGCOMP Enzo Biochem D0JZ8X THERCLAS Antisense D0JZ8X DRUGTYPE Antisense drug D0JZ8X HIGHSTAT Phase 2 D0K4VW DRUG__ID D0K4VW D0K4VW DRUGCOMP Eleos D0K4VW DRUGTYPE Antisense drug D0K4VW DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OC)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)O D0K4VW HIGHSTAT Phase 2 D0K9UK DRUG__ID D0K9UK D0K9UK DRUGINCH 1S/C22H25NO5/c1-14-18(19(24)15(2)21(28-3)20(14)25)12-17(22(26)27)10-6-4-5-8-16-9-7-11-23-13-16/h7,9,11-13H,4-6,8,10H2,1-3H3,(H,26,27)/b17-12+ D0K9UK DRUGINKE WWYFKRSBSWBEGV-SFQUDFHCSA-N D0K9UK DRUGSMIL CC1=C(C(=O)C(=C(C1=O)OC)C)C=C(CCCCCC2=CN=CC=C2)C(=O)O D0K9UK HIGHSTAT Phase 2 D0L6LD DRUG__ID D0L6LD D0L6LD DRUGINCH 1S/C32H42N4O4S/c1-3-35(4-2)20-21-36(19-18-33-17-14-26-12-13-28(37)30-31(26)41-32(39)34-30)29(38)16-23-40-22-15-25-10-7-9-24-8-5-6-11-27(24)25/h5-13,33,37H,3-4,14-23H2,1-2H3,(H,34,39) D0L6LD DRUGINKE ZVULMJYRVAVKCP-UHFFFAOYSA-N D0L6LD DRUGSMIL CCN(CC)CCN(CCNCCC1=C2C(=C(C=C1)O)NC(=O)S2)C(=O)CCOCCC3=CC=CC4=CC=CC=C43 D0L6LD HIGHSTAT Phase 2 D0N6CS DRUG__ID D0N6CS D0N6CS DRUGINCH 1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17) D0N6CS DRUGINKE OUQVKRKGTAUJQA-UHFFFAOYSA-N D0N6CS DRUGSMIL C1=CC=C2C(=C1)C(=C(N=C2Cl)C(=O)NCC(=O)O)O D0N6CS HIGHSTAT Phase 2 D0Q4NX DRUG__ID D0Q4NX D0Q4NX DRUGCOMP Gradalis Carrollton, TX D0Q4NX THERCLAS Anticancer Agents D0Q4NX DRUGTYPE Vaccine D0Q4NX HIGHSTAT Phase 2 D0Q9IY DRUG__ID D0Q9IY D0Q9IY DRUGINCH 1S/C24H30N6O.ClH/c31-20(27-11-3-4-12-27)17-30-19-10-2-1-9-18(19)21-22(28-13-5-6-14-28)25-24(26-23(21)30)29-15-7-8-16-29;/h1-2,9-10H,3-8,11-17H2;1H D0Q9IY DRUGINKE RLFYAIUQWFELJD-UHFFFAOYSA-N D0Q9IY DRUGSMIL C1CCN(C1)C2=NC(=NC3=C2C4=CC=CC=C4N3CC(=O)N5CCCC5)N6CCCC6.Cl D0Q9IY HIGHSTAT Phase 2 D0R4NR DRUG__ID D0R4NR D0R4NR DRUGCOMP Zalicus Cambridge, MA D0R4NR DRUGTYPE Combination drug D0R4NR DRUGSMIL failed D0R4NR HIGHSTAT Phase 2 D0RN3S DRUG__ID D0RN3S D0RN3S DRUGINCH 1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33) D0RN3S DRUGINKE YIDDLAAKOYYGJG-UHFFFAOYSA-N D0RN3S DRUGSMIL CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F D0RN3S HIGHSTAT Phase 2 D0S5WP DRUG__ID D0S5WP D0S5WP DRUGCOMP GlaxoSmithKline D0S5WP DRUGTYPE Combination drug D0S5WP DRUGSMIL failed D0S5WP HIGHSTAT Phase 2 D0UD4Y DRUG__ID D0UD4Y D0UD4Y DRUGINCH 1S/C19H20N4O2/c1-2-9-25-15-6-3-13(4-7-15)18-11-20-19(24)23(18)14-5-8-16-17(10-14)22-12-21-16/h3-8,10,12,18H,2,9,11H2,1H3,(H,20,24)(H,21,22)/t18-/m1/s1 D0UD4Y DRUGINKE XHIKZWOEFZENIX-GOSISDBHSA-N D0UD4Y DRUGSMIL CCCOC1=CC=C(C=C1)C2CNC(=O)N2C3=CC4=C(C=C3)N=CN4 D0UD4Y HIGHSTAT Phase 2 D0X8QO DRUG__ID D0X8QO D0X8QO DRUGINCH 1S/C82H127N27O20S2/c1-6-9-11-15-25-62(112)98-59-41-130-131-42-60(76(126)104-56(34-47-26-28-49(111)29-27-47)79(129)109-39-57(66(83)116)105-77(127)61(109)24-18-32-93-82(88)89)107-74(124)58(40-110)106-78(128)65(44(4)8-3)108-70(120)52(23-17-31-92-81(86)87)100-73(123)55(36-64(114)115)103-69(119)51(21-10-7-2)99-68(118)50(22-16-30-91-80(84)85)97-63(113)38-94-67(117)45(5)96-71(121)53(33-46-19-13-12-14-20-46)101-72(122)54(102-75(59)125)35-48-37-90-43-95-48/h12-14,19-20,26-29,37,43-45,50-61,65,110-111H,6-11,15-18,21-25,30-36,38-42H2,1-5H3,(H2,83,116)(H,90,95)(H,94,117)(H,96,121)(H,97,113)(H,98,112)(H,99,118)(H,100,123)(H,101,122)(H,102,125)(H,103,119)(H,104,126)(H,105,127)(H,106,128)(H,107,124)(H,108,120)(H,114,115)(H4,84,85,91)(H4,86,87,92)(H4,88,89,93)/t44-,45+,50-,51+,52-,53-,54-,55-,56-,57+,58-,59+,60-,61-,65-/m0/s1 D0X8QO DRUGINKE HSHVZRILAMZYHY-WXSGKXQHSA-N D0X8QO DRUGSMIL CCCCCCC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CNC=N2)CC3=CC=CC=C3)C)CCCNC(=N)N)CCCC)CC(=O)O)CCCNC(=N)N)C(C)CC)CO)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N5CC(NC(=O)C5CCCNC(=N)N)C(=O)N D0X8QO HIGHSTAT Phase 2 D0Z4YF DRUG__ID D0Z4YF D0Z4YF DRUGCOMP CanSino Biologicals D0Z4YF THERCLAS Antiviral Agents D0Z4YF DRUGTYPE Vaccine D0Z4YF HIGHSTAT Phase 2 Trial D0Z6KF DRUG__ID D0Z6KF D0Z6KF DRUGINCH 1S/C21H29N3O6S/c1-16(17-6-4-9-19(14-17)30-18-7-2-3-8-18)23-31(27,28)13-5-12-29-15-24-11-10-20(25)22-21(24)26/h4,6,9-11,14,16,18,23H,2-3,5,7-8,12-13,15H2,1H3,(H,22,25,26)/t16-/m1/s1 D0Z6KF DRUGINKE AMCGLRWKUQPNKD-MRXNPFEDSA-N D0Z6KF DRUGSMIL CC(C1=CC(=CC=C1)OC2CCCC2)NS(=O)(=O)CCCOCN3C=CC(=O)NC3=O D0Z6KF HIGHSTAT Phase 2 D00CQI DRUG__ID D00CQI D00CQI DRUGCOMP Biotest D00CQI DRUGTYPE Monoclonal antibody D00CQI HIGHSTAT Phase 2 D00DSV DRUG__ID D00DSV D00DSV DRUGCOMP Vaccinoma Inc D00DSV DRUGTYPE Vaccine D00DSV HIGHSTAT Phase 2 D00KQN DRUG__ID D00KQN D00KQN DRUGCOMP Aerovance D00KQN DRUGTYPE Monoclonal antibody D00KQN HIGHSTAT Phase 2 D00LGA DRUG__ID D00LGA D00LGA DRUGCOMP ZymoGenetics Inc D00LGA DRUGTYPE Antibody D00LGA HIGHSTAT Phase 2 D00MBR DRUG__ID D00MBR D00MBR DRUGCOMP Medarex D00MBR DRUGTYPE Antibody D00MBR HIGHSTAT Phase 2 D00QXB DRUG__ID D00QXB D00QXB DRUGCOMP Charity Medical School of the Humboldt University of Berlin D00QXB DRUGTYPE Vaccine D00QXB HIGHSTAT Phase 2 D00UKN DRUG__ID D00UKN D00UKN THERCLAS Antiviral Agents D00UKN DRUGTYPE Cell therapy D00UKN HIGHSTAT Phase 2 Trial D00VUG DRUG__ID D00VUG D00VUG DRUGCOMP Fujifilm Pharmaceuticals D00VUG DRUGTYPE Antibody D00VUG HIGHSTAT Phase 2 D00WME DRUG__ID D00WME D00WME DRUGCOMP Amgen; Takeda D00WME DRUGTYPE Monoclonal antibody D00WME HIGHSTAT Phase 2 D00YWL DRUG__ID D00YWL D00YWL DRUGCOMP Medarex Inc D00YWL DRUGTYPE Antibody D00YWL HIGHSTAT Phase 2 D01AAH DRUG__ID D01AAH D01AAH DRUGCOMP The First Affiliated Hospital of Soochow University D01AAH DRUGTYPE CAR T Cell Therapy D01AAH HIGHSTAT Phase 2 D01AIN DRUG__ID D01AIN D01AIN DRUGCOMP Wyeth; pfizer D01AIN DRUGTYPE Antibody D01AIN HIGHSTAT Phase 2 D01DXI DRUG__ID D01DXI D01DXI DRUGCOMP Pfizer D01DXI DRUGTYPE Vaccine D01DXI HIGHSTAT Phase 2 D01EYI DRUG__ID D01EYI D01EYI THERCLAS Antiviral Agents D01EYI DRUGTYPE Cell therapy D01EYI HIGHSTAT Phase 2 Trial D01GOY DRUG__ID D01GOY D01GOY DRUGCOMP AiVita Biomedical D01GOY DRUGTYPE Vaccine D01GOY HIGHSTAT Phase 2 D01HQJ DRUG__ID D01HQJ D01HQJ THERCLAS Antiviral Agents D01HQJ DRUGTYPE Cell therapy D01HQJ HIGHSTAT Phase 2 Trial D01IJJ DRUG__ID D01IJJ D01IJJ DRUGCOMP Nisco International Inc D01IJJ DRUGTYPE Oncolytic virus therapy D01IJJ HIGHSTAT Phase 2 D01IKM DRUG__ID D01IKM D01IKM THERCLAS Antiviral Agents D01IKM DRUGTYPE Cell therapy D01IKM HIGHSTAT Phase 2 Trial D01KWK DRUG__ID D01KWK D01KWK THERCLAS Antiviral Agents D01KWK DRUGTYPE Combination drug D01KWK HIGHSTAT Phase 2 Trial D01LFC DRUG__ID D01LFC D01LFC DRUGCOMP National Cancer Institute D01LFC DRUGTYPE Vaccine D01LFC HIGHSTAT Phase 2 D01LSY DRUG__ID D01LSY D01LSY THERCLAS Antiviral Agents D01LSY DRUGTYPE Combination drug D01LSY HIGHSTAT Phase 2 Trial D01OYX DRUG__ID D01OYX D01OYX THERCLAS Antiviral Agents D01OYX DRUGTYPE Combination drug D01OYX HIGHSTAT Phase 2 Trial D01PQK DRUG__ID D01PQK D01PQK THERCLAS Antiviral Agents D01PQK DRUGTYPE Combination drug D01PQK HIGHSTAT Phase 2 Trial D01QLP DRUG__ID D01QLP D01QLP DRUGCOMP Oncomed pharmaceuticals D01QLP DRUGTYPE Monoclonal antibody D01QLP HIGHSTAT Phase 2 D01UFK DRUG__ID D01UFK D01UFK DRUGCOMP Apitope Technology (Bristol) Ltd D01UFK DRUGTYPE Vaccine D01UFK HIGHSTAT Phase 2 D01UNS DRUG__ID D01UNS D01UNS THERCLAS Antiviral Agents D01UNS DRUGTYPE Combination drug D01UNS HIGHSTAT Phase 2 Trial D01VDI DRUG__ID D01VDI D01VDI DRUGCOMP AVI BioPharma D01VDI DRUGTYPE Antisense drug D01VDI HIGHSTAT Phase 2 D01WQQ DRUG__ID D01WQQ D01WQQ DRUGCOMP AbbVie D01WQQ DRUGTYPE Monoclonal antibody D01WQQ HIGHSTAT Phase 2 D01YGD DRUG__ID D01YGD D01YGD DRUGCOMP Russian National Cancer Research Center D01YGD DRUGTYPE Antibody D01YGD HIGHSTAT Phase 2 D01ZLK DRUG__ID D01ZLK D01ZLK DRUGCOMP Apexigen San Carlos, CA D01ZLK DRUGTYPE Antibody D01ZLK HIGHSTAT Phase 2 D02CKH DRUG__ID D02CKH D02CKH DRUGCOMP Quark Pharm; Pfizer D02CKH DRUGTYPE siRNA drug D02CKH HIGHSTAT Phase 2 D02DJG DRUG__ID D02DJG D02DJG DRUGCOMP Eli lilly D02DJG DRUGTYPE Antibody D02DJG HIGHSTAT Phase 2 D02EHE DRUG__ID D02EHE D02EHE DRUGCOMP Boehringer Ingelheim D02EHE DRUGTYPE Small molecular drug D02EHE HIGHSTAT Phase 2 D02EOH DRUG__ID D02EOH D02EOH DRUGCOMP Synergene Therapeutics Inc D02EOH DRUGTYPE Gene therapy D02EOH HIGHSTAT Phase 2 D02HKC DRUG__ID D02HKC D02HKC DRUGCOMP University of Pittsburgh D02HKC DRUGTYPE Vaccine D02HKC HIGHSTAT Phase 2 D02MLO DRUG__ID D02MLO D02MLO DRUGCOMP University of Antwerp; Argos Therapeutics Durham; NC Geron; Dendreon Seattle; WA; ImmunoCellular Therapeutics D02MLO DRUGTYPE Vaccine D02MLO HIGHSTAT Phase 2 D02ONR DRUG__ID D02ONR D02ONR DRUGCOMP Roche D02ONR DRUGTYPE Antibody D02ONR HIGHSTAT Phase 2 D02RXJ DRUG__ID D02RXJ D02RXJ THERCLAS Antiviral Agents D02RXJ DRUGTYPE Combination drug D02RXJ HIGHSTAT Phase 2 Trial D02WSB DRUG__ID D02WSB D02WSB DRUGCOMP Aduro BioTech D02WSB DRUGTYPE Vaccine D02WSB HIGHSTAT Phase 2 D02XFH DRUG__ID D02XFH D02XFH DRUGCOMP Lilly D02XFH DRUGTYPE Monoclonal antibody D02XFH HIGHSTAT Phase 2 D02YIP DRUG__ID D02YIP D02YIP DRUGCOMP Abgenomics international D02YIP DRUGTYPE Antibody D02YIP HIGHSTAT Phase 2 D03BBU DRUG__ID D03BBU D03BBU DRUGCOMP Novartis Pharmaceuticals D03BBU DRUGTYPE Monoclonal antibody D03BBU HIGHSTAT Phase 2 D03DAY DRUG__ID D03DAY D03DAY DRUGCOMP Immunotech Laboratories D03DAY DRUGTYPE Vaccine D03DAY HIGHSTAT Phase 2 D03EHN DRUG__ID D03EHN D03EHN THERCLAS Antiviral Agents D03EHN DRUGTYPE Monoclonal antibody D03EHN HIGHSTAT Phase 2 Trial D03ING DRUG__ID D03ING D03ING DRUGCOMP Genentech D03ING DRUGTYPE Monoclonal antibody D03ING HIGHSTAT Phase 2 D03LTO DRUG__ID D03LTO D03LTO DRUGCOMP Daiichi Sankyo D03LTO DRUGTYPE Monoclonal antibody D03LTO HIGHSTAT Phase 2 D03PSP DRUG__ID D03PSP D03PSP DRUGCOMP Aridis Pharmaceuticals D03PSP DRUGTYPE Monoclonal antibody D03PSP HIGHSTAT Phase 2 D03QMY DRUG__ID D03QMY D03QMY DRUGCOMP Biotech Synergy D03QMY DRUGTYPE Vaccine D03QMY HIGHSTAT Phase 2 D03RIX DRUG__ID D03RIX D03RIX THERCLAS Antiviral Agents D03RIX DRUGTYPE Monoclonal antibody D03RIX HIGHSTAT Phase 2 Trial D03SXS DRUG__ID D03SXS D03SXS DRUGCOMP Eli lilly D03SXS DRUGTYPE Antibody D03SXS HIGHSTAT Phase 2 D03UBW DRUG__ID D03UBW D03UBW DRUGCOMP AVEO Pharmaceuticals D03UBW DRUGTYPE Monoclonal antibody D03UBW HIGHSTAT Phase 2 D03UEO DRUG__ID D03UEO D03UEO THERCLAS Antiviral Agents D03UEO DRUGTYPE Monoclonal antibody D03UEO HIGHSTAT Phase 2 Trial D03VNB DRUG__ID D03VNB D03VNB DRUGCOMP NovImmune SA D03VNB DRUGTYPE Antibody D03VNB HIGHSTAT Phase 2 D03YIU DRUG__ID D03YIU D03YIU THERCLAS Antiviral Agents D03YIU DRUGTYPE Combination drug D03YIU HIGHSTAT Phase 2 Trial D04BOT DRUG__ID D04BOT D04BOT DRUGCOMP Merck D04BOT DRUGTYPE Monoclonal antibody D04BOT HIGHSTAT Phase 2 D04CWS DRUG__ID D04CWS D04CWS DRUGCOMP Genentech D04CWS DRUGTYPE Antibody D04CWS HIGHSTAT Phase 2 D04FFM DRUG__ID D04FFM D04FFM DRUGCOMP Advaxis D04FFM DRUGTYPE Vaccine D04FFM HIGHSTAT Phase 2 D04GWO DRUG__ID D04GWO D04GWO THERCLAS Antiviral Agents D04GWO DRUGTYPE Monoclonal antibody D04GWO HIGHSTAT Phase 2 Trial D04HOT DRUG__ID D04HOT D04HOT DRUGCOMP Novartis AG D04HOT DRUGTYPE Antibody D04HOT HIGHSTAT Phase 2 D04JFG DRUG__ID D04JFG D04JFG THERCLAS Antiviral Agents D04JFG DRUGTYPE Monoclonal antibody D04JFG HIGHSTAT Phase 2 Trial D04KTI DRUG__ID D04KTI D04KTI THERCLAS Antiviral Agents D04KTI DRUGTYPE Monoclonal antibody D04KTI HIGHSTAT Phase 2 Trial D04MGW DRUG__ID D04MGW D04MGW DRUGCOMP Boehringer Ingelheim Pharmaceuticals D04MGW DRUGTYPE Antibody D04MGW HIGHSTAT Phase 2 D04PUI DRUG__ID D04PUI D04PUI DRUGCOMP Biotest Pharmaceuticals; ImmunoGen D04PUI DRUGTYPE Antibody D04PUI HIGHSTAT Phase 2 D04REV DRUG__ID D04REV D04REV DRUGCOMP Medarex Inc D04REV DRUGTYPE Vaccine D04REV HIGHSTAT Phase 2 D04RMM DRUG__ID D04RMM D04RMM DRUGCOMP Bristol-myers squibb; alder biopharmaceuticals D04RMM DRUGTYPE Monoclonal antibody D04RMM HIGHSTAT Phase 2 D04VOE DRUG__ID D04VOE D04VOE DRUGCOMP Antisoma D04VOE DRUGTYPE Antibody D04VOE HIGHSTAT Phase 2 D04WIF DRUG__ID D04WIF D04WIF DRUGCOMP ISIS Pharm D04WIF DRUGTYPE Antisense drug D04WIF HIGHSTAT Phase 2 D04WQJ DRUG__ID D04WQJ D04WQJ DRUGCOMP Amgen; astrazeneca D04WQJ DRUGTYPE Antibody D04WQJ HIGHSTAT Phase 2 D04XYL DRUG__ID D04XYL D04XYL DRUGTYPE Small molecular drug D04XYL DRUGSMIL C1CC(OC1CO)N2C=NC3=C2NC=NC3=O D04XYL HIGHSTAT Phase 2 D04ZHJ DRUG__ID D04ZHJ D04ZHJ DRUGCOMP Neovacs SA D04ZHJ DRUGTYPE Vaccine D04ZHJ HIGHSTAT Phase 2 D05BPD DRUG__ID D05BPD D05BPD DRUGCOMP EMD Serono; Oncothyreon D05BPD DRUGTYPE Vaccine D05BPD HIGHSTAT Phase 2 D05CFH DRUG__ID D05CFH D05CFH DRUGCOMP Allergan D05CFH THERCLAS Analgesics D05CFH HIGHSTAT Phase 2 D05CJU DRUG__ID D05CJU D05CJU DRUGCOMP ESBATech AG D05CJU DRUGTYPE Antibody D05CJU HIGHSTAT Phase 2 D05CMY DRUG__ID D05CMY D05CMY THERCLAS Antiviral Agents D05CMY DRUGTYPE Protein/peptide drug D05CMY HIGHSTAT Phase 2 Trial D05DFV DRUG__ID D05DFV D05DFV DRUGCOMP Leiden University Medical Center D05DFV DRUGTYPE Antisense drug D05DFV HIGHSTAT Phase 2 D05EPV DRUG__ID D05EPV D05EPV DRUGCOMP Pfizer New York, NY D05EPV DRUGTYPE Monoclonal antibody D05EPV HIGHSTAT Phase 2 D05FGN DRUG__ID D05FGN D05FGN THERCLAS Antiviral Agents D05FGN DRUGTYPE Protein/peptide drug D05FGN HIGHSTAT Phase 2 Trial D05FPZ DRUG__ID D05FPZ D05FPZ DRUGCOMP EMD SeronoRockland, MA D05FPZ DRUGTYPE Antibody D05FPZ HIGHSTAT Phase 2 D05GBH DRUG__ID D05GBH D05GBH DRUGCOMP GlaxoSmithKline plc D05GBH DRUGTYPE Vaccine D05GBH HIGHSTAT Phase 2 D05GXC DRUG__ID D05GXC D05GXC THERCLAS Antiviral Agents D05GXC DRUGTYPE Protein/peptide drug D05GXC HIGHSTAT Phase 2 Trial D05HKG DRUG__ID D05HKG D05HKG THERCLAS Antiviral Agents D05HKG DRUGTYPE Protein/peptide drug D05HKG HIGHSTAT Phase 2 Trial D05HZJ DRUG__ID D05HZJ D05HZJ DRUGCOMP Japanese National Cancer Center D05HZJ DRUGTYPE Vaccine D05HZJ HIGHSTAT Phase 2 D05IYA DRUG__ID D05IYA D05IYA DRUGCOMP AstraZeneca D05IYA DRUGTYPE Antibody D05IYA HIGHSTAT Phase 2 D05KKP DRUG__ID D05KKP D05KKP DRUGCOMP Pfizer D05KKP DRUGTYPE Antibody D05KKP HIGHSTAT Phase 2 D05MGQ DRUG__ID D05MGQ D05MGQ DRUGCOMP Medarex D05MGQ DRUGTYPE Antibody D05MGQ HIGHSTAT Phase 2 D05NIR DRUG__ID D05NIR D05NIR DRUGCOMP Ablynx NV D05NIR DRUGTYPE Antibody D05NIR HIGHSTAT Phase 2 D05RRU DRUG__ID D05RRU D05RRU DRUGCOMP Baylor College of Medicine D05RRU DRUGTYPE Vaccine D05RRU HIGHSTAT Phase 2 D05YFL DRUG__ID D05YFL D05YFL DRUGCOMP Cell-Medicine Inc D05YFL DRUGTYPE Vaccine D05YFL HIGHSTAT Phase 2 D06BKH DRUG__ID D06BKH D06BKH DRUGCOMP Galectin therapeutics D06BKH DRUGTYPE Protein D06BKH HIGHSTAT Phase 2 D06ECI DRUG__ID D06ECI D06ECI DRUGCOMP Transderm D06ECI DRUGTYPE siRNA drug D06ECI HIGHSTAT Phase 2 D06EVZ DRUG__ID D06EVZ D06EVZ DRUGCOMP Zhujiang Hospital D06EVZ DRUGTYPE CAR T Cell Therapy D06EVZ HIGHSTAT Phase 2 D06GUG DRUG__ID D06GUG D06GUG DRUGCOMP BioTie Therapies Corp D06GUG DRUGTYPE Antibody D06GUG HIGHSTAT Phase 2 D06KCF DRUG__ID D06KCF D06KCF DRUGCOMP MedImmune D06KCF DRUGTYPE Antibody D06KCF HIGHSTAT Phase 2 D06KIJ DRUG__ID D06KIJ D06KIJ DRUGCOMP Agenus Inc; Antigenics D06KIJ DRUGTYPE Vaccine D06KIJ HIGHSTAT Phase 2 D06KZL DRUG__ID D06KZL D06KZL DRUGCOMP Pfizer D06KZL THERCLAS Anticancer Agents D06KZL HIGHSTAT Phase 2 D06NAG DRUG__ID D06NAG D06NAG DRUGCOMP Bristol-Myers Squibb D06NAG DRUGTYPE Antibody D06NAG HIGHSTAT Phase 2 D06OFZ DRUG__ID D06OFZ D06OFZ DRUGCOMP Infectious Disease Research Institute D06OFZ DRUGTYPE Vaccine D06OFZ HIGHSTAT Phase 2 D06PVA DRUG__ID D06PVA D06PVA DRUGCOMP Abbott Laboratories D06PVA DRUGTYPE Antibody D06PVA HIGHSTAT Phase 2 D06TKR DRUG__ID D06TKR D06TKR DRUGCOMP University of Pennsylvania D06TKR DRUGTYPE CAR T Cell Therapy D06TKR HIGHSTAT Phase 2 D06WUK DRUG__ID D06WUK D06WUK DRUGCOMP Janssen biotech D06WUK DRUGTYPE Antibody D06WUK HIGHSTAT Phase 2 D06XBN DRUG__ID D06XBN D06XBN DRUGCOMP Aptamera Inc D06XBN DRUGTYPE Aptamer D06XBN HIGHSTAT Phase 2 D06XDS DRUG__ID D06XDS D06XDS DRUGCOMP GlaxoSmithKline D06XDS DRUGTYPE Antibody D06XDS HIGHSTAT Phase 2 D06XIT DRUG__ID D06XIT D06XIT DRUGCOMP Abbvie D06XIT DRUGTYPE Antibody D06XIT HIGHSTAT Phase 2 D07ACL DRUG__ID D07ACL D07ACL DRUGCOMP ProNAi Therapeutics Inc D07ACL DRUGTYPE Antisense drug D07ACL HIGHSTAT Phase 2 D07CQW DRUG__ID D07CQW D07CQW DRUGCOMP Actinium pharmaceuticals D07CQW DRUGTYPE Monoclonal antibody D07CQW HIGHSTAT Phase 2 D07CUR DRUG__ID D07CUR D07CUR DRUGCOMP bluebird bioCambridge, MACelgeneSummit, NJ D07CUR DRUGTYPE CAR T Cell Therapy D07CUR HIGHSTAT Phase 2 D07FGK DRUG__ID D07FGK D07FGK DRUGCOMP ImmunoGen Inc D07FGK DRUGTYPE Antibody D07FGK HIGHSTAT Phase 2 D07GMF DRUG__ID D07GMF D07GMF DRUGCOMP University of Oxford D07GMF DRUGTYPE Vaccine D07GMF HIGHSTAT Phase 2 D07KAQ DRUG__ID D07KAQ D07KAQ DRUGCOMP Philogen SpA D07KAQ DRUGTYPE Antibody D07KAQ HIGHSTAT Phase 2 D07KTA DRUG__ID D07KTA D07KTA DRUGCOMP Pfizer Inc D07KTA DRUGTYPE Antibody D07KTA HIGHSTAT Phase 2 D07NBA DRUG__ID D07NBA D07NBA DRUGCOMP Takeda D07NBA DRUGTYPE Monoclonal antibody D07NBA HIGHSTAT Phase 2 D07PRH DRUG__ID D07PRH D07PRH DRUGCOMP Centocor Ortho Biotech Inc D07PRH DRUGTYPE Antibody D07PRH HIGHSTAT Phase 2 D07SKJ DRUG__ID D07SKJ D07SKJ DRUGCOMP Eli lilly D07SKJ DRUGTYPE Antibody D07SKJ HIGHSTAT Phase 2 D07SYZ DRUG__ID D07SYZ D07SYZ DRUGCOMP Rexahn D07SYZ THERCLAS Anticancer Agents D07SYZ HIGHSTAT Phase 2 D07TFL DRUG__ID D07TFL D07TFL DRUGCOMP Lilly D07TFL DRUGTYPE Monoclonal antibody D07TFL HIGHSTAT Phase 2 D08DWM DRUG__ID D08DWM D08DWM DRUGCOMP National Cancer Institute D08DWM DRUGTYPE Vaccine D08DWM HIGHSTAT Phase 2 D08ECW DRUG__ID D08ECW D08ECW DRUGCOMP The Center of Molecular Immunology D08ECW DRUGTYPE Monoclonal antibody D08ECW HIGHSTAT Phase 2 D08GVP DRUG__ID D08GVP D08GVP DRUGCOMP Horizon Therapeutics D08GVP DRUGTYPE Monoclonal antibody D08GVP HIGHSTAT Phase 2 D08HQI DRUG__ID D08HQI D08HQI DRUGCOMP ISIS Pharm D08HQI DRUGTYPE Antisense drug D08HQI HIGHSTAT Phase 2 D08JHZ DRUG__ID D08JHZ D08JHZ THERCLAS Antiviral Agents D08JHZ DRUGTYPE Small molecular drug D08JHZ HIGHSTAT Phase 2 Trial D08PKG DRUG__ID D08PKG D08PKG DRUGCOMP Eli Lilly D08PKG DRUGTYPE Antibody D08PKG HIGHSTAT Phase 2 D08QYS DRUG__ID D08QYS D08QYS DRUGCOMP Agenus D08QYS DRUGTYPE Vaccine D08QYS HIGHSTAT Phase 2 D08SIC DRUG__ID D08SIC D08SIC DRUGCOMP Birdie Biopharmaceuticals; Seven and Eight Biopharmaceuticals D08SIC DRUGTYPE Antibody D08SIC HIGHSTAT Phase 2 D08UGS DRUG__ID D08UGS D08UGS DRUGCOMP Janssen Research & Development Raritan, NJ D08UGS DRUGTYPE Monoclonal antibody D08UGS HIGHSTAT Phase 2 D08XPN DRUG__ID D08XPN D08XPN DRUGCOMP CeMines D08XPN DRUGTYPE Antibody D08XPN HIGHSTAT Phase 2 D09BWG DRUG__ID D09BWG D09BWG DRUGCOMP The First Affiliated Hospital of Soochow University D09BWG DRUGTYPE CAR T Cell Therapy D09BWG HIGHSTAT Phase 2 D09GIA DRUG__ID D09GIA D09GIA DRUGCOMP Sanofi D09GIA DRUGTYPE Antibody D09GIA HIGHSTAT Phase 2 D09LOZ DRUG__ID D09LOZ D09LOZ DRUGCOMP PharmAbcine D09LOZ DRUGTYPE Antibody D09LOZ HIGHSTAT Phase 2 D09MRL DRUG__ID D09MRL D09MRL DRUGCOMP CureTech D09MRL DRUGTYPE Monoclonal antibody D09MRL HIGHSTAT Phase 2 D09NCU DRUG__ID D09NCU D09NCU DRUGCOMP Gilead Sciences D09NCU DRUGTYPE Antibody D09NCU HIGHSTAT Phase 2 D09NFW DRUG__ID D09NFW D09NFW DRUGCOMP University of Bonn D09NFW DRUGTYPE Vaccine D09NFW HIGHSTAT Phase 2 D09RMZ DRUG__ID D09RMZ D09RMZ DRUGCOMP Nuron biotech D09RMZ DRUGTYPE Vaccine D09RMZ HIGHSTAT Phase 2 D09SHX DRUG__ID D09SHX D09SHX DRUGCOMP Thomas Jefferson University D09SHX DRUGTYPE Vaccine D09SHX HIGHSTAT Phase 2 D09SQM DRUG__ID D09SQM D09SQM DRUGCOMP MorphoSys; Novartis Pharmaceuticals D09SQM DRUGTYPE Antibody D09SQM HIGHSTAT Phase 2 D09UAI DRUG__ID D09UAI D09UAI DRUGCOMP ThromboGenics D09UAI DRUGTYPE Antibody D09UAI HIGHSTAT Phase 2 D09WCN DRUG__ID D09WCN D09WCN DRUGCOMP Janssen Biotech D09WCN DRUGTYPE Monoclonal antibody D09WCN HIGHSTAT Phase 2 D09WKM DRUG__ID D09WKM D09WKM DRUGCOMP Boehringer Ingelheim Pharmaceuticals D09WKM DRUGTYPE Antibody D09WKM HIGHSTAT Phase 2 D0A3JJ DRUG__ID D0A3JJ D0A3JJ DRUGCOMP IBC Pharmaceuticals Inc D0A3JJ DRUGTYPE Antibody D0A3JJ HIGHSTAT Phase 2 D0A5EN DRUG__ID D0A5EN D0A5EN DRUGCOMP Genmab; Amgen D0A5EN DRUGTYPE Antibody D0A5EN HIGHSTAT Phase 2 D0A7NB DRUG__ID D0A7NB D0A7NB DRUGCOMP Medlmmune; AstraZeneca D0A7NB DRUGTYPE Antibody D0A7NB HIGHSTAT Phase 2 D0A7NZ DRUG__ID D0A7NZ D0A7NZ DRUGCOMP Janssen research & development D0A7NZ DRUGTYPE Antibody D0A7NZ HIGHSTAT Phase 2 D0A9ML DRUG__ID D0A9ML D0A9ML DRUGCOMP Selexys Pharmaceuticals D0A9ML DRUGTYPE Antibody D0A9ML HIGHSTAT Phase 2 D0AD6P DRUG__ID D0AD6P D0AD6P THERCLAS Antiviral Agents D0AD6P DRUGTYPE Combination drug D0AD6P HIGHSTAT Phase 2 Trial D0AG7N DRUG__ID D0AG7N D0AG7N DRUGCOMP MedImmune D0AG7N DRUGTYPE Antibody D0AG7N HIGHSTAT Phase 2 D0AJ9V DRUG__ID D0AJ9V D0AJ9V DRUGCOMP Zymeworks D0AJ9V DRUGTYPE Antibody D0AJ9V HIGHSTAT Phase 2 D0B0FK DRUG__ID D0B0FK D0B0FK THERCLAS Antiviral Agents D0B0FK DRUGTYPE Vaccine D0B0FK HIGHSTAT Phase 2 Trial D0B1IC DRUG__ID D0B1IC D0B1IC DRUGCOMP Crucell D0B1IC DRUGTYPE Antibody D0B1IC HIGHSTAT Phase 2 D0B1KA DRUG__ID D0B1KA D0B1KA DRUGCOMP Scientific D0B1KA DRUGTYPE Monoclonal antibody D0B1KA HIGHSTAT Phase 2 D0B5EB DRUG__ID D0B5EB D0B5EB DRUGCOMP Rinat Neuroscience Corp D0B5EB DRUGTYPE Antibody D0B5EB HIGHSTAT Phase 2 D0B6AZ DRUG__ID D0B6AZ D0B6AZ DRUGCOMP Instil Bio Dallas, TX D0B6AZ DRUGTYPE Cell therapy D0B6AZ HIGHSTAT Phase 2 D0BH7Z DRUG__ID D0BH7Z D0BH7Z DRUGCOMP Wilex D0BH7Z DRUGTYPE Monoclonal antibody D0BH7Z HIGHSTAT Phase 2 D0BR8X DRUG__ID D0BR8X D0BR8X THERCLAS Antiviral Agents D0BR8X DRUGTYPE Protein/peptide drug D0BR8X HIGHSTAT Phase 2 Trial D0BZ7V DRUG__ID D0BZ7V D0BZ7V DRUGCOMP Merck KgaA; Merck KGaA D0BZ7V DRUGTYPE Antibody D0BZ7V HIGHSTAT Phase 2 D0C0LO DRUG__ID D0C0LO D0C0LO DRUGCOMP ImmunoGen D0C0LO DRUGTYPE Antibody D0C0LO HIGHSTAT Phase 2 D0C1UF DRUG__ID D0C1UF D0C1UF DRUGCOMP Medarex D0C1UF DRUGTYPE Antibody D0C1UF HIGHSTAT Phase 2 D0C3LL DRUG__ID D0C3LL D0C3LL DRUGCOMP The Center of Molecular Immunology D0C3LL DRUGTYPE Vaccine D0C3LL HIGHSTAT Phase 2 D0C5FQ DRUG__ID D0C5FQ D0C5FQ DRUGCOMP Bayhill Therapeutics D0C5FQ DRUGTYPE Vaccine D0C5FQ HIGHSTAT Phase 2 D0C8AL DRUG__ID D0C8AL D0C8AL DRUGCOMP Immune Targeting Systems Ltd D0C8AL DRUGTYPE Vaccine D0C8AL HIGHSTAT Phase 2 D0C8NG DRUG__ID D0C8NG D0C8NG DRUGCOMP Boehringer ingelheim pharmaceuticals D0C8NG DRUGTYPE Antibody D0C8NG HIGHSTAT Phase 2 D0CN9D DRUG__ID D0CN9D D0CN9D DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D0CN9D DRUGTYPE Antibody drug conjugate D0CN9D HIGHSTAT Phase 2 D0D4LP DRUG__ID D0D4LP D0D4LP DRUGCOMP Colby Pharmaceutical D0D4LP DRUGTYPE Vaccine D0D4LP HIGHSTAT Phase 2 D0DV8Z DRUG__ID D0DV8Z D0DV8Z DRUGCOMP AbbVie D0DV8Z DRUGTYPE Antibody D0DV8Z HIGHSTAT Phase 2 D0E1ZV DRUG__ID D0E1ZV D0E1ZV DRUGCOMP Immunomedics D0E1ZV DRUGTYPE Monoclonal antibody D0E1ZV HIGHSTAT Phase 2 D0E5BW DRUG__ID D0E5BW D0E5BW DRUGCOMP Elsevier D0E5BW DRUGTYPE Antibody D0E5BW HIGHSTAT Phase 2 D0E5DP DRUG__ID D0E5DP D0E5DP DRUGCOMP Lilly D0E5DP DRUGTYPE Monoclonal antibody D0E5DP HIGHSTAT Phase 2 D0E8SV DRUG__ID D0E8SV D0E8SV DRUGCOMP Roche D0E8SV DRUGTYPE Small molecular drug D0E8SV HIGHSTAT Phase 2 D0F0ZK DRUG__ID D0F0ZK D0F0ZK DRUGCOMP Kalobios pharmaceuticals D0F0ZK DRUGTYPE Antibody D0F0ZK HIGHSTAT Phase 2 D0F1HT DRUG__ID D0F1HT D0F1HT DRUGCOMP Shanghai Children's Medical Center D0F1HT DRUGTYPE CAR T Cell Therapy D0F1HT HIGHSTAT Phase 2 D0F3EO DRUG__ID D0F3EO D0F3EO DRUGCOMP Heat Biologics D0F3EO DRUGTYPE Vaccine D0F3EO HIGHSTAT Phase 2 D0F3GL DRUG__ID D0F3GL D0F3GL DRUGCOMP Bionor Pharma D0F3GL DRUGTYPE Vaccine D0F3GL HIGHSTAT Phase 2 D0F8XK DRUG__ID D0F8XK D0F8XK DRUGCOMP ISIS Pharm D0F8XK DRUGTYPE Antisense drug D0F8XK HIGHSTAT Phase 2 D0F9QH DRUG__ID D0F9QH D0F9QH DRUGCOMP Emd serono D0F9QH DRUGTYPE Antibody D0F9QH HIGHSTAT Phase 2 D0FI5C DRUG__ID D0FI5C D0FI5C DRUGCOMP MedImmune D0FI5C DRUGTYPE Monoclonal antibody D0FI5C HIGHSTAT Phase 2 D0FK9H DRUG__ID D0FK9H D0FK9H DRUGCOMP EisaiWoodcliff Lake, NJ MorphotekExton, PA D0FK9H DRUGTYPE Antibody D0FK9H HIGHSTAT Phase 2 D0G3TJ DRUG__ID D0G3TJ D0G3TJ DRUGCOMP Astellas pharma us; kyowa hakko kirin pharma D0G3TJ DRUGTYPE Antibody D0G3TJ HIGHSTAT Phase 2 D0G4IW DRUG__ID D0G4IW D0G4IW DRUGCOMP University of Pennsylvania D0G4IW DRUGTYPE CAR T Cell Therapy D0G4IW HIGHSTAT Phase 2 D0G5YR DRUG__ID D0G5YR D0G5YR DRUGCOMP ImmunoGen Inc D0G5YR DRUGTYPE Antibody D0G5YR HIGHSTAT Phase 2 D0G6EB DRUG__ID D0G6EB D0G6EB DRUGCOMP Immune System Therapeutics Ltd D0G6EB DRUGTYPE Antibody D0G6EB HIGHSTAT Phase 2 D0G7ZT DRUG__ID D0G7ZT D0G7ZT DRUGCOMP Agensys D0G7ZT DRUGTYPE Monoclonal antibody D0G7ZT HIGHSTAT Phase 2 D0G9EI DRUG__ID D0G9EI D0G9EI DRUGCOMP MedImmune D0G9EI DRUGTYPE Monoclonal antibody D0G9EI HIGHSTAT Phase 2 D0G9JQ DRUG__ID D0G9JQ D0G9JQ DRUGCOMP Phasebio pharmaceuticals D0G9JQ DRUGTYPE Recombinant protein D0G9JQ HIGHSTAT Phase 2 D0G9ZU DRUG__ID D0G9ZU D0G9ZU DRUGCOMP ESBATech AG D0G9ZU DRUGTYPE Antibody D0G9ZU HIGHSTAT Phase 2 D0GF2R DRUG__ID D0GF2R D0GF2R DRUGCOMP TRACON Pharmaceuticals D0GF2R DRUGTYPE Antibody D0GF2R HIGHSTAT Phase 2 D0GL9N DRUG__ID D0GL9N D0GL9N THERCLAS Antiviral Agents D0GL9N DRUGTYPE Protein/peptide drug D0GL9N HIGHSTAT Phase 2 Trial D0GR5X DRUG__ID D0GR5X D0GR5X DRUGCOMP Dynavax Technologies D0GR5X DRUGTYPE Vaccine D0GR5X HIGHSTAT Phase 2 D0GW4K DRUG__ID D0GW4K D0GW4K THERCLAS Antiviral Agents D0GW4K DRUGTYPE Combination drug D0GW4K HIGHSTAT Phase 2 Trial D0GZ3A DRUG__ID D0GZ3A D0GZ3A DRUGCOMP Philogen SpA D0GZ3A DRUGTYPE Antibody D0GZ3A HIGHSTAT Phase 2 D0H5ER DRUG__ID D0H5ER D0H5ER DRUGCOMP Millennium Pharmaceuticals D0H5ER DRUGTYPE Antibody D0H5ER HIGHSTAT Phase 2 D0H5ES DRUG__ID D0H5ES D0H5ES DRUGCOMP Genentech D0H5ES DRUGTYPE Antibody D0H5ES HIGHSTAT Phase 2 D0H5KA DRUG__ID D0H5KA D0H5KA DRUGCOMP Vaccine Research Center (NIAID) D0H5KA DRUGTYPE Vaccine D0H5KA HIGHSTAT Phase 2 D0H6SH DRUG__ID D0H6SH D0H6SH DRUGCOMP National Institute of Allergy and Infectious Diseases (NIAID) D0H6SH DRUGTYPE Monoclonal antibody D0H6SH HIGHSTAT Phase 2 D0HFJ8 DRUG__ID D0HFJ8 D0HFJ8 DRUGCOMP Sanaria D0HFJ8 DRUGTYPE Vaccine D0HFJ8 HIGHSTAT Phase 2 D0HM1V DRUG__ID D0HM1V D0HM1V DRUGCOMP Masonic Cancer Center, University of Minnesota D0HM1V DRUGTYPE CAR T Cell Therapy D0HM1V HIGHSTAT Phase 2 D0HN7I DRUG__ID D0HN7I D0HN7I DRUGCOMP UCB Celltech D0HN7I DRUGTYPE Antibody D0HN7I HIGHSTAT Phase 2 D0HN8P DRUG__ID D0HN8P D0HN8P THERCLAS Antiviral Agents D0HN8P DRUGTYPE Monoclonal antibody D0HN8P HIGHSTAT Phase 2 Trial D0HT2X DRUG__ID D0HT2X D0HT2X DRUGCOMP Janssen biotech D0HT2X DRUGTYPE Antibody D0HT2X HIGHSTAT Phase 2 D0I0NJ DRUG__ID D0I0NJ D0I0NJ DRUGCOMP University of Pennsylvania D0I0NJ DRUGTYPE CAR T Cell Therapy D0I0NJ HIGHSTAT Phase 2 D0I0UM DRUG__ID D0I0UM D0I0UM DRUGCOMP Novartis Pharmaceuticals D0I0UM DRUGTYPE CAR T Cell Therapy D0I0UM HIGHSTAT Phase 2 D0I2VW DRUG__ID D0I2VW D0I2VW DRUGCOMP GlaxoSmithKline D0I2VW DRUGTYPE Small molecular drug D0I2VW HIGHSTAT Phase 2 D0I3OS DRUG__ID D0I3OS D0I3OS DRUGCOMP Genesis Biopharma D0I3OS DRUGTYPE Antibody D0I3OS HIGHSTAT Phase 2 D0I3XR DRUG__ID D0I3XR D0I3XR DRUGCOMP Inhibitex D0I3XR DRUGTYPE Monoclonal antibody D0I3XR HIGHSTAT Phase 2 D0I5ZX DRUG__ID D0I5ZX D0I5ZX THERCLAS Antiviral Agents D0I5ZX DRUGTYPE Vaccine D0I5ZX HIGHSTAT Phase 2 Trial D0I6RI DRUG__ID D0I6RI D0I6RI DRUGCOMP Argos Therapeutics D0I6RI DRUGTYPE Vaccine D0I6RI HIGHSTAT Phase 2 D0I7BD DRUG__ID D0I7BD D0I7BD DRUGCOMP Cytos Biotechnology AG D0I7BD DRUGTYPE Vaccine D0I7BD HIGHSTAT Phase 2 D0I7PU DRUG__ID D0I7PU D0I7PU DRUGCOMP Bristol-Myers Squibb D0I7PU DRUGTYPE Monoclonal antibody D0I7PU HIGHSTAT Phase 2 D0I8BH DRUG__ID D0I8BH D0I8BH DRUGCOMP Vaxon Biotech SA D0I8BH DRUGTYPE Vaccine D0I8BH HIGHSTAT Phase 2 D0I8OY DRUG__ID D0I8OY D0I8OY DRUGCOMP The First Affiliated Hospital with Nanjing Medical University D0I8OY DRUGTYPE CAR T Cell Therapy D0I8OY HIGHSTAT Phase 2 D0I8YS DRUG__ID D0I8YS D0I8YS DRUGCOMP Roche D0I8YS DRUGTYPE Monoclonal antibody D0I8YS HIGHSTAT Phase 2 D0ID4Y DRUG__ID D0ID4Y D0ID4Y THERCLAS Antiviral Agents D0ID4Y DRUGTYPE Monoclonal antibody D0ID4Y HIGHSTAT Phase 2 Trial D0J1QX DRUG__ID D0J1QX D0J1QX THERCLAS Antiviral Agents D0J1QX DRUGTYPE Small molecular drug D0J1QX HIGHSTAT Phase 2 Trial D0J2AJ DRUG__ID D0J2AJ D0J2AJ THERCLAS Antiviral Agents D0J2AJ DRUGTYPE Monoclonal antibody D0J2AJ HIGHSTAT Phase 2 Trial D0J4PM DRUG__ID D0J4PM D0J4PM DRUGCOMP G2 Therapies Ltd D0J4PM DRUGTYPE Antibody D0J4PM HIGHSTAT Phase 2 D0J6FE DRUG__ID D0J6FE D0J6FE DRUGCOMP AVI BioPharma D0J6FE DRUGTYPE Antisense drug D0J6FE HIGHSTAT Phase 2 D0J7KD DRUG__ID D0J7KD D0J7KD DRUGCOMP Tessa Therapeutics D0J7KD DRUGTYPE CAR-T cell therapy D0J7KD HIGHSTAT Phase 2 D0JH5K DRUG__ID D0JH5K D0JH5K DRUGCOMP TVAX Biomedical D0JH5K DRUGTYPE Vaccine D0JH5K HIGHSTAT Phase 2 D0JP8D DRUG__ID D0JP8D D0JP8D DRUGCOMP GlaxoSmithKline D0JP8D DRUGTYPE Antibody D0JP8D HIGHSTAT Phase 2 D0JR9Y DRUG__ID D0JR9Y D0JR9Y THERCLAS Antiviral Agents D0JR9Y DRUGTYPE Small molecular drug D0JR9Y HIGHSTAT Phase 2 Trial D0JT6Q DRUG__ID D0JT6Q D0JT6Q THERCLAS Antiviral Agents D0JT6Q DRUGTYPE Monoclonal antibody D0JT6Q HIGHSTAT Phase 2 Trial D0K1AK DRUG__ID D0K1AK D0K1AK DRUGCOMP Nanjing Legend Biotech Co. D0K1AK DRUGTYPE CAR T Cell Therapy D0K1AK HIGHSTAT Phase 2 D0K3XB DRUG__ID D0K3XB D0K3XB DRUGCOMP Juno Therapeutics, Inc. D0K3XB DRUGTYPE CAR T Cell Therapy D0K3XB HIGHSTAT Phase 2 D0K4OF DRUG__ID D0K4OF D0K4OF DRUGCOMP University of Oxford D0K4OF DRUGTYPE Vaccine D0K4OF HIGHSTAT Phase 2 D0K9MC DRUG__ID D0K9MC D0K9MC DRUGCOMP Glycotope GmbH D0K9MC DRUGTYPE Antibody D0K9MC HIGHSTAT Phase 2 D0KA9L DRUG__ID D0KA9L D0KA9L DRUGCOMP MENTRIK Biotech D0KA9L DRUGTYPE Antibody D0KA9L HIGHSTAT Phase 2 D0KC1H DRUG__ID D0KC1H D0KC1H THERCLAS Antiviral Agents D0KC1H DRUGTYPE Monoclonal antibody D0KC1H HIGHSTAT Phase 2 Trial D0KG5D DRUG__ID D0KG5D D0KG5D DRUGCOMP Human Genome Sciences D0KG5D DRUGTYPE Monoclonal antibody D0KG5D HIGHSTAT Phase 2 D0KX6E DRUG__ID D0KX6E D0KX6E DRUGCOMP Alopexx Oncology D0KX6E DRUGTYPE Recombinant protein D0KX6E HIGHSTAT Phase 2 D0KY7S DRUG__ID D0KY7S D0KY7S DRUGCOMP ISIS Pharm D0KY7S DRUGTYPE Antisense drug D0KY7S HIGHSTAT Phase 2 D0L1HK DRUG__ID D0L1HK D0L1HK DRUGCOMP Theraclone Sciences D0L1HK DRUGTYPE Antibody D0L1HK HIGHSTAT Phase 2 D0L1OC DRUG__ID D0L1OC D0L1OC DRUGCOMP Genentech D0L1OC DRUGTYPE Antibody D0L1OC HIGHSTAT Phase 2 D0L3IL DRUG__ID D0L3IL D0L3IL DRUGCOMP Pharmaxis D0L3IL DRUGTYPE Antisense drug D0L3IL HIGHSTAT Phase 2 D0L5HM DRUG__ID D0L5HM D0L5HM DRUGCOMP Southwest Hospital, China D0L5HM DRUGTYPE CAR T Cell Therapy D0L5HM HIGHSTAT Phase 2 D0L7LH DRUG__ID D0L7LH D0L7LH DRUGCOMP Bristol-myers squibb D0L7LH DRUGTYPE Antibody D0L7LH HIGHSTAT Phase 2 D0M0OT DRUG__ID D0M0OT D0M0OT DRUGCOMP BioSante Pharmaceuticals D0M0OT DRUGTYPE Vaccine D0M0OT HIGHSTAT Phase 2 D0M3GQ DRUG__ID D0M3GQ D0M3GQ DRUGCOMP National Cancer Institute D0M3GQ DRUGTYPE Antibody D0M3GQ HIGHSTAT Phase 2 D0M4MG DRUG__ID D0M4MG D0M4MG DRUGCOMP Cook Pharmica D0M4MG DRUGTYPE Antisense drug D0M4MG HIGHSTAT Phase 2 D0M4TO DRUG__ID D0M4TO D0M4TO DRUGCOMP Bavarian Nordic D0M4TO DRUGTYPE Vaccine D0M4TO HIGHSTAT Phase 2 D0M5JA DRUG__ID D0M5JA D0M5JA DRUGCOMP IDEC Pharmaceuticals Corp; Biogen Idec D0M5JA DRUGTYPE Antibody D0M5JA HIGHSTAT Phase 2 D0M5PD DRUG__ID D0M5PD D0M5PD THERCLAS Antiviral Agents D0M5PD DRUGTYPE Vaccine D0M5PD HIGHSTAT Phase 2 Trial D0M7VE DRUG__ID D0M7VE D0M7VE DRUGCOMP Roche D0M7VE DRUGTYPE Antibody D0M7VE HIGHSTAT Phase 2 D0MC2S DRUG__ID D0MC2S D0MC2S DRUGCOMP Cytos Biotechnology AG D0MC2S DRUGTYPE Vaccine D0MC2S HIGHSTAT Phase 2 D0MW7S DRUG__ID D0MW7S D0MW7S DRUGCOMP Cambridge Antibody Technology Group plc D0MW7S DRUGTYPE Antibody D0MW7S HIGHSTAT Phase 2 D0N1SH DRUG__ID D0N1SH D0N1SH DRUGCOMP Vaccinex Inc D0N1SH DRUGTYPE Antibody D0N1SH HIGHSTAT Phase 2 D0N3JT DRUG__ID D0N3JT D0N3JT DRUGCOMP ImmunoGen Inc; ImmunoGen D0N3JT DRUGTYPE Monoclonal antibody D0N3JT HIGHSTAT Phase 2 D0N4SF DRUG__ID D0N4SF D0N4SF DRUGCOMP GlobeImmune D0N4SF DRUGTYPE Vaccine D0N4SF HIGHSTAT Phase 2 D0N7FD DRUG__ID D0N7FD D0N7FD DRUGCOMP Memorial Sloan-Kettering Cancer Center D0N7FD DRUGTYPE Vaccine D0N7FD HIGHSTAT Phase 2 D0N7GN DRUG__ID D0N7GN D0N7GN DRUGCOMP Harvard Medical School D0N7GN DRUGTYPE Antibody D0N7GN HIGHSTAT Phase 2 D0N7LA DRUG__ID D0N7LA D0N7LA DRUGCOMP Boehringer Ingelheim D0N7LA DRUGTYPE Antibody D0N7LA HIGHSTAT Phase 2 D0NN5H DRUG__ID D0NN5H D0NN5H DRUGCOMP Quark Pharm; Pfizer D0NN5H DRUGTYPE siRNA drug D0NN5H HIGHSTAT Phase 2 D0NO1L DRUG__ID D0NO1L D0NO1L DRUGCOMP Novartis D0NO1L DRUGTYPE Monoclonal antibody D0NO1L HIGHSTAT Phase 2 D0NQ0V DRUG__ID D0NQ0V D0NQ0V DRUGCOMP Biotest D0NQ0V DRUGTYPE Antibody D0NQ0V HIGHSTAT Phase 2 D0NT1S DRUG__ID D0NT1S D0NT1S DRUGCOMP Cosmo Pharmaceuticals D0NT1S DRUGTYPE Vaccine D0NT1S HIGHSTAT Phase 2 D0O1TJ DRUG__ID D0O1TJ D0O1TJ DRUGCOMP Sanofi D0O1TJ DRUGTYPE Small molecular drug D0O1TJ HIGHSTAT Phase 2 D0O2JI DRUG__ID D0O2JI D0O2JI DRUGCOMP Trion D0O2JI DRUGTYPE Antibody D0O2JI HIGHSTAT Phase 2 D0O2VZ DRUG__ID D0O2VZ D0O2VZ DRUGCOMP GSK D0O2VZ DRUGTYPE Monoclonal antibody D0O2VZ HIGHSTAT Phase 2 D0O4SH DRUG__ID D0O4SH D0O4SH DRUGCOMP Sanofi D0O4SH DRUGTYPE Antibody D0O4SH HIGHSTAT Phase 2 D0O5KH DRUG__ID D0O5KH D0O5KH DRUGCOMP Novartis D0O5KH DRUGTYPE Monoclonal antibody D0O5KH HIGHSTAT Phase 2 D0O5XF DRUG__ID D0O5XF D0O5XF DRUGCOMP Titan Pharmaceuticals D0O5XF DRUGTYPE Vaccine D0O5XF HIGHSTAT Phase 2 D0O8AY DRUG__ID D0O8AY D0O8AY DRUGCOMP National Institutes of Health D0O8AY DRUGTYPE Vaccine D0O8AY HIGHSTAT Phase 2 D0OR6L DRUG__ID D0OR6L D0OR6L DRUGCOMP The First Affiliated Hospital of Soochow University D0OR6L DRUGTYPE CAR T Cell Therapy D0OR6L HIGHSTAT Phase 2 D0OX5H DRUG__ID D0OX5H D0OX5H DRUGCOMP AbbVie D0OX5H DRUGTYPE Monoclonal antibody D0OX5H HIGHSTAT Phase 2 D0OY9L DRUG__ID D0OY9L D0OY9L DRUGCOMP Alexion Pharmaceuticals D0OY9L DRUGTYPE Antibody D0OY9L HIGHSTAT Phase 2 D0P1CE DRUG__ID D0P1CE D0P1CE DRUGCOMP Cytheris D0P1CE THERCLAS Anticancer Agents D0P1CE HIGHSTAT Phase 2 D0P2ME DRUG__ID D0P2ME D0P2ME DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0P2ME DRUGTYPE Vaccine D0P2ME HIGHSTAT Phase 2 D0P2SI DRUG__ID D0P2SI D0P2SI DRUGCOMP Biogen Idec D0P2SI DRUGTYPE Antibody D0P2SI HIGHSTAT Phase 2 D0P6CF DRUG__ID D0P6CF D0P6CF DRUGCOMP GlaxoSmithKline D0P6CF DRUGTYPE Monoclonal antibody D0P6CF HIGHSTAT Phase 2 D0P7KI DRUG__ID D0P7KI D0P7KI DRUGCOMP Transtarget; barbara ann karmanos cancer institute D0P7KI DRUGTYPE Antibody D0P7KI HIGHSTAT Phase 2 D0P7SO DRUG__ID D0P7SO D0P7SO DRUGCOMP Aaron Diamond AIDS Research Center D0P7SO DRUGTYPE Vaccine D0P7SO HIGHSTAT Phase 2 D0PA1B DRUG__ID D0PA1B D0PA1B DRUGCOMP Genentech D0PA1B DRUGTYPE Antibody D0PA1B HIGHSTAT Phase 2 D0Q1WI DRUG__ID D0Q1WI D0Q1WI DRUGCOMP Genentech D0Q1WI DRUGTYPE Antibody D0Q1WI HIGHSTAT Phase 2 D0Q1XV DRUG__ID D0Q1XV D0Q1XV DRUGCOMP GlaxoSmithKline Biologicals D0Q1XV DRUGTYPE Vaccine D0Q1XV HIGHSTAT Phase 2 D0Q2KM DRUG__ID D0Q2KM D0Q2KM DRUGCOMP Merrimack D0Q2KM DRUGTYPE Monoclonal antibody D0Q2KM HIGHSTAT Phase 2 D0Q4CQ DRUG__ID D0Q4CQ D0Q4CQ DRUGCOMP Heat biologics D0Q4CQ DRUGTYPE Vaccine D0Q4CQ HIGHSTAT Phase 2 D0Q5SI DRUG__ID D0Q5SI D0Q5SI DRUGCOMP Takeda D0Q5SI DRUGTYPE Recombinant protein D0Q5SI HIGHSTAT Phase 2 D0Q7OE DRUG__ID D0Q7OE D0Q7OE DRUGCOMP BioInvent International D0Q7OE DRUGTYPE Antibody D0Q7OE HIGHSTAT Phase 2 D0Q8LL DRUG__ID D0Q8LL D0Q8LL DRUGCOMP Sylentis Sau D0Q8LL DRUGTYPE siRNA drug D0Q8LL HIGHSTAT Phase 2 D0QF7Z DRUG__ID D0QF7Z D0QF7Z DRUGCOMP Fred Hutchinson Cancer Research Center D0QF7Z DRUGTYPE Vaccine D0QF7Z HIGHSTAT Phase 2 D0QM4O DRUG__ID D0QM4O D0QM4O DRUGCOMP Ultimovacs D0QM4O DRUGTYPE Vaccine D0QM4O HIGHSTAT Phase 2 D0R0SP DRUG__ID D0R0SP D0R0SP DRUGCOMP Sanofi Pasteur D0R0SP DRUGTYPE Vaccine D0R0SP HIGHSTAT Phase 2 D0R3LQ DRUG__ID D0R3LQ D0R3LQ DRUGCOMP ISIS Pharm; Excaliard D0R3LQ DRUGTYPE Antisense drug D0R3LQ HIGHSTAT Phase 2 D0R3ZE DRUG__ID D0R3ZE D0R3ZE DRUGCOMP MedImmune D0R3ZE DRUGTYPE Antibody D0R3ZE HIGHSTAT Phase 2 D0R6MJ DRUG__ID D0R6MJ D0R6MJ DRUGCOMP Eisai D0R6MJ DRUGTYPE Antibody D0R6MJ HIGHSTAT Phase 2 D0R9IH DRUG__ID D0R9IH D0R9IH DRUGCOMP Targeted Molecules Corp D0R9IH DRUGTYPE Antibody D0R9IH HIGHSTAT Phase 2 D0RA1R DRUG__ID D0RA1R D0RA1R DRUGCOMP Uppsala University D0RA1R DRUGTYPE CAR T Cell Therapy D0RA1R HIGHSTAT Phase 2 D0RB6L DRUG__ID D0RB6L D0RB6L THERCLAS Antiviral Agents D0RB6L DRUGTYPE Protein/peptide drug D0RB6L HIGHSTAT Phase 2 Trial D0RG8Z DRUG__ID D0RG8Z D0RG8Z DRUGCOMP Formula pharmaceuticals D0RG8Z DRUGTYPE Vaccine D0RG8Z HIGHSTAT Phase 2 D0RK1O DRUG__ID D0RK1O D0RK1O DRUGCOMP Arrowhead Pharmaceuticals D0RK1O DRUGTYPE RNA interference D0RK1O HIGHSTAT Phase 2 D0S0FD DRUG__ID D0S0FD D0S0FD DRUGCOMP Eisai D0S0FD DRUGTYPE Small molecular drug D0S0FD HIGHSTAT Phase 2 D0S4JL DRUG__ID D0S4JL D0S4JL DRUGCOMP Gilead sciences D0S4JL DRUGTYPE Monoclonal antibody D0S4JL HIGHSTAT Phase 2 D0S9WW DRUG__ID D0S9WW D0S9WW DRUGCOMP GlobeImmune D0S9WW DRUGTYPE Vaccine D0S9WW HIGHSTAT Phase 2 D0SL8T DRUG__ID D0SL8T D0SL8T DRUGCOMP ISIS Pharm D0SL8T DRUGTYPE Antisense drug D0SL8T HIGHSTAT Phase 2 D0SM6N DRUG__ID D0SM6N D0SM6N DRUGCOMP Isis Pharmaceuticals D0SM6N DRUGTYPE Antisense drug D0SM6N HIGHSTAT Phase 2 D0T1KL DRUG__ID D0T1KL D0T1KL DRUGCOMP Glycotope GmbH D0T1KL DRUGTYPE Antibody D0T1KL HIGHSTAT Phase 2 D0T2FC DRUG__ID D0T2FC D0T2FC DRUGCOMP Neogenix Oncology D0T2FC DRUGTYPE Antibody D0T2FC HIGHSTAT Phase 2 D0T4FY DRUG__ID D0T4FY D0T4FY DRUGCOMP The First Affiliated Hospital of Soochow University D0T4FY DRUGTYPE CAR T Cell Therapy D0T4FY HIGHSTAT Phase 2 D0T4IW DRUG__ID D0T4IW D0T4IW DRUGCOMP United Therapeutics D0T4IW DRUGTYPE Monoclonal antibody D0T4IW HIGHSTAT Phase 2 D0U0NS DRUG__ID D0U0NS D0U0NS DRUGCOMP BioSante Pharmaceuticals D0U0NS DRUGTYPE Vaccine D0U0NS HIGHSTAT Phase 2 D0U9MN DRUG__ID D0U9MN D0U9MN DRUGCOMP Sanofi D0U9MN DRUGTYPE Vaccine D0U9MN HIGHSTAT Phase 2 D0UG0K DRUG__ID D0UG0K D0UG0K DRUGCOMP GenentechSouth San Francisco, CA D0UG0K DRUGTYPE Antibody drug conjugate D0UG0K HIGHSTAT Phase 2 D0V0VR DRUG__ID D0V0VR D0V0VR DRUGCOMP City of Hope D0V0VR DRUGTYPE Vaccine D0V0VR HIGHSTAT Phase 2 D0V2SP DRUG__ID D0V2SP D0V2SP DRUGCOMP Introgen Therapeutics D0V2SP DRUGTYPE Vaccine D0V2SP HIGHSTAT Phase 2 D0V9LY DRUG__ID D0V9LY D0V9LY DRUGCOMP Cambridge Antibody Technology D0V9LY DRUGTYPE Monoclonal antibody D0V9LY HIGHSTAT Phase 2 D0VI9P DRUG__ID D0VI9P D0VI9P DRUGCOMP Opsona therapeutics D0VI9P DRUGTYPE Antibody D0VI9P HIGHSTAT Phase 2 D0W6WC DRUG__ID D0W6WC D0W6WC DRUGCOMP PDL BioPharma D0W6WC DRUGTYPE Monoclonal antibody D0W6WC HIGHSTAT Phase 2 D0WJ7H DRUG__ID D0WJ7H D0WJ7H DRUGCOMP AgenusLexington, MA D0WJ7H DRUGTYPE Monoclonal antibody D0WJ7H HIGHSTAT Phase 2 D0X3ER DRUG__ID D0X3ER D0X3ER DRUGCOMP Leiden University Medical Center D0X3ER DRUGTYPE Peptide D0X3ER HIGHSTAT Phase 2 D0X8HP DRUG__ID D0X8HP D0X8HP DRUGCOMP Targacept D0X8HP DRUGTYPE Small molecular drug D0X8HP HIGHSTAT Phase 2 D0X9UA DRUG__ID D0X9UA D0X9UA DRUGCOMP Pharmaceuticals D0X9UA DRUGTYPE Antibody D0X9UA HIGHSTAT Phase 2 D0X9VR DRUG__ID D0X9VR D0X9VR DRUGCOMP BergenBio AS D0X9VR DRUGTYPE siRNA drug D0X9VR HIGHSTAT Phase 2 D0XP4A DRUG__ID D0XP4A D0XP4A DRUGCOMP Immunomedics D0XP4A DRUGTYPE Antibody D0XP4A HIGHSTAT Phase 2 D0XY4A DRUG__ID D0XY4A D0XY4A DRUGCOMP Novartis AG D0XY4A DRUGTYPE Antibody D0XY4A HIGHSTAT Phase 2 D0Y3HP DRUG__ID D0Y3HP D0Y3HP DRUGCOMP Southwest Hospital, China D0Y3HP DRUGTYPE CAR T Cell Therapy D0Y3HP HIGHSTAT Phase 2 D0Y5VR DRUG__ID D0Y5VR D0Y5VR DRUGCOMP GlaxoSmithKline plc D0Y5VR DRUGTYPE Vaccine D0Y5VR HIGHSTAT Phase 2 D0Y9PZ DRUG__ID D0Y9PZ D0Y9PZ DRUGCOMP University of Manchester D0Y9PZ DRUGTYPE Antibody D0Y9PZ HIGHSTAT Phase 2 D0Z2BO DRUG__ID D0Z2BO D0Z2BO DRUGCOMP CytomX Therapeutics South San Francisco, CA D0Z2BO DRUGTYPE Antibody D0Z2BO HIGHSTAT Phase 2 D0Z2NJ DRUG__ID D0Z2NJ D0Z2NJ DRUGCOMP Arsanis D0Z2NJ DRUGTYPE Monoclonal antibody D0Z2NJ HIGHSTAT Phase 2 D0Z6AR DRUG__ID D0Z6AR D0Z6AR DRUGCOMP Cartesian Therapeutics D0Z6AR DRUGTYPE CAR T Cell Therapy D0Z6AR HIGHSTAT Phase 2 D0ZT5T DRUG__ID D0ZT5T D0ZT5T DRUGCOMP GlaxoSmithKline plc D0ZT5T DRUGTYPE Vaccine D0ZT5T HIGHSTAT Phase 2 D0ZW8B DRUG__ID D0ZW8B D0ZW8B DRUGCOMP Molecular Targeting Technologies Inc D0ZW8B DRUGTYPE Monoclonal antibody D0ZW8B HIGHSTAT Phase 2 D12THW DRUG__ID D12THW D12THW DRUGCOMP Allergan D12THW DRUGTYPE Small molecular drug D12THW HIGHSTAT Phase 2 D14SKB DRUG__ID D14SKB D14SKB DRUGCOMP Magenta Therapeutics D14SKB DRUGTYPE Cell therapy D14SKB HIGHSTAT Phase 2 D19FJS DRUG__ID D19FJS D19FJS DRUGCOMP Moderna D19FJS DRUGTYPE Vaccine D19FJS HIGHSTAT Phase 2 D1CG5M DRUG__ID D1CG5M D1CG5M DRUGCOMP VelosBio D1CG5M DRUGTYPE Antibody drug conjugate D1CG5M HIGHSTAT Phase 2 D1GWL7 DRUG__ID D1GWL7 D1GWL7 DRUGCOMP Peptilogics D1GWL7 DRUGTYPE Peptide D1GWL7 HIGHSTAT Phase 2 D1IFS2 DRUG__ID D1IFS2 D1IFS2 DRUGCOMP Goldfinch Bio Cambridge, MA D1IFS2 DRUGTYPE Small molecule D1IFS2 HIGHSTAT Phase 2 D1J4CI DRUG__ID D1J4CI D1J4CI DRUGCOMP Merus D1J4CI DRUGTYPE Monoclonal antibody D1J4CI HIGHSTAT Phase 2 D1KO3P DRUG__ID D1KO3P D1KO3P DRUGCOMP Promentis Pharmaceuticals D1KO3P DRUGTYPE Small molecular drug D1KO3P HIGHSTAT Phase 2 D1LU7W DRUG__ID D1LU7W D1LU7W DRUGCOMP Neuraltus Pharmaceuticals D1LU7W DRUGTYPE Small molecular drug D1LU7W HIGHSTAT Phase 2 D1NDO8 DRUG__ID D1NDO8 D1NDO8 DRUGCOMP Amgen D1NDO8 DRUGTYPE Fusion Protein D1NDO8 HIGHSTAT Phase 2 D1O4MP DRUG__ID D1O4MP D1O4MP DRUGCOMP Gilead; Lilly D1O4MP DRUGTYPE Antibody D1O4MP HIGHSTAT Phase 2 D1PC9J DRUG__ID D1PC9J D1PC9J DRUGCOMP CytomX Therapeutics D1PC9J DRUGTYPE Probody drug conjugate D1PC9J HIGHSTAT Phase 2 D1RHZ5 DRUG__ID D1RHZ5 D1RHZ5 DRUGCOMP Moderna D1RHZ5 DRUGTYPE Vaccine D1RHZ5 HIGHSTAT Phase 2 D1RIW2 DRUG__ID D1RIW2 D1RIW2 DRUGCOMP Apeiron Biologics D1RIW2 DRUGTYPE Small interfering RNA D1RIW2 HIGHSTAT Phase 2 D1W8RK DRUG__ID D1W8RK D1W8RK DRUGCOMP Protagonist Therapeutics Newark, CA D1W8RK DRUGTYPE peptide D1W8RK HIGHSTAT Phase 2 D1X2VT DRUG__ID D1X2VT D1X2VT DRUGCOMP Janssen D1X2VT DRUGTYPE Antibody D1X2VT HIGHSTAT Phase 2 D21SVO DRUG__ID D21SVO D21SVO DRUGCOMP GlaxoSmithKline D21SVO DRUGTYPE Antibody D21SVO HIGHSTAT Phase 2 D27SXO DRUG__ID D27SXO D27SXO DRUGCOMP FerruMax Pharmaceuticals D27SXO DRUGTYPE Recombinant protein D27SXO HIGHSTAT Phase 2 D2AQW7 DRUG__ID D2AQW7 D2AQW7 DRUGCOMP AbbVie D2AQW7 DRUGTYPE Antibody drug conjugate D2AQW7 HIGHSTAT Phase 2 D2AYS0 DRUG__ID D2AYS0 D2AYS0 DRUGCOMP Pfizer D2AYS0 DRUGTYPE Antisense oligonucleotide D2AYS0 HIGHSTAT Phase 2 D2C0DY DRUG__ID D2C0DY D2C0DY DRUGCOMP Splash Pharmaceuticals D2C0DY DRUGTYPE Peptide D2C0DY HIGHSTAT Phase 2 D2H4RZ DRUG__ID D2H4RZ D2H4RZ DRUGCOMP Bristol-Myers Squibb D2H4RZ DRUGTYPE Small interfering RNA D2H4RZ HIGHSTAT Phase 2 D2KFH5 DRUG__ID D2KFH5 D2KFH5 DRUGCOMP Moderna D2KFH5 DRUGTYPE Vaccine D2KFH5 HIGHSTAT Phase 2 D2MA0E DRUG__ID D2MA0E D2MA0E DRUGCOMP Ionis Pharmaceuticals D2MA0E DRUGTYPE Antisense oligonucleotide D2MA0E HIGHSTAT Phase 2 D2OZ4R DRUG__ID D2OZ4R D2OZ4R DRUGCOMP Sanofi D2OZ4R DRUGTYPE Vaccine D2OZ4R HIGHSTAT Phase 2 D2Q0OI DRUG__ID D2Q0OI D2Q0OI DRUGCOMP Caladrius Biosciences D2Q0OI DRUGTYPE Cell therapy D2Q0OI HIGHSTAT Phase 2 D2QO5J DRUG__ID D2QO5J D2QO5J DRUGCOMP Bristol-Myers Squibb D2QO5J DRUGTYPE Antibody D2QO5J HIGHSTAT Phase 2 D2R0UM DRUG__ID D2R0UM D2R0UM DRUGCOMP Debiopharm D2R0UM DRUGTYPE Antibody D2R0UM HIGHSTAT Phase 2 D2S3NF DRUG__ID D2S3NF D2S3NF DRUGCOMP BIONTECH D2S3NF DRUGTYPE Cell therapy D2S3NF HIGHSTAT Phase 2 D2SDM0 DRUG__ID D2SDM0 D2SDM0 DRUGCOMP Silence Therapeutics D2SDM0 DRUGTYPE RNA interference D2SDM0 HIGHSTAT Phase 2 D2U5CW DRUG__ID D2U5CW D2U5CW DRUGCOMP GlaxoSmithKline D2U5CW DRUGTYPE Antisense oligonucleotide D2U5CW HIGHSTAT Phase 2 D30EUC DRUG__ID D30EUC D30EUC DRUGCOMP GlaxoSmithKline D30EUC DRUGTYPE Vaccine D30EUC HIGHSTAT Phase 2 D30EZF DRUG__ID D30EZF D30EZF DRUGCOMP Alnylam Pharmaceuticals Cambridge, MA D30EZF DRUGTYPE RNA interference D30EZF HIGHSTAT Phase 2 D31NIC DRUG__ID D31NIC D31NIC DRUGCOMP PDS Biotechnology D31NIC DRUGTYPE Vaccine D31NIC HIGHSTAT Phase 2 D32PZT DRUG__ID D32PZT D32PZT DRUGCOMP Eli Lilly & Co D32PZT DRUGTYPE Antibody D32PZT HIGHSTAT Phase 2 D36JFT DRUG__ID D36JFT D36JFT DRUGCOMP Arrevus D36JFT DRUGTYPE Small molecule D36JFT HIGHSTAT Phase 2 D38OHM DRUG__ID D38OHM D38OHM DRUGCOMP GlaxoSmithKline D38OHM DRUGTYPE Antibody D38OHM HIGHSTAT Phase 2 D3IK7O DRUG__ID D3IK7O D3IK7O DRUGCOMP Aptinyx D3IK7O DRUGTYPE Small molecular drug D3IK7O HIGHSTAT Phase 2 D3J9XC DRUG__ID D3J9XC D3J9XC DRUGCOMP Alnylam Pharmaceuticals D3J9XC DRUGTYPE Small interfering RNA D3J9XC HIGHSTAT Phase 2 D3JN6C DRUG__ID D3JN6C D3JN6C DRUGCOMP GreenPeptide D3JN6C DRUGTYPE Vaccine D3JN6C HIGHSTAT Phase 2 D3L7YG DRUG__ID D3L7YG D3L7YG DRUGCOMP Ionis; Biogen D3L7YG DRUGTYPE Antisense oligonucleotide D3L7YG HIGHSTAT Phase 2 D3LT5W DRUG__ID D3LT5W D3LT5W DRUGCOMP Affinivax; Astellas Pharma D3LT5W DRUGTYPE Vaccine D3LT5W HIGHSTAT Phase 2 D3LW8A DRUG__ID D3LW8A D3LW8A DRUGCOMP Hexima D3LW8A DRUGTYPE Peptide D3LW8A HIGHSTAT Phase 2 D3M7FK DRUG__ID D3M7FK D3M7FK DRUGCOMP Censa Pharmaceuticals D3M7FK DRUGTYPE Small molecular drug D3M7FK HIGHSTAT Phase 2 D3NSU0 DRUG__ID D3NSU0 D3NSU0 DRUGCOMP Kiniksa Pharmaceuticals Lexington, MA D3NSU0 DRUGTYPE Antibody D3NSU0 HIGHSTAT Phase 2 D3OC5Y DRUG__ID D3OC5Y D3OC5Y DRUGCOMP GlaxoSmithKline D3OC5Y DRUGTYPE Vaccine D3OC5Y HIGHSTAT Phase 2 D3XP8N DRUG__ID D3XP8N D3XP8N DRUGCOMP Roche D3XP8N DRUGTYPE Antibody D3XP8N HIGHSTAT Phase 2 D40GBC DRUG__ID D40GBC D40GBC DRUGCOMP Lilly D40GBC DRUGTYPE Small molecule D40GBC HIGHSTAT Phase 2 D41OJE DRUG__ID D41OJE D41OJE DRUGCOMP Beech Tree Labs D41OJE DRUGTYPE Small molecular drug D41OJE HIGHSTAT Phase 2 D42TUS DRUG__ID D42TUS D42TUS DRUGCOMP AbbVie D42TUS DRUGTYPE Antibody D42TUS HIGHSTAT Phase 2 D43GZX DRUG__ID D43GZX D43GZX DRUGCOMP Sanofi D43GZX DRUGTYPE Antibody D43GZX HIGHSTAT Phase 2 D47RUF DRUG__ID D47RUF D47RUF DRUGCOMP Recursion Pharmaceuticals Salt Lake City, UT D47RUF DRUGTYPE Small molecule D47RUF HIGHSTAT Phase 2 D4A2DQ DRUG__ID D4A2DQ D4A2DQ DRUGCOMP Sage Therapeutics D4A2DQ DRUGTYPE Small molecular drug D4A2DQ HIGHSTAT Phase 2 D4AGB6 DRUG__ID D4AGB6 D4AGB6 DRUGCOMP Vyriad D4AGB6 DRUGTYPE Oncolytic virus therapy D4AGB6 HIGHSTAT Phase 2 D4B9KS DRUG__ID D4B9KS D4B9KS DRUGCOMP Novartis Pharmaceuticals D4B9KS DRUGTYPE Antibody D4B9KS HIGHSTAT Phase 2 D4D0XY DRUG__ID D4D0XY D4D0XY DRUGCOMP FluGen D4D0XY DRUGTYPE Vaccine D4D0XY HIGHSTAT Phase 2 D4HM0Y DRUG__ID D4HM0Y D4HM0Y DRUGCOMP GlaxoSmithKline D4HM0Y DRUGTYPE Small molecule D4HM0Y HIGHSTAT Phase 2 D4K7BI DRUG__ID D4K7BI D4K7BI DRUGCOMP DermaGen AB; Promore Pharma D4K7BI DRUGTYPE Peptide D4K7BI HIGHSTAT Phase 2 D4LJO1 DRUG__ID D4LJO1 D4LJO1 DRUGCOMP RegeneRx Biopharmaceuticals D4LJO1 DRUGTYPE Peptide D4LJO1 HIGHSTAT Phase 2 D4LJO9 DRUG__ID D4LJO9 D4LJO9 DRUGCOMP Alcon D4LJO9 DRUGTYPE Antibody D4LJO9 HIGHSTAT Phase 2 D4ME2Z DRUG__ID D4ME2Z D4ME2Z DRUGCOMP ngmbio D4ME2Z DRUGTYPE Antibody D4ME2Z HIGHSTAT Phase 2 D4MZR2 DRUG__ID D4MZR2 D4MZR2 DRUGCOMP Berg Framingham, MA D4MZR2 DRUGTYPE Lipid-drug conjugate D4MZR2 HIGHSTAT Phase 2 D4N2JV DRUG__ID D4N2JV D4N2JV DRUGCOMP ProThena; Roche D4N2JV DRUGTYPE Antibody D4N2JV HIGHSTAT Phase 2 D4NF0L DRUG__ID D4NF0L D4NF0L DRUGCOMP Genentech D4NF0L DRUGTYPE Antibody D4NF0L HIGHSTAT Phase 2 D4RD0C DRUG__ID D4RD0C D4RD0C DRUGCOMP Sylentis D4RD0C DRUGTYPE Small interfering RNA D4RD0C HIGHSTAT Phase 2 D4T8JV DRUG__ID D4T8JV D4T8JV DRUGCOMP Marker Therapeutics D4T8JV DRUGTYPE Cell therapy D4T8JV HIGHSTAT Phase 2 D4X6SZ DRUG__ID D4X6SZ D4X6SZ DRUGCOMP PTC Therapeutics D4X6SZ DRUGTYPE Gene therapy D4X6SZ HIGHSTAT Phase 2 D4ZLC2 DRUG__ID D4ZLC2 D4ZLC2 DRUGCOMP Phio Pharmaceuticals D4ZLC2 DRUGTYPE Small interfering RNA D4ZLC2 HIGHSTAT Phase 2 D50ESV DRUG__ID D50ESV D50ESV DRUGCOMP Roche/Genentech D50ESV DRUGTYPE Antibody D50ESV HIGHSTAT Phase 2 D50OLM DRUG__ID D50OLM D50OLM DRUGCOMP Incyte D50OLM DRUGTYPE Small molecular drug D50OLM HIGHSTAT Phase 2 D52GSK DRUG__ID D52GSK D52GSK DRUGCOMP Bioventus Durham, NC D52GSK DRUGTYPE Cell therapy D52GSK HIGHSTAT Phase 2 D54QKH DRUG__ID D54QKH D54QKH DRUGCOMP TAKEDA D54QKH DRUGTYPE Monoclonal antibody D54QKH HIGHSTAT Phase 2 D5BUV4 DRUG__ID D5BUV4 D5BUV4 DRUGCOMP GlaxoSmithKline D5BUV4 DRUGTYPE Vaccine D5BUV4 HIGHSTAT Phase 2 D5H9TE DRUG__ID D5H9TE D5H9TE DRUGCOMP boehringer-ingelheim D5H9TE DRUGTYPE Small molecule D5H9TE HIGHSTAT Phase 2 D5J3BL DRUG__ID D5J3BL D5J3BL DRUGCOMP EMD Serono; GlaxoSmithKline D5J3BL DRUGTYPE Recombinant protein D5J3BL HIGHSTAT Phase 2 D5ON9Z DRUG__ID D5ON9Z D5ON9Z DRUGCOMP Astellas D5ON9Z DRUGTYPE Small molecular drug D5ON9Z HIGHSTAT Phase 2 D5Q6FS DRUG__ID D5Q6FS D5Q6FS DRUGCOMP Mesoblast D5Q6FS DRUGTYPE Cell therapy D5Q6FS HIGHSTAT Phase 2 D5R6AG DRUG__ID D5R6AG D5R6AG DRUGCOMP Antios Therapeutics D5R6AG DRUGTYPE Small molecular drug D5R6AG HIGHSTAT Phase 2 D5T3OY DRUG__ID D5T3OY D5T3OY DRUGCOMP Immunovaccine D5T3OY DRUGTYPE Vaccine D5T3OY HIGHSTAT Phase 2 D5TJ6M DRUG__ID D5TJ6M D5TJ6M DRUGCOMP ngmbio D5TJ6M DRUGTYPE Protein D5TJ6M HIGHSTAT Phase 2 D61PGU DRUG__ID D61PGU D61PGU DRUGCOMP Prometheus Biosciences D61PGU DRUGTYPE Antibody D61PGU HIGHSTAT Phase 2 D62FLA DRUG__ID D62FLA D62FLA DRUGCOMP Novartis D62FLA DRUGTYPE Antibody D62FLA HIGHSTAT Phase 2 D62LIX DRUG__ID D62LIX D62LIX DRUGCOMP BioNTech D62LIX DRUGTYPE Vaccine D62LIX HIGHSTAT Phase 2 D62LZO DRUG__ID D62LZO D62LZO DRUGCOMP Arthrosi Therapeutics D62LZO DRUGTYPE Small molecule D62LZO HIGHSTAT Phase 2 D67AKN DRUG__ID D67AKN D67AKN DRUGCOMP Poxel SA D67AKN DRUGTYPE Small molecular drug D67AKN HIGHSTAT Phase 2 D6A7KB DRUG__ID D6A7KB D6A7KB DRUGCOMP Endeavor BioMedicines D6A7KB DRUGTYPE Small molecule D6A7KB HIGHSTAT Phase 2 D6C7FG DRUG__ID D6C7FG D6C7FG DRUGCOMP Ventyx Biosciences Encinitas, CA D6C7FG DRUGTYPE Small molecule D6C7FG HIGHSTAT Phase 2 D6CS1B DRUG__ID D6CS1B D6CS1B DRUGCOMP MeiraGTx D6CS1B DRUGTYPE Gene therapy D6CS1B HIGHSTAT Phase 2 D6DPI4 DRUG__ID D6DPI4 D6DPI4 DRUGCOMP Assembly Biosciences D6DPI4 DRUGTYPE Small molecular drug D6DPI4 HIGHSTAT Phase 2 D6EQ3X DRUG__ID D6EQ3X D6EQ3X DRUGCOMP Themis Bioscience D6EQ3X DRUGTYPE Vaccine D6EQ3X HIGHSTAT Phase 2 D6FNV9 DRUG__ID D6FNV9 D6FNV9 DRUGCOMP InterveXion Therapeutics D6FNV9 DRUGTYPE Antibody D6FNV9 HIGHSTAT Phase 2 D6INZ9 DRUG__ID D6INZ9 D6INZ9 DRUGCOMP Aclaris Therapeutics D6INZ9 DRUGTYPE Small molecular drug D6INZ9 HIGHSTAT Phase 2 D6KEW7 DRUG__ID D6KEW7 D6KEW7 DRUGCOMP Youngene Therapeutics Shanghai, China D6KEW7 DRUGTYPE Small molecule D6KEW7 HIGHSTAT Phase 2 D6Q5MG DRUG__ID D6Q5MG D6Q5MG DRUGCOMP Argen Boston; Janssen D6Q5MG DRUGTYPE Antibody D6Q5MG HIGHSTAT Phase 2 D6R8MN DRUG__ID D6R8MN D6R8MN DRUGCOMP GlaxoSmithKline D6R8MN DRUGTYPE Vaccine D6R8MN HIGHSTAT Phase 2 D6SJ0B DRUG__ID D6SJ0B D6SJ0B DRUGCOMP Pfzer D6SJ0B DRUGTYPE Fusion protein D6SJ0B HIGHSTAT Phase 2 D6TS7K DRUG__ID D6TS7K D6TS7K DRUGCOMP Pfzer D6TS7K DRUGTYPE Fusion protein D6TS7K HIGHSTAT Phase 2 D6Z3HR DRUG__ID D6Z3HR D6Z3HR DRUGCOMP Meissa Vaccines D6Z3HR DRUGTYPE Vaccine D6Z3HR HIGHSTAT Phase 2 D6ZWX3 DRUG__ID D6ZWX3 D6ZWX3 DRUGCOMP BioNTech D6ZWX3 DRUGTYPE Antibody D6ZWX3 HIGHSTAT Phase 2 D74CFW DRUG__ID D74CFW D74CFW DRUGCOMP Phoenix Tissue Repair D74CFW DRUGTYPE Protein D74CFW HIGHSTAT Phase 2 D76INB DRUG__ID D76INB D76INB DRUGCOMP Novartis D76INB DRUGTYPE Antibody D76INB HIGHSTAT Phase 2 D7A5LO DRUG__ID D7A5LO D7A5LO DRUGCOMP Neuraly D7A5LO DRUGTYPE Small molecule D7A5LO HIGHSTAT Phase 2 D7AOL8 DRUG__ID D7AOL8 D7AOL8 DRUGCOMP BioNTech D7AOL8 DRUGTYPE Antibody D7AOL8 HIGHSTAT Phase 2 D7I3JM DRUG__ID D7I3JM D7I3JM DRUGCOMP Amgen D7I3JM DRUGTYPE Small molecule D7I3JM HIGHSTAT Phase 2 D7K3FB DRUG__ID D7K3FB D7K3FB DRUGCOMP CicloMed D7K3FB DRUGTYPE Small molecular drug D7K3FB HIGHSTAT Phase 2 D7NEV4 DRUG__ID D7NEV4 D7NEV4 DRUGCOMP ProMore Pharma D7NEV4 DRUGTYPE Peptide D7NEV4 HIGHSTAT Phase 2 D7NRF6 DRUG__ID D7NRF6 D7NRF6 DRUGCOMP ImmunityBio D7NRF6 DRUGTYPE Cell therapy D7NRF6 HIGHSTAT Phase 2 D7PVH4 DRUG__ID D7PVH4 D7PVH4 DRUGCOMP Novartis D7PVH4 DRUGTYPE Small molecular drug D7PVH4 HIGHSTAT Phase 2 D7RL1M DRUG__ID D7RL1M D7RL1M DRUGCOMP HeloCyte D7RL1M DRUGTYPE Vaccine D7RL1M HIGHSTAT Phase 2 D7XE8J DRUG__ID D7XE8J D7XE8J DRUGCOMP Valneva D7XE8J DRUGTYPE Vaccine D7XE8J HIGHSTAT Phase 2 D7XIR1 DRUG__ID D7XIR1 D7XIR1 DRUGCOMP Moderna D7XIR1 DRUGTYPE Vaccine D7XIR1 HIGHSTAT Phase 2 D81AQG DRUG__ID D81AQG D81AQG DRUGCOMP Amgen D81AQG DRUGTYPE Small interfering RNA D81AQG HIGHSTAT Phase 2 D81WHA DRUG__ID D81WHA D81WHA DRUGCOMP AstraZeneca; Ionis D81WHA DRUGTYPE Antisense oligonucleotide D81WHA HIGHSTAT Phase 2 D82BZH DRUG__ID D82BZH D82BZH DRUGCOMP BioAlta D82BZH DRUGTYPE Antibody drug conjugate D82BZH HIGHSTAT Phase 2 D82COK DRUG__ID D82COK D82COK DRUGCOMP Emergent BioSolutions D82COK DRUGTYPE Vaccine D82COK HIGHSTAT Phase 2 D82MSU DRUG__ID D82MSU D82MSU DRUGCOMP Teva Pharmaceutical D82MSU DRUGTYPE Antibody D82MSU HIGHSTAT Phase 2 D85NEG DRUG__ID D85NEG D85NEG DRUGCOMP Bayer D85NEG DRUGTYPE Small molecular drug D85NEG HIGHSTAT Phase 2 D87KMZ DRUG__ID D87KMZ D87KMZ DRUGCOMP ISA Pharmaceuticals D87KMZ DRUGTYPE Vaccine D87KMZ HIGHSTAT Phase 2 D89BYW DRUG__ID D89BYW D89BYW DRUGCOMP MiMedx Group Marietta, GA D89BYW DRUGTYPE Cell therapy D89BYW HIGHSTAT Phase 2 D89CRB DRUG__ID D89CRB D89CRB DRUGCOMP 4D Pharma D89CRB DRUGTYPE Live biotherapeutic D89CRB HIGHSTAT Phase 2 D8GJ1E DRUG__ID D8GJ1E D8GJ1E DRUGCOMP JOHNSON & JOHNSON D8GJ1E DRUGTYPE Small molecule D8GJ1E HIGHSTAT Phase 2 D8GVM1 DRUG__ID D8GVM1 D8GVM1 DRUGCOMP Sanofi D8GVM1 DRUGTYPE Small molecule D8GVM1 HIGHSTAT Phase 2 D8MIR2 DRUG__ID D8MIR2 D8MIR2 DRUGCOMP GlaxoSmithKline D8MIR2 DRUGTYPE Vaccine D8MIR2 HIGHSTAT Phase 2 D8N6HX DRUG__ID D8N6HX D8N6HX DRUGCOMP Bavarian Nordic D8N6HX DRUGTYPE Vaccine D8N6HX HIGHSTAT Phase 2 D8P1KS DRUG__ID D8P1KS D8P1KS DRUGCOMP Oncternal Therapeutics D8P1KS DRUGTYPE Monoclonal antibody D8P1KS HIGHSTAT Phase 2 D8PE7D DRUG__ID D8PE7D D8PE7D DRUGCOMP Aravive D8PE7D DRUGTYPE Protein D8PE7D HIGHSTAT Phase 2 D8SV9R DRUG__ID D8SV9R D8SV9R DRUGCOMP DNAtrix D8SV9R DRUGTYPE Oncolytic virus therapy D8SV9R HIGHSTAT Phase 2 D8U2EM DRUG__ID D8U2EM D8U2EM DRUGCOMP PapiVax Biotech D8U2EM DRUGTYPE Vaccine D8U2EM HIGHSTAT Phase 2 D8VJT5 DRUG__ID D8VJT5 D8VJT5 DRUGCOMP Zenith Epigenetics D8VJT5 DRUGTYPE Small molecular drug D8VJT5 HIGHSTAT Phase 2 D8ZNW0 DRUG__ID D8ZNW0 D8ZNW0 DRUGCOMP Medeor Therapeutics D8ZNW0 DRUGTYPE Cell therapy D8ZNW0 HIGHSTAT Phase 2 D90UZW DRUG__ID D90UZW D90UZW DRUGCOMP Ziopharm Oncology D90UZW DRUGTYPE Gene therapy D90UZW HIGHSTAT Phase 2 D92IFQ DRUG__ID D92IFQ D92IFQ DRUGCOMP Moderna D92IFQ DRUGTYPE Vaccine D92IFQ HIGHSTAT Phase 2 D93TWL DRUG__ID D93TWL D93TWL DRUGCOMP GlaxoSmithKline D93TWL DRUGTYPE Vaccine D93TWL HIGHSTAT Phase 2 D94NTP DRUG__ID D94NTP D94NTP DRUGCOMP GlaxoSmithKline D94NTP DRUGTYPE Vaccine D94NTP HIGHSTAT Phase 2 D96DPA DRUG__ID D96DPA D96DPA DRUGCOMP ExCellThera D96DPA DRUGTYPE Cell therapy D96DPA HIGHSTAT Phase 2 D96UBZ DRUG__ID D96UBZ D96UBZ DRUGCOMP Roche/Genentech D96UBZ DRUGTYPE Monoclonal antibody D96UBZ HIGHSTAT Phase 2 D97BHT DRUG__ID D97BHT D97BHT DRUGCOMP Pfzer D97BHT DRUGTYPE Monoclonal antibody D97BHT HIGHSTAT Phase 2 D9DS8O DRUG__ID D9DS8O D9DS8O DRUGCOMP NovaDigm Therapeutics D9DS8O DRUGTYPE Vaccine D9DS8O HIGHSTAT Phase 2 D9DWC6 DRUG__ID D9DWC6 D9DWC6 DRUGCOMP Anthos Therapeutics D9DWC6 DRUGTYPE Monoclonal antibody D9DWC6 HIGHSTAT Phase 2 D9EGS5 DRUG__ID D9EGS5 D9EGS5 DRUGCOMP Immunomic Therapeutics D9EGS5 DRUGTYPE Vaccine D9EGS5 HIGHSTAT Phase 2 D9HY7D DRUG__ID D9HY7D D9HY7D DRUGCOMP Seneca Therapeutics D9HY7D DRUGTYPE Oncolytic virus therapy D9HY7D HIGHSTAT Phase 2 D9J6XV DRUG__ID D9J6XV D9J6XV DRUGCOMP Ablynx D9J6XV DRUGTYPE Antibody D9J6XV HIGHSTAT Phase 2 D9LT5G DRUG__ID D9LT5G D9LT5G DRUGCOMP Bavarian Nordic D9LT5G DRUGTYPE Vaccine D9LT5G HIGHSTAT Phase 2 D9M8FK DRUG__ID D9M8FK D9M8FK DRUGCOMP Sarepta Therapeutics D9M8FK DRUGTYPE Gene therapy D9M8FK HIGHSTAT Phase 2 D9NJS5 DRUG__ID D9NJS5 D9NJS5 DRUGCOMP Inovio Pharmaceuticals D9NJS5 DRUGTYPE Vaccine D9NJS5 HIGHSTAT Phase 2 D9OS5I DRUG__ID D9OS5I D9OS5I DRUGCOMP SanBio; Sunovion Pharmaceuticals D9OS5I DRUGTYPE Cell therapy D9OS5I HIGHSTAT Phase 2 D9UZ5Q DRUG__ID D9UZ5Q D9UZ5Q DRUGCOMP NextCure D9UZ5Q DRUGTYPE Antibody D9UZ5Q HIGHSTAT Phase 2 D9VR6X DRUG__ID D9VR6X D9VR6X DRUGCOMP Ionis D9VR6X DRUGTYPE Ligand-conjugated antisense D9VR6X HIGHSTAT Phase 2 D9Y8OG DRUG__ID D9Y8OG D9Y8OG DRUGCOMP Cellvation D9Y8OG DRUGTYPE Cell therapy D9Y8OG HIGHSTAT Phase 2 DA08WU DRUG__ID DA08WU DA08WU DRUGCOMP Enanta Pharmaceuticals DA08WU DRUGTYPE Small molecular drug DA08WU HIGHSTAT Phase 2 DA1L7V DRUG__ID DA1L7V DA1L7V DRUGCOMP Axon Neuroscience DA1L7V DRUGTYPE Vaccine DA1L7V HIGHSTAT Phase 2 DA42VN DRUG__ID DA42VN DA42VN DRUGCOMP Adiso Therapeutics DA42VN DRUGTYPE Live biotherapeutic DA42VN HIGHSTAT Phase 2 DA6NG5 DRUG__ID DA6NG5 DA6NG5 DRUGCOMP Bird Rock Bio DA6NG5 DRUGTYPE Antibody DA6NG5 HIGHSTAT Phase 2 DA85NC DRUG__ID DA85NC DA85NC DRUGCOMP 60 Degrees Pharmaceuticals DA85NC DRUGTYPE Small molecular drug DA85NC HIGHSTAT Phase 2 DA85YQ DRUG__ID DA85YQ DA85YQ DRUGCOMP Takeda DA85YQ DRUGTYPE Antibody DA85YQ HIGHSTAT Phase 2 DA8W3Q DRUG__ID DA8W3Q DA8W3Q DRUGCOMP Oxurion DA8W3Q DRUGTYPE Small molecular drug DA8W3Q HIGHSTAT Phase 2 DA9O1Q DRUG__ID DA9O1Q DA9O1Q DRUGCOMP GlaxoSmithKline DA9O1Q DRUGTYPE Vaccine DA9O1Q HIGHSTAT Phase 2 DAL5C7 DRUG__ID DAL5C7 DAL5C7 DRUGCOMP Immutep DAL5C7 DRUGTYPE Recombinant?protein DAL5C7 HIGHSTAT Phase 2 DB18SE DRUG__ID DB18SE DB18SE DRUGCOMP Sage Therapeutics DB18SE DRUGTYPE Small molecular drug DB18SE HIGHSTAT Phase 2 DB5YU0 DRUG__ID DB5YU0 DB5YU0 DRUGCOMP Dermata Therapeutics DB5YU0 DRUGTYPE Small molecular drug DB5YU0 HIGHSTAT Phase 2 DBA40S DRUG__ID DBA40S DBA40S DRUGCOMP Pfizer DBA40S DRUGTYPE Antibody DBA40S HIGHSTAT Phase 2 DBF26U DRUG__ID DBF26U DBF26U DRUGCOMP boehringer-ingelheim DBF26U DRUGTYPE Small molecule DBF26U HIGHSTAT Phase 2 DBJ50D DRUG__ID DBJ50D DBJ50D DRUGCOMP Takeda DBJ50D DRUGTYPE Enzyme replacement DBJ50D HIGHSTAT Phase 2 DBU4N1 DRUG__ID DBU4N1 DBU4N1 DRUGCOMP Avalo Therapeutics DBU4N1 DRUGTYPE Antibody DBU4N1 HIGHSTAT Phase 2 DC1AV3 DRUG__ID DC1AV3 DC1AV3 DRUGCOMP Denali Therapeutics DC1AV3 DRUGTYPE Small molecular drug DC1AV3 HIGHSTAT Phase 2 DC29HL DRUG__ID DC29HL DC29HL DRUGCOMP Lundbeck DC29HL DRUGTYPE Small molecular drug DC29HL HIGHSTAT Phase 2 DC5NS1 DRUG__ID DC5NS1 DC5NS1 DRUGCOMP Peptron, Inc. DC5NS1 DRUGTYPE Peptide DC5NS1 HIGHSTAT Phase 2 DC6IR4 DRUG__ID DC6IR4 DC6IR4 DRUGCOMP Inovio Pharmaceuticals; GeneOne Life Science DC6IR4 DRUGTYPE Vaccine DC6IR4 HIGHSTAT Phase 2 DC86WO DRUG__ID DC86WO DC86WO DRUGCOMP Ionis; AstraZeneca DC86WO DRUGTYPE Ligand-conjugated antisense DC86WO HIGHSTAT Phase 2 DC9VX6 DRUG__ID DC9VX6 DC9VX6 DRUGCOMP Astelllas DC9VX6 DRUGTYPE Cell therapy DC9VX6 HIGHSTAT Phase 2 DCE09U DRUG__ID DCE09U DCE09U DRUGCOMP GlaxoSmithKline DCE09U DRUGTYPE Vaccine DCE09U HIGHSTAT Phase 2 DCL35B DRUG__ID DCL35B DCL35B DRUGCOMP JOHNSON & JOHNSON DCL35B DRUGTYPE Antibody DCL35B HIGHSTAT Phase 2 DCSZ97 DRUG__ID DCSZ97 DCSZ97 DRUGCOMP GlaxoSmithKline DCSZ97 DRUGTYPE Antibody DCSZ97 HIGHSTAT Phase 2 DCU94X DRUG__ID DCU94X DCU94X DRUGCOMP JN-International Medical DCU94X DRUGTYPE Vaccine DCU94X HIGHSTAT Phase 2 DCWS23 DRUG__ID DCWS23 DCWS23 DRUGCOMP Terumo DCWS23 DRUGTYPE Radiopharmaceutical therapy agent DCWS23 HIGHSTAT Phase 2 DD10IZ DRUG__ID DD10IZ DD10IZ DRUGCOMP AstraZeneca DD10IZ DRUGTYPE Antibody drug conjugate DD10IZ HIGHSTAT Phase 2 DD1ZV6 DRUG__ID DD1ZV6 DD1ZV6 DRUGCOMP Boehringer Ingelheim DD1ZV6 DRUGTYPE Small molecular drug DD1ZV6 HIGHSTAT Phase 2 DD25UM DRUG__ID DD25UM DD25UM DRUGCOMP Novartis/AAA DD25UM DRUGTYPE Radiopharmaceutical therapy agent DD25UM HIGHSTAT Phase 2 DD2C5E DRUG__ID DD2C5E DD2C5E DRUGCOMP Ionis Pharmaceuticals DD2C5E DRUGTYPE Antisense oligonucleotide DD2C5E HIGHSTAT Phase 2 DD3IE7 DRUG__ID DD3IE7 DD3IE7 DRUGCOMP Energenesis Biomedical DD3IE7 DRUGTYPE Small molecular drug DD3IE7 HIGHSTAT Phase 2 DD4E9T DRUG__ID DD4E9T DD4E9T DRUGCOMP CSL Behring DD4E9T DRUGTYPE Antibody DD4E9T HIGHSTAT Phase 2 DD6A7P DRUG__ID DD6A7P DD6A7P DRUGCOMP EQRx DD6A7P DRUGTYPE Small molecule DD6A7P HIGHSTAT Phase 2 DD76ER DRUG__ID DD76ER DD76ER DRUGCOMP RhoVac DD76ER DRUGTYPE Vaccine DD76ER HIGHSTAT Phase 2 DD9J4X DRUG__ID DD9J4X DD9J4X DRUGCOMP Sensei Biotherapeutics DD9J4X DRUGTYPE Vaccine DD9J4X HIGHSTAT Phase 2 DDAH09 DRUG__ID DDAH09 DDAH09 DRUGCOMP Merck DDAH09 DRUGTYPE Small molecule DDAH09 HIGHSTAT Phase 2 DDIO36 DRUG__ID DDIO36 DDIO36 DRUGCOMP Regeneron Pharmaceuticals DDIO36 DRUGTYPE Antibody DDIO36 HIGHSTAT Phase 2 DDL86V DRUG__ID DDL86V DDL86V DRUGCOMP Magenta Therapeutics DDL86V DRUGTYPE Cell therapy DDL86V HIGHSTAT Phase 2 DDP27A DRUG__ID DDP27A DDP27A DRUGCOMP Janssen DDP27A DRUGTYPE Vaccine DDP27A HIGHSTAT Phase 2 DDQH94 DRUG__ID DDQH94 DDQH94 DRUGCOMP Klus Pharma DDQH94 DRUGTYPE Small molecule DDQH94 HIGHSTAT Phase 2 DDU2Y0 DRUG__ID DDU2Y0 DDU2Y0 DRUGCOMP Akcea Therapeutics; Ionis Pharmaceuticals DDU2Y0 DRUGTYPE Antisense oligonucleotide DDU2Y0 HIGHSTAT Phase 2 DE09IO DRUG__ID DE09IO DE09IO DRUGCOMP Bioniz Therapeutics DE09IO DRUGTYPE Peptide DE09IO HIGHSTAT Phase 2 DE2H7C DRUG__ID DE2H7C DE2H7C DRUGCOMP Sanofi DE2H7C DRUGTYPE Vaccine DE2H7C HIGHSTAT Phase 2 DE2V3Y DRUG__ID DE2V3Y DE2V3Y DRUGCOMP Anchiano Therapeutics DE2V3Y DRUGTYPE Gene therapy DE2V3Y HIGHSTAT Phase 2 DE58RZ DRUG__ID DE58RZ DE58RZ DRUGCOMP Cue Biopharma DE58RZ DRUGTYPE Recombinant?protein DE58RZ HIGHSTAT Phase 2 DE5VG3 DRUG__ID DE5VG3 DE5VG3 DRUGCOMP NanoScope Technologies Bedford, TX DE5VG3 DRUGTYPE Gene therapy DE5VG3 HIGHSTAT Phase 2 DE61WB DRUG__ID DE61WB DE61WB DRUGCOMP NGM Biopharma DE61WB DRUGTYPE Antibody DE61WB HIGHSTAT Phase 2 DE6GF4 DRUG__ID DE6GF4 DE6GF4 DRUGCOMP Zydus Cadila DE6GF4 DRUGTYPE Small molecular drug DE6GF4 HIGHSTAT Phase 2 DEI4U0 DRUG__ID DEI4U0 DEI4U0 DRUGCOMP Hemera Biosciences DEI4U0 DRUGTYPE Gene therapy DEI4U0 HIGHSTAT Phase 2 DF04YM DRUG__ID DF04YM DF04YM DRUGCOMP AiCuris DF04YM DRUGTYPE Small molecular drug DF04YM HIGHSTAT Phase 2 DF0R5I DRUG__ID DF0R5I DF0R5I DRUGCOMP Astellas Pharma DF0R5I DRUGTYPE Small molecular drug DF0R5I HIGHSTAT Phase 2 DF1JO7 DRUG__ID DF1JO7 DF1JO7 DRUGCOMP Complexa DF1JO7 DRUGTYPE Small molecular drug DF1JO7 HIGHSTAT Phase 2 DF58YX DRUG__ID DF58YX DF58YX DRUGCOMP Amgen DF58YX DRUGTYPE Antibody peptide conjugate DF58YX HIGHSTAT Phase 2 DFG87U DRUG__ID DFG87U DFG87U DRUGCOMP AstraZeneca DFG87U DRUGTYPE Antibody DFG87U HIGHSTAT Phase 2 DFKH83 DRUG__ID DFKH83 DFKH83 DRUGCOMP ExeGi Pharma DFKH83 DRUGTYPE Live biotherapeutic DFKH83 HIGHSTAT Phase 2 DFS8A7 DRUG__ID DFS8A7 DFS8A7 DRUGCOMP IMV DFS8A7 DRUGTYPE Vaccine DFS8A7 HIGHSTAT Phase 2 DFTV08 DRUG__ID DFTV08 DFTV08 DRUGCOMP Tetherex Pharmaceuticals Oklahoma City, OK DFTV08 DRUGTYPE Antibody DFTV08 HIGHSTAT Phase 2 DFW5P7 DRUG__ID DFW5P7 DFW5P7 DRUGCOMP Genetic Immunity DFW5P7 DRUGTYPE Vaccine DFW5P7 HIGHSTAT Phase 2 DFX7K1 DRUG__ID DFX7K1 DFX7K1 DRUGCOMP ILiAD Biotechnologies DFX7K1 DRUGTYPE Vaccine DFX7K1 HIGHSTAT Phase 2 DFY5L8 DRUG__ID DFY5L8 DFY5L8 DRUGCOMP Adaptimmune Philadelphia, PA DFY5L8 DRUGTYPE CAR-T cell therapy DFY5L8 HIGHSTAT Phase 2 DFYL50 DRUG__ID DFYL50 DFYL50 DRUGCOMP I-MAB Biopharma Shanghai, China DFYL50 DRUGTYPE Antibody DFYL50 HIGHSTAT Phase 2 DFZ19J DRUG__ID DFZ19J DFZ19J DRUGCOMP BioNTech DFZ19J DRUGTYPE Antibody DFZ19J HIGHSTAT Phase 2 DG07WN DRUG__ID DG07WN DG07WN DRUGCOMP REGENXBIO DG07WN DRUGTYPE Gene therapy DG07WN HIGHSTAT Phase 2 DG2E7X DRUG__ID DG2E7X DG2E7X DRUGCOMP BioNTech DG2E7X DRUGTYPE Vaccine DG2E7X HIGHSTAT Phase 2 DG31WX DRUG__ID DG31WX DG31WX DRUGCOMP Allena Pharmaceuticals Newton, MA DG31WX DRUGTYPE Enzyme replacement DG31WX HIGHSTAT Phase 2 DG4X8E DRUG__ID DG4X8E DG4X8E DRUGCOMP Audentes Therapeutics DG4X8E DRUGTYPE Gene therapy DG4X8E HIGHSTAT Phase 2 DG5K6D DRUG__ID DG5K6D DG5K6D DRUGCOMP Apeiron Biologics DG5K6D DRUGTYPE Antibody DG5K6D HIGHSTAT Phase 2 DG61OC DRUG__ID DG61OC DG61OC DRUGCOMP Mirati Therapeutics DG61OC DRUGTYPE Small molecular drug DG61OC HIGHSTAT Phase 2 DG68CL DRUG__ID DG68CL DG68CL DRUGCOMP vTv Therapeutics DG68CL DRUGTYPE Small interfering RNA DG68CL HIGHSTAT Phase 2 DG9QY7 DRUG__ID DG9QY7 DG9QY7 DRUGCOMP Adynxx DG9QY7 DRUGTYPE Oligonucleotide DG9QY7 HIGHSTAT Phase 2 DGD93X DRUG__ID DGD93X DGD93X DRUGCOMP Ellipses Pharma DGD93X DRUGTYPE Nanoparticle-drug conjugate DGD93X HIGHSTAT Phase 2 DGOQ25 DRUG__ID DGOQ25 DGOQ25 DRUGCOMP Caliway Biopharmaceuticals New Taipei City, Taiwan DGOQ25 DRUGTYPE Small molecule DGOQ25 HIGHSTAT Phase 2 DH0A6O DRUG__ID DH0A6O DH0A6O DRUGCOMP Klus Pharma DH0A6O DRUGTYPE Small molecule DH0A6O HIGHSTAT Phase 2 DH0M2P DRUG__ID DH0M2P DH0M2P DRUGCOMP Cellectar DH0M2P DRUGTYPE Radiopharmaceutical therapy agent DH0M2P HIGHSTAT Phase 2 DH1W0G DRUG__ID DH1W0G DH1W0G DRUGCOMP Voyager Therapeutics DH1W0G DRUGTYPE Gene therapy DH1W0G HIGHSTAT Phase 2 DH82BG DRUG__ID DH82BG DH82BG DRUGCOMP Arcutis Biotherapeutics DH82BG DRUGTYPE Small molecular drug DH82BG HIGHSTAT Phase 2 DH8FY6 DRUG__ID DH8FY6 DH8FY6 DRUGCOMP Archemix DH8FY6 DRUGTYPE Small molecular drug DH8FY6 HIGHSTAT Phase 2 DHB2K8 DRUG__ID DHB2K8 DHB2K8 DRUGCOMP Olix Pharmaceuticals DHB2K8 DRUGTYPE Small interfering RNA DHB2K8 HIGHSTAT Phase 2 DHG2O3 DRUG__ID DHG2O3 DHG2O3 DRUGCOMP Colby Pharmaceuticals DHG2O3 DRUGTYPE Small interfering RNA DHG2O3 HIGHSTAT Phase 2 DHTN76 DRUG__ID DHTN76 DHTN76 DRUGCOMP Alnylam Pharmaceuticals: Cemdisiran DHTN76 DRUGTYPE Antisense oligonucleotide DHTN76 HIGHSTAT Phase 2 DI1S4K DRUG__ID DI1S4K DI1S4K DRUGCOMP GlaxoSmithKline DI1S4K DRUGTYPE Vaccine DI1S4K HIGHSTAT Phase 2 DI1TY4 DRUG__ID DI1TY4 DI1TY4 DRUGCOMP Lilly DI1TY4 DRUGTYPE Monoclonal Antibody DI1TY4 HIGHSTAT Phase 2 DI37UY DRUG__ID DI37UY DI37UY DRUGCOMP ViraCyte DI37UY DRUGTYPE Cell therapy DI37UY HIGHSTAT Phase 2 DI54FM DRUG__ID DI54FM DI54FM DRUGCOMP Sage Therapeutics DI54FM DRUGTYPE Small molecule DI54FM HIGHSTAT Phase 2 DI57MF DRUG__ID DI57MF DI57MF DRUGCOMP Memorial Sloan Kettering; Y-mAbs Therapeutics DI57MF DRUGTYPE Antibody DI57MF HIGHSTAT Phase 2 DI5V7K DRUG__ID DI5V7K DI5V7K DRUGCOMP Merck DI5V7K DRUGTYPE Vaccine DI5V7K HIGHSTAT Phase 2 DI6G5U DRUG__ID DI6G5U DI6G5U DRUGCOMP Sanofi DI6G5U DRUGTYPE Antibody DI6G5U HIGHSTAT Phase 2 DIAM05 DRUG__ID DIAM05 DIAM05 DRUGCOMP Wintree Therapeutics DIAM05 DRUGTYPE Small molecular drug DIAM05 HIGHSTAT Phase 2 DIC20P DRUG__ID DIC20P DIC20P DRUGCOMP Hope Biosciences DIC20P DRUGTYPE Cell therapy DIC20P HIGHSTAT Phase 2 DIKA27 DRUG__ID DIKA27 DIKA27 DRUGCOMP Tessa Therapeutics DIKA27 DRUGTYPE CAR-T cell therapy DIKA27 HIGHSTAT Phase 2 DILV59 DRUG__ID DILV59 DILV59 DRUGCOMP Hookipa Pharma DILV59 DRUGTYPE Vaccine DILV59 HIGHSTAT Phase 2 DIQ9G6 DRUG__ID DIQ9G6 DIQ9G6 DRUGCOMP VBI Vaccines DIQ9G6 DRUGTYPE Vaccine DIQ9G6 HIGHSTAT Phase 2 DIWL76 DRUG__ID DIWL76 DIWL76 DRUGCOMP Istari Oncology DIWL76 DRUGTYPE Vaccine DIWL76 HIGHSTAT Phase 2 DJ2N3L DRUG__ID DJ2N3L DJ2N3L DRUGCOMP Bristol-Myers Squibb DJ2N3L DRUGTYPE Antibody DJ2N3L HIGHSTAT Phase 2 DJ81QF DRUG__ID DJ81QF DJ81QF DRUGCOMP Vedanta Biosciences DJ81QF DRUGTYPE Live biotherapeutic product DJ81QF HIGHSTAT Phase 2 DJF1S3 DRUG__ID DJF1S3 DJF1S3 DRUGCOMP boehringer-ingelheim DJF1S3 DRUGTYPE Antibody DJF1S3 HIGHSTAT Phase 2 DJH56Z DRUG__ID DJH56Z DJH56Z DRUGCOMP Janssen DJH56Z DRUGTYPE Monoclonal antibody DJH56Z HIGHSTAT Phase 2 DJHY39 DRUG__ID DJHY39 DJHY39 DRUGCOMP Asklepios BioPharmaceutical Research DJHY39 DRUGTYPE Gene therapy DJHY39 HIGHSTAT Phase 2 DJM3W0 DRUG__ID DJM3W0 DJM3W0 DRUGCOMP Rezolute DJM3W0 DRUGTYPE Antibody DJM3W0 HIGHSTAT Phase 2 DJX61M DRUG__ID DJX61M DJX61M DRUGCOMP Xencor DJX61M DRUGTYPE Bispecific antibody DJX61M HIGHSTAT Phase 2 DK0I3U DRUG__ID DK0I3U DK0I3U DRUGCOMP Destiny Pharma DK0I3U DRUGTYPE Live biotherapeutic DK0I3U HIGHSTAT Phase 2 DK6BL5 DRUG__ID DK6BL5 DK6BL5 DRUGCOMP Roche/Genentech DK6BL5 DRUGTYPE Monoclonal antibody DK6BL5 HIGHSTAT Phase 2 DKB8X2 DRUG__ID DKB8X2 DKB8X2 DRUGCOMP Medeor Therapeutics DKB8X2 DRUGTYPE Cell therapy DKB8X2 HIGHSTAT Phase 2 DKF95S DRUG__ID DKF95S DKF95S DRUGCOMP BioNTech DKF95S DRUGTYPE Vaccine DKF95S HIGHSTAT Phase 2 DKM79E DRUG__ID DKM79E DKM79E DRUGCOMP Incyte DKM79E DRUGTYPE Small molecular drug DKM79E HIGHSTAT Phase 2 DKP0T7 DRUG__ID DKP0T7 DKP0T7 DRUGCOMP Gossamer Bio San Diego, CA DKP0T7 DRUGTYPE Small molecule DKP0T7 HIGHSTAT Phase 2 DKV13J DRUG__ID DKV13J DKV13J DRUGCOMP GlaxoSmithKline DKV13J DRUGTYPE Vaccine DKV13J HIGHSTAT Phase 2 DL2AD7 DRUG__ID DL2AD7 DL2AD7 DRUGCOMP Epitopoietic Research DL2AD7 DRUGTYPE Vaccine DL2AD7 HIGHSTAT Phase 2 DL2HO7 DRUG__ID DL2HO7 DL2HO7 DRUGCOMP Evive Biotech Bridgewater, NJ DL2HO7 DRUGTYPE Recombinant protein DL2HO7 HIGHSTAT Phase 2 DL5C1W DRUG__ID DL5C1W DL5C1W DRUGCOMP Iovance Biotherapeutics DL5C1W DRUGTYPE Cell therapy DL5C1W HIGHSTAT Phase 2 DL76CW DRUG__ID DL76CW DL76CW DRUGCOMP Esperance Pharmaceuticals DL76CW DRUGTYPE Peptide DL76CW HIGHSTAT Phase 2 DL7HD5 DRUG__ID DL7HD5 DL7HD5 DRUGCOMP Rocket Pharmaceuticals DL7HD5 DRUGTYPE Gene therapy DL7HD5 HIGHSTAT Phase 2 DL7J8B DRUG__ID DL7J8B DL7J8B DRUGCOMP Rapa Therapeutics DL7J8B DRUGTYPE Cell therapy DL7J8B HIGHSTAT Phase 2 DLCB65 DRUG__ID DLCB65 DLCB65 DRUGCOMP Ionis Pharmaceuticals DLCB65 DRUGTYPE Antisense oligonucleotide DLCB65 HIGHSTAT Phase 2 DLM8G6 DRUG__ID DLM8G6 DLM8G6 DRUGCOMP Xencor DLM8G6 DRUGTYPE Bispecific antibody DLM8G6 HIGHSTAT Phase 2 DLN4R8 DRUG__ID DLN4R8 DLN4R8 DRUGCOMP MorphoSys DLN4R8 DRUGTYPE Antibody DLN4R8 HIGHSTAT Phase 2 DLPD74 DRUG__ID DLPD74 DLPD74 DRUGCOMP Neurotech DLPD74 DRUGTYPE Cell therapy DLPD74 HIGHSTAT Phase 2 DLQ4N0 DRUG__ID DLQ4N0 DLQ4N0 DRUGCOMP Regeneron Pharmaceuticals DLQ4N0 DRUGTYPE Antibody DLQ4N0 HIGHSTAT Phase 2 DLQS16 DRUG__ID DLQS16 DLQS16 DRUGCOMP Ionis Pharmaceuticals DLQS16 DRUGTYPE RNA interference DLQS16 HIGHSTAT Phase 2 DLV0Z8 DRUG__ID DLV0Z8 DLV0Z8 DRUGCOMP REMD Biotherapeutics DLV0Z8 DRUGTYPE Antibody DLV0Z8 HIGHSTAT Phase 2 DM7WY2 DRUG__ID DM7WY2 DM7WY2 DRUGCOMP Miracogen DM7WY2 DRUGTYPE Antibody drug conjugate DM7WY2 HIGHSTAT Phase 2 DMF73Z DRUG__ID DMF73Z DMF73Z DRUGCOMP Leap Therapeutics DMF73Z DRUGTYPE Antibody DMF73Z HIGHSTAT Phase 2 DMN03O DRUG__ID DMN03O DMN03O DRUGCOMP Immuron DMN03O DRUGTYPE Antibody DMN03O HIGHSTAT Phase 2 DMVJ21 DRUG__ID DMVJ21 DMVJ21 DRUGCOMP Urovant Sciences DMVJ21 DRUGTYPE Gene therapy DMVJ21 HIGHSTAT Phase 2 DMYS25 DRUG__ID DMYS25 DMYS25 DRUGCOMP BeiGene DMYS25 DRUGTYPE Small molecular drug DMYS25 HIGHSTAT Phase 2 DN28SH DRUG__ID DN28SH DN28SH DRUGCOMP Cartesian Therapeutics DN28SH DRUGTYPE CAR T Cell Therapy DN28SH HIGHSTAT Phase 2 DN2OL8 DRUG__ID DN2OL8 DN2OL8 DRUGCOMP Sanofi Bridgewater, NJ DN2OL8 DRUGTYPE Antibody DN2OL8 HIGHSTAT Phase 2 DN3IG4 DRUG__ID DN3IG4 DN3IG4 DRUGCOMP Merck DN3IG4 DRUGTYPE Vaccine DN3IG4 HIGHSTAT Phase 2 DN3KQ2 DRUG__ID DN3KQ2 DN3KQ2 DRUGCOMP BioNTech DN3KQ2 DRUGTYPE mRNA (modRNA) DN3KQ2 HIGHSTAT Phase 2 DN50JC DRUG__ID DN50JC DN50JC DRUGCOMP GlaxoSmithKline DN50JC DRUGTYPE Vaccine DN50JC HIGHSTAT Phase 2 DN5J9R DRUG__ID DN5J9R DN5J9R DRUGCOMP Scholar Rock DN5J9R DRUGTYPE Antibody DN5J9R HIGHSTAT Phase 2 DN8VS3 DRUG__ID DN8VS3 DN8VS3 DRUGCOMP Aelis Farma DN8VS3 DRUGTYPE Small molecular drug DN8VS3 HIGHSTAT Phase 2 DNCA54 DRUG__ID DNCA54 DNCA54 DRUGCOMP Cellectar Biosciences DNCA54 DRUGTYPE Small molecular drug DNCA54 HIGHSTAT Phase 2 DNET17 DRUG__ID DNET17 DNET17 DRUGCOMP ViiV Healthcare DNET17 DRUGTYPE Antibody DNET17 HIGHSTAT Phase 2 DNH67V DRUG__ID DNH67V DNH67V DRUGCOMP Silenseed DNH67V DRUGTYPE Small interfering RNA DNH67V HIGHSTAT Phase 2 DNHW41 DRUG__ID DNHW41 DNHW41 DRUGCOMP AnGes USA DNHW41 DRUGTYPE Gene therapy DNHW41 HIGHSTAT Phase 2 DNI61P DRUG__ID DNI61P DNI61P DRUGCOMP Finch Therapeutics DNI61P DRUGTYPE Small molecular drug DNI61P HIGHSTAT Phase 2 DNI7E3 DRUG__ID DNI7E3 DNI7E3 DRUGCOMP AstraZeneca DNI7E3 DRUGTYPE Antibody DNI7E3 HIGHSTAT Phase 2 DNS58L DRUG__ID DNS58L DNS58L DRUGCOMP Azevan Pharmaceuticals DNS58L DRUGTYPE Small molecular drug DNS58L HIGHSTAT Phase 2 DNV17I DRUG__ID DNV17I DNV17I DRUGCOMP Eli Lilly DNV17I DRUGTYPE Antibody DNV17I HIGHSTAT Phase 2 DNV2Y6 DRUG__ID DNV2Y6 DNV2Y6 DRUGCOMP Protara Therapeutics New York, NY DNV2Y6 DRUGTYPE Cell therapy DNV2Y6 HIGHSTAT Phase 2 DO0GJ1 DRUG__ID DO0GJ1 DO0GJ1 DRUGCOMP Novartis DO0GJ1 DRUGTYPE Antibody DO0GJ1 HIGHSTAT Phase 2 DO9B3Y DRUG__ID DO9B3Y DO9B3Y DRUGCOMP Arbutus Biopharma DO9B3Y DRUGTYPE Small interfering RNA DO9B3Y HIGHSTAT Phase 2 DOE7C4 DRUG__ID DOE7C4 DOE7C4 DRUGCOMP GlaxoSmithKline DOE7C4 DRUGTYPE Antisense oligonucleotide DOE7C4 HIGHSTAT Phase 2 DOE96M DRUG__ID DOE96M DOE96M DRUGCOMP Dicerna Pharmaceuticals DOE96M DRUGTYPE RNA interference DOE96M HIGHSTAT Phase 2 DOI7H2 DRUG__ID DOI7H2 DOI7H2 DRUGCOMP Agenis; Incyte DOI7H2 DRUGTYPE Antibody DOI7H2 HIGHSTAT Phase 2 DOJ2A5 DRUG__ID DOJ2A5 DOJ2A5 DRUGCOMP Pfzer DOJ2A5 DRUGTYPE Gene therapy DOJ2A5 HIGHSTAT Phase 2 DOYP92 DRUG__ID DOYP92 DOYP92 DRUGCOMP Merck DOYP92 DRUGTYPE Vaccine DOYP92 HIGHSTAT Phase 2 DP48WE DRUG__ID DP48WE DP48WE DRUGCOMP Allarity Therapeutics DP48WE DRUGTYPE Small molecular drug DP48WE HIGHSTAT Phase 2 DP9SF6 DRUG__ID DP9SF6 DP9SF6 DRUGCOMP Oxurion DP9SF6 DRUGTYPE Small molecular drug DP9SF6 HIGHSTAT Phase 2 DPB04G DRUG__ID DPB04G DPB04G DRUGCOMP GeneOne Life Science DPB04G DRUGTYPE Small molecular drug DPB04G HIGHSTAT Phase 2 DPC0T8 DRUG__ID DPC0T8 DPC0T8 DRUGCOMP Xalud Therapeutics DPC0T8 DRUGTYPE Gene therapy DPC0T8 HIGHSTAT Phase 2 DPJ01T DRUG__ID DPJ01T DPJ01T DRUGCOMP Hennepin Life Sciences DPJ01T DRUGTYPE Small molecular drug DPJ01T HIGHSTAT Phase 2 DQ18VG DRUG__ID DQ18VG DQ18VG DRUGCOMP Boston Pharmaceuticals DQ18VG DRUGTYPE Small molecular drug DQ18VG HIGHSTAT Phase 2 DQ1OJ4 DRUG__ID DQ1OJ4 DQ1OJ4 DRUGCOMP Alnylam Pharmaceuticals; Vir Biotechnology DQ1OJ4 DRUGTYPE Small interfering RNA DQ1OJ4 HIGHSTAT Phase 2 DQ2Y7L DRUG__ID DQ2Y7L DQ2Y7L DRUGCOMP Ionis Pharmaceuticals DQ2Y7L DRUGTYPE Antisense oligonucleotide DQ2Y7L HIGHSTAT Phase 2 DQ45GY DRUG__ID DQ45GY DQ45GY DRUGCOMP Visterra DQ45GY DRUGTYPE Antibody DQ45GY HIGHSTAT Phase 2 DQ5YL2 DRUG__ID DQ5YL2 DQ5YL2 DRUGCOMP Eledon Pharmaceuticals Irvine, CA DQ5YL2 DRUGTYPE Antibody DQ5YL2 HIGHSTAT Phase 2 DQ72BV DRUG__ID DQ72BV DQ72BV DRUGCOMP GlaxoSmithKline DQ72BV DRUGTYPE Antibody DQ72BV HIGHSTAT Phase 2 DQ7I6M DRUG__ID DQ7I6M DQ7I6M DRUGCOMP Arcturus Therapeutics DQ7I6M DRUGTYPE mRNA therapy DQ7I6M HIGHSTAT Phase 2 DQ7PB1 DRUG__ID DQ7PB1 DQ7PB1 DRUGCOMP Ionis Pharmaceuticals DQ7PB1 DRUGTYPE Antisense oligonucleotide DQ7PB1 HIGHSTAT Phase 2 DQ83JW DRUG__ID DQ83JW DQ83JW DRUGCOMP Invectys DQ83JW DRUGTYPE Vaccine DQ83JW HIGHSTAT Phase 2 DQ8X4A DRUG__ID DQ8X4A DQ8X4A DRUGCOMP Krystal Biotech DQ8X4A DRUGTYPE Gene therapy DQ8X4A HIGHSTAT Phase 2 DQGF20 DRUG__ID DQGF20 DQGF20 DRUGCOMP Alkermes DQGF20 DRUGTYPE Protein DQGF20 HIGHSTAT Phase 2 DQM48O DRUG__ID DQM48O DQM48O DRUGCOMP Roche DQM48O DRUGTYPE Antibody DQM48O HIGHSTAT Phase 2 DQY14Z DRUG__ID DQY14Z DQY14Z DRUGCOMP CSL Behring DQY14Z DRUGTYPE Recombinant?protein DQY14Z HIGHSTAT Phase 2 DR05IX DRUG__ID DR05IX DR05IX DRUGCOMP MacroGenics Rockville, MD DR05IX DRUGTYPE Bispecific antibody DR05IX HIGHSTAT Phase 2 DR07XM DRUG__ID DR07XM DR07XM DRUGCOMP Moderna DR07XM DRUGTYPE mRNA DR07XM HIGHSTAT Phase 2 DR39GZ DRUG__ID DR39GZ DR39GZ DRUGCOMP BioNTech DR39GZ DRUGTYPE Vaccine DR39GZ HIGHSTAT Phase 2 DR3F1P DRUG__ID DR3F1P DR3F1P DRUGCOMP BioNTech DR3F1P DRUGTYPE Vaccine DR3F1P HIGHSTAT Phase 2 DR76TW DRUG__ID DR76TW DR76TW DRUGCOMP Lilly Indianapolis, IN DR76TW DRUGTYPE Peptide DR76TW HIGHSTAT Phase 2 DR7EV6 DRUG__ID DR7EV6 DR7EV6 DRUGCOMP Arrowhead Pharmaceuticals DR7EV6 DRUGTYPE Small interfering RNA DR7EV6 HIGHSTAT Phase 2 DR8CM0 DRUG__ID DR8CM0 DR8CM0 DRUGCOMP Merck DR8CM0 DRUGTYPE Monoclonal antibody DR8CM0 HIGHSTAT Phase 2 DRFT15 DRUG__ID DRFT15 DRFT15 DRUGCOMP Caladrius Biosciences DRFT15 DRUGTYPE Cell therapy DRFT15 HIGHSTAT Phase 2 DRH03S DRUG__ID DRH03S DRH03S DRUGCOMP Amgen DRH03S DRUGTYPE Bispecific T-cell engager DRH03S HIGHSTAT Phase 2 DRQN21 DRUG__ID DRQN21 DRQN21 DRUGCOMP Zentalis Pharmaceuticals DRQN21 DRUGTYPE Small molecular drug DRQN21 HIGHSTAT Phase 2 DRT2P7 DRUG__ID DRT2P7 DRT2P7 DRUGCOMP Celsion DRT2P7 DRUGTYPE Gene therapy DRT2P7 HIGHSTAT Phase 2 DRV14M DRUG__ID DRV14M DRV14M DRUGCOMP GlaxoSmithKline DRV14M DRUGTYPE Vaccine DRV14M HIGHSTAT Phase 2 DS01GZ DRUG__ID DS01GZ DS01GZ DRUGCOMP Nohla Therapeutics DS01GZ DRUGTYPE Cell therapy DS01GZ HIGHSTAT Phase 2 DS15QG DRUG__ID DS15QG DS15QG DRUGCOMP Cellerant Therapeutics DS15QG DRUGTYPE Cell therapy DS15QG HIGHSTAT Phase 2 DS31JZ DRUG__ID DS31JZ DS31JZ DRUGCOMP Sunovion Pharmaceuticals DS31JZ DRUGTYPE Small molecular drug DS31JZ HIGHSTAT Phase 2 DS40LF DRUG__ID DS40LF DS40LF DRUGCOMP Y-mAbs Therapeutics DS40LF DRUGTYPE Vaccine DS40LF HIGHSTAT Phase 2 DS40LV DRUG__ID DS40LV DS40LV DRUGCOMP GlaxoSmithKline DS40LV DRUGTYPE Vaccine DS40LV HIGHSTAT Phase 2 DS6B1L DRUG__ID DS6B1L DS6B1L DRUGCOMP Seattle Genetics DS6B1L DRUGTYPE Antibody drug conjugate DS6B1L HIGHSTAT Phase 2 DS70MP DRUG__ID DS70MP DS70MP DRUGCOMP DiaMedica Therapeutics DS70MP DRUGTYPE Recombinant?protein DS70MP HIGHSTAT Phase 2 DS79KP DRUG__ID DS79KP DS79KP DRUGCOMP Tonix Pharmaceuticals DS79KP DRUGTYPE Recombinant protein DS79KP HIGHSTAT Phase 2 DSC3P4 DRUG__ID DSC3P4 DSC3P4 DRUGCOMP Moderna DSC3P4 DRUGTYPE mRNA therapy DSC3P4 HIGHSTAT Phase 2 DSIT20 DRUG__ID DSIT20 DSIT20 DRUGCOMP Actinium Pharmaceuticals DSIT20 DRUGTYPE Radiotherapy DSIT20 HIGHSTAT Phase 2 DT2N8D DRUG__ID DT2N8D DT2N8D DRUGCOMP Lilly DT2N8D DRUGTYPE Small interfering RNA DT2N8D HIGHSTAT Phase 2 DT3OE6 DRUG__ID DT3OE6 DT3OE6 DRUGCOMP Ayala Pharmaceuticals DT3OE6 DRUGTYPE Small molecular drug DT3OE6 HIGHSTAT Phase 2 DT7O8R DRUG__ID DT7O8R DT7O8R DRUGCOMP OncoSec Medical DT7O8R DRUGTYPE Gene therapy DT7O8R HIGHSTAT Phase 2 DTU7W2 DRUG__ID DTU7W2 DTU7W2 DRUGCOMP Kiadis Pharma DTU7W2 DRUGTYPE Cell therapy DTU7W2 HIGHSTAT Phase 2 DTY5W0 DRUG__ID DTY5W0 DTY5W0 DRUGCOMP Moderna Therapeutics; Merck DTY5W0 DRUGTYPE Vaccine DTY5W0 HIGHSTAT Phase 2 DU04SO DRUG__ID DU04SO DU04SO DRUGCOMP RegeneRx Biopharmaceuticals DU04SO DRUGTYPE Peptide DU04SO HIGHSTAT Phase 2 DU6O4B DRUG__ID DU6O4B DU6O4B DRUGCOMP Novartis Pharmaceuticals DU6O4B DRUGTYPE Antibody DU6O4B HIGHSTAT Phase 2 DUAO82 DRUG__ID DUAO82 DUAO82 DRUGCOMP Evotec DUAO82 DRUGTYPE Small molecular drug DUAO82 HIGHSTAT Phase 2 DUZ35W DRUG__ID DUZ35W DUZ35W DRUGCOMP Pfizer DUZ35W DRUGTYPE Vaccine DUZ35W HIGHSTAT Phase 2 DV2CR7 DRUG__ID DV2CR7 DV2CR7 DRUGCOMP Amgen DV2CR7 DRUGTYPE Small molecular drug DV2CR7 HIGHSTAT Phase 2 DV2N5P DRUG__ID DV2N5P DV2N5P DRUGCOMP Alphamab Oncology DV2N5P DRUGTYPE Antibody DV2N5P HIGHSTAT Phase 2 DVCB87 DRUG__ID DVCB87 DVCB87 DRUGCOMP Merck DVCB87 DRUGTYPE Small molecule DVCB87 HIGHSTAT Phase 2 DVCN93 DRUG__ID DVCN93 DVCN93 DRUGCOMP Agenis; Incyte DVCN93 DRUGTYPE Antibody DVCN93 HIGHSTAT Phase 2 DVG1O0 DRUG__ID DVG1O0 DVG1O0 DRUGCOMP HORIZON DVG1O0 DRUGTYPE Monoclonal antibody DVG1O0 HIGHSTAT Phase 2 DVI21W DRUG__ID DVI21W DVI21W DRUGCOMP Palatin Technologies Cranbury, NJ DVI21W DRUGTYPE Small molecule DVI21W HIGHSTAT Phase 2 DVQ1F5 DRUG__ID DVQ1F5 DVQ1F5 DRUGCOMP CoImmune Durham, NC DVQ1F5 DRUGTYPE Cell therapy DVQ1F5 HIGHSTAT Phase 2 DVS81T DRUG__ID DVS81T DVS81T DRUGCOMP Zhejiang DTRM Biopharma DVS81T DRUGTYPE Small molecular drug DVS81T HIGHSTAT Phase 2 DVT3F8 DRUG__ID DVT3F8 DVT3F8 DRUGCOMP Brickell Biotech DVT3F8 DRUGTYPE Small molecular drug DVT3F8 HIGHSTAT Phase 2 DVYW59 DRUG__ID DVYW59 DVYW59 DRUGCOMP AstraZeneca DVYW59 DRUGTYPE antibody DVYW59 HIGHSTAT Phase 2 DW08BG DRUG__ID DW08BG DW08BG DRUGCOMP Moderna Therapeutics DW08BG DRUGTYPE Vaccine DW08BG HIGHSTAT Phase 2 DW43DG DRUG__ID DW43DG DW43DG DRUGCOMP Novartis DW43DG DRUGTYPE Antibody DW43DG HIGHSTAT Phase 2 DW5UI2 DRUG__ID DW5UI2 DW5UI2 DRUGCOMP Larimar Therapeutics Bala Cynwyd, PA DW5UI2 DRUGTYPE Recombinant protein DW5UI2 HIGHSTAT Phase 2 DW7J9D DRUG__ID DW7J9D DW7J9D DRUGCOMP TrueBinding DW7J9D DRUGTYPE Monoclonal antibody DW7J9D HIGHSTAT Phase 2 DW7XC5 DRUG__ID DW7XC5 DW7XC5 DRUGCOMP Ionis Pharmaceuticals DW7XC5 DRUGTYPE Antisense oligonucleotide DW7XC5 HIGHSTAT Phase 2 DW9Y0Q DRUG__ID DW9Y0Q DW9Y0Q DRUGCOMP Raziel Therapeutics Rehovot, Israel DW9Y0Q DRUGTYPE Small molecule DW9Y0Q HIGHSTAT Phase 2 DWB8C5 DRUG__ID DWB8C5 DWB8C5 DRUGCOMP Pfizer; Valneva DWB8C5 DRUGTYPE Vaccine DWB8C5 HIGHSTAT Phase 2 DWD3V2 DRUG__ID DWD3V2 DWD3V2 DRUGCOMP AmMax Bio redwood City, CA DWD3V2 DRUGTYPE Antibody DWD3V2 HIGHSTAT Phase 2 DWK5H3 DRUG__ID DWK5H3 DWK5H3 DRUGCOMP Armata Pharmaceuticals DWK5H3 DRUGTYPE Peptide DWK5H3 HIGHSTAT Phase 2 DWZ02M DRUG__ID DWZ02M DWZ02M DRUGCOMP MimiVax Buffalo, NY DWZ02M DRUGTYPE Vaccine DWZ02M HIGHSTAT Phase 2 DWZX75 DRUG__ID DWZX75 DWZX75 DRUGCOMP Moderna DWZX75 DRUGTYPE Vaccine DWZX75 HIGHSTAT Phase 2 DX1U3C DRUG__ID DX1U3C DX1U3C DRUGCOMP Boehringer Ingelheim; Zealand Pharma DX1U3C DRUGTYPE Small molecular drug DX1U3C HIGHSTAT Phase 2 DX56JK DRUG__ID DX56JK DX56JK DRUGCOMP Metacrine DX56JK DRUGTYPE Small molecular drug DX56JK HIGHSTAT Phase 2 DX5A8D DRUG__ID DX5A8D DX5A8D DRUGCOMP Daiichi Sankyo Basking Ridge, NJ DX5A8D DRUGTYPE Antibody drug conjugate DX5A8D HIGHSTAT Phase 2 DX9KC2 DRUG__ID DX9KC2 DX9KC2 DRUGCOMP PTC Therapeutics DX9KC2 DRUGTYPE Gene therapy DX9KC2 HIGHSTAT Phase 2 DXCR87 DRUG__ID DXCR87 DXCR87 DRUGCOMP Okogen DXCR87 DRUGTYPE Protein DXCR87 HIGHSTAT Phase 2 DXD69J DRUG__ID DXD69J DXD69J DRUGCOMP AstraZeneca DXD69J DRUGTYPE Small molecular drug DXD69J HIGHSTAT Phase 2 DXJH93 DRUG__ID DXJH93 DXJH93 DRUGCOMP Akeso Biopharma DXJH93 DRUGTYPE Antibody DXJH93 HIGHSTAT Phase 2 DXM30Y DRUG__ID DXM30Y DXM30Y DRUGCOMP La Jolla Pharmaceutical DXM30Y DRUGTYPE Peptide DXM30Y HIGHSTAT Phase 2 DXPU73 DRUG__ID DXPU73 DXPU73 DRUGCOMP Moderna DXPU73 DRUGTYPE Vaccine DXPU73 HIGHSTAT Phase 2 DXR7G0 DRUG__ID DXR7G0 DXR7G0 DRUGCOMP Sanofi DXR7G0 DRUGTYPE Vaccine DXR7G0 HIGHSTAT Phase 2 DXW68B DRUG__ID DXW68B DXW68B DRUGCOMP Applied Molecular Transport South San Francisco, CA DXW68B DRUGTYPE Fusion protein DXW68B HIGHSTAT Phase 2 DXWP72 DRUG__ID DXWP72 DXWP72 DRUGCOMP VasGene Therapeutics DXWP72 DRUGTYPE Recombinant protein DXWP72 HIGHSTAT Phase 2 DY67HC DRUG__ID DY67HC DY67HC DRUGCOMP Merck DY67HC DRUGTYPE Peptide DY67HC HIGHSTAT Phase 2 DY6DS3 DRUG__ID DY6DS3 DY6DS3 DRUGCOMP AbbVie DY6DS3 DRUGTYPE Monoclonal antibody DY6DS3 HIGHSTAT Phase 2 DYHI06 DRUG__ID DYHI06 DYHI06 DRUGCOMP Caladrius Biosciences DYHI06 DRUGTYPE Cell therapy DYHI06 HIGHSTAT Phase 2 DYI4L2 DRUG__ID DYI4L2 DYI4L2 DRUGCOMP BioAtla DYI4L2 DRUGTYPE Antibody drug conjugate DYI4L2 HIGHSTAT Phase 2 DYP56K DRUG__ID DYP56K DYP56K DRUGCOMP Vaxart DYP56K DRUGTYPE Vaccine DYP56K HIGHSTAT Phase 2 DYSA16 DRUG__ID DYSA16 DYSA16 DRUGCOMP Renova Therapeutics DYSA16 DRUGTYPE Peptide DYSA16 HIGHSTAT Phase 2 DYT9B4 DRUG__ID DYT9B4 DYT9B4 DRUGCOMP AbbVie DYT9B4 DRUGTYPE Monoclonal antibody DYT9B4 HIGHSTAT Phase 2 DYU37E DRUG__ID DYU37E DYU37E DRUGCOMP Evelo Biosciences DYU37E DRUGTYPE Live biotherapeutic product DYU37E HIGHSTAT Phase 2 DYW34G DRUG__ID DYW34G DYW34G DRUGCOMP jCyte DYW34G DRUGTYPE Cell therapy DYW34G HIGHSTAT Phase 2 DYZA20 DRUG__ID DYZA20 DYZA20 DRUGCOMP Morphic Therapeutic Waltham, MA DYZA20 DRUGTYPE Small molecule DYZA20 HIGHSTAT Phase 2 DZ35AP DRUG__ID DZ35AP DZ35AP DRUGCOMP Takeda DZ35AP DRUGTYPE Small molecule DZ35AP HIGHSTAT Phase 2 DZ4A1W DRUG__ID DZ4A1W DZ4A1W DRUGCOMP Takara Bio DZ4A1W DRUGTYPE Oncolytic virus therapy DZ4A1W HIGHSTAT Phase 2 DZ7Q8I DRUG__ID DZ7Q8I DZ7Q8I DRUGCOMP Ionis DZ7Q8I DRUGTYPE Antisense oligonucleotide DZ7Q8I HIGHSTAT Phase 2 DZ9BD3 DRUG__ID DZ9BD3 DZ9BD3 DRUGCOMP Emergent BioSolutions DZ9BD3 DRUGTYPE Vaccine DZ9BD3 HIGHSTAT Phase 2 DZ9N5O DRUG__ID DZ9N5O DZ9N5O DRUGCOMP BioCryst Pharmaceuticals DZ9N5O DRUGTYPE Small molecule DZ9N5O HIGHSTAT Phase 2 DZD7W6 DRUG__ID DZD7W6 DZD7W6 DRUGCOMP Merck DZD7W6 DRUGTYPE Monoclonal antibody DZD7W6 HIGHSTAT Phase 2 DZEF27 DRUG__ID DZEF27 DZEF27 DRUGCOMP OcuNexus Therapeutics DZEF27 DRUGTYPE Small molecular drug DZEF27 HIGHSTAT Phase 2 DZM2L1 DRUG__ID DZM2L1 DZM2L1 DRUGCOMP Affimed Therapeutics DZM2L1 DRUGTYPE Antibody DZM2L1 HIGHSTAT Phase 2 DZMO76 DRUG__ID DZMO76 DZMO76 DRUGCOMP Jounce Therapeutics DZMO76 DRUGTYPE Antibody DZMO76 HIGHSTAT Phase 2 DZNH43 DRUG__ID DZNH43 DZNH43 DRUGCOMP Molecular Templates DZNH43 DRUGTYPE Recombinant?protein DZNH43 HIGHSTAT Phase 2 DZQI76 DRUG__ID DZQI76 DZQI76 DRUGCOMP Araclon Biotech DZQI76 DRUGTYPE Vaccine DZQI76 HIGHSTAT Phase 2 DZW53X DRUG__ID DZW53X DZW53X DRUGCOMP AnaptysBio DZW53X DRUGTYPE Antibody DZW53X HIGHSTAT Phase 2 D00ABE DRUG__ID D00ABE D00ABE DRUGCOMP Aldagen Durham, NC D00ABE HIGHSTAT Phase 2 D00AES DRUG__ID D00AES D00AES DRUGCOMP Cantex Pharmaceuticals Weston, FL D00AES HIGHSTAT Phase 2 D00AKL DRUG__ID D00AKL D00AKL DRUGCOMP Eurocine Vaccines AB D00AKL HIGHSTAT Phase 2 D00AKQ DRUG__ID D00AKQ D00AKQ DRUGCOMP ParinGenix D00AKQ HIGHSTAT Phase 2 D00AKR DRUG__ID D00AKR D00AKR DRUGCOMP Amgen D00AKR HIGHSTAT Phase 2 D00ALJ DRUG__ID D00ALJ D00ALJ DRUGCOMP Pervasis Therapeutics D00ALJ HIGHSTAT Phase 2 D00ARS DRUG__ID D00ARS D00ARS DRUGCOMP Mercia Pharma Inc D00ARS HIGHSTAT Phase 2 D00AVH DRUG__ID D00AVH D00AVH DRUGCOMP Ventria bioscience D00AVH HIGHSTAT Phase 2 D00CPQ DRUG__ID D00CPQ D00CPQ DRUGCOMP United Therapeutics Silver Spring, MD D00CPQ HIGHSTAT Phase 2 D00CQQ DRUG__ID D00CQQ D00CQQ DRUGCOMP Fabre Kramer Pharmaceuticals Inc D00CQQ HIGHSTAT Phase 2 D00CSA DRUG__ID D00CSA D00CSA DRUGCOMP Novartis pharmaceuticals D00CSA HIGHSTAT Phase 2 D00CTZ DRUG__ID D00CTZ D00CTZ DRUGCOMP AstraZeneca D00CTZ HIGHSTAT Phase 2 D00EFO DRUG__ID D00EFO D00EFO DRUGCOMP Hanall biopharma; medtronic D00EFO HIGHSTAT Phase 2 D00EGN DRUG__ID D00EGN D00EGN DRUGCOMP E-Therapeutics Ltd D00EGN HIGHSTAT Phase 2 D00EJP DRUG__ID D00EJP D00EJP DRUGCOMP GlaxoSmithKline D00EJP HIGHSTAT Phase 2 D00EMB DRUG__ID D00EMB D00EMB DRUGCOMP GlaxoSmithKline plc D00EMB HIGHSTAT Phase 2 D00FBC DRUG__ID D00FBC D00FBC DRUGCOMP Kyowa Hakko Kirin Co Ltd D00FBC HIGHSTAT Phase 2 D00FJQ DRUG__ID D00FJQ D00FJQ DRUGCOMP NuSirt Biopharma Nashville, TN D00FJQ HIGHSTAT Phase 2 D00FMW DRUG__ID D00FMW D00FMW DRUGCOMP Iomai D00FMW HIGHSTAT Phase 2 D00FZZ DRUG__ID D00FZZ D00FZZ DRUGCOMP Bristol-Myers Squibb D00FZZ HIGHSTAT Phase 2 D00GFV DRUG__ID D00GFV D00GFV DRUGCOMP GD Searle & Co D00GFV HIGHSTAT Phase 2 D00GHG DRUG__ID D00GHG D00GHG DRUGCOMP VaxInnate D00GHG HIGHSTAT Phase 2 D00GIR DRUG__ID D00GIR D00GIR DRUGCOMP DAC Srl D00GIR HIGHSTAT Phase 2 D00GJK DRUG__ID D00GJK D00GJK DRUGCOMP Laboratorios Leti SL D00GJK HIGHSTAT Phase 2 D00GOH DRUG__ID D00GOH D00GOH DRUGCOMP XTL Biopharmaceuticals D00GOH HIGHSTAT Phase 2 D00HDB DRUG__ID D00HDB D00HDB DRUGCOMP Acorda therapeutics D00HDB HIGHSTAT Phase 2 D00HMZ DRUG__ID D00HMZ D00HMZ DRUGCOMP Tvax biomedical D00HMZ HIGHSTAT Phase 2 D00HQE DRUG__ID D00HQE D00HQE DRUGCOMP Avant Immunotherapeutics D00HQE HIGHSTAT Phase 2 D00ICD DRUG__ID D00ICD D00ICD DRUGCOMP Bayer Schering Pharma AG; Novogen Ltd D00ICD HIGHSTAT Phase 2 D00ICY DRUG__ID D00ICY D00ICY DRUGCOMP Forward Pharma A/S D00ICY HIGHSTAT Phase 2 D00IDR DRUG__ID D00IDR D00IDR DRUGCOMP Biomarin pharmaceutical D00IDR HIGHSTAT Phase 2 D00IJM DRUG__ID D00IJM D00IJM DRUGCOMP Edison Pharmaceuticals Inc D00IJM HIGHSTAT Phase 2 D00IZD DRUG__ID D00IZD D00IZD DRUGCOMP DNAVEC Corp D00IZD HIGHSTAT Phase 2 D00IZY DRUG__ID D00IZY D00IZY DRUGCOMP Deacon biosciences D00IZY HIGHSTAT Phase 2 D00KHD DRUG__ID D00KHD D00KHD DRUGCOMP Mitsubishi Pharma Corp D00KHD HIGHSTAT Phase 2 D00LJF DRUG__ID D00LJF D00LJF DRUGCOMP DAVA Pharmaceuticals; IntelGenx D00LJF HIGHSTAT Phase 2 D00MTG DRUG__ID D00MTG D00MTG DRUGCOMP Sanofi D00MTG HIGHSTAT Phase 2 D00NBF DRUG__ID D00NBF D00NBF DRUGCOMP Genervon Biopharmaceuticals Pasadena, CA D00NBF HIGHSTAT Phase 2 D00NNI DRUG__ID D00NNI D00NNI DRUGCOMP Astellas Pharma Inc D00NNI HIGHSTAT Phase 2 D00NSD DRUG__ID D00NSD D00NSD DRUGCOMP Exelixis D00NSD HIGHSTAT Phase 2 D00NXT DRUG__ID D00NXT D00NXT DRUGCOMP Amgen; Xencor D00NXT HIGHSTAT Phase 2 D00ORZ DRUG__ID D00ORZ D00ORZ DRUGCOMP Bristol-Myers Squibb Co D00ORZ HIGHSTAT Phase 2 D00OWU DRUG__ID D00OWU D00OWU DRUGCOMP Reckitt benckiser pharmaceutical D00OWU HIGHSTAT Phase 2 D00OYC DRUG__ID D00OYC D00OYC DRUGCOMP VentiRx Pharmaceuticals Seattle, WA D00OYC HIGHSTAT Phase 2 D00PSG DRUG__ID D00PSG D00PSG DRUGCOMP Medinox Inc D00PSG HIGHSTAT Phase 2 D00PUT DRUG__ID D00PUT D00PUT DRUGCOMP Abbvie D00PUT HIGHSTAT Phase 2 D00QGV DRUG__ID D00QGV D00QGV DRUGCOMP Amarillo biosciences D00QGV HIGHSTAT Phase 2 D00QKS DRUG__ID D00QKS D00QKS DRUGCOMP Exonhit D00QKS HIGHSTAT Phase 2 D00RYU DRUG__ID D00RYU D00RYU DRUGCOMP Innate Pharma SA D00RYU HIGHSTAT Phase 2 D00SIZ DRUG__ID D00SIZ D00SIZ DRUGCOMP Genentech South San Francisco, CA D00SIZ HIGHSTAT Phase 2 D00THG DRUG__ID D00THG D00THG DRUGCOMP Santen Pharmaceutical Co Ltd D00THG HIGHSTAT Phase 2 D00TMK DRUG__ID D00TMK D00TMK DRUGCOMP Sanofi PasteurSwiftwater, PA D00TMK HIGHSTAT Phase 2 D00TUR DRUG__ID D00TUR D00TUR DRUGCOMP Eli Lilly D00TUR HIGHSTAT Phase 2 D00UFZ DRUG__ID D00UFZ D00UFZ DRUGCOMP Amgen D00UFZ HIGHSTAT Phase 2 D00UGX DRUG__ID D00UGX D00UGX DRUGCOMP Celgene Cellular Therapeutics D00UGX HIGHSTAT Phase 2 D00UNK DRUG__ID D00UNK D00UNK DRUGCOMP ImmunoGen Waltham, MA D00UNK HIGHSTAT Phase 2 D00UYR DRUG__ID D00UYR D00UYR DRUGCOMP Innovative Med Concepts Tuscaloosa, AL D00UYR HIGHSTAT Phase 2 D00VKK DRUG__ID D00VKK D00VKK DRUGCOMP Vascular Pharmaceuticals Research Triangle Park, NC D00VKK HIGHSTAT Phase 2 D00WBN DRUG__ID D00WBN D00WBN DRUGCOMP Alvine Pharmaceuticals Inc D00WBN HIGHSTAT Phase 2 D00WCT DRUG__ID D00WCT D00WCT DRUGCOMP Eagle Vision Pharmaceutical Corp D00WCT HIGHSTAT Phase 2 D00WMJ DRUG__ID D00WMJ D00WMJ DRUGCOMP CMC Contrast AB D00WMJ HIGHSTAT Phase 2 D00XNW DRUG__ID D00XNW D00XNW DRUGCOMP Alcon Research Ltd D00XNW HIGHSTAT Phase 2 D00ZHM DRUG__ID D00ZHM D00ZHM DRUGCOMP Anterogen Co Ltd D00ZHM HIGHSTAT Phase 2 D00ZLC DRUG__ID D00ZLC D00ZLC DRUGCOMP GenVec D00ZLC HIGHSTAT Phase 2 D01ADH DRUG__ID D01ADH D01ADH DRUGCOMP AdeTherapeutics Inc D01ADH HIGHSTAT Phase 2 D01AHI DRUG__ID D01AHI D01AHI DRUGCOMP Dance BiopharmaBrisbane, CA D01AHI HIGHSTAT Phase 2 D01BAU DRUG__ID D01BAU D01BAU DRUGCOMP Supernus Pharmaceuticals D01BAU HIGHSTAT Phase 2 D01CBE DRUG__ID D01CBE D01CBE DRUGCOMP Oncopeptides Stockholm, Sweden D01CBE HIGHSTAT Phase 2 D01CBG DRUG__ID D01CBG D01CBG DRUGCOMP Sarepta Therapeutics Cambridge, MA D01CBG HIGHSTAT Phase 2 D01CEG DRUG__ID D01CEG D01CEG DRUGCOMP Piramal Healthcare Ltd D01CEG HIGHSTAT Phase 2 D01CXJ DRUG__ID D01CXJ D01CXJ DRUGCOMP Pacgen life science D01CXJ HIGHSTAT Phase 2 D01DJI DRUG__ID D01DJI D01DJI DRUGCOMP PhytoCeutica Inc D01DJI HIGHSTAT Phase 2 D01DLT DRUG__ID D01DLT D01DLT DRUGCOMP PharmaCyte Biotech Laguna Hills, CA D01DLT HIGHSTAT Phase 2 D01DTO DRUG__ID D01DTO D01DTO DRUGCOMP AOBiome Cambridge, MA D01DTO HIGHSTAT Phase 2 D01EJG DRUG__ID D01EJG D01EJG DRUGCOMP AC Immune Lausanne, Switzerland Genentech South San Francisco, CA D01EJG HIGHSTAT Phase 2 D01EKN DRUG__ID D01EKN D01EKN DRUGCOMP Raven Biotechnologies D01EKN HIGHSTAT Phase 2 D01ERE DRUG__ID D01ERE D01ERE DRUGCOMP Astellas Pharma US Northbrook, IL D01ERE HIGHSTAT Phase 2 D01EXL DRUG__ID D01EXL D01EXL DRUGCOMP Vaccinogen D01EXL HIGHSTAT Phase 2 D01FBP DRUG__ID D01FBP D01FBP DRUGCOMP Janssen Alzheimer Immunotherapy; Pfizer D01FBP HIGHSTAT Phase 2 D01FBS DRUG__ID D01FBS D01FBS DRUGCOMP INSERM D01FBS HIGHSTAT Phase 2 D01FHL DRUG__ID D01FHL D01FHL DRUGCOMP Allergan Inc D01FHL HIGHSTAT Phase 2 D01FZX DRUG__ID D01FZX D01FZX DRUGCOMP LEO Pharma D01FZX HIGHSTAT Phase 2 D01GSE DRUG__ID D01GSE D01GSE DRUGCOMP Archemix Corp D01GSE HIGHSTAT Phase 2 D01GVM DRUG__ID D01GVM D01GVM DRUGCOMP QLT Inc D01GVM HIGHSTAT Phase 2 D01HYQ DRUG__ID D01HYQ D01HYQ DRUGCOMP onis Pharmaceuticals Carlsbad, CA D01HYQ HIGHSTAT Phase 2 D01ICY DRUG__ID D01ICY D01ICY DRUGCOMP Sanofi D01ICY HIGHSTAT Phase 2 D01ILA DRUG__ID D01ILA D01ILA DRUGCOMP GeNeuro SA D01ILA HIGHSTAT Phase 2 D01ITB DRUG__ID D01ITB D01ITB DRUGCOMP TheraVasc Cleveland, OH D01ITB HIGHSTAT Phase 2 D01IZE DRUG__ID D01IZE D01IZE DRUGCOMP Dynport vaccine D01IZE HIGHSTAT Phase 2 D01JMX DRUG__ID D01JMX D01JMX DRUGCOMP Insmed Inc D01JMX HIGHSTAT Phase 2 D01JNE DRUG__ID D01JNE D01JNE DRUGCOMP Cytopia Ltd; Cytopia D01JNE HIGHSTAT Phase 2 D01JPA DRUG__ID D01JPA D01JPA DRUGCOMP TRACON Pharmaceuticals D01JPA HIGHSTAT Phase 2 D01KMY DRUG__ID D01KMY D01KMY DRUGCOMP Merck D01KMY HIGHSTAT Phase 2 D01KQW DRUG__ID D01KQW D01KQW DRUGCOMP Infectious disease research institute; aeras global tb vaccine foundation D01KQW HIGHSTAT Phase 2 D01KWJ DRUG__ID D01KWJ D01KWJ DRUGCOMP Vertex Pharmaceuticals Boston, MA D01KWJ HIGHSTAT Phase 2 D01LES DRUG__ID D01LES D01LES DRUGCOMP Genentech D01LES HIGHSTAT Phase 2 D01LRM DRUG__ID D01LRM D01LRM DRUGCOMP Synageva BioPharma Corp D01LRM HIGHSTAT Phase 2 D01LSB DRUG__ID D01LSB D01LSB DRUGCOMP Genentech D01LSB HIGHSTAT Phase 2 D01MUW DRUG__ID D01MUW D01MUW DRUGCOMP Burzynski research institute D01MUW HIGHSTAT Phase 2 D01MVO DRUG__ID D01MVO D01MVO DRUGCOMP ArGentis Pharmaceuticals D01MVO HIGHSTAT Phase 2 D01NCS DRUG__ID D01NCS D01NCS DRUGCOMP Toltec Pharmaceuticals Llc D01NCS HIGHSTAT Phase 2 D01NDF DRUG__ID D01NDF D01NDF DRUGCOMP Avineuro Pharmaceuticals D01NDF HIGHSTAT Phase 2 D01NTH DRUG__ID D01NTH D01NTH DRUGCOMP University of Edinburgh D01NTH HIGHSTAT Phase 2 D01NXF DRUG__ID D01NXF D01NXF DRUGCOMP Celladon; Targeted Genetics D01NXF HIGHSTAT Phase 2 D01OMM DRUG__ID D01OMM D01OMM DRUGCOMP Vivaldi Biosciences Fort Collins, CO D01OMM HIGHSTAT Phase 2 D01PHK DRUG__ID D01PHK D01PHK DRUGCOMP Novactyl D01PHK HIGHSTAT Phase 2 D01QMK DRUG__ID D01QMK D01QMK DRUGCOMP Seattle GeneticsBothell, WA D01QMK HIGHSTAT Phase 2 D01SAV DRUG__ID D01SAV D01SAV DRUGCOMP Oshadi Drug Administration Ltd D01SAV HIGHSTAT Phase 2 D01SKT DRUG__ID D01SKT D01SKT DRUGCOMP Biogen, Cambridge, MA Ionis Pharmaceuticals Carlsbad, CA D01SKT HIGHSTAT Phase 2 D01SNV DRUG__ID D01SNV D01SNV DRUGCOMP Dompe, Milan, Italy D01SNV HIGHSTAT Phase 2 D01SQI DRUG__ID D01SQI D01SQI DRUGCOMP University of Pennsylvania D01SQI HIGHSTAT Phase 2 D01THN DRUG__ID D01THN D01THN DRUGCOMP Japan Tobacco Inc D01THN HIGHSTAT Phase 2 D01TMW DRUG__ID D01TMW D01TMW DRUGCOMP Boehringer Ingelheim Pharmaceuticals type 2 diabetes (pediatric) Bridgewater, NJ Eli Lilly Indianapolis, IN D01TMW HIGHSTAT Phase 2 D01UAD DRUG__ID D01UAD D01UAD DRUGCOMP Palvella Therapeutics Wayne, PA D01UAD HIGHSTAT Phase 2 D01UAU DRUG__ID D01UAU D01UAU DRUGCOMP Concert Pharmaceuticals Lexington, MA D01UAU HIGHSTAT Phase 2 D01UHA DRUG__ID D01UHA D01UHA DRUGCOMP Innate Therapeutics Ltd D01UHA HIGHSTAT Phase 2 D01UKK DRUG__ID D01UKK D01UKK DRUGCOMP Pfizer New York, NY D01UKK HIGHSTAT Phase 2 D01VLT DRUG__ID D01VLT D01VLT DRUGCOMP Astellas D01VLT HIGHSTAT Phase 2 D01VMZ DRUG__ID D01VMZ D01VMZ DRUGCOMP Arisaph Pharmaceuticals D01VMZ HIGHSTAT Phase 2 D01VRQ DRUG__ID D01VRQ D01VRQ DRUGCOMP Bayer D01VRQ HIGHSTAT Phase 2 D01VWD DRUG__ID D01VWD D01VWD DRUGCOMP Hemodynamic Therapeutics D01VWD HIGHSTAT Phase 2 D01WHC DRUG__ID D01WHC D01WHC DRUGCOMP Vical Inc D01WHC HIGHSTAT Phase 2 D01WLB DRUG__ID D01WLB D01WLB DRUGCOMP H Lundbeck A/S D01WLB HIGHSTAT Phase 2 D01XMC DRUG__ID D01XMC D01XMC DRUGCOMP Allergan Parsippany, NJ D01XMC HIGHSTAT Phase 2 D01YKR DRUG__ID D01YKR D01YKR DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ RegeneRx Biopharmaceuticals Louisville, KY D01YKR HIGHSTAT Phase 2 D01ZFK DRUG__ID D01ZFK D01ZFK DRUGCOMP GlaxoSmithKlineResearch Triangle Park, NC D01ZFK HIGHSTAT Phase 2 D01ZPY DRUG__ID D01ZPY D01ZPY DRUGCOMP Walter Reed Army Institute of Research D01ZPY HIGHSTAT Phase 2 D02BPX DRUG__ID D02BPX D02BPX DRUGCOMP Ngm biopharmaceuticals D02BPX HIGHSTAT Phase 2 D02CAF DRUG__ID D02CAF D02CAF DRUGCOMP NOXXON Pharma AG; Avant Immunotherapeutics D02CAF HIGHSTAT Phase 2 D02CFV DRUG__ID D02CFV D02CFV DRUGCOMP University of Tennessee D02CFV HIGHSTAT Phase 2 D02DWX DRUG__ID D02DWX D02DWX DRUGCOMP Therion Biologics D02DWX HIGHSTAT Phase 2 D02EEK DRUG__ID D02EEK D02EEK DRUGCOMP BZL Biologics D02EEK HIGHSTAT Phase 2 D02EFJ DRUG__ID D02EFJ D02EFJ DRUGCOMP Med Discovery SA D02EFJ HIGHSTAT Phase 2 D02FIC DRUG__ID D02FIC D02FIC DRUGCOMP Synphora AB D02FIC HIGHSTAT Phase 2 D02FPT DRUG__ID D02FPT D02FPT DRUGCOMP Novartis Vaccines & Diagnostics D02FPT HIGHSTAT Phase 2 D02FTV DRUG__ID D02FTV D02FTV DRUGCOMP Multivir; Introgen Therapeutics D02FTV HIGHSTAT Phase 2 D02FYE DRUG__ID D02FYE D02FYE DRUGCOMP Waratah Pharmaceuticals Inc D02FYE HIGHSTAT Phase 2 D02GGG DRUG__ID D02GGG D02GGG DRUGCOMP Braintree Laboratories Inc D02GGG HIGHSTAT Phase 2 D02GWJ DRUG__ID D02GWJ D02GWJ DRUGCOMP Laxdale Ltd D02GWJ HIGHSTAT Phase 2 D02HRD DRUG__ID D02HRD D02HRD DRUGCOMP Kissei Pharmaceutical Co Ltd D02HRD HIGHSTAT Phase 2 D02ITL DRUG__ID D02ITL D02ITL DRUGCOMP Avigen Inc D02ITL HIGHSTAT Phase 2 D02JBI DRUG__ID D02JBI D02JBI DRUGCOMP INtRON Biotechnology Inc D02JBI HIGHSTAT Phase 2 D02JDN DRUG__ID D02JDN D02JDN DRUGCOMP Hanall biopharma D02JDN HIGHSTAT Phase 2 D02JND DRUG__ID D02JND D02JND DRUGCOMP Argenta Discovery Ltd D02JND HIGHSTAT Phase 2 D02JZJ DRUG__ID D02JZJ D02JZJ DRUGCOMP E-Therapeutics Ltd D02JZJ HIGHSTAT Phase 2 D02KEL DRUG__ID D02KEL D02KEL DRUGCOMP Activartis biotech D02KEL HIGHSTAT Phase 2 D02KTA DRUG__ID D02KTA D02KTA DRUGCOMP Sol-Gel Technologies Ltd D02KTA HIGHSTAT Phase 2 D02MMF DRUG__ID D02MMF D02MMF DRUGCOMP FemmePharma Inc D02MMF HIGHSTAT Phase 2 D02MSG DRUG__ID D02MSG D02MSG DRUGCOMP Medidermis Ltd D02MSG HIGHSTAT Phase 2 D02NDC DRUG__ID D02NDC D02NDC DRUGCOMP GlaxoSmithKline Biologicals D02NDC HIGHSTAT Phase 2 D02NMR DRUG__ID D02NMR D02NMR DRUGCOMP Evgen Pharma D02NMR HIGHSTAT Phase 2 D02NOC DRUG__ID D02NOC D02NOC DRUGCOMP Peregrine Pharmaceuticals D02NOC HIGHSTAT Phase 2 D02PNP DRUG__ID D02PNP D02PNP DRUGCOMP Allergan D02PNP HIGHSTAT Phase 2 D02POH DRUG__ID D02POH D02POH DRUGCOMP Tanabe Seiyaku Co Ltd D02POH HIGHSTAT Phase 2 D02PSS DRUG__ID D02PSS D02PSS DRUGCOMP Roche D02PSS HIGHSTAT Phase 2 D02QDQ DRUG__ID D02QDQ D02QDQ DRUGCOMP Novartis AG D02QDQ HIGHSTAT Phase 2 D02QLQ DRUG__ID D02QLQ D02QLQ DRUGCOMP Serentis Ltd D02QLQ HIGHSTAT Phase 2 D02QZR DRUG__ID D02QZR D02QZR DRUGCOMP Eli Lilly & Co D02QZR HIGHSTAT Phase 2 D02REJ DRUG__ID D02REJ D02REJ DRUGCOMP Johnson & Johnson D02REJ HIGHSTAT Phase 2 D02RKG DRUG__ID D02RKG D02RKG DRUGCOMP Eisai D02RKG HIGHSTAT Phase 2 D02ROU DRUG__ID D02ROU D02ROU DRUGCOMP Astellas Pharma Inc D02ROU HIGHSTAT Phase 2 D02SEU DRUG__ID D02SEU D02SEU DRUGCOMP Pique therapeutics D02SEU HIGHSTAT Phase 2 D02SNJ DRUG__ID D02SNJ D02SNJ DRUGCOMP Shire D02SNJ HIGHSTAT Phase 2 D02SVQ DRUG__ID D02SVQ D02SVQ DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D02SVQ HIGHSTAT Phase 2 D02SXZ DRUG__ID D02SXZ D02SXZ DRUGCOMP Shionogi D02SXZ HIGHSTAT Phase 2 D02SYV DRUG__ID D02SYV D02SYV DRUGCOMP Humanigen Brisbane, CA D02SYV HIGHSTAT Phase 2 D02TSJ DRUG__ID D02TSJ D02TSJ DRUGCOMP Charleston Laboratories Jupiter, FL D02TSJ HIGHSTAT Phase 2 D02TXV DRUG__ID D02TXV D02TXV DRUGCOMP Theron pharmaceuticals D02TXV HIGHSTAT Phase 2 D02TYV DRUG__ID D02TYV D02TYV DRUGCOMP DermiPsor Ltd D02TYV HIGHSTAT Phase 2 D02TZB DRUG__ID D02TZB D02TZB DRUGCOMP XBiotech D02TZB HIGHSTAT Phase 2 D02UMF DRUG__ID D02UMF D02UMF DRUGCOMP Kotobuki Pharmaceutical Co Ltd D02UMF HIGHSTAT Phase 2 D02VBL DRUG__ID D02VBL D02VBL DRUGCOMP Transition Therapeutics D02VBL HIGHSTAT Phase 2 D02VIF DRUG__ID D02VIF D02VIF DRUGCOMP Olatec industries D02VIF HIGHSTAT Phase 2 D02VLT DRUG__ID D02VLT D02VLT DRUGCOMP Vaccine Technologies D02VLT HIGHSTAT Phase 2 D02VTB DRUG__ID D02VTB D02VTB DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ D02VTB HIGHSTAT Phase 2 D02VYE DRUG__ID D02VYE D02VYE DRUGCOMP Bristol-Myers Squibb Princeton, NJ D02VYE HIGHSTAT Phase 2 D02WMX DRUG__ID D02WMX D02WMX DRUGCOMP Crucell; celldex therapeutics; rockefeller university D02WMX HIGHSTAT Phase 2 D02XKK DRUG__ID D02XKK D02XKK DRUGCOMP Forum pharmaceuticals D02XKK HIGHSTAT Phase 2 D02XMD DRUG__ID D02XMD D02XMD DRUGCOMP Novartis AG D02XMD HIGHSTAT Phase 2 D02XUC DRUG__ID D02XUC D02XUC DRUGCOMP Factor Therapeutics tissue growth factor D02XUC HIGHSTAT Phase 2 D02XUN DRUG__ID D02XUN D02XUN DRUGCOMP Juvaris BioTherapeutics Inc D02XUN HIGHSTAT Phase 2 D02XXF DRUG__ID D02XXF D02XXF DRUGCOMP BioMarin Pharmaceuticals San Rafael, CA D02XXF HIGHSTAT Phase 2 D02ZAN DRUG__ID D02ZAN D02ZAN DRUGCOMP PharmAthene D02ZAN HIGHSTAT Phase 2 D02ZMB DRUG__ID D02ZMB D02ZMB DRUGCOMP Bristol-Myers Squibb Princeton, NJ D02ZMB HIGHSTAT Phase 2 D02ZZC DRUG__ID D02ZZC D02ZZC DRUGCOMP Novo Nordisk A/S D02ZZC HIGHSTAT Phase 2 D03AKH DRUG__ID D03AKH D03AKH DRUGCOMP Cerenis Therapeutics D03AKH HIGHSTAT Phase 2 D03AQZ DRUG__ID D03AQZ D03AQZ DRUGCOMP Activartis Biotech D03AQZ HIGHSTAT Phase 2 D03AXQ DRUG__ID D03AXQ D03AXQ DRUGCOMP Rockwell Medical Technologies D03AXQ HIGHSTAT Phase 2 D03BAC DRUG__ID D03BAC D03BAC DRUGCOMP ProCorde GmbH D03BAC HIGHSTAT Phase 2 D03CDK DRUG__ID D03CDK D03CDK DRUGCOMP Astellas Pharma Inc D03CDK HIGHSTAT Phase 2 D03DSX DRUG__ID D03DSX D03DSX DRUGCOMP Sanofi-Aventis D03DSX HIGHSTAT Phase 2 D03DUI DRUG__ID D03DUI D03DUI DRUGCOMP Glenmark Pharmaceuticals Mumbai, India D03DUI HIGHSTAT Phase 2 D03EZR DRUG__ID D03EZR D03EZR DRUGCOMP Cell medica D03EZR HIGHSTAT Phase 2 D03FFL DRUG__ID D03FFL D03FFL DRUGCOMP Croma Pharma GmbH D03FFL HIGHSTAT Phase 2 D03FUG DRUG__ID D03FUG D03FUG DRUGCOMP Sangart D03FUG HIGHSTAT Phase 2 D03GPK DRUG__ID D03GPK D03GPK DRUGCOMP Dong-A Pharmaceutical Co Ltd D03GPK HIGHSTAT Phase 2 D03GRD DRUG__ID D03GRD D03GRD DRUGCOMP SYGNIS Bioscience GmbH & Co KG D03GRD HIGHSTAT Phase 2 D03GSN DRUG__ID D03GSN D03GSN DRUGCOMP KalVista Pharmaceuticals Cambridge, MA D03GSN HIGHSTAT Phase 2 D03HAW DRUG__ID D03HAW D03HAW DRUGCOMP Neumedicines Inc D03HAW HIGHSTAT Phase 2 D03HSA DRUG__ID D03HSA D03HSA DRUGCOMP Actinium Pharmaceuticals New York, NY D03HSA HIGHSTAT Phase 2 D03IGB DRUG__ID D03IGB D03IGB DRUGCOMP Biovitrum D03IGB HIGHSTAT Phase 2 D03JCA DRUG__ID D03JCA D03JCA DRUGCOMP Mazence Inc D03JCA HIGHSTAT Phase 2 D03KHN DRUG__ID D03KHN D03KHN DRUGCOMP Cellectar LLC D03KHN HIGHSTAT Phase 2 D03KIZ DRUG__ID D03KIZ D03KIZ DRUGCOMP Genentech D03KIZ HIGHSTAT Phase 2 D03KVY DRUG__ID D03KVY D03KVY DRUGCOMP Intellectual property executives D03KVY HIGHSTAT Phase 2 D03LAI DRUG__ID D03LAI D03LAI DRUGCOMP Emd serono D03LAI HIGHSTAT Phase 2 D03LKU DRUG__ID D03LKU D03LKU DRUGCOMP Titan Pharmaceuticals D03LKU HIGHSTAT Phase 2 D03LKV DRUG__ID D03LKV D03LKV DRUGCOMP BioMarin Pharmaceutical San Rafael, CA D03LKV HIGHSTAT Phase 2 D03MSF DRUG__ID D03MSF D03MSF DRUGCOMP Bayer healthcare pharmaceuticals D03MSF HIGHSTAT Phase 2 D03MSV DRUG__ID D03MSV D03MSV DRUGCOMP PhaseBio Pharmaceuticals D03MSV HIGHSTAT Phase 2 D03MZU DRUG__ID D03MZU D03MZU DRUGCOMP APT D03MZU HIGHSTAT Phase 2 D03NIW DRUG__ID D03NIW D03NIW DRUGCOMP AOBiome Cambridge, MA D03NIW HIGHSTAT Phase 2 D03NMQ DRUG__ID D03NMQ D03NMQ DRUGCOMP University of Michigan D03NMQ HIGHSTAT Phase 2 D03NVS DRUG__ID D03NVS D03NVS DRUGCOMP NeuroCure Ltd D03NVS HIGHSTAT Phase 2 D03ONZ DRUG__ID D03ONZ D03ONZ DRUGCOMP DoNatur GmbH D03ONZ HIGHSTAT Phase 2 D03OSE DRUG__ID D03OSE D03OSE DRUGCOMP Biosante pharmaceuticals D03OSE HIGHSTAT Phase 2 D03OVH DRUG__ID D03OVH D03OVH DRUGCOMP CSL Ltd D03OVH HIGHSTAT Phase 2 D03PBW DRUG__ID D03PBW D03PBW DRUGCOMP The Procter & Gamble Co D03PBW HIGHSTAT Phase 2 D03PRC DRUG__ID D03PRC D03PRC DRUGCOMP Johns Hopkins University D03PRC HIGHSTAT Phase 2 D03PRM DRUG__ID D03PRM D03PRM DRUGCOMP Nippon Shinyaku Co Ltd D03PRM HIGHSTAT Phase 2 D03PXT DRUG__ID D03PXT D03PXT DRUGCOMP Nabi Biologics D03PXT HIGHSTAT Phase 2 D03RRJ DRUG__ID D03RRJ D03RRJ DRUGTYPE Antibody D03RRJ HIGHSTAT Phase 2 D03RVC DRUG__ID D03RVC D03RVC DRUGCOMP Yuhan Corp D03RVC HIGHSTAT Phase 2 D03RXS DRUG__ID D03RXS D03RXS DRUGCOMP Takeda Deerfield, IL D03RXS HIGHSTAT Phase 2 D03RYJ DRUG__ID D03RYJ D03RYJ DRUGCOMP Relmada Therapeutics New York, NY D03RYJ HIGHSTAT Phase 2 D03SKC DRUG__ID D03SKC D03SKC DRUGCOMP ActivX Biosciences D03SKC HIGHSTAT Phase 2 D03SLK DRUG__ID D03SLK D03SLK DRUGCOMP Sanofi-aventis; Glenmark Pharmaceuticals D03SLK HIGHSTAT Phase 2 D03STV DRUG__ID D03STV D03STV DRUGCOMP GlaxoSmithKline Biologicals D03STV HIGHSTAT Phase 2 D03SVG DRUG__ID D03SVG D03SVG DRUGCOMP Glaxosmithkline D03SVG HIGHSTAT Phase 2 D03TNG DRUG__ID D03TNG D03TNG DRUGCOMP GammaCan D03TNG HIGHSTAT Phase 2 D03TVY DRUG__ID D03TVY D03TVY DRUGCOMP Osiris Therapeutics D03TVY HIGHSTAT Phase 2 D03TYJ DRUG__ID D03TYJ D03TYJ DRUGCOMP Athersys D03TYJ HIGHSTAT Phase 2 D03TYY DRUG__ID D03TYY D03TYY DRUGCOMP Cytos Biotechnology D03TYY HIGHSTAT Phase 2 D03UBI DRUG__ID D03UBI D03UBI DRUGCOMP National Biopreparations Center D03UBI HIGHSTAT Phase 2 D03UZP DRUG__ID D03UZP D03UZP DRUGTYPE Antibody D03UZP HIGHSTAT Phase 2 D03VCJ DRUG__ID D03VCJ D03VCJ DRUGCOMP Medesis Pharma SA D03VCJ HIGHSTAT Phase 2 D03VLG DRUG__ID D03VLG D03VLG DRUGCOMP Development Centre for Biotechnology D03VLG HIGHSTAT Phase 2 D03VPM DRUG__ID D03VPM D03VPM DRUGCOMP Ubivac D03VPM HIGHSTAT Phase 2 D03WMZ DRUG__ID D03WMZ D03WMZ DRUGCOMP MedImmune Gaithersburg, MD D03WMZ HIGHSTAT Phase 2 D03XEY DRUG__ID D03XEY D03XEY DRUGCOMP Dana-Farber Cancer Institute Inc D03XEY HIGHSTAT Phase 2 D03XLX DRUG__ID D03XLX D03XLX DRUGCOMP Pfizer Inc D03XLX HIGHSTAT Phase 2 D03YIX DRUG__ID D03YIX D03YIX DRUGCOMP Medipost Co Ltd D03YIX HIGHSTAT Phase 2 D03YKQ DRUG__ID D03YKQ D03YKQ DRUGCOMP Sosei R&D Ltd D03YKQ HIGHSTAT Phase 2 D03ZYZ DRUG__ID D03ZYZ D03ZYZ DRUGCOMP Walter Reed Army Institute of Research D03ZYZ HIGHSTAT Phase 2 D03ZZM DRUG__ID D03ZZM D03ZZM DRUGCOMP Dermata Therapeutics San Diego, CA D03ZZM HIGHSTAT Phase 2 D04AIB DRUG__ID D04AIB D04AIB DRUGCOMP Ardelyx; astrazeneca D04AIB HIGHSTAT Phase 2 D04BFI DRUG__ID D04BFI D04BFI DRUGCOMP Ligand D04BFI HIGHSTAT Phase 2 D04BHS DRUG__ID D04BHS D04BHS DRUGCOMP SinoBiomed D04BHS HIGHSTAT Phase 2 D04BNA DRUG__ID D04BNA D04BNA DRUGCOMP DynPort Vaccine Company D04BNA HIGHSTAT Phase 2 D04BOK DRUG__ID D04BOK D04BOK DRUGCOMP Living Cell Technologies Ltd D04BOK HIGHSTAT Phase 2 D04BXX DRUG__ID D04BXX D04BXX DRUGCOMP Natco Pharma Ltd D04BXX HIGHSTAT Phase 2 D04CQK DRUG__ID D04CQK D04CQK DRUGCOMP Merck D04CQK HIGHSTAT Phase 2 D04DKL DRUG__ID D04DKL D04DKL DRUGCOMP Altor BioScience D04DKL HIGHSTAT Phase 2 D04DLW DRUG__ID D04DLW D04DLW DRUGCOMP Arbor Vita D04DLW HIGHSTAT Phase 2 D04DNB DRUG__ID D04DNB D04DNB DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D04DNB HIGHSTAT Phase 2 D04EAT DRUG__ID D04EAT D04EAT DRUGCOMP Novartis pharmaceuticals D04EAT HIGHSTAT Phase 2 D04ELS DRUG__ID D04ELS D04ELS DRUGCOMP Biotech Australia D04ELS HIGHSTAT Phase 2 D04FRU DRUG__ID D04FRU D04FRU DRUGCOMP Novartis East Hanover, NJ D04FRU HIGHSTAT Phase 2 D04GKP DRUG__ID D04GKP D04GKP DRUGCOMP Emd serono D04GKP HIGHSTAT Phase 2 D04GNX DRUG__ID D04GNX D04GNX DRUGCOMP Shire Lexington, MA D04GNX HIGHSTAT Phase 2 D04GRB DRUG__ID D04GRB D04GRB DRUGCOMP GlaxoSmithKline; Theravance D04GRB HIGHSTAT Phase 2 D04GTA DRUG__ID D04GTA D04GTA DRUGCOMP Amgen D04GTA HIGHSTAT Phase 2 D04HJE DRUG__ID D04HJE D04HJE DRUGCOMP Allozyne Inc D04HJE HIGHSTAT Phase 2 D04HMK DRUG__ID D04HMK D04HMK DRUGCOMP Oxford BioMedica D04HMK HIGHSTAT Phase 2 D04HQA DRUG__ID D04HQA D04HQA DRUGCOMP FIT Biotech Oyj Plc D04HQA HIGHSTAT Phase 2 D04IAJ DRUG__ID D04IAJ D04IAJ DRUGCOMP Emory University D04IAJ HIGHSTAT Phase 2 D04IHB DRUG__ID D04IHB D04IHB DRUGCOMP Archivel Farma SL D04IHB HIGHSTAT Phase 2 D04IKF DRUG__ID D04IKF D04IKF DRUGCOMP Lantheus medical imaging D04IKF HIGHSTAT Phase 2 D04IQH DRUG__ID D04IQH D04IQH DRUGCOMP Quark Pharmaceuticals D04IQH HIGHSTAT Phase 2 D04IXD DRUG__ID D04IXD D04IXD DRUGCOMP Innate Pharma D04IXD HIGHSTAT Phase 2 D04JAB DRUG__ID D04JAB D04JAB DRUGCOMP Opexa therapeutics D04JAB HIGHSTAT Phase 2 D04KBU DRUG__ID D04KBU D04KBU DRUGCOMP Aires pharmaceuticals D04KBU HIGHSTAT Phase 2 D04KYB DRUG__ID D04KYB D04KYB DRUGCOMP AndroScience D04KYB HIGHSTAT Phase 2 D04LEH DRUG__ID D04LEH D04LEH DRUGCOMP Acura Pharmaceuticals Palatine, IL D04LEH HIGHSTAT Phase 2 D04LJB DRUG__ID D04LJB D04LJB DRUGCOMP NovaBiotics Ltd D04LJB HIGHSTAT Phase 2 D04LMZ DRUG__ID D04LMZ D04LMZ DRUGCOMP 22nd Century Group D04LMZ HIGHSTAT Phase 2 D04LTQ DRUG__ID D04LTQ D04LTQ DRUGCOMP Orexigen Therapeutics D04LTQ HIGHSTAT Phase 2 D04LXB DRUG__ID D04LXB D04LXB DRUGCOMP SPECTRUM pharmaceuticals D04LXB HIGHSTAT Phase 2 D04MYS DRUG__ID D04MYS D04MYS DRUGCOMP Lupin Ltd D04MYS HIGHSTAT Phase 2 D04NDK DRUG__ID D04NDK D04NDK DRUGCOMP Latona Life Sciences D04NDK HIGHSTAT Phase 2 D04NIZ DRUG__ID D04NIZ D04NIZ DRUGCOMP Amgen D04NIZ HIGHSTAT Phase 2 D04NJP DRUG__ID D04NJP D04NJP DRUGCOMP TRF Pharma Inc D04NJP HIGHSTAT Phase 2 D04NRV DRUG__ID D04NRV D04NRV DRUGCOMP Immodulon Therapeutics Limited D04NRV HIGHSTAT Phase 2 D04NWU DRUG__ID D04NWU D04NWU DRUGCOMP Ono Pharmaceutical Co Ltd D04NWU HIGHSTAT Phase 2 D04OJM DRUG__ID D04OJM D04OJM DRUGCOMP Immunservice GmbH D04OJM HIGHSTAT Phase 2 D04OTH DRUG__ID D04OTH D04OTH DRUGCOMP Advanced Accelerator Applications Saint-Genis-Pouilly, France University of Iowa Iowa City, IA D04OTH HIGHSTAT Phase 2 D04OZL DRUG__ID D04OZL D04OZL DRUGCOMP Ludwig Institute for Cancer Research D04OZL HIGHSTAT Phase 2 D04PEO DRUG__ID D04PEO D04PEO DRUGCOMP Cytocom Orlando, FL D04PEO HIGHSTAT Phase 2 D04PIH DRUG__ID D04PIH D04PIH DRUGCOMP Novagenetics Inc D04PIH HIGHSTAT Phase 2 D04PMS DRUG__ID D04PMS D04PMS DRUGCOMP GlaxoSmithKline D04PMS HIGHSTAT Phase 2 D04PUO DRUG__ID D04PUO D04PUO DRUGCOMP Opiant Pharmaceuticals Santa Monica, CA D04PUO HIGHSTAT Phase 2 D04QUX DRUG__ID D04QUX D04QUX DRUGCOMP Pfizer Inc D04QUX HIGHSTAT Phase 2 D04SBI DRUG__ID D04SBI D04SBI DRUGCOMP Mallinckrodt Pharmaceuticals St. Louis, MO D04SBI HIGHSTAT Phase 2 D04SEJ DRUG__ID D04SEJ D04SEJ DRUGCOMP Ironwood Pharmaceuticals Inc D04SEJ HIGHSTAT Phase 2 D04SHH DRUG__ID D04SHH D04SHH DRUGCOMP Targacept Inc D04SHH HIGHSTAT Phase 2 D04SQO DRUG__ID D04SQO D04SQO DRUGCOMP DebiopharmLausanne, Switzerland ImmunoGenWaltham, MA D04SQO HIGHSTAT Phase 2 D04SRO DRUG__ID D04SRO D04SRO DRUGCOMP Grunenthal GmbH D04SRO HIGHSTAT Phase 2 D04SUX DRUG__ID D04SUX D04SUX DRUGCOMP Biomay AG D04SUX HIGHSTAT Phase 2 D04TEF DRUG__ID D04TEF D04TEF DRUGCOMP Transgene SA D04TEF HIGHSTAT Phase 2 D04TFL DRUG__ID D04TFL D04TFL DRUGCOMP Soligenix, Princeton, NJ D04TFL HIGHSTAT Phase 2 D04TJL DRUG__ID D04TJL D04TJL DRUGCOMP Almirall Prodesfarma SA D04TJL HIGHSTAT Phase 2 D04TPU DRUG__ID D04TPU D04TPU DRUGCOMP F Hoffmann-La Roche Ltd D04TPU HIGHSTAT Phase 2 D04UME DRUG__ID D04UME D04UME DRUGCOMP Boehringer Ingelheim Pharmaceuticals D04UME HIGHSTAT Phase 2 D04VHB DRUG__ID D04VHB D04VHB DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D04VHB HIGHSTAT Phase 2 D04VHK DRUG__ID D04VHK D04VHK DRUGCOMP Clera Inc D04VHK HIGHSTAT Phase 2 D04VMM DRUG__ID D04VMM D04VMM DRUGCOMP Rogosin Institute D04VMM HIGHSTAT Phase 2 D04VQH DRUG__ID D04VQH D04VQH DRUGCOMP Bristol-Myers Squibb Co D04VQH HIGHSTAT Phase 2 D04VVL DRUG__ID D04VVL D04VVL DRUGCOMP GlaxoSmithKlineResearch Triangle Park, NC D04VVL HIGHSTAT Phase 2 D04WCJ DRUG__ID D04WCJ D04WCJ DRUGCOMP DiaVacs Edgewater, NJ D04WCJ HIGHSTAT Phase 2 D04WDA DRUG__ID D04WDA D04WDA DRUGCOMP CSL Ltd D04WDA HIGHSTAT Phase 2 D04WVY DRUG__ID D04WVY D04WVY DRUGCOMP Selten Pharma, Saratoga, CA D04WVY HIGHSTAT Phase 2 D04WXG DRUG__ID D04WXG D04WXG DRUGCOMP DynPort Vaccine Company LLC D04WXG HIGHSTAT Phase 2 D04XIV DRUG__ID D04XIV D04XIV DRUGCOMP Mesoblast D04XIV HIGHSTAT Phase 2 D04XJE DRUG__ID D04XJE D04XJE DRUGCOMP Adgero Biopharmaceuticals Princeton, NJ D04XJE HIGHSTAT Phase 2 D04XPD DRUG__ID D04XPD D04XPD DRUGCOMP Diavacs D04XPD HIGHSTAT Phase 2 D04XTK DRUG__ID D04XTK D04XTK DRUGCOMP Shire pharmaceuticals D04XTK HIGHSTAT Phase 2 D04XVE DRUG__ID D04XVE D04XVE DRUGCOMP Novartis AG D04XVE HIGHSTAT Phase 2 D04YCQ DRUG__ID D04YCQ D04YCQ DRUGCOMP Genocea biosciences D04YCQ HIGHSTAT Phase 2 D04YLQ DRUG__ID D04YLQ D04YLQ DRUGCOMP Amgen D04YLQ HIGHSTAT Phase 2 D04ZBU DRUG__ID D04ZBU D04ZBU DRUGCOMP Japan Tobacco Inc D04ZBU HIGHSTAT Phase 2 D04ZNL DRUG__ID D04ZNL D04ZNL DRUGCOMP F Hoffmann-La Roche Ltd D04ZNL HIGHSTAT Phase 2 D04ZZT DRUG__ID D04ZZT D04ZZT DRUGCOMP Argos Therapeutics D04ZZT HIGHSTAT Phase 2 D05AEE DRUG__ID D05AEE D05AEE DRUGTYPE Antibody D05AEE HIGHSTAT Phase 2 D05AHC DRUG__ID D05AHC D05AHC DRUGCOMP Novelos Therapeutics Inc D05AHC HIGHSTAT Phase 2 D05AKH DRUG__ID D05AKH D05AKH DRUGCOMP Allergan Parsippany, NJ D05AKH HIGHSTAT Phase 2 D05AVB DRUG__ID D05AVB D05AVB DRUGCOMP Dong Wha Pharmaceutical Co Ltd D05AVB HIGHSTAT Phase 2 D05BBB DRUG__ID D05BBB D05BBB DRUGCOMP BioVascular D05BBB HIGHSTAT Phase 2 D05BGY DRUG__ID D05BGY D05BGY DRUGCOMP PharmaMar Madrid, Spain D05BGY HIGHSTAT Phase 2 D05BMC DRUG__ID D05BMC D05BMC DRUGCOMP GW Pharmaceuticals plc D05BMC HIGHSTAT Phase 2 D05BWH DRUG__ID D05BWH D05BWH DRUGCOMP Nanotherapeutics D05BWH HIGHSTAT Phase 2 D05BYP DRUG__ID D05BYP D05BYP DRUGCOMP Norwood Immunology D05BYP HIGHSTAT Phase 2 D05CFV DRUG__ID D05CFV D05CFV DRUGCOMP Biogen Cambridge, MAUCBSmyrna, GA D05CFV HIGHSTAT Phase 2 D05DQR DRUG__ID D05DQR D05DQR DRUGCOMP Hepasome Pharmaceuticals D05DQR HIGHSTAT Phase 2 D05DZA DRUG__ID D05DZA D05DZA DRUGCOMP PurGenesis Technologies Inc D05DZA HIGHSTAT Phase 2 D05EKO DRUG__ID D05EKO D05EKO DRUGCOMP TxCell SA D05EKO HIGHSTAT Phase 2 D05ELY DRUG__ID D05ELY D05ELY DRUGCOMP Baxter Healthcare D05ELY HIGHSTAT Phase 2 D05ERA DRUG__ID D05ERA D05ERA DRUGCOMP PharmaSurgics AB D05ERA HIGHSTAT Phase 2 D05EUI DRUG__ID D05EUI D05EUI DRUGCOMP Avir Green Hills Biotechnology GmbH D05EUI HIGHSTAT Phase 2 D05HJR DRUG__ID D05HJR D05HJR DRUGCOMP Genprex Austin, TX D05HJR HIGHSTAT Phase 2 D05HUG DRUG__ID D05HUG D05HUG DRUGCOMP Omeros; New York State Psychiatric Institute D05HUG HIGHSTAT Phase 2 D05IHZ DRUG__ID D05IHZ D05IHZ DRUGCOMP Hines VA Hospital; viropharma D05IHZ HIGHSTAT Phase 2 D05INV DRUG__ID D05INV D05INV DRUGCOMP Halozyme Therapeutics San Diego, CA D05INV HIGHSTAT Phase 2 D05ISO DRUG__ID D05ISO D05ISO DRUGCOMP Five Prime Therapeutics South San Francisco, CA D05ISO HIGHSTAT Phase 2 D05JAA DRUG__ID D05JAA D05JAA DRUGCOMP Array BioPharma; Celgene D05JAA HIGHSTAT Phase 2 D05JFA DRUG__ID D05JFA D05JFA DRUGCOMP Cerus D05JFA HIGHSTAT Phase 2 D05KAC DRUG__ID D05KAC D05KAC DRUGCOMP PanGenetics BV D05KAC HIGHSTAT Phase 2 D05KLQ DRUG__ID D05KLQ D05KLQ DRUGCOMP The Chinese Centre for Disease Control and Prevention D05KLQ HIGHSTAT Phase 2 D05KXJ DRUG__ID D05KXJ D05KXJ DRUGCOMP GlaxoSmithKline D05KXJ HIGHSTAT Phase 2 D05LDK DRUG__ID D05LDK D05LDK DRUGCOMP Impax pharmaceuticals D05LDK HIGHSTAT Phase 2 D05MJS DRUG__ID D05MJS D05MJS DRUGCOMP Realm Therapeutics Malvern, PA D05MJS HIGHSTAT Phase 2 D05NWJ DRUG__ID D05NWJ D05NWJ DRUGCOMP Solvay SA D05NWJ HIGHSTAT Phase 2 D05OTL DRUG__ID D05OTL D05OTL DRUGCOMP Newron pharmaceuticals D05OTL HIGHSTAT Phase 2 D05PDJ DRUG__ID D05PDJ D05PDJ DRUGCOMP Sage Therapeutics D05PDJ HIGHSTAT Phase 2 D05PGM DRUG__ID D05PGM D05PGM DRUGCOMP Advantagene D05PGM HIGHSTAT Phase 2 D05PTH DRUG__ID D05PTH D05PTH DRUGCOMP Merck D05PTH HIGHSTAT Phase 2 D05PXA DRUG__ID D05PXA D05PXA DRUGCOMP Botanix Pharmaceuticals Plymouth Meeting, PA D05PXA HIGHSTAT Phase 2 D05PXL DRUG__ID D05PXL D05PXL DRUGCOMP Palatin Technologies D05PXL HIGHSTAT Phase 2 D05QBH DRUG__ID D05QBH D05QBH DRUGCOMP Almirall Prodesfarma SA D05QBH HIGHSTAT Phase 2 D05QHO DRUG__ID D05QHO D05QHO DRUGCOMP Glaxo Wellcome plc D05QHO HIGHSTAT Phase 2 D05QPC DRUG__ID D05QPC D05QPC DRUGCOMP Syntrix biosystems D05QPC HIGHSTAT Phase 2 D05RQY DRUG__ID D05RQY D05RQY DRUGCOMP Merrimack Pharmaceuticals D05RQY HIGHSTAT Phase 2 D05RTV DRUG__ID D05RTV D05RTV DRUGCOMP Weizmann Institute of Science; Nippon Kayaku Co Ltd; Boehringer Ingelheim Corp D05RTV HIGHSTAT Phase 2 D05RXW DRUG__ID D05RXW D05RXW DRUGCOMP Almirall Prodesfarma SA D05RXW HIGHSTAT Phase 2 D05SLM DRUG__ID D05SLM D05SLM DRUGCOMP Eli Lilly & Co D05SLM HIGHSTAT Phase 2 D05TRI DRUG__ID D05TRI D05TRI DRUGCOMP GeNO Atlanta, GA D05TRI HIGHSTAT Phase 2 D05TSG DRUG__ID D05TSG D05TSG DRUGCOMP AnaptysBio San Diego, CA D05TSG HIGHSTAT Phase 2 D05TUL DRUG__ID D05TUL D05TUL DRUGCOMP Mazence Inc D05TUL HIGHSTAT Phase 2 D05UTV DRUG__ID D05UTV D05UTV DRUGCOMP ViroXis Corp D05UTV HIGHSTAT Phase 2 D05VKS DRUG__ID D05VKS D05VKS DRUGCOMP Vicus Therapeutics Morristown, NJ D05VKS HIGHSTAT Phase 2 D05VTE DRUG__ID D05VTE D05VTE DRUGCOMP Tactical Therapeutics Inc D05VTE HIGHSTAT Phase 2 D05XEA DRUG__ID D05XEA D05XEA DRUGCOMP Reviva Pharmaceuticals D05XEA HIGHSTAT Phase 2 D05XXF DRUG__ID D05XXF D05XXF DRUGCOMP Oramed Pharmaceuticals Inc D05XXF HIGHSTAT Phase 2 D05XZQ DRUG__ID D05XZQ D05XZQ DRUGCOMP Promethera Biosciences SA/NV D05XZQ HIGHSTAT Phase 2 D05YLN DRUG__ID D05YLN D05YLN DRUGCOMP Merrimack Pharmaceuticals; Sanofi D05YLN HIGHSTAT Phase 2 D05YLP DRUG__ID D05YLP D05YLP DRUGCOMP Synergy Pharmaceuticals Inc D05YLP HIGHSTAT Phase 2 D05YYP DRUG__ID D05YYP D05YYP DRUGCOMP Genentech Inc D05YYP HIGHSTAT Phase 2 D05ZXS DRUG__ID D05ZXS D05ZXS DRUGCOMP Maxygen D05ZXS HIGHSTAT Phase 2 D06ANS DRUG__ID D06ANS D06ANS DRUGCOMP CardioVascular BioTherapeutics Inc; CardioVascular Biotherapeutics D06ANS HIGHSTAT Phase 2 D06APO DRUG__ID D06APO D06APO DRUGCOMP SunTen Phytotech Co Ltd D06APO HIGHSTAT Phase 2 D06BBV DRUG__ID D06BBV D06BBV DRUGCOMP Beijing peking university wbl biotech D06BBV HIGHSTAT Phase 2 D06BIE DRUG__ID D06BIE D06BIE DRUGCOMP Protein Sciences D06BIE HIGHSTAT Phase 2 D06BMO DRUG__ID D06BMO D06BMO DRUGCOMP Boehringer ingelheim pharmaceuticals D06BMO HIGHSTAT Phase 2 D06BSE DRUG__ID D06BSE D06BSE DRUGCOMP Edimer pharmaceuticals D06BSE HIGHSTAT Phase 2 D06CFT DRUG__ID D06CFT D06CFT DRUGCOMP Pinnacle Pharmaceuticals D06CFT HIGHSTAT Phase 2 D06DLN DRUG__ID D06DLN D06DLN DRUGCOMP Shire, Lexington, MA D06DLN HIGHSTAT Phase 2 D06DOJ DRUG__ID D06DOJ D06DOJ DRUGCOMP Merrimack Pharmaceuticals Cambridge, MA D06DOJ HIGHSTAT Phase 2 D06DSQ DRUG__ID D06DSQ D06DSQ DRUGCOMP Immunotech D06DSQ HIGHSTAT Phase 2 D06EIJ DRUG__ID D06EIJ D06EIJ DRUGCOMP University of Texas Southwestern Medical Center D06EIJ HIGHSTAT Phase 2 D06EWT DRUG__ID D06EWT D06EWT DRUGCOMP Novelos Therapeutics D06EWT HIGHSTAT Phase 2 D06FIT DRUG__ID D06FIT D06FIT DRUGCOMP Sangamo BioSciences D06FIT HIGHSTAT Phase 2 D06FQS DRUG__ID D06FQS D06FQS DRUGCOMP Fabre-Kramer Pharmaceuticals D06FQS HIGHSTAT Phase 2 D06FRB DRUG__ID D06FRB D06FRB DRUGCOMP Achillion Pharmaceuticals Inc D06FRB HIGHSTAT Phase 2 D06FTM DRUG__ID D06FTM D06FTM DRUGCOMP Roche D06FTM HIGHSTAT Phase 2 D06FUE DRUG__ID D06FUE D06FUE DRUGCOMP Celldex Therapeutics Hampton, NJ D06FUE HIGHSTAT Phase 2 D06FYE DRUG__ID D06FYE D06FYE DRUGCOMP Ferrer Internacional Barcelona, Spain D06FYE HIGHSTAT Phase 2 D06HBJ DRUG__ID D06HBJ D06HBJ DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ Ionis Pharmaceuticals Carlsbad, CA D06HBJ HIGHSTAT Phase 2 D06HMO DRUG__ID D06HMO D06HMO DRUGCOMP CardioVascular BioTherapeutics Dallas, TX D06HMO HIGHSTAT Phase 2 D06IFR DRUG__ID D06IFR D06IFR DRUGCOMP Pfizer Inc D06IFR HIGHSTAT Phase 2 D06JKO DRUG__ID D06JKO D06JKO DRUGCOMP Greer Laboratories Inc D06JKO HIGHSTAT Phase 2 D06JNC DRUG__ID D06JNC D06JNC DRUGCOMP Cardoz AB D06JNC HIGHSTAT Phase 2 D06JTW DRUG__ID D06JTW D06JTW DRUGCOMP Forbes Medi-Tech D06JTW HIGHSTAT Phase 2 D06JTZ DRUG__ID D06JTZ D06JTZ DRUGCOMP Nabriva Therapeutics King of Prussia, PA D06JTZ HIGHSTAT Phase 2 D06JUE DRUG__ID D06JUE D06JUE DRUGCOMP Novo Nordisk D06JUE HIGHSTAT Phase 2 D06KOM DRUG__ID D06KOM D06KOM DRUGCOMP Dendreon D06KOM HIGHSTAT Phase 2 D06KQN DRUG__ID D06KQN D06KQN DRUGCOMP TransForm Pharmaceuticals D06KQN HIGHSTAT Phase 2 D06LPT DRUG__ID D06LPT D06LPT DRUGCOMP Sorrento TherapeuticsSan Diego, CA D06LPT HIGHSTAT Phase 2 D06LVJ DRUG__ID D06LVJ D06LVJ DRUGCOMP Marinomed Biotechnologie GmbH D06LVJ HIGHSTAT Phase 2 D06LXP DRUG__ID D06LXP D06LXP DRUGCOMP Polyphor Ltd D06LXP HIGHSTAT Phase 2 D06MGW DRUG__ID D06MGW D06MGW DRUGCOMP Microgen Inc D06MGW HIGHSTAT Phase 2 D06MOY DRUG__ID D06MOY D06MOY DRUGCOMP DiaMedica Inc D06MOY HIGHSTAT Phase 2 D06MYP DRUG__ID D06MYP D06MYP DRUGCOMP SK Chemicals Co Ltd D06MYP HIGHSTAT Phase 2 D06NNQ DRUG__ID D06NNQ D06NNQ DRUGCOMP GenVec; Vaccine Research Center (NIAID) D06NNQ HIGHSTAT Phase 2 D06NQH DRUG__ID D06NQH D06NQH DRUGCOMP Roche D06NQH HIGHSTAT Phase 2 D06NXG DRUG__ID D06NXG D06NXG DRUGCOMP Pfizer New York, NY D06NXG HIGHSTAT Phase 2 D06OVF DRUG__ID D06OVF D06OVF DRUGCOMP Santalis Pharmaceuticals San Antonio, TX D06OVF HIGHSTAT Phase 2 D06PDQ DRUG__ID D06PDQ D06PDQ DRUGCOMP AOP Orphan Pharmaceuticals AG D06PDQ HIGHSTAT Phase 2 D06PHS DRUG__ID D06PHS D06PHS DRUGCOMP Evotec Princeton, NJ D06PHS HIGHSTAT Phase 2 D06PLP DRUG__ID D06PLP D06PLP DRUGCOMP Cook Pharmica D06PLP HIGHSTAT Phase 2 D06QBX DRUG__ID D06QBX D06QBX DRUGCOMP Vidac Pharma Jerusalem, Israel D06QBX HIGHSTAT Phase 2 D06QQH DRUG__ID D06QQH D06QQH DRUGCOMP Laboratoires Thea D06QQH HIGHSTAT Phase 2 D06QWM DRUG__ID D06QWM D06QWM DRUGCOMP Novo Nordisk D06QWM HIGHSTAT Phase 2 D06RNK DRUG__ID D06RNK D06RNK DRUGCOMP Oxford BioMedica D06RNK HIGHSTAT Phase 2 D06SBL DRUG__ID D06SBL D06SBL DRUGCOMP Merrimack pharmaceuticals; sanofi us D06SBL HIGHSTAT Phase 2 D06SCP DRUG__ID D06SCP D06SCP DRUGCOMP Forsight vision5 D06SCP HIGHSTAT Phase 2 D06SCQ DRUG__ID D06SCQ D06SCQ DRUGCOMP Novartis pharmaceuticals D06SCQ HIGHSTAT Phase 2 D06SCY DRUG__ID D06SCY D06SCY DRUGCOMP Biomay AG D06SCY HIGHSTAT Phase 2 D06TME DRUG__ID D06TME D06TME DRUGCOMP AstraZeneca D06TME HIGHSTAT Phase 2 D06TWA DRUG__ID D06TWA D06TWA DRUGCOMP BioInvent International Lund, Sweden Oncurious Leuven, Belgium D06TWA HIGHSTAT Phase 2 D06TZZ DRUG__ID D06TZZ D06TZZ DRUGCOMP Catabasis Pharmaceuticals D06TZZ HIGHSTAT Phase 2 D06UIS DRUG__ID D06UIS D06UIS DRUGCOMP Eli Lilly & Co D06UIS HIGHSTAT Phase 2 D06UNI DRUG__ID D06UNI D06UNI DRUGCOMP Ranbaxy Laboratories Ltd D06UNI HIGHSTAT Phase 2 D06URI DRUG__ID D06URI D06URI DRUGCOMP Atlab pharma; weill medical college D06URI HIGHSTAT Phase 2 D06UTH DRUG__ID D06UTH D06UTH DRUGCOMP Ardea Biosciences Inc D06UTH HIGHSTAT Phase 2 D06VLI DRUG__ID D06VLI D06VLI DRUGCOMP Roswell Park Cancer Institute D06VLI HIGHSTAT Phase 2 D06XAA DRUG__ID D06XAA D06XAA DRUGCOMP Roche D06XAA HIGHSTAT Phase 2 D06XCF DRUG__ID D06XCF D06XCF DRUGCOMP Equispharm Co Ltd D06XCF HIGHSTAT Phase 2 D06XFV DRUG__ID D06XFV D06XFV DRUGCOMP Tengion D06XFV HIGHSTAT Phase 2 D06XGB DRUG__ID D06XGB D06XGB DRUGCOMP Aastrom Biosciences D06XGB HIGHSTAT Phase 2 D06XJQ DRUG__ID D06XJQ D06XJQ DRUGCOMP Sol-Gel Technologies Ness Ziona, Israel D06XJQ HIGHSTAT Phase 2 D06XMW DRUG__ID D06XMW D06XMW DRUGCOMP DermaGen AB D06XMW HIGHSTAT Phase 2 D06XSB DRUG__ID D06XSB D06XSB DRUGCOMP GlaxoSmithKline plc D06XSB HIGHSTAT Phase 2 D06XVX DRUG__ID D06XVX D06XVX DRUGCOMP Reviva Pharmaceuticals Inc D06XVX HIGHSTAT Phase 2 D06YRR DRUG__ID D06YRR D06YRR DRUGCOMP GlaxoSmithKline D06YRR HIGHSTAT Phase 2 D06ZCP DRUG__ID D06ZCP D06ZCP DRUGCOMP Stemedica cell technologies D06ZCP HIGHSTAT Phase 2 D06ZHZ DRUG__ID D06ZHZ D06ZHZ DRUGCOMP Funxional Therapeutics Ltd D06ZHZ HIGHSTAT Phase 2 D06ZPX DRUG__ID D06ZPX D06ZPX DRUGCOMP Beech Tree Labs Inc D06ZPX HIGHSTAT Phase 2 D06ZQL DRUG__ID D06ZQL D06ZQL DRUGCOMP Diamyd Medical D06ZQL HIGHSTAT Phase 2 D07ADU DRUG__ID D07ADU D07ADU DRUGCOMP Lipimetix development D07ADU HIGHSTAT Phase 2 D07AUI DRUG__ID D07AUI D07AUI DRUGCOMP IBio D07AUI HIGHSTAT Phase 2 D07AYN DRUG__ID D07AYN D07AYN DRUGCOMP Inviragen D07AYN HIGHSTAT Phase 2 D07CNY DRUG__ID D07CNY D07CNY DRUGCOMP Fkd therapies D07CNY HIGHSTAT Phase 2 D07DPM DRUG__ID D07DPM D07DPM DRUGCOMP Healthpoint Biotherapeutics D07DPM HIGHSTAT Phase 2 D07DSN DRUG__ID D07DSN D07DSN DRUGTYPE Antibody D07DSN HIGHSTAT Phase 2 D07DTZ DRUG__ID D07DTZ D07DTZ DRUGCOMP Viking therapeutics D07DTZ HIGHSTAT Phase 2 D07DWB DRUG__ID D07DWB D07DWB DRUGCOMP Angioblast Systems; Mesoblast D07DWB HIGHSTAT Phase 2 D07ENB DRUG__ID D07ENB D07ENB DRUGCOMP Nucryst Pharmaceuticals D07ENB HIGHSTAT Phase 2 D07FQL DRUG__ID D07FQL D07FQL DRUGCOMP Altavita Pharmaceuticals; Astellas Pharma D07FQL HIGHSTAT Phase 2 D07FXF DRUG__ID D07FXF D07FXF DRUGCOMP Cornerstone pharmaceuticals D07FXF HIGHSTAT Phase 2 D07FZC DRUG__ID D07FZC D07FZC DRUGCOMP Biomay AG D07FZC HIGHSTAT Phase 2 D07HOT DRUG__ID D07HOT D07HOT DRUGCOMP Alexion Pharmaceuticals New Haven, CT D07HOT HIGHSTAT Phase 2 D07HSR DRUG__ID D07HSR D07HSR DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D07HSR HIGHSTAT Phase 2 D07IEC DRUG__ID D07IEC D07IEC DRUGCOMP GlaxoSmithKline D07IEC HIGHSTAT Phase 2 D07JHK DRUG__ID D07JHK D07JHK DRUGCOMP Amgen D07JHK HIGHSTAT Phase 2 D07JWO DRUG__ID D07JWO D07JWO DRUGCOMP Bristol-Myers Squibb D07JWO HIGHSTAT Phase 2 D07JXN DRUG__ID D07JXN D07JXN DRUGCOMP Speedel Pharma D07JXN HIGHSTAT Phase 2 D07KAB DRUG__ID D07KAB D07KAB DRUGCOMP Asterias Biotherapeutics Fremont, CA D07KAB HIGHSTAT Phase 2 D07KAK DRUG__ID D07KAK D07KAK DRUGCOMP OsteoScreen Inc D07KAK HIGHSTAT Phase 2 D07KGR DRUG__ID D07KGR D07KGR DRUGCOMP VIVUS D07KGR HIGHSTAT Phase 2 D07KIE DRUG__ID D07KIE D07KIE DRUGCOMP Lycera Ann Arbor, MI D07KIE HIGHSTAT Phase 2 D07LCA DRUG__ID D07LCA D07LCA DRUGCOMP Genmab A/S D07LCA HIGHSTAT Phase 2 D07LMO DRUG__ID D07LMO D07LMO DRUGTYPE Antibody D07LMO HIGHSTAT Phase 2 D07LUA DRUG__ID D07LUA D07LUA DRUGCOMP Sanaria Rockville, MD D07LUA HIGHSTAT Phase 2 D07LWL DRUG__ID D07LWL D07LWL DRUGCOMP WhanIn Pharmaceutical Co Ltd D07LWL HIGHSTAT Phase 2 D07MGC DRUG__ID D07MGC D07MGC DRUGCOMP Janssen Research & Development Raritan, NJ D07MGC HIGHSTAT Phase 2 D07NKZ DRUG__ID D07NKZ D07NKZ DRUGCOMP Verva Pharmaceuticals Ltd D07NKZ HIGHSTAT Phase 2 D07NUO DRUG__ID D07NUO D07NUO DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D07NUO HIGHSTAT Phase 2 D07OAD DRUG__ID D07OAD D07OAD DRUGCOMP Genus Oncology D07OAD HIGHSTAT Phase 2 D07ORE DRUG__ID D07ORE D07ORE DRUGCOMP TheVaxCape Canaveral, FL D07ORE HIGHSTAT Phase 2 D07PFG DRUG__ID D07PFG D07PFG DRUGCOMP HanAll Biopharma Co Ltd D07PFG HIGHSTAT Phase 2 D07QCA DRUG__ID D07QCA D07QCA DRUGCOMP Brainstorm cell therapeutics D07QCA HIGHSTAT Phase 2 D07QFM DRUG__ID D07QFM D07QFM DRUGCOMP Avant Immunotherapeutics D07QFM HIGHSTAT Phase 2 D07QIT DRUG__ID D07QIT D07QIT DRUGCOMP Gem Pharmaceuticals LLC D07QIT HIGHSTAT Phase 2 D07RDU DRUG__ID D07RDU D07RDU DRUGCOMP Dow Pharmaceutical Sciences D07RDU HIGHSTAT Phase 2 D07RHP DRUG__ID D07RHP D07RHP DRUGCOMP Incyte Wilmington, DE D07RHP HIGHSTAT Phase 2 D07RKO DRUG__ID D07RKO D07RKO DRUGCOMP Morria Biopharmaceuticals plc D07RKO HIGHSTAT Phase 2 D07RQR DRUG__ID D07RQR D07RQR DRUGCOMP Biotie Therapies D07RQR HIGHSTAT Phase 2 D07RST DRUG__ID D07RST D07RST DRUGCOMP Tech elds pharma D07RST HIGHSTAT Phase 2 D07RWY DRUG__ID D07RWY D07RWY DRUGCOMP Lantheus Medical Imaging D07RWY HIGHSTAT Phase 2 D07SKN DRUG__ID D07SKN D07SKN DRUGCOMP Pfizer Inc D07SKN HIGHSTAT Phase 2 D07SNO DRUG__ID D07SNO D07SNO DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D07SNO HIGHSTAT Phase 2 D07TBJ DRUG__ID D07TBJ D07TBJ DRUGCOMP Emergent BioSolutions Gaithersburg, MD D07TBJ HIGHSTAT Phase 2 D07TJT DRUG__ID D07TJT D07TJT DRUGCOMP Opexa therapeutics D07TJT HIGHSTAT Phase 2 D07TKZ DRUG__ID D07TKZ D07TKZ DRUGCOMP Biodel D07TKZ HIGHSTAT Phase 2 D07TYJ DRUG__ID D07TYJ D07TYJ DRUGCOMP Genentech Inc D07TYJ HIGHSTAT Phase 2 D07TYM DRUG__ID D07TYM D07TYM DRUGCOMP Pervasis Therapeutics D07TYM HIGHSTAT Phase 2 D07UKT DRUG__ID D07UKT D07UKT DRUGCOMP Aileron Therapeutics Cambridge, MA D07UKT HIGHSTAT Phase 2 D07VHU DRUG__ID D07VHU D07VHU DRUGCOMP Novartis Oncology East Hanover, D07VHU HIGHSTAT Phase 2 D07WDW DRUG__ID D07WDW D07WDW DRUGCOMP Vectura D07WDW HIGHSTAT Phase 2 D07WFQ DRUG__ID D07WFQ D07WFQ DRUGCOMP Veloce BioPharma Fort Lauderdale, FL D07WFQ HIGHSTAT Phase 2 D07WGE DRUG__ID D07WGE D07WGE DRUGCOMP Chakshu Research Inc D07WGE HIGHSTAT Phase 2 D07YLO DRUG__ID D07YLO D07YLO DRUGCOMP Juventas Therapeutics D07YLO HIGHSTAT Phase 2 D07YNM DRUG__ID D07YNM D07YNM DRUGCOMP Novo Nordisk D07YNM HIGHSTAT Phase 2 D07YRV DRUG__ID D07YRV D07YRV DRUGCOMP Bayer Corp D07YRV HIGHSTAT Phase 2 D07YRW DRUG__ID D07YRW D07YRW DRUGCOMP Astellas D07YRW HIGHSTAT Phase 2 D07ZMQ DRUG__ID D07ZMQ D07ZMQ DRUGCOMP Nippon Zoki Pharmaceutical Co Ltd D07ZMQ HIGHSTAT Phase 2 D08AHH DRUG__ID D08AHH D08AHH DRUGCOMP Novartis pharmaceuticals D08AHH HIGHSTAT Phase 2 D08ANE DRUG__ID D08ANE D08ANE DRUGCOMP Bristol-Myers Squib Princeton, NJ D08ANE HIGHSTAT Phase 2 D08APZ DRUG__ID D08APZ D08APZ DRUGCOMP Nora Therapeutics Palo Alto, CA D08APZ HIGHSTAT Phase 2 D08BBU DRUG__ID D08BBU D08BBU DRUGCOMP GW PharmaceuticalCambridge, United Kingdom Ichan School of MedicineNew York, NY D08BBU HIGHSTAT Phase 2 D08BMV DRUG__ID D08BMV D08BMV DRUGCOMP Phage Biotechnology Corp D08BMV HIGHSTAT Phase 2 D08CJM DRUG__ID D08CJM D08CJM DRUGCOMP Emisphere Technologies Inc D08CJM HIGHSTAT Phase 2 D08COR DRUG__ID D08COR D08COR DRUGCOMP Arrowhead research D08COR HIGHSTAT Phase 2 D08DFF DRUG__ID D08DFF D08DFF DRUGCOMP DermAct Pharmaceutical Inc D08DFF HIGHSTAT Phase 2 D08DIU DRUG__ID D08DIU D08DIU DRUGCOMP Lion Biotechnologies San Carlos, CA D08DIU HIGHSTAT Phase 2 D08DJH DRUG__ID D08DJH D08DJH DRUGCOMP ISTO Technologies D08DJH HIGHSTAT Phase 2 D08DOE DRUG__ID D08DOE D08DOE DRUGCOMP Milkhaus Laboratory Inc D08DOE HIGHSTAT Phase 2 D08EES DRUG__ID D08EES D08EES DRUGCOMP Xenova D08EES HIGHSTAT Phase 2 D08EWM DRUG__ID D08EWM D08EWM DRUGCOMP UCB SA D08EWM HIGHSTAT Phase 2 D08FAC DRUG__ID D08FAC D08FAC DRUGCOMP InflaRx GmbH D08FAC HIGHSTAT Phase 2 D08FKD DRUG__ID D08FKD D08FKD DRUGCOMP Dartmouth-Hitchcock Medical Center D08FKD HIGHSTAT Phase 2 D08FWJ DRUG__ID D08FWJ D08FWJ DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D08FWJ HIGHSTAT Phase 2 D08GLX DRUG__ID D08GLX D08GLX DRUGCOMP Medtronic Inc D08GLX HIGHSTAT Phase 2 D08GSC DRUG__ID D08GSC D08GSC DRUGCOMP Kemin Pharma Europe D08GSC HIGHSTAT Phase 2 D08GVB DRUG__ID D08GVB D08GVB DRUGCOMP Amorcyte; Progenitor Cell Therapy D08GVB HIGHSTAT Phase 2 D08HGR DRUG__ID D08HGR D08HGR DRUGCOMP Lupin Ltd D08HGR HIGHSTAT Phase 2 D08HHT DRUG__ID D08HHT D08HHT DRUGCOMP Genticel D08HHT HIGHSTAT Phase 2 D08IST DRUG__ID D08IST D08IST DRUGCOMP Sangamo BioSciences D08IST HIGHSTAT Phase 2 D08IVF DRUG__ID D08IVF D08IVF DRUGCOMP Bio-Path Holdings Houston, TX D08IVF HIGHSTAT Phase 2 D08IYF DRUG__ID D08IYF D08IYF DRUGCOMP Glaxosmithkline D08IYF HIGHSTAT Phase 2 D08JBL DRUG__ID D08JBL D08JBL DRUGCOMP Pfizer New York, NY D08JBL HIGHSTAT Phase 2 D08JGB DRUG__ID D08JGB D08JGB DRUGCOMP Aptevo Therapeutics Seattle, WA D08JGB HIGHSTAT Phase 2 D08JGE DRUG__ID D08JGE D08JGE DRUGCOMP ImaRx Therapeutics D08JGE HIGHSTAT Phase 2 D08JHG DRUG__ID D08JHG D08JHG DRUGCOMP St Louis University D08JHG HIGHSTAT Phase 2 D08JNI DRUG__ID D08JNI D08JNI DRUGCOMP AstraZeneca D08JNI HIGHSTAT Phase 2 D08KAD DRUG__ID D08KAD D08KAD DRUGCOMP Cytos Biotechnology AG D08KAD HIGHSTAT Phase 2 D08KDK DRUG__ID D08KDK D08KDK DRUGCOMP Taro Pharmaceutical Industries Ltd D08KDK HIGHSTAT Phase 2 D08KPA DRUG__ID D08KPA D08KPA DRUGCOMP Bionovo D08KPA HIGHSTAT Phase 2 D08KTO DRUG__ID D08KTO D08KTO DRUGCOMP ADial Pharmaceuticals Charlottesville, VA D08KTO HIGHSTAT Phase 2 D08LCB DRUG__ID D08LCB D08LCB DRUGCOMP GlaxoSmithKline plc D08LCB HIGHSTAT Phase 2 D08LXJ DRUG__ID D08LXJ D08LXJ DRUGCOMP Cytonet D08LXJ HIGHSTAT Phase 2 D08LYZ DRUG__ID D08LYZ D08LYZ DRUGCOMP UroGen Pharma New York, NY D08LYZ HIGHSTAT Phase 2 D08MCC DRUG__ID D08MCC D08MCC DRUGCOMP NeuroRx Wilmington, DE D08MCC HIGHSTAT Phase 2 D08MIG DRUG__ID D08MIG D08MIG DRUGCOMP Emergent BioSolutions D08MIG HIGHSTAT Phase 2 D08MPA DRUG__ID D08MPA D08MPA DRUGCOMP Amakem D08MPA HIGHSTAT Phase 2 D08NDA DRUG__ID D08NDA D08NDA DRUGTYPE Antisense drug D08NDA HIGHSTAT Phase 2 D08NPG DRUG__ID D08NPG D08NPG DRUGCOMP Metabolex Inc D08NPG HIGHSTAT Phase 2 D08NTW DRUG__ID D08NTW D08NTW DRUGCOMP Burzynski Research Institute Houston, TX D08NTW HIGHSTAT Phase 2 D08NZG DRUG__ID D08NZG D08NZG DRUGCOMP Humanigen Brisbane, CA Olivia Newton-John Cancer Research Institute Heidelberg, Australia D08NZG HIGHSTAT Phase 2 D08OJF DRUG__ID D08OJF D08OJF DRUGCOMP Icagen D08OJF HIGHSTAT Phase 2 D08OXU DRUG__ID D08OXU D08OXU DRUGCOMP Idera Pharmaceuticals D08OXU HIGHSTAT Phase 2 D08OYF DRUG__ID D08OYF D08OYF DRUGCOMP University of Iowa D08OYF HIGHSTAT Phase 2 D08PKI DRUG__ID D08PKI D08PKI DRUGCOMP Evolva SA D08PKI HIGHSTAT Phase 2 D08PRP DRUG__ID D08PRP D08PRP DRUGCOMP ImmunogenX Newport Beach, CA D08PRP HIGHSTAT Phase 2 D08PSI DRUG__ID D08PSI D08PSI DRUGCOMP Medicago Inc D08PSI HIGHSTAT Phase 2 D08PYC DRUG__ID D08PYC D08PYC DRUGCOMP Alcon Research Ltd D08PYC HIGHSTAT Phase 2 D08QHX DRUG__ID D08QHX D08QHX DRUGCOMP Proximagen Group plc D08QHX HIGHSTAT Phase 2 D08RBV DRUG__ID D08RBV D08RBV DRUGCOMP Activartis biotech D08RBV HIGHSTAT Phase 2 D08RDD DRUG__ID D08RDD D08RDD DRUGCOMP Pfizer, New York, NY D08RDD HIGHSTAT Phase 2 D08RSL DRUG__ID D08RSL D08RSL DRUGCOMP Genzyme Corp D08RSL HIGHSTAT Phase 2 D08TLI DRUG__ID D08TLI D08TLI DRUGCOMP Laboratorios Dr Esteve SA D08TLI HIGHSTAT Phase 2 D08VAR DRUG__ID D08VAR D08VAR DRUGCOMP Aphios Corp D08VAR HIGHSTAT Phase 2 D08VJC DRUG__ID D08VJC D08VJC DRUGCOMP Progenics Pharmaceuticals D08VJC HIGHSTAT Phase 2 D08VZH DRUG__ID D08VZH D08VZH DRUGCOMP Amarantus Bioscience New York, NY D08VZH HIGHSTAT Phase 2 D08WOJ DRUG__ID D08WOJ D08WOJ DRUGCOMP OBEcure D08WOJ HIGHSTAT Phase 2 D08WQH DRUG__ID D08WQH D08WQH DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D08WQH HIGHSTAT Phase 2 D08WQU DRUG__ID D08WQU D08WQU DRUGCOMP Aeglea Biotherapeutics Austin, TX D08WQU HIGHSTAT Phase 2 D08WSG DRUG__ID D08WSG D08WSG DRUGCOMP AstraZeneca plc D08WSG HIGHSTAT Phase 2 D08WYK DRUG__ID D08WYK D08WYK DRUGCOMP Jeil Pharmaceutical Co Ltd D08WYK HIGHSTAT Phase 2 D08WZQ DRUG__ID D08WZQ D08WZQ DRUGCOMP miRagen Therapeutics Boulder, CO D08WZQ HIGHSTAT Phase 2 D08XHN DRUG__ID D08XHN D08XHN DRUGCOMP Alcon Research Ltd D08XHN HIGHSTAT Phase 2 D08XVR DRUG__ID D08XVR D08XVR DRUGCOMP Biogen Idec D08XVR HIGHSTAT Phase 2 D08YHB DRUG__ID D08YHB D08YHB DRUGCOMP Biogen Idec D08YHB HIGHSTAT Phase 2 D08YJN DRUG__ID D08YJN D08YJN DRUGCOMP Biomed Research & Technologies Inc D08YJN HIGHSTAT Phase 2 D08YVP DRUG__ID D08YVP D08YVP DRUGCOMP Bayer healthcare pharmaceutical D08YVP HIGHSTAT Phase 2 D08ZCC DRUG__ID D08ZCC D08ZCC DRUGCOMP Mimetica Pty Ltd D08ZCC HIGHSTAT Phase 2 D08ZHL DRUG__ID D08ZHL D08ZHL DRUGCOMP CardioVascular BioTherape. D08ZHL HIGHSTAT Phase 2 D08ZXQ DRUG__ID D08ZXQ D08ZXQ DRUGCOMP Biogen Idec D08ZXQ HIGHSTAT Phase 2 D08ZYZ DRUG__ID D08ZYZ D08ZYZ DRUGCOMP PaxVaxRedwood City, CA D08ZYZ HIGHSTAT Phase 2 D09AGG DRUG__ID D09AGG D09AGG DRUGCOMP GlaxoSmithKline D09AGG HIGHSTAT Phase 2 D09AHK DRUG__ID D09AHK D09AHK DRUGCOMP Zynerba Pharmaceuticals Devon, PA D09AHK HIGHSTAT Phase 2 D09AWM DRUG__ID D09AWM D09AWM DRUGCOMP ParinGenix Inc D09AWM HIGHSTAT Phase 2 D09BAP DRUG__ID D09BAP D09BAP DRUGCOMP Baxter International Inc D09BAP HIGHSTAT Phase 2 D09BBW DRUG__ID D09BBW D09BBW DRUGCOMP VioQuest D09BBW HIGHSTAT Phase 2 D09BCL DRUG__ID D09BCL D09BCL DRUGCOMP Development Centre for Biotechnology D09BCL HIGHSTAT Phase 2 D09BIX DRUG__ID D09BIX D09BIX DRUGCOMP CoDa Therapeutics D09BIX HIGHSTAT Phase 2 D09BXF DRUG__ID D09BXF D09BXF DRUGCOMP Cutanea Wayne, PA D09BXF HIGHSTAT Phase 2 D09BZJ DRUG__ID D09BZJ D09BZJ DRUGCOMP Genentech Inc D09BZJ HIGHSTAT Phase 2 D09CLH DRUG__ID D09CLH D09CLH DRUGCOMP EUSA Pharma D09CLH HIGHSTAT Phase 2 D09CMK DRUG__ID D09CMK D09CMK DRUGCOMP Astion Pharma A/S D09CMK HIGHSTAT Phase 2 D09EDA DRUG__ID D09EDA D09EDA DRUGCOMP Promedior D09EDA HIGHSTAT Phase 2 D09FTJ DRUG__ID D09FTJ D09FTJ DRUGCOMP TransTech Pharma Inc D09FTJ HIGHSTAT Phase 2 D09GVI DRUG__ID D09GVI D09GVI DRUGCOMP Vanda Pharmaceuticals D09GVI HIGHSTAT Phase 2 D09HFL DRUG__ID D09HFL D09HFL DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D09HFL HIGHSTAT Phase 2 D09HOW DRUG__ID D09HOW D09HOW DRUGCOMP Shionogi D09HOW HIGHSTAT Phase 2 D09IGR DRUG__ID D09IGR D09IGR DRUGCOMP AzERx Inc D09IGR HIGHSTAT Phase 2 D09IOF DRUG__ID D09IOF D09IOF DRUGCOMP Vernalis D09IOF HIGHSTAT Phase 2 D09IUR DRUG__ID D09IUR D09IUR DRUGCOMP Asahi Glass Co Ltd D09IUR HIGHSTAT Phase 2 D09LKU DRUG__ID D09LKU D09LKU DRUGCOMP NOXXON Pharma AG D09LKU HIGHSTAT Phase 2 D09MPO DRUG__ID D09MPO D09MPO DRUGCOMP Highland Therapeutics Toronto, Canada Ironshore Pharmaceuticals Toronto, Canada D09MPO HIGHSTAT Phase 2 D09OOQ DRUG__ID D09OOQ D09OOQ DRUGCOMP Fabre Kramer Pharmaceuticals Inc D09OOQ HIGHSTAT Phase 2 D09PCL DRUG__ID D09PCL D09PCL DRUGCOMP Janssen Research & Development Raritan, NJ D09PCL HIGHSTAT Phase 2 D09PGG DRUG__ID D09PGG D09PGG DRUGCOMP Madison vaccines D09PGG HIGHSTAT Phase 2 D09PGT DRUG__ID D09PGT D09PGT DRUGCOMP Johann Wolfgang Goethe-Universitat Frankfurt am Main D09PGT HIGHSTAT Phase 2 D09POH DRUG__ID D09POH D09POH DRUGCOMP Aegera Therapeutics Inc D09POH HIGHSTAT Phase 2 D09PYV DRUG__ID D09PYV D09PYV DRUGCOMP Asahi Kasei D09PYV HIGHSTAT Phase 2 D09QMX DRUG__ID D09QMX D09QMX DRUGCOMP Quro Science Inc D09QMX HIGHSTAT Phase 2 D09RSY DRUG__ID D09RSY D09RSY DRUGCOMP VaxOnco D09RSY HIGHSTAT Phase 2 D09RXG DRUG__ID D09RXG D09RXG DRUGCOMP Exponential Biotherapies Inc D09RXG HIGHSTAT Phase 2 D09RZM DRUG__ID D09RZM D09RZM DRUGCOMP Eisai Co Ltd D09RZM HIGHSTAT Phase 2 D09SJE DRUG__ID D09SJE D09SJE DRUGCOMP KaloBios Pharmaceuticals D09SJE HIGHSTAT Phase 2 D09TCY DRUG__ID D09TCY D09TCY DRUGCOMP Celldex Therapeutics D09TCY HIGHSTAT Phase 2 D09THN DRUG__ID D09THN D09THN DRUGCOMP ImmunoGen D09THN HIGHSTAT Phase 2 D09TOK DRUG__ID D09TOK D09TOK DRUGCOMP Pfizer Inc D09TOK HIGHSTAT Phase 2 D09TQY DRUG__ID D09TQY D09TQY DRUGCOMP MedImmune Gaithersburg, MD D09TQY HIGHSTAT Phase 2 D09TSD DRUG__ID D09TSD D09TSD DRUGCOMP SurModics D09TSD HIGHSTAT Phase 2 D09TUW DRUG__ID D09TUW D09TUW DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D09TUW HIGHSTAT Phase 2 D09VFA DRUG__ID D09VFA D09VFA DRUGCOMP Finlay Institute D09VFA HIGHSTAT Phase 2 D09VYF DRUG__ID D09VYF D09VYF DRUGCOMP Sanofi pasteur; glaxosmithkline; walter reed army institute of research; naval medical research center; army medical research and materiel command D09VYF HIGHSTAT Phase 2 D09WPI DRUG__ID D09WPI D09WPI DRUGCOMP Geovax labs D09WPI HIGHSTAT Phase 2 D09WWB DRUG__ID D09WWB D09WWB DRUGCOMP Novartis Vaccine & Diagnostics D09WWB HIGHSTAT Phase 2 D09XHQ DRUG__ID D09XHQ D09XHQ DRUGCOMP Celtic Pharma D09XHQ HIGHSTAT Phase 2 D09XHU DRUG__ID D09XHU D09XHU DRUGCOMP Pharmexa D09XHU HIGHSTAT Phase 2 D09XJF DRUG__ID D09XJF D09XJF DRUGCOMP BioElectron Technology Mountain View, CA Sumitomo Dainippon Pharma Osaka, Japan D09XJF HIGHSTAT Phase 2 D09YGZ DRUG__ID D09YGZ D09YGZ DRUGCOMP Ocera Therapeutics Palo Alto, CA D09YGZ HIGHSTAT Phase 2 D09YRA DRUG__ID D09YRA D09YRA DRUGCOMP Seaside Therapeutics; Roche D09YRA HIGHSTAT Phase 2 D09ZMV DRUG__ID D09ZMV D09ZMV DRUGCOMP Evolutec Group plc; Evolutec D09ZMV HIGHSTAT Phase 2 D0A0MT DRUG__ID D0A0MT D0A0MT DRUGCOMP Krele Pharmaceuticals D0A0MT HIGHSTAT Phase 2 D0A0SK DRUG__ID D0A0SK D0A0SK DRUGCOMP H-Phar Co D0A0SK HIGHSTAT Phase 2 D0A0TF DRUG__ID D0A0TF D0A0TF DRUGCOMP Cell Point Centennial D0A0TF HIGHSTAT Phase 2 D0A0TI DRUG__ID D0A0TI D0A0TI DRUGCOMP Children's Hospital Inc D0A0TI HIGHSTAT Phase 2 D0A0TT DRUG__ID D0A0TT D0A0TT DRUGCOMP Ionis Pharmaceuticals Carlsbad, CA D0A0TT HIGHSTAT Phase 2 D0A0YQ DRUG__ID D0A0YQ D0A0YQ DRUGCOMP Cavion Charlottesville, VA D0A0YQ HIGHSTAT Phase 2 D0A2BS DRUG__ID D0A2BS D0A2BS DRUGCOMP Selexys pharmaceuticals D0A2BS HIGHSTAT Phase 2 D0A2KH DRUG__ID D0A2KH D0A2KH DRUGCOMP Toray Industries Inc D0A2KH HIGHSTAT Phase 2 D0A2XY DRUG__ID D0A2XY D0A2XY DRUGCOMP AgenBio Baltimore, MD D0A2XY HIGHSTAT Phase 2 D0A3CH DRUG__ID D0A3CH D0A3CH DRUGCOMP BrightPath Biotherapeutics Tokyo, Japan D0A3CH HIGHSTAT Phase 2 D0A3EX DRUG__ID D0A3EX D0A3EX DRUGCOMP Glenmark Pharmaceuticals Ltd D0A3EX HIGHSTAT Phase 2 D0A4PJ DRUG__ID D0A4PJ D0A4PJ DRUGCOMP Kite Pharma Santa Monica, CA D0A4PJ HIGHSTAT Phase 2 D0A4TU DRUG__ID D0A4TU D0A4TU DRUGCOMP AstraZeneca; Medarex; MedImmune D0A4TU HIGHSTAT Phase 2 D0A4ZZ DRUG__ID D0A4ZZ D0A4ZZ DRUGCOMP Ohr pharmaceutical D0A4ZZ HIGHSTAT Phase 2 D0A5BV DRUG__ID D0A5BV D0A5BV DRUGCOMP SmithKline Beecham plc D0A5BV HIGHSTAT Phase 2 D0A5IL DRUG__ID D0A5IL D0A5IL DRUGCOMP Iba molecular us D0A5IL HIGHSTAT Phase 2 D0A5ZL DRUG__ID D0A5ZL D0A5ZL DRUGCOMP Biogen Idec D0A5ZL HIGHSTAT Phase 2 D0A6CC DRUG__ID D0A6CC D0A6CC DRUGCOMP AbbVieNorth Chicago, IL D0A6CC HIGHSTAT Phase 2 D0A6DY DRUG__ID D0A6DY D0A6DY DRUGCOMP AstraZeneca D0A6DY HIGHSTAT Phase 2 D0A6MN DRUG__ID D0A6MN D0A6MN DRUGCOMP GlaxoSmithKline D0A6MN HIGHSTAT Phase 2 D0A6OS DRUG__ID D0A6OS D0A6OS DRUGCOMP Takeda Pharmaceutical Co Ltd D0A6OS HIGHSTAT Phase 2 D0A6VA DRUG__ID D0A6VA D0A6VA DRUGCOMP Mundipharma AG D0A6VA HIGHSTAT Phase 2 D0A6VM DRUG__ID D0A6VM D0A6VM DRUGCOMP Vical San Diego, CA D0A6VM HIGHSTAT Phase 2 D0A6WA DRUG__ID D0A6WA D0A6WA DRUGCOMP Selective Genetics Inc D0A6WA HIGHSTAT Phase 2 D0A7LL DRUG__ID D0A7LL D0A7LL DRUGCOMP Progenics pharmaceuticals D0A7LL HIGHSTAT Phase 2 D0A8JB DRUG__ID D0A8JB D0A8JB DRUGCOMP VaxInnate D0A8JB HIGHSTAT Phase 2 D0A8MH DRUG__ID D0A8MH D0A8MH DRUGCOMP Maruho Co Ltd D0A8MH HIGHSTAT Phase 2 D0A8QM DRUG__ID D0A8QM D0A8QM DRUGCOMP H Lundbeck A/S D0A8QM HIGHSTAT Phase 2 D0A9BI DRUG__ID D0A9BI D0A9BI DRUGCOMP Oxxon Therapeutics Ltd D0A9BI HIGHSTAT Phase 2 D0A9HT DRUG__ID D0A9HT D0A9HT DRUGCOMP Genentech South San Francisco, CA D0A9HT HIGHSTAT Phase 2 D0AD5S DRUG__ID D0AD5S D0AD5S DRUGCOMP Sarepta Therapeutics Cambridge, MA D0AD5S HIGHSTAT Phase 2 D0AE3U DRUG__ID D0AE3U D0AE3U DRUGCOMP Sanofi D0AE3U HIGHSTAT Phase 2 D0AF5P DRUG__ID D0AF5P D0AF5P DRUGCOMP Dermavant Sciences Phoenix, AZ D0AF5P HIGHSTAT Phase 2 D0AG6K DRUG__ID D0AG6K D0AG6K DRUGCOMP Micromet AG D0AG6K HIGHSTAT Phase 2 D0AO5F DRUG__ID D0AO5F D0AO5F DRUGCOMP Jupiter Orphan Therapeutics Jupiter, FL D0AO5F HIGHSTAT Phase 2 D0AO8L DRUG__ID D0AO8L D0AO8L DRUGCOMP Kite PharmaSanta Monica, CA National Cancer Institute Bethesda, MD D0AO8L HIGHSTAT Phase 2 D0AU2T DRUG__ID D0AU2T D0AU2T DRUGCOMP Regeneron Pharmaceuticals Tarrytown, NY D0AU2T HIGHSTAT Phase 2 D0B0NH DRUG__ID D0B0NH D0B0NH DRUGCOMP Ikaria D0B0NH HIGHSTAT Phase 2 D0B1ET DRUG__ID D0B1ET D0B1ET DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0B1ET HIGHSTAT Phase 2 D0B1GE DRUG__ID D0B1GE D0B1GE DRUGCOMP Krystal Biotech Pittsburgh, PA D0B1GE HIGHSTAT Phase 2 D0B1OH DRUG__ID D0B1OH D0B1OH DRUGCOMP Daiichi Sankyo D0B1OH HIGHSTAT Phase 2 D0B1RX DRUG__ID D0B1RX D0B1RX DRUGCOMP Zydus-Cadila Group D0B1RX HIGHSTAT Phase 2 D0B1TI DRUG__ID D0B1TI D0B1TI DRUGCOMP Genentech D0B1TI HIGHSTAT Phase 2 D0B1TL DRUG__ID D0B1TL D0B1TL DRUGCOMP Baylor College of Medicine D0B1TL HIGHSTAT Phase 2 D0B2HC DRUG__ID D0B2HC D0B2HC DRUGCOMP GlaxoSmithKline plc D0B2HC HIGHSTAT Phase 2 D0B2SW DRUG__ID D0B2SW D0B2SW DRUGCOMP Astellas Pharma Inc D0B2SW HIGHSTAT Phase 2 D0B2XS DRUG__ID D0B2XS D0B2XS DRUGCOMP Fina Biotech Slu D0B2XS HIGHSTAT Phase 2 D0B3RL DRUG__ID D0B3RL D0B3RL DRUGCOMP Merck-Serono Laboratories D0B3RL HIGHSTAT Phase 2 D0B3TA DRUG__ID D0B3TA D0B3TA DRUGCOMP LEO Pharma A/S D0B3TA HIGHSTAT Phase 2 D0B3YK DRUG__ID D0B3YK D0B3YK DRUGCOMP AstraZeneca Wilmington, DE D0B3YK HIGHSTAT Phase 2 D0B4MH DRUG__ID D0B4MH D0B4MH DRUGCOMP Cell medica; center for gene and cell therapy at baylor college of medicine D0B4MH HIGHSTAT Phase 2 D0B4XX DRUG__ID D0B4XX D0B4XX DRUGCOMP Quigley Pharma Inc D0B4XX HIGHSTAT Phase 2 D0B5VA DRUG__ID D0B5VA D0B5VA DRUGCOMP Santarus D0B5VA HIGHSTAT Phase 2 D0B6LT DRUG__ID D0B6LT D0B6LT DRUGCOMP Opiant PharmaceuticalsSanta Monica, CANational Institute on Drug Abuse Rockville, MD D0B6LT HIGHSTAT Phase 2 D0B6QZ DRUG__ID D0B6QZ D0B6QZ DRUGCOMP Aventis SA D0B6QZ HIGHSTAT Phase 2 D0B7LZ DRUG__ID D0B7LZ D0B7LZ DRUGCOMP Novartis AG D0B7LZ HIGHSTAT Phase 2 D0B7OY DRUG__ID D0B7OY D0B7OY DRUGCOMP Creabilis Therapeutics D0B7OY HIGHSTAT Phase 2 D0B8IZ DRUG__ID D0B8IZ D0B8IZ DRUGCOMP Halozyme Therapeutics D0B8IZ HIGHSTAT Phase 2 D0B8ZR DRUG__ID D0B8ZR D0B8ZR DRUGCOMP Nanotherapeutics; national cancer institute D0B8ZR HIGHSTAT Phase 2 D0BA1Y DRUG__ID D0BA1Y D0BA1Y DRUGCOMP Sylentis Sau D0BA1Y HIGHSTAT Phase 2 D0BA7K DRUG__ID D0BA7K D0BA7K DRUGCOMP BAS Medical D0BA7K HIGHSTAT Phase 2 D0BD5J DRUG__ID D0BD5J D0BD5J DRUGCOMP Glaxosmithkline D0BD5J HIGHSTAT Phase 2 D0BE1A DRUG__ID D0BE1A D0BE1A DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0BE1A HIGHSTAT Phase 2 D0BF9K DRUG__ID D0BF9K D0BF9K DRUGTYPE Antibody D0BF9K HIGHSTAT Phase 2 D0BG3B DRUG__ID D0BG3B D0BG3B DRUGCOMP Vertex pharmaceuticals D0BG3B HIGHSTAT Phase 2 D0BJ2W DRUG__ID D0BJ2W D0BJ2W DRUGCOMP DrugAbuse Sciences D0BJ2W HIGHSTAT Phase 2 D0BL6E DRUG__ID D0BL6E D0BL6E DRUGCOMP Kuros Biosurgery AG D0BL6E HIGHSTAT Phase 2 D0BM4T DRUG__ID D0BM4T D0BM4T DRUGCOMP Acasti Pharma Quebec, Canada D0BM4T HIGHSTAT Phase 2 D0BO6I DRUG__ID D0BO6I D0BO6I DRUGCOMP Enzo Biochem Inc D0BO6I HIGHSTAT Phase 2 D0BS7T DRUG__ID D0BS7T D0BS7T DRUGCOMP National Biopreparations Center D0BS7T HIGHSTAT Phase 2 D0BT6G DRUG__ID D0BT6G D0BT6G DRUGCOMP Emd serono D0BT6G HIGHSTAT Phase 2 D0BT6H DRUG__ID D0BT6H D0BT6H DRUGCOMP Bionomics; ironwood pharmaceuticals D0BT6H HIGHSTAT Phase 2 D0BT7R DRUG__ID D0BT7R D0BT7R DRUGCOMP Astellas Pharma D0BT7R HIGHSTAT Phase 2 D0C0DY DRUG__ID D0C0DY D0C0DY DRUGCOMP Novavax D0C0DY HIGHSTAT Phase 2 D0C0OB DRUG__ID D0C0OB D0C0OB DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0C0OB HIGHSTAT Phase 2 D0C0ZN DRUG__ID D0C0ZN D0C0ZN DRUGCOMP VaxartSouth San Francisco, CA D0C0ZN HIGHSTAT Phase 2 D0C3DA DRUG__ID D0C3DA D0C3DA DRUGCOMP Planet Biotechnology Inc D0C3DA HIGHSTAT Phase 2 D0C3FK DRUG__ID D0C3FK D0C3FK DRUGCOMP Celtic PharmaBermudaNational Institute on Drug Abuse Rockville, MD D0C3FK HIGHSTAT Phase 2 D0C3TI DRUG__ID D0C3TI D0C3TI DRUGCOMP Angimmune D0C3TI HIGHSTAT Phase 2 D0C3VQ DRUG__ID D0C3VQ D0C3VQ DRUGCOMP SciClone Pharmaceuticals D0C3VQ HIGHSTAT Phase 2 D0C3XD DRUG__ID D0C3XD D0C3XD DRUGCOMP BioMarck Pharmaceuticals D0C3XD HIGHSTAT Phase 2 D0C4BL DRUG__ID D0C4BL D0C4BL DRUGCOMP Viralytics D0C4BL HIGHSTAT Phase 2 D0C4GX DRUG__ID D0C4GX D0C4GX DRUGCOMP Grannus BioSciences Ltd D0C4GX HIGHSTAT Phase 2 D0C4YQ DRUG__ID D0C4YQ D0C4YQ DRUGCOMP GlaxoSmithKline D0C4YQ HIGHSTAT Phase 2 D0C5WR DRUG__ID D0C5WR D0C5WR DRUGCOMP Redox Pharmaceutical Corp D0C5WR HIGHSTAT Phase 2 D0C6EA DRUG__ID D0C6EA D0C6EA DRUGCOMP Luye pharmaceutical; Beijing peking university wbl biotech D0C6EA HIGHSTAT Phase 2 D0C6RD DRUG__ID D0C6RD D0C6RD DRUGCOMP Xiamen Amoytop Biotech Co Ltd D0C6RD HIGHSTAT Phase 2 D0C6ZS DRUG__ID D0C6ZS D0C6ZS DRUGCOMP Coley Pharmaceutical Group Inc; Coley Pharmaceutical D0C6ZS HIGHSTAT Phase 2 D0C7DY DRUG__ID D0C7DY D0C7DY DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0C7DY HIGHSTAT Phase 2 D0C7ZB DRUG__ID D0C7ZB D0C7ZB DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0C7ZB HIGHSTAT Phase 2 D0C8IF DRUG__ID D0C8IF D0C8IF DRUGCOMP Eli Lilly Indianapolis, IN D0C8IF HIGHSTAT Phase 2 D0C8KP DRUG__ID D0C8KP D0C8KP DRUGCOMP Santalis Healthcare San Antonio, TX D0C8KP HIGHSTAT Phase 2 D0C8MG DRUG__ID D0C8MG D0C8MG DRUGCOMP Selecta Biosciences Watertown, MA D0C8MG HIGHSTAT Phase 2 D0C9AV DRUG__ID D0C9AV D0C9AV DRUGCOMP Crescita Therapeutics Mississauga, Canada Ferndale Laboratories Ferndale, MI D0C9AV HIGHSTAT Phase 2 D0C9EN DRUG__ID D0C9EN D0C9EN DRUGCOMP Astrazeneca; isis pharmaceuticals D0C9EN HIGHSTAT Phase 2 D0C9IS DRUG__ID D0C9IS D0C9IS DRUGCOMP Zymenex A/S D0C9IS HIGHSTAT Phase 2 D0C9SW DRUG__ID D0C9SW D0C9SW DRUGCOMP Nastech Pharmaceutical; Emisphere Technologies Inc; Critical Pharmaceuticals Ltd; Altus Pharmaceuticals Inc D0C9SW HIGHSTAT Phase 2 D0C9TP DRUG__ID D0C9TP D0C9TP DRUGCOMP Bellicum Pharmaceuticals Inc D0C9TP HIGHSTAT Phase 2 D0CG0K DRUG__ID D0CG0K D0CG0K DRUGCOMP Aclaris Therapeutics Wayne, PA D0CG0K HIGHSTAT Phase 2 D0CG1A DRUG__ID D0CG1A D0CG1A DRUGCOMP ATARA Biotherapeutics South San Francisco, CA D0CG1A HIGHSTAT Phase 2 D0CH9G DRUG__ID D0CH9G D0CH9G DRUGCOMP Helocyte New York, NY D0CH9G HIGHSTAT Phase 2 D0CJ7Z DRUG__ID D0CJ7Z D0CJ7Z DRUGCOMP Allergan Parsippany, NJ Molecular Partners Zurich, Switzerland D0CJ7Z HIGHSTAT Phase 2 D0CK7F DRUG__ID D0CK7F D0CK7F DRUGCOMP AOBiome Cambridge, MA D0CK7F HIGHSTAT Phase 2 D0CO2W DRUG__ID D0CO2W D0CO2W DRUGCOMP Amgen Thousand Oaks, CA Novartis Pharmaceuticals East Hanover, NJ D0CO2W HIGHSTAT Phase 2 D0CO5F DRUG__ID D0CO5F D0CO5F DRUGCOMP Allodynic Therapeutics North Miami, FL D0CO5F HIGHSTAT Phase 2 D0CO9B DRUG__ID D0CO9B D0CO9B DRUGCOMP Transgene SA D0CO9B HIGHSTAT Phase 2 D0CQ1X DRUG__ID D0CQ1X D0CQ1X DRUGCOMP BioTime D0CQ1X HIGHSTAT Phase 2 D0CR1I DRUG__ID D0CR1I D0CR1I DRUGCOMP Tsumura & Co D0CR1I HIGHSTAT Phase 2 D0CT7M DRUG__ID D0CT7M D0CT7M DRUGCOMP Angstrom pharmaceuticals D0CT7M HIGHSTAT Phase 2 D0CW2N DRUG__ID D0CW2N D0CW2N DRUGCOMP Oncolytics Biotech Calgary, Canada D0CW2N HIGHSTAT Phase 2 D0D0DH DRUG__ID D0D0DH D0D0DH DRUGCOMP Cancer InsightSan Antonio, TX Elios Therapeutics Austin, TX D0D0DH HIGHSTAT Phase 2 D0D0FB DRUG__ID D0D0FB D0D0FB DRUGCOMP TheraVasc D0D0FB HIGHSTAT Phase 2 D0D0OC DRUG__ID D0D0OC D0D0OC DRUGCOMP Agenus D0D0OC HIGHSTAT Phase 2 D0D0OT DRUG__ID D0D0OT D0D0OT DRUGCOMP Gilead sciences D0D0OT HIGHSTAT Phase 2 D0D1ZS DRUG__ID D0D1ZS D0D1ZS DRUGCOMP Sorbent therapeutics D0D1ZS HIGHSTAT Phase 2 D0D3QN DRUG__ID D0D3QN D0D3QN DRUGCOMP Galderma Fort Worth, TX D0D3QN HIGHSTAT Phase 2 D0D3RY DRUG__ID D0D3RY D0D3RY DRUGCOMP Institut Pasteur D0D3RY HIGHSTAT Phase 2 D0D3TQ DRUG__ID D0D3TQ D0D3TQ DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0D3TQ HIGHSTAT Phase 2 D0D4NJ DRUG__ID D0D4NJ D0D4NJ DRUGCOMP Cytos Biotechnology AG D0D4NJ HIGHSTAT Phase 2 D0D4VK DRUG__ID D0D4VK D0D4VK DRUGCOMP Regio Biosciences D0D4VK HIGHSTAT Phase 2 D0D4VN DRUG__ID D0D4VN D0D4VN DRUGCOMP National Cancer Institute D0D4VN HIGHSTAT Phase 2 D0D5MU DRUG__ID D0D5MU D0D5MU DRUGCOMP Vernalis Pharmaceuticals D0D5MU HIGHSTAT Phase 2 D0D5NV DRUG__ID D0D5NV D0D5NV DRUGCOMP Korea Center for Disease Control & Prevention D0D5NV HIGHSTAT Phase 2 D0D6XS DRUG__ID D0D6XS D0D6XS DRUGCOMP LG Life Sciences Ltd D0D6XS HIGHSTAT Phase 2 D0D7DU DRUG__ID D0D7DU D0D7DU DRUGCOMP Valentis D0D7DU HIGHSTAT Phase 2 D0D7MJ DRUG__ID D0D7MJ D0D7MJ DRUGCOMP Relevare Pharmaceuticals Ltd D0D7MJ HIGHSTAT Phase 2 D0D7VO DRUG__ID D0D7VO D0D7VO DRUGCOMP Forest Laboratories D0D7VO HIGHSTAT Phase 2 D0D7YA DRUG__ID D0D7YA D0D7YA DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0D7YA HIGHSTAT Phase 2 D0D8LK DRUG__ID D0D8LK D0D8LK DRUGCOMP National Institutes of Health D0D8LK HIGHSTAT Phase 2 D0D8SN DRUG__ID D0D8SN D0D8SN DRUGCOMP Cytomedix D0D8SN HIGHSTAT Phase 2 D0DI1B DRUG__ID D0DI1B D0DI1B DRUGCOMP vTv Therapeutics High Point, NC D0DI1B HIGHSTAT Phase 2 D0DQ3H DRUG__ID D0DQ3H D0DQ3H DRUGCOMP Biogen Cambridge, MA D0DQ3H HIGHSTAT Phase 2 D0DR0P DRUG__ID D0DR0P D0DR0P DRUGCOMP ArQule D0DR0P HIGHSTAT Phase 2 D0DT1Y DRUG__ID D0DT1Y D0DT1Y DRUGCOMP Wilson Therapeutics Westford, MA D0DT1Y HIGHSTAT Phase 2 D0DV2Q DRUG__ID D0DV2Q D0DV2Q DRUGCOMP Biomarin pharmaceutical D0DV2Q HIGHSTAT Phase 2 D0E1LB DRUG__ID D0E1LB D0E1LB DRUGCOMP Merck Bioventures D0E1LB HIGHSTAT Phase 2 D0E1RT DRUG__ID D0E1RT D0E1RT DRUGCOMP Astellas D0E1RT HIGHSTAT Phase 2 D0E1SV DRUG__ID D0E1SV D0E1SV DRUGCOMP Meta-IQ Aps D0E1SV HIGHSTAT Phase 2 D0E2EY DRUG__ID D0E2EY D0E2EY DRUGCOMP BioLite Taipei, Taiwan D0E2EY HIGHSTAT Phase 2 D0E2LH DRUG__ID D0E2LH D0E2LH DRUGCOMP Thrombotargets D0E2LH HIGHSTAT Phase 2 D0E2RA DRUG__ID D0E2RA D0E2RA DRUGCOMP Emergent BioSolutions D0E2RA HIGHSTAT Phase 2 D0E3EO DRUG__ID D0E3EO D0E3EO DRUGCOMP Akros pharma D0E3EO HIGHSTAT Phase 2 D0E4DO DRUG__ID D0E4DO D0E4DO DRUGCOMP Phytrix AG D0E4DO HIGHSTAT Phase 2 D0E5FA DRUG__ID D0E5FA D0E5FA DRUGCOMP Proportional Technologies Inc D0E5FA HIGHSTAT Phase 2 D0E5QY DRUG__ID D0E5QY D0E5QY DRUGCOMP Cantab Biopharmaceuticals Ltd D0E5QY HIGHSTAT Phase 2 D0E5RA DRUG__ID D0E5RA D0E5RA DRUGCOMP Zymenex A/S D0E5RA HIGHSTAT Phase 2 D0E5TH DRUG__ID D0E5TH D0E5TH DRUGCOMP Beech tree labs D0E5TH HIGHSTAT Phase 2 D0E5WX DRUG__ID D0E5WX D0E5WX DRUGCOMP Pfizer New York, NY D0E5WX HIGHSTAT Phase 2 D0E6HT DRUG__ID D0E6HT D0E6HT DRUGCOMP Janssen Vaccines and Prevention Leiden, Netherlands D0E6HT HIGHSTAT Phase 2 D0E6SQ DRUG__ID D0E6SQ D0E6SQ DRUGCOMP ISIS Pharm; Antisense Therapeutics D0E6SQ HIGHSTAT Phase 2 D0E7AK DRUG__ID D0E7AK D0E7AK DRUGCOMP Viking Therapeutics San Diego, CA D0E7AK HIGHSTAT Phase 2 D0E7WH DRUG__ID D0E7WH D0E7WH DRUGCOMP K-PAX Pharmaceuticals Mill Valley, CA D0E7WH HIGHSTAT Phase 2 D0E7XM DRUG__ID D0E7XM D0E7XM DRUGCOMP Bayer D0E7XM HIGHSTAT Phase 2 D0E8DK DRUG__ID D0E8DK D0E8DK DRUGCOMP Columbia Laboratories Inc D0E8DK HIGHSTAT Phase 2 D0E8KO DRUG__ID D0E8KO D0E8KO DRUGCOMP University of Michigan D0E8KO HIGHSTAT Phase 2 D0E8PG DRUG__ID D0E8PG D0E8PG DRUGCOMP BeiGene Cambridge, MA D0E8PG HIGHSTAT Phase 2 D0E8QE DRUG__ID D0E8QE D0E8QE DRUGCOMP Heat biologics D0E8QE HIGHSTAT Phase 2 D0E8YH DRUG__ID D0E8YH D0E8YH DRUGCOMP NicOx SA D0E8YH HIGHSTAT Phase 2 D0E9MI DRUG__ID D0E9MI D0E9MI DRUGCOMP Faraday Pharmaceuticals Seattle, WA D0E9MI HIGHSTAT Phase 2 D0E9XR DRUG__ID D0E9XR D0E9XR DRUGCOMP Sirnaomics Gaithersburg, MD D0E9XR HIGHSTAT Phase 2 D0EE3Y DRUG__ID D0EE3Y D0EE3Y DRUGCOMP Novavax Inc D0EE3Y HIGHSTAT Phase 2 D0EE9G DRUG__ID D0EE9G D0EE9G DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D0EE9G HIGHSTAT Phase 2 D0EJ0O DRUG__ID D0EJ0O D0EJ0O DRUGCOMP Sancilio Riveria Beach, FL D0EJ0O HIGHSTAT Phase 2 D0EL5Q DRUG__ID D0EL5Q D0EL5Q DRUGCOMP Jounce Therapeutics Cambridge, MA D0EL5Q HIGHSTAT Phase 2 D0EM1D DRUG__ID D0EM1D D0EM1D DRUGCOMP Roche Basel, Switzerland D0EM1D HIGHSTAT Phase 2 D0ES6N DRUG__ID D0ES6N D0ES6N DRUGCOMP Symic Bio Emeryville, CA D0ES6N HIGHSTAT Phase 2 D0ES7H DRUG__ID D0ES7H D0ES7H DRUGCOMP TVAX Biomedical Olathe, KS D0ES7H HIGHSTAT Phase 2 D0ET2T DRUG__ID D0ET2T D0ET2T DRUGCOMP GlaxoSmithKline D0ET2T HIGHSTAT Phase 2 D0EV1L DRUG__ID D0EV1L D0EV1L DRUGCOMP Zealand Pharma A/S D0EV1L HIGHSTAT Phase 2 D0EV9B DRUG__ID D0EV9B D0EV9B DRUGCOMP Balance Therapeutics San Bruno, CA D0EV9B HIGHSTAT Phase 2 D0EY1E DRUG__ID D0EY1E D0EY1E DRUGCOMP NasVax Ltd D0EY1E HIGHSTAT Phase 2 D0F0NW DRUG__ID D0F0NW D0F0NW DRUGCOMP Circassia Ltd D0F0NW HIGHSTAT Phase 2 D0F1ZI DRUG__ID D0F1ZI D0F1ZI DRUGCOMP Philogen SpA D0F1ZI HIGHSTAT Phase 2 D0F2KY DRUG__ID D0F2KY D0F2KY DRUGCOMP Sanofi D0F2KY HIGHSTAT Phase 2 D0F3JL DRUG__ID D0F3JL D0F3JL DRUGCOMP Resolve Therapeutics Seattle, WA D0F3JL HIGHSTAT Phase 2 D0F4SN DRUG__ID D0F4SN D0F4SN DRUGCOMP Kuros Biosurgery AG D0F4SN HIGHSTAT Phase 2 D0F5VX DRUG__ID D0F5VX D0F5VX DRUGCOMP MetronomX D0F5VX HIGHSTAT Phase 2 D0F5WX DRUG__ID D0F5WX D0F5WX DRUGCOMP Unigene Laboratories Inc D0F5WX HIGHSTAT Phase 2 D0F6SS DRUG__ID D0F6SS D0F6SS DRUGCOMP Mabvax therapeutics D0F6SS HIGHSTAT Phase 2 D0F7IG DRUG__ID D0F7IG D0F7IG DRUGCOMP Pherin Pharmaceuticals Los Altos, CA D0F7IG HIGHSTAT Phase 2 D0F7OY DRUG__ID D0F7OY D0F7OY DRUGCOMP DynPort Vaccine Company LLC D0F7OY HIGHSTAT Phase 2 D0F8HN DRUG__ID D0F8HN D0F8HN DRUGCOMP Dong-A Pharmaceutical Co Ltd D0F8HN HIGHSTAT Phase 2 D0F9IE DRUG__ID D0F9IE D0F9IE DRUGCOMP Merck Kenilworth, NJ D0F9IE HIGHSTAT Phase 2 D0F9NA DRUG__ID D0F9NA D0F9NA DRUGCOMP Molecular Research Center Inc D0F9NA HIGHSTAT Phase 2 D0F9XG DRUG__ID D0F9XG D0F9XG DRUGCOMP AstraZeneca D0F9XG HIGHSTAT Phase 2 D0FA0A DRUG__ID D0FA0A D0FA0A DRUGCOMP Context Therapeutics Philadelphia, PA D0FA0A HIGHSTAT Phase 2 D0FA5Z DRUG__ID D0FA5Z D0FA5Z DRUGCOMP Lexicon Pharmaceuticals Inc D0FA5Z HIGHSTAT Phase 2 D0FB1C DRUG__ID D0FB1C D0FB1C DRUGCOMP BioPharmX Menlo Park, CA D0FB1C HIGHSTAT Phase 2 D0FC8O DRUG__ID D0FC8O D0FC8O DRUGCOMP Daewoong Pharmaceutical Co Ltd D0FC8O HIGHSTAT Phase 2 D0FD7H DRUG__ID D0FD7H D0FD7H DRUGCOMP Altor bioscience D0FD7H HIGHSTAT Phase 2 D0FE7D DRUG__ID D0FE7D D0FE7D DRUGCOMP Eli Lilly Indianapolis, IN D0FE7D HIGHSTAT Phase 2 D0FF0I DRUG__ID D0FF0I D0FF0I DRUGCOMP OPKO Biologics Nes Ziona, Israel D0FF0I HIGHSTAT Phase 2 D0FF2S DRUG__ID D0FF2S D0FF2S DRUGCOMP Ritter Pharmaceuticals Inc D0FF2S HIGHSTAT Phase 2 D0FG2Z DRUG__ID D0FG2Z D0FG2Z DRUGCOMP NanoCarrier Chiba, Japan D0FG2Z HIGHSTAT Phase 2 D0FH5N DRUG__ID D0FH5N D0FH5N DRUGCOMP Ironwood Pharmaceuticals Inc D0FH5N HIGHSTAT Phase 2 D0FN4T DRUG__ID D0FN4T D0FN4T DRUGCOMP Aspyrian Therapeutics San Diego, CA D0FN4T HIGHSTAT Phase 2 D0FR7E DRUG__ID D0FR7E D0FR7E DRUGCOMP RespireRx Pharmaceuticals Glen Rock, NJ D0FR7E HIGHSTAT Phase 2 D0FS3H DRUG__ID D0FS3H D0FS3H DRUGCOMP Ortho Dermatologics Raleigh, NC D0FS3H HIGHSTAT Phase 2 D0FV8P DRUG__ID D0FV8P D0FV8P DRUGCOMP Polyphor Ltd D0FV8P HIGHSTAT Phase 2 D0FW2D DRUG__ID D0FW2D D0FW2D DRUGCOMP NexGenix D0FW2D HIGHSTAT Phase 2 D0FW8Z DRUG__ID D0FW8Z D0FW8Z DRUGCOMP Stocosil Industry, CA D0FW8Z HIGHSTAT Phase 2 D0FZ1W DRUG__ID D0FZ1W D0FZ1W DRUGCOMP Biota pharmaceuticals D0FZ1W HIGHSTAT Phase 2 D0FZ7Q DRUG__ID D0FZ7Q D0FZ7Q DRUGCOMP NanOlogy Fort Worth, TX D0FZ7Q HIGHSTAT Phase 2 D0G0GP DRUG__ID D0G0GP D0G0GP DRUGCOMP Capnia Redwood City, CA D0G0GP HIGHSTAT Phase 2 D0G1HX DRUG__ID D0G1HX D0G1HX DRUGCOMP Caladrius Biosciences Basking Ridge, NJ D0G1HX HIGHSTAT Phase 2 D0G1IV DRUG__ID D0G1IV D0G1IV DRUGCOMP TransDermal Technologies Inc; Clarus Therapeutics Inc D0G1IV HIGHSTAT Phase 2 D0G1RM DRUG__ID D0G1RM D0G1RM DRUGCOMP Amarillo biosciences D0G1RM HIGHSTAT Phase 2 D0G1YA DRUG__ID D0G1YA D0G1YA DRUGCOMP Pfizer New York, NY D0G1YA HIGHSTAT Phase 2 D0G2FV DRUG__ID D0G2FV D0G2FV DRUGCOMP AdociaLyon, France Eli Lilly Indianapolis, IN D0G2FV HIGHSTAT Phase 2 D0G3GR DRUG__ID D0G3GR D0G3GR DRUGCOMP Johns Hopkins University D0G3GR HIGHSTAT Phase 2 D0G4AL DRUG__ID D0G4AL D0G4AL DRUGCOMP Patara Pharma San Diego, CA D0G4AL HIGHSTAT Phase 2 D0G4CY DRUG__ID D0G4CY D0G4CY DRUGCOMP Patara Pharma San Diego, CA D0G4CY HIGHSTAT Phase 2 D0G4JC DRUG__ID D0G4JC D0G4JC DRUGCOMP AnaptysBio San Diego, CA D0G4JC HIGHSTAT Phase 2 D0G4QL DRUG__ID D0G4QL D0G4QL DRUGCOMP Uni-Bio Science Group Limited D0G4QL HIGHSTAT Phase 2 D0G4XE DRUG__ID D0G4XE D0G4XE DRUGCOMP Baxter Healthcare D0G4XE HIGHSTAT Phase 2 D0G4YN DRUG__ID D0G4YN D0G4YN DRUGCOMP RadioMedix Houston, TX Excel Diagnostics and Nuclear Oncology Houston, TXUniversity of California-Los Angeles Los Angeles, CA D0G4YN HIGHSTAT Phase 2 D0G4YR DRUG__ID D0G4YR D0G4YR DRUGCOMP Mitsubishi tanabe pharma D0G4YR HIGHSTAT Phase 2 D0G5BL DRUG__ID D0G5BL D0G5BL DRUGCOMP Genentech South San Francisco, CA D0G5BL HIGHSTAT Phase 2 D0G5GB DRUG__ID D0G5GB D0G5GB DRUGCOMP MacroGenics D0G5GB HIGHSTAT Phase 2 D0G5OE DRUG__ID D0G5OE D0G5OE DRUGTYPE Antibody D0G5OE HIGHSTAT Phase 2 D0G5UW DRUG__ID D0G5UW D0G5UW DRUGCOMP Grunenthal GmbH D0G5UW HIGHSTAT Phase 2 D0G6VC DRUG__ID D0G6VC D0G6VC DRUGCOMP Cellerix D0G6VC HIGHSTAT Phase 2 D0G7XA DRUG__ID D0G7XA D0G7XA DRUGCOMP NanoBio D0G7XA HIGHSTAT Phase 2 D0G9OH DRUG__ID D0G9OH D0G9OH DRUGCOMP Vivozon Inc D0G9OH HIGHSTAT Phase 2 D0G9ZV DRUG__ID D0G9ZV D0G9ZV DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0G9ZV HIGHSTAT Phase 2 D0GA7H DRUG__ID D0GA7H D0GA7H DRUGCOMP Circassia Ltd D0GA7H HIGHSTAT Phase 2 D0GB5X DRUG__ID D0GB5X D0GB5X DRUGCOMP Bristol-Myers SquibbPrinceton, NJ D0GB5X HIGHSTAT Phase 2 D0GG5I DRUG__ID D0GG5I D0GG5I DRUGCOMP Simcere Pharmaceutical Group D0GG5I HIGHSTAT Phase 2 D0GI6O DRUG__ID D0GI6O D0GI6O DRUGCOMP Philogen SpA D0GI6O HIGHSTAT Phase 2 D0GJ7N DRUG__ID D0GJ7N D0GJ7N DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D0GJ7N HIGHSTAT Phase 2 D0GL0Q DRUG__ID D0GL0Q D0GL0Q DRUGCOMP Intercytex D0GL0Q HIGHSTAT Phase 2 D0GM8E DRUG__ID D0GM8E D0GM8E DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0GM8E HIGHSTAT Phase 2 D0GNF7 DRUG__ID D0GNF7 D0GNF7 DRUGTYPE Small interfering RNA D0GNF7 HIGHSTAT Phase 2 D0GO0R DRUG__ID D0GO0R D0GO0R DRUGCOMP Steba BiotechLuxembourg City, Luxembourg D0GO0R HIGHSTAT Phase 2 D0GO4T DRUG__ID D0GO4T D0GO4T DRUGCOMP Innate Pharma Marseille, France D0GO4T HIGHSTAT Phase 2 D0GR0I DRUG__ID D0GR0I D0GR0I DRUGCOMP Baylor College of Medicine D0GR0I HIGHSTAT Phase 2 D0GU9J DRUG__ID D0GU9J D0GU9J DRUGCOMP Genzyme D0GU9J HIGHSTAT Phase 2 D0GX0I DRUG__ID D0GX0I D0GX0I DRUGCOMP Edimer Pharmaceuticals Cambridge, MA D0GX0I HIGHSTAT Phase 2 D0H0BQ DRUG__ID D0H0BQ D0H0BQ DRUGCOMP Neumedicines Pasadena, CA D0H0BQ HIGHSTAT Phase 2 D0H1MK DRUG__ID D0H1MK D0H1MK DRUGCOMP Innovate Biopharmaceuticals Raleigh, NC D0H1MK HIGHSTAT Phase 2 D0H1TG DRUG__ID D0H1TG D0H1TG DRUGCOMP ISIS pharmaceuticals D0H1TG HIGHSTAT Phase 2 D0H1YZ DRUG__ID D0H1YZ D0H1YZ DRUGCOMP Amarantus biosciences D0H1YZ HIGHSTAT Phase 2 D0H2CV DRUG__ID D0H2CV D0H2CV DRUGCOMP Novartis AG D0H2CV HIGHSTAT Phase 2 D0H2EM DRUG__ID D0H2EM D0H2EM DRUGCOMP University of Oxford D0H2EM HIGHSTAT Phase 2 D0H3ST DRUG__ID D0H3ST D0H3ST DRUGCOMP Akcea Therapeutics Cambridge, MA D0H3ST HIGHSTAT Phase 2 D0H4EM DRUG__ID D0H4EM D0H4EM DRUGCOMP Sanofi pasteur D0H4EM HIGHSTAT Phase 2 D0H4GU DRUG__ID D0H4GU D0H4GU DRUGCOMP Epygenix Therapeutics Paramus, NJ D0H4GU HIGHSTAT Phase 2 D0H4IM DRUG__ID D0H4IM D0H4IM DRUGCOMP Pherin Corp D0H4IM HIGHSTAT Phase 2 D0H5DM DRUG__ID D0H5DM D0H5DM DRUGCOMP DBV Technologies Summit, NJ D0H5DM HIGHSTAT Phase 2 D0H5MW DRUG__ID D0H5MW D0H5MW DRUGCOMP PhytoHealth Corp D0H5MW HIGHSTAT Phase 2 D0H6PK DRUG__ID D0H6PK D0H6PK DRUGCOMP Fabre-Kramer Pharmaceuticals Houston, TX D0H6PK HIGHSTAT Phase 2 D0H6ZA DRUG__ID D0H6ZA D0H6ZA DRUGCOMP Nascent Biotech Vero Beach, FL D0H6ZA HIGHSTAT Phase 2 D0H7BF DRUG__ID D0H7BF D0H7BF DRUGCOMP EisaiWoodcliff Lake, NJH3 Biomedicine Cambridge, MA D0H7BF HIGHSTAT Phase 2 D0H7KQ DRUG__ID D0H7KQ D0H7KQ DRUGCOMP AbbVie North Chicago, IL C2N Diagnostics St. Louis, MO D0H7KQ HIGHSTAT Phase 2 D0H7TS DRUG__ID D0H7TS D0H7TS DRUGCOMP Stemedica Cell Technologies San Diego, CA D0H7TS HIGHSTAT Phase 2 D0H8DS DRUG__ID D0H8DS D0H8DS DRUGCOMP Lion biotechnologies; national cancer institute D0H8DS HIGHSTAT Phase 2 D0H8GW DRUG__ID D0H8GW D0H8GW DRUGCOMP Schering-Plough D0H8GW HIGHSTAT Phase 2 D0H9MA DRUG__ID D0H9MA D0H9MA DRUGCOMP Corimmun GmbH D0H9MA HIGHSTAT Phase 2 D0H9RN DRUG__ID D0H9RN D0H9RN DRUGCOMP ARCA biopharma D0H9RN HIGHSTAT Phase 2 D0H9VP DRUG__ID D0H9VP D0H9VP DRUGCOMP Sangart Inc D0H9VP HIGHSTAT Phase 2 D0H9WY DRUG__ID D0H9WY D0H9WY DRUGCOMP Boston Therapeutics D0H9WY HIGHSTAT Phase 2 D0HD8X DRUG__ID D0HD8X D0HD8X DRUGCOMP Memgen D0HD8X HIGHSTAT Phase 2 D0HG9P DRUG__ID D0HG9P D0HG9P DRUGCOMP Aerogen Pharma Galway, Ireland D0HG9P HIGHSTAT Phase 2 D0HH0U DRUG__ID D0HH0U D0HH0U DRUGCOMP OncoTherapy Science Inc D0HH0U HIGHSTAT Phase 2 D0HJ1R DRUG__ID D0HJ1R D0HJ1R DRUGCOMP Incyte Wilmington, DE D0HJ1R HIGHSTAT Phase 2 D0HM2S DRUG__ID D0HM2S D0HM2S DRUGCOMP Boston Therapeutics, Newton, MA D0HM2S HIGHSTAT Phase 2 D0HM5L DRUG__ID D0HM5L D0HM5L DRUGCOMP BioSante Pharmaceuticals D0HM5L HIGHSTAT Phase 2 D0I1DZ DRUG__ID D0I1DZ D0I1DZ DRUGCOMP Santen Pharmaceutical Co Ltd D0I1DZ HIGHSTAT Phase 2 D0I1EX DRUG__ID D0I1EX D0I1EX DRUGCOMP Aderis Pharmaceuticals D0I1EX HIGHSTAT Phase 2 D0I1FT DRUG__ID D0I1FT D0I1FT DRUGCOMP VIRxSYS D0I1FT HIGHSTAT Phase 2 D0I1FU DRUG__ID D0I1FU D0I1FU DRUGCOMP GlaxoSmithKline D0I1FU HIGHSTAT Phase 2 D0I1JG DRUG__ID D0I1JG D0I1JG DRUGCOMP Essentys AB D0I1JG HIGHSTAT Phase 2 D0I3AS DRUG__ID D0I3AS D0I3AS DRUGCOMP Galderma SA D0I3AS HIGHSTAT Phase 2 D0I3GT DRUG__ID D0I3GT D0I3GT DRUGCOMP Inviragen D0I3GT HIGHSTAT Phase 2 D0I3RN DRUG__ID D0I3RN D0I3RN DRUGCOMP ProSci D0I3RN HIGHSTAT Phase 2 D0I3VS DRUG__ID D0I3VS D0I3VS DRUGCOMP National Cancer Institute D0I3VS HIGHSTAT Phase 2 D0I3VV DRUG__ID D0I3VV D0I3VV DRUGCOMP Oncolys Biopharma Tokyo, Japan D0I3VV HIGHSTAT Phase 2 D0I4HS DRUG__ID D0I4HS D0I4HS DRUGCOMP Phasebio pharmaceuticals D0I4HS HIGHSTAT Phase 2 D0I4LM DRUG__ID D0I4LM D0I4LM DRUGCOMP Abiogen pharma D0I4LM HIGHSTAT Phase 2 D0I5US DRUG__ID D0I5US D0I5US DRUGCOMP United Biomedical D0I5US HIGHSTAT Phase 2 D0I5ZM DRUG__ID D0I5ZM D0I5ZM DRUGCOMP Bhv pharma D0I5ZM HIGHSTAT Phase 2 D0I6IQ DRUG__ID D0I6IQ D0I6IQ DRUGCOMP AbGenomics International Los Altos, CA D0I6IQ HIGHSTAT Phase 2 D0I6LN DRUG__ID D0I6LN D0I6LN DRUGCOMP Impel NeuroPharma Seattle, WA D0I6LN HIGHSTAT Phase 2 D0I7NG DRUG__ID D0I7NG D0I7NG DRUGCOMP Lorus Therapeutics D0I7NG HIGHSTAT Phase 2 D0I8CK DRUG__ID D0I8CK D0I8CK DRUGCOMP Inflazyme Pharmaceuticals D0I8CK HIGHSTAT Phase 2 D0I8FS DRUG__ID D0I8FS D0I8FS DRUGCOMP Biogen Cambridge, MA D0I8FS HIGHSTAT Phase 2 D0I8QJ DRUG__ID D0I8QJ D0I8QJ DRUGCOMP Tamir Biotechnology D0I8QJ HIGHSTAT Phase 2 D0I8ZM DRUG__ID D0I8ZM D0I8ZM DRUGCOMP Rottapharm Madaus D0I8ZM HIGHSTAT Phase 2 D0I9IL DRUG__ID D0I9IL D0I9IL DRUGCOMP On Target Laboratories West Lafayette, IN D0I9IL HIGHSTAT Phase 2 D0IA8W DRUG__ID D0IA8W D0IA8W DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0IA8W HIGHSTAT Phase 2 D0IA9E DRUG__ID D0IA9E D0IA9E DRUGCOMP BlackThorn Therapeutics San Francisco, CA D0IA9E HIGHSTAT Phase 2 D0IK1I DRUG__ID D0IK1I D0IK1I DRUGCOMP PhytoHealth Corp D0IK1I HIGHSTAT Phase 2 D0IL4C DRUG__ID D0IL4C D0IL4C DRUGCOMP Targeted Genetics Corp D0IL4C HIGHSTAT Phase 2 D0IN8Z DRUG__ID D0IN8Z D0IN8Z DRUGCOMP Lilly D0IN8Z HIGHSTAT Phase 2 D0IO9Z DRUG__ID D0IO9Z D0IO9Z DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0IO9Z HIGHSTAT Phase 2 D0IV7F DRUG__ID D0IV7F D0IV7F DRUGCOMP Dow Pharmaceutical Sciences D0IV7F HIGHSTAT Phase 2 D0J0EM DRUG__ID D0J0EM D0J0EM DRUGCOMP Pharmsynthez ZAO D0J0EM HIGHSTAT Phase 2 D0J0YH DRUG__ID D0J0YH D0J0YH DRUGCOMP Boehringer ingelheim pharmaceuticals D0J0YH HIGHSTAT Phase 2 D0J1AU DRUG__ID D0J1AU D0J1AU DRUGCOMP Coda therapeutics D0J1AU HIGHSTAT Phase 2 D0J1GA DRUG__ID D0J1GA D0J1GA DRUGCOMP GlaxoSmithKline plc D0J1GA HIGHSTAT Phase 2 D0J1KS DRUG__ID D0J1KS D0J1KS DRUGCOMP Bristol-Myers Squibb; Alder Biopharmaceuticals D0J1KS HIGHSTAT Phase 2 D0J2NX DRUG__ID D0J2NX D0J2NX DRUGCOMP Insys Therapeutics D0J2NX HIGHSTAT Phase 2 D0J4WA DRUG__ID D0J4WA D0J4WA DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ D0J4WA HIGHSTAT Phase 2 D0J5HG DRUG__ID D0J5HG D0J5HG DRUGCOMP E-Therapeutics Ltd D0J5HG HIGHSTAT Phase 2 D0J5XS DRUG__ID D0J5XS D0J5XS DRUGCOMP Teva pharmaceutical D0J5XS HIGHSTAT Phase 2 D0J6DU DRUG__ID D0J6DU D0J6DU DRUGCOMP Novavax D0J6DU HIGHSTAT Phase 2 D0J6NV DRUG__ID D0J6NV D0J6NV DRUGCOMP GlobeImmune D0J6NV HIGHSTAT Phase 2 D0J6NW DRUG__ID D0J6NW D0J6NW DRUGCOMP Emergent BioSolutions D0J6NW HIGHSTAT Phase 2 D0J6VE DRUG__ID D0J6VE D0J6VE DRUGCOMP Transgene D0J6VE HIGHSTAT Phase 2 D0J6ZA DRUG__ID D0J6ZA D0J6ZA DRUGCOMP Surface Therapeutics Ltd D0J6ZA HIGHSTAT Phase 2 D0J7LV DRUG__ID D0J7LV D0J7LV DRUGCOMP Novavax D0J7LV HIGHSTAT Phase 2 D0J7MQ DRUG__ID D0J7MQ D0J7MQ DRUGCOMP Colby pharmaceuticals D0J7MQ HIGHSTAT Phase 2 D0J8BZ DRUG__ID D0J8BZ D0J8BZ DRUGCOMP Biogen Idec D0J8BZ HIGHSTAT Phase 2 D0J8EC DRUG__ID D0J8EC D0J8EC DRUGCOMP Actelion Pharmaceuticals D0J8EC HIGHSTAT Phase 2 D0J9PD DRUG__ID D0J9PD D0J9PD DRUGCOMP Sigma-Tau Pharmaceuticals Inc D0J9PD HIGHSTAT Phase 2 D0J9SB DRUG__ID D0J9SB D0J9SB DRUGCOMP Peregrine Pharmaceuticals Tustin, CA D0J9SB HIGHSTAT Phase 2 D0J9UY DRUG__ID D0J9UY D0J9UY DRUGCOMP Merck D0J9UY HIGHSTAT Phase 2 D0J9VG DRUG__ID D0J9VG D0J9VG DRUGCOMP Neuralstem D0J9VG HIGHSTAT Phase 2 D0JF3M DRUG__ID D0JF3M D0JF3M DRUGCOMP Digna Biotech SL D0JF3M HIGHSTAT Phase 2 D0JH9T DRUG__ID D0JH9T D0JH9T DRUGCOMP ACE BioSciences D0JH9T HIGHSTAT Phase 2 D0JM0G DRUG__ID D0JM0G D0JM0G DRUGCOMP Xeme biopharma D0JM0G HIGHSTAT Phase 2 D0JM7Z DRUG__ID D0JM7Z D0JM7Z DRUGCOMP Astellas Northbrook, IL D0JM7Z HIGHSTAT Phase 2 D0JO8T DRUG__ID D0JO8T D0JO8T DRUGCOMP Acer Therapeutics Cambridge, MA D0JO8T HIGHSTAT Phase 2 D0JQ2W DRUG__ID D0JQ2W D0JQ2W DRUGCOMP Immunomic Therapeutics Rockville, MD Duke University Durham, NC University of Florida Gainesville, FL D0JQ2W HIGHSTAT Phase 2 D0JS8H DRUG__ID D0JS8H D0JS8H DRUGCOMP Meiji seika pharma D0JS8H HIGHSTAT Phase 2 D0JU3A DRUG__ID D0JU3A D0JU3A DRUGCOMP Transdermal Specialties Broomall, PA D0JU3A HIGHSTAT Phase 2 D0JV0O DRUG__ID D0JV0O D0JV0O DRUGCOMP Genervon biopharmaceuticals D0JV0O HIGHSTAT Phase 2 D0JV8Z DRUG__ID D0JV8Z D0JV8Z DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0JV8Z HIGHSTAT Phase 2 D0JW0V DRUG__ID D0JW0V D0JW0V DRUGCOMP La jolla pharmaceutical D0JW0V HIGHSTAT Phase 2 D0JW6R DRUG__ID D0JW6R D0JW6R DRUGCOMP LAM Therapeutics Guilford, CT D0JW6R HIGHSTAT Phase 2 D0K0IS DRUG__ID D0K0IS D0K0IS DRUGCOMP Cell Therapeutics Inc D0K0IS HIGHSTAT Phase 2 D0K0KQ DRUG__ID D0K0KQ D0K0KQ DRUGCOMP BioCancell Therapeutics D0K0KQ HIGHSTAT Phase 2 D0K0TZ DRUG__ID D0K0TZ D0K0TZ DRUGCOMP BiondVax Pharmaceuticals Ltd D0K0TZ HIGHSTAT Phase 2 D0K1AP DRUG__ID D0K1AP D0K1AP DRUGCOMP NeuroDiscovery Ltd D0K1AP HIGHSTAT Phase 2 D0K1EO DRUG__ID D0K1EO D0K1EO DRUGCOMP Central Drug Research Institute D0K1EO HIGHSTAT Phase 2 D0K1SR DRUG__ID D0K1SR D0K1SR DRUGCOMP Pfizer D0K1SR HIGHSTAT Phase 2 D0K2KS DRUG__ID D0K2KS D0K2KS DRUGCOMP NeuroSpheres Ltd D0K2KS HIGHSTAT Phase 2 D0K4CD DRUG__ID D0K4CD D0K4CD DRUGCOMP Astellas Pharma Inc D0K4CD HIGHSTAT Phase 2 D0K4JI DRUG__ID D0K4JI D0K4JI DRUGCOMP Jupiter Orphan Therapeutics Jupiter, FL D0K4JI HIGHSTAT Phase 2 D0K5TE DRUG__ID D0K5TE D0K5TE DRUGCOMP Bristol-myers squibb D0K5TE HIGHSTAT Phase 2 D0K6HE DRUG__ID D0K6HE D0K6HE DRUGCOMP ProRetina Therapeutics SL D0K6HE HIGHSTAT Phase 2 D0K6HG DRUG__ID D0K6HG D0K6HG DRUGCOMP Purdue pharma D0K6HG HIGHSTAT Phase 2 D0K7LA DRUG__ID D0K7LA D0K7LA DRUGCOMP TikoMed AB D0K7LA HIGHSTAT Phase 2 D0K7NI DRUG__ID D0K7NI D0K7NI DRUGCOMP Abbvie; reata pharmaceuticals D0K7NI HIGHSTAT Phase 2 D0K8LB DRUG__ID D0K8LB D0K8LB DRUGCOMP Progen Industries D0K8LB HIGHSTAT Phase 2 D0K8YG DRUG__ID D0K8YG D0K8YG DRUGCOMP Leiden University Medical Center D0K8YG HIGHSTAT Phase 2 D0K9BV DRUG__ID D0K9BV D0K9BV DRUGCOMP 3-v biosciences D0K9BV HIGHSTAT Phase 2 D0K9CZ DRUG__ID D0K9CZ D0K9CZ DRUGCOMP Max-Planck-Gesellschaft zur Forderung der Wissenschaften eV D0K9CZ HIGHSTAT Phase 2 D0K9KN DRUG__ID D0K9KN D0K9KN DRUGCOMP ALZA Corp D0K9KN HIGHSTAT Phase 2 D0K9NJ DRUG__ID D0K9NJ D0K9NJ DRUGCOMP Iba molecular; aposense D0K9NJ HIGHSTAT Phase 2 D0K9WL DRUG__ID D0K9WL D0K9WL DRUGCOMP Xeris Pharmaceuticals Austin, TX D0K9WL HIGHSTAT Phase 2 D0K9WP DRUG__ID D0K9WP D0K9WP DRUGCOMP TransMolecular Inc D0K9WP HIGHSTAT Phase 2 D0KB6S DRUG__ID D0KB6S D0KB6S DRUGCOMP Bavarian Nordic A/S D0KB6S HIGHSTAT Phase 2 D0KC9U DRUG__ID D0KC9U D0KC9U DRUGCOMP Adelaide Research & Innovation Pty Ltd D0KC9U HIGHSTAT Phase 2 D0KE4Q DRUG__ID D0KE4Q D0KE4Q DRUGCOMP Promius Pharma Princeton, NJ D0KE4Q HIGHSTAT Phase 2 D0KK1I DRUG__ID D0KK1I D0KK1I DRUGCOMP Universidad Nacional Autonoma De Mexico D0KK1I HIGHSTAT Phase 2 D0KK9V DRUG__ID D0KK9V D0KK9V DRUGCOMP GlobeImmune D0KK9V HIGHSTAT Phase 2 D0KL4T DRUG__ID D0KL4T D0KL4T DRUGCOMP Precision Biologics Dallas, TX D0KL4T HIGHSTAT Phase 2 D0KM1B DRUG__ID D0KM1B D0KM1B DRUGCOMP Glycotope GmbH D0KM1B HIGHSTAT Phase 2 D0KN0I DRUG__ID D0KN0I D0KN0I DRUGTYPE Antibody D0KN0I HIGHSTAT Phase 2 D0KN5B DRUG__ID D0KN5B D0KN5B DRUGCOMP Cytheris D0KN5B HIGHSTAT Phase 2 D0KQ8W DRUG__ID D0KQ8W D0KQ8W DRUGCOMP MimiVax Rochester, NY D0KQ8W HIGHSTAT Phase 2 D0KS6F DRUG__ID D0KS6F D0KS6F DRUGCOMP IRX Therapeutics D0KS6F HIGHSTAT Phase 2 D0KV3M DRUG__ID D0KV3M D0KV3M DRUGCOMP Celldex Therapeutics Hampton, NJ D0KV3M HIGHSTAT Phase 2 D0KZ3Q DRUG__ID D0KZ3Q D0KZ3Q DRUGCOMP Syntrix Biosystems Auburn, WA D0KZ3Q HIGHSTAT Phase 2 D0L0RO DRUG__ID D0L0RO D0L0RO DRUGCOMP Antigen Express D0L0RO HIGHSTAT Phase 2 D0L1PH DRUG__ID D0L1PH D0L1PH DRUGCOMP Canopus biopharma D0L1PH HIGHSTAT Phase 2 D0L2BC DRUG__ID D0L2BC D0L2BC DRUGCOMP MedImmune D0L2BC HIGHSTAT Phase 2 D0L2CN DRUG__ID D0L2CN D0L2CN DRUGCOMP EMD Serono D0L2CN HIGHSTAT Phase 2 D0L2LG DRUG__ID D0L2LG D0L2LG DRUGCOMP Warner Chilcott plc D0L2LG HIGHSTAT Phase 2 D0L2ZY DRUG__ID D0L2ZY D0L2ZY DRUGCOMP Tyrogenex West Palm Beach D0L2ZY HIGHSTAT Phase 2 D0L3KA DRUG__ID D0L3KA D0L3KA DRUGCOMP Bio-Path Ogden, Utah D0L3KA HIGHSTAT Phase 2 D0L3XE DRUG__ID D0L3XE D0L3XE DRUGCOMP Greer Laboratories D0L3XE HIGHSTAT Phase 2 D0L4US DRUG__ID D0L4US D0L4US DRUGCOMP Bristol-Myers Squibb D0L4US HIGHSTAT Phase 2 D0L5IL DRUG__ID D0L5IL D0L5IL DRUGCOMP Anaborex Inc D0L5IL HIGHSTAT Phase 2 D0L7PK DRUG__ID D0L7PK D0L7PK DRUGCOMP Pierre Fabre SA D0L7PK HIGHSTAT Phase 2 D0L7TN DRUG__ID D0L7TN D0L7TN DRUGCOMP Glaxosmithkline D0L7TN HIGHSTAT Phase 2 D0L7VC DRUG__ID D0L7VC D0L7VC DRUGCOMP GlobeImmune D0L7VC HIGHSTAT Phase 2 D0L8IO DRUG__ID D0L8IO D0L8IO DRUGCOMP Avineuro Pharmaceuticals D0L8IO HIGHSTAT Phase 2 D0L8VA DRUG__ID D0L8VA D0L8VA DRUGCOMP Csl D0L8VA HIGHSTAT Phase 2 D0L9CD DRUG__ID D0L9CD D0L9CD DRUGCOMP AstraZeneca D0L9CD HIGHSTAT Phase 2 D0L9XS DRUG__ID D0L9XS D0L9XS DRUGCOMP Grifols therapeutics D0L9XS HIGHSTAT Phase 2 D0LB8Z DRUG__ID D0LB8Z D0LB8Z DRUGCOMP Andarix Pharmaceuticals Somerville, NJ, Jacksonville, FL D0LB8Z HIGHSTAT Phase 2 D0LG1H DRUG__ID D0LG1H D0LG1H DRUGCOMP Neuropharm Group plc D0LG1H HIGHSTAT Phase 2 D0LI5N DRUG__ID D0LI5N D0LI5N DRUGCOMP onis Pharmaceuticals Carlsbad, CA D0LI5N HIGHSTAT Phase 2 D0LJ4E DRUG__ID D0LJ4E D0LJ4E DRUGCOMP Novartis Oncology East Hanover, D0LJ4E HIGHSTAT Phase 2 D0LJ4J DRUG__ID D0LJ4J D0LJ4J DRUGCOMP Denovo Biopharma San Diego, CA D0LJ4J HIGHSTAT Phase 2 D0LL1N DRUG__ID D0LL1N D0LL1N DRUGCOMP ADC Therapeutics Murray Hill, NJ D0LL1N HIGHSTAT Phase 2 D0LO2G DRUG__ID D0LO2G D0LO2G DRUGCOMP HSRx Biopharmaceutical Tucson, AZ D0LO2G HIGHSTAT Phase 2 D0LS3U DRUG__ID D0LS3U D0LS3U DRUGCOMP Chemo-Sero-Therapeutic Research Inst D0LS3U HIGHSTAT Phase 2 D0LU5Q DRUG__ID D0LU5Q D0LU5Q DRUGCOMP Phosphagenics D0LU5Q HIGHSTAT Phase 2 D0LX8Z DRUG__ID D0LX8Z D0LX8Z DRUGCOMP OncoTherapy Science Inc D0LX8Z HIGHSTAT Phase 2 D0M0YB DRUG__ID D0M0YB D0M0YB DRUGCOMP Bayer healthcare pharmaceuticals D0M0YB HIGHSTAT Phase 2 D0M1YS DRUG__ID D0M1YS D0M1YS DRUGCOMP PSivida D0M1YS HIGHSTAT Phase 2 D0M2LI DRUG__ID D0M2LI D0M2LI DRUGCOMP Novo Nordisk A/S D0M2LI HIGHSTAT Phase 2 D0M2QR DRUG__ID D0M2QR D0M2QR DRUGCOMP Tolerion D0M2QR HIGHSTAT Phase 2 D0M2TC DRUG__ID D0M2TC D0M2TC DRUGCOMP Solace Pharmaceuticals D0M2TC HIGHSTAT Phase 2 D0M2TG DRUG__ID D0M2TG D0M2TG DRUGCOMP Phytopharm D0M2TG HIGHSTAT Phase 2 D0M3SS DRUG__ID D0M3SS D0M3SS DRUGCOMP FIT Biotech Oyj Plc D0M3SS HIGHSTAT Phase 2 D0M5CD DRUG__ID D0M5CD D0M5CD DRUGCOMP Bayer HealthCare Pharmaceuticals; Biocompatibles D0M5CD HIGHSTAT Phase 2 D0M5CW DRUG__ID D0M5CW D0M5CW DRUGCOMP Pfizer Inc D0M5CW HIGHSTAT Phase 2 D0M6GC DRUG__ID D0M6GC D0M6GC DRUGCOMP Trubion Pharmaceuticals Inc; Trubion D0M6GC HIGHSTAT Phase 2 D0M7BL DRUG__ID D0M7BL D0M7BL DRUGCOMP Bayer HealthCare Pharmaceuticals D0M7BL HIGHSTAT Phase 2 D0M7MB DRUG__ID D0M7MB D0M7MB DRUGCOMP Medistem D0M7MB HIGHSTAT Phase 2 D0M7MR DRUG__ID D0M7MR D0M7MR DRUGCOMP Memorial Sloan-Kettering Cancer Center D0M7MR HIGHSTAT Phase 2 D0M7SG DRUG__ID D0M7SG D0M7SG DRUGCOMP Ortho Dermatologics Raleigh, NC D0M7SG HIGHSTAT Phase 2 D0M7YU DRUG__ID D0M7YU D0M7YU DRUGCOMP Galena Biopharma D0M7YU HIGHSTAT Phase 2 D0M8CL DRUG__ID D0M8CL D0M8CL DRUGCOMP Endo Pharmaceuticals D0M8CL HIGHSTAT Phase 2 D0M8VL DRUG__ID D0M8VL D0M8VL DRUGCOMP GlaxoSmithKline plc D0M8VL HIGHSTAT Phase 2 D0MC5O DRUG__ID D0MC5O D0MC5O DRUGCOMP Capricor D0MC5O HIGHSTAT Phase 2 D0MI0S DRUG__ID D0MI0S D0MI0S DRUGCOMP Hadassah Medical Organization D0MI0S HIGHSTAT Phase 2 D0MJ2H DRUG__ID D0MJ2H D0MJ2H DRUGCOMP Kalypsys Inc D0MJ2H HIGHSTAT Phase 2 D0MM0N DRUG__ID D0MM0N D0MM0N DRUGCOMP Mesoblast, New York, NY D0MM0N HIGHSTAT Phase 2 D0MM6A DRUG__ID D0MM6A D0MM6A DRUGCOMP Edison Pharmaceuticals Inc D0MM6A HIGHSTAT Phase 2 D0MP1M DRUG__ID D0MP1M D0MP1M DRUGCOMP Ceregene D0MP1M HIGHSTAT Phase 2 D0MT5U DRUG__ID D0MT5U D0MT5U DRUGCOMP Synagile D0MT5U HIGHSTAT Phase 2 D0MT8G DRUG__ID D0MT8G D0MT8G DRUGCOMP Fabre-Kramer Pharmaceuticals Houston, TX D0MT8G HIGHSTAT Phase 2 D0MX6K DRUG__ID D0MX6K D0MX6K DRUGCOMP Kyowa Hakko Kirin Pharma Tokyo, Japan Ultragenyx Novato, CA D0MX6K HIGHSTAT Phase 2 D0MY3C DRUG__ID D0MY3C D0MY3C DRUGCOMP Arbor pharmaceuticals D0MY3C HIGHSTAT Phase 2 D0N0PW DRUG__ID D0N0PW D0N0PW DRUGCOMP Dow Pharmaceutical Sciences D0N0PW HIGHSTAT Phase 2 D0N1PZ DRUG__ID D0N1PZ D0N1PZ DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D0N1PZ HIGHSTAT Phase 2 D0N1VG DRUG__ID D0N1VG D0N1VG DRUGCOMP Inviragen D0N1VG HIGHSTAT Phase 2 D0N2JI DRUG__ID D0N2JI D0N2JI DRUGCOMP Vasopharm GmbH D0N2JI HIGHSTAT Phase 2 D0N2QI DRUG__ID D0N2QI D0N2QI DRUGCOMP Celtic Pharma D0N2QI HIGHSTAT Phase 2 D0N3BB DRUG__ID D0N3BB D0N3BB DRUGCOMP Cebix D0N3BB HIGHSTAT Phase 2 D0N4DF DRUG__ID D0N4DF D0N4DF DRUGCOMP Alkermes Inc D0N4DF HIGHSTAT Phase 2 D0N4JA DRUG__ID D0N4JA D0N4JA DRUGCOMP Cellerant Therapeutics D0N4JA HIGHSTAT Phase 2 D0N4JI DRUG__ID D0N4JI D0N4JI DRUGCOMP Apogenix GmbH D0N4JI HIGHSTAT Phase 2 D0N4NH DRUG__ID D0N4NH D0N4NH DRUGCOMP Actinium Pharmaceuticals New York, NY D0N4NH HIGHSTAT Phase 2 D0N4VN DRUG__ID D0N4VN D0N4VN DRUGCOMP Exsulin D0N4VN HIGHSTAT Phase 2 D0N5NI DRUG__ID D0N5NI D0N5NI DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0N5NI HIGHSTAT Phase 2 D0N6MX DRUG__ID D0N6MX D0N6MX DRUGCOMP Grifols USA Los Angeles, CA D0N6MX HIGHSTAT Phase 2 D0N6UA DRUG__ID D0N6UA D0N6UA DRUGCOMP Inovio Pharmaceuticals; University of Southampton D0N6UA HIGHSTAT Phase 2 D0N7XW DRUG__ID D0N7XW D0N7XW DRUGCOMP Sinovac Biotech Ltd D0N7XW HIGHSTAT Phase 2 D0N8PV DRUG__ID D0N8PV D0N8PV DRUGCOMP PharmAAware SEPSIS BV; AM-Pharma Holding BV D0N8PV HIGHSTAT Phase 2 D0N9AD DRUG__ID D0N9AD D0N9AD DRUGCOMP Revalesio Corp D0N9AD HIGHSTAT Phase 2 D0N9PQ DRUG__ID D0N9PQ D0N9PQ DRUGCOMP Daval International D0N9PQ HIGHSTAT Phase 2 D0NA5L DRUG__ID D0NA5L D0NA5L DRUGCOMP NightstaRx London, England D0NA5L HIGHSTAT Phase 2 D0NB9T DRUG__ID D0NB9T D0NB9T DRUGCOMP Kadmon pharmaceuticals D0NB9T HIGHSTAT Phase 2 D0ND3F DRUG__ID D0ND3F D0ND3F DRUGCOMP LifeMax Laboratories Palo Alto, CA D0ND3F HIGHSTAT Phase 2 D0NF1Z DRUG__ID D0NF1Z D0NF1Z DRUGCOMP UnityBiotechnology D0NF1Z HIGHSTAT Phase 2 D0NJ2R DRUG__ID D0NJ2R D0NJ2R DRUGCOMP Promius Pharma Princeton, NJ D0NJ2R HIGHSTAT Phase 2 D0NK8M DRUG__ID D0NK8M D0NK8M DRUGCOMP Cytonet D0NK8M HIGHSTAT Phase 2 D0NR6T DRUG__ID D0NR6T D0NR6T DRUGCOMP United Biomedical D0NR6T HIGHSTAT Phase 2 D0NS7A DRUG__ID D0NS7A D0NS7A DRUGCOMP Apeiron biologics D0NS7A HIGHSTAT Phase 2 D0NT6P DRUG__ID D0NT6P D0NT6P DRUGCOMP Merck D0NT6P HIGHSTAT Phase 2 D0NZ2D DRUG__ID D0NZ2D D0NZ2D DRUGCOMP Theragene Pharmaceuticals San Diego, CA D0NZ2D HIGHSTAT Phase 2 D0O0EX DRUG__ID D0O0EX D0O0EX DRUGCOMP Sanofi D0O0EX HIGHSTAT Phase 2 D0O0QM DRUG__ID D0O0QM D0O0QM DRUGCOMP ViroMed D0O0QM HIGHSTAT Phase 2 D0O1BL DRUG__ID D0O1BL D0O1BL DRUGCOMP BioMarin Pharmaceutical San Rafael, CA D0O1BL HIGHSTAT Phase 2 D0O1CJ DRUG__ID D0O1CJ D0O1CJ DRUGCOMP Crucell D0O1CJ HIGHSTAT Phase 2 D0O1VU DRUG__ID D0O1VU D0O1VU DRUGCOMP Bonti Newport Beach, CA D0O1VU HIGHSTAT Phase 2 D0O2XW DRUG__ID D0O2XW D0O2XW DRUGCOMP Viron therapeutics D0O2XW HIGHSTAT Phase 2 D0O3DK DRUG__ID D0O3DK D0O3DK DRUGCOMP Gastrotech Pharma D0O3DK HIGHSTAT Phase 2 D0O3DW DRUG__ID D0O3DW D0O3DW DRUGCOMP JN-International Medical Oakland, Nebraska D0O3DW HIGHSTAT Phase 2 D0O3VP DRUG__ID D0O3VP D0O3VP DRUGCOMP Bristol-Myers Squibb D0O3VP HIGHSTAT Phase 2 D0O3XU DRUG__ID D0O3XU D0O3XU DRUGCOMP HealOr Ltd D0O3XU HIGHSTAT Phase 2 D0O4VW DRUG__ID D0O4VW D0O4VW DRUGCOMP Talecris Therapeutics D0O4VW HIGHSTAT Phase 2 D0O5ZB DRUG__ID D0O5ZB D0O5ZB DRUGCOMP Renovo Group plc D0O5ZB HIGHSTAT Phase 2 D0O6OK DRUG__ID D0O6OK D0O6OK DRUGCOMP Eli LillyIndianapolis, IN D0O6OK HIGHSTAT Phase 2 D0O7PS DRUG__ID D0O7PS D0O7PS DRUGCOMP Crucell NV D0O7PS HIGHSTAT Phase 2 D0O7UU DRUG__ID D0O7UU D0O7UU DRUGCOMP Gemac Bio D0O7UU HIGHSTAT Phase 2 D0O8KI DRUG__ID D0O8KI D0O8KI DRUGCOMP Alcon Inc D0O8KI HIGHSTAT Phase 2 D0O9EX DRUG__ID D0O9EX D0O9EX DRUGCOMP NantKwest Culver City, CA D0O9EX HIGHSTAT Phase 2 D0OB4R DRUG__ID D0OB4R D0OB4R DRUGCOMP EnVivo Pharmaceuticals D0OB4R HIGHSTAT Phase 2 D0OE5S DRUG__ID D0OE5S D0OE5S DRUGCOMP Actinogen Medical Sydney, Australia D0OE5S HIGHSTAT Phase 2 D0OK1N DRUG__ID D0OK1N D0OK1N DRUGCOMP Pfizer New York, NY D0OK1N HIGHSTAT Phase 2 D0OK3O DRUG__ID D0OK3O D0OK3O DRUGCOMP Nile Therapeutics D0OK3O HIGHSTAT Phase 2 D0OO8M DRUG__ID D0OO8M D0OO8M DRUGCOMP Novartis East Hanover, NJ D0OO8M HIGHSTAT Phase 2 D0OQ5W DRUG__ID D0OQ5W D0OQ5W DRUGCOMP Sanofi pasteur D0OQ5W HIGHSTAT Phase 2 D0OS7K DRUG__ID D0OS7K D0OS7K DRUGCOMP EGEN D0OS7K HIGHSTAT Phase 2 D0OU6W DRUG__ID D0OU6W D0OU6W DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0OU6W HIGHSTAT Phase 2 D0P0BY DRUG__ID D0P0BY D0P0BY DRUGCOMP GenentechSouth San Francisco, CA D0P0BY HIGHSTAT Phase 2 D0P0SD DRUG__ID D0P0SD D0P0SD DRUGCOMP Erytech Pharma Cambridge, MA D0P0SD HIGHSTAT Phase 2 D0P1DI DRUG__ID D0P1DI D0P1DI DRUGCOMP MerusUtrecht, Netherlands D0P1DI HIGHSTAT Phase 2 D0P1FZ DRUG__ID D0P1FZ D0P1FZ DRUGCOMP Bone Therapeutics SA D0P1FZ HIGHSTAT Phase 2 D0P2ED DRUG__ID D0P2ED D0P2ED DRUGCOMP Glenmark Pharmaceuticals Ltd D0P2ED HIGHSTAT Phase 2 D0P3SJ DRUG__ID D0P3SJ D0P3SJ DRUGCOMP Xenoport D0P3SJ HIGHSTAT Phase 2 D0P4WO DRUG__ID D0P4WO D0P4WO DRUGCOMP Addex Pharma. D0P4WO HIGHSTAT Phase 2 D0P4ZR DRUG__ID D0P4ZR D0P4ZR DRUGCOMP Merrimack Pharmaceuticals Cambridge, MA D0P4ZR HIGHSTAT Phase 2 D0P5SU DRUG__ID D0P5SU D0P5SU DRUGCOMP Coherus Biosciences Redwood City, CA D0P5SU HIGHSTAT Phase 2 D0P6JD DRUG__ID D0P6JD D0P6JD DRUGCOMP Regenerx biopharmaceuticals D0P6JD HIGHSTAT Phase 2 D0P6LE DRUG__ID D0P6LE D0P6LE DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0P6LE HIGHSTAT Phase 2 D0P7MO DRUG__ID D0P7MO D0P7MO DRUGCOMP Regulon Inc D0P7MO HIGHSTAT Phase 2 D0P7PY DRUG__ID D0P7PY D0P7PY DRUGCOMP Oncternal Therapeutics San Diego, CA D0P7PY HIGHSTAT Phase 2 D0P8IU DRUG__ID D0P8IU D0P8IU DRUGCOMP Antigen Express Wellesley, MA D0P8IU HIGHSTAT Phase 2 D0P8NV DRUG__ID D0P8NV D0P8NV DRUGCOMP BrainCells D0P8NV HIGHSTAT Phase 2 D0P8UN DRUG__ID D0P8UN D0P8UN DRUGCOMP InvionBrisbane, Australia D0P8UN HIGHSTAT Phase 2 D0P9QW DRUG__ID D0P9QW D0P9QW DRUGCOMP Transgene D0P9QW HIGHSTAT Phase 2 D0P9RG DRUG__ID D0P9RG D0P9RG DRUGTYPE Antibody D0P9RG HIGHSTAT Phase 2 D0P9XM DRUG__ID D0P9XM D0P9XM DRUGCOMP miRagen Therapeutics Boulder, CO D0P9XM HIGHSTAT Phase 2 D0PG0F DRUG__ID D0PG0F D0PG0F DRUGCOMP Favrille D0PG0F HIGHSTAT Phase 2 D0PN4D DRUG__ID D0PN4D D0PN4D DRUGCOMP Chase pharmaceuticals D0PN4D HIGHSTAT Phase 2 D0PO0T DRUG__ID D0PO0T D0PO0T DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0PO0T HIGHSTAT Phase 2 D0PP8G DRUG__ID D0PP8G D0PP8G DRUGCOMP Ono Pharmaceutical Co Ltd D0PP8G HIGHSTAT Phase 2 D0PR4O DRUG__ID D0PR4O D0PR4O DRUGCOMP Immunicum Gothenburg, Sweden D0PR4O HIGHSTAT Phase 2 D0PU9C DRUG__ID D0PU9C D0PU9C DRUGCOMP TransTech Pharma D0PU9C HIGHSTAT Phase 2 D0PV0I DRUG__ID D0PV0I D0PV0I DRUGCOMP Akcea Therapeutics Cambridge, MA D0PV0I HIGHSTAT Phase 2 D0PX0N DRUG__ID D0PX0N D0PX0N DRUGCOMP Techfields Pharma Dover, DE D0PX0N HIGHSTAT Phase 2 D0Q0IX DRUG__ID D0Q0IX D0Q0IX DRUGCOMP Biodel D0Q0IX HIGHSTAT Phase 2 D0Q0SK DRUG__ID D0Q0SK D0Q0SK DRUGCOMP MolMed SpA D0Q0SK HIGHSTAT Phase 2 D0Q0TI DRUG__ID D0Q0TI D0Q0TI DRUGCOMP Neurotec Pharma SL D0Q0TI HIGHSTAT Phase 2 D0Q0UA DRUG__ID D0Q0UA D0Q0UA DRUGCOMP Taiho Pharmaceutical D0Q0UA HIGHSTAT Phase 2 D0Q1MX DRUG__ID D0Q1MX D0Q1MX DRUGCOMP OncoSec Medical San Diego, CA D0Q1MX HIGHSTAT Phase 2 D0Q1RN DRUG__ID D0Q1RN D0Q1RN DRUGCOMP Genentech South San Francisco, CA D0Q1RN HIGHSTAT Phase 2 D0Q2WE DRUG__ID D0Q2WE D0Q2WE DRUGCOMP Promius Pharma Princeton, NJ D0Q2WE HIGHSTAT Phase 2 D0Q3ER DRUG__ID D0Q3ER D0Q3ER DRUGCOMP CardioVascular BioTherapeutics Dallas, TX D0Q3ER HIGHSTAT Phase 2 D0Q3PB DRUG__ID D0Q3PB D0Q3PB DRUGCOMP Chemocentryx D0Q3PB HIGHSTAT Phase 2 D0Q4QV DRUG__ID D0Q4QV D0Q4QV DRUGCOMP Tapimmune D0Q4QV HIGHSTAT Phase 2 D0Q4WG DRUG__ID D0Q4WG D0Q4WG DRUGCOMP FirstString Research D0Q4WG HIGHSTAT Phase 2 D0Q4WR DRUG__ID D0Q4WR D0Q4WR DRUGCOMP Protherics plc D0Q4WR HIGHSTAT Phase 2 D0Q5BK DRUG__ID D0Q5BK D0Q5BK DRUGCOMP Shire Human Genetic Therapies Inc D0Q5BK HIGHSTAT Phase 2 D0Q5CH DRUG__ID D0Q5CH D0Q5CH DRUGCOMP Apeptico Forschung und Entwicklung GmbH D0Q5CH HIGHSTAT Phase 2 D0Q5OC DRUG__ID D0Q5OC D0Q5OC DRUGCOMP Argos Therapeutics D0Q5OC HIGHSTAT Phase 2 D0Q6MA DRUG__ID D0Q6MA D0Q6MA DRUGCOMP Genethon D0Q6MA HIGHSTAT Phase 2 D0Q8VM DRUG__ID D0Q8VM D0Q8VM DRUGCOMP Transition Therapeutics D0Q8VM HIGHSTAT Phase 2 D0Q9QC DRUG__ID D0Q9QC D0Q9QC DRUGCOMP Avicena Group Inc D0Q9QC HIGHSTAT Phase 2 D0QC2V DRUG__ID D0QC2V D0QC2V DRUGCOMP Aevi Genomic Medicine Wayne, PA D0QC2V HIGHSTAT Phase 2 D0QF2W DRUG__ID D0QF2W D0QF2W DRUGCOMP Agtc; applied genetic technologies D0QF2W HIGHSTAT Phase 2 D0QH3H DRUG__ID D0QH3H D0QH3H DRUGCOMP Northwest biotherapeutics D0QH3H HIGHSTAT Phase 2 D0QH5K DRUG__ID D0QH5K D0QH5K DRUGCOMP Asahi Kasei Pharma Corp D0QH5K HIGHSTAT Phase 2 D0QL1U DRUG__ID D0QL1U D0QL1U DRUGCOMP Hatchtech D0QL1U HIGHSTAT Phase 2 D0QV4A DRUG__ID D0QV4A D0QV4A DRUGCOMP NovImmune SA D0QV4A HIGHSTAT Phase 2 D0QW0E DRUG__ID D0QW0E D0QW0E DRUGCOMP Chongqing Jiachen Biotechnology Ltd D0QW0E HIGHSTAT Phase 2 D0QZ3P DRUG__ID D0QZ3P D0QZ3P DRUGCOMP Novartis pharmaceuticals D0QZ3P HIGHSTAT Phase 2 D0QZ7V DRUG__ID D0QZ7V D0QZ7V DRUGCOMP RXi Pharmaceuticals Marlborough, MA D0QZ7V HIGHSTAT Phase 2 D0R0BI DRUG__ID D0R0BI D0R0BI DRUGCOMP Central Drug Research Institute D0R0BI HIGHSTAT Phase 2 D0R0GK DRUG__ID D0R0GK D0R0GK DRUGCOMP Nuron biotech D0R0GK HIGHSTAT Phase 2 D0R0HY DRUG__ID D0R0HY D0R0HY DRUGCOMP Biogen Cambridge, MA, Ionis Pharmaceuticals Carlsbad, CA D0R0HY HIGHSTAT Phase 2 D0R0YW DRUG__ID D0R0YW D0R0YW DRUGCOMP Hutchison Medipharma Enterprises Ltd D0R0YW HIGHSTAT Phase 2 D0R1JO DRUG__ID D0R1JO D0R1JO DRUGCOMP Shire, Lexington, MA D0R1JO HIGHSTAT Phase 2 D0R1UE DRUG__ID D0R1UE D0R1UE DRUGCOMP Novartis East Hanover, NJ D0R1UE HIGHSTAT Phase 2 D0R2QG DRUG__ID D0R2QG D0R2QG DRUGCOMP Talima Therapeutics Inc D0R2QG HIGHSTAT Phase 2 D0R3KL DRUG__ID D0R3KL D0R3KL DRUGCOMP Pfizer Vaccines D0R3KL HIGHSTAT Phase 2 D0R4AE DRUG__ID D0R4AE D0R4AE DRUGCOMP Mitsubishi Tanabe Pharma Jersey City, NJ D0R4AE HIGHSTAT Phase 2 D0R4UA DRUG__ID D0R4UA D0R4UA DRUGCOMP Y-mAbs Therapeutics New York, NY D0R4UA HIGHSTAT Phase 2 D0R5ER DRUG__ID D0R5ER D0R5ER DRUGCOMP BioPharmX Menlo Park, CA D0R5ER HIGHSTAT Phase 2 D0R5LL DRUG__ID D0R5LL D0R5LL DRUGCOMP Cytokine PharmaSciences D0R5LL HIGHSTAT Phase 2 D0R6AI DRUG__ID D0R6AI D0R6AI DRUGCOMP Orthotrophix D0R6AI HIGHSTAT Phase 2 D0R6EC DRUG__ID D0R6EC D0R6EC DRUGCOMP Nabriva Therapeutics AG D0R6EC HIGHSTAT Phase 2 D0R6JV DRUG__ID D0R6JV D0R6JV DRUGCOMP Cortex Pharmaceuticals Inc D0R6JV HIGHSTAT Phase 2 D0R6VH DRUG__ID D0R6VH D0R6VH DRUGCOMP Hunter Immunology Pty Ltd D0R6VH HIGHSTAT Phase 2 D0R8AG DRUG__ID D0R8AG D0R8AG DRUGCOMP Agenus, Lexington, MA D0R8AG HIGHSTAT Phase 2 D0R8SY DRUG__ID D0R8SY D0R8SY DRUGCOMP Moberg Derma AB D0R8SY HIGHSTAT Phase 2 D0R9FM DRUG__ID D0R9FM D0R9FM DRUGCOMP Sentoclone Therapeutics Ab D0R9FM HIGHSTAT Phase 2 D0R9PS DRUG__ID D0R9PS D0R9PS DRUGCOMP BRAIN Biotechnology Research and Information Network GmbH D0R9PS HIGHSTAT Phase 2 D0RC0J DRUG__ID D0RC0J D0RC0J DRUGCOMP Abbott Laboratories D0RC0J HIGHSTAT Phase 2 D0RD0Y DRUG__ID D0RD0Y D0RD0Y DRUGCOMP Oxford BioMedica plc D0RD0Y HIGHSTAT Phase 2 D0RI4I DRUG__ID D0RI4I D0RI4I DRUGCOMP BioElectron Technology Mountain View, CA D0RI4I HIGHSTAT Phase 2 D0RI9A DRUG__ID D0RI9A D0RI9A DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0RI9A HIGHSTAT Phase 2 D0RJ0V DRUG__ID D0RJ0V D0RJ0V DRUGCOMP Genfit D0RJ0V HIGHSTAT Phase 2 D0RJ1W DRUG__ID D0RJ1W D0RJ1W DRUGCOMP Inflazyme Pharmaceuticals D0RJ1W HIGHSTAT Phase 2 D0RK8U DRUG__ID D0RK8U D0RK8U DRUGCOMP Jenken Biosciences D0RK8U HIGHSTAT Phase 2 D0RX6F DRUG__ID D0RX6F D0RX6F DRUGCOMP Cellectar Biosciences Madison, WI D0RX6F HIGHSTAT Phase 2 D0S0KP DRUG__ID D0S0KP D0S0KP DRUGCOMP CovX Pharmaceuticals Inc D0S0KP HIGHSTAT Phase 2 D0S0MP DRUG__ID D0S0MP D0S0MP DRUGTYPE Antibody D0S0MP HIGHSTAT Phase 2 D0S1BF DRUG__ID D0S1BF D0S1BF DRUGCOMP Affiris; GlaxoSmithKline D0S1BF HIGHSTAT Phase 2 D0S1UZ DRUG__ID D0S1UZ D0S1UZ DRUGCOMP Pfizer D0S1UZ HIGHSTAT Phase 2 D0S1WV DRUG__ID D0S1WV D0S1WV DRUGCOMP MacroGenics Rockville, MD D0S1WV HIGHSTAT Phase 2 D0S1YX DRUG__ID D0S1YX D0S1YX DRUGCOMP Bayer AG D0S1YX HIGHSTAT Phase 2 D0S2DU DRUG__ID D0S2DU D0S2DU DRUGCOMP Emisphere Technologies D0S2DU HIGHSTAT Phase 2 D0S2PY DRUG__ID D0S2PY D0S2PY THERCLAS Anticancer Agents D0S2PY HIGHSTAT Phase 2 D0S3AQ DRUG__ID D0S3AQ D0S3AQ DRUGCOMP Catabasis pharmaceuticals D0S3AQ HIGHSTAT Phase 2 D0S3CX DRUG__ID D0S3CX D0S3CX DRUGCOMP Momenta pharmaceuticals D0S3CX HIGHSTAT Phase 2 D0S3ZP DRUG__ID D0S3ZP D0S3ZP DRUGCOMP Winston Pharmaceuticals Mount Vernon, IL D0S3ZP HIGHSTAT Phase 2 D0S4LP DRUG__ID D0S4LP D0S4LP DRUGCOMP Hep C Ltd D0S4LP HIGHSTAT Phase 2 D0S5BV DRUG__ID D0S5BV D0S5BV DRUGCOMP Abbott Laboratories D0S5BV HIGHSTAT Phase 2 D0S5XO DRUG__ID D0S5XO D0S5XO DRUGCOMP Vaxin Inc D0S5XO HIGHSTAT Phase 2 D0S7FR DRUG__ID D0S7FR D0S7FR DRUGCOMP Zelos Therape. D0S7FR HIGHSTAT Phase 2 D0S8DU DRUG__ID D0S8DU D0S8DU DRUGCOMP Fabre-Kramer Pharmaceuticals D0S8DU HIGHSTAT Phase 2 D0S9LK DRUG__ID D0S9LK D0S9LK DRUGCOMP GlaxoSmithKline Biologicals D0S9LK HIGHSTAT Phase 2 D0SC1I DRUG__ID D0SC1I D0SC1I DRUGCOMP GlaxoSmithKline D0SC1I HIGHSTAT Phase 2 D0SD6V DRUG__ID D0SD6V D0SD6V DRUGCOMP Novartis pharmaceuticals D0SD6V HIGHSTAT Phase 2 D0SD7G DRUG__ID D0SD7G D0SD7G DRUGCOMP Eli lilly D0SD7G HIGHSTAT Phase 2 D0SQ6A DRUG__ID D0SQ6A D0SQ6A DRUGCOMP Fabre-Kramer Pharmaceuticals Houston, TX D0SQ6A HIGHSTAT Phase 2 D0SU4D DRUG__ID D0SU4D D0SU4D DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ Regeneron Pharmaceuticals Tarrytown, NY D0SU4D HIGHSTAT Phase 2 D0SZ9R DRUG__ID D0SZ9R D0SZ9R DRUGCOMP 2X Oncology Cambridge, MA D0SZ9R HIGHSTAT Phase 2 D0T0QU DRUG__ID D0T0QU D0T0QU DRUGCOMP AstraZeneca D0T0QU HIGHSTAT Phase 2 D0T1HE DRUG__ID D0T1HE D0T1HE DRUGCOMP Acacia Pharma Ltd D0T1HE HIGHSTAT Phase 2 D0T2AE DRUG__ID D0T2AE D0T2AE DRUGCOMP Pierre Fabre SA D0T2AE HIGHSTAT Phase 2 D0T2LR DRUG__ID D0T2LR D0T2LR DRUGCOMP PolyMedix Inc D0T2LR HIGHSTAT Phase 2 D0T3QR DRUG__ID D0T3QR D0T3QR DRUGCOMP GlaxoSmithKline D0T3QR HIGHSTAT Phase 2 D0T3QU DRUG__ID D0T3QU D0T3QU DRUGCOMP Massbiologics D0T3QU HIGHSTAT Phase 2 D0T4KG DRUG__ID D0T4KG D0T4KG DRUGCOMP Pfizer D0T4KG HIGHSTAT Phase 2 D0T5ES DRUG__ID D0T5ES D0T5ES DRUGCOMP Prima BioMed Sydney D0T5ES HIGHSTAT Phase 2 D0T5GO DRUG__ID D0T5GO D0T5GO DRUGCOMP Medgenics D0T5GO HIGHSTAT Phase 2 D0T5JS DRUG__ID D0T5JS D0T5JS DRUGCOMP TriAct Therapeutics D0T5JS HIGHSTAT Phase 2 D0T5NB DRUG__ID D0T5NB D0T5NB DRUGCOMP GlobeImmune, Louisville, CO D0T5NB HIGHSTAT Phase 2 D0T5TN DRUG__ID D0T5TN D0T5TN DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0T5TN HIGHSTAT Phase 2 D0T5TU DRUG__ID D0T5TU D0T5TU DRUGCOMP NicOx SA D0T5TU HIGHSTAT Phase 2 D0T5YX DRUG__ID D0T5YX D0T5YX DRUGCOMP DiaMedica Inc D0T5YX HIGHSTAT Phase 2 D0T6EE DRUG__ID D0T6EE D0T6EE DRUGCOMP Acceleron Pharma D0T6EE HIGHSTAT Phase 2 D0T6KV DRUG__ID D0T6KV D0T6KV DRUGCOMP GlaxoSmithKline D0T6KV HIGHSTAT Phase 2 D0T7BI DRUG__ID D0T7BI D0T7BI DRUGCOMP Merck Kenilworth, NJ D0T7BI HIGHSTAT Phase 2 D0T7OI DRUG__ID D0T7OI D0T7OI DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0T7OI HIGHSTAT Phase 2 D0T8QE DRUG__ID D0T8QE D0T8QE DRUGCOMP Foamix Bridgewater, NJ D0T8QE HIGHSTAT Phase 2 D0T9OC DRUG__ID D0T9OC D0T9OC DRUGCOMP Tiltan pharma D0T9OC HIGHSTAT Phase 2 D0TF2D DRUG__ID D0TF2D D0TF2D DRUGCOMP CelldexHampton, NJCancer Immunotherapy Trials Ntwk. Bethesda, MD D0TF2D HIGHSTAT Phase 2 D0TI3R DRUG__ID D0TI3R D0TI3R DRUGCOMP Flex Pharma, Boston, MA D0TI3R HIGHSTAT Phase 2 D0TI4C DRUG__ID D0TI4C D0TI4C DRUGCOMP Allakos San Carlos, CA D0TI4C HIGHSTAT Phase 2 D0TJ0R DRUG__ID D0TJ0R D0TJ0R DRUGCOMP Cantab Biopharmaceuticals Ltd; Xenova Group plc D0TJ0R HIGHSTAT Phase 2 D0TN1J DRUG__ID D0TN1J D0TN1J DRUGCOMP Cytocom Orlando, FL D0TN1J HIGHSTAT Phase 2 D0TR3Y DRUG__ID D0TR3Y D0TR3Y DRUGCOMP AiVita Biomedical Irvine, CA D0TR3Y HIGHSTAT Phase 2 D0TR4Y DRUG__ID D0TR4Y D0TR4Y DRUGCOMP Lion Biotechnologies San Carlos, CA D0TR4Y HIGHSTAT Phase 2 D0TU7V DRUG__ID D0TU7V D0TU7V DRUGCOMP Mazence Inc D0TU7V HIGHSTAT Phase 2 D0TU9W DRUG__ID D0TU9W D0TU9W DRUGCOMP Biogen Cambridge, MA D0TU9W HIGHSTAT Phase 2 D0TY1Y DRUG__ID D0TY1Y D0TY1Y DRUGCOMP Sanaria Rockville, MD D0TY1Y HIGHSTAT Phase 2 D0U0DD DRUG__ID D0U0DD D0U0DD DRUGCOMP Laboratorios Leti SL D0U0DD HIGHSTAT Phase 2 D0U1MO DRUG__ID D0U1MO D0U1MO DRUGCOMP Ceregene D0U1MO HIGHSTAT Phase 2 D0U1XG DRUG__ID D0U1XG D0U1XG DRUGCOMP Hanmi Pharmaceutical Co Ltd D0U1XG HIGHSTAT Phase 2 D0U2DA DRUG__ID D0U2DA D0U2DA DRUGCOMP Bionomics Ltd D0U2DA HIGHSTAT Phase 2 D0U2DO DRUG__ID D0U2DO D0U2DO DRUGCOMP FivePrime Therapeutics Inc D0U2DO HIGHSTAT Phase 2 D0U2TZ DRUG__ID D0U2TZ D0U2TZ DRUGCOMP Aptinyx Evanston, IL D0U2TZ HIGHSTAT Phase 2 D0U2XU DRUG__ID D0U2XU D0U2XU DRUGCOMP Xenome D0U2XU HIGHSTAT Phase 2 D0U3AL DRUG__ID D0U3AL D0U3AL DRUGCOMP OncoSec Medical D0U3AL HIGHSTAT Phase 2 D0U3GB DRUG__ID D0U3GB D0U3GB DRUGCOMP Liquidia Technologies D0U3GB HIGHSTAT Phase 2 D0U3GT DRUG__ID D0U3GT D0U3GT DRUGCOMP Merck D0U3GT HIGHSTAT Phase 2 D0U3MQ DRUG__ID D0U3MQ D0U3MQ DRUGCOMP Ultragenyx pharmaceuticals D0U3MQ HIGHSTAT Phase 2 D0U3QK DRUG__ID D0U3QK D0U3QK DRUGCOMP Omeros D0U3QK HIGHSTAT Phase 2 D0U5YW DRUG__ID D0U5YW D0U5YW DRUGCOMP Ocular therapeutix D0U5YW HIGHSTAT Phase 2 D0U6PJ DRUG__ID D0U6PJ D0U6PJ DRUGCOMP LTT Bio-Pharma Co Ltd D0U6PJ HIGHSTAT Phase 2 D0U7SR DRUG__ID D0U7SR D0U7SR DRUGCOMP F Hoffmann-La Roche Ltd D0U7SR HIGHSTAT Phase 2 D0U7SU DRUG__ID D0U7SU D0U7SU DRUGCOMP Amarillo Biosciences D0U7SU HIGHSTAT Phase 2 D0U7VU DRUG__ID D0U7VU D0U7VU DRUGCOMP Millenium; The Takeda oncology company D0U7VU HIGHSTAT Phase 2 D0U8IU DRUG__ID D0U8IU D0U8IU DRUGCOMP Izun Pharmaceuticals Corp D0U8IU HIGHSTAT Phase 2 D0U8QB DRUG__ID D0U8QB D0U8QB DRUGCOMP Akros pharma D0U8QB HIGHSTAT Phase 2 D0U9IZ DRUG__ID D0U9IZ D0U9IZ DRUGCOMP AM-Pharma D0U9IZ HIGHSTAT Phase 2 D0U9LV DRUG__ID D0U9LV D0U9LV DRUGCOMP Eli Lilly & Co D0U9LV HIGHSTAT Phase 2 D0UB5A DRUG__ID D0UB5A D0UB5A DRUGTYPE Antibody D0UB5A HIGHSTAT Phase 2 D0UC5G DRUG__ID D0UC5G D0UC5G DRUGCOMP Microbion Bozeman, MT D0UC5G HIGHSTAT Phase 2 D0UF8E DRUG__ID D0UF8E D0UF8E DRUGCOMP XOMA Ltd D0UF8E HIGHSTAT Phase 2 D0UG3Q DRUG__ID D0UG3Q D0UG3Q DRUGCOMP Veloce BioPharma Fort Lauderdale, FL D0UG3Q HIGHSTAT Phase 2 D0UH4P DRUG__ID D0UH4P D0UH4P DRUGCOMP Cumberland Pharmaceuticals Nashville, TN D0UH4P HIGHSTAT Phase 2 D0UI4K DRUG__ID D0UI4K D0UI4K DRUGCOMP Viventia Biotech Winnipeg, Canada D0UI4K HIGHSTAT Phase 2 D0UQ5I DRUG__ID D0UQ5I D0UQ5I DRUGCOMP Dynport vaccine D0UQ5I HIGHSTAT Phase 2 D0UT7F DRUG__ID D0UT7F D0UT7F DRUGCOMP Zz biotech D0UT7F HIGHSTAT Phase 2 D0UV2E DRUG__ID D0UV2E D0UV2E DRUGCOMP Levolta Pharmaceuticals Bethlehem, PA D0UV2E HIGHSTAT Phase 2 D0UV4H DRUG__ID D0UV4H D0UV4H DRUGCOMP GlaxoSmithKline plc D0UV4H HIGHSTAT Phase 2 D0V0AR DRUG__ID D0V0AR D0V0AR DRUGCOMP University of Miami D0V0AR HIGHSTAT Phase 2 D0V0UH DRUG__ID D0V0UH D0V0UH DRUGCOMP Amgen Thousand D0V0UH HIGHSTAT Phase 2 D0V2RF DRUG__ID D0V2RF D0V2RF DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0V2RF HIGHSTAT Phase 2 D0V3CK DRUG__ID D0V3CK D0V3CK DRUGCOMP Institute of Medicinal Molecular Design Inc D0V3CK HIGHSTAT Phase 2 D0V3YY DRUG__ID D0V3YY D0V3YY DRUGCOMP Novo Nordisk, Plainsboro, NJ D0V3YY HIGHSTAT Phase 2 D0V4IJ DRUG__ID D0V4IJ D0V4IJ DRUGCOMP Akcea Therapeutics Cambridge, MA D0V4IJ HIGHSTAT Phase 2 D0V4IQ DRUG__ID D0V4IQ D0V4IQ DRUGCOMP Biopharm GmbH D0V4IQ HIGHSTAT Phase 2 D0V4TV DRUG__ID D0V4TV D0V4TV DRUGCOMP Cleveland BioLabs Inc D0V4TV HIGHSTAT Phase 2 D0V4YA DRUG__ID D0V4YA D0V4YA DRUGCOMP Kyowa Kirin USA Princeton, NJ D0V4YA HIGHSTAT Phase 2 D0V5JH DRUG__ID D0V5JH D0V5JH DRUGCOMP Altor bioscience D0V5JH HIGHSTAT Phase 2 D0V5KJ DRUG__ID D0V5KJ D0V5KJ THERCLAS Respiratory Agents D0V5KJ HIGHSTAT Phase 2 D0V5QH DRUG__ID D0V5QH D0V5QH DRUGCOMP Ono pharmaceutical D0V5QH HIGHSTAT Phase 2 D0V5VR DRUG__ID D0V5VR D0V5VR DRUGCOMP LEO Pharma D0V5VR HIGHSTAT Phase 2 D0V6BE DRUG__ID D0V6BE D0V6BE DRUGCOMP Veloce Therapeutics Fort Lauderdale, FL D0V6BE HIGHSTAT Phase 2 D0V6CE DRUG__ID D0V6CE D0V6CE DRUGCOMP Garnet biotherapeutics D0V6CE HIGHSTAT Phase 2 D0V7DQ DRUG__ID D0V7DQ D0V7DQ DRUGCOMP Cellular Biomedicine Cupertino, CA D0V7DQ HIGHSTAT Phase 2 D0V7KJ DRUG__ID D0V7KJ D0V7KJ DRUGCOMP US Army Medical Research Institute of Infectious Diseases D0V7KJ HIGHSTAT Phase 2 D0V7SY DRUG__ID D0V7SY D0V7SY DRUGCOMP Layton BioScience D0V7SY HIGHSTAT Phase 2 D0V8AR DRUG__ID D0V8AR D0V8AR DRUGCOMP Nielson BioSciences San Diego, CA D0V8AR HIGHSTAT Phase 2 D0V8BU DRUG__ID D0V8BU D0V8BU DRUGCOMP Piramal Life Sciences Ltd D0V8BU HIGHSTAT Phase 2 D0V8HB DRUG__ID D0V8HB D0V8HB DRUGCOMP DBV Technologies D0V8HB HIGHSTAT Phase 2 D0V9EX DRUG__ID D0V9EX D0V9EX DRUGCOMP ImmunoGen, Waltham, MA D0V9EX HIGHSTAT Phase 2 D0V9FU DRUG__ID D0V9FU D0V9FU DRUGCOMP Weizmann Institute of Science D0V9FU HIGHSTAT Phase 2 D0V9PB DRUG__ID D0V9PB D0V9PB DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D0V9PB HIGHSTAT Phase 2 D0V9UA DRUG__ID D0V9UA D0V9UA DRUGCOMP AlgiPharma AS D0V9UA HIGHSTAT Phase 2 D0VE3U DRUG__ID D0VE3U D0VE3U DRUGCOMP JYANT Technologies Marietta, GA D0VE3U HIGHSTAT Phase 2 D0VG7I DRUG__ID D0VG7I D0VG7I DRUGCOMP Immune Therapeutics Orlando, FL D0VG7I HIGHSTAT Phase 2 D0VH0X DRUG__ID D0VH0X D0VH0X DRUGCOMP University of California Los Angeles D0VH0X HIGHSTAT Phase 2 D0VH3D DRUG__ID D0VH3D D0VH3D DRUGCOMP Institut Pasteur D0VH3D HIGHSTAT Phase 2 D0VI7R DRUG__ID D0VI7R D0VI7R DRUGCOMP Karyopharm Therapeutics Newton, MA D0VI7R HIGHSTAT Phase 2 D0VJ4N DRUG__ID D0VJ4N D0VJ4N DRUGCOMP Center for Genetic Engineering and Biotechnology D0VJ4N HIGHSTAT Phase 2 D0VQ8Q DRUG__ID D0VQ8Q D0VQ8Q DRUGCOMP Seattle Genetics Bothell, WA D0VQ8Q HIGHSTAT Phase 2 D0VS2R DRUG__ID D0VS2R D0VS2R DRUGCOMP Baylor College of Medicine D0VS2R HIGHSTAT Phase 2 D0VS2W DRUG__ID D0VS2W D0VS2W DRUGCOMP Y's Therapeutics D0VS2W HIGHSTAT Phase 2 D0VV6V DRUG__ID D0VV6V D0VV6V DRUGCOMP Oncolytics Biotech D0VV6V HIGHSTAT Phase 2 D0VW0A DRUG__ID D0VW0A D0VW0A DRUGCOMP Oculus Innovative Sciences D0VW0A HIGHSTAT Phase 2 D0VZ5X DRUG__ID D0VZ5X D0VZ5X DRUGCOMP Boehringer Ingelheim Corp D0VZ5X HIGHSTAT Phase 2 D0W0JP DRUG__ID D0W0JP D0W0JP DRUGCOMP Omeros D0W0JP HIGHSTAT Phase 2 D0W0YI DRUG__ID D0W0YI D0W0YI DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0W0YI HIGHSTAT Phase 2 D0W1AR DRUG__ID D0W1AR D0W1AR DRUGCOMP Epitopoietic research D0W1AR HIGHSTAT Phase 2 D0W1QA DRUG__ID D0W1QA D0W1QA DRUGCOMP Green Cross Corp D0W1QA HIGHSTAT Phase 2 D0W2KA DRUG__ID D0W2KA D0W2KA DRUGCOMP Biogen Idec D0W2KA HIGHSTAT Phase 2 D0W3DV DRUG__ID D0W3DV D0W3DV DRUGCOMP Acceleron Pharma Cambridge, MA Celgene Summit, NJ D0W3DV HIGHSTAT Phase 2 D0W3GE DRUG__ID D0W3GE D0W3GE DRUGCOMP DynPort Vaccine D0W3GE HIGHSTAT Phase 2 D0W3MH DRUG__ID D0W3MH D0W3MH DRUGCOMP Bayer HealthCare Pharmaceuticals D0W3MH HIGHSTAT Phase 2 D0W3UV DRUG__ID D0W3UV D0W3UV DRUGCOMP Celgene D0W3UV HIGHSTAT Phase 2 D0W4AR DRUG__ID D0W4AR D0W4AR DRUGCOMP Baxter international; kuros biosurgery D0W4AR HIGHSTAT Phase 2 D0W5PN DRUG__ID D0W5PN D0W5PN DRUGCOMP Melinta therapeutics D0W5PN HIGHSTAT Phase 2 D0W5RE DRUG__ID D0W5RE D0W5RE DRUGCOMP Asubio Pharma Co Ltd D0W5RE HIGHSTAT Phase 2 D0W5VV DRUG__ID D0W5VV D0W5VV DRUGCOMP Taro Pharmaceuticals USA Hawthorne, NY D0W5VV HIGHSTAT Phase 2 D0W6HO DRUG__ID D0W6HO D0W6HO DRUGCOMP Idera Pharmaceuticals D0W6HO HIGHSTAT Phase 2 D0W8DA DRUG__ID D0W8DA D0W8DA DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0W8DA HIGHSTAT Phase 2 D0W8FE DRUG__ID D0W8FE D0W8FE DRUGCOMP BN ImmunoTherapeutics D0W8FE HIGHSTAT Phase 2 D0W8GT DRUG__ID D0W8GT D0W8GT DRUGCOMP Sephoris Pharmaceuticals San Diego, CA D0W8GT HIGHSTAT Phase 2 D0W8TQ DRUG__ID D0W8TQ D0W8TQ DRUGCOMP Stemline Therapeutics D0W8TQ HIGHSTAT Phase 2 D0W8YY DRUG__ID D0W8YY D0W8YY DRUGCOMP Yale University D0W8YY HIGHSTAT Phase 2 D0W9IT DRUG__ID D0W9IT D0W9IT DRUGCOMP Neuraxon D0W9IT HIGHSTAT Phase 2 D0W9QG DRUG__ID D0W9QG D0W9QG DRUGCOMP Emergent BioSolutions; Pfizer D0W9QG HIGHSTAT Phase 2 D0W9SN DRUG__ID D0W9SN D0W9SN DRUGCOMP GenentechSouth San Francisco, CA D0W9SN HIGHSTAT Phase 2 D0WB0R DRUG__ID D0WB0R D0WB0R DRUGCOMP Novartis PharmaceuticalsEast Hanover, NJ D0WB0R HIGHSTAT Phase 2 D0WG8A DRUG__ID D0WG8A D0WG8A DRUGCOMP Sarfez Pharmaceuticals Vienna, VA D0WG8A HIGHSTAT Phase 2 D0WJ8M DRUG__ID D0WJ8M D0WJ8M DRUGCOMP Daiichi Sankyo Basking Ridge, NJ D0WJ8M HIGHSTAT Phase 2 D0WK1M DRUG__ID D0WK1M D0WK1M DRUGCOMP Cell Medica Houston, TX D0WK1M HIGHSTAT Phase 2 D0WK7Y DRUG__ID D0WK7Y D0WK7Y DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0WK7Y HIGHSTAT Phase 2 D0WL4D DRUG__ID D0WL4D D0WL4D DRUGCOMP Biogen Idec D0WL4D HIGHSTAT Phase 2 D0WN1T DRUG__ID D0WN1T D0WN1T DRUGCOMP PulmoScience Inc D0WN1T HIGHSTAT Phase 2 D0WP0U DRUG__ID D0WP0U D0WP0U DRUGCOMP Immune Design, Seattle, WA D0WP0U HIGHSTAT Phase 2 D0WP2R DRUG__ID D0WP2R D0WP2R DRUGCOMP TWi Biotechnology Taipei, Taiwan D0WP2R HIGHSTAT Phase 2 D0WQ5U DRUG__ID D0WQ5U D0WQ5U DRUGCOMP Meditor Pharmaceuticals D0WQ5U HIGHSTAT Phase 2 D0WR7C DRUG__ID D0WR7C D0WR7C DRUGCOMP Pherin Corp D0WR7C HIGHSTAT Phase 2 D0WR9U DRUG__ID D0WR9U D0WR9U DRUGCOMP MedImmune Gaithersburg, MA D0WR9U HIGHSTAT Phase 2 D0WV8Z DRUG__ID D0WV8Z D0WV8Z DRUGCOMP MedImmune Gaithersburg, MD D0WV8Z HIGHSTAT Phase 2 D0WZ0E DRUG__ID D0WZ0E D0WZ0E DRUGCOMP TVAX Biomedical Olathe, KS D0WZ0E HIGHSTAT Phase 2 D0X0IU DRUG__ID D0X0IU D0X0IU DRUGCOMP National Cancer Institute D0X0IU HIGHSTAT Phase 2 D0X0PQ DRUG__ID D0X0PQ D0X0PQ DRUGCOMP Merck Serono SA D0X0PQ HIGHSTAT Phase 2 D0X0SK DRUG__ID D0X0SK D0X0SK DRUGCOMP GlaxoSmithKline plc D0X0SK HIGHSTAT Phase 2 D0X0TM DRUG__ID D0X0TM D0X0TM DRUGCOMP University of Iowa D0X0TM HIGHSTAT Phase 2 D0X1XA DRUG__ID D0X1XA D0X1XA DRUGCOMP Proportional Technologies Inc D0X1XA HIGHSTAT Phase 2 D0X2EM DRUG__ID D0X2EM D0X2EM DRUGCOMP Uni-Bio Science Group Limited D0X2EM HIGHSTAT Phase 2 D0X2LB DRUG__ID D0X2LB D0X2LB DRUGCOMP Ortho Dermatologics Raleigh, NC D0X2LB HIGHSTAT Phase 2 D0X2RL DRUG__ID D0X2RL D0X2RL DRUGCOMP Lilly D0X2RL HIGHSTAT Phase 2 D0X3JK DRUG__ID D0X3JK D0X3JK DRUGCOMP Purdue Pharma Stamford, CT Shionogi Florham Park, NJ D0X3JK HIGHSTAT Phase 2 D0X3JY DRUG__ID D0X3JY D0X3JY DRUGCOMP Neotropix D0X3JY HIGHSTAT Phase 2 D0X3QR DRUG__ID D0X3QR D0X3QR DRUGCOMP Avalanche biotechnologies D0X3QR HIGHSTAT Phase 2 D0X4PP DRUG__ID D0X4PP D0X4PP DRUGCOMP Epygenix Therapeutics Paramus, NJ D0X4PP HIGHSTAT Phase 2 D0X4YJ DRUG__ID D0X4YJ D0X4YJ DRUGCOMP Valletta Health BV D0X4YJ HIGHSTAT Phase 2 D0X5ZU DRUG__ID D0X5ZU D0X5ZU DRUGCOMP Eirion Therapeutics Woburn, MA D0X5ZU HIGHSTAT Phase 2 D0X6EM DRUG__ID D0X6EM D0X6EM DRUGCOMP Johann Wolfgang Goethe-Universitat Frankfurt am Main D0X6EM HIGHSTAT Phase 2 D0X6NZ DRUG__ID D0X6NZ D0X6NZ DRUGCOMP Affinium pharmaceuticals D0X6NZ HIGHSTAT Phase 2 D0X7CV DRUG__ID D0X7CV D0X7CV DRUGCOMP Phytrix AG D0X7CV HIGHSTAT Phase 2 D0X9LC DRUG__ID D0X9LC D0X9LC DRUGCOMP Intercell D0X9LC HIGHSTAT Phase 2 D0XA4U DRUG__ID D0XA4U D0XA4U DRUGCOMP GlaxoSmithKlineResearch Triangle Park, NC D0XA4U HIGHSTAT Phase 2 D0XD5N DRUG__ID D0XD5N D0XD5N DRUGCOMP Eli Lilly Indianapolis, IN D0XD5N HIGHSTAT Phase 2 D0XE4G DRUG__ID D0XE4G D0XE4G DRUGCOMP BrainStorm Cell Therapeutics Hackensack, NJ D0XE4G HIGHSTAT Phase 2 D0XG3Y DRUG__ID D0XG3Y D0XG3Y DRUGCOMP Tranzyme Pharma D0XG3Y HIGHSTAT Phase 2 D0XH8X DRUG__ID D0XH8X D0XH8X DRUGCOMP Dendreon Corp D0XH8X HIGHSTAT Phase 2 D0XL1T DRUG__ID D0XL1T D0XL1T DRUGCOMP Pinnacle Biologics Chicago, IL D0XL1T HIGHSTAT Phase 2 D0XO7Q DRUG__ID D0XO7Q D0XO7Q DRUGCOMP Hadassah Medical Organization D0XO7Q HIGHSTAT Phase 2 D0XP7V DRUG__ID D0XP7V D0XP7V DRUGCOMP Sol-Gel Technologies Ness Ziona, Israel D0XP7V HIGHSTAT Phase 2 D0XQ6V DRUG__ID D0XQ6V D0XQ6V DRUGCOMP Acacia Pharma Ltd D0XQ6V HIGHSTAT Phase 2 D0XR0B DRUG__ID D0XR0B D0XR0B DRUGCOMP SPECTRUM pharmaceuticals D0XR0B HIGHSTAT Phase 2 D0XT5Q DRUG__ID D0XT5Q D0XT5Q DRUGCOMP AgensysSanta Monica, CA D0XT5Q HIGHSTAT Phase 2 D0XT8W DRUG__ID D0XT8W D0XT8W DRUGCOMP SOM Biotech Cambridge, MA D0XT8W HIGHSTAT Phase 2 D0XW6B DRUG__ID D0XW6B D0XW6B DRUGCOMP University of Barcelona D0XW6B HIGHSTAT Phase 2 D0XX2I DRUG__ID D0XX2I D0XX2I DRUGCOMP Piramal Healthcare Ltd D0XX2I HIGHSTAT Phase 2 D0Y0HR DRUG__ID D0Y0HR D0Y0HR DRUGCOMP XOMA, Berkeley, CA D0Y0HR HIGHSTAT Phase 2 D0Y0KY DRUG__ID D0Y0KY D0Y0KY DRUGTYPE Antisense drug D0Y0KY HIGHSTAT Phase 2 D0Y0PY DRUG__ID D0Y0PY D0Y0PY DRUGCOMP Peptimmune D0Y0PY HIGHSTAT Phase 2 D0Y0VC DRUG__ID D0Y0VC D0Y0VC DRUGCOMP NLS Pharma Stans, Switzerland D0Y0VC HIGHSTAT Phase 2 D0Y1XD DRUG__ID D0Y1XD D0Y1XD DRUGCOMP Proneuron Biotechnologies D0Y1XD HIGHSTAT Phase 2 D0Y2VA DRUG__ID D0Y2VA D0Y2VA DRUGCOMP Pharmalink AB D0Y2VA HIGHSTAT Phase 2 D0Y3BU DRUG__ID D0Y3BU D0Y3BU DRUGCOMP Novartis AG D0Y3BU HIGHSTAT Phase 2 D0Y3JI DRUG__ID D0Y3JI D0Y3JI DRUGCOMP Narhex Life Sciences Ltd D0Y3JI HIGHSTAT Phase 2 D0Y4ZE DRUG__ID D0Y4ZE D0Y4ZE DRUGCOMP BTG plc D0Y4ZE HIGHSTAT Phase 2 D0Y5JZ DRUG__ID D0Y5JZ D0Y5JZ DRUGCOMP Synphora D0Y5JZ HIGHSTAT Phase 2 D0Y5KL DRUG__ID D0Y5KL D0Y5KL DRUGCOMP Novavax D0Y5KL HIGHSTAT Phase 2 D0Y5MY DRUG__ID D0Y5MY D0Y5MY DRUGCOMP Geron D0Y5MY HIGHSTAT Phase 2 D0Y7TC DRUG__ID D0Y7TC D0Y7TC DRUGCOMP Thomas Jefferson University D0Y7TC HIGHSTAT Phase 2 D0Y7YB DRUG__ID D0Y7YB D0Y7YB DRUGCOMP GlaxoSmithKline D0Y7YB HIGHSTAT Phase 2 D0YA1B DRUG__ID D0YA1B D0YA1B DRUGCOMP MacroGenics Rockville, MD D0YA1B HIGHSTAT Phase 2 D0YB3N DRUG__ID D0YB3N D0YB3N DRUGCOMP Ichor Medical Systems San Diego, CAUnited States Army Medical Research and Materiel Command Fort Detrick, MD D0YB3N HIGHSTAT Phase 2 D0YB7P DRUG__ID D0YB7P D0YB7P DRUGCOMP NeovacsParis, France D0YB7P HIGHSTAT Phase 2 D0YC4F DRUG__ID D0YC4F D0YC4F DRUGCOMP Kowa Co Ltd D0YC4F HIGHSTAT Phase 2 D0YC8W DRUG__ID D0YC8W D0YC8W DRUGCOMP Spectrum Pharmaceuticals Henderson, NV D0YC8W HIGHSTAT Phase 2 D0YC9M DRUG__ID D0YC9M D0YC9M DRUGCOMP Anergis SA D0YC9M HIGHSTAT Phase 2 D0YH5V DRUG__ID D0YH5V D0YH5V DRUGCOMP Merck Kenilworth, NJ D0YH5V HIGHSTAT Phase 2 D0YJ2G DRUG__ID D0YJ2G D0YJ2G DRUGCOMP Advaxis, Princeton, NJ D0YJ2G HIGHSTAT Phase 2 D0YL9G DRUG__ID D0YL9G D0YL9G DRUGCOMP Taisho Pharmaceutical D0YL9G HIGHSTAT Phase 2 D0YO4B DRUG__ID D0YO4B D0YO4B DRUGCOMP Bristol-Myers Squibb Princeton, NJFive Prime Therapeutics South San Francisco, CA D0YO4B HIGHSTAT Phase 2 D0YO7Y DRUG__ID D0YO7Y D0YO7Y DRUGCOMP Nexbio D0YO7Y HIGHSTAT Phase 2 D0YV0N DRUG__ID D0YV0N D0YV0N DRUGCOMP GlaxoSmithKline Philadelphia, PA D0YV0N HIGHSTAT Phase 2 D0Z0TU DRUG__ID D0Z0TU D0Z0TU DRUGCOMP Intarcia Therapeutics Inc D0Z0TU HIGHSTAT Phase 2 D0Z0ZT DRUG__ID D0Z0ZT D0Z0ZT DRUGCOMP Celtaxsys, Atlanta, GA D0Z0ZT HIGHSTAT Phase 2 D0Z1CZ DRUG__ID D0Z1CZ D0Z1CZ DRUGCOMP Orchestra Therapeutics D0Z1CZ HIGHSTAT Phase 2 D0Z1OT DRUG__ID D0Z1OT D0Z1OT DRUGCOMP Alder biopharmaceuticals D0Z1OT HIGHSTAT Phase 2 D0Z1UB DRUG__ID D0Z1UB D0Z1UB DRUGCOMP Vicuron Pharmaceuticals Inc D0Z1UB HIGHSTAT Phase 2 D0Z2JP DRUG__ID D0Z2JP D0Z2JP DRUGCOMP Novartis Vaccines Institute for Global Health D0Z2JP HIGHSTAT Phase 2 D0Z3RZ DRUG__ID D0Z3RZ D0Z3RZ DRUGCOMP Viroxis D0Z3RZ HIGHSTAT Phase 2 D0Z4OQ DRUG__ID D0Z4OQ D0Z4OQ DRUGCOMP Takeda Pharmaceutical Co Ltd D0Z4OQ HIGHSTAT Phase 2 D0Z4SP DRUG__ID D0Z4SP D0Z4SP DRUGCOMP Bayhill Therapeutics D0Z4SP HIGHSTAT Phase 2 D0Z5FC DRUG__ID D0Z5FC D0Z5FC DRUGCOMP University of Edinburgh D0Z5FC HIGHSTAT Phase 2 D0Z5HA DRUG__ID D0Z5HA D0Z5HA DRUGCOMP Valentis Inc; Valentis D0Z5HA HIGHSTAT Phase 2 D0Z5TS DRUG__ID D0Z5TS D0Z5TS DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0Z5TS HIGHSTAT Phase 2 D0Z6DE DRUG__ID D0Z6DE D0Z6DE DRUGCOMP Thios Pharmaceuticals D0Z6DE HIGHSTAT Phase 2 D0Z6KK DRUG__ID D0Z6KK D0Z6KK DRUGCOMP AstraZeneca plc D0Z6KK HIGHSTAT Phase 2 D0Z7TR DRUG__ID D0Z7TR D0Z7TR DRUGCOMP Hemostemix Calgary, Canada D0Z7TR HIGHSTAT Phase 2 D0Z8EA DRUG__ID D0Z8EA D0Z8EA DRUGCOMP Foamix Bridgewater, NJ D0Z8EA HIGHSTAT Phase 2 D0Z9AV DRUG__ID D0Z9AV D0Z9AV DRUGCOMP National Institutes of Health; Generex Biotechnology D0Z9AV HIGHSTAT Phase 2 D0Z9ZT DRUG__ID D0Z9ZT D0Z9ZT DRUGCOMP Medicenna Therapeutics Toronto, Canada D0Z9ZT HIGHSTAT Phase 2 D0ZA6V DRUG__ID D0ZA6V D0ZA6V DRUGCOMP Monopar Therapeutics Wilmette, IL D0ZA6V HIGHSTAT Phase 2 D0ZI4L DRUG__ID D0ZI4L D0ZI4L DRUGCOMP Cantex Pharmaceuticals Weston, FL D0ZI4L HIGHSTAT Phase 2 D0ZJ6W DRUG__ID D0ZJ6W D0ZJ6W DRUGCOMP Circassia Ltd D0ZJ6W HIGHSTAT Phase 2 D0ZK0N DRUG__ID D0ZK0N D0ZK0N DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0ZK0N HIGHSTAT Phase 2 D0ZK3X DRUG__ID D0ZK3X D0ZK3X DRUGCOMP Brickell Biotech Boulder, CO D0ZK3X HIGHSTAT Phase 2 D0ZO7A DRUG__ID D0ZO7A D0ZO7A DRUGCOMP Newlink genetics D0ZO7A HIGHSTAT Phase 2 D0ZP2E DRUG__ID D0ZP2E D0ZP2E DRUGCOMP Adocia SAS D0ZP2E HIGHSTAT Phase 2 D0ZR4W DRUG__ID D0ZR4W D0ZR4W DRUGCOMP Avanir Pharmaceuticals Aliso Viejo, CA D0ZR4W HIGHSTAT Phase 2 D0ZR6E DRUG__ID D0ZR6E D0ZR6E DRUGCOMP TVAX Biomedical Olathe, KS D0ZR6E HIGHSTAT Phase 2 D0ZS5X DRUG__ID D0ZS5X D0ZS5X DRUGCOMP Shire, Lexington, MA D0ZS5X HIGHSTAT Phase 2 D0ZW1W DRUG__ID D0ZW1W D0ZW1W DRUGCOMP Iroko Pharmaceuticals Philadelphia, PA D0ZW1W HIGHSTAT Phase 2 D0ZZ3Q DRUG__ID D0ZZ3Q D0ZZ3Q DRUGCOMP AOBiome Cambridge, MA D0ZZ3Q HIGHSTAT Phase 2 D0ZZ6C DRUG__ID D0ZZ6C D0ZZ6C DRUGCOMP Bonti Newport Beach, CA D0ZZ6C HIGHSTAT Phase 2 D17HKT DRUG__ID D17HKT D17HKT DRUGCOMP Chugai Pharmaceutical D17HKT HIGHSTAT Phase 2 D27MAS DRUG__ID D27MAS D27MAS DRUGCOMP JOHNSON & JOHNSON D27MAS HIGHSTAT Phase 2 D2A8EQ DRUG__ID D2A8EQ D2A8EQ DRUGTYPE Vaccine D2A8EQ HIGHSTAT Phase 2 D2FCM4 DRUG__ID D2FCM4 D2FCM4 DRUGCOMP Vyome Therapeutics D2FCM4 HIGHSTAT Phase 2 D2KTG5 DRUG__ID D2KTG5 D2KTG5 DRUGCOMP Theravance Biopharma D2KTG5 HIGHSTAT Phase 2 D2Q5XO DRUG__ID D2Q5XO D2Q5XO DRUGCOMP Cytocom D2Q5XO HIGHSTAT Phase 2 D2W0LG DRUG__ID D2W0LG D2W0LG DRUGCOMP Pfzer D2W0LG HIGHSTAT Phase 2 D2YT5I DRUG__ID D2YT5I D2YT5I DRUGCOMP Adaptimmune D2YT5I HIGHSTAT Phase 2 D2ZA8S DRUG__ID D2ZA8S D2ZA8S DRUGCOMP Kissei Pharmaceutical Co., Ltd. D2ZA8S HIGHSTAT Phase 2 D31XQD DRUG__ID D31XQD D31XQD DRUGCOMP Takeda D31XQD HIGHSTAT Phase 2 D3UB9H DRUG__ID D3UB9H D3UB9H DRUGCOMP National Neuroscience Institute D3UB9H HIGHSTAT Phase 2 D3YT8E DRUG__ID D3YT8E D3YT8E DRUGCOMP Regenera Pharma D3YT8E HIGHSTAT Phase 2 D41PKY DRUG__ID D41PKY D41PKY DRUGCOMP Band Therapeutics D41PKY HIGHSTAT Phase 2 D49KHP DRUG__ID D49KHP D49KHP DRUGCOMP Novartis D49KHP HIGHSTAT Phase 2 D4DK2R DRUG__ID D4DK2R D4DK2R DRUGCOMP DermBiont D4DK2R HIGHSTAT Phase 2 D53BEH DRUG__ID D53BEH D53BEH DRUGCOMP T3D Therapeutics, Alzheimer's Association, NIA D53BEH HIGHSTAT Phase 2 D53YZV DRUG__ID D53YZV D53YZV DRUGTYPE Fusion protein D53YZV HIGHSTAT Phase 2 D5BMY9 DRUG__ID D5BMY9 D5BMY9 DRUGCOMP Teijin Pharma D5BMY9 HIGHSTAT Phase 2 D5IZ1S DRUG__ID D5IZ1S D5IZ1S DRUGCOMP Boehringer Ingelheim D5IZ1S HIGHSTAT Phase 2 D5QW0B DRUG__ID D5QW0B D5QW0B DRUGCOMP OPKO Health D5QW0B HIGHSTAT Phase 2 D6AZ5H DRUG__ID D6AZ5H D6AZ5H DRUGCOMP Glenmark Pharmaceuticals D6AZ5H HIGHSTAT Phase 2 D6B7FP DRUG__ID D6B7FP D6B7FP DRUGCOMP Bayer Pharmaceuticals D6B7FP HIGHSTAT Phase 2 D6WO5I DRUG__ID D6WO5I D6WO5I DRUGTYPE Antibody D6WO5I HIGHSTAT Phase 2 D7CX6S DRUG__ID D7CX6S D7CX6S DRUGCOMP Novartis D7CX6S HIGHSTAT Phase 2 D7OHR6 DRUG__ID D7OHR6 D7OHR6 DRUGCOMP HighTide Biopharma D7OHR6 HIGHSTAT Phase 2 D7ULC1 DRUG__ID D7ULC1 D7ULC1 DRUGCOMP Center Laboratories D7ULC1 HIGHSTAT Phase 2 D7VL3T DRUG__ID D7VL3T D7VL3T DRUGCOMP Phrixus Pharmaceuticals D7VL3T HIGHSTAT Phase 2 D84KSZ DRUG__ID D84KSZ D84KSZ DRUGCOMP Novartis D84KSZ HIGHSTAT Phase 2 D89BQK DRUG__ID D89BQK D89BQK DRUGCOMP Shanton Pharma Shanghai, China D89BQK HIGHSTAT Phase 2 D8DYX3 DRUG__ID D8DYX3 D8DYX3 DRUGCOMP NLS Pharmaceutics D8DYX3 HIGHSTAT Phase 2 D8HR4P DRUG__ID D8HR4P D8HR4P DRUGCOMP GlaxoSmithKline D8HR4P HIGHSTAT Phase 2 D8J3SW DRUG__ID D8J3SW D8J3SW DRUGCOMP Glyscend Therapeutics Lowell, MA D8J3SW HIGHSTAT Phase 2 D8SO5T DRUG__ID D8SO5T D8SO5T DRUGCOMP Revalesio D8SO5T HIGHSTAT Phase 2 D9EHD7 DRUG__ID D9EHD7 D9EHD7 DRUGCOMP Revolo Biotherapeutics New Orleans, LA D9EHD7 HIGHSTAT Phase 2 D9S1KL DRUG__ID D9S1KL D9S1KL DRUGCOMP Taisho Pharmaceutical D9S1KL HIGHSTAT Phase 2 D9SMF2 DRUG__ID D9SMF2 D9SMF2 DRUGCOMP KalVista Pharmaceuticals D9SMF2 HIGHSTAT Phase 2 DA53NS DRUG__ID DA53NS DA53NS DRUGCOMP PolyPid DA53NS HIGHSTAT Phase 2 DA59TH DRUG__ID DA59TH DA59TH DRUGCOMP Roche DA59TH HIGHSTAT Phase 2 DAD95G DRUG__ID DAD95G DAD95G DRUGCOMP Vertex DAD95G HIGHSTAT Phase 2 DAHF05 DRUG__ID DAHF05 DAHF05 DRUGCOMP Takeda DAHF05 HIGHSTAT Phase 2 DB2U3O DRUG__ID DB2U3O DB2U3O DRUGCOMP ViiV Healthcare DB2U3O HIGHSTAT Phase 2 DB34JE DRUG__ID DB34JE DB34JE DRUGCOMP GlaxoSmithKline DB34JE HIGHSTAT Phase 2 DB35WK DRUG__ID DB35WK DB35WK DRUGTYPE Antibody DB35WK HIGHSTAT Phase 2 DB5U4E DRUG__ID DB5U4E DB5U4E DRUGCOMP Dyve Biosciences DB5U4E HIGHSTAT Phase 2 DC2DO5 DRUG__ID DC2DO5 DC2DO5 DRUGCOMP BioLite DC2DO5 HIGHSTAT Phase 2 DC4U0L DRUG__ID DC4U0L DC4U0L DRUGCOMP Taro Pharmaceuticals DC4U0L HIGHSTAT Phase 2 DC5J6L DRUG__ID DC5J6L DC5J6L DRUGCOMP iVIEW Therapeutics DC5J6L HIGHSTAT Phase 2 DC7UF3 DRUG__ID DC7UF3 DC7UF3 DRUGCOMP miRagen Therapeutics DC7UF3 HIGHSTAT Phase 2 DCIX20 DRUG__ID DCIX20 DCIX20 DRUGTYPE Small molecular drug DCIX20 HIGHSTAT Phase 2 DD9VR3 DRUG__ID DD9VR3 DD9VR3 DRUGCOMP Novartis; Cadent Therapeutics DD9VR3 HIGHSTAT Phase 2 DE2WS7 DRUG__ID DE2WS7 DE2WS7 DRUGCOMP Novartis DE2WS7 HIGHSTAT Phase 2 DF32PZ DRUG__ID DF32PZ DF32PZ DRUGCOMP Janssen Research & Development Raritan, NJ DF32PZ HIGHSTAT Phase 2 DF5R7E DRUG__ID DF5R7E DF5R7E DRUGTYPE Antibody DF5R7E HIGHSTAT Phase 2 DF6Z3C DRUG__ID DF6Z3C DF6Z3C DRUGTYPE Nanobody DF6Z3C HIGHSTAT Phase 2 DF7V1X DRUG__ID DF7V1X DF7V1X DRUGCOMP Lilly DF7V1X HIGHSTAT Phase 2 DFV73I DRUG__ID DFV73I DFV73I DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ DFV73I HIGHSTAT Phase 2 DGL7Z2 DRUG__ID DGL7Z2 DGL7Z2 DRUGCOMP Afimmune Dublin, Ireland DGL7Z2 HIGHSTAT Phase 2 DGT01I DRUG__ID DGT01I DGT01I DRUGCOMP Bristol-Myers Squibb DGT01I HIGHSTAT Phase 2 DGT7B6 DRUG__ID DGT7B6 DGT7B6 DRUGCOMP Yungjin Pharm DGT7B6 HIGHSTAT Phase 2 DH08CI DRUG__ID DH08CI DH08CI DRUGCOMP Regor Therapeutics DH08CI HIGHSTAT Phase 2 DH6G1L DRUG__ID DH6G1L DH6G1L DRUGCOMP Aphios DH6G1L HIGHSTAT Phase 2 DHN9I5 DRUG__ID DHN9I5 DHN9I5 DRUGCOMP Takeda DHN9I5 HIGHSTAT Phase 2 DHQI14 DRUG__ID DHQI14 DHQI14 DRUGCOMP Sanofi DHQI14 HIGHSTAT Phase 2 DHR39I DRUG__ID DHR39I DHR39I DRUGCOMP AstraZeneca DHR39I HIGHSTAT Phase 2 DI7SP5 DRUG__ID DI7SP5 DI7SP5 DRUGCOMP Yamo Pharmaceuticals DI7SP5 HIGHSTAT Phase 2 DIE75V DRUG__ID DIE75V DIE75V DRUGCOMP Aimmune Therapeutics DIE75V HIGHSTAT Phase 2 DJ1L4K DRUG__ID DJ1L4K DJ1L4K DRUGCOMP JOHNSON & JOHNSON DJ1L4K HIGHSTAT Phase 2 DK03ND DRUG__ID DK03ND DK03ND DRUGCOMP Verrica Pharmaceuticals DK03ND HIGHSTAT Phase 2 DK8BS7 DRUG__ID DK8BS7 DK8BS7 DRUGCOMP Bayer DK8BS7 HIGHSTAT Phase 2 DKO16W DRUG__ID DKO16W DKO16W DRUGCOMP Mineralys Therapeutics DKO16W HIGHSTAT Phase 2 DKS3G5 DRUG__ID DKS3G5 DKS3G5 DRUGTYPE Peptide DKS3G5 HIGHSTAT Phase 2 DLI53W DRUG__ID DLI53W DLI53W DRUGCOMP Roche DLI53W HIGHSTAT Phase 2 DM3F1L DRUG__ID DM3F1L DM3F1L DRUGCOMP PRG S&T DM3F1L HIGHSTAT Phase 2 DM4K9V DRUG__ID DM4K9V DM4K9V DRUGTYPE Small molecular drug DM4K9V HIGHSTAT Phase 2 DM95PZ DRUG__ID DM95PZ DM95PZ DRUGCOMP IlDong Pharmaceutical DM95PZ HIGHSTAT Phase 2 DMEV15 DRUG__ID DMEV15 DMEV15 DRUGTYPE Antibody DMEV15 HIGHSTAT Phase 2 DMO43U DRUG__ID DMO43U DMO43U DRUGCOMP Chiesi DMO43U HIGHSTAT Phase 2 DMOG46 DRUG__ID DMOG46 DMOG46 DRUGCOMP Aveta Biomics DMOG46 HIGHSTAT Phase 2 DN3Z5D DRUG__ID DN3Z5D DN3Z5D DRUGCOMP Helix BioPharma DN3Z5D HIGHSTAT Phase 2 DNA7I1 DRUG__ID DNA7I1 DNA7I1 DRUGCOMP Opthea DNA7I1 HIGHSTAT Phase 2 DNGT70 DRUG__ID DNGT70 DNGT70 DRUGCOMP Cardurion Pharmaceuticals DNGT70 HIGHSTAT Phase 2 DNM9C4 DRUG__ID DNM9C4 DNM9C4 DRUGTYPE siRNA drug DNM9C4 HIGHSTAT Phase 2 DNS4D6 DRUG__ID DNS4D6 DNS4D6 DRUGCOMP Kaleido Biosciences DNS4D6 HIGHSTAT Phase 2 DO6UX3 DRUG__ID DO6UX3 DO6UX3 DRUGCOMP AstraZeneca DO6UX3 HIGHSTAT Phase 2 DOVW19 DRUG__ID DOVW19 DOVW19 DRUGCOMP XBiotech Austin, TX DOVW19 HIGHSTAT Phase 2 DP4D9X DRUG__ID DP4D9X DP4D9X DRUGCOMP Aardvark Therapeutics San Diego, CA DP4D9X HIGHSTAT Phase 2 DPDI65 DRUG__ID DPDI65 DPDI65 DRUGCOMP HORIZON DPDI65 HIGHSTAT Phase 2 DPLH50 DRUG__ID DPLH50 DPLH50 DRUGCOMP Globavir Biosciences DPLH50 HIGHSTAT Phase 2 DQ4OU8 DRUG__ID DQ4OU8 DQ4OU8 DRUGCOMP Merck DQ4OU8 HIGHSTAT Phase 2 DQI1F2 DRUG__ID DQI1F2 DQI1F2 DRUGCOMP Novartis DQI1F2 HIGHSTAT Phase 2 DR3J7T DRUG__ID DR3J7T DR3J7T DRUGCOMP Yiviva DR3J7T HIGHSTAT Phase 2 DR7ZU0 DRUG__ID DR7ZU0 DR7ZU0 DRUGCOMP Gtree Pharmaceuticals DR7ZU0 HIGHSTAT Phase 2 DRWI71 DRUG__ID DRWI71 DRWI71 DRUGCOMP Boehringer Ingelheim Ridgefield, CT DRWI71 HIGHSTAT Phase 2 DS4CL2 DRUG__ID DS4CL2 DS4CL2 DRUGCOMP Daehwa Pharmaceutical Co. DS4CL2 HIGHSTAT Phase 2 DS68GD DRUG__ID DS68GD DS68GD DRUGTYPE Antibody DS68GD HIGHSTAT Phase 2 DSG73N DRUG__ID DSG73N DSG73N DRUGCOMP Lumen Bioscience DSG73N HIGHSTAT Phase 2 DSIW85 DRUG__ID DSIW85 DSIW85 DRUGCOMP Otsuka Pharmaceutical DSIW85 HIGHSTAT Phase 2 DSK7I5 DRUG__ID DSK7I5 DSK7I5 DRUGCOMP Mediti Pharma DSK7I5 HIGHSTAT Phase 2 DT30ZG DRUG__ID DT30ZG DT30ZG DRUGCOMP Novus Therapeutics DT30ZG HIGHSTAT Phase 2 DT41EO DRUG__ID DT41EO DT41EO DRUGCOMP Cassiopea DT41EO HIGHSTAT Phase 2 DTQ3Z8 DRUG__ID DTQ3Z8 DTQ3Z8 DRUGTYPE Antibody DTQ3Z8 HIGHSTAT Phase 2 DU26QH DRUG__ID DU26QH DU26QH DRUGCOMP Ionis DU26QH HIGHSTAT Phase 2 DUF48L DRUG__ID DUF48L DUF48L DRUGCOMP Bukwang Pharmaceutical DUF48L HIGHSTAT Phase 2 DUT8C6 DRUG__ID DUT8C6 DUT8C6 DRUGCOMP Takeda DUT8C6 HIGHSTAT Phase 2 DVX3H0 DRUG__ID DVX3H0 DVX3H0 DRUGTYPE Antibody DVX3H0 HIGHSTAT Phase 2 DVZJ75 DRUG__ID DVZJ75 DVZJ75 DRUGCOMP Imbria Pharmaceuticals Boston, MA DVZJ75 HIGHSTAT Phase 2 DW3ZG6 DRUG__ID DW3ZG6 DW3ZG6 DRUGCOMP HemoShear Therapeutics DW3ZG6 HIGHSTAT Phase 2 DW4J6M DRUG__ID DW4J6M DW4J6M DRUGCOMP Genervon Biopharmaceuticals DW4J6M HIGHSTAT Phase 2 DW9C6F DRUG__ID DW9C6F DW9C6F DRUGCOMP Medi Help Line DW9C6F HIGHSTAT Phase 2 DWSO57 DRUG__ID DWSO57 DWSO57 DRUGCOMP SAb Biotherapeutics DWSO57 HIGHSTAT Phase 2 DX5T4D DRUG__ID DX5T4D DX5T4D DRUGCOMP Lilly DX5T4D HIGHSTAT Phase 2 DXC8I9 DRUG__ID DXC8I9 DXC8I9 DRUGCOMP Dyve Biosciences DXC8I9 HIGHSTAT Phase 2 DY2GF8 DRUG__ID DY2GF8 DY2GF8 DRUGCOMP JOHNSON & JOHNSON DY2GF8 HIGHSTAT Phase 2 DY46GM DRUG__ID DY46GM DY46GM DRUGCOMP Mologen DY46GM HIGHSTAT Phase 2 DYB14S DRUG__ID DYB14S DYB14S DRUGCOMP National University Hospital, Singapore DYB14S HIGHSTAT Phase 2 DZGI51 DRUG__ID DZGI51 DZGI51 DRUGCOMP AstraZeneca Wilmington, DE DZGI51 HIGHSTAT Phase 2 DZM65T DRUG__ID DZM65T DZM65T DRUGCOMP InnoCare Pharma DZM65T HIGHSTAT Phase 2 D00BUO DRUG__ID D00BUO D00BUO HIGHSTAT Phase 2 D00LHI DRUG__ID D00LHI D00LHI HIGHSTAT Phase 2 D00QOJ DRUG__ID D00QOJ D00QOJ HIGHSTAT Phase 2 D00URZ DRUG__ID D00URZ D00URZ HIGHSTAT Phase 2 D01CJY DRUG__ID D01CJY D01CJY HIGHSTAT Phase 2 D01EJJ DRUG__ID D01EJJ D01EJJ HIGHSTAT Phase 2 D01FFG DRUG__ID D01FFG D01FFG HIGHSTAT Phase 2 D01JTW DRUG__ID D01JTW D01JTW HIGHSTAT Phase 2 D01NYQ DRUG__ID D01NYQ D01NYQ HIGHSTAT Phase 2 D01OIR DRUG__ID D01OIR D01OIR HIGHSTAT Phase 2 D01QIX DRUG__ID D01QIX D01QIX HIGHSTAT Phase 2 D01QMC DRUG__ID D01QMC D01QMC HIGHSTAT Phase 2 D02TNW DRUG__ID D02TNW D02TNW HIGHSTAT Phase 2 D03BSK DRUG__ID D03BSK D03BSK HIGHSTAT Phase 2 D03GXU DRUG__ID D03GXU D03GXU HIGHSTAT Phase 2 D03OPE DRUG__ID D03OPE D03OPE HIGHSTAT Phase 2 D03RFK DRUG__ID D03RFK D03RFK HIGHSTAT Phase 2 D03YJC DRUG__ID D03YJC D03YJC HIGHSTAT Phase 2 D04FWP DRUG__ID D04FWP D04FWP HIGHSTAT Phase 2 D04PVE DRUG__ID D04PVE D04PVE HIGHSTAT Phase 2 D04XBU DRUG__ID D04XBU D04XBU HIGHSTAT Phase 2 D06AQJ DRUG__ID D06AQJ D06AQJ HIGHSTAT Phase 2 D06DUS DRUG__ID D06DUS D06DUS HIGHSTAT Phase 2 D07JKY DRUG__ID D07JKY D07JKY HIGHSTAT Phase 2 D07TCS DRUG__ID D07TCS D07TCS HIGHSTAT Phase 2 D07XBI DRUG__ID D07XBI D07XBI HIGHSTAT Phase 2 D08QED DRUG__ID D08QED D08QED HIGHSTAT Phase 2 D08UQC DRUG__ID D08UQC D08UQC HIGHSTAT Phase 2 D09CEJ DRUG__ID D09CEJ D09CEJ HIGHSTAT Phase 2 D09WND DRUG__ID D09WND D09WND HIGHSTAT Phase 2 D0B6VN DRUG__ID D0B6VN D0B6VN HIGHSTAT Phase 2 D0D5FR DRUG__ID D0D5FR D0D5FR HIGHSTAT Phase 2 D0D8XG DRUG__ID D0D8XG D0D8XG HIGHSTAT Phase 2 D0E2QC DRUG__ID D0E2QC D0E2QC HIGHSTAT Phase 2 D0E3HY DRUG__ID D0E3HY D0E3HY HIGHSTAT Phase 2 D0E4RH DRUG__ID D0E4RH D0E4RH HIGHSTAT Phase 2 D0E6ZN DRUG__ID D0E6ZN D0E6ZN HIGHSTAT Phase 2 D0E7VY DRUG__ID D0E7VY D0E7VY HIGHSTAT Phase 2 D0F4UM DRUG__ID D0F4UM D0F4UM HIGHSTAT Phase 2 D0G0MB DRUG__ID D0G0MB D0G0MB HIGHSTAT Phase 2 D0G1JO DRUG__ID D0G1JO D0G1JO HIGHSTAT Phase 2 D0I9DN DRUG__ID D0I9DN D0I9DN HIGHSTAT Phase 2 D0K2OV DRUG__ID D0K2OV D0K2OV HIGHSTAT Phase 2 D0K4OS DRUG__ID D0K4OS D0K4OS HIGHSTAT Phase 2 D0K6CW DRUG__ID D0K6CW D0K6CW HIGHSTAT Phase 2 D0L4AL DRUG__ID D0L4AL D0L4AL HIGHSTAT Phase 2 D0L4HL DRUG__ID D0L4HL D0L4HL HIGHSTAT Phase 2 D0L6KC DRUG__ID D0L6KC D0L6KC HIGHSTAT Phase 2 D0N0BW DRUG__ID D0N0BW D0N0BW HIGHSTAT Phase 2 D0N3WN DRUG__ID D0N3WN D0N3WN HIGHSTAT Phase 2 D0N4ZX DRUG__ID D0N4ZX D0N4ZX HIGHSTAT Phase 2 D0N6AC DRUG__ID D0N6AC D0N6AC HIGHSTAT Phase 2 D0N9KZ DRUG__ID D0N9KZ D0N9KZ HIGHSTAT Phase 2 D0O5OF DRUG__ID D0O5OF D0O5OF HIGHSTAT Phase 2 D0O6BJ DRUG__ID D0O6BJ D0O6BJ HIGHSTAT Phase 2 D0O6DE DRUG__ID D0O6DE D0O6DE HIGHSTAT Phase 2 D0OG6N DRUG__ID D0OG6N D0OG6N HIGHSTAT Phase 2 D0P4RC DRUG__ID D0P4RC D0P4RC HIGHSTAT Phase 2 D0P9XW DRUG__ID D0P9XW D0P9XW HIGHSTAT Phase 2 D0PX8I DRUG__ID D0PX8I D0PX8I HIGHSTAT Phase 2 D0Q1PS DRUG__ID D0Q1PS D0Q1PS HIGHSTAT Phase 2 D0Q8CV DRUG__ID D0Q8CV D0Q8CV HIGHSTAT Phase 2 D0T5YB DRUG__ID D0T5YB D0T5YB HIGHSTAT Phase 2 D0U1QE DRUG__ID D0U1QE D0U1QE HIGHSTAT Phase 2 D0V3LM DRUG__ID D0V3LM D0V3LM HIGHSTAT Phase 2 D0X8OW DRUG__ID D0X8OW D0X8OW HIGHSTAT Phase 2 D0ZT1L DRUG__ID D0ZT1L D0ZT1L HIGHSTAT Phase 2 D98UXE DRUG__ID D98UXE D98UXE HIGHSTAT Phase 2 DN9K2Y DRUG__ID DN9K2Y DN9K2Y HIGHSTAT Phase 2 D0OK4O DRUG__ID D0OK4O D0OK4O DRUGCOMP KV1.3 Therapeutics D0OK4O DRUGINCH 1S/C184H296N57O55PS7/c1-14-94(5)139-172(283)223-124(79-138(254)255)162(273)238-144(100(11)249)176(287)236-140(95(6)15-2)178(289)240-68-33-46-135(240)171(282)217-112(41-24-28-61-187)152(263)224-125(82-242)163(274)212-116(45-32-66-204-182(197)198)153(264)229-134-91-304-303-89-132-168(279)214-114(43-30-64-202-180(193)194)148(259)210-113(42-25-29-62-188)156(267)237-143(99(10)248)175(286)232-130(147(258)206-81-137(253)234-141(97(8)246)174(285)227-129(145(192)256)86-299-301-90-133(169(280)235-139)231-166(277)128(85-245)233-179(290)184(58-34-67-205-183(199)200,295-71-70-294-69-63-189)241(101(12)250)177(288)109(190)74-104-49-53-108(54-50-104)296-297(291,292)293)87-300-302-88-131(228-154(265)117(55-56-136(191)252)215-158(269)120(75-102-35-18-16-19-36-102)218-146(257)96(7)208-173(284)142(98(9)247)239-170(134)281)167(278)213-111(40-23-27-60-186)150(261)222-123(78-106-80-201-92-207-106)161(272)226-126(83-243)164(275)216-118(57-72-298-13)155(266)209-110(39-22-26-59-185)149(260)220-122(77-105-47-51-107(251)52-48-105)159(270)211-115(44-31-65-203-181(195)196)151(262)219-119(73-93(3)4)157(268)225-127(84-244)165(276)221-121(160(271)230-132)76-103-37-20-17-21-38-103/h16-21,35-38,47-54,80,92-100,109-135,139-144,242-249,251H,14-15,22-34,39-46,55-79,81-91,185-190H2,1-13H3,(H2,191,252)(H2,192,256)(H,201,207)(H,206,258)(H,208,284)(H,209,266)(H,210,259)(H,211,270)(H,212,274)(H,213,278)(H,214,279)(H,215,269)(H,216,275)(H,217,282)(H,218,257)(H,219,262)(H,220,260)(H,221,276)(H,222,261)(H,223,283)(H,224,263)(H,225,268)(H,226,272)(H,227,285)(H,228,265)(H,229,264)(H,230,271)(H,231,277)(H,232,286)(H,233,290)(H,234,253)(H,235,280)(H,236,287)(H,237,267)(H,238,273)(H,239,281)(H,254,255)(H4,193,194,202)(H4,195,196,203)(H4,197,198,204)(H4,199,200,205)(H2,291,292,293)/t94-,95-,96-,97+,98+,99+,100+,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130?,131-,132-,133-,134-,135-,139-,140-,141-,142-,143-,144-,184+/m0/s1 D0OK4O DRUGINKE GORAHSAIYZMTHZ-LBFSFEBVSA-N D0OK4O DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC3CSSCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC5=CC=CC=C5)CO)CC(C)C)CCCNC(=N)N)CC6=CC=C(C=C6)O)CCCCN)CCSC)CO)CC7=CNC=N7)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC3=O)C(C)O)C)CC8=CC=CC=C8)CCC(=O)N)C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)(N(C(=O)C)C(=O)C(CC9=CC=C(C=C9)OP(=O)(O)O)N)OCCOCCN)C(=O)N)C(C)O)C(C)O)CCCCN)CCCNC(=N)N)CCCNC(=N)N)CO)CCCCN)C(C)CC)C(C)O)CC(=O)O D0OK4O HIGHSTAT Phase 1b/2a D00BPH DRUG__ID D00BPH D00BPH DRUGCOMP Covagen/Johnson & Johnson D00BPH DRUGTYPE Monoclonal antibody D00BPH HIGHSTAT Phase 1/2a DE2Z7V DRUG__ID DE2Z7V DE2Z7V DRUGCOMP Bicycle Therapeutics DE2Z7V DRUGTYPE Bicycle toxin conjugate DE2Z7V HIGHSTAT Phase 1/2a D01XEO DRUG__ID D01XEO D01XEO DRUGCOMP Kineta D01XEO HIGHSTAT Phase 1b/2a D02ZUO DRUG__ID D02ZUO D02ZUO DRUGCOMP BioCryst Pharma. D02ZUO THERCLAS Anticancer Agents D02ZUO DRUGTYPE Small molecular drug D02ZUO DRUGINCH 1S/C11H14N4O4/c16-2-5-9(17)10(18)7(15-5)4-1-12-8-6(4)13-3-14-11(8)19/h1,3,5,7,9-10,12,15-18H,2H2,(H,13,14,19)/t5-,7+,9-,10+/m1/s1 D02ZUO DRUGINKE IWKXDMQDITUYRK-KUBHLMPHSA-N D02ZUO DRUGSMIL C1=C(C2=C(N1)C(=O)NC=N2)C3C(C(C(N3)CO)O)O D02ZUO HIGHSTAT Phase 1/2 D03YOS DRUG__ID D03YOS D03YOS DRUGCOMP Marshall Edwards D03YOS THERCLAS Anticancer Agents D03YOS DRUGTYPE Small molecular drug D03YOS DRUGINCH 1S/C15H12O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-8,16-17H,9H2 D03YOS DRUGINKE ZZUBHVMHNVYXRR-UHFFFAOYSA-N D03YOS DRUGSMIL C1C(=CC2=C(O1)C=C(C=C2)O)C3=CC=C(C=C3)O D03YOS HIGHSTAT Phase 1/2 D0G2QH DRUG__ID D0G2QH D0G2QH DRUGCOMP Novartis AG D0G2QH THERCLAS Anticancer Agents D0G2QH DRUGTYPE Small molecular drug D0G2QH DRUGINCH 1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1 D0G2QH DRUGINKE OONFNUWBHFSNBT-HXUWFJFHSA-N D0G2QH DRUGSMIL CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4NC(C)C5=CC=CC=C5 D0G2QH HIGHSTAT Phase 1/2 D00LHF DRUG__ID D00LHF D00LHF DRUGCOMP Gilead Sciences Inc D00LHF DRUGTYPE Small molecular drug D00LHF DRUGINCH 1S/C21H35N8O6P/c1-5-34-19(30)13(3)27-36(32,28-14(4)20(31)35-6-2)12-33-10-9-29-11-23-16-17(24-15-7-8-15)25-21(22)26-18(16)29/h11,13-15H,5-10,12H2,1-4H3,(H2,27,28,32)(H3,22,24,25,26)/t13-,14-/m0/s1 D00LHF DRUGINKE ANSPEDQTHURSFQ-KBPBESRZSA-N D00LHF DRUGSMIL CCOC(=O)C(C)NP(=O)(COCCN1C=NC2=C(N=C(N=C21)N)NC3CC3)NC(C)C(=O)OCC D00LHF HIGHSTAT Phase 1/2 D00MYW DRUG__ID D00MYW D00MYW DRUGCOMP Nippon Shinyaku D00MYW DRUGTYPE Small molecular drug D00MYW DRUGINCH 1S/C21H20FN7/c1-14(15-3-5-18(22)6-4-15)26-19-9-16(17-11-25-29(2)13-17)10-20(27-19)28-21-12-23-7-8-24-21/h3-14H,1-2H3,(H2,24,26,27,28)/t14-/m0/s1 D00MYW DRUGINKE UQTPDWDAYHAZNT-AWEZNQCLSA-N D00MYW DRUGSMIL CC(C1=CC=C(C=C1)F)NC2=CC(=CC(=N2)NC3=NC=CN=C3)C4=CN(N=C4)C D00MYW HIGHSTAT Phase 1/2 D02CZF DRUG__ID D02CZF D02CZF DRUGCOMP Incyte Corp D02CZF DRUGTYPE Small molecular drug D02CZF DRUGINCH 1S/C21H28N4O5/c1-30-20(28)25-14-21(7-8-21)13-16(18(26)22-29)17(25)19(27)24-11-9-23(10-12-24)15-5-3-2-4-6-15/h2-6,16-17,29H,7-14H2,1H3,(H,22,26)/t16-,17-/m0/s1 D02CZF DRUGINKE DJXMSZSZEIKLQZ-IRXDYDNUSA-N D02CZF DRUGSMIL COC(=O)N1CC2(CC2)CC(C1C(=O)N3CCN(CC3)C4=CC=CC=C4)C(=O)NO D02CZF HIGHSTAT Phase 1/2 D02DWK DRUG__ID D02DWK D02DWK DRUGCOMP Bridge BioResearch International Ltd D02DWK DRUGTYPE Small molecular drug D02DWK DRUGINCH 1S/C18H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(19)18(20)21/h9-10,17,19H,2-8,11-16H2,1H3,(H,20,21)/b10-9- D02DWK DRUGINKE JBSOOFITVPOOSY-KTKRTIGZSA-N D02DWK DRUGSMIL CCCCCCCCC=CCCCCCCC(C(=O)O)O D02DWK HIGHSTAT Phase 1/2 D02ECG DRUG__ID D02ECG D02ECG DRUGCOMP EmphyCorp Inc D02ECG DRUGTYPE Small molecular drug D02ECG DRUGINCH 1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1 D02ECG DRUGINKE DAEPDZWVDSPTHF-UHFFFAOYSA-M D02ECG DRUGSMIL CC(=O)C(=O)[O-].[Na+] D02ECG HIGHSTAT Phase 1/2 D02NNN DRUG__ID D02NNN D02NNN DRUGCOMP CanBas D02NNN DRUGTYPE Small molecular drug D02NNN DRUGINCH 1S/C86H122F5N29O17/c87-64-49(65(88)67(90)68(91)66(64)89)39-60(118-80(135)62(42-122)120-77(132)59(38-47-40-109-51-19-8-7-18-48(47)51)117-79(134)61(41-121)119-70(125)50(92)36-44-25-27-46(28-26-44)69(124)45-16-5-2-6-17-45)78(133)116-58(37-43-14-3-1-4-15-43)76(131)113-54(22-11-33-106-84(98)99)72(127)110-52(20-9-31-104-82(94)95)71(126)111-53(21-10-32-105-83(96)97)73(128)114-56(29-30-63(93)123)75(130)112-55(23-12-34-107-85(100)101)74(129)115-57(81(136)137)24-13-35-108-86(102)103/h2,5-8,16-19,25-28,40,43,50,52-62,109,121-122H,1,3-4,9-15,20-24,29-39,41-42,92H2,(H2,93,123)(H,110,127)(H,111,126)(H,112,130)(H,113,131)(H,114,128)(H,115,129)(H,116,133)(H,117,134)(H,118,135)(H,119,125)(H,120,132)(H,136,137)(H4,94,95,104)(H4,96,97,105)(H4,98,99,106)(H4,100,101,107)(H4,102,103,108)/t50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-/m1/s1 D02NNN DRUGINKE DEZJGRPRBZSAKI-KMGSDFBDSA-N D02NNN DRUGSMIL C1CCC(CC1)CC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC2=C(C(=C(C(=C2F)F)F)F)F)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)C(=O)C6=CC=CC=C6)N D02NNN HIGHSTAT Phase 1/2 D02YNI DRUG__ID D02YNI D02YNI DRUGCOMP Constellation pharmaceuticals D02YNI DRUGTYPE Small molecular drug D02YNI DRUGINCH 1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11,20,32H,12H2,1-3H3,(H,27,33)/t20-/m0/s1 D02YNI DRUGINKE GNMUEVRJHCWKTO-FQEVSTJZSA-N D02YNI DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C D02YNI HIGHSTAT Phase 1/2 D03BZN DRUG__ID D03BZN D03BZN DRUGCOMP Satiogen Pharmaceuticals Inc D03BZN DRUGTYPE Small molecular drug D03BZN DRUGINCH 1S/C26H45NO7S.Na/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29;/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34);/q;+1/p-1/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-;/m1./s1 D03BZN DRUGINKE JAJWGJBVLPIOOH-IZYKLYLVSA-M D03BZN DRUGSMIL CC(CCC(=O)NCCS(=O)(=O)[O-])C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C.[Na+] D03BZN HIGHSTAT Phase 1/2 D03ISJ DRUG__ID D03ISJ D03ISJ DRUGCOMP Bristol Myers Squibb D03ISJ DRUGTYPE Small molecular drug D03ISJ DRUGINCH 1S/C14H12ClN3O2/c15-7-3-4-10-8(6-7)11-12(20-10)14(19)18-13(17-11)9-2-1-5-16-9/h3-4,6,9,16H,1-2,5H2,(H,17,18,19)/t9-/m0/s1 D03ISJ DRUGINKE JJWLXRKVUJDJKG-VIFPVBQESA-N D03ISJ DRUGSMIL C1CC(NC1)C2=NC3=C(C(=O)N2)OC4=C3C=C(C=C4)Cl D03ISJ HIGHSTAT Phase 1/2 D03IXK DRUG__ID D03IXK D03IXK DRUGCOMP Mei pharma D03IXK DRUGTYPE Small molecular drug D03IXK DRUGINCH 1S/C22H20O4/c1-13-20(25)11-10-18-21(15-4-8-17(24)9-5-15)19(12-26-22(13)18)14-2-6-16(23)7-3-14/h2-11,19,21,23-25H,12H2,1H3/t19-,21-/m0/s1 D03IXK DRUGINKE QVCAATSEPLQVBX-FPOVZHCZSA-N D03IXK DRUGSMIL CC1=C(C=CC2=C1OCC(C2C3=CC=C(C=C3)O)C4=CC=C(C=C4)O)O D03IXK HIGHSTAT Phase 1/2 D03OVA DRUG__ID D03OVA D03OVA DRUGCOMP MD Anderson Cancer Center D03OVA DRUGTYPE Small molecular drug D03OVA DRUGINCH 1S/C10H12ClN5O4/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,13,14)/t3-,5-,6-,9-/m1/s1 D03OVA DRUGINKE MHDPPLULTMGBSI-UUOKFMHZSA-N D03OVA DRUGSMIL C1=NC(=C2C(=N1)N(C(=N2)Cl)C3C(C(C(O3)CO)O)O)N D03OVA HIGHSTAT Phase 1/2 D04AHY DRUG__ID D04AHY D04AHY DRUGCOMP Dart NeuroScience D04AHY DRUGTYPE Small molecular drug D04AHY DRUGINCH 1S/C21H13F3N2O/c22-21(23,24)14-7-6-8-15(13-14)25-19-17-11-4-5-12-18(17)26(20(19)27)16-9-2-1-3-10-16/h1-13H D04AHY DRUGINKE TXCGMRVPXUBHAL-UHFFFAOYSA-N D04AHY DRUGSMIL C1=CC=C(C=C1)N2C3=CC=CC=C3C(=NC4=CC=CC(=C4)C(F)(F)F)C2=O D04AHY HIGHSTAT Phase 1/2 D04EON DRUG__ID D04EON D04EON DRUGCOMP Basilea Pharmaceutica International Ltd D04EON DRUGTYPE Small molecular drug D04EON DRUGINCH 1S/C26H29N9O3/c27-13-4-3-6-19(29)26(37)31-18-11-9-17(10-12-18)22(36)16-35-21-8-2-1-7-20(21)32-25(35)23-24(34-38-33-23)30-15-5-14-28/h1-2,7-12,19H,3-6,13,15-16,27,29H2,(H,30,34)(H,31,37)/t19-/m0/s1 D04EON DRUGINKE NIPZLALJRAHABJ-IBGZPJMESA-N D04EON DRUGSMIL C1=CC=C2C(=C1)N=C(N2CC(=O)C3=CC=C(C=C3)NC(=O)C(CCCCN)N)C4=NON=C4NCCC#N D04EON HIGHSTAT Phase 1/2 D04MXN DRUG__ID D04MXN D04MXN DRUGCOMP Teva pharmaceutical D04MXN DRUGTYPE Small molecular drug D04MXN DRUGINCH 1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33) D04MXN DRUGINKE DKNUPRMJNUQNHR-UHFFFAOYSA-N D04MXN DRUGSMIL CC(C)(C1=CC(=NO1)NC(=O)NC2=CC(=CC=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(F)(F)F D04MXN HIGHSTAT Phase 1/2 D04RSR DRUG__ID D04RSR D04RSR DRUGCOMP EpiCept Tarrytown, NY D04RSR DRUGTYPE Small molecular drug D04RSR DRUGINCH 1S/C18H17BrN4O3/c1-24-13-6-8(5-11(19)17(13)25-2)14-9-3-4-12(21)15(22)16(9)26-18(23)10(14)7-20/h3-6,14H,21-23H2,1-2H3/t14-/m1/s1 D04RSR DRUGINKE JXONINOYTKKXQQ-CQSZACIVSA-N D04RSR DRUGSMIL COC1=C(C(=CC(=C1)C2C3=C(C(=C(C=C3)N)N)OC(=C2C#N)N)Br)OC D04RSR HIGHSTAT Phase 1/2 D05BIN DRUG__ID D05BIN D05BIN DRUGCOMP Pierre Fabre SA D05BIN DRUGTYPE Small molecular drug D05BIN DRUGINCH 1S/C33H47N5O8/c1-42-26-13-20(14-27(43-2)32(26)40)29-21-15-24-25(46-19-45-24)16-22(21)31(23-18-44-33(41)30(23)29)38-28(39)17-37-12-6-11-36-9-4-3-8-35-10-5-7-34/h13-16,23,29-31,35-37,40H,3-12,17-19,34H2,1-2H3,(H,38,39)/t23-,29+,30-,31+/m0/s1 D05BIN DRUGINKE NUZMJDHDPVKFJN-TYDXHICZSA-N D05BIN DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)NC(=O)CNCCCNCCCCNCCCN D05BIN HIGHSTAT Phase 1/2 D05CBJ DRUG__ID D05CBJ D05CBJ DRUGCOMP Chugai Pharmaceutical Co Ltd D05CBJ DRUGTYPE Small molecular drug D05CBJ DRUGINCH 1S/C15H19N7O3S/c1-26(23,24)22-3-2-11-12(10-8-17-14(16)18-9-10)19-15(20-13(11)22)21-4-6-25-7-5-21/h8-9H,2-7H2,1H3,(H2,16,17,18) D05CBJ DRUGINKE JEGHXKRHKHPBJD-UHFFFAOYSA-N D05CBJ DRUGSMIL CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N D05CBJ HIGHSTAT Phase 1/2 D05EXN DRUG__ID D05EXN D05EXN DRUGCOMP Celgene D05EXN DRUGTYPE Small molecular drug D05EXN DRUGINCH 1S/C21H27N5O3/c1-21(2,28)17-9-4-13(10-22-17)16-11-23-19-20(25-16)26(18(27)12-24-19)14-5-7-15(29-3)8-6-14/h4,9-11,14-15,28H,5-8,12H2,1-3H3,(H,23,24) D05EXN DRUGINKE UFKLYTOEMRFKAD-UHFFFAOYSA-N D05EXN DRUGSMIL CC(C)(C1=NC=C(C=C1)C2=CN=C3C(=N2)N(C(=O)CN3)C4CCC(CC4)OC)O D05EXN HIGHSTAT Phase 1/2 D05FBZ DRUG__ID D05FBZ D05FBZ DRUGCOMP F Hoffmann-La Roche Ltd D05FBZ DRUGTYPE Small molecular drug D05FBZ DRUGINCH 1S/C16H24N2O6/c19-13(17-9-3-5-11(17)15(21)22)7-1-2-8-14(20)18-10-4-6-12(18)16(23)24/h11-12H,1-10H2,(H,21,22)(H,23,24)/t11-,12-/m1/s1 D05FBZ DRUGINKE HZLAWYIBLZNRFZ-VXGBXAGGSA-N D05FBZ DRUGSMIL C1CC(N(C1)C(=O)CCCCC(=O)N2CCCC2C(=O)O)C(=O)O D05FBZ HIGHSTAT Phase 1/2 D05TMW DRUG__ID D05TMW D05TMW THERCLAS Antiviral Agents D05TMW DRUGTYPE Small molecular drug D05TMW DRUGINCH 1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1 D05TMW DRUGINKE FBOZXECLQNJBKD-ZDUSSCGKSA-N D05TMW DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D05TMW HIGHSTAT Phase 1/2 Trial D06GKR DRUG__ID D06GKR D06GKR THERCLAS Antiviral Agents D06GKR DRUGTYPE Small molecular drug D06GKR DRUGINCH 1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34) D06GKR DRUGINKE UBQYURCVBFRUQT-UHFFFAOYSA-N D06GKR DRUGSMIL CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O D06GKR HIGHSTAT Phase 1/2 Trial D06LFE DRUG__ID D06LFE D06LFE THERCLAS Antiviral Agents D06LFE DRUGTYPE Small molecular drug D06LFE DRUGINCH 1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) D06LFE DRUGINKE CGIGDMFJXJATDK-UHFFFAOYSA-N D06LFE DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O D06LFE HIGHSTAT Phase 1/2 Trial D06TKI DRUG__ID D06TKI D06TKI DRUGCOMP Chroma Therapeutics Ltd D06TKI DRUGTYPE Small molecular drug D06TKI DRUGINCH 1S/C20H19FN6O2/c21-13-2-4-17-11(5-13)1-3-14(25-17)8-22-18-15-9-27(10-16(15)18)20-23-6-12(7-24-20)19(28)26-29/h1-7,15-16,18,22,29H,8-10H2,(H,26,28)/t15-,16+,18? D06TKI DRUGINKE QRGHOAATPOLDPF-BYICEURKSA-N D06TKI DRUGSMIL C1C2C(C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO D06TKI HIGHSTAT Phase 1/2 D07CWH DRUG__ID D07CWH D07CWH DRUGCOMP Incyte D07CWH DRUGTYPE Small molecular drug D07CWH DRUGINCH 1S/C20H16FN7OS/c1-10-7-30-20-27-15(11(2)26-18-16-17(23-8-22-16)24-9-25-18)14(19(29)28(10)20)12-4-3-5-13(21)6-12/h3-9,11H,1-2H3,(H2,22,23,24,25,26)/t11-/m0/s1 D07CWH DRUGINKE RSIWALKZYXPAGW-NSHDSACASA-N D07CWH DRUGSMIL CC1=CSC2=NC(=C(C(=O)N12)C3=CC(=CC=C3)F)C(C)NC4=NC=NC5=C4NC=N5 D07CWH HIGHSTAT Phase 1/2 D07JRL DRUG__ID D07JRL D07JRL DRUGCOMP BioDiem Ltd D07JRL DRUGTYPE Small molecular drug D07JRL DRUGINCH 1S/C14H22N4O9/c1-6(15)12(25)17-7(2-3-9(19)20)14(27)18-8(4-10(21)22)13(26)16-5-11(23)24/h6-8H,2-5,15H2,1H3,(H,16,26)(H,17,25)(H,18,27)(H,19,20)(H,21,22)(H,23,24)/t6-,7-,8-/m0/s1 D07JRL DRUGINKE HGHOBRRUMWJWCU-FXQIFTODSA-N D07JRL DRUGSMIL CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NCC(=O)O)N D07JRL HIGHSTAT Phase 1/2 D07KDI DRUG__ID D07KDI D07KDI DRUGCOMP Arno Therapeutics D07KDI DRUGTYPE Small molecular drug D07KDI DRUGINCH 1S/C18H20N2O3/c1-12(2)16(13-6-4-3-5-7-13)18(22)19-15-10-8-14(9-11-15)17(21)20-23/h3-12,16,23H,1-2H3,(H,19,22)(H,20,21)/t16-/m0/s1 D07KDI DRUGINKE LAMIXXKAWNLXOC-INIZCTEOSA-N D07KDI DRUGSMIL CC(C)C(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO D07KDI HIGHSTAT Phase 1/2 D07MME DRUG__ID D07MME D07MME DRUGCOMP Santen D07MME DRUGTYPE Small molecular drug D07MME DRUGINCH 1S/C38H59FO6/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-34(43)45-26-33(42)38(44)27(2)23-31-30-20-19-28-24-29(40)21-22-35(28,3)37(30,39)32(41)25-36(31,38)4/h21-22,24,27,30-32,41,44H,5-20,23,25-26H2,1-4H3/t27-,30+,31+,32+,35+,36+,37+,38+/m1/s1 D07MME DRUGINKE WDPYZTKOEFDTCU-WDJQFAPHSA-N D07MME DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)O D07MME HIGHSTAT Phase 1/2 D07MPL DRUG__ID D07MPL D07MPL DRUGCOMP Serenex D07MPL DRUGTYPE Small molecular drug D07MPL DRUGINCH 1S/C25H30F3N5O4/c1-24(2)10-18-21(19(34)11-24)22(25(26,27)28)32-33(18)14-5-8-16(23(30)36)17(9-14)31-13-3-6-15(7-4-13)37-20(35)12-29/h5,8-9,13,15,31H,3-4,6-7,10-12,29H2,1-2H3,(H2,30,36) D07MPL DRUGINKE AVDSOVJPJZVBTC-UHFFFAOYSA-N D07MPL DRUGSMIL CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)OC(=O)CN)C(F)(F)F)C D07MPL HIGHSTAT Phase 1/2 D08BEA DRUG__ID D08BEA D08BEA DRUGCOMP Sapphire therapeutics D08BEA DRUGTYPE Small molecular drug D08BEA DRUGINCH 1S/C38H49N9O5/c1-38(2,41)37(52)47-32(21-28-22-42-23-43-28)36(51)46-31(20-25-15-16-26-12-6-7-13-27(26)18-25)35(50)45-30(19-24-10-4-3-5-11-24)34(49)44-29(33(40)48)14-8-9-17-39/h3-7,10-13,15-16,18,22-23,29-32H,8-9,14,17,19-21,39,41H2,1-2H3,(H2,40,48)(H,42,43)(H,44,49)(H,45,50)(H,46,51)(H,47,52)/t29-,30+,31+,32-/m0/s1 D08BEA DRUGINKE NEHWBYHLYZGBNO-BVEPWEIPSA-N D08BEA DRUGSMIL CC(C)(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCCN)C(=O)N)N D08BEA HIGHSTAT Phase 1/2 D08CDE DRUG__ID D08CDE D08CDE DRUGCOMP Migenix D08CDE DRUGTYPE Small molecular drug D08CDE DRUGINCH 1S/C12H21NO5/c1-2-3-9(15)18-8-6-13-5-4-7(14)10(13)12(17)11(8)16/h7-8,10-12,14,16-17H,2-6H2,1H3/t7-,8-,10+,11+,12+/m0/s1 D08CDE DRUGINKE HTJGLYIJVSDQAE-VWNXEWBOSA-N D08CDE DRUGSMIL CCCC(=O)OC1CN2CCC(C2C(C1O)O)O D08CDE HIGHSTAT Phase 1/2 D08EYQ DRUG__ID D08EYQ D08EYQ DRUGCOMP Millennium Pharmaceuticals Inc D08EYQ DRUGTYPE Small molecular drug D08EYQ DRUGINCH 1S/C19H23Cl2N3O4/c1-11(2)3-16(18(25)26)23-17(19(27)28)7-15-8-22-10-24(15)9-12-4-13(20)6-14(21)5-12/h4-6,8,10-11,16-17,23H,3,7,9H2,1-2H3,(H,25,26)(H,27,28)/t16-,17-/m0/s1 D08EYQ DRUGINKE NTCCRGGIJNDEAB-IRXDYDNUSA-N D08EYQ DRUGSMIL CC(C)CC(C(=O)O)NC(CC1=CN=CN1CC2=CC(=CC(=C2)Cl)Cl)C(=O)O D08EYQ HIGHSTAT Phase 1/2 D08FHZ DRUG__ID D08FHZ D08FHZ DRUGCOMP University of Virginia D08FHZ DRUGTYPE Small molecular drug D08FHZ DRUGINCH 1S/C23H29N7O6/c1-35-23(34)29-9-7-12(8-10-29)3-2-4-14-27-19(24)15-20(28-14)30(11-25-15)22-17(32)16(31)18(36-22)21(33)26-13-5-6-13/h11-13,16-18,22,31-32H,3,5-10H2,1H3,(H,26,33)(H2,24,27,28)/t16-,17+,18-,22+/m0/s1 D08FHZ DRUGINKE SQJXTUJMBYVDBB-RQXXJAGISA-N D08FHZ DRUGSMIL COC(=O)N1CCC(CC1)CC#CC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)C(=O)NC5CC5)O)O)N D08FHZ HIGHSTAT Phase 1/2 D08WOW DRUG__ID D08WOW D08WOW DRUGCOMP Eli Lilly D08WOW DRUGTYPE Small molecular drug D08WOW DRUGINCH 1S/C22H23F3N4O4/c1-13(27-17(31)8-9-22(23,24)25)20(32)28-18-15-6-3-2-5-14(15)16-7-4-10-26-19(16)29(11-12-30)21(18)33/h2-7,10,13,18,30H,8-9,11-12H2,1H3,(H,27,31)(H,28,32)/t13-,18-/m0/s1 D08WOW DRUGINKE YCBAQKQAINQRFW-UGSOOPFHSA-N D08WOW DRUGSMIL CC(C(=O)NC1C2=CC=CC=C2C3=C(N=CC=C3)N(C1=O)CCO)NC(=O)CCC(F)(F)F D08WOW HIGHSTAT Phase 1/2 D08WYH DRUG__ID D08WYH D08WYH DRUGCOMP Lilly D08WYH DRUGTYPE Small molecular drug D08WYH DRUGINCH 1S/C24H29FN6/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30) D08WYH DRUGINKE XPPBBJCBDOEXDN-UHFFFAOYSA-N D08WYH DRUGSMIL CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N D08WYH HIGHSTAT Phase 1/2 D09PSZ DRUG__ID D09PSZ D09PSZ DRUGCOMP University of Florida D09PSZ DRUGTYPE Small molecular drug D09PSZ DRUGINCH 1S/C11H11NO4S/c1-11(10(15)16)5-17-9(12-11)7-3-2-6(13)4-8(7)14/h2-4,13-14H,5H2,1H3,(H,15,16)/t11-/m1/s1 D09PSZ DRUGINKE OEUUFNIKLCFNLN-LLVKDONJSA-N D09PSZ DRUGSMIL CC1(CSC(=N1)C2=C(C=C(C=C2)O)O)C(=O)O D09PSZ HIGHSTAT Phase 1/2 D0A5XN DRUG__ID D0A5XN D0A5XN DRUGCOMP GE Healthcare D0A5XN DRUGTYPE Small molecular drug D0A5XN DRUGINCH 1S/C16H29N5O8.Dy/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+3/p-3 D0A5XN DRUGINKE ABWHOEHSTSEVRD-UHFFFAOYSA-K D0A5XN DRUGSMIL CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Dy+3] D0A5XN HIGHSTAT Phase 1/2 D0AD4H DRUG__ID D0AD4H D0AD4H DRUGCOMP Alseres Pharmaceuticals Purchased rights for Cethrin from BioAxone Therapeutic D0AD4H DRUGTYPE Small molecular drug D0AD4H DRUGINCH 1S/C23H30ClN3O.2ClH/c1-5-27(6-2)11-7-8-16(3)25-22-14-18(24)15-23-20(22)13-17-12-19(28-4)9-10-21(17)26-23;;/h9-10,12-16,25H,5-8,11H2,1-4H3;2*1H D0AD4H DRUGINKE QKAZHUGLNKCCGY-UHFFFAOYSA-N D0AD4H DRUGSMIL CCN(CC)CCCC(C)NC1=CC(=CC2=C1C=C3C=C(C=CC3=N2)OC)Cl.Cl.Cl D0AD4H HIGHSTAT Phase 1/2 D0C3ZR DRUG__ID D0C3ZR D0C3ZR DRUGCOMP TargeGen D0C3ZR DRUGTYPE Small molecular drug D0C3ZR DRUGINCH 1S/C18H14N6O2/c19-16-15-17(24-18(20)23-16)22-14(10-4-2-6-12(26)8-10)13(21-15)9-3-1-5-11(25)7-9/h1-8,25-26H,(H4,19,20,22,23,24) D0C3ZR DRUGINKE UJIAQDJKSXQLIT-UHFFFAOYSA-N D0C3ZR DRUGSMIL C1=CC(=CC(=C1)O)C2=NC3=C(N=C(N=C3N=C2C4=CC(=CC=C4)O)N)N D0C3ZR HIGHSTAT Phase 1/2 D0C6GK DRUG__ID D0C6GK D0C6GK DRUGCOMP Epizyme D0C6GK DRUGTYPE Small molecular drug D0C6GK DRUGINCH 1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(40)29(41-22)38-15-34-24-27(31)32-14-33-28(24)38)19-10-17(11-19)6-9-23-35-20-8-7-18(30(3,4)5)12-21(20)36-23/h7-8,12,14-17,19,22,25-26,29,39-40H,6,9-11,13H2,1-5H3,(H,35,36)(H2,31,32,33)/t17?,19?,22-,25-,26-,29-/m1/s1 D0C6GK DRUGINKE LXFOLMYKSYSZQS-XKHGBIBOSA-N D0C6GK DRUGSMIL CC(C)N(CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C D0C6GK HIGHSTAT Phase 1/2 D0D1CL DRUG__ID D0D1CL D0D1CL DRUGCOMP Ligand Pharmaceuticals D0D1CL DRUGTYPE Small molecular drug D0D1CL DRUGINCH 1S/C17H21N4O8P/c18-13-3-7-21(17(24)20-13)16-15(23)14(22)12(28-16)9-27-30(25)26-8-4-11(29-30)10-1-5-19-6-2-10/h1-3,5-7,11-12,14-16,22-23H,4,8-9H2,(H2,18,20,24)/t11-,12+,14+,15-,16+,30?/m0/s1 D0D1CL DRUGINKE HOAHIHGOMCBTFW-WUTQSZGESA-N D0D1CL DRUGSMIL C1COP(=O)(OC1C2=CC=NC=C2)OCC3C(C(C(O3)N4C=CC(=NC4=O)N)O)O D0D1CL HIGHSTAT Phase 1/2 D0D4LS DRUG__ID D0D4LS D0D4LS DRUGCOMP Pulmatrix D0D4LS DRUGTYPE Small molecular drug D0D4LS DRUGINCH 1S/C6H6N4O/c1-3-9-5-4(6(11)10-3)7-2-8-5/h2H,1H3,(H2,7,8,9,10,11) D0D4LS DRUGINKE JXLWCABYHOMQHE-UHFFFAOYSA-N D0D4LS DRUGSMIL CC1=NC2=C(C(=O)N1)NC=N2 D0D4LS HIGHSTAT Phase 1/2 D0D5TN DRUG__ID D0D5TN D0D5TN DRUGCOMP Benitec Ltd D0D5TN DRUGTYPE Small molecular drug D0D5TN DRUGINCH 1S/C11H15N5.ClH/c1-8(2)7-16-11(13-14-15-16)9-4-3-5-10(12)6-9;/h3-6,8H,7,12H2,1-2H3;1H D0D5TN DRUGINKE QRFDPUUTKDZZIX-UHFFFAOYSA-N D0D5TN DRUGSMIL CC(C)CN1C(=NN=N1)C2=CC(=CC=C2)N.Cl D0D5TN HIGHSTAT Phase 1/2 D0D9LJ DRUG__ID D0D9LJ D0D9LJ DRUGCOMP Callisto Pharm. D0D9LJ DRUGTYPE Small molecular drug D0D9LJ DRUGINCH 1S/C22H44N2/c1-5-10-21(11-6-2)12-14-22(15-13-21)16-19-24(20-22)18-9-17-23(7-3)8-4/h5-20H2,1-4H3 D0D9LJ DRUGINKE SERHTTSLBVGRBY-UHFFFAOYSA-N D0D9LJ DRUGSMIL CCCC1(CCC2(CC1)CCN(C2)CCCN(CC)CC)CCC D0D9LJ HIGHSTAT Phase 1/2 D0DC6U DRUG__ID D0DC6U D0DC6U DRUGCOMP International Partnership for Microbicides, Inc. D0DC6U DRUGTYPE Small molecular drug D0DC6U DRUGINCH 1S/C20H19N5/c1-13-10-14(2)19(15(3)11-13)24-18-8-9-22-20(25-18)23-17-6-4-16(12-21)5-7-17/h4-11H,1-3H3,(H2,22,23,24,25) D0DC6U DRUGINKE ILAYIAGXTHKHNT-UHFFFAOYSA-N D0DC6U DRUGSMIL CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C D0DC6U HIGHSTAT Phase 1/2 D0E0NM DRUG__ID D0E0NM D0E0NM DRUGCOMP Deciphera Pharmaceuticals D0E0NM DRUGTYPE Small molecular drug D0E0NM DRUGINCH 1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40) D0E0NM DRUGINKE WVXNSAVVKYZVOE-UHFFFAOYSA-N D0E0NM DRUGSMIL CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5 D0E0NM HIGHSTAT Phase 1/2 D0E6UZ DRUG__ID D0E6UZ D0E6UZ DRUGCOMP Curis D0E6UZ DRUGTYPE Small molecular drug D0E6UZ DRUGINCH 1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32) D0E6UZ DRUGINKE JOWXJLIFIIOYMS-UHFFFAOYSA-N D0E6UZ DRUGSMIL CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO D0E6UZ HIGHSTAT Phase 1/2 D0F6TV DRUG__ID D0F6TV D0F6TV DRUGCOMP Vertex Pharmaceuticals D0F6TV DRUGTYPE Small molecular drug D0F6TV DRUGINCH 1S/C43H45ClN4O6.2CH4O3S/c1-47(43(51)40(49)34-27-38(52-2)41(54-4)39(28-34)53-3)37(26-32-10-14-35(44)15-11-32)42(50)48(29-33-8-6-5-7-9-33)36(16-12-30-18-22-45-23-19-30)17-13-31-20-24-46-25-21-31;2*1-5(2,3)4/h5-11,14-15,18-25,27-28,36-37H,12-13,16-17,26,29H2,1-4H3;2*1H3,(H,2,3,4)/t37-;;/m0../s1 D0F6TV DRUGINKE LXIAWDJOQUWVQS-SHRURHRBSA-N D0F6TV DRUGSMIL CN(C(CC1=CC=C(C=C1)Cl)C(=O)N(CC2=CC=CC=C2)C(CCC3=CC=NC=C3)CCC4=CC=NC=C4)C(=O)C(=O)C5=CC(=C(C(=C5)OC)OC)OC.CS(=O)(=O)O.CS(=O)(=O)O D0F6TV HIGHSTAT Phase 1/2 D0GL7H DRUG__ID D0GL7H D0GL7H DRUGCOMP Hana Biosciences; Dana-Farber Cancer Institute Inc D0GL7H DRUGTYPE Small molecular drug D0GL7H DRUGINCH 1S/C27H27N9O6/c28-21-20-22(36-27(29)35-21)32-13-16(33-20)12-31-15-9-7-14(8-10-15)23(37)34-19(26(41)42)6-3-11-30-24(38)17-4-1-2-5-18(17)25(39)40/h1-2,4-5,7-10,13,19,31H,3,6,11-12H2,(H,30,38)(H,34,37)(H,39,40)(H,41,42)(H4,28,29,32,35,36)/t19-/m0/s1 D0GL7H DRUGINKE NYQPLPNEESYGNO-IBGZPJMESA-N D0GL7H DRUGSMIL C1=CC=C(C(=C1)C(=O)NCCCC(C(=O)O)NC(=O)C2=CC=C(C=C2)NCC3=CN=C4C(=N3)C(=NC(=N4)N)N)C(=O)O D0GL7H HIGHSTAT Phase 1/2 D0IV4C DRUG__ID D0IV4C D0IV4C DRUGCOMP MD Anderson Cancer Center D0IV4C DRUGTYPE Small molecular drug D0IV4C DRUGINCH 1S/C17H14BrN3O/c1-12(13-6-3-2-4-7-13)20-17(22)14(11-19)10-15-8-5-9-16(18)21-15/h2-10,12H,1H3,(H,20,22)/b14-10+/t12-/m0/s1 D0IV4C DRUGINKE VFUAJMPDXIRPKO-LQELWAHVSA-N D0IV4C DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C(=CC2=NC(=CC=C2)Br)C#N D0IV4C HIGHSTAT Phase 1/2 D0L9PA DRUG__ID D0L9PA D0L9PA DRUGCOMP Xcovery D0L9PA DRUGTYPE Small molecular drug D0L9PA DRUGINCH 1S/C25H25Cl2FN6O3/c1-14(21-17(26)7-8-18(28)22(21)27)37-20-13-19(31-32-23(20)29)24(35)30-16-5-3-15(4-6-16)25(36)34-11-9-33(2)10-12-34/h3-8,13-14H,9-12H2,1-2H3,(H2,29,32)(H,30,35)/t14-/m1/s1 D0L9PA DRUGINKE ONPGOSVDVDPBCY-CQSZACIVSA-N D0L9PA DRUGSMIL CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC(=NN=C2N)C(=O)NC3=CC=C(C=C3)C(=O)N4CCN(CC4)C D0L9PA HIGHSTAT Phase 1/2 D0N2GC DRUG__ID D0N2GC D0N2GC DRUGCOMP Bristol-Myers Squibb Co D0N2GC DRUGTYPE Small molecular drug D0N2GC DRUGINCH 1S/C67H92N16O22S3/c1-32-9-7-11-45-46(26-47(33(2)23-38-30-106-35(4)74-38)105-52(90)27-48(84)67(5,6)55(92)34(3)54(32)91)83(45)19-20-103-66(102)104-21-22-107-108-31-44(63(100)101)80-60(96)43(25-51(88)89)79-58(94)40(10-8-18-71-64(68)69)77-59(95)42(24-50(86)87)76-49(85)17-16-41(62(98)99)78-57(93)36-12-14-37(15-13-36)72-28-39-29-73-56-53(75-39)61(97)82-65(70)81-56/h12-15,23,29-30,32,34,40-48,54,72,84,91H,7-11,16-22,24-28,31H2,1-6H3,(H,76,85)(H,77,95)(H,78,93)(H,79,94)(H,80,96)(H,86,87)(H,88,89)(H,98,99)(H,100,101)(H4,68,69,71)(H3,70,73,81,82,97)/b33-23+/t32-,34+,40-,41-,42-,43-,44-,45+,46-,47-,48-,54-,83?/m0/s1 D0N2GC DRUGINKE TURJYGRXEJIBGT-OCOMGVANSA-N D0N2GC DRUGSMIL CC1CCCC2C(N2CCOC(=O)OCCSSCC(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)CCC(C(=O)O)NC(=O)C3=CC=C(C=C3)NCC4=CN=C5C(=N4)C(=O)NC(=N5)N)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC6=CSC(=N6)C)C D0N2GC HIGHSTAT Phase 1/2 D0N4HQ DRUG__ID D0N4HQ D0N4HQ DRUGCOMP OXiGENE South D0N4HQ DRUGTYPE Small molecular drug D0N4HQ DRUGINCH 1S/C18H22O12P2.4Na/c1-25-13-8-7-12(16(29-31(19,20)21)18(13)30-32(22,23)24)6-5-11-9-14(26-2)17(28-4)15(10-11)27-3;;;;/h5-10H,1-4H3,(H2,19,20,21)(H2,22,23,24);;;;/q;4*+1/p-4/b6-5-;;;; D0N4HQ DRUGINKE NRKFVEPAQNCYNJ-YGGCHVFLSA-J D0N4HQ DRUGSMIL COC1=C(C(=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)([O-])[O-])OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Na+] D0N4HQ HIGHSTAT Phase 1/2 D0N4IV DRUG__ID D0N4IV D0N4IV DRUGCOMP Shionogi & Co Ltd D0N4IV DRUGTYPE Small molecular drug D0N4IV DRUGINCH 1S/C24H20N2O4S2/c1-16-6-8-17(9-7-16)10-11-19-12-13-23(31-19)32(29,30)26-22(24(27)28)14-18-15-25-21-5-3-2-4-20(18)21/h2-9,12-13,15,22,25-26H,14H2,1H3,(H,27,28)/t22-/m1/s1 D0N4IV DRUGINKE YWCLDDLVLSQGSZ-JOCHJYFZSA-N D0N4IV DRUGSMIL CC1=CC=C(C=C1)C#CC2=CC=C(S2)S(=O)(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O D0N4IV HIGHSTAT Phase 1/2 D0O6HP DRUG__ID D0O6HP D0O6HP DRUGCOMP KAI Pharma. D0O6HP DRUGTYPE Small molecular drug D0O6HP DRUGINCH 1S/C120H199N45O34S2/c1-61(2)48-80(96(179)145-55-92(174)148-86(56-166)110(193)163-85(114(198)199)49-62(3)4)159-106(189)78(37-39-93(175)176)156-107(190)83(52-65-30-34-67(170)35-31-65)161-112(195)88(58-168)165-109(192)84(53-90(126)172)162-108(191)82(50-63-18-6-5-7-19-63)160-111(194)87(57-167)164-95(178)69(124)60-201-200-59-68(123)94(177)158-81(51-64-28-32-66(169)33-29-64)97(180)146-54-91(173)147-70(22-12-42-139-115(127)128)98(181)149-71(20-8-10-40-121)99(182)150-72(21-9-11-41-122)100(183)151-73(23-13-43-140-116(129)130)101(184)152-75(25-15-45-142-118(133)134)103(186)155-77(36-38-89(125)171)105(188)154-74(24-14-44-141-117(131)132)102(185)153-76(26-16-46-143-119(135)136)104(187)157-79(113(196)197)27-17-47-144-120(137)138/h5-7,18-19,28-35,61-62,68-88,166-170H,8-17,20-27,36-60,121-124H2,1-4H3,(H2,125,171)(H2,126,172)(H,145,179)(H,146,180)(H,147,173)(H,148,174)(H,149,181)(H,150,182)(H,151,183)(H,152,184)(H,153,185)(H,154,188)(H,155,186)(H,156,190)(H,157,187)(H,158,177)(H,159,189)(H,160,194)(H,161,195)(H,162,191)(H,163,193)(H,164,178)(H,165,192)(H,175,176)(H,196,197)(H,198,199)(H4,127,128,139)(H4,129,130,140)(H4,131,132,141)(H4,133,134,142)(H4,135,136,143)(H4,137,138,144)/t68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-/m0/s1 D0O6HP DRUGINKE XPXZTVWPRKJTAA-PJKOMPQUSA-N D0O6HP DRUGSMIL CC(C)CC(C(=O)NCC(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CSSCC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)N)N D0O6HP HIGHSTAT Phase 1/2 D0Q7JC DRUG__ID D0Q7JC D0Q7JC DRUGCOMP Parion Sciences Inc D0Q7JC DRUGTYPE Small molecular drug D0Q7JC DRUGINCH 1S/C19H26ClN7O4/c20-15-17(22)26-16(21)14(25-15)18(30)27-19(23)24-8-2-1-3-11-4-6-13(7-5-11)31-10-12(29)9-28/h4-7,12,28-29H,1-3,8-10H2,(H4,21,22,26)(H3,23,24,27,30) D0Q7JC DRUGINKE NTRKMGDUWYBLMS-UHFFFAOYSA-N D0Q7JC DRUGSMIL C1=CC(=CC=C1CCCCN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N)OCC(CO)O D0Q7JC HIGHSTAT Phase 1/2 D0QK5C DRUG__ID D0QK5C D0QK5C DRUGCOMP Eli Lilly D0QK5C DRUGTYPE Small molecular drug D0QK5C DRUGINCH 1S/C19H20F6N5O5PS/c1-32-12-2-4-13(5-3-12)37-16-14-15(28-17(26)29-16)30(10-27-14)6-7-33-11-36(31,34-8-18(20,21)22)35-9-19(23,24)25/h2-5,10H,6-9,11H2,1H3,(H2,26,28,29) D0QK5C DRUGINKE VDBGPMJFHCJMOL-UHFFFAOYSA-N D0QK5C DRUGSMIL COC1=CC=C(C=C1)SC2=NC(=NC3=C2N=CN3CCOCP(=O)(OCC(F)(F)F)OCC(F)(F)F)N D0QK5C HIGHSTAT Phase 1/2 D0S6JV DRUG__ID D0S6JV D0S6JV DRUGCOMP Menarini D0S6JV DRUGTYPE Small molecular drug D0S6JV DRUGINCH 1S/C45H60N10O14/c1-21(2)13-31(45(67)68)53-43(66)32-19-48-34(58)17-30(50-39(62)26(46)16-35(59)55-44-36(49-22(3)57)38(61)37(60)33(20-56)69-44)42(65)52-29(15-24-18-47-27-12-8-7-11-25(24)27)41(64)51-28(40(63)54-32)14-23-9-5-4-6-10-23/h4-12,18,21,26,28-33,36-38,44,47,56,60-61H,13-17,19-20,46H2,1-3H3,(H,48,58)(H,49,57)(H,50,62)(H,51,64)(H,52,65)(H,53,66)(H,54,63)(H,55,59)(H,67,68)/t26-,28-,29-,30-,31-,32-,33+,36+,37+,38+,44+/m0/s1 D0S6JV DRUGINKE NPSVXOVMLVOMDD-SXRVEDALSA-N D0S6JV DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C1CNC(=O)CC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)NC(=O)C(CC(=O)NC5C(C(C(C(O5)CO)O)O)NC(=O)C)N D0S6JV HIGHSTAT Phase 1/2 D0SN1T DRUG__ID D0SN1T D0SN1T DRUGCOMP Bayer AG D0SN1T DRUGTYPE Small molecular drug D0SN1T DRUGINCH 1S/C20H25N5O10/c1-7(13(28)9-3-2-8(26)6-22-9)11(21)17(31)24-12(19(32)33)16-14(29)15(30)18(35-16)25-5-4-10(27)23-20(25)34/h2-7,11-16,18,26,28-30H,21H2,1H3,(H,24,31)(H,32,33)(H,23,27,34)/t7-,11-,12-,13-,14-,15+,16+,18+/m0/s1 D0SN1T DRUGINKE WWJFFVUVFNBJTN-VHDFTHOZSA-N D0SN1T DRUGSMIL CC(C(C1=NC=C(C=C1)O)O)C(C(=O)NC(C2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)C(=O)O)N D0SN1T HIGHSTAT Phase 1/2 D0SY7H DRUG__ID D0SY7H D0SY7H DRUGCOMP Idenix Pharmaceuticals Inc D0SY7H DRUGTYPE Small molecular drug D0SY7H DRUGINCH 1S/C25H35N6O9PS/c1-24(2,13-32)22(35)42-10-9-38-41(37,28-11-15-7-5-4-6-8-15)39-12-16-18(33)25(3,36)21(40-16)31-14-27-17-19(31)29-23(26)30-20(17)34/h4-8,14,16,18,21,32-33,36H,9-13H2,1-3H3,(H,28,37)(H3,26,29,30,34)/t16-,18-,21-,25-,41?/m1/s1 D0SY7H DRUGINKE FGHMGRXAHIXTBM-TWFJNEQDSA-N D0SY7H DRUGSMIL CC1(C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(NCC4=CC=CC=C4)OCCSC(=O)C(C)(C)CO)O)O D0SY7H HIGHSTAT Phase 1/2 D0U9LT DRUG__ID D0U9LT D0U9LT DRUGCOMP Mitsubishi Pharma Corp D0U9LT DRUGTYPE Small molecular drug D0U9LT DRUGINCH 1S/C16H16N4O/c1-10(17)11-2-4-12(5-3-11)16(21)20-14-7-9-19-15-13(14)6-8-18-15/h2-10H,17H2,1H3,(H2,18,19,20,21)/t10-/m1/s1 D0U9LT DRUGINKE JTVBXQAYBIJXRP-SNVBAGLBSA-N D0U9LT DRUGSMIL CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N D0U9LT HIGHSTAT Phase 1/2 D0W0SL DRUG__ID D0W0SL D0W0SL DRUGCOMP Lilly D0W0SL DRUGTYPE Small molecular drug D0W0SL DRUGINCH 1S/C26H24F4N6O/c1-34(25(37)20-8-7-16(27)15-21(20)26(28,29)30)17-10-13-36(14-11-17)24-19-6-4-3-5-18(19)23(32-33-24)22-9-12-31-35(22)2/h3-9,12,15,17H,10-11,13-14H2,1-2H3 D0W0SL DRUGINKE SZBGQDXLNMELTB-UHFFFAOYSA-N D0W0SL DRUGSMIL CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F D0W0SL HIGHSTAT Phase 1/2 D0X7IN DRUG__ID D0X7IN D0X7IN DRUGCOMP Novartis D0X7IN DRUGTYPE Small molecular drug D0X7IN DRUGINCH 1S/C28H25F3N6O2/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36/h3-8,13-16,32H,9-12H2,1-2H3 D0X7IN DRUGINKE BMMXYEBLEBULND-UHFFFAOYSA-N D0X7IN DRUGSMIL CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4=CC(=C(C=C4)N5CCNCC5)C(F)(F)F)C6=CN=C(C=C6)OC D0X7IN HIGHSTAT Phase 1/2 D0X8SY DRUG__ID D0X8SY D0X8SY DRUGCOMP University of Florida D0X8SY DRUGTYPE Small molecular drug D0X8SY DRUGINCH 1S/C14H15BrN4O/c1-8-12-13(18-17-8)10-7-9(15)3-4-11(10)19(14(12)20)6-2-5-16/h3-4,7H,2,5-6,16H2,1H3,(H,17,18) D0X8SY DRUGINKE LLKFNPUXQZHIAE-UHFFFAOYSA-N D0X8SY DRUGSMIL CC1=C2C(=NN1)C3=C(C=CC(=C3)Br)N(C2=O)CCCN D0X8SY HIGHSTAT Phase 1/2 D0Y1NC DRUG__ID D0Y1NC D0Y1NC DRUGCOMP LEO Pharma A/S D0Y1NC DRUGTYPE Small molecular drug D0Y1NC DRUGINCH 1S/C19H22ClN5O/c20-16-5-7-18(8-6-16)26-14-4-2-1-3-11-23-19(24-15-21)25-17-9-12-22-13-10-17/h5-10,12-13H,1-4,11,14H2,(H2,22,23,24,25) D0Y1NC DRUGINKE BOIPLTNGIAPDBY-UHFFFAOYSA-N D0Y1NC DRUGSMIL C1=CC(=CC=C1OCCCCCCN=C(NC#N)NC2=CC=NC=C2)Cl D0Y1NC HIGHSTAT Phase 1/2 D0Y3AG DRUG__ID D0Y3AG D0Y3AG DRUGCOMP IPF PharmaCeuticals GmbH D0Y3AG DRUGTYPE Small molecular drug D0Y3AG DRUGINCH 1S/C224H322N42O51S2/c1-23-131(17)183(255-187(279)135(21)230-192(284)146(89-93-177(271)272)234-189(281)145(227)107-125(5)6)220(312)263-103-59-85-171(263)212(304)251-165-123-318-319-124-166(207(299)250-164(122-268)205(297)258-186(134(20)26-4)223(315)266-106-62-88-174(266)219(311)262-102-58-84-170(262)209(301)237-149(92-96-180(277)278)195(287)244-158(114-140-69-41-30-42-70-140)200(292)240-154(110-128(11)12)198(290)242-156(112-138-65-37-28-38-66-138)191(283)229-120-176(270)233-151(80-52-54-98-226)217(309)260-100-56-82-168(260)211(303)246-161(117-143-75-47-33-48-76-143)203(295)254-182(130(15)16)215(307)248-162(224(316)317)118-144-77-49-34-50-78-144)252-213(305)172-86-60-104-264(172)221(313)184(132(18)24-2)256-188(280)136(22)231-193(285)147(90-94-178(273)274)235-196(288)152(108-126(7)8)238-201(293)159(115-141-71-43-31-44-72-141)247-214(306)181(129(13)14)253-202(294)160(116-142-73-45-32-46-74-142)245-210(302)167-81-55-99-259(167)216(308)150(79-51-53-97-225)232-175(269)119-228-190(282)155(111-137-63-35-27-36-64-137)241-197(289)153(109-127(9)10)239-199(291)157(113-139-67-39-29-40-68-139)243-194(286)148(91-95-179(275)276)236-208(300)169-83-57-101-261(169)218(310)173-87-61-105-265(173)222(314)185(133(19)25-3)257-204(296)163(121-267)249-206(165)298/h27-50,63-78,125-136,145-174,181-186,267-268H,23-26,51-62,79-124,225-227H2,1-22H3,(H,228,282)(H,229,283)(H,230,284)(H,231,285)(H,232,269)(H,233,270)(H,234,281)(H,235,288)(H,236,300)(H,237,301)(H,238,293)(H,239,291)(H,240,292)(H,241,289)(H,242,290)(H,243,286)(H,244,287)(H,245,302)(H,246,303)(H,247,306)(H,248,307)(H,249,298)(H,250,299)(H,251,304)(H,252,305)(H,253,294)(H,254,295)(H,255,279)(H,256,280)(H,257,296)(H,258,297)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,316,317)/t131-,132-,133-,134-,135-,136-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,181-,182-,183-,184-,185-,186-/m0/s1 D0Y3AG DRUGINKE QMLQPHUSDUODMB-MFQMBSFASA-N D0Y3AG DRUGSMIL CCC(C)C1C(=O)N2CCCC2C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)CCC(=O)O)CC(C)C)CC6=CC=CC=C6)C(C)C)CC7=CC=CC=C7)CCCCN)CC8=CC=CC=C8)CC(C)C)CC9=CC=CC=C9)CCC(=O)O)C(C)CC)CO)NC(=O)C1CCCN1C(=O)C(C(C)CC)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)N)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)N1CCCC1C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)NCC(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)O D0Y3AG HIGHSTAT Phase 1/2 D0Y8AW DRUG__ID D0Y8AW D0Y8AW DRUGCOMP Cougar Biotechnology D0Y8AW DRUGTYPE Small molecular drug D0Y8AW DRUGINCH 1S/C22H23NO7/c1-23-8-7-11-9-14-20(29-10-28-14)21(27-4)15(11)17(23)18-12-5-6-13(25-2)19(26-3)16(12)22(24)30-18/h5-6,9,17-18H,7-8,10H2,1-4H3/t17-,18+/m1/s1 D0Y8AW DRUGINKE AKNNEGZIBPJZJG-MSOLQXFVSA-N D0Y8AW DRUGSMIL CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3 D0Y8AW HIGHSTAT Phase 1/2 D0Z7BX DRUG__ID D0Z7BX D0Z7BX DRUGCOMP GlaxoSmithKline D0Z7BX DRUGTYPE Small molecular drug D0Z7BX DRUGINCH 1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1 D0Z7BX DRUGINKE ATQAGKAMBISZQM-HNNXBMFYSA-N D0Z7BX DRUGSMIL C1CC2=C(C(=CC(=C2)F)F)NC(=O)C1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4 D0Z7BX HIGHSTAT Phase 1/2 D1MK7G DRUG__ID D1MK7G D1MK7G DRUGCOMP Aridis Pharmaceuticals D1MK7G DRUGTYPE Small molecular drug D1MK7G DRUGINCH 1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3 D1MK7G DRUGINKE YEEGWNXDUZONAA-UHFFFAOYSA-K D1MK7G DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ga+3] D1MK7G HIGHSTAT Phase 1/2 D28HJI DRUG__ID D28HJI D28HJI DRUGCOMP FUJIFILM Pharmaceuticals D28HJI DRUGTYPE Small molecular drug D28HJI DRUGINCH 1S/C29H38N8O2/c1-6-17-31-27-24(21-33-29(35-27)34-25-15-13-23(20-30)14-16-25)11-8-7-9-18-32-28(39)22(2)37(5)26(38)12-10-19-36(3)4/h10,12-16,21-22H,6-7,9,17-19H2,1-5H3,(H,32,39)(H2,31,33,34,35)/b12-10+/t22-/m0/s1 D28HJI DRUGINKE HJFSVYUFOXAVAA-YUAYGMJFSA-N D28HJI DRUGSMIL CCCNC1=NC(=NC=C1C#CCCCNC(=O)C(C)N(C)C(=O)C=CCN(C)C)NC2=CC=C(C=C2)C#N D28HJI HIGHSTAT Phase 1/2 D2Y7ZG DRUG__ID D2Y7ZG D2Y7ZG DRUGCOMP Ascentage Pharma D2Y7ZG DRUGTYPE Small molecular drug D2Y7ZG DRUGINCH 1S/C45H48ClN7O8S/c46-33-4-2-30(3-5-33)39-25-45(12-1-13-45)14-10-32(39)28-51-16-18-52(19-17-51)34-6-8-38(42(23-34)61-35-22-31-11-15-47-43(31)49-26-35)44(54)50-62(57,58)37-7-9-40(41(24-37)53(55)56)48-27-36-29-59-20-21-60-36/h2-9,11,15,22-24,26,36,48H,1,10,12-14,16-21,25,27-29H2,(H,47,49)(H,50,54)/t36-/m0/s1 D2Y7ZG DRUGINKE FNBXDBIYRAPDPI-BHVANESWSA-N D2Y7ZG DRUGSMIL C1CC2(C1)CCC(=C(C2)C3=CC=C(C=C3)Cl)CN4CCN(CC4)C5=CC(=C(C=C5)C(=O)NS(=O)(=O)C6=CC(=C(C=C6)NCC7COCCO7)[N+](=O)[O-])OC8=CN=C9C(=C8)C=CN9 D2Y7ZG HIGHSTAT Phase 1/2 D39TVC DRUG__ID D39TVC D39TVC DRUGCOMP Mundipharma D39TVC DRUGTYPE Small molecule D39TVC DRUGINCH InChI=1S/C19H28Cl2N4O2/c1-24-17-9-8-15(25(12-10-20)13-11-21)14-16(17)22-18(24)6-4-2-3-5-7-19(26)23-27/h8-9,14,27H,2-7,10-13H2,1H3,(H,23,26) D39TVC DRUGINKE GISXTRIGVCKQBX-UHFFFAOYSA-N D39TVC DRUGSMIL CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO D39TVC HIGHSTAT Phase 1/2 D3QEZ2 DRUG__ID D3QEZ2 D3QEZ2 DRUGCOMP Eli Lilly D3QEZ2 DRUGTYPE Small molecular drug D3QEZ2 DRUGINCH 1S/C24H26ClF2N5O2/c1-14-10-21(31-30-14)29-20-7-6-18(26)19(28-20)12-24(23(33)34)8-9-32(15(2)11-24)13-16-4-3-5-17(25)22(16)27/h3-7,10,15H,8-9,11-13H2,1-2H3,(H,33,34)(H2,28,29,30,31)/t15-,24-/m1/s1 D3QEZ2 DRUGINKE YQQZZYYQTCPEAS-OYLFLEFRSA-N D3QEZ2 DRUGSMIL CC1CC(CCN1CC2=C(C(=CC=C2)Cl)F)(CC3=C(C=CC(=N3)NC4=NNC(=C4)C)F)C(=O)O D3QEZ2 HIGHSTAT Phase 1/2 D3XE7Y DRUG__ID D3XE7Y D3XE7Y DRUGCOMP Arvinas D3XE7Y DRUGTYPE Small molecule D3XE7Y DRUGINCH InChI=1S/C45H54FN7O6/c1-44(2)42(45(3,4)43(44)59-33-12-8-30(26-47)37(25-33)58-5)50-39(55)29-6-9-31(10-7-29)52-18-16-28(17-19-52)27-51-20-22-53(23-21-51)32-11-13-34(35(46)24-32)40(56)48-36-14-15-38(54)49-41(36)57/h6-13,24-25,28,36,42-43H,14-23,27H2,1-5H3,(H,48,56)(H,50,55)(H,49,54,57)/t36-,42?,43?/m0/s1 D3XE7Y DRUGINKE RDPPBRKNBBXPNZ-PJXMSJPKSA-N D3XE7Y DRUGSMIL CC1(C(C(C1OC2=CC(=C(C=C2)C#N)OC)(C)C)NC(=O)C3=CC=C(C=C3)N4CCC(CC4)CN5CCN(CC5)C6=CC(=C(C=C6)C(=O)NC7CCC(=O)NC7=O)F)C D3XE7Y HIGHSTAT Phase 1/2 D4Y0IM DRUG__ID D4Y0IM D4Y0IM DRUGCOMP Incyte D4Y0IM DRUGTYPE Small molecular drug D4Y0IM DRUGINCH 1S/C19H16N4O3/c1-10-16(11(2)26-22-10)12-6-7-14-17-18(12)25-9-15(23(17)19(24)21-14)13-5-3-4-8-20-13/h3-8,15H,9H2,1-2H3,(H,21,24)/t15-/m1/s1 D4Y0IM DRUGINKE XYLPKCDRAAYATL-OAHLLOKOSA-N D4Y0IM DRUGSMIL CC1=C(C(=NO1)C)C2=C3C4=C(C=C2)NC(=O)N4C(CO3)C5=CC=CC=N5 D4Y0IM HIGHSTAT Phase 1/2 D5I9EV DRUG__ID D5I9EV D5I9EV DRUGCOMP University of Ibadan D5I9EV DRUGTYPE Small molecule D5I9EV DRUGINCH InChI=1S/C22H32O5/c1-12-15(24)9-14-10-18-21(5,27-18)8-7-17-22(6,26-17)11-16(25-13(2)23)19(12)20(14,3)4/h14,16-19H,1,7-11H2,2-6H3/t14-,16+,17-,18-,19-,21-,22-/m0/s1 D5I9EV DRUGINKE HNPAHGHFONBTLV-KSJQNFQUSA-N D5I9EV DRUGSMIL CC(=O)OC1CC2(C(O2)CCC3(C(O3)CC4CC(=O)C(=C)C1C4(C)C)C)C D5I9EV HIGHSTAT Phase 1/2 D7FJQ3 DRUG__ID D7FJQ3 D7FJQ3 DRUGCOMP Incyte D7FJQ3 DRUGTYPE Small molecular drug D7FJQ3 DRUGINCH 1S/C20H21N3O5S/c1-20(2)19(25)23(4)15-9-11(29(5,26)27)8-13(17(15)28-20)14-10-22(3)18(24)16-12(14)6-7-21-16/h6-10,21H,1-5H3 D7FJQ3 DRUGINKE VZSAMEOETVNDQH-UHFFFAOYSA-N D7FJQ3 DRUGSMIL CC1(C(=O)N(C2=CC(=CC(=C2O1)C3=CN(C(=O)C4=C3C=CN4)C)S(=O)(=O)C)C)C D7FJQ3 HIGHSTAT Phase 1/2 D82DMK DRUG__ID D82DMK D82DMK DRUGCOMP PharmatrophiX Menlo Park, CA D82DMK DRUGTYPE Small molecular drug D82DMK DRUGINCH 1S/C12H25N3O2/c1-3-10(2)11(13)12(16)14-4-5-15-6-8-17-9-7-15/h10-11H,3-9,13H2,1-2H3,(H,14,16)/t10-,11-/m0/s1 D82DMK DRUGINKE YNMUTYLWSRFTPX-QWRGUYRKSA-N D82DMK DRUGSMIL CCC(C)C(C(=O)NCCN1CCOCC1)N D82DMK HIGHSTAT Phase 1/2 D8AF1M DRUG__ID D8AF1M D8AF1M DRUGCOMP Otsuka America Pharmaceutical D8AF1M DRUGTYPE Small molecular drug D8AF1M DRUGINCH 1S/C21H20ClF3N2O4/c22-11-7-14(24)20(15(25)8-11)27-6-5-21(30,17(28)9-27)10-31-16-3-2-13(23)19-12(16)1-4-18(29)26-19/h2-3,7-8,17,28,30H,1,4-6,9-10H2,(H,26,29)/t17-,21-/m1/s1 D8AF1M DRUGINKE XZISSTDXPBUCJA-DYESRHJHSA-N D8AF1M DRUGSMIL C1CC(=O)NC2=C(C=CC(=C21)OCC3(CCN(CC3O)C4=C(C=C(C=C4F)Cl)F)O)F D8AF1M HIGHSTAT Phase 1/2 D8EB7G DRUG__ID D8EB7G D8EB7G DRUGCOMP eFFECTOR Therapeutics D8EB7G DRUGTYPE Small molecular drug D8EB7G DRUGINCH 1S/C28H29N3O5/c1-31(2)16-20-23(18-8-6-5-7-9-18)28(19-12-10-17(15-29)11-13-19)27(33,25(20)32)24-21(36-28)14-22(34-3)30-26(24)35-4/h5-14,20,23,25,32-33H,16H2,1-4H3/t20-,23-,25-,27+,28+/m1/s1 D8EB7G DRUGINKE QYCXWOACFWMQFO-WZWZCULESA-N D8EB7G DRUGSMIL CN(C)CC1C(C2(C(C1O)(C3=C(N=C(C=C3O2)OC)OC)O)C4=CC=C(C=C4)C#N)C5=CC=CC=C5 D8EB7G HIGHSTAT Phase 1/2 D97YGW DRUG__ID D97YGW D97YGW DRUGCOMP Syndax Pharmaceuticals D97YGW DRUGTYPE Small molecular drug D97YGW DRUGINCH 1S/C32H47FN6O4S/c1-5-39(23(3)4)31(40)27-17-25(33)9-12-28(27)43-29-18-34-22-35-30(29)38-20-32(21-38)13-15-37(16-14-32)19-24-7-10-26(11-8-24)36-44(41,42)6-2/h9,12,17-18,22-24,26,36H,5-8,10-11,13-16,19-21H2,1-4H3 D97YGW DRUGINKE FRVSRBKUQZKTOW-UHFFFAOYSA-N D97YGW DRUGSMIL CCN(C(C)C)C(=O)C1=C(C=CC(=C1)F)OC2=CN=CN=C2N3CC4(C3)CCN(CC4)CC5CCC(CC5)NS(=O)(=O)CC D97YGW HIGHSTAT Phase 1/2 D9FJ5V DRUG__ID D9FJ5V D9FJ5V DRUGCOMP Black Diamond Therapeutics D9FJ5V DRUGTYPE Small molecular drug D9FJ5V DRUGINCH 1S/C29H29ClN6O4/c1-2-28(37)35-25-16-22-24(17-27(25)39-14-11-36-9-12-38-13-10-36)32-19-33-29(22)34-20-6-7-26(23(30)15-20)40-18-21-5-3-4-8-31-21/h2-8,15-17,19H,1,9-14,18H2,(H,35,37)(H,32,33,34) D9FJ5V DRUGINKE HIBPKFXWOPYJPZ-UHFFFAOYSA-N D9FJ5V DRUGSMIL C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5 D9FJ5V HIGHSTAT Phase 1/2 D9RH0V DRUG__ID D9RH0V D9RH0V DRUGCOMP Deciphera Pharmaceuticals D9RH0V DRUGTYPE Small molecular drug D9RH0V DRUGINCH 1S/C23H25N7O2/c1-14(2)27-23-25-12-18(22(31)30(23)5)19-6-7-21(15(3)28-19)32-17-8-9-24-20(10-17)16-11-26-29(4)13-16/h6-14H,1-5H3,(H,25,27) D9RH0V DRUGINKE TVGAHWWPABTBCX-UHFFFAOYSA-N D9RH0V DRUGSMIL CC1=C(C=CC(=N1)C2=CN=C(N(C2=O)C)NC(C)C)OC3=CC(=NC=C3)C4=CN(N=C4)C D9RH0V HIGHSTAT Phase 1/2 DA1MG8 DRUG__ID DA1MG8 DA1MG8 DRUGCOMP Ono Pharmaceutical DA1MG8 DRUGTYPE Small molecular drug DA1MG8 DRUGINCH 1S/C32H26N4O6/c1-40-28-16-21-24(17-29(28)41-2)33-14-13-27(21)42-20-11-12-30(34-18-20)35-31(38)23-15-22-25(9-6-10-26(22)37)36(32(23)39)19-7-4-3-5-8-19/h3-5,7-8,11-18H,6,9-10H2,1-2H3,(H,34,35,38) DA1MG8 DRUGINKE WHMMKPWGWNYYFE-UHFFFAOYSA-N DA1MG8 DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CN=C(C=C3)NC(=O)C4=CC5=C(CCCC5=O)N(C4=O)C6=CC=CC=C6 DA1MG8 HIGHSTAT Phase 1/2 DA91HS DRUG__ID DA91HS DA91HS DRUGCOMP Orion DA91HS DRUGTYPE Small molecular drug DA91HS DRUGINCH 1S/C22H21N3O3/c1-13-9-16-10-18(21-14(2)24-28-15(21)3)20(27-4)11-19(16)25(22(13)26)12-17-7-5-6-8-23-17/h5-11H,12H2,1-4H3 DA91HS DRUGINKE YVGWSVHZXWFLIT-UHFFFAOYSA-N DA91HS DRUGSMIL CC1=CC2=CC(=C(C=C2N(C1=O)CC3=CC=CC=N3)OC)C4=C(ON=C4C)C DA91HS HIGHSTAT Phase 1/2 DC72LG DRUG__ID DC72LG DC72LG DRUGCOMP RMJ Holdings DC72LG DRUGTYPE Small molecular drug DC72LG DRUGINCH 1S/2C6H8O7.3Mg/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6 DC72LG DRUGINKE PLSARIKBYIPYPF-UHFFFAOYSA-H DC72LG DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Mg+2].[Mg+2].[Mg+2] DC72LG HIGHSTAT Phase 1/2 DCT2Q3 DRUG__ID DCT2Q3 DCT2Q3 DRUGCOMP Moleculin Biotech DCT2Q3 DRUGTYPE Small molecular drug DCT2Q3 DRUGINCH 1S/C26H25IO11/c1-9-19(30)24(35)18(27)25(37-9)38-13-7-26(36,14(29)8-28)6-12-15(13)23(34)17-16(22(12)33)20(31)10-4-2-3-5-11(10)21(17)32/h2-5,9,13,18-19,24-25,28,30,33-36H,6-8H2,1H3/t9-,13-,18+,19-,24-,25-,26-/m0/s1 DCT2Q3 DRUGINKE CIDNKDMVSINJCG-GKXONYSUSA-N DCT2Q3 DRUGSMIL CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)CO)O)I)O)O DCT2Q3 HIGHSTAT Phase 1/2 DDSW97 DRUG__ID DDSW97 DDSW97 DRUGCOMP Roche DDSW97 DRUGTYPE Small molecule DDSW97 DRUGINCH InChI=1S/C21H26N6O3/c1-13-12-29-7-6-26(13)19-8-17(21(28)9-14-2-3-15(10-21)30-14)16-11-23-27(20(16)24-19)18-4-5-22-25-18/h4-5,8,11,13-15,28H,2-3,6-7,9-10,12H2,1H3,(H,22,25)/t13-,14-,15+,21?/m1/s1 DDSW97 DRUGINKE YIHHYCIYAIVQKX-YNOVCBQDSA-N DDSW97 DRUGSMIL CC1COCCN1C2=NC3=C(C=NN3C4=CC=NN4)C(=C2)C5(CC6CCC(C5)O6)O DDSW97 HIGHSTAT Phase 1/2 DIY4C2 DRUG__ID DIY4C2 DIY4C2 DRUGCOMP CellCentric DIY4C2 DRUGTYPE Small molecular drug DIY4C2 DRUGINCH 1S/C30H32F2N4O3/c1-17-29(18(2)39-34-17)19-7-14-26-25(15-19)33-30(36(26)20-8-11-22(38-3)12-9-20)27-5-4-6-28(37)35(27)21-10-13-23(31)24(32)16-21/h7,10,13-16,20,22,27H,4-6,8-9,11-12H2,1-3H3/t20?,22?,27-/m0/s1 DIY4C2 DRUGINKE SKDNDJWEBPQKCS-RIQBOWGZSA-N DIY4C2 DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)C4CCCC(=O)N4C5=CC(=C(C=C5)F)F)C6CCC(CC6)OC DIY4C2 HIGHSTAT Phase 1/2 DJMK69 DRUG__ID DJMK69 DJMK69 DRUGCOMP Actinogen Medical DJMK69 DRUGTYPE Small molecule DJMK69 DRUGINCH InChI=1S/C19H19N5O2S/c25-17(12-6-16(27-11-12)13-9-22-23-10-13)24-14-2-3-15(24)8-19(26,7-14)18-20-4-1-5-21-18/h1,4-6,9-11,14-15,26H,2-3,7-8H2,(H,22,23)/t14-,15+,19? DJMK69 DRUGINKE MMZFGTAMARVHAF-RTHVDDQRSA-N DJMK69 DRUGSMIL C1CC2CC(CC1N2C(=O)C3=CSC(=C3)C4=CNN=C4)(C5=NC=CC=N5)O DJMK69 HIGHSTAT Phase 1/2 DL30JC DRUG__ID DL30JC DL30JC DRUGCOMP FUJIFILM Pharmaceuticals DL30JC DRUGTYPE Small molecular drug DL30JC DRUGINCH 1S/C9H12FN3O3S/c10-6-7(15)4(3-14)17-8(6)13-2-1-5(11)12-9(13)16/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16)/t4-,6+,7-,8-/m1/s1 DL30JC DRUGINKE NIDPJRZOVFIBQB-PXBUCIJWSA-N DL30JC DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(S2)CO)O)F DL30JC HIGHSTAT Phase 1/2 DMBQ10 DRUG__ID DMBQ10 DMBQ10 DRUGCOMP Ability Pharmaceuticals Barcelona, Spain DMBQ10 DRUGTYPE Small molecule DMBQ10 DRUGINCH InChI=1S/C18H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17(19)18(20)21/h6-7,9-10,17,19H,2-5,8,11-16H2,1H3,(H,20,21)/b7-6-,10-9- DMBQ10 DRUGINKE AFDSETGKYZMEEA-HZJYTTRNSA-N DMBQ10 DRUGSMIL CCCCCC=CCC=CCCCCCCC(C(=O)O)O DMBQ10 HIGHSTAT Phase 1/2 DPNT63 DRUG__ID DPNT63 DPNT63 DRUGCOMP AstraZeneca DPNT63 DRUGTYPE Small molecular drug DPNT63 DRUGINCH 1S/C18H20N8O2/c1-11-7-15-20-10-21-25(15)9-13(11)22-17-19-8-14-16(23-17)26(18(27)24(14)2)12-3-5-28-6-4-12/h7-10,12H,3-6H2,1-2H3,(H,19,22,23) DPNT63 DRUGINKE XISVSTPEXYIKJL-UHFFFAOYSA-N DPNT63 DRUGSMIL CC1=CC2=NC=NN2C=C1NC3=NC=C4C(=N3)N(C(=O)N4C)C5CCOCC5 DPNT63 HIGHSTAT Phase 1/2 DS4JE8 DRUG__ID DS4JE8 DS4JE8 DRUGCOMP Kura Oncology DS4JE8 DRUGTYPE Small molecular drug DS4JE8 DRUGINCH 1S/C33H42F3N9O2S2/c1-21(43-11-13-44(14-12-43)49(4,46)47)19-45-25(18-37)15-27-22(2)23(5-6-29(27)45)20-42-9-7-24(8-10-42)39-30-28-16-26(17-33(34,35)36)48-31(28)41-32(38-3)40-30/h5-6,15-16,21,24H,7-14,17,19-20H2,1-4H3,(H2,38,39,40,41)/t21-/m0/s1 DS4JE8 DRUGINKE BGGALFIXXQOTPY-NRFANRHFSA-N DS4JE8 DRUGSMIL CC1=C(C=CC2=C1C=C(N2CC(C)N3CCN(CC3)S(=O)(=O)C)C#N)CN4CCC(CC4)NC5=C6C=C(SC6=NC(=N5)NC)CC(F)(F)F DS4JE8 HIGHSTAT Phase 1/2 DS6VD0 DRUG__ID DS6VD0 DS6VD0 DRUGCOMP Gilead Sciences DS6VD0 DRUGTYPE Small molecular drug DS6VD0 DRUGINCH 1S/C6H6N2O2/c1-10-6(9)5-2-3-7-8-4-5/h2-4H,1H3 DS6VD0 DRUGINKE IJFLWNYKGMQQOW-UHFFFAOYSA-N DS6VD0 DRUGSMIL COC(=O)C1=CN=NC=C1 DS6VD0 HIGHSTAT Phase 1/2 DT3BA1 DRUG__ID DT3BA1 DT3BA1 DRUGCOMP Aptose Biosciences DT3BA1 DRUGTYPE Small molecular drug DT3BA1 DRUGINCH 1S/C26H19F4N5O2/c1-13-11-31-23(33-13)19-8-7-17(20-12-32-24(36)22(19)20)18-6-5-16(10-21(18)27)35-25(37)34-15-4-2-3-14(9-15)26(28,29)30/h2-11H,12H2,1H3,(H,31,33)(H,32,36)(H2,34,35,37) DT3BA1 DRUGINKE BOLRZWTVMUHQQU-UHFFFAOYSA-N DT3BA1 DRUGSMIL CC1=CN=C(N1)C2=C3C(=C(C=C2)C4=C(C=C(C=C4)NC(=O)NC5=CC=CC(=C5)C(F)(F)F)F)CNC3=O DT3BA1 HIGHSTAT Phase 1/2 DUI59O DRUG__ID DUI59O DUI59O DRUGCOMP Purple Biotech DUI59O DRUGTYPE Small molecular drug DUI59O DRUGINCH 1S/C16H14BrNO5S/c17-14-9(1-3-10(19)16(14)23)2-4-13(24)18-7-8-5-11(20)15(22)12(21)6-8/h1-6,19-23H,7H2,(H,18,24)/b4-2+ DUI59O DRUGINKE XDDQKKXXQHUUHJ-DUXPYHPUSA-N DUI59O DRUGSMIL C1=CC(=C(C(=C1C=CC(=S)NCC2=CC(=C(C(=C2)O)O)O)Br)O)O DUI59O HIGHSTAT Phase 1/2 DUOX13 DRUG__ID DUOX13 DUOX13 DRUGCOMP ENB Therapeutics New York, NY DUOX13 DRUGTYPE Small molecule DUOX13 DRUGINCH InChI=1S/C34H51N5O7.Na/c1-8-9-16-25(31(42)43)35-29(40)26(18-23-20-38(33(45)46-7)28-17-11-10-15-24(23)28)36-30(41)27(19-34(4,5)6)37-32(44)39-21(2)13-12-14-22(39)3;/h10-11,15,17,20-22,25-27H,8-9,12-14,16,18-19H2,1-7H3,(H,35,40)(H,36,41)(H,37,44)(H,42,43);/q;+1/p-1/t21-,22+,25-,26-,27+;/m1./s1/i2D,3D; DUOX13 DRUGINKE QCVIFBRTTLMEOV-ZOHSNMQTSA-M DUOX13 DRUGSMIL CCCCC(C(=O)[O-])NC(=O)C(CC1=CN(C2=CC=CC=C21)C(=O)OC)NC(=O)C(CC(C)(C)C)NC(=O)N3C(CCCC3C)C.[Na+] DUOX13 HIGHSTAT Phase 1/2 DURD59 DRUG__ID DURD59 DURD59 DRUGCOMP Spero Therapeutics DURD59 DRUGTYPE Small molecular drug DURD59 DRUGINCH 1S/C21H26FN6O6P/c1-4-23-20(29)28-19-26-13-8-12(16(22)15(17(13)27-19)14-6-5-7-33-14)11-9-24-18(25-10-11)21(2,3)34-35(30,31)32/h8-10,14H,4-7H2,1-3H3,(H2,30,31,32)(H3,23,26,27,28,29)/t14-/m1/s1 DURD59 DRUGINKE COTQDURISRILOR-CQSZACIVSA-N DURD59 DRUGSMIL CCNC(=O)NC1=NC2=C(N1)C=C(C(=C2C3CCCO3)F)C4=CN=C(N=C4)C(C)(C)OP(=O)(O)O DURD59 HIGHSTAT Phase 1/2 DV74BT DRUG__ID DV74BT DV74BT DRUGCOMP Carrick Therapeutics DV74BT DRUGTYPE Small molecule DV74BT DRUGINCH InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1 DV74BT DRUGINKE YCVGLKWJKIKVBI-MJGOQNOKSA-N DV74BT DRUGSMIL CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NCC4CCNCC4O DV74BT HIGHSTAT Phase 1/2 DXJ4B7 DRUG__ID DXJ4B7 DXJ4B7 DRUGCOMP Esperas Pharma DXJ4B7 DRUGTYPE Small molecular drug DXJ4B7 DRUGINCH 1S/C19H23N7O2/c1-12-5-6-14(19(22-12)27-2)15-8-16(26-25-15)23-17-10-21-11-18(24-17)28-13-4-3-7-20-9-13/h5-6,8,10-11,13,20H,3-4,7,9H2,1-2H3,(H2,23,24,25,26)/t13-/m1/s1 DXJ4B7 DRUGINKE LAEFIEWPUJMANC-CYBMUJFWSA-N DXJ4B7 DRUGSMIL CC1=NC(=C(C=C1)C2=CC(=NN2)NC3=CN=CC(=N3)OC4CCCNC4)OC DXJ4B7 HIGHSTAT Phase 1/2 D00DBO DRUG__ID D00DBO D00DBO DRUGTYPE Small molecular drug D00DBO DRUGINCH 1S/C21H30FN3O2/c22-18-8-6-17(7-9-18)19(26)5-4-12-24-15-10-21(11-16-24,20(23)27)25-13-2-1-3-14-25/h6-9H,1-5,10-16H2,(H2,23,27) D00DBO DRUGINKE AXKPFOAXAHJUAG-UHFFFAOYSA-N D00DBO DRUGSMIL C1CCN(CC1)C2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C(=O)N D00DBO HIGHSTAT Phase 1/2 D00DFP DRUG__ID D00DFP D00DFP DRUGCOMP KBP Biosciences Princeton, NJ D00DFP DRUGINCH 1S/C28H30ClN5O2/c29-23-15-19(6-5-18(23)16-30)34-27(17-3-1-2-4-17)22-8-9-24-21(26(22)32-34)7-10-25(31-24)28(36)33-13-11-20(35)12-14-33/h5-7,10,15,17,20,22,27,35H,1-4,8-9,11-14H2/t22-,27+/m1/s1 D00DFP DRUGINKE UXHQLGLGLZKHTC-AMGIVPHBSA-N D00DFP DRUGSMIL C1CCC(C1)C2C3CCC4=C(C3=NN2C5=CC(=C(C=C5)C#N)Cl)C=CC(=N4)C(=O)N6CCC(CC6)O D00DFP HIGHSTAT Phase 1/2 D00DRL DRUG__ID D00DRL D00DRL DRUGTYPE Small molecular drug D00DRL DRUGINCH 1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1 D00DRL DRUGINKE JGEBLDKNWBUGRZ-HXUWFJFHSA-N D00DRL DRUGSMIL CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)NS(=O)(=O)N(C)CC5COCCO5)N=C2 D00DRL HIGHSTAT Phase 1/2 D00EFT DRUG__ID D00EFT D00EFT DRUGTYPE Small molecular drug D00EFT DRUGINCH 1S/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 D00EFT DRUGINKE LRQKBLKVPFOOQJ-YFKPBYRVSA-N D00EFT DRUGSMIL CCCCC(C(=O)O)N D00EFT HIGHSTAT Phase 1/2 D00LGR DRUG__ID D00LGR D00LGR DRUGCOMP Tolero Pharmaceuticals Lehi, UT D00LGR DRUGINCH 1S/C24H30ClN7O2S/c1-30(2)35(33,34)22-7-5-4-6-21(22)28-23-20(25)16-26-24(29-23)27-19-10-8-18(9-11-19)17-32-14-12-31(3)13-15-32/h4-11,16H,12-15,17H2,1-3H3,(H2,26,27,28,29) D00LGR DRUGINKE YUAALFPUEOYPNX-UHFFFAOYSA-N D00LGR DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)N(C)C)Cl D00LGR HIGHSTAT Phase 1/2 D00UVU DRUG__ID D00UVU D00UVU DRUGCOMP Lunamed Operations AG D00UVU DRUGINCH 1S/C39H70N2O13/c1-5-7-9-11-12-13-14-15-16-17-18-20-22-31(45)52-28(24-49-30(44)21-19-10-8-6-2)25-50-39-36(48)37(34(46)29(23-42)53-39)54-38-33(41-27(4)43)35(47)32(40)26(3)51-38/h14-15,26,28-29,32-39,42,46-48H,5-13,16-25,40H2,1-4H3,(H,41,43)/b15-14+/t26-,28-,29-,32+,33-,34-,35+,36-,37+,38+,39+/m1/s1 D00UVU DRUGINKE PANDRCFROUDETH-YLSOAJEOSA-N D00UVU DRUGSMIL CCCCCCCC=CCCCCCC(=O)OC(COC1C(C(C(C(O1)CO)O)OC2C(C(C(C(O2)C)N)O)NC(=O)C)O)COC(=O)CCCCCC D00UVU HIGHSTAT Phase 1/2 D00XVL DRUG__ID D00XVL D00XVL DRUGCOMP Intra-Cellular; Takeda D00XVL DRUGINCH 1S/C29H26FN7O/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3/t22-,23+/m1/s1 D00XVL DRUGINKE BBIPVJCGIASXJB-PKTZIBPZSA-N D00XVL DRUGSMIL CN1C(=O)C2=C(N(N=C2N3C1=NC4C3CCC4)CC5=CC=C(C=C5)C6=NC(=CC=C6)F)NC7=CC=CC=C7 D00XVL HIGHSTAT Phase 1/2 D01HKZ DRUG__ID D01HKZ D01HKZ DRUGCOMP Tesaro D01HKZ DRUGINCH 1S/C33H44FN5O3/c1-21(2)35-30(40)24-8-12-27(13-9-24)39-29-19-22(20-38-17-15-25(16-18-38)33(3,4)42)5-14-28(29)36-32(39)37-31(41)23-6-10-26(34)11-7-23/h5-7,10-11,14,19,21,24-25,27,42H,8-9,12-13,15-18,20H2,1-4H3,(H,35,40)(H,36,37,41) D01HKZ DRUGINKE WSTUJEXAPHIEIM-UHFFFAOYSA-N D01HKZ DRUGSMIL CC(C)NC(=O)C1CCC(CC1)N2C3=C(C=CC(=C3)CN4CCC(CC4)C(C)(C)O)N=C2NC(=O)C5=CC=C(C=C5)F D01HKZ HIGHSTAT Phase 1/2 D01TJM DRUG__ID D01TJM D01TJM DRUGCOMP Chemokine Therapeutics Corp; Chemokine Therapeutics D01TJM DRUGINCH 1S/C86H147N27O23/c1-45(2)35-58(104-81(133)64(43-116)110-83(135)68(47(5)6)112-66(120)39-99-71(123)53(89)17-9-12-30-87)75(127)108-62(41-114)79(131)106-60(37-49-22-26-51(118)27-23-49)77(129)102-56(20-15-33-97-85(92)93)73(125)96-32-14-11-19-55(70(91)122)101-74(126)57(21-16-34-98-86(94)95)103-78(130)61(38-50-24-28-52(119)29-25-50)107-80(132)63(42-115)109-76(128)59(36-46(3)4)105-82(134)65(44-117)111-84(136)69(48(7)8)113-67(121)40-100-72(124)54(90)18-10-13-31-88/h22-29,45-48,53-65,68-69,114-119H,9-21,30-44,87-90H2,1-8H3,(H2,91,122)(H,96,125)(H,99,123)(H,100,124)(H,101,126)(H,102,129)(H,103,130)(H,104,133)(H,105,134)(H,106,131)(H,107,132)(H,108,127)(H,109,128)(H,110,135)(H,111,136)(H,112,120)(H,113,121)(H4,92,93,97)(H4,94,95,98)/t53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,68-,69-/m0/s1 D01TJM DRUGINKE VUYRSKROGTWHDC-HZGLMRDYSA-N D01TJM DRUGSMIL CC(C)CC(C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=N)N)C(=O)NCCCCC(C(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CCCCN)N)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CCCCN)N D01TJM HIGHSTAT Phase 1/2 D03CGQ DRUG__ID D03CGQ D03CGQ DRUGCOMP Pfizer Inc D03CGQ DRUGINCH 1S/C26H22FN7O/c1-16-13-25(34(2)33-16)26(35)30-24-15-19(7-10-21(24)27)29-18-6-9-20-22(31-32-23(20)14-18)11-8-17-5-3-4-12-28-17/h3-15,29H,1-2H3,(H,30,35)(H,31,32)/b11-8+ D03CGQ DRUGINKE JXSVVZKPEDIRTN-DHZHZOJOSA-N D03CGQ DRUGSMIL CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)C=CC5=CC=CC=N5)F)C D03CGQ HIGHSTAT Phase 1/2 D03CVT DRUG__ID D03CVT D03CVT DRUGCOMP Allachem D03CVT DRUGINCH 1S/C22H16F4N4O3S/c1-28-18(31)15-5-4-14(9-17(15)23)30-20(34)29(19(32)21(30)6-7-33-11-21)13-3-2-12(10-27)16(8-13)22(24,25)26/h2-5,8-9H,6-7,11H2,1H3,(H,28,31)/t21-/m1/s1 D03CVT DRUGINKE QKKPJFTYJCXESR-OAQYLSRUSA-N D03CVT DRUGSMIL CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCOC3)C4=CC(=C(C=C4)C#N)C(F)(F)F)F D03CVT HIGHSTAT Phase 1/2 D03JDA DRUG__ID D03JDA D03JDA DRUGCOMP Lakewood-Amedex Inc D03JDA DRUGINCH 1S/C18H32N2O11P2/c1-4-6-8-27-32(23,24)29-12-15-14(31-33(25,26)28-9-7-5-2)10-16(30-15)20-11-13(3)17(21)19-18(20)22/h11,14-16H,4-10,12H2,1-3H3,(H,23,24)(H,25,26)(H,19,21,22)/t14-,15+,16+/m0/s1 D03JDA DRUGINKE ZXQBUNYVGNOEBQ-ARFHVFGLSA-N D03JDA DRUGSMIL CCCCOP(=O)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)OP(=O)(O)OCCCC D03JDA HIGHSTAT Phase 1/2 D03JJY DRUG__ID D03JJY D03JJY DRUGCOMP Avera Pharmaceuticals D03JJY DRUGINCH 1S/C53H69ClN2O14.2ClH/c1-55(19-15-34-26-41(59-3)43(61-5)30-37(34)40(55)23-33-24-45(63-7)51(67-11)46(25-33)64-8)17-13-22-70-53(58)39(54)32-49(57)69-21-14-18-56(2)20-16-35-27-42(60-4)44(62-6)31-38(35)50(56)36-28-47(65-9)52(68-12)48(29-36)66-10;;/h24-32,40,50H,13-23H2,1-12H3;2*1H/q+2;;/p-2/b39-32-;;/t40-,50+,55-,56+;;/m1../s1 D03JJY DRUGINKE SDIFKXLSGXCGEN-WJUBNSBASA-L D03JJY DRUGSMIL C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)C(=CC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4C6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C)Cl.[Cl-].[Cl-] D03JJY HIGHSTAT Phase 1/2 D04AEQ DRUG__ID D04AEQ D04AEQ DRUGCOMP Vernalis D04AEQ DRUGINCH 1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13-3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/t15-/m0/s1 D04AEQ DRUGINKE KURQKNMKCGYWRJ-HNNXBMFYSA-N D04AEQ DRUGSMIL CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5 D04AEQ HIGHSTAT Phase 1/2 D04BSV DRUG__ID D04BSV D04BSV DRUGTYPE Small molecular drug D04BSV DRUGINCH 1S/C65H89N9O25/c1-28(2)19-37(60(91)69-36-21-47(98-30(4)53(36)84)99-42-23-65(96,43(79)27-77)22-34-49(42)57(88)51-50(55(34)86)54(85)33-13-9-14-41(97-5)48(33)56(51)87)70-61(92)38(25-75)72-59(90)35(17-18-44(66)80)68-64(95)52(31-11-7-6-8-12-31)73-62(93)39(26-76)71-58(89)29(3)67-63(94)40-20-32(78)24-74(40)45(81)15-10-16-46(82)83/h9,13-14,28-32,35-40,42,47,52-53,75-78,84,86,88,96H,6-8,10-12,15-27H2,1-5H3,(H2,66,80)(H,67,94)(H,68,95)(H,69,91)(H,70,92)(H,71,89)(H,72,90)(H,73,93)(H,82,83)/t29-,30-,32?,35-,36-,37-,38-,39-,40-,42-,47-,52-,53+,65-/m0/s1 D04BSV DRUGINKE CZXGBIFEWYVYJY-ATFCTERFSA-N D04BSV DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(C6CCCCC6)NC(=O)C(CO)NC(=O)C(C)NC(=O)C7CC(CN7C(=O)CCCC(=O)O)O)O D04BSV HIGHSTAT Phase 1/2 D04GSV DRUG__ID D04GSV D04GSV DRUGTYPE Small molecular drug D04GSV DRUGINCH 1S/C13H16N6O4/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(22)8(21)6(3-20)23-13/h2,4,6,8-9,13,20-22H,3H2,1H3,(H2,14,17)/t6-,8-,9-,13-/m1/s1 D04GSV DRUGINKE HOGVTUZUJGHKPL-HTVVRFAVSA-N D04GSV DRUGSMIL CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)CO)O)O)C(=N1)N D04GSV HIGHSTAT Phase 1/2 D04RYY DRUG__ID D04RYY D04RYY DRUGTYPE Small molecular drug D04RYY DRUGINCH 1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11-,12-/m1/s1 D04RYY DRUGINKE GUBGYTABKSRVRQ-QUYVBRFLSA-N D04RYY DRUGSMIL C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O D04RYY HIGHSTAT Phase 1/2 D04UBI DRUG__ID D04UBI D04UBI DRUGCOMP Arcus Biosciences Hayward, CA D04UBI DRUGINCH 1S/C23H22N8O/c1-14-15(11-24)6-4-8-17(14)18-10-19(28-22(25)27-18)20-13-31(30-29-20)12-16-7-5-9-21(26-16)23(2,3)32/h4-10,13,32H,12H2,1-3H3,(H2,25,27,28) D04UBI DRUGINKE BUXIAWLTBSXYSW-UHFFFAOYSA-N D04UBI DRUGSMIL CC1=C(C=CC=C1C2=CC(=NC(=N2)N)C3=CN(N=N3)CC4=NC(=CC=C4)C(C)(C)O)C#N D04UBI HIGHSTAT Phase 1/2 D05CQS DRUG__ID D05CQS D05CQS DRUGTYPE Small molecular drug D05CQS DRUGINCH 1S/C21H25BrN3O9P/c1-13(20(28)31-2)24-35(30,34-15-6-4-3-5-7-15)32-12-17-16(26)10-18(33-17)25-11-14(8-9-22)19(27)23-21(25)29/h3-9,11,13,16-18,26H,10,12H2,1-2H3,(H,24,30)(H,23,27,29)/b9-8+/t13-,16-,17+,18+,35?/m0/s1 D05CQS DRUGINKE CFBLUORPOFELCE-BACVZHSASA-N D05CQS DRUGSMIL CC(C(=O)OC)NP(=O)(OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C=CBr)O)OC3=CC=CC=C3 D05CQS HIGHSTAT Phase 1/2 D05KBP DRUG__ID D05KBP D05KBP DRUGCOMP Inotek pharmaceuticals D05KBP DRUGINCH 1S/C15H20N6O6/c22-11-9(5-26-21(24)25)27-15(12(11)23)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,22-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1 D05KBP DRUGINKE AQLVRTWKJDTWQQ-SDBHATRESA-N D05KBP DRUGSMIL C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO[N+](=O)[O-])O)O D05KBP HIGHSTAT Phase 1/2 D05RVA DRUG__ID D05RVA D05RVA DRUGCOMP Novartis pharmaceuticals D05RVA DRUGINCH 1S/C14H13ClN4O/c1-10-2-4-16-9-12(10)19-7-6-18(14(19)20)11-3-5-17-13(15)8-11/h2-5,8-9H,6-7H2,1H3 D05RVA DRUGINKE ZVIFCOOHWGNPHJ-UHFFFAOYSA-N D05RVA DRUGSMIL CC1=C(C=NC=C1)N2CCN(C2=O)C3=CC(=NC=C3)Cl D05RVA HIGHSTAT Phase 1/2 D05TPI DRUG__ID D05TPI D05TPI DRUGTYPE Small molecular drug D05TPI DRUGINCH 1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15-/m1/s1 D05TPI DRUGINKE PFTAWBLQPZVEMU-UKRRQHHQSA-N D05TPI DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O D05TPI HIGHSTAT Phase 1/2 D06HBT DRUG__ID D06HBT D06HBT DRUGCOMP Lumen Therapeutics D06HBT DRUGINCH 1S/C54H110N36O10/c55-28(10-1-19-74-46(56)57)37(91)83-29(11-2-20-75-47(58)59)38(92)84-30(12-3-21-76-48(60)61)39(93)85-31(13-4-22-77-49(62)63)40(94)86-32(14-5-23-78-50(64)65)41(95)87-33(15-6-24-79-51(66)67)42(96)88-34(16-7-25-80-52(68)69)43(97)89-35(17-8-26-81-53(70)71)44(98)90-36(45(99)100)18-9-27-82-54(72)73/h28-36H,1-27,55H2,(H,83,91)(H,84,92)(H,85,93)(H,86,94)(H,87,95)(H,88,96)(H,89,97)(H,90,98)(H,99,100)(H4,56,57,74)(H4,58,59,75)(H4,60,61,76)(H4,62,63,77)(H4,64,65,78)(H4,66,67,79)(H4,68,69,80)(H4,70,71,81)(H4,72,73,82)/t28-,29-,30-,31-,32-,33-,34-,35-,36-/m0/s1 D06HBT DRUGINKE XUNKPNYCNUKOAU-VXJRNSOOSA-N D06HBT DRUGSMIL C(CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)N)CN=C(N)N D06HBT HIGHSTAT Phase 1/2 D06ILL DRUG__ID D06ILL D06ILL DRUGCOMP Bristol-Myers Squibb Princeton, NJ D06ILL DRUGINCH 1S/C30H33N5O2/c1-19-28(34(4)33-32-19)22-16-26-27(31-18-22)24-11-10-23(30(2,3)36)17-25(24)35(26)29(20-8-6-5-7-9-20)21-12-14-37-15-13-21/h5-11,16-18,21,29,36H,12-15H2,1-4H3/t29-/m1/s1 D06ILL DRUGINKE KGERZPVQIRYWRK-GDLZYMKVSA-N D06ILL DRUGSMIL CC1=C(N(N=N1)C)C2=CC3=C(C4=C(N3C(C5CCOCC5)C6=CC=CC=C6)C=C(C=C4)C(C)(C)O)N=C2 D06ILL HIGHSTAT Phase 1/2 D07BXC DRUG__ID D07BXC D07BXC DRUGTYPE Small molecular drug D07BXC DRUGINCH 1S/C24H26N2OS2/c1-4-15-6-5-7-19-22(15)25-23(29-19)28-17-9-10-18-16(14-17)8-11-20-24(18,2)13-12-21(27)26(20)3/h5-7,9-10,14,20H,4,8,11-13H2,1-3H3/t20-,24-/m1/s1 D07BXC DRUGINKE VMGWGDPZHXPFTC-HYBUGGRVSA-N D07BXC DRUGSMIL CCC1=C2C(=CC=C1)SC(=N2)SC3=CC4=C(C=C3)C5(CCC(=O)N(C5CC4)C)C D07BXC HIGHSTAT Phase 1/2 D07EHV DRUG__ID D07EHV D07EHV DRUGCOMP Novartis D07EHV DRUGINCH 1S/C24H23F3N4O/c1-13-9-14(11-15(28)10-13)16-7-8-29-12-21(16)31-24(32)20-6-5-19(27)23(30-20)22-17(25)3-2-4-18(22)26/h2-8,12-15H,9-11,28H2,1H3,(H,31,32)/t13-,14+,15-/m0/s1 D07EHV DRUGINKE VRQXRVAKPDCRCI-ZNMIVQPWSA-N D07EHV DRUGSMIL CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F D07EHV HIGHSTAT Phase 1/2 D07MEX DRUG__ID D07MEX D07MEX DRUGCOMP Cellectar LLC D07MEX DRUGINCH 1S/C29H53INO4P/c1-31(2,3)25-27-35-36(32,33)34-26-19-17-15-13-11-9-7-5-4-6-8-10-12-14-16-18-20-28-21-23-29(30)24-22-28/h21-24H,4-20,25-27H2,1-3H3 D07MEX DRUGINKE ZOAIEFWMQLYMTF-UHFFFAOYSA-N D07MEX DRUGSMIL C[N+](C)(C)CCOP(=O)([O-])OCCCCCCCCCCCCCCCCCCC1=CC=C(C=C1)I D07MEX HIGHSTAT Phase 1/2 D07TSW DRUG__ID D07TSW D07TSW DRUGTYPE Small molecular drug D07TSW DRUGINCH 1S/C9H18O9S2/c10-1-7(18-20(15,16)17)5(12)3-19-4-6(13)9(14)8(19)2-11/h5-14H,1-4H2/t5-,6-,7+,8-,9+,19?/m1/s1 D07TSW DRUGINKE SOWRVDSZMRPKRG-XESHOGEWSA-N D07TSW DRUGSMIL C1C(C(C([S+]1CC(C(CO)OS(=O)(=O)[O-])O)CO)O)O D07TSW HIGHSTAT Phase 1/2 D08DUY DRUG__ID D08DUY D08DUY DRUGTYPE Small molecular drug D08DUY DRUGINCH 1S/C235H341N57O67/c1-20-120(13)194(290-218(342)155(69-83-184(246)303)258-198(322)122(15)254-201(325)149(63-77-178(240)297)263-211(335)157(71-85-187(307)308)270-221(345)166(97-117(7)8)280-222(346)164(95-115(3)4)277-199(323)124(17)256-235(359)196(125(18)294)292-234(358)195(121(14)21-2)291-217(341)148(58-38-42-94-239)261-205(329)150(64-78-179(241)298)265-212(336)158(72-86-188(309)310)272-227(351)172(104-131-111-251-142-52-32-27-47-137(131)142)284-215(339)159(73-87-189(311)312)267-208(332)153(67-81-182(244)301)269-226(350)170(257-126(19)295)102-129-109-249-140-50-30-25-45-135(129)140)233(357)275-154(68-82-183(245)302)209(333)264-151(65-79-180(242)299)207(331)266-156(70-84-186(305)306)210(334)260-146(56-36-40-92-237)204(328)287-175(107-185(247)304)230(354)274-161(75-89-191(315)316)214(338)282-169(101-128-59-61-134(296)62-60-128)225(349)271-160(74-88-190(313)314)213(337)279-165(96-116(5)6)220(344)268-152(66-80-181(243)300)206(330)259-145(55-35-39-91-236)202(326)278-167(98-118(9)10)224(348)288-176(108-193(319)320)231(355)262-147(57-37-41-93-238)203(327)283-171(103-130-110-250-141-51-31-26-46-136(130)141)219(343)255-123(16)200(324)289-177(114-293)232(356)281-168(99-119(11)12)223(347)286-173(105-132-112-252-143-53-33-28-48-138(132)143)228(352)273-162(76-90-192(317)318)216(340)285-174(106-133-113-253-144-54-34-29-49-139(133)144)229(353)276-163(197(248)321)100-127-43-23-22-24-44-127/h22-34,43-54,59-62,109-113,115-125,145-177,194-196,249-253,293-294,296H,20-21,35-42,55-58,63-108,114,236-239H2,1-19H3,(H2,240,297)(H2,241,298)(H2,242,299)(H2,243,300)(H2,244,301)(H2,245,302)(H2,246,303)(H2,247,304)(H2,248,321)(H,254,325)(H,255,343)(H,256,359)(H,257,295)(H,258,322)(H,259,330)(H,260,334)(H,261,329)(H,262,355)(H,263,335)(H,264,333)(H,265,336)(H,266,331)(H,267,332)(H,268,344)(H,269,350)(H,270,345)(H,271,349)(H,272,351)(H,273,352)(H,274,354)(H,275,357)(H,276,353)(H,277,323)(H,278,326)(H,279,337)(H,280,346)(H,281,356)(H,282,338)(H,283,327)(H,284,339)(H,285,340)(H,286,347)(H,287,328)(H,288,348)(H,289,324)(H,290,342)(H,291,341)(H,292,358)(H,305,306)(H,307,308)(H,309,310)(H,311,312)(H,313,314)(H,315,316)(H,317,318)(H,319,320)/t120-,121-,122-,123-,124-,125+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,194-,195-,196-/m0/s1 D08DUY DRUGINKE ZFEAMMNVDPDEGE-LGRGJMMZSA-N D08DUY DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCC(=O)O)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CC8=CC=CC=C8)C(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC9=CNC1=CC=CC=C19)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C D08DUY HIGHSTAT Phase 1/2 D08EQD DRUG__ID D08EQD D08EQD DRUGCOMP Novartis Oncology East Hanover, NJ D08EQD DRUGINCH 1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36) D08EQD DRUGINKE BHKDKKZMPODMIQ-UHFFFAOYSA-N D08EQD DRUGSMIL CN1CCN(C(=O)C1)CC2=C(N=C3C(=C2)CCCN3C(=O)NC4=NC=C(C(=C4)NCCOC)C#N)C=O D08EQD HIGHSTAT Phase 1/2 D08XQV DRUG__ID D08XQV D08XQV DRUGCOMP Upsher-Smith Maple Grove, MN D08XQV DRUGINCH 1S/C24H34N6O/c1-19(2)28-15-9-21(10-16-28)29-13-4-14-30(18-17-29)23-6-3-5-22(27-23)24(31)26-20-7-11-25-12-8-20/h3,5-8,11-12,19,21H,4,9-10,13-18H2,1-2H3,(H,25,26,31) D08XQV DRUGINKE XNUNVQKARNSSEO-UHFFFAOYSA-N D08XQV DRUGSMIL CC(C)N1CCC(CC1)N2CCCN(CC2)C3=CC=CC(=N3)C(=O)NC4=CC=NC=C4 D08XQV HIGHSTAT Phase 1/2 D09BZS DRUG__ID D09BZS D09BZS DRUGCOMP Checkpoint Therapeutics New York, NY D09BZS DRUGINCH 1S/C29H28F2N6O2/c1-2-25(39)33-21-7-3-5-19(17-21)22-8-4-6-20-18-32-29(35-28(20)22)34-23-9-10-24(27(31)26(23)30)37-13-11-36(12-14-37)15-16-38/h2-10,17-18,38H,1,11-16H2,(H,33,39)(H,32,34,35) D09BZS DRUGINKE IDRGFNPZDVBSSE-UHFFFAOYSA-N D09BZS DRUGSMIL C=CC(=O)NC1=CC=CC(=C1)C2=CC=CC3=CN=C(N=C32)NC4=C(C(=C(C=C4)N5CCN(CC5)CCO)F)F D09BZS HIGHSTAT Phase 1/2 D09NTG DRUG__ID D09NTG D09NTG DRUGTYPE Small molecular drug D09NTG DRUGINCH 1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1 D09NTG DRUGINKE WBWWGRHZICKQGZ-HZAMXZRMSA-N D09NTG DRUGSMIL CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C D09NTG HIGHSTAT Phase 1/2 D09XZL DRUG__ID D09XZL D09XZL DRUGCOMP Lexicon Pharmaceuticals Inc D09XZL DRUGINCH 1S/C23H29N7O3/c1-15-12-25-19-18(15)20(27-14-26-19)30-9-7-23(13-24,8-10-30)21(31)28-16-5-4-6-17(11-16)33-22(32)29(2)3/h4-6,11-12,14H,7-10,13,24H2,1-3H3,(H,28,31)(H,25,26,27) D09XZL DRUGINKE PWPNYABQEOGNNC-UHFFFAOYSA-N D09XZL DRUGSMIL CC1=CNC2=C1C(=NC=N2)N3CCC(CC3)(CN)C(=O)NC4=CC(=CC=C4)OC(=O)N(C)C D09XZL HIGHSTAT Phase 1/2 D0AH6V DRUG__ID D0AH6V D0AH6V DRUGCOMP Spirogen Ltd D0AH6V DRUGINCH 1S/C31H32N4O6/c1-18-8-20-14-32-24-12-28(26(38-3)10-22(24)30(36)34(20)16-18)40-6-5-7-41-29-13-25-23(11-27(29)39-4)31(37)35-17-19(2)9-21(35)15-33-25/h10-15,20-21H,1-2,5-9,16-17H2,3-4H3/t20-,21-/m0/s1 D0AH6V DRUGINKE RWZVMMQNDHPRQD-SFTDATJTSA-N D0AH6V DRUGSMIL COC1=C(C=C2C(=C1)C(=O)N3CC(=C)CC3C=N2)OCCCOC4=C(C=C5C(=C4)N=CC6CC(=C)CN6C5=O)OC D0AH6V HIGHSTAT Phase 1/2 D0B9XW DRUG__ID D0B9XW D0B9XW DRUGCOMP Nordic Nanovector AS D0B9XW DRUGINCH 1S/C30H47N7O10S/c31-24(29(46)47)3-1-2-8-32-30(48)33-22-6-4-21(5-7-22)15-23-16-36(19-27(42)43)12-11-34(17-25(38)39)9-10-35(18-26(40)41)13-14-37(23)20-28(44)45/h4-7,23-24H,1-3,8-20,31H2,(H,38,39)(H,40,41)(H,42,43)(H,44,45)(H,46,47)(H2,32,33,48)/t23?,24-/m0/s1 D0B9XW DRUGINKE RMJFCRKHOJOLIN-CGAIIQECSA-N D0B9XW DRUGSMIL C1CN(CCN(C(CN(CCN1CC(=O)O)CC(=O)O)CC2=CC=C(C=C2)NC(=S)NCCCCC(C(=O)O)N)CC(=O)O)CC(=O)O D0B9XW HIGHSTAT Phase 1/2 D0C7XM DRUG__ID D0C7XM D0C7XM DRUGCOMP Bryan Oncor D0C7XM DRUGINCH 1S/C12H22O2/c1-2-3-4-5-10-6-8-11(9-7-10)12(13)14/h10-11H,2-9H2,1H3,(H,13,14) D0C7XM DRUGINKE RVLAXPQGTRTHEV-UHFFFAOYSA-N D0C7XM DRUGSMIL CCCCCC1CCC(CC1)C(=O)O D0C7XM HIGHSTAT Phase 1/2 D0D3VT DRUG__ID D0D3VT D0D3VT DRUGTYPE Small molecular drug D0D3VT DRUGINCH 1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2/t14-,17-/m0/s1 D0D3VT DRUGINKE BGOQGUHWXBGXJW-YOEHRIQHSA-N D0D3VT DRUGSMIL C1CC2=CC(=C(C=C2C3C1NCC4=CC=CC=C34)O)O D0D3VT HIGHSTAT Phase 1/2 D0D7AM DRUG__ID D0D7AM D0D7AM DRUGCOMP Laboratoires Mayoly Spindler D0D7AM DRUGINCH 1S/C16H23NOS/c1-16(2,3)14-6-4-13(5-7-14)12-18-17-15-8-10-19-11-9-15/h4-7H,8-12H2,1-3H3 D0D7AM DRUGINKE QKZIKPBOHKELOB-UHFFFAOYSA-N D0D7AM DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CON=C2CCSCC2 D0D7AM HIGHSTAT Phase 1/2 D0DA5M DRUG__ID D0DA5M D0DA5M DRUGCOMP PRISM Pharma Yokohama, Japan D0DA5M DRUGINCH 1S/C8H7ClN4/c9-6-1-3-7(4-2-6)11-8-5-10-13-12-8/h1-5H,(H2,10,11,12,13) D0DA5M DRUGINKE IUTZKZLVPUPHDA-UHFFFAOYSA-N D0DA5M DRUGSMIL C1=CC(=CC=C1NC2=NNN=C2)Cl D0DA5M HIGHSTAT Phase 1/2 D0E4IB DRUG__ID D0E4IB D0E4IB DRUGCOMP Novartis OncologyEast Hanover, NJ Palobiofarma Barcelona, Spain D0E4IB DRUGINCH 1S/C10H8BrN7/c11-7-8(12)15-10(18-6-2-4-14-18)16-9(7)17-5-1-3-13-17/h1-6H,(H2,12,15,16) D0E4IB DRUGINKE ATFXVNUWQOXRRU-UHFFFAOYSA-N D0E4IB DRUGSMIL C1=CN(N=C1)C2=NC(=NC(=C2Br)N)N3C=CC=N3 D0E4IB HIGHSTAT Phase 1/2 D0E6AG DRUG__ID D0E6AG D0E6AG DRUGCOMP Constellation Pharmaceuticals Cambridge, MA D0E6AG DRUGINCH 1S/C27H33F3N4O3/c1-16-13-23(37-4)21(25(35)32-16)14-31-26(36)24-18(3)34(22-8-6-5-7-20(22)24)17(2)19-9-11-33(12-10-19)15-27(28,29)30/h5-8,13,17,19H,9-12,14-15H2,1-4H3,(H,31,36)(H,32,35)/t17-/m1/s1 D0E6AG DRUGINKE HPODOLXTMDHLLC-QGZVFWFLSA-N D0E6AG DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCN(CC4)CC(F)(F)F)C)OC D0E6AG HIGHSTAT Phase 1/2 D0E9UH DRUG__ID D0E9UH D0E9UH DRUGCOMP Replimmune Woburn, MA D0E9UH DRUGINCH 1S/C10H12N5O5PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13)/t4-,6-,7-,10-,21?/m1/s1 D0E9UH DRUGINKE SMPNJFHAPJOHPP-JOILOJCLSA-N D0E9UH DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)O D0E9UH HIGHSTAT Phase 1/2 D0H3UR DRUG__ID D0H3UR D0H3UR DRUGCOMP EMD Serono Rockland, MA D0H3UR DRUGINCH 1S/C24H21ClFN5O3/c1-33-22-5-4-20(29-30-22)24(32)16-11-17(19(26)12-18(16)25)23-15-3-2-14(10-21(15)27-13-28-23)31-6-8-34-9-7-31/h2-5,10-13,24,32H,6-9H2,1H3/t24-/m0/s1 D0H3UR DRUGINKE MOWXJLUYGFNTAL-DEOSSOPVSA-N D0H3UR DRUGSMIL COC1=NN=C(C=C1)C(C2=C(C=C(C(=C2)C3=NC=NC4=C3C=CC(=C4)N5CCOCC5)F)Cl)O D0H3UR HIGHSTAT Phase 1/2 D0H7PW DRUG__ID D0H7PW D0H7PW DRUGTYPE Small molecular drug D0H7PW DRUGINCH 1S/C17H19NO3/c19-17(18-10-4-1-5-11-18)7-3-2-6-14-8-9-15-16(12-14)21-13-20-15/h2-3,6-9,12H,1,4-5,10-11,13H2/b6-2+,7-3+ D0H7PW DRUGINKE MXXWOMGUGJBKIW-YPCIICBESA-N D0H7PW DRUGSMIL C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3 D0H7PW HIGHSTAT Phase 1/2 D0H7XJ DRUG__ID D0H7XJ D0H7XJ DRUGCOMP Astellas Pharma Inc D0H7XJ DRUGINCH 1S/C19H26N2O3/c1-19(2,23)12-13-6-8-21(9-7-13)18(22)17-11-14-10-15(24-3)4-5-16(14)20-17/h4-5,10-11,13,20,23H,6-9,12H2,1-3H3 D0H7XJ DRUGINKE OXSCPDKUZWPWFR-UHFFFAOYSA-N D0H7XJ DRUGSMIL CC(C)(CC1CCN(CC1)C(=O)C2=CC3=C(N2)C=CC(=C3)OC)O D0H7XJ HIGHSTAT Phase 1/2 D0I0NU DRUG__ID D0I0NU D0I0NU DRUGCOMP Niiki Pharma Inc D0I0NU DRUGINCH 1S/3C9H7NO.Ga/c3*11-8-5-1-3-7-4-2-6-10-9(7)8;/h3*1-6,11H;/q;;;+3/p-3 D0I0NU DRUGINKE KWQNQSDKCINQQP-UHFFFAOYSA-K D0I0NU DRUGSMIL C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Ga+3] D0I0NU HIGHSTAT Phase 1/2 D0I8KA DRUG__ID D0I8KA D0I8KA DRUGCOMP Blaze Bioscience D0I8KA DRUGINCH 1S/C203H296N58O52S12/c1-107(2)85-130-178(291)253-139(185(298)240-129(196(309)310)50-36-76-223-201(215)216)100-319-317-98-137-171(284)225-93-154(268)224-94-155(269)231-120(46-32-72-219-197(207)208)168(281)226-95-156(270)232-121(47-33-73-220-198(209)210)169(282)227-96-157(271)233-122(45-27-28-71-218-153(267)55-22-17-29-77-258-145-64-58-113-41-23-25-43-117(113)162(145)202(6,7)149(258)53-20-14-13-15-21-54-150-203(8,9)163-118-44-26-24-42-114(118)59-65-146(163)259(150)78-30-31-84-325(311,312)313)173(286)250-141-102-322-324-105-144-189(302)243-132(86-111-39-18-16-19-40-111)183(296)256-165(110(5)263)194(307)257-164(109(4)262)193(306)247-136(91-161(277)278)181(294)244-133(88-115-92-217-106-229-115)179(292)236-125(62-66-151(205)265)176(289)237-127(69-82-315-11)172(285)230-108(3)166(279)234-123(48-34-74-221-199(211)212)174(287)235-124(49-35-75-222-200(213)214)175(288)251-142(103-321-320-101-140(186(299)241-130)252-177(290)126(63-67-152(206)266)238-191(304)147-51-37-79-260(147)158(272)97-228-170(283)131(242-187(141)300)87-112-56-60-116(264)61-57-112)188(301)246-134(89-159(273)274)180(293)245-135(90-160(275)276)182(295)254-143(190(303)249-137)104-323-318-99-138(248-167(280)119(204)68-81-314-10)184(297)239-128(70-83-316-12)195(308)261-80-38-52-148(261)192(305)255-144/h13-16,18-21,23-26,39-44,53-54,56-61,64-65,92,106-110,119-144,147-148,164-165,262-263H,17,22,27-38,45-52,55,62-63,66-91,93-105,204H2,1-12H3,(H64-,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257,264,265,266,267,268,269,270,271,273,274,275,276,277,278,279,280,281,282,283,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,300,301,302,303,304,305,306,307,309,310,311,312,313)/t108-,109+,110+,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,147-,148-,164-,165-/m0/s1 D0I8KA DRUGINKE LWXYOERUKGQNKQ-IQDTYCCDSA-N D0I8KA DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(CSSCC4C(=O)NCC(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCSC)CCC(=O)N)CC5=CNC=N5)CC(=O)O)C(C)O)C(C)O)CC6=CC=CC=C6)NC(=O)C7CCCN7C(=O)C(NC(=O)C(CSSCC(C(=O)N4)NC(=O)C(NC(=O)C(NC2=O)CC(=O)O)CC(=O)O)NC(=O)C(CCSC)N)CCSC)C(=O)NC(C(=O)NCC(=O)N8CCCC8C(=O)NC(C(=O)N3)CCC(=O)N)CC9=CC=C(C=C9)O)CCCCNC(=O)CCCCCN1C2=C(C3=CC=CC=C3C=C2)C(C1=CC=CC=CC=CC1=[N+](C2=C(C1(C)C)C1=CC=CC=C1C=C2)CCCCS(=O)(=O)[O-])(C)C)CCCNC(=N)N)CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)CC(C)C)CCCNC(=N)N)CCCNC(=N)N D0I8KA HIGHSTAT Phase 1/2 D0JF6C DRUG__ID D0JF6C D0JF6C DRUGCOMP Karyopharm Therapeutics Newton, MA D0JF6C DRUGINCH 1S/C17H10F6N6O/c18-16(19,20)11-1-9(2-12(3-11)17(21,22)23)15-27-8-29(28-15)6-13(14(24)30)10-4-25-7-26-5-10/h1-8H,(H2,24,30)/b13-6+ D0JF6C DRUGINKE JFBAVWVBLRIWHM-AWNIVKPZSA-N D0JF6C DRUGSMIL C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)C2=NN(C=N2)C=C(C3=CN=CN=C3)C(=O)N D0JF6C HIGHSTAT Phase 1/2 D0K8TO DRUG__ID D0K8TO D0K8TO DRUGCOMP Bellicum Pharmaceuticals D0K8TO DRUGINCH 1S/C78H98N4O20/c1-13-57(53-43-67(93-7)73(97-11)68(44-53)94-8)75(85)81-37-17-15-25-59(81)77(87)101-61(31-27-49-29-33-63(89-3)65(39-49)91-5)51-21-19-23-55(41-51)99-47-71(83)79-35-36-80-72(84)48-100-56-24-20-22-52(42-56)62(32-28-50-30-34-64(90-4)66(40-50)92-6)102-78(88)60-26-16-18-38-82(60)76(86)58(14-2)54-45-69(95-9)74(98-12)70(46-54)96-10/h19-24,29-30,33-34,39-46,57-62H,13-18,25-28,31-32,35-38,47-48H2,1-12H3,(H,79,83)(H,80,84)/t57-,58-,59-,60-,61+,62+/m0/s1 D0K8TO DRUGINKE GQLCLPLEEOUJQC-ZTQDTCGGSA-N D0K8TO DRUGSMIL CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC D0K8TO HIGHSTAT Phase 1/2 D0L1YM DRUG__ID D0L1YM D0L1YM DRUGCOMP McNeil Laboratories D0L1YM THERCLAS Psychiatric D0L1YM DRUGTYPE Small molecular drug D0L1YM DRUGSMIL CN1CC(=O)N=C1NC(=O)NC2=CC(=CC=C2)Cl D0L1YM HIGHSTAT Phase 1/2 D0M5XN DRUG__ID D0M5XN D0M5XN DRUGTYPE Small molecular drug D0M5XN DRUGINCH 1S/C25H17F3N4O3/c26-25(27,28)11-1-4-15-16(9-11)31-24(30-15)21-20-14-10-12(2-5-17(14)35-22(20)21)34-18-7-8-29-23-13(18)3-6-19(33)32-23/h1-2,4-5,7-10,20-22H,3,6H2,(H,30,31)(H,29,32,33)/t20-,21-,22-/m0/s1 D0M5XN DRUGINKE NGFFVZQXSRKHBM-FKBYEOEOSA-N D0M5XN DRUGSMIL C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)OC5C4C5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F D0M5XN HIGHSTAT Phase 1/2 D0N7DQ DRUG__ID D0N7DQ D0N7DQ DRUGCOMP Adamis Pharmaceuticals D0N7DQ DRUGINCH 1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3 D0N7DQ DRUGINKE SEBPXHSZHLFWRL-UHFFFAOYSA-N D0N7DQ DRUGSMIL CC1=C(C2=C(CCC(O2)(C)C)C(=C1O)C)C D0N7DQ HIGHSTAT Phase 1/2 D0O6WV DRUG__ID D0O6WV D0O6WV DRUGTYPE Small molecular drug D0O6WV DRUGINCH 1S/C25H19ClF2N4O4/c1-2-35-19-10-12-32(16-6-3-14(27)4-7-16)25(34)21(19)24(33)31-15-5-8-18(17(28)13-15)36-20-9-11-30-23(29)22(20)26/h3-13H,2H2,1H3,(H2,29,30)(H,31,33) D0O6WV DRUGINKE VNBRGSXVFBYQNN-UHFFFAOYSA-N D0O6WV DRUGSMIL CCOC1=C(C(=O)N(C=C1)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F D0O6WV HIGHSTAT Phase 1/2 D0P0KN DRUG__ID D0P0KN D0P0KN DRUGTYPE Small molecular drug D0P0KN DRUGINCH 1S/C23H24N4O/c1-27-13-3-2-4-14-28-21-10-6-8-19(16-21)22-11-12-24-23(26-22)25-20-9-5-7-18(15-20)17-27/h2-3,5-12,15-16H,4,13-14,17H2,1H3,(H,24,25,26)/b3-2+ D0P0KN DRUGINKE VXBAJLGYBMTJCY-NSCUHMNNSA-N D0P0KN DRUGSMIL CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1 D0P0KN HIGHSTAT Phase 1/2 D0P9MW DRUG__ID D0P9MW D0P9MW DRUGCOMP Immutep SA D0P9MW DRUGINCH 1S/C56H78N18O14S/c57-23-3-1-6-41(70-55(88)43(27-34-7-13-39(75)14-8-34)72-52(85)35-9-11-36(12-10-35)68-56(89)73-59)53(86)71-42(15-20-50(82)83)54(87)69-40(51(58)84)5-2-4-26-74(48(80)30-64-46(78)18-16-44(76)62-24-21-37-28-60-32-66-37)49(81)31-65-47(79)19-17-45(77)63-25-22-38-29-61-33-67-38/h7-14,28-29,32-33,40-43,75H,1-6,15-27,30-31,57,59H2,(H2,58,84)(H,60,66)(H,61,67)(H,62,76)(H,63,77)(H,64,78)(H,65,79)(H,69,87)(H,70,88)(H,71,86)(H,72,85)(H,82,83)(H2,68,73,89)/t40-,41-,42-,43-/m1/s1 D0P9MW DRUGINKE ONKCBKDTKZIWHZ-MRWFHJSOSA-N D0P9MW DRUGSMIL C1=CC(=CC=C1CC(C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN(C(=O)CNC(=O)CCC(=O)NCCC2=CN=CN2)C(=O)CNC(=O)CCC(=O)NCCC3=CN=CN3)C(=O)N)NC(=O)C4=CC=C(C=C4)NC(=S)NN)O D0P9MW HIGHSTAT Phase 1/2 D0Q0ZY DRUG__ID D0Q0ZY D0Q0ZY DRUGCOMP PRISM BioLab D0Q0ZY DRUGINCH 1S/C33H35N6O7P/c1-22-31-38(29(40)21-36(2)39(31)33(42)35-19-24-8-4-3-5-9-24)28(18-23-13-15-27(16-14-23)46-47(43,44)45)32(41)37(22)20-26-11-6-10-25-12-7-17-34-30(25)26/h3-17,22,28,31H,18-21H2,1-2H3,(H,35,42)(H2,43,44,45)/t22-,28-,31-/m0/s1 D0Q0ZY DRUGINKE VHOZWHQPEJGPCC-AZXNYEMZSA-N D0Q0ZY DRUGSMIL CC1C2N(C(C(=O)N1CC3=CC=CC4=C3N=CC=C4)CC5=CC=C(C=C5)OP(=O)(O)O)C(=O)CN(N2C(=O)NCC6=CC=CC=C6)C D0Q0ZY HIGHSTAT Phase 1/2 D0Q1SQ DRUG__ID D0Q1SQ D0Q1SQ DRUGCOMP Mundipharma Cambridge, United Kingdom D0Q1SQ DRUGINCH 1S/C19H28Cl2N4O2/c1-24-17-9-8-15(25(12-10-20)13-11-21)14-16(17)22-18(24)6-4-2-3-5-7-19(26)23-27/h8-9,14,27H,2-7,10-13H2,1H3,(H,23,26) D0Q1SQ DRUGINKE GISXTRIGVCKQBX-UHFFFAOYSA-N D0Q1SQ DRUGSMIL CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO D0Q1SQ HIGHSTAT Phase 1/2 D0Q9IK DRUG__ID D0Q9IK D0Q9IK DRUGCOMP Cephalon D0Q9IK DRUGINCH 1S/C24H26N4O3/c1-26-9-11-27(12-10-26)13-28-23(29)18-14-5-3-6-15(14)22-20(21(18)24(28)30)19-16(25-22)7-4-8-17(19)31-2/h4,7-8,25H,3,5-6,9-13H2,1-2H3 D0Q9IK DRUGINKE CTLOSZHDGZLOQE-UHFFFAOYSA-N D0Q9IK DRUGSMIL CN1CCN(CC1)CN2C(=O)C3=C(C2=O)C4=C(C5=C3CCC5)NC6=C4C(=CC=C6)OC D0Q9IK HIGHSTAT Phase 1/2 D0R7HL DRUG__ID D0R7HL D0R7HL DRUGCOMP Novartis Oncology East Hanover, NJ D0R7HL DRUGINCH 1S/C22H23F3N8O/c1-21(27)6-10-33(11-7-21)15-5-3-9-29-19(15)32-20(34)17-18(26)30-12-14(31-17)16-13(22(23,24)25)4-2-8-28-16/h2-5,8-9,12H,6-7,10-11,27H2,1H3,(H2,26,30)(H,29,32,34) D0R7HL DRUGINKE XXJXHXJWQSCNPX-UHFFFAOYSA-N D0R7HL DRUGSMIL CC1(CCN(CC1)C2=C(N=CC=C2)NC(=O)C3=NC(=CN=C3N)C4=C(C=CC=N4)C(F)(F)F)N D0R7HL HIGHSTAT Phase 1/2 D0RS4X DRUG__ID D0RS4X D0RS4X DRUGCOMP Tarveda Therapeutics Watertown, MA D0RS4X DRUGINCH 1S/C49H49N7O9/c1-5-31-33-20-30(8-9-38(33)50-43-35(31)24-55-40(43)22-37-36(45(55)59)25-64-46(60)49(37,63)6-2)65-48(62)54-16-12-27(13-17-54)11-15-53-18-14-28-19-29(7-10-39(28)53)56-44(51-52-47(56)61)34-21-32(26(3)4)41(57)23-42(34)58/h7-10,14,18-23,26-27,57-58,63H,5-6,11-13,15-17,24-25H2,1-4H3,(H,52,61)/t49-/m0/s1 D0RS4X DRUGINKE QTPZAEAYDWMVJO-GGCSAXROSA-N D0RS4X DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)CCN7C=CC8=C7C=CC(=C8)N9C(=NNC9=O)C1=CC(=C(C=C1O)O)C(C)C D0RS4X HIGHSTAT Phase 1/2 D0SD9Z DRUG__ID D0SD9Z D0SD9Z DRUGCOMP Janssen Research & Development Raritan, NJTRACON PharmaceuticalsSan Diego, CA D0SD9Z DRUGINCH 1S/C23H21F3N6O2S/c24-23(25,26)17-10-15(13-29-18(17)11-27)31-20(33)22(6-1-7-22)32(21(31)35)14-2-3-19(30-12-14)34-16-4-8-28-9-5-16/h2-3,10,12-13,16,28H,1,4-9H2 D0SD9Z DRUGINKE OUEHJEYKNYQVRC-UHFFFAOYSA-N D0SD9Z DRUGSMIL C1CC2(C1)C(=O)N(C(=S)N2C3=CN=C(C=C3)OC4CCNCC4)C5=CC(=C(N=C5)C#N)C(F)(F)F D0SD9Z HIGHSTAT Phase 1/2 D0UO0C DRUG__ID D0UO0C D0UO0C DRUGCOMP Novartis Oncology East Hanover, NJ D0UO0C DRUGINCH 1S/C20H17FN6O/c1-12-13(3-2-7-22-12)16-10-24-20(27-11-25-26-19(16)27)23-9-15-14-6-8-28-18(14)5-4-17(15)21/h2-5,7,10-11H,6,8-9H2,1H3,(H,23,24) D0UO0C DRUGINKE XLIBABIFOBYHSV-UHFFFAOYSA-N D0UO0C DRUGSMIL CC1=C(C=CC=N1)C2=CN=C(N3C2=NN=C3)NCC4=C(C=CC5=C4CCO5)F D0UO0C HIGHSTAT Phase 1/2 D0W3UH DRUG__ID D0W3UH D0W3UH DRUGCOMP Othera Pharmaceuticals Inc D0W3UH DRUGINCH 1S/C25H36N2O8/c1-15-9-19(28)20(29)10-18(15)22(31)34-13-17(35-23(32)25(4)6-7-25)11-27-24(2,3)14-26-21(30)16-5-8-33-12-16/h9-10,16-17,27-29H,5-8,11-14H2,1-4H3,(H,26,30)/t16?,17-/m0/s1 D0W3UH DRUGINKE ANXXSWNMHQHOQC-DJNXLDHESA-N D0W3UH DRUGSMIL CC1=CC(=C(C=C1C(=O)OCC(CNC(C)(C)CNC(=O)C2CCOC2)OC(=O)C3(CC3)C)O)O D0W3UH HIGHSTAT Phase 1/2 D0WM5O DRUG__ID D0WM5O D0WM5O DRUGTYPE Small molecular drug D0WM5O DRUGINCH 1S/C21H18BrNO3/c1-11(24)12-5-6-18-15(7-12)13-3-2-4-14(13)21(23-18)16-8-19-20(9-17(16)22)26-10-25-19/h2-3,5-9,13-14,21,23H,4,10H2,1H3/t13-,14+,21-/m1/s1 D0WM5O DRUGINKE VHSVKVWHYFBIFJ-HKZYLEAXSA-N D0WM5O DRUGSMIL CC(=O)C1=CC2=C(C=C1)NC(C3C2C=CC3)C4=CC5=C(C=C4Br)OCO5 D0WM5O HIGHSTAT Phase 1/2 D0Y2NS DRUG__ID D0Y2NS D0Y2NS DRUGCOMP Takeda D0Y2NS DRUGINCH 1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22) D0Y2NS DRUGINKE BLGWHBSBBJNKJO-UHFFFAOYSA-N D0Y2NS DRUGSMIL C1COCCN1C(=O)C2=CN=C3N2C=C(C=C3)C4=CC5=C(C=C4)OC(=N5)N D0Y2NS HIGHSTAT Phase 1/2 D0YI4F DRUG__ID D0YI4F D0YI4F DRUGCOMP Sunesis Pharmaceuticals South San Francisco, CA D0YI4F DRUGINCH 1S/C22H24ClF4N7O2/c23-12-6-11(22(25,26)27)7-13(8-12)32-15-2-1-4-34(21(15)36)16-9-33(5-3-14(16)19(29)35)20-17(24)18(28)30-10-31-20/h6-8,10,14-16,32H,1-5,9H2,(H2,29,35)(H2,28,30,31)/t14-,15+,16-/m0/s1 D0YI4F DRUGINKE QLRRJMOBVVGXEJ-XHSDSOJGSA-N D0YI4F DRUGSMIL C1CC(C(=O)N(C1)C2CN(CCC2C(=O)N)C3=NC=NC(=C3F)N)NC4=CC(=CC(=C4)C(F)(F)F)Cl D0YI4F HIGHSTAT Phase 1/2 D0YZ1Q DRUG__ID D0YZ1Q D0YZ1Q DRUGCOMP Rgenix New York, NY D0YZ1Q DRUGINCH 1S/C34H33ClF3NO3.ClH/c1-24(18-19-42-29-16-8-10-25(20-29)21-32(40)41)39(22-28-15-9-17-31(33(28)35)34(36,37)38)23-30(26-11-4-2-5-12-26)27-13-6-3-7-14-27;/h2-17,20,24,30H,18-19,21-23H2,1H3,(H,40,41);1H/t24-;/m1./s1 D0YZ1Q DRUGINKE LCMIYQOJZLRHTO-GJFSDDNBSA-N D0YZ1Q DRUGSMIL CC(CCOC1=CC=CC(=C1)CC(=O)O)N(CC2=C(C(=CC=C2)C(F)(F)F)Cl)CC(C3=CC=CC=C3)C4=CC=CC=C4.Cl D0YZ1Q HIGHSTAT Phase 1/2 D0Z4CY DRUG__ID D0Z4CY D0Z4CY DRUGCOMP Tarveda Therapeutics Watertown, MA D0Z4CY DRUGINCH 1S/C83H109ClN14O20S4/c1-44-18-17-24-65(115-9)83(113)39-64(116-81(112)96-83)45(2)71-82(5,118-71)66(38-68(102)98(7)62-35-50(32-44)36-63(114-8)69(62)84)117-80(111)46(3)97(6)67(101)29-31-119-120-41-59(72(87)103)92-78(109)61-43-122-121-42-60(93-73(104)54(86)33-48-19-11-10-12-20-48)77(108)90-57(34-49-25-27-52(100)28-26-49)75(106)91-58(37-51-40-88-55-22-14-13-21-53(51)55)76(107)89-56(23-15-16-30-85)74(105)95-70(47(4)99)79(110)94-61/h10-14,17-22,24-28,35-36,40,45-47,54,56-61,64-66,70-71,88,99-100,113H,15-16,23,29-34,37-39,41-43,85-86H2,1-9H3,(H2,87,103)(H,89,107)(H,90,108)(H,91,106)(H,92,109)(H,93,104)(H,94,110)(H,95,105)(H,96,112)/b24-17+,44-18+/t45-,46+,47-,54-,56+,57+,58-,59+,60+,61+,64+,65-,66+,70+,71+,82+,83+/m1/s1 D0Z4CY DRUGINKE JVPMJFUBODFGNB-UFDFPQQFSA-N D0Z4CY DRUGSMIL CC1C2CC(C(C=CC=C(CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)CC(C4(C1O4)C)OC(=O)C(C)N(C)C(=O)CCSSCC(C(=O)N)NC(=O)C5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N5)C(C)O)CCCCN)CC6=CNC7=CC=CC=C76)CC8=CC=C(C=C8)O)NC(=O)C(CC9=CC=CC=C9)N)C)C)OC)(NC(=O)O2)O D0Z4CY HIGHSTAT Phase 1/2 D0Z5VW DRUG__ID D0Z5VW D0Z5VW DRUGCOMP EisaiWoodcliff Lake, NJH3 Biomedicine Cambridge, MA D0Z5VW DRUGINCH 1S/C30H29F4N5O2/c1-39(2)27(40)9-6-14-35-15-16-41-26-13-11-22(19-36-26)28(21-10-12-25-23(17-21)29(31)38-37-25)24(18-30(32,33)34)20-7-4-3-5-8-20/h3-13,17,19,35H,14-16,18H2,1-2H3,(H,37,38)/b9-6+,28-24- D0Z5VW DRUGINKE JPFTZIJTXCHJNE-HMOQVRKWSA-N D0Z5VW DRUGSMIL CN(C)C(=O)C=CCNCCOC1=NC=C(C=C1)C(=C(CC(F)(F)F)C2=CC=CC=C2)C3=CC4=C(NN=C4C=C3)F D0Z5VW HIGHSTAT Phase 1/2 D09OTX DRUG__ID D09OTX D09OTX DRUGINCH 1S/C24H28N6O/c1-5-19-22-11-21(27-30(22)13-16(3)25-19)20-12-23(31)29-14-18(10-15(2)24(29)26-20)17-6-8-28(4)9-7-17/h10-14,17H,5-9H2,1-4H3 D09OTX DRUGINKE GYFRQCMDLBNZSF-UHFFFAOYSA-N D09OTX DRUGSMIL CCC1=NC(=CN2C1=CC(=N2)C3=CC(=O)N4C=C(C=C(C4=N3)C)C5CCN(CC5)C)C D09OTX HIGHSTAT Phase 1/2 D0B1UO DRUG__ID D0B1UO D0B1UO DRUGCOMP Shenzhen Geno-Immune Medical Institute D0B1UO THERCLAS Antiviral Agents D0B1UO DRUGTYPE Vaccine D0B1UO HIGHSTAT Phase 1/2 Trial D0C1JP DRUG__ID D0C1JP D0C1JP DRUGCOMP Aegera Therapeutics D0C1JP THERCLAS siRNA D0C1JP DRUGTYPE siRNA drug D0C1JP HIGHSTAT Phase 1/2 D0DX7J DRUG__ID D0DX7J D0DX7J THERCLAS Antiviral Agents D0DX7J DRUGTYPE Protein/peptide drug D0DX7J DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N D0DX7J HIGHSTAT Phase 1/2 Trial D0KY3W DRUG__ID D0KY3W D0KY3W DRUGCOMP Inovio Pharmaceuticals D0KY3W THERCLAS Antiviral Agents D0KY3W DRUGTYPE Vaccine D0KY3W HIGHSTAT Phase 1/2 Trial D0N7WW DRUG__ID D0N7WW D0N7WW DRUGCOMP Resverlogix D0N7WW DRUGTYPE Small molecular drug D0N7WW DRUGSMIL CC1=CC(=CC(=C1OCCO)C)C2=NC(=O)C3=C(N2)C=C(C=C3OC)OC D0N7WW HIGHSTAT Phase 1/2 D00FIO DRUG__ID D00FIO D00FIO DRUGCOMP Southwest Hospital, China D00FIO DRUGTYPE CAR T Cell Therapy D00FIO HIGHSTAT Phase 1/2 D00GAM DRUG__ID D00GAM D00GAM DRUGCOMP Santaris Pharma A/S D00GAM DRUGTYPE Antisense drug D00GAM HIGHSTAT Phase 1/2 D00GBZ DRUG__ID D00GBZ D00GBZ DRUGCOMP Cequent Pharmaceuticals Inc D00GBZ DRUGTYPE siRNA drug D00GBZ HIGHSTAT Phase 1/2 D00HDZ DRUG__ID D00HDZ D00HDZ THERCLAS Antiviral Agents D00HDZ DRUGTYPE Cell therapy D00HDZ HIGHSTAT Phase 1/2 Trial D00JWN DRUG__ID D00JWN D00JWN THERCLAS Antiviral Agents D00JWN DRUGTYPE Cell therapy D00JWN HIGHSTAT Phase 1/2 Trial D00NBW DRUG__ID D00NBW D00NBW DRUGCOMP Targovax Oslo, Norway D00NBW DRUGTYPE Oncolytic virus therapy D00NBW HIGHSTAT Phase 1/2 D00PBS DRUG__ID D00PBS D00PBS THERCLAS Antiviral Agents D00PBS DRUGTYPE Cell therapy D00PBS HIGHSTAT Phase 1/2 Trial D00PEN DRUG__ID D00PEN D00PEN DRUGCOMP MacroGenics D00PEN DRUGTYPE Monoclonal antibody D00PEN HIGHSTAT Phase 1/2 D00QWK DRUG__ID D00QWK D00QWK DRUGCOMP Shenzhen Geno-Immune Medical Institute D00QWK DRUGTYPE CAR T Cell Therapy D00QWK HIGHSTAT Phase 1/2 D00RAM DRUG__ID D00RAM D00RAM THERCLAS Antiviral Agents D00RAM DRUGTYPE Cell therapy D00RAM HIGHSTAT Phase 1/2 Trial D00ROR DRUG__ID D00ROR D00ROR THERCLAS Antiviral Agents D00ROR DRUGTYPE Cell therapy D00ROR HIGHSTAT Phase 1/2 Trial D00UGY DRUG__ID D00UGY D00UGY THERCLAS Antiviral Agents D00UGY DRUGTYPE Cell therapy D00UGY HIGHSTAT Phase 1/2 Trial D00UOQ DRUG__ID D00UOQ D00UOQ DRUGCOMP Universitat Wurzburg D00UOQ DRUGTYPE Antibody D00UOQ HIGHSTAT Phase 1/2 D00YXG DRUG__ID D00YXG D00YXG DRUGCOMP National Cancer Institute (NCI) D00YXG DRUGTYPE CAR T Cell Therapy D00YXG HIGHSTAT Phase 1/2 D01CUC DRUG__ID D01CUC D01CUC DRUGCOMP Shenzhen Geno-Immune Medical Institute D01CUC DRUGTYPE CAR T Cell Therapy D01CUC HIGHSTAT Phase 1/2 D01KKI DRUG__ID D01KKI D01KKI DRUGCOMP Seattle genetics D01KKI DRUGTYPE Antibody D01KKI HIGHSTAT Phase 1/2 D01MDX DRUG__ID D01MDX D01MDX DRUGCOMP Autolus Limited D01MDX DRUGTYPE CAR T Cell Therapy D01MDX HIGHSTAT Phase 1/2 D01YCF DRUG__ID D01YCF D01YCF DRUGCOMP Shenzhen Geno-Immune Medical Institute D01YCF DRUGTYPE CAR T Cell Therapy D01YCF HIGHSTAT Phase 1/2 D02BCY DRUG__ID D02BCY D02BCY DRUGCOMP Shenzhen Second People's Hospital D02BCY DRUGTYPE CAR T Cell Therapy D02BCY HIGHSTAT Phase 1/2 D02BHW DRUG__ID D02BHW D02BHW DRUGCOMP Beijing Immunochina Medical Science & Technology Co., Ltd. D02BHW DRUGTYPE CAR T Cell Therapy D02BHW HIGHSTAT Phase 1/2 D02CLV DRUG__ID D02CLV D02CLV DRUGCOMP University of Oxford D02CLV DRUGTYPE Vaccine D02CLV HIGHSTAT Phase 1/2 D02DVK DRUG__ID D02DVK D02DVK DRUGCOMP CureVac GmbH D02DVK DRUGTYPE Vaccine D02DVK HIGHSTAT Phase 1/2 D02FYI DRUG__ID D02FYI D02FYI DRUGCOMP Andarix Pharmaceuticals D02FYI DRUGTYPE Radiopharmaceutical therapy agent D02FYI HIGHSTAT Phase 1/2 D02JNC DRUG__ID D02JNC D02JNC DRUGCOMP Henan Cancer Hospital D02JNC DRUGTYPE CAR T Cell Therapy D02JNC HIGHSTAT Phase 1/2 D02ONA DRUG__ID D02ONA D02ONA DRUGCOMP Autolus Limited D02ONA DRUGTYPE CAR T Cell Therapy (Dual specific) D02ONA HIGHSTAT Phase 1/2 D02OZT DRUG__ID D02OZT D02OZT DRUGCOMP Dicerna pharmaceuticals D02OZT DRUGTYPE siRNA drug D02OZT HIGHSTAT Phase 1/2 D02WLS DRUG__ID D02WLS D02WLS DRUGCOMP Cancer Research Campaign; VaxOnco D02WLS DRUGTYPE Vaccine D02WLS HIGHSTAT Phase 1/2 D02WSY DRUG__ID D02WSY D02WSY DRUGCOMP CovX D02WSY DRUGTYPE Antibody D02WSY HIGHSTAT Phase 1/2 D02YRD DRUG__ID D02YRD D02YRD DRUGCOMP Shenzhen Geno-Immune Medical Institute D02YRD DRUGTYPE CAR T Cell Therapy (Dual specific) D02YRD HIGHSTAT Phase 1/2 D02ZXK DRUG__ID D02ZXK D02ZXK THERCLAS Antiviral Agents D02ZXK DRUGTYPE Monoclonal antibody D02ZXK HIGHSTAT Phase 1/2 Trial D03BZU DRUG__ID D03BZU D03BZU DRUGCOMP Roche/Genentech South San Francisco, CA D03BZU DRUGTYPE Antibody D03BZU HIGHSTAT Phase 1/2 D03EOF DRUG__ID D03EOF D03EOF THERCLAS Antiviral Agents D03EOF DRUGTYPE Monoclonal antibody D03EOF HIGHSTAT Phase 1/2 Trial D03HML DRUG__ID D03HML D03HML DRUGCOMP Shenzhen Geno-Immune Medical Institute D03HML DRUGTYPE CAR T Cell Therapy D03HML HIGHSTAT Phase 1/2 D03IHD DRUG__ID D03IHD D03IHD DRUGCOMP Affiliated Hospital to Academy of Military Medical Sciences D03IHD DRUGTYPE CAR T Cell Therapy D03IHD HIGHSTAT Phase 1/2 D03JOA DRUG__ID D03JOA D03JOA DRUGCOMP Fred Hutchinson Cancer Research Center D03JOA DRUGTYPE CAR T Cell Therapy D03JOA HIGHSTAT Phase 1/2 D03KHQ DRUG__ID D03KHQ D03KHQ DRUGCOMP US Naval Medical Research Center D03KHQ DRUGTYPE Vaccine D03KHQ HIGHSTAT Phase 1/2 D03LUF DRUG__ID D03LUF D03LUF DRUGCOMP Wuhan Sian Medical Technology Co., Ltd D03LUF DRUGTYPE CAR T Cell Therapy D03LUF HIGHSTAT Phase 1/2 D03MDY DRUG__ID D03MDY D03MDY DRUGCOMP Plexxikon D03MDY DRUGTYPE Small molecular drug D03MDY HIGHSTAT Phase 1/2 D03UNT DRUG__ID D03UNT D03UNT DRUGCOMP Chinese PLA General Hospital D03UNT DRUGTYPE CAR T Cell Therapy D03UNT HIGHSTAT Phase 1/2 D03ZCH DRUG__ID D03ZCH D03ZCH DRUGCOMP Shenzhen Geno-Immune Medical Institute D03ZCH DRUGTYPE CAR T Cell Therapy (Dual specific) D03ZCH HIGHSTAT Phase 1/2 D04ACK DRUG__ID D04ACK D04ACK DRUGCOMP Peking University D04ACK DRUGTYPE CAR T Cell Therapy D04ACK HIGHSTAT Phase 1/2 D04CKC DRUG__ID D04CKC D04CKC DRUGCOMP Shanghai GeneChem Co., Ltd. D04CKC DRUGTYPE CAR T Cell Therapy D04CKC HIGHSTAT Phase 1/2 D04DHZ DRUG__ID D04DHZ D04DHZ DRUGCOMP Chinese PLA General Hospital D04DHZ DRUGTYPE CAR T Cell Therapy D04DHZ HIGHSTAT Phase 1/2 D04FPN DRUG__ID D04FPN D04FPN DRUGCOMP Federal Research Institute of Pediatric Hematology, Oncology and Immunology D04FPN DRUGTYPE CAR T Cell Therapy D04FPN HIGHSTAT Phase 1/2 D04GIO DRUG__ID D04GIO D04GIO DRUGCOMP Shanghai Longyao Biotechnology Inc., Ltd. D04GIO DRUGTYPE CAR T Cell Therapy (Dual specific) D04GIO HIGHSTAT Phase 1/2 D04JHH DRUG__ID D04JHH D04JHH DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D04JHH DRUGTYPE CAR T Cell Therapy D04JHH HIGHSTAT Phase 1/2 D04JOE DRUG__ID D04JOE D04JOE DRUGCOMP GSK; Domantis; Cephalon D04JOE DRUGTYPE Monoclonal antibody D04JOE HIGHSTAT Phase 1/2 D04MLR DRUG__ID D04MLR D04MLR DRUGCOMP Shenzhen Geno-Immune Medical Institute D04MLR DRUGTYPE CAR T Cell Therapy D04MLR HIGHSTAT Phase 1/2 D04NOE DRUG__ID D04NOE D04NOE DRUGCOMP OncoTherapy Science Inc D04NOE DRUGTYPE Vaccine D04NOE HIGHSTAT Phase 1/2 D04PIU DRUG__ID D04PIU D04PIU DRUGCOMP The First Affiliated Hospital of Soochow University D04PIU DRUGTYPE CAR T Cell Therapy D04PIU HIGHSTAT Phase 1/2 D04UFI DRUG__ID D04UFI D04UFI DRUGCOMP Hadassah Medical Organization D04UFI DRUGTYPE Vaccine D04UFI HIGHSTAT Phase 1/2 D04VCQ DRUG__ID D04VCQ D04VCQ DRUGCOMP Chinese PLA General Hospital D04VCQ DRUGTYPE CAR T Cell Therapy D04VCQ HIGHSTAT Phase 1/2 D04WIE DRUG__ID D04WIE D04WIE DRUGCOMP Sirna Therapeutics D04WIE DRUGTYPE siRNA drug D04WIE HIGHSTAT Phase 1/2 D05CSS DRUG__ID D05CSS D05CSS DRUGCOMP Shenzhen Geno-Immune Medical Institute D05CSS DRUGTYPE CAR T Cell Therapy D05CSS HIGHSTAT Phase 1/2 D05CTQ DRUG__ID D05CTQ D05CTQ DRUGCOMP Shenzhen Geno-Immune Medical Institute D05CTQ DRUGTYPE CAR T Cell Therapy D05CTQ HIGHSTAT Phase 1/2 D05ECA DRUG__ID D05ECA D05ECA DRUGCOMP Novartis pharmaceuticals D05ECA DRUGTYPE Antibody D05ECA HIGHSTAT Phase 1/2 D05FUP DRUG__ID D05FUP D05FUP DRUGCOMP Shenzhen Geno-Immune Medical Institute D05FUP DRUGTYPE CAR T Cell Therapy D05FUP HIGHSTAT Phase 1/2 D05LIH DRUG__ID D05LIH D05LIH DRUGCOMP PersonGen BioTherapeutics (Suzhou) Co., Ltd. D05LIH DRUGTYPE CAR T Cell Therapy D05LIH HIGHSTAT Phase 1/2 D05NYO DRUG__ID D05NYO D05NYO DRUGCOMP Ganymed Pharmaceuticals AG D05NYO DRUGTYPE Monoclonal antibody D05NYO HIGHSTAT Phase 1/2 D05OAI DRUG__ID D05OAI D05OAI DRUGCOMP Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd D05OAI DRUGTYPE CAR T Cell Therapy (Dual specific) D05OAI HIGHSTAT Phase 1/2 D05OHY DRUG__ID D05OHY D05OHY DRUGCOMP Fuda Cancer Hospital, Guangzhou D05OHY DRUGTYPE CAR T Cell Therapy D05OHY HIGHSTAT Phase 1/2 D05ORA DRUG__ID D05ORA D05ORA DRUGCOMP Glaxosmithkline D05ORA DRUGTYPE Antibody D05ORA HIGHSTAT Phase 1/2 D05PZI DRUG__ID D05PZI D05PZI DRUGCOMP Miltenyi Biotec GmbH D05PZI DRUGTYPE CAR T Cell Therapy D05PZI HIGHSTAT Phase 1/2 D05VNS DRUG__ID D05VNS D05VNS DRUGCOMP Chinese PLA General Hospital D05VNS DRUGTYPE CAR T Cell Therapy (Dual specific) D05VNS HIGHSTAT Phase 1/2 D05VXF DRUG__ID D05VXF D05VXF DRUGCOMP Y's Therapeutics Co Ltd D05VXF DRUGTYPE Antibody D05VXF HIGHSTAT Phase 1/2 D05ZBV DRUG__ID D05ZBV D05ZBV DRUGCOMP Rubius Therapeutics D05ZBV DRUGTYPE Cell therapy D05ZBV HIGHSTAT Phase 1/2 D06FAA DRUG__ID D06FAA D06FAA DRUGCOMP Cambridge Antibody Technology Group plc; MedImmune D06FAA DRUGTYPE Antibody D06FAA HIGHSTAT Phase 1/2 D06KQG DRUG__ID D06KQG D06KQG DRUGCOMP Fuda Cancer Hospital, Guangzhou D06KQG DRUGTYPE CAR T Cell Therapy D06KQG HIGHSTAT Phase 1/2 D06TWS DRUG__ID D06TWS D06TWS DRUGCOMP Shenzhen Geno-Immune Medical Institute D06TWS DRUGTYPE CAR T Cell Therapy D06TWS HIGHSTAT Phase 1/2 D06VFF DRUG__ID D06VFF D06VFF DRUGCOMP University of Pittsburgh D06VFF DRUGTYPE Antisense drug D06VFF HIGHSTAT Phase 1/2 D06WNQ DRUG__ID D06WNQ D06WNQ DRUGCOMP Tekmira Pharmaceuticals D06WNQ DRUGTYPE siRNA drug D06WNQ HIGHSTAT Phase 1/2 D07AKD DRUG__ID D07AKD D07AKD DRUGCOMP Tolera Therapeutics Inc D07AKD DRUGTYPE Antibody D07AKD HIGHSTAT Phase 1/2 D07AYI DRUG__ID D07AYI D07AYI DRUGCOMP JW Pharmaceutical D07AYI DRUGTYPE Small molecular drug D07AYI HIGHSTAT Phase 1/2 D07GHA DRUG__ID D07GHA D07GHA DRUGCOMP Plexxikon D07GHA DRUGTYPE Small molecular drug D07GHA HIGHSTAT Phase 1/2 D07GNO DRUG__ID D07GNO D07GNO DRUGCOMP Kyowa Hakko Kirin Pharma D07GNO DRUGTYPE Antibody D07GNO HIGHSTAT Phase 1/2 D07NHZ DRUG__ID D07NHZ D07NHZ DRUGCOMP Sheba Medical Center D07NHZ DRUGTYPE CAR T Cell Therapy D07NHZ HIGHSTAT Phase 1/2 D07PJS DRUG__ID D07PJS D07PJS DRUGCOMP Janssen Research & Development, LLC D07PJS DRUGTYPE CAR T Cell Therapy D07PJS HIGHSTAT Phase 1/2 D07QIQ DRUG__ID D07QIQ D07QIQ DRUGCOMP Southwest Hospital, China D07QIQ DRUGTYPE CAR T Cell Therapy D07QIQ HIGHSTAT Phase 1/2 D07XYT DRUG__ID D07XYT D07XYT DRUGCOMP Flamel Technol D07XYT THERCLAS Anticancer Agents D07XYT HIGHSTAT Phase 1/2 D08BPS DRUG__ID D08BPS D08BPS DRUGCOMP Juno Therapeutics, Inc. D08BPS DRUGTYPE CAR T Cell Therapy D08BPS HIGHSTAT Phase 1/2 D08FVH DRUG__ID D08FVH D08FVH DRUGCOMP Zhujiang Hospital D08FVH DRUGTYPE CAR T Cell Therapy (Dual specific) D08FVH HIGHSTAT Phase 1/2 D08JHY DRUG__ID D08JHY D08JHY THERCLAS Antiviral Agents D08JHY DRUGTYPE Small molecular drug D08JHY HIGHSTAT Phase 1/2 Trial D08JTI DRUG__ID D08JTI D08JTI DRUGCOMP Chinese PLA General Hospital D08JTI DRUGTYPE CAR T Cell Therapy (Dual specific) D08JTI HIGHSTAT Phase 1/2 D08NEM DRUG__ID D08NEM D08NEM THERCLAS Antiviral Agents D08NEM DRUGTYPE Vaccine D08NEM HIGHSTAT Phase 1/2 Trial D08QAN DRUG__ID D08QAN D08QAN THERCLAS Antiviral Agents D08QAN DRUGTYPE Vaccine D08QAN HIGHSTAT Phase 1/2 Trial D08QYW DRUG__ID D08QYW D08QYW DRUGCOMP First Affiliated Hospital of Chengdu Medical College D08QYW DRUGTYPE CAR T Cell Therapy D08QYW HIGHSTAT Phase 1/2 D08QZH DRUG__ID D08QZH D08QZH DRUGCOMP Zhi Yang D08QZH DRUGTYPE CAR T Cell Therapy D08QZH HIGHSTAT Phase 1/2 D08RJY DRUG__ID D08RJY D08RJY DRUGCOMP National Cancer Institute (NCI) D08RJY DRUGTYPE CAR T Cell Therapy D08RJY HIGHSTAT Phase 1/2 D08SIF DRUG__ID D08SIF D08SIF DRUGCOMP Immunomedics D08SIF DRUGTYPE Antibody D08SIF HIGHSTAT Phase 1/2 D08TYK DRUG__ID D08TYK D08TYK THERCLAS Antiviral Agents D08TYK DRUGTYPE Vaccine D08TYK HIGHSTAT Phase 1/2 Trial D08VXD DRUG__ID D08VXD D08VXD DRUGCOMP Novartis D08VXD DRUGTYPE Gene therapy D08VXD HIGHSTAT Phase 1/2 D08WII DRUG__ID D08WII D08WII DRUGCOMP PersonGen BioTherapeutics (Suzhou) Co., Ltd. D08WII DRUGTYPE CAR T Cell Therapy D08WII HIGHSTAT Phase 1/2 D08ZDI DRUG__ID D08ZDI D08ZDI DRUGCOMP Genentech D08ZDI DRUGTYPE Antibody D08ZDI HIGHSTAT Phase 1/2 D08ZSJ DRUG__ID D08ZSJ D08ZSJ DRUGCOMP Vertex Pharmaceuticals Boston, MA D08ZSJ DRUGTYPE Cell therapy D08ZSJ HIGHSTAT Phase 1/2 D09GSV DRUG__ID D09GSV D09GSV DRUGCOMP TRION Pharma GmbH D09GSV DRUGTYPE Antibody D09GSV HIGHSTAT Phase 1/2 D09GYJ DRUG__ID D09GYJ D09GYJ THERCLAS Antiviral Agents D09GYJ DRUGTYPE Vaccine D09GYJ HIGHSTAT Phase 1/2 Trial D09JKN DRUG__ID D09JKN D09JKN DRUGCOMP Poseida Therapeutics San Diego, CA D09JKN DRUGTYPE CAR T Cell Therapy D09JKN HIGHSTAT Phase 1/2 D09KWN DRUG__ID D09KWN D09KWN DRUGCOMP The First Affiliated Hospital of Guangdong Pharmaceutical University D09KWN DRUGTYPE CAR T Cell Therapy D09KWN HIGHSTAT Phase 1/2 D09NUH DRUG__ID D09NUH D09NUH DRUGCOMP Shenzhen Geno-Immune Medical Institute D09NUH DRUGTYPE CAR T Cell Therapy D09NUH HIGHSTAT Phase 1/2 D09ROP DRUG__ID D09ROP D09ROP DRUGCOMP uniQure Biopharma D09ROP DRUGTYPE Gene therapy D09ROP HIGHSTAT Phase 1/2 D09SCP DRUG__ID D09SCP D09SCP DRUGCOMP Advaxis Inc D09SCP DRUGTYPE Antibody D09SCP HIGHSTAT Phase 1/2 D09UFZ DRUG__ID D09UFZ D09UFZ DRUGCOMP Shenzhen Geno-Immune Medical Institute D09UFZ DRUGTYPE CAR T Cell Therapy D09UFZ HIGHSTAT Phase 1/2 D09VBN DRUG__ID D09VBN D09VBN DRUGCOMP CRISPR Therapeutics D09VBN DRUGTYPE Gene therapy D09VBN HIGHSTAT Phase 1/2 D0A3OE DRUG__ID D0A3OE D0A3OE DRUGCOMP Shenzhen BinDeBio Ltd. D0A3OE DRUGTYPE CAR T Cell Therapy D0A3OE HIGHSTAT Phase 1/2 D0AC9S DRUG__ID D0AC9S D0AC9S DRUGCOMP The First Affiliated Hospital of Soochow University D0AC9S DRUGTYPE CAR T Cell Therapy (Dual specific) D0AC9S HIGHSTAT Phase 1/2 D0AI7H DRUG__ID D0AI7H D0AI7H DRUGCOMP The First Affiliated Hospital of Guangdong Pharmaceutical University D0AI7H DRUGTYPE CAR T Cell Therapy D0AI7H HIGHSTAT Phase 1/2 D0ARB7 DRUG__ID D0ARB7 D0ARB7 DRUGCOMP XenoTherapeutics Boston, MA D0ARB7 DRUGTYPE Cell therapy D0ARB7 HIGHSTAT Phase 1/2 D0B1TT DRUG__ID D0B1TT D0B1TT DRUGCOMP University of Oxford D0B1TT DRUGTYPE Vaccine D0B1TT HIGHSTAT Phase 1/2 D0B3HF DRUG__ID D0B3HF D0B3HF DRUGCOMP Seattle Children's Hospital D0B3HF DRUGTYPE CAR T Cell Therapy D0B3HF HIGHSTAT Phase 1/2 D0B4MK DRUG__ID D0B4MK D0B4MK DRUGCOMP ISIS Pharm D0B4MK DRUGTYPE Antisense drug D0B4MK HIGHSTAT Phase 1/2 D0B8UW DRUG__ID D0B8UW D0B8UW DRUGCOMP Autolus Limited D0B8UW DRUGTYPE CAR T Cell Therapy (Dual specific) D0B8UW HIGHSTAT Phase 1/2 D0BE6M DRUG__ID D0BE6M D0BE6M DRUGCOMP Shenzhen BinDeBio Ltd. D0BE6M DRUGTYPE CAR T Cell Therapy D0BE6M HIGHSTAT Phase 1/2 D0BH2M DRUG__ID D0BH2M D0BH2M DRUGCOMP Shenzhen Geno-Immune Medical Institute D0BH2M DRUGTYPE CAR T Cell Therapy (Dual specific) D0BH2M HIGHSTAT Phase 1/2 D0C2PH DRUG__ID D0C2PH D0C2PH DRUGCOMP Shanghai Sinobioway Sunterra Biotech D0C2PH DRUGTYPE CAR T Cell Therapy D0C2PH HIGHSTAT Phase 1/2 D0C2YZ DRUG__ID D0C2YZ D0C2YZ DRUGCOMP Clarity Pharmaceuticals D0C2YZ DRUGTYPE Small molecular drug D0C2YZ HIGHSTAT Phase 1/2 D0C5MT DRUG__ID D0C5MT D0C5MT THERCLAS Antiviral Agents D0C5MT DRUGTYPE Protein/peptide drug D0C5MT HIGHSTAT Phase 1/2 Trial D0C6IQ DRUG__ID D0C6IQ D0C6IQ DRUGCOMP Wyeth D0C6IQ DRUGTYPE Antibody D0C6IQ HIGHSTAT Phase 1/2 D0C9MJ DRUG__ID D0C9MJ D0C9MJ DRUGCOMP PersonGen BioTherapeutics (Suzhou) Co., Ltd. D0C9MJ DRUGTYPE CAR T Cell Therapy D0C9MJ HIGHSTAT Phase 1/2 D0CE0Y DRUG__ID D0CE0Y D0CE0Y DRUGCOMP Shanghai GeneChem Co., Ltd. D0CE0Y DRUGTYPE CAR T Cell Therapy D0CE0Y HIGHSTAT Phase 1/2 D0D4ZN DRUG__ID D0D4ZN D0D4ZN DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0D4ZN DRUGTYPE CAR T Cell Therapy D0D4ZN HIGHSTAT Phase 1/2 D0D8EY DRUG__ID D0D8EY D0D8EY DRUGCOMP Pharming Group NV D0D8EY DRUGTYPE Peptide D0D8EY HIGHSTAT Phase 1/2 D0D8KU DRUG__ID D0D8KU D0D8KU DRUGCOMP MAT Biopharma D0D8KU DRUGTYPE Antibody D0D8KU HIGHSTAT Phase 1/2 D0D9BL DRUG__ID D0D9BL D0D9BL DRUGCOMP Kai Lin Xu; Jun Nian Zheng D0D9BL DRUGTYPE CAR T Cell Therapy D0D9BL HIGHSTAT Phase 1/2 D0DO8E DRUG__ID D0DO8E D0DO8E DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0DO8E DRUGTYPE CAR T Cell Therapy D0DO8E HIGHSTAT Phase 1/2 D0E0RP DRUG__ID D0E0RP D0E0RP DRUGCOMP Beijing Biohealthcare Biotechnology Co.,Ltd D0E0RP DRUGTYPE CAR T Cell Therapy D0E0RP HIGHSTAT Phase 1/2 D0E1ST DRUG__ID D0E1ST D0E1ST DRUGCOMP Fuda Cancer Hospital, Guangzhou D0E1ST DRUGTYPE CAR T Cell Therapy D0E1ST HIGHSTAT Phase 1/2 D0E2CS DRUG__ID D0E2CS D0E2CS DRUGCOMP Xuzhou Medical University D0E2CS DRUGTYPE CAR T Cell Therapy (Dual specific) D0E2CS HIGHSTAT Phase 1/2 D0EH1J DRUG__ID D0EH1J D0EH1J DRUGCOMP Xinqiao Hospital of Chongqing D0EH1J DRUGTYPE CAR T Cell Therapy D0EH1J HIGHSTAT Phase 1/2 D0EQ6D DRUG__ID D0EQ6D D0EQ6D DRUGCOMP Juno Therapeutics, Inc. D0EQ6D DRUGTYPE CAR T Cell Therapy D0EQ6D HIGHSTAT Phase 1/2 D0FF0N DRUG__ID D0FF0N D0FF0N DRUGCOMP Takara Bio Inc. D0FF0N DRUGTYPE CAR T Cell Therapy D0FF0N HIGHSTAT Phase 1/2 D0FJ9W DRUG__ID D0FJ9W D0FJ9W DRUGCOMP KaloBios Pharmaceuticals Inc D0FJ9W DRUGTYPE Antibody D0FJ9W HIGHSTAT Phase 1/2 D0FR3J DRUG__ID D0FR3J D0FR3J DRUGCOMP Seattle Children's Hospital D0FR3J DRUGTYPE CAR T Cell Therapy D0FR3J HIGHSTAT Phase 1/2 D0FY5E DRUG__ID D0FY5E D0FY5E DRUGCOMP Shanghai GeneChem Co., Ltd. D0FY5E DRUGTYPE CAR T Cell Therapy D0FY5E HIGHSTAT Phase 1/2 D0FZ1Y DRUG__ID D0FZ1Y D0FZ1Y DRUGCOMP Chinese PLA General Hospital D0FZ1Y DRUGTYPE CAR T Cell Therapy D0FZ1Y HIGHSTAT Phase 1/2 D0G0PI DRUG__ID D0G0PI D0G0PI DRUGCOMP Chinese PLA General Hospital D0G0PI DRUGTYPE CAR T Cell Therapy (Dual specific) D0G0PI HIGHSTAT Phase 1/2 D0G1IG DRUG__ID D0G1IG D0G1IG DRUGCOMP Philogen SpA D0G1IG DRUGTYPE Antibody D0G1IG HIGHSTAT Phase 1/2 D0G1ZU DRUG__ID D0G1ZU D0G1ZU DRUGCOMP Shenzhen Second People's Hospital D0G1ZU DRUGTYPE CAR T Cell Therapy D0G1ZU HIGHSTAT Phase 1/2 D0G9MY DRUG__ID D0G9MY D0G9MY DRUGCOMP Shenzhen Geno-Immune Medical Institute D0G9MY DRUGTYPE CAR T Cell Therapy D0G9MY HIGHSTAT Phase 1/2 D0GT3R DRUG__ID D0GT3R D0GT3R DRUGCOMP Shenzhen BinDeBio Ltd. D0GT3R DRUGTYPE CAR T Cell Therapy D0GT3R HIGHSTAT Phase 1/2 D0H4GT DRUG__ID D0H4GT D0H4GT DRUGCOMP ETH Zurich D0H4GT DRUGTYPE Antibody D0H4GT HIGHSTAT Phase 1/2 D0HO1A DRUG__ID D0HO1A D0HO1A DRUGCOMP Jichi Medical University D0HO1A DRUGTYPE CAR T Cell Therapy D0HO1A HIGHSTAT Phase 1/2 D0HV7A DRUG__ID D0HV7A D0HV7A DRUGCOMP Actinium Pharmaceuticals D0HV7A DRUGTYPE Monoclonal antibody D0HV7A HIGHSTAT Phase 1/2 D0I4HG DRUG__ID D0I4HG D0I4HG DRUGCOMP Shenzhen Geno-Immune Medical Institute D0I4HG DRUGTYPE CAR T Cell Therapy (Dual specific) D0I4HG HIGHSTAT Phase 1/2 D0I5GS DRUG__ID D0I5GS D0I5GS DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0I5GS DRUGTYPE CAR T Cell Therapy D0I5GS HIGHSTAT Phase 1/2 D0IN2K DRUG__ID D0IN2K D0IN2K DRUGCOMP Kai Lin Xu; Jun Nian Zheng D0IN2K DRUGTYPE CAR T Cell Therapy D0IN2K HIGHSTAT Phase 1/2 D0IN7R DRUG__ID D0IN7R D0IN7R DRUGCOMP Second Affiliated Hospital, School of Medicine, Zhejiang University D0IN7R DRUGTYPE CAR T Cell Therapy D0IN7R HIGHSTAT Phase 1/2 D0IQ3E DRUG__ID D0IQ3E D0IQ3E DRUGCOMP Shenzhen Geno-Immune Medical Institute D0IQ3E DRUGTYPE CAR T Cell Therapy D0IQ3E HIGHSTAT Phase 1/2 D0J0XN DRUG__ID D0J0XN D0J0XN DRUGCOMP Cell Cure Neuroscience D0J0XN DRUGTYPE Human embryonic stem (hES) cell-derived therapeutics D0J0XN HIGHSTAT Phase 1/2 D0J1MO DRUG__ID D0J1MO D0J1MO DRUGCOMP Gitr D0J1MO DRUGTYPE Antibody D0J1MO HIGHSTAT Phase 1/2 D0J2IN DRUG__ID D0J2IN D0J2IN DRUGCOMP Shanghai GeneChem Co., Ltd. D0J2IN DRUGTYPE CAR T Cell Therapy D0J2IN HIGHSTAT Phase 1/2 D0J3DN DRUG__ID D0J3DN D0J3DN DRUGCOMP National Cancer Institute (NCI) D0J3DN DRUGTYPE CAR T Cell Therapy D0J3DN HIGHSTAT Phase 1/2 D0J7UL DRUG__ID D0J7UL D0J7UL DRUGCOMP ALX Oncology D0J7UL DRUGTYPE Protein D0J7UL HIGHSTAT Phase 1/2 D0J7VH DRUG__ID D0J7VH D0J7VH DRUGCOMP Shenzhen Geno-Immune Medical Institute D0J7VH DRUGTYPE CAR T Cell Therapy (Dual specific) D0J7VH HIGHSTAT Phase 1/2 D0JD4T DRUG__ID D0JD4T D0JD4T DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D0JD4T DRUGTYPE CAR T Cell Therapy D0JD4T HIGHSTAT Phase 1/2 D0JF2I DRUG__ID D0JF2I D0JF2I THERCLAS Antiviral Agents D0JF2I DRUGTYPE Vaccine D0JF2I HIGHSTAT Phase 1/2 Trial D0JL0C DRUG__ID D0JL0C D0JL0C THERCLAS Antiviral Agents D0JL0C DRUGTYPE Combination drug D0JL0C HIGHSTAT Phase 1/2 Trial D0JO4O DRUG__ID D0JO4O D0JO4O THERCLAS Antiviral Agents D0JO4O DRUGTYPE Combination drug D0JO4O HIGHSTAT Phase 1/2 Trial D0JV4R DRUG__ID D0JV4R D0JV4R DRUGCOMP Timmune Biotech Inc. D0JV4R DRUGTYPE CAR T Cell Therapy D0JV4R HIGHSTAT Phase 1/2 D0K5MC DRUG__ID D0K5MC D0K5MC DRUGCOMP NKMax America D0K5MC DRUGTYPE Cell therapy D0K5MC HIGHSTAT Phase 1/2 D0K8WE DRUG__ID D0K8WE D0K8WE DRUGCOMP Shenzhen BinDeBio Ltd. D0K8WE DRUGTYPE CAR T Cell Therapy D0K8WE HIGHSTAT Phase 1/2 D0K8YX DRUG__ID D0K8YX D0K8YX DRUGCOMP Shenzhen Geno-Immune Medical Institute D0K8YX DRUGTYPE CAR T Cell Therapy (Dual specific) D0K8YX HIGHSTAT Phase 1/2 D0KC2S DRUG__ID D0KC2S D0KC2S DRUGCOMP Shanghai GeneChem Co., Ltd. D0KC2S DRUGTYPE CAR T Cell Therapy D0KC2S HIGHSTAT Phase 1/2 D0KE9G DRUG__ID D0KE9G D0KE9G DRUGCOMP Asterias Biotherapeutics D0KE9G DRUGTYPE Human embryonic stem (hES) cell-derived therapeutics D0KE9G HIGHSTAT Phase 1/2 D0KF9T DRUG__ID D0KF9T D0KF9T DRUGCOMP The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine D0KF9T DRUGTYPE CAR T Cell Therapy D0KF9T HIGHSTAT Phase 1/2 D0KK4N DRUG__ID D0KK4N D0KK4N DRUGCOMP ISA Pharmaceuticals BV D0KK4N DRUGTYPE Vaccine D0KK4N HIGHSTAT Phase 1/2 D0LF6M DRUG__ID D0LF6M D0LF6M DRUGCOMP Southwest Hospital, China D0LF6M DRUGTYPE CAR T Cell Therapy D0LF6M HIGHSTAT Phase 1/2 D0LJ2S DRUG__ID D0LJ2S D0LJ2S DRUGCOMP Shenzhen BinDeBio Ltd. D0LJ2S DRUGTYPE CAR T Cell Therapy D0LJ2S HIGHSTAT Phase 1/2 D0LJ4H DRUG__ID D0LJ4H D0LJ4H DRUGCOMP Passage Bio D0LJ4H DRUGTYPE Gene therapy D0LJ4H HIGHSTAT Phase 1/2 D0LV4B DRUG__ID D0LV4B D0LV4B THERCLAS Antiviral Agents D0LV4B DRUGTYPE Vaccine D0LV4B HIGHSTAT Phase 1/2 Trial D0LW4A DRUG__ID D0LW4A D0LW4A DRUGCOMP Shenzhen BinDeBio Ltd. D0LW4A DRUGTYPE CAR T Cell Therapy D0LW4A HIGHSTAT Phase 1/2 D0M0CO DRUG__ID D0M0CO D0M0CO DRUGCOMP PersonGen BioTherapeutics (Suzhou) Co., Ltd. D0M0CO DRUGTYPE CAR T Cell Therapy D0M0CO HIGHSTAT Phase 1/2 D0M3RI DRUG__ID D0M3RI D0M3RI DRUGCOMP Chinese PLA General Hospital D0M3RI DRUGTYPE CAR T Cell Therapy D0M3RI HIGHSTAT Phase 1/2 D0M4AH DRUG__ID D0M4AH D0M4AH THERCLAS Antiviral Agents D0M4AH DRUGTYPE Vaccine D0M4AH HIGHSTAT Phase 1/2 Trial D0M4UR DRUG__ID D0M4UR D0M4UR THERCLAS Antiviral Agents D0M4UR DRUGTYPE Vaccine D0M4UR HIGHSTAT Phase 1/2 Trial D0M5DP DRUG__ID D0M5DP D0M5DP THERCLAS Antiviral Agents D0M5DP DRUGTYPE Vaccine D0M5DP HIGHSTAT Phase 1/2 Trial D0M5JC DRUG__ID D0M5JC D0M5JC DRUGCOMP Tapimmune; mabvax therapeutics D0M5JC DRUGTYPE Monoclonal antibody D0M5JC HIGHSTAT Phase 1/2 D0M6SB DRUG__ID D0M6SB D0M6SB THERCLAS Antiviral Agents D0M6SB DRUGTYPE Vaccine D0M6SB HIGHSTAT Phase 1/2 Trial D0M8EF DRUG__ID D0M8EF D0M8EF DRUGCOMP Chinese PLA General Hospital D0M8EF DRUGTYPE CAR T Cell Therapy D0M8EF HIGHSTAT Phase 1/2 D0M9NI DRUG__ID D0M9NI D0M9NI THERCLAS Antiviral Agents D0M9NI DRUGTYPE Vaccine D0M9NI HIGHSTAT Phase 1/2 Trial D0MA4F DRUG__ID D0MA4F D0MA4F DRUGCOMP Bambino Gesù Hospital and Research Institute D0MA4F DRUGTYPE CAR T Cell Therapy D0MA4F HIGHSTAT Phase 1/2 D0MA4O DRUG__ID D0MA4O D0MA4O DRUGCOMP Southwest Hospital, China D0MA4O DRUGTYPE CAR T Cell Therapy (Dual specific) D0MA4O HIGHSTAT Phase 1/2 D0MG0O DRUG__ID D0MG0O D0MG0O THERCLAS Antiviral Agents D0MG0O DRUGTYPE Vaccine D0MG0O HIGHSTAT Phase 1/2 Trial D0MK7H DRUG__ID D0MK7H D0MK7H DRUGCOMP Shenzhen BinDeBio Ltd. D0MK7H DRUGTYPE CAR T Cell Therapy D0MK7H HIGHSTAT Phase 1/2 D0MV4T DRUG__ID D0MV4T D0MV4T DRUGCOMP University Hospital Heidelberg D0MV4T DRUGTYPE CAR T Cell Therapy D0MV4T HIGHSTAT Phase 1/2 D0MY0F DRUG__ID D0MY0F D0MY0F DRUGCOMP MacroGenics Rockville, MD D0MY0F DRUGTYPE Antibody D0MY0F HIGHSTAT Phase 1/2 D0N0OV DRUG__ID D0N0OV D0N0OV DRUGCOMP Xinqiao Hospital of Chongqing D0N0OV DRUGTYPE CAR T Cell Therapy D0N0OV HIGHSTAT Phase 1/2 D0N3GE DRUG__ID D0N3GE D0N3GE DRUGCOMP Shanghai Bioray Laboratory Inc. D0N3GE DRUGTYPE CAR T Cell Therapy D0N3GE HIGHSTAT Phase 1/2 D0N6PE DRUG__ID D0N6PE D0N6PE DRUGCOMP The Affiliated Hospital of the Chinese Academy of Military Medical Sciences D0N6PE DRUGTYPE CAR T Cell Therapy D0N6PE HIGHSTAT Phase 1/2 D0N6TD DRUG__ID D0N6TD D0N6TD DRUGCOMP Kyowa Hakko Kirin Pharma D0N6TD DRUGTYPE Antibody D0N6TD HIGHSTAT Phase 1/2 D0NA4J DRUG__ID D0NA4J D0NA4J DRUGCOMP Shenzhen Geno-Immune Medical Institute D0NA4J DRUGTYPE CAR T Cell Therapy D0NA4J HIGHSTAT Phase 1/2 D0NJ3T DRUG__ID D0NJ3T D0NJ3T DRUGCOMP The Affiliated Hospital of the Chinese Academy of Military Medical Sciences D0NJ3T DRUGTYPE CAR T Cell Therapy D0NJ3T HIGHSTAT Phase 1/2 D0NN7P DRUG__ID D0NN7P D0NN7P DRUGCOMP Chinese PLA General Hospital D0NN7P DRUGTYPE CAR T Cell Therapy D0NN7P HIGHSTAT Phase 1/2 D0NS1X DRUG__ID D0NS1X D0NS1X DRUGCOMP ImmunoGen Inc D0NS1X DRUGTYPE Antibody D0NS1X HIGHSTAT Phase 1/2 D0O2ZI DRUG__ID D0O2ZI D0O2ZI DRUGCOMP National Cancer Institute D0O2ZI DRUGTYPE Monoclonal antibody D0O2ZI HIGHSTAT Phase 1/2 D0O4IN DRUG__ID D0O4IN D0O4IN DRUGCOMP Celgene summit; nj morphosys D0O4IN DRUGTYPE Antibody D0O4IN HIGHSTAT Phase 1/2 D0O4RB DRUG__ID D0O4RB D0O4RB DRUGCOMP Benitec Ltd D0O4RB DRUGTYPE RNAi therapeutics D0O4RB HIGHSTAT Phase 1/2 D0O6LR DRUG__ID D0O6LR D0O6LR DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0O6LR DRUGTYPE CAR T Cell Therapy D0O6LR HIGHSTAT Phase 1/2 D0OO1S DRUG__ID D0OO1S D0OO1S DRUGCOMP Shenzhen BinDeBio Ltd. D0OO1S DRUGTYPE CAR T Cell Therapy D0OO1S HIGHSTAT Phase 1/2 D0OP7I DRUG__ID D0OP7I D0OP7I DRUGCOMP Fondazione Matilde Tettamanti Menotti De Marchi Onlus D0OP7I DRUGTYPE CAR T Cell Therapy D0OP7I HIGHSTAT Phase 1/2 D0OZ5H DRUG__ID D0OZ5H D0OZ5H DRUGCOMP Bambino Gesù Hospital and Research Institute D0OZ5H DRUGTYPE CAR T Cell Therapy D0OZ5H HIGHSTAT Phase 1/2 D0P0NS DRUG__ID D0P0NS D0P0NS DRUGCOMP Southwest Hospital, China D0P0NS DRUGTYPE CAR T Cell Therapy D0P0NS HIGHSTAT Phase 1/2 D0P5SC DRUG__ID D0P5SC D0P5SC DRUGCOMP VaxOnco; National Institute of Allergy and Infectious Diseases; National Institutes of Health D0P5SC DRUGTYPE Vaccine D0P5SC HIGHSTAT Phase 1/2 D0PD4C DRUG__ID D0PD4C D0PD4C DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0PD4C DRUGTYPE CAR T Cell Therapy D0PD4C HIGHSTAT Phase 1/2 D0PN3M DRUG__ID D0PN3M D0PN3M DRUGCOMP Shanghai Tongji Hospital, Tongji University School of Medicine D0PN3M DRUGTYPE CAR T Cell Therapy D0PN3M HIGHSTAT Phase 1/2 D0PY7Z DRUG__ID D0PY7Z D0PY7Z DRUGCOMP Novartis Vaccines & Diagnostics D0PY7Z DRUGTYPE Vaccine D0PY7Z HIGHSTAT Phase 1/2 D0Q0HZ DRUG__ID D0Q0HZ D0Q0HZ DRUGCOMP OncoTherapy Science Inc D0Q0HZ DRUGTYPE Vaccine D0Q0HZ HIGHSTAT Phase 1/2 D0Q0RX DRUG__ID D0Q0RX D0Q0RX DRUGCOMP Fred Hutchinson Cancer Research Center D0Q0RX DRUGTYPE CAR T Cell Therapy D0Q0RX HIGHSTAT Phase 1/2 D0Q4EJ DRUG__ID D0Q4EJ D0Q4EJ DRUGCOMP Shenzhen BinDeBio Ltd. D0Q4EJ DRUGTYPE CAR T Cell Therapy D0Q4EJ HIGHSTAT Phase 1/2 D0Q5EH DRUG__ID D0Q5EH D0Q5EH DRUGCOMP Wuhan Sian Medical Technology Co., Ltd D0Q5EH DRUGTYPE CAR T Cell Therapy D0Q5EH HIGHSTAT Phase 1/2 D0Q5GK DRUG__ID D0Q5GK D0Q5GK DRUGCOMP Xijing Hospital D0Q5GK DRUGTYPE CAR T Cell Therapy D0Q5GK HIGHSTAT Phase 1/2 D0QB1O DRUG__ID D0QB1O D0QB1O DRUGCOMP Chinese PLA General Hospital D0QB1O DRUGTYPE CAR T Cell Therapy (Dual specific) D0QB1O HIGHSTAT Phase 1/2 D0QF0L DRUG__ID D0QF0L D0QF0L DRUGCOMP Henan Cancer Hospital D0QF0L DRUGTYPE CAR T Cell Therapy D0QF0L HIGHSTAT Phase 1/2 D0R1BA DRUG__ID D0R1BA D0R1BA DRUGCOMP Shenzhen Geno-Immune Medical Institute D0R1BA DRUGTYPE CAR T Cell Therapy D0R1BA HIGHSTAT Phase 1/2 D0R3IG DRUG__ID D0R3IG D0R3IG DRUGCOMP St. Jude Children's Research Hospital D0R3IG DRUGTYPE CAR T Cell Therapy D0R3IG HIGHSTAT Phase 1/2 D0R6UR DRUG__ID D0R6UR D0R6UR DRUGCOMP AC Immune SA D0R6UR DRUGTYPE Vaccine D0R6UR HIGHSTAT Phase 1/2 D0R8LV DRUG__ID D0R8LV D0R8LV DRUGCOMP NovImmune D0R8LV DRUGTYPE Antibody D0R8LV HIGHSTAT Phase 1/2 D0RA9C DRUG__ID D0RA9C D0RA9C DRUGCOMP Shanghai Sinobioway Sunterra Biotech D0RA9C DRUGTYPE CAR T Cell Therapy D0RA9C HIGHSTAT Phase 1/2 D0RI6Q DRUG__ID D0RI6Q D0RI6Q DRUGCOMP AstraZeneca; Innate Pharma D0RI6Q DRUGTYPE Antibody D0RI6Q HIGHSTAT Phase 1/2 D0RJ2V DRUG__ID D0RJ2V D0RJ2V DRUGCOMP The Second Hospital of Nanjing Medical University D0RJ2V DRUGTYPE CAR T Cell Therapy D0RJ2V HIGHSTAT Phase 1/2 D0RO2L DRUG__ID D0RO2L D0RO2L DRUGCOMP Shenzhen Geno-Immune Medical Institute D0RO2L DRUGTYPE CAR T Cell Therapy D0RO2L HIGHSTAT Phase 1/2 D0S1CR DRUG__ID D0S1CR D0S1CR DRUGCOMP Southwest Hospital, China D0S1CR DRUGTYPE CAR T Cell Therapy D0S1CR HIGHSTAT Phase 1/2 D0S4GT DRUG__ID D0S4GT D0S4GT DRUGCOMP Shenzhen Geno-Immune Medical Institute D0S4GT DRUGTYPE CAR T Cell Therapy D0S4GT HIGHSTAT Phase 1/2 D0S4IR DRUG__ID D0S4IR D0S4IR DRUGCOMP Precision BioSciences, Inc. D0S4IR DRUGTYPE CAR T Cell Therapy D0S4IR HIGHSTAT Phase 1/2 D0S8HD DRUG__ID D0S8HD D0S8HD DRUGCOMP Pepscan Systems BV D0S8HD DRUGTYPE Vaccine D0S8HD HIGHSTAT Phase 1/2 D0SV4A DRUG__ID D0SV4A D0SV4A DRUGCOMP Zhejiang University D0SV4A DRUGTYPE CAR T Cell Therapy D0SV4A HIGHSTAT Phase 1/2 D0SZT3 DRUG__ID D0SZT3 D0SZT3 DRUGCOMP NexImmune D0SZT3 DRUGTYPE Cell therapy D0SZT3 HIGHSTAT Phase 1/2 D0T5DC DRUG__ID D0T5DC D0T5DC DRUGCOMP Shanghai GeneChem Co., Ltd. D0T5DC DRUGTYPE CAR T Cell Therapy D0T5DC HIGHSTAT Phase 1/2 D0TBF3 DRUG__ID D0TBF3 D0TBF3 DRUGCOMP Amicus Therapeutics D0TBF3 DRUGTYPE Gene therapy D0TBF3 HIGHSTAT Phase 1/2 D0TE0L DRUG__ID D0TE0L D0TE0L DRUGCOMP Shenzhen Geno-Immune Medical Institute D0TE0L DRUGTYPE CAR T Cell Therapy D0TE0L HIGHSTAT Phase 1/2 D0TU1E DRUG__ID D0TU1E D0TU1E DRUGCOMP Atlas Pharmaceuticals Inc D0TU1E DRUGTYPE Vaccine D0TU1E HIGHSTAT Phase 1/2 D0TY6U DRUG__ID D0TY6U D0TY6U DRUGCOMP Bellicum Pharmaceuticals D0TY6U DRUGTYPE CAR T Cell Therapy D0TY6U HIGHSTAT Phase 1/2 D0U0BN DRUG__ID D0U0BN D0U0BN DRUGCOMP Fred Hutchinson Cancer Research Center D0U0BN DRUGTYPE CAR T Cell Therapy D0U0BN HIGHSTAT Phase 1/2 D0U1GP DRUG__ID D0U1GP D0U1GP DRUGCOMP Shenzhen Geno-Immune Medical Institute D0U1GP DRUGTYPE CAR T Cell Therapy D0U1GP HIGHSTAT Phase 1/2 D0UA0U DRUG__ID D0UA0U D0UA0U DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0UA0U DRUGTYPE CAR T Cell Therapy D0UA0U HIGHSTAT Phase 1/2 D0UJ3C DRUG__ID D0UJ3C D0UJ3C DRUGCOMP Shenzhen Geno-Immune Medical Institute D0UJ3C DRUGTYPE CAR T Cell Therapy D0UJ3C HIGHSTAT Phase 1/2 D0UM8Q DRUG__ID D0UM8Q D0UM8Q DRUGCOMP Chinese PLA General Hospital D0UM8Q DRUGTYPE CAR T Cell Therapy D0UM8Q HIGHSTAT Phase 1/2 D0V2ZC DRUG__ID D0V2ZC D0V2ZC DRUGCOMP Menarini D0V2ZC DRUGTYPE Small molecular drug D0V2ZC HIGHSTAT Phase 1/2 D0V5LG DRUG__ID D0V5LG D0V5LG DRUGCOMP Inovio Pharmaceuticals; ChronTech Pharma D0V5LG DRUGTYPE Vaccine D0V5LG HIGHSTAT Phase 1/2 D0V6VD DRUG__ID D0V6VD D0V6VD DRUGCOMP Chinese PLA General Hospital D0V6VD DRUGTYPE CAR T Cell Therapy D0V6VD HIGHSTAT Phase 1/2 D0VI8T DRUG__ID D0VI8T D0VI8T DRUGCOMP Shenzhen Geno-Immune Medical Institute D0VI8T DRUGTYPE CAR T Cell Therapy D0VI8T HIGHSTAT Phase 1/2 D0W0XS DRUG__ID D0W0XS D0W0XS DRUGCOMP Treos Bio D0W0XS DRUGTYPE Vaccine D0W0XS HIGHSTAT Phase 1/2 D0W2MI DRUG__ID D0W2MI D0W2MI DRUGCOMP Southwest Hospital, China D0W2MI DRUGTYPE CAR T Cell Therapy D0W2MI HIGHSTAT Phase 1/2 D0W4SM DRUG__ID D0W4SM D0W4SM DRUGCOMP Ruijin Hospital D0W4SM DRUGTYPE CAR T Cell Therapy (Dual specific) D0W4SM HIGHSTAT Phase 1/2 D0W7FC DRUG__ID D0W7FC D0W7FC DRUGCOMP Millennium Pharmaceuticals D0W7FC DRUGTYPE Antibody D0W7FC HIGHSTAT Phase 1/2 D0W8WG DRUG__ID D0W8WG D0W8WG DRUGCOMP Fuda Cancer Hospital, Guangzhou D0W8WG DRUGTYPE CAR T Cell Therapy D0W8WG HIGHSTAT Phase 1/2 D0W9IH DRUG__ID D0W9IH D0W9IH DRUGCOMP International AIDS Vaccine Initiative D0W9IH DRUGTYPE Vaccine D0W9IH HIGHSTAT Phase 1/2 D0WN2Y DRUG__ID D0WN2Y D0WN2Y DRUGCOMP Fuda Cancer Hospital, Guangzhou D0WN2Y DRUGTYPE CAR T Cell Therapy D0WN2Y HIGHSTAT Phase 1/2 D0WZX4 DRUG__ID D0WZX4 D0WZX4 DRUGCOMP Angiocrine Bioscience D0WZX4 DRUGTYPE Cell therapy D0WZX4 HIGHSTAT Phase 1/2 D0X1BX DRUG__ID D0X1BX D0X1BX DRUGCOMP Viacyte D0X1BX DRUGTYPE Human embryonic stem (hES) cell-derived therapeutics D0X1BX HIGHSTAT Phase 1/2 D0X1SV DRUG__ID D0X1SV D0X1SV DRUGCOMP Immunomedics D0X1SV DRUGTYPE Monoclonal antibody D0X1SV HIGHSTAT Phase 1/2 D0X8TK DRUG__ID D0X8TK D0X8TK DRUGCOMP Immunocore D0X8TK DRUGTYPE Recombinant protein D0X8TK HIGHSTAT Phase 1/2 D0XD7V DRUG__ID D0XD7V D0XD7V DRUGCOMP FLX BioSouth San Francisco, CA D0XD7V DRUGTYPE Small molecular drug D0XD7V HIGHSTAT Phase 1/2 D0XG0L DRUG__ID D0XG0L D0XG0L DRUGCOMP Peking University D0XG0L DRUGTYPE CAR T Cell Therapy D0XG0L HIGHSTAT Phase 1/2 D0XY6T DRUG__ID D0XY6T D0XY6T DRUGCOMP Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd D0XY6T DRUGTYPE CAR T Cell Therapy D0XY6T HIGHSTAT Phase 1/2 D0XZ2S DRUG__ID D0XZ2S D0XZ2S DRUGCOMP Shenzhen Geno-Immune Medical Institute D0XZ2S DRUGTYPE CAR T Cell Therapy D0XZ2S HIGHSTAT Phase 1/2 D0XZ4Y DRUG__ID D0XZ4Y D0XZ4Y DRUGCOMP Prevail Therapeutics D0XZ4Y DRUGTYPE Gene therapy D0XZ4Y HIGHSTAT Phase 1/2 D0Y4MA DRUG__ID D0Y4MA D0Y4MA DRUGCOMP The First Affiliated Hospital of Soochow University D0Y4MA DRUGTYPE CAR T Cell Therapy D0Y4MA HIGHSTAT Phase 1/2 D0Y6BO DRUG__ID D0Y6BO D0Y6BO DRUGCOMP Immunomedics D0Y6BO DRUGTYPE Antibody drug conjugate D0Y6BO HIGHSTAT Phase 1/2 D0YY6O DRUG__ID D0YY6O D0YY6O DRUGCOMP Ottawa Hospital Research Institute D0YY6O DRUGTYPE CAR T Cell Therapy D0YY6O HIGHSTAT Phase 1/2 D0Z8GD DRUG__ID D0Z8GD D0Z8GD DRUGCOMP Fred Hutchinson Cancer Research Center D0Z8GD DRUGTYPE CAR T Cell Therapy D0Z8GD HIGHSTAT Phase 1/2 D0ZQ3K DRUG__ID D0ZQ3K D0ZQ3K DRUGCOMP Shenzhen BinDeBio Ltd. D0ZQ3K DRUGTYPE CAR T Cell Therapy D0ZQ3K HIGHSTAT Phase 1/2 D0ZVM5 DRUG__ID D0ZVM5 D0ZVM5 DRUGCOMP Advanced Accelerator Applications D0ZVM5 DRUGTYPE Small molecular drug D0ZVM5 HIGHSTAT Phase 1/2 D1CZ8K DRUG__ID D1CZ8K D1CZ8K DRUGCOMP Advanced Accelerator Applications D1CZ8K DRUGTYPE Small molecular drug D1CZ8K HIGHSTAT Phase 1/2 D1HID7 DRUG__ID D1HID7 D1HID7 DRUGCOMP Allogene Therapeutics South San Francisco, CA D1HID7 DRUGTYPE CAR-T cell therapy D1HID7 HIGHSTAT Phase 1/2 D1LEU5 DRUG__ID D1LEU5 D1LEU5 DRUGCOMP AbbVie; Jacobio Pharmaceuticals D1LEU5 DRUGTYPE Small molecular drug D1LEU5 HIGHSTAT Phase 1/2 D1RMS5 DRUG__ID D1RMS5 D1RMS5 DRUGCOMP Orchard Therapeutics D1RMS5 DRUGTYPE Gene therapy D1RMS5 HIGHSTAT Phase 1/2 D1TS4V DRUG__ID D1TS4V D1TS4V DRUGCOMP Taysha Gene Therapies Dallas, TX D1TS4V DRUGTYPE Gene therapy D1TS4V HIGHSTAT Phase 1/2 D1U4BC DRUG__ID D1U4BC D1U4BC DRUGCOMP Applied Genetic Technologies D1U4BC DRUGTYPE Gene therapy D1U4BC HIGHSTAT Phase 1/2 D1W2DS DRUG__ID D1W2DS D1W2DS DRUGCOMP AbbVie; Genmab D1W2DS DRUGTYPE Antibody D1W2DS HIGHSTAT Phase 1/2 D1WB6Z DRUG__ID D1WB6Z D1WB6Z DRUGCOMP KAHR Medical D1WB6Z DRUGTYPE Recombinant?protein D1WB6Z HIGHSTAT Phase 1/2 D1XI9E DRUG__ID D1XI9E D1XI9E DRUGCOMP Bolt Biotherapeutics D1XI9E DRUGTYPE Antibody drug conjugate D1XI9E HIGHSTAT Phase 1/2 D1ZAW4 DRUG__ID D1ZAW4 D1ZAW4 DRUGCOMP Dynacure Jenkintown, PA D1ZAW4 DRUGTYPE Antisense oligonucleotide D1ZAW4 HIGHSTAT Phase 1/2 D20OCB DRUG__ID D20OCB D20OCB DRUGCOMP Janssen D20OCB DRUGTYPE Vaccine D20OCB HIGHSTAT Phase 1/2 D2AG4O DRUG__ID D2AG4O D2AG4O DRUGCOMP TAKEDA D2AG4O DRUGTYPE Fusion protein D2AG4O HIGHSTAT Phase 1/2 D2H6NI DRUG__ID D2H6NI D2H6NI DRUGCOMP OBI Pharma D2H6NI DRUGTYPE Antibody drug conjugate D2H6NI HIGHSTAT Phase 1/2 D2JZ3U DRUG__ID D2JZ3U D2JZ3U DRUGCOMP Alexion AstraZeneca Rare Disease Boston, MA D2JZ3U DRUGTYPE Small molecule D2JZ3U HIGHSTAT Phase 1/2 D2QMZ9 DRUG__ID D2QMZ9 D2QMZ9 DRUGCOMP AC Immune D2QMZ9 DRUGTYPE Vaccine D2QMZ9 HIGHSTAT Phase 1/2 D3A9TZ DRUG__ID D3A9TZ D3A9TZ DRUGCOMP Biogen; Ionis D3A9TZ DRUGTYPE Antisense oligonucleotide D3A9TZ HIGHSTAT Phase 1/2 D3BZ0H DRUG__ID D3BZ0H D3BZ0H DRUGCOMP Ionis Pharmaceuticals Carlsbad, CA D3BZ0H DRUGTYPE RNA interference D3BZ0H HIGHSTAT Phase 1/2 D3C0LO DRUG__ID D3C0LO D3C0LO DRUGCOMP JOHNSON & JOHNSON D3C0LO DRUGTYPE Vaccine D3C0LO HIGHSTAT Phase 1/2 D3C9MX DRUG__ID D3C9MX D3C9MX DRUGCOMP Janssen D3C9MX DRUGTYPE Vaccine D3C9MX HIGHSTAT Phase 1/2 D3G1BJ DRUG__ID D3G1BJ D3G1BJ DRUGCOMP Sanofi D3G1BJ DRUGTYPE Vaccine D3G1BJ HIGHSTAT Phase 1/2 D3JP7R DRUG__ID D3JP7R D3JP7R DRUGCOMP Vedanta Biosciences D3JP7R DRUGTYPE Live biotherapeutic product D3JP7R HIGHSTAT Phase 1/2 D3M6SN DRUG__ID D3M6SN D3M6SN DRUGCOMP Applied Genetic Technologies D3M6SN DRUGTYPE Gene therapy D3M6SN HIGHSTAT Phase 1/2 D3O5XK DRUG__ID D3O5XK D3O5XK DRUGCOMP Spark Therapeutics D3O5XK DRUGTYPE Gene therapy D3O5XK HIGHSTAT Phase 1/2 D3RT4A DRUG__ID D3RT4A D3RT4A DRUGCOMP Sarepta Therapeutics D3RT4A DRUGTYPE Gene therapy D3RT4A HIGHSTAT Phase 1/2 D3W5TL DRUG__ID D3W5TL D3W5TL DRUGCOMP Abeona Therapeutics D3W5TL DRUGTYPE Gene therapy D3W5TL HIGHSTAT Phase 1/2 D3X1TS DRUG__ID D3X1TS D3X1TS DRUGCOMP Bayer D3X1TS DRUGTYPE Small molecular drug D3X1TS HIGHSTAT Phase 1/2 D3ZY1K DRUG__ID D3ZY1K D3ZY1K DRUGCOMP Arvinas D3ZY1K DRUGTYPE Small molecular drug D3ZY1K HIGHSTAT Phase 1/2 D42SLV DRUG__ID D42SLV D42SLV DRUGCOMP Agenus D42SLV DRUGTYPE Monoclonal antibody D42SLV HIGHSTAT Phase 1/2 D46IVH DRUG__ID D46IVH D46IVH DRUGCOMP GeneTx Biotherapeutics Sarasota, FL D46IVH DRUGTYPE Antisense oligonucleotide D46IVH HIGHSTAT Phase 1/2 D4IWF1 DRUG__ID D4IWF1 D4IWF1 DRUGCOMP MeiraGTx D4IWF1 DRUGTYPE Gene therapy D4IWF1 HIGHSTAT Phase 1/2 D4RMC9 DRUG__ID D4RMC9 D4RMC9 DRUGCOMP AstraZeneca D4RMC9 DRUGTYPE Bispecific antibody D4RMC9 HIGHSTAT Phase 1/2 D4WN2M DRUG__ID D4WN2M D4WN2M DRUGCOMP Ascentage Pharma D4WN2M DRUGTYPE Small molecular drug D4WN2M HIGHSTAT Phase 1/2 D51VYQ DRUG__ID D51VYQ D51VYQ DRUGCOMP XBiotech D51VYQ DRUGTYPE Antibody D51VYQ HIGHSTAT Phase 1/2 D52NOH DRUG__ID D52NOH D52NOH DRUGCOMP BioNTech D52NOH DRUGTYPE Small molecular drug D52NOH HIGHSTAT Phase 1/2 D53CGK DRUG__ID D53CGK D53CGK DRUGCOMP PMV Pharmaceuticals D53CGK DRUGTYPE Small interfering RNA D53CGK HIGHSTAT Phase 1/2 D56WJV DRUG__ID D56WJV D56WJV DRUGCOMP MeiraGTx D56WJV DRUGTYPE Gene therapy D56WJV HIGHSTAT Phase 1/2 D59OTG DRUG__ID D59OTG D59OTG DRUGCOMP OBI Pharma D59OTG DRUGTYPE Antibody D59OTG HIGHSTAT Phase 1/2 D5C4YE DRUG__ID D5C4YE D5C4YE DRUGCOMP Prevail Therapeutics D5C4YE DRUGTYPE Gene therapy D5C4YE HIGHSTAT Phase 1/2 D5CP3S DRUG__ID D5CP3S D5CP3S DRUGCOMP BriaCell Therapeutics D5CP3S DRUGTYPE Vaccine D5CP3S HIGHSTAT Phase 1/2 D5GVZ1 DRUG__ID D5GVZ1 D5GVZ1 DRUGCOMP Astelllas D5GVZ1 DRUGTYPE Small molecule D5GVZ1 HIGHSTAT Phase 1/2 D5MV0R DRUG__ID D5MV0R D5MV0R DRUGCOMP Amgen D5MV0R DRUGTYPE Antibody D5MV0R HIGHSTAT Phase 1/2 D5R8YF DRUG__ID D5R8YF D5R8YF DRUGCOMP Biocytogen D5R8YF DRUGTYPE Antibody drug conjugate D5R8YF HIGHSTAT Phase 1/2 D5SZK9 DRUG__ID D5SZK9 D5SZK9 DRUGCOMP Homology Medicines D5SZK9 DRUGTYPE Gene therapy D5SZK9 HIGHSTAT Phase 1/2 D5V7XP DRUG__ID D5V7XP D5V7XP DRUGCOMP Lokon Pharma D5V7XP DRUGTYPE Oncolytic virus D5V7XP HIGHSTAT Phase 1/2 D62OSE DRUG__ID D62OSE D62OSE DRUGCOMP Forge Biologics D62OSE DRUGTYPE Gene therapy D62OSE HIGHSTAT Phase 1/2 D67IRW DRUG__ID D67IRW D67IRW DRUGCOMP Bristol-Myers Squibb; Dragonfly Therapeutics D67IRW DRUGTYPE Recombinant?protein D67IRW HIGHSTAT Phase 1/2 D68DPH DRUG__ID D68DPH D68DPH DRUGCOMP Iovance Biotherapeutics D68DPH DRUGTYPE Cell therapy D68DPH HIGHSTAT Phase 1/2 D6EI9F DRUG__ID D6EI9F D6EI9F DRUGCOMP NexImmune D6EI9F DRUGTYPE Cell therapy D6EI9F HIGHSTAT Phase 1/2 D6L5YT DRUG__ID D6L5YT D6L5YT DRUGCOMP Regeneron Tarrytown, NY D6L5YT DRUGTYPE Bispecific antibody D6L5YT HIGHSTAT Phase 1/2 D6SL3N DRUG__ID D6SL3N D6SL3N DRUGCOMP Merus D6SL3N DRUGTYPE Antibody D6SL3N HIGHSTAT Phase 1/2 D6UEI3 DRUG__ID D6UEI3 D6UEI3 DRUGCOMP Lexeo Therapeutics D6UEI3 DRUGTYPE Gene therapy D6UEI3 HIGHSTAT Phase 1/2 D6W2MF DRUG__ID D6W2MF D6W2MF DRUGCOMP Sanofi; Sangamo Therapeutics D6W2MF DRUGTYPE Cell therapy D6W2MF HIGHSTAT Phase 1/2 D6XMS1 DRUG__ID D6XMS1 D6XMS1 DRUGCOMP Ultragenyx Pharmaceutical D6XMS1 DRUGTYPE Gene therapy D6XMS1 HIGHSTAT Phase 1/2 D6XS7L DRUG__ID D6XS7L D6XS7L DRUGCOMP Bristol-Myers Squibb D6XS7L DRUGTYPE Antibody D6XS7L HIGHSTAT Phase 1/2 D70HZT DRUG__ID D70HZT D70HZT DRUGCOMP Nuvation Bio D70HZT DRUGTYPE Small molecule D70HZT HIGHSTAT Phase 1/2 D72UDH DRUG__ID D72UDH D72UDH DRUGCOMP Oxford BioMedica; Axovant Sciences D72UDH DRUGTYPE Gene therapy D72UDH HIGHSTAT Phase 1/2 D79HBK DRUG__ID D79HBK D79HBK DRUGCOMP NBE-Therapeutics D79HBK DRUGTYPE Antibody drug conjugate D79HBK HIGHSTAT Phase 1/2 D7BF8Y DRUG__ID D7BF8Y D7BF8Y DRUGCOMP Bristol-Myers Squibb D7BF8Y DRUGTYPE Probody D7BF8Y HIGHSTAT Phase 1/2 D7GQR3 DRUG__ID D7GQR3 D7GQR3 DRUGCOMP Novartis D7GQR3 DRUGTYPE Gene therapy D7GQR3 HIGHSTAT Phase 1/2 D7KQ6N DRUG__ID D7KQ6N D7KQ6N DRUGCOMP Taysha Gene Therapies D7KQ6N DRUGTYPE Gene therapy D7KQ6N HIGHSTAT Phase 1/2 D7LU8R DRUG__ID D7LU8R D7LU8R DRUGCOMP Precision Biosciences D7LU8R DRUGTYPE CAR T Cell Therapy D7LU8R HIGHSTAT Phase 1/2 D7NLU3 DRUG__ID D7NLU3 D7NLU3 DRUGCOMP Celularity D7NLU3 DRUGTYPE Cell therapy D7NLU3 HIGHSTAT Phase 1/2 D7SXA1 DRUG__ID D7SXA1 D7SXA1 DRUGCOMP Gamida Cell D7SXA1 DRUGTYPE Cell therapy D7SXA1 HIGHSTAT Phase 1/2 D7UIZ1 DRUG__ID D7UIZ1 D7UIZ1 DRUGCOMP BeiGene D7UIZ1 DRUGTYPE Antibody D7UIZ1 HIGHSTAT Phase 1/2 D82GST DRUG__ID D82GST D82GST DRUGCOMP Bavarian Nordic; Janssen D82GST DRUGTYPE Vaccine D82GST HIGHSTAT Phase 1/2 D84EGX DRUG__ID D84EGX D84EGX DRUGCOMP Audentes Therapeutics D84EGX DRUGTYPE Gene therapy D84EGX HIGHSTAT Phase 1/2 D87TMY DRUG__ID D87TMY D87TMY DRUGCOMP Orphan Technologies D87TMY DRUGTYPE Recombinant protein D87TMY HIGHSTAT Phase 1/2 D8BJX5 DRUG__ID D8BJX5 D8BJX5 DRUGCOMP Bavarian Nordic D8BJX5 DRUGTYPE Vaccine D8BJX5 HIGHSTAT Phase 1/2 D8BYU3 DRUG__ID D8BYU3 D8BYU3 DRUGCOMP Bayer Pharmaceuticals D8BYU3 DRUGTYPE Gene therapy D8BYU3 HIGHSTAT Phase 1/2 D8FX9H DRUG__ID D8FX9H D8FX9H DRUGCOMP Passage Bio D8FX9H DRUGTYPE Gene therapy D8FX9H HIGHSTAT Phase 1/2 D8RN3B DRUG__ID D8RN3B D8RN3B DRUGCOMP Janssen D8RN3B DRUGTYPE Vaccine D8RN3B HIGHSTAT Phase 1/2 D8TE4F DRUG__ID D8TE4F D8TE4F DRUGCOMP AtlasMedx D8TE4F DRUGTYPE Small molecular drug D8TE4F HIGHSTAT Phase 1/2 D8UZM7 DRUG__ID D8UZM7 D8UZM7 DRUGCOMP Regeneron Pharmaceuticals D8UZM7 DRUGTYPE Antibody D8UZM7 HIGHSTAT Phase 1/2 D93JPW DRUG__ID D93JPW D93JPW DRUGCOMP Passage Bio D93JPW DRUGTYPE Gene therapy D93JPW HIGHSTAT Phase 1/2 D94DTN DRUG__ID D94DTN D94DTN DRUGCOMP BioMarin Pharmaceutical D94DTN DRUGTYPE Gene therapy D94DTN HIGHSTAT Phase 1/2 D9HX2V DRUG__ID D9HX2V D9HX2V DRUGCOMP Eureka Therapeutics D9HX2V DRUGTYPE Cell therapy D9HX2V HIGHSTAT Phase 1/2 D9J4ZI DRUG__ID D9J4ZI D9J4ZI DRUGCOMP Janssen D9J4ZI DRUGTYPE Vaccine D9J4ZI HIGHSTAT Phase 1/2 D9O7GC DRUG__ID D9O7GC D9O7GC DRUGCOMP GT Biopharma D9O7GC DRUGTYPE Recombinant protein D9O7GC HIGHSTAT Phase 1/2 DA01IB DRUG__ID DA01IB DA01IB DRUGCOMP MiNA Therapeutics DA01IB DRUGTYPE Small activating RNA DA01IB HIGHSTAT Phase 1/2 DA27CP DRUG__ID DA27CP DA27CP DRUGCOMP Genethon DA27CP DRUGTYPE Gene therapy DA27CP HIGHSTAT Phase 1/2 DA4W1I DRUG__ID DA4W1I DA4W1I DRUGCOMP Arch Oncology DA4W1I DRUGTYPE Antibody DA4W1I HIGHSTAT Phase 1/2 DA6OU0 DRUG__ID DA6OU0 DA6OU0 DRUGCOMP Genelux DA6OU0 DRUGTYPE Oncolytic virus therapy DA6OU0 HIGHSTAT Phase 1/2 DAD65R DRUG__ID DAD65R DAD65R DRUGCOMP Repare Therapeutics DAD65R DRUGTYPE Small molecular drug DAD65R HIGHSTAT Phase 1/2 DALG29 DRUG__ID DALG29 DALG29 DRUGCOMP Kymab DALG29 DRUGTYPE Antibody DALG29 HIGHSTAT Phase 1/2 DARV32 DRUG__ID DARV32 DARV32 DRUGCOMP Geistlich DARV32 DRUGTYPE Small molecular drug DARV32 HIGHSTAT Phase 1/2 DB26FH DRUG__ID DB26FH DB26FH DRUGCOMP Enterome Biosciences DB26FH DRUGTYPE Vaccine DB26FH HIGHSTAT Phase 1/2 DB8G4D DRUG__ID DB8G4D DB8G4D DRUGCOMP Jasper Therapeutics DB8G4D DRUGTYPE Antibody DB8G4D HIGHSTAT Phase 1/2 DB91HQ DRUG__ID DB91HQ DB91HQ DRUGCOMP Adagene DB91HQ DRUGTYPE Antibody DB91HQ HIGHSTAT Phase 1/2 DBKE38 DRUG__ID DBKE38 DBKE38 DRUGCOMP Aspa Therapeutics DBKE38 DRUGTYPE Gene therapy DBKE38 HIGHSTAT Phase 1/2 DBU2J7 DRUG__ID DBU2J7 DBU2J7 DRUGCOMP GMP BIO, BHT Lifescience Australia DBU2J7 DRUGTYPE Cell therapy DBU2J7 HIGHSTAT Phase 1/2 DC37YW DRUG__ID DC37YW DC37YW DRUGCOMP ImmuneSensor Therapeutics DC37YW DRUGTYPE Small molecular drug DC37YW HIGHSTAT Phase 1/2 DC3DV9 DRUG__ID DC3DV9 DC3DV9 DRUGCOMP Moderna DC3DV9 DRUGTYPE Vaccine DC3DV9 HIGHSTAT Phase 1/2 DC3ZD5 DRUG__ID DC3ZD5 DC3ZD5 DRUGCOMP Dracen Pharmaceuticals DC3ZD5 DRUGTYPE Small molecular drug DC3ZD5 HIGHSTAT Phase 1/2 DC57TE DRUG__ID DC57TE DC57TE DRUGCOMP Bicycle Therapeutics DC57TE DRUGTYPE Bicycle?toxin conjugate DC57TE HIGHSTAT Phase 1/2 DC5VW9 DRUG__ID DC5VW9 DC5VW9 DRUGCOMP BeiGene DC5VW9 DRUGTYPE Antibody DC5VW9 HIGHSTAT Phase 1/2 DCI8V2 DRUG__ID DCI8V2 DCI8V2 DRUGCOMP Genocea Biosciences DCI8V2 DRUGTYPE Vaccine DCI8V2 HIGHSTAT Phase 1/2 DCY10V DRUG__ID DCY10V DCY10V DRUGCOMP Ultragenyx Pharmaceutical DCY10V DRUGTYPE Gene therapy DCY10V HIGHSTAT Phase 1/2 DD4H6V DRUG__ID DD4H6V DD4H6V DRUGCOMP BioInvent DD4H6V DRUGTYPE Antibody DD4H6V HIGHSTAT Phase 1/2 DD52FT DRUG__ID DD52FT DD52FT DRUGCOMP Avotres DD52FT DRUGTYPE Cell therapy DD52FT HIGHSTAT Phase 1/2 DD5NX2 DRUG__ID DD5NX2 DD5NX2 DRUGCOMP Atea Pharmaceuticals DD5NX2 DRUGTYPE Small molecular drug DD5NX2 HIGHSTAT Phase 1/2 DD94ZN DRUG__ID DD94ZN DD94ZN DRUGCOMP KLUS Pharma DD94ZN DRUGTYPE Antibody drug conjugate DD94ZN HIGHSTAT Phase 1/2 DDL79K DRUG__ID DDL79K DDL79K DRUGCOMP Mersana Therapeutics DDL79K DRUGTYPE Antibody drug conjugate DDL79K HIGHSTAT Phase 1/2 DDN3B1 DRUG__ID DDN3B1 DDN3B1 DRUGCOMP Sangamo Therapeutics DDN3B1 DRUGTYPE Cell therapy DDN3B1 HIGHSTAT Phase 1/2 DDP74J DRUG__ID DDP74J DDP74J DRUGCOMP MacroGenics DDP74J DRUGTYPE Antibody drug conjugate DDP74J HIGHSTAT Phase 1/2 DDRI16 DRUG__ID DDRI16 DDRI16 DRUGCOMP ViaCyte DDRI16 DRUGTYPE Cell therapy DDRI16 HIGHSTAT Phase 1/2 DDX95P DRUG__ID DDX95P DDX95P DRUGCOMP MeiraGTx DDX95P DRUGTYPE Gene therapy DDX95P HIGHSTAT Phase 1/2 DE0L6O DRUG__ID DE0L6O DE0L6O DRUGCOMP Ichnos Sciences DE0L6O DRUGTYPE Antibody DE0L6O HIGHSTAT Phase 1/2 DE3M8U DRUG__ID DE3M8U DE3M8U DRUGCOMP Sangamo Therapeutics DE3M8U DRUGTYPE Gene therapy DE3M8U HIGHSTAT Phase 1/2 DE7N6F DRUG__ID DE7N6F DE7N6F DRUGCOMP Astex Pharmaceuticals DE7N6F DRUGTYPE Small molecular drug DE7N6F HIGHSTAT Phase 1/2 DF0PR6 DRUG__ID DF0PR6 DF0PR6 DRUGCOMP Zentalis Pharmaceuticals DF0PR6 DRUGTYPE Small molecular drug DF0PR6 HIGHSTAT Phase 1/2 DF37QR DRUG__ID DF37QR DF37QR DRUGCOMP Vedanta Biosciences DF37QR DRUGTYPE Live biotherapeutic product DF37QR HIGHSTAT Phase 1/2 DF3QH8 DRUG__ID DF3QH8 DF3QH8 DRUGCOMP Immuron DF3QH8 DRUGTYPE Antibody DF3QH8 HIGHSTAT Phase 1/2 DF7R6C DRUG__ID DF7R6C DF7R6C DRUGCOMP Amicus Therapeutics Philadelphia, PA DF7R6C DRUGTYPE Gene therapy DF7R6C HIGHSTAT Phase 1/2 DG1CX7 DRUG__ID DG1CX7 DG1CX7 DRUGCOMP Abeona Therapeutics DG1CX7 DRUGTYPE Gene therapy DG1CX7 HIGHSTAT Phase 1/2 DG1ED2 DRUG__ID DG1ED2 DG1ED2 DRUGCOMP Vaccinex DG1ED2 DRUGTYPE Antibody DG1ED2 HIGHSTAT Phase 1/2 DG30KD DRUG__ID DG30KD DG30KD DRUGCOMP Kolon Life Science DG30KD DRUGTYPE Gene therapy DG30KD HIGHSTAT Phase 1/2 DH40QT DRUG__ID DH40QT DH40QT DRUGCOMP Sangamo Therapeutics DH40QT DRUGTYPE Gene therapy DH40QT HIGHSTAT Phase 1/2 DHX7S8 DRUG__ID DHX7S8 DHX7S8 DRUGCOMP Zenshine Pharmaceuticals Nanjing, China DHX7S8 DRUGTYPE Small molecule DHX7S8 HIGHSTAT Phase 1/2 DI0ZA3 DRUG__ID DI0ZA3 DI0ZA3 DRUGCOMP GenMab DI0ZA3 DRUGTYPE Antibody DI0ZA3 HIGHSTAT Phase 1/2 DI1VM3 DRUG__ID DI1VM3 DI1VM3 DRUGCOMP Hanmi Pharmaceutical DI1VM3 DRUGTYPE Small molecular drug DI1VM3 HIGHSTAT Phase 1/2 DIOB35 DRUG__ID DIOB35 DIOB35 DRUGCOMP NC Medial Research Tokyo, Japan DIOB35 DRUGTYPE Cell therapy DIOB35 HIGHSTAT Phase 1/2 DJ1W5R DRUG__ID DJ1W5R DJ1W5R DRUGCOMP Zentalis Pharmaceuticals DJ1W5R DRUGTYPE Small molecular drug DJ1W5R HIGHSTAT Phase 1/2 DJ5I6L DRUG__ID DJ5I6L DJ5I6L DRUGCOMP Spark Therapeutics DJ5I6L DRUGTYPE Gene therapy DJ5I6L HIGHSTAT Phase 1/2 DJ6AW5 DRUG__ID DJ6AW5 DJ6AW5 DRUGCOMP CARsgen Houston, TX DJ6AW5 DRUGTYPE CAR-T cell therapy DJ6AW5 HIGHSTAT Phase 1/2 DJA64B DRUG__ID DJA64B DJA64B DRUGCOMP TCR2 Therapeutics DJA64B DRUGTYPE Cell therapy DJA64B HIGHSTAT Phase 1/2 DJN3E2 DRUG__ID DJN3E2 DJN3E2 DRUGCOMP Moderna Therapeutics DJN3E2 DRUGTYPE mRNA therapy DJN3E2 HIGHSTAT Phase 1/2 DK0B7G DRUG__ID DK0B7G DK0B7G DRUGCOMP Inozyme Pharma Boston, MA DK0B7G DRUGTYPE Enzyme replacement DK0B7G HIGHSTAT Phase 1/2 DK0S5Y DRUG__ID DK0S5Y DK0S5Y DRUGCOMP ViaCyte DK0S5Y DRUGTYPE Cell therapy DK0S5Y HIGHSTAT Phase 1/2 DK3QD9 DRUG__ID DK3QD9 DK3QD9 DRUGCOMP Orinove DK3QD9 DRUGTYPE Small interfering RNA DK3QD9 HIGHSTAT Phase 1/2 DK3U6C DRUG__ID DK3U6C DK3U6C DRUGCOMP BioMarin Pharmaceutical DK3U6C DRUGTYPE Fusion protein DK3U6C HIGHSTAT Phase 1/2 DK65RJ DRUG__ID DK65RJ DK65RJ DRUGCOMP DiscGenics DK65RJ DRUGTYPE Cell therapy DK65RJ HIGHSTAT Phase 1/2 DK6J7M DRUG__ID DK6J7M DK6J7M DRUGCOMP NextCure DK6J7M DRUGTYPE Recombinant protein DK6J7M HIGHSTAT Phase 1/2 DK8QG3 DRUG__ID DK8QG3 DK8QG3 DRUGCOMP Affimed Therapeutics DK8QG3 DRUGTYPE Antibody DK8QG3 HIGHSTAT Phase 1/2 DKM90C DRUG__ID DKM90C DKM90C DRUGCOMP Sanofi DKM90C DRUGTYPE Vaccine DKM90C HIGHSTAT Phase 1/2 DL1FG3 DRUG__ID DL1FG3 DL1FG3 DRUGCOMP Sanofi DL1FG3 DRUGTYPE Antibody DL1FG3 HIGHSTAT Phase 1/2 DL5JN0 DRUG__ID DL5JN0 DL5JN0 DRUGCOMP Hope Biosciences Sugar Land, TX DL5JN0 DRUGTYPE Cell therapy DL5JN0 HIGHSTAT Phase 1/2 DL6EZ5 DRUG__ID DL6EZ5 DL6EZ5 DRUGCOMP Intrexon T1D Partners; ActoBio Therapeutics DL6EZ5 DRUGTYPE Gene therapy DL6EZ5 HIGHSTAT Phase 1/2 DL6W8B DRUG__ID DL6W8B DL6W8B DRUGCOMP Aeglea Biotherapeutics DL6W8B DRUGTYPE Enzyme replacement DL6W8B HIGHSTAT Phase 1/2 DL73JW DRUG__ID DL73JW DL73JW DRUGCOMP Merck DL73JW DRUGTYPE Small molecule DL73JW HIGHSTAT Phase 1/2 DLB34X DRUG__ID DLB34X DLB34X DRUGCOMP GenSight Biologics DLB34X DRUGTYPE Gene therapy DLB34X HIGHSTAT Phase 1/2 DLJQ42 DRUG__ID DLJQ42 DLJQ42 DRUGCOMP Mustang Bio; St. Jude Children's Research Hospital DLJQ42 DRUGTYPE Gene therapy DLJQ42 HIGHSTAT Phase 1/2 DLK3E1 DRUG__ID DLK3E1 DLK3E1 DRUGCOMP Orchard Therapeutics DLK3E1 DRUGTYPE Cell therapy DLK3E1 HIGHSTAT Phase 1/2 DM1FD5 DRUG__ID DM1FD5 DM1FD5 DRUGCOMP Astex Pharmaceuticals DM1FD5 DRUGTYPE Small molecular drug DM1FD5 HIGHSTAT Phase 1/2 DM2DE9 DRUG__ID DM2DE9 DM2DE9 DRUGCOMP Sangamo Therapeutics DM2DE9 DRUGTYPE Cell therapy DM2DE9 HIGHSTAT Phase 1/2 DM5X0L DRUG__ID DM5X0L DM5X0L DRUGCOMP Jiangsu Hengrui DM5X0L DRUGTYPE Small molecular drug DM5X0L HIGHSTAT Phase 1/2 DM8Y2N DRUG__ID DM8Y2N DM8Y2N DRUGCOMP Dizal Pharmaceuticals DM8Y2N DRUGTYPE Small molecular drug DM8Y2N HIGHSTAT Phase 1/2 DM90BJ DRUG__ID DM90BJ DM90BJ DRUGCOMP Janssen; MeiraGTx DM90BJ DRUGTYPE Gene therapy DM90BJ HIGHSTAT Phase 1/2 DMBG04 DRUG__ID DMBG04 DMBG04 DRUGCOMP Amal Therapeutics; Boehringer Ingelheim DMBG04 DRUGTYPE Vaccine DMBG04 HIGHSTAT Phase 1/2 DMK65T DRUG__ID DMK65T DMK65T DRUGCOMP Longeveron Miami, Fl DMK65T DRUGTYPE Cell therapy DMK65T HIGHSTAT Phase 1/2 DN2MC5 DRUG__ID DN2MC5 DN2MC5 DRUGCOMP Autolus Therapeutics DN2MC5 DRUGTYPE CAR T Cell Therapy DN2MC5 HIGHSTAT Phase 1/2 DN4O0S DRUG__ID DN4O0S DN4O0S DRUGCOMP Axovant Gene Therapies DN4O0S DRUGTYPE Gene therapy DN4O0S HIGHSTAT Phase 1/2 DN6YE0 DRUG__ID DN6YE0 DN6YE0 DRUGCOMP Precigen DN6YE0 DRUGTYPE Vaccine DN6YE0 HIGHSTAT Phase 1/2 DN71VY DRUG__ID DN71VY DN71VY DRUGCOMP Takeda DN71VY DRUGTYPE CAR-NK Cell therapy DN71VY HIGHSTAT Phase 1/2 DNC79U DRUG__ID DNC79U DNC79U DRUGCOMP Ichnos Sciences DNC79U DRUGTYPE Antibody DNC79U HIGHSTAT Phase 1/2 DNXH76 DRUG__ID DNXH76 DNXH76 DRUGCOMP Hema Biologics DNXH76 DRUGTYPE Small molecular drug DNXH76 HIGHSTAT Phase 1/2 DO4K0I DRUG__ID DO4K0I DO4K0I DRUGCOMP Precigen DO4K0I DRUGTYPE Vaccine DO4K0I HIGHSTAT Phase 1/2 DO76YM DRUG__ID DO76YM DO76YM DRUGCOMP Applied Genetic Technologies DO76YM DRUGTYPE Gene therapy DO76YM HIGHSTAT Phase 1/2 DOD24G DRUG__ID DOD24G DOD24G DRUGCOMP Buzzard Pharmaceuticals DOD24G DRUGTYPE Recombinant protein DOD24G HIGHSTAT Phase 1/2 DOL04T DRUG__ID DOL04T DOL04T DRUGCOMP Regenerative Patch Technologies DOL04T DRUGTYPE Cell therapy DOL04T HIGHSTAT Phase 1/2 DOS62C DRUG__ID DOS62C DOS62C DRUGCOMP KLUS Pharma DOS62C DRUGTYPE Antibody drug conjugate DOS62C HIGHSTAT Phase 1/2 DP4J2K DRUG__ID DP4J2K DP4J2K DRUGCOMP 4D Pharma DP4J2K DRUGTYPE Live biotherapeutic product DP4J2K HIGHSTAT Phase 1/2 DP58GD DRUG__ID DP58GD DP58GD DRUGCOMP Adrenas Therapeutics DP58GD DRUGTYPE Gene therapy DP58GD HIGHSTAT Phase 1/2 DP6J5K DRUG__ID DP6J5K DP6J5K DRUGCOMP Novartis/AAA DP6J5K DRUGTYPE Radiopharmaceutical therapy agent DP6J5K HIGHSTAT Phase 1/2 DP85ES DRUG__ID DP85ES DP85ES DRUGCOMP Ipsen DP85ES DRUGTYPE Radiopharmaceutical therapy agent DP85ES HIGHSTAT Phase 1/2 DPG5T9 DRUG__ID DPG5T9 DPG5T9 DRUGCOMP Acticor Biotech DPG5T9 DRUGTYPE Small molecular drug DPG5T9 HIGHSTAT Phase 1/2 DPS6V0 DRUG__ID DPS6V0 DPS6V0 DRUGCOMP Spark Therapeutics DPS6V0 DRUGTYPE Gene therapy DPS6V0 HIGHSTAT Phase 1/2 DQ0I4N DRUG__ID DQ0I4N DQ0I4N DRUGCOMP Rocket Pharmaceuticals DQ0I4N DRUGTYPE Gene therapy DQ0I4N HIGHSTAT Phase 1/2 DQ1P6X DRUG__ID DQ1P6X DQ1P6X DRUGCOMP AstraZeneca DQ1P6X DRUGTYPE Small molecular drug DQ1P6X HIGHSTAT Phase 1/2 DQ43PA DRUG__ID DQ43PA DQ43PA DRUGCOMP Janssen DQ43PA DRUGTYPE Antibody DQ43PA HIGHSTAT Phase 1/2 DQ5V7F DRUG__ID DQ5V7F DQ5V7F DRUGCOMP Inovio Pharmaceuticals DQ5V7F DRUGTYPE Vaccine DQ5V7F HIGHSTAT Phase 1/2 DQ62VF DRUG__ID DQ62VF DQ62VF DRUGCOMP Swedish Orphan Biovitrum DQ62VF DRUGTYPE Recombinant protein DQ62VF HIGHSTAT Phase 1/2 DQ84CE DRUG__ID DQ84CE DQ84CE DRUGCOMP Amgen DQ84CE DRUGTYPE Fusion protein DQ84CE HIGHSTAT Phase 1/2 DQJX34 DRUG__ID DQJX34 DQJX34 DRUGCOMP Lilly; Junshi Biosciences DQJX34 DRUGTYPE Antibody DQJX34 HIGHSTAT Phase 1/2 DR5F9A DRUG__ID DR5F9A DR5F9A DRUGCOMP Purple DR5F9A DRUGTYPE Antibody DR5F9A HIGHSTAT Phase 1/2 DR5GC8 DRUG__ID DR5GC8 DR5GC8 DRUGCOMP 4D Pharma DR5GC8 DRUGTYPE Live biotherapeutic DR5GC8 HIGHSTAT Phase 1/2 DR5VQ1 DRUG__ID DR5VQ1 DR5VQ1 DRUGCOMP Cyteir Therapeutics DR5VQ1 DRUGTYPE Small molecular drug DR5VQ1 HIGHSTAT Phase 1/2 DRF94Z DRUG__ID DRF94Z DRF94Z DRUGCOMP AiViva BioPharma DRF94Z DRUGTYPE Small molecular drug DRF94Z HIGHSTAT Phase 1/2 DS41PJ DRUG__ID DS41PJ DS41PJ DRUGCOMP Arvinas DS41PJ DRUGTYPE Small molecular drug DS41PJ HIGHSTAT Phase 1/2 DS53MJ DRUG__ID DS53MJ DS53MJ DRUGCOMP TCR2 Therapeutics DS53MJ DRUGTYPE TCR-T cell therapy DS53MJ HIGHSTAT Phase 1/2 DS5C0K DRUG__ID DS5C0K DS5C0K DRUGCOMP Bicycle Therapeutics DS5C0K DRUGTYPE Bicycle?toxin conjugate DS5C0K HIGHSTAT Phase 1/2 DS6C1Y DRUG__ID DS6C1Y DS6C1Y DRUGCOMP FibroGenesis (SpinalCyte) DS6C1Y DRUGTYPE Cell therapy DS6C1Y HIGHSTAT Phase 1/2 DS6MP8 DRUG__ID DS6MP8 DS6MP8 DRUGCOMP Merck DS6MP8 DRUGTYPE Antibody DS6MP8 HIGHSTAT Phase 1/2 DS7CY4 DRUG__ID DS7CY4 DS7CY4 DRUGCOMP Turning Point Therapeutics DS7CY4 DRUGTYPE Small interfering RNA DS7CY4 HIGHSTAT Phase 1/2 DSP1W2 DRUG__ID DSP1W2 DSP1W2 DRUGCOMP Tmunity Philadelphia, PA DSP1W2 DRUGTYPE Cell therapy DSP1W2 HIGHSTAT Phase 1/2 DT1R9E DRUG__ID DT1R9E DT1R9E DRUGCOMP Regeneron Tarrytown, NY DT1R9E DRUGTYPE Bispecific antibody DT1R9E HIGHSTAT Phase 1/2 DT28NV DRUG__ID DT28NV DT28NV DRUGCOMP AVROBIO DT28NV DRUGTYPE Gene therapy DT28NV HIGHSTAT Phase 1/2 DT6EN8 DRUG__ID DT6EN8 DT6EN8 DRUGCOMP Precision Biosciences DT6EN8 DRUGTYPE CAR T Cell Therapy DT6EN8 HIGHSTAT Phase 1/2 DT8R1L DRUG__ID DT8R1L DT8R1L DRUGCOMP Daiichi Sankyo DT8R1L DRUGTYPE Antibody drug conjugate DT8R1L HIGHSTAT Phase 1/2 DU6H3C DRUG__ID DU6H3C DU6H3C DRUGCOMP RHEACELL DU6H3C DRUGTYPE Cell therapy DU6H3C HIGHSTAT Phase 1/2 DU7G5P DRUG__ID DU7G5P DU7G5P DRUGCOMP Xentria DU7G5P DRUGTYPE Antibody DU7G5P HIGHSTAT Phase 1/2 DUDT78 DRUG__ID DUDT78 DUDT78 DRUGCOMP Aruvant Sciences DUDT78 DRUGTYPE Gene therapy DUDT78 HIGHSTAT Phase 1/2 DUIA46 DRUG__ID DUIA46 DUIA46 DRUGCOMP Sarepta Therapeutics DUIA46 DRUGTYPE Gene therapy DUIA46 HIGHSTAT Phase 1/2 DUVH60 DRUG__ID DUVH60 DUVH60 DRUGCOMP Numab Therapeutics DUVH60 DRUGTYPE Antibody DUVH60 HIGHSTAT Phase 1/2 DV7O1M DRUG__ID DV7O1M DV7O1M DRUGCOMP Fate Therapeutics DV7O1M DRUGTYPE Cell therapy DV7O1M HIGHSTAT Phase 1/2 DVD0E9 DRUG__ID DVD0E9 DVD0E9 DRUGCOMP Genprex DVD0E9 DRUGTYPE Gene therapy DVD0E9 HIGHSTAT Phase 1/2 DVU2Y5 DRUG__ID DVU2Y5 DVU2Y5 DRUGCOMP CRISPR Therapeutics; Vertex Pharmaceuticals DVU2Y5 DRUGTYPE Gene therapy DVU2Y5 HIGHSTAT Phase 1/2 DW7PT6 DRUG__ID DW7PT6 DW7PT6 DRUGCOMP Spark Therapeutics DW7PT6 DRUGTYPE Gene therapy DW7PT6 HIGHSTAT Phase 1/2 DWQ6J1 DRUG__ID DWQ6J1 DWQ6J1 DRUGCOMP EpimAb Biotherapeutics DWQ6J1 DRUGTYPE Antibody DWQ6J1 HIGHSTAT Phase 1/2 DWS5G1 DRUG__ID DWS5G1 DWS5G1 DRUGCOMP Arrowhead Pharmaceuticals DWS5G1 DRUGTYPE Small interfering RNA DWS5G1 HIGHSTAT Phase 1/2 DX0NW9 DRUG__ID DX0NW9 DX0NW9 DRUGCOMP Takeda DX0NW9 DRUGTYPE Gene therapy DX0NW9 HIGHSTAT Phase 1/2 DX2J9R DRUG__ID DX2J9R DX2J9R DRUGCOMP PNP Therapeutics DX2J9R DRUGTYPE Small molecular drug DX2J9R HIGHSTAT Phase 1/2 DX3SD2 DRUG__ID DX3SD2 DX3SD2 DRUGCOMP Torque Therapeutics DX3SD2 DRUGTYPE Cell therapy DX3SD2 HIGHSTAT Phase 1/2 DX5HW2 DRUG__ID DX5HW2 DX5HW2 DRUGCOMP Sangamo Therapeutics DX5HW2 DRUGTYPE Gene therapy DX5HW2 HIGHSTAT Phase 1/2 DX6O9V DRUG__ID DX6O9V DX6O9V DRUGCOMP TCR2 Therapeutics DX6O9V DRUGTYPE TCR-T cell therapy DX6O9V HIGHSTAT Phase 1/2 DX71CK DRUG__ID DX71CK DX71CK DRUGCOMP ProQR Therapeutics Leiden, Netherlands Ionis Pharmaceuticals Carlsbad, CA DX71CK DRUGTYPE Antisense oligonucleotide DX71CK HIGHSTAT Phase 1/2 DXAI94 DRUG__ID DXAI94 DXAI94 DRUGCOMP AlaMab Therapeutics Princeton, MA DXAI94 DRUGTYPE Small molecule DXAI94 HIGHSTAT Phase 1/2 DXK49H DRUG__ID DXK49H DXK49H DRUGCOMP Treadwell Therapeutics DXK49H DRUGTYPE Small molecular drug DXK49H HIGHSTAT Phase 1/2 DY13WU DRUG__ID DY13WU DY13WU DRUGCOMP Taiho Oncology DY13WU DRUGTYPE Small molecular drug DY13WU HIGHSTAT Phase 1/2 DY21QW DRUG__ID DY21QW DY21QW DRUGCOMP REGENXBIO DY21QW DRUGTYPE Gene therapy DY21QW HIGHSTAT Phase 1/2 DY2UG0 DRUG__ID DY2UG0 DY2UG0 DRUGCOMP Dragonfly Therapeutics DY2UG0 DRUGTYPE Recombinant?protein DY2UG0 HIGHSTAT Phase 1/2 DY48QG DRUG__ID DY48QG DY48QG DRUGCOMP Orchard Therapeutics DY48QG DRUGTYPE Cell therapy DY48QG HIGHSTAT Phase 1/2 DY8D2C DRUG__ID DY8D2C DY8D2C DRUGCOMP Lysogene DY8D2C DRUGTYPE Gene therapy DY8D2C HIGHSTAT Phase 1/2 DY9DX8 DRUG__ID DY9DX8 DY9DX8 DRUGCOMP Sangamo Therapeutics DY9DX8 DRUGTYPE Gene therapy DY9DX8 HIGHSTAT Phase 1/2 DY9G1D DRUG__ID DY9G1D DY9G1D DRUGCOMP Regeneron Pharmaceuticals; Sanofi DY9G1D DRUGTYPE Antibody DY9G1D HIGHSTAT Phase 1/2 DYM1J4 DRUG__ID DYM1J4 DYM1J4 DRUGCOMP Astellas Pharma DYM1J4 DRUGTYPE Cell therapy DYM1J4 HIGHSTAT Phase 1/2 DYRC18 DRUG__ID DYRC18 DYRC18 DRUGCOMP Applied Genetic Technologies DYRC18 DRUGTYPE Gene therapy DYRC18 HIGHSTAT Phase 1/2 DYWK46 DRUG__ID DYWK46 DYWK46 DRUGCOMP Sangamo Therapeutics DYWK46 DRUGTYPE Gene therapy DYWK46 HIGHSTAT Phase 1/2 DZ1F3N DRUG__ID DZ1F3N DZ1F3N DRUGCOMP CytomX Therapeutics South San Francisco, CA DZ1F3N DRUGTYPE Antibody drug conjugate DZ1F3N HIGHSTAT Phase 1/2 DZ1IL2 DRUG__ID DZ1IL2 DZ1IL2 DRUGCOMP Merck DZ1IL2 DRUGTYPE Antibody DZ1IL2 HIGHSTAT Phase 1/2 DZ1XV8 DRUG__ID DZ1XV8 DZ1XV8 DRUGCOMP Lexeo Therapeutics DZ1XV8 DRUGTYPE Gene therapy DZ1XV8 HIGHSTAT Phase 1/2 DZ40HL DRUG__ID DZ40HL DZ40HL DRUGCOMP Taysha Gene Therapies DZ40HL DRUGTYPE Gene therapy DZ40HL HIGHSTAT Phase 1/2 DZ8FV2 DRUG__ID DZ8FV2 DZ8FV2 DRUGCOMP MeiraGTx DZ8FV2 DRUGTYPE Gene therapy DZ8FV2 HIGHSTAT Phase 1/2 DZ91HE DRUG__ID DZ91HE DZ91HE DRUGCOMP Olema Pharmaceuticals; Otsuka America Pharmaceutical DZ91HE DRUGTYPE Small interfering RNA DZ91HE HIGHSTAT Phase 1/2 DZ97RW DRUG__ID DZ97RW DZ97RW DRUGCOMP 4D Molecular Therapeutics DZ97RW DRUGTYPE Gene therapy DZ97RW HIGHSTAT Phase 1/2 DZDL28 DRUG__ID DZDL28 DZDL28 DRUGCOMP Alnylam Pharmaceuticals Cambridge, MA DZDL28 DRUGTYPE RNA interference DZDL28 HIGHSTAT Phase 1/2 DZL8S6 DRUG__ID DZL8S6 DZL8S6 DRUGCOMP Sumitomo Dainippon Pharma DZL8S6 DRUGTYPE Small molecular drug DZL8S6 HIGHSTAT Phase 1/2 DZLH13 DRUG__ID DZLH13 DZLH13 DRUGCOMP EpicentRx DZLH13 DRUGTYPE Oncolytic virus DZLH13 HIGHSTAT Phase 1/2 DZQ32M DRUG__ID DZQ32M DZQ32M DRUGCOMP Kiromic DZQ32M DRUGTYPE Vaccine DZQ32M HIGHSTAT Phase 1/2 DZU9Q5 DRUG__ID DZU9Q5 DZU9Q5 DRUGCOMP Cambium Medical Technologies DZU9Q5 DRUGTYPE Cell therapy DZU9Q5 HIGHSTAT Phase 1/2 D00ANG DRUG__ID D00ANG D00ANG DRUGCOMP Medgenics D00ANG HIGHSTAT Phase 1/2 D00BJV DRUG__ID D00BJV D00BJV DRUGCOMP Bristol-Myers Squibb Princeton, NJ D00BJV HIGHSTAT Phase 1/2 D00ESH DRUG__ID D00ESH D00ESH DRUGCOMP Northwest biotherapeutics D00ESH HIGHSTAT Phase 1/2 D00LRP DRUG__ID D00LRP D00LRP DRUGCOMP Pieris AG D00LRP HIGHSTAT Phase 1/2 D00OON DRUG__ID D00OON D00OON DRUGCOMP BioAtla San Diego, CA D00OON HIGHSTAT Phase 1/2 D00QKL DRUG__ID D00QKL D00QKL DRUGCOMP Johann Wolfgang Goethe-Universitat Frankfurt am Main D00QKL HIGHSTAT Phase 1/2 D00QUZ DRUG__ID D00QUZ D00QUZ DRUGCOMP TransTech Pharma Inc D00QUZ HIGHSTAT Phase 1/2 D00UGC DRUG__ID D00UGC D00UGC DRUGCOMP Histogen San Diego, CA D00UGC HIGHSTAT Phase 1/2 D00WOX DRUG__ID D00WOX D00WOX DRUGCOMP Advanced cell technology D00WOX HIGHSTAT Phase 1/2 D00YBW DRUG__ID D00YBW D00YBW DRUGCOMP NormOxys Inc D00YBW HIGHSTAT Phase 1/2 D01DIM DRUG__ID D01DIM D01DIM DRUGCOMP Novartis OncologyEast Hanover, NJ D01DIM HIGHSTAT Phase 1/2 D01EMD DRUG__ID D01EMD D01EMD DRUGCOMP Northwest Biotherapeutics D01EMD HIGHSTAT Phase 1/2 D01EYR DRUG__ID D01EYR D01EYR DRUGCOMP BioVex D01EYR HIGHSTAT Phase 1/2 D01FBO DRUG__ID D01FBO D01FBO DRUGCOMP Novavax D01FBO HIGHSTAT Phase 1/2 D01HHJ DRUG__ID D01HHJ D01HHJ DRUGCOMP Global Biotech Inc D01HHJ HIGHSTAT Phase 1/2 D01MQP DRUG__ID D01MQP D01MQP DRUGCOMP Inovio D01MQP HIGHSTAT Phase 1/2 D01MYJ DRUG__ID D01MYJ D01MYJ DRUGCOMP Chugai Pharmaceutical Co Ltd D01MYJ HIGHSTAT Phase 1/2 D01OBM DRUG__ID D01OBM D01OBM DRUGCOMP Astrazeneca; medimmune D01OBM HIGHSTAT Phase 1/2 D01PTS DRUG__ID D01PTS D01PTS DRUGCOMP Bionovo Inc D01PTS HIGHSTAT Phase 1/2 D01QQC DRUG__ID D01QQC D01QQC DRUGCOMP Advantagene D01QQC HIGHSTAT Phase 1/2 D01RLS DRUG__ID D01RLS D01RLS DRUGCOMP Stematix Inc D01RLS HIGHSTAT Phase 1/2 D01SCR DRUG__ID D01SCR D01SCR DRUGCOMP Piramal Healthcare Ltd D01SCR HIGHSTAT Phase 1/2 D01VWB DRUG__ID D01VWB D01VWB DRUGCOMP National Cancer Institute D01VWB HIGHSTAT Phase 1/2 D01XDO DRUG__ID D01XDO D01XDO DRUGCOMP The Center of Molecular Immunology D01XDO HIGHSTAT Phase 1/2 D02AIZ DRUG__ID D02AIZ D02AIZ DRUGCOMP Biosceptre D02AIZ HIGHSTAT Phase 1/2 D02BIY DRUG__ID D02BIY D02BIY DRUGCOMP Northwest Biotherapeutics Bethesda, MD D02BIY HIGHSTAT Phase 1/2 D02BVW DRUG__ID D02BVW D02BVW DRUGCOMP FUJIFILM Pharmaceuticals U.S.A. Cambridge, MA D02BVW HIGHSTAT Phase 1/2 D02BWY DRUG__ID D02BWY D02BWY DRUGCOMP Aduro BiotechBerkeley, CAJanssen Research & Development Raritan, NJ D02BWY HIGHSTAT Phase 1/2 D02DEZ DRUG__ID D02DEZ D02DEZ DRUGCOMP Galena biopharma D02DEZ HIGHSTAT Phase 1/2 D02KVT DRUG__ID D02KVT D02KVT DRUGCOMP Genprex D02KVT HIGHSTAT Phase 1/2 D02NYA DRUG__ID D02NYA D02NYA DRUGCOMP LeafBio, San Diego, CA, Mapp Biopharmaceutical San Diego, CA D02NYA HIGHSTAT Phase 1/2 D02SWB DRUG__ID D02SWB D02SWB DRUGCOMP Biotech Tools SA D02SWB HIGHSTAT Phase 1/2 D02TDV DRUG__ID D02TDV D02TDV DRUGCOMP Lee's Pharmaceutical Holdings (Hong Kong) Ltd D02TDV HIGHSTAT Phase 1/2 D02TWR DRUG__ID D02TWR D02TWR DRUGCOMP Biogen Cambridge, MA Ionis Pharmaceuticals Carlsbad, CA D02TWR HIGHSTAT Phase 1/2 D02WEU DRUG__ID D02WEU D02WEU DRUGCOMP Tolarex Ltd D02WEU HIGHSTAT Phase 1/2 D02XBN DRUG__ID D02XBN D02XBN DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D02XBN HIGHSTAT Phase 1/2 D02XXW DRUG__ID D02XXW D02XXW DRUGCOMP Biocardia D02XXW HIGHSTAT Phase 1/2 D02YEO DRUG__ID D02YEO D02YEO DRUGCOMP Nanobiotix Paris, France D02YEO HIGHSTAT Phase 1/2 D02YWD DRUG__ID D02YWD D02YWD DRUGCOMP Ludwig-Maximilians University of Munich D02YWD HIGHSTAT Phase 1/2 D03BNF DRUG__ID D03BNF D03BNF DRUGCOMP ImmunoGen Waltham, MA D03BNF HIGHSTAT Phase 1/2 D03CNV DRUG__ID D03CNV D03CNV DRUGCOMP VM Discovery D03CNV HIGHSTAT Phase 1/2 D03DVD DRUG__ID D03DVD D03DVD DRUGCOMP Ligocyte pharmaceuticals D03DVD HIGHSTAT Phase 1/2 D03KHX DRUG__ID D03KHX D03KHX DRUGCOMP LigoCyte Pharmaceuticals Inc D03KHX HIGHSTAT Phase 1/2 D03OVN DRUG__ID D03OVN D03OVN DRUGCOMP ReNeuron Group plc D03OVN HIGHSTAT Phase 1/2 D03SXI DRUG__ID D03SXI D03SXI DRUGCOMP Agenus Lexington, MA Incyte Wilmington, DE D03SXI HIGHSTAT Phase 1/2 D03TQB DRUG__ID D03TQB D03TQB DRUGCOMP Aurora BioPharma Cambridge, MA D03TQB HIGHSTAT Phase 1/2 D03VLH DRUG__ID D03VLH D03VLH DRUGCOMP Hybrid BioSystems Ltd D03VLH HIGHSTAT Phase 1/2 D03YJW DRUG__ID D03YJW D03YJW DRUGCOMP Genprex D03YJW HIGHSTAT Phase 1/2 D03ZIP DRUG__ID D03ZIP D03ZIP DRUGCOMP Lokon Pharma Uppsala, Sweden D03ZIP HIGHSTAT Phase 1/2 D03ZSA DRUG__ID D03ZSA D03ZSA DRUGCOMP Bristol-Myers Squibb D03ZSA HIGHSTAT Phase 1/2 D03ZZC DRUG__ID D03ZZC D03ZZC DRUGCOMP Pervasis Therapeutics D03ZZC HIGHSTAT Phase 1/2 D04EJG DRUG__ID D04EJG D04EJG DRUGCOMP Jiangsu HengRui Medicine Shanghai, China D04EJG HIGHSTAT Phase 1/2 D04FSD DRUG__ID D04FSD D04FSD DRUGCOMP University of London D04FSD HIGHSTAT Phase 1/2 D04GBP DRUG__ID D04GBP D04GBP DRUGCOMP ProQR Therapeutics Palo Alto, CA D04GBP HIGHSTAT Phase 1/2 D04JKE DRUG__ID D04JKE D04JKE DRUGCOMP Medipost Co Ltd D04JKE HIGHSTAT Phase 1/2 D04JVU DRUG__ID D04JVU D04JVU DRUGCOMP Hanmi Pharmaceutical Co Ltd D04JVU HIGHSTAT Phase 1/2 D04KZS DRUG__ID D04KZS D04KZS DRUGCOMP Prosensa Therapeutics BV D04KZS HIGHSTAT Phase 1/2 D04LZF DRUG__ID D04LZF D04LZF DRUGCOMP NuvOx Pharma Tucson, AZ D04LZF HIGHSTAT Phase 1/2 D04QLL DRUG__ID D04QLL D04QLL DRUGCOMP Ocata Therapeutics D04QLL HIGHSTAT Phase 1/2 D04QPA DRUG__ID D04QPA D04QPA DRUGCOMP Asterias Biotherapeutics Fremont, CA D04QPA HIGHSTAT Phase 1/2 D04QQZ DRUG__ID D04QQZ D04QQZ DRUGCOMP Audentes Therapeutics San Francisco, CA D04QQZ HIGHSTAT Phase 1/2 D04TIT DRUG__ID D04TIT D04TIT DRUGCOMP Nowarta Biopharma Huntington Beach, CA D04TIT HIGHSTAT Phase 1/2 D04WHM DRUG__ID D04WHM D04WHM DRUGCOMP Genus 0ncology D04WHM HIGHSTAT Phase 1/2 D04XSP DRUG__ID D04XSP D04XSP DRUGCOMP Kite Pharma Inc D04XSP HIGHSTAT Phase 1/2 D04YIA DRUG__ID D04YIA D04YIA DRUGCOMP MD Anderson Cancer Center D04YIA HIGHSTAT Phase 1/2 D04YRD DRUG__ID D04YRD D04YRD DRUGCOMP Dimension Therapeutics Cambridge, MA D04YRD HIGHSTAT Phase 1/2 D04ZFO DRUG__ID D04ZFO D04ZFO DRUGCOMP WaVe Life Sciences Cambridge, MA D04ZFO HIGHSTAT Phase 1/2 D05ATD DRUG__ID D05ATD D05ATD DRUGCOMP AlphaVax D05ATD HIGHSTAT Phase 1/2 D05CGX DRUG__ID D05CGX D05CGX DRUGCOMP Spark Therapeutics Philadelphia, PA D05CGX HIGHSTAT Phase 1/2 D05ELZ DRUG__ID D05ELZ D05ELZ DRUGCOMP Bellicum Pharmaceuticals Houston, TXM.D. Anderson Cancer Center Houston, TX D05ELZ HIGHSTAT Phase 1/2 D05ENG DRUG__ID D05ENG D05ENG DRUGCOMP Alphavax D05ENG HIGHSTAT Phase 1/2 D05ETC DRUG__ID D05ETC D05ETC DRUGCOMP University of Auckland D05ETC HIGHSTAT Phase 1/2 D05EUH DRUG__ID D05EUH D05EUH DRUGCOMP Novavax D05EUH HIGHSTAT Phase 1/2 D05ICS DRUG__ID D05ICS D05ICS DRUGCOMP Oxford BioMedica plc D05ICS HIGHSTAT Phase 1/2 D05KCJ DRUG__ID D05KCJ D05KCJ DRUGCOMP Aduro BioTech D05KCJ HIGHSTAT Phase 1/2 D05NYF DRUG__ID D05NYF D05NYF DRUGCOMP Genmab A/S D05NYF HIGHSTAT Phase 1/2 D05NYK DRUG__ID D05NYK D05NYK DRUGCOMP Belrose Pharmaceuticals Princeton, NJ D05NYK HIGHSTAT Phase 1/2 D05PRV DRUG__ID D05PRV D05PRV DRUGCOMP Glaxosmithkline; okairos D05PRV HIGHSTAT Phase 1/2 D05TRJ DRUG__ID D05TRJ D05TRJ DRUGCOMP Sangamo Therapeutics Richmond, CA D05TRJ HIGHSTAT Phase 1/2 D05TVW DRUG__ID D05TVW D05TVW DRUGCOMP Northwest biotherapeutics D05TVW HIGHSTAT Phase 1/2 D05TWD DRUG__ID D05TWD D05TWD DRUGCOMP Compugen Ltd D05TWD HIGHSTAT Phase 1/2 D05YUI DRUG__ID D05YUI D05YUI DRUGCOMP San Raffaele Telethon Institute for Gene Therapy D05YUI HIGHSTAT Phase 1/2 D06AAG DRUG__ID D06AAG D06AAG DRUGCOMP Emergent BioSolutions D06AAG HIGHSTAT Phase 1/2 D06AWA DRUG__ID D06AWA D06AWA DRUGCOMP Scancell Ltd D06AWA HIGHSTAT Phase 1/2 D06BHI DRUG__ID D06BHI D06BHI DRUGCOMP Bristol-Myers Squibb Princeton, NJ D06BHI HIGHSTAT Phase 1/2 D06CAV DRUG__ID D06CAV D06CAV DRUGCOMP Kiromic Houston, TX D06CAV HIGHSTAT Phase 1/2 D06CJN DRUG__ID D06CJN D06CJN DRUGCOMP Agenus Lexington, MA Incyte Wilmington, DE D06CJN HIGHSTAT Phase 1/2 D06DBJ DRUG__ID D06DBJ D06DBJ DRUGCOMP Regeneron pharmaceuticals D06DBJ HIGHSTAT Phase 1/2 D06FQU DRUG__ID D06FQU D06FQU DRUGCOMP Incyte Wilmington, DE D06FQU HIGHSTAT Phase 1/2 D06HRD DRUG__ID D06HRD D06HRD DRUGCOMP Aptalis Pharma Inc D06HRD HIGHSTAT Phase 1/2 D06IZQ DRUG__ID D06IZQ D06IZQ DRUGCOMP Jenken Bioscience Inc D06IZQ HIGHSTAT Phase 1/2 D06LHE DRUG__ID D06LHE D06LHE DRUGCOMP National Institute of Allergy and Infectious Diseases D06LHE HIGHSTAT Phase 1/2 D06LUI DRUG__ID D06LUI D06LUI DRUGCOMP ZIOPHARM Oncology D06LUI HIGHSTAT Phase 1/2 D06LYI DRUG__ID D06LYI D06LYI DRUGCOMP Bellicum pharmaceuticals D06LYI HIGHSTAT Phase 1/2 D06PZO DRUG__ID D06PZO D06PZO DRUGCOMP America stem cell D06PZO HIGHSTAT Phase 1/2 D06QOC DRUG__ID D06QOC D06QOC DRUGCOMP Genovax Srl D06QOC HIGHSTAT Phase 1/2 D06TJQ DRUG__ID D06TJQ D06TJQ DRUGCOMP BlueLink Pharmaceuticals Ames, IA D06TJQ HIGHSTAT Phase 1/2 D06UEC DRUG__ID D06UEC D06UEC DRUGCOMP Advaxis Inc D06UEC HIGHSTAT Phase 1/2 D06XAT DRUG__ID D06XAT D06XAT DRUGCOMP Bio-Cancer Treatment International Ltd D06XAT HIGHSTAT Phase 1/2 D07ACZ DRUG__ID D07ACZ D07ACZ DRUGCOMP Novartis pharmaceuticals D07ACZ HIGHSTAT Phase 1/2 D07DJP DRUG__ID D07DJP D07DJP DRUGCOMP Avigen D07DJP HIGHSTAT Phase 1/2 D07GWZ DRUG__ID D07GWZ D07GWZ DRUGCOMP Neurotech usa D07GWZ HIGHSTAT Phase 1/2 D07HCH DRUG__ID D07HCH D07HCH DRUGCOMP Lilly D07HCH HIGHSTAT Phase 1/2 D07ISE DRUG__ID D07ISE D07ISE DRUGCOMP Medgenics Inc D07ISE HIGHSTAT Phase 1/2 D07MNT DRUG__ID D07MNT D07MNT DRUGCOMP Seattle Biomedical Research Institute D07MNT HIGHSTAT Phase 1/2 D07NVF DRUG__ID D07NVF D07NVF DRUGCOMP Children's hospital boston; genethon D07NVF HIGHSTAT Phase 1/2 D07PCZ DRUG__ID D07PCZ D07PCZ DRUGCOMP OncoQuest Edmonton, Canada D07PCZ HIGHSTAT Phase 1/2 D07RZW DRUG__ID D07RZW D07RZW DRUGCOMP AstraZeneca D07RZW HIGHSTAT Phase 1/2 D07YGQ DRUG__ID D07YGQ D07YGQ DRUGCOMP OncoQuest Edmonton, Canada D07YGQ HIGHSTAT Phase 1/2 D07YNC DRUG__ID D07YNC D07YNC DRUGCOMP Moderna Therapeutics Cambridge, MD D07YNC HIGHSTAT Phase 1/2 D07YPV DRUG__ID D07YPV D07YPV DRUGCOMP Abela Pharmaceuticals Inc D07YPV HIGHSTAT Phase 1/2 D07ZAK DRUG__ID D07ZAK D07ZAK DRUGCOMP REGENXBIO Rockville, MD University of Pennsylvania Philadelphia, PA D07ZAK HIGHSTAT Phase 1/2 D07ZAO DRUG__ID D07ZAO D07ZAO DRUGCOMP OncoVista Innovative Therapies D07ZAO HIGHSTAT Phase 1/2 D08ANJ DRUG__ID D08ANJ D08ANJ DRUGCOMP Acesion Pharma D08ANJ HIGHSTAT Phase 1/2 D08BQJ DRUG__ID D08BQJ D08BQJ DRUGCOMP Northwest Biotherapeutics D08BQJ HIGHSTAT Phase 1/2 D08DMY DRUG__ID D08DMY D08DMY DRUGCOMP BriaCell Therapeutics Berkeley, CA D08DMY HIGHSTAT Phase 1/2 D08DZO DRUG__ID D08DZO D08DZO DRUGCOMP U.S. Naval Medical Research Center; Vical D08DZO HIGHSTAT Phase 1/2 D08EIK DRUG__ID D08EIK D08EIK DRUGCOMP Eli lilly D08EIK HIGHSTAT Phase 1/2 D08GKU DRUG__ID D08GKU D08GKU DRUGCOMP BriaCell Therapeutics Berkeley, CA D08GKU HIGHSTAT Phase 1/2 D08HRD DRUG__ID D08HRD D08HRD DRUGCOMP Walter Reed Army Institute of Research D08HRD HIGHSTAT Phase 1/2 D08JOY DRUG__ID D08JOY D08JOY DRUGCOMP Anesiva D08JOY HIGHSTAT Phase 1/2 D08KCJ DRUG__ID D08KCJ D08KCJ DRUGCOMP Affibody Holding AB D08KCJ HIGHSTAT Phase 1/2 D08KCK DRUG__ID D08KCK D08KCK DRUGCOMP Arana Therapeutics D08KCK HIGHSTAT Phase 1/2 D08KXC DRUG__ID D08KXC D08KXC DRUGCOMP Soligenix D08KXC HIGHSTAT Phase 1/2 D08MKR DRUG__ID D08MKR D08MKR DRUGCOMP Wake Forest University D08MKR HIGHSTAT Phase 1/2 D08OMM DRUG__ID D08OMM D08OMM DRUGCOMP BioLineRx D08OMM HIGHSTAT Phase 1/2 D08OPS DRUG__ID D08OPS D08OPS DRUGCOMP aTyr Pharma, San Diego, CA D08OPS HIGHSTAT Phase 1/2 D08POH DRUG__ID D08POH D08POH DRUGCOMP Walter Reed Army Institute of Research D08POH HIGHSTAT Phase 1/2 D08RWO DRUG__ID D08RWO D08RWO DRUGCOMP BioAtlaSan Diego, CA D08RWO HIGHSTAT Phase 1/2 D08UJH DRUG__ID D08UJH D08UJH DRUGCOMP Tocagen D08UJH HIGHSTAT Phase 1/2 D08UMZ DRUG__ID D08UMZ D08UMZ DRUGCOMP SunTen Phytotech Co Ltd D08UMZ HIGHSTAT Phase 1/2 D08XDO DRUG__ID D08XDO D08XDO DRUGCOMP Q Therapeutics Inc D08XDO HIGHSTAT Phase 1/2 D08XFA DRUG__ID D08XFA D08XFA DRUGCOMP Flamel Technologies SA D08XFA HIGHSTAT Phase 1/2 D08ZQI DRUG__ID D08ZQI D08ZQI DRUGCOMP Five prime therapeutics D08ZQI HIGHSTAT Phase 1/2 D08ZZP DRUG__ID D08ZZP D08ZZP DRUGCOMP OncoGenex Pharmaceuticals Inc D08ZZP HIGHSTAT Phase 1/2 D09CCZ DRUG__ID D09CCZ D09CCZ DRUGCOMP Cahaba pharmaceuticals D09CCZ HIGHSTAT Phase 1/2 D09CXE DRUG__ID D09CXE D09CXE DRUGCOMP LigoCyte Pharmaceuticals D09CXE HIGHSTAT Phase 1/2 D09EWK DRUG__ID D09EWK D09EWK DRUGCOMP Prosensa Therapeutics BV D09EWK HIGHSTAT Phase 1/2 D09GRH DRUG__ID D09GRH D09GRH DRUGCOMP AVAX Technologies Inc D09GRH HIGHSTAT Phase 1/2 D09HRS DRUG__ID D09HRS D09HRS DRUGCOMP Avir Green Hills Biotechnology GmbH D09HRS HIGHSTAT Phase 1/2 D09NHS DRUG__ID D09NHS D09NHS DRUGCOMP RMF Dictagene SA D09NHS HIGHSTAT Phase 1/2 D09PAU DRUG__ID D09PAU D09PAU DRUGCOMP Vision 7 GmbH D09PAU HIGHSTAT Phase 1/2 D09QVR DRUG__ID D09QVR D09QVR DRUGCOMP Bristol-Myers Squibb Princeton, NJ D09QVR HIGHSTAT Phase 1/2 D09QVU DRUG__ID D09QVU D09QVU DRUGCOMP Aphios D09QVU HIGHSTAT Phase 1/2 D09RYU DRUG__ID D09RYU D09RYU DRUGCOMP Viracta Therapeutics Cardiff, CA D09RYU HIGHSTAT Phase 1/2 D09SFX DRUG__ID D09SFX D09SFX DRUGCOMP Agenus Lexington, MA D09SFX HIGHSTAT Phase 1/2 D09TLT DRUG__ID D09TLT D09TLT DRUGCOMP Novartis pharmaceuticals D09TLT HIGHSTAT Phase 1/2 D09WXY DRUG__ID D09WXY D09WXY DRUGCOMP Celldex Therapeutics Hampton, NJ D09WXY HIGHSTAT Phase 1/2 D09YVQ DRUG__ID D09YVQ D09YVQ DRUGCOMP Osiris Therapeutics D09YVQ HIGHSTAT Phase 1/2 D09ZNL DRUG__ID D09ZNL D09ZNL DRUGCOMP Linkoping University D09ZNL HIGHSTAT Phase 1/2 D0A0BK DRUG__ID D0A0BK D0A0BK DRUGCOMP Calimmune D0A0BK HIGHSTAT Phase 1/2 D0A0CY DRUG__ID D0A0CY D0A0CY DRUGCOMP Coronado Biosciences D0A0CY HIGHSTAT Phase 1/2 D0A2KL DRUG__ID D0A2KL D0A2KL DRUGCOMP GT Biopharma Washington, DC D0A2KL HIGHSTAT Phase 1/2 D0A6KA DRUG__ID D0A6KA D0A6KA DRUGCOMP MaxCyte D0A6KA HIGHSTAT Phase 1/2 D0A9PW DRUG__ID D0A9PW D0A9PW DRUGCOMP Amsterdam Molecular Therapeutics BV D0A9PW HIGHSTAT Phase 1/2 D0AF8E DRUG__ID D0AF8E D0AF8E DRUGCOMP BioXcel Branford, CT D0AF8E HIGHSTAT Phase 1/2 D0AN3N DRUG__ID D0AN3N D0AN3N DRUGCOMP Solid Biosciences Cambridge, MA D0AN3N HIGHSTAT Phase 1/2 D0AO9Q DRUG__ID D0AO9Q D0AO9Q DRUGCOMP Syntimmune Boston, MA D0AO9Q HIGHSTAT Phase 1/2 D0AZ1N DRUG__ID D0AZ1N D0AZ1N DRUGCOMP Kiromic Houston, TX D0AZ1N HIGHSTAT Phase 1/2 D0B1TX DRUG__ID D0B1TX D0B1TX DRUGCOMP Cyto Pulse Sciences Inc D0B1TX HIGHSTAT Phase 1/2 D0B4OK DRUG__ID D0B4OK D0B4OK DRUGCOMP Symphogen Somerville, NJ D0B4OK HIGHSTAT Phase 1/2 D0B6EA DRUG__ID D0B6EA D0B6EA DRUGCOMP Catherex D0B6EA HIGHSTAT Phase 1/2 D0BE8H DRUG__ID D0BE8H D0BE8H DRUGCOMP Incyte Wilmington, DE D0BE8H HIGHSTAT Phase 1/2 D0BI3K DRUG__ID D0BI3K D0BI3K DRUGCOMP Y-mAbs Therapeutics New York, NY D0BI3K HIGHSTAT Phase 1/2 D0BS6F DRUG__ID D0BS6F D0BS6F DRUGCOMP Janssen Vaccines and Prevention Leiden, Netherlands D0BS6F HIGHSTAT Phase 1/2 D0C3MW DRUG__ID D0C3MW D0C3MW DRUGCOMP Metabasis Therapeutics Inc D0C3MW HIGHSTAT Phase 1/2 D0C6KS DRUG__ID D0C6KS D0C6KS DRUGCOMP Kiromic Houston, TX D0C6KS HIGHSTAT Phase 1/2 D0C6NV DRUG__ID D0C6NV D0C6NV DRUGCOMP Ruthigen D0C6NV HIGHSTAT Phase 1/2 D0C6VO DRUG__ID D0C6VO D0C6VO DRUGCOMP Stratatech D0C6VO HIGHSTAT Phase 1/2 D0C6YH DRUG__ID D0C6YH D0C6YH DRUGCOMP Arcion Therapeutics Inc D0C6YH HIGHSTAT Phase 1/2 D0C7YE DRUG__ID D0C7YE D0C7YE DRUGCOMP Celyad Boston, MA D0C7YE HIGHSTAT Phase 1/2 D0C8ES DRUG__ID D0C8ES D0C8ES DRUGCOMP Cleveland biolabs D0C8ES HIGHSTAT Phase 1/2 D0D1UQ DRUG__ID D0D1UQ D0D1UQ DRUGCOMP Neurim Pharmaceuticals D0D1UQ HIGHSTAT Phase 1/2 D0D2CY DRUG__ID D0D2CY D0D2CY DRUGCOMP National Human Genome Research Institute D0D2CY HIGHSTAT Phase 1/2 D0D2XA DRUG__ID D0D2XA D0D2XA DRUGCOMP Momotaro-Gene D0D2XA HIGHSTAT Phase 1/2 D0D8ZK DRUG__ID D0D8ZK D0D8ZK DRUGCOMP Oncolys Biopharma D0D8ZK HIGHSTAT Phase 1/2 D0D9YB DRUG__ID D0D9YB D0D9YB DRUGCOMP Immunovaccine Halifax, Canada D0D9YB HIGHSTAT Phase 1/2 D0DG6C DRUG__ID D0DG6C D0DG6C DRUGCOMP Amcyte D0DG6C HIGHSTAT Phase 1/2 D0DG9F DRUG__ID D0DG9F D0DG9F DRUGCOMP Imperial College London D0DG9F HIGHSTAT Phase 1/2 D0DJ2H DRUG__ID D0DJ2H D0DJ2H DRUGCOMP Aduro BioTech Berkeley, CA D0DJ2H HIGHSTAT Phase 1/2 D0DQ2T DRUG__ID D0DQ2T D0DQ2T DRUGCOMP Procypra Therapeutics Sausalito, CA D0DQ2T HIGHSTAT Phase 1/2 D0DX1F DRUG__ID D0DX1F D0DX1F DRUGCOMP Applied Genetic Technologies Corp D0DX1F HIGHSTAT Phase 1/2 D0DX9T DRUG__ID D0DX9T D0DX9T DRUGCOMP Stratatech Madison, WI D0DX9T HIGHSTAT Phase 1/2 D0DY9K DRUG__ID D0DY9K D0DY9K DRUGCOMP Baxalta Bannockburn, IL D0DY9K HIGHSTAT Phase 1/2 D0E0AX DRUG__ID D0E0AX D0E0AX DRUGCOMP Anaconda Pharma SAS D0E0AX HIGHSTAT Phase 1/2 D0E1FP DRUG__ID D0E1FP D0E1FP DRUGCOMP Biotecnol SA D0E1FP HIGHSTAT Phase 1/2 D0E2DL DRUG__ID D0E2DL D0E2DL DRUGCOMP Iwate Medical University D0E2DL HIGHSTAT Phase 1/2 D0E4DN DRUG__ID D0E4DN D0E4DN DRUGCOMP Stem centrx D0E4DN HIGHSTAT Phase 1/2 D0E4LS DRUG__ID D0E4LS D0E4LS DRUGCOMP Novartis Oncology East Hanover, NJ D0E4LS HIGHSTAT Phase 1/2 D0E6PF DRUG__ID D0E6PF D0E6PF DRUGCOMP Bionor Immuno AS D0E6PF HIGHSTAT Phase 1/2 D0E7IM DRUG__ID D0E7IM D0E7IM DRUGCOMP Otsuka America Pharmaceutical D0E7IM HIGHSTAT Phase 1/2 D0E7MA DRUG__ID D0E7MA D0E7MA DRUGCOMP CoMentis D0E7MA HIGHSTAT Phase 1/2 D0E7RQ DRUG__ID D0E7RQ D0E7RQ DRUGCOMP Flanders Interuniversity Institute for Biotechnology (VIB) D0E7RQ HIGHSTAT Phase 1/2 D0EL9Z DRUG__ID D0EL9Z D0EL9Z DRUGCOMP Alopexx VaccineConcord, MA D0EL9Z HIGHSTAT Phase 1/2 D0EV4B DRUG__ID D0EV4B D0EV4B DRUGCOMP CreaGene Inc D0EV4B HIGHSTAT Phase 1/2 D0EZ5Y DRUG__ID D0EZ5Y D0EZ5Y DRUGCOMP Kiromic Houston, TX D0EZ5Y HIGHSTAT Phase 1/2 D0F2WN DRUG__ID D0F2WN D0F2WN DRUGCOMP Digna Biotech SL D0F2WN HIGHSTAT Phase 1/2 D0F3MT DRUG__ID D0F3MT D0F3MT DRUGCOMP Alphavax D0F3MT HIGHSTAT Phase 1/2 D0F5BL DRUG__ID D0F5BL D0F5BL DRUGCOMP Glycadia Inc D0F5BL HIGHSTAT Phase 1/2 D0F6SY DRUG__ID D0F6SY D0F6SY DRUGCOMP Oxford BioMedica plc D0F6SY HIGHSTAT Phase 1/2 D0F7CR DRUG__ID D0F7CR D0F7CR DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0F7CR HIGHSTAT Phase 1/2 D0F7FY DRUG__ID D0F7FY D0F7FY DRUGCOMP ImmunitorVancouver, Canada D0F7FY HIGHSTAT Phase 1/2 D0F7QP DRUG__ID D0F7QP D0F7QP DRUGCOMP Sanofi us D0F7QP HIGHSTAT Phase 1/2 D0F8SK DRUG__ID D0F8SK D0F8SK DRUGCOMP ImaRx Therapeutics Inc D0F8SK HIGHSTAT Phase 1/2 D0F8SW DRUG__ID D0F8SW D0F8SW DRUGCOMP Senesco Technologies D0F8SW HIGHSTAT Phase 1/2 D0FF2G DRUG__ID D0FF2G D0FF2G DRUGCOMP Symphogen Somerville, NJ D0FF2G HIGHSTAT Phase 1/2 D0FI1L DRUG__ID D0FI1L D0FI1L DRUGCOMP Cadent Therapeutics D0FI1L HIGHSTAT Phase 1/2 D0FN4K DRUG__ID D0FN4K D0FN4K DRUGCOMP University of Queensland D0FN4K HIGHSTAT Phase 1/2 D0G1EA DRUG__ID D0G1EA D0G1EA DRUGCOMP Leiden University Medical Center D0G1EA HIGHSTAT Phase 1/2 D0G2OZ DRUG__ID D0G2OZ D0G2OZ DRUGCOMP Eisai Woodcliff Lake, NJ D0G2OZ HIGHSTAT Phase 1/2 D0G4AJ DRUG__ID D0G4AJ D0G4AJ DRUGCOMP Allergan Inc D0G4AJ HIGHSTAT Phase 1/2 D0G5WV DRUG__ID D0G5WV D0G5WV DRUGCOMP Kite pharma santa monica; national cancer institute D0G5WV HIGHSTAT Phase 1/2 D0G9MC DRUG__ID D0G9MC D0G9MC DRUGCOMP Taiwan Liposome Company Taipei, Taiwan D0G9MC HIGHSTAT Phase 1/2 D0GB2L DRUG__ID D0GB2L D0GB2L DRUGCOMP NeuroNova AB D0GB2L HIGHSTAT Phase 1/2 D0GY0U DRUG__ID D0GY0U D0GY0U DRUGCOMP MultiGene D0GY0U HIGHSTAT Phase 1/2 D0H0ZQ DRUG__ID D0H0ZQ D0H0ZQ DRUGCOMP National Institute of Allergy and Infectious Diseases D0H0ZQ HIGHSTAT Phase 1/2 D0H2IQ DRUG__ID D0H2IQ D0H2IQ DRUGCOMP Univalor D0H2IQ HIGHSTAT Phase 1/2 D0H3HV DRUG__ID D0H3HV D0H3HV DRUGCOMP Action Pharma A/S D0H3HV HIGHSTAT Phase 1/2 D0H5MS DRUG__ID D0H5MS D0H5MS DRUGCOMP City of Hope D0H5MS HIGHSTAT Phase 1/2 D0H6EF DRUG__ID D0H6EF D0H6EF DRUGCOMP Bavarian Nordic A/S D0H6EF HIGHSTAT Phase 1/2 D0H7DM DRUG__ID D0H7DM D0H7DM DRUGCOMP Immix Biopharma Los Angeles, CA D0H7DM HIGHSTAT Phase 1/2 D0H7LN DRUG__ID D0H7LN D0H7LN DRUGCOMP Lionex Diagnostics & Therapeutics GmbH D0H7LN HIGHSTAT Phase 1/2 D0HE9J DRUG__ID D0HE9J D0HE9J DRUGCOMP Polymun Scientific Immunobiologische Forschung GmbH D0HE9J HIGHSTAT Phase 1/2 D0HH2I DRUG__ID D0HH2I D0HH2I DRUGCOMP CureVac GmbH D0HH2I HIGHSTAT Phase 1/2 D0HI0L DRUG__ID D0HI0L D0HI0L DRUGCOMP Crusade Laboratories Ltd D0HI0L HIGHSTAT Phase 1/2 D0HT4Y DRUG__ID D0HT4Y D0HT4Y DRUGCOMP Celgene Summit, NJ D0HT4Y HIGHSTAT Phase 1/2 D0HW1L DRUG__ID D0HW1L D0HW1L DRUGCOMP Harpoon Therapeutics D0HW1L HIGHSTAT Phase 1/2 D0HZ2A DRUG__ID D0HZ2A D0HZ2A DRUGCOMP Recoly NV D0HZ2A HIGHSTAT Phase 1/2 D0I0KP DRUG__ID D0I0KP D0I0KP DRUGCOMP International Stem Cell Carlsbad, CA D0I0KP HIGHSTAT Phase 1/2 D0I0LP DRUG__ID D0I0LP D0I0LP DRUGCOMP Meridian Biosciences D0I0LP HIGHSTAT Phase 1/2 D0I1QJ DRUG__ID D0I1QJ D0I1QJ DRUGCOMP Kinetek Pharmaceuticals Inc D0I1QJ HIGHSTAT Phase 1/2 D0I3HI DRUG__ID D0I3HI D0I3HI DRUGCOMP Kaken Pharmaceutical Co Ltd D0I3HI HIGHSTAT Phase 1/2 D0I5QV DRUG__ID D0I5QV D0I5QV DRUGCOMP Virax Holdings Ltd D0I5QV HIGHSTAT Phase 1/2 D0I6EK DRUG__ID D0I6EK D0I6EK DRUGCOMP University of Arkansas D0I6EK HIGHSTAT Phase 1/2 D0I9YM DRUG__ID D0I9YM D0I9YM DRUGCOMP Immunocore Oxford, United Kingdom D0I9YM HIGHSTAT Phase 1/2 D0IL0H DRUG__ID D0IL0H D0IL0H DRUGCOMP Takara bio D0IL0H HIGHSTAT Phase 1/2 D0IN9G DRUG__ID D0IN9G D0IN9G DRUGCOMP Amgen Inc D0IN9G HIGHSTAT Phase 1/2 D0IR2V DRUG__ID D0IR2V D0IR2V DRUGCOMP DNage BV D0IR2V HIGHSTAT Phase 1/2 D0IW4E DRUG__ID D0IW4E D0IW4E DRUGCOMP Galena Biopharma San Ramon, CA D0IW4E HIGHSTAT Phase 1/2 D0J1IT DRUG__ID D0J1IT D0J1IT DRUGCOMP LigoCyte Pharmaceuticals Inc D0J1IT HIGHSTAT Phase 1/2 D0J2ES DRUG__ID D0J2ES D0J2ES DRUGCOMP Humanetics Corporation D0J2ES HIGHSTAT Phase 1/2 D0J3DC DRUG__ID D0J3DC D0J3DC DRUGCOMP Ligocyte pharmaceuticals (takeda) D0J3DC HIGHSTAT Phase 1/2 D0J4BO DRUG__ID D0J4BO D0J4BO DRUGCOMP LigoCyte Pharmaceuticals D0J4BO HIGHSTAT Phase 1/2 D0J6AJ DRUG__ID D0J6AJ D0J6AJ DRUGCOMP Juno Therapeutics Seattle, WA D0J6AJ HIGHSTAT Phase 1/2 D0J6FF DRUG__ID D0J6FF D0J6FF DRUGCOMP VGX Pharmaceuticals LLC D0J6FF HIGHSTAT Phase 1/2 D0J6NG DRUG__ID D0J6NG D0J6NG DRUGCOMP Acucela; otsuka pharmaceutical D0J6NG HIGHSTAT Phase 1/2 D0J6WA DRUG__ID D0J6WA D0J6WA DRUGCOMP Jiangsu Hansoh Pharmaceutical Jiangsi, China D0J6WA HIGHSTAT Phase 1/2 D0JK2R DRUG__ID D0JK2R D0JK2R DRUGCOMP RMJ Holdings Ashburn, VA D0JK2R HIGHSTAT Phase 1/2 D0JN6P DRUG__ID D0JN6P D0JN6P DRUGCOMP Annias Immunotherapeutics Chapel Hill, NC D0JN6P HIGHSTAT Phase 1/2 D0JN8C DRUG__ID D0JN8C D0JN8C DRUGCOMP Moderna Therapeutics Cambridge, MA D0JN8C HIGHSTAT Phase 1/2 D0K3FX DRUG__ID D0K3FX D0K3FX DRUGCOMP Neurotech Pharmaceuticals Inc D0K3FX HIGHSTAT Phase 1/2 D0K3SM DRUG__ID D0K3SM D0K3SM DRUGCOMP MBiotec GmbH D0K3SM HIGHSTAT Phase 1/2 D0K3ZL DRUG__ID D0K3ZL D0K3ZL DRUGCOMP Advanced Cell Technology Inc D0K3ZL HIGHSTAT Phase 1/2 D0K6UG DRUG__ID D0K6UG D0K6UG DRUGCOMP SymbioTec GmbH D0K6UG HIGHSTAT Phase 1/2 D0K9JO DRUG__ID D0K9JO D0K9JO DRUGCOMP Asklepios biopharmaceutical D0K9JO HIGHSTAT Phase 1/2 D0KL4E DRUG__ID D0KL4E D0KL4E DRUGCOMP Sanofi US, Bridgewater, NJ D0KL4E HIGHSTAT Phase 1/2 D0L1CO DRUG__ID D0L1CO D0L1CO DRUGCOMP Adaptimmune Philadelphia, PA D0L1CO HIGHSTAT Phase 1/2 D0L1FN DRUG__ID D0L1FN D0L1FN DRUGCOMP Zenyth Therapeutics Ltd D0L1FN HIGHSTAT Phase 1/2 D0L2WK DRUG__ID D0L2WK D0L2WK DRUGCOMP Camurus Lund, Sweden D0L2WK HIGHSTAT Phase 1/2 D0L3RZ DRUG__ID D0L3RZ D0L3RZ DRUGCOMP Alexion Pharmaceuticals New Haven, CT D0L3RZ HIGHSTAT Phase 1/2 D0L5IA DRUG__ID D0L5IA D0L5IA DRUGCOMP Halozyme Therapeutics San Diego; CA D0L5IA HIGHSTAT Phase 1/2 D0L6RR DRUG__ID D0L6RR D0L6RR DRUGCOMP Fresenius Biotech GmbH D0L6RR HIGHSTAT Phase 1/2 D0L7LT DRUG__ID D0L7LT D0L7LT DRUGCOMP Northwest biotherapeutics D0L7LT HIGHSTAT Phase 1/2 D0L8IH DRUG__ID D0L8IH D0L8IH DRUGCOMP Immatics biotechnologies GmbH D0L8IH HIGHSTAT Phase 1/2 D0L9TD DRUG__ID D0L9TD D0L9TD DRUGCOMP Virax Holdings Ltd D0L9TD HIGHSTAT Phase 1/2 D0LA9K DRUG__ID D0LA9K D0LA9K DRUGTYPE Antibody D0LA9K HIGHSTAT Phase 1/2 D0LL9W DRUG__ID D0LL9W D0LL9W DRUGCOMP VBI Vaccines Cambridge, MA D0LL9W HIGHSTAT Phase 1/2 D0LM0X DRUG__ID D0LM0X D0LM0X DRUGCOMP Keystone Nano State College, PA D0LM0X HIGHSTAT Phase 1/2 D0LP2P DRUG__ID D0LP2P D0LP2P DRUGCOMP Lakewood Amedex Sarasota, FL D0LP2P HIGHSTAT Phase 1/2 D0LS8H DRUG__ID D0LS8H D0LS8H DRUGCOMP Midatech Pharma US Raleigh, NC D0LS8H HIGHSTAT Phase 1/2 D0LU4N DRUG__ID D0LU4N D0LU4N DRUGCOMP Kite pharma santa monica; national cancer institute D0LU4N HIGHSTAT Phase 1/2 D0M1WW DRUG__ID D0M1WW D0M1WW DRUGCOMP GlaxoSmithKlineResearch Triangle Park, NC U.S. Army Medical Research and Materiel Command Fort Detrick, MD D0M1WW HIGHSTAT Phase 1/2 D0M2UT DRUG__ID D0M2UT D0M2UT DRUGCOMP NantKwest Culver City, CA D0M2UT HIGHSTAT Phase 1/2 D0M2XK DRUG__ID D0M2XK D0M2XK DRUGCOMP Formula Pharmaceuticals Berwyn, PA D0M2XK HIGHSTAT Phase 1/2 D0M3HV DRUG__ID D0M3HV D0M3HV DRUGCOMP MaxCyte; Northern Therapeutics D0M3HV HIGHSTAT Phase 1/2 D0M3QT DRUG__ID D0M3QT D0M3QT DRUGCOMP Cancer Research Technology Ltd D0M3QT HIGHSTAT Phase 1/2 D0M4PV DRUG__ID D0M4PV D0M4PV DRUGCOMP uniQure, Lexington, MA D0M4PV HIGHSTAT Phase 1/2 D0ME7Q DRUG__ID D0ME7Q D0ME7Q DRUGCOMP Molecular Partners Zurich, Switzerland D0ME7Q HIGHSTAT Phase 1/2 D0MI5G DRUG__ID D0MI5G D0MI5G DRUGCOMP Repligen D0MI5G HIGHSTAT Phase 1/2 D0MK2Y DRUG__ID D0MK2Y D0MK2Y DRUGCOMP Shantha Biotechnics PVT Ltd D0MK2Y HIGHSTAT Phase 1/2 D0MT3A DRUG__ID D0MT3A D0MT3A DRUGCOMP jCyte, Newport Beach, CA D0MT3A HIGHSTAT Phase 1/2 D0MX5N DRUG__ID D0MX5N D0MX5N DRUGCOMP Lifecells Irvine, CA D0MX5N HIGHSTAT Phase 1/2 D0N1RH DRUG__ID D0N1RH D0N1RH DRUGCOMP Advanced Plant Pharmaceuticals Inc D0N1RH HIGHSTAT Phase 1/2 D0N1XJ DRUG__ID D0N1XJ D0N1XJ DRUGCOMP Assistance Publique-Hopitaux de Paris (AP-HP) D0N1XJ HIGHSTAT Phase 1/2 D0O2JT DRUG__ID D0O2JT D0O2JT DRUGCOMP Genitope D0O2JT HIGHSTAT Phase 1/2 D0O4CH DRUG__ID D0O4CH D0O4CH DRUGCOMP Novelos Therapeutics D0O4CH HIGHSTAT Phase 1/2 D0O4QS DRUG__ID D0O4QS D0O4QS DRUGCOMP UCB SA D0O4QS HIGHSTAT Phase 1/2 D0OA0H DRUG__ID D0OA0H D0OA0H DRUGCOMP Inovio pharmaceuticals D0OA0H HIGHSTAT Phase 1/2 D0OC0W DRUG__ID D0OC0W D0OC0W DRUGCOMP Formation Biologics Austin, TX D0OC0W HIGHSTAT Phase 1/2 D0OI8M DRUG__ID D0OI8M D0OI8M DRUGCOMP Beech Tree Labs Inc D0OI8M HIGHSTAT Phase 1/2 D0OM5L DRUG__ID D0OM5L D0OM5L DRUGCOMP ViaCyte, San Diego, CA D0OM5L HIGHSTAT Phase 1/2 D0OT3L DRUG__ID D0OT3L D0OT3L DRUGCOMP Galena biopharma D0OT3L HIGHSTAT Phase 1/2 D0OZ0Z DRUG__ID D0OZ0Z D0OZ0Z DRUGCOMP CureLab Oncology Canton, MA D0OZ0Z HIGHSTAT Phase 1/2 D0P0EI DRUG__ID D0P0EI D0P0EI DRUGCOMP Prolexys Pharmaceuticals D0P0EI HIGHSTAT Phase 1/2 D0P2YP DRUG__ID D0P2YP D0P2YP DRUGCOMP ArmaGen Technologies Calabasas, CA D0P2YP HIGHSTAT Phase 1/2 D0P3BS DRUG__ID D0P3BS D0P3BS DRUGCOMP Thymon D0P3BS HIGHSTAT Phase 1/2 D0P3NZ DRUG__ID D0P3NZ D0P3NZ DRUGCOMP CMP Therapeutics Ltd D0P3NZ HIGHSTAT Phase 1/2 D0P3ZF DRUG__ID D0P3ZF D0P3ZF DRUGCOMP IGF OncologySt. Paul, MN D0P3ZF HIGHSTAT Phase 1/2 D0P5FA DRUG__ID D0P5FA D0P5FA DRUGCOMP NovaLead Pharma Shrewsbury, MA D0P5FA HIGHSTAT Phase 1/2 D0P5RD DRUG__ID D0P5RD D0P5RD DRUGCOMP Nabi Biopharmaceuticals D0P5RD HIGHSTAT Phase 1/2 D0P5UQ DRUG__ID D0P5UQ D0P5UQ DRUGCOMP Aastrom Biosciences D0P5UQ HIGHSTAT Phase 1/2 D0P7FM DRUG__ID D0P7FM D0P7FM DRUGCOMP Incyte Wilmington, DE D0P7FM HIGHSTAT Phase 1/2 D0P7IL DRUG__ID D0P7IL D0P7IL DRUGCOMP GLG Pharma Jupiter, FL D0P7IL HIGHSTAT Phase 1/2 D0P8MB DRUG__ID D0P8MB D0P8MB DRUGCOMP Adma biologics; emergent biosolutions D0P8MB HIGHSTAT Phase 1/2 D0PT1Y DRUG__ID D0PT1Y D0PT1Y DRUGCOMP Sanofi D0PT1Y HIGHSTAT Phase 1/2 D0PT9G DRUG__ID D0PT9G D0PT9G DRUGCOMP Intensity Therapeutics Westport, CT D0PT9G HIGHSTAT Phase 1/2 D0PX7X DRUG__ID D0PX7X D0PX7X DRUGCOMP Diatide Inc D0PX7X HIGHSTAT Phase 1/2 D0Q0TK DRUG__ID D0Q0TK D0Q0TK DRUGCOMP RetroSense Therapeutics Ann Arbor, MI D0Q0TK HIGHSTAT Phase 1/2 D0Q1JZ DRUG__ID D0Q1JZ D0Q1JZ DRUGCOMP Providence Health System - Oregon D0Q1JZ HIGHSTAT Phase 1/2 D0Q4DS DRUG__ID D0Q4DS D0Q4DS DRUGCOMP AVAX Technologies D0Q4DS HIGHSTAT Phase 1/2 D0Q6EH DRUG__ID D0Q6EH D0Q6EH DRUGCOMP Stealth BioTherapeutics Newton, MA D0Q6EH HIGHSTAT Phase 1/2 D0Q6QU DRUG__ID D0Q6QU D0Q6QU DRUGCOMP AstraZeneca D0Q6QU HIGHSTAT Phase 1/2 D0Q8GV DRUG__ID D0Q8GV D0Q8GV DRUGCOMP FK Biotecnologia SA D0Q8GV HIGHSTAT Phase 1/2 D0QI1K DRUG__ID D0QI1K D0QI1K DRUGCOMP GenmabPrinceton, NJSeattle GeneticsBothell, WA D0QI1K HIGHSTAT Phase 1/2 D0QP8X DRUG__ID D0QP8X D0QP8X DRUGCOMP Ono Pharmaceutical Osaka, Japan D0QP8X HIGHSTAT Phase 1/2 D0QZ1Z DRUG__ID D0QZ1Z D0QZ1Z DRUGCOMP Pervasis Therapeutics D0QZ1Z HIGHSTAT Phase 1/2 D0R0NX DRUG__ID D0R0NX D0R0NX DRUGCOMP Aura Biosciences Cambridge, MA D0R0NX HIGHSTAT Phase 1/2 D0R0WZ DRUG__ID D0R0WZ D0R0WZ DRUGCOMP Kinex Pharmaceuticals D0R0WZ HIGHSTAT Phase 1/2 D0R4RL DRUG__ID D0R4RL D0R4RL DRUGCOMP Myonexus Therapeutics New Albany, OH D0R4RL HIGHSTAT Phase 1/2 D0R7CD DRUG__ID D0R7CD D0R7CD DRUGCOMP IncyteWilmington, DE D0R7CD HIGHSTAT Phase 1/2 D0R9GF DRUG__ID D0R9GF D0R9GF DRUGCOMP Sarepta Therapeutics Cambridge, MA Nationwide Children's Hospital Columbus, OH D0R9GF HIGHSTAT Phase 1/2 D0RC0P DRUG__ID D0RC0P D0RC0P DRUGCOMP Queensland Institute of Medical Research D0RC0P HIGHSTAT Phase 1/2 D0RK4B DRUG__ID D0RK4B D0RK4B DRUGCOMP Ionis Pharmaceuticals Carlsbad, CA D0RK4B HIGHSTAT Phase 1/2 D0RM6A DRUG__ID D0RM6A D0RM6A DRUGCOMP RetroSense Therapeutics D0RM6A HIGHSTAT Phase 1/2 D0S0VR DRUG__ID D0S0VR D0S0VR DRUGCOMP Inhibitex Inc D0S0VR HIGHSTAT Phase 1/2 D0S7AW DRUG__ID D0S7AW D0S7AW DRUGCOMP Kadmon pharmaceuticals D0S7AW HIGHSTAT Phase 1/2 D0S7CM DRUG__ID D0S7CM D0S7CM DRUGCOMP Highland therapeutics D0S7CM HIGHSTAT Phase 1/2 D0S8BG DRUG__ID D0S8BG D0S8BG DRUGTYPE Antibody D0S8BG HIGHSTAT Phase 1/2 D0SQ9O DRUG__ID D0SQ9O D0SQ9O DRUGCOMP AuRx D0SQ9O HIGHSTAT Phase 1/2 D0SS1Q DRUG__ID D0SS1Q D0SS1Q DRUGCOMP Iomai D0SS1Q HIGHSTAT Phase 1/2 D0T0BF DRUG__ID D0T0BF D0T0BF DRUGCOMP St Jude Children's Research Hospital D0T0BF HIGHSTAT Phase 1/2 D0T2IF DRUG__ID D0T2IF D0T2IF DRUGCOMP Immunovaccine D0T2IF HIGHSTAT Phase 1/2 D0T2NV DRUG__ID D0T2NV D0T2NV DRUGCOMP Immunomic Therapeutics Rockville, MD D0T2NV HIGHSTAT Phase 1/2 D0T3HL DRUG__ID D0T3HL D0T3HL DRUGCOMP Cellerix SL D0T3HL HIGHSTAT Phase 1/2 D0T4GG DRUG__ID D0T4GG D0T4GG DRUGCOMP NantKwest Culver City, CA D0T4GG HIGHSTAT Phase 1/2 D0T5CH DRUG__ID D0T5CH D0T5CH DRUGCOMP Novartis pharmaceuticals D0T5CH HIGHSTAT Phase 1/2 D0T5QC DRUG__ID D0T5QC D0T5QC DRUGCOMP Milo biotechnology D0T5QC HIGHSTAT Phase 1/2 D0T7MZ DRUG__ID D0T7MZ D0T7MZ DRUGCOMP Sellas Life Sciences New York, NY D0T7MZ HIGHSTAT Phase 1/2 D0T7OE DRUG__ID D0T7OE D0T7OE DRUGCOMP Neonc technologies D0T7OE HIGHSTAT Phase 1/2 D0T7QC DRUG__ID D0T7QC D0T7QC DRUGCOMP Emergent BioSolutions D0T7QC HIGHSTAT Phase 1/2 D0T8CE DRUG__ID D0T8CE D0T8CE DRUGCOMP Amgen D0T8CE HIGHSTAT Phase 1/2 D0T8JY DRUG__ID D0T8JY D0T8JY DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0T8JY HIGHSTAT Phase 1/2 D0T9JW DRUG__ID D0T9JW D0T9JW DRUGCOMP Aurora BioPharma Cambridge, MA D0T9JW HIGHSTAT Phase 1/2 D0TN1N DRUG__ID D0TN1N D0TN1N DRUGCOMP Adaptimmune Philadelphia, PA GlaxoSmithKline Philadelphia, PA D0TN1N HIGHSTAT Phase 1/2 D0TN4M DRUG__ID D0TN4M D0TN4M DRUGCOMP Y-mAbs TherapeuticsNew York, NY D0TN4M HIGHSTAT Phase 1/2 D0TT6L DRUG__ID D0TT6L D0TT6L DRUGCOMP SciFluor Life Sciences Cambridge, MA D0TT6L HIGHSTAT Phase 1/2 D0TV6H DRUG__ID D0TV6H D0TV6H DRUGCOMP PDL BioPharma Inc D0TV6H HIGHSTAT Phase 1/2 D0U0VY DRUG__ID D0U0VY D0U0VY DRUGCOMP Centocor Ortho Biotech Inc D0U0VY HIGHSTAT Phase 1/2 D0U1DD DRUG__ID D0U1DD D0U1DD DRUGCOMP Kiromic Houston, TX D0U1DD HIGHSTAT Phase 1/2 D0U1SA DRUG__ID D0U1SA D0U1SA DRUGCOMP Kaketsuken; teijin pharma D0U1SA HIGHSTAT Phase 1/2 D0U1VR DRUG__ID D0U1VR D0U1VR DRUGCOMP Afecta Pharmaceuticals D0U1VR HIGHSTAT Phase 1/2 D0U1WU DRUG__ID D0U1WU D0U1WU DRUGCOMP Etubics D0U1WU HIGHSTAT Phase 1/2 D0U3FP DRUG__ID D0U3FP D0U3FP DRUGCOMP GlaxoSmithKline D0U3FP HIGHSTAT Phase 1/2 D0U4JX DRUG__ID D0U4JX D0U4JX DRUGCOMP Weizmann Institute of Science D0U4JX HIGHSTAT Phase 1/2 D0U5AN DRUG__ID D0U5AN D0U5AN DRUGCOMP Immutep SA D0U5AN HIGHSTAT Phase 1/2 D0U6BQ DRUG__ID D0U6BQ D0U6BQ DRUGCOMP Pervasis Therapeutics D0U6BQ HIGHSTAT Phase 1/2 D0U8FG DRUG__ID D0U8FG D0U8FG DRUGCOMP Anaeropharma Science Inc D0U8FG HIGHSTAT Phase 1/2 D0U8QC DRUG__ID D0U8QC D0U8QC DRUGCOMP Astralis Ltd D0U8QC HIGHSTAT Phase 1/2 D0U9PV DRUG__ID D0U9PV D0U9PV DRUGCOMP Krenitsky Pharmaceuticals Inc D0U9PV HIGHSTAT Phase 1/2 D0UD6S DRUG__ID D0UD6S D0UD6S DRUGCOMP Adaptimmune D0UD6S HIGHSTAT Phase 1/2 D0UF0N DRUG__ID D0UF0N D0UF0N DRUGCOMP Acerta pharma D0UF0N HIGHSTAT Phase 1/2 D0UI4L DRUG__ID D0UI4L D0UI4L DRUGCOMP NeuroDerm Ltd D0UI4L HIGHSTAT Phase 1/2 D0UI8Y DRUG__ID D0UI8Y D0UI8Y DRUGCOMP Novocell D0UI8Y HIGHSTAT Phase 1/2 D0UZ4G DRUG__ID D0UZ4G D0UZ4G DRUGCOMP Temple University D0UZ4G HIGHSTAT Phase 1/2 D0V0HU DRUG__ID D0V0HU D0V0HU DRUGCOMP Neovacs SA D0V0HU HIGHSTAT Phase 1/2 D0V1KS DRUG__ID D0V1KS D0V1KS DRUGCOMP AstraZeneca D0V1KS HIGHSTAT Phase 1/2 D0V4VQ DRUG__ID D0V4VQ D0V4VQ DRUGCOMP Genethon D0V4VQ HIGHSTAT Phase 1/2 D0V5QY DRUG__ID D0V5QY D0V5QY DRUGCOMP Gangagen D0V5QY HIGHSTAT Phase 1/2 D0V6AN DRUG__ID D0V6AN D0V6AN DRUGCOMP ViaCyte D0V6AN HIGHSTAT Phase 1/2 D0VD9X DRUG__ID D0VD9X D0VD9X DRUGCOMP Nature Cell Seoul, South Korea D0VD9X HIGHSTAT Phase 1/2 D0VJ0Q DRUG__ID D0VJ0Q D0VJ0Q DRUGCOMP U.S. Naval Medical Research Center; Vical D0VJ0Q HIGHSTAT Phase 1/2 D0VQ7Y DRUG__ID D0VQ7Y D0VQ7Y DRUGCOMP Spark Therapeutics Philadelphia, PA D0VQ7Y HIGHSTAT Phase 1/2 D0VU8K DRUG__ID D0VU8K D0VU8K DRUGCOMP Momotaro-Gene Okayama, Japan D0VU8K HIGHSTAT Phase 1/2 D0W5QJ DRUG__ID D0W5QJ D0W5QJ DRUGCOMP Gene Shears Pty Ltd D0W5QJ HIGHSTAT Phase 1/2 D0W5YC DRUG__ID D0W5YC D0W5YC DRUGCOMP Bionor Immuno AS D0W5YC HIGHSTAT Phase 1/2 D0W5YP DRUG__ID D0W5YP D0W5YP DRUGCOMP WaVe Life Sciences Cambridge, MA D0W5YP HIGHSTAT Phase 1/2 D0W6QN DRUG__ID D0W6QN D0W6QN DRUGCOMP Living Cell Technologies Ltd D0W6QN HIGHSTAT Phase 1/2 D0W7TQ DRUG__ID D0W7TQ D0W7TQ DRUGCOMP Idenix Pharmaceuticals Inc D0W7TQ HIGHSTAT Phase 1/2 D0WC4Y DRUG__ID D0WC4Y D0WC4Y DRUGCOMP Fibrocell Science Exton, PA Intrexon Germantown, MD D0WC4Y HIGHSTAT Phase 1/2 D0WM3Z DRUG__ID D0WM3Z D0WM3Z DRUGCOMP Arch Oncology San Francisco, CA D0WM3Z HIGHSTAT Phase 1/2 D0WT9A DRUG__ID D0WT9A D0WT9A DRUGCOMP Baxter D0WT9A HIGHSTAT Phase 1/2 D0WY1E DRUG__ID D0WY1E D0WY1E DRUGCOMP Mustang Bio New York, NY D0WY1E HIGHSTAT Phase 1/2 D0X1ST DRUG__ID D0X1ST D0X1ST DRUGCOMP Escalier Biosciences Encinitas, CA D0X1ST HIGHSTAT Phase 1/2 D0X2JY DRUG__ID D0X2JY D0X2JY DRUGCOMP Mbeya Medical Research Programme D0X2JY HIGHSTAT Phase 1/2 D0X2QH DRUG__ID D0X2QH D0X2QH DRUGCOMP ProMetic Life Sciences Inc D0X2QH HIGHSTAT Phase 1/2 D0X4FW DRUG__ID D0X4FW D0X4FW DRUGCOMP Astex therapeutics D0X4FW HIGHSTAT Phase 1/2 D0X4OJ DRUG__ID D0X4OJ D0X4OJ DRUGCOMP Bioheart D0X4OJ HIGHSTAT Phase 1/2 D0X7GX DRUG__ID D0X7GX D0X7GX DRUGCOMP ImmunoRestoration Warminster, PA D0X7GX HIGHSTAT Phase 1/2 D0X8ID DRUG__ID D0X8ID D0X8ID DRUGCOMP Selvita Life Sciences Solutions D0X8ID HIGHSTAT Phase 1/2 D0X9JR DRUG__ID D0X9JR D0X9JR DRUGCOMP ProQR Therapeutics Leiden, Netherlands D0X9JR HIGHSTAT Phase 1/2 D0X9WC DRUG__ID D0X9WC D0X9WC DRUGTYPE Antisense drug D0X9WC HIGHSTAT Phase 1/2 D0XB8Y DRUG__ID D0XB8Y D0XB8Y DRUGCOMP Collegium Pharmaceutical Canton, MA D0XB8Y HIGHSTAT Phase 1/2 D0XI3E DRUG__ID D0XI3E D0XI3E DRUGCOMP Calithera Biosciences; Incyte D0XI3E HIGHSTAT Phase 1/2 D0XJ5I DRUG__ID D0XJ5I D0XJ5I DRUGCOMP National Institute of Allergy and Infectious Diseases Rockville, MD D0XJ5I HIGHSTAT Phase 1/2 D0XY8C DRUG__ID D0XY8C D0XY8C DRUGCOMP Rogosin Institute D0XY8C HIGHSTAT Phase 1/2 D0Y7YH DRUG__ID D0Y7YH D0Y7YH DRUGCOMP Universite Pierre et Marie Curie D0Y7YH HIGHSTAT Phase 1/2 D0YO5Z DRUG__ID D0YO5Z D0YO5Z DRUGCOMP Sanofi us D0YO5Z HIGHSTAT Phase 1/2 D0YU1M DRUG__ID D0YU1M D0YU1M DRUGCOMP MediGene Inc D0YU1M HIGHSTAT Phase 1/2 D0YW6P DRUG__ID D0YW6P D0YW6P DRUGCOMP R-tech ueno D0YW6P HIGHSTAT Phase 1/2 D0Z1OR DRUG__ID D0Z1OR D0Z1OR DRUGCOMP Centre National de la Recherche Scientifique (CNRS) D0Z1OR HIGHSTAT Phase 1/2 D0Z2UY DRUG__ID D0Z2UY D0Z2UY DRUGCOMP Genzyme Molecular Oncology D0Z2UY HIGHSTAT Phase 1/2 D0Z2ZY DRUG__ID D0Z2ZY D0Z2ZY DRUGCOMP Stemline Therapeutics D0Z2ZY HIGHSTAT Phase 1/2 D0ZC6X DRUG__ID D0ZC6X D0ZC6X DRUGCOMP Protalex D0ZC6X HIGHSTAT Phase 1/2 D0ZE0S DRUG__ID D0ZE0S D0ZE0S DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0ZE0S HIGHSTAT Phase 1/2 D0ZH2L DRUG__ID D0ZH2L D0ZH2L DRUGCOMP RNL Bio Co Ltd D0ZH2L HIGHSTAT Phase 1/2 D0ZT8A DRUG__ID D0ZT8A D0ZT8A DRUGCOMP T3d therapeutics D0ZT8A HIGHSTAT Phase 1/2 D1B3VP DRUG__ID D1B3VP D1B3VP DRUGCOMP TAKEDA D1B3VP HIGHSTAT Phase 1/2 D1KES8 DRUG__ID D1KES8 D1KES8 DRUGCOMP Ikena Oncology Boston, MA D1KES8 HIGHSTAT Phase 1/2 D1KIY9 DRUG__ID D1KIY9 D1KIY9 DRUGCOMP HaiHe Biopharma D1KIY9 HIGHSTAT Phase 1/2 D1P8BK DRUG__ID D1P8BK D1P8BK DRUGCOMP Intralytix Columbia, MD D1P8BK HIGHSTAT Phase 1/2 D1PBC7 DRUG__ID D1PBC7 D1PBC7 DRUGCOMP BioXcel Therapeutics D1PBC7 HIGHSTAT Phase 1/2 D2A6QI DRUG__ID D2A6QI D2A6QI DRUGCOMP Alzamend Neuro Atlanta, GA D2A6QI HIGHSTAT Phase 1/2 D2OWE3 DRUG__ID D2OWE3 D2OWE3 DRUGCOMP Felix Biotechnology D2OWE3 HIGHSTAT Phase 1/2 D2YN1W DRUG__ID D2YN1W D2YN1W DRUGCOMP Nektar Therapeutics D2YN1W HIGHSTAT Phase 1/2 D49LPT DRUG__ID D49LPT D49LPT DRUGCOMP Veru Miami, FL D49LPT HIGHSTAT Phase 1/2 D4GH1L DRUG__ID D4GH1L D4GH1L DRUGCOMP Clarity Pharmaceuticals Sydney, Australia D4GH1L HIGHSTAT Phase 1/2 D4IS0G DRUG__ID D4IS0G D4IS0G DRUGCOMP Gan & Lee Pharmaceuticals D4IS0G HIGHSTAT Phase 1/2 D6KY5Q DRUG__ID D6KY5Q D6KY5Q DRUGCOMP LogicBio Therapeutics Lexington, MA D6KY5Q HIGHSTAT Phase 1/2 D6YB1E DRUG__ID D6YB1E D6YB1E DRUGCOMP Codiak BioSciences D6YB1E HIGHSTAT Phase 1/2 D8JN5H DRUG__ID D8JN5H D8JN5H DRUGCOMP Nektar Therapeutics D8JN5H HIGHSTAT Phase 1/2 D8ZV2Q DRUG__ID D8ZV2Q D8ZV2Q DRUGCOMP Fochon Pharmaceuticals D8ZV2Q HIGHSTAT Phase 1/2 D96XNU DRUG__ID D96XNU D96XNU DRUGCOMP CDA Research Group D96XNU HIGHSTAT Phase 1/2 D9OMQ3 DRUG__ID D9OMQ3 D9OMQ3 DRUGTYPE Antibody D9OMQ3 HIGHSTAT Phase 1/2 D9RYF5 DRUG__ID D9RYF5 D9RYF5 DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D9RYF5 HIGHSTAT Phase 1/2 D9XJ0U DRUG__ID D9XJ0U D9XJ0U DRUGCOMP Organicell D9XJ0U HIGHSTAT Phase 1/2 DBHQ20 DRUG__ID DBHQ20 DBHQ20 DRUGCOMP Clarity Pharmaceuticals Sydney, Australia DBHQ20 HIGHSTAT Phase 1/2 DC1GH7 DRUG__ID DC1GH7 DC1GH7 DRUGCOMP TAKEDA DC1GH7 HIGHSTAT Phase 1/2 DDM7A2 DRUG__ID DDM7A2 DDM7A2 DRUGCOMP Allergan DDM7A2 HIGHSTAT Phase 1/2 DEXM29 DRUG__ID DEXM29 DEXM29 DRUGTYPE Small molecular drug DEXM29 HIGHSTAT Phase 1/2 DFDT39 DRUG__ID DFDT39 DFDT39 DRUGTYPE Cell therapy DFDT39 HIGHSTAT Phase 1/2 DID20W DRUG__ID DID20W DID20W DRUGCOMP Accendatech USA Houston, TX DID20W HIGHSTAT Phase 1/2 DILZ67 DRUG__ID DILZ67 DILZ67 DRUGCOMP Hookipa Pharma DILZ67 HIGHSTAT Phase 1/2 DIM2B6 DRUG__ID DIM2B6 DIM2B6 DRUGCOMP NeoImmuneTech Rockville, MD DIM2B6 HIGHSTAT Phase 1/2 DIM79Y DRUG__ID DIM79Y DIM79Y DRUGCOMP Taipei Veterans General Hospital, Taiwan DIM79Y HIGHSTAT Phase 1/2 DJ8TN2 DRUG__ID DJ8TN2 DJ8TN2 DRUGCOMP Kechow Pharma DJ8TN2 HIGHSTAT Phase 1/2 DM14CQ DRUG__ID DM14CQ DM14CQ DRUGCOMP Harpoon Therapeutics DM14CQ HIGHSTAT Phase 1/2 DN0A1J DRUG__ID DN0A1J DN0A1J DRUGCOMP Brigham and Women's Hospital DN0A1J HIGHSTAT Phase 1/2 DPN1F0 DRUG__ID DPN1F0 DPN1F0 DRUGCOMP Advaxis DPN1F0 HIGHSTAT Phase 1/2 DQ2T3S DRUG__ID DQ2T3S DQ2T3S DRUGCOMP Hookipa Pharma DQ2T3S HIGHSTAT Phase 1/2 DR7Q5N DRUG__ID DR7Q5N DR7Q5N DRUGTYPE Antibody DR7Q5N HIGHSTAT Phase 1/2 DR8JH4 DRUG__ID DR8JH4 DR8JH4 DRUGCOMP Lava Therapeutics DR8JH4 HIGHSTAT Phase 1/2 DXL38G DRUG__ID DXL38G DXL38G DRUGTYPE Small molecular drug DXL38G HIGHSTAT Phase 1/2 DYJ0V9 DRUG__ID DYJ0V9 DYJ0V9 DRUGTYPE Cell therapy DYJ0V9 HIGHSTAT Phase 1/2 DZ5K6F DRUG__ID DZ5K6F DZ5K6F DRUGCOMP Gossamer Bio DZ5K6F HIGHSTAT Phase 1/2 D02XJJ DRUG__ID D02XJJ D02XJJ HIGHSTAT Phase 1/2 D09HTE DRUG__ID D09HTE D09HTE HIGHSTAT Phase 1/2 D0UI0I DRUG__ID D0UI0I D0UI0I HIGHSTAT Phase 1/2 D03DUY DRUG__ID D03DUY D03DUY DRUGCOMP Exelixis; Bristol-Myers Squibb D03DUY DRUGTYPE Small molecular drug D03DUY DRUGINCH 1S/C30H27N5O/c1-20-12-13-21(19-31-2)18-27(20)33-29(36)23-14-16-24(17-15-23)32-30-34-26-11-7-6-10-25(26)28(35-30)22-8-4-3-5-9-22/h3-18,31H,19H2,1-2H3,(H,33,36)(H,32,34,35) D03DUY DRUGINKE KLRRGBHZCJLIEL-UHFFFAOYSA-N D03DUY DRUGSMIL CC1=C(C=C(C=C1)CNC)NC(=O)C2=CC=C(C=C2)NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5 D03DUY HIGHSTAT Phase 1b D08WUK DRUG__ID D08WUK D08WUK THERCLAS Antiviral Agents D08WUK DRUGTYPE Vaccine D08WUK HIGHSTAT Phase 1b Trial D08WNO DRUG__ID D08WNO D08WNO DRUGCOMP Acorda Therapeutics D08WNO HIGHSTAT Phase 1b D09GPI DRUG__ID D09GPI D09GPI DRUGCOMP Forum pharmaceuticals D09GPI HIGHSTAT Phase 1b D0Q6IF DRUG__ID D0Q6IF D0Q6IF DRUGCOMP Immunomedics D0Q6IF HIGHSTAT Phase 1b D0V4XY DRUG__ID D0V4XY D0V4XY DRUGCOMP Shionogi D0V4XY HIGHSTAT Phase 1b D00CMV DRUG__ID D00CMV D00CMV DRUGCOMP Abbott D00CMV THERCLAS Analgesics D00CMV DRUGTYPE Small molecular drug D00CMV DRUGINCH 1S/C21H24N4O/c1-21(2,3)14-8-9-15-13(11-14)7-10-18(15)24-20(26)23-17-5-4-6-19-16(17)12-22-25-19/h4-6,8-9,11-12,18H,7,10H2,1-3H3,(H,22,25)(H2,23,24,26)/t18-/m1/s1 D00CMV DRUGINKE TYOYXJNGINZFET-GOSISDBHSA-N D00CMV DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C(CC2)NC(=O)NC3=CC=CC4=C3C=NN4 D00CMV HIGHSTAT Phase 1 D03LRU DRUG__ID D03LRU D03LRU DRUGCOMP Bristol-Myers Squibb; Kosan Biosci. D03LRU THERCLAS Anticancer Agents D03LRU DRUGTYPE Small molecular drug D03LRU DRUGINCH 1S/C32H48N4O8.ClH/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8;/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40);1H/b11-9-,19-10+,21-16+;/t18-,20+,25+,26+,28-,30+;/m1./s1 D03LRU DRUGINKE DFSYBWLNYPEFJK-IHLRWNDRSA-N D03LRU DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)C)OC)OC(=O)N)C)C)O)OC.Cl D03LRU HIGHSTAT Phase 1 D05NJI DRUG__ID D05NJI D05NJI DRUGCOMP Amgen D05NJI THERCLAS Anticancer Agents D05NJI DRUGTYPE Small molecular drug D05NJI DRUGINCH 1S/C14H15NO5S/c15-21(17,18)20-9-6-7-11-10-4-2-1-3-5-12(10)14(16)19-13(11)8-9/h6-8H,1-5H2,(H2,15,17,18) D05NJI DRUGINKE DSLPMJSGSBLWRE-UHFFFAOYSA-N D05NJI DRUGSMIL C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N D05NJI HIGHSTAT Phase 1 D06YSP DRUG__ID D06YSP D06YSP DRUGCOMP Astex Therape. D06YSP THERCLAS Anticancer Agents D06YSP DRUGTYPE Small molecular drug D06YSP DRUGINCH 1S/C24H31N3O3/c1-16(2)20-11-21(23(29)12-22(20)28)24(30)27-14-18-5-4-17(10-19(18)15-27)13-26-8-6-25(3)7-9-26/h4-5,10-12,16,28-29H,6-9,13-15H2,1-3H3 D06YSP DRUGINKE IFRGXKKQHBVPCQ-UHFFFAOYSA-N D06YSP DRUGSMIL CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C D06YSP HIGHSTAT Phase 1 D07DTV DRUG__ID D07DTV D07DTV DRUGCOMP Astex Therape. D07DTV THERCLAS Anticancer Agents D07DTV DRUGTYPE Small molecular drug D07DTV DRUGINCH 1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24) D07DTV DRUGINKE OVPNQJVDAFNBDN-UHFFFAOYSA-N D07DTV DRUGSMIL C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl D07DTV HIGHSTAT Phase 1 D07FPY DRUG__ID D07FPY D07FPY DRUGCOMP GlaxoSmithKline D07FPY THERCLAS Anticancer Agents D07FPY DRUGTYPE Small molecular drug D07FPY DRUGINCH 1S/C24H28N4O2/c29-24(26-30)13-10-20-8-11-22-21(18-20)25-23(12-9-19-6-2-1-3-7-19)28(22)17-16-27-14-4-5-15-27/h1-3,6-8,10-11,13,18,30H,4-5,9,12,14-17H2,(H,26,29)/b13-10+ D07FPY DRUGINKE RCDIZKAYZBEALO-JLHYYAGUSA-N D07FPY DRUGSMIL C1CCN(C1)CCN2C3=C(C=C(C=C3)C=CC(=O)NO)N=C2CCC4=CC=CC=C4 D07FPY HIGHSTAT Phase 1 D07HPJ DRUG__ID D07HPJ D07HPJ DRUGCOMP Novartis AG D07HPJ THERCLAS Anticancer Agents D07HPJ DRUGTYPE Small molecular drug D07HPJ DRUGINCH 1S/C27H29N5O/c28-26-25-24(21-8-4-9-23(14-21)33-17-19-6-2-1-3-7-19)16-32(27(25)30-18-29-26)22-12-20(13-22)15-31-10-5-11-31/h1-4,6-9,14,16,18,20,22H,5,10-13,15,17H2,(H2,28,29,30) D07HPJ DRUGINKE AECDBHGVIIRMOI-UHFFFAOYSA-N D07HPJ DRUGSMIL C1CN(C1)CC2CC(C2)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC=C5)OCC6=CC=CC=C6 D07HPJ HIGHSTAT Phase 1 D07HRU DRUG__ID D07HRU D07HRU DRUGCOMP Kirin D07HRU THERCLAS Anticancer Agents D07HRU DRUGTYPE Small molecular drug D07HRU DRUGINCH 1S/C20H21ClN4O4/c1-4-7-22-20(26)25-15-6-5-12(8-14(15)21)29-19-13-9-17(27-2)18(28-3)10-16(13)23-11-24-19/h5-6,8-11H,4,7H2,1-3H3,(H2,22,25,26) D07HRU DRUGINKE VPBYZLCHOKSGRX-UHFFFAOYSA-N D07HRU DRUGSMIL CCCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)Cl D07HRU HIGHSTAT Phase 1 D08RMJ DRUG__ID D08RMJ D08RMJ DRUGCOMP GlaxoSmithKline D08RMJ THERCLAS Anticancer Agents D08RMJ DRUGTYPE Small molecular drug D08RMJ DRUGINCH 1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1 D08RMJ DRUGINKE ZHJGWYRLJUCMRT-QGZVFWFLSA-N D08RMJ DRUGSMIL CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N D08RMJ HIGHSTAT Phase 1 D0A5MC DRUG__ID D0A5MC D0A5MC DRUGCOMP Millenium; Takeda D0A5MC THERCLAS Anticancer Agents D0A5MC DRUGTYPE Small molecular drug D0A5MC DRUGINCH 1S/C25H15ClF2N4O2/c26-15-6-9-17-18(10-15)23(21-19(27)2-1-3-20(21)28)29-11-14-12-30-25(32-22(14)17)31-16-7-4-13(5-8-16)24(33)34/h1-10,12H,11H2,(H,33,34)(H,30,31,32) D0A5MC DRUGINKE HHFBDROWDBDFBR-UHFFFAOYSA-N D0A5MC DRUGSMIL C1C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=C(C=CC=C4F)F)NC5=CC=C(C=C5)C(=O)O D0A5MC HIGHSTAT Phase 1 D0CY1B DRUG__ID D0CY1B D0CY1B DRUGCOMP Cyclacel Limited D0CY1B THERCLAS Anticancer Agents D0CY1B DRUGTYPE Small molecular drug D0CY1B DRUGINCH 1S/C18H20N6OS/c1-12-16(26-17(19)21-12)15-6-7-20-18(23-15)22-13-2-4-14(5-3-13)24-8-10-25-11-9-24/h2-7H,8-11H2,1H3,(H2,19,21)(H,20,22,23) D0CY1B DRUGINKE GPSZYOIFQZPWEJ-UHFFFAOYSA-N D0CY1B DRUGSMIL CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4 D0CY1B HIGHSTAT Phase 1 D0E5JC DRUG__ID D0E5JC D0E5JC DRUGCOMP Metastatix D0E5JC THERCLAS Anticancer Agents D0E5JC DRUGTYPE Small molecular drug D0E5JC DRUGINCH 1S/C16H16N6/c1-7-17-15(18-8-1)21-11-13-3-5-14(6-4-13)12-22-16-19-9-2-10-20-16/h1-10H,11-12H2,(H,17,18,21)(H,19,20,22) D0E5JC DRUGINKE PXZXYRKDDXKDTK-UHFFFAOYSA-N D0E5JC DRUGSMIL C1=CN=C(N=C1)NCC2=CC=C(C=C2)CNC3=NC=CC=N3 D0E5JC HIGHSTAT Phase 1 D0H2UB DRUG__ID D0H2UB D0H2UB DRUGCOMP Bayer Pharmaceuticals Corporation D0H2UB THERCLAS Antinematodal Agents D0H2UB DRUGTYPE Small molecular drug D0H2UB DRUGINCH 1S/C51H40N6O23S6/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80) D0H2UB DRUGINKE FIAFUQMPZJWCLV-UHFFFAOYSA-N D0H2UB DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C D0H2UB HIGHSTAT Phase 1 D0H4IU DRUG__ID D0H4IU D0H4IU DRUGCOMP MGI Pharma D0H4IU THERCLAS Analgesics D0H4IU DRUGTYPE Small molecular drug D0H4IU DRUGINCH 1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(12)13-11/h4,11-12H,1-3H2,(H,7,8)(H,9,10) D0H4IU DRUGINKE HKANXFJUBKMWSW-UHFFFAOYSA-N D0H4IU DRUGSMIL C(CC(=O)O)C(CP(O)OO)C(=O)O D0H4IU HIGHSTAT Phase 1 D0N8RV DRUG__ID D0N8RV D0N8RV DRUGCOMP OSI Pharmaceuticals D0N8RV THERCLAS Anticancer Agents D0N8RV DRUGTYPE Small molecular drug D0N8RV DRUGINCH 1S/C22H16F3N3O2S/c23-22(24,25)30-16-7-5-15(6-8-16)28-21(29)20-19(10-12-31-20)27-13-14-9-11-26-18-4-2-1-3-17(14)18/h1-12,27H,13H2,(H,28,29) D0N8RV DRUGINKE FGTCROZDHDSNIO-UHFFFAOYSA-N D0N8RV DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F D0N8RV HIGHSTAT Phase 1 D0OA5G DRUG__ID D0OA5G D0OA5G DRUGCOMP Sunesis Pharma D0OA5G THERCLAS Anticancer Agents D0OA5G DRUGTYPE Small molecular drug D0OA5G DRUGINCH 1S/C18H15ClN6OS2/c19-11-2-1-3-12(8-11)24-17(26)25-18-21-9-13(28-18)4-6-20-16-15-14(5-7-27-15)22-10-23-16/h1-3,5,7-10H,4,6H2,(H,20,22,23)(H2,21,24,25,26) D0OA5G DRUGINKE FAYAUAZLLLJJGH-UHFFFAOYSA-N D0OA5G DRUGSMIL C1=CC(=CC(=C1)Cl)NC(=O)NC2=NC=C(S2)CCNC3=NC=NC4=C3SC=C4 D0OA5G HIGHSTAT Phase 1 D0R1VU DRUG__ID D0R1VU D0R1VU DRUGCOMP AEterna Zentaris D0R1VU THERCLAS Anticancer Agents D0R1VU DRUGTYPE Small molecular drug D0R1VU DRUGINCH 1S/C25H52NO4P/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-29-31(27,28)30-25-20-22-26(2,3)23-21-25/h25H,4-24H2,1-3H3 D0R1VU DRUGINKE SZFPYBIJACMNJV-UHFFFAOYSA-N D0R1VU DRUGSMIL CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C D0R1VU HIGHSTAT Phase 1 D0S0WN DRUG__ID D0S0WN D0S0WN DRUGCOMP Intarcia Therape. D0S0WN THERCLAS Anticancer Agents D0S0WN DRUGTYPE Small molecular drug D0S0WN DRUGINCH 1S/C28H36O7/c1-5-8-21-23(13-10-19-11-14-25(28(30)31)35-26(19)21)33-16-7-17-34-24-15-12-20(18(3)29)27(32-4)22(24)9-6-2/h10,12-13,15,25H,5-9,11,14,16-17H2,1-4H3,(H,30,31) D0S0WN DRUGINKE ZVVCSBSDFGYRCB-UHFFFAOYSA-N D0S0WN DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)C)OC)CCC D0S0WN HIGHSTAT Phase 1 D0S5RC DRUG__ID D0S5RC D0S5RC DRUGCOMP Sunesis; Bristol Myers Squibb D0S5RC THERCLAS Anticancer Agents D0S5RC DRUGTYPE Small molecular drug D0S5RC DRUGINCH 1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22) D0S5RC DRUGINKE OUSFTKFNBAZUKL-UHFFFAOYSA-N D0S5RC DRUGSMIL CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3 D0S5RC HIGHSTAT Phase 1 D0V7YA DRUG__ID D0V7YA D0V7YA DRUGCOMP Gemin X D0V7YA THERCLAS Anticancer Agents D0V7YA DRUGTYPE Small molecular drug D0V7YA DRUGINCH 1S/C30H42ClN5O8.ClH/c1-38-16-17-39-18-19-40-20-21-41-22-23-43-30(37)44-25-36-13-10-27(11-14-36)35-29(34-24-32)33-12-4-2-3-5-15-42-28-8-6-26(31)7-9-28;/h6-11,13-14H,2-5,12,15-23,25H2,1H3,(H,33,34);1H D0V7YA DRUGINKE DAHMXVAETAAQOZ-UHFFFAOYSA-N D0V7YA DRUGSMIL COCCOCCOCCOCCOC(=O)OC[N+]1=CC=C(C=C1)NC(=NCCCCCCOC2=CC=C(C=C2)Cl)NC#N.[Cl-] D0V7YA HIGHSTAT Phase 1 D0VI8H DRUG__ID D0VI8H D0VI8H DRUGCOMP Hoffmann-La Roche pharmaceutical company D0VI8H THERCLAS Antiviral Agents D0VI8H DRUGTYPE Small molecular drug D0VI8H DRUGINCH 1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1 D0VI8H DRUGINKE IWUCXVSUMQZMFG-AFCXAGJDSA-N D0VI8H DRUGSMIL C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N D0VI8H HIGHSTAT Phase 1 Trial D0Z1NY DRUG__ID D0Z1NY D0Z1NY DRUGCOMP Bristol-Myers Squibb D0Z1NY THERCLAS Anticancer Agents D0Z1NY DRUGTYPE Small molecular drug D0Z1NY DRUGINCH 1S/C25H23N5O2S2/c26-13-20-8-9-24-21(11-20)15-30(34(31,32)25-7-4-10-33-25)23(12-19-5-2-1-3-6-19)17-29(24)16-22-14-27-18-28-22/h1-11,14,18,23H,12,15-17H2,(H,27,28)/t23-/m1/s1 D0Z1NY DRUGINKE OLCWFLWEHWLBTO-HSZRJFAPSA-N D0Z1NY DRUGSMIL C1C(N(CC2=C(N1CC3=CN=CN3)C=CC(=C2)C#N)S(=O)(=O)C4=CC=CS4)CC5=CC=CC=C5 D0Z1NY HIGHSTAT Phase 1 D0ZU5F DRUG__ID D0ZU5F D0ZU5F DRUGCOMP SGX Pharma; Eli Lilly D0ZU5F THERCLAS Anticancer Agents D0ZU5F DRUGTYPE Small molecular drug D0ZU5F DRUGINCH 1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3 D0ZU5F DRUGINKE BCZUAADEACICHN-UHFFFAOYSA-N D0ZU5F DRUGSMIL CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2 D0ZU5F HIGHSTAT Phase 1 D00ABO DRUG__ID D00ABO D00ABO DRUGCOMP Kyowa Hakko Kogyo Co Ltd D00ABO DRUGTYPE Small molecular drug D00ABO DRUGINCH 1S/C20H20N4O/c25-20(24-13-11-21-12-14-24)16-8-5-15(6-9-16)7-10-19-17-3-1-2-4-18(17)22-23-19/h1-10,21H,11-14H2,(H,22,23)/b10-7+ D00ABO DRUGINKE YYLKKYCXAOBSRM-JXMROGBWSA-N D00ABO DRUGSMIL C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43 D00ABO HIGHSTAT Phase 1 D00BND DRUG__ID D00BND D00BND DRUGCOMP Biofrontera D00BND DRUGTYPE Small molecular drug D00BND DRUGINCH 1S/C22H25NO2S/c1-4-25-16-8-9-17-20(14-16)26-19-7-5-6-18(24-3)22(19)21(17)15-10-12-23(2)13-11-15/h5-9,14H,4,10-13H2,1-3H3 D00BND DRUGINKE ANZVBVKYXOGOQC-UHFFFAOYSA-N D00BND DRUGSMIL CCOC1=CC2=C(C=C1)C(=C3CCN(CC3)C)C4=C(C=CC=C4S2)OC D00BND HIGHSTAT Phase 1 D00BTW DRUG__ID D00BTW D00BTW DRUGCOMP Biosyn D00BTW DRUGTYPE Small molecular drug D00BTW DRUGINCH 1S/C17H18ClNO2S/c1-11(2)6-8-21-16-10-13(4-5-15(16)18)19-17(22)14-7-9-20-12(14)3/h4-7,9-10H,8H2,1-3H3,(H,19,22) D00BTW DRUGINKE YZHIXLCGPOTQNB-UHFFFAOYSA-N D00BTW DRUGSMIL CC1=C(C=CO1)C(=S)NC2=CC(=C(C=C2)Cl)OCC=C(C)C D00BTW HIGHSTAT Phase 1 D00EZO DRUG__ID D00EZO D00EZO DRUGCOMP Targacept D00EZO DRUGTYPE Small molecular drug D00EZO DRUGINCH 1S/C12H17N3/c1-3-11(9-13-6-1)15-8-5-12(10-15)4-2-7-14-12/h1,3,6,9,14H,2,4-5,7-8,10H2 D00EZO DRUGINKE NXIPMBQVNTWEEX-UHFFFAOYSA-N D00EZO DRUGSMIL C1CC2(CCN(C2)C3=CN=CC=C3)NC1 D00EZO HIGHSTAT Phase 1 D00HBR DRUG__ID D00HBR D00HBR DRUGCOMP Aiko Biotechnology Inc D00HBR DRUGTYPE Small molecular drug D00HBR DRUGINCH 1S/C20H25NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,14-15,18,22-24H,1-2,5-10H2/t14-,15-,18+,19+,20-/m1/s1 D00HBR DRUGINKE JLVNEHKORQFVQJ-PYIJOLGTSA-N D00HBR DRUGSMIL C1CC1CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O D00HBR HIGHSTAT Phase 1 D00IFR DRUG__ID D00IFR D00IFR DRUGCOMP AstraZeneca D00IFR DRUGTYPE Small molecular drug D00IFR DRUGINCH 1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12-/t16-/m1/s1 D00IFR DRUGINKE MCUJKPPARUPFJM-UWCCDQBKSA-N D00IFR DRUGSMIL C1CC(CN(C1)C2=C(C=CC=C2C3=CC=CC=C3)C=C4C(=O)NC(=O)S4)N D00IFR HIGHSTAT Phase 1 D00JJW DRUG__ID D00JJW D00JJW THERCLAS Anticancer Agents D00JJW DRUGTYPE Small molecular drug D00JJW DRUGINCH 1S/C12H14N2O3/c1-7-9(13-2-3-13)12(17)8(6-15)10(11(7)16)14-4-5-14/h15H,2-6H2,1H3 D00JJW DRUGINKE JKDLOGLNPDVUCX-UHFFFAOYSA-N D00JJW DRUGSMIL CC1=C(C(=O)C(=C(C1=O)N2CC2)CO)N3CC3 D00JJW HIGHSTAT Phase 1 D00MAN DRUG__ID D00MAN D00MAN DRUGCOMP Glenmark Pharmaceuticals Ltd D00MAN DRUGTYPE Small molecular drug D00MAN DRUGINCH 1S/C22H20FN3O2/c23-15-5-6-20-17(11-15)19(12-22(28-20)8-2-9-22)26-21(27)25-18-4-1-3-14-13-24-10-7-16(14)18/h1,3-7,10-11,13,19H,2,8-9,12H2,(H2,25,26,27)/t19-/m1/s1 D00MAN DRUGINKE JADKHWDNSKIILG-LJQANCHMSA-N D00MAN DRUGSMIL C1CC2(C1)CC(C3=C(O2)C=CC(=C3)F)NC(=O)NC4=CC=CC5=C4C=CN=C5 D00MAN HIGHSTAT Phase 1 D00MBY DRUG__ID D00MBY D00MBY DRUGCOMP GNT Pharma Co Ltd D00MBY DRUGTYPE Small molecular drug D00MBY DRUGINCH 1S/C16H14F3NO3/c17-16(18,19)11-3-1-10(2-4-11)7-8-20-12-5-6-14(21)13(9-12)15(22)23/h1-6,9,20-21H,7-8H2,(H,22,23) D00MBY DRUGINKE UTMVACIBQLDZLP-UHFFFAOYSA-N D00MBY DRUGSMIL C1=CC(=CC=C1CCNC2=CC(=C(C=C2)O)C(=O)O)C(F)(F)F D00MBY HIGHSTAT Phase 1 D00OOZ DRUG__ID D00OOZ D00OOZ DRUGCOMP Eisai Co Ltd D00OOZ DRUGTYPE Small molecular drug D00OOZ DRUGINCH 1S/C40H66N2O9/c1-7-32(44)29(4)37-33(49-37)26-39(5,47)19-12-13-27(2)36-28(3)16-17-34(40(6,48)20-18-31(43)25-35(45)51-36)50-38(46)42-23-21-41(22-24-42)30-14-10-8-9-11-15-30/h12-13,16-17,19,28-34,36-37,43-44,47-48H,7-11,14-15,18,20-26H2,1-6H3/b17-16+,19-12+,27-13+ D00OOZ DRUGINKE MNOMBFWMICHMKG-DDEPDXEBSA-N D00OOZ DRUGSMIL CCC(C(C)C1C(O1)CC(C)(C=CC=C(C)C2C(C=CC(C(CCC(CC(=O)O2)O)(C)O)OC(=O)N3CCN(CC3)C4CCCCCC4)C)O)O D00OOZ HIGHSTAT Phase 1 D00RMC DRUG__ID D00RMC D00RMC DRUGCOMP Boehringer Ingelheim Corp D00RMC DRUGTYPE Small molecular drug D00RMC DRUGINCH 1S/C18H19ClFN7/c1-27-6-4-11(5-7-27)25-18-21-9-15-16(26-18)17(23-10-22-15)24-12-2-3-14(20)13(19)8-12/h2-3,8-11H,4-7H2,1H3,(H,21,25,26)(H,22,23,24) D00RMC DRUGINKE FTFRZXFNZVCRSK-UHFFFAOYSA-N D00RMC DRUGSMIL CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl D00RMC HIGHSTAT Phase 1 D00SVP DRUG__ID D00SVP D00SVP DRUGCOMP Pfizer Inc D00SVP DRUGTYPE Small molecular drug D00SVP DRUGINCH 1S/C21H28N2O2S.ClH/c1-17(2)15-22-16-18-9-11-19(12-10-18)20-7-3-4-8-21(20)26(24,25)23-13-5-6-14-23;/h3-4,7-12,17,22H,5-6,13-16H2,1-2H3;1H D00SVP DRUGINKE WRNZYMZEVIVCFL-UHFFFAOYSA-N D00SVP DRUGSMIL CC(C)CNCC1=CC=C(C=C1)C2=CC=CC=C2S(=O)(=O)N3CCCC3.Cl D00SVP HIGHSTAT Phase 1 D00WPT DRUG__ID D00WPT D00WPT DRUGCOMP Metabolic Pharmaceuticals D00WPT THERCLAS Analgesics D00WPT DRUGINCH 1S/C71H103N23O25S4/c1-3-32(2)55-68(117)89-44(56(74)105)27-120-122-30-47-65(114)88-43(26-95)62(111)87-42(23-54(103)104)70(119)94-18-6-8-48(94)66(115)81-36(7-4-16-78-71(75)76)57(106)90-46(29-123-121-28-45(63(112)91-47)80-51(98)24-72)64(113)84-39(21-50(73)97)60(109)83-38(19-33-10-12-35(96)13-11-33)59(108)85-40(22-53(101)102)61(110)86-41(20-34-25-77-31-79-34)69(118)93-17-5-9-49(93)67(116)82-37(58(107)92-55)14-15-52(99)100/h10-13,25,31-32,36-49,55,95-96H,3-9,14-24,26-30,72H2,1-2H3,(H2,73,97)(H2,74,105)(H,77,79)(H,80,98)(H,81,115)(H,82,116)(H,83,109)(H,84,113)(H,85,108)(H,86,110)(H,87,111)(H,88,114)(H,89,117)(H,90,106)(H,91,112)(H,92,107)(H,99,100)(H,101,102)(H,103,104)(H4,75,76,78)/t32-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,55-/m0/s1 D00WPT DRUGINKE KJQOYUHYAZGPIZ-PIJHVLQJSA-N D00WPT DRUGSMIL CCC(C)C1C(=O)NC(CSSCC2C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(CSSCC(C(=O)N2)NC(=O)CN)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)N1)CCC(=O)O)CC5=CNC=N5)CC(=O)O)CC6=CC=C(C=C6)O)CC(=O)N)CCCNC(=N)N)CC(=O)O)CO)C(=O)N D00WPT HIGHSTAT Phase 1 D00XWB DRUG__ID D00XWB D00XWB DRUGCOMP Pierre Fabre SA D00XWB DRUGTYPE Small molecular drug D00XWB DRUGINCH 1S/C20H25NO2S2.BrH/c1-15(13-24-19-9-5-3-7-17(19)22-2)11-21-16-12-23-18-8-4-6-10-20(18)25-14-16;/h3-10,15-16,21H,11-14H2,1-2H3;1H/t15-,16+;/m0./s1 D00XWB DRUGINKE CUWFVJMNULNBTG-IDVLALEDSA-N D00XWB DRUGSMIL CC(CNC1COC2=CC=CC=C2SC1)CSC3=CC=CC=C3OC.Br D00XWB HIGHSTAT Phase 1 D00ZEG DRUG__ID D00ZEG D00ZEG DRUGCOMP Solvay SA D00ZEG DRUGTYPE Small molecular drug D00ZEG DRUGINCH 1S/C28H40N4O5/c1-5-6-14-31-24(33)22-26(35)32(27(36)23(25(31)34)28(22,2)3)15-10-9-13-29-16-18-30(19-17-29)20-11-7-8-12-21(20)37-4/h7-8,11-12,22-23H,5-6,9-10,13-19H2,1-4H3 D00ZEG DRUGINKE BXNRTMZZILHVNJ-UHFFFAOYSA-N D00ZEG DRUGSMIL CCCCN1C(=O)C2C(=O)N(C(=O)C(C1=O)C2(C)C)CCCCN3CCN(CC3)C4=CC=CC=C4OC D00ZEG HIGHSTAT Phase 1 D01ABX DRUG__ID D01ABX D01ABX DRUGCOMP Pfizer Inc D01ABX DRUGTYPE Small molecular drug D01ABX DRUGINCH 1S/C23H32FN3O4/c1-22(2)18-4-3-17(24)13-19(18)27(20(22)28)21(29)25-14-16-5-9-26(10-6-16)15-23(30)7-11-31-12-8-23/h3-4,13,16,30H,5-12,14-15H2,1-2H3,(H,25,29) D01ABX DRUGINKE AGMOFKKOVMRGAK-UHFFFAOYSA-N D01ABX DRUGSMIL CC1(C2=C(C=C(C=C2)F)N(C1=O)C(=O)NCC3CCN(CC3)CC4(CCOCC4)O)C D01ABX HIGHSTAT Phase 1 D01CDE DRUG__ID D01CDE D01CDE DRUGCOMP Boehringer Ingelheim Corp D01CDE DRUGTYPE Small molecular drug D01CDE DRUGINCH 1S/C18H24N4O2/c1-3-21-15-6-4-5-7-16(15)22(18(21)24)17(23)19-12-10-13-8-9-14(11-12)20(13)2/h4-7,12-14H,3,8-11H2,1-2H3,(H,19,23)/t12?,13-,14?/m0/s1 D01CDE DRUGINKE MZRKHUUDDHJVHS-MOKVOYLWSA-N D01CDE DRUGSMIL CCN1C2=CC=CC=C2N(C1=O)C(=O)NC3CC4CCC(C3)N4C D01CDE HIGHSTAT Phase 1 D01FQV DRUG__ID D01FQV D01FQV DRUGCOMP University of Alberta D01FQV DRUGTYPE Small molecular drug D01FQV DRUGINCH 1S/C2H2Cl2O2.Na/c3-1(4)2(5)6;/h1H,(H,5,6);/q;+1/p-1 D01FQV DRUGINKE LUPNKHXLFSSUGS-UHFFFAOYSA-M D01FQV DRUGSMIL C(C(=O)[O-])(Cl)Cl.[Na+] D01FQV HIGHSTAT Phase 1 D01FUL DRUG__ID D01FUL D01FUL DRUGCOMP Roche D01FUL DRUGTYPE Small molecular drug D01FUL DRUGINCH 1S/C21H30N6O8/c1-10(2)17(28)32-9-21(25-26-23)15(34-19(30)12(5)6)14(33-18(29)11(3)4)16(35-21)27-8-7-13(22)24-20(27)31/h7-8,10-12,14-16H,9H2,1-6H3,(H2,22,24,31)/t14-,15+,16-,21-/m1/s1 D01FUL DRUGINKE VKXWOLCNTHXCLF-DXEZIKHYSA-N D01FUL DRUGSMIL CC(C)C(=O)OCC1(C(C(C(O1)N2C=CC(=NC2=O)N)OC(=O)C(C)C)OC(=O)C(C)C)N=[N+]=[N-] D01FUL HIGHSTAT Phase 1 D01GXL DRUG__ID D01GXL D01GXL DRUGCOMP Replidyne D01GXL DRUGTYPE Small molecular drug D01GXL DRUGINCH 1S/C20H21BrFN3OS/c1-12-17(27-20(13(2)22)19(12)21)11-23-8-5-9-24-18-10-16(26)14-6-3-4-7-15(14)25-18/h3-4,6-7,10,23H,2,5,8-9,11H2,1H3,(H2,24,25,26) D01GXL DRUGINKE BGJMKHPWCFXMOW-UHFFFAOYSA-N D01GXL DRUGSMIL CC1=C(SC(=C1Br)C(=C)F)CNCCCNC2=CC(=O)C3=CC=CC=C3N2 D01GXL HIGHSTAT Phase 1 D01LCC DRUG__ID D01LCC D01LCC DRUGCOMP Pfizer D01LCC DRUGTYPE Small molecular drug D01LCC DRUGINCH 1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2 D01LCC DRUGINKE PDMUGYOXRHVNMO-UHFFFAOYSA-N D01LCC DRUGSMIL C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1 D01LCC HIGHSTAT Phase 1 D01MHL DRUG__ID D01MHL D01MHL DRUGCOMP Fujifilm pharmaceuticals; toyama chemical D01MHL DRUGTYPE Small molecular drug D01MHL DRUGINCH 1S/C25H35N5O2/c26-24(27)20-4-8-22(9-5-20)31-17-1-3-19-12-15-30(16-13-19)14-2-18-32-23-10-6-21(7-11-23)25(28)29/h4-11,19H,1-3,12-18H2,(H3,26,27)(H3,28,29) D01MHL DRUGINKE KUNDLEJVAIBADY-UHFFFAOYSA-N D01MHL DRUGSMIL C1CN(CCC1CCCOC2=CC=C(C=C2)C(=N)N)CCCOC3=CC=C(C=C3)C(=N)N D01MHL HIGHSTAT Phase 1 D01QSG DRUG__ID D01QSG D01QSG DRUGCOMP Vitae Pharmaceuticals D01QSG DRUGTYPE Small molecular drug D01QSG DRUGINCH 1S/C26H41ClN4O5/c1-28-23(14-19-6-5-12-35-18-19)16-30-25(32)31-11-4-8-21(17-31)24(20-7-3-9-22(27)15-20)36-13-10-29-26(33)34-2/h3,7,9,15,19,21,23-24,28H,4-6,8,10-14,16-18H2,1-2H3,(H,29,33)(H,30,32)/t19-,21-,23+,24+/m1/s1 D01QSG DRUGINKE NXWASIVXQMMPLM-ZXMXYHOLSA-N D01QSG DRUGSMIL CNC(CC1CCCOC1)CNC(=O)N2CCCC(C2)C(C3=CC(=CC=C3)Cl)OCCNC(=O)OC D01QSG HIGHSTAT Phase 1 D01QXY DRUG__ID D01QXY D01QXY DRUGCOMP NuVax Therapeutics D01QXY DRUGTYPE Small molecular drug D01QXY DRUGINCH 1S/C20H24O4/c1-12(2)17-9-15(5-6-19(17)21)10-18-13(3)7-16(8-14(18)4)24-11-20(22)23/h5-9,12,21H,10-11H2,1-4H3,(H,22,23) D01QXY DRUGINKE QNAZTOHXCZPOSA-UHFFFAOYSA-N D01QXY DRUGSMIL CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCC(=O)O D01QXY HIGHSTAT Phase 1 D01RVA DRUG__ID D01RVA D01RVA DRUGCOMP Adria Laboratories Inc D01RVA DRUGTYPE Small molecular drug D01RVA DRUGINCH 1S/C14H18ClN3O2.ClH/c15-11-6-10(13-9(12(11)16)3-5-20-13)14(19)18-7-8-2-1-4-17-8;/h6,8,17H,1-5,7,16H2,(H,18,19);1H/t8-;/m0./s1 D01RVA DRUGINKE PCBGZTCWZUGEJX-QRPNPIFTSA-N D01RVA DRUGSMIL C1CC(NC1)CNC(=O)C2=CC(=C(C3=C2OCC3)N)Cl.Cl D01RVA HIGHSTAT Phase 1 D01SJT DRUG__ID D01SJT D01SJT DRUGCOMP Pfizer D01SJT DRUGTYPE Small molecular drug D01SJT DRUGINCH 1S/C21H20F3N7O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30) D01SJT DRUGINKE MZDKLVOWGIOKTN-UHFFFAOYSA-N D01SJT DRUGSMIL CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C D01SJT HIGHSTAT Phase 1 D01SYU DRUG__ID D01SYU D01SYU DRUGCOMP Pfizer New York, NY D01SYU DRUGTYPE Small molecular drug D01SYU DRUGINCH 1S/C25H24F2N2O3/c1-14(2)32-24(31)17-12-29(23(30)15-9-10-18(26)19(27)11-15)13-25(3,4)21-16-7-5-6-8-20(16)28-22(17)21/h5-12,14,28H,13H2,1-4H3 D01SYU DRUGINKE INASOKQDNHHMRE-UHFFFAOYSA-N D01SYU DRUGSMIL CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F D01SYU HIGHSTAT Phase 1 D01XUE DRUG__ID D01XUE D01XUE DRUGCOMP Lundbeck; Takeda Pharmaceuticals D01XUE DRUGTYPE Small molecular drug D01XUE DRUGINCH 1S/C18H21NS/c1-14-6-8-16(9-7-14)20-18-5-3-2-4-17(18)15-10-12-19-13-11-15/h2-9,15,19H,10-13H2,1H3 D01XUE DRUGINKE CVASBKDYSQKLSO-UHFFFAOYSA-N D01XUE DRUGSMIL CC1=CC=C(C=C1)SC2=CC=CC=C2C3CCNCC3 D01XUE HIGHSTAT Phase 1 D02ADC DRUG__ID D02ADC D02ADC DRUGCOMP Novartis AG D02ADC DRUGTYPE Small molecular drug D02ADC DRUGINCH 1S/C20H27N5O6/c1-23-17-16(18(27)24(2)20(23)28)25(8-9-29-3)19(22-17)21-13(11-26)12-6-7-14(30-4)15(10-12)31-5/h6-7,10,13,26H,8-9,11H2,1-5H3,(H,21,22)/t13-/m0/s1 D02ADC DRUGINKE VZLFAVFWNOZVFM-ZDUSSCGKSA-N D02ADC DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)NC(CO)C3=CC(=C(C=C3)OC)OC)CCOC D02ADC HIGHSTAT Phase 1 D02BAW DRUG__ID D02BAW D02BAW DRUGCOMP Merck D02BAW DRUGTYPE Small molecular drug D02BAW DRUGINCH 1S/C42H56N6O9S/c1-41(20-21-41)58(53,54)47-39(51)42-24-27(42)14-8-4-3-5-9-16-32-38(50)48-25-29(23-34(48)36(49)46-42)56-37-31(43-30-19-18-28(55-2)22-33(30)44-37)15-10-6-7-12-26-13-11-17-35(26)57-40(52)45-32/h8,14,18-19,22,26-27,29,32,34-35H,3-7,9-13,15-17,20-21,23-25H2,1-2H3,(H,45,52)(H,46,49)(H,47,51)/b14-8+/t26-,27-,29-,32+,34+,35-,42-/m1/s1 D02BAW DRUGINKE BLFKRFGLQFYXDF-WAZRELCSSA-N D02BAW DRUGSMIL CC1(CC1)S(=O)(=O)NC(=O)C23CC2C=CCCCCCC4C(=O)N5CC(CC5C(=O)N3)OC6=NC7=C(C=CC(=C7)OC)N=C6CCCCCC8CCCC8OC(=O)N4 D02BAW HIGHSTAT Phase 1 D02ESL DRUG__ID D02ESL D02ESL DRUGCOMP Onconova Therapeutics Inc D02ESL DRUGTYPE Small molecular drug D02ESL DRUGINCH 1S/C16H13ClO4S.Na/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19;/h1-10H,11H2,(H,18,19);/q;+1/p-1/b10-9+; D02ESL DRUGINKE PRFBWBYKWZVQJF-RRABGKBLSA-M D02ESL DRUGSMIL C1=CC(=CC=C1CS(=O)(=O)C=CC2=CC=C(C=C2)C(=O)[O-])Cl.[Na+] D02ESL HIGHSTAT Phase 1 D02GNH DRUG__ID D02GNH D02GNH DRUGCOMP SENEX BIOTECHNOLOGY INC D02GNH DRUGTYPE Small molecular drug D02GNH DRUGINCH 1S/C27H26N6O/c1-32-10-12-33(13-11-32)27(34)23-6-5-21-14-19(2-4-22(21)16-23)8-9-29-26-24-15-20(17-28)3-7-25(24)30-18-31-26/h2-7,14-16,18H,8-13H2,1H3,(H,29,30,31) D02GNH DRUGINKE VNADJTWHOAMTLY-UHFFFAOYSA-N D02GNH DRUGSMIL CN1CCN(CC1)C(=O)C2=CC3=C(C=C2)C=C(C=C3)CCNC4=NC=NC5=C4C=C(C=C5)C#N D02GNH HIGHSTAT Phase 1 D02KLD DRUG__ID D02KLD D02KLD DRUGCOMP Swedish Orphan Biovitrum AB D02KLD DRUGTYPE Small molecular drug D02KLD DRUGINCH 1S/C21H24N2O5S/c1-14-3-4-19(26-2)18(11-14)23-29(24,25)17-12-15-7-10-27-21(15)20(13-17)28-16-5-8-22-9-6-16/h3-4,7,10-13,16,22-23H,5-6,8-9H2,1-2H3 D02KLD DRUGINKE UPQJYTNALAIZCC-UHFFFAOYSA-N D02KLD DRUGSMIL CC1=CC(=C(C=C1)OC)NS(=O)(=O)C2=CC(=C3C(=C2)C=CO3)OC4CCNCC4 D02KLD HIGHSTAT Phase 1 D02PGP DRUG__ID D02PGP D02PGP THERCLAS Anticancer Agents D02PGP DRUGTYPE Small molecular drug D02PGP DRUGINCH 1S/C19H25N5O3/c1-5-6-7-24-15(23-16-18(20)21-11-22-19(16)24)10-12-8-13(25-2)17(27-4)14(9-12)26-3/h8-9,11H,5-7,10H2,1-4H3,(H2,20,21,22) D02PGP DRUGINKE TUOSCZDRWRYPRS-UHFFFAOYSA-N D02PGP DRUGSMIL CCCCN1C(=NC2=C(N=CN=C21)N)CC3=CC(=C(C(=C3)OC)OC)OC D02PGP HIGHSTAT Phase 1 D02VER DRUG__ID D02VER D02VER DRUGCOMP Sarepta therapeutics D02VER DRUGTYPE Small molecular drug D02VER DRUGINCH 1S/C253H398N116O87P20/c1-153-74-354(246(386)302-227(153)371)184-73-270-72-160(437-184)119-417-458(395,310(10)11)333-83-163(442-189(104-333)355-75-154(2)228(372)303-247(355)387)122-420-463(400,315(20)21)336-95-175(445-192(107-336)358-78-157(5)231(375)306-250(358)390)137-435-474(411,327-56-46-267-47-57-327)347-97-177(440-187(102-347)352-54-44-182(256)292-244(352)384)133-431-461(398,313(16)17)334-84-164(443-190(105-334)356-76-155(3)229(373)304-248(356)388)123-421-465(402,317(24)25)338-85-165(448-195(110-338)361-144-281-204-213(258)271-139-276-218(204)361)124-422-460(397,312(14)15)332-82-162(439-186(101-332)351-53-43-181(255)291-243(351)383)121-419-462(399,314(18)19)335-94-174(444-191(106-335)357-77-156(4)230(374)305-249(357)389)136-434-475(412,328-58-48-268-49-59-328)348-98-178(441-188(103-348)353-55-45-183(257)293-245(353)385)134-432-469(406,321(32)33)342-89-169(452-199(114-342)365-148-285-208-217(262)275-143-280-222(208)365)128-427-471(408,323(36)37)344-92-172(455-202(116-344)368-151-288-211-225(368)296-240(265)300-236(211)380)131-429-468(405,320(30)31)341-87-167(450-198(113-341)364-147-284-207-216(261)274-142-279-221(207)364)126-425-466(403,318(26)27)339-88-168(451-197(111-339)363-146-283-206-215(260)273-141-278-220(206)363)127-426-470(407,322(34)35)343-91-171(454-201(115-343)367-150-287-210-224(367)295-239(264)299-235(210)379)130-428-467(404,319(28)29)340-86-166(449-196(112-340)362-145-282-205-214(259)272-140-277-219(205)362)125-424-464(401,316(22)23)337-96-176(446-193(108-337)359-79-158(6)232(376)307-251(359)391)138-436-476(413,329-60-50-269-51-61-329)349-99-179(447-194(109-349)360-80-159(7)233(377)308-252(360)392)135-433-473(410,325(40)41)346-93-173(456-203(118-346)369-152-289-212-226(369)297-241(266)301-237(212)381)132-430-472(409,324(38)39)345-90-170(453-200(117-345)366-149-286-209-223(366)294-238(263)298-234(209)378)129-423-459(396,311(12)13)331-81-161(438-185(100-331)350-52-42-180(254)290-242(350)382)120-418-457(394,309(8)9)330-64-62-326(63-65-330)253(393)416-71-70-415-69-68-414-67-66-370/h42-45,52-55,74-80,139-152,160-179,184-203,267-270,370H,46-51,56-73,81-138H2,1-41H3,(H2,254,290,382)(H2,255,291,383)(H2,256,292,384)(H2,257,293,385)(H2,258,271,276)(H2,259,272,277)(H2,260,273,278)(H2,261,274,279)(H2,262,275,280)(H,302,371,386)(H,303,372,387)(H,304,373,388)(H,305,374,389)(H,306,375,390)(H,307,376,391)(H,308,377,392)(H3,263,294,298,378)(H3,264,295,299,379)(H3,265,296,300,380)(H3,266,297,301,381)/t160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,184+,185+,186+,187+,188+,189+,190+,191+,192+,193+,194+,195+,196+,197+,198+,199+,200+,201+,202+,203+,457?,458?,459?,460?,461?,462?,463?,464?,465?,466?,467?,468?,469?,470?,471?,472?,473?,474?,475?,476?/m0/s1 D02VER DRUGINKE UGGITRSRFHZMKU-WEIZIPMPSA-N D02VER DRUGSMIL CC1=CN(C(=O)NC1=O)C2CNCC(O2)COP(=O)(N3CC(OC(C3)N4C=C(C(=O)NC4=O)C)COP(=O)(N5CC(OC(C5)N6C=C(C(=O)NC6=O)C)COP(=O)(N7CCNCC7)N8CC(OC(C8)N9C=CC(=NC9=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CCNCC1)N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CCNCC1)N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CCN(CC1)C(=O)OCCOCCOCCO)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C D02VER HIGHSTAT Phase 1 D02XLI DRUG__ID D02XLI D02XLI DRUGCOMP Eli Lilly & Co D02XLI DRUGTYPE Small molecular drug D02XLI DRUGINCH 1S/C13H17N5O5S/c1-4(14)9(19)17-13(11(22)23)2-5(24-12-15-3-16-18-12)6-7(8(6)13)10(20)21/h3-8H,2,14H2,1H3,(H,17,19)(H,20,21)(H,22,23)(H,15,16,18)/t4-,5+,6-,7-,8-,13-/m0/s1 D02XLI DRUGINKE BBGHHIUQOKQCBW-LDZWZCGGSA-N D02XLI DRUGSMIL CC(C(=O)NC1(CC(C2C1C2C(=O)O)SC3=NC=NN3)C(=O)O)N D02XLI HIGHSTAT Phase 1 D02YKI DRUG__ID D02YKI D02YKI DRUGCOMP Pfizer Inc D02YKI DRUGTYPE Small molecular drug D02YKI DRUGINCH 1S/C23H32N2O6/c26-23(7-12-27-13-8-23)16-25-9-4-17(5-10-25)14-29-22-21-19(30-18-6-11-28-15-18)2-1-3-20(21)31-24-22/h1-3,17-18,26H,4-16H2/t18-/m1/s1 D02YKI DRUGINKE WLLOFQROROXOMO-GOSISDBHSA-N D02YKI DRUGSMIL C1CN(CCC1COC2=NOC3=C2C(=CC=C3)OC4CCOC4)CC5(CCOCC5)O D02YKI HIGHSTAT Phase 1 D02ZPN DRUG__ID D02ZPN D02ZPN DRUGCOMP Novo Nordisk A/S D02ZPN DRUGTYPE Small molecular drug D02ZPN DRUGINCH 1S/C9H10ClN3O2S2/c1-9(2-3-9)12-8-11-5-4-6(10)16-7(5)17(14,15)13-8/h4H,2-3H2,1H3,(H2,11,12,13) D02ZPN DRUGINKE KYSFUHHFTIGRJN-UHFFFAOYSA-N D02ZPN DRUGSMIL CC1(CC1)N=C2NC3=C(SC(=C3)Cl)S(=O)(=O)N2 D02ZPN HIGHSTAT Phase 1 D03BHZ DRUG__ID D03BHZ D03BHZ DRUGCOMP Astrazeneca D03BHZ DRUGTYPE Small molecular drug D03BHZ DRUGINCH 1S/C24H25F2N3O4/c1-14(27-18-11-16(25)10-17(26)12-18)19-8-15(24(31)28(2)3)9-20-21(30)13-22(33-23(19)20)29-4-6-32-7-5-29/h8-14,27H,4-7H2,1-3H3/t14-/m1/s1 D03BHZ DRUGINKE LMJFJIDLEAWOQJ-CQSZACIVSA-N D03BHZ DRUGSMIL CC(C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F D03BHZ HIGHSTAT Phase 1 D03BXU DRUG__ID D03BXU D03BXU DRUGCOMP Link Medicine D03BXU DRUGTYPE Small molecular drug D03BXU DRUGINCH 1S/C29H22ClN3O2/c1-4-19-6-5-7-20(14-19)24-16-28(34)33(3)26-13-10-22(15-25(24)26)29(35,27-17-31-18-32(27)2)21-8-11-23(30)12-9-21/h1,5-18,35H,2-3H3/t29-/m1/s1 D03BXU DRUGINKE JAHDAIPFBPPQHQ-GDLZYMKVSA-N D03BXU DRUGSMIL CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC=CC(=C5)C#C)C)O D03BXU HIGHSTAT Phase 1 D03DKV DRUG__ID D03DKV D03DKV DRUGCOMP GPC Biotech AG D03DKV DRUGTYPE Small molecular drug D03DKV DRUGINCH 1S/C29H35N7O4.2ClH/c1-39-16-13-34-9-11-35(12-10-34)19-20-5-7-21(8-6-20)26-25-27(32-31-26)22-3-2-4-23(24(22)28(25)37)30-29(38)33-36-14-17-40-18-15-36;;/h2-8H,9-19H2,1H3,(H,31,32)(H2,30,33,38);2*1H D03DKV DRUGINKE WJVMGQMXUBAAPL-UHFFFAOYSA-N D03DKV DRUGSMIL COCCN1CCN(CC1)CC2=CC=C(C=C2)C3=NNC4=C3C(=O)C5=C4C=CC=C5NC(=O)NN6CCOCC6.Cl.Cl D03DKV HIGHSTAT Phase 1 D03EZE DRUG__ID D03EZE D03EZE DRUGCOMP GlaxoSmithKline D03EZE DRUGTYPE Small molecular drug D03EZE DRUGINCH 1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3 D03EZE DRUGINKE CGBJSGAELGCMKE-UHFFFAOYSA-N D03EZE DRUGSMIL COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F D03EZE HIGHSTAT Phase 1 D03JRO DRUG__ID D03JRO D03JRO DRUGCOMP National Institutes of Health D03JRO DRUGTYPE Small molecular drug D03JRO DRUGINCH 1S/C16H14N2O/c17-15(19)16-12-7-3-1-5-10(12)9-14(18-16)11-6-2-4-8-13(11)16/h1-8,14,18H,9H2,(H2,17,19) D03JRO DRUGINKE IFLVGRRVGPXYON-UHFFFAOYSA-N D03JRO DRUGSMIL C1C2C3=CC=CC=C3C(N2)(C4=CC=CC=C41)C(=O)N D03JRO HIGHSTAT Phase 1 D03PKJ DRUG__ID D03PKJ D03PKJ DRUGCOMP Merck & Co Inc D03PKJ DRUGTYPE Small molecular drug D03PKJ DRUGINCH 1S/C21H12Cl2N6O/c22-13-6-12(9-24)7-14(8-13)30-20-16-10-26-29(19(16)4-3-17(20)23)11-18-15-2-1-5-25-21(15)28-27-18/h1-8,10H,11H2,(H,25,27,28) D03PKJ DRUGINKE FZBAOOQVQXATRL-UHFFFAOYSA-N D03PKJ DRUGSMIL C1=CC2=C(NN=C2N=C1)CN3C4=C(C=N3)C(=C(C=C4)Cl)OC5=CC(=CC(=C5)C#N)Cl D03PKJ HIGHSTAT Phase 1 D03PRV DRUG__ID D03PRV D03PRV DRUGCOMP Sankyo Co Ltd D03PRV DRUGTYPE Small molecular drug D03PRV DRUGINCH 1S/2C19H23N3O5.C4H4O4/c2*1-20-18(12-13-26-16-10-6-15(7-11-16)22(24)25)14-4-8-17(9-5-14)27-19(23)21(2)3;5-3(6)1-2-4(7)8/h2*4-11,18,20H,12-13H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*18-;/m00./s1 D03PRV DRUGINKE JOSUCKKYZJUIPW-SOBORHNCSA-N D03PRV DRUGSMIL CNC(CCOC1=CC=C(C=C1)[N+](=O)[O-])C2=CC=C(C=C2)OC(=O)N(C)C.CNC(CCOC1=CC=C(C=C1)[N+](=O)[O-])C2=CC=C(C=C2)OC(=O)N(C)C.C(=CC(=O)O)C(=O)O D03PRV HIGHSTAT Phase 1 D03QEB DRUG__ID D03QEB D03QEB DRUGCOMP Inovio Pharmaceuticals D03QEB DRUGTYPE Small molecular drug D03QEB DRUGINCH 1S/C11H11NO3/c13-11(14)7-9-6-10(12-15-9)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,13,14) D03QEB DRUGINKE MUFJHYRCIHHATF-UHFFFAOYSA-N D03QEB DRUGSMIL C1C(ON=C1C2=CC=CC=C2)CC(=O)O D03QEB HIGHSTAT Phase 1 D03QZJ DRUG__ID D03QZJ D03QZJ DRUGCOMP Celgene D03QZJ DRUGTYPE Small molecular drug D03QZJ DRUGINCH 1S/C14H14N4O3/c1-7-16-9-4-2-3-8(15)12(9)14(21)18(7)10-5-6-11(19)17-13(10)20/h2-4,10H,5-6,15H2,1H3,(H,17,19,20) D03QZJ DRUGINKE RSNPAKAFCAAMBH-UHFFFAOYSA-N D03QZJ DRUGSMIL CC1=NC2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N D03QZJ HIGHSTAT Phase 1 D03RJZ DRUG__ID D03RJZ D03RJZ DRUGCOMP Merck Sante SA D03RJZ DRUGTYPE Small molecular drug D03RJZ DRUGINCH 1S/C19H22O4/c1-13(9-18(20)21)5-6-14-11-19(2,3)12-23-17-8-7-15(22-4)10-16(14)17/h5-11H,12H2,1-4H3,(H,20,21)/b6-5+,13-9+ D03RJZ DRUGINKE FVGXANXBVWECQE-BYWGDBCOSA-N D03RJZ DRUGSMIL CC(=CC(=O)O)C=CC1=CC(COC2=C1C=C(C=C2)OC)(C)C D03RJZ HIGHSTAT Phase 1 D03TDW DRUG__ID D03TDW D03TDW DRUGCOMP Novartis AG D03TDW DRUGTYPE Small molecular drug D03TDW DRUGINCH 1S/C11H16N2OS.H3O4P/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2;1-5(2,3)4/h5,7-8,10H,3-4,6H2,1-2H3;(H3,1,2,3,4)/t8-,10-;/m0./s1 D03TDW DRUGINKE PSRPKRDUWXFVQS-GNAZCLTHSA-N D03TDW DRUGSMIL CCC1C(CSC1=O)CC2=CN=CN2C.OP(=O)(O)O D03TDW HIGHSTAT Phase 1 D03XCR DRUG__ID D03XCR D03XCR DRUGCOMP Taxolog Inc D03XCR DRUGTYPE Small molecular drug D03XCR DRUGINCH 1S/C46H57NO15S/c1-23(2)58-42(55)47-33(29-18-13-19-63-29)34(50)41(54)59-28-21-46(56)38(61-40(53)27-14-9-8-10-15-27)36-44(7,30(49)20-31-45(36,22-57-31)62-25(4)48)37(51)35(32(24(28)3)43(46,5)6)60-39(52)26-16-11-12-17-26/h8-10,13-15,18-19,23,26,28,30-31,33-36,38,49-50,56H,11-12,16-17,20-22H2,1-7H3,(H,47,55)/t28-,30-,31+,33-,34+,35+,36-,38-,44+,45-,46+/m0/s1 D03XCR DRUGINKE SLGIWUWTSWJBQE-VLCCYYTCSA-N D03XCR DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CS5)NC(=O)OC(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)OC(=O)C7CCCC7 D03XCR HIGHSTAT Phase 1 D03YSQ DRUG__ID D03YSQ D03YSQ DRUGCOMP Ascenta Therapeutics; Sanofi US D03YSQ DRUGTYPE Small molecular drug D03YSQ DRUGINCH 1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23-,25+,29+/m0/s1 D03YSQ DRUGINKE IDKAKZRYYDCJDU-AEPXTFJPSA-N D03YSQ DRUGSMIL CC(C)(C)CC1C2(C(C(N1)C(=O)NC3CCC(CC3)O)C4=C(C(=CC=C4)Cl)F)C5=C(C=C(C=C5)Cl)NC2=O D03YSQ HIGHSTAT Phase 1 D03ZPX DRUG__ID D03ZPX D03ZPX DRUGCOMP Epix Pharmaceutical D03ZPX DRUGTYPE Small molecular drug D03ZPX DRUGINCH 1S/C21H28ClN3O4S.ClH/c1-14(17-11-15(22)12-19(28-2)21(17)29-3)24-18-13-16(25-9-7-23-8-10-25)5-6-20(18)30(4,26)27;/h5-6,11-14,23-24H,7-10H2,1-4H3;1H D03ZPX DRUGINKE PILCQJJJAFRKHO-UHFFFAOYSA-N D03ZPX DRUGSMIL CC(C1=C(C(=CC(=C1)Cl)OC)OC)NC2=C(C=CC(=C2)N3CCNCC3)S(=O)(=O)C.Cl D03ZPX HIGHSTAT Phase 1 D03ZXZ DRUG__ID D03ZXZ D03ZXZ DRUGCOMP Exelixis D03ZXZ DRUGTYPE Small molecular drug D03ZXZ DRUGINCH 1S/C22H31N9O/c1-14(2)17-10-16(32-29-17)13-23-22-25-19(24-20-11-18(27-28-20)15-4-5-15)12-21(26-22)31-8-6-30(3)7-9-31/h10-12,14-15H,4-9,13H2,1-3H3,(H3,23,24,25,26,27,28) D03ZXZ DRUGINKE ALKJNCZNEOTEMP-UHFFFAOYSA-N D03ZXZ DRUGSMIL CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)N3CCN(CC3)C)NC4=NNC(=C4)C5CC5 D03ZXZ HIGHSTAT Phase 1 D04CWI DRUG__ID D04CWI D04CWI THERCLAS Antiviral Agents D04CWI DRUGTYPE Small molecular drug D04CWI DRUGINCH 1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1 D04CWI DRUGINKE AMFDITJFBUXZQN-KUBHLMPHSA-N D04CWI DRUGSMIL C1=C(C2=C(N1)C(=NC=N2)N)C3C(C(C(N3)CO)O)O D04CWI HIGHSTAT Phase 1 Trial D04FKX DRUG__ID D04FKX D04FKX DRUGCOMP Dendreon D04FKX DRUGTYPE Small molecular drug D04FKX DRUGINCH 1S/C21H31N3O3/c1-13(2)16-7-5-14(3)11-17(16)20(25)24-18-8-6-15(27-4)12-19(18)23(10-9-22)21(24)26/h6,8,12-14,16-17H,5,7,9-11,22H2,1-4H3/t14-,16+,17-/m1/s1 D04FKX DRUGINKE ZGTYTFYRCIRWBL-HYVNUMGLSA-N D04FKX DRUGSMIL CC1CCC(C(C1)C(=O)N2C3=C(C=C(C=C3)OC)N(C2=O)CCN)C(C)C D04FKX HIGHSTAT Phase 1 D04HDZ DRUG__ID D04HDZ D04HDZ DRUGCOMP Geron Corp D04HDZ DRUGTYPE Small molecular drug D04HDZ DRUGINCH 1S/C15H28B3N3O8P2S2/c16-13-1-7(19)11(28-13)5-25-31(24,33)21-9-3-15(18)29-12(9)6-26-30(23,32)20-8-2-14(17)27-10(8)4-22/h7-15,22H,1-6,19H2,(H2,20,23,32)(H2,21,24,33)/p-2 D04HDZ DRUGINKE HHVGDFKKILAWTA-UHFFFAOYSA-L D04HDZ DRUGSMIL [B]C1CC(C(O1)COP(=S)(NC2CC(OC2COP(=S)(NC3CC(OC3CO)[B])[O-])[B])[O-])N D04HDZ HIGHSTAT Phase 1 D04JZH DRUG__ID D04JZH D04JZH DRUGCOMP Pfizer Inc D04JZH DRUGTYPE Small molecular drug D04JZH DRUGINCH 1S/C13H10Cl3N3O/c1-18-13(20)10-3-2-7(12(17)19-10)8-4-6(14)5-9(15)11(8)16/h2-5H,1H3,(H2,17,19)(H,18,20) D04JZH DRUGINKE HPIUHDCRVYDAEJ-UHFFFAOYSA-N D04JZH DRUGSMIL CNC(=O)C1=NC(=C(C=C1)C2=C(C(=CC(=C2)Cl)Cl)Cl)N D04JZH HIGHSTAT Phase 1 D04KJT DRUG__ID D04KJT D04KJT DRUGCOMP Abbott D04KJT DRUGTYPE Small molecular drug D04KJT DRUGINCH 1S/C26H27N3O5S/c1-26(2,3)22-15-20(29-11-10-23(30)27-25(29)31)14-21(24(22)34-4)18-7-6-17-13-19(28-35(5,32)33)9-8-16(17)12-18/h6-15,28H,1-5H3,(H,27,30,31) D04KJT DRUGINKE NBRBXGKOEOGLOI-UHFFFAOYSA-N D04KJT DRUGSMIL CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O D04KJT HIGHSTAT Phase 1 D04KMQ DRUG__ID D04KMQ D04KMQ DRUGCOMP Glaxosmithkline D04KMQ DRUGTYPE Small molecular drug D04KMQ DRUGINCH 1S/C22H33N3O4/c26-20(25-28)13-12-18-11-10-16(14-23-18)15-24-21(17-6-2-1-3-7-17)22(27)29-19-8-4-5-9-19/h10-11,14,17,19,21,24,28H,1-9,12-13,15H2,(H,25,26)/t21-/m0/s1 D04KMQ DRUGINKE AFDPFLDWOXXHQM-NRFANRHFSA-N D04KMQ DRUGSMIL C1CCC(CC1)C(C(=O)OC2CCCC2)NCC3=CN=C(C=C3)CCC(=O)NO D04KMQ HIGHSTAT Phase 1 D04KRV DRUG__ID D04KRV D04KRV DRUGCOMP Molecular Insight Pharmaceuticals D04KRV DRUGTYPE Small molecular drug D04KRV DRUGINCH 1S/C19H26IN3O7/c20-13-6-4-12(5-7-13)11-21-10-2-1-3-14(17(26)27)22-19(30)23-15(18(28)29)8-9-16(24)25/h4-7,14-15,21H,1-3,8-11H2,(H,24,25)(H,26,27)(H,28,29)(H2,22,23,30)/t14-,15-/m0/s1/i20-4 D04KRV DRUGINKE OXUUJYOSVPMNKP-ZANJDRPYSA-N D04KRV DRUGSMIL C1=CC(=CC=C1CNCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)I D04KRV HIGHSTAT Phase 1 D04KWY DRUG__ID D04KWY D04KWY DRUGCOMP Research Triangle Institute D04KWY DRUGTYPE Small molecular drug D04KWY DRUGINCH 1S/C24H25ClN2O.ClH/c1-15-3-5-17(6-4-15)21-14-23(28-26-21)24-20(16-7-9-18(25)10-8-16)13-19-11-12-22(24)27(19)2;/h3-10,14,19-20,22,24H,11-13H2,1-2H3;1H/t19-,20+,22+,24-;/m0./s1 D04KWY DRUGINKE IZMZEMAKFSYLMD-SXBQIKTFSA-N D04KWY DRUGSMIL CC1=CC=C(C=C1)C2=NOC(=C2)C3C4CCC(N4C)CC3C5=CC=C(C=C5)Cl.Cl D04KWY HIGHSTAT Phase 1 D04LSD DRUG__ID D04LSD D04LSD DRUGCOMP Abbott D04LSD DRUGTYPE Small molecular drug D04LSD DRUGINCH 1S/C22H22N2O/c1-16-3-2-11-24(16)12-10-21-14-20-13-19(8-9-22(20)25-21)18-6-4-17(15-23)5-7-18/h4-9,13-14,16H,2-3,10-12H2,1H3/t16-/m1/s1 D04LSD DRUGINKE KFHYZKCRXNRKRC-MRXNPFEDSA-N D04LSD DRUGSMIL CC1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C4=CC=C(C=C4)C#N D04LSD HIGHSTAT Phase 1 D04LWT DRUG__ID D04LWT D04LWT DRUGCOMP GlaxoSmithKline D04LWT DRUGTYPE Small molecular drug D04LWT DRUGINCH 1S/C30H29Cl2N3O6/c1-33(28(36)17-35-25-14-23(31)24(32)15-27(25)41-18-29(35)37)26(16-34-10-12-40-13-11-34)21-6-2-19(3-7-21)20-4-8-22(9-5-20)30(38)39/h2-9,14-15,26H,10-13,16-18H2,1H3,(H,38,39)/t26-/m0/s1 D04LWT DRUGINKE YNBJTYUXPHTSFF-SANMLTNESA-N D04LWT DRUGSMIL CN(C(CN1CCOCC1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)O)C(=O)CN4C(=O)COC5=CC(=C(C=C54)Cl)Cl D04LWT HIGHSTAT Phase 1 D04MGD DRUG__ID D04MGD D04MGD DRUGCOMP Jazz Pharmaceuticals D04MGD DRUGTYPE Small molecular drug D04MGD DRUGINCH 1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17) D04MGD DRUGINKE NNXUYJFHOVCRSM-UHFFFAOYSA-N D04MGD DRUGSMIL C1=C(C=C(C(=C1C2=NC=C(N=C2N)N)Cl)Cl)Cl D04MGD HIGHSTAT Phase 1 D04OLK DRUG__ID D04OLK D04OLK DRUGCOMP Allist Pharmaceutical Inc D04OLK DRUGTYPE Small molecular drug D04OLK DRUGINCH 1S/C24H18ClFN4O2/c1-2-23(31)29-17-6-8-21-19(11-17)24(28-14-27-21)30-18-7-9-22(20(25)12-18)32-13-15-4-3-5-16(26)10-15/h2-12,14H,1,13H2,(H,29,31)(H,27,28,30) D04OLK DRUGINKE MVZGYPSXNDCANY-UHFFFAOYSA-N D04OLK DRUGSMIL C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl D04OLK HIGHSTAT Phase 1 D04OSA DRUG__ID D04OSA D04OSA DRUGCOMP AstraZeneca plc D04OSA DRUGTYPE Small molecular drug D04OSA DRUGINCH 1S/C24H16F3N5/c25-19-6-2-5-18-21(19)23(28)32-24(18,17-7-8-31-20(10-17)22(26)27)16-4-1-3-14(9-16)15-11-29-13-30-12-15/h1-13,22H,(H2,28,32)/t24-/m0/s1 D04OSA DRUGINKE MRXBCEQZNKUUIP-DEOSSOPVSA-N D04OSA DRUGSMIL C1=CC(=CC(=C1)C2(C3=C(C(=CC=C3)F)C(=N2)N)C4=CC(=NC=C4)C(F)F)C5=CN=CN=C5 D04OSA HIGHSTAT Phase 1 D04TIJ DRUG__ID D04TIJ D04TIJ DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D04TIJ DRUGTYPE Small molecular drug D04TIJ DRUGINCH 1S/C23H22N4O5/c1-2-23(30)17-9-19-20-15(11-27(19)21(28)16(17)12-31-22(23)29)14(10-25-32-8-7-24)13-5-3-4-6-18(13)26-20/h3-6,9-10,30H,2,7-8,11-12,24H2,1H3/b25-10+/t23-/m0/s1 D04TIJ DRUGINKE IBTISPLPBBHVSU-UVOOVGFISA-N D04TIJ DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)C=NOCCN)O D04TIJ HIGHSTAT Phase 1 D04TSO DRUG__ID D04TSO D04TSO DRUGCOMP Unibioscreen SA D04TSO DRUGTYPE Small molecular drug D04TSO DRUGINCH 1S/C31H43NO9S/c1-16-11-30(32-24(34)14-42-30)31(37)26(39-16)40-22-10-18-3-4-21-20(28(18,15-33)12-23(22)41-31)5-7-27(2)19(6-8-29(21,27)36)17-9-25(35)38-13-17/h9,16,18-23,26,33,36-37H,3-8,10-15H2,1-2H3,(H,32,34)/t16-,18+,19-,20+,21-,22+,23+,26+,27-,28-,29+,30+,31-/m1/s1 D04TSO DRUGINKE GRINEMOQBRCRRY-OVGHKGCDSA-N D04TSO DRUGSMIL CC1CC2(C3(C(O1)OC4CC5CCC6C(C5(CC4O3)CO)CCC7(C6(CCC7C8=CC(=O)OC8)O)C)O)NC(=O)CS2 D04TSO HIGHSTAT Phase 1 D04ZWQ DRUG__ID D04ZWQ D04ZWQ DRUGCOMP Organon BioSciences D04ZWQ DRUGTYPE Small molecular drug D04ZWQ DRUGINCH 1S/C19H31NO6/c1-7-15(20(8-10-22-3)9-11-23-4)19(21)26-18-16(24-5)12-14(2)13-17(18)25-6/h12-13,15H,7-11H2,1-6H3/t15-/m1/s1 D04ZWQ DRUGINKE GKRFHHRXDUACIN-OAHLLOKOSA-N D04ZWQ DRUGSMIL CCC(C(=O)OC1=C(C=C(C=C1OC)C)OC)N(CCOC)CCOC D04ZWQ HIGHSTAT Phase 1 D05FIJ DRUG__ID D05FIJ D05FIJ DRUGCOMP Glaxosmithkline D05FIJ DRUGTYPE Small molecular drug D05FIJ DRUGINCH 1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1 D05FIJ DRUGINKE FKSFKBQGSFSOSM-QFIPXVFZSA-N D05FIJ DRUGSMIL CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C D05FIJ HIGHSTAT Phase 1 D05GZD DRUG__ID D05GZD D05GZD DRUGCOMP GSK D05GZD DRUGTYPE Small molecular drug D05GZD DRUGINCH 1S/C40H38F5N3O3S/c1-51-22-21-46-19-17-32(18-20-46)47(24-27-9-11-28(12-10-27)29-13-15-31(16-14-29)40(43,44)45)37(50)25-48-35-8-3-2-6-33(35)36(49)23-38(48)52-26-30-5-4-7-34(41)39(30)42/h2-16,23,32H,17-22,24-26H2,1H3 D05GZD DRUGINKE NNBGCSGCRSCFEA-UHFFFAOYSA-N D05GZD DRUGSMIL COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C5=CC=CC=C5C(=O)C=C4SCC6=C(C(=CC=C6)F)F D05GZD HIGHSTAT Phase 1 D05HBZ DRUG__ID D05HBZ D05HBZ DRUGCOMP Eisai Co. Ltd. D05HBZ DRUGTYPE Small molecular drug D05HBZ DRUGINCH 1S/C24H43N3O4/c1-15(2)19(14-17(5)23(30)31)26(9)22(29)20(24(6,7)8)25-21(28)18-12-10-11-13-27(18)16(3)4/h14-16,18-20H,10-13H2,1-9H3,(H,25,28)(H,30,31)/b17-14+/t18-,19-,20-/m1/s1 D05HBZ DRUGINKE FWYMMXUDTATKLG-PGLMLKKXSA-N D05HBZ DRUGSMIL CC(C)C(C=C(C)C(=O)O)N(C)C(=O)C(C(C)(C)C)NC(=O)C1CCCCN1C(C)C D05HBZ HIGHSTAT Phase 1 D05LBN DRUG__ID D05LBN D05LBN THERCLAS Antiviral Agents D05LBN DRUGTYPE Small molecular drug D05LBN DRUGINCH 1S/C25H28ClN5O5S2/c1-13-18(23-19-7-16(26)3-2-14(19)4-5-29-23)9-22(37-13)24(33)20-10-28-12-30-25(20)31-17-6-15(21(32)8-17)11-36-38(27,34)35/h2-3,7,9-10,12,15,17,21,23,29,32H,4-6,8,11H2,1H3,(H2,27,34,35)(H,28,30,31)/t15-,17-,21+,23+/m1/s1 D05LBN DRUGINKE LXRZVMYMQHNYJB-UNXOBOICSA-N D05LBN DRUGSMIL CC1=C(C=C(S1)C(=O)C2=CN=CN=C2NC3CC(C(C3)O)COS(=O)(=O)N)C4C5=C(CCN4)C=CC(=C5)Cl D05LBN HIGHSTAT Phase 1 Trial D05LPW DRUG__ID D05LPW D05LPW DRUGCOMP Dong-A Pharmaceutical Co Ltd D05LPW DRUGTYPE Small molecular drug D05LPW DRUGINCH 1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1 D05LPW DRUGINKE LCDDAGSJHKEABN-MLGOLLRUSA-N D05LPW DRUGSMIL CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N D05LPW HIGHSTAT Phase 1 D05OMT DRUG__ID D05OMT D05OMT DRUGCOMP Merck D05OMT DRUGTYPE Small molecular drug D05OMT DRUGINCH 1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3 D05OMT DRUGINKE VMJFTOSOFDEKTM-UHFFFAOYSA-N D05OMT DRUGSMIL CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)CS(=O)(=O)NCC5=CC=CC=N5)N=C2 D05OMT HIGHSTAT Phase 1 D05QIU DRUG__ID D05QIU D05QIU DRUGCOMP Sankyo Co Ltd D05QIU DRUGTYPE Small molecular drug D05QIU DRUGINCH 1S/C27H25F3N4O3S/c1-18(27(35,15-34-17-32-16-33-34)23-9-8-21(28)11-25(23)30)38-22-13-36-26(37-14-22)5-3-2-4-20-7-6-19(12-31)10-24(20)29/h2-11,16-18,22,26,35H,13-15H2,1H3/b4-2+,5-3+/t18-,22?,26?,27-/m1/s1 D05QIU DRUGINKE XSRKBFUVSRRJDX-ILLAMVBCSA-N D05QIU DRUGSMIL CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)SC3COC(OC3)C=CC=CC4=C(C=C(C=C4)C#N)F D05QIU HIGHSTAT Phase 1 D05UCM DRUG__ID D05UCM D05UCM THERCLAS Antiviral Agents D05UCM DRUGTYPE Small molecular drug D05UCM DRUGINCH 1S/3C20H14N4O3S.Mn/c3*25-28(26,27)20-11-18-9-16-4-3-14(22-16)7-12-1-2-13(21-12)8-15-5-6-17(23-15)10-19(20)24-18;/h3*1-11,22,24H,(H,25,26,27);/q;;;+3/p-3 D05UCM DRUGINKE COMOCQDNBJIJET-UHFFFAOYSA-K D05UCM DRUGSMIL C1=CC2=CC3=CC(=C(N3)C=C4C=CC(=N4)C=C5C=CC(=N5)C=C1N2)S(=O)(=O)[O-].C1=CC2=CC3=CC(=C(N3)C=C4C=CC(=N4)C=C5C=CC(=N5)C=C1N2)S(=O)(=O)[O-].C1=CC2=CC3=CC(=C(N3)C=C4C=CC(=N4)C=C5C=CC(=N5)C=C1N2)S(=O)(=O)[O-].[Mn+3] D05UCM HIGHSTAT Phase 1 Trial D05WUQ DRUG__ID D05WUQ D05WUQ DRUGCOMP Pharmagenesis; Pierre Fabre Pharmaceuticals D05WUQ DRUGTYPE Small molecular drug D05WUQ DRUGINCH 1S/C24H28O9/c1-10(2)22-17(32-22)18-24(33-18)21(3)7-6-11-12(9-29-19(11)28)13(21)8-14-23(24,31-14)20(22)30-16(27)5-4-15(25)26/h10,13-14,17-18,20H,4-9H2,1-3H3,(H,25,26)/t13-,14-,17-,18-,20+,21-,22-,23+,24+/m0/s1 D05WUQ DRUGINKE HROMYAWHLUOUPY-AHCCQAQQSA-N D05WUQ DRUGSMIL CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2OC(=O)CCC(=O)O)O7)COC6=O)C D05WUQ HIGHSTAT Phase 1 D05WWJ DRUG__ID D05WWJ D05WWJ DRUGCOMP NPS Pharmaceuticals D05WWJ DRUGTYPE Small molecular drug D05WWJ DRUGINCH 1S/C24H24FNO3/c1-26(17-24(27)28)16-15-23(20-7-11-21(25)12-8-20)29-22-13-9-19(10-14-22)18-5-3-2-4-6-18/h2-14,23H,15-17H2,1H3,(H,27,28)/t23-/m1/s1 D05WWJ DRUGINKE FDORQEIHOKEJNX-HSZRJFAPSA-N D05WWJ DRUGSMIL CN(CCC(C1=CC=C(C=C1)F)OC2=CC=C(C=C2)C3=CC=CC=C3)CC(=O)O D05WWJ HIGHSTAT Phase 1 D06CVN DRUG__ID D06CVN D06CVN DRUGCOMP Endocyte D06CVN DRUGTYPE Small molecular drug D06CVN DRUGINCH 1S/C111H156N22O43S2/c1-6-107(172)39-52-40-110(104(170)175-5,89-57(29-33-132(46-52)51-107)56-11-8-9-12-60(56)120-89)59-37-58-68(38-75(59)174-4)131(3)101-109(58)31-34-133-32-10-30-108(7-2,100(109)133)102(168)111(101,173)103(169)129-130-106(171)176-35-36-177-178-50-67(99(166)167)126-96(162)63(19-25-78(145)116-45-71(139)85(153)88(156)74(142)49-136)122-95(161)65(22-28-81(149)150)124-93(159)62(18-24-77(144)115-44-70(138)84(152)87(155)73(141)48-135)121-94(160)64(21-27-80(147)148)123-92(158)61(17-23-76(143)114-43-69(137)83(151)86(154)72(140)47-134)119-79(146)26-20-66(98(164)165)125-91(157)53-13-15-54(16-14-53)113-41-55-42-117-90-82(118-55)97(163)128-105(112)127-90/h8-16,30,37-38,42,52,61-67,69-74,83-88,100-102,113,120,134-142,151-156,168,172-173H,6-7,17-29,31-36,39-41,43-51H2,1-5H3,(H,114,143)(H,115,144)(H,116,145)(H,119,146)(H,121,160)(H,122,161)(H,123,158)(H,124,159)(H,125,157)(H,126,162)(H,129,169)(H,130,171)(H,147,148)(H,149,150)(H,164,165)(H,166,167)(H3,112,117,127,128,163)/t52-,61-,62-,63-,64-,65-,66-,67-,69-,70-,71-,72+,73+,74+,83+,84+,85+,86+,87+,88+,100-,101+,102+,107-,108+,109+,110-,111-/m0/s1 D06CVN DRUGINKE PHCAWPRQWLBYTH-HCDHKMFTSA-N D06CVN DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NNC(=O)OCCSSCC(C(=O)O)NC(=O)C(CCC(=O)NCC(C(C(C(CO)O)O)O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)NCC(C(C(C(CO)O)O)O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)NCC(C(C(C(CO)O)O)O)O)NC(=O)CCC(C(=O)O)NC(=O)C1=CC=C(C=C1)NCC1=CN=C2C(=N1)C(=O)NC(=N2)N)O)O)CC)OC)C(=O)OC)O D06CVN HIGHSTAT Phase 1 D06IPZ DRUG__ID D06IPZ D06IPZ DRUGCOMP Merck D06IPZ DRUGTYPE Small molecular drug D06IPZ DRUGINCH 1S/C29H37N3O3/c1-30(2)15-16-31(3)22-18-32-25-17-21(29(33)34)13-14-23(25)27(20-9-5-4-6-10-20)28(32)24-11-7-8-12-26(24)35-19-22/h7-8,11-14,17,20,22H,4-6,9-10,15-16,18-19H2,1-3H3,(H,33,34)/t22-/m1/s1 D06IPZ DRUGINKE YQUCBFIQSJVCOR-JOCHJYFZSA-N D06IPZ DRUGSMIL CN(C)CCN(C)C1CN2C3=C(C=CC(=C3)C(=O)O)C(=C2C4=CC=CC=C4OC1)C5CCCCC5 D06IPZ HIGHSTAT Phase 1 D06KUY DRUG__ID D06KUY D06KUY DRUGCOMP Achillion pharmaceuticals D06KUY DRUGTYPE Small molecular drug D06KUY DRUGINCH 1S/C45H56F2N6O8S2/c1-26(2)34-24-62-41(49-34)33-21-37(32-15-16-36(60-4)27(3)39(32)48-33)61-30-20-35-40(55)50-45(43(57)51-63(58,59)31-13-14-31)22-29(45)12-9-7-5-6-8-11-28(42(56)53(35)23-30)19-38(54)52-18-10-17-44(46,47)25-52/h9,12,15-16,21,24,26,28-31,35H,5-8,10-11,13-14,17-20,22-23,25H2,1-4H3,(H,50,55)(H,51,57)/b12-9-/t28-,29-,30-,35+,45-/m1/s1 D06KUY DRUGINKE UDMJANYPQWEDFT-ZAWFUYGJSA-N D06KUY DRUGSMIL CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(=O)NC5(CC5C=CCCCCCC(C(=O)N4C3)CC(=O)N6CCCC(C6)(F)F)C(=O)NS(=O)(=O)C7CC7)C8=NC(=CS8)C(C)C)OC D06KUY HIGHSTAT Phase 1 D06MHZ DRUG__ID D06MHZ D06MHZ DRUGCOMP Newlink genetics D06MHZ DRUGTYPE Small molecular drug D06MHZ DRUGINCH 1S/C18H22N2O/c21-18(13-6-2-1-3-7-13)10-16-14-8-4-5-9-15(14)17-11-19-12-20(16)17/h4-5,8-9,11-13,16,18,21H,1-3,6-7,10H2 D06MHZ DRUGINKE YTRRAUACYORZLX-UHFFFAOYSA-N D06MHZ DRUGSMIL C1CCC(CC1)C(CC2C3=CC=CC=C3C4=CN=CN24)O D06MHZ HIGHSTAT Phase 1 D06OZJ DRUG__ID D06OZJ D06OZJ THERCLAS Analgesics D06OZJ DRUGTYPE Small molecular drug D06OZJ DRUGINCH 1S/C27H24FN3O/c28-24-13-11-22(12-14-24)26-27(23-15-17-29-18-16-23)31(25(30-26)10-4-5-20-32)19-6-9-21-7-2-1-3-8-21/h1-3,7-8,11-18,32H,5-6,9,19-20H2 D06OZJ DRUGINKE QSUSKMBNZQHHPA-UHFFFAOYSA-N D06OZJ DRUGSMIL C1=CC=C(C=C1)CCCN2C(=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F)C#CCCO D06OZJ HIGHSTAT Phase 1 D06QOA DRUG__ID D06QOA D06QOA DRUGCOMP Pharmasset D06QOA DRUGTYPE Small molecular drug D06QOA DRUGINCH 1S/C16H23FN5O6P/c1-5-24-13-10-12(20-15(18)21-13)22(7-19-10)14-16(4,17)11-9(26-14)6-25-29(23,28-11)27-8(2)3/h7-9,11,14H,5-6H2,1-4H3,(H2,18,20,21)/t9-,11-,14-,16-,29?/m1/s1 D06QOA DRUGINKE PVRFQJIRERYGTQ-UYISCHNFSA-N D06QOA DRUGSMIL CCOC1=NC(=NC2=C1N=CN2C3C(C4C(O3)COP(=O)(O4)OC(C)C)(C)F)N D06QOA HIGHSTAT Phase 1 D06SUS DRUG__ID D06SUS D06SUS DRUGCOMP Theravance Inc D06SUS DRUGTYPE Small molecular drug D06SUS DRUGINCH 1S/C19H29NO5/c1-5-11-24-19(22)13-15-9-10-16(17(12-15)23-8-4)25-14-18(21)20(6-2)7-3/h9-10,12H,5-8,11,13-14H2,1-4H3 D06SUS DRUGINKE QPUVKSKJCNGSGT-UHFFFAOYSA-N D06SUS DRUGSMIL CCCOC(=O)CC1=CC(=C(C=C1)OCC(=O)N(CC)CC)OCC D06SUS HIGHSTAT Phase 1 D06VAQ DRUG__ID D06VAQ D06VAQ DRUGCOMP Eukarion Inc D06VAQ DRUGTYPE Small molecular drug D06VAQ DRUGINCH 1S/C20H24N2O4.C2H4O2.Mn/c1-3-25-17-9-5-7-15(19(17)23)13-21-11-12-22-14-16-8-6-10-18(20(16)24)26-4-2;1-2(3)4;/h5-10,13-14,23-24H,3-4,11-12H2,1-2H3;1H3,(H,3,4);/p-2 D06VAQ DRUGINKE SZYIPDLZPMRUNA-UHFFFAOYSA-L D06VAQ DRUGSMIL CCOC1=CC=CC(=C1[O-])C=NCCN=CC2=C(C(=CC=C2)OCC)[O-].CC(=O)O.[Mn] D06VAQ HIGHSTAT Phase 1 D06VRI DRUG__ID D06VRI D06VRI THERCLAS Antiviral Agents D06VRI DRUGTYPE Small molecular drug D06VRI DRUGINCH 1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18) D06VRI DRUGINKE VHOGYURTWQBHIL-UHFFFAOYSA-N D06VRI DRUGSMIL CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F D06VRI HIGHSTAT Phase 1 Trial D06XDJ DRUG__ID D06XDJ D06XDJ DRUGCOMP Eiger BioPharmaceuticals D06XDJ DRUGTYPE Small molecular drug D06XDJ DRUGINCH 1S/C19H20ClN3/c20-16-9-7-15(8-10-16)13-23-18-6-2-1-5-17(18)21-19(23)14-22-11-3-4-12-22/h1-2,5-10H,3-4,11-14H2 D06XDJ DRUGINKE CJXAEXPPLWQRFR-UHFFFAOYSA-N D06XDJ DRUGSMIL C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl D06XDJ HIGHSTAT Phase 1 D06ZVO DRUG__ID D06ZVO D06ZVO THERCLAS Anticancer Agents D06ZVO DRUGTYPE Small molecular drug D06ZVO DRUGINCH 1S/C13H18Cl2N2O3.2ClH/c14-5-7-17(20,8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19;;/h1-4,12H,5-9,16H2,(H,18,19);2*1H/t12-;;/m0../s1 D06ZVO DRUGINKE GIGCDIVNDFQKRA-LTCKWSDVSA-N D06ZVO DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)[N+](CCCl)(CCCl)[O-].Cl.Cl D06ZVO HIGHSTAT Phase 1 D07BIK DRUG__ID D07BIK D07BIK DRUGCOMP Nippon Chemiphar Co Ltd D07BIK DRUGTYPE Small molecular drug D07BIK DRUGINCH 1S/C14H25NO5.Na/c1-8(2)5-10(7-19-6-9(3)4)15-13(16)11-12(20-11)14(17)18;/h8-12H,5-7H2,1-4H3,(H,15,16)(H,17,18);/q;+1/p-1/t10-,11-,12-;/m0./s1 D07BIK DRUGINKE SGAKODIXAHVUKL-LFELFHSZSA-M D07BIK DRUGSMIL CC(C)CC(COCC(C)C)NC(=O)C1C(O1)C(=O)[O-].[Na+] D07BIK HIGHSTAT Phase 1 D07BKR DRUG__ID D07BKR D07BKR DRUGCOMP ArQule D07BKR DRUGTYPE Small molecular drug D07BKR DRUGINCH 1S/C28H24Cl2FN5O2/c1-2-8-24(35(16-7-15-32)27(37)21-11-6-12-22(30)25(21)31)26-33-23-17-18(29)13-14-20(23)28(38)36(26)34-19-9-4-3-5-10-19/h1,3-6,9-14,17,24,34H,7-8,15-16,32H2/t24-/m1/s1 D07BKR DRUGINKE UPJSUQWHUVLLNW-XMMPIXPASA-N D07BKR DRUGSMIL C#CCC(C1=NC2=C(C=CC(=C2)Cl)C(=O)N1NC3=CC=CC=C3)N(CCCN)C(=O)C4=C(C(=CC=C4)Cl)F D07BKR HIGHSTAT Phase 1 D07BXE DRUG__ID D07BXE D07BXE DRUGCOMP National Cancer Institute D07BXE DRUGTYPE Small molecular drug D07BXE DRUGINCH 1S/C15H11N3O/c16-10-5-6-13-9(7-10)8-18-14(17-13)11-3-1-2-4-12(11)15(18)19/h1-7H,8,16H2 D07BXE DRUGINKE SRIOCKJKFXAKHK-UHFFFAOYSA-N D07BXE DRUGSMIL C1C2=C(C=CC(=C2)N)N=C3N1C(=O)C4=CC=CC=C43 D07BXE HIGHSTAT Phase 1 D07EHB DRUG__ID D07EHB D07EHB DRUGCOMP University of Wisconsin-Madison D07EHB DRUGTYPE Small molecular drug D07EHB DRUGINCH 1S/C20H29NO5S/c1-13-5-3-4-6-14(2)9-18(22)25-16-10-15(8-7-13)26-20(24,11-16)17-12-27-19(23)21-17/h3,5,9,13,15-17,24H,4,6-8,10-12H2,1-2H3,(H,21,23)/b5-3-,14-9-/t13-,15-,16-,17+,20-/m1/s1 D07EHB DRUGINKE NSHPHXHGRHSMIK-JRIKCGFMSA-N D07EHB DRUGSMIL CC1CCC2CC(CC(O2)(C3CSC(=O)N3)O)OC(=O)C=C(CCC=C1)C D07EHB HIGHSTAT Phase 1 D07EPV DRUG__ID D07EPV D07EPV DRUGCOMP Mitsubishi Pharma America D07EPV DRUGTYPE Small molecular drug D07EPV DRUGINCH 1S/C22H30N6OS/c1-17-13-21(28(24-17)18-5-3-2-4-6-18)26-9-7-25(8-10-26)19-14-20(23-15-19)22(29)27-11-12-30-16-27/h2-6,13,19-20,23H,7-12,14-16H2,1H3/t19-,20-/m0/s1 D07EPV DRUGINKE WGRQANOPCQRCME-PMACEKPBSA-N D07EPV DRUGSMIL CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5 D07EPV HIGHSTAT Phase 1 D07LWK DRUG__ID D07LWK D07LWK DRUGCOMP Sanofi-Aventis D07LWK DRUGTYPE Small molecular drug D07LWK DRUGINCH 1S/C30H29N3O3/c1-36-25-14-12-22(13-15-25)19-29(34)33-21-24-8-2-3-9-26(24)27-10-4-5-11-28(27)30(35)32-18-16-23-7-6-17-31-20-23/h2-15,17,20H,16,18-19,21H2,1H3,(H,32,35)(H,33,34) D07LWK DRUGINKE CHDSRMIDIQABTP-UHFFFAOYSA-N D07LWK DRUGSMIL COC1=CC=C(C=C1)CC(=O)NCC2=CC=CC=C2C3=CC=CC=C3C(=O)NCCC4=CN=CC=C4 D07LWK HIGHSTAT Phase 1 D07LYC DRUG__ID D07LYC D07LYC DRUGCOMP SCYNEXIS Inc D07LYC DRUGTYPE Small molecular drug D07LYC DRUGINCH 1S/C17H14BF4NO3/c1-16(2)12-6-4-10(8-14(12)18(25)26-16)23-15(24)11-5-3-9(19)7-13(11)17(20,21)22/h3-8,25H,1-2H3,(H,23,24) D07LYC DRUGINKE PTYGDEXEGLDNAZ-UHFFFAOYSA-N D07LYC DRUGSMIL B1(C2=C(C=CC(=C2)NC(=O)C3=C(C=C(C=C3)F)C(F)(F)F)C(O1)(C)C)O D07LYC HIGHSTAT Phase 1 D07OFM DRUG__ID D07OFM D07OFM DRUGCOMP GlaxoSmithKline D07OFM DRUGTYPE Small molecular drug D07OFM DRUGINCH 1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1 D07OFM DRUGINKE AAAQFGUYHFJNHI-SFHVURJKSA-N D07OFM DRUGSMIL CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C D07OFM HIGHSTAT Phase 1 D07OIO DRUG__ID D07OIO D07OIO DRUGCOMP AstraZeneca D07OIO DRUGTYPE Small molecular drug D07OIO DRUGINCH 1S/C22H22FN3O3/c1-29-15-8-10-26(11-9-15)22(28)18-12-14(6-7-19(18)23)13-20-16-4-2-3-5-17(16)21(27)25-24-20/h2-7,12,15H,8-11,13H2,1H3,(H,25,27) D07OIO DRUGINKE HYNBNUYQTQIHJK-UHFFFAOYSA-N D07OIO DRUGSMIL COC1CCN(CC1)C(=O)C2=C(C=CC(=C2)CC3=NNC(=O)C4=CC=CC=C43)F D07OIO HIGHSTAT Phase 1 D07PMG DRUG__ID D07PMG D07PMG DRUGCOMP Bayer AG D07PMG DRUGTYPE Small molecular drug D07PMG DRUGINCH 1S/C45H49N7O11S/c1-6-45(30-17-33-35-25(15-24-9-7-8-10-31(24)49-35)19-52(33)40(56)29(30)20-60-43(45)58)63-41(57)34(22(2)3)51-39(55)32(16-27-18-46-21-47-27)50-44(64)48-26-11-13-28(14-12-26)62-42-37(54)38(59-5)36(53)23(4)61-42/h7-15,17-18,21-23,32,34,36-38,42,53-54H,6,16,19-20H2,1-5H3,(H,46,47)(H,51,55)(H2,48,50,64)/t23-,32-,34-,36+,37-,38+,42+,45-/m0/s1 D07PMG DRUGINKE SLOJCSGNHWIKIG-JNYZSSQASA-N D07PMG DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C(C(C)C)NC(=O)C(CC6=CN=CN6)NC(=S)NC7=CC=C(C=C7)OC8C(C(C(C(O8)C)O)OC)O D07PMG HIGHSTAT Phase 1 D07PNT DRUG__ID D07PNT D07PNT DRUGCOMP Exelixis D07PNT THERCLAS Anticancer Agents D07PNT DRUGINCH 1S/C26H28FN5O/c1-3-32-11-9-19(10-12-32)30-20-7-8-22-21(14-20)24(26(33)31-22)23(25-28-15-16(2)29-25)17-5-4-6-18(27)13-17/h4-8,13-15,19,30H,3,9-12H2,1-2H3,(H,28,29)(H,31,33)/b24-23- D07PNT DRUGINKE DMQYDVBIPXAAJA-VHXPQNKSSA-N D07PNT DRUGSMIL CCN1CCC(CC1)NC2=CC3=C(C=C2)NC(=O)C3=C(C4=CC(=CC=C4)F)C5=NC=C(N5)C D07PNT HIGHSTAT Phase 1 D07PRC DRUG__ID D07PRC D07PRC DRUGCOMP Basilea Pharmaceutica International Ltd D07PRC DRUGTYPE Small molecular drug D07PRC DRUGINCH 1S/C16H18N6O10S2/c1-16(2)12(14(26)22(16)32-34(28,29)30)19-13(25)11(8-6-33-15(17)18-8)20-31-5-7-3-9(23)10(24)4-21(7)27/h3-4,6,12,24,27H,5H2,1-2H3,(H2,17,18)(H,19,25)(H,28,29,30)/b20-11+/t12-/m1/s1 D07PRC DRUGINKE KLFSEZJCLYBFKQ-ZICWZVMQSA-N D07PRC DRUGSMIL CC1(C(C(=O)N1OS(=O)(=O)O)NC(=O)C(=NOCC2=CC(=O)C(=CN2O)O)C3=CSC(=N3)N)C D07PRC HIGHSTAT Phase 1 D07QWW DRUG__ID D07QWW D07QWW DRUGCOMP Neurocrine Biosciences; GlaxoSmithKline D07QWW DRUGTYPE Small molecular drug D07QWW DRUGINCH 1S/C22H26Cl2N4/c1-4-6-16(7-5-2)27-10-11-28-22-19(27)12-14(3)25-21(22)20(26-28)17-9-8-15(23)13-18(17)24/h8-9,12-13,16H,4-7,10-11H2,1-3H3 D07QWW DRUGINKE AKLMUGFDGONMAA-UHFFFAOYSA-N D07QWW DRUGSMIL CCCC(CCC)N1CCN2C3=C1C=C(N=C3C(=N2)C4=C(C=C(C=C4)Cl)Cl)C D07QWW HIGHSTAT Phase 1 D07RUD DRUG__ID D07RUD D07RUD THERCLAS Antiviral Agents D07RUD DRUGTYPE Small molecular drug D07RUD DRUGINCH 1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 D07RUD DRUGINKE RJKFOVLPORLFTN-LEKSSAKUSA-N D07RUD DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C D07RUD HIGHSTAT Phase 1 Trial D07TWK DRUG__ID D07TWK D07TWK DRUGCOMP Cahaba Pharmaceuticals D07TWK DRUGTYPE Small molecular drug D07TWK DRUGINCH 1S/C13H17N6O7P/c1-18-11-7-5(10(14)17-18)2-19(12(7)16-4-15-11)13-9(21)8(20)6(26-13)3-25-27(22,23)24/h2,4,6,8-9,13,20-21H,3H2,1H3,(H2,14,17)(H2,22,23,24)/t6-,8-,9-,13-/m1/s1 D07TWK DRUGINKE URLYINUFLXOMHP-HTVVRFAVSA-N D07TWK DRUGSMIL CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)COP(=O)(O)O)O)O)C(=N1)N D07TWK HIGHSTAT Phase 1 D07XDQ DRUG__ID D07XDQ D07XDQ DRUGCOMP Boehringer Ingelheim Corp D07XDQ DRUGTYPE Small molecular drug D07XDQ DRUGINCH 1S/C27H31F6N3O/c1-34(10-9-20-15-22(26(28,29)30)17-23(16-20)27(31,32)33)25(37)24(21-5-3-2-4-6-21)36-13-11-35(12-14-36)18-19-7-8-19/h2-6,15-17,19,24H,7-14,18H2,1H3/t24-/m0/s1 D07XDQ DRUGINKE HUTHJVYJUPXHDF-DEOSSOPVSA-N D07XDQ DRUGSMIL CN(CCC1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)C(=O)C(C2=CC=CC=C2)N3CCN(CC3)CC4CC4 D07XDQ HIGHSTAT Phase 1 D07XUC DRUG__ID D07XUC D07XUC DRUGCOMP GlaxoSmithKline D07XUC DRUGTYPE Small molecule D07XUC DRUGINCH InChI=1S/C18H23N3O3/c1-12-4-3-5-16(13(12)2)24-15-6-8-21(9-7-15)11-14-10-17(22)20-18(23)19-14/h3-5,10,15H,6-9,11H2,1-2H3,(H2,19,20,22,23) D07XUC DRUGINKE AZOFJHATIPDIER-UHFFFAOYSA-N D07XUC DRUGSMIL CC1=C(C(=CC=C1)OC2CCN(CC2)CC3=CC(=O)NC(=O)N3)C D07XUC HIGHSTAT Phase 1 D08CNP DRUG__ID D08CNP D08CNP DRUGCOMP Ambit Biosciences D08CNP DRUGTYPE Small molecular drug D08CNP DRUGINCH 1S/C19H16FN5O/c1-11-10-16(25-24-11)22-18-14-4-2-3-5-15(14)21-19(23-18)17(26)12-6-8-13(20)9-7-12/h2-10,17,26H,1H3,(H2,21,22,23,24,25) D08CNP DRUGINKE DCRWIATZWHLIPN-UHFFFAOYSA-N D08CNP DRUGSMIL CC1=CC(=NN1)NC2=NC(=NC3=CC=CC=C32)C(C4=CC=C(C=C4)F)O D08CNP HIGHSTAT Phase 1 D08DFU DRUG__ID D08DFU D08DFU DRUGCOMP Chimerix D08DFU DRUGTYPE Small molecular drug D08DFU DRUGINCH 1S/C28H52N5O5P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-36-19-17-20-38-39(34,35)24-37-25(2)21-33-23-32-26-27(29)30-22-31-28(26)33/h22-23,25H,3-21,24H2,1-2H3,(H,34,35)(H2,29,30,31)/t25-/m1/s1 D08DFU DRUGINKE SCTJKHUUZLXJIP-RUZDIDTESA-N D08DFU DRUGSMIL CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)O D08DFU HIGHSTAT Phase 1 D08DGG DRUG__ID D08DGG D08DGG THERCLAS Antiviral Agents D08DGG DRUGTYPE Small molecular drug D08DGG DRUGINCH 1S/C34H32N4O4.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);/q-4;+4/b25-13-,26-13?,27-14?,28-15-,29-14-,30-15?,31-16?,32-16?; D08DGG DRUGINKE VWEYNEFKXXWVHZ-IBPJAKCHSA-N D08DGG DRUGSMIL CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=C(C(=C([N-]5)C=C1[N-]2)C=C)C)[N-]4)C=C)C)C)CCC(=O)O)CCC(=O)O.[Sn+4] D08DGG HIGHSTAT Phase 1 Trial D08DPN DRUG__ID D08DPN D08DPN DRUGCOMP GlaxoSmithKline plc D08DPN DRUGTYPE Small molecular drug D08DPN DRUGINCH 1S/C26H32N4O5S/c1-25(2,3)19-8-7-17(13-20(19)35-5)23(31)30-21(22-27-10-12-36-22)18(15-34-4)14-26(30,24(32)33)16-29-11-6-9-28-29/h6-13,18,21H,14-16H2,1-5H3,(H,32,33)/t18-,21-,26-/m1/s1 D08DPN DRUGINKE HLQXYDHLDZTWDW-KAWPREARSA-N D08DPN DRUGSMIL CC(C)(C)C1=C(C=C(C=C1)C(=O)N2C(C(CC2(CN3C=CC=N3)C(=O)O)COC)C4=NC=CS4)OC D08DPN HIGHSTAT Phase 1 D08EWE DRUG__ID D08EWE D08EWE THERCLAS Antiviral Agents D08EWE DRUGTYPE Small molecular drug D08EWE DRUGINCH 1S/C57H87N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-34,36,39-44,46-47,49,66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1 D08EWE DRUGINKE UUSZLLQJYRSZIS-LXNNNBEUSA-N D08EWE DRUGSMIL CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O D08EWE HIGHSTAT Phase 1 Trial D08HFW DRUG__ID D08HFW D08HFW DRUGCOMP Takeda D08HFW DRUGTYPE Small molecular drug D08HFW DRUGINCH 1S/C28H32N4O3S/c1-5-36(34,35)21-8-6-7-19(14-21)23-15-22(28(33)30-20-9-11-32(4)12-10-20)18(3)26-25(23)24-13-17(2)16-29-27(24)31-26/h6-8,13-16,20H,5,9-12H2,1-4H3,(H,29,31)(H,30,33) D08HFW DRUGINKE WKDACQVEJIVHMZ-UHFFFAOYSA-N D08HFW DRUGSMIL CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=C(N3)N=CC(=C4)C)C)C(=O)NC5CCN(CC5)C D08HFW HIGHSTAT Phase 1 D08LLM DRUG__ID D08LLM D08LLM DRUGCOMP Nippon Shinyaku Co Ltd D08LLM DRUGTYPE Small molecular drug D08LLM DRUGINCH 1S/C12H10FN3/c1-7-9(6-14)12(15)16-11(7)8-4-2-3-5-10(8)13/h2-5,16H,15H2,1H3 D08LLM DRUGINKE KVDWOQGDMAEJLM-UHFFFAOYSA-N D08LLM DRUGSMIL CC1=C(NC(=C1C#N)N)C2=CC=CC=C2F D08LLM HIGHSTAT Phase 1 D08MHM DRUG__ID D08MHM D08MHM DRUGCOMP Pfizer D08MHM DRUGTYPE Small molecular drug D08MHM DRUGINCH 1S/C25H30N8OS/c1-15-26-18-11-12-35-20(18)23(27-15)29-22-17-13-33(25(2,3)21(17)30-31-22)24(34)28-19(14-32(4)5)16-9-7-6-8-10-16/h6-12,19H,13-14H2,1-5H3,(H,28,34)(H2,26,27,29,30,31)/t19-/m1/s1 D08MHM DRUGINKE AYCPARAPKDAOEN-LJQANCHMSA-N D08MHM DRUGSMIL CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)NC(CN(C)C)C5=CC=CC=C5)SC=C2 D08MHM HIGHSTAT Phase 1 D08ONJ DRUG__ID D08ONJ D08ONJ DRUGCOMP Myriad Genetics Inc D08ONJ DRUGTYPE Small molecular drug D08ONJ DRUGINCH 1S/C22H25BrN6O4S/c1-12(30)21(31)28-5-2-13(3-6-28)4-7-29-20-18(19(24)25-10-26-20)27-22(29)34-17-9-16-15(8-14(17)23)32-11-33-16/h8-10,12-13,30H,2-7,11H2,1H3,(H2,24,25,26)/t12-/m0/s1 D08ONJ DRUGINKE CVBWTNHDKVVFMI-LBPRGKRZSA-N D08ONJ DRUGSMIL CC(C(=O)N1CCC(CC1)CCN2C3=NC=NC(=C3N=C2SC4=C(C=C5C(=C4)OCO5)Br)N)O D08ONJ HIGHSTAT Phase 1 D08OUV DRUG__ID D08OUV D08OUV DRUGCOMP Chiesi Farmaceutici SpA D08OUV DRUGTYPE Small molecular drug D08OUV DRUGINCH 1S/C30H33NO4/c1-33-25-12-7-23(8-13-25)29-21-35-30-20-24(32)9-14-27(30)28(29)19-22-5-10-26(11-6-22)34-18-17-31-15-3-2-4-16-31/h5-14,20,32H,2-4,15-19,21H2,1H3 D08OUV DRUGINKE ZUDXUNPSRMREOJ-UHFFFAOYSA-N D08OUV DRUGSMIL COC1=CC=C(C=C1)C2=C(C3=C(C=C(C=C3)O)OC2)CC4=CC=C(C=C4)OCCN5CCCCC5 D08OUV HIGHSTAT Phase 1 D08OVG DRUG__ID D08OVG D08OVG DRUGCOMP Chong Kun Dang Pharmaceutical Corp D08OVG DRUGTYPE Small molecular drug D08OVG DRUGINCH 1S/C26H28N6O5S.ClH/c1-14(2)22(27)25(34)31-26-30-18(11-38-26)15-6-7-17(19(8-15)32-13-28-12-29-32)23(33)16-9-20(35-3)24(37-5)21(10-16)36-4;/h6-14,22H,27H2,1-5H3,(H,30,31,34);1H/t22-;/m0./s1 D08OVG DRUGINKE FIAUXCMEQTWLQZ-FTBISJDPSA-N D08OVG DRUGSMIL CC(C)C(C(=O)NC1=NC(=CS1)C2=CC(=C(C=C2)C(=O)C3=CC(=C(C(=C3)OC)OC)OC)N4C=NC=N4)N.Cl D08OVG HIGHSTAT Phase 1 D08SIT DRUG__ID D08SIT D08SIT DRUGCOMP Niiki Pharma D08SIT DRUGTYPE Small molecular drug D08SIT DRUGINCH 1S/2C7H6N2.4ClH.Na.Ru/c2*1-2-4-7-6(3-1)5-8-9-7;;;;;;/h2*1-5H,(H,8,9);4*1H;;/q;;;;;;+1;+3/p-4 D08SIT DRUGINKE WVVOCRYXBTVDRN-UHFFFAOYSA-J D08SIT DRUGSMIL C1=CC=C2C(=C1)C=NN2.C1=CC=C2C(=C1)C=NN2.[Na+].Cl[Ru-](Cl)(Cl)Cl D08SIT HIGHSTAT Phase 1 D08WBJ DRUG__ID D08WBJ D08WBJ DRUGCOMP Kosan Biosci. D08WBJ DRUGTYPE Small molecular drug D08WBJ DRUGINCH 1S/C43H73NO13/c1-22(2)44(12)30-19-24(4)53-40(33(30)46)57-37-26(6)34(55-31-21-42(10,52-13)36(48)28(8)54-31)27(7)39(49)56-38(29-17-15-14-16-18-29)43(11,51)35(47)25(5)32(45)23(3)20-41(37,9)50/h14-18,22-28,30-38,40,45-48,50-51H,19-21H2,1-13H3/t23-,24?,25+,26+,27-,28?,30?,31?,32+,33?,34+,35-,36?,37-,38-,40?,41-,42?,43+/m1/s1 D08WBJ DRUGINKE BCKWPVFDVOGCTM-AFGVNUEFSA-N D08WBJ DRUGSMIL CC1CC(C(C(O1)OC2C(C(C(C(=O)OC(C(C(C(C(C(CC2(C)O)C)O)C)O)(C)O)C3=CC=CC=C3)C)OC4CC(C(C(O4)C)O)(C)OC)C)O)N(C)C(C)C D08WBJ HIGHSTAT Phase 1 D08XBF DRUG__ID D08XBF D08XBF DRUGCOMP BioAlliance Pharma SA D08XBF DRUGTYPE Small molecular drug D08XBF DRUGINCH 1S/CH6NO3P/c2-1-6(3,4)5/h1-2H2,(H2,3,4,5) D08XBF DRUGINKE MGRVRXRGTBOSHW-UHFFFAOYSA-N D08XBF DRUGSMIL C(N)P(=O)(O)O D08XBF HIGHSTAT Phase 1 D09DJC DRUG__ID D09DJC D09DJC DRUGCOMP Io Therapeutics D09DJC DRUGTYPE Small molecular drug D09DJC DRUGINCH 1S/C24H32O2/c1-16(13-21(25)26)7-8-18-15-24(18,6)17-9-10-19-20(14-17)23(4,5)12-11-22(19,2)3/h7-10,13-14,18H,11-12,15H2,1-6H3,(H,25,26)/b8-7+,16-13+/t18-,24-/m1/s1 D09DJC DRUGINKE BOOOLEGQBVUTKC-NVQSDHBMSA-N D09DJC DRUGSMIL CC(=CC(=O)O)C=CC1CC1(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C D09DJC HIGHSTAT Phase 1 D09ETH DRUG__ID D09ETH D09ETH DRUGCOMP Eisai Co Ltd D09ETH DRUGTYPE Small molecular drug D09ETH DRUGINCH 1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45) D09ETH DRUGINKE UQRCJCNVNUFYDX-UHFFFAOYSA-N D09ETH DRUGSMIL CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F D09ETH HIGHSTAT Phase 1 D09GEK DRUG__ID D09GEK D09GEK DRUGCOMP Astellas Pharma D09GEK DRUGTYPE Small molecular drug D09GEK DRUGINCH 1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) D09GEK DRUGINKE MGGBYMDAPCCKCT-UHFFFAOYSA-N D09GEK DRUGSMIL CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC D09GEK HIGHSTAT Phase 1 D09HFJ DRUG__ID D09HFJ D09HFJ DRUGCOMP Genzyme D09HFJ DRUGTYPE Small molecular drug D09HFJ DRUGINCH 1S/C13H12O6/c1-6(12(15)16)10-4-7-3-8(18-2)5-9(14)11(7)13(17)19-10/h3-6,14H,1-2H3,(H,15,16) D09HFJ DRUGINKE BPZCXUROMKDLGX-UHFFFAOYSA-N D09HFJ DRUGSMIL CC(C1=CC2=CC(=CC(=C2C(=O)O1)O)OC)C(=O)O D09HFJ HIGHSTAT Phase 1 D09JGK DRUG__ID D09JGK D09JGK DRUGCOMP Millennium Pharmaceuticals D09JGK DRUGTYPE Small molecular drug D09JGK DRUGINCH 1S/C27H34F3N7O3/c1-35-10-8-16(9-11-35)32-24(38)18-12-22(40-3)20(13-19(18)28)33-26-31-14-21-23(34-26)37(17-6-4-5-7-17)15-27(29,30)25(39)36(21)2/h12-14,16-17H,4-11,15H2,1-3H3,(H,32,38)(H,31,33,34) D09JGK DRUGINKE GWRSATNRNFYMDI-UHFFFAOYSA-N D09JGK DRUGSMIL CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC D09JGK HIGHSTAT Phase 1 D09PPU DRUG__ID D09PPU D09PPU DRUGCOMP Curis Lexington, MA D09PPU DRUGTYPE Small molecule immunotherapy D09PPU DRUGINCH 1S/C4H10N2.2ClH/c5-4-1-2-6-3-4;;/h4,6H,1-3,5H2;2*1H D09PPU DRUGINKE NJPNCMOUEXEGBL-UHFFFAOYSA-N D09PPU DRUGSMIL C1CNCC1N.Cl.Cl D09PPU HIGHSTAT Phase 1 D09PYZ DRUG__ID D09PYZ D09PYZ DRUGCOMP Merck D09PYZ DRUGTYPE Small molecular drug D09PYZ DRUGINCH 1S/C14H9FN4O/c1-19-5-4-8-6-9(7-16-12(8)19)13-17-10-2-3-11(15)18-14(10)20-13/h2-7H,1H3 D09PYZ DRUGINKE WYQHKOHCTMNFAU-UHFFFAOYSA-N D09PYZ DRUGSMIL CN1C=CC2=CC(=CN=C21)C3=NC4=C(O3)N=C(C=C4)F D09PYZ HIGHSTAT Phase 1 D09QKI DRUG__ID D09QKI D09QKI DRUGCOMP Pharmacor Inc D09QKI DRUGTYPE Small molecular drug D09QKI DRUGINCH 1S/C33H44N4O6S/c1-24(2)22-37(44(41,42)29-19-17-27(34)18-20-29)28(23-38)16-10-11-21-35-32(39)31(36-33(40)43-3)30(25-12-6-4-7-13-25)26-14-8-5-9-15-26/h4-9,12-15,17-20,24,28,30-31,38H,10-11,16,21-23,34H2,1-3H3,(H,35,39)(H,36,40)/t28-,31-/m0/s1 D09QKI DRUGINKE QAHLFXYLXBBCPS-IZEXYCQBSA-N D09QKI DRUGSMIL CC(C)CN(C(CCCCNC(=O)C(C(C1=CC=CC=C1)C2=CC=CC=C2)NC(=O)OC)CO)S(=O)(=O)C3=CC=C(C=C3)N D09QKI HIGHSTAT Phase 1 D09SFV DRUG__ID D09SFV D09SFV DRUGCOMP Genentech D09SFV DRUGTYPE Small molecular drug D09SFV DRUGINCH 1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2 D09SFV DRUGINKE CZQHHVNHHHRRDU-UHFFFAOYSA-N D09SFV DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4 D09SFV HIGHSTAT Phase 1 D09TLE DRUG__ID D09TLE D09TLE DRUGCOMP Chroma Therapeutics Ltd D09TLE DRUGTYPE Small molecular drug D09TLE DRUGINCH 1S/C28H37N3O5/c32-25(14-6-1-2-7-15-26(33)31-35)30-23-18-16-21(17-19-23)20-29-27(22-10-4-3-5-11-22)28(34)36-24-12-8-9-13-24/h3-5,10-11,16-19,24,27,29,35H,1-2,6-9,12-15,20H2,(H,30,32)(H,31,33)/t27-/m0/s1 D09TLE DRUGINKE GLNWREBYRLDPQP-MHZLTWQESA-N D09TLE DRUGSMIL C1CCC(C1)OC(=O)C(C2=CC=CC=C2)NCC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO D09TLE HIGHSTAT Phase 1 D09VBE DRUG__ID D09VBE D09VBE DRUGCOMP Novartis Pharmaceuticals; Portola Pharmaceuticals D09VBE DRUGTYPE Small molecular drug D09VBE DRUGINCH 1S/C20H15ClFN5O5S2/c1-23-15-9-14-12(8-13(15)22)18(28)27(20(30)25-14)11-4-2-10(3-5-11)24-19(29)26-34(31,32)17-7-6-16(21)33-17/h2-9,23H,1H3,(H,25,30)(H2,24,26,29) D09VBE DRUGINKE LGSDFTPAICUONK-UHFFFAOYSA-N D09VBE DRUGSMIL CNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)(=O)C4=CC=C(S4)Cl)F D09VBE HIGHSTAT Phase 1 D09VWI DRUG__ID D09VWI D09VWI DRUGCOMP Biorex Research and Development Co D09VWI DRUGTYPE Small molecular drug D09VWI DRUGINCH 1S/C14H20N4O/c1-2-7-18(8-3-1)10-13-11-19-17-14(16-13)12-5-4-6-15-9-12/h4-6,9,13H,1-3,7-8,10-11H2,(H,16,17) D09VWI DRUGINKE QWVRTSZDKPRPDF-UHFFFAOYSA-N D09VWI DRUGSMIL C1CCN(CC1)CC2CONC(=N2)C3=CN=CC=C3 D09VWI HIGHSTAT Phase 1 D09WGH DRUG__ID D09WGH D09WGH DRUGCOMP State University of New York D09WGH DRUGTYPE Small molecular drug D09WGH DRUGINCH 1S/C9H11IN2O4/c10-5-2-11-9(15)12(3-5)8-1-6(14)7(4-13)16-8/h2-3,6-8,13-14H,1,4H2/t6-,7+,8+/m0/s1 D09WGH DRUGINKE XIJXHOVKJAXCGJ-XLPZGREQSA-N D09WGH DRUGSMIL C1C(C(OC1N2C=C(C=NC2=O)I)CO)O D09WGH HIGHSTAT Phase 1 D09ZLZ DRUG__ID D09ZLZ D09ZLZ DRUGCOMP Radius Health Inc D09ZLZ DRUGTYPE Small molecular drug D09ZLZ DRUGINCH 1S/C20H16ClN5O2/c1-11-16(8-7-15(10-23)17(11)21)24-18(12(2)27)20-26-25-19(28-20)14-5-3-13(9-22)4-6-14/h3-8,12,18,24,27H,1-2H3/t12-,18+/m0/s1 D09ZLZ DRUGINKE XMBUPPIEVAFYHO-KPZWWZAWSA-N D09ZLZ DRUGSMIL CC1=C(C=CC(=C1Cl)C#N)NC(C2=NN=C(O2)C3=CC=C(C=C3)C#N)C(C)O D09ZLZ HIGHSTAT Phase 1 D09ZVC DRUG__ID D09ZVC D09ZVC DRUGCOMP Wyeth D09ZVC DRUGTYPE Small molecular drug D09ZVC DRUGINCH 1S/C9H8ClF6NO3S2/c10-5-1-2-6(21-5)22(19,20)17-4(3-18)7(8(11,12)13)9(14,15)16/h1-2,4,7,17-18H,3H2/t4-/m1/s1 D09ZVC DRUGINKE PSXOKXJMVRSARX-SCSAIBSYSA-N D09ZVC DRUGSMIL C1=C(SC(=C1)Cl)S(=O)(=O)NC(CO)C(C(F)(F)F)C(F)(F)F D09ZVC HIGHSTAT Phase 1 D0A1LS DRUG__ID D0A1LS D0A1LS DRUGCOMP Genzyme Corp D0A1LS DRUGTYPE Small molecular drug D0A1LS DRUGINCH 1S/C22H21N3O5/c1-23-4-5-25-21-14-8-19-20(30-11-29-19)9-16(14)24-10-15(21)12-6-17(27-2)18(28-3)7-13(12)22(25)26/h6-10,23H,4-5,11H2,1-3H3 D0A1LS DRUGINKE BAORCAMWLWRZQG-UHFFFAOYSA-N D0A1LS DRUGSMIL CNCCN1C2=C(C=NC3=CC4=C(C=C32)OCO4)C5=CC(=C(C=C5C1=O)OC)OC D0A1LS HIGHSTAT Phase 1 D0A7KI DRUG__ID D0A7KI D0A7KI DRUGCOMP Ferrer Internacional SA D0A7KI DRUGTYPE Small molecular drug D0A7KI DRUGINCH 1S/C25H25FN2O5/c26-18-2-4-20-23(12-18)33-27-24(20)16-6-9-28(10-7-16)8-1-11-31-19-3-5-21-22(13-19)32-15-17(14-29)25(21)30/h2-5,12-13,15-16,29H,1,6-11,14H2 D0A7KI DRUGINKE ICAXEUYZCLRXKY-UHFFFAOYSA-N D0A7KI DRUGSMIL C1CN(CCC1C2=NOC3=C2C=CC(=C3)F)CCCOC4=CC5=C(C=C4)C(=O)C(=CO5)CO D0A7KI HIGHSTAT Phase 1 D0AX9S DRUG__ID D0AX9S D0AX9S DRUGCOMP Ligand Pharmaceuticals Inc D0AX9S DRUGTYPE Small molecular drug D0AX9S DRUGINCH 1S/C31H30N2O5/c1-21(19-29(34)24-9-5-3-6-10-24)32-28(31(35)36)20-23-13-15-26(16-14-23)37-18-17-27-22(2)38-30(33-27)25-11-7-4-8-12-25/h3-16,19,28,32H,17-18,20H2,1-2H3,(H,35,36)/b21-19-/t28-/m0/s1 D0AX9S DRUGINKE GGUVRMBIEPYOKL-WMVCGJOFSA-N D0AX9S DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC(C(=O)O)NC(=CC(=O)C4=CC=CC=C4)C D0AX9S HIGHSTAT Phase 1 D0B0ZR DRUG__ID D0B0ZR D0B0ZR DRUGCOMP Institute of Materia Medica Chinese Academy of Medical Science D0B0ZR DRUGTYPE Small molecular drug D0B0ZR DRUGINCH 1S/C51H58N2O13/c1-26-17-16-18-27(2)50(61)53-40-35(25-52-66-48(33-19-12-10-13-20-33)34-21-14-11-15-22-34)44(58)37-38(45(40)59)43(57)31(6)47-39(37)49(60)51(8,65-47)63-24-23-36(62-9)28(3)46(64-32(7)54)30(5)42(56)29(4)41(26)55/h10-26,28-30,36,41-42,46,48,55-59H,1-9H3,(H,53,61)/b17-16+,24-23+,27-18-,52-25+/t26-,28+,29+,30+,36-,41-,42+,46+,51-/m0/s1 D0B0ZR DRUGINKE ZGOGYVJXKPGNCZ-SDDCJGPJSA-N D0B0ZR DRUGSMIL CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NOC(C5=CC=CC=C5)C6=CC=CC=C6)C D0B0ZR HIGHSTAT Phase 1 D0B3GF DRUG__ID D0B3GF D0B3GF DRUGCOMP Johnson & Johnson Pharmaceutical D0B3GF DRUGTYPE Small molecular drug D0B3GF DRUGINCH 1S/C21H20N4/c1-2-4-21-20(3-1)16(15-24-21)9-14-23-17-5-7-18(8-6-17)25-19-10-12-22-13-11-19/h1-8,10-13,15,23-24H,9,14H2,(H,22,25) D0B3GF DRUGINKE CEGSUKYESLWKJP-UHFFFAOYSA-N D0B3GF DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4 D0B3GF HIGHSTAT Phase 1 D0B5RZ DRUG__ID D0B5RZ D0B5RZ DRUGCOMP Gilead Sciences Inc D0B5RZ DRUGTYPE Small molecular drug D0B5RZ DRUGINCH 1S/C29H37N6O9P/c1-17(2)26(36)42-24-22(43-29(15-30,28(24,6)38)23-13-12-21-25(31)32-16-33-35(21)23)14-40-45(39,44-20-10-8-7-9-11-20)34-19(5)27(37)41-18(3)4/h7-13,16-19,22,24,38H,14H2,1-6H3,(H,34,39)(H2,31,32,33)/t19-,22+,24+,28+,29-,45?/m0/s1 D0B5RZ DRUGINKE YAAQYJCOIFNMKX-CVANIGNKSA-N D0B5RZ DRUGSMIL CC(C)C(=O)OC1C(OC(C1(C)O)(C#N)C2=CC=C3N2N=CN=C3N)COP(=O)(NC(C)C(=O)OC(C)C)OC4=CC=CC=C4 D0B5RZ HIGHSTAT Phase 1 D0B9MR DRUG__ID D0B9MR D0B9MR DRUGCOMP GlaxoSmithKline D0B9MR DRUGTYPE Small molecular drug D0B9MR DRUGINCH 1S/C20H23ClN6O2/c1-12(2)27-19(9-13(3)25-27)24-18-10-17(15(21)11-22-18)23-16-8-6-5-7-14(16)20(28)26-29-4/h5-12H,1-4H3,(H,26,28)(H2,22,23,24) D0B9MR DRUGINKE BVAHPPKGOOJSPU-UHFFFAOYSA-N D0B9MR DRUGSMIL CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C D0B9MR HIGHSTAT Phase 1 D0C1WL DRUG__ID D0C1WL D0C1WL DRUGCOMP Merck & Co Inc D0C1WL DRUGTYPE Small molecular drug D0C1WL DRUGINCH 1S/C9H19NO3S.C2HF6NO4S2/c11-14(12,13)9-5-4-8-10-6-2-1-3-7-10;3-1(4,5)14(10,11)9-15(12,13)2(6,7)8/h1-9H2,(H,11,12,13);9H D0C1WL DRUGINKE IMVWFEMFPIUJGS-UHFFFAOYSA-N D0C1WL DRUGSMIL C1CCN(CC1)CCCCS(=O)(=O)O.C(F)(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F D0C1WL HIGHSTAT Phase 1 D0C1ZO DRUG__ID D0C1ZO D0C1ZO DRUGCOMP AstraZeneca D0C1ZO DRUGTYPE Small molecular drug D0C1ZO DRUGINCH 1S/C26H30N4O4/c1-18-3-8-21(30-11-9-28(2)10-12-30)25-24(18)22(31)17-23(34-25)26(32)27-19-4-6-20(7-5-19)29-13-15-33-16-14-29/h3-8,17H,9-16H2,1-2H3,(H,27,32)/i2T3 D0C1ZO DRUGINKE JKPWOPNZKYPRPZ-BHTRQJOGSA-N D0C1ZO DRUGSMIL CC1=C2C(=O)C=C(OC2=C(C=C1)N3CCN(CC3)C)C(=O)NC4=CC=C(C=C4)N5CCOCC5 D0C1ZO HIGHSTAT Phase 1 D0C2HI DRUG__ID D0C2HI D0C2HI DRUGCOMP Nektar/Regeneron D0C2HI DRUGTYPE Small molecular drug D0C2HI DRUGINCH 1S/C21H21ClN2O/c1-14(25)24-11-8-15(9-12-24)20-19-7-6-18(22)13-17(19)5-4-16-3-2-10-23-21(16)20/h2-3,6-7,10,13H,4-5,8-9,11-12H2,1H3 D0C2HI DRUGINKE FLTBEMVEAFMWDD-UHFFFAOYSA-N D0C2HI DRUGSMIL CC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1 D0C2HI HIGHSTAT Phase 1 D0C7WO DRUG__ID D0C7WO D0C7WO DRUGCOMP GlaxoSmithKline D0C7WO DRUGTYPE Small molecular drug D0C7WO DRUGINCH 1S/C22H27N5OS/c23-19-9-3-1-7-17(19)22(28)24-11-5-6-12-26-13-15-27(16-14-26)21-18-8-2-4-10-20(18)29-25-21/h1-4,7-10H,5-6,11-16,23H2,(H,24,28) D0C7WO DRUGINKE GMDXHLCLNHCEIC-UHFFFAOYSA-N D0C7WO DRUGSMIL C1CN(CCN1CCCCNC(=O)C2=CC=CC=C2N)C3=NSC4=CC=CC=C43 D0C7WO HIGHSTAT Phase 1 D0CE8J DRUG__ID D0CE8J D0CE8J DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D0CE8J DRUGTYPE Small molecular drug D0CE8J DRUGINCH 1S/C13H15F2N3O3S/c1-9(22(2,20)21)13(19,6-18-8-16-7-17-18)11-4-3-10(14)5-12(11)15/h3-5,7-9,19H,6H2,1-2H3/t9-,13-/m1/s1 D0CE8J DRUGINKE HFGZFHCWKKQGIS-NOZJJQNGSA-N D0CE8J DRUGSMIL CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)S(=O)(=O)C D0CE8J HIGHSTAT Phase 1 D0CI3Z DRUG__ID D0CI3Z D0CI3Z DRUGCOMP AstraZeneca D0CI3Z DRUGTYPE Small molecule D0CI3Z DRUGINCH InChI=1S/C30H41FN2O6/c1-29(9-4-10-29)16-32-27(35)24-17-5-6-18(13-17)25(24)33-26(34)20-14-23(21(31)15-22(20)38-3)39-19-7-11-30(2,12-8-19)28(36)37/h14-15,17-19,24-25H,4-13,16H2,1-3H3,(H,32,35)(H,33,34)(H,36,37)/t17-,18+,19?,24+,25-,30?/m1/s1 D0CI3Z DRUGINKE LYUYYIGCZIZIGF-SRHODNEWSA-N D0CI3Z DRUGSMIL CC1(CCC1)CNC(=O)C2C3CCC(C3)C2NC(=O)C4=CC(=C(C=C4OC)F)OC5CCC(CC5)(C)C(=O)O D0CI3Z HIGHSTAT Phase 1 D0D2WX DRUG__ID D0D2WX D0D2WX DRUGCOMP GlaxoSmithKline D0D2WX DRUGTYPE Combination drug (small molecular drug) D0D2WX DRUGINCH 1S/C21H27NO3/c1-4-22(5-2)17(3)16-25-20(23)21(24,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,24H,4-5,16H2,1-3H3/p+1/t17-/m1/s1 D0D2WX DRUGINKE DULUETYTNBOZNG-QGZVFWFLSA-O D0D2WX DRUGSMIL CC[NH+](CC)C(C)COC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O D0D2WX HIGHSTAT Phase 1 D0D9LB DRUG__ID D0D9LB D0D9LB DRUGCOMP Boehringer Ingelheim D0D9LB DRUGTYPE Small molecular drug D0D9LB DRUGINCH 1S/C23H27N5O2/c1-23(2,3)28-22(26-16-24)27-19-10-6-8-17(14-19)20(11-4-5-12-21(29)30)18-9-7-13-25-15-18/h6-11,13-15H,4-5,12H2,1-3H3,(H,29,30)(H2,26,27,28)/b20-11+ D0D9LB DRUGINKE XUTLOCQNGLJNSA-RGVLZGJSSA-N D0D9LB DRUGSMIL CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)C(=CCCCC(=O)O)C2=CN=CC=C2 D0D9LB HIGHSTAT Phase 1 D0E5XA DRUG__ID D0E5XA D0E5XA THERCLAS Anticancer Agents D0E5XA DRUGTYPE Small molecular drug D0E5XA DRUGINCH 1S/C24H30FN7O/c1-14-11-17(5-6-19(14)32-9-7-31(2)8-10-32)28-24-27-13-18(25)23(30-24)29-21-16-4-3-15(12-16)20(21)22(26)33/h3-6,11,13,15-16,20-21H,7-10,12H2,1-2H3,(H2,26,33)(H2,27,28,29,30)/t15-,16+,20+,21-/m1/s1 D0E5XA DRUGINKE KSOVGRCOLZZTPF-QMKUDKLTSA-N D0E5XA DRUGSMIL CC1=C(C=CC(=C1)NC2=NC=C(C(=N2)NC3C4CC(C3C(=O)N)C=C4)F)N5CCN(CC5)C D0E5XA HIGHSTAT Phase 1 D0EJ3B DRUG__ID D0EJ3B D0EJ3B DRUGCOMP Amgen Thousand D0EJ3B DRUGTYPE Small molecular drug D0EJ3B DRUGINCH 1S/C28H21N7OS/c1-17-15-24(37-16-17)25-20-5-2-3-6-21(20)26(35-34-25)32-18-8-10-19(11-9-18)36-27-22(7-4-13-30-27)23-12-14-31-28(29)33-23/h2-16H,1H3,(H,32,35)(H2,29,31,33) D0EJ3B DRUGINKE IVUGFMLRJOCGAS-UHFFFAOYSA-N D0EJ3B DRUGSMIL CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N D0EJ3B HIGHSTAT Phase 1 D0EK1C DRUG__ID D0EK1C D0EK1C DRUGCOMP PharmEste SRL D0EK1C DRUGTYPE Small molecular drug D0EK1C DRUGINCH 1S/C16H26N2O.ClH/c1-11(2)18(12(3)4)10-15(19)17-16-13(5)8-7-9-14(16)6;/h7-9,11-12H,10H2,1-6H3,(H,17,19);1H D0EK1C DRUGINKE OJTPHJHZGWBMET-UHFFFAOYSA-N D0EK1C DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C[NH+](C(C)C)C(C)C.[Cl-] D0EK1C HIGHSTAT Phase 1 D0EM4S DRUG__ID D0EM4S D0EM4S DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D0EM4S DRUGTYPE Small molecular drug D0EM4S DRUGINCH 1S/C25H21F3N2O/c1-24(2,31)20-6-4-3-5-19(20)17-10-13-21-22(15-17)30-23(29-21)14-9-16-7-11-18(12-8-16)25(26,27)28/h3-15,31H,1-2H3,(H,29,30)/b14-9+ D0EM4S DRUGINKE ORDHXXHTBUZRCN-NTEUORMPSA-N D0EM4S DRUGSMIL CC(C)(C1=CC=CC=C1C2=CC3=C(C=C2)N=C(N3)C=CC4=CC=C(C=C4)C(F)(F)F)O D0EM4S HIGHSTAT Phase 1 D0EO2C DRUG__ID D0EO2C D0EO2C DRUGCOMP Eli Lilly & Co D0EO2C DRUGTYPE Small molecular drug D0EO2C DRUGINCH 1S/C33H33NO3/c1-2-5-29(22-32(35)36)27-12-14-30(15-13-27)37-24-26-10-8-25(9-11-26)23-34-20-18-33(19-21-34)17-16-28-6-3-4-7-31(28)33/h3-4,6-17,29H,18-24H2,1H3,(H,35,36)/t29-/m0/s1 D0EO2C DRUGINKE FHRWHNJJQGSCQC-LJAQVGFWSA-N D0EO2C DRUGSMIL CC#CC(CC(=O)O)C1=CC=C(C=C1)OCC2=CC=C(C=C2)CN3CCC4(CC3)C=CC5=CC=CC=C45 D0EO2C HIGHSTAT Phase 1 D0EY0A DRUG__ID D0EY0A D0EY0A DRUGCOMP AstraZeneca D0EY0A DRUGTYPE Small molecular drug D0EY0A DRUGINCH 1S/C21H25N3O3/c1-12-19(24-20(21(22)27)13(2)23-12)17-9-7-16(8-10-17)15-5-3-14(4-6-15)11-18(25)26/h7-10,14-15H,3-6,11H2,1-2H3,(H2,22,27)(H,25,26) D0EY0A DRUGINKE YXFNPRHZMOGREC-UHFFFAOYSA-N D0EY0A DRUGSMIL CC1=C(N=C(C(=N1)C)C(=O)N)C2=CC=C(C=C2)C3CCC(CC3)CC(=O)O D0EY0A HIGHSTAT Phase 1 D0F0FZ DRUG__ID D0F0FZ D0F0FZ DRUGCOMP Drais Pharmaceuticals D0F0FZ DRUGTYPE Small molecular drug D0F0FZ DRUGINCH 1S/C17H18N4O3/c1-20(2)6-7-21-15(22)12-5-3-4-10-8-11(19-17(18)24)9-13(14(10)12)16(21)23/h3-5,8-9H,6-7H2,1-2H3,(H3,18,19,24) D0F0FZ DRUGINKE WCKZRLOUKYFJDY-UHFFFAOYSA-N D0F0FZ DRUGSMIL CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)NC(=O)N D0F0FZ HIGHSTAT Phase 1 D0F0JJ DRUG__ID D0F0JJ D0F0JJ DRUGCOMP Eisai D0F0JJ DRUGTYPE Small molecular drug D0F0JJ DRUGINCH 1S/C25H26FN3O2/c1-17-15-28(16-27-17)23-11-6-19(14-24(23)31-3)13-21-5-4-12-29(25(21)30)18(2)20-7-9-22(26)10-8-20/h6-11,13-16,18H,4-5,12H2,1-3H3/b21-13+/t18-/m0/s1 D0F0JJ DRUGINKE PUOAETJYKQITMO-LANLRWRYSA-N D0F0JJ DRUGSMIL CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3CCCN(C3=O)C(C)C4=CC=C(C=C4)F)OC D0F0JJ HIGHSTAT Phase 1 D0F2JY DRUG__ID D0F2JY D0F2JY DRUGCOMP Eli Lilly & Co D0F2JY DRUGTYPE Small molecular drug D0F2JY DRUGINCH 1S/C17H25F2N3O5/c1-3-5-10(6-4-2)14(25)20-12-7-8-22(16(26)21-12)15-17(18,19)13(24)11(9-23)27-15/h7-8,10-11,13,15,23-24H,3-6,9H2,1-2H3,(H,20,21,25,26)/t11-,13-,15-/m1/s1 D0F2JY DRUGINKE MEOYFIHNRBNEPI-UXIGCNINSA-N D0F2JY DRUGSMIL CCCC(CCC)C(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)(F)F D0F2JY HIGHSTAT Phase 1 D0F6ZT DRUG__ID D0F6ZT D0F6ZT DRUGCOMP Gliknik D0F6ZT DRUGTYPE Small molecular drug D0F6ZT DRUGINCH 1S/C13H18N2O3/c1-13(2,3)18-12(16)14-9-11(15-17)10-7-5-4-6-8-10/h4-8,17H,9H2,1-3H3,(H,14,16)/b15-11+ D0F6ZT DRUGINKE OYCHXXYYNVNOEE-RVDMUPIBSA-N D0F6ZT DRUGSMIL CC(C)(C)OC(=O)NCC(=NO)C1=CC=CC=C1 D0F6ZT HIGHSTAT Phase 1 D0FD6D DRUG__ID D0FD6D D0FD6D DRUGCOMP Cephalon D0FD6D DRUGTYPE Small molecular drug D0FD6D DRUGINCH 1S/C28H27N7O/c1-15(2)13-35-22-8-5-16(32-28-29-9-4-10-30-28)11-18(22)24-19-12-31-27(36)25(19)23-17(26(24)35)6-7-21-20(23)14-34(3)33-21/h4-5,8-11,14-15H,6-7,12-13H2,1-3H3,(H,31,36)(H,29,30,32) D0FD6D DRUGINKE AEULIVPVIDOLIN-UHFFFAOYSA-N D0FD6D DRUGSMIL CC(C)CN1C2=C(C=C(C=C2)NC3=NC=CC=N3)C4=C1C5=C(C6=CN(N=C6CC5)C)C7=C4CNC7=O D0FD6D HIGHSTAT Phase 1 D0FM7Z DRUG__ID D0FM7Z D0FM7Z DRUGCOMP Tel Aviv University D0FM7Z DRUGTYPE Small molecular drug D0FM7Z DRUGINCH 1S/C23H28N2O.ClH/c1-25(23(26)13-6-16-24)17-7-12-22-20-10-4-2-8-18(20)14-15-19-9-3-5-11-21(19)22;/h2-5,8-12H,6-7,13-17,24H2,1H3;1H D0FM7Z DRUGINKE DEKZAWRGNGHZKY-UHFFFAOYSA-N D0FM7Z DRUGSMIL CN(CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31)C(=O)CCCN.Cl D0FM7Z HIGHSTAT Phase 1 D0FP0D DRUG__ID D0FP0D D0FP0D DRUGCOMP AstraZeneca plc D0FP0D DRUGTYPE Small molecular drug D0FP0D DRUGINCH 1S/C21H36N4O3/c1-3-28-20(27)23-14-10-21(2,11-15-23)24-12-8-16(9-13-24)25-18-7-5-4-6-17(18)22-19(25)26/h16-18H,3-15H2,1-2H3,(H,22,26)/t17-,18-/m0/s1 D0FP0D DRUGINKE IVJDEIANCSDDAO-ROUUACIJSA-N D0FP0D DRUGSMIL CCOC(=O)N1CCC(CC1)(C)N2CCC(CC2)N3C4CCCCC4NC3=O D0FP0D HIGHSTAT Phase 1 D0G1TY DRUG__ID D0G1TY D0G1TY DRUGCOMP Coley Pharma. D0G1TY DRUGTYPE Small molecular drug D0G1TY DRUGINCH 1S/C24H32N6O2/c1-28(2)11-10-25-23-19-16-21(31-3)22(32-4)17-20(19)26-24(27-23)30-14-12-29(13-15-30)18-8-6-5-7-9-18/h5-9,16-17H,10-15H2,1-4H3,(H,25,26,27) D0G1TY DRUGINKE NRDOWTUUBQCUMC-UHFFFAOYSA-N D0G1TY DRUGSMIL CN(C)CCNC1=NC(=NC2=CC(=C(C=C21)OC)OC)N3CCN(CC3)C4=CC=CC=C4 D0G1TY HIGHSTAT Phase 1 D0G1YO DRUG__ID D0G1YO D0G1YO DRUGCOMP GlaxoSmithKline D0G1YO DRUGTYPE Small molecular drug D0G1YO DRUGINCH 1S/C24H20F2N4/c25-22-11-19(15-6-3-7-18(8-15)24-28-14-29-30-24)12-23(26)21(22)13-27-20-9-16-4-1-2-5-17(16)10-20/h1-8,11-12,14,20,27H,9-10,13H2,(H,28,29,30) D0G1YO DRUGINKE WIEDUMBCZQRGSY-UHFFFAOYSA-N D0G1YO DRUGSMIL C1C(CC2=CC=CC=C21)NCC3=C(C=C(C=C3F)C4=CC(=CC=C4)C5=NC=NN5)F D0G1YO HIGHSTAT Phase 1 D0G3MN DRUG__ID D0G3MN D0G3MN DRUGCOMP GlaxoSmithKline D0G3MN DRUGTYPE Small molecular drug D0G3MN DRUGINCH 1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30) D0G3MN DRUGINKE XTKLTGBKIDQGQL-UHFFFAOYSA-N D0G3MN DRUGSMIL CC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C(C=C(C=C32)N4CCOCC4)C(=O)O)C D0G3MN HIGHSTAT Phase 1 D0G3ZX DRUG__ID D0G3ZX D0G3ZX DRUGCOMP OMRIX Biopharmaceuticals SA D0G3ZX DRUGTYPE Small molecular drug D0G3ZX DRUGINCH 1S/C2H7N5/c3-1(4)7-2(5)6/h(H7,3,4,5,6,7) D0G3ZX DRUGINKE XNCOSPRUTUOJCJ-UHFFFAOYSA-N D0G3ZX DRUGSMIL C(=NC(=N)N)(N)N D0G3ZX HIGHSTAT Phase 1 D0G4ES DRUG__ID D0G4ES D0G4ES DRUGCOMP West Virginia University D0G4ES DRUGTYPE Small molecular drug D0G4ES DRUGINCH 1S/C38H42N2O6/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)17-23-7-10-27(11-8-23)45-33-19-24(9-12-31(33)41-3)18-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30-/m0/s1 D0G4ES DRUGINKE WVTKBKWTSCPRNU-KYJUHHDHSA-N D0G4ES DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC D0G4ES HIGHSTAT Phase 1 D0GE5B DRUG__ID D0GE5B D0GE5B DRUGCOMP Repligen D0GE5B DRUGTYPE Small molecular drug D0GE5B DRUGINCH 1S/C20H25N3O2/c1-15-10-12-16(13-11-15)20(25)22-14-6-2-3-9-19(24)23-18-8-5-4-7-17(18)21/h4-5,7-8,10-13H,2-3,6,9,14,21H2,1H3,(H,22,25)(H,23,24) D0GE5B DRUGINKE VOPDXHFYDJAYNS-UHFFFAOYSA-N D0GE5B DRUGSMIL CC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NC2=CC=CC=C2N D0GE5B HIGHSTAT Phase 1 D0GS2W DRUG__ID D0GS2W D0GS2W DRUGCOMP Chengdu Kanghong Pharmaceutical Group Co Ltd D0GS2W DRUGTYPE Small molecular drug D0GS2W DRUGINCH 1S/C38H41BrN2O6/c1-40-15-13-24-20-31(43-4)33-21-27(24)28(40)17-22-7-10-25(11-8-22)46-32-19-23(9-12-30(32)42-3)18-29-34-26(14-16-41(29)2)35(39)37(44-5)38(45-6)36(34)47-33/h7-12,19-21,28-29H,13-18H2,1-6H3/t28-,29-/m0/s1 D0GS2W DRUGINKE ANJMFZGRGHQXMA-VMPREFPWSA-N D0GS2W DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(CCN6C)C(=C(C(=C7O3)OC)OC)Br)OC)OC D0GS2W HIGHSTAT Phase 1 D0H2DS DRUG__ID D0H2DS D0H2DS DRUGCOMP IGI Inc D0H2DS DRUGTYPE Small molecular drug D0H2DS DRUGINCH 1S/C156H243N47O40S2/c1-80(2)57-106(189-148(237)114(67-120(162)207)196-146(235)112(65-90-72-169-78-176-90)195-139(228)103(48-55-244-13)179-129(218)93(160)61-86-31-17-15-18-32-86)130(219)174-74-121(208)178-95(37-23-26-50-157)131(220)194-111(64-89-71-168-77-175-89)145(234)192-109(60-83(7)8)143(232)200-118(76-205)152(241)201-117(75-204)151(240)186-104(49-56-245-14)138(227)184-101(43-46-122(209)210)135(224)182-99(41-30-54-172-156(166)167)140(229)202-126(84(9)10)153(242)187-102(44-47-123(211)212)137(226)193-110(63-88-70-173-94-36-22-21-35-92(88)94)144(233)191-108(59-82(5)6)141(230)183-98(40-29-53-171-155(164)165)133(222)180-96(38-24-27-51-158)132(221)181-97(39-25-28-52-159)134(223)190-107(58-81(3)4)142(231)185-100(42-45-119(161)206)136(225)197-116(69-125(215)216)150(239)203-127(85(11)12)154(243)199-113(66-91-73-170-79-177-91)147(236)198-115(68-124(213)214)149(238)188-105(128(163)217)62-87-33-19-16-20-34-87/h15-22,31-36,70-73,77-85,93,95-118,126-127,173,204-205H,23-30,37-69,74-76,157-160H2,1-14H3,(H2,161,206)(H2,162,207)(H2,163,217)(H,168,175)(H,169,176)(H,170,177)(H,174,219)(H,178,208)(H,179,218)(H,180,222)(H,181,221)(H,182,224)(H,183,230)(H,184,227)(H,185,231)(H,186,240)(H,187,242)(H,188,238)(H,189,237)(H,190,223)(H,191,233)(H,192,234)(H,193,226)(H,194,220)(H,195,228)(H,196,235)(H,197,225)(H,198,236)(H,199,243)(H,200,232)(H,201,241)(H,202,229)(H,203,239)(H,209,210)(H,211,212)(H,213,214)(H,215,216)(H4,164,165,171)(H4,166,167,172)/t93-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,126-,127-/m0/s1 D0H2DS DRUGINKE YKGRXSLQYRREKO-DFOPOJAZSA-N D0H2DS DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(CCSC)NC(=O)C(CC7=CC=CC=C7)N D0H2DS HIGHSTAT Phase 1 D0H7AR DRUG__ID D0H7AR D0H7AR DRUGCOMP MIKA Pharma GmbH D0H7AR DRUGTYPE Small molecular drug D0H7AR DRUGINCH 1S/C25H25N3O/c29-25(27-16-20-15-26-23-12-4-3-11-22(20)23)24-13-6-14-28(24)17-19-9-5-8-18-7-1-2-10-21(18)19/h1-5,7-12,15,24,26H,6,13-14,16-17H2,(H,27,29)/t24-/m0/s1 D0H7AR DRUGINKE CUWTVICBYHBSOX-DEOSSOPVSA-N D0H7AR DRUGSMIL C1CC(N(C1)CC2=CC=CC3=CC=CC=C32)C(=O)NCC4=CNC5=CC=CC=C54 D0H7AR HIGHSTAT Phase 1 D0H9HT DRUG__ID D0H9HT D0H9HT DRUGCOMP Takeda D0H9HT DRUGTYPE Small molecular drug D0H9HT DRUGINCH 1S/C18H16N6S2/c1-24-16(18(23)26-15-9-5-3-7-13(15)21)11(10-19)17(22)25-14-8-4-2-6-12(14)20/h2-9H,20-23H2/b17-11+,18-16- D0H9HT DRUGINKE OSXOBXXOVNWNOP-UNEKJRSWSA-N D0H9HT DRUGSMIL [C-]#[N+]C(=C(N)SC1=CC=CC=C1N)C(=C(N)SC2=CC=CC=C2N)C#N D0H9HT HIGHSTAT Phase 1 D0HI1K DRUG__ID D0HI1K D0HI1K DRUGCOMP GSK D0HI1K DRUGTYPE Small molecular drug D0HI1K DRUGINCH 1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H D0HI1K DRUGINKE SWZTYAVBMYWFGS-UHFFFAOYSA-N D0HI1K DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl D0HI1K HIGHSTAT Phase 1 D0I3RD DRUG__ID D0I3RD D0I3RD DRUGCOMP Millennium Pharmaceuticals D0I3RD DRUGTYPE Small molecular drug D0I3RD DRUGINCH 1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1 D0I3RD DRUGINKE RCLQNICOARASSR-SECBINFHSA-N D0I3RD DRUGSMIL CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O D0I3RD HIGHSTAT Phase 1 D0I3TU DRUG__ID D0I3TU D0I3TU DRUGCOMP Merck & Co Inc D0I3TU DRUGTYPE Small molecular drug D0I3TU DRUGINCH 1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-21(25)26)17-4-2-3-5-19(17)24(20)13-15/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26)/t15-/m1/s1 D0I3TU DRUGINKE JTCAGRAKUAAYDY-OAHLLOKOSA-N D0I3TU DRUGSMIL CN(C1CCC2=C(C3=CC=CC=C3N2C1)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F D0I3TU HIGHSTAT Phase 1 D0I5BN DRUG__ID D0I5BN D0I5BN DRUGCOMP Novogen Ltd D0I5BN DRUGTYPE Small molecular drug D0I5BN DRUGINCH 1S/C22H20O4/c1-25-18-9-4-15(5-10-18)22-19-11-8-17(24)12-21(19)26-13-20(22)14-2-6-16(23)7-3-14/h2-12,20,22-24H,13H2,1H3/t20-,22-/m0/s1 D0I5BN DRUGINKE KQCJZAUNKSGEFM-UNMCSNQZSA-N D0I5BN DRUGSMIL COC1=CC=C(C=C1)C2C(COC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O D0I5BN HIGHSTAT Phase 1 D0I7BU DRUG__ID D0I7BU D0I7BU DRUGCOMP GSK D0I7BU THERCLAS Analgesics D0I7BU DRUGINCH 1S/C14H14ClF3N2O2/c1-20-10(5-6-11(20)21)13(22)19-7-8-3-2-4-9(12(8)15)14(16,17)18/h2-4,10H,5-7H2,1H3,(H,19,22) D0I7BU DRUGINKE BJEMSIVBBUBXMZ-UHFFFAOYSA-N D0I7BU DRUGSMIL CN1C(CCC1=O)C(=O)NCC2=C(C(=CC=C2)C(F)(F)F)Cl D0I7BU HIGHSTAT Phase 1 D0IQ0Z DRUG__ID D0IQ0Z D0IQ0Z DRUGCOMP GlaxoSmith-Kline D0IQ0Z DRUGTYPE Small molecular drug D0IQ0Z DRUGINCH 1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38) D0IQ0Z DRUGINKE QTBWCSQGBMPECM-UHFFFAOYSA-N D0IQ0Z DRUGSMIL CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C D0IQ0Z HIGHSTAT Phase 1 D0IX4B DRUG__ID D0IX4B D0IX4B DRUGCOMP Pfizer D0IX4B DRUGTYPE Small molecular drug D0IX4B DRUGINCH 1S/C23H20F2N6/c1-3-26-9-14-10-27-11-17(12(14)2)13-4-5-19-16(6-13)21(31-30-19)23-28-20-8-15(24)7-18(25)22(20)29-23/h4-8,10-11,26H,3,9H2,1-2H3,(H,28,29)(H,30,31) D0IX4B DRUGINKE MEKASOQEXYKAKM-UHFFFAOYSA-N D0IX4B DRUGSMIL CCNCC1=CN=CC(=C1C)C2=CC3=C(C=C2)NN=C3C4=NC5=C(N4)C=C(C=C5F)F D0IX4B HIGHSTAT Phase 1 D0J0RG DRUG__ID D0J0RG D0J0RG DRUGCOMP Pfizer Ltd D0J0RG DRUGTYPE Small molecular drug D0J0RG DRUGINCH 1S/C18H24N4O3S/c1-26(24,25)20-16-4-2-15(3-5-16)18(23)14-21-10-12-22(13-11-21)17-6-8-19-9-7-17/h2-9,18,20,23H,10-14H2,1H3 D0J0RG DRUGINKE MXVFGNOLZDAKQJ-UHFFFAOYSA-N D0J0RG DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C(CN2CCN(CC2)C3=CC=NC=C3)O D0J0RG HIGHSTAT Phase 1 D0J4MY DRUG__ID D0J4MY D0J4MY DRUGCOMP Genzyme D0J4MY DRUGTYPE Small molecular drug D0J4MY DRUGINCH 1S/C32H58N6O5.ClH/c1-19(2)24(33-28(40)25(20(3)4)35(10)11)30(42)36(12)26(21(5)6)31(43)38-18-14-16-23(38)29(41)37-17-13-15-22(37)27(39)34-32(7,8)9;/h19-26H,13-18H2,1-12H3,(H,33,40)(H,34,39);1H/t22-,23-,24-,25-,26-;/m0./s1 D0J4MY DRUGINKE OOKIODJYZSVHDO-QMYFOHRPSA-N D0J4MY DRUGSMIL CC(C)C(C(=O)N(C)C(C(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C)(C)C)NC(=O)C(C(C)C)N(C)C.Cl D0J4MY HIGHSTAT Phase 1 D0J7ML DRUG__ID D0J7ML D0J7ML DRUGCOMP ASTA Medica AG D0J7ML DRUGTYPE Small molecular drug D0J7ML DRUGINCH 1S/C26H54NO4P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21-25-30-32(28,29)31-26-24-27(2)22-19-18-20-23-27/h3-26H2,1-2H3/p+1 D0J7ML DRUGINKE CUQJLYFFQBHUGW-UHFFFAOYSA-O D0J7ML DRUGSMIL CCCCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+]1(CCCCC1)C D0J7ML HIGHSTAT Phase 1 D0JI2E DRUG__ID D0JI2E D0JI2E DRUGCOMP Wyeth D0JI2E DRUGTYPE Small molecular drug D0JI2E DRUGINCH 1S/C28H27NO3/c1-18-6-5-7-20(14-18)21-10-13-25-23(15-21)24(26(30)27(31)32)17-29(25)16-19-8-11-22(12-9-19)28(2,3)4/h5-15,17H,16H2,1-4H3,(H,31,32) D0JI2E DRUGINKE HSXLMAFNWCSZGP-UHFFFAOYSA-N D0JI2E DRUGSMIL CC1=CC(=CC=C1)C2=CC3=C(C=C2)N(C=C3C(=O)C(=O)O)CC4=CC=C(C=C4)C(C)(C)C D0JI2E HIGHSTAT Phase 1 D0K0GF DRUG__ID D0K0GF D0K0GF DRUGCOMP Sanofi-Aventis D0K0GF DRUGTYPE Small molecular drug D0K0GF DRUGINCH 1S/C24H27ClN2O3/c25-18-6-9-22-23(12-18)30-21(15-29-22)14-26-13-16-10-19-7-8-20(11-16)27(19)24(28)17-4-2-1-3-5-17/h1-6,9,12,16,19-21,26H,7-8,10-11,13-15H2/t16?,19-,20+,21-/m0/s1 D0K0GF DRUGINKE VDQJQKSTXHXBME-DTHFOOOUSA-N D0K0GF DRUGSMIL C1CC2CC(CC1N2C(=O)C3=CC=CC=C3)CNCC4COC5=C(O4)C=C(C=C5)Cl D0K0GF HIGHSTAT Phase 1 D0K2HA DRUG__ID D0K2HA D0K2HA DRUGCOMP Pfizer Inc D0K2HA DRUGTYPE Small molecular drug D0K2HA DRUGINCH 1S/C18H21N3O3S/c1-11-7-15(8-12(2)16(11)9-19)24-18-13(3)21(10-25(4,22)23)20-17(18)14-5-6-14/h7-8,14H,5-6,10H2,1-4H3 D0K2HA DRUGINKE QSFGZNVRVZHUGV-UHFFFAOYSA-N D0K2HA DRUGSMIL CC1=CC(=CC(=C1C#N)C)OC2=C(N(N=C2C3CC3)CS(=O)(=O)C)C D0K2HA HIGHSTAT Phase 1 D0K2PS DRUG__ID D0K2PS D0K2PS DRUGCOMP Merck KGaA D0K2PS DRUGTYPE Small molecular drug D0K2PS DRUGINCH 1S/C24H26N2O2/c27-24(28)20-9-10-23-22(16-20)21(17-25-23)8-4-5-13-26-14-11-19(12-15-26)18-6-2-1-3-7-18/h1-3,6-7,9-11,16-17,25H,4-5,8,12-15H2,(H,27,28) D0K2PS DRUGINKE AFSOIHMEOKEZJF-UHFFFAOYSA-N D0K2PS DRUGSMIL C1CN(CC=C1C2=CC=CC=C2)CCCCC3=CNC4=C3C=C(C=C4)C(=O)O D0K2PS HIGHSTAT Phase 1 D0K4FP DRUG__ID D0K4FP D0K4FP DRUGCOMP AstraZeneca plc D0K4FP DRUGTYPE Small molecular drug D0K4FP DRUGINCH 1S/C23H21ClFN7O4/c1-2-20(33)36-21(14-3-6-17(25)7-4-14)23(35)32-19(9-10-28-32)22(34)26-12-15-11-16(24)5-8-18(15)31-13-27-29-30-31/h3-8,10-11,13,19,21H,2,9,12H2,1H3,(H,26,34)/t19-,21+/m0/s1 D0K4FP DRUGINKE YUHNXUAATAMVKD-PZJWPPBQSA-N D0K4FP DRUGSMIL CCC(=O)OC(C1=CC=C(C=C1)F)C(=O)N2C(CC=N2)C(=O)NCC3=C(C=CC(=C3)Cl)N4C=NN=N4 D0K4FP HIGHSTAT Phase 1 D0K5BP DRUG__ID D0K5BP D0K5BP DRUGCOMP Novartis AG D0K5BP DRUGTYPE Small molecular drug D0K5BP DRUGINCH 1S/C20H18FN5O2/c1-10-18-16(26-20(22)23-10)9-15(25-19(18)27)12-7-6-11(21)8-13(12)14-4-3-5-17(24-14)28-2/h3-8,15H,9H2,1-2H3,(H,25,27)(H2,22,23,26)/t15-/m1/s1 D0K5BP DRUGINKE WSMQUUGTQYPVPD-OAHLLOKOSA-N D0K5BP DRUGSMIL CC1=C2C(=NC(=N1)N)CC(NC2=O)C3=C(C=C(C=C3)F)C4=NC(=CC=C4)OC D0K5BP HIGHSTAT Phase 1 D0K9DI DRUG__ID D0K9DI D0K9DI DRUGCOMP Glaxosmithkline D0K9DI DRUGTYPE Small molecular drug D0K9DI DRUGINCH 1S/C21H25N7O2S/c1-4-28-20-15(11-23-28)19(25-14-5-7-29-8-6-14)16(10-22-20)21-27-26-18(30-21)9-17-12(2)24-13(3)31-17/h10-11,14H,4-9H2,1-3H3,(H,22,25) D0K9DI DRUGINKE AWDJJMXJUOHGLC-UHFFFAOYSA-N D0K9DI DRUGSMIL CCN1C2=NC=C(C(=C2C=N1)NC3CCOCC3)C4=NN=C(O4)CC5=C(N=C(S5)C)C D0K9DI HIGHSTAT Phase 1 D0KE4Z DRUG__ID D0KE4Z D0KE4Z DRUGCOMP Fisons plc D0KE4Z DRUGTYPE Small molecular drug D0KE4Z DRUGINCH 1S/C14H22Cl2N5O12P3S/c1-2-3-37-13-19-10(17)7-11(20-13)21(5-18-7)12-9(23)8(22)6(32-12)4-31-36(29,30)33-35(27,28)14(15,16)34(24,25)26/h5-6,8-9,12,22-23H,2-4H2,1H3,(H,27,28)(H,29,30)(H2,17,19,20)(H2,24,25,26)/t6-,8-,9-,12-/m1/s1 D0KE4Z DRUGINKE ZLIAJZQKKBOFJR-WOUKDFQISA-N D0KE4Z DRUGSMIL CCCSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)N D0KE4Z HIGHSTAT Phase 1 D0KJ2J DRUG__ID D0KJ2J D0KJ2J DRUGCOMP Bayer HealthCare Pharmaceuticals D0KJ2J DRUGTYPE Small molecular drug D0KJ2J DRUGINCH 1S/C25H30N6O5/c1-16-18(4-3-7-26-16)24(33)29-25-28-21-19(23-27-8-9-31(23)25)5-6-20(22(21)34-2)36-15-17(32)14-30-10-12-35-13-11-30/h3-7,17,27,32H,8-15H2,1-2H3/t17-/m0/s1 D0KJ2J DRUGINKE QJTLLKKDFGPDPF-KRWDZBQOSA-N D0KJ2J DRUGSMIL CC1=C(C=CC=N1)C(=O)N=C2N=C3C(=C4N2CCN4)C=CC(=C3OC)OCC(CN5CCOCC5)O D0KJ2J HIGHSTAT Phase 1 D0KR1N DRUG__ID D0KR1N D0KR1N DRUGCOMP Praecis Pharmaceuticals D0KR1N DRUGTYPE Small molecular drug D0KR1N DRUGINCH 1S/C22H36N2O6/c1-12(2)7-8-15-21(5,30-15)18-17(27-6)14(9-10-22(18)11-28-22)29-20(26)24-16(13(3)4)19(23)25/h7,13-18H,8-11H2,1-6H3,(H2,23,25)(H,24,26)/t14-,15-,16-,17-,18-,21+,22+/m1/s1 D0KR1N DRUGINKE QBDVVYNLLXGUGN-XGTBZJOHSA-N D0KR1N DRUGSMIL CC(C)C(C(=O)N)NC(=O)OC1CCC2(CO2)C(C1OC)C3(C(O3)CC=C(C)C)C D0KR1N HIGHSTAT Phase 1 D0KR5K DRUG__ID D0KR5K D0KR5K DRUGCOMP Shionogi & Co Ltd D0KR5K DRUGTYPE Small molecular drug D0KR5K DRUGINCH 1S/C20H20Cl2N4O2S/c1-12(2)18-19(29-16-8-14(21)7-15(22)9-16)26(10-13-3-5-24-6-4-13)17(25-18)11-28-20(23)27/h3-9,12H,10-11H2,1-2H3,(H2,23,27) D0KR5K DRUGINKE YQXCVAGCMNFUMQ-UHFFFAOYSA-N D0KR5K DRUGSMIL CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl D0KR5K HIGHSTAT Phase 1 D0L3JI DRUG__ID D0L3JI D0L3JI DRUGCOMP Schering-Plough D0L3JI DRUGTYPE Small molecular drug D0L3JI DRUGINCH 1S/C18H20N6/c1-2-5-15(6-3-1)17-21-13-16(22-17)14-23-9-11-24(12-10-23)18-19-7-4-8-20-18/h1-8,13H,9-12,14H2,(H,21,22) D0L3JI DRUGINKE OTVQCHUIPJYASM-UHFFFAOYSA-N D0L3JI DRUGSMIL C1CN(CCN1CC2=CN=C(N2)C3=CC=CC=C3)C4=NC=CC=N4 D0L3JI HIGHSTAT Phase 1 D0L6KK DRUG__ID D0L6KK D0L6KK DRUGCOMP Immunomedics D0L6KK DRUGTYPE Small molecular drug D0L6KK DRUGINCH 1S/C19H21F3N2O4S/c1-4-24(14-8-6-5-7-9-14)29(27,28)15-10-11-16(13(2)12-15)23-17(25)18(3,26)19(20,21)22/h5-12,26H,4H2,1-3H3,(H,23,25)/t18-/m1/s1 D0L6KK DRUGINKE SHEIQJGQDUYUBE-GOSISDBHSA-N D0L6KK DRUGSMIL CCN(C1=CC=CC=C1)S(=O)(=O)C2=CC(=C(C=C2)NC(=O)C(C)(C(F)(F)F)O)C D0L6KK HIGHSTAT Phase 1 D0L6VH DRUG__ID D0L6VH D0L6VH DRUGCOMP Biofor Inc D0L6VH DRUGTYPE Small molecular drug D0L6VH DRUGINCH 1S/C20H29NO3/c1-19(2,3)15-11-13(12-16(17(15)22)20(4,5)6)10-14-8-9-24-21(7)18(14)23/h10-12,22H,8-9H2,1-7H3/b14-10+ D0L6VH DRUGINKE BWRYNNCGEDOTRW-GXDHUFHOSA-N D0L6VH DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2CCON(C2=O)C D0L6VH HIGHSTAT Phase 1 D0L9QM DRUG__ID D0L9QM D0L9QM DRUGCOMP Merck D0L9QM DRUGTYPE Small molecular drug D0L9QM DRUGINCH 1S/C26H30N2O6/c1-15-17(3-5-19-21(15)13-33-25(19)31)23(29)11-27-7-9-28(10-8-27)12-24(30)18-4-6-20-22(16(18)2)14-34-26(20)32/h3-6,23-24,29-30H,7-14H2,1-2H3/t23-,24-/m0/s1 D0L9QM DRUGINKE OCKGFTQIICXDQW-ZEQRLZLVSA-N D0L9QM DRUGSMIL CC1=C(C=CC2=C1COC2=O)C(CN3CCN(CC3)CC(C4=C(C5=C(C=C4)C(=O)OC5)C)O)O D0L9QM HIGHSTAT Phase 1 D0M3IN DRUG__ID D0M3IN D0M3IN DRUGCOMP Schering-Plough D0M3IN DRUGTYPE Small molecular drug D0M3IN DRUGINCH 1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11) D0M3IN DRUGINKE LRFVTYWOQMYALW-UHFFFAOYSA-N D0M3IN DRUGSMIL C1=NC2=C(N1)C(=O)NC(=O)N2 D0M3IN HIGHSTAT Phase 1 D0M3YX DRUG__ID D0M3YX D0M3YX DRUGCOMP Nobelpharma Co Ltd D0M3YX DRUGTYPE Small molecular drug D0M3YX DRUGINCH 1S/C11H19NO9/c1-4(14)12-8(5(15)2-6(16)11(20)21)10(19)9(18)7(17)3-13/h5,7-10,13,15,17-19H,2-3H2,1H3,(H,12,14)(H,20,21)/t5-,7+,8+,9+,10+/m0/s1 D0M3YX DRUGINKE KBGAYAKRZNYFFG-BOHATCBPSA-N D0M3YX DRUGSMIL CC(=O)NC(C(CC(=O)C(=O)O)O)C(C(C(CO)O)O)O D0M3YX HIGHSTAT Phase 1 D0M8AI DRUG__ID D0M8AI D0M8AI DRUGCOMP Array BioPharma D0M8AI DRUGTYPE Small molecular drug D0M8AI DRUGINCH 1S/C29H27N7O4S/c1-19-13-21(4-7-26(19)39-22-9-11-36-28(15-22)32-18-34-36)35-29-24-14-20(3-6-25(24)31-17-33-29)27-8-5-23(40-27)16-30-10-12-41(2,37)38/h3-9,11,13-15,17-18,30H,10,12,16H2,1-2H3,(H,31,33,35) D0M8AI DRUGINKE QVMNYGOVNWWFKF-UHFFFAOYSA-N D0M8AI DRUGSMIL CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)C4=CC=C(O4)CNCCS(=O)(=O)C)OC5=CC6=NC=NN6C=C5 D0M8AI HIGHSTAT Phase 1 D0MB2Z DRUG__ID D0MB2Z D0MB2Z DRUGCOMP Atterocor D0MB2Z DRUGTYPE Small molecular drug D0MB2Z DRUGINCH 1S/C27H39N3O.ClH/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6;/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31);1H D0MB2Z DRUGINKE SDOOGTHIDFZUNM-UHFFFAOYSA-N D0MB2Z DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C.Cl D0MB2Z HIGHSTAT Phase 1 D0MS3Z DRUG__ID D0MS3Z D0MS3Z THERCLAS Anticancer Agents D0MS3Z DRUGTYPE Small molecular drug D0MS3Z DRUGINCH 1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1 D0MS3Z DRUGINKE KGPGFQWBCSZGEL-ZDUSSCGKSA-N D0MS3Z DRUGSMIL CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N D0MS3Z HIGHSTAT Phase 1 D0N1BF DRUG__ID D0N1BF D0N1BF DRUGCOMP Eli Lilly & Co D0N1BF DRUGTYPE Small molecular drug D0N1BF DRUGINCH 1S/C15H14F2N4S/c1-15(2-3-22-14(18)21-15)11-4-10(12(16)5-13(11)17)9-6-19-8-20-7-9/h4-8H,2-3H2,1H3,(H2,18,21)/t15-/m0/s1 D0N1BF DRUGINKE MJQMRGWYPNIERM-HNNXBMFYSA-N D0N1BF DRUGSMIL CC1(CCSC(=N1)N)C2=C(C=C(C(=C2)C3=CN=CN=C3)F)F D0N1BF HIGHSTAT Phase 1 D0N1EZ DRUG__ID D0N1EZ D0N1EZ DRUGCOMP Centre National de la Recherche Scientifique (CNRS) D0N1EZ DRUGTYPE Small molecular drug D0N1EZ DRUGINCH 1S/C261H403N87O57/c1-151(310-231(383)171(86-47-110-294-254(270)271)318-198(349)143-302-246(398)190-94-55-119-341(190)206(357)135-262)215(367)333-182(127-159-63-17-9-18-64-159)227(379)289-106-42-35-80-168(328-242(394)186(131-163-71-25-13-26-72-163)337-219(371)155(5)314-235(387)175(90-51-114-298-258(278)279)322-202(353)147-306-250(402)194-98-59-123-345(194)210(361)139-266)224(376)287-104-40-33-79-167(326-240(392)180(331-244(396)188(133-165-75-29-15-30-76-165)339-221(373)157(7)316-237(389)177(92-53-116-300-260(282)283)324-204(355)149-308-252(404)196-100-61-125-347(196)212(363)141-268)84-38-45-108-291-229(381)184(129-161-67-21-11-22-68-161)335-217(369)153(3)312-233(385)173(88-49-112-296-256(274)275)320-200(351)145-304-248(400)192-96-57-121-343(192)208(359)137-264)223(375)286-103-41-34-82-170(226(378)293-118-102-214(365)366)327-239(391)179(330-241(393)181(332-245(397)189(134-166-77-31-16-32-78-166)340-222(374)158(8)317-238(390)178(93-54-117-301-261(284)285)325-205(356)150-309-253(405)197-101-62-126-348(197)213(364)142-269)85-39-46-109-292-230(382)185(130-162-69-23-12-24-70-162)336-218(370)154(4)313-234(386)174(89-50-113-297-257(276)277)321-201(352)146-305-249(401)193-97-58-122-344(193)209(360)138-265)83-37-44-105-288-225(377)169(329-243(395)187(132-164-73-27-14-28-74-164)338-220(372)156(6)315-236(388)176(91-52-115-299-259(280)281)323-203(354)148-307-251(403)195-99-60-124-346(195)211(362)140-267)81-36-43-107-290-228(380)183(128-160-65-19-10-20-66-160)334-216(368)152(2)311-232(384)172(87-48-111-295-255(272)273)319-199(350)144-303-247(399)191-95-56-120-342(191)207(358)136-263/h9-32,63-78,151-158,167-197H,33-62,79-150,262-269H2,1-8H3,(H,286,375)(H,287,376)(H,288,377)(H,289,379)(H,290,380)(H,291,381)(H,292,382)(H,293,378)(H,302,398)(H,303,399)(H,304,400)(H,305,401)(H,306,402)(H,307,403)(H,308,404)(H,309,405)(H,310,383)(H,311,384)(H,312,385)(H,313,386)(H,314,387)(H,315,388)(H,316,389)(H,317,390)(H,318,349)(H,319,350)(H,320,351)(H,321,352)(H,322,353)(H,323,354)(H,324,355)(H,325,356)(H,326,392)(H,327,391)(H,328,394)(H,329,395)(H,330,393)(H,331,396)(H,332,397)(H,333,367)(H,334,368)(H,335,369)(H,336,370)(H,337,371)(H,338,372)(H,339,373)(H,340,374)(H,365,366)(H4,270,271,294)(H4,272,273,295)(H4,274,275,296)(H4,276,277,297)(H4,278,279,298)(H4,280,281,299)(H4,282,283,300)(H4,284,285,301)/t151-,152-,153-,154-,155-,156-,157-,158-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-/m0/s1 D0N1EZ DRUGINKE SDVOJIRXJLEGCY-ZFRLFKIJSA-N D0N1EZ DRUGSMIL CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NCCCCC(C(=O)NCCCCC(C(=O)NCCCCC(C(=O)NCCC(=O)O)NC(=O)C(CCCCNC(=O)C(CCCCNC(=O)C(CC2=CC=CC=C2)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C3CCCN3C(=O)CN)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C5CCCN5C(=O)CN)NC(=O)C(CCCCNC(=O)C(CC6=CC=CC=C6)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C7CCCN7C(=O)CN)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C9CCCN9C(=O)CN)NC(=O)C(CCCCNC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C1CCCN1C(=O)CN)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C1CCCN1C(=O)CN)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C1CCCN1C(=O)CN)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C1CCCN1C(=O)CN D0N1EZ HIGHSTAT Phase 1 D0N6NM DRUG__ID D0N6NM D0N6NM DRUGCOMP Teva pharmaceutical D0N6NM DRUGTYPE Small molecular drug D0N6NM DRUGINCH 1S/C30H38ClN7O3/c1-32-29(40)23-7-3-4-9-25(23)34-28-24(31)19-33-30(36-28)35-26-11-10-20-18-21(6-5-8-22(20)27(26)41-2)38-14-12-37(13-15-38)16-17-39/h3-4,7,9-11,19,21,39H,5-6,8,12-18H2,1-2H3,(H,32,40)(H2,33,34,35,36)/t21-/m0/s1 D0N6NM DRUGINKE BCSHRERPHLTPEE-NRFANRHFSA-N D0N6NM DRUGSMIL CNC(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C4=C(CC(CCC4)N5CCN(CC5)CCO)C=C3)OC D0N6NM HIGHSTAT Phase 1 D0N9PL DRUG__ID D0N9PL D0N9PL DRUGCOMP Acceleron Pharma D0N9PL DRUGTYPE Small molecular drug D0N9PL DRUGINCH 1S/C8H9BrN2O/c1-5-3-8(11-6(2)12)7(9)4-10-5/h3-4H,1-2H3,(H,10,11,12) D0N9PL DRUGINKE OMGSODSTISOTIL-UHFFFAOYSA-N D0N9PL DRUGSMIL CC1=CC(=C(C=N1)Br)NC(=O)C D0N9PL HIGHSTAT Phase 1 D0N9TY DRUG__ID D0N9TY D0N9TY DRUGCOMP Arrow Therapeutics Ltd D0N9TY DRUGTYPE Small molecular drug D0N9TY DRUGINCH 1S/C32H35F3N4O5S/c1-2-19-45(42,43)39-17-15-38(16-18-39)21-22-3-11-26(12-4-22)36-30(40)24-7-5-23(6-8-24)28-20-27(37-31(41)25-9-10-25)13-14-29(28)44-32(33,34)35/h3-8,11-14,20,25H,2,9-10,15-19,21H2,1H3,(H,36,40)(H,37,41) D0N9TY DRUGINKE MAQDQJWCSSCURR-UHFFFAOYSA-N D0N9TY DRUGSMIL CCCS(=O)(=O)N1CCN(CC1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C4=C(C=CC(=C4)NC(=O)C5CC5)OC(F)(F)F D0N9TY HIGHSTAT Phase 1 D0NR7H DRUG__ID D0NR7H D0NR7H DRUGCOMP Abbott D0NR7H DRUGTYPE Small molecular drug D0NR7H DRUGINCH 1S/C24H27N3O6S2/c1-14(2)11-12-24(3)17-8-6-5-7-16(17)21(28)20(22(24)29)23-25-18-10-9-15(26-34(4,30)31)13-19(18)35(32,33)27-23/h5-10,13-14,26,28H,11-12H2,1-4H3,(H,25,27)/t24-/m1/s1 D0NR7H DRUGINKE ZTRJLSWOQIDJIS-XMMPIXPASA-N D0NR7H DRUGSMIL CC(C)CCC1(C2=CC=CC=C2C(=C(C1=O)C3=NS(=O)(=O)C4=C(N3)C=CC(=C4)NS(=O)(=O)C)O)C D0NR7H HIGHSTAT Phase 1 D0NU6Y DRUG__ID D0NU6Y D0NU6Y DRUGCOMP Burroughs Wellcome Inc D0NU6Y DRUGTYPE Small molecular drug D0NU6Y DRUGINCH 1S/C20H33N3O4S/c1-2-22-16-11-15(28-10-6-9-19(25)26)12-17(16)23(20(22)27)21-13-18(24)14-7-4-3-5-8-14/h13-18,24H,2-12H2,1H3,(H,25,26)/b21-13+ D0NU6Y DRUGINKE YDMMNNOYPGHBEY-FYJGNVAPSA-N D0NU6Y DRUGSMIL CCN1C2CC(CC2N(C1=O)N=CC(C3CCCCC3)O)SCCCC(=O)O D0NU6Y HIGHSTAT Phase 1 D0O1IM DRUG__ID D0O1IM D0O1IM DRUGCOMP Celgene D0O1IM DRUGTYPE Small molecular drug D0O1IM DRUGINCH 1S/C16H16N8O/c1-3-24-13(25)7-18-15-16(24)22-12(6-17-15)10-4-5-11(21-9(10)2)14-19-8-20-23-14/h4-6,8H,3,7H2,1-2H3,(H,17,18)(H,19,20,23) D0O1IM DRUGINKE GMYLVKUGJMYTFB-UHFFFAOYSA-N D0O1IM DRUGSMIL CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C D0O1IM HIGHSTAT Phase 1 D0O1LD DRUG__ID D0O1LD D0O1LD THERCLAS Anticancer Agents D0O1LD DRUGTYPE Small molecular drug D0O1LD DRUGINCH 1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2 D0O1LD DRUGINKE HGVNLRPZOWWDKD-UHFFFAOYSA-N D0O1LD DRUGSMIL C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5 D0O1LD HIGHSTAT Phase 1 D0O1ZI DRUG__ID D0O1ZI D0O1ZI DRUGCOMP AstraZeneca D0O1ZI DRUGTYPE Small molecular drug D0O1ZI DRUGINCH 1S/C25H31N3O3/c1-25(2,3)22-20(13-26-28(22)19-6-4-16(5-7-19)24(30)31)23(29)27-21-17-9-14-8-15(11-17)12-18(21)10-14/h4-7,13-15,17-18,21H,8-12H2,1-3H3,(H,27,29)(H,30,31) D0O1ZI DRUGINKE XWBXJBSVYVJAMZ-UHFFFAOYSA-N D0O1ZI DRUGSMIL CC(C)(C)C1=C(C=NN1C2=CC=C(C=C2)C(=O)O)C(=O)NC3C4CC5CC(C4)CC3C5 D0O1ZI HIGHSTAT Phase 1 D0O3QW DRUG__ID D0O3QW D0O3QW DRUGCOMP Genaera D0O3QW DRUGTYPE Small molecular drug D0O3QW DRUGINCH 1S/C37H72N4O5S/c1-26(2)34(46-47(43,44)45)13-10-27(3)30-11-12-31-35-32(15-17-37(30,31)5)36(4)16-14-29(24-28(36)25-33(35)42)41-23-9-22-40-20-7-6-19-39-21-8-18-38/h26-35,39-42H,6-25,38H2,1-5H3,(H,43,44,45)/t27-,28-,29+,30-,31+,32+,33-,34-,35+,36+,37-/m1/s1 D0O3QW DRUGINKE WUJVPODXELZABP-FWJXURDUSA-N D0O3QW DRUGSMIL CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCNCCCN)C)O)C)OS(=O)(=O)O D0O3QW HIGHSTAT Phase 1 D0O8JW DRUG__ID D0O8JW D0O8JW DRUGCOMP Elbion AG D0O8JW DRUGTYPE Small molecular drug D0O8JW DRUGINCH 1S/C21H13Cl2FN4O2/c22-16-8-25-9-17(23)18(16)27-21(30)19(29)15-11-28(20-14(15)2-1-7-26-20)10-12-3-5-13(24)6-4-12/h1-9,11H,10H2,(H,25,27,30) D0O8JW DRUGINKE JERXUPDBWDWFCF-UHFFFAOYSA-N D0O8JW DRUGSMIL C1=CC2=C(N=C1)N(C=C2C(=O)C(=O)NC3=C(C=NC=C3Cl)Cl)CC4=CC=C(C=C4)F D0O8JW HIGHSTAT Phase 1 D0O9LN DRUG__ID D0O9LN D0O9LN DRUGCOMP Marshall Edwards D0O9LN DRUGTYPE Small molecular drug D0O9LN DRUGINCH 1S/C21H18O4/c22-15-5-1-13(2-6-15)19-12-25-20-11-17(24)9-10-18(20)21(19)14-3-7-16(23)8-4-14/h1-11,19,21-24H,12H2 D0O9LN DRUGINKE VXHSDGZMRLGSEJ-UHFFFAOYSA-N D0O9LN DRUGSMIL C1C(C(C2=C(O1)C=C(C=C2)O)C3=CC=C(C=C3)O)C4=CC=C(C=C4)O D0O9LN HIGHSTAT Phase 1 D0O9UC DRUG__ID D0O9UC D0O9UC DRUGCOMP Takeda D0O9UC DRUGTYPE Small molecular drug D0O9UC DRUGINCH 1S/C31H41ClN4O3/c1-22-4-9-28(21-29(22)32)36(31(39)27-12-18-35(19-13-27)23(2)37)15-3-14-34-16-10-25(11-17-34)20-24-5-7-26(8-6-24)30(33)38/h4-9,21,25,27H,3,10-20H2,1-2H3,(H2,33,38) D0O9UC DRUGINKE ASSJTMUEFHUKMJ-UHFFFAOYSA-N D0O9UC DRUGSMIL CC1=C(C=C(C=C1)N(CCCN2CCC(CC2)CC3=CC=C(C=C3)C(=O)N)C(=O)C4CCN(CC4)C(=O)C)Cl D0O9UC HIGHSTAT Phase 1 D0O9XN DRUG__ID D0O9XN D0O9XN DRUGCOMP Arena Pharmaceuticals Inc D0O9XN DRUGTYPE Small molecular drug D0O9XN DRUGINCH 1S/C21H29N5O6S/c1-13(2)31-21(27)26-10-8-15(9-11-26)32-20-18(30-4)19(22-12-23-20)25-16-6-7-17(24-14(16)3)33(5,28)29/h6-7,12-13,15H,8-11H2,1-5H3,(H,22,23,25) D0O9XN DRUGINKE WPDCHTSXOPUOII-UHFFFAOYSA-N D0O9XN DRUGSMIL CC1=C(C=CC(=N1)S(=O)(=O)C)NC2=C(C(=NC=N2)OC3CCN(CC3)C(=O)OC(C)C)OC D0O9XN HIGHSTAT Phase 1 D0P0TA DRUG__ID D0P0TA D0P0TA DRUGCOMP Genzyme D0P0TA DRUGTYPE Small molecular drug D0P0TA DRUGINCH 1S/C211H345N61O62S/c1-32-107(20)161(265-170(297)112(25)233-167(294)109(22)237-195(322)159(105(16)17)263-189(316)136(86-101(8)9)251-171(298)122(212)73-82-335-31)198(325)248-129(63-68-149(213)280)180(307)260-144(96-273)191(318)234-108(21)166(293)231-94-152(283)239-133(83-98(2)3)188(315)267-162(114(27)275)199(326)249-132(67-72-157(291)292)181(308)266-163(115(28)276)200(327)254-135(85-100(6)7)183(310)253-140(92-150(214)281)186(313)242-124(52-40-75-227-208(218)219)175(302)244-128(64-69-154(285)286)172(299)232-95-153(284)262-158(104(14)15)196(323)256-139(91-120-59-61-121(279)62-60-120)190(317)268-165(117(30)278)202(329)264-160(106(18)19)197(324)255-137(89-118-47-35-33-36-48-118)182(309)238-113(26)203(330)270-79-44-57-147(270)194(321)269-164(116(29)277)201(328)257-141(93-151(215)282)187(314)246-130(65-70-155(287)288)174(301)236-110(23)168(295)250-138(90-119-49-37-34-38-50-119)185(312)241-123(51-39-74-226-207(216)217)173(300)235-111(24)169(296)258-142(87-102(10)11)204(331)272-81-46-58-148(272)205(332)271-80-45-56-146(271)193(320)247-127(55-43-78-230-211(224)225)176(303)245-131(66-71-156(289)290)179(306)240-126(54-42-77-229-210(222)223)178(305)261-145(97-274)192(319)243-125(53-41-76-228-209(220)221)177(304)252-134(84-99(4)5)184(311)259-143(206(333)334)88-103(12)13/h33-38,47-50,59-62,98-117,122-148,158-165,273-279H,32,39-46,51-58,63-97,212H2,1-31H3,(H2,213,280)(H2,214,281)(H2,215,282)(H,231,293)(H,232,299)(H,233,294)(H,234,318)(H,235,300)(H,236,301)(H,237,322)(H,238,309)(H,239,283)(H,240,306)(H,241,312)(H,242,313)(H,243,319)(H,244,302)(H,245,303)(H,246,314)(H,247,320)(H,248,325)(H,249,326)(H,250,295)(H,251,298)(H,252,304)(H,253,310)(H,254,327)(H,255,324)(H,256,323)(H,257,328)(H,258,296)(H,259,311)(H,260,307)(H,261,305)(H,262,284)(H,263,316)(H,264,329)(H,265,297)(H,266,308)(H,267,315)(H,268,317)(H,269,321)(H,285,286)(H,287,288)(H,289,290)(H,291,292)(H,333,334)(H4,216,217,226)(H4,218,219,227)(H4,220,221,228)(H4,222,223,229)(H4,224,225,230)/t107-,108-,109-,110-,111-,112-,113-,114+,115+,116+,117+,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,147-,148-,158-,159-,160-,161-,162-,163-,164-,165-/m0/s1 D0P0TA DRUGINKE ZRKFYGHZFMAOKI-QMGMOQQFSA-N D0P0TA DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(C)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)N3CCCC3C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCSC)N D0P0TA HIGHSTAT Phase 1 D0P1CV DRUG__ID D0P1CV D0P1CV DRUGCOMP Nerviano Medical Sciences Srl D0P1CV DRUGTYPE Small molecular drug D0P1CV DRUGINCH 1S/C19H31N5O2/c1-12(2)10-15(25)20-17-14-11-24(19(3,4)16(14)21-22-17)18(26)13-6-8-23(5)9-7-13/h12-13H,6-11H2,1-5H3,(H2,20,21,22,25) D0P1CV DRUGINKE HUXYBQXJVXOMKX-UHFFFAOYSA-N D0P1CV DRUGSMIL CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C D0P1CV HIGHSTAT Phase 1 D0P9KA DRUG__ID D0P9KA D0P9KA DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0P9KA DRUGTYPE Small molecular drug D0P9KA DRUGINCH 1S/C30H37N3O9/c1-19-26(29(35)39-3)28(27(20(2)32-19)30(36)40-4)24-16-21(33(37)38)12-13-25(24)41-15-9-8-14-31-17-22(34)18-42-23-10-6-5-7-11-23/h5-7,10-13,16,22,28,31-32,34H,8-9,14-15,17-18H2,1-4H3 D0P9KA DRUGINKE GQJFGCIETONRNJ-UHFFFAOYSA-N D0P9KA DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=C(C=CC(=C2)[N+](=O)[O-])OCCCCNCC(COC3=CC=CC=C3)O)C(=O)OC D0P9KA HIGHSTAT Phase 1 D0P9YP DRUG__ID D0P9YP D0P9YP DRUGCOMP AVANIR Pharmaceuticals Inc D0P9YP DRUGTYPE Small molecular drug D0P9YP DRUGINCH 1S/C30H29N5O2/c36-28(35-26-3-1-2-10-31-26)22-6-9-24-25(14-22)34-27(33-24)21-4-7-23(8-5-21)32-29(37)30-15-18-11-19(16-30)13-20(12-18)17-30/h1-10,14,18-20H,11-13,15-17H2,(H,32,37)(H,33,34)(H,31,35,36) D0P9YP DRUGINKE LUPHOOKVGNVAFT-UHFFFAOYSA-N D0P9YP DRUGSMIL C1C2CC3CC1CC(C2)(C3)C(=O)NC4=CC=C(C=C4)C5=NC6=C(N5)C=C(C=C6)C(=O)NC7=CC=CC=N7 D0P9YP HIGHSTAT Phase 1 D0PM7Q DRUG__ID D0PM7Q D0PM7Q DRUGCOMP AstraZeneca D0PM7Q DRUGTYPE Small molecular drug D0PM7Q DRUGINCH 1S/C17H19FN4O2S/c18-11-4-1-3-10(7-11)14-8-13(22-17(19)24)15(25-14)16(23)21-12-5-2-6-20-9-12/h1,3-4,7-8,12,20H,2,5-6,9H2,(H,21,23)(H3,19,22,24)/t12-/m0/s1 D0PM7Q DRUGINKE IAYGCINLNONXHY-LBPRGKRZSA-N D0PM7Q DRUGSMIL C1CC(CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N D0PM7Q HIGHSTAT Phase 1 D0PO0B DRUG__ID D0PO0B D0PO0B DRUGCOMP Boehringer Ingelheim Corp D0PO0B DRUGTYPE Small molecular drug D0PO0B DRUGINCH 1S/C28H38N2O5/c1-32-24-8-7-20(14-25(24)33-2)9-12-29-11-5-6-21(18-29)19-30-13-10-22-15-26(34-3)27(35-4)16-23(22)17-28(30)31/h7-8,14-16,21H,5-6,9-13,17-19H2,1-4H3/t21-/m0/s1 D0PO0B DRUGINKE OBUFMJDDZTXJPY-NRFANRHFSA-N D0PO0B DRUGSMIL COC1=C(C=C(C=C1)CCN2CCCC(C2)CN3CCC4=CC(=C(C=C4CC3=O)OC)OC)OC D0PO0B HIGHSTAT Phase 1 D0Q3QS DRUG__ID D0Q3QS D0Q3QS DRUGCOMP Athpharma Ltd D0Q3QS DRUGTYPE Small molecular drug D0Q3QS DRUGINCH 1S/C7H7NO3.Na/c8-4-1-2-5(7(10)11)6(9)3-4;/h1-3,9H,8H2,(H,10,11);/q;+1/p-1 D0Q3QS DRUGINKE FVVDKUPCWXUVNP-UHFFFAOYSA-M D0Q3QS DRUGSMIL C1=CC(=C(C=C1N)O)C(=O)[O-].[Na+] D0Q3QS HIGHSTAT Phase 1 D0Q4JM DRUG__ID D0Q4JM D0Q4JM DRUGCOMP Millennium Pharmaceuticals D0Q4JM DRUGTYPE Small molecular drug D0Q4JM DRUGINCH 1S/C28H31F3N4O6/c1-3-19-13-20-23(27(40)35(19)14-21(37)17-7-5-4-6-8-17)25(41-16-28(29,30)31)24(33(20)2)26(39)32-18-9-11-34(12-10-18)22(38)15-36/h4-8,13,18,36H,3,9-12,14-16H2,1-2H3,(H,32,39) D0Q4JM DRUGINKE ZADWXQMNNVICKB-UHFFFAOYSA-N D0Q4JM DRUGSMIL CCC1=CC2=C(C(=C(N2C)C(=O)NC3CCN(CC3)C(=O)CO)OCC(F)(F)F)C(=O)N1CC(=O)C4=CC=CC=C4 D0Q4JM HIGHSTAT Phase 1 D0Q5TH DRUG__ID D0Q5TH D0Q5TH DRUGCOMP Xenova Group plc D0Q5TH DRUGTYPE Small molecular drug D0Q5TH DRUGINCH 1S/C34H34N8O2/c1-21-7-3-11-25-29(21)41-31-23(9-5-13-27(31)39-25)33(43)37-19-17-35-15-16-36-18-20-38-34(44)24-10-6-14-28-32(24)42-30-22(2)8-4-12-26(30)40-28/h3-14,35-36H,15-20H2,1-2H3,(H,37,43)(H,38,44) D0Q5TH DRUGINKE SFOADSRLCHRTKT-UHFFFAOYSA-N D0Q5TH DRUGSMIL CC1=C2C(=CC=C1)N=C3C=CC=C(C3=N2)C(=O)NCCNCCNCCNC(=O)C4=CC=CC5=NC6=CC=CC(=C6N=C54)C D0Q5TH HIGHSTAT Phase 1 D0Q7QY DRUG__ID D0Q7QY D0Q7QY DRUGCOMP Sanofi-Aventis D0Q7QY DRUGTYPE Small molecular drug D0Q7QY DRUGINCH 1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22) D0Q7QY DRUGINKE LUBHDINQXIHVLS-UHFFFAOYSA-N D0Q7QY DRUGSMIL CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC D0Q7QY HIGHSTAT Phase 1 D0Q8WG DRUG__ID D0Q8WG D0Q8WG DRUGCOMP Glenmark Pharmaceuticals Ltd D0Q8WG DRUGTYPE Small molecular drug D0Q8WG DRUGINCH 1S/C19H21F2N3O/c1-19(2,3)22-18(25)16-15-10-4-5-11(8-10)17(15)24(23-16)14-7-6-12(20)9-13(14)21/h6-7,9-11H,4-5,8H2,1-3H3,(H,22,25)/t10-,11+/m0/s1 D0Q8WG DRUGINKE NTPZXHMTJGOMCJ-WDEREUQCSA-N D0Q8WG DRUGSMIL CC(C)(C)NC(=O)C1=NN(C2=C1C3CCC2C3)C4=C(C=C(C=C4)F)F D0Q8WG HIGHSTAT Phase 1 D0Q9RP DRUG__ID D0Q9RP D0Q9RP DRUGCOMP Incuron Buffalo, NY D0Q9RP DRUGTYPE Small molecular drug D0Q9RP DRUGINCH 1S/C21H24N2O2.ClH/c1-13(2)22-9-10-23-20-7-5-16(14(3)24)11-18(20)19-12-17(15(4)25)6-8-21(19)23;/h5-8,11-13,22H,9-10H2,1-4H3;1H D0Q9RP DRUGINKE IXRKBBVMDMKAEB-UHFFFAOYSA-N D0Q9RP DRUGSMIL CC(C)NCCN1C2=C(C=C(C=C2)C(=O)C)C3=C1C=CC(=C3)C(=O)C.Cl D0Q9RP HIGHSTAT Phase 1 D0R2OU DRUG__ID D0R2OU D0R2OU DRUGCOMP Cephalon D0R2OU DRUGTYPE Small molecular drug D0R2OU DRUGINCH 1S/C18H23N3O2/c1-14-4-2-11-21(14)12-3-13-23-16-7-5-15(6-8-16)17-9-10-18(22)20-19-17/h5-10,14H,2-4,11-13H2,1H3,(H,20,22)/t14-/m1/s1 D0R2OU DRUGINKE XUKROCVZGZNGSI-CQSZACIVSA-N D0R2OU DRUGSMIL CC1CCCN1CCCOC2=CC=C(C=C2)C3=NNC(=O)C=C3 D0R2OU HIGHSTAT Phase 1 D0R3VK DRUG__ID D0R3VK D0R3VK DRUGCOMP Genentech D0R3VK DRUGTYPE Small molecular drug D0R3VK DRUGINCH 1S/C16H14FIN4O3/c17-13-7-10(18)1-4-14(13)20-15-12(16(24)21-25-6-5-23)3-2-11-8-19-9-22(11)15/h1-4,7-9,20,23H,5-6H2,(H,21,24) D0R3VK DRUGINKE RFWVETIZUQEJEF-UHFFFAOYSA-N D0R3VK DRUGSMIL C1=CC(=C(C=C1I)F)NC2=C(C=CC3=CN=CN32)C(=O)NOCCO D0R3VK HIGHSTAT Phase 1 D0R4YQ DRUG__ID D0R4YQ D0R4YQ DRUGCOMP Catalyst biosciences; pfizer D0R4YQ DRUGTYPE Small molecular drug D0R4YQ DRUGINCH 1S/C20H28ClNO2/c21-19-15-16(9-10-18(19)17-6-2-1-3-7-17)5-4-8-20(23)22-11-13-24-14-12-22/h9-10,15,17H,1-8,11-14H2 D0R4YQ DRUGINKE GCECPNQPPJYYOR-UHFFFAOYSA-N D0R4YQ DRUGSMIL C1CCC(CC1)C2=C(C=C(C=C2)CCCC(=O)N3CCOCC3)Cl D0R4YQ HIGHSTAT Phase 1 D0R8HY DRUG__ID D0R8HY D0R8HY DRUGCOMP Merck D0R8HY DRUGTYPE Small molecular drug D0R8HY DRUGINCH 1S/C22H29Cl2NO3S/c23-17-5-6-19(20(24)11-17)21(26)25-14-22(12-15-1-2-15)9-7-18(8-10-22)29(27,28)13-16-3-4-16/h5-6,11,15-16,18H,1-4,7-10,12-14H2,(H,25,26) D0R8HY DRUGINKE PSIMLOLEQCVVJV-UHFFFAOYSA-N D0R8HY DRUGSMIL C1CC1CC2(CCC(CC2)S(=O)(=O)CC3CC3)CNC(=O)C4=C(C=C(C=C4)Cl)Cl D0R8HY HIGHSTAT Phase 1 D0R8PE DRUG__ID D0R8PE D0R8PE DRUGCOMP CeNeRx BioPharma D0R8PE DRUGTYPE Small molecular drug D0R8PE DRUGINCH 1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12) D0R8PE DRUGINKE SRPNQDXRVRCTNK-UHFFFAOYSA-N D0R8PE DRUGSMIL CC(C)(C)C(=O)NCCCC(=O)O D0R8PE HIGHSTAT Phase 1 D0R9IU DRUG__ID D0R9IU D0R9IU DRUGCOMP Portola Pharmaceuticals Inc D0R9IU DRUGTYPE Small molecular drug D0R9IU DRUGINCH 1S/C19H23N9O/c20-15-6-1-2-7-16(15)26-19-22-11-14(17(21)29)18(27-19)25-12-4-3-5-13(10-12)28-23-8-9-24-28/h3-5,8-11,15-16H,1-2,6-7,20H2,(H2,21,29)(H2,22,25,26,27)/t15-,16+/m0/s1 D0R9IU DRUGINKE TXGKRVFSSHPBAJ-JKSUJKDBSA-N D0R9IU DRUGSMIL C1CCC(C(C1)N)NC2=NC=C(C(=N2)NC3=CC(=CC=C3)N4N=CC=N4)C(=O)N D0R9IU HIGHSTAT Phase 1 D0R9KG DRUG__ID D0R9KG D0R9KG DRUGCOMP Arena Pharmaceuticals; Arena Pharmaceuticals Inc D0R9KG DRUGTYPE Small molecular drug D0R9KG DRUGINCH 1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29) D0R9KG DRUGINKE ZEOQUKRCASTCFR-UHFFFAOYSA-N D0R9KG DRUGSMIL CN1C(=CC=N1)C2=C(C=CC(=C2)NC(=O)C3=CC(=CC=C3)OC)OCCN4CCOCC4 D0R9KG HIGHSTAT Phase 1 D0RN6V DRUG__ID D0RN6V D0RN6V DRUGCOMP SmithKline Beecham plc D0RN6V DRUGTYPE Small molecular drug D0RN6V DRUGINCH 1S/C19H25F3N2O/c20-19(21,22)16-8-6-15(7-9-16)13-18(25)24-12-2-1-5-17(24)14-23-10-3-4-11-23/h6-9,17H,1-5,10-14H2/t17-/m0/s1 D0RN6V DRUGINKE RFTWMVGLYKJUCZ-KRWDZBQOSA-N D0RN6V DRUGSMIL C1CCN(C(C1)CN2CCCC2)C(=O)CC3=CC=C(C=C3)C(F)(F)F D0RN6V HIGHSTAT Phase 1 D0S4PN DRUG__ID D0S4PN D0S4PN DRUGCOMP Conjugon D0S4PN DRUGTYPE Small molecular drug D0S4PN DRUGINCH 1S/C9H7NO/c11-9-6-10-5-7-3-1-2-4-8(7)9/h1-6,11H D0S4PN DRUGINKE DXTUTXYCHFWRQC-UHFFFAOYSA-N D0S4PN DRUGSMIL C1=CC=C2C(=C1)C=NC=C2O D0S4PN HIGHSTAT Phase 1 D0S5EF DRUG__ID D0S5EF D0S5EF DRUGCOMP Pfizer Inc D0S5EF DRUGTYPE Small molecular drug D0S5EF DRUGINCH 1S/C23H20FNO5/c1-29-19-8-4-17-11-20(9-5-16(17)10-19)30-14-23(22(27)28)12-25(13-23)21(26)15-2-6-18(24)7-3-15/h2-11H,12-14H2,1H3,(H,27,28) D0S5EF DRUGINKE LWJGMYMNSNVCEM-UHFFFAOYSA-N D0S5EF DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)OCC3(CN(C3)C(=O)C4=CC=C(C=C4)F)C(=O)O D0S5EF HIGHSTAT Phase 1 D0S6KA DRUG__ID D0S6KA D0S6KA DRUGCOMP Sarawak MediChem Pharmaceuticals D0S6KA DRUGTYPE Small molecular drug D0S6KA DRUGINCH 1S/C22H26O5/c1-6-7-13-10-15(23)26-21-16(13)20-14(8-9-22(4,5)27-20)19-17(21)18(24)11(2)12(3)25-19/h8-12,18,24H,6-7H2,1-5H3/t11-,12-,18+/m1/s1 D0S6KA DRUGINKE NIDRYBLTWYFCFV-FMTVUPSXSA-N D0S6KA DRUGSMIL CCCC1=CC(=O)OC2=C1C3=C(C=CC(O3)(C)C)C4=C2C(C(C(O4)C)C)O D0S6KA HIGHSTAT Phase 1 D0S8XP DRUG__ID D0S8XP D0S8XP DRUGCOMP Depomed; Janssen Research & Development D0S8XP DRUGTYPE Small molecular drug D0S8XP DRUGINCH 1S/C24H25FO5S.C4H11N5/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14;1-9(2)4(7)8-3(5)6/h2-10,19,21-24,26-29H,11-12H2,1H3;1-2H3,(H5,5,6,7,8)/t19-,21-,22+,23-,24+;/m1./s1 D0S8XP DRUGINKE WLJCALZLZJOJML-FVYJGOGTSA-N D0S8XP DRUGSMIL CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.CN(C)C(=N)N=C(N)N D0S8XP HIGHSTAT Phase 1 D0S9FU DRUG__ID D0S9FU D0S9FU DRUGCOMP Simcere Pharmaceutical Group D0S9FU DRUGTYPE Small molecular drug D0S9FU DRUGINCH 1S/C25H26ClFN4O4/c1-32-21-12-20-17(23(29-15-28-20)30-16-2-3-19(27)18(26)10-16)11-22(21)33-7-6-31-13-24(4-5-24)25(14-31)34-8-9-35-25/h2-3,10-12,15H,4-9,13-14H2,1H3,(H,28,29,30) D0S9FU DRUGINKE OXWUWXCJDBRCCG-UHFFFAOYSA-N D0S9FU DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCN4CC5(CC5)C6(C4)OCCO6 D0S9FU HIGHSTAT Phase 1 D0S9OH DRUG__ID D0S9OH D0S9OH DRUGCOMP BioNumerik Pharmaceuticals D0S9OH DRUGTYPE Small molecular drug D0S9OH DRUGINCH 1S/C21H21N7O5/c1-10(19(30)31)8-14(20(32)33)26-18(29)12-5-2-11(3-6-12)4-7-13-9-24-17-15(25-13)16(22)27-21(23)28-17/h2-3,5-6,9,14H,1,4,7-8H2,(H,26,29)(H,30,31)(H,32,33)(H4,22,23,24,27,28)/t14-/m0/s1 D0S9OH DRUGINKE QCLDSHDOWCMFBV-AWEZNQCLSA-N D0S9OH DRUGSMIL C=C(CC(C(=O)O)NC(=O)C1=CC=C(C=C1)CCC2=CN=C3C(=N2)C(=NC(=N3)N)N)C(=O)O D0S9OH HIGHSTAT Phase 1 D0T0KT DRUG__ID D0T0KT D0T0KT DRUGCOMP Onconova therapeutics D0T0KT DRUGTYPE Small molecular drug D0T0KT DRUGINCH 1S/C19H23O10PS/c1-25-14-10-17(27-3)15(18(11-14)28-4)7-8-31(23,24)12-13-5-6-16(26-2)19(9-13)29-30(20,21)22/h5-11H,12H2,1-4H3,(H2,20,21,22)/b8-7+ D0T0KT DRUGINKE LXENKEWVEVKKGV-BQYQJAHWSA-N D0T0KT DRUGSMIL COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)OP(=O)(O)O D0T0KT HIGHSTAT Phase 1 D0T3DG DRUG__ID D0T3DG D0T3DG DRUGCOMP BrainCells D0T3DG DRUGTYPE Small molecular drug D0T3DG DRUGINCH 1S/C15H14Cl2FNO5/c16-8-2-1-6(3-9(8)17)5-24-10-4-7-11(14(7,18)12(20)21)15(10,19)13(22)23/h1-3,7,10-11H,4-5,19H2,(H,20,21)(H,22,23)/t7-,10-,11+,14-,15+/m1/s1 D0T3DG DRUGINKE LFAGGDAZZKUVKO-JAGWWQSPSA-N D0T3DG DRUGSMIL C1C2C(C2(C(=O)O)F)C(C1OCC3=CC(=C(C=C3)Cl)Cl)(C(=O)O)N D0T3DG HIGHSTAT Phase 1 D0T5AW DRUG__ID D0T5AW D0T5AW DRUGCOMP HF Arzneimittelforschung GmbH & Co KG D0T5AW DRUGTYPE Small molecular drug D0T5AW DRUGINCH 1S/C11H12N2/c1-2-5-10-9(4-1)8-13-7-3-6-11(13)12-10/h1-2,4-5H,3,6-8H2 D0T5AW DRUGINKE WUFQLZTXIWKION-UHFFFAOYSA-N D0T5AW DRUGSMIL C1CC2=NC3=CC=CC=C3CN2C1 D0T5AW HIGHSTAT Phase 1 D0T9FU DRUG__ID D0T9FU D0T9FU DRUGCOMP Nabriva Therapeutics AG D0T9FU DRUGTYPE Small molecular drug D0T9FU DRUGINCH 1S/C32H52N2O5S/c1-8-30(6)16-24(31(7)20(4)11-13-32(21(5)28(30)37)14-12-23(35)27(31)32)39-25(36)18-40-22-10-9-15-34(17-22)29(38)26(33)19(2)3/h8,19-22,24,26-28,37H,1,9-18,33H2,2-7H3/t20-,21+,22?,24-,26-,27+,28+,30-,31+,32+/m1/s1 D0T9FU DRUGINKE AFYOQRIZFPJUAR-UBTCORFISA-N D0T9FU DRUGSMIL CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCCN(C4)C(=O)C(C(C)C)N)C D0T9FU HIGHSTAT Phase 1 D0TJ3M DRUG__ID D0TJ3M D0TJ3M DRUGCOMP National Cancer Institute D0TJ3M DRUGTYPE Small molecular drug D0TJ3M DRUGINCH 1S/C14H21NO7S2/c1-12-10-14(5-4-13(12)11-16)15(6-8-21-23(2,17)18)7-9-22-24(3,19)20/h4-5,10-11H,6-9H2,1-3H3 D0TJ3M DRUGINKE CQVKMVQRSNNAGO-UHFFFAOYSA-N D0TJ3M DRUGSMIL CC1=C(C=CC(=C1)N(CCOS(=O)(=O)C)CCOS(=O)(=O)C)C=O D0TJ3M HIGHSTAT Phase 1 D0TX5P DRUG__ID D0TX5P D0TX5P DRUGCOMP Itherx D0TX5P DRUGTYPE Small molecular drug D0TX5P DRUGINCH 1S/C30H37N3O7S.ClH/c1-30(2,3)20-18-24(28(38-4)25(19-20)32-41(5,36)37)31-29(35)27(34)23-10-11-26(22-9-7-6-8-21(22)23)40-17-14-33-12-15-39-16-13-33;/h6-11,18-19,32H,12-17H2,1-5H3,(H,31,35);1H D0TX5P DRUGINKE ICIJBYYMEBOTQP-UHFFFAOYSA-N D0TX5P DRUGSMIL CC(C)(C)C1=CC(=C(C(=C1)NS(=O)(=O)C)OC)NC(=O)C(=O)C2=CC=C(C3=CC=CC=C32)OCCN4CCOCC4.Cl D0TX5P HIGHSTAT Phase 1 D0U1HN DRUG__ID D0U1HN D0U1HN DRUGCOMP Amira Pharmaceuticals Inc D0U1HN DRUGTYPE Small molecular drug D0U1HN DRUGINCH 1S/C27H27F3N2O4/c1-3-32(26(35)31-16-18-7-5-4-6-8-18)17-20-15-21(27(28,29)30)10-11-22(20)23-13-19(14-25(33)34)9-12-24(23)36-2/h4-13,15H,3,14,16-17H2,1-2H3,(H,31,35)(H,33,34) D0U1HN DRUGINKE OPXIRFWNLBDKQB-UHFFFAOYSA-N D0U1HN DRUGSMIL CCN(CC1=C(C=CC(=C1)C(F)(F)F)C2=C(C=CC(=C2)CC(=O)O)OC)C(=O)NCC3=CC=CC=C3 D0U1HN HIGHSTAT Phase 1 D0U3DP DRUG__ID D0U3DP D0U3DP DRUGCOMP Verastem D0U3DP DRUGTYPE Small molecular drug D0U3DP DRUGINCH 1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20) D0U3DP DRUGINKE QYBGBLQCOOISAR-UHFFFAOYSA-N D0U3DP DRUGSMIL CC1=NC2=C(N=C(N=C2N1C(C)C)N3CCOCC3)C4=CN=C(N=C4)N D0U3DP HIGHSTAT Phase 1 D0U6FT DRUG__ID D0U6FT D0U6FT DRUGCOMP Wyeth D0U6FT DRUGTYPE Small molecular drug D0U6FT DRUGINCH 1S/C11H18ClNO3S2/c1-3-8(4-2)9(7-14)13-18(15,16)11-6-5-10(12)17-11/h5-6,8-9,13-14H,3-4,7H2,1-2H3/t9-/m1/s1 D0U6FT DRUGINKE PYZFRRVBPNGCBX-SECBINFHSA-N D0U6FT DRUGSMIL CCC(CC)C(CO)NS(=O)(=O)C1=CC=C(S1)Cl D0U6FT HIGHSTAT Phase 1 D0U8QH DRUG__ID D0U8QH D0U8QH DRUGCOMP Genentech D0U8QH DRUGTYPE Small molecular drug D0U8QH DRUGINCH 1S/C24H32N6O3/c1-3-25-24(31)26-18-6-4-17(5-7-18)22-27-21-12-29(19-14-33-15-19)9-8-20(21)23(28-22)30-10-11-32-13-16(30)2/h4-7,16,19H,3,8-15H2,1-2H3,(H2,25,26,31)/t16-/m0/s1 D0U8QH DRUGINKE RGJOJUGRHPQXGF-INIZCTEOSA-N D0U8QH DRUGSMIL CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C D0U8QH HIGHSTAT Phase 1 D0UU1E DRUG__ID D0UU1E D0UU1E DRUGCOMP Chemigen D0UU1E DRUGTYPE Small molecular drug D0UU1E DRUGINCH 1S/C25H19NO3/c27-24-13-11-18(14-21(24)25(28)29)26-22-12-10-16-6-4-5-9-19(16)20(22)15-23(26)17-7-2-1-3-8-17/h1-9,11,13-15,27H,10,12H2,(H,28,29) D0UU1E DRUGINKE HAWWPSYXSLJRBO-UHFFFAOYSA-N D0UU1E DRUGSMIL C1CC2=C(C=C(N2C3=CC(=C(C=C3)O)C(=O)O)C4=CC=CC=C4)C5=CC=CC=C51 D0UU1E HIGHSTAT Phase 1 D0V2YJ DRUG__ID D0V2YJ D0V2YJ DRUGCOMP Merck & Co Inc D0V2YJ DRUGTYPE Small molecular drug D0V2YJ DRUGINCH 1S/C25H28F3N3O2/c1-29-11-10-23(22(28)15-29)30(2)24(33)31-14-17(20-12-19(26)8-9-21(20)27)13-25(31,16-32)18-6-4-3-5-7-18/h3-9,12-13,22-23,32H,10-11,14-16H2,1-2H3/t22-,23+,25-/m1/s1 D0V2YJ DRUGINKE MYBGWENAVMIGMM-GIFXNVAJSA-N D0V2YJ DRUGSMIL CN1CCC(C(C1)F)N(C)C(=O)N2CC(=CC2(CO)C3=CC=CC=C3)C4=C(C=CC(=C4)F)F D0V2YJ HIGHSTAT Phase 1 D0V5FQ DRUG__ID D0V5FQ D0V5FQ DRUGCOMP Novartis AG D0V5FQ DRUGTYPE Small molecular drug D0V5FQ DRUGINCH 1S/C25H24FNO6/c1-4-32-25(31)24(30)27-18-11-14(2)23(15(3)12-18)33-19-9-10-21(28)20(13-19)22(29)16-5-7-17(26)8-6-16/h5-13,22,28-29H,4H2,1-3H3,(H,27,30) D0V5FQ DRUGINKE FUBBWDWIGBTUPQ-UHFFFAOYSA-N D0V5FQ DRUGSMIL CCOC(=O)C(=O)NC1=CC(=C(C(=C1)C)OC2=CC(=C(C=C2)O)C(C3=CC=C(C=C3)F)O)C D0V5FQ HIGHSTAT Phase 1 D0V6XW DRUG__ID D0V6XW D0V6XW DRUGCOMP Cephalon D0V6XW DRUGTYPE Small molecular drug D0V6XW DRUGINCH 1S/C30H42ClN5O8/c1-38-16-17-39-18-19-40-20-21-41-22-23-43-30(37)44-25-36-13-10-27(11-14-36)35-29(34-24-32)33-12-4-2-3-5-15-42-28-8-6-26(31)7-9-28/h6-11,13-14H,2-5,12,15-23,25H2,1H3,(H,33,34)/p+1 D0V6XW DRUGINKE RXXJCNMVVRGOJB-UHFFFAOYSA-O D0V6XW DRUGSMIL COCCOCCOCCOCCOC(=O)OC[N+]1=CC=C(C=C1)NC(=NCCCCCCOC2=CC=C(C=C2)Cl)NC#N D0V6XW HIGHSTAT Phase 1 D0V7PL DRUG__ID D0V7PL D0V7PL DRUGCOMP Boehringer Ingelheim Corp D0V7PL DRUGTYPE Small molecular drug D0V7PL DRUGINCH 1S/C23H25N3O6/c1-30-20(27)12-17-11-18(25-22(17)28)13-32-19-9-7-15(8-10-19)14-3-5-16(6-4-14)21(24)26-23(29)31-2/h3-10,17-18H,11-13H2,1-2H3,(H,25,28)(H2,24,26,29)/t17-,18-/m0/s1 D0V7PL DRUGINKE PGCFXITVMNNKON-ROUUACIJSA-N D0V7PL DRUGSMIL COC(=O)CC1CC(NC1=O)COC2=CC=C(C=C2)C3=CC=C(C=C3)C(=NC(=O)OC)N D0V7PL HIGHSTAT Phase 1 D0VH3H DRUG__ID D0VH3H D0VH3H DRUGCOMP 7TM Pharma A/S D0VH3H DRUGTYPE Small molecular drug D0VH3H DRUGINCH 1S/C30H25Cl2F3N4OS/c1-2-23-27(29(40)37-38-16-4-3-5-17-38)36-39(25-14-11-21(31)18-24(25)32)28(23)26-15-13-22(41-26)12-8-19-6-9-20(10-7-19)30(33,34)35/h6-7,9-11,13-15,18H,2-5,16-17H2,1H3,(H,37,40) D0VH3H DRUGINKE VQOCBFYUDSBDCZ-UHFFFAOYSA-N D0VH3H DRUGSMIL CCC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(S4)C#CC5=CC=C(C=C5)C(F)(F)F D0VH3H HIGHSTAT Phase 1 D0VIG4 DRUG__ID D0VIG4 D0VIG4 DRUGCOMP Eli Lilly D0VIG4 DRUGTYPE Small molecular drug D0VIG4 DRUGINCH 1S/C26H39N7O3/c1-18(2)22-16-27-33-23(15-19(3)28-25(22)33)29-20-8-12-31(13-9-20)26(35)36-21-10-14-32(17-21)24(34)7-6-11-30(4)5/h6-7,15-16,18,20-21,29H,8-14,17H2,1-5H3/b7-6+/t21-/m0/s1 D0VIG4 DRUGINKE GRDAHPJRLCTJNA-BXKJMJEDSA-N D0VIG4 DRUGSMIL CC1=NC2=C(C=NN2C(=C1)NC3CCN(CC3)C(=O)OC4CCN(C4)C(=O)C=CCN(C)C)C(C)C D0VIG4 HIGHSTAT Phase 1 D0VO5S DRUG__ID D0VO5S D0VO5S DRUGCOMP Eli Lilly & Co D0VO5S DRUGTYPE Small molecular drug D0VO5S DRUGINCH 1S/C21H19F4N7/c1-31-10-17(13-2-3-16(22)15(8-13)21(23,24)25)29-19(31)12-4-6-32(7-5-12)20-14-9-28-30-18(14)26-11-27-20/h2-3,8-12H,4-7H2,1H3,(H,26,27,28,30) D0VO5S DRUGINKE FYXRSVDHGLUMHB-UHFFFAOYSA-N D0VO5S DRUGSMIL CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F D0VO5S HIGHSTAT Phase 1 D0W6LW DRUG__ID D0W6LW D0W6LW DRUGCOMP Biotron D0W6LW DRUGTYPE Small molecular drug D0W6LW DRUGINCH 1S/C16H15N5O/c1-21-9-12(8-19-21)13-4-2-3-10-7-11(5-6-14(10)13)15(22)20-16(17)18/h2-9H,1H3,(H4,17,18,20,22) D0W6LW DRUGINKE WVROWPPEIMRGAB-UHFFFAOYSA-N D0W6LW DRUGSMIL CN1C=C(C=N1)C2=CC=CC3=C2C=CC(=C3)C(=O)N=C(N)N D0W6LW HIGHSTAT Phase 1 D0W7LO DRUG__ID D0W7LO D0W7LO DRUGCOMP Pfizer D0W7LO DRUGTYPE Small molecular drug D0W7LO DRUGINCH 1S/C19H18N2O/c1-2-10-20-13-17-11-16-12-18(8-9-19(16)21-17)22-14-15-6-4-3-5-7-15/h1,3-9,11-12,20-21H,10,13-14H2 D0W7LO DRUGINKE YFPNAYXYKXAKJC-UHFFFAOYSA-N D0W7LO DRUGSMIL C#CCNCC1=CC2=C(N1)C=CC(=C2)OCC3=CC=CC=C3 D0W7LO HIGHSTAT Phase 1 D0W8XT DRUG__ID D0W8XT D0W8XT DRUGCOMP Tau therapeutics; cavion D0W8XT DRUGTYPE Small molecular drug D0W8XT DRUGINCH 1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1 D0W8XT DRUGINKE HBNPJJILLOYFJU-VMPREFPWSA-N D0W8XT DRUGSMIL CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F D0W8XT HIGHSTAT Phase 1 D0X2JM DRUG__ID D0X2JM D0X2JM DRUGCOMP Exelixis D0X2JM THERCLAS Anticancer Agents D0X2JM DRUGINCH 1S/C26H32BrF3N8O/c1-17-19(31-6-9-36-7-2-3-8-36)14-18(21(39)4-5-26(28,29)30)15-20(17)37-10-12-38(13-11-37)25-22-23(27)34-35-24(22)32-16-33-25/h14-16,31H,2-13H2,1H3,(H,32,33,34,35) D0X2JM DRUGINKE IKBSEBRGSVFUHM-UHFFFAOYSA-N D0X2JM DRUGSMIL CC1=C(C=C(C=C1N2CCN(CC2)C3=NC=NC4=NNC(=C43)Br)C(=O)CCC(F)(F)F)NCCN5CCCC5 D0X2JM HIGHSTAT Phase 1 D0X2NN DRUG__ID D0X2NN D0X2NN DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0X2NN DRUGTYPE Small molecular drug D0X2NN DRUGINCH 1S/C25H31N7O3/c1-25(29-15-22(33)34,24(35)32-11-3-4-12-32)17-7-10-20-19(13-17)30-21(31(20)2)14-28-18-8-5-16(6-9-18)23(26)27/h5-10,13,28-29H,3-4,11-12,14-15H2,1-2H3,(H3,26,27)(H,33,34)/t25-/m1/s1 D0X2NN DRUGINKE MAOALPSHCIBFJZ-RUZDIDTESA-N D0X2NN DRUGSMIL CC(C1=CC2=C(C=C1)N(C(=N2)CNC3=CC=C(C=C3)C(=N)N)C)(C(=O)N4CCCC4)NCC(=O)O D0X2NN HIGHSTAT Phase 1 D0X3CD DRUG__ID D0X3CD D0X3CD DRUGCOMP Access Pharmaceuticals D0X3CD DRUGTYPE Small molecular drug D0X3CD DRUGINCH 1S/C9H13N3O4S/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1 D0X3CD DRUGINKE GAKJJSAXUFZQTL-CCXZUQQUSA-N D0X3CD DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(S2)CO)O)O D0X3CD HIGHSTAT Phase 1 D0X8XT DRUG__ID D0X8XT D0X8XT DRUGCOMP Daiichi Sankyo D0X8XT DRUGTYPE Small molecular drug D0X8XT DRUGINCH 1S/C21H30N2O2/c1-16-7-9-17(10-8-16)5-4-6-20(25)19-12-11-18(23(19)3)13-14-21(2,22)15-24/h7-12,24H,4-6,13-15,22H2,1-3H3/t21-/m1/s1 D0X8XT DRUGINKE YXEQXPNSBUIRDZ-OAQYLSRUSA-N D0X8XT DRUGSMIL CC1=CC=C(C=C1)CCCC(=O)C2=CC=C(N2C)CCC(C)(CO)N D0X8XT HIGHSTAT Phase 1 D0XB1M DRUG__ID D0XB1M D0XB1M DRUGCOMP Medivir AB D0XB1M DRUGTYPE Small molecular drug D0XB1M DRUGINCH 1S/C19H17FN4O3/c1-2-15(25)11-4-5-13(20)17(18(11)26)12-7-14(12)23-19(27)24-16-6-3-10(8-21)9-22-16/h3-6,9,12,14,26H,2,7H2,1H3,(H2,22,23,24,27)/t12-,14+/m0/s1 D0XB1M DRUGINKE NKPHEWJJTGPRSL-GXTWGEPZSA-N D0XB1M DRUGSMIL CCC(=O)C1=C(C(=C(C=C1)F)C2CC2NC(=O)NC3=NC=C(C=C3)C#N)O D0XB1M HIGHSTAT Phase 1 D0Y4HO DRUG__ID D0Y4HO D0Y4HO DRUGCOMP Deutsches Krebsforschungszentrum D0Y4HO DRUGTYPE Small molecular drug D0Y4HO DRUGINCH 1S/C11H16OS2.K/c13-11(14)12-10-5-6-4-9(10)8-3-1-2-7(6)8;/h6-10H,1-5H2,(H,13,14);/q;+1/p-1/t6-,7-,8-,9-,10+;/m1./s1 D0Y4HO DRUGINKE IGULCCCBGBDZKQ-UATZLORTSA-M D0Y4HO DRUGSMIL C1CC2C(C1)C3CC2CC3OC(=S)[S-].[K+] D0Y4HO HIGHSTAT Phase 1 D0Y4OI DRUG__ID D0Y4OI D0Y4OI DRUGCOMP SmithKline Beecham plc D0Y4OI DRUGTYPE Small molecular drug D0Y4OI DRUGINCH 1S/C18H17N3OS/c1-23(22)15-6-4-13(5-7-15)17-18(14-8-10-19-11-9-14)21-12-2-3-16(21)20-17/h4-11H,2-3,12H2,1H3 D0Y4OI DRUGINKE KSEJZTWORQXILM-UHFFFAOYSA-N D0Y4OI DRUGSMIL CS(=O)C1=CC=C(C=C1)C2=C(N3CCCC3=N2)C4=CC=NC=C4 D0Y4OI HIGHSTAT Phase 1 D0Y5QD DRUG__ID D0Y5QD D0Y5QD DRUGCOMP EntreMed D0Y5QD DRUGTYPE Small molecular drug D0Y5QD DRUGINCH 1S/C20H25NO2/c1-20-8-3-4-17(20)14-6-5-12-10-16(19(21)22)18(23-2)11-15(12)13(14)7-9-20/h3,8,10-11,13-14,17H,4-7,9H2,1-2H3,(H2,21,22)/t13-,14+,17-,20-/m0/s1 D0Y5QD DRUGINKE YQJWOUQGXATDAE-ACNBBOPNSA-N D0Y5QD DRUGSMIL CC12CCC3C(C1CC=C2)CCC4=CC(=C(C=C34)OC)C(=O)N D0Y5QD HIGHSTAT Phase 1 D0Y8BW DRUG__ID D0Y8BW D0Y8BW DRUGCOMP Janssen research & development D0Y8BW DRUGTYPE Small molecular drug D0Y8BW DRUGINCH 1S/C32H38N4O6S/c1-34-13-15-42-16-14-35(2)43(39,40)33-31(37)22-9-11-27-28(19-22)36-20-24(32(34)38)17-23-18-25(41-3)10-12-26(23)30(36)29(27)21-7-5-4-6-8-21/h9-12,17-19,21H,4-8,13-16,20H2,1-3H3,(H,33,37) D0Y8BW DRUGINKE UOBYJVFBFSLCTQ-UHFFFAOYSA-N D0Y8BW DRUGSMIL CN1CCOCCN(S(=O)(=O)NC(=O)C2=CC3=C(C=C2)C(=C4N3CC(=CC5=C4C=CC(=C5)OC)C1=O)C6CCCCC6)C D0Y8BW HIGHSTAT Phase 1 D0Y9XO DRUG__ID D0Y9XO D0Y9XO DRUGCOMP Novartis AG D0Y9XO DRUGTYPE Small molecular drug D0Y9XO DRUGINCH 1S/C25H29NO5/c1-24(2,3)20(27)16-8-12-18(13-9-16)22(26-30-7)31-23(29)19-14-10-17(11-15-19)21(28)25(4,5)6/h8-15H,1-7H3/b26-22+ D0Y9XO DRUGINKE YXIAKADBIZQTQI-XTCLZLMSSA-N D0Y9XO DRUGSMIL CC(C)(C)C(=O)C1=CC=C(C=C1)C(=NOC)OC(=O)C2=CC=C(C=C2)C(=O)C(C)(C)C D0Y9XO HIGHSTAT Phase 1 D0YT8P DRUG__ID D0YT8P D0YT8P DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0YT8P DRUGTYPE Small molecular drug D0YT8P DRUGINCH 1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3 D0YT8P DRUGINKE JRWCBEOAFGHNNU-UHFFFAOYSA-N D0YT8P DRUGSMIL CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2 D0YT8P HIGHSTAT Phase 1 D0Z0AM DRUG__ID D0Z0AM D0Z0AM DRUGCOMP Pfizer D0Z0AM DRUGTYPE Small molecular drug D0Z0AM DRUGINCH 1S/C21H18ClNO3/c22-14-8-5-12(6-9-14)11-17-20(24)18(21(25)26)16-10-7-13-3-1-2-4-15(13)19(16)23-17/h5-10,24H,1-4,11H2,(H,25,26) D0Z0AM DRUGINKE DIEPFYNZGUUVHD-UHFFFAOYSA-N D0Z0AM DRUGSMIL C1CCC2=C(C1)C=CC3=C(C(=C(N=C23)CC4=CC=C(C=C4)Cl)O)C(=O)O D0Z0AM HIGHSTAT Phase 1 D0Z1RJ DRUG__ID D0Z1RJ D0Z1RJ DRUGCOMP Mayo Foundation D0Z1RJ DRUGTYPE Small molecular drug D0Z1RJ DRUGINCH 1S/C24H27NO4/c26-21-5-6-22(27)19(10-21)14-25-20-3-1-18(2-4-20)23(28)29-24-11-15-7-16(12-24)9-17(8-15)13-24/h1-6,10,15-17,25-27H,7-9,11-14H2 D0Z1RJ DRUGINKE YJZSUCFGHXQWDM-UHFFFAOYSA-N D0Z1RJ DRUGSMIL C1C2CC3CC1CC(C2)(C3)OC(=O)C4=CC=C(C=C4)NCC5=C(C=CC(=C5)O)O D0Z1RJ HIGHSTAT Phase 1 D0Z2FD DRUG__ID D0Z2FD D0Z2FD DRUGCOMP Exelixis; Bristol-Myers Squibb D0Z2FD DRUGTYPE Small molecular drug D0Z2FD DRUGINCH 1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31) D0Z2FD DRUGINKE MMNNTJYFHUDSKL-UHFFFAOYSA-N D0Z2FD DRUGSMIL CC1=C(C=C(C=C1)Cl)N2C(=O)C3=CC=CC=C3C2(C4=CC5=C(C=C4)N=C(N5)NC(=O)OC)O D0Z2FD HIGHSTAT Phase 1 D0Z4RC DRUG__ID D0Z4RC D0Z4RC DRUGCOMP Curis D0Z4RC DRUGTYPE Small molecular drug D0Z4RC DRUGINCH 1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27) D0Z4RC DRUGINKE PLIVFNIUGLLCEK-UHFFFAOYSA-N D0Z4RC DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO D0Z4RC HIGHSTAT Phase 1 D0Z5DM DRUG__ID D0Z5DM D0Z5DM DRUGCOMP Institute of Medicinal Molecular Design Inc D0Z5DM DRUGTYPE Small molecular drug D0Z5DM DRUGINCH 1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25) D0Z5DM DRUGINKE CHILCFMQWMQVAL-UHFFFAOYSA-N D0Z5DM DRUGSMIL C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O D0Z5DM HIGHSTAT Phase 1 D0Z6WI DRUG__ID D0Z6WI D0Z6WI DRUGCOMP Euro-peptides SA D0Z6WI DRUGTYPE Small molecular drug D0Z6WI DRUGINCH 1S/C46H58N10O5/c1-26-32(29-13-4-7-16-35(29)50-26)23-39(53-42(57)20-12-22-48)44(59)55-41(25-34-28(3)52-37-18-9-6-15-31(34)37)46(61)56-40(45(60)54-38(43(49)58)19-10-11-21-47)24-33-27(2)51-36-17-8-5-14-30(33)36/h4-9,13-18,38-41,50-52H,10-12,19-25,47-48H2,1-3H3,(H2,49,58)(H,53,57)(H,54,60)(H,55,59)(H,56,61)/t38-,39+,40-,41+/m0/s1 D0Z6WI DRUGINKE DFXFDNPRHWLXON-AANMMBORSA-N D0Z6WI DRUGSMIL CC1=C(C2=CC=CC=C2N1)CC(C(=O)NC(CC3=C(NC4=CC=CC=C43)C)C(=O)NC(CC5=C(NC6=CC=CC=C65)C)C(=O)NC(CCCCN)C(=O)N)NC(=O)CCCN D0Z6WI HIGHSTAT Phase 1 D0Z7BE DRUG__ID D0Z7BE D0Z7BE DRUGCOMP Humanetics Corp D0Z7BE DRUGTYPE Small molecular drug D0Z7BE DRUGINCH 1S/C11H11N3O3/c12-5-6-13-10(15)7-14-9-3-1-8(2-4-9)11(16)17/h1-4,14H,6-7H2,(H,13,15)(H,16,17) D0Z7BE DRUGINKE ILTWRLHXJMWZHP-UHFFFAOYSA-N D0Z7BE DRUGSMIL C1=CC(=CC=C1C(=O)O)NCC(=O)NCC#N D0Z7BE HIGHSTAT Phase 1 D0Z9RJ DRUG__ID D0Z9RJ D0Z9RJ DRUGCOMP Gilead Sciences D0Z9RJ DRUGTYPE Small molecular drug D0Z9RJ DRUGINCH 1S/C21H24FN5O4S/c22-11-4-1-2-7-15(11)32-8-14-17(29)18(30)21(31-14)27-10-25-16-19(23-9-24-20(16)27)26-12-5-3-6-13(12)28/h1-2,4,7,9-10,12-14,17-18,21,28-30H,3,5-6,8H2,(H,23,24,26)/t12-,13-,14-,17-,18-,21-/m1/s1 D0Z9RJ DRUGINKE IZRXENCTXNMAMI-DIJFLQFKSA-N D0Z9RJ DRUGSMIL C1CC(C(C1)O)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CSC5=CC=CC=C5F)O)O D0Z9RJ HIGHSTAT Phase 1 D0ZI5A DRUG__ID D0ZI5A D0ZI5A DRUGCOMP Pfizer New York, NY D0ZI5A DRUGTYPE Small molecular drug D0ZI5A DRUGINCH 1S/C26H27N3O5/c1-17-25(26(30)27-2)21-6-4-19(16-24(21)33-17)34-23-7-8-28-22-15-18(3-5-20(22)23)32-14-11-29-9-12-31-13-10-29/h3-8,15-16H,9-14H2,1-2H3,(H,27,30) D0ZI5A DRUGINKE LGXVKMDGSIWEHL-UHFFFAOYSA-N D0ZI5A DRUGSMIL CC1=C(C2=C(O1)C=C(C=C2)OC3=C4C=CC(=CC4=NC=C3)OCCN5CCOCC5)C(=O)NC D0ZI5A HIGHSTAT Phase 1 D10LNV DRUG__ID D10LNV D10LNV DRUGCOMP Meryx D10LNV DRUGTYPE Small molecular drug D10LNV DRUGINCH 1S/C29H40N6O/c1-33-14-16-34(17-15-33)19-22-4-6-23(7-5-22)27-20-35(24-8-10-25(36)11-9-24)28-26(27)18-31-29(32-28)30-13-12-21-2-3-21/h4-7,18,20-21,24-25,36H,2-3,8-17,19H2,1H3,(H,30,31,32) D10LNV DRUGINKE LBEJYFVJIPQSNX-UHFFFAOYSA-N D10LNV DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)C3=CN(C4=NC(=NC=C34)NCCC5CC5)C6CCC(CC6)O D10LNV HIGHSTAT Phase 1 D15BZU DRUG__ID D15BZU D15BZU DRUGCOMP Reviva Pharmaceuticals D15BZU DRUGTYPE Small molecule D15BZU DRUGINCH InChI=1S/C22H25Cl2N3O3/c23-17-4-3-5-19(22(17)24)27-11-9-26(10-12-27)8-1-2-13-29-16-6-7-20-18(14-16)25-21(28)15-30-20/h3-7,14H,1-2,8-13,15H2,(H,25,28) D15BZU DRUGINKE PMKMNTBZJOXTJW-UHFFFAOYSA-N D15BZU DRUGSMIL C1CN(CCN1CCCCOC2=CC3=C(C=C2)OCC(=O)N3)C4=C(C(=CC=C4)Cl)Cl D15BZU HIGHSTAT Phase 1 D15ZUR DRUG__ID D15ZUR D15ZUR DRUGCOMP Roche D15ZUR DRUGTYPE Small molecular drug D15ZUR DRUGINCH 1S/C27H34ClN7OS/c1-17-18(2)37-27-24(17)25(20-6-8-21(28)9-7-20)30-22(26-32-31-19(3)35(26)27)16-23(36)29-10-5-11-34-14-12-33(4)13-15-34/h6-9,22H,5,10-16H2,1-4H3,(H,29,36)/t22-/m0/s1 D15ZUR DRUGINKE PKQXLRYFPSZKDU-QFIPXVFZSA-N D15ZUR DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NCCCN4CCN(CC4)C)C5=CC=C(C=C5)Cl)C D15ZUR HIGHSTAT Phase 1 D1BG7C DRUG__ID D1BG7C D1BG7C DRUGCOMP Boston Pharmaceuticals D1BG7C DRUGTYPE Small molecular drug D1BG7C DRUGINCH 1S/2C25H23F3N4O4.C6H10O4/c2*1-24(2,25(26,27)28)21-11-23(36-32-21)31-22(33)7-14-5-6-17(29-12-14)16-8-15-9-19(34-3)20(35-4)10-18(15)30-13-16;7-5(8)3-1-2-4-6(9)10/h2*5-6,8-13H,7H2,1-4H3,(H,31,33);1-4H2,(H,7,8)(H,9,10) D1BG7C DRUGINKE KIKHVJAFGVCFGH-UHFFFAOYSA-N D1BG7C DRUGSMIL CC(C)(C1=NOC(=C1)NC(=O)CC2=CN=C(C=C2)C3=CN=C4C=C(C(=CC4=C3)OC)OC)C(F)(F)F.CC(C)(C1=NOC(=C1)NC(=O)CC2=CN=C(C=C2)C3=CN=C4C=C(C(=CC4=C3)OC)OC)C(F)(F)F.C(CCC(=O)O)CC(=O)O D1BG7C HIGHSTAT Phase 1 D1RLY2 DRUG__ID D1RLY2 D1RLY2 DRUGCOMP Avalo Therapeutics Wayne, PA D1RLY2 DRUGTYPE Small molecule D1RLY2 DRUGINCH InChI=1S/C21H22N6O3/c1-30-15-4-2-3-13-9-14(25-16(13)15)17-18-19(22)23-10-24-27(18)20(26-17)11-5-7-12(8-6-11)21(28)29/h2-4,9-12,25H,5-8H2,1H3,(H,28,29)(H2,22,23,24) D1RLY2 DRUGINKE JROFGZPOBKIAEW-UHFFFAOYSA-N D1RLY2 DRUGSMIL COC1=CC=CC2=C1NC(=C2)C3=C4C(=NC=NN4C(=N3)C5CCC(CC5)C(=O)O)N D1RLY2 HIGHSTAT Phase 1 D1TNJ2 DRUG__ID D1TNJ2 D1TNJ2 DRUGCOMP Exelixis D1TNJ2 DRUGTYPE Small molecular drug D1TNJ2 DRUGINCH 1S/C29H25FN4O5/c1-31-26(35)22-15-21-23(16-25(22)38-2)32-14-11-24(21)39-20-9-7-19(8-10-20)34-28(37)29(12-13-29)27(36)33-18-5-3-17(30)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,35)(H,33,36)(H,34,37) D1TNJ2 DRUGINKE JSPCKALGNNVYOO-UHFFFAOYSA-N D1TNJ2 DRUGSMIL CNC(=O)C1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F D1TNJ2 HIGHSTAT Phase 1 D1TS9A DRUG__ID D1TS9A D1TS9A DRUGCOMP Pfzer D1TS9A DRUGTYPE Small molecule D1TS9A DRUGINCH InChI=1S/C24H30N6O4/c1-13-12-30(5)28-15(13)22(24(2)9-6-7-10-24)27-17-16(20(32)21(17)33)26-14-8-11-25-18(19(14)31)23(34)29(3)4/h8,11-12,22,27,31H,6-7,9-10H2,1-5H3,(H,25,26)/t22-/m0/s1 D1TS9A DRUGINKE WZBSYWCLIMRAHO-QFIPXVFZSA-N D1TS9A DRUGSMIL CC1=CN(N=C1C(C2(CCCC2)C)NC3=C(C(=O)C3=O)NC4=C(C(=NC=C4)C(=O)N(C)C)O)C D1TS9A HIGHSTAT Phase 1 D2GJ4P DRUG__ID D2GJ4P D2GJ4P DRUGCOMP Sumitomo Dainippon Pharma D2GJ4P DRUGTYPE Small molecular drug D2GJ4P DRUGINCH 1S/C21H21ClNO8P/c1-23-7-6-12(16(26)10-23)19-18(31-32(27,28)29)9-15(25)20-14(24)8-17(30-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,16,25-26H,6-7,10H2,1H3,(H2,27,28,29)/t12-,16+/m0/s1 D2GJ4P DRUGINKE YRNFLVUMZIRYKY-BLLLJJGKSA-N D2GJ4P DRUGSMIL CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)OP(=O)(O)O D2GJ4P HIGHSTAT Phase 1 D34RXC DRUG__ID D34RXC D34RXC DRUGCOMP Vincerx Pharma Palo Alto, CA D34RXC DRUGTYPE Small molecule D34RXC DRUGINCH InChI=1S/C19H18F2N4O2S/c1-27-17-8-13(20)3-4-14(17)15-9-19(24-10-16(15)21)25-18-7-12(5-6-23-18)11-28(2,22)26/h3-10,22H,11H2,1-2H3,(H,23,24,25)/t28-/m0/s1 D34RXC DRUGINKE YZCUMZWULWOUMD-NDEPHWFRSA-N D34RXC DRUGSMIL COC1=C(C=CC(=C1)F)C2=CC(=NC=C2F)NC3=NC=CC(=C3)CS(=N)(=O)C D34RXC HIGHSTAT Phase 1 D34YLZ DRUG__ID D34YLZ D34YLZ DRUGCOMP Allyx Therapeutics D34YLZ DRUGTYPE Small molecule D34YLZ DRUGINCH InChI=1S/C22H15ClN2O2/c23-19-9-5-4-8-18(19)21-20(25-22(26)27-21)17-12-16(13-24-14-17)11-10-15-6-2-1-3-7-15/h1-9,12-14,20-21H,(H,25,26)/t20-,21-/m1/s1 D34YLZ DRUGINKE IAYVUQJOKDFLAL-NHCUHLMSSA-N D34YLZ DRUGSMIL C1=CC=C(C=C1)C#CC2=CC(=CN=C2)C3C(OC(=O)N3)C4=CC=CC=C4Cl D34YLZ HIGHSTAT Phase 1 D39UDP DRUG__ID D39UDP D39UDP DRUGCOMP Pfzer D39UDP DRUGTYPE Small molecule D39UDP DRUGINCH InChI=1S/C25H27FN6O2/c1-15(18-12-21(34-3)29-13-20(18)26)24(33)32-10-7-25(14-32)6-5-17-11-19(16(2)30-22(17)31-25)23-27-8-4-9-28-23/h4,8-9,11-13,15H,5-7,10,14H2,1-3H3,(H,30,31)/t15-,25+/m1/s1 D39UDP DRUGINKE PARGFYLSRQUWHR-BZQUYTCOSA-N D39UDP DRUGSMIL CC1=C(C=C2CCC3(CCN(C3)C(=O)C(C)C4=CC(=NC=C4F)OC)NC2=N1)C5=NC=CC=N5 D39UDP HIGHSTAT Phase 1 D3C9RJ DRUG__ID D3C9RJ D3C9RJ DRUGCOMP Lung Therapeutics D3C9RJ DRUGTYPE Peptide D3C9RJ DRUGINCH InChI=1S/C39H57N7O12/c1-19(2)28(35(53)46-32(23(6)50)39(57)58)42-37(55)31(22(5)49)44-34(52)27(18-25-15-11-8-12-16-25)41-36(54)29(20(3)47)45-38(56)30(21(4)48)43-33(51)26(40)17-24-13-9-7-10-14-24/h7-16,19-23,26-32,47-50H,17-18,40H2,1-6H3,(H,41,54)(H,42,55)(H,43,51)(H,44,52)(H,45,56)(H,46,53)(H,57,58)/t20-,21-,22-,23-,26+,27+,28+,29+,30+,31+,32+/m1/s1 D3C9RJ DRUGINKE MPQBITKUSWZKQD-DVPOGPKQSA-N D3C9RJ DRUGSMIL CC(C)C(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)N D3C9RJ HIGHSTAT Phase 1 D3OWG9 DRUG__ID D3OWG9 D3OWG9 DRUGCOMP EMD Serono D3OWG9 DRUGTYPE Small molecular drug D3OWG9 DRUGINCH 1S/C23H22N.ClHO4/c1-15-13-16(2)22(17(3)14-15)23-18-9-5-7-11-20(18)24(4)21-12-8-6-10-19(21)23;2-1(3,4)5/h5-14H,1-4H3;(H,2,3,4,5)/q+1;/p-1 D3OWG9 DRUGINKE LFMBERYWDLWXNO-UHFFFAOYSA-M D3OWG9 DRUGSMIL CC1=CC(=C(C(=C1)C)C2=C3C=CC=CC3=[N+](C4=CC=CC=C42)C)C.[O-]Cl(=O)(=O)=O D3OWG9 HIGHSTAT Phase 1 D3S2UY DRUG__ID D3S2UY D3S2UY DRUGCOMP Gilead Sciences D3S2UY DRUGTYPE Small molecular drug D3S2UY DRUGINCH 1S/C13H12ClF3N2O/c14-11-3-7(13(15,16)17)6-18-12(11)19-8-1-2-9(19)5-10(20)4-8/h3,6,8-9H,1-2,4-5H2 D3S2UY DRUGINKE AEMSNEYRKJMXAR-UHFFFAOYSA-N D3S2UY DRUGSMIL C1CC2CC(=O)CC1N2C3=C(C=C(C=N3)C(F)(F)F)Cl D3S2UY HIGHSTAT Phase 1 D3U8YR DRUG__ID D3U8YR D3U8YR DRUGCOMP Moleculin Biotech D3U8YR DRUGTYPE Small molecular drug D3U8YR DRUGINCH 1S/C19H16BrN3O/c1-14(15-7-3-2-4-8-15)22-19(24)16(13-21)9-5-10-17-11-6-12-18(20)23-17/h2-12,14H,1H3,(H,22,24)/b10-5+,16-9+/t14-/m0/s1 D3U8YR DRUGINKE IVAUEQVCSQZMGV-QIUCFAMLSA-N D3U8YR DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C(=CC=CC2=NC(=CC=C2)Br)C#N D3U8YR HIGHSTAT Phase 1 D4VZ2A DRUG__ID D4VZ2A D4VZ2A DRUGCOMP TransThera Biosciences D4VZ2A DRUGTYPE Small molecular drug D4VZ2A DRUGINCH 1S/C20H19ClN6O/c1-12-18-20(26-25-12)23-16-10-17(27-6-8-28-9-7-27)22-11-14(16)19(24-18)13-4-2-3-5-15(13)21/h2-5,10-11H,6-9H2,1H3,(H2,23,25,26) D4VZ2A DRUGINKE DQFCVOOFMXEPOC-UHFFFAOYSA-N D4VZ2A DRUGSMIL CC1=C2C(=NN1)NC3=CC(=NC=C3C(=N2)C4=CC=CC=C4Cl)N5CCOCC5 D4VZ2A HIGHSTAT Phase 1 D53BVX DRUG__ID D53BVX D53BVX DRUGCOMP Altimmune Gaithersburg, MD D53BVX DRUGTYPE Small molecule D53BVX DRUGINCH InChI=1S/C178H270N38O53/c1-15-97(8)142(173(264)199-117(64-69-134(183)224)158(249)206-128(84-106-88-188-112-50-37-36-49-110(106)112)167(258)202-122(78-95(4)5)162(253)200-121(77-94(2)3)161(252)197-118(65-70-135(184)225)160(251)215-143(100(11)219)149(185)240)214-170(261)127(81-103-47-33-30-34-48-103)204-159(250)120(67-72-139(231)232)196-155(246)114(51-38-41-73-179)193-151(242)99(10)191-150(241)98(9)192-154(245)113(53-40-43-75-187-175(266)148-146(238)145(237)147(239)176(269-148)268-76-44-28-26-24-22-20-18-16-17-19-21-23-25-27-35-54-137(227)228)194-157(248)119(66-71-138(229)230)198-168(259)129(86-140(233)234)207-163(254)123(79-96(6)7)201-164(255)124(82-104-55-59-108(221)60-56-104)203-156(247)115(52-39-42-74-180)195-171(262)131(91-217)210-165(256)125(83-105-57-61-109(222)62-58-105)205-169(260)130(87-141(235)236)208-172(263)132(92-218)211-166(257)126(80-102-45-31-29-32-46-102)209-174(265)144(101(12)220)213-136(226)90-189-153(244)116(63-68-133(182)223)212-177(267)178(13,14)216-152(243)111(181)85-107-89-186-93-190-107/h29-34,36-37,45-50,55-62,88-89,93-101,111,113-132,142-148,176,188,217-222,237-239H,15-28,35,38-44,51-54,63-87,90-92,179-181H2,1-14H3,(H2,182,223)(H2,183,224)(H2,184,225)(H2,185,240)(H,186,190)(H,187,266)(H,189,244)(H,191,241)(H,192,245)(H,193,242)(H,194,248)(H,195,262)(H,196,246)(H,197,252)(H,198,259)(H,199,264)(H,200,253)(H,201,255)(H,202,258)(H,203,247)(H,204,250)(H,205,260)(H,206,249)(H,207,254)(H,208,263)(H,209,265)(H,210,256)(H,211,257)(H,212,267)(H,213,226)(H,214,261)(H,215,251)(H,216,243)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)/t97-,98-,99-,100+,101+,111-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,142-,143-,144-,145-,146-,147+,148-,176+/m0/s1 D53BVX DRUGINKE PNRXPXQSTNKDJB-VGUJMDGVSA-N D53BVX DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCCCNC(=O)C4C(C(C(C(O4)OCCCCCCCCCCCCCCCCCC(=O)O)O)O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(CC8=CNC=N8)N D53BVX HIGHSTAT Phase 1 D54WUR DRUG__ID D54WUR D54WUR DRUGCOMP Iterion Therapeutics Houston, TX D54WUR DRUGTYPE Small molecule D54WUR DRUGINCH InChI=1S/C28H36N4O6S2/c1-17-9-18(2)14-31(13-17)39(35,36)21-5-7-23-25(11-21)28(30-34)26-12-22(6-8-24(26)27(23)29-33)40(37,38)32-15-19(3)10-20(4)16-32/h5-8,11-12,17-20,29,33H,9-10,13-16H2,1-4H3/t17-,18+,19-,20+ D54WUR DRUGINKE OMWCXCBGEFHCTN-FGYAAKKASA-N D54WUR DRUGSMIL CC1CC(CN(C1)S(=O)(=O)C2=CC3=C(C=C2)C(=C4C=CC(=CC4=C3N=O)S(=O)(=O)N5CC(CC(C5)C)C)NO)C D54WUR HIGHSTAT Phase 1 D5GI0O DRUG__ID D5GI0O D5GI0O DRUGCOMP Veana Therapeutics D5GI0O DRUGTYPE Small molecular drug D5GI0O DRUGINCH 1S/C31H52O4/c1-21(2)12-9-13-22(3)14-10-15-23(4)16-11-18-31(8)19-17-27-26(7)29(34-20-28(32)33)24(5)25(6)30(27)35-31/h21-23H,9-20H2,1-8H3,(H,32,33)/t22-,23-,31-/m1/s1 D5GI0O DRUGINKE LCFWOFKPFDWYLR-CEFNRUSXSA-N D5GI0O DRUGSMIL CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OCC(=O)O)C D5GI0O HIGHSTAT Phase 1 D5T7QW DRUG__ID D5T7QW D5T7QW DRUGCOMP Lexicon Pharmaceuticals D5T7QW DRUGTYPE Small molecular drug D5T7QW DRUGINCH 1S/C32H47N3O6S/c1-20-10-15-23(29-27(38)26(37)28(39)30(41-29)42-6)19-24(20)18-22-13-11-21(12-14-22)8-7-9-25(36)34-32(2,3)31(40)33-16-17-35(4)5/h10-15,19,26-30,37-39H,7-9,16-18H2,1-6H3,(H,33,40)(H,34,36)/t26-,27-,28+,29+,30-/m1/s1 D5T7QW DRUGINKE BNPZTRDIESRGTC-IXYVTWBDSA-N D5T7QW DRUGSMIL CC1=C(C=C(C=C1)C2C(C(C(C(O2)SC)O)O)O)CC3=CC=C(C=C3)CCCC(=O)NC(C)(C)C(=O)NCCN(C)C D5T7QW HIGHSTAT Phase 1 D5W7BG DRUG__ID D5W7BG D5W7BG DRUGCOMP Merganser Biotech D5W7BG DRUGTYPE Small molecular drug D5W7BG DRUGINCH 1S/C7H6Cl2/c8-7(9)6-4-2-1-3-5-6/h1-5,7H D5W7BG DRUGINKE CAHQGWAXKLQREW-UHFFFAOYSA-N D5W7BG DRUGSMIL C1=CC=C(C=C1)C(Cl)Cl D5W7BG HIGHSTAT Phase 1 D5WU7B DRUG__ID D5WU7B D5WU7B DRUGCOMP Cend Therapeutics D5WU7B DRUGTYPE Peptide D5WU7B DRUGINCH 1S/C35H57N13O14S2/c36-8-2-1-5-18-30(57)42-14-25(50)48-10-4-7-23(48)33(60)46-21(12-27(53)54)32(59)47-22(34(61)62)16-64-63-15-17(37)28(55)44-19(6-3-9-40-35(38)39)29(56)41-13-24(49)43-20(11-26(51)52)31(58)45-18/h17-23H,1-16,36-37H2,(H,41,56)(H,42,57)(H,43,49)(H,44,55)(H,45,58)(H,46,60)(H,47,59)(H,51,52)(H,53,54)(H,61,62)(H4,38,39,40)/t17-,18-,19-,20-,21-,22-,23-/m0/s1 D5WU7B DRUGINKE YHTTWXCDIRTOQX-FQJIPJFPSA-N D5WU7B DRUGSMIL C1CC2C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)N2C1)CCCCN)CC(=O)O)CCCN=C(N)N)N)C(=O)O)CC(=O)O D5WU7B HIGHSTAT Phase 1 D6P9OU DRUG__ID D6P9OU D6P9OU DRUGCOMP Oncoceutics D6P9OU DRUGTYPE Small molecular drug D6P9OU DRUGINCH 1S/C23H22F2N4O/c24-18-7-6-17(20(25)12-18)14-29-22(30)19-15-27(13-16-4-2-1-3-5-16)10-8-21(19)28-11-9-26-23(28)29/h1-7,12H,8-11,13-15H2 D6P9OU DRUGINKE ITMGVSSHWMTJRR-UHFFFAOYSA-N D6P9OU DRUGSMIL C1CN(CC2=C1N3CCN=C3N(C2=O)CC4=C(C=C(C=C4)F)F)CC5=CC=CC=C5 D6P9OU HIGHSTAT Phase 1 D7CE6N DRUG__ID D7CE6N D7CE6N DRUGCOMP Arcus Biosciences D7CE6N DRUGTYPE Small molecular drug D7CE6N DRUGINCH 1S/C20H24ClFN4O9P2/c1-10(11-4-2-3-5-13(11)22)24-14-6-16(21)25-19-12(14)7-23-26(19)20-18(28)17(27)15(35-20)8-34-37(32,33)9-36(29,30)31/h2-7,10,15,17-18,20,27-28H,8-9H2,1H3,(H,24,25)(H,32,33)(H2,29,30,31)/t10-,15+,17+,18+,20+/m0/s1 D7CE6N DRUGINKE MFYLCAMJNGIULC-KCVUFLITSA-N D7CE6N DRUGSMIL CC(C1=CC=CC=C1F)NC2=CC(=NC3=C2C=NN3C4C(C(C(O4)COP(=O)(CP(=O)(O)O)O)O)O)Cl D7CE6N HIGHSTAT Phase 1 D7GTX4 DRUG__ID D7GTX4 D7GTX4 DRUGCOMP Biogen D7GTX4 DRUGTYPE Small molecule D7GTX4 DRUGINCH InChI=1S/C28H34N10O2/c1-28(2,3)38-15-25(34-35-38)26(39)32-24-8-10-37(21-16-40-17-21)13-19-11-18(5-6-22(19)24)23-7-9-29-27(33-23)31-20-12-30-36(4)14-20/h5-7,9,11-12,14-15,21,24H,8,10,13,16-17H2,1-4H3,(H,32,39)(H,29,31,33)/t24-/m1/s1 D7GTX4 DRUGINKE JSAQBOQCZJHWMA-XMMPIXPASA-N D7GTX4 DRUGSMIL CC(C)(C)N1C=C(N=N1)C(=O)NC2CCN(CC3=C2C=CC(=C3)C4=NC(=NC=C4)NC5=CN(N=C5)C)C6COC6 D7GTX4 HIGHSTAT Phase 1 D7HZ3T DRUG__ID D7HZ3T D7HZ3T DRUGCOMP Ignyta D7HZ3T DRUGTYPE Small molecular drug D7HZ3T DRUGINCH 1S/C31H26F2N4O6/c1-17(2)36-16-22(30(39)37(31(36)40)20-8-5-18(32)6-9-20)29(38)35-19-7-10-26(23(33)13-19)43-25-11-12-34-24-15-28(42-4)27(41-3)14-21(24)25/h5-17H,1-4H3,(H,35,38) D7HZ3T DRUGINKE FKCWHHYUMFGOPY-UHFFFAOYSA-N D7HZ3T DRUGSMIL CC(C)N1C=C(C(=O)N(C1=O)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C5C=C(C(=CC5=NC=C4)OC)OC)F D7HZ3T HIGHSTAT Phase 1 D7KRB9 DRUG__ID D7KRB9 D7KRB9 DRUGCOMP Roche D7KRB9 DRUGTYPE Small molecule D7KRB9 DRUGINCH InChI=1S/C20H29N3O3S/c1-2-23-11-9-16(10-12-23)27(25,26)22-20(24)21-19-17-7-3-5-14(17)13-15-6-4-8-18(15)19/h13,16H,2-12H2,1H3,(H2,21,22,24) D7KRB9 DRUGINKE OHIFQOUPTWBQLE-UHFFFAOYSA-N D7KRB9 DRUGSMIL CCN1CCC(CC1)S(=O)(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4 D7KRB9 HIGHSTAT Phase 1 D7LC8N DRUG__ID D7LC8N D7LC8N DRUGCOMP Novartis; Servier D7LC8N DRUGTYPE Small molecular drug D7LC8N DRUGINCH 1S/C47H44ClFN6O6S/c1-29-34(16-17-38(42(29)48)59-25-24-55-22-20-54(2)21-23-55)40-41-45(51-28-52-46(41)62-43(40)30-12-14-32(49)15-13-30)61-39(47(56)57)26-31-8-4-6-10-36(31)60-27-33-18-19-50-44(53-33)35-9-5-7-11-37(35)58-3/h4-19,28,39H,20-27H2,1-3H3,(H,56,57)/t39-/m1/s1 D7LC8N DRUGINKE PKYIMGFMRFVOMB-LDLOPFEMSA-N D7LC8N DRUGSMIL CC1=C(C=CC(=C1Cl)OCCN2CCN(CC2)C)C3=C(SC4=NC=NC(=C34)OC(CC5=CC=CC=C5OCC6=NC(=NC=C6)C7=CC=CC=C7OC)C(=O)O)C8=CC=C(C=C8)F D7LC8N HIGHSTAT Phase 1 D7M8LI DRUG__ID D7M8LI D7M8LI DRUGCOMP Turning Point Therapeutics D7M8LI DRUGTYPE Small molecular drug D7M8LI DRUGINCH 1S/C20H20FN7O2/c1-3-27-10-13-12(8-22)14(21)4-5-15(13)30-11(2)9-24-20(29)17-18(23)26-28-7-6-16(27)25-19(17)28/h4-7,11H,3,9-10H2,1-2H3,(H2,23,26)(H,24,29)/t11-/m0/s1 D7M8LI DRUGINKE UUDPUQDMSHQSKH-NSHDSACASA-N D7M8LI DRUGSMIL CCN1CC2=C(C=CC(=C2C#N)F)OC(CNC(=O)C3=C4N=C1C=CN4N=C3N)C D7M8LI HIGHSTAT Phase 1 D7PX3O DRUG__ID D7PX3O D7PX3O DRUGCOMP TB D7PX3O DRUGTYPE Small molecule D7PX3O DRUGINCH InChI=1S/C17H20FN3O5/c1-24-15(22)19-5-12-6-21(16(23)26-12)11-2-3-14(13(18)4-11)20-7-17(8-20)9-25-10-17/h2-4,12H,5-10H2,1H3,(H,19,22)/t12-/m0/s1 D7PX3O DRUGINKE ZNBRXLSWXJKKLJ-LBPRGKRZSA-N D7PX3O DRUGSMIL COC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CC4(C3)COC4)F D7PX3O HIGHSTAT Phase 1 D7X8AQ DRUG__ID D7X8AQ D7X8AQ DRUGCOMP EMD Serono D7X8AQ DRUGTYPE Small molecular drug D7X8AQ DRUGINCH 1S/C17H20BNO5/c20-17(13-8-11-5-6-15(13)24-11)19-16(18(21)22)7-10-9-23-14-4-2-1-3-12(10)14/h1-4,9,11,13,15-16,21-22H,5-8H2,(H,19,20)/t11-,13-,15+,16+/m1/s1 D7X8AQ DRUGINKE RFQDLTYXNINJON-OYNZBZHQSA-N D7X8AQ DRUGSMIL B(C(CC1=COC2=CC=CC=C21)NC(=O)C3CC4CCC3O4)(O)O D7X8AQ HIGHSTAT Phase 1 D7YN4H DRUG__ID D7YN4H D7YN4H DRUGCOMP Nurix D7YN4H DRUGTYPE Small molecule D7YN4H DRUGINCH InChI=1S/C39H45N9O5/c40-35(50)34-36(43-32(21-41-34)46-15-2-1-3-16-46)42-27-6-4-25(5-7-27)26-13-17-45(18-14-26)22-24-12-19-47(23-24)28-8-9-29-30(20-28)39(53)48(38(29)52)31-10-11-33(49)44-37(31)51/h4-9,20-21,24,26,31H,1-3,10-19,22-23H2,(H2,40,50)(H,42,43)(H,44,49,51)/t24-,31?/m0/s1 D7YN4H DRUGINKE XLWJWCMQMBVNSG-ACXKHFGCSA-N D7YN4H DRUGSMIL C1CCN(CC1)C2=CN=C(C(=N2)NC3=CC=C(C=C3)C4CCN(CC4)CC5CCN(C5)C6=CC7=C(C=C6)C(=O)N(C7=O)C8CCC(=O)NC8=O)C(=O)N D7YN4H HIGHSTAT Phase 1 D7Z1CR DRUG__ID D7Z1CR D7Z1CR DRUGCOMP Sumitomo Dainippon Pharma D7Z1CR DRUGTYPE Small molecular drug D7Z1CR DRUGINCH 1S/C22H25F3N4O/c1-21(2,30)15-6-8-17(9-7-15)27-19-10-11-20-26-13-18(29(20)28-19)14-4-3-5-16(12-14)22(23,24)25/h3-5,10-13,15,17,30H,6-9H2,1-2H3,(H,27,28) D7Z1CR DRUGINKE XRNVABDYQLHODA-UHFFFAOYSA-N D7Z1CR DRUGSMIL CC(C)(C1CCC(CC1)NC2=NN3C(=NC=C3C4=CC(=CC=C4)C(F)(F)F)C=C2)O D7Z1CR HIGHSTAT Phase 1 D81YNE DRUG__ID D81YNE D81YNE DRUGCOMP Treadwell Therapeutics D81YNE DRUGTYPE Small molecular drug D81YNE DRUGINCH 1S/C28H30N6O3/c1-17-10-19(5-8-22(17)27(35)32-20-6-7-20)23-16-31-34-24(30-14-18-12-28(2,36)13-18)11-25(33-26(23)34)37-21-4-3-9-29-15-21/h3-5,8-11,15-16,18,20,30,36H,6-7,12-14H2,1-2H3,(H,32,35) D81YNE DRUGINKE PMQUGSPFUBGJCZ-UHFFFAOYSA-N D81YNE DRUGSMIL CC1=C(C=CC(=C1)C2=C3N=C(C=C(N3N=C2)NCC4CC(C4)(C)O)OC5=CN=CC=C5)C(=O)NC6CC6 D81YNE HIGHSTAT Phase 1 D8XK7F DRUG__ID D8XK7F D8XK7F DRUGCOMP Regulus Therapeutics D8XK7F DRUGTYPE Oligonucleotide D8XK7F DRUGINCH 1S/C95H115F3N32O51P8S8/c1-32-92(22-131)65(61(162-32)83(170-92)128-29-110-50-69(102)106-27-108-71(50)128)179-189(150,197)160-25-95-35(4)164-63(84(173-95)130-31-112-52-73(130)119-86(104)121-75(52)137)67(95)180-186(147,194)157-21-40-56(58(151-5)79(168-40)124-13-8-42(100)114-88(124)139)177-185(146,193)155-19-38-55(48(98)78(167-38)127-28-109-49-68(101)105-26-107-70(49)127)176-183(144,191)154-17-36-53(46(96)76(165-36)122-12-7-41(99)113-87(122)138)174-182(143,190)153-18-37-54(47(97)77(166-37)123-14-9-43(132)115-89(123)140)175-184(145,192)156-20-39-57(59(152-6)80(169-39)125-15-10-44(133)116-90(125)141)178-187(148,195)159-24-94-34(3)163-62(82(172-94)126-16-11-45(134)117-91(126)142)66(94)181-188(149,196)158-23-93-33(2)161-60(64(93)135)81(171-93)129-30-111-51-72(129)118-85(103)120-74(51)136/h7-16,26-40,46-48,53-67,76-84,131,135H,17-25H2,1-6H3,(H,143,190)(H,144,191)(H,145,192)(H,146,193)(H,147,194)(H,148,195)(H,149,196)(H,150,197)(H2,99,113,138)(H2,100,114,139)(H2,101,105,107)(H2,102,106,108)(H,115,132,140)(H,116,133,141)(H,117,134,142)(H3,103,118,120,136)(H3,104,119,121,137)/t32-,33-,34-,35-,36+,37+,38+,39+,40+,46+,47+,48+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64-,65-,66-,67-,76+,77+,78+,79+,80+,81+,82+,83+,84+,92-,93-,94-,95-,182?,183?,184?,185?,186?,187?,188?,189?/m0/s1 D8XK7F DRUGINKE WAVSYQSKUSIMAY-IOHKGNKKSA-N D8XK7F DRUGSMIL CC1C2(C(C(O1)C(O2)N3C=NC4=C(N=CN=C43)N)OP(=S)(O)OCC56C(OC(C5OP(=O)(OCC7C(C(C(O7)N8C=CC(=NC8=O)N)OC)OP(=S)(O)OCC9C(C(C(O9)N1C=NC2=C(N=CN=C21)N)F)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)F)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)F)OP(=S)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)OP(=S)(O)OCC12C(OC(C1OP(=S)(O)OCC13C(OC(C1O)C(O3)N1C=NC3=C1N=C(NC3=O)N)C)C(O2)N1C=CC(=O)NC1=O)C)S)C(O6)N1C=NC2=C1N=C(NC2=O)N)C)CO D8XK7F HIGHSTAT Phase 1 D92KUQ DRUG__ID D92KUQ D92KUQ DRUGCOMP Arrien Pharmaceuticals; Boston Pharmaceuticals D92KUQ DRUGTYPE Small molecular drug D92KUQ DRUGINCH 1S/C21H21F3N2O3/c1-28-19-12-15-13(11-18(19)26-5-7-29-8-6-26)9-14(20(15)27)10-17-16(21(22,23)24)3-2-4-25-17/h2-4,11-12,14H,5-10H2,1H3 D92KUQ DRUGINKE CQSDLVKTQRLMJB-UHFFFAOYSA-N D92KUQ DRUGSMIL COC1=C(C=C2CC(C(=O)C2=C1)CC3=C(C=CC=N3)C(F)(F)F)N4CCOCC4 D92KUQ HIGHSTAT Phase 1 D9FT0A DRUG__ID D9FT0A D9FT0A DRUGCOMP Rigel D9FT0A DRUGTYPE Small molecular drug D9FT0A DRUGINCH 1S/C4H5NS2/c1-6-4-5-2-3-7-4/h2-3H,1H3 D9FT0A DRUGINKE VQNOAXZUEKPSJC-UHFFFAOYSA-N D9FT0A DRUGSMIL CSC1=NC=CS1 D9FT0A HIGHSTAT Phase 1 D9HQE2 DRUG__ID D9HQE2 D9HQE2 DRUGCOMP Pop Test Cortisol Cliffside Park, NJ D9HQE2 DRUGTYPE Small molecule D9HQE2 DRUGINCH InChI=1S/C28H30O4/c1-3-11-28(30)12-10-23-21-7-4-17-13-19(29)6-8-20(17)26(21)22(15-27(23,28)2)18-5-9-24-25(14-18)32-16-31-24/h5,9,13-14,21-23,30H,4,6-8,10,12,15-16H2,1-2H3/t21?,22-,23?,27+,28+/m1/s1 D9HQE2 DRUGINKE DFELGYQKEOCHOA-RBXNTRDFSA-N D9HQE2 DRUGSMIL CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC6=C(C=C5)OCO6)C)O D9HQE2 HIGHSTAT Phase 1 DA03JS DRUG__ID DA03JS DA03JS DRUGCOMP Lantheus DA03JS DRUGTYPE Small molecule DA03JS DRUGINCH InChI=1S/C19H25IN4O8/c20-11-4-6-12(7-5-11)22-18(31)21-10-2-1-3-13(16(27)28)23-19(32)24-14(17(29)30)8-9-15(25)26/h4-7,13-14H,1-3,8-10H2,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)(H2,23,24,32)/t13-,14-/m0/s1 DA03JS DRUGINKE LFEGKCKGGNXWDV-KBPBESRZSA-N DA03JS DRUGSMIL C1=CC(=CC=C1NC(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)I DA03JS HIGHSTAT Phase 1 DAT0U5 DRUG__ID DAT0U5 DAT0U5 DRUGCOMP Navitor Pharmaceuticals DAT0U5 DRUGTYPE Small molecular drug DAT0U5 DRUGINCH 1S/C7H13F2NO2/c1-7(2,6(8)9)3-4(10)5(11)12/h4,6H,3,10H2,1-2H3,(H,11,12)/t4-/m0/s1 DAT0U5 DRUGINKE HRFIMCJTDKEPPV-BYPYZUCNSA-N DAT0U5 DRUGSMIL CC(C)(CC(C(=O)O)N)C(F)F DAT0U5 HIGHSTAT Phase 1 DAY4L1 DRUG__ID DAY4L1 DAY4L1 DRUGCOMP Syntrix Biosystems DAY4L1 DRUGTYPE Small molecular drug DAY4L1 DRUGINCH 1S/C19H14BF4N3O4S/c21-13-1-3-14(4-2-13)27-17(28)12-8-25-18(26-9-12)32-10-11-7-15(31-19(22,23)24)5-6-16(11)20(29)30/h1-9,29-30H,10H2,(H,27,28) DAY4L1 DRUGINKE SDUDZBCEHIZMFZ-UHFFFAOYSA-N DAY4L1 DRUGSMIL B(C1=C(C=C(C=C1)OC(F)(F)F)CSC2=NC=C(C=N2)C(=O)NC3=CC=C(C=C3)F)(O)O DAY4L1 HIGHSTAT Phase 1 DB5O1U DRUG__ID DB5O1U DB5O1U DRUGCOMP H3 Biomedicine DB5O1U DRUGTYPE Small molecular drug DB5O1U DRUGINCH 1S/C31H45N3O6/c1-22(26-11-6-7-16-32-26)9-8-10-23(2)29-24(3)12-13-27(39-30(37)34-19-17-33(5)18-20-34)31(4,38)15-14-25(35)21-28(36)40-29/h6-13,16,22,24-25,27,29,35,38H,14-15,17-21H2,1-5H3/b9-8+,13-12+,23-10+/t22-,24+,25-,27+,29-,31-/m1/s1 DB5O1U DRUGINKE YOIQWBAHJZGRFW-WVRLKXNASA-N DB5O1U DRUGSMIL CC1C=CC(C(CCC(CC(=O)OC1C(=CC=CC(C)C2=CC=CC=N2)C)O)(C)O)OC(=O)N3CCN(CC3)C DB5O1U HIGHSTAT Phase 1 DB7W8H DRUG__ID DB7W8H DB7W8H DRUGCOMP Plus Therapeutics Austin, TX DB7W8H DRUGTYPE Small molecule DB7W8H DRUGINCH InChI=1S/Re/i1+0 DB7W8H DRUGINKE WUAPFZMCVAUBPE-IGMARMGPSA-N DB7W8H DRUGSMIL [Re] DB7W8H HIGHSTAT Phase 1 DBI81F DRUG__ID DBI81F DBI81F DRUGCOMP Amgen DBI81F DRUGTYPE Small molecular drug DBI81F DRUGINCH 1S/C42H57ClN4O5S/c1-29-8-6-18-42(51-3,27-45-20-21-46-19-5-4-10-35(46)25-45)37-14-11-33(37)24-47-26-41(17-7-9-31-22-34(43)13-15-36(31)41)28-52-39-16-12-32(23-38(39)47)40(48)44-53(49,50)30(29)2/h6,12-13,15-16,18,22-23,29-30,33,35,37H,4-5,7-11,14,17,19-21,24-28H2,1-3H3,(H,44,48)/b18-6+/t29-,30+,33-,35+,37+,41-,42-/m0/s1 DBI81F DRUGINKE BJTFTQIBRVBSBH-VCQPVEJUSA-N DBI81F DRUGSMIL CC1CC=CC(C2CCC2CN3CC4(CCCC5=C4C=CC(=C5)Cl)COC6=C3C=C(C=C6)C(=O)NS(=O)(=O)C1C)(CN7CCN8CCCCC8C7)OC DBI81F HIGHSTAT Phase 1 DCN2U9 DRUG__ID DCN2U9 DCN2U9 DRUGCOMP Nabriva Therapeutics DCN2U9 DRUGTYPE Small molecular drug DCN2U9 DRUGINCH 1S/C29H40O5S/c1-6-27(4)15-23(34-24(32)17-35-21-9-7-8-20(14-21)16-30)28(5)18(2)10-12-29(19(3)26(27)33)13-11-22(31)25(28)29/h6-9,14,18-19,23,25-26,30,33H,1,10-13,15-17H2,2-5H3/t18-,19+,23-,25+,26+,27-,28+,29+/m1/s1 DCN2U9 DRUGINKE KELRBTWVTDHIHS-KGTFJIFRSA-N DCN2U9 DRUGSMIL CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4=CC=CC(=C4)CO)C DCN2U9 HIGHSTAT Phase 1 DCWT40 DRUG__ID DCWT40 DCWT40 DRUGCOMP Salarius Pharmaceuticals DCWT40 DRUGTYPE Small molecular drug DCWT40 DRUGINCH 1S/C20H23ClN4O4S/c1-14(18-13-16(21)6-7-19(18)26)22-23-20(27)15-4-3-5-17(12-15)30(28,29)25-10-8-24(2)9-11-25/h3-7,12-13,26H,8-11H2,1-2H3,(H,23,27)/b22-14+ DCWT40 DRUGINKE MVSQDUZRRVBYLA-HYARGMPZSA-N DCWT40 DRUGSMIL CC(=NNC(=O)C1=CC(=CC=C1)S(=O)(=O)N2CCN(CC2)C)C3=C(C=CC(=C3)Cl)O DCWT40 HIGHSTAT Phase 1 DD36YG DRUG__ID DD36YG DD36YG DRUGCOMP Meiji Seika Pharma DD36YG DRUGTYPE Small molecular drug DD36YG DRUGINCH 1S/C9H16N4O7S/c10-3-4-19-11-8(14)7-2-1-6-5-12(7)9(15)13(6)20-21(16,17)18/h6-7H,1-5,10H2,(H,11,14)(H,16,17,18)/t6-,7+/m1/s1 DD36YG DRUGINKE RSBPYSTVZQAADE-RQJHMYQMSA-N DD36YG DRUGSMIL C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NOCCN DD36YG HIGHSTAT Phase 1 DDE6F1 DRUG__ID DDE6F1 DDE6F1 DRUGCOMP GlaxoSmithKline DDE6F1 DRUGTYPE Small molecule DDE6F1 DRUGINCH InChI=1S/C24H28N6O5S/c1-14-11-30(12-15(2)34-14)13-18-9-26-23(35-18)19-5-16(6-21-20(19)10-27-28-21)17-7-22(29-36(4,31)32)24(33-3)25-8-17/h5-10,14-15,29H,11-13H2,1-4H3,(H,27,28)/t14-,15+ DDE6F1 DRUGINKE NLUPPCTVKHDVIQ-GASCZTMLSA-N DDE6F1 DRUGSMIL CC1CN(CC(O1)C)CC2=CN=C(O2)C3=C4C=NNC4=CC(=C3)C5=CC(=C(N=C5)OC)NS(=O)(=O)C DDE6F1 HIGHSTAT Phase 1 DDXH71 DRUG__ID DDXH71 DDXH71 DRUGCOMP Gibson Oncology DDXH71 DRUGTYPE Small molecular drug DDXH71 DRUGINCH 1S/C24H24N2O7/c1-30-17-8-13-16(11-18(17)31-2)24(29)26(6-3-4-25-5-7-27)22-14-9-19-20(33-12-32-19)10-15(14)23(28)21(13)22/h8-11,25,27H,3-7,12H2,1-2H3 DDXH71 DRUGINKE QCSDJDQOJBQTDV-UHFFFAOYSA-N DDXH71 DRUGSMIL COC1=C(C=C2C(=C1)C3=C(C4=CC5=C(C=C4C3=O)OCO5)N(C2=O)CCCNCCO)OC DDXH71 HIGHSTAT Phase 1 DE8OJ0 DRUG__ID DE8OJ0 DE8OJ0 DRUGCOMP Zydus Cadila DE8OJ0 DRUGTYPE Small molecular drug DE8OJ0 DRUGINCH 1S/C16H16N2O6/c19-12(20)7-17-15(22)13-14(21)10-3-1-2-4-11(10)18(16(13)23)24-8-9-5-6-9/h1-4,9,21H,5-8H2,(H,17,22)(H,19,20) DE8OJ0 DRUGINKE IKRKQQLJYBAPQT-UHFFFAOYSA-N DE8OJ0 DRUGSMIL C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O DE8OJ0 HIGHSTAT Phase 1 DEZV54 DRUG__ID DEZV54 DEZV54 DRUGCOMP Spero Therapeutics DEZV54 DRUGTYPE Small molecular drug DEZV54 DRUGINCH 1S/C52H82ClN15O12/c1-27(2)21-38-48(76)62-34(13-17-54)44(72)61-36(15-19-56)47(75)68-42(28(3)69)51(79)59-20-16-37(46(74)60-35(14-18-55)45(73)65-39(49(77)64-38)22-30-9-6-5-7-10-30)63-50(78)40(26-58)66-52(80)43(29(4)70)67-41(71)24-32(25-57)31-11-8-12-33(53)23-31/h5-12,23,27-29,32,34-40,42-43,69-70H,13-22,24-26,54-58H2,1-4H3,(H,59,79)(H,60,74)(H,61,72)(H,62,76)(H,63,78)(H,64,77)(H,65,73)(H,66,80)(H,67,71)(H,68,75)/t28-,29-,32-,34+,35+,36+,37+,38+,39-,40+,42+,43+/m1/s1 DEZV54 DRUGINKE VAZVBVUQVUHPMS-DFEDBOKMSA-N DEZV54 DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CN)NC(=O)C(C(C)O)NC(=O)CC(CN)C3=CC(=CC=C3)Cl)C(C)O)CCN)CCN DEZV54 HIGHSTAT Phase 1 DFZ0V3 DRUG__ID DFZ0V3 DFZ0V3 DRUGCOMP Janssen DFZ0V3 DRUGTYPE Small molecular drug DFZ0V3 DRUGINCH 1S/C22H23BrN6O2/c23-15-8-12-3-1-11(7-16(12)28-21(15)25)2-4-13-9-17(19(31)18(13)30)29-6-5-14-20(24)26-10-27-22(14)29/h1,3,5-8,10,13,17-19,30-31H,2,4,9H2,(H2,25,28)(H2,24,26,27)/t13-,17+,18+,19-/m0/s1 DFZ0V3 DRUGINKE DBSMLQTUDJVICQ-CJODITQLSA-N DFZ0V3 DRUGSMIL C1C(C(C(C1N2C=CC3=C(N=CN=C32)N)O)O)CCC4=CC5=NC(=C(C=C5C=C4)Br)N DFZ0V3 HIGHSTAT Phase 1 DGV8K5 DRUG__ID DGV8K5 DGV8K5 DRUGCOMP GlaxoSmithKline DGV8K5 DRUGTYPE Small molecular drug DGV8K5 DRUGINCH 1S/C17H15ClN2O4/c1-10(13-4-2-3-7-19-13)23-16-9-15-11(8-12(16)18)14(20-24-15)5-6-17(21)22/h2-4,7-10H,5-6H2,1H3,(H,21,22)/t10-/m1/s1 DGV8K5 DRUGINKE WPAHVUADNLXSOM-SNVBAGLBSA-N DGV8K5 DRUGSMIL CC(C1=CC=CC=N1)OC2=C(C=C3C(=C2)ON=C3CCC(=O)O)Cl DGV8K5 HIGHSTAT Phase 1 DH5F4M DRUG__ID DH5F4M DH5F4M DRUGCOMP Oryn Therapeutics Vacaville, CA DH5F4M DRUGTYPE Small molecule DH5F4M DRUGINCH InChI=1S/C82H137N33O19S6/c1-8-41(6)60-76(133)112-56-38-140-136-34-52(110-68(125)50(30-43-17-10-9-11-18-43)100-57(117)31-98-63(120)45(20-13-25-94-79(85)86)105-77(134)61(42(7)116)115-74(56)131)70(127)103-47(22-15-27-96-81(89)90)65(122)107-53-35-137-139-37-55(73(130)114-60)108-66(123)48(23-16-28-97-82(91)92)104-71(128)54-36-138-135-33-51(109-67(124)49(29-39(2)3)106-72(53)129)69(126)102-46(21-14-26-95-80(87)88)64(121)101-44(19-12-24-93-78(83)84)62(119)99-32-58(118)113-59(40(4)5)75(132)111-54/h9-11,17-18,39-42,44-56,59-61,116H,8,12-16,19-38H2,1-7H3,(H,98,120)(H,99,119)(H,100,117)(H,101,121)(H,102,126)(H,103,127)(H,104,128)(H,105,134)(H,106,129)(H,107,122)(H,108,123)(H,109,124)(H,110,125)(H,111,132)(H,112,133)(H,113,118)(H,114,130)(H,115,131)(H4,83,84,93)(H4,85,86,94)(H4,87,88,95)(H4,89,90,96)(H4,91,92,97)/t41-,42+,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,59-,60-,61-/m0/s1 DH5F4M DRUGINKE BEOLWJVNPROZQJ-AQSKNYQYSA-N DH5F4M DRUGSMIL CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC3CSSCC(C(=O)N1)NC(=O)C(NC(=O)C4CSSCC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N4)C(C)C)CCCNC(=N)N)CCCNC(=N)N)NC(=O)C(NC3=O)CC(C)C)CCCNC(=N)N)CCCNC(=N)N)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC2=O)C(C)O)CCCNC(=N)N)CC5=CC=CC=C5 DH5F4M HIGHSTAT Phase 1 DHYZ53 DRUG__ID DHYZ53 DHYZ53 DRUGCOMP GlaxoSmithKline DHYZ53 DRUGTYPE Small molecular drug DHYZ53 DRUGINCH 1S/C20H38N4O2/c1-5-25-15-20(16-26-6-2)9-7-17(8-10-20)19-18(13-22-23-19)14-24(4)12-11-21-3/h13,17,21H,5-12,14-16H2,1-4H3,(H,22,23) DHYZ53 DRUGINKE SPEGERVLTUWZPA-UHFFFAOYSA-N DHYZ53 DRUGSMIL CCOCC1(CCC(CC1)C2=C(C=NN2)CN(C)CCNC)COCC DHYZ53 HIGHSTAT Phase 1 DI1L7M DRUG__ID DI1L7M DI1L7M DRUGCOMP Pfizer DI1L7M DRUGTYPE Small molecular drug DI1L7M DRUGINCH 1S/C22H24Cl2N2O5/c1-11-6-17(29-2)15(21(27)25-11)8-26-5-4-13-16(23)7-14(19(24)18(13)22(26)28)20(30-3)12-9-31-10-12/h6-7,12,20H,4-5,8-10H2,1-3H3,(H,25,27)/t20-/m1/s1 DI1L7M DRUGINKE RXCVUHMIWHRLDF-HXUWFJFHSA-N DI1L7M DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C(C4COC4)OC)Cl)OC DI1L7M HIGHSTAT Phase 1 DI6EL3 DRUG__ID DI6EL3 DI6EL3 DRUGCOMP 1ST Biotherapeutics, Inc. DI6EL3 DRUGTYPE Small molecule DI6EL3 DRUGINCH InChI=1S/C19H23F2N3O2/c20-14-16(22)13-9-11(19(25)26)10-24(12-5-6-12)17(13)15(21)18(14)23-7-3-1-2-4-8-23/h10,12H,1-9,22H2,(H,25,26) DI6EL3 DRUGINKE XIADACXCBGCKCI-UHFFFAOYSA-N DI6EL3 DRUGSMIL C1CCCN(CC1)C2=C(C(=C3CC(=CN(C3=C2F)C4CC4)C(=O)O)N)F DI6EL3 HIGHSTAT Phase 1 DIX61C DRUG__ID DIX61C DIX61C DRUGCOMP Bristol-Myers Squibb DIX61C DRUGTYPE Small molecular drug DIX61C DRUGINCH 1S/C21H21NO4S/c1-22-12-19(16-5-3-4-6-17(16)21(22)23)18-11-15(27(2,24)25)9-10-20(18)26-13-14-7-8-14/h3-6,9-12,14H,7-8,13H2,1-2H3 DIX61C DRUGINKE UWZAJPITKGWMFJ-UHFFFAOYSA-N DIX61C DRUGSMIL CN1C=C(C2=CC=CC=C2C1=O)C3=C(C=CC(=C3)S(=O)(=O)C)OCC4CC4 DIX61C HIGHSTAT Phase 1 DJ0P6A DRUG__ID DJ0P6A DJ0P6A DRUGCOMP Palobiofarma DJ0P6A DRUGTYPE Small molecular drug DJ0P6A DRUGINCH 1S/C9H8BrN7/c1-2-3-13-8-6(10)7(11)15-9(16-8)17-5-12-4-14-17/h1,4-5H,3H2,(H3,11,13,15,16) DJ0P6A DRUGINKE OQCWNHHZPYJHQR-UHFFFAOYSA-N DJ0P6A DRUGSMIL C#CCNC1=NC(=NC(=C1Br)N)N2C=NC=N2 DJ0P6A HIGHSTAT Phase 1 DJ74CB DRUG__ID DJ74CB DJ74CB DRUGCOMP Viking Therapeutics San Diego, CA DJ74CB DRUGTYPE Small molecule DJ74CB DRUGINCH InChI=1S/C23H25O5P/c1-16-10-21(28-15-29(25,26)27)11-17(2)22(16)14-19-8-9-23(24)20(13-19)12-18-6-4-3-5-7-18/h3-11,13,24H,12,14-15H2,1-2H3,(H2,25,26,27) DJ74CB DRUGINKE GFJCILQBXUTOGN-UHFFFAOYSA-N DJ74CB DRUGSMIL CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)CC3=CC=CC=C3)C)OCP(=O)(O)O DJ74CB HIGHSTAT Phase 1 DJ7K9G DRUG__ID DJ7K9G DJ7K9G DRUGCOMP Ribon Therapeutics DJ7K9G DRUGTYPE Small molecular drug DJ7K9G DRUGINCH 1S/C20H23F6N7O3/c1-12(30-14-10-29-31-17(35)16(14)20(24,25)26)11-36-7-2-15(34)32-3-5-33(6-4-32)18-27-8-13(9-28-18)19(21,22)23/h8-10,12H,2-7,11H2,1H3,(H2,30,31,35)/t12-/m0/s1 DJ7K9G DRUGINKE UQZCQKXJAXKZQH-LBPRGKRZSA-N DJ7K9G DRUGSMIL CC(COCCC(=O)N1CCN(CC1)C2=NC=C(C=N2)C(F)(F)F)NC3=C(C(=O)NN=C3)C(F)(F)F DJ7K9G HIGHSTAT Phase 1 DJ8QW7 DRUG__ID DJ8QW7 DJ8QW7 DRUGCOMP Pfzer DJ8QW7 DRUGTYPE Small molecule DJ8QW7 DRUGINCH InChI=1S/C19H19ClF2N4O3S/c1-11-13(6-7-14-16(11)19(27)26(2)10-23-14)24-18-12(22)4-5-15(17(18)20)25-30(28,29)9-3-8-21/h4-7,10,24-25H,3,8-9H2,1-2H3 DJ8QW7 DRUGINKE VVLVISDSGRHLMB-UHFFFAOYSA-N DJ8QW7 DRUGSMIL CC1=C(C=CC2=C1C(=O)N(C=N2)C)NC3=C(C=CC(=C3Cl)NS(=O)(=O)CCCF)F DJ8QW7 HIGHSTAT Phase 1 DK26FL DRUG__ID DK26FL DK26FL DRUGCOMP Cyclacel Pharmaceuticals DK26FL DRUGTYPE Small molecular drug DK26FL DRUGINCH 1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30-/m0/s1 DK26FL DRUGINKE BBAWEDCPNXPBQM-YQYHUCGXSA-N DK26FL DRUGSMIL CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5 DK26FL HIGHSTAT Phase 1 DKCU40 DRUG__ID DKCU40 DKCU40 DRUGCOMP Fosun Pharmaceutical DKCU40 DRUGTYPE Small molecular drug DKCU40 DRUGINCH 1S/C22H25N9O/c1-30-8-10-31(11-9-30)13-15-2-4-16(5-3-15)27-22(32)19-18(12-26-29-19)28-21-17-6-7-23-20(17)24-14-25-21/h2-7,12,14H,8-11,13H2,1H3,(H,26,29)(H,27,32)(H2,23,24,25,28) DKCU40 DRUGINKE VXLAKHWYGRKCGI-UHFFFAOYSA-N DKCU40 DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)NC(=O)C3=C(C=NN3)NC4=NC=NC5=C4C=CN5 DKCU40 HIGHSTAT Phase 1 DKW80C DRUG__ID DKW80C DKW80C DRUGCOMP Gilead DKW80C DRUGTYPE Small molecule DKW80C DRUGINCH InChI=1S/C4HCl2IN2/c5-3-2(7)1-8-4(6)9-3/h1H DKW80C DRUGINKE RGJNPJRAXMSHKN-UHFFFAOYSA-N DKW80C DRUGSMIL C1=C(C(=NC(=N1)Cl)Cl)I DKW80C HIGHSTAT Phase 1 DL8T4I DRUG__ID DL8T4I DL8T4I DRUGCOMP Sun Pharma Advanced Research Company DL8T4I DRUGTYPE Small molecular drug DL8T4I DRUGINCH 1S/C27H20ClN3O2/c1-17-10-12-22(26(32)30-31-27(33)25-18(2)6-5-8-23(25)28)15-20(17)13-11-19-14-21-7-3-4-9-24(21)29-16-19/h3-10,12,14-16H,1-2H3,(H,30,32)(H,31,33) DL8T4I DRUGINKE ZQOBVMHBVWNVBG-UHFFFAOYSA-N DL8T4I DRUGSMIL CC1=C(C(=CC=C1)Cl)C(=O)NNC(=O)C2=CC(=C(C=C2)C)C#CC3=CC4=CC=CC=C4N=C3 DL8T4I HIGHSTAT Phase 1 DM16HS DRUG__ID DM16HS DM16HS DRUGCOMP AbbVie; Jacobio Pharmaceuticals DM16HS DRUGTYPE Small molecular drug DM16HS DRUGINCH 1S/C22H26F2N6O2S/c1-13(31)30-11-22(23,24)18-14(30)3-2-4-15(18)33-20-19(26)28-17(9-27-20)29-7-5-21(6-8-29)12-32-10-16(21)25/h2-4,9,16H,5-8,10-12,25H2,1H3,(H2,26,28)/t16-/m1/s1 DM16HS DRUGINKE HGYTYZKWKUXRKA-MRXNPFEDSA-N DM16HS DRUGSMIL CC(=O)N1CC(C2=C1C=CC=C2SC3=NC=C(N=C3N)N4CCC5(CC4)COCC5N)(F)F DM16HS HIGHSTAT Phase 1 DM8RI3 DRUG__ID DM8RI3 DM8RI3 DRUGCOMP GlaxoSmithKline DM8RI3 DRUGTYPE Small molecule DM8RI3 DRUGINCH InChI=1S/C21H23FN6O2/c22-17-4-3-15(24-21(29)27-6-1-2-7-27)13-16(17)18-5-8-28-19(14-23-20(28)25-18)26-9-11-30-12-10-26/h3-5,8,13-14H,1-2,6-7,9-12H2,(H,24,29) DM8RI3 DRUGINKE SAJUCKZZYFFICP-UHFFFAOYSA-N DM8RI3 DRUGSMIL C1CCN(C1)C(=O)NC2=CC(=C(C=C2)F)C3=NC4=NC=C(N4C=C3)N5CCOCC5 DM8RI3 HIGHSTAT Phase 1 DMK6W0 DRUG__ID DMK6W0 DMK6W0 DRUGCOMP Bayer; Drugs for Neglected Diseases Initiative DMK6W0 DRUGTYPE Small molecular drug DMK6W0 DRUGINCH 1S/C60H90N6O14/c1-37(2)31-47-57(71)77-41(9)53(67)61(11)50(34-40(7)8)60(74)80-52(36-44-17-21-46(22-18-44)66-25-29-76-30-26-66)56(70)64(14)48(32-38(3)4)58(72)78-42(10)54(68)62(12)49(33-39(5)6)59(73)79-51(55(69)63(47)13)35-43-15-19-45(20-16-43)65-23-27-75-28-24-65/h15-22,37-42,47-52H,23-36H2,1-14H3/t41-,42-,47+,48+,49+,50+,51-,52-/m1/s1 DMK6W0 DRUGINKE ZMQMTKVVAMWKNY-YSXLEBCMSA-N DMK6W0 DRUGSMIL CC1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C DMK6W0 HIGHSTAT Phase 1 DMQ86J DRUG__ID DMQ86J DMQ86J DRUGCOMP Qpex Biopharma DMQ86J DRUGTYPE Small molecule DMQ86J DRUGINCH InChI=1S/C10H8BFO4/c12-7-2-1-4-5-3-6(5)11(15)16-9(4)8(7)10(13)14/h1-2,5-6,15H,3H2,(H,13,14)/t5-,6-/m1/s1 DMQ86J DRUGINKE KOHUFVUIYUCFNG-PHDIDXHHSA-N DMQ86J DRUGSMIL B1(C2CC2C3=C(O1)C(=C(C=C3)F)C(=O)O)O DMQ86J HIGHSTAT Phase 1 DMVR61 DRUG__ID DMVR61 DMVR61 DRUGCOMP Bayer DMVR61 DRUGTYPE Small molecular drug DMVR61 DRUGINCH 1S/C18H18ClN5O3/c1-11(10-25)21-17(26)15-7-16(12-3-5-13(19)6-4-12)22-24(18(15)27)14-8-20-23(2)9-14/h3-9,11,25H,10H2,1-2H3,(H,21,26)/t11-/m0/s1 DMVR61 DRUGINKE YAGSZKAJPHGVOV-NSHDSACASA-N DMVR61 DRUGSMIL CC(CO)NC(=O)C1=CC(=NN(C1=O)C2=CN(N=C2)C)C3=CC=C(C=C3)Cl DMVR61 HIGHSTAT Phase 1 DN18SP DRUG__ID DN18SP DN18SP DRUGCOMP Microbio DN18SP DRUGTYPE Small molecular drug DN18SP DRUGINCH 1S/C50H48N6O4S2/c57-45(37-23-24-37)53-43(35-9-3-1-4-10-35)49(59)55-27-7-13-39(55)47-51-29-41(61-47)33-19-15-31(16-20-33)32-17-21-34(22-18-32)42-30-52-48(62-42)40-14-8-28-56(40)50(60)44(36-11-5-2-6-12-36)54-46(58)38-25-26-38/h1-6,9-12,15-22,29-30,37-40,43-44H,7-8,13-14,23-28H2,(H,53,57)(H,54,58)/t39-,40-,43+,44+/m0/s1 DN18SP DRUGINKE FZCLQOXUWMCXCV-XCIZVNRNSA-N DN18SP DRUGSMIL C1CC(N(C1)C(=O)C(C2=CC=CC=C2)NC(=O)C3CC3)C4=NC=C(S4)C5=CC=C(C=C5)C6=CC=C(C=C6)C7=CN=C(S7)C8CCCN8C(=O)C(C9=CC=CC=C9)NC(=O)C1CC1 DN18SP HIGHSTAT Phase 1 DN6MT7 DRUG__ID DN6MT7 DN6MT7 DRUGCOMP OncoTartis DN6MT7 DRUGTYPE Small molecular drug DN6MT7 DRUGINCH 1S/C26H21FN4O/c27-24-8-4-19(5-9-24)3-6-22-16-23(7-10-25(22)21-11-14-28-15-12-21)26(32)29-13-1-2-20-17-30-31-18-20/h4-5,7-12,14-18H,1-2,13H2,(H,29,32)(H,30,31) DN6MT7 DRUGINKE CEPAXRIKSUXHHB-UHFFFAOYSA-N DN6MT7 DRUGSMIL C1=CC(=CC=C1C#CC2=C(C=CC(=C2)C(=O)NCCCC3=CNN=C3)C4=CC=NC=C4)F DN6MT7 HIGHSTAT Phase 1 DN9IC4 DRUG__ID DN9IC4 DN9IC4 DRUGCOMP GlaxoSmithKline DN9IC4 DRUGTYPE Small molecular drug DN9IC4 DRUGINCH 1S/C19H28F3N7O3S/c1-12-11-29(7-8-32-12)17-15-10-23-18(25-16(15)26-27-17)24-13-2-4-14(5-3-13)28-33(30,31)9-6-19(20,21)22/h10,12-14,28H,2-9,11H2,1H3,(H2,23,24,25,26,27)/t12-,13?,14?/m0/s1 DN9IC4 DRUGINKE RQWCISVRFNZHMJ-HSBZDZAISA-N DN9IC4 DRUGSMIL CC1CN(CCO1)C2=NNC3=NC(=NC=C32)NC4CCC(CC4)NS(=O)(=O)CCC(F)(F)F DN9IC4 HIGHSTAT Phase 1 DNI28K DRUG__ID DNI28K DNI28K DRUGCOMP Sumitomo Dainippon Pharma DNI28K DRUGTYPE Small molecular drug DNI28K DRUGINCH 1S/C26H28N8O/c1-33-14-16-34(17-15-33)22-9-8-19(18-23(22)35-2)30-26-29-13-10-24(32-26)31-21-7-5-12-28-25(21)20-6-3-4-11-27-20/h3-13,18H,14-17H2,1-2H3,(H2,29,30,31,32) DNI28K DRUGINKE XSQKEVGTZSBVBR-UHFFFAOYSA-N DNI28K DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC=CC(=N3)NC4=C(N=CC=C4)C5=CC=CC=N5)OC DNI28K HIGHSTAT Phase 1 DO57QB DRUG__ID DO57QB DO57QB DRUGCOMP Entasis Therapeutics Waltham, MA DO57QB DRUGTYPE Small molecule DO57QB DRUGINCH InChI=1S/C13H18FN3O5/c1-6(2)21-12(19)10(14)22-17-9-5-16(13(17)20)8(11(15)18)4-7(9)3/h4,6,8-10H,5H2,1-3H3,(H2,15,18)/t8-,9+,10+/m1/s1 DO57QB DRUGINKE OMNVFPBGXYKTDB-UTLUCORTSA-N DO57QB DRUGSMIL CC1=CC(N2CC1N(C2=O)OC(C(=O)OC(C)C)F)C(=O)N DO57QB HIGHSTAT Phase 1 DOJG79 DRUG__ID DOJG79 DOJG79 DRUGCOMP Ryvu Therapeutics DOJG79 DRUGTYPE Small molecular drug DOJG79 DRUGINCH 1S/C15H18Br2N4.ClH/c1-9-11(16)12(17)10-3-2-6-21-14(10)13(9)19-15(21)20-7-4-18-5-8-20;/h18H,2-8H2,1H3;1H DOJG79 DRUGINKE GQXLWUCQESKBSC-UHFFFAOYSA-N DOJG79 DRUGSMIL CC1=C2C3=C(CCCN3C(=N2)N4CCNCC4)C(=C1Br)Br.Cl DOJG79 HIGHSTAT Phase 1 DP6Y5N DRUG__ID DP6Y5N DP6Y5N DRUGCOMP Alectos DP6Y5N DRUGTYPE Small molecular drug DP6Y5N DRUGINCH 1S/C9H14F2N2O3S/c1-2-12-9-13-3-4(14)5(15)6(7(10)11)16-8(3)17-9/h3-8,14-15H,2H2,1H3,(H,12,13)/t3-,4-,5+,6+,8-/m1/s1 DP6Y5N DRUGINKE UDQTXCHQKHIQMH-KYGLGHNPSA-N DP6Y5N DRUGSMIL CCN=C1NC2C(C(C(OC2S1)C(F)F)O)O DP6Y5N HIGHSTAT Phase 1 DQ5Y6Z DRUG__ID DQ5Y6Z DQ5Y6Z DRUGCOMP Pfizer DQ5Y6Z DRUGTYPE Small molecular drug DQ5Y6Z DRUGINCH 1S/C23H24ClFN4O3/c1-13(2)17-10-27-21(16-7-14(24)3-4-19(16)25)8-22(17)29-20-5-6-26-9-18(20)23(32)28-15(11-30)12-31/h3-10,13,15,30-31H,11-12H2,1-2H3,(H,28,32)(H,26,27,29) DQ5Y6Z DRUGINKE IPBLCOKXDQHSQW-UHFFFAOYSA-N DQ5Y6Z DRUGSMIL CC(C)C1=CN=C(C=C1NC2=C(C=NC=C2)C(=O)NC(CO)CO)C3=C(C=CC(=C3)Cl)F DQ5Y6Z HIGHSTAT Phase 1 DQ9B8C DRUG__ID DQ9B8C DQ9B8C DRUGCOMP NuCana DQ9B8C DRUGTYPE Small molecular drug DQ9B8C DRUGINCH 1S/C29H29FN3O9P/c1-18(28(36)39-16-19-8-3-2-4-9-19)32-43(38,42-24-13-7-11-20-10-5-6-12-21(20)24)40-17-25-23(34)14-26(41-25)33-15-22(30)27(35)31-29(33)37/h2-13,15,18,23,25-26,34H,14,16-17H2,1H3,(H,32,38)(H,31,35,37)/t18-,23-,25+,26+,43?/m0/s1 DQ9B8C DRUGINKE BIOWRMNRHMERIO-ZVAHOJSLSA-N DQ9B8C DRUGSMIL CC(C(=O)OCC1=CC=CC=C1)NP(=O)(OCC2C(CC(O2)N3C=C(C(=O)NC3=O)F)O)OC4=CC=CC5=CC=CC=C54 DQ9B8C HIGHSTAT Phase 1 DQCJ39 DRUG__ID DQCJ39 DQCJ39 DRUGCOMP IM Therapeutics DQCJ39 DRUGTYPE Small molecule DQCJ39 DRUGINCH InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m1/s1 DQCJ39 DRUGINKE CJCSPKMFHVPWAR-SNVBAGLBSA-N DQCJ39 DRUGSMIL CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N DQCJ39 HIGHSTAT Phase 1 DR3FA8 DRUG__ID DR3FA8 DR3FA8 DRUGCOMP Janssen DR3FA8 DRUGTYPE Small molecular drug DR3FA8 DRUGINCH 1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34) DR3FA8 DRUGINKE RRMJMHOQSALEJJ-UHFFFAOYSA-N DR3FA8 DRUGSMIL CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC DR3FA8 HIGHSTAT Phase 1 DRL76S DRUG__ID DRL76S DRL76S DRUGCOMP Aminex Therapeutics DRL76S DRUGTYPE Small molecular drug DRL76S DRUGINCH 1S/C32H68N6O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-22-31(39)37-28-16-15-21-30(34)32(40)38-29-20-27-36-25-18-17-24-35-26-19-23-33/h30,35-36H,2-29,33-34H2,1H3,(H,37,39)(H,38,40)/t30-/m0/s1 DRL76S DRUGINKE USNCWPSRPOWEBG-PMERELPUSA-N DRL76S DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NCCCNCCCCNCCCN)N DRL76S HIGHSTAT Phase 1 DS2J7Q DRUG__ID DS2J7Q DS2J7Q DRUGCOMP iTeos Therapeutics DS2J7Q DRUGTYPE Small molecular drug DS2J7Q DRUGINCH 1S/C25H26F2N8O4S2/c1-41(37)12-11-39-19-14-17(15(26)13-16(19)27)33-7-4-32(5-8-33)6-9-34-22-20(40-25(34)36)23-29-21(18-3-2-10-38-18)31-35(23)24(28)30-22/h2-3,10,13-14H,4-9,11-12H2,1H3,(H2,28,30)/t41-/m0/s1 DS2J7Q DRUGINKE QYCCLUSYHJXDEX-RWYGWLOXSA-N DS2J7Q DRUGSMIL CS(=O)CCOC1=C(C=C(C(=C1)N2CCN(CC2)CCN3C4=C(C5=NC(=NN5C(=N4)N)C6=CC=CO6)SC3=O)F)F DS2J7Q HIGHSTAT Phase 1 DS8V3L DRUG__ID DS8V3L DS8V3L DRUGCOMP MODAG GmbH DS8V3L DRUGTYPE Small molecule DS8V3L DRUGINCH InChI=1S/C16H11BrN2O2/c17-12-3-1-2-10(6-12)13-8-14(19-18-13)11-4-5-15-16(7-11)21-9-20-15/h1-8H,9H2,(H,18,19) DS8V3L DRUGINKE RCQIIBJSUWYYFU-UHFFFAOYSA-N DS8V3L DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=CC(=NN3)C4=CC(=CC=C4)Br DS8V3L HIGHSTAT Phase 1 DSEP59 DRUG__ID DSEP59 DSEP59 DRUGCOMP Pfizer DSEP59 DRUGTYPE Small molecule DSEP59 DRUGINCH InChI=1S/C19H16FN5O2/c1-11(18-15(5-6-17(26)24-18)25-8-2-7-22-25)27-16-10-12-9-13(20)3-4-14(12)23-19(16)21/h2-11H,1H3,(H2,21,23)(H,24,26)/t11-/m0/s1 DSEP59 DRUGINKE CLEFVPILGAPOTG-NSHDSACASA-N DSEP59 DRUGSMIL CC(C1=C(C=CC(=O)N1)N2C=CC=N2)OC3=C(N=C4C=CC(=CC4=C3)F)N DSEP59 HIGHSTAT Phase 1 DSUT71 DRUG__ID DSUT71 DSUT71 DRUGCOMP JOHNSON & JOHNSON DSUT71 DRUGTYPE Small molecule DSUT71 DRUGINCH InChI=1S/C22H28N6O2/c1-22(2,30)13-26-19(29)11-18-27-17-12-25-21-16(8-10-24-21)20(17)28(18)15-5-3-14(4-6-15)7-9-23/h8,10,12,14-15,30H,3-7,11,13H2,1-2H3,(H,24,25)(H,26,29) DSUT71 DRUGINKE NJKMSBSVJSQUBU-UHFFFAOYSA-N DSUT71 DRUGSMIL CC(C)(CNC(=O)CC1=NC2=CN=C3C(=C2N1C4CCC(CC4)CC#N)C=CN3)O DSUT71 HIGHSTAT Phase 1 DT30FV DRUG__ID DT30FV DT30FV DRUGCOMP VenatoRx Pharmaceuticals DT30FV DRUGTYPE Small molecular drug DT30FV DRUGINCH 1S/C19H28BN3O5/c21-8-9-22-14-6-4-12(5-7-14)10-17(24)23-16-11-13-2-1-3-15(19(25)26)18(13)28-20(16)27/h1-3,12,14,16,22,27H,4-11,21H2,(H,23,24)(H,25,26)/t12?,14?,16-/m0/s1 DT30FV DRUGINKE PFZUWUXKQPRWAL-PXCJXSSVSA-N DT30FV DRUGSMIL B1(C(CC2=C(O1)C(=CC=C2)C(=O)O)NC(=O)CC3CCC(CC3)NCCN)O DT30FV HIGHSTAT Phase 1 DT4WU3 DRUG__ID DT4WU3 DT4WU3 DRUGCOMP TTC Oncology DT4WU3 DRUGTYPE Small molecular drug DT4WU3 DRUGINCH 1S/C20H13FO3S/c21-13-3-1-12(2-4-13)19-17-10-7-15(23)11-18(17)25-20(19)24-16-8-5-14(22)6-9-16/h1-11,22-23H DT4WU3 DRUGINKE UDBMVVLTKJMPCJ-UHFFFAOYSA-N DT4WU3 DRUGSMIL C1=CC(=CC=C1C2=C(SC3=C2C=CC(=C3)O)OC4=CC=C(C=C4)O)F DT4WU3 HIGHSTAT Phase 1 DTF20P DRUG__ID DTF20P DTF20P DRUGCOMP Hanmi Pharmaceutical DTF20P DRUGTYPE Small molecular drug DTF20P DRUGINCH 1S/C26H26N6O3/c1-3-23(33)27-19-5-4-6-21(17-19)35-25-24-22(11-16-34-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30) DTF20P DRUGINKE LZMJNVRJMFMYQS-UHFFFAOYSA-N DTF20P DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)OC=C4 DTF20P HIGHSTAT Phase 1 DTOM05 DRUG__ID DTOM05 DTOM05 DRUGCOMP Klus Pharma DTOM05 DRUGTYPE Small molecule DTOM05 DRUGINCH InChI=1S/C49H84O17/c1-24-40(56-13)26(3)47(10,52)65-41(24)35-17-16-33(60-35)34-18-20-37(61-34)46(9)42(57-14)28(5)49(66-46)25(2)36(55-12)22-31(63-49)23-38-45(8,58-15)43(27(4)48(53,64-38)29(6)44(50)51)62-39-21-19-32(54-11)30(7)59-39/h24-43,52-53H,16-23H2,1-15H3,(H,50,51) DTOM05 DRUGINKE RHDSQRNKIIRGBB-UHFFFAOYSA-N DTOM05 DRUGSMIL CC1C(OC(C(C1OC)C)(C)O)C2CCC(O2)C3CCC(O3)C4(C(C(C5(O4)C(C(CC(O5)CC6C(C(C(C(O6)(C(C)C(=O)O)O)C)OC7CCC(C(O7)C)OC)(C)OC)OC)C)C)OC)C DTOM05 HIGHSTAT Phase 1 DU2G0C DRUG__ID DU2G0C DU2G0C DRUGCOMP Novartis DU2G0C DRUGTYPE Small molecular drug DU2G0C DRUGINCH 1S/C29H32F2N3O7P/c1-18-14-22(41-13-12-40-11-10-29(30,31)42(37,38)39)7-6-21(18)5-2-20-15-24-23-8-3-19(4-9-26(35)36)16-25(23)34-28(32)27(24)33-17-20/h3,6-8,14-17H,2,4-5,9-13H2,1H3,(H2,32,34)(H,35,36)(H2,37,38,39) DU2G0C DRUGINKE SDLWKRZBLTZSEL-UHFFFAOYSA-N DU2G0C DRUGSMIL CC1=C(C=CC(=C1)OCCOCCC(F)(F)P(=O)(O)O)CCC2=CC3=C4C=CC(=CC4=NC(=C3N=C2)N)CCC(=O)O DU2G0C HIGHSTAT Phase 1 DU3GQ9 DRUG__ID DU3GQ9 DU3GQ9 DRUGCOMP Tetraphase Pharmaceuticals DU3GQ9 DRUGTYPE Small molecular drug DU3GQ9 DRUGINCH 1S/C27H31FN4O8/c1-31(2)19-12-8-10-7-11-13(28)9-14(30-26(39)15-5-4-6-32(15)3)20(33)17(11)21(34)16(10)23(36)27(12,40)24(37)18(22(19)35)25(29)38/h9-10,12,15,19,33-34,37,40H,4-8H2,1-3H3,(H2,29,38)(H,30,39)/t10-,12-,15-,19-,27-/m0/s1 DU3GQ9 DRUGINKE VIWUYPVRNWIKLS-HMFHYXQTSA-N DU3GQ9 DRUGSMIL CN1CCCC1C(=O)NC2=CC(=C3CC4CC5C(C(=O)C(=C(C5(C(=O)C4=C(C3=C2O)O)O)O)C(=O)N)N(C)C)F DU3GQ9 HIGHSTAT Phase 1 DU98JH DRUG__ID DU98JH DU98JH DRUGCOMP Hanmi Pharmaceutical DU98JH DRUGTYPE Small molecular drug DU98JH DRUGINCH 1S/C23H16ClFN6OS/c1-11-5-6-13-12(7-8-27-22(13)30-16-4-2-3-15(24)17(16)25)18(11)31-23(32)14-9-33-20-19(14)28-10-29-21(20)26/h2-10H,1H3,(H,27,30)(H,31,32)(H2,26,28,29) DU98JH DRUGINKE KVCQTKNUUQOELD-UHFFFAOYSA-N DU98JH DRUGSMIL CC1=C(C2=C(C=C1)C(=NC=C2)NC3=C(C(=CC=C3)Cl)F)NC(=O)C4=CSC5=C4N=CN=C5N DU98JH HIGHSTAT Phase 1 DUAI04 DRUG__ID DUAI04 DUAI04 DRUGCOMP Mycovia Pharmaceuticals DUAI04 DRUGTYPE Small molecule DUAI04 DRUGINCH InChI=1S/C31H20F4N6O2/c32-25-10-13-27(28(33)15-25)30(42,19-41-20-38-39-40-41)31(34,35)29-14-9-23(17-37-29)4-1-21-7-11-26(12-8-21)43-18-24-5-2-22(16-36)3-6-24/h2-3,5-15,17,20,42H,18-19H2/t30-/m0/s1 DUAI04 DRUGINKE UDGASIIGNCBLSI-PMERELPUSA-N DUAI04 DRUGSMIL C1=CC(=CC=C1COC2=CC=C(C=C2)C#CC3=CN=C(C=C3)C(C(CN4C=NN=N4)(C5=C(C=C(C=C5)F)F)O)(F)F)C#N DUAI04 HIGHSTAT Phase 1 DUM25X DRUG__ID DUM25X DUM25X DRUGCOMP Bristol-Myers Squibb DUM25X DRUGTYPE Small molecular drug DUM25X DRUGINCH 1S/C23H23N5O5S2/c1-13-17(25-21(34-13)27-4-6-31-7-5-27)12-32-18-8-14(29-2)9-19-15(18)10-20(33-19)16-11-28-22(24-16)35-23(26-28)30-3/h8-11H,4-7,12H2,1-3H3 DUM25X DRUGINKE MINMDCMSHDBHKG-UHFFFAOYSA-N DUM25X DRUGSMIL CC1=C(N=C(S1)N2CCOCC2)COC3=CC(=CC4=C3C=C(O4)C5=CN6C(=N5)SC(=N6)OC)OC DUM25X HIGHSTAT Phase 1 DUP48T DRUG__ID DUP48T DUP48T DRUGCOMP Spero Therapeutics DUP48T DRUGTYPE Small molecular drug DUP48T DRUGINCH 1S/C44H73N13O13/c1-22(2)19-31-40(66)52-27(11-15-45)36(62)51-29(13-17-47)39(65)57-34(23(3)59)43(69)48-18-14-30(53-42(68)33(21-58)56-44(70)35(24(4)60)49-25(5)61)38(64)50-28(12-16-46)37(63)55-32(41(67)54-31)20-26-9-7-6-8-10-26/h6-10,22-24,27-35,58-60H,11-21,45-47H2,1-5H3,(H,48,69)(H,49,61)(H,50,64)(H,51,62)(H,52,66)(H,53,68)(H,54,67)(H,55,63)(H,56,70)(H,57,65)/t23-,24-,27+,28+,29+,30+,31+,32-,33-,34+,35+/m1/s1 DUP48T DRUGINKE JBFNEVNUGGFPBQ-DDMCRLCFSA-N DUP48T DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C)C(C)O)CCN)CCN DUP48T HIGHSTAT Phase 1 DV3WF1 DRUG__ID DV3WF1 DV3WF1 DRUGCOMP LMP400 DV3WF1 DRUGTYPE Small molecular drug DV3WF1 DRUGINCH 1S/C26H26N2O7/c1-31-19-10-15-18(13-20(19)32-2)26(30)28(5-3-4-27-6-8-33-9-7-27)24-16-11-21-22(35-14-34-21)12-17(16)25(29)23(15)24/h10-13H,3-9,14H2,1-2H3 DV3WF1 DRUGINKE FMFIFGLHVOZDEL-UHFFFAOYSA-N DV3WF1 DRUGSMIL COC1=C(C=C2C(=C1)C3=C(C4=CC5=C(C=C4C3=O)OCO5)N(C2=O)CCCN6CCOCC6)OC DV3WF1 HIGHSTAT Phase 1 DVXG31 DRUG__ID DVXG31 DVXG31 DRUGCOMP Gilead DVXG31 DRUGTYPE Small molecule DVXG31 DRUGINCH InChI=1S/C4H4N2S/c7-4-1-2-5-3-6-4/h1-3H,(H,5,6,7) DVXG31 DRUGINKE MGAXHFMCFLLMNG-UHFFFAOYSA-N DVXG31 DRUGSMIL C1=CN=CNC1=S DVXG31 HIGHSTAT Phase 1 DW4O2J DRUG__ID DW4O2J DW4O2J DRUGCOMP Abrexa DW4O2J DRUGTYPE Small molecule DW4O2J DRUGINCH InChI=1S/C18H17F3N2O2/c1-12-7-8-16(13(2)9-12)23(17(24)18(19,20)21)22-11-14-5-4-6-15(10-14)25-3/h4-11H,1-3H3/b22-11+ DW4O2J DRUGINKE HYMZAYGFKNNHDN-SSDVNMTOSA-N DW4O2J DRUGSMIL CC1=CC(=C(C=C1)N(C(=O)C(F)(F)F)N=CC2=CC(=CC=C2)OC)C DW4O2J HIGHSTAT Phase 1 DW5Z1R DRUG__ID DW5Z1R DW5Z1R DRUGCOMP Roche DW5Z1R DRUGTYPE Small molecular drug DW5Z1R DRUGINCH 1S/C15H11BrFNO3/c16-11-8-10(17)3-4-12(11)18-15(21)6-2-9-1-5-13(19)14(20)7-9/h1-8,19-20H,(H,18,21)/b6-2+ DW5Z1R DRUGINKE XOHNWHLPLQQICZ-QHHAFSJGSA-N DW5Z1R DRUGSMIL C1=CC(=C(C=C1C=CC(=O)NC2=C(C=C(C=C2)F)Br)O)O DW5Z1R HIGHSTAT Phase 1 DWD06K DRUG__ID DWD06K DWD06K DRUGCOMP Avineuro DWD06K DRUGTYPE Small molecular drug DWD06K DRUGINCH 1S/C17H19N5O2S.ClH/c1-18-16-15(25(23,24)13-6-4-3-5-7-13)17-19-10-12-11-21(2)9-8-14(12)22(17)20-16;/h3-7,10H,8-9,11H2,1-2H3,(H,18,20);1H DWD06K DRUGINKE HLQZXWFRTGIZIJ-UHFFFAOYSA-N DWD06K DRUGSMIL CNC1=NN2C3=C(CN(CC3)C)C=NC2=C1S(=O)(=O)C4=CC=CC=C4.Cl DWD06K HIGHSTAT Phase 1 DX72LV DRUG__ID DX72LV DX72LV DRUGCOMP AstraZeneca DX72LV DRUGTYPE Small molecule DX72LV DRUGINCH InChI=1S/C28H31F2N7O4S/c1-36-10-12-37(13-11-36)22(16-41-2)27(38)33-21-8-4-6-17-18(14-31-26(17)21)25-19(29)15-32-28(35-25)34-20-7-5-9-23(24(20)30)42(3,39)40/h4-9,14-15,22,31H,10-13,16H2,1-3H3,(H,33,38)(H,32,34,35)/t22-/m1/s1 DX72LV DRUGINKE JNUZADQZHYFJGW-JOCHJYFZSA-N DX72LV DRUGSMIL CN1CCN(CC1)C(COC)C(=O)NC2=CC=CC3=C2NC=C3C4=NC(=NC=C4F)NC5=C(C(=CC=C5)S(=O)(=O)C)F DX72LV HIGHSTAT Phase 1 DY03KH DRUG__ID DY03KH DY03KH DRUGCOMP Kineta DY03KH DRUGTYPE Small molecular drug DY03KH DRUGINCH 1S/C27H28N2O2/c1-19(2)31-24-14-12-23(13-15-24)29-18-28-25-17-21(9-16-26(25)29)6-5-20-7-10-22(11-8-20)27(3,4)30/h5-19,30H,1-4H3/b6-5- DY03KH DRUGINKE DBNZTRPIBJSUIX-WAYWQWQTSA-N DY03KH DRUGSMIL CC(C)OC1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)C=CC4=CC=C(C=C4)C(C)(C)O DY03KH HIGHSTAT Phase 1 DYF2N4 DRUG__ID DYF2N4 DYF2N4 DRUGCOMP HaiHe Biopharma DYF2N4 DRUGTYPE Small molecular drug DYF2N4 DRUGINCH 1S/C24H29F3N8O5S/c1-39-23(36)29-20-12-18(24(25,26)27)17(13-28-20)21-30-22(33-7-9-40-10-8-33)19-11-16(15-35(19)31-21)14-32-3-5-34(6-4-32)41(2,37)38/h11-13,15H,3-10,14H2,1-2H3,(H,28,29,36) DYF2N4 DRUGINKE KTLQDDGRBDLKMN-UHFFFAOYSA-N DYF2N4 DRUGSMIL COC(=O)NC1=NC=C(C(=C1)C(F)(F)F)C2=NN3C=C(C=C3C(=N2)N4CCOCC4)CN5CCN(CC5)S(=O)(=O)C DYF2N4 HIGHSTAT Phase 1 DYS52Z DRUG__ID DYS52Z DYS52Z DRUGCOMP AmyriAD Therapeutics Los Angeles, CA DYS52Z DRUGTYPE Small molecule DYS52Z DRUGINCH InChI=1S/C28H37F3N4O/c1-19-10-13-32-21(3)25(19)26(36)33-14-11-27(5,12-15-33)34-16-17-35(20(2)18-34)22(4)23-6-8-24(9-7-23)28(29,30)31/h6-10,13,20,22H,11-12,14-18H2,1-5H3/t20-,22-/m0/s1 DYS52Z DRUGINKE DTKUANPECHGGBY-UNMCSNQZSA-N DYS52Z DRUGSMIL CC1CN(CCN1C(C)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(C=CN=C4C)C)C DYS52Z HIGHSTAT Phase 1 DYT06V DRUG__ID DYT06V DYT06V DRUGCOMP TB DYT06V DRUGTYPE Small molecule DYT06V DRUGINCH InChI=1S/C31H37BrN4O7/c1-36(2)12-11-31(37,19-15-24(38-3)34-25(16-19)39-4)27(21-17-26(40-5)35-30(43-8)28(21)41-6)22-14-18-13-20(32)9-10-23(18)33-29(22)42-7/h9-10,13-17,27,37H,11-12H2,1-8H3/t27-,31-/m1/s1 DYT06V DRUGINKE HHDDKDPLFXIPBX-DLFZDVPBSA-N DYT06V DRUGSMIL CN(C)CCC(C1=CC(=NC(=C1)OC)OC)(C(C2=CC(=NC(=C2OC)OC)OC)C3=C(N=C4C=CC(=CC4=C3)Br)OC)O DYT06V HIGHSTAT Phase 1 DZ02CQ DRUG__ID DZ02CQ DZ02CQ DRUGCOMP Anavex Life Sciences DZ02CQ DRUGTYPE Small molecule DZ02CQ DRUGINCH InChI=1S/C20H27N3OS/c1-15-23(14-20(25-15)9-11-22(2)12-10-20)19(24)8-7-16-13-21-18-6-4-3-5-17(16)18/h3-6,13,15,21H,7-12,14H2,1-2H3 DZ02CQ DRUGINKE XWMHYQATSBWUNT-UHFFFAOYSA-N DZ02CQ DRUGSMIL CC1N(CC2(S1)CCN(CC2)C)C(=O)CCC3=CNC4=CC=CC=C43 DZ02CQ HIGHSTAT Phase 1 DZ0LJ5 DRUG__ID DZ0LJ5 DZ0LJ5 DRUGCOMP AbbVie DZ0LJ5 DRUGTYPE Small molecular drug DZ0LJ5 DRUGINCH 1S/C53H82FNO17/c1-13-40-36(27-66-52-49(64-12)48(63-11)44(60)31(5)68-52)22-28(2)14-19-38(57)29(3)23-35(20-21-56)46(30(4)39(58)24-41(59)70-40)72-51-45(61)43(55(9)10)47(32(6)69-51)71-42-25-53(8,62)50(33(7)67-42)65-26-34-15-17-37(54)18-16-34/h14-19,21-22,29-33,35-36,39-40,42-52,58,60-62H,13,20,23-27H2,1-12H3/b19-14+,28-22+/t29-,30+,31-,32-,33+,35+,36-,39-,40-,42+,43-,44-,45-,46-,47-,48-,49-,50+,51+,52-,53-/m1/s1 DZ0LJ5 DRUGINKE FVQGMXUKQAXPIP-JLTQGABHSA-N DZ0LJ5 DRUGSMIL CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)OCC4=CC=C(C=C4)F)(C)O)N(C)C)O)CC=O)C)C)COC5C(C(C(C(O5)C)O)OC)OC DZ0LJ5 HIGHSTAT Phase 1 DZ2PC5 DRUG__ID DZ2PC5 DZ2PC5 DRUGCOMP Takeda DZ2PC5 DRUGTYPE Small molecule DZ2PC5 DRUGINCH InChI=1S/C21H32N2O5S/c1-27-21(24)23-14-6-9-19(22-29(2,25)26)20(23)15-28-18-12-10-17(11-13-18)16-7-4-3-5-8-16/h3-5,7-8,17-20,22H,6,9-15H2,1-2H3/t17?,18?,19-,20-/m0/s1 DZ2PC5 DRUGINKE UXZAJSZFFARTEI-GUMHCPJTSA-N DZ2PC5 DRUGSMIL COC(=O)N1CCCC(C1COC2CCC(CC2)C3=CC=CC=C3)NS(=O)(=O)C DZ2PC5 HIGHSTAT Phase 1 DZ2RH6 DRUG__ID DZ2RH6 DZ2RH6 DRUGCOMP Genentech DZ2RH6 DRUGTYPE Small molecule DZ2RH6 DRUGINCH InChI=1S/C28H28ClF2N9O3/c1-37(10-2-8-32)19-6-12-38(13-7-19)24(41)17-39-16-22(35-27(42)21-15-34-40-11-3-9-33-26(21)40)25(36-39)20-14-18(29)4-5-23(20)43-28(30)31/h3-5,9,11,14-16,19,28H,2,6-7,10,12-13,17H2,1H3,(H,35,42) DZ2RH6 DRUGINKE ITNFPSJJBYFVEA-UHFFFAOYSA-N DZ2RH6 DRUGSMIL CN(CCC#N)C1CCN(CC1)C(=O)CN2C=C(C(=N2)C3=C(C=CC(=C3)Cl)OC(F)F)NC(=O)C4=C5N=CC=CN5N=C4 DZ2RH6 HIGHSTAT Phase 1 DZ31NW DRUG__ID DZ31NW DZ31NW DRUGCOMP TB DZ31NW DRUGTYPE Small molecule DZ31NW DRUGINCH InChI=1S/C30H33BrFN3O5/c1-35(2)13-12-30(36,19-16-25(38-4)34-26(17-19)39-5)27(21-8-7-9-24(37-3)28(21)32)22-15-18-14-20(31)10-11-23(18)33-29(22)40-6/h7-11,14-17,27,36H,12-13H2,1-6H3/t27-,30-/m1/s1 DZ31NW DRUGINKE JJEGOJPMKLRSPJ-POURPWNDSA-N DZ31NW DRUGSMIL CN(C)CCC(C1=CC(=NC(=C1)OC)OC)(C(C2=C(C(=CC=C2)OC)F)C3=C(N=C4C=CC(=CC4=C3)Br)OC)O DZ31NW HIGHSTAT Phase 1 DZ76PB DRUG__ID DZ76PB DZ76PB DRUGCOMP Pfizer DZ76PB DRUGTYPE Small molecular drug DZ76PB DRUGINCH 1S/C25H23ClF4N4O3/c1-13-11-32(12-31-13)19-3-4-20-24(36)33(7-8-34(20)23(19)35)14(2)21-5-6-22(37-21)15-9-18(27)17(26)10-16(15)25(28,29)30/h3-4,9-12,14,21-22H,5-8H2,1-2H3/t14-,21-,22+/m0/s1 DZ76PB DRUGINKE AKCDDYGYIGPEKL-JQOQJDEVSA-N DZ76PB DRUGSMIL CC1=CN(C=N1)C2=CC=C3C(=O)N(CCN3C2=O)C(C)C4CCC(O4)C5=CC(=C(C=C5C(F)(F)F)Cl)F DZ76PB HIGHSTAT Phase 1 D00AYW DRUG__ID D00AYW D00AYW DRUGCOMP Hua Medicine Shanghai, China D00AYW DRUGINCH 1S/C22H27ClN4O5/c1-14(2)9-18(22(31)24-20-7-8-26(25-20)11-15(29)13-28)27-12-16(10-21(27)30)32-19-6-4-3-5-17(19)23/h3-8,10,14-15,18,28-29H,9,11-13H2,1-2H3,(H,24,25,31)/t15-,18+/m1/s1 D00AYW DRUGINKE HMUMWSORCUWQJO-QAPCUYQASA-N D00AYW DRUGSMIL CC(C)CC(C(=O)NC1=NN(C=C1)CC(CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl D00AYW HIGHSTAT Phase 1 D00CGH DRUG__ID D00CGH D00CGH DRUGTYPE Small molecular drug D00CGH DRUGINCH 1S/C27H38O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-12,18,22,24-25,28-30H,2,7-9,13,15-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,24+,25+,27-/m1/s1 D00CGH DRUGINKE JKFZMIQMKFWJAY-RQJQXFIZSA-N D00CGH DRUGSMIL CC(CC#CC(C)(C)O)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C D00CGH HIGHSTAT Phase 1 D00CLM DRUG__ID D00CLM D00CLM DRUGCOMP Nissan Chemical Industries Ltd D00CLM DRUGINCH 1S/C18H12Cl2N2O4S2/c1-8(21-22-17(24)13-4-5-14(28-13)18(25)26)10-7-27-16(15(10)23)9-2-3-11(19)12(20)6-9/h2-7,23H,1H3,(H,22,24)(H,25,26)/b21-8- D00CLM DRUGINKE JYODIYJKYDDIDN-WNFQYIGGSA-N D00CLM DRUGSMIL CC(=NNC(=O)C1=CC=C(S1)C(=O)O)C2=CSC(=C2O)C3=CC(=C(C=C3)Cl)Cl D00CLM HIGHSTAT Phase 1 D00EHX DRUG__ID D00EHX D00EHX DRUGCOMP Northwestern University D00EHX DRUGINCH 1S/C23H21N7/c1-2-5-19(6-3-1)21-17-20(18-7-11-24-12-8-18)22(28-27-21)29-13-15-30(16-14-29)23-25-9-4-10-26-23/h1-12,17H,13-16H2 D00EHX DRUGINKE ZPJGUEPHFXPAQF-UHFFFAOYSA-N D00EHX DRUGSMIL C1CN(CCN1C2=NN=C(C=C2C3=CC=NC=C3)C4=CC=CC=C4)C5=NC=CC=N5 D00EHX HIGHSTAT Phase 1 D00JDJ DRUG__ID D00JDJ D00JDJ DRUGCOMP Artax Biopharma Cambridge, MA D00JDJ DRUGINCH 1S/C21H22FNO2/c1-24-18-8-9-20-19(12-18)21(15-4-6-17(22)7-5-15)16(14-25-20)13-23-10-2-3-11-23/h4-9,12H,2-3,10-11,13-14H2,1H3 D00JDJ DRUGINKE VMMKGVRPILDZML-UHFFFAOYSA-N D00JDJ DRUGSMIL COC1=CC2=C(C=C1)OCC(=C2C3=CC=C(C=C3)F)CN4CCCC4 D00JDJ HIGHSTAT Phase 1 D00JQE DRUG__ID D00JQE D00JQE DRUGCOMP Bayer AG D00JQE DRUGINCH 1S/C30H37F4NO/c1-29(2)16-22-25(23(36)17-29)24(18-8-4-3-5-9-18)26(28(35-22)20-10-6-7-11-20)27(31)19-12-14-21(15-13-19)30(32,33)34/h12-15,18,20,23,27,36H,3-11,16-17H2,1-2H3/t23-,27-/m0/s1 D00JQE DRUGINKE BHKIPHICFOJGLD-HOFKKMOUSA-N D00JQE DRUGSMIL CC1(CC(C2=C(C1)N=C(C(=C2C3CCCCC3)C(C4=CC=C(C=C4)C(F)(F)F)F)C5CCCC5)O)C D00JQE HIGHSTAT Phase 1 D00KVX DRUG__ID D00KVX D00KVX DRUGTYPE Small molecular drug D00KVX DRUGINCH 1S/C22H19N3O4S/c1-29-21-13-14(6-8-24-21)22(26)16-10-15(11-17(12-16)25-30(2,27)28)18-4-3-5-20-19(18)7-9-23-20/h3-13,23,25H,1-2H3 D00KVX DRUGINKE YUVDELGTFILMBB-UHFFFAOYSA-N D00KVX DRUGSMIL COC1=NC=CC(=C1)C(=O)C2=CC(=CC(=C2)C3=C4C=CNC4=CC=C3)NS(=O)(=O)C D00KVX HIGHSTAT Phase 1 D00LOB DRUG__ID D00LOB D00LOB DRUGTYPE Small molecular drug D00LOB DRUGINCH 1S/C18H23F2N7O3/c1-12-9-24-15(25-11-18(19,20)13-5-3-2-4-6-13)16(29)27(12)10-14(28)23-7-8-30-26-17(21)22/h2-6,9H,7-8,10-11H2,1H3,(H,23,28)(H,24,25)(H4,21,22,26) D00LOB DRUGINKE IDCKXHIGLKQWMM-UHFFFAOYSA-N D00LOB DRUGSMIL CC1=CN=C(C(=O)N1CC(=O)NCCON=C(N)N)NCC(C2=CC=CC=C2)(F)F D00LOB HIGHSTAT Phase 1 D00OAU DRUG__ID D00OAU D00OAU DRUGTYPE Small molecular drug D00OAU DRUGINCH 1S/C21H26N10O4/c1-2-31-28-18(27-29-31)16-14(33)15(34)20(35-16)30-10-23-13-17(22)25-21(26-19(13)30)24-12(9-32)8-11-6-4-3-5-7-11/h3-7,10,12,14-16,20,32-34H,2,8-9H2,1H3,(H3,22,24,25,26)/t12-,14-,15+,16-,20+/m0/s1 D00OAU DRUGINKE FLBKPDIBGNWXMT-NIQZGXKPSA-N D00OAU DRUGSMIL CCN1N=C(N=N1)C2C(C(C(O2)N3C=NC4=C(N=C(N=C43)NC(CC5=CC=CC=C5)CO)N)O)O D00OAU HIGHSTAT Phase 1 D00QWU DRUG__ID D00QWU D00QWU DRUGCOMP Bristol-Myers Squibb; Exelixis D00QWU DRUGINCH 1S/C28H29ClN2O3S/c1-27(2,23-11-6-7-12-24(23)29)26-30-25(28(3,4)32)18-31(26)21-15-13-19(14-16-21)20-9-8-10-22(17-20)35(5,33)34/h6-18,32H,1-5H3 D00QWU DRUGINKE JLPURTXCSILYLW-UHFFFAOYSA-N D00QWU DRUGSMIL CC(C)(C1=CC=CC=C1Cl)C2=NC(=CN2C3=CC=C(C=C3)C4=CC(=CC=C4)S(=O)(=O)C)C(C)(C)O D00QWU HIGHSTAT Phase 1 D00RYA DRUG__ID D00RYA D00RYA DRUGCOMP S*BIO Pte Ltd D00RYA DRUGINCH 1S/C26H30N4O4/c1-2-12-30(11-1)13-16-33-24-7-5-21-17-20(24)18-31-14-3-4-15-32-19-22-6-8-25(34-22)23-9-10-27-26(28-21)29-23/h3-10,17H,1-2,11-16,18-19H2,(H,27,28,29)/b4-3+ D00RYA DRUGINKE NNXDIGHYPZHXTR-ONEGZZNKSA-N D00RYA DRUGSMIL C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC=C(O4)C5=NC(=NC=C5)NC(=C3)C=C2 D00RYA HIGHSTAT Phase 1 D00SFY DRUG__ID D00SFY D00SFY DRUGCOMP Ajinomoto Co Inc D00SFY DRUGINCH 1S/C21H29FN2O7/c1-10(2)24-11(3)14(7-12-5-6-13(29-4)8-15(12)22)20(23-24)31-21-19(28)18(27)17(26)16(9-25)30-21/h5-6,8,10,16-19,21,25-28H,7,9H2,1-4H3/t16-,17-,18+,19-,21+/m1/s1 D00SFY DRUGINKE AOBLNYCSGWSIPG-YRIDSSQKSA-N D00SFY DRUGSMIL CC1=C(C(=NN1C(C)C)OC2C(C(C(C(O2)CO)O)O)O)CC3=C(C=C(C=C3)OC)F D00SFY HIGHSTAT Phase 1 D00SSZ DRUG__ID D00SSZ D00SSZ DRUGCOMP Astellas Pharma Inc D00SSZ DRUGINCH 1S/C20H31N3O6S2/c1-11(2)18-15(24)9-17(26)29-13-6-4-5-7-30-31-10-14(20(28)23-18)22-19(27)12(3)21-16(25)8-13/h4,6,11-15,18,24H,5,7-10H2,1-3H3,(H,21,25)(H,22,27)(H,23,28)/b6-4+/t12-,13-,14-,15+,18-/m1/s1 D00SSZ DRUGINKE XFLBOEMFLGLWFF-HDXRNPEWSA-N D00SSZ DRUGSMIL CC1C(=O)NC2CSSCCC=CC(CC(=O)N1)OC(=O)CC(C(NC2=O)C(C)C)O D00SSZ HIGHSTAT Phase 1 D00UEC DRUG__ID D00UEC D00UEC DRUGCOMP Astellas D00UEC DRUGINCH 1S/C19H16ClF3N4O2/c1-19(2,29-15-13(22)7-10(20)8-14(15)23)18-26-25-17(27(18)3)11-5-4-9(16(24)28)6-12(11)21/h4-8H,1-3H3,(H2,24,28) D00UEC DRUGINKE CMQOKZCYVZFZLZ-UHFFFAOYSA-N D00UEC DRUGSMIL CC(C)(C1=NN=C(N1C)C2=C(C=C(C=C2)C(=O)N)F)OC3=C(C=C(C=C3F)Cl)F D00UEC HIGHSTAT Phase 1 D00VNH DRUG__ID D00VNH D00VNH DRUGTYPE Small molecular drug D00VNH DRUGINCH 1S/C14H15F3N3O6P/c15-14(16,17)8-5-9-11(6-10(8)19-1-3-26-4-2-19)20(7-27(23,24)25)13(22)12(21)18-9/h5-6H,1-4,7H2,(H,18,21)(H2,23,24,25) D00VNH DRUGINKE WZMQMKNCWDCCMT-UHFFFAOYSA-N D00VNH DRUGSMIL C1COCCN1C2=CC3=C(C=C2C(F)(F)F)NC(=O)C(=O)N3CP(=O)(O)O D00VNH HIGHSTAT Phase 1 D00VUN DRUG__ID D00VUN D00VUN DRUGCOMP TaiRx Taipei, Taiwan D00VUN DRUGINCH 1S/C16H13FNO5P.2Na/c1-23-14-6-5-11-15(16(14)24(20,21)22)13(19)8-12(18-11)9-3-2-4-10(17)7-9;;/h2-8H,1H3,(H,18,19)(H2,20,21,22);;/q;2*+1/p-2 D00VUN DRUGINKE ZRPWVAHVWBPHID-UHFFFAOYSA-L D00VUN DRUGSMIL COC1=C(C2=C(C=C1)NC(=CC2=O)C3=CC(=CC=C3)F)P(=O)([O-])[O-].[Na+].[Na+] D00VUN HIGHSTAT Phase 1 D00WDY DRUG__ID D00WDY D00WDY DRUGCOMP Bristol-Myers Squibb Co D00WDY DRUGINCH 1S/C21H19Cl2FN4O4S/c1-33(30,31)15-2-3-18(17(24)8-15)28-12-16(23)19(9-20(28)29)32-14-4-6-27(7-5-14)21-25-10-13(22)11-26-21/h2-3,8-12,14H,4-7H2,1H3 D00WDY DRUGINKE OGIAVRWXUPYGGC-UHFFFAOYSA-N D00WDY DRUGSMIL CS(=O)(=O)C1=CC(=C(C=C1)N2C=C(C(=CC2=O)OC3CCN(CC3)C4=NC=C(C=N4)Cl)Cl)F D00WDY HIGHSTAT Phase 1 D00XBC DRUG__ID D00XBC D00XBC DRUGCOMP GlaxoSmithKline plc D00XBC DRUGINCH 1S/C24H25ClN4O5S2/c1-24(2,31)23(30)26-13-15-6-4-7-16(12-15)14-29-17-8-5-9-18(34-3)21(17)22(27-29)28-36(32,33)20-11-10-19(25)35-20/h4-12,31H,13-14H2,1-3H3,(H,26,30)(H,27,28) D00XBC DRUGINKE YTEVTHHGQMUPHC-UHFFFAOYSA-N D00XBC DRUGSMIL CC(C)(C(=O)NCC1=CC(=CC=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl)O D00XBC HIGHSTAT Phase 1 D00YBZ DRUG__ID D00YBZ D00YBZ DRUGCOMP Ocucure therapeutics D00YBZ DRUGINCH 1S/C20H16N2O/c23-20-17-8-4-5-9-18(17)21-19(22-20)16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13,19,21H,(H,22,23) D00YBZ DRUGINKE XRUAOBKXCFNPCK-UHFFFAOYSA-N D00YBZ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C3NC4=CC=CC=C4C(=O)N3 D00YBZ HIGHSTAT Phase 1 D00ZGF DRUG__ID D00ZGF D00ZGF DRUGCOMP Dong-A Pharmaceutical Co Ltd D00ZGF DRUGINCH 1S/C19H27ClN6O2/c1-28-18-12-17(21)16(20)11-15(18)19(27)22-13-14-3-8-25(9-4-14)6-2-7-26-10-5-23-24-26/h5,10-12,14H,2-4,6-9,13,21H2,1H3,(H,22,27) D00ZGF DRUGINKE AULLTYAISZREAX-UHFFFAOYSA-N D00ZGF DRUGSMIL COC1=CC(=C(C=C1C(=O)NCC2CCN(CC2)CCCN3C=CN=N3)Cl)N D00ZGF HIGHSTAT Phase 1 D00ZPT DRUG__ID D00ZPT D00ZPT DRUGCOMP Boehringer Ingelheim Corp D00ZPT DRUGINCH 1S/C22H23ClN4O4.Na/c1-13-9-14(3-6-19(13)27-7-8-31-12-20(27)28)22(29)26-18(11-30-2)21-24-16-5-4-15(23)10-17(16)25-21;/h3-6,9-10,18H,7-8,11-12H2,1-2H3,(H2,24,25,26,29);/q;+1/p-1/t18-;/m0./s1 D00ZPT DRUGINKE OJSUHLVJVGHFKW-FERBBOLQSA-M D00ZPT DRUGSMIL CC1=C(C=CC(=C1)C(=O)[N-]C(COC)C2=NC3=C(N2)C=C(C=C3)Cl)N4CCOCC4=O.[Na+] D00ZPT HIGHSTAT Phase 1 D01FYA DRUG__ID D01FYA D01FYA DRUGTYPE Small molecular drug D01FYA DRUGINCH 1S/C18H21IN6O2S/c1-10(2)21-4-3-5-25-17-15(16(20)22-8-23-17)24-18(25)28-14-7-13-12(6-11(14)19)26-9-27-13/h6-8,10,21H,3-5,9H2,1-2H3,(H2,20,22,23) D01FYA DRUGINKE SUPVGFZUWFMATN-UHFFFAOYSA-N D01FYA DRUGSMIL CC(C)NCCCN1C2=NC=NC(=C2N=C1SC3=C(C=C4C(=C3)OCO4)I)N D01FYA HIGHSTAT Phase 1 D01FZZ DRUG__ID D01FZZ D01FZZ DRUGCOMP Genentech South San Francisco, CA Xenon Pharmaceuticals Burnaby, Canada D01FZZ DRUGINCH 1S/C25H25ClF6N2O4S/c1-39(36,37)33-23(35)18-10-17(14-2-3-14)21(11-20(18)27)38-13-24(29)4-6-34(7-5-24)12-15-8-16(25(30,31)32)9-19(26)22(15)28/h8-11,14H,2-7,12-13H2,1H3,(H,33,35) D01FZZ DRUGINKE FCTMRPTVPHVTTN-UHFFFAOYSA-N D01FZZ DRUGSMIL CS(=O)(=O)NC(=O)C1=C(C=C(C(=C1)C2CC2)OCC3(CCN(CC3)CC4=C(C(=CC(=C4)C(F)(F)F)Cl)F)F)F D01FZZ HIGHSTAT Phase 1 D01HLO DRUG__ID D01HLO D01HLO DRUGCOMP Pfizer Inc D01HLO DRUGINCH 1S/C29H32N6OS/c1-19-11-25(31-18-30-19)22-3-5-24-21(12-22)4-6-26(24)35-16-29(17-35)7-9-33(10-8-29)27(36)13-23-15-34-14-20(2)37-28(34)32-23/h3,5,11-12,14-15,18,26H,4,6-10,13,16-17H2,1-2H3/t26-/m1/s1 D01HLO DRUGINKE ZIUDADZJCKGWKR-AREMUKBSSA-N D01HLO DRUGSMIL CC1=CC(=NC=N1)C2=CC3=C(C=C2)C(CC3)N4CC5(C4)CCN(CC5)C(=O)CC6=CN7C=C(SC7=N6)C D01HLO HIGHSTAT Phase 1 D01HQU DRUG__ID D01HQU D01HQU DRUGCOMP Akeso Biopharma Guangdong, China Merck Kenilworth, NJ D01HQU DRUGINCH 1S/C21H15N5O/c1-3-15(19-22-9-10-23-19)4-2-14(1)18-13-26-21(27-18)17-7-5-16(6-8-17)20-24-11-12-25-20/h1-13H,(H,22,23)(H,24,25) D01HQU DRUGINKE POIOBVFAFSUWGR-UHFFFAOYSA-N D01HQU DRUGSMIL C1=CC(=CC=C1C2=CN=C(O2)C3=CC=C(C=C3)C4=NC=CN4)C5=NC=CN5 D01HQU HIGHSTAT Phase 1 D01KMW DRUG__ID D01KMW D01KMW DRUGCOMP Bristol-Myers Squibb D01KMW DRUGINCH 1S/C24H22ClN2O7PS/c1-32-20-10-17(8-9-19(20)33-12-21(14-2-3-14)34-35(29,30)31)27-13-26-18-11-22(36-23(18)24(27)28)15-4-6-16(25)7-5-15/h4-11,13-14,21H,2-3,12H2,1H3,(H2,29,30,31)/t21-/m0/s1 D01KMW DRUGINKE YDTUJCNTIMWHPJ-NRFANRHFSA-N D01KMW DRUGSMIL COC1=C(C=CC(=C1)N2C=NC3=C(C2=O)SC(=C3)C4=CC=C(C=C4)Cl)OCC(C5CC5)OP(=O)(O)O D01KMW HIGHSTAT Phase 1 D01KTG DRUG__ID D01KTG D01KTG DRUGCOMP Novartis pharmaceuticals D01KTG DRUGINCH 1S/C26H24Cl2N6O4/c1-13(2)33-21-19(30-22(33)17-11-29-26(38-5)31-23(17)37-4)25(36)34(18-10-16(28)12-32(3)24(18)35)20(21)14-6-8-15(27)9-7-14/h6-13,20H,1-5H3/t20-/m0/s1 D01KTG DRUGINKE AGBSXNCBIWWLHD-FQEVSTJZSA-N D01KTG DRUGSMIL CC(C)N1C2=C(C(=O)N(C2C3=CC=C(C=C3)Cl)C4=CC(=CN(C4=O)C)Cl)N=C1C5=CN=C(N=C5OC)OC D01KTG HIGHSTAT Phase 1 D01QNR DRUG__ID D01QNR D01QNR DRUGCOMP Novartis Oncology East Hanover, NJ D01QNR DRUGINCH 1S/C24H23F3N4O/c1-13-9-14(11-15(28)10-13)16-7-8-29-12-21(16)31-24(32)20-6-5-19(27)23(30-20)22-17(25)3-2-4-18(22)26/h2-8,12-15H,9-11,28H2,1H3,(H,31,32)/t13-,14+,15-/m0/s1 D01QNR DRUGINKE VRQXRVAKPDCRCI-ZNMIVQPWSA-N D01QNR DRUGSMIL CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F D01QNR HIGHSTAT Phase 1 D01RRF DRUG__ID D01RRF D01RRF DRUGTYPE Small molecular drug D01RRF DRUGINCH 1S/C22H16N4O2S/c1-14-10-20(29-25-14)24-22(28)21(27)18-12-17(26-9-3-2-4-19(18)26)11-15-5-7-16(13-23)8-6-15/h2-10,12H,11H2,1H3,(H,24,28) D01RRF DRUGINKE IZZYUABKZYIINT-UHFFFAOYSA-N D01RRF DRUGSMIL CC1=NSC(=C1)NC(=O)C(=O)C2=C3C=CC=CN3C(=C2)CC4=CC=C(C=C4)C#N D01RRF HIGHSTAT Phase 1 D01SHJ DRUG__ID D01SHJ D01SHJ DRUGCOMP Adlai Nortye Hangzhou, China D01SHJ DRUGINCH 1S/C22H18F5N3O4/c1-11(12-6-8-13(9-7-12)21(32)33)28-19(31)16-17(18(23)24)29-30(2)20(16)34-15-5-3-4-14(10-15)22(25,26)27/h3-11,18H,1-2H3,(H,28,31)(H,32,33)/t11-/m0/s1 D01SHJ DRUGINKE MKLKAQMPKHNQPR-NSHDSACASA-N D01SHJ DRUGSMIL CC(C1=CC=C(C=C1)C(=O)O)NC(=O)C2=C(N(N=C2C(F)F)C)OC3=CC=CC(=C3)C(F)(F)F D01SHJ HIGHSTAT Phase 1 D01SPJ DRUG__ID D01SPJ D01SPJ DRUGCOMP Oligovax SAS D01SPJ DRUGINCH 1S/C256H322N95O129P25S25/c1-101-44-330(248(371)317-227(101)354)166-18-110(353)137(431-166)54-405-481(380,506)468-123-31-179(339-88-292-192-205(261)274-79-283-214(192)339)444-150(123)67-418-483(382,508)457-112-20-167(326-14-10-162(257)305-244(326)367)432-138(112)55-407-487(386,512)461-116-24-172(332-46-103(3)229(356)319-250(332)373)440-146(116)63-415-499(398,524)477-132-40-188(348-97-301-201-223(348)309-240(270)313-236(201)363)452-158(132)75-426-484(383,509)460-115-23-170(329-17-13-165(260)308-247(329)370)435-141(115)58-410-496(395,521)471-127-35-183(343-92-296-196-209(265)278-83-287-218(196)343)451-157(127)74-425-505(404,530)480-135-43-191(351-100-304-204-226(351)312-243(273)316-239(204)366)455-161(135)78-429-493(392,518)467-122-30-178(338-52-109(9)235(362)325-256(338)379)439-145(122)62-414-498(397,523)473-129-37-185(345-94-298-198-211(267)280-85-289-220(198)345)446-152(129)69-420-491(390,516)465-120-28-176(336-50-107(7)233(360)323-254(336)377)437-143(120)60-412-489(388,514)463-118-26-174(334-48-105(5)231(358)321-252(334)375)442-148(118)65-417-500(399,525)478-133-41-189(349-98-302-202-224(349)310-241(271)314-237(202)364)453-159(133)76-427-485(384,510)458-113-21-168(327-15-11-163(258)306-245(327)368)433-139(113)56-408-494(393,519)469-125-33-181(341-90-294-194-207(263)276-81-285-216(194)341)448-154(125)71-423-503(402,528)475-130-38-186(346-95-299-199-212(268)281-86-290-221(199)346)447-153(130)70-421-492(391,517)466-121-29-177(337-51-108(8)234(361)324-255(337)378)438-144(121)61-413-497(396,522)472-128-36-184(344-93-297-197-210(266)279-84-288-219(197)344)445-151(128)68-419-490(389,515)464-119-27-175(335-49-106(6)232(359)322-253(335)376)436-142(119)59-411-488(387,513)462-117-25-173(333-47-104(4)230(357)320-251(333)374)441-147(117)64-416-501(400,526)479-134-42-190(350-99-303-203-225(350)311-242(272)315-238(203)365)454-160(134)77-428-486(385,511)459-114-22-169(328-16-12-164(259)307-246(328)369)434-140(114)57-409-495(394,520)470-126-34-182(342-91-295-195-208(264)277-82-286-217(195)342)449-155(126)72-424-504(403,529)476-131-39-187(347-96-300-200-213(269)282-87-291-222(200)347)450-156(131)73-422-502(401,527)474-124-32-180(340-89-293-193-206(262)275-80-284-215(193)340)443-149(124)66-406-482(381,507)456-111-19-171(430-136(111)53-352)331-45-102(2)228(355)318-249(331)372/h10-17,44-52,79-100,110-161,166-191,352-353H,18-43,53-78H2,1-9H3,(H,380,506)(H,381,507)(H,382,508)(H,383,509)(H,384,510)(H,385,511)(H,386,512)(H,387,513)(H,388,514)(H,389,515)(H,390,516)(H,391,517)(H,392,518)(H,393,519)(H,394,520)(H,395,521)(H,396,522)(H,397,523)(H,398,524)(H,399,525)(H,400,526)(H,401,527)(H,402,528)(H,403,529)(H,404,530)(H2,257,305,367)(H2,258,306,368)(H2,259,307,369)(H2,260,308,370)(H2,261,274,283)(H2,262,275,284)(H2,263,276,285)(H2,264,277,286)(H2,265,278,287)(H2,266,279,288)(H2,267,280,289)(H2,268,281,290)(H2,269,282,291)(H,317,354,371)(H,318,355,372)(H,319,356,373)(H,320,357,374)(H,321,358,375)(H,322,359,376)(H,323,360,377)(H,324,361,378)(H,325,362,379)(H3,270,309,313,363)(H3,271,310,314,364)(H3,272,311,315,365)(H3,273,312,316,366) D01SPJ DRUGINKE CJZRVARTODENJN-UHFFFAOYSA-N D01SPJ DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)O D01SPJ HIGHSTAT Phase 1 D01TJY DRUG__ID D01TJY D01TJY DRUGCOMP ProStrakan Group plc D01TJY DRUGINCH 1S/C29H37N7O5S/c1-18-26(31-17-25(29(37)38)35-42(39,40)23-9-7-22(41-3)8-10-23)32-19(2)33-28(18)36-15-12-20(13-16-36)24-11-6-21-5-4-14-30-27(21)34-24/h6-11,20,25,35H,4-5,12-17H2,1-3H3,(H,30,34)(H,37,38)(H,31,32,33)/t25-/m0/s1 D01TJY DRUGINKE CXHCNOMGODVIKB-VWLOTQADSA-N D01TJY DRUGSMIL CC1=C(N=C(N=C1N2CCC(CC2)C3=NC4=C(CCCN4)C=C3)C)NCC(C(=O)O)NS(=O)(=O)C5=CC=C(C=C5)OC D01TJY HIGHSTAT Phase 1 D01WKZ DRUG__ID D01WKZ D01WKZ DRUGCOMP Celgene Summit, NJ D01WKZ DRUGINCH 1S/C24H26ClN5O3/c25-20-12-7-8-13-21(20)30(19-10-4-3-5-11-19)24-27-16-18(17-28-24)23(32)26-15-9-2-1-6-14-22(31)29-33/h3-5,7-8,10-13,16-17,33H,1-2,6,9,14-15H2,(H,26,32)(H,29,31) D01WKZ DRUGINKE VLIUIBXPEDFJRF-UHFFFAOYSA-N D01WKZ DRUGSMIL C1=CC=C(C=C1)N(C2=CC=CC=C2Cl)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO D01WKZ HIGHSTAT Phase 1 D01YIF DRUG__ID D01YIF D01YIF DRUGTYPE Small molecular drug D01YIF DRUGINCH 1S/C23H28N4O2/c1-2-7-20-10-6-11-21(23(20)29)16-24-25-22(28)18-27-14-12-26(13-15-27)17-19-8-4-3-5-9-19/h2-6,8-11,16,29H,1,7,12-15,17-18H2,(H,25,28)/b24-16+ D01YIF DRUGINKE YQNRVGJCPCNMKT-LFVJCYFKSA-N D01YIF DRUGSMIL C=CCC1=C(C(=CC=C1)C=NNC(=O)CN2CCN(CC2)CC3=CC=CC=C3)O D01YIF HIGHSTAT Phase 1 D01ZUV DRUG__ID D01ZUV D01ZUV DRUGCOMP Genentech D01ZUV DRUGINCH 1S/C18H19N5O/c1-2-23-8-5-12(6-9-23)24-17-14(10-19)21-11-15-16(17)13-4-3-7-20-18(13)22-15/h3-4,7,11-12H,2,5-6,8-9H2,1H3,(H,20,22) D01ZUV DRUGINKE XEZLBMHDUXSICI-UHFFFAOYSA-N D01ZUV DRUGSMIL CCN1CCC(CC1)OC2=C3C4=C(NC3=CN=C2C#N)N=CC=C4 D01ZUV HIGHSTAT Phase 1 D02ABO DRUG__ID D02ABO D02ABO DRUGTYPE Small molecular drug D02ABO DRUGINCH 1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2 D02ABO DRUGINKE FTVWIRXFELQLPI-UHFFFAOYSA-N D02ABO DRUGSMIL C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O D02ABO HIGHSTAT Phase 1 D02HUY DRUG__ID D02HUY D02HUY DRUGCOMP Debiopharm D02HUY DRUGINCH 1S/C22H34N2O6S3/c1-4-28-22(27)30-16(2)29-20(25)13-24-21(26)18(12-17-8-6-5-7-9-17)14-32-33-15-19(23)10-11-31-3/h5-9,16,18-19H,4,10-15,23H2,1-3H3,(H,24,26) D02HUY DRUGINKE BJCNUZJDFWFVBY-UHFFFAOYSA-N D02HUY DRUGSMIL CCOC(=O)OC(C)OC(=O)CNC(=O)C(CC1=CC=CC=C1)CSSCC(CCSC)N D02HUY HIGHSTAT Phase 1 D02IKF DRUG__ID D02IKF D02IKF DRUGCOMP EMD Serono Rockland, MA D02IKF DRUGINCH 1S/C9H7NO2S/c1-5-10-7-4-6(9(11)12)2-3-8(7)13-5/h2-4H,1H3,(H,11,12) D02IKF DRUGINKE TVUFPZOJUJGDDD-UHFFFAOYSA-N D02IKF DRUGSMIL CC1=NC2=C(S1)C=CC(=C2)C(=O)O D02IKF HIGHSTAT Phase 1 D02NIP DRUG__ID D02NIP D02NIP DRUGTYPE Small molecular drug D02NIP DRUGINCH 1S/C16H20N4O2/c1-19-11-6-7-12(19)9-10(8-11)17-15(21)20-14-5-3-2-4-13(14)18-16(20)22/h2-5,10-12H,6-9H2,1H3,(H,17,21)(H,18,22)/t10?,11-,12+ D02NIP DRUGINKE RWXRJSRJIITQAK-YOGCLGLASA-N D02NIP DRUGSMIL CN1C2CCC1CC(C2)NC(=O)N3C4=CC=CC=C4NC3=O D02NIP HIGHSTAT Phase 1 D02ONT DRUG__ID D02ONT D02ONT DRUGTYPE Small molecular drug D02ONT DRUGINCH 1S/C4H3FN2O/c5-3-1-6-4(8)7-2-3/h1-2H,(H,6,7,8) D02ONT DRUGINKE HPABFFGQPLJKBP-UHFFFAOYSA-N D02ONT DRUGSMIL C1=C(C=NC(=O)N1)F D02ONT HIGHSTAT Phase 1 D02QWY DRUG__ID D02QWY D02QWY DRUGTYPE Small molecular drug D02QWY DRUGINCH 1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1 D02QWY DRUGINKE LQVXSNNAFNGRAH-QHCPKHFHSA-N D02QWY DRUGSMIL CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F D02QWY HIGHSTAT Phase 1 D02RRX DRUG__ID D02RRX D02RRX DRUGTYPE Small molecular drug D02RRX DRUGINCH 1S/C19H20ClN3O4/c20-13-5-6-17-15(11-13)21-19(27)14-3-1-2-4-16(14)23(17)18(26)12-22(7-9-24)8-10-25/h1-6,11,24-25H,7-10,12H2,(H,21,27) D02RRX DRUGINKE DDBKYWMANNIJRH-UHFFFAOYSA-N D02RRX DRUGSMIL C1=CC=C2C(=C1)C(=O)NC3=C(N2C(=O)CN(CCO)CCO)C=CC(=C3)Cl D02RRX HIGHSTAT Phase 1 D02TTL DRUG__ID D02TTL D02TTL DRUGCOMP Debiopharm D02TTL DRUGINCH 1S/C22H30N6O2S/c1-22(2,3)12-24-8-9-28-14-6-7-25-20(23)19(14)26-21(28)31-18-11-17-16(29-13-30-17)10-15(18)27(4)5/h6-7,10-11,24H,8-9,12-13H2,1-5H3,(H2,23,25) D02TTL DRUGINKE RVJIQAYFTOPTKK-UHFFFAOYSA-N D02TTL DRUGSMIL CC(C)(C)CNCCN1C2=C(C(=NC=C2)N)N=C1SC3=CC4=C(C=C3N(C)C)OCO4 D02TTL HIGHSTAT Phase 1 D02UFQ DRUG__ID D02UFQ D02UFQ DRUGTYPE Small molecular drug D02UFQ DRUGINCH 1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34) D02UFQ DRUGINKE ZYQXEVJIFYIBHZ-UHFFFAOYSA-N D02UFQ DRUGSMIL CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O D02UFQ HIGHSTAT Phase 1 D02VKC DRUG__ID D02VKC D02VKC DRUGTYPE Small molecular drug D02VKC DRUGINCH 1S/C12H8N4O6S/c13-23(21,22)8-3-1-2-5-9(8)7(16(19)20)4-6-10(5)15-12(18)11(17)14-6/h1-4H,(H,14,17)(H,15,18)(H2,13,21,22) D02VKC DRUGINKE UQNAFPHGVPVTAL-UHFFFAOYSA-N D02VKC DRUGSMIL C1=CC2=C3C(=CC(=C2C(=C1)S(=O)(=O)N)[N+](=O)[O-])NC(=O)C(=O)N3 D02VKC HIGHSTAT Phase 1 D02YQO DRUG__ID D02YQO D02YQO DRUGTYPE Small molecular drug D02YQO DRUGINCH 1S/C20H19N7O2/c1-28-14-8-6-13(7-9-14)4-2-10-26-18-15(12-22-26)19-23-17(16-5-3-11-29-16)25-27(19)20(21)24-18/h3,5-9,11-12H,2,4,10H2,1H3,(H2,21,24) D02YQO DRUGINKE AEULVFLPCJOBCE-UHFFFAOYSA-N D02YQO DRUGSMIL COC1=CC=C(C=C1)CCCN2C3=C(C=N2)C4=NC(=NN4C(=N3)N)C5=CC=CO5 D02YQO HIGHSTAT Phase 1 D03AVS DRUG__ID D03AVS D03AVS DRUGTYPE Small molecular drug D03AVS DRUGINCH 1S/C25H22N2O5/c1-4-31-24(28)13-6-8-19-15(10-13)17-12-18-16-11-14(25(29)32-5-2)7-9-20(16)27-22(18)23(30-3)21(17)26-19/h6-12,26-27H,4-5H2,1-3H3 D03AVS DRUGINKE BMTPVPNVQOYGAP-UHFFFAOYSA-N D03AVS DRUGSMIL CCOC(=O)C1=CC2=C(C=C1)NC3=C(C4=C(C=C23)C5=C(N4)C=CC(=C5)C(=O)OCC)OC D03AVS HIGHSTAT Phase 1 D03BKV DRUG__ID D03BKV D03BKV DRUGCOMP Komipharm International Co Ltd D03BKV DRUGINCH 1S/C16H15ClN2O4/c1-11(12-2-4-13(17)5-3-12)18-16(20)10-23-15-8-6-14(7-9-15)19(21)22/h2-9,11H,10H2,1H3,(H,18,20) D03BKV DRUGINKE FIOKOSHFWPOUGX-UHFFFAOYSA-N D03BKV DRUGSMIL CC(C1=CC=C(C=C1)Cl)NC(=O)COC2=CC=C(C=C2)[N+](=O)[O-] D03BKV HIGHSTAT Phase 1 D03BYM DRUG__ID D03BYM D03BYM DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D03BYM DRUGINCH 1S/C20H21N7O/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16/h3-8,11,13H,9-10,12H2,1-2H3,(H,22,25)/t13-/m1/s1 D03BYM DRUGINKE YBXRSCXGRPSTMW-CYBMUJFWSA-N D03BYM DRUGSMIL CC1COCCN1C2=NC3=C(C=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C D03BYM HIGHSTAT Phase 1 D03DKR DRUG__ID D03DKR D03DKR DRUGTYPE Small molecular drug D03DKR DRUGINCH 1S/C10H19Cl2NO5.ClH/c11-1-3-13(4-2-12)5-6-7(14)8(15)9(16)10(17)18-6;/h6-10,14-17H,1-5H2;1H/t6-,7+,8+,9-,10?;/m1./s1 D03DKR DRUGINKE YPEQSOJVCFFDKJ-IBUKJIQJSA-N D03DKR DRUGSMIL C(CCl)N(CCCl)CC1C(C(C(C(O1)O)O)O)O.Cl D03DKR HIGHSTAT Phase 1 D03FOP DRUG__ID D03FOP D03FOP DRUGCOMP Amgen Thousand D03FOP DRUGINCH 1S/C21H16FN7/c1-12(28-21-19-20(25-10-24-19)26-11-27-21)15-8-13-5-6-14(22)9-17(13)29-18(15)16-4-2-3-7-23-16/h2-12H,1H3,(H2,24,25,26,27,28)/t12-/m0/s1 D03FOP DRUGINKE KWRYMZHCQIOOEB-LBPRGKRZSA-N D03FOP DRUGSMIL CC(C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5 D03FOP HIGHSTAT Phase 1 D03GNI DRUG__ID D03GNI D03GNI DRUGTYPE Small molecular drug D03GNI DRUGINCH 1S/C20H22ClN3O/c1-3-24(4-2)13-14-5-7-16(12-20(14)25)23-18-9-10-22-19-11-15(21)6-8-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23) D03GNI DRUGINKE QGFYFOHMBDMGBZ-UHFFFAOYSA-N D03GNI DRUGSMIL CCN(CC)CC1=C(C=C(C=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O D03GNI HIGHSTAT Phase 1 D03IJO DRUG__ID D03IJO D03IJO DRUGCOMP Gilead Sciences D03IJO DRUGINCH 1S/C21H16FN7O/c1-12(27-19-17-18(24-10-23-17)25-11-26-19)20-28-16-8-7-13(22)9-15(16)21(30)29(20)14-5-3-2-4-6-14/h2-12H,1H3,(H2,23,24,25,26,27)/t12-/m0/s1 D03IJO DRUGINKE DOCINCLJNAXZQF-LBPRGKRZSA-N D03IJO DRUGSMIL CC(C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 D03IJO HIGHSTAT Phase 1 D03JLR DRUG__ID D03JLR D03JLR DRUGCOMP Plexxikon Berkeley, CA D03JLR DRUGINCH 1S/C26H22N4O3/c1-15-24(17(3)33-29-15)20-12-23-25(28-13-20)21(18-7-9-19(10-8-18)26(31)32)14-30(23)16(2)22-6-4-5-11-27-22/h4-14,16H,1-3H3,(H,31,32)/t16-/m0/s1 D03JLR DRUGINKE AMSUHYUVOVCWTP-INIZCTEOSA-N D03JLR DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=C(C(=CN3C(C)C4=CC=CC=N4)C5=CC=C(C=C5)C(=O)O)N=C2 D03JLR HIGHSTAT Phase 1 D03MDW DRUG__ID D03MDW D03MDW DRUGCOMP Daiichi Sankyo D03MDW DRUGINCH 1S/C14H19NO/c1-11-8-15(9-12(2)14(11)16)10-13-6-4-3-5-7-13/h3-7,11-12H,8-10H2,1-2H3 D03MDW DRUGINKE KUUYMZATYJQLLZ-UHFFFAOYSA-N D03MDW DRUGSMIL CC1CN(CC(C1=O)C)CC2=CC=CC=C2 D03MDW HIGHSTAT Phase 1 D03MLA DRUG__ID D03MLA D03MLA DRUGTYPE Small molecular drug D03MLA DRUGINCH 1S/C12H12FN3S2/c13-10-3-1-9(2-4-10)5-6-14-11(17)16-12-15-7-8-18-12/h1-4,7-8H,5-6H2,(H2,14,15,16,17) D03MLA DRUGINKE WGSDLRNUZBUXDV-UHFFFAOYSA-N D03MLA DRUGSMIL C1=CC(=CC=C1CCNC(=S)NC2=NC=CS2)F D03MLA HIGHSTAT Phase 1 D03NHS DRUG__ID D03NHS D03NHS DRUGCOMP Chugai Pharma USA Berkeley Heights, NJ D03NHS DRUGINCH 1S/C29H32F3N5O6S/c1-17-15-20(37-26(40)34-24(38)27(37,3)4)16-18(2)22(17)9-14-44(41,42)36-12-10-28(11-13-36)25(39)33-23(35-28)19-5-7-21(8-6-19)43-29(30,31)32/h5-8,15-16H,9-14H2,1-4H3,(H,33,35,39)(H,34,38,40) D03NHS DRUGINKE LDZJFVOUPUFOHX-UHFFFAOYSA-N D03NHS DRUGSMIL CC1=CC(=CC(=C1CCS(=O)(=O)N2CCC3(CC2)C(=O)NC(=N3)C4=CC=C(C=C4)OC(F)(F)F)C)N5C(=O)NC(=O)C5(C)C D03NHS HIGHSTAT Phase 1 D03QAO DRUG__ID D03QAO D03QAO DRUGCOMP AstraZeneca plc D03QAO DRUGINCH 1S/C25H26FN5O3/c26-20-16-30(7-8-31-22-11-17(13-27)1-2-18(22)3-4-25(31)32)6-5-21(20)29-14-19-12-23-24(15-28-19)34-10-9-33-23/h1-4,11-12,15,20-21,29H,5-10,14,16H2/t20-,21+/m1/s1 D03QAO DRUGINKE JYJKOWWSKTWAJA-RTWAWAEBSA-N D03QAO DRUGSMIL C1CN(CC(C1NCC2=CC3=C(C=N2)OCCO3)F)CCN4C(=O)C=CC5=C4C=C(C=C5)C#N D03QAO HIGHSTAT Phase 1 D03QKW DRUG__ID D03QKW D03QKW DRUGCOMP Kissei Pharmaceutical Co Ltd D03QKW DRUGINCH 1S/C21H27NO5/c1-13-11-19(27-12-20(24)25)14(2)10-17(13)8-9-22-15(3)21(26)16-4-6-18(23)7-5-16/h4-7,10-11,15,21-23,26H,8-9,12H2,1-3H3,(H,24,25)/t15-,21-/m0/s1 D03QKW DRUGINKE VMMYRRFPMAGXNP-BTYIYWSLSA-N D03QKW DRUGSMIL CC1=CC(=C(C=C1OCC(=O)O)C)CCNC(C)C(C2=CC=C(C=C2)O)O D03QKW HIGHSTAT Phase 1 D03RMN DRUG__ID D03RMN D03RMN DRUGTYPE Small molecular drug D03RMN DRUGINCH 1S/C18H20N4O6/c1-24-12-7-11(8-13(25-2)17(12)26-3)10-28-16-6-5-15-19-14(9-22(15)21-16)20-18(23)27-4/h5-9H,10H2,1-4H3,(H,20,23) D03RMN DRUGINKE UMSHZWFCVXIDEO-UHFFFAOYSA-N D03RMN DRUGSMIL COC1=CC(=CC(=C1OC)OC)COC2=NN3C=C(N=C3C=C2)NC(=O)OC D03RMN HIGHSTAT Phase 1 D03UDF DRUG__ID D03UDF D03UDF DRUGCOMP Bayer Pharmaceuticals Whippany, NJ; Loxo Oncology Stamford, CT D03UDF DRUGINCH 1S/C20H21FN6O/c1-12-4-5-16-14(9-13(21)10-22-16)17-3-2-7-26(17)18-6-8-27-19(25-18)15(11-23-27)20(28)24-12/h6,8-12,17H,2-5,7H2,1H3,(H,24,28)/t12-,17-/m1/s1 D03UDF DRUGINKE OEBIHOVSAMBXIB-SJKOYZFVSA-N D03UDF DRUGSMIL CC1CCC2=C(C=C(C=N2)F)C3CCCN3C4=NC5=C(C=NN5C=C4)C(=O)N1 D03UDF HIGHSTAT Phase 1 D03XHS DRUG__ID D03XHS D03XHS DRUGCOMP Actelion Ltd D03XHS DRUGINCH 1S/C33H38Cl3N3O4/c1-21-15-29(35)32(30(36)16-21)43-14-13-42-31-8-4-23(18-38-31)26-9-11-37-19-27(26)33(40)39(25-5-6-25)20-24-17-22(10-12-41-2)3-7-28(24)34/h3-4,7-8,15-18,25-27,37H,5-6,9-14,19-20H2,1-2H3/t26-,27+/m1/s1 D03XHS DRUGINKE PGSRKJVMAOWDEC-SXOMAYOGSA-N D03XHS DRUGSMIL CC1=CC(=C(C(=C1)Cl)OCCOC2=NC=C(C=C2)C3CCNCC3C(=O)N(CC4=C(C=CC(=C4)CCOC)Cl)C5CC5)Cl D03XHS HIGHSTAT Phase 1 D04AHQ DRUG__ID D04AHQ D04AHQ DRUGCOMP Lilly D04AHQ DRUGINCH 1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30) D04AHQ DRUGINKE HHCBMISMPSAZBF-UHFFFAOYSA-N D04AHQ DRUGSMIL CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F D04AHQ HIGHSTAT Phase 1 D04AZM DRUG__ID D04AZM D04AZM DRUGCOMP ArQule D04AZM DRUGINCH 1S/C25H27N8O8PS.2Na/c1-31-11-8-21(30-31)43(37,38)32-10-3-5-18(15-32)27-24-26-9-7-20(28-24)23-22(29-25-33(23)12-13-39-25)17-4-2-6-19(14-17)40-16-41-42(34,35)36;;/h2,4,6-9,11-14,18H,3,5,10,15-16H2,1H3,(H,26,27,28)(H2,34,35,36);;/q;2*+1/p-2/t18-;;/m1../s1 D04AZM DRUGINKE HXINDCTZKGGRDE-JPKZNVRTSA-L D04AZM DRUGSMIL CN1C=CC(=N1)S(=O)(=O)N2CCCC(C2)NC3=NC=CC(=N3)C4=C(N=C5N4C=CO5)C6=CC(=CC=C6)OCOP(=O)([O-])[O-].[Na+].[Na+] D04AZM HIGHSTAT Phase 1 D04CJE DRUG__ID D04CJE D04CJE DRUGCOMP Novartis AG D04CJE DRUGINCH 1S/C30H30N2O4/c1-6-16-36-24-13-14-26-25(18-24)29(23-11-9-22(10-12-23)20(3)4)31-30(33)32(26)19-21-8-15-27(34-5)28(17-21)35-7-2/h1,8-15,17-18,20H,7,16,19H2,2-5H3 D04CJE DRUGINKE IIBRYYCFSIBSFT-UHFFFAOYSA-N D04CJE DRUGSMIL CCOC1=C(C=CC(=C1)CN2C3=C(C=C(C=C3)OCC#C)C(=NC2=O)C4=CC=C(C=C4)C(C)C)OC D04CJE HIGHSTAT Phase 1 D04DSD DRUG__ID D04DSD D04DSD DRUGTYPE Small molecular drug D04DSD DRUGINCH 1S/C21H34O5S/c1-26-20(25)10-6-3-7-13-27-21-16(18(23)14-19(21)24)11-12-17(22)15-8-4-2-5-9-15/h11-12,15-18,21-23H,2-10,13-14H2,1H3/b12-11+/t16-,17?,18+,21+/m0/s1 D04DSD DRUGINKE QNKCYDKEIICCMC-RJOSLXAASA-N D04DSD DRUGSMIL COC(=O)CCCCCSC1C(C(CC1=O)O)C=CC(C2CCCCC2)O D04DSD HIGHSTAT Phase 1 D04ERQ DRUG__ID D04ERQ D04ERQ DRUGCOMP AstraZeneca plc D04ERQ DRUGINCH 1S/C24H29N5O/c1-17-21(15-28(2)27-17)16-29-13-11-19(12-14-29)18-7-9-20(10-8-18)24(30)26-23-6-4-3-5-22(23)25/h3-10,15,19H,11-14,16,25H2,1-2H3,(H,26,30) D04ERQ DRUGINKE JHDZMASHNBKTPS-UHFFFAOYSA-N D04ERQ DRUGSMIL CC1=NN(C=C1CN2CCC(CC2)C3=CC=C(C=C3)C(=O)NC4=CC=CC=C4N)C D04ERQ HIGHSTAT Phase 1 D04FMB DRUG__ID D04FMB D04FMB DRUGTYPE Small molecular drug D04FMB DRUGINCH 1S/C17H13ClN2O4.Na/c1-10(17(21)22)23-12-3-5-13(6-4-12)24-16-9-19-14-7-2-11(18)8-15(14)20-16;/h2-10H,1H3,(H,21,22);/q;+1/p-1 D04FMB DRUGINKE OJENKXNXJPNEPU-UHFFFAOYSA-M D04FMB DRUGSMIL CC(C(=O)[O-])OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl.[Na+] D04FMB HIGHSTAT Phase 1 D04JTX DRUG__ID D04JTX D04JTX DRUGCOMP Gilead Sciences D04JTX DRUGINCH 1S/C27H26N2O4/c1-15-21(25(26(30)31)33-27(2,3)4)23(17-7-5-6-8-19(17)29-15)18-9-10-20-22-16(12-14-32-20)11-13-28-24(18)22/h5-11,13,25H,12,14H2,1-4H3,(H,30,31)/t25-/m0/s1 D04JTX DRUGINKE MIXIIJCBELCMCZ-VWLOTQADSA-N D04JTX DRUGSMIL CC1=NC2=CC=CC=C2C(=C1C(C(=O)O)OC(C)(C)C)C3=C4C5=C(C=C3)OCCC5=CC=N4 D04JTX HIGHSTAT Phase 1 D04KKT DRUG__ID D04KKT D04KKT DRUGTYPE Small molecular drug D04KKT DRUGINCH 1S/C12H13NO4/c1-16-12(15)7-10-6-11(13-17-10)8-2-4-9(14)5-3-8/h2-5,10,14H,6-7H2,1H3 D04KKT DRUGINKE AIXMJTYHQHQJLU-UHFFFAOYSA-N D04KKT DRUGSMIL COC(=O)CC1CC(=NO1)C2=CC=C(C=C2)O D04KKT HIGHSTAT Phase 1 D04KNL DRUG__ID D04KNL D04KNL DRUGCOMP Progen Pharmaceuticals Ltd D04KNL DRUGINCH 1S/C51H88O60S13.13Na/c1-22(2)7-6-8-23(3)27-11-12-28-26-10-9-24-17-25(13-15-50(24,4)29(26)14-16-51(27,28)5)95-46-42(108-121(79,80)81)38(104-117(67,68)69)34(30(96-46)18-91-112(52,53)54)100-47-43(109-122(82,83)84)39(105-118(70,71)72)35(31(97-47)19-92-113(55,56)57)101-48-44(110-123(85,86)87)40(106-119(73,74)75)36(32(98-48)20-93-114(58,59)60)102-49-45(111-124(88,89)90)41(107-120(76,77)78)37(103-116(64,65)66)33(99-49)21-94-115(61,62)63;;;;;;;;;;;;;/h22-49H,6-21H2,1-5H3,(H,52,53,54)(H,55,56,57)(H,58,59,60)(H,61,62,63)(H,64,65,66)(H,67,68,69)(H,70,71,72)(H,73,74,75)(H,76,77,78)(H,79,80,81)(H,82,83,84)(H,85,86,87)(H,88,89,90);;;;;;;;;;;;;/q;13*+1/p-13/t23-,24+,25+,26+,27-,28+,29+,30-,31-,32-,33-,34-,35-,36-,37-,38+,39+,40+,41+,42-,43-,44-,45-,46-,47-,48-,49-,50+,51-;;;;;;;;;;;;;/m1............./s1 D04KNL DRUGINKE PHIUHBOJEMIHQZ-YAPWIAIGSA-A D04KNL DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)OC5C(C(C(C(O5)COS(=O)(=O)[O-])OC6C(C(C(C(O6)COS(=O)(=O)[O-])OC7C(C(C(C(O7)COS(=O)(=O)[O-])OC8C(C(C(C(O8)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])C)C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D04KNL HIGHSTAT Phase 1 D04KVQ DRUG__ID D04KVQ D04KVQ DRUGCOMP Bayer AG D04KVQ DRUGINCH 1S/C10H12FNO3/c11-6-15-8-3-1-7(2-4-8)5-9(12)10(13)14/h1-4,9H,5-6,12H2,(H,13,14)/t9-/m1/s1/i11-1 D04KVQ DRUGINKE GEBHVOHKNWLITQ-DEVVULMSSA-N D04KVQ DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)OCF D04KVQ HIGHSTAT Phase 1 D04SOU DRUG__ID D04SOU D04SOU DRUGCOMP Merck & Co Inc D04SOU DRUGINCH 1S/C33H31N3O6/c1-19-18-36(24-4-5-24)26-13-21(14-29(41-2)30(19)26)31(38)35-9-7-33(8-10-35)15-27(37)25-12-20(3-6-28(25)42-33)22-11-23(32(39)40)17-34-16-22/h3,6,11-14,16-18,24H,4-5,7-10,15H2,1-2H3,(H,39,40) D04SOU DRUGINKE WDBNGXLHMZSUEI-UHFFFAOYSA-N D04SOU DRUGSMIL CC1=CN(C2=C1C(=CC(=C2)C(=O)N3CCC4(CC3)CC(=O)C5=C(O4)C=CC(=C5)C6=CC(=CN=C6)C(=O)O)OC)C7CC7 D04SOU HIGHSTAT Phase 1 D04UNO DRUG__ID D04UNO D04UNO DRUGCOMP Kissei Pharmaceutical Co Ltd D04UNO DRUGINCH 1S/C19H23NO5/c1-13(19(24)15-4-6-16(21)7-5-15)20-11-10-14-2-8-17(9-3-14)25-12-18(22)23/h2-9,13,19-21,24H,10-12H2,1H3,(H,22,23)/t13-,19-/m0/s1 D04UNO DRUGINKE KKXPBQQLKHBRDA-DJJJIMSYSA-N D04UNO DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)OCC(=O)O D04UNO HIGHSTAT Phase 1 D04UPW DRUG__ID D04UPW D04UPW DRUGCOMP RW Johnson Pharmaceutical Research Institute D04UPW DRUGINCH 1S/C34H37Cl3N4O4/c35-34(36,37)31(42)39-33(23-26-8-3-1-4-9-26)15-14-27(24-33)25-41(32(43)38-28-10-5-2-6-11-28)29-12-7-13-30(22-29)45-21-18-40-16-19-44-20-17-40/h1-13,22,24H,14-21,23,25H2,(H,38,43)(H,39,42)/t33-/m1/s1 D04UPW DRUGINKE DPBURRXPRULCQN-MGBGTMOVSA-N D04UPW DRUGSMIL C1CC(C=C1CN(C2=CC(=CC=C2)OCCN3CCOCC3)C(=O)NC4=CC=CC=C4)(CC5=CC=CC=C5)NC(=O)C(Cl)(Cl)Cl D04UPW HIGHSTAT Phase 1 D04VMG DRUG__ID D04VMG D04VMG DRUGTYPE Small molecular drug D04VMG DRUGINCH 1S/C15H24/c1-7-15(6)9-8-13(11(2)3)10-14(15)12(4)5/h7,13-14H,1-2,4,8-10H2,3,5-6H3 D04VMG DRUGINKE OPFTUNCRGUEPRZ-UHFFFAOYSA-N D04VMG DRUGSMIL CC(=C)C1CCC(C(C1)C(=C)C)(C)C=C D04VMG HIGHSTAT Phase 1 D04ZQB DRUG__ID D04ZQB D04ZQB DRUGCOMP Karyopharm Therapeutics Newton, MA D04ZQB DRUGINCH 1S/C35H29F3N4O3/c36-28-9-7-24(8-10-28)30-19-26(23-3-5-25(6-4-23)34(44)42-15-13-35(37,38)14-16-42)17-27-18-29(45-33(27)30)21-41-32(43)12-2-22-1-11-31(39)40-20-22/h1-12,17-20H,13-16,21H2,(H2,39,40)(H,41,43)/b12-2+ D04ZQB DRUGINKE MRFOPLWJZULAQD-SWGQDTFXSA-N D04ZQB DRUGSMIL C1CN(CCC1(F)F)C(=O)C2=CC=C(C=C2)C3=CC(=C4C(=C3)C=C(O4)CNC(=O)C=CC5=CN=C(C=C5)N)C6=CC=C(C=C6)F D04ZQB HIGHSTAT Phase 1 D05ECQ DRUG__ID D05ECQ D05ECQ DRUGCOMP Resolvyx Pharmaceuticals D05ECQ DRUGINCH 1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18+,19-/m1/s1 D05ECQ DRUGINKE AOPOCGPBAIARAV-OTBJXLELSA-N D05ECQ DRUGSMIL CCC(C=CC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O)O D05ECQ HIGHSTAT Phase 1 D05EPU DRUG__ID D05EPU D05EPU DRUGTYPE Small molecular drug D05EPU DRUGINCH 1S/C22H30N2O6/c1-27-13-12-24-22(26)17-30-21-9-7-20(8-10-21)28-14-11-23-15-18(25)16-29-19-5-3-2-4-6-19/h2-10,18,23,25H,11-17H2,1H3,(H,24,26)/t18-/m0/s1 D05EPU DRUGINKE RVMBDLSFFNKKLG-SFHVURJKSA-N D05EPU DRUGSMIL COCCNC(=O)COC1=CC=C(C=C1)OCCNCC(COC2=CC=CC=C2)O D05EPU HIGHSTAT Phase 1 D05FKU DRUG__ID D05FKU D05FKU DRUGCOMP Biomedical Sciences Institute SingaporeD3 (Drug Product and Development) Singapore D05FKU DRUGINCH 1S/C19H17N7O3/c1-24-17-16(18(28)25(2)19(24)29)26(11-20-17)10-15(27)21-14-9-8-13(22-23-14)12-6-4-3-5-7-12/h3-9,11H,10H2,1-2H3,(H,21,23,27) D05FKU DRUGINKE QTRXIFVSTWXRJJ-UHFFFAOYSA-N D05FKU DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)NC3=NN=C(C=C3)C4=CC=CC=C4 D05FKU HIGHSTAT Phase 1 D05GUK DRUG__ID D05GUK D05GUK DRUGTYPE Small molecular drug D05GUK DRUGINCH 1S/C21H24N4O/c1-13-12-23-21(22-9-4-10-25(2)3)19-18-16-7-6-15(26)11-14(16)5-8-17(18)24-20(13)19/h5-8,11-12,24,26H,4,9-10H2,1-3H3,(H,22,23) D05GUK DRUGINKE QROONAIPJKQFMC-UHFFFAOYSA-N D05GUK DRUGSMIL CC1=CN=C(C2=C1NC3=C2C4=C(C=C3)C=C(C=C4)O)NCCCN(C)C D05GUK HIGHSTAT Phase 1 D05HAD DRUG__ID D05HAD D05HAD DRUGCOMP Merck & Co Inc D05HAD DRUGINCH 1S/C19H16ClF3N6O2/c20-15-9-27-17(28-11-19(22,23)14-5-1-2-6-25-14)18(31)29(15)10-16(30)26-8-13-12(21)4-3-7-24-13/h1-7,9H,8,10-11H2,(H,26,30)(H,27,28) D05HAD DRUGINKE AATHXZYXWMKUFC-UHFFFAOYSA-N D05HAD DRUGSMIL C1=CC=NC(=C1)C(CNC2=NC=C(N(C2=O)CC(=O)NCC3=C(C=CC=N3)F)Cl)(F)F D05HAD HIGHSTAT Phase 1 D05HGL DRUG__ID D05HGL D05HGL DRUGCOMP GlaxoSmithKline plc D05HGL DRUGINCH 1S/C26H21Cl2N3O6S/c1-3-24(32)31-38(35,36)20-5-6-22(15(2)8-20)30-25(33)14-37-23-7-4-18(27)12-21(23)26(34)17-9-16(13-29)10-19(28)11-17/h4-12H,3,14H2,1-2H3,(H,30,33)(H,31,32) D05HGL DRUGINKE GAQZNFUDILDDDI-UHFFFAOYSA-N D05HGL DRUGSMIL CCC(=O)NS(=O)(=O)C1=CC(=C(C=C1)NC(=O)COC2=C(C=C(C=C2)Cl)C(=O)C3=CC(=CC(=C3)C#N)Cl)C D05HGL HIGHSTAT Phase 1 D05ICT DRUG__ID D05ICT D05ICT DRUGCOMP AbbVieNorth Chicago, IL D05ICT DRUGINCH 1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28(4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3,(H,30,33) D05ICT DRUGINKE OEDSFMUSNZDJFD-UHFFFAOYSA-N D05ICT DRUGSMIL CCNC(=O)C1=CC2=C(N1)C(=O)N(C=C2C3=C(C=CC(=C3)C(C)(C)O)OC4=C(C=C(C=C4C)F)C)C D05ICT HIGHSTAT Phase 1 D05KNG DRUG__ID D05KNG D05KNG DRUGCOMP Bessor-brightwaters pharma D05KNG DRUGINCH 1S/C47H60N4O9S.2ClH/c1-9-43(55)23-28-24-46(41(53)58-6,37-30(14-18-50(25-28)26-43)31-20-29(61-8)12-13-34(31)48-37)33-21-32-35(22-36(33)57-5)49(4)39-45(32)16-19-51-17-11-15-44(10-2,38(45)51)40(60-27(3)52)47(39,56)42(54)59-7;;/h11-13,15,20-22,28,38-40,48,55-56H,9-10,14,16-19,23-26H2,1-8H3;2*1H/t28-,38-,39+,40+,43-,44+,45+,46-,47-;;/m0../s1 D05KNG DRUGINKE MTABGSVEFKMZFG-USKOTZBXSA-N D05KNG DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=C(N3)C=CC(=C4)SC)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.Cl.Cl D05KNG HIGHSTAT Phase 1 D05LRD DRUG__ID D05LRD D05LRD DRUGCOMP Bristol-Myers Squibb D05LRD DRUGINCH 1S/C16H19N7O/c1-4-22-5-2-12(1)16(9-22)8-18-15(24-16)21-13-7-14(20-10-19-13)23-6-3-17-11-23/h3,6-7,10-12H,1-2,4-5,8-9H2,(H,18,19,20,21)/t16-/m0/s1 D05LRD DRUGINKE RLXBHTUZCPORKT-INIZCTEOSA-N D05LRD DRUGSMIL C1CN2CCC1C3(C2)CN=C(O3)NC4=CC(=NC=N4)N5C=CN=C5 D05LRD HIGHSTAT Phase 1 D05ONA DRUG__ID D05ONA D05ONA DRUGCOMP Tulane University D05ONA DRUGINCH 1S/C35H40N6O5/c36-27(18-23-13-15-25(42)16-14-23)32(43)39-29-12-6-7-17-37-33(44)30(19-22-8-2-1-3-9-22)40-35(46)31(41-34(29)45)20-24-21-38-28-11-5-4-10-26(24)28/h1-5,8-11,13-16,21,27,29-31,38,42H,6-7,12,17-20,36H2,(H,37,44)(H,39,43)(H,40,46)(H,41,45)/t27-,29+,30-,31-/m0/s1 D05ONA DRUGINKE CFVGCGXJRNVTFP-LYXINOJLSA-N D05ONA DRUGSMIL C1CCNC(=O)C(NC(=O)C(NC(=O)C(C1)NC(=O)C(CC2=CC=C(C=C2)O)N)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5 D05ONA HIGHSTAT Phase 1 D05QHU DRUG__ID D05QHU D05QHU DRUGCOMP Cardiovascular Systems Inc D05QHU DRUGINCH 1S/C19H19Br2N3O2S/c20-11-8-12-14(2-6-26-18(12)13(21)9-11)22-4-1-5-23-17-10-16(25)19-15(24-17)3-7-27-19/h3,7-10,14,22H,1-2,4-6H2,(H2,23,24,25)/t14-/m1/s1 D05QHU DRUGINKE NNTYBKTXMKBRFA-CQSZACIVSA-N D05QHU DRUGSMIL C1COC2=C(C1NCCCNC3=CC(=O)C4=C(N3)C=CS4)C=C(C=C2Br)Br D05QHU HIGHSTAT Phase 1 D05REB DRUG__ID D05REB D05REB DRUGTYPE Small molecular drug D05REB DRUGINCH 1S/C23H23ClN2O3/c1-4-17-14-7-13(2)11-23(17,18-5-6-21(27)26-19(18)9-14)25-12-15-8-16(24)10-20(29-3)22(15)28/h4-8,10,12,14,28H,9,11H2,1-3H3,(H,26,27)/b17-4+,25-12?/t14-,23+/m0/s1 D05REB DRUGINKE UYRWZANUXPUEPQ-OWNLDCJBSA-N D05REB DRUGSMIL CC=C1C2CC3=C(C1(CC(=C2)C)N=CC4=C(C(=CC(=C4)Cl)OC)O)C=CC(=O)N3 D05REB HIGHSTAT Phase 1 D05RGV DRUG__ID D05RGV D05RGV DRUGCOMP Merck D05RGV DRUGINCH 1S/C14H24N2O/c1-10(15)11-5-7-12(8-6-11)13(17)9-16-14(2,3)4/h5-8,10,13,16-17H,9,15H2,1-4H3/t10-,13+/m0/s1 D05RGV DRUGINKE KUHBBYPXWKYKKR-GXFFZTMASA-N D05RGV DRUGSMIL CC(C1=CC=C(C=C1)C(CNC(C)(C)C)O)N D05RGV HIGHSTAT Phase 1 D05TIS DRUG__ID D05TIS D05TIS DRUGTYPE Small molecular drug D05TIS DRUGINCH 1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6?/m1/s1 D05TIS DRUGINKE NBSCHQHZLSJFNQ-GASJEMHNSA-N D05TIS DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)OP(=O)(O)O D05TIS HIGHSTAT Phase 1 D05VNP DRUG__ID D05VNP D05VNP DRUGTYPE Small molecular drug D05VNP DRUGINCH 1S/C30H46O3/c1-4-5-6-20-7-9-21(10-8-20)28(32)33-27-14-13-25-24-12-11-22-19-23(31)15-17-29(22,2)26(24)16-18-30(25,27)3/h19-21,24-27H,4-18H2,1-3H3/t20?,21?,24-,25-,26-,27-,29-,30-/m0/s1 D05VNP DRUGINKE ODZDZTOROXGJAV-IRWJKHRASA-N D05VNP DRUGSMIL CCCCC1CCC(CC1)C(=O)OC2CCC3C2(CCC4C3CCC5=CC(=O)CCC45C)C D05VNP HIGHSTAT Phase 1 D05WSP DRUG__ID D05WSP D05WSP DRUGTYPE Small molecular drug D05WSP DRUGINCH 1S/C12H21N3O2/c1-2-6-15-8-11(14-9-15)7-10(12(16)17)4-3-5-13/h8-10H,2-7,13H2,1H3,(H,16,17)/t10-/m0/s1 D05WSP DRUGINKE OTDGPKRCQXSTPV-JTQLQIEISA-N D05WSP DRUGSMIL CCCN1C=C(N=C1)CC(CCCN)C(=O)O D05WSP HIGHSTAT Phase 1 D06BGZ DRUG__ID D06BGZ D06BGZ DRUGCOMP Eli Lilly Indianapolis, IN D06BGZ DRUGINCH 1S/C24H29N5O3/c1-24(2,30)21-13-17(5-9-25-21)27-22-14-19(6-10-26-22)32-20-15-29(18-3-4-18)28-23(20)16-7-11-31-12-8-16/h5-6,9-10,13-16,18,30H,3-4,7-8,11-12H2,1-2H3,(H,25,26,27) D06BGZ DRUGINKE PNPFMWIDAKQFPY-UHFFFAOYSA-N D06BGZ DRUGSMIL CC(C)(C1=NC=CC(=C1)NC2=NC=CC(=C2)OC3=CN(N=C3C4CCOCC4)C5CC5)O D06BGZ HIGHSTAT Phase 1 D06DMQ DRUG__ID D06DMQ D06DMQ DRUGCOMP Vertex pharmaceuticals D06DMQ DRUGINCH 1S/C24H25N5O3S/c1-15(2)33(30,31)19-10-8-18(9-11-19)21-14-27-24(25)23(28-21)22-12-20(29-32-22)17-6-4-16(5-7-17)13-26-3/h4-12,14-15,26H,13H2,1-3H3,(H2,25,27) D06DMQ DRUGINKE JZCWLJDSIRUGIN-UHFFFAOYSA-N D06DMQ DRUGSMIL CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N D06DMQ HIGHSTAT Phase 1 D06EDP DRUG__ID D06EDP D06EDP DRUGCOMP Sunovion pharmaceuticals D06EDP DRUGINCH 1S/C14H12FNO/c15-13-8-4-3-7-12(13)11-6-2-1-5-10(11)9-14(16)17/h1-8H,9H2,(H2,16,17) D06EDP DRUGINKE MWAPNZXZUGCADE-UHFFFAOYSA-N D06EDP DRUGSMIL C1=CC=C(C(=C1)CC(=O)N)C2=CC=CC=C2F D06EDP HIGHSTAT Phase 1 D06EFW DRUG__ID D06EFW D06EFW DRUGCOMP Chugai; Roche D06EFW DRUGINCH 1S/C12H12N4O/c1-16(11-7-12(17)15-13-9-11)14-8-10-5-3-2-4-6-10/h2-9H,1H3,(H,15,17)/b14-8- D06EFW DRUGINKE CTGDOGPKSFBVDA-ZSOIEALJSA-N D06EFW DRUGSMIL CN(C1=CC(=O)NN=C1)N=CC2=CC=CC=C2 D06EFW HIGHSTAT Phase 1 D06ESU DRUG__ID D06ESU D06ESU DRUGCOMP Amira Pharmaceuticals Inc D06ESU DRUGINCH 1S/C25H33NO5S/c1-24(2,3)23(29)26-18-9-11-19(17(14-18)15-32-25(4,5)6)31-21-12-16(13-22(27)28)8-10-20(21)30-7/h8-12,14H,13,15H2,1-7H3,(H,26,29)(H,27,28) D06ESU DRUGINKE SDHFXINHZHARIB-UHFFFAOYSA-N D06ESU DRUGSMIL CC(C)(C)C(=O)NC1=CC(=C(C=C1)OC2=C(C=CC(=C2)CC(=O)O)OC)CSC(C)(C)C D06ESU HIGHSTAT Phase 1 D06EXA DRUG__ID D06EXA D06EXA DRUGTYPE Small molecular drug D06EXA DRUGINCH 1S/C23H28O8/c1-12(24)30-16-9-15(20(26)28-4)22(2)7-5-14-21(27)31-17(13-6-8-29-11-13)10-23(14,3)19(22)18(16)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1 D06EXA DRUGINKE OBSYBRPAKCASQB-AGQYDFLVSA-N D06EXA DRUGSMIL CC(=O)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D06EXA HIGHSTAT Phase 1 D06HMN DRUG__ID D06HMN D06HMN DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D06HMN DRUGINCH 1S/C19H18F2N4O2S/c1-27-17-8-13(20)3-4-14(17)15-9-19(24-10-16(15)21)25-18-7-12(5-6-23-18)11-28(2,22)26/h3-10,22H,11H2,1-2H3,(H,23,24,25) D06HMN DRUGINKE YZCUMZWULWOUMD-UHFFFAOYSA-N D06HMN DRUGSMIL COC1=C(C=CC(=C1)F)C2=CC(=NC=C2F)NC3=NC=CC(=C3)CS(=N)(=O)C D06HMN HIGHSTAT Phase 1 D06HYF DRUG__ID D06HYF D06HYF DRUGCOMP EMD Serono Rockland, MA D06HYF DRUGINCH 1S/C21H19ClF3N5O/c22-16-6-5-12(9-15(16)21(23,24)25)17(10-30-7-2-8-30)29-20-14-4-1-3-13(19(26)31)18(14)27-11-28-20/h1,3-6,9,11,17H,2,7-8,10H2,(H2,26,31)(H,27,28,29)/t17-/m1/s1 D06HYF DRUGINKE HXAUJHZZPCBFPN-QGZVFWFLSA-N D06HYF DRUGSMIL C1CN(C1)CC(C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N D06HYF HIGHSTAT Phase 1 D06KXS DRUG__ID D06KXS D06KXS DRUGTYPE Small molecular drug D06KXS DRUGINCH 1S/C16H16BrClFN3OS/c1-2-23-13-5-4-12(19)11(15(13)18)7-8-20-16(24)22-14-6-3-10(17)9-21-14/h3-6,9H,2,7-8H2,1H3,(H2,20,21,22,24) D06KXS DRUGINKE DTHZUSMREBJMBT-UHFFFAOYSA-N D06KXS DRUGSMIL CCOC1=C(C(=C(C=C1)F)CCNC(=S)NC2=NC=C(C=C2)Br)Cl D06KXS HIGHSTAT Phase 1 D06LQF DRUG__ID D06LQF D06LQF DRUGCOMP Progenics Pharmaceuticals New York, NY D06LQF DRUGINCH 1S/C19H25IN4O8/c20-11-4-6-12(7-5-11)22-18(31)21-10-2-1-3-13(16(27)28)23-19(32)24-14(17(29)30)8-9-15(25)26/h4-7,13-14H,1-3,8-10H2,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)(H2,23,24,32)/t13-,14-/m0/s1/i20+4 D06LQF DRUGINKE LFEGKCKGGNXWDV-LUOJOMRDSA-N D06LQF DRUGSMIL C1=CC(=CC=C1NC(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)I D06LQF HIGHSTAT Phase 1 D06QBV DRUG__ID D06QBV D06QBV DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D06QBV DRUGINCH 1S/C25H27N5O2/c1-16-13-21(28-29(3)25(16)31)24-27-22-15-26-20(19-9-11-32-12-10-19)14-23(22)30(24)17(2)18-7-5-4-6-8-18/h4-8,13-15,17,19H,9-12H2,1-3H3/t17-/m0/s1 D06QBV DRUGINKE QNFGQQDKBYVNAS-KRWDZBQOSA-N D06QBV DRUGSMIL CC1=CC(=NN(C1=O)C)C2=NC3=CN=C(C=C3N2C(C)C4=CC=CC=C4)C5CCOCC5 D06QBV HIGHSTAT Phase 1 D06RYY DRUG__ID D06RYY D06RYY DRUGCOMP AstraZeneca plc D06RYY DRUGINCH 1S/C19H14ClN3O4/c1-9-7-11(27-2)4-6-14(9)23-19(26)15-16(18(25)22-23)21-13-8-10(20)3-5-12(13)17(15)24/h3-8H,1-2H3,(H,21,24)(H,22,25) D06RYY DRUGINKE PSTDMIAVUUYOOQ-UHFFFAOYSA-N D06RYY DRUGSMIL CC1=C(C=CC(=C1)OC)N2C(=O)C3=C(C(=O)N2)NC4=C(C3=O)C=CC(=C4)Cl D06RYY HIGHSTAT Phase 1 D06SBD DRUG__ID D06SBD D06SBD DRUGCOMP Daiichi Sankyo D06SBD DRUGINCH 1S/C9H12N2O2/c1-6(2)8-4-3-7(11(12)13)5-9(8)10/h3-6H,10H2,1-2H3 D06SBD DRUGINKE VKEVGYZHNPSPOF-UHFFFAOYSA-N D06SBD DRUGSMIL CC(C)C1=C(C=C(C=C1)[N+](=O)[O-])N D06SBD HIGHSTAT Phase 1 D06SJZ DRUG__ID D06SJZ D06SJZ DRUGTYPE Small molecular drug D06SJZ DRUGINCH 1S/C18H15ClN2O4/c1-11(18(22)23-2)24-13-4-6-14(7-5-13)25-17-10-20-15-8-3-12(19)9-16(15)21-17/h3-11H,1-2H3 D06SJZ DRUGINKE NPUWJNOFOGQLSR-UHFFFAOYSA-N D06SJZ DRUGSMIL CC(C(=O)OC)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl D06SJZ HIGHSTAT Phase 1 D06SYN DRUG__ID D06SYN D06SYN DRUGCOMP Bayer Schering Pharma AG D06SYN DRUGINCH 1S/C21H25FIN3O3/c1-4-26(5-2)11-10-24-21(28)16-12-17(23)18(13-19(16)29-3)25-20(27)14-6-8-15(22)9-7-14/h6-9,12-13H,4-5,10-11H2,1-3H3,(H,24,28)(H,25,27)/i23+4 D06SYN DRUGINKE UPRRZQGAQRAODM-AWUWEVMDSA-N D06SYN DRUGSMIL CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)NC(=O)C2=CC=C(C=C2)F)I D06SYN HIGHSTAT Phase 1 D06TWE DRUG__ID D06TWE D06TWE DRUGCOMP Calyx Therapeutics Inc; Calyx Therapeutics D06TWE DRUGINCH 1S/C28H25NO7S/c1-33-22-12-18(13-23(16-22)34-2)14-24(27(31)35-3)19-6-10-21(11-7-19)36-20-8-4-17(5-9-20)15-25-26(30)29-28(32)37-25/h4-14,16,25H,15H2,1-3H3,(H,29,30,32)/b24-14+ D06TWE DRUGINKE IVAQJHSXBVHUQT-ZVHZXABRSA-N D06TWE DRUGSMIL COC1=CC(=CC(=C1)C=C(C2=CC=C(C=C2)OC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=O)OC)OC D06TWE HIGHSTAT Phase 1 D06UWF DRUG__ID D06UWF D06UWF DRUGCOMP Soricimed biopharma D06UWF DRUGINCH 1S/C72H116N20O19/c1-39(2)31-48(84-63(102)49(33-42-17-8-7-9-18-42)85-60(99)46(24-25-56(94)95)81-59(98)44(75)19-10-12-26-73)62(101)88-52(34-43-36-78-38-80-43)70(109)92-30-16-23-55(92)67(106)89-53(37-93)65(104)82-45(20-11-13-27-74)61(100)90-58(41(5)6)68(107)86-50(35-57(96)97)64(103)87-51(32-40(3)4)69(108)91-29-15-22-54(91)66(105)83-47(71(110)111)21-14-28-79-72(76)77/h7-9,17-18,36,38-41,44-55,58,93H,10-16,19-35,37,73-75H2,1-6H3,(H,78,80)(H,81,98)(H,82,104)(H,83,105)(H,84,102)(H,85,99)(H,86,107)(H,87,103)(H,88,101)(H,89,106)(H,90,100)(H,94,95)(H,96,97)(H,110,111)(H4,76,77,79)/t44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,58-/m0/s1 D06UWF DRUGINKE LGANPTNILMNMES-TVNHODDRSA-N D06UWF DRUGSMIL CC(C)CC(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)N D06UWF HIGHSTAT Phase 1 D06WHY DRUG__ID D06WHY D06WHY DRUGTYPE Small molecular drug D06WHY DRUGINCH 1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22) D06WHY DRUGINKE WJRRGYBTGDJBFX-UHFFFAOYSA-N D06WHY DRUGSMIL CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C D06WHY HIGHSTAT Phase 1 D06XCP DRUG__ID D06XCP D06XCP DRUGCOMP AstraZeneca Wilmington, DE D06XCP DRUGINCH 1S/C35H34ClN5O3S2/c1-20-31-29(38-40(20)3)19-45-17-22-15-23(41(4)37-22)18-46-24-14-21-8-5-6-9-25(21)30(16-24)44-13-7-10-26-27-11-12-28(36)32(31)33(27)39(2)34(26)35(42)43/h5-6,8-9,11-12,14-16H,7,10,13,17-19H2,1-4H3,(H,42,43) D06XCP DRUGINKE KBQCEQAXHPIRTF-UHFFFAOYSA-N D06XCP DRUGSMIL CC1=C2C(=NN1C)CSCC3=NN(C(=C3)CSC4=CC5=CC=CC=C5C(=C4)OCCCC6=C(N(C7=C6C=CC(=C27)Cl)C)C(=O)O)C D06XCP HIGHSTAT Phase 1 D07ANO DRUG__ID D07ANO D07ANO DRUGTYPE Small molecular drug D07ANO DRUGINCH 1S/C9H10ClN2O5PS/c1-15-18(14,16-2)19-5-12-8-7(17-9(12)13)3-6(10)4-11-8/h3-4H,5H2,1-2H3 D07ANO DRUGINKE VNKBTWQZTQIWDV-UHFFFAOYSA-N D07ANO DRUGSMIL COP(=O)(OC)SCN1C2=C(C=C(C=N2)Cl)OC1=O D07ANO HIGHSTAT Phase 1 D07CAQ DRUG__ID D07CAQ D07CAQ DRUGTYPE Small molecular drug D07CAQ DRUGINCH 1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/t17-,18-/m0/s1 D07CAQ DRUGINKE OTKJDMGTUTTYMP-ROUUACIJSA-N D07CAQ DRUGSMIL CCCCCCCCCCCCCCCC(C(CO)N)O D07CAQ HIGHSTAT Phase 1 D07CLV DRUG__ID D07CLV D07CLV DRUGTYPE Small molecular drug D07CLV DRUGINCH 1S/C25H34N6O3S/c1-16(26-2)22(32)27-21(18-12-7-4-8-13-18)25(34)31-15-9-14-19(31)23(33)28-24-20(29-30-35-24)17-10-5-3-6-11-17/h3,5-6,10-11,16,18-19,21,26H,4,7-9,12-15H2,1-2H3,(H,27,32)(H,28,33)/t16-,19-,21-/m0/s1 D07CLV DRUGINKE WZRFLSDVFPIXOV-LRQRDZAKSA-N D07CLV DRUGSMIL CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C(=O)NC3=C(N=NS3)C4=CC=CC=C4)NC D07CLV HIGHSTAT Phase 1 D07DAU DRUG__ID D07DAU D07DAU DRUGCOMP Pierre Fabre SA D07DAU DRUGINCH 1S/C45H35F10O20P/c1-13-64-9-22-39(70-13)42(72-23(56)10-65-40-33(52)29(48)27(46)30(49)34(40)53)43(73-24(57)11-66-41-35(54)31(50)28(47)32(51)36(41)55)45(71-22)74-37-16-7-19-18(68-12-69-19)6-15(16)25(26-17(37)8-67-44(26)58)14-4-20(62-2)38(21(5-14)63-3)75-76(59,60)61/h4-7,13,17,22,25-26,37,39,42-43,45H,8-12H2,1-3H3,(H2,59,60,61)/t13-,17+,22-,25-,26+,37-,39-,42+,43-,45+/m1/s1 D07DAU DRUGINKE RTJVUHUGTUDWRK-CSLCKUBZSA-N D07DAU DRUGSMIL CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)OP(=O)(O)O)OC)OC(=O)COC8=C(C(=C(C(=C8F)F)F)F)F)OC(=O)COC9=C(C(=C(C(=C9F)F)F)F)F D07DAU HIGHSTAT Phase 1 D07DIX DRUG__ID D07DIX D07DIX DRUGTYPE Small molecular drug D07DIX DRUGINCH 1S/C15H9FN2O2/c16-8-5-6-10-9-3-1-2-4-11(9)15(12(10)7-8)13(19)17-14(20)18-15/h1-7H,(H2,17,18,19,20) D07DIX DRUGINKE JRGBXEJDIMXJAP-UHFFFAOYSA-N D07DIX DRUGSMIL C1=CC=C2C(=C1)C3=C(C24C(=O)NC(=O)N4)C=C(C=C3)F D07DIX HIGHSTAT Phase 1 D07EFM DRUG__ID D07EFM D07EFM DRUGTYPE Small molecular drug D07EFM DRUGINCH 1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3 D07EFM DRUGINKE HJJPJSXJAXAIPN-UHFFFAOYSA-N D07EFM DRUGSMIL CN1CCC=C(C1)C(=O)OC D07EFM HIGHSTAT Phase 1 D07FPR DRUG__ID D07FPR D07FPR DRUGCOMP Roche D07FPR DRUGINCH 1S/C11H9ClO2/c12-9-3-1-8(2-4-9)11-6-5-10(7-13)14-11/h1-6,13H,7H2 D07FPR DRUGINKE PMHZVTQIEAIJBK-UHFFFAOYSA-N D07FPR DRUGSMIL C1=CC(=CC=C1C2=CC=C(O2)CO)Cl D07FPR HIGHSTAT Phase 1 D07GHV DRUG__ID D07GHV D07GHV DRUGCOMP Pfizer D07GHV DRUGINCH 1S/C19H17F3N8/c1-11-27-15(17-18(29-6-3-7-29)24-10-26-30(11)17)13-9-25-28(2)16(13)14-5-4-12(8-23-14)19(20,21)22/h4-5,8-10H,3,6-7H2,1-2H3 D07GHV DRUGINKE CLGCHUKGBICQTE-UHFFFAOYSA-N D07GHV DRUGSMIL CC1=NC(=C2N1N=CN=C2N3CCC3)C4=C(N(N=C4)C)C5=NC=C(C=C5)C(F)(F)F D07GHV HIGHSTAT Phase 1 D07JAI DRUG__ID D07JAI D07JAI DRUGTYPE Small molecular drug D07JAI DRUGINCH 1S/C21H20BrN5O3/c1-13-10-15(8-9-18(13)30-21-23-11-14(22)12-24-21)25-20(29)26-19(28)16-6-4-5-7-17(16)27(2)3/h4-12H,1-3H3,(H2,25,26,28,29) D07JAI DRUGINKE JNGQUJZDVFZPEN-UHFFFAOYSA-N D07JAI DRUGSMIL CC1=C(C=CC(=C1)NC(=O)NC(=O)C2=CC=CC=C2N(C)C)OC3=NC=C(C=N3)Br D07JAI HIGHSTAT Phase 1 D07JBE DRUG__ID D07JBE D07JBE DRUGCOMP CrystalGenomics Inc D07JBE DRUGINCH 1S/C24H33N3O4/c1-27(2)17-9-16-25-24(29)20(11-4-3-5-15-23(28)26-30)18-31-22-14-8-12-19-10-6-7-13-21(19)22/h6-8,10-14,30H,3-5,9,15-18H2,1-2H3,(H,25,29)(H,26,28)/b20-11+ D07JBE DRUGINKE AUGCSOFQTDKPSO-RGVLZGJSSA-N D07JBE DRUGSMIL CN(C)CCCNC(=O)C(=CCCCCC(=O)NO)COC1=CC=CC2=CC=CC=C21 D07JBE HIGHSTAT Phase 1 D07KBM DRUG__ID D07KBM D07KBM DRUGCOMP AstraZeneca Wilmington, DE D07KBM DRUGINCH 1S/C22H28ClN5O2/c1-13(29)26-15-6-4-5-14(7-15)21(30)27-20-8-16(18(23)11-24-20)17-10-25-28-12-22(2,3)9-19(17)28/h8,10-11,14-15H,4-7,9,12H2,1-3H3,(H,26,29)(H,24,27,30)/t14-,15+/m0/s1 D07KBM DRUGINKE AVIWDYSJSPOOAR-LSDHHAIUSA-N D07KBM DRUGSMIL CC(=O)NC1CCCC(C1)C(=O)NC2=NC=C(C(=C2)C3=C4CC(CN4N=C3)(C)C)Cl D07KBM HIGHSTAT Phase 1 D07LPT DRUG__ID D07LPT D07LPT DRUGCOMP eXIthera Pharmaceuticals Westborough, MA D07LPT DRUGINCH 1S/C21H30N4O4/c1-13(15-7-5-3-2-4-6-8-15)24-21(29)25-18(20(27)28)16(19(25)26)11-14-9-10-23-17(22)12-14/h9-10,12-13,15-16,18H,2-8,11H2,1H3,(H2,22,23)(H,24,29)(H,27,28)/t13-,16-,18+/m1/s1 D07LPT DRUGINKE QPVLDUCHRPJGCJ-QBIMZIAESA-N D07LPT DRUGSMIL CC(C1CCCCCCC1)NC(=O)N2C(C(C2=O)CC3=CC(=NC=C3)N)C(=O)O D07LPT HIGHSTAT Phase 1 D07NFW DRUG__ID D07NFW D07NFW DRUGTYPE Small molecular drug D07NFW DRUGINCH 1S/C24H26F2N2O5S/c1-34(31,32)28-21-14-18(9-12-22(21)29)23(30)15-27-20(13-16-5-3-2-4-6-16)17-7-10-19(11-8-17)33-24(25)26/h2-12,14,20,23-24,27-30H,13,15H2,1H3/t20-,23+/m1/s1 D07NFW DRUGINKE XWLVOJZVWRCRMD-OFNKIYASSA-N D07NFW DRUGSMIL CS(=O)(=O)NC1=C(C=CC(=C1)C(CNC(CC2=CC=CC=C2)C3=CC=C(C=C3)OC(F)F)O)O D07NFW HIGHSTAT Phase 1 D07PEH DRUG__ID D07PEH D07PEH DRUGCOMP AstraZeneca plc D07PEH DRUGINCH 1S/C25H31N5O/c1-17(2)11-12-28-23-10-7-18(14-26)13-21(23)27-24(28)16-30-22-6-4-3-5-19(22)15-29(25(30)31)20-8-9-20/h3-7,10,13,17,20H,8-9,11-12,14-16,26H2,1-2H3 D07PEH DRUGINKE SIFAULUPFCKXAX-UHFFFAOYSA-N D07PEH DRUGSMIL CC(C)CCN1C2=C(C=C(C=C2)CN)N=C1CN3C4=CC=CC=C4CN(C3=O)C5CC5 D07PEH HIGHSTAT Phase 1 D07RKN DRUG__ID D07RKN D07RKN DRUGCOMP Kirax D07RKN DRUGINCH 1S/C23H31N5O4/c1-15(2)11-18(22(30)31)26-23(32)28-10-9-27(13-19-16(3)24-14-25-19)21(29)20(28)12-17-7-5-4-6-8-17/h4-8,14-15,18,20H,9-13H2,1-3H3,(H,24,25)(H,26,32)(H,30,31)/t18-,20-/m0/s1 D07RKN DRUGINKE COLCNDRDBCLVOC-ICSRJNTNSA-N D07RKN DRUGSMIL CC1=C(N=CN1)CN2CCN(C(C2=O)CC3=CC=CC=C3)C(=O)NC(CC(C)C)C(=O)O D07RKN HIGHSTAT Phase 1 D07TAS DRUG__ID D07TAS D07TAS DRUGTYPE Small molecular drug D07TAS DRUGINCH 1S/C14H15N5O3S.Na/c1-7(2)22-11-9-6-8(21-3)4-5-10(9)23-12(11)13(20)15-14-16-18-19-17-14;/h4-7H,1-3H3,(H2,15,16,17,18,19,20);/q;+1/p-1 D07TAS DRUGINKE UCLODRCAPZIYOW-UHFFFAOYSA-M D07TAS DRUGSMIL CC(C)OC1=C(SC2=C1C=C(C=C2)OC)C(=O)NC3=NN=N[N-]3.[Na+] D07TAS HIGHSTAT Phase 1 D07TRP DRUG__ID D07TRP D07TRP DRUGCOMP Aptose biosciences D07TRP DRUGINCH 1S/C22H14FN5/c1-11-17(15-10-12(23)6-7-16(15)26-11)22-27-20-13-4-2-8-24-18(13)19-14(21(20)28-22)5-3-9-25-19/h2-10,26H,1H3,(H,27,28) D07TRP DRUGINKE NIRXBXIPHUTNNI-UHFFFAOYSA-N D07TRP DRUGSMIL CC1=C(C2=C(N1)C=CC(=C2)F)C3=NC4=C5C=CC=NC5=C6C(=C4N3)C=CC=N6 D07TRP HIGHSTAT Phase 1 D07UGA DRUG__ID D07UGA D07UGA DRUGTYPE Small molecular drug D07UGA DRUGINCH 1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/b15-14+/t17-,18+/m0/s1 D07UGA DRUGINKE DUYSYHSSBDVJSM-KRWOKUGFSA-N D07UGA DRUGSMIL CCCCCCCCCCCCCC=CC(C(COP(=O)(O)O)N)O D07UGA HIGHSTAT Phase 1 D07UUB DRUG__ID D07UUB D07UUB DRUGCOMP 4SC AG D07UUB DRUGINCH 1S/C33H38N8O4S/c1-21-6-9-27(43-3)26(16-21)37-32(42)39-33-38-24-8-7-22(17-30(24)46-33)36-31-23-18-28(44-4)29(19-25(23)34-20-35-31)45-15-5-10-41-13-11-40(2)12-14-41/h6-9,16-20H,5,10-15H2,1-4H3,(H,34,35,36)(H2,37,38,39,42) D07UUB DRUGINKE MAFACRSJGNJHCF-UHFFFAOYSA-N D07UUB DRUGSMIL CC1=CC(=C(C=C1)OC)NC(=O)NC2=NC3=C(S2)C=C(C=C3)NC4=NC=NC5=CC(=C(C=C54)OC)OCCCN6CCN(CC6)C D07UUB HIGHSTAT Phase 1 D07VNH DRUG__ID D07VNH D07VNH DRUGCOMP Celtaxsys Atlanta, GA D07VNH DRUGINCH 1S/C29H27N3O4/c33-29(34)23-5-1-20(2-6-23)16-31-18-25-15-24(31)19-32(25)17-21-3-9-26(10-4-21)36-27-11-7-22(8-12-27)28-30-13-14-35-28/h1-14,24-25H,15-19H2,(H,33,34)/t24-,25-/m0/s1 D07VNH DRUGINKE GERJIEKMNDGSCS-DQEYMECFSA-N D07VNH DRUGSMIL C1C2CN(C1CN2CC3=CC=C(C=C3)OC4=CC=C(C=C4)C5=NC=CO5)CC6=CC=C(C=C6)C(=O)O D07VNH HIGHSTAT Phase 1 D08AAB DRUG__ID D08AAB D08AAB DRUGCOMP Vivolux Uppsala, Sweden D08AAB DRUGINCH 1S/C17H15N7/c1-10-6-5-7-12-14(10)19-16-15(12)22-24-17(20-16)23-21-11(2)13-8-3-4-9-18-13/h3-9H,1-2H3,(H2,19,20,23,24)/b21-11+ D08AAB DRUGINKE UQOSBPRTQFFUOA-SRZZPIQSSA-N D08AAB DRUGSMIL CC1=C2C(=CC=C1)C3=C(N2)N=C(N=N3)NN=C(C)C4=CC=CC=N4 D08AAB HIGHSTAT Phase 1 D08AAV DRUG__ID D08AAV D08AAV DRUGCOMP AstraZeneca plc D08AAV DRUGINCH 1S/C25H32F3N7O2/c1-18(36)33-14-12-32(13-15-33)16-17-37-21-4-2-19(3-5-21)20-8-10-34(11-9-20)23-7-6-22-29-30-24(25(26,27)28)35(22)31-23/h2-5,20H,6-17H2,1H3 D08AAV DRUGINKE JMEYDSHPKCSIJC-UHFFFAOYSA-N D08AAV DRUGSMIL CC(=O)N1CCN(CC1)CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5C(F)(F)F)CC4 D08AAV HIGHSTAT Phase 1 D08DCP DRUG__ID D08DCP D08DCP DRUGCOMP Boehringer Ingelheim Pharmaceuticals D08DCP DRUGINCH 1S/C29H28N4O2/c1-4-30-26(34)17-13-20-12-16-24-25(18-20)32-29(35)27(24)28(22-8-6-5-7-9-22)31-23-14-10-21(11-15-23)19-33(2)3/h5-12,14-16,18,32,35H,4,19H2,1-3H3,(H,30,34) D08DCP DRUGINKE OCUQMWSIGPQEMX-UHFFFAOYSA-N D08DCP DRUGSMIL CCNC(=O)C#CC1=CC2=C(C=C1)C(=C(N2)O)C(=NC3=CC=C(C=C3)CN(C)C)C4=CC=CC=C4 D08DCP HIGHSTAT Phase 1 D08DMH DRUG__ID D08DMH D08DMH DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D08DMH DRUGINCH 1S/C21H18ClF5N4O4/c1-3-30-17(9-32)29-31(20(30)34)15-8-16(35-10(2)21(25,26)27)11(7-14(15)24)19(33)28-18-12(22)5-4-6-13(18)23/h4-8,10,32H,3,9H2,1-2H3,(H,28,33)/t10-/m0/s1 D08DMH DRUGINKE KNVJMHHAXCPZHF-JTQLQIEISA-N D08DMH DRUGSMIL CCN1C(=NN(C1=O)C2=C(C=C(C(=C2)OC(C)C(F)(F)F)C(=O)NC3=C(C=CC=C3Cl)F)F)CO D08DMH HIGHSTAT Phase 1 D08EEU DRUG__ID D08EEU D08EEU DRUGTYPE Small molecular drug D08EEU DRUGINCH 1S/C20H19NO3S.Na/c22-19-18(25-20(23)21-19)12-14-6-9-17-15(10-14)7-8-16(24-17)11-13-4-2-1-3-5-13;/h1-6,9-10,16,18H,7-8,11-12H2,(H,21,22,23);/q;+1/p-1/t16-,18?;/m1./s1 D08EEU DRUGINKE JQWYNJRCVYGLMO-GPPXSFHXSA-M D08EEU DRUGSMIL C1CC2=C(C=CC(=C2)CC3C(=O)[N-]C(=O)S3)OC1CC4=CC=CC=C4.[Na+] D08EEU HIGHSTAT Phase 1 D08EOW DRUG__ID D08EOW D08EOW DRUGCOMP Roche D08EOW DRUGINCH 1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1 D08EOW DRUGINKE QBGKPEROWUKSBK-QPPIDDCLSA-N D08EOW DRUGSMIL CCOC1=C(C=CC(=C1)C(C)(C)C)C2=NC(C(N2C(=O)N3CCN(CC3)CCCS(=O)(=O)C)(C)C4=CC=C(C=C4)Cl)(C)C5=CC=C(C=C5)Cl D08EOW HIGHSTAT Phase 1 D08ESA DRUG__ID D08ESA D08ESA DRUGTYPE Small molecular drug D08ESA DRUGINCH 1S/C23H21F6NO3/c24-22(25,26)18-7-3-15(4-8-18)20(16-5-9-19(10-6-16)23(27,28)29)33-13-12-30-11-1-2-17(14-30)21(31)32/h2-10,20H,1,11-14H2,(H,31,32) D08ESA DRUGINKE CMHQDSBIBSKHFP-UHFFFAOYSA-N D08ESA DRUGSMIL C1CN(CC(=C1)C(=O)O)CCOC(C2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)C(F)(F)F D08ESA HIGHSTAT Phase 1 D08FIX DRUG__ID D08FIX D08FIX DRUGTYPE Small molecular drug D08FIX DRUGINCH 1S/C25H28Cl2N4O2/c1-14(32)18-12-28-22-9-8-21(16-10-19(26)25(33)20(27)11-16)30-24(22)23(18)29-17-6-4-15(5-7-17)13-31(2)3/h8-12,15,17,33H,4-7,13H2,1-3H3,(H,28,29) D08FIX DRUGINKE DKZYXHCYPUVGAF-UHFFFAOYSA-N D08FIX DRUGSMIL CC(=O)C1=CN=C2C=CC(=NC2=C1NC3CCC(CC3)CN(C)C)C4=CC(=C(C(=C4)Cl)O)Cl D08FIX HIGHSTAT Phase 1 D08FKL DRUG__ID D08FKL D08FKL DRUGCOMP Achaogen D08FKL DRUGINCH 1S/C20H23N3O4/c1-20(2,21)17(19(26)23-27)22-18(25)14-9-7-13(8-10-14)5-3-4-6-15-11-16(15)12-24/h7-10,15-17,24,27H,11-12,21H2,1-2H3,(H,22,25)(H,23,26)/t15-,16+,17-/m1/s1 D08FKL DRUGINKE GOCUUDXEOKIQRU-IXDOHACOSA-N D08FKL DRUGSMIL CC(C)(C(C(=O)NO)NC(=O)C1=CC=C(C=C1)C#CC#CC2CC2CO)N D08FKL HIGHSTAT Phase 1 D08KIB DRUG__ID D08KIB D08KIB DRUGCOMP Sanofi D08KIB DRUGINCH 1S/C25H34N4O7S/c1-4-20(22(31)23-27-25(36-28-23)18-8-6-5-7-9-18)26-24(32)19(16-37(33,34)15-17(2)3)14-21(30)29-10-12-35-13-11-29/h5-9,17,19-20H,4,10-16H2,1-3H3,(H,26,32)/t19?,20-/m0/s1 D08KIB DRUGINKE IUMMRYVGHFJSRD-ANYOKISRSA-N D08KIB DRUGSMIL CCC(C(=O)C1=NOC(=N1)C2=CC=CC=C2)NC(=O)C(CC(=O)N3CCOCC3)CS(=O)(=O)CC(C)C D08KIB HIGHSTAT Phase 1 D08LAE DRUG__ID D08LAE D08LAE DRUGCOMP Ligand Pharmaceuticals D08LAE DRUGINCH 1S/C14H12F6N2O/c15-13(16,17)10-6-9(4-3-8(10)7-21)22-5-1-2-11(22)12(23)14(18,19)20/h3-4,6,11-12,23H,1-2,5H2/t11-,12-/m1/s1 D08LAE DRUGINKE OPSIVAKKLQRWKC-VXGBXAGGSA-N D08LAE DRUGSMIL C1CC(N(C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)C(C(F)(F)F)O D08LAE HIGHSTAT Phase 1 D08OBT DRUG__ID D08OBT D08OBT DRUGTYPE Small molecular drug D08OBT DRUGINCH 1S/C12H11N5O/c13-12-16-9-8(4-7-2-1-3-14-5-7)6-15-10(9)11(18)17-12/h1-3,5-6,15H,4H2,(H3,13,16,17,18) D08OBT DRUGINKE DOHVAKFYAHLCJP-UHFFFAOYSA-N D08OBT DRUGSMIL C1=CC(=CN=C1)CC2=CNC3=C2N=C(NC3=O)N D08OBT HIGHSTAT Phase 1 D08OOJ DRUG__ID D08OOJ D08OOJ DRUGCOMP Cleave biosciences D08OOJ DRUGINCH 1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28) D08OOJ DRUGINKE RDALZZCKQFLGJP-UHFFFAOYSA-N D08OOJ DRUGSMIL CC1=CC2=C(C=CC=C2N1C3=NC4=C(COCC4)C(=N3)NCC5=CC=CC=C5)C(=O)N D08OOJ HIGHSTAT Phase 1 D08OUL DRUG__ID D08OUL D08OUL DRUGCOMP Theracos D08OUL DRUGINCH 1S/C24H29ClO7.2C5H9NO2/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18;2*7-5(8)4-2-1-3-6-4/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2;2*4,6H,1-3H2,(H,7,8) D08OUL DRUGINKE DAQOCDWUCJBXEI-UHFFFAOYSA-N D08OUL DRUGSMIL C1CC(NC1)C(=O)O.C1CC(NC1)C(=O)O.C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl D08OUL HIGHSTAT Phase 1 D08QDF DRUG__ID D08QDF D08QDF DRUGCOMP ProteoTech Inc D08QDF DRUGINCH 1S/C13H11NO5/c15-9-3-1-7(5-11(9)17)13(19)14-8-2-4-10(16)12(18)6-8/h1-6,15-18H,(H,14,19) D08QDF DRUGINKE XIKSEDLKDYKPTO-UHFFFAOYSA-N D08QDF DRUGSMIL C1=CC(=C(C=C1C(=O)NC2=CC(=C(C=C2)O)O)O)O D08QDF HIGHSTAT Phase 1 D08SGE DRUG__ID D08SGE D08SGE DRUGCOMP EMD Serono Rockland, MA D08SGE DRUGINCH 1S/C15H18N2O2S/c1-3-17(14-7-5-4-6-8-14)20(18,19)15-11-13(16)10-9-12(15)2/h4-11H,3,16H2,1-2H3 D08SGE DRUGINKE ZAXMFSSGOARPBM-UHFFFAOYSA-N D08SGE DRUGSMIL CCN(C1=CC=CC=C1)S(=O)(=O)C2=C(C=CC(=C2)N)C D08SGE HIGHSTAT Phase 1 D08VBV DRUG__ID D08VBV D08VBV DRUGCOMP Novartis pharmaceuticals D08VBV DRUGINCH 1S/C34H40F6N6O4/c1-4-26-13-28(14-27(5-2)46(26)32(49)50-29-8-6-21(7-9-29)30(47)48)45(31-41-15-22(16-42-31)23-17-43-44(3)19-23)18-20-10-24(33(35,36)37)12-25(11-20)34(38,39)40/h10-12,15-17,19,21,26-29H,4-9,13-14,18H2,1-3H3,(H,47,48)/t21?,26-,27+,28?,29? D08VBV DRUGINKE KSPXRTYMEVDHAB-LTZKBQIGSA-N D08VBV DRUGSMIL CCC1CC(CC(N1C(=O)OC2CCC(CC2)C(=O)O)CC)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)C5=CN(N=C5)C D08VBV HIGHSTAT Phase 1 D08VSQ DRUG__ID D08VSQ D08VSQ DRUGCOMP Bristol-Myers Squibb Co D08VSQ DRUGINCH 1S/C21H27NO3/c23-18-11-22(12-18)19(24)10-21(15-4-2-1-3-5-15)16-6-13-7-17(21)9-14(8-16)20(13)25/h1-5,13-14,16-18,20,23,25H,6-12H2 D08VSQ DRUGINKE OAAZMUGLOXGVNH-UHFFFAOYSA-N D08VSQ DRUGSMIL C1C2CC3CC(C2O)CC1C3(CC(=O)N4CC(C4)O)C5=CC=CC=C5 D08VSQ HIGHSTAT Phase 1 D08XKL DRUG__ID D08XKL D08XKL DRUGCOMP Satori Pharmaceuticals Inc D08XKL DRUGINCH 1S/CH2O3.2La.2O/c2-1(3)4;;;;/h(H2,2,3,4);;;;/q;2*+3;2*-2/p-2 D08XKL DRUGINKE VMVUIGXLELJYAZ-UHFFFAOYSA-L D08XKL DRUGSMIL C(=O)([O-])[O-].[O-2].[O-2].[La+3].[La+3] D08XKL HIGHSTAT Phase 1 D08ZRR DRUG__ID D08ZRR D08ZRR DRUGTYPE Small molecular drug D08ZRR DRUGINCH 1S/C19H26N6O.C4H4O4/c20-12-16(13-21)19-23-7-11-25(19)10-6-22-14-17-4-5-18(26-17)15-24-8-2-1-3-9-24;5-3(6)1-2-4(7)8/h4-5,22-23H,1-3,6-11,14-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1+ D08ZRR DRUGINKE ULJCVCIVEVXIKD-WLHGVMLRSA-N D08ZRR DRUGSMIL C1CCN(CC1)CC2=CC=C(O2)CNCCN3CCNC3=C(C#N)C#N.C(=CC(=O)O)C(=O)O D08ZRR HIGHSTAT Phase 1 D09AOO DRUG__ID D09AOO D09AOO DRUGCOMP Anavex D09AOO DRUGINCH 1S/C19H23NO.ClH/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17;/h3-12,18H,13-15H2,1-2H3;1H D09AOO DRUGINKE FEQOLYDPQKHFTD-UHFFFAOYSA-N D09AOO DRUGSMIL CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3.Cl D09AOO HIGHSTAT Phase 1 D09BBA DRUG__ID D09BBA D09BBA DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D09BBA DRUGINCH 1S/C24H24FN3O3/c1-15-17(11-16-3-5-18(6-4-16)28-9-2-8-26-28)12-19-20(23(15)25)13-27(24(19)30)21-14-31-10-7-22(21)29/h2-6,8-9,12,21-22,29H,7,10-11,13-14H2,1H3/t21-,22-/m0/s1 D09BBA DRUGINKE WFSARWQASFQZMG-VXKWHMMOSA-N D09BBA DRUGSMIL CC1=C(C2=C(C=C1CC3=CC=C(C=C3)N4C=CC=N4)C(=O)N(C2)C5COCCC5O)F D09BBA HIGHSTAT Phase 1 D09BZY DRUG__ID D09BZY D09BZY DRUGTYPE Small molecular drug D09BZY DRUGINCH 1S/C22H29N3O3.ClH/c1-3-24(4-2)17-9-8-12-21(18-10-6-5-7-11-18)23-22(26)19-13-15-20(16-14-19)25(27)28;/h5-7,10-11,13-16,21H,3-4,8-9,12,17H2,1-2H3,(H,23,26);1H D09BZY DRUGINKE CHCBAYRWJULIDW-UHFFFAOYSA-N D09BZY DRUGSMIL CCN(CC)CCCCC(C1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-].Cl D09BZY HIGHSTAT Phase 1 D09CLC DRUG__ID D09CLC D09CLC DRUGCOMP StemMed Houston, TX D09CLC DRUGINCH 1S/C27H21NO5S/c1-33-18-11-13-19(14-12-18)34(31,32)28-24-16-23(27(30)22-9-5-4-8-21(22)24)26-20-7-3-2-6-17(20)10-15-25(26)29/h2-16,28-30H,1H3 D09CLC DRUGINKE QDCJDYWGYVPBDO-UHFFFAOYSA-N D09CLC DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)NC2=CC(=C(C3=CC=CC=C32)O)C4=C(C=CC5=CC=CC=C54)O D09CLC HIGHSTAT Phase 1 D09CZS DRUG__ID D09CZS D09CZS DRUGTYPE Small molecular drug D09CZS DRUGINCH 1S/C22H20N2O6/c1-2-22(28)15-10-17-18-13(9-12-5-3-4-6-16(12)23-18)20(29-8-7-25)24(17)19(26)14(15)11-30-21(22)27/h3-6,9-10,20,25,28H,2,7-8,11H2,1H3/t20?,22-/m0/s1 D09CZS DRUGINKE XAKLYHGHEFMDAP-IAXKEJLGSA-N D09CZS DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OCCO)O D09CZS HIGHSTAT Phase 1 D09DUQ DRUG__ID D09DUQ D09DUQ DRUGCOMP Anacor pharmaceuticals D09DUQ DRUGINCH 1S/C7H6BClO2/c9-6-1-2-7-5(3-6)4-11-8(7)10/h1-3,10H,4H2 D09DUQ DRUGINKE HMAFTPZYFJFEHK-UHFFFAOYSA-N D09DUQ DRUGSMIL B1(C2=C(CO1)C=C(C=C2)Cl)O D09DUQ HIGHSTAT Phase 1 D09DXX DRUG__ID D09DXX D09DXX DRUGCOMP Pfizer D09DXX DRUGINCH 1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21) D09DXX DRUGINKE ICYNYWFGIDGBRD-UHFFFAOYSA-N D09DXX DRUGSMIL COC1=C(C=C(C=C1)Cl)C2=CC(=O)NC(=S)N2CC(=O)N D09DXX HIGHSTAT Phase 1 D09HJS DRUG__ID D09HJS D09HJS DRUGTYPE Small molecular drug D09HJS DRUGINCH 1S/C43H36Cl2N8O5/c1-19-15-46-39-33(54)11-31-37(35(19)39)23(13-44)17-52(31)41(56)29-9-21-7-25(3-5-27(21)50-29)48-43(58)49-26-4-6-28-22(8-26)10-30(51-28)42(57)53-18-24(14-45)38-32(53)12-34(55)40-36(38)20(2)16-47-40/h3-12,15-16,23-24,46-47,50-51,54-55H,13-14,17-18H2,1-2H3,(H2,48,49,58)/t23-,24-/m1/s1 D09HJS DRUGINKE FONKWHRXTPJODV-DNQXCXABSA-N D09HJS DRUGSMIL CC1=CNC2=C(C=C3C(=C12)C(CN3C(=O)C4=CC5=C(N4)C=CC(=C5)NC(=O)NC6=CC7=C(C=C6)NC(=C7)C(=O)N8CC(C9=C1C(=CNC1=C(C=C98)O)C)CCl)CCl)O D09HJS HIGHSTAT Phase 1 D09IYM DRUG__ID D09IYM D09IYM DRUGCOMP Astex pharmaceuticals D09IYM DRUGINCH 1S/C17H16ClN3O/c18-16-7-5-15(6-8-16)17(22,11-19)14-3-1-12(2-4-14)13-9-20-21-10-13/h1-10,22H,11,19H2,(H,20,21)/t17-/m0/s1 D09IYM DRUGINKE IIRWNGPLJQXWFJ-KRWDZBQOSA-N D09IYM DRUGSMIL C1=CC(=CC=C1C2=CNN=C2)C(CN)(C3=CC=C(C=C3)Cl)O D09IYM HIGHSTAT Phase 1 D09LKR DRUG__ID D09LKR D09LKR DRUGTYPE Small molecular drug D09LKR DRUGINCH 1S/C11H14ClN3O2/c12-10-7-9(13-8-14-16)1-2-11(10)15-3-5-17-6-4-15/h1-2,7-8,16H,3-6H2,(H,13,14) D09LKR DRUGINKE ZTXADXBIGLLOFX-UHFFFAOYSA-N D09LKR DRUGSMIL C1COCCN1C2=C(C=C(C=C2)N=CNO)Cl D09LKR HIGHSTAT Phase 1 D09NAW DRUG__ID D09NAW D09NAW DRUGCOMP Pfizer Inc D09NAW DRUGINCH 1S/C26H21FN2O3/c1-17(19-9-11-23(27)12-10-19)29(16-18-5-4-7-21(13-18)26(31)32)25(30)22-14-20-6-2-3-8-24(20)28-15-22/h2-15,17H,16H2,1H3,(H,31,32)/t17-/m1/s1 D09NAW DRUGINKE BXNMZRPTQFVRFA-QGZVFWFLSA-N D09NAW DRUGSMIL CC(C1=CC=C(C=C1)F)N(CC2=CC(=CC=C2)C(=O)O)C(=O)C3=CC4=CC=CC=C4N=C3 D09NAW HIGHSTAT Phase 1 D09OCK DRUG__ID D09OCK D09OCK DRUGTYPE Small molecular drug D09OCK DRUGINCH 1S/C23H33N7O5S/c1-6-18-19-20(27-28(18)4)22(31)26-21(25-19)17-12-16(13-24-23(17)35-15(3)14-34-5)36(32,33)30-10-8-29(7-2)9-11-30/h12-13,15H,6-11,14H2,1-5H3,(H,25,26,31)/t15-/m1/s1 D09OCK DRUGINKE WKISNFXGTYNPOO-OAHLLOKOSA-N D09OCK DRUGSMIL CCC1=C2C(=NN1C)C(=O)NC(=N2)C3=C(N=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OC(C)COC D09OCK HIGHSTAT Phase 1 D09OHR DRUG__ID D09OHR D09OHR DRUGCOMP Syros Pharmaceuticals Cambridge, MA D09OHR DRUGINCH 1S/C31H35ClN8O2/c1-31(39-29(42)26-13-12-21(17-33-26)36-27(41)11-7-15-40(2)3)14-6-8-20(16-31)37-30-35-19-24(32)28(38-30)23-18-34-25-10-5-4-9-22(23)25/h4-5,7,9-13,17-20,34H,6,8,14-16H2,1-3H3,(H,36,41)(H,39,42)(H,35,37,38)/b11-7+/t20-,31+/m1/s1 D09OHR DRUGINKE SCJNYBYSTCRPAO-LXBQGUBHSA-N D09OHR DRUGSMIL CC1(CCCC(C1)NC2=NC=C(C(=N2)C3=CNC4=CC=CC=C43)Cl)NC(=O)C5=NC=C(C=C5)NC(=O)C=CCN(C)C D09OHR HIGHSTAT Phase 1 D09POQ DRUG__ID D09POQ D09POQ DRUGCOMP OM Pharma D09POQ DRUGINCH 1S/C52H100N2O20P2/c1-4-7-10-13-16-19-22-25-28-31-38(56)34-42(57)53-45-48(61)47(60)41(72-52(45)74-76(66,67)68)37-69-51-46(49(62)50(40(36-55)71-51)73-75(63,64)65)54-43(58)35-39(32-29-26-23-20-17-14-11-8-5-2)70-44(59)33-30-27-24-21-18-15-12-9-6-3/h38-41,45-52,55-56,60-62H,4-37H2,1-3H3,(H,53,57)(H,54,58)(H2,63,64,65)(H2,66,67,68)/t38-,39-,40-,41-,45-,46-,47-,48-,49-,50-,51-,52-/m1/s1 D09POQ DRUGINKE GOWLTLODGKPXMN-MWJFIXGVSA-N D09POQ DRUGSMIL CCCCCCCCCCCC(CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)CO)OP(=O)(O)O)O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)O)O)O D09POQ HIGHSTAT Phase 1 D09PRN DRUG__ID D09PRN D09PRN DRUGTYPE Small molecular drug D09PRN DRUGINCH 1S/C13H13BrN4S.ClH/c14-10-4-5-12(17-9-10)18-13(19)16-8-6-11-3-1-2-7-15-11;/h1-5,7,9H,6,8H2,(H2,16,17,18,19);1H D09PRN DRUGINKE IUQKLSJRANLIKE-UHFFFAOYSA-N D09PRN DRUGSMIL C1=CC=NC(=C1)CCNC(=S)NC2=NC=C(C=C2)Br.Cl D09PRN HIGHSTAT Phase 1 D09QWN DRUG__ID D09QWN D09QWN DRUGCOMP Cohbar D09QWN DRUGINCH 1S/C9H12BrN/c1-9(2,11)7-3-5-8(10)6-4-7/h3-6H,11H2,1-2H3 D09QWN DRUGINKE IQKKTIWXHJDLFL-UHFFFAOYSA-N D09QWN DRUGSMIL CC(C)(C1=CC=C(C=C1)Br)N D09QWN HIGHSTAT Phase 1 D09RJN DRUG__ID D09RJN D09RJN DRUGTYPE Small molecular drug D09RJN DRUGINCH 1S/C22H28N2O2S/c25-21(18-13-17(18)15-6-2-1-3-7-15)24-19-9-5-4-8-16(19)12-20(24)22(26)23-10-11-27-14-23/h1-3,6-7,16-20H,4-5,8-14H2/t16-,17-,18+,19-,20-/m0/s1 D09RJN DRUGINKE NXSXRIHXEQSYEZ-KNJMJIDISA-N D09RJN DRUGSMIL C1CCC2C(C1)CC(N2C(=O)C3CC3C4=CC=CC=C4)C(=O)N5CCSC5 D09RJN HIGHSTAT Phase 1 D09UDL DRUG__ID D09UDL D09UDL DRUGCOMP Lytix Biopharma AS D09UDL DRUGINCH 1S/C78H106N18O9/c79-38-18-13-30-57(84)71(98)90-62(35-15-20-40-81)73(100)93-66(44-52-47-87-59-32-11-8-28-55(52)59)76(103)95-65(43-51-46-86-58-31-10-7-27-54(51)58)75(102)92-63(36-16-21-41-82)72(99)91-64(37-17-22-42-83)74(101)94-67(45-53-48-88-60-33-12-9-29-56(53)60)77(104)96-69(78(105)89-61(70(85)97)34-14-19-39-80)68(49-23-3-1-4-24-49)50-25-5-2-6-26-50/h1-12,23-29,31-33,46-48,57,61-69,86-88H,13-22,30,34-45,79-84H2,(H2,85,97)(H,89,105)(H,90,98)(H,91,99)(H,92,102)(H,93,100)(H,94,101)(H,95,103)(H,96,104)/t57-,61-,62-,63-,64-,65-,66-,67-,69-/m0/s1 D09UDL DRUGINKE GGAKLYWEFZCVIT-TVEKFXMRSA-N D09UDL DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C(CCCCN)NC(=O)C(CCCCN)N D09UDL HIGHSTAT Phase 1 D09URP DRUG__ID D09URP D09URP DRUGTYPE Small molecular drug D09URP DRUGINCH 1S/C9H18Cl2N2.C4H4O4/c10-1-3-12-5-7-13(9-12,4-2-11)8-6-12;5-3(6)1-2-4(7)8/h1-9H2;1-2H,(H,5,6)(H,7,8)/q+2;/p-1/b;2-1- D09URP DRUGINKE HKVBKOPISPWMSR-BTJKTKAUSA-M D09URP DRUGSMIL C1C[N+]2(CC[N+]1(C2)CCCl)CCCl.C(=CC(=O)[O-])C(=O)O D09URP HIGHSTAT Phase 1 D09VAS DRUG__ID D09VAS D09VAS DRUGCOMP Momenta Pharmaceuticals Cambridge, MA D09VAS DRUGINCH 1S/C7H11ClO4/c1-3-11-6(9)5(8)7(10)12-4-2/h5H,3-4H2,1-2H3 D09VAS DRUGINKE WLWCQKMQYZFTDR-UHFFFAOYSA-N D09VAS DRUGSMIL CCOC(=O)C(C(=O)OCC)Cl D09VAS HIGHSTAT Phase 1 D09XXH DRUG__ID D09XXH D09XXH DRUGCOMP ViroChem Pharma Inc D09XXH DRUGINCH 1S/C34H50F2N4O3/c1-24(2)40-32(42)38(22-25-13-18-43-19-14-25)23-33(40)20-28-8-9-29(21-33)39(28)17-12-30(26-6-4-3-5-7-26)37-31(41)27-10-15-34(35,36)16-11-27/h3-7,24-25,27-30H,8-23H2,1-2H3,(H,37,41)/t28-,29+,30-,33?/m0/s1 D09XXH DRUGINKE YZGXEGUSPLSQOJ-VUQZBIHUSA-N D09XXH DRUGSMIL CC(C)N1C(=O)N(CC12CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)CC6CCOCC6 D09XXH HIGHSTAT Phase 1 D0A1DG DRUG__ID D0A1DG D0A1DG DRUGCOMP Kura Oncology San Diego, CA D0A1DG DRUGINCH 1S/C21H17N5O/c27-21-23-18-11-19-17(20(25-24-19)15-6-8-22-9-7-15)10-16(18)13-26(21)12-14-4-2-1-3-5-14/h1-11H,12-13H2,(H,23,27)(H,24,25) D0A1DG DRUGINKE ODIUJYZERXVGEI-UHFFFAOYSA-N D0A1DG DRUGSMIL C1C2=CC3=C(C=C2NC(=O)N1CC4=CC=CC=C4)NN=C3C5=CC=NC=C5 D0A1DG HIGHSTAT Phase 1 D0A2VZ DRUG__ID D0A2VZ D0A2VZ DRUGCOMP Protein Sciences Corp D0A2VZ DRUGINCH 1S/C10H14O5/c1-6-10(15-8(3)12)9(4-5-13-6)14-7(2)11/h4-6,9-10H,1-3H3/t6?,9-,10+/m0/s1 D0A2VZ DRUGINKE NDEGMKQAZZBNBB-YNMRDIRWSA-N D0A2VZ DRUGSMIL CC1C(C(C=CO1)OC(=O)C)OC(=O)C D0A2VZ HIGHSTAT Phase 1 D0A6VD DRUG__ID D0A6VD D0A6VD DRUGCOMP Verastem D0A6VD DRUGINCH 1S/C25H26F3N5O3/c1-29-24(34)17-5-3-4-6-19(17)31-21-14-23(30-15-18(21)25(26,27)28)32-20-8-7-16(13-22(20)35-2)33-9-11-36-12-10-33/h3-8,13-15H,9-12H2,1-2H3,(H,29,34)(H2,30,31,32) D0A6VD DRUGINKE IGUBBWJDMLCRIK-UHFFFAOYSA-N D0A6VD DRUGSMIL CNC(=O)C1=CC=CC=C1NC2=CC(=NC=C2C(F)(F)F)NC3=C(C=C(C=C3)N4CCOCC4)OC D0A6VD HIGHSTAT Phase 1 D0A8KQ DRUG__ID D0A8KQ D0A8KQ DRUGCOMP GlaxoSmithKline D0A8KQ DRUGINCH 1S/C21H24F3N7O/c1-12-28-19(26-2)31-20(29-12)30-16-5-3-4-14(9-16)18(32)27-11-15-7-6-13(10-25)8-17(15)21(22,23)24/h6-8,14,16H,3-5,9,11H2,1-2H3,(H,27,32)(H2,26,28,29,30,31)/t14-,16+/m1/s1 D0A8KQ DRUGINKE LQHDJQIMETZMPH-ZBFHGGJFSA-N D0A8KQ DRUGSMIL CC1=NC(=NC(=N1)NC2CCCC(C2)C(=O)NCC3=C(C=C(C=C3)C#N)C(F)(F)F)NC D0A8KQ HIGHSTAT Phase 1 D0A8LP DRUG__ID D0A8LP D0A8LP DRUGTYPE Small molecular drug D0A8LP DRUGINCH 1S/C18H21N5O6S2/c19-18-22-14-13(16(27)23-18)31-9(7-20-14)2-1-8-3-5-11(30-8)15(26)21-10(17(28)29)4-6-12(24)25/h3,5,9-10H,1-2,4,6-7H2,(H,21,26)(H,24,25)(H,28,29)(H4,19,20,22,23,27)/t9-,10-/m0/s1 D0A8LP DRUGINKE HHKAOUMVRGSKLS-UWVGGRQHSA-N D0A8LP DRUGSMIL C1C(SC2=C(N1)N=C(NC2=O)N)CCC3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O D0A8LP HIGHSTAT Phase 1 D0AX4H DRUG__ID D0AX4H D0AX4H DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0AX4H DRUGINCH 1S/C22H21F4N3O4/c1-4-32-16-9-19(30)27-11-14(16)12-5-6-13(15(23)7-12)8-20(31)28-18-10-17(33-29-18)21(2,3)22(24,25)26/h5-7,9-11H,4,8H2,1-3H3,(H,27,30)(H,28,29,31) D0AX4H DRUGINKE IDXKJSSOUXWLDB-UHFFFAOYSA-N D0AX4H DRUGSMIL CCOC1=CC(=O)NC=C1C2=CC(=C(C=C2)CC(=O)NC3=NOC(=C3)C(C)(C)C(F)(F)F)F D0AX4H HIGHSTAT Phase 1 D0AY8A DRUG__ID D0AY8A D0AY8A DRUGCOMP Curis Lexington, MA D0AY8A DRUGINCH 1S/C21H19N7O3/c22-18-5-4-13(11-23-18)15-2-1-3-16(26-15)20(29)25-14-10-17-19(24-12-14)27-21(31-17)28-6-8-30-9-7-28/h1-5,10-12H,6-9H2,(H2,22,23)(H,25,29) D0AY8A DRUGINKE RWIMETUXCNDSLE-UHFFFAOYSA-N D0AY8A DRUGSMIL C1COCCN1C2=NC3=C(O2)C=C(C=N3)NC(=O)C4=CC=CC(=N4)C5=CN=C(C=C5)N D0AY8A HIGHSTAT Phase 1 D0B0FU DRUG__ID D0B0FU D0B0FU DRUGTYPE Small molecular drug D0B0FU DRUGINCH 1S/C21H41N5O11/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31/h5-21,26-32H,2-4,22-25H2,1H3/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-/m1/s1 D0B0FU DRUGINKE XZNUGFQTQHRASN-XQENGBIVSA-N D0B0FU DRUGSMIL CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O D0B0FU HIGHSTAT Phase 1 D0B4CD DRUG__ID D0B4CD D0B4CD DRUGCOMP Praecis Pharmaceuticals Inc D0B4CD DRUGINCH 1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6-18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H,28,29) D0B4CD DRUGINKE NFIGDBFIDKDNIG-UHFFFAOYSA-N D0B4CD DRUGSMIL CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl D0B4CD HIGHSTAT Phase 1 D0B4KU DRUG__ID D0B4KU D0B4KU DRUGCOMP Pfizer D0B4KU DRUGINCH 1S/C23H22ClN7O3/c1-23(2,12-32)31-11-18(17-10-28-22(25)30-21(17)31)20(34)13-5-16(9-26-7-13)29-19(33)6-15-4-3-14(24)8-27-15/h3-5,7-11,32H,6,12H2,1-2H3,(H,29,33)(H2,25,28,30) D0B4KU DRUGINKE BPIWZDNVMQQBQX-UHFFFAOYSA-N D0B4KU DRUGSMIL CC(C)(CO)N1C=C(C2=CN=C(N=C21)N)C(=O)C3=CC(=CN=C3)NC(=O)CC4=NC=C(C=C4)Cl D0B4KU HIGHSTAT Phase 1 D0B5HF DRUG__ID D0B5HF D0B5HF DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0B5HF DRUGINCH 1S/C28H32N2O4/c1-20(21-10-12-22(13-11-21)23-14-16-29(4)25(31)18-23)30-17-15-28(34-26(30)32,19-27(2,3)33)24-8-6-5-7-9-24/h5-14,16,18,20,33H,15,17,19H2,1-4H3/t20-,28-/m0/s1 D0B5HF DRUGINKE TXNPQZGSVXLGGP-MMTVBGGISA-N D0B5HF DRUGSMIL CC(C1=CC=C(C=C1)C2=CC(=O)N(C=C2)C)N3CCC(OC3=O)(CC(C)(C)O)C4=CC=CC=C4 D0B5HF HIGHSTAT Phase 1 D0BH9I DRUG__ID D0BH9I D0BH9I DRUGCOMP Innovate Biopharmaceuticals Raleigh, NC D0BH9I DRUGINCH 1S/C15H12N2O5/c18-13-6-5-11(8-12(13)15(21)22)17-16-10-3-1-9(2-4-10)7-14(19)20/h1-6,8,18H,7H2,(H,19,20)(H,21,22) D0BH9I DRUGINKE FNRNBCNUWGWVFO-UHFFFAOYSA-N D0BH9I DRUGSMIL C1=CC(=CC=C1CC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O D0BH9I HIGHSTAT Phase 1 D0BT0Z DRUG__ID D0BT0Z D0BT0Z DRUGCOMP Pfizer Inc D0BT0Z DRUGINCH 1S/C19H21ClN4O4S/c1-11(2)10-28-19-16(20)8-14(9-21-19)24-17-6-5-13(7-15(17)12(3)22-24)18(25)23-29(4,26)27/h5-9,11H,10H2,1-4H3,(H,23,25) D0BT0Z DRUGINKE RVTSXVZXEGFIPW-UHFFFAOYSA-N D0BT0Z DRUGSMIL CC1=NN(C2=C1C=C(C=C2)C(=O)NS(=O)(=O)C)C3=CC(=C(N=C3)OCC(C)C)Cl D0BT0Z HIGHSTAT Phase 1 D0C2BP DRUG__ID D0C2BP D0C2BP DRUGCOMP Agios Pharmaceuticals Cambridge, MA D0C2BP DRUGINCH 1S/C18H23N3O3.ClH/c1-14-12-17(15-4-3-5-16(13-15)23-2)19-21(18(14)22)7-6-20-8-10-24-11-9-20;/h3-5,12-13H,6-11H2,1-2H3;1H D0C2BP DRUGINKE REOUTEBTFSILJY-UHFFFAOYSA-N D0C2BP DRUGSMIL CC1=CC(=NN(C1=O)CCN2CCOCC2)C3=CC(=CC=C3)OC.Cl D0C2BP HIGHSTAT Phase 1 D0C2NT DRUG__ID D0C2NT D0C2NT DRUGCOMP Novita Pharmaceuticals New York, NY D0C2NT DRUGINCH 1S/C21H16F3N3O2/c1-13-16(10-11-29-13)20(28)25-19-17-4-2-3-5-18(17)27(26-19)12-14-6-8-15(9-7-14)21(22,23)24/h2-11H,12H2,1H3,(H,25,26,28) D0C2NT DRUGINKE XLLRLAABUFOJPC-UHFFFAOYSA-N D0C2NT DRUGSMIL CC1=C(C=CO1)C(=O)NC2=NN(C3=CC=CC=C32)CC4=CC=C(C=C4)C(F)(F)F D0C2NT HIGHSTAT Phase 1 D0C3ZZ DRUG__ID D0C3ZZ D0C3ZZ DRUGCOMP Merck Kenilworth, NJ Bionomics Thebarton, Australia D0C3ZZ DRUGINCH 1S/C19H23ClN2O3S/c1-19(2)15(11-22-16-10-13(20)6-9-17(16)25-3)18(19)12-4-7-14(8-5-12)26(21,23)24/h4-10,15,18,22H,11H2,1-3H3,(H2,21,23,24)/t15-,18-/m1/s1 D0C3ZZ DRUGINKE LWWDCTBUJUEFDE-CRAIPNDOSA-N D0C3ZZ DRUGSMIL CC1(C(C1C2=CC=C(C=C2)S(=O)(=O)N)CNC3=C(C=CC(=C3)Cl)OC)C D0C3ZZ HIGHSTAT Phase 1 D0C5NP DRUG__ID D0C5NP D0C5NP DRUGCOMP Pfizer D0C5NP DRUGINCH 1S/C28H29FN2O4/c1-28(2,18-19-8-14-23(29)15-9-19)31-27(35)24(16-17-25(32)33)30-26(34)22-12-10-21(11-13-22)20-6-4-3-5-7-20/h3-15,24H,16-18H2,1-2H3,(H,30,34)(H,31,35)(H,32,33)/t24-/m0/s1 D0C5NP DRUGINKE JWQMTWCFNZSLNR-DEOSSOPVSA-N D0C5NP DRUGSMIL CC(C)(CC1=CC=C(C=C1)F)NC(=O)C(CCC(=O)O)NC(=O)C2=CC=C(C=C2)C3=CC=CC=C3 D0C5NP HIGHSTAT Phase 1 D0C6RM DRUG__ID D0C6RM D0C6RM DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D0C6RM DRUGINCH 1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1 D0C6RM DRUGINKE RNMAUIMMNAHKQR-QFBILLFUSA-N D0C6RM DRUGSMIL CC1CC(CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F D0C6RM HIGHSTAT Phase 1 D0C9JJ DRUG__ID D0C9JJ D0C9JJ DRUGTYPE Small molecular drug D0C9JJ DRUGINCH 1S/C26H19F3N4O/c27-26(28,29)24-14-23(33(32-24)20-10-8-19(9-11-20)31-25(34)15-30)18-7-12-22-17(13-18)6-5-16-3-1-2-4-21(16)22/h1-14H,15,30H2,(H,31,34) D0C9JJ DRUGINKE YULUCECVQOCQFQ-UHFFFAOYSA-N D0C9JJ DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F D0C9JJ HIGHSTAT Phase 1 D0CW8S DRUG__ID D0CW8S D0CW8S DRUGCOMP Abide Therapeutics San Diego, CA D0CW8S DRUGINCH 1S/C20H22F9N3O2/c21-18(22,23)14-4-3-13(15(11-14)31-5-1-2-6-31)12-30-7-9-32(10-8-30)17(33)34-16(19(24,25)26)20(27,28)29/h3-4,11,16H,1-2,5-10,12H2 D0CW8S DRUGINKE SQZJGTOZFRNWCX-UHFFFAOYSA-N D0CW8S DRUGSMIL C1CCN(C1)C2=C(C=CC(=C2)C(F)(F)F)CN3CCN(CC3)C(=O)OC(C(F)(F)F)C(F)(F)F D0CW8S HIGHSTAT Phase 1 D0D0PB DRUG__ID D0D0PB D0D0PB DRUGCOMP AiCuris GmbH & Co KG D0D0PB DRUGINCH 1S/C19H12Cl2F2N4O2/c20-11-3-10(4-12(22)5-11)17-7-16(19(29)26-8-18(28)24-9-26)25-27(17)13-1-2-15(23)14(21)6-13/h1-7H,8-9H2,(H,24,28) D0D0PB DRUGINKE JPOJKNJIKXMZRB-UHFFFAOYSA-N D0D0PB DRUGSMIL C1C(=O)NCN1C(=O)C2=NN(C(=C2)C3=CC(=CC(=C3)Cl)F)C4=CC(=C(C=C4)F)Cl D0D0PB HIGHSTAT Phase 1 D0D2LF DRUG__ID D0D2LF D0D2LF DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0D2LF DRUGINCH 1S/C16H13N3/c1-2-4-15-13(3-1)14-6-5-11(8-16(14)19-15)7-12-9-17-10-18-12/h1-6,8-10,19H,7H2,(H,17,18) D0D2LF DRUGINKE SHWQRVBJVFBWGP-UHFFFAOYSA-N D0D2LF DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)CC4=CN=CN4 D0D2LF HIGHSTAT Phase 1 D0D4OL DRUG__ID D0D4OL D0D4OL DRUGCOMP Taisho Pharmaceutical Co Ltd D0D4OL DRUGINCH 1S/C15H12N8O5S3/c16-15-18-10(21-31-15)9(20-28)17-11(24)7-12(25)23-8(14(26)27)5(3-29-13(7)23)1-2-6-4-30-22-19-6/h1-2,4,7,13,28H,3H2,(H,26,27)(H2,16,18,21)(H,17,20,24)/b2-1+/t7?,13-/m1/s1 D0D4OL DRUGINKE HFOMCBOZKJQJHK-CLIAQYSASA-N D0D4OL DRUGSMIL C1C(=C(N2C(S1)C(C2=O)C(=O)NC(=NO)C3=NSC(=N3)N)C(=O)O)C=CC4=CSN=N4 D0D4OL HIGHSTAT Phase 1 D0D4VH DRUG__ID D0D4VH D0D4VH DRUGTYPE Small molecular drug D0D4VH DRUGINCH 1S/C23H25Cl2N3/c1-17-19(16-27-13-11-26(2)12-14-27)15-23(18-3-5-20(24)6-4-18)28(17)22-9-7-21(25)8-10-22/h3-10,15H,11-14,16H2,1-2H3 D0D4VH DRUGINKE YWZIODCWLMCMMW-UHFFFAOYSA-N D0D4VH DRUGSMIL CC1=C(C=C(N1C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)CN4CCN(CC4)C D0D4VH HIGHSTAT Phase 1 D0D6XT DRUG__ID D0D6XT D0D6XT DRUGCOMP EisaiWoodcliff Lake, NJH3 Biomedicine Cambridge, MA D0D6XT DRUGINCH 1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34-23-16-24(33-17-32-23)37(3)29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2,2-5H3,(H,35,40)(H,36,41)(H,32,33,34) D0D6XT DRUGINKE MBWRLLRCTIYXDW-UHFFFAOYSA-N D0D6XT DRUGSMIL CCN1CCN(CC1)C2=CC(=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl)NC(=O)C=C D0D6XT HIGHSTAT Phase 1 D0D7CH DRUG__ID D0D7CH D0D7CH DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D0D7CH DRUGINCH 1S/C28H32FN3O5/c1-28(2)8-6-16-13-18(14-20(29)24(16)28)30-26(35)25-19-4-5-22(37-3)31-21(19)7-9-32(25)27(36)17-10-15(11-17)12-23(33)34/h4-5,13-15,17,25H,6-12H2,1-3H3,(H,30,35)(H,33,34)/t15?,17?,25-/m1/s1 D0D7CH DRUGINKE ICMFYVOUDGRBLG-NJMNTPMDSA-N D0D7CH DRUGSMIL CC1(CCC2=C1C(=CC(=C2)NC(=O)C3C4=C(CCN3C(=O)C5CC(C5)CC(=O)O)N=C(C=C4)OC)F)C D0D7CH HIGHSTAT Phase 1 D0DX4J DRUG__ID D0DX4J D0DX4J DRUGCOMP Nicholas Piramal D0DX4J DRUGINCH 1S/C22H19ClF3NO5/c1-27-5-4-12(14(27)9-28)19-15(29)7-16(30)20-17(31)8-18(32-21(19)20)11-3-2-10(6-13(11)23)22(24,25)26/h2-3,6-8,12,14,28-30H,4-5,9H2,1H3/t12-,14+/m1/s1 D0DX4J DRUGINKE MRPGRAKIAJJGMM-OCCSQVGLSA-N D0DX4J DRUGSMIL CN1CCC(C1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=C(C=C(C=C4)C(F)(F)F)Cl)O)O D0DX4J HIGHSTAT Phase 1 D0E0YW DRUG__ID D0E0YW D0E0YW DRUGCOMP Daiichi Sankyo Basking Ridge, NJ D0E0YW DRUGINCH 1S/C6H7ClN2O3/c1-2-11-6(10)5-8-4(3-7)12-9-5/h2-3H2,1H3 D0E0YW DRUGINKE AUTFGCQEAOOQAR-UHFFFAOYSA-N D0E0YW DRUGSMIL CCOC(=O)C1=NOC(=N1)CCl D0E0YW HIGHSTAT Phase 1 D0E1VV DRUG__ID D0E1VV D0E1VV DRUGTYPE Small molecular drug D0E1VV DRUGINCH 1S/C29H32ClN3O4.ClH/c1-4-29(36)12-26(34)37-15-21-22(29)10-25-27-20(14-33(25)28(21)35)19(13-32-7-5-16(2)6-8-32)18-9-17(3)23(30)11-24(18)31-27;/h9-11,16,36H,4-8,12-15H2,1-3H3;1H/t29-;/m1./s1 D0E1VV DRUGINKE OLYFGLXPXPABOP-XXIQNXCHSA-N D0E1VV DRUGSMIL CCC1(CC(=O)OCC2=C1C=C3C4=NC5=C(C=C(C(=C5)Cl)C)C(=C4CN3C2=O)CN6CCC(CC6)C)O.Cl D0E1VV HIGHSTAT Phase 1 D0E2LA DRUG__ID D0E2LA D0E2LA DRUGTYPE Small molecular drug D0E2LA DRUGINCH 1S/C20H19N3O2/c1-23(2)10-9-21-20-18-17(13-5-3-4-6-14(13)19(18)25)15-8-7-12(24)11-16(15)22-20/h3-8,11,24H,9-10H2,1-2H3,(H,21,22) D0E2LA DRUGINKE ROWSTIYZUWEOMM-UHFFFAOYSA-N D0E2LA DRUGSMIL CN(C)CCNC1=NC2=C(C=CC(=C2)O)C3=C1C(=O)C4=CC=CC=C43 D0E2LA HIGHSTAT Phase 1 D0EV5O DRUG__ID D0EV5O D0EV5O DRUGCOMP NeuroGenetic Pharmaceuticals Rancho Santa Fe, CA D0EV5O DRUGINCH 1S/C23H23FN4S/c1-5-17-10-20(15(3)8-14(17)2)26-23-27-21(12-29-23)18-6-7-22(19(24)9-18)28-11-16(4)25-13-28/h6-13H,5H2,1-4H3,(H,26,27) D0EV5O DRUGINKE WDEKUGNKKOGFOA-UHFFFAOYSA-N D0EV5O DRUGSMIL CCC1=CC(=C(C=C1C)C)NC2=NC(=CS2)C3=CC(=C(C=C3)N4C=C(N=C4)C)F D0EV5O HIGHSTAT Phase 1 D0F3NF DRUG__ID D0F3NF D0F3NF DRUGCOMP Taiho Oncology Princeton, NJ D0F3NF DRUGINCH 1S/C25H26N8O/c1-5-16-10-17(24(26)34)6-7-20(16)33-25-22(23(30-33)15(2)3)21(8-9-27-25)32-13-19(28-14-32)18-11-29-31(4)12-18/h6-15H,5H2,1-4H3,(H2,26,34) D0F3NF DRUGINKE NVVPMZUGELHVMH-UHFFFAOYSA-N D0F3NF DRUGSMIL CCC1=C(C=CC(=C1)C(=O)N)N2C3=NC=CC(=C3C(=N2)C(C)C)N4C=C(N=C4)C5=CN(N=C5)C D0F3NF HIGHSTAT Phase 1 D0F3RQ DRUG__ID D0F3RQ D0F3RQ DRUGCOMP Bayer HealthCare Pharmaceuticals D0F3RQ DRUGINCH 1S/C26H26F3N7O2/c1-17-14-22(25-31-24(33-38-25)19-2-6-21(7-3-19)37-26(27,28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3,6-9,14-15,20H,4-5,10-13,16H2,1H3 D0F3RQ DRUGINKE CDJNNOJINJAXPV-UHFFFAOYSA-N D0F3RQ DRUGSMIL CC1=CC(=NN1CC2=CC(=NC=C2)N3CCN(CC3)C4CC4)C5=NC(=NO5)C6=CC=C(C=C6)OC(F)(F)F D0F3RQ HIGHSTAT Phase 1 D0F4RX DRUG__ID D0F4RX D0F4RX DRUGTYPE Small molecular drug D0F4RX DRUGINCH 1S/C26H35N3O3/c1-17-13-18(2)24(31)23-21(17)15-26(3,4)25(23)27-22(30)16-28-9-11-29(12-10-28)19-7-6-8-20(14-19)32-5/h6-8,13-14,25,31H,9-12,15-16H2,1-5H3,(H,27,30) D0F4RX DRUGINKE LYAUICDWKQJAGX-UHFFFAOYSA-N D0F4RX DRUGSMIL CC1=CC(=C(C2=C1CC(C2NC(=O)CN3CCN(CC3)C4=CC(=CC=C4)OC)(C)C)O)C D0F4RX HIGHSTAT Phase 1 D0F5JZ DRUG__ID D0F5JZ D0F5JZ DRUGTYPE Small molecular drug D0F5JZ DRUGINCH 1S/C17H14ClF2N3O3S/c1-2-5-27(25,26)23-13-4-3-12(19)14(15(13)20)16(24)11-8-22-17-10(11)6-9(18)7-21-17/h3-4,6-8,23H,2,5H2,1H3,(H,21,22) D0F5JZ DRUGINKE YZDJQTHVDDOVHR-UHFFFAOYSA-N D0F5JZ DRUGSMIL CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)Cl)F D0F5JZ HIGHSTAT Phase 1 D0F7GX DRUG__ID D0F7GX D0F7GX DRUGTYPE Small molecular drug D0F7GX DRUGINCH 1S/C10H12N2O4/c1-3-16-10-6-8(12(14)15)4-5-9(10)11-7(2)13/h4-6H,3H2,1-2H3,(H,11,13) D0F7GX DRUGINKE XZWVZJDHIDYKPB-UHFFFAOYSA-N D0F7GX DRUGSMIL CCOC1=C(C=CC(=C1)[N+](=O)[O-])NC(=O)C D0F7GX HIGHSTAT Phase 1 D0F7NT DRUG__ID D0F7NT D0F7NT DRUGTYPE Small molecular drug D0F7NT DRUGINCH 1S/C14H16N2O.ClH/c17-14-7-4-11-10-12(5-6-13(11)15-14)16-8-2-1-3-9-16;/h4-7,10H,1-3,8-9H2,(H,15,17);1H D0F7NT DRUGINKE KYTREJMWHJPVSI-UHFFFAOYSA-N D0F7NT DRUGSMIL C1CCN(CC1)C2=CC3=C(C=C2)NC(=O)C=C3.Cl D0F7NT HIGHSTAT Phase 1 D0F8HS DRUG__ID D0F8HS D0F8HS DRUGTYPE Small molecular drug D0F8HS DRUGINCH 1S/C19H21ClF2N4O/c1-13-9-24-17(25-10-13)11-23-12-19(22)4-6-26(7-5-19)18(27)14-2-3-16(21)15(20)8-14/h2-3,8-10,23H,4-7,11-12H2,1H3 D0F8HS DRUGINKE WAAXKNFGOFTGLP-UHFFFAOYSA-N D0F8HS DRUGSMIL CC1=CN=C(N=C1)CNCC2(CCN(CC2)C(=O)C3=CC(=C(C=C3)F)Cl)F D0F8HS HIGHSTAT Phase 1 D0F9IX DRUG__ID D0F9IX D0F9IX DRUGTYPE Small molecular drug D0F9IX DRUGINCH 1S/C47H48N8O6S2/c1-26(2)38(52-46(58)60-3)44(56)55-21-9-13-37(55)43-49-33-19-18-30(22-34(33)50-43)32-25-63-40-31(24-62-41(32)40)27-14-16-28(17-15-27)35-23-48-42(51-35)36-12-8-20-54(36)45(57)39(53-47(59)61-4)29-10-6-5-7-11-29/h5-7,10-11,14-19,22-26,36-39H,8-9,12-13,20-21H2,1-4H3,(H,48,51)(H,49,50)(H,52,58)(H,53,59)/t36-,37-,38-,39+/m0/s1 D0F9IX DRUGINKE ATOLIHZIXHZSBA-BTSKBWHGSA-N D0F9IX DRUGSMIL CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CSC5=C4SC=C5C6=CC=C(C=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)NC(=O)OC D0F9IX HIGHSTAT Phase 1 D0FA6S DRUG__ID D0FA6S D0FA6S DRUGCOMP Deciphera pharmaceuticals D0FA6S DRUGINCH 1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34) D0FA6S DRUGINKE GNNDEPIMDAZHRQ-UHFFFAOYSA-N D0FA6S DRUGSMIL C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F D0FA6S HIGHSTAT Phase 1 D0FL2K DRUG__ID D0FL2K D0FL2K DRUGCOMP Kazia Therapeutics Sydney, Australia D0FL2K DRUGINCH 1S/C24H24O6/c1-13-19(26)9-8-17-22(14-4-6-16(25)7-5-14)18(12-30-24(13)17)15-10-20(28-2)23(27)21(11-15)29-3/h4-11,18,22,25-27H,12H2,1-3H3/t18-,22-/m0/s1 D0FL2K DRUGINKE JFVVPUGGRUGRBJ-AVRDEDQJSA-N D0FL2K DRUGSMIL CC1=C(C=CC2=C1OCC(C2C3=CC=C(C=C3)O)C4=CC(=C(C(=C4)OC)O)OC)O D0FL2K HIGHSTAT Phase 1 D0G2XR DRUG__ID D0G2XR D0G2XR DRUGCOMP TCD Pharma D0G2XR DRUGINCH 1S/C46H38Cl2N4/c1-49(39-23-19-37(47)20-24-39)43-27-29-51(45-9-5-3-7-41(43)45)31-33-11-15-35(16-12-33)36-17-13-34(14-18-36)32-52-30-28-44(42-8-4-6-10-46(42)52)50(2)40-25-21-38(48)22-26-40/h3-30H,31-32H2,1-2H3/q+2 D0G2XR DRUGINKE QGYGTMZEJNOHNU-UHFFFAOYSA-N D0G2XR DRUGSMIL CN(C1=CC=C(C=C1)Cl)C2=CC=[N+](C3=CC=CC=C32)CC4=CC=C(C=C4)C5=CC=C(C=C5)C[N+]6=CC=C(C7=CC=CC=C76)N(C)C8=CC=C(C=C8)Cl D0G2XR HIGHSTAT Phase 1 D0G4CF DRUG__ID D0G4CF D0G4CF DRUGTYPE Small molecular drug D0G4CF DRUGINCH 1S/C21H21F3N6O2/c1-3-8-30-19(31)16-18(29(4-2)20(30)32)27-17(26-16)14-10-25-28(12-14)11-13-6-5-7-15(9-13)21(22,23)24/h5-7,9-10,12H,3-4,8,11H2,1-2H3,(H,26,27) D0G4CF DRUGINKE KOYXXLLNCXWUNF-UHFFFAOYSA-N D0G4CF DRUGSMIL CCCN1C(=O)C2=C(N=C(N2)C3=CN(N=C3)CC4=CC(=CC=C4)C(F)(F)F)N(C1=O)CC D0G4CF HIGHSTAT Phase 1 D0G5LY DRUG__ID D0G5LY D0G5LY DRUGCOMP Louisiana State University D0G5LY DRUGINCH 1S/C15H12N2O5S/c18-11-7-5-10(6-8-11)16-14(19)9-17-15(20)12-3-1-2-4-13(12)23(17,21)22/h1-8,18H,9H2,(H,16,19) D0G5LY DRUGINKE PUPNJSIFIXXJCH-UHFFFAOYSA-N D0G5LY DRUGSMIL C1=CC=C2C(=C1)C(=O)N(S2(=O)=O)CC(=O)NC3=CC=C(C=C3)O D0G5LY HIGHSTAT Phase 1 D0G6HI DRUG__ID D0G6HI D0G6HI DRUGCOMP MerLion Pharmaceuticals Pte Ltd; Combinature Biopharm AG D0G6HI DRUGINCH 1S/C59H94N14O19/c1-30(2)19-14-12-10-8-9-11-13-15-22-41(75)65-35(25-40(61)74)52(84)71-49-34(7)64-53(85)39-21-18-24-73(39)57(89)46(31(3)4)69-56(88)48(33(6)60)68-43(77)29-63-50(82)36(26-44(78)79)66-42(76)28-62-51(83)37(27-45(80)81)67-55(87)47(32(5)59(91)92)70-54(86)38-20-16-17-23-72(38)58(49)90/h13,15,30-39,46-49H,8-12,14,16-29,60H2,1-7H3,(H2,61,74)(H,62,83)(H,63,82)(H,64,85)(H,65,75)(H,66,76)(H,67,87)(H,68,77)(H,69,88)(H,70,86)(H,71,84)(H,78,79)(H,80,81)(H,91,92)/b15-13-/t32-,33+,34-,35-,36-,37-,38+,39-,46-,47-,48+,49-/m0/s1 D0G6HI DRUGINKE HVYFVLAUKMGKHL-USKUEUQVSA-N D0G6HI DRUGSMIL CC1C(C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N1)C(C)C)C(C)N)CC(=O)O)CC(=O)O)C(C)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)CC=CCCCCCCCC(C)C D0G6HI HIGHSTAT Phase 1 D0G6UQ DRUG__ID D0G6UQ D0G6UQ DRUGCOMP Organon BioSciences D0G6UQ DRUGINCH 1S/C79H125N7O56S7.8Na/c1-39-33-46(115-4)40(2)41(3)69(39)143(95,96)85-44(71(89)84-45(72(90)86-24-14-13-15-25-86)34-42-18-20-43(21-19-42)70(80)81)35-51(88)82-22-16-17-50(87)83-23-26-124-27-28-125-29-30-126-31-32-127-52-47(36-128-144(97,98)99)132-76(64(120-9)55(52)116-5)136-59-57(118-7)66(122-11)78(139-62(59)73(91)92)135-54-49(38-130-146(103,104)105)133-79(68(142-149(112,113)114)61(54)140-147(106,107)108)137-60-58(119-8)65(121-10)77(138-63(60)74(93)94)134-53-48(37-129-145(100,101)102)131-75(123-12)67(56(53)117-6)141-148(109,110)111;;;;;;;;/h18-21,33,44-45,47-49,52-68,75-79,85H,13-17,22-32,34-38H2,1-12H3,(H3,80,81)(H,82,88)(H,83,87)(H,84,89)(H,91,92)(H,93,94)(H,97,98,99)(H,100,101,102)(H,103,104,105)(H,106,107,108)(H,109,110,111)(H,112,113,114);;;;;;;;/t44-,45+,47+,48+,49+,52+,53+,54+,55-,56-,57-,58-,59-,60-,61-,62-,63+,64+,65+,66+,67+,68+,75-,76+,77+,78+,79+;;;;;;;;/m0......../s1 D0G6UQ DRUGINKE QYMUZBCRFQFXJQ-KIDSDGJESA-N D0G6UQ DRUGSMIL CC1=CC(=C(C(=C1S(=O)(=O)NC(CC(=O)NCCCC(=O)NCCOCCOCCOCCOC2C(OC(C(C2OC)OC)OC3C(C(C(OC3C(=O)O)OC4C(OC(C(C4OS(=O)(=O)O)OS(=O)(=O)O)OC5C(C(C(OC5C(=O)O)OC6C(OC(C(C6OC)OS(=O)(=O)O)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O)C(=O)NC(CC7=CC=C(C=C7)C(=N)N)C(=O)N8CCCCC8)C)C)OC.[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na] D0G6UQ HIGHSTAT Phase 1 D0G7IF DRUG__ID D0G7IF D0G7IF DRUGCOMP VivoLux, Ashburn, VA D0G7IF DRUGINCH 1S/C23H17F2N3O6/c1-2-22(29)26-8-7-16(9-14-3-5-18(24)20(11-14)27(31)32)23(30)17(13-26)10-15-4-6-19(25)21(12-15)28(33)34/h2-6,9-12H,1,7-8,13H2/b16-9+,17-10+ D0G7IF DRUGINKE SCKXBVLYWLLALY-CZCYGEDCSA-N D0G7IF DRUGSMIL C=CC(=O)N1CCC(=CC2=CC(=C(C=C2)F)[N+](=O)[O-])C(=O)C(=CC3=CC(=C(C=C3)F)[N+](=O)[O-])C1 D0G7IF HIGHSTAT Phase 1 D0G8CU DRUG__ID D0G8CU D0G8CU DRUGCOMP Cotinga Pharmaceuticals London, Canada D0G8CU DRUGINCH 1S/C19H22N6S/c26-19(23-22-16-7-3-5-15-6-4-10-21-18(15)16)25-13-11-24(12-14-25)17-8-1-2-9-20-17/h1-2,4,6,8-10H,3,5,7,11-14H2,(H,23,26)/b22-16+ D0G8CU DRUGINKE UTDAKQMBNSHJJB-CJLVFECKSA-N D0G8CU DRUGSMIL C1CC2=C(C(=NNC(=S)N3CCN(CC3)C4=CC=CC=N4)C1)N=CC=C2 D0G8CU HIGHSTAT Phase 1 D0GG7L DRUG__ID D0GG7L D0GG7L DRUGCOMP Bristol-Myers SquibbPrinceton, NJ D0GG7L DRUGINCH 1S/C22H35NO/c1-2-3-4-5-6-17-7-8-19-14-20(10-9-18(19)13-17)21-11-12-22(23,15-21)16-24/h9-10,14,17,21,24H,2-8,11-13,15-16,23H2,1H3/t17-,21+,22-/m1/s1 D0GG7L DRUGINKE BPMMYKAHRIEVDH-VOQZNFBZSA-N D0GG7L DRUGSMIL CCCCCCC1CCC2=C(C1)C=CC(=C2)C3CCC(C3)(CO)N D0GG7L HIGHSTAT Phase 1 D0GM6E DRUG__ID D0GM6E D0GM6E DRUGCOMP Bristol-Myers Squibb D0GM6E DRUGINCH 1S/C27H46N6O13S/c1-42-12-8-31-26(40)45-15-18(16-46-27(41)32-9-13-43-2)44-11-3-4-21(34)29-6-7-30-22(35)5-10-33-23(36)14-20(24(33)37)47-17-19(28)25(38)39/h18-20H,3-17,28H2,1-2H3,(H,29,34)(H,30,35)(H,31,40)(H,32,41)(H,38,39)/t19-,20?/m0/s1 D0GM6E DRUGINKE PQEJXGNZBLONLG-XJDOXCRVSA-N D0GM6E DRUGSMIL COCCNC(=O)OCC(COC(=O)NCCOC)OCCCC(=O)NCCNC(=O)CCN1C(=O)CC(C1=O)SCC(C(=O)O)N D0GM6E HIGHSTAT Phase 1 D0GR1Y DRUG__ID D0GR1Y D0GR1Y DRUGCOMP Minneamrita Therapeutics Tampa, FL D0GR1Y DRUGINCH 1S/C21H27O10P.2Na/c1-9(2)19-14(30-19)15-21(31-15)18(3)5-4-10-11(7-26-16(10)22)12(18)6-13-20(21,29-13)17(19)27-8-28-32(23,24)25;;/h9,12-15,17H,4-8H2,1-3H3,(H2,23,24,25);;/q;2*+1/p-2/t12-,13-,14-,15-,17+,18-,19-,20+,21+;;/m0../s1 D0GR1Y DRUGINKE ZHBJMVNZRZUQEP-KIKMAQITSA-L D0GR1Y DRUGSMIL CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2OCOP(=O)([O-])[O-])O7)COC6=O)C.[Na+].[Na+] D0GR1Y HIGHSTAT Phase 1 D0GV0Q DRUG__ID D0GV0Q D0GV0Q DRUGTYPE Small molecular drug D0GV0Q DRUGINCH 1S/C20H17F3N4O3/c1-9-15-17(28)12(20(29)30)8-27(14-3-2-10(21)6-13(14)22)18(15)25-19(16(9)23)26-5-4-11(24)7-26/h2-3,6,8,11H,4-5,7,24H2,1H3,(H,29,30)/t11-/m0/s1 D0GV0Q DRUGINKE SKYPQEVVXGJKIJ-NSHDSACASA-N D0GV0Q DRUGSMIL CC1=C2C(=O)C(=CN(C2=NC(=C1F)N3CCC(C3)N)C4=C(C=C(C=C4)F)F)C(=O)O D0GV0Q HIGHSTAT Phase 1 D0GY1Y DRUG__ID D0GY1Y D0GY1Y DRUGCOMP Daiichi Sankyo Inc D0GY1Y DRUGINCH 1S/C61H99N2.ClHO4/c1-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-44-52-62-56-48-42-40-46-54(56)60(3,4)58(62)50-38-37-39-51-59-61(5,6)55-47-41-43-49-57(55)63(59)53-45-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-2;2-1(3,4)5/h37-43,46-51H,7-36,44-45,52-53H2,1-6H3;(H,2,3,4,5)/q+1;/p-1 D0GY1Y DRUGINKE ZQSBJPAQPRVNHU-UHFFFAOYSA-M D0GY1Y DRUGSMIL CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2C(C1=CC=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCCCCCCCCCCCCCCCCC)(C)C.[O-]Cl(=O)(=O)=O D0GY1Y HIGHSTAT Phase 1 D0H0FX DRUG__ID D0H0FX D0H0FX DRUGCOMP NicOx D0H0FX DRUGINCH 1S/C37H42FN3O8/c1-25(2)35-34(37(45)39-29-13-7-4-8-14-29)33(26-11-5-3-6-12-26)36(27-15-17-28(38)18-16-27)40(35)20-19-30(42)23-31(43)24-32(44)48-21-9-10-22-49-41(46)47/h3-8,11-18,25,30-31,42-43H,9-10,19-24H2,1-2H3,(H,39,45)/t30-,31-/m1/s1 D0H0FX DRUGINKE QBBIDMMGINYIJJ-FIRIVFDPSA-N D0H0FX DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)OCCCCO[N+](=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 D0H0FX HIGHSTAT Phase 1 D0H1OL DRUG__ID D0H1OL D0H1OL DRUGTYPE Small molecular drug D0H1OL DRUGINCH 1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1 D0H1OL DRUGINKE NYHBQMYGNKIUIF-UUOKFMHZSA-N D0H1OL DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(NC2=O)N D0H1OL HIGHSTAT Phase 1 D0H2HZ DRUG__ID D0H2HZ D0H2HZ DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0H2HZ DRUGINCH 1S/C24H26N2O2/c1-17-8-13-26-21(14-17)16-28-23-5-3-4-22(27-2)24(23)20-7-6-18-9-11-25-12-10-19(18)15-20/h3-8,13-15,25H,9-12,16H2,1-2H3 D0H2HZ DRUGINKE KYANYGKXMNYFBX-UHFFFAOYSA-N D0H2HZ DRUGSMIL CC1=CC(=NC=C1)COC2=CC=CC(=C2C3=CC4=C(CCNCC4)C=C3)OC D0H2HZ HIGHSTAT Phase 1 D0H4DR DRUG__ID D0H4DR D0H4DR DRUGCOMP Bristol-myers squibb D0H4DR DRUGINCH 1S/C29H28Cl2F2N2O4S/c1-28(2,26-19(30)7-6-8-20(26)31)27-34-25(29(3,4)37)14-35(27)23-10-9-16(11-22(23)33)17-12-21(32)18(15-36)24(13-17)40(5,38)39/h6-14,36-37H,15H2,1-5H3 D0H4DR DRUGINKE HNAJDMYOTDNOBK-UHFFFAOYSA-N D0H4DR DRUGSMIL CC(C)(C1=CN(C(=N1)C(C)(C)C2=C(C=CC=C2Cl)Cl)C3=C(C=C(C=C3)C4=CC(=C(C(=C4)S(=O)(=O)C)CO)F)F)O D0H4DR HIGHSTAT Phase 1 D0H9FR DRUG__ID D0H9FR D0H9FR DRUGCOMP Principia Biopharma South San Francisco, CA D0H9FR DRUGINCH 1S/C26H30Cl2N6O4/c1-5-20(35)33-11-9-32(10-12-33)7-6-8-34-24-16(15-30-26(29-2)31-24)13-17(25(34)36)21-22(27)18(37-3)14-19(38-4)23(21)28/h5,13-15H,1,6-12H2,2-4H3,(H,29,30,31) D0H9FR DRUGINKE PUIXMSRTTHLNKI-UHFFFAOYSA-N D0H9FR DRUGSMIL CNC1=NC=C2C=C(C(=O)N(C2=N1)CCCN3CCN(CC3)C(=O)C=C)C4=C(C(=CC(=C4Cl)OC)OC)Cl D0H9FR HIGHSTAT Phase 1 D0HE7C DRUG__ID D0HE7C D0HE7C DRUGCOMP ORIC Pharmaceuticals South San Francisco, CA D0HE7C DRUGINCH 1S/C34H47NO2/c1-22(2)35(7)25-11-8-23(9-12-25)29-21-33(6)30(16-17-34(33,37)19-18-32(3,4)5)28-14-10-24-20-26(36)13-15-27(24)31(28)29/h8-9,11-12,20,22,27-31,37H,10,13-17,21H2,1-7H3/t27-,28-,29+,30-,31+,33-,34+/m0/s1 D0HE7C DRUGINKE VNLTWJIWEYPBIF-KMSLUKAPSA-N D0HE7C DRUGSMIL CC(C)N(C)C1=CC=C(C=C1)C2CC3(C(CCC3(C#CC(C)(C)C)O)C4C2C5CCC(=O)C=C5CC4)C D0HE7C HIGHSTAT Phase 1 D0HY9S DRUG__ID D0HY9S D0HY9S DRUGCOMP Boston Pharmaceuticals Cambridge, MA D0HY9S DRUGINCH 1S/C24H30N8O/c1-7-33-19-11-16(22-31-27-14-32(22)6)8-9-18(19)29-23-25-12-17-10-15(2)28-21(20(17)30-23)26-13-24(3,4)5/h8-12,14H,7,13H2,1-6H3,(H,26,28)(H,25,29,30) D0HY9S DRUGINKE SGWLRDAOCLITOM-UHFFFAOYSA-N D0HY9S DRUGSMIL CCOC1=C(C=CC(=C1)C2=NN=CN2C)NC3=NC=C4C=C(N=C(C4=N3)NCC(C)(C)C)C D0HY9S HIGHSTAT Phase 1 D0I0JG DRUG__ID D0I0JG D0I0JG DRUGTYPE Small molecular drug D0I0JG DRUGINCH 1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18) D0I0JG DRUGINKE DWPQODZAOSWNHB-UHFFFAOYSA-N D0I0JG DRUGSMIL CN1CC(=O)NC1=NC(=O)NC2=CC(=CC=C2)Cl D0I0JG HIGHSTAT Phase 1 D0I1OS DRUG__ID D0I1OS D0I1OS DRUGCOMP Eisai Co Ltd D0I1OS DRUGINCH 1S/C25H23F3N6O/c1-16-14-33(15-29-16)21-11-9-17(30-24(21)35-2)10-12-22-31-23-19(7-5-13-34(23)32-22)18-6-3-4-8-20(18)25(26,27)28/h3-4,6,8-12,14-15,19H,5,7,13H2,1-2H3/b12-10+/t19-/m0/s1 D0I1OS DRUGINKE SSGLBUGNISHUAO-RDELFYGPSA-N D0I1OS DRUGSMIL CC1=CN(C=N1)C2=C(N=C(C=C2)C=CC3=NN4CCCC(C4=N3)C5=CC=CC=C5C(F)(F)F)OC D0I1OS HIGHSTAT Phase 1 D0I2XM DRUG__ID D0I2XM D0I2XM DRUGTYPE Small molecular drug D0I2XM DRUGINCH 1S/C31H27F3N4O3S2/c32-31(33,34)25-9-5-22(6-10-25)28-20-42-30(37-28)23-7-13-27(14-8-23)43(40,41)38-26-11-3-21(4-12-26)15-17-36-19-29(39)24-2-1-16-35-18-24/h1-14,16,18,20,29,36,38-39H,15,17,19H2/t29-/m0/s1 D0I2XM DRUGINKE MSOUIIHPMJCUNI-LJAQVGFWSA-N D0I2XM DRUGSMIL C1=CC(=CN=C1)C(CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)C4=NC(=CS4)C5=CC=C(C=C5)C(F)(F)F)O D0I2XM HIGHSTAT Phase 1 D0I4ZN DRUG__ID D0I4ZN D0I4ZN DRUGCOMP Glaxosmithkline D0I4ZN DRUGINCH 1S/C23H28N2O2/c26-23(27)20-8-6-18(7-9-20)16-25-12-10-17(11-13-25)15-24-22-14-21(22)19-4-2-1-3-5-19/h1-9,17,21-22,24H,10-16H2,(H,26,27)/t21-,22+/m0/s1 D0I4ZN DRUGINKE LRULVYSBRWUVGR-FCHUYYIVSA-N D0I4ZN DRUGSMIL C1CN(CCC1CNC2CC2C3=CC=CC=C3)CC4=CC=C(C=C4)C(=O)O D0I4ZN HIGHSTAT Phase 1 D0I5DP DRUG__ID D0I5DP D0I5DP DRUGCOMP AmgenThousand Oaks, CA D0I5DP DRUGINCH 1S/C33H41ClN2O5S/c1-21-6-4-8-30(40-3)27-12-9-25(27)18-36-19-33(15-5-7-23-16-26(34)11-13-28(23)33)20-41-31-14-10-24(17-29(31)36)32(37)35-42(38,39)22(21)2/h4,8,10-11,13-14,16-17,21-22,25,27,30H,5-7,9,12,15,18-20H2,1-3H3,(H,35,37)/b8-4+/t21-,22+,25-,27+,30-,33-/m0/s1 D0I5DP DRUGINKE JQNINBDKGLWYMU-GEAQBIRJSA-N D0I5DP DRUGSMIL CC1CC=CC(C2CCC2CN3CC4(CCCC5=C4C=CC(=C5)Cl)COC6=C3C=C(C=C6)C(=O)NS(=O)(=O)C1C)OC D0I5DP HIGHSTAT Phase 1 D0I8DH DRUG__ID D0I8DH D0I8DH DRUGCOMP Onyx Pharmaceuticals D0I8DH DRUGINCH 1S/C32H33N5O10/c1-2-13-37(25-10-5-18-14-24-21(15-20(18)25)30(43)36-26(16-38)33-24)19-6-3-17(4-7-19)29(42)35-23(32(46)47)8-11-27(39)34-22(31(44)45)9-12-28(40)41/h1,3-4,6-7,14-15,22-23,25,38H,5,8-13,16H2,(H,34,39)(H,35,42)(H,40,41)(H,44,45)(H,46,47)(H,33,36,43)/t22-,23+,25+/m1/s1 D0I8DH DRUGINKE NVHRBQOZEMFKLD-CUYJMHBOSA-N D0I8DH DRUGSMIL C#CCN(C1CCC2=CC3=C(C=C12)C(=O)NC(=N3)CO)C4=CC=C(C=C4)C(=O)NC(CCC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O D0I8DH HIGHSTAT Phase 1 D0IE9L DRUG__ID D0IE9L D0IE9L DRUGCOMP EMD Serono Rockland, MA; Vertex Pharmaceuticals Boston, MA D0IE9L DRUGINCH 1S/C25H29F2N9O3/c26-16-9-30-23-20(22(28)32-36(23)12-16)24(37)31-19-11-29-10-18(27)21(19)34-3-1-15(2-4-34)25(38)35-7-5-33(6-8-35)17-13-39-14-17/h9-12,15,17H,1-8,13-14H2,(H2,28,32)(H,31,37) D0IE9L DRUGINKE QAYHKBLKSXWOEO-UHFFFAOYSA-N D0IE9L DRUGSMIL C1CN(CCC1C(=O)N2CCN(CC2)C3COC3)C4=C(C=NC=C4NC(=O)C5=C6N=CC(=CN6N=C5N)F)F D0IE9L HIGHSTAT Phase 1 D0IJ7O DRUG__ID D0IJ7O D0IJ7O DRUGTYPE Small molecular drug D0IJ7O DRUGINCH 1S/C19H17NO7/c20-18(26)14-11(22)6-9-5-8-4-7-2-1-3-10(21)12(7)15(23)13(8)16(24)19(9,27)17(14)25/h1-3,8-9,21,23,25,27H,4-6H2,(H2,20,26)/t8-,9-,19-/m0/s1 D0IJ7O DRUGINKE NBRQRXRBIHVLGI-OWXODZSWSA-N D0IJ7O DRUGSMIL C1C2CC3=C(C(=CC=C3)O)C(=C2C(=O)C4(C1CC(=O)C(=C4O)C(=O)N)O)O D0IJ7O HIGHSTAT Phase 1 D0IV7Z DRUG__ID D0IV7Z D0IV7Z DRUGCOMP AstraZeneca plc D0IV7Z DRUGINCH 1S/C19H20ClN3O3/c1-10(11-4-5-11)23-9-13-6-12(7-14(20)17(13)19(23)25)16-8-15(21-26-16)18(24)22(2)3/h6-8,10-11H,4-5,9H2,1-3H3/t10-/m0/s1 D0IV7Z DRUGINKE MCPBSUCAISQZQK-JTQLQIEISA-N D0IV7Z DRUGSMIL CC(C1CC1)N2CC3=C(C2=O)C(=CC(=C3)C4=CC(=NO4)C(=O)N(C)C)Cl D0IV7Z HIGHSTAT Phase 1 D0IZ1A DRUG__ID D0IZ1A D0IZ1A DRUGTYPE Small molecular drug D0IZ1A DRUGINCH 1S/C19H23N5O6S/c20-19-23-15-11(16(27)24-19)7-9(8-21-15)1-2-10-3-5-13(31-10)17(28)22-12(18(29)30)4-6-14(25)26/h3,5,9,12H,1-2,4,6-8H2,(H,22,28)(H,25,26)(H,29,30)(H4,20,21,23,24,27)/t9-,12+/m1/s1 D0IZ1A DRUGINKE GQCXGHHHNACOGE-SKDRFNHKSA-N D0IZ1A DRUGSMIL C1C(CNC2=C1C(=O)NC(=N2)N)CCC3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O D0IZ1A HIGHSTAT Phase 1 D0J0JT DRUG__ID D0J0JT D0J0JT DRUGCOMP Celgene Corp D0J0JT DRUGINCH 1S/C18H17N3O5/c22-13-7-6-12(16(24)20-13)21-17(25)11-3-1-2-10(14(11)18(21)26)8-19-15(23)9-4-5-9/h1-3,9,12H,4-8H2,(H,19,23)(H,20,22,24) D0J0JT DRUGINKE ZBXHNCURDISBRO-UHFFFAOYSA-N D0J0JT DRUGSMIL C1CC1C(=O)NCC2=C3C(=CC=C2)C(=O)N(C3=O)C4CCC(=O)NC4=O D0J0JT HIGHSTAT Phase 1 D0J1HB DRUG__ID D0J1HB D0J1HB DRUGCOMP iTeos Therapeutics Gosselies, Belgium Pfizer New York, NY D0J1HB DRUGINCH 1S/C12H9FN2O2/c13-6-1-2-10-7(3-6)9(5-14-10)8-4-11(16)15-12(8)17/h1-3,5,8,14H,4H2,(H,15,16,17) D0J1HB DRUGINKE MXKLDYKORJEOPR-UHFFFAOYSA-N D0J1HB DRUGSMIL C1C(C(=O)NC1=O)C2=CNC3=C2C=C(C=C3)F D0J1HB HIGHSTAT Phase 1 D0J2RV DRUG__ID D0J2RV D0J2RV DRUGTYPE Small molecular drug D0J2RV DRUGINCH 1S/C29H37N5O3/c1-4-17(3)32-25-14-23(16(2)11-24(25)28(30)36)29(37)33-20-12-21-8-9-22(13-20)34(21)26-10-7-19(15-31-26)27(35)18-5-6-18/h7,10-11,14-15,17-18,20-22,32H,4-6,8-9,12-13H2,1-3H3,(H2,30,36)(H,33,37)/t17-,20?,21-,22+/m1/s1 D0J2RV DRUGINKE LHGWWAFKVCIILM-AMZGXZFVSA-N D0J2RV DRUGSMIL CCC(C)NC1=C(C=C(C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C)C(=O)N D0J2RV HIGHSTAT Phase 1 D0J5HR DRUG__ID D0J5HR D0J5HR DRUGTYPE Small molecular drug D0J5HR DRUGINCH 1S/C23H20N6O/c1-15-9-17(12-28-23(15)18-5-6-25-16(2)10-18)11-22(30)29-21-4-3-19(13-27-21)20-14-24-7-8-26-20/h3-10,12-14H,11H2,1-2H3,(H,27,29,30) D0J5HR DRUGINKE XXYGTCZJJLTAGH-UHFFFAOYSA-N D0J5HR DRUGSMIL CC1=CC(=CN=C1C2=CC(=NC=C2)C)CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4 D0J5HR HIGHSTAT Phase 1 D0J6AB DRUG__ID D0J6AB D0J6AB DRUGTYPE Small molecular drug D0J6AB DRUGINCH 1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27) D0J6AB DRUGINKE LCVIRAZGMYMNNT-UHFFFAOYSA-N D0J6AB DRUGSMIL C1CC(CCC1OC2=C(C(=CC=C2)Cl)F)(CC3=NC(=CC=C3)NC4=NC=CS4)C(=O)O D0J6AB HIGHSTAT Phase 1 D0J6RV DRUG__ID D0J6RV D0J6RV DRUGCOMP Bayer healthcare pharmaceuticals D0J6RV DRUGINCH 1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1 D0J6RV DRUGINKE NRJKIOCCERLIDG-GOSISDBHSA-N D0J6RV DRUGSMIL CC(C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3 D0J6RV HIGHSTAT Phase 1 D0JY2X DRUG__ID D0JY2X D0JY2X DRUGCOMP Gnt pharma D0JY2X DRUGINCH 1S/C15H8F7NO3/c16-10-7(11(17)13(19)9(12(10)18)15(20,21)22)4-23-5-1-2-8(24)6(3-5)14(25)26/h1-3,23-24H,4H2,(H,25,26) D0JY2X DRUGINKE HABROHXUHNHQMY-UHFFFAOYSA-N D0JY2X DRUGSMIL C1=CC(=C(C=C1NCC2=C(C(=C(C(=C2F)F)C(F)(F)F)F)F)C(=O)O)O D0JY2X HIGHSTAT Phase 1 D0K0IM DRUG__ID D0K0IM D0K0IM DRUGCOMP Merck D0K0IM DRUGINCH 1S/C29H31NO6S/c1-17-10-22(35-8-5-9-37(3,33)34)11-18(2)26(17)20-7-4-6-19(12-20)16-36-25-14-21-13-23-27(24(21)15-30-25)28(23)29(31)32/h4,6-7,10-12,14-15,23,27-28H,5,8-9,13,16H2,1-3H3,(H,31,32)/t23-,27-,28+/m1/s1 D0K0IM DRUGINKE CODQKEMYZZKQAE-QPVYNBJUSA-N D0K0IM DRUGSMIL CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=NC=C4C5C(C5C(=O)O)CC4=C3)C)OCCCS(=O)(=O)C D0K0IM HIGHSTAT Phase 1 D0K2NA DRUG__ID D0K2NA D0K2NA DRUGTYPE Small molecular drug D0K2NA DRUGINCH 1S/C32H33ClN6O5S2.Na.H2O/c1-32(2,3)28-20-45-30(35-28)19-43-24-8-4-7-22(17-24)31(40)34-26-16-21(9-14-27(26)44-18-29-36-38-39-37-29)6-5-15-46(41,42)25-12-10-23(33)11-13-25;;/h4,7-14,16-17,20H,5-6,15,18-19H2,1-3H3,(H2,34,36,37,38,39,40);;1H2/q;+1;/p-1 D0K2NA DRUGINKE XHOMMMSIYBSJNL-UHFFFAOYSA-M D0K2NA DRUGSMIL CC(C)(C)C1=CSC(=N1)COC2=CC=CC(=C2)C(=O)[N-]C3=C(C=CC(=C3)CCCS(=O)(=O)C4=CC=C(C=C4)Cl)OCC5=NNN=N5.O.[Na+] D0K2NA HIGHSTAT Phase 1 D0K5CJ DRUG__ID D0K5CJ D0K5CJ DRUGTYPE Small molecular drug D0K5CJ DRUGINCH 1S/C43H56N6O7/c1-6-39(53)21-25-22-42(38(52)56-5,33-27(13-17-48(23-25)24-39)26-11-8-9-12-30(26)45-33)29-19-28-31(20-32(29)55-4)47(3)35-41(28)15-18-49-16-10-14-40(7-2,34(41)49)36(50)43(35,54)37(51)46-44/h8-12,14,19-20,25,34-36,45,50,53-54H,6-7,13,15-18,21-24,44H2,1-5H3,(H,46,51)/t25-,34+,35-,36-,39+,40-,41-,42+,43+/m1/s1 D0K5CJ DRUGINKE PPRGGNQLPSVURC-KOTLKJBCSA-N D0K5CJ DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NN)O)O)CC)OC)C(=O)OC)O D0K5CJ HIGHSTAT Phase 1 D0K7OW DRUG__ID D0K7OW D0K7OW DRUGCOMP GlaxoSmithKline plc D0K7OW DRUGINCH 1S/C14H17Cl2NO/c1-18-9-13-7-14(13,4-5-17-8-13)10-2-3-11(15)12(16)6-10/h2-3,6,17H,4-5,7-9H2,1H3/t13-,14-/m0/s1 D0K7OW DRUGINKE ICXJGCSEMJXNQF-KBPBESRZSA-N D0K7OW DRUGSMIL COCC12CC1(CCNC2)C3=CC(=C(C=C3)Cl)Cl D0K7OW HIGHSTAT Phase 1 D0K9IF DRUG__ID D0K9IF D0K9IF DRUGCOMP Pfizer D0K9IF DRUGINCH 1S/C15H22N4O/c1-8(13(17)20)12(16)14-18-10-6-5-9(15(2,3)4)7-11(10)19-14/h5-8,12H,16H2,1-4H3,(H2,17,20)(H,18,19)/t8-,12+/m1/s1 D0K9IF DRUGINKE APWZIFIAVVFPNT-PELKAZGASA-N D0K9IF DRUGSMIL CC(C(C1=NC2=C(N1)C=C(C=C2)C(C)(C)C)N)C(=O)N D0K9IF HIGHSTAT Phase 1 D0K9OU DRUG__ID D0K9OU D0K9OU DRUGCOMP University of Alabama at Birmingham D0K9OU DRUGINCH 1S/C11H13N5O3/c12-10-14-8-7(9(19)15-10)13-5-16(8)2-6-1-11(6,3-17)4-18/h2,5,17-18H,1,3-4H2,(H3,12,14,15,19)/b6-2- D0K9OU DRUGINKE KMUNHOKTIVSFRA-KXFIGUGUSA-N D0K9OU DRUGSMIL C1C(=CN2C=NC3=C2N=C(NC3=O)N)C1(CO)CO D0K9OU HIGHSTAT Phase 1 D0KK9D DRUG__ID D0KK9D D0KK9D DRUGCOMP Concentric Analgesics Los Altos, CA D0KK9D DRUGINCH 1S/C9H7N3O2S/c10-9-11-8(5-15-9)6-1-3-7(4-2-6)12(13)14/h1-5H,(H2,10,11) D0KK9D DRUGINKE RIKJWJIWXCUKQV-UHFFFAOYSA-N D0KK9D DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)N)[N+](=O)[O-] D0KK9D HIGHSTAT Phase 1 D0KV6C DRUG__ID D0KV6C D0KV6C DRUGCOMP Repligen D0KV6C DRUGINCH 1S/C21H23Cl2N5O/c22-15-3-1-4-16(23)14(15)11-28-9-7-13(8-10-28)12-29-18-6-2-5-17-19(18)20(24)27-21(25)26-17/h1-6,13H,7-12H2,(H4,24,25,26,27) D0KV6C DRUGINKE MNLHFGXIUJNDAF-UHFFFAOYSA-N D0KV6C DRUGSMIL C1CN(CCC1COC2=CC=CC3=C2C(=NC(=N3)N)N)CC4=C(C=CC=C4Cl)Cl D0KV6C HIGHSTAT Phase 1 D0L0YG DRUG__ID D0L0YG D0L0YG DRUGTYPE Small molecular drug D0L0YG DRUGINCH 1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h14-15,17-18,20-21H,2-13,16,19H2,1H3/b15-14+/t17-,18+/m0/s1 D0L0YG DRUGINKE WWUZIQQURGPMPG-KRWOKUGFSA-N D0L0YG DRUGSMIL CCCCCCCCCCCCCC=CC(C(CO)N)O D0L0YG HIGHSTAT Phase 1 D0L1GD DRUG__ID D0L1GD D0L1GD DRUGCOMP Merck Kenilworth, NJ D0L1GD DRUGINCH 1S/C37H41N9O3S/c1-24(2)49-32-12-9-28(20-38-32)34-30-19-29(10-11-31(30)41-42-34)40-36(48)37(50-4)15-18-45(22-37)21-33(47)46-16-13-26(14-17-46)25-5-7-27(8-6-25)35-39-23-44(3)43-35/h5-13,19-20,23-24H,14-18,21-22H2,1-4H3,(H,40,48)(H,41,42)/t37-/m0/s1 D0L1GD DRUGINKE KPQQGHGDBBJGFA-QNGWXLTQSA-N D0L1GD DRUGSMIL CC(C)OC1=NC=C(C=C1)C2=NNC3=C2C=C(C=C3)NC(=O)C4(CCN(C4)CC(=O)N5CCC(=CC5)C6=CC=C(C=C6)C7=NN(C=N7)C)SC D0L1GD HIGHSTAT Phase 1 D0L5VS DRUG__ID D0L5VS D0L5VS DRUGTYPE Small molecular drug D0L5VS DRUGINCH 1S/C22H28N4O4/c1-6-12-25-20-19(21(27)26(13-7-2)22(25)28)24(3)18(23-20)11-9-15-8-10-16(29-4)17(14-15)30-5/h8-11,14H,6-7,12-13H2,1-5H3/b11-9+ D0L5VS DRUGINKE UQGGPCQNHJCOPS-PKNBQFBNSA-N D0L5VS DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C D0L5VS HIGHSTAT Phase 1 D0L6XO DRUG__ID D0L6XO D0L6XO DRUGCOMP AstraZeneca Wilmington, DE D0L6XO DRUGINCH 1S/C27H32FN5O2/c1-18(2)33-26-21-14-20(22(28)15-23(21)29-17-24(26)31(3)27(33)34)19-8-9-25(30-16-19)35-13-7-12-32-10-5-4-6-11-32/h8-9,14-18H,4-7,10-13H2,1-3H3 D0L6XO DRUGINKE VQSZIPCGAGVRRP-UHFFFAOYSA-N D0L6XO DRUGSMIL CC(C)N1C2=C(C=NC3=CC(=C(C=C32)C4=CN=C(C=C4)OCCCN5CCCCC5)F)N(C1=O)C D0L6XO HIGHSTAT Phase 1 D0L6XQ DRUG__ID D0L6XQ D0L6XQ DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D0L6XQ DRUGINCH 1S/C30H26ClFN2O5/c1-39-26-14-18(6-9-24(26)33-27(35)22-15-21(32)7-8-23(22)31)28(36)34-13-12-30(11-10-20(17-30)29(37)38)16-19-4-2-3-5-25(19)34/h2-9,14-15,17H,10-13,16H2,1H3,(H,33,35)(H,37,38)/t30-/m0/s1 D0L6XQ DRUGINKE ZHFPIMSXEZPRLC-PMERELPUSA-N D0L6XQ DRUGSMIL COC1=C(C=CC(=C1)C(=O)N2CCC3(CCC(=C3)C(=O)O)CC4=CC=CC=C42)NC(=O)C5=C(C=CC(=C5)F)Cl D0L6XQ HIGHSTAT Phase 1 D0L8HB DRUG__ID D0L8HB D0L8HB DRUGCOMP MedImmune Gaithersburg, MD D0L8HB DRUGINCH 1S/C36H59N5O2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-27-33(42)38-28-22-23-29-43-41-32(26-6-4-2)40-34-35(41)30-24-20-21-25-31(30)39-36(34)37/h20-21,24-25H,3-19,22-23,26-29H2,1-2H3,(H2,37,39)(H,38,42) D0L8HB DRUGINKE RRTPWQXEERTRRK-UHFFFAOYSA-N D0L8HB DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)NCCCCON1C(=NC2=C1C3=CC=CC=C3N=C2N)CCCC D0L8HB HIGHSTAT Phase 1 D0LG8T DRUG__ID D0LG8T D0LG8T DRUGCOMP Daiichi Sankyo Basking Ridge, NJ D0LG8T DRUGINCH 1S/C14H13N3O2/c1-9-15-8-10(16-9)6-7-17-13(18)11-4-2-3-5-12(11)14(17)19/h2-5,8H,6-7H2,1H3,(H,15,16) D0LG8T DRUGINKE QTGYNKYZRZATJB-UHFFFAOYSA-N D0LG8T DRUGSMIL CC1=NC=C(N1)CCN2C(=O)C3=CC=CC=C3C2=O D0LG8T HIGHSTAT Phase 1 D0LL4Y DRUG__ID D0LL4Y D0LL4Y DRUGCOMP Takeda Oncology Deerfield, IL D0LL4Y DRUGINCH 1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m0/s1 D0LL4Y DRUGINKE XGVXKJKTISMIOW-ZDUSSCGKSA-N D0LL4Y DRUGSMIL CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)C4CC5CCN4CC5 D0LL4Y HIGHSTAT Phase 1 D0M2TS DRUG__ID D0M2TS D0M2TS DRUGCOMP AbbVieNorth Chicago, IL D0M2TS DRUGINCH 1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6-4-13(23)10-18(20)24)16(11-14)17-12-27(2)22(28)21-15(17)8-9-25-21/h4-12,25-26H,3H2,1-2H3 D0M2TS DRUGINKE RDONXGFGWSSFMY-UHFFFAOYSA-N D0M2TS DRUGSMIL CCS(=O)(=O)NC1=CC(=C(C=C1)OC2=C(C=C(C=C2)F)F)C3=CN(C(=O)C4=C3C=CN4)C D0M2TS HIGHSTAT Phase 1 D0M8YM DRUG__ID D0M8YM D0M8YM DRUGCOMP Hengrui Therapeutics Princeton, NJ D0M8YM DRUGINCH 1S/C32H31ClN6O3/c1-3-41-30-17-27-25(16-28(30)38-31(40)12-10-24-8-6-14-39(24)2)32(21(18-34)19-36-27)37-22-9-11-29(26(33)15-22)42-20-23-7-4-5-13-35-23/h4-5,7,9-13,15-17,19,24H,3,6,8,14,20H2,1-2H3,(H,36,37)(H,38,40)/b12-10+/t24-/m1/s1 D0M8YM DRUGINKE SADXACCFNXBCFY-IYNHSRRRSA-N D0M8YM DRUGSMIL CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C D0M8YM HIGHSTAT Phase 1 D0M9RI DRUG__ID D0M9RI D0M9RI DRUGCOMP Suven Life Sciences Hyderabad, India D0M9RI DRUGINCH 1S/C21H29N5O2/c1-15(2)26-18-8-5-4-7-17(18)19(24-26)21-23-22-20(28-21)16-9-12-25(13-10-16)11-6-14-27-3/h4-5,7-8,15-16H,6,9-14H2,1-3H3 D0M9RI DRUGINKE DWTFBJGTRBMHPG-UHFFFAOYSA-N D0M9RI DRUGSMIL CC(C)N1C2=CC=CC=C2C(=N1)C3=NN=C(O3)C4CCN(CC4)CCCOC D0M9RI HIGHSTAT Phase 1 D0MA0F DRUG__ID D0MA0F D0MA0F DRUGTYPE Small molecular drug D0MA0F DRUGINCH 1S/C38H60O11/c1-18(2)19(3)38(10)26(41)16-37(9)22-11-12-25-34(5,6)31(49-33-29(44)28(43)27(42)24(17-39)48-33)23(47-20(4)40)15-35(25,7)21(22)13-14-36(37,8)30(38)32(45)46/h18-19,23-25,27-31,33,39,42-44H,11-17H2,1-10H3,(H,45,46)/t19?,23-,24-,25+,27-,28+,29-,30-,31+,33+,35-,36+,37-,38+/m1/s1 D0MA0F DRUGINKE FBAPXRMZLULGNA-LEAUMUBASA-N D0MA0F DRUGSMIL CC(C)C(C)C1(C(C2(CCC3=C(C2(CC1=O)C)CCC4C3(CC(C(C4(C)C)OC5C(C(C(C(O5)CO)O)O)O)OC(=O)C)C)C)C(=O)O)C D0MA0F HIGHSTAT Phase 1 D0N3NL DRUG__ID D0N3NL D0N3NL DRUGTYPE Small molecular drug D0N3NL DRUGINCH 1S/C14H13N3.C13H11N3.ClH/c1-17-13-7-11(15)4-2-9(13)6-10-3-5-12(16)8-14(10)17;14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10;/h2-8H,1H3,(H3,15,16);1-7H,14-15H2;1H D0N3NL DRUGINKE PEJLNXHANOHNSU-UHFFFAOYSA-N D0N3NL DRUGSMIL C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(C=CC(=C3)N)C=C21)N.[Cl-] D0N3NL HIGHSTAT Phase 1 D0N6ZP DRUG__ID D0N6ZP D0N6ZP DRUGCOMP SmithKline Beecham plc D0N6ZP DRUGINCH 1S/C54H83N15O10/c1-4-79-35-21-19-34(20-22-35)29-39-48(75)67-40(28-33-14-7-5-8-15-33)50(77)69-44(32(2)3)51(78)68-41(30-42(55)70)49(76)66-37(16-11-25-54(31-43(71)63-39)23-9-6-10-24-54)47(74)65-38(18-13-27-62-53(59)60)46(73)64-36(45(56)72)17-12-26-61-52(57)58/h5,7-8,14-15,19-22,32,36-41,44H,4,6,9-13,16-18,23-31H2,1-3H3,(H2,55,70)(H2,56,72)(H,63,71)(H,64,73)(H,65,74)(H,66,76)(H,67,75)(H,68,78)(H,69,77)(H4,57,58,61)(H4,59,60,62)/t36-,37+,38+,39-,40+,41+,44+/m1/s1 D0N6ZP DRUGINKE PZEDOGNXHJQAKP-CQRSLYTBSA-N D0N6ZP DRUGSMIL CCOC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCCC3(CCCCC3)CC(=O)N2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)N)CC(=O)N)C(C)C)CC4=CC=CC=C4 D0N6ZP HIGHSTAT Phase 1 D0N7BL DRUG__ID D0N7BL D0N7BL DRUGTYPE Small molecular drug D0N7BL DRUGINCH 1S/C11H11Cl2N3O5S/c1-22(20,21)16(2-3-17)9-7(13)5(12)4-6-8(9)15-11(19)10(18)14-6/h4,17H,2-3H2,1H3,(H,14,18)(H,15,19) D0N7BL DRUGINKE BGJHUMNCODFLCH-UHFFFAOYSA-N D0N7BL DRUGSMIL CS(=O)(=O)N(CCO)C1=C2C(=CC(=C1Cl)Cl)NC(=O)C(=O)N2 D0N7BL HIGHSTAT Phase 1 D0NP8P DRUG__ID D0NP8P D0NP8P DRUGCOMP Ascentage Pharma Rockville, MD D0NP8P DRUGINCH 1S/C60H72N10O10S2/c1-39(61-3)55(71)63-49-37-67(34-32-45-28-30-51(69(45)59(49)75)57(73)65-53(41-18-9-5-10-19-41)42-20-11-6-12-21-42)81(77,78)47-26-17-27-48(36-47)82(79,80)68-35-33-46-29-31-52(70(46)60(76)50(38-68)64-56(72)40(2)62-4)58(74)66-54(43-22-13-7-14-23-43)44-24-15-8-16-25-44/h5-27,36,39-40,45-46,49-54,61-62H,28-35,37-38H2,1-4H3,(H,63,71)(H,64,72)(H,65,73)(H,66,74)/t39-,40-,45+,46+,49-,50-,51-,52-/m0/s1 D0NP8P DRUGINKE AKLBERUGKZNEJY-RTEPGWBGSA-N D0NP8P DRUGSMIL CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CCC7CCC(N7C(=O)C(C6)NC(=O)C(C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC D0NP8P HIGHSTAT Phase 1 D0NS6Z DRUG__ID D0NS6Z D0NS6Z DRUGCOMP Novonco Therapeutics Los Angeles, CA D0NS6Z DRUGINCH 1S/C22H16N2O5S/c25-15-8-6-13(10-17(15)27)19-20(12-4-2-1-3-5-12)30-22(23-19)24-21(29)14-7-9-16(26)18(28)11-14/h1-11,25-28H,(H,23,24,29) D0NS6Z DRUGINKE LGGDLPSXAGQFSG-UHFFFAOYSA-N D0NS6Z DRUGSMIL C1=CC=C(C=C1)C2=C(N=C(S2)NC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)O D0NS6Z HIGHSTAT Phase 1 D0NW8C DRUG__ID D0NW8C D0NW8C DRUGCOMP EMD Serono Rockland, MA D0NW8C DRUGINCH 1S/C3H5NO4/c4-1(2(5)6)3(7)8/h1H,4H2,(H,5,6)(H,7,8) D0NW8C DRUGINKE JINBYESILADKFW-UHFFFAOYSA-N D0NW8C DRUGSMIL C(C(=O)O)(C(=O)O)N D0NW8C HIGHSTAT Phase 1 D0O1LU DRUG__ID D0O1LU D0O1LU DRUGCOMP Euro-peptides SA D0O1LU DRUGINCH 1S/C28H34N6O3/c1-15-19(17-9-5-7-11-21(17)31-15)13-23(25(29)35)33-26(36)24(34-27(37)28(3,4)30)14-20-16(2)32-22-12-8-6-10-18(20)22/h5-12,23-24,31-32H,13-14,30H2,1-4H3,(H2,29,35)(H,33,36)(H,34,37)/t23-,24-/m1/s1 D0O1LU DRUGINKE RVAXPKJGCHKWJV-DNQXCXABSA-N D0O1LU DRUGSMIL CC1=C(C2=CC=CC=C2N1)CC(C(=O)N)NC(=O)C(CC3=C(NC4=CC=CC=C43)C)NC(=O)C(C)(C)N D0O1LU HIGHSTAT Phase 1 D0O3OI DRUG__ID D0O3OI D0O3OI DRUGCOMP Anvyl pharmaceuticals D0O3OI DRUGINCH 1S/C19H15Cl2N3O2/c1-12-10-18(26-24-12)17(11-22-15-6-2-13(20)3-7-15)19(25)23-16-8-4-14(21)5-9-16/h2-11,22H,1H3,(H,23,25)/b17-11- D0O3OI DRUGINKE VMAKIACTLSBBIY-BOPFTXTBSA-N D0O3OI DRUGSMIL CC1=NOC(=C1)C(=CNC2=CC=C(C=C2)Cl)C(=O)NC3=CC=C(C=C3)Cl D0O3OI HIGHSTAT Phase 1 D0O8UB DRUG__ID D0O8UB D0O8UB DRUGCOMP Roche D0O8UB DRUGINCH 1S/C18H14F3N5O2/c1-17(18(20,21)9-28-16(23)26-17)12-6-11(3-4-13(12)19)25-15(27)14-5-2-10(7-22)8-24-14/h2-6,8H,9H2,1H3,(H2,23,26)(H,25,27)/t17-/m1/s1 D0O8UB DRUGINKE DVMUZHLUMHPCGZ-QGZVFWFLSA-N D0O8UB DRUGSMIL CC1(C(COC(=N1)N)(F)F)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F D0O8UB HIGHSTAT Phase 1 D0OS8C DRUG__ID D0OS8C D0OS8C DRUGCOMP NicOx SA D0OS8C DRUGINCH 1S/C29H34NO9/c1-27-11-9-20(31)13-19(27)7-8-21-22-10-12-29(35,28(22,2)14-23(32)25(21)27)24(33)16-38-26(34)18-5-3-17(4-6-18)15-39-30(36)37/h3-6,9,11,13,21-23,25,32,35H,7-8,10,12,14-16H2,1-2H3,(H,36,37)/q+1/t21-,22-,23-,25+,27-,28-,29-/m0/s1 D0OS8C DRUGINKE HSVTZTOFRYKVEA-KGWLDMEJSA-N D0OS8C DRUGSMIL CC12CC(C3C(C1CCC2(C(=O)COC(=O)C4=CC=C(C=C4)CO[N+](=O)O)O)CCC5=CC(=O)C=CC35C)O D0OS8C HIGHSTAT Phase 1 D0OW9L DRUG__ID D0OW9L D0OW9L DRUGCOMP Merck D0OW9L DRUGINCH 1S/C25H26F3N3O2/c1-16-29-22-7-3-6-21(25(26,27)28)23(22)24(32)31(16)18-8-10-19(11-9-18)33-20-12-14-30(15-13-20)17-4-2-5-17/h3,6-11,17,20H,2,4-5,12-15H2,1H3 D0OW9L DRUGINKE ZWUFGBNOUKQGBR-UHFFFAOYSA-N D0OW9L DRUGSMIL CC1=NC2=CC=CC(=C2C(=O)N1C3=CC=C(C=C3)OC4CCN(CC4)C5CCC5)C(F)(F)F D0OW9L HIGHSTAT Phase 1 D0P1JA DRUG__ID D0P1JA D0P1JA DRUGTYPE Small molecular drug D0P1JA DRUGINCH 1S/C17H9Cl2FN4O2/c18-13-5-11(24-17(26)23-15(25)8-22-24)6-14(19)16(13)12(7-21)9-1-3-10(20)4-2-9/h1-6,8,12H,(H,23,25,26) D0P1JA DRUGINKE XQKYUBTUOHHNDV-UHFFFAOYSA-N D0P1JA DRUGSMIL C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)F D0P1JA HIGHSTAT Phase 1 D0P2BD DRUG__ID D0P2BD D0P2BD DRUGTYPE Small molecular drug D0P2BD DRUGINCH 1S/C15H23N3O4/c1-21-9-3-6-17-14(19)12-5-8-16-13(11-12)15(20)18-7-4-10-22-2/h5,8,11H,3-4,6-7,9-10H2,1-2H3,(H,17,19)(H,18,20) D0P2BD DRUGINKE HLSXICGBWKECLM-UHFFFAOYSA-N D0P2BD DRUGSMIL COCCCNC(=O)C1=CC(=NC=C1)C(=O)NCCCOC D0P2BD HIGHSTAT Phase 1 D0P5AA DRUG__ID D0P5AA D0P5AA DRUGCOMP Kinex Pharmaceuticals D0P5AA DRUGINCH 1S/C33H38N4O6.ClH/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m1./s1 D0P5AA DRUGINKE GURKHSYORGJETM-MGDILKBHSA-N D0P5AA DRUGSMIL CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl D0P5AA HIGHSTAT Phase 1 D0P5CM DRUG__ID D0P5CM D0P5CM DRUGCOMP AstraZeneca plc D0P5CM DRUGINCH 1S/C23H21F3N4O4/c1-32-21-10-28-19(9-29-21)17-3-2-4-20-18(17)7-16(12-34-20)30-22(31)14-5-6-15(27-8-14)11-33-13-23(24,25)26/h2-6,8-10,16H,7,11-13H2,1H3,(H,30,31)/t16-/m0/s1 D0P5CM DRUGINKE LRHQXIQLHVPUNA-INIZCTEOSA-N D0P5CM DRUGSMIL COC1=NC=C(N=C1)C2=C3CC(COC3=CC=C2)NC(=O)C4=CN=C(C=C4)COCC(F)(F)F D0P5CM HIGHSTAT Phase 1 D0PB0D DRUG__ID D0PB0D D0PB0D DRUGCOMP Azevan Pharmaceuticals Inc D0PB0D DRUGINCH 1S/C43H48F3N5O5/c1-47(28-31-14-11-17-33(26-31)43(44,45)46)40(53)36(27-38(52)49-24-20-34(21-25-49)48-22-9-4-10-23-48)50-35(19-18-30-12-5-2-6-13-30)39(41(50)54)51-37(29-56-42(51)55)32-15-7-3-8-16-32/h2-3,5-8,11-19,26,34-37,39H,4,9-10,20-25,27-29H2,1H3/b19-18+/t35-,36-,37-,39+/m1/s1 D0PB0D DRUGINKE GOQPVIZMGXUXOL-GRLAPFOSSA-N D0PB0D DRUGSMIL CN(CC1=CC(=CC=C1)C(F)(F)F)C(=O)C(CC(=O)N2CCC(CC2)N3CCCCC3)N4C(C(C4=O)N5C(COC5=O)C6=CC=CC=C6)C=CC7=CC=CC=C7 D0PB0D HIGHSTAT Phase 1 D0PH9I DRUG__ID D0PH9I D0PH9I DRUGCOMP AstraZeneca Wilmington, DE D0PH9I DRUGINCH 1S/C25H33N7O3/c1-18-24(33)29(2)14-15-30(18)16-17-35-21-6-4-19(5-7-21)20-10-12-31(13-11-20)23-9-8-22-26-27-25(34-3)32(22)28-23/h4-9,18,20H,10-17H2,1-3H3/t18-/m1/s1 D0PH9I DRUGINKE RSMYFSPOTCDHHJ-GOSISDBHSA-N D0PH9I DRUGSMIL CC1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C D0PH9I HIGHSTAT Phase 1 D0PK3W DRUG__ID D0PK3W D0PK3W DRUGCOMP Wakamoto Pharmaceutical Co Ltd D0PK3W DRUGINCH 1S/C73H111N17O21/c1-38(2)17-14-20-43-32-56(94)80-53(37-92)69(106)88-59(61(98)62(77)99)71(108)87-52(36-91)63(100)79-35-57(95)89(7)54(30-41-18-10-9-11-19-41)70(107)86-49(29-39(3)4)66(103)81-46(23-15-27-74)64(101)82-47(25-26-58(96)97)65(102)85-51(33-55(76)93)68(105)84-50(31-42-34-78-45-22-13-12-21-44(42)45)67(104)83-48(24-16-28-75)72(109)90(8)60(40(5)6)73(110)111-43/h9-13,18-19,21-22,34,38-40,43,46-54,59-61,78,91-92,98H,14-17,20,23-33,35-37,74-75H2,1-8H3,(H2,76,93)(H2,77,99)(H,79,100)(H,80,94)(H,81,103)(H,82,101)(H,83,104)(H,84,105)(H,85,102)(H,86,107)(H,87,108)(H,88,106)(H,96,97)/t43-,46-,47+,48-,49+,50-,51-,52+,53+,54-,59-,60+,61-/m1/s1 D0PK3W DRUGINKE LEKBQPKGXGFBAN-MMXTXZKOSA-N D0PK3W DRUGSMIL CC(C)CCCC1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)O1)C(C)C)C)CCCN)CC2=CNC3=CC=CC=C32)CC(=O)N)CCC(=O)O)CCCN)CC(C)C)CC4=CC=CC=C4)C)CO)C(C(=O)N)O)CO D0PK3W HIGHSTAT Phase 1 D0PL7P DRUG__ID D0PL7P D0PL7P DRUGCOMP Cyclacel Pharmaceuticals Berkeley Heights, NJ D0PL7P DRUGINCH 1S/C21H31N7O/c1-7-17(15(6)29)25-21-26-19(18-20(27-21)28(11-24-18)12(2)3)23-10-16-9-22-14(5)8-13(16)4/h8-9,11-12,15,17,29H,7,10H2,1-6H3,(H2,23,25,26,27)/t15-,17+/m1/s1 D0PL7P DRUGINKE DLPIYBKBHMZCJI-WBVHZDCISA-N D0PL7P DRUGSMIL CCC(C(C)O)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CN=C(C=C3C)C D0PL7P HIGHSTAT Phase 1 D0PQ8T DRUG__ID D0PQ8T D0PQ8T DRUGTYPE Small molecular drug D0PQ8T DRUGINCH 1S/C23H29Cl2N3O2/c1-27(2)11-3-13-30-20-7-4-17(5-8-20)15-28-12-10-19(16-28)26-23(29)18-6-9-21(24)22(25)14-18/h4-9,14,19H,3,10-13,15-16H2,1-2H3,(H,26,29)/t19-/m0/s1 D0PQ8T DRUGINKE AMSSIFVGNFEEFU-IBGZPJMESA-N D0PQ8T DRUGSMIL CN(C)CCCOC1=CC=C(C=C1)CN2CCC(C2)NC(=O)C3=CC(=C(C=C3)Cl)Cl D0PQ8T HIGHSTAT Phase 1 D0PR6H DRUG__ID D0PR6H D0PR6H DRUGTYPE Small molecular drug D0PR6H DRUGINCH 1S/C8H6Cl5NO2/c1-15-5-3(9)6(8(11,12)13)14-7(16-2)4(5)10/h1-2H3 D0PR6H DRUGINKE DZVPGIORVGSQMC-UHFFFAOYSA-N D0PR6H DRUGSMIL COC1=C(C(=NC(=C1Cl)OC)C(Cl)(Cl)Cl)Cl D0PR6H HIGHSTAT Phase 1 D0Q0JI DRUG__ID D0Q0JI D0Q0JI DRUGCOMP Astellas Pharma Inc D0Q0JI DRUGINCH 1S/C19H12F6N4O2/c1-9(18(20,21)22)30-15-5-3-11(6-12(15)19(23,24)25)17-28-16(29-31-17)10-2-4-13-14(7-10)27-8-26-13/h2-9H,1H3,(H,26,27)/t9-/m0/s1 D0Q0JI DRUGINKE NJNXCJPSMWKXHO-VIFPVBQESA-N D0Q0JI DRUGSMIL CC(C(F)(F)F)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=CC4=C(C=C3)N=CN4)C(F)(F)F D0Q0JI HIGHSTAT Phase 1 D0Q0KX DRUG__ID D0Q0KX D0Q0KX DRUGCOMP ACEA Biosciences D0Q0KX DRUGINCH 1S/C14H12F2S3/c15-13-5-1-11(2-6-13)9-17-19-18-10-12-3-7-14(16)8-4-12/h1-8H,9-10H2 D0Q0KX DRUGINKE XCOWUOOCXCXCNS-UHFFFAOYSA-N D0Q0KX DRUGSMIL C1=CC(=CC=C1CSSSCC2=CC=C(C=C2)F)F D0Q0KX HIGHSTAT Phase 1 D0Q4IX DRUG__ID D0Q4IX D0Q4IX DRUGCOMP Genentech D0Q4IX DRUGINCH 1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1 D0Q4IX DRUGINKE RZUOCXOYPYGSKL-GOSISDBHSA-N D0Q4IX DRUGSMIL CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)C(CO)C4=CC(=C(C=C4)Cl)F D0Q4IX HIGHSTAT Phase 1 D0Q5QC DRUG__ID D0Q5QC D0Q5QC DRUGTYPE Small molecular drug D0Q5QC DRUGINCH 1S/C25H31F3N4O2/c1-32(2)13-12-29-24(33)30-15-18-9-10-19-22(16-6-4-3-5-7-16)31-21-11-8-17(25(26,27)28)14-20(21)23(19)34-18/h3-8,11,14,18-19,22-23,31H,9-10,12-13,15H2,1-2H3,(H2,29,30,33)/t18-,19+,22+,23+/m1/s1 D0Q5QC DRUGINKE MARIUIDCPUZLKZ-FUKQBSRTSA-N D0Q5QC DRUGSMIL CN(C)CCNC(=O)NCC1CCC2C(NC3=C(C2O1)C=C(C=C3)C(F)(F)F)C4=CC=CC=C4 D0Q5QC HIGHSTAT Phase 1 D0Q5VW DRUG__ID D0Q5VW D0Q5VW DRUGTYPE Small molecular drug D0Q5VW DRUGINCH 1S/C22H20ClN5O/c23-19-2-1-3-20(10-19)28-9-8-26(15-22(28)29)14-21-12-25-16-27(21)13-18-6-4-17(11-24)5-7-18/h1-7,10,12,16H,8-9,13-15H2 D0Q5VW DRUGINKE JNUGFGAVPBYSHF-UHFFFAOYSA-N D0Q5VW DRUGSMIL C1CN(C(=O)CN1CC2=CN=CN2CC3=CC=C(C=C3)C#N)C4=CC(=CC=C4)Cl D0Q5VW HIGHSTAT Phase 1 D0Q6GD DRUG__ID D0Q6GD D0Q6GD DRUGCOMP Wockhardt Ltd D0Q6GD DRUGINCH 1S/C21H26FN3O4/c1-21(2)10-24(7-6-15(21)23)17-14(22)8-12-16(19(17)29-3)25(11-4-5-11)9-13(18(12)26)20(27)28/h8-9,11,15H,4-7,10,23H2,1-3H3,(H,27,28)/t15-/m0/s1 D0Q6GD DRUGINKE PMBHAWNZPPNADR-HNNXBMFYSA-N D0Q6GD DRUGSMIL CC1(CN(CCC1N)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F)C D0Q6GD HIGHSTAT Phase 1 D0Q7AG DRUG__ID D0Q7AG D0Q7AG DRUGCOMP Novartis pharmaceuticals D0Q7AG DRUGINCH 1S/C38H47ClN4O4/c1-25(2)47-35-22-33-28(20-34(35)46-5)21-36(44)43(38(33)27-8-10-29(39)11-9-27)32-16-14-30(15-17-32)41(4)23-26-6-12-31(13-7-26)42-19-18-40(3)37(45)24-42/h8-11,14-17,20,22,25-26,31,38H,6-7,12-13,18-19,21,23-24H2,1-5H3/t26?,31?,38-/m0/s1 D0Q7AG DRUGINKE CLRSLRWKONPSRQ-CPOWQTMSSA-N D0Q7AG DRUGSMIL CC(C)OC1=C(C=C2CC(=O)N(C(C2=C1)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)N(C)CC5CCC(CC5)N6CCN(C(=O)C6)C)OC D0Q7AG HIGHSTAT Phase 1 D0Q7RE DRUG__ID D0Q7RE D0Q7RE DRUGTYPE Small molecular drug D0Q7RE DRUGINCH 1S/C26H30FN7O3/c1-2-34(10-11-35)9-4-12-37-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(36)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17,35H,2,4,9-12,15H2,1H3,(H,30,36)(H2,28,29,31,32,33) D0Q7RE DRUGINKE QYZOGCMHVIGURT-UHFFFAOYSA-N D0Q7RE DRUGSMIL CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO D0Q7RE HIGHSTAT Phase 1 D0QX9K DRUG__ID D0QX9K D0QX9K DRUGCOMP Amgen Thousand Oaks, CA D0QX9K DRUGINCH 1S/C25H29N7O4S/c1-15-10-19(14-26-11-15)24-29-30-25(32(24)22-20(35-5)8-7-9-21(22)36-6)31-37(33,34)18(4)17(3)23-27-12-16(2)13-28-23/h7-14,17-18H,1-6H3,(H,30,31)/t17-,18-/m0/s1 D0QX9K DRUGINKE DOMQFIFVDIAOOT-ROUUACIJSA-N D0QX9K DRUGSMIL CC1=CC(=CN=C1)C2=NN=C(N2C3=C(C=CC=C3OC)OC)NS(=O)(=O)C(C)C(C)C4=NC=C(C=N4)C D0QX9K HIGHSTAT Phase 1 D0R0LB DRUG__ID D0R0LB D0R0LB DRUGCOMP Pfizer New York, NY D0R0LB DRUGINCH 1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1 D0R0LB DRUGINKE JYIUNVOCEFIUIU-GHMZBOCLSA-N D0R0LB DRUGSMIL CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4CC(C(C4)F)NC(=O)C=C)N(C=N3)C D0R0LB HIGHSTAT Phase 1 D0R3XI DRUG__ID D0R3XI D0R3XI DRUGCOMP Central Drug Research Institute D0R3XI DRUGINCH 1S/C28H36O8/c1-17(24-15-33-28(36-35-24)21-11-18-10-19(13-21)14-22(28)12-18)20-4-6-23(7-5-20)34-27(2,3)16-32-26(31)9-8-25(29)30/h4-7,18-19,21-22,24H,1,8-16H2,2-3H3,(H,29,30) D0R3XI DRUGINKE LKAAAECAYCDCQW-UHFFFAOYSA-N D0R3XI DRUGSMIL CC(C)(COC(=O)CCC(=O)O)OC1=CC=C(C=C1)C(=C)C2COC3(C4CC5CC(C4)CC3C5)OO2 D0R3XI HIGHSTAT Phase 1 D0R4EN DRUG__ID D0R4EN D0R4EN DRUGTYPE Small molecular drug D0R4EN DRUGINCH 1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8-5-12)16-2-1-3-17(19(16)28-29)21(25,26)27/h1-10H,11H2 D0R4EN DRUGINKE KYWWJENKIMRJBI-UHFFFAOYSA-N D0R4EN DRUGSMIL C1=CC2=C(N(N=C2C(=C1)C(F)(F)F)CC3=C(C=C(C=C3)F)Cl)C4=CC=C(C=C4)F D0R4EN HIGHSTAT Phase 1 D0R9YR DRUG__ID D0R9YR D0R9YR DRUGTYPE Small molecular drug D0R9YR DRUGINCH 1S/C30H48O3/c1-18(2)19-10-15-30(25(32)33)17-16-28(6)20(24(19)30)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h19-24,31H,1,8-17H2,2-7H3,(H,32,33)/t19-,20+,21-,22+,23-,24+,27-,28+,29+,30-/m0/s1 D0R9YR DRUGINKE QGJZLNKBHJESQX-FZFNOLFKSA-N D0R9YR DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C(=O)O D0R9YR HIGHSTAT Phase 1 D0RE4L DRUG__ID D0RE4L D0RE4L DRUGCOMP Kinex pharmaceuticals D0RE4L DRUGINCH 1S/C24H24FN3O2/c25-21-3-1-2-18(14-21)16-27-24(29)15-22-7-4-20(17-26-22)19-5-8-23(9-6-19)28-10-12-30-13-11-28/h1-9,14,17H,10-13,15-16H2,(H,27,29) D0RE4L DRUGINKE CMKKPJNMYLOUCE-UHFFFAOYSA-N D0RE4L DRUGSMIL C1COCCN1C2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC(=CC=C4)F D0RE4L HIGHSTAT Phase 1 D0RU7T DRUG__ID D0RU7T D0RU7T DRUGTYPE Small molecular drug D0RU7T DRUGINCH 1S/C15H15N3O3/c1-21-13-5-4-11(14(16)19)7-12(13)15(20)18-9-10-3-2-6-17-8-10/h2-8H,9H2,1H3,(H2,16,19)(H,18,20) D0RU7T DRUGINKE QWZWECXMQXZQOG-UHFFFAOYSA-N D0RU7T DRUGSMIL COC1=C(C=C(C=C1)C(=O)N)C(=O)NCC2=CN=CC=C2 D0RU7T HIGHSTAT Phase 1 D0RZ9V DRUG__ID D0RZ9V D0RZ9V DRUGCOMP Novartis Oncology East Hanover, NJ D0RZ9V DRUGINCH 1S/C23H22F4N6O2/c1-12-8-17(30-10-16(12)15-4-6-28-19(9-15)23(25,26)27)14(3)31-21-29-7-5-20(32-21)33-18(13(2)24)11-35-22(33)34/h4-10,13-14,18H,11H2,1-3H3,(H,29,31,32)/t13-,14-,18+/m0/s1 D0RZ9V DRUGINKE DCGDPJCUIKLTDU-SUNYJGFJSA-N D0RZ9V DRUGSMIL CC1=CC(=NC=C1C2=CC(=NC=C2)C(F)(F)F)C(C)NC3=NC=CC(=N3)N4C(COC4=O)C(C)F D0RZ9V HIGHSTAT Phase 1 D0S0OI DRUG__ID D0S0OI D0S0OI DRUGTYPE Small molecular drug D0S0OI DRUGINCH 1S/C21H25N5O2/c1-3-22-18-5-4-8-23-20(18)25-9-11-26(12-10-25)21(27)19-14-15-13-16(28-2)6-7-17(15)24-19/h4-8,13-14,22,24H,3,9-12H2,1-2H3 D0S0OI DRUGINKE UCPOMLWZWRTIAA-UHFFFAOYSA-N D0S0OI DRUGSMIL CCNC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)OC D0S0OI HIGHSTAT Phase 1 D0S1BN DRUG__ID D0S1BN D0S1BN DRUGTYPE Small molecular drug D0S1BN DRUGINCH 1S/C9H21N/c1-7(2)9(5,6)10-8(3)4/h7-8,10H,1-6H3 D0S1BN DRUGINKE RGWFHCMKBAMWDX-UHFFFAOYSA-N D0S1BN DRUGSMIL CC(C)C(C)(C)NC(C)C D0S1BN HIGHSTAT Phase 1 D0S3BF DRUG__ID D0S3BF D0S3BF DRUGCOMP 3SBio D0S3BF DRUGINCH 1S/C13H24N2O6/c1-20-8-9-21-12(17)6-5-11(16)15-7-3-2-4-10(14)13(18)19/h10H,2-9,14H2,1H3,(H,15,16)(H,18,19)/t10-/m0/s1 D0S3BF DRUGINKE PNFORBBPPMQASU-JTQLQIEISA-N D0S3BF DRUGSMIL COCCOC(=O)CCC(=O)NCCCCC(C(=O)O)N D0S3BF HIGHSTAT Phase 1 D0S7UQ DRUG__ID D0S7UQ D0S7UQ DRUGCOMP F Hoffmann-La Roche Ltd D0S7UQ DRUGINCH 1S/C161H260N46O46/c1-18-19-38-99(136(230)180-85(10)132(226)179-86(11)133(227)183-100(40-24-30-59-163)137(231)187-103-44-28-34-63-174-123(218)74-117(200-152(246)116(73-122(169)217)199-148(242)110(67-83(6)7)194-149(243)111(196-141(103)235)69-93-46-50-96(213)51-47-93)153(247)195-109(66-82(4)5)147(241)188-102(42-26-32-61-165)138(232)184-98(39-23-29-58-162)135(229)177-77-124(219)176-78-125(220)204-128(88(13)209)131(170)225)185-143(237)106(54-56-120(167)215)190-139(233)101(41-25-31-60-164)186-140(234)105(45-35-64-175-160(171)172)189-146(240)108(65-81(2)3)193-142(236)104(43-27-33-62-166)191-157(251)129(89(14)210)205-154(248)112(70-94-48-52-97(214)53-49-94)197-151(245)115(72-121(168)216)198-144(238)107(55-57-126(221)222)192-158(252)130(90(15)211)206-155(249)113(68-92-36-21-20-22-37-92)203-159(253)161(17,84(8)9)207-134(228)87(12)181-145(239)118(75-127(223)224)201-156(250)119(79-208)202-150(244)114(182-91(16)212)71-95-76-173-80-178-95/h20-22,36-37,46-53,76,80-90,98-119,128-130,208-211,213-214H,18-19,23-35,38-45,54-75,77-79,162-166H2,1-17H3,(H2,167,215)(H2,168,216)(H2,169,217)(H2,170,225)(H,173,178)(H,174,218)(H,176,219)(H,177,229)(H,179,226)(H,180,230)(H,181,239)(H,182,212)(H,183,227)(H,184,232)(H,185,237)(H,186,234)(H,187,231)(H,188,241)(H,189,240)(H,190,233)(H,191,251)(H,192,252)(H,193,236)(H,194,243)(H,195,247)(H,196,235)(H,197,245)(H,198,238)(H,199,242)(H,200,246)(H,201,250)(H,202,244)(H,203,253)(H,204,220)(H,205,248)(H,206,249)(H,207,228)(H,221,222)(H,223,224)(H4,171,172,175)/t85-,86-,87-,88?,89?,90?,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,128-,129-,130-,161-/m0/s1 D0S7UQ DRUGINKE AXQOGBKHHSARHC-CEPMLMOKSA-N D0S7UQ DRUGSMIL CCCCC(C(=O)NC(C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC1CCCCNC(=O)CC(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CC=C(C=C2)O)CC(C)C)CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NCC(=O)NCC(=O)NC(C(C)O)C(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C)(C(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC5=CN=CN5)NC(=O)C D0S7UQ HIGHSTAT Phase 1 D0S9IE DRUG__ID D0S9IE D0S9IE DRUGCOMP Bayer healthcare pharmaceuticals D0S9IE DRUGINCH 1S/C23H21N5O/c24-22(29)18-11-12-19-26-20(21(28(19)27-18)16-5-2-1-3-6-16)15-7-9-17(10-8-15)23(25)13-4-14-23/h1-3,5-12H,4,13-14,25H2,(H2,24,29) D0S9IE DRUGINKE JBGYKRAZYDNCNV-UHFFFAOYSA-N D0S9IE DRUGSMIL C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N D0S9IE HIGHSTAT Phase 1 D0S9MD DRUG__ID D0S9MD D0S9MD DRUGCOMP Delta-fly pharma D0S9MD DRUGINCH 1S/C32H26ClFN4O12/c1-4-26(39)48-24-11-19(12-25(36-24)49-27(40)5-2)31(44)47-22-13-23(35-14-20(22)33)50-30(43)18-9-7-8-17(10-18)28(41)38-29(42)21(34)15-37(32(38)45)16-46-6-3/h7-15H,4-6,16H2,1-3H3 D0S9MD DRUGINKE WUQYJRNEHOAADL-UHFFFAOYSA-N D0S9MD DRUGSMIL CCC(=O)OC1=CC(=CC(=N1)OC(=O)CC)C(=O)OC2=CC(=NC=C2Cl)OC(=O)C3=CC=CC(=C3)C(=O)N4C(=O)C(=CN(C4=O)COCC)F D0S9MD HIGHSTAT Phase 1 D0SI9L DRUG__ID D0SI9L D0SI9L DRUGCOMP ChromaDex Irvine, CA D0SI9L DRUGINCH 1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1 D0SI9L DRUGINKE JLEBZPBDRKPWTD-TURQNECASA-O D0SI9L DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)CO)O)O)C(=O)N D0SI9L HIGHSTAT Phase 1 D0SP6A DRUG__ID D0SP6A D0SP6A DRUGCOMP Stemline Therapeutics New York, NY D0SP6A DRUGINCH 1S/C18H21ClF3N3O3/c1-10-11(9-28-8-7-17(2,3)4)16(27)25(15(10)26)24-13-6-5-12(14(19)23-13)18(20,21)22/h5-6H,7-9H2,1-4H3,(H,23,24) D0SP6A DRUGINKE CMASLSTVVOYJQY-UHFFFAOYSA-N D0SP6A DRUGSMIL CC1=C(C(=O)N(C1=O)NC2=NC(=C(C=C2)C(F)(F)F)Cl)COCCC(C)(C)C D0SP6A HIGHSTAT Phase 1 D0SZ1G DRUG__ID D0SZ1G D0SZ1G DRUGCOMP AstraZeneca Wilmington, DE D0SZ1G DRUGINCH 1S/C27H28F2N4O3/c1-17(2)24(31-26(35)27(3,28)29)25(18-8-6-5-7-9-18)36-21-11-12-22-19(14-21)15-30-33(22)20-10-13-23(34)32(4)16-20/h5-17,24-25H,1-4H3,(H,31,35)/t24-,25+/m0/s1 D0SZ1G DRUGINKE ZQFNDBISEYQVRR-LOSJGSFVSA-N D0SZ1G DRUGSMIL CC(C)C(C(C1=CC=CC=C1)OC2=CC3=C(C=C2)N(N=C3)C4=CN(C(=O)C=C4)C)NC(=O)C(C)(F)F D0SZ1G HIGHSTAT Phase 1 D0T2ER DRUG__ID D0T2ER D0T2ER DRUGTYPE Small molecular drug D0T2ER DRUGINCH 1S/C23H23N7O3/c1-13-4-7-16(11-17(13)24-23(32)18-10-14(2)27-29(18)3)33-21-9-8-20-25-19(12-30(20)28-21)26-22(31)15-5-6-15/h4,7-12,15H,5-6H2,1-3H3,(H,24,32)(H,26,31) D0T2ER DRUGINKE DZFZXPPHBWCXPQ-UHFFFAOYSA-N D0T2ER DRUGSMIL CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C D0T2ER HIGHSTAT Phase 1 D0T3DO DRUG__ID D0T3DO D0T3DO DRUGCOMP Vitae Pharmaceuticals D0T3DO DRUGINCH 1S/C22H22ClF2NO4/c1-21(2)5-6-22(3,4)16-12(21)9-11(18(27)17(16)23)19(28)26-10-7-13(24)15(20(29)30)14(25)8-10/h7-9,27H,5-6H2,1-4H3,(H,26,28)(H,29,30) D0T3DO DRUGINKE PNAWUIKCVQSLFG-UHFFFAOYSA-N D0T3DO DRUGSMIL CC1(CCC(C2=C1C=C(C(=C2Cl)O)C(=O)NC3=CC(=C(C(=C3)F)C(=O)O)F)(C)C)C D0T3DO HIGHSTAT Phase 1 D0T4PA DRUG__ID D0T4PA D0T4PA DRUGCOMP Takeda Oncology Deerfield, IL D0T4PA DRUGINCH 1S/C19H20F3N5O5S2/c20-19(21,22)33-12-3-1-2-10(6-12)13-8-16-24-5-4-15(27(16)26-13)25-14-7-11(17(28)18(14)29)9-32-34(23,30)31/h1-6,8,11,14,17-18,25,28-29H,7,9H2,(H2,23,30,31)/t11-,14-,17-,18+/m1/s1 D0T4PA DRUGINKE KJDAGXLMHXUAGV-DGWLBADLSA-N D0T4PA DRUGSMIL C1C(C(C(C1NC2=CC=NC3=CC(=NN23)C4=CC(=CC=C4)SC(F)(F)F)O)O)COS(=O)(=O)N D0T4PA HIGHSTAT Phase 1 D0T4QA DRUG__ID D0T4QA D0T4QA DRUGCOMP Novartis Oncology East Hanover, NJ D0T4QA DRUGINCH 1S/C25H25F3N4O4/c1-16-2-3-19(30-24(34)17-4-5-29-21(12-17)25(26,27)28)15-20(16)18-13-22(32-6-9-35-10-7-32)31-23(14-18)36-11-8-33/h2-5,12-15,33H,6-11H2,1H3,(H,30,34) D0T4QA DRUGINKE UEPXBTCUIIGYCY-UHFFFAOYSA-N D0T4QA DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=NC=C2)C(F)(F)F)C3=CC(=NC(=C3)OCCO)N4CCOCC4 D0T4QA HIGHSTAT Phase 1 D0TJ9S DRUG__ID D0TJ9S D0TJ9S DRUGCOMP N & N Scientific Inc D0TJ9S DRUGINCH 1S/C12H16N2O4/c1-6-4-14(11(18)13-10(6)17)8-2-9(16)12(5-15)3-7(8)12/h4,7-9,15-16H,2-3,5H2,1H3,(H,13,17,18)/t7-,8+,9+,12+/m1/s1 D0TJ9S DRUGINKE NOWRLNPOENZFHP-ARHDFHRDSA-N D0TJ9S DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C3(C2C3)CO)O D0TJ9S HIGHSTAT Phase 1 D0TN3Q DRUG__ID D0TN3Q D0TN3Q DRUGCOMP Eli Lilly Indianapolis, IN D0TN3Q DRUGINCH 1S/C22H27N7O2S/c1-22(2)19-15(20(30)29(22)9-8-28-10-12-31-13-11-28)14-17(32-19)16-4-6-23-21(25-16)26-18-5-7-24-27(18)3/h4-7,14H,8-13H2,1-3H3,(H,23,25,26) D0TN3Q DRUGINKE JNPRPMBJODOFEC-UHFFFAOYSA-N D0TN3Q DRUGSMIL CC1(C2=C(C=C(S2)C3=NC(=NC=C3)NC4=CC=NN4C)C(=O)N1CCN5CCOCC5)C D0TN3Q HIGHSTAT Phase 1 D0TN6K DRUG__ID D0TN6K D0TN6K DRUGCOMP Novartis Oncology East Hanover, NJ D0TN6K DRUGINCH 1S/C25H17F3O4S/c1-25(27,28)20-12-15(26)5-9-18(20)24-23(19-10-6-16(29)13-21(19)33-24)32-17-7-2-14(3-8-17)4-11-22(30)31/h2-13,29H,1H3,(H,30,31)/b11-4+ D0TN6K DRUGINKE SJXNPGGVGZXKKI-NYYWCZLTSA-N D0TN6K DRUGSMIL CC(C1=C(C=CC(=C1)F)C2=C(C3=C(S2)C=C(C=C3)O)OC4=CC=C(C=C4)C=CC(=O)O)(F)F D0TN6K HIGHSTAT Phase 1 D0TO2R DRUG__ID D0TO2R D0TO2R DRUGCOMP PNP Therapeutics Birmingham, LA D0TO2R DRUGINCH 1S/C10H13FN5O7P/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,14,15)(H2,19,20,21)/t3-,5-,6+,9-/m1/s1 D0TO2R DRUGINKE GIUYCYHIANZCFB-FJFJXFQQSA-N D0TO2R DRUGSMIL C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)COP(=O)(O)O)O)O)F)N D0TO2R HIGHSTAT Phase 1 D0TS8E DRUG__ID D0TS8E D0TS8E DRUGCOMP Addex Pharmaceuticals; Johnson & Johnson Pharmaceutical D0TS8E DRUGINCH 1S/C20H25ClN2O/c1-2-3-12-23-15-11-18(19(21)20(23)24)22-13-9-17(10-14-22)16-7-5-4-6-8-16/h4-8,11,15,17H,2-3,9-10,12-14H2,1H3 D0TS8E DRUGINKE HYOGJHCDLQSAHX-UHFFFAOYSA-N D0TS8E DRUGSMIL CCCCN1C=CC(=C(C1=O)Cl)N2CCC(CC2)C3=CC=CC=C3 D0TS8E HIGHSTAT Phase 1 D0TT5K DRUG__ID D0TT5K D0TT5K DRUGTYPE Small molecular drug D0TT5K DRUGINCH 1S/C10H11N3O2S/c1-13-9(8-6-4-3-5-7-8)11-12-10(13)16(2,14)15/h3-7H,1-2H3 D0TT5K DRUGINKE DPGDRICHXKQXEN-UHFFFAOYSA-N D0TT5K DRUGSMIL CN1C(=NN=C1S(=O)(=O)C)C2=CC=CC=C2 D0TT5K HIGHSTAT Phase 1 D0U0AU DRUG__ID D0U0AU D0U0AU DRUGCOMP AstraZeneca plc D0U0AU DRUGINCH 1S/C25H19F3N6O2/c1-3-30-23(35)22-24(36)33(19-6-4-5-17(13-19)25(26,27)28)15(2)21(32-22)20-11-12-31-34(20)18-9-7-16(14-29)8-10-18/h4-13H,3H2,1-2H3,(H,30,35) D0U0AU DRUGINKE ZRJDPTREGVHMGQ-UHFFFAOYSA-N D0U0AU DRUGSMIL CCNC(=O)C1=NC(=C(N(C1=O)C2=CC=CC(=C2)C(F)(F)F)C)C3=CC=NN3C4=CC=C(C=C4)C#N D0U0AU HIGHSTAT Phase 1 D0U1OO DRUG__ID D0U1OO D0U1OO DRUGCOMP ARMGO Pharma Tarrytown, NY D0U1OO DRUGINCH 1S/C18H19NO3S/c1-22-16-6-7-17-15(10-16)12-19(8-9-23-17)11-13-2-4-14(5-3-13)18(20)21/h2-7,10H,8-9,11-12H2,1H3,(H,20,21) D0U1OO DRUGINKE JIGDAUOKKYKRKO-UHFFFAOYSA-N D0U1OO DRUGSMIL COC1=CC2=C(C=C1)SCCN(C2)CC3=CC=C(C=C3)C(=O)O D0U1OO HIGHSTAT Phase 1 D0U5BF DRUG__ID D0U5BF D0U5BF DRUGTYPE Small molecular drug D0U5BF DRUGINCH 1S/C7H10FN3O2/c8-3-7(9,6(12)13)1-5-2-10-4-11-5/h2,4H,1,3,9H2,(H,10,11)(H,12,13) D0U5BF DRUGINKE AJFGLTPLWPTALJ-UHFFFAOYSA-N D0U5BF DRUGSMIL C1=C(NC=N1)CC(CF)(C(=O)O)N D0U5BF HIGHSTAT Phase 1 D0U7OS DRUG__ID D0U7OS D0U7OS DRUGCOMP Cardiavent Inc D0U7OS DRUGINCH 1S/C29H48O2/c1-7-22(19(2)3)11-10-20(4)26-14-15-27-23(9-8-16-29(26,27)6)12-13-24-17-25(30)18-28(31)21(24)5/h12-13,19-20,22,25-28,30-31H,5,7-11,14-18H2,1-4,6H3/b23-12+,24-13-/t20-,22-,25-,26-,27+,28+,29-/m1/s1 D0U7OS DRUGINKE NWFOBODUYTUMNC-VPSCEVSQSA-N D0U7OS DRUGSMIL CCC(CCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)C(C)C D0U7OS HIGHSTAT Phase 1 D0UN1S DRUG__ID D0UN1S D0UN1S DRUGCOMP Kotinos Pharmaceuticals D0UN1S DRUGINCH 1S/C82H119N21O34S3/c1-35(104)64(100-69(123)48(17-20-58(84)112)90-73(127)52(93-68(122)46(83)16-21-60(114)115)25-43-28-86-47-11-9-8-10-45(43)47)79(133)96-54(27-63(120)121)75(129)95-53(26-59(85)113)74(128)97-55(29-138-32-87-39(5)108)76(130)92-49(18-22-61(116)117)70(124)101-65(36(2)105)80(134)99-57(31-140-34-89-41(7)110)78(132)102-66(37(3)106)81(135)98-56(30-139-33-88-40(6)109)77(131)94-51(24-42-12-14-44(111)15-13-42)72(126)91-50(19-23-62(118)119)71(125)103-67(38(4)107)82(136)137/h8-15,28,35-38,46,48-57,64-67,86,104-107,111H,16-27,29-34,83H2,1-7H3,(H2,84,112)(H2,85,113)(H,87,108)(H,88,109)(H,89,110)(H,90,127)(H,91,126)(H,92,130)(H,93,122)(H,94,131)(H,95,129)(H,96,133)(H,97,128)(H,98,135)(H,99,134)(H,100,123)(H,101,124)(H,102,132)(H,103,125)(H,114,115)(H,116,117)(H,118,119)(H,120,121)(H,136,137)/t35-,36-,37-,38-,46+,48+,49+,50+,51+,52+,53+,54+,55+,56+,57+,64+,65+,66+,67+/m1/s1 D0UN1S DRUGINKE ZRXXHPDJLAQCPC-SFJRRRFZSA-N D0UN1S DRUGSMIL CC(C(C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CSCNC(=O)C)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CSCNC(=O)C)C(=O)NC(C(C)O)C(=O)NC(CSCNC(=O)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)O)N)O D0UN1S HIGHSTAT Phase 1 D0V0NL DRUG__ID D0V0NL D0V0NL DRUGTYPE Small molecular drug D0V0NL DRUGINCH 1S/CH6N4/c2-1(3)5-4/h4H2,(H4,2,3,5) D0V0NL DRUGINKE HAMNKKUPIHEESI-UHFFFAOYSA-N D0V0NL DRUGSMIL C(=NN)(N)N D0V0NL HIGHSTAT Phase 1 D0V0UK DRUG__ID D0V0UK D0V0UK DRUGTYPE Small molecular drug D0V0UK DRUGINCH 1S/H4N2O2S/c1-5(2,3)4/h(H4,1,2,3,4) D0V0UK DRUGINKE NVBFHJWHLNUMCV-UHFFFAOYSA-N D0V0UK DRUGSMIL NS(=O)(=O)N D0V0UK HIGHSTAT Phase 1 D0V2LL DRUG__ID D0V2LL D0V2LL DRUGCOMP Pfizer New York, NY D0V2LL DRUGINCH 1S/C20H27F2N5O4S/c1-20(29)7-3-4-15(20)27-17-12(10-14(16(21)22)18(27)28)11-23-19(25-17)24-13-5-8-26(9-6-13)32(2,30)31/h10-11,13,15-16,29H,3-9H2,1-2H3,(H,23,24,25)/t15-,20-/m1/s1 D0V2LL DRUGINKE QIEKHLDZKRQLLN-FOIQADDNSA-N D0V2LL DRUGSMIL CC1(CCCC1N2C3=NC(=NC=C3C=C(C2=O)C(F)F)NC4CCN(CC4)S(=O)(=O)C)O D0V2LL HIGHSTAT Phase 1 D0V3BZ DRUG__ID D0V3BZ D0V3BZ DRUGCOMP Meiji Seika Kaisha Ltd D0V3BZ DRUGINCH 1S/C8H12O4.2Na/c1-3-5(7(9)10)6(4-2)8(11)12;;/h3-4H2,1-2H3,(H,9,10)(H,11,12);;/q;2*+1/p-2/b6-5-;; D0V3BZ DRUGINKE GLJFFZOATODZQQ-XNOMRPDFSA-L D0V3BZ DRUGSMIL CCC(=C(CC)C(=O)[O-])C(=O)[O-].[Na+].[Na+] D0V3BZ HIGHSTAT Phase 1 D0V3HP DRUG__ID D0V3HP D0V3HP DRUGCOMP Molecular Partners AG D0V3HP DRUGINCH 1S/C7H8N2O3/c1-12-6-4-2-3-5(8)7(6)9(10)11/h2-4H,8H2,1H3 D0V3HP DRUGINKE RITQAMSEQYWFML-UHFFFAOYSA-N D0V3HP DRUGSMIL COC1=CC=CC(=C1[N+](=O)[O-])N D0V3HP HIGHSTAT Phase 1 D0V4YO DRUG__ID D0V4YO D0V4YO DRUGTYPE Small molecular drug D0V4YO DRUGINCH 1S/C15H25N5O3/c1-10(2)21-6-12(7-22-11(3)4)23-9-20-8-18-13-5-17-15(16)19-14(13)20/h5,8,10-12H,6-7,9H2,1-4H3,(H2,16,17,19) D0V4YO DRUGINKE FBHWXSOQXQBXER-UHFFFAOYSA-N D0V4YO DRUGSMIL CC(C)OCC(COC(C)C)OCN1C=NC2=CN=C(N=C21)N D0V4YO HIGHSTAT Phase 1 D0V5JO DRUG__ID D0V5JO D0V5JO DRUGTYPE Small molecular drug D0V5JO DRUGINCH 1S/C20H36O16.C11H11N.C7H15NO2.C7H12O3.C6H6O.C5H13N.C4H8N2O2.6C4H10.C3H7NO.H2O/c1-3-6-9(21)12(24)15(27)18(33-6)31-4-7-10(22)13(25)16(28)19(34-7)32-5-8-11(23)14(26)17(30-2)20(35-8)36-29;1-2-9-7-8-12-11-6-4-3-5-10(9)11;1-3-7(9)8-5-4-6-10-2;1-2-7(9)4-3-5-10-6(7)8;7-6-4-2-1-3-5-6;1-3-4-5-6-2;1-3(7)6-2-4(5)8;6*1-3-4-2;1-3(5)4-2;/h6-29H,3-5H2,1-2H3;3-8H,2H2,1H3;3-6H2,1-2H3,(H,8,9);9H,2-5H2,1H3;1-4H,5H2;6H,3-5H2,1-2H3;2H2,1H3,(H2,5,8)(H,6,7);6*3-4H2,1-2H3;1-2H3,(H,4,5);1H2/t6-,7?,8-,9-,10-,11-,12+,13+,14+,15-,16-,17-,18+,19+,20-;;;7-;;;;;;;;;;;/m1..0.........../s1 D0V5JO DRUGINKE HYSLQFLGTWXGPE-JCQKILSGSA-N D0V5JO DRUGSMIL CCCC.CCCC.CCCC.CCCC.CCCC.CCCC.CCCCNC.CCC1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC3C(C(C(C(O3)OO)OC)O)O)O)O)O)O)O)O.CCC1=CC=NC2=CC=CC=C12.CCC(=O)NCCCOC.CCC1(CCCOC1=O)O.CC(=O)NC.CC(=O)NCC(=O)N.C1C=CC=CC1=O.O D0V5JO HIGHSTAT Phase 1 D0V9LJ DRUG__ID D0V9LJ D0V9LJ DRUGCOMP Autoimmune technologies D0V9LJ DRUGINCH 1S/C87H133N19O29/c1-13-44(10)70(105-75(122)52(20-16-17-29-88)95-86(133)71(46(12)108)106-82(129)61(37-68(117)118)101-74(121)54(26-28-66(113)114)94-84(131)69(90)43(8)9)85(132)102-60(36-67(115)116)81(128)97-55(30-40(2)3)77(124)99-58(34-48-38-91-51-19-15-14-18-50(48)51)80(127)104-63(39-107)83(130)98-57(33-47-21-23-49(109)24-22-47)79(126)100-59(35-64(89)110)76(123)92-45(11)72(119)93-53(25-27-65(111)112)73(120)96-56(31-41(4)5)78(125)103-62(87(134)135)32-42(6)7/h14-15,18-19,21-24,38,40-46,52-63,69-71,91,107-109H,13,16-17,20,25-37,39,88,90H2,1-12H3,(H2,89,110)(H,92,123)(H,93,119)(H,94,131)(H,95,133)(H,96,120)(H,97,128)(H,98,130)(H,99,124)(H,100,126)(H,101,121)(H,102,132)(H,103,125)(H,104,127)(H,105,122)(H,106,129)(H,111,112)(H,113,114)(H,115,116)(H,117,118)(H,134,135)/t44-,45-,46+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,69-,70-,71-/m0/s1 D0V9LJ DRUGINKE GIKLOXPFVONKJH-PJLATTGVSA-N D0V9LJ DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(=O)N)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)N D0V9LJ HIGHSTAT Phase 1 D0V9MR DRUG__ID D0V9MR D0V9MR DRUGTYPE Small molecular drug D0V9MR DRUGINCH 1S/C29H37N5O3/c1-4-17(3)32-25-14-23(16(2)11-24(25)28(30)36)29(37)33-20-12-21-8-9-22(13-20)34(21)26-10-7-19(15-31-26)27(35)18-5-6-18/h7,10-11,14-15,17-18,20-22,32H,4-6,8-9,12-13H2,1-3H3,(H2,30,36)(H,33,37)/t17-,20?,21?,22?/m1/s1 D0V9MR DRUGINKE LHGWWAFKVCIILM-LAQKFSSHSA-N D0V9MR DRUGSMIL CCC(C)NC1=C(C=C(C(=C1)C(=O)NC2CC3CCC(C2)N3C4=NC=C(C=C4)C(=O)C5CC5)C)C(=O)N D0V9MR HIGHSTAT Phase 1 D0VE7B DRUG__ID D0VE7B D0VE7B DRUGCOMP Sumitomo Dainippon Pharma D0VE7B DRUGINCH 1S/C20H20F3N5O2/c1-10(19(24)29)25-9-16-26-15-5-6-17(27-20(15)28(16)11-3-2-4-11)30-12-7-13(21)18(23)14(22)8-12/h5-8,10-11,25H,2-4,9H2,1H3,(H2,24,29)/t10-/m0/s1 D0VE7B DRUGINKE HHXCJIMPEJSJTG-JTQLQIEISA-N D0VE7B DRUGSMIL CC(C(=O)N)NCC1=NC2=C(N1C3CCC3)N=C(C=C2)OC4=CC(=C(C(=C4)F)F)F D0VE7B HIGHSTAT Phase 1 D0VI4N DRUG__ID D0VI4N D0VI4N DRUGCOMP Janssen Research & Development Raritan, NJ D0VI4N DRUGINCH 1S/C18H13ClF4N6O/c1-9-15-13(29(27-26-15)17-24-7-10(20)8-25-17)5-6-28(9)16(30)11-3-2-4-12(14(11)19)18(21,22)23/h2-4,7-9H,5-6H2,1H3/t9-/m1/s1 D0VI4N DRUGINKE CWFVVQFVGMFTBD-SECBINFHSA-N D0VI4N DRUGSMIL CC1C2=C(CCN1C(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl)N(N=N2)C4=NC=C(C=N4)F D0VI4N HIGHSTAT Phase 1 D0VS3W DRUG__ID D0VS3W D0VS3W DRUGCOMP Karos Pharmaceuticals New Haven, CT D0VS3W DRUGINCH 1S/C29H31ClF3N5O3/c1-2-40-26(39)22-16-28(17-35-22)10-12-38(13-11-28)23-15-24(37-27(34)36-23)41-25(29(31,32)33)20-9-8-19(30)14-21(20)18-6-4-3-5-7-18/h3-9,14-15,22,25,35H,2,10-13,16-17H2,1H3,(H2,34,36,37)/t22-,25+/m0/s1 D0VS3W DRUGINKE TZSZZENYCISATO-WIOPSUGQSA-N D0VS3W DRUGSMIL CCOC(=O)C1CC2(CCN(CC2)C3=CC(=NC(=N3)N)OC(C4=C(C=C(C=C4)Cl)C5=CC=CC=C5)C(F)(F)F)CN1 D0VS3W HIGHSTAT Phase 1 D0VW0I DRUG__ID D0VW0I D0VW0I DRUGTYPE Small molecular drug D0VW0I DRUGINCH 1S/C10H13N3O4/c11-7-1-2-13(10(17)12-7)6-3-5(4-14)8(15)9(6)16/h1-3,6,8-9,14-16H,4H2,(H2,11,12,17)/t6-,8-,9+/m1/s1 D0VW0I DRUGINKE DUJGMZAICVPCBJ-VDAHYXPESA-N D0VW0I DRUGSMIL C1=CN(C(=O)N=C1N)C2C=C(C(C2O)O)CO D0VW0I HIGHSTAT Phase 1 D0W0VR DRUG__ID D0W0VR D0W0VR DRUGCOMP Advanced cancer therapeutics D0W0VR DRUGINCH 1S/C18H11F3N2O/c19-18(20,21)14-3-1-12-2-4-15(23-16(12)11-14)5-6-17(24)13-7-9-22-10-8-13/h1-11H/b6-5+ D0W0VR DRUGINKE IAJOMYABKVAZCN-AATRIKPKSA-N D0W0VR DRUGSMIL C1=CC(=CC2=C1C=CC(=N2)C=CC(=O)C3=CC=NC=C3)C(F)(F)F D0W0VR HIGHSTAT Phase 1 D0W1SL DRUG__ID D0W1SL D0W1SL DRUGTYPE Small molecular drug D0W1SL DRUGINCH 1S/C15H24O/c1-10-8-11(14(2,3)4)13(16)12(9-10)15(5,6)7/h8-9,16H,1-7H3 D0W1SL DRUGINKE NLZUEZXRPGMBCV-UHFFFAOYSA-N D0W1SL DRUGSMIL CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C D0W1SL HIGHSTAT Phase 1 D0W5YY DRUG__ID D0W5YY D0W5YY DRUGCOMP PharmaMar D0W5YY DRUGINCH 1S/C31H45N3O7/c1-8-9-14-23(40-30(32)38)15-12-19-33-28(36)27(31(4,5)6)34-26(35)16-11-10-13-21(2)20-22(3)24-17-18-25(39-7)29(37)41-24/h8-13,16,18-20,22-24,27H,14-15,17H2,1-7H3,(H2,32,38)(H,33,36)(H,34,35)/b9-8-,13-10-,16-11-,19-12-,21-20+/t22-,23-,24-,27+/m0/s1 D0W5YY DRUGINKE IEKGSKLKBICCHQ-BDOJOPHNSA-N D0W5YY DRUGSMIL CC=CCC(CC=CNC(=O)C(C(C)(C)C)NC(=O)C=CC=CC(=CC(C)C1CC=C(C(=O)O1)OC)C)OC(=O)N D0W5YY HIGHSTAT Phase 1 D0W8OJ DRUG__ID D0W8OJ D0W8OJ DRUGTYPE Small molecular drug D0W8OJ DRUGINCH 1S/C54H75NO7/c1-7-22-54(61)24-21-43-40-15-11-34-27-37(56)14-16-39(34)49(40)41(31-52(43,54)4)33-9-12-36(13-10-33)55(6)25-26-62-38-20-23-51(3)35(28-38)29-46(57)50-44-18-17-42(32(2)8-19-48(59)60)53(44,5)47(58)30-45(50)51/h9-10,12-13,27,32,35,38,40-47,50,57-58,61H,8,11,14-21,23-26,28-31H2,1-6H3,(H,59,60)/t32-,35+,38+,40+,41-,42-,43+,44+,45+,46-,47+,50+,51+,52+,53-,54+/m1/s1 D0W8OJ DRUGINKE LEUWECPXLBIBOF-NZWIZOFBSA-N D0W8OJ DRUGSMIL CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)CCOC6CCC7(C(C6)CC(C8C7CC(C9(C8CCC9C(C)CCC(=O)O)C)O)O)C)C)O D0W8OJ HIGHSTAT Phase 1 D0X0BI DRUG__ID D0X0BI D0X0BI DRUGTYPE Small molecular drug D0X0BI DRUGINCH 1S/C50H73N15O11/c51-32(16-7-21-56-49(52)53)45(72)65-25-11-20-39(65)47(74)64-24-9-18-37(64)43(70)58-28-40(67)59-34(26-30-12-3-1-4-13-30)41(68)62-36(29-66)46(73)63-23-10-19-38(63)44(71)61-35(27-31-14-5-2-6-15-31)42(69)60-33(48(75)76)17-8-22-57-50(54)55/h1-6,12-15,32-39,66H,7-11,16-29,51H2,(H,58,70)(H,59,67)(H,60,69)(H,61,71)(H,62,68)(H,75,76)(H4,52,53,56)(H4,54,55,57)/t32-,33-,34-,35-,36-,37-,38-,39-/m0/s1 D0X0BI DRUGINKE QXZGBUJJYSLZLT-FDISYFBBSA-N D0X0BI DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O D0X0BI HIGHSTAT Phase 1 D0X0PP DRUG__ID D0X0PP D0X0PP DRUGCOMP Amgen D0X0PP DRUGINCH 1S/C25H23N5O3/c1-16(31)30-14-10-17(11-15-30)22-25(27-13-12-26-22)33-19-8-6-18(7-9-19)23(32)24-28-20-4-2-3-5-21(20)29-24/h2-9,12-13,17H,10-11,14-15H2,1H3,(H,28,29) D0X0PP DRUGINKE ZNPDAYJZIRPRFQ-UHFFFAOYSA-N D0X0PP DRUGSMIL CC(=O)N1CCC(CC1)C2=NC=CN=C2OC3=CC=C(C=C3)C(=O)C4=NC5=CC=CC=C5N4 D0X0PP HIGHSTAT Phase 1 D0X1OW DRUG__ID D0X1OW D0X1OW DRUGCOMP AstraZeneca Wilmington, DE D0X1OW DRUGINCH 1S/C25H25F3N2O2/c1-14-10-17-16-6-4-5-7-20(16)29-23(17)24(30(14)13-25(2,3)28)22-18(26)11-15(12-19(22)27)8-9-21(31)32/h4-9,11-12,14,24,29H,10,13H2,1-3H3,(H,31,32)/b9-8+/t14-,24-/m1/s1 D0X1OW DRUGINKE DFBDRVGWBHBJNR-BBNFHIFMSA-N D0X1OW DRUGSMIL CC1CC2=C(C(N1CC(C)(C)F)C3=C(C=C(C=C3F)C=CC(=O)O)F)NC4=CC=CC=C24 D0X1OW HIGHSTAT Phase 1 D0X3TI DRUG__ID D0X3TI D0X3TI DRUGCOMP Sirtris D0X3TI DRUGINCH 1S/C31H31N5O2S2/c1-38-17-9-14-26-27(35-29(39-26)22-10-3-2-4-11-22)28(37)33-24-13-6-5-12-23(24)30-34-25-18-21(19-32-31(25)40-30)20-36-15-7-8-16-36/h2-6,10-13,18-19H,7-9,14-17,20H2,1H3,(H,33,37) D0X3TI DRUGINKE MRRXPMZNBRXCPZ-UHFFFAOYSA-N D0X3TI DRUGSMIL COCCCC1=C(N=C(S1)C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C4=NC5=C(S4)N=CC(=C5)CN6CCCC6 D0X3TI HIGHSTAT Phase 1 D0XD4I DRUG__ID D0XD4I D0XD4I DRUGCOMP AstraZeneca Wilmington, DE D0XD4I DRUGINCH 1S/C26H31N5O3/c1-29(2)11-4-12-34-24-8-6-19(16-28-24)18-5-7-22-21(15-18)25-23(17-27-22)30(3)26(32)31(25)20-9-13-33-14-10-20/h5-8,15-17,20H,4,9-14H2,1-3H3 D0XD4I DRUGINKE AOTRIQLYUAFVSC-UHFFFAOYSA-N D0XD4I DRUGSMIL CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4CCOCC4)C5=CN=C(C=C5)OCCCN(C)C D0XD4I HIGHSTAT Phase 1 D0XE4W DRUG__ID D0XE4W D0XE4W DRUGCOMP Actinium Pharmaceuticals New York, NY D0XE4W DRUGINCH 1S/Ac/i1-2 D0XE4W DRUGINKE QQINRWTZWGJFDB-YPZZEJLDSA-N D0XE4W DRUGSMIL [Ac] D0XE4W HIGHSTAT Phase 1 D0XI4P DRUG__ID D0XI4P D0XI4P DRUGCOMP Bristol-Myers Squibb D0XI4P DRUGINCH 1S/C24H24FN7O/c1-14-27-13-32(31-14)20-11-8-17(12-21(20)33-3)28-24-29-22-18(15-4-6-16(25)7-5-15)9-10-19(22)23(26-2)30-24/h4-8,11-13,18H,9-10H2,1-3H3,(H2,26,28,29,30)/t18-/m0/s1 D0XI4P DRUGINKE NDVMOVOEROCRIO-SFHVURJKSA-N D0XI4P DRUGSMIL CC1=NN(C=N1)C2=C(C=C(C=C2)NC3=NC4=C(CCC4C5=CC=C(C=C5)F)C(=N3)NC)OC D0XI4P HIGHSTAT Phase 1 D0XJ6C DRUG__ID D0XJ6C D0XJ6C DRUGTYPE Small molecular drug D0XJ6C DRUGINCH 1S/C32H31N5O/c1-2-3-5-13-29-28-12-8-9-14-30(28)37(21-23-10-6-4-7-11-23)32(29)26-16-15-25-20-27(18-17-24(25)19-26)38-22-31-33-35-36-34-31/h4,6-12,14-20H,2-3,5,13,21-22H2,1H3,(H,33,34,35,36) D0XJ6C DRUGINKE BDPXZFKVHDEPIQ-UHFFFAOYSA-N D0XJ6C DRUGSMIL CCCCCC1=C(N(C2=CC=CC=C21)CC3=CC=CC=C3)C4=CC5=C(C=C4)C=C(C=C5)OCC6=NNN=N6 D0XJ6C HIGHSTAT Phase 1 D0XZ1D DRUG__ID D0XZ1D D0XZ1D DRUGCOMP Blueprint Medicines Cambridge, MA D0XZ1D DRUGINCH 1S/C24H24Cl2N4O4/c1-4-20(31)28-16-7-8-34-12-17(16)30-24-27-11-14-9-13(5-6-15(14)29-24)21-22(25)18(32-2)10-19(33-3)23(21)26/h4-6,9-11,16-17H,1,7-8,12H2,2-3H3,(H,28,31)(H,27,29,30)/t16-,17+/m0/s1 D0XZ1D DRUGINKE MGZKYOAQVGSSGC-DLBZAZTESA-N D0XZ1D DRUGSMIL COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)NC4COCCC4NC(=O)C=C)Cl)OC D0XZ1D HIGHSTAT Phase 1 D0Y0FE DRUG__ID D0Y0FE D0Y0FE DRUGCOMP Pathway Therapeutics Ltd D0Y0FE DRUGINCH 1S/C26H30F2N8O4S/c1-34(2)13-16-41(37,38)33-18-9-7-17(8-10-18)23-30-25(35-11-14-40-15-12-35)32-26(31-23)36-19-5-4-6-20(39-3)21(19)29-24(36)22(27)28/h4-10,22,33H,11-16H2,1-3H3 D0Y0FE DRUGINKE GDCJHDUWWAKBIW-UHFFFAOYSA-N D0Y0FE DRUGSMIL CN(C)CCS(=O)(=O)NC1=CC=C(C=C1)C2=NC(=NC(=N2)N3CCOCC3)N4C5=C(C(=CC=C5)OC)N=C4C(F)F D0Y0FE HIGHSTAT Phase 1 D0Y2GJ DRUG__ID D0Y2GJ D0Y2GJ DRUGCOMP Sunovion Pharmaceuticals D0Y2GJ DRUGINCH 1S/C26H32BrNO4/c1-30-14-15-32-26-18-21(2-4-23(26)27)16-20-7-11-28(12-8-20)10-6-19-3-5-25-22(17-19)24(29)9-13-31-25/h2-5,17-18,20H,6-16H2,1H3 D0Y2GJ DRUGINKE ZSVLGHSNQJYODD-UHFFFAOYSA-N D0Y2GJ DRUGSMIL COCCOC1=C(C=CC(=C1)CC2CCN(CC2)CCC3=CC4=C(C=C3)OCCC4=O)Br D0Y2GJ HIGHSTAT Phase 1 D0Y3XA DRUG__ID D0Y3XA D0Y3XA DRUGTYPE Small molecular drug D0Y3XA DRUGINCH 1S/C56H55N15O10S6/c1-24(2)39-55-70-42(36(87-55)19-80-5)47(77)59-17-38(73)67-43(44(74)26-10-7-6-8-11-26)54-66-34(23-85-54)52-63-31(20-83-52)41-27(50-64-32(21-82-50)46(76)61-29(16-37(72)58-4)53-69-40(25(3)86-53)48(78)68-39)13-14-28(60-41)51-65-33(22-84-51)49-62-30(18-81-49)56(79)71-15-9-12-35(71)45(57)75/h6-8,10-11,13-14,20-24,29-30,35,39,43-44,74H,9,12,15-19H2,1-5H3,(H2,57,75)(H,58,72)(H,59,77)(H,61,76)(H,67,73)(H,68,78) D0Y3XA DRUGINKE JMDULECOHIXMNX-UHFFFAOYSA-N D0Y3XA DRUGSMIL CC1=C2C(=O)NC(C3=NC(=C(S3)COC)C(=O)NCC(=O)NC(C4=NC(=CS4)C5=NC(=CS5)C6=C(C=CC(=N6)C7=NC(=CS7)C8=NC(CO8)C(=O)N9CCCC9C(=O)N)C3=NC(=CS3)C(=O)NC(C(=N2)S1)CC(=O)NC)C(C1=CC=CC=C1)O)C(C)C D0Y3XA HIGHSTAT Phase 1 D0Y5NA DRUG__ID D0Y5NA D0Y5NA DRUGCOMP Pfizer New York, NY D0Y5NA DRUGINCH 1S/C18H19F2N5O3S2/c1-9-4-10-6-30-17(21)25-18(10,8-27-9)15-24-13(7-29-15)23-14(26)12-3-2-11(5-22-12)28-16(19)20/h2-3,5,7,9-10,16H,4,6,8H2,1H3,(H2,21,25)(H,23,26)/t9-,10-,18-/m0/s1 D0Y5NA DRUGINKE ZLZUHACSRMOLLV-RAALSFIWSA-N D0Y5NA DRUGSMIL CC1CC2CSC(=NC2(CO1)C3=NC(=CS3)NC(=O)C4=NC=C(C=C4)OC(F)F)N D0Y5NA HIGHSTAT Phase 1 D0Y7CO DRUG__ID D0Y7CO D0Y7CO DRUGCOMP Abbott D0Y7CO DRUGINCH 1S/C24H27N3O5S/c1-24(2,3)20-15-19(27-13-12-21(28)25-23(27)29)14-17(22(20)32-4)9-6-16-7-10-18(11-8-16)26-33(5,30)31/h6-15,26H,1-5H3,(H,25,28,29)/b9-6+ D0Y7CO DRUGINKE XMZSTQYSBYEENY-RMKNXTFCSA-N D0Y7CO DRUGSMIL CC(C)(C)C1=CC(=CC(=C1OC)C=CC2=CC=C(C=C2)NS(=O)(=O)C)N3C=CC(=O)NC3=O D0Y7CO HIGHSTAT Phase 1 D0Y8UV DRUG__ID D0Y8UV D0Y8UV DRUGCOMP Merck KGaA D0Y8UV DRUGINCH 1S/C25H27N7O3/c1-30-18-21(14-28-30)23-5-6-24(33)32(29-23)17-19-3-2-4-20(13-19)25-26-15-22(16-27-25)35-12-9-31-7-10-34-11-8-31/h2-6,13-16,18H,7-12,17H2,1H3 D0Y8UV DRUGINKE CIUKPBWULKEZMF-UHFFFAOYSA-N D0Y8UV DRUGSMIL CN1C=C(C=N1)C2=NN(C(=O)C=C2)CC3=CC(=CC=C3)C4=NC=C(C=N4)OCCN5CCOCC5 D0Y8UV HIGHSTAT Phase 1 D0Z0XM DRUG__ID D0Z0XM D0Z0XM DRUGCOMP Cleveland biolabs D0Z0XM DRUGINCH 1S/C21H24N2O2/c1-13(2)22-9-10-23-20-7-5-16(14(3)24)11-18(20)19-12-17(15(4)25)6-8-21(19)23/h5-8,11-13,22H,9-10H2,1-4H3 D0Z0XM DRUGINKE JKCSODVERGVDLT-UHFFFAOYSA-N D0Z0XM DRUGSMIL CC(C)NCCN1C2=C(C=C(C=C2)C(=O)C)C3=C1C=CC(=C3)C(=O)C D0Z0XM HIGHSTAT Phase 1 D0Z3LC DRUG__ID D0Z3LC D0Z3LC DRUGTYPE Small molecular drug D0Z3LC DRUGINCH 1S/C8H9F3N4O4/c9-8(10,11)5(16)3-13-6(17)4-14-2-1-12-7(14)15(18)19/h1-2,5,16H,3-4H2,(H,13,17) D0Z3LC DRUGINKE BTLNRJMECFTISR-UHFFFAOYSA-N D0Z3LC DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NCC(C(F)(F)F)O D0Z3LC HIGHSTAT Phase 1 D0Z5VG DRUG__ID D0Z5VG D0Z5VG DRUGTYPE Small molecular drug D0Z5VG DRUGINCH 1S/C23H20N2O5/c1-3-19(26)30-23(4-2)16-10-18-20-14(9-13-7-5-6-8-17(13)24-20)11-25(18)21(27)15(16)12-29-22(23)28/h5-10H,3-4,11-12H2,1-2H3/t23-/m0/s1 D0Z5VG DRUGINKE YCNIQYLWIPCLNY-QHCPKHFHSA-N D0Z5VG DRUGSMIL CCC(=O)OC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)CC D0Z5VG HIGHSTAT Phase 1 D0Z6GW DRUG__ID D0Z6GW D0Z6GW DRUGCOMP Medivir; Tibotec D0Z6GW DRUGINCH 1S/C18H26N6O6/c1-9(2)15(25)28-8-18(22-23-20)13(29-16(26)10(3)4)11(5)14(30-18)24-7-6-12(19)21-17(24)27/h6-7,9-11,13-14H,8H2,1-5H3,(H2,19,21,27)/t11-,13-,14+,18+/m0/s1 D0Z6GW DRUGINKE XJBILYMRFVHPJB-XJQUKVTJSA-N D0Z6GW DRUGSMIL CC1C(C(OC1N2C=CC(=NC2=O)N)(COC(=O)C(C)C)N=[N+]=[N-])OC(=O)C(C)C D0Z6GW HIGHSTAT Phase 1 D0Z8KU DRUG__ID D0Z8KU D0Z8KU DRUGCOMP Seattle Genetics Bothell, WA D0Z8KU DRUGINCH 1S/C6H11FO4/c1-2-4(8)5(9)3(7)6(10)11-2/h2-6,8-10H,1H3/t2-,3-,4+,5-,6?/m0/s1 D0Z8KU DRUGINKE IRKXGKIPOMIQOD-ZZWDRFIYSA-N D0Z8KU DRUGSMIL CC1C(C(C(C(O1)O)F)O)O D0Z8KU HIGHSTAT Phase 1 D0ZW4W DRUG__ID D0ZW4W D0ZW4W DRUGTYPE Small molecular drug D0ZW4W DRUGINCH 1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1 D0ZW4W DRUGINKE DNVXATUJJDPFDM-KRWDZBQOSA-N D0ZW4W DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C D0ZW4W HIGHSTAT Phase 1 D47MOS DRUG__ID D47MOS D47MOS DRUGTYPE Small molecular drug D47MOS DRUGINCH 1S/C19H15N3O6S/c1-12-8-18(22(25)26)17(10-16(12)14-5-3-7-20-11-14)21-29(27,28)15-6-2-4-13(9-15)19(23)24/h2-11,21H,1H3,(H,23,24) D47MOS DRUGINKE QUQGQIASFYWKAB-UHFFFAOYSA-N D47MOS DRUGSMIL CC1=CC(=C(C=C1C2=CN=CC=C2)NS(=O)(=O)C3=CC=CC(=C3)C(=O)O)[N+](=O)[O-] D47MOS HIGHSTAT Phase 1 D4MW3O DRUG__ID D4MW3O D4MW3O DRUGTYPE Small molecular drug D4MW3O DRUGINCH 1S/C15H18BrN7/c1-22-8-10(6-19-22)11-7-20-23-14(17)12(16)13(21-15(11)23)9-3-2-4-18-5-9/h6-9,18H,2-5,17H2,1H3 D4MW3O DRUGINKE GMIZZEXBPRLVIV-UHFFFAOYSA-N D4MW3O DRUGSMIL CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4 D4MW3O HIGHSTAT Phase 1 D7LQJ8 DRUG__ID D7LQJ8 D7LQJ8 DRUGTYPE Small molecular drug D7LQJ8 DRUGINCH 1S/C29H22Cl3NO4/c30-23-2-1-3-24(31)26(23)27-22(28(37-33-27)16-6-7-16)14-36-18-10-11-19(25(32)12-18)21-13-20(21)15-4-8-17(9-5-15)29(34)35/h1-5,8-12,16,20-21H,6-7,13-14H2,(H,34,35)/t20-,21-/m1/s1 D7LQJ8 DRUGINKE XBUXXJUEBFDQHD-NHCUHLMSSA-N D7LQJ8 DRUGSMIL C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5CC5C6=CC=C(C=C6)C(=O)O)Cl D7LQJ8 HIGHSTAT Phase 1 D9Q5UP DRUG__ID D9Q5UP D9Q5UP DRUGTYPE Small molecular drug D9Q5UP DRUGINCH 1S/C19H15F3N4O5/c20-19(21,22)31-14-4-2-13(3-5-14)16-6-1-12(7-23-16)10-29-15-8-25-9-17(26(27)28)24-18(25)30-11-15/h1-7,9,15H,8,10-11H2/t15-/m0/s1 D9Q5UP DRUGINKE ZXSGSFMORAILEY-HNNXBMFYSA-N D9Q5UP DRUGSMIL C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CN=C(C=C3)C4=CC=C(C=C4)OC(F)(F)F D9Q5UP HIGHSTAT Phase 1 DMDS20 DRUG__ID DMDS20 DMDS20 DRUGTYPE Small molecular drug DMDS20 DRUGINCH 1S/C28H29NO4S/c1-3-6-22(17-27(30)31)20-10-12-23(13-11-20)33-19-25-15-14-24(34-25)18-29-16-5-8-21-7-4-9-26(32-2)28(21)29/h4,7,9-15,22H,5,8,16-19H2,1-2H3,(H,30,31)/t22-/m0/s1 DMDS20 DRUGINKE VJVDLRVFJTVWEO-QFIPXVFZSA-N DMDS20 DRUGSMIL CC#CC(CC(=O)O)C1=CC=C(C=C1)OCC2=CC=C(S2)CN3CCCC4=C3C(=CC=C4)OC DMDS20 HIGHSTAT Phase 1 DP17AI DRUG__ID DP17AI DP17AI DRUGTYPE Small molecular drug DP17AI DRUGINCH 1S/C24H22O6/c1-14(25)16-6-9-18-19-11-22(28-3)23(12-21(19)30-24(26)20(18)10-16)29-13-15-4-7-17(27-2)8-5-15/h4-12,14,25H,13H2,1-3H3 DP17AI DRUGINKE YEAHTLOYHVWAKW-UHFFFAOYSA-N DP17AI DRUGSMIL CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O DP17AI HIGHSTAT Phase 1 DTO06Y DRUG__ID DTO06Y DTO06Y DRUGTYPE Small molecular drug DTO06Y DRUGINCH 1S/C20H23F3N4O3S/c21-20(22,23)14-10-15-17(16(11-14)27(29)30)31-19(24-18(15)28)26-8-6-25(7-9-26)12-13-4-2-1-3-5-13/h10-11,13H,1-9,12H2 DTO06Y DRUGINKE BJDZBXGJNBMCAV-UHFFFAOYSA-N DTO06Y DRUGSMIL C1CCC(CC1)CN2CCN(CC2)C3=NC(=O)C4=C(S3)C(=CC(=C4)C(F)(F)F)[N+](=O)[O-] DTO06Y HIGHSTAT Phase 1 D00IXN DRUG__ID D00IXN D00IXN DRUGINCH 1S/C6H11BO2/c8-7(9)6-4-2-1-3-5-6/h4,8-9H,1-3,5H2 D00IXN DRUGINKE XZWQKJXJNKYMAP-UHFFFAOYSA-N D00IXN DRUGSMIL B(C1=CCCCC1)(O)O D00IXN HIGHSTAT Phase 1 D00POS DRUG__ID D00POS D00POS DRUGINCH 1S/C23H27N5OS/c1-29-21-10-6-5-9-20(21)27-13-11-26(12-14-27)16-17-15-24-22-18-7-3-4-8-19(18)25-23(30-2)28(17)22/h3-10,17H,11-16H2,1-2H3 D00POS DRUGINKE DVYBIZHLZSDANU-UHFFFAOYSA-N D00POS DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CC3CN=C4N3C(=NC5=CC=CC=C54)SC D00POS HIGHSTAT Phase 1 D00RNB DRUG__ID D00RNB D00RNB DRUGINCH 1S/C18H26N2O/c1-13-6-5-7-14(2)17(13)19-18(21)16-8-3-4-11-20(16)12-15-9-10-15/h5-7,15-16H,3-4,8-12H2,1-2H3,(H,19,21) D00RNB DRUGINKE DNUYDQISHIJMLD-UHFFFAOYSA-N D00RNB DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2CC3CC3 D00RNB HIGHSTAT Phase 1 D01GXB DRUG__ID D01GXB D01GXB DRUGCOMP Sanofi D01GXB DRUGTYPE Combination drug D01GXB DRUGSMIL failed D01GXB HIGHSTAT Phase 1 D01PGJ DRUG__ID D01PGJ D01PGJ DRUGINCH 1S/C11H13N3O3.2BrH/c12-11(7-14-4-2-1-3-5-14)6-8(9(15)16)13-10(11)17;;/h1-5,8H,6-7,12H2,(H-,13,15,16,17);2*1H/t8-,11+;;/m1../s1 D01PGJ DRUGINKE GIZKBHWITTWBAP-IEQXMABBSA-N D01PGJ DRUGSMIL C1C(NC(=O)C1(C[N+]2=CC=CC=C2)N)C(=O)O.Br.[Br-] D01PGJ HIGHSTAT Phase 1 D01RQN DRUG__ID D01RQN D01RQN DRUGINCH 1S/C17H23NO5/c1-17(2,3)23-16(21)18-9-13(14(10-18)15(19)20)11-5-7-12(22-4)8-6-11/h5-8,13-14H,9-10H2,1-4H3,(H,19,20) D01RQN DRUGINKE ISEHHCOIDMZBSU-UHFFFAOYSA-N D01RQN DRUGSMIL CC(C)(C)OC(=O)N1CC(C(C1)C(=O)O)C2=CC=C(C=C2)OC D01RQN HIGHSTAT Phase 1 D03MEU DRUG__ID D03MEU D03MEU DRUGCOMP Shenzhen Geno-Immune Medical Institute D03MEU THERCLAS Antiviral Agents D03MEU DRUGTYPE Vaccine D03MEU HIGHSTAT Phase 1 Trial D05LTJ DRUG__ID D05LTJ D05LTJ DRUGCOMP Licensed to Ortho-McNeil, Inc. D05LTJ THERCLAS Antisense D05LTJ DRUGTYPE Antisense drug D05LTJ HIGHSTAT Phase 1 D05MVA DRUG__ID D05MVA D05MVA DRUGINCH 1S/C26H45N5O6/c1-2-31(23(33)10-6-9-18-11-13-28-14-12-18)17-22(32)29-21(16-24(34)35)26(37)30-20(25(27)36)15-19-7-4-3-5-8-19/h18-21,28H,2-17H2,1H3,(H2,27,36)(H,29,32)(H,30,37)(H,34,35)/t20-,21-/m0/s1 D05MVA DRUGINKE PWINFPFVCZSLBF-SFTDATJTSA-N D05MVA DRUGSMIL CCN(CC(=O)NC(CC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)N)C(=O)CCCC2CCNCC2 D05MVA HIGHSTAT Phase 1 D06RHC DRUG__ID D06RHC D06RHC DRUGINCH 1S/C13H12ClNO3/c1-18-7-6-15-11-10(14)12(16)8-4-2-3-5-9(8)13(11)17/h2-5,15H,6-7H2,1H3 D06RHC DRUGINKE IAPJSKHYZZLKBU-UHFFFAOYSA-N D06RHC DRUGSMIL COCCNC1=C(C(=O)C2=CC=CC=C2C1=O)Cl D06RHC HIGHSTAT Phase 1 D07NUL DRUG__ID D07NUL D07NUL DRUGINCH 1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1 D07NUL DRUGINKE JKDGKIBAOAFRPJ-ZBINZKHDSA-N D07NUL DRUGSMIL CCC1C(NC(=O)C1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N D07NUL HIGHSTAT Phase 1 D09UMN DRUG__ID D09UMN D09UMN DRUGINCH 1S/C25H32N6O/c1-17-16-30(11-12-31(17)23-15-26-22(14-27-23)25(4,5)32)24-19(3)18(2)21(28-29-24)13-20-9-7-6-8-10-20/h6-10,14-15,17,32H,11-13,16H2,1-5H3/t17-/m1/s1 D09UMN DRUGINKE POERAARDVFVDLO-QGZVFWFLSA-N D09UMN DRUGSMIL CC1CN(CCN1C2=NC=C(N=C2)C(C)(C)O)C3=NN=C(C(=C3C)C)CC4=CC=CC=C4 D09UMN HIGHSTAT Phase 1 D0A3CL DRUG__ID D0A3CL D0A3CL DRUGINCH 1S/C25H26N4O5/c1-31-19-8-4-18(5-9-19)22-26-27-23(34-22)24(30)29-11-21(12-29)33-20-6-2-17(3-7-20)10-28-13-25(14-28)15-32-16-25/h2-9,21H,10-16H2,1H3 D0A3CL DRUGINKE BKKPIQPFRAPEAY-UHFFFAOYSA-N D0A3CL DRUGSMIL COC1=CC=C(C=C1)C2=NN=C(O2)C(=O)N3CC(C3)OC4=CC=C(C=C4)CN5CC6(C5)COC6 D0A3CL HIGHSTAT Phase 1 D0CO6D DRUG__ID D0CO6D D0CO6D DRUGINCH 1S/C20H12F5N3O4/c21-12-2-1-7-26-17(12)16(10-4-6-15(13(22)8-10)32-20(23,24)25)28-18(29)14-5-3-11(9-27-14)19(30)31/h1-9,16H,(H,28,29)(H,30,31)/t16-/m0/s1 D0CO6D DRUGINKE QEBYISWYMFIXOZ-INIZCTEOSA-N D0CO6D DRUGSMIL C1=CC(=C(N=C1)C(C2=CC(=C(C=C2)OC(F)(F)F)F)NC(=O)C3=NC=C(C=C3)C(=O)O)F D0CO6D HIGHSTAT Phase 1 D0D3XM DRUG__ID D0D3XM D0D3XM DRUGINCH 1S/C19H16N2O3S/c22-25(23)14-13-21-12-4-7-18(19(21)20-25)15-8-10-17(11-9-15)24-16-5-2-1-3-6-16/h1-12H,13-14H2 D0D3XM DRUGINKE VKKLOYOLCCDGLD-UHFFFAOYSA-N D0D3XM DRUGSMIL C1CS(=O)(=O)N=C2N1C=CC=C2C3=CC=C(C=C3)OC4=CC=CC=C4 D0D3XM HIGHSTAT Phase 1 D0DK5X DRUG__ID D0DK5X D0DK5X DRUGINCH 1S/C31H31FN8O2/c1-2-18-13-27(41)22(32)14-21(18)19-6-7-20-24(12-19)37-38-29(20)30-35-23-8-11-40(17-26(23)36-30)31(42)25-15-34-28(16-33-25)39-9-4-3-5-10-39/h6-7,12-16,41H,2-5,8-11,17H2,1H3,(H,35,36)(H,37,38) D0DK5X DRUGINKE XDJGNPSZQSWJCV-UHFFFAOYSA-N D0DK5X DRUGSMIL CCC1=CC(=C(C=C1C2=CC3=C(C=C2)C(=NN3)C4=NC5=C(N4)CN(CC5)C(=O)C6=CN=C(C=N6)N7CCCCC7)F)O D0DK5X HIGHSTAT Phase 1 D0DP0J DRUG__ID D0DP0J D0DP0J DRUGINCH 1S/C37H38N4O5/c1-22-27-14-8-7-13-25(27)18-29(22)35(44)39-23(2)34(43)41-32(19-26-20-38-30-16-10-9-15-28(26)30)36(45)40-31(33(42)37(3)21-46-37)17-24-11-5-4-6-12-24/h4-16,20,23,31-32,38H,17-19,21H2,1-3H3,(H,39,44)(H,40,45)(H,41,43)/t23-,31+,32+,37-/m1/s1 D0DP0J DRUGINKE ADBUEVSHEJICCM-LZNHGOJSSA-N D0DP0J DRUGSMIL CC1=C(CC2=CC=CC=C12)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)C6(CO6)C D0DP0J HIGHSTAT Phase 1 D0E5GI DRUG__ID D0E5GI D0E5GI DRUGINCH 1S/C32H38N2O3/c1-21(2)24-14-15-28(37-3)25(18-24)19-33-30-26-16-17-34(20-27(26)32(35)36)31(30)29(22-10-6-4-7-11-22)23-12-8-5-9-13-23/h4-15,18,21,26-27,29-31,33H,16-17,19-20H2,1-3H3,(H,35,36)/t26-,27-,30-,31-/m0/s1 D0E5GI DRUGINKE UGYNIDYASJFWTR-FXZOGHEHSA-N D0E5GI DRUGSMIL CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3C(=O)O D0E5GI HIGHSTAT Phase 1 D0E6VR DRUG__ID D0E6VR D0E6VR DRUGINCH 1S/C5H10N2O2/c8-5(9)4-3-6-1-2-7-4/h4,6-7H,1-3H2,(H,8,9) D0E6VR DRUGINKE JSSXHAMIXJGYCS-UHFFFAOYSA-N D0E6VR DRUGSMIL C1CNC(CN1)C(=O)O D0E6VR HIGHSTAT Phase 1 D0F3PU DRUG__ID D0F3PU D0F3PU DRUGCOMP GSK D0F3PU DRUGTYPE Combination drug D0F3PU DRUGSMIL failed D0F3PU HIGHSTAT Phase 1 D0H9RD DRUG__ID D0H9RD D0H9RD DRUGINCH 1S/C22H29N3O6S/c1-11-16-15(12(2)26)19(27)25(16)17(20(28)30-10-31-21(29)22(3,4)5)18(11)32-13-8-14-23-6-7-24(14)9-13/h6-7,11-13,15-16,26H,8-10H2,1-5H3/t11-,12-,13+,15-,16+/m1/s1 D0H9RD DRUGINKE SVIXKYNOOFZUFA-QUEVPRLRSA-N D0H9RD DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC4=NC=CN4C3)C(=O)OCOC(=O)C(C)(C)C)C(C)O D0H9RD HIGHSTAT Phase 1 D0K7ZH DRUG__ID D0K7ZH D0K7ZH DRUGINCH 1S/C19H16F3N3O3/c1-10-9-12(28-17-14(19(20,21)22)5-4-8-23-17)6-7-13(10)15-11(2)16(26)24-18(27)25(15)3/h4-9H,1-3H3,(H,24,26,27) D0K7ZH DRUGINKE AKQXQLUNFKDZBN-UHFFFAOYSA-N D0K7ZH DRUGSMIL CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C D0K7ZH HIGHSTAT Phase 1 D0L3DC DRUG__ID D0L3DC D0L3DC DRUGINCH 1S/C35H41N5O6/c1-22(2)19-29(31(43)37-28(20-30(41)42)25-12-7-6-8-13-25)40-32(44)35(4,5)39(34(40)46)21-24-15-17-26(18-16-24)36-33(45)38-27-14-10-9-11-23(27)3/h6-18,22,28-29H,19-21H2,1-5H3,(H,37,43)(H,41,42)(H2,36,38,45)/t28-,29-/m0/s1 D0L3DC DRUGINKE OPZVCXYTOHAOHN-VMPREFPWSA-N D0L3DC DRUGSMIL CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CN3C(=O)N(C(=O)C3(C)C)C(CC(C)C)C(=O)NC(CC(=O)O)C4=CC=CC=C4 D0L3DC HIGHSTAT Phase 1 D0T5FU DRUG__ID D0T5FU D0T5FU DRUGINCH 1S/C10H18BrNO3/c1-10(2,3)15-9(13)12-4-5-14-8(6-11)7-12/h8H,4-7H2,1-3H3/t8-/m1/s1 D0T5FU DRUGINKE RLXCSEPIBOWMOJ-MRVPVSSYSA-N D0T5FU DRUGSMIL CC(C)(C)OC(=O)N1CCOC(C1)CBr D0T5FU HIGHSTAT Phase 1 D0U5PT DRUG__ID D0U5PT D0U5PT DRUGINCH 1S/C22H17ClFN9O/c23-13-5-6-14(24)17-15(13)21(34)33(11-2-1-7-28-9-11)20(30-17)16(10-3-4-10)29-19-12(8-25)18(26)31-22(27)32-19/h1-2,5-7,9-10,16H,3-4H2,(H5,26,27,29,31,32)/t16-/m0/s1 D0U5PT DRUGINKE XDSXYMOZKDUASY-INIZCTEOSA-N D0U5PT DRUGSMIL C1CC1C(C2=NC3=C(C=CC(=C3C(=O)N2C4=CN=CC=C4)Cl)F)NC5=NC(=NC(=C5C#N)N)N D0U5PT HIGHSTAT Phase 1 D0W2BK DRUG__ID D0W2BK D0W2BK DRUGCOMP ISIS Pharm; iCo Therapeutics D0W2BK THERCLAS Antisense D0W2BK DRUGTYPE Antisense drug D0W2BK HIGHSTAT Phase 1 D0W4YO DRUG__ID D0W4YO D0W4YO DRUGINCH 1S/C79H129N27O22/c1-41(2)33-54(72(122)95-44(5)66(116)103-56(36-59(84)110)73(123)102-53(77(127)128)27-28-58(83)109)104-70(120)49(23-13-15-29-80)100-69(119)52(26-18-32-90-79(87)88)99-65(115)43(4)96-75(125)57(40-107)105-71(121)50(24-14-16-30-81)101-68(118)51(25-17-31-89-78(85)86)98-64(114)42(3)94-61(112)39-93-76(126)63(45(6)108)106-74(124)55(35-47-21-11-8-12-22-47)97-62(113)38-91-60(111)37-92-67(117)48(82)34-46-19-9-7-10-20-46/h7-12,19-22,41-45,48-57,63,107-108H,13-18,23-40,80-82H2,1-6H3,(H2,83,109)(H2,84,110)(H,91,111)(H,92,117)(H,93,126)(H,94,112)(H,95,122)(H,96,125)(H,97,113)(H,98,114)(H,99,115)(H,100,119)(H,101,118)(H,102,123)(H,103,116)(H,104,120)(H,105,121)(H,106,124)(H,127,128)(H4,85,86,89)(H4,87,88,90)/t42-,43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-/m0/s1 D0W4YO DRUGINKE PULGYDLMFSFVBL-SMFNREODSA-N D0W4YO DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0W4YO HIGHSTAT Phase 1 D00CQL DRUG__ID D00CQL D00CQL DRUGCOMP Dynavax Technologies Corp D00CQL DRUGTYPE Vaccine D00CQL HIGHSTAT Phase 1 D00EQY DRUG__ID D00EQY D00EQY DRUGCOMP Kolltan pharmaceuticals D00EQY DRUGTYPE Antibody D00EQY HIGHSTAT Phase 1 D00FZH DRUG__ID D00FZH D00FZH THERCLAS Antiviral Agents D00FZH DRUGTYPE Cell therapy D00FZH HIGHSTAT Phase 1 Trial D00HAN DRUG__ID D00HAN D00HAN DRUGCOMP Beijing Immunochina Medical Science & Technology Co., Ltd. D00HAN DRUGTYPE CAR T Cell Therapy D00HAN HIGHSTAT Phase 1 D00HHU DRUG__ID D00HHU D00HHU DRUGCOMP Statens Serum Institut D00HHU DRUGTYPE Vaccine D00HHU HIGHSTAT Phase 1 D00JCB DRUG__ID D00JCB D00JCB DRUGCOMP Crystal Mackall, MD D00JCB DRUGTYPE CAR T Cell Therapy (Dual specific) D00JCB HIGHSTAT Phase 1 D00JDL DRUG__ID D00JDL D00JDL DRUGCOMP MacroGenics D00JDL DRUGTYPE Monoclonal antibody D00JDL HIGHSTAT Phase 1 D00JMY DRUG__ID D00JMY D00JMY DRUGCOMP Amplimmune Gaithersburg, MD D00JMY DRUGTYPE Monoclonal antibody D00JMY HIGHSTAT Phase 1 D00KDQ DRUG__ID D00KDQ D00KDQ DRUGCOMP Sorrento Therapeutics, Inc. D00KDQ DRUGTYPE CAR T Cell Therapy D00KDQ HIGHSTAT Phase 1 D00MUC DRUG__ID D00MUC D00MUC DRUGCOMP Tianjin Mycure Medical Technology Co., Ltd D00MUC DRUGTYPE CAR T Cell Therapy D00MUC HIGHSTAT Phase 1 D00NEL DRUG__ID D00NEL D00NEL DRUGCOMP Boehringer Ingelheim D00NEL DRUGTYPE Monoclonal antibody D00NEL HIGHSTAT Phase 1 D00OXP DRUG__ID D00OXP D00OXP DRUGCOMP bluebird bio D00OXP DRUGTYPE CAR T Cell Therapy D00OXP HIGHSTAT Phase 1 D00XIP DRUG__ID D00XIP D00XIP DRUGCOMP Bavarian Nordic D00XIP DRUGTYPE Vaccine D00XIP HIGHSTAT Phase 1 D00YOV DRUG__ID D00YOV D00YOV DRUGCOMP Micromet AG D00YOV DRUGTYPE Antibody D00YOV HIGHSTAT Phase 1 D00YUQ DRUG__ID D00YUQ D00YUQ DRUGCOMP University of Pennsylvania D00YUQ DRUGTYPE CAR T Cell Therapy D00YUQ HIGHSTAT Phase 1 D01ARU DRUG__ID D01ARU D01ARU DRUGCOMP DisperSol Technologies D01ARU DRUGTYPE Small molecular drug D01ARU HIGHSTAT Phase 1 D01AYF DRUG__ID D01AYF D01AYF DRUGCOMP Glaxosmithkline; novavax; vaxart D01AYF DRUGTYPE Vaccine D01AYF HIGHSTAT Phase 1 D01BPP DRUG__ID D01BPP D01BPP DRUGTYPE Small molecular drug D01BPP DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NN)O)O)CC)OC)C(=O)OC)O.CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N.C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N D01BPP HIGHSTAT Phase 1 D01CUO DRUG__ID D01CUO D01CUO DRUGCOMP Trillium Therapeutics Mississauga, Canada D01CUO DRUGTYPE Recombinant protein D01CUO HIGHSTAT Phase 1 D01CXW DRUG__ID D01CXW D01CXW DRUGCOMP Medimmune D01CXW DRUGTYPE Monoclonal antibody D01CXW HIGHSTAT Phase 1 D01FCY DRUG__ID D01FCY D01FCY THERCLAS Antiviral Agents D01FCY DRUGTYPE Cell therapy D01FCY HIGHSTAT Phase 1 Trial D01FSX DRUG__ID D01FSX D01FSX DRUGCOMP Regeneron Pharmaceuticals D01FSX DRUGTYPE Antibody D01FSX HIGHSTAT Phase 1 D01HAT DRUG__ID D01HAT D01HAT DRUGCOMP Baylor College of Medicine D01HAT DRUGTYPE CAR T Cell Therapy D01HAT HIGHSTAT Phase 1 D01HGT DRUG__ID D01HGT D01HGT DRUGCOMP Seattle Genetics; Genentech D01HGT DRUGTYPE Antibody D01HGT HIGHSTAT Phase 1 D01IJM DRUG__ID D01IJM D01IJM DRUGCOMP Eli Lilly D01IJM DRUGTYPE Monoclonal antibody D01IJM HIGHSTAT Phase 1 D01LWE DRUG__ID D01LWE D01LWE DRUGCOMP Gary Archer Ph.D. D01LWE DRUGTYPE CAR T Cell Therapy D01LWE HIGHSTAT Phase 1 D01NGH DRUG__ID D01NGH D01NGH DRUGCOMP St Jude Children's Research Hospital D01NGH DRUGTYPE Vaccine D01NGH HIGHSTAT Phase 1 D01SFN DRUG__ID D01SFN D01SFN DRUGCOMP Baylor College of Medicine D01SFN DRUGTYPE CAR T Cell Therapy D01SFN HIGHSTAT Phase 1 D01SXH DRUG__ID D01SXH D01SXH DRUGCOMP Xin Wang D01SXH DRUGTYPE CAR T Cell Therapy D01SXH HIGHSTAT Phase 1 D01SXY DRUG__ID D01SXY D01SXY DRUGCOMP Novacta Biosystems Ltd D01SXY DRUGTYPE Peptide D01SXY HIGHSTAT Phase 1 D01TNK DRUG__ID D01TNK D01TNK DRUGCOMP Jian-Kun Hu D01TNK DRUGTYPE CAR T Cell Therapy D01TNK HIGHSTAT Phase 1 D01YZF DRUG__ID D01YZF D01YZF DRUGCOMP University of Pennsylvania D01YZF DRUGTYPE CAR T Cell Therapy D01YZF HIGHSTAT Phase 1 D02BAA DRUG__ID D02BAA D02BAA DRUGCOMP Seattle Children's Hospital D02BAA DRUGTYPE CAR T Cell Therapy (Dual specific) D02BAA HIGHSTAT Phase 1 D02DXC DRUG__ID D02DXC D02DXC DRUGCOMP Supernus Pharmaceuticals Inc D02DXC DRUGTYPE Antisense drug D02DXC HIGHSTAT Phase 1 D02EWF DRUG__ID D02EWF D02EWF DRUGCOMP Soligenix D02EWF DRUGTYPE Vaccine D02EWF HIGHSTAT Phase 1 D02IYC DRUG__ID D02IYC D02IYC DRUGCOMP Immutep SA D02IYC DRUGTYPE Antibody D02IYC HIGHSTAT Phase 1 D02JEW DRUG__ID D02JEW D02JEW DRUGCOMP Glaxosmithkline D02JEW DRUGTYPE Vaccine D02JEW HIGHSTAT Phase 1 D02KAW DRUG__ID D02KAW D02KAW DRUGCOMP Biogen Idec D02KAW DRUGTYPE Antibody D02KAW HIGHSTAT Phase 1 D02LNU DRUG__ID D02LNU D02LNU DRUGCOMP University of Pennsylvania D02LNU DRUGTYPE CAR T Cell Therapy (Dual specific) D02LNU HIGHSTAT Phase 1 D02MYI DRUG__ID D02MYI D02MYI DRUGCOMP First Affiliated Hospital of Harbin Medical University D02MYI DRUGTYPE CAR T Cell Therapy D02MYI HIGHSTAT Phase 1 D02NFE DRUG__ID D02NFE D02NFE DRUGCOMP Shenzhen Second People's Hospital D02NFE DRUGTYPE CAR T Cell Therapy D02NFE HIGHSTAT Phase 1 D02NSS DRUG__ID D02NSS D02NSS DRUGCOMP Zhujiang Hospital D02NSS DRUGTYPE CAR T Cell Therapy D02NSS HIGHSTAT Phase 1 D02RPO DRUG__ID D02RPO D02RPO DRUGCOMP Bristol-Myers Squibb D02RPO DRUGTYPE Antibody D02RPO HIGHSTAT Phase 1 D02SAC DRUG__ID D02SAC D02SAC DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D02SAC DRUGTYPE CAR T Cell Therapy D02SAC HIGHSTAT Phase 1 D02SSR DRUG__ID D02SSR D02SSR THERCLAS Antiviral Agents D02SSR DRUGTYPE Combination drug D02SSR HIGHSTAT Phase 1 Trial D02XYW DRUG__ID D02XYW D02XYW DRUGCOMP Chinese PLA General Hospital D02XYW DRUGTYPE CAR T Cell Therapy D02XYW HIGHSTAT Phase 1 D03CMZ DRUG__ID D03CMZ D03CMZ DRUGCOMP Shenzhen Geno-Immune Medical Institute D03CMZ DRUGTYPE CAR T Cell Therapy D03CMZ HIGHSTAT Phase 1 D03EIA DRUG__ID D03EIA D03EIA DRUGCOMP Beijing Doing Biomedical Co., Ltd. D03EIA DRUGTYPE CAR T Cell Therapy D03EIA HIGHSTAT Phase 1 D03FVR DRUG__ID D03FVR D03FVR DRUGCOMP GlaxoSmithKline plc D03FVR DRUGTYPE Antibody D03FVR HIGHSTAT Phase 1 D03GTO DRUG__ID D03GTO D03GTO DRUGCOMP The Second Hospital of Nanjing Medical University D03GTO DRUGTYPE CAR T Cell Therapy (Dual specific) D03GTO HIGHSTAT Phase 1 D03HIG DRUG__ID D03HIG D03HIG DRUGCOMP Avaxia Biologics Inc D03HIG DRUGTYPE Antibody D03HIG HIGHSTAT Phase 1 D03JZC DRUG__ID D03JZC D03JZC DRUGCOMP Pfizer D03JZC DRUGTYPE Antibody D03JZC HIGHSTAT Phase 1 D03KLF DRUG__ID D03KLF D03KLF DRUGCOMP Medarex Inc D03KLF DRUGTYPE Antibody D03KLF HIGHSTAT Phase 1 D03KVW DRUG__ID D03KVW D03KVW DRUGCOMP Medarex Inc D03KVW DRUGTYPE Antibody D03KVW HIGHSTAT Phase 1 D03LFA DRUG__ID D03LFA D03LFA DRUGCOMP The Affiliated Hospital of the Chinese Academy of Military Medical Sciences D03LFA DRUGTYPE CAR T Cell Therapy D03LFA HIGHSTAT Phase 1 D03OIO DRUG__ID D03OIO D03OIO DRUGCOMP Chinese PLA General Hospital D03OIO DRUGTYPE CAR T Cell Therapy D03OIO HIGHSTAT Phase 1 D03PQW DRUG__ID D03PQW D03PQW DRUGCOMP Bayer HealthCare Pharmaceuticals D03PQW DRUGTYPE Antibody D03PQW HIGHSTAT Phase 1 D03RCB DRUG__ID D03RCB D03RCB DRUGCOMP Functional genetics D03RCB DRUGTYPE Antibody D03RCB HIGHSTAT Phase 1 D03TAY DRUG__ID D03TAY D03TAY DRUGCOMP Inovio Pharmaceuticals D03TAY DRUGTYPE Vaccine D03TAY HIGHSTAT Phase 1 D03XRA DRUG__ID D03XRA D03XRA DRUGCOMP GlaxoSmithKline D03XRA DRUGTYPE Antibody D03XRA HIGHSTAT Phase 1 D03YEG DRUG__ID D03YEG D03YEG DRUGCOMP Regeneron Pharmaceuticals Inc D03YEG DRUGTYPE Antibody D03YEG HIGHSTAT Phase 1 D03YEM DRUG__ID D03YEM D03YEM DRUGCOMP National Cancer Institute (NCI) D03YEM DRUGTYPE CAR T Cell Therapy (Dual specific) D03YEM HIGHSTAT Phase 1 D04BVL DRUG__ID D04BVL D04BVL DRUGCOMP Beijing Immunochina Medical Science & Technology Co., Ltd. D04BVL DRUGTYPE CAR T Cell Therapy D04BVL HIGHSTAT Phase 1 D04CYD DRUG__ID D04CYD D04CYD DRUGCOMP Oncothyreon D04CYD DRUGTYPE Vaccine D04CYD HIGHSTAT Phase 1 D04KWO DRUG__ID D04KWO D04KWO DRUGCOMP Astrazeneca; medimmune D04KWO DRUGTYPE Antibody D04KWO HIGHSTAT Phase 1 D04MBQ DRUG__ID D04MBQ D04MBQ DRUGCOMP Rikagaku Kenkyusho (RIKEN) Institute D04MBQ DRUGTYPE Human embryonic stem (hES) cell-derived therapeutics D04MBQ HIGHSTAT Phase 1 D04MZP DRUG__ID D04MZP D04MZP DRUGCOMP NovImmune SA D04MZP DRUGTYPE Antibody D04MZP HIGHSTAT Phase 1 D04NQZ DRUG__ID D04NQZ D04NQZ DRUGCOMP Merck D04NQZ DRUGTYPE Vaccine D04NQZ HIGHSTAT Phase 1 D04RDW DRUG__ID D04RDW D04RDW DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D04RDW DRUGTYPE CAR T Cell Therapy D04RDW HIGHSTAT Phase 1 D04RNG DRUG__ID D04RNG D04RNG DRUGCOMP Sichuan University D04RNG DRUGTYPE CAR T Cell Therapy D04RNG HIGHSTAT Phase 1 D04SKM DRUG__ID D04SKM D04SKM DRUGCOMP Zhujiang Hospital D04SKM DRUGTYPE CAR T Cell Therapy D04SKM HIGHSTAT Phase 1 D04UNY DRUG__ID D04UNY D04UNY DRUGCOMP Cancer Research UK D04UNY DRUGTYPE CAR T Cell Therapy D04UNY HIGHSTAT Phase 1 D04UWG DRUG__ID D04UWG D04UWG DRUGCOMP Roger Williams Medical Center D04UWG DRUGTYPE Antibody D04UWG HIGHSTAT Phase 1 D04ZIZ DRUG__ID D04ZIZ D04ZIZ DRUGCOMP Genentech D04ZIZ DRUGTYPE Antibody D04ZIZ HIGHSTAT Phase 1 D05ATQ DRUG__ID D05ATQ D05ATQ DRUGCOMP Pharmexa A/S D05ATQ DRUGTYPE Vaccine D05ATQ HIGHSTAT Phase 1 D05BPO DRUG__ID D05BPO D05BPO DRUGCOMP Pfizer New York, NY D05BPO DRUGTYPE Antibody D05BPO HIGHSTAT Phase 1 D05BYO DRUG__ID D05BYO D05BYO DRUGCOMP ISIS Pharm D05BYO DRUGTYPE Antisense drug D05BYO HIGHSTAT Phase 1 D05CPS DRUG__ID D05CPS D05CPS DRUGCOMP National Cancer Institute D05CPS DRUGTYPE Vaccine D05CPS HIGHSTAT Phase 1 D05CVC DRUG__ID D05CVC D05CVC DRUGCOMP Wilex AG D05CVC DRUGTYPE Antibody D05CVC HIGHSTAT Phase 1 D05DKT DRUG__ID D05DKT D05DKT DRUGCOMP Shenzhen Second People's Hospital D05DKT DRUGTYPE CAR T Cell Therapy D05DKT HIGHSTAT Phase 1 D05KFH DRUG__ID D05KFH D05KFH DRUGCOMP Seattle Children's Hospital D05KFH DRUGTYPE CAR T Cell Therapy D05KFH HIGHSTAT Phase 1 D05OWB DRUG__ID D05OWB D05OWB DRUGCOMP Stanford University D05OWB DRUGTYPE Monoclonal antibody D05OWB HIGHSTAT Phase 1 D05OXZ DRUG__ID D05OXZ D05OXZ DRUGCOMP Boehringer Ingelheim D05OXZ DRUGTYPE Antibody D05OXZ HIGHSTAT Phase 1 D05UOU DRUG__ID D05UOU D05UOU DRUGCOMP Guangdong General Hospital D05UOU DRUGTYPE CAR T Cell Therapy D05UOU HIGHSTAT Phase 1 D05WET DRUG__ID D05WET D05WET DRUGCOMP Sorrento Therapeutics, Inc. D05WET DRUGTYPE CAR T Cell Therapy D05WET HIGHSTAT Phase 1 D05WQT DRUG__ID D05WQT D05WQT DRUGCOMP Eli lilly D05WQT DRUGTYPE Antibody D05WQT HIGHSTAT Phase 1 D05XNF DRUG__ID D05XNF D05XNF DRUGCOMP Peking Union Medical College Hospital D05XNF DRUGTYPE CAR T Cell Therapy D05XNF HIGHSTAT Phase 1 D05XPZ DRUG__ID D05XPZ D05XPZ DRUGCOMP Peking University D05XPZ DRUGTYPE CAR T Cell Therapy D05XPZ HIGHSTAT Phase 1 D05YQL DRUG__ID D05YQL D05YQL DRUGCOMP BioMedics Japan Inc D05YQL DRUGTYPE Antibody D05YQL HIGHSTAT Phase 1 D05YQT DRUG__ID D05YQT D05YQT DRUGCOMP Labrys biologics D05YQT DRUGTYPE Antibody D05YQT HIGHSTAT Phase 1 D05ZEW DRUG__ID D05ZEW D05ZEW DRUGCOMP Inovio Pharmaceuticals D05ZEW DRUGTYPE Vaccine D05ZEW HIGHSTAT Phase 1 D05ZSX DRUG__ID D05ZSX D05ZSX DRUGCOMP ZymoGenetics Inc D05ZSX DRUGTYPE Antibody D05ZSX HIGHSTAT Phase 1 D06ALK DRUG__ID D06ALK D06ALK DRUGCOMP Xencor D06ALK DRUGTYPE Antibody D06ALK HIGHSTAT Phase 1 D06CIJ DRUG__ID D06CIJ D06CIJ DRUGCOMP ISIS Pharm D06CIJ DRUGTYPE Antisense drug D06CIJ HIGHSTAT Phase 1 D06FPF DRUG__ID D06FPF D06FPF DRUGCOMP Pharmathene D06FPF DRUGTYPE Antibody D06FPF HIGHSTAT Phase 1 D06HPP DRUG__ID D06HPP D06HPP DRUGCOMP ArmaGen Technologies Inc D06HPP DRUGTYPE Antibody D06HPP HIGHSTAT Phase 1 D06JAL DRUG__ID D06JAL D06JAL DRUGCOMP Memorial Sloan-Kettering Cancer Center D06JAL DRUGTYPE Antibody D06JAL HIGHSTAT Phase 1 D06JBV DRUG__ID D06JBV D06JBV DRUGCOMP Seattle genetics D06JBV DRUGTYPE Antibody D06JBV HIGHSTAT Phase 1 D06JQS DRUG__ID D06JQS D06JQS DRUGCOMP Targa therapeutics D06JQS DRUGTYPE Antibody D06JQS HIGHSTAT Phase 1 D06MMU DRUG__ID D06MMU D06MMU DRUGCOMP Cantab Biopharmaceuticals Ltd D06MMU DRUGTYPE Antibody D06MMU HIGHSTAT Phase 1 D06OES DRUG__ID D06OES D06OES DRUGCOMP Zhujiang Hospital D06OES DRUGTYPE CAR T Cell Therapy D06OES HIGHSTAT Phase 1 D06PZC DRUG__ID D06PZC D06PZC DRUGCOMP Pack of Parker; OncoMab GmbH D06PZC DRUGTYPE Antibody D06PZC HIGHSTAT Phase 1 D06RCE DRUG__ID D06RCE D06RCE DRUGCOMP Baylor College of Medicine D06RCE DRUGTYPE CAR T Cell Therapy D06RCE HIGHSTAT Phase 1 D06TNO DRUG__ID D06TNO D06TNO DRUGCOMP Third Military Medical University D06TNO DRUGTYPE CAR T Cell Therapy D06TNO HIGHSTAT Phase 1 D06URX DRUG__ID D06URX D06URX DRUGCOMP First Affiliated Hospital of Harbin Medical University D06URX DRUGTYPE CAR T Cell Therapy D06URX HIGHSTAT Phase 1 D06UTM DRUG__ID D06UTM D06UTM DRUGCOMP National Cancer Institute (NCI) D06UTM DRUGTYPE CAR T Cell Therapy D06UTM HIGHSTAT Phase 1 D06VCC DRUG__ID D06VCC D06VCC DRUGCOMP Regeneron pharmaceuticals; sanofi us D06VCC DRUGTYPE Antibody D06VCC HIGHSTAT Phase 1 D06XWD DRUG__ID D06XWD D06XWD DRUGCOMP First Affiliated Hospital of Harbin Medical University D06XWD DRUGTYPE CAR T Cell Therapy D06XWD HIGHSTAT Phase 1 D07AJC DRUG__ID D07AJC D07AJC DRUGCOMP Profectus biosciences D07AJC DRUGTYPE Vaccine D07AJC HIGHSTAT Phase 1 D07BNG DRUG__ID D07BNG D07BNG DRUGCOMP Mayo Foundation D07BNG DRUGTYPE Antibody D07BNG HIGHSTAT Phase 1 D07CXM DRUG__ID D07CXM D07CXM DRUGCOMP Sarepta therapeutics D07CXM DRUGTYPE Antisense drug D07CXM HIGHSTAT Phase 1 D07DWC DRUG__ID D07DWC D07DWC DRUGCOMP SynDevRx Cambridge, MA D07DWC DRUGTYPE Polymer drug conjugate D07DWC HIGHSTAT Phase 1 D07HJS DRUG__ID D07HJS D07HJS DRUGCOMP The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine D07HJS DRUGTYPE CAR T Cell Therapy D07HJS HIGHSTAT Phase 1 D07HKV DRUG__ID D07HKV D07HKV DRUGCOMP Centocor Ortho Biotech Inc D07HKV DRUGTYPE Antibody D07HKV HIGHSTAT Phase 1 D07ITH DRUG__ID D07ITH D07ITH DRUGCOMP The First People's Hospital of Yunnan D07ITH DRUGTYPE CAR T Cell Therapy D07ITH HIGHSTAT Phase 1 D07KHR DRUG__ID D07KHR D07KHR DRUGCOMP Alphavax D07KHR DRUGTYPE Vaccine D07KHR HIGHSTAT Phase 1 D07LCY DRUG__ID D07LCY D07LCY DRUGCOMP Wyeth Pharmaceuticals D07LCY DRUGTYPE Vaccine D07LCY HIGHSTAT Phase 1 D07SQT DRUG__ID D07SQT D07SQT DRUGCOMP Eli Lilly D07SQT DRUGTYPE Antibody D07SQT HIGHSTAT Phase 1 D07TCV DRUG__ID D07TCV D07TCV DRUGCOMP Beijing Doing Biomedical Co., Ltd. D07TCV DRUGTYPE CAR T Cell Therapy (Dual specific) D07TCV HIGHSTAT Phase 1 D07TMJ DRUG__ID D07TMJ D07TMJ DRUGCOMP Memorial Sloan Kettering Cancer Center D07TMJ DRUGTYPE CAR T Cell Therapy D07TMJ HIGHSTAT Phase 1 D07UKJ DRUG__ID D07UKJ D07UKJ DRUGCOMP Abbott Laboratories D07UKJ DRUGTYPE Antibody D07UKJ HIGHSTAT Phase 1 D07UZY DRUG__ID D07UZY D07UZY DRUGCOMP Lpath Inc D07UZY DRUGTYPE Monoclonal antibody D07UZY HIGHSTAT Phase 1 D07YPB DRUG__ID D07YPB D07YPB DRUGCOMP University of Pennsylvania D07YPB DRUGTYPE CAR T Cell Therapy D07YPB HIGHSTAT Phase 1 D07ZNF DRUG__ID D07ZNF D07ZNF DRUGCOMP Eli Lilly D07ZNF DRUGTYPE Antibody D07ZNF HIGHSTAT Phase 1 D08DSF DRUG__ID D08DSF D08DSF DRUGCOMP AstraZeneca D08DSF DRUGTYPE Antibody D08DSF HIGHSTAT Phase 1 D08ENB DRUG__ID D08ENB D08ENB DRUGCOMP Quark Pharmaceuticals D08ENB DRUGTYPE Antibody D08ENB HIGHSTAT Phase 1 D08FMR DRUG__ID D08FMR D08FMR DRUGCOMP Archemix Corp D08FMR DRUGTYPE Aptamer D08FMR HIGHSTAT Phase 1 D08GOI DRUG__ID D08GOI D08GOI DRUGCOMP Fate Therapeutics D08GOI DRUGTYPE Cell therapy D08GOI HIGHSTAT Phase 1 D08HKK DRUG__ID D08HKK D08HKK DRUGCOMP Zhujiang Hospital D08HKK DRUGTYPE CAR T Cell Therapy (Dual specific) D08HKK HIGHSTAT Phase 1 D08HSS DRUG__ID D08HSS D08HSS DRUGCOMP Eli Lilly Indianapolis, IN D08HSS DRUGTYPE Monoclonal antibody D08HSS HIGHSTAT Phase 1 D08IDB DRUG__ID D08IDB D08IDB DRUGCOMP UCB Celltech D08IDB DRUGTYPE Antibody D08IDB HIGHSTAT Phase 1 D08IRG DRUG__ID D08IRG D08IRG DRUGCOMP Biogen Idec D08IRG DRUGTYPE Antibody D08IRG HIGHSTAT Phase 1 D08JMI DRUG__ID D08JMI D08JMI DRUGCOMP Alnylam Pharmaceuticals D08JMI DRUGTYPE RNAi therapeutics D08JMI HIGHSTAT Phase 1 D08JYV DRUG__ID D08JYV D08JYV DRUGCOMP Alphavax D08JYV DRUGTYPE Vaccine D08JYV HIGHSTAT Phase 1 D08LLB DRUG__ID D08LLB D08LLB DRUGCOMP Hrain Biotechnology Co., Ltd. D08LLB DRUGTYPE CAR T Cell Therapy D08LLB HIGHSTAT Phase 1 D08QTK DRUG__ID D08QTK D08QTK DRUGCOMP Genentech D08QTK DRUGTYPE Antibody D08QTK HIGHSTAT Phase 1 D08RGH DRUG__ID D08RGH D08RGH THERCLAS Antiviral Agents D08RGH DRUGTYPE Vaccine D08RGH HIGHSTAT Phase 1 Trial D08TRM DRUG__ID D08TRM D08TRM THERCLAS Antiviral Agents D08TRM DRUGTYPE Vaccine D08TRM HIGHSTAT Phase 1 Trial D08UNC DRUG__ID D08UNC D08UNC DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D08UNC DRUGTYPE CAR T Cell Therapy D08UNC HIGHSTAT Phase 1 D08UVN DRUG__ID D08UVN D08UVN DRUGCOMP Roger Williams Medical Center D08UVN DRUGTYPE CAR T Cell Therapy D08UVN HIGHSTAT Phase 1 D08YHE DRUG__ID D08YHE D08YHE DRUGCOMP Celyad (formerly named Cardio3 BioSciences) D08YHE DRUGTYPE CAR T Cell Therapy D08YHE HIGHSTAT Phase 1 D08ZAC DRUG__ID D08ZAC D08ZAC DRUGCOMP Immune Cell, Inc. D08ZAC DRUGTYPE CAR T Cell Therapy D08ZAC HIGHSTAT Phase 1 D09AXQ DRUG__ID D09AXQ D09AXQ DRUGCOMP Zhujiang Hospital D09AXQ DRUGTYPE CAR T Cell Therapy (Dual specific) D09AXQ HIGHSTAT Phase 1 D09DIQ DRUG__ID D09DIQ D09DIQ DRUGCOMP University of Pennsylvania D09DIQ DRUGTYPE CAR T Cell Therapy D09DIQ HIGHSTAT Phase 1 D09DND DRUG__ID D09DND D09DND DRUGCOMP National Cancer Institute (NCI) D09DND DRUGTYPE CAR T Cell Therapy D09DND HIGHSTAT Phase 1 D09ELC DRUG__ID D09ELC D09ELC DRUGCOMP Sarepta therapeutics D09ELC DRUGTYPE Antisense drug D09ELC HIGHSTAT Phase 1 D09FTC DRUG__ID D09FTC D09FTC THERCLAS Antiviral Agents D09FTC DRUGTYPE Vaccine D09FTC HIGHSTAT Phase 1 Trial D09GME DRUG__ID D09GME D09GME THERCLAS Antiviral Agents D09GME DRUGTYPE Vaccine D09GME HIGHSTAT Phase 1 Trial D09GWA DRUG__ID D09GWA D09GWA THERCLAS Antiviral Agents D09GWA DRUGTYPE Vaccine D09GWA HIGHSTAT Phase 1 Trial D09HRH DRUG__ID D09HRH D09HRH DRUGCOMP Chinese PLA General Hospital D09HRH DRUGTYPE CAR T Cell Therapy D09HRH HIGHSTAT Phase 1 D09ICH DRUG__ID D09ICH D09ICH DRUGCOMP Baylor College of Medicine D09ICH DRUGTYPE CAR T Cell Therapy D09ICH HIGHSTAT Phase 1 D09NBH DRUG__ID D09NBH D09NBH DRUGCOMP Immunocellular therapeutics D09NBH DRUGTYPE Vaccine D09NBH HIGHSTAT Phase 1 D09OJI DRUG__ID D09OJI D09OJI DRUGCOMP InventisBio D09OJI DRUGTYPE Small molecular drug D09OJI HIGHSTAT Phase 1 D09OSC DRUG__ID D09OSC D09OSC DRUGCOMP Beijing Sanbo Brain Hospital D09OSC DRUGTYPE CAR T Cell Therapy D09OSC HIGHSTAT Phase 1 D09PQP DRUG__ID D09PQP D09PQP DRUGCOMP Seattle Genetics D09PQP DRUGTYPE Antibody D09PQP HIGHSTAT Phase 1 D09RND DRUG__ID D09RND D09RND DRUGCOMP Santaris Pharma A/S D09RND DRUGTYPE Antisense drug D09RND HIGHSTAT Phase 1 D09SAH DRUG__ID D09SAH D09SAH DRUGCOMP Pinze Lifetechnology Co. Ltd. D09SAH DRUGTYPE CAR T Cell Therapy D09SAH HIGHSTAT Phase 1 D09SBE DRUG__ID D09SBE D09SBE DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D09SBE DRUGTYPE CAR T Cell Therapy D09SBE HIGHSTAT Phase 1 D09TGO DRUG__ID D09TGO D09TGO DRUGCOMP Aeon Therapeutics (Shanghai) Co., Ltd. D09TGO DRUGTYPE CAR T Cell Therapy D09TGO HIGHSTAT Phase 1 D09UGG DRUG__ID D09UGG D09UGG DRUGCOMP Novartis AG D09UGG DRUGTYPE Antibody D09UGG HIGHSTAT Phase 1 D09XOF DRUG__ID D09XOF D09XOF DRUGCOMP Ludwig Institute for Cancer Research D09XOF DRUGTYPE Vaccine D09XOF HIGHSTAT Phase 1 D09XRQ DRUG__ID D09XRQ D09XRQ DRUGCOMP Biogen Inc D09XRQ DRUGTYPE Antibody D09XRQ HIGHSTAT Phase 1 D09YAS DRUG__ID D09YAS D09YAS DRUGCOMP Cytos Biotechnology AG D09YAS DRUGTYPE Vaccine D09YAS HIGHSTAT Phase 1 D09YXN DRUG__ID D09YXN D09YXN DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D09YXN DRUGTYPE CAR T Cell Therapy D09YXN HIGHSTAT Phase 1 D09ZDY DRUG__ID D09ZDY D09ZDY DRUGCOMP UNC Lineberger Comprehensive Cancer Center D09ZDY DRUGTYPE CAR T Cell Therapy D09ZDY HIGHSTAT Phase 1 D09ZKB DRUG__ID D09ZKB D09ZKB DRUGCOMP International AIDS Vaccine Initiative D09ZKB DRUGTYPE Vaccine D09ZKB HIGHSTAT Phase 1 D0A2RX DRUG__ID D0A2RX D0A2RX DRUGCOMP Memorial Sloan Kettering Cancer Center D0A2RX DRUGTYPE CAR T Cell Therapy D0A2RX HIGHSTAT Phase 1 D0A6XC DRUG__ID D0A6XC D0A6XC DRUGCOMP jiuwei cui D0A6XC DRUGTYPE CAR T Cell Therapy D0A6XC HIGHSTAT Phase 1 D0A8AU DRUG__ID D0A8AU D0A8AU DRUGCOMP MabSpace Biosciences Suzhou, China D0A8AU DRUGTYPE Monoclonal antibody D0A8AU HIGHSTAT Phase 1 D0A9GI DRUG__ID D0A9GI D0A9GI DRUGCOMP Wyeth; pfizer D0A9GI DRUGTYPE Antibody D0A9GI HIGHSTAT Phase 1 D0AF1I DRUG__ID D0AF1I D0AF1I DRUGCOMP Pfzer D0AF1I DRUGTYPE Small molecule D0AF1I HIGHSTAT Phase 1 D0AW4T DRUG__ID D0AW4T D0AW4T DRUGCOMP Zhujiang Hospital D0AW4T DRUGTYPE CAR T Cell Therapy D0AW4T HIGHSTAT Phase 1 D0AY1I DRUG__ID D0AY1I D0AY1I DRUGCOMP GlaxoSmithKline plc D0AY1I DRUGTYPE Antibody D0AY1I HIGHSTAT Phase 1 D0B0VD DRUG__ID D0B0VD D0B0VD DRUGCOMP Eisai D0B0VD DRUGTYPE Antibody D0B0VD HIGHSTAT Phase 1 D0B1CU DRUG__ID D0B1CU D0B1CU DRUGCOMP University College, London D0B1CU DRUGTYPE CAR T Cell Therapy D0B1CU HIGHSTAT Phase 1 D0B2WU DRUG__ID D0B2WU D0B2WU DRUGCOMP Second Affiliated Hospital of Xi'an Jiaotong University D0B2WU DRUGTYPE CAR T Cell Therapy D0B2WU HIGHSTAT Phase 1 D0B5PV DRUG__ID D0B5PV D0B5PV DRUGCOMP University of Pennsylvania D0B5PV DRUGTYPE CAR T Cell Therapy D0B5PV HIGHSTAT Phase 1 D0B5RU DRUG__ID D0B5RU D0B5RU DRUGCOMP City of Hope Medical Center D0B5RU DRUGTYPE CAR T Cell Therapy D0B5RU HIGHSTAT Phase 1 D0B5UH DRUG__ID D0B5UH D0B5UH DRUGCOMP Ablynx D0B5UH DRUGTYPE Monoclonal antibody D0B5UH HIGHSTAT Phase 1 D0B8MS DRUG__ID D0B8MS D0B8MS DRUGCOMP AstraZeneca D0B8MS DRUGTYPE Antibody D0B8MS HIGHSTAT Phase 1 D0BC6M DRUG__ID D0BC6M D0BC6M DRUGCOMP Seattle Genetics; Agensys D0BC6M DRUGTYPE Antibody D0BC6M HIGHSTAT Phase 1 D0BOM7 DRUG__ID D0BOM7 D0BOM7 DRUGCOMP Xencor D0BOM7 DRUGTYPE Antibody D0BOM7 HIGHSTAT Phase 1 D0BQ0C DRUG__ID D0BQ0C D0BQ0C DRUGCOMP Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd D0BQ0C DRUGTYPE CAR T Cell Therapy D0BQ0C HIGHSTAT Phase 1 D0BV0U DRUG__ID D0BV0U D0BV0U DRUGCOMP Actinium pharmaceuticals D0BV0U DRUGTYPE Monoclonal antibody D0BV0U HIGHSTAT Phase 1 D0BX5L DRUG__ID D0BX5L D0BX5L DRUGCOMP Livzon Pharmaceutical Zhuhai City, China D0BX5L DRUGTYPE Monoclonal antibody D0BX5L HIGHSTAT Phase 1 D0C2UH DRUG__ID D0C2UH D0C2UH DRUGCOMP Merck; Vical D0C2UH DRUGTYPE Vaccine D0C2UH HIGHSTAT Phase 1 D0C4BD DRUG__ID D0C4BD D0C4BD DRUGCOMP Chengdu Kanghong Biotechnologies Co Ltd D0C4BD DRUGTYPE Vaccine D0C4BD HIGHSTAT Phase 1 D0C4GN DRUG__ID D0C4GN D0C4GN DRUGCOMP M.D. Anderson Cancer Center D0C4GN DRUGTYPE CAR T Cell Therapy D0C4GN HIGHSTAT Phase 1 D0C6ID DRUG__ID D0C6ID D0C6ID DRUGCOMP Viventia Biotech Inc D0C6ID DRUGTYPE Antibody D0C6ID HIGHSTAT Phase 1 D0C8QA DRUG__ID D0C8QA D0C8QA DRUGCOMP Kite, A Gilead Company D0C8QA DRUGTYPE CAR T Cell Therapy D0C8QA HIGHSTAT Phase 1 D0CA3M DRUG__ID D0CA3M D0CA3M DRUGCOMP Chinese PLA General Hospital D0CA3M DRUGTYPE CAR T Cell Therapy D0CA3M HIGHSTAT Phase 1 D0CS3A DRUG__ID D0CS3A D0CS3A DRUGCOMP Henan Cancer Hospital D0CS3A DRUGTYPE CAR T Cell Therapy D0CS3A HIGHSTAT Phase 1 D0CW9M DRUG__ID D0CW9M D0CW9M DRUGCOMP Sanofi D0CW9M DRUGTYPE Nanobody D0CW9M HIGHSTAT Phase 1 D0D1HI DRUG__ID D0D1HI D0D1HI DRUGCOMP University of Pennsylvania D0D1HI DRUGTYPE CAR T Cell Therapy D0D1HI HIGHSTAT Phase 1 D0D2LE DRUG__ID D0D2LE D0D2LE DRUGCOMP Shanghai GeneChem Co., Ltd. D0D2LE DRUGTYPE CAR T Cell Therapy D0D2LE HIGHSTAT Phase 1 D0D4TC DRUG__ID D0D4TC D0D4TC DRUGCOMP Symphogen Somerville, NJ D0D4TC DRUGTYPE Monoclonal antibody D0D4TC HIGHSTAT Phase 1 D0D4UT DRUG__ID D0D4UT D0D4UT DRUGCOMP Glaxosmithkline D0D4UT DRUGTYPE Antibody D0D4UT HIGHSTAT Phase 1 D0D5LX DRUG__ID D0D5LX D0D5LX DRUGCOMP Nkt therapeutics D0D5LX DRUGTYPE Antibody D0D5LX HIGHSTAT Phase 1 D0D7FV DRUG__ID D0D7FV D0D7FV DRUGCOMP Crystal Mackall, MD D0D7FV DRUGTYPE CAR T Cell Therapy (Dual specific) D0D7FV HIGHSTAT Phase 1 D0D8NG DRUG__ID D0D8NG D0D8NG DRUGCOMP Immunomedics D0D8NG DRUGTYPE Monoclonal antibody D0D8NG HIGHSTAT Phase 1 D0DA1U DRUG__ID D0DA1U D0DA1U DRUGCOMP Baylor College of Medicine D0DA1U DRUGTYPE CAR T Cell Therapy D0DA1U HIGHSTAT Phase 1 D0DBS7 DRUG__ID D0DBS7 D0DBS7 DRUGCOMP Glenmark Pharmaceuticals D0DBS7 DRUGTYPE Antibody D0DBS7 HIGHSTAT Phase 1 D0DJ8S DRUG__ID D0DJ8S D0DJ8S DRUGCOMP Zhujiang Hospital D0DJ8S DRUGTYPE CAR T Cell Therapy D0DJ8S HIGHSTAT Phase 1 D0DR6N DRUG__ID D0DR6N D0DR6N DRUGCOMP Zhujiang Hospital D0DR6N DRUGTYPE CAR T Cell Therapy D0DR6N HIGHSTAT Phase 1 D0DU4T DRUG__ID D0DU4T D0DU4T DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0DU4T DRUGTYPE CAR T Cell Therapy D0DU4T HIGHSTAT Phase 1 D0E0SH DRUG__ID D0E0SH D0E0SH DRUGCOMP Zhujiang Hospital D0E0SH DRUGTYPE CAR T Cell Therapy D0E0SH HIGHSTAT Phase 1 D0E2VF DRUG__ID D0E2VF D0E2VF DRUGCOMP Shanghai GeneChem Co., Ltd. D0E2VF DRUGTYPE CAR T Cell Therapy D0E2VF HIGHSTAT Phase 1 D0E2ZX DRUG__ID D0E2ZX D0E2ZX DRUGCOMP Seattle genetics D0E2ZX DRUGTYPE Antibody D0E2ZX HIGHSTAT Phase 1 D0E7RC DRUG__ID D0E7RC D0E7RC DRUGCOMP Ohio State University D0E7RC DRUGTYPE Vaccine D0E7RC HIGHSTAT Phase 1 D0E8ZL DRUG__ID D0E8ZL D0E8ZL DRUGCOMP Zhujiang Hospital D0E8ZL DRUGTYPE CAR T Cell Therapy (Dual specific) D0E8ZL HIGHSTAT Phase 1 D0E9HQ DRUG__ID D0E9HQ D0E9HQ DRUGCOMP Roche D0E9HQ DRUGTYPE Antibody D0E9HQ HIGHSTAT Phase 1 D0EB0Y DRUG__ID D0EB0Y D0EB0Y DRUGCOMP University of Pennsylvania D0EB0Y DRUGTYPE CAR T Cell Therapy D0EB0Y HIGHSTAT Phase 1 D0EO6G DRUG__ID D0EO6G D0EO6G DRUGCOMP National Cancer Institute (NCI) D0EO6G DRUGTYPE CAR T Cell Therapy D0EO6G HIGHSTAT Phase 1 D0EX1C DRUG__ID D0EX1C D0EX1C DRUGCOMP Arizona State University D0EX1C DRUGTYPE Vaccine D0EX1C HIGHSTAT Phase 1 D0F0VW DRUG__ID D0F0VW D0F0VW DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0F0VW DRUGTYPE CAR T Cell Therapy D0F0VW HIGHSTAT Phase 1 D0F1OH DRUG__ID D0F1OH D0F1OH DRUGCOMP University College, London D0F1OH DRUGTYPE CAR T Cell Therapy D0F1OH HIGHSTAT Phase 1 D0F1ZB DRUG__ID D0F1ZB D0F1ZB DRUGCOMP Novartis AG D0F1ZB DRUGTYPE Antibody D0F1ZB HIGHSTAT Phase 1 D0F4LP DRUG__ID D0F4LP D0F4LP DRUGCOMP Assistance publique, H pitaux de Paris D0F4LP DRUGTYPE Human embryonic stem (hES) cell-derived therapeutics D0F4LP HIGHSTAT Phase 1 D0F5GF DRUG__ID D0F5GF D0F5GF DRUGCOMP Antigen express D0F5GF DRUGTYPE Vaccine D0F5GF HIGHSTAT Phase 1 D0F6KM DRUG__ID D0F6KM D0F6KM DRUGCOMP ISIS Pharm D0F6KM DRUGTYPE Antisense drug D0F6KM HIGHSTAT Phase 1 D0F9TL DRUG__ID D0F9TL D0F9TL DRUGCOMP Biotest AG D0F9TL DRUGTYPE Antibody D0F9TL HIGHSTAT Phase 1 D0FB4W DRUG__ID D0FB4W D0FB4W DRUGCOMP Celyad (formerly named Cardio3 BioSciences) D0FB4W DRUGTYPE CAR T Cell Therapy D0FB4W HIGHSTAT Phase 1 D0FL5S DRUG__ID D0FL5S D0FL5S DRUGCOMP Zhujiang Hospital D0FL5S DRUGTYPE CAR T Cell Therapy D0FL5S HIGHSTAT Phase 1 D0G3EU DRUG__ID D0G3EU D0G3EU DRUGCOMP Amgen; astrazeneca D0G3EU DRUGTYPE Antibody D0G3EU HIGHSTAT Phase 1 D0G4GY DRUG__ID D0G4GY D0G4GY DRUGCOMP Chinese PLA General Hospital D0G4GY DRUGTYPE CAR T Cell Therapy D0G4GY HIGHSTAT Phase 1 D0G4OS DRUG__ID D0G4OS D0G4OS DRUGCOMP Massachusetts Biologic Laboratories D0G4OS DRUGTYPE Monoclonal antibody D0G4OS HIGHSTAT Phase 1 D0G7SM DRUG__ID D0G7SM D0G7SM DRUGCOMP Antigen Express Inc D0G7SM DRUGTYPE Vaccine D0G7SM HIGHSTAT Phase 1 D0G8LN DRUG__ID D0G8LN D0G8LN DRUGCOMP ISIS Pharm D0G8LN DRUGTYPE Antisense drug D0G8LN HIGHSTAT Phase 1 D0G8YJ DRUG__ID D0G8YJ D0G8YJ DRUGCOMP Timmune Biotech Inc. D0G8YJ DRUGTYPE CAR T Cell Therapy D0G8YJ HIGHSTAT Phase 1 D0GA8I DRUG__ID D0GA8I D0GA8I DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0GA8I DRUGTYPE CAR T Cell Therapy D0GA8I HIGHSTAT Phase 1 D0GC3U DRUG__ID D0GC3U D0GC3U DRUGCOMP Peking Union Medical College Hospital D0GC3U DRUGTYPE CAR T Cell Therapy D0GC3U HIGHSTAT Phase 1 D0GD9E DRUG__ID D0GD9E D0GD9E DRUGCOMP Baylor College of Medicine D0GD9E DRUGTYPE CAR T Cell Therapy D0GD9E HIGHSTAT Phase 1 D0GJ2G DRUG__ID D0GJ2G D0GJ2G DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0GJ2G DRUGTYPE CAR T Cell Therapy D0GJ2G HIGHSTAT Phase 1 D0GMN2 DRUG__ID D0GMN2 D0GMN2 DRUGCOMP Junshi Biosciences D0GMN2 DRUGTYPE Antibody D0GMN2 HIGHSTAT Phase 1 D0GP9M DRUG__ID D0GP9M D0GP9M DRUGCOMP Sanofi D0GP9M DRUGTYPE Antibody D0GP9M HIGHSTAT Phase 1 D0GR9H DRUG__ID D0GR9H D0GR9H DRUGCOMP Seattle Children's Hospital D0GR9H DRUGTYPE CAR T Cell Therapy D0GR9H HIGHSTAT Phase 1 D0H0LK DRUG__ID D0H0LK D0H0LK DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0H0LK DRUGTYPE CAR T Cell Therapy D0H0LK HIGHSTAT Phase 1 D0H2CF DRUG__ID D0H2CF D0H2CF DRUGCOMP Quest PharmaTech D0H2CF DRUGTYPE Monoclonal antibody D0H2CF HIGHSTAT Phase 1 D0H2LC DRUG__ID D0H2LC D0H2LC DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0H2LC DRUGTYPE CAR T Cell Therapy D0H2LC HIGHSTAT Phase 1 D0H4UP DRUG__ID D0H4UP D0H4UP DRUGCOMP Carsgen Therapeutics, Ltd. D0H4UP DRUGTYPE CAR T Cell Therapy D0H4UP HIGHSTAT Phase 1 D0H7ZN DRUG__ID D0H7ZN D0H7ZN DRUGCOMP ViroMed Co Ltd D0H7ZN DRUGTYPE Vaccine D0H7ZN HIGHSTAT Phase 1 D0H8PX DRUG__ID D0H8PX D0H8PX DRUGCOMP Eisai D0H8PX DRUGTYPE Antibody D0H8PX HIGHSTAT Phase 1 D0H9OT DRUG__ID D0H9OT D0H9OT DRUGCOMP Biomedical Primate Research Centre D0H9OT DRUGTYPE Vaccine D0H9OT HIGHSTAT Phase 1 D0I0ZO DRUG__ID D0I0ZO D0I0ZO DRUGCOMP Baylor College of Medicine D0I0ZO DRUGTYPE Antibody D0I0ZO HIGHSTAT Phase 1 D0I1PF DRUG__ID D0I1PF D0I1PF DRUGCOMP Second Affiliated Hospital of Xi'an Jiaotong University D0I1PF DRUGTYPE CAR T Cell Therapy D0I1PF HIGHSTAT Phase 1 D0I7ZH DRUG__ID D0I7ZH D0I7ZH DRUGCOMP Seattle Children's Hospital D0I7ZH DRUGTYPE CAR T Cell Therapy D0I7ZH HIGHSTAT Phase 1 D0IA5O DRUG__ID D0IA5O D0IA5O DRUGCOMP GlaxoSmithKline plc D0IA5O DRUGTYPE Vaccine D0IA5O HIGHSTAT Phase 1 D0IQ4V DRUG__ID D0IQ4V D0IQ4V DRUGCOMP RenJi Hospital D0IQ4V DRUGTYPE CAR T Cell Therapy D0IQ4V HIGHSTAT Phase 1 D0J2VB DRUG__ID D0J2VB D0J2VB DRUGCOMP GSK D0J2VB DRUGTYPE Combination drug (Antibody) D0J2VB HIGHSTAT Phase 1 D0J6WE DRUG__ID D0J6WE D0J6WE DRUGCOMP Bioceltech Therapeutics, Ltd. D0J6WE DRUGTYPE CAR T Cell Therapy D0J6WE HIGHSTAT Phase 1 D0J7OU DRUG__ID D0J7OU D0J7OU DRUGCOMP Hebei Yanda Ludaopei Hospital D0J7OU DRUGTYPE CAR T Cell Therapy D0J7OU HIGHSTAT Phase 1 D0J7QC DRUG__ID D0J7QC D0J7QC DRUGCOMP MRI Interventions D0J7QC DRUGTYPE Antibody D0J7QC HIGHSTAT Phase 1 D0J9UA DRUG__ID D0J9UA D0J9UA DRUGCOMP Pfizer D0J9UA DRUGTYPE Human embryonic stem (hES) cell-derived therapeutics D0J9UA HIGHSTAT Phase 1 D0JD6Y DRUG__ID D0JD6Y D0JD6Y DRUGCOMP Shanghai Tong Ren Hospital D0JD6Y DRUGTYPE CAR T Cell Therapy D0JD6Y HIGHSTAT Phase 1 D0JF9Z DRUG__ID D0JF9Z D0JF9Z DRUGCOMP Csl; janssen research & development D0JF9Z DRUGTYPE Antibody D0JF9Z HIGHSTAT Phase 1 D0JI4M DRUG__ID D0JI4M D0JI4M DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D0JI4M DRUGTYPE CAR T Cell Therapy D0JI4M HIGHSTAT Phase 1 D0JO9M DRUG__ID D0JO9M D0JO9M DRUGCOMP National Cancer Institute (NCI) D0JO9M DRUGTYPE CAR T Cell Therapy D0JO9M HIGHSTAT Phase 1 D0JX7M DRUG__ID D0JX7M D0JX7M DRUGCOMP Affiliated Hospital to Academy of Military Medical Sciences D0JX7M DRUGTYPE CAR T Cell Therapy D0JX7M HIGHSTAT Phase 1 D0JY0M DRUG__ID D0JY0M D0JY0M DRUGCOMP Affiliated Hospital to Academy of Military Medical Sciences D0JY0M DRUGTYPE CAR T Cell Therapy (Dual specific) D0JY0M HIGHSTAT Phase 1 D0K0WA DRUG__ID D0K0WA D0K0WA DRUGCOMP Janssen Biotech D0K0WA DRUGTYPE Antibody D0K0WA HIGHSTAT Phase 1 D0K1OK DRUG__ID D0K1OK D0K1OK DRUGCOMP Progenics Pharmaceuticals D0K1OK DRUGTYPE Antibody D0K1OK HIGHSTAT Phase 1 D0K6JQ DRUG__ID D0K6JQ D0K6JQ DRUGCOMP Inovio pharmaceuticals D0K6JQ DRUGTYPE Vaccine D0K6JQ HIGHSTAT Phase 1 D0KP9A DRUG__ID D0KP9A D0KP9A DRUGCOMP Bristol-Myers Squibb D0KP9A DRUGTYPE Antibody D0KP9A HIGHSTAT Phase 1 D0KV2E DRUG__ID D0KV2E D0KV2E DRUGCOMP Lpath D0KV2E DRUGTYPE Antibody D0KV2E HIGHSTAT Phase 1 D0KZ0V DRUG__ID D0KZ0V D0KZ0V DRUGCOMP Baylor College of Medicine D0KZ0V DRUGTYPE CAR T Cell Therapy D0KZ0V HIGHSTAT Phase 1 D0L5KK DRUG__ID D0L5KK D0L5KK DRUGCOMP M.D. Anderson Cancer Center D0L5KK DRUGTYPE CAR T Cell Therapy D0L5KK HIGHSTAT Phase 1 D0L5ZH DRUG__ID D0L5ZH D0L5ZH DRUGCOMP AnaptysBio San Diego, CA Celgene Summit, NJ D0L5ZH DRUGTYPE Antibody D0L5ZH HIGHSTAT Phase 1 D0L6HU DRUG__ID D0L6HU D0L6HU DRUGCOMP First Affiliated Hospital of Harbin Medical University D0L6HU DRUGTYPE CAR T Cell Therapy D0L6HU HIGHSTAT Phase 1 D0L6SS DRUG__ID D0L6SS D0L6SS DRUGCOMP Bellicum Pharmaceuticals D0L6SS DRUGTYPE Vaccine D0L6SS HIGHSTAT Phase 1 D0L7OJ DRUG__ID D0L7OJ D0L7OJ DRUGCOMP First Affiliated Hospital of Harbin Medical University D0L7OJ DRUGTYPE CAR T Cell Therapy D0L7OJ HIGHSTAT Phase 1 D0L8OP DRUG__ID D0L8OP D0L8OP DRUGCOMP Emergent biosolutions D0L8OP DRUGTYPE Antibody D0L8OP HIGHSTAT Phase 1 D0L9PU DRUG__ID D0L9PU D0L9PU DRUGCOMP Klus Pharma D0L9PU DRUGTYPE Monoclonal antibody D0L9PU HIGHSTAT Phase 1 D0LF3K DRUG__ID D0LF3K D0LF3K DRUGCOMP Glaxosmithkline; novavax; vaxart D0LF3K DRUGTYPE Vaccine D0LF3K HIGHSTAT Phase 1 D0LU1O DRUG__ID D0LU1O D0LU1O DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0LU1O DRUGTYPE Monoclonal antibody D0LU1O HIGHSTAT Phase 1 D0LY0C DRUG__ID D0LY0C D0LY0C DRUGCOMP Ludwig Institute for Cancer Research D0LY0C DRUGTYPE Antibody D0LY0C HIGHSTAT Phase 1 D0M0NF DRUG__ID D0M0NF D0M0NF THERCLAS Antiviral Agents D0M0NF DRUGTYPE Vaccine D0M0NF HIGHSTAT Phase 1 Trial D0M0WM DRUG__ID D0M0WM D0M0WM DRUGCOMP Novartis AG D0M0WM DRUGTYPE Antibody D0M0WM HIGHSTAT Phase 1 D0M2YX DRUG__ID D0M2YX D0M2YX DRUGCOMP Center for Genetic Engineering and Biotechnology D0M2YX DRUGTYPE Vaccine D0M2YX HIGHSTAT Phase 1 D0M3NW DRUG__ID D0M3NW D0M3NW DRUGCOMP Sanofi D0M3NW DRUGTYPE Antibody D0M3NW HIGHSTAT Phase 1 D0M4MH DRUG__ID D0M4MH D0M4MH DRUGCOMP Wyeth D0M4MH DRUGTYPE Antibody D0M4MH HIGHSTAT Phase 1 D0M4OG DRUG__ID D0M4OG D0M4OG THERCLAS Antiviral Agents D0M4OG DRUGTYPE Vaccine D0M4OG HIGHSTAT Phase 1 Trial D0M5II DRUG__ID D0M5II D0M5II DRUGCOMP University of Pennsylvania D0M5II DRUGTYPE CAR T Cell Therapy D0M5II HIGHSTAT Phase 1 D0M6QJ DRUG__ID D0M6QJ D0M6QJ THERCLAS Antiviral Agents D0M6QJ DRUGTYPE Combination drug D0M6QJ HIGHSTAT Phase 1 Trial D0MA2E DRUG__ID D0MA2E D0MA2E DRUGCOMP Baylor College of Medicine D0MA2E DRUGTYPE CAR T Cell Therapy D0MA2E HIGHSTAT Phase 1 D0MD8S DRUG__ID D0MD8S D0MD8S DRUGCOMP First Affiliated Hospital of Wenzhou Medical University D0MD8S DRUGTYPE CAR T Cell Therapy (Dual specific) D0MD8S HIGHSTAT Phase 1 D0MG3Z DRUG__ID D0MG3Z D0MG3Z DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D0MG3Z DRUGTYPE CAR T Cell Therapy D0MG3Z HIGHSTAT Phase 1 D0ML1G DRUG__ID D0ML1G D0ML1G THERCLAS Antiviral Agents D0ML1G DRUGTYPE Vaccine D0ML1G HIGHSTAT Phase 1 Trial D0MO7Y DRUG__ID D0MO7Y D0MO7Y THERCLAS Antiviral Agents D0MO7Y DRUGTYPE Vaccine D0MO7Y HIGHSTAT Phase 1 Trial D0MQ6B DRUG__ID D0MQ6B D0MQ6B THERCLAS Antiviral Agents D0MQ6B DRUGTYPE Vaccine D0MQ6B HIGHSTAT Phase 1 Trial D0MR2D DRUG__ID D0MR2D D0MR2D THERCLAS Antiviral Agents D0MR2D DRUGTYPE Vaccine D0MR2D HIGHSTAT Phase 1 Trial D0MS2T DRUG__ID D0MS2T D0MS2T DRUGCOMP Fred Hutchinson Cancer Research Center D0MS2T DRUGTYPE CAR T Cell Therapy D0MS2T HIGHSTAT Phase 1 D0MT6W DRUG__ID D0MT6W D0MT6W THERCLAS Antiviral Agents D0MT6W DRUGTYPE Vaccine D0MT6W HIGHSTAT Phase 1 Trial D0MWS2 DRUG__ID D0MWS2 D0MWS2 DRUGCOMP Novartis D0MWS2 DRUGTYPE CAR T Cell Therapy D0MWS2 HIGHSTAT Phase 1 D0N2AM DRUG__ID D0N2AM D0N2AM DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0N2AM DRUGTYPE CAR T Cell Therapy D0N2AM HIGHSTAT Phase 1 D0N2QW DRUG__ID D0N2QW D0N2QW DRUGCOMP Daiichi sankyo D0N2QW DRUGTYPE Antibody D0N2QW HIGHSTAT Phase 1 D0N5VK DRUG__ID D0N5VK D0N5VK DRUGCOMP TESARO Waltham, MA D0N5VK DRUGTYPE Monoclonal antibody D0N5VK HIGHSTAT Phase 1 D0N6QB DRUG__ID D0N6QB D0N6QB DRUGCOMP Amgenl; bayer healthcare pharmaceuticals D0N6QB DRUGTYPE Antibody D0N6QB HIGHSTAT Phase 1 D0N9JB DRUG__ID D0N9JB D0N9JB DRUGCOMP Sanofi D0N9JB DRUGTYPE Antibody D0N9JB HIGHSTAT Phase 1 D0NC9M DRUG__ID D0NC9M D0NC9M DRUGCOMP Celyad (formerly named Cardio3 BioSciences) D0NC9M DRUGTYPE CAR T Cell Therapy D0NC9M HIGHSTAT Phase 1 D0NG3T DRUG__ID D0NG3T D0NG3T DRUGCOMP The Pregene (ShenZhen) Biotechnology Company, Ltd. D0NG3T DRUGTYPE CAR T Cell Therapy D0NG3T HIGHSTAT Phase 1 D0NK6K DRUG__ID D0NK6K D0NK6K DRUGCOMP Poseida Therapeutics, Inc. D0NK6K DRUGTYPE CAR T Cell Therapy D0NK6K HIGHSTAT Phase 1 D0NO1A DRUG__ID D0NO1A D0NO1A DRUGCOMP Affitech D0NO1A DRUGTYPE Antibody D0NO1A HIGHSTAT Phase 1 D0NQ1S DRUG__ID D0NQ1S D0NQ1S DRUGCOMP Janssen Research & Development Raritan, NJ D0NQ1S DRUGTYPE Bispecific antibody D0NQ1S HIGHSTAT Phase 1 D0NU9L DRUG__ID D0NU9L D0NU9L DRUGCOMP Medical College of Wisconsin D0NU9L DRUGTYPE CAR T Cell Therapy (Dual specific) D0NU9L HIGHSTAT Phase 1 D0NU9N DRUG__ID D0NU9N D0NU9N DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D0NU9N DRUGTYPE CAR T Cell Therapy D0NU9N HIGHSTAT Phase 1 D0NV6I DRUG__ID D0NV6I D0NV6I DRUGCOMP Hebei Senlang Biotechnology Inc., Ltd. D0NV6I DRUGTYPE CAR T Cell Therapy D0NV6I HIGHSTAT Phase 1 D0NY1Y DRUG__ID D0NY1Y D0NY1Y DRUGCOMP Zhujiang Hospital D0NY1Y DRUGTYPE CAR T Cell Therapy D0NY1Y HIGHSTAT Phase 1 D0O0RG DRUG__ID D0O0RG D0O0RG DRUGCOMP Microvax D0O0RG DRUGTYPE Vaccine D0O0RG HIGHSTAT Phase 1 D0O1WR DRUG__ID D0O1WR D0O1WR DRUGCOMP African Malaria Network Trust D0O1WR DRUGTYPE Vaccine D0O1WR HIGHSTAT Phase 1 D0O2XK DRUG__ID D0O2XK D0O2XK DRUGCOMP Memorial Sloan Kettering Cancer Center D0O2XK DRUGTYPE CAR T Cell Therapy D0O2XK HIGHSTAT Phase 1 D0O7VZ DRUG__ID D0O7VZ D0O7VZ DRUGCOMP Case Comprehensive Cancer Center D0O7VZ DRUGTYPE CAR T Cell Therapy D0O7VZ HIGHSTAT Phase 1 D0O9HF DRUG__ID D0O9HF D0O9HF DRUGCOMP Glycotope GmbH D0O9HF DRUGTYPE Antibody D0O9HF HIGHSTAT Phase 1 D0OC5C DRUG__ID D0OC5C D0OC5C DRUGCOMP Immune Cell, Inc. D0OC5C DRUGTYPE CAR T Cell Therapy D0OC5C HIGHSTAT Phase 1 D0OD8T DRUG__ID D0OD8T D0OD8T DRUGCOMP Institute of Hematology & Blood Diseases Hospital D0OD8T DRUGTYPE CAR T Cell Therapy D0OD8T HIGHSTAT Phase 1 D0OQ5R DRUG__ID D0OQ5R D0OQ5R DRUGCOMP Igenica D0OQ5R DRUGTYPE Antibody D0OQ5R HIGHSTAT Phase 1 D0OV2F DRUG__ID D0OV2F D0OV2F DRUGCOMP OranoMed/Radiomedix D0OV2F DRUGTYPE Radiopharmaceutical therapy agent D0OV2F HIGHSTAT Phase 1 D0OX1Y DRUG__ID D0OX1Y D0OX1Y DRUGCOMP Crucell NV D0OX1Y DRUGTYPE Vaccine D0OX1Y HIGHSTAT Phase 1 D0P2GA DRUG__ID D0P2GA D0P2GA DRUGCOMP University of Pennsylvania D0P2GA DRUGTYPE CAR T Cell Therapy D0P2GA HIGHSTAT Phase 1 D0P2GU DRUG__ID D0P2GU D0P2GU DRUGCOMP Janssen Biotech D0P2GU DRUGTYPE Antibody D0P2GU HIGHSTAT Phase 1 D0P5PD DRUG__ID D0P5PD D0P5PD DRUGCOMP Immunomedics D0P5PD DRUGTYPE Antibody D0P5PD HIGHSTAT Phase 1 D0P6YN DRUG__ID D0P6YN D0P6YN DRUGCOMP Zhujiang Hospital D0P6YN DRUGTYPE CAR T Cell Therapy D0P6YN HIGHSTAT Phase 1 D0P7KU DRUG__ID D0P7KU D0P7KU DRUGCOMP Lilly D0P7KU DRUGTYPE Antibody D0P7KU HIGHSTAT Phase 1 D0P9KD DRUG__ID D0P9KD D0P9KD DRUGCOMP Pfizer D0P9KD DRUGTYPE Antibody D0P9KD HIGHSTAT Phase 1 D0PE3J DRUG__ID D0PE3J D0PE3J DRUGCOMP Seattle Children's Hospital D0PE3J DRUGTYPE CAR T Cell Therapy D0PE3J HIGHSTAT Phase 1 D0PH6Z DRUG__ID D0PH6Z D0PH6Z DRUGCOMP M.D. Anderson Cancer Center D0PH6Z DRUGTYPE CAR T Cell Therapy D0PH6Z HIGHSTAT Phase 1 D0PO0L DRUG__ID D0PO0L D0PO0L DRUGCOMP Xinqiao Hospital of Chongqing D0PO0L DRUGTYPE CAR T Cell Therapy D0PO0L HIGHSTAT Phase 1 D0PT2M DRUG__ID D0PT2M D0PT2M DRUGCOMP Gary Archer Ph.D. D0PT2M DRUGTYPE CAR T Cell Therapy D0PT2M HIGHSTAT Phase 1 D0PT5D DRUG__ID D0PT5D D0PT5D DRUGCOMP China Meitan General Hospital D0PT5D DRUGTYPE CAR T Cell Therapy D0PT5D HIGHSTAT Phase 1 D0PT6W DRUG__ID D0PT6W D0PT6W DRUGCOMP PIN Pharma New York, NY D0PT6W DRUGTYPE Peptide D0PT6W HIGHSTAT Phase 1 D0PY3L DRUG__ID D0PY3L D0PY3L DRUGCOMP MedImmune D0PY3L DRUGTYPE Monoclonal antibody D0PY3L HIGHSTAT Phase 1 D0PY5I DRUG__ID D0PY5I D0PY5I DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0PY5I DRUGTYPE CAR T Cell Therapy D0PY5I HIGHSTAT Phase 1 D0Q8ML DRUG__ID D0Q8ML D0Q8ML DRUGCOMP Fred Hutchinson Cancer Research Center D0Q8ML DRUGTYPE CAR T Cell Therapy D0Q8ML HIGHSTAT Phase 1 D0Q8XO DRUG__ID D0Q8XO D0Q8XO DRUGCOMP Beijing Sanwater Biological Technology Co., Ltd. D0Q8XO DRUGTYPE CAR T Cell Therapy D0Q8XO HIGHSTAT Phase 1 D0QB7N DRUG__ID D0QB7N D0QB7N DRUGCOMP Baylor College of Medicine D0QB7N DRUGTYPE CAR T Cell Therapy D0QB7N HIGHSTAT Phase 1 D0QE4F DRUG__ID D0QE4F D0QE4F DRUGCOMP City of Hope Medical Center D0QE4F DRUGTYPE CAR T Cell Therapy (Dual specific) D0QE4F HIGHSTAT Phase 1 D0QR2K DRUG__ID D0QR2K D0QR2K DRUGCOMP Celyad (formerly named Cardio3 BioSciences) D0QR2K DRUGTYPE CAR T Cell Therapy D0QR2K HIGHSTAT Phase 1 D0QV9Q DRUG__ID D0QV9Q D0QV9Q DRUGCOMP University of Pennsylvania D0QV9Q DRUGTYPE CAR T Cell Therapy D0QV9Q HIGHSTAT Phase 1 D0R1CG DRUG__ID D0R1CG D0R1CG DRUGCOMP Seattle Genetics; Agensys D0R1CG DRUGTYPE Antibody D0R1CG HIGHSTAT Phase 1 D0R1XF DRUG__ID D0R1XF D0R1XF DRUGCOMP National Cancer Institute D0R1XF DRUGTYPE Monoclonal antibody D0R1XF HIGHSTAT Phase 1 D0R5NU DRUG__ID D0R5NU D0R5NU DRUGCOMP University of Pennsylvania D0R5NU DRUGTYPE CAR T Cell Therapy D0R5NU HIGHSTAT Phase 1 D0R7YH DRUG__ID D0R7YH D0R7YH DRUGCOMP Roche/Genentech D0R7YH DRUGTYPE Vaccine D0R7YH HIGHSTAT Phase 1 D0RA7L DRUG__ID D0RA7L D0RA7L DRUGCOMP Shenzhen Second People's Hospital D0RA7L DRUGTYPE CAR T Cell Therapy D0RA7L HIGHSTAT Phase 1 D0RD0D DRUG__ID D0RD0D D0RD0D DRUGCOMP University of Pennsylvania D0RD0D DRUGTYPE CAR T Cell Therapy D0RD0D HIGHSTAT Phase 1 D0RD1I DRUG__ID D0RD1I D0RD1I DRUGCOMP Xoma; national institute of allergy and infectious diseases D0RD1I DRUGTYPE Antibody D0RD1I HIGHSTAT Phase 1 D0RH3S DRUG__ID D0RH3S D0RH3S DRUGCOMP Dana-Farber Cancer Institute Inc D0RH3S DRUGTYPE Vaccine D0RH3S HIGHSTAT Phase 1 D0S1QN DRUG__ID D0S1QN D0S1QN DRUGCOMP Southwest Hospital, China D0S1QN DRUGTYPE CAR T Cell Therapy D0S1QN HIGHSTAT Phase 1 D0S3AE DRUG__ID D0S3AE D0S3AE DRUGCOMP Quest pharmatech D0S3AE DRUGTYPE Monoclonal antibody D0S3AE HIGHSTAT Phase 1 D0S3YV DRUG__ID D0S3YV D0S3YV DRUGCOMP Baylor College of Medicine D0S3YV DRUGTYPE CAR T Cell Therapy D0S3YV HIGHSTAT Phase 1 D0S4KJ DRUG__ID D0S4KJ D0S4KJ DRUGCOMP Kyowa Hakko Kirin Pharma D0S4KJ DRUGTYPE Antibody D0S4KJ HIGHSTAT Phase 1 D0S5BC DRUG__ID D0S5BC D0S5BC DRUGCOMP Henan Cancer Hospital D0S5BC DRUGTYPE CAR T Cell Therapy D0S5BC HIGHSTAT Phase 1 D0S9FI DRUG__ID D0S9FI D0S9FI DRUGCOMP Memorial Sloan Kettering Cancer Center D0S9FI DRUGTYPE CAR T Cell Therapy D0S9FI HIGHSTAT Phase 1 D0SD9R DRUG__ID D0SD9R D0SD9R DRUGCOMP Sara V. Latorre D0SD9R DRUGTYPE CAR T Cell Therapy D0SD9R HIGHSTAT Phase 1 D0SF5Q DRUG__ID D0SF5Q D0SF5Q DRUGCOMP Inovio Pharmaceuticals D0SF5Q DRUGTYPE Vaccine D0SF5Q HIGHSTAT Phase 1 D0SOG8 DRUG__ID D0SOG8 D0SOG8 DRUGCOMP NatureWise Biotech & Medicals D0SOG8 DRUGTYPE Small molecular drug D0SOG8 HIGHSTAT Phase 1 D0T0SE DRUG__ID D0T0SE D0T0SE DRUGCOMP RenJi Hospital D0T0SE DRUGTYPE CAR T Cell Therapy D0T0SE HIGHSTAT Phase 1 D0T4BL DRUG__ID D0T4BL D0T4BL DRUGCOMP Ferrer; Hospira; LG Life Sciences; AEterna Zentaris D0T4BL THERCLAS Anticancer Agents D0T4BL HIGHSTAT Phase 1 D0T5LQ DRUG__ID D0T5LQ D0T5LQ DRUGCOMP University College London D0T5LQ DRUGTYPE Antibody D0T5LQ HIGHSTAT Phase 1 D0T6KI DRUG__ID D0T6KI D0T6KI DRUGCOMP Second Affiliated Hospital of Guangzhou Medical University D0T6KI DRUGTYPE CAR T Cell Therapy D0T6KI HIGHSTAT Phase 1 D0T7CR DRUG__ID D0T7CR D0T7CR DRUGCOMP University of Pennsylvania D0T7CR DRUGTYPE CAR T Cell Therapy D0T7CR HIGHSTAT Phase 1 D0T7LV DRUG__ID D0T7LV D0T7LV DRUGCOMP INRS-Institut Armand-Frappier D0T7LV DRUGTYPE Vaccine D0T7LV HIGHSTAT Phase 1 D0T8RV DRUG__ID D0T8RV D0T8RV DRUGCOMP University of Pennsylvania D0T8RV DRUGTYPE CAR T Cell Therapy (Dual specific) D0T8RV HIGHSTAT Phase 1 D0T9CE DRUG__ID D0T9CE D0T9CE DRUGCOMP Henan Cancer Hospital D0T9CE DRUGTYPE CAR T Cell Therapy D0T9CE HIGHSTAT Phase 1 D0TC6X DRUG__ID D0TC6X D0TC6X DRUGCOMP National Cancer Institute (NCI) D0TC6X DRUGTYPE CAR T Cell Therapy D0TC6X HIGHSTAT Phase 1 D0TD0O DRUG__ID D0TD0O D0TD0O DRUGCOMP First Affiliated Hospital of Wenzhou Medical University D0TD0O DRUGTYPE CAR T Cell Therapy D0TD0O HIGHSTAT Phase 1 D0TN5W DRUG__ID D0TN5W D0TN5W DRUGCOMP City of Hope Medical Center D0TN5W DRUGTYPE CAR T Cell Therapy D0TN5W HIGHSTAT Phase 1 D0U1HR DRUG__ID D0U1HR D0U1HR DRUGCOMP Chinese PLA General Hospital D0U1HR DRUGTYPE CAR T Cell Therapy (Dual specific) D0U1HR HIGHSTAT Phase 1 D0U2PS DRUG__ID D0U2PS D0U2PS DRUGCOMP Mie University School of Medicine D0U2PS DRUGTYPE Vaccine D0U2PS HIGHSTAT Phase 1 D0U2PU DRUG__ID D0U2PU D0U2PU DRUGCOMP Allife Medical Science and Technology Co., Ltd. D0U2PU DRUGTYPE CAR T Cell Therapy D0U2PU HIGHSTAT Phase 1 D0U2QI DRUG__ID D0U2QI D0U2QI DRUGCOMP Intervexion therapeutics D0U2QI DRUGTYPE Monoclonal antibody D0U2QI HIGHSTAT Phase 1 D0U5AQ DRUG__ID D0U5AQ D0U5AQ DRUGCOMP UNC Lineberger Comprehensive Cancer Center D0U5AQ DRUGTYPE CAR T Cell Therapy (Dual specific) D0U5AQ HIGHSTAT Phase 1 D0U7VS DRUG__ID D0U7VS D0U7VS DRUGCOMP Sinobioway Cell Therapy Co., Ltd. D0U7VS DRUGTYPE CAR T Cell Therapy D0U7VS HIGHSTAT Phase 1 D0U7WY DRUG__ID D0U7WY D0U7WY DRUGCOMP Peng Liu D0U7WY DRUGTYPE CAR T Cell Therapy (Dual specific) D0U7WY HIGHSTAT Phase 1 D0U7XJ DRUG__ID D0U7XJ D0U7XJ DRUGCOMP Bicara Therapeutics D0U7XJ DRUGTYPE Antibody D0U7XJ HIGHSTAT Phase 1 D0U8PE DRUG__ID D0U8PE D0U8PE DRUGCOMP Henan Cancer Hospital D0U8PE DRUGTYPE CAR T Cell Therapy D0U8PE HIGHSTAT Phase 1 D0UL7L DRUG__ID D0UL7L D0UL7L DRUGCOMP Zensun (Shanghai) Sci-Tech Co Ltd D0UL7L DRUGTYPE Vaccine D0UL7L HIGHSTAT Phase 1 D0UM4S DRUG__ID D0UM4S D0UM4S DRUGCOMP Agensys; seattle genetics D0UM4S DRUGTYPE Antibody D0UM4S HIGHSTAT Phase 1 D0UO9R DRUG__ID D0UO9R D0UO9R DRUGCOMP Rgenix D0UO9R DRUGTYPE Small molecular drug D0UO9R HIGHSTAT Phase 1 D0UP8U DRUG__ID D0UP8U D0UP8U DRUGCOMP Second Affiliated Hospital of Xi'an Jiaotong University D0UP8U DRUGTYPE CAR T Cell Therapy D0UP8U HIGHSTAT Phase 1 D0V0BO DRUG__ID D0V0BO D0V0BO DRUGCOMP Genentech D0V0BO DRUGTYPE Antibody D0V0BO HIGHSTAT Phase 1 D0V3EQ DRUG__ID D0V3EQ D0V3EQ DRUGCOMP Affiris; GlaxoSmithKline D0V3EQ DRUGTYPE Vaccine D0V3EQ HIGHSTAT Phase 1 D0V4YW DRUG__ID D0V4YW D0V4YW DRUGCOMP Eli Lilly D0V4YW DRUGTYPE Antibody D0V4YW HIGHSTAT Phase 1 D0V5DD DRUG__ID D0V5DD D0V5DD DRUGCOMP University of Pennsylvania D0V5DD DRUGTYPE CAR T Cell Therapy (Dual specific) D0V5DD HIGHSTAT Phase 1 D0V6KU DRUG__ID D0V6KU D0V6KU DRUGCOMP Glaxosmithkline D0V6KU DRUGTYPE Vaccine D0V6KU HIGHSTAT Phase 1 D0V6MX DRUG__ID D0V6MX D0V6MX DRUGCOMP Immatics D0V6MX DRUGTYPE Cell therapy D0V6MX HIGHSTAT Phase 1 D0V7BD DRUG__ID D0V7BD D0V7BD DRUGCOMP University of Pennsylvania D0V7BD DRUGTYPE CAR T Cell Therapy D0V7BD HIGHSTAT Phase 1 D0V7QW DRUG__ID D0V7QW D0V7QW DRUGCOMP Genentech D0V7QW DRUGTYPE Antibody D0V7QW HIGHSTAT Phase 1 D0W1GP DRUG__ID D0W1GP D0W1GP DRUGCOMP Fred Hutchinson Cancer Research Center D0W1GP DRUGTYPE CAR T Cell Therapy D0W1GP HIGHSTAT Phase 1 D0W1MU DRUG__ID D0W1MU D0W1MU DRUGCOMP National Institute of Cholera and Enteric Diseases D0W1MU DRUGTYPE Vaccine D0W1MU HIGHSTAT Phase 1 D0W3BC DRUG__ID D0W3BC D0W3BC DRUGCOMP ISIS Pharm; Antisense Therapeutics D0W3BC DRUGTYPE Antisense drug D0W3BC HIGHSTAT Phase 1 D0W7AB DRUG__ID D0W7AB D0W7AB DRUGCOMP National Cancer Institute (NCI) D0W7AB DRUGTYPE CAR T Cell Therapy D0W7AB HIGHSTAT Phase 1 D0W7UD DRUG__ID D0W7UD D0W7UD DRUGCOMP Beijing Sanbo Brain Hospital D0W7UD DRUGTYPE CAR T Cell Therapy D0W7UD HIGHSTAT Phase 1 D0W9QI DRUG__ID D0W9QI D0W9QI DRUGCOMP NeoPharm D0W9QI DRUGTYPE Antisense drug D0W9QI HIGHSTAT Phase 1 D0WK6V DRUG__ID D0WK6V D0WK6V DRUGCOMP Pfizer D0WK6V DRUGTYPE Antibody D0WK6V HIGHSTAT Phase 1 D0X0OF DRUG__ID D0X0OF D0X0OF DRUGCOMP Inovio Pharmaceuticals D0X0OF DRUGTYPE Vaccine D0X0OF HIGHSTAT Phase 1 D0X1GN DRUG__ID D0X1GN D0X1GN DRUGCOMP Bristol-Myers Squibb D0X1GN DRUGTYPE Small molecule immunotherapy D0X1GN HIGHSTAT Phase 1 D0X2UK DRUG__ID D0X2UK D0X2UK DRUGCOMP Affiris GmbH D0X2UK DRUGTYPE Vaccine D0X2UK HIGHSTAT Phase 1 D0X3YY DRUG__ID D0X3YY D0X3YY DRUGCOMP Glaxosmithkline; oncomed pharmaceuticals D0X3YY DRUGTYPE Antibody D0X3YY HIGHSTAT Phase 1 D0X6FU DRUG__ID D0X6FU D0X6FU DRUGCOMP Cellular Biomedicine Group Ltd. D0X6FU DRUGTYPE CAR T Cell Therapy D0X6FU HIGHSTAT Phase 1 D0X7MY DRUG__ID D0X7MY D0X7MY DRUGCOMP Astellas D0X7MY DRUGTYPE Monoclonal antibody D0X7MY HIGHSTAT Phase 1 D0XO9F DRUG__ID D0XO9F D0XO9F DRUGCOMP F-star Biotechnology Cambridge, United Kingdom D0XO9F DRUGTYPE Antibody D0XO9F HIGHSTAT Phase 1 D0Y2XZ DRUG__ID D0Y2XZ D0Y2XZ DRUGCOMP Merck D0Y2XZ DRUGTYPE Antibody D0Y2XZ HIGHSTAT Phase 1 D0Y5ED DRUG__ID D0Y5ED D0Y5ED DRUGCOMP Aveo oncology D0Y5ED DRUGTYPE Antibody D0Y5ED HIGHSTAT Phase 1 D0YF6K DRUG__ID D0YF6K D0YF6K DRUGCOMP Seattle Children's Hospital D0YF6K DRUGTYPE CAR T Cell Therapy D0YF6K HIGHSTAT Phase 1 D0YG4P DRUG__ID D0YG4P D0YG4P DRUGCOMP AgonOx D0YG4P DRUGTYPE Monoclonal antibody D0YG4P HIGHSTAT Phase 1 D0YH5L DRUG__ID D0YH5L D0YH5L DRUGCOMP Zhujiang Hospital D0YH5L DRUGTYPE CAR T Cell Therapy D0YH5L HIGHSTAT Phase 1 D0YK9O DRUG__ID D0YK9O D0YK9O DRUGCOMP AstraZeneca D0YK9O DRUGTYPE Small molecule D0YK9O HIGHSTAT Phase 1 D0YU0L DRUG__ID D0YU0L D0YU0L DRUGCOMP Timmune Biotech Inc. D0YU0L DRUGTYPE CAR T Cell Therapy D0YU0L HIGHSTAT Phase 1 D0Z0EP DRUG__ID D0Z0EP D0Z0EP DRUGCOMP Center for Genetic Engineering and Biotechnology D0Z0EP DRUGTYPE Antibody D0Z0EP HIGHSTAT Phase 1 D0Z7QK DRUG__ID D0Z7QK D0Z7QK DRUGCOMP Cellectis S.A. D0Z7QK DRUGTYPE CAR T Cell Therapy D0Z7QK HIGHSTAT Phase 1 D0ZDP2 DRUG__ID D0ZDP2 D0ZDP2 DRUGCOMP Takeda D0ZDP2 DRUGTYPE Recombinant protein D0ZDP2 HIGHSTAT Phase 1 D0ZF9J DRUG__ID D0ZF9J D0ZF9J DRUGCOMP University of Pennsylvania D0ZF9J DRUGTYPE CAR T Cell Therapy D0ZF9J HIGHSTAT Phase 1 D0ZL3U DRUG__ID D0ZL3U D0ZL3U DRUGCOMP The Affiliated Hospital of the Chinese Academy of Military Medical Sciences D0ZL3U DRUGTYPE CAR T Cell Therapy D0ZL3U HIGHSTAT Phase 1 D0ZP8Z DRUG__ID D0ZP8Z D0ZP8Z DRUGCOMP University of Pennsylvania D0ZP8Z DRUGTYPE CAR T Cell Therapy D0ZP8Z HIGHSTAT Phase 1 D0ZQ6N DRUG__ID D0ZQ6N D0ZQ6N DRUGCOMP First Affiliated Hospital of Harbin Medical University D0ZQ6N DRUGTYPE CAR T Cell Therapy D0ZQ6N HIGHSTAT Phase 1 D0ZX6F DRUG__ID D0ZX6F D0ZX6F DRUGCOMP Roche D0ZX6F DRUGTYPE Bispecific antibody D0ZX6F HIGHSTAT Phase 1 D10GPJ DRUG__ID D10GPJ D10GPJ DRUGCOMP Sutro Biopharma D10GPJ DRUGTYPE Antibody drug conjugate D10GPJ HIGHSTAT Phase 1 D10KTZ DRUG__ID D10KTZ D10KTZ DRUGCOMP Sanofi D10KTZ DRUGTYPE Antibody D10KTZ HIGHSTAT Phase 1 D12AIV DRUG__ID D12AIV D12AIV DRUGCOMP Precigen D12AIV DRUGTYPE CAR T Cell Therapy D12AIV HIGHSTAT Phase 1 D12EFM DRUG__ID D12EFM D12EFM DRUGCOMP Roche D12EFM DRUGTYPE Small molecular drug D12EFM HIGHSTAT Phase 1 D12QYO DRUG__ID D12QYO D12QYO DRUGCOMP Janssen D12QYO DRUGTYPE Vaccine D12QYO HIGHSTAT Phase 1 D17DXO DRUG__ID D17DXO D17DXO DRUGCOMP Arrowhead Pharmaceuticals Pasadena, CA D17DXO DRUGTYPE RNA interference D17DXO HIGHSTAT Phase 1 D17OQM DRUG__ID D17OQM D17OQM DRUGCOMP Baylx Irvine, CA D17OQM DRUGTYPE Cell therapy D17OQM HIGHSTAT Phase 1 D17URP DRUG__ID D17URP D17URP DRUGCOMP Checkpoint Therapeutics D17URP DRUGTYPE Antibody D17URP HIGHSTAT Phase 1 D18QIB DRUG__ID D18QIB D18QIB DRUGCOMP Novartis D18QIB DRUGTYPE Antibody D18QIB HIGHSTAT Phase 1 D1A5GK DRUG__ID D1A5GK D1A5GK DRUGCOMP Genentech D1A5GK DRUGTYPE Antibody drug conjugate D1A5GK HIGHSTAT Phase 1 D1A7OP DRUG__ID D1A7OP D1A7OP DRUGCOMP Pfzer D1A7OP DRUGTYPE Antibody D1A7OP HIGHSTAT Phase 1 D1A8NU DRUG__ID D1A8NU D1A8NU DRUGCOMP PsiOxus Therapeutics D1A8NU DRUGTYPE Gene therapy D1A8NU HIGHSTAT Phase 1 D1AVT5 DRUG__ID D1AVT5 D1AVT5 DRUGCOMP Seagen D1AVT5 DRUGTYPE Antibody D1AVT5 HIGHSTAT Phase 1 D1B2US DRUG__ID D1B2US D1B2US DRUGCOMP Boston Therapeutics D1B2US DRUGTYPE Peptide D1B2US HIGHSTAT Phase 1 D1BA7Z DRUG__ID D1BA7Z D1BA7Z DRUGCOMP Gilead D1BA7Z DRUGTYPE Small molecule D1BA7Z HIGHSTAT Phase 1 D1BT2M DRUG__ID D1BT2M D1BT2M DRUGCOMP NapaJen Pharma D1BT2M DRUGTYPE Antisense oligonucleotide D1BT2M HIGHSTAT Phase 1 D1C0WB DRUG__ID D1C0WB D1C0WB DRUGCOMP Dizal Pharmaceuticals D1C0WB DRUGTYPE Small molecular drug D1C0WB HIGHSTAT Phase 1 D1EW3O DRUG__ID D1EW3O D1EW3O DRUGCOMP InxMed D1EW3O DRUGTYPE Small molecular drug D1EW3O HIGHSTAT Phase 1 D1FO9C DRUG__ID D1FO9C D1FO9C DRUGCOMP GlycoNex D1FO9C DRUGTYPE Antibody D1FO9C HIGHSTAT Phase 1 D1FUQ2 DRUG__ID D1FUQ2 D1FUQ2 DRUGCOMP Astellas Pharma D1FUQ2 DRUGTYPE Oncolytic virus therapy D1FUQ2 HIGHSTAT Phase 1 D1G4EK DRUG__ID D1G4EK D1G4EK DRUGCOMP Adlai Nortye Biopharma D1G4EK DRUGTYPE Small molecule D1G4EK HIGHSTAT Phase 1 D1L7DE DRUG__ID D1L7DE D1L7DE DRUGCOMP Gemoab D1L7DE DRUGTYPE Antibody D1L7DE HIGHSTAT Phase 1 D1LP4B DRUG__ID D1LP4B D1LP4B DRUGCOMP Pfzer D1LP4B DRUGTYPE Antibody D1LP4B HIGHSTAT Phase 1 D1M4KO DRUG__ID D1M4KO D1M4KO DRUGCOMP Sanofi D1M4KO DRUGTYPE Vaccine D1M4KO HIGHSTAT Phase 1 D1NC2O DRUG__ID D1NC2O D1NC2O DRUGCOMP Morphogenesis D1NC2O DRUGTYPE Vaccine D1NC2O HIGHSTAT Phase 1 D1ONZ8 DRUG__ID D1ONZ8 D1ONZ8 DRUGCOMP Bristol-Myers Squibb D1ONZ8 DRUGTYPE Small molecular drug D1ONZ8 HIGHSTAT Phase 1 D1PYC8 DRUG__ID D1PYC8 D1PYC8 DRUGCOMP MacroGenics D1PYC8 DRUGTYPE Antibody D1PYC8 HIGHSTAT Phase 1 D1R6VD DRUG__ID D1R6VD D1R6VD DRUGCOMP CRISPR Therapeutics D1R6VD DRUGTYPE Cell therapy D1R6VD HIGHSTAT Phase 1 D1R9KZ DRUG__ID D1R9KZ D1R9KZ DRUGCOMP Cantero Therapeutics San Francisco, CA D1R9KZ DRUGTYPE Small molecule D1R9KZ HIGHSTAT Phase 1 D1ROU2 DRUG__ID D1ROU2 D1ROU2 DRUGCOMP iLab D1ROU2 DRUGTYPE Small molecule D1ROU2 HIGHSTAT Phase 1 D1S7EP DRUG__ID D1S7EP D1S7EP DRUGCOMP SystImmune D1S7EP DRUGTYPE Antibody D1S7EP HIGHSTAT Phase 1 D1SL2W DRUG__ID D1SL2W D1SL2W DRUGCOMP Prelude Therapeutics D1SL2W DRUGTYPE Small molecular drug D1SL2W HIGHSTAT Phase 1 D1WOX4 DRUG__ID D1WOX4 D1WOX4 DRUGCOMP CARsgen Therapeutics D1WOX4 DRUGTYPE CAR T Cell Therapy D1WOX4 HIGHSTAT Phase 1 D1YXQ4 DRUG__ID D1YXQ4 D1YXQ4 DRUGCOMP Biocytogen D1YXQ4 DRUGTYPE Antibody D1YXQ4 HIGHSTAT Phase 1 D1YZ5O DRUG__ID D1YZ5O D1YZ5O DRUGCOMP Corvus Pharmaceuticals D1YZ5O DRUGTYPE Small molecular drug D1YZ5O HIGHSTAT Phase 1 D1Z6TS DRUG__ID D1Z6TS D1Z6TS DRUGCOMP Oncorus D1Z6TS DRUGTYPE Oncolytic virus therapy D1Z6TS HIGHSTAT Phase 1 D1ZD0N DRUG__ID D1ZD0N D1ZD0N DRUGCOMP VM Oncology D1ZD0N DRUGTYPE Small molecular drug D1ZD0N HIGHSTAT Phase 1 D1ZG5E DRUG__ID D1ZG5E D1ZG5E DRUGCOMP University of Tokyo/Centre Leon-Berard D1ZG5E DRUGTYPE Antibody D1ZG5E HIGHSTAT Phase 1 D21OLD DRUG__ID D21OLD D21OLD DRUGCOMP BlueWillow Biologics D21OLD DRUGTYPE Vaccine D21OLD HIGHSTAT Phase 1 D23VYO DRUG__ID D23VYO D23VYO DRUGCOMP Ionis; Biogen D23VYO DRUGTYPE Antisense oligonucleotide D23VYO HIGHSTAT Phase 1 D24ILA DRUG__ID D24ILA D24ILA DRUGCOMP The Foundation for Orthopaedics and Regenerative Medicine D24ILA DRUGTYPE Cell therapy D24ILA HIGHSTAT Phase 1 D26DCA DRUG__ID D26DCA D26DCA DRUGCOMP Replimune D26DCA DRUGTYPE Oncolytic virus therapy D26DCA HIGHSTAT Phase 1 D28MNU DRUG__ID D28MNU D28MNU DRUGCOMP Celldex Therapeutics D28MNU DRUGTYPE Antibody D28MNU HIGHSTAT Phase 1 D28VIO DRUG__ID D28VIO D28VIO DRUGCOMP DNAtrix D28VIO DRUGTYPE Oncolytic virus therapy D28VIO HIGHSTAT Phase 1 D2AO6J DRUG__ID D2AO6J D2AO6J DRUGCOMP Ionis; Biogen D2AO6J DRUGTYPE Antisense oligonucleotide D2AO6J HIGHSTAT Phase 1 D2CL0D DRUG__ID D2CL0D D2CL0D DRUGCOMP Roche D2CL0D DRUGTYPE Small molecule D2CL0D HIGHSTAT Phase 1 D2CN7L DRUG__ID D2CN7L D2CN7L DRUGCOMP Pfzer D2CN7L DRUGTYPE Vaccine D2CN7L HIGHSTAT Phase 1 D2CR0K DRUG__ID D2CR0K D2CR0K DRUGCOMP Fate Therapeutics D2CR0K DRUGTYPE Cell therapy D2CR0K HIGHSTAT Phase 1 D2CZR3 DRUG__ID D2CZR3 D2CZR3 DRUGCOMP NantBioScience D2CZR3 DRUGTYPE Vaccine D2CZR3 HIGHSTAT Phase 1 D2DB5T DRUG__ID D2DB5T D2DB5T DRUGCOMP Taiga Biotechnologies D2DB5T DRUGTYPE Cell therapy D2DB5T HIGHSTAT Phase 1 D2DX6Z DRUG__ID D2DX6Z D2DX6Z DRUGCOMP AstraZeneca D2DX6Z DRUGTYPE Enzyme replacement D2DX6Z HIGHSTAT Phase 1 D2EF8M DRUG__ID D2EF8M D2EF8M DRUGCOMP AstraZeneca D2EF8M DRUGTYPE Small molecule D2EF8M HIGHSTAT Phase 1 D2GY5C DRUG__ID D2GY5C D2GY5C DRUGCOMP Aptevo D2GY5C DRUGTYPE Antibody D2GY5C HIGHSTAT Phase 1 D2H5CI DRUG__ID D2H5CI D2H5CI DRUGCOMP Rebiotix D2H5CI DRUGTYPE Live biotherapeutic product D2H5CI HIGHSTAT Phase 1 D2HE9I DRUG__ID D2HE9I D2HE9I DRUGCOMP Molecular Templates D2HE9I DRUGTYPE Recombinant protein D2HE9I HIGHSTAT Phase 1 D2ITJ1 DRUG__ID D2ITJ1 D2ITJ1 DRUGCOMP Five Prime Therapeutics D2ITJ1 DRUGTYPE Recombinant protein D2ITJ1 HIGHSTAT Phase 1 D2KA0W DRUG__ID D2KA0W D2KA0W DRUGCOMP Gilead Sciences D2KA0W DRUGTYPE Antibody D2KA0W HIGHSTAT Phase 1 D2KB3W DRUG__ID D2KB3W D2KB3W DRUGCOMP Allogene Therapeutics D2KB3W DRUGTYPE CAR T Cell Therapy D2KB3W HIGHSTAT Phase 1 D2KOX5 DRUG__ID D2KOX5 D2KOX5 DRUGCOMP Bristol-Myers Squibb D2KOX5 DRUGTYPE Small molecular drug D2KOX5 HIGHSTAT Phase 1 D2KV0F DRUG__ID D2KV0F D2KV0F DRUGCOMP Biogen D2KV0F DRUGTYPE Small molecule D2KV0F HIGHSTAT Phase 1 D2L9MD DRUG__ID D2L9MD D2L9MD DRUGCOMP Roche D2L9MD DRUGTYPE Antibody D2L9MD HIGHSTAT Phase 1 D2LUK7 DRUG__ID D2LUK7 D2LUK7 DRUGCOMP Pfizer D2LUK7 DRUGTYPE Vaccine D2LUK7 HIGHSTAT Phase 1 D2MZF8 DRUG__ID D2MZF8 D2MZF8 DRUGCOMP Takeda D2MZF8 DRUGTYPE CAR T Cell Therapy D2MZF8 HIGHSTAT Phase 1 D2O5WA DRUG__ID D2O5WA D2O5WA DRUGCOMP AstraZeneca D2O5WA DRUGTYPE Small interfering RNA D2O5WA HIGHSTAT Phase 1 D2OZ9D DRUG__ID D2OZ9D D2OZ9D DRUGCOMP Codagenix D2OZ9D DRUGTYPE Vaccine D2OZ9D HIGHSTAT Phase 1 D2P8LR DRUG__ID D2P8LR D2P8LR DRUGCOMP Agenus D2P8LR DRUGTYPE Antibody D2P8LR HIGHSTAT Phase 1 D2PFI8 DRUG__ID D2PFI8 D2PFI8 DRUGCOMP Sanofi Bridgewater, NJ D2PFI8 DRUGTYPE Cell therapy D2PFI8 HIGHSTAT Phase 1 D2PFY3 DRUG__ID D2PFY3 D2PFY3 DRUGCOMP Amgen D2PFY3 DRUGTYPE Antibody D2PFY3 HIGHSTAT Phase 1 D2QY0Z DRUG__ID D2QY0Z D2QY0Z DRUGCOMP Merus D2QY0Z DRUGTYPE Antibody D2QY0Z HIGHSTAT Phase 1 D2SRG1 DRUG__ID D2SRG1 D2SRG1 DRUGCOMP Pfizer D2SRG1 DRUGTYPE Small molecule D2SRG1 HIGHSTAT Phase 1 D2TH1E DRUG__ID D2TH1E D2TH1E DRUGCOMP Altimmune D2TH1E DRUGTYPE Vaccine D2TH1E HIGHSTAT Phase 1 D2V4YI DRUG__ID D2V4YI D2V4YI DRUGCOMP Boehringer Ingelheim D2V4YI DRUGTYPE Small molecular drug D2V4YI HIGHSTAT Phase 1 D2V6BI DRUG__ID D2V6BI D2V6BI DRUGCOMP AbViro D2V6BI DRUGTYPE Antibody D2V6BI HIGHSTAT Phase 1 D2V6MO DRUG__ID D2V6MO D2V6MO DRUGCOMP Vaxart D2V6MO DRUGTYPE Vaccine D2V6MO HIGHSTAT Phase 1 D2V9RQ DRUG__ID D2V9RQ D2V9RQ DRUGCOMP GammaDelta Therapeutics London, United Kingdom D2V9RQ DRUGTYPE Cell therapy D2V9RQ HIGHSTAT Phase 1 D2VRE1 DRUG__ID D2VRE1 D2VRE1 DRUGCOMP NGM Biopharmaceuticals D2VRE1 DRUGTYPE Antibody D2VRE1 HIGHSTAT Phase 1 D2XEH5 DRUG__ID D2XEH5 D2XEH5 DRUGCOMP Roche D2XEH5 DRUGTYPE Nucleic acid D2XEH5 HIGHSTAT Phase 1 D2Y9IG DRUG__ID D2Y9IG D2Y9IG DRUGCOMP Janssen D2Y9IG DRUGTYPE Antibody D2Y9IG HIGHSTAT Phase 1 D2YGA4 DRUG__ID D2YGA4 D2YGA4 DRUGCOMP AstraZeneca; Ionis D2YGA4 DRUGTYPE Small molecule D2YGA4 HIGHSTAT Phase 1 D2Z6WF DRUG__ID D2Z6WF D2Z6WF DRUGCOMP Curis D2Z6WF DRUGTYPE Small molecular drug D2Z6WF HIGHSTAT Phase 1 D2Z7EL DRUG__ID D2Z7EL D2Z7EL DRUGCOMP Celyad Oncology D2Z7EL DRUGTYPE CAR T Cell Therapy D2Z7EL HIGHSTAT Phase 1 D31CPE DRUG__ID D31CPE D31CPE DRUGCOMP Sanofi D31CPE DRUGTYPE Nanobody D31CPE HIGHSTAT Phase 1 D31ORV DRUG__ID D31ORV D31ORV DRUGCOMP Adaptimmune D31ORV DRUGTYPE CAR-T cell therapy D31ORV HIGHSTAT Phase 1 D31ZLD DRUG__ID D31ZLD D31ZLD DRUGCOMP Gradalis D31ZLD DRUGTYPE Short hairpin RNA D31ZLD HIGHSTAT Phase 1 D34CWV DRUG__ID D34CWV D34CWV DRUGCOMP EpiThany D34CWV DRUGTYPE Vaccine D34CWV HIGHSTAT Phase 1 D37AYZ DRUG__ID D37AYZ D37AYZ DRUGCOMP AstraZeneca D37AYZ DRUGTYPE Antibody D37AYZ HIGHSTAT Phase 1 D3B1MS DRUG__ID D3B1MS D3B1MS DRUGCOMP OncoImmune D3B1MS DRUGTYPE Antibody D3B1MS HIGHSTAT Phase 1 D3CG6E DRUG__ID D3CG6E D3CG6E DRUGCOMP Mapp Biopharmaceutical D3CG6E DRUGTYPE Antibody D3CG6E HIGHSTAT Phase 1 D3DM8Y DRUG__ID D3DM8Y D3DM8Y DRUGCOMP Amgen D3DM8Y DRUGTYPE Small interfering RNA D3DM8Y HIGHSTAT Phase 1 D3DPR8 DRUG__ID D3DPR8 D3DPR8 DRUGCOMP Ziopharm Oncology D3DPR8 DRUGTYPE CAR T Cell Therapy D3DPR8 HIGHSTAT Phase 1 D3G2BO DRUG__ID D3G2BO D3G2BO DRUGCOMP Vir Biotechnology D3G2BO DRUGTYPE Antibody D3G2BO HIGHSTAT Phase 1 D3HBJ1 DRUG__ID D3HBJ1 D3HBJ1 DRUGCOMP GenMab D3HBJ1 DRUGTYPE Antibody D3HBJ1 HIGHSTAT Phase 1 D3HL1R DRUG__ID D3HL1R D3HL1R DRUGCOMP NeoImmuneTech D3HL1R DRUGTYPE Recombinant protein D3HL1R HIGHSTAT Phase 1 D3KMC9 DRUG__ID D3KMC9 D3KMC9 DRUGCOMP Gilead Sciences D3KMC9 DRUGTYPE Antibody D3KMC9 HIGHSTAT Phase 1 D3KZ6M DRUG__ID D3KZ6M D3KZ6M DRUGCOMP Eli Lilly & Co D3KZ6M DRUGTYPE Antibody D3KZ6M HIGHSTAT Phase 1 D3MGD9 DRUG__ID D3MGD9 D3MGD9 DRUGCOMP Instill Bio Dallas, TX D3MGD9 DRUGTYPE Cell therapy D3MGD9 HIGHSTAT Phase 1 D3NTA9 DRUG__ID D3NTA9 D3NTA9 DRUGCOMP Merck D3NTA9 DRUGTYPE Small molecular drug D3NTA9 HIGHSTAT Phase 1 D3NV0S DRUG__ID D3NV0S D3NV0S DRUGCOMP Pfizer D3NV0S DRUGTYPE Vaccine D3NV0S HIGHSTAT Phase 1 D3NX6T DRUG__ID D3NX6T D3NX6T DRUGCOMP Amgen D3NX6T DRUGTYPE Small molecule D3NX6T HIGHSTAT Phase 1 D3OUH0 DRUG__ID D3OUH0 D3OUH0 DRUGCOMP NeuPharma D3OUH0 DRUGTYPE Small molecular drug D3OUH0 HIGHSTAT Phase 1 D3Q0FU DRUG__ID D3Q0FU D3Q0FU DRUGCOMP CSL Behring D3Q0FU DRUGTYPE Antibody D3Q0FU HIGHSTAT Phase 1 D3Q4SZ DRUG__ID D3Q4SZ D3Q4SZ DRUGCOMP Zhejiang DTRM Biopharma D3Q4SZ DRUGTYPE Small molecular drug D3Q4SZ HIGHSTAT Phase 1 D3SPE5 DRUG__ID D3SPE5 D3SPE5 DRUGCOMP Bayer D3SPE5 DRUGTYPE Antibody D3SPE5 HIGHSTAT Phase 1 D3T7NY DRUG__ID D3T7NY D3T7NY DRUGCOMP Arcellx D3T7NY DRUGTYPE CAR T Cell Therapy D3T7NY HIGHSTAT Phase 1 D3TW6X DRUG__ID D3TW6X D3TW6X DRUGCOMP Zenith Epigenetics D3TW6X DRUGTYPE Small molecular drug D3TW6X HIGHSTAT Phase 1 D3U2QM DRUG__ID D3U2QM D3U2QM DRUGCOMP Lineage Cell Therapeutics D3U2QM DRUGTYPE Vaccine D3U2QM HIGHSTAT Phase 1 D3UQO1 DRUG__ID D3UQO1 D3UQO1 DRUGCOMP 4D Molecular Therapeutics D3UQO1 DRUGTYPE Gene therapy D3UQO1 HIGHSTAT Phase 1 D3ZN5U DRUG__ID D3ZN5U D3ZN5U DRUGCOMP Syndax Pharmaceuticals D3ZN5U DRUGTYPE Antibody D3ZN5U HIGHSTAT Phase 1 D40NQW DRUG__ID D40NQW D40NQW DRUGCOMP Green3Bio D40NQW DRUGTYPE Small molecule D40NQW HIGHSTAT Phase 1 D46XOD DRUG__ID D46XOD D46XOD DRUGCOMP Moderna D46XOD DRUGTYPE Vaccine D46XOD HIGHSTAT Phase 1 D48UEV DRUG__ID D48UEV D48UEV DRUGCOMP IGM Biosciences D48UEV DRUGTYPE Antibody D48UEV HIGHSTAT Phase 1 D48ZBO DRUG__ID D48ZBO D48ZBO DRUGCOMP Fortis Therapeutics D48ZBO DRUGTYPE Antibody drug conjugate D48ZBO HIGHSTAT Phase 1 D49YEO DRUG__ID D49YEO D49YEO DRUGCOMP Assembly Biosciences D49YEO DRUGTYPE Small molecular drug D49YEO HIGHSTAT Phase 1 D4AY6B DRUG__ID D4AY6B D4AY6B DRUGCOMP Suven Life Sciences D4AY6B DRUGTYPE Small molecular drug D4AY6B HIGHSTAT Phase 1 D4BC6I DRUG__ID D4BC6I D4BC6I DRUGCOMP Roche/Genentech D4BC6I DRUGTYPE Recombinant protein D4BC6I HIGHSTAT Phase 1 D4CGN3 DRUG__ID D4CGN3 D4CGN3 DRUGCOMP Roche/Genentech D4CGN3 DRUGTYPE Antibody D4CGN3 HIGHSTAT Phase 1 D4D6XG DRUG__ID D4D6XG D4D6XG DRUGCOMP Roche D4D6XG DRUGTYPE Cell therapy D4D6XG HIGHSTAT Phase 1 D4GUO8 DRUG__ID D4GUO8 D4GUO8 DRUGCOMP Pfizer D4GUO8 DRUGTYPE Vaccine D4GUO8 HIGHSTAT Phase 1 D4HDR2 DRUG__ID D4HDR2 D4HDR2 DRUGCOMP Lyvgen Biopharma D4HDR2 DRUGTYPE Antibody D4HDR2 HIGHSTAT Phase 1 D4J9HV DRUG__ID D4J9HV D4J9HV DRUGCOMP AbbVie D4J9HV DRUGTYPE Antibody drug conjugate D4J9HV HIGHSTAT Phase 1 D4JPV8 DRUG__ID D4JPV8 D4JPV8 DRUGCOMP Mercia Pharma D4JPV8 DRUGTYPE Vaccine D4JPV8 HIGHSTAT Phase 1 D4JU8H DRUG__ID D4JU8H D4JU8H DRUGCOMP Merck D4JU8H DRUGTYPE Small molecular drug D4JU8H HIGHSTAT Phase 1 D4JV0H DRUG__ID D4JV0H D4JV0H DRUGCOMP Astellas Pharma; Potenza Therapeutics D4JV0H DRUGTYPE Antibody D4JV0H HIGHSTAT Phase 1 D4JYH3 DRUG__ID D4JYH3 D4JYH3 DRUGCOMP Fusion Pharmaceuticals D4JYH3 DRUGTYPE Radiopharmaceutical therapy D4JYH3 HIGHSTAT Phase 1 D4K2OF DRUG__ID D4K2OF D4K2OF DRUGCOMP Eureka Therapeutics D4K2OF DRUGTYPE CAR-T cell therapy D4K2OF HIGHSTAT Phase 1 D4KTA9 DRUG__ID D4KTA9 D4KTA9 DRUGCOMP Agenis; Incyte D4KTA9 DRUGTYPE Antibody D4KTA9 HIGHSTAT Phase 1 D4L3IZ DRUG__ID D4L3IZ D4L3IZ DRUGCOMP Symphogen D4L3IZ DRUGTYPE Antibody D4L3IZ HIGHSTAT Phase 1 D4N7TE DRUG__ID D4N7TE D4N7TE DRUGCOMP Moderna Therapeutics D4N7TE DRUGTYPE mRNA therapy D4N7TE HIGHSTAT Phase 1 D4NGM6 DRUG__ID D4NGM6 D4NGM6 DRUGCOMP Janssen Research & Development Raritan, NJ D4NGM6 DRUGTYPE CAR-T cell therapy D4NGM6 HIGHSTAT Phase 1 D4OB2H DRUG__ID D4OB2H D4OB2H DRUGCOMP GlaxoSmithKline D4OB2H DRUGTYPE Vaccine D4OB2H HIGHSTAT Phase 1 D4ON2Y DRUG__ID D4ON2Y D4ON2Y DRUGCOMP Moderna Therapeutics D4ON2Y DRUGTYPE Vaccine D4ON2Y HIGHSTAT Phase 1 D4P8YO DRUG__ID D4P8YO D4P8YO DRUGCOMP Aronora D4P8YO DRUGTYPE Antibody D4P8YO HIGHSTAT Phase 1 D4PV0B DRUG__ID D4PV0B D4PV0B DRUGCOMP AbbVie D4PV0B DRUGTYPE Small molecular drug D4PV0B HIGHSTAT Phase 1 D4QZ3O DRUG__ID D4QZ3O D4QZ3O DRUGCOMP Seagen D4QZ3O DRUGTYPE Antibody D4QZ3O HIGHSTAT Phase 1 D4SE2H DRUG__ID D4SE2H D4SE2H DRUGCOMP Flexion Therapeutics D4SE2H DRUGTYPE Gene therapy D4SE2H HIGHSTAT Phase 1 D4TGN3 DRUG__ID D4TGN3 D4TGN3 DRUGCOMP Pfzer D4TGN3 DRUGTYPE Vaccine D4TGN3 HIGHSTAT Phase 1 D4TI9A DRUG__ID D4TI9A D4TI9A DRUGCOMP Janssen D4TI9A DRUGTYPE Antibody D4TI9A HIGHSTAT Phase 1 D4UQ2B DRUG__ID D4UQ2B D4UQ2B DRUGCOMP Gilead D4UQ2B DRUGTYPE CAR-T cell therapy D4UQ2B HIGHSTAT Phase 1 D4VR3P DRUG__ID D4VR3P D4VR3P DRUGCOMP BioNTech D4VR3P DRUGTYPE Antibody D4VR3P HIGHSTAT Phase 1 D4XL6Z DRUG__ID D4XL6Z D4XL6Z DRUGCOMP Roche D4XL6Z DRUGTYPE Antibody D4XL6Z HIGHSTAT Phase 1 D4YD7V DRUG__ID D4YD7V D4YD7V DRUGCOMP Eli Lilly D4YD7V DRUGTYPE Monoclonal antibody D4YD7V HIGHSTAT Phase 1 D50CXM DRUG__ID D50CXM D50CXM DRUGCOMP Prelude Therapeutics D50CXM DRUGTYPE Small molecular drug D50CXM HIGHSTAT Phase 1 D51HBQ DRUG__ID D51HBQ D51HBQ DRUGCOMP iCell Gene Therapeutics D51HBQ DRUGTYPE CAR T Cell Therapy D51HBQ HIGHSTAT Phase 1 D53KHJ DRUG__ID D53KHJ D53KHJ DRUGCOMP Moderna D53KHJ DRUGTYPE Vaccine D53KHJ HIGHSTAT Phase 1 D56AJO DRUG__ID D56AJO D56AJO DRUGCOMP Klus Pharma D56AJO DRUGTYPE Antibody drug conjugate D56AJO HIGHSTAT Phase 1 D56ECJ DRUG__ID D56ECJ D56ECJ DRUGCOMP Bliss Biopharmaceutical D56ECJ DRUGTYPE Antibody drug conjugate D56ECJ HIGHSTAT Phase 1 D56ERU DRUG__ID D56ERU D56ERU DRUGCOMP Inhibrx D56ERU DRUGTYPE Antibody drug conjugate D56ERU HIGHSTAT Phase 1 D58AMF DRUG__ID D58AMF D58AMF DRUGCOMP AbbVie; CytomX Therapeutics D58AMF DRUGTYPE Antibody drug conjugate D58AMF HIGHSTAT Phase 1 D5D6ZM DRUG__ID D5D6ZM D5D6ZM DRUGCOMP Ikena Oncology D5D6ZM DRUGTYPE Small molecular drug D5D6ZM HIGHSTAT Phase 1 D5DBU7 DRUG__ID D5DBU7 D5DBU7 DRUGCOMP iCell Gene Therapeutics D5DBU7 DRUGTYPE CAR T Cell Therapy D5DBU7 HIGHSTAT Phase 1 D5EOV9 DRUG__ID D5EOV9 D5EOV9 DRUGCOMP AbbVie; Calico Life Sciences D5EOV9 DRUGTYPE Antibody D5EOV9 HIGHSTAT Phase 1 D5EP4C DRUG__ID D5EP4C D5EP4C DRUGCOMP Ionis D5EP4C DRUGTYPE Gene therapy D5EP4C HIGHSTAT Phase 1 D5FCP1 DRUG__ID D5FCP1 D5FCP1 DRUGCOMP Trillium Therapeutics D5FCP1 DRUGTYPE Recombinant protein D5FCP1 HIGHSTAT Phase 1 D5IA0S DRUG__ID D5IA0S D5IA0S DRUGCOMP GeoVax Labs D5IA0S DRUGTYPE Vaccine D5IA0S HIGHSTAT Phase 1 D5KX2H DRUG__ID D5KX2H D5KX2H DRUGCOMP GlaxoSmithKline D5KX2H DRUGTYPE Small molecule D5KX2H HIGHSTAT Phase 1 D5LB7Y DRUG__ID D5LB7Y D5LB7Y DRUGCOMP Dicerna Pharmaceuticals; Roche D5LB7Y DRUGTYPE Small interfering RNA D5LB7Y HIGHSTAT Phase 1 D5P3SI DRUG__ID D5P3SI D5P3SI DRUGCOMP ST Pharm D5P3SI DRUGTYPE Small molecular drug D5P3SI HIGHSTAT Phase 1 D5QKY2 DRUG__ID D5QKY2 D5QKY2 DRUGCOMP AbbVie D5QKY2 DRUGTYPE Monoclonal antibody D5QKY2 HIGHSTAT Phase 1 D5S9GI DRUG__ID D5S9GI D5S9GI DRUGCOMP InSilico Medicine D5S9GI DRUGTYPE Small molecule D5S9GI HIGHSTAT Phase 1 D5T1RN DRUG__ID D5T1RN D5T1RN DRUGCOMP Bayer D5T1RN DRUGTYPE Antibody D5T1RN HIGHSTAT Phase 1 D5T6DY DRUG__ID D5T6DY D5T6DY DRUGCOMP Amgen D5T6DY DRUGTYPE Antibody D5T6DY HIGHSTAT Phase 1 D5T9GZ DRUG__ID D5T9GZ D5T9GZ DRUGCOMP iCell Gene Therapeutics D5T9GZ DRUGTYPE CAR T Cell Therapy D5T9GZ HIGHSTAT Phase 1 D5TH2B DRUG__ID D5TH2B D5TH2B DRUGCOMP Pfizer D5TH2B DRUGTYPE Small molecular drug D5TH2B HIGHSTAT Phase 1 D5UA0Z DRUG__ID D5UA0Z D5UA0Z DRUGCOMP Moderna D5UA0Z DRUGTYPE Vaccine D5UA0Z HIGHSTAT Phase 1 D5V1CL DRUG__ID D5V1CL D5V1CL DRUGCOMP Neuraly Gaithersburg, MD D5V1CL DRUGTYPE Peptide D5V1CL HIGHSTAT Phase 1 D5V2HR DRUG__ID D5V2HR D5V2HR DRUGCOMP Innovent Biologics D5V2HR DRUGTYPE Antibody D5V2HR HIGHSTAT Phase 1 D5VE7C DRUG__ID D5VE7C D5VE7C DRUGCOMP Sanofi D5VE7C DRUGTYPE Antibody D5VE7C HIGHSTAT Phase 1 D5VMP4 DRUG__ID D5VMP4 D5VMP4 DRUGCOMP BioTheryX D5VMP4 DRUGTYPE Small molecular drug D5VMP4 HIGHSTAT Phase 1 D5WAG1 DRUG__ID D5WAG1 D5WAG1 DRUGCOMP Ultragenyx Pharmaceutical D5WAG1 DRUGTYPE Gene therapy D5WAG1 HIGHSTAT Phase 1 D5WB0F DRUG__ID D5WB0F D5WB0F DRUGCOMP Roche/Genentech D5WB0F DRUGTYPE Recombinant protein D5WB0F HIGHSTAT Phase 1 D5YN8U DRUG__ID D5YN8U D5YN8U DRUGCOMP Allogene Therapeutics D5YN8U DRUGTYPE CAR T Cell Therapy D5YN8U HIGHSTAT Phase 1 D62LKT DRUG__ID D62LKT D62LKT DRUGCOMP Boehringer Ingelheim D62LKT DRUGTYPE Antibody D62LKT HIGHSTAT Phase 1 D62RIY DRUG__ID D62RIY D62RIY DRUGCOMP Moderna D62RIY DRUGTYPE mRNA therapy D62RIY HIGHSTAT Phase 1 D62XNL DRUG__ID D62XNL D62XNL DRUGCOMP Cortexyme D62XNL DRUGTYPE Small molecule D62XNL HIGHSTAT Phase 1 D63QIY DRUG__ID D63QIY D63QIY DRUGCOMP AbbVie D63QIY DRUGTYPE Small molecular drug D63QIY HIGHSTAT Phase 1 D64FNH DRUG__ID D64FNH D64FNH DRUGCOMP Sanofi D64FNH DRUGTYPE Antibody D64FNH HIGHSTAT Phase 1 D67ABL DRUG__ID D67ABL D67ABL DRUGCOMP Matrivax D67ABL DRUGTYPE Vaccine D67ABL HIGHSTAT Phase 1 D67TOB DRUG__ID D67TOB D67TOB DRUGCOMP TAKEDA D67TOB DRUGTYPE CAR-T cell therapy D67TOB HIGHSTAT Phase 1 D67ZDJ DRUG__ID D67ZDJ D67ZDJ DRUGCOMP Novartis D67ZDJ DRUGTYPE CAR T Cell Therapy D67ZDJ HIGHSTAT Phase 1 D68PVB DRUG__ID D68PVB D68PVB DRUGCOMP Affiris D68PVB DRUGTYPE Vaccine D68PVB HIGHSTAT Phase 1 D68RMI DRUG__ID D68RMI D68RMI DRUGCOMP Cullinan Oncology; Taiho Pharmaceutical D68RMI DRUGTYPE Small molecular drug D68RMI HIGHSTAT Phase 1 D69KBS DRUG__ID D69KBS D69KBS DRUGCOMP Astellas Pharma D69KBS DRUGTYPE Cell therapy D69KBS HIGHSTAT Phase 1 D6AHO2 DRUG__ID D6AHO2 D6AHO2 DRUGCOMP Eli Lilly D6AHO2 DRUGTYPE Small molecular drug D6AHO2 HIGHSTAT Phase 1 D6CV1Q DRUG__ID D6CV1Q D6CV1Q DRUGCOMP Transgene D6CV1Q DRUGTYPE Vaccine D6CV1Q HIGHSTAT Phase 1 D6DO9A DRUG__ID D6DO9A D6DO9A DRUGCOMP Rocket Pharmaceuticals D6DO9A DRUGTYPE Gene therapy D6DO9A HIGHSTAT Phase 1 D6DR8F DRUG__ID D6DR8F D6DR8F DRUGCOMP Inovio Pharmaceuticals D6DR8F DRUGTYPE Vaccine D6DR8F HIGHSTAT Phase 1 D6EU7R DRUG__ID D6EU7R D6EU7R DRUGCOMP HaiHe Biopharma D6EU7R DRUGTYPE Small molecular drug D6EU7R HIGHSTAT Phase 1 D6FTN1 DRUG__ID D6FTN1 D6FTN1 DRUGCOMP Abbisko Therapeutics D6FTN1 DRUGTYPE Small molecular drug D6FTN1 HIGHSTAT Phase 1 D6H9TE DRUG__ID D6H9TE D6H9TE DRUGCOMP Seagen D6H9TE DRUGTYPE Antibody D6H9TE HIGHSTAT Phase 1 D6IOB5 DRUG__ID D6IOB5 D6IOB5 DRUGCOMP Bayer D6IOB5 DRUGTYPE Antibody D6IOB5 HIGHSTAT Phase 1 D6JM8Z DRUG__ID D6JM8Z D6JM8Z DRUGCOMP Baili pharm D6JM8Z DRUGTYPE Antibody D6JM8Z HIGHSTAT Phase 1 D6K9WN DRUG__ID D6K9WN D6K9WN DRUGCOMP BioNTech D6K9WN DRUGTYPE mRNA (modRNA) D6K9WN HIGHSTAT Phase 1 D6KWF3 DRUG__ID D6KWF3 D6KWF3 DRUGCOMP Neuronascent, NIA D6KWF3 DRUGTYPE Small molecule D6KWF3 HIGHSTAT Phase 1 D6N8UJ DRUG__ID D6N8UJ D6N8UJ DRUGCOMP Gamida Cell D6N8UJ DRUGTYPE Cell therapy D6N8UJ HIGHSTAT Phase 1 D6ONY2 DRUG__ID D6ONY2 D6ONY2 DRUGCOMP Kuur Therapeutics D6ONY2 DRUGTYPE CAR T Cell Therapy D6ONY2 HIGHSTAT Phase 1 D6Q4TS DRUG__ID D6Q4TS D6Q4TS DRUGCOMP Janssen D6Q4TS DRUGTYPE Vaccine D6Q4TS HIGHSTAT Phase 1 D6RT9L DRUG__ID D6RT9L D6RT9L DRUGCOMP Roche D6RT9L DRUGTYPE Bispecific antibody D6RT9L HIGHSTAT Phase 1 D6S1DT DRUG__ID D6S1DT D6S1DT DRUGCOMP Trellis Bioscience D6S1DT DRUGTYPE Antibody D6S1DT HIGHSTAT Phase 1 D6YQ2A DRUG__ID D6YQ2A D6YQ2A DRUGCOMP Sanofi D6YQ2A DRUGTYPE Vaccine D6YQ2A HIGHSTAT Phase 1 D70SHJ DRUG__ID D70SHJ D70SHJ DRUGCOMP Moderna Therapeutics D70SHJ DRUGTYPE mRNA therapy D70SHJ HIGHSTAT Phase 1 D73FNL DRUG__ID D73FNL D73FNL DRUGCOMP Amgen D73FNL DRUGTYPE Bispecific T-cell engager D73FNL HIGHSTAT Phase 1 D74BRK DRUG__ID D74BRK D74BRK DRUGCOMP BeiGene D74BRK DRUGTYPE Small molecular drug D74BRK HIGHSTAT Phase 1 D74ZUI DRUG__ID D74ZUI D74ZUI DRUGCOMP GlaxoSmithKline D74ZUI DRUGTYPE Vaccine D74ZUI HIGHSTAT Phase 1 D75LNO DRUG__ID D75LNO D75LNO DRUGCOMP Bristol-Myers Squibb D75LNO DRUGTYPE Small molecular drug D75LNO HIGHSTAT Phase 1 D79JZU DRUG__ID D79JZU D79JZU DRUGCOMP Fate Therapeutics D79JZU DRUGTYPE Cell therapy D79JZU HIGHSTAT Phase 1 D7AFK9 DRUG__ID D7AFK9 D7AFK9 DRUGCOMP Kuur Therapeutics D7AFK9 DRUGTYPE CAR-NKT Cell therapy D7AFK9 HIGHSTAT Phase 1 D7AT3H DRUG__ID D7AT3H D7AT3H DRUGCOMP GlaxoSmithKline D7AT3H DRUGTYPE Antibody-drug conjugate D7AT3H HIGHSTAT Phase 1 D7C3JA DRUG__ID D7C3JA D7C3JA DRUGCOMP Cellectis D7C3JA DRUGTYPE CAR T Cell Therapy D7C3JA HIGHSTAT Phase 1 D7CI9P DRUG__ID D7CI9P D7CI9P DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D7CI9P DRUGTYPE Small molecule D7CI9P HIGHSTAT Phase 1 D7D9QH DRUG__ID D7D9QH D7D9QH DRUGCOMP CSL Behring D7D9QH DRUGTYPE Gene therapy D7D9QH HIGHSTAT Phase 1 D7EJI9 DRUG__ID D7EJI9 D7EJI9 DRUGCOMP Upstream Biosciences D7EJI9 DRUGTYPE Antibody D7EJI9 HIGHSTAT Phase 1 D7G1JR DRUG__ID D7G1JR D7G1JR DRUGCOMP UCB Biopharma SRL D7G1JR DRUGTYPE Monoclonal antibody D7G1JR HIGHSTAT Phase 1 D7IA0N DRUG__ID D7IA0N D7IA0N DRUGCOMP Amgen D7IA0N DRUGTYPE Antibody D7IA0N HIGHSTAT Phase 1 D7J2NK DRUG__ID D7J2NK D7J2NK DRUGCOMP Tizona Therapeutics D7J2NK DRUGTYPE Antibody D7J2NK HIGHSTAT Phase 1 D7K5XP DRUG__ID D7K5XP D7K5XP DRUGCOMP Precision Biologics D7K5XP DRUGTYPE Antibody D7K5XP HIGHSTAT Phase 1 D7L1MP DRUG__ID D7L1MP D7L1MP DRUGCOMP AstraZeneca D7L1MP DRUGTYPE Antibody D7L1MP HIGHSTAT Phase 1 D7L8JC DRUG__ID D7L8JC D7L8JC DRUGCOMP Oncochel Therapeutics D7L8JC DRUGTYPE Small molecular drug D7L8JC HIGHSTAT Phase 1 D7LN0E DRUG__ID D7LN0E D7LN0E DRUGCOMP Teneobio D7LN0E DRUGTYPE Antibody D7LN0E HIGHSTAT Phase 1 D7LPV6 DRUG__ID D7LPV6 D7LPV6 DRUGCOMP Moderna Therapeutics Cambridge, MA D7LPV6 DRUGTYPE Vaccine D7LPV6 HIGHSTAT Phase 1 D7MYO0 DRUG__ID D7MYO0 D7MYO0 DRUGCOMP AstraZeneca D7MYO0 DRUGTYPE Small molecule D7MYO0 HIGHSTAT Phase 1 D7OPS6 DRUG__ID D7OPS6 D7OPS6 DRUGCOMP Cinphloro D7OPS6 DRUGTYPE Small molecule D7OPS6 HIGHSTAT Phase 1 D7PFL1 DRUG__ID D7PFL1 D7PFL1 DRUGCOMP GlaxoSmithKline D7PFL1 DRUGTYPE Small molecule D7PFL1 HIGHSTAT Phase 1 D7PWY2 DRUG__ID D7PWY2 D7PWY2 DRUGCOMP GlaxoSmithKline D7PWY2 DRUGTYPE Small molecule D7PWY2 HIGHSTAT Phase 1 D7QHV6 DRUG__ID D7QHV6 D7QHV6 DRUGCOMP AbbVie D7QHV6 DRUGTYPE TCR-T cell therapy D7QHV6 HIGHSTAT Phase 1 D7SJE2 DRUG__ID D7SJE2 D7SJE2 DRUGCOMP Bavarian Nordic D7SJE2 DRUGTYPE Vaccine D7SJE2 HIGHSTAT Phase 1 D7TB6I DRUG__ID D7TB6I D7TB6I DRUGCOMP Emergent BioSolutions D7TB6I DRUGTYPE Vaccine D7TB6I HIGHSTAT Phase 1 D7TV5I DRUG__ID D7TV5I D7TV5I DRUGCOMP Merck D7TV5I DRUGTYPE Antibody D7TV5I HIGHSTAT Phase 1 D7V0MU DRUG__ID D7V0MU D7V0MU DRUGCOMP GlaxoSmithKline D7V0MU DRUGTYPE Vaccine D7V0MU HIGHSTAT Phase 1 D7W6SO DRUG__ID D7W6SO D7W6SO DRUGCOMP Immunotope D7W6SO DRUGTYPE Vaccine D7W6SO HIGHSTAT Phase 1 D7WMF3 DRUG__ID D7WMF3 D7WMF3 DRUGCOMP Pfzer D7WMF3 DRUGTYPE Antibody D7WMF3 HIGHSTAT Phase 1 D7WOL5 DRUG__ID D7WOL5 D7WOL5 DRUGCOMP Compugen D7WOL5 DRUGTYPE Antibody D7WOL5 HIGHSTAT Phase 1 D7X8CB DRUG__ID D7X8CB D7X8CB DRUGCOMP Roche D7X8CB DRUGTYPE Antibody D7X8CB HIGHSTAT Phase 1 D81YIK DRUG__ID D81YIK D81YIK DRUGCOMP Novartis D81YIK DRUGTYPE Antibody D81YIK HIGHSTAT Phase 1 D82UVG DRUG__ID D82UVG D82UVG DRUGCOMP Alpine Immune Sciences D82UVG DRUGTYPE Protein D82UVG HIGHSTAT Phase 1 D87PWZ DRUG__ID D87PWZ D87PWZ DRUGCOMP AstraZeneca D87PWZ DRUGTYPE Antibody D87PWZ HIGHSTAT Phase 1 D89XBL DRUG__ID D89XBL D89XBL DRUGCOMP Siolta Therapeutics D89XBL DRUGTYPE Live biotherapeutic product D89XBL HIGHSTAT Phase 1 D8AOC1 DRUG__ID D8AOC1 D8AOC1 DRUGCOMP Amgen D8AOC1 DRUGTYPE Antibody D8AOC1 HIGHSTAT Phase 1 D8C1OA DRUG__ID D8C1OA D8C1OA DRUGCOMP Accutar Biotechnology D8C1OA DRUGTYPE PROTAC D8C1OA HIGHSTAT Phase 1 D8CFX3 DRUG__ID D8CFX3 D8CFX3 DRUGCOMP Regeneron Pharmaceuticals D8CFX3 DRUGTYPE Antibody D8CFX3 HIGHSTAT Phase 1 D8DJX0 DRUG__ID D8DJX0 D8DJX0 DRUGCOMP Oxford BioTherapeutics D8DJX0 DRUGTYPE Antibody drug conjugate D8DJX0 HIGHSTAT Phase 1 D8EIB7 DRUG__ID D8EIB7 D8EIB7 DRUGCOMP MaxCyte D8EIB7 DRUGTYPE CAR-PBMC Cell therapy D8EIB7 HIGHSTAT Phase 1 D8FJ9K DRUG__ID D8FJ9K D8FJ9K DRUGCOMP Xencor D8FJ9K DRUGTYPE Antibody D8FJ9K HIGHSTAT Phase 1 D8JN6C DRUG__ID D8JN6C D8JN6C DRUGCOMP Arrowhead Pharmaceuticals Pasadena, CA D8JN6C DRUGTYPE RNA interference D8JN6C HIGHSTAT Phase 1 D8MS6C DRUG__ID D8MS6C D8MS6C DRUGCOMP BeiGene D8MS6C DRUGTYPE Small molecular drug D8MS6C HIGHSTAT Phase 1 D8NZ7T DRUG__ID D8NZ7T D8NZ7T DRUGCOMP Acceleron Pharma D8NZ7T DRUGTYPE Protein D8NZ7T HIGHSTAT Phase 1 D8OJX6 DRUG__ID D8OJX6 D8OJX6 DRUGCOMP SOTIO D8OJX6 DRUGTYPE Recombinant protein D8OJX6 HIGHSTAT Phase 1 D8PJM3 DRUG__ID D8PJM3 D8PJM3 DRUGCOMP BioNTech D8PJM3 DRUGTYPE mRNA (modRNA) D8PJM3 HIGHSTAT Phase 1 D8TO6D DRUG__ID D8TO6D D8TO6D DRUGCOMP Neumora Therapeutics D8TO6D DRUGTYPE Small molecule D8TO6D HIGHSTAT Phase 1 D8UNG2 DRUG__ID D8UNG2 D8UNG2 DRUGCOMP TG Therapeutics D8UNG2 DRUGTYPE Antibody D8UNG2 HIGHSTAT Phase 1 D8UZ5R DRUG__ID D8UZ5R D8UZ5R DRUGCOMP Nitto Biopharma D8UZ5R DRUGTYPE Small interfering RNA D8UZ5R HIGHSTAT Phase 1 D8W0NQ DRUG__ID D8W0NQ D8W0NQ DRUGCOMP Alnylam Pharmaceuticals D8W0NQ DRUGTYPE RNA interference D8W0NQ HIGHSTAT Phase 1 D8W1DJ DRUG__ID D8W1DJ D8W1DJ DRUGCOMP Oncolix/Isotherapeutics D8W1DJ DRUGTYPE Radiopharmaceutical therapy agent D8W1DJ HIGHSTAT Phase 1 D8XHT1 DRUG__ID D8XHT1 D8XHT1 DRUGCOMP REGENXBIO D8XHT1 DRUGTYPE Gene therapy D8XHT1 HIGHSTAT Phase 1 D91CMX DRUG__ID D91CMX D91CMX DRUGCOMP Amgen D91CMX DRUGTYPE Antibody D91CMX HIGHSTAT Phase 1 D93YJK DRUG__ID D93YJK D93YJK DRUGCOMP Lilly D93YJK DRUGTYPE Monoclonal antibody D93YJK HIGHSTAT Phase 1 D94LRF DRUG__ID D94LRF D94LRF DRUGCOMP Amgen D94LRF DRUGTYPE Monoclonal antibody D94LRF HIGHSTAT Phase 1 D95GKC DRUG__ID D95GKC D95GKC DRUGCOMP Boston Children's Hospital; bluebird bio D95GKC DRUGTYPE Short hairpin RNA D95GKC HIGHSTAT Phase 1 D95YSW DRUG__ID D95YSW D95YSW DRUGCOMP Betta Pharmaceutical D95YSW DRUGTYPE Small molecular drug D95YSW HIGHSTAT Phase 1 D98FBH DRUG__ID D98FBH D98FBH DRUGCOMP Shanghai De Novo Pharmatech D98FBH DRUGTYPE Small molecular drug D98FBH HIGHSTAT Phase 1 D9DN5J DRUG__ID D9DN5J D9DN5J DRUGCOMP Roche/Genentech D9DN5J DRUGTYPE Recombinant protein D9DN5J HIGHSTAT Phase 1 D9DQ1I DRUG__ID D9DQ1I D9DQ1I DRUGCOMP Boehringer Ingelheim D9DQ1I DRUGTYPE Antibody D9DQ1I HIGHSTAT Phase 1 D9FGB3 DRUG__ID D9FGB3 D9FGB3 DRUGCOMP Amgen D9FGB3 DRUGTYPE CAR T Cell Therapy D9FGB3 HIGHSTAT Phase 1 D9FMA2 DRUG__ID D9FMA2 D9FMA2 DRUGCOMP Sanofi D9FMA2 DRUGTYPE Antibody D9FMA2 HIGHSTAT Phase 1 D9ICV2 DRUG__ID D9ICV2 D9ICV2 DRUGCOMP Takeda D9ICV2 DRUGTYPE Antibody drug conjugate D9ICV2 HIGHSTAT Phase 1 D9IQ6N DRUG__ID D9IQ6N D9IQ6N DRUGCOMP I-MAB Biopharma; TRACON Pharmaceuticals D9IQ6N DRUGTYPE Antibody D9IQ6N HIGHSTAT Phase 1 D9JHN4 DRUG__ID D9JHN4 D9JHN4 DRUGCOMP Ionova Life Sciences D9JHN4 DRUGTYPE Small molecular drug D9JHN4 HIGHSTAT Phase 1 D9L2WN DRUG__ID D9L2WN D9L2WN DRUGCOMP Annias Immunotherapeutics D9L2WN DRUGTYPE Vaccine D9L2WN HIGHSTAT Phase 1 D9LA6Q DRUG__ID D9LA6Q D9LA6Q DRUGCOMP Compugen D9LA6Q DRUGTYPE Antibody D9LA6Q HIGHSTAT Phase 1 D9M0KJ DRUG__ID D9M0KJ D9M0KJ DRUGCOMP Surface oncology D9M0KJ DRUGTYPE Antibody D9M0KJ HIGHSTAT Phase 1 D9OZ3B DRUG__ID D9OZ3B D9OZ3B DRUGCOMP Janssen D9OZ3B DRUGTYPE Antibody D9OZ3B HIGHSTAT Phase 1 D9PM2E DRUG__ID D9PM2E D9PM2E DRUGCOMP Imvax D9PM2E DRUGTYPE Vaccine D9PM2E HIGHSTAT Phase 1 D9QPI0 DRUG__ID D9QPI0 D9QPI0 DRUGCOMP Amgen D9QPI0 DRUGTYPE Bispecific T-cell engager D9QPI0 HIGHSTAT Phase 1 D9R6YC DRUG__ID D9R6YC D9R6YC DRUGCOMP BlueRock Therapeutics D9R6YC DRUGTYPE Cell therapy D9R6YC HIGHSTAT Phase 1 D9S7XO DRUG__ID D9S7XO D9S7XO DRUGCOMP Jiangxi Qingfeng Pharmaceutical D9S7XO DRUGTYPE Small molecular drug D9S7XO HIGHSTAT Phase 1 D9SL1N DRUG__ID D9SL1N D9SL1N DRUGCOMP Takeda D9SL1N DRUGTYPE Recombinant protein D9SL1N HIGHSTAT Phase 1 D9TG4H DRUG__ID D9TG4H D9TG4H DRUGCOMP Janssen D9TG4H DRUGTYPE Antibody D9TG4H HIGHSTAT Phase 1 D9TW0X DRUG__ID D9TW0X D9TW0X DRUGCOMP Sanofi Bridgewater, NJ D9TW0X DRUGTYPE Nanobody D9TW0X HIGHSTAT Phase 1 D9U5LY DRUG__ID D9U5LY D9U5LY DRUGCOMP Regeneron Pharmaceuticals; Sanofi D9U5LY DRUGTYPE Antibody D9U5LY HIGHSTAT Phase 1 D9XS2Y DRUG__ID D9XS2Y D9XS2Y DRUGCOMP Biogen D9XS2Y DRUGTYPE Monoclonal antibody D9XS2Y HIGHSTAT Phase 1 D9Y8ZU DRUG__ID D9Y8ZU D9Y8ZU DRUGCOMP Boehringer Ingelheim D9Y8ZU DRUGTYPE Antibody D9Y8ZU HIGHSTAT Phase 1 D9ZEM7 DRUG__ID D9ZEM7 D9ZEM7 DRUGCOMP vTv Therapeutics D9ZEM7 DRUGTYPE Small molecular drug D9ZEM7 HIGHSTAT Phase 1 D9ZQ7T DRUG__ID D9ZQ7T D9ZQ7T DRUGCOMP Vyera Pharmaceuticals D9ZQ7T DRUGTYPE Small molecular drug D9ZQ7T HIGHSTAT Phase 1 DA0Q5P DRUG__ID DA0Q5P DA0Q5P DRUGCOMP Eureka Therapeutics DA0Q5P DRUGTYPE CAR-T cell therapy DA0Q5P HIGHSTAT Phase 1 DA1X5W DRUG__ID DA1X5W DA1X5W DRUGCOMP Inhibrx DA1X5W DRUGTYPE Antibody DA1X5W HIGHSTAT Phase 1 DA3F2X DRUG__ID DA3F2X DA3F2X DRUGCOMP Tetraphase Pharmaceuticals DA3F2X DRUGTYPE Small interfering RNA DA3F2X HIGHSTAT Phase 1 DA3JV7 DRUG__ID DA3JV7 DA3JV7 DRUGCOMP Advaxis DA3JV7 DRUGTYPE Vaccine DA3JV7 HIGHSTAT Phase 1 DA3LS4 DRUG__ID DA3LS4 DA3LS4 DRUGCOMP GlaxoSmithKline DA3LS4 DRUGTYPE Vaccine DA3LS4 HIGHSTAT Phase 1 DA4O8C DRUG__ID DA4O8C DA4O8C DRUGCOMP ImmunoGen; MacroGenics DA4O8C DRUGTYPE Antibody drug conjugate DA4O8C HIGHSTAT Phase 1 DA5J0E DRUG__ID DA5J0E DA5J0E DRUGCOMP Roche DA5J0E DRUGTYPE Monoclonal antibody DA5J0E HIGHSTAT Phase 1 DA78ZH DRUG__ID DA78ZH DA78ZH DRUGCOMP AstraZeneca DA78ZH DRUGTYPE Oncolytic virus therapy DA78ZH HIGHSTAT Phase 1 DA8MK6 DRUG__ID DA8MK6 DA8MK6 DRUGCOMP EMD Serono DA8MK6 DRUGTYPE Antibody DA8MK6 HIGHSTAT Phase 1 DA9N4O DRUG__ID DA9N4O DA9N4O DRUGCOMP BJ Bioscience DA9N4O DRUGTYPE Recombinant protein DA9N4O HIGHSTAT Phase 1 DAD62Z DRUG__ID DAD62Z DAD62Z DRUGCOMP Ossium Health DAD62Z DRUGTYPE Cell therapy DAD62Z HIGHSTAT Phase 1 DAPZ09 DRUG__ID DAPZ09 DAPZ09 DRUGCOMP AlphaVax DAPZ09 DRUGTYPE Vaccine DAPZ09 HIGHSTAT Phase 1 DAS4D6 DRUG__ID DAS4D6 DAS4D6 DRUGCOMP Tmunity DAS4D6 DRUGTYPE CAR T Cell Therapy DAS4D6 HIGHSTAT Phase 1 DAX06Q DRUG__ID DAX06Q DAX06Q DRUGCOMP Amgen DAX06Q DRUGTYPE Antibody DAX06Q HIGHSTAT Phase 1 DB18NR DRUG__ID DB18NR DB18NR DRUGCOMP GlaxoSmithKline DB18NR DRUGTYPE MRNA vaccine DB18NR HIGHSTAT Phase 1 DB29TN DRUG__ID DB29TN DB29TN DRUGCOMP Mercia Pharma DB29TN DRUGTYPE Vaccine DB29TN HIGHSTAT Phase 1 DB4C5H DRUG__ID DB4C5H DB4C5H DRUGCOMP iCell Gene Therapeutics DB4C5H DRUGTYPE CAR T Cell Therapy DB4C5H HIGHSTAT Phase 1 DB53NH DRUG__ID DB53NH DB53NH DRUGCOMP Atridia; Hengrui Therapeutics DB53NH DRUGTYPE Small molecular drug DB53NH HIGHSTAT Phase 1 DB5UO0 DRUG__ID DB5UO0 DB5UO0 DRUGCOMP Cantargia DB5UO0 DRUGTYPE Antibody DB5UO0 HIGHSTAT Phase 1 DB6GK4 DRUG__ID DB6GK4 DB6GK4 DRUGCOMP Daiichi Sankyo DB6GK4 DRUGTYPE Antibody DB6GK4 HIGHSTAT Phase 1 DB7V3D DRUG__ID DB7V3D DB7V3D DRUGCOMP Yale University, NIA DB7V3D DRUGTYPE Small molecule DB7V3D HIGHSTAT Phase 1 DB8J2U DRUG__ID DB8J2U DB8J2U DRUGCOMP Kangpu Biopharmaceuticals DB8J2U DRUGTYPE Small molecular drug DB8J2U HIGHSTAT Phase 1 DB8MR6 DRUG__ID DB8MR6 DB8MR6 DRUGCOMP OncoSynergy DB8MR6 DRUGTYPE Antibody DB8MR6 HIGHSTAT Phase 1 DB93YI DRUG__ID DB93YI DB93YI DRUGCOMP Eureka Therapeutics DB93YI DRUGTYPE CAR-T cell therapy DB93YI HIGHSTAT Phase 1 DBDW09 DRUG__ID DBDW09 DBDW09 DRUGCOMP GlycoMimetics DBDW09 DRUGTYPE Small molecular drug DBDW09 HIGHSTAT Phase 1 DBE26P DRUG__ID DBE26P DBE26P DRUGCOMP Advaxis; Amgen DBE26P DRUGTYPE Vaccine DBE26P HIGHSTAT Phase 1 DBE87X DRUG__ID DBE87X DBE87X DRUGCOMP miRagen Therapeutics DBE87X DRUGTYPE Oligonucleotide DBE87X HIGHSTAT Phase 1 DBGD91 DRUG__ID DBGD91 DBGD91 DRUGCOMP Pelican Therapeutics DBGD91 DRUGTYPE Antibody DBGD91 HIGHSTAT Phase 1 DBIQ02 DRUG__ID DBIQ02 DBIQ02 DRUGCOMP ImmuneCyte DBIQ02 DRUGTYPE Cell therapy DBIQ02 HIGHSTAT Phase 1 DBNJ30 DRUG__ID DBNJ30 DBNJ30 DRUGCOMP AstraZeneca DBNJ30 DRUGTYPE Antibody DBNJ30 HIGHSTAT Phase 1 DBP9Q5 DRUG__ID DBP9Q5 DBP9Q5 DRUGCOMP Sanofi DBP9Q5 DRUGTYPE Antibody DBP9Q5 HIGHSTAT Phase 1 DBPV74 DRUG__ID DBPV74 DBPV74 DRUGCOMP Bio-Path Holdings DBPV74 DRUGTYPE Antisense oligonucleotide DBPV74 HIGHSTAT Phase 1 DBU13L DRUG__ID DBU13L DBU13L DRUGCOMP Exicure DBU13L DRUGTYPE Small molecular drug DBU13L HIGHSTAT Phase 1 DBU16T DRUG__ID DBU16T DBU16T DRUGCOMP JS InnoPharm DBU16T DRUGTYPE Small molecular drug DBU16T HIGHSTAT Phase 1 DBZ87Q DRUG__ID DBZ87Q DBZ87Q DRUGCOMP BeiGene DBZ87Q DRUGTYPE Antibody DBZ87Q HIGHSTAT Phase 1 DC0DU9 DRUG__ID DC0DU9 DC0DU9 DRUGCOMP I-Mab Biopharma DC0DU9 DRUGTYPE Vaccine DC0DU9 HIGHSTAT Phase 1 DC3Y7O DRUG__ID DC3Y7O DC3Y7O DRUGCOMP Affimed Therapeutics; Roche/Genentech DC3Y7O DRUGTYPE Antibody DC3Y7O HIGHSTAT Phase 1 DC5A9Q DRUG__ID DC5A9Q DC5A9Q DRUGCOMP Moderna Therapeutics DC5A9Q DRUGTYPE mRNA therapy DC5A9Q HIGHSTAT Phase 1 DC6LS1 DRUG__ID DC6LS1 DC6LS1 DRUGCOMP Angiocrine Bioscience DC6LS1 DRUGTYPE Cell therapy DC6LS1 HIGHSTAT Phase 1 DC6UG5 DRUG__ID DC6UG5 DC6UG5 DRUGCOMP Prelude Therapeutics DC6UG5 DRUGTYPE Small molecular drug DC6UG5 HIGHSTAT Phase 1 DC8HR6 DRUG__ID DC8HR6 DC8HR6 DRUGCOMP Eli Lilly DC8HR6 DRUGTYPE Antibody DC8HR6 HIGHSTAT Phase 1 DCD1M8 DRUG__ID DCD1M8 DCD1M8 DRUGCOMP AbbVie DCD1M8 DRUGTYPE Small molecular drug DCD1M8 HIGHSTAT Phase 1 DCJ95T DRUG__ID DCJ95T DCJ95T DRUGCOMP Moderna DCJ95T DRUGTYPE Vaccine DCJ95T HIGHSTAT Phase 1 DCL84J DRUG__ID DCL84J DCL84J DRUGCOMP Valneva DCL84J DRUGTYPE Vaccine DCL84J HIGHSTAT Phase 1 DCMG03 DRUG__ID DCMG03 DCMG03 DRUGCOMP AbbVie DCMG03 DRUGTYPE Antibody DCMG03 HIGHSTAT Phase 1 DCP0I8 DRUG__ID DCP0I8 DCP0I8 DRUGCOMP Acumen Pharmaceuticals Charlottesville, VA DCP0I8 DRUGTYPE Antibody DCP0I8 HIGHSTAT Phase 1 DCUQ32 DRUG__ID DCUQ32 DCUQ32 DRUGCOMP Roche/Genentech DCUQ32 DRUGTYPE Bispecific antibody DCUQ32 HIGHSTAT Phase 1 DCW89Z DRUG__ID DCW89Z DCW89Z DRUGCOMP Bristol-Myers Squibb DCW89Z DRUGTYPE Small molecule DCW89Z HIGHSTAT Phase 1 DD1TJ8 DRUG__ID DD1TJ8 DD1TJ8 DRUGCOMP Xencor DD1TJ8 DRUGTYPE Antibody DD1TJ8 HIGHSTAT Phase 1 DD4XR3 DRUG__ID DD4XR3 DD4XR3 DRUGCOMP Mustang Bio DD4XR3 DRUGTYPE CAR T Cell Therapy DD4XR3 HIGHSTAT Phase 1 DD6AZ5 DRUG__ID DD6AZ5 DD6AZ5 DRUGCOMP Bionomics DD6AZ5 DRUGTYPE Antibody DD6AZ5 HIGHSTAT Phase 1 DDE3Z4 DRUG__ID DDE3Z4 DDE3Z4 DRUGCOMP Hutchison MediPharma DDE3Z4 DRUGTYPE Small molecular drug DDE3Z4 HIGHSTAT Phase 1 DDE82F DRUG__ID DDE82F DDE82F DRUGCOMP AbbVie DDE82F DRUGTYPE Antibody drug conjugate DDE82F HIGHSTAT Phase 1 DDG8W9 DRUG__ID DDG8W9 DDG8W9 DRUGCOMP Seagen DDG8W9 DRUGTYPE Antibody drug conjugate DDG8W9 HIGHSTAT Phase 1 DDKY53 DRUG__ID DDKY53 DDKY53 DRUGCOMP Boehringer Ingelheim DDKY53 DRUGTYPE Antibody DDKY53 HIGHSTAT Phase 1 DDV8H5 DRUG__ID DDV8H5 DDV8H5 DRUGCOMP Orano Med; RadioMedix DDV8H5 DRUGTYPE Peptide DDV8H5 HIGHSTAT Phase 1 DDY51F DRUG__ID DDY51F DDY51F DRUGCOMP Enanta Pharmaceuticals DDY51F DRUGTYPE Small molecular drug DDY51F HIGHSTAT Phase 1 DE0TD1 DRUG__ID DE0TD1 DE0TD1 DRUGCOMP Roche DE0TD1 DRUGTYPE Small molecular drug DE0TD1 HIGHSTAT Phase 1 DE1XF0 DRUG__ID DE1XF0 DE1XF0 DRUGCOMP Cabaletta Bio Philadelphia, PA DE1XF0 DRUGTYPE CAR-T cell therapy DE1XF0 HIGHSTAT Phase 1 DE3LH7 DRUG__ID DE3LH7 DE3LH7 DRUGCOMP AstraZeneca DE3LH7 DRUGTYPE Antibody DE3LH7 HIGHSTAT Phase 1 DE49RW DRUG__ID DE49RW DE49RW DRUGCOMP CRISPR Therapeutics DE49RW DRUGTYPE CAR T Cell Therapy DE49RW HIGHSTAT Phase 1 DE6C0U DRUG__ID DE6C0U DE6C0U DRUGCOMP Celavie Biosciences DE6C0U DRUGTYPE Cell therapy DE6C0U HIGHSTAT Phase 1 DE8S2F DRUG__ID DE8S2F DE8S2F DRUGCOMP Delta-Fly Pharma DE8S2F DRUGTYPE Small molecular drug DE8S2F HIGHSTAT Phase 1 DE8V1R DRUG__ID DE8V1R DE8V1R DRUGCOMP Arrowhead Pharmaceuticals DE8V1R DRUGTYPE Antisense oligonucleotide DE8V1R HIGHSTAT Phase 1 DE94CW DRUG__ID DE94CW DE94CW DRUGCOMP Novartis DE94CW DRUGTYPE Gene therapy DE94CW HIGHSTAT Phase 1 DEC8O3 DRUG__ID DEC8O3 DEC8O3 DRUGCOMP Carmot Therapeutics DEC8O3 DRUGTYPE Small molecular drug DEC8O3 HIGHSTAT Phase 1 DECJ17 DRUG__ID DECJ17 DECJ17 DRUGCOMP Biohaven Pharmaceuticals DECJ17 DRUGTYPE Antibody DECJ17 HIGHSTAT Phase 1 DEDP81 DRUG__ID DEDP81 DEDP81 DRUGCOMP Amgen DEDP81 DRUGTYPE Antibody DEDP81 HIGHSTAT Phase 1 DEI07S DRUG__ID DEI07S DEI07S DRUGCOMP Advanced Innovative Partners DEI07S DRUGTYPE Radiopharmaceutical therapy agent DEI07S HIGHSTAT Phase 1 DELW64 DRUG__ID DELW64 DELW64 DRUGCOMP Nurix DELW64 DRUGTYPE Small molecule DELW64 HIGHSTAT Phase 1 DEP3Z8 DRUG__ID DEP3Z8 DEP3Z8 DRUGCOMP Amgen DEP3Z8 DRUGTYPE Antibody DEP3Z8 HIGHSTAT Phase 1 DES1G5 DRUG__ID DES1G5 DES1G5 DRUGCOMP Roche DES1G5 DRUGTYPE Fusion protein DES1G5 HIGHSTAT Phase 1 DEU08Q DRUG__ID DEU08Q DEU08Q DRUGCOMP Gilead Sciences DEU08Q DRUGTYPE Antibody DEU08Q HIGHSTAT Phase 1 DEU8O6 DRUG__ID DEU8O6 DEU8O6 DRUGCOMP Symphogen DEU8O6 DRUGTYPE Antibody DEU8O6 HIGHSTAT Phase 1 DEUC70 DRUG__ID DEUC70 DEUC70 DRUGCOMP I-MAB Biopharma DEUC70 DRUGTYPE Antibody DEUC70 HIGHSTAT Phase 1 DEX8D5 DRUG__ID DEX8D5 DEX8D5 DRUGCOMP Novartis DEX8D5 DRUGTYPE Antibody drug conjugate DEX8D5 HIGHSTAT Phase 1 DF0DN4 DRUG__ID DF0DN4 DF0DN4 DRUGCOMP Enanta Pharmaceuticals DF0DN4 DRUGTYPE Small molecular drug DF0DN4 HIGHSTAT Phase 1 DF0PI8 DRUG__ID DF0PI8 DF0PI8 DRUGCOMP Bayer DF0PI8 DRUGTYPE Small molecular drug DF0PI8 HIGHSTAT Phase 1 DF14RB DRUG__ID DF14RB DF14RB DRUGCOMP Curevo Vaccine DF14RB DRUGTYPE Vaccine DF14RB HIGHSTAT Phase 1 DF21MW DRUG__ID DF21MW DF21MW DRUGCOMP reMYND, NeuroScios GmbH DF21MW DRUGTYPE Small molecule DF21MW HIGHSTAT Phase 1 DF2E5G DRUG__ID DF2E5G DF2E5G DRUGCOMP Vaxart DF2E5G DRUGTYPE Vaccine DF2E5G HIGHSTAT Phase 1 DF43EH DRUG__ID DF43EH DF43EH DRUGCOMP Amgen DF43EH DRUGTYPE Antibody DF43EH HIGHSTAT Phase 1 DF5PB0 DRUG__ID DF5PB0 DF5PB0 DRUGCOMP Klus Pharma DF5PB0 DRUGTYPE Monoclonal antibody DF5PB0 HIGHSTAT Phase 1 DF6BU4 DRUG__ID DF6BU4 DF6BU4 DRUGCOMP Biocytogen DF6BU4 DRUGTYPE Antibody DF6BU4 HIGHSTAT Phase 1 DF6Y1J DRUG__ID DF6Y1J DF6Y1J DRUGCOMP Merck DF6Y1J DRUGTYPE Small molecular drug DF6Y1J HIGHSTAT Phase 1 DF8X5N DRUG__ID DF8X5N DF8X5N DRUGCOMP Roche DF8X5N DRUGTYPE Bispecific antibody DF8X5N HIGHSTAT Phase 1 DF8ZT3 DRUG__ID DF8ZT3 DF8ZT3 DRUGCOMP NGM Biopharma DF8ZT3 DRUGTYPE Antibody DF8ZT3 HIGHSTAT Phase 1 DF9S1L DRUG__ID DF9S1L DF9S1L DRUGCOMP Atara Biotherapeutics DF9S1L DRUGTYPE CAR T Cell Therapy DF9S1L HIGHSTAT Phase 1 DFB64U DRUG__ID DFB64U DFB64U DRUGCOMP Sangamo BioSciences Brisbane, CA DFB64U DRUGTYPE Cell therapy DFB64U HIGHSTAT Phase 1 DFC0V4 DRUG__ID DFC0V4 DFC0V4 DRUGCOMP Cleave Therapeutics DFC0V4 DRUGTYPE Small molecular drug DFC0V4 HIGHSTAT Phase 1 DFJO04 DRUG__ID DFJO04 DFJO04 DRUGCOMP Nkarta DFJO04 DRUGTYPE CAR-NK cell therapy DFJO04 HIGHSTAT Phase 1 DFP0R6 DRUG__ID DFP0R6 DFP0R6 DRUGCOMP Rocket Pharmaceuticals DFP0R6 DRUGTYPE Gene therapy DFP0R6 HIGHSTAT Phase 1 DFQ17Y DRUG__ID DFQ17Y DFQ17Y DRUGCOMP TaiMed Biologics DFQ17Y DRUGTYPE Antibody DFQ17Y HIGHSTAT Phase 1 DFV71O DRUG__ID DFV71O DFV71O DRUGCOMP Actus Therapeutics DFV71O DRUGTYPE Gene therapy DFV71O HIGHSTAT Phase 1 DFXP94 DRUG__ID DFXP94 DFXP94 DRUGCOMP Biogen DFXP94 DRUGTYPE Antisense oligonucleotide DFXP94 HIGHSTAT Phase 1 DFZJ79 DRUG__ID DFZJ79 DFZJ79 DRUGCOMP Scholar Rock DFZJ79 DRUGTYPE Antibody DFZJ79 HIGHSTAT Phase 1 DG0NA1 DRUG__ID DG0NA1 DG0NA1 DRUGCOMP AstraZeneca; Moderna Therapeutics DG0NA1 DRUGTYPE mRNA therapy DG0NA1 HIGHSTAT Phase 1 DG15YL DRUG__ID DG15YL DG15YL DRUGCOMP GlaxoSmithKline DG15YL DRUGTYPE Antibody DG15YL HIGHSTAT Phase 1 DG17UJ DRUG__ID DG17UJ DG17UJ DRUGCOMP Amgen DG17UJ DRUGTYPE Antibody DG17UJ HIGHSTAT Phase 1 DG2EK3 DRUG__ID DG2EK3 DG2EK3 DRUGCOMP Pulmatrix Lexington, MA DG2EK3 DRUGTYPE Small molecule DG2EK3 HIGHSTAT Phase 1 DG4YF6 DRUG__ID DG4YF6 DG4YF6 DRUGCOMP Symphogen DG4YF6 DRUGTYPE Antibody DG4YF6 HIGHSTAT Phase 1 DG6V7E DRUG__ID DG6V7E DG6V7E DRUGCOMP Agenus; Gilead Sciences DG6V7E DRUGTYPE Antibody DG6V7E HIGHSTAT Phase 1 DG80IS DRUG__ID DG80IS DG80IS DRUGCOMP AstraZeneca DG80IS DRUGTYPE Antibody drug conjugate DG80IS HIGHSTAT Phase 1 DG97OH DRUG__ID DG97OH DG97OH DRUGCOMP BIONTECH DG97OH DRUGTYPE Cell therapy DG97OH HIGHSTAT Phase 1 DG9LF8 DRUG__ID DG9LF8 DG9LF8 DRUGCOMP Novartis DG9LF8 DRUGTYPE Small molecular drug DG9LF8 HIGHSTAT Phase 1 DGH83L DRUG__ID DGH83L DGH83L DRUGCOMP Denali Therapeutics DGH83L DRUGTYPE Small molecular drug DGH83L HIGHSTAT Phase 1 DH09QZ DRUG__ID DH09QZ DH09QZ DRUGCOMP Zymeworks DH09QZ DRUGTYPE Antibody drug conjugate DH09QZ HIGHSTAT Phase 1 DH17JI DRUG__ID DH17JI DH17JI DRUGCOMP Daiichi Sankyo DH17JI DRUGTYPE Antibody DH17JI HIGHSTAT Phase 1 DH19QJ DRUG__ID DH19QJ DH19QJ DRUGCOMP CRISPR Therapeutics DH19QJ DRUGTYPE CAR T Cell Therapy DH19QJ HIGHSTAT Phase 1 DH1OY4 DRUG__ID DH1OY4 DH1OY4 DRUGCOMP Omeros DH1OY4 DRUGTYPE Small interfering RNA DH1OY4 HIGHSTAT Phase 1 DH2S8X DRUG__ID DH2S8X DH2S8X DRUGCOMP Grid Therapeutics DH2S8X DRUGTYPE Antibody DH2S8X HIGHSTAT Phase 1 DH42RF DRUG__ID DH42RF DH42RF DRUGCOMP ImmunityBio; NantKwest DH42RF DRUGTYPE CAR T Cell Therapy DH42RF HIGHSTAT Phase 1 DH5BX2 DRUG__ID DH5BX2 DH5BX2 DRUGCOMP Bristol-Myers Squibb DH5BX2 DRUGTYPE Antibody drug conjugate DH5BX2 HIGHSTAT Phase 1 DH5S6Z DRUG__ID DH5S6Z DH5S6Z DRUGCOMP Cancer Targeted Technology DH5S6Z DRUGTYPE Small molecular drug DH5S6Z HIGHSTAT Phase 1 DH6GK7 DRUG__ID DH6GK7 DH6GK7 DRUGCOMP Adagene DH6GK7 DRUGTYPE Antibody DH6GK7 HIGHSTAT Phase 1 DH7ZV4 DRUG__ID DH7ZV4 DH7ZV4 DRUGCOMP JOHNSON & JOHNSON DH7ZV4 DRUGTYPE Bispecific antibody DH7ZV4 HIGHSTAT Phase 1 DHC3L2 DRUG__ID DHC3L2 DHC3L2 DRUGCOMP Moderna DHC3L2 DRUGTYPE Vaccine DHC3L2 HIGHSTAT Phase 1 DHD2S9 DRUG__ID DHD2S9 DHD2S9 DRUGCOMP Denali Therapeutics DHD2S9 DRUGTYPE Small molecular drug DHD2S9 HIGHSTAT Phase 1 DHLU46 DRUG__ID DHLU46 DHLU46 DRUGCOMP GlaxoSmithKline DHLU46 DRUGTYPE Vaccine DHLU46 HIGHSTAT Phase 1 DHMO41 DRUG__ID DHMO41 DHMO41 DRUGCOMP Gilead Sciences; Kite Pharma DHMO41 DRUGTYPE TCR-T cell therapy DHMO41 HIGHSTAT Phase 1 DHQ9S3 DRUG__ID DHQ9S3 DHQ9S3 DRUGCOMP Amgen DHQ9S3 DRUGTYPE Protein DHQ9S3 HIGHSTAT Phase 1 DHS3X7 DRUG__ID DHS3X7 DHS3X7 DRUGCOMP GlaxoSmithKline DHS3X7 DRUGTYPE TCR-T cell therapy DHS3X7 HIGHSTAT Phase 1 DHWF68 DRUG__ID DHWF68 DHWF68 DRUGCOMP Roche DHWF68 DRUGTYPE Bispecific antibody DHWF68 HIGHSTAT Phase 1 DI10NU DRUG__ID DI10NU DI10NU DRUGCOMP Amgen DI10NU DRUGTYPE Small molecular drug DI10NU HIGHSTAT Phase 1 DI17KH DRUG__ID DI17KH DI17KH DRUGCOMP Taiho Oncology; Astex Pharmaceuticals DI17KH DRUGTYPE Small molecular drug DI17KH HIGHSTAT Phase 1 DI19BZ DRUG__ID DI19BZ DI19BZ DRUGCOMP Kinaset Therapeutics DI19BZ DRUGTYPE Small molecule DI19BZ HIGHSTAT Phase 1 DI29VD DRUG__ID DI29VD DI29VD DRUGCOMP Moderna Therapeutics DI29VD DRUGTYPE Vaccine DI29VD HIGHSTAT Phase 1 DI5K9S DRUG__ID DI5K9S DI5K9S DRUGCOMP BioNTech DI5K9S DRUGTYPE Vaccine DI5K9S HIGHSTAT Phase 1 DI6BK9 DRUG__ID DI6BK9 DI6BK9 DRUGCOMP Gilead DI6BK9 DRUGTYPE CAR-T cell therapy DI6BK9 HIGHSTAT Phase 1 DI6SC3 DRUG__ID DI6SC3 DI6SC3 DRUGCOMP GlaxoSmithKline DI6SC3 DRUGTYPE Antibody DI6SC3 HIGHSTAT Phase 1 DI7NZ6 DRUG__ID DI7NZ6 DI7NZ6 DRUGCOMP Roche DI7NZ6 DRUGTYPE Vaccine DI7NZ6 HIGHSTAT Phase 1 DI9GC3 DRUG__ID DI9GC3 DI9GC3 DRUGCOMP Accutar Biotechnology DI9GC3 DRUGTYPE PROTAC DI9GC3 HIGHSTAT Phase 1 DI9X5U DRUG__ID DI9X5U DI9X5U DRUGCOMP Libella Gene Therapeutics DI9X5U DRUGTYPE Gene therapy DI9X5U HIGHSTAT Phase 1 DIA08F DRUG__ID DIA08F DIA08F DRUGCOMP Genosco DIA08F DRUGTYPE Small molecular drug DIA08F HIGHSTAT Phase 1 DIB8G5 DRUG__ID DIB8G5 DIB8G5 DRUGCOMP Kentucky BioProcessing DIB8G5 DRUGTYPE Vaccine DIB8G5 HIGHSTAT Phase 1 DIBP49 DRUG__ID DIBP49 DIBP49 DRUGCOMP Roche DIBP49 DRUGTYPE Monoclonal antibody DIBP49 HIGHSTAT Phase 1 DIPY14 DRUG__ID DIPY14 DIPY14 DRUGCOMP ABL Bio DIPY14 DRUGTYPE Antibody DIPY14 HIGHSTAT Phase 1 DIQE54 DRUG__ID DIQE54 DIQE54 DRUGCOMP Roche/Genentech; Xencor DIQE54 DRUGTYPE Recombinant protein DIQE54 HIGHSTAT Phase 1 DIS4N5 DRUG__ID DIS4N5 DIS4N5 DRUGCOMP ABM Therapeutics DIS4N5 DRUGTYPE Small molecular drug DIS4N5 HIGHSTAT Phase 1 DISJ28 DRUG__ID DISJ28 DISJ28 DRUGCOMP Daiichi Sankyo Basking Ridge, NJ DISJ28 DRUGTYPE Antibody drug conjugate DISJ28 HIGHSTAT Phase 1 DIW37N DRUG__ID DIW37N DIW37N DRUGCOMP Neuropore Therapies DIW37N DRUGTYPE Small molecular drug DIW37N HIGHSTAT Phase 1 DIWU14 DRUG__ID DIWU14 DIWU14 DRUGCOMP Pfzer DIWU14 DRUGTYPE Antibody DIWU14 HIGHSTAT Phase 1 DJ0P6Z DRUG__ID DJ0P6Z DJ0P6Z DRUGCOMP Sanofi DJ0P6Z DRUGTYPE Antibody DJ0P6Z HIGHSTAT Phase 1 DJ25DI DRUG__ID DJ25DI DJ25DI DRUGCOMP Bayer DJ25DI DRUGTYPE Radiopharmaceutical therapy agent DJ25DI HIGHSTAT Phase 1 DJ29KW DRUG__ID DJ29KW DJ29KW DRUGCOMP Gilead Sciences DJ29KW DRUGTYPE Antibody DJ29KW HIGHSTAT Phase 1 DJ2OV7 DRUG__ID DJ2OV7 DJ2OV7 DRUGCOMP Lundbeck DJ2OV7 DRUGTYPE Small molecule DJ2OV7 HIGHSTAT Phase 1 DJ3M0Q DRUG__ID DJ3M0Q DJ3M0Q DRUGCOMP Shionogi Florham Park, NJ DJ3M0Q DRUGTYPE Small molecule DJ3M0Q HIGHSTAT Phase 1 DJ3QK6 DRUG__ID DJ3QK6 DJ3QK6 DRUGCOMP Nurix DJ3QK6 DRUGTYPE Cell therapy DJ3QK6 HIGHSTAT Phase 1 DJ4B2E DRUG__ID DJ4B2E DJ4B2E DRUGCOMP Syros Pharmaceuticals Cambridge, MA DJ4B2E DRUGTYPE Small molecule DJ4B2E HIGHSTAT Phase 1 DJ4GE9 DRUG__ID DJ4GE9 DJ4GE9 DRUGCOMP Inovio Pharmaceuticals; Coalition for Epidemic Preparedness Innovations DJ4GE9 DRUGTYPE Vaccine DJ4GE9 HIGHSTAT Phase 1 DJ4X7D DRUG__ID DJ4X7D DJ4X7D DRUGCOMP Daiichi Sankyo DJ4X7D DRUGTYPE Antibody drug conjugate DJ4X7D HIGHSTAT Phase 1 DJ5XY8 DRUG__ID DJ5XY8 DJ5XY8 DRUGCOMP Silence Therapeutics DJ5XY8 DRUGTYPE Small interfering RNA DJ5XY8 HIGHSTAT Phase 1 DJ6NE2 DRUG__ID DJ6NE2 DJ6NE2 DRUGCOMP Leap Therapeutics DJ6NE2 DRUGTYPE Antibody DJ6NE2 HIGHSTAT Phase 1 DJ6ZB0 DRUG__ID DJ6ZB0 DJ6ZB0 DRUGCOMP BeiGene DJ6ZB0 DRUGTYPE PROTAC DJ6ZB0 HIGHSTAT Phase 1 DJ8B6F DRUG__ID DJ8B6F DJ8B6F DRUGCOMP Goldfinch Bio Cambridge, MA DJ8B6F DRUGTYPE Antibody DJ8B6F HIGHSTAT Phase 1 DJ9H4F DRUG__ID DJ9H4F DJ9H4F DRUGCOMP INmune Bio DJ9H4F DRUGTYPE Cell therapy DJ9H4F HIGHSTAT Phase 1 DJ9WC4 DRUG__ID DJ9WC4 DJ9WC4 DRUGCOMP Syros Pharmaceuticals DJ9WC4 DRUGTYPE Small molecular drug DJ9WC4 HIGHSTAT Phase 1 DJCN38 DRUG__ID DJCN38 DJCN38 DRUGCOMP Regeneron Pharmaceuticals; Sanofi DJCN38 DRUGTYPE Antibody DJCN38 HIGHSTAT Phase 1 DJNY65 DRUG__ID DJNY65 DJNY65 DRUGCOMP GlaxoSmithKline DJNY65 DRUGTYPE Vaccine DJNY65 HIGHSTAT Phase 1 DJQ96R DRUG__ID DJQ96R DJQ96R DRUGCOMP HiberCell New York, NY DJQ96R DRUGTYPE Small molecule DJQ96R HIGHSTAT Phase 1 DJR94F DRUG__ID DJR94F DJR94F DRUGCOMP Phoenix Molecular Designs DJR94F DRUGTYPE Small molecular drug DJR94F HIGHSTAT Phase 1 DJVC36 DRUG__ID DJVC36 DJVC36 DRUGCOMP Klus Pharma DJVC36 DRUGTYPE Small molecule DJVC36 HIGHSTAT Phase 1 DJVH04 DRUG__ID DJVH04 DJVH04 DRUGCOMP Bristol-Myers Squibb DJVH04 DRUGTYPE CAR T Cell Therapy DJVH04 HIGHSTAT Phase 1 DJVR06 DRUG__ID DJVR06 DJVR06 DRUGCOMP Kadmon DJVR06 DRUGTYPE Recombinant protein DJVR06 HIGHSTAT Phase 1 DJX7K9 DRUG__ID DJX7K9 DJX7K9 DRUGCOMP Roche DJX7K9 DRUGTYPE Antisense oligonucleotide DJX7K9 HIGHSTAT Phase 1 DJXI69 DRUG__ID DJXI69 DJXI69 DRUGCOMP Takeda DJXI69 DRUGTYPE CAR-T cell therapy DJXI69 HIGHSTAT Phase 1 DJYD13 DRUG__ID DJYD13 DJYD13 DRUGCOMP Seagen DJYD13 DRUGTYPE Antibody drug conjugate DJYD13 HIGHSTAT Phase 1 DK1CU4 DRUG__ID DK1CU4 DK1CU4 DRUGCOMP SynerGene Therapeutics DK1CU4 DRUGTYPE Gene therapy DK1CU4 HIGHSTAT Phase 1 DK1PA2 DRUG__ID DK1PA2 DK1PA2 DRUGCOMP Actinium Pharmaceuticals DK1PA2 DRUGTYPE Radiopharmaceutical therapy agent DK1PA2 HIGHSTAT Phase 1 DK28GS DRUG__ID DK28GS DK28GS DRUGCOMP Nouscom DK28GS DRUGTYPE Vaccine DK28GS HIGHSTAT Phase 1 DK28NV DRUG__ID DK28NV DK28NV DRUGCOMP Ionis Pharmaceuticals DK28NV DRUGTYPE Antisense oligonucleotide DK28NV HIGHSTAT Phase 1 DK4I9R DRUG__ID DK4I9R DK4I9R DRUGCOMP Merck DK4I9R DRUGTYPE Antibody DK4I9R HIGHSTAT Phase 1 DK52QX DRUG__ID DK52QX DK52QX DRUGCOMP Roche/Genentech DK52QX DRUGTYPE Antibody DK52QX HIGHSTAT Phase 1 DK6S3G DRUG__ID DK6S3G DK6S3G DRUGCOMP Compass Therapeutics DK6S3G DRUGTYPE Antibody DK6S3G HIGHSTAT Phase 1 DK87UQ DRUG__ID DK87UQ DK87UQ DRUGCOMP Pfizer DK87UQ DRUGTYPE Antibody DK87UQ HIGHSTAT Phase 1 DKCI94 DRUG__ID DKCI94 DKCI94 DRUGCOMP AbbVie DKCI94 DRUGTYPE Antibody DKCI94 HIGHSTAT Phase 1 DKGB36 DRUG__ID DKGB36 DKGB36 DRUGCOMP Tmunity DKGB36 DRUGTYPE CAR T Cell Therapy DKGB36 HIGHSTAT Phase 1 DKL13E DRUG__ID DKL13E DKL13E DRUGCOMP Corvus Pharmaceuticals DKL13E DRUGTYPE Antibody DKL13E HIGHSTAT Phase 1 DKL3Z7 DRUG__ID DKL3Z7 DKL3Z7 DRUGCOMP Bristol-Myers Squibb DKL3Z7 DRUGTYPE Antibody DKL3Z7 HIGHSTAT Phase 1 DKM7S3 DRUG__ID DKM7S3 DKM7S3 DRUGCOMP Celldex Therapeutics DKM7S3 DRUGTYPE Antibody DKM7S3 HIGHSTAT Phase 1 DKOY58 DRUG__ID DKOY58 DKOY58 DRUGCOMP AstraZeneca DKOY58 DRUGTYPE Small molecule DKOY58 HIGHSTAT Phase 1 DKUF26 DRUG__ID DKUF26 DKUF26 DRUGCOMP Shattuck Labs DKUF26 DRUGTYPE Recombinant protein DKUF26 HIGHSTAT Phase 1 DKUP06 DRUG__ID DKUP06 DKUP06 DRUGCOMP United Neuroscience Ltd. DKUP06 DRUGTYPE Vaccine DKUP06 HIGHSTAT Phase 1 DKWS78 DRUG__ID DKWS78 DKWS78 DRUGCOMP Moderna DKWS78 DRUGTYPE mRNA DKWS78 HIGHSTAT Phase 1 DKX1U6 DRUG__ID DKX1U6 DKX1U6 DRUGCOMP Amgen DKX1U6 DRUGTYPE Bispecific T-cell engager DKX1U6 HIGHSTAT Phase 1 DKX8W5 DRUG__ID DKX8W5 DKX8W5 DRUGCOMP Sanofi DKX8W5 DRUGTYPE Nanobody DKX8W5 HIGHSTAT Phase 1 DL05NG DRUG__ID DL05NG DL05NG DRUGCOMP GlaxoSmithKline DL05NG DRUGTYPE Vaccine DL05NG HIGHSTAT Phase 1 DL07ZP DRUG__ID DL07ZP DL07ZP DRUGCOMP AnaptysBio; GlaxoSmithKline DL07ZP DRUGTYPE Antibody DL07ZP HIGHSTAT Phase 1 DL0C5E DRUG__ID DL0C5E DL0C5E DRUGCOMP VLP Therapeutics DL0C5E DRUGTYPE Vaccine DL0C5E HIGHSTAT Phase 1 DL1XC2 DRUG__ID DL1XC2 DL1XC2 DRUGCOMP 3SBio DL1XC2 DRUGTYPE Antibody DL1XC2 HIGHSTAT Phase 1 DL5UR0 DRUG__ID DL5UR0 DL5UR0 DRUGCOMP Boehringer Ingelheim DL5UR0 DRUGTYPE Small molecular drug DL5UR0 HIGHSTAT Phase 1 DL69MN DRUG__ID DL69MN DL69MN DRUGCOMP Novo Nordisk Plainsboro, NJ DL69MN DRUGTYPE Small molecule DL69MN HIGHSTAT Phase 1 DL6F3E DRUG__ID DL6F3E DL6F3E DRUGCOMP Sanofi DL6F3E DRUGTYPE Antibody DL6F3E HIGHSTAT Phase 1 DL81ME DRUG__ID DL81ME DL81ME DRUGCOMP Astelllas DL81ME DRUGTYPE Small molecule DL81ME HIGHSTAT Phase 1 DL97UQ DRUG__ID DL97UQ DL97UQ DRUGCOMP Klus Pharma DL97UQ DRUGTYPE Bispecific antibody DL97UQ HIGHSTAT Phase 1 DL9ZT4 DRUG__ID DL9ZT4 DL9ZT4 DRUGCOMP Pfizer DL9ZT4 DRUGTYPE Antibody DL9ZT4 HIGHSTAT Phase 1 DLBA13 DRUG__ID DLBA13 DLBA13 DRUGCOMP Roche DLBA13 DRUGTYPE Peptide DLBA13 HIGHSTAT Phase 1 DLCX50 DRUG__ID DLCX50 DLCX50 DRUGCOMP HiberCell DLCX50 DRUGTYPE Antibody DLCX50 HIGHSTAT Phase 1 DLJN17 DRUG__ID DLJN17 DLJN17 DRUGCOMP Sumitomo Dainippon Pharma DLJN17 DRUGTYPE Small molecular drug DLJN17 HIGHSTAT Phase 1 DLXO91 DRUG__ID DLXO91 DLXO91 DRUGCOMP Mustang Bio DLXO91 DRUGTYPE Oncolytic virus therapy DLXO91 HIGHSTAT Phase 1 DLY65X DRUG__ID DLY65X DLY65X DRUGCOMP Amgen DLY65X DRUGTYPE Antibody DLY65X HIGHSTAT Phase 1 DLY89F DRUG__ID DLY89F DLY89F DRUGCOMP Surface oncology DLY89F DRUGTYPE Antibody DLY89F HIGHSTAT Phase 1 DM1F3R DRUG__ID DM1F3R DM1F3R DRUGCOMP GlaxoSmithKline DM1F3R DRUGTYPE Antibody DM1F3R HIGHSTAT Phase 1 DM2Y8T DRUG__ID DM2Y8T DM2Y8T DRUGCOMP GlaxoSmithKline DM2Y8T DRUGTYPE Small molecular drug DM2Y8T HIGHSTAT Phase 1 DM38KC DRUG__ID DM38KC DM38KC DRUGCOMP Adaptimmune DM38KC DRUGTYPE CAR-T cell therapy DM38KC HIGHSTAT Phase 1 DM5PA2 DRUG__ID DM5PA2 DM5PA2 DRUGCOMP Astelllas DM5PA2 DRUGTYPE Recombinant protein DM5PA2 HIGHSTAT Phase 1 DM6CE2 DRUG__ID DM6CE2 DM6CE2 DRUGCOMP Cancer Targeted Technologies DM6CE2 DRUGTYPE Radiopharmaceutical therapy agent DM6CE2 HIGHSTAT Phase 1 DM9GO4 DRUG__ID DM9GO4 DM9GO4 DRUGCOMP Immune-Onc Therapeutics DM9GO4 DRUGTYPE Antibody DM9GO4 HIGHSTAT Phase 1 DMA7E5 DRUG__ID DMA7E5 DMA7E5 DRUGCOMP Pfzer DMA7E5 DRUGTYPE Antibody DMA7E5 HIGHSTAT Phase 1 DMAU56 DRUG__ID DMAU56 DMAU56 DRUGCOMP Moderna Therapeutics DMAU56 DRUGTYPE Vaccine DMAU56 HIGHSTAT Phase 1 DMD0H5 DRUG__ID DMD0H5 DMD0H5 DRUGCOMP Sarepta Therapeutics DMD0H5 DRUGTYPE Gene therapy DMD0H5 HIGHSTAT Phase 1 DMD9W8 DRUG__ID DMD9W8 DMD9W8 DRUGCOMP Axial Biotherapeutics DMD9W8 DRUGTYPE Small molecular drug DMD9W8 HIGHSTAT Phase 1 DMEQ73 DRUG__ID DMEQ73 DMEQ73 DRUGCOMP Novartis DMEQ73 DRUGTYPE Antibody DMEQ73 HIGHSTAT Phase 1 DMLY68 DRUG__ID DMLY68 DMLY68 DRUGCOMP Klus Pharma DMLY68 DRUGTYPE Small molecule DMLY68 HIGHSTAT Phase 1 DMR72A DRUG__ID DMR72A DMR72A DRUGCOMP Janssen DMR72A DRUGTYPE Antibody DMR72A HIGHSTAT Phase 1 DMSL68 DRUG__ID DMSL68 DMSL68 DRUGCOMP Bristol-Myers Squibb DMSL68 DRUGTYPE Antibody DMSL68 HIGHSTAT Phase 1 DMV5C7 DRUG__ID DMV5C7 DMV5C7 DRUGCOMP Pfzer DMV5C7 DRUGTYPE Small molecule DMV5C7 HIGHSTAT Phase 1 DMXD02 DRUG__ID DMXD02 DMXD02 DRUGCOMP Merck; Moderna Therapeutics DMXD02 DRUGTYPE Vaccine DMXD02 HIGHSTAT Phase 1 DN28KM DRUG__ID DN28KM DN28KM DRUGCOMP GenMab DN28KM DRUGTYPE Antibody DN28KM HIGHSTAT Phase 1 DN2B4A DRUG__ID DN2B4A DN2B4A DRUGCOMP Teva Pharmaceutical DN2B4A DRUGTYPE Antibody DN2B4A HIGHSTAT Phase 1 DN2Z5C DRUG__ID DN2Z5C DN2Z5C DRUGCOMP Landos Biopharma Blacksburg, VA DN2Z5C DRUGTYPE Small molecule DN2Z5C HIGHSTAT Phase 1 DN3B5E DRUG__ID DN3B5E DN3B5E DRUGCOMP Kangpu Biopharmaceuticals DN3B5E DRUGTYPE Small molecular drug DN3B5E HIGHSTAT Phase 1 DN46RL DRUG__ID DN46RL DN46RL DRUGCOMP Kite Pharma DN46RL DRUGTYPE TCR-T cell therapy DN46RL HIGHSTAT Phase 1 DN48GC DRUG__ID DN48GC DN48GC DRUGCOMP TAKEDA DN48GC DRUGTYPE Antibody DN48GC HIGHSTAT Phase 1 DN5F7C DRUG__ID DN5F7C DN5F7C DRUGCOMP BioNTech; Sanofi DN5F7C DRUGTYPE Gene therapy DN5F7C HIGHSTAT Phase 1 DN62IU DRUG__ID DN62IU DN62IU DRUGCOMP Agios Pharmaceuticals DN62IU DRUGTYPE Small molecular drug DN62IU HIGHSTAT Phase 1 DN68MW DRUG__ID DN68MW DN68MW DRUGCOMP Poseida Therapeutics DN68MW DRUGTYPE CAR T Cell Therapy DN68MW HIGHSTAT Phase 1 DN7H3D DRUG__ID DN7H3D DN7H3D DRUGCOMP BioNTech DN7H3D DRUGTYPE Vaccine DN7H3D HIGHSTAT Phase 1 DN7M4T DRUG__ID DN7M4T DN7M4T DRUGCOMP NaVire Pharma DN7M4T DRUGTYPE Small molecular drug DN7M4T HIGHSTAT Phase 1 DN81JB DRUG__ID DN81JB DN81JB DRUGCOMP Rockville DN81JB DRUGTYPE Small interfering RNA DN81JB HIGHSTAT Phase 1 DN91RC DRUG__ID DN91RC DN91RC DRUGCOMP IGM Biosciences DN91RC DRUGTYPE Antibody DN91RC HIGHSTAT Phase 1 DNI5M0 DRUG__ID DNI5M0 DNI5M0 DRUGCOMP Sinovent DNI5M0 DRUGTYPE Small molecule DNI5M0 HIGHSTAT Phase 1 DNMF63 DRUG__ID DNMF63 DNMF63 DRUGCOMP Biocytogen DNMF63 DRUGTYPE Antibody DNMF63 HIGHSTAT Phase 1 DNML54 DRUG__ID DNML54 DNML54 DRUGCOMP Innate Pharma DNML54 DRUGTYPE Antibody DNML54 HIGHSTAT Phase 1 DNS2P1 DRUG__ID DNS2P1 DNS2P1 DRUGCOMP Amgen DNS2P1 DRUGTYPE Antibody DNS2P1 HIGHSTAT Phase 1 DNW79M DRUG__ID DNW79M DNW79M DRUGCOMP AstraZeneca DNW79M DRUGTYPE Enzyme replacement DNW79M HIGHSTAT Phase 1 DO0C7S DRUG__ID DO0C7S DO0C7S DRUGCOMP Astelllas DO0C7S DRUGTYPE Antibody DO0C7S HIGHSTAT Phase 1 DO0LP3 DRUG__ID DO0LP3 DO0LP3 DRUGCOMP Nerviano Medical Sciences DO0LP3 DRUGTYPE Small molecular drug DO0LP3 HIGHSTAT Phase 1 DO20LT DRUG__ID DO20LT DO20LT DRUGCOMP Atreca DO20LT DRUGTYPE Antibody DO20LT HIGHSTAT Phase 1 DO2LE6 DRUG__ID DO2LE6 DO2LE6 DRUGCOMP Cocrystal Pharma DO2LE6 DRUGTYPE Small molecular drug DO2LE6 HIGHSTAT Phase 1 DO2P5G DRUG__ID DO2P5G DO2P5G DRUGCOMP Cerevance DO2P5G DRUGTYPE Small molecular drug DO2P5G HIGHSTAT Phase 1 DO31MK DRUG__ID DO31MK DO31MK DRUGCOMP Aprinoia Therapeutics Taipei, Taiwan DO31MK DRUGTYPE Monoclonal antibody DO31MK HIGHSTAT Phase 1 DO40BQ DRUG__ID DO40BQ DO40BQ DRUGCOMP Moderna DO40BQ DRUGTYPE mRNA therapy DO40BQ HIGHSTAT Phase 1 DO7D1L DRUG__ID DO7D1L DO7D1L DRUGCOMP Eisai DO7D1L DRUGTYPE Small molecular drug DO7D1L HIGHSTAT Phase 1 DO7MC9 DRUG__ID DO7MC9 DO7MC9 DRUGCOMP iCell Gene Therapeutics DO7MC9 DRUGTYPE CAR T Cell Therapy DO7MC9 HIGHSTAT Phase 1 DOA3J0 DRUG__ID DOA3J0 DOA3J0 DRUGCOMP Agenus; Gilead Sciences DOA3J0 DRUGTYPE Antibody DOA3J0 HIGHSTAT Phase 1 DOBZ63 DRUG__ID DOBZ63 DOBZ63 DRUGCOMP NKarta DOBZ63 DRUGTYPE CAR T Cell Therapy DOBZ63 HIGHSTAT Phase 1 DODG42 DRUG__ID DODG42 DODG42 DRUGCOMP Hutchison MediPharma DODG42 DRUGTYPE Small molecular drug DODG42 HIGHSTAT Phase 1 DOHM41 DRUG__ID DOHM41 DOHM41 DRUGCOMP 7 Hills Pharma DOHM41 DRUGTYPE Vaccine DOHM41 HIGHSTAT Phase 1 DOJ6E8 DRUG__ID DOJ6E8 DOJ6E8 DRUGCOMP Amgen DOJ6E8 DRUGTYPE Antibody DOJ6E8 HIGHSTAT Phase 1 DOQ13X DRUG__ID DOQ13X DOQ13X DRUGCOMP Bristol-Myers Squibb DOQ13X DRUGTYPE Antibody DOQ13X HIGHSTAT Phase 1 DP0G9N DRUG__ID DP0G9N DP0G9N DRUGCOMP Atara Biotherapeutics DP0G9N DRUGTYPE CAR T Cell Therapy DP0G9N HIGHSTAT Phase 1 DP0NU9 DRUG__ID DP0NU9 DP0NU9 DRUGCOMP AffyImmune Therapeutics DP0NU9 DRUGTYPE CAR T Cell Therapy DP0NU9 HIGHSTAT Phase 1 DP14YH DRUG__ID DP14YH DP14YH DRUGCOMP Adiso Therapeutics San Diego, CA DP14YH DRUGTYPE Small molecule DP14YH HIGHSTAT Phase 1 DP2X4C DRUG__ID DP2X4C DP2X4C DRUGCOMP Statera Biopharma DP2X4C DRUGTYPE Protein DP2X4C HIGHSTAT Phase 1 DP3S1J DRUG__ID DP3S1J DP3S1J DRUGCOMP Imugene DP3S1J DRUGTYPE Vaccine DP3S1J HIGHSTAT Phase 1 DP4KH3 DRUG__ID DP4KH3 DP4KH3 DRUGCOMP Pfizer DP4KH3 DRUGTYPE Small molecular drug DP4KH3 HIGHSTAT Phase 1 DP5J8S DRUG__ID DP5J8S DP5J8S DRUGCOMP Ionis DP5J8S DRUGTYPE Antisense oligonucleotide DP5J8S HIGHSTAT Phase 1 DP63FS DRUG__ID DP63FS DP63FS DRUGCOMP Novartis DP63FS DRUGTYPE Small molecular drug DP63FS HIGHSTAT Phase 1 DP6GC3 DRUG__ID DP6GC3 DP6GC3 DRUGCOMP Surface oncology DP6GC3 DRUGTYPE Antibody DP6GC3 HIGHSTAT Phase 1 DP7J0Z DRUG__ID DP7J0Z DP7J0Z DRUGCOMP Astrazeneca; medimmune DP7J0Z DRUGTYPE Antibody DP7J0Z HIGHSTAT Phase 1 DPFY92 DRUG__ID DPFY92 DPFY92 DRUGCOMP AstraZeneca DPFY92 DRUGTYPE Small molecule DPFY92 HIGHSTAT Phase 1 DPI9N4 DRUG__ID DPI9N4 DPI9N4 DRUGCOMP GlaxoSmithKline DPI9N4 DRUGTYPE Antibody DPI9N4 HIGHSTAT Phase 1 DPIE08 DRUG__ID DPIE08 DPIE08 DRUGCOMP Astelllas DPIE08 DRUGTYPE Small molecule DPIE08 HIGHSTAT Phase 1 DPIR35 DRUG__ID DPIR35 DPIR35 DRUGCOMP OncoMed DPIR35 DRUGTYPE Antibody DPIR35 HIGHSTAT Phase 1 DPJ70I DRUG__ID DPJ70I DPJ70I DRUGCOMP Sanofi DPJ70I DRUGTYPE Recombinant protein DPJ70I HIGHSTAT Phase 1 DPJM92 DRUG__ID DPJM92 DPJM92 DRUGCOMP J&J/Fusion Pharma DPJM92 DRUGTYPE Radiopharmaceutical therapy agent DPJM92 HIGHSTAT Phase 1 DPQ6Y9 DRUG__ID DPQ6Y9 DPQ6Y9 DRUGCOMP Pfizer DPQ6Y9 DRUGTYPE Vaccine DPQ6Y9 HIGHSTAT Phase 1 DPS29T DRUG__ID DPS29T DPS29T DRUGCOMP ORIC Pharmaceuticals DPS29T DRUGTYPE Small molecule DPS29T HIGHSTAT Phase 1 DPTM94 DRUG__ID DPTM94 DPTM94 DRUGCOMP Amplyx Pharmaceuticals DPTM94 DRUGTYPE Antibody DPTM94 HIGHSTAT Phase 1 DPU26Z DRUG__ID DPU26Z DPU26Z DRUGCOMP Lundbeck DPU26Z DRUGTYPE Monoclonal antibody DPU26Z HIGHSTAT Phase 1 DPYA76 DRUG__ID DPYA76 DPYA76 DRUGCOMP Shanghai Hengrui Pharmaceutical DPYA76 DRUGTYPE Monoclonal antibody DPYA76 HIGHSTAT Phase 1 DPZ6V9 DRUG__ID DPZ6V9 DPZ6V9 DRUGCOMP GlaxoSmithKline DPZ6V9 DRUGTYPE Vaccine DPZ6V9 HIGHSTAT Phase 1 DQ04FJ DRUG__ID DQ04FJ DQ04FJ DRUGCOMP Beijing Mabworks Biotech DQ04FJ DRUGTYPE Antibody DQ04FJ HIGHSTAT Phase 1 DQ12XP DRUG__ID DQ12XP DQ12XP DRUGCOMP Bexion Pharmaceuticals DQ12XP DRUGTYPE Recombinant protein DQ12XP HIGHSTAT Phase 1 DQ15HJ DRUG__ID DQ15HJ DQ15HJ DRUGCOMP AbbVie DQ15HJ DRUGTYPE Antibody DQ15HJ HIGHSTAT Phase 1 DQ1RZ8 DRUG__ID DQ1RZ8 DQ1RZ8 DRUGCOMP Acepodia DQ1RZ8 DRUGTYPE Antibody DQ1RZ8 HIGHSTAT Phase 1 DQ21NM DRUG__ID DQ21NM DQ21NM DRUGCOMP TG Therapeutics DQ21NM DRUGTYPE Small molecular drug DQ21NM HIGHSTAT Phase 1 DQ2XP5 DRUG__ID DQ2XP5 DQ2XP5 DRUGCOMP ViraCyte DQ2XP5 DRUGTYPE Cell therapy DQ2XP5 HIGHSTAT Phase 1 DQ5YV2 DRUG__ID DQ5YV2 DQ5YV2 DRUGCOMP Pfzer DQ5YV2 DRUGTYPE Small molecule DQ5YV2 HIGHSTAT Phase 1 DQ8F7A DRUG__ID DQ8F7A DQ8F7A DRUGCOMP Klus Pharma DQ8F7A DRUGTYPE Small molecule DQ8F7A HIGHSTAT Phase 1 DQ8K3R DRUG__ID DQ8K3R DQ8K3R DRUGCOMP Kairos Pharma Los Angeles, CA DQ8K3R DRUGTYPE Antibody DQ8K3R HIGHSTAT Phase 1 DQ9T7I DRUG__ID DQ9T7I DQ9T7I DRUGCOMP ViraCyte DQ9T7I DRUGTYPE Cell therapy DQ9T7I HIGHSTAT Phase 1 DQC80I DRUG__ID DQC80I DQC80I DRUGCOMP Triphase Accelerator DQC80I DRUGTYPE Antibody drug conjugate DQC80I HIGHSTAT Phase 1 DQD1T2 DRUG__ID DQD1T2 DQD1T2 DRUGCOMP Gemoab DQD1T2 DRUGTYPE Antibody DQD1T2 HIGHSTAT Phase 1 DQPF85 DRUG__ID DQPF85 DQPF85 DRUGCOMP HORIZON DQPF85 DRUGTYPE Cell therapy DQPF85 HIGHSTAT Phase 1 DQVR30 DRUG__ID DQVR30 DQVR30 DRUGCOMP Novartis DQVR30 DRUGTYPE Antibody drug conjugate DQVR30 HIGHSTAT Phase 1 DQX83Z DRUG__ID DQX83Z DQX83Z DRUGCOMP Incyte DQX83Z DRUGTYPE Small molecular drug DQX83Z HIGHSTAT Phase 1 DR03FL DRUG__ID DR03FL DR03FL DRUGCOMP Inovio Pharmaceuticals; GeneOne Life Science DR03FL DRUGTYPE Vaccine DR03FL HIGHSTAT Phase 1 DR07FQ DRUG__ID DR07FQ DR07FQ DRUGCOMP Ionis; AstraZeneca DR07FQ DRUGTYPE Antisense oligonucleotide DR07FQ HIGHSTAT Phase 1 DR0L8A DRUG__ID DR0L8A DR0L8A DRUGCOMP Precigen DR0L8A DRUGTYPE CAR-T cell therapy DR0L8A HIGHSTAT Phase 1 DR0M3F DRUG__ID DR0M3F DR0M3F DRUGCOMP Sorrento Therapeutics DR0M3F DRUGTYPE CAR T Cell Therapy DR0M3F HIGHSTAT Phase 1 DR15DO DRUG__ID DR15DO DR15DO DRUGCOMP Fate Therapeutics DR15DO DRUGTYPE CAR T Cell Therapy DR15DO HIGHSTAT Phase 1 DR1YQ7 DRUG__ID DR1YQ7 DR1YQ7 DRUGCOMP Genocea Biosciences DR1YQ7 DRUGTYPE Cell therapy DR1YQ7 HIGHSTAT Phase 1 DR4K0V DRUG__ID DR4K0V DR4K0V DRUGCOMP Boehringer Ingelheim DR4K0V DRUGTYPE Small molecular drug DR4K0V HIGHSTAT Phase 1 DR4ND6 DRUG__ID DR4ND6 DR4ND6 DRUGCOMP Istari Oncology DR4ND6 DRUGTYPE Antibody DR4ND6 HIGHSTAT Phase 1 DR5LW8 DRUG__ID DR5LW8 DR5LW8 DRUGCOMP INmune Bio DR5LW8 DRUGTYPE Protein DR5LW8 HIGHSTAT Phase 1 DRAL63 DRUG__ID DRAL63 DRAL63 DRUGCOMP Gilead DRAL63 DRUGTYPE Antibody DRAL63 HIGHSTAT Phase 1 DRDX09 DRUG__ID DRDX09 DRDX09 DRUGCOMP Moderna DRDX09 DRUGTYPE Vaccine DRDX09 HIGHSTAT Phase 1 DRGC82 DRUG__ID DRGC82 DRGC82 DRUGCOMP TaiMed Biologics DRGC82 DRUGTYPE Antibody DRGC82 HIGHSTAT Phase 1 DRI23U DRUG__ID DRI23U DRI23U DRUGCOMP Merck DRI23U DRUGTYPE Small molecular drug DRI23U HIGHSTAT Phase 1 DRI97M DRUG__ID DRI97M DRI97M DRUGCOMP MacroGenics DRI97M DRUGTYPE Antibody DRI97M HIGHSTAT Phase 1 DRK7Q1 DRUG__ID DRK7Q1 DRK7Q1 DRUGCOMP Bayer DRK7Q1 DRUGTYPE Small molecular drug DRK7Q1 HIGHSTAT Phase 1 DRU0M6 DRUG__ID DRU0M6 DRU0M6 DRUGCOMP Mustang Bio DRU0M6 DRUGTYPE CAR T Cell Therapy DRU0M6 HIGHSTAT Phase 1 DRZ1J4 DRUG__ID DRZ1J4 DRZ1J4 DRUGCOMP Minerva Biotechnologies DRZ1J4 DRUGTYPE CAR T Cell Therapy DRZ1J4 HIGHSTAT Phase 1 DS0I9O DRUG__ID DS0I9O DS0I9O DRUGCOMP AstraZeneca DS0I9O DRUGTYPE Peptide DS0I9O HIGHSTAT Phase 1 DS1BJ7 DRUG__ID DS1BJ7 DS1BJ7 DRUGCOMP Repertoire Immune Medicines DS1BJ7 DRUGTYPE Cell therapy DS1BJ7 HIGHSTAT Phase 1 DS39MT DRUG__ID DS39MT DS39MT DRUGCOMP GlaxoSmithKline DS39MT DRUGTYPE TCR-T cell therapy DS39MT HIGHSTAT Phase 1 DS4M1A DRUG__ID DS4M1A DS4M1A DRUGCOMP Biosplice DS4M1A DRUGTYPE Small molecular drug DS4M1A HIGHSTAT Phase 1 DS5UH0 DRUG__ID DS5UH0 DS5UH0 DRUGCOMP VBI Vaccines DS5UH0 DRUGTYPE Vaccine DS5UH0 HIGHSTAT Phase 1 DS60CK DRUG__ID DS60CK DS60CK DRUGCOMP Molecular Templates DS60CK DRUGTYPE Recombinant?protein DS60CK HIGHSTAT Phase 1 DS6BE2 DRUG__ID DS6BE2 DS6BE2 DRUGCOMP Seagen DS6BE2 DRUGTYPE Antibody drug conjugate DS6BE2 HIGHSTAT Phase 1 DS6OV9 DRUG__ID DS6OV9 DS6OV9 DRUGCOMP Oxurion DS6OV9 DRUGTYPE Small molecular drug DS6OV9 HIGHSTAT Phase 1 DS6W8Z DRUG__ID DS6W8Z DS6W8Z DRUGCOMP Cellectis DS6W8Z DRUGTYPE CAR T Cell Therapy DS6W8Z HIGHSTAT Phase 1 DS86KN DRUG__ID DS86KN DS86KN DRUGCOMP Roche DS86KN DRUGTYPE CAR-T cell therapy DS86KN HIGHSTAT Phase 1 DS9R3G DRUG__ID DS9R3G DS9R3G DRUGCOMP Revolution Medicines DS9R3G DRUGTYPE Small molecular drug DS9R3G HIGHSTAT Phase 1 DSE59Z DRUG__ID DSE59Z DSE59Z DRUGCOMP Gradalis DSE59Z DRUGTYPE Short hairpin RNA DSE59Z HIGHSTAT Phase 1 DSEF47 DRUG__ID DSEF47 DSEF47 DRUGCOMP KBP Biosciences DSEF47 DRUGTYPE Small molecular drug DSEF47 HIGHSTAT Phase 1 DSI4G9 DRUG__ID DSI4G9 DSI4G9 DRUGCOMP Actinium Pharmaceuticals DSI4G9 DRUGTYPE Radiopharmaceutical therapy agent DSI4G9 HIGHSTAT Phase 1 DSN1B6 DRUG__ID DSN1B6 DSN1B6 DRUGCOMP TransThera Biosciences DSN1B6 DRUGTYPE Small molecule DSN1B6 HIGHSTAT Phase 1 DSOE74 DRUG__ID DSOE74 DSOE74 DRUGCOMP GeneQuantum Healthcare DSOE74 DRUGTYPE Antibody drug conjugate DSOE74 HIGHSTAT Phase 1 DSWZ60 DRUG__ID DSWZ60 DSWZ60 DRUGCOMP Celularity; Sorrento Therapeutics DSWZ60 DRUGTYPE CAR T Cell Therapy DSWZ60 HIGHSTAT Phase 1 DSYM73 DRUG__ID DSYM73 DSYM73 DRUGCOMP Fate Therapeutics DSYM73 DRUGTYPE Cell therapy DSYM73 HIGHSTAT Phase 1 DT1Z9I DRUG__ID DT1Z9I DT1Z9I DRUGCOMP Heat Biologics DT1Z9I DRUGTYPE Cell therapy DT1Z9I HIGHSTAT Phase 1 DT2B6G DRUG__ID DT2B6G DT2B6G DRUGCOMP Seres Therapeutics DT2B6G DRUGTYPE Live biotherapeutic product DT2B6G HIGHSTAT Phase 1 DT3OZ4 DRUG__ID DT3OZ4 DT3OZ4 DRUGCOMP BioNTech DT3OZ4 DRUGTYPE mRNA (uRNA) DT3OZ4 HIGHSTAT Phase 1 DT53BH DRUG__ID DT53BH DT53BH DRUGCOMP Neuropore Therapies San Diego, CA DT53BH DRUGTYPE Small molecule DT53BH HIGHSTAT Phase 1 DT6QP4 DRUG__ID DT6QP4 DT6QP4 DRUGCOMP BioNTech DT6QP4 DRUGTYPE Vaccine DT6QP4 HIGHSTAT Phase 1 DT6ZE3 DRUG__ID DT6ZE3 DT6ZE3 DRUGCOMP Astellas Pharma DT6ZE3 DRUGTYPE Vaccine DT6ZE3 HIGHSTAT Phase 1 DT7I5A DRUG__ID DT7I5A DT7I5A DRUGCOMP ImmunityBio DT7I5A DRUGTYPE Recombinant protein DT7I5A HIGHSTAT Phase 1 DTB43H DRUG__ID DTB43H DTB43H DRUGCOMP Boehringer Ingelheim DTB43H DRUGTYPE Antibody DTB43H HIGHSTAT Phase 1 DTBX40 DRUG__ID DTBX40 DTBX40 DRUGCOMP Aptorum DTBX40 DRUGTYPE Small molecule DTBX40 HIGHSTAT Phase 1 DTHR46 DRUG__ID DTHR46 DTHR46 DRUGCOMP ImmuneOncia Therapeutics DTHR46 DRUGTYPE Antibody DTHR46 HIGHSTAT Phase 1 DTJ5W8 DRUG__ID DTJ5W8 DTJ5W8 DRUGCOMP Auro Vaccines DTJ5W8 DRUGTYPE Vaccine DTJ5W8 HIGHSTAT Phase 1 DTM8B0 DRUG__ID DTM8B0 DTM8B0 DRUGCOMP PsiOxus Therapeutics DTM8B0 DRUGTYPE Gene therapy DTM8B0 HIGHSTAT Phase 1 DTQL30 DRUG__ID DTQL30 DTQL30 DRUGCOMP Astelllas DTQL30 DRUGTYPE Antibody DTQL30 HIGHSTAT Phase 1 DTR05Z DRUG__ID DTR05Z DTR05Z DRUGCOMP iCell Gene Therapeutics DTR05Z DRUGTYPE CAR T Cell Therapy DTR05Z HIGHSTAT Phase 1 DTV17S DRUG__ID DTV17S DTV17S DRUGCOMP Klus Pharma DTV17S DRUGTYPE Small molecule DTV17S HIGHSTAT Phase 1 DTYP21 DRUG__ID DTYP21 DTYP21 DRUGCOMP Holy Stone Healthcare DTYP21 DRUGTYPE Small molecular drug DTYP21 HIGHSTAT Phase 1 DU1CV0 DRUG__ID DU1CV0 DU1CV0 DRUGCOMP Surrozen DU1CV0 DRUGTYPE Antibody DU1CV0 HIGHSTAT Phase 1 DU1DL0 DRUG__ID DU1DL0 DU1DL0 DRUGCOMP Relay Therapeutics DU1DL0 DRUGTYPE Small molecular drug DU1DL0 HIGHSTAT Phase 1 DU54BA DRUG__ID DU54BA DU54BA DRUGCOMP Mustang Bio DU54BA DRUGTYPE CAR T Cell Therapy DU54BA HIGHSTAT Phase 1 DU6H8Z DRUG__ID DU6H8Z DU6H8Z DRUGCOMP Tanabe Research Laboratories DU6H8Z DRUGTYPE Antibody drug conjugate DU6H8Z HIGHSTAT Phase 1 DU6SH2 DRUG__ID DU6SH2 DU6SH2 DRUGCOMP Klus Pharma DU6SH2 DRUGTYPE Antibody DU6SH2 HIGHSTAT Phase 1 DUA7N4 DRUG__ID DUA7N4 DUA7N4 DRUGCOMP Silicon Therapeutics DUA7N4 DRUGTYPE Small molecular drug DUA7N4 HIGHSTAT Phase 1 DUA7P2 DRUG__ID DUA7P2 DUA7P2 DRUGCOMP Silverback Therapeutics DUA7P2 DRUGTYPE Antibody drug conjugate DUA7P2 HIGHSTAT Phase 1 DUB8X2 DRUG__ID DUB8X2 DUB8X2 DRUGCOMP Caladrius Biosciences DUB8X2 DRUGTYPE Cell therapy DUB8X2 HIGHSTAT Phase 1 DUE5G9 DRUG__ID DUE5G9 DUE5G9 DRUGCOMP Pfizer DUE5G9 DRUGTYPE Small molecule DUE5G9 HIGHSTAT Phase 1 DUI1N7 DRUG__ID DUI1N7 DUI1N7 DRUGCOMP Tetraphase Pharmaceuticals DUI1N7 DRUGTYPE Small molecular drug DUI1N7 HIGHSTAT Phase 1 DUJ16L DRUG__ID DUJ16L DUJ16L DRUGCOMP Pfzer DUJ16L DRUGTYPE Small molecule DUJ16L HIGHSTAT Phase 1 DUK2V4 DRUG__ID DUK2V4 DUK2V4 DRUGCOMP Lantern Pharma DUK2V4 DRUGTYPE Small molecular drug DUK2V4 HIGHSTAT Phase 1 DUL9K5 DRUG__ID DUL9K5 DUL9K5 DRUGCOMP Rubius Therapeutics DUL9K5 DRUGTYPE Cell therapy DUL9K5 HIGHSTAT Phase 1 DUQ78I DRUG__ID DUQ78I DUQ78I DRUGCOMP Candel Therapeutics Needham, MA DUQ78I DRUGTYPE Oncolytic virus DUQ78I HIGHSTAT Phase 1 DUWB31 DRUG__ID DUWB31 DUWB31 DRUGCOMP Ionis DUWB31 DRUGTYPE Antisense oligonucleotide DUWB31 HIGHSTAT Phase 1 DUZ0F7 DRUG__ID DUZ0F7 DUZ0F7 DRUGCOMP Amgen DUZ0F7 DRUGTYPE Antibody DUZ0F7 HIGHSTAT Phase 1 DV1R0X DRUG__ID DV1R0X DV1R0X DRUGCOMP Bristol-Myers Squibb DV1R0X DRUGTYPE Small molecular drug DV1R0X HIGHSTAT Phase 1 DV3E9U DRUG__ID DV3E9U DV3E9U DRUGCOMP Kashiv BioSciences DV3E9U DRUGTYPE Antibody DV3E9U HIGHSTAT Phase 1 DV3ZI0 DRUG__ID DV3ZI0 DV3ZI0 DRUGCOMP NantKwest DV3ZI0 DRUGTYPE CAR-NK Cell therapy DV3ZI0 HIGHSTAT Phase 1 DV8I4Q DRUG__ID DV8I4Q DV8I4Q DRUGCOMP Merus DV8I4Q DRUGTYPE Antibody DV8I4Q HIGHSTAT Phase 1 DV9M0Y DRUG__ID DV9M0Y DV9M0Y DRUGCOMP Bristol-Myers Squibb; Eureka Therapeutics DV9M0Y DRUGTYPE CAR T Cell Therapy DV9M0Y HIGHSTAT Phase 1 DVA36E DRUG__ID DVA36E DVA36E DRUGCOMP Agenis; Incyte DVA36E DRUGTYPE Antibody DVA36E HIGHSTAT Phase 1 DVC36K DRUG__ID DVC36K DVC36K DRUGCOMP Genascence DVC36K DRUGTYPE Gene therapy DVC36K HIGHSTAT Phase 1 DVIY25 DRUG__ID DVIY25 DVIY25 DRUGCOMP CRISPR Therapeutics DVIY25 DRUGTYPE CAR T Cell Therapy DVIY25 HIGHSTAT Phase 1 DVLH37 DRUG__ID DVLH37 DVLH37 DRUGCOMP CSL Behring DVLH37 DRUGTYPE Protein DVLH37 HIGHSTAT Phase 1 DVO4H2 DRUG__ID DVO4H2 DVO4H2 DRUGCOMP Apollomics DVO4H2 DRUGTYPE Antibody DVO4H2 HIGHSTAT Phase 1 DVOB28 DRUG__ID DVOB28 DVOB28 DRUGCOMP Affimed Therapeutics DVOB28 DRUGTYPE Antibody DVOB28 HIGHSTAT Phase 1 DVR84A DRUG__ID DVR84A DVR84A DRUGCOMP Cellectar DVR84A DRUGTYPE Radiopharmaceutical therapy agent DVR84A HIGHSTAT Phase 1 DVS91L DRUG__ID DVS91L DVS91L DRUGCOMP bluebird bio DVS91L DRUGTYPE TCR-T cell therapy DVS91L HIGHSTAT Phase 1 DVX18N DRUG__ID DVX18N DVX18N DRUGCOMP Prolong Pharmaceuticals South Plainfield, NJ DVX18N DRUGTYPE Peptide DVX18N HIGHSTAT Phase 1 DVX4P3 DRUG__ID DVX4P3 DVX4P3 DRUGCOMP GenMab DVX4P3 DRUGTYPE Antibody DVX4P3 HIGHSTAT Phase 1 DVY5D9 DRUG__ID DVY5D9 DVY5D9 DRUGCOMP TAXIS Pharmaceuticals DVY5D9 DRUGTYPE Small interfering RNA DVY5D9 HIGHSTAT Phase 1 DVZN13 DRUG__ID DVZN13 DVZN13 DRUGCOMP IN8bio DVZN13 DRUGTYPE Cell therapy DVZN13 HIGHSTAT Phase 1 DW01LJ DRUG__ID DW01LJ DW01LJ DRUGCOMP Cellerant Therapeutics DW01LJ DRUGTYPE Antibody drug conjugate DW01LJ HIGHSTAT Phase 1 DW1H9O DRUG__ID DW1H9O DW1H9O DRUGCOMP AbbVie DW1H9O DRUGTYPE Antibody DW1H9O HIGHSTAT Phase 1 DW3AX4 DRUG__ID DW3AX4 DW3AX4 DRUGCOMP Boehringer Ingelheim DW3AX4 DRUGTYPE Small molecular drug DW3AX4 HIGHSTAT Phase 1 DW3J9N DRUG__ID DW3J9N DW3J9N DRUGCOMP Eli Lilly DW3J9N DRUGTYPE Peptide DW3J9N HIGHSTAT Phase 1 DW65MU DRUG__ID DW65MU DW65MU DRUGCOMP Moderna DW65MU DRUGTYPE Vaccine DW65MU HIGHSTAT Phase 1 DW95VT DRUG__ID DW95VT DW95VT DRUGCOMP Intellia Therapeutics Cambridge, MA Regeneron Tarrytown, NY DW95VT DRUGTYPE Gene therapy DW95VT HIGHSTAT Phase 1 DWER81 DRUG__ID DWER81 DWER81 DRUGCOMP Artugen Therapeutics DWER81 DRUGTYPE Live biotherapeutic DWER81 HIGHSTAT Phase 1 DWJ3A7 DRUG__ID DWJ3A7 DWJ3A7 DRUGCOMP Daiichi Sankyo DWJ3A7 DRUGTYPE Small molecular drug DWJ3A7 HIGHSTAT Phase 1 DWOY01 DRUG__ID DWOY01 DWOY01 DRUGCOMP Reata Pharmaceuticals DWOY01 DRUGTYPE Small molecular drug DWOY01 HIGHSTAT Phase 1 DWS76U DRUG__ID DWS76U DWS76U DRUGCOMP Tessa Therapeutics DWS76U DRUGTYPE CAR-T cell therapy DWS76U HIGHSTAT Phase 1 DWX4A0 DRUG__ID DWX4A0 DWX4A0 DRUGCOMP Shanghai Zhimeng Biopharma DWX4A0 DRUGTYPE Small molecular drug DWX4A0 HIGHSTAT Phase 1 DX06ZU DRUG__ID DX06ZU DX06ZU DRUGCOMP AiVita Biomedical DX06ZU DRUGTYPE Vaccine DX06ZU HIGHSTAT Phase 1 DX1LD3 DRUG__ID DX1LD3 DX1LD3 DRUGCOMP iCell Gene Therapeutics DX1LD3 DRUGTYPE CAR T Cell Therapy DX1LD3 HIGHSTAT Phase 1 DX30BA DRUG__ID DX30BA DX30BA DRUGCOMP Innovent Biologics DX30BA DRUGTYPE Antibody DX30BA HIGHSTAT Phase 1 DX31VA DRUG__ID DX31VA DX31VA DRUGCOMP Pfzer DX31VA DRUGTYPE Small molecule DX31VA HIGHSTAT Phase 1 DX36OY DRUG__ID DX36OY DX36OY DRUGCOMP Rocket Pharmaceuticals DX36OY DRUGTYPE Gene therapy DX36OY HIGHSTAT Phase 1 DX4A3Q DRUG__ID DX4A3Q DX4A3Q DRUGCOMP Dong-A ST DX4A3Q DRUGTYPE Small molecular drug DX4A3Q HIGHSTAT Phase 1 DX5T9B DRUG__ID DX5T9B DX5T9B DRUGCOMP AstraZeneca DX5T9B DRUGTYPE Antibody DX5T9B HIGHSTAT Phase 1 DX6J8M DRUG__ID DX6J8M DX6J8M DRUGCOMP Bristol-Myers Squibb DX6J8M DRUGTYPE CAR T Cell Therapy DX6J8M HIGHSTAT Phase 1 DX8QZ3 DRUG__ID DX8QZ3 DX8QZ3 DRUGCOMP Cellenkos DX8QZ3 DRUGTYPE Cell therapy DX8QZ3 HIGHSTAT Phase 1 DX9T0N DRUG__ID DX9T0N DX9T0N DRUGCOMP AstraZeneca; Ionis Pharmaceuticals DX9T0N DRUGTYPE Antisense oligonucleotide DX9T0N HIGHSTAT Phase 1 DXB8M6 DRUG__ID DXB8M6 DXB8M6 DRUGCOMP CoA Therapeutics DXB8M6 DRUGTYPE Small molecule DXB8M6 HIGHSTAT Phase 1 DXC94O DRUG__ID DXC94O DXC94O DRUGCOMP GeneCure Biotechnologies DXC94O DRUGTYPE Vaccine DXC94O HIGHSTAT Phase 1 DXF93J DRUG__ID DXF93J DXF93J DRUGCOMP Curis DXF93J DRUGTYPE Antibody DXF93J HIGHSTAT Phase 1 DXO1V4 DRUG__ID DXO1V4 DXO1V4 DRUGCOMP Atea Pharmaceuticals DXO1V4 DRUGTYPE Small molecular drug DXO1V4 HIGHSTAT Phase 1 DXOR23 DRUG__ID DXOR23 DXOR23 DRUGCOMP Convergent Therapeutics DXOR23 DRUGTYPE Antibody DXOR23 HIGHSTAT Phase 1 DXV67Q DRUG__ID DXV67Q DXV67Q DRUGCOMP Bayer DXV67Q DRUGTYPE Radiopharmaceutical therapy agent DXV67Q HIGHSTAT Phase 1 DXVA93 DRUG__ID DXVA93 DXVA93 DRUGCOMP Pfzer DXVA93 DRUGTYPE Small molecule DXVA93 HIGHSTAT Phase 1 DXZ72Q DRUG__ID DXZ72Q DXZ72Q DRUGCOMP GlaxoSmithKline DXZ72Q DRUGTYPE Vaccine DXZ72Q HIGHSTAT Phase 1 DY0IS1 DRUG__ID DY0IS1 DY0IS1 DRUGCOMP NGM Biopharma DY0IS1 DRUGTYPE Antibody DY0IS1 HIGHSTAT Phase 1 DY1H2Z DRUG__ID DY1H2Z DY1H2Z DRUGCOMP Nucorion Pharmaceuticals DY1H2Z DRUGTYPE Small molecular drug DY1H2Z HIGHSTAT Phase 1 DY36LD DRUG__ID DY36LD DY36LD DRUGCOMP GlaxoSmithKline DY36LD DRUGTYPE Antibody DY36LD HIGHSTAT Phase 1 DY36ZS DRUG__ID DY36ZS DY36ZS DRUGCOMP The University of Texas Health Science Center, Houston DY36ZS DRUGTYPE Fecal Microbiota Transplantation DY36ZS HIGHSTAT Phase 1 DY4X5W DRUG__ID DY4X5W DY4X5W DRUGCOMP AbbVie DY4X5W DRUGTYPE Antibody DY4X5W HIGHSTAT Phase 1 DY5FX1 DRUG__ID DY5FX1 DY5FX1 DRUGCOMP JOHNSON & JOHNSON DY5FX1 DRUGTYPE Vaccine DY5FX1 HIGHSTAT Phase 1 DY7D9A DRUG__ID DY7D9A DY7D9A DRUGCOMP ZAI Lab DY7D9A DRUGTYPE Antibody DY7D9A HIGHSTAT Phase 1 DY7Q1O DRUG__ID DY7Q1O DY7Q1O DRUGCOMP ESSA Pharma DY7Q1O DRUGTYPE Small molecular drug DY7Q1O HIGHSTAT Phase 1 DY9CP0 DRUG__ID DY9CP0 DY9CP0 DRUGCOMP Takeda DY9CP0 DRUGTYPE Vaccine DY9CP0 HIGHSTAT Phase 1 DYA4W9 DRUG__ID DYA4W9 DYA4W9 DRUGCOMP Redx; AstraZeneca DYA4W9 DRUGTYPE Small molecule DYA4W9 HIGHSTAT Phase 1 DYCI37 DRUG__ID DYCI37 DYCI37 DRUGCOMP Transcenta DYCI37 DRUGTYPE Antibody DYCI37 HIGHSTAT Phase 1 DYH42L DRUG__ID DYH42L DYH42L DRUGCOMP Intrexon DYH42L DRUGTYPE Gene therapy DYH42L HIGHSTAT Phase 1 DYH94Z DRUG__ID DYH94Z DYH94Z DRUGCOMP Regor Pharmaceuticals Cambridge, MA DYH94Z DRUGTYPE Small molecule DYH94Z HIGHSTAT Phase 1 DYJ0Z1 DRUG__ID DYJ0Z1 DYJ0Z1 DRUGCOMP PACT Pharma DYJ0Z1 DRUGTYPE TCR-T cell therapy DYJ0Z1 HIGHSTAT Phase 1 DYJ76M DRUG__ID DYJ76M DYJ76M DRUGCOMP JOHNSON & JOHNSON DYJ76M DRUGTYPE Small molecule DYJ76M HIGHSTAT Phase 1 DYK5U6 DRUG__ID DYK5U6 DYK5U6 DRUGCOMP Elixiron Immunotherapeutics DYK5U6 DRUGTYPE Small molecular drug DYK5U6 HIGHSTAT Phase 1 DYK9H4 DRUG__ID DYK9H4 DYK9H4 DRUGCOMP Sio Gene Therapies DYK9H4 DRUGTYPE Gene therapy DYK9H4 HIGHSTAT Phase 1 DYQ0M8 DRUG__ID DYQ0M8 DYQ0M8 DRUGCOMP GlaxoSmithKline DYQ0M8 DRUGTYPE Vaccine DYQ0M8 HIGHSTAT Phase 1 DYQZ38 DRUG__ID DYQZ38 DYQZ38 DRUGCOMP Relay Therapeutics DYQZ38 DRUGTYPE Small molecular drug DYQZ38 HIGHSTAT Phase 1 DYSI03 DRUG__ID DYSI03 DYSI03 DRUGCOMP Astellas Pharma; Potenza Therapeutics DYSI03 DRUGTYPE Antibody DYSI03 HIGHSTAT Phase 1 DZ1W4B DRUG__ID DZ1W4B DZ1W4B DRUGCOMP AstraZeneca DZ1W4B DRUGTYPE Antibody DZ1W4B HIGHSTAT Phase 1 DZ27CY DRUG__ID DZ27CY DZ27CY DRUGCOMP IN8bio DZ27CY DRUGTYPE Cell therapy DZ27CY HIGHSTAT Phase 1 DZ4LX5 DRUG__ID DZ4LX5 DZ4LX5 DRUGCOMP Neurocrine Biosciences DZ4LX5 DRUGTYPE Gene therapy DZ4LX5 HIGHSTAT Phase 1 DZ5PX2 DRUG__ID DZ5PX2 DZ5PX2 DRUGCOMP Rallybio DZ5PX2 DRUGTYPE Antibody DZ5PX2 HIGHSTAT Phase 1 DZ7OC3 DRUG__ID DZ7OC3 DZ7OC3 DRUGCOMP Actinium Pharmaceuticals DZ7OC3 DRUGTYPE Antibody DZ7OC3 HIGHSTAT Phase 1 DZBV67 DRUG__ID DZBV67 DZBV67 DRUGCOMP Boehringer Ingelheim; OSE Immunotherapeutics DZBV67 DRUGTYPE Antibody DZBV67 HIGHSTAT Phase 1 DZD4R6 DRUG__ID DZD4R6 DZD4R6 DRUGCOMP Roche/Genentech DZD4R6 DRUGTYPE Bispecific antibody DZD4R6 HIGHSTAT Phase 1 DZL3F8 DRUG__ID DZL3F8 DZL3F8 DRUGCOMP Vanda Pharmaceuticals Washington, DC DZL3F8 DRUGTYPE Small molecular drug DZL3F8 HIGHSTAT Phase 1 DZTL59 DRUG__ID DZTL59 DZTL59 DRUGCOMP Inovio Pharmaceuticals DZTL59 DRUGTYPE Antibody DZTL59 HIGHSTAT Phase 1 DZU72C DRUG__ID DZU72C DZU72C DRUGCOMP OnKure Therapeutics DZU72C DRUGTYPE Small molecular drug DZU72C HIGHSTAT Phase 1 DZV8X5 DRUG__ID DZV8X5 DZV8X5 DRUGCOMP Moderna DZV8X5 DRUGTYPE Vaccine DZV8X5 HIGHSTAT Phase 1 DZX8J3 DRUG__ID DZX8J3 DZX8J3 DRUGCOMP SalubrisBio DZX8J3 DRUGTYPE Fusion protein DZX8J3 HIGHSTAT Phase 1 D00AHT DRUG__ID D00AHT D00AHT DRUGCOMP GlaxoSmithKline D00AHT HIGHSTAT Phase 1 D00BLS DRUG__ID D00BLS D00BLS DRUGCOMP AstraZeneca Wilmington, DE D00BLS HIGHSTAT Phase 1 D00BVJ DRUG__ID D00BVJ D00BVJ DRUGCOMP Emd serono; national cancer institute D00BVJ HIGHSTAT Phase 1 D00BZZ DRUG__ID D00BZZ D00BZZ DRUGCOMP Biorexis Pharmaceutical Corp D00BZZ HIGHSTAT Phase 1 D00CGX DRUG__ID D00CGX D00CGX DRUGCOMP Dynavax Technologies D00CGX HIGHSTAT Phase 1 D00CLC DRUG__ID D00CLC D00CLC DRUGCOMP Solvay SA D00CLC HIGHSTAT Phase 1 D00DIB DRUG__ID D00DIB D00DIB DRUGCOMP Intrexon Germantown, MD ZIOPHARM Oncology Boston, MA D00DIB HIGHSTAT Phase 1 D00DIM DRUG__ID D00DIM D00DIM DRUGCOMP Universiteit Maastricht D00DIM HIGHSTAT Phase 1 D00DXH DRUG__ID D00DXH D00DXH DRUGCOMP Eli Lilly & Co D00DXH HIGHSTAT Phase 1 D00DYN DRUG__ID D00DYN D00DYN DRUGCOMP DynPort Vaccine Company D00DYN HIGHSTAT Phase 1 D00EYC DRUG__ID D00EYC D00EYC DRUGCOMP Catalyst biosciences; pfizer D00EYC HIGHSTAT Phase 1 D00FDD DRUG__ID D00FDD D00FDD DRUGCOMP IntelGenx Corp D00FDD HIGHSTAT Phase 1 D00FGW DRUG__ID D00FGW D00FGW DRUGCOMP Intercell USA D00FGW HIGHSTAT Phase 1 D00FSB DRUG__ID D00FSB D00FSB DRUGCOMP Biogen D00FSB HIGHSTAT Phase 1 D00GCA DRUG__ID D00GCA D00GCA DRUGCOMP Merck D00GCA HIGHSTAT Phase 1 D00GPY DRUG__ID D00GPY D00GPY DRUGCOMP Oncomed pharmaceuticals; Bayer HealthCare Pharmaceuticals; OncoMed Pharmaceuticals D00GPY HIGHSTAT Phase 1 D00HGY DRUG__ID D00HGY D00HGY DRUGCOMP Orban Biotech LLC D00HGY HIGHSTAT Phase 1 D00HYD DRUG__ID D00HYD D00HYD DRUGCOMP SCOLR Pharma D00HYD HIGHSTAT Phase 1 D00HZA DRUG__ID D00HZA D00HZA DRUGCOMP Xiamen Amoytop Biotech Co Ltd D00HZA HIGHSTAT Phase 1 D00IFH DRUG__ID D00IFH D00IFH DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D00IFH HIGHSTAT Phase 1 D00IFQ DRUG__ID D00IFQ D00IFQ DRUGCOMP MabVax Therapeutics San Diego, CA D00IFQ HIGHSTAT Phase 1 D00IKI DRUG__ID D00IKI D00IKI DRUGCOMP Pfizer D00IKI HIGHSTAT Phase 1 D00IVN DRUG__ID D00IVN D00IVN DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D00IVN HIGHSTAT Phase 1 D00KGI DRUG__ID D00KGI D00KGI DRUGCOMP ImVisioN Therapeutics Inc D00KGI HIGHSTAT Phase 1 D00KHI DRUG__ID D00KHI D00KHI DRUGCOMP TNK TherapeuticsSan Diego, CA Sorrento Therapeutics San Diego, CA D00KHI HIGHSTAT Phase 1 D00KML DRUG__ID D00KML D00KML DRUGCOMP Synermore Biologics Taipei, Taiwan D00KML HIGHSTAT Phase 1 D00KMQ DRUG__ID D00KMQ D00KMQ DRUGCOMP Novo Nordisk D00KMQ HIGHSTAT Phase 1 D00KNI DRUG__ID D00KNI D00KNI DRUGCOMP Boehringer Ingelheim Pharmaceuticals D00KNI HIGHSTAT Phase 1 D00MJI DRUG__ID D00MJI D00MJI DRUGCOMP GenentechSouth San Francisco, CA D00MJI HIGHSTAT Phase 1 D00MNG DRUG__ID D00MNG D00MNG DRUGCOMP Mymetics D00MNG HIGHSTAT Phase 1 D00OTM DRUG__ID D00OTM D00OTM DRUGCOMP Eli Lilly Indianapolis, IN D00OTM HIGHSTAT Phase 1 D00OVE DRUG__ID D00OVE D00OVE DRUGCOMP Pfizer D00OVE HIGHSTAT Phase 1 D00RGF DRUG__ID D00RGF D00RGF DRUGCOMP Green cross D00RGF HIGHSTAT Phase 1 D00RGX DRUG__ID D00RGX D00RGX DRUGCOMP GenentechSouth San Francisco, CA D00RGX HIGHSTAT Phase 1 D00ROY DRUG__ID D00ROY D00ROY DRUGCOMP Biodel D00ROY HIGHSTAT Phase 1 D00SBU DRUG__ID D00SBU D00SBU DRUGCOMP Ensysce Biosciences San Diego, CA D00SBU HIGHSTAT Phase 1 D00SIA DRUG__ID D00SIA D00SIA DRUGCOMP ArQule D00SIA HIGHSTAT Phase 1 D00SKM DRUG__ID D00SKM D00SKM DRUGCOMP Tessa Therapeutics Singapore D00SKM HIGHSTAT Phase 1 D00SYV DRUG__ID D00SYV D00SYV DRUGCOMP Glaxosmithkline D00SYV HIGHSTAT Phase 1 D00TED DRUG__ID D00TED D00TED DRUGCOMP Janssen Research & Development Raritan, NJ D00TED HIGHSTAT Phase 1 D00TNZ DRUG__ID D00TNZ D00TNZ DRUGCOMP PsiOxus Therapeutics Plymouth Meeting, PA D00TNZ HIGHSTAT Phase 1 D00TXL DRUG__ID D00TXL D00TXL DRUGCOMP University of Pennsylvania D00TXL HIGHSTAT Phase 1 D00UQW DRUG__ID D00UQW D00UQW DRUGCOMP Roche D00UQW HIGHSTAT Phase 1 D00VFH DRUG__ID D00VFH D00VFH DRUGCOMP Pharmaxis Ltd D00VFH HIGHSTAT Phase 1 D00VOE DRUG__ID D00VOE D00VOE DRUGCOMP GenVec D00VOE HIGHSTAT Phase 1 D00WJC DRUG__ID D00WJC D00WJC DRUGCOMP Roche/GenentechSouth San Francisco, CA D00WJC HIGHSTAT Phase 1 D00XLE DRUG__ID D00XLE D00XLE DRUGCOMP Pfizer Inc D00XLE HIGHSTAT Phase 1 D00XVE DRUG__ID D00XVE D00XVE DRUGCOMP Bayer HealthCare Pharmaceuticals Whippany, NJ D00XVE HIGHSTAT Phase 1 D00YAH DRUG__ID D00YAH D00YAH DRUGCOMP Eisai Woodcliff Lake, NJ D00YAH HIGHSTAT Phase 1 D00YDN DRUG__ID D00YDN D00YDN DRUGCOMP CXR Biosciences Ltd D00YDN HIGHSTAT Phase 1 D00YUP DRUG__ID D00YUP D00YUP DRUGCOMP Lumosa Therapeutics Taipei, Taiwan D00YUP HIGHSTAT Phase 1 D00YXU DRUG__ID D00YXU D00YXU DRUGCOMP ChemoCentryx Inc D00YXU HIGHSTAT Phase 1 D00ZDO DRUG__ID D00ZDO D00ZDO DRUGCOMP Selecta Biosciences Watertown, MA D00ZDO HIGHSTAT Phase 1 D00ZFQ DRUG__ID D00ZFQ D00ZFQ DRUGCOMP National Institute of Allergy and Infectious Diseases D00ZFQ HIGHSTAT Phase 1 D00ZMU DRUG__ID D00ZMU D00ZMU DRUGCOMP CDG Therapeutics Chicago, IL D00ZMU HIGHSTAT Phase 1 D00ZRS DRUG__ID D00ZRS D00ZRS DRUGCOMP National Cancer Institute D00ZRS HIGHSTAT Phase 1 D00ZVM DRUG__ID D00ZVM D00ZVM DRUGCOMP Bayer healthcare pharmaceuticals D00ZVM HIGHSTAT Phase 1 D01AKU DRUG__ID D01AKU D01AKU DRUGCOMP Mt Cook Pharma D01AKU HIGHSTAT Phase 1 D01BRD DRUG__ID D01BRD D01BRD DRUGCOMP Seattle Genetics Bothell, WA D01BRD HIGHSTAT Phase 1 D01CIB DRUG__ID D01CIB D01CIB DRUGCOMP Sanofi D01CIB HIGHSTAT Phase 1 D01CYK DRUG__ID D01CYK D01CYK DRUGCOMP Meiji seika pharma D01CYK HIGHSTAT Phase 1 D01CYT DRUG__ID D01CYT D01CYT DRUGCOMP Elan Corp plc D01CYT HIGHSTAT Phase 1 D01DCJ DRUG__ID D01DCJ D01DCJ DRUGCOMP Geron Corp D01DCJ HIGHSTAT Phase 1 D01EXG DRUG__ID D01EXG D01EXG DRUGCOMP AmgenThousand Oaks, CA D01EXG HIGHSTAT Phase 1 D01FFC DRUG__ID D01FFC D01FFC DRUGCOMP Otsuka America Pharmaceutical D01FFC HIGHSTAT Phase 1 D01FYX DRUG__ID D01FYX D01FYX DRUGCOMP Andes Biotechnologies Santiago, Chile D01FYX HIGHSTAT Phase 1 D01GQD DRUG__ID D01GQD D01GQD DRUGCOMP Santaris Pharma A/S D01GQD HIGHSTAT Phase 1 D01GQO DRUG__ID D01GQO D01GQO DRUGCOMP Stemedica Cell Technologies San Diego, CA D01GQO HIGHSTAT Phase 1 D01GTC DRUG__ID D01GTC D01GTC DRUGCOMP Takeda Deerfield, IL D01GTC HIGHSTAT Phase 1 D01GVC DRUG__ID D01GVC D01GVC DRUGCOMP Metabasis Therapeutics Inc D01GVC HIGHSTAT Phase 1 D01HOL DRUG__ID D01HOL D01HOL DRUGCOMP Bayer healthcare pharmaceuticals D01HOL HIGHSTAT Phase 1 D01HVR DRUG__ID D01HVR D01HVR DRUGCOMP Sumagen D01HVR HIGHSTAT Phase 1 D01IDW DRUG__ID D01IDW D01IDW DRUGCOMP OscotecChonan, South Korea D01IDW HIGHSTAT Phase 1 D01IGH DRUG__ID D01IGH D01IGH DRUGCOMP BIKEN D01IGH HIGHSTAT Phase 1 D01ILP DRUG__ID D01ILP D01ILP DRUGCOMP Janssen biotech D01ILP HIGHSTAT Phase 1 D01IMN DRUG__ID D01IMN D01IMN DRUGCOMP Valneva Lyon, France D01IMN HIGHSTAT Phase 1 D01IPT DRUG__ID D01IPT D01IPT DRUGCOMP ImutexLondon, United Kingdom National Institute of Allergy and Infectious Diseases Bethesda, MD D01IPT HIGHSTAT Phase 1 D01JKV DRUG__ID D01JKV D01JKV DRUGCOMP Merck D01JKV HIGHSTAT Phase 1 D01JSI DRUG__ID D01JSI D01JSI DRUGCOMP Pfizer New York, NY D01JSI HIGHSTAT Phase 1 D01JTL DRUG__ID D01JTL D01JTL DRUGCOMP Kainos Medicine Inc D01JTL HIGHSTAT Phase 1 D01JWH DRUG__ID D01JWH D01JWH DRUGCOMP SANOS Bioscience A/S D01JWH HIGHSTAT Phase 1 D01JYT DRUG__ID D01JYT D01JYT DRUGCOMP IntelGenx Corp D01JYT HIGHSTAT Phase 1 D01KDM DRUG__ID D01KDM D01KDM DRUGCOMP GT Biopharma Washington, DC D01KDM HIGHSTAT Phase 1 D01KGP DRUG__ID D01KGP D01KGP DRUGCOMP Inflazyme Pharmaceuticals D01KGP HIGHSTAT Phase 1 D01KXE DRUG__ID D01KXE D01KXE DRUGCOMP OptiNose AS D01KXE HIGHSTAT Phase 1 D01LFH DRUG__ID D01LFH D01LFH DRUGCOMP Signpath Pharma D01LFH HIGHSTAT Phase 1 D01LFN DRUG__ID D01LFN D01LFN DRUGCOMP Oragenics D01LFN HIGHSTAT Phase 1 D01LMM DRUG__ID D01LMM D01LMM DRUGCOMP Novartis pharmaceuticals D01LMM HIGHSTAT Phase 1 D01MCB DRUG__ID D01MCB D01MCB DRUGCOMP Merck; Vical D01MCB HIGHSTAT Phase 1 D01NAP DRUG__ID D01NAP D01NAP DRUGCOMP Merrimack Pharmaceuticals D01NAP HIGHSTAT Phase 1 D01NSM DRUG__ID D01NSM D01NSM DRUGCOMP Cangene Winnipeg, Canada D01NSM HIGHSTAT Phase 1 D01NTQ DRUG__ID D01NTQ D01NTQ DRUGCOMP Sanofi D01NTQ HIGHSTAT Phase 1 D01NXX DRUG__ID D01NXX D01NXX DRUGCOMP Sanofi D01NXX HIGHSTAT Phase 1 D01NZH DRUG__ID D01NZH D01NZH DRUGCOMP AbbVieNorth Chicago, IL D01NZH HIGHSTAT Phase 1 D01NZT DRUG__ID D01NZT D01NZT DRUGCOMP MD Anderson Cancer Center D01NZT HIGHSTAT Phase 1 D01OGV DRUG__ID D01OGV D01OGV DRUGCOMP Polyphor Ltd D01OGV HIGHSTAT Phase 1 D01OOQ DRUG__ID D01OOQ D01OOQ DRUGCOMP Pnp therapeutics D01OOQ HIGHSTAT Phase 1 D01OYS DRUG__ID D01OYS D01OYS DRUGCOMP Karolinska Institute D01OYS HIGHSTAT Phase 1 D01PCB DRUG__ID D01PCB D01PCB DRUGCOMP National Biopreparations Center D01PCB HIGHSTAT Phase 1 D01PVV DRUG__ID D01PVV D01PVV DRUGCOMP Kalypsys D01PVV HIGHSTAT Phase 1 D01PXH DRUG__ID D01PXH D01PXH DRUGCOMP Gamida Cell Jerusalem, Israel D01PXH HIGHSTAT Phase 1 D01PYH DRUG__ID D01PYH D01PYH DRUGCOMP The Institute of Virology and Immunoprophylaxis D01PYH HIGHSTAT Phase 1 D01QKZ DRUG__ID D01QKZ D01QKZ DRUGTYPE Antibody D01QKZ HIGHSTAT Phase 1 D01QTJ DRUG__ID D01QTJ D01QTJ DRUGCOMP Xenon D01QTJ HIGHSTAT Phase 1 D01QWS DRUG__ID D01QWS D01QWS DRUGCOMP Galectin Therapeutics D01QWS HIGHSTAT Phase 1 D01RDR DRUG__ID D01RDR D01RDR DRUGCOMP Arch Biopartners Toronto, Canada D01RDR HIGHSTAT Phase 1 D01REJ DRUG__ID D01REJ D01REJ DRUGCOMP Virobay Inc D01REJ HIGHSTAT Phase 1 D01RQP DRUG__ID D01RQP D01RQP DRUGCOMP ImmunGeneCamarillo, CA D01RQP HIGHSTAT Phase 1 D01SIB DRUG__ID D01SIB D01SIB DRUGCOMP Merck & Co Inc D01SIB HIGHSTAT Phase 1 D01SSK DRUG__ID D01SSK D01SSK DRUGCOMP Spectrum Pharmaceuticals D01SSK HIGHSTAT Phase 1 D01SZA DRUG__ID D01SZA D01SZA DRUGCOMP Mochida Pharmaceutical Co Ltd D01SZA HIGHSTAT Phase 1 D01TDY DRUG__ID D01TDY D01TDY DRUGCOMP Theratechnologies Inc D01TDY HIGHSTAT Phase 1 D01TLV DRUG__ID D01TLV D01TLV DRUGCOMP Evotec D01TLV HIGHSTAT Phase 1 D01UAM DRUG__ID D01UAM D01UAM DRUGCOMP Memorial Sloan-Kettering Cancer Center D01UAM HIGHSTAT Phase 1 D01UFZ DRUG__ID D01UFZ D01UFZ DRUGCOMP Relmada Therapeutics New York, NY D01UFZ HIGHSTAT Phase 1 D01UJK DRUG__ID D01UJK D01UJK DRUGCOMP Sanofi-Aventis D01UJK HIGHSTAT Phase 1 D01UYA DRUG__ID D01UYA D01UYA DRUGCOMP MedImmune Gaithersburg, MD D01UYA HIGHSTAT Phase 1 D01VQM DRUG__ID D01VQM D01VQM DRUGCOMP Chroma Therapeutics Ltd D01VQM HIGHSTAT Phase 1 D01WCL DRUG__ID D01WCL D01WCL DRUGCOMP Abbott Laboratories D01WCL HIGHSTAT Phase 1 D01WMO DRUG__ID D01WMO D01WMO DRUGCOMP DynPort Vaccine D01WMO HIGHSTAT Phase 1 D01WZL DRUG__ID D01WZL D01WZL DRUGCOMP The michael j. fox foundation for parkinson's research; sanofi us D01WZL HIGHSTAT Phase 1 D01XQQ DRUG__ID D01XQQ D01XQQ DRUGCOMP Taligen Therapeutics Inc D01XQQ HIGHSTAT Phase 1 D01YDH DRUG__ID D01YDH D01YDH DRUGCOMP Glaxosmithkline D01YDH HIGHSTAT Phase 1 D01ZJB DRUG__ID D01ZJB D01ZJB DRUGCOMP Tca cellular therapy D01ZJB HIGHSTAT Phase 1 D01ZLR DRUG__ID D01ZLR D01ZLR DRUGCOMP Pfizer D01ZLR HIGHSTAT Phase 1 D01ZPT DRUG__ID D01ZPT D01ZPT DRUGCOMP Unum Therapeutics Cambridge, MA D01ZPT HIGHSTAT Phase 1 D01ZSP DRUG__ID D01ZSP D01ZSP DRUGCOMP Janssen Alzheimer Immunotherapy; Pfizer D01ZSP HIGHSTAT Phase 1 D02AMG DRUG__ID D02AMG D02AMG DRUGCOMP Aegera Therapeutics Inc D02AMG HIGHSTAT Phase 1 D02ANO DRUG__ID D02ANO D02ANO DRUGCOMP Eli Lilly & Co D02ANO HIGHSTAT Phase 1 D02AVC DRUG__ID D02AVC D02AVC DRUGCOMP Bristol-Myers Squibb Co D02AVC HIGHSTAT Phase 1 D02CUN DRUG__ID D02CUN D02CUN DRUGCOMP Microbiome therapeutics D02CUN HIGHSTAT Phase 1 D02DBA DRUG__ID D02DBA D02DBA DRUGCOMP Novartis Vaccines & Diagnostics D02DBA HIGHSTAT Phase 1 D02DJR DRUG__ID D02DJR D02DJR DRUGCOMP Amgen Thousand D02DJR HIGHSTAT Phase 1 D02DZK DRUG__ID D02DZK D02DZK DRUGCOMP Eli Lilly Indianapolis, IN D02DZK HIGHSTAT Phase 1 D02EOR DRUG__ID D02EOR D02EOR DRUGCOMP Abbvie D02EOR HIGHSTAT Phase 1 D02EOS DRUG__ID D02EOS D02EOS DRUGCOMP Pfizer D02EOS HIGHSTAT Phase 1 D02EYZ DRUG__ID D02EYZ D02EYZ DRUGCOMP Glaxosmithkline D02EYZ HIGHSTAT Phase 1 D02GRR DRUG__ID D02GRR D02GRR DRUGCOMP MedImmune Gaithersburg, MD D02GRR HIGHSTAT Phase 1 D02HFN DRUG__ID D02HFN D02HFN DRUGCOMP GenentechSouth San Francisco, CA D02HFN HIGHSTAT Phase 1 D02HHM DRUG__ID D02HHM D02HHM DRUGCOMP Seattle Genetics Bothell, WA D02HHM HIGHSTAT Phase 1 D02HUW DRUG__ID D02HUW D02HUW DRUGCOMP Sanofi D02HUW HIGHSTAT Phase 1 D02IIM DRUG__ID D02IIM D02IIM DRUGCOMP Fibrocell Exton, PA Intrexon Germantown, MD D02IIM HIGHSTAT Phase 1 D02IKQ DRUG__ID D02IKQ D02IKQ DRUGCOMP Pfizer D02IKQ HIGHSTAT Phase 1 D02JGD DRUG__ID D02JGD D02JGD DRUGCOMP SK Life Science D02JGD HIGHSTAT Phase 1 D02JMZ DRUG__ID D02JMZ D02JMZ DRUGCOMP Newsummit Biopharma Co Ltd D02JMZ HIGHSTAT Phase 1 D02JYT DRUG__ID D02JYT D02JYT DRUGCOMP Glaxosmithkline D02JYT HIGHSTAT Phase 1 D02KBE DRUG__ID D02KBE D02KBE DRUGCOMP Winship Cancer Institute D02KBE HIGHSTAT Phase 1 D02KPJ DRUG__ID D02KPJ D02KPJ DRUGCOMP Allogene Therapeutics South San Francisco, CA ServierParis, France D02KPJ HIGHSTAT Phase 1 D02MFC DRUG__ID D02MFC D02MFC DRUGCOMP Proportional Technologies Inc D02MFC HIGHSTAT Phase 1 D02MMP DRUG__ID D02MMP D02MMP DRUGCOMP Vertex D02MMP HIGHSTAT Phase 1 D02MRX DRUG__ID D02MRX D02MRX DRUGCOMP ONO Pharmaceutical D02MRX HIGHSTAT Phase 1 D02MVA DRUG__ID D02MVA D02MVA DRUGCOMP NovImmune SA D02MVA HIGHSTAT Phase 1 D02MZD DRUG__ID D02MZD D02MZD DRUGCOMP Amgen D02MZD HIGHSTAT Phase 1 D02NHY DRUG__ID D02NHY D02NHY DRUGCOMP Aduro BioTech Berkeley, CA D02NHY HIGHSTAT Phase 1 D02NJE DRUG__ID D02NJE D02NJE DRUGCOMP Healthbanks biotech usa D02NJE HIGHSTAT Phase 1 D02NXR DRUG__ID D02NXR D02NXR DRUGCOMP Purdue pharma; shionogi D02NXR HIGHSTAT Phase 1 D02PMT DRUG__ID D02PMT D02PMT DRUGCOMP Vernalis plc D02PMT HIGHSTAT Phase 1 D02PTI DRUG__ID D02PTI D02PTI DRUGCOMP Exicure Skokie, IL Purdue Pharma Stamford, CT D02PTI HIGHSTAT Phase 1 D02PYB DRUG__ID D02PYB D02PYB DRUGCOMP Sandoz AG D02PYB HIGHSTAT Phase 1 D02PYM DRUG__ID D02PYM D02PYM DRUGCOMP Novartis AG D02PYM HIGHSTAT Phase 1 D02QYY DRUG__ID D02QYY D02QYY DRUGCOMP Luye Pharma Shanghai, China D02QYY HIGHSTAT Phase 1 D02RHC DRUG__ID D02RHC D02RHC DRUGCOMP Eureka Therapeutics Emeryville, CA D02RHC HIGHSTAT Phase 1 D02RVC DRUG__ID D02RVC D02RVC DRUGCOMP Presidio pharmaceuticals D02RVC HIGHSTAT Phase 1 D02SHI DRUG__ID D02SHI D02SHI DRUGCOMP EMD Serono Rockland, MA D02SHI HIGHSTAT Phase 1 D02SME DRUG__ID D02SME D02SME DRUGCOMP Inotek Pharmaceuticals Corp D02SME HIGHSTAT Phase 1 D02STG DRUG__ID D02STG D02STG DRUGCOMP Ono pharma usa D02STG HIGHSTAT Phase 1 D02SUB DRUG__ID D02SUB D02SUB DRUGCOMP SWITCH Biotech LLC D02SUB HIGHSTAT Phase 1 D02SYQ DRUG__ID D02SYQ D02SYQ DRUGCOMP Fundacao Oswaldo Cruz D02SYQ HIGHSTAT Phase 1 D02TGN DRUG__ID D02TGN D02TGN DRUGCOMP Mersana Therapeutics Cambridge, MA D02TGN HIGHSTAT Phase 1 D02TMO DRUG__ID D02TMO D02TMO DRUGCOMP Bracco SpA D02TMO HIGHSTAT Phase 1 D02TVU DRUG__ID D02TVU D02TVU DRUGCOMP Merck; Vical D02TVU HIGHSTAT Phase 1 D02UBC DRUG__ID D02UBC D02UBC DRUGTYPE Antibody D02UBC HIGHSTAT Phase 1 D02UIC DRUG__ID D02UIC D02UIC DRUGCOMP Sanofi-Synthelabo D02UIC HIGHSTAT Phase 1 D02USG DRUG__ID D02USG D02USG DRUGCOMP Piramal Life Sciences Ltd D02USG HIGHSTAT Phase 1 D02UYM DRUG__ID D02UYM D02UYM DRUGCOMP Novan Morrisville, NC D02UYM HIGHSTAT Phase 1 D02XAS DRUG__ID D02XAS D02XAS DRUGCOMP Second Genome South San Francisco, CA D02XAS HIGHSTAT Phase 1 D02XGC DRUG__ID D02XGC D02XGC DRUGCOMP Pfizer Inc D02XGC HIGHSTAT Phase 1 D02XSL DRUG__ID D02XSL D02XSL DRUGCOMP Merck & Co Inc D02XSL HIGHSTAT Phase 1 D02XTN DRUG__ID D02XTN D02XTN DRUGCOMP Roche D02XTN HIGHSTAT Phase 1 D02XTT DRUG__ID D02XTT D02XTT DRUGCOMP Immune design D02XTT HIGHSTAT Phase 1 D02XXQ DRUG__ID D02XXQ D02XXQ DRUGCOMP Astrazeneca; medimmune D02XXQ HIGHSTAT Phase 1 D02YEG DRUG__ID D02YEG D02YEG DRUGCOMP Virobay Inc D02YEG HIGHSTAT Phase 1 D02YZK DRUG__ID D02YZK D02YZK DRUGCOMP Hoffmann-La Roche AG D02YZK HIGHSTAT Phase 1 D02ZCE DRUG__ID D02ZCE D02ZCE DRUGCOMP Arakis D02ZCE HIGHSTAT Phase 1 D02ZCM DRUG__ID D02ZCM D02ZCM DRUGCOMP Crucell D02ZCM HIGHSTAT Phase 1 D03ACE DRUG__ID D03ACE D03ACE DRUGCOMP Astellas Pharma US Northbrook, IL D03ACE HIGHSTAT Phase 1 D03AGK DRUG__ID D03AGK D03AGK DRUGCOMP Pfizer New York, NY D03AGK HIGHSTAT Phase 1 D03APM DRUG__ID D03APM D03APM DRUGCOMP Abbvie D03APM HIGHSTAT Phase 1 D03BFS DRUG__ID D03BFS D03BFS DRUGCOMP Supernus Pharmaceuticals Inc D03BFS HIGHSTAT Phase 1 D03BGG DRUG__ID D03BGG D03BGG DRUGCOMP Sapphire Therapeutics Inc D03BGG HIGHSTAT Phase 1 D03BKN DRUG__ID D03BKN D03BKN DRUGCOMP EMD Serono Rockland, MA D03BKN HIGHSTAT Phase 1 D03BLG DRUG__ID D03BLG D03BLG DRUGTYPE Antibody D03BLG HIGHSTAT Phase 1 D03BZS DRUG__ID D03BZS D03BZS DRUGCOMP Merck D03BZS HIGHSTAT Phase 1 D03CCY DRUG__ID D03CCY D03CCY DRUGCOMP Xel Pharmaceuticals D03CCY HIGHSTAT Phase 1 D03CLP DRUG__ID D03CLP D03CLP DRUGCOMP Malaghan Institute of Medical Research D03CLP HIGHSTAT Phase 1 D03CWX DRUG__ID D03CWX D03CWX DRUGCOMP Memory Pharmaceuticals Corp D03CWX HIGHSTAT Phase 1 D03DHM DRUG__ID D03DHM D03DHM DRUGCOMP ChemoCentryxMountain View, CA D03DHM HIGHSTAT Phase 1 D03DUH DRUG__ID D03DUH D03DUH DRUGCOMP Acambis D03DUH HIGHSTAT Phase 1 D03FGI DRUG__ID D03FGI D03FGI DRUGCOMP Bristol-Myers Squib Princeton, NJ D03FGI HIGHSTAT Phase 1 D03HDL DRUG__ID D03HDL D03HDL DRUGCOMP Alectos Therapeutics Vancouver, Canada Merck Whitehouse Station, NJ D03HDL HIGHSTAT Phase 1 D03HHJ DRUG__ID D03HHJ D03HHJ DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D03HHJ HIGHSTAT Phase 1 D03HKR DRUG__ID D03HKR D03HKR DRUGCOMP Celldex Therapeutics Hampton, NJ D03HKR HIGHSTAT Phase 1 D03INQ DRUG__ID D03INQ D03INQ DRUGCOMP Dongguan Kaifa Biomedicine Inc D03INQ HIGHSTAT Phase 1 D03IRG DRUG__ID D03IRG D03IRG DRUGCOMP CelgeneSummit, NJ D03IRG HIGHSTAT Phase 1 D03JNS DRUG__ID D03JNS D03JNS DRUGCOMP Allertein Therapeutics D03JNS HIGHSTAT Phase 1 D03JTL DRUG__ID D03JTL D03JTL DRUGCOMP Aptevo Therapeutics Seattle, WAMorphoSysPlanegg, Germany D03JTL HIGHSTAT Phase 1 D03JUF DRUG__ID D03JUF D03JUF DRUGCOMP Krele Pharmaceuticals D03JUF HIGHSTAT Phase 1 D03JWU DRUG__ID D03JWU D03JWU DRUGCOMP Recardio San Francisco, CA D03JWU HIGHSTAT Phase 1 D03KJU DRUG__ID D03KJU D03KJU DRUGCOMP Novogen D03KJU HIGHSTAT Phase 1 D03LAL DRUG__ID D03LAL D03LAL DRUGCOMP Barros Research Institute D03LAL HIGHSTAT Phase 1 D03LAV DRUG__ID D03LAV D03LAV DRUGCOMP AmgenThousand Oaks, CA MedImmune Gaithersburg, MD D03LAV HIGHSTAT Phase 1 D03MBU DRUG__ID D03MBU D03MBU DRUGCOMP AbbVieNorth Chicago, IL D03MBU HIGHSTAT Phase 1 D03MIN DRUG__ID D03MIN D03MIN DRUGCOMP Janssen Pharmaceutica NV D03MIN HIGHSTAT Phase 1 D03MWZ DRUG__ID D03MWZ D03MWZ DRUGCOMP Phage Biotechnology Corp D03MWZ HIGHSTAT Phase 1 D03NLQ DRUG__ID D03NLQ D03NLQ DRUGCOMP Abbott Laboratories D03NLQ HIGHSTAT Phase 1 D03NTF DRUG__ID D03NTF D03NTF DRUGCOMP JW Pharmaceutical Corp D03NTF HIGHSTAT Phase 1 D03ODX DRUG__ID D03ODX D03ODX DRUGCOMP Intercell AG; novartis vaccines D03ODX HIGHSTAT Phase 1 D03OFN DRUG__ID D03OFN D03OFN DRUGCOMP Nippon Kayaku Co Ltd D03OFN HIGHSTAT Phase 1 D03OKS DRUG__ID D03OKS D03OKS DRUGCOMP ZIOPHARM Oncology D03OKS HIGHSTAT Phase 1 D03POY DRUG__ID D03POY D03POY DRUGTYPE Antisense drug D03POY HIGHSTAT Phase 1 D03QBL DRUG__ID D03QBL D03QBL DRUGCOMP E Bayer HealthCare Pharmaceuticals D03QBL HIGHSTAT Phase 1 D03QHM DRUG__ID D03QHM D03QHM DRUGCOMP Aduro BiotechBerkeley, CAJanssen Research & Development Raritan, NJ D03QHM HIGHSTAT Phase 1 D03QWG DRUG__ID D03QWG D03QWG DRUGCOMP MD Anderson Cancer Center D03QWG HIGHSTAT Phase 1 D03TBD DRUG__ID D03TBD D03TBD DRUGCOMP Bristol-Myers Squibb Princeton, NJ D03TBD HIGHSTAT Phase 1 D03UDW DRUG__ID D03UDW D03UDW DRUGCOMP Acusphere D03UDW HIGHSTAT Phase 1 D03UHV DRUG__ID D03UHV D03UHV DRUGCOMP Ono Pharmaceutical; Bristol-Myers Squibb D03UHV HIGHSTAT Phase 1 D03UIW DRUG__ID D03UIW D03UIW DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D03UIW HIGHSTAT Phase 1 D03UKI DRUG__ID D03UKI D03UKI DRUGCOMP Tella Inc D03UKI HIGHSTAT Phase 1 D03UMA DRUG__ID D03UMA D03UMA DRUGCOMP Janssen research & development D03UMA HIGHSTAT Phase 1 D03UUL DRUG__ID D03UUL D03UUL DRUGCOMP Apeiron Biologics; GlaxoSmithKline D03UUL HIGHSTAT Phase 1 D03UZC DRUG__ID D03UZC D03UZC DRUGCOMP Daiichi sankyo D03UZC HIGHSTAT Phase 1 D03VWB DRUG__ID D03VWB D03VWB DRUGCOMP Mitsubishi Tanabe Pharma Corp D03VWB HIGHSTAT Phase 1 D03WDN DRUG__ID D03WDN D03WDN DRUGCOMP Boehringer Ingelheim Corp D03WDN HIGHSTAT Phase 1 D03WNN DRUG__ID D03WNN D03WNN DRUGCOMP F Hoffmann-La Roche Ltd D03WNN HIGHSTAT Phase 1 D03WOQ DRUG__ID D03WOQ D03WOQ DRUGCOMP Eli Lilly Indianapolis, IN D03WOQ HIGHSTAT Phase 1 D03XFH DRUG__ID D03XFH D03XFH DRUGCOMP Unum Therapeutics Cambridge, MA Seattle Genetics Bothell, WA D03XFH HIGHSTAT Phase 1 D03XZP DRUG__ID D03XZP D03XZP DRUGCOMP Baylor College of Medicine D03XZP HIGHSTAT Phase 1 D03YBJ DRUG__ID D03YBJ D03YBJ DRUGTYPE Antibody D03YBJ HIGHSTAT Phase 1 D03YBQ DRUG__ID D03YBQ D03YBQ DRUGCOMP Denali Therapeutics South San Francisco, CA D03YBQ HIGHSTAT Phase 1 D03YGL DRUG__ID D03YGL D03YGL DRUGCOMP Acorda Therapeutics Ardsley, NY D03YGL HIGHSTAT Phase 1 D03YGP DRUG__ID D03YGP D03YGP DRUGCOMP Celgene D03YGP HIGHSTAT Phase 1 D03ZLN DRUG__ID D03ZLN D03ZLN DRUGCOMP Selecta Biosciences Watertown, MA D03ZLN HIGHSTAT Phase 1 D03ZZX DRUG__ID D03ZZX D03ZZX DRUGCOMP Institute for Neurodegenerative Disorders D03ZZX HIGHSTAT Phase 1 D04AKG DRUG__ID D04AKG D04AKG DRUGCOMP Seres Therapeutics Cambridge, MA D04AKG HIGHSTAT Phase 1 D04ASP DRUG__ID D04ASP D04ASP DRUGCOMP Vical D04ASP HIGHSTAT Phase 1 D04AZT DRUG__ID D04AZT D04AZT DRUGCOMP Eli Lilly Indianapolis, IN; MedImmune Gaithersburg, MD D04AZT HIGHSTAT Phase 1 D04CJN DRUG__ID D04CJN D04CJN DRUGCOMP CoNCERT Pharmaceuticals Inc D04CJN HIGHSTAT Phase 1 D04CTD DRUG__ID D04CTD D04CTD DRUGCOMP Syndax Pharmaceuticals Waltham, MA D04CTD HIGHSTAT Phase 1 D04CXX DRUG__ID D04CXX D04CXX DRUGCOMP SBI Biotech D04CXX HIGHSTAT Phase 1 D04DQO DRUG__ID D04DQO D04DQO DRUGCOMP AbbVieNorth Chicago, IL D04DQO HIGHSTAT Phase 1 D04DUH DRUG__ID D04DUH D04DUH DRUGCOMP Louisiana State University D04DUH HIGHSTAT Phase 1 D04EZI DRUG__ID D04EZI D04EZI DRUGCOMP Celldex Therapeutics Inc D04EZI HIGHSTAT Phase 1 D04FYM DRUG__ID D04FYM D04FYM DRUGCOMP NanoBio Corp D04FYM HIGHSTAT Phase 1 D04GAG DRUG__ID D04GAG D04GAG DRUGCOMP Glenmark Pharmaceuticals Mumbai, India D04GAG HIGHSTAT Phase 1 D04GBW DRUG__ID D04GBW D04GBW DRUGCOMP Intercell D04GBW HIGHSTAT Phase 1 D04GGJ DRUG__ID D04GGJ D04GGJ DRUGCOMP WinSanTor San Diego, CA D04GGJ HIGHSTAT Phase 1 D04GNG DRUG__ID D04GNG D04GNG DRUGCOMP CelgeneSummit, NJ D04GNG HIGHSTAT Phase 1 D04HSH DRUG__ID D04HSH D04HSH DRUGCOMP Immunogen D04HSH HIGHSTAT Phase 1 D04HWK DRUG__ID D04HWK D04HWK DRUGCOMP Charit | - Universit tsmedizin Berlin: Charit | D04HWK HIGHSTAT Phase 1 D04IXL DRUG__ID D04IXL D04IXL DRUGCOMP Chiron Vaccines Co D04IXL HIGHSTAT Phase 1 D04JAT DRUG__ID D04JAT D04JAT DRUGCOMP Labrys biologics D04JAT HIGHSTAT Phase 1 D04JMI DRUG__ID D04JMI D04JMI DRUGCOMP DynPort Vaccine Company LLC D04JMI HIGHSTAT Phase 1 D04KVA DRUG__ID D04KVA D04KVA DRUGCOMP BioVascular D04KVA HIGHSTAT Phase 1 D04LFR DRUG__ID D04LFR D04LFR DRUGCOMP Sanofi D04LFR HIGHSTAT Phase 1 D04LIH DRUG__ID D04LIH D04LIH DRUGCOMP AVI BioPharma Inc D04LIH HIGHSTAT Phase 1 D04MDO DRUG__ID D04MDO D04MDO DRUGCOMP Galaxy Biotech Sunnyvale, CA D04MDO HIGHSTAT Phase 1 D04MUQ DRUG__ID D04MUQ D04MUQ DRUGCOMP Soligenix Princeton, NJ D04MUQ HIGHSTAT Phase 1 D04NHQ DRUG__ID D04NHQ D04NHQ DRUGCOMP Sanofi Pasteur Swiftwater, PA D04NHQ HIGHSTAT Phase 1 D04NJS DRUG__ID D04NJS D04NJS DRUGCOMP Sanofi-Aventis D04NJS HIGHSTAT Phase 1 D04OFY DRUG__ID D04OFY D04OFY DRUGCOMP AbbVieNorth Chicago, IL D04OFY HIGHSTAT Phase 1 D04OGH DRUG__ID D04OGH D04OGH DRUGCOMP Selecta Biosciences D04OGH HIGHSTAT Phase 1 D04OMR DRUG__ID D04OMR D04OMR DRUGCOMP Pfizer New York, NY D04OMR HIGHSTAT Phase 1 D04OQU DRUG__ID D04OQU D04OQU DRUGCOMP Astellas Pharma US; Perseid Therapeutics D04OQU HIGHSTAT Phase 1 D04OXG DRUG__ID D04OXG D04OXG DRUGCOMP Pharmazz Willowbrook, IL D04OXG HIGHSTAT Phase 1 D04PPK DRUG__ID D04PPK D04PPK DRUGCOMP Montreal Heart Institute D04PPK HIGHSTAT Phase 1 D04RFX DRUG__ID D04RFX D04RFX DRUGCOMP Avant Immunotherapeutics D04RFX HIGHSTAT Phase 1 D04RHJ DRUG__ID D04RHJ D04RHJ DRUGCOMP Roche D04RHJ HIGHSTAT Phase 1 D04RLB DRUG__ID D04RLB D04RLB DRUGCOMP St Jude Children's Research Hospital D04RLB HIGHSTAT Phase 1 D04RWV DRUG__ID D04RWV D04RWV DRUGCOMP Insmed Bridgewater, NJ D04RWV HIGHSTAT Phase 1 D04SBW DRUG__ID D04SBW D04SBW DRUGCOMP GlaxoSmithKline plc D04SBW HIGHSTAT Phase 1 D04SIU DRUG__ID D04SIU D04SIU DRUGCOMP Mithridion Inc; University of Toledo D04SIU HIGHSTAT Phase 1 D04SJT DRUG__ID D04SJT D04SJT DRUGCOMP Mazence Inc D04SJT HIGHSTAT Phase 1 D04SQJ DRUG__ID D04SQJ D04SQJ DRUGCOMP Sangamo BioSciences D04SQJ HIGHSTAT Phase 1 D04SZA DRUG__ID D04SZA D04SZA DRUGCOMP Piramal Life Sciences Ltd D04SZA HIGHSTAT Phase 1 D04TKU DRUG__ID D04TKU D04TKU DRUGCOMP National Institute of Allergy and Infectious Diseases D04TKU HIGHSTAT Phase 1 D04TUN DRUG__ID D04TUN D04TUN DRUGCOMP Jiangsu Hengrui Medicine Jiangsu, China D04TUN HIGHSTAT Phase 1 D04UQF DRUG__ID D04UQF D04UQF DRUGCOMP Abbott Laboratories D04UQF HIGHSTAT Phase 1 D04UTH DRUG__ID D04UTH D04UTH DRUGCOMP Hanmi pharmaceutical D04UTH HIGHSTAT Phase 1 D04VJQ DRUG__ID D04VJQ D04VJQ DRUGCOMP Novartis Pharmaceuticals D04VJQ HIGHSTAT Phase 1 D04VVD DRUG__ID D04VVD D04VVD DRUGCOMP Adamis Pharmaceuticals D04VVD HIGHSTAT Phase 1 D04VZS DRUG__ID D04VZS D04VZS DRUGCOMP CoMentis D04VZS HIGHSTAT Phase 1 D04XAB DRUG__ID D04XAB D04XAB DRUGCOMP Bayer Innovation D04XAB HIGHSTAT Phase 1 D04XCK DRUG__ID D04XCK D04XCK DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D04XCK HIGHSTAT Phase 1 D04XJG DRUG__ID D04XJG D04XJG DRUGCOMP BioKier Chapel Hill, NC D04XJG HIGHSTAT Phase 1 D04XNQ DRUG__ID D04XNQ D04XNQ DRUGCOMP Baxter D04XNQ HIGHSTAT Phase 1 D04XWX DRUG__ID D04XWX D04XWX DRUGCOMP Bristol-Myers Squibb Co D04XWX HIGHSTAT Phase 1 D04YAK DRUG__ID D04YAK D04YAK DRUGCOMP Myriad Genetics Inc D04YAK HIGHSTAT Phase 1 D04YFA DRUG__ID D04YFA D04YFA DRUGCOMP Vaxinnate; emergent biosolutions D04YFA HIGHSTAT Phase 1 D04YHJ DRUG__ID D04YHJ D04YHJ DRUGCOMP Sanofi pasteur D04YHJ HIGHSTAT Phase 1 D04ZIO DRUG__ID D04ZIO D04ZIO DRUGCOMP Neurocrine Biosciences San Diego, CA D04ZIO HIGHSTAT Phase 1 D04ZSL DRUG__ID D04ZSL D04ZSL DRUGCOMP Sangamo Biosciences D04ZSL HIGHSTAT Phase 1 D05ASV DRUG__ID D05ASV D05ASV DRUGCOMP VentiRx Pharmaceuticals Inc D05ASV HIGHSTAT Phase 1 D05AVL DRUG__ID D05AVL D05AVL DRUGCOMP Janssen Research & Development Raritan, NJ D05AVL HIGHSTAT Phase 1 D05BNS DRUG__ID D05BNS D05BNS DRUGCOMP Veana Therapeutics Portland, OR D05BNS HIGHSTAT Phase 1 D05BSG DRUG__ID D05BSG D05BSG DRUGCOMP Multimmune GmbH D05BSG HIGHSTAT Phase 1 D05BYJ DRUG__ID D05BYJ D05BYJ DRUGCOMP Pfizer D05BYJ HIGHSTAT Phase 1 D05CFQ DRUG__ID D05CFQ D05CFQ DRUGCOMP Amgen Inc D05CFQ HIGHSTAT Phase 1 D05CHN DRUG__ID D05CHN D05CHN DRUGCOMP MGI Pharma D05CHN HIGHSTAT Phase 1 D05CRY DRUG__ID D05CRY D05CRY DRUGCOMP ADC Therapeutics Murray Hill, NJ D05CRY HIGHSTAT Phase 1 D05DCL DRUG__ID D05DCL D05DCL DRUGCOMP Zydus-Cadila Group D05DCL HIGHSTAT Phase 1 D05DOY DRUG__ID D05DOY D05DOY DRUGTYPE Antibody D05DOY HIGHSTAT Phase 1 D05DSS DRUG__ID D05DSS D05DSS DRUGCOMP GlobeImmune D05DSS HIGHSTAT Phase 1 D05DXT DRUG__ID D05DXT D05DXT DRUGCOMP Xention Ltd D05DXT HIGHSTAT Phase 1 D05EBY DRUG__ID D05EBY D05EBY DRUGCOMP Bristol-myers squibb D05EBY HIGHSTAT Phase 1 D05EHS DRUG__ID D05EHS D05EHS DRUGCOMP Transgene SA D05EHS HIGHSTAT Phase 1 D05EPE DRUG__ID D05EPE D05EPE DRUGCOMP National Institutes of Health D05EPE HIGHSTAT Phase 1 D05EUS DRUG__ID D05EUS D05EUS DRUGCOMP Kaleido Biosciences Bedford, MA D05EUS HIGHSTAT Phase 1 D05FGP DRUG__ID D05FGP D05FGP DRUGCOMP Daewoong Pharmaceutical Co Ltd D05FGP HIGHSTAT Phase 1 D05FHZ DRUG__ID D05FHZ D05FHZ DRUGCOMP MacroGenics Rockville, MD D05FHZ HIGHSTAT Phase 1 D05FVK DRUG__ID D05FVK D05FVK DRUGCOMP ReceptoPharm Inc; ReceptoPharm D05FVK HIGHSTAT Phase 1 D05FWF DRUG__ID D05FWF D05FWF DRUGCOMP University of Messina D05FWF HIGHSTAT Phase 1 D05GPB DRUG__ID D05GPB D05GPB DRUGCOMP Neose Technologies Inc D05GPB HIGHSTAT Phase 1 D05HIX DRUG__ID D05HIX D05HIX DRUGCOMP Merck & Co Inc D05HIX HIGHSTAT Phase 1 D05IEN DRUG__ID D05IEN D05IEN DRUGCOMP The University of Birmingham D05IEN HIGHSTAT Phase 1 D05IQI DRUG__ID D05IQI D05IQI DRUGCOMP Lexicon Pharmaceuticals The Woodlands, TX D05IQI HIGHSTAT Phase 1 D05ISV DRUG__ID D05ISV D05ISV DRUGCOMP National Institute of Allergy and Infectious Diseases D05ISV HIGHSTAT Phase 1 D05JMW DRUG__ID D05JMW D05JMW DRUGCOMP RGene Therapeutics Inc D05JMW HIGHSTAT Phase 1 D05JPJ DRUG__ID D05JPJ D05JPJ DRUGCOMP Elan Corp plc D05JPJ HIGHSTAT Phase 1 D05KGG DRUG__ID D05KGG D05KGG DRUGCOMP Immatics US Houston, TX D05KGG HIGHSTAT Phase 1 D05KME DRUG__ID D05KME D05KME DRUGCOMP DURECT D05KME HIGHSTAT Phase 1 D05KOP DRUG__ID D05KOP D05KOP DRUGCOMP Antigen Express D05KOP HIGHSTAT Phase 1 D05KUP DRUG__ID D05KUP D05KUP DRUGCOMP Wyeth D05KUP HIGHSTAT Phase 1 D05LKZ DRUG__ID D05LKZ D05LKZ DRUGCOMP TransTech Pharma Inc D05LKZ HIGHSTAT Phase 1 D05LMC DRUG__ID D05LMC D05LMC DRUGCOMP Amgen D05LMC HIGHSTAT Phase 1 D05LOV DRUG__ID D05LOV D05LOV DRUGCOMP Advinus Therapeutics D05LOV HIGHSTAT Phase 1 D05MEP DRUG__ID D05MEP D05MEP DRUGCOMP Generex Biotechnology Corp D05MEP HIGHSTAT Phase 1 D05MIQ DRUG__ID D05MIQ D05MIQ DRUGCOMP Eunice Kennedy Shriver National Institutes of Child Health and Human Development D05MIQ HIGHSTAT Phase 1 D05MVX DRUG__ID D05MVX D05MVX DRUGCOMP Atara Biotherapeutics South San Francisco, CA D05MVX HIGHSTAT Phase 1 D05NDY DRUG__ID D05NDY D05NDY DRUGCOMP Pfizer D05NDY HIGHSTAT Phase 1 D05NHT DRUG__ID D05NHT D05NHT DRUGCOMP Meabco A/S D05NHT HIGHSTAT Phase 1 D05NLD DRUG__ID D05NLD D05NLD DRUGCOMP Array BioPharma; Novartis Pharmaceuticals D05NLD HIGHSTAT Phase 1 D05NUP DRUG__ID D05NUP D05NUP DRUGCOMP SemBioSys Genetics Inc D05NUP HIGHSTAT Phase 1 D05ODU DRUG__ID D05ODU D05ODU DRUGCOMP Nautilus Biotech D05ODU HIGHSTAT Phase 1 D05ORO DRUG__ID D05ORO D05ORO DRUGTYPE Antibody D05ORO HIGHSTAT Phase 1 D05OZG DRUG__ID D05OZG D05OZG DRUGCOMP Molecular Targeting Technologies D05OZG HIGHSTAT Phase 1 D05RBH DRUG__ID D05RBH D05RBH DRUGCOMP Novo Nordisk D05RBH HIGHSTAT Phase 1 D05RCZ DRUG__ID D05RCZ D05RCZ DRUGCOMP PowderMed D05RCZ HIGHSTAT Phase 1 D05RIM DRUG__ID D05RIM D05RIM DRUGCOMP Supernus Pharmaceuticals D05RIM HIGHSTAT Phase 1 D05RWL DRUG__ID D05RWL D05RWL DRUGCOMP NeuroSearch A/S D05RWL HIGHSTAT Phase 1 D05SGI DRUG__ID D05SGI D05SGI DRUGCOMP BeiGene Cambridge, MA D05SGI HIGHSTAT Phase 1 D05SJK DRUG__ID D05SJK D05SJK DRUGCOMP Texas Heart Institute D05SJK HIGHSTAT Phase 1 D05SOH DRUG__ID D05SOH D05SOH DRUGCOMP Cytochroma Inc D05SOH HIGHSTAT Phase 1 D05TMA DRUG__ID D05TMA D05TMA DRUGCOMP Adaptimmune Philadelphia, PA D05TMA HIGHSTAT Phase 1 D05UCW DRUG__ID D05UCW D05UCW DRUGCOMP MedImmune D05UCW HIGHSTAT Phase 1 D05UFJ DRUG__ID D05UFJ D05UFJ DRUGCOMP Minneamrita therapeutics D05UFJ HIGHSTAT Phase 1 D05UJF DRUG__ID D05UJF D05UJF DRUGCOMP Profectus biosciences D05UJF HIGHSTAT Phase 1 D05UJS DRUG__ID D05UJS D05UJS DRUGCOMP Aaron Diamond AIDS Research Center; International AIDS Vaccine Initiative Ichor Medical Systems D05UJS HIGHSTAT Phase 1 D05UTW DRUG__ID D05UTW D05UTW DRUGCOMP MaxCyte D05UTW HIGHSTAT Phase 1 D05VAE DRUG__ID D05VAE D05VAE DRUGCOMP Qr pharma D05VAE HIGHSTAT Phase 1 D05VFZ DRUG__ID D05VFZ D05VFZ DRUGCOMP Amgen Thousand Oaks, CA D05VFZ HIGHSTAT Phase 1 D05VHB DRUG__ID D05VHB D05VHB DRUGCOMP Allertein therapeutics D05VHB HIGHSTAT Phase 1 D05VSH DRUG__ID D05VSH D05VSH DRUGCOMP Regeneron Pharmaceuticals Tarrytown, NY; Sanofi Bridgewater, NJ D05VSH HIGHSTAT Phase 1 D05VUX DRUG__ID D05VUX D05VUX DRUGCOMP Biohaven Pharmaceutical New Haven, CT D05VUX HIGHSTAT Phase 1 D05WLE DRUG__ID D05WLE D05WLE DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D05WLE HIGHSTAT Phase 1 D05WOS DRUG__ID D05WOS D05WOS DRUGCOMP Bristol-Myers Squibb Princeton, NJ D05WOS HIGHSTAT Phase 1 D05YEI DRUG__ID D05YEI D05YEI DRUGCOMP Sun Pharma Advanced Research Mumbai, India D05YEI HIGHSTAT Phase 1 D05ZLY DRUG__ID D05ZLY D05ZLY DRUGCOMP Exicure Skokie, IL D05ZLY HIGHSTAT Phase 1 D06BKK DRUG__ID D06BKK D06BKK DRUGCOMP Novo Nordisk, Plainsboro, NJ D06BKK HIGHSTAT Phase 1 D06CSK DRUG__ID D06CSK D06CSK DRUGCOMP Novartis AG D06CSK HIGHSTAT Phase 1 D06CWV DRUG__ID D06CWV D06CWV DRUGCOMP NanoBio Corp D06CWV HIGHSTAT Phase 1 D06DKD DRUG__ID D06DKD D06DKD DRUGCOMP Quintessence Biosciences D06DKD HIGHSTAT Phase 1 D06DQF DRUG__ID D06DQF D06DQF DRUGCOMP Hoffmann-La Roche Inc D06DQF HIGHSTAT Phase 1 D06ERY DRUG__ID D06ERY D06ERY DRUGCOMP Bristol-Myers Squibb D06ERY HIGHSTAT Phase 1 D06EXI DRUG__ID D06EXI D06EXI DRUGCOMP ENKAM Pharmaceuticals A/S D06EXI HIGHSTAT Phase 1 D06FGJ DRUG__ID D06FGJ D06FGJ DRUGCOMP Nexia Biotechnologies Inc D06FGJ HIGHSTAT Phase 1 D06FHQ DRUG__ID D06FHQ D06FHQ DRUGCOMP Bristol-Myers Squibb D06FHQ HIGHSTAT Phase 1 D06FLP DRUG__ID D06FLP D06FLP DRUGCOMP Amgen D06FLP HIGHSTAT Phase 1 D06FZH DRUG__ID D06FZH D06FZH DRUGCOMP Takara bio D06FZH HIGHSTAT Phase 1 D06GAP DRUG__ID D06GAP D06GAP DRUGCOMP Sanofi D06GAP HIGHSTAT Phase 1 D06HUS DRUG__ID D06HUS D06HUS DRUGCOMP Pfizer New York, NY D06HUS HIGHSTAT Phase 1 D06HYC DRUG__ID D06HYC D06HYC DRUGCOMP VectorLogics Inc; University of Alabama at Birmingham D06HYC HIGHSTAT Phase 1 D06IEX DRUG__ID D06IEX D06IEX DRUGCOMP Digna Biotech SL D06IEX HIGHSTAT Phase 1 D06IGW DRUG__ID D06IGW D06IGW DRUGCOMP BioCardia South D06IGW HIGHSTAT Phase 1 D06JCO DRUG__ID D06JCO D06JCO DRUGCOMP Paloma Pharmaceuticals Inc D06JCO HIGHSTAT Phase 1 D06JDV DRUG__ID D06JDV D06JDV DRUGCOMP Kowa Research Institute Morrisville, NC D06JDV HIGHSTAT Phase 1 D06JLG DRUG__ID D06JLG D06JLG DRUGCOMP Alphavax; novartis vaccines D06JLG HIGHSTAT Phase 1 D06JPY DRUG__ID D06JPY D06JPY DRUGCOMP Navidea pharmaceuticals D06JPY HIGHSTAT Phase 1 D06KNE DRUG__ID D06KNE D06KNE DRUGCOMP Incyte D06KNE HIGHSTAT Phase 1 D06KPR DRUG__ID D06KPR D06KPR DRUGCOMP Cerenis Therapeutics D06KPR HIGHSTAT Phase 1 D06KWU DRUG__ID D06KWU D06KWU DRUGCOMP Daewoong Pharmaceutical Co Ltd D06KWU HIGHSTAT Phase 1 D06LEA DRUG__ID D06LEA D06LEA DRUGCOMP Merrion Pharmaceuticals D06LEA HIGHSTAT Phase 1 D06LHK DRUG__ID D06LHK D06LHK DRUGCOMP 2X Oncology Cambridge, MA D06LHK HIGHSTAT Phase 1 D06MNC DRUG__ID D06MNC D06MNC DRUGCOMP Pieris AG D06MNC HIGHSTAT Phase 1 D06MWK DRUG__ID D06MWK D06MWK DRUGCOMP Constab Pharmaceutical D06MWK HIGHSTAT Phase 1 D06NDP DRUG__ID D06NDP D06NDP DRUGCOMP Center for Genetic Engineering and Biotechnology D06NDP HIGHSTAT Phase 1 D06NND DRUG__ID D06NND D06NND DRUGCOMP Five Prime Therapeutics South San Francisco, ca D06NND HIGHSTAT Phase 1 D06NOF DRUG__ID D06NOF D06NOF DRUGCOMP ARYx Therapeutics Inc D06NOF HIGHSTAT Phase 1 D06NQA DRUG__ID D06NQA D06NQA DRUGCOMP Inovio Pharmaceuticals Inc D06NQA HIGHSTAT Phase 1 D06OFD DRUG__ID D06OFD D06OFD DRUGCOMP University of Sydney D06OFD HIGHSTAT Phase 1 D06PDT DRUG__ID D06PDT D06PDT DRUGCOMP National Cancer Institute D06PDT HIGHSTAT Phase 1 D06PSU DRUG__ID D06PSU D06PSU DRUGCOMP Bayer healthcare pharmaceuticals D06PSU HIGHSTAT Phase 1 D06PTG DRUG__ID D06PTG D06PTG DRUGCOMP Ambrx La Jolla, CA D06PTG HIGHSTAT Phase 1 D06RSE DRUG__ID D06RSE D06RSE DRUGCOMP Geron D06RSE HIGHSTAT Phase 1 D06RUK DRUG__ID D06RUK D06RUK DRUGCOMP University of Texas Southwestern Medical Center D06RUK HIGHSTAT Phase 1 D06RWM DRUG__ID D06RWM D06RWM DRUGCOMP Phrixus Pharmaceuticals Ann Arbor, MI D06RWM HIGHSTAT Phase 1 D06SCK DRUG__ID D06SCK D06SCK DRUGCOMP Meridian Biopharmaceuticals D06SCK HIGHSTAT Phase 1 D06SDQ DRUG__ID D06SDQ D06SDQ DRUGCOMP UCB Smyrna, GA D06SDQ HIGHSTAT Phase 1 D06SHZ DRUG__ID D06SHZ D06SHZ DRUGCOMP ShireLexington, MA D06SHZ HIGHSTAT Phase 1 D06SNV DRUG__ID D06SNV D06SNV DRUGCOMP Morphotek Inc D06SNV HIGHSTAT Phase 1 D06SWS DRUG__ID D06SWS D06SWS DRUGCOMP Novo Nordisk A/S D06SWS HIGHSTAT Phase 1 D06THG DRUG__ID D06THG D06THG DRUGCOMP Daiichi Sankyo Parsippany, NJ D06THG HIGHSTAT Phase 1 D06TTT DRUG__ID D06TTT D06TTT DRUGCOMP Istituto Superiore di Sanita D06TTT HIGHSTAT Phase 1 D06UND DRUG__ID D06UND D06UND DRUGCOMP University of Oxford D06UND HIGHSTAT Phase 1 D06UOU DRUG__ID D06UOU D06UOU DRUGCOMP MacroGenics D06UOU HIGHSTAT Phase 1 D06VVH DRUG__ID D06VVH D06VVH DRUGCOMP GlaxoSmithKline plc D06VVH HIGHSTAT Phase 1 D06WAM DRUG__ID D06WAM D06WAM DRUGCOMP Athenex Buffalo, NY D06WAM HIGHSTAT Phase 1 D06WCR DRUG__ID D06WCR D06WCR DRUGCOMP International Centre for Genetic Engineering & Biotechnology D06WCR HIGHSTAT Phase 1 D06WTQ DRUG__ID D06WTQ D06WTQ DRUGCOMP Theravance Biopharma South San Francisco, CA D06WTQ HIGHSTAT Phase 1 D06XKM DRUG__ID D06XKM D06XKM DRUGCOMP CSL Behring King of Prussia, PA D06XKM HIGHSTAT Phase 1 D06XYL DRUG__ID D06XYL D06XYL DRUGCOMP University of Massachusetts Medical School D06XYL HIGHSTAT Phase 1 D06YCR DRUG__ID D06YCR D06YCR DRUGCOMP GenPhar D06YCR HIGHSTAT Phase 1 D06YPQ DRUG__ID D06YPQ D06YPQ DRUGCOMP Sequoia Pharmaceuticals Inc D06YPQ HIGHSTAT Phase 1 D06YUM DRUG__ID D06YUM D06YUM DRUGCOMP Astrazeneca D06YUM HIGHSTAT Phase 1 D06ZEC DRUG__ID D06ZEC D06ZEC DRUGCOMP Biodel, Danbury, CT D06ZEC HIGHSTAT Phase 1 D06ZHN DRUG__ID D06ZHN D06ZHN DRUGCOMP Novozymes GroPep Limited D06ZHN HIGHSTAT Phase 1 D06ZXF DRUG__ID D06ZXF D06ZXF DRUGCOMP Amgen Thousand; Daiichi D06ZXF HIGHSTAT Phase 1 D07APS DRUG__ID D07APS D07APS DRUGCOMP TRACON Pharmaceuticals D07APS HIGHSTAT Phase 1 D07AUS DRUG__ID D07AUS D07AUS DRUGCOMP Krele Pharmaceuticals D07AUS HIGHSTAT Phase 1 D07BAJ DRUG__ID D07BAJ D07BAJ DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D07BAJ HIGHSTAT Phase 1 D07CBH DRUG__ID D07CBH D07CBH DRUGCOMP SK Biopharmaceuticals Fair Lawn, NJ D07CBH HIGHSTAT Phase 1 D07DLA DRUG__ID D07DLA D07DLA DRUGCOMP Dia-B Tech D07DLA HIGHSTAT Phase 1 D07DPC DRUG__ID D07DPC D07DPC DRUGCOMP Immunogen D07DPC HIGHSTAT Phase 1 D07EFB DRUG__ID D07EFB D07EFB DRUGCOMP Haikou vti biological institute D07EFB HIGHSTAT Phase 1 D07EKK DRUG__ID D07EKK D07EKK DRUGCOMP PTC Therapeutics South Plainfield, NJ D07EKK HIGHSTAT Phase 1 D07ELT DRUG__ID D07ELT D07ELT DRUGCOMP Medinox D07ELT HIGHSTAT Phase 1 D07FGU DRUG__ID D07FGU D07FGU DRUGCOMP Sanofi US Bridgewater, NJ D07FGU HIGHSTAT Phase 1 D07FIC DRUG__ID D07FIC D07FIC DRUGCOMP CytImmune Sciences D07FIC HIGHSTAT Phase 1 D07FKX DRUG__ID D07FKX D07FKX DRUGCOMP Hutchison Medipharma Enterprises Ltd D07FKX HIGHSTAT Phase 1 D07FZF DRUG__ID D07FZF D07FZF DRUGCOMP Mersana Therapeutics Cambridge, MA D07FZF HIGHSTAT Phase 1 D07GDR DRUG__ID D07GDR D07GDR DRUGTYPE Antibody D07GDR HIGHSTAT Phase 1 D07GLB DRUG__ID D07GLB D07GLB DRUGCOMP Pevion Biotech Ltd D07GLB HIGHSTAT Phase 1 D07GVM DRUG__ID D07GVM D07GVM DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D07GVM HIGHSTAT Phase 1 D07HLZ DRUG__ID D07HLZ D07HLZ DRUGCOMP Sanofi D07HLZ HIGHSTAT Phase 1 D07HPH DRUG__ID D07HPH D07HPH DRUGCOMP MedImmune Gaithersburg, MD D07HPH HIGHSTAT Phase 1 D07HYR DRUG__ID D07HYR D07HYR DRUGCOMP Kangwon University Pharmaceutical College D07HYR HIGHSTAT Phase 1 D07HZP DRUG__ID D07HZP D07HZP DRUGTYPE Antibody D07HZP HIGHSTAT Phase 1 D07IGC DRUG__ID D07IGC D07IGC DRUGCOMP Sunovion Pharmaceuticals D07IGC HIGHSTAT Phase 1 D07IVS DRUG__ID D07IVS D07IVS DRUGCOMP Bird Rock Bio, La Jolla, CA D07IVS HIGHSTAT Phase 1 D07JFE DRUG__ID D07JFE D07JFE DRUGCOMP Acorda Therapeutics Ardsley, NY D07JFE HIGHSTAT Phase 1 D07JSX DRUG__ID D07JSX D07JSX DRUGCOMP Vical D07JSX HIGHSTAT Phase 1 D07JVT DRUG__ID D07JVT D07JVT DRUGCOMP Novartis Oncology East Hanover, NJ D07JVT HIGHSTAT Phase 1 D07LBQ DRUG__ID D07LBQ D07LBQ DRUGTYPE Antibody D07LBQ HIGHSTAT Phase 1 D07LCP DRUG__ID D07LCP D07LCP DRUGCOMP McMaster University D07LCP HIGHSTAT Phase 1 D07MPI DRUG__ID D07MPI D07MPI DRUGCOMP Astrazeneca; medimmune D07MPI HIGHSTAT Phase 1 D07MTT DRUG__ID D07MTT D07MTT DRUGCOMP Intercytex Ltd D07MTT HIGHSTAT Phase 1 D07NZC DRUG__ID D07NZC D07NZC DRUGCOMP Amgen D07NZC HIGHSTAT Phase 1 D07OBJ DRUG__ID D07OBJ D07OBJ DRUGCOMP Phenomix Corp D07OBJ HIGHSTAT Phase 1 D07ODC DRUG__ID D07ODC D07ODC DRUGCOMP Virobay D07ODC HIGHSTAT Phase 1 D07OSS DRUG__ID D07OSS D07OSS DRUGCOMP University of Alabama at Birmingham D07OSS HIGHSTAT Phase 1 D07OTW DRUG__ID D07OTW D07OTW DRUGCOMP Sunovion pharmaceuticals D07OTW HIGHSTAT Phase 1 D07OXW DRUG__ID D07OXW D07OXW DRUGCOMP Inovio pharmaceuticals D07OXW HIGHSTAT Phase 1 D07PFU DRUG__ID D07PFU D07PFU DRUGCOMP Janssen Research & Development Raritan, NJ D07PFU HIGHSTAT Phase 1 D07PSL DRUG__ID D07PSL D07PSL DRUGCOMP Daiichi sankyo D07PSL HIGHSTAT Phase 1 D07PSX DRUG__ID D07PSX D07PSX DRUGCOMP AbbVie North Chicago, IL D07PSX HIGHSTAT Phase 1 D07QDT DRUG__ID D07QDT D07QDT DRUGCOMP Astellas Northbrook, IL Mitobridge Cambridge, MA D07QDT HIGHSTAT Phase 1 D07QXM DRUG__ID D07QXM D07QXM DRUGCOMP AVI BioPharma D07QXM HIGHSTAT Phase 1 D07RDQ DRUG__ID D07RDQ D07RDQ DRUGCOMP Selecta Biosciences Watertown, MA D07RDQ HIGHSTAT Phase 1 D07RIJ DRUG__ID D07RIJ D07RIJ DRUGCOMP Dana-Farber Cancer Institute Inc D07RIJ HIGHSTAT Phase 1 D07RPT DRUG__ID D07RPT D07RPT DRUGCOMP International Therapeutics Inc D07RPT HIGHSTAT Phase 1 D07SBP DRUG__ID D07SBP D07SBP DRUGCOMP AstraZeneca Wilmington, DE D07SBP HIGHSTAT Phase 1 D07SLJ DRUG__ID D07SLJ D07SLJ DRUGCOMP Juno Therapeutics Seattle, WA D07SLJ HIGHSTAT Phase 1 D07SPG DRUG__ID D07SPG D07SPG DRUGCOMP ArGEN-X BV D07SPG HIGHSTAT Phase 1 D07SYO DRUG__ID D07SYO D07SYO DRUGCOMP Proteonomix D07SYO HIGHSTAT Phase 1 D07TYV DRUG__ID D07TYV D07TYV DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D07TYV HIGHSTAT Phase 1 D07UKF DRUG__ID D07UKF D07UKF DRUGCOMP Virobay Inc D07UKF HIGHSTAT Phase 1 D07USV DRUG__ID D07USV D07USV DRUGCOMP Merrimack Pharmaceuticals D07USV HIGHSTAT Phase 1 D07VJI DRUG__ID D07VJI D07VJI DRUGCOMP Albert B. Sabin Vaccine Institute D07VJI HIGHSTAT Phase 1 D07WJU DRUG__ID D07WJU D07WJU DRUGCOMP Suven Life Sciences Ltd D07WJU HIGHSTAT Phase 1 D07WMD DRUG__ID D07WMD D07WMD DRUGCOMP Merck D07WMD HIGHSTAT Phase 1 D07WTH DRUG__ID D07WTH D07WTH DRUGCOMP Biogen Idec D07WTH HIGHSTAT Phase 1 D07WUJ DRUG__ID D07WUJ D07WUJ DRUGCOMP Glaxosmithkline; novavax; vaxart D07WUJ HIGHSTAT Phase 1 D07XEV DRUG__ID D07XEV D07XEV DRUGCOMP Intralytix Inc D07XEV HIGHSTAT Phase 1 D07XXT DRUG__ID D07XXT D07XXT DRUGCOMP Genentech D07XXT HIGHSTAT Phase 1 D07YEK DRUG__ID D07YEK D07YEK DRUGCOMP Novogen D07YEK HIGHSTAT Phase 1 D07YIX DRUG__ID D07YIX D07YIX DRUGCOMP Jn-international medical D07YIX HIGHSTAT Phase 1 D07YKQ DRUG__ID D07YKQ D07YKQ DRUGCOMP Epygenix Therapeutics Paramus, NJ D07YKQ HIGHSTAT Phase 1 D07YMP DRUG__ID D07YMP D07YMP DRUGCOMP Shanghai Junshi Biosciences Shanghai, China D07YMP HIGHSTAT Phase 1 D07YZQ DRUG__ID D07YZQ D07YZQ DRUGCOMP Ichor Medical Systems; Memorial Sloan-Kettering Cancer Center D07YZQ HIGHSTAT Phase 1 D07ZVO DRUG__ID D07ZVO D07ZVO DRUGCOMP Phico Therapeutics Ltd D07ZVO HIGHSTAT Phase 1 D07ZZI DRUG__ID D07ZZI D07ZZI DRUGCOMP Solvay SA D07ZZI HIGHSTAT Phase 1 D07ZZS DRUG__ID D07ZZS D07ZZS DRUGCOMP Agensys; seattle genetics D07ZZS HIGHSTAT Phase 1 D08AJF DRUG__ID D08AJF D08AJF DRUGCOMP Peptimmune D08AJF HIGHSTAT Phase 1 D08ANF DRUG__ID D08ANF D08ANF DRUGCOMP EnGeneIC New York, NY D08ANF HIGHSTAT Phase 1 D08BIJ DRUG__ID D08BIJ D08BIJ DRUGCOMP Lilly D08BIJ HIGHSTAT Phase 1 D08CGG DRUG__ID D08CGG D08CGG DRUGCOMP Vical; Vaccine Research Center D08CGG HIGHSTAT Phase 1 D08COU DRUG__ID D08COU D08COU DRUGCOMP Pantec Biosolutions AG D08COU HIGHSTAT Phase 1 D08CPL DRUG__ID D08CPL D08CPL DRUGCOMP Mistral Pharma Inc D08CPL HIGHSTAT Phase 1 D08CUE DRUG__ID D08CUE D08CUE DRUGCOMP Boehringer Ingelheim Corp D08CUE HIGHSTAT Phase 1 D08DJV DRUG__ID D08DJV D08DJV DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D08DJV HIGHSTAT Phase 1 D08DRU DRUG__ID D08DRU D08DRU DRUGCOMP Glaxosmithkline D08DRU HIGHSTAT Phase 1 D08DTD DRUG__ID D08DTD D08DTD DRUGCOMP Asklepios biopharmaceuticals D08DTD HIGHSTAT Phase 1 D08DTR DRUG__ID D08DTR D08DTR DRUGCOMP National Institute of Allergy and Infectious Diseases D08DTR HIGHSTAT Phase 1 D08DVE DRUG__ID D08DVE D08DVE DRUGCOMP Boehringer Ingelheim Corp D08DVE HIGHSTAT Phase 1 D08DWC DRUG__ID D08DWC D08DWC DRUGCOMP EMD Serono D08DWC HIGHSTAT Phase 1 D08EEM DRUG__ID D08EEM D08EEM DRUGCOMP Wellstat Biologics Corp D08EEM HIGHSTAT Phase 1 D08EEO DRUG__ID D08EEO D08EEO DRUGCOMP Biomedica Life Sciences SA D08EEO HIGHSTAT Phase 1 D08FHP DRUG__ID D08FHP D08FHP DRUGCOMP Genentech South San Francisco, CA D08FHP HIGHSTAT Phase 1 D08FIB DRUG__ID D08FIB D08FIB DRUGCOMP Eli Lilly Indianapolis, IN D08FIB HIGHSTAT Phase 1 D08FNJ DRUG__ID D08FNJ D08FNJ DRUGCOMP Laboratorios Farmaceuticos Rovi SA D08FNJ HIGHSTAT Phase 1 D08FXE DRUG__ID D08FXE D08FXE DRUGCOMP Aus Bio Ltd D08FXE HIGHSTAT Phase 1 D08FYH DRUG__ID D08FYH D08FYH DRUGCOMP Pfizer Inc D08FYH HIGHSTAT Phase 1 D08GFN DRUG__ID D08GFN D08GFN DRUGCOMP BN ImmunoTherapeutics D08GFN HIGHSTAT Phase 1 D08GZE DRUG__ID D08GZE D08GZE DRUGCOMP AbGenomics Corp D08GZE HIGHSTAT Phase 1 D08IAQ DRUG__ID D08IAQ D08IAQ DRUGCOMP Arrowhead Research Pasadena, CA D08IAQ HIGHSTAT Phase 1 D08IID DRUG__ID D08IID D08IID DRUGCOMP Novartis Oncology East Hanover, NJ D08IID HIGHSTAT Phase 1 D08IMP DRUG__ID D08IMP D08IMP DRUGCOMP Genzyme D08IMP HIGHSTAT Phase 1 D08JAN DRUG__ID D08JAN D08JAN DRUGCOMP Jiangsu Hengrui Medicine Co Ltd D08JAN HIGHSTAT Phase 1 D08JSQ DRUG__ID D08JSQ D08JSQ DRUGCOMP Daiichi sankyo D08JSQ HIGHSTAT Phase 1 D08JVS DRUG__ID D08JVS D08JVS DRUGCOMP Kirin Brewery Co Ltd D08JVS HIGHSTAT Phase 1 D08JWM DRUG__ID D08JWM D08JWM DRUGCOMP Mayo Clinic D08JWM HIGHSTAT Phase 1 D08JXW DRUG__ID D08JXW D08JXW DRUGCOMP University of Wisconsin-Madison D08JXW HIGHSTAT Phase 1 D08KDU DRUG__ID D08KDU D08KDU DRUGCOMP Pear Tree Pharmaceuticals D08KDU HIGHSTAT Phase 1 D08KNG DRUG__ID D08KNG D08KNG DRUGCOMP University of Strathclyde D08KNG HIGHSTAT Phase 1 D08KSV DRUG__ID D08KSV D08KSV DRUGCOMP Roche/Genentech South San Francisco, CA D08KSV HIGHSTAT Phase 1 D08KYN DRUG__ID D08KYN D08KYN DRUGCOMP Pennsylvania State University D08KYN HIGHSTAT Phase 1 D08KZM DRUG__ID D08KZM D08KZM DRUGCOMP National Cancer Institute D08KZM HIGHSTAT Phase 1 D08LQS DRUG__ID D08LQS D08LQS DRUGCOMP Etubics Seattle, WA NantBioScience Culver City, CA D08LQS HIGHSTAT Phase 1 D08MCI DRUG__ID D08MCI D08MCI DRUGCOMP Liquidia technologies D08MCI HIGHSTAT Phase 1 D08NIN DRUG__ID D08NIN D08NIN DRUGCOMP Novo Nordisk A/S D08NIN HIGHSTAT Phase 1 D08NXP DRUG__ID D08NXP D08NXP DRUGCOMP AbbVie North Chicago, IL D08NXP HIGHSTAT Phase 1 D08OHK DRUG__ID D08OHK D08OHK DRUGCOMP JCR Pharmaceuticals Co Ltd D08OHK HIGHSTAT Phase 1 D08OPX DRUG__ID D08OPX D08OPX DRUGCOMP 4SC AG D08OPX HIGHSTAT Phase 1 D08OVR DRUG__ID D08OVR D08OVR DRUGCOMP Amgen D08OVR HIGHSTAT Phase 1 D08PCR DRUG__ID D08PCR D08PCR DRUGCOMP CellMed AG D08PCR HIGHSTAT Phase 1 D08PIK DRUG__ID D08PIK D08PIK DRUGCOMP GlaxoSmithKline plc D08PIK HIGHSTAT Phase 1 D08PSC DRUG__ID D08PSC D08PSC DRUGCOMP Boehringer ingelheim pharmaceuticals D08PSC HIGHSTAT Phase 1 D08QEF DRUG__ID D08QEF D08QEF DRUGCOMP Kyowa hakko kirin pharma; teva pharmaceutical D08QEF HIGHSTAT Phase 1 D08RKZ DRUG__ID D08RKZ D08RKZ DRUGCOMP Inovio D08RKZ HIGHSTAT Phase 1 D08SAX DRUG__ID D08SAX D08SAX DRUGCOMP Daiichi Sankyo D08SAX HIGHSTAT Phase 1 D08SDI DRUG__ID D08SDI D08SDI DRUGCOMP Curalogic D08SDI HIGHSTAT Phase 1 D08SHE DRUG__ID D08SHE D08SHE DRUGCOMP Sunovion Pharmaceuticals D08SHE HIGHSTAT Phase 1 D08SJY DRUG__ID D08SJY D08SJY DRUGCOMP Mirna therapeutics D08SJY HIGHSTAT Phase 1 D08SXV DRUG__ID D08SXV D08SXV DRUGCOMP Daewoong Pharmaceutical Co Ltd D08SXV HIGHSTAT Phase 1 D08TGG DRUG__ID D08TGG D08TGG DRUGCOMP Transdermal Global D08TGG HIGHSTAT Phase 1 D08TNG DRUG__ID D08TNG D08TNG DRUGCOMP Genentech D08TNG HIGHSTAT Phase 1 D08TRX DRUG__ID D08TRX D08TRX DRUGCOMP Rush University Medical Center D08TRX HIGHSTAT Phase 1 D08TVI DRUG__ID D08TVI D08TVI DRUGCOMP High Point Pharmaceuticals D08TVI HIGHSTAT Phase 1 D08UDG DRUG__ID D08UDG D08UDG DRUGCOMP MedImmune Gaithersburg, MD D08UDG HIGHSTAT Phase 1 D08UUD DRUG__ID D08UUD D08UUD DRUGCOMP Roche Holding AG D08UUD HIGHSTAT Phase 1 D08WAN DRUG__ID D08WAN D08WAN DRUGCOMP H Lundbeck A/S D08WAN HIGHSTAT Phase 1 D08WFH DRUG__ID D08WFH D08WFH DRUGCOMP EuroVacc D08WFH HIGHSTAT Phase 1 D08WHX DRUG__ID D08WHX D08WHX DRUGCOMP Agios pharmaceuticals D08WHX HIGHSTAT Phase 1 D08WLY DRUG__ID D08WLY D08WLY DRUGCOMP MEI Pharma San Diego,CA D08WLY HIGHSTAT Phase 1 D08WUF DRUG__ID D08WUF D08WUF DRUGCOMP PowderMed D08WUF HIGHSTAT Phase 1 D08XDL DRUG__ID D08XDL D08XDL DRUGCOMP Kyowa Kirin Princeton, NJ D08XDL HIGHSTAT Phase 1 D08XFJ DRUG__ID D08XFJ D08XFJ DRUGCOMP Novo Nordisk A/S D08XFJ HIGHSTAT Phase 1 D08XZQ DRUG__ID D08XZQ D08XZQ DRUGCOMP Pfizer Inc D08XZQ HIGHSTAT Phase 1 D08YGY DRUG__ID D08YGY D08YGY DRUGCOMP Insmed Inc D08YGY HIGHSTAT Phase 1 D08YLC DRUG__ID D08YLC D08YLC DRUGCOMP Onconova Therapeutics Newton, MA D08YLC HIGHSTAT Phase 1 D08YTQ DRUG__ID D08YTQ D08YTQ DRUGCOMP VaxInnate Corporation D08YTQ HIGHSTAT Phase 1 D08YWN DRUG__ID D08YWN D08YWN DRUGCOMP Janssen Vaccines and Prevention Leiden, Netherlands D08YWN HIGHSTAT Phase 1 D08YWY DRUG__ID D08YWY D08YWY DRUGCOMP Merck D08YWY HIGHSTAT Phase 1 D08ZCI DRUG__ID D08ZCI D08ZCI DRUGCOMP Alnylam Pharmaceuticals Cambridge, MA D08ZCI HIGHSTAT Phase 1 D08ZJX DRUG__ID D08ZJX D08ZJX DRUGCOMP Eli Lilly Indianapolis, IN D08ZJX HIGHSTAT Phase 1 D08ZOY DRUG__ID D08ZOY D08ZOY DRUGCOMP Daiichi Seiyaku Co Ltd D08ZOY HIGHSTAT Phase 1 D08ZUC DRUG__ID D08ZUC D08ZUC DRUGCOMP Apexigen San Carlos, CA; Toray Tokyo, Japan D08ZUC HIGHSTAT Phase 1 D08ZXM DRUG__ID D08ZXM D08ZXM DRUGCOMP Regado Biosciences D08ZXM HIGHSTAT Phase 1 D09ACC DRUG__ID D09ACC D09ACC DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D09ACC HIGHSTAT Phase 1 D09AIH DRUG__ID D09AIH D09AIH DRUGCOMP Pellficure Pharmaceuticals San Diego, CA D09AIH HIGHSTAT Phase 1 D09AIT DRUG__ID D09AIT D09AIT DRUGCOMP Bayhill therapeutics D09AIT HIGHSTAT Phase 1 D09AJU DRUG__ID D09AJU D09AJU DRUGCOMP Taisho Pharmaceutical D09AJU HIGHSTAT Phase 1 D09APB DRUG__ID D09APB D09APB DRUGCOMP Idenix D09APB HIGHSTAT Phase 1 D09ATR DRUG__ID D09ATR D09ATR DRUGCOMP Pfizer New York, NY D09ATR HIGHSTAT Phase 1 D09BEJ DRUG__ID D09BEJ D09BEJ DRUGCOMP Aquestive Therapeutics Warren, NJ D09BEJ HIGHSTAT Phase 1 D09BJH DRUG__ID D09BJH D09BJH DRUGCOMP Case Western Reserve University D09BJH HIGHSTAT Phase 1 D09BNR DRUG__ID D09BNR D09BNR DRUGCOMP GenentechSouth San Francisco, CA D09BNR HIGHSTAT Phase 1 D09BQO DRUG__ID D09BQO D09BQO DRUGCOMP Antares D09BQO HIGHSTAT Phase 1 D09CEY DRUG__ID D09CEY D09CEY DRUGCOMP SK Life Science D09CEY HIGHSTAT Phase 1 D09EPU DRUG__ID D09EPU D09EPU DRUGCOMP Bayer AG D09EPU HIGHSTAT Phase 1 D09FDN DRUG__ID D09FDN D09FDN DRUGCOMP Immatics US Houston, TX D09FDN HIGHSTAT Phase 1 D09FHY DRUG__ID D09FHY D09FHY DRUGCOMP BN ImmunoTherapeutics D09FHY HIGHSTAT Phase 1 D09FOP DRUG__ID D09FOP D09FOP DRUGCOMP Mt Cook Pharma D09FOP HIGHSTAT Phase 1 D09GLS DRUG__ID D09GLS D09GLS DRUGCOMP GSK D09GLS HIGHSTAT Phase 1 D09HUU DRUG__ID D09HUU D09HUU DRUGCOMP Endocyte D09HUU HIGHSTAT Phase 1 D09IMN DRUG__ID D09IMN D09IMN DRUGCOMP Sanofi D09IMN HIGHSTAT Phase 1 D09INX DRUG__ID D09INX D09INX DRUGCOMP Sumitomo Dainippon Pharma D09INX HIGHSTAT Phase 1 D09ISS DRUG__ID D09ISS D09ISS DRUGCOMP Zengen Inc D09ISS HIGHSTAT Phase 1 D09JCH DRUG__ID D09JCH D09JCH DRUGCOMP Colby Pharmaceuticals D09JCH HIGHSTAT Phase 1 D09JMW DRUG__ID D09JMW D09JMW DRUGCOMP Profectus Biosciences Baltimore, MD D09JMW HIGHSTAT Phase 1 D09KEW DRUG__ID D09KEW D09KEW DRUGCOMP Kiniksa Pharmaceuticals Lexington, MA D09KEW HIGHSTAT Phase 1 D09KIG DRUG__ID D09KIG D09KIG DRUGCOMP ETX Pharma, Maryland D09KIG HIGHSTAT Phase 1 D09KRU DRUG__ID D09KRU D09KRU DRUGCOMP Boehringer Ingelheim Pharmaceuticals D09KRU HIGHSTAT Phase 1 D09KWX DRUG__ID D09KWX D09KWX DRUGCOMP Iconic therapeutics D09KWX HIGHSTAT Phase 1 D09KYZ DRUG__ID D09KYZ D09KYZ DRUGCOMP Vernalis D09KYZ HIGHSTAT Phase 1 D09LSY DRUG__ID D09LSY D09LSY DRUGCOMP Enanta Pharmaceuticals Inc D09LSY HIGHSTAT Phase 1 D09LVD DRUG__ID D09LVD D09LVD DRUGCOMP ISIS pharmaceuticals D09LVD HIGHSTAT Phase 1 D09MEV DRUG__ID D09MEV D09MEV DRUGCOMP Seoul University D09MEV HIGHSTAT Phase 1 D09MJH DRUG__ID D09MJH D09MJH DRUGCOMP Seattle Genetics Bothell, WA D09MJH HIGHSTAT Phase 1 D09MJJ DRUG__ID D09MJJ D09MJJ DRUGCOMP Rhizen PharmaceuticalsLa Chaux-de-Fonds, Switzerland D09MJJ HIGHSTAT Phase 1 D09MKL DRUG__ID D09MKL D09MKL DRUGCOMP Theravance D09MKL HIGHSTAT Phase 1 D09MPD DRUG__ID D09MPD D09MPD DRUGCOMP Bristol-myers squibb D09MPD HIGHSTAT Phase 1 D09MSE DRUG__ID D09MSE D09MSE DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D09MSE HIGHSTAT Phase 1 D09NQX DRUG__ID D09NQX D09NQX DRUGCOMP Hawaii Biotech D09NQX HIGHSTAT Phase 1 D09NVR DRUG__ID D09NVR D09NVR DRUGCOMP Principia Biopharma South San Francisco, CA Sanofi Bridgewater, NJ D09NVR HIGHSTAT Phase 1 D09NVU DRUG__ID D09NVU D09NVU DRUGCOMP Zealand Pharma A/S D09NVU HIGHSTAT Phase 1 D09OMK DRUG__ID D09OMK D09OMK DRUGCOMP Peregrine Pharmaceuticals D09OMK HIGHSTAT Phase 1 D09ONL DRUG__ID D09ONL D09ONL DRUGCOMP Immune DesignSeattle, WASanofiBridgewater, NJ D09ONL HIGHSTAT Phase 1 D09PFR DRUG__ID D09PFR D09PFR DRUGCOMP University of Modena; Reggio Emilia D09PFR HIGHSTAT Phase 1 D09PJB DRUG__ID D09PJB D09PJB DRUGCOMP ArGentis Pharmaceuticals D09PJB HIGHSTAT Phase 1 D09PSY DRUG__ID D09PSY D09PSY DRUGCOMP Amygdala Neurosciences Palo Alto, CA D09PSY HIGHSTAT Phase 1 D09PTD DRUG__ID D09PTD D09PTD DRUGCOMP Bristol-Myers Squibb Princeton, NJ D09PTD HIGHSTAT Phase 1 D09QHP DRUG__ID D09QHP D09QHP DRUGCOMP Pharmacopeia Inc D09QHP HIGHSTAT Phase 1 D09QRI DRUG__ID D09QRI D09QRI DRUGCOMP Nephrx D09QRI HIGHSTAT Phase 1 D09QSC DRUG__ID D09QSC D09QSC DRUGCOMP Progenics Pharmaceuticals D09QSC HIGHSTAT Phase 1 D09QWD DRUG__ID D09QWD D09QWD DRUGCOMP EvoGenix Pty Ltd D09QWD HIGHSTAT Phase 1 D09RLQ DRUG__ID D09RLQ D09RLQ DRUGCOMP Celldex Therapeutics D09RLQ HIGHSTAT Phase 1 D09RTK DRUG__ID D09RTK D09RTK DRUGCOMP Vion Pharmaceuticals D09RTK HIGHSTAT Phase 1 D09RUO DRUG__ID D09RUO D09RUO DRUGCOMP Seattle Genetics Bothell, WA D09RUO HIGHSTAT Phase 1 D09RZH DRUG__ID D09RZH D09RZH DRUGCOMP Baylor College of Medicine D09RZH HIGHSTAT Phase 1 D09SGL DRUG__ID D09SGL D09SGL DRUGCOMP Placon Therapeutics Cambridge, MA D09SGL HIGHSTAT Phase 1 D09SHL DRUG__ID D09SHL D09SHL DRUGCOMP Nabi Biopharmaceuticals D09SHL HIGHSTAT Phase 1 D09SYB DRUG__ID D09SYB D09SYB DRUGCOMP University of Maryland D09SYB HIGHSTAT Phase 1 D09SZY DRUG__ID D09SZY D09SZY DRUGCOMP IQ Therapeutics BV D09SZY HIGHSTAT Phase 1 D09TGD DRUG__ID D09TGD D09TGD DRUGCOMP Kuros Biosurgery AG D09TGD HIGHSTAT Phase 1 D09TGT DRUG__ID D09TGT D09TGT DRUGCOMP Silence Therapeutics AG D09TGT HIGHSTAT Phase 1 D09TOL DRUG__ID D09TOL D09TOL DRUGCOMP Roche D09TOL HIGHSTAT Phase 1 D09UKH DRUG__ID D09UKH D09UKH DRUGCOMP Exelixis; Daiichi-Sankyo D09UKH HIGHSTAT Phase 1 D09UMR DRUG__ID D09UMR D09UMR DRUGCOMP Ultimovacs Oslo, Norway D09UMR HIGHSTAT Phase 1 D09VAD DRUG__ID D09VAD D09VAD DRUGCOMP Eli Lilly Indianapolis, IN D09VAD HIGHSTAT Phase 1 D09VIX DRUG__ID D09VIX D09VIX DRUGCOMP National Institute of Allergy and Infectious Diseases Rockville, MD; Xencor Monrovia, CA D09VIX HIGHSTAT Phase 1 D09WIR DRUG__ID D09WIR D09WIR DRUGCOMP Celgene Summit, NJ D09WIR HIGHSTAT Phase 1 D09WSR DRUG__ID D09WSR D09WSR DRUGCOMP Novartis Oncology East Hanover, NJ D09WSR HIGHSTAT Phase 1 D09WYE DRUG__ID D09WYE D09WYE DRUGCOMP DURECT Corp D09WYE HIGHSTAT Phase 1 D09WZU DRUG__ID D09WZU D09WZU DRUGCOMP BrainCells D09WZU HIGHSTAT Phase 1 D09XKO DRUG__ID D09XKO D09XKO DRUGCOMP Kwang Dong Pharmaceutical Co Ltd D09XKO HIGHSTAT Phase 1 D09YPJ DRUG__ID D09YPJ D09YPJ DRUGCOMP Samumed San Diego, CA D09YPJ HIGHSTAT Phase 1 D09YXT DRUG__ID D09YXT D09YXT DRUGCOMP Eli Lilly Indianapolis, IN D09YXT HIGHSTAT Phase 1 D09ZFJ DRUG__ID D09ZFJ D09ZFJ DRUGCOMP Amgen Thousand Oaks, CA D09ZFJ HIGHSTAT Phase 1 D09ZRB DRUG__ID D09ZRB D09ZRB DRUGCOMP Pulmatrix D09ZRB HIGHSTAT Phase 1 D09ZZB DRUG__ID D09ZZB D09ZZB DRUGCOMP National Health Research Institutes D09ZZB HIGHSTAT Phase 1 D0A0FB DRUG__ID D0A0FB D0A0FB DRUGCOMP Zydus Cadila Group D0A0FB HIGHSTAT Phase 1 D0A0TS DRUG__ID D0A0TS D0A0TS DRUGCOMP Profectus Biosciences Baltimore, MD D0A0TS HIGHSTAT Phase 1 D0A0UU DRUG__ID D0A0UU D0A0UU DRUGCOMP GenentechSouth San Francisco, CA D0A0UU HIGHSTAT Phase 1 D0A0ZW DRUG__ID D0A0ZW D0A0ZW DRUGCOMP Arrien Pharmaceuticals Salt Lake City, UT Boston Pharmaceuticals Cambridge, MA D0A0ZW HIGHSTAT Phase 1 D0A1FB DRUG__ID D0A1FB D0A1FB DRUGCOMP PharmAthene D0A1FB HIGHSTAT Phase 1 D0A1GR DRUG__ID D0A1GR D0A1GR DRUGCOMP Calando pharmaceuticals D0A1GR HIGHSTAT Phase 1 D0A1PS DRUG__ID D0A1PS D0A1PS DRUGCOMP Protalix biotherapeutics D0A1PS HIGHSTAT Phase 1 D0A1WS DRUG__ID D0A1WS D0A1WS DRUGCOMP AbbVieNorth Chicago, IL D0A1WS HIGHSTAT Phase 1 D0A1XU DRUG__ID D0A1XU D0A1XU DRUGCOMP EnVivo Pharmaceuticals Inc D0A1XU HIGHSTAT Phase 1 D0A1YF DRUG__ID D0A1YF D0A1YF DRUGCOMP AbbVie D0A1YF HIGHSTAT Phase 1 D0A2PA DRUG__ID D0A2PA D0A2PA DRUGCOMP ImmunoFrontier Tokyo, Japan D0A2PA HIGHSTAT Phase 1 D0A3CF DRUG__ID D0A3CF D0A3CF DRUGCOMP Merck Kenilworth, NJ D0A3CF HIGHSTAT Phase 1 D0A3MJ DRUG__ID D0A3MJ D0A3MJ DRUGCOMP Xenon D0A3MJ HIGHSTAT Phase 1 D0A4UW DRUG__ID D0A4UW D0A4UW DRUGCOMP Bayer AG D0A4UW HIGHSTAT Phase 1 D0A4VJ DRUG__ID D0A4VJ D0A4VJ DRUGCOMP EUSA Pharma D0A4VJ HIGHSTAT Phase 1 D0A5WQ DRUG__ID D0A5WQ D0A5WQ DRUGCOMP Myelin Repair Foundation Saratoga, CANational Institute of Neurological Disorders and StrokeBethesda, MD D0A5WQ HIGHSTAT Phase 1 D0A7GI DRUG__ID D0A7GI D0A7GI DRUGCOMP INSERM D0A7GI HIGHSTAT Phase 1 D0A8HN DRUG__ID D0A8HN D0A8HN DRUGCOMP GlaxoSmithKline D0A8HN HIGHSTAT Phase 1 D0A8NW DRUG__ID D0A8NW D0A8NW DRUGCOMP Population Council D0A8NW HIGHSTAT Phase 1 D0A8WR DRUG__ID D0A8WR D0A8WR DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D0A8WR HIGHSTAT Phase 1 D0A9BU DRUG__ID D0A9BU D0A9BU DRUGCOMP Celtic Biotech Ltd D0A9BU HIGHSTAT Phase 1 D0A9GE DRUG__ID D0A9GE D0A9GE DRUGCOMP Fate Therapeutics La Jolla, CA D0A9GE HIGHSTAT Phase 1 D0A9PD DRUG__ID D0A9PD D0A9PD DRUGCOMP Lundbeck Deerfield, IL Otsuka Pharmaceutical Tokyo, Japan D0A9PD HIGHSTAT Phase 1 D0A9PR DRUG__ID D0A9PR D0A9PR DRUGCOMP Janssen Vaccines and Prevention Leiden, Netherlands D0A9PR HIGHSTAT Phase 1 D0AA5K DRUG__ID D0AA5K D0AA5K DRUGCOMP Alpha Cancer Technologies Toronto, Canada D0AA5K HIGHSTAT Phase 1 D0AC8L DRUG__ID D0AC8L D0AC8L DRUGCOMP Eleven Biotherapeutics Cambridge, MA D0AC8L HIGHSTAT Phase 1 D0AD0B DRUG__ID D0AD0B D0AD0B DRUGCOMP PaxVax Redwood City, CA D0AD0B HIGHSTAT Phase 1 D0AD3V DRUG__ID D0AD3V D0AD3V DRUGCOMP PfizerNew York, NY StemcentrxSouth San Francisco, CA D0AD3V HIGHSTAT Phase 1 D0AE1X DRUG__ID D0AE1X D0AE1X DRUGCOMP Parion Sciences Inc D0AE1X HIGHSTAT Phase 1 D0AI8V DRUG__ID D0AI8V D0AI8V DRUGCOMP Sunovion Pharmaceuticals Marlborough, MA D0AI8V HIGHSTAT Phase 1 D0AO0K DRUG__ID D0AO0K D0AO0K DRUGCOMP Janssen biotech; morphosys D0AO0K HIGHSTAT Phase 1 D0AP7A DRUG__ID D0AP7A D0AP7A DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0AP7A HIGHSTAT Phase 1 D0AR5N DRUG__ID D0AR5N D0AR5N DRUGCOMP Bristol-Myers Squibb D0AR5N HIGHSTAT Phase 1 D0AR7L DRUG__ID D0AR7L D0AR7L DRUGCOMP Sanofi D0AR7L HIGHSTAT Phase 1 D0AY8D DRUG__ID D0AY8D D0AY8D DRUGCOMP Nobilis Therapeutics Portland, OR D0AY8D HIGHSTAT Phase 1 D0AZ3Y DRUG__ID D0AZ3Y D0AZ3Y DRUGCOMP Chemokine Therapeutics D0AZ3Y HIGHSTAT Phase 1 D0AZ4S DRUG__ID D0AZ4S D0AZ4S DRUGCOMP Vigeo Therapeutics Cambridge, MA D0AZ4S HIGHSTAT Phase 1 D0B0OA DRUG__ID D0B0OA D0B0OA DRUGCOMP LEO Pharma A/S D0B0OA HIGHSTAT Phase 1 D0B2HF DRUG__ID D0B2HF D0B2HF DRUGCOMP Novo Nordisk D0B2HF HIGHSTAT Phase 1 D0B3DV DRUG__ID D0B3DV D0B3DV DRUGCOMP Kite Pharma Santa Monica, CA D0B3DV HIGHSTAT Phase 1 D0B3HP DRUG__ID D0B3HP D0B3HP DRUGCOMP SGC Pharma D0B3HP HIGHSTAT Phase 1 D0B4DL DRUG__ID D0B4DL D0B4DL DRUGCOMP Cerus D0B4DL HIGHSTAT Phase 1 D0B5PK DRUG__ID D0B5PK D0B5PK DRUGCOMP Tensha Therapeutics D0B5PK HIGHSTAT Phase 1 D0B5TM DRUG__ID D0B5TM D0B5TM DRUGCOMP Amplimmune Inc D0B5TM HIGHSTAT Phase 1 D0B6LP DRUG__ID D0B6LP D0B6LP DRUGCOMP Tengion D0B6LP HIGHSTAT Phase 1 D0B7TM DRUG__ID D0B7TM D0B7TM DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0B7TM HIGHSTAT Phase 1 D0B8BY DRUG__ID D0B8BY D0B8BY DRUGCOMP NewLink Genetics Ames, IA D0B8BY HIGHSTAT Phase 1 D0B8ZJ DRUG__ID D0B8ZJ D0B8ZJ DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D0B8ZJ HIGHSTAT Phase 1 D0B9DI DRUG__ID D0B9DI D0B9DI DRUGCOMP H Lundbeck A/S D0B9DI HIGHSTAT Phase 1 D0B9NU DRUG__ID D0B9NU D0B9NU DRUGCOMP Vical Inc D0B9NU HIGHSTAT Phase 1 D0BA5E DRUG__ID D0BA5E D0BA5E DRUGCOMP Cadila Healthcare Gujarat, India D0BA5E HIGHSTAT Phase 1 D0BB2V DRUG__ID D0BB2V D0BB2V DRUGCOMP AbbVieNorth Chicago, IL D0BB2V HIGHSTAT Phase 1 D0BI7J DRUG__ID D0BI7J D0BI7J DRUGCOMP Foresee Pharmaceuticals Newark, DE D0BI7J HIGHSTAT Phase 1 D0BJ8Q DRUG__ID D0BJ8Q D0BJ8Q DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0BJ8Q HIGHSTAT Phase 1 D0BK7D DRUG__ID D0BK7D D0BK7D DRUGCOMP Teikyo University D0BK7D HIGHSTAT Phase 1 D0BN9R DRUG__ID D0BN9R D0BN9R DRUGCOMP Nanotherapeutics D0BN9R HIGHSTAT Phase 1 D0BR1S DRUG__ID D0BR1S D0BR1S DRUGCOMP OncBioMune Pharmaceuticals Baton Rouge, LA D0BR1S HIGHSTAT Phase 1 D0BS2S DRUG__ID D0BS2S D0BS2S DRUGCOMP Teikoku Pharma USA San Jose, CA D0BS2S HIGHSTAT Phase 1 D0BW2N DRUG__ID D0BW2N D0BW2N DRUGCOMP Sanofi D0BW2N HIGHSTAT Phase 1 D0BY6W DRUG__ID D0BY6W D0BY6W DRUGCOMP Progenics Pharmaceuticals D0BY6W HIGHSTAT Phase 1 D0BZ1D DRUG__ID D0BZ1D D0BZ1D DRUGCOMP Curegenix Burlingame, CA D0BZ1D HIGHSTAT Phase 1 D0C0QT DRUG__ID D0C0QT D0C0QT DRUGCOMP Presidio D0C0QT HIGHSTAT Phase 1 D0C0SX DRUG__ID D0C0SX D0C0SX DRUGCOMP Merck D0C0SX HIGHSTAT Phase 1 D0C0TV DRUG__ID D0C0TV D0C0TV DRUGCOMP StemImmune San Diego, CA D0C0TV HIGHSTAT Phase 1 D0C1IG DRUG__ID D0C1IG D0C1IG DRUGCOMP Curis (Genentech) D0C1IG HIGHSTAT Phase 1 D0C2HG DRUG__ID D0C2HG D0C2HG DRUGCOMP Nycomed D0C2HG HIGHSTAT Phase 1 D0C3AA DRUG__ID D0C3AA D0C3AA DRUGCOMP Chong Kun Dang Pharmaceutical Corp D0C3AA HIGHSTAT Phase 1 D0C4FS DRUG__ID D0C4FS D0C4FS DRUGCOMP Akashi Therapeutics Cambridge, MA D0C4FS HIGHSTAT Phase 1 D0C4PB DRUG__ID D0C4PB D0C4PB DRUGCOMP Eli Lilly Indianapolis, IN D0C4PB HIGHSTAT Phase 1 D0C5FA DRUG__ID D0C5FA D0C5FA DRUGCOMP Janssen Research & Development Raritan, NJ D0C5FA HIGHSTAT Phase 1 D0C5IZ DRUG__ID D0C5IZ D0C5IZ DRUGCOMP Vical Inc D0C5IZ HIGHSTAT Phase 1 D0C5LJ DRUG__ID D0C5LJ D0C5LJ DRUGCOMP Alligator Bioscience AB D0C5LJ HIGHSTAT Phase 1 D0C6DX DRUG__ID D0C6DX D0C6DX DRUGCOMP BioCardia San Carlos, CA D0C6DX HIGHSTAT Phase 1 D0C6RR DRUG__ID D0C6RR D0C6RR DRUGCOMP Unum Therapeutics Cambridge, MA D0C6RR HIGHSTAT Phase 1 D0C6YQ DRUG__ID D0C6YQ D0C6YQ DRUGCOMP Novartis Oncology East Hanover, NJ D0C6YQ HIGHSTAT Phase 1 D0C7OT DRUG__ID D0C7OT D0C7OT DRUGCOMP St Georges University of London D0C7OT HIGHSTAT Phase 1 D0C8JW DRUG__ID D0C8JW D0C8JW DRUGCOMP Asklepios BioPharmaceutical D0C8JW HIGHSTAT Phase 1 D0C8KY DRUG__ID D0C8KY D0C8KY DRUGCOMP Synta Pharma D0C8KY HIGHSTAT Phase 1 D0C9KX DRUG__ID D0C9KX D0C9KX DRUGCOMP GenomIdea Inc D0C9KX HIGHSTAT Phase 1 D0C9TH DRUG__ID D0C9TH D0C9TH DRUGCOMP Cytomedix D0C9TH HIGHSTAT Phase 1 D0C9WN DRUG__ID D0C9WN D0C9WN DRUGCOMP CTL Immunotherapies Corp D0C9WN HIGHSTAT Phase 1 D0CB6N DRUG__ID D0CB6N D0CB6N DRUGCOMP Genphar D0CB6N HIGHSTAT Phase 1 D0CH4T DRUG__ID D0CH4T D0CH4T DRUGCOMP Axon Biochemicals BV D0CH4T HIGHSTAT Phase 1 D0CJ3R DRUG__ID D0CJ3R D0CJ3R DRUGCOMP EMD Serono Rockland, MA D0CJ3R HIGHSTAT Phase 1 D0CL5D DRUG__ID D0CL5D D0CL5D DRUGCOMP Stallergenes D0CL5D HIGHSTAT Phase 1 D0CM3Z DRUG__ID D0CM3Z D0CM3Z DRUGCOMP Aton Pharma Inc D0CM3Z HIGHSTAT Phase 1 D0CN8U DRUG__ID D0CN8U D0CN8U DRUGCOMP Pfizer New York, NY D0CN8U HIGHSTAT Phase 1 D0CQ2P DRUG__ID D0CQ2P D0CQ2P DRUGCOMP Starpharma D0CQ2P HIGHSTAT Phase 1 D0CQ5A DRUG__ID D0CQ5A D0CQ5A DRUGCOMP SK Biopharmaceuticals Fair Lawn, NJ D0CQ5A HIGHSTAT Phase 1 D0CR4Z DRUG__ID D0CR4Z D0CR4Z DRUGCOMP Infinity Pharmaceuticals Inc D0CR4Z HIGHSTAT Phase 1 D0CT1S DRUG__ID D0CT1S D0CT1S DRUGCOMP National Institutes of Health D0CT1S HIGHSTAT Phase 1 D0CU2Q DRUG__ID D0CU2Q D0CU2Q DRUGCOMP Genentech South San Francisco, CA D0CU2Q HIGHSTAT Phase 1 D0CY2Q DRUG__ID D0CY2Q D0CY2Q DRUGCOMP Immune Response BioPharma Atlantic City, NJ D0CY2Q HIGHSTAT Phase 1 D0D0GH DRUG__ID D0D0GH D0D0GH DRUGCOMP NsGene A/S D0D0GH HIGHSTAT Phase 1 D0D0KZ DRUG__ID D0D0KZ D0D0KZ DRUGCOMP Allachem D0D0KZ HIGHSTAT Phase 1 D0D0OR DRUG__ID D0D0OR D0D0OR DRUGCOMP Merck D0D0OR HIGHSTAT Phase 1 D0D0WH DRUG__ID D0D0WH D0D0WH DRUGCOMP Bristol-Myers Squib Princeton, NJ D0D0WH HIGHSTAT Phase 1 D0D1XW DRUG__ID D0D1XW D0D1XW DRUGCOMP ZymoGenetics D0D1XW HIGHSTAT Phase 1 D0D2XQ DRUG__ID D0D2XQ D0D2XQ DRUGCOMP Asana BioSciences Lawrenceville, NJ D0D2XQ HIGHSTAT Phase 1 D0D2YZ DRUG__ID D0D2YZ D0D2YZ DRUGCOMP MD Anderson Cancer Center D0D2YZ HIGHSTAT Phase 1 D0D3UI DRUG__ID D0D3UI D0D3UI DRUGCOMP Zydus Cadila Group D0D3UI HIGHSTAT Phase 1 D0D3UQ DRUG__ID D0D3UQ D0D3UQ DRUGCOMP University of Alabama at Birmingham D0D3UQ HIGHSTAT Phase 1 D0D4HO DRUG__ID D0D4HO D0D4HO DRUGCOMP GliaCure Boston, MA D0D4HO HIGHSTAT Phase 1 D0D5BJ DRUG__ID D0D5BJ D0D5BJ DRUGCOMP Bellicum pharmaceuticals D0D5BJ HIGHSTAT Phase 1 D0D5EJ DRUG__ID D0D5EJ D0D5EJ DRUGCOMP Biodel D0D5EJ HIGHSTAT Phase 1 D0D6BT DRUG__ID D0D6BT D0D6BT DRUGCOMP Unigene Laboratories D0D6BT HIGHSTAT Phase 1 D0D6OO DRUG__ID D0D6OO D0D6OO DRUGCOMP Napo Pharmaceuticals D0D6OO HIGHSTAT Phase 1 D0D7XM DRUG__ID D0D7XM D0D7XM DRUGCOMP Nanocarrier D0D7XM HIGHSTAT Phase 1 D0D8MG DRUG__ID D0D8MG D0D8MG DRUGCOMP NOXXON Pharma AG D0D8MG HIGHSTAT Phase 1 D0D9AL DRUG__ID D0D9AL D0D9AL DRUGCOMP ATON Pharma D0D9AL HIGHSTAT Phase 1 D0DA4B DRUG__ID D0DA4B D0DA4B DRUGCOMP Kite Pharma Santa Monica, CA D0DA4B HIGHSTAT Phase 1 D0DA6X DRUG__ID D0DA6X D0DA6X DRUGCOMP Janssen research & development D0DA6X HIGHSTAT Phase 1 D0DC0S DRUG__ID D0DC0S D0DC0S DRUGCOMP Octapharma usa D0DC0S HIGHSTAT Phase 1 D0DC8J DRUG__ID D0DC8J D0DC8J DRUGCOMP CytImmune sciences INC D0DC8J HIGHSTAT Phase 1 D0DD4N DRUG__ID D0DD4N D0DD4N DRUGCOMP Ge healthcare D0DD4N HIGHSTAT Phase 1 D0DJ0S DRUG__ID D0DJ0S D0DJ0S DRUGCOMP NGM Biopharmaceuticals South San Francisco, CA D0DJ0S HIGHSTAT Phase 1 D0DN7Y DRUG__ID D0DN7Y D0DN7Y DRUGCOMP Serina Therapeutics Huntsville, AL D0DN7Y HIGHSTAT Phase 1 D0DO5J DRUG__ID D0DO5J D0DO5J DRUGCOMP BioNumerik Pharmaceuticals D0DO5J HIGHSTAT Phase 1 D0DP1O DRUG__ID D0DP1O D0DP1O DRUGCOMP Avicena Group Inc D0DP1O HIGHSTAT Phase 1 D0DR3T DRUG__ID D0DR3T D0DR3T DRUGCOMP Mount Sinai School of Medicine D0DR3T HIGHSTAT Phase 1 D0DR4O DRUG__ID D0DR4O D0DR4O DRUGCOMP Surface Oncology Cambridge, MA D0DR4O HIGHSTAT Phase 1 D0DS3J DRUG__ID D0DS3J D0DS3J DRUGCOMP Savant HWP San Carlos, CA D0DS3J HIGHSTAT Phase 1 D0DT2S DRUG__ID D0DT2S D0DT2S DRUGCOMP Takeda Oncology Deerfield, IL D0DT2S HIGHSTAT Phase 1 D0DT5H DRUG__ID D0DT5H D0DT5H DRUGCOMP AstraZeneca Wilmington, DEIonis Pharmaceuticals Carlsbad, CA D0DT5H HIGHSTAT Phase 1 D0DT8Y DRUG__ID D0DT8Y D0DT8Y DRUGCOMP AstraZeneca D0DT8Y HIGHSTAT Phase 1 D0DV4F DRUG__ID D0DV4F D0DV4F DRUGCOMP F Hoffmann-La Roche Ltd D0DV4F HIGHSTAT Phase 1 D0DX0G DRUG__ID D0DX0G D0DX0G DRUGCOMP NewLink Genetics Ames, IA D0DX0G HIGHSTAT Phase 1 D0E0BE DRUG__ID D0E0BE D0E0BE DRUGCOMP Sabin Vaccine Institute Washington, DC D0E0BE HIGHSTAT Phase 1 D0E0NL DRUG__ID D0E0NL D0E0NL DRUGCOMP Tolerx D0E0NL HIGHSTAT Phase 1 D0E0WU DRUG__ID D0E0WU D0E0WU DRUGCOMP TRIN Pharma GmbH D0E0WU HIGHSTAT Phase 1 D0E1AN DRUG__ID D0E1AN D0E1AN DRUGCOMP Genentech Inc D0E1AN HIGHSTAT Phase 1 D0E1HF DRUG__ID D0E1HF D0E1HF DRUGCOMP Faustus Forschungs Cie Translational Cancer Research GmbH D0E1HF HIGHSTAT Phase 1 D0E2AJ DRUG__ID D0E2AJ D0E2AJ DRUGCOMP University of Lausanne D0E2AJ HIGHSTAT Phase 1 D0E2HS DRUG__ID D0E2HS D0E2HS DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D0E2HS HIGHSTAT Phase 1 D0E2NQ DRUG__ID D0E2NQ D0E2NQ DRUGCOMP Eli Lilly D0E2NQ HIGHSTAT Phase 1 D0E2QG DRUG__ID D0E2QG D0E2QG DRUGCOMP NanoCarrier Chiba, Japan D0E2QG HIGHSTAT Phase 1 D0E2TH DRUG__ID D0E2TH D0E2TH DRUGCOMP Alphavax D0E2TH HIGHSTAT Phase 1 D0E2ZA DRUG__ID D0E2ZA D0E2ZA DRUGCOMP Antalium Inc D0E2ZA HIGHSTAT Phase 1 D0E3CX DRUG__ID D0E3CX D0E3CX DRUGCOMP M3 Biotechnology Seattle, WA D0E3CX HIGHSTAT Phase 1 D0E4GE DRUG__ID D0E4GE D0E4GE DRUGCOMP AstraZeneca plc D0E4GE HIGHSTAT Phase 1 D0E4MB DRUG__ID D0E4MB D0E4MB DRUGCOMP GenentechSouth San Francisco, CA D0E4MB HIGHSTAT Phase 1 D0E4MT DRUG__ID D0E4MT D0E4MT DRUGCOMP Novartis vaccines D0E4MT HIGHSTAT Phase 1 D0E4SX DRUG__ID D0E4SX D0E4SX DRUGCOMP Viropharma D0E4SX HIGHSTAT Phase 1 D0E4YR DRUG__ID D0E4YR D0E4YR DRUGCOMP Inovio pharmaceuticals D0E4YR HIGHSTAT Phase 1 D0E6KN DRUG__ID D0E6KN D0E6KN DRUGCOMP GlaxoSmithKline D0E6KN HIGHSTAT Phase 1 D0E6NH DRUG__ID D0E6NH D0E6NH DRUGCOMP AstraZeneca; MedImmune D0E6NH HIGHSTAT Phase 1 D0E6RX DRUG__ID D0E6RX D0E6RX DRUGCOMP Aradigm D0E6RX HIGHSTAT Phase 1 D0E6VF DRUG__ID D0E6VF D0E6VF DRUGCOMP VaxInnate D0E6VF HIGHSTAT Phase 1 D0E7AS DRUG__ID D0E7AS D0E7AS DRUGCOMP Daiichi Suntory Biomedical Research Co Ltd D0E7AS HIGHSTAT Phase 1 D0E7BY DRUG__ID D0E7BY D0E7BY DRUGCOMP Gradalis Carrollton, TX D0E7BY HIGHSTAT Phase 1 D0E7DH DRUG__ID D0E7DH D0E7DH DRUGCOMP Chiron; Shire Pharmaceuticals D0E7DH HIGHSTAT Phase 1 D0E7FC DRUG__ID D0E7FC D0E7FC DRUGCOMP Sutro Biopharma South San Francisco, CA D0E7FC HIGHSTAT Phase 1 D0E8AE DRUG__ID D0E8AE D0E8AE DRUGCOMP Elixir Medical D0E8AE HIGHSTAT Phase 1 D0E8TK DRUG__ID D0E8TK D0E8TK DRUGCOMP Supernus Pharmaceuticals D0E8TK HIGHSTAT Phase 1 D0E9ME DRUG__ID D0E9ME D0E9ME DRUGCOMP MedImmune Gaithersburg, MD D0E9ME HIGHSTAT Phase 1 D0E9XP DRUG__ID D0E9XP D0E9XP DRUGCOMP Novavax D0E9XP HIGHSTAT Phase 1 D0EF9Y DRUG__ID D0EF9Y D0EF9Y DRUGCOMP Vyriad Rochester, NY D0EF9Y HIGHSTAT Phase 1 D0EG5P DRUG__ID D0EG5P D0EG5P DRUGCOMP Isconova AB D0EG5P HIGHSTAT Phase 1 D0EH0C DRUG__ID D0EH0C D0EH0C DRUGCOMP Avera Pharmaceuticals Inc D0EH0C HIGHSTAT Phase 1 D0EI2V DRUG__ID D0EI2V D0EI2V DRUGCOMP San Diego, CA D0EI2V HIGHSTAT Phase 1 D0EJ8K DRUG__ID D0EJ8K D0EJ8K DRUGCOMP Glaxosmithkline D0EJ8K HIGHSTAT Phase 1 D0EL0F DRUG__ID D0EL0F D0EL0F DRUGCOMP Sanofi pasteur; glaxosmithkline; walter reed army institute of research; naval medical research center; army medical research and materiel command D0EL0F HIGHSTAT Phase 1 D0EM6S DRUG__ID D0EM6S D0EM6S DRUGCOMP GenPhar; Crucell; Vaccine Research Center (NIAID) D0EM6S HIGHSTAT Phase 1 D0EY1Y DRUG__ID D0EY1Y D0EY1Y DRUGCOMP Aduro BioTech, Berkeley, CA D0EY1Y HIGHSTAT Phase 1 D0F0NB DRUG__ID D0F0NB D0F0NB DRUGCOMP Biodel D0F0NB HIGHSTAT Phase 1 D0F1JY DRUG__ID D0F1JY D0F1JY DRUGCOMP Almirall Prodesfarma SA D0F1JY HIGHSTAT Phase 1 D0F2IM DRUG__ID D0F2IM D0F2IM DRUGCOMP MedImmune D0F2IM HIGHSTAT Phase 1 D0F2NF DRUG__ID D0F2NF D0F2NF DRUGCOMP GlaxoSmithKline plc D0F2NF HIGHSTAT Phase 1 D0F2NG DRUG__ID D0F2NG D0F2NG DRUGCOMP GlaxoSmithKline D0F2NG HIGHSTAT Phase 1 D0F3FV DRUG__ID D0F3FV D0F3FV DRUGCOMP Moderna Therapeutics Cambridge, MA D0F3FV HIGHSTAT Phase 1 D0F3VW DRUG__ID D0F3VW D0F3VW DRUGCOMP United Therapeutics Hauppauge, NY D0F3VW HIGHSTAT Phase 1 D0F3ZG DRUG__ID D0F3ZG D0F3ZG DRUGCOMP Scantibodies Laboratory; biogen Idec D0F3ZG HIGHSTAT Phase 1 D0F4NN DRUG__ID D0F4NN D0F4NN DRUGCOMP Oncos Therapeutics Ltd D0F4NN HIGHSTAT Phase 1 D0F4NP DRUG__ID D0F4NP D0F4NP DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development D0F4NP HIGHSTAT Phase 1 D0F4NW DRUG__ID D0F4NW D0F4NW DRUGCOMP Hoffmann-La Roche AG D0F4NW HIGHSTAT Phase 1 D0F5KN DRUG__ID D0F5KN D0F5KN DRUGCOMP Molecular Insight Pharmaceuticals D0F5KN HIGHSTAT Phase 1 D0F7FM DRUG__ID D0F7FM D0F7FM DRUGCOMP Astellas D0F7FM HIGHSTAT Phase 1 D0F7LI DRUG__ID D0F7LI D0F7LI DRUGCOMP Panacea Pharmaceuticals Gaithersburg, MD D0F7LI HIGHSTAT Phase 1 D0F7ZR DRUG__ID D0F7ZR D0F7ZR DRUGCOMP Ambrx D0F7ZR HIGHSTAT Phase 1 D0F8TB DRUG__ID D0F8TB D0F8TB DRUGCOMP TESARO Waltham, MA D0F8TB HIGHSTAT Phase 1 D0F8ZG DRUG__ID D0F8ZG D0F8ZG DRUGCOMP Genexine Co Ltd D0F8ZG HIGHSTAT Phase 1 D0F9AO DRUG__ID D0F9AO D0F9AO DRUGCOMP Biohaven Pharmaceuticals New Haven, CT D0F9AO HIGHSTAT Phase 1 D0FC4R DRUG__ID D0FC4R D0FC4R DRUGCOMP Pfizer D0FC4R HIGHSTAT Phase 1 D0FC7H DRUG__ID D0FC7H D0FC7H DRUGCOMP MicroVAXManassas, VA D0FC7H HIGHSTAT Phase 1 D0FE3P DRUG__ID D0FE3P D0FE3P DRUGCOMP Population Council New York, NY D0FE3P HIGHSTAT Phase 1 D0FJ0W DRUG__ID D0FJ0W D0FJ0W DRUGCOMP Bayer HealthCare Pharmaceuticals D0FJ0W HIGHSTAT Phase 1 D0FL6L DRUG__ID D0FL6L D0FL6L DRUGCOMP Immatics US Houston, TX D0FL6L HIGHSTAT Phase 1 D0FP4R DRUG__ID D0FP4R D0FP4R DRUGCOMP Palau Pharma SA D0FP4R HIGHSTAT Phase 1 D0FP9N DRUG__ID D0FP9N D0FP9N DRUGCOMP Piramal enterprises D0FP9N HIGHSTAT Phase 1 D0FS0F DRUG__ID D0FS0F D0FS0F DRUGCOMP Checkpoint Therapeutics New York, NY D0FS0F HIGHSTAT Phase 1 D0FS1B DRUG__ID D0FS1B D0FS1B DRUGCOMP Nationwide Children's Hospital Columbus, OH Sarepta Therapeutics Cambridge, MA D0FS1B HIGHSTAT Phase 1 D0FT5T DRUG__ID D0FT5T D0FT5T DRUGCOMP Cypress Bioscience (Royalty Pharma) D0FT5T HIGHSTAT Phase 1 D0FU0O DRUG__ID D0FU0O D0FU0O DRUGCOMP Xencor Monrovia, CA D0FU0O HIGHSTAT Phase 1 D0FU1J DRUG__ID D0FU1J D0FU1J DRUGCOMP Protagonist Therapeutics Milpitas, CA D0FU1J HIGHSTAT Phase 1 D0FW0B DRUG__ID D0FW0B D0FW0B DRUGCOMP Zealand Pharma A/S D0FW0B HIGHSTAT Phase 1 D0FW2B DRUG__ID D0FW2B D0FW2B DRUGCOMP Baxalta Bannockburn, IL D0FW2B HIGHSTAT Phase 1 D0FY0D DRUG__ID D0FY0D D0FY0D DRUGCOMP DreamPharma Corp D0FY0D HIGHSTAT Phase 1 D0FY1W DRUG__ID D0FY1W D0FY1W DRUGCOMP University of Alabama at Birmingham D0FY1W HIGHSTAT Phase 1 D0FY4J DRUG__ID D0FY4J D0FY4J DRUGCOMP Brickell Biotech Boulder, CO D0FY4J HIGHSTAT Phase 1 D0FY4L DRUG__ID D0FY4L D0FY4L DRUGCOMP Sanofi US Bridgewater, NJ D0FY4L HIGHSTAT Phase 1 D0G0ER DRUG__ID D0G0ER D0G0ER DRUGCOMP Daewoong Pharmaceutical Co Ltd D0G0ER HIGHSTAT Phase 1 D0G0FQ DRUG__ID D0G0FQ D0G0FQ DRUGCOMP Immatics biotechnologies D0G0FQ HIGHSTAT Phase 1 D0G0PU DRUG__ID D0G0PU D0G0PU DRUGCOMP Hoffmann-La Roche AG D0G0PU HIGHSTAT Phase 1 D0G0ZE DRUG__ID D0G0ZE D0G0ZE DRUGCOMP TransTech Pharma Inc D0G0ZE HIGHSTAT Phase 1 D0G1WC DRUG__ID D0G1WC D0G1WC DRUGCOMP University of Pennsylvania D0G1WC HIGHSTAT Phase 1 D0G1WM DRUG__ID D0G1WM D0G1WM DRUGCOMP Glaxosmithkline D0G1WM HIGHSTAT Phase 1 D0G4RI DRUG__ID D0G4RI D0G4RI DRUGCOMP Pfizer D0G4RI HIGHSTAT Phase 1 D0G5HI DRUG__ID D0G5HI D0G5HI DRUGCOMP Pfizer D0G5HI HIGHSTAT Phase 1 D0G5UZ DRUG__ID D0G5UZ D0G5UZ DRUGCOMP Biomed valley discoveries D0G5UZ HIGHSTAT Phase 1 D0G6GB DRUG__ID D0G6GB D0G6GB DRUGCOMP VasGene Therapeutics D0G6GB HIGHSTAT Phase 1 D0G6OL DRUG__ID D0G6OL D0G6OL DRUGCOMP Madison Vaccines Madison, WI D0G6OL HIGHSTAT Phase 1 D0G7BR DRUG__ID D0G7BR D0G7BR DRUGCOMP AnaMar Medical AB D0G7BR HIGHSTAT Phase 1 D0G7LC DRUG__ID D0G7LC D0G7LC DRUGCOMP Inovio pharmaceuticals; national institute of allergy and infectious diseases D0G7LC HIGHSTAT Phase 1 D0G7YS DRUG__ID D0G7YS D0G7YS DRUGCOMP Onyx Pharmaceuticals Inc D0G7YS HIGHSTAT Phase 1 D0G8DV DRUG__ID D0G8DV D0G8DV DRUGCOMP Mayo Foundation D0G8DV HIGHSTAT Phase 1 D0G9NN DRUG__ID D0G9NN D0G9NN DRUGCOMP Tapimmune; mabvax therapeutics D0G9NN HIGHSTAT Phase 1 D0G9PD DRUG__ID D0G9PD D0G9PD DRUGCOMP Janssen Raritan, NJ D0G9PD HIGHSTAT Phase 1 D0G9SH DRUG__ID D0G9SH D0G9SH DRUGCOMP Santen Pharmaceutical Co Ltd D0G9SH HIGHSTAT Phase 1 D0GB3Z DRUG__ID D0GB3Z D0GB3Z DRUGCOMP Cantex Pharmaceuticals Weston, FL D0GB3Z HIGHSTAT Phase 1 D0GJ1U DRUG__ID D0GJ1U D0GJ1U DRUGCOMP Avidia D0GJ1U HIGHSTAT Phase 1 D0GL0K DRUG__ID D0GL0K D0GL0K DRUGCOMP Merz & Co GmbH D0GL0K HIGHSTAT Phase 1 D0GP0H DRUG__ID D0GP0H D0GP0H DRUGCOMP Circadian Technologies D0GP0H HIGHSTAT Phase 1 D0GS9X DRUG__ID D0GS9X D0GS9X DRUGCOMP GlaxoSmithKline D0GS9X HIGHSTAT Phase 1 D0GU1S DRUG__ID D0GU1S D0GU1S DRUGCOMP Janssen Research & Development Raritan, NJ D0GU1S HIGHSTAT Phase 1 D0GU4Z DRUG__ID D0GU4Z D0GU4Z DRUGCOMP Sorbent therapeutics D0GU4Z HIGHSTAT Phase 1 D0H0YZ DRUG__ID D0H0YZ D0H0YZ DRUGCOMP Acorda therapeutics D0H0YZ HIGHSTAT Phase 1 D0H0ZV DRUG__ID D0H0ZV D0H0ZV DRUGCOMP AstraZeneca D0H0ZV HIGHSTAT Phase 1 D0H2MM DRUG__ID D0H2MM D0H2MM DRUGCOMP FluGen Madison, WI D0H2MM HIGHSTAT Phase 1 D0H2QL DRUG__ID D0H2QL D0H2QL DRUGCOMP Walter Reed Army Medical Center D0H2QL HIGHSTAT Phase 1 D0H2YY DRUG__ID D0H2YY D0H2YY DRUGCOMP Jennerex Biotherapeutics D0H2YY HIGHSTAT Phase 1 D0H3GK DRUG__ID D0H3GK D0H3GK DRUGCOMP University of Toronto D0H3GK HIGHSTAT Phase 1 D0H3ID DRUG__ID D0H3ID D0H3ID DRUGCOMP Pfizer D0H3ID HIGHSTAT Phase 1 D0H3JC DRUG__ID D0H3JC D0H3JC DRUGCOMP Stallergenes D0H3JC HIGHSTAT Phase 1 D0H3ND DRUG__ID D0H3ND D0H3ND DRUGCOMP AstellasNorthbrook, IL D0H3ND HIGHSTAT Phase 1 D0H3PV DRUG__ID D0H3PV D0H3PV DRUGCOMP AstraZenecaWilmington, DEJuvenile Diabetes Research Foundation New York, NY D0H3PV HIGHSTAT Phase 1 D0H3VK DRUG__ID D0H3VK D0H3VK DRUGCOMP Biogen Idec D0H3VK HIGHSTAT Phase 1 D0H4IP DRUG__ID D0H4IP D0H4IP DRUGCOMP Quest PharmaTech Inc D0H4IP HIGHSTAT Phase 1 D0H4LI DRUG__ID D0H4LI D0H4LI DRUGCOMP National Institute of Allergy and Infectious Diseases D0H4LI HIGHSTAT Phase 1 D0H5FW DRUG__ID D0H5FW D0H5FW DRUGCOMP Pulmatrix Inc D0H5FW HIGHSTAT Phase 1 D0H5OX DRUG__ID D0H5OX D0H5OX DRUGCOMP HAL AllergyLeiden, Netherlands D0H5OX HIGHSTAT Phase 1 D0H5ZS DRUG__ID D0H5ZS D0H5ZS DRUGCOMP Cytotech D0H5ZS HIGHSTAT Phase 1 D0H6FY DRUG__ID D0H6FY D0H6FY DRUGCOMP Karolinska Institute D0H6FY HIGHSTAT Phase 1 D0H6UL DRUG__ID D0H6UL D0H6UL DRUGCOMP Iconic Therapeutics South San Francisco, CA D0H6UL HIGHSTAT Phase 1 D0H6VZ DRUG__ID D0H6VZ D0H6VZ DRUGCOMP Evolutec Group plc D0H6VZ HIGHSTAT Phase 1 D0H6YK DRUG__ID D0H6YK D0H6YK DRUGCOMP Merck D0H6YK HIGHSTAT Phase 1 D0H7AM DRUG__ID D0H7AM D0H7AM DRUGCOMP MedImmune Gaithersburg, MD D0H7AM HIGHSTAT Phase 1 D0H7YU DRUG__ID D0H7YU D0H7YU DRUGCOMP Microgen State Scientific Industrial Company D0H7YU HIGHSTAT Phase 1 D0H8WX DRUG__ID D0H8WX D0H8WX DRUGCOMP MedImmune D0H8WX HIGHSTAT Phase 1 D0H8ZI DRUG__ID D0H8ZI D0H8ZI DRUGCOMP PDS Biotechnology Corp D0H8ZI HIGHSTAT Phase 1 D0HF2D DRUG__ID D0HF2D D0HF2D DRUGCOMP Palobiofarma Barcelona, Spain D0HF2D HIGHSTAT Phase 1 D0HH0G DRUG__ID D0HH0G D0HH0G DRUGCOMP Abbott Laboratories Abbott D0HH0G HIGHSTAT Phase 1 D0HI1T DRUG__ID D0HI1T D0HI1T DRUGCOMP Sanofi Bridgewater, NJ D0HI1T HIGHSTAT Phase 1 D0HJ5Y DRUG__ID D0HJ5Y D0HJ5Y DRUGCOMP Immune Response Biopharma Atlantic City, NJ D0HJ5Y HIGHSTAT Phase 1 D0HJ7I DRUG__ID D0HJ7I D0HJ7I DRUGCOMP Kotobuki Pharmaceutical Co Ltd D0HJ7I HIGHSTAT Phase 1 D0HN6Q DRUG__ID D0HN6Q D0HN6Q DRUGCOMP Roche Holding AG D0HN6Q HIGHSTAT Phase 1 D0HN7B DRUG__ID D0HN7B D0HN7B DRUGCOMP Corvidia Therapeutics Waltham, MA D0HN7B HIGHSTAT Phase 1 D0HP8Q DRUG__ID D0HP8Q D0HP8Q DRUGCOMP Regulus Therapeutics San Diego, CA, Sanofi US Bridgewater, NJ D0HP8Q HIGHSTAT Phase 1 D0HRC9 DRUG__ID D0HRC9 D0HRC9 DRUGCOMP Annovis Bio D0HRC9 HIGHSTAT Phase 1 D0HU0A DRUG__ID D0HU0A D0HU0A DRUGCOMP Oncternal Therapeutics San Diego, CA D0HU0A HIGHSTAT Phase 1 D0HV4B DRUG__ID D0HV4B D0HV4B DRUGCOMP ADC Therapeutics Murray Hill, NJ D0HV4B HIGHSTAT Phase 1 D0HX1T DRUG__ID D0HX1T D0HX1T DRUGCOMP Daiichi Seiyaku Co Ltd D0HX1T HIGHSTAT Phase 1 D0HY3D DRUG__ID D0HY3D D0HY3D DRUGCOMP Syros Pharmaceuticals Cambridge, MA D0HY3D HIGHSTAT Phase 1 D0HZ4C DRUG__ID D0HZ4C D0HZ4C DRUGCOMP Alfasigma Bologna, Italy D0HZ4C HIGHSTAT Phase 1 D0I0FA DRUG__ID D0I0FA D0I0FA DRUGCOMP Juno Therapeutics Seattle, WA D0I0FA HIGHSTAT Phase 1 D0I0YS DRUG__ID D0I0YS D0I0YS DRUGCOMP Transtech pharma D0I0YS HIGHSTAT Phase 1 D0I2HV DRUG__ID D0I2HV D0I2HV DRUGCOMP Pfizer D0I2HV HIGHSTAT Phase 1 D0I2IY DRUG__ID D0I2IY D0I2IY DRUGCOMP Abbott Laboratories Abbott D0I2IY HIGHSTAT Phase 1 D0I2VT DRUG__ID D0I2VT D0I2VT DRUGCOMP Neuro3d D0I2VT HIGHSTAT Phase 1 D0I3BS DRUG__ID D0I3BS D0I3BS DRUGCOMP Krele Pharmaceuticals D0I3BS HIGHSTAT Phase 1 D0I3QJ DRUG__ID D0I3QJ D0I3QJ DRUGCOMP Hydra Biosciences Cambridge, MA D0I3QJ HIGHSTAT Phase 1 D0I4BK DRUG__ID D0I4BK D0I4BK DRUGCOMP Xencor Monrovia, CA D0I4BK HIGHSTAT Phase 1 D0I4QA DRUG__ID D0I4QA D0I4QA DRUGTYPE Antibody D0I4QA HIGHSTAT Phase 1 D0I5CN DRUG__ID D0I5CN D0I5CN DRUGCOMP Diartis Pharmaceuticals D0I5CN HIGHSTAT Phase 1 D0I5FP DRUG__ID D0I5FP D0I5FP DRUGCOMP University of Ulm D0I5FP HIGHSTAT Phase 1 D0I6AU DRUG__ID D0I6AU D0I6AU DRUGCOMP Berolina Innovative Research and Development Services Pharma AG D0I6AU HIGHSTAT Phase 1 D0I6MR DRUG__ID D0I6MR D0I6MR DRUGCOMP Novo Nordisk, Plainsboro, NJ D0I6MR HIGHSTAT Phase 1 D0I6NH DRUG__ID D0I6NH D0I6NH DRUGCOMP TG Therapeutics New York, NY D0I6NH HIGHSTAT Phase 1 D0I7HB DRUG__ID D0I7HB D0I7HB DRUGCOMP Amarantus biosciences D0I7HB HIGHSTAT Phase 1 D0I7MG DRUG__ID D0I7MG D0I7MG DRUGCOMP Agenus D0I7MG HIGHSTAT Phase 1 D0I8DX DRUG__ID D0I8DX D0I8DX DRUGCOMP Amgen Thousand D0I8DX HIGHSTAT Phase 1 D0I8TW DRUG__ID D0I8TW D0I8TW DRUGCOMP Orban Biotech D0I8TW HIGHSTAT Phase 1 D0I9WR DRUG__ID D0I9WR D0I9WR DRUGCOMP Janssen Biotech D0I9WR HIGHSTAT Phase 1 D0I9ZV DRUG__ID D0I9ZV D0I9ZV DRUGCOMP Progenics Pharmaceuticals D0I9ZV HIGHSTAT Phase 1 D0IA1G DRUG__ID D0IA1G D0IA1G DRUGCOMP Patagonia Pharmaceuticals Woodcliff Lake, NJ D0IA1G HIGHSTAT Phase 1 D0ID9W DRUG__ID D0ID9W D0ID9W DRUGCOMP Atara Biotherapeutics South San Francisco, CA D0ID9W HIGHSTAT Phase 1 D0IG2Y DRUG__ID D0IG2Y D0IG2Y DRUGCOMP Tara Immuno-Oncology New York, NY D0IG2Y HIGHSTAT Phase 1 D0IG7W DRUG__ID D0IG7W D0IG7W DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0IG7W HIGHSTAT Phase 1 D0II7M DRUG__ID D0II7M D0II7M DRUGCOMP MD Anderson Cancer Center D0II7M HIGHSTAT Phase 1 D0IK5R DRUG__ID D0IK5R D0IK5R DRUGCOMP Chugai Pharma USA Berkeley Heights, NJ D0IK5R HIGHSTAT Phase 1 D0IM1B DRUG__ID D0IM1B D0IM1B DRUGCOMP King's College London D0IM1B HIGHSTAT Phase 1 D0IQ2P DRUG__ID D0IQ2P D0IQ2P DRUGCOMP Nexpep Pty Ltd D0IQ2P HIGHSTAT Phase 1 D0IS5Z DRUG__ID D0IS5Z D0IS5Z DRUGCOMP Harvard Medical School D0IS5Z HIGHSTAT Phase 1 D0IT1V DRUG__ID D0IT1V D0IT1V DRUGCOMP Sanofi Pasteur, Swiftwater, PA D0IT1V HIGHSTAT Phase 1 D0IW6R DRUG__ID D0IW6R D0IW6R DRUGCOMP Eli Lilly Indianapolis, IN D0IW6R HIGHSTAT Phase 1 D0IX9E DRUG__ID D0IX9E D0IX9E DRUGCOMP Novartis Oncology East Hanover, D0IX9E HIGHSTAT Phase 1 D0IX9O DRUG__ID D0IX9O D0IX9O DRUGCOMP Cytos Biotechnology D0IX9O HIGHSTAT Phase 1 D0J0HE DRUG__ID D0J0HE D0J0HE DRUGCOMP Merck D0J0HE HIGHSTAT Phase 1 D0J1FB DRUG__ID D0J1FB D0J1FB DRUGCOMP GSK D0J1FB HIGHSTAT Phase 1 D0J1OG DRUG__ID D0J1OG D0J1OG DRUGCOMP Oncolix Houston, TX D0J1OG HIGHSTAT Phase 1 D0J1TN DRUG__ID D0J1TN D0J1TN DRUGCOMP Vaccine Technologies D0J1TN HIGHSTAT Phase 1 D0J2LG DRUG__ID D0J2LG D0J2LG DRUGCOMP Celldex Therapeutics; Rockefeller University D0J2LG HIGHSTAT Phase 1 D0J2OC DRUG__ID D0J2OC D0J2OC DRUGCOMP Microbiotix D0J2OC HIGHSTAT Phase 1 D0J2YR DRUG__ID D0J2YR D0J2YR DRUGCOMP Progen Industries D0J2YR HIGHSTAT Phase 1 D0J3EN DRUG__ID D0J3EN D0J3EN DRUGCOMP Arcus Biosciences Hayward, CA D0J3EN HIGHSTAT Phase 1 D0J3HE DRUG__ID D0J3HE D0J3HE DRUGCOMP Sanofi pasteur; national institute of allergy and infectious diseases D0J3HE HIGHSTAT Phase 1 D0J3KY DRUG__ID D0J3KY D0J3KY DRUGCOMP ReNeuron Group plc D0J3KY HIGHSTAT Phase 1 D0J3TI DRUG__ID D0J3TI D0J3TI DRUGCOMP OncoMed Pharmaceuticals Redwood City, CA D0J3TI HIGHSTAT Phase 1 D0J4CV DRUG__ID D0J4CV D0J4CV DRUGCOMP Genzyme D0J4CV HIGHSTAT Phase 1 D0J5NA DRUG__ID D0J5NA D0J5NA DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0J5NA HIGHSTAT Phase 1 D0J5YU DRUG__ID D0J5YU D0J5YU DRUGCOMP TESARO Waltham, MA D0J5YU HIGHSTAT Phase 1 D0J6AE DRUG__ID D0J6AE D0J6AE DRUGCOMP CelyadNew York, NY D0J6AE HIGHSTAT Phase 1 D0J6LU DRUG__ID D0J6LU D0J6LU DRUGCOMP Vesta Therapeutics D0J6LU HIGHSTAT Phase 1 D0J6UV DRUG__ID D0J6UV D0J6UV DRUGCOMP Icon Bioscience Sunnyvale, CA D0J6UV HIGHSTAT Phase 1 D0J7HV DRUG__ID D0J7HV D0J7HV DRUGCOMP NantKwest Culver City, CA D0J7HV HIGHSTAT Phase 1 D0J8AE DRUG__ID D0J8AE D0J8AE DRUGCOMP Omnitura therapeutics D0J8AE HIGHSTAT Phase 1 D0J8MA DRUG__ID D0J8MA D0J8MA DRUGCOMP Karus Therapeutics Oxfordshire, United Kingdom D0J8MA HIGHSTAT Phase 1 D0J8PR DRUG__ID D0J8PR D0J8PR DRUGCOMP Luye Pharma Shanghai, China D0J8PR HIGHSTAT Phase 1 D0J9CG DRUG__ID D0J9CG D0J9CG DRUGCOMP JN-International Medical D0J9CG HIGHSTAT Phase 1 D0J9GR DRUG__ID D0J9GR D0J9GR DRUGCOMP Orexo AB D0J9GR HIGHSTAT Phase 1 D0J9PS DRUG__ID D0J9PS D0J9PS DRUGCOMP Astrazeneca D0J9PS HIGHSTAT Phase 1 D0J9QS DRUG__ID D0J9QS D0J9QS DRUGCOMP GenentechSouth San Francisco, CA D0J9QS HIGHSTAT Phase 1 D0J9YS DRUG__ID D0J9YS D0J9YS DRUGCOMP Genentech D0J9YS HIGHSTAT Phase 1 D0JA7V DRUG__ID D0JA7V D0JA7V DRUGCOMP Hebrew University of Jerusalem D0JA7V HIGHSTAT Phase 1 D0JA8R DRUG__ID D0JA8R D0JA8R DRUGCOMP Immusant D0JA8R HIGHSTAT Phase 1 D0JB0D DRUG__ID D0JB0D D0JB0D DRUGCOMP IBio Inc D0JB0D HIGHSTAT Phase 1 D0JB9C DRUG__ID D0JB9C D0JB9C DRUGCOMP Pfizer New York, NY D0JB9C HIGHSTAT Phase 1 D0JC9K DRUG__ID D0JC9K D0JC9K DRUGCOMP Viela Bio Gaithersburg, MD D0JC9K HIGHSTAT Phase 1 D0JG2X DRUG__ID D0JG2X D0JG2X DRUGCOMP Juno Therapeutics Seattle, WA D0JG2X HIGHSTAT Phase 1 D0JI4J DRUG__ID D0JI4J D0JI4J DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0JI4J HIGHSTAT Phase 1 D0JL4D DRUG__ID D0JL4D D0JL4D DRUGCOMP CBT Pharmaceuticals Pleasanton, CA D0JL4D HIGHSTAT Phase 1 D0JN9Z DRUG__ID D0JN9Z D0JN9Z DRUGCOMP Denovo BiopharmaSan Diego, CA D0JN9Z HIGHSTAT Phase 1 D0JQ4S DRUG__ID D0JQ4S D0JQ4S DRUGCOMP Xencor Inc D0JQ4S HIGHSTAT Phase 1 D0JS9U DRUG__ID D0JS9U D0JS9U DRUGCOMP GlaxoSmithKline plc D0JS9U HIGHSTAT Phase 1 D0JW2O DRUG__ID D0JW2O D0JW2O DRUGCOMP Genentech D0JW2O HIGHSTAT Phase 1 D0JZ4C DRUG__ID D0JZ4C D0JZ4C DRUGCOMP Pfenex San Diego, CA D0JZ4C HIGHSTAT Phase 1 D0JZ5Y DRUG__ID D0JZ5Y D0JZ5Y DRUGCOMP Memorial Sloan-Kettering Cancer Center D0JZ5Y HIGHSTAT Phase 1 D0K0IN DRUG__ID D0K0IN D0K0IN DRUGCOMP Kenta Biotech Ltd D0K0IN HIGHSTAT Phase 1 D0K0KG DRUG__ID D0K0KG D0K0KG DRUGCOMP Admune Therapeutics Danvers, MA D0K0KG HIGHSTAT Phase 1 D0K1AI DRUG__ID D0K1AI D0K1AI DRUGCOMP Canji Inc D0K1AI HIGHSTAT Phase 1 D0K1LJ DRUG__ID D0K1LJ D0K1LJ DRUGCOMP University of Iowa D0K1LJ HIGHSTAT Phase 1 D0K2GV DRUG__ID D0K2GV D0K2GV DRUGCOMP GeoVax Labs; GlaxoSmithKline D0K2GV HIGHSTAT Phase 1 D0K2KD DRUG__ID D0K2KD D0K2KD DRUGCOMP Kemin Pharma Europe D0K2KD HIGHSTAT Phase 1 D0K2RV DRUG__ID D0K2RV D0K2RV DRUGCOMP Greer Laboratories Inc D0K2RV HIGHSTAT Phase 1 D0K3JQ DRUG__ID D0K3JQ D0K3JQ DRUGCOMP ReceptoPharm Inc D0K3JQ HIGHSTAT Phase 1 D0K4IV DRUG__ID D0K4IV D0K4IV DRUGCOMP Theravance Biopharma South San Francisco, CA D0K4IV HIGHSTAT Phase 1 D0K4RU DRUG__ID D0K4RU D0K4RU DRUGCOMP Merck Kenilworth, NJ D0K4RU HIGHSTAT Phase 1 D0K4UT DRUG__ID D0K4UT D0K4UT DRUGCOMP DNAtrix Houston, TX D0K4UT HIGHSTAT Phase 1 D0K4UV DRUG__ID D0K4UV D0K4UV DRUGCOMP Kareus Therapeutics La Chaux-de-Fonds, Switzerland D0K4UV HIGHSTAT Phase 1 D0K6JZ DRUG__ID D0K6JZ D0K6JZ DRUGCOMP GenentechSouth San Francisco, CA D0K6JZ HIGHSTAT Phase 1 D0K6KU DRUG__ID D0K6KU D0K6KU DRUGCOMP Afecta Pharmaceuticals D0K6KU HIGHSTAT Phase 1 D0K6LX DRUG__ID D0K6LX D0K6LX DRUGCOMP Merck D0K6LX HIGHSTAT Phase 1 D0K6NW DRUG__ID D0K6NW D0K6NW DRUGCOMP Recardio San Francisco, CA D0K6NW HIGHSTAT Phase 1 D0K6QU DRUG__ID D0K6QU D0K6QU DRUGCOMP IntezyneTampa, FL D0K6QU HIGHSTAT Phase 1 D0K6UQ DRUG__ID D0K6UQ D0K6UQ DRUGCOMP Juntendo University D0K6UQ HIGHSTAT Phase 1 D0K6UV DRUG__ID D0K6UV D0K6UV DRUGCOMP Denali Therapeutics South San Francisco, CA D0K6UV HIGHSTAT Phase 1 D0K6ZI DRUG__ID D0K6ZI D0K6ZI DRUGCOMP National Institute of Allergy and Infectious Diseases D0K6ZI HIGHSTAT Phase 1 D0K7PD DRUG__ID D0K7PD D0K7PD DRUGCOMP Antigen Laboratories Inc D0K7PD HIGHSTAT Phase 1 D0K7QQ DRUG__ID D0K7QQ D0K7QQ DRUGCOMP Taisho Pharmaceutical R&D Morristown, NJ D0K7QQ HIGHSTAT Phase 1 D0K8BJ DRUG__ID D0K8BJ D0K8BJ DRUGCOMP Mallinckrodt pharmaceuticals D0K8BJ HIGHSTAT Phase 1 D0K9YJ DRUG__ID D0K9YJ D0K9YJ DRUGCOMP Janssen Research & Development Raritan, NJ D0K9YJ HIGHSTAT Phase 1 D0KG1U DRUG__ID D0KG1U D0KG1U DRUGCOMP BioXcel Therapeutics Branford, CT D0KG1U HIGHSTAT Phase 1 D0KJ4S DRUG__ID D0KJ4S D0KJ4S DRUGCOMP Adamas Pharmaceuticals Emeryville, CA D0KJ4S HIGHSTAT Phase 1 D0KN7Y DRUG__ID D0KN7Y D0KN7Y DRUGCOMP Proclara Biosciences Cambridge, MA D0KN7Y HIGHSTAT Phase 1 D0KT8D DRUG__ID D0KT8D D0KT8D DRUGCOMP ACEA Biosciences San Diego, CA D0KT8D HIGHSTAT Phase 1 D0KV1Z DRUG__ID D0KV1Z D0KV1Z DRUGCOMP BioVex Inc D0KV1Z HIGHSTAT Phase 1 D0KW9T DRUG__ID D0KW9T D0KW9T DRUGCOMP Sichuan Huiyang Chengdu City, China D0KW9T HIGHSTAT Phase 1 D0KX8B DRUG__ID D0KX8B D0KX8B DRUGCOMP Gradalis D0KX8B HIGHSTAT Phase 1 D0L0DA DRUG__ID D0L0DA D0L0DA DRUGCOMP Prothena Biosciences South San Francisco, CA D0L0DA HIGHSTAT Phase 1 D0L0DZ DRUG__ID D0L0DZ D0L0DZ DRUGCOMP Exelixis; X-Ceptor Therapeutics Inc D0L0DZ HIGHSTAT Phase 1 D0L0HV DRUG__ID D0L0HV D0L0HV DRUGCOMP Vertex D0L0HV HIGHSTAT Phase 1 D0L1UH DRUG__ID D0L1UH D0L1UH DRUGCOMP Astellas Pharma Inc D0L1UH HIGHSTAT Phase 1 D0L1VP DRUG__ID D0L1VP D0L1VP DRUGCOMP Garnet BioTherapeutics Inc D0L1VP HIGHSTAT Phase 1 D0L1ZK DRUG__ID D0L1ZK D0L1ZK DRUGCOMP The Medicines Company D0L1ZK HIGHSTAT Phase 1 D0L1ZM DRUG__ID D0L1ZM D0L1ZM DRUGCOMP St Marianna University School of Medicine D0L1ZM HIGHSTAT Phase 1 D0L2JE DRUG__ID D0L2JE D0L2JE DRUGCOMP XencorMonrovia, CA D0L2JE HIGHSTAT Phase 1 D0L2KL DRUG__ID D0L2KL D0L2KL DRUGCOMP GeoVax D0L2KL HIGHSTAT Phase 1 D0L2OT DRUG__ID D0L2OT D0L2OT DRUGCOMP Lipotek Pty Ltd D0L2OT HIGHSTAT Phase 1 D0L2XU DRUG__ID D0L2XU D0L2XU DRUGCOMP Bayer Schering Pharma AG D0L2XU HIGHSTAT Phase 1 D0L2YF DRUG__ID D0L2YF D0L2YF DRUGCOMP Case Western Reserve University D0L2YF HIGHSTAT Phase 1 D0L3CQ DRUG__ID D0L3CQ D0L3CQ DRUGCOMP Meda AB D0L3CQ HIGHSTAT Phase 1 D0L3RO DRUG__ID D0L3RO D0L3RO DRUGCOMP Taiho oncology D0L3RO HIGHSTAT Phase 1 D0L3VT DRUG__ID D0L3VT D0L3VT DRUGCOMP Advanced Cell Technology D0L3VT HIGHSTAT Phase 1 D0L4BU DRUG__ID D0L4BU D0L4BU DRUGCOMP Sanaria Inc D0L4BU HIGHSTAT Phase 1 D0L4CN DRUG__ID D0L4CN D0L4CN DRUGCOMP Genentech South San Francisco, CA D0L4CN HIGHSTAT Phase 1 D0L4GX DRUG__ID D0L4GX D0L4GX DRUGCOMP Akros pharma D0L4GX HIGHSTAT Phase 1 D0L4ZK DRUG__ID D0L4ZK D0L4ZK DRUGCOMP Roche Holding AG D0L4ZK HIGHSTAT Phase 1 D0L5FB DRUG__ID D0L5FB D0L5FB DRUGCOMP Takeda Pharmaceuticals U.S.A. D0L5FB HIGHSTAT Phase 1 D0L5NU DRUG__ID D0L5NU D0L5NU DRUGCOMP ZymoGenetics D0L5NU HIGHSTAT Phase 1 D0L6AF DRUG__ID D0L6AF D0L6AF DRUGCOMP AEterna Zentaris D0L6AF HIGHSTAT Phase 1 D0L6OY DRUG__ID D0L6OY D0L6OY DRUGCOMP GlaxoSmithKline plc D0L6OY HIGHSTAT Phase 1 D0L6RF DRUG__ID D0L6RF D0L6RF DRUGCOMP Bayer healthcare pharmaceuticals D0L6RF HIGHSTAT Phase 1 D0L8PZ DRUG__ID D0L8PZ D0L8PZ DRUGCOMP ArQule Burlington, MA D0L8PZ HIGHSTAT Phase 1 D0L8RD DRUG__ID D0L8RD D0L8RD DRUGCOMP Cary Pharmaceuticals; IntelGenx D0L8RD HIGHSTAT Phase 1 D0L9BV DRUG__ID D0L9BV D0L9BV DRUGCOMP 3D Matrix Inc D0L9BV HIGHSTAT Phase 1 D0L9HZ DRUG__ID D0L9HZ D0L9HZ DRUGCOMP VaxOnco; National Institute of Allergy and Infectious Diseases D0L9HZ HIGHSTAT Phase 1 D0LB2L DRUG__ID D0LB2L D0LB2L DRUGCOMP EMD Serono Rockland, MA D0LB2L HIGHSTAT Phase 1 D0LB6D DRUG__ID D0LB6D D0LB6D DRUGCOMP Roche D0LB6D HIGHSTAT Phase 1 D0LB8B DRUG__ID D0LB8B D0LB8B DRUGCOMP Memorial Sloan-Kettering Cancer Center D0LB8B HIGHSTAT Phase 1 D0LC5L DRUG__ID D0LC5L D0LC5L DRUGCOMP PfizerNew York, NY D0LC5L HIGHSTAT Phase 1 D0LE5N DRUG__ID D0LE5N D0LE5N DRUGCOMP Novartis OncologyEast Hanover, NJ University of Pennsylvania Philadelphia, PA D0LE5N HIGHSTAT Phase 1 D0LM4U DRUG__ID D0LM4U D0LM4U DRUGCOMP Millendo Therapeutics Ann Arbor, MI D0LM4U HIGHSTAT Phase 1 D0LO3F DRUG__ID D0LO3F D0LO3F DRUGCOMP Bristol-Myers Squibb Princeton, NJ PsiOxus Therapeutics Plymouth Meeting, PA D0LO3F HIGHSTAT Phase 1 D0LO5N DRUG__ID D0LO5N D0LO5N DRUGCOMP Sanofi D0LO5N HIGHSTAT Phase 1 D0LP7U DRUG__ID D0LP7U D0LP7U DRUGCOMP Amphivena Therapeutics South San Francisco, CA D0LP7U HIGHSTAT Phase 1 D0LQ7V DRUG__ID D0LQ7V D0LQ7V DRUGCOMP GeneCure Biotechnologies Norcross, GA D0LQ7V HIGHSTAT Phase 1 D0LR1Z DRUG__ID D0LR1Z D0LR1Z DRUGCOMP Merck, Kenilworth, NJ D0LR1Z HIGHSTAT Phase 1 D0LT2Z DRUG__ID D0LT2Z D0LT2Z DRUGCOMP Centro de Investigaciones Oncol gicas CIO-FUCA D0LT2Z HIGHSTAT Phase 1 D0LZ7G DRUG__ID D0LZ7G D0LZ7G DRUGCOMP Unum Therapeutics Cambridge, MA D0LZ7G HIGHSTAT Phase 1 D0LZ7Z DRUG__ID D0LZ7Z D0LZ7Z DRUGCOMP Roche/Genentech Basel, Switzerland D0LZ7Z HIGHSTAT Phase 1 D0M0FY DRUG__ID D0M0FY D0M0FY DRUGCOMP Kringle pharma D0M0FY HIGHSTAT Phase 1 D0M0UB DRUG__ID D0M0UB D0M0UB DRUGCOMP Navidea pharmaceuticals D0M0UB HIGHSTAT Phase 1 D0M0UU DRUG__ID D0M0UU D0M0UU DRUGCOMP Zydus-Cadila Group D0M0UU HIGHSTAT Phase 1 D0M0XU DRUG__ID D0M0XU D0M0XU DRUGCOMP Crucell; genphar; vaccine research center (niaid) D0M0XU HIGHSTAT Phase 1 D0M1DG DRUG__ID D0M1DG D0M1DG DRUGCOMP Artielle immunotherapeutics D0M1DG HIGHSTAT Phase 1 D0M1EP DRUG__ID D0M1EP D0M1EP DRUGCOMP Vical D0M1EP HIGHSTAT Phase 1 D0M1LM DRUG__ID D0M1LM D0M1LM DRUGCOMP Diamyd MedicalStockholm, Sweden University of Alabama Birmingham, AL D0M1LM HIGHSTAT Phase 1 D0M1MN DRUG__ID D0M1MN D0M1MN DRUGCOMP Adaptimmune Philadelphia, PA D0M1MN HIGHSTAT Phase 1 D0M2DM DRUG__ID D0M2DM D0M2DM DRUGCOMP Brickell Biotech Boulder, CO D0M2DM HIGHSTAT Phase 1 D0M2FH DRUG__ID D0M2FH D0M2FH DRUGCOMP Medicago USA D0M2FH HIGHSTAT Phase 1 D0M3GK DRUG__ID D0M3GK D0M3GK DRUGCOMP GenentechSouth San Francisco, CA D0M3GK HIGHSTAT Phase 1 D0M3TD DRUG__ID D0M3TD D0M3TD DRUGCOMP Organon BioSciences D0M3TD HIGHSTAT Phase 1 D0M3XE DRUG__ID D0M3XE D0M3XE DRUGCOMP Pfizer New York, NY D0M3XE HIGHSTAT Phase 1 D0M4BB DRUG__ID D0M4BB D0M4BB DRUGCOMP Cancer Research UK D0M4BB HIGHSTAT Phase 1 D0M4HL DRUG__ID D0M4HL D0M4HL DRUGCOMP Piramal enterprises D0M4HL HIGHSTAT Phase 1 D0M5KQ DRUG__ID D0M5KQ D0M5KQ DRUGCOMP Janssen Research & Development Raritan, NJ D0M5KQ HIGHSTAT Phase 1 D0M5XJ DRUG__ID D0M5XJ D0M5XJ DRUGCOMP Deciphera Pharmaceuticals Waltham, MA D0M5XJ HIGHSTAT Phase 1 D0M6AR DRUG__ID D0M6AR D0M6AR DRUGCOMP Longeveron Miami, FL D0M6AR HIGHSTAT Phase 1 D0M7FX DRUG__ID D0M7FX D0M7FX DRUGCOMP Kaketsuken D0M7FX HIGHSTAT Phase 1 D0M8HV DRUG__ID D0M8HV D0M8HV DRUGCOMP AstraZeneca plc D0M8HV HIGHSTAT Phase 1 D0M8RW DRUG__ID D0M8RW D0M8RW DRUGCOMP Crucell D0M8RW HIGHSTAT Phase 1 D0M8XX DRUG__ID D0M8XX D0M8XX DRUGCOMP Azaya Therapeutics D0M8XX HIGHSTAT Phase 1 D0M9TO DRUG__ID D0M9TO D0M9TO DRUGCOMP Juno Therapeutics Seattle, WA D0M9TO HIGHSTAT Phase 1 D0M9XT DRUG__ID D0M9XT D0M9XT DRUGCOMP NanoBio Corp D0M9XT HIGHSTAT Phase 1 D0MC6Y DRUG__ID D0MC6Y D0MC6Y DRUGCOMP Acura Pharmaceuticals Palatine, IL D0MC6Y HIGHSTAT Phase 1 D0MD7Y DRUG__ID D0MD7Y D0MD7Y DRUGCOMP Woodmont Pharmaceuticals Atlanta, GA D0MD7Y HIGHSTAT Phase 1 D0ME2T DRUG__ID D0ME2T D0ME2T DRUGCOMP Reata Pharmaceuticals Irving, TX D0ME2T HIGHSTAT Phase 1 D0MG0F DRUG__ID D0MG0F D0MG0F DRUGCOMP Immuneworks D0MG0F HIGHSTAT Phase 1 D0MG2R DRUG__ID D0MG2R D0MG2R DRUGCOMP Ablynx NV D0MG2R HIGHSTAT Phase 1 D0MH1F DRUG__ID D0MH1F D0MH1F DRUGCOMP MedImmune Gaithersburg, MD D0MH1F HIGHSTAT Phase 1 D0MI8Z DRUG__ID D0MI8Z D0MI8Z DRUGCOMP Oncobiologics, Cranbury, NJ D0MI8Z HIGHSTAT Phase 1 D0ML5T DRUG__ID D0ML5T D0ML5T DRUGCOMP Eurand Pharmaceuticals Ltd D0ML5T HIGHSTAT Phase 1 D0MM4H DRUG__ID D0MM4H D0MM4H DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0MM4H HIGHSTAT Phase 1 D0MS6B DRUG__ID D0MS6B D0MS6B DRUGCOMP Lorus Therapeutics D0MS6B HIGHSTAT Phase 1 D0MU1F DRUG__ID D0MU1F D0MU1F DRUGCOMP XTL Biopharmaceuticals D0MU1F HIGHSTAT Phase 1 D0MU7N DRUG__ID D0MU7N D0MU7N DRUGCOMP Molecular Neuroimaging Llc D0MU7N HIGHSTAT Phase 1 D0N0AJ DRUG__ID D0N0AJ D0N0AJ DRUGCOMP Tulane University D0N0AJ HIGHSTAT Phase 1 D0N1GB DRUG__ID D0N1GB D0N1GB DRUGCOMP Arena Pharmaceuticals Inc D0N1GB HIGHSTAT Phase 1 D0N2GQ DRUG__ID D0N2GQ D0N2GQ DRUGCOMP The Procter & Gamble Co D0N2GQ HIGHSTAT Phase 1 D0N2HU DRUG__ID D0N2HU D0N2HU DRUGCOMP National Institute of Allergy and Infectious Diseases D0N2HU HIGHSTAT Phase 1 D0N2YY DRUG__ID D0N2YY D0N2YY DRUGCOMP Eunice Kennedy Shriver National Institutes of Child Health and Human Development D0N2YY HIGHSTAT Phase 1 D0N3PC DRUG__ID D0N3PC D0N3PC DRUGCOMP IVAX Corp D0N3PC HIGHSTAT Phase 1 D0N3QF DRUG__ID D0N3QF D0N3QF DRUGCOMP AstraZeneca plc D0N3QF HIGHSTAT Phase 1 D0N3UQ DRUG__ID D0N3UQ D0N3UQ DRUGCOMP Institute for Neurodegenerative Disorders D0N3UQ HIGHSTAT Phase 1 D0N3YT DRUG__ID D0N3YT D0N3YT DRUGCOMP Galapagos NV D0N3YT HIGHSTAT Phase 1 D0N4KK DRUG__ID D0N4KK D0N4KK DRUGCOMP NanoBio D0N4KK HIGHSTAT Phase 1 D0N4NJ DRUG__ID D0N4NJ D0N4NJ DRUGCOMP SK Pharmaceuticals D0N4NJ HIGHSTAT Phase 1 D0N4VB DRUG__ID D0N4VB D0N4VB DRUGCOMP NewLink Genetics Ames, IA D0N4VB HIGHSTAT Phase 1 D0N5NC DRUG__ID D0N5NC D0N5NC DRUGCOMP Taiho Oncology Princeton, NJ D0N5NC HIGHSTAT Phase 1 D0N6GW DRUG__ID D0N6GW D0N6GW DRUGCOMP Archimedes Pharma Ltd D0N6GW HIGHSTAT Phase 1 D0N6VK DRUG__ID D0N6VK D0N6VK DRUGCOMP SnowBrand Pharmaceuticals Inc D0N6VK HIGHSTAT Phase 1 D0N6WX DRUG__ID D0N6WX D0N6WX DRUGCOMP Acusphere Inc D0N6WX HIGHSTAT Phase 1 D0N7JS DRUG__ID D0N7JS D0N7JS DRUGCOMP Progen Pharmaceuticals D0N7JS HIGHSTAT Phase 1 D0N8GC DRUG__ID D0N8GC D0N8GC DRUGCOMP Cipla USA Miami, FL MEDRx Kagawa, Japan D0N8GC HIGHSTAT Phase 1 D0N8IG DRUG__ID D0N8IG D0N8IG DRUGCOMP PowderMed D0N8IG HIGHSTAT Phase 1 D0N8QR DRUG__ID D0N8QR D0N8QR DRUGCOMP Alkahest San Carlos, CA D0N8QR HIGHSTAT Phase 1 D0N8RA DRUG__ID D0N8RA D0N8RA DRUGCOMP Gilead Sciences Foster City, CA D0N8RA HIGHSTAT Phase 1 D0NC1Q DRUG__ID D0NC1Q D0NC1Q DRUGCOMP Amgen D0NC1Q HIGHSTAT Phase 1 D0NF1D DRUG__ID D0NF1D D0NF1D DRUGCOMP Bayer D0NF1D HIGHSTAT Phase 1 D0NF5J DRUG__ID D0NF5J D0NF5J DRUGCOMP Santaris Pharma A/S D0NF5J HIGHSTAT Phase 1 D0NG1C DRUG__ID D0NG1C D0NG1C DRUGCOMP Nabi Biopharmaceuticals D0NG1C HIGHSTAT Phase 1 D0NI0X DRUG__ID D0NI0X D0NI0X DRUGCOMP Fkd therapies D0NI0X HIGHSTAT Phase 1 D0NN7L DRUG__ID D0NN7L D0NN7L DRUGCOMP Amylin Pharmaceuticals; Biocon D0NN7L HIGHSTAT Phase 1 D0NR9E DRUG__ID D0NR9E D0NR9E DRUGCOMP Effexus Pharmaceuticals Leawood, KS D0NR9E HIGHSTAT Phase 1 D0NT4H DRUG__ID D0NT4H D0NT4H DRUGCOMP Belrose Pharma, Princeton, NJ, Zywie, Princeton, NJ D0NT4H HIGHSTAT Phase 1 D0NW2H DRUG__ID D0NW2H D0NW2H DRUGCOMP LTB4 AG D0NW2H HIGHSTAT Phase 1 D0NW8L DRUG__ID D0NW8L D0NW8L DRUGCOMP Juno Therapeutics Seattle, WAMemorial Sloan Kettering New York, NY D0NW8L HIGHSTAT Phase 1 D0NX0S DRUG__ID D0NX0S D0NX0S DRUGCOMP Prescient Therapeutics South Melbourne, Australia D0NX0S HIGHSTAT Phase 1 D0NX8G DRUG__ID D0NX8G D0NX8G DRUGCOMP VaxartSouth San Francisco, CA D0NX8G HIGHSTAT Phase 1 D0NY5Y DRUG__ID D0NY5Y D0NY5Y DRUGCOMP Wyeth D0NY5Y HIGHSTAT Phase 1 D0NZ3C DRUG__ID D0NZ3C D0NZ3C DRUGCOMP TTC Oncology Edina, MN D0NZ3C HIGHSTAT Phase 1 D0O0GX DRUG__ID D0O0GX D0O0GX DRUGCOMP AXIM Biotechnologies New York, NY D0O0GX HIGHSTAT Phase 1 D0O0JB DRUG__ID D0O0JB D0O0JB DRUGCOMP Endocyte D0O0JB HIGHSTAT Phase 1 D0O0VE DRUG__ID D0O0VE D0O0VE DRUGCOMP XEME Biopharma Lombard, IL D0O0VE HIGHSTAT Phase 1 D0O1XV DRUG__ID D0O1XV D0O1XV DRUGCOMP GlaxoSmithKline D0O1XV HIGHSTAT Phase 1 D0O2MO DRUG__ID D0O2MO D0O2MO DRUGCOMP GlaxoSmithKline D0O2MO HIGHSTAT Phase 1 D0O2OU DRUG__ID D0O2OU D0O2OU DRUGCOMP Geneart AG D0O2OU HIGHSTAT Phase 1 D0O3EP DRUG__ID D0O3EP D0O3EP DRUGCOMP Sirtris D0O3EP HIGHSTAT Phase 1 D0O3XS DRUG__ID D0O3XS D0O3XS DRUGCOMP Glaxosmithkline D0O3XS HIGHSTAT Phase 1 D0O4KT DRUG__ID D0O4KT D0O4KT DRUGCOMP NanoMed Pharmaceuticals Inc D0O4KT HIGHSTAT Phase 1 D0O4LG DRUG__ID D0O4LG D0O4LG DRUGCOMP St Georges University of London D0O4LG HIGHSTAT Phase 1 D0O4NJ DRUG__ID D0O4NJ D0O4NJ DRUGCOMP Zeria Pharmaceutical Co Ltd D0O4NJ HIGHSTAT Phase 1 D0O4UZ DRUG__ID D0O4UZ D0O4UZ DRUGCOMP Mymetics D0O4UZ HIGHSTAT Phase 1 D0O4YE DRUG__ID D0O4YE D0O4YE DRUGCOMP Intrexon Germantown, MD ZIOPHARM Oncology Boston, MA D0O4YE HIGHSTAT Phase 1 D0O5CV DRUG__ID D0O5CV D0O5CV DRUGCOMP AstraZeneca D0O5CV HIGHSTAT Phase 1 D0O5XJ DRUG__ID D0O5XJ D0O5XJ DRUGCOMP Exelixis; Bristol-Myers Squibb D0O5XJ HIGHSTAT Phase 1 D0O6EQ DRUG__ID D0O6EQ D0O6EQ DRUGCOMP Moderna Therapeutics Cambridge, MA D0O6EQ HIGHSTAT Phase 1 D0O6SA DRUG__ID D0O6SA D0O6SA DRUGCOMP Karus Therapeutics Oxfordshire, United Kingdom D0O6SA HIGHSTAT Phase 1 D0O6YE DRUG__ID D0O6YE D0O6YE DRUGCOMP Seattle Genetics; Roche D0O6YE HIGHSTAT Phase 1 D0O7KV DRUG__ID D0O7KV D0O7KV DRUGCOMP Eli Lilly & Co D0O7KV HIGHSTAT Phase 1 D0O7QQ DRUG__ID D0O7QQ D0O7QQ DRUGCOMP Biogen Idec D0O7QQ HIGHSTAT Phase 1 D0O7RY DRUG__ID D0O7RY D0O7RY DRUGCOMP Inimex Pharmaceuticals Inc D0O7RY HIGHSTAT Phase 1 D0O7XA DRUG__ID D0O7XA D0O7XA DRUGCOMP Juno Therapeutics Seattle, WAMemorial Sloan Kettering New York, NY D0O7XA HIGHSTAT Phase 1 D0O8QU DRUG__ID D0O8QU D0O8QU DRUGCOMP NuVax Therapeutics D0O8QU HIGHSTAT Phase 1 D0O8SB DRUG__ID D0O8SB D0O8SB DRUGCOMP OPKO Health D0O8SB HIGHSTAT Phase 1 D0O9AF DRUG__ID D0O9AF D0O9AF DRUGCOMP Tekmira pharmaceuticals; canada department of defense; tekmira pharmaceuticals D0O9AF HIGHSTAT Phase 1 D0O9FH DRUG__ID D0O9FH D0O9FH DRUGCOMP Fred Hutchinson Cancer Research Center D0O9FH HIGHSTAT Phase 1 D0O9HG DRUG__ID D0O9HG D0O9HG DRUGCOMP Bayer AG D0O9HG HIGHSTAT Phase 1 D0O9OC DRUG__ID D0O9OC D0O9OC DRUGCOMP AstraZeneca D0O9OC HIGHSTAT Phase 1 D0O9ZT DRUG__ID D0O9ZT D0O9ZT DRUGCOMP Crucell; Vaccine Research Center (NIAID) D0O9ZT HIGHSTAT Phase 1 D0OC5T DRUG__ID D0OC5T D0OC5T DRUGCOMP Annexon Biosciences South San Francisco, CA D0OC5T HIGHSTAT Phase 1 D0OF4A DRUG__ID D0OF4A D0OF4A DRUGCOMP Kurume University D0OF4A HIGHSTAT Phase 1 D0OG0X DRUG__ID D0OG0X D0OG0X DRUGCOMP GeneOne Life Science Seoul, South Korea Inovio Pharmaceuticals Plymouth Meeting, PA D0OG0X HIGHSTAT Phase 1 D0OK5R DRUG__ID D0OK5R D0OK5R DRUGCOMP Vaccinex Inc D0OK5R HIGHSTAT Phase 1 D0OK6F DRUG__ID D0OK6F D0OK6F DRUGCOMP Trevena Chesterbrook, PA D0OK6F HIGHSTAT Phase 1 D0OO3J DRUG__ID D0OO3J D0OO3J DRUGCOMP Mucosis BV D0OO3J HIGHSTAT Phase 1 D0OP1L DRUG__ID D0OP1L D0OP1L DRUGCOMP Sorrento Therapeutics San Diego, CATNK TherapeuticsSan Diego, CA D0OP1L HIGHSTAT Phase 1 D0OQ1A DRUG__ID D0OQ1A D0OQ1A DRUGCOMP Johnson & Johnson D0OQ1A HIGHSTAT Phase 1 D0OS3C DRUG__ID D0OS3C D0OS3C DRUGCOMP Pfizer Inc D0OS3C HIGHSTAT Phase 1 D0P0HU DRUG__ID D0P0HU D0P0HU DRUGCOMP GlaxoSmithKline D0P0HU HIGHSTAT Phase 1 D0P0LT DRUG__ID D0P0LT D0P0LT DRUGCOMP Glaxosmithkline D0P0LT HIGHSTAT Phase 1 D0P0PC DRUG__ID D0P0PC D0P0PC DRUGCOMP Shionogi & GlaxoSmithKline D0P0PC HIGHSTAT Phase 1 D0P0YU DRUG__ID D0P0YU D0P0YU DRUGCOMP NantKwest Culver City, CA D0P0YU HIGHSTAT Phase 1 D0P0ZY DRUG__ID D0P0ZY D0P0ZY DRUGCOMP Eli Lilly D0P0ZY HIGHSTAT Phase 1 D0P1ID DRUG__ID D0P1ID D0P1ID DRUGCOMP Tolerx D0P1ID HIGHSTAT Phase 1 D0P1KJ DRUG__ID D0P1KJ D0P1KJ DRUGCOMP SOM Biotech Cambridge, MA D0P1KJ HIGHSTAT Phase 1 D0P1RC DRUG__ID D0P1RC D0P1RC DRUGCOMP Pfizer New York, NY D0P1RC HIGHSTAT Phase 1 D0P2KG DRUG__ID D0P2KG D0P2KG DRUGCOMP GSK D0P2KG HIGHSTAT Phase 1 D0P2OK DRUG__ID D0P2OK D0P2OK DRUGCOMP TransTech Pharma Inc D0P2OK HIGHSTAT Phase 1 D0P2ZY DRUG__ID D0P2ZY D0P2ZY DRUGCOMP CytRx D0P2ZY HIGHSTAT Phase 1 D0P3WH DRUG__ID D0P3WH D0P3WH DRUGCOMP Aduro BioTech Berkeley, CA Merck Kenilworth, NJ D0P3WH HIGHSTAT Phase 1 D0P4IL DRUG__ID D0P4IL D0P4IL DRUGCOMP Regeneron D0P4IL HIGHSTAT Phase 1 D0P4JJ DRUG__ID D0P4JJ D0P4JJ DRUGCOMP Adaptimmune Ltd D0P4JJ HIGHSTAT Phase 1 D0P4KU DRUG__ID D0P4KU D0P4KU DRUGCOMP Celgene D0P4KU HIGHSTAT Phase 1 D0P4MN DRUG__ID D0P4MN D0P4MN DRUGCOMP Arteriocyte D0P4MN HIGHSTAT Phase 1 D0P5IZ DRUG__ID D0P5IZ D0P5IZ DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0P5IZ HIGHSTAT Phase 1 D0P5JH DRUG__ID D0P5JH D0P5JH DRUGCOMP AbbVieNorth Chicago, IL D0P5JH HIGHSTAT Phase 1 D0P5MG DRUG__ID D0P5MG D0P5MG DRUGCOMP Bayer HealthCare Pharmaceuticals D0P5MG HIGHSTAT Phase 1 D0P5PJ DRUG__ID D0P5PJ D0P5PJ DRUGCOMP Merck & Co Inc D0P5PJ HIGHSTAT Phase 1 D0P5QB DRUG__ID D0P5QB D0P5QB DRUGCOMP Adheron therapeutics D0P5QB HIGHSTAT Phase 1 D0P5XM DRUG__ID D0P5XM D0P5XM DRUGCOMP Samumed D0P5XM HIGHSTAT Phase 1 D0P6NP DRUG__ID D0P6NP D0P6NP DRUGCOMP Enanta pharmaceuticals; novartis pharmaceuticals D0P6NP HIGHSTAT Phase 1 D0P6YD DRUG__ID D0P6YD D0P6YD DRUGCOMP Merck Kenilworth, NJ D0P6YD HIGHSTAT Phase 1 D0P7QG DRUG__ID D0P7QG D0P7QG DRUGCOMP Clene Nanomedicine Salt Lake City, UT D0P7QG HIGHSTAT Phase 1 D0P7TK DRUG__ID D0P7TK D0P7TK DRUGCOMP NovavaxGaithersburg, MD D0P7TK HIGHSTAT Phase 1 D0P8ED DRUG__ID D0P8ED D0P8ED DRUGCOMP Xeme biopharma D0P8ED HIGHSTAT Phase 1 D0P8YJ DRUG__ID D0P8YJ D0P8YJ DRUGCOMP Proteotech D0P8YJ HIGHSTAT Phase 1 D0P9AK DRUG__ID D0P9AK D0P9AK DRUGCOMP Capricor D0P9AK HIGHSTAT Phase 1 D0P9CB DRUG__ID D0P9CB D0P9CB DRUGCOMP Lentigen D0P9CB HIGHSTAT Phase 1 D0P9OW DRUG__ID D0P9OW D0P9OW DRUGCOMP Merck & Co Inc D0P9OW HIGHSTAT Phase 1 D0P9QR DRUG__ID D0P9QR D0P9QR DRUGCOMP Janssen Vaccines and Prevention Leiden, Netherlands D0P9QR HIGHSTAT Phase 1 D0P9UX DRUG__ID D0P9UX D0P9UX DRUGCOMP AmgenThousand Oaks, CA MedImmune Gaithersburg, MD D0P9UX HIGHSTAT Phase 1 D0PE3Z DRUG__ID D0PE3Z D0PE3Z DRUGCOMP Janssen Research & Development Raritan, NJ D0PE3Z HIGHSTAT Phase 1 D0PF8B DRUG__ID D0PF8B D0PF8B DRUGCOMP GenVec Inc D0PF8B HIGHSTAT Phase 1 D0PH5J DRUG__ID D0PH5J D0PH5J DRUGCOMP Inovio pharmaceuticals D0PH5J HIGHSTAT Phase 1 D0PL8D DRUG__ID D0PL8D D0PL8D DRUGCOMP Plexxikon Berkeley, CA D0PL8D HIGHSTAT Phase 1 D0PP6A DRUG__ID D0PP6A D0PP6A DRUGCOMP AbbVieNorth Chicago, IL D0PP6A HIGHSTAT Phase 1 D0PR5H DRUG__ID D0PR5H D0PR5H DRUGCOMP Biscayne Neurotherapeutics Miami, FL D0PR5H HIGHSTAT Phase 1 D0PS4C DRUG__ID D0PS4C D0PS4C DRUGCOMP Angiogenix D0PS4C HIGHSTAT Phase 1 D0PZ5Q DRUG__ID D0PZ5Q D0PZ5Q DRUGCOMP Merck D0PZ5Q HIGHSTAT Phase 1 D0Q0IM DRUG__ID D0Q0IM D0Q0IM DRUGCOMP Sienna Biopharmaceuticals Westlake Village, CA D0Q0IM HIGHSTAT Phase 1 D0Q0LF DRUG__ID D0Q0LF D0Q0LF DRUGCOMP Nautilus Biotech SA D0Q0LF HIGHSTAT Phase 1 D0Q0PO DRUG__ID D0Q0PO D0Q0PO DRUGCOMP Lilly D0Q0PO HIGHSTAT Phase 1 D0Q0RK DRUG__ID D0Q0RK D0Q0RK DRUGCOMP Astrazeneca D0Q0RK HIGHSTAT Phase 1 D0Q1GL DRUG__ID D0Q1GL D0Q1GL DRUGCOMP Celleron Therapeutics D0Q1GL HIGHSTAT Phase 1 D0Q1HD DRUG__ID D0Q1HD D0Q1HD DRUGCOMP Trevena Chesterbrook, PA D0Q1HD HIGHSTAT Phase 1 D0Q1RZ DRUG__ID D0Q1RZ D0Q1RZ DRUGCOMP Atara Biotherapeutics South San Francisco, CA D0Q1RZ HIGHSTAT Phase 1 D0Q2BB DRUG__ID D0Q2BB D0Q2BB DRUGCOMP Sanofi-Aventis D0Q2BB HIGHSTAT Phase 1 D0Q2EJ DRUG__ID D0Q2EJ D0Q2EJ DRUGCOMP Crimson Pharmaceutical (Hong Kong) Ltd D0Q2EJ HIGHSTAT Phase 1 D0Q2VU DRUG__ID D0Q2VU D0Q2VU DRUGCOMP MerckKenilworth, NJModerna Therapeutics Cambridge, MA D0Q2VU HIGHSTAT Phase 1 D0Q3BG DRUG__ID D0Q3BG D0Q3BG DRUGCOMP Nagoya University D0Q3BG HIGHSTAT Phase 1 D0Q4CX DRUG__ID D0Q4CX D0Q4CX DRUGCOMP Millennium Pharmaceuticals Inc D0Q4CX HIGHSTAT Phase 1 D0Q4LG DRUG__ID D0Q4LG D0Q4LG DRUGCOMP Intezyne D0Q4LG HIGHSTAT Phase 1 D0Q4OV DRUG__ID D0Q4OV D0Q4OV DRUGCOMP Pfenex, San Diego, CA D0Q4OV HIGHSTAT Phase 1 D0Q5DT DRUG__ID D0Q5DT D0Q5DT DRUGCOMP ImmunoMetHouston, TX D0Q5DT HIGHSTAT Phase 1 D0Q5QV DRUG__ID D0Q5QV D0Q5QV DRUGCOMP MabVax Therapeutics San Diego, CA D0Q5QV HIGHSTAT Phase 1 D0Q5SX DRUG__ID D0Q5SX D0Q5SX DRUGCOMP Ion channel innovations D0Q5SX HIGHSTAT Phase 1 D0Q6AU DRUG__ID D0Q6AU D0Q6AU DRUGCOMP Neon Therapeutics Cambridge, MA D0Q6AU HIGHSTAT Phase 1 D0Q6SF DRUG__ID D0Q6SF D0Q6SF DRUGCOMP Apoxis SA D0Q6SF HIGHSTAT Phase 1 D0Q7AH DRUG__ID D0Q7AH D0Q7AH DRUGCOMP Glaxosmithkline D0Q7AH HIGHSTAT Phase 1 D0Q7IX DRUG__ID D0Q7IX D0Q7IX DRUGCOMP Pfizer D0Q7IX HIGHSTAT Phase 1 D0Q9ZU DRUG__ID D0Q9ZU D0Q9ZU DRUGCOMP Altimmune Gaithersburg, MD D0Q9ZU HIGHSTAT Phase 1 D0QD4A DRUG__ID D0QD4A D0QD4A DRUGCOMP AbbVieNorth Chicago, IL D0QD4A HIGHSTAT Phase 1 D0QJ2K DRUG__ID D0QJ2K D0QJ2K DRUGCOMP LEO Pharma A/S D0QJ2K HIGHSTAT Phase 1 D0QJ6L DRUG__ID D0QJ6L D0QJ6L DRUGCOMP Biomedica Life Sciences SA D0QJ6L HIGHSTAT Phase 1 D0QL0D DRUG__ID D0QL0D D0QL0D DRUGCOMP BioInceptCherry Hill, NJUniversity of Miami Miami, Florida D0QL0D HIGHSTAT Phase 1 D0QM9P DRUG__ID D0QM9P D0QM9P DRUGCOMP Seqirus Cambridge, MA D0QM9P HIGHSTAT Phase 1 D0QN5M DRUG__ID D0QN5M D0QN5M DRUGCOMP LAM Therapeutics Guilford, CT D0QN5M HIGHSTAT Phase 1 D0QO6N DRUG__ID D0QO6N D0QO6N DRUGCOMP MacroGenicsRockville, MDTakeda Pharmaceuticals D0QO6N HIGHSTAT Phase 1 D0QP1X DRUG__ID D0QP1X D0QP1X DRUGCOMP PaxVax Redwood City, CA D0QP1X HIGHSTAT Phase 1 D0QQ0W DRUG__ID D0QQ0W D0QQ0W DRUGCOMP Roche/Genentech South San Francisco, CA D0QQ0W HIGHSTAT Phase 1 D0QQ7I DRUG__ID D0QQ7I D0QQ7I DRUGCOMP Bayer Pharmaceuticals Whippany, NJ D0QQ7I HIGHSTAT Phase 1 D0R0JN DRUG__ID D0R0JN D0R0JN DRUGCOMP Praxis Precision Medicines Cambridge, MA D0R0JN HIGHSTAT Phase 1 D0R0ME DRUG__ID D0R0ME D0R0ME DRUGCOMP Il Dong Pharmaceutical Co Ltd D0R0ME HIGHSTAT Phase 1 D0R0ZP DRUG__ID D0R0ZP D0R0ZP DRUGCOMP VaxartSouth San Francisco, CA D0R0ZP HIGHSTAT Phase 1 D0R2GU DRUG__ID D0R2GU D0R2GU DRUGCOMP Xcellerex D0R2GU HIGHSTAT Phase 1 D0R2KO DRUG__ID D0R2KO D0R2KO DRUGCOMP Statens Serum Institut D0R2KO HIGHSTAT Phase 1 D0R2LY DRUG__ID D0R2LY D0R2LY DRUGCOMP Ludwig Institute for Cancer Research D0R2LY HIGHSTAT Phase 1 D0R3RG DRUG__ID D0R3RG D0R3RG DRUGCOMP Applied genetic technologies D0R3RG HIGHSTAT Phase 1 D0R3YO DRUG__ID D0R3YO D0R3YO DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0R3YO HIGHSTAT Phase 1 D0R4IZ DRUG__ID D0R4IZ D0R4IZ DRUGCOMP Greer Laboratories D0R4IZ HIGHSTAT Phase 1 D0R5GF DRUG__ID D0R5GF D0R5GF DRUGCOMP Merck D0R5GF HIGHSTAT Phase 1 D0R5HA DRUG__ID D0R5HA D0R5HA DRUGCOMP Bayer AG D0R5HA HIGHSTAT Phase 1 D0R6VV DRUG__ID D0R6VV D0R6VV DRUGCOMP Inovio Pharmaceuticals Inc D0R6VV HIGHSTAT Phase 1 D0R6WL DRUG__ID D0R6WL D0R6WL DRUGCOMP Eli Lilly Indianapolis, IN D0R6WL HIGHSTAT Phase 1 D0R8EW DRUG__ID D0R8EW D0R8EW DRUGCOMP Quest PharmaTech Inc D0R8EW HIGHSTAT Phase 1 D0R8ID DRUG__ID D0R8ID D0R8ID DRUGCOMP Piramal Life Sciences Ltd D0R8ID HIGHSTAT Phase 1 D0R8RO DRUG__ID D0R8RO D0R8RO DRUGCOMP Coley Pharmaceutical Group Inc D0R8RO HIGHSTAT Phase 1 D0R9HE DRUG__ID D0R9HE D0R9HE DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0R9HE HIGHSTAT Phase 1 D0R9VX DRUG__ID D0R9VX D0R9VX DRUGCOMP Daiichi Sankyo D0R9VX HIGHSTAT Phase 1 D0R9WD DRUG__ID D0R9WD D0R9WD DRUGCOMP Egalet Wayne, PA D0R9WD HIGHSTAT Phase 1 D0RC1R DRUG__ID D0RC1R D0RC1R DRUGCOMP Anosys D0RC1R HIGHSTAT Phase 1 D0RD1Z DRUG__ID D0RD1Z D0RD1Z DRUGCOMP ProteoTech D0RD1Z HIGHSTAT Phase 1 D0RE0K DRUG__ID D0RE0K D0RE0K DRUGCOMP Pfizer Inc D0RE0K HIGHSTAT Phase 1 D0RI7N DRUG__ID D0RI7N D0RI7N DRUGCOMP Stemedica Cell Technologies Inc D0RI7N HIGHSTAT Phase 1 D0RK4I DRUG__ID D0RK4I D0RK4I DRUGCOMP Boehringer Ingelheim Pharmaceuticals diabetes Ridgefield, CT Eli Lilly Indianapolis, IN D0RK4I HIGHSTAT Phase 1 D0RO8H DRUG__ID D0RO8H D0RO8H DRUGCOMP Acadia pharmaceuticals D0RO8H HIGHSTAT Phase 1 D0RS0Q DRUG__ID D0RS0Q D0RS0Q DRUGCOMP Multivir Houston, TX D0RS0Q HIGHSTAT Phase 1 D0RU5R DRUG__ID D0RU5R D0RU5R DRUGCOMP Neovia Oncology Bellevue, WA D0RU5R HIGHSTAT Phase 1 D0RV6U DRUG__ID D0RV6U D0RV6U DRUGCOMP Aduro biotech D0RV6U HIGHSTAT Phase 1 D0RW5O DRUG__ID D0RW5O D0RW5O DRUGCOMP Immunovaccine D0RW5O HIGHSTAT Phase 1 D0RY4N DRUG__ID D0RY4N D0RY4N DRUGCOMP Memorial Sloan-Kettering Cancer Center D0RY4N HIGHSTAT Phase 1 D0S0GO DRUG__ID D0S0GO D0S0GO DRUGCOMP Genentech D0S0GO HIGHSTAT Phase 1 D0S0NX DRUG__ID D0S0NX D0S0NX DRUGCOMP Allozyne D0S0NX HIGHSTAT Phase 1 D0S0ZQ DRUG__ID D0S0ZQ D0S0ZQ DRUGCOMP UroGen, New York, NY D0S0ZQ HIGHSTAT Phase 1 D0S1KR DRUG__ID D0S1KR D0S1KR DRUGCOMP Axovant Sciences New York, NY D0S1KR HIGHSTAT Phase 1 D0S1YN DRUG__ID D0S1YN D0S1YN DRUGCOMP MyoKardia South San Francisco, CA Sanofi Bridgewater, NJ D0S1YN HIGHSTAT Phase 1 D0S2MG DRUG__ID D0S2MG D0S2MG DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0S2MG HIGHSTAT Phase 1 D0S3EK DRUG__ID D0S3EK D0S3EK DRUGCOMP EvotecHamburg, GermanyJanssen Research & Development Raritan, NJ D0S3EK HIGHSTAT Phase 1 D0S4XZ DRUG__ID D0S4XZ D0S4XZ DRUGCOMP Novartis Institutes for BioMedical Research Inc D0S4XZ HIGHSTAT Phase 1 D0S5CY DRUG__ID D0S5CY D0S5CY DRUGCOMP Seattle Genetics Bothell, WA D0S5CY HIGHSTAT Phase 1 D0S5XD DRUG__ID D0S5XD D0S5XD DRUGCOMP Pfzer D0S5XD HIGHSTAT Phase 1 D0S6GY DRUG__ID D0S6GY D0S6GY DRUGCOMP Roche Holding AG D0S6GY HIGHSTAT Phase 1 D0S6RY DRUG__ID D0S6RY D0S6RY DRUGCOMP Otsuka america pharmaceutical D0S6RY HIGHSTAT Phase 1 D0S7NS DRUG__ID D0S7NS D0S7NS DRUGCOMP Moerae Matrix Inc D0S7NS HIGHSTAT Phase 1 D0S7UH DRUG__ID D0S7UH D0S7UH DRUGCOMP Ablynx NV D0S7UH HIGHSTAT Phase 1 D0S7VI DRUG__ID D0S7VI D0S7VI DRUGCOMP Novartis AG D0S7VI HIGHSTAT Phase 1 D0S8AF DRUG__ID D0S8AF D0S8AF DRUGCOMP Infectious Diseases Research Institute D0S8AF HIGHSTAT Phase 1 D0S9EK DRUG__ID D0S9EK D0S9EK DRUGCOMP Nordic Nanovector Oslo, Norway D0S9EK HIGHSTAT Phase 1 D0S9GJ DRUG__ID D0S9GJ D0S9GJ DRUGCOMP Antigen Express Inc D0S9GJ HIGHSTAT Phase 1 D0S9LR DRUG__ID D0S9LR D0S9LR DRUGCOMP Soligenix Princeton, NJ D0S9LR HIGHSTAT Phase 1 D0S9UO DRUG__ID D0S9UO D0S9UO DRUGCOMP Sucampo pharmaceuticals D0S9UO HIGHSTAT Phase 1 D0SB2G DRUG__ID D0SB2G D0SB2G DRUGCOMP Vaxonco; national institute of allergy and infectious diseases D0SB2G HIGHSTAT Phase 1 D0SB2U DRUG__ID D0SB2U D0SB2U DRUGCOMP Bavarian Nordic Morrisville, NC D0SB2U HIGHSTAT Phase 1 D0SD2J DRUG__ID D0SD2J D0SD2J DRUGCOMP Impel NeuroPharma Seattle, WA D0SD2J HIGHSTAT Phase 1 D0SD3E DRUG__ID D0SD3E D0SD3E DRUGCOMP Pfizer Inc D0SD3E HIGHSTAT Phase 1 D0SF8V DRUG__ID D0SF8V D0SF8V DRUGCOMP Roche/Genentech South San Francisco, CA D0SF8V HIGHSTAT Phase 1 D0SH7J DRUG__ID D0SH7J D0SH7J DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0SH7J HIGHSTAT Phase 1 D0SM4E DRUG__ID D0SM4E D0SM4E DRUGCOMP Cidara Therapeutics San Diego, CA D0SM4E HIGHSTAT Phase 1 D0SN2I DRUG__ID D0SN2I D0SN2I DRUGCOMP AbbVieNorth Chicago, IL D0SN2I HIGHSTAT Phase 1 D0SN4Y DRUG__ID D0SN4Y D0SN4Y DRUGCOMP TARIS Biomedical Lexington, MA D0SN4Y HIGHSTAT Phase 1 D0SQ1O DRUG__ID D0SQ1O D0SQ1O DRUGCOMP Xencor, Monrovia, CA D0SQ1O HIGHSTAT Phase 1 D0SX9C DRUG__ID D0SX9C D0SX9C DRUGCOMP National Cancer Institute (NCI) D0SX9C HIGHSTAT Phase 1 D0SZ2G DRUG__ID D0SZ2G D0SZ2G DRUGCOMP AbbVieNorth Chicago, IL D0SZ2G HIGHSTAT Phase 1 D0SZ5G DRUG__ID D0SZ5G D0SZ5G DRUGCOMP Teva Pharmaceuticals USA D0SZ5G HIGHSTAT Phase 1 D0T0FT DRUG__ID D0T0FT D0T0FT DRUGCOMP Agenus Lexington, MA D0T0FT HIGHSTAT Phase 1 D0T0NL DRUG__ID D0T0NL D0T0NL DRUGCOMP Archer Pharmaceuticals D0T0NL HIGHSTAT Phase 1 D0T2EO DRUG__ID D0T2EO D0T2EO DRUGCOMP Maxygen Inc D0T2EO HIGHSTAT Phase 1 D0T2RU DRUG__ID D0T2RU D0T2RU DRUGCOMP Pfizer Inc D0T2RU HIGHSTAT Phase 1 D0T3JZ DRUG__ID D0T3JZ D0T3JZ DRUGCOMP AbbVieNorth Chicago, IL D0T3JZ HIGHSTAT Phase 1 D0T3RR DRUG__ID D0T3RR D0T3RR DRUGTYPE Antisense drug D0T3RR HIGHSTAT Phase 1 D0T3VF DRUG__ID D0T3VF D0T3VF DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0T3VF HIGHSTAT Phase 1 D0T4GX DRUG__ID D0T4GX D0T4GX DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0T4GX HIGHSTAT Phase 1 D0T4ME DRUG__ID D0T4ME D0T4ME DRUGTYPE Vaccine D0T4ME HIGHSTAT Phase 1 D0T4NV DRUG__ID D0T4NV D0T4NV DRUGCOMP Celldex therapeutics D0T4NV HIGHSTAT Phase 1 D0T4WK DRUG__ID D0T4WK D0T4WK DRUGCOMP Uniqure; university of california san francisco D0T4WK HIGHSTAT Phase 1 D0T4YH DRUG__ID D0T4YH D0T4YH DRUGCOMP Pfizer Inc D0T4YH HIGHSTAT Phase 1 D0T5HO DRUG__ID D0T5HO D0T5HO DRUGCOMP Vical D0T5HO HIGHSTAT Phase 1 D0T6LU DRUG__ID D0T6LU D0T6LU DRUGCOMP Medicago Inc D0T6LU HIGHSTAT Phase 1 D0T6RG DRUG__ID D0T6RG D0T6RG DRUGCOMP Sanofi D0T6RG HIGHSTAT Phase 1 D0T7MJ DRUG__ID D0T7MJ D0T7MJ DRUGCOMP Pfizer D0T7MJ HIGHSTAT Phase 1 D0T7QN DRUG__ID D0T7QN D0T7QN DRUGCOMP Supernus Pharmaceuticals D0T7QN HIGHSTAT Phase 1 D0TA8O DRUG__ID D0TA8O D0TA8O DRUGCOMP Novartis Oncology East Hanover, NJ D0TA8O HIGHSTAT Phase 1 D0TJ7S DRUG__ID D0TJ7S D0TJ7S DRUGCOMP Theratechnologies Inc D0TJ7S HIGHSTAT Phase 1 D0TM0Y DRUG__ID D0TM0Y D0TM0Y DRUGCOMP FORMA Therapeutics Watertown, MA D0TM0Y HIGHSTAT Phase 1 D0TMF3 DRUG__ID D0TMF3 D0TMF3 DRUGCOMP Janssen D0TMF3 HIGHSTAT Phase 1 D0TN7S DRUG__ID D0TN7S D0TN7S DRUGCOMP Bayer AG D0TN7S HIGHSTAT Phase 1 D0TO0C DRUG__ID D0TO0C D0TO0C DRUGCOMP Five Prime Therapeutics South San Francisco, CA D0TO0C HIGHSTAT Phase 1 D0TP1P DRUG__ID D0TP1P D0TP1P DRUGCOMP Catalyst pharmaceutical partners D0TP1P HIGHSTAT Phase 1 D0TQ4Y DRUG__ID D0TQ4Y D0TQ4Y DRUGCOMP Pfizer New York, NY D0TQ4Y HIGHSTAT Phase 1 D0TV0E DRUG__ID D0TV0E D0TV0E DRUGCOMP Janssen Research & Development Raritan, NJ D0TV0E HIGHSTAT Phase 1 D0TW3L DRUG__ID D0TW3L D0TW3L DRUGCOMP Barbara Ann Karmanos Cancer Institute D0TW3L HIGHSTAT Phase 1 D0TZ8J DRUG__ID D0TZ8J D0TZ8J DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0TZ8J HIGHSTAT Phase 1 D0U0BA DRUG__ID D0U0BA D0U0BA DRUGCOMP Aeras Global TB Vaccine Foundation D0U0BA HIGHSTAT Phase 1 D0U0BP DRUG__ID D0U0BP D0U0BP DRUGCOMP Delta-Fly Pharma Tokushima, Japan D0U0BP HIGHSTAT Phase 1 D0U0CF DRUG__ID D0U0CF D0U0CF DRUGCOMP Centrexion Therapeutics Boston, MA D0U0CF HIGHSTAT Phase 1 D0U0EC DRUG__ID D0U0EC D0U0EC DRUGCOMP MedImmune Gaithersburg, MD D0U0EC HIGHSTAT Phase 1 D0U0QC DRUG__ID D0U0QC D0U0QC DRUGCOMP AbbVie D0U0QC HIGHSTAT Phase 1 D0U0RJ DRUG__ID D0U0RJ D0U0RJ DRUGCOMP CEL-SCI D0U0RJ HIGHSTAT Phase 1 D0U0SD DRUG__ID D0U0SD D0U0SD DRUGCOMP AstraZeneca Wilmington, DE Regulus Therapeutics San Diego, CA D0U0SD HIGHSTAT Phase 1 D0U0SK DRUG__ID D0U0SK D0U0SK DRUGTYPE Antibody D0U0SK HIGHSTAT Phase 1 D0U0XL DRUG__ID D0U0XL D0U0XL DRUGCOMP Novo Nordisk A/S D0U0XL HIGHSTAT Phase 1 D0U1BR DRUG__ID D0U1BR D0U1BR DRUGCOMP Pfizer D0U1BR HIGHSTAT Phase 1 D0U1KE DRUG__ID D0U1KE D0U1KE DRUGCOMP FUJIFILM Pharmaceuticals U.S.A Valhalla, NJ D0U1KE HIGHSTAT Phase 1 D0U1UN DRUG__ID D0U1UN D0U1UN DRUGCOMP Daewoong Pharmaceutical Co Ltd D0U1UN HIGHSTAT Phase 1 D0U1US DRUG__ID D0U1US D0U1US DRUGCOMP Taisho Pharmaceutical Co Ltd D0U1US HIGHSTAT Phase 1 D0U1WP DRUG__ID D0U1WP D0U1WP DRUGCOMP National Cancer Institute D0U1WP HIGHSTAT Phase 1 D0U2PY DRUG__ID D0U2PY D0U2PY DRUGCOMP Sequoia SciencesSt. Louis, MO D0U2PY HIGHSTAT Phase 1 D0U3GA DRUG__ID D0U3GA D0U3GA DRUGCOMP Santaris Pharma A/S D0U3GA HIGHSTAT Phase 1 D0U3GW DRUG__ID D0U3GW D0U3GW DRUGCOMP PaxVax Redwood City, CA D0U3GW HIGHSTAT Phase 1 D0U3UJ DRUG__ID D0U3UJ D0U3UJ DRUGCOMP University College London D0U3UJ HIGHSTAT Phase 1 D0U3VH DRUG__ID D0U3VH D0U3VH DRUGCOMP US Army Medical Research Institute of Infectious Diseases D0U3VH HIGHSTAT Phase 1 D0U3XL DRUG__ID D0U3XL D0U3XL DRUGCOMP Johnson & Johnson D0U3XL HIGHSTAT Phase 1 D0U4GL DRUG__ID D0U4GL D0U4GL DRUGCOMP GLWL Research Montreal, Canada D0U4GL HIGHSTAT Phase 1 D0U4KJ DRUG__ID D0U4KJ D0U4KJ DRUGCOMP Novartis Oncology East Hanover, NJ D0U4KJ HIGHSTAT Phase 1 D0U4YD DRUG__ID D0U4YD D0U4YD DRUGCOMP SK Life Science Fair Lawn, NJ D0U4YD HIGHSTAT Phase 1 D0U5JR DRUG__ID D0U5JR D0U5JR DRUGCOMP National Institute of Allergy and Infectious Diseases D0U5JR HIGHSTAT Phase 1 D0U6CL DRUG__ID D0U6CL D0U6CL DRUGCOMP Celgene D0U6CL HIGHSTAT Phase 1 D0U6PK DRUG__ID D0U6PK D0U6PK DRUGCOMP Arteriocyte; compass biomedical D0U6PK HIGHSTAT Phase 1 D0U6XE DRUG__ID D0U6XE D0U6XE DRUGCOMP OSI Pharmaceuticals Inc D0U6XE HIGHSTAT Phase 1 D0U7NG DRUG__ID D0U7NG D0U7NG DRUGCOMP Bayer HealthCare Pharmaceuticals D0U7NG HIGHSTAT Phase 1 D0U7PM DRUG__ID D0U7PM D0U7PM DRUGCOMP Osprey Pharmaceuticals Ltd D0U7PM HIGHSTAT Phase 1 D0U8PR DRUG__ID D0U8PR D0U8PR DRUGCOMP High Point Pharmaceuticals D0U8PR HIGHSTAT Phase 1 D0U8XW DRUG__ID D0U8XW D0U8XW DRUGCOMP ApeX Therapeutics D0U8XW HIGHSTAT Phase 1 D0U9HM DRUG__ID D0U9HM D0U9HM DRUGCOMP GlaxoSmithKline plc D0U9HM HIGHSTAT Phase 1 D0U9NN DRUG__ID D0U9NN D0U9NN DRUGCOMP Novo Nordisk D0U9NN HIGHSTAT Phase 1 D0U9OC DRUG__ID D0U9OC D0U9OC DRUGCOMP Astellas Northbrook, IL Potenza Therapeutics Cambridge, MA D0U9OC HIGHSTAT Phase 1 D0UC5C DRUG__ID D0UC5C D0UC5C DRUGCOMP Dauntless Pharmaceuticals San Diego, CA D0UC5C HIGHSTAT Phase 1 D0UD1J DRUG__ID D0UD1J D0UD1J DRUGCOMP Evelo Biosciences Cambridge, MA D0UD1J HIGHSTAT Phase 1 D0UF1D DRUG__ID D0UF1D D0UF1D DRUGCOMP GenentechSouth San Francisco, CA D0UF1D HIGHSTAT Phase 1 D0UF8M DRUG__ID D0UF8M D0UF8M DRUGCOMP Idera Pharmaceuticals Cambridge, MA D0UF8M HIGHSTAT Phase 1 D0UK7B DRUG__ID D0UK7B D0UK7B DRUGTYPE Antibody D0UK7B HIGHSTAT Phase 1 D0UL2X DRUG__ID D0UL2X D0UL2X DRUGCOMP CelgeneSummit, NJ D0UL2X HIGHSTAT Phase 1 D0UP2Y DRUG__ID D0UP2Y D0UP2Y DRUGCOMP US Army Medical Research Institute of Infectious Diseases D0UP2Y HIGHSTAT Phase 1 D0UW4A DRUG__ID D0UW4A D0UW4A DRUGCOMP The Procter & Gamble Co D0UW4A HIGHSTAT Phase 1 D0V0JQ DRUG__ID D0V0JQ D0V0JQ DRUGCOMP Chiesi D0V0JQ HIGHSTAT Phase 1 D0V0VI DRUG__ID D0V0VI D0V0VI DRUGCOMP AstraZeneca plc D0V0VI HIGHSTAT Phase 1 D0V0XV DRUG__ID D0V0XV D0V0XV DRUGCOMP SEEK D0V0XV HIGHSTAT Phase 1 D0V0YA DRUG__ID D0V0YA D0V0YA DRUGCOMP Immunomedics D0V0YA HIGHSTAT Phase 1 D0V1AV DRUG__ID D0V1AV D0V1AV DRUGCOMP Janssen Research & Development Raritan, NJ D0V1AV HIGHSTAT Phase 1 D0V1OC DRUG__ID D0V1OC D0V1OC DRUGCOMP Dong-A Pharmaceutical Co Ltd D0V1OC HIGHSTAT Phase 1 D0V2NK DRUG__ID D0V2NK D0V2NK DRUGCOMP Inovio Pharmaceuticals Plymouth Meeting, PA D0V2NK HIGHSTAT Phase 1 D0V3ZX DRUG__ID D0V3ZX D0V3ZX DRUGCOMP Dong-A Pharmaceutical Co Ltd D0V3ZX HIGHSTAT Phase 1 D0V4XG DRUG__ID D0V4XG D0V4XG DRUGCOMP Glaxosmithkline D0V4XG HIGHSTAT Phase 1 D0V4XL DRUG__ID D0V4XL D0V4XL DRUGCOMP Industrial Technology Research Institute D0V4XL HIGHSTAT Phase 1 D0V5AL DRUG__ID D0V5AL D0V5AL DRUGCOMP Leuchemix Inc D0V5AL HIGHSTAT Phase 1 D0V5HA DRUG__ID D0V5HA D0V5HA DRUGCOMP Vertex Pharmaceuticals Boston, MA D0V5HA HIGHSTAT Phase 1 D0V5TP DRUG__ID D0V5TP D0V5TP DRUGCOMP Cytori Therapeutics Inc D0V5TP HIGHSTAT Phase 1 D0V5ZG DRUG__ID D0V5ZG D0V5ZG DRUGCOMP Theraclone sciences D0V5ZG HIGHSTAT Phase 1 D0V6JF DRUG__ID D0V6JF D0V6JF DRUGCOMP Sanofi D0V6JF HIGHSTAT Phase 1 D0V6TP DRUG__ID D0V6TP D0V6TP DRUGCOMP PDL BioPharma D0V6TP HIGHSTAT Phase 1 D0V6TY DRUG__ID D0V6TY D0V6TY DRUGCOMP Myonexus Therapeutics New Albany, OH D0V6TY HIGHSTAT Phase 1 D0V7GS DRUG__ID D0V7GS D0V7GS DRUGCOMP Roche/Genentech South San Francisco, CA D0V7GS HIGHSTAT Phase 1 D0V7QO DRUG__ID D0V7QO D0V7QO DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D0V7QO HIGHSTAT Phase 1 D0V7RN DRUG__ID D0V7RN D0V7RN DRUGCOMP Central Drug Research Institute D0V7RN HIGHSTAT Phase 1 D0V8RV DRUG__ID D0V8RV D0V8RV DRUGCOMP POLYVAC D0V8RV HIGHSTAT Phase 1 D0V8UJ DRUG__ID D0V8UJ D0V8UJ DRUGCOMP SEEK D0V8UJ HIGHSTAT Phase 1 D0V9AL DRUG__ID D0V9AL D0V9AL DRUGCOMP Genentech D0V9AL HIGHSTAT Phase 1 D0V9HL DRUG__ID D0V9HL D0V9HL DRUGCOMP Bristol-Myers Squibb D0V9HL HIGHSTAT Phase 1 D0V9MT DRUG__ID D0V9MT D0V9MT DRUGCOMP Samus Therapeutics Topsfield, MA D0V9MT HIGHSTAT Phase 1 D0V9WE DRUG__ID D0V9WE D0V9WE DRUGCOMP Translational Sciences Phoenix, AZ D0V9WE HIGHSTAT Phase 1 D0VC8Y DRUG__ID D0VC8Y D0VC8Y DRUGCOMP Sanofi USBridgewater, NJ D0VC8Y HIGHSTAT Phase 1 D0VE9F DRUG__ID D0VE9F D0VE9F DRUGCOMP Sun BioPharma, Waconia, MN D0VE9F HIGHSTAT Phase 1 D0VH4T DRUG__ID D0VH4T D0VH4T DRUGCOMP Ono Pharmaceutical Osaka, Japan D0VH4T HIGHSTAT Phase 1 D0VH6V DRUG__ID D0VH6V D0VH6V DRUGCOMP CDG Therapeutics Chicago, IL D0VH6V HIGHSTAT Phase 1 D0VJ9X DRUG__ID D0VJ9X D0VJ9X DRUGCOMP Axsome Therapeutics New York, NY D0VJ9X HIGHSTAT Phase 1 D0VL4M DRUG__ID D0VL4M D0VL4M DRUGCOMP AnGes Osaka, Japan D0VL4M HIGHSTAT Phase 1 D0VO0A DRUG__ID D0VO0A D0VO0A DRUGCOMP Inviragen D0VO0A HIGHSTAT Phase 1 D0VO7R DRUG__ID D0VO7R D0VO7R DRUGTYPE Antibody D0VO7R HIGHSTAT Phase 1 D0VR7F DRUG__ID D0VR7F D0VR7F DRUGCOMP Centrexion Therapeutics Boston, MA D0VR7F HIGHSTAT Phase 1 D0VS3U DRUG__ID D0VS3U D0VS3U DRUGCOMP Takeda Pharmaceuticals Deerfield, IL D0VS3U HIGHSTAT Phase 1 D0VS9E DRUG__ID D0VS9E D0VS9E DRUGCOMP GenentechSouth San Francisco, CA D0VS9E HIGHSTAT Phase 1 D0VT6X DRUG__ID D0VT6X D0VT6X DRUGCOMP AbbVie D0VT6X HIGHSTAT Phase 1 D0VW1I DRUG__ID D0VW1I D0VW1I DRUGCOMP GeneOne Life Science Seoul, South Korea Inovio Pharmaceuticals Plymouth Meeting, PA D0VW1I HIGHSTAT Phase 1 D0VZ0U DRUG__ID D0VZ0U D0VZ0U DRUGCOMP Sanofi pasteur D0VZ0U HIGHSTAT Phase 1 D0VZ1C DRUG__ID D0VZ1C D0VZ1C DRUGCOMP Shanghai Sunway Biotech Co Ltd D0VZ1C HIGHSTAT Phase 1 D0W0GE DRUG__ID D0W0GE D0W0GE DRUGCOMP CSL Behring D0W0GE HIGHSTAT Phase 1 D0W1SD DRUG__ID D0W1SD D0W1SD DRUGCOMP University of Tennessee D0W1SD HIGHSTAT Phase 1 D0W1TK DRUG__ID D0W1TK D0W1TK DRUGCOMP Nektar Therapeutics D0W1TK HIGHSTAT Phase 1 D0W1TL DRUG__ID D0W1TL D0W1TL DRUGCOMP Benovus Bio Atlanta, GA D0W1TL HIGHSTAT Phase 1 D0W1YV DRUG__ID D0W1YV D0W1YV DRUGCOMP Plexxikon Inc D0W1YV HIGHSTAT Phase 1 D0W2RI DRUG__ID D0W2RI D0W2RI DRUGCOMP Akros Pharma Princeton, NJ D0W2RI HIGHSTAT Phase 1 D0W3JH DRUG__ID D0W3JH D0W3JH DRUGCOMP CalciMedica D0W3JH HIGHSTAT Phase 1 D0W3WD DRUG__ID D0W3WD D0W3WD DRUGCOMP GenVec; Vaccine Research Center (NIAID) D0W3WD HIGHSTAT Phase 1 D0W4HA DRUG__ID D0W4HA D0W4HA DRUGCOMP Genmab A/S D0W4HA HIGHSTAT Phase 1 D0W5UD DRUG__ID D0W5UD D0W5UD DRUGCOMP Cytori Therapeutics D0W5UD HIGHSTAT Phase 1 D0W6NW DRUG__ID D0W6NW D0W6NW DRUGCOMP Sosei Group Corp D0W6NW HIGHSTAT Phase 1 D0W6PM DRUG__ID D0W6PM D0W6PM DRUGCOMP BioMed Valley Discoveries Kansas City, MO D0W6PM HIGHSTAT Phase 1 D0W6YR DRUG__ID D0W6YR D0W6YR DRUGCOMP Pfizer New York, NY D0W6YR HIGHSTAT Phase 1 D0W7AE DRUG__ID D0W7AE D0W7AE DRUGCOMP HanAll Biopharma Co Ltd D0W7AE HIGHSTAT Phase 1 D0W7NL DRUG__ID D0W7NL D0W7NL DRUGCOMP Pfizer D0W7NL HIGHSTAT Phase 1 D0W7SX DRUG__ID D0W7SX D0W7SX DRUGCOMP Centocor Ortho Biotech Inc D0W7SX HIGHSTAT Phase 1 D0W8AG DRUG__ID D0W8AG D0W8AG DRUGCOMP TapImmune Jacksonville, FL D0W8AG HIGHSTAT Phase 1 D0W8NB DRUG__ID D0W8NB D0W8NB DRUGCOMP AbbVieNorth Chicago, IL D0W8NB HIGHSTAT Phase 1 D0W8PU DRUG__ID D0W8PU D0W8PU DRUGCOMP Ablaris therapeutics D0W8PU HIGHSTAT Phase 1 D0W9IZ DRUG__ID D0W9IZ D0W9IZ DRUGCOMP Pfizer Inc D0W9IZ HIGHSTAT Phase 1 D0W9LS DRUG__ID D0W9LS D0W9LS DRUGCOMP AC Immune Lausanne, Switzerland Janssen Research & Development Raritan, NJ D0W9LS HIGHSTAT Phase 1 D0W9MJ DRUG__ID D0W9MJ D0W9MJ DRUGCOMP TapImmune Jacksonville, FL D0W9MJ HIGHSTAT Phase 1 D0WA1R DRUG__ID D0WA1R D0WA1R DRUGCOMP Amgen D0WA1R HIGHSTAT Phase 1 D0WB8J DRUG__ID D0WB8J D0WB8J DRUGCOMP Pfizer New York, NY D0WB8J HIGHSTAT Phase 1 D0WG1T DRUG__ID D0WG1T D0WG1T DRUGCOMP Immune cell therapy D0WG1T HIGHSTAT Phase 1 D0WG3X DRUG__ID D0WG3X D0WG3X DRUGCOMP Walter Reed Army Institute of Research D0WG3X HIGHSTAT Phase 1 D0WI9W DRUG__ID D0WI9W D0WI9W DRUGCOMP Allergan Parsippany, NJ Chase Pharmaceuticals Washington, DC D0WI9W HIGHSTAT Phase 1 D0WJ1H DRUG__ID D0WJ1H D0WJ1H DRUGCOMP GeneCure Biotechnologies Norcross, GA D0WJ1H HIGHSTAT Phase 1 D0WJ3C DRUG__ID D0WJ3C D0WJ3C DRUGCOMP Vaxine Pty Ltd D0WJ3C HIGHSTAT Phase 1 D0WL5T DRUG__ID D0WL5T D0WL5T DRUGCOMP Biogen Cambridge, MA D0WL5T HIGHSTAT Phase 1 D0WM3D DRUG__ID D0WM3D D0WM3D DRUGCOMP TARIS Biomedical Lexington, MA D0WM3D HIGHSTAT Phase 1 D0WM7M DRUG__ID D0WM7M D0WM7M DRUGCOMP Kite PharmaSanta Monica, CA National Cancer Institute Bethesda, MD D0WM7M HIGHSTAT Phase 1 D0WM8D DRUG__ID D0WM8D D0WM8D DRUGCOMP Cadent Therapeutics Cambridge, MA D0WM8D HIGHSTAT Phase 1 D0WO7R DRUG__ID D0WO7R D0WO7R DRUGCOMP AbbVieNorth Chicago, IL D0WO7R HIGHSTAT Phase 1 D0WP4E DRUG__ID D0WP4E D0WP4E DRUGCOMP Hoffmann-La Roche Inc D0WP4E HIGHSTAT Phase 1 D0WP9A DRUG__ID D0WP9A D0WP9A DRUGCOMP Biogen Cambridge, MA D0WP9A HIGHSTAT Phase 1 D0WS4E DRUG__ID D0WS4E D0WS4E DRUGCOMP Cortexyme South San Francisco, CA D0WS4E HIGHSTAT Phase 1 D0WU7X DRUG__ID D0WU7X D0WU7X DRUGCOMP Embera NeuroTherapeutics D0WU7X HIGHSTAT Phase 1 D0WW1V DRUG__ID D0WW1V D0WW1V DRUGCOMP Merrimack Pharmaceuticals Cambridge, MA D0WW1V HIGHSTAT Phase 1 D0WW3O DRUG__ID D0WW3O D0WW3O DRUGCOMP Xenon D0WW3O HIGHSTAT Phase 1 D0WY3J DRUG__ID D0WY3J D0WY3J DRUGCOMP Pfizer D0WY3J HIGHSTAT Phase 1 D0WZ3G DRUG__ID D0WZ3G D0WZ3G DRUGCOMP Cleveland BioLabs Buffalo, NY D0WZ3G HIGHSTAT Phase 1 D0WZ9R DRUG__ID D0WZ9R D0WZ9R DRUGCOMP Pieris Pharmaceuticals Boston, MA D0WZ9R HIGHSTAT Phase 1 D0X0FW DRUG__ID D0X0FW D0X0FW DRUGCOMP Boehringer 1ngelheim pharmaceuticals D0X0FW HIGHSTAT Phase 1 D0X0WQ DRUG__ID D0X0WQ D0X0WQ DRUGCOMP Shire Lexington, MA D0X0WQ HIGHSTAT Phase 1 D0X1BR DRUG__ID D0X1BR D0X1BR DRUGCOMP AstraZeneca D0X1BR HIGHSTAT Phase 1 D0X1EV DRUG__ID D0X1EV D0X1EV DRUGCOMP South San Francisco, CA D0X1EV HIGHSTAT Phase 1 D0X1IL DRUG__ID D0X1IL D0X1IL DRUGCOMP Santaris Pharma A/S D0X1IL HIGHSTAT Phase 1 D0X1LW DRUG__ID D0X1LW D0X1LW DRUGCOMP Stallergenes SA D0X1LW HIGHSTAT Phase 1 D0X1XK DRUG__ID D0X1XK D0X1XK DRUGCOMP Allergan Parsippany, NJ Chase Pharmaceuticals Washington, DC D0X1XK HIGHSTAT Phase 1 D0X2HJ DRUG__ID D0X2HJ D0X2HJ DRUGCOMP Pain Therapeutics Austin, TX D0X2HJ HIGHSTAT Phase 1 D0X2TZ DRUG__ID D0X2TZ D0X2TZ DRUGCOMP Sanofi pasteur D0X2TZ HIGHSTAT Phase 1 D0X3BG DRUG__ID D0X3BG D0X3BG DRUGCOMP Genzyme D0X3BG HIGHSTAT Phase 1 D0X3JV DRUG__ID D0X3JV D0X3JV DRUGCOMP Apovia AG D0X3JV HIGHSTAT Phase 1 D0X3XV DRUG__ID D0X3XV D0X3XV DRUGCOMP Vaxin Inc D0X3XV HIGHSTAT Phase 1 D0X4KN DRUG__ID D0X4KN D0X4KN DRUGCOMP Boehringer Ingelheim Pharmaceuticals D0X4KN HIGHSTAT Phase 1 D0X4RT DRUG__ID D0X4RT D0X4RT DRUGCOMP Daiichi Sankyo D0X4RT HIGHSTAT Phase 1 D0X4VA DRUG__ID D0X4VA D0X4VA DRUGCOMP AmgenThousand Oaks, CA D0X4VA HIGHSTAT Phase 1 D0X4ZV DRUG__ID D0X4ZV D0X4ZV DRUGCOMP Archemix Corp D0X4ZV HIGHSTAT Phase 1 D0X6DC DRUG__ID D0X6DC D0X6DC DRUGCOMP Atara Biotherapeutics South San Francisco, CA D0X6DC HIGHSTAT Phase 1 D0X6VC DRUG__ID D0X6VC D0X6VC DRUGCOMP Institut Pasteur D0X6VC HIGHSTAT Phase 1 D0X6ZG DRUG__ID D0X6ZG D0X6ZG DRUGCOMP BioFocus DPI D0X6ZG HIGHSTAT Phase 1 D0X7BN DRUG__ID D0X7BN D0X7BN DRUGCOMP Takeda Oncology Cambridge, MA D0X7BN HIGHSTAT Phase 1 D0X7HQ DRUG__ID D0X7HQ D0X7HQ DRUGCOMP NOLabs Ab D0X7HQ HIGHSTAT Phase 1 D0X7JC DRUG__ID D0X7JC D0X7JC DRUGCOMP Bayer AG D0X7JC HIGHSTAT Phase 1 D0X7ZE DRUG__ID D0X7ZE D0X7ZE DRUGCOMP Crucell D0X7ZE HIGHSTAT Phase 1 D0X8RS DRUG__ID D0X8RS D0X8RS DRUGCOMP RocheBasel, Switzerland D0X8RS HIGHSTAT Phase 1 D0X8VX DRUG__ID D0X8VX D0X8VX DRUGCOMP Dynavax Berkeley, CA D0X8VX HIGHSTAT Phase 1 D0X9GE DRUG__ID D0X9GE D0X9GE DRUGCOMP Center for Genetic Engineering and Biotechnology D0X9GE HIGHSTAT Phase 1 D0X9HF DRUG__ID D0X9HF D0X9HF DRUGCOMP Abbvie D0X9HF HIGHSTAT Phase 1 D0X9YB DRUG__ID D0X9YB D0X9YB DRUGCOMP Otsuka Pharmaceutical Co Ltd D0X9YB HIGHSTAT Phase 1 D0XD0N DRUG__ID D0XD0N D0XD0N DRUGCOMP Relmada Therapeutics New York, NY D0XD0N HIGHSTAT Phase 1 D0XE2O DRUG__ID D0XE2O D0XE2O DRUGCOMP BiogenCambridge, MA D0XE2O HIGHSTAT Phase 1 D0XE5M DRUG__ID D0XE5M D0XE5M DRUGCOMP Sanofi Bridgewater, NJ D0XE5M HIGHSTAT Phase 1 D0XJ9U DRUG__ID D0XJ9U D0XJ9U DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0XJ9U HIGHSTAT Phase 1 D0XL8W DRUG__ID D0XL8W D0XL8W DRUGCOMP Asana BioSciences Lawrenceville, NJ D0XL8W HIGHSTAT Phase 1 D0XO1O DRUG__ID D0XO1O D0XO1O DRUGCOMP Astellas Northbrook, IL Chromocell North Brunswick, NJ D0XO1O HIGHSTAT Phase 1 D0XO4K DRUG__ID D0XO4K D0XO4K DRUGCOMP Cancer Research Campaign Technology Ltd D0XO4K HIGHSTAT Phase 1 D0XO7I DRUG__ID D0XO7I D0XO7I DRUGCOMP Pfizer New York, NY D0XO7I HIGHSTAT Phase 1 D0XR7R DRUG__ID D0XR7R D0XR7R DRUGCOMP Roche/Genentech South San Francisco, CA D0XR7R HIGHSTAT Phase 1 D0XS7I DRUG__ID D0XS7I D0XS7I DRUGCOMP Pfizer New York, NY D0XS7I HIGHSTAT Phase 1 D0XV0Y DRUG__ID D0XV0Y D0XV0Y DRUGCOMP Celltrion Incheon, South Korea Teva Pharmaceuticals North wales, PA D0XV0Y HIGHSTAT Phase 1 D0XV6L DRUG__ID D0XV6L D0XV6L DRUGCOMP KangLaiTe USA Inc D0XV6L HIGHSTAT Phase 1 D0Y0FZ DRUG__ID D0Y0FZ D0Y0FZ DRUGCOMP Pfizer New York, NY D0Y0FZ HIGHSTAT Phase 1 D0Y0HC DRUG__ID D0Y0HC D0Y0HC DRUGCOMP PfizerNew York, NY D0Y0HC HIGHSTAT Phase 1 D0Y0RF DRUG__ID D0Y0RF D0Y0RF DRUGCOMP EMD Millipore D0Y0RF HIGHSTAT Phase 1 D0Y1FP DRUG__ID D0Y1FP D0Y1FP DRUGCOMP Hoffmann-La Roche Inc D0Y1FP HIGHSTAT Phase 1 D0Y1FU DRUG__ID D0Y1FU D0Y1FU DRUGCOMP DLK-1 protein inhibitor D0Y1FU HIGHSTAT Phase 1 D0Y1GJ DRUG__ID D0Y1GJ D0Y1GJ DRUGCOMP Xenova Group plc D0Y1GJ HIGHSTAT Phase 1 D0Y2NN DRUG__ID D0Y2NN D0Y2NN DRUGCOMP GeneCure Biotechnologies D0Y2NN HIGHSTAT Phase 1 D0Y3AR DRUG__ID D0Y3AR D0Y3AR DRUGCOMP Genzyme D0Y3AR HIGHSTAT Phase 1 D0Y3AZ DRUG__ID D0Y3AZ D0Y3AZ DRUGCOMP Merck D0Y3AZ HIGHSTAT Phase 1 D0Y3VT DRUG__ID D0Y3VT D0Y3VT DRUGCOMP Orbis Biosciences Lenexa, KS D0Y3VT HIGHSTAT Phase 1 D0Y3WY DRUG__ID D0Y3WY D0Y3WY DRUGCOMP Genentech D0Y3WY HIGHSTAT Phase 1 D0Y3ZC DRUG__ID D0Y3ZC D0Y3ZC DRUGCOMP CBT Pharmaceuticals Santa Clara, CA D0Y3ZC HIGHSTAT Phase 1 D0Y4CN DRUG__ID D0Y4CN D0Y4CN DRUGCOMP Eli lilly; imclone systems D0Y4CN HIGHSTAT Phase 1 D0Y4IR DRUG__ID D0Y4IR D0Y4IR DRUGCOMP UnityBiotechnology D0Y4IR HIGHSTAT Phase 1 D0Y4MJ DRUG__ID D0Y4MJ D0Y4MJ DRUGCOMP Kaneq Bioscience Montreal, Canada D0Y4MJ HIGHSTAT Phase 1 D0Y5QA DRUG__ID D0Y5QA D0Y5QA DRUGCOMP Aravive Biologics Houston, TX D0Y5QA HIGHSTAT Phase 1 D0Y5WX DRUG__ID D0Y5WX D0Y5WX DRUGCOMP Glenmark Pharmaceuticals Mumbai, India D0Y5WX HIGHSTAT Phase 1 D0Y6KY DRUG__ID D0Y6KY D0Y6KY DRUGCOMP Enzo Biochem, New York, NY D0Y6KY HIGHSTAT Phase 1 D0Y7LV DRUG__ID D0Y7LV D0Y7LV DRUGCOMP Sorrento Therapeutics San Diego, CA D0Y7LV HIGHSTAT Phase 1 D0Y7SN DRUG__ID D0Y7SN D0Y7SN DRUGCOMP Pain Therapeutics D0Y7SN HIGHSTAT Phase 1 D0Y8RS DRUG__ID D0Y8RS D0Y8RS DRUGCOMP Sunovion Pharmaceuticals Marlborough, MA D0Y8RS HIGHSTAT Phase 1 D0Y9SB DRUG__ID D0Y9SB D0Y9SB DRUGCOMP Genentech D0Y9SB HIGHSTAT Phase 1 D0Y9VC DRUG__ID D0Y9VC D0Y9VC DRUGCOMP Immunotope D0Y9VC HIGHSTAT Phase 1 D0Y9YG DRUG__ID D0Y9YG D0Y9YG DRUGCOMP Solvay SA D0Y9YG HIGHSTAT Phase 1 D0YE6C DRUG__ID D0YE6C D0YE6C DRUGCOMP Bavarian Nordic Morrisville, NCNational Cancer Institute Bethesda, MD D0YE6C HIGHSTAT Phase 1 D0YH0I DRUG__ID D0YH0I D0YH0I DRUGCOMP Pharmexa D0YH0I HIGHSTAT Phase 1 D0YH8F DRUG__ID D0YH8F D0YH8F DRUGCOMP Genentech; Roche D0YH8F HIGHSTAT Phase 1 D0YI6W DRUG__ID D0YI6W D0YI6W DRUGCOMP Supernus Pharmaceuticals D0YI6W HIGHSTAT Phase 1 D0YJ5F DRUG__ID D0YJ5F D0YJ5F DRUGCOMP Phosplatin Therapeutics New York, NY D0YJ5F HIGHSTAT Phase 1 D0YN4S DRUG__ID D0YN4S D0YN4S DRUGCOMP Boehringer Ingelheim Pharmaceuticals Ridgefield, CT D0YN4S HIGHSTAT Phase 1 D0YN4Y DRUG__ID D0YN4Y D0YN4Y DRUGCOMP Pain therapeutics D0YN4Y HIGHSTAT Phase 1 D0YN9Y DRUG__ID D0YN9Y D0YN9Y DRUGCOMP Mustang Bio New York, NY D0YN9Y HIGHSTAT Phase 1 D0YP0C DRUG__ID D0YP0C D0YP0C DRUGCOMP Boehringer Ingelheim Corp D0YP0C HIGHSTAT Phase 1 D0YP8F DRUG__ID D0YP8F D0YP8F DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0YP8F HIGHSTAT Phase 1 D0YQ9I DRUG__ID D0YQ9I D0YQ9I DRUGCOMP FUJIFILM Pharmaceuticals U.S.A. Cambridge, MA D0YQ9I HIGHSTAT Phase 1 D0YU1L DRUG__ID D0YU1L D0YU1L DRUGCOMP Mitsubishi Tanabe Pharma D0YU1L HIGHSTAT Phase 1 D0YZ4T DRUG__ID D0YZ4T D0YZ4T DRUGCOMP Applied Genetic Technologies Corp D0YZ4T HIGHSTAT Phase 1 D0Z0CU DRUG__ID D0Z0CU D0Z0CU DRUGCOMP Mesoblast; stemedica cell technologies D0Z0CU HIGHSTAT Phase 1 D0Z0FA DRUG__ID D0Z0FA D0Z0FA DRUGCOMP Millennium pharmaceuticals D0Z0FA HIGHSTAT Phase 1 D0Z1AB DRUG__ID D0Z1AB D0Z1AB DRUGCOMP AbbVieNorth Chicago, IL D0Z1AB HIGHSTAT Phase 1 D0Z1GP DRUG__ID D0Z1GP D0Z1GP DRUGCOMP Fate therapeutics D0Z1GP HIGHSTAT Phase 1 D0Z1NF DRUG__ID D0Z1NF D0Z1NF DRUGCOMP Fluoropharma D0Z1NF HIGHSTAT Phase 1 D0Z1OS DRUG__ID D0Z1OS D0Z1OS DRUGCOMP Arisaph Pharmaceuticals D0Z1OS HIGHSTAT Phase 1 D0Z1QR DRUG__ID D0Z1QR D0Z1QR DRUGCOMP Theravance Biopharma South San Francisco, CA D0Z1QR HIGHSTAT Phase 1 D0Z1UW DRUG__ID D0Z1UW D0Z1UW DRUGCOMP TransTech Pharma D0Z1UW HIGHSTAT Phase 1 D0Z2BI DRUG__ID D0Z2BI D0Z2BI DRUGCOMP Moderna Therapeutics Cambridge, MA D0Z2BI HIGHSTAT Phase 1 D0Z2GQ DRUG__ID D0Z2GQ D0Z2GQ DRUGCOMP Dynavax D0Z2GQ HIGHSTAT Phase 1 D0Z2HG DRUG__ID D0Z2HG D0Z2HG DRUGCOMP Merck D0Z2HG HIGHSTAT Phase 1 D0Z2WV DRUG__ID D0Z2WV D0Z2WV DRUGCOMP Astellas Pharma US Northbrook, IL D0Z2WV HIGHSTAT Phase 1 D0Z3HF DRUG__ID D0Z3HF D0Z3HF DRUGCOMP Antigen express D0Z3HF HIGHSTAT Phase 1 D0Z5LI DRUG__ID D0Z5LI D0Z5LI DRUGCOMP MedImmune Gaithersburg, MD D0Z5LI HIGHSTAT Phase 1 D0Z6AM DRUG__ID D0Z6AM D0Z6AM DRUGCOMP Bayer healthcare pharmaceuticals; oncomed pharmaceuticals D0Z6AM HIGHSTAT Phase 1 D0Z6RW DRUG__ID D0Z6RW D0Z6RW DRUGCOMP Baylor College of Medicine D0Z6RW HIGHSTAT Phase 1 D0Z7FK DRUG__ID D0Z7FK D0Z7FK DRUGCOMP Mersana Therapeutics D0Z7FK HIGHSTAT Phase 1 D0Z8JR DRUG__ID D0Z8JR D0Z8JR DRUGCOMP Bristol-Myers Squibb D0Z8JR HIGHSTAT Phase 1 D0Z8PO DRUG__ID D0Z8PO D0Z8PO DRUGCOMP Kemin Pharma Europe D0Z8PO HIGHSTAT Phase 1 D0Z9NY DRUG__ID D0Z9NY D0Z9NY DRUGCOMP Allergan Inc D0Z9NY HIGHSTAT Phase 1 D0Z9QX DRUG__ID D0Z9QX D0Z9QX DRUGCOMP Cingulate Therapeutics Kansas City, KS D0Z9QX HIGHSTAT Phase 1 D0ZA0W DRUG__ID D0ZA0W D0ZA0W DRUGCOMP OncBioMune Pharmaceuticals Baton Rouge, LA D0ZA0W HIGHSTAT Phase 1 D0ZA1K DRUG__ID D0ZA1K D0ZA1K DRUGCOMP Bellicum Pharmaceuticals Houston, TX D0ZA1K HIGHSTAT Phase 1 D0ZA6P DRUG__ID D0ZA6P D0ZA6P DRUGCOMP CBT Pharmaceuticals Pleasanton, CA D0ZA6P HIGHSTAT Phase 1 D0ZF8F DRUG__ID D0ZF8F D0ZF8F DRUGCOMP CureDM D0ZF8F HIGHSTAT Phase 1 D0ZI5U DRUG__ID D0ZI5U D0ZI5U DRUGCOMP Xeris Pharmaceuticals Chicago, IL D0ZI5U HIGHSTAT Phase 1 D0ZJ0R DRUG__ID D0ZJ0R D0ZJ0R DRUGCOMP Hapten Sciences Memphis, TN D0ZJ0R HIGHSTAT Phase 1 D0ZL5J DRUG__ID D0ZL5J D0ZL5J DRUGCOMP Exicure Skokie, IL D0ZL5J HIGHSTAT Phase 1 D0ZM5E DRUG__ID D0ZM5E D0ZM5E DRUGCOMP Vical Inc D0ZM5E HIGHSTAT Phase 1 D0ZO5K DRUG__ID D0ZO5K D0ZO5K DRUGCOMP MedImmune Gaithersburg, MD D0ZO5K HIGHSTAT Phase 1 D0ZR1Z DRUG__ID D0ZR1Z D0ZR1Z DRUGCOMP ImmunoGenWaltham, MA D0ZR1Z HIGHSTAT Phase 1 D0ZT4J DRUG__ID D0ZT4J D0ZT4J DRUGCOMP Jerini AG D0ZT4J HIGHSTAT Phase 1 D0ZW2I DRUG__ID D0ZW2I D0ZW2I DRUGCOMP Axovant Sciences New York, NY D0ZW2I HIGHSTAT Phase 1 D0ZW6X DRUG__ID D0ZW6X D0ZW6X DRUGCOMP Bristol-Myers Squibb Princeton, MA D0ZW6X HIGHSTAT Phase 1 D0ZX1E DRUG__ID D0ZX1E D0ZX1E DRUGCOMP Janssen biotech D0ZX1E HIGHSTAT Phase 1 D0ZX2D DRUG__ID D0ZX2D D0ZX2D DRUGCOMP University of Pittsburgh D0ZX2D HIGHSTAT Phase 1 D0ZX2L DRUG__ID D0ZX2L D0ZX2L DRUGCOMP GlaxoSmithKline Research Triangle Park, NC D0ZX2L HIGHSTAT Phase 1 D12DYT DRUG__ID D12DYT D12DYT DRUGCOMP AbbVie D12DYT HIGHSTAT Phase 1 D13VWF DRUG__ID D13VWF D13VWF DRUGCOMP MicuRx Pharmaceuticals D13VWF HIGHSTAT Phase 1 D1FH8R DRUG__ID D1FH8R D1FH8R DRUGCOMP Aldeyra Therapeutics D1FH8R HIGHSTAT Phase 1 D1G7XU DRUG__ID D1G7XU D1G7XU DRUGCOMP Chugai Pharmaceutical D1G7XU HIGHSTAT Phase 1 D1NW2F DRUG__ID D1NW2F D1NW2F DRUGCOMP JOHNSON & JOHNSON D1NW2F HIGHSTAT Phase 1 D20IMG DRUG__ID D20IMG D20IMG DRUGCOMP AI Therapeutics D20IMG HIGHSTAT Phase 1 D28EMJ DRUG__ID D28EMJ D28EMJ DRUGTYPE Recombinant protein D28EMJ HIGHSTAT Phase 1 D2MFD0 DRUG__ID D2MFD0 D2MFD0 DRUGCOMP Gilead D2MFD0 HIGHSTAT Phase 1 D2OEG6 DRUG__ID D2OEG6 D2OEG6 DRUGCOMP CinFina Pharma D2OEG6 HIGHSTAT Phase 1 D2Q3VY DRUG__ID D2Q3VY D2Q3VY DRUGTYPE Antibody D2Q3VY HIGHSTAT Phase 1 D2UB6Z DRUG__ID D2UB6Z D2UB6Z DRUGCOMP Roche D2UB6Z HIGHSTAT Phase 1 D2UE8B DRUG__ID D2UE8B D2UE8B DRUGCOMP Qpex Biopharma D2UE8B HIGHSTAT Phase 1 D37JBX DRUG__ID D37JBX D37JBX DRUGCOMP Merck D37JBX HIGHSTAT Phase 1 D39NLO DRUG__ID D39NLO D39NLO DRUGCOMP Roche D39NLO HIGHSTAT Phase 1 D3D9CL DRUG__ID D3D9CL D3D9CL DRUGCOMP Boehringer Ingelheim Pharmaceuticals D3D9CL HIGHSTAT Phase 1 D3FYE1 DRUG__ID D3FYE1 D3FYE1 DRUGTYPE Antibody D3FYE1 HIGHSTAT Phase 1 D3GIQ9 DRUG__ID D3GIQ9 D3GIQ9 DRUGCOMP Janssen D3GIQ9 HIGHSTAT Phase 1 D3HBL2 DRUG__ID D3HBL2 D3HBL2 DRUGCOMP MedImmune D3HBL2 HIGHSTAT Phase 1 D3KZ4Y DRUG__ID D3KZ4Y D3KZ4Y DRUGCOMP Novo Nordisk D3KZ4Y HIGHSTAT Phase 1 D3NB8K DRUG__ID D3NB8K D3NB8K DRUGCOMP NGM Biopharmaceuticals D3NB8K HIGHSTAT Phase 1 D3SP2U DRUG__ID D3SP2U D3SP2U DRUGCOMP Bristol-Myers Squibb D3SP2U HIGHSTAT Phase 1 D48MDS DRUG__ID D48MDS D48MDS DRUGCOMP Harpoon Therapeutics D48MDS HIGHSTAT Phase 1 D4P3EC DRUG__ID D4P3EC D4P3EC DRUGCOMP JOHNSON & JOHNSON D4P3EC HIGHSTAT Phase 1 D4VLI7 DRUG__ID D4VLI7 D4VLI7 DRUGCOMP Janssen Research & Development Raritan, NJ D4VLI7 HIGHSTAT Phase 1 D52MXY DRUG__ID D52MXY D52MXY DRUGCOMP Akros Pharma D52MXY HIGHSTAT Phase 1 D53NSY DRUG__ID D53NSY D53NSY DRUGCOMP Teva Pharmaceutical D53NSY HIGHSTAT Phase 1 D54FYW DRUG__ID D54FYW D54FYW DRUGCOMP Tempest Therapeutics D54FYW HIGHSTAT Phase 1 D57NHD DRUG__ID D57NHD D57NHD DRUGCOMP Roche D57NHD HIGHSTAT Phase 1 D5H2SZ DRUG__ID D5H2SZ D5H2SZ DRUGCOMP Mallinckrodt D5H2SZ HIGHSTAT Phase 1 D5KIL8 DRUG__ID D5KIL8 D5KIL8 DRUGCOMP Immunocore; Roche/Genentech D5KIL8 HIGHSTAT Phase 1 D5QR2M DRUG__ID D5QR2M D5QR2M DRUGCOMP GlaxoSmithKline D5QR2M HIGHSTAT Phase 1 D61LJZ DRUG__ID D61LJZ D61LJZ DRUGCOMP RiMO Therapeutics D61LJZ HIGHSTAT Phase 1 D63WFO DRUG__ID D63WFO D63WFO DRUGCOMP AstraZeneca Wilmington, DE D63WFO HIGHSTAT Phase 1 D6CZ0T DRUG__ID D6CZ0T D6CZ0T DRUGTYPE Small molecular drug D6CZ0T HIGHSTAT Phase 1 D6E1GI DRUG__ID D6E1GI D6E1GI DRUGCOMP Pfzer D6E1GI HIGHSTAT Phase 1 D6FX2G DRUG__ID D6FX2G D6FX2G DRUGCOMP VITRAC Therapeutics D6FX2G HIGHSTAT Phase 1 D6QO5V DRUG__ID D6QO5V D6QO5V DRUGCOMP Coordination Pharmaceuticals D6QO5V HIGHSTAT Phase 1 D6QRJ2 DRUG__ID D6QRJ2 D6QRJ2 DRUGCOMP Roche/Genentech D6QRJ2 HIGHSTAT Phase 1 D6V9SI DRUG__ID D6V9SI D6V9SI DRUGCOMP Lilly Indianapolis, IN D6V9SI HIGHSTAT Phase 1 D6ZGP9 DRUG__ID D6ZGP9 D6ZGP9 DRUGCOMP Lilly D6ZGP9 HIGHSTAT Phase 1 D73GNI DRUG__ID D73GNI D73GNI DRUGCOMP JOHNSON & JOHNSON D73GNI HIGHSTAT Phase 1 D73ZML DRUG__ID D73ZML D73ZML DRUGCOMP ImmVira Pharma D73ZML HIGHSTAT Phase 1 D75WVO DRUG__ID D75WVO D75WVO DRUGCOMP Statera Biopharma D75WVO HIGHSTAT Phase 1 D7CWQ0 DRUG__ID D7CWQ0 D7CWQ0 DRUGCOMP Roche/Genentech D7CWQ0 HIGHSTAT Phase 1 D7FJX0 DRUG__ID D7FJX0 D7FJX0 DRUGCOMP Astrocyte Pharmaceuticals D7FJX0 HIGHSTAT Phase 1 D7FPZ4 DRUG__ID D7FPZ4 D7FPZ4 DRUGTYPE Antibody D7FPZ4 HIGHSTAT Phase 1 D7NQ0Z DRUG__ID D7NQ0Z D7NQ0Z DRUGCOMP Roche D7NQ0Z HIGHSTAT Phase 1 D7PGM4 DRUG__ID D7PGM4 D7PGM4 DRUGCOMP Merck D7PGM4 HIGHSTAT Phase 1 D7PY9O DRUG__ID D7PY9O D7PY9O DRUGCOMP GlaxoSmithKline D7PY9O HIGHSTAT Phase 1 D7T5AN DRUG__ID D7T5AN D7T5AN DRUGCOMP Checkmate Pharmaceuticals D7T5AN HIGHSTAT Phase 1 D7XB0Q DRUG__ID D7XB0Q D7XB0Q DRUGCOMP Sunovion Pharmaceuticals D7XB0Q HIGHSTAT Phase 1 D80OLH DRUG__ID D80OLH D80OLH DRUGCOMP Coordination Pharmaceuticals D80OLH HIGHSTAT Phase 1 D83IYO DRUG__ID D83IYO D83IYO DRUGCOMP Roche D83IYO HIGHSTAT Phase 1 D8G7UL DRUG__ID D8G7UL D8G7UL DRUGCOMP Novo Nordisk D8G7UL HIGHSTAT Phase 1 D8ID3Y DRUG__ID D8ID3Y D8ID3Y DRUGCOMP GlaxoSmithKline D8ID3Y HIGHSTAT Phase 1 D8IJR1 DRUG__ID D8IJR1 D8IJR1 DRUGCOMP LOXO Oncology D8IJR1 HIGHSTAT Phase 1 D8OTE9 DRUG__ID D8OTE9 D8OTE9 DRUGCOMP GlaxoSmithKline D8OTE9 HIGHSTAT Phase 1 D8PO7Y DRUG__ID D8PO7Y D8PO7Y DRUGCOMP Boehringer Ingelheim Pharmaceuticals D8PO7Y HIGHSTAT Phase 1 D91DAH DRUG__ID D91DAH D91DAH DRUGCOMP Roche D91DAH HIGHSTAT Phase 1 D92KBX DRUG__ID D92KBX D92KBX DRUGCOMP Roche D92KBX HIGHSTAT Phase 1 D98VPM DRUG__ID D98VPM D98VPM DRUGCOMP MingSight Pharmaceuticals D98VPM HIGHSTAT Phase 1 D9OQ6R DRUG__ID D9OQ6R D9OQ6R DRUGCOMP Vaxiion Therapeutics D9OQ6R HIGHSTAT Phase 1 DA02DE DRUG__ID DA02DE DA02DE DRUGTYPE Small molecular drug DA02DE HIGHSTAT Phase 1 DA79HM DRUG__ID DA79HM DA79HM DRUGCOMP F-star Therapeutics DA79HM HIGHSTAT Phase 1 DAOT46 DRUG__ID DAOT46 DAOT46 DRUGTYPE Antibody DAOT46 HIGHSTAT Phase 1 DB2Q4X DRUG__ID DB2Q4X DB2Q4X DRUGCOMP Hutchison MediPharma Shanghai, China DB2Q4X HIGHSTAT Phase 1 DB2R5Y DRUG__ID DB2R5Y DB2R5Y DRUGCOMP Cytocom DB2R5Y HIGHSTAT Phase 1 DB2VY6 DRUG__ID DB2VY6 DB2VY6 DRUGCOMP GlaxoSmithKline DB2VY6 HIGHSTAT Phase 1 DB9C7F DRUG__ID DB9C7F DB9C7F DRUGCOMP Boehringer Ingelheim Pharmaceuticals DB9C7F HIGHSTAT Phase 1 DB9O4X DRUG__ID DB9O4X DB9O4X DRUGCOMP Cytocom DB9O4X HIGHSTAT Phase 1 DBL5H8 DRUG__ID DBL5H8 DBL5H8 DRUGCOMP Merck DBL5H8 HIGHSTAT Phase 1 DBL96D DRUG__ID DBL96D DBL96D DRUGCOMP Xoc Pharmaceuticals DBL96D HIGHSTAT Phase 1 DBO39X DRUG__ID DBO39X DBO39X DRUGCOMP Janssen DBO39X HIGHSTAT Phase 1 DBT1H4 DRUG__ID DBT1H4 DBT1H4 DRUGCOMP Chemigen DBT1H4 HIGHSTAT Phase 1 DBY42T DRUG__ID DBY42T DBY42T DRUGCOMP Newave Pharmaceuticals DBY42T HIGHSTAT Phase 1 DC0P6U DRUG__ID DC0P6U DC0P6U DRUGCOMP Atea Pharmaceuticals DC0P6U HIGHSTAT Phase 1 DC25FH DRUG__ID DC25FH DC25FH DRUGCOMP JOHNSON & JOHNSON DC25FH HIGHSTAT Phase 1 DC29BL DRUG__ID DC29BL DC29BL DRUGCOMP ERX Pharmaceuticals Cambridge, MA DC29BL HIGHSTAT Phase 1 DC3I7P DRUG__ID DC3I7P DC3I7P DRUGCOMP GlaxoSmithKline DC3I7P HIGHSTAT Phase 1 DC7P4Z DRUG__ID DC7P4Z DC7P4Z DRUGCOMP Inhibikase Therapeutics, Inc. DC7P4Z HIGHSTAT Phase 1 DCQ6L4 DRUG__ID DCQ6L4 DCQ6L4 DRUGTYPE Cell therapy DCQ6L4 HIGHSTAT Phase 1 DCXB47 DRUG__ID DCXB47 DCXB47 DRUGCOMP Quadriga BioSciences DCXB47 HIGHSTAT Phase 1 DD90AS DRUG__ID DD90AS DD90AS DRUGCOMP Dantari DD90AS HIGHSTAT Phase 1 DDEI09 DRUG__ID DDEI09 DDEI09 DRUGCOMP TransThera Sciences Nanjing, China DDEI09 HIGHSTAT Phase 1 DDZ6B0 DRUG__ID DDZ6B0 DDZ6B0 DRUGCOMP Roche/Genentech DDZ6B0 HIGHSTAT Phase 1 DE6P0A DRUG__ID DE6P0A DE6P0A DRUGCOMP Lilly Indianapolis DE6P0A HIGHSTAT Phase 1 DE7Q3R DRUG__ID DE7Q3R DE7Q3R DRUGCOMP Fulgent Pharma Temple City, CA DE7Q3R HIGHSTAT Phase 1 DEQW79 DRUG__ID DEQW79 DEQW79 DRUGCOMP Lilly Indianapolis, IN DEQW79 HIGHSTAT Phase 1 DEY48G DRUG__ID DEY48G DEY48G DRUGCOMP JOHNSON & JOHNSON DEY48G HIGHSTAT Phase 1 DF0L3G DRUG__ID DF0L3G DF0L3G DRUGCOMP Incyte DF0L3G HIGHSTAT Phase 1 DF63BG DRUG__ID DF63BG DF63BG DRUGCOMP Biom Therapeutics DF63BG HIGHSTAT Phase 1 DF8M1T DRUG__ID DF8M1T DF8M1T DRUGCOMP Tempest Therapeutics DF8M1T HIGHSTAT Phase 1 DFM7X6 DRUG__ID DFM7X6 DFM7X6 DRUGCOMP BeyondBio DFM7X6 HIGHSTAT Phase 1 DFO5W3 DRUG__ID DFO5W3 DFO5W3 DRUGCOMP Merck DFO5W3 HIGHSTAT Phase 1 DG38QS DRUG__ID DG38QS DG38QS DRUGCOMP G1 Therapeutics DG38QS HIGHSTAT Phase 1 DG5T9Q DRUG__ID DG5T9Q DG5T9Q DRUGCOMP Artielle ImmunoTherapeutics DG5T9Q HIGHSTAT Phase 1 DGCQ13 DRUG__ID DGCQ13 DGCQ13 DRUGCOMP Merck DGCQ13 HIGHSTAT Phase 1 DGV5Z3 DRUG__ID DGV5Z3 DGV5Z3 DRUGCOMP Merck DGV5Z3 HIGHSTAT Phase 1 DGY9E0 DRUG__ID DGY9E0 DGY9E0 DRUGCOMP Roche DGY9E0 HIGHSTAT Phase 1 DH4Y3O DRUG__ID DH4Y3O DH4Y3O DRUGCOMP Eli Lilly DH4Y3O HIGHSTAT Phase 1 DHQD71 DRUG__ID DHQD71 DHQD71 DRUGCOMP Takeda DHQD71 HIGHSTAT Phase 1 DHX7A6 DRUG__ID DHX7A6 DHX7A6 DRUGCOMP GlaxoSmithKline DHX7A6 HIGHSTAT Phase 1 DI8WC4 DRUG__ID DI8WC4 DI8WC4 DRUGTYPE Antibody DI8WC4 HIGHSTAT Phase 1 DIE8M7 DRUG__ID DIE8M7 DIE8M7 DRUGCOMP Roche DIE8M7 HIGHSTAT Phase 1 DIK3P4 DRUG__ID DIK3P4 DIK3P4 DRUGCOMP Gilead DIK3P4 HIGHSTAT Phase 1 DJ0E7P DRUG__ID DJ0E7P DJ0E7P DRUGTYPE Antisense oligonucleotide DJ0E7P HIGHSTAT Phase 1 DJ51FH DRUG__ID DJ51FH DJ51FH DRUGTYPE Antibody DJ51FH HIGHSTAT Phase 1 DJLX87 DRUG__ID DJLX87 DJLX87 DRUGCOMP Lilly (LOXO Oncology) Indianapolis, IN DJLX87 HIGHSTAT Phase 1 DJME35 DRUG__ID DJME35 DJME35 DRUGCOMP Novartis Pharmaceuticals DJME35 HIGHSTAT Phase 1 DJR71Z DRUG__ID DJR71Z DJR71Z DRUGCOMP AlaMab Therapeutics DJR71Z HIGHSTAT Phase 1 DJX7I5 DRUG__ID DJX7I5 DJX7I5 DRUGCOMP Lilly Indianapolis DJX7I5 HIGHSTAT Phase 1 DK3WQ5 DRUG__ID DK3WQ5 DK3WQ5 DRUGCOMP NeuroTherapia DK3WQ5 HIGHSTAT Phase 1 DK42QY DRUG__ID DK42QY DK42QY DRUGCOMP Roche DK42QY HIGHSTAT Phase 1 DK5JP3 DRUG__ID DK5JP3 DK5JP3 DRUGCOMP Genzada Pharmaceuticals DK5JP3 HIGHSTAT Phase 1 DK5T9H DRUG__ID DK5T9H DK5T9H DRUGCOMP Gilead DK5T9H HIGHSTAT Phase 1 DKI1A8 DRUG__ID DKI1A8 DKI1A8 DRUGCOMP AstraZeneca DKI1A8 HIGHSTAT Phase 1 DLN0P8 DRUG__ID DLN0P8 DLN0P8 DRUGCOMP Sumitomo Dainippon Pharma DLN0P8 HIGHSTAT Phase 1 DLP9J8 DRUG__ID DLP9J8 DLP9J8 DRUGCOMP Lilly Indianapolis DLP9J8 HIGHSTAT Phase 1 DM1VE5 DRUG__ID DM1VE5 DM1VE5 DRUGCOMP Pfizer DM1VE5 HIGHSTAT Phase 1 DMKG40 DRUG__ID DMKG40 DMKG40 DRUGTYPE Antibody DMKG40 HIGHSTAT Phase 1 DMP6A9 DRUG__ID DMP6A9 DMP6A9 DRUGCOMP Ziopharm Oncology DMP6A9 HIGHSTAT Phase 1 DN2F9A DRUG__ID DN2F9A DN2F9A DRUGTYPE Protein DN2F9A HIGHSTAT Phase 1 DN47VK DRUG__ID DN47VK DN47VK DRUGCOMP AstraZeneca DN47VK HIGHSTAT Phase 1 DN5O8K DRUG__ID DN5O8K DN5O8K DRUGCOMP Gan & Lee Pharmaceuticals USA Bridgewater, NJ DN5O8K HIGHSTAT Phase 1 DN65GW DRUG__ID DN65GW DN65GW DRUGCOMP Eli Lilly DN65GW HIGHSTAT Phase 1 DNC97Y DRUG__ID DNC97Y DNC97Y DRUGCOMP Boehringer Ingelheim DNC97Y HIGHSTAT Phase 1 DNH51Q DRUG__ID DNH51Q DNH51Q DRUGCOMP Aphios DNH51Q HIGHSTAT Phase 1 DNTW18 DRUG__ID DNTW18 DNTW18 DRUGCOMP Sun Pharma Advanced Research Company DNTW18 HIGHSTAT Phase 1 DNY63Z DRUG__ID DNY63Z DNY63Z DRUGCOMP Bristol-Myers Squibb DNY63Z HIGHSTAT Phase 1 DNYC95 DRUG__ID DNYC95 DNYC95 DRUGCOMP Locus Biosciences DNYC95 HIGHSTAT Phase 1 DO3E7R DRUG__ID DO3E7R DO3E7R DRUGCOMP Pfizer DO3E7R HIGHSTAT Phase 1 DO3XB8 DRUG__ID DO3XB8 DO3XB8 DRUGCOMP Novartis DO3XB8 HIGHSTAT Phase 1 DO61WZ DRUG__ID DO61WZ DO61WZ DRUGCOMP ViiV Healthcare DO61WZ HIGHSTAT Phase 1 DO6T4G DRUG__ID DO6T4G DO6T4G DRUGCOMP Pfzer DO6T4G HIGHSTAT Phase 1 DO83IK DRUG__ID DO83IK DO83IK DRUGCOMP Sanofi DO83IK HIGHSTAT Phase 1 DO8W9E DRUG__ID DO8W9E DO8W9E DRUGCOMP EMD Serono DO8W9E HIGHSTAT Phase 1 DOJM42 DRUG__ID DOJM42 DOJM42 DRUGCOMP Merck Kenilworth, NJ DOJM42 HIGHSTAT Phase 1 DOY1D6 DRUG__ID DOY1D6 DOY1D6 DRUGCOMP Hengrui Therapeutics DOY1D6 HIGHSTAT Phase 1 DOY4E6 DRUG__ID DOY4E6 DOY4E6 DRUGTYPE Antibody DOY4E6 HIGHSTAT Phase 1 DP1SI9 DRUG__ID DP1SI9 DP1SI9 DRUGCOMP GlaxoSmithKline DP1SI9 HIGHSTAT Phase 1 DP7Z9Q DRUG__ID DP7Z9Q DP7Z9Q DRUGTYPE Antibody DP7Z9Q HIGHSTAT Phase 1 DPAS02 DRUG__ID DPAS02 DPAS02 DRUGCOMP Agenus; Gilead Sciences DPAS02 HIGHSTAT Phase 1 DQ6J0W DRUG__ID DQ6J0W DQ6J0W DRUGCOMP GlaxoSmithKline DQ6J0W HIGHSTAT Phase 1 DQA23T DRUG__ID DQA23T DQA23T DRUGTYPE Small molecule DQA23T HIGHSTAT Phase 1 DQB70D DRUG__ID DQB70D DQB70D DRUGCOMP Roche DQB70D HIGHSTAT Phase 1 DQO46V DRUG__ID DQO46V DQO46V DRUGCOMP Carmot Therapeutics Berkeley, CA DQO46V HIGHSTAT Phase 1 DR7TY4 DRUG__ID DR7TY4 DR7TY4 DRUGCOMP JOHNSON & JOHNSON DR7TY4 HIGHSTAT Phase 1 DRFS19 DRUG__ID DRFS19 DRFS19 DRUGCOMP JOHNSON & JOHNSON DRFS19 HIGHSTAT Phase 1 DRG3B4 DRUG__ID DRG3B4 DRG3B4 DRUGCOMP Takeda DRG3B4 HIGHSTAT Phase 1 DRGZ61 DRUG__ID DRGZ61 DRGZ61 DRUGCOMP Shionogi DRGZ61 HIGHSTAT Phase 1 DRT09Y DRUG__ID DRT09Y DRT09Y DRUGCOMP Eisai DRT09Y HIGHSTAT Phase 1 DS70NZ DRUG__ID DS70NZ DS70NZ DRUGCOMP Asceneuron DS70NZ HIGHSTAT Phase 1 DSF65Q DRUG__ID DSF65Q DSF65Q DRUGCOMP Roche DSF65Q HIGHSTAT Phase 1 DSM39E DRUG__ID DSM39E DSM39E DRUGCOMP GlaxoSmithKline DSM39E HIGHSTAT Phase 1 DT7GB8 DRUG__ID DT7GB8 DT7GB8 DRUGCOMP Roche DT7GB8 HIGHSTAT Phase 1 DT8IL6 DRUG__ID DT8IL6 DT8IL6 DRUGCOMP FORMA Therapeutics DT8IL6 HIGHSTAT Phase 1 DTYQ45 DRUG__ID DTYQ45 DTYQ45 DRUGCOMP Takeda DTYQ45 HIGHSTAT Phase 1 DU47WT DRUG__ID DU47WT DU47WT DRUGCOMP Luye Pharma Group Ltd. DU47WT HIGHSTAT Phase 1 DU5W3E DRUG__ID DU5W3E DU5W3E DRUGCOMP Roche DU5W3E HIGHSTAT Phase 1 DUF26L DRUG__ID DUF26L DUF26L DRUGCOMP Sunovion Pharmaceuticals DUF26L HIGHSTAT Phase 1 DUO7Y0 DRUG__ID DUO7Y0 DUO7Y0 DRUGCOMP Merck DUO7Y0 HIGHSTAT Phase 1 DUR0F6 DRUG__ID DUR0F6 DUR0F6 DRUGCOMP Symphogen DUR0F6 HIGHSTAT Phase 1 DUV3B0 DRUG__ID DUV3B0 DUV3B0 DRUGCOMP Roche DUV3B0 HIGHSTAT Phase 1 DV3J1P DRUG__ID DV3J1P DV3J1P DRUGCOMP Pfzer DV3J1P HIGHSTAT Phase 1 DVB59Y DRUG__ID DVB59Y DVB59Y DRUGCOMP Lilly Indianapolis, IN DVB59Y HIGHSTAT Phase 1 DVI8T3 DRUG__ID DVI8T3 DVI8T3 DRUGCOMP Sunovion Pharmaceuticals DVI8T3 HIGHSTAT Phase 1 DVM21E DRUG__ID DVM21E DVM21E DRUGCOMP Teva Pharmaceutical DVM21E HIGHSTAT Phase 1 DVRS03 DRUG__ID DVRS03 DVRS03 DRUGCOMP GlaxoSmithKline DVRS03 HIGHSTAT Phase 1 DVU2H8 DRUG__ID DVU2H8 DVU2H8 DRUGCOMP CureVac DVU2H8 HIGHSTAT Phase 1 DW0VB7 DRUG__ID DW0VB7 DW0VB7 DRUGCOMP JOHNSON & JOHNSON DW0VB7 HIGHSTAT Phase 1 DW12LD DRUG__ID DW12LD DW12LD DRUGCOMP Otsuka Pharmaceutical DW12LD HIGHSTAT Phase 1 DW27CA DRUG__ID DW27CA DW27CA DRUGCOMP InnoMedica Schweiz AG DW27CA HIGHSTAT Phase 1 DWF4O2 DRUG__ID DWF4O2 DWF4O2 DRUGCOMP Sanofi DWF4O2 HIGHSTAT Phase 1 DWNR12 DRUG__ID DWNR12 DWNR12 DRUGCOMP IGC Pharma DWNR12 HIGHSTAT Phase 1 DXVD02 DRUG__ID DXVD02 DXVD02 DRUGCOMP Roche DXVD02 HIGHSTAT Phase 1 DY70GQ DRUG__ID DY70GQ DY70GQ DRUGCOMP Novo Nordisk DY70GQ HIGHSTAT Phase 1 DYC40H DRUG__ID DYC40H DYC40H DRUGCOMP AstraZeneca DYC40H HIGHSTAT Phase 1 DYN4W0 DRUG__ID DYN4W0 DYN4W0 DRUGCOMP Synspira DYN4W0 HIGHSTAT Phase 1 DYNT08 DRUG__ID DYNT08 DYNT08 DRUGCOMP Kainos Medicine DYNT08 HIGHSTAT Phase 1 DYR01B DRUG__ID DYR01B DYR01B DRUGCOMP JOHNSON & JOHNSON DYR01B HIGHSTAT Phase 1 DYZ76K DRUG__ID DYZ76K DYZ76K DRUGCOMP Basking Biosciences DYZ76K HIGHSTAT Phase 1 DZ46KV DRUG__ID DZ46KV DZ46KV DRUGCOMP JOHNSON & JOHNSON DZ46KV HIGHSTAT Phase 1 DZ68IC DRUG__ID DZ68IC DZ68IC DRUGCOMP Merck DZ68IC HIGHSTAT Phase 1 DZJ3D5 DRUG__ID DZJ3D5 DZJ3D5 DRUGCOMP Pfizer DZJ3D5 HIGHSTAT Phase 1 DZLM72 DRUG__ID DZLM72 DZLM72 DRUGCOMP Jiangsu Hengrui DZLM72 HIGHSTAT Phase 1 DZM0J8 DRUG__ID DZM0J8 DZM0J8 DRUGCOMP Sound Biologics Bothell, WA DZM0J8 HIGHSTAT Phase 1 DZY4R2 DRUG__ID DZY4R2 DZY4R2 DRUGCOMP Janssen DZY4R2 HIGHSTAT Phase 1 D00EGU DRUG__ID D00EGU D00EGU HIGHSTAT Phase 1 D00EXZ DRUG__ID D00EXZ D00EXZ HIGHSTAT Phase 1 D00FMK DRUG__ID D00FMK D00FMK HIGHSTAT Phase 1 D00VJC DRUG__ID D00VJC D00VJC HIGHSTAT Phase 1 D00XEX DRUG__ID D00XEX D00XEX HIGHSTAT Phase 1 D00XMZ DRUG__ID D00XMZ D00XMZ HIGHSTAT Phase 1 D01RCM DRUG__ID D01RCM D01RCM HIGHSTAT Phase 1 D01XZG DRUG__ID D01XZG D01XZG HIGHSTAT Phase 1 D01YLK DRUG__ID D01YLK D01YLK HIGHSTAT Phase 1 D02AWQ DRUG__ID D02AWQ D02AWQ HIGHSTAT Phase 1 D02UPI DRUG__ID D02UPI D02UPI HIGHSTAT Phase 1 D02URD DRUG__ID D02URD D02URD HIGHSTAT Phase 1 D02XAC DRUG__ID D02XAC D02XAC HIGHSTAT Phase 1 D03GGN DRUG__ID D03GGN D03GGN HIGHSTAT Phase 1 D03IQD DRUG__ID D03IQD D03IQD HIGHSTAT Phase 1 D03SZK DRUG__ID D03SZK D03SZK HIGHSTAT Phase 1 D03WWW DRUG__ID D03WWW D03WWW HIGHSTAT Phase 1 D04MBK DRUG__ID D04MBK D04MBK HIGHSTAT Phase 1 D04XUJ DRUG__ID D04XUJ D04XUJ HIGHSTAT Phase 1 D05HID DRUG__ID D05HID D05HID HIGHSTAT Phase 1 D05ODE DRUG__ID D05ODE D05ODE HIGHSTAT Phase 1 D05TDJ DRUG__ID D05TDJ D05TDJ HIGHSTAT Phase 1 D05YRP DRUG__ID D05YRP D05YRP HIGHSTAT Phase 1 D06HNO DRUG__ID D06HNO D06HNO HIGHSTAT Phase 1 D06MKG DRUG__ID D06MKG D06MKG HIGHSTAT Phase 1 D06UBF DRUG__ID D06UBF D06UBF HIGHSTAT Phase 1 D07ZUX DRUG__ID D07ZUX D07ZUX HIGHSTAT Phase 1 D08UHV DRUG__ID D08UHV D08UHV HIGHSTAT Phase 1 D09ALM DRUG__ID D09ALM D09ALM HIGHSTAT Phase 1 D09FYW DRUG__ID D09FYW D09FYW HIGHSTAT Phase 1 D09JSM DRUG__ID D09JSM D09JSM HIGHSTAT Phase 1 D09MPX DRUG__ID D09MPX D09MPX HIGHSTAT Phase 1 D09QYD DRUG__ID D09QYD D09QYD HIGHSTAT Phase 1 D0B2NF DRUG__ID D0B2NF D0B2NF HIGHSTAT Phase 1 D0B8MB DRUG__ID D0B8MB D0B8MB HIGHSTAT Phase 1 D0BL0G DRUG__ID D0BL0G D0BL0G HIGHSTAT Phase 1 D0C0SZ DRUG__ID D0C0SZ D0C0SZ HIGHSTAT Phase 1 D0C1AY DRUG__ID D0C1AY D0C1AY HIGHSTAT Phase 1 D0C1TR DRUG__ID D0C1TR D0C1TR HIGHSTAT Phase 1 D0C5OK DRUG__ID D0C5OK D0C5OK HIGHSTAT Phase 1 D0CN7I DRUG__ID D0CN7I D0CN7I HIGHSTAT Phase 1 D0D1HS DRUG__ID D0D1HS D0D1HS HIGHSTAT Phase 1 D0D3FP DRUG__ID D0D3FP D0D3FP HIGHSTAT Phase 1 D0D6XH DRUG__ID D0D6XH D0D6XH HIGHSTAT Phase 1 D0F470 DRUG__ID D0F470 D0F470 HIGHSTAT Phase 1 D0G0TT DRUG__ID D0G0TT D0G0TT HIGHSTAT Phase 1 D0I5JM DRUG__ID D0I5JM D0I5JM HIGHSTAT Phase 1 D0I5NN DRUG__ID D0I5NN D0I5NN HIGHSTAT Phase 1 D0J0BN DRUG__ID D0J0BN D0J0BN HIGHSTAT Phase 1 D0J0WX DRUG__ID D0J0WX D0J0WX HIGHSTAT Phase 1 D0JA3Y DRUG__ID D0JA3Y D0JA3Y HIGHSTAT Phase 1 D0JB4V DRUG__ID D0JB4V D0JB4V HIGHSTAT Phase 1 D0JS0W DRUG__ID D0JS0W D0JS0W HIGHSTAT Phase 1 D0K2HU DRUG__ID D0K2HU D0K2HU HIGHSTAT Phase 1 D0K4IS DRUG__ID D0K4IS D0K4IS HIGHSTAT Phase 1 D0KV1I DRUG__ID D0KV1I D0KV1I HIGHSTAT Phase 1 D0L2GX DRUG__ID D0L2GX D0L2GX HIGHSTAT Phase 1 D0L5DK DRUG__ID D0L5DK D0L5DK HIGHSTAT Phase 1 D0L5JA DRUG__ID D0L5JA D0L5JA HIGHSTAT Phase 1 D0N0DU DRUG__ID D0N0DU D0N0DU HIGHSTAT Phase 1 D0OU3Q DRUG__ID D0OU3Q D0OU3Q HIGHSTAT Phase 1 D0PB0U DRUG__ID D0PB0U D0PB0U HIGHSTAT Phase 1 D0PH4R DRUG__ID D0PH4R D0PH4R HIGHSTAT Phase 1 D0Q1UB DRUG__ID D0Q1UB D0Q1UB HIGHSTAT Phase 1 D0T6ES DRUG__ID D0T6ES D0T6ES HIGHSTAT Phase 1 D0T7BD DRUG__ID D0T7BD D0T7BD HIGHSTAT Phase 1 D0U8LD DRUG__ID D0U8LD D0U8LD HIGHSTAT Phase 1 D0UL2I DRUG__ID D0UL2I D0UL2I HIGHSTAT Phase 1 D0V5JQ DRUG__ID D0V5JQ D0V5JQ HIGHSTAT Phase 1 D0VJ7G DRUG__ID D0VJ7G D0VJ7G HIGHSTAT Phase 1 D0W2RY DRUG__ID D0W2RY D0W2RY HIGHSTAT Phase 1 D0W6XV DRUG__ID D0W6XV D0W6XV HIGHSTAT Phase 1 D0W8NP DRUG__ID D0W8NP D0W8NP HIGHSTAT Phase 1 D0X1QM DRUG__ID D0X1QM D0X1QM HIGHSTAT Phase 1 D0Z3BU DRUG__ID D0Z3BU D0Z3BU HIGHSTAT Phase 1 D0ZY3R DRUG__ID D0ZY3R D0ZY3R HIGHSTAT Phase 1 D62JOV DRUG__ID D62JOV D62JOV HIGHSTAT Phase 1 D00EPS DRUG__ID D00EPS D00EPS DRUGTYPE Small molecular drug D00EPS DRUGINCH 1S/C21H27N5O6S/c22-19(23)16-8-6-14(7-9-16)10-24-20(29)17(11-27)25-21(30)18(12-28)26-33(31,32)13-15-4-2-1-3-5-15/h1-9,17-18,26-28H,10-13H2,(H3,22,23)(H,24,29)(H,25,30)/t17-,18+/m0/s1 D00EPS DRUGINKE ZNOKJHWJKULOGM-ZWKOTPCHSA-N D00EPS DRUGSMIL C1=CC=C(C=C1)CS(=O)(=O)NC(CO)C(=O)NC(CO)C(=O)NCC2=CC=C(C=C2)C(=N)N D00EPS HIGHSTAT Clinical trial D00HTY DRUG__ID D00HTY D00HTY DRUGTYPE Small molecular drug D00HTY DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 D00HTY DRUGINKE PXGPLTODNUVGFL-YNNPMVKQSA-N D00HTY DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O D00HTY HIGHSTAT Clinical trial D00XKB DRUG__ID D00XKB D00XKB DRUGTYPE Small molecular drug D00XKB DRUGINCH 1S/C30H25FN4O/c1-4-8-20-14-22(17-33-16-20)21-9-6-10-23(15-21)30(24-13-19(3)29(36)35(5-2)18-24)25-11-7-12-26(31)27(25)28(32)34-30/h6-7,9-18H,5H2,1-3H3,(H2,32,34)/t30-/m0/s1 D00XKB DRUGINKE TUGLMYZSOPKJOA-PMERELPUSA-N D00XKB DRUGSMIL CCN1C=C(C=C(C1=O)C)C2(C3=C(C(=CC=C3)F)C(=N2)N)C4=CC=CC(=C4)C5=CN=CC(=C5)C#CC D00XKB HIGHSTAT Clinical trial D02NHW DRUG__ID D02NHW D02NHW DRUGTYPE Small molecular drug D02NHW DRUGINCH 1S/C17H21N3O4S/c1-13-15(19-17(21)18-14-8-4-2-5-9-14)12-16(24-13)25(22,23)20-10-6-3-7-11-20/h2,4-5,8-9,12H,3,6-7,10-11H2,1H3,(H2,18,19,21) D02NHW DRUGINKE LVOVQRPAMXCXTM-UHFFFAOYSA-N D02NHW DRUGSMIL CC1=C(C=C(O1)S(=O)(=O)N2CCCCC2)NC(=O)NC3=CC=CC=C3 D02NHW HIGHSTAT Clinical trial D02NUT DRUG__ID D02NUT D02NUT DRUGTYPE Small molecular drug D02NUT DRUGINCH 1S/C30H33N3O5S/c1-19-16-32(17-20(2)37-19)18-28(35)31-23-6-7-27-22(13-23)12-21-4-3-5-25(30(21)39-27)26-14-24(34)15-29(38-26)33-8-10-36-11-9-33/h3-7,13-15,19-20H,8-12,16-18H2,1-2H3,(H,31,35)/t19-,20+ D02NUT DRUGINKE SCELLOWTHJGVIC-BGYRXZFFSA-N D02NUT DRUGSMIL CC1CN(CC(O1)C)CC(=O)NC2=CC3=C(C=C2)SC4=C(C3)C=CC=C4C5=CC(=O)C=C(O5)N6CCOCC6 D02NUT HIGHSTAT Clinical trial D02ZQS DRUG__ID D02ZQS D02ZQS DRUGTYPE Small molecular drug D02ZQS DRUGINCH 1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38) D02ZQS DRUGINKE YOVNFNXUCOWYSG-UHFFFAOYSA-N D02ZQS DRUGSMIL CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6 D02ZQS HIGHSTAT Clinical trial D03JRG DRUG__ID D03JRG D03JRG DRUGTYPE Small molecular drug D03JRG DRUGINCH 1S/C26H27FN4O2/c27-22-6-3-7-23(17-22)31-18-29-25(33)26(31)10-13-30(14-11-26)15-12-28-24(32)21-9-8-19-4-1-2-5-20(19)16-21/h1-9,16-17H,10-15,18H2,(H,28,32)(H,29,33) D03JRG DRUGINKE MSTXJJGAXXJCBY-UHFFFAOYSA-N D03JRG DRUGSMIL C1CN(CCC12C(=O)NCN2C3=CC(=CC=C3)F)CCNC(=O)C4=CC5=CC=CC=C5C=C4 D03JRG HIGHSTAT Clinical trial D05EMV DRUG__ID D05EMV D05EMV DRUGTYPE Small molecular drug D05EMV DRUGINCH 1S/C15H11F3N2O2S/c1-9-4-2-5-10(8-9)19-20-12(14(22)15(16,17)18)13(21)11-6-3-7-23-11/h2-8,21H,1H3 D05EMV DRUGINKE OETQEFUTOKYBSL-UHFFFAOYSA-N D05EMV DRUGSMIL CC1=CC(=CC=C1)N=NC(=C(C2=CC=CS2)O)C(=O)C(F)(F)F D05EMV HIGHSTAT Clinical trial D05TKW DRUG__ID D05TKW D05TKW DRUGTYPE Small molecular drug D05TKW DRUGINCH 1S/C29H43BrN10O5S/c1-16(2)22(25(43)38-20(6-4-12-35-27(31)32)23(41)26-34-14-15-46-26)40-24(42)21(7-5-13-36-28(33)44)39-29(45)37-17(3)18-8-10-19(30)11-9-18/h8-11,14-17,20-22H,4-7,12-13H2,1-3H3,(H,38,43)(H,40,42)(H4,31,32,35)(H3,33,36,44)(H2,37,39,45)/t17-,20+,21+,22+/m1/s1 D05TKW DRUGINKE BGBJLVHKOHYLME-MNAPGUCWSA-N D05TKW DRUGSMIL CC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)C1=NC=CS1)NC(=O)C(CCCNC(=O)N)NC(=O)NC(C)C2=CC=C(C=C2)Br D05TKW HIGHSTAT Clinical trial D07QTG DRUG__ID D07QTG D07QTG DRUGTYPE Small molecular drug D07QTG DRUGINCH 1S/C28H32N4O2S/c33-26(25-12-7-15-29-27(25)35-24-10-5-2-6-11-24)30-22-28(13-20-34-21-14-28)32-18-16-31(17-19-32)23-8-3-1-4-9-23/h1-12,15H,13-14,16-22H2,(H,30,33) D07QTG DRUGINKE XREFXUCWSYMIOG-UHFFFAOYSA-N D07QTG DRUGSMIL C1COCCC1(CNC(=O)C2=C(N=CC=C2)SC3=CC=CC=C3)N4CCN(CC4)C5=CC=CC=C5 D07QTG HIGHSTAT Clinical trial D08KMU DRUG__ID D08KMU D08KMU DRUGTYPE Small molecular drug D08KMU DRUGINCH 1S/C19H26N2O3/c1-6-24-11-21-16(10-15-8-13(4)7-14(5)9-15)17(12(2)3)18(22)20-19(21)23/h7-9,12H,6,10-11H2,1-5H3,(H,20,22,23) D08KMU DRUGINKE NVGVZWUORYLPAL-UHFFFAOYSA-N D08KMU DRUGSMIL CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC(=CC(=C2)C)C D08KMU HIGHSTAT Clinical trial D08QWQ DRUG__ID D08QWQ D08QWQ DRUGTYPE Small molecular drug D08QWQ DRUGINCH 1S/C23H32O5/c24-18(13-12-17-8-4-3-5-9-17)14-15-20-19(21(25)16-22(20)26)10-6-1-2-7-11-23(27)28/h1,3-6,8-9,14-15,18-22,24-26H,2,7,10-13,16H2,(H,27,28)/b6-1-,15-14+/t18-,19+,20+,21-,22+/m0/s1 D08QWQ DRUGINKE YFHHIZGZVLHBQZ-KDACTHKWSA-N D08QWQ DRUGSMIL C1C(C(C(C1O)C=CC(CCC2=CC=CC=C2)O)CC=CCCCC(=O)O)O D08QWQ HIGHSTAT Clinical trial D0A4RF DRUG__ID D0A4RF D0A4RF DRUGTYPE Small molecular drug D0A4RF DRUGINCH 1S/C20H19FN2O6/c1-2-27-12-11-20(17(24)22-19(26)23-18(20)25)29-16-9-7-15(8-10-16)28-14-5-3-13(21)4-6-14/h3-10H,2,11-12H2,1H3,(H2,22,23,24,25,26) D0A4RF DRUGINKE XRSYNYGEEYTXJV-UHFFFAOYSA-N D0A4RF DRUGSMIL CCOCCC1(C(=O)NC(=O)NC1=O)OC2=CC=C(C=C2)OC3=CC=C(C=C3)F D0A4RF HIGHSTAT Clinical trial D0A8UP DRUG__ID D0A8UP D0A8UP DRUGTYPE Small molecular drug D0A8UP DRUGINCH 1S/C22H33N3O4/c1-22(2,3)17-6-4-16(5-7-17)20(26)23-18-8-10-19(11-9-18)29-21(27)24-25-12-14-28-15-13-25/h8-11,16-17H,4-7,12-15H2,1-3H3,(H,23,26)(H,24,27) D0A8UP DRUGINKE XSLDWDIQZLTRHG-UHFFFAOYSA-N D0A8UP DRUGSMIL CC(C)(C)C1CCC(CC1)C(=O)NC2=CC=C(C=C2)OC(=O)NN3CCOCC3 D0A8UP HIGHSTAT Clinical trial D0CG8S DRUG__ID D0CG8S D0CG8S DRUGTYPE Small molecular drug D0CG8S DRUGINCH 1S/C19H15F4N5O2/c1-18(7-15(19(21,22)23)30-17(25)28-18)12-6-11(3-4-13(12)20)27-16(29)14-5-2-10(8-24)9-26-14/h2-6,9,15H,7H2,1H3,(H2,25,28)(H,27,29)/t15-,18-/m0/s1 D0CG8S DRUGINKE MELQHVBGGSKVJQ-YJBOKZPZSA-N D0CG8S DRUGSMIL CC1(CC(OC(=N1)N)C(F)(F)F)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F D0CG8S HIGHSTAT Clinical trial D0FE7H DRUG__ID D0FE7H D0FE7H DRUGTYPE Small molecular drug D0FE7H DRUGINCH 1S/C44H40BrCl2N3O8/c1-56-39-24-34(35(45)25-40(39)57-2)42(53)48-37(22-27-9-8-12-31(21-27)58-30-10-4-3-5-11-30)38(51)26-49(19-17-28-15-16-29(46)23-36(28)47)41(52)18-20-50-43(54)32-13-6-7-14-33(32)44(50)55/h3-16,21,23-25,37-38,51H,17-20,22,26H2,1-2H3,(H,48,53)/t37-,38-/m0/s1 D0FE7H DRUGINKE DQHKQRXAVNDAFY-UWXQCODUSA-N D0FE7H DRUGSMIL COC1=C(C=C(C(=C1)C(=O)NC(CC2=CC(=CC=C2)OC3=CC=CC=C3)C(CN(CCC4=C(C=C(C=C4)Cl)Cl)C(=O)CCN5C(=O)C6=CC=CC=C6C5=O)O)Br)OC D0FE7H HIGHSTAT Clinical trial D0G0YZ DRUG__ID D0G0YZ D0G0YZ DRUGTYPE Small molecular drug D0G0YZ DRUGINCH 1S/C17H13ClN4O2/c18-14-8-21-15(22-17(19)20)13-7-10(4-5-12(13)14)9-2-1-3-11(6-9)16(23)24/h1-8H,(H,23,24)(H4,19,20,21,22) D0G0YZ DRUGINKE UXNWIRHZMHGOCE-UHFFFAOYSA-N D0G0YZ DRUGSMIL C1=CC(=CC(=C1)C(=O)O)C2=CC3=C(C=C2)C(=CN=C3N=C(N)N)Cl D0G0YZ HIGHSTAT Clinical trial D0H6AG DRUG__ID D0H6AG D0H6AG DRUGTYPE Small molecular drug D0H6AG DRUGINCH 1S/C27H36F4N2O4S/c1-26(2,3)19-7-5-6-16(9-19)12-33-21-15-38(35)14-18(25(21)34)8-17-10-20(28)24(32)22(11-17)37-23(13-36-4)27(29,30)31/h5-7,9-11,18,21,23,25,33-34H,8,12-15,32H2,1-4H3/t18-,21+,23-,25+,38-/m1/s1 D0H6AG DRUGINKE FIUDDEQHPBHZBI-XPLIUGCLSA-N D0H6AG DRUGSMIL CC(C)(C)C1=CC=CC(=C1)CNC2CS(=O)CC(C2O)CC3=CC(=C(C(=C3)F)N)OC(COC)C(F)(F)F D0H6AG HIGHSTAT Clinical trial D0I2FI DRUG__ID D0I2FI D0I2FI DRUGTYPE Small molecular drug D0I2FI DRUGINCH 1S/C30H38N4/c1-23-21-27(31)25-15-9-11-17-29(25)33(23)19-13-7-5-3-4-6-8-14-20-34-24(2)22-28(32)26-16-10-12-18-30(26)34/h9-12,15-18,21-22,31-32H,3-8,13-14,19-20H2,1-2H3/p+2 D0I2FI DRUGINKE PCSWXVJAIHCTMO-UHFFFAOYSA-P D0I2FI DRUGSMIL CC1=[N+](C2=CC=CC=C2C(=C1)N)CCCCCCCCCC[N+]3=C(C=C(C4=CC=CC=C43)N)C D0I2FI HIGHSTAT Clinical trial D0I8HJ DRUG__ID D0I8HJ D0I8HJ DRUGTYPE Small molecular drug D0I8HJ DRUGINCH 1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3 D0I8HJ DRUGINKE FJIKWRGCXUCUIG-UHFFFAOYSA-N D0I8HJ DRUGSMIL CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl D0I8HJ HIGHSTAT Clinical trial D0J3SU DRUG__ID D0J3SU D0J3SU DRUGTYPE Small molecular drug D0J3SU DRUGINCH 1S/C26H24N2O5S/c29-25-23-16-22(13-14-24(23)27(26(25)30)17-19-8-3-1-4-9-19)34(31,32)28-15-7-10-20(28)18-33-21-11-5-2-6-12-21/h1-6,8-9,11-14,16,20H,7,10,15,17-18H2/t20-/m0/s1 D0J3SU DRUGINKE PKOUAUWPBMZQCH-FQEVSTJZSA-N D0J3SU DRUGSMIL C1CC(N(C1)S(=O)(=O)C2=CC3=C(C=C2)N(C(=O)C3=O)CC4=CC=CC=C4)COC5=CC=CC=C5 D0J3SU HIGHSTAT Clinical trial D0J6XC DRUG__ID D0J6XC D0J6XC DRUGTYPE Small molecular drug D0J6XC DRUGINCH 1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20) D0J6XC DRUGINKE UOWZUVNAGUAEQC-UHFFFAOYSA-N D0J6XC DRUGSMIL C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O D0J6XC HIGHSTAT Clinical trial D0L4VI DRUG__ID D0L4VI D0L4VI DRUGTYPE Small molecular drug D0L4VI DRUGINCH 1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1 D0L4VI DRUGINKE XUJNEKJLAYXESH-REOHCLBHSA-N D0L4VI DRUGSMIL C(C(C(=O)O)N)S D0L4VI HIGHSTAT Clinical trial D0LB0X DRUG__ID D0LB0X D0LB0X DRUGTYPE Small molecular drug D0LB0X DRUGINCH 1S/C31H37NO4/c33-30(16-10-2-1-5-11-25-12-6-3-7-13-25)32-28(19-22-31(34)35)23-26-17-20-29(21-18-26)36-24-27-14-8-4-9-15-27/h3-4,6-9,12-15,17-18,20-21,28H,1-2,5,10-11,16,19,22-24H2,(H,32,33)(H,34,35)/t28-/m0/s1 D0LB0X DRUGINKE KWLUIYFCMHKLKY-NDEPHWFRSA-N D0LB0X DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)NC(CCC(=O)O)CC2=CC=C(C=C2)OCC3=CC=CC=C3 D0LB0X HIGHSTAT Clinical trial D0M8KY DRUG__ID D0M8KY D0M8KY DRUGTYPE Small molecular drug D0M8KY DRUGINCH 1S/C22H20N2O6/c1-2-22(28)11-13-10-16-17-14(9-12-5-3-4-6-15(12)23-17)20(29-8-7-25)24(16)19(26)18(13)30-21(22)27/h3-6,9-10,20,25,28H,2,7-8,11H2,1H3/t20-,22-/m0/s1 D0M8KY DRUGINKE UPAYPYZHFCRCMO-UNMCSNQZSA-N D0M8KY DRUGSMIL CCC1(CC2=C(C(=O)N3C(C4=CC5=CC=CC=C5N=C4C3=C2)OCCO)OC1=O)O D0M8KY HIGHSTAT Clinical trial D0M9RQ DRUG__ID D0M9RQ D0M9RQ DRUGTYPE Small molecular drug D0M9RQ DRUGINCH 1S/C23H24F3N3O2/c1-16-27-20-7-4-6-19(23(24,25)26)21(20)22(30)29(16)17-8-10-18(11-9-17)31-15-5-14-28-12-2-3-13-28/h4,6-11H,2-3,5,12-15H2,1H3 D0M9RQ DRUGINKE DDDZBLNULGDPGA-UHFFFAOYSA-N D0M9RQ DRUGSMIL CC1=NC2=CC=CC(=C2C(=O)N1C3=CC=C(C=C3)OCCCN4CCCC4)C(F)(F)F D0M9RQ HIGHSTAT Clinical trial D0O7HP DRUG__ID D0O7HP D0O7HP DRUGTYPE Small molecular drug D0O7HP DRUGINCH 1S/C18H18ClFN4O2/c1-10-5-11(19)7-22-16(10)17(25)23-12-3-4-14(20)13(6-12)18(2)9-26-8-15(21)24-18/h3-7H,8-9H2,1-2H3,(H2,21,24)(H,23,25)/t18-/m0/s1 D0O7HP DRUGINKE RAFVKOLBEOKYJW-SFHVURJKSA-N D0O7HP DRUGSMIL CC1=CC(=CN=C1C(=O)NC2=CC(=C(C=C2)F)C3(COCC(=N3)N)C)Cl D0O7HP HIGHSTAT Clinical trial D0OG4A DRUG__ID D0OG4A D0OG4A DRUGTYPE Small molecular drug D0OG4A DRUGINCH 1S/C43H60N2O12/c1-9-11-13-21-31-42(6,7)38(50)39(51)43(54,57-31)28(10-2)40(52)44-23-17-16-19-26(4)36(55-8)27(5)37-35(49)34(48)30(56-37)20-15-12-14-18-25(3)33(47)32-29(46)22-24-45-41(32)53/h9,11-22,24,27-28,30-31,34-39,48-51,54H,10,23H2,1-8H3,(H,44,52)(H2,45,46,53)/b11-9-,14-12+,17-16+,20-15+,21-13+,25-18+,26-19+/t27-,28-,30-,31+,34+,35+,36-,37+,38+,39-,43-/m1/s1 D0OG4A DRUGINKE HMSYAPGFKGSXAJ-PAHGNTJYSA-N D0OG4A DRUGSMIL CCC(C(=O)NCC=CC=C(C)C(C(C)C1C(C(C(O1)C=CC=CC=C(C)C(=O)C2=C(C=CNC2=O)O)O)O)OC)C3(C(C(C(C(O3)C=CC=CC)(C)C)O)O)O D0OG4A HIGHSTAT Clinical trial D0PK7J DRUG__ID D0PK7J D0PK7J DRUGTYPE Small molecular drug D0PK7J DRUGINCH 1S/C33H35N11O4S/c34-31(35)26-11-9-22(10-12-26)16-36-32(45)29-14-27-19-43(41-38-27)17-24-7-4-8-25(13-24)18-44-20-28(39-42-44)15-30(33(46)37-29)40-49(47,48)21-23-5-2-1-3-6-23/h1-13,19-20,29-30,40H,14-18,21H2,(H3,34,35)(H,36,45)(H,37,46)/t29-,30+/m0/s1 D0PK7J DRUGINKE BKSCOHJNKDJECO-XZWHSSHBSA-N D0PK7J DRUGSMIL C1C(C(=O)NC(CC2=CN(CC3=CC=CC(=C3)CN4C=C1N=N4)N=N2)C(=O)NCC5=CC=C(C=C5)C(=N)N)NS(=O)(=O)CC6=CC=CC=C6 D0PK7J HIGHSTAT Clinical trial D0Q6NN DRUG__ID D0Q6NN D0Q6NN DRUGTYPE Small molecular drug D0Q6NN DRUGINCH 1S/C27H31NO.ClH.H2O/c1-28(2)17-16-21-8-13-26-19-27(15-14-25(26)18-21)29-20-22-9-11-24(12-10-22)23-6-4-3-5-7-23;;/h3-7,9-12,14-15,19,21H,8,13,16-18,20H2,1-2H3;1H;1H2/t21-;;/m0../s1 D0Q6NN DRUGINKE VBMPTAUGUUBFJK-FGJQBABTSA-N D0Q6NN DRUGSMIL CN(C)CCC1CCC2=C(C1)C=CC(=C2)OCC3=CC=C(C=C3)C4=CC=CC=C4.O.Cl D0Q6NN HIGHSTAT Clinical trial D0R7EA DRUG__ID D0R7EA D0R7EA DRUGTYPE Small molecular drug D0R7EA DRUGINCH 1S/C15H18N4O3/c1-15(2,3)10-7-5-9(6-8-10)12(20)17-14-16-11(18-19-14)13(21)22-4/h5-8H,1-4H3,(H2,16,17,18,19,20) D0R7EA DRUGINKE LVKKWCOINMSBPK-UHFFFAOYSA-N D0R7EA DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NC2=NNC(=N2)C(=O)OC D0R7EA HIGHSTAT Clinical trial D0S6TK DRUG__ID D0S6TK D0S6TK DRUGTYPE Small molecular drug D0S6TK DRUGINCH 1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30) D0S6TK DRUGINKE NHHQJBCNYHBUSI-UHFFFAOYSA-N D0S6TK DRUGSMIL CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C D0S6TK HIGHSTAT Clinical trial D0T7BV DRUG__ID D0T7BV D0T7BV DRUGTYPE Small molecular drug D0T7BV DRUGINCH 1S/C33H44N4O4S/c1-21(40-5)29(39)37-26(16-22-8-6-9-24(14-22)31-34-12-13-42-31)28(38)20-35-27-18-33(10-7-11-33)41-30-25(27)15-23(19-36-30)17-32(2,3)4/h6,8-9,12-15,19,21,26-28,35,38H,7,10-11,16-18,20H2,1-5H3,(H,37,39)/t21-,26+,27+,28-/m1/s1 D0T7BV DRUGINKE IUSARDYWEPUTPN-OZBXUNDUSA-N D0T7BV DRUGSMIL CC(C(=O)NC(CC1=CC(=CC=C1)C2=NC=CS2)C(CNC3CC4(CCC4)OC5=C3C=C(C=N5)CC(C)(C)C)O)OC D0T7BV HIGHSTAT Clinical trial D0X6QL DRUG__ID D0X6QL D0X6QL DRUGTYPE Small molecular drug D0X6QL DRUGINCH 1S/C14H12BrN3OS/c15-11-5-1-3-9(7-11)13(17-18-14(16)20)10-4-2-6-12(19)8-10/h1-8,19H,(H3,16,18,20)/b17-13+ D0X6QL DRUGINKE ZDBKSZKTCPOBFR-GHRIWEEISA-N D0X6QL DRUGSMIL C1=CC(=CC(=C1)O)C(=NNC(=S)N)C2=CC(=CC=C2)Br D0X6QL HIGHSTAT Clinical trial D0Y4LI DRUG__ID D0Y4LI D0Y4LI DRUGTYPE Small molecular drug D0Y4LI DRUGINCH 1S/C19H21F3N6/c1-2-13-10-23-12-24-18(13)28-7-5-27(6-8-28)11-17-25-15-4-3-14(19(20,21)22)9-16(15)26-17/h3-4,9-10,12H,2,5-8,11H2,1H3,(H,25,26) D0Y4LI DRUGINKE FBLPQCAQRNSVHB-UHFFFAOYSA-N D0Y4LI DRUGSMIL CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F D0Y4LI HIGHSTAT Clinical trial D0Y9FX DRUG__ID D0Y9FX D0Y9FX DRUGTYPE Small molecular drug D0Y9FX DRUGINCH 1S/C21H22N6O/c1-2-28-20-19-18(25-21(26-20)27-11-9-23-10-12-27)16-4-3-15(13-17(16)24-19)14-5-7-22-8-6-14/h3-8,13,23-24H,2,9-12H2,1H3 D0Y9FX DRUGINKE HFGHRUCCKVYFKL-UHFFFAOYSA-N D0Y9FX DRUGSMIL CCOC1=NC(=NC2=C1NC3=C2C=CC(=C3)C4=CC=NC=C4)N5CCNCC5 D0Y9FX HIGHSTAT Clinical trial D53CMU DRUG__ID D53CMU D53CMU DRUGTYPE Small molecular drug D53CMU DRUGINCH 1S/C4H9NO2Se/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1 D53CMU DRUGINKE XDSSPSLGNGIIHP-VKHMYHEASA-N D53CMU DRUGSMIL C[Se]CC(C(=O)O)N D53CMU HIGHSTAT Clinical Trial D01JCT DRUG__ID D01JCT D01JCT DRUGCOMP First Affiliated Hospital of Harbin Medical University D01JCT DRUGTYPE CAR T Cell Therapy D01JCT HIGHSTAT Clinical trial D04PDI DRUG__ID D04PDI D04PDI DRUGCOMP Qingdao Central Hospital D04PDI DRUGTYPE CAR T Cell Therapy D04PDI HIGHSTAT Clinical trial D04WZL DRUG__ID D04WZL D04WZL DRUGCOMP Shenzhen BinDeBio Ltd. D04WZL DRUGTYPE CAR T Cell Therapy D04WZL HIGHSTAT Clinical trial D05FZM DRUG__ID D05FZM D05FZM DRUGCOMP Shanghai Bioray Laboratory Inc. D05FZM DRUGTYPE CAR T Cell Therapy D05FZM HIGHSTAT Clinical trial D06CWZ DRUG__ID D06CWZ D06CWZ DRUGCOMP Kang YU D06CWZ DRUGTYPE CAR T Cell Therapy D06CWZ HIGHSTAT Clinical trial D09IAN DRUG__ID D09IAN D09IAN DRUGCOMP National Taiwan University Hospital D09IAN DRUGTYPE CAR T Cell Therapy D09IAN HIGHSTAT Clinical trial D09RPP DRUG__ID D09RPP D09RPP DRUGCOMP Kang YU D09RPP DRUGTYPE CAR T Cell Therapy D09RPP HIGHSTAT Clinical trial D09VYT DRUG__ID D09VYT D09VYT DRUGCOMP Sinobioway Cell Therapy Co., Ltd. D09VYT DRUGTYPE CAR T Cell Therapy D09VYT HIGHSTAT Clinical trial D09ZGK DRUG__ID D09ZGK D09ZGK DRUGCOMP Shanghai Bioray Laboratory Inc. D09ZGK DRUGTYPE CAR T Cell Therapy D09ZGK HIGHSTAT Clinical trial D0B8BZ DRUG__ID D0B8BZ D0B8BZ DRUGCOMP Innovative Cellular Therapeutics Co., Ltd. D0B8BZ DRUGTYPE CAR T Cell Therapy D0B8BZ HIGHSTAT Clinical trial D0LP1L DRUG__ID D0LP1L D0LP1L DRUGCOMP Zhujiang Hospital D0LP1L DRUGTYPE CAR T Cell Therapy D0LP1L HIGHSTAT Clinical trial D0N8NT DRUG__ID D0N8NT D0N8NT DRUGCOMP Shanghai Bioray Laboratory Inc. D0N8NT DRUGTYPE CAR T Cell Therapy D0N8NT HIGHSTAT Clinical trial D0NL9N DRUG__ID D0NL9N D0NL9N DRUGCOMP Chinese PLA General Hospital D0NL9N DRUGTYPE CAR T Cell Therapy (Dual specific) D0NL9N HIGHSTAT Clinical trial D0P1BM DRUG__ID D0P1BM D0P1BM DRUGCOMP RenJi Hospital D0P1BM DRUGTYPE CAR T Cell Therapy D0P1BM HIGHSTAT Clinical trial D0PF1A DRUG__ID D0PF1A D0PF1A DRUGCOMP Kang YU D0PF1A DRUGTYPE CAR T Cell Therapy D0PF1A HIGHSTAT Clinical trial D0RI8E DRUG__ID D0RI8E D0RI8E DRUGCOMP Sinobioway Cell Therapy Co., Ltd. D0RI8E DRUGTYPE CAR T Cell Therapy D0RI8E HIGHSTAT Clinical trial D0T6NG DRUG__ID D0T6NG D0T6NG DRUGCOMP Zhujiang Hospital D0T6NG DRUGTYPE CAR T Cell Therapy D0T6NG HIGHSTAT Clinical trial D0T8DD DRUG__ID D0T8DD D0T8DD DRUGCOMP Sinobioway Cell Therapy Co., Ltd. D0T8DD DRUGTYPE CAR T Cell Therapy D0T8DD HIGHSTAT Clinical trial D0U5NO DRUG__ID D0U5NO D0U5NO DRUGCOMP Kang YU D0U5NO DRUGTYPE CAR T Cell Therapy D0U5NO HIGHSTAT Clinical trial D0V6WU DRUG__ID D0V6WU D0V6WU DRUGCOMP Zhujiang Hospital D0V6WU DRUGTYPE CAR T Cell Therapy D0V6WU HIGHSTAT Clinical trial D0V6WW DRUG__ID D0V6WW D0V6WW DRUGCOMP Zhujiang Hospital D0V6WW DRUGTYPE CAR T Cell Therapy D0V6WW HIGHSTAT Clinical trial D1KC8H DRUG__ID D1KC8H D1KC8H DRUGCOMP Axial Biotherapeutics D1KC8H DRUGTYPE Small molecular drug D1KC8H HIGHSTAT Clinical Trial DAN93C DRUG__ID DAN93C DAN93C DRUGCOMP Atara Biotherapeutics DAN93C DRUGTYPE Cell therapy DAN93C HIGHSTAT Clinical trial DNEH27 DRUG__ID DNEH27 DNEH27 DRUGCOMP Azora Therapeutics DNEH27 DRUGTYPE Small molecule DNEH27 HIGHSTAT Clinical trial DO4YS2 DRUG__ID DO4YS2 DO4YS2 DRUGCOMP AVROBIO DO4YS2 DRUGTYPE Gene therapy DO4YS2 HIGHSTAT Clinical trial DSYN57 DRUG__ID DSYN57 DSYN57 DRUGCOMP Catapult Therapeutics Lelystad, The Netherlands DSYN57 DRUGTYPE Antibody DSYN57 HIGHSTAT Clinical trial DWD24I DRUG__ID DWD24I DWD24I DRUGCOMP BioNTech DWD24I DRUGTYPE Vaccine DWD24I HIGHSTAT Clinical trial D05CMT DRUG__ID D05CMT D05CMT DRUGCOMP OrbusNeich Fort Lauderdale, FL D05CMT HIGHSTAT Clinical trial D0E6EF DRUG__ID D0E6EF D0E6EF DRUGCOMP Bristol-Myers Squibb Princeton, NJ D0E6EF HIGHSTAT Clinical trial D0GR6I DRUG__ID D0GR6I D0GR6I DRUGCOMP NantCellCulver City, CA D0GR6I HIGHSTAT Clinical trial D0PLX5 DRUG__ID D0PLX5 D0PLX5 DRUGCOMP Sarfez Pharmaceuticals D0PLX5 HIGHSTAT Clinical trial D0QA3C DRUG__ID D0QA3C D0QA3C DRUGCOMP Novartis Pharmaceuticals East Hanover, NJ D0QA3C HIGHSTAT Clinical trial D0SW1D DRUG__ID D0SW1D D0SW1D DRUGCOMP Biostage Holliston, MA D0SW1D HIGHSTAT Clinical trial D0V0WE DRUG__ID D0V0WE D0V0WE DRUGCOMP Niadyne Pharma Fort Worth, TX D0V0WE HIGHSTAT Clinical trial D0VP7B DRUG__ID D0VP7B D0VP7B DRUGCOMP Sarfez Pharmaceuticals D0VP7B HIGHSTAT Clinical trial D8GN2C DRUG__ID D8GN2C D8GN2C DRUGCOMP Tris Pharma D8GN2C HIGHSTAT Clinical Trial DDNL40 DRUG__ID DDNL40 DDNL40 DRUGCOMP Kaleido Biosciences DDNL40 HIGHSTAT Clinical Trial DE4YT3 DRUG__ID DE4YT3 DE4YT3 DRUGCOMP Sarfez Pharmaceuticals DE4YT3 HIGHSTAT Clinical trial DF8M3V DRUG__ID DF8M3V DF8M3V DRUGCOMP Kaleido Biosciences DF8M3V HIGHSTAT Clinical Trial DS4A5E DRUG__ID DS4A5E DS4A5E DRUGCOMP Sarfez Pharmaceuticals DS4A5E HIGHSTAT Clinical trial DZVF15 DRUG__ID DZVF15 DZVF15 DRUGCOMP Tris Pharma DZVF15 HIGHSTAT Clinical Trial D00AIO DRUG__ID D00AIO D00AIO DRUGCOMP UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1 D00AIO DRUGTYPE Small molecular drug D00AIO DRUGINCH 1S/C18H14N2O/c1-21-13-8-6-12(7-9-13)14-10-11-19-18-17(14)15-4-2-3-5-16(15)20-18/h2-11H,1H3,(H,19,20) D00AIO DRUGINKE PJJCQNCRSXRPLV-UHFFFAOYSA-N D00AIO DRUGSMIL COC1=CC=C(C=C1)C2=C3C4=CC=CC=C4NC3=NC=C2 D00AIO HIGHSTAT Patented D00AIO COMPCLAS Pyridoindole derivatives D00BXK DRUG__ID D00BXK D00BXK DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D00BXK DRUGTYPE Small molecular drug D00BXK DRUGINCH 1S/C24H18Cl2FN5O/c25-15-7-5-14(6-8-15)23-18(13-21(28)29)22(24(33)30-17-11-9-16(27)10-12-17)31-32(23)20-4-2-1-3-19(20)26/h1-12H,13H2,(H3,28,29)(H,30,33) D00BXK DRUGINKE QWOVGBHZFLBBHN-UHFFFAOYSA-N D00BXK DRUGSMIL C1=CC=C(C(=C1)N2C(=C(C(=N2)C(=O)NC3=CC=C(C=C3)F)CC(=N)N)C4=CC=C(C=C4)Cl)Cl D00BXK HIGHSTAT Patented D00BXK COMPCLAS Pyrazole derivatives D00CRQ DRUG__ID D00CRQ D00CRQ DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D00CRQ DRUGTYPE Small molecule immunotherapy D00CRQ DRUGINCH 1S/C28H29BrClNO5/c1-18(2)11-12-35-25-14-26(23(30)13-21(25)15-31-24(16-32)28(33)34)36-17-20-9-6-10-22(27(20)29)19-7-4-3-5-8-19/h3-11,13-14,24,31-32H,12,15-17H2,1-2H3,(H,33,34) D00CRQ DRUGINKE HXFYELRCMXNMTR-UHFFFAOYSA-N D00CRQ DRUGSMIL CC(=CCOC1=CC(=C(C=C1CNC(CO)C(=O)O)Cl)OCC2=C(C(=CC=C2)C3=CC=CC=C3)Br)C D00CRQ HIGHSTAT Patented D00CRQ COMPCLAS Phenylate derivatives D00DDX DRUG__ID D00DDX D00DDX DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D00DDX DRUGTYPE Small molecular drug D00DDX DRUGINCH 1S/C19H16F4N4O3S/c1-30-15-7-12(20)3-4-13(15)14-8-17(25-10-24-14)27-18-6-11(9-31(2,28)29)5-16(26-18)19(21,22)23/h3-8,10H,9H2,1-2H3,(H,24,25,26,27) D00DDX DRUGINKE WUAZMKUDCHZMEP-UHFFFAOYSA-N D00DDX DRUGSMIL COC1=C(C=CC(=C1)F)C2=CC(=NC=N2)NC3=CC(=CC(=N3)C(F)(F)F)CS(=O)(=O)C D00DDX HIGHSTAT Patented D00DDX COMPCLAS N-(pyridin-2-yl)pyrimidin-4-amine derivatives D00DIZ DRUG__ID D00DIZ D00DIZ DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven S. CONDROSKI, Kevin Ronald HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy SEO, Jeongbeob D00DIZ DRUGTYPE Small molecular drug D00DIZ DRUGINCH 1S/C23H26FN5O4/c24-15-8-14(9-18(10-15)33-13-17(31)12-30)20-2-1-6-28(20)21-5-7-29-22(27-21)19(11-25-29)23(32)26-16-3-4-16/h5,7-11,16-17,20,30-31H,1-4,6,12-13H2,(H,26,32)/t17?,20-/m1/s1 D00DIZ DRUGINKE YDZSAJWQPHVDHL-UUSAFJCLSA-N D00DIZ DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)C(=O)NC4CC4)C5=CC(=CC(=C5)F)OCC(CO)O D00DIZ HIGHSTAT Patented D00DIZ COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D00FUZ DRUG__ID D00FUZ D00FUZ DRUGCOMP Pharma. Ip. General, Inc. Mamoto Health Science University D00FUZ DRUGTYPE Small molecular drug D00FUZ DRUGINCH 1S/C22H13ClN4O3/c23-14-8-9-17-15(11-14)16(12-18(24-17)13-5-2-1-3-6-13)20(28)25-22-27-26-21(30-22)19-7-4-10-29-19/h1-12H,(H,25,27,28) D00FUZ DRUGINKE GMIGNWBMEJMRDV-UHFFFAOYSA-N D00FUZ DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C=C(C=C3)Cl)C(=C2)C(=O)NC4=NN=C(O4)C5=CC=CO5 D00FUZ HIGHSTAT Patented D00FUZ COMPCLAS Quinoline carboxamide derivatives D00GMJ DRUG__ID D00GMJ D00GMJ DRUGCOMP Kissei Pharmaceutical Co. Ltd D00GMJ DRUGTYPE Small molecular drug D00GMJ DRUGINCH 1S/C15H9N3O3/c16-8-10-6-13(18-12(10)2-1-5-17-18)9-3-4-11(15(20)21)14(19)7-9/h1-7,19H,(H,20,21) D00GMJ DRUGINKE NSOWXVMDKNRRTI-UHFFFAOYSA-N D00GMJ DRUGSMIL C1=CC2=C(C=C(N2N=C1)C3=CC(=C(C=C3)C(=O)O)O)C#N D00GMJ HIGHSTAT Patented D00GMJ COMPCLAS Azaindole derivatives D00GOM DRUG__ID D00GOM D00GOM DRUGCOMP SNU R&DB Foundation, S. Korea D00GOM DRUGTYPE Small molecular drug D00GOM DRUGINCH 1S/C22H24O5/c1-22(2)11-10-16-18(27-22)9-7-15(21(16)26-5)17(23)12-14-6-8-19(24-3)20(13-14)25-4/h6-11,13H,12H2,1-5H3 D00GOM DRUGINKE TZRPLTHVBYHDBJ-UHFFFAOYSA-N D00GOM DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2OC)C(=O)CC3=CC(=C(C=C3)OC)OC)C D00GOM HIGHSTAT Patented D00GOM COMPCLAS 2,2-dimethylbenzopyran derivatives D00GTY DRUG__ID D00GTY D00GTY DRUGCOMP MEDIVATION TECHNOLOGIES, INC D00GTY DRUGTYPE Small molecular drug D00GTY DRUGINCH 1S/C21H17FN4O/c22-15-5-14(8-17(27)9-15)18-10-26(21-19(18)20(23)24-11-25-21)16-6-12-3-1-2-4-13(12)7-16/h1-5,8-11,16,27H,6-7H2,(H2,23,24,25) D00GTY DRUGINKE FOYDQEHGCZAQII-UHFFFAOYSA-N D00GTY DRUGSMIL C1C(CC2=CC=CC=C21)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC(=C5)F)O D00GTY HIGHSTAT Patented D00GTY COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D00ICS DRUG__ID D00ICS D00ICS DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D00ICS DRUGTYPE Small molecular drug D00ICS DRUGINCH 1S/C23H27F2N7O2/c1-14-10-27-20(11-26-14)19-9-22(31(2)30-19)29-23(33)28-21-13-32(6-7-34-3)12-16(21)15-4-5-17(24)18(25)8-15/h4-5,8-11,16,21H,6-7,12-13H2,1-3H3,(H2,28,29,33)/t16-,21+/m0/s1 D00ICS DRUGINKE NPZQKAJVRDLUTI-HRAATJIYSA-N D00ICS DRUGSMIL CC1=CN=C(C=N1)C2=NN(C(=C2)NC(=O)NC3CN(CC3C4=CC(=C(C=C4)F)F)CCOC)C D00ICS HIGHSTAT Patented D00ICS COMPCLAS Pyrrolidinyl urea derivatives D00JCQ DRUG__ID D00JCQ D00JCQ DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D00JCQ DRUGTYPE Small molecular drug D00JCQ DRUGINCH 1S/C26H32N4O3/c31-24(27-14-17-28-15-8-3-9-16-28)29-18-19-30-23(20-29)26(33-25(30)32,21-10-4-1-5-11-21)22-12-6-2-7-13-22/h1-2,4-7,10-13,23H,3,8-9,14-20H2,(H,27,31) D00JCQ DRUGINKE JJDDRYMIPIEXKX-UHFFFAOYSA-N D00JCQ DRUGSMIL C1CCN(CC1)CCNC(=O)N2CCN3C(C2)C(OC3=O)(C4=CC=CC=C4)C5=CC=CC=C5 D00JCQ HIGHSTAT Patented D00JCQ COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D00KDT DRUG__ID D00KDT D00KDT DRUGCOMP NEW YORK UNIVERSITY UNIVERSITY OF SOUTHERN CALIFORNIA ARORA, Paramjit S. OLENYUK, Bogdan LAU, Brooke Bullock GRISHAGIN, Ivan D00KDT DRUGTYPE Small molecular drug D00KDT DRUGINCH 1S/C24H42N6O5/c1-14(2)12-17-23(34)29(9-8-27-17)19(13-15(3)4)24(35)28-10-11-30(22(33)16(28)5)18(21(26)32)6-7-20(25)31/h14-19,27H,6-13H2,1-5H3,(H2,25,31)(H2,26,32)/t16-,17-,18-,19-/m0/s1 D00KDT DRUGINKE FMTAQWMOLHFOLT-VJANTYMQSA-N D00KDT DRUGSMIL CC1C(=O)N(CCN1C(=O)C(CC(C)C)N2CCNC(C2=O)CC(C)C)C(CCC(=O)N)C(=O)N D00KDT HIGHSTAT Patented D00KDT COMPCLAS Oligooxopiperazine derivatives D00KEX DRUG__ID D00KEX D00KEX DRUGCOMP PHARMACYCLICS, INC D00KEX DRUGTYPE Small molecular drug D00KEX DRUGINCH 1S/C27H30N6O2/c1-18-11-12-19(14-23(18)35-5)22-16-33(27-25(22)26(28)29-17-30-27)21-9-6-8-20(15-21)32(4)24(34)10-7-13-31(2)3/h6-12,14-17H,13H2,1-5H3,(H2,28,29,30)/b10-7+ D00KEX DRUGINKE XIEVUMXHZAXKDT-JXMROGBWSA-N D00KEX DRUGSMIL CC1=C(C=C(C=C1)C2=CN(C3=NC=NC(=C23)N)C4=CC(=CC=C4)N(C)C(=O)C=CCN(C)C)OC D00KEX HIGHSTAT Patented D00KEX COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D00KFI DRUG__ID D00KFI D00KFI DRUGCOMP JANSSEN PHARMACEUTICA NV D00KFI DRUGTYPE Small molecular drug D00KFI DRUGINCH 1S/C21H18ClF3N4O2S2/c22-17-14-2-1-12(21(23,24)25)7-16(14)33-18(17)20(31)29-8-13(9-29)27-3-5-28(6-4-27)19(30)15-10-32-11-26-15/h1-2,7,10-11,13H,3-6,8-9H2 D00KFI DRUGINKE HKKPDZNDQBHUOD-UHFFFAOYSA-N D00KFI DRUGSMIL C1CN(CCN1C2CN(C2)C(=O)C3=C(C4=C(S3)C=C(C=C4)C(F)(F)F)Cl)C(=O)C5=CSC=N5 D00KFI HIGHSTAT Patented D00KFI COMPCLAS Azetidinyl-piperazine derivatives D00KPQ DRUG__ID D00KPQ D00KPQ DRUGCOMP ADVINUS THERAPEUTICS LIMITED D00KPQ DRUGTYPE Small molecular drug D00KPQ DRUGINCH 1S/C36H35N7O2/c1-41-13-15-42(16-14-41)20-23-5-7-25(8-6-23)32-18-30-34(37-22-38-35(30)40-32)29-3-2-4-33(31(29)21-44)43-36(45)28-12-11-26(24-9-10-24)17-27(28)19-39-43/h2-8,11-12,17-19,22,24,44H,9-10,13-16,20-21H2,1H3,(H,37,38,40) D00KPQ DRUGINKE HPYIZQVYHGPMDT-UHFFFAOYSA-N D00KPQ DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N=CN=C4N3)C5=C(C(=CC=C5)N6C(=O)C7=C(C=C(C=C7)C8CC8)C=N6)CO D00KPQ HIGHSTAT Patented D00KPQ COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D00ONN DRUG__ID D00ONN D00ONN DRUGCOMP Pfizer Incorporated D00ONN DRUGTYPE Small molecular drug D00ONN DRUGINCH 1S/C19H18F3N7/c1-11-26-15(17-18(27(2)3)23-10-25-29(11)17)14-9-24-28(4)16(14)12-5-7-13(8-6-12)19(20,21)22/h5-10H,1-4H3 D00ONN DRUGINKE UXZUQMRCSXERSI-UHFFFAOYSA-N D00ONN DRUGSMIL CC1=NC(=C2N1N=CN=C2N(C)C)C3=C(N(N=C3)C)C4=CC=C(C=C4)C(F)(F)F D00ONN HIGHSTAT Patented D00ONN COMPCLAS Imidazo triazine derivatives D00PFD DRUG__ID D00PFD D00PFD DRUGCOMP IRONWOOD PHARMACEUTICALS, INC. HUDSON, Colleen BARDEN, Timothy, C. JIA, James MERMERIAN, Ara PENG, Bo YANG, Jane YU, Xiang, Y. SPROTT, Kevin FRETZEN, AngelikIRONWOOD PHARMACEUTICALS, INC. SPROTT, Kevin TALLEY, John, Jeffrey YANG, Jane PENG, Bo D00PFD DRUGTYPE Small molecular drug D00PFD DRUGINCH 1S/C23H20ClN3O3S/c1-13-10-18-22(31-13)20(14(2)27(18)12-15-4-6-16(24)7-5-15)21(28)23(29)26-17-8-9-25-19(11-17)30-3/h4-11H,12H2,1-3H3,(H,25,26,29) D00PFD DRUGINKE KJJWMDHJTAKZAD-UHFFFAOYSA-N D00PFD DRUGSMIL CC1=CC2=C(S1)C(=C(N2CC3=CC=C(C=C3)Cl)C)C(=O)C(=O)NC4=CC(=NC=C4)OC D00PFD HIGHSTAT Patented D00PFD COMPCLAS Benzyl pyrrolyloxoacetamide derivatives D00PGP DRUG__ID D00PGP D00PGP DRUGCOMP THE JOHNS HOPKINS UNIVERSITY The National Institutes of Health D00PGP DRUGTYPE Small molecular drug D00PGP DRUGINCH 1S/C26H27N3O4S/c30-26(27-23-7-11-25(12-8-23)34(31,32)29-15-17-33-18-16-29)21-5-9-24(10-6-21)28-14-13-20-3-1-2-4-22(20)19-28/h1-12H,13-19H2,(H,27,30) D00PGP DRUGINKE AXIVYOPFBOAPKD-UHFFFAOYSA-N D00PGP DRUGSMIL C1CN(CC2=CC=CC=C21)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)S(=O)(=O)N5CCOCC5 D00PGP HIGHSTAT Patented D00PGP COMPCLAS Benzamide derivatives D00QJA DRUG__ID D00QJA D00QJA DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj GRECO, Michael, N. SHOOK, Brian XU, Guozhang ZHANG, Rui D00QJA DRUGTYPE Small molecular drug D00QJA DRUGINCH 1S/C33H27ClF6N2O3/c1-18-13-20(31(45)41-12-11-30(43)44)4-8-26(18)28-15-23(33(38,39)40)5-3-21(28)17-42-24-7-10-27(29(34)16-24)25-9-6-22(14-19(25)2)32(35,36)37/h3-10,13-16,42H,11-12,17H2,1-2H3,(H,41,45)(H,43,44) D00QJA DRUGINKE DUDZHUBPDPKULT-UHFFFAOYSA-N D00QJA DRUGSMIL CC1=C(C=CC(=C1)C(=O)NCCC(=O)O)C2=C(C=CC(=C2)C(F)(F)F)CNC3=CC(=C(C=C3)C4=C(C=C(C=C4)C(F)(F)F)C)Cl D00QJA HIGHSTAT Patented D00QJA COMPCLAS Biphenyl carboxamidopropanoic acid derivatives D00TXZ DRUG__ID D00TXZ D00TXZ DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D00TXZ DRUGTYPE Small molecular drug D00TXZ DRUGINCH 1S/C13H9NO2S/c15-9-5-7-13(16,8-6-9)12-14-10-3-1-2-4-11(10)17-12/h1-8,16H D00TXZ DRUGINKE SDYBYKXWYDVVKP-UHFFFAOYSA-N D00TXZ DRUGSMIL C1=CC=C2C(=C1)N=C(S2)C3(C=CC(=O)C=C3)O D00TXZ HIGHSTAT Patented D00TXZ COMPCLAS 4-aryl quinol derivatives D00VEM DRUG__ID D00VEM D00VEM DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D00VEM DRUGTYPE Small molecular drug D00VEM DRUGINCH 1S/C21H19ClN6OS/c22-13-8-9-17-19(12-13)30-21(27-17)26-16-6-3-5-15(16)25-20(29)14-4-1-2-7-18(14)28-23-10-11-24-28/h1-2,4,7-12,15-16H,3,5-6H2,(H,25,29)(H,26,27)/t15-,16-/m0/s1 D00VEM DRUGINKE PCFLJOMEOCZUJL-HOTGVXAUSA-N D00VEM DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=C(S4)C=C(C=C5)Cl D00VEM HIGHSTAT Patented D00VEM COMPCLAS 1,2-diamino cyclopentane-based derivatives D00WZJ DRUG__ID D00WZJ D00WZJ DRUGCOMP Shenyang Pharmaceutical University, Peop. Rep. China D00WZJ DRUGTYPE Small molecular drug D00WZJ DRUGINCH 1S/C21H20O5/c1-21(2)11-10-15-18(26-21)9-6-14(20(15)24)16(22)7-4-13-5-8-19(25-3)17(23)12-13/h4-12,23-24H,1-3H3/b7-4+ D00WZJ DRUGINKE XCJXATSREUCGQN-QPJJXVBHSA-N D00WZJ DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)C=CC3=CC(=C(C=C3)OC)O)C D00WZJ HIGHSTAT Patented D00WZJ COMPCLAS 2,2-dimethylbenzopyran derivatives D00XFM DRUG__ID D00XFM D00XFM DRUGCOMP GLENMARK PHARMACEUTICALS S.A D00XFM DRUGTYPE Small molecular drug D00XFM DRUGINCH 1S/C27H23ClF2N4O3/c1-27(2,3)26(37)31-13-15-4-8-21(28)20(10-15)24(35)33-18-7-5-16-14-32-34(25(36)19(16)12-18)23-9-6-17(29)11-22(23)30/h4-12,14H,13H2,1-3H3,(H,31,37)(H,33,35) D00XFM DRUGINKE UWLKNQSOSOPRPR-UHFFFAOYSA-N D00XFM DRUGSMIL CC(C)(C)C(=O)NCC1=CC(=C(C=C1)Cl)C(=O)NC2=CC3=C(C=C2)C=NN(C3=O)C4=C(C=C(C=C4)F)F D00XFM HIGHSTAT Patented D00XFM COMPCLAS Phthalazinone derivatives D01CJE DRUG__ID D01CJE D01CJE DRUGCOMP CHANGZHOU LE SUN PHARMACEUTICALS LIMITED D01CJE DRUGTYPE Small molecular drug D01CJE DRUGINCH 1S/C15H15FN6O2S2/c1-8-13(25-15(18-2)20-8)12-11(16)7-19-14(22-12)21-9-4-3-5-10(6-9)26(17,23)24/h3-7H,1-2H3,(H,18,20)(H2,17,23,24)(H,19,21,22) D01CJE DRUGINKE GAIOPWBQKZMUNO-UHFFFAOYSA-N D01CJE DRUGSMIL CC1=C(SC(=N1)NC)C2=NC(=NC=C2F)NC3=CC(=CC=C3)S(=O)(=O)N D01CJE HIGHSTAT Patented D01CJE COMPCLAS 4-(thiazol-5-yl)-pyrimidine derivatives D01DSL DRUG__ID D01DSL D01DSL DRUGCOMP Institute of Materia Medica, Chinese Academy of Medical Sciences, Peop. Rep. China D01DSL DRUGTYPE Small molecular drug D01DSL DRUGINCH 1S/C29H29FO8/c1-25(2,33)28-21(37-28)22-29(38-22)26(3)11-10-16-17(13-34-23(16)32)18(26)12-19-27(29,36-19)24(28)35-20(31)9-6-14-4-7-15(30)8-5-14/h4-9,18-19,21-22,24,33H,10-13H2,1-3H3/b9-6+/t18-,19-,21-,22-,24-,26-,27+,28-,29+/m0/s1 D01DSL DRUGINKE FVQHGGQECDTHSW-YZAYWNIQSA-N D01DSL DRUGSMIL CC12CCC3=C(C1CC4C5(C26C(O6)C7C(C5OC(=O)C=CC8=CC=C(C=C8)F)(O7)C(C)(C)O)O4)COC3=O D01DSL HIGHSTAT Patented D01DSL COMPCLAS Triptolidenol analogs D01EHZ DRUG__ID D01EHZ D01EHZ DRUGCOMP Novartis AG D01EHZ DRUGTYPE Small molecular drug D01EHZ DRUGINCH 1S/C18H29N5O3/c1-14(2)21-10-12-23(13-11-21)18(25)26-15-6-8-22(9-7-15)16-4-5-17(24)20(3)19-16/h4-5,14-15H,6-13H2,1-3H3 D01EHZ DRUGINKE JXFIKXGRFYNISW-UHFFFAOYSA-N D01EHZ DRUGSMIL CC(C)N1CCN(CC1)C(=O)OC2CCN(CC2)C3=NN(C(=O)C=C3)C D01EHZ HIGHSTAT Patented D01EHZ COMPCLAS Piperazine carbamate/urea derivatives D01EKS DRUG__ID D01EKS D01EKS DRUGCOMP ASTON UNIVERSITY D01EKS DRUGTYPE Small molecular drug D01EKS DRUGINCH 1S/C19H28BrN3O3/c20-11-16(24)21-12-17(25)22-1-3-23(4-2-22)18(26)19-8-13-5-14(9-19)7-15(6-13)10-19/h13-15H,1-12H2,(H,21,24) D01EKS DRUGINKE SCSKGYPISIGLDU-UHFFFAOYSA-N D01EKS DRUGSMIL C1CN(CCN1C(=O)CNC(=O)CBr)C(=O)C23CC4CC(C2)CC(C4)C3 D01EKS HIGHSTAT Patented D01EKS COMPCLAS Acyl piperidine derivatives D01IJA DRUG__ID D01IJA D01IJA DRUGCOMP Novartis AG D01IJA DRUGTYPE Small molecular drug D01IJA DRUGINCH 1S/C19H29N5O3/c1-14(2)22-9-11-24(12-10-22)19(26)27-16-5-7-23(8-6-16)15-3-4-17(18(20)25)21-13-15/h3-4,13-14,16H,5-12H2,1-2H3,(H2,20,25) D01IJA DRUGINKE NJPLXPIWGPHUGQ-UHFFFAOYSA-N D01IJA DRUGSMIL CC(C)N1CCN(CC1)C(=O)OC2CCN(CC2)C3=CN=C(C=C3)C(=O)N D01IJA HIGHSTAT Patented D01IJA COMPCLAS Piperazine carbamate/urea derivatives D01ITP DRUG__ID D01ITP D01ITP DRUGCOMP LUNDBECK & CO AS H [DK] D01ITP DRUGTYPE Small molecular drug D01ITP DRUGINCH 1S/C17H13ClN4O/c1-10-16-20-21-17(11-6-3-4-7-12(11)18)22(16)15-13(19-10)8-5-9-14(15)23-2/h3-9H,1-2H3 D01ITP DRUGINKE MGVXODADYYKJPQ-UHFFFAOYSA-N D01ITP DRUGSMIL CC1=NC2=C(C(=CC=C2)OC)N3C1=NN=C3C4=CC=CC=C4Cl D01ITP HIGHSTAT Patented D01ITP COMPCLAS Triazolo-pyridine derivatives D01IVR DRUG__ID D01IVR D01IVR DRUGCOMP WASHINGTON UNIVERSITY D01IVR DRUGTYPE Small molecular drug D01IVR DRUGINCH 1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3 D01IVR DRUGINKE BKQFRNYHFIQEKN-UHFFFAOYSA-N D01IVR DRUGSMIL CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl D01IVR HIGHSTAT Patented D01IVR COMPCLAS Piperazinyl methyl quinazolinone derivatives D01KJZ DRUG__ID D01KJZ D01KJZ DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori IMASHIRO, Ritsuo SATO, Atsush D01KJZ DRUGTYPE Small molecular drug D01KJZ DRUGINCH 1S/C25H28Cl2N6O3/c1-2-28-25(35)29-13-16-36-23-21(24(34)31-32-14-5-6-15-32)30-33(20-8-4-3-7-19(20)27)22(23)17-9-11-18(26)12-10-17/h3-4,7-12H,2,5-6,13-16H2,1H3,(H,31,34)(H2,28,29,35) D01KJZ DRUGINKE ZDSBVGULFYUNNF-UHFFFAOYSA-N D01KJZ DRUGSMIL CCNC(=O)NCCOC1=C(N(N=C1C(=O)NN2CCCC2)C3=CC=CC=C3Cl)C4=CC=C(C=C4)Cl D01KJZ HIGHSTAT Patented D01KJZ COMPCLAS Pyrazole derivatives D01KPW DRUG__ID D01KPW D01KPW DRUGCOMP COCENSYS, INC D01KPW DRUGTYPE Small molecular drug D01KPW DRUGINCH 1S/C21H21ClN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3 D01KPW DRUGINKE RAVIZVQZGXBOQO-UHFFFAOYSA-N D01KPW DRUGSMIL CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl D01KPW HIGHSTAT Patented D01KPW COMPCLAS Isoquinoline carboxamide derivatives D01NST DRUG__ID D01NST D01NST DRUGCOMP MERCK PATENT GMBH SHERER, Brian A D01NST DRUGTYPE Small molecular drug D01NST DRUGINCH 1S/C18H19F3N2O/c19-14-3-1-2-13-16-9-22-10-23(16)15(17(13)14)8-18(20,21)11-4-6-12(24)7-5-11/h1-3,9-12,15,24H,4-8H2 D01NST DRUGINKE UNSORNINUVZBRF-UHFFFAOYSA-N D01NST DRUGSMIL C1CC(CCC1C(CC2C3=C(C=CC=C3F)C4=CN=CN24)(F)F)O D01NST HIGHSTAT Patented D01NST COMPCLAS Monofluorine derivatives D01NWU DRUG__ID D01NWU D01NWU DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D01NWU DRUGTYPE Small molecular drug D01NWU DRUGINCH 1S/C21H22FN3O3S/c1-27-16-7-4-8-17(28-2)19(16)20(26)23-13-5-3-6-14(13)24-21-25-15-10-9-12(22)11-18(15)29-21/h4,7-11,13-14H,3,5-6H2,1-2H3,(H,23,26)(H,24,25)/t13-,14-/m0/s1 D01NWU DRUGINKE FFLQAHCLFLUGAV-KBPBESRZSA-N D01NWU DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2CCCC2NC3=NC4=C(S3)C=C(C=C4)F D01NWU HIGHSTAT Patented D01NWU COMPCLAS 1,2-diamino cyclopentane-based derivatives D01RBE DRUG__ID D01RBE D01RBE DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D01RBE DRUGTYPE Small molecular drug D01RBE DRUGINCH 1S/C30H34ClF3N4O/c1-18-13-28(38(35-18)21-6-8-26(33)25(31)15-21)19-9-11-36(12-10-19)29(39)24-17-37(30(2,3)4)16-23(24)22-7-5-20(32)14-27(22)34/h5-8,13-15,19,23-24H,9-12,16-17H2,1-4H3/t23-,24+/m0/s1 D01RBE DRUGINKE UGINLDOCQNRWSG-BJKOFHAPSA-N D01RBE DRUGSMIL CC1=NN(C(=C1)C2CCN(CC2)C(=O)C3CN(CC3C4=C(C=C(C=C4)F)F)C(C)(C)C)C5=CC(=C(C=C5)F)Cl D01RBE HIGHSTAT Patented D01RBE COMPCLAS Pyrrolidine carboxamide derivatives D01THA DRUG__ID D01THA D01THA DRUGCOMP JANSSEN PHARMACEUTICA N.V. APODACA, Richard BREITENBUCHER, J., Guy CHAMBERS, Alison, L. DENG, Xiaohu HAWRYLUK, Natalie, A. KEITH, John, M. MANI, Neelakandha, S. MERIT, Jeffrey, E. PIERCE, Joan, M. SEIERSTAD, Mark XIAO, Wei D01THA DRUGTYPE Small molecular drug D01THA DRUGINCH 1S/C20H20ClN3O2/c1-2-26-19-9-8-15(10-16(19)21)17-11-20(24-13-23-17)22-12-18(25)14-6-4-3-5-7-14/h3-11,13,18,25H,2,12H2,1H3,(H,22,23,24)/t18-/m0/s1 D01THA DRUGINKE MOEQPDYTFQLEOK-SFHVURJKSA-N D01THA DRUGSMIL CCOC1=C(C=C(C=C1)C2=CC(=NC=N2)NCC(C3=CC=CC=C3)O)Cl D01THA HIGHSTAT Patented D01THA COMPCLAS Ethylaminopyrimidine derivatives D01WCU DRUG__ID D01WCU D01WCU DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D01WCU DRUGTYPE Small molecular drug D01WCU DRUGINCH 1S/C20H14FNO4S/c21-15-6-7-18-14(12-15)13-19(20(24)10-8-16(23)9-11-20)22(18)27(25,26)17-4-2-1-3-5-17/h1-13,24H D01WCU DRUGINKE KASRNHWIQQCDNO-UHFFFAOYSA-N D01WCU DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)N2C3=C(C=C(C=C3)F)C=C2C4(C=CC(=O)C=C4)O D01WCU HIGHSTAT Patented D01WCU COMPCLAS 4-aryl quinol derivatives D02CCF DRUG__ID D02CCF D02CCF DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D02CCF DRUGTYPE Small molecular drug D02CCF DRUGINCH 1S/C21H20N6O2/c28-20(14-6-1-3-10-18(14)27-22-12-13-23-27)24-15-8-5-9-16(15)25-21-26-17-7-2-4-11-19(17)29-21/h1-4,6-7,10-13,15-16H,5,8-9H2,(H,24,28)(H,25,26)/t15-,16-/m0/s1 D02CCF DRUGINKE BYPDPBCQZDTPSH-HOTGVXAUSA-N D02CCF DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=CC=CC=C5O4 D02CCF HIGHSTAT Patented D02CCF COMPCLAS 1,2-diamino cyclopentane-based derivatives D02FWA DRUG__ID D02FWA D02FWA DRUGCOMP RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY THE BROAD INSTITUTE, INC D02FWA DRUGTYPE Small molecular drug D02FWA DRUGINCH 1S/C25H24F3NO6S/c1-13(2)35-24(32)21(23(31)25(26,27)28)18-12-19(16-7-5-6-8-17(16)22(18)30)29-36(33,34)20-10-9-14(3)11-15(20)4/h5-13,21,29-30H,1-4H3 D02FWA DRUGINKE PCUXRYBEDDOJPT-UHFFFAOYSA-N D02FWA DRUGSMIL CC1=CC(=C(C=C1)S(=O)(=O)NC2=CC(=C(C3=CC=CC=C32)O)C(C(=O)C(F)(F)F)C(=O)OC(C)C)C D02FWA HIGHSTAT Patented D02FWA COMPCLAS Naphthalene derivatives D02FWO DRUG__ID D02FWO D02FWO DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John VILE, Julia GELMAN, Danny M. GAI, Xinjie BARKER, Oliver Robin DEBOVES, Herv Jean Claude EAST, Stephen Peter BOESEN, Thomas D02FWO DRUGTYPE Small molecular drug D02FWO DRUGINCH 1S/C18H18N2O2/c1-12(21)13-7-8-14-16(10-13)20-9-5-4-6-15(20)18(14)17(22)11-19(2)3/h4-10H,11H2,1-3H3 D02FWO DRUGINKE QISRGBAMCCXAKB-UHFFFAOYSA-N D02FWO DRUGSMIL CC(=O)C1=CC2=C(C=C1)C(=C3N2C=CC=C3)C(=O)CN(C)C D02FWO HIGHSTAT Patented D02FWO COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D02JER DRUG__ID D02JER D02JER DRUGCOMP BIAL PORTELA & CA SA [PT] D02JER DRUGTYPE Small molecular drug D02JER DRUGINCH 1S/C16H18FN3O2/c1-19(12-4-2-3-5-12)16(22)20-9-14(18-10-20)11-6-7-15(21)13(17)8-11/h6-10,12,21H,2-5H2,1H3 D02JER DRUGINKE IWRLZEZXDCIMHJ-UHFFFAOYSA-N D02JER DRUGSMIL CN(C1CCCC1)C(=O)N2C=C(N=C2)C3=CC(=C(C=C3)O)F D02JER HIGHSTAT Patented D02JER COMPCLAS Tetra-substituted urea derivatives D02LJQ DRUG__ID D02LJQ D02LJQ DRUGCOMP INFINITY PHARMACEUTICALS, INC. AUSTAD, Brian, C. GRENIER, Louis GROGAN, Michael, J. LIU, Tao LO, Ching Kam MARTINOT, Theodore, A. YU, Lin-Chen D02LJQ DRUGTYPE Small molecular drug D02LJQ DRUGINCH 1S/C12H9BF2O2/c14-10-3-1-2-8(6-10)9-4-5-11(13(16)17)12(15)7-9/h1-7,16-17H D02LJQ DRUGINKE WAWBMXWYDGQRBT-UHFFFAOYSA-N D02LJQ DRUGSMIL B(C1=C(C=C(C=C1)C2=CC(=CC=C2)F)F)(O)O D02LJQ HIGHSTAT Patented D02LJQ COMPCLAS Boronic acid derivatives D02LWJ DRUG__ID D02LWJ D02LWJ DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D02LWJ DRUGTYPE Small molecular drug D02LWJ DRUGINCH 1S/C21H18F2N6OS/c22-12-5-7-18(29-24-8-9-25-29)14(10-12)20(30)26-15-2-1-3-16(15)27-21-28-17-6-4-13(23)11-19(17)31-21/h4-11,15-16H,1-3H2,(H,26,30)(H,27,28)/t15-,16-/m0/s1 D02LWJ DRUGINKE WLEKLMFGOMPGEX-HOTGVXAUSA-N D02LWJ DRUGSMIL C1CC(C(C1)NC(=O)C2=C(C=CC(=C2)F)N3N=CC=N3)NC4=NC5=C(S4)C=C(C=C5)F D02LWJ HIGHSTAT Patented D02LWJ COMPCLAS 1,2-diamino cyclopentane-based derivatives D02NPB DRUG__ID D02NPB D02NPB DRUGCOMP COGNITION THERAPEUTICS, INC D02NPB DRUGTYPE Small molecular drug D02NPB DRUGINCH 1S/C21H24F3NO4S/c1-20(2,10-9-14-7-8-17(26)18(11-14)29-21(22,23)24)25-12-15-5-4-6-19(16(15)13-25)30(3,27)28/h4-8,11,26H,9-10,12-13H2,1-3H3 D02NPB DRUGINKE ZBXIRNVCPMZPFS-UHFFFAOYSA-N D02NPB DRUGSMIL CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C D02NPB HIGHSTAT Patented D02NPB COMPCLAS Isoindoline derivatives D02QWP DRUG__ID D02QWP D02QWP DRUGCOMP GENZYME CORPORATION D02QWP DRUGTYPE Small molecular drug D02QWP DRUGINCH 1S/C24H29F3N6O3S/c1-23(2)20(34)33(17-6-8-18(9-7-17)37-24(25,26)27)22(36)32(23)15-16-10-12-28-19(14-16)30-21(35)29-11-5-13-31(3)4/h6-10,12,14H,5,11,13,15H2,1-4H3,(H2,28,29,30,35) D02QWP DRUGINKE GDSXQEMDEPFVIA-UHFFFAOYSA-N D02QWP DRUGSMIL CC1(C(=O)N(C(=O)N1CC2=CC(=NC=C2)NC(=O)NCCCN(C)C)C3=CC=C(C=C3)SC(F)(F)F)C D02QWP HIGHSTAT Patented D02QWP COMPCLAS N-arylmethyl-N-phenyl cyclic urea derivatives D02SJB DRUG__ID D02SJB D02SJB DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D02SJB DRUGTYPE Small molecular drug D02SJB DRUGINCH 1S/C27H31FN8O2/c1-16-29-22(32-31-16)25(38)34-11-12-35(27(5,6)15-34)24(37)21-14-36-23(30-21)19(26(2,3)4)13-20(33-36)17-7-9-18(28)10-8-17/h7-10,13-14H,11-12,15H2,1-6H3,(H,29,31,32) D02SJB DRUGINKE DWEGVIUHJKAMGX-UHFFFAOYSA-N D02SJB DRUGSMIL CC1=NC(=NN1)C(=O)N2CCN(C(C2)(C)C)C(=O)C3=CN4C(=N3)C(=CC(=N4)C5=CC=C(C=C5)F)C(C)(C)C D02SJB HIGHSTAT Patented D02SJB COMPCLAS Imidazopyridazine derivatives D02SNQ DRUG__ID D02SNQ D02SNQ DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori IMASHIRO, Ritsuo SATO, Atsush D02SNQ DRUGTYPE Small molecular drug D02SNQ DRUGINCH 1S/C22H18Cl2F4N4O2/c23-14-7-5-13(6-8-14)18-19(34-21(25)26)17(29-32(18)16-4-2-1-3-15(16)24)20(33)30-31-11-9-22(27,28)10-12-31/h1-8,21H,9-12H2,(H,30,33) D02SNQ DRUGINKE UTHOXBJQLSAVTJ-UHFFFAOYSA-N D02SNQ DRUGSMIL C1CN(CCC1(F)F)NC(=O)C2=NN(C(=C2OC(F)F)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl D02SNQ HIGHSTAT Patented D02SNQ COMPCLAS Pyrazole derivatives D02SPI DRUG__ID D02SPI D02SPI DRUGCOMP CUREVEDA, LLC D02SPI DRUGTYPE Small molecular drug D02SPI DRUGINCH 1S/C15H12ClNO2/c1-19-14-7-4-10-17-15(14)13(18)9-8-11-5-2-3-6-12(11)16/h2-10H,1H3/b9-8+ D02SPI DRUGINKE ADUCKBZUFASKCP-CMDGGOBGSA-N D02SPI DRUGSMIL COC1=C(N=CC=C1)C(=O)C=CC2=CC=CC=C2Cl D02SPI HIGHSTAT Patented D02SPI COMPCLAS Chalcone derivatives D02TOI DRUG__ID D02TOI D02TOI DRUGCOMP NORTHEASTERN UNIVERSITY MAKRIYANNIS, Alexandros THAKUR, Ganesh, A. SHARMA, Rishi D02TOI DRUGTYPE Small molecular drug D02TOI DRUGINCH 1S/C24H36O5/c1-6-7-10-28-22(27)23(2,3)16-12-19(26)21-17-11-15(14-25)8-9-18(17)24(4,5)29-20(21)13-16/h12-13,15,17-18,25-26H,6-11,14H2,1-5H3/t15-,17-,18-/m1/s1 D02TOI DRUGINKE OSVHLUXLWQLPIY-KBAYOESNSA-N D02TOI DRUGSMIL CCCCOC(=O)C(C)(C)C1=CC(=C2C3CC(CCC3C(OC2=C1)(C)C)CO)O D02TOI HIGHSTAT Patented D02TOI COMPCLAS Tricyclic phytocannabinoid derivatives D02VDD DRUG__ID D02VDD D02VDD DRUGCOMP SHANGHAI PHARMACEUTICALS HOLDING CO., LTD D02VDD DRUGTYPE Small molecular drug D02VDD DRUGINCH 1S/C29H34ClN5O3/c1-34-8-10-35(11-9-34)7-4-12-38-28-15-24-22(14-27(28)37-3)29(20(17-31)18-32-24)33-25-16-26(36-2)23(30)13-21(25)19-5-6-19/h13-16,18-19H,4-12H2,1-3H3,(H,32,33)/i1D D02VDD DRUGINKE YHGWVQSJPYSYIE-MICDWDOJSA-N D02VDD DRUGSMIL CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4C5CC5)Cl)OC)C#N)OC D02VDD HIGHSTAT Patented D02VDD COMPCLAS Deuterated 3-cyanoquinoline derivatives D02VYR DRUG__ID D02VYR D02VYR DRUGCOMP Kissei Pharmaceutical Co. Ltd D02VYR DRUGTYPE Small molecular drug D02VYR DRUGINCH 1S/C15H9N3O3/c16-8-10-7-12(13-2-1-5-17-18(10)13)9-3-4-11(15(20)21)14(19)6-9/h1-7,19H,(H,20,21) D02VYR DRUGINKE CMWZLOJCASLPFW-UHFFFAOYSA-N D02VYR DRUGSMIL C1=CC2=C(C=C(N2N=C1)C#N)C3=CC(=C(C=C3)C(=O)O)O D02VYR HIGHSTAT Patented D02VYR COMPCLAS Azaindole derivatives D02XVC DRUG__ID D02XVC D02XVC DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D02XVC DRUGTYPE Small molecule immunotherapy D02XVC DRUGINCH 1S/C31H31BrClNO7/c32-30-20(2-1-3-23(30)19-6-7-26-29(11-19)39-9-8-38-26)17-41-28-13-27(40-16-18-4-5-18)21(10-24(28)33)14-34-15-22(35)12-25(34)31(36)37/h1-3,6-7,10-11,13,18,22,25,35H,4-5,8-9,12,14-17H2,(H,36,37)/t22-,25-/m0/s1 D02XVC DRUGINKE JLLTUBDWNGWHPK-DHLKQENFSA-N D02XVC DRUGSMIL C1CC1COC2=CC(=C(C=C2CN3CC(CC3C(=O)O)O)Cl)OCC4=C(C(=CC=C4)C5=CC6=C(C=C5)OCCO6)Br D02XVC HIGHSTAT Patented D02XVC COMPCLAS Phenylate derivatives D02YUQ DRUG__ID D02YUQ D02YUQ DRUGCOMP Kalvista Pharmaceuticals Limited D02YUQ DRUGTYPE Small molecular drug D02YUQ DRUGINCH 1S/C25H28N6O/c1-18-11-28-30(14-18)15-20-3-5-21(6-4-20)16-31-17-24(13-29-31)25(32)27-12-23-8-7-22(10-26)9-19(23)2/h3-9,11,13-14,17H,10,12,15-16,26H2,1-2H3,(H,27,32) D02YUQ DRUGINKE KMRPNZXNLYKBNI-UHFFFAOYSA-N D02YUQ DRUGSMIL CC1=C(C=CC(=C1)CN)CNC(=O)C2=CN(N=C2)CC3=CC=C(C=C3)CN4C=C(C=N4)C D02YUQ HIGHSTAT Patented D02YUQ COMPCLAS Benzyl amine derivatives D02ZVY DRUG__ID D02ZVY D02ZVY DRUGCOMP RESEARCH TRIANGLE INSTITUTE D02ZVY DRUGTYPE Small molecular drug D02ZVY DRUGINCH 1S/C25H24Cl2N6O2/c1-2-35-25(34)30-17-11-13-32(14-12-17)23-21-24(29-15-28-23)33(18-9-7-16(26)8-10-18)22(31-21)19-5-3-4-6-20(19)27/h3-10,15,17H,2,11-14H2,1H3,(H,30,34) D02ZVY DRUGINKE YNFZOBCSHAKXPA-UHFFFAOYSA-N D02ZVY DRUGSMIL CCOC(=O)NC1CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D02ZVY HIGHSTAT Patented D02ZVY COMPCLAS Diphenyl purine derivatives D03ARS DRUG__ID D03ARS D03ARS DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D03ARS DRUGTYPE Small molecular drug D03ARS DRUGINCH 1S/C29H28F5N3O5S/c1-36(43(41,42)28-26(33)24(31)23(30)25(32)27(28)34)16-22(38)37(21-13-11-20(12-14-21)29(39)35-40)15-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h7-14,18,40H,2-6,15-16H2,1H3,(H,35,39) D03ARS DRUGINKE QPSUYVALAOXFGL-UHFFFAOYSA-N D03ARS DRUGSMIL CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC=C(C=C3)C(=O)NO)S(=O)(=O)C4=C(C(=C(C(=C4F)F)F)F)F D03ARS HIGHSTAT Patented D03ARS COMPCLAS Salicylic acid derivatives D03ASG DRUG__ID D03ASG D03ASG DRUGCOMP MERCK SHARP &amDOHME CORP. GRAHAM, Thomas, H. SHEN, Dong-Ming SHU, Min D03ASG DRUGTYPE Small molecular drug D03ASG DRUGINCH 1S/C28H27F2N3/c29-23-10-6-21(7-11-23)26-19-33(16-14-20-4-2-1-3-5-20)17-15-25(26)28-18-27(31-32-28)22-8-12-24(30)13-9-22/h1-13,18,25-26H,14-17,19H2,(H,31,32)/t25-,26+/m1/s1 D03ASG DRUGINKE HJPVPXYGXWGSIG-FTJBHMTQSA-N D03ASG DRUGSMIL C1CN(CC(C1C2=CC(=NN2)C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)CCC5=CC=CC=C5 D03ASG HIGHSTAT Patented D03ASG COMPCLAS Piperidinyl pyrazole derivatives D03CYB DRUG__ID D03CYB D03CYB DRUGCOMP INVENTISBIO INC D03CYB DRUGTYPE Small molecular drug D03CYB DRUGINCH 1S/C24H28N4O3/c1-2-28(20-8-12-31-13-9-20)22-21(27-19-6-4-17(15-25)5-7-19)14-18(16-26-22)24(23(29)30)10-3-11-24/h4-7,14,16,20,27H,2-3,8-13H2,1H3,(H,29,30) D03CYB DRUGINKE OQNDTVBPYVYWIY-UHFFFAOYSA-N D03CYB DRUGSMIL CCN(C1CCOCC1)C2=C(C=C(C=N2)C3(CCC3)C(=O)O)NC4=CC=C(C=C4)C#N D03CYB HIGHSTAT Patented D03CYB COMPCLAS Aryl 1,2-diamine derivatives D03EHI DRUG__ID D03EHI D03EHI DRUGCOMP SUVEN LIFE SCIENCES LIMITED D03EHI DRUGTYPE Small molecular drug D03EHI DRUGINCH 1S/C22H30N2O3/c25-22(24-14-16-26-17-15-24)9-6-18-4-7-20(8-5-18)27-21-10-12-23(13-11-21)19-2-1-3-19/h4-9,19,21H,1-3,10-17H2/b9-6+ D03EHI DRUGINKE MXFWFZGVHOHBHI-RMKNXTFCSA-N D03EHI DRUGSMIL C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)C=CC(=O)N4CCOCC4 D03EHI HIGHSTAT Patented D03EHI COMPCLAS Acrylamide compounds D03EMY DRUG__ID D03EMY D03EMY DRUGCOMP IRM LLC REN, Pingda WANG, Xia JIANG, Songchun NAGLE, Advait OKRAM, Barun HE, Yun XIE, Yongping WANG, Xing HUANG, Shenlin WANG, Xiaodong LIU, Yi ALBAUGH, Pamela, A. GRAY, Nathanael, S. ZHANG, Guobao D03EMY DRUGTYPE Small molecular drug D03EMY DRUGINCH 1S/C22H15F3N4O2/c23-22(24,25)14-4-1-3-13(11-14)20(30)28-15-5-2-6-16(12-15)29-21(31)18-8-10-27-19-17(18)7-9-26-19/h1-12H,(H,26,27)(H,28,30)(H,29,31) D03EMY DRUGINKE NFUORXLZMPSICI-UHFFFAOYSA-N D03EMY DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C(=O)NC2=CC(=CC=C2)NC(=O)C3=C4C=CNC4=NC=C3 D03EMY HIGHSTAT Patented D03EMY COMPCLAS Pyrrolo[2,3-b]pyridine carboxamide derivatives D03ENW DRUG__ID D03ENW D03ENW DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D03ENW DRUGTYPE Small molecular drug D03ENW DRUGINCH 1S/C21H18N2O3/c1-22(2)21(24)26-20-17-12-8-14-23(17)16-11-6-7-13-18(16)25-19(20)15-9-4-3-5-10-15/h3-14H,1-2H3 D03ENW DRUGINKE ROZBXXFOBQMJQB-UHFFFAOYSA-N D03ENW DRUGSMIL CN(C)C(=O)OC1=C(OC2=CC=CC=C2N3C1=CC=C3)C4=CC=CC=C4 D03ENW HIGHSTAT Patented D03ENW COMPCLAS Benzothiazepine analogs D03EYT DRUG__ID D03EYT D03EYT DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D03EYT DRUGTYPE Small molecular drug D03EYT DRUGINCH 1S/C19H17F2N3O3S/c1-27-17-8-13(20)3-4-14(17)15-9-19(23-10-16(15)21)24-18-7-12(5-6-22-18)11-28(2,25)26/h3-10H,11H2,1-2H3,(H,22,23,24) D03EYT DRUGINKE VRHHAMWTRSVIEX-UHFFFAOYSA-N D03EYT DRUGSMIL COC1=C(C=CC(=C1)F)C2=CC(=NC=C2F)NC3=NC=CC(=C3)CS(=O)(=O)C D03EYT HIGHSTAT Patented D03EYT COMPCLAS N-(pyridin-2-yl)pyridine methylsulfone derivatives D03GPW DRUG__ID D03GPW D03GPW DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason LouiMerck & Co., Inc., Kenilworth, NJ, USA D03GPW DRUGTYPE Small molecular drug D03GPW DRUGINCH 1S/C25H22ClF3N2O2/c26-18-9-12-30-22(15-18)23-20-3-1-2-4-21(20)24(33-23)10-13-31(14-11-24)16-17-5-7-19(8-6-17)32-25(27,28)29/h1-9,12,15,23H,10-11,13-14,16H2 D03GPW DRUGINKE LFFCKQUVNSOFQR-UHFFFAOYSA-N D03GPW DRUGSMIL C1CN(CCC12C3=CC=CC=C3C(O2)C4=NC=CC(=C4)Cl)CC5=CC=C(C=C5)OC(F)(F)F D03GPW HIGHSTAT Patented D03GPW COMPCLAS Benzodihydroisofuran derivatives D03HEP DRUG__ID D03HEP D03HEP DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM PRIEBE, Waldemar KATO, Takayuki FOKT, Izabela CONRAD, Charles MADDEN, Timothy SKORA, Stanislaw D03HEP DRUGTYPE Small molecular drug D03HEP DRUGINCH 1S/C14H20O9S.C6H15P.Au/c1-6(15)19-5-10-11(20-7(2)16)12(21-8(3)17)13(14(24)23-10)22-9(4)18;1-4-7(5-2)6-3;/h10-14,24H,5H2,1-4H3;4-6H2,1-3H3;/q;;+1/p-1/t10-,11-,12+,13+,14+;;/m1../s1 D03HEP DRUGINKE AUJRCFUBUPVWSZ-QAZNCASESA-M D03HEP DRUGSMIL CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+] D03HEP HIGHSTAT Patented D03HEP COMPCLAS Gold-complexed thiosaccharide derivatives D03JAZ DRUG__ID D03JAZ D03JAZ DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D03JAZ DRUGTYPE Small molecular drug D03JAZ DRUGINCH 1S/C21H22ClN3O3S/c1-27-16-7-4-8-17(28-2)19(16)20(26)23-13-5-3-6-14(13)24-21-25-15-10-9-12(22)11-18(15)29-21/h4,7-11,13-14H,3,5-6H2,1-2H3,(H,23,26)(H,24,25) D03JAZ DRUGINKE XFIKRNAXHULGOU-UHFFFAOYSA-N D03JAZ DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2CCCC2NC3=NC4=C(S3)C=C(C=C4)Cl D03JAZ HIGHSTAT Patented D03JAZ COMPCLAS 1,2-diamino cyclopentane-based derivatives D03PQB DRUG__ID D03PQB D03PQB DRUGCOMP HANGZHOU INNOGATE PHARMA CO., LTD D03PQB DRUGTYPE Small molecular drug D03PQB DRUGINCH 1S/C20H23FN2O2/c21-14-3-1-2-13-16-11-22-12-23(16)15(18(13)14)10-17(24)19-4-7-20(25,8-5-19)9-6-19/h1-3,11-12,15,17,24-25H,4-10H2 D03PQB DRUGINKE IUJILQYRZOXDQY-UHFFFAOYSA-N D03PQB DRUGSMIL C1CC2(CCC1(CC2)C(CC3C4=C(C=CC=C4F)C5=CN=CN35)O)O D03PQB HIGHSTAT Patented D03PQB COMPCLAS Imidazoleisoindoles derivatives D03RTM DRUG__ID D03RTM D03RTM DRUGCOMP Korea Institute of Radiological & Medical Sciences, S D03RTM DRUGTYPE Small molecular drug D03RTM DRUGINCH 1S/C17H11BrN2O/c18-14-6-2-3-11-12(14)4-1-5-13(11)17-20-15-9-10(19)7-8-16(15)21-17/h1-9H,19H2 D03RTM DRUGINKE XWSBTBHNERIRTD-UHFFFAOYSA-N D03RTM DRUGSMIL C1=CC2=C(C=CC=C2Br)C(=C1)C3=NC4=C(O3)C=CC(=C4)N D03RTM HIGHSTAT Patented D03RTM COMPCLAS Benzo[d]oxazole derivatives D03ULH DRUG__ID D03ULH D03ULH DRUGCOMP PHARMACYCLICS, INC. CHEN, Wei LOURY, David, J. MODY, Tarak, D. WANG, Longcheng D03ULH DRUGTYPE Small molecular drug D03ULH DRUGINCH 1S/C28H30N6O2/c1-32(2)15-6-9-25(35)33-16-14-21(17-33)34-18-24(26-27(29)30-19-31-28(26)34)20-10-12-23(13-11-20)36-22-7-4-3-5-8-22/h3-13,18-19,21H,14-17H2,1-2H3,(H2,29,30,31)/b9-6+ D03ULH DRUGINKE QKYMWVAQZSLTKG-RMKNXTFCSA-N D03ULH DRUGSMIL CN(C)CC=CC(=O)N1CCC(C1)N2C=C(C3=C(N=CN=C32)N)C4=CC=C(C=C4)OC5=CC=CC=C5 D03ULH HIGHSTAT Patented D03ULH COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D03UNB DRUG__ID D03UNB D03UNB DRUGCOMP SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. JIANGSU HENGRUI MEDICINE CO., LTD D03UNB DRUGTYPE Small molecular drug D03UNB DRUGINCH 1S/C14H12BrNO2S/c15-9-2-3-11-10(8-9)12(4-7-16-11)19-14(13(17)18)5-1-6-14/h2-4,7-8H,1,5-6H2,(H,17,18) D03UNB DRUGINKE QGBWIYLNOBYNDL-UHFFFAOYSA-N D03UNB DRUGSMIL C1CC(C1)(C(=O)O)SC2=C3C=C(C=CC3=NC=C2)Br D03UNB HIGHSTAT Patented D03UNB COMPCLAS Cycloalkyl acid derivatives D03USW DRUG__ID D03USW D03USW DRUGCOMP ARRAY BIOPHARMA INC. HAAS, Julia ANDREWS, Steven, W. JIANG, Yutong ZHANG, Gan D03USW DRUGTYPE Small molecular drug D03USW DRUGINCH 1S/C21H18F2N6O/c22-13-3-4-15(23)14(10-13)17-2-1-8-28(17)18-5-9-29-19(27-18)16(11-25-29)26-20(30)21(12-24)6-7-21/h3-5,9-11,17H,1-2,6-8H2,(H,26,30)/t17-/m1/s1 D03USW DRUGINKE XFKSYGFIGZCVDN-QGZVFWFLSA-N D03USW DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)C4(CC4)C#N)C5=C(C=CC(=C5)F)F D03USW HIGHSTAT Patented D03USW COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D03WDH DRUG__ID D03WDH D03WDH DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D03WDH DRUGTYPE Small molecular drug D03WDH DRUGINCH 1S/C29H30BrF2N3O2/c30-22-5-1-19(2-6-22)26-18-24(35-13-15-37-16-14-35)9-10-25(26)29(36)34-28(20-3-7-23(31)8-4-20)21-11-12-33-27(32)17-21/h1-8,11-12,17,24-26,28H,9-10,13-16,18H2,(H,34,36)/t24-,25-,26+,28?/m1/s1 D03WDH DRUGINKE SPLGKYRHYYLJLJ-OCYUSGCXSA-N D03WDH DRUGSMIL C1CC(C(CC1N2CCOCC2)C3=CC=C(C=C3)Br)C(=O)NC(C4=CC=C(C=C4)F)C5=CC(=NC=C5)F D03WDH HIGHSTAT Patented D03WDH COMPCLAS Cyclohexane carboxamide derivatives D03XAK DRUG__ID D03XAK D03XAK DRUGCOMP Pharma. Ip. General, Inc. Mamoto Health Science University D03XAK DRUGTYPE Small molecular drug D03XAK DRUGINCH 1S/C22H14N4O3/c27-20(24-22-26-25-21(29-22)19-11-6-12-28-19)16-13-18(14-7-2-1-3-8-14)23-17-10-5-4-9-15(16)17/h1-13H,(H,24,26,27) D03XAK DRUGINKE MNPXTRXFUMGQLK-UHFFFAOYSA-N D03XAK DRUGSMIL C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)NC4=NN=C(O4)C5=CC=CO5 D03XAK HIGHSTAT Patented D03XAK COMPCLAS Quinoline carboxamide derivatives D03YMA DRUG__ID D03YMA D03YMA DRUGCOMP INGENIUM PHARMACEUTICALS GMBH ALLGEIER, HANS AUGUSTIN, MARTIN MUELLER, ANKE ZEITLMANN, LUTZ MARQUARDT, ANDREAS PLEISS, MICHAEL A. HEISER, ULRICH NIESTROJ, ANDR JOHANNES D03YMA DRUGTYPE Small molecular drug D03YMA DRUGINCH 1S/C17H20N4O2/c1-23-15-7-3-2-6-13(15)14-9-16(20-11-19-14)21-17(22)12-5-4-8-18-10-12/h2-3,6-7,9,11-12,18H,4-5,8,10H2,1H3,(H,19,20,21,22) D03YMA DRUGINKE HWNURWPCYJPMQP-UHFFFAOYSA-N D03YMA DRUGSMIL COC1=CC=CC=C1C2=CC(=NC=N2)NC(=O)C3CCCNC3 D03YMA HIGHSTAT Patented D03YMA COMPCLAS Aryl pyrimidine derivatives D03ZMX DRUG__ID D03ZMX D03ZMX DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D03ZMX DRUGTYPE Small molecular drug D03ZMX DRUGINCH 1S/C23H29F3N4O2S/c1-13(2)12-30(15-6-4-3-5-7-15)19-9-8-14(16-11-17(16)20(31)32)10-18(19)27-22-28-21(29-33-22)23(24,25)26/h8-10,13,15-17H,3-7,11-12H2,1-2H3,(H,31,32)(H,27,28,29) D03ZMX DRUGINKE NXZKEHFQEXBLSD-UHFFFAOYSA-N D03ZMX DRUGSMIL CC(C)CN(C1CCCCC1)C2=C(C=C(C=C2)C3CC3C(=O)O)NC4=NC(=NS4)C(F)(F)F D03ZMX HIGHSTAT Patented D03ZMX COMPCLAS Monoaryl-1,2-diamine derivatives D03ZOR DRUG__ID D03ZOR D03ZOR DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D03ZOR DRUGTYPE Small molecular drug D03ZOR DRUGINCH 1S/C19H16FN5O5S/c20-10-3-1-9(2-4-10)13-7-31-19(24-13)25-16(26)12(5-11-6-21-8-22-11)23-17(27)14-15(30-14)18(28)29/h1-4,6-8,12,14-15H,5H2,(H,21,22)(H,23,27)(H,28,29)(H,24,25,26)/t12-,14+,15+/m0/s1 D03ZOR DRUGINKE LWEKDSQGUMPMSP-NWANDNLSSA-N D03ZOR DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)NC(=O)C(CC3=CN=CN3)NC(=O)C4C(O4)C(=O)O)F D03ZOR HIGHSTAT Patented D03ZOR COMPCLAS Epoxysuccinate derivatives D04AKA DRUG__ID D04AKA D04AKA DRUGCOMP NOVARTIS AG BRAIN, Christopher, Thomas CHO, Young Shin GIRALDES, John, William LAGU, Bharat LEVELL, Julian LUZZIO, Michael PEREZ, Lawrence, Blas WANG, Yaping YANG, Fan D04AKA DRUGTYPE Small molecular drug D04AKA DRUGINCH 1S/C31H36N8O2/c1-31(2,3)21-7-11-24(12-8-21)39-25(29(41)37(4)5)14-20-16-33-30(36-27(20)39)35-26-13-6-19(15-32-26)28(40)38-17-22-9-10-23(18-38)34-22/h6-8,11-16,22-23,34H,9-10,17-18H2,1-5H3,(H,32,33,35,36) D04AKA DRUGINKE VTSDFHMWTKRCAL-UHFFFAOYSA-N D04AKA DRUGSMIL CC(C)(C)C1=CC=C(C=C1)N2C(=CC3=CN=C(N=C32)NC4=NC=C(C=C4)C(=O)N5CC6CCC(C5)N6)C(=O)N(C)C D04AKA HIGHSTAT Patented D04AKA COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D04AMY DRUG__ID D04AMY D04AMY DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D04AMY DRUGTYPE Small molecular drug D04AMY DRUGINCH 1S/C24H23N5O/c1-24(17-6-4-3-5-7-17)12-13-29(23(24)30)18-10-8-16(9-11-18)19-14-28(2)22-20(19)21(25)26-15-27-22/h3-11,14-15H,12-13H2,1-2H3,(H2,25,26,27) D04AMY DRUGINKE CMUGNAXHKVXXNK-UHFFFAOYSA-N D04AMY DRUGSMIL CC1(CCN(C1=O)C2=CC=C(C=C2)C3=CN(C4=NC=NC(=C34)N)C)C5=CC=CC=C5 D04AMY HIGHSTAT Patented D04AMY COMPCLAS Phenylpyrrolidinone derivatives D04ANB DRUG__ID D04ANB D04ANB DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D04ANB DRUGTYPE Small molecular drug D04ANB DRUGINCH 1S/C31H29F5N2O7S/c1-17(39)45-23-14-21(12-13-22(23)31(41)42)38(15-18-8-10-20(11-9-18)19-6-4-3-5-7-19)24(40)16-37(2)46(43,44)30-28(35)26(33)25(32)27(34)29(30)36/h8-14,19H,3-7,15-16H2,1-2H3,(H,41,42) D04ANB DRUGINKE MXLQNCLPTUVOQV-UHFFFAOYSA-N D04ANB DRUGSMIL CC(=O)OC1=C(C=CC(=C1)N(CC2=CC=C(C=C2)C3CCCCC3)C(=O)CN(C)S(=O)(=O)C4=C(C(=C(C(=C4F)F)F)F)F)C(=O)O D04ANB HIGHSTAT Patented D04ANB COMPCLAS Salicylic acid derivatives D04AQR DRUG__ID D04AQR D04AQR DRUGCOMP ELARA PHARMACEUTICALS GMBH [DE] D04AQR DRUGTYPE Small molecular drug D04AQR DRUGINCH 1S/C24H23N5O2/c30-29(31)21-9-6-19(7-10-21)24-22(17-27-14-12-25-13-15-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18/h1-11,16,25H,12-15,17H2 D04AQR DRUGINKE VFRSRPDPDQUSDK-UHFFFAOYSA-N D04AQR DRUGSMIL C1CN(CCN1)CC2=C(N=C3N2C=C(C=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-] D04AQR HIGHSTAT Patented D04AQR COMPCLAS Imidazo [1,2-a]pyridine compounds D04BIF DRUG__ID D04BIF D04BIF DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D04BIF DRUGTYPE Small molecular drug D04BIF DRUGINCH 1S/C16H19N5/c1-21-10-12(7-19-21)13-8-17-16-15(13)20-14(9-18-16)11-5-3-2-4-6-11/h7-11H,2-6H2,1H3,(H,17,18) D04BIF DRUGINKE KOKYJLMPOHNWTA-UHFFFAOYSA-N D04BIF DRUGSMIL CN1C=C(C=N1)C2=CNC3=NC=C(N=C23)C4CCCCC4 D04BIF HIGHSTAT Patented D04BIF COMPCLAS 7-azaindole derivatives D04BXA DRUG__ID D04BXA D04BXA DRUGCOMP GREEN CROSS CORPORATION LEE, Sung-Han SEO, Hee Jeong LEE, Jinhwa KIM, Min-ah KIM, Jeong Min KANG, Suk Youn AHN, Kwang-Woo LEE, Suk Ho D04BXA DRUGTYPE Small molecular drug D04BXA DRUGINCH 1S/C25H22BrCl2N5OS/c1-25(2,3)24-31-30-23(35-24)20-19(22(34)29-16-9-10-16)21(13-4-6-14(26)7-5-13)33(32-20)18-11-8-15(27)12-17(18)28/h4-8,11-12,16H,9-10H2,1-3H3,(H,29,34) D04BXA DRUGINKE GBQKLVGYQWGQEF-UHFFFAOYSA-N D04BXA DRUGSMIL CC(C)(C)C1=NN=C(S1)C2=NN(C(=C2C(=O)NC3CC3)C4=CC=C(C=C4)Br)C5=C(C=C(C=C5)Cl)Cl D04BXA HIGHSTAT Patented D04BXA COMPCLAS Pyrazole derivatives D04DUF DRUG__ID D04DUF D04DUF DRUGCOMP OXYGEN HEALTHCARE RESEARCH PVT. LTD SHIRSATH, Vikas S. PATEL, Shailesh M SHETH, Nehal M. SINGH, Jitendra K. PATIL, Pawan D. PAWAR, Anil D. MOTIVARAS, Jitendra D D04DUF DRUGTYPE Small molecular drug D04DUF DRUGINCH 1S/C23H27N3O2S/c27-22(9-6-14-25-12-4-5-13-25)24-19-10-11-21-20(17-19)26(15-16-29-21)23(28)18-7-2-1-3-8-18/h1-3,7-8,10-11,17H,4-6,9,12-16H2,(H,24,27) D04DUF DRUGINKE NSMKNQYJLDRTTI-UHFFFAOYSA-N D04DUF DRUGSMIL C1CCN(C1)CCCC(=O)NC2=CC3=C(C=C2)SCCN3C(=O)C4=CC=CC=C4 D04DUF HIGHSTAT Patented D04DUF COMPCLAS Phenylsulfonyl derivatives D04EFQ DRUG__ID D04EFQ D04EFQ DRUGCOMP ELI LILLY AND COMPANY ARNOLD, Macklin, Brian BEAUCHAMP, Thomas, James CANADA, Emily, Jane HEMBRE, Erik, James LU, Jianliang RIZZO, John, Robert SCHAUS, John, Mehnert SHI, Qing D04EFQ DRUGTYPE Small molecular drug D04EFQ DRUGINCH 1S/C25H26N4O3/c1-2-32-19-10-7-18(8-11-19)23(30)28-25(13-14-25)24(31)27-20-12-9-17-5-3-4-6-21(17)29-16-15-26-22(20)29/h3-8,10-11,15-16,20H,2,9,12-14H2,1H3,(H,27,31)(H,28,30)/t20-/m1/s1 D04EFQ DRUGINKE JIKPZJNVLNBRBQ-HXUWFJFHSA-N D04EFQ DRUGSMIL CCOC1=CC=C(C=C1)C(=O)NC2(CC2)C(=O)NC3CCC4=CC=CC=C4N5C3=NC=C5 D04EFQ HIGHSTAT Patented D04EFQ COMPCLAS Benzamide derivatives D04ELA DRUG__ID D04ELA D04ELA DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj KREUTTER, Kevin POWELL, Mark SHOOK, Brian SONG, Fengbin XU, Guozhang YANG, Shyh-ming ZHANG, Rui ZHAO, Bao-pin D04ELA DRUGTYPE Small molecular drug D04ELA DRUGINCH 1S/C30H24Cl2F3N3O3/c1-17-12-21(31)5-8-23(17)18-2-6-22(7-3-18)37-16-25-24(13-20(14-26(25)32)30(33,34)35)19-4-9-27(38-15-19)29(41)36-11-10-28(39)40/h2-9,12-15,37H,10-11,16H2,1H3,(H,36,41)(H,39,40) D04ELA DRUGINKE OUHVBZQQNWUOOU-UHFFFAOYSA-N D04ELA DRUGSMIL CC1=C(C=CC(=C1)Cl)C2=CC=C(C=C2)NCC3=C(C=C(C=C3Cl)C(F)(F)F)C4=CN=C(C=C4)C(=O)NCCC(=O)O D04ELA HIGHSTAT Patented D04ELA COMPCLAS Picolinamido propanoic acid derivatives D04GIJ DRUG__ID D04GIJ D04GIJ DRUGCOMP PROXIMAGEN LTD. BOYD, Joe William MEO, Paul HIGGINBOTTOM, Michael SIMPSON, Iain MOUNTFORD, David Mark SAVORY, Edward Daniel D04GIJ DRUGTYPE Small molecular drug D04GIJ DRUGINCH 1S/C21H26N4O/c22-20(23)19-8-6-18(7-9-19)15-24-21(26)25-12-10-17(11-13-25)14-16-4-2-1-3-5-16/h1-9,17H,10-15H2,(H3,22,23)(H,24,26) D04GIJ DRUGINKE PPLAJHCOIUEWGN-UHFFFAOYSA-N D04GIJ DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)C(=O)NCC3=CC=C(C=C3)C(=N)N D04GIJ HIGHSTAT Patented D04GIJ COMPCLAS Piperazine urea derivatives D04HTM DRUG__ID D04HTM D04HTM DRUGCOMP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI D04HTM DRUGTYPE Small molecular drug D04HTM DRUGINCH 1S/C20H19ClN2O2/c1-12-5-3-4-6-15(12)20(25)22-14-7-8-16(21)18(11-14)23-17-9-10-19(24)13(17)2/h3-8,11,23H,9-10H2,1-2H3,(H,22,25) D04HTM DRUGINKE FVUVHLFQVZUBCL-UHFFFAOYSA-N D04HTM DRUGSMIL CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)Cl)NC3=C(C(=O)CC3)C D04HTM HIGHSTAT Patented D04HTM COMPCLAS Aminocyclopentenone compounds D04ILM DRUG__ID D04ILM D04ILM DRUGCOMP KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY D04ILM DRUGTYPE Small molecular drug D04ILM DRUGINCH 1S/C15H13ClO3S/c1-19-14-8-4-5-9-15(14)20(17,18)11-10-12-6-2-3-7-13(12)16/h2-11H,1H3/b11-10+ D04ILM DRUGINKE KVDYSDOWSIXKPB-ZHACJKMWSA-N D04ILM DRUGSMIL COC1=CC=CC=C1S(=O)(=O)C=CC2=CC=CC=C2Cl D04ILM HIGHSTAT Patented D04ILM COMPCLAS Vinyl sulfone derivatives D04JEH DRUG__ID D04JEH D04JEH DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. NIHON, NOHYAKU CO., LTD. NAKAZATO, Atsuro OKUBO, Taketoshi NAKAMURA, Toshio CHAKI, Shigeyuki TOMISAWA, Kazuyuki NAGAMINE, Masashi YAMAMOTO, Kenji HARADA, Koichiro YOSHIDA, Masanori D04JEH DRUGTYPE Small molecular drug D04JEH DRUGINCH 1S/C24H24ClNO3/c1-17(2)28-23-12-8-7-9-19(23)16-26(18(3)27)22-14-13-20(25)15-24(22)29-21-10-5-4-6-11-21/h4-15,17H,16H2,1-3H3 D04JEH DRUGINKE CGUBOFYHGYNUDL-UHFFFAOYSA-N D04JEH DRUGSMIL CC(C)OC1=CC=CC=C1CN(C2=C(C=C(C=C2)Cl)OC3=CC=CC=C3)C(=O)C D04JEH HIGHSTAT Patented D04JEH COMPCLAS Aryl oxyanilide derivatives D04JLF DRUG__ID D04JLF D04JLF DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D04JLF DRUGTYPE Small molecular drug D04JLF DRUGINCH 1S/C28H27ClN4O5S/c1-36-22-9-6-10-23(37-2)25(22)26(34)30-20-14-33(28(35)38-16-17-7-4-3-5-8-17)15-21(20)32-27-31-19-12-11-18(29)13-24(19)39-27/h3-13,20-21H,14-16H2,1-2H3,(H,30,34)(H,31,32) D04JLF DRUGINKE YUAQEWZWSNKNGF-UHFFFAOYSA-N D04JLF DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2CN(CC2NC3=NC4=C(S3)C=C(C=C4)Cl)C(=O)OCC5=CC=CC=C5 D04JLF HIGHSTAT Patented D04JLF COMPCLAS 1,2-diamino cyclopentane-based derivatives D04KUD DRUG__ID D04KUD D04KUD DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John VILE, Julia GELMAN, Danny M. GAI, Xinjie BARKER, Oliver Robin DEBOVES, Herv Jean Claude EAST, Stephen Peter BOESEN, Thomas D04KUD DRUGTYPE Small molecular drug D04KUD DRUGINCH 1S/C19H21N3O4/c1-21(2)10-11-26-19(24)17-14-8-7-13(18(23)20-25-3)12-16(14)22-9-5-4-6-15(17)22/h4-9,12H,10-11H2,1-3H3,(H,20,23) D04KUD DRUGINKE ZZDUDEMXVPDTNG-UHFFFAOYSA-N D04KUD DRUGSMIL CN(C)CCOC(=O)C1=C2C=CC=CN2C3=C1C=CC(=C3)C(=O)NOC D04KUD HIGHSTAT Patented D04KUD COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D04LLK DRUG__ID D04LLK D04LLK DRUGCOMP N Zyme Biotech GmbH D04LLK DRUGTYPE Small molecular drug D04LLK DRUGINCH 1S/C15H17ClN2O7/c16-6-13(21)24-9-11(14(22)17-7-12(19)20)18-15(23)25-8-10-4-2-1-3-5-10/h1-5,11H,6-9H2,(H,17,22)(H,18,23)(H,19,20)/t11-/m0/s1 D04LLK DRUGINKE UEILGHHGUUQOCS-NSHDSACASA-N D04LLK DRUGSMIL C1=CC=C(C=C1)COC(=O)NC(COC(=O)CCl)C(=O)NCC(=O)O D04LLK HIGHSTAT Patented D04LLK COMPCLAS Chloroacetyl ester derivatives D04NUS DRUG__ID D04NUS D04NUS DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D04NUS DRUGTYPE Small molecular drug D04NUS DRUGINCH 1S/C34H51N7O2/c1-32(2,3)19-18-27(23-12-14-25(15-13-23)30(42)35-22-28-37-39-40-38-28)41-31(43)29(24-10-8-7-9-11-24)36-34(41)20-16-26(17-21-34)33(4,5)6/h12-15,24,26-27H,7-11,16-22H2,1-6H3,(H,35,42)(H,37,38,39,40)/t26?,27-,34?/m1/s1 D04NUS DRUGINKE PTRTYSISBCSORS-XSUYSUAISA-N D04NUS DRUGSMIL CC(C)(C)CCC(C1=CC=C(C=C1)C(=O)NCC2=NNN=N2)N3C(=O)C(=NC34CCC(CC4)C(C)(C)C)C5CCCCC5 D04NUS HIGHSTAT Patented D04NUS COMPCLAS Spiroimidazolone derivatives D04QGW DRUG__ID D04QGW D04QGW DRUGCOMP MERCK SHARP & DOHME CORP. GRAHAM, Thomas SHEN, Dong-Ming NARGUND, Ravi, P. WU, Zhicai LIU, Wenshen D04QGW DRUGTYPE Small molecular drug D04QGW DRUGINCH 1S/C28H38N4O5/c1-2-3-4-5-6-16-37-28-30-25(29)24-26(31-28)36-17-15-32(27(24)35)22-13-11-21(12-14-22)20-9-7-19(8-10-20)18-23(33)34/h11-14,19-20H,2-10,15-18H2,1H3,(H,33,34)(H2,29,30,31) D04QGW DRUGINKE ZERDUDAYCJCZOG-UHFFFAOYSA-N D04QGW DRUGSMIL CCCCCCCOC1=NC(=C2C(=N1)OCCN(C2=O)C3=CC=C(C=C3)C4CCC(CC4)CC(=O)O)N D04QGW HIGHSTAT Patented D04QGW COMPCLAS Lactam derivatives D04QHI DRUG__ID D04QHI D04QHI DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, W. HAAS, Julia JIANG, Yutong ZHANG, Gan D04QHI DRUGTYPE Small molecular drug D04QHI DRUGINCH 1S/C24H22F2N6O3S/c1-36(34,35)30-17-7-4-15(5-8-17)24(33)28-23-14-27-21-10-11-22(29-32(21)23)31-12-2-3-20(31)18-13-16(25)6-9-19(18)26/h4-11,13-14,20,30H,2-3,12H2,1H3,(H,28,33)/t20-/m1/s1 D04QHI DRUGINKE CDMQMPKUGUVGIR-HXUWFJFHSA-N D04QHI DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C(=O)NC2=CN=C3N2N=C(C=C3)N4CCCC4C5=C(C=CC(=C5)F)F D04QHI HIGHSTAT Patented D04QHI COMPCLAS Imidazo[1,2-b]pyridazine derivatives D04QLC DRUG__ID D04QLC D04QLC DRUGCOMP Pfizer Product Inc D04QLC DRUGTYPE Small molecular drug D04QLC DRUGINCH 1S/C18H13Cl3N4O3/c19-13-4-2-11(25-18(28)24-16(26)9-23-25)8-12(13)17(27)22-6-5-10-1-3-14(20)15(21)7-10/h1-4,7-9H,5-6H2,(H,22,27)(H,24,26,28) D04QLC DRUGINKE VLOHQHGTVRQRSC-UHFFFAOYSA-N D04QLC DRUGSMIL C1=CC(=C(C=C1CCNC(=O)C2=C(C=CC(=C2)N3C(=O)NC(=O)C=N3)Cl)Cl)Cl D04QLC HIGHSTAT Patented D04QLC COMPCLAS Benzamide derivatives D04SHK DRUG__ID D04SHK D04SHK DRUGCOMP GLAXO GROUP LIMITED DEAN, David, Kenneth WALTER, Daryl, Simon D04SHK DRUGTYPE Small molecular drug D04SHK DRUGINCH 1S/C13H15ClF3N3O3S/c1-19-7-10(20(2)24(19,22)23)12(21)18-6-8-4-3-5-9(11(8)14)13(15,16)17/h3-5,10H,6-7H2,1-2H3,(H,18,21) D04SHK DRUGINKE FDFVMILOAWFGGO-UHFFFAOYSA-N D04SHK DRUGSMIL CN1CC(N(S1(=O)=O)C)C(=O)NCC2=C(C(=CC=C2)C(F)(F)F)Cl D04SHK HIGHSTAT Patented D04SHK COMPCLAS Isothiazolidine derivatives D04VYE DRUG__ID D04VYE D04VYE DRUGCOMP IRONWOOD PHARMACEUTICALS, INCIRONWOOD PHARMACEUTICALS, INC D04VYE DRUGTYPE Small molecular drug D04VYE DRUGINCH 1S/C24H19F3N4O4/c1-12-22(23(32)24(33)30-14-4-5-28-21(7-14)35-3)15-8-20(34-2)17(27)9-19(15)31(12)11-18-16(26)6-13(25)10-29-18/h4-10H,11H2,1-3H3,(H,28,30,33) D04VYE DRUGINKE SUOOBQNAIURDKV-UHFFFAOYSA-N D04VYE DRUGSMIL CC1=C(C2=CC(=C(C=C2N1CC3=C(C=C(C=N3)F)F)F)OC)C(=O)C(=O)NC4=CC(=NC=C4)OC D04VYE HIGHSTAT Patented D04VYE COMPCLAS Benzyl pyrrolyloxoacetamide derivatives D04ZLC DRUG__ID D04ZLC D04ZLC DRUGCOMP THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN GREIG, lain Robert ROSS, Ruth Alexandra PERTWEE, Roger Guy TREMBLEAU, Laurent Alain Claude ABDEL-RAHMAN, Mostafa Hamed BAILLIE, Gemma Louise D04ZLC DRUGTYPE Small molecular drug D04ZLC DRUGINCH 1S/C17H18N2O4S/c1-22-14-5-3-12(4-6-14)11-18-24(20,21)17-10-13-9-15(23-2)7-8-16(13)19-17/h3-10,18-19H,11H2,1-2H3 D04ZLC DRUGINKE ZYAIUNMZKGHCRV-UHFFFAOYSA-N D04ZLC DRUGSMIL COC1=CC=C(C=C1)CNS(=O)(=O)C2=CC3=C(N2)C=CC(=C3)OC D04ZLC HIGHSTAT Patented D04ZLC COMPCLAS N-(arylalkyl)-1H-indole-2-sulfonic acid amide derivatives D05AWM DRUG__ID D05AWM D05AWM DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D05AWM DRUGTYPE Small molecular drug D05AWM DRUGINCH 1S/C40H57N7O3/c1-37(2,3)20-19-32(27-13-15-28(16-14-27)35(48)41-26-33-43-45-46-44-33)47-36(49)34(42-40(47)21-17-30(18-22-40)39(7,8)9)29-11-10-12-31(25-29)50-24-23-38(4,5)6/h10-16,25,30,32H,17-24,26H2,1-9H3,(H,41,48)(H,43,44,45,46)/t30?,32-,40?/m1/s1 D05AWM DRUGINKE BKPCTAJENJTTAU-WHPMNUFOSA-N D05AWM DRUGSMIL CC(C)(C)CCC(C1=CC=C(C=C1)C(=O)NCC2=NNN=N2)N3C(=O)C(=NC34CCC(CC4)C(C)(C)C)C5=CC(=CC=C5)OCCC(C)(C)C D05AWM HIGHSTAT Patented D05AWM COMPCLAS Spiroimidazolone derivatives D05FQX DRUG__ID D05FQX D05FQX DRUGCOMP ALLERGAN, INC. WOODWARD, David F. MARTOS, Jose L. CARLING, William R. POLOSO, Neil J. WANG, Jenny W D05FQX DRUGTYPE Small molecular drug D05FQX DRUGINCH 1S/C29H39N3O6/c1-37-22-14-12-21(13-15-26(33)34)23(18-22)29(36)32-17-7-11-25(32)28-31-24(19-38-28)27(35)30-16-6-5-10-20-8-3-2-4-9-20/h12,14,18-20,25H,2-11,13,15-17H2,1H3,(H,30,35)(H,33,34)/t25-/m0/s1 D05FQX DRUGINKE CQXXOQIYQSPKKU-VWLOTQADSA-N D05FQX DRUGSMIL COC1=CC(=C(C=C1)CCC(=O)O)C(=O)N2CCCC2C3=NC(=CO3)C(=O)NCCCCC4CCCCC4 D05FQX HIGHSTAT Patented D05FQX COMPCLAS N-alkyl-4-oxazolecar boxamide derivatives D05GDS DRUG__ID D05GDS D05GDS DRUGCOMP THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN GREIG, lain Robert ROSS, Ruth Alexandra PERTWEE, Roger Guy TREMBLEAU, Laurent Alain Claude ABDEL-RAHMAN, Mostafa Hamed BAILLIE, Gemma Louise D05GDS DRUGTYPE Small molecular drug D05GDS DRUGINCH 1S/C21H17FN2O2S/c22-19-11-9-17(10-12-19)16-7-5-15(6-8-16)14-23-27(25,26)21-13-18-3-1-2-4-20(18)24-21/h1-13,23-24H,14H2 D05GDS DRUGINKE ZYXQIXCJTWOQOB-UHFFFAOYSA-N D05GDS DRUGSMIL C1=CC=C2C(=C1)C=C(N2)S(=O)(=O)NCC3=CC=C(C=C3)C4=CC=C(C=C4)F D05GDS HIGHSTAT Patented D05GDS COMPCLAS N-(arylalkyl)-1H-indole-2-sulfonic acid amide derivatives D05GJL DRUG__ID D05GJL D05GJL DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D05GJL DRUGTYPE Small molecular drug D05GJL DRUGINCH 1S/C22H20N2O3/c1-15-10-12-16(13-11-15)20-21(27-22(25)23(2)3)18-8-6-14-24(18)17-7-4-5-9-19(17)26-20/h4-14H,1-3H3 D05GJL DRUGINKE KVEJUNNTLYYMDH-UHFFFAOYSA-N D05GJL DRUGSMIL CC1=CC=C(C=C1)C2=C(C3=CC=CN3C4=CC=CC=C4O2)OC(=O)N(C)C D05GJL HIGHSTAT Patented D05GJL COMPCLAS Benzothiazepine analogs D05GPL DRUG__ID D05GPL D05GPL DRUGCOMP ZENITH EPIGENETICS CORP D05GPL DRUGTYPE Small molecular drug D05GPL DRUGINCH 1S/C21H22N4O2/c1-4-26-21-23-20-17(22)10-16(19-13(2)24-27-14(19)3)11-18(20)25(21)12-15-8-6-5-7-9-15/h5-11H,4,12,22H2,1-3H3 D05GPL DRUGINKE AURDBDSAYLFHPT-UHFFFAOYSA-N D05GPL DRUGSMIL CCOC1=NC2=C(C=C(C=C2N1CC3=CC=CC=C3)C4=C(ON=C4C)C)N D05GPL HIGHSTAT Patented D05GPL COMPCLAS Isoxazole-based bicyclic compounds D05HJF DRUG__ID D05HJF D05HJF DRUGCOMP INFINITY PHARMACEUTICALS, INC. CASTRO, Alfredo, C. GROGAN, Michael, J. SNYDER, Daniel, A D05HJF DRUGTYPE Small molecular drug D05HJF DRUGINCH 1S/C16H16BNO3/c19-16-15-7-6-14(17(20)21)10-13(15)11-18(16)9-8-12-4-2-1-3-5-12/h1-7,10,20-21H,8-9,11H2 D05HJF DRUGINKE OWKXCKRUGQYZKS-UHFFFAOYSA-N D05HJF DRUGSMIL B(C1=CC2=C(C=C1)C(=O)N(C2)CCC3=CC=CC=C3)(O)O D05HJF HIGHSTAT Patented D05HJF COMPCLAS Boronic acid derivatives D05KXF DRUG__ID D05KXF D05KXF DRUGCOMP RENOVIS, INC. KELLY, Michael, G. KINCAID, John GOWLUGARI, Sumithra KAUB, Carl D05KXF DRUGTYPE Small molecular drug D05KXF DRUGINCH 1S/C24H22N4/c1-2-6-18(7-3-1)16-28-13-11-22-20(17-28)10-12-25-24(22)27-21-14-19-8-4-5-9-23(19)26-15-21/h1-10,12,14-15H,11,13,16-17H2,(H,25,27) D05KXF DRUGINKE WVIVDSQVVHCZNX-UHFFFAOYSA-N D05KXF DRUGSMIL C1CN(CC2=C1C(=NC=C2)NC3=CC4=CC=CC=C4N=C3)CC5=CC=CC=C5 D05KXF HIGHSTAT Patented D05KXF COMPCLAS Tetra-hydro-naphthyridine derivatives D05LZV DRUG__ID D05LZV D05LZV DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D05LZV DRUGTYPE Small molecular drug D05LZV DRUGINCH 1S/C19H20FN3O5S/c1-9(2)7-12(21-17(25)14-15(28-14)18(26)27)16(24)23-19-22-13(8-29-19)10-3-5-11(20)6-4-10/h3-6,8-9,12,14-15H,7H2,1-2H3,(H,21,25)(H,26,27)(H,22,23,24)/t12-,14-,15-/m0/s1 D05LZV DRUGINKE WVMZJHSGEWZNEO-QEJZJMRPSA-N D05LZV DRUGSMIL CC(C)CC(C(=O)NC1=NC(=CS1)C2=CC=C(C=C2)F)NC(=O)C3C(O3)C(=O)O D05LZV HIGHSTAT Patented D05LZV COMPCLAS Epoxysuccinate derivatives D05MKN DRUG__ID D05MKN D05MKN DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. TICHENOR, Mark, S. MERIT, Jeffrey, E. HAWRYLUK, Natalie, A. CHAMBERS, Alison, L. KEITH, John, M D05MKN DRUGTYPE Small molecular drug D05MKN DRUGINCH 1S/C25H23ClN4O3/c26-19-4-6-21(7-5-19)33-23-3-1-2-22(13-23)32-11-9-17-15-30(16-17)25(31)29-20-12-18-8-10-27-24(18)28-14-20/h1-8,10,12-14,17H,9,11,15-16H2,(H,27,28)(H,29,31) D05MKN DRUGINKE XAYGGDSGTNLICL-UHFFFAOYSA-N D05MKN DRUGSMIL C1C(CN1C(=O)NC2=CN=C3C(=C2)C=CN3)CCOC4=CC(=CC=C4)OC5=CC=C(C=C5)Cl D05MKN HIGHSTAT Patented D05MKN COMPCLAS Azetidine urea derivatives D05NQZ DRUG__ID D05NQZ D05NQZ DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason LouiMerck & Co., Inc., Kenilworth, NJ, USA D05NQZ DRUGTYPE Small molecular drug D05NQZ DRUGINCH 1S/C25H21Cl2F3N2O2/c26-18-12-17(13-19(27)14-18)22-21-2-1-9-31-23(21)24(34-22)7-10-32(11-8-24)15-16-3-5-20(6-4-16)33-25(28,29)30/h1-6,9,12-14,22H,7-8,10-11,15H2 D05NQZ DRUGINKE LKCGVBONYVRCLD-UHFFFAOYSA-N D05NQZ DRUGSMIL C1CN(CCC12C3=C(C=CC=N3)C(O2)C4=CC(=CC(=C4)Cl)Cl)CC5=CC=C(C=C5)OC(F)(F)F D05NQZ HIGHSTAT Patented D05NQZ COMPCLAS Benzodihydroisofuran derivatives D05PXW DRUG__ID D05PXW D05PXW DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher Joseph ROSE, Nathan SEKIRNIK, Rok D05PXW DRUGTYPE Small molecular drug D05PXW DRUGINCH 1S/C6H12N2S4/c1-3-7-5(9)11-12-6(10)8-4-2/h3-4H2,1-2H3,(H,7,9)(H,8,10) D05PXW DRUGINKE AMFIBVNSEBYBAM-UHFFFAOYSA-N D05PXW DRUGSMIL CCNC(=S)SSC(=S)NCC D05PXW HIGHSTAT Patented D05PXW COMPCLAS Disulfiram analogs D05PZG DRUG__ID D05PZG D05PZG DRUGCOMP FORMA THERAPEUTICS INC D05PZG DRUGTYPE Small molecular drug D05PZG DRUGINCH 1S/C20H27N3O3/c1-4-11-26-20-17(16-12-21-22(13-16)9-10-24)7-8-19-18(20)6-5-14(2)23(19)15(3)25/h7-8,12-14,24H,4-6,9-11H2,1-3H3/t14-/m0/s1 D05PZG DRUGINKE LCUMODKDHNQTRE-AWEZNQCLSA-N D05PZG DRUGSMIL CCCOC1=C(C=CC2=C1CCC(N2C(=O)C)C)C3=CN(N=C3)CCO D05PZG HIGHSTAT Patented D05PZG COMPCLAS Tetra-hydro-quinoline derivatives D05QWJ DRUG__ID D05QWJ D05QWJ DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D05QWJ DRUGTYPE Small molecular drug D05QWJ DRUGINCH 1S/C22H24N4O3/c1-28-18-11-6-12-19(29-2)21(18)22(27)26-17-10-5-9-16(17)25-20-13-23-14-7-3-4-8-15(14)24-20/h3-4,6-8,11-13,16-17H,5,9-10H2,1-2H3,(H,24,25)(H,26,27)/t16-,17-/m0/s1 D05QWJ DRUGINKE GIWGNHDZELXXNP-IRXDYDNUSA-N D05QWJ DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2CCCC2NC3=NC4=CC=CC=C4N=C3 D05QWJ HIGHSTAT Patented D05QWJ COMPCLAS 1,2-diamino cyclopentane-based derivatives D05RKT DRUG__ID D05RKT D05RKT DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, Wade CONDROSKI, Kevin, Ronald HAAS, Julia JIANG, Yutong KOLAKOWSKI, Gabrielle, R. SEO, Jeongbeob YANG, Hong-Woon ZHAO, Qian D05RKT DRUGTYPE Small molecular drug D05RKT DRUGINCH 1S/C19H19FN6O3/c20-11-6-13-15-2-1-4-25(15)16-3-5-26-17(23-16)14(8-22-26)18(28)21-7-12(27)10-24(9-11)19(13)29/h3,5-6,8-9,12,15,27H,1-2,4,7,10H2,(H,21,28)/t12-,15+/m0/s1 D05RKT DRUGINKE UHWGZELMUUQSBI-SWLSCSKDSA-N D05RKT DRUGSMIL C1CC2C3=CC(=CN(C3=O)CC(CNC(=O)C4=C5N=C(N2C1)C=CN5N=C4)O)F D05RKT HIGHSTAT Patented D05RKT COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D05RQF DRUG__ID D05RQF D05RQF DRUGCOMP RENOVIS, INC. KAUB, Carl GOWLUGARI, Sumithra KINCAID, John JOHNSON, Russell, James O'MAHONY, Donogh, John Roger ESTIARTE-MARTINEZ, Maria, de los Angeles DUNCTON, Matthew D05RQF DRUGTYPE Small molecular drug D05RQF DRUGINCH 1S/C25H21N3O/c1-2-27-12-11-19-13-17(7-9-23(19)27)18-8-10-24-22(14-18)26-25(29-24)28-15-20-5-3-4-6-21(20)16-28/h3-14H,2,15-16H2,1H3 D05RQF DRUGINKE JRHOETSWOCHDIA-UHFFFAOYSA-N D05RQF DRUGSMIL CCN1C=CC2=C1C=CC(=C2)C3=CC4=C(C=C3)OC(=N4)N5CC6=CC=CC=C6C5 D05RQF HIGHSTAT Patented D05RQF COMPCLAS Benzoxazole derivatives D05SJB DRUG__ID D05SJB D05SJB DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D05SJB DRUGTYPE Small molecular drug D05SJB DRUGINCH 1S/C18H17N5/c1-23(2)15-5-3-12(4-6-15)13-7-16-17(14-9-21-22-10-14)11-20-18(16)19-8-13/h3-11H,1-2H3,(H,19,20)(H,21,22) D05SJB DRUGINKE IPPNJZWFNCNYSG-UHFFFAOYSA-N D05SJB DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC3=C(NC=C3C4=CNN=C4)N=C2 D05SJB HIGHSTAT Patented D05SJB COMPCLAS 7-azaindole derivatives D05TQG DRUG__ID D05TQG D05TQG DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeong Min CHANG, Chong-Hwan Jonathan LEE, Suk Ho SEO, Hee Jeong KANG, Suk Youn SONG, Kwang-Seop KIM, Jong Yup KIM, Min Ju LEE, Sung-Han AHN, Kwang-Woo JUNG, Myung Eu D05TQG DRUGTYPE Small molecular drug D05TQG DRUGINCH 1S/C23H20Cl3N3O/c1-13-20(22-27-12-19(30-22)23(2,3)4)28-29(18-10-9-16(25)11-17(18)26)21(13)14-5-7-15(24)8-6-14/h5-12H,1-4H3 D05TQG DRUGINKE ILTATKGFTNWDTG-UHFFFAOYSA-N D05TQG DRUGSMIL CC1=C(N(N=C1C2=NC=C(O2)C(C)(C)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D05TQG HIGHSTAT Patented D05TQG COMPCLAS Pyrazole derivatives D05TYI DRUG__ID D05TYI D05TYI DRUGCOMP ORIBASE PHARMA D05TYI DRUGTYPE Small molecular drug D05TYI DRUGINCH 1S/C25H21F3N4O3/c1-14-6-7-19(31-23(33)15-4-3-5-18(8-15)25(26,27)28)10-17(14)12-29-20-9-16-11-21(24(34)35-2)32-22(16)30-13-20/h3-11,13,29H,12H2,1-2H3,(H,30,32)(H,31,33) D05TYI DRUGINKE QERVGYYPIGRNLQ-UHFFFAOYSA-N D05TYI DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)CNC3=CN=C4C(=C3)C=C(N4)C(=O)OC D05TYI HIGHSTAT Patented D05TYI COMPCLAS Azaindole derivatives D05UJQ DRUG__ID D05UJQ D05UJQ DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D05UJQ DRUGTYPE Small molecular drug D05UJQ DRUGINCH 1S/C18H13F8N3O2S2/c1-32(30,31)9-10-4-12(7-13(5-10)33(22,23,24,25)26)28-18-27-8-16(21)17(29-18)14-3-2-11(19)6-15(14)20/h2-8H,9H2,1H3,(H,27,28,29) D05UJQ DRUGINKE QPEXAIXCVQPMDQ-UHFFFAOYSA-N D05UJQ DRUGSMIL CS(=O)(=O)CC1=CC(=CC(=C1)S(F)(F)(F)(F)F)NC2=NC=C(C(=N2)C3=C(C=C(C=C3)F)F)F D05UJQ HIGHSTAT Patented D05UJQ COMPCLAS Alkyl sulfone derivatives D05UXK DRUG__ID D05UXK D05UXK DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D05UXK DRUGTYPE Small molecular drug D05UXK DRUGINCH 1S/C24H23FN8O2/c1-24(2,3)23-31-21(32-35-23)22(34)26-9-14-6-5-13(7-17(14)25)19-16-8-18(15-10-29-33(4)11-15)30-20(16)28-12-27-19/h5-8,10-12H,9H2,1-4H3,(H,26,34)(H,27,28,30) D05UXK DRUGINKE XRNHJQXCSOAXLV-UHFFFAOYSA-N D05UXK DRUGSMIL CC(C)(C)C1=NC(=NO1)C(=O)NCC2=C(C=C(C=C2)C3=C4C=C(NC4=NC=N3)C5=CN(N=C5)C)F D05UXK HIGHSTAT Patented D05UXK COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D05VBJ DRUG__ID D05VBJ D05VBJ DRUGCOMP LUNDBECK & CO AS H [DK] D05VBJ DRUGTYPE Small molecular drug D05VBJ DRUGINCH 1S/C15H10ClN5/c1-9-14-19-20-15(10-4-2-3-5-11(10)16)21(14)13-8-17-7-6-12(13)18-9/h2-8H,1H3 D05VBJ DRUGINKE SNQXTEAQGLZIDL-UHFFFAOYSA-N D05VBJ DRUGSMIL CC1=NC2=C(C=NC=C2)N3C1=NN=C3C4=CC=CC=C4Cl D05VBJ HIGHSTAT Patented D05VBJ COMPCLAS Triazolo-pyridine derivatives D05YNZ DRUG__ID D05YNZ D05YNZ DRUGCOMP NOVARTIS AG HENG, Richard HOEGENAUER, Elizabeth, Kate KOCH, Guido PULZ, Robert, Alexander VULPETTI, Anna WAELCHLI, Rudolf D05YNZ DRUGTYPE Small molecular drug D05YNZ DRUGINCH 1S/C31H33FN6O2S/c1-17-5-6-26-20(11-17)12-27(41-26)30(39)36-24-14-21(32)13-22(18(24)2)28-23-15-25(35-29(23)34-16-33-28)19-7-9-38(10-8-19)31(40)37(3)4/h7,12-17H,5-6,8-11H2,1-4H3,(H,36,39)(H,33,34,35) D05YNZ DRUGINKE AFEUSBPUCPEXMI-UHFFFAOYSA-N D05YNZ DRUGSMIL CC1CCC2=C(C1)C=C(S2)C(=O)NC3=CC(=CC(=C3C)C4=C5C=C(NC5=NC=N4)C6=CCN(CC6)C(=O)N(C)C)F D05YNZ HIGHSTAT Patented D05YNZ COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D05ZBB DRUG__ID D05ZBB D05ZBB DRUGCOMP CHENGDU DI AO PHARMACEUTICAL GROUP CO LTD [CN] D05ZBB DRUGTYPE Small molecular drug D05ZBB DRUGINCH 1S/C25H26FN5O4/c1-29(2)25(9-10-25)24(34)31-13-11-30(12-14-31)23(33)19-15-16(7-8-20(19)26)35-22-18-6-4-3-5-17(18)21(32)27-28-22/h3-8,15H,9-14H2,1-2H3,(H,27,32) D05ZBB DRUGINKE DZWVGXKLZPKLKS-UHFFFAOYSA-N D05ZBB DRUGSMIL CN(C)C1(CC1)C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)OC4=NNC(=O)C5=CC=CC=C54)F D05ZBB HIGHSTAT Patented D05ZBB COMPCLAS Phthalazine ketone derivatives D06FJL DRUG__ID D06FJL D06FJL DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D06FJL DRUGTYPE Small molecular drug D06FJL DRUGINCH 1S/C26H24FN3O3/c27-22-13-11-19(12-14-22)17-28-24(31)29-15-16-30-23(18-29)26(33-25(30)32,20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-14,23H,15-18H2,(H,28,31) D06FJL DRUGINKE SFRQIPRTNYHJHP-UHFFFAOYSA-N D06FJL DRUGSMIL C1CN2C(CN1C(=O)NCC3=CC=C(C=C3)F)C(OC2=O)(C4=CC=CC=C4)C5=CC=CC=C5 D06FJL HIGHSTAT Patented D06FJL COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D06FNA DRUG__ID D06FNA D06FNA DRUGCOMP COGNITION THERAPEUTICS, INC D06FNA DRUGTYPE Small molecular drug D06FNA DRUGINCH 1S/C22H21Cl2N/c1-15(6-7-16-8-11-21(23)22(24)12-16)25-13-18-10-9-17-4-2-3-5-19(17)20(18)14-25/h2-5,8-12,15H,6-7,13-14H2,1H3 D06FNA DRUGINKE SNYFWQWLZIRNKD-UHFFFAOYSA-N D06FNA DRUGSMIL CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3 D06FNA HIGHSTAT Patented D06FNA COMPCLAS Isoindoline derivatives D06GGI DRUG__ID D06GGI D06GGI DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L. CALDARELLI, Marina BERIA, Italo COLOMBO, Nicoletta PIUTTI, Claudia SALSA, Matteo TRAQUANDI, Gabriella D06GGI DRUGTYPE Small molecular drug D06GGI DRUGINCH 1S/C21H22N6O3/c1-26-8-10-27(11-9-26)14-3-5-15(6-4-14)29-21-23-12-13-2-7-16-18(17(13)24-21)25-30-19(16)20(22)28/h3-6,12H,2,7-11H2,1H3,(H2,22,28) D06GGI DRUGINKE CMFVPEXDTAEYSG-UHFFFAOYSA-N D06GGI DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)OC3=NC=C4CCC5=C(ON=C5C4=N3)C(=O)N D06GGI HIGHSTAT Patented D06GGI COMPCLAS Tricyclic isoxazoloquinazoline derivatives D06HMY DRUG__ID D06HMY D06HMY DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj GRECO, Michael, N. SHOOK, Brian XU, Guozhang ZHANG, Rui D06HMY DRUGTYPE Small molecular drug D06HMY DRUGINCH 1S/C32H25ClF6N2O3/c1-18-14-22(31(34,35)36)8-10-25(18)26-11-9-24(16-28(26)33)41-17-21-6-7-23(32(37,38)39)15-27(21)19-2-4-20(5-3-19)30(44)40-13-12-29(42)43/h2-11,14-16,41H,12-13,17H2,1H3,(H,40,44)(H,42,43) D06HMY DRUGINKE XNDCNDSKAXXGMD-UHFFFAOYSA-N D06HMY DRUGSMIL CC1=C(C=CC(=C1)C(F)(F)F)C2=C(C=C(C=C2)NCC3=C(C=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C(=O)NCCC(=O)O)Cl D06HMY HIGHSTAT Patented D06HMY COMPCLAS Biphenyl carboxamidopropanoic acid derivatives D06KOH DRUG__ID D06KOH D06KOH DRUGCOMP Korea institute of radiological & medical sciences, S D06KOH DRUGTYPE Small molecular drug D06KOH DRUGINCH 1S/C16H23NO2/c1-13(18)17-15-7-9-16(10-8-15)19-12-11-14-5-3-2-4-6-14/h7-10,14H,2-6,11-12H2,1H3,(H,17,18) D06KOH DRUGINKE XXEWOEJZHUIISK-UHFFFAOYSA-N D06KOH DRUGSMIL CC(=O)NC1=CC=C(C=C1)OCCC2CCCCC2 D06KOH HIGHSTAT Patented D06KOH COMPCLAS 4-(2-cyclohexylethoxy) aniline derivatives D06LEZ DRUG__ID D06LEZ D06LEZ DRUGCOMP PFIZER LIMITED D06LEZ DRUGTYPE Small molecular drug D06LEZ DRUGINCH 1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25) D06LEZ DRUGINKE ZYSCOUXLBXGGIM-UHFFFAOYSA-N D06LEZ DRUGSMIL C1=CC(=C(C=C1Cl)C2=C(NN=C2)N)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=CSC=N4)F D06LEZ HIGHSTAT Patented D06LEZ COMPCLAS Benzene sulfonamide derivatives D06NPZ DRUG__ID D06NPZ D06NPZ DRUGCOMP CMG PHARMACEUTICAL CO., LTD. HANDOK INC D06NPZ DRUGTYPE Small molecular drug D06NPZ DRUGINCH 1S/C23H23F2N5O2/c24-17-4-5-19(25)18(14-17)20-2-1-8-29(20)21-7-9-30-23(27-21)16(15-26-30)3-6-22(31)28-10-12-32-13-11-28/h3-7,9,14-15,20H,1-2,8,10-13H2/b6-3+/t20-/m1/s1 D06NPZ DRUGINKE FFDHOZJDUKYFPJ-SQZHUTIHSA-N D06NPZ DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)C=CC(=O)N4CCOCC4)C5=C(C=CC(=C5)F)F D06NPZ HIGHSTAT Patented D06NPZ COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D06NRQ DRUG__ID D06NRQ D06NRQ DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D06NRQ DRUGTYPE Small molecular drug D06NRQ DRUGINCH 1S/C22H20F2N6OS/c1-29(21(31)15-11-13(23)6-8-18(15)30-25-9-10-26-30)19-4-2-3-16(19)27-22-28-17-7-5-14(24)12-20(17)32-22/h5-12,16,19H,2-4H2,1H3,(H,27,28)/t16-,19-/m0/s1 D06NRQ DRUGINKE AWDZNHIULYTTNC-LPHOPBHVSA-N D06NRQ DRUGSMIL CN(C1CCCC1NC2=NC3=C(S2)C=C(C=C3)F)C(=O)C4=C(C=CC(=C4)F)N5N=CC=N5 D06NRQ HIGHSTAT Patented D06NRQ COMPCLAS 1,2-diamino cyclopentane-based derivatives D06OTA DRUG__ID D06OTA D06OTA DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D06OTA DRUGTYPE Small molecular drug D06OTA DRUGINCH 1S/C20H20F3N7O/c1-19(29-17-12-24-16(11-25-17)20(21,22)23)8-4-7-15(19)28-18(31)13-5-2-3-6-14(13)30-26-9-10-27-30/h2-3,5-6,9-12,15H,4,7-8H2,1H3,(H,25,29)(H,28,31)/t15-,19-/m0/s1 D06OTA DRUGINKE HMHQKDBOHKCIIS-KXBFYZLASA-N D06OTA DRUGSMIL CC1(CCCC1NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC=C(N=C4)C(F)(F)F D06OTA HIGHSTAT Patented D06OTA COMPCLAS 1,2-diamino cyclopentane-based derivatives D06PIP DRUG__ID D06PIP D06PIP DRUGCOMP CADILA HEALTHCARE LIMITED D06PIP DRUGTYPE Small molecular drug D06PIP DRUGINCH 1S/C19H28F2N4O3S/c1-23(2)29(26,27)25-9-12-7-24(8-13(12)10-25)15-6-18(22)19(28-11-15)16-5-14(20)3-4-17(16)21/h3-5,12-13,15,18-19H,6-11,22H2,1-2H3/t12?,13?,15-,18+,19-/m1/s1 D06PIP DRUGINKE YOZMZFRQIDLSLZ-RVBDROBCSA-N D06PIP DRUGSMIL CN(C)S(=O)(=O)N1CC2CN(CC2C1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N D06PIP HIGHSTAT Patented D06PIP COMPCLAS Aminopiperidine derivatives D06QPW DRUG__ID D06QPW D06QPW DRUGCOMP GILEAD SCIENCES, INC. MELVIN, Lawrence, S., Jr. GRAUPE, Michael VENKATARAMANI, Chandrasekar D06QPW DRUGTYPE Small molecular drug D06QPW DRUGINCH 1S/C18H14N6O2/c25-17(23-26)12-4-6-13(7-5-12)21-18-19-9-8-14(22-18)15-11-20-16-3-1-2-10-24(15)16/h1-11,26H,(H,23,25)(H,19,21,22) D06QPW DRUGINKE YUKQHEDCOBZZTJ-UHFFFAOYSA-N D06QPW DRUGSMIL C1=CC2=NC=C(N2C=C1)C3=NC(=NC=C3)NC4=CC=C(C=C4)C(=O)NO D06QPW HIGHSTAT Patented D06QPW COMPCLAS Aniline derivatives D06STX DRUG__ID D06STX D06STX DRUGCOMP BUCK INSTITUTE FOR RESEARCH ON AGING JOHN, Varghese ZHANG, Qiang BREDESEN, Dale, E D06STX DRUGTYPE Small molecular drug D06STX DRUGINCH 1S/C20H22N4OS/c1-5-24(18(25)15-7-6-12-21-13-15)19-23-22-17(26-19)14-8-10-16(11-9-14)20(2,3)4/h6-13H,5H2,1-4H3 D06STX DRUGINKE XMRKDXZDAAFZDU-UHFFFAOYSA-N D06STX DRUGSMIL CCN(C1=NN=C(S1)C2=CC=C(C=C2)C(C)(C)C)C(=O)C3=CN=CC=C3 D06STX HIGHSTAT Patented D06STX COMPCLAS Thiadiazolyl carboxamide derivatives D06TFC DRUG__ID D06TFC D06TFC DRUGCOMP RESEARCH TRIANGLE INSTITUTE D06TFC DRUGTYPE Small molecular drug D06TFC DRUGINCH 1S/C26H36N2O3/c1-20(2)18-26(21-10-6-5-7-11-21)23-19-28(17-12-22(23)25(30)31-26)24(29)13-16-27-14-8-3-4-9-15-27/h5-7,10-11,20H,3-4,8-9,12-19H2,1-2H3 D06TFC DRUGINKE GPTJWUZEJKIMBY-UHFFFAOYSA-N D06TFC DRUGSMIL CC(C)CC1(C2=C(CCN(C2)C(=O)CCN3CCCCCC3)C(=O)O1)C4=CC=CC=C4 D06TFC HIGHSTAT Patented D06TFC COMPCLAS 4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivatives D06XJG DRUG__ID D06XJG D06XJG DRUGCOMP Teizin Pharma Ltd D06XJG DRUGTYPE Small molecular drug D06XJG DRUGINCH 1S/C15H15N5O3S/c1-8(2)23-12-5-4-10(6-11(12)20-7-16-18-19-20)14-17-9(3)13(24-14)15(21)22/h4-8H,1-3H3,(H,21,22) D06XJG DRUGINKE GTRJSEARYANTGP-UHFFFAOYSA-N D06XJG DRUGSMIL CC1=C(SC(=N1)C2=CC(=C(C=C2)OC(C)C)N3C=NN=N3)C(=O)O D06XJG HIGHSTAT Patented D06XJG COMPCLAS Azole benzene derivatives D06YBF DRUG__ID D06YBF D06YBF DRUGCOMP ASTON UNIVERSITY D06YBF DRUGTYPE Small molecular drug D06YBF DRUGINCH 1S/C18H22BrN3O6/c1-27-17(25)14-4-2-13(3-5-14)12-28-18(26)22-8-6-21(7-9-22)16(24)11-20-15(23)10-19/h2-5H,6-12H2,1H3,(H,20,23) D06YBF DRUGINKE DHKHYJYAEPJCDA-UHFFFAOYSA-N D06YBF DRUGSMIL COC(=O)C1=CC=C(C=C1)COC(=O)N2CCN(CC2)C(=O)CNC(=O)CBr D06YBF HIGHSTAT Patented D06YBF COMPCLAS Acyl piperidine derivatives D06YON DRUG__ID D06YON D06YON DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D06YON DRUGTYPE Small molecular drug D06YON DRUGINCH 1S/C24H27ClFN5O3/c1-15-22(31(29-23(15)32)17-6-4-3-5-7-17)28-24(33)27-21-14-30(10-11-34-2)13-18(21)16-8-9-20(26)19(25)12-16/h3-9,12,18,21H,10-11,13-14H2,1-2H3,(H,29,32)(H2,27,28,33)/t18-,21+/m0/s1 D06YON DRUGINKE GIFBEFSILNFYRM-GHTZIAJQSA-N D06YON DRUGSMIL CC1=C(N(NC1=O)C2=CC=CC=C2)NC(=O)NC3CN(CC3C4=CC(=C(C=C4)F)Cl)CCOC D06YON HIGHSTAT Patented D06YON COMPCLAS Pyrrolidinyl urea derivatives D06ZNU DRUG__ID D06ZNU D06ZNU DRUGCOMP PRINCIPIA BIOPHARMA INCPRINCIPIA BIOPHARMA INC. GOLDSTEIN, David Michael BRAMELD, Kenneth Albert D06ZNU DRUGTYPE Small molecular drug D06ZNU DRUGINCH 1S/C30H28N6O2/c31-16-22(15-20-8-9-20)30(37)35-14-4-5-23(17-35)36-18-26(27-28(32)33-19-34-29(27)36)21-10-12-25(13-11-21)38-24-6-2-1-3-7-24/h1-3,6-7,10-13,15,18-20,23H,4-5,8-9,14,17H2,(H2,32,33,34)/b22-15- D06ZNU DRUGINKE QBWDAFICRCELKK-JCMHNJIXSA-N D06ZNU DRUGSMIL C1CC(CN(C1)C(=O)C(=CC2CC2)C#N)N3C=C(C4=C(N=CN=C43)N)C5=CC=C(C=C5)OC6=CC=CC=C6 D06ZNU HIGHSTAT Patented D06ZNU COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D07CSE DRUG__ID D07CSE D07CSE DRUGCOMP FORMA THERAPEUTICS, INC D07CSE DRUGTYPE Small molecular drug D07CSE DRUGINCH 1S/C24H30N4O3/c1-16-14-26(24(30)31-21-8-3-4-9-21)23-12-18(10-11-22(23)28(16)17(2)29)19-13-25-27(15-19)20-6-5-7-20/h10-13,15-16,20-21H,3-9,14H2,1-2H3/t16-/m0/s1 D07CSE DRUGINKE YYISYQUFPYKFLD-INIZCTEOSA-N D07CSE DRUGSMIL CC1CN(C2=C(N1C(=O)C)C=CC(=C2)C3=CN(N=C3)C4CCC4)C(=O)OC5CCCC5 D07CSE HIGHSTAT Patented D07CSE COMPCLAS Benzothiazepine analogs D07DUX DRUG__ID D07DUX D07DUX DRUGCOMP UNIVERZITA PALACKEHO V OLOMOUCI BIOPATTERNS S.R.O D07DUX DRUGTYPE Small molecular drug D07DUX DRUGINCH 1S/C26H32N8O/c27-18-8-10-19(11-9-18)31-26-32-24(23-25(33-26)34(16-30-23)20-4-1-2-5-20)29-15-17-7-12-21(28-14-17)22-6-3-13-35-22/h3,6-7,12-14,16,18-20H,1-2,4-5,8-11,15,27H2,(H2,29,31,32,33) D07DUX DRUGINKE MDEXMDFOZRJJIN-UHFFFAOYSA-N D07DUX DRUGSMIL C1CCC(C1)N2C=NC3=C(N=C(N=C32)NC4CCC(CC4)N)NCC5=CN=C(C=C5)C6=CC=CO6 D07DUX HIGHSTAT Patented D07DUX COMPCLAS Roscovitine derivatives D07EUB DRUG__ID D07EUB D07EUB DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D07EUB DRUGTYPE Small molecular drug D07EUB DRUGINCH 1S/C17H14FN5O2/c1-9-15-22-21-13-6-7-14(25-3)20-17(13)23(15)16(19-9)11-8-10(24-2)4-5-12(11)18/h4-8H,1-3H3 D07EUB DRUGINKE HLUWBLAYMFWHOF-UHFFFAOYSA-N D07EUB DRUGSMIL CC1=C2N=NC3=C(N2C(=N1)C4=C(C=CC(=C4)OC)F)N=C(C=C3)OC D07EUB HIGHSTAT Patented D07EUB COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D07JMG DRUG__ID D07JMG D07JMG DRUGCOMP INFINITY PHARMACEUTICALS, INC. CASTRO, Alfredo, C. GROGAN, Michael, J. SNYDER, Daniel, A D07JMG DRUGTYPE Small molecular drug D07JMG DRUGINCH 1S/C17H16BNO3/c20-17-16-7-6-15(18(21)22)12-14(16)9-11-19(17)10-8-13-4-2-1-3-5-13/h1-7,9,11-12,21-22H,8,10H2 D07JMG DRUGINKE MPFOFZNQFUHKAK-UHFFFAOYSA-N D07JMG DRUGSMIL B(C1=CC2=C(C=C1)C(=O)N(C=C2)CCC3=CC=CC=C3)(O)O D07JMG HIGHSTAT Patented D07JMG COMPCLAS Boronic acid derivatives D07KMK DRUG__ID D07KMK D07KMK DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D07KMK DRUGTYPE Small molecular drug D07KMK DRUGINCH 1S/C17H20N4/c1-21-11-14(9-20-21)16-10-19-17-15(16)7-13(8-18-17)12-5-3-2-4-6-12/h7-12H,2-6H2,1H3,(H,18,19) D07KMK DRUGINKE FZQRKZMGFGTWJG-UHFFFAOYSA-N D07KMK DRUGSMIL CN1C=C(C=N1)C2=CNC3=C2C=C(C=N3)C4CCCCC4 D07KMK HIGHSTAT Patented D07KMK COMPCLAS 7-azaindole derivatives D07PKU DRUG__ID D07PKU D07PKU DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D07PKU DRUGTYPE Small molecular drug D07PKU DRUGINCH 1S/C20H15NO4S/c22-16-10-12-20(23,13-11-16)19-14-15-6-4-5-9-18(15)21(19)26(24,25)17-7-2-1-3-8-17/h1-14,23H D07PKU DRUGINKE HWKQYGBAAMKHDY-UHFFFAOYSA-N D07PKU DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)N2C3=CC=CC=C3C=C2C4(C=CC(=O)C=C4)O D07PKU HIGHSTAT Patented D07PKU COMPCLAS 4-aryl quinol derivatives D07PND DRUG__ID D07PND D07PND DRUGCOMP RESEARCH TRIANGLE INSTITUTE D07PND DRUGTYPE Small molecular drug D07PND DRUGINCH 1S/C25H27Cl2N7O2S/c26-18-9-11-19(12-10-18)34-24(20-3-1-2-4-21(20)27)33-22-23(30-15-31-25(22)34)29-13-16-5-7-17(8-6-16)14-32-37(28,35)36/h1-4,9-12,15-17,32H,5-8,13-14H2,(H2,28,35,36)(H,29,30,31) D07PND DRUGINKE FSGQETVZTNOSAH-UHFFFAOYSA-N D07PND DRUGSMIL C1CC(CCC1CNC2=C3C(=NC=N2)N(C(=N3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl)CNS(=O)(=O)N D07PND HIGHSTAT Patented D07PND COMPCLAS Diphenyl purine derivatives D07QIP DRUG__ID D07QIP D07QIP DRUGCOMP THE UNIVERSITY OF NOTTINGHAM WANG, Shudong SHI, Shenhua ZAYTSEV, Andrey FISCHER, Peter MartiCYCLACEL LIMITED WANG, Shudong MEADES, Christopher WOOD, Gavin OSNOWSKI, Andrew FISCHER, Peter, MartiCYCLACEL LIMITED FISCHER, Peter, Martin WANG, Shudong WOOD, Gavin D07QIP DRUGTYPE Small molecular drug D07QIP DRUGINCH 1S/C16H14N6OS/c1-9-14(24-16(18-2)20-9)13-10(7-17)8-19-15(22-13)21-11-4-3-5-12(23)6-11/h3-6,8,23H,1-2H3,(H,18,20)(H,19,21,22) D07QIP DRUGINKE NYRVLHGVDPPWJS-UHFFFAOYSA-N D07QIP DRUGSMIL CC1=C(SC(=N1)NC)C2=NC(=NC=C2C#N)NC3=CC(=CC=C3)O D07QIP HIGHSTAT Patented D07QIP COMPCLAS 4-(thiazol-5-yl)-pyrimidine derivatives D07QLD DRUG__ID D07QLD D07QLD DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori IMASHIRO, Ritsuo SATO, Atsush D07QLD DRUGTYPE Small molecular drug D07QLD DRUGINCH 1S/C28H23Cl2F2N5O3/c1-40-26-24(33-37(23-5-3-2-4-21(23)30)25(26)17-6-8-18(29)9-7-17)27(38)34-36-14-12-35(13-15-36)28(39)20-11-10-19(31)16-22(20)32/h2-11,16H,12-15H2,1H3,(H,34,38) D07QLD DRUGINKE RXXJWLVGDKFAMN-UHFFFAOYSA-N D07QLD DRUGSMIL COC1=C(N(N=C1C(=O)NN2CCN(CC2)C(=O)C3=C(C=C(C=C3)F)F)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl D07QLD HIGHSTAT Patented D07QLD COMPCLAS Pyrazole derivatives D07RIZ DRUG__ID D07RIZ D07RIZ DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D07RIZ DRUGTYPE Small molecular drug D07RIZ DRUGINCH 1S/C26H26ClN5O/c27-22-9-7-19(8-10-22)23-17-24(32(30-23)26-28-13-4-14-29-26)20-11-15-31(16-12-20)18-25(33)21-5-2-1-3-6-21/h1-10,13-14,17,20,25,33H,11-12,15-16,18H2 D07RIZ DRUGINKE VSNXVFRRZXFFLD-UHFFFAOYSA-N D07RIZ DRUGSMIL C1CN(CCC1C2=CC(=NN2C3=NC=CC=N3)C4=CC=C(C=C4)Cl)CC(C5=CC=CC=C5)O D07RIZ HIGHSTAT Patented D07RIZ COMPCLAS Piperidinyl triazole derivatives D07SYY DRUG__ID D07SYY D07SYY DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori SHIRAI, Kimihiro OI, Marik D07SYY DRUGTYPE Small molecular drug D07SYY DRUGINCH 1S/C26H18Cl3N5O/c1-33(19-6-4-5-18(28)13-19)32-26(35)22-15-31-34-24(16-9-11-17(27)12-10-16)21(14-30-25(22)34)20-7-2-3-8-23(20)29/h2-15H,1H3,(H,32,35) D07SYY DRUGINKE VZJOGKVKWHCJNG-UHFFFAOYSA-N D07SYY DRUGSMIL CN(C1=CC(=CC=C1)Cl)NC(=O)C2=C3N=CC(=C(N3N=C2)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D07SYY HIGHSTAT Patented D07SYY COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D07TEZ DRUG__ID D07TEZ D07TEZ DRUGCOMP Korea Institute of Radiological & Medical Sciences, S D07TEZ DRUGTYPE Small molecular drug D07TEZ DRUGINCH 1S/C17H12N2O/c18-12-8-9-16-15(10-12)19-17(20-16)14-7-3-5-11-4-1-2-6-13(11)14/h1-10H,18H2 D07TEZ DRUGINKE NCQQMVULPNMPEH-UHFFFAOYSA-N D07TEZ DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C3=NC4=C(O3)C=CC(=C4)N D07TEZ HIGHSTAT Patented D07TEZ COMPCLAS Benzo[d]oxazole derivatives D07VLC DRUG__ID D07VLC D07VLC DRUGCOMP Roche D07VLC DRUGTYPE Small molecular drug D07VLC DRUGINCH 1S/C21H16FN3O2/c22-15-8-6-14(7-9-15)20-13-16(26)10-12-25(20)21(27)24-19-5-1-4-18-17(19)3-2-11-23-18/h1-12,20H,13H2,(H,24,27)/t20-/m0/s1 D07VLC DRUGINKE ZREAHQPXWUVTDX-FQEVSTJZSA-N D07VLC DRUGSMIL C1C(N(C=CC1=O)C(=O)NC2=CC=CC3=C2C=CC=N3)C4=CC=C(C=C4)F D07VLC HIGHSTAT Patented D07VLC COMPCLAS Fluorophenyl-substituted heterocyclic amide analogs D07WOT DRUG__ID D07WOT D07WOT DRUGCOMP ASTRAZENECA AB [SE] D07WOT DRUGTYPE Small molecular drug D07WOT DRUGINCH 1S/C22H18N2O7S2/c1-30-18-13-15(10-11-16(18)19-12-14-6-2-3-7-17(14)31-19)22(25)24-33(28,29)21-9-5-4-8-20(21)32(23,26)27/h2-13H,1H3,(H,24,25)(H2,23,26,27) D07WOT DRUGINKE JTTOZXONFHYBAF-UHFFFAOYSA-N D07WOT DRUGSMIL COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2S(=O)(=O)N)C3=CC4=CC=CC=C4O3 D07WOT HIGHSTAT Patented D07WOT COMPCLAS Betais-sulfonylamino derivatives D08CGI DRUG__ID D08CGI D08CGI DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D08CGI DRUGTYPE Small molecular drug D08CGI DRUGINCH 1S/C19H15FN4O5S2/c20-10-3-1-9(2-4-10)13-7-31-19(23-13)24-16(25)12(5-11-6-30-8-21-11)22-17(26)14-15(29-14)18(27)28/h1-4,6-8,12,14-15H,5H2,(H,22,26)(H,27,28)(H,23,24,25)/t12-,14+,15+/m0/s1 D08CGI DRUGINKE WRGOUJJZKXTKBL-NWANDNLSSA-N D08CGI DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)NC(=O)C(CC3=CSC=N3)NC(=O)C4C(O4)C(=O)O)F D08CGI HIGHSTAT Patented D08CGI COMPCLAS Epoxysuccinate derivatives D08DWG DRUG__ID D08DWG D08DWG DRUGCOMP NOVARTIS AG PFISTER, Keith B SENDZIK, Martin D08DWG DRUGTYPE Small molecular drug D08DWG DRUGINCH 1S/C23H29ClN4O2/c24-21-15-27-22(28-23(29)18-4-2-8-25-14-18)12-20(21)17-3-1-5-19(11-17)26-13-16-6-9-30-10-7-16/h1,3,5,11-12,15-16,18,25-26H,2,4,6-10,13-14H2,(H,27,28,29) D08DWG DRUGINKE UUPXZCDRKZMXRB-UHFFFAOYSA-N D08DWG DRUGSMIL C1CC(CNC1)C(=O)NC2=NC=C(C(=C2)C3=CC(=CC=C3)NCC4CCOCC4)Cl D08DWG HIGHSTAT Patented D08DWG COMPCLAS Phenylpyridine derivatives D08EID DRUG__ID D08EID D08EID DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D08EID DRUGTYPE Small molecular drug D08EID DRUGINCH 1S/C29H27F5N2O5S/c1-35(42(40,41)28-26(33)24(31)23(30)25(32)27(28)34)16-22(37)36(21-13-11-20(12-14-21)29(38)39)15-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h7-14,18H,2-6,15-16H2,1H3,(H,38,39) D08EID DRUGINKE VFPYGNNOSJWBHF-UHFFFAOYSA-N D08EID DRUGSMIL CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC=C(C=C3)C(=O)O)S(=O)(=O)C4=C(C(=C(C(=C4F)F)F)F)F D08EID HIGHSTAT Patented D08EID COMPCLAS Salicylic acid derivatives D08EMW DRUG__ID D08EMW D08EMW DRUGCOMP PFIZER INC D08EMW DRUGTYPE Small molecular drug D08EMW DRUGINCH 1S/C21H29F3N2O6S/c1-15(2)26(33(29,30)17-6-4-3-5-7-17)16-12-20(31-14-16)8-10-25(11-9-20)19(28)32-18(13-27)21(22,23)24/h3-7,15-16,18,27H,8-14H2,1-2H3/t16-,18-/m1/s1 D08EMW DRUGINKE FNERRHFFFPJRAG-SJLPKXTDSA-N D08EMW DRUGSMIL CC(C)N(C1CC2(CCN(CC2)C(=O)OC(CO)C(F)(F)F)OC1)S(=O)(=O)C3=CC=CC=C3 D08EMW HIGHSTAT Patented D08EMW COMPCLAS Carbamate derivatives D08EYN DRUG__ID D08EYN D08EYN DRUGCOMP SUVEN LIFE SCIENCES LIMITED D08EYN DRUGTYPE Small molecular drug D08EYN DRUGINCH 1S/C22H30N2O3/c25-22(24-14-16-26-17-15-24)9-6-18-4-7-20(8-5-18)27-21-10-12-23(13-11-21)19-2-1-3-19/h4-9,19,21H,1-3,10-17H2/b9-6+ D08EYN DRUGINKE MXFWFZGVHOHBHI-RMKNXTFCSA-N D08EYN DRUGSMIL C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)C=CC(=O)N4CCOCC4 D08EYN HIGHSTAT Patented D08EYN COMPCLAS Acrylamide compounds D08IWT DRUG__ID D08IWT D08IWT DRUGCOMP ARRAY BIOPHARMA INC. HAAS, Julia ANDREWS, Steven, W. JIANG, Yutong ZHANG, Gan D08IWT DRUGTYPE Small molecular drug D08IWT DRUGINCH 1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18-/m1/s1 D08IWT DRUGINKE NYNZQNWKBKUAII-RDTXWAMCSA-N D08IWT DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F D08IWT HIGHSTAT Patented D08IWT COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D08IZA DRUG__ID D08IZA D08IZA DRUGCOMP ORION CORPORATION D08IZA DRUGTYPE Small molecular drug D08IZA DRUGINCH 1S/C20H18N4O3/c1-12-20(13(2)27-23-12)15-9-14-5-6-19(25)24(16(14)10-17(15)26-3)11-18-21-7-4-8-22-18/h4-10H,11H2,1-3H3 D08IZA DRUGINKE NWOCKSNGLNHMMB-UHFFFAOYSA-N D08IZA DRUGSMIL CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)C=CC(=O)N3CC4=NC=CC=N4)OC D08IZA HIGHSTAT Patented D08IZA COMPCLAS Isoxazole-based bicyclic compounds D08JHQ DRUG__ID D08JHQ D08JHQ DRUGCOMP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI D08JHQ DRUGTYPE Small molecular drug D08JHQ DRUGINCH 1S/C23H19ClN2O2/c1-14-20(11-12-22(14)27)26-21-13-16(9-10-19(21)24)25-23(28)18-8-4-6-15-5-2-3-7-17(15)18/h2-10,13,26H,11-12H2,1H3,(H,25,28) D08JHQ DRUGINKE HRGRBMHGQQBNSK-UHFFFAOYSA-N D08JHQ DRUGSMIL CC1=C(CCC1=O)NC2=C(C=CC(=C2)NC(=O)C3=CC=CC4=CC=CC=C43)Cl D08JHQ HIGHSTAT Patented D08JHQ COMPCLAS Aminocyclopentenone compounds D08JII DRUG__ID D08JII D08JII DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D08JII DRUGTYPE Small molecular drug D08JII DRUGINCH 1S/C23H19F3N6O2/c1-31-11-15(18-19(27)28-12-29-20(18)31)13-5-7-14(8-6-13)32-10-9-22(34,21(32)33)16-3-2-4-17(30-16)23(24,25)26/h2-8,11-12,34H,9-10H2,1H3,(H2,27,28,29) D08JII DRUGINKE DHELRXCAKDZMKY-UHFFFAOYSA-N D08JII DRUGSMIL CN1C=C(C2=C(N=CN=C21)N)C3=CC=C(C=C3)N4CCC(C4=O)(C5=NC(=CC=C5)C(F)(F)F)O D08JII HIGHSTAT Patented D08JII COMPCLAS Phenylpyrrolidinone derivatives D08KAH DRUG__ID D08KAH D08KAH DRUGCOMP Janssen Pharmaceutica NV D08KAH DRUGTYPE Small molecular drug D08KAH DRUGINCH 1S/C24H26N4O2/c29-23-19-7-2-4-9-22(19)28(24(30)26-23)13-5-12-27-14-10-17(11-15-27)20-16-25-21-8-3-1-6-18(20)21/h1-4,6-9,16-17,25H,5,10-15H2,(H,26,29,30) D08KAH DRUGINKE MAJCEXQEEGYUCA-UHFFFAOYSA-N D08KAH DRUGSMIL C1CN(CCC1C2=CNC3=CC=CC=C32)CCCN4C5=CC=CC=C5C(=O)NC4=O D08KAH HIGHSTAT Patented D08KAH COMPCLAS Quinazolinedione derivatives D08KKC DRUG__ID D08KKC D08KKC DRUGCOMP NOVARTIS AG ASTEX THERAPEUTICS LTD. BESONG, Gilbert BRAIN, Christopher Thomas BROOKS, Clinton A. CONGREVE, Miles Stuart DAGOSTIN, Claudio HE, Guo HOU, Ying HOWARD, Steven LI, Yue LU, Yipin MORTENSON, Paul SMITH, Troy SUNG, Moo WOODHEAD, Steven WRONA, Wojciech D08KKC DRUGTYPE Small molecular drug D08KKC DRUGINCH 1S/C26H36N8O/c1-18(2)32-11-13-33(14-12-32)21-9-10-23(27-17-21)29-26-28-16-19-15-22(25(35)31(3)4)34(24(19)30-26)20-7-5-6-8-20/h9-10,15-18,20H,5-8,11-14H2,1-4H3,(H,27,28,29,30) D08KKC DRUGINKE XVVBHKGQHJECBA-UHFFFAOYSA-N D08KKC DRUGSMIL CC(C)N1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C(N(C4=N3)C5CCCC5)C(=O)N(C)C D08KKC HIGHSTAT Patented D08KKC COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D08KYM DRUG__ID D08KYM D08KYM DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D08KYM DRUGTYPE Small molecular drug D08KYM DRUGINCH 1S/C21H19FN6O2/c22-13-8-9-19-17(12-13)27-21(30-19)26-16-6-3-5-15(16)25-20(29)14-4-1-2-7-18(14)28-23-10-11-24-28/h1-2,4,7-12,15-16H,3,5-6H2,(H,25,29)(H,26,27)/t15-,16-/m0/s1 D08KYM DRUGINKE JFPYMDXVSVUGTP-HOTGVXAUSA-N D08KYM DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=C(O4)C=CC(=C5)F D08KYM HIGHSTAT Patented D08KYM COMPCLAS 1,2-diamino cyclopentane-based derivatives D08OKB DRUG__ID D08OKB D08OKB DRUGCOMP H. LUNDBECK A/S D08OKB DRUGTYPE Small molecular drug D08OKB DRUGINCH 1S/C24H31FN4O2/c1-24(2)16-7-6-15(18(24)12-16)13-26-22(30)20-4-3-5-21-27-19(14-29(20)21)23(31)28-10-8-17(25)9-11-28/h3-5,14-18H,6-13H2,1-2H3,(H,26,30)/t15-,16-,18-/m0/s1 D08OKB DRUGINKE AOWWKPWFEIOIDV-BQFCYCMXSA-N D08OKB DRUGSMIL CC1(C2CCC(C1C2)CNC(=O)C3=CC=CC4=NC(=CN43)C(=O)N5CCC(CC5)F)C D08OKB HIGHSTAT Patented D08OKB COMPCLAS Bicyclic heteroaryl amide derivatives D08PXF DRUG__ID D08PXF D08PXF DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D08PXF DRUGTYPE Small molecular drug D08PXF DRUGINCH 1S/C26H34N8OS/c1-4-24(35)27-19-5-7-20(8-6-19)36-25-29-21(28-22-15-18(2)31-32-22)16-23(30-25)34-13-10-26(11-14-34)9-12-33(3)17-26/h5-8,15-16H,4,9-14,17H2,1-3H3,(H,27,35)(H2,28,29,30,31,32) D08PXF DRUGINKE ODMCGDLIMBCHLX-UHFFFAOYSA-N D08PXF DRUGSMIL CCC(=O)NC1=CC=C(C=C1)SC2=NC(=CC(=N2)N3CCC4(CCN(C4)C)CC3)NC5=NNC(=C5)C D08PXF HIGHSTAT Patented D08PXF COMPCLAS Aminopyrimidine derivatives D08SDJ DRUG__ID D08SDJ D08SDJ DRUGCOMP ABRAXIS BIOSCIENCE, LLC D08SDJ DRUGTYPE Small molecular drug D08SDJ DRUGINCH 1S/C18H22N8S2/c1-12-11-20-17(27-12)22-15-21-16(26-9-7-25(2)8-10-26)24-18(23-15)28-14-5-3-13(19)4-6-14/h3-6,11H,7-10,19H2,1-2H3,(H,20,21,22,23,24) D08SDJ DRUGINKE WLWGUMHFVGHNRD-UHFFFAOYSA-N D08SDJ DRUGSMIL CC1=CN=C(S1)NC2=NC(=NC(=N2)SC3=CC=C(C=C3)N)N4CCN(CC4)C D08SDJ HIGHSTAT Patented D08SDJ COMPCLAS Ureido-phenyl-substituted triazine derivatives D08VAT DRUG__ID D08VAT D08VAT DRUGCOMP EWHA UNIVERSITY - INDUSTRY COLLABORATION FOUNDATION KWON, Young Joo D08VAT DRUGTYPE Small molecular drug D08VAT DRUGINCH 1S/C11H20O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2H,1,3-10H2,(H,12,13) D08VAT DRUGINKE FRPZMMHWLSIFAZ-UHFFFAOYSA-N D08VAT DRUGSMIL C=CCCCCCCCCC(=O)O D08VAT HIGHSTAT Patented D08VAT COMPCLAS Undecylenic acid derivatives D08XOA DRUG__ID D08XOA D08XOA DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D08XOA DRUGTYPE Small molecular drug D08XOA DRUGINCH 1S/C23H22N2O2S/c1-3-24(4-2)23(26)27-21-19-14-10-16-25(19)18-13-8-9-15-20(18)28-22(21)17-11-6-5-7-12-17/h5-16H,3-4H2,1-2H3 D08XOA DRUGINKE LEFJQLQZGXZKSP-UHFFFAOYSA-N D08XOA DRUGSMIL CCN(CC)C(=O)OC1=C(SC2=CC=CC=C2N3C1=CC=C3)C4=CC=CC=C4 D08XOA HIGHSTAT Patented D08XOA COMPCLAS Benzothiazepine analogs D09AAB DRUG__ID D09AAB D09AAB DRUGCOMP NORTHEASTERN UNIVERSITY MAKRIYANNIS, Alexandros PANDARINATHAN, Lakshimpathi ZVONOK, Nikolai PARKKARI, Teija CHAPMAN, Lauren D09AAB DRUGTYPE Small molecular drug D09AAB DRUGINCH 1S/C15H18ClN3O/c1-18(10-6-5-9-16)15(20)19-11-14(17-12-19)13-7-3-2-4-8-13/h2-4,7-8,11-12H,5-6,9-10H2,1H3 D09AAB DRUGINKE ULOIHJOBJLPNOI-UHFFFAOYSA-N D09AAB DRUGSMIL CN(CCCCCl)C(=O)N1C=C(N=C1)C2=CC=CC=C2 D09AAB HIGHSTAT Patented D09AAB COMPCLAS Imidazolyl urea derivatives D09BDD DRUG__ID D09BDD D09BDD DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GmbH D09BDD DRUGTYPE Small molecular drug D09BDD DRUGINCH 1S/C16H11ClN4/c1-10-15-19-20-16(11-6-2-3-7-12(11)17)21(15)14-9-5-4-8-13(14)18-10/h2-9H,1H3 D09BDD DRUGINKE CTBSIWZADWNGPL-UHFFFAOYSA-N D09BDD DRUGSMIL CC1=NC2=CC=CC=C2N3C1=NN=C3C4=CC=CC=C4Cl D09BDD HIGHSTAT Patented D09BDD COMPCLAS 1,2,4-triazole [4,3-a]quinoxaline derivatives D09CAM DRUG__ID D09CAM D09CAM DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D09CAM DRUGTYPE Small molecular drug D09CAM DRUGINCH 1S/C16H12ClFN2/c17-13-4-3-6-15(10-13)20-11-16(18,12-20)8-7-14-5-1-2-9-19-14/h1-6,9-10H,11-12H2 D09CAM DRUGINKE KUOSCBGVFZTWCN-UHFFFAOYSA-N D09CAM DRUGSMIL C1C(CN1C2=CC(=CC=C2)Cl)(C#CC3=CC=CC=N3)F D09CAM HIGHSTAT Patented D09CAM COMPCLAS Central azetidine derivatives D09CIC DRUG__ID D09CIC D09CIC DRUGCOMP PRESIDENT AND FELLOWS OF HARVARD COLLEGE FINLEY, Daniel KING, Randall, W. LEE, Byung-Hoon LEE, Min, Jae GAHMAN, Timothy, C D09CIC DRUGTYPE Small molecular drug D09CIC DRUGINCH 1S/C14H17N3S/c1-17(9-6-7-9)13-12-10-4-2-3-5-11(10)18-14(12)16-8-15-13/h8-9H,2-7H2,1H3 D09CIC DRUGINKE PGGINYVNLNKQRD-UHFFFAOYSA-N D09CIC DRUGSMIL CN(C1CC1)C2=C3C4=C(CCCC4)SC3=NC=N2 D09CIC HIGHSTAT Patented D09CIC COMPCLAS Tricyclic heterocycle derivatives D09DZI DRUG__ID D09DZI D09DZI DRUGCOMP ACTELION PHARMACEUTICALS LTD FRETZ, Heinz GATFIELD, John ISLER, Markus KIMMERLIN, Thierry KOBERSTEIN, Ralf LYOTHIER, Isabelle MONNIER, Lucile POTHIER, Julien VALDENAIRE, Anja D09DZI DRUGTYPE Small molecular drug D09DZI DRUGINCH 1S/C27H26N2O2/c1-20-9-5-6-10-21(20)19-28-15-17-29(18-16-28)27(22-11-3-2-4-12-22)25(30)23-13-7-8-14-24(23)26(27)31/h2-14H,15-19H2,1H3 D09DZI DRUGINKE SOPZMNPHLBGVQQ-UHFFFAOYSA-N D09DZI DRUGSMIL CC1=CC=CC=C1CN2CCN(CC2)C3(C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5 D09DZI HIGHSTAT Patented D09DZI COMPCLAS Indandione derivatives D09ENS DRUG__ID D09ENS D09ENS DRUGCOMP ZENITH EPIGENETICS CORP D09ENS DRUGTYPE Small molecular drug D09ENS DRUGINCH 1S/C23H28N4O4/c1-27-9-7-14(8-10-27)24-18-11-15(29-2)5-6-17(18)22-25-19-12-16(30-3)13-20(31-4)21(19)23(28)26-22/h5-6,11-14,24H,7-10H2,1-4H3,(H,25,26,28) D09ENS DRUGINKE FRAHQMXXLOFANF-UHFFFAOYSA-N D09ENS DRUGSMIL CN1CCC(CC1)NC2=C(C=CC(=C2)OC)C3=NC4=C(C(=CC(=C4)OC)OC)C(=O)N3 D09ENS HIGHSTAT Patented D09ENS COMPCLAS Quinazolinone derivatives D09FVR DRUG__ID D09FVR D09FVR DRUGCOMP NOVARTIS AG [CHBLANK JUTTA [CHBOLD GUIDO [CHBORDAS VINCENT [CHCOTESTA SIMONA [CHGUAGNANO VITO [CHR EGER HEINRICH [CHVAUPEL ANDREA [CH] D09FVR DRUGTYPE Small molecular drug D09FVR DRUGINCH 1S/C27H26ClN7O2/c1-14-10-21(29-26-23(14)30-31-32(26)3)35-24(17-6-8-18(28)9-7-17)25-22(27(35)37)20(16-4-5-16)13-34(25)19-11-33(12-19)15(2)36/h6-10,13,16,19,24H,4-5,11-12H2,1-3H3 D09FVR DRUGINKE NBJPFMDWXKYTQF-UHFFFAOYSA-N D09FVR DRUGSMIL CC1=CC(=NC2=C1N=NN2C)N3C(C4=C(C3=O)C(=CN4C5CN(C5)C(=O)C)C6CC6)C7=CC=C(C=C7)Cl D09FVR HIGHSTAT Patented D09FVR COMPCLAS Pyrrolo-pyrrolone derivatives D09FZF DRUG__ID D09FZF D09FZF DRUGCOMP BIOGEN MA INC D09FZF DRUGTYPE Small molecular drug D09FZF DRUGINCH 1S/C19H28O4/c1-11-4-6-15-12(2)16(20)8-9-19(15,3)14(11)7-5-13-17(21)10-23-18(13)22/h5,12,14-17,20-21H,1,4,6-10H2,2-3H3/b13-5+/t12-,14-,15-,16-,17-,19+/m1/s1 D09FZF DRUGINKE VIGAUKOHNZARKF-YGQNBZPJSA-N D09FZF DRUGSMIL CC1C2CCC(=C)C(C2(CCC1O)C)CC=C3C(COC3=O)O D09FZF HIGHSTAT Patented D09FZF COMPCLAS Diterpenoid derivatives D09GJQ DRUG__ID D09GJQ D09GJQ DRUGCOMP NORTHEASTERN UNIVERSITY MAKRIYANNIS, Alexandros THAKUR, Ganesh, A. SHARMA, Rishi D09GJQ DRUGTYPE Small molecular drug D09GJQ DRUGINCH 1S/C24H34O5/c1-6-7-10-28-22(27)23(2,3)16-12-19(26)21-17-11-15(14-25)8-9-18(17)24(4,5)29-20(21)13-16/h8,12-13,17-18,25-26H,6-7,9-11,14H2,1-5H3/t17-,18-/m1/s1 D09GJQ DRUGINKE AUMCYBWLZBTQLN-QZTJIDSGSA-N D09GJQ DRUGSMIL CCCCOC(=O)C(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O D09GJQ HIGHSTAT Patented D09GJQ COMPCLAS Tricyclic phytocannabinoid derivatives D09IOW DRUG__ID D09IOW D09IOW DRUGCOMP ACEA BIOSCIENCES INC D09IOW DRUGTYPE Small molecular drug D09IOW DRUGINCH 1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32) D09IOW DRUGINKE UOFYSRZSLXWIQB-UHFFFAOYSA-N D09IOW DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F D09IOW HIGHSTAT Patented D09IOW COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D09JFR DRUG__ID D09JFR D09JFR DRUGCOMP RESEARCH TRIANGLE INSTITUTE D09JFR DRUGTYPE Small molecular drug D09JFR DRUGINCH 1S/C27H30N2O3/c1-18(2)15-27(21-10-4-3-5-11-21)23-17-29(13-12-22(23)26(31)32-27)25(30)24-14-19-8-6-7-9-20(19)16-28-24/h3-11,18,24,28H,12-17H2,1-2H3 D09JFR DRUGINKE XMIBEMVACFABOS-UHFFFAOYSA-N D09JFR DRUGSMIL CC(C)CC1(C2=C(CCN(C2)C(=O)C3CC4=CC=CC=C4CN3)C(=O)O1)C5=CC=CC=C5 D09JFR HIGHSTAT Patented D09JFR COMPCLAS 4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivatives D09JVJ DRUG__ID D09JVJ D09JVJ DRUGCOMP Myrexis D09JVJ DRUGTYPE Small molecular drug D09JVJ DRUGINCH 1S/C29H34N6O4/c1-34(2)13-14-35(3)28(36)24-7-6-22(18-27(24)37-4)32-29-31-12-9-25(33-29)20-5-8-26(21(17-20)19-30)39-23-10-15-38-16-11-23/h5-9,12,17-18,23H,10-11,13-16H2,1-4H3,(H,31,32,33) D09JVJ DRUGINKE XAXIBPFXBWPLTP-UHFFFAOYSA-N D09JVJ DRUGSMIL CN(C)CCN(C)C(=O)C1=C(C=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)OC4CCOCC4)C#N)OC D09JVJ HIGHSTAT Patented D09JVJ COMPCLAS Aminopyrimidine derivatives D09MSN DRUG__ID D09MSN D09MSN DRUGCOMP THE GENERAL HOSPITAL CORPORATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA D09MSN DRUGTYPE Small molecular drug D09MSN DRUGINCH 1S/C24H17N5O3S/c30-29(31)20-13-14-21(23-19(20)12-7-15-25-23)33-24-27-26-22(16-32-18-10-5-2-6-11-18)28(24)17-8-3-1-4-9-17/h1-15H,16H2 D09MSN DRUGINKE RVYWJVIYWKCDEE-UHFFFAOYSA-N D09MSN DRUGSMIL C1=CC=C(C=C1)N2C(=NN=C2SC3=C4C(=C(C=C3)[N+](=O)[O-])C=CC=N4)COC5=CC=CC=C5 D09MSN HIGHSTAT Patented D09MSN COMPCLAS 1-phenyl-1,3,4-triazole derivatives D09QQS DRUG__ID D09QQS D09QQS DRUGCOMP NOVARTIS AG BEHNKE, Dirk CARCACHE, David ERTL, Peter KOLLER, Manuel ORAIN, David D09QQS DRUGTYPE Small molecular drug D09QQS DRUGINCH 1S/C19H18N2O3/c1-12-6-7-18(24-12)15-10-16-13-4-3-5-17(23-2)14(13)8-9-21(16)19(22)11-20-15/h3-7,10H,8-9,11H2,1-2H3 D09QQS DRUGINKE JTMQTEDUASKITJ-UHFFFAOYSA-N D09QQS DRUGSMIL CC1=CC=C(O1)C2=NCC(=O)N3CCC4=C(C3=C2)C=CC=C4OC D09QQS HIGHSTAT Patented D09QQS COMPCLAS Diazepinone derivatives D09QSH DRUG__ID D09QSH D09QSH DRUGCOMP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI D09QSH DRUGTYPE Small molecular drug D09QSH DRUGINCH 1S/C17H22ClN3O3S/c1-12-15(7-8-17(12)22)19-16-11-13(5-6-14(16)18)20-25(23,24)21-9-3-2-4-10-21/h5-6,11,19-20H,2-4,7-10H2,1H3 D09QSH DRUGINKE SJCLYADRAFNYBC-UHFFFAOYSA-N D09QSH DRUGSMIL CC1=C(CCC1=O)NC2=C(C=CC(=C2)NS(=O)(=O)N3CCCCC3)Cl D09QSH HIGHSTAT Patented D09QSH COMPCLAS Aminocyclopentenone compounds D09SYD DRUG__ID D09SYD D09SYD DRUGCOMP ARRAY BIOPHARMA INC. HAAS, Julia ANDREWS, Steven, W. JIANG, Yutong ZHANG, Gan D09SYD DRUGTYPE Small molecular drug D09SYD DRUGINCH 1S/C23H27FN6O3/c1-33-20-7-6-15(24)12-17(20)19-5-3-10-29(19)21-8-11-30-22(27-21)18(13-25-30)26-23(32)28-9-2-4-16(31)14-28/h6-8,11-13,16,19,31H,2-5,9-10,14H2,1H3,(H,26,32)/t16-,19+/m0/s1 D09SYD DRUGINKE RGIQATAASXNYCK-QFBILLFUSA-N D09SYD DRUGSMIL COC1=C(C=C(C=C1)F)C2CCCN2C3=NC4=C(C=NN4C=C3)NC(=O)N5CCCC(C5)O D09SYD HIGHSTAT Patented D09SYD COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D09TSM DRUG__ID D09TSM D09TSM DRUGCOMP HANGZHOU INNOGATE PHARMA CO., LTD D09TSM DRUGTYPE Small molecular drug D09TSM DRUGINCH 1S/C22H25FN2O2/c23-16-3-1-2-15-18-10-24-11-25(18)17(20(15)16)6-19(26)22-7-12-4-13(8-22)21(27)14(5-12)9-22/h1-3,10-14,17,19,21,26-27H,4-9H2 D09TSM DRUGINKE SPKRAWSVCLOAAN-UHFFFAOYSA-N D09TSM DRUGSMIL C1C2CC3CC(C2)(CC1C3O)C(CC4C5=C(C=CC=C5F)C6=CN=CN46)O D09TSM HIGHSTAT Patented D09TSM COMPCLAS Imidazoleisoindoles derivatives D09VEY DRUG__ID D09VEY D09VEY DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. KEITH, John, M. JONES, William, M D09VEY DRUGTYPE Small molecular drug D09VEY DRUGINCH 1S/C26H26Cl2N4O2/c27-20-4-6-23(7-5-20)34-24-3-1-2-19(12-24)16-31-10-8-26(9-11-31)17-32(18-26)25(33)30-22-13-21(28)14-29-15-22/h1-7,12-15H,8-11,16-18H2,(H,30,33) D09VEY DRUGINKE UNZBUFAASDCGFU-UHFFFAOYSA-N D09VEY DRUGSMIL C1CN(CCC12CN(C2)C(=O)NC3=CC(=CN=C3)Cl)CC4=CC(=CC=C4)OC5=CC=C(C=C5)Cl D09VEY HIGHSTAT Patented D09VEY COMPCLAS Spirocyclic diamine urea derivatives D09WUA DRUG__ID D09WUA D09WUA DRUGCOMP SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A D09WUA DRUGTYPE Small molecular drug D09WUA DRUGINCH 1S/C20H22N4O/c21-20(25)24-13-10-17-8-9-18(22-19(17)24)16-6-4-15(5-7-16)14-23-11-2-1-3-12-23/h4-10,13H,1-3,11-12,14H2,(H2,21,25) D09WUA DRUGINKE HIBOPBGHLVWFCH-UHFFFAOYSA-N D09WUA DRUGSMIL C1CCN(CC1)CC2=CC=C(C=C2)C3=NC4=C(C=C3)C=CN4C(=O)N D09WUA HIGHSTAT Patented D09WUA COMPCLAS 7-azaindole derivatives D09XLY DRUG__ID D09XLY D09XLY DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D09XLY DRUGTYPE Small molecular drug D09XLY DRUGINCH 1S/C20H19ClF3N7O/c1-19(30-17-11-25-16(10-26-17)20(22,23)24)6-2-3-15(19)29-18(32)13-9-12(21)4-5-14(13)31-27-7-8-28-31/h4-5,7-11,15H,2-3,6H2,1H3,(H,26,30)(H,29,32)/t15-,19-/m0/s1 D09XLY DRUGINKE WFGSTTYRNIKJJI-KXBFYZLASA-N D09XLY DRUGSMIL CC1(CCCC1NC(=O)C2=C(C=CC(=C2)Cl)N3N=CC=N3)NC4=NC=C(N=C4)C(F)(F)F D09XLY HIGHSTAT Patented D09XLY COMPCLAS 1,2-diamino cyclopentane-based derivatives D09XUI DRUG__ID D09XUI D09XUI DRUGCOMP ELI LILLY AND COMPANY SCHAUS, John, Mehner D09XUI DRUGTYPE Small molecular drug D09XUI DRUGINCH 1S/C25H22F6N4O2/c1-23(2,20-12-13-32-22(33-20)24(26,27)28)34-18-14-19(15-6-4-3-5-7-15)35(21(18)36)16-8-10-17(11-9-16)37-25(29,30)31/h3-13,18-19,34H,14H2,1-2H3/t18-,19-/m1/s1 D09XUI DRUGINKE RZNGNBDYOQOCCY-RTBURBONSA-N D09XUI DRUGSMIL CC(C)(C1=NC(=NC=C1)C(F)(F)F)NC2CC(N(C2=O)C3=CC=C(C=C3)OC(F)(F)F)C4=CC=CC=C4 D09XUI HIGHSTAT Patented D09XUI COMPCLAS 1,5-diphenylpyrrolidin-2-one derivatives D09ZCV DRUG__ID D09ZCV D09ZCV DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D09ZCV DRUGTYPE Small molecular drug D09ZCV DRUGINCH 1S/C36H30F8N2O6S/c37-29-30(38)32(40)34(33(41)31(29)39)53(51,52)45(18-23-8-4-5-9-26(23)36(42,43)44)19-28(48)46(24-14-15-25(35(49)50)27(47)16-24)17-20-10-12-22(13-11-20)21-6-2-1-3-7-21/h4-5,8-16,21,47H,1-3,6-7,17-19H2,(H,49,50) D09ZCV DRUGINKE UEUVIKQOEXBPOQ-UHFFFAOYSA-N D09ZCV DRUGSMIL C1CCC(CC1)C2=CC=C(C=C2)CN(C3=CC(=C(C=C3)C(=O)O)O)C(=O)CN(CC4=CC=CC=C4C(F)(F)F)S(=O)(=O)C5=C(C(=C(C(=C5F)F)F)F)F D09ZCV HIGHSTAT Patented D09ZCV COMPCLAS Salicylic acid derivatives D0A2ZO DRUG__ID D0A2ZO D0A2ZO DRUGCOMP RICHTER GEDEON NYRT D0A2ZO DRUGTYPE Small molecular drug D0A2ZO DRUGINCH 1S/C19H30N2O2/c1-2-13-21(14-3-1)15-4-16-22-17-5-7-18(8-6-17)23-19-9-11-20-12-10-19/h5-8,19-20H,1-4,9-16H2 D0A2ZO DRUGINKE IRTTXYWMHFLYFK-UHFFFAOYSA-N D0A2ZO DRUGSMIL C1CCN(CC1)CCCOC2=CC=C(C=C2)OC3CCNCC3 D0A2ZO HIGHSTAT Patented D0A2ZO COMPCLAS Phenoxypiperidine derivatives D0A4RP DRUG__ID D0A4RP D0A4RP DRUGCOMP ORION CORPORATION D0A4RP DRUGTYPE Small molecular drug D0A4RP DRUGINCH 1S/C23H20F3N3O4/c1-12-20(13(2)33-28-12)16-8-14-9-17(21(30)23(24,25)26)22(31)29(18(14)10-19(16)32-3)11-15-6-4-5-7-27-15/h4-10,21,30H,11H2,1-3H3 D0A4RP DRUGINKE KORFDBDOHJBIRP-UHFFFAOYSA-N D0A4RP DRUGSMIL CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)C=C(C(=O)N3CC4=CC=CC=N4)C(C(F)(F)F)O)OC D0A4RP HIGHSTAT Patented D0A4RP COMPCLAS Isoxazole-based bicyclic compounds D0A4YR DRUG__ID D0A4YR D0A4YR DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0A4YR DRUGTYPE Small molecular drug D0A4YR DRUGINCH 1S/C24H28FN5O3/c1-16-22(30(28-23(16)31)19-9-4-3-5-10-19)27-24(32)26-21-15-29(11-12-33-2)14-20(21)17-7-6-8-18(25)13-17/h3-10,13,20-21H,11-12,14-15H2,1-2H3,(H,28,31)(H2,26,27,32)/t20-,21+/m0/s1 D0A4YR DRUGINKE HIHSIUUJZCQIBY-LEWJYISDSA-N D0A4YR DRUGSMIL CC1=C(N(NC1=O)C2=CC=CC=C2)NC(=O)NC3CN(CC3C4=CC(=CC=C4)F)CCOC D0A4YR HIGHSTAT Patented D0A4YR COMPCLAS Pyrrolidinyl urea derivatives D0A5OT DRUG__ID D0A5OT D0A5OT DRUGCOMP UANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD [CN] D0A5OT DRUGTYPE Small molecule immunotherapy D0A5OT DRUGINCH 1S/C29H28F3NO5/c1-18-20(4-3-5-23(18)21-9-11-25-26(15-21)38-13-12-37-25)7-8-22-14-19(6-10-24(22)29(30,31)32)16-33-28(2,17-34)27(35)36/h3-11,14-15,33-34H,12-13,16-17H2,1-2H3,(H,35,36)/b8-7+ D0A5OT DRUGINKE PTGUEPRQUFAZLN-BQYQJAHWSA-N D0A5OT DRUGSMIL CC1=C(C=CC=C1C2=CC3=C(C=C2)OCCO3)C=CC4=C(C=CC(=C4)CNC(C)(CO)C(=O)O)C(F)(F)F D0A5OT HIGHSTAT Patented D0A5OT COMPCLAS Aromatic acetylene derivatives D0A6LI DRUG__ID D0A6LI D0A6LI DRUGCOMP CADILA HEALTHCARE LIMITED D0A6LI DRUGTYPE Small molecular drug D0A6LI DRUGINCH 1S/C19H27F2N3O3S/c1-28(25,26)24-7-5-19(12-24)4-6-23(11-19)14-9-17(22)18(27-10-14)15-8-13(20)2-3-16(15)21/h2-3,8,14,17-18H,4-7,9-12,22H2,1H3/t14-,17+,18-,19?/m1/s1 D0A6LI DRUGINKE ICJHPFIPAVQZIX-HCGGPHHBSA-N D0A6LI DRUGSMIL CS(=O)(=O)N1CCC2(C1)CCN(C2)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N D0A6LI HIGHSTAT Patented D0A6LI COMPCLAS Aminopiperidine derivatives D0A6QI DRUG__ID D0A6QI D0A6QI DRUGCOMP THE UNIVERSITY OF MISSISSIPPI SHARIAT-MADAR, Ziaeddin RIMOLDI, John, Matthew GADEPALLI, Rama Sarma, Venkata SubbarahmanyUniversity of Mississippi D0A6QI DRUGTYPE Small molecular drug D0A6QI DRUGINCH 1S/C22H41N3O2/c1-2-3-4-5-6-7-8-9-10-11-16-24-21(26)20-15-13-18-25(20)22(27)19-14-12-17-23-19/h19-20,23H,2-18H2,1H3,(H,24,26)/t19-,20-/m0/s1 D0A6QI DRUGINKE VWPVALOPPKNSFP-PMACEKPBSA-N D0A6QI DRUGSMIL CCCCCCCCCCCCNC(=O)C1CCCN1C(=O)C2CCCN2 D0A6QI HIGHSTAT Patented D0A6QI COMPCLAS Proline amide derivatives D0A8EV DRUG__ID D0A8EV D0A8EV DRUGCOMP LUNDBECK & CO AS H [DK] D0A8EV DRUGTYPE Small molecular drug D0A8EV DRUGINCH 1S/C16H10ClFN4/c1-9-15-20-21-16(10-5-2-3-6-11(10)17)22(15)14-12(18)7-4-8-13(14)19-9/h2-8H,1H3 D0A8EV DRUGINKE ZXWSCYGUZHTXLO-UHFFFAOYSA-N D0A8EV DRUGSMIL CC1=NC2=C(C(=CC=C2)F)N3C1=NN=C3C4=CC=CC=C4Cl D0A8EV HIGHSTAT Patented D0A8EV COMPCLAS Triazolo-pyridine derivatives D0A8KL DRUG__ID D0A8KL D0A8KL DRUGCOMP Shanghai Kechow Pharma D0A8KL DRUGTYPE Small molecular drug D0A8KL DRUGINCH 1S/C19H18BrClFN3O4S2/c20-10-1-2-13(12(21)5-10)24-17-14(6-15-18(16(17)22)23-9-30-15)25-31(28,29)19(3-4-19)7-11(27)8-26/h1-2,5-6,9,11,24-27H,3-4,7-8H2 D0A8KL DRUGINKE AITYBOUARXLEQK-UHFFFAOYSA-N D0A8KL DRUGSMIL C1CC1(CC(CO)O)S(=O)(=O)NC2=CC3=C(C(=C2NC4=C(C=C(C=C4)Br)Cl)F)N=CS3 D0A8KL HIGHSTAT Patented D0A8KL COMPCLAS Benzoheterocyclic compounds D0A8SI DRUG__ID D0A8SI D0A8SI DRUGCOMP MERCK SHARP & DOHME CORP. GRAHAM, Thomas SHEN, Dong-Ming NARGUND, Ravi, P. WU, Zhicai LIU, Wenshen D0A8SI DRUGTYPE Small molecular drug D0A8SI DRUGINCH 1S/C29H40N4O4/c1-2-3-4-5-6-7-8-24-31-27(30)26-28(32-24)37-18-17-33(29(26)36)23-15-13-22(14-16-23)21-11-9-20(10-12-21)19-25(34)35/h13-16,20-21H,2-12,17-19H2,1H3,(H,34,35)(H2,30,31,32) D0A8SI DRUGINKE AGYANLSXRVBLRK-UHFFFAOYSA-N D0A8SI DRUGSMIL CCCCCCCCC1=NC(=C2C(=N1)OCCN(C2=O)C3=CC=C(C=C3)C4CCC(CC4)CC(=O)O)N D0A8SI HIGHSTAT Patented D0A8SI COMPCLAS Lactam derivatives D0AF0O DRUG__ID D0AF0O D0AF0O DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0AF0O DRUGTYPE Small molecular drug D0AF0O DRUGINCH 1S/C29H30BrClFN3O2/c30-22-5-1-19(2-6-22)26-18-24(35-13-15-37-16-14-35)9-10-25(26)29(36)34-28(20-3-7-23(31)8-4-20)21-11-12-33-27(32)17-21/h1-8,11-12,17,24-26,28H,9-10,13-16,18H2,(H,34,36)/t24-,25-,26+,28?/m1/s1 D0AF0O DRUGINKE ABJSOROVZZKJGI-OCYUSGCXSA-N D0AF0O DRUGSMIL C1CC(C(CC1N2CCOCC2)C3=CC=C(C=C3)Br)C(=O)NC(C4=CC=C(C=C4)Cl)C5=CC(=NC=C5)F D0AF0O HIGHSTAT Patented D0AF0O COMPCLAS Cyclohexane carboxamide derivatives D0AH1A DRUG__ID D0AH1A D0AH1A DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PRIEPKE, Henning DOODS, Henri KUELZER, Raimund PFAU, Roland STENKAMP, Dirk ROENN, Robert PELCMAN, Benjamin D0AH1A DRUGTYPE Small molecular drug D0AH1A DRUGINCH 1S/C29H20BrCl2F2N3O4/c1-41-24-11-7-18(13-20(24)28(39)36-17-5-3-16(30)4-6-17)37-27(38)19-12-15(2-8-21(19)31)14-35-29(40)25-22(33)9-10-23(34)26(25)32/h2-13H,14H2,1H3,(H,35,40)(H,36,39)(H,37,38) D0AH1A DRUGINKE OKMLKFQCNOUSOP-UHFFFAOYSA-N D0AH1A DRUGSMIL COC1=C(C=C(C=C1)NC(=O)C2=C(C=CC(=C2)CNC(=O)C3=C(C=CC(=C3Cl)F)F)Cl)C(=O)NC4=CC=C(C=C4)Br D0AH1A HIGHSTAT Patented D0AH1A COMPCLAS Benzamide derivatives D0AH8N DRUG__ID D0AH8N D0AH8N DRUGCOMP UNIVERSITY OF VIRGINIA PATENT FOUNDATION LYNCH, Kevin, R. MACDONALD, Timothy, L. MATHEWS, Thomas, P. KENNEDY, Andrew KHAREL, Yugesh D0AH8N DRUGTYPE Small molecular drug D0AH8N DRUGINCH 1S/C22H41N3O3/c23-20(25-27)22(14-15-22)21(26)24-16-10-5-3-1-2-4-6-11-17-28-18-19-12-8-7-9-13-19/h19,27H,1-18H2,(H2,23,25)(H,24,26) D0AH8N DRUGINKE CHCOBYPQLKIPPD-UHFFFAOYSA-N D0AH8N DRUGSMIL C1CCC(CC1)COCCCCCCCCCCNC(=O)C2(CC2)C(=NO)N D0AH8N HIGHSTAT Patented D0AH8N COMPCLAS Imidamide derivatives D0AJ3F DRUG__ID D0AJ3F D0AJ3F DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D0AJ3F DRUGTYPE Small molecular drug D0AJ3F DRUGINCH 1S/C34H46FN3O4Si/c1-33(2,3)18-16-28(23-10-12-24(13-11-23)31(41)36-21-17-29(39)40)38-32(42)30(25-8-7-9-26(35)22-25)37-34(38)19-14-27(15-20-34)43(4,5)6/h7-13,22,27-28H,14-21H2,1-6H3,(H,36,41)(H,39,40)/t27?,28-,34?/m1/s1 D0AJ3F DRUGINKE RBMROQXTXSWPGO-IXDCWVCYSA-N D0AJ3F DRUGSMIL CC(C)(C)CCC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)N2C(=O)C(=NC23CCC(CC3)[Si](C)(C)C)C4=CC(=CC=C4)F D0AJ3F HIGHSTAT Patented D0AJ3F COMPCLAS Spiroimidazolone derivatives D0AK4X DRUG__ID D0AK4X D0AK4X DRUGCOMP DAINIPPON SUMITOMO PHARMA CO., LTD D0AK4X DRUGTYPE Small molecular drug D0AK4X DRUGINCH 1S/C18H13ClFN3O2/c19-12-3-1-2-11(8-12)18(24)23-7-6-16-15(10-23)22-17(25-16)14-5-4-13(20)9-21-14/h1-5,8-9H,6-7,10H2 D0AK4X DRUGINKE NZJPQHNBSVEQFL-UHFFFAOYSA-N D0AK4X DRUGSMIL C1CN(CC2=C1OC(=N2)C3=NC=C(C=C3)F)C(=O)C4=CC(=CC=C4)Cl D0AK4X HIGHSTAT Patented D0AK4X COMPCLAS Tetra-hydro-oxazolopyridine derivatives D0AL3I DRUG__ID D0AL3I D0AL3I DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0AL3I DRUGTYPE Small molecular drug D0AL3I DRUGINCH 1S/C22H20FN5O2S/c1-12-24-21(30-28-12)15-6-3-2-5-14(15)20(29)25-16-7-4-8-17(16)26-22-27-18-10-9-13(23)11-19(18)31-22/h2-3,5-6,9-11,16-17H,4,7-8H2,1H3,(H,25,29)(H,26,27)/t16-,17-/m0/s1 D0AL3I DRUGINKE HAQWTGIMJAZGBJ-IRXDYDNUSA-N D0AL3I DRUGSMIL CC1=NOC(=N1)C2=CC=CC=C2C(=O)NC3CCCC3NC4=NC5=C(S4)C=C(C=C5)F D0AL3I HIGHSTAT Patented D0AL3I COMPCLAS 1,2-diamino cyclopentane-based derivatives D0AN7Z DRUG__ID D0AN7Z D0AN7Z DRUGCOMP CHENGDU DI AO PHARMACEUTICAL GROUP CO LTD [CN] D0AN7Z DRUGTYPE Small molecular drug D0AN7Z DRUGINCH 1S/C25H26FN5O4/c26-21-9-8-17(35-23-19-7-3-2-6-18(19)22(32)27-28-23)16-20(21)24(33)29-12-14-31(15-13-29)25(34)30-10-4-1-5-11-30/h2-3,6-9,16H,1,4-5,10-15H2,(H,27,32) D0AN7Z DRUGINKE BCFBHNMOIFYWBS-UHFFFAOYSA-N D0AN7Z DRUGSMIL C1CCN(CC1)C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)OC4=NNC(=O)C5=CC=CC=C54)F D0AN7Z HIGHSTAT Patented D0AN7Z COMPCLAS Phthalazine ketone derivatives D0AP4V DRUG__ID D0AP4V D0AP4V DRUGCOMP UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1 D0AP4V DRUGTYPE Small molecular drug D0AP4V DRUGINCH 1S/C19H14N2/c1-2-6-14(7-3-1)10-11-15-12-17-16-8-4-5-9-18(16)21-19(17)20-13-15/h1-13H,(H,20,21)/b11-10+ D0AP4V DRUGINKE UNSLEGIUCMXDGG-ZHACJKMWSA-N D0AP4V DRUGSMIL C1=CC=C(C=C1)C=CC2=CC3=C(NC4=CC=CC=C43)N=C2 D0AP4V HIGHSTAT Patented D0AP4V COMPCLAS Pyridoindole derivatives D0AR0L DRUG__ID D0AR0L D0AR0L DRUGCOMP THE GENERAL HOSPITAL CORPORATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA D0AR0L DRUGTYPE Small molecular drug D0AR0L DRUGINCH 1S/C20H15N5O3S/c26-25(27)16-11-12-19(21-13-16)29-20-23-22-18(14-28-17-9-5-2-6-10-17)24(20)15-7-3-1-4-8-15/h1-13H,14H2 D0AR0L DRUGINKE OZUBDKIROJPQGE-UHFFFAOYSA-N D0AR0L DRUGSMIL C1=CC=C(C=C1)N2C(=NN=C2SC3=NC=C(C=C3)[N+](=O)[O-])COC4=CC=CC=C4 D0AR0L HIGHSTAT Patented D0AR0L COMPCLAS 1-phenyl-1,3,4-triazole derivatives D0AY5G DRUG__ID D0AY5G D0AY5G DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0AY5G DRUGTYPE Small molecular drug D0AY5G DRUGINCH 1S/C19H13F8N5OS2/c1-34(33,30-10-28)9-11-4-13(7-14(5-11)35(23,24,25,26)27)31-19-29-8-17(22)18(32-19)15-3-2-12(20)6-16(15)21/h2-8H,9H2,1H3,(H,29,31,32) D0AY5G DRUGINKE ASMMFFMWZUTPQZ-UHFFFAOYSA-N D0AY5G DRUGSMIL CS(=NC#N)(=O)CC1=CC(=CC(=C1)S(F)(F)(F)(F)F)NC2=NC=C(C(=N2)C3=C(C=C(C=C3)F)F)F D0AY5G HIGHSTAT Patented D0AY5G COMPCLAS N-phenyl-pyrimidin-4-amine derivatives D0AY8W DRUG__ID D0AY8W D0AY8W DRUGCOMP Eisai R & D Management Co., Ltd., Japan D0AY8W DRUGTYPE Small molecular drug D0AY8W DRUGINCH 1S/C32H29N5O2/c33-30-29(7-4-18-34-30)32(39)37-21-19-36(20-22-37)23-26-10-14-27(15-11-26)31(38)35-28-16-12-25(13-17-28)9-8-24-5-2-1-3-6-24/h1-7,10-18H,19-23H2,(H2,33,34)(H,35,38) D0AY8W DRUGINKE YPMOWWPVPPPBET-UHFFFAOYSA-N D0AY8W DRUGSMIL C1CN(CCN1CC2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)C#CC4=CC=CC=C4)C(=O)C5=C(N=CC=C5)N D0AY8W HIGHSTAT Patented D0AY8W COMPCLAS Benzanilide compounds D0B0BJ DRUG__ID D0B0BJ D0B0BJ DRUGCOMP UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1 D0B0BJ DRUGTYPE Small molecular drug D0B0BJ DRUGINCH 1S/C28H24N4O/c1-2-4-20(5-3-1)6-7-21-16-25-24-17-22(8-10-27(24)31-28(25)30-18-21)26-11-9-23(19-29-26)32-12-14-33-15-13-32/h1-11,16-19H,12-15H2,(H,30,31)/b7-6+ D0B0BJ DRUGINKE RPPRUVFNILNTHG-VOTSOKGWSA-N D0B0BJ DRUGSMIL C1COCCN1C2=CN=C(C=C2)C3=CC4=C(C=C3)NC5=C4C=C(C=N5)C=CC6=CC=CC=C6 D0B0BJ HIGHSTAT Patented D0B0BJ COMPCLAS Pyridoindole derivatives D0B2VS DRUG__ID D0B2VS D0B2VS DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D0B2VS DRUGTYPE Small molecule immunotherapy D0B2VS DRUGINCH 1S/C31H26BrClN2O5/c32-30-23(10-5-11-25(30)22-8-2-1-3-9-22)19-40-29-14-28(39-18-21-7-4-6-20(12-21)15-34)24(13-26(29)33)16-35-27(17-36)31(37)38/h1-14,27,35-36H,16-19H2,(H,37,38) D0B2VS DRUGINKE GSJUKYYDHBOJEP-UHFFFAOYSA-N D0B2VS DRUGSMIL C1=CC=C(C=C1)C2=CC=CC(=C2Br)COC3=C(C=C(C(=C3)OCC4=CC(=CC=C4)C#N)CNC(CO)C(=O)O)Cl D0B2VS HIGHSTAT Patented D0B2VS COMPCLAS Benzyl phenyl ether derivatives D0B4FV DRUG__ID D0B4FV D0B4FV DRUGCOMP CHENGDU DI AO PHARMACEUTICAL GROUP CO LTD [CN] D0B4FV DRUGTYPE Small molecular drug D0B4FV DRUGINCH 1S/C25H27FN4O4/c1-3-16(4-2)24(32)29-11-13-30(14-12-29)25(33)20-15-17(9-10-21(20)26)34-23-19-8-6-5-7-18(19)22(31)27-28-23/h5-10,15-16H,3-4,11-14H2,1-2H3,(H,27,31) D0B4FV DRUGINKE IJSAVXZCXLCXRP-UHFFFAOYSA-N D0B4FV DRUGSMIL CCC(CC)C(=O)N1CCN(CC1)C(=O)C2=C(C=CC(=C2)OC3=NNC(=O)C4=CC=CC=C43)F D0B4FV HIGHSTAT Patented D0B4FV COMPCLAS Phthalazine ketone derivatives D0B5DX DRUG__ID D0B5DX D0B5DX DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0B5DX DRUGTYPE Small molecular drug D0B5DX DRUGINCH 1S/C26H31F3N8OS/c1-17-14-22(35-34-17)31-21-15-23(37-12-8-19(9-13-37)36-10-2-3-11-36)33-25(32-21)39-20-6-4-18(5-7-20)30-24(38)16-26(27,28)29/h4-7,14-15,19H,2-3,8-13,16H2,1H3,(H,30,38)(H2,31,32,33,34,35) D0B5DX DRUGINKE SFNFDXQNCXVCLJ-UHFFFAOYSA-N D0B5DX DRUGSMIL CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)CC(F)(F)F)N4CCC(CC4)N5CCCC5 D0B5DX HIGHSTAT Patented D0B5DX COMPCLAS Aminopyrimidine derivatives D0B6DN DRUG__ID D0B6DN D0B6DN DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. NAKAMURA Toshio SAKAGAMI Kazunari KONISHI Kazuhide YAMAMOTO Kanako MASUDA Seiji D0B6DN DRUGTYPE Small molecular drug D0B6DN DRUGINCH 1S/C20H17ClN4O2S/c1-24-20(25-12-16-6-7-18(21)10-17(16)13-25)15(11-23-24)5-2-14-3-8-19(9-4-14)28(22,26)27/h3-4,6-11H,12-13H2,1H3,(H2,22,26,27) D0B6DN DRUGINKE CAOKQZMINRCCBM-UHFFFAOYSA-N D0B6DN DRUGSMIL CN1C(=C(C=N1)C#CC2=CC=C(C=C2)S(=O)(=O)N)N3CC4=C(C3)C=C(C=C4)Cl D0B6DN HIGHSTAT Patented D0B6DN COMPCLAS Ethinyl-pyrazole derivatives D0B6NT DRUG__ID D0B6NT D0B6NT DRUGCOMP MITSUBISHI TANABE PHARMA CORPORATION TANIMOTO, Koichi OI, Mariko TSUBOI, Yasunori MORITANI, Yasunor D0B6NT DRUGTYPE Small molecular drug D0B6NT DRUGINCH 1S/C26H24Cl2N4O5S/c1-26(10-13-38(35,36)15-26)30-24(34)21-23-29-14-19(18-4-2-3-5-20(18)28)22(16-6-8-17(27)9-7-16)32(23)31-25(21)37-12-11-33/h2-9,14,33H,10-13,15H2,1H3,(H,30,34) D0B6NT DRUGINKE UNFBOPQOKSVPNI-UHFFFAOYSA-N D0B6NT DRUGSMIL CC1(CCS(=O)(=O)C1)NC(=O)C2=C3N=CC(=C(N3N=C2OCCO)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0B6NT HIGHSTAT Patented D0B6NT COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0B8GA DRUG__ID D0B8GA D0B8GA DRUGCOMP ZENITH EPIGENETICS CORP D0B8GA DRUGTYPE Small molecular drug D0B8GA DRUGINCH 1S/C21H21N5O3/c1-4-22-21-23-20-17(25(21)12-15-8-6-5-7-9-15)10-16(11-18(20)26(27)28)19-13(2)24-29-14(19)3/h5-11H,4,12H2,1-3H3,(H,22,23) D0B8GA DRUGINKE ANFSRXMOJNUJCH-UHFFFAOYSA-N D0B8GA DRUGSMIL CCNC1=NC2=C(N1CC3=CC=CC=C3)C=C(C=C2[N+](=O)[O-])C4=C(ON=C4C)C D0B8GA HIGHSTAT Patented D0B8GA COMPCLAS Isoxazole-based bicyclic compounds D0BB2F DRUG__ID D0BB2F D0BB2F DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeong Min CHANG, Chong-Hwan Jonathan LEE, Suk Ho SEO, Hee Jeong KANG, Suk Youn SONG, Kwang-Seop KIM, Jong Yup KIM, Min Ju LEE, Sung-Han AHN, Kwang-Woo JUNG, Myung Eu D0BB2F DRUGTYPE Small molecular drug D0BB2F DRUGINCH 1S/C25H17Cl3F3N7O/c26-15-4-2-14(3-5-15)21-17(11-37-13-32-12-33-37)20(36-38(21)19-7-6-16(27)10-18(19)28)22-34-35-23(39-22)24(8-1-9-24)25(29,30)31/h2-7,10,12-13H,1,8-9,11H2 D0BB2F DRUGINKE MXDYVLWGDAKEMQ-UHFFFAOYSA-N D0BB2F DRUGSMIL C1CC(C1)(C2=NN=C(O2)C3=NN(C(=C3CN4C=NC=N4)C5=CC=C(C=C5)Cl)C6=C(C=C(C=C6)Cl)Cl)C(F)(F)F D0BB2F HIGHSTAT Patented D0BB2F COMPCLAS Pyrazole derivatives D0BE9U DRUG__ID D0BE9U D0BE9U DRUGCOMP IRM LLC NOVARTIS AG ALBAUGH, Pamela CHOPIUK, Gregory S. DING, Qiang HUANG, Shenlin LIU, Zuosheng PAN, Shifeng REN, Pingda WANG, Xia WANG, Xing XIE, Yongping ZHANG, Chengzhi ZHANG, Qiong ZHANG, Guobao POON, Daniel RENHOWE, Paul SENDZIK, Martin D0BE9U DRUGTYPE Small molecular drug D0BE9U DRUGINCH 1S/C28H31F3N8O/c1-16(2)33-14-19-9-20(11-21(10-19)28(29,30)31)27(40)36-22-7-6-17(3)23(12-22)37-26-8-18(4)38-39(26)25-13-24(32-5)34-15-35-25/h6-13,15-16,33,37H,14H2,1-5H3,(H,36,40)(H,32,34,35) D0BE9U DRUGINKE ZBUIYGDQZSKXHD-UHFFFAOYSA-N D0BE9U DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC(=C2)CNC(C)C)C(F)(F)F)NC3=CC(=NN3C4=NC=NC(=C4)NC)C D0BE9U HIGHSTAT Patented D0BE9U COMPCLAS Pyrimidinyl pyrazolamine derivatives D0BK5N DRUG__ID D0BK5N D0BK5N DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John D0BK5N DRUGTYPE Small molecular drug D0BK5N DRUGINCH 1S/C18H19N3O3/c1-20(2)10-8-19-17(22)12-6-7-13-15(11-12)21-9-4-3-5-14(21)16(13)18(23)24/h3-7,9,11H,8,10H2,1-2H3,(H,19,22)(H,23,24) D0BK5N DRUGINKE OMVKEKNQENTGRO-UHFFFAOYSA-N D0BK5N DRUGSMIL CN(C)CCNC(=O)C1=CC2=C(C=C1)C(=C3N2C=CC=C3)C(=O)O D0BK5N HIGHSTAT Patented D0BK5N COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D0BP6R DRUG__ID D0BP6R D0BP6R DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. NAKAMURA Toshio SAKAGAMI Kazunari KONISHI Kazuhide YAMAMOTO Kanako MASUDA Seiji D0BP6R DRUGTYPE Small molecular drug D0BP6R DRUGINCH 1S/C20H16F3N3O3S/c1-26-19(13-29-17-9-7-16(8-10-17)20(21,22)23)15(12-25-26)6-5-14-3-2-4-18(11-14)30(24,27)28/h2-4,7-12H,13H2,1H3,(H2,24,27,28) D0BP6R DRUGINKE RTQHVIORPPJRPP-UHFFFAOYSA-N D0BP6R DRUGSMIL CN1C(=C(C=N1)C#CC2=CC(=CC=C2)S(=O)(=O)N)COC3=CC=C(C=C3)C(F)(F)F D0BP6R HIGHSTAT Patented D0BP6R COMPCLAS Ethinyl-pyrazole derivatives D0BP9B DRUG__ID D0BP9B D0BP9B DRUGCOMP ARRAY BIOPHARMA INC D0BP9B DRUGTYPE Small molecular drug D0BP9B DRUGINCH 1S/C25H21F3N8O/c1-16-22(17-14-29-34(2)15-17)33-36(19-11-7-4-8-12-19)23(16)31-24(37)30-21-13-20(25(26,27)28)32-35(21)18-9-5-3-6-10-18/h3-15H,1-2H3,(H2,30,31,37) D0BP9B DRUGINKE QJVHIMLGONEYEE-UHFFFAOYSA-N D0BP9B DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC=CC=C3)NC(=O)NC4=CC(=NN4C5=CC=CC=C5)C(F)(F)F D0BP9B HIGHSTAT Patented D0BP9B COMPCLAS N,N-bis(5-pyrazoyl)urea derivatives D0BZ0N DRUG__ID D0BZ0N D0BZ0N DRUGCOMP AAPA B.V D0BZ0N DRUGTYPE Small molecular drug D0BZ0N DRUGINCH 1S/C26H35N3O4/c1-3-24(26-25(4-1)32-19-20-33-26)29-12-10-27(11-13-29)9-2-16-31-23-7-5-22(6-8-23)21-28-14-17-30-18-15-28/h1,3-8H,2,9-21H2 D0BZ0N DRUGINKE VZAPQDNGQVGEES-UHFFFAOYSA-N D0BZ0N DRUGSMIL C1CN(CCN1CCCOC2=CC=C(C=C2)CN3CCOCC3)C4=C5C(=CC=C4)OCCO5 D0BZ0N HIGHSTAT Patented D0BZ0N COMPCLAS Benzo[d]oxazol-2(3H)-one derivatives D0BZ0T DRUG__ID D0BZ0T D0BZ0T DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven S. CONDROSKI, Kevin Ronald HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy SEO, Jeongbeob D0BZ0T DRUGTYPE Small molecular drug D0BZ0T DRUGINCH 1S/C26H31FN6O3/c27-18-3-6-23(36-15-12-31-10-13-35-14-11-31)20(16-18)22-2-1-8-32(22)24-7-9-33-25(30-24)21(17-28-33)26(34)29-19-4-5-19/h3,6-7,9,16-17,19,22H,1-2,4-5,8,10-15H2,(H,29,34)/t22-/m1/s1 D0BZ0T DRUGINKE DXRCURBJOZPWHE-JOCHJYFZSA-N D0BZ0T DRUGSMIL C1CC(N(C1)C2=NC3=C(C=NN3C=C2)C(=O)NC4CC4)C5=C(C=CC(=C5)F)OCCN6CCOCC6 D0BZ0T HIGHSTAT Patented D0BZ0T COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0C1YW DRUG__ID D0C1YW D0C1YW DRUGCOMP Wisconsin Alumni Research Foundation D0C1YW DRUGTYPE Small molecular drug D0C1YW DRUGINCH 1S/C17H28N2O2/c1-3-5-13-18(14-6-4-2)15-7-8-16-9-11-17(12-10-16)19(20)21/h9-12H,3-8,13-15H2,1-2H3 D0C1YW DRUGINKE RQYGHCATHJZLFY-UHFFFAOYSA-N D0C1YW DRUGSMIL CCCCN(CCCC)CCCC1=CC=C(C=C1)[N+](=O)[O-] D0C1YW HIGHSTAT Patented D0C1YW COMPCLAS Phenylpropylamine derivatives D0C2YI DRUG__ID D0C2YI D0C2YI DRUGCOMP NANJING SANHOME PHARMACEUTICAL CO LTD [CN] D0C2YI DRUGTYPE Small molecular drug D0C2YI DRUGINCH 1S/C31H28F3N5O/c1-21-6-7-24(16-23(21)9-8-22-4-3-5-29-27(22)18-35-20-36-29)30(40)37-26-11-10-25(28(17-26)31(32,33)34)19-39-14-12-38(2)13-15-39/h3-7,10-11,16-18,20H,12-15,19H2,1-2H3,(H,37,40) D0C2YI DRUGINKE KLHNJZVWTSMTCC-UHFFFAOYSA-N D0C2YI DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=C5C=NC=NC5=CC=C4 D0C2YI HIGHSTAT Patented D0C2YI COMPCLAS Alkynyl-heteroaromatic ring compounds D0C2ZJ DRUG__ID D0C2ZJ D0C2ZJ DRUGCOMP EISAI R&D MANAGEMENT CO., LTD D0C2ZJ DRUGTYPE Small molecular drug D0C2ZJ DRUGINCH 1S/C22H24ClN3O2/c1-13-9-17(10-14(2)24-13)21-19-7-8-28-15(3)12-26(19)22(25-21)16-5-6-18(23)20(11-16)27-4/h5-6,9-11,15H,7-8,12H2,1-4H3/t15-/m1/s1 D0C2ZJ DRUGINKE MPBPPCNVMAZSGS-OAHLLOKOSA-N D0C2ZJ DRUGSMIL CC1CN2C(=C(N=C2C3=CC(=C(C=C3)Cl)OC)C4=CC(=NC(=C4)C)C)CCO1 D0C2ZJ HIGHSTAT Patented D0C2ZJ COMPCLAS Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivatives D0C4YX DRUG__ID D0C4YX D0C4YX DRUGCOMP ABBVIE DEUTSCHLAND [DEABBVIE INC [US] D0C4YX DRUGTYPE Small molecular drug D0C4YX DRUGINCH 1S/C27H30N6O4/c34-24(27(36)29-20-8-9-20)23(17-19-5-2-1-3-6-19)30-26(35)22-7-4-11-28-25(22)33-12-10-21(31-33)18-32-13-15-37-16-14-32/h1-7,10-12,20,23H,8-9,13-18H2,(H,29,36)(H,30,35) D0C4YX DRUGINKE POGBERZVWORYJW-UHFFFAOYSA-N D0C4YX DRUGSMIL C1CC1NC(=O)C(=O)C(CC2=CC=CC=C2)NC(=O)C3=C(N=CC=C3)N4C=CC(=N4)CN5CCOCC5 D0C4YX HIGHSTAT Patented D0C4YX COMPCLAS Carboxamide derivatives D0C6GE DRUG__ID D0C6GE D0C6GE DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0C6GE DRUGTYPE Small molecular drug D0C6GE DRUGINCH 1S/C21H20N6OS/c28-20(14-6-1-3-10-18(14)27-22-12-13-23-27)24-15-8-5-9-16(15)25-21-26-17-7-2-4-11-19(17)29-21/h1-4,6-7,10-13,15-16H,5,8-9H2,(H,24,28)(H,25,26)/t15-,16-/m0/s1 D0C6GE DRUGINKE XAHDEDDXRWKNQO-HOTGVXAUSA-N D0C6GE DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=CC=CC=C5S4 D0C6GE HIGHSTAT Patented D0C6GE COMPCLAS 1,2-diamino cyclopentane-based derivatives D0C8CI DRUG__ID D0C8CI D0C8CI DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0C8CI DRUGTYPE Small molecular drug D0C8CI DRUGINCH 1S/C17H15NO8S/c19-15(17(22)23)18-14(16(20)21)10-11-6-8-12(9-7-11)26-27(24,25)13-4-2-1-3-5-13/h1-9,14H,10H2,(H,18,19)(H,20,21)(H,22,23)/t14-/m1/s1 D0C8CI DRUGINKE DNGSYQKIFPNAEQ-CQSZACIVSA-N D0C8CI DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)CC(C(=O)O)NC(=O)C(=O)O D0C8CI HIGHSTAT Patented D0C8CI COMPCLAS N-oxalyl-D-tyrosine derivatives D0C9WD DRUG__ID D0C9WD D0C9WD DRUGCOMP Actelion pharmaceuticals Ltd D0C9WD DRUGTYPE Small molecular drug D0C9WD DRUGINCH 1S/C16H14Cl2N2O2/c1-9-4-10(17)5-13(18)12(9)6-16(21)20-14-8-22-15-7-19-3-2-11(14)15/h2-5,7,14H,6,8H2,1H3,(H,20,21) D0C9WD DRUGINKE CPLYQTQQYXUOCX-UHFFFAOYSA-N D0C9WD DRUGSMIL CC1=CC(=CC(=C1CC(=O)NC2COC3=C2C=CN=C3)Cl)Cl D0C9WD HIGHSTAT Patented D0C9WD COMPCLAS Thiazole-fused cycloalkyl carboxamide derivatives D0CL1D DRUG__ID D0CL1D D0CL1D DRUGCOMP Leland Stanford Junior University D0CL1D DRUGTYPE Small molecular drug D0CL1D DRUGINCH 1S/C26H23BrFN5O4/c27-24-10-19(37-33-24)13-31-25(34)23(8-17-12-30-22-6-5-18(28)9-20(17)22)32-26(35)36-14-15-7-16-3-1-2-4-21(16)29-11-15/h1-7,9,11-12,19,23,30H,8,10,13-14H2,(H,31,34)(H,32,35)/t19?,23-/m0/s1 D0CL1D DRUGINKE SUDBOOMQYSPULE-BVHINDKJSA-N D0CL1D DRUGSMIL C1C(ON=C1Br)CNC(=O)C(CC2=CNC3=C2C=C(C=C3)F)NC(=O)OCC4=CC5=CC=CC=C5N=C4 D0CL1D HIGHSTAT Patented D0CL1D COMPCLAS Dihydroisoxazole derivatives D0D0QT DRUG__ID D0D0QT D0D0QT DRUGCOMP LUNDBECK & CO AS H [DKJOERGENSEN MORTEN [DKBRUUN ANNE TECHAU [DKRASMUSSEN LARS KYHN [DK] D0D0QT DRUGTYPE Small molecular drug D0D0QT DRUGINCH 1S/C15H10ClN5/c1-9-14-19-20-15(10-4-2-3-5-11(10)16)21(14)13-6-7-17-8-12(13)18-9/h2-8H,1H3 D0D0QT DRUGINKE NUACZBDSBLGPGS-UHFFFAOYSA-N D0D0QT DRUGSMIL CC1=NC2=C(C=CN=C2)N3C1=NN=C3C4=CC=CC=C4Cl D0D0QT HIGHSTAT Patented D0D0QT COMPCLAS Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivatives D0D1EI DRUG__ID D0D1EI D0D1EI DRUGCOMP RESEARCH TRIANGLE INSTITUTE D0D1EI DRUGTYPE Small molecular drug D0D1EI DRUGINCH 1S/C27H28Cl2N6O/c1-2-3-8-23(36)32-19-13-15-34(16-14-19)26-24-27(31-17-30-26)35(20-11-9-18(28)10-12-20)25(33-24)21-6-4-5-7-22(21)29/h4-7,9-12,17,19H,2-3,8,13-16H2,1H3,(H,32,36) D0D1EI DRUGINKE JSIOAJBHLWGADL-UHFFFAOYSA-N D0D1EI DRUGSMIL CCCCC(=O)NC1CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0D1EI HIGHSTAT Patented D0D1EI COMPCLAS Diphenyl purine derivatives D0D3GL DRUG__ID D0D3GL D0D3GL DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0D3GL DRUGTYPE Small molecular drug D0D3GL DRUGINCH 1S/C18H13ClF2N4O/c19-12-5-11(6-14(21)7-12)18(26)24-3-4-25-15(10-24)8-17(23-25)16-2-1-13(20)9-22-16/h1-2,5-9H,3-4,10H2 D0D3GL DRUGINKE PAVOURBCAONWKJ-UHFFFAOYSA-N D0D3GL DRUGSMIL C1CN2C(=CC(=N2)C3=NC=C(C=C3)F)CN1C(=O)C4=CC(=CC(=C4)Cl)F D0D3GL HIGHSTAT Patented D0D3GL COMPCLAS Tetra-hydro-pyrazolopyrazine derivatives D0D4FR DRUG__ID D0D4FR D0D4FR DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0D4FR DRUGTYPE Small molecular drug D0D4FR DRUGINCH 1S/C22H23N7O/c1-13-10-14(2)29(26-13)18-8-9-28(22(18)30)16-6-4-15(5-7-16)17-11-27(3)21-19(17)20(23)24-12-25-21/h4-7,10-12,18H,8-9H2,1-3H3,(H2,23,24,25) D0D4FR DRUGINKE WBRYMNNSAHRQTO-UHFFFAOYSA-N D0D4FR DRUGSMIL CC1=CC(=NN1C2CCN(C2=O)C3=CC=C(C=C3)C4=CN(C5=NC=NC(=C45)N)C)C D0D4FR HIGHSTAT Patented D0D4FR COMPCLAS Phenylpyrrolidinone derivatives D0D5MQ DRUG__ID D0D5MQ D0D5MQ DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeong Min CHANG, Chong-Hwan Jonathan LEE, Suk Ho SEO, Hee Jeong KANG, Suk Youn SONG, Kwang-Seop KIM, Jong Yup KIM, Min Ju LEE, Sung-Han AHN, Kwang-Woo JUNG, Myung Eu D0D5MQ DRUGTYPE Small molecular drug D0D5MQ DRUGINCH 1S/C29H20Cl3N7S/c30-20-8-6-18(7-9-20)26-22(15-38-17-33-16-34-38)25(37-39(26)24-11-10-21(31)14-23(24)32)27-35-36-28(40-27)29(12-13-29)19-4-2-1-3-5-19/h1-11,14,16-17H,12-13,15H2 D0D5MQ DRUGINKE IYLHAOFOPKLWMF-UHFFFAOYSA-N D0D5MQ DRUGSMIL C1CC1(C2=CC=CC=C2)C3=NN=C(S3)C4=NN(C(=C4CN5C=NC=N5)C6=CC=C(C=C6)Cl)C7=C(C=C(C=C7)Cl)Cl D0D5MQ HIGHSTAT Patented D0D5MQ COMPCLAS Pyrazole derivatives D0D6UF DRUG__ID D0D6UF D0D6UF DRUGCOMP CMG PHARMACEUTICAL CO., LTD. HANDOK INC D0D6UF DRUGTYPE Small molecular drug D0D6UF DRUGINCH 1S/C22H22F2N6S/c1-22(2,3)21-28-27-20(31-21)15-12-25-30-10-8-18(26-19(15)30)29-9-4-5-17(29)14-11-13(23)6-7-16(14)24/h6-8,10-12,17H,4-5,9H2,1-3H3 D0D6UF DRUGINKE ZSOVHNMIBOQEED-UHFFFAOYSA-N D0D6UF DRUGSMIL CC(C)(C)C1=NN=C(S1)C2=C3N=C(C=CN3N=C2)N4CCCC4C5=C(C=CC(=C5)F)F D0D6UF HIGHSTAT Patented D0D6UF COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0D6UT DRUG__ID D0D6UT D0D6UT DRUGCOMP Kissei Pharmaceutical Co. Ltd D0D6UT DRUGTYPE Small molecular drug D0D6UT DRUGINCH 1S/C16H11N3O4/c1-23-15-5-4-13-12(7-10(8-17)19(13)18-15)9-2-3-11(16(21)22)14(20)6-9/h2-7,20H,1H3,(H,21,22) D0D6UT DRUGINKE QEYWGQCVGIFYQF-UHFFFAOYSA-N D0D6UT DRUGSMIL COC1=NN2C(=C(C=C2C#N)C3=CC(=C(C=C3)C(=O)O)O)C=C1 D0D6UT HIGHSTAT Patented D0D6UT COMPCLAS Azaindole derivatives D0D8LP DRUG__ID D0D8LP D0D8LP DRUGCOMP OXYGEN HEALTHCARE RESEARCH PVT. LTD SHIRSATH, Vikas S. PATEL, Shailesh M SHETH, Nehal M. SINGH, Jitendra K. PATIL, Pawan D. PAWAR, Anil D. MOTIVARAS, Jitendra D D0D8LP DRUGTYPE Small molecular drug D0D8LP DRUGINCH 1S/C22H28N2O3S2/c25-29(26,20-8-3-1-4-9-20)24-15-17-28-22-11-10-19(18-21(22)24)27-16-7-14-23-12-5-2-6-13-23/h1,3-4,8-11,18H,2,5-7,12-17H2 D0D8LP DRUGINKE DHYQKBDAADLGAK-UHFFFAOYSA-N D0D8LP DRUGSMIL C1CCN(CC1)CCCOC2=CC3=C(C=C2)SCCN3S(=O)(=O)C4=CC=CC=C4 D0D8LP HIGHSTAT Patented D0D8LP COMPCLAS Phenylsulfonyl derivatives D0D8RR DRUG__ID D0D8RR D0D8RR DRUGCOMP Pharma. Ip. General, Inc. Mamoto Health Science University D0D8RR DRUGTYPE Small molecular drug D0D8RR DRUGINCH 1S/C23H13F3N4O4/c24-23(25,26)34-14-8-9-17-15(11-14)16(12-18(27-17)13-5-2-1-3-6-13)20(31)28-22-30-29-21(33-22)19-7-4-10-32-19/h1-12H,(H,28,30,31) D0D8RR DRUGINKE OGCHQJNHUGTSIR-UHFFFAOYSA-N D0D8RR DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C=C(C=C3)OC(F)(F)F)C(=C2)C(=O)NC4=NN=C(O4)C5=CC=CO5 D0D8RR HIGHSTAT Patented D0D8RR COMPCLAS Quinoline carboxamide derivatives D0DA8D DRUG__ID D0DA8D D0DA8D DRUGCOMP IOMET PHARMA LTD D0DA8D DRUGTYPE Small molecular drug D0DA8D DRUGINCH 1S/C18H22N2O3S/c1-13(2)23-15-6-8-16(9-7-15)24(21,22)20-18-5-3-4-14-12-19-11-10-17(14)18/h6-13,18,20H,3-5H2,1-2H3 D0DA8D DRUGINKE XINKWGLXVLWLIU-UHFFFAOYSA-N D0DA8D DRUGSMIL CC(C)OC1=CC=C(C=C1)S(=O)(=O)NC2CCCC3=C2C=CN=C3 D0DA8D HIGHSTAT Patented D0DA8D COMPCLAS Hexahydro quinoline derivatives D0DB3L DRUG__ID D0DB3L D0DB3L DRUGCOMP Array BioPharma D0DB3L DRUGTYPE Small molecular drug D0DB3L DRUGINCH 1S/C21H23BrF2N4O3/c1-21(2,3)30-7-8-31-27-20(29)13-10-16-19(25-11-28(16)4)17(24)18(13)26-15-6-5-12(22)9-14(15)23/h5-6,9-11,26H,7-8H2,1-4H3,(H,27,29) D0DB3L DRUGINKE MZHRFHRSYBBMON-UHFFFAOYSA-N D0DB3L DRUGSMIL CC(C)(C)OCCONC(=O)C1=CC2=C(C(=C1NC3=C(C=C(C=C3)Br)F)F)N=CN2C D0DB3L HIGHSTAT Patented D0DB3L COMPCLAS Benzoimidazole derivatives D0DC3S DRUG__ID D0DC3S D0DC3S DRUGCOMP MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH D0DC3S DRUGTYPE Small molecular drug D0DC3S DRUGINCH 1S/C27H26BrN5O5S/c1-30-26(34)16-38-17-27(35)31-21-8-2-18(3-9-21)14-22-15-25(19-4-6-20(28)7-5-19)33(32-22)23-10-12-24(13-11-23)39(29,36)37/h2-13,15H,14,16-17H2,1H3,(H,30,34)(H,31,35)(H2,29,36,37) D0DC3S DRUGINKE WRRXKPVOAFTNLS-UHFFFAOYSA-N D0DC3S DRUGSMIL CNC(=O)COCC(=O)NC1=CC=C(C=C1)CC2=NN(C(=C2)C3=CC=C(C=C3)Br)C4=CC=C(C=C4)S(=O)(=O)N D0DC3S HIGHSTAT Patented D0DC3S COMPCLAS Pyrazole derivatives D0DE0C DRUG__ID D0DE0C D0DE0C DRUGCOMP RESEARCH TRIANGLE INSTITUTE D0DE0C DRUGTYPE Small molecular drug D0DE0C DRUGINCH 1S/C28H28Cl2N6O/c29-19-9-11-21(12-10-19)36-25(22-7-3-4-8-23(22)30)34-24-26(31-17-32-27(24)36)35-15-13-20(14-16-35)33-28(37)18-5-1-2-6-18/h3-4,7-12,17-18,20H,1-2,5-6,13-16H2,(H,33,37) D0DE0C DRUGINKE XCAAVBMCEMDRAB-UHFFFAOYSA-N D0DE0C DRUGSMIL C1CCC(C1)C(=O)NC2CCN(CC2)C3=NC=NC4=C3N=C(N4C5=CC=C(C=C5)Cl)C6=CC=CC=C6Cl D0DE0C HIGHSTAT Patented D0DE0C COMPCLAS Diphenyl purine derivatives D0DE4E DRUG__ID D0DE4E D0DE4E DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D0DE4E DRUGTYPE Small molecular drug D0DE4E DRUGINCH 1S/C37H56N8O2/c1-35(2,3)19-17-30(26-11-13-27(14-12-26)33(46)38-23-31-40-42-43-41-31)45-34(47)32(44-22-18-25-9-7-8-10-28(25)24-44)39-37(45)20-15-29(16-21-37)36(4,5)6/h11-14,25,28-30H,7-10,15-24H2,1-6H3,(H,38,46)(H,40,41,42,43)/t25?,28?,29?,30-,37?/m1/s1 D0DE4E DRUGINKE QRNMPSNUYHYWGG-RLLJVHIDSA-N D0DE4E DRUGSMIL CC(C)(C)CCC(C1=CC=C(C=C1)C(=O)NCC2=NNN=N2)N3C(=O)C(=NC34CCC(CC4)C(C)(C)C)N5CCC6CCCCC6C5 D0DE4E HIGHSTAT Patented D0DE4E COMPCLAS Spiroimidazolone derivatives D0DL1O DRUG__ID D0DL1O D0DL1O DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0DL1O DRUGTYPE Small molecular drug D0DL1O DRUGINCH 1S/C16H12ClFN4O/c17-10-5-12(8-19-6-10)22-4-3-15-14(9-22)21-16(23-15)13-2-1-11(18)7-20-13/h1-2,5-8H,3-4,9H2 D0DL1O DRUGINKE OEQFRGKRTUFWNP-UHFFFAOYSA-N D0DL1O DRUGSMIL C1CN(CC2=C1OC(=N2)C3=NC=C(C=C3)F)C4=CC(=CN=C4)Cl D0DL1O HIGHSTAT Patented D0DL1O COMPCLAS Tetra-hydro-oxazolopyridine derivatives D0DL7P DRUG__ID D0DL7P D0DL7P DRUGCOMP NOVARTIS AG BEHNKE, Dirk CARCACHE, David ERTL, Peter KOLLER, Manuel ORAIN, David D0DL7P DRUGTYPE Small molecular drug D0DL7P DRUGINCH 1S/C24H19FN4O2/c1-31-23-11-15(7-9-26-23)20-12-21-19-4-2-3-17(16-5-6-22(25)28-13-16)18(19)8-10-29(21)24(30)14-27-20/h2-7,9,11-13H,8,10,14H2,1H3 D0DL7P DRUGINKE GISRGWUSGUAUMX-UHFFFAOYSA-N D0DL7P DRUGSMIL COC1=NC=CC(=C1)C2=NCC(=O)N3CCC4=C(C=CC=C4C3=C2)C5=CN=C(C=C5)F D0DL7P HIGHSTAT Patented D0DL7P COMPCLAS Diazepinone derivatives D0E2TY DRUG__ID D0E2TY D0E2TY DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIVANDERBILT UNIVERSITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANI D0E2TY DRUGTYPE Small molecular drug D0E2TY DRUGINCH 1S/C21H21ClN2O5S/c1-13-17-12-16(29-2)8-9-19(17)24(21(26)14-4-6-15(22)7-5-14)18(13)10-11-20(25)23-30(3,27)28/h4-9,12H,10-11H2,1-3H3,(H,23,25) D0E2TY DRUGINKE PLYKGAOPLXCEPT-UHFFFAOYSA-N D0E2TY DRUGSMIL CC1=C(N(C2=C1C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl)CCC(=O)NS(=O)(=O)C D0E2TY HIGHSTAT Patented D0E2TY COMPCLAS Indomethacin analogs D0E3ED DRUG__ID D0E3ED D0E3ED DRUGCOMP HOFFMANN LA ROCHE [CHHOFFMANN LA ROCHE [US] D0E3ED DRUGTYPE Small molecular drug D0E3ED DRUGINCH 1S/C23H23F4N3O5S/c24-20-9-18(35-23(25,26)27)5-1-14(20)4-8-21(31)29-10-16-12-30(13-17(16)11-29)22(32)15-2-6-19(7-3-15)36(28,33)34/h1-3,5-7,9,16-17H,4,8,10-13H2,(H2,28,33,34)/t16-,17+ D0E3ED DRUGINKE MRXFENNJFHPMOW-CALCHBBNSA-N D0E3ED DRUGSMIL C1C2CN(CC2CN1C(=O)CCC3=C(C=C(C=C3)OC(F)(F)F)F)C(=O)C4=CC=C(C=C4)S(=O)(=O)N D0E3ED HIGHSTAT Patented D0E3ED COMPCLAS Octahydro-pyrrolo[3,4-c]-pyrrole derivatives D0E6KF DRUG__ID D0E6KF D0E6KF DRUGCOMP GLAXOSMITHKLINE LLGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED QIN, Donghui CHEUNG, Mui JOSHI, Hemant TANGIRALA, Raghuram BETHI, Sridhar, Reddy D0E6KF DRUGTYPE Small molecular drug D0E6KF DRUGINCH 1S/C27H25F3N4O4/c1-2-16-3-6-19(7-4-16)33-25(38)34-22-14-31-21(13-32-22)18-5-8-20-17(11-18)9-10-26(24(20)37,12-23(35)36)15-27(28,29)30/h3-8,11,13-14H,2,9-10,12,15H2,1H3,(H,35,36)(H2,32,33,34,38) D0E6KF DRUGINKE YPGWBIYAJJSEDN-UHFFFAOYSA-N D0E6KF DRUGSMIL CCC1=CC=C(C=C1)NC(=O)NC2=NC=C(N=C2)C3=CC4=C(C=C3)C(=O)C(CC4)(CC(=O)O)CC(F)(F)F D0E6KF HIGHSTAT Patented D0E6KF COMPCLAS Carbamide derivatives D0E8AS DRUG__ID D0E8AS D0E8AS DRUGCOMP MERCK SHARP & DOHME CORP. BURNETT, Duane, A. ZHAO, Zhiqiang COLE, David JOSIEN, Hubert PISSARNITSKI, Dmitri, A. SASIKUMAR, Thavalakulamgar WU, Wen-Lian DOMALSKI, Martin D0E8AS DRUGTYPE Small molecular drug D0E8AS DRUGINCH 1S/C22H29N7O4/c1-6-7-11-28-16-17(24-19-26(5)15(30)13-29(19)18(16)31)25-20(28)27-10-8-9-14(12-27)23-21(32)33-22(2,3)4/h14H,8-13H2,1-5H3,(H,23,32)/t14-/m1/s1 D0E8AS DRUGINKE CBLPHWVBNDVSJU-CQSZACIVSA-N D0E8AS DRUGSMIL CC#CCN1C2=C(N=C3N(C(=O)CN3C2=O)C)N=C1N4CCCC(C4)NC(=O)OC(C)(C)C D0E8AS HIGHSTAT Patented D0E8AS COMPCLAS Tricyclic heterocycle derivatives D0E9CK DRUG__ID D0E9CK D0E9CK DRUGCOMP UNIVERSITA' DEGLI STUDI DI PAVIA D0E9CK DRUGTYPE Small molecular drug D0E9CK DRUGINCH 1S/C21H27NO/c23-17-21(13-16-22-14-5-2-6-15-22)20-11-9-19(10-12-20)18-7-3-1-4-8-18/h1,3-4,7-12,21,23H,2,5-6,13-17H2 D0E9CK DRUGINKE DUVDSTKOGVWACP-UHFFFAOYSA-N D0E9CK DRUGSMIL C1CCN(CC1)CCC(CO)C2=CC=C(C=C2)C3=CC=CC=C3 D0E9CK HIGHSTAT Patented D0E9CK COMPCLAS Aryl alkanolamine derivatives D0EG3N DRUG__ID D0EG3N D0EG3N DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0EG3N DRUGTYPE Small molecular drug D0EG3N DRUGINCH 1S/C21H19FN6OS/c22-13-7-8-16-18(12-13)30-21(27-16)26-15-5-1-4-14(15)25-20(29)19-17(6-2-9-23-19)28-11-3-10-24-28/h2-3,6-12,14-15H,1,4-5H2,(H,25,29)(H,26,27)/t14-,15-/m0/s1 D0EG3N DRUGINKE ZNHYIIOVQSLYRA-GJZGRUSLSA-N D0EG3N DRUGSMIL C1CC(C(C1)NC(=O)C2=C(C=CC=N2)N3C=CC=N3)NC4=NC5=C(S4)C=C(C=C5)F D0EG3N HIGHSTAT Patented D0EG3N COMPCLAS 1,2-diamino cyclopentane-based derivatives D0EO3S DRUG__ID D0EO3S D0EO3S DRUGCOMP CUREVEDA, LLC D0EO3S DRUGTYPE Small molecular drug D0EO3S DRUGINCH 1S/C16H12F3NO2/c1-22-15-8-9-20-10-12(15)14(21)7-6-11-4-2-3-5-13(11)16(17,18)19/h2-10H,1H3/b7-6+ D0EO3S DRUGINKE ZYPJWXKOHCZQCI-VOTSOKGWSA-N D0EO3S DRUGSMIL COC1=C(C=NC=C1)C(=O)C=CC2=CC=CC=C2C(F)(F)F D0EO3S HIGHSTAT Patented D0EO3S COMPCLAS Chalcone derivatives D0EQ3O DRUG__ID D0EQ3O D0EQ3O DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori SHIRAI, Kimihiro OI, Marik D0EQ3O DRUGTYPE Small molecular drug D0EQ3O DRUGINCH 1S/C26H17Cl2F3N6O/c1-36(20-8-4-5-13-32-20)35-25(38)21-23(26(29,30)31)34-37-22(15-9-11-16(27)12-10-15)18(14-33-24(21)37)17-6-2-3-7-19(17)28/h2-14H,1H3,(H,35,38) D0EQ3O DRUGINKE BOANGAFVCNVTRF-UHFFFAOYSA-N D0EQ3O DRUGSMIL CN(C1=CC=CC=N1)NC(=O)C2=C3N=CC(=C(N3N=C2C(F)(F)F)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0EQ3O HIGHSTAT Patented D0EQ3O COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0ET3L DRUG__ID D0ET3L D0ET3L DRUGCOMP MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH D0ET3L DRUGTYPE Small molecular drug D0ET3L DRUGINCH 1S/C24H21BrN4O3S/c1-16(30)27-20-8-2-17(3-9-20)14-21-15-24(18-4-6-19(25)7-5-18)29(28-21)22-10-12-23(13-11-22)33(26,31)32/h2-13,15H,14H2,1H3,(H,27,30)(H2,26,31,32) D0ET3L DRUGINKE RPELRWHDWCPVAL-UHFFFAOYSA-N D0ET3L DRUGSMIL CC(=O)NC1=CC=C(C=C1)CC2=NN(C(=C2)C3=CC=C(C=C3)Br)C4=CC=C(C=C4)S(=O)(=O)N D0ET3L HIGHSTAT Patented D0ET3L COMPCLAS Pyrazole derivatives D0EX9O DRUG__ID D0EX9O D0EX9O DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D0EX9O DRUGTYPE Small molecular drug D0EX9O DRUGINCH 1S/C37H37F3N2O6S/c1-25-11-18-31(19-12-25)49(47,48)41(23-29-9-5-6-10-33(29)37(38,39)40)24-35(44)42(30-17-20-32(36(45)46)34(43)21-30)22-26-13-15-28(16-14-26)27-7-3-2-4-8-27/h5-6,9-21,27,43H,2-4,7-8,22-24H2,1H3,(H,45,46) D0EX9O DRUGINKE GFASCHAWPQEYTQ-UHFFFAOYSA-N D0EX9O DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N(CC2=CC=CC=C2C(F)(F)F)CC(=O)N(CC3=CC=C(C=C3)C4CCCCC4)C5=CC(=C(C=C5)C(=O)O)O D0EX9O HIGHSTAT Patented D0EX9O COMPCLAS Salicylic acid derivatives D0EY9S DRUG__ID D0EY9S D0EY9S DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0EY9S DRUGTYPE Small molecule immunotherapy D0EY9S DRUGINCH 1S/C7H13N5O3/c8-3(1-5(10)14)7-11-6(12-15-7)4(9)2-13/h3-4,13H,1-2,8-9H2,(H2,10,14)/t3-,4-/m0/s1 D0EY9S DRUGINKE GBRIVGUQMYWVTC-IMJSIDKUSA-N D0EY9S DRUGSMIL C(C(C1=NC(=NO1)C(CO)N)N)C(=O)N D0EY9S HIGHSTAT Patented D0EY9S COMPCLAS 1,2,4-oxadiazole derivatives D0F0PK DRUG__ID D0F0PK D0F0PK DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIVANDERBILT UNIVERSITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANI D0F0PK DRUGTYPE Small molecular drug D0F0PK DRUGINCH 1S/C18H14ClNO4/c1-24-14-6-7-16-15(9-14)12(8-17(21)22)10-20(16)18(23)11-2-4-13(19)5-3-11/h2-7,9-10H,8H2,1H3,(H,21,22) D0F0PK DRUGINKE DHEMTWWLRLOBKI-UHFFFAOYSA-N D0F0PK DRUGSMIL COC1=CC2=C(C=C1)N(C=C2CC(=O)O)C(=O)C3=CC=C(C=C3)Cl D0F0PK HIGHSTAT Patented D0F0PK COMPCLAS Indomethacin analogs D0F3VN DRUG__ID D0F3VN D0F3VN DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0F3VN DRUGTYPE Small molecular drug D0F3VN DRUGINCH 1S/C27H37ClFN5O5S/c1-18(2)16-34(20-8-6-5-7-9-20)25-13-11-21(39-17-26(35)32-40(37,38)33(3)4)15-24(25)31-27(36)30-23-12-10-19(28)14-22(23)29/h10-15,18,20H,5-9,16-17H2,1-4H3,(H,32,35)(H2,30,31,36) D0F3VN DRUGINKE GXQLSHAYKCFGCU-UHFFFAOYSA-N D0F3VN DRUGSMIL CC(C)CN(C1CCCCC1)C2=C(C=C(C=C2)OCC(=O)NS(=O)(=O)N(C)C)NC(=O)NC3=C(C=C(C=C3)Cl)F D0F3VN HIGHSTAT Patented D0F3VN COMPCLAS Sulfamoylamide derivatives D0F4AW DRUG__ID D0F4AW D0F4AW DRUGCOMP NANT HOLDINGS IP, LLC D0F4AW DRUGTYPE Small molecular drug D0F4AW DRUGINCH 1S/C24H26F2N8O/c1-13-9-15-22(26)18(10-16(25)23(15)27-13)35-24-29-19(28-20-11-17(31-32-20)14-3-4-14)12-21(30-24)34-7-5-33(2)6-8-34/h9-12,14,27H,3-8H2,1-2H3,(H2,28,29,30,31,32) D0F4AW DRUGINKE UUZGSTUXCIFCOJ-UHFFFAOYSA-N D0F4AW DRUGSMIL CC1=CC2=C(C(=CC(=C2N1)F)OC3=NC(=CC(=N3)N4CCN(CC4)C)NC5=NNC(=C5)C6CC6)F D0F4AW HIGHSTAT Patented D0F4AW COMPCLAS Indol-5-ol derivatives D0F4IF DRUG__ID D0F4IF D0F4IF DRUGCOMP INCYTE CORPORATION D0F4IF DRUGTYPE Small molecule immunotherapy D0F4IF DRUGINCH 1S/C23H25N3O2/c1-16-13-22(25-15-19(16)14-24-11-12-27)23(28)26-21-10-6-9-20(17(21)2)18-7-4-3-5-8-18/h3-10,13,15,24,27H,11-12,14H2,1-2H3,(H,26,28) D0F4IF DRUGINKE JIWMSDANMZCAFN-UHFFFAOYSA-N D0F4IF DRUGSMIL CC1=CC(=NC=C1CNCCO)C(=O)NC2=CC=CC(=C2C)C3=CC=CC=C3 D0F4IF HIGHSTAT Patented D0F4IF COMPCLAS N-phenyl-pyridine-2-carboxamide derivatives D0F6VD DRUG__ID D0F6VD D0F6VD DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED D0F6VD DRUGTYPE Small molecular drug D0F6VD DRUGINCH 1S/C19H14Cl2N4O2/c20-12-3-6-14(15(21)9-12)11-1-4-13(5-2-11)25-7-8-27-18-16(19(25)26)17(22)23-10-24-18/h1-6,9-10H,7-8H2,(H2,22,23,24) D0F6VD DRUGINKE QDUBGZSEYIQVEI-UHFFFAOYSA-N D0F6VD DRUGSMIL C1COC2=NC=NC(=C2C(=O)N1C3=CC=C(C=C3)C4=C(C=C(C=C4)Cl)Cl)N D0F6VD HIGHSTAT Patented D0F6VD COMPCLAS Lactam derivatives D0F8XU DRUG__ID D0F8XU D0F8XU DRUGCOMP COGNITION THERAPEUTICS, INC D0F8XU DRUGTYPE Small molecular drug D0F8XU DRUGINCH 1S/C20H23Cl2NO2/c1-13(4-5-14-6-7-17(21)18(22)8-14)23-11-15-9-19(24-2)20(25-3)10-16(15)12-23/h6-10,13H,4-5,11-12H2,1-3H3/t13-/m1/s1 D0F8XU DRUGINKE QOXCLDKXSCBOOF-CYBMUJFWSA-N D0F8XU DRUGSMIL CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC D0F8XU HIGHSTAT Patented D0F8XU COMPCLAS Isoindoline derivatives D0F9RK DRUG__ID D0F9RK D0F9RK DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D0F9RK DRUGTYPE Small molecular drug D0F9RK DRUGINCH 1S/C30H44N4O4/c1-5-24(21-9-11-22(12-10-21)27(37)31-18-15-25(35)36)34-28(38)26(33-19-7-6-8-20-33)32-30(34)16-13-23(14-17-30)29(2,3)4/h9-12,23-24H,5-8,13-20H2,1-4H3,(H,31,37)(H,35,36)/t23?,24-,30?/m1/s1 D0F9RK DRUGINKE RSTWUMARZLVIKV-OLYGOTPTSA-N D0F9RK DRUGSMIL CCC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)N2C(=O)C(=NC23CCC(CC3)C(C)(C)C)N4CCCCC4 D0F9RK HIGHSTAT Patented D0F9RK COMPCLAS Spiroimidazolone derivatives D0FB3R DRUG__ID D0FB3R D0FB3R DRUGCOMP UCL BUSINESS PLC D0FB3R DRUGTYPE Small molecular drug D0FB3R DRUGINCH 1S/C27H34N2O2/c1-4-18-17-29-12-10-19-7-5-6-8-22(19)25(29)14-21(18)13-24-23-16-27(31-3)26(30-2)15-20(23)9-11-28-24/h5-8,15-16,24-25,28H,4,9-14,17H2,1-3H3/t24-,25+/m1/s1 D0FB3R DRUGINKE GAUYNTGXYGJOSH-RPBOFIJWSA-N D0FB3R DRUGSMIL CCC1=C(CC2C3=CC=CC=C3CCN2C1)CC4C5=CC(=C(C=C5CCN4)OC)OC D0FB3R HIGHSTAT Patented D0FB3R COMPCLAS Alkaloid derivatives D0FI1W DRUG__ID D0FI1W D0FI1W DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0FI1W DRUGTYPE Small molecular drug D0FI1W DRUGINCH 1S/C20H20ClN3O4S/c1-26-15-4-3-5-16(27-2)18(15)19(25)22-13-9-28-10-14(13)24-20-23-12-7-6-11(21)8-17(12)29-20/h3-8,13-14H,9-10H2,1-2H3,(H,22,25)(H,23,24) D0FI1W DRUGINKE VWEKNQAXJFBOQH-UHFFFAOYSA-N D0FI1W DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2COCC2NC3=NC4=C(S3)C=C(C=C4)Cl D0FI1W HIGHSTAT Patented D0FI1W COMPCLAS 1,2-diamino cyclopentane-based derivatives D0FJ3N DRUG__ID D0FJ3N D0FJ3N DRUGCOMP Novartis AG D0FJ3N DRUGTYPE Small molecular drug D0FJ3N DRUGINCH 1S/C19H29N5O3/c1-14(2)22-9-11-24(12-10-22)19(26)27-16-5-7-23(8-6-16)17-4-3-15(13-21-17)18(20)25/h3-4,13-14,16H,5-12H2,1-2H3,(H2,20,25) D0FJ3N DRUGINKE SLFVKTUERQHULI-UHFFFAOYSA-N D0FJ3N DRUGSMIL CC(C)N1CCN(CC1)C(=O)OC2CCN(CC2)C3=NC=C(C=C3)C(=O)N D0FJ3N HIGHSTAT Patented D0FJ3N COMPCLAS Piperazine carbamate/urea derivatives D0FK0Y DRUG__ID D0FK0Y D0FK0Y DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0FK0Y DRUGTYPE Small molecular drug D0FK0Y DRUGINCH 1S/C12H17NOS/c1-8(2)12-11(14-3)9-4-6-13-7-5-10(9)15-12/h13H,1,4-7H2,2-3H3 D0FK0Y DRUGINKE BQUIRHQLEFJFBK-UHFFFAOYSA-N D0FK0Y DRUGSMIL CC(=C)C1=C(C2=C(S1)CCNCC2)OC D0FK0Y HIGHSTAT Patented D0FK0Y COMPCLAS Heteroaryl-azepine derivatives D0FR8L DRUG__ID D0FR8L D0FR8L DRUGCOMP H. LUNDBECK A/S D0FR8L DRUGTYPE Small molecular drug D0FR8L DRUGINCH 1S/C20H19Cl2F3N2O/c21-16-3-1-2-15(18(16)22)19(28)26-12-17(13-4-6-14(23)7-5-13)27-10-8-20(24,25)9-11-27/h1-7,17H,8-12H2,(H,26,28) D0FR8L DRUGINKE ASROAJWWBQODIW-UHFFFAOYSA-N D0FR8L DRUGSMIL C1CN(CCC1(F)F)C(CNC(=O)C2=C(C(=CC=C2)Cl)Cl)C3=CC=C(C=C3)F D0FR8L HIGHSTAT Patented D0FR8L COMPCLAS Chlorobenzamide derivatives D0FR9I DRUG__ID D0FR9I D0FR9I DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. NIHON, NOHYAKU CO., LTD. NAKAZATO, Atsuro OKUBO, Taketoshi NAKAMURA, Toshio CHAKI, Shigeyuki TOMISAWA, Kazuyuki NAGAMINE, Masashi YAMAMOTO, Kenji HARADA, Koichiro YOSHIDA, Masanor D0FR9I DRUGTYPE Small molecular drug D0FR9I DRUGINCH 1S/C23H22FNO4/c1-16(26)25(15-17-13-20(27-2)10-12-22(17)28-3)21-14-18(24)9-11-23(21)29-19-7-5-4-6-8-19/h4-14H,15H2,1-3H3 D0FR9I DRUGINKE DCRZYADKQRHHSF-UHFFFAOYSA-N D0FR9I DRUGSMIL CC(=O)N(CC1=C(C=CC(=C1)OC)OC)C2=C(C=CC(=C2)F)OC3=CC=CC=C3 D0FR9I HIGHSTAT Patented D0FR9I COMPCLAS Aryl oxyanilide derivatives D0FS4S DRUG__ID D0FS4S D0FS4S DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, W. HAAS, Julia JIANG, Yutong ZHANG, Gan D0FS4S DRUGTYPE Small molecular drug D0FS4S DRUGINCH 1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)17-2-1-8-28(17)19-6-5-18-24-11-20(29(18)26-19)25-21(31)27-9-7-14(30)12-27/h3-6,10-11,14,17,30H,1-2,7-9,12H2,(H,25,31)/t14-,17+/m0/s1 D0FS4S DRUGINKE JSJOUFCSIYXYAC-WMLDXEAASA-N D0FS4S DRUGSMIL C1CC(N(C1)C2=NN3C(=NC=C3NC(=O)N4CCC(C4)O)C=C2)C5=C(C=CC(=C5)F)F D0FS4S HIGHSTAT Patented D0FS4S COMPCLAS Imidazo[1,2-b]pyridazine derivatives D0FS8K DRUG__ID D0FS8K D0FS8K DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj GRECO, Michael, N. SHOOK, Brian XU, Guozhang ZHANG, Rui D0FS8K DRUGTYPE Small molecular drug D0FS8K DRUGINCH 1S/C30H26Cl2N2O3/c1-19(34-26-13-8-21(9-14-26)20-6-10-24(31)11-7-20)27-15-12-25(32)18-28(27)22-2-4-23(5-3-22)30(37)33-17-16-29(35)36/h2-15,18-19,34H,16-17H2,1H3,(H,33,37)(H,35,36) D0FS8K DRUGINKE VTPFIFMNWSMPMA-UHFFFAOYSA-N D0FS8K DRUGSMIL CC(C1=C(C=C(C=C1)Cl)C2=CC=C(C=C2)C(=O)NCCC(=O)O)NC3=CC=C(C=C3)C4=CC=C(C=C4)Cl D0FS8K HIGHSTAT Patented D0FS8K COMPCLAS Biphenyl carboxamidopropanoic acid derivatives D0FV9Z DRUG__ID D0FV9Z D0FV9Z DRUGCOMP THE BROAD INSTITUTE, INC. DANA-FARBER CANCER INSTITUE, INC. THE GENERAL HOSPITAL CORPORATION D/B/A D0FV9Z DRUGTYPE Small molecular drug D0FV9Z DRUGINCH 1S/C20H23N3O2/c1-11-16-17(12-7-5-6-8-15(12)25-4)18-13(21-19(16)23-22-11)9-20(2,3)10-14(18)24/h5-8,17H,9-10H2,1-4H3,(H2,21,22,23)/t17-/m0/s1 D0FV9Z DRUGINKE KYFJPYWXCUCRPE-KRWDZBQOSA-N D0FV9Z DRUGSMIL CC1=C2C(C3=C(CC(CC3=O)(C)C)NC2=NN1)C4=CC=CC=C4OC D0FV9Z HIGHSTAT Patented D0FV9Z COMPCLAS Pyrazolodihydropyridine derivatives D0FX6I DRUG__ID D0FX6I D0FX6I DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PRIEPKE, Henning DOODS, Henri KUELZER, Raimund PFAU, Roland STENKAMP, Dirk ROENN, Robert PELCMAN, Benjamin D0FX6I DRUGTYPE Small molecular drug D0FX6I DRUGINCH 1S/C26H24BrCl2N3O3/c1-26(2,3)25(35)30-14-15-4-10-21(28)19(12-15)23(33)32-18-9-11-22(29)20(13-18)24(34)31-17-7-5-16(27)6-8-17/h4-13H,14H2,1-3H3,(H,30,35)(H,31,34)(H,32,33) D0FX6I DRUGINKE YFQGXIHVHCEKFN-UHFFFAOYSA-N D0FX6I DRUGSMIL CC(C)(C)C(=O)NCC1=CC(=C(C=C1)Cl)C(=O)NC2=CC(=C(C=C2)Cl)C(=O)NC3=CC=C(C=C3)Br D0FX6I HIGHSTAT Patented D0FX6I COMPCLAS Benzamide derivatives D0FY9K DRUG__ID D0FY9K D0FY9K DRUGCOMP ZENITH EPIGENETICS CORP D0FY9K DRUGTYPE Small molecular drug D0FY9K DRUGINCH 1S/C23H28N4O4/c1-27-8-7-14(13-27)12-24-18-9-15(29-2)5-6-17(18)22-25-19-10-16(30-3)11-20(31-4)21(19)23(28)26-22/h5-6,9-11,14,24H,7-8,12-13H2,1-4H3,(H,25,26,28) D0FY9K DRUGINKE PRDGUEJBCFBYCA-UHFFFAOYSA-N D0FY9K DRUGSMIL CN1CCC(C1)CNC2=C(C=CC(=C2)OC)C3=NC4=C(C(=CC(=C4)OC)OC)C(=O)N3 D0FY9K HIGHSTAT Patented D0FY9K COMPCLAS Quinazolinone derivatives D0G2SI DRUG__ID D0G2SI D0G2SI DRUGCOMP LEAD DISCOVERY CENTER GMBH D0G2SI DRUGTYPE Small molecular drug D0G2SI DRUGINCH 1S/C21H28N6O/c1-14(2)18-13-23-27-19(18)25-21(28-17-10-7-11-22-12-17)26-20(27)24-15(3)16-8-5-4-6-9-16/h4-6,8-9,13-15,17,22H,7,10-12H2,1-3H3,(H,24,25,26)/t15-,17?/m0/s1 D0G2SI DRUGINKE GTZAVJAMAXSTOG-MYJWUSKBSA-N D0G2SI DRUGSMIL CC(C)C1=C2N=C(N=C(N2N=C1)NC(C)C3=CC=CC=C3)OC4CCCNC4 D0G2SI HIGHSTAT Patented D0G2SI COMPCLAS Pyrazolo-triazine derivatives D0G3DM DRUG__ID D0G3DM D0G3DM DRUGCOMP LYCERA CORPORATION D0G3DM DRUGTYPE Small molecular drug D0G3DM DRUGINCH 1S/C21H18N8O2S/c30-7-6-29-12-15(11-23-29)19(31)24-16-3-1-2-13(8-16)20-27-28-21(32-20)25-17-4-5-18-14(9-17)10-22-26-18/h1-5,8-12,30H,6-7H2,(H,22,26)(H,24,31)(H,25,28) D0G3DM DRUGINKE QFQWUHMXGFJZJO-UHFFFAOYSA-N D0G3DM DRUGSMIL C1=CC(=CC(=C1)NC(=O)C2=CN(N=C2)CCO)C3=NN=C(S3)NC4=CC5=C(C=C4)NN=C5 D0G3DM HIGHSTAT Patented D0G3DM COMPCLAS Indazolyl-thiadiazolamine derivatives D0G4GT DRUG__ID D0G4GT D0G4GT DRUGCOMP Wisconsin Alumni Research Foundation D0G4GT DRUGTYPE Small molecular drug D0G4GT DRUGINCH 1S/C16H26N2O2/c1-2-3-4-5-6-13-17-14-7-8-15-9-11-16(12-10-15)18(19)20/h9-12,17H,2-8,13-14H2,1H3 D0G4GT DRUGINKE LAKCRRVRMIUBSO-UHFFFAOYSA-N D0G4GT DRUGSMIL CCCCCCCNCCCC1=CC=C(C=C1)[N+](=O)[O-] D0G4GT HIGHSTAT Patented D0G4GT COMPCLAS Phenylpropylamine derivatives D0G5EI DRUG__ID D0G5EI D0G5EI DRUGCOMP JANSSEN PHARMACEUTICA NV D0G5EI DRUGTYPE Small molecular drug D0G5EI DRUGINCH 1S/C24H23BrN6O3/c1-30-20(17(25)12-28-30)11-23(32)31-7-6-14-8-15(4-5-19(14)31)29-24-16-9-21(33-2)22(34-3)10-18(16)26-13-27-24/h4-5,8-10,12-13H,6-7,11H2,1-3H3,(H,26,27,29) D0G5EI DRUGINKE KVVYJCRBQJOKHQ-UHFFFAOYSA-N D0G5EI DRUGSMIL CN1C(=C(C=N1)Br)CC(=O)N2CCC3=C2C=CC(=C3)NC4=NC=NC5=CC(=C(C=C54)OC)OC D0G5EI HIGHSTAT Patented D0G5EI COMPCLAS Indoline derivatives D0G6DW DRUG__ID D0G6DW D0G6DW DRUGCOMP CHDI FOUNDATION, INC D0G6DW DRUGTYPE Small molecular drug D0G6DW DRUGINCH 1S/C12H10Cl2O3/c1-5-9(10(5)12(16)17)11(15)6-2-3-7(13)8(14)4-6/h2-5,9-10H,1H3,(H,16,17)/t5-,9-,10-/m0/s1 D0G6DW DRUGINKE JFJFPXNBPGWPNH-AGEOJFDCSA-N D0G6DW DRUGSMIL CC1C(C1C(=O)O)C(=O)C2=CC(=C(C=C2)Cl)Cl D0G6DW HIGHSTAT Patented D0G6DW COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0G7HK DRUG__ID D0G7HK D0G7HK DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D0G7HK DRUGTYPE Small molecular drug D0G7HK DRUGINCH 1S/C21H17ClN2O3/c1-23(2)21(25)27-20-17-12-7-13-24(17)16-11-6-10-15(22)19(16)26-18(20)14-8-4-3-5-9-14/h3-13H,1-2H3 D0G7HK DRUGINKE PGDWEEZRRKJANX-UHFFFAOYSA-N D0G7HK DRUGSMIL CN(C)C(=O)OC1=C(OC2=C(C=CC=C2Cl)N3C1=CC=C3)C4=CC=CC=C4 D0G7HK HIGHSTAT Patented D0G7HK COMPCLAS Benzothiazepine analogs D0G7KY DRUG__ID D0G7KY D0G7KY DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0G7KY DRUGTYPE Small molecular drug D0G7KY DRUGINCH 1S/C27H30FN7O2/c1-26(2,3)19-14-21(17-6-8-18(28)9-7-17)32-35-15-22(30-23(19)35)25(37)34-13-12-33(16-27(34,4)5)24(36)20-10-11-29-31-20/h6-11,14-15H,12-13,16H2,1-5H3,(H,29,31) D0G7KY DRUGINKE DUTWPNVXOWFNEY-UHFFFAOYSA-N D0G7KY DRUGSMIL CC1(CN(CCN1C(=O)C2=CN3C(=N2)C(=CC(=N3)C4=CC=C(C=C4)F)C(C)(C)C)C(=O)C5=CC=NN5)C D0G7KY HIGHSTAT Patented D0G7KY COMPCLAS Imidazopyridazine derivatives D0G8VB DRUG__ID D0G8VB D0G8VB DRUGCOMP THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA VANDERBILT UNIVERSITY D0G8VB DRUGTYPE Small molecular drug D0G8VB DRUGINCH 1S/C15H16O3/c1-3-14(15(16)17)12-5-4-11-9-13(18-2)7-6-10(11)8-12/h4-9,14H,3H2,1-2H3,(H,16,17)/t14-/m1/s1 D0G8VB DRUGINKE LSDAHSHHKKHOKE-CQSZACIVSA-N D0G8VB DRUGSMIL CCC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O D0G8VB HIGHSTAT Patented D0G8VB COMPCLAS Beta-naphthylacetic acids derivatives D0G9HY DRUG__ID D0G9HY D0G9HY DRUGCOMP Univ China Pharma D0G9HY DRUGTYPE Small molecular drug D0G9HY DRUGINCH 1S/C30H37N5O/c31-25(19-21-20-34-26-14-6-3-11-22(21)26)30(36)33-18-10-2-1-9-17-32-29-23-12-4-7-15-27(23)35-28-16-8-5-13-24(28)29/h3-4,6-7,11-12,14-15,20,25,34H,1-2,5,8-10,13,16-19,31H2,(H,32,35)(H,33,36)/t25-/m0/s1 D0G9HY DRUGINKE KADKUQSSIRPDHT-VWLOTQADSA-N D0G9HY DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCNC(=O)C(CC4=CNC5=CC=CC=C54)N D0G9HY HIGHSTAT Patented D0G9HY COMPCLAS Tacrine-indole hybrid derivatives D0GH4B DRUG__ID D0GH4B D0GH4B DRUGCOMP AMOREPACIFIC CORPORATION ( ) SHIN, Song Seok HONG, Yong Deog BYOUN, Kyoung Hee PARK, Mi Young CHOI, Jin Ky D0GH4B DRUGTYPE Small molecular drug D0GH4B DRUGINCH 1S/C24H24ClFN4O2/c1-3-32-15-20-23(16-7-9-18(25)10-8-16)24-27-22(29(2)11-12-31)14-21(30(24)28-20)17-5-4-6-19(26)13-17/h4-10,13-14,31H,3,11-12,15H2,1-2H3 D0GH4B DRUGINKE HYBHLUDFJVRRSM-UHFFFAOYSA-N D0GH4B DRUGSMIL CCOCC1=NN2C(=CC(=NC2=C1C3=CC=C(C=C3)Cl)N(C)CCO)C4=CC(=CC=C4)F D0GH4B HIGHSTAT Patented D0GH4B COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0GN5R DRUG__ID D0GN5R D0GN5R DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D0GN5R DRUGTYPE Small molecular drug D0GN5R DRUGINCH 1S/C24H24N2O3/c1-4-25(5-2)24(27)29-23-20-10-8-16-26(20)19-9-6-7-11-21(19)28-22(23)18-14-12-17(3)13-15-18/h6-16H,4-5H2,1-3H3 D0GN5R DRUGINKE DUPMTWWDEZKFAZ-UHFFFAOYSA-N D0GN5R DRUGSMIL CCN(CC)C(=O)OC1=C(OC2=CC=CC=C2N3C1=CC=C3)C4=CC=C(C=C4)C D0GN5R HIGHSTAT Patented D0GN5R COMPCLAS Benzothiazepine analogs D0GQ6D DRUG__ID D0GQ6D D0GQ6D DRUGCOMP Roche D0GQ6D DRUGTYPE Small molecular drug D0GQ6D DRUGINCH 1S/C24H21FN2O5S/c1-33(30,31)19-9-5-17(6-10-19)20(12-15-2-7-18(25)8-3-15)23(29)27-24-26-21-11-4-16(14-28)13-22(21)32-24/h2-11,13,20,28H,12,14H2,1H3,(H,26,27,29) D0GQ6D DRUGINKE BSRLERQMZLOWBH-UHFFFAOYSA-N D0GQ6D DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C(CC2=CC=C(C=C2)F)C(=O)NC3=NC4=C(O3)C=C(C=C4)CO D0GQ6D HIGHSTAT Patented D0GQ6D COMPCLAS Aminobenzoxazole analogs D0GR1X DRUG__ID D0GR1X D0GR1X DRUGCOMP NATIONAL CANCER CENTER ANYGEN CO., LTD. KIM, Young-Chul LEE, Ju-Yeon KIM, Soo Youl LEE, Byung Il D0GR1X DRUGTYPE Small molecular drug D0GR1X DRUGINCH 1S/C18H33N5S/c1-13(2)9-22-11-15(7-5-6-8-19)20-18(24)17-16(22)12-23(21-17)10-14(3)4/h12-15H,5-11,19H2,1-4H3,(H,20,24)/t15-/m0/s1 D0GR1X DRUGINKE SRDGVWFRHBVJPL-HNNXBMFYSA-N D0GR1X DRUGSMIL CC(C)CN1CC(NC(=S)C2=NN(C=C21)CC(C)C)CCCCN D0GR1X HIGHSTAT Patented D0GR1X COMPCLAS Pyrazolodiazepine derivatives D0GV6B DRUG__ID D0GV6B D0GV6B DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0GV6B DRUGTYPE Small molecular drug D0GV6B DRUGINCH 1S/C24H31ClN2O2/c1-3-13-27(16-17-5-6-17)23-12-7-19(18(4-2)15-24(28)29)14-22(23)26-21-10-8-20(25)9-11-21/h7-12,14,17-18,26H,3-6,13,15-16H2,1-2H3,(H,28,29) D0GV6B DRUGINKE XRVVTNJDVWWYSU-UHFFFAOYSA-N D0GV6B DRUGSMIL CCCN(CC1CC1)C2=C(C=C(C=C2)C(CC)CC(=O)O)NC3=CC=C(C=C3)Cl D0GV6B HIGHSTAT Patented D0GV6B COMPCLAS Monoaryl-1,2-diamine derivatives D0GX6V DRUG__ID D0GX6V D0GX6V DRUGCOMP SOLVAY PHARMACEUTICALS B.V. LANGE, Josephus H.M. KRUSE, Cornelis G. VAN VLIET, Bernard J D0GX6V DRUGTYPE Small molecular drug D0GX6V DRUGINCH 1S/C22H21Cl3N4OS/c1-31-21-19(22(30)27-28-11-3-2-4-12-28)26-29(18-10-9-16(24)13-17(18)25)20(21)14-5-7-15(23)8-6-14/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D0GX6V DRUGINKE MDNGVPOVESSODT-UHFFFAOYSA-N D0GX6V DRUGSMIL CSC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D0GX6V HIGHSTAT Patented D0GX6V COMPCLAS Pyrazole derivatives D0GY0E DRUG__ID D0GY0E D0GY0E DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D0GY0E DRUGTYPE Small molecular drug D0GY0E DRUGINCH 1S/C21H17NO3/c1-14-9-11-16(12-10-14)20-21(24-15(2)23)18-7-5-13-22(18)17-6-3-4-8-19(17)25-20/h3-13H,1-2H3 D0GY0E DRUGINKE SJEIIHOXPXOSSN-UHFFFAOYSA-N D0GY0E DRUGSMIL CC1=CC=C(C=C1)C2=C(C3=CC=CN3C4=CC=CC=C4O2)OC(=O)C D0GY0E HIGHSTAT Patented D0GY0E COMPCLAS Benzothiazepine analogs D0GY2Z DRUG__ID D0GY2Z D0GY2Z DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIVANDERBILT UNIVERSITY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANI D0GY2Z DRUGTYPE Small molecular drug D0GY2Z DRUGINCH 1S/C20H18ClNO4/c1-12-16(8-10-19(23)24)17-11-15(26-2)7-9-18(17)22(12)20(25)13-3-5-14(21)6-4-13/h3-7,9,11H,8,10H2,1-2H3,(H,23,24) D0GY2Z DRUGINKE ZXFPVIQVVULPBC-UHFFFAOYSA-N D0GY2Z DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CCC(=O)O D0GY2Z HIGHSTAT Patented D0GY2Z COMPCLAS Indomethacin analogs D0H0MO DRUG__ID D0H0MO D0H0MO DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0H0MO DRUGTYPE Small molecule immunotherapy D0H0MO DRUGINCH 1S/C14H17N7O6/c1-6(22)10(13(24)25)19-14(26)18-7(4-9(15)23)11-20-21-12(27-11)8-5-16-2-3-17-8/h2-3,5-7,10,22H,4H2,1H3,(H2,15,23)(H,24,25)(H2,18,19,26)/t6?,7-,10-/m0/s1 D0H0MO DRUGINKE FQAXMNWDINGSGZ-MXMVMAASSA-N D0H0MO DRUGSMIL CC(C(C(=O)O)NC(=O)NC(CC(=O)N)C1=NN=C(O1)C2=NC=CN=C2)O D0H0MO HIGHSTAT Patented D0H0MO COMPCLAS 1,3,4-oxadiazole derivatives D0H1WN DRUG__ID D0H1WN D0H1WN DRUGCOMP JANSSEN PHARMACEUTICA NV D0H1WN DRUGTYPE Small molecular drug D0H1WN DRUGINCH 1S/C26H21F3N4O3/c1-35-22-11-17-20(12-23(22)36-2)30-13-31-26(17)32-19-5-6-21-16(25(19)29)7-8-33(21)24(34)10-14-9-15(27)3-4-18(14)28/h3-6,9,11-13H,7-8,10H2,1-2H3,(H,30,31,32) D0H1WN DRUGINKE BJJFQLVMCHTWRM-UHFFFAOYSA-N D0H1WN DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C4=C(C=C3)N(CC4)C(=O)CC5=C(C=CC(=C5)F)F)F)OC D0H1WN HIGHSTAT Patented D0H1WN COMPCLAS Indoline derivatives D0H2SE DRUG__ID D0H2SE D0H2SE DRUGCOMP UNIVERSITE DE LILLE 2 DROIT ET SANTE CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) D0H2SE DRUGTYPE Small molecular drug D0H2SE DRUGINCH 1S/C18H20Cl2N2O/c1-22(13-14-6-3-2-4-7-14)9-5-8-21-18(23)15-10-16(19)12-17(20)11-15/h2-4,6-7,10-12H,5,8-9,13H2,1H3,(H,21,23) D0H2SE DRUGINKE KXRBNMSGFUSFLX-UHFFFAOYSA-N D0H2SE DRUGSMIL CN(CCCNC(=O)C1=CC(=CC(=C1)Cl)Cl)CC2=CC=CC=C2 D0H2SE HIGHSTAT Patented D0H2SE COMPCLAS Benzamide derivatives D0H2WY DRUG__ID D0H2WY D0H2WY DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED BIRCH, Alan Martin BUTLIN, Roger John CAMPBELL, Leonie GREEN, Clive LEACH, Andrew MURRAY, Paul Michael RYBERG, Per Olof WARING, Michael James D0H2WY DRUGTYPE Small molecular drug D0H2WY DRUGINCH 1S/C25H25ClN4O4/c1-13-21(29-22(23(27)32)14(2)28-13)17-8-6-16(7-9-17)18-10-5-15(11-19(18)26)12-20(31)30-25(3,4)24(33)34/h5-11H,12H2,1-4H3,(H2,27,32)(H,30,31)(H,33,34) D0H2WY DRUGINKE XXCQLRBQKLTUDU-UHFFFAOYSA-N D0H2WY DRUGSMIL CC1=C(N=C(C(=N1)C)C(=O)N)C2=CC=C(C=C2)C3=C(C=C(C=C3)CC(=O)NC(C)(C)C(=O)O)Cl D0H2WY HIGHSTAT Patented D0H2WY COMPCLAS Pyrazine carboxamide derivatives D0H6AL DRUG__ID D0H6AL D0H6AL DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0H6AL DRUGTYPE Small molecule immunotherapy D0H6AL DRUGINCH 1S/C20H25N7O6/c21-12(7-10-8-23-13-4-2-1-3-11(10)13)17-26-27-18(33-17)15(9-28)25-20(32)24-14(19(30)31)5-6-16(22)29/h1-4,8,12,14-15,23,28H,5-7,9,21H2,(H2,22,29)(H,30,31)(H2,24,25,32)/t12-,14-,15-/m0/s1 D0H6AL DRUGINKE WXNTYOHOKYKDDS-QEJZJMRPSA-N D0H6AL DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C3=NN=C(O3)C(CO)NC(=O)NC(CCC(=O)N)C(=O)O)N D0H6AL HIGHSTAT Patented D0H6AL COMPCLAS 1,3,4-oxadiazole derivatives D0H7OC DRUG__ID D0H7OC D0H7OC DRUGCOMP Novartis AG D0H7OC DRUGTYPE Small molecular drug D0H7OC DRUGINCH 1S/C21H31N5O2/c1-16(2)23-10-12-25(13-11-23)21(27)28-19-5-8-24(9-6-19)18-4-7-26-15-17(3)22-20(26)14-18/h4,7,14-16,19H,5-6,8-13H2,1-3H3 D0H7OC DRUGINKE XAQBWJISZRMNHF-UHFFFAOYSA-N D0H7OC DRUGSMIL CC1=CN2C=CC(=CC2=N1)N3CCC(CC3)OC(=O)N4CCN(CC4)C(C)C D0H7OC HIGHSTAT Patented D0H7OC COMPCLAS Piperazine carbamate/urea derivatives D0H8LZ DRUG__ID D0H8LZ D0H8LZ DRUGCOMP INFINITY PHARMACEUTICALS, INC. CASTRO, Alfredo, C. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J D0H8LZ DRUGTYPE Small molecular drug D0H8LZ DRUGINCH 1S/C16H24BNO3/c19-16(18-12-10-15(11-13-18)17(20)21)9-5-4-8-14-6-2-1-3-7-14/h1-3,6-7,15,20-21H,4-5,8-13H2 D0H8LZ DRUGINKE WOTYQRKKBABLCX-UHFFFAOYSA-N D0H8LZ DRUGSMIL B(C1CCN(CC1)C(=O)CCCCC2=CC=CC=C2)(O)O D0H8LZ HIGHSTAT Patented D0H8LZ COMPCLAS Boronic acid derivatives D0H8XH DRUG__ID D0H8XH D0H8XH DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven S. CONDROSKI, Kevin Ronald HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy SEO, Jeongbeob D0H8XH DRUGTYPE Small molecular drug D0H8XH DRUGINCH 1S/C20H20FN5O2/c21-13-3-1-2-12(8-13)17-9-15(27)11-25(17)18-6-7-26-19(24-18)16(10-22-26)20(28)23-14-4-5-14/h1-3,6-8,10,14-15,17,27H,4-5,9,11H2,(H,23,28)/t15-,17-/m1/s1 D0H8XH DRUGINKE DHEFBJXZYSKWIF-NVXWUHKLSA-N D0H8XH DRUGSMIL C1CC1NC(=O)C2=C3N=C(C=CN3N=C2)N4CC(CC4C5=CC(=CC=C5)F)O D0H8XH HIGHSTAT Patented D0H8XH COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0H9RP DRUG__ID D0H9RP D0H9RP DRUGCOMP GLAXOSMITHKLINE LLGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED QIN, Donghui CHEUNG, Mui JOSHI, Hemant TANGIRALA, Raghuram BETHI, Sridhar, Reddy D0H9RP DRUGTYPE Small molecular drug D0H9RP DRUGINCH 1S/C22H16F3N5O3/c23-22(24,25)33-16-3-1-2-14(11-16)29-7-6-13-10-15(4-5-17(13)29)30-8-9-32-20-18(21(30)31)19(26)27-12-28-20/h1-7,10-12H,8-9H2,(H2,26,27,28) D0H9RP DRUGINKE QBBURCWZLKKIPV-UHFFFAOYSA-N D0H9RP DRUGSMIL C1COC2=NC=NC(=C2C(=O)N1C3=CC4=C(C=C3)N(C=C4)C5=CC(=CC=C5)OC(F)(F)F)N D0H9RP HIGHSTAT Patented D0H9RP COMPCLAS Lactam derivatives D0HB3F DRUG__ID D0HB3F D0HB3F DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN D0HB3F DRUGTYPE Small molecular drug D0HB3F DRUGINCH 1S/C24H25N7O2/c1-11-21(12(2)33-30-11)16-8-18-15(9-19(16)32-5)22-23(27-18)25-13(3)26-24(22)28-20-10-17(14-6-7-14)29-31(20)4/h8-10,14H,6-7H2,1-5H3,(H2,25,26,27,28) D0HB3F DRUGINKE JIYPVUCBRQNICX-UHFFFAOYSA-N D0HB3F DRUGSMIL CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)NC4=C3C(=NC(=N4)C)NC5=CC(=NN5C)C6CC6)OC D0HB3F HIGHSTAT Patented D0HB3F COMPCLAS Pyrimido-indole derivatives D0HE8M DRUG__ID D0HE8M D0HE8M DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0HE8M DRUGTYPE Small molecule immunotherapy D0HE8M DRUGINCH 1S/C12H20N6O7/c1-4(20)8(11(22)23)16-12(24)15-6(2-7(14)21)10-17-9(18-25-10)5(13)3-19/h4-6,8,19-20H,2-3,13H2,1H3,(H2,14,21)(H,22,23)(H2,15,16,24)/t4?,5-,6-,8+/m0/s1 D0HE8M DRUGINKE HFOBENSCBRZVSP-FMKRDQFVSA-N D0HE8M DRUGSMIL CC(C(C(=O)O)NC(=O)NC(CC(=O)N)C1=NC(=NO1)C(CO)N)O D0HE8M HIGHSTAT Patented D0HE8M COMPCLAS 1,2,4-oxadiazole derivatives D0HF0R DRUG__ID D0HF0R D0HF0R DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0HF0R DRUGTYPE Small molecular drug D0HF0R DRUGINCH 1S/C28H32F3N9S/c1-18-15-25(37-36-18)33-24-17-26(40-13-11-39(12-14-40)20-7-9-38(2)10-8-20)35-27(34-24)41-21-4-5-22-19(16-21)3-6-23(32-22)28(29,30)31/h3-6,15-17,20H,7-14H2,1-2H3,(H2,33,34,35,36,37) D0HF0R DRUGINKE CBMIRUJKKBNHQV-UHFFFAOYSA-N D0HF0R DRUGSMIL CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC4=C(C=C3)N=C(C=C4)C(F)(F)F)N5CCN(CC5)C6CCN(CC6)C D0HF0R HIGHSTAT Patented D0HF0R COMPCLAS Aminopyrimidine derivatives D0HH1K DRUG__ID D0HH1K D0HH1K DRUGCOMP ARIZONA BOARD OF REGENTS, ACTING ON BEHALF OF THE UNIVERSITY OF ARIZONA UNIVERSITY OF PITTSBURGH POWIS, Garth WIPF, Pete D0HH1K DRUGTYPE Small molecular drug D0HH1K DRUGINCH 1S/C20H12O4/c21-14-7-3-6-13-19(14)15(22)10-11-20(13)23-16-8-1-4-12-5-2-9-17(24-20)18(12)16/h1-11,21H D0HH1K DRUGINKE LVOXAJYEGVDSQA-UHFFFAOYSA-N D0HH1K DRUGSMIL C1=CC2=C3C(=C1)OC4(C=CC(=O)C5=C4C=CC=C5O)OC3=CC=C2 D0HH1K HIGHSTAT Patented D0HH1K COMPCLAS Palmarumycin derivatives D0HL5C DRUG__ID D0HL5C D0HL5C DRUGCOMP PRINCIPIA BIOPHARMA INC D0HL5C DRUGTYPE Small molecular drug D0HL5C DRUGINCH 1S/C20H21N5O2/c1-5-16(26)23-13-8-6-7-12(9-13)15-11-22-18-17(24-15)14(10-21-18)19(27)25-20(2,3)4/h5-11H,1H2,2-4H3,(H,21,22)(H,23,26)(H,25,27) D0HL5C DRUGINKE RGYYZLGXRYSDRO-UHFFFAOYSA-N D0HL5C DRUGSMIL CC(C)(C)NC(=O)C1=CNC2=NC=C(N=C12)C3=CC(=CC=C3)NC(=O)C=C D0HL5C HIGHSTAT Patented D0HL5C COMPCLAS Pyrrolo-pyrazine derivatives D0HO8V DRUG__ID D0HO8V D0HO8V DRUGCOMP NOVARTIS AG [CHBLANK JUTTA [CHBOLD GUIDO [CHBORDAS VINCENT [CHCOTESTA SIMONA [CHGUAGNANO VITO [CHR EGER HEINRICH [CHVAUPEL ANDREA [CH] D0HO8V DRUGTYPE Small molecular drug D0HO8V DRUGINCH 1S/C22H19ClF2N8O2/c1-10-8-14(30-33-19(10)28-29-20(33)18(24)25)32-16(11-4-6-12(23)7-5-11)17-15(21(32)34)13(9-31(17)3)27-22(35)26-2/h4-9,16,18H,1-3H3,(H2,26,27,35) D0HO8V DRUGINKE RNLAJPMWXHNSOJ-UHFFFAOYSA-N D0HO8V DRUGSMIL CC1=CC(=NN2C1=NN=C2C(F)F)N3C(C4=C(C3=O)C(=CN4C)NC(=O)NC)C5=CC=C(C=C5)Cl D0HO8V HIGHSTAT Patented D0HO8V COMPCLAS Pyrrolo-pyrrolone derivatives D0HV7T DRUG__ID D0HV7T D0HV7T DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj KREUTTER, Kevin POWELL, Mark SHOOK, Brian SONG, Fengbin XU, Guozhang YANG, Shyh-ming ZHANG, Rui ZHAO, Bao-pin D0HV7T DRUGTYPE Small molecular drug D0HV7T DRUGINCH 1S/C30H23ClF3N3O4/c1-17-14-21(31)6-10-23(17)18-2-7-22(8-3-18)37-28(40)24-9-5-20(30(32,33)34)15-25(24)19-4-11-26(36-16-19)29(41)35-13-12-27(38)39/h2-11,14-16H,12-13H2,1H3,(H,35,41)(H,37,40)(H,38,39) D0HV7T DRUGINKE QISSKZBXYOVUJU-UHFFFAOYSA-N D0HV7T DRUGSMIL CC1=C(C=CC(=C1)Cl)C2=CC=C(C=C2)NC(=O)C3=C(C=C(C=C3)C(F)(F)F)C4=CN=C(C=C4)C(=O)NCCC(=O)O D0HV7T HIGHSTAT Patented D0HV7T COMPCLAS Picolinamido propanoic acid derivatives D0HZ1Z DRUG__ID D0HZ1Z D0HZ1Z DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0HZ1Z DRUGTYPE Small molecular drug D0HZ1Z DRUGINCH 1S/C16H18F2N2O5/c1-7(2)6-10(19-15(22)12-13(25-12)16(23)24)14(21)20-11-8(17)4-3-5-9(11)18/h3-5,7,10,12-13H,6H2,1-2H3,(H,19,22)(H,20,21)(H,23,24)/t10-,12-,13-/m0/s1 D0HZ1Z DRUGINKE RZWURLBUPSDTKT-DRZSPHRISA-N D0HZ1Z DRUGSMIL CC(C)CC(C(=O)NC1=C(C=CC=C1F)F)NC(=O)C2C(O2)C(=O)O D0HZ1Z HIGHSTAT Patented D0HZ1Z COMPCLAS Epoxysuccinate derivatives D0HZ7J DRUG__ID D0HZ7J D0HZ7J DRUGCOMP ALLERGAN, INC. WOODWARD, David F. MARTOS, Jose L. CARLING, William R. POLOSO, Neil J. WANG, Jenny W D0HZ7J DRUGTYPE Small molecular drug D0HZ7J DRUGINCH 1S/C31H44N4O7S/c1-3-43(39,40)34-28(36)17-15-23-14-16-24(41-2)20-25(23)31(38)35-19-9-13-27(35)30-33-26(21-42-30)29(37)32-18-8-7-12-22-10-5-4-6-11-22/h14,16,20-22,27H,3-13,15,17-19H2,1-2H3,(H,32,37)(H,34,36)/t27-/m0/s1 D0HZ7J DRUGINKE CARRKGKFLQFOPT-MHZLTWQESA-N D0HZ7J DRUGSMIL CCS(=O)(=O)NC(=O)CCC1=C(C=C(C=C1)OC)C(=O)N2CCCC2C3=NC(=CO3)C(=O)NCCCCC4CCCCC4 D0HZ7J HIGHSTAT Patented D0HZ7J COMPCLAS N-alkyl-4-oxazolecar boxamide derivatives D0I0BN DRUG__ID D0I0BN D0I0BN DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D0I0BN DRUGTYPE Small molecular drug D0I0BN DRUGINCH 1S/C26H25N3O3/c30-24(27-18-20-10-4-1-5-11-20)28-16-17-29-23(19-28)26(32-25(29)31,21-12-6-2-7-13-21)22-14-8-3-9-15-22/h1-15,23H,16-19H2,(H,27,30) D0I0BN DRUGINKE WPBWKKIZKTUNIP-UHFFFAOYSA-N D0I0BN DRUGSMIL C1CN2C(CN1C(=O)NCC3=CC=CC=C3)C(OC2=O)(C4=CC=CC=C4)C5=CC=CC=C5 D0I0BN HIGHSTAT Patented D0I0BN COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D0I0JE DRUG__ID D0I0JE D0I0JE DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0I0JE DRUGTYPE Small molecule immunotherapy D0I0JE DRUGINCH 1S/C12H20N6O7/c1-4(20)8(11(22)23)16-12(24)15-6(2-7(14)21)10-18-17-9(25-10)5(13)3-19/h4-6,8,19-20H,2-3,13H2,1H3,(H2,14,21)(H,22,23)(H2,15,16,24)/t4?,5-,6-,8-/m0/s1 D0I0JE DRUGINKE HODUKYLKCHJNCA-WHFCDURNSA-N D0I0JE DRUGSMIL CC(C(C(=O)O)NC(=O)NC(CC(=O)N)C1=NN=C(O1)C(CO)N)O D0I0JE HIGHSTAT Patented D0I0JE COMPCLAS 1,3,4-thiadiazole derivatives D0I0VJ DRUG__ID D0I0VJ D0I0VJ DRUGCOMP SOLVAY PHARMACEUTICALS B.V. LANGE, Josephus H.M. KRUSE, Cornelis G. VAN VLIET, Bernard J D0I0VJ DRUGTYPE Small molecular drug D0I0VJ DRUGINCH 1S/C22H21Cl3N4O3S/c1-33(31,32)21-19(22(30)27-28-11-3-2-4-12-28)26-29(18-10-9-16(24)13-17(18)25)20(21)14-5-7-15(23)8-6-14/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D0I0VJ DRUGINKE WUMRQUSTSNHTOT-UHFFFAOYSA-N D0I0VJ DRUGSMIL CS(=O)(=O)C1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D0I0VJ HIGHSTAT Patented D0I0VJ COMPCLAS Pyrazole derivatives D0I1VK DRUG__ID D0I1VK D0I1VK DRUGCOMP MERCK & CO., INC. BAKER, Robert, K. HALE, Jeffrey, J. MIAO, Shouwu RUPPRECHT, Kathleen, M D0I1VK DRUGTYPE Small molecular drug D0I1VK DRUGINCH 1S/C30H26F2N6O/c1-30(2,32)26(23-10-19(15-34)11-25(31)13-23)24-16-38(17-24)27(20-8-6-18(14-33)7-9-20)21-4-3-5-22(12-21)28-36-37-29(35)39-28/h3-13,24,26-27H,16-17H2,1-2H3,(H2,35,37) D0I1VK DRUGINKE AKSVEYGFHNXCSL-UHFFFAOYSA-N D0I1VK DRUGSMIL CC(C)(C(C1CN(C1)C(C2=CC=C(C=C2)C#N)C3=CC=CC(=C3)C4=NN=C(O4)N)C5=CC(=CC(=C5)C#N)F)F D0I1VK HIGHSTAT Patented D0I1VK COMPCLAS Heterocyclic-substituted 3-alkyl azetidine derivatives D0I1XE DRUG__ID D0I1XE D0I1XE DRUGCOMP RESEARCH TRIANGLE INSTITUTE D0I1XE DRUGTYPE Small molecular drug D0I1XE DRUGINCH 1S/C30H32Cl2N6O/c31-21-10-12-23(13-11-21)38-28(24-8-4-5-9-25(24)32)36-27-29(33-19-34-30(27)38)37-16-14-22(15-17-37)35-26(39)18-20-6-2-1-3-7-20/h4-5,8-13,19-20,22H,1-3,6-7,14-18H2,(H,35,39) D0I1XE DRUGINKE ZGMMGSCAIDATIP-UHFFFAOYSA-N D0I1XE DRUGSMIL C1CCC(CC1)CC(=O)NC2CCN(CC2)C3=NC=NC4=C3N=C(N4C5=CC=C(C=C5)Cl)C6=CC=CC=C6Cl D0I1XE HIGHSTAT Patented D0I1XE COMPCLAS Diphenyl purine derivatives D0I2DV DRUG__ID D0I2DV D0I2DV DRUGCOMP THE GENERAL HOSPITAL CORPORATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA D0I2DV DRUGTYPE Small molecular drug D0I2DV DRUGINCH 1S/C23H15N5O2S/c29-28(30)19-13-14-20(21-18(19)12-7-15-24-21)31-23-26-25-22(16-8-3-1-4-9-16)27(23)17-10-5-2-6-11-17/h1-15H D0I2DV DRUGINKE RAPJMMAHETVTFD-UHFFFAOYSA-N D0I2DV DRUGSMIL C1=CC=C(C=C1)C2=NN=C(N2C3=CC=CC=C3)SC4=C5C(=C(C=C4)[N+](=O)[O-])C=CC=N5 D0I2DV HIGHSTAT Patented D0I2DV COMPCLAS 1-phenyl-1,3,4-triazole derivatives D0I2HK DRUG__ID D0I2HK D0I2HK DRUGCOMP UNIVERSITY OF SUNDERLAND D0I2HK DRUGTYPE Small molecular drug D0I2HK DRUGINCH 1S/C25H23N3O6S2/c1-17-5-10-20(11-6-17)35(30,31)27-22-14-9-19(26-25(29)24-4-3-15-34-24)16-23(22)28-36(32,33)21-12-7-18(2)8-13-21/h3-16,27-28H,1-2H3,(H,26,29) D0I2HK DRUGINKE CFHMKQXRBRHXQD-UHFFFAOYSA-N D0I2HK DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=C(C=C(C=C2)NC(=O)C3=CC=CO3)NS(=O)(=O)C4=CC=C(C=C4)C D0I2HK HIGHSTAT Patented D0I2HK COMPCLAS Bis-sulfonamide derivatives D0I5DM DRUG__ID D0I5DM D0I5DM DRUGCOMP GENZYME CORPORATION D0I5DM DRUGTYPE Small molecular drug D0I5DM DRUGINCH 1S/C23H20F3N5O2S/c1-22(2)20(32)31(16-6-8-17(9-7-16)34-23(24,25)26)21(33)30(22)14-15-10-12-28-19(13-15)29-18-5-3-4-11-27-18/h3-13H,14H2,1-2H3,(H,27,28,29) D0I5DM DRUGINKE CYMSBDAPHJQPRL-UHFFFAOYSA-N D0I5DM DRUGSMIL CC1(C(=O)N(C(=O)N1CC2=CC(=NC=C2)NC3=CC=CC=N3)C4=CC=C(C=C4)SC(F)(F)F)C D0I5DM HIGHSTAT Patented D0I5DM COMPCLAS N-arylmethyl-N-phenyl cyclic urea derivatives D0I6RC DRUG__ID D0I6RC D0I6RC DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D0I6RC DRUGTYPE Small molecule immunotherapy D0I6RC DRUGINCH 1S/C30H26BrClN2O3/c31-30-24(10-5-11-26(30)23-8-2-1-3-9-23)20-37-29-16-28(25(15-27(29)32)18-34-12-13-35)36-19-22-7-4-6-21(14-22)17-33/h1-11,14-16,34-35H,12-13,18-20H2 D0I6RC DRUGINKE WFKSDDBJJFYOET-UHFFFAOYSA-N D0I6RC DRUGSMIL C1=CC=C(C=C1)C2=CC=CC(=C2Br)COC3=C(C=C(C(=C3)OCC4=CC(=CC=C4)C#N)CNCCO)Cl D0I6RC HIGHSTAT Patented D0I6RC COMPCLAS Benzyl phenyl ether derivatives D0I7KU DRUG__ID D0I7KU D0I7KU DRUGCOMP Univ China Pharma D0I7KU DRUGTYPE Small molecular drug D0I7KU DRUGINCH 1S/C31H33N5O/c37-31(28-19-24-21-11-3-6-14-25(21)36-29(24)20-34-28)33-18-10-2-1-9-17-32-30-22-12-4-7-15-26(22)35-27-16-8-5-13-23(27)30/h3-4,6-7,11-12,14-15,19-20,36H,1-2,5,8-10,13,16-18H2,(H,32,35)(H,33,37) D0I7KU DRUGINKE OLKLOVAJULLISR-UHFFFAOYSA-N D0I7KU DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCNC(=O)C4=NC=C5C(=C4)C6=CC=CC=C6N5 D0I7KU HIGHSTAT Patented D0I7KU COMPCLAS Tacrine-indole hybrid derivatives D0I8AY DRUG__ID D0I8AY D0I8AY DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0I8AY DRUGTYPE Small molecular drug D0I8AY DRUGINCH 1S/C24H26F3N5O3/c1-14-22(32(30-23(14)33)16-6-4-3-5-7-16)29-24(34)28-20-13-31(8-9-35-2)12-17(20)15-10-18(25)21(27)19(26)11-15/h3-7,10-11,17,20H,8-9,12-13H2,1-2H3,(H,30,33)(H2,28,29,34)/t17-,20+/m0/s1 D0I8AY DRUGINKE YWWGXKZIBWIKLW-FXAWDEMLSA-N D0I8AY DRUGSMIL CC1=C(N(NC1=O)C2=CC=CC=C2)NC(=O)NC3CN(CC3C4=CC(=C(C(=C4)F)F)F)CCOC D0I8AY HIGHSTAT Patented D0I8AY COMPCLAS Pyrrolidinyl urea derivatives D0IA7Z DRUG__ID D0IA7Z D0IA7Z DRUGCOMP JANSSEN PHARMACEUTICA NV KEITH, John, M. LIU, Jing D0IA7Z DRUGTYPE Small molecular drug D0IA7Z DRUGINCH 1S/C18H17ClF2N4O3/c19-13-3-4-22-10-14(13)23-17(26)25-7-5-24(6-8-25)11-12-1-2-15-16(9-12)28-18(20,21)27-15/h1-4,9-10H,5-8,11H2,(H,23,26) D0IA7Z DRUGINKE YWGYNGCRVZLMCS-UHFFFAOYSA-N D0IA7Z DRUGSMIL C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl D0IA7Z HIGHSTAT Patented D0IA7Z COMPCLAS Carbamide derivatives D0IC8O DRUG__ID D0IC8O D0IC8O DRUGCOMP The Ohio State University Research Foundation D0IC8O DRUGTYPE Small molecular drug D0IC8O DRUGINCH 1S/C28H32O6/c1-31-22-12-8-20(18-24(22)33-3)10-14-26(29)28(16-6-5-7-17-28)27(30)15-11-21-9-13-23(32-2)25(19-21)34-4/h8-15,18-19H,5-7,16-17H2,1-4H3/b14-10+,15-11+ D0IC8O DRUGINKE NQDROBVIYYEMDQ-WFYKWJGLSA-N D0IC8O DRUGSMIL COC1=C(C=C(C=C1)C=CC(=O)C2(CCCCC2)C(=O)C=CC3=CC(=C(C=C3)OC)OC)OC D0IC8O HIGHSTAT Patented D0IC8O COMPCLAS Curcumin analogs D0IE8M DRUG__ID D0IE8M D0IE8M DRUGCOMP CURADEV PHARMA PVT. LTD D0IE8M DRUGTYPE Small molecular drug D0IE8M DRUGINCH 1S/C17H13F3N2O3/c18-17(19,20)13-8-4-7-12(9-13)15-21(10-14(23)22(15)25)16(24)11-5-2-1-3-6-11/h1-9,15,25H,10H2 D0IE8M DRUGINKE KDNAARNFNBRRTM-UHFFFAOYSA-N D0IE8M DRUGSMIL C1C(=O)N(C(N1C(=O)C2=CC=CC=C2)C3=CC(=CC=C3)C(F)(F)F)O D0IE8M HIGHSTAT Patented D0IE8M COMPCLAS Cyclic hydroxamate derivatives D0IF0T DRUG__ID D0IF0T D0IF0T DRUGCOMP Myrexis D0IF0T DRUGTYPE Small molecular drug D0IF0T DRUGINCH 1S/C26H27N5O3/c27-18-20-17-19(1-6-25(20)34-23-8-13-32-14-9-23)24-7-10-28-26(30-24)29-21-2-4-22(5-3-21)31-11-15-33-16-12-31/h1-7,10,17,23H,8-9,11-16H2,(H,28,29,30) D0IF0T DRUGINKE BWABTWGSXHTHCG-UHFFFAOYSA-N D0IF0T DRUGSMIL C1COCCC1OC2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCOCC5)C#N D0IF0T HIGHSTAT Patented D0IF0T COMPCLAS Aminopyrimidine derivatives D0IT9C DRUG__ID D0IT9C D0IT9C DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj KREUTTER, Kevin POWELL, Mark SHOOK, Brian SONG, Fengbin XU, Guozhang YANG, Shyh-ming ZHANG, Rui ZHAO, Bao-pin D0IT9C DRUGTYPE Small molecular drug D0IT9C DRUGINCH 1S/C31H24ClF6N3O3/c1-17-12-20(30(33,34)35)5-7-23(17)24-8-6-22(14-26(24)32)40-15-18-2-4-21(31(36,37)38)13-25(18)19-3-9-27(41-16-19)29(44)39-11-10-28(42)43/h2-9,12-14,16,40H,10-11,15H2,1H3,(H,39,44)(H,42,43) D0IT9C DRUGINKE GPKUFXAKPUJEDG-UHFFFAOYSA-N D0IT9C DRUGSMIL CC1=C(C=CC(=C1)C(F)(F)F)C2=C(C=C(C=C2)NCC3=C(C=C(C=C3)C(F)(F)F)C4=CN=C(C=C4)C(=O)NCCC(=O)O)Cl D0IT9C HIGHSTAT Patented D0IT9C COMPCLAS Picolinamido propanoic acid derivatives D0IX2C DRUG__ID D0IX2C D0IX2C DRUGCOMP Impact Therapeutics Inc D0IX2C DRUGTYPE Small molecular drug D0IX2C DRUGINCH 1S/C24H21FN6O3/c25-18-6-2-7-19-20(18)21(32)28-24(34)31(19)15-16-4-1-5-17(14-16)22(33)29-10-12-30(13-11-29)23-26-8-3-9-27-23/h1-9,14H,10-13,15H2,(H,28,32,34) D0IX2C DRUGINKE QUTRGYJIPOIOGH-UHFFFAOYSA-N D0IX2C DRUGSMIL C1CN(CCN1C2=NC=CC=N2)C(=O)C3=CC=CC(=C3)CN4C5=C(C(=CC=C5)F)C(=O)NC4=O D0IX2C HIGHSTAT Patented D0IX2C COMPCLAS Quinazolinedione derivatives D0IX7O DRUG__ID D0IX7O D0IX7O DRUGCOMP PHARMASCIENCE INC D0IX7O DRUGTYPE Small molecular drug D0IX7O DRUGINCH 1S/C27H25FN6O2/c1-16(2)34-13-21(24-26(29)32-15-33-27(24)34)19-7-9-20(10-8-19)36-23-6-4-5-22(25(23)28)35-14-18-11-30-17(3)31-12-18/h4-13,15-16H,14H2,1-3H3,(H2,29,32,33) D0IX7O DRUGINKE HVHZPWHNJSXHGP-UHFFFAOYSA-N D0IX7O DRUGSMIL CC1=NC=C(C=N1)COC2=C(C(=CC=C2)OC3=CC=C(C=C3)C4=CN(C5=NC=NC(=C45)N)C(C)C)F D0IX7O HIGHSTAT Patented D0IX7O COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0J1KT DRUG__ID D0J1KT D0J1KT DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. TICHENOR, Mark, S. MERIT, Jeffrey, E. HAWRYLUK, Natalie, A. CHAMBERS, Alison, L. KEITH, John, M D0J1KT DRUGTYPE Small molecular drug D0J1KT DRUGINCH 1S/C24H22ClN5O3/c25-18-6-8-19(9-7-18)33-21-4-1-3-20(13-21)32-12-10-17-15-29(16-17)24(31)28-23-14-26-22-5-2-11-27-30(22)23/h1-9,11,13-14,17H,10,12,15-16H2,(H,28,31) D0J1KT DRUGINKE DUGFOZRFNIVGIA-UHFFFAOYSA-N D0J1KT DRUGSMIL C1C(CN1C(=O)NC2=CN=C3N2N=CC=C3)CCOC4=CC(=CC=C4)OC5=CC=C(C=C5)Cl D0J1KT HIGHSTAT Patented D0J1KT COMPCLAS Azetidine urea derivatives D0J2SR DRUG__ID D0J2SR D0J2SR DRUGCOMP Impact Therapeutics Inc D0J2SR DRUGTYPE Small molecular drug D0J2SR DRUGINCH 1S/C24H21FN6O3/c25-19-7-6-16(15-31-20-5-2-1-4-17(20)21(32)28-24(31)34)14-18(19)22(33)29-10-12-30(13-11-29)23-26-8-3-9-27-23/h1-9,14H,10-13,15H2,(H,28,32,34) D0J2SR DRUGINKE LYSWZKKQEGTMEA-UHFFFAOYSA-N D0J2SR DRUGSMIL C1CN(CCN1C2=NC=CC=N2)C(=O)C3=C(C=CC(=C3)CN4C5=CC=CC=C5C(=O)NC4=O)F D0J2SR HIGHSTAT Patented D0J2SR COMPCLAS Quinazolinedione derivatives D0J3NY DRUG__ID D0J3NY D0J3NY DRUGCOMP INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY KWON, Ho Jeong HAN, Gyoon Hee D0J3NY DRUGTYPE Small molecular drug D0J3NY DRUGINCH 1S/C18H15NO3S/c20-17-10-8-16(9-11-17)19-23(21,22)18-12-6-15(7-13-18)14-4-2-1-3-5-14/h1-13,19-20H D0J3NY DRUGINKE SZOPCHOOHZIDKC-UHFFFAOYSA-N D0J3NY DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)NC3=CC=C(C=C3)O D0J3NY HIGHSTAT Patented D0J3NY COMPCLAS Benzene sulfonamide derivatives D0J3TN DRUG__ID D0J3TN D0J3TN DRUGCOMP MERCK SHARP &amDOHME CORP. GRAHAM, Thomas, H. SHEN, Dong-Ming SHU, Min D0J3TN DRUGTYPE Small molecular drug D0J3TN DRUGINCH 1S/C28H29FN4/c1-32-27(21-25(31-32)23-10-12-24(29)13-11-23)28(26-9-5-6-17-30-26)15-19-33(20-16-28)18-14-22-7-3-2-4-8-22/h2-13,17,21H,14-16,18-20H2,1H3 D0J3TN DRUGINKE KJFTYICXBUEONK-UHFFFAOYSA-N D0J3TN DRUGSMIL CN1C(=CC(=N1)C2=CC=C(C=C2)F)C3(CCN(CC3)CCC4=CC=CC=C4)C5=CC=CC=N5 D0J3TN HIGHSTAT Patented D0J3TN COMPCLAS Piperidinyl pyrazole derivatives D0J3ZM DRUG__ID D0J3ZM D0J3ZM DRUGCOMP Teizin Pharma Ltd D0J3ZM DRUGTYPE Small molecular drug D0J3ZM DRUGINCH 1S/C16H17N5O3S/c1-9(2)7-24-13-5-4-11(6-12(13)21-8-17-19-20-21)15-18-10(3)14(25-15)16(22)23/h4-6,8-9H,7H2,1-3H3,(H,22,23) D0J3ZM DRUGINKE DKEWYKIZSPDHOY-UHFFFAOYSA-N D0J3ZM DRUGSMIL CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)N3C=NN=N3)C(=O)O D0J3ZM HIGHSTAT Patented D0J3ZM COMPCLAS Azole benzene derivatives D0J4GP DRUG__ID D0J4GP D0J4GP DRUGCOMP Myrexis D0J4GP DRUGTYPE Small molecular drug D0J4GP DRUGINCH 1S/C25H25N5O3/c1-17(31)28-16-18-2-5-21(6-3-18)29-25-27-11-8-23(30-25)19-4-7-24(20(14-19)15-26)33-22-9-12-32-13-10-22/h2-8,11,14,22H,9-10,12-13,16H2,1H3,(H,28,31)(H,27,29,30) D0J4GP DRUGINKE AZLRFMPKDVYEQH-UHFFFAOYSA-N D0J4GP DRUGSMIL CC(=O)NCC1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)OC4CCOCC4)C#N D0J4GP HIGHSTAT Patented D0J4GP COMPCLAS Aminopyrimidine derivatives D0J4QE DRUG__ID D0J4QE D0J4QE DRUGCOMP NOVARTIS AG BEHNKE, Dirk CARCACHE, David ERTL, Peter KOLLER, Manuel ORAIN, David D0J4QE DRUGTYPE Small molecular drug D0J4QE DRUGINCH 1S/C20H21N5O/c1-13-22-12-25(23-13)19-10-18-17-7-3-6-15(14-4-2-5-14)16(17)8-9-24(18)20(26)11-21-19/h3,6-7,10,12,14H,2,4-5,8-9,11H2,1H3 D0J4QE DRUGINKE DDWMQMPXDUENHH-UHFFFAOYSA-N D0J4QE DRUGSMIL CC1=NN(C=N1)C2=NCC(=O)N3CCC4=C(C=CC=C4C3=C2)C5CCC5 D0J4QE HIGHSTAT Patented D0J4QE COMPCLAS Diazepinone derivatives D0J4YW DRUG__ID D0J4YW D0J4YW DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0J4YW DRUGTYPE Small molecular drug D0J4YW DRUGINCH 1S/C21H19ClN6OS/c22-13-8-9-19-17(12-13)27-21(30-19)26-16-6-3-5-15(16)25-20(29)14-4-1-2-7-18(14)28-23-10-11-24-28/h1-2,4,7-12,15-16H,3,5-6H2,(H,25,29)(H,26,27)/t15-,16-/m0/s1 D0J4YW DRUGINKE XRCGVDTUCHXOPF-HOTGVXAUSA-N D0J4YW DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=C(S4)C=CC(=C5)Cl D0J4YW HIGHSTAT Patented D0J4YW COMPCLAS 1,2-diamino cyclopentane-based derivatives D0J5GS DRUG__ID D0J5GS D0J5GS DRUGCOMP Kissei Pharmaceutical Co. Ltd D0J5GS DRUGTYPE Small molecular drug D0J5GS DRUGINCH 1S/C16H11N3O3/c1-9-2-5-14-13(7-11(8-17)19(14)18-9)10-3-4-12(16(21)22)15(20)6-10/h2-7,20H,1H3,(H,21,22) D0J5GS DRUGINKE OVRDXWKIIUUQMR-UHFFFAOYSA-N D0J5GS DRUGSMIL CC1=NN2C(=C(C=C2C#N)C3=CC(=C(C=C3)C(=O)O)O)C=C1 D0J5GS HIGHSTAT Patented D0J5GS COMPCLAS Azaindole derivatives D0J5OO DRUG__ID D0J5OO D0J5OO DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0J5OO DRUGTYPE Small molecular drug D0J5OO DRUGINCH 1S/C26H28F3N5O2/c27-26(28,29)36-15-14-33-16-21(18-8-3-1-4-9-18)23(17-33)30-25(35)31-24-20-12-7-13-22(20)32-34(24)19-10-5-2-6-11-19/h1-6,8-11,21,23H,7,12-17H2,(H2,30,31,35)/t21-,23+/m0/s1 D0J5OO DRUGINKE AMRJQXCVKABTNA-JTHBVZDNSA-N D0J5OO DRUGSMIL C1CC2=C(N(N=C2C1)C3=CC=CC=C3)NC(=O)NC4CN(CC4C5=CC=CC=C5)CCOC(F)(F)F D0J5OO HIGHSTAT Patented D0J5OO COMPCLAS Pyrrolidinyl urea derivatives D0J8UO DRUG__ID D0J8UO D0J8UO DRUGCOMP UNIVERSITY OF UTAH RESEARCH FOUNDATION D0J8UO DRUGTYPE Small molecular drug D0J8UO DRUGINCH 1S/C25H23ClN6O2/c1-2-21(33)28-17-6-3-5-16(13-17)23-22-20(26)15-27-24(22)31-25(30-23)29-18-7-4-8-19(14-18)32-9-11-34-12-10-32/h2-8,13-15H,1,9-12H2,(H,28,33)(H2,27,29,30,31) D0J8UO DRUGINKE OQGHSORLLAGPRT-UHFFFAOYSA-N D0J8UO DRUGSMIL C=CC(=O)NC1=CC=CC(=C1)C2=C3C(=CNC3=NC(=N2)NC4=CC(=CC=C4)N5CCOCC5)Cl D0J8UO HIGHSTAT Patented D0J8UO COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0JJ0T DRUG__ID D0JJ0T D0JJ0T DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0JJ0T DRUGTYPE Small molecular drug D0JJ0T DRUGINCH 1S/C28H33N5O4/c1-36-18-25(27(34)37-2)32-16-22(19-10-5-3-6-11-19)24(17-32)29-28(35)30-26-21-14-9-15-23(21)31-33(26)20-12-7-4-8-13-20/h3-8,10-13,22,24-25H,9,14-18H2,1-2H3,(H2,29,30,35)/t22-,24+,25?/m0/s1 D0JJ0T DRUGINKE JOOGNXILJRJIEZ-LNJIZIIWSA-N D0JJ0T DRUGSMIL COCC(C(=O)OC)N1CC(C(C1)NC(=O)NC2=C3CCCC3=NN2C4=CC=CC=C4)C5=CC=CC=C5 D0JJ0T HIGHSTAT Patented D0JJ0T COMPCLAS Pyrrolidinyl urea derivatives D0JO6Z DRUG__ID D0JO6Z D0JO6Z DRUGCOMP Kalvista Pharmaceuticals Limited D0JO6Z DRUGTYPE Small molecular drug D0JO6Z DRUGINCH 1S/C26H26F4N6O/c1-16-10-33-35(12-16)13-18-3-5-19(6-4-18)14-36-15-22(24(34-36)26(28,29)30)25(37)32-11-21-8-7-20(9-31)23(27)17(21)2/h3-8,10,12,15H,9,11,13-14,31H2,1-2H3,(H,32,37) D0JO6Z DRUGINKE PKZHZUNPMZRBCV-UHFFFAOYSA-N D0JO6Z DRUGSMIL CC1=CN(N=C1)CC2=CC=C(C=C2)CN3C=C(C(=N3)C(F)(F)F)C(=O)NCC4=C(C(=C(C=C4)CN)F)C D0JO6Z HIGHSTAT Patented D0JO6Z COMPCLAS Benzyl amine derivatives D0JQ9Z DRUG__ID D0JQ9Z D0JQ9Z DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher Joseph ROSE, Nathan SEKIRNIK, Rok D0JQ9Z DRUGTYPE Small molecular drug D0JQ9Z DRUGINCH 1S/C10H16N2S4/c13-9(11-5-1-2-6-11)15-16-10(14)12-7-3-4-8-12/h1-8H2 D0JQ9Z DRUGINKE KCGUGVQODCQMBI-UHFFFAOYSA-N D0JQ9Z DRUGSMIL C1CCN(C1)C(=S)SSC(=S)N2CCCC2 D0JQ9Z HIGHSTAT Patented D0JQ9Z COMPCLAS Disulfiram analogs D0K1GJ DRUG__ID D0K1GJ D0K1GJ DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0K1GJ DRUGTYPE Small molecular drug D0K1GJ DRUGINCH 1S/C26H26ClN5/c27-23-9-7-21(8-10-23)24-19-25(32(30-24)26-28-14-4-15-29-26)22-12-17-31(18-13-22)16-11-20-5-2-1-3-6-20/h1-10,14-15,19,22H,11-13,16-18H2 D0K1GJ DRUGINKE SVHYVLJAAMPZJM-UHFFFAOYSA-N D0K1GJ DRUGSMIL C1CN(CCC1C2=CC(=NN2C3=NC=CC=N3)C4=CC=C(C=C4)Cl)CCC5=CC=CC=C5 D0K1GJ HIGHSTAT Patented D0K1GJ COMPCLAS Piperidinyl triazole derivatives D0K1ZY DRUG__ID D0K1ZY D0K1ZY DRUGCOMP RESEARCH TRIANGLE INSTITUTE D0K1ZY DRUGTYPE Small molecular drug D0K1ZY DRUGINCH 1S/C30H38N4O3/c1-22(2)19-30(24-10-5-4-6-11-24)26-21-34(14-13-25(26)28(35)37-30)29(36)31-20-23-9-7-8-12-27(23)33-17-15-32(3)16-18-33/h4-12,22H,13-21H2,1-3H3,(H,31,36) D0K1ZY DRUGINKE VAJNMLPRDFYTCT-UHFFFAOYSA-N D0K1ZY DRUGSMIL CC(C)CC1(C2=C(CCN(C2)C(=O)NCC3=CC=CC=C3N4CCN(CC4)C)C(=O)O1)C5=CC=CC=C5 D0K1ZY HIGHSTAT Patented D0K1ZY COMPCLAS 4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivatives D0K2GH DRUG__ID D0K2GH D0K2GH DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0K2GH DRUGTYPE Small molecular drug D0K2GH DRUGINCH 1S/C27H33F2N5O4/c1-33-26(15-24(32-33)18-4-7-20(8-5-18)38-13-12-37-3)31-27(35)30-25-17-34(10-11-36-2)16-21(25)19-6-9-22(28)23(29)14-19/h4-9,14-15,21,25H,10-13,16-17H2,1-3H3,(H2,30,31,35)/t21-,25+/m0/s1 D0K2GH DRUGINKE JNRIBRHEHFYMHN-SQJMNOBHSA-N D0K2GH DRUGSMIL CN1C(=CC(=N1)C2=CC=C(C=C2)OCCOC)NC(=O)NC3CN(CC3C4=CC(=C(C=C4)F)F)CCOC D0K2GH HIGHSTAT Patented D0K2GH COMPCLAS Pyrrolidinyl urea derivatives D0K2ZQ DRUG__ID D0K2ZQ D0K2ZQ DRUGCOMP MERCK SHARP & DOHME CORP. BURNETT, Duane, A. ZHAO, Zhiqiang COLE, David JOSIEN, Hubert PISSARNITSKI, Dmitri, A. SASIKUMAR, Thavalakulamgar WU, Wen-Lian DOMALSKI, Martin D0K2ZQ DRUGTYPE Small molecular drug D0K2ZQ DRUGINCH 1S/C26H29N9O/c1-3-4-13-33-22-23(31-26(33)32-12-7-8-18(27)15-32)34-14-11-28-25(34)35(24(22)36)16-21-29-17(2)19-9-5-6-10-20(19)30-21/h5-6,9-10,18H,7-8,11-16,27H2,1-2H3/t18-/m1/s1 D0K2ZQ DRUGINKE WDWDEKNARRTAAI-GOSISDBHSA-N D0K2ZQ DRUGSMIL CC#CCN1C2=C(N=C1N3CCCC(C3)N)N4CCN=C4N(C2=O)CC5=NC6=CC=CC=C6C(=N5)C D0K2ZQ HIGHSTAT Patented D0K2ZQ COMPCLAS Xanthine/amino piperidine compounds D0K3QT DRUG__ID D0K3QT D0K3QT DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0K3QT DRUGTYPE Small molecular drug D0K3QT DRUGINCH 1S/C28H29ClF3N7O2/c1-16-26(18-12-33-37(2)13-18)36-39(24-6-4-5-20(29)25(24)32)27(16)35-28(40)34-23-15-38(9-10-41-3)14-19(23)17-7-8-21(30)22(31)11-17/h4-8,11-13,19,23H,9-10,14-15H2,1-3H3,(H2,34,35,40)/t19-,23+/m0/s1 D0K3QT DRUGINKE RFVRMWNCZARMFM-WMZHIEFXSA-N D0K3QT DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=C(C(=CC=C3)Cl)F)NC(=O)NC4CN(CC4C5=CC(=C(C=C5)F)F)CCOC D0K3QT HIGHSTAT Patented D0K3QT COMPCLAS Pyrrolidinyl urea derivatives D0KA3L DRUG__ID D0KA3L D0KA3L DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0KA3L DRUGTYPE Small molecular drug D0KA3L DRUGINCH 1S/C16H15N3O5S/c20-14(18-9-4-2-1-3-5-9)11(6-10-7-25-8-17-10)19-15(21)12-13(24-12)16(22)23/h1-5,7-8,11-13H,6H2,(H,18,20)(H,19,21)(H,22,23)/t11-,12-,13-/m0/s1 D0KA3L DRUGINKE SLAUAVANSQIASN-AVGNSLFASA-N D0KA3L DRUGSMIL C1=CC=C(C=C1)NC(=O)C(CC2=CSC=N2)NC(=O)C3C(O3)C(=O)O D0KA3L HIGHSTAT Patented D0KA3L COMPCLAS Epoxysuccinate derivatives D0KD5X DRUG__ID D0KD5X D0KD5X DRUGCOMP GREEN CROSS CORPORATION LEE, Sung-Han SEO, Hee Jeong LEE, Jinhwa KIM, Min-ah KIM, Jeong Min KANG, Suk Youn AHN, Kwang-Woo LEE, Suk Ho D0KD5X DRUGTYPE Small molecular drug D0KD5X DRUGINCH 1S/C27H21Cl3N6O2/c1-27(2,3)26-34-33-25(38-26)22-21(24(37)32-20-6-4-5-13-31-20)23(15-7-9-16(28)10-8-15)36(35-22)19-12-11-17(29)14-18(19)30/h4-14H,1-3H3,(H,31,32,37) D0KD5X DRUGINKE UGTKDMCWCRRUHZ-UHFFFAOYSA-N D0KD5X DRUGSMIL CC(C)(C)C1=NN=C(O1)C2=NN(C(=C2C(=O)NC3=CC=CC=N3)C4=CC=C(C=C4)Cl)C5=C(C=C(C=C5)Cl)Cl D0KD5X HIGHSTAT Patented D0KD5X COMPCLAS Pyrazole derivatives D0KF8C DRUG__ID D0KF8C D0KF8C DRUGCOMP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI D0KF8C DRUGTYPE Small molecular drug D0KF8C DRUGINCH 1S/C19H19ClN2O3S/c1-13-17(9-10-19(13)23)21-18-11-15(7-8-16(18)20)22-26(24,25)12-14-5-3-2-4-6-14/h2-8,11,21-22H,9-10,12H2,1H3 D0KF8C DRUGINKE NCJRKRWVOHVDGS-UHFFFAOYSA-N D0KF8C DRUGSMIL CC1=C(CCC1=O)NC2=C(C=CC(=C2)NS(=O)(=O)CC3=CC=CC=C3)Cl D0KF8C HIGHSTAT Patented D0KF8C COMPCLAS Aminocyclopentenone compounds D0KG1T DRUG__ID D0KG1T D0KG1T DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN D0KG1T DRUGTYPE Small molecular drug D0KG1T DRUGINCH 1S/C26H29N7O2/c1-6-33-26(16-9-7-8-10-19(16)31-33)30-25-23-17-12-21(34-5)18(22-13(2)32-35-14(22)3)11-20(17)29-24(23)27-15(4)28-25/h11-12H,6-10H2,1-5H3,(H2,27,28,29,30) D0KG1T DRUGINKE PKOGGTPBCXRZNX-UHFFFAOYSA-N D0KG1T DRUGSMIL CCN1C(=C2CCCCC2=N1)NC3=NC(=NC4=C3C5=CC(=C(C=C5N4)C6=C(ON=C6C)C)OC)C D0KG1T HIGHSTAT Patented D0KG1T COMPCLAS Pyrimido-indole derivatives D0KT1Q DRUG__ID D0KT1Q D0KT1Q DRUGCOMP 7TM PHARMA A/S COOPER, Martin RECEVEUR, Jean-Marie HOEGBERG, Thomas NIELSEN, Peter, Aadal LINGET, Jean-Michel NOEREGAARD, Pia, Karina D0KT1Q DRUGTYPE Small molecular drug D0KT1Q DRUGINCH 1S/C22H15Cl2N5O3/c23-14-7-5-13(6-8-14)20-16(11-18(30)31)19(22(32)27-15-3-1-9-25-12-15)28-29(20)21-17(24)4-2-10-26-21/h1-10,12H,11H2,(H,27,32)(H,30,31) D0KT1Q DRUGINKE RHWMIURMWNGDKU-UHFFFAOYSA-N D0KT1Q DRUGSMIL C1=CC(=CN=C1)NC(=O)C2=NN(C(=C2CC(=O)O)C3=CC=C(C=C3)Cl)C4=C(C=CC=N4)Cl D0KT1Q HIGHSTAT Patented D0KT1Q COMPCLAS Pyrazole derivatives D0KX8N DRUG__ID D0KX8N D0KX8N DRUGCOMP SCHERING CORPORATION SCOTT, Jack, D. STAMFORD, Andre D0KX8N DRUGTYPE Small molecular drug D0KX8N DRUGINCH 1S/C22H22Cl3NO4/c1-22(2,3)30-20(27)11-19-21(28)26(15-7-4-13(23)5-8-15)18(12-29-19)16-9-6-14(24)10-17(16)25/h4-10,18-19H,11-12H2,1-3H3 D0KX8N DRUGINKE XAGXRDZNWDXEAM-UHFFFAOYSA-N D0KX8N DRUGSMIL CC(C)(C)OC(=O)CC1C(=O)N(C(CO1)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)Cl D0KX8N HIGHSTAT Patented D0KX8N COMPCLAS Diaryl morpholine derivatives D0L0CD DRUG__ID D0L0CD D0L0CD DRUGCOMP Wisconsin Alumni Research Foundation D0L0CD DRUGTYPE Small molecular drug D0L0CD DRUGINCH 1S/C21H36N2O2/c1-2-3-4-5-6-7-8-9-10-11-18-22-19-12-13-20-14-16-21(17-15-20)23(24)25/h14-17,22H,2-13,18-19H2,1H3 D0L0CD DRUGINKE HPQAMSDOLBKJBM-UHFFFAOYSA-N D0L0CD DRUGSMIL CCCCCCCCCCCCNCCCC1=CC=C(C=C1)[N+](=O)[O-] D0L0CD HIGHSTAT Patented D0L0CD COMPCLAS Phenylpropylamine derivatives D0L0YA DRUG__ID D0L0YA D0L0YA DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0L0YA DRUGTYPE Small molecular drug D0L0YA DRUGINCH 1S/C23H22FN5O2S/c1-13-25-21(31-28-13)15-6-3-4-7-16(15)22(30)29(2)19-9-5-8-17(19)26-23-27-18-11-10-14(24)12-20(18)32-23/h3-4,6-7,10-12,17,19H,5,8-9H2,1-2H3,(H,26,27)/t17-,19-/m0/s1 D0L0YA DRUGINKE ZZOMOANEXSPUDO-HKUYNNGSSA-N D0L0YA DRUGSMIL CC1=NOC(=N1)C2=CC=CC=C2C(=O)N(C)C3CCCC3NC4=NC5=C(S4)C=C(C=C5)F D0L0YA HIGHSTAT Patented D0L0YA COMPCLAS 1,2-diamino cyclopentane-based derivatives D0L2MA DRUG__ID D0L2MA D0L2MA DRUGCOMP AMOREPACIFIC CORPORATION ( ) SHIN, Song Seok HONG, Yong Deog BYOUN, Kyoung Hee PARK, Mi Young CHOI, Jin Ky D0L2MA DRUGTYPE Small molecular drug D0L2MA DRUGINCH 1S/C25H24ClFN4O2/c1-33-15-21-24(16-7-9-18(26)10-8-16)25-28-23(30-11-3-6-20(30)14-32)13-22(31(25)29-21)17-4-2-5-19(27)12-17/h2,4-5,7-10,12-13,20,32H,3,6,11,14-15H2,1H3/t20-/m0/s1 D0L2MA DRUGINKE USQDDAWNOFWURT-FQEVSTJZSA-N D0L2MA DRUGSMIL COCC1=NN2C(=CC(=NC2=C1C3=CC=C(C=C3)Cl)N4CCCC4CO)C5=CC(=CC=C5)F D0L2MA HIGHSTAT Patented D0L2MA COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0L2NG DRUG__ID D0L2NG D0L2NG DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D0L2NG DRUGTYPE Small molecular drug D0L2NG DRUGINCH 1S/C14H10O2S/c15-11-5-7-14(16,8-6-11)13-9-10-3-1-2-4-12(10)17-13/h1-9,16H D0L2NG DRUGINKE TXEIZQHZDIXJLD-UHFFFAOYSA-N D0L2NG DRUGSMIL C1=CC=C2C(=C1)C=C(S2)C3(C=CC(=O)C=C3)O D0L2NG HIGHSTAT Patented D0L2NG COMPCLAS 4-aryl quinol derivatives D0L6XG DRUG__ID D0L6XG D0L6XG DRUGCOMP PFIZER INC D0L6XG DRUGTYPE Small molecular drug D0L6XG DRUGINCH 1S/C18H23F3N2O6S/c19-18(20,21)15(11-24)29-16(25)23-8-6-17(7-9-23)10-13(12-28-17)22-30(26,27)14-4-2-1-3-5-14/h1-5,13,15,22,24H,6-12H2/t13-,15-/m1/s1 D0L6XG DRUGINKE KBPUJKKMMQDFKB-UKRRQHHQSA-N D0L6XG DRUGSMIL C1CN(CCC12CC(CO2)NS(=O)(=O)C3=CC=CC=C3)C(=O)OC(CO)C(F)(F)F D0L6XG HIGHSTAT Patented D0L6XG COMPCLAS Carbamate derivatives D0L7MP DRUG__ID D0L7MP D0L7MP DRUGCOMP NUMERATE, INC. THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY GRIFFIN, John RAIMUNDO, Brian MADRID, Peter KHOSLA, Chaitan JIN, Xi KLOECK, Cornelius D0L7MP DRUGTYPE Small molecular drug D0L7MP DRUGINCH 1S/C17H12ClNO3/c1-22-15-8-3-2-5-10(15)14(20)9-11-16-12(18)6-4-7-13(16)19-17(11)21/h2-9H,1H3,(H,19,21)/b11-9+ D0L7MP DRUGINKE ULAXMAMZNHGQMV-PKNBQFBNSA-N D0L7MP DRUGSMIL COC1=CC=CC=C1C(=O)C=C2C3=C(C=CC=C3Cl)NC2=O D0L7MP HIGHSTAT Patented D0L7MP COMPCLAS 3-acylidene-2-oxoindole derivatives D0L8VH DRUG__ID D0L8VH D0L8VH DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D0L8VH DRUGTYPE Small molecular drug D0L8VH DRUGINCH 1S/C30H34Cl2F2N4O/c1-18-13-28(38(35-18)21-6-8-25(31)26(32)15-21)19-9-11-37(12-10-19)29(39)24-17-30(2,36(3)4)16-23(24)22-7-5-20(33)14-27(22)34/h5-8,13-15,19,23-24H,9-12,16-17H2,1-4H3/t23-,24+,30-/m0/s1 D0L8VH DRUGINKE XMOICBGWKUUJPT-BBANNHEPSA-N D0L8VH DRUGSMIL CC1=NN(C(=C1)C2CCN(CC2)C(=O)C3CC(CC3C4=C(C=C(C=C4)F)F)(C)N(C)C)C5=CC(=C(C=C5)Cl)Cl D0L8VH HIGHSTAT Patented D0L8VH COMPCLAS Cyclopentane carboxamide derivatives D0LB7Z DRUG__ID D0LB7Z D0LB7Z DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0LB7Z DRUGTYPE Small molecular drug D0LB7Z DRUGINCH 1S/C28H30F3N7O2/c1-17-26(19-13-32-36(2)14-19)35-38(21-7-5-20(29)6-8-21)27(17)34-28(39)33-25-16-37(10-11-40-3)15-22(25)18-4-9-23(30)24(31)12-18/h4-9,12-14,22,25H,10-11,15-16H2,1-3H3,(H2,33,34,39)/t22-,25+/m0/s1 D0LB7Z DRUGINKE XWJMJPIDPZSDIR-WIOPSUGQSA-N D0LB7Z DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC=C(C=C3)F)NC(=O)NC4CN(CC4C5=CC(=C(C=C5)F)F)CCOC D0LB7Z HIGHSTAT Patented D0LB7Z COMPCLAS Pyrrolidinyl urea derivatives D0LI2E DRUG__ID D0LI2E D0LI2E DRUGCOMP EISAI R&D MANAGEMENT CO., LTD D0LI2E DRUGTYPE Small molecular drug D0LI2E DRUGINCH 1S/C24H26F3N3O2/c1-5-31-21-12-17(6-7-19(21)24(25,26)27)23-29-22(18-10-14(2)28-15(3)11-18)20-8-9-32-16(4)13-30(20)23/h6-7,10-12,16H,5,8-9,13H2,1-4H3/t16-/m1/s1 D0LI2E DRUGINKE NVGWTIMTJOAYSJ-MRXNPFEDSA-N D0LI2E DRUGSMIL CCOC1=C(C=CC(=C1)C2=NC(=C3N2CC(OCC3)C)C4=CC(=NC(=C4)C)C)C(F)(F)F D0LI2E HIGHSTAT Patented D0LI2E COMPCLAS Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivatives D0LK6V DRUG__ID D0LK6V D0LK6V DRUGCOMP EMORY UNIVERSITY GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION VAN MEIR, Erwin WANG, Binghe D0LK6V DRUGTYPE Small molecular drug D0LK6V DRUGINCH 1S/C23H28N2O5S/c1-23(2)13-12-19-20(30-23)10-8-16(24-19)15-25(17-6-5-7-17)31(26,27)18-9-11-21(28-3)22(14-18)29-4/h8-14,17H,5-7,15H2,1-4H3 D0LK6V DRUGINKE CQGIUFASDNXPRB-UHFFFAOYSA-N D0LK6V DRUGSMIL CC1(C=CC2=C(O1)C=CC(=N2)CN(C3CCC3)S(=O)(=O)C4=CC(=C(C=C4)OC)OC)C D0LK6V HIGHSTAT Patented D0LK6V COMPCLAS 2,2-dimethylbenzopyran derivatives D0LM6D DRUG__ID D0LM6D D0LM6D DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0LM6D DRUGTYPE Small molecule immunotherapy D0LM6D DRUGINCH 1S/C19H26N4O6S/c1-27-12-11-20-17(24)10-9-15(23-30(25,26)13-7-8-13)19-22-21-18(29-19)14-5-3-4-6-16(14)28-2/h3-6,13,15,23H,7-12H2,1-2H3,(H,20,24)/t15-/m0/s1 D0LM6D DRUGINKE FYAJXXVCAGXKAN-HNNXBMFYSA-N D0LM6D DRUGSMIL COCCNC(=O)CCC(C1=NN=C(O1)C2=CC=CC=C2OC)NS(=O)(=O)C3CC3 D0LM6D HIGHSTAT Patented D0LM6D COMPCLAS 1,3,4-oxadiazole derivatives D0LR2Y DRUG__ID D0LR2Y D0LR2Y DRUGCOMP SCHERING CORPORATION TADIKONDA, Praveen, K. CAUBLE, David, F., Jr. GUZI, Timothy, J. SIDDIQUI, Arshad, MSCHERING CORPORATION LABROLI, Marc, A. POKER, Cory, Seth WONG, Tzu, T. REDDY, Panduranga, Adulla, P. GUZI, Timothy, J. SIDDIQUI, M. ArshaSCHERING CORPORATION SHIPPS, Gerald, W., Jr. RICHARDS, Matthew CHENG, Cliff, C. HUANG, Xiaohua D0LR2Y DRUGTYPE Small molecular drug D0LR2Y DRUGINCH 1S/C19H19N7O2S/c27-17(23-13-2-1-4-21-10-13)15-12-29-19(25-15)18(28)24-14-11-22-5-3-16(14)26-8-6-20-7-9-26/h1-5,10-12,20H,6-9H2,(H,23,27)(H,24,28) D0LR2Y DRUGINKE VFDWSNCXADMJQH-UHFFFAOYSA-N D0LR2Y DRUGSMIL C1CN(CCN1)C2=C(C=NC=C2)NC(=O)C3=NC(=CS3)C(=O)NC4=CN=CC=C4 D0LR2Y HIGHSTAT Patented D0LR2Y COMPCLAS Diamidothiazole derivatives D0LU9X DRUG__ID D0LU9X D0LU9X DRUGCOMP DAINIPPON SUMITOMO PHARMA CO., LTD D0LU9X DRUGTYPE Small molecular drug D0LU9X DRUGINCH 1S/C18H12ClF2N3O2/c19-11-5-10(6-13(21)7-11)18(25)24-4-3-16-15(9-24)23-17(26-16)14-2-1-12(20)8-22-14/h1-2,5-8H,3-4,9H2 D0LU9X DRUGINKE CHAFCAFCZBTARK-UHFFFAOYSA-N D0LU9X DRUGSMIL C1CN(CC2=C1OC(=N2)C3=NC=C(C=C3)F)C(=O)C4=CC(=CC(=C4)Cl)F D0LU9X HIGHSTAT Patented D0LU9X COMPCLAS Tetra-hydro-oxazolopyridine derivatives D0LZ4A DRUG__ID D0LZ4A D0LZ4A DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason LouiMerck & Co., Inc., Kenilworth, NJ, USA D0LZ4A DRUGTYPE Small molecular drug D0LZ4A DRUGINCH 1S/C26H25ClF3N3O2/c1-24(2,17-5-7-19(8-6-17)34-26(28,29)30)33-14-10-25(11-15-33)23-20(4-3-12-32-23)22(35-25)21-16-18(27)9-13-31-21/h3-9,12-13,16,22H,10-11,14-15H2,1-2H3 D0LZ4A DRUGINKE YOXWNCRWJMZYKR-UHFFFAOYSA-N D0LZ4A DRUGSMIL CC(C)(C1=CC=C(C=C1)OC(F)(F)F)N2CCC3(CC2)C4=C(C=CC=N4)C(O3)C5=NC=CC(=C5)Cl D0LZ4A HIGHSTAT Patented D0LZ4A COMPCLAS Benzodihydroisofuran derivatives D0M1ND DRUG__ID D0M1ND D0M1ND DRUGCOMP JANSSEN PHARMACEUTICA NV HAWRYLUK, Natalie, A. BREITENBUCHER, J., Guy JONES, William, M. CHAMBERS, Alison, L. KEITH, John, M. SEIERSTAD, Mark D0M1ND DRUGTYPE Small molecular drug D0M1ND DRUGINCH 1S/C19H14ClF5N4/c20-13-5-11(1-3-12(13)19(23,24)25)17-7-18(29-9-28-17)27-8-16(26)10-2-4-14(21)15(22)6-10/h1-7,9,16H,8,26H2,(H,27,28,29)/t16-/m0/s1 D0M1ND DRUGINKE WKWUCPXAFUCNHR-INIZCTEOSA-N D0M1ND DRUGSMIL C1=CC(=C(C=C1C2=CC(=NC=N2)NCC(C3=CC(=C(C=C3)F)F)N)Cl)C(F)(F)F D0M1ND HIGHSTAT Patented D0M1ND COMPCLAS Pyrimidinyl ethylenediamine derivatives D0M2RT DRUG__ID D0M2RT D0M2RT DRUGCOMP SOLVAY PHARMACEUTICALS B.V. LANGE, Josephus H.M. KRUSE, Cornelis G. VAN VLIET, Bernard J D0M2RT DRUGTYPE Small molecular drug D0M2RT DRUGINCH 1S/C22H21Cl3N4O2S/c1-32(31)21-19(22(30)27-28-11-3-2-4-12-28)26-29(18-10-9-16(24)13-17(18)25)20(21)14-5-7-15(23)8-6-14/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D0M2RT DRUGINKE LMXGOWNIGCDDEQ-UHFFFAOYSA-N D0M2RT DRUGSMIL CS(=O)C1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D0M2RT HIGHSTAT Patented D0M2RT COMPCLAS Pyrazole derivatives D0M2ZX DRUG__ID D0M2ZX D0M2ZX DRUGCOMP Korea Institute of Radiological & Medical Sciences, S D0M2ZX DRUGTYPE Small molecular drug D0M2ZX DRUGINCH 1S/C16H16N2O4/c1-19-13-6-9(7-14(20-2)15(13)21-3)16-18-11-8-10(17)4-5-12(11)22-16/h4-8H,17H2,1-3H3 D0M2ZX DRUGINKE HVSQIFZUOAJQOV-UHFFFAOYSA-N D0M2ZX DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2=NC3=C(O2)C=CC(=C3)N D0M2ZX HIGHSTAT Patented D0M2ZX COMPCLAS Benzo[d]oxazole derivatives D0M3DM DRUG__ID D0M3DM D0M3DM DRUGCOMP ACTELION PHARMACEUTICALS LTD FRETZ, Heinz GATFIELD, John ISLER, Markus KIMMERLIN, Thierry KOBERSTEIN, Ralf LYOTHIER, Isabelle MONNIER, Lucile POTHIER, Julien VALDENAIRE, Anja D0M3DM DRUGTYPE Small molecular drug D0M3DM DRUGINCH 1S/C26H24N2O2/c29-24-22-13-7-8-14-23(22)25(30)26(24,21-11-5-2-6-12-21)28-17-15-27(16-18-28)19-20-9-3-1-4-10-20/h1-14H,15-19H2 D0M3DM DRUGINKE NYQQLNFEZNJIIX-UHFFFAOYSA-N D0M3DM DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3(C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5 D0M3DM HIGHSTAT Patented D0M3DM COMPCLAS Indandione derivatives D0M4BI DRUG__ID D0M4BI D0M4BI DRUGCOMP Washington University D0M4BI DRUGTYPE Small molecular drug D0M4BI DRUGINCH 1S/C24H31BrN2O5/c1-29-20-11-16-7-10-27(15-17(16)12-21(20)30-2)9-6-5-8-26-24(28)19-13-18(25)14-22(31-3)23(19)32-4/h11-14H,5-10,15H2,1-4H3,(H,26,28)/i25-4 D0M4BI DRUGINKE UNYNHWPKQAKANT-VEFBWTBNSA-N D0M4BI DRUGSMIL COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br D0M4BI HIGHSTAT Patented D0M4BI COMPCLAS Benzamide derivatives D0M5AR DRUG__ID D0M5AR D0M5AR DRUGCOMP MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH D0M5AR DRUGTYPE Small molecular drug D0M5AR DRUGINCH 1S/C20H22BrN3O2S/c1-14(2)3-8-17-13-20(15-4-6-16(21)7-5-15)24(23-17)18-9-11-19(12-10-18)27(22,25)26/h4-7,9-14H,3,8H2,1-2H3,(H2,22,25,26) D0M5AR DRUGINKE BDSMHQBMCUYDCT-UHFFFAOYSA-N D0M5AR DRUGSMIL CC(C)CCC1=NN(C(=C1)C2=CC=C(C=C2)Br)C3=CC=C(C=C3)S(=O)(=O)N D0M5AR HIGHSTAT Patented D0M5AR COMPCLAS Pyrazole derivatives D0M5DX DRUG__ID D0M5DX D0M5DX DRUGCOMP CURIS, INC. QIAN, Changgeng CAI, Xiong ZHAI, Haixiao D0M5DX DRUGTYPE Small molecular drug D0M5DX DRUGINCH 1S/C23H28N4O5S2/c1-23(2,3)17-12-24-20(32-17)14-33-21-13-25-22(34-21)26-19(29)11-15-6-8-16(9-7-15)31-10-4-5-18(28)27-30/h6-9,12-13,30H,4-5,10-11,14H2,1-3H3,(H,27,28)(H,25,26,29) D0M5DX DRUGINKE VGEVFXUUILGVIP-UHFFFAOYSA-N D0M5DX DRUGSMIL CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)CC3=CC=C(C=C3)OCCCC(=O)NO D0M5DX HIGHSTAT Patented D0M5DX COMPCLAS Oxazolyl methylthiothiazole derivatives D0M8OV DRUG__ID D0M8OV D0M8OV DRUGCOMP MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH D0M8OV DRUGTYPE Small molecular drug D0M8OV DRUGINCH 1S/C29H23BrN4O3S/c30-23-10-8-21(9-11-23)28-19-25(33-34(28)26-14-16-27(17-15-26)38(31,36)37)18-20-6-12-24(13-7-20)32-29(35)22-4-2-1-3-5-22/h1-17,19H,18H2,(H,32,35)(H2,31,36,37) D0M8OV DRUGINKE BOVRIAJBTGLLDC-UHFFFAOYSA-N D0M8OV DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)CC3=NN(C(=C3)C4=CC=C(C=C4)Br)C5=CC=C(C=C5)S(=O)(=O)N D0M8OV HIGHSTAT Patented D0M8OV COMPCLAS Pyrazole derivatives D0M9FZ DRUG__ID D0M9FZ D0M9FZ DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori IMASHIRO, Ritsuo SATO, Atsush D0M9FZ DRUGTYPE Small molecular drug D0M9FZ DRUGINCH 1S/C19H14Cl2F3N3O2/c1-29-17-15(18(28)25-10-19(22,23)24)26-27(14-5-3-2-4-13(14)21)16(17)11-6-8-12(20)9-7-11/h2-9H,10H2,1H3,(H,25,28) D0M9FZ DRUGINKE SOPUIDIJDHHXJF-UHFFFAOYSA-N D0M9FZ DRUGSMIL COC1=C(N(N=C1C(=O)NCC(F)(F)F)C2=CC=CC=C2Cl)C3=CC=C(C=C3)Cl D0M9FZ HIGHSTAT Patented D0M9FZ COMPCLAS Pyrazole derivatives D0ME5D DRUG__ID D0ME5D D0ME5D DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0ME5D DRUGTYPE Small molecular drug D0ME5D DRUGINCH 1S/C27H29F3N8O2/c1-16-25(18-10-32-36(2)13-18)35-38(20-9-19(28)11-31-12-20)26(16)34-27(39)33-24-15-37(6-7-40-3)14-21(24)17-4-5-22(29)23(30)8-17/h4-5,8-13,21,24H,6-7,14-15H2,1-3H3,(H2,33,34,39)/t21-,24+/m0/s1 D0ME5D DRUGINKE UNGZVJKZTCHIBB-XUZZJYLKSA-N D0ME5D DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC(=CN=C3)F)NC(=O)NC4CN(CC4C5=CC(=C(C=C5)F)F)CCOC D0ME5D HIGHSTAT Patented D0ME5D COMPCLAS Pyrrolidinyl urea derivatives D0MG6V DRUG__ID D0MG6V D0MG6V DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0MG6V DRUGTYPE Small molecule immunotherapy D0MG6V DRUGINCH 1S/C15H16N6O5/c1-3-4-9(18-15(25)19-11(8(2)22)14(23)24)13-20-12(21-26-13)10-7-16-5-6-17-10/h1,5-9,11,22H,4H2,2H3,(H,23,24)(H2,18,19,25)/t8?,9-,11-/m0/s1 D0MG6V DRUGINKE DGLNBPSKIUYJIJ-PCFYAGROSA-N D0MG6V DRUGSMIL CC(C(C(=O)O)NC(=O)NC(CC#C)C1=NC(=NO1)C2=NC=CN=C2)O D0MG6V HIGHSTAT Patented D0MG6V COMPCLAS 3-substituted-1,2,4-oxadiazole derivatives D0MM8M DRUG__ID D0MM8M D0MM8M DRUGCOMP NOVARTIS AG BEHNKE, Dirk CARCACHE, David ERTL, Peter KOLLER, Manuel ORAIN, David D0MM8M DRUGTYPE Small molecular drug D0MM8M DRUGINCH 1S/C19H19IN4O/c1-12(2)24-11-13(9-22-24)17-8-18-15-4-3-5-16(20)14(15)6-7-23(18)19(25)10-21-17/h3-5,8-9,11-12H,6-7,10H2,1-2H3 D0MM8M DRUGINKE WBNYTWXVORUJBL-UHFFFAOYSA-N D0MM8M DRUGSMIL CC(C)N1C=C(C=N1)C2=NCC(=O)N3CCC4=C(C3=C2)C=CC=C4I D0MM8M HIGHSTAT Patented D0MM8M COMPCLAS Diazepinone derivatives D0MZ4V DRUG__ID D0MZ4V D0MZ4V DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0MZ4V DRUGTYPE Small molecule immunotherapy D0MZ4V DRUGINCH 1S/C14H22N6O4/c15-11(22)6-10(17-12(23)9-5-8(21)7-16-9)13-18-14(19-24-13)20-3-1-2-4-20/h8-10,16,21H,1-7H2,(H2,15,22)(H,17,23)/t8-,9-,10-/m0/s1 D0MZ4V DRUGINKE SFGGVDXQGJRZAI-GUBZILKMSA-N D0MZ4V DRUGSMIL C1CCN(C1)C2=NOC(=N2)C(CC(=O)N)NC(=O)C3CC(CN3)O D0MZ4V HIGHSTAT Patented D0MZ4V COMPCLAS 1,2,4-oxadiazole derivatives D0N0XU DRUG__ID D0N0XU D0N0XU DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeong Min CHANG, Chong-Hwan Jonathan LEE, Suk Ho SEO, Hee Jeong KANG, Suk Youn SONG, Kwang-Seop KIM, Jong Yup KIM, Min Ju LEE, Sung-Han AHN, Kwang-Woo JUNG, Myung Eu D0N0XU DRUGTYPE Small molecular drug D0N0XU DRUGINCH 1S/C25H26Cl3N5/c1-6-15(4)25-29-24(31-32(25)14(2)3)22-16(5)23(17-7-9-18(26)10-8-17)33(30-22)21-12-11-19(27)13-20(21)28/h7-15H,6H2,1-5H3 D0N0XU DRUGINKE WWSDQOOUHRYSSK-UHFFFAOYSA-N D0N0XU DRUGSMIL CCC(C)C1=NC(=NN1C(C)C)C2=NN(C(=C2C)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl D0N0XU HIGHSTAT Patented D0N0XU COMPCLAS Pyrazole derivatives D0N2TV DRUG__ID D0N2TV D0N2TV DRUGCOMP ACTELION PHARMACEUTICALS LTD HILPERT, Kurt HUBLER, Francis MURPHY, Mark RENNEBERG, Dorte D0N2TV DRUGTYPE Small molecular drug D0N2TV DRUGINCH 1S/C18H20ClN3O3S/c19-14-5-4-12(26-15-6-9-20-17(24)22-15)10-13(14)16(23)21-11-18(25)7-2-1-3-8-18/h4-6,9-10,25H,1-3,7-8,11H2,(H,21,23)(H,20,22,24) D0N2TV DRUGINKE VFMSFNBMUAXYTM-UHFFFAOYSA-N D0N2TV DRUGSMIL C1CCC(CC1)(CNC(=O)C2=C(C=CC(=C2)SC3=CC=NC(=O)N3)Cl)O D0N2TV HIGHSTAT Patented D0N2TV COMPCLAS Benzamide derivatives D0N3AF DRUG__ID D0N3AF D0N3AF DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0N3AF DRUGTYPE Small molecular drug D0N3AF DRUGINCH 1S/C24H26F3N5O2/c1-22(2,3)16-12-17(14-6-8-15(9-7-14)24(25,26)27)30-32-13-18(29-19(16)32)20(33)31-11-10-28-21(34)23(31,4)5/h6-9,12-13H,10-11H2,1-5H3,(H,28,34) D0N3AF DRUGINKE GVNHDAXNAQFWSN-UHFFFAOYSA-N D0N3AF DRUGSMIL CC1(C(=O)NCCN1C(=O)C2=CN3C(=N2)C(=CC(=N3)C4=CC=C(C=C4)C(F)(F)F)C(C)(C)C)C D0N3AF HIGHSTAT Patented D0N3AF COMPCLAS Imidazopyridazine derivatives D0N4ON DRUG__ID D0N4ON D0N4ON DRUGCOMP OSCOTEC INC [KR] D0N4ON DRUGTYPE Small molecular drug D0N4ON DRUGINCH 1S/C23H27NO5/c1-15-12-22(16(2)11-20(15)17(3)24-28-6)29-13-18-9-7-8-10-19(18)21(14-26-4)23(25)27-5/h7-12,14H,13H2,1-6H3/b21-14+,24-17+ D0N4ON DRUGINKE LMRXZYBAUUHKCX-UDLHRNPOSA-N D0N4ON DRUGSMIL CC1=CC(=C(C=C1OCC2=CC=CC=C2C(=COC)C(=O)OC)C)C(=NOC)C D0N4ON HIGHSTAT Patented D0N4ON COMPCLAS Aryl methoxyacrylate derivatives D0N4RJ DRUG__ID D0N4RJ D0N4RJ DRUGCOMP MERCK SHARP &amDOHME CORP. LABROLI, Marc CZARNIECKI, Michael, F. POKER, Cory Seth D0N4RJ DRUGTYPE Small molecular drug D0N4RJ DRUGINCH 1S/C26H18ClF3N4O3S/c1-16-21(26(28,29)30)7-4-8-22(16)33-13-14-34-23(24(33)35)31-32-25(34)38(36,37)15-18-5-2-3-6-20(18)17-9-11-19(27)12-10-17/h2-14H,15H2,1H3 D0N4RJ DRUGINKE BEOJDRXHECGYFM-UHFFFAOYSA-N D0N4RJ DRUGSMIL CC1=C(C=CC=C1N2C=CN3C(=NN=C3S(=O)(=O)CC4=CC=CC=C4C5=CC=C(C=C5)Cl)C2=O)C(F)(F)F D0N4RJ HIGHSTAT Patented D0N4RJ COMPCLAS Triazolo-pyrazinone derivatives D0N6JZ DRUG__ID D0N6JZ D0N6JZ DRUGCOMP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI D0N6JZ DRUGTYPE Small molecular drug D0N6JZ DRUGINCH 1S/C19H19ClN2O3S/c1-12-5-3-4-6-19(12)26(24,25)22-14-7-8-15(20)17(11-14)21-16-9-10-18(23)13(16)2/h3-8,11,21-22H,9-10H2,1-2H3 D0N6JZ DRUGINKE GGISCUHENYTWDU-UHFFFAOYSA-N D0N6JZ DRUGSMIL CC1=CC=CC=C1S(=O)(=O)NC2=CC(=C(C=C2)Cl)NC3=C(C(=O)CC3)C D0N6JZ HIGHSTAT Patented D0N6JZ COMPCLAS Aminocyclopentenone compounds D0N8BA DRUG__ID D0N8BA D0N8BA DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED D0N8BA DRUGTYPE Small molecular drug D0N8BA DRUGINCH 1S/C22H20F4N4O3/c1-21(2)12-30-19(29(21)3)8-18(28-20(30)31)32-11-13-4-5-17(16(23)6-13)33-15-7-14(9-27-10-15)22(24,25)26/h4-10H,11-12H2,1-3H3 D0N8BA DRUGINKE PPKNPJKYLRQSCE-UHFFFAOYSA-N D0N8BA DRUGSMIL CC1(CN2C(=CC(=NC2=O)OCC3=CC(=C(C=C3)OC4=CN=CC(=C4)C(F)(F)F)F)N1C)C D0N8BA HIGHSTAT Patented D0N8BA COMPCLAS Bicyclic pyrimidine derivatives D0N8CU DRUG__ID D0N8CU D0N8CU DRUGCOMP AAPA B.V D0N8CU DRUGTYPE Small molecular drug D0N8CU DRUGINCH 1S/C28H37N3O3/c1-3-23(4-1)30-13-11-25(12-14-30)34-24-9-7-22(8-10-24)21-29-15-17-31(18-16-29)26-5-2-6-27-28(26)33-20-19-32-27/h2,5-10,23,25H,1,3-4,11-21H2 D0N8CU DRUGINKE DOVAYWNSWPTVKL-UHFFFAOYSA-N D0N8CU DRUGSMIL C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)CN4CCN(CC4)C5=C6C(=CC=C5)OCCO6 D0N8CU HIGHSTAT Patented D0N8CU COMPCLAS Benzo[d]oxazol-2(3H)-one derivatives D0N9IA DRUG__ID D0N9IA D0N9IA DRUGCOMP EISAI R&D MANAGEMENT CO., LTD D0N9IA DRUGTYPE Small molecular drug D0N9IA DRUGINCH 1S/C27H26FN3O2/c1-18-14-22(15-19(2)29-18)26-24-10-12-32-13-11-31(24)27(30-26)21-8-9-25(23(28)16-21)33-17-20-6-4-3-5-7-20/h3-9,14-16H,10-13,17H2,1-2H3 D0N9IA DRUGINKE DNUJOEZUOUPUCH-UHFFFAOYSA-N D0N9IA DRUGSMIL CC1=CC(=CC(=N1)C)C2=C3CCOCCN3C(=N2)C4=CC(=C(C=C4)OCC5=CC=CC=C5)F D0N9IA HIGHSTAT Patented D0N9IA COMPCLAS Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivatives D0ND6T DRUG__ID D0ND6T D0ND6T DRUGCOMP Korea institute of radiological & medical sciences, S D0ND6T DRUGTYPE Small molecular drug D0ND6T DRUGINCH 1S/C18H25NO4/c20-17(10-11-18(21)22)19-15-6-8-16(9-7-15)23-13-12-14-4-2-1-3-5-14/h6-9,14H,1-5,10-13H2,(H,19,20)(H,21,22) D0ND6T DRUGINKE NUDKZKXLJIDEDG-UHFFFAOYSA-N D0ND6T DRUGSMIL C1CCC(CC1)CCOC2=CC=C(C=C2)NC(=O)CCC(=O)O D0ND6T HIGHSTAT Patented D0ND6T COMPCLAS 4-(2-cyclohexylethoxy) aniline derivatives D0NE0W DRUG__ID D0NE0W D0NE0W DRUGCOMP EISAI R&D MANAGEMENT CO., LTD D0NE0W DRUGTYPE Small molecular drug D0NE0W DRUGINCH 1S/C23H20F4N4O2/c1-13-7-16(8-14(2)29-13)21-19-5-6-32-18(10-24)12-31(19)22(30-21)15-3-4-20(17(9-15)11-28)33-23(25,26)27/h3-4,7-9,18H,5-6,10,12H2,1-2H3/t18-/m1/s1 D0NE0W DRUGINKE XEHQUSUNPCVWGP-GOSISDBHSA-N D0NE0W DRUGSMIL CC1=CC(=CC(=N1)C)C2=C3CCOC(CN3C(=N2)C4=CC(=C(C=C4)OC(F)(F)F)C#N)CF D0NE0W HIGHSTAT Patented D0NE0W COMPCLAS Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivatives D0NG6O DRUG__ID D0NG6O D0NG6O DRUGCOMP GSK D0NG6O DRUGTYPE Small molecular drug D0NG6O DRUGINCH 1S/C15H16ClF3N2O2/c1-21-11(6-3-7-12(21)22)14(23)20-8-9-4-2-5-10(13(9)16)15(17,18)19/h2,4-5,11H,3,6-8H2,1H3,(H,20,23) D0NG6O DRUGINKE YGCMKVHDGGAEFD-UHFFFAOYSA-N D0NG6O DRUGSMIL CN1C(CCCC1=O)C(=O)NCC2=C(C(=CC=C2)C(F)(F)F)Cl D0NG6O HIGHSTAT Patented D0NG6O COMPCLAS Piperidinone derivatives D0NH2H DRUG__ID D0NH2H D0NH2H DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0NH2H DRUGTYPE Small molecular drug D0NH2H DRUGINCH 1S/C20H15F4N5O/c21-15-6-3-12(19(30)28-14-4-5-14)7-11(15)1-2-13-8-29(9-20(22,23)24)18-16(13)17(25)26-10-27-18/h3,6-8,10,14H,4-5,9H2,(H,28,30)(H2,25,26,27) D0NH2H DRUGINKE SHIKADMSFNHXTC-UHFFFAOYSA-N D0NH2H DRUGSMIL C1CC1NC(=O)C2=CC(=C(C=C2)F)C#CC3=CN(C4=NC=NC(=C34)N)CC(F)(F)F D0NH2H HIGHSTAT Patented D0NH2H COMPCLAS Pyrrolo-pyrimidine derivatives D0NJ0S DRUG__ID D0NJ0S D0NJ0S DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa SEO, Hee Jeong KIM, Min-Ah KIM, Jeongmin LEE, Sung-Han JUNG, Myung Eun KIM, Mi-Soo D0NJ0S DRUGTYPE Small molecular drug D0NJ0S DRUGINCH 1S/C23H17Cl2F3N4O2S2/c1-36(33,34)19-17(20-29-30-21(35-20)22(11-4-12-22)23(26,27)28)31-32(16-6-3-2-5-15(16)25)18(19)13-7-9-14(24)10-8-13/h2-3,5-10H,4,11-12H2,1H3 D0NJ0S DRUGINKE JEHNKOMECQRUIV-UHFFFAOYSA-N D0NJ0S DRUGSMIL CS(=O)(=O)C1=C(N(N=C1C2=NN=C(S2)C3(CCC3)C(F)(F)F)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl D0NJ0S HIGHSTAT Patented D0NJ0S COMPCLAS Pyrazole derivatives D0NS6S DRUG__ID D0NS6S D0NS6S DRUGCOMP MEDIVATION TECHNOLOGIES, INC D0NS6S DRUGTYPE Small molecular drug D0NS6S DRUGINCH 1S/C23H27FN8O/c1-13(2)17-11-20(31-30-17)28-21-15-5-3-6-16(15)27-23(29-21)32-10-4-7-18(32)22(33)26-14-8-9-19(24)25-12-14/h8-9,11-13,18H,3-7,10H2,1-2H3,(H,26,33)(H2,27,28,29,30,31) D0NS6S DRUGINKE GZDATWXVIVEVAM-UHFFFAOYSA-N D0NS6S DRUGSMIL CC(C)C1=CC(=NN1)NC2=NC(=NC3=C2CCC3)N4CCCC4C(=O)NC5=CN=C(C=C5)F D0NS6S HIGHSTAT Patented D0NS6S COMPCLAS Cyclopenta[d]pyrimidine derivatives D0NT8N DRUG__ID D0NT8N D0NT8N DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0NT8N DRUGTYPE Small molecular drug D0NT8N DRUGINCH 1S/C27H26FN5O2/c28-22-9-7-20(8-10-22)24-17-25(33(31-24)27-29-13-4-14-30-27)21-11-15-32(16-12-21)18-23(26(34)35)19-5-2-1-3-6-19/h1-10,13-14,17,21,23H,11-12,15-16,18H2,(H,34,35) D0NT8N DRUGINKE ASWVEQWRTMUNCF-UHFFFAOYSA-N D0NT8N DRUGSMIL C1CN(CCC1C2=CC(=NN2C3=NC=CC=N3)C4=CC=C(C=C4)F)CC(C5=CC=CC=C5)C(=O)O D0NT8N HIGHSTAT Patented D0NT8N COMPCLAS Piperidinyl triazole derivatives D0NX4W DRUG__ID D0NX4W D0NX4W DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0NX4W DRUGTYPE Small molecular drug D0NX4W DRUGINCH 1S/C22H20FN5OS/c23-14-9-10-18-20(13-14)30-22(27-18)26-17-7-3-6-16(17)25-21(29)15-5-1-2-8-19(15)28-12-4-11-24-28/h1-2,4-5,8-13,16-17H,3,6-7H2,(H,25,29)(H,26,27)/t16-,17-/m0/s1 D0NX4W DRUGINKE IJDOZFOBWAKVFH-IRXDYDNUSA-N D0NX4W DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3C=CC=N3)NC4=NC5=C(S4)C=C(C=C5)F D0NX4W HIGHSTAT Patented D0NX4W COMPCLAS 1,2-diamino cyclopentane-based derivatives D0NY7M DRUG__ID D0NY7M D0NY7M DRUGCOMP SELVITA SA D0NY7M DRUGTYPE Small molecular drug D0NY7M DRUGINCH 1S/C14H15Br3N4/c15-9-8-2-1-5-21-13(8)12(11(17)10(9)16)19-14(21)20-6-3-18-4-7-20/h18H,1-7H2 D0NY7M DRUGINKE FUOROZXAYONUGD-UHFFFAOYSA-N D0NY7M DRUGSMIL C1CC2=C3C(=C(C(=C2Br)Br)Br)N=C(N3C1)N4CCNCC4 D0NY7M HIGHSTAT Patented D0NY7M COMPCLAS Tricyclic benzimidazole derivatives D0O0RB DRUG__ID D0O0RB D0O0RB DRUGCOMP F. HOFFMANN-LA ROCHE AG GAZZARD, Lewis J. HANAN, Emily KINTZ, Samuel LYSSIKATOS, Joseph P. PURKEY, Hans Edward D0O0RB DRUGTYPE Small molecular drug D0O0RB DRUGINCH 1S/C20H18N2O2/c1-12-2-7-17(23)10-18(12)15-6-5-14-9-19(21-11-16(14)8-15)22-20(24)13-3-4-13/h2,5-11,13,23H,3-4H2,1H3,(H,21,22,24) D0O0RB DRUGINKE JLLTUBSBILQEOE-UHFFFAOYSA-N D0O0RB DRUGSMIL CC1=C(C=C(C=C1)O)C2=CC3=CN=C(C=C3C=C2)NC(=O)C4CC4 D0O0RB HIGHSTAT Patented D0O0RB COMPCLAS 6,6-fused nitrogenous heterocyclic compounds D0O4ML DRUG__ID D0O4ML D0O4ML DRUGCOMP ACTELION PHARMACEUTICALS LTD FRETZ, Heinz GATFIELD, John ISLER, Markus KIMMERLIN, Thierry KOBERSTEIN, Ralf LYOTHIER, Isabelle MONNIER, Lucile POTHIER, Julien VALDENAIRE, Anja D0O4ML DRUGTYPE Small molecular drug D0O4ML DRUGINCH 1S/C27H26N2O3/c1-32-24-14-8-5-9-20(24)19-28-15-17-29(18-16-28)27(21-10-3-2-4-11-21)25(30)22-12-6-7-13-23(22)26(27)31/h2-14H,15-19H2,1H3 D0O4ML DRUGINKE DLIPFFRYKOCUMK-UHFFFAOYSA-N D0O4ML DRUGSMIL COC1=CC=CC=C1CN2CCN(CC2)C3(C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5 D0O4ML HIGHSTAT Patented D0O4ML COMPCLAS Indandione derivatives D0O6LW DRUG__ID D0O6LW D0O6LW DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED ASTEX THERAPEUTICS LIMITED D0O6LW DRUGTYPE Small molecular drug D0O6LW DRUGINCH 1S/C9H9ClO2/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-2,4-5H,3,6H2,(H,11,12)/p-1 D0O6LW DRUGINKE BBSLOKZINKEUCR-UHFFFAOYSA-M D0O6LW DRUGSMIL C1=CC(=CC=C1CCC(=O)[O-])Cl D0O6LW HIGHSTAT Patented D0O6LW COMPCLAS 3-phenyl propanoic derivatives D0O8DG DRUG__ID D0O8DG D0O8DG DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D0O8DG DRUGTYPE Small molecular drug D0O8DG DRUGINCH 1S/C21H17ClN2O2S/c1-23(2)21(25)26-18-16-12-7-13-24(16)17-11-6-10-15(22)20(17)27-19(18)14-8-4-3-5-9-14/h3-13H,1-2H3 D0O8DG DRUGINKE VCZPXCAFIGMLIM-UHFFFAOYSA-N D0O8DG DRUGSMIL CN(C)C(=O)OC1=C(SC2=C(C=CC=C2Cl)N3C1=CC=C3)C4=CC=CC=C4 D0O8DG HIGHSTAT Patented D0O8DG COMPCLAS Benzothiazepine analogs D0O9WQ DRUG__ID D0O9WQ D0O9WQ DRUGCOMP NOVARTIS AG [CHBLANK JUTTA [CHBOLD GUIDO [CHBORDAS VINCENT [CHCOTESTA SIMONA [CHGUAGNANO VITO [CHR EGER HEINRICH [CHVAUPEL ANDREA [CH] D0O9WQ DRUGTYPE Small molecular drug D0O9WQ DRUGINCH 1S/C26H24ClN5O4/c1-14-10-17(13-30(2)24(14)33)32-21(15-6-8-16(27)9-7-15)22-18(25(32)34)11-20(31(22)3)19-12-28-26(36-5)29-23(19)35-4/h6-13,21H,1-5H3/t21-/m1/s1 D0O9WQ DRUGINKE QLRYSHYUZMZZPY-OAQYLSRUSA-N D0O9WQ DRUGSMIL CC1=CC(=CN(C1=O)C)N2C(C3=C(C2=O)C=C(N3C)C4=CN=C(N=C4OC)OC)C5=CC=C(C=C5)Cl D0O9WQ HIGHSTAT Patented D0O9WQ COMPCLAS Pyrrolo-pyrrolone derivatives D0OG3Z DRUG__ID D0OG3Z D0OG3Z DRUGCOMP H. LUNDBECK A/S D0OG3Z DRUGTYPE Small molecular drug D0OG3Z DRUGINCH 1S/C24H31N5O2/c25-18-3-5-28(14-18)23(31)20-9-21-19(2-1-4-29(21)27-20)26-22(30)13-24-10-15-6-16(11-24)8-17(7-15)12-24/h1-2,4,9,15-18H,3,5-8,10-14,25H2,(H,26,30)/t15?,16?,17?,18-,24?/m1/s1 D0OG3Z DRUGINKE CHANXFBBIWKIAI-ZWGBCBFGSA-N D0OG3Z DRUGSMIL C1CN(CC1N)C(=O)C2=NN3C=CC=C(C3=C2)NC(=O)CC45CC6CC(C4)CC(C6)C5 D0OG3Z HIGHSTAT Patented D0OG3Z COMPCLAS Bicyclic heteroaryl amide derivatives D0OI8P DRUG__ID D0OI8P D0OI8P DRUGCOMP INFINITY PHARMACEUTICALS, INC. BEHNKE, Mark, L. CASTRO, Alfredo, C. CHAN, Lawrence, K. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LEBLANC, Yves LIU, Tao PELUSO, Stephane SNYDER, Daniel, A. TIBBITTS, Thomas, T D0OI8P DRUGTYPE Small molecular drug D0OI8P DRUGINCH 1S/C22H16N2O3/c23-15-16-6-10-20(11-7-16)26-22-14-21(27-24-22)17-8-12-19(13-9-17)25-18-4-2-1-3-5-18/h1-13,21H,14H2/t21-/m0/s1 D0OI8P DRUGINKE QRYXBMPYZGEVSA-NRFANRHFSA-N D0OI8P DRUGSMIL C1C(ON=C1OC2=CC=C(C=C2)C#N)C3=CC=C(C=C3)OC4=CC=CC=C4 D0OI8P HIGHSTAT Patented D0OI8P COMPCLAS Isoxazoline derivatives D0ON7G DRUG__ID D0ON7G D0ON7G DRUGCOMP ZENITH EPIGENETICS CORP D0ON7G DRUGTYPE Small molecular drug D0ON7G DRUGINCH 1S/C19H18N4O2/c1-11-17(12(2)25-22-11)14-8-15(20)18-16(9-14)23(19(24)21-18)10-13-6-4-3-5-7-13/h3-9H,10,20H2,1-2H3,(H,21,24) D0ON7G DRUGINKE HWHJKVNNLYESRW-UHFFFAOYSA-N D0ON7G DRUGSMIL CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)N(C(=O)N3)CC4=CC=CC=C4)N D0ON7G HIGHSTAT Patented D0ON7G COMPCLAS Isoxazole-based bicyclic compounds D0OR2V DRUG__ID D0OR2V D0OR2V DRUGCOMP Ardea Biosciences D0OR2V DRUGTYPE Small molecular drug D0OR2V DRUGINCH 1S/C18H17F4IN2O4S/c19-11-5-9(23)1-2-14(11)24-17-15(22)12(20)6-13(21)16(17)25-30(28,29)18(3-4-18)7-10(27)8-26/h1-2,5-6,10,24-27H,3-4,7-8H2 D0OR2V DRUGINKE DDZSGPZIFZFUSF-UHFFFAOYSA-N D0OR2V DRUGSMIL C1CC1(CC(CO)O)S(=O)(=O)NC2=C(C(=C(C=C2F)F)F)NC3=C(C=C(C=C3)I)F D0OR2V HIGHSTAT Patented D0OR2V COMPCLAS N-(arylamino)sulfonamide derivatives D0OZ1P DRUG__ID D0OZ1P D0OZ1P DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0OZ1P DRUGTYPE Small molecular drug D0OZ1P DRUGINCH 1S/C26H35N3O2/c1-3-15-28-16-18-29(19-17-28)25-14-8-11-22-23(25)12-7-13-24(22)27(2)26(30)31-20-21-9-5-4-6-10-21/h4-6,8-11,14,24H,3,7,12-13,15-20H2,1-2H3 D0OZ1P DRUGINKE YZQOEMNLUIMOMX-UHFFFAOYSA-N D0OZ1P DRUGSMIL CCCN1CCN(CC1)C2=CC=CC3=C2CCCC3N(C)C(=O)OCC4=CC=CC=C4 D0OZ1P HIGHSTAT Patented D0OZ1P COMPCLAS Fused aryl carbocycle derivatives D0P3EG DRUG__ID D0P3EG D0P3EG DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0P3EG DRUGTYPE Small molecule immunotherapy D0P3EG DRUGINCH 1S/C22H25N5O5S/c1-31-19-7-3-2-6-17(19)21-25-26-22(32-21)18(27-33(29,30)16-8-9-16)10-11-20(28)24-14-15-5-4-12-23-13-15/h2-7,12-13,16,18,27H,8-11,14H2,1H3,(H,24,28)/t18-/m0/s1 D0P3EG DRUGINKE JHNLLRMWPHPFLP-SFHVURJKSA-N D0P3EG DRUGSMIL COC1=CC=CC=C1C2=NN=C(O2)C(CCC(=O)NCC3=CN=CC=C3)NS(=O)(=O)C4CC4 D0P3EG HIGHSTAT Patented D0P3EG COMPCLAS 1,3,4-oxadiazole derivatives D0P3YA DRUG__ID D0P3YA D0P3YA DRUGCOMP BeiGene Ltd D0P3YA DRUGTYPE Small molecular drug D0P3YA DRUGINCH 1S/C22H28N4O/c1-22(2)13-16-20-18(14-22)26(12-11-25-9-4-3-5-10-25)17-8-6-7-15(19(17)20)21(27)24-23-16/h6-8H,3-5,9-14H2,1-2H3,(H,24,27) D0P3YA DRUGINKE LNWPRZVIPZXIHL-UHFFFAOYSA-N D0P3YA DRUGSMIL CC1(CC2=C3C(=NNC(=O)C4=C3C(=CC=C4)N2CCN5CCCCC5)C1)C D0P3YA HIGHSTAT Patented D0P3YA COMPCLAS Dihydrodiazepinocarbazolone derivatives D0P4NP DRUG__ID D0P4NP D0P4NP DRUGCOMP BAYER INTELLECTUAL PROPERTY GMBBAYER IP GMBH [DE] D0P4NP DRUGTYPE Small molecular drug D0P4NP DRUGINCH 1S/C21H19F2N5O2S/c1-3-31(29,26-13-24)12-14-5-4-6-16(9-14)27-21-25-11-18(23)20(28-21)17-8-7-15(22)10-19(17)30-2/h4-11H,3,12H2,1-2H3,(H,25,27,28) D0P4NP DRUGINKE QEYANDLEJXFZFA-UHFFFAOYSA-N D0P4NP DRUGSMIL CCS(=NC#N)(=O)CC1=CC(=CC=C1)NC2=NC=C(C(=N2)C3=C(C=C(C=C3)F)OC)F D0P4NP HIGHSTAT Patented D0P4NP COMPCLAS Diaryl amine derivatives D0P5SF DRUG__ID D0P5SF D0P5SF DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN D0P5SF DRUGTYPE Small molecular drug D0P5SF DRUGINCH 1S/C26H21N5O3/c1-13-23(14(2)34-31-13)18-11-20-17(12-22(18)32-4)24-25(30-20)28-15(3)29-26(24)33-21-9-10-27-19-8-6-5-7-16(19)21/h5-12H,1-4H3,(H,28,29,30) D0P5SF DRUGINKE RYLREOMADHRZEY-UHFFFAOYSA-N D0P5SF DRUGSMIL CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)NC4=C3C(=NC(=N4)C)OC5=CC=NC6=CC=CC=C65)OC D0P5SF HIGHSTAT Patented D0P5SF COMPCLAS Pyrimido-indole derivatives D0P6GJ DRUG__ID D0P6GJ D0P6GJ DRUGCOMP MEDSHINE DISCOVERY INC D0P6GJ DRUGTYPE Small molecular drug D0P6GJ DRUGINCH 1S/C17H21N3O2S/c1-12-10-18-11-13-4-2-6-16(17(12)13)23(21,22)20-9-7-14-15(20)5-3-8-19-14/h2,4,6,10-11,14-15,19H,3,5,7-9H2,1H3 D0P6GJ DRUGINKE WDKSGCASJPRCLY-UHFFFAOYSA-N D0P6GJ DRUGSMIL CC1=CN=CC2=C1C(=CC=C2)S(=O)(=O)N3CCC4C3CCCN4 D0P6GJ HIGHSTAT Patented D0P6GJ COMPCLAS Isoquinoline sulfonyl derivatives D0P7HQ DRUG__ID D0P7HQ D0P7HQ DRUGCOMP 7TM PHARMA A/S COOPER, Martin RECEVEUR, Jean-Marie HOEGBERG, Thomas NIELSEN, Peter, Aadal LINGET, Jean-Michel NOEREGAARD, Pia, Karina D0P7HQ DRUGTYPE Small molecular drug D0P7HQ DRUGINCH 1S/C25H17Cl2F3N8O/c26-17-9-5-15(6-10-17)22-18(12-20-33-36-37-34-20)21(35-38(22)23-19(27)2-1-11-31-23)24(39)32-13-14-3-7-16(8-4-14)25(28,29)30/h1-11H,12-13H2,(H,32,39)(H,33,34,36,37) D0P7HQ DRUGINKE FXZYLULQTVQTLV-UHFFFAOYSA-N D0P7HQ DRUGSMIL C1=CC(=C(N=C1)N2C(=C(C(=N2)C(=O)NCC3=CC=C(C=C3)C(F)(F)F)CC4=NNN=N4)C5=CC=C(C=C5)Cl)Cl D0P7HQ HIGHSTAT Patented D0P7HQ COMPCLAS Pyrazole derivatives D0P8AX DRUG__ID D0P8AX D0P8AX DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0P8AX DRUGTYPE Small molecular drug D0P8AX DRUGINCH 1S/C21H19FN6OS/c22-13-8-9-19-17(12-13)27-21(30-19)26-16-6-3-5-15(16)25-20(29)14-4-1-2-7-18(14)28-23-10-11-24-28/h1-2,4,7-12,15-16H,3,5-6H2,(H,25,29)(H,26,27)/t15-,16-/m0/s1 D0P8AX DRUGINKE QOKFERXTHYZAHW-HOTGVXAUSA-N D0P8AX DRUGSMIL C1CC(C(C1)NC(=O)C2=CC=CC=C2N3N=CC=N3)NC4=NC5=C(S4)C=CC(=C5)F D0P8AX HIGHSTAT Patented D0P8AX COMPCLAS 1,2-diamino cyclopentane-based derivatives D0P9WR DRUG__ID D0P9WR D0P9WR DRUGCOMP COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH D0P9WR DRUGTYPE Small molecular drug D0P9WR DRUGINCH 1S/C23H21Cl2NO5/c1-26-8-7-14(20(30)11-26)21-18(28)10-19(29)22-17(27)9-12(31-23(21)22)5-6-13-15(24)3-2-4-16(13)25/h2-6,9-10,14,20,28-30H,7-8,11H2,1H3/b6-5+ D0P9WR DRUGINKE NFTJDXGFOUFNKG-AATRIKPKSA-N D0P9WR DRUGSMIL CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C=CC4=C(C=CC=C4Cl)Cl)O)O D0P9WR HIGHSTAT Patented D0P9WR COMPCLAS Flavopiridol analogs D0PE1R DRUG__ID D0PE1R D0PE1R DRUGCOMP NOVARTIS AG [CHBLANK JUTTA [CHBOLD GUIDO [CHBORDAS VINCENT [CHCOTESTA SIMONA [CHGUAGNANO VITO [CHR EGER HEINRICH [CHVAUPEL ANDREA [CH] D0PE1R DRUGTYPE Small molecular drug D0PE1R DRUGINCH 1S/C23H21ClN6O2/c1-12-9-15(10-17-19(12)26-27-29(17)4)30-20(13-5-7-14(24)8-6-13)21-18(23(30)32)16(11-28(21)3)22(31)25-2/h5-11,20H,1-4H3,(H,25,31) D0PE1R DRUGINKE VQZKOWOEYPJMPU-UHFFFAOYSA-N D0PE1R DRUGSMIL CC1=CC(=CC2=C1N=NN2C)N3C(C4=C(C3=O)C(=CN4C)C(=O)NC)C5=CC=C(C=C5)Cl D0PE1R HIGHSTAT Patented D0PE1R COMPCLAS Pyrrolo-pyrrolone derivatives D0PI1X DRUG__ID D0PI1X D0PI1X DRUGCOMP H. LUNDBECK A/S D0PI1X DRUGTYPE Small molecular drug D0PI1X DRUGINCH 1S/C26H27N5O/c1-19-8-5-10-22-23(19)21(17-31(22)25-28-14-7-15-29-25)24(32)30-18-26(11-3-2-4-12-26)20-9-6-13-27-16-20/h5-10,13-17H,2-4,11-12,18H2,1H3,(H,30,32) D0PI1X DRUGINKE OIKQYDBRBPIGDB-UHFFFAOYSA-N D0PI1X DRUGSMIL CC1=C2C(=CC=C1)N(C=C2C(=O)NCC3(CCCCC3)C4=CN=CC=C4)C5=NC=CC=N5 D0PI1X HIGHSTAT Patented D0PI1X COMPCLAS Bicyclic heteroaryl amide derivatives D0PK4M DRUG__ID D0PK4M D0PK4M DRUGCOMP ORION CORPORATION D0PK4M DRUGTYPE Small molecular drug D0PK4M DRUGINCH 1S/C22H21N3O4/c1-14-22(15(2)29-24-14)18-11-16-6-7-21(27)25(13-17-5-3-4-8-23-17)19(16)12-20(18)28-10-9-26/h3-8,11-12,26H,9-10,13H2,1-2H3 D0PK4M DRUGINKE OAVYHERNZVHDFP-UHFFFAOYSA-N D0PK4M DRUGSMIL CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)C=CC(=O)N3CC4=CC=CC=N4)OCCO D0PK4M HIGHSTAT Patented D0PK4M COMPCLAS Isoxazole-based bicyclic compounds D0PK6X DRUG__ID D0PK6X D0PK6X DRUGCOMP LUPIN LIMITED D0PK6X DRUGTYPE Small molecular drug D0PK6X DRUGINCH 1S/C24H22FIN6O4/c1-12-20-19(21(30(2)22(12)34)29-17-8-7-13(26)9-16(17)25)23(35)31(3)24(36)32(20)15-6-4-5-14(10-15)28-11-18(27)33/h4-10,28-29H,11H2,1-3H3,(H2,27,33) D0PK6X DRUGINKE KAVFKXKOUQPGQL-UHFFFAOYSA-N D0PK6X DRUGSMIL CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NCC(=O)N)C D0PK6X HIGHSTAT Patented D0PK6X COMPCLAS Pyridopyrimidine derivatives D0PM3J DRUG__ID D0PM3J D0PM3J DRUGCOMP Leland Stanford Junior University D0PM3J DRUGTYPE Small molecular drug D0PM3J DRUGINCH 1S/C23H23BrN4O4/c24-21-11-17(32-28-21)13-26-22(29)20(10-16-12-25-19-9-5-4-8-18(16)19)27-23(30)31-14-15-6-2-1-3-7-15/h1-9,12,17,20,25H,10-11,13-14H2,(H,26,29)(H,27,30)/t17?,20-/m0/s1 D0PM3J DRUGINKE MAQVWGRATZCTBU-OZBJMMHXSA-N D0PM3J DRUGSMIL C1C(ON=C1Br)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4 D0PM3J HIGHSTAT Patented D0PM3J COMPCLAS Dihydroisoxazole derivatives D0PU2A DRUG__ID D0PU2A D0PU2A DRUGCOMP INFINITY PHARMACEUTICALS, INC BEHNKE, Mark, L. CASTRO, Alfredo, C. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LIU, Tao SNYDER, Daniel, A. TIBBITTS, Thomas, T D0PU2A DRUGTYPE Small molecular drug D0PU2A DRUGINCH 1S/C13H10BN3O3/c18-14(19)11-5-3-9(4-6-11)12-16-17-13(20-12)10-2-1-7-15-8-10/h1-8,18-19H D0PU2A DRUGINKE GUJFLRGCBMMKFL-UHFFFAOYSA-N D0PU2A DRUGSMIL B(C1=CC=C(C=C1)C2=NN=C(O2)C3=CN=CC=C3)(O)O D0PU2A HIGHSTAT Patented D0PU2A COMPCLAS Boronic acid derivatives D0PY1G DRUG__ID D0PY1G D0PY1G DRUGCOMP ELAN PHARMACEUTICALS, LLC D0PY1G DRUGTYPE Small molecular drug D0PY1G DRUGINCH 1S/C14H9ClFN3O2S2/c15-11-6-5-10(23-11)13(21)17-18-14-19(12(20)7-22-14)9-3-1-8(16)2-4-9/h1-6H,7H2,(H,17,21)/b18-14+ D0PY1G DRUGINKE SDAYOLNMRBBFQH-NBVRZTHBSA-N D0PY1G DRUGSMIL C1C(=O)N(C(=NNC(=O)C2=CC=C(S2)Cl)S1)C3=CC=C(C=C3)F D0PY1G HIGHSTAT Patented D0PY1G COMPCLAS Hydrazide derivatives D0Q1BE DRUG__ID D0Q1BE D0Q1BE DRUGCOMP ADVINUS THERAPEUTICS LIMITED D0Q1BE DRUGTYPE Small molecular drug D0Q1BE DRUGINCH 1S/C37H38N6O3/c1-41-13-15-42(16-14-41)21-24-5-7-26(8-6-24)32-20-30-35(38-23-39-36(30)40-32)28-3-2-4-33(31(28)22-44)43-17-18-46-34-19-27(25-9-10-25)11-12-29(34)37(43)45/h2-8,11-12,19-20,23,25,44H,9-10,13-18,21-22H2,1H3,(H,38,39,40) D0Q1BE DRUGINKE AYQKNTPWCXIAQQ-UHFFFAOYSA-N D0Q1BE DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N=CN=C4N3)C5=C(C(=CC=C5)N6CCOC7=C(C6=O)C=CC(=C7)C8CC8)CO D0Q1BE HIGHSTAT Patented D0Q1BE COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0Q2FC DRUG__ID D0Q2FC D0Q2FC DRUGCOMP EISAI R&D MANAGEMENT CO., LTD D0Q2FC DRUGTYPE Small molecular drug D0Q2FC DRUGINCH 1S/C25H28FN3O2/c1-15-10-18(4-7-23(15)31-21-5-6-21)25-28-24(19-11-16(2)27-20(12-19)13-26)22-8-9-30-17(3)14-29(22)25/h4,7,10-12,17,21H,5-6,8-9,13-14H2,1-3H3/t17-/m1/s1 D0Q2FC DRUGINKE AOKFYLVAJDLEJH-QGZVFWFLSA-N D0Q2FC DRUGSMIL CC1CN2C(=C(N=C2C3=CC(=C(C=C3)OC4CC4)C)C5=CC(=NC(=C5)C)CF)CCO1 D0Q2FC HIGHSTAT Patented D0Q2FC COMPCLAS Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivatives D0Q2SE DRUG__ID D0Q2SE D0Q2SE DRUGCOMP YALE UNIVERSITY GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED CAMBRIDGE ENTERPRISE LIMITED UNIVERSITY OF CAMBRIDGE D0Q2SE DRUGTYPE Small molecular drug D0Q2SE DRUGINCH 1S/C21H22N4O5/c1-13-6-17(30-24-13)8-20(27)25-11-16(26)7-18(25)21(28)23-9-14-2-4-15(5-3-14)19-10-22-12-29-19/h2-6,10,12,16,18,26H,7-9,11H2,1H3,(H,23,28)/t16-,18+/m1/s1 D0Q2SE DRUGINKE HFCLIEBJTGJKSV-AEFFLSMTSA-N D0Q2SE DRUGSMIL CC1=NOC(=C1)CC(=O)N2CC(CC2C(=O)NCC3=CC=C(C=C3)C4=CN=CO4)O D0Q2SE HIGHSTAT Patented D0Q2SE COMPCLAS Pyrrolidine carboxamide derivatives D0Q4ST DRUG__ID D0Q4ST D0Q4ST DRUGCOMP NOVARTIS AG BEHNKE, Dirk CARCACHE, David ERTL, Peter KOLLER, Manuel ORAIN, David D0Q4ST DRUGTYPE Small molecular drug D0Q4ST DRUGINCH 1S/C18H16N2O2S/c1-22-16-5-2-4-12-13(16)7-8-20-15(12)10-14(19-11-18(20)21)17-6-3-9-23-17/h2-6,9-10H,7-8,11H2,1H3 D0Q4ST DRUGINKE ZCPJZMIIRATEAI-UHFFFAOYSA-N D0Q4ST DRUGSMIL COC1=CC=CC2=C1CCN3C2=CC(=NCC3=O)C4=CC=CS4 D0Q4ST HIGHSTAT Patented D0Q4ST COMPCLAS Diazepinone derivatives D0Q5IR DRUG__ID D0Q5IR D0Q5IR DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John D0Q5IR DRUGTYPE Small molecular drug D0Q5IR DRUGINCH 1S/C16H14N2O4/c19-8-6-17-15(20)10-4-5-11-13(9-10)18-7-2-1-3-12(18)14(11)16(21)22/h1-5,7,9,19H,6,8H2,(H,17,20)(H,21,22) D0Q5IR DRUGINKE OVCGCJPQKMNJNJ-UHFFFAOYSA-N D0Q5IR DRUGSMIL C1=CC2=C(C3=C(N2C=C1)C=C(C=C3)C(=O)NCCO)C(=O)O D0Q5IR HIGHSTAT Patented D0Q5IR COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D0Q6GP DRUG__ID D0Q6GP D0Q6GP DRUGCOMP INFINITY PHARMACEUTICALS, INC. BEHNKE, Mark, L. CASTRO, Alfredo, C. CHAN, Lawrence, K. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LEBLANC, Yves LIU, Tao PELUSO, Stephane SNYDER, Daniel, A. TIBBITTS, Thomas, T D0Q6GP DRUGTYPE Small molecular drug D0Q6GP DRUGINCH 1S/C10H10BrNO2/c1-13-8-4-2-3-7(5-8)9-6-10(11)12-14-9/h2-5,9H,6H2,1H3/t9-/m0/s1 D0Q6GP DRUGINKE IWLKUWXPADWQAT-VIFPVBQESA-N D0Q6GP DRUGSMIL COC1=CC=CC(=C1)C2CC(=NO2)Br D0Q6GP HIGHSTAT Patented D0Q6GP COMPCLAS Isoxazoline derivatives D0Q8RC DRUG__ID D0Q8RC D0Q8RC DRUGCOMP ASTELLAS PHARMA INC. AZAMI, Hidenori ABE, Tomoaki KAKEFUDA, Akio D0Q8RC DRUGTYPE Small molecular drug D0Q8RC DRUGINCH 1S/C19H26N2O3/c1-19(2,23)12-13-6-8-21(9-7-13)18(22)17-11-14-10-15(24-3)4-5-16(14)20-17/h4-5,10-11,13,20,23H,6-9,12H2,1-3H3 D0Q8RC DRUGINKE OXSCPDKUZWPWFR-UHFFFAOYSA-N D0Q8RC DRUGSMIL CC(C)(CC1CCN(CC1)C(=O)C2=CC3=C(N2)C=CC(=C3)OC)O D0Q8RC HIGHSTAT Patented D0Q8RC COMPCLAS N-(indolylcarbonyl)-piperidine derivatives D0Q9QQ DRUG__ID D0Q9QQ D0Q9QQ DRUGCOMP BIOGEN MA INC D0Q9QQ DRUGTYPE Small molecular drug D0Q9QQ DRUGINCH 1S/C20H27F3O4/c1-11-4-6-15-12(2)19(26,20(21,22)23)9-8-18(15,3)14(11)7-5-13-16(24)10-27-17(13)25/h5,12,14-16,24,26H,1,4,6-10H2,2-3H3/b13-5+/t12-,14-,15-,16-,18+,19+/m1/s1 D0Q9QQ DRUGINKE NDMPTVODOMVTKE-YDWKZQRASA-N D0Q9QQ DRUGSMIL CC1C2CCC(=C)C(C2(CCC1(C(F)(F)F)O)C)CC=C3C(COC3=O)O D0Q9QQ HIGHSTAT Patented D0Q9QQ COMPCLAS Diterpenoid derivatives D0QD5Y DRUG__ID D0QD5Y D0QD5Y DRUGCOMP DEBIOPHARM SA [CHAURIGENE DISCOVERY TECH LTD [IN] D0QD5Y DRUGTYPE Small molecular drug D0QD5Y DRUGINCH 1S/C33H32F3N7O2/c1-21-6-7-25(38-30(44)22-4-3-5-23(18-22)33(34,35)36)19-29(21)43-13-12-28-27(31(43)45)20-37-32(40-28)39-24-8-10-26(11-9-24)42-16-14-41(2)15-17-42/h3-11,18-20H,12-17H2,1-2H3,(H,38,44)(H,37,39,40) D0QD5Y DRUGINKE WVGSOXRZIVSEQO-UHFFFAOYSA-N D0QD5Y DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)N3CCC4=NC(=NC=C4C3=O)NC5=CC=C(C=C5)N6CCN(CC6)C D0QD5Y HIGHSTAT Patented D0QD5Y COMPCLAS Aromatic bicyclic compounds D0QD6T DRUG__ID D0QD6T D0QD6T DRUGCOMP F. HOFFMANN-LA ROCHE AG GAZZARD, Lewis J. HANAN, Emily KINTZ, Samuel LYSSIKATOS, Joseph P. PURKEY, Hans Edward D0QD6T DRUGTYPE Small molecular drug D0QD6T DRUGINCH 1S/C19H16FN3O/c1-11-16(9-21-10-17(11)20)14-5-4-13-7-18(22-8-15(13)6-14)23-19(24)12-2-3-12/h4-10,12H,2-3H2,1H3,(H,22,23,24) D0QD6T DRUGINKE GSLMJIPSSNUWRV-UHFFFAOYSA-N D0QD6T DRUGSMIL CC1=C(C=NC=C1C2=CC3=CN=C(C=C3C=C2)NC(=O)C4CC4)F D0QD6T HIGHSTAT Patented D0QD6T COMPCLAS 6,6-fused nitrogenous heterocyclic compounds D0QM0D DRUG__ID D0QM0D D0QM0D DRUGCOMP AMURA THERAPEUTICS LIMITED QUIBELL, Martin WATTS, John, Paul FLINN, Nicholas, Sean D0QM0D DRUGTYPE Small molecular drug D0QM0D DRUGINCH 1S/C24H27ClN4O4/c25-18-12-29(21-19(30)13-33-22(18)21)24(32)20(14-5-2-1-3-6-14)28-23(31)16-8-4-7-15(9-16)17-10-26-27-11-17/h4,7-11,14,18,20-22H,1-3,5-6,12-13H2,(H,26,27)(H,28,31)/t18-,20-,21+,22+/m0/s1 D0QM0D DRUGINKE CTSFUIJCUAXDOL-VXSCBNMQSA-N D0QM0D DRUGSMIL C1CCC(CC1)C(C(=O)N2CC(C3C2C(=O)CO3)Cl)NC(=O)C4=CC=CC(=C4)C5=CNN=C5 D0QM0D HIGHSTAT Patented D0QM0D COMPCLAS Oxotetrahydro-2-H-furo[3.2-b]pyrrol-4(5-H)-yl derivatives D0QM1D DRUG__ID D0QM1D D0QM1D DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D0QM1D DRUGTYPE Small molecular drug D0QM1D DRUGINCH 1S/C17H14ClFN2/c1-13-6-8-20-15(9-13)5-7-17(19)11-21(12-17)16-4-2-3-14(18)10-16/h2-4,6,8-10H,11-12H2,1H3 D0QM1D DRUGINKE CCKHKYMAGHMQLN-UHFFFAOYSA-N D0QM1D DRUGSMIL CC1=CC(=NC=C1)C#CC2(CN(C2)C3=CC(=CC=C3)Cl)F D0QM1D HIGHSTAT Patented D0QM1D COMPCLAS Central azetidine derivatives D0QM1R DRUG__ID D0QM1R D0QM1R DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. MASUDA Seiji MATSUDA Yohei SAKAGAMI Kazunari KONISHI Kazuhide URABE Hiroki SHIMONO Rie OKADA Kumiko D0QM1R DRUGTYPE Small molecular drug D0QM1R DRUGINCH 1S/C21H17F3N6O3/c1-11-7-12(18(25)31)3-5-14(11)19-28-20(33-29-19)15-9-27-30(2)16(15)10-32-17-6-4-13(8-26-17)21(22,23)24/h3-9H,10H2,1-2H3,(H2,25,31) D0QM1R DRUGINKE QBSSBYCWTIBHGM-UHFFFAOYSA-N D0QM1R DRUGSMIL CC1=C(C=CC(=C1)C(=O)N)C2=NOC(=N2)C3=C(N(N=C3)C)COC4=NC=C(C=C4)C(F)(F)F D0QM1R HIGHSTAT Patented D0QM1R COMPCLAS Pyrazole derivatives D0QS2B DRUG__ID D0QS2B D0QS2B DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0QS2B DRUGTYPE Small molecular drug D0QS2B DRUGINCH 1S/C19H17F4N5O2S/c1-30-15-7-12(20)3-4-13(15)14-8-17(26-10-25-14)28-18-6-11(9-31(2,24)29)5-16(27-18)19(21,22)23/h3-8,10,24H,9H2,1-2H3,(H,25,26,27,28) D0QS2B DRUGINKE BYCJOJLDGATDTD-UHFFFAOYSA-N D0QS2B DRUGSMIL COC1=C(C=CC(=C1)F)C2=CC(=NC=N2)NC3=CC(=CC(=N3)C(F)(F)F)CS(=N)(=O)C D0QS2B HIGHSTAT Patented D0QS2B COMPCLAS N-(pyridin-2-yl)pyrimidin-4-amine derivatives D0QW4H DRUG__ID D0QW4H D0QW4H DRUGCOMP PHARMACYCLICS, INC. CHEN, Wei LOURY, David, J. MODY, Tarak, D. WANG, Longcheng D0QW4H DRUGTYPE Small molecular drug D0QW4H DRUGINCH 1S/C33H32N6O2/c1-37(24-15-16-24)19-7-12-30(40)38(2)25-8-6-9-26(20-25)39-21-29(31-32(34)35-22-36-33(31)39)23-13-17-28(18-14-23)41-27-10-4-3-5-11-27/h3-14,17-18,20-22,24H,15-16,19H2,1-2H3,(H2,34,35,36)/b12-7+ D0QW4H DRUGINKE NARJNVJAUDCMNV-KPKJPENVSA-N D0QW4H DRUGSMIL CN(CC=CC(=O)N(C)C1=CC=CC(=C1)N2C=C(C3=C(N=CN=C32)N)C4=CC=C(C=C4)OC5=CC=CC=C5)C6CC6 D0QW4H HIGHSTAT Patented D0QW4H COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0QX6W DRUG__ID D0QX6W D0QX6W DRUGCOMP Universit de Montral D0QX6W DRUGTYPE Small molecular drug D0QX6W DRUGINCH 1S/C20H20N4O3/c1-20(2,3)27-19(26)21-15-11-8-14(9-12-15)10-13-18(25)24-17-7-5-4-6-16(17)22-23-24/h4-13H,1-3H3,(H,21,26)/b13-10+ D0QX6W DRUGINKE HXHBNXDLCDLAKO-JLHYYAGUSA-N D0QX6W DRUGSMIL CC(C)(C)OC(=O)NC1=CC=C(C=C1)C=CC(=O)N2C3=CC=CC=C3N=N2 D0QX6W HIGHSTAT Patented D0QX6W COMPCLAS Benzotriazole derivatives D0QY3L DRUG__ID D0QY3L D0QY3L DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D0QY3L DRUGTYPE Small molecular drug D0QY3L DRUGINCH 1S/C25H24N4O3/c30-23(27-17-21-13-7-8-14-26-21)28-15-16-29-22(18-28)25(32-24(29)31,19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-14,22H,15-18H2,(H,27,30) D0QY3L DRUGINKE ONMOMQJIMXCMOJ-UHFFFAOYSA-N D0QY3L DRUGSMIL C1CN2C(CN1C(=O)NCC3=CC=CC=N3)C(OC2=O)(C4=CC=CC=C4)C5=CC=CC=C5 D0QY3L HIGHSTAT Patented D0QY3L COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D0QZ8K DRUG__ID D0QZ8K D0QZ8K DRUGCOMP NEWLINK GENETICS CORPORATION MAUTINO, Mario KUMAR, Sanjeev WALDO, Jesse JAIPURI, Firoz KESHARWANI, Tanay ZHANG, Xiaoxia D0QZ8K DRUGTYPE Small molecular drug D0QZ8K DRUGINCH 1S/C24H31N3O2/c28-23(14-21-19-8-4-5-9-20(19)22-15-25-16-27(21)22)17-10-12-26(13-11-17)24(29)18-6-2-1-3-7-18/h4-5,8-9,15-18,21,23,28H,1-3,6-7,10-14H2 D0QZ8K DRUGINKE FDUHADIZUWTWAZ-UHFFFAOYSA-N D0QZ8K DRUGSMIL C1CCC(CC1)C(=O)N2CCC(CC2)C(CC3C4=CC=CC=C4C5=CN=CN35)O D0QZ8K HIGHSTAT Patented D0QZ8K COMPCLAS Acyl piperidine derivatives D0R0GY DRUG__ID D0R0GY D0R0GY DRUGCOMP NOVARTIS AG AUBERSON, Yves BOCK, Mark Gary BRAGA, Dario CURZI, Marco DODD, Stephanie Kay GIAFFREDA, Stefano Luca JIANG, Haiyang KARPINSKI, Piotr TROXLER, Thomas J. WANG, Tielin WANG, Xiaoyang ZHANG, XuechuNOVARTIS AG D0R0GY DRUGTYPE Small molecular drug D0R0GY DRUGINCH 1S/C19H29N5O3/c1-21-18(25)6-5-17(20-21)23-9-7-16(8-10-23)27-19(26)24-13-11-22(12-14-24)15-3-2-4-15/h5-6,15-16H,2-4,7-14H2,1H3 D0R0GY DRUGINKE BVUJMFFRMZRNAT-UHFFFAOYSA-N D0R0GY DRUGSMIL CN1C(=O)C=CC(=N1)N2CCC(CC2)OC(=O)N3CCN(CC3)C4CCC4 D0R0GY HIGHSTAT Patented D0R0GY COMPCLAS Piperazine carbamate/urea derivatives D0R2AI DRUG__ID D0R2AI D0R2AI DRUGCOMP Korea institute of radiological & medical sciences, S D0R2AI DRUGTYPE Small molecular drug D0R2AI DRUGINCH 1S/C14H21NO/c15-13-6-8-14(9-7-13)16-11-10-12-4-2-1-3-5-12/h6-9,12H,1-5,10-11,15H2 D0R2AI DRUGINKE KZIPKNLJWRDAKV-UHFFFAOYSA-N D0R2AI DRUGSMIL C1CCC(CC1)CCOC2=CC=C(C=C2)N D0R2AI HIGHSTAT Patented D0R2AI COMPCLAS 4-(2-cyclohexylethoxy) aniline derivatives D0R2XX DRUG__ID D0R2XX D0R2XX DRUGCOMP COCENSYS, INC D0R2XX DRUGTYPE Small molecular drug D0R2XX DRUGINCH 1S/C16H12Cl2N2O/c1-20-14-7-6-12(18)8-13(14)16(19-9-15(20)21)10-2-4-11(17)5-3-10/h2-8H,9H2,1H3 D0R2XX DRUGINKE PUMYFTJOWAJIKF-UHFFFAOYSA-N D0R2XX DRUGSMIL CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=C(C=C3)Cl D0R2XX HIGHSTAT Patented D0R2XX COMPCLAS Benzodiazepine derivatives D0R3JK DRUG__ID D0R3JK D0R3JK DRUGCOMP INFINITY PHARMACEUTICALS, INC. BEHNKE, Mark, L. CASTRO, Alfredo, C. CHAN, Lawrence, K. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LEBLANC, Yves LIU, Tao PELUSO, Stephane SNYDER, Daniel, A. TIBBITTS, Thomas, T D0R3JK DRUGTYPE Small molecular drug D0R3JK DRUGINCH 1S/C10H10BrNO2/c1-13-8-4-2-3-7(5-8)9-6-10(11)12-14-9/h2-5,9H,6H2,1H3/t9-/m1/s1 D0R3JK DRUGINKE IWLKUWXPADWQAT-SECBINFHSA-N D0R3JK DRUGSMIL COC1=CC=CC(=C1)C2CC(=NO2)Br D0R3JK HIGHSTAT Patented D0R3JK COMPCLAS Isoxazoline derivatives D0R4IT DRUG__ID D0R4IT D0R4IT DRUGCOMP GSK D0R4IT DRUGTYPE Small molecular drug D0R4IT DRUGINCH 1S/C16H11ClF3N5OS/c17-13-9(2-1-3-10(13)16(18,19)20)15(26)24-4-5-25-12(6-24)22-23-14(25)11-7-27-8-21-11/h1-3,7-8H,4-6H2 D0R4IT DRUGINKE BDKXTJZVSCTDFF-UHFFFAOYSA-N D0R4IT DRUGSMIL C1CN2C(=NN=C2C3=CSC=N3)CN1C(=O)C4=C(C(=CC=C4)C(F)(F)F)Cl D0R4IT HIGHSTAT Patented D0R4IT COMPCLAS Heterocyclic-fused piperazine derivatives D0R5HG DRUG__ID D0R5HG D0R5HG DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0R5HG DRUGTYPE Small molecular drug D0R5HG DRUGINCH 1S/C19H15ClFN3O3S/c20-16-9-12(1-8-18(16)27-14-4-5-14)17-10-19(23-11-22-17)24-28(25,26)15-6-2-13(21)3-7-15/h1-3,6-11,14H,4-5H2,(H,22,23,24) D0R5HG DRUGINKE NHNNNQMEILXDMV-UHFFFAOYSA-N D0R5HG DRUGSMIL C1CC1OC2=C(C=C(C=C2)C3=CC(=NC=N3)NS(=O)(=O)C4=CC=C(C=C4)F)Cl D0R5HG HIGHSTAT Patented D0R5HG COMPCLAS Pyrimidine benzenesulfonamide derivatives D0R9HP DRUG__ID D0R9HP D0R9HP DRUGCOMP TAIHO PHARMACEUTICAL CO., LTD D0R9HP DRUGTYPE Small molecular drug D0R9HP DRUGINCH 1S/C21H18ClN7O3/c1-2-16(30)28-6-5-12(8-28)29-9-13(17-18(23)24-10-25-19(17)29)20(31)27-21-26-14-7-11(22)3-4-15(14)32-21/h2-4,7,9-10,12H,1,5-6,8H2,(H2,23,24,25)(H,26,27,31) D0R9HP DRUGINKE HDJGAVFAWSMJSN-UHFFFAOYSA-N D0R9HP DRUGSMIL C=CC(=O)N1CCC(C1)N2C=C(C3=C(N=CN=C32)N)C(=O)NC4=NC5=C(O4)C=CC(=C5)Cl D0R9HP HIGHSTAT Patented D0R9HP COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0RG4J DRUG__ID D0RG4J D0RG4J DRUGCOMP H. LUNDBECK A/S D0RG4J DRUGTYPE Small molecular drug D0RG4J DRUGINCH 1S/C20H17ClF6N2O/c21-15-4-2-1-3-14(15)17(30)29-11-13(9-18(7-8-18)20(25,26)27)12-5-6-16(28-10-12)19(22,23)24/h1-6,10,13H,7-9,11H2,(H,29,30) D0RG4J DRUGINKE GRQCSOYTLVIPEY-UHFFFAOYSA-N D0RG4J DRUGSMIL C1CC1(CC(CNC(=O)C2=CC=CC=C2Cl)C3=CN=C(C=C3)C(F)(F)F)C(F)(F)F D0RG4J HIGHSTAT Patented D0RG4J COMPCLAS Chlorobenzamide derivatives D0RI3W DRUG__ID D0RI3W D0RI3W DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GmbH D0RI3W DRUGTYPE Small molecular drug D0RI3W DRUGINCH 1S/C20H19ClN4O/c1-3-4-11-26-14-9-10-16(21)15(12-14)20-24-23-19-13(2)22-17-7-5-6-8-18(17)25(19)20/h5-10,12H,3-4,11H2,1-2H3 D0RI3W DRUGINKE ITEIGISUTJIFPA-UHFFFAOYSA-N D0RI3W DRUGSMIL CCCCOC1=CC(=C(C=C1)Cl)C2=NN=C3N2C4=CC=CC=C4N=C3C D0RI3W HIGHSTAT Patented D0RI3W COMPCLAS 1,2,4-triazole [4,3-a]quinoxaline derivatives D0RM0U DRUG__ID D0RM0U D0RM0U DRUGCOMP AureliaSan GBH D0RM0U DRUGTYPE Small molecular drug D0RM0U DRUGINCH 1S/C30H46O3/c1-19(2)9-8-10-20(26(32)33)21-13-17-30(7)23-11-12-24-27(3,4)25(31)15-16-28(24,5)22(23)14-18-29(21,30)6/h9,20-21,24H,8,10-18H2,1-7H3,(H,32,33)/t20-,21-,24?,28?,29-,30+/m0/s1 D0RM0U DRUGINKE XLPAINGDLCDYQV-MSEQJIGISA-N D0RM0U DRUGSMIL CC(=CCCC(C1CCC2(C1(CCC3=C2CCC4C3(CCC(=O)C4(C)C)C)C)C)C(=O)O)C D0RM0U HIGHSTAT Patented D0RM0U COMPCLAS Boswellia acid derivatives D0RP4W DRUG__ID D0RP4W D0RP4W DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John VILE, Julia GELMAN, Danny M. GAI, Xinjie BARKER, Oliver Robin DEBOVES, Herv Jean Claude EAST, Stephen Peter BOESEN, Thomas D0RP4W DRUGTYPE Small molecular drug D0RP4W DRUGINCH 1S/C22H27N3O3/c1-23(2)12-10-20(26)16-8-9-17-19(15-16)25-11-6-5-7-18(25)21(17)22(27)28-14-13-24(3)4/h5-9,11,15H,10,12-14H2,1-4H3 D0RP4W DRUGINKE HQWDSOCFKBELNH-UHFFFAOYSA-N D0RP4W DRUGSMIL CN(C)CCC(=O)C1=CC2=C(C=C1)C(=C3N2C=CC=C3)C(=O)OCCN(C)C D0RP4W HIGHSTAT Patented D0RP4W COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D0RT4U DRUG__ID D0RT4U D0RT4U DRUGCOMP Italfarmaco, S.A., Spain D0RT4U DRUGTYPE Small molecular drug D0RT4U DRUGINCH 1S/C21H19N3O4/c1-24(16-7-3-2-4-8-16)21(27)28-17-9-10-19(25)18(12-17)20(26)23-14-15-6-5-11-22-13-15/h2-13,25H,14H2,1H3,(H,23,26) D0RT4U DRUGINKE DSHOFHQFNJBXHY-UHFFFAOYSA-N D0RT4U DRUGSMIL CN(C1=CC=CC=C1)C(=O)OC2=CC(=C(C=C2)O)C(=O)NCC3=CN=CC=C3 D0RT4U HIGHSTAT Patented D0RT4U COMPCLAS Aryl carbamate analogs D0RU0W DRUG__ID D0RU0W D0RU0W DRUGCOMP DAINIPPON SUMITOMO PHARMA CO., LTD D0RU0W DRUGTYPE Small molecular drug D0RU0W DRUGINCH 1S/C18H14ClN3O2/c19-13-6-7-14(20-10-13)17-21-15-11-22(9-8-16(15)24-17)18(23)12-4-2-1-3-5-12/h1-7,10H,8-9,11H2 D0RU0W DRUGINKE NUNJYRYJNBEYPH-UHFFFAOYSA-N D0RU0W DRUGSMIL C1CN(CC2=C1OC(=N2)C3=NC=C(C=C3)Cl)C(=O)C4=CC=CC=C4 D0RU0W HIGHSTAT Patented D0RU0W COMPCLAS Tetra-hydro-oxazolopyridine derivatives D0RX6D DRUG__ID D0RX6D D0RX6D DRUGCOMP NUMERATE, INC. THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY GRIFFIN, John RAIMUNDO, Brian MADRID, Peter KHOSLA, Chaitan JIN, Xi KLOECK, Cornelius D0RX6D DRUGTYPE Small molecular drug D0RX6D DRUGINCH 1S/C21H13ClN2O2/c22-17-9-4-10-18-20(17)16(12-19(25)14-6-5-11-23-13-14)21(26)24(18)15-7-2-1-3-8-15/h1-13H/b16-12+ D0RX6D DRUGINKE MAXLUMXHDRQNGJ-FOWTUZBSSA-N D0RX6D DRUGSMIL C1=CC=C(C=C1)N2C3=C(C(=CC=C3)Cl)C(=CC(=O)C4=CN=CC=C4)C2=O D0RX6D HIGHSTAT Patented D0RX6D COMPCLAS 3-acylidene-2-oxoindole derivatives D0RX8U DRUG__ID D0RX8U D0RX8U DRUGCOMP JANSSEN PHARMACEUTICA NV D0RX8U DRUGTYPE Small molecular drug D0RX8U DRUGINCH 1S/C29H27N5O3/c1-17-21(20-6-4-5-7-23(20)32-17)14-28(35)34-11-10-18-12-19(8-9-25(18)34)33-29-22-13-26(36-2)27(37-3)15-24(22)30-16-31-29/h4-9,12-13,15-16,32H,10-11,14H2,1-3H3,(H,30,31,33) D0RX8U DRUGINKE XPDZQQQJQXPBBO-UHFFFAOYSA-N D0RX8U DRUGSMIL CC1=C(C2=CC=CC=C2N1)CC(=O)N3CCC4=C3C=CC(=C4)NC5=NC=NC6=CC(=C(C=C65)OC)OC D0RX8U HIGHSTAT Patented D0RX8U COMPCLAS Indoline derivatives D0RZ5O DRUG__ID D0RZ5O D0RZ5O DRUGCOMP NORTHEASTERN UNIVERSITY MAKRIYANNIS, Alexandros PANDARINATHAN, Lakshimpathi ZVONOK, Nikolai PARKKARI, Teija CHAPMAN, Lauren D0RZ5O DRUGTYPE Small molecular drug D0RZ5O DRUGINCH 1S/C14H16Cl3N5O/c1-21(7-3-2-6-15)14(23)22-19-13(18-20-22)8-10-4-5-11(16)9-12(10)17/h4-5,9H,2-3,6-8H2,1H3 D0RZ5O DRUGINKE OQUPYXJFXDHGPX-UHFFFAOYSA-N D0RZ5O DRUGSMIL CN(CCCCCl)C(=O)N1N=C(N=N1)CC2=C(C=C(C=C2)Cl)Cl D0RZ5O HIGHSTAT Patented D0RZ5O COMPCLAS Tetrazolyl urea derivatives D0S1DI DRUG__ID D0S1DI D0S1DI DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0S1DI DRUGTYPE Small molecular drug D0S1DI DRUGINCH 1S/C24H26N8O2S2/c1-13(2)27-19-9-21(29-15-4-5-18-20(8-15)35-12-26-18)25-10-17(19)22-30-31-23(36-22)24(34)32-7-6-16(11-32)28-14(3)33/h4-5,8-10,12-13,16H,6-7,11H2,1-3H3,(H,28,33)(H2,25,27,29) D0S1DI DRUGINKE OYYXHUJLHDYELY-UHFFFAOYSA-N D0S1DI DRUGSMIL CC(C)NC1=CC(=NC=C1C2=NN=C(S2)C(=O)N3CCC(C3)NC(=O)C)NC4=CC5=C(C=C4)N=CS5 D0S1DI HIGHSTAT Patented D0S1DI COMPCLAS Diaminopyridine analogs D0S3AL DRUG__ID D0S3AL D0S3AL DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0S3AL DRUGTYPE Small molecular drug D0S3AL DRUGINCH 1S/C28H28FN5O2/c1-36-27(35)24(20-6-3-2-4-7-20)19-33-16-12-22(13-17-33)26-18-25(21-8-10-23(29)11-9-21)32-34(26)28-30-14-5-15-31-28/h2-11,14-15,18,22,24H,12-13,16-17,19H2,1H3 D0S3AL DRUGINKE SVWGQADPJAOQRT-UHFFFAOYSA-N D0S3AL DRUGSMIL COC(=O)C(CN1CCC(CC1)C2=CC(=NN2C3=NC=CC=N3)C4=CC=C(C=C4)F)C5=CC=CC=C5 D0S3AL HIGHSTAT Patented D0S3AL COMPCLAS Piperidinyl triazole derivatives D0S3ON DRUG__ID D0S3ON D0S3ON DRUGCOMP COGNITION THERAPEUTICS, INC D0S3ON DRUGTYPE Small molecular drug D0S3ON DRUGINCH 1S/C25H33N3O3/c1-25(2,10-9-18-7-8-22(29)23(15-18)31-3)28-16-19-5-4-6-20(21(19)17-28)24(30)27-13-11-26-12-14-27/h4-8,15,26,29H,9-14,16-17H2,1-3H3 D0S3ON DRUGINKE XNAGJLRFPOQPPM-UHFFFAOYSA-N D0S3ON DRUGSMIL CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4 D0S3ON HIGHSTAT Patented D0S3ON COMPCLAS Isoindoline derivatives D0S4UG DRUG__ID D0S4UG D0S4UG DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0S4UG DRUGTYPE Small molecular drug D0S4UG DRUGINCH 1S/C22H21F3N6O/c1-21(31-18-13-28-17(12-29-18)22(23,24)25)9-4-8-16(21)30-20(32)15-7-3-2-6-14(15)19-26-10-5-11-27-19/h2-3,5-7,10-13,16H,4,8-9H2,1H3,(H,29,31)(H,30,32)/t16-,21-/m0/s1 D0S4UG DRUGINKE WZNUKPZCVKITNK-KKSFZXQISA-N D0S4UG DRUGSMIL CC1(CCCC1NC(=O)C2=CC=CC=C2C3=NC=CC=N3)NC4=NC=C(N=C4)C(F)(F)F D0S4UG HIGHSTAT Patented D0S4UG COMPCLAS 1,2-diamino cyclopentane-based derivatives D0S5ID DRUG__ID D0S5ID D0S5ID DRUGCOMP FORMA THERAPEUTICS, INC D0S5ID DRUGTYPE Small molecular drug D0S5ID DRUGINCH 1S/C24H30N4O5S/c1-16-14-26(24(30)33-21-4-3-5-21)23-12-18(6-7-22(23)28(16)17(2)29)19-13-25-27(15-19)20-8-10-34(31,32)11-9-20/h6-7,12-13,15-16,20-21H,3-5,8-11,14H2,1-2H3/t16-/m0/s1 D0S5ID DRUGINKE OCRGMHCAJOHZLW-INIZCTEOSA-N D0S5ID DRUGSMIL CC1CN(C2=C(N1C(=O)C)C=CC(=C2)C3=CN(N=C3)C4CCS(=O)(=O)CC4)C(=O)OC5CCC5 D0S5ID HIGHSTAT Patented D0S5ID COMPCLAS Benzothiazepine analogs D0SA6L DRUG__ID D0SA6L D0SA6L DRUGCOMP Myrexis D0SA6L DRUGTYPE Small molecular drug D0SA6L DRUGINCH 1S/C29H34N6O4/c1-37-27-19-21(18-22(20-30)28(27)39-25-7-16-38-17-8-25)26-6-9-31-29(33-26)32-23-2-4-24(5-3-23)35-12-10-34(11-13-35)14-15-36/h2-6,9,18-19,25,36H,7-8,10-17H2,1H3,(H,31,32,33) D0SA6L DRUGINKE XDKGLOMIIQBBCB-UHFFFAOYSA-N D0SA6L DRUGSMIL COC1=CC(=CC(=C1OC2CCOCC2)C#N)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(CC5)CCO D0SA6L HIGHSTAT Patented D0SA6L COMPCLAS Aminopyrimidine derivatives D0SG9F DRUG__ID D0SG9F D0SG9F DRUGCOMP ZENITH EPIGENETICS CORP D0SG9F DRUGTYPE Small molecular drug D0SG9F DRUGINCH 1S/C19H18N4O/c1-12-18(13(2)24-22-12)15-8-16(20)19-17(9-15)23(11-21-19)10-14-6-4-3-5-7-14/h3-9,11H,10,20H2,1-2H3 D0SG9F DRUGINKE JNHVPJQTAXBUHN-UHFFFAOYSA-N D0SG9F DRUGSMIL CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)N(C=N3)CC4=CC=CC=C4)N D0SG9F HIGHSTAT Patented D0SG9F COMPCLAS Isoxazole-based bicyclic compounds D0SM2O DRUG__ID D0SM2O D0SM2O DRUGCOMP ASTELLAS PHARMA INC. AZAMI, Hidenori ABE, Tomoaki KAKEFUDA, Akio HIRANO, Masaaki WATANABE, Kazushi D0SM2O DRUGTYPE Small molecular drug D0SM2O DRUGINCH 1S/C17H23N3O2/c1-17(2,22)10-12-4-7-20(8-5-12)16(21)14-9-13-3-6-18-11-15(13)19-14/h3,6,9,11-12,19,22H,4-5,7-8,10H2,1-2H3 D0SM2O DRUGINKE HSSJHQZLKSLBPS-UHFFFAOYSA-N D0SM2O DRUGSMIL CC(C)(CC1CCN(CC1)C(=O)C2=CC3=C(N2)C=NC=C3)O D0SM2O HIGHSTAT Patented D0SM2O COMPCLAS N-(pyridinepyrroylylcarbonyl)-piperidine derivatives D0SV2S DRUG__ID D0SV2S D0SV2S DRUGCOMP FORMA THERAPEUTICS INC D0SV2S DRUGTYPE Small molecular drug D0SV2S DRUGINCH 1S/C20H24FN3O3/c1-13-3-6-17-18(24(13)20(25)26-2)8-7-16(19(17)27-10-9-21)14-11-22-23(12-14)15-4-5-15/h7-8,11-13,15H,3-6,9-10H2,1-2H3/t13-/m0/s1 D0SV2S DRUGINKE LVOBMWBVNYYGFM-ZDUSSCGKSA-N D0SV2S DRUGSMIL CC1CCC2=C(N1C(=O)OC)C=CC(=C2OCCF)C3=CN(N=C3)C4CC4 D0SV2S HIGHSTAT Patented D0SV2S COMPCLAS Tetra-hydro-quinoline derivatives D0SV6D DRUG__ID D0SV6D D0SV6D DRUGCOMP MERCK & CO., INC. BAKER, Robert, K. HALE, Jeffrey, J. MIAO, Shouwu RUPPRECHT, Kathleen, M D0SV6D DRUGTYPE Small molecular drug D0SV6D DRUGINCH 1S/C29H25ClF2N4O2/c1-29(2,32)25(20-11-21(13-24(31)12-20)27-34-35-28(37)38-27)22-15-36(16-22)26(18-6-8-23(30)9-7-18)19-5-3-4-17(10-19)14-33/h3-13,22,25-26H,15-16H2,1-2H3,(H,35,37)/t25-,26?/m1/s1 D0SV6D DRUGINKE DQKCYKJTBAXWFL-DCWQJPKNSA-N D0SV6D DRUGSMIL CC(C)(C(C1CN(C1)C(C2=CC=C(C=C2)Cl)C3=CC=CC(=C3)C#N)C4=CC(=CC(=C4)C5=NNC(=O)O5)F)F D0SV6D HIGHSTAT Patented D0SV6D COMPCLAS Heterocyclic-substituted 3-alkyl azetidine derivatives D0T5WX DRUG__ID D0T5WX D0T5WX DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0T5WX DRUGTYPE Small molecular drug D0T5WX DRUGINCH 1S/C28H34N4O2S/c1-18(2)17-32(21-8-4-3-5-9-21)25-15-14-20(22-10-6-7-11-23(22)27(33)34)16-24(25)29-28-31-30-26(35-28)19-12-13-19/h6-7,10-11,14-16,18-19,21H,3-5,8-9,12-13,17H2,1-2H3,(H,29,31)(H,33,34) D0T5WX DRUGINKE PWIBECCFTAUDGG-UHFFFAOYSA-N D0T5WX DRUGSMIL CC(C)CN(C1CCCCC1)C2=C(C=C(C=C2)C3=CC=CC=C3C(=O)O)NC4=NN=C(S4)C5CC5 D0T5WX HIGHSTAT Patented D0T5WX COMPCLAS Biphenyl 1,2-diamine derivatives D0T6CM DRUG__ID D0T6CM D0T6CM DRUGCOMP LEAD DISCOVERY CENTER GMBH D0T6CM DRUGTYPE Small molecular drug D0T6CM DRUGINCH 1S/C24H30N8O/c1-17(2)20-15-27-32-22(20)28-24(33-19-8-11-30(3)12-9-19)29-23(32)26-14-18-6-4-5-7-21(18)31-13-10-25-16-31/h4-7,10,13,15-17,19H,8-9,11-12,14H2,1-3H3,(H,26,28,29) D0T6CM DRUGINKE KLTSWTPLJGXFTH-UHFFFAOYSA-N D0T6CM DRUGSMIL CC(C)C1=C2N=C(N=C(N2N=C1)NCC3=CC=CC=C3N4C=CN=C4)OC5CCN(CC5)C D0T6CM HIGHSTAT Patented D0T6CM COMPCLAS Pyrazolo-triazine derivatives D0T7QY DRUG__ID D0T7QY D0T7QY DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D0T7QY DRUGTYPE Small molecular drug D0T7QY DRUGINCH 1S/C26H19Cl2N5O2/c27-19-11-9-18(10-12-19)25-20(13-23(30)34)24(32-33(25)22-4-2-1-3-21(22)28)26(35)31-15-17-7-5-16(14-29)6-8-17/h1-12H,13,15H2,(H2,30,34)(H,31,35) D0T7QY DRUGINKE XBSLPZFPNMDPEG-UHFFFAOYSA-N D0T7QY DRUGSMIL C1=CC=C(C(=C1)N2C(=C(C(=N2)C(=O)NCC3=CC=C(C=C3)C#N)CC(=O)N)C4=CC=C(C=C4)Cl)Cl D0T7QY HIGHSTAT Patented D0T7QY COMPCLAS Pyrazole derivatives D0T7WW DRUG__ID D0T7WW D0T7WW DRUGCOMP Korea institute of radiological & medical sciences, S D0T7WW DRUGTYPE Small molecular drug D0T7WW DRUGINCH 1S/C24H29BrN2O4/c25-19-7-4-8-21(15-19)27-24(29)17-30-16-23(28)26-20-9-11-22(12-10-20)31-14-13-18-5-2-1-3-6-18/h4,7-12,15,18H,1-3,5-6,13-14,16-17H2,(H,26,28)(H,27,29) D0T7WW DRUGINKE SUIJKJPCTOXCER-UHFFFAOYSA-N D0T7WW DRUGSMIL C1CCC(CC1)CCOC2=CC=C(C=C2)NC(=O)COCC(=O)NC3=CC(=CC=C3)Br D0T7WW HIGHSTAT Patented D0T7WW COMPCLAS 4-(2-cyclohexylethoxy) aniline derivatives D0T8AS DRUG__ID D0T8AS D0T8AS DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0T8AS DRUGTYPE Small molecular drug D0T8AS DRUGINCH 1S/C19H16ClN3O3S/c20-16-10-13(6-9-18(16)26-14-7-8-14)17-11-19(22-12-21-17)23-27(24,25)15-4-2-1-3-5-15/h1-6,9-12,14H,7-8H2,(H,21,22,23) D0T8AS DRUGINKE AJZPXSIAEFVSBW-UHFFFAOYSA-N D0T8AS DRUGSMIL C1CC1OC2=C(C=C(C=C2)C3=CC(=NC=N3)NS(=O)(=O)C4=CC=CC=C4)Cl D0T8AS HIGHSTAT Patented D0T8AS COMPCLAS Pyrimidine benzenesulfonamide derivatives D0T9OL DRUG__ID D0T9OL D0T9OL DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0T9OL DRUGTYPE Small molecular drug D0T9OL DRUGINCH 1S/C19H24N2O/c22-18(21-6-5-16-3-1-2-4-17(16)21)20-19-10-13-7-14(11-19)9-15(8-13)12-19/h1-4,13-15H,5-12H2,(H,20,22) D0T9OL DRUGINKE CQDFSOMWSQOSOR-UHFFFAOYSA-N D0T9OL DRUGSMIL C1CN(C2=CC=CC=C21)C(=O)NC34CC5CC(C3)CC(C5)C4 D0T9OL HIGHSTAT Patented D0T9OL COMPCLAS Adamantyl derivatives D0TD8R DRUG__ID D0TD8R D0TD8R DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0TD8R DRUGTYPE Small molecular drug D0TD8R DRUGINCH 1S/C17H14BrFN2O2.ClH/c18-11-3-1-10(2-4-11)15-16(23-8-7-20)13-6-5-12(19)9-14(13)17(22)21-15;/h1-6,9H,7-8,20H2,(H,21,22);1H D0TD8R DRUGINKE BSCLHAQBYMRPSH-UHFFFAOYSA-N D0TD8R DRUGSMIL C1=CC(=CC=C1C2=C(C3=C(C=C(C=C3)F)C(=O)N2)OCCN)Br.Cl D0TD8R HIGHSTAT Patented D0TD8R COMPCLAS 3-phenyl isoquinolin-1(2H) derivatives D0TF0T DRUG__ID D0TF0T D0TF0T DRUGCOMP Daiichi Sankyo Co., Ltd D0TF0T DRUGTYPE Small molecular drug D0TF0T DRUGINCH 1S/C27H26N4O4S/c1-15-10-20(11-16(2)25(15)28)35-19-8-9-21-22(13-19)31(3)24(29-21)14-34-18-6-4-17(5-7-18)12-23-26(32)30-27(33)36-23/h4-11,13,23H,12,14,28H2,1-3H3,(H,30,32,33) D0TF0T DRUGINKE JCYNMRJCUYVDBC-UHFFFAOYSA-N D0TF0T DRUGSMIL CC1=CC(=CC(=C1N)C)OC2=CC3=C(C=C2)N=C(N3C)COC4=CC=C(C=C4)CC5C(=O)NC(=O)S5 D0TF0T HIGHSTAT Patented D0TF0T COMPCLAS Thiazolidine dione crystalline derivatives D0TF2N DRUG__ID D0TF2N D0TF2N DRUGCOMP ORION CORPORATION D0TF2N DRUGTYPE Small molecular drug D0TF2N DRUGINCH 1S/C21H21ClN2O3/c1-13-21(14(2)27-23-13)17-10-20-18(11-19(17)25-3)24(8-9-26-20)12-15-4-6-16(22)7-5-15/h4-7,10-11H,8-9,12H2,1-3H3 D0TF2N DRUGINKE QYWOLKVTQWOHRO-UHFFFAOYSA-N D0TF2N DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=C(C=C2OC)N(CCO3)CC4=CC=C(C=C4)Cl D0TF2N HIGHSTAT Patented D0TF2N COMPCLAS Isoxazole-based bicyclic compounds D0TK5U DRUG__ID D0TK5U D0TK5U DRUGCOMP Myrexis D0TK5U DRUGTYPE Small molecular drug D0TK5U DRUGINCH 1S/C26H28N6O2/c1-18(2)15-25(33)30-23-8-3-19(16-20(23)17-27)24-9-10-28-26(31-24)29-21-4-6-22(7-5-21)32-11-13-34-14-12-32/h3-10,16,18H,11-15H2,1-2H3,(H,30,33)(H,28,29,31) D0TK5U DRUGINKE MIMBVFVOQLKELD-UHFFFAOYSA-N D0TK5U DRUGSMIL CC(C)CC(=O)NC1=C(C=C(C=C1)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4)C#N D0TK5U HIGHSTAT Patented D0TK5U COMPCLAS Aminopyrimidine derivatives D0TM4R DRUG__ID D0TM4R D0TM4R DRUGCOMP Novartis AG D0TM4R DRUGTYPE Small molecular drug D0TM4R DRUGINCH 1S/C18H28N4O3/c1-14(2)20-9-11-22(12-10-20)18(24)25-16-5-7-21(8-6-16)15-3-4-17(23)19-13-15/h3-4,13-14,16H,5-12H2,1-2H3,(H,19,23) D0TM4R DRUGINKE ONRCNWHOGZJSOB-UHFFFAOYSA-N D0TM4R DRUGSMIL CC(C)N1CCN(CC1)C(=O)OC2CCN(CC2)C3=CNC(=O)C=C3 D0TM4R HIGHSTAT Patented D0TM4R COMPCLAS Piperazine carbamate/urea derivatives D0TS3S DRUG__ID D0TS3S D0TS3S DRUGCOMP MERCK & CO., INC. BAKER, Robert, K. HALE, Jeffrey, J. MIAO, Shouwu RUPPRECHT, Kathleen, M D0TS3S DRUGTYPE Small molecular drug D0TS3S DRUGINCH 1S/C29H25F3N4O2/c1-29(2,32)25(21-11-23(30)13-24(31)12-21)22-15-36(16-22)26(20-5-3-4-17(10-20)14-33)18-6-8-19(9-7-18)27-34-35-28(37)38-27/h3-13,22,25-26H,15-16H2,1-2H3,(H,35,37) D0TS3S DRUGINKE SROKVDFDVQITLS-UHFFFAOYSA-N D0TS3S DRUGSMIL CC(C)(C(C1CN(C1)C(C2=CC=C(C=C2)C3=NNC(=O)O3)C4=CC=CC(=C4)C#N)C5=CC(=CC(=C5)F)F)F D0TS3S HIGHSTAT Patented D0TS3S COMPCLAS Heterocyclic-substituted 3-alkyl azetidine derivatives D0TV4O DRUG__ID D0TV4O D0TV4O DRUGCOMP OSCOTEC INC [KR] D0TV4O DRUGTYPE Small molecular drug D0TV4O DRUGINCH 1S/C26H33NO5/c1-7-13-32-27-24(8-2)22-14-19(4)25(15-18(22)3)31-16-20-11-9-10-12-21(20)23(17-29-5)26(28)30-6/h9-12,14-15,17H,7-8,13,16H2,1-6H3/b23-17+,27-24+ D0TV4O DRUGINKE SLZOIVOTSYQKJP-FQGYVBMWSA-N D0TV4O DRUGSMIL CCCON=C(CC)C1=C(C=C(C(=C1)C)OCC2=CC=CC=C2C(=COC)C(=O)OC)C D0TV4O HIGHSTAT Patented D0TV4O COMPCLAS Aryl methoxyacrylate derivatives D0U0MZ DRUG__ID D0U0MZ D0U0MZ DRUGCOMP GLAXOSMITHKLINE LLGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED QIN, Donghui CHEUNG, Mui JOSHI, Hemant TANGIRALA, Raghuram BETHI, Sridhar, Reddy D0U0MZ DRUGTYPE Small molecular drug D0U0MZ DRUGINCH 1S/C20H15ClN6O2/c21-13-2-1-3-14(9-13)26-5-4-12-8-15(10-23-18(12)26)27-6-7-29-19-16(20(27)28)17(22)24-11-25-19/h1-5,8-11H,6-7H2,(H2,22,24,25) D0U0MZ DRUGINKE IHNUTZUAQGMDQV-UHFFFAOYSA-N D0U0MZ DRUGSMIL C1COC2=NC=NC(=C2C(=O)N1C3=CN=C4C(=C3)C=CN4C5=CC(=CC=C5)Cl)N D0U0MZ HIGHSTAT Patented D0U0MZ COMPCLAS Lactam derivatives D0U0QQ DRUG__ID D0U0QQ D0U0QQ DRUGCOMP BIAL PORTELA & CA SA [PT] D0U0QQ DRUGTYPE Small molecular drug D0U0QQ DRUGINCH 1S/C14H18N4O/c1-17(11-7-3-2-4-8-11)14(19)18-13-10-6-5-9-12(13)15-16-18/h5-6,9-11H,2-4,7-8H2,1H3 D0U0QQ DRUGINKE ATPCFTJMZOBYDC-UHFFFAOYSA-N D0U0QQ DRUGSMIL CN(C1CCCCC1)C(=O)N2C3=CC=CC=C3N=N2 D0U0QQ HIGHSTAT Patented D0U0QQ COMPCLAS Tetra-substituted urea derivatives D0U6OY DRUG__ID D0U6OY D0U6OY DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0U6OY DRUGTYPE Small molecular drug D0U6OY DRUGINCH 1S/C26H33N3O2/c1-2-11-27-13-15-28(16-14-27)22-8-9-23-21-10-12-29(25(17-21)24(23)18-22)26(30)31-19-20-6-4-3-5-7-20/h3-9,18,21,25H,2,10-17,19H2,1H3 D0U6OY DRUGINKE FFCRKESJGXTNRJ-UHFFFAOYSA-N D0U6OY DRUGSMIL CCCN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5 D0U6OY HIGHSTAT Patented D0U6OY COMPCLAS Piperazinyl norbenzomorphane compounds D0U7LL DRUG__ID D0U7LL D0U7LL DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D0U7LL DRUGTYPE Small molecular drug D0U7LL DRUGINCH 1S/C29H27F5N2O6S/c1-35(43(41,42)28-26(33)24(31)23(30)25(32)27(28)34)15-22(38)36(19-11-12-20(29(39)40)21(37)13-19)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h7-13,17,37H,2-6,14-15H2,1H3,(H,39,40) D0U7LL DRUGINKE WNVSFFVDMUSXSX-UHFFFAOYSA-N D0U7LL DRUGSMIL CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC(=C(C=C3)C(=O)O)O)S(=O)(=O)C4=C(C(=C(C(=C4F)F)F)F)F D0U7LL HIGHSTAT Patented D0U7LL COMPCLAS Salicylic acid derivatives D0U7VC DRUG__ID D0U7VC D0U7VC DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0U7VC DRUGTYPE Small molecular drug D0U7VC DRUGINCH 1S/C22H24FN3O3S/c1-26(21(27)20-17(28-2)8-5-9-18(20)29-3)16-7-4-6-14(16)24-22-25-15-11-10-13(23)12-19(15)30-22/h5,8-12,14,16H,4,6-7H2,1-3H3,(H,24,25)/t14-,16-/m0/s1 D0U7VC DRUGINKE QIQQOZYTKFYTFE-HOCLYGCPSA-N D0U7VC DRUGSMIL CN(C1CCCC1NC2=NC3=C(S2)C=C(C=C3)F)C(=O)C4=C(C=CC=C4OC)OC D0U7VC HIGHSTAT Patented D0U7VC COMPCLAS 1,2-diamino cyclopentane-based derivatives D0U9RB DRUG__ID D0U9RB D0U9RB DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D0U9RB DRUGTYPE Small molecular drug D0U9RB DRUGINCH 1S/C16H19N5/c1-21-10-13(9-18-21)15-14-7-12(8-17-16(14)20-19-15)11-5-3-2-4-6-11/h7-11H,2-6H2,1H3,(H,17,19,20) D0U9RB DRUGINKE RKYRUOWFAUYZLA-UHFFFAOYSA-N D0U9RB DRUGSMIL CN1C=C(C=N1)C2=C3C=C(C=NC3=NN2)C4CCCCC4 D0U9RB HIGHSTAT Patented D0U9RB COMPCLAS 7-azaindole derivatives D0U9TR DRUG__ID D0U9TR D0U9TR DRUGCOMP THE JOHNS HOPKINS UNIVERSITY BISWAL, Shyam THIMMULAPPA, Rajesh KUMAR, Sarvesh MALHOTRA, Sanjay, V. KUMAR, Vineet JUNG-HYUN, Kim D0U9TR DRUGTYPE Small molecular drug D0U9TR DRUGINCH 1S/C17H13F3O2/c1-22-16-9-5-3-7-13(16)15(21)11-10-12-6-2-4-8-14(12)17(18,19)20/h2-11H,1H3/b11-10+ D0U9TR DRUGINKE BDZOPPCXQXPRKH-ZHACJKMWSA-N D0U9TR DRUGSMIL COC1=CC=CC=C1C(=O)C=CC2=CC=CC=C2C(F)(F)F D0U9TR HIGHSTAT Patented D0U9TR COMPCLAS Chalcone derivatives D0UJ8Z DRUG__ID D0UJ8Z D0UJ8Z DRUGCOMP CHDI FOUNDATION, INC D0UJ8Z DRUGTYPE Small molecular drug D0UJ8Z DRUGINCH 1S/C13H12Cl2O3/c1-13(2)9(10(13)12(17)18)11(16)6-3-4-7(14)8(15)5-6/h3-5,9-10H,1-2H3,(H,17,18)/t9-,10-/m0/s1 D0UJ8Z DRUGINKE LZXZDLJRRHTOOA-UWVGGRQHSA-N D0UJ8Z DRUGSMIL CC1(C(C1C(=O)O)C(=O)C2=CC(=C(C=C2)Cl)Cl)C D0UJ8Z HIGHSTAT Patented D0UJ8Z COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0UN9X DRUG__ID D0UN9X D0UN9X DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0UN9X DRUGTYPE Small molecular drug D0UN9X DRUGINCH 1S/C23H26FN5O2/c1-22(2,3)16-12-17(14-6-8-15(24)9-7-14)27-29-13-18(26-19(16)29)20(30)28-11-10-25-21(31)23(28,4)5/h6-9,12-13H,10-11H2,1-5H3,(H,25,31) D0UN9X DRUGINKE DTASTQAQBOZSRR-UHFFFAOYSA-N D0UN9X DRUGSMIL CC1(C(=O)NCCN1C(=O)C2=CN3C(=N2)C(=CC(=N3)C4=CC=C(C=C4)F)C(C)(C)C)C D0UN9X HIGHSTAT Patented D0UN9X COMPCLAS Imidazopyridazine derivatives D0UU0V DRUG__ID D0UU0V D0UU0V DRUGCOMP LEAD DISCOVERY CENTER GMBH [DEBAYER IP GMBH [DE]; D0UU0V DRUGTYPE Small molecular drug D0UU0V DRUGINCH 1S/C19H19N3O3S/c1-25-18-8-3-2-7-17(18)15-9-10-21-19(12-15)22-16-6-4-5-14(11-16)13-26(20,23)24/h2-12H,13H2,1H3,(H,21,22)(H2,20,23,24) D0UU0V DRUGINKE WIMRMIUJTYQVQS-UHFFFAOYSA-N D0UU0V DRUGSMIL COC1=CC=CC=C1C2=CC(=NC=C2)NC3=CC=CC(=C3)CS(=O)(=O)N D0UU0V HIGHSTAT Patented D0UU0V COMPCLAS 1,5-di-substituted pyridine derivatives D0V3PA DRUG__ID D0V3PA D0V3PA DRUGCOMP THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO FISHEL, Melissa, L D0V3PA DRUGTYPE Small molecular drug D0V3PA DRUGINCH 1S/C29H26F6N2O5S/c1-36(43(41,42)28-26(34)24(32)23(31)25(33)27(28)35)15-22(38)37(19-11-12-20(29(39)40)21(30)13-19)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h7-13,17H,2-6,14-15H2,1H3,(H,39,40) D0V3PA DRUGINKE PSOITMRLZWEHSO-UHFFFAOYSA-N D0V3PA DRUGSMIL CN(CC(=O)N(CC1=CC=C(C=C1)C2CCCCC2)C3=CC(=C(C=C3)C(=O)O)F)S(=O)(=O)C4=C(C(=C(C(=C4F)F)F)F)F D0V3PA HIGHSTAT Patented D0V3PA COMPCLAS Salicylic acid derivatives D0V4FE DRUG__ID D0V4FE D0V4FE DRUGCOMP NOVASAID AB WANNBERG, Johan ALTERMAN, Mathias MALM, Johan STENBERG, Patric WESTMAN, Jacob WALLBERG, Hans D0V4FE DRUGTYPE Small molecular drug D0V4FE DRUGINCH 1S/C29H32N4O2/c1-19-15-26-27(16-20(19)2)33(25-8-7-21-5-3-4-6-23(21)17-25)29(31-26)32-12-9-22(10-13-32)28(34)30-24-11-14-35-18-24/h3-8,15-17,22,24H,9-14,18H2,1-2H3,(H,30,34) D0V4FE DRUGINKE CPCIYGHUPLRYBW-UHFFFAOYSA-N D0V4FE DRUGSMIL CC1=CC2=C(C=C1C)N(C(=N2)N3CCC(CC3)C(=O)NC4CCOC4)C5=CC6=CC=CC=C6C=C5 D0V4FE HIGHSTAT Patented D0V4FE COMPCLAS Piperidine carboxamide derivatives D0V7QU DRUG__ID D0V7QU D0V7QU DRUGCOMP ABRAXIS BIOSCIENCE, LLC D0V7QU DRUGTYPE Small molecular drug D0V7QU DRUGINCH 1S/C25H27N9OS2/c1-17-16-26-24(36-17)30-21-29-22(34-14-12-33(2)13-15-34)32-25(31-21)37-20-10-8-19(9-11-20)28-23(35)27-18-6-4-3-5-7-18/h3-11,16H,12-15H2,1-2H3,(H2,27,28,35)(H,26,29,30,31,32) D0V7QU DRUGINKE RZAWEAWFWJQMTD-UHFFFAOYSA-N D0V7QU DRUGSMIL CC1=CN=C(S1)NC2=NC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)NC4=CC=CC=C4)N5CCN(CC5)C D0V7QU HIGHSTAT Patented D0V7QU COMPCLAS Ureido-phenyl-substituted triazine derivatives D0V7RP DRUG__ID D0V7RP D0V7RP DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0V7RP DRUGTYPE Small molecular drug D0V7RP DRUGINCH 1S/C20H20F2N4O3S/c1-28-17-8-13(21)4-5-14(17)15-9-18(24-10-16(15)22)25-19-6-12(11-30(3,23)27)7-20(26-19)29-2/h4-10,23H,11H2,1-3H3,(H,24,25,26) D0V7RP DRUGINKE OOPSDSZASQDBNK-UHFFFAOYSA-N D0V7RP DRUGSMIL COC1=CC(=CC(=N1)NC2=NC=C(C(=C2)C3=C(C=C(C=C3)F)OC)F)CS(=N)(=O)C D0V7RP HIGHSTAT Patented D0V7RP COMPCLAS 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives D0V8JZ DRUG__ID D0V8JZ D0V8JZ DRUGCOMP PRINCIPIA BIOPHARMA INCPRINCIPIA BIOPHARMA INC. GOLDSTEIN, David Michael BRAMELD, Kenneth Albert D0V8JZ DRUGTYPE Small molecular drug D0V8JZ DRUGINCH 1S/C32H35N7O2/c1-32(2,37(3)4)17-23(18-33)31(40)39-16-8-9-24(39)19-38-20-27(28-29(34)35-21-36-30(28)38)22-12-14-26(15-13-22)41-25-10-6-5-7-11-25/h5-7,10-15,17,20-21,24H,8-9,16,19H2,1-4H3,(H2,34,35,36)/b23-17+ D0V8JZ DRUGINKE BJBBMHJDZCVALB-HAVVHWLPSA-N D0V8JZ DRUGSMIL CC(C)(C=C(C#N)C(=O)N1CCCC1CN2C=C(C3=C(N=CN=C32)N)C4=CC=C(C=C4)OC5=CC=CC=C5)N(C)C D0V8JZ HIGHSTAT Patented D0V8JZ COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0VA1R DRUG__ID D0VA1R D0VA1R DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D0VA1R DRUGTYPE Small molecular drug D0VA1R DRUGINCH 1S/C21H17NO4S/c1-15-6-8-18(9-7-15)27(25,26)22-19-5-3-2-4-16(19)14-20(22)21(24)12-10-17(23)11-13-21/h2-14,24H,1H3 D0VA1R DRUGINKE NLFCLJPNQJYXHL-UHFFFAOYSA-N D0VA1R DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C3=CC=CC=C3C=C2C4(C=CC(=O)C=C4)O D0VA1R HIGHSTAT Patented D0VA1R COMPCLAS 4-aryl quinol derivatives D0VC0P DRUG__ID D0VC0P D0VC0P DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0VC0P DRUGTYPE Small molecular drug D0VC0P DRUGINCH 1S/C24H29N3O2/c1-25-11-13-26(14-12-25)20-7-8-21-19-9-10-27(23(15-19)22(21)16-20)24(28)29-17-18-5-3-2-4-6-18/h2-8,16,19,23H,9-15,17H2,1H3 D0VC0P DRUGINKE CQQWIHMDQBNBBE-UHFFFAOYSA-N D0VC0P DRUGSMIL CN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5 D0VC0P HIGHSTAT Patented D0VC0P COMPCLAS Piperazinyl norbenzomorphane compounds D0VC9V DRUG__ID D0VC9V D0VC9V DRUGCOMP Dongguk University Industry-Academic Cooperation Foundation D0VC9V DRUGTYPE Small molecular drug D0VC9V DRUGINCH 1S/C21H20N4O/c1-2-7-17(8-3-1)10-11-19-21(26-16-15-25-13-4-5-14-25)24-18-9-6-12-22-20(18)23-19/h1-3,6-9,12H,4-5,13-16H2 D0VC9V DRUGINKE MNYJJHBAEYKXEG-UHFFFAOYSA-N D0VC9V DRUGSMIL C1CCN(C1)CCOC2=NC3=C(N=CC=C3)N=C2C#CC4=CC=CC=C4 D0VC9V HIGHSTAT Patented D0VC9V COMPCLAS 2-alkyloxy-3-phenylethynyl-4a,5-dihydropyrido[2,3-b]pyrazine derivatives D0VE3H DRUG__ID D0VE3H D0VE3H DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0VE3H DRUGTYPE Small molecular drug D0VE3H DRUGINCH 1S/C23H22FN5OS/c1-28(22(30)16-6-2-3-8-19(16)29-13-5-12-25-29)20-9-4-7-17(20)26-23-27-18-11-10-15(24)14-21(18)31-23/h2-3,5-6,8,10-14,17,20H,4,7,9H2,1H3,(H,26,27)/t17-,20-/m0/s1 D0VE3H DRUGINKE OQAWFCAOFHFFQS-PXNSSMCTSA-N D0VE3H DRUGSMIL CN(C1CCCC1NC2=NC3=C(S2)C=C(C=C3)F)C(=O)C4=CC=CC=C4N5C=CC=N5 D0VE3H HIGHSTAT Patented D0VE3H COMPCLAS 1,2-diamino cyclopentane-based derivatives D0VI1V DRUG__ID D0VI1V D0VI1V DRUGCOMP HUNAN NONFERROUS METALS GROUP CHEMBIO PHARMACY CO., LTD D0VI1V DRUGTYPE Small molecular drug D0VI1V DRUGINCH 1S/C23H17ClF3N5O2/c1-28-21-20-16(8-10-30-21)19(9-11-29-20)34-15-5-2-13(3-6-15)31-22(33)32-14-4-7-18(24)17(12-14)23(25,26)27/h2-12H,1H3,(H,28,30)(H2,31,32,33) D0VI1V DRUGINKE ORNWLDOEVOUMBW-UHFFFAOYSA-N D0VI1V DRUGSMIL CNC1=NC=CC2=C(C=CN=C21)OC3=CC=C(C=C3)NC(=O)NC4=CC(=C(C=C4)Cl)C(F)(F)F D0VI1V HIGHSTAT Patented D0VI1V COMPCLAS Carbamide derivatives D0VI7E DRUG__ID D0VI7E D0VI7E DRUGCOMP DEBIOPHARM SA [CHAURIGENE DISCOVERY TECH LTD [IN] D0VI7E DRUGTYPE Small molecular drug D0VI7E DRUGINCH 1S/C32H29ClF3N7O2/c1-41-13-15-42(16-14-41)24-8-5-22(6-9-24)39-31-37-19-25-27(40-31)11-12-43(30(25)45)28-18-23(7-10-26(28)33)38-29(44)20-3-2-4-21(17-20)32(34,35)36/h2-10,17-19H,11-16H2,1H3,(H,38,44)(H,37,39,40) D0VI7E DRUGINKE SGLDXZLAQLSXFP-UHFFFAOYSA-N D0VI7E DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C4C(=N3)CCN(C4=O)C5=C(C=CC(=C5)NC(=O)C6=CC(=CC=C6)C(F)(F)F)Cl D0VI7E HIGHSTAT Patented D0VI7E COMPCLAS Aromatic bicyclic compounds D0VR1K DRUG__ID D0VR1K D0VR1K DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0VR1K DRUGTYPE Small molecular drug D0VR1K DRUGINCH 1S/C21H23N3O3S/c1-26-16-10-6-11-17(27-2)19(16)20(25)22-13-8-5-9-14(13)23-21-24-15-7-3-4-12-18(15)28-21/h3-4,6-7,10-14H,5,8-9H2,1-2H3,(H,22,25)(H,23,24)/t13-,14+/m0/s1 D0VR1K DRUGINKE PQSRJJBKNVQRDI-UONOGXRCSA-N D0VR1K DRUGSMIL COC1=C(C(=CC=C1)OC)C(=O)NC2CCCC2NC3=NC4=CC=CC=C4S3 D0VR1K HIGHSTAT Patented D0VR1K COMPCLAS 1,2-diamino cyclopentane-based derivatives D0VX0H DRUG__ID D0VX0H D0VX0H DRUGCOMP MEDSHINE DISCOVERY INC D0VX0H DRUGTYPE Small molecular drug D0VX0H DRUGINCH 1S/C17H21N3O2S/c1-12-8-18-9-13-4-2-6-16(17(12)13)23(21,22)20-10-14-5-3-7-19-15(14)11-20/h2,4,6,8-9,14-15,19H,3,5,7,10-11H2,1H3 D0VX0H DRUGINKE GPOFEWOVDWONOA-UHFFFAOYSA-N D0VX0H DRUGSMIL CC1=CN=CC2=C1C(=CC=C2)S(=O)(=O)N3CC4CCCNC4C3 D0VX0H HIGHSTAT Patented D0VX0H COMPCLAS Isoquinoline sulfonyl derivatives D0VY5N DRUG__ID D0VY5N D0VY5N DRUGCOMP Teizin Pharma Ltd D0VY5N DRUGTYPE Small molecular drug D0VY5N DRUGINCH 1S/C17H18N4O3S/c1-10(2)9-24-14-5-4-12(8-13(14)21-7-6-18-20-21)16-19-11(3)15(25-16)17(22)23/h4-8,10H,9H2,1-3H3,(H,22,23) D0VY5N DRUGINKE VBUUZRSRCDYYFW-UHFFFAOYSA-N D0VY5N DRUGSMIL CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)N3C=CN=N3)C(=O)O D0VY5N HIGHSTAT Patented D0VY5N COMPCLAS Azole benzene derivatives D0W3BE DRUG__ID D0W3BE D0W3BE DRUGCOMP BIOGEN MA INC. SUNESIS PHARMACEUTICALS, INC D0W3BE DRUGTYPE Small molecular drug D0W3BE DRUGINCH 1S/C33H34N6O3S/c1-20-15-23(9-10-24(20)17-34-30(40)31-35-18-27(43-31)33(2,3)4)28-25-16-26(38-29(25)37-19-36-28)21-5-7-22(8-6-21)32(41)39-11-13-42-14-12-39/h5-10,15-16,18-19H,11-14,17H2,1-4H3,(H,34,40)(H,36,37,38) D0W3BE DRUGINKE HVNCDYSVQHLXPA-UHFFFAOYSA-N D0W3BE DRUGSMIL CC1=C(C=CC(=C1)C2=C3C=C(NC3=NC=N2)C4=CC=C(C=C4)C(=O)N5CCOCC5)CNC(=O)C6=NC=C(S6)C(C)(C)C D0W3BE HIGHSTAT Patented D0W3BE COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0W3TS DRUG__ID D0W3TS D0W3TS DRUGCOMP UNIVERSITE DE LILLE 2 DROIT ET SANTE CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) D0W3TS DRUGTYPE Small molecular drug D0W3TS DRUGINCH 1S/C18H21ClN2O/c1-21(14-15-6-3-2-4-7-15)13-5-12-20-18(22)16-8-10-17(19)11-9-16/h2-4,6-11H,5,12-14H2,1H3,(H,20,22) D0W3TS DRUGINKE TVEZSZAKGLHZOD-UHFFFAOYSA-N D0W3TS DRUGSMIL CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2 D0W3TS HIGHSTAT Patented D0W3TS COMPCLAS Benzamide derivatives D0W5ND DRUG__ID D0W5ND D0W5ND DRUGCOMP Universit de Montral D0W5ND DRUGTYPE Small molecular drug D0W5ND DRUGINCH 1S/C14H10N2O3/c17-14(12-2-1-9-15-10-12)8-5-11-3-6-13(7-4-11)16(18)19/h1-10H/b8-5+ D0W5ND DRUGINKE DFXQMCHHZQLWHB-VMPITWQZSA-N D0W5ND DRUGSMIL C1=CC(=CN=C1)C(=O)C=CC2=CC=C(C=C2)[N+](=O)[O-] D0W5ND HIGHSTAT Patented D0W5ND COMPCLAS Azachalcone derivatives D0WC4Z DRUG__ID D0WC4Z D0WC4Z DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0WC4Z DRUGTYPE Small molecular drug D0WC4Z DRUGINCH 1S/C21H23NO8S/c1-21(2,3)14-6-10-16(11-7-14)31(28,29)30-15-8-4-13(5-9-15)12-17(19(24)25)22-18(23)20(26)27/h4-11,17H,12H2,1-3H3,(H,22,23)(H,24,25)(H,26,27)/t17-/m1/s1 D0WC4Z DRUGINKE GZIYVGKVNVGZAL-QGZVFWFLSA-N D0WC4Z DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)CC(C(=O)O)NC(=O)C(=O)O D0WC4Z HIGHSTAT Patented D0WC4Z COMPCLAS N-oxalyl-D-tyrosine derivatives D0WD1Z DRUG__ID D0WD1Z D0WD1Z DRUGCOMP The Ohio State University Research Foundation D0WD1Z DRUGTYPE Small molecular drug D0WD1Z DRUGINCH 1S/C25H28O6/c1-25(2,23(26)13-9-17-7-11-19(28-3)21(15-17)30-5)24(27)14-10-18-8-12-20(29-4)22(16-18)31-6/h7-16H,1-6H3/b13-9+,14-10+ D0WD1Z DRUGINKE VMMZAMVBGQWOHT-UTLPMFLDSA-N D0WD1Z DRUGSMIL CC(C)(C(=O)C=CC1=CC(=C(C=C1)OC)OC)C(=O)C=CC2=CC(=C(C=C2)OC)OC D0WD1Z HIGHSTAT Patented D0WD1Z COMPCLAS Curcumin analogs D0WM3Y DRUG__ID D0WM3Y D0WM3Y DRUGCOMP ZENITH EPIGENETICS CORP D0WM3Y DRUGTYPE Small molecular drug D0WM3Y DRUGINCH 1S/C18H16N4O2/c1-11-16(12(2)24-21-11)14-8-15-17(19-9-14)20-18(23)22(15)10-13-6-4-3-5-7-13/h3-9H,10H2,1-2H3,(H,19,20,23) D0WM3Y DRUGINKE QUVHLUHSXDYNJU-UHFFFAOYSA-N D0WM3Y DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=C(NC(=O)N3CC4=CC=CC=C4)N=C2 D0WM3Y HIGHSTAT Patented D0WM3Y COMPCLAS Isoxazole-based bicyclic compounds D0WN2X DRUG__ID D0WN2X D0WN2X DRUGCOMP ADVINUS THERAPEUTICS LIMITED D0WN2X DRUGTYPE Small molecular drug D0WN2X DRUGINCH 1S/C34H32N6O2/c1-21-27(3-2-4-29(21)39-33(41)25-11-7-23(8-12-25)22-5-6-22)31-28-19-30(38-32(28)37-20-36-31)24-9-13-26(14-10-24)34(42)40-17-15-35-16-18-40/h2-4,7-14,19-20,22,35H,5-6,15-18H2,1H3,(H,39,41)(H,36,37,38) D0WN2X DRUGINKE JIGUYYJYCISLMS-UHFFFAOYSA-N D0WN2X DRUGSMIL CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C3CC3)C4=C5C=C(NC5=NC=N4)C6=CC=C(C=C6)C(=O)N7CCNCC7 D0WN2X HIGHSTAT Patented D0WN2X COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0WP5S DRUG__ID D0WP5S D0WP5S DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD D0WP5S DRUGTYPE Small molecular drug D0WP5S DRUGINCH 1S/C20H17F3N6O4S/c1-29-16(10-32-17-7-6-14(8-25-17)20(21,22)23)15(9-26-29)19-27-18(28-33-19)13-4-2-12(3-5-13)11-34(24,30)31/h2-9H,10-11H2,1H3,(H2,24,30,31) D0WP5S DRUGINKE VICSEUMXTLYERW-UHFFFAOYSA-N D0WP5S DRUGSMIL CN1C(=C(C=N1)C2=NC(=NO2)C3=CC=C(C=C3)CS(=O)(=O)N)COC4=NC=C(C=C4)C(F)(F)F D0WP5S HIGHSTAT Patented D0WP5S COMPCLAS N-substituted pyrazole derivatives D0WR7B DRUG__ID D0WR7B D0WR7B DRUGCOMP JIANGSU HENGRUI MEDICINE CO [CNSHANGHAI HENGRUI PHARMACEUTICAL CO LTD [CN] D0WR7B DRUGTYPE Small molecular drug D0WR7B DRUGINCH 1S/C25H24FN5/c1-29-15-19(13-28-29)17-5-7-20(8-6-17)30-11-9-18(10-12-30)25-24-21(3-2-4-22(24)26)23-14-27-16-31(23)25/h2-8,13-16,18,25H,9-12H2,1H3/t25-/m0/s1 D0WR7B DRUGINKE UJGQDAMZVUNFBQ-VWLOTQADSA-N D0WR7B DRUGSMIL CN1C=C(C=N1)C2=CC=C(C=C2)N3CCC(CC3)C4C5=C(C=CC=C5F)C6=CN=CN46 D0WR7B HIGHSTAT Patented D0WR7B COMPCLAS Imidazo isoindole derivatives D0WS4U DRUG__ID D0WS4U D0WS4U DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0WS4U DRUGTYPE Small molecular drug D0WS4U DRUGINCH 1S/C16H18F2N2O5/c1-7(2)6-10(19-15(22)12-13(25-12)16(23)24)14(21)20-11-8(17)4-3-5-9(11)18/h3-5,7,10,12-13H,6H2,1-2H3,(H,19,22)(H,20,21)(H,23,24)/t10-,12+,13+/m0/s1 D0WS4U DRUGINKE RZWURLBUPSDTKT-CYZMBNFOSA-N D0WS4U DRUGSMIL CC(C)CC(C(=O)NC1=C(C=CC=C1F)F)NC(=O)C2C(O2)C(=O)O D0WS4U HIGHSTAT Patented D0WS4U COMPCLAS Epoxysuccinate derivatives D0WT7D DRUG__ID D0WT7D D0WT7D DRUGCOMP NOVARTIS AG ASTEX THERAPEUTICS LIMITED HOWARD, Steven MORTENSON, Paul Neil HISCOCK, Steven Douglas WOOLFORD, Alison Jo-Anne WOODHEAD, Andrew James CHESSARI, Gianni O'REILLY, Marc CONGREVE, Miles Stuart DAGOSTIN, Claudio CHO, Young Shin YANG, Fan CHEN, Christine Hiu-Tung BRAIN, Christopher Thomas LAGU, Bharat WANG, Yaping KIM, Sunkyu GRIALDES, John LUZZIO, Michael Joseph PEREZ, Lawrence Blas LU, Yipin D0WT7D DRUGTYPE Small molecular drug D0WT7D DRUGINCH 1S/C30H27N7O/c1-36(2)22-11-13-37(14-12-22)27-10-9-26-29(34-27)35-30(33-26)28(38)19-7-8-20(16-31)24(15-19)25-18-32-17-21-5-3-4-6-23(21)25/h3-10,15,17-18,22H,11-14H2,1-2H3,(H,33,34,35) D0WT7D DRUGINKE AZXYPCBAGCXZPP-UHFFFAOYSA-N D0WT7D DRUGSMIL CN(C)C1CCN(CC1)C2=NC3=C(C=C2)NC(=N3)C(=O)C4=CC(=C(C=C4)C#N)C5=CN=CC6=CC=CC=C65 D0WT7D HIGHSTAT Patented D0WT7D COMPCLAS Imidazo pyridine derivatives D0X0YJ DRUG__ID D0X0YJ D0X0YJ DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0X0YJ DRUGTYPE Small molecular drug D0X0YJ DRUGINCH 1S/C25H26F3N5O/c26-25(27,28)16-32-14-20(17-8-3-1-4-9-17)22(15-32)29-24(34)30-23-19-12-7-13-21(19)31-33(23)18-10-5-2-6-11-18/h1-6,8-11,20,22H,7,12-16H2,(H2,29,30,34)/t20-,22+/m0/s1 D0X0YJ DRUGINKE AFWYYOYVHRLTSQ-RBBKRZOGSA-N D0X0YJ DRUGSMIL C1CC2=C(N(N=C2C1)C3=CC=CC=C3)NC(=O)NC4CN(CC4C5=CC=CC=C5)CC(F)(F)F D0X0YJ HIGHSTAT Patented D0X0YJ COMPCLAS Pyrrolidinyl urea derivatives D0X5IV DRUG__ID D0X5IV D0X5IV DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0X5IV DRUGTYPE Small molecule immunotherapy D0X5IV DRUGINCH 1S/C16H28N6O7/c1-3-6-18-11(25)5-4-10(14-21-13(22-29-14)9(17)7-23)19-16(28)20-12(8(2)24)15(26)27/h8-10,12,23-24H,3-7,17H2,1-2H3,(H,18,25)(H,26,27)(H2,19,20,28)/t8?,9-,10-,12-/m0/s1 D0X5IV DRUGINKE YZLYUYDWVJSYRO-BCBKFXIMSA-N D0X5IV DRUGSMIL CCCNC(=O)CCC(C1=NC(=NO1)C(CO)N)NC(=O)NC(C(C)O)C(=O)O D0X5IV HIGHSTAT Patented D0X5IV COMPCLAS 1,2,4-oxadiazole derivatives D0X7DZ DRUG__ID D0X7DZ D0X7DZ DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori SHIRAI, Kimihiro OI, Marik D0X7DZ DRUGTYPE Small molecular drug D0X7DZ DRUGINCH 1S/C25H22Cl2N4O/c26-17-12-10-16(11-13-17)23-20(19-8-4-5-9-22(19)27)14-28-24-21(15-29-31(23)24)25(32)30-18-6-2-1-3-7-18/h4-5,8-15,18H,1-3,6-7H2,(H,30,32) D0X7DZ DRUGINKE ZZBARLOXOSWJIH-UHFFFAOYSA-N D0X7DZ DRUGSMIL C1CCC(CC1)NC(=O)C2=C3N=CC(=C(N3N=C2)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0X7DZ HIGHSTAT Patented D0X7DZ COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0X7MV DRUG__ID D0X7MV D0X7MV DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. TICHENOR, Mark, S. MERIT, Jeffrey, E. HAWRYLUK, Natalie, A. CHAMBERS, Alison, L. KEITH, John, M D0X7MV DRUGTYPE Small molecular drug D0X7MV DRUGINCH 1S/C24H24FN3O2/c25-20-8-10-22(11-9-20)30-23-5-1-3-18(15-23)6-7-19-12-14-28(17-19)24(29)27-21-4-2-13-26-16-21/h1-5,8-11,13,15-16,19H,6-7,12,14,17H2,(H,27,29) D0X7MV DRUGINKE BDZREAHMWOSTKO-UHFFFAOYSA-N D0X7MV DRUGSMIL C1CN(CC1CCC2=CC(=CC=C2)OC3=CC=C(C=C3)F)C(=O)NC4=CN=CC=C4 D0X7MV HIGHSTAT Patented D0X7MV COMPCLAS Pyrrolidinyl urea derivatives D0X8VL DRUG__ID D0X8VL D0X8VL DRUGCOMP INFINITY PHARMACEUTICALS, INC. BEHNKE, Mark, L. CASTRO, Alfredo, C. CHAN, Lawrence, K. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LEBLANC, Yves LIU, Tao PELUSO, Stephane SNYDER, Daniel, A. TIBBITTS, Thomas, T D0X8VL DRUGTYPE Small molecular drug D0X8VL DRUGINCH 1S/C22H16N2O3/c23-15-16-6-10-20(11-7-16)26-22-14-21(27-24-22)17-8-12-19(13-9-17)25-18-4-2-1-3-5-18/h1-13,21H,14H2/t21-/m1/s1 D0X8VL DRUGINKE QRYXBMPYZGEVSA-OAQYLSRUSA-N D0X8VL DRUGSMIL C1C(ON=C1OC2=CC=C(C=C2)C#N)C3=CC=C(C=C3)OC4=CC=CC=C4 D0X8VL HIGHSTAT Patented D0X8VL COMPCLAS Isoxazoline derivatives D0X9DL DRUG__ID D0X9DL D0X9DL DRUGCOMP ABBVIE DEUTSCHLAND [DEABBVIE INC [US] D0X9DL DRUGTYPE Small molecular drug D0X9DL DRUGINCH 1S/C24H26N6O4/c25-22(32)21(31)20(15-17-5-2-1-3-6-17)27-24(33)19-7-4-9-26-23(19)30-10-8-18(28-30)16-29-11-13-34-14-12-29/h1-10,20H,11-16H2,(H2,25,32)(H,27,33) D0X9DL DRUGINKE LNYKWHMNUSKRNS-UHFFFAOYSA-N D0X9DL DRUGSMIL C1COCCN1CC2=NN(C=C2)C3=C(C=CC=N3)C(=O)NC(CC4=CC=CC=C4)C(=O)C(=O)N D0X9DL HIGHSTAT Patented D0X9DL COMPCLAS Carboxamide derivatives D0X9VH DRUG__ID D0X9VH D0X9VH DRUGCOMP ORIBASE PHARMA D0X9VH DRUGTYPE Small molecular drug D0X9VH DRUGINCH 1S/C30H31F3N6O3/c1-18-3-6-23(12-22(18)15-34-24-11-21-14-26(29(41)42)37-27(21)35-16-24)36-28(40)19-4-5-20(25(13-19)30(31,32)33)17-39-9-7-38(2)8-10-39/h3-6,11-14,16,34H,7-10,15,17H2,1-2H3,(H,35,37)(H,36,40)(H,41,42) D0X9VH DRUGINKE DZMBOVWOPRYRNU-UHFFFAOYSA-N D0X9VH DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)CNC4=CN=C5C(=C4)C=C(N5)C(=O)O D0X9VH HIGHSTAT Patented D0X9VH COMPCLAS Azaindole derivatives D0XL1M DRUG__ID D0XL1M D0XL1M DRUGCOMP F. HOFFMANN-LA ROCHE AG GAZZARD, Lewis J. HANAN, Emily KINTZ, Samuel LYSSIKATOS, Joseph P. PURKEY, Hans Edward D0XL1M DRUGTYPE Small molecular drug D0XL1M DRUGINCH 1S/C21H17F4N3O2/c1-10-4-17(19(29)21(23,24)25)26-9-15(10)12-3-2-11-6-18(27-8-13(11)5-12)28-20(30)14-7-16(14)22/h2-6,8-9,14,16,19,29H,7H2,1H3,(H,27,28,30)/t14-,16+,19+/m1/s1 D0XL1M DRUGINKE LTXJULOSIPKSDB-ALKREAHSSA-N D0XL1M DRUGSMIL CC1=CC(=NC=C1C2=CC3=CN=C(C=C3C=C2)NC(=O)C4CC4F)C(C(F)(F)F)O D0XL1M HIGHSTAT Patented D0XL1M COMPCLAS 6,6-fused nitrogenous heterocyclic compounds D0XR7S DRUG__ID D0XR7S D0XR7S DRUGCOMP DAIICHI SANKYO CO LTD [JP] D0XR7S DRUGTYPE Small molecular drug D0XR7S DRUGINCH 1S/C22H27F2N5O3/c1-10(30)28-8-5-11(6-9-28)27-18-15(23)17(25)14-19(16(18)24)29-12(4-7-22(29,2)3)13(20(14)31)21(26)32/h11,27H,4-9,25H2,1-3H3,(H2,26,32) D0XR7S DRUGINKE KPYGNCXHNQMYPD-UHFFFAOYSA-N D0XR7S DRUGSMIL CC(=O)N1CCC(CC1)NC2=C(C(=C3C(=C2F)N4C(=C(C3=O)C(=O)N)CCC4(C)C)N)F D0XR7S HIGHSTAT Patented D0XR7S COMPCLAS Tricyclic 5-quinolone derivatives D0XR9Y DRUG__ID D0XR9Y D0XR9Y DRUGCOMP NOVARTIS AG [CHBLANK JUTTA [CHBOLD GUIDO [CHBORDAS VINCENT [CHCOTESTA SIMONA [CHGUAGNANO VITO [CHR EGER HEINRICH [CHVAUPEL ANDREA [CH] D0XR9Y DRUGTYPE Small molecular drug D0XR9Y DRUGINCH 1S/C29H28ClN5O4/c1-5-39-29(37)35-24(20-10-12-38-13-11-20)17(3)23-26(35)25(19-6-8-21(30)9-7-19)34(28(23)36)22-14-16(2)27-32-31-18(4)33(27)15-22/h6-10,14-15,25H,5,11-13H2,1-4H3 D0XR9Y DRUGINKE XQCLLKJYKDIUDW-UHFFFAOYSA-N D0XR9Y DRUGSMIL CCOC(=O)N1C2=C(C(=C1C3=CCOCC3)C)C(=O)N(C2C4=CC=C(C=C4)Cl)C5=CN6C(=NN=C6C(=C5)C)C D0XR9Y HIGHSTAT Patented D0XR9Y COMPCLAS Pyrrolo-pyrrolone derivatives D0XT7O DRUG__ID D0XT7O D0XT7O DRUGCOMP GLAXOSMITHKLINE LLGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED QIN, Donghui CHEUNG, Mui JOSHI, Hemant TANGIRALA, Raghuram BETHI, Sridhar, Reddy D0XT7O DRUGTYPE Small molecular drug D0XT7O DRUGINCH 1S/C17H17N5/c1-2-8-21-9-6-13-10-12(3-4-15(13)21)14-11-19-16-5-7-20-22(16)17(14)18/h3-7,9-11H,2,8,18H2,1H3 D0XT7O DRUGINKE WYJQPMFWZLKCBR-UHFFFAOYSA-N D0XT7O DRUGSMIL CCCN1C=CC2=C1C=CC(=C2)C3=C(N4C(=CC=N4)N=C3)N D0XT7O HIGHSTAT Patented D0XT7O COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0XV7Y DRUG__ID D0XV7Y D0XV7Y DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0XV7Y DRUGTYPE Small molecule immunotherapy D0XV7Y DRUGINCH 1S/C34H30ClN5O5/c1-21-24(6-5-7-26(21)30-17-38-28-8-3-4-9-29(28)40-30)19-45-32-12-31(44-18-23-10-22(13-36)14-37-15-23)25(11-27(32)35)16-39-34(2,20-41)33(42)43/h3-12,14-15,17,39,41H,16,18-20H2,1-2H3,(H,42,43)/t34-/m1/s1 D0XV7Y DRUGINKE KJGBSKXWCFJEDI-UUWRZZSWSA-N D0XV7Y DRUGSMIL CC1=C(C=CC=C1C2=NC3=CC=CC=C3N=C2)COC4=C(C=C(C(=C4)OCC5=CC(=CN=C5)C#N)CNC(C)(CO)C(=O)O)Cl D0XV7Y HIGHSTAT Patented D0XV7Y COMPCLAS 1,3-dihydroxy phenyl derivatives D0XW4G DRUG__ID D0XW4G D0XW4G DRUGCOMP Shanghai Hengrui Pharm D0XW4G DRUGTYPE Small molecular drug D0XW4G DRUGINCH 1S/C22H21F2IN4O5S/c1-4-35(32,33)28-14-6-5-7-16(11(14)2)34-19-17(20(26)30)21(29(3)22(31)18(19)24)27-15-9-8-12(25)10-13(15)23/h5-10,27-28H,4H2,1-3H3,(H2,26,30) D0XW4G DRUGINKE ABFMVRPVXUKQEQ-UHFFFAOYSA-N D0XW4G DRUGSMIL CCS(=O)(=O)NC1=C(C(=CC=C1)OC2=C(C(=O)N(C(=C2C(=O)N)NC3=C(C=C(C=C3)I)F)C)F)C D0XW4G HIGHSTAT Patented D0XW4G COMPCLAS Pyridic ketone derivatives D0XX9N DRUG__ID D0XX9N D0XX9N DRUGCOMP DAINIPPON SUMITOMO PHARMA CO., LTD D0XX9N DRUGTYPE Small molecular drug D0XX9N DRUGINCH 1S/C19H15ClFN3O2/c1-11-6-12(8-13(20)7-11)19(25)24-5-4-17-16(10-24)23-18(26-17)15-3-2-14(21)9-22-15/h2-3,6-9H,4-5,10H2,1H3 D0XX9N DRUGINKE NMKCKZQPMUTSIC-UHFFFAOYSA-N D0XX9N DRUGSMIL CC1=CC(=CC(=C1)Cl)C(=O)N2CCC3=C(C2)N=C(O3)C4=NC=C(C=C4)F D0XX9N HIGHSTAT Patented D0XX9N COMPCLAS Tetra-hydro-oxazolopyridine derivatives D0XY7C DRUG__ID D0XY7C D0XY7C DRUGCOMP Teizin Pharma Ltd D0XY7C DRUGTYPE Small molecular drug D0XY7C DRUGINCH 1S/C18H20N4O3S/c1-11-15(17(23)24)26-16(20-11)12-5-6-14(25-10-18(2,3)4)13(9-12)22-8-7-19-21-22/h5-9H,10H2,1-4H3,(H,23,24) D0XY7C DRUGINKE MWDSDCKUTZIOBZ-UHFFFAOYSA-N D0XY7C DRUGSMIL CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)(C)C)N3C=CN=N3)C(=O)O D0XY7C HIGHSTAT Patented D0XY7C COMPCLAS Azole benzene derivatives D0Y2PO DRUG__ID D0Y2PO D0Y2PO DRUGCOMP UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. UNIVERSITY OF TORONTO MISSISSAUGA TURKSON, James GUNNING, Patrick D0Y2PO DRUGTYPE Small molecular drug D0Y2PO DRUGINCH 1S/C26H30FN7O3S/c27-21-10-12-22(13-11-21)31-24-23-25(34(17-30-23)14-15-37-38(28,35)36)33-26(32-24)29-16-18-6-8-20(9-7-18)19-4-2-1-3-5-19/h6-13,17,19H,1-5,14-16H2,(H2,28,35,36)(H2,29,31,32,33) D0Y2PO DRUGINKE SDEPDOGWVAMEDD-UHFFFAOYSA-N D0Y2PO DRUGSMIL C1CCC(CC1)C2=CC=C(C=C2)CNC3=NC(=C4C(=N3)N(C=N4)CCOS(=O)(=O)N)NC5=CC=C(C=C5)F D0Y2PO HIGHSTAT Patented D0Y2PO COMPCLAS Tri-substituted purine derivatives D0Y7YC DRUG__ID D0Y7YC D0Y7YC DRUGCOMP FORMA THERAPEUTICS, INC D0Y7YC DRUGTYPE Small molecular drug D0Y7YC DRUGINCH 1S/C22H27FN4O4/c1-14-9-25(21(29)31-13-22(3,4)23)20-7-16(5-6-19(20)27(14)15(2)28)17-8-24-26(10-17)18-11-30-12-18/h5-8,10,14,18H,9,11-13H2,1-4H3/t14-/m0/s1 D0Y7YC DRUGINKE HUMZKOSJUNGVKQ-AWEZNQCLSA-N D0Y7YC DRUGSMIL CC1CN(C2=C(N1C(=O)C)C=CC(=C2)C3=CN(N=C3)C4COC4)C(=O)OCC(C)(C)F D0Y7YC HIGHSTAT Patented D0Y7YC COMPCLAS Benzothiazepine analogs D0YK8M DRUG__ID D0YK8M D0YK8M DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0YK8M DRUGTYPE Small molecule immunotherapy D0YK8M DRUGINCH 1S/C16H27N7O7/c17-6-2-1-3-8(18)13-22-23-14(30-13)10(7-11(19)24)21-16(29)20-9(15(27)28)4-5-12(25)26/h8-10H,1-7,17-18H2,(H2,19,24)(H,25,26)(H,27,28)(H2,20,21,29)/t8-,9-,10-/m0/s1 D0YK8M DRUGINKE SIMOVBGEPUKIIM-GUBZILKMSA-N D0YK8M DRUGSMIL C(CCN)CC(C1=NN=C(O1)C(CC(=O)N)NC(=O)NC(CCC(=O)O)C(=O)O)N D0YK8M HIGHSTAT Patented D0YK8M COMPCLAS 1,3,4-oxadiazole derivatives D0YM3G DRUG__ID D0YM3G D0YM3G DRUGCOMP NOVARTIS AG [CHBLANK JUTTA [CHBOLD GUIDO [CHBORDAS VINCENT [CHCOTESTA SIMONA [CHGUAGNANO VITO [CHR EGER HEINRICH [CHVAUPEL ANDREA [CH] D0YM3G DRUGTYPE Small molecular drug D0YM3G DRUGINCH 1S/C28H27ClN6O2/c1-15-10-21(13-33-16(2)30-31-27(15)33)35-25(19-6-8-20(29)9-7-19)26-24(28(35)37)23(18-4-5-18)14-34(26)22-11-32(12-22)17(3)36/h6-10,13-14,18,22,25H,4-5,11-12H2,1-3H3 D0YM3G DRUGINKE CASINEGODQBEAL-UHFFFAOYSA-N D0YM3G DRUGSMIL CC1=CC(=CN2C1=NN=C2C)N3C(C4=C(C3=O)C(=CN4C5CN(C5)C(=O)C)C6CC6)C7=CC=C(C=C7)Cl D0YM3G HIGHSTAT Patented D0YM3G COMPCLAS Pyrrolo-pyrrolone derivatives D0YN2I DRUG__ID D0YN2I D0YN2I DRUGCOMP UNIVERSITY OF CONNECTICUT MAKRIYANNIS, Alexandros VEMURI, Venkata, Kiran THOTAPALLY, Rajesh OLSZEWSKA, Teresa D0YN2I DRUGTYPE Small molecular drug D0YN2I DRUGINCH 1S/C26H23Cl2N5O3/c27-20-9-10-23(22(28)16-20)33-25(19-7-5-18(6-8-19)4-2-1-3-11-29)21(17-34)24(30-33)26(35)31-32-12-14-36-15-13-32/h5-10,16,34H,1,3,12-15,17H2,(H,31,35) D0YN2I DRUGINKE VQXIVPLXEIZJTH-UHFFFAOYSA-N D0YN2I DRUGSMIL C1COCCN1NC(=O)C2=NN(C(=C2CO)C3=CC=C(C=C3)C#CCCC#N)C4=C(C=C(C=C4)Cl)Cl D0YN2I HIGHSTAT Patented D0YN2I COMPCLAS Pyrazole derivatives D0YO3X DRUG__ID D0YO3X D0YO3X DRUGCOMP NOVASAID AB WANNBERG, Johan ALTERMAN, Mathias STENBERG, Patric WESTMAN, Jacob D0YO3X DRUGTYPE Small molecular drug D0YO3X DRUGINCH 1S/C23H16F6N2O3/c24-22(25,26)18-10-3-2-9-17(18)21(33)31-16-8-5-7-14(12-16)20(32)30-13-15-6-1-4-11-19(15)34-23(27,28)29/h1-12H,13H2,(H,30,32)(H,31,33) D0YO3X DRUGINKE BLXNFXQRCFAJKN-UHFFFAOYSA-N D0YO3X DRUGSMIL C1=CC=C(C(=C1)CNC(=O)C2=CC(=CC=C2)NC(=O)C3=CC=CC=C3C(F)(F)F)OC(F)(F)F D0YO3X HIGHSTAT Patented D0YO3X COMPCLAS Benzamide derivatives D0YP5U DRUG__ID D0YP5U D0YP5U DRUGCOMP DAINIPPON SUMITOMO PHARMA CO [JP] D0YP5U DRUGTYPE Small molecular drug D0YP5U DRUGINCH 1S/C26H21N3O7/c1-16-2-9-20(10-3-16)36-15-17-4-6-18(7-5-17)21-12-13-35-24(21)26(32)28-27-25(31)19-8-11-23(30)22(14-19)29(33)34/h2-14,30H,15H2,1H3,(H,27,31)(H,28,32) D0YP5U DRUGINKE BTGUVNBWMLTDRT-UHFFFAOYSA-N D0YP5U DRUGSMIL CC1=CC=C(C=C1)OCC2=CC=C(C=C2)C3=C(OC=C3)C(=O)NNC(=O)C4=CC(=C(C=C4)O)[N+](=O)[O-] D0YP5U HIGHSTAT Patented D0YP5U COMPCLAS 3-substituted-2-furancarboxylic acid hydrazide derivatives D0YP7A DRUG__ID D0YP7A D0YP7A DRUGCOMP Medicis Corp D0YP7A DRUGTYPE Small molecular drug D0YP7A DRUGINCH 1S/C3H4N2OS/c4-3(6)1-5-2-7/h1H2,(H2,4,6) D0YP7A DRUGINKE LXDZRHJIMQYSSD-UHFFFAOYSA-N D0YP7A DRUGSMIL C(C(=O)N)N=C=S D0YP7A HIGHSTAT Patented D0YP7A COMPCLAS Isothiocyanate derivatives D0Z0KL DRUG__ID D0Z0KL D0Z0KL DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0Z0KL DRUGTYPE Small molecule immunotherapy D0Z0KL DRUGINCH 1S/C19H26N6O6/c1-30-14-8-3-2-6-11(14)16-24-25-17(31-16)13(10-15(21)26)23-19(29)22-12(18(27)28)7-4-5-9-20/h2-3,6,8,12-13H,4-5,7,9-10,20H2,1H3,(H2,21,26)(H,27,28)(H2,22,23,29)/t12-,13-/m0/s1 D0Z0KL DRUGINKE SAUWXUYDAXFMAR-STQMWFEESA-N D0Z0KL DRUGSMIL COC1=CC=CC=C1C2=NN=C(O2)C(CC(=O)N)NC(=O)NC(CCCCN)C(=O)O D0Z0KL HIGHSTAT Patented D0Z0KL COMPCLAS 1,3,4-oxadiazole derivatives D0Z1KU DRUG__ID D0Z1KU D0Z1KU DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giusepp D0Z1KU DRUGTYPE Small molecular drug D0Z1KU DRUGINCH 1S/C23H22N2O3/c1-3-24(4-2)23(26)28-22-19-14-10-16-25(19)18-13-8-9-15-20(18)27-21(22)17-11-6-5-7-12-17/h5-16H,3-4H2,1-2H3 D0Z1KU DRUGINKE ZLLBRSQVPPSYMP-UHFFFAOYSA-N D0Z1KU DRUGSMIL CCN(CC)C(=O)OC1=C(OC2=CC=CC=C2N3C1=CC=C3)C4=CC=CC=C4 D0Z1KU HIGHSTAT Patented D0Z1KU COMPCLAS Benzothiazepine analogs D0Z2MX DRUG__ID D0Z2MX D0Z2MX DRUGCOMP INST CHEMII ORGANICZNEJ POLSKIEJ AKADEMII NAUK [PLWARSZAWSKI UNIV MEDYCZNY [PL] D0Z2MX DRUGTYPE Small molecular drug D0Z2MX DRUGINCH 1S/C23H26F6N2O6/c1-5-36-17(32)10-30-20(34)16(9-12(2)3)31-19(33)13(4)11-37-21(35)18-14(22(24,25)26)7-6-8-15(18)23(27,28)29/h6-8,12,16H,4-5,9-11H2,1-3H3,(H,30,34)(H,31,33) D0Z2MX DRUGINKE PIBIRGYHHYAZIQ-UHFFFAOYSA-N D0Z2MX DRUGSMIL CCOC(=O)CNC(=O)C(CC(C)C)NC(=O)C(=C)COC(=O)C1=C(C=CC=C1C(F)(F)F)C(F)(F)F D0Z2MX HIGHSTAT Patented D0Z2MX COMPCLAS Acyl oxymethyl acrylamide ester derivatives D0Z2YB DRUG__ID D0Z2YB D0Z2YB DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John D0Z2YB DRUGTYPE Small molecular drug D0Z2YB DRUGINCH 1S/C17H16N2O4/c1-23-9-7-18-16(20)11-5-6-12-14(10-11)19-8-3-2-4-13(19)15(12)17(21)22/h2-6,8,10H,7,9H2,1H3,(H,18,20)(H,21,22) D0Z2YB DRUGINKE HHIORJMMUBJBIN-UHFFFAOYSA-N D0Z2YB DRUGSMIL COCCNC(=O)C1=CC2=C(C=C1)C(=C3N2C=CC=C3)C(=O)O D0Z2YB HIGHSTAT Patented D0Z2YB COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D0Z4IA DRUG__ID D0Z4IA D0Z4IA DRUGCOMP LUNDBECK & CO AS H [DKJOERGENSEN MORTEN [DKBRUUN ANNE TECHAU [DKRASMUSSEN LARS KYHN [DK] D0Z4IA DRUGTYPE Small molecular drug D0Z4IA DRUGINCH 1S/C16H12ClN5/c1-9-5-3-6-11(17)13(9)16-21-20-15-10(2)19-14-12(22(15)16)7-4-8-18-14/h3-8H,1-2H3 D0Z4IA DRUGINKE GBABEYRPJLOPCN-UHFFFAOYSA-N D0Z4IA DRUGSMIL CC1=C(C(=CC=C1)Cl)C2=NN=C3N2C4=C(N=CC=C4)N=C3C D0Z4IA HIGHSTAT Patented D0Z4IA COMPCLAS Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivatives D0Z4QT DRUG__ID D0Z4QT D0Z4QT DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0Z4QT DRUGTYPE Small molecule immunotherapy D0Z4QT DRUGINCH 1S/C15H24N6O6/c1-8(22)11(13(24)25)18-15(26)17-9(7-10(16)23)12-19-14(20-27-12)21-5-3-2-4-6-21/h8-9,11,22H,2-7H2,1H3,(H2,16,23)(H,24,25)(H2,17,18,26)/t8?,9-,11-/m0/s1 D0Z4QT DRUGINKE YPPJFPAGRYMZTM-PCFYAGROSA-N D0Z4QT DRUGSMIL CC(C(C(=O)O)NC(=O)NC(CC(=O)N)C1=NC(=NO1)N2CCCCC2)O D0Z4QT HIGHSTAT Patented D0Z4QT COMPCLAS 3-substituted-1,2,4-oxadiazole derivatives D0Z5NP DRUG__ID D0Z5NP D0Z5NP DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0Z5NP DRUGTYPE Small molecular drug D0Z5NP DRUGINCH 1S/C23H18F3N5O/c1-30-10-18(20-21(27)28-11-29-22(20)30)17-3-2-15(9-19(17)26)31-5-4-16(23(31)32)12-6-13(24)8-14(25)7-12/h2-3,6-11,16H,4-5H2,1H3,(H2,27,28,29) D0Z5NP DRUGINKE JZSDPOSETBCTOH-UHFFFAOYSA-N D0Z5NP DRUGSMIL CN1C=C(C2=C(N=CN=C21)N)C3=C(C=C(C=C3)N4CCC(C4=O)C5=CC(=CC(=C5)F)F)F D0Z5NP HIGHSTAT Patented D0Z5NP COMPCLAS Phenylpyrrolidinone derivatives D0Z6LB DRUG__ID D0Z6LB D0Z6LB DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven, W. BLAKE, James, F. CONDROSKI, Kevin, R. HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy KOLAKOWSKI, Gabrielle R. SEO, Jeongbeob D0Z6LB DRUGTYPE Small molecular drug D0Z6LB DRUGINCH 1S/C25H27F2N7O2/c1-32-24(13-20(31-32)22-4-3-5-23-28-8-9-34(22)23)30-25(35)29-21-15-33(10-11-36-2)14-17(21)16-6-7-18(26)19(27)12-16/h3-9,12-13,17,21H,10-11,14-15H2,1-2H3,(H2,29,30,35)/t17-,21+/m0/s1 D0Z6LB DRUGINKE SRPJIAHTEPDSEX-LAUBAEHRSA-N D0Z6LB DRUGSMIL CN1C(=CC(=N1)C2=CC=CC3=NC=CN32)NC(=O)NC4CN(CC4C5=CC(=C(C=C5)F)F)CCOC D0Z6LB HIGHSTAT Patented D0Z6LB COMPCLAS Pyrrolidinyl urea derivatives D0Z6RI DRUG__ID D0Z6RI D0Z6RI DRUGCOMP THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN UNIVERSITA' DI SIENA WILLIAMS, David, Clive ZISTERER, Daniela, M. NACCI, Vito CAMPIANI, Giuseppe D0Z6RI DRUGTYPE Small molecular drug D0Z6RI DRUGINCH 1S/C21H18N2O2S/c1-22(2)21(24)25-19-17-12-8-14-23(17)16-11-6-7-13-18(16)26-20(19)15-9-4-3-5-10-15/h3-14H,1-2H3 D0Z6RI DRUGINKE FGXDSIINDRBSII-UHFFFAOYSA-N D0Z6RI DRUGSMIL CN(C)C(=O)OC1=C(SC2=CC=CC=C2N3C1=CC=C3)C4=CC=CC=C4 D0Z6RI HIGHSTAT Patented D0Z6RI COMPCLAS Benzothiazepine analogs D0ZC1O DRUG__ID D0ZC1O D0ZC1O DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0ZC1O DRUGTYPE Small molecular drug D0ZC1O DRUGINCH 1S/C22H24FN3O3S/c1-26(22-25-15-11-10-13(23)12-19(15)30-22)16-7-4-6-14(16)24-21(27)20-17(28-2)8-5-9-18(20)29-3/h5,8-12,14,16H,4,6-7H2,1-3H3,(H,24,27)/t14-,16-/m0/s1 D0ZC1O DRUGINKE TWWJAOFWTFXPRC-HOCLYGCPSA-N D0ZC1O DRUGSMIL CN(C1CCCC1NC(=O)C2=C(C=CC=C2OC)OC)C3=NC4=C(S3)C=C(C=C4)F D0ZC1O HIGHSTAT Patented D0ZC1O COMPCLAS 1,2-diamino cyclopentane-based derivatives D0ZC7W DRUG__ID D0ZC7W D0ZC7W DRUGCOMP OXYGEN HEALTHCARE RESEARCH PVT. LTD SHIRSATH, Vikas S. PATEL, Shailesh M SHETH, Nehal M. SINGH, Jitendra K. PATIL, Pawan D. PAWAR, Anil D. MOTIVARAS, Jitendra D D0ZC7W DRUGTYPE Small molecular drug D0ZC7W DRUGINCH 1S/C22H28N2O3S2/c1-18-7-5-12-23(18)13-6-15-27-19-10-11-22-21(17-19)24(14-16-28-22)29(25,26)20-8-3-2-4-9-20/h2-4,8-11,17-18H,5-7,12-16H2,1H3 D0ZC7W DRUGINKE OBXKKQAGOFTSNE-UHFFFAOYSA-N D0ZC7W DRUGSMIL CC1CCCN1CCCOC2=CC3=C(C=C2)SCCN3S(=O)(=O)C4=CC=CC=C4 D0ZC7W HIGHSTAT Patented D0ZC7W COMPCLAS Phenylsulfonyl derivatives D0ZE5U DRUG__ID D0ZE5U D0ZE5U DRUGCOMP Schering AG D0ZE5U DRUGTYPE Small molecular drug D0ZE5U DRUGINCH 1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8- D0ZE5U DRUGINKE DFURSNCTQGJRRX-JYRVWZFOSA-N D0ZE5U DRUGSMIL CC(=C1C2=C(C=CC(=C2)NC(=O)N)NC1=O)C3=CC=CN3 D0ZE5U HIGHSTAT Patented D0ZE5U COMPCLAS Indolinone derivatives D0ZY6C DRUG__ID D0ZY6C D0ZY6C DRUGCOMP INTERVET INTERNATIONAL B.V. DEMONG, Duane, Eugene MILLER, Michael, W. GILBERT, Eric, J. SCOTT, Jack, D. STAMFORD, Andrew GREENLEE, William, J. CELLY, Chander, Shekher D0ZY6C DRUGTYPE Small molecular drug D0ZY6C DRUGINCH 1S/C24H22Cl2N2O2/c1-30-23-10-6-5-9-19(23)24(29)27-13-14-28(21-12-11-18(25)15-20(21)26)22(16-27)17-7-3-2-4-8-17/h2-12,15,22H,13-14,16H2,1H3 D0ZY6C DRUGINKE HXMSNSZTEVRLDE-UHFFFAOYSA-N D0ZY6C DRUGSMIL COC1=CC=CC=C1C(=O)N2CCN(C(C2)C3=CC=CC=C3)C4=C(C=C(C=C4)Cl)Cl D0ZY6C HIGHSTAT Patented D0ZY6C COMPCLAS Diaryl piperazine derivatives D0ZZ6N DRUG__ID D0ZZ6N D0ZZ6N DRUGCOMP ARIZONA BOARD OF REGENTS, ACTING ON BEHALF OF THE UNIVERSITY OF ARIZONA UNIVERSITY OF PITTSBURGH POWIS, Garth WIPF, Pete D0ZZ6N DRUGTYPE Small molecular drug D0ZZ6N DRUGINCH 1S/C22H15NO6.C2HF3O2/c23-11-19(26)27-16-7-8-18-20-12(16)3-1-6-17(20)28-22(29-18)10-9-15(25)21-13(22)4-2-5-14(21)24;3-2(4,5)1(6)7/h1-10,24H,11,23H2;(H,6,7) D0ZZ6N DRUGINKE BRTORUASIGAKNH-UHFFFAOYSA-N D0ZZ6N DRUGSMIL C1=CC2=C(C=CC3=C2C(=C1)OC4(O3)C=CC(=O)C5=C4C=CC=C5O)OC(=O)CN.C(=O)(C(F)(F)F)O D0ZZ6N HIGHSTAT Patented D0ZZ6N COMPCLAS Palmarumycin derivatives D00ACL DRUG__ID D00ACL D00ACL DRUGCOMP KARUS THERAPEUTICS LTD D00ACL DRUGTYPE Small molecular drug D00ACL DRUGINCH 1S/C16H13FN6O2/c17-13-7-11(16(24)22-25)1-2-12(13)10-23(14-8-18-3-5-20-14)15-9-19-4-6-21-15/h1-9,25H,10H2,(H,22,24) D00ACL DRUGINKE PLETUCDALFTIQN-UHFFFAOYSA-N D00ACL DRUGSMIL C1=CC(=C(C=C1C(=O)NO)F)CN(C2=NC=CN=C2)C3=NC=CN=C3 D00ACL HIGHSTAT Patented D00BFF DRUG__ID D00BFF D00BFF DRUGTYPE Small molecular drug D00BFF DRUGINCH 1S/C22H14Cl2N2O6S2/c23-15-2-1-3-16(24)14(15)11-34(31,32)13-5-7-20-17(10-13)25-22(28)21(33-20)9-12-4-6-19(27)18(8-12)26(29)30/h1-10,27H,11H2,(H,25,28)/b21-9- D00BFF DRUGINKE DOMBZVXKSRQDOJ-NKVSQWTQSA-N D00BFF DRUGSMIL C1=CC(=C(C(=C1)Cl)CS(=O)(=O)C2=CC3=C(C=C2)SC(=CC4=CC(=C(C=C4)O)[N+](=O)[O-])C(=O)N3)Cl D00BFF HIGHSTAT Patented D00BFF COMPCLAS Benzothiazine derivatives D00BQR DRUG__ID D00BQR D00BQR DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D00BQR DRUGTYPE Small molecular drug D00BQR DRUGINCH 1S/C11H12ClFN4O3/c12-11-15-8(14)4-1-2-17(9(4)16-11)10-6(13)7(19)5(3-18)20-10/h1-2,5-7,10,18-19H,3H2,(H2,14,15,16)/t5-,6+,7-,10-/m1/s1 D00BQR DRUGINKE VLXMLGCQJSJFSY-JTGULSINSA-N D00BQR DRUGSMIL C1=CN(C2=NC(=NC(=C21)N)Cl)C3C(C(C(O3)CO)O)F D00BQR HIGHSTAT Patented D00CKV DRUG__ID D00CKV D00CKV DRUGTYPE Small molecular drug D00CKV DRUGINCH 1S/C24H16F3NO2/c1-15(29)22-20(16-7-3-2-4-8-16)21(19-9-5-6-14-28(19)22)23(30)17-10-12-18(13-11-17)24(25,26)27/h2-14H,1H3 D00CKV DRUGINKE GLIRMGCILWOVQU-UHFFFAOYSA-N D00CKV DRUGSMIL CC(=O)C1=C(C(=C2N1C=CC=C2)C(=O)C3=CC=C(C=C3)C(F)(F)F)C4=CC=CC=C4 D00CKV HIGHSTAT Patented D00CKV COMPCLAS Indolizine derivatives D00DXC DRUG__ID D00DXC D00DXC DRUGCOMP CS THERAPEUTICS INC D00DXC DRUGTYPE Small molecular drug D00DXC DRUGINCH 1S/C20H18FN5O3/c1-11-14-8-13(21)3-4-16(14)27-5-6-28-20-18(15(9-22)26(2)25-20)12-7-17(29-11)19(23)24-10-12/h3-4,7-8,10-11H,5-6H2,1-2H3,(H2,23,24) D00DXC DRUGINKE IAURDDBZTWBKOT-UHFFFAOYSA-N D00DXC DRUGSMIL CC1C2=C(C=CC(=C2)F)OCCOC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C D00DXC HIGHSTAT Patented D00DYI DRUG__ID D00DYI D00DYI DRUGTYPE Small molecular drug D00DYI DRUGINCH 1S/C13H9NOS/c15-10-7-5-9(6-8-10)13-14-11-3-1-2-4-12(11)16-13/h1-8,15H D00DYI DRUGINKE ODMDLCWSMSFWCW-UHFFFAOYSA-N D00DYI DRUGSMIL C1=CC=C2C(=C1)N=C(S2)C3=CC=C(C=C3)O D00DYI HIGHSTAT Patented D00DYI COMPCLAS Benzothiazole analogs D00EGV DRUG__ID D00EGV D00EGV DRUGCOMP UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette D00EGV DRUGTYPE Small molecular drug D00EGV DRUGINCH 1S/C21H21NO/c1-3-8-18(9-4-1)14-15-22-17-19-10-7-13-21(16-19)23-20-11-5-2-6-12-20/h1-13,16,22H,14-15,17H2 D00EGV DRUGINKE VXWOCJGIIONIQR-UHFFFAOYSA-N D00EGV DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC(=CC=C2)OC3=CC=CC=C3 D00EGV HIGHSTAT Patented D00HXJ DRUG__ID D00HXJ D00HXJ DRUGCOMP UNIVERSIT T REGENSBURG [DEFRIEDRICH SCHILLER UNIVERSIT T JENA [DEUNIVERSIT TSKLINIKUM JENA [DE] D00HXJ DRUGTYPE Small molecular drug D00HXJ DRUGINCH 1S/C22H20N4O4/c1-24-21(28)16-11-25(22(24)29)12-18-19(16)15-4-2-3-5-17(15)26(18)10-13-6-8-14(9-7-13)20(27)23-30/h2-9,16,30H,10-12H2,1H3,(H,23,27) D00HXJ DRUGINKE ZCAIUGLOTHAUQX-UHFFFAOYSA-N D00HXJ DRUGSMIL CN1C(=O)C2CN(C1=O)CC3=C2C4=CC=CC=C4N3CC5=CC=C(C=C5)C(=O)NO D00HXJ HIGHSTAT Patented D00JAH DRUG__ID D00JAH D00JAH DRUGCOMP Janssen Pharmaceutica NV D00JAH DRUGTYPE Small molecular drug D00JAH DRUGINCH 1S/C23H20N4O/c1-23(14-25,12-16-5-4-6-17(13-24)26-16)15-9-10-19-18-7-2-3-8-20(18)22(28)27-21(19)11-15/h4-6,9-11H,2-3,7-8,12H2,1H3,(H,27,28) D00JAH DRUGINKE WVGLSASLDWFLFS-UHFFFAOYSA-N D00JAH DRUGSMIL CC(CC1=NC(=CC=C1)C#N)(C#N)C2=CC3=C(C=C2)C4=C(CCCC4)C(=O)N3 D00JAH HIGHSTAT Patented D00KCT DRUG__ID D00KCT D00KCT DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D00KCT DRUGTYPE Small molecular drug D00KCT DRUGINCH 1S/C19H19ClN2O3/c20-14-8-9-15(13-6-2-1-3-7-13)16(12-14)21-18(25)22-19(17(23)24)10-4-5-11-19/h1-3,6-9,12H,4-5,10-11H2,(H,23,24)(H2,21,22,25) D00KCT DRUGINKE YBQHFZNBCISVBS-UHFFFAOYSA-N D00KCT DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C=CC(=C2)Cl)C3=CC=CC=C3 D00KCT HIGHSTAT Patented D00KTN DRUG__ID D00KTN D00KTN DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D00KTN DRUGTYPE Small molecular drug D00KTN DRUGINCH 1S/C21H22F3N5O2/c22-21(23,24)14-8-7-13(17(11-14)29-9-2-1-3-10-29)12-25-19(30)26-15-5-4-6-16-18(15)28-20(31)27-16/h4-8,11H,1-3,9-10,12H2,(H2,25,26,30)(H2,27,28,31) D00KTN DRUGINKE ILFYSMXXQODUJS-UHFFFAOYSA-N D00KTN DRUGSMIL C1CCN(CC1)C2=C(C=CC(=C2)C(F)(F)F)CNC(=O)NC3=CC=CC4=C3NC(=O)N4 D00KTN HIGHSTAT Patented D00MXR DRUG__ID D00MXR D00MXR DRUGCOMP KAINOS MEDICINE, INC D00MXR DRUGTYPE Small molecular drug D00MXR DRUGINCH 1S/C22H21ClN4O4S/c1-13-25-26-22-19(12-31-32(28,29)17-8-9-17)24-21(14-3-5-15(23)6-4-14)18-11-16(30-2)7-10-20(18)27(13)22/h3-7,10-11,17,19H,8-9,12H2,1-2H3/t19-/m0/s1 D00MXR DRUGINKE BTVRKLXZFWPBGV-IBGZPJMESA-N D00MXR DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2COS(=O)(=O)C4CC4)C5=CC=C(C=C5)Cl D00MXR HIGHSTAT Patented D00NCJ DRUG__ID D00NCJ D00NCJ DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D00NCJ DRUGTYPE Small molecular drug D00NCJ DRUGINCH 1S/C25H26F3N5O3/c1-15(2)11-20(33-21-8-5-17(12-30-21)24(36)29-10-9-22(34)35)18-13-31-23(32-14-18)16-3-6-19(7-4-16)25(26,27)28/h3-8,12-15,20H,9-11H2,1-2H3,(H,29,36)(H,30,33)(H,34,35)/t20-/m0/s1 D00NCJ DRUGINKE DROAORWMIULFBS-FQEVSTJZSA-N D00NCJ DRUGSMIL CC(C)CC(C1=CN=C(N=C1)C2=CC=C(C=C2)C(F)(F)F)NC3=NC=C(C=C3)C(=O)NCCC(=O)O D00NCJ HIGHSTAT Patented D00NDF DRUG__ID D00NDF D00NDF DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D00NDF DRUGTYPE Small molecular drug D00NDF DRUGINCH 1S/C4H8O2/c1-3(5)4(2)6/h3,5H,1-2H3 D00NDF DRUGINKE ROWKJAVDOGWPAT-UHFFFAOYSA-N D00NDF DRUGSMIL CC(C(=O)C)O D00NDF HIGHSTAT Patented D00PFT DRUG__ID D00PFT D00PFT DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D00PFT DRUGTYPE Small molecular drug D00PFT DRUGINCH 1S/C25H26N6O/c1-17(2)28-24(32)18-5-8-21(9-6-18)29-25-27-12-11-22(30-25)19-7-10-23(20(15-19)16-26)31-13-3-4-14-31/h5-12,15,17H,3-4,13-14H2,1-2H3,(H,28,32)(H,27,29,30) D00PFT DRUGINKE FJNGYFUMQJIPOQ-UHFFFAOYSA-N D00PFT DRUGSMIL CC(C)NC(=O)C1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)N4CCCC4)C#N D00PFT HIGHSTAT Patented D00PJE DRUG__ID D00PJE D00PJE DRUGTYPE Small molecular drug D00PJE DRUGINCH 1S/C29H33N3O3/c1-2-20-5-3-6-21(15-20)17-32-24-18-31(14-8-22(24)23-7-4-13-30-26(23)32)25(33)16-28-9-11-29(19-28,12-10-28)27(34)35/h3-7,13,15H,2,8-12,14,16-19H2,1H3,(H,34,35) D00PJE DRUGINKE KFNXYFDWAKJOGZ-UHFFFAOYSA-N D00PJE DRUGSMIL CCC1=CC(=CC=C1)CN2C3=C(CCN(C3)C(=O)CC45CCC(C4)(CC5)C(=O)O)C6=C2N=CC=C6 D00PJE HIGHSTAT Patented D00PJE COMPCLAS Tetra-hydro-carboline derivatives D00PVH DRUG__ID D00PVH D00PVH DRUGCOMP Abbott D00PVH DRUGTYPE Small molecular drug D00PVH DRUGINCH 1S/C19H15Cl2N5S/c1-12-24-25-19(26(12)16-6-2-5-15(20)17(16)21)23-10-13-4-3-8-22-18(13)14-7-9-27-11-14/h2-9,11H,10H2,1H3,(H,23,25) D00PVH DRUGINKE SMJNWZUHIGQMEW-UHFFFAOYSA-N D00PVH DRUGSMIL CC1=NN=C(N1C2=C(C(=CC=C2)Cl)Cl)NCC3=C(N=CC=C3)C4=CSC=C4 D00PVH HIGHSTAT Patented D00RDL DRUG__ID D00RDL D00RDL DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D00RDL DRUGTYPE Small molecular drug D00RDL DRUGINCH 1S/C20H19F3N2O3/c21-20(22,23)14-8-9-15(13-6-2-1-3-7-13)16(12-14)24-18(28)25-19(17(26)27)10-4-5-11-19/h1-3,6-9,12H,4-5,10-11H2,(H,26,27)(H2,24,25,28) D00RDL DRUGINKE LZSZOARSNJNBDV-UHFFFAOYSA-N D00RDL DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C=CC(=C2)C(F)(F)F)C3=CC=CC=C3 D00RDL HIGHSTAT Patented D00SAH DRUG__ID D00SAH D00SAH DRUGCOMP Japan Science and Technology Agency D00SAH DRUGTYPE Small molecular drug D00SAH DRUGINCH 1S/C12H19NO3/c1-10(2)13(7-8-14)6-5-11(15)12-4-3-9-16-12/h3-4,9-10,14H,5-8H2,1-2H3 D00SAH DRUGINKE DCZMNFQBOIDRNH-UHFFFAOYSA-N D00SAH DRUGSMIL CC(C)N(CCC(=O)C1=CC=CO1)CCO D00SAH HIGHSTAT Patented D00SZR DRUG__ID D00SZR D00SZR DRUGCOMP Celus-Pharmaceuticals D00SZR DRUGTYPE Small molecular drug D00SZR DRUGINCH 1S/C29H43FO2/c1-6-29(32,7-2)17-8-10-20(3)25-14-15-26-22(11-9-16-28(25,26)5)12-13-23-18-24(31)19-27(30)21(23)4/h8,12-14,17,20,24,26-27,31-32H,4,6-7,9-11,15-16,18-19H2,1-3,5H3/b17-8+,22-12+,23-13-/t20-,24+,26-,27-,28+/m0/s1 D00SZR DRUGINKE LRLWXBHFPGSUOX-GJQYOBCGSA-N D00SZR DRUGSMIL CCC(CC)(C=CCC(C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)F)O)C)O D00SZR HIGHSTAT Patented D00TMQ DRUG__ID D00TMQ D00TMQ DRUGTYPE Small molecular drug D00TMQ DRUGINCH 1S/C22H24ClF3N2O2/c1-21(2,3)27-20(29)28-12-16(13-28)30-19(14-8-10-15(23)11-9-14)17-6-4-5-7-18(17)22(24,25)26/h4-11,16,19H,12-13H2,1-3H3,(H,27,29)/t19-/m1/s1 D00TMQ DRUGINKE BNLYOVHLLDBOFZ-LJQANCHMSA-N D00TMQ DRUGSMIL CC(C)(C)NC(=O)N1CC(C1)OC(C2=CC=C(C=C2)Cl)C3=CC=CC=C3C(F)(F)F D00TMQ HIGHSTAT Patented D00TMQ COMPCLAS Azetidine-1-carboxamide derivatives D00TVL DRUG__ID D00TVL D00TVL DRUGCOMP China Pharmaceutical University D00TVL DRUGTYPE Small molecular drug D00TVL DRUGINCH 1S/C31H31NO8S/c1-19-15-20(2)31(21(3)16-19)41(37,38)32(18-30(35)36)26-13-14-27(25-8-6-5-7-24(25)26)40-28(17-29(33)34)22-9-11-23(39-4)12-10-22/h5-16,28H,17-18H2,1-4H3,(H,33,34)(H,35,36) D00TVL DRUGINKE PSPVUIANHULZSQ-UHFFFAOYSA-N D00TVL DRUGSMIL CC1=CC(=C(C(=C1)C)S(=O)(=O)N(CC(=O)O)C2=CC=C(C3=CC=CC=C32)OC(CC(=O)O)C4=CC=C(C=C4)OC)C D00TVL HIGHSTAT Patented D00VLQ DRUG__ID D00VLQ D00VLQ DRUGTYPE Small molecular drug D00VLQ DRUGINCH 1S/C10H7NO3/c12-8-4-3-7(10(13)14)6-2-1-5-11-9(6)8/h1-5,12H,(H,13,14) D00VLQ DRUGINKE JGRPKOGHYBAVMW-UHFFFAOYSA-N D00VLQ DRUGSMIL C1=CC2=C(C=CC(=C2N=C1)O)C(=O)O D00VLQ HIGHSTAT Patented D00VLQ COMPCLAS Hydroxyqunoline analogs D00VXV DRUG__ID D00VXV D00VXV DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D00VXV DRUGTYPE Small molecular drug D00VXV DRUGINCH 1S/C60H70BrN9O8/c1-35(62-3)54(71)66-48-34-70(50-21-12-11-20-49(50)69(59(48)76)33-46-44-28-27-42(61)30-41(44)26-29-52(46)78-5)58(75)40-24-22-39(23-25-40)56(73)64-43-31-51(57(74)65-47-19-13-17-37-14-9-10-18-45(37)47)68(32-43)60(77)53(38-15-7-6-8-16-38)67-55(72)36(2)63-4/h9-12,14,18,20-30,35-36,38,43,47-48,51,53,62-63H,6-8,13,15-17,19,31-34H2,1-5H3,(H,64,73)(H,65,74)(H,66,71)(H,67,72)/t35-,36-,43-,47+,48-,51-,53-/m0/s1 D00VXV DRUGINKE OVCDDAXIBKWFRB-SFDZCEMOSA-N D00VXV DRUGSMIL CC(C(=O)NC1CN(C2=CC=CC=C2N(C1=O)CC3=C(C=CC4=C3C=CC(=C4)Br)OC)C(=O)C5=CC=C(C=C5)C(=O)NC6CC(N(C6)C(=O)C(C7CCCCC7)NC(=O)C(C)NC)C(=O)NC8CCCC9=CC=CC=C89)NC D00VXV HIGHSTAT Patented D00YXA DRUG__ID D00YXA D00YXA DRUGCOMP ABBVIE INC D00YXA DRUGTYPE Small molecular drug D00YXA DRUGINCH 1S/C22H21F2N3O/c1-13-10-18-15(12-25-13)7-9-20(24)21(18)27-22(28)26-16-8-6-14(11-16)17-4-2-3-5-19(17)23/h2-5,7,9-10,12,14,16H,6,8,11H2,1H3,(H2,26,27,28)/t14-,16+/m0/s1 D00YXA DRUGINKE PJVXUKARZNCIRA-GOEBONIOSA-N D00YXA DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC=CC=C4F)F)C=N1 D00YXA HIGHSTAT Patented D01AFN DRUG__ID D01AFN D01AFN DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D01AFN DRUGTYPE Small molecular drug D01AFN DRUGINCH 1S/C18H17FN2O2S/c1-24(22,23)17-7-4-6-16(13-17)21-12-10-18(19,14-21)9-8-15-5-2-3-11-20-15/h2-7,11,13H,10,12,14H2,1H3 D01AFN DRUGINKE FBIPFOUWZKBKQR-UHFFFAOYSA-N D01AFN DRUGSMIL CS(=O)(=O)C1=CC=CC(=C1)N2CCC(C2)(C#CC3=CC=CC=N3)F D01AFN HIGHSTAT Patented D01CCT DRUG__ID D01CCT D01CCT DRUGCOMP Universit de Montral D01CCT DRUGTYPE Small molecular drug D01CCT DRUGINCH 1S/C18H13N5O5/c24-18(10-5-13-1-6-15(7-2-13)22(25)26)17-12-21(20-19-17)11-14-3-8-16(9-4-14)23(27)28/h1-10,12H,11H2/b10-5+ D01CCT DRUGINKE CVKOJPBBOPIMAL-BJMVGYQFSA-N D01CCT DRUGSMIL C1=CC(=CC=C1CN2C=C(N=N2)C(=O)C=CC3=CC=C(C=C3)[N+](=O)[O-])[N+](=O)[O-] D01CCT HIGHSTAT Patented D01CFL DRUG__ID D01CFL D01CFL DRUGTYPE Small molecular drug D01CFL DRUGINCH 1S/C15H14ClNO3S/c1-19-11-5-8(6-12(20-2)14(11)18)15-17-10-7-9(16)3-4-13(10)21-15/h3-7,15,17-18H,1-2H3 D01CFL DRUGINKE LQDWIAAYFSZPAR-UHFFFAOYSA-N D01CFL DRUGSMIL COC1=CC(=CC(=C1O)OC)C2NC3=C(S2)C=CC(=C3)Cl D01CFL HIGHSTAT Patented D01CFL COMPCLAS Benzothiazoline derivatives D01DHT DRUG__ID D01DHT D01DHT DRUGCOMP MERCK SHARP &amDOHME CORP. DEVITA, Robert, J. HE, Shuwen LIU, Jian CERNAK, Timothy, A. KRIKORIAN, Arto, D. YANG, Ginger XuQiang WU, Zhicai YU, Yang SHEN, Dong-Ming LAI, Zhong HONG, Qingmei NARGUND, Ravi, P D01DHT DRUGTYPE Small molecular drug D01DHT DRUGINCH 1S/C27H25FN4O2/c28-23-3-1-2-21(15-23)26-30-27(32-31-26)22-12-13-24(29-16-22)20-10-8-19(9-11-20)18-6-4-17(5-7-18)14-25(33)34/h1-3,8-13,15-18H,4-7,14H2,(H,33,34)(H,30,31,32) D01DHT DRUGINKE IMVHPASOWCDZEL-UHFFFAOYSA-N D01DHT DRUGSMIL C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)C4=NNC(=N4)C5=CC(=CC=C5)F D01DHT HIGHSTAT Patented D01DNH DRUG__ID D01DNH D01DNH DRUGCOMP Amorepacific Corp D01DNH DRUGTYPE Small molecular drug D01DNH DRUGINCH 1S/C22H23F2N3O3S2/c1-12(2)14-6-5-7-15(8-14)22-26-19(11-31-22)21(28)25-13(3)16-9-17(23)20(18(24)10-16)27-32(4,29)30/h5-13,27H,1-4H3,(H,25,28)/t13-/m1/s1 D01DNH DRUGINKE PCULXRGTXBQRDF-CYBMUJFWSA-N D01DNH DRUGSMIL CC(C)C1=CC=CC(=C1)C2=NC(=CS2)C(=O)NC(C)C3=CC(=C(C(=C3)F)NS(=O)(=O)C)F D01DNH HIGHSTAT Patented D01EBW DRUG__ID D01EBW D01EBW DRUGCOMP AstraZeneca D01EBW DRUGTYPE Small molecular drug D01EBW DRUGINCH 1S/C22H28ClN3O3/c1-14-3-2-9-22(29,11-14)13-24-21(28)20-16-4-7-19(26-10-8-15(27)12-26)25-18(16)6-5-17(20)23/h4-7,14-15,27,29H,2-3,8-13H2,1H3,(H,24,28)/t14-,15+,22-/m0/s1 D01EBW DRUGINKE GTFTZKPCYSYNOU-KIMHZCHSSA-N D01EBW DRUGSMIL CC1CCCC(C1)(CNC(=O)C2=C(C=CC3=C2C=CC(=N3)N4CCC(C4)O)Cl)O D01EBW HIGHSTAT Patented D01GCI DRUG__ID D01GCI D01GCI DRUGCOMP Vantia Ltd D01GCI DRUGTYPE Small molecular drug D01GCI DRUGINCH 1S/C31H38Cl2N6O2/c1-31(2,3)11-14-38-12-9-20(10-13-38)29(40)34-17-22-6-5-21(15-25(22)33)30(41)39-19-23-18-35-37(4)28(23)36-26-16-24(32)7-8-27(26)39/h5-8,15-16,18,20,36H,9-14,17,19H2,1-4H3,(H,34,40) D01GCI DRUGINKE QYCFYRDBJAXOJI-UHFFFAOYSA-N D01GCI DRUGSMIL CC(C)(C)CCN1CCC(CC1)C(=O)NCC2=C(C=C(C=C2)C(=O)N3CC4=C(NC5=C3C=CC(=C5)Cl)N(N=C4)C)Cl D01GCI HIGHSTAT Patented D01GEK DRUG__ID D01GEK D01GEK DRUGCOMP Sanofi D01GEK DRUGTYPE Small molecular drug D01GEK DRUGINCH 1S/C24H19F4N5O/c25-18-4-1-3-15(9-18)14-33-20(11-16-10-17(24(26,27)28)12-30-22(16)33)23(34)31-19-5-6-21(29-13-19)32-7-2-8-32/h1,3-6,9-13H,2,7-8,14H2,(H,31,34) D01GEK DRUGINKE DXPFHQMFHSGNDI-UHFFFAOYSA-N D01GEK DRUGSMIL C1CN(C1)C2=NC=C(C=C2)NC(=O)C3=CC4=CC(=CN=C4N3CC5=CC(=CC=C5)F)C(F)(F)F D01GEK HIGHSTAT Patented D01GTU DRUG__ID D01GTU D01GTU DRUGCOMP REATA PHARMACEUTICALS, INC. ANDERSON, Eric JIANG, Xin VISNICK, Melean BENDER, Christopher, F. LIU, Xiaofeng D01GTU DRUGTYPE Small molecular drug D01GTU DRUGINCH 1S/C31H41NO4/c1-18-20-8-9-29(5)23(28(20,4)15-19(17-32)25(18)34)14-22(33)24-21-16-27(2,3)10-12-31(21,26(35)36-7)13-11-30(24,29)6/h14-15,18,20-21,24H,8-13,16H2,1-7H3/t18-,20-,21?,24?,28-,29+,30+,31-/m0/s1 D01GTU DRUGINKE MAOZWESYDBKVCY-HZCQYKMZSA-N D01GTU DRUGSMIL CC1C2CCC3(C(=CC(=O)C4C3(CCC5(C4CC(CC5)(C)C)C(=O)OC)C)C2(C=C(C1=O)C#N)C)C D01GTU HIGHSTAT Patented D01GWS DRUG__ID D01GWS D01GWS DRUGCOMP Asan Foundation D01GWS DRUGTYPE Small molecular drug D01GWS DRUGINCH 1S/C20H23FIN3O4/c1-20(2,28)10-29-24-18(26)16-12-5-4-6-13(12)19(27)25(3)17(16)23-15-8-7-11(22)9-14(15)21/h7-9,23,28H,4-6,10H2,1-3H3,(H,24,26) D01GWS DRUGINKE WMBPVWDVQRPCQY-UHFFFAOYSA-N D01GWS DRUGSMIL CC(C)(CONC(=O)C1=C(N(C(=O)C2=C1CCC2)C)NC3=C(C=C(C=C3)I)F)O D01GWS HIGHSTAT Patented D01HED DRUG__ID D01HED D01HED DRUGCOMP Janssen Pharmaceutica NV D01HED DRUGTYPE Small molecular drug D01HED DRUGINCH 1S/C26H26F6N6/c27-25(28,29)17-6-8-18(9-7-17)34-22-19-10-15-37(23-20(26(30,31)32)5-4-12-33-23)16-11-21(19)35-24(36-22)38-13-2-1-3-14-38/h4-9,12H,1-3,10-11,13-16H2,(H,34,35,36) D01HED DRUGINKE MRHHSXHMRZMNIM-UHFFFAOYSA-N D01HED DRUGSMIL C1CCN(CC1)C2=NC3=C(CCN(CC3)C4=C(C=CC=N4)C(F)(F)F)C(=N2)NC5=CC=C(C=C5)C(F)(F)F D01HED HIGHSTAT Patented D01HJQ DRUG__ID D01HJQ D01HJQ DRUGTYPE Small molecular drug D01HJQ DRUGINCH 1S/C29H27Cl2F2N3O4/c1-2-40-28(39)15-34-26(37)14-27(38)36(24-12-22(32)11-23(33)13-24)25-16-35(17-25)29(18-3-7-20(30)8-4-18)19-5-9-21(31)10-6-19/h3-13,25,29H,2,14-17H2,1H3,(H,34,37) D01HJQ DRUGINKE JLIDBGJVXRJCFP-UHFFFAOYSA-N D01HJQ DRUGSMIL CCOC(=O)CNC(=O)CC(=O)N(C1CN(C1)C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)C4=CC(=CC(=C4)F)F D01HJQ HIGHSTAT Patented D01HJQ COMPCLAS Aminoazetidine derivatives D01JEH DRUG__ID D01JEH D01JEH DRUGCOMP ENSEMBLE THERAPEUTICS CORPORATION D01JEH DRUGTYPE Small molecular drug D01JEH DRUGINCH 1S/C80H96N16O14/c1-45(81-9)69(97)87-67(79(3,4)5)75(103)93-33-31-63-65(93)73(101)83-59(39-49-19-25-51-15-11-13-17-53(51)35-49)71(99)85-61(77(105)106)37-47-23-29-58(30-24-47)110-44-56-42-96(92-90-56)64-32-34-94(76(104)68(80(6,7)8)88-70(98)46(2)82-10)66(64)74(102)84-60(40-50-20-26-52-16-12-14-18-54(52)36-50)72(100)86-62(78(107)108)38-48-21-27-57(28-22-48)109-43-55-41-95(63)91-89-55/h11-30,35-36,41-42,45-46,59-68,81-82H,31-34,37-40,43-44H2,1-10H3,(H,83,101)(H,84,102)(H,85,99)(H,86,100)(H,87,97)(H,88,98)(H,105,106)(H,107,108)/t45-,46-,59-,60-,61-,62-,63+,64+,65-,66-,67+,68+/m0/s1 D01JEH DRUGINKE MBKNBOLIPVRUSC-YZMHPAFASA-N D01JEH DRUGSMIL CC(C(=O)NC(C(=O)N1CCC2C1C(=O)NC(C(=O)NC(CC3=CC=C(C=C3)OCC4=CN(C5CCN(C5C(=O)NC(C(=O)NC(CC6=CC=C(C=C6)OCC7=CN2N=N7)C(=O)O)CC8=CC9=CC=CC=C9C=C8)C(=O)C(C(C)(C)C)NC(=O)C(C)NC)N=N4)C(=O)O)CC1=CC2=CC=CC=C2C=C1)C(C)(C)C)NC D01JEH HIGHSTAT Patented D01KIJ DRUG__ID D01KIJ D01KIJ DRUGCOMP NOVARTIS AG DODD, Stephanie Kay FURET, Pascal GROTZFELD, Robert Martin JAHNKE, Wolfgang JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph D01KIJ DRUGTYPE Small molecular drug D01KIJ DRUGINCH 1S/C20H17ClF3N5O3/c21-20(23,24)32-14-3-1-12(2-4-14)27-19(31)11-7-15(17-16(22)9-26-28-17)18(25-8-11)29-6-5-13(30)10-29/h1-4,7-9,13,30H,5-6,10H2,(H,26,28)(H,27,31)/t13-/m1/s1 D01KIJ DRUGINKE NAXNSUPRCUTVTP-CYBMUJFWSA-N D01KIJ DRUGSMIL C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=C(C=NN4)F D01KIJ HIGHSTAT Patented D01LMW DRUG__ID D01LMW D01LMW DRUGCOMP NOVA DECISION [FRAZASYNTH [FR] D01LMW DRUGTYPE Small molecular drug D01LMW DRUGINCH 1S/C17H14F3N3O2/c1-25-16(24)14-7-11-6-12(9-22-15(11)23-14)21-8-10-4-2-3-5-13(10)17(18,19)20/h2-7,9,21H,8H2,1H3,(H,22,23) D01LMW DRUGINKE MFAPLYWBOUSVJJ-UHFFFAOYSA-N D01LMW DRUGSMIL COC(=O)C1=CC2=CC(=CN=C2N1)NCC3=CC=CC=C3C(F)(F)F D01LMW HIGHSTAT Patented D01LOJ DRUG__ID D01LOJ D01LOJ DRUGTYPE Small molecular drug D01LOJ DRUGINCH 1S/C21H26N4O2/c1-6-24(7-2)19(26)13-18-20(16-8-10-17(27-5)11-9-16)23-25-15(4)12-14(3)22-21(18)25/h8-12H,6-7,13H2,1-5H3 D01LOJ DRUGINKE ILZWUAWCTNWSFZ-UHFFFAOYSA-N D01LOJ DRUGSMIL CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OC)C)C D01LOJ HIGHSTAT Patented D01LOJ COMPCLAS Pyrazolopyrimidine acetamide analogs D01LUJ DRUG__ID D01LUJ D01LUJ DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED HENDRICKSON, Thomas, Francis HO, Koc-Kan SAUNDERS, Michael, David STEVENS, Brian, John SWIERCZEK, Krzysztof WRIGHT, Kevin, Bret D01LUJ DRUGTYPE Small molecular drug D01LUJ DRUGINCH 1S/C16H19ClN8O3S/c17-9-1-2-19-16(24-9)20-3-4-29-5-8-11(26)12(27)15(28-8)25-7-23-10-13(18)21-6-22-14(10)25/h1-2,6-8,11-12,15,26-27H,3-5H2,(H2,18,21,22)(H,19,20,24)/t8-,11-,12-,15-/m0/s1 D01LUJ DRUGINKE ZWBSJRQJKXXDKA-REXDEQPNSA-N D01LUJ DRUGSMIL C1=CN=C(N=C1Cl)NCCSCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O D01LUJ HIGHSTAT Patented D01MMT DRUG__ID D01MMT D01MMT DRUGCOMP MSN LABORATORIES LIMITED THIRUMALAI RAJAN, Srinivasan ESWARAIAH, Sajja VENKAT REDDY, Ghojala D01MMT DRUGTYPE Small molecular drug D01MMT DRUGINCH 1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15?,17?,18?/m1/s1 D01MMT DRUGINKE QGJUIPDUBHWZPV-UGTKGIOISA-N D01MMT DRUGSMIL C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N D01MMT HIGHSTAT Patented D01MSP DRUG__ID D01MSP D01MSP DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D01MSP DRUGTYPE Small molecule immunotherapy D01MSP DRUGINCH 1S/C35H34N2O7/c1-22-13-28(18-37-30(19-38)35(39)40)33(43-20-25-6-3-5-24(14-25)17-36)16-32(22)44-21-27-7-4-8-29(23(27)2)26-9-10-31-34(15-26)42-12-11-41-31/h3-10,13-16,30,37-38H,11-12,18-21H2,1-2H3,(H,39,40) D01MSP DRUGINKE UWNXGZKSIKQKAH-UHFFFAOYSA-N D01MSP DRUGSMIL CC1=CC(=C(C=C1OCC2=C(C(=CC=C2)C3=CC4=C(C=C3)OCCO4)C)OCC5=CC(=CC=C5)C#N)CNC(CO)C(=O)O D01MSP HIGHSTAT Patented D01NBW DRUG__ID D01NBW D01NBW DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D01NBW DRUGTYPE Small molecular drug D01NBW DRUGINCH 1S/C18H20N4/c1-3-7-13(8-4-1)16-21-17-15(11-12-19-17)18(22-16)20-14-9-5-2-6-10-14/h1,3-4,7-8,11-12,14H,2,5-6,9-10H2,(H2,19,20,21,22) D01NBW DRUGINKE QWRCXRFAIZINSM-UHFFFAOYSA-N D01NBW DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2C=CN3)C4=CC=CC=C4 D01NBW HIGHSTAT Patented D01OEF DRUG__ID D01OEF D01OEF DRUGCOMP MethylGene Inc D01OEF DRUGTYPE Small molecular drug D01OEF DRUGINCH 1S/C31H25N5O4S/c1-38-21-7-5-20(6-8-21)34-31-35-24-15-22(9-11-26(24)40-31)39-27-12-13-32-25-16-28(41-30(25)27)23-10-4-19(17-33-23)18-36-14-2-3-29(36)37/h4-13,15-17H,2-3,14,18H2,1H3,(H,34,35) D01OEF DRUGINKE NMDJVUTXFINSAW-UHFFFAOYSA-N D01OEF DRUGSMIL COC1=CC=C(C=C1)NC2=NC3=C(O2)C=CC(=C3)OC4=C5C(=NC=C4)C=C(S5)C6=NC=C(C=C6)CN7CCCC7=O D01OEF HIGHSTAT Patented D01OQQ DRUG__ID D01OQQ D01OQQ DRUGCOMP INCYTE CORPORATION D01OQQ DRUGTYPE Small molecule immunotherapy D01OQQ DRUGINCH 1S/C25H24N4O5/c1-29-15-16(14-27-7-8-30)11-19(25(29)32)24(31)28-21-4-2-3-18(20(21)13-26)17-5-6-22-23(12-17)34-10-9-33-22/h2-6,11-12,15,27,30H,7-10,14H2,1H3,(H,28,31) D01OQQ DRUGINKE CAWQORGXRONNAU-UHFFFAOYSA-N D01OQQ DRUGSMIL CN1C=C(C=C(C1=O)C(=O)NC2=CC=CC(=C2C#N)C3=CC4=C(C=C3)OCCO4)CNCCO D01OQQ HIGHSTAT Patented D01OYY DRUG__ID D01OYY D01OYY DRUGCOMP NATCO PHARMA LIMITED KOMPELLA, Amala, Kishan RACHAKONDA, Sreenivas ADIBHATLA KALISATYA, Bhujanga, Rao VENKAIAH CHOWDARY, Nannapanen D01OYY DRUGTYPE Small molecular drug D01OYY DRUGINCH 1S/C25H17F6N5O/c1-14-4-5-19(12-21(14)36-23-33-8-6-20(35-23)15-3-2-7-32-13-15)34-22(37)16-9-17(24(26,27)28)11-18(10-16)25(29,30)31/h2-13H,1H3,(H,34,37)(H,33,35,36) D01OYY DRUGINKE LCPGCGAJBOWMIP-UHFFFAOYSA-N D01OYY DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)NC3=NC=CC(=N3)C4=CN=CC=C4 D01OYY HIGHSTAT Patented D01PKZ DRUG__ID D01PKZ D01PKZ DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D01PKZ DRUGTYPE Small molecular drug D01PKZ DRUGINCH 1S/C21H19FN2O3/c1-14(25)23-11-10-16-13-24-20-8-7-18(12-19(16)20)27-21(26)9-4-15-2-5-17(22)6-3-15/h2-9,12-13,24H,10-11H2,1H3,(H,23,25)/b9-4+ D01PKZ DRUGINKE SAMHXGDYEAOVQC-RUDMXATFSA-N D01PKZ DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC(=O)C=CC3=CC=C(C=C3)F D01PKZ HIGHSTAT Patented D01PSK DRUG__ID D01PSK D01PSK DRUGCOMP Janssen Pharmaceutica NV D01PSK DRUGTYPE Small molecular drug D01PSK DRUGINCH 1S/C23H24N4O3/c1-23(13-24,12-19-26-20(29-2)11-21(27-19)30-3)14-8-9-16-15-6-4-5-7-17(15)22(28)25-18(16)10-14/h8-11H,4-7,12H2,1-3H3,(H,25,28) D01PSK DRUGINKE FITDTEZFVLDGBX-UHFFFAOYSA-N D01PSK DRUGSMIL CC(CC1=NC(=CC(=N1)OC)OC)(C#N)C2=CC3=C(C=C2)C4=C(CCCC4)C(=O)N3 D01PSK HIGHSTAT Patented D01PUS DRUG__ID D01PUS D01PUS DRUGCOMP C4T S.C. A.R.L D01PUS DRUGTYPE Small molecular drug D01PUS DRUGINCH 1S/C24H23NO5S2/c26-23-20-12-11-19(30-32(27,28)22-10-7-15-31-22)16-21(20)29-24(13-5-2-6-14-24)25(23)17-18-8-3-1-4-9-18/h1,3-4,7-12,15-16H,2,5-6,13-14,17H2 D01PUS DRUGINKE XBCSLRKNSRBEMJ-UHFFFAOYSA-N D01PUS DRUGSMIL C1CCC2(CC1)N(C(=O)C3=C(O2)C=C(C=C3)OS(=O)(=O)C4=CC=CS4)CC5=CC=CC=C5 D01PUS HIGHSTAT Patented D01PYM DRUG__ID D01PYM D01PYM DRUGCOMP RIGAS, Basil D01PYM DRUGTYPE Small molecular drug D01PYM DRUGINCH 1S/C20H32O12P2/c1-6-26-33(23,27-7-2)30-15-17(32-34(24,28-8-3)29-9-4)14-25-20(22)18-12-10-11-13-19(18)31-16(5)21/h10-13,17H,6-9,14-15H2,1-5H3 D01PYM DRUGINKE UISLTGPOZYGIOG-UHFFFAOYSA-N D01PYM DRUGSMIL CCOP(=O)(OCC)OCC(COC(=O)C1=CC=CC=C1OC(=O)C)OP(=O)(OCC)OCC D01PYM HIGHSTAT Patented D01RIT DRUG__ID D01RIT D01RIT DRUGTYPE Small molecular drug D01RIT DRUGINCH 1S/C25H28Cl2N4OS/c1-3-4-6-9-19-11-13-22(33-19)24-17(2)23(25(32)29-30-14-7-5-8-15-30)28-31(24)21-12-10-18(26)16-20(21)27/h6,9-13,16H,3-5,7-8,14-15H2,1-2H3,(H,29,32)/b9-6+ D01RIT DRUGINKE IHFQVFSRVQQXSC-RMKNXTFCSA-N D01RIT DRUGSMIL CCCC=CC1=CC=C(S1)C2=C(C(=NN2C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCCC4)C D01RIT HIGHSTAT Patented D01RIT COMPCLAS Pyrazole derivatives D01RTO DRUG__ID D01RTO D01RTO DRUGTYPE Small molecular drug D01RTO DRUGINCH 1S/C24H27NO4/c26-19-3-1-18(22(28)9-19)13-25-23(29)17-2-4-21(27)20(8-17)24-10-14-5-15(11-24)7-16(6-14)12-24/h1-4,8-9,14-16,26-28H,5-7,10-13H2,(H,25,29) D01RTO DRUGINKE FXWMRZHJFYXBFU-UHFFFAOYSA-N D01RTO DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C(=O)NCC5=C(C=C(C=C5)O)O)O D01RTO HIGHSTAT Patented D01RTO COMPCLAS Polyhydroxy benzamide derivatives D01RUK DRUG__ID D01RUK D01RUK DRUGCOMP Purdue Pharma L.P D01RUK DRUGTYPE Small molecular drug D01RUK DRUGINCH 1S/C20H20ClF4N3O3/c21-15-9-12(16(30)11-29)10-26-17(15)19(22)5-7-28(8-6-19)18(31)27-14-3-1-13(2-4-14)20(23,24)25/h1-4,9-10,16,29-30H,5-8,11H2,(H,27,31)/t16-/m1/s1 D01RUK DRUGINKE DSVBUDHKIZVCPH-MRXNPFEDSA-N D01RUK DRUGSMIL C1CN(CCC1(C2=C(C=C(C=N2)C(CO)O)Cl)F)C(=O)NC3=CC=C(C=C3)C(F)(F)F D01RUK HIGHSTAT Patented D01SQO DRUG__ID D01SQO D01SQO DRUGTYPE Small molecular drug D01SQO DRUGINCH 1S/C11H12N2O/c14-10-5-6-13-7-8-3-1-2-4-9(8)12-11(10)13/h1-4,10,14H,5-7H2/t10-/m1/s1 D01SQO DRUGINKE YIICVSCAKJMMDJ-SNVBAGLBSA-N D01SQO DRUGSMIL C1CN2CC3=CC=CC=C3N=C2C1O D01SQO HIGHSTAT Patented D01SQO COMPCLAS Quinazoline alkaloid derivatives D01TGE DRUG__ID D01TGE D01TGE DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D01TGE DRUGTYPE Small molecular drug D01TGE DRUGINCH 1S/C28H28F3NO4/c1-18(2)17-25(21-3-5-22(6-4-21)27(35)32-16-15-26(33)34)36-24-13-9-20(10-14-24)19-7-11-23(12-8-19)28(29,30)31/h3-14,18,25H,15-17H2,1-2H3,(H,32,35)(H,33,34) D01TGE DRUGINKE KVQXZASOMKRHSG-UHFFFAOYSA-N D01TGE DRUGSMIL CC(C)CC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)OC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F D01TGE HIGHSTAT Patented D01TJW DRUG__ID D01TJW D01TJW DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D01TJW DRUGTYPE Small molecular drug D01TJW DRUGINCH 1S/C19H18Cl2N2O3/c20-13-10-14(21)16(12-6-2-1-3-7-12)15(11-13)22-18(26)23-19(17(24)25)8-4-5-9-19/h1-3,6-7,10-11H,4-5,8-9H2,(H,24,25)(H2,22,23,26) D01TJW DRUGINKE XKZSVPIUPDFCIQ-UHFFFAOYSA-N D01TJW DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C(=CC(=C2)Cl)Cl)C3=CC=CC=C3 D01TJW HIGHSTAT Patented D01UAL DRUG__ID D01UAL D01UAL DRUGCOMP GEORGETOWN UNIVERSITY YENUGONDA, Venkata, Mahidhar BROWN, Milton, L D01UAL DRUGTYPE Small molecular drug D01UAL DRUGINCH 1S/C34H42ClN9O4S/c1-20(2)27(18-45)40-34-41-31(30-32(42-34)44(19-37-30)21(3)4)39-22-13-14-25(26(35)17-22)33(46)36-15-16-38-49(47,48)29-12-8-9-23-24(29)10-7-11-28(23)43(5)6/h7-14,17,19-21,27,38,45H,15-16,18H2,1-6H3,(H,36,46)(H2,39,40,41,42)/t27-/m0/s1 D01UAL DRUGINKE NJNQGMFCZFMREY-MHZLTWQESA-N D01UAL DRUGSMIL CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=C(C=C3)C(=O)NCCNS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)Cl D01UAL HIGHSTAT Patented D01UBA DRUG__ID D01UBA D01UBA DRUGCOMP PIRAMAL HEALTHCARE LIMITED SIVAKUMAR, Meenakshi JOSHI, Kalpana Sanjay AWARE, Valmik Sopan SARDE, Ankush Gangaram BAGUL, Sandeep Mukunda MANOHAR, Sonal Mohan D01UBA DRUGTYPE Small molecular drug D01UBA DRUGINCH 1S/C13H14N2O3/c1-2-3-12-14-13(18-15-12)7-5-9-4-6-10(16)11(17)8-9/h4-8,16-17H,2-3H2,1H3/b7-5+ D01UBA DRUGINKE MAWOOXDYMFRJNN-FNORWQNLSA-N D01UBA DRUGSMIL CCCC1=NOC(=N1)C=CC2=CC(=C(C=C2)O)O D01UBA HIGHSTAT Patented D01UTX DRUG__ID D01UTX D01UTX DRUGCOMP NOVARTIS AG BURGER, Matthew DING, Yu HAN, Wooseok LINDVALL, Mika NISHIGUCHI, Gisele A. RICO, Alice SMITH, Aaron TANNER, Huw WAN, Lifeng D01UTX DRUGTYPE Small molecular drug D01UTX DRUGINCH 1S/C25H27N5O4/c26-23-22(29-17(14-28-23)15-6-2-1-3-7-15)24(32)30-18-13-27-11-9-16(18)19-12-20(31)25(33)10-5-4-8-21(25)34-19/h1-3,6-7,9,11,13-14,19-21,31,33H,4-5,8,10,12H2,(H2,26,28)(H,30,32)/t19-,20-,21-,25+/m1/s1 D01UTX DRUGINKE MHELWFWYAKEXOQ-YCFYUYSTSA-N D01UTX DRUGSMIL C1CCC2(C(C1)OC(CC2O)C3=C(C=NC=C3)NC(=O)C4=NC(=CN=C4N)C5=CC=CC=C5)O D01UTX HIGHSTAT Patented D01VTT DRUG__ID D01VTT D01VTT DRUGTYPE Small molecular drug D01VTT DRUGINCH 1S/C17H17NO3/c19-15-6-1-13(2-7-15)5-10-17(21)18-12-11-14-3-8-16(20)9-4-14/h1-10,19-20H,11-12H2,(H,18,21)/b10-5+ D01VTT DRUGINKE RXGUTQNKCXHALN-BJMVGYQFSA-N D01VTT DRUGSMIL C1=CC(=CC=C1CCNC(=O)C=CC2=CC=C(C=C2)O)O D01VTT HIGHSTAT Patented D01VTT COMPCLAS P-coumaric acid derivatives D01VZE DRUG__ID D01VZE D01VZE DRUGCOMP ELI LILLY AND COMPANY D01VZE DRUGTYPE Small molecular drug D01VZE DRUGINCH 1S/C17H16Cl2N4O5S/c18-7-2-1-6(3-8(7)19)4-28-13-12(29-16-21-5-22-23-16)9-10(14(24)25)11(9)17(13,20)15(26)27/h1-3,5,9-13H,4,20H2,(H,24,25)(H,26,27)(H,21,22,23)/t9-,10-,11-,12-,13+,17+/m0/s1 D01VZE DRUGINKE QHBLXVIRCXAIGL-WNAOHANSSA-N D01VZE DRUGSMIL C1=CC(=C(C=C1COC2C(C3C(C3C2(C(=O)O)N)C(=O)O)SC4=NC=NN4)Cl)Cl D01VZE HIGHSTAT Patented D01XIW DRUG__ID D01XIW D01XIW DRUGCOMP ALIOS BIOPHARMA, INC D01XIW DRUGTYPE Small molecular drug D01XIW DRUGINCH 1S/C30H26Cl2N2O4/c1-34-25(18-4-2-5-20(14-18)30(35)36)12-10-19-15-21(11-13-26(19)34)37-16-22-28(33-38-29(22)17-8-9-17)27-23(31)6-3-7-24(27)32/h2-7,11,13-15,17,25H,8-10,12,16H2,1H3,(H,35,36) D01XIW DRUGINKE WROIATMBIYLPMI-UHFFFAOYSA-N D01XIW DRUGSMIL CN1C(CCC2=C1C=CC(=C2)OCC3=C(ON=C3C4=C(C=CC=C4Cl)Cl)C5CC5)C6=CC(=CC=C6)C(=O)O D01XIW HIGHSTAT Patented D02BGU DRUG__ID D02BGU D02BGU DRUGCOMP ELI LILLY AND COMPANY D02BGU DRUGTYPE Small molecular drug D02BGU DRUGINCH 1S/C21H23N7O2/c29-20(13-30-6-5-17-10-23-27-26-17)28-11-16-9-22-21(25-19(16)12-28)24-18-7-14-3-1-2-4-15(14)8-18/h1-4,9-10,18H,5-8,11-13H2,(H,22,24,25)(H,23,26,27) D02BGU DRUGINKE ILOFWCAZDNILKY-UHFFFAOYSA-N D02BGU DRUGSMIL C1C(CC2=CC=CC=C21)NC3=NC=C4CN(CC4=N3)C(=O)COCCC5=NNN=C5 D02BGU HIGHSTAT Patented D02DLG DRUG__ID D02DLG D02DLG DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D02DLG DRUGTYPE Small molecular drug D02DLG DRUGINCH 1S/C16H24N4O2/c1-3-9-19-14-12(15(21)20(10-4-2)16(19)22)17-13(18-14)11-7-5-6-8-11/h11H,3-10H2,1-2H3,(H,17,18) D02DLG DRUGINKE FFBDFADSZUINTG-UHFFFAOYSA-N D02DLG DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CCCC3 D02DLG HIGHSTAT Patented D02DLL DRUG__ID D02DLL D02DLL DRUGCOMP ALMAC DISCOVERY LIMITED HARRISON, Timothy BURKAMP, Frank JORDAN, Linda BELL, Mark JANSSEN, Dominic MIEL, Hugues MCFARLAND, Mary D02DLL DRUGTYPE Small molecular drug D02DLL DRUGINCH 1S/C26H37N3O/c1-25(2)11-12-26(3,4)22-19-20(9-10-21(22)25)23-7-5-8-24(27-23)29-16-14-28(15-17-29)13-6-18-30/h5,7-10,19,30H,6,11-18H2,1-4H3 D02DLL DRUGINKE ITCPVAVDRJPVOV-UHFFFAOYSA-N D02DLL DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C3=NC(=CC=C3)N4CCN(CC4)CCCO)(C)C)C D02DLL HIGHSTAT Patented D02EKO DRUG__ID D02EKO D02EKO DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D02EKO DRUGTYPE Small molecular drug D02EKO DRUGINCH 1S/C20H22ClN5O2/c21-14-8-7-13(17(11-14)26-9-2-1-3-10-26)12-22-19(27)23-15-5-4-6-16-18(15)25-20(28)24-16/h4-8,11H,1-3,9-10,12H2,(H2,22,23,27)(H2,24,25,28) D02EKO DRUGINKE UDSQXLZVIWKXME-UHFFFAOYSA-N D02EKO DRUGSMIL C1CCN(CC1)C2=C(C=CC(=C2)Cl)CNC(=O)NC3=CC=CC4=C3NC(=O)N4 D02EKO HIGHSTAT Patented D02EME DRUG__ID D02EME D02EME DRUGTYPE Small molecular drug D02EME DRUGINCH 1S/C23H28N2O2/c26-23-11-9-19-8-10-21(16-22(19)24-23)27-15-5-1-4-13-25-14-12-18-6-2-3-7-20(18)17-25/h2-3,6-8,10,16H,1,4-5,9,11-15,17H2,(H,24,26) D02EME DRUGINKE MANGBYSAGCIUHY-UHFFFAOYSA-N D02EME DRUGSMIL C1CC(=O)NC2=C1C=CC(=C2)OCCCCCN3CCC4=CC=CC=C4C3 D02EME HIGHSTAT Patented D02EME COMPCLAS Tetra-hydro-isoquinoline derivatives D02FAA DRUG__ID D02FAA D02FAA DRUGCOMP KEMPHYS LTD D02FAA DRUGTYPE Small molecular drug D02FAA DRUGINCH 1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26) D02FAA DRUGINKE MUTNCGKQJGXKEM-UHFFFAOYSA-N D02FAA DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C D02FAA HIGHSTAT Patented D02FRR DRUG__ID D02FRR D02FRR DRUGCOMP NTZ LAB LTD [BG] D02FRR DRUGTYPE Small molecular drug D02FRR DRUGINCH 1S/C15H11F2N3O/c1-20-14-5-2-9(6-10(14)8-18-20)15(21)19-11-3-4-12(16)13(17)7-11/h2-8H,1H3,(H,19,21) D02FRR DRUGINKE MDOHBHVKAWMFFN-UHFFFAOYSA-N D02FRR DRUGSMIL CN1C2=C(C=C(C=C2)C(=O)NC3=CC(=C(C=C3)F)F)C=N1 D02FRR HIGHSTAT Patented D02FWR DRUG__ID D02FWR D02FWR DRUGCOMP GODAVARI BIOREFINERIES LIMITED D02FWR DRUGTYPE Small molecular drug D02FWR DRUGINCH 1S/C17H17N3O2S/c1-4-22-17(21)14-11(3)13-15(18-9-19-16(13)23-14)20-12-7-5-10(2)6-8-12/h5-9H,4H2,1-3H3,(H,18,19,20) D02FWR DRUGINKE CLDHQOVMQCROQN-UHFFFAOYSA-N D02FWR DRUGSMIL CCOC(=O)C1=C(C2=C(N=CN=C2S1)NC3=CC=C(C=C3)C)C D02FWR HIGHSTAT Patented D02FWT DRUG__ID D02FWT D02FWT DRUGCOMP PHARMAKEA, INC D02FWT DRUGTYPE Small molecular drug D02FWT DRUGINCH 1S/C26H27FN4O4/c1-25(2,23(33)34)14-31-22(32)20-26(3,4)19-17-6-5-11-28-21(17)29(18(19)13-30(20)24(31)35)12-15-7-9-16(27)10-8-15/h5-11,20H,12-14H2,1-4H3,(H,33,34) D02FWT DRUGINKE PZDULKFJLQEMQQ-UHFFFAOYSA-N D02FWT DRUGSMIL CC1(C2C(=O)N(C(=O)N2CC3=C1C4=C(N3CC5=CC=C(C=C5)F)N=CC=C4)CC(C)(C)C(=O)O)C D02FWT HIGHSTAT Patented D02GEJ DRUG__ID D02GEJ D02GEJ DRUGCOMP SELVITA S.A D02GEJ DRUGTYPE Small molecular drug D02GEJ DRUGINCH 1S/C9H7Br4N3/c1-16(2)9-14-7-5(12)3(10)4(11)6(13)8(7)15-9/h1-2H3,(H,14,15) D02GEJ DRUGINKE SLPJGDQJLTYWCI-UHFFFAOYSA-N D02GEJ DRUGSMIL CN(C)C1=NC2=C(N1)C(=C(C(=C2Br)Br)Br)Br D02GEJ HIGHSTAT Patented D02ILH DRUG__ID D02ILH D02ILH DRUGCOMP H. Lee Moffitt Cancer Center and Research Institute, University of Central Florida Research Foundation D02ILH DRUGTYPE Small molecular drug D02ILH DRUGINCH 1S/C14H10O9/c15-7-2-6(3-8(16)11(7)18)14(22)23-10-4-5(13(20)21)1-9(17)12(10)19/h1-4,15-19H,(H,20,21) D02ILH DRUGINKE COVFEVWNJUOYRL-UHFFFAOYSA-N D02ILH DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)O D02ILH HIGHSTAT Patented D02JDR DRUG__ID D02JDR D02JDR DRUGCOMP Leland Stanford Junior University, USA D02JDR DRUGTYPE Small molecular drug D02JDR DRUGINCH 1S/C27H34N2O2/c1-4-18-17-29-12-10-20-15-26(30-2)27(31-3)16-23(20)25(29)14-21(18)13-24-22-8-6-5-7-19(22)9-11-28-24/h5-8,15-16,24-25,28H,4,9-14,17H2,1-3H3 D02JDR DRUGINKE HDIJLRXRAJUXQB-UHFFFAOYSA-N D02JDR DRUGSMIL CCC1=C(CC2C3=CC(=C(C=C3CCN2C1)OC)OC)CC4C5=CC=CC=C5CCN4 D02JDR HIGHSTAT Patented D02JOK DRUG__ID D02JOK D02JOK DRUGCOMP PFIZER LIMITED D02JOK DRUGTYPE Small molecular drug D02JOK DRUGINCH 1S/C17H9ClN4O3S2/c18-15-8-13(2-1-11(15)9-19)25-16-4-3-14(7-12(16)10-20)27(23,24)22-17-21-5-6-26-17/h1-8H,(H,21,22) D02JOK DRUGINKE JONVMVCPXBMHHN-UHFFFAOYSA-N D02JOK DRUGSMIL C1=CC(=C(C=C1OC2=C(C=C(C=C2)S(=O)(=O)NC3=NC=CS3)C#N)Cl)C#N D02JOK HIGHSTAT Patented D02JQB DRUG__ID D02JQB D02JQB DRUGCOMP Novartis AG D02JQB DRUGTYPE Small molecular drug D02JQB DRUGINCH 1S/C17H15ClN2O2/c1-10(2)16-19-15-9-13(21)7-8-14(15)17(22)20(16)12-5-3-11(18)4-6-12/h3-10,21H,1-2H3 D02JQB DRUGINKE OJVMSICJWQFIOS-UHFFFAOYSA-N D02JQB DRUGSMIL CC(C)C1=NC2=C(C=CC(=C2)O)C(=O)N1C3=CC=C(C=C3)Cl D02JQB HIGHSTAT Patented D02KMI DRUG__ID D02KMI D02KMI DRUGCOMP SHANGHAI HENGRUI PHARM CO LTD [CNJIANGSU HENGRUI MEDICINE CO [CNTANG PENGCHO [CNLI XIN [CNLI XIANGQIN [CNCHEN YANG [CNWANG BIN [CNZHU ZHE [CN] D02KMI DRUGTYPE Small molecular drug D02KMI DRUGINCH 1S/C22H16F4N6O2/c23-16-6-5-12(10-17-13-3-1-2-4-14(13)19(33)29-28-17)9-15(16)20(34)31-7-8-32-18(11-31)27-21(30-32)22(24,25)26/h1-6,9H,7-8,10-11H2,(H,29,33) D02KMI DRUGINKE XJGXCBHXFWBOTN-UHFFFAOYSA-N D02KMI DRUGSMIL C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F D02KMI HIGHSTAT Patented D02KNW DRUG__ID D02KNW D02KNW DRUGCOMP NOVARTIS AG FURET, Pascal GROTZFELD, Robert Martin JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas MOUSSAOUI, Saliha PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph JAHNKE, Wolfgang D02KNW DRUGTYPE Small molecular drug D02KNW DRUGINCH 1S/C18H12ClF2N3O2/c19-18(20,21)26-16-6-4-15(5-7-16)24-17(25)13-3-1-2-12(8-13)14-9-22-11-23-10-14/h1-11H,(H,24,25) D02KNW DRUGINKE IEPKEELESQZYDU-UHFFFAOYSA-N D02KNW DRUGSMIL C1=CC(=CC(=C1)C(=O)NC2=CC=C(C=C2)OC(F)(F)Cl)C3=CN=CN=C3 D02KNW HIGHSTAT Patented D02LBZ DRUG__ID D02LBZ D02LBZ DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. STEIN, Ross, L. CASE, April YEH, Li-An CUNY, Greg DUVAL, Eric D02LBZ DRUGTYPE Small molecular drug D02LBZ DRUGINCH 1S/C20H16N4O2S2/c21-23-16(25)12-28-20-22-18-17(15(11-27-18)13-7-3-1-4-8-13)19(26)24(20)14-9-5-2-6-10-14/h1-11H,12,21H2,(H,23,25) D02LBZ DRUGINKE WLBUICQBNZXIDJ-UHFFFAOYSA-N D02LBZ DRUGSMIL C1=CC=C(C=C1)C2=CSC3=C2C(=O)N(C(=N3)SCC(=O)NN)C4=CC=CC=C4 D02LBZ HIGHSTAT Patented D02OGA DRUG__ID D02OGA D02OGA DRUGTYPE Small molecular drug D02OGA DRUGINCH 1S/C14H16N2O3S/c17-13-15(10-12-7-4-8-19-12)14(18)20-16(13)9-11-5-2-1-3-6-11/h1-3,5-6,12H,4,7-10H2 D02OGA DRUGINKE AGFKNYDGTJNEDN-UHFFFAOYSA-N D02OGA DRUGSMIL C1CC(OC1)CN2C(=O)N(SC2=O)CC3=CC=CC=C3 D02OGA HIGHSTAT Patented D02OGA COMPCLAS Thiadiazolidindione derivatives D02RCY DRUG__ID D02RCY D02RCY DRUGCOMP NOVARTIS AG CHIANELLI, Donatella LIU, Xiaodong MOLTENI, Valentina NELSON, John ROLAND, Jason RUCKER, Paul TULLY, David D02RCY DRUGTYPE Small molecular drug D02RCY DRUGINCH 1S/C28H21ClF2N4O5/c1-34-26-19-11-17(29)6-8-23(19)40-14-20(26)25(33-34)27(37)35(12-15-3-2-4-18(30)9-15)13-24(36)32-22-10-16(28(38)39)5-7-21(22)31/h2-11H,12-14H2,1H3,(H,32,36)(H,38,39) D02RCY DRUGINKE VJLVLEHRWCLRBO-UHFFFAOYSA-N D02RCY DRUGSMIL CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC(=CC=C4)F)CC(=O)NC5=C(C=CC(=C5)C(=O)O)F D02RCY HIGHSTAT Patented D02SGL DRUG__ID D02SGL D02SGL DRUGCOMP Boiteau JG, Barbuis CM, Bouquet K D02SGL DRUGTYPE Small molecular drug D02SGL DRUGINCH 1S/C10H8N2O2S/c13-9(14)7-3-1-6(2-4-7)8-5-11-10(15)12-8/h1-5H,(H,13,14)(H2,11,12,15) D02SGL DRUGINKE RUEHTYRZLLKGKE-UHFFFAOYSA-N D02SGL DRUGSMIL C1=CC(=CC=C1C2=CNC(=S)N2)C(=O)O D02SGL HIGHSTAT Patented D02TIY DRUG__ID D02TIY D02TIY DRUGCOMP UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette D02TIY DRUGTYPE Small molecular drug D02TIY DRUGINCH 1S/C15H17N/c1-3-7-14(8-4-1)11-12-16-13-15-9-5-2-6-10-15/h1-10,16H,11-13H2 D02TIY DRUGINKE UPABQMWFWCMOFV-UHFFFAOYSA-N D02TIY DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC=CC=C2 D02TIY HIGHSTAT Patented D02UJS DRUG__ID D02UJS D02UJS DRUGCOMP INCYTE CORPORATION D02UJS DRUGTYPE Small molecule immunotherapy D02UJS DRUGINCH 1S/C27H29N3O4/c1-18-21(20-9-4-3-5-10-20)11-8-12-23(18)28-25(31)22-15-19(16-29(2)26(22)32)17-30-14-7-6-13-24(30)27(33)34/h3-5,8-12,15-16,24H,6-7,13-14,17H2,1-2H3,(H,28,31)(H,33,34)/t24-/m0/s1 D02UJS DRUGINKE DNPQQJGPLXEEDA-DEOSSOPVSA-N D02UJS DRUGSMIL CC1=C(C=CC=C1NC(=O)C2=CC(=CN(C2=O)C)CN3CCCCC3C(=O)O)C4=CC=CC=C4 D02UJS HIGHSTAT Patented D02UMS DRUG__ID D02UMS D02UMS DRUGCOMP TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED D02UMS DRUGTYPE Small molecular drug D02UMS DRUGINCH 1S/C17H14ClN3O2/c1-21(2)17(22)23-16-12-8-4-6-10-14(12)19-15(20-16)11-7-3-5-9-13(11)18/h3-10H,1-2H3 D02UMS DRUGINKE IKJKKLDPZAPXOQ-UHFFFAOYSA-N D02UMS DRUGSMIL CN(C)C(=O)OC1=NC(=NC2=CC=CC=C21)C3=CC=CC=C3Cl D02UMS HIGHSTAT Patented D02UOD DRUG__ID D02UOD D02UOD DRUGCOMP ASTEX THERAPEUTICS LIMITED D02UOD DRUGTYPE Small molecular drug D02UOD DRUGINCH 1S/C32H36FN5O2/c1-21-16-36(26(14-34-21)18-37-17-23-6-4-5-7-27(23)31(37)40)19-30(39)38-20-32(2,3)28-15-35-25(13-29(28)38)12-22-8-10-24(33)11-9-22/h4-11,13,15,21,26,34H,12,14,16-20H2,1-3H3/t21-,26-/m1/s1 D02UOD DRUGINKE LINGVLYPDLNMKZ-QFQXNSOFSA-N D02UOD DRUGSMIL CC1CN(C(CN1)CN2CC3=CC=CC=C3C2=O)CC(=O)N4CC(C5=C4C=C(N=C5)CC6=CC=C(C=C6)F)(C)C D02UOD HIGHSTAT Patented D02VTV DRUG__ID D02VTV D02VTV DRUGCOMP PIERRE FABRE MEDICAMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) D02VTV DRUGTYPE Small molecular drug D02VTV DRUGINCH 1S/C38H38N6O/c1-2-6-30(7-3-1)31-12-10-28(11-13-31)25-41-38-34-15-14-32(24-37(34)42-27-43-38)45-26-29-17-21-44(22-18-29)23-20-40-36-16-19-39-35-9-5-4-8-33(35)36/h1-16,19,24,27,29H,17-18,20-23,25-26H2,(H,39,40)(H,41,42,43) D02VTV DRUGINKE GPQPTJSUKRSGBL-UHFFFAOYSA-N D02VTV DRUGSMIL C1CN(CCC1COC2=CC3=C(C=C2)C(=NC=N3)NCC4=CC=C(C=C4)C5=CC=CC=C5)CCNC6=CC=NC7=CC=CC=C76 D02VTV HIGHSTAT Patented D02XQE DRUG__ID D02XQE D02XQE DRUGCOMP MERCK PATENT GMBH SHERER, Brian A D02XQE DRUGTYPE Small molecular drug D02XQE DRUGINCH 1S/C18H20F2N2/c19-14-8-4-7-13-17-10-21-11-22(17)16(18(13)14)9-15(20)12-5-2-1-3-6-12/h4,7-8,10-12,15-16H,1-3,5-6,9H2 D02XQE DRUGINKE OHWIXLJBJCDWBA-UHFFFAOYSA-N D02XQE DRUGSMIL C1CCC(CC1)C(CC2C3=C(C=CC=C3F)C4=CN=CN24)F D02XQE HIGHSTAT Patented D02XYT DRUG__ID D02XYT D02XYT DRUGTYPE Small molecular drug D02XYT DRUGINCH 1S/C28H22Cl2N4O5/c1-28(2,3)25(37)24-23(32-21(36)12-35)19-11-18(14-4-7-16(29)8-5-14)22(33-27(19)39-24)17-9-6-15(10-20(17)30)26-31-13-38-34-26/h4-11,13,35H,12H2,1-3H3,(H,32,36) D02XYT DRUGINKE SPKFHHXBXRKREW-UHFFFAOYSA-N D02XYT DRUGSMIL CC(C)(C)C(=O)C1=C(C2=CC(=C(N=C2O1)C3=C(C=C(C=C3)C4=NOC=N4)Cl)C5=CC=C(C=C5)Cl)NC(=O)CO D02XYT HIGHSTAT Patented D02XYT COMPCLAS Furopyridine derivatives D02YLT DRUG__ID D02YLT D02YLT DRUGCOMP CHDI FOUNDATION, INC D02YLT DRUGTYPE Small molecular drug D02YLT DRUGINCH 1S/C21H21F2N3O2/c1-12-16(4-3-5-17(12)22)21(20(27)25-28)9-8-13(10-21)15-7-6-14-11-24-26(2)19(14)18(15)23/h3-7,11,13,28H,8-10H2,1-2H3,(H,25,27) D02YLT DRUGINKE CFMBAUBXRNMZPH-UHFFFAOYSA-N D02YLT DRUGSMIL CC1=C(C=CC=C1F)C2(CCC(C2)C3=C(C4=C(C=C3)C=NN4C)F)C(=O)NO D02YLT HIGHSTAT Patented D03CJT DRUG__ID D03CJT D03CJT DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D03CJT DRUGTYPE Small molecular drug D03CJT DRUGINCH 1S/C19H18ClFN2O3/c20-14-11-16(13(10-15(14)21)12-6-2-1-3-7-12)22-18(26)23-19(17(24)25)8-4-5-9-19/h1-3,6-7,10-11H,4-5,8-9H2,(H,24,25)(H2,22,23,26) D03CJT DRUGINKE OZCRNUIWAXZIST-UHFFFAOYSA-N D03CJT DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=CC(=C(C=C2C3=CC=CC=C3)F)Cl D03CJT HIGHSTAT Patented D03CTR DRUG__ID D03CTR D03CTR DRUGCOMP EMCURE PHARMACEUTICALS LIMITED D03CTR DRUGTYPE Small molecular drug D03CTR DRUGINCH 1S/C27H29N3O2/c1-19-24-17-28-18-30(24)23(26(19)21-8-4-2-5-9-21)16-25(31)20-12-14-29(15-13-20)27(32)22-10-6-3-7-11-22/h2-11,17-18,20,23,25,31H,12-16H2,1H3 D03CTR DRUGINKE AJSXKLLHMGVTFL-UHFFFAOYSA-N D03CTR DRUGSMIL CC1=C(C(N2C1=CN=C2)CC(C3CCN(CC3)C(=O)C4=CC=CC=C4)O)C5=CC=CC=C5 D03CTR HIGHSTAT Patented D03DQW DRUG__ID D03DQW D03DQW DRUGCOMP TETRALOGIC PHARMACEUTICALS CORP. CONDON, Stephen, M. DENG, Yijun ALEXANDER, Matthew, D. LAPORTE, Matthew, G D03DQW DRUGTYPE Small molecular drug D03DQW DRUGINCH 1S/C23H34F2N4O5S/c1-13(26-5)21(30)27-20(23(2,3)4)22(31)28-10-9-17-19(28)18(12-29(17)35(6,32)33)34-14-7-8-15(24)16(25)11-14/h7-8,11,13,17-20,26H,9-10,12H2,1-6H3,(H,27,30)/t13-,17+,18-,19-,20+/m0/s1 D03DQW DRUGINKE JFUYRIMMOJAVPX-FOGBYNIYSA-N D03DQW DRUGSMIL CC(C(=O)NC(C(=O)N1CCC2C1C(CN2S(=O)(=O)C)OC3=CC(=C(C=C3)F)F)C(C)(C)C)NC D03DQW HIGHSTAT Patented D03EEA DRUG__ID D03EEA D03EEA DRUGCOMP Japan Tobacco, Inc D03EEA DRUGTYPE Small molecular drug D03EEA DRUGINCH 1S/C26H30N4O4/c1-17-8-10-22(27-12-17)30-19(14-31)15-33-24-20(6-5-7-21(24)30)25(32)29-18-9-11-23(28-13-18)34-16-26(2,3)4/h5-13,19,31H,14-16H2,1-4H3,(H,29,32)/t19-/m0/s1 D03EEA DRUGINKE LMURYRLZRMJVEI-IBGZPJMESA-N D03EEA DRUGSMIL CC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C(=O)NC4=CN=C(C=C4)OCC(C)(C)C)CO D03EEA HIGHSTAT Patented D03FSF DRUG__ID D03FSF D03FSF DRUGCOMP Japan Tobacco, Inc D03FSF DRUGTYPE Small molecular drug D03FSF DRUGINCH 1S/C25H27Cl2N3O2/c1-25(2,3)18-8-10-19(11-9-18)29-24(31)17-7-12-20(26)22(16-17)30(14-15-32-4)23-21(27)6-5-13-28-23/h5-13,16H,14-15H2,1-4H3,(H,29,31) D03FSF DRUGINKE ZYJYGKAKEUKYMJ-UHFFFAOYSA-N D03FSF DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2)Cl)N(CCOC)C3=C(C=CC=N3)Cl D03FSF HIGHSTAT Patented D03HAA DRUG__ID D03HAA D03HAA DRUGCOMP INCYTE CORPORATION D03HAA DRUGTYPE Small molecule immunotherapy D03HAA DRUGINCH 1S/C19H18N2S/c1-13-15(14-6-3-2-4-7-14)8-5-9-16(13)19-21-17-10-11-20-12-18(17)22-19/h2-9,20H,10-12H2,1H3 D03HAA DRUGINKE DISXBCWMOVBSKF-UHFFFAOYSA-N D03HAA DRUGSMIL CC1=C(C=CC=C1C2=NC3=C(S2)CNCC3)C4=CC=CC=C4 D03HAA HIGHSTAT Patented D03HED DRUG__ID D03HED D03HED DRUGCOMP G1 THERAPEUTICS, INCG1 THERAPEUTICS, INC. STRUM, Jay C. TAVARES, Francis, X D03HED DRUGTYPE Small molecular drug D03HED DRUGINCH 1S/C23H28N8O/c32-21-18-12-16-13-26-22(28-19-5-4-17(14-25-19)30-10-8-24-9-11-30)29-20(16)31(18)23(15-27-21)6-2-1-3-7-23/h4-5,12-14,24H,1-3,6-11,15H2,(H,27,32)(H,25,26,28,29) D03HED DRUGINKE TWTKMJWAXOPXSX-UHFFFAOYSA-N D03HED DRUGSMIL C1CCC2(CC1)CNC(=O)C3=CC4=CN=C(N=C4N23)NC5=NC=C(C=C5)N6CCNCC6 D03HED HIGHSTAT Patented D03IMJ DRUG__ID D03IMJ D03IMJ DRUGCOMP SUNSHINE LAKE PHARMA CO., LTD D03IMJ DRUGTYPE Small molecular drug D03IMJ DRUGINCH 1S/C28H23Cl2N3O6S/c1-40(35,36)33-28(34)17-8-5-15-9-10-21-22(38-23(15)13-17)11-12-24(31-21)37-14-18-26(32-39-27(18)16-6-7-16)25-19(29)3-2-4-20(25)30/h2-5,8,11-13,16H,6-7,9-10,14H2,1H3,(H,33,34) D03IMJ DRUGINKE ADZBYRFCADJPGB-UHFFFAOYSA-N D03IMJ DRUGSMIL CS(=O)(=O)NC(=O)C1=CC2=C(CCC3=C(O2)C=CC(=N3)OCC4=C(ON=C4C5=C(C=CC=C5Cl)Cl)C6CC6)C=C1 D03IMJ HIGHSTAT Patented D03JDR DRUG__ID D03JDR D03JDR DRUGCOMP Kissei Pharmaceutical Co. Ltd D03JDR DRUGTYPE Small molecular drug D03JDR DRUGINCH 1S/C14H9N3O2S/c1-7-12(14(18)19)20-13(17-7)9-4-8-2-3-16-11(8)10(5-9)6-15/h2-5,16H,1H3,(H,18,19) D03JDR DRUGINKE QJWAUWFGCGISKV-UHFFFAOYSA-N D03JDR DRUGSMIL CC1=C(SC(=N1)C2=CC(=C3C(=C2)C=CN3)C#N)C(=O)O D03JDR HIGHSTAT Patented D03JJW DRUG__ID D03JJW D03JJW DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED JOHANSSON, Lars, Anders, Mikael JUDKINS, Robert, Andrew LI, Lanna LOFBERG, Bjorn, Christian, Ingvar PERSSON, Joachim D03JJW DRUGTYPE Small molecular drug D03JJW DRUGINCH 1S/C24H23ClN4O4/c25-18-5-3-17(4-6-18)21-26-27-22(33-21)23(30)29-10-20(11-29)32-19-7-1-16(2-8-19)9-28-12-24(13-28)14-31-15-24/h1-8,20H,9-15H2 D03JJW DRUGINKE OVCNWJXOBLGBEA-UHFFFAOYSA-N D03JJW DRUGSMIL C1C(CN1C(=O)C2=NN=C(O2)C3=CC=C(C=C3)Cl)OC4=CC=C(C=C4)CN5CC6(C5)COC6 D03JJW HIGHSTAT Patented D03JQL DRUG__ID D03JQL D03JQL DRUGCOMP IOMET PHARMA LTD D03JQL DRUGTYPE Small molecular drug D03JQL DRUGINCH 1S/C17H15ClN2O/c1-11(12-5-3-2-4-6-12)19-17(21)16-10-13-9-14(18)7-8-15(13)20-16/h2-11,20H,1H3,(H,19,21)/t11-/m0/s1 D03JQL DRUGINKE KNBUEFQZZKXGIC-NSHDSACASA-N D03JQL DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC3=C(N2)C=CC(=C3)Cl D03JQL HIGHSTAT Patented D03KKJ DRUG__ID D03KKJ D03KKJ DRUGCOMP UNIVERSITY OF CANBERRA D03KKJ DRUGTYPE Small molecular drug D03KKJ DRUGINCH 1S/C14H13F3N4O2/c15-14(16,17)9-3-4-10(19-6-7-22)21-11(9)12(23)8-2-1-5-20-13(8)18/h1-5,22H,6-7H2,(H2,18,20)(H,19,21) D03KKJ DRUGINKE DIAKBWXIPYINLL-UHFFFAOYSA-N D03KKJ DRUGSMIL C1=CC(=C(N=C1)N)C(=O)C2=C(C=CC(=N2)NCCO)C(F)(F)F D03KKJ HIGHSTAT Patented D03KNZ DRUG__ID D03KNZ D03KNZ DRUGCOMP UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette D03KNZ DRUGTYPE Small molecular drug D03KNZ DRUGINCH 1S/C17H21N/c1-14-8-9-17(12-15(14)2)13-18-11-10-16-6-4-3-5-7-16/h3-9,12,18H,10-11,13H2,1-2H3 D03KNZ DRUGINKE XXTJZYJWHSDDJG-UHFFFAOYSA-N D03KNZ DRUGSMIL CC1=C(C=C(C=C1)CNCCC2=CC=CC=C2)C D03KNZ HIGHSTAT Patented D03KWP DRUG__ID D03KWP D03KWP DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D03KWP DRUGTYPE Small molecular drug D03KWP DRUGINCH 1S/C22H20FN3O2/c1-3-21-24-19-9-8-17(12-20(19)25(21)2)26-11-10-18(13-22(26)27)28-14-15-4-6-16(23)7-5-15/h4-13H,3,14H2,1-2H3 D03KWP DRUGINKE UDLQRAVGQUJISV-UHFFFAOYSA-N D03KWP DRUGSMIL CCC1=NC2=C(N1C)C=C(C=C2)N3C=CC(=CC3=O)OCC4=CC=C(C=C4)F D03KWP HIGHSTAT Patented D03KYL DRUG__ID D03KYL D03KYL DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D03KYL DRUGTYPE Small molecular drug D03KYL DRUGINCH 1S/C22H18F4N6O2/c1-2-21(34,22(24,25)26)19-11-32(31-30-19)10-12-3-5-14-15(16-6-4-13(23)9-28-16)8-18(20(27)33)29-17(14)7-12/h3-9,11,34H,2,10H2,1H3,(H2,27,33)/t21-/m1/s1 D03KYL DRUGINKE HPUYYHXUYOZNBL-OAQYLSRUSA-N D03KYL DRUGSMIL CCC(C1=CN(N=N1)CC2=CC3=C(C=C2)C(=CC(=N3)C(=O)N)C4=NC=C(C=C4)F)(C(F)(F)F)O D03KYL HIGHSTAT Patented D03LZO DRUG__ID D03LZO D03LZO DRUGCOMP PIERRE FABRE MEDICAMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) D03LZO DRUGTYPE Small molecular drug D03LZO DRUGINCH 1S/C34H38N6O/c1-2-7-26(8-3-1)9-6-17-37-34-30-13-12-28(23-33(30)38-25-39-34)41-24-27-15-20-40(21-16-27)22-19-36-32-14-18-35-31-11-5-4-10-29(31)32/h1-5,7-8,10-14,18,23,25,27H,6,9,15-17,19-22,24H2,(H,35,36)(H,37,38,39) D03LZO DRUGINKE DPNGRMNVFKZZSM-UHFFFAOYSA-N D03LZO DRUGSMIL C1CN(CCC1COC2=CC3=C(C=C2)C(=NC=N3)NCCCC4=CC=CC=C4)CCNC5=CC=NC6=CC=CC=C65 D03LZO HIGHSTAT Patented D03MYI DRUG__ID D03MYI D03MYI DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D03MYI DRUGTYPE Small molecular drug D03MYI DRUGINCH 1S/C31H39N3O2S/c1-5-25(24-11-14-32-15-12-24)29-22(4)28-27(37-29)13-16-34(31(28)35)18-26-20(2)17-21(3)33-30(26)36-19-23-9-7-6-8-10-23/h6-10,17,24-25,32H,5,11-16,18-19H2,1-4H3 D03MYI DRUGINKE SJBPGCIWHCAKKL-UHFFFAOYSA-N D03MYI DRUGSMIL CCC(C1CCNCC1)C2=C(C3=C(S2)CCN(C3=O)CC4=C(N=C(C=C4C)C)OCC5=CC=CC=C5)C D03MYI HIGHSTAT Patented D03NWT DRUG__ID D03NWT D03NWT DRUGCOMP MEDIVATION TECHNOLOGIES, INC D03NWT DRUGTYPE Small molecular drug D03NWT DRUGINCH 1S/C17H17NO3/c1-3-16(20)18(2)14-9-13(10-15(19)11-14)17(21)12-7-5-4-6-8-12/h3-11,17,19,21H,1H2,2H3/t17-/m1/s1 D03NWT DRUGINKE ISTAOAGDLRWZMS-QGZVFWFLSA-N D03NWT DRUGSMIL CN(C1=CC(=CC(=C1)C(C2=CC=CC=C2)O)O)C(=O)C=C D03NWT HIGHSTAT Patented D03OIA DRUG__ID D03OIA D03OIA DRUGCOMP CT NAC INVESTIGACIONES ONCOLOGICAS CNIO [ES] D03OIA DRUGTYPE Small molecular drug D03OIA DRUGINCH 1S/C17H19N5O/c1-3-13-11-14(4-1)23-10-9-18-7-2-8-19-16-5-6-17-20-12-15(13)22(17)21-16/h1,3-6,11-12,18H,2,7-10H2,(H,19,21) D03OIA DRUGINKE LGJSILJEEDDVAZ-UHFFFAOYSA-N D03OIA DRUGSMIL C1CNCCOC2=CC=CC(=C2)C3=CN=C4N3N=C(C=C4)NC1 D03OIA HIGHSTAT Patented D03OYJ DRUG__ID D03OYJ D03OYJ DRUGCOMP MEDICAL RESEARCH COUNCIL CHEESEMAN, Michael, T BROWN, Steve. D. M D03OYJ DRUGTYPE Small molecular drug D03OYJ DRUGINCH 1S/C32H48N4O8/c1-18-14-22-27(34-12-13-36(5)6)24(37)17-23(29(22)39)35-31(40)19(2)10-9-11-25(42-7)30(44-32(33)41)21(4)16-20(3)28(38)26(15-18)43-8/h9-11,16-18,20,25-26,28,30,34,38H,12-15H2,1-8H3,(H2,33,41)(H,35,40)/b11-9-,19-10+,21-16+/t18-,20+,25+,26+,28-,30+/m1/s1 D03OYJ DRUGINKE KUFRQPKVAWMTJO-LMZWQJSESA-N D03OYJ DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)C)OC)OC(=O)N)C)C)O)OC D03OYJ HIGHSTAT Patented D03PLQ DRUG__ID D03PLQ D03PLQ DRUGTYPE Small molecular drug D03PLQ DRUGINCH 1S/C24H23N3O3S3/c1-16-4-9-20-21(15-16)32-24(26-20)18-5-7-19(8-6-18)25-23(28)17-10-12-27(13-11-17)33(29,30)22-3-2-14-31-22/h2-9,14-15,17H,10-13H2,1H3,(H,25,28) D03PLQ DRUGINKE IVGKSFUEBSXSAE-UHFFFAOYSA-N D03PLQ DRUGSMIL CC1=CC2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NC(=O)C4CCN(CC4)S(=O)(=O)C5=CC=CS5 D03PLQ HIGHSTAT Patented D03PLQ COMPCLAS Benzothiazole analogs D03PRA DRUG__ID D03PRA D03PRA DRUGTYPE Small molecular drug D03PRA DRUGINCH 1S/C20H16F3N5O4S/c1-28-17(11-31-14-7-5-13(6-8-14)20(21,22)23)16(10-25-28)19-26-18(27-32-19)12-3-2-4-15(9-12)33(24,29)30/h2-10H,11H2,1H3,(H2,24,29,30) D03PRA DRUGINKE ZHBWEWSSDGSLAK-UHFFFAOYSA-N D03PRA DRUGSMIL CN1C(=C(C=N1)C2=NC(=NO2)C3=CC(=CC=C3)S(=O)(=O)N)COC4=CC=C(C=C4)C(F)(F)F D03PRA HIGHSTAT Patented D03PRA COMPCLAS Heteroaryl-pyrazole derivatives D03PYA DRUG__ID D03PYA D03PYA DRUGTYPE Small molecular drug D03PYA DRUGINCH 1S/C17H25NO2/c1-17(2,3)14-11-7-8-12-15(14)20-16(19)18-13-9-5-4-6-10-13/h4-6,9-10,14-15H,7-8,11-12H2,1-3H3,(H,18,19) D03PYA DRUGINKE IQFJKVNORUXJJY-UHFFFAOYSA-N D03PYA DRUGSMIL CC(C)(C)C1CCCCC1OC(=O)NC2=CC=CC=C2 D03PYA HIGHSTAT Patented D03PYA COMPCLAS Cyclohexyl carbamate derivatives D03RAU DRUG__ID D03RAU D03RAU DRUGTYPE Small molecular drug D03RAU DRUGINCH 1S/C21H26ClN3O4/c1-2-3-4-6-18-24-17(15-8-10-16(22)11-9-15)13-20(27)25(18)14-19(26)23-12-5-7-21(28)29/h8-11,13H,2-7,12,14H2,1H3,(H,23,26)(H,28,29) D03RAU DRUGINKE GMCBZWCKSMXZFV-UHFFFAOYSA-N D03RAU DRUGSMIL CCCCCC1=NC(=CC(=O)N1CC(=O)NCCCC(=O)O)C2=CC=C(C=C2)Cl D03RAU HIGHSTAT Patented D03RAU COMPCLAS Pyrimidinone derivatives D03RPJ DRUG__ID D03RPJ D03RPJ DRUGCOMP MEDIVATION TECHNOLOGIES, INC D03RPJ DRUGTYPE Small molecular drug D03RPJ DRUGINCH 1S/C22H25NO4/c1-6-19(24)23(5)17-12-16(20(25)15-10-8-7-9-11-15)13-18(14-17)27-21(26)22(2,3)4/h6-14,20,25H,1H2,2-5H3 D03RPJ DRUGINKE ZPLXDAHNNDDTEM-UHFFFAOYSA-N D03RPJ DRUGSMIL CC(C)(C)C(=O)OC1=CC(=CC(=C1)N(C)C(=O)C=C)C(C2=CC=CC=C2)O D03RPJ HIGHSTAT Patented D03TCR DRUG__ID D03TCR D03TCR DRUGCOMP ASTRAZENECA AB [SEASTRAZENECA UK LTD [GBBOEKMAN-WINIWARTER SUSANNE DORIS MARGIT [SEFREDENWALL MARLENE [SEHOGNER CARL ANDERS [SEJOHANSSON LARS ANDERS MIKAEL [SEJUDKINS ROBERT ANDREW [SELI LANNA [SELOEFBERG BJOERN CHRISTIAN INGVAR [SEUNGE SVERKER VON [SE] D03TCR DRUGTYPE Small molecular drug D03TCR DRUGINCH 1S/C24H25ClN4O4/c1-16-12-17(13-28-8-10-31-11-9-28)2-7-21(16)32-20-14-29(15-20)24(30)23-27-26-22(33-23)18-3-5-19(25)6-4-18/h2-7,12,20H,8-11,13-15H2,1H3 D03TCR DRUGINKE PGIWDCQJRFXKTN-UHFFFAOYSA-N D03TCR DRUGSMIL CC1=C(C=CC(=C1)CN2CCOCC2)OC3CN(C3)C(=O)C4=NN=C(O4)C5=CC=C(C=C5)Cl D03TCR HIGHSTAT Patented D03TPE DRUG__ID D03TPE D03TPE DRUGTYPE Small molecular drug D03TPE DRUGINCH 1S/C10H7NO3/c12-8-3-1-2-6-7(10(13)14)4-5-11-9(6)8/h1-5,12H,(H,13,14) D03TPE DRUGINKE KPTUKANGPPVLMD-UHFFFAOYSA-N D03TPE DRUGSMIL C1=CC2=C(C=CN=C2C(=C1)O)C(=O)O D03TPE HIGHSTAT Patented D03TPE COMPCLAS Hydroxyqunoline analogs D03VLV DRUG__ID D03VLV D03VLV DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D03VLV DRUGTYPE Small molecular drug D03VLV DRUGINCH 1S/C9H12N4O2/c1-5-10-7-6(11(5)2)8(14)13(4)9(15)12(7)3/h1-4H3 D03VLV DRUGINKE LFHHOHMIVKIHMG-UHFFFAOYSA-N D03VLV DRUGSMIL CC1=NC2=C(N1C)C(=O)N(C(=O)N2C)C D03VLV HIGHSTAT Patented D03VPP DRUG__ID D03VPP D03VPP DRUGCOMP TETRALOGIC PHARMACEUTICALS CORP. CONDON, Stephen M. LAPORTE, Matthew G. HAIMOWITZ, Thomas D03VPP DRUGTYPE Small molecular drug D03VPP DRUGINCH 1S/C30H40N6O4S/c1-19(31-5)28(37)33-26(30(2,3)4)29(38)35-16-14-24-25(35)22(17-36(24)41(6,39)40)23-18-34-15-10-13-21(27(34)32-23)20-11-8-7-9-12-20/h7-13,15,18-19,22,24-26,31H,14,16-17H2,1-6H3,(H,33,37)/t19-,22+,24+,25+,26+/m0/s1 D03VPP DRUGINKE CDYZPYAGGGZKJG-PFCQFSIYSA-N D03VPP DRUGSMIL CC(C(=O)NC(C(=O)N1CCC2C1C(CN2S(=O)(=O)C)C3=CN4C=CC=C(C4=N3)C5=CC=CC=C5)C(C)(C)C)NC D03VPP HIGHSTAT Patented D03VXP DRUG__ID D03VXP D03VXP DRUGCOMP DAEWOONG PHARMACEUTICAL CO., LTD. KIM, Ji Duck YOON, Hong Chul KIM, In Woo CHO, Min Jae LEE, In Young LEE, Sang Ho PARK, Eun Kyung LIM, Kwon Jo NAM, Sang Hyun D03VXP DRUGTYPE Small molecular drug D03VXP DRUGINCH 1S/C23H18ClF3N4O3/c1-33-14-5-6-19(28-9-14)31-13(10-32)11-34-21-15(3-2-4-18(21)31)22-29-17-8-12(23(25,26)27)7-16(24)20(17)30-22/h2-9,13,32H,10-11H2,1H3,(H,29,30)/t13-/m0/s1 D03VXP DRUGINKE CKJDUPIYRSXWAL-ZDUSSCGKSA-N D03VXP DRUGSMIL COC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C4=NC5=C(N4)C=C(C=C5Cl)C(F)(F)F)CO D03VXP HIGHSTAT Patented D03XTA DRUG__ID D03XTA D03XTA DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D03XTA DRUGTYPE Small molecular drug D03XTA DRUGINCH 1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3 D03XTA DRUGINKE BYPFEZZEUUWMEJ-UHFFFAOYSA-N D03XTA DRUGSMIL CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C D03XTA HIGHSTAT Patented D03YFL DRUG__ID D03YFL D03YFL DRUGCOMP Japan Tobacco, Inc D03YFL DRUGTYPE Small molecular drug D03YFL DRUGINCH 1S/C23H21F3N4O4/c1-14-5-7-19(27-9-14)30-16(11-31)12-33-21-17(3-2-4-18(21)30)22(32)29-15-6-8-20(28-10-15)34-13-23(24,25)26/h2-10,16,31H,11-13H2,1H3,(H,29,32)/t16-/m0/s1 D03YFL DRUGINKE QZUCKCLSVBFSOS-INIZCTEOSA-N D03YFL DRUGSMIL CC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C(=O)NC4=CN=C(C=C4)OCC(F)(F)F)CO D03YFL HIGHSTAT Patented D03ZXG DRUG__ID D03ZXG D03ZXG DRUGCOMP VANDERBILT UNIVERSITY D03ZXG DRUGTYPE Small molecular drug D03ZXG DRUGINCH 1S/C18H11F2N5O2/c19-11-1-2-16(23-8-11)24-18(26)15-6-14(10-25-4-3-22-17(15)25)27-13-5-12(20)7-21-9-13/h1-10H,(H,23,24,26) D03ZXG DRUGINKE GVUNIJCXLHRUNZ-UHFFFAOYSA-N D03ZXG DRUGSMIL C1=CC(=NC=C1F)NC(=O)C2=CC(=CN3C2=NC=C3)OC4=CC(=CN=C4)F D03ZXG HIGHSTAT Patented D04AXC DRUG__ID D04AXC D04AXC DRUGTYPE Small molecular drug D04AXC DRUGINCH 1S/C21H24N2O2/c24-21-9-7-17-6-8-19(14-20(17)22-21)25-13-3-11-23-12-10-16-4-1-2-5-18(16)15-23/h1-2,4-6,8,14H,3,7,9-13,15H2,(H,22,24) D04AXC DRUGINKE VUVLHXICIKCCTI-UHFFFAOYSA-N D04AXC DRUGSMIL C1CC(=O)NC2=C1C=CC(=C2)OCCCN3CCC4=CC=CC=C4C3 D04AXC HIGHSTAT Patented D04AXC COMPCLAS Tetra-hydro-isoquinoline derivatives D04ESE DRUG__ID D04ESE D04ESE DRUGTYPE Small molecular drug D04ESE DRUGINCH 1S/C20H23ClN4O/c1-5-24(6-2)18(26)12-17-19(15-7-9-16(21)10-8-15)22-20-13(3)11-14(4)23-25(17)20/h7-11H,5-6,12H2,1-4H3 D04ESE DRUGINKE SNOFNBFMBXYLMZ-UHFFFAOYSA-N D04ESE DRUGSMIL CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)Cl D04ESE HIGHSTAT Patented D04ESE COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D04ESH DRUG__ID D04ESH D04ESH DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D04ESH DRUGTYPE Small molecule immunotherapy D04ESH DRUGINCH 1S/C41H47ClF2N4O6/c1-28-32(7-4-8-34(28)35-9-5-10-37(29(35)2)52-14-6-12-48-13-11-41(43,44)24-48)23-54-39-17-38(53-22-31-15-30(18-45)19-46-20-31)33(16-36(39)42)21-47(3)40(25-49,26-50)27-51/h4-5,7-10,15-17,19-20,49-51H,6,11-14,21-27H2,1-3H3 D04ESH DRUGINKE KNCHTQJZTIPCIA-UHFFFAOYSA-N D04ESH DRUGSMIL CC1=C(C=CC=C1C2=C(C(=CC=C2)OCCCN3CCC(C3)(F)F)C)COC4=C(C=C(C(=C4)OCC5=CC(=CN=C5)C#N)CN(C)C(CO)(CO)CO)Cl D04ESH HIGHSTAT Patented D04FRL DRUG__ID D04FRL D04FRL DRUGCOMP GRUENENTHAL GMBH [DE] D04FRL DRUGTYPE Small molecular drug D04FRL DRUGINCH 1S/C24H25F4N3O2/c1-14(2)16-5-4-6-19(9-16)31-20(11-22(30-31)24(26,27)28)12-29-23(33)15(3)17-7-8-18(13-32)21(25)10-17/h4-11,14-15,32H,12-13H2,1-3H3,(H,29,33) D04FRL DRUGINKE WEWXHMWEKISRRJ-UHFFFAOYSA-N D04FRL DRUGSMIL CC(C)C1=CC(=CC=C1)N2C(=CC(=N2)C(F)(F)F)CNC(=O)C(C)C3=CC(=C(C=C3)CO)F D04FRL HIGHSTAT Patented D04GVY DRUG__ID D04GVY D04GVY DRUGCOMP H. Lee Moffitt Cancer Center and Research Institute, University of Central Florida Research Foundation D04GVY DRUGTYPE Small molecular drug D04GVY DRUGINCH 1S/C25H19NO15S2/c27-17-4-11(24(32)33)5-19(22(17)30)41-25(34)15-8-18(28)23(31)21(29)16(15)9-26-12-2-1-10-3-13(42(35,36)37)7-20(14(10)6-12)43(38,39)40/h1-8,26-31H,9H2,(H,32,33)(H,35,36,37)(H,38,39,40) D04GVY DRUGINKE AIBIWCKHWTUBPW-UHFFFAOYSA-N D04GVY DRUGSMIL C1=CC(=CC2=C(C=C(C=C21)S(=O)(=O)O)S(=O)(=O)O)NCC3=C(C(=C(C=C3C(=O)OC4=CC(=CC(=C4O)O)C(=O)O)O)O)O D04GVY HIGHSTAT Patented D04GYR DRUG__ID D04GYR D04GYR DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D04GYR DRUGTYPE Small molecular drug D04GYR DRUGINCH 1S/C22H22N4O/c1-22(2,3)15-26-19(27)13-12-17(23-26)20-18-11-7-8-14-25(18)24-21(20)16-9-5-4-6-10-16/h4-14H,15H2,1-3H3 D04GYR DRUGINKE XGZUBYNARGEPRB-UHFFFAOYSA-N D04GYR DRUGSMIL CC(C)(C)CN1C(=O)C=CC(=N1)C2=C3C=CC=CN3N=C2C4=CC=CC=C4 D04GYR HIGHSTAT Patented D04HBL DRUG__ID D04HBL D04HBL DRUGCOMP RIJKSUNIVERSITEIT GRONINGEN D04HBL DRUGTYPE Small molecule immunotherapy D04HBL DRUGINCH 1S/C35H33N5O3/c36-23-31-30(28-9-5-2-6-10-28)15-16-38-35(31)42-25-33-39-34(29-13-11-27(12-14-29)26-7-3-1-4-8-26)32(43-33)24-37-17-18-40-19-21-41-22-20-40/h1-16,37H,17-22,24-25H2 D04HBL DRUGINKE LEMZNPCBMGJIOU-UHFFFAOYSA-N D04HBL DRUGSMIL C1COCCN1CCNCC2=C(N=C(O2)COC3=NC=CC(=C3C#N)C4=CC=CC=C4)C5=CC=C(C=C5)C6=CC=CC=C6 D04HBL HIGHSTAT Patented D04IGE DRUG__ID D04IGE D04IGE DRUGCOMP Korea Bio Health Co. Ltd D04IGE DRUGTYPE Small molecular drug D04IGE DRUGINCH 1S/C19H20O5/c1-5-11(2)18(21)23-16-9-13-8-12-6-7-17(20)22-14(12)10-15(13)24-19(16,3)4/h5-8,10,16H,9H2,1-4H3/b11-5-/t16-/m1/s1 D04IGE DRUGINKE AGABNGOXUSXQDD-YLBKJFSISA-N D04IGE DRUGSMIL CC=C(C)C(=O)OC1CC2=C(C=C3C(=C2)C=CC(=O)O3)OC1(C)C D04IGE HIGHSTAT Patented D04IGZ DRUG__ID D04IGZ D04IGZ DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D04IGZ DRUGTYPE Small molecular drug D04IGZ DRUGINCH 1S/C16H19FN2O/c1-2-3-7-15(20)19-12-10-16(17,13-19)9-8-14-6-4-5-11-18-14/h4-6,11H,2-3,7,10,12-13H2,1H3 D04IGZ DRUGINKE HKFZZVZBEQGITN-UHFFFAOYSA-N D04IGZ DRUGSMIL CCCCC(=O)N1CCC(C1)(C#CC2=CC=CC=N2)F D04IGZ HIGHSTAT Patented D04JIH DRUG__ID D04JIH D04JIH DRUGCOMP IKERCHEM S L [ESUNIV DEL PA S VASCO [ES] D04JIH DRUGTYPE Small molecular drug D04JIH DRUGINCH 1S/C24H21NO9/c1-33-11-7-15-20(19(8-11)34-2)14(12-3-5-16(26)23(31)21(12)29)9-25(15)10-18(28)13-4-6-17(27)24(32)22(13)30/h3-9,26-27,29-32H,10H2,1-2H3 D04JIH DRUGINKE GBDRNHMXDAEPNN-UHFFFAOYSA-N D04JIH DRUGSMIL COC1=CC2=C(C(=C1)OC)C(=CN2CC(=O)C3=C(C(=C(C=C3)O)O)O)C4=C(C(=C(C=C4)O)O)O D04JIH HIGHSTAT Patented D04JVY DRUG__ID D04JVY D04JVY DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D04JVY DRUGTYPE Small molecular drug D04JVY DRUGINCH 1S/C32H28N8O2S/c1-40(2)18-6-11-29(41)35-24-8-5-7-21(19-24)30(42)36-22-12-14-23(15-13-22)37-32-34-17-16-26(39-32)25(20-33)31-38-27-9-3-4-10-28(27)43-31/h3-17,19,38H,18H2,1-2H3,(H,35,41)(H,36,42)(H,34,37,39)/b11-6+,31-25+ D04JVY DRUGINKE HOHLJRLTAVJARA-KCBYSLGISA-N D04JVY DRUGSMIL CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)NC3=NC=CC(=N3)C(=C4NC5=CC=CC=C5S4)C#N D04JVY HIGHSTAT Patented D04KQU DRUG__ID D04KQU D04KQU DRUGCOMP KARUS THERAPEUTICS LTD D04KQU DRUGTYPE Small molecular drug D04KQU DRUGINCH 1S/C23H25N5O4/c1-31-20-7-9-22(25-15-20)28(16-17-2-4-18(5-3-17)23(29)26-30)21-8-6-19(14-24-21)27-10-12-32-13-11-27/h2-9,14-15,30H,10-13,16H2,1H3,(H,26,29) D04KQU DRUGINKE ATEJVBHLZROGEX-UHFFFAOYSA-N D04KQU DRUGSMIL COC1=CN=C(C=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)N4CCOCC4 D04KQU HIGHSTAT Patented D04LRT DRUG__ID D04LRT D04LRT DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D04LRT DRUGTYPE Small molecular drug D04LRT DRUGINCH 1S/C26H18F4N4O/c27-17-8-6-16(7-9-17)19-12-22(25(31)35)32-21-11-15(5-10-18(19)21)14-34-23-4-2-1-3-20(23)33-24(34)13-26(28,29)30/h1-12H,13-14H2,(H2,31,35) D04LRT DRUGINKE OOWXUDJNUOKLDH-UHFFFAOYSA-N D04LRT DRUGSMIL C1=CC=C2C(=C1)N=C(N2CC3=CC4=C(C=C3)C(=CC(=N4)C(=O)N)C5=CC=C(C=C5)F)CC(F)(F)F D04LRT HIGHSTAT Patented D04MPV DRUG__ID D04MPV D04MPV DRUGTYPE Small molecular drug D04MPV DRUGINCH 1S/C27H22Cl2FN3O3/c1-27(2,17-9-13-19(30)14-10-17)31-26(36)24-20(15-23(34)35)25(16-7-11-18(28)12-8-16)33(32-24)22-6-4-3-5-21(22)29/h3-14H,15H2,1-2H3,(H,31,36)(H,34,35) D04MPV DRUGINKE YBFWRMNFSYACJD-UHFFFAOYSA-N D04MPV DRUGSMIL CC(C)(C1=CC=C(C=C1)F)NC(=O)C2=NN(C(=C2CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl D04MPV HIGHSTAT Patented D04MPV COMPCLAS Pyrazole derivatives D04MQZ DRUG__ID D04MQZ D04MQZ DRUGCOMP Merck & Co., Inc D04MQZ DRUGTYPE Small molecular drug D04MQZ DRUGINCH 1S/C10H8N2O2/c13-10(14)6-5-9-11-7-3-1-2-4-8(7)12-9/h1-6H,(H,11,12)(H,13,14)/b6-5+ D04MQZ DRUGINKE FEGNPBYZFFAMCR-AATRIKPKSA-N D04MQZ DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C=CC(=O)O D04MQZ HIGHSTAT Patented D04NIU DRUG__ID D04NIU D04NIU DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D04NIU DRUGTYPE Small molecular drug D04NIU DRUGINCH 1S/C25H25N3O2/c1-27-23-14-19(9-10-22(23)21-8-5-12-26-16-24(21)27)28-13-11-20(15-25(28)29)30-17-18-6-3-2-4-7-18/h2-4,6-7,9-11,13-15,26H,5,8,12,16-17H2,1H3 D04NIU DRUGINKE BCAMBGJXPGJPAB-UHFFFAOYSA-N D04NIU DRUGSMIL CN1C2=C(CCCNC2)C3=C1C=C(C=C3)N4C=CC(=CC4=O)OCC5=CC=CC=C5 D04NIU HIGHSTAT Patented D04OPJ DRUG__ID D04OPJ D04OPJ DRUGTYPE Small molecular drug D04OPJ DRUGINCH 1S/C21H32N2/c1-3-8-19(9-4-1)21(17-18-10-11-20(21)16-18)22-12-7-15-23-13-5-2-6-14-23/h1,3-4,8-9,18,20,22H,2,5-7,10-17H2 D04OPJ DRUGINKE XUIHNTYMWPNMJK-UHFFFAOYSA-N D04OPJ DRUGSMIL C1CCN(CC1)CCCNC2(CC3CCC2C3)C4=CC=CC=C4 D04OPJ HIGHSTAT Patented D04OPJ COMPCLAS Bicyclo-heptan-2-amine derivatives D04QBY DRUG__ID D04QBY D04QBY DRUGCOMP SALK INSTITUTE FOR BIOLOGICAL STUDIE D04QBY DRUGTYPE Small molecular drug D04QBY DRUGINCH 1S/C32H35FN2O3/c1-34(2)28-17-15-24(16-18-28)26-13-14-27(30(33)21-26)22-35(32(37)25-9-5-4-6-10-25)29-11-7-8-23(20-29)12-19-31(36)38-3/h7-8,11-21,25H,4-6,9-10,22H2,1-3H3/b19-12+/i22D D04QBY DRUGINKE BRNNEWSVEXDLGK-OFSGRHOTSA-N D04QBY DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC(=C(C=C2)CN(C3=CC=CC(=C3)C=CC(=O)OC)C(=O)C4CCCCC4)F D04QBY HIGHSTAT Patented D04QVK DRUG__ID D04QVK D04QVK DRUGTYPE Small molecular drug D04QVK DRUGINCH 1S/C22H22Cl3N3O/c23-14-6-9-17(10-7-14)28-13-20(22(29)26-16-4-2-1-3-5-16)27-21(28)18-11-8-15(24)12-19(18)25/h6-12,16,20H,1-5,13H2,(H,26,29) D04QVK DRUGINKE AUDPPCIKFUVJJY-UHFFFAOYSA-N D04QVK DRUGSMIL C1CCC(CC1)NC(=O)C2CN(C(=N2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D04QVK HIGHSTAT Patented D04QVK COMPCLAS 1,2,4-tri-substituted imidazoline derivatives D04TIU DRUG__ID D04TIU D04TIU DRUGCOMP Amorepacific Corp D04TIU DRUGTYPE Small molecular drug D04TIU DRUGINCH 1S/C21H16F6N2O4S/c1-10(12-8-15(23)19(16(24)9-12)29-34(2,31)32)28-20(30)18-6-5-17(33-18)11-3-4-14(22)13(7-11)21(25,26)27/h3-10,29H,1-2H3,(H,28,30)/t10-/m1/s1 D04TIU DRUGINKE UERGSQUAPFQUKE-SNVBAGLBSA-N D04TIU DRUGSMIL CC(C1=CC(=C(C(=C1)F)NS(=O)(=O)C)F)NC(=O)C2=CC=C(O2)C3=CC(=C(C=C3)F)C(F)(F)F D04TIU HIGHSTAT Patented D04TSP DRUG__ID D04TSP D04TSP DRUGCOMP KOWA COMPANY, LTD D04TSP DRUGTYPE Small molecular drug D04TSP DRUGINCH 1S/C23H30N6OS3/c1-16-14-19(31-2)21(22(24-16)32-3)27-20(30)15-29-10-8-28(9-11-29)12-13-33-23-25-17-6-4-5-7-18(17)26-23/h4-7,14H,8-13,15H2,1-3H3,(H,25,26)(H,27,30) D04TSP DRUGINKE VGGMTOYKEDKFLN-UHFFFAOYSA-N D04TSP DRUGSMIL CC1=CC(=C(C(=N1)SC)NC(=O)CN2CCN(CC2)CCSC3=NC4=CC=CC=C4N3)SC D04TSP HIGHSTAT Patented D04VAE DRUG__ID D04VAE D04VAE DRUGCOMP F. HOFFMANN-LA ROCHE AF. Hoffmann-La Roche AG D04VAE DRUGTYPE Small molecular drug D04VAE DRUGINCH 1S/C24H15N3O/c25-16-19-7-4-8-20(13-19)22-15-24(28)27-23-14-18(11-12-21(23)26-22)10-9-17-5-2-1-3-6-17/h1-8,11-14H,15H2,(H,27,28) D04VAE DRUGINKE YQYIKKPJWMTPST-UHFFFAOYSA-N D04VAE DRUGSMIL C1C(=NC2=C(C=C(C=C2)C#CC3=CC=CC=C3)NC1=O)C4=CC=CC(=C4)C#N D04VAE HIGHSTAT Patented D04VQE DRUG__ID D04VQE D04VQE DRUGCOMP KARUS THERAPEUTICS LTD D04VQE DRUGTYPE Small molecular drug D04VQE DRUGINCH 1S/C16H15N5O3/c1-11-18-16(24-20-11)21(14-4-2-3-9-17-14)10-12-5-7-13(8-6-12)15(22)19-23/h2-9,23H,10H2,1H3,(H,19,22) D04VQE DRUGINKE DUVRIRNTROCZMI-UHFFFAOYSA-N D04VQE DRUGSMIL CC1=NOC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC=N3 D04VQE HIGHSTAT Patented D04WNN DRUG__ID D04WNN D04WNN DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D04WNN DRUGTYPE Small molecular drug D04WNN DRUGINCH 1S/C22H29N5O4S/c1-4-23-32(29,30)18-7-5-6-16(14-18)24-20-9-8-19-21(25-20)27(15(2)22(28)26(19)3)17-10-12-31-13-11-17/h5-9,14-15,17,23H,4,10-13H2,1-3H3,(H,24,25)/t15-/m1/s1 D04WNN DRUGINKE IVGZHVCCAQPDME-OAHLLOKOSA-N D04WNN DRUGSMIL CCNS(=O)(=O)C1=CC=CC(=C1)NC2=NC3=C(C=C2)N(C(=O)C(N3C4CCOCC4)C)C D04WNN HIGHSTAT Patented D04YKV DRUG__ID D04YKV D04YKV DRUGCOMP THE HAMNER INSTITUTES D04YKV DRUGTYPE Small molecular drug D04YKV DRUGINCH 1S/C8H10N2O/c1-6-2-4-7(5-3-6)8(11)10-9/h2-5H,9H2,1H3,(H,10,11) D04YKV DRUGINKE MFFVZXOPRXMVET-UHFFFAOYSA-N D04YKV DRUGSMIL CC1=CC=C(C=C1)C(=O)NN D04YKV HIGHSTAT Patented D04ZXR DRUG__ID D04ZXR D04ZXR DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA DAR, Arvin SHOKAT, Kevan M D04ZXR DRUGTYPE Small molecular drug D04ZXR DRUGINCH 1S/C22H20F3N7O/c1-12(2)32-20-17(19(26)27-11-28-20)18(31-32)13-6-8-15(9-7-13)29-21(33)30-16-5-3-4-14(10-16)22(23,24)25/h3-12H,1-2H3,(H2,26,27,28)(H2,29,30,33) D04ZXR DRUGINKE LEERPLGXOHLQPF-UHFFFAOYSA-N D04ZXR DRUGSMIL CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F)N D04ZXR HIGHSTAT Patented D05BVP DRUG__ID D05BVP D05BVP DRUGCOMP Department of Health and Human Services (NIH, Bethesda, US) D05BVP DRUGTYPE Small molecular drug D05BVP DRUGINCH 1S/C20H15N3O2S/c1-2-15(26-7-1)10-21-20-16-8-13(3-5-17(16)22-11-23-20)14-4-6-18-19(9-14)25-12-24-18/h1-9,11H,10,12H2,(H,21,22,23) D05BVP DRUGINKE QFBOPHGXTBOQRN-UHFFFAOYSA-N D05BVP DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=CC4=C(C=C3)N=CN=C4NCC5=CC=CS5 D05BVP HIGHSTAT Patented D05CBS DRUG__ID D05CBS D05CBS DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D05CBS DRUGTYPE Small molecular drug D05CBS DRUGINCH 1S/C25H17F6N3/c1-14-10-19(11-15(2)32-14)17-4-3-5-18(12-17)23-33-21(13-22(34-23)25(29,30)31)16-6-8-20(9-7-16)24(26,27)28/h3-13H,1-2H3 D05CBS DRUGINKE UTZMRRRZFDOYFQ-UHFFFAOYSA-N D05CBS DRUGSMIL CC1=CC(=CC(=N1)C)C2=CC(=CC=C2)C3=NC(=CC(=N3)C(F)(F)F)C4=CC=C(C=C4)C(F)(F)F D05CBS HIGHSTAT Patented D05COE DRUG__ID D05COE D05COE DRUGCOMP Incyte Corporation D05COE DRUGTYPE Small molecule immunotherapy D05COE DRUGINCH 1S/C22H18N6OS/c1-28-19-7-3-5-14(16(19)11-25-28)13-4-2-6-17(15(13)10-23)26-21(29)22-27-18-8-9-24-12-20(18)30-22/h2-7,11,24H,8-9,12H2,1H3,(H,26,29) D05COE DRUGINKE UPRJKKJMZSATGW-UHFFFAOYSA-N D05COE DRUGSMIL CN1C2=CC=CC(=C2C=N1)C3=C(C(=CC=C3)NC(=O)C4=NC5=C(S4)CNCC5)C#N D05COE HIGHSTAT Patented D05DSL DRUG__ID D05DSL D05DSL DRUGCOMP IKERCHEM S L [ESUNIV DEL PA S VASCO [ES] D05DSL DRUGTYPE Small molecular drug D05DSL DRUGINCH 1S/C22H15F2NO3/c23-15-9-19(24)22-18(13-1-5-16(26)6-2-13)11-25(20(22)10-15)12-21(28)14-3-7-17(27)8-4-14/h1-11,26-27H,12H2 D05DSL DRUGINKE ZSLQOKAZOXSRMM-UHFFFAOYSA-N D05DSL DRUGSMIL C1=CC(=CC=C1C2=CN(C3=C2C(=CC(=C3)F)F)CC(=O)C4=CC=C(C=C4)O)O D05DSL HIGHSTAT Patented D05EON DRUG__ID D05EON D05EON DRUGCOMP PFIZER INC. DIDIUK, Mary FILIPSKI, Kevin J. GUZMAN-PEREZ, Angel LEE, Esther C. PFEFFERKORN, Jeffrey A. STEVENS, Benjamin TU, Meihua D05EON DRUGTYPE Small molecular drug D05EON DRUGINCH 1S/C24H27N3O3/c1-3-6-20(26-23-16(2)15-19-7-4-5-8-21(19)27-23)17-9-11-18(12-10-17)24(30)25-14-13-22(28)29/h4-5,7-12,15,20H,3,6,13-14H2,1-2H3,(H,25,30)(H,26,27)(H,28,29) D05EON DRUGINKE KQBQZWBDDOVGRD-UHFFFAOYSA-N D05EON DRUGSMIL CCCC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)NC2=NC3=CC=CC=C3C=C2C D05EON HIGHSTAT Patented D05HDJ DRUG__ID D05HDJ D05HDJ DRUGCOMP IRM LLC DING, Qiang SIM, Tae-bo ZHANG, Guobao ADRIAN, Francisco GRAY, Nathanael, S D05HDJ DRUGTYPE Small molecular drug D05HDJ DRUGINCH 1S/C18H13F3N6O/c19-18(20,21)28-14-5-3-13(4-6-14)26-16-15-9-25-27(17(15)24-11-23-16)10-12-2-1-7-22-8-12/h1-9,11H,10H2,(H,23,24,26) D05HDJ DRUGINKE JOLSWPYDQLCFEP-UHFFFAOYSA-N D05HDJ DRUGSMIL C1=CC(=CN=C1)CN2C3=NC=NC(=C3C=N2)NC4=CC=C(C=C4)OC(F)(F)F D05HDJ HIGHSTAT Patented D05HLQ DRUG__ID D05HLQ D05HLQ DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PFRENGLE, Waldemar FRANK, Markus KLEIN, Thomas D05HLQ DRUGTYPE Small molecular drug D05HLQ DRUGINCH 1S/C50H56N16O4/c1-6-8-24-63-40-42(56-46(63)61-22-14-16-31(51)27-61)59(4)48(69)65(44(40)67)29-38-53-35-20-12-10-18-33(35)37(55-38)26-50(3)34-19-11-13-21-36(34)54-39(58-50)30-66-45(68)41-43(60(5)49(66)70)57-47(64(41)25-9-7-2)62-23-15-17-32(52)28-62/h10-13,18-21,31-32H,14-17,22-30,51-52H2,1-5H3,(H,54,58)/t31-,32-,50?/m1/s1 D05HLQ DRUGINKE CEWRYIAJQLCIAT-BZDWUGKRSA-N D05HLQ DRUGSMIL CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC(C5=CC=CC=C5N4)(C)CC6=NC(=NC7=CC=CC=C76)CN8C(=O)C9=C(N=C(N9CC#CC)N1CCCC(C1)N)N(C8=O)C)C D05HLQ HIGHSTAT Patented D05KKZ DRUG__ID D05KKZ D05KKZ DRUGCOMP AAPA B.V D05KKZ DRUGTYPE Small molecular drug D05KKZ DRUGINCH 1S/C30H40N4O3/c1-22-30(35)31(2)27-7-4-8-28(29(27)36-22)34-19-17-32(18-20-34)21-23-9-11-25(12-10-23)37-26-13-15-33(16-14-26)24-5-3-6-24/h4,7-12,22,24,26H,3,5-6,13-21H2,1-2H3 D05KKZ DRUGINKE FPIGKLIJDSBXLG-UHFFFAOYSA-N D05KKZ DRUGSMIL CC1C(=O)N(C2=C(O1)C(=CC=C2)N3CCN(CC3)CC4=CC=C(C=C4)OC5CCN(CC5)C6CCC6)C D05KKZ HIGHSTAT Patented D05KRX DRUG__ID D05KRX D05KRX DRUGCOMP Janssen Pharmaceutica D05KRX DRUGTYPE Small molecular drug D05KRX DRUGINCH 1S/C25H27ClF3N7O2/c26-18-2-3-19-17(1-4-21(34-19)36-6-5-16(30)14-36)22(18)23(37)31-13-20(35-7-9-38-10-8-35)15-11-32-24(33-12-15)25(27,28)29/h1-4,11-12,16,20H,5-10,13-14,30H2,(H,31,37)/t16-,20?/m0/s1 D05KRX DRUGINKE WVZNREBVNBJZKF-DJZRFWRSSA-N D05KRX DRUGSMIL C1CN(CC1N)C2=NC3=C(C=C2)C(=C(C=C3)Cl)C(=O)NCC(C4=CN=C(N=C4)C(F)(F)F)N5CCOCC5 D05KRX HIGHSTAT Patented D05LTB DRUG__ID D05LTB D05LTB DRUGCOMP SignalRx Pharmaceuticals, Inc D05LTB DRUGTYPE Small molecular drug D05LTB DRUGINCH 1S/C18H16N2O5S/c21-17-16-15(25-18(19-17)20-3-5-22-6-4-20)12(10-26-16)11-1-2-13-14(9-11)24-8-7-23-13/h1-2,9-10H,3-8H2 D05LTB DRUGINKE RQLXBUCYHIVDGH-UHFFFAOYSA-N D05LTB DRUGSMIL C1COCCN1C2=NC(=O)C3=C(O2)C(=CS3)C4=CC5=C(C=C4)OCCO5 D05LTB HIGHSTAT Patented D05MTZ DRUG__ID D05MTZ D05MTZ DRUGCOMP KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION D05MTZ DRUGTYPE Small molecular drug D05MTZ DRUGINCH 1S/C32H33NO7/c1-37-29(35)23-4-2-5-25(13-23)33-28(34)19-39-26-9-7-24(8-10-26)31-14-21-12-22(15-31)17-32(16-21,20-31)30(36)40-18-27-6-3-11-38-27/h2-11,13,21-22H,12,14-20H2,1H3,(H,33,34) D05MTZ DRUGINKE GQISNYKUWPQVDL-UHFFFAOYSA-N D05MTZ DRUGSMIL COC(=O)C1=CC(=CC=C1)NC(=O)COC2=CC=C(C=C2)C34CC5CC(C3)CC(C5)(C4)C(=O)OCC6=CC=CO6 D05MTZ HIGHSTAT Patented D05NBR DRUG__ID D05NBR D05NBR DRUGCOMP ARRAY BIOPHARMA INC D05NBR DRUGTYPE Small molecular drug D05NBR DRUGINCH 1S/C25H26Cl2N6O2/c1-16-23(18-14-28-32(2)15-18)31-33(19-9-5-4-6-10-19)24(16)30-25(34)29-22-13-21(27)20(26)12-17(22)8-7-11-35-3/h4-6,9-10,12-15H,7-8,11H2,1-3H3,(H2,29,30,34) D05NBR DRUGINKE UZWKONVGWZDEMU-UHFFFAOYSA-N D05NBR DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC=CC=C3)NC(=O)NC4=CC(=C(C=C4CCCOC)Cl)Cl D05NBR HIGHSTAT Patented D05PDI DRUG__ID D05PDI D05PDI DRUGCOMP BIOCRYST PHARMACEUTICALS, INC. BABU, Yarlagadda, S. KOTIAN, Pravin, L. CHINTAREDDY, Venkat, R D05PDI DRUGTYPE Small molecular drug D05PDI DRUGINCH 1S/C19H13FN4O/c20-14-7-10(25)5-6-11(14)17-13-8-21-19-16(13)18(22-9-23-19)12-3-1-2-4-15(12)24-17/h1-9,17,24-25H,(H,21,22,23) D05PDI DRUGINKE IROWCEJAOYOCFJ-UHFFFAOYSA-N D05PDI DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=CNC4=NC=N3)C(N2)C5=C(C=C(C=C5)O)F D05PDI HIGHSTAT Patented D05QJY DRUG__ID D05QJY D05QJY DRUGCOMP ENANTA PHARMACEUTICALS, INC D05QJY DRUGTYPE Small molecular drug D05QJY DRUGINCH 1S/C26H44N4O2/c1-5-17-21-14-16(31)10-12-26(21,4)20-11-13-25(3)18(7-8-19(25)23(20)24(17)32)15(2)6-9-22-27-29-30-28-22/h15-21,23-24,31-32H,5-14H2,1-4H3,(H,27,28,29,30)/t15-,16-,17-,18-,19?,20?,21+,23?,24-,25-,26-/m1/s1 D05QJY DRUGINKE NGMMYLUHCOHSOR-AMGBFIHRSA-N D05QJY DRUGSMIL CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC5=NNN=N5)C)C)O D05QJY HIGHSTAT Patented D05RBF DRUG__ID D05RBF D05RBF DRUGCOMP PURDUE PHARMA LP [USSHIONOGI & CO [JPTAFESSE LAYKEA [USANDO SHIGERU [JPKUROSE NORIYUKI [JP] D05RBF DRUGTYPE Small molecular drug D05RBF DRUGINCH 1S/C21H24FN5O3S/c1-12-3-4-16-18(7-12)31-20(24-16)25-21(30)27-6-5-26(10-13(27)2)19-15(22)8-14(9-23-19)17(29)11-28/h3-4,7-9,13,17,28-29H,5-6,10-11H2,1-2H3,(H,24,25,30)/t13-,17+/m0/s1 D05RBF DRUGINKE MOYYIRTYGZTKTA-SUMWQHHRSA-N D05RBF DRUGSMIL CC1CN(CCN1C(=O)NC2=NC3=C(S2)C=C(C=C3)C)C4=C(C=C(C=N4)C(CO)O)F D05RBF HIGHSTAT Patented D05REP DRUG__ID D05REP D05REP DRUGCOMP MERCK SHARP & DOHME CORP. TING, Pauline, C. ASLANIAN, Robert CAO, Jianhua KIM, David ZORN, Nicolas D05REP DRUGTYPE Small molecular drug D05REP DRUGINCH 1S/C29H27N3O5/c33-28(26-11-10-25(37-26)21-5-2-1-3-6-21)31-23-9-12-27(30-18-23)32-15-13-20(14-16-32)19-36-24-8-4-7-22(17-24)29(34)35/h1-12,17-18,20H,13-16,19H2,(H,31,33)(H,34,35) D05REP DRUGINKE FQDLXNVBCMMHLG-UHFFFAOYSA-N D05REP DRUGSMIL C1CN(CCC1COC2=CC=CC(=C2)C(=O)O)C3=NC=C(C=C3)NC(=O)C4=CC=C(O4)C5=CC=CC=C5 D05REP HIGHSTAT Patented D05SMP DRUG__ID D05SMP D05SMP DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D05SMP DRUGTYPE Small molecular drug D05SMP DRUGINCH 1S/C20H21ClFN5O3S/c21-13-1-2-16-17(9-13)31-19(24-16)25-20(30)27-5-3-26(4-6-27)18-15(22)8-12(10-23-18)7-14(29)11-28/h1-2,8-10,14,28-29H,3-7,11H2,(H,24,25,30)/t14-/m1/s1 D05SMP DRUGINKE STXPENJJMUYCAL-CQSZACIVSA-N D05SMP DRUGSMIL C1CN(CCN1C2=C(C=C(C=N2)CC(CO)O)F)C(=O)NC3=NC4=C(S3)C=C(C=C4)Cl D05SMP HIGHSTAT Patented D05SWL DRUG__ID D05SWL D05SWL DRUGCOMP ABBVIE INC D05SWL DRUGTYPE Small molecular drug D05SWL DRUGINCH 1S/C22H21F5N2O3/c23-10-21(11-24)9-18(15-5-4-13(22(25,26)27)7-19(15)32-21)29-20(31)28-17-3-1-2-12-6-14(30)8-16(12)17/h1-5,7,14,18,30H,6,8-11H2,(H2,28,29,31)/t14-,18-/m1/s1 D05SWL DRUGINKE PPTIROVBLCDDBO-RDTXWAMCSA-N D05SWL DRUGSMIL C1C(CC2=C1C=CC=C2NC(=O)NC3CC(OC4=C3C=CC(=C4)C(F)(F)F)(CF)CF)O D05SWL HIGHSTAT Patented D05TMN DRUG__ID D05TMN D05TMN DRUGCOMP Takeda Pharmaceutical Co. Ltd D05TMN DRUGTYPE Small molecular drug D05TMN DRUGINCH 1S/C19H13F3N4O2/c20-19(21,22)13-6-14(16-9-23-11-28-16)17-24-8-15(26(17)10-13)18(27)25-7-12-4-2-1-3-5-12/h1-6,8-11H,7H2,(H,25,27) D05TMN DRUGINKE PSHYVANCPSFWJM-UHFFFAOYSA-N D05TMN DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CN=C3N2C=C(C=C3C4=CN=CO4)C(F)(F)F D05TMN HIGHSTAT Patented D05VIN DRUG__ID D05VIN D05VIN DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeongmin JUNG, Myung Eun KIM, Jong Yup AHN, Kwangwoo SEO, Hee Jeong LEE, Sung-Han LEE, Suk Ho D05VIN DRUGTYPE Small molecular drug D05VIN DRUGINCH 1S/C24H22BrCl2N3O/c1-5-19-21(23-28-13-20(31-23)24(2,3)4)29-22(17-11-8-15(26)12-18(17)27)30(19)16-9-6-14(25)7-10-16/h6-13H,5H2,1-4H3 D05VIN DRUGINKE PLHFPYNOQHOWQO-UHFFFAOYSA-N D05VIN DRUGSMIL CCC1=C(N=C(N1C2=CC=C(C=C2)Br)C3=C(C=C(C=C3)Cl)Cl)C4=NC=C(O4)C(C)(C)C D05VIN HIGHSTAT Patented D05VXK DRUG__ID D05VXK D05VXK DRUGCOMP NEOPHARM CO.,LTD. ( ) GWAK, Hyung Sub KIM, Yong Zu KIM, Uk Il PARK, Byeong Deog PARK, Tae Kyo WOO, Sung Ho D05VXK DRUGTYPE Small molecular drug D05VXK DRUGINCH 1S/C26H30N4O2/c1-19-24(20-8-4-2-5-9-20)30-18-22(12-13-23(30)27-19)26(32)29-16-14-28(15-17-29)25(31)21-10-6-3-7-11-21/h2,4-5,8-9,12-13,18,21H,3,6-7,10-11,14-17H2,1H3 D05VXK DRUGINKE BQTLJTZGAMQFGS-UHFFFAOYSA-N D05VXK DRUGSMIL CC1=C(N2C=C(C=CC2=N1)C(=O)N3CCN(CC3)C(=O)C4CCCCC4)C5=CC=CC=C5 D05VXK HIGHSTAT Patented D05XAH DRUG__ID D05XAH D05XAH DRUGTYPE Small molecular drug D05XAH DRUGINCH 1S/C19H18N4O3/c1-25-18(24)14-8-6-13(7-9-14)11-21-19(20)23-22-12-16-10-15-4-2-3-5-17(15)26-16/h2-10,12H,11H2,1H3,(H3,20,21,23)/b22-12+ D05XAH DRUGINKE WGIBSILJKFPWDM-WSDLNYQXSA-N D05XAH DRUGSMIL COC(=O)C1=CC=C(C=C1)CN=C(N)NN=CC2=CC3=CC=CC=C3O2 D05XAH HIGHSTAT Patented D05XAH COMPCLAS Aromatic hydrazine carboxyimidoamide derivatives D05XAT DRUG__ID D05XAT D05XAT DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D05XAT DRUGTYPE Small molecular drug D05XAT DRUGINCH 1S/C19H18ClFN2O3/c20-13-5-8-15(12-3-6-14(21)7-4-12)16(11-13)22-18(26)23-19(17(24)25)9-1-2-10-19/h3-8,11H,1-2,9-10H2,(H,24,25)(H2,22,23,26) D05XAT DRUGINKE PDTYXZFDMKYTCF-UHFFFAOYSA-N D05XAT DRUGSMIL C1CCC(C1)(C(=O)O)NC(=O)NC2=C(C=CC(=C2)Cl)C3=CC=C(C=C3)F D05XAT HIGHSTAT Patented D05XXS DRUG__ID D05XXS D05XXS DRUGCOMP MEDIVATION TECHNOLOGIES, INC D05XXS DRUGTYPE Small molecular drug D05XXS DRUGINCH 1S/C17H17NO3/c1-3-16(20)18(2)14-9-13(10-15(19)11-14)17(21)12-7-5-4-6-8-12/h3-11,17,19,21H,1H2,2H3 D05XXS DRUGINKE ISTAOAGDLRWZMS-UHFFFAOYSA-N D05XXS DRUGSMIL CN(C1=CC(=CC(=C1)C(C2=CC=CC=C2)O)O)C(=O)C=C D05XXS HIGHSTAT Patented D05YAD DRUG__ID D05YAD D05YAD DRUGCOMP CURIS, INC D05YAD DRUGTYPE Small molecular drug D05YAD DRUGINCH 1S/C23H28ClN7O3S/c1-14-8-7-9-16(24)21(14)30-22(33)17-13-26-23(35-17)29-19-12-18(27-15(2)28-19)25-11-6-4-3-5-10-20(32)31-34/h7-9,12-13,34H,3-6,10-11H2,1-2H3,(H,30,33)(H,31,32)(H2,25,26,27,28,29) D05YAD DRUGINKE UHHSKEMLNIATAI-UHFFFAOYSA-N D05YAD DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)NCCCCCCC(=O)NO)C D05YAD HIGHSTAT Patented D05YBG DRUG__ID D05YBG D05YBG DRUGCOMP EPITHERAPEUTICS APS D05YBG DRUGTYPE Small molecular drug D05YBG DRUGINCH 1S/C11H17N3O2/c1-14(2)6-5-12-8-10-7-9(11(15)16)3-4-13-10/h3-4,7,12H,5-6,8H2,1-2H3,(H,15,16) D05YBG DRUGINKE SAAOFVWGGZSWSS-UHFFFAOYSA-N D05YBG DRUGSMIL CN(C)CCNCC1=NC=CC(=C1)C(=O)O D05YBG HIGHSTAT Patented D05ZHR DRUG__ID D05ZHR D05ZHR DRUGCOMP SAMUMED, LLC D05ZHR DRUGTYPE Small molecular drug D05ZHR DRUGINCH 1S/C25H26N6O/c1-17-5-7-21(15-27-17)28-25(32)24-22-12-19(6-8-23(22)29-30-24)20-11-18(13-26-14-20)16-31-9-3-2-4-10-31/h5-8,11-15H,2-4,9-10,16H2,1H3,(H,28,32)(H,29,30) D05ZHR DRUGINKE HVEOEVJLUUUHNZ-UHFFFAOYSA-N D05ZHR DRUGSMIL CC1=NC=C(C=C1)NC(=O)C2=NNC3=C2C=C(C=C3)C4=CN=CC(=C4)CN5CCCCC5 D05ZHR HIGHSTAT Patented D06BFA DRUG__ID D06BFA D06BFA DRUGCOMP NTZ LAB LTD [BG] D06BFA DRUGTYPE Small molecular drug D06BFA DRUGINCH 1S/C14H10ClN3O2/c15-11-6-10(2-4-13(11)19)17-14(20)8-1-3-12-9(5-8)7-16-18-12/h1-7,19H,(H,16,18)(H,17,20) D06BFA DRUGINKE VNFLUMWXDOMPIE-UHFFFAOYSA-N D06BFA DRUGSMIL C1=CC2=C(C=C1C(=O)NC3=CC(=C(C=C3)O)Cl)C=NN2 D06BFA HIGHSTAT Patented D06BSV DRUG__ID D06BSV D06BSV DRUGCOMP INCYTE CORPORATION D06BSV DRUGTYPE Small molecule immunotherapy D06BSV DRUGINCH 1S/C22H24N2OS/c1-15(25)13-24-12-11-20-21(14-24)26-22(23-20)19-10-6-9-18(16(19)2)17-7-4-3-5-8-17/h3-10,15,25H,11-14H2,1-2H3/t15-/m0/s1 D06BSV DRUGINKE HABSDVBVXAIOBF-HNNXBMFYSA-N D06BSV DRUGSMIL CC1=C(C=CC=C1C2=NC3=C(S2)CN(CC3)CC(C)O)C4=CC=CC=C4 D06BSV HIGHSTAT Patented D06CBI DRUG__ID D06CBI D06CBI DRUGCOMP ONCOTHYREON INC. PETERSON, Scott PESTANO, Linda FOWLER, Kerry VO, Cong, Hung D06CBI DRUGTYPE Small molecular drug D06CBI DRUGINCH 1S/C10H15ClN2/c11-6-8-13-10-3-1-9(2-4-10)5-7-12/h1-4,13H,5-8,12H2 D06CBI DRUGINKE CPOKZPJUSOYUNW-UHFFFAOYSA-N D06CBI DRUGSMIL C1=CC(=CC=C1CCN)NCCCl D06CBI HIGHSTAT Patented D06EIP DRUG__ID D06EIP D06EIP DRUGCOMP NTZ LAB LTD [BG] D06EIP DRUGTYPE Small molecular drug D06EIP DRUGINCH 1S/C14H9ClFN3O/c15-11-6-10(2-3-12(11)16)18-14(20)8-1-4-13-9(5-8)7-17-19-13/h1-7H,(H,17,19)(H,18,20) D06EIP DRUGINKE IMFUMEKCOMLOPY-UHFFFAOYSA-N D06EIP DRUGSMIL C1=CC2=C(C=C1C(=O)NC3=CC(=C(C=C3)F)Cl)C=NN2 D06EIP HIGHSTAT Patented D06FHJ DRUG__ID D06FHJ D06FHJ DRUGCOMP IOMET PHARMA LTD D06FHJ DRUGTYPE Small molecular drug D06FHJ DRUGINCH 1S/C13H16N2O3S/c1-10(2)9-19(16,17)15-12-8-14-18-13(12)11-6-4-3-5-7-11/h3-8,10,15H,9H2,1-2H3 D06FHJ DRUGINKE PNZONOIXJUOMIU-UHFFFAOYSA-N D06FHJ DRUGSMIL CC(C)CS(=O)(=O)NC1=C(ON=C1)C2=CC=CC=C2 D06FHJ HIGHSTAT Patented D06FVQ DRUG__ID D06FVQ D06FVQ DRUGCOMP H. LUNDBECK A/S D06FVQ DRUGTYPE Small molecular drug D06FVQ DRUGINCH 1S/C23H24N4O/c1-16-12-25-14-20(26-16)21(28)27-23-10-18-7-19(11-23)9-22(8-18,15-23)5-4-17-3-2-6-24-13-17/h2-3,6,12-14,18-19H,7-11,15H2,1H3,(H,27,28) D06FVQ DRUGINKE LHOOHRUEDKJGBG-UHFFFAOYSA-N D06FVQ DRUGSMIL CC1=CN=CC(=N1)C(=O)NC23CC4CC(C2)CC(C4)(C3)C#CC5=CN=CC=C5 D06FVQ HIGHSTAT Patented D06HIJ DRUG__ID D06HIJ D06HIJ DRUGCOMP BAYER SCHERING PHARMA AKTIENGESELLSCHAFT LEHMANN, Lutz THIELE, Andrea HEINRICH, Tobias VOLLMER, Sonja D06HIJ DRUGTYPE Small molecular drug D06HIJ DRUGINCH 1S/C24H25FN2O5/c1-17(28)27(16-18-15-21(30-3)10-11-23(18)31-14-12-25)22-5-4-13-26-24(22)32-20-8-6-19(29-2)7-9-20/h4-11,13,15H,12,14,16H2,1-3H3/i25-1 D06HIJ DRUGINKE WDCDJYGFOQXTQD-FNNGWQQSSA-N D06HIJ DRUGSMIL CC(=O)N(CC1=C(C=CC(=C1)OC)OCCF)C2=C(N=CC=C2)OC3=CC=C(C=C3)OC D06HIJ HIGHSTAT Patented D06HOA DRUG__ID D06HOA D06HOA DRUGCOMP IOMET PHARMA LTD D06HOA DRUGTYPE Small molecular drug D06HOA DRUGINCH 1S/C14H19ClN4O2S/c1-14(2)9-18(4-5-19(14)22(3,20)21)13-7-10(15)6-12-11(13)8-16-17-12/h6-8H,4-5,9H2,1-3H3,(H,16,17) D06HOA DRUGINKE RJWPSUXKQOQTSP-UHFFFAOYSA-N D06HOA DRUGSMIL CC1(CN(CCN1S(=O)(=O)C)C2=CC(=CC3=C2C=NN3)Cl)C D06HOA HIGHSTAT Patented D06IIL DRUG__ID D06IIL D06IIL DRUGCOMP KARUS THERAPEUTICS LTD D06IIL DRUGTYPE Small molecular drug D06IIL DRUGINCH 1S/C17H16FN5O2/c1-22-9-8-16(20-22)23(15-7-6-14(18)10-19-15)11-12-2-4-13(5-3-12)17(24)21-25/h2-10,25H,11H2,1H3,(H,21,24) D06IIL DRUGINKE YBRKYFUMBLZQCO-UHFFFAOYSA-N D06IIL DRUGSMIL CN1C=CC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)F D06IIL HIGHSTAT Patented D06JFS DRUG__ID D06JFS D06JFS DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D06JFS DRUGTYPE Small molecular drug D06JFS DRUGINCH 1S/C16H16BrN5OS/c1-2-15-19-11-3-5-21(6-4-13(11)24-15)16(23)12-7-14-18-8-10(17)9-22(14)20-12/h7-9H,2-6H2,1H3 D06JFS DRUGINKE OEYKQCOFIDDHKA-UHFFFAOYSA-N D06JFS DRUGSMIL CCC1=NC2=C(S1)CCN(CC2)C(=O)C3=NN4C=C(C=NC4=C3)Br D06JFS HIGHSTAT Patented D06JHW DRUG__ID D06JHW D06JHW DRUGCOMP GRUENENTHAL GMBH [DE] D06JHW DRUGTYPE Small molecular drug D06JHW DRUGINCH 1S/C23H18ClF3N4O/c1-14(19-7-2-4-15-12-28-9-8-20(15)19)22(32)29-13-18-11-21(23(25,26)27)30-31(18)17-6-3-5-16(24)10-17/h2-12,14H,13H2,1H3,(H,29,32) D06JHW DRUGINKE ZBOCDMVUEHZVGP-UHFFFAOYSA-N D06JHW DRUGSMIL CC(C1=CC=CC2=C1C=CN=C2)C(=O)NCC3=CC(=NN3C4=CC(=CC=C4)Cl)C(F)(F)F D06JHW HIGHSTAT Patented D06KKO DRUG__ID D06KKO D06KKO DRUGCOMP Boiteau J-G, Barbuis CM, Talano S D06KKO DRUGTYPE Small molecular drug D06KKO DRUGINCH 1S/C10H10N2OS/c13-6-7-1-3-8(4-2-7)9-5-11-10(14)12-9/h1-5,13H,6H2,(H2,11,12,14) D06KKO DRUGINKE BTFQSXRRGYWCHB-UHFFFAOYSA-N D06KKO DRUGSMIL C1=CC(=CC=C1CO)C2=CNC(=S)N2 D06KKO HIGHSTAT Patented D06LIQ DRUG__ID D06LIQ D06LIQ DRUGTYPE Small molecular drug D06LIQ DRUGINCH 1S/C14H27NO2/c1-6-11(3)15-13(16)17-12-7-10(2)8-14(4,5)9-12/h10-12H,6-9H2,1-5H3,(H,15,16) D06LIQ DRUGINKE UJUIRNFIDXYYDT-UHFFFAOYSA-N D06LIQ DRUGSMIL CCC(C)NC(=O)OC1CC(CC(C1)(C)C)C D06LIQ HIGHSTAT Patented D06LIQ COMPCLAS Cyclohexyl carbamate derivatives D06LMS DRUG__ID D06LMS D06LMS DRUGTYPE Small molecular drug D06LMS DRUGINCH 1S/C17H19NO4/c19-14-5-1-12(2-6-14)9-10-18-17(22)8-4-13-3-7-15(20)16(21)11-13/h1-3,5-7,11,19-21H,4,8-10H2,(H,18,22) D06LMS DRUGINKE RIYORZPRGANLCW-UHFFFAOYSA-N D06LMS DRUGSMIL C1=CC(=CC=C1CCNC(=O)CCC2=CC(=C(C=C2)O)O)O D06LMS HIGHSTAT Patented D06LMS COMPCLAS P-coumaric acid derivatives D06NZY DRUG__ID D06NZY D06NZY DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D06NZY DRUGTYPE Small molecular drug D06NZY DRUGINCH 1S/C22H16F3N5/c1-13-10-16(14-2-4-17(5-3-14)22(23,24)25)11-19(29-13)18-7-9-28-21(30-18)15-6-8-27-20(26)12-15/h2-12H,1H3,(H2,26,27) D06NZY DRUGINKE RODNKGNVQQLSIE-UHFFFAOYSA-N D06NZY DRUGSMIL CC1=CC(=CC(=N1)C2=NC(=NC=C2)C3=CC(=NC=C3)N)C4=CC=C(C=C4)C(F)(F)F D06NZY HIGHSTAT Patented D06QRW DRUG__ID D06QRW D06QRW DRUGCOMP Roche Holding AG D06QRW DRUGTYPE Small molecular drug D06QRW DRUGINCH 1S/C8H10ClN3O/c9-6-1-2-7(12-5-6)8(13)11-4-3-10/h1-2,5H,3-4,10H2,(H,11,13) D06QRW DRUGINKE JZXRLKWWVNUZRB-UHFFFAOYSA-N D06QRW DRUGSMIL C1=CC(=NC=C1Cl)C(=O)NCCN D06QRW HIGHSTAT Patented D06RBL DRUG__ID D06RBL D06RBL DRUGCOMP H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INCH. Lee Moffitt Cancer Center and Research Institute, University of Central Florida Research Foundation D06RBL DRUGTYPE Small molecular drug D06RBL DRUGINCH 1S/C33H31NO5/c35-31-20-17-27(21-30(31)33(37)38)34(22-23-11-13-25(14-12-23)24-7-3-1-4-8-24)32(36)26-15-18-29(19-16-26)39-28-9-5-2-6-10-28/h2,5-6,9-21,24,35H,1,3-4,7-8,22H2,(H,37,38) D06RBL DRUGINKE ZJMHQDKLWUWPDR-UHFFFAOYSA-N D06RBL DRUGSMIL C1CCC(CC1)C2=CC=C(C=C2)CN(C3=CC(=C(C=C3)O)C(=O)O)C(=O)C4=CC=C(C=C4)OC5=CC=CC=C5 D06RBL HIGHSTAT Patented D06TAS DRUG__ID D06TAS D06TAS DRUGTYPE Small molecular drug D06TAS DRUGINCH 1S/C23H15F3N6O2/c1-13-19(18-9-10-29-32(18)16-7-5-14(12-27)6-8-16)30-20(21(28)33)22(34)31(13)17-4-2-3-15(11-17)23(24,25)26/h2-11H,1H3,(H2,28,33) D06TAS DRUGINKE IKJNJNORSFGSID-UHFFFAOYSA-N D06TAS DRUGSMIL CC1=C(N=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)N)C3=CC=NN3C4=CC=C(C=C4)C#N D06TAS HIGHSTAT Patented D06TAS COMPCLAS 2-pyrazinone derivatives D06TIU DRUG__ID D06TIU D06TIU DRUGCOMP SAMUMED, LLC D06TIU DRUGTYPE Small molecular drug D06TIU DRUGINCH 1S/C24H24N6O/c31-24(27-20-5-4-8-25-15-20)23-21-12-18(6-7-22(21)28-29-23)19-11-17(13-26-14-19)16-30-9-2-1-3-10-30/h4-8,11-15H,1-3,9-10,16H2,(H,27,31)(H,28,29) D06TIU DRUGINKE VCNIUYPAMGFBLR-UHFFFAOYSA-N D06TIU DRUGSMIL C1CCN(CC1)CC2=CC(=CN=C2)C3=CC4=C(C=C3)NN=C4C(=O)NC5=CN=CC=C5 D06TIU HIGHSTAT Patented D06VYF DRUG__ID D06VYF D06VYF DRUGCOMP ABBVIE INC D06VYF DRUGTYPE Small molecular drug D06VYF DRUGINCH 1S/C22H21F2N3O/c1-13-9-19-16(12-25-13)6-8-20(24)21(19)27-22(28)26-18-7-5-15(11-18)14-3-2-4-17(23)10-14/h2-4,6,8-10,12,15,18H,5,7,11H2,1H3,(H2,26,27,28)/t15-,18+/m0/s1 D06VYF DRUGINKE PAFRMBKESKKSIA-MAUKXSAKSA-N D06VYF DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC(=CC=C4)F)F)C=N1 D06VYF HIGHSTAT Patented D06VZX DRUG__ID D06VZX D06VZX DRUGCOMP CEPHALON, INC. BIERLMAIER, Stephen CHRISTIE, Michael COURVOISIER, Laurent FIELD, R. Scott HALTIWANGER, R. Curtis HE, Linli JACOBS, Martin J. KRESS, Michael MCKEAN, Robert E. MOWREY, Dale R. PETRAITIS, Joseph YAZDANIAN, MehraCEPHALON, INC. DIEBOLD, James, L. HUDKINS, Robert, L. MIKNYOCZKI, Sheila, J. RUGGERI, BrucTEVA(Cephalon,Inc.) D06VZX DRUGTYPE Small molecular drug D06VZX DRUGINCH 1S/C24H26N4O3/c1-26-9-11-27(12-10-26)13-28-23(29)18-14-5-3-6-15(14)22-20(21(18)24(28)30)19-16(25-22)7-4-8-17(19)31-2/h4,7-8,25H,3,5-6,9-13H2,1-2H3 D06VZX DRUGINKE CTLOSZHDGZLOQE-UHFFFAOYSA-N D06VZX DRUGSMIL CN1CCN(CC1)CN2C(=O)C3=C(C2=O)C4=C(C5=C3CCC5)NC6=C4C(=CC=C6)OC D06VZX HIGHSTAT Patented D06WAW DRUG__ID D06WAW D06WAW DRUGCOMP F. HOFFMANN-LA ROCHE AG D06WAW DRUGTYPE Small molecular drug D06WAW DRUGINCH 1S/C25H19F3N4O6S/c1-38-24(35)20-18(13-30-23(34)14-7-9-16(10-8-14)39(29,36)37)21(33)17-11-12-19(25(26,27)28)31-22(17)32(20)15-5-3-2-4-6-15/h2-12H,13H2,1H3,(H,30,34)(H2,29,36,37) D06WAW DRUGINKE HRBSYTKTEPLYNB-UHFFFAOYSA-N D06WAW DRUGSMIL COC(=O)C1=C(C(=O)C2=C(N1C3=CC=CC=C3)N=C(C=C2)C(F)(F)F)CNC(=O)C4=CC=C(C=C4)S(=O)(=O)N D06WAW HIGHSTAT Patented D06XXJ DRUG__ID D06XXJ D06XXJ DRUGCOMP EPITHERAPEUTICS APS D06XXJ DRUGTYPE Small molecular drug D06XXJ DRUGINCH 1S/C14H21N3O3/c1-3-4-7-17(2)13(18)10-15-9-12-8-11(14(19)20)5-6-16-12/h5-6,8,15H,3-4,7,9-10H2,1-2H3,(H,19,20) D06XXJ DRUGINKE ZASDPPHIPJCPAA-UHFFFAOYSA-N D06XXJ DRUGSMIL CCCCN(C)C(=O)CNCC1=NC=CC(=C1)C(=O)O D06XXJ HIGHSTAT Patented D06ZRL DRUG__ID D06ZRL D06ZRL DRUGTYPE Small molecular drug D06ZRL DRUGINCH 1S/C14H11N5O/c20-14(19-13-9-15-7-8-17-13)18-12-5-6-16-11-4-2-1-3-10(11)12/h1-9H,(H2,16,17,18,19,20) D06ZRL DRUGINKE LNIDFQVRZCDVBI-UHFFFAOYSA-N D06ZRL DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)NC(=O)NC3=NC=CN=C3 D06ZRL HIGHSTAT Patented D06ZRL COMPCLAS Quinolinyl pyrazinyl urea derivatives D07BFP DRUG__ID D07BFP D07BFP DRUGCOMP CONSEJO SUPERIOR DE INVESTIGACIONES CIENTICAS (CSIC) UNIVERSIDAD DE ALCAL DE HENARES UNIVERSIDAD COMPLUTENSE DE MADRID D07BFP DRUGTYPE Small molecular drug D07BFP DRUGINCH 1S/C21H28N2O3/c1-6-7-8-9-10-20(2,3)13-11-15(24)16-17-14(12-22-23-17)21(4,5)26-19(16)18(13)25/h11-12H,6-10H2,1-5H3,(H,22,23) D07BFP DRUGINKE XRDIITMVNDBOHN-UHFFFAOYSA-N D07BFP DRUGSMIL CCCCCCC(C)(C)C1=CC(=O)C2=C(C1=O)OC(C3=C2NN=C3)(C)C D07BFP HIGHSTAT Patented D07BWC DRUG__ID D07BWC D07BWC DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. PRESIDENT AND FELLOWS OF HARVARD COLLEGE UNIVERSITY PAUL CEZANNE MARSEILLE III/AIX D07BWC DRUGTYPE Small molecular drug D07BWC DRUGINCH 1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3 D07BWC DRUGINKE ZFOMCSNUEHMROO-UHFFFAOYSA-N D07BWC DRUGSMIL COC1=CC2=C(C=C1)N=C3C=CC(=CC3=C2SCCCN)OC D07BWC HIGHSTAT Patented D07BZW DRUG__ID D07BZW D07BZW DRUGCOMP Japan Tobacco, Inc D07BZW DRUGTYPE Small molecular drug D07BZW DRUGINCH 1S/C23H19Cl2F3N4O4/c1-35-12-13-8-18(25)21(30-10-13)32(11-20(29)33)19-9-14(2-7-17(19)24)22(34)31-15-3-5-16(6-4-15)36-23(26,27)28/h2-10H,11-12H2,1H3,(H2,29,33)(H,31,34) D07BZW DRUGINKE DQUAXWYLWLLDLL-UHFFFAOYSA-N D07BZW DRUGSMIL COCC1=CC(=C(N=C1)N(CC(=O)N)C2=C(C=CC(=C2)C(=O)NC3=CC=C(C=C3)OC(F)(F)F)Cl)Cl D07BZW HIGHSTAT Patented D07CLY DRUG__ID D07CLY D07CLY DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D07CLY DRUGTYPE Small molecular drug D07CLY DRUGINCH 1S/C27H29F3N4O3/c1-16(2)12-23(22-9-6-19(14-32-22)26(37)31-11-10-24(35)36)34-21-13-17(3)25(33-15-21)18-4-7-20(8-5-18)27(28,29)30/h4-9,13-16,23,34H,10-12H2,1-3H3,(H,31,37)(H,35,36) D07CLY DRUGINKE XWKCFFJMDVSXKD-UHFFFAOYSA-N D07CLY DRUGSMIL CC1=CC(=CN=C1C2=CC=C(C=C2)C(F)(F)F)NC(CC(C)C)C3=NC=C(C=C3)C(=O)NCCC(=O)O D07CLY HIGHSTAT Patented D07CYB DRUG__ID D07CYB D07CYB DRUGCOMP EPITHERAPEUTICS APS D07CYB DRUGTYPE Small molecular drug D07CYB DRUGINCH 1S/C22H30N4O4/c1-5-26(13-12-25(2)3)21(27)16-23-15-18-14-17(10-11-24-18)22(28)30-20-8-6-19(29-4)7-9-20/h6-11,14,23H,5,12-13,15-16H2,1-4H3 D07CYB DRUGINKE VCJMVGNCXKDPNL-UHFFFAOYSA-N D07CYB DRUGSMIL CCN(CCN(C)C)C(=O)CNCC1=NC=CC(=C1)C(=O)OC2=CC=C(C=C2)OC D07CYB HIGHSTAT Patented D07DGB DRUG__ID D07DGB D07DGB DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D07DGB DRUGTYPE Small molecular drug D07DGB DRUGINCH 1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8+,11-/m1/s1 D07DGB DRUGINKE HDZZVAMISRMYHH-HGIWHZBTSA-N D07DGB DRUGSMIL C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CO)O)O D07DGB HIGHSTAT Patented D07EAV DRUG__ID D07EAV D07EAV DRUGCOMP GRENTHAL GMBH FRANK, Robert BAHRENBERG, Gregor CHRISTOPH, Thomas SCHIENE, Klaus DE VRY, Jean DAMANN, Nils FRORMANN, Sven LESCH, Bernhard LEE, Jeewoo KIM, Yong-Soo KIM, Myeon-Seop D07EAV DRUGTYPE Small molecular drug D07EAV DRUGINCH 1S/C24H28ClFN4O3S/c1-15(16-9-10-21(20(26)11-16)29-34(5,32)33)23(31)27-14-19-13-22(24(2,3)4)28-30(19)18-8-6-7-17(25)12-18/h6-13,15,29H,14H2,1-5H3,(H,27,31)/t15-/m0/s1 D07EAV DRUGINKE WVJARZWJWNGZDX-HNNXBMFYSA-N D07EAV DRUGSMIL CC(C1=CC(=C(C=C1)NS(=O)(=O)C)F)C(=O)NCC2=CC(=NN2C3=CC(=CC=C3)Cl)C(C)(C)C D07EAV HIGHSTAT Patented D07EBW DRUG__ID D07EBW D07EBW DRUGCOMP Janssen Pharmaceutica D07EBW DRUGTYPE Small molecular drug D07EBW DRUGINCH 1S/C19H16ClF3N6O/c1-2-12-10-29-16(14-8-24-6-7-25-14)26-27-17(29)18(30)28(12)9-11-4-3-5-13(15(11)20)19(21,22)23/h3-8,12H,2,9-10H2,1H3/t12-/m0/s1 D07EBW DRUGINKE XOUUTQMOXWSZSL-LBPRGKRZSA-N D07EBW DRUGSMIL CCC1CN2C(=NN=C2C(=O)N1CC3=C(C(=CC=C3)C(F)(F)F)Cl)C4=NC=CN=C4 D07EBW HIGHSTAT Patented D07EDS DRUG__ID D07EDS D07EDS DRUGCOMP SALK INSTITUTE FOR BIOLOGICAL STUDIE D07EDS DRUGTYPE Small molecular drug D07EDS DRUGINCH 1S/C33H34F2N2O3/c1-36(2)28-11-9-23(10-12-28)24-7-8-26(31(35)18-24)20-37(33(39)30-17-21-4-6-25(30)14-21)29-16-22(15-27(34)19-29)5-13-32(38)40-3/h5,7-13,15-16,18-19,21,25,30H,4,6,14,17,20H2,1-3H3/b13-5+/t21-,25+,30?/m0/s1/i20D/t20?,21-,25+,30? D07EDS DRUGINKE AYPFTLSDFVNKEW-TZCKJPFISA-N D07EDS DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC(=C(C=C2)CN(C3=CC(=CC(=C3)C=CC(=O)OC)F)C(=O)C4CC5CCC4C5)F D07EDS HIGHSTAT Patented D07EGF DRUG__ID D07EGF D07EGF DRUGCOMP GRUENENTHAL GMBH [DE] D07EGF DRUGTYPE Small molecular drug D07EGF DRUGINCH 1S/C22H27F4N5O3S/c1-13-6-8-31(9-7-13)20-15(4-5-18(29-20)22(24,25)26)11-28-21(32)14(2)16-10-17(23)19(27-12-16)30-35(3,33)34/h4-5,10,12-14H,6-9,11H2,1-3H3,(H,27,30)(H,28,32) D07EGF DRUGINKE PZSVFYQEXXZEFT-UHFFFAOYSA-N D07EGF DRUGSMIL CC1CCN(CC1)C2=C(C=CC(=N2)C(F)(F)F)CNC(=O)C(C)C3=CC(=C(N=C3)NS(=O)(=O)C)F D07EGF HIGHSTAT Patented D07FCV DRUG__ID D07FCV D07FCV DRUGCOMP J-PHARMA CO., LTD. WEMPE, Michael, F. ENDOU, Hitoshi D07FCV DRUGTYPE Small molecular drug D07FCV DRUGINCH 1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3 D07FCV DRUGINKE WHQCHUCQKNIQEC-UHFFFAOYSA-N D07FCV DRUGSMIL CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br D07FCV HIGHSTAT Patented D07FIY DRUG__ID D07FIY D07FIY DRUGCOMP GRUENENTHAL GMBH [DE] D07FIY DRUGTYPE Small molecular drug D07FIY DRUGINCH 1S/C21H21ClF3N5O2/c1-13(14-5-6-19(27-11-14)26-7-8-31)20(32)28-12-17-10-18(21(23,24)25)29-30(17)16-4-2-3-15(22)9-16/h2-6,9-11,13,31H,7-8,12H2,1H3,(H,26,27)(H,28,32) D07FIY DRUGINKE QZMPZIHZYACLIU-UHFFFAOYSA-N D07FIY DRUGSMIL CC(C1=CN=C(C=C1)NCCO)C(=O)NCC2=CC(=NN2C3=CC(=CC=C3)Cl)C(F)(F)F D07FIY HIGHSTAT Patented D07FRU DRUG__ID D07FRU D07FRU DRUGCOMP NOVARTIS AG STRAUB, Christopher Sean CHEN, Zhuoliang D07FRU DRUGTYPE Small molecular drug D07FRU DRUGINCH 1S/C70H82F2N10O6/c1-43(73-3)65(83)79-63(47-13-7-5-8-14-47)69(87)81-31-11-17-61(81)55-33-51(37-75-39-55)59-29-27-57(71)35-53(59)41-77-67(85)49-23-19-45(20-24-49)46-21-25-50(26-22-46)68(86)78-42-54-36-58(72)28-30-60(54)52-34-56(40-76-38-52)62-18-12-32-82(62)70(88)64(48-15-9-6-10-16-48)80-66(84)44(2)74-4/h19-30,33-40,43-44,47-48,61-64,73-74H,5-18,31-32,41-42H2,1-4H3,(H,77,85)(H,78,86)(H,79,83)(H,80,84)/t43-,44-,61-,62-,63-,64-/m0/s1 D07FRU DRUGINKE MZOSJSCTFRNVMS-PDAHXLKQSA-N D07FRU DRUGSMIL CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C3=CN=CC(=C3)C4=C(C=C(C=C4)F)CNC(=O)C5=CC=C(C=C5)C6=CC=C(C=C6)C(=O)NCC7=C(C=CC(=C7)F)C8=CC(=CN=C8)C9CCCN9C(=O)C(C1CCCCC1)NC(=O)C(C)NC)NC D07FRU HIGHSTAT Patented D07HJT DRUG__ID D07HJT D07HJT DRUGCOMP PROXIMAGEN LIMITED D07HJT DRUGTYPE Small molecular drug D07HJT DRUGINCH 1S/C21H20N4O3S/c22-20(23)16-6-4-14(5-7-16)13-25-21(26)18-3-1-2-17(12-18)15-8-10-19(11-9-15)29(24,27)28/h1-12H,13H2,(H3,22,23)(H,25,26)(H2,24,27,28) D07HJT DRUGINKE TZCOUVBQGJRRJR-UHFFFAOYSA-N D07HJT DRUGSMIL C1=CC(=CC(=C1)C(=O)NCC2=CC=C(C=C2)C(=N)N)C3=CC=C(C=C3)S(=O)(=O)N D07HJT HIGHSTAT Patented D07IYX DRUG__ID D07IYX D07IYX DRUGCOMP KAINOS MEDICINE, INC D07IYX DRUGTYPE Small molecular drug D07IYX DRUGINCH 1S/C23H21ClN6O3S/c1-14-27-28-23-20(13-33-34(3,31)32)26-22(15-4-7-18(24)8-5-15)19-10-16(6-9-21(19)30(14)23)17-11-25-29(2)12-17/h4-12,20H,13H2,1-3H3/t20-/m0/s1 D07IYX DRUGINKE YAFLYAXZAFQVAT-FQEVSTJZSA-N D07IYX DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)C4=CN(N=C4)C)C(=NC2COS(=O)(=O)C)C5=CC=C(C=C5)Cl D07IYX HIGHSTAT Patented D07JFY DRUG__ID D07JFY D07JFY DRUGCOMP REDX PHARMA PLC D07JFY DRUGTYPE Small molecular drug D07JFY DRUGINCH 1S/C17H13BrClN3O/c18-10-1-2-12(14(19)5-10)17(23)6-15-11-3-4-20-7-13(11)16-8-21-9-22(15)16/h1-5,7-9,15,17,23H,6H2 D07JFY DRUGINKE FULOIPPDAZMZJS-UHFFFAOYSA-N D07JFY DRUGSMIL C1=CC(=C(C=C1Br)Cl)C(CC2C3=C(C=NC=C3)C4=CN=CN24)O D07JFY HIGHSTAT Patented D07JTJ DRUG__ID D07JTJ D07JTJ DRUGTYPE Small molecular drug D07JTJ DRUGINCH 1S/C22H22FN7O3/c1-14-12-29(13-21(32)28(2)7-3-6-24)22(33)19-9-18(27-30(14)19)16-5-4-15(11-25)8-17(16)26-20(31)10-23/h4-5,8-9,14H,3,7,10,12-13H2,1-2H3,(H,26,31)/t14-/m0/s1 D07JTJ DRUGINKE TXOZRELGSIJTEA-AWEZNQCLSA-N D07JTJ DRUGSMIL CC1CN(C(=O)C2=CC(=NN12)C3=C(C=C(C=C3)C#N)NC(=O)CF)CC(=O)N(C)CCC#N D07JTJ HIGHSTAT Patented D07JTJ COMPCLAS Pyrazole derivatives D07KQB DRUG__ID D07KQB D07KQB DRUGCOMP CHDI FOUNDATION, INC D07KQB DRUGTYPE Small molecular drug D07KQB DRUGINCH 1S/C21H16F3N3O3/c22-20(23)30-15-10-25-18(26-11-15)14-8-6-13(7-9-14)17-16(12-4-2-1-3-5-12)21(17,24)19(28)27-29/h1-11,16-17,20,29H,(H,27,28)/t16-,17-,21+/m1/s1 D07KQB DRUGINKE RUTGGTYDBCHEPE-LZJOCLMNSA-N D07KQB DRUGSMIL C1=CC=C(C=C1)C2C(C2(C(=O)NO)F)C3=CC=C(C=C3)C4=NC=C(C=N4)OC(F)F D07KQB HIGHSTAT Patented D07MJJ DRUG__ID D07MJJ D07MJJ DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D07MJJ DRUGTYPE Small molecular drug D07MJJ DRUGINCH 1S/C26H25N3O2/c1-27-24-13-20(7-8-22(24)23-16-28-11-9-19(15-28)26(23)27)29-12-10-21(14-25(29)30)31-17-18-5-3-2-4-6-18/h2-8,10,12-14,19H,9,11,15-17H2,1H3 D07MJJ DRUGINKE UPOGSKZLDRHZBU-UHFFFAOYSA-N D07MJJ DRUGSMIL CN1C2=C(C=CC(=C2)N3C=CC(=CC3=O)OCC4=CC=CC=C4)C5=C1C6CCN(C6)C5 D07MJJ HIGHSTAT Patented D07MNI DRUG__ID D07MNI D07MNI DRUGCOMP Sanofi-Aventis D07MNI DRUGTYPE Small molecular drug D07MNI DRUGINCH 1S/C26H22FN5O/c27-19-4-6-22-18(13-19)14-24(32(22)16-17-8-10-28-11-9-17)26(33)29-20-5-7-23-21(15-20)30-25-3-1-2-12-31(23)25/h4-11,13-15H,1-3,12,16H2,(H,29,33) D07MNI DRUGINKE NFRFMCDNQXJWRI-UHFFFAOYSA-N D07MNI DRUGSMIL C1CCN2C(=NC3=C2C=CC(=C3)NC(=O)C4=CC5=C(N4CC6=CC=NC=C6)C=CC(=C5)F)C1 D07MNI HIGHSTAT Patented D07NAA DRUG__ID D07NAA D07NAA DRUGTYPE Small molecular drug D07NAA DRUGINCH 1S/C22H20F6N2O5S/c1-35-20(32)15-11-17(22(26,27)28)13-18(12-15)36(33,34)30-8-6-29(7-9-30)19(31)10-14-2-4-16(5-3-14)21(23,24)25/h2-5,11-13H,6-10H2,1H3 D07NAA DRUGINKE GJGRAMGTQURCNW-UHFFFAOYSA-N D07NAA DRUGSMIL COC(=O)C1=CC(=CC(=C1)S(=O)(=O)N2CCN(CC2)C(=O)CC3=CC=C(C=C3)C(F)(F)F)C(F)(F)F D07NAA HIGHSTAT Patented D07NAA COMPCLAS Sulfonylated piperazine derivatives D07NFQ DRUG__ID D07NFQ D07NFQ DRUGCOMP AUCKLAND UNISERVICES LIMITED D07NFQ DRUGTYPE Small molecular drug D07NFQ DRUGINCH 1S/C7H6ClN3O/c1-3-2-4(8)10-7-5(3)6(9)11-12-7/h2H,1H3,(H2,9,11) D07NFQ DRUGINKE FQUKGVSRJVUOPA-UHFFFAOYSA-N D07NFQ DRUGSMIL CC1=CC(=NC2=C1C(=NO2)N)Cl D07NFQ HIGHSTAT Patented D07QBL DRUG__ID D07QBL D07QBL DRUGCOMP AJINOMOTO CO., INC D07QBL DRUGTYPE Small molecular drug D07QBL DRUGINCH 1S/C26H32N2O2/c29-17-24-7-4-12-28(24)16-23-15-22-14-21(10-11-26(22)27-23)20-6-3-5-19(13-20)18-30-25-8-1-2-9-25/h3,5-6,10-11,13-15,24-25,27,29H,1-2,4,7-9,12,16-18H2/t24-/m1/s1 D07QBL DRUGINKE GCKSLJXLYRTNCV-XMMPIXPASA-N D07QBL DRUGSMIL C1CCC(C1)OCC2=CC(=CC=C2)C3=CC4=C(C=C3)NC(=C4)CN5CCCC5CO D07QBL HIGHSTAT Patented D07RLB DRUG__ID D07RLB D07RLB DRUGCOMP GENZYME CORPORATION D07RLB DRUGTYPE Small molecular drug D07RLB DRUGINCH 1S/C26H26N6O3/c1-31-15-20(13-29-31)19-11-22-25(28-12-19)32(26(27)30-22)14-18-6-9-23(24(10-18)34-3)35-16-17-4-7-21(33-2)8-5-17/h4-13,15H,14,16H2,1-3H3,(H2,27,30) D07RLB DRUGINKE HVRWZFQFSQUILC-UHFFFAOYSA-N D07RLB DRUGSMIL CN1C=C(C=N1)C2=CC3=C(N=C2)N(C(=N3)N)CC4=CC(=C(C=C4)OCC5=CC=C(C=C5)OC)OC D07RLB HIGHSTAT Patented D07RWQ DRUG__ID D07RWQ D07RWQ DRUGTYPE Small molecular drug D07RWQ DRUGINCH 1S/C20H23BrN4O/c1-5-24(6-2)18(26)12-17-19(15-7-9-16(21)10-8-15)22-20-13(3)11-14(4)23-25(17)20/h7-11H,5-6,12H2,1-4H3 D07RWQ DRUGINKE WBBNDNCIVIIEMF-UHFFFAOYSA-N D07RWQ DRUGSMIL CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)Br D07RWQ HIGHSTAT Patented D07RWQ COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D07RYM DRUG__ID D07RYM D07RYM DRUGCOMP Sanofi D07RYM DRUGTYPE Small molecular drug D07RYM DRUGINCH 1S/C22H17F4N5O/c1-27-19-6-5-17(11-28-19)30-21(32)18-9-14-8-15(22(24,25)26)10-29-20(14)31(18)12-13-3-2-4-16(23)7-13/h2-11H,12H2,1H3,(H,27,28)(H,30,32) D07RYM DRUGINKE XTNRHSVPOQBJCX-UHFFFAOYSA-N D07RYM DRUGSMIL CNC1=NC=C(C=C1)NC(=O)C2=CC3=CC(=CN=C3N2CC4=CC(=CC=C4)F)C(F)(F)F D07RYM HIGHSTAT Patented D07TTT DRUG__ID D07TTT D07TTT DRUGCOMP Kissei Pharmaceutical Co. Ltd D07TTT DRUGTYPE Small molecular drug D07TTT DRUGINCH 1S/C16H10N2O3S/c17-6-11-7-18(8-14(11)10-3-4-22-9-10)12-1-2-13(16(20)21)15(19)5-12/h1-5,7-9,19H,(H,20,21) D07TTT DRUGINKE ZWWRXUXPUSYNGI-UHFFFAOYSA-N D07TTT DRUGSMIL C1=CC(=C(C=C1N2C=C(C(=C2)C3=CSC=C3)C#N)O)C(=O)O D07TTT HIGHSTAT Patented D07ULI DRUG__ID D07ULI D07ULI DRUGCOMP ISIS INNOVATION LIMITED D07ULI DRUGTYPE Small molecular drug D07ULI DRUGINCH 1S/C13H14N4S/c1-2-3-8-18-13-15-12-11(16-17-13)9-6-4-5-7-10(9)14-12/h4-7H,2-3,8H2,1H3,(H,14,15,17) D07ULI DRUGINKE JLINGBANGFPKNS-UHFFFAOYSA-N D07ULI DRUGSMIL CCCCSC1=NC2=C(C3=CC=CC=C3N2)N=N1 D07ULI HIGHSTAT Patented D07UNH DRUG__ID D07UNH D07UNH DRUGCOMP INHIBITAXIN LIMITED D07UNH DRUGTYPE Small molecular drug D07UNH DRUGINCH 1S/C24H21FN4OS/c25-17-7-5-16(6-8-17)13-21-18-14-29(12-11-19(18)26-15-27-21)24(30)10-9-23-28-20-3-1-2-4-22(20)31-23/h1-8,15H,9-14H2 D07UNH DRUGINKE JGNVAVQZDSOAGO-UHFFFAOYSA-N D07UNH DRUGSMIL C1CN(CC2=C1N=CN=C2CC3=CC=C(C=C3)F)C(=O)CCC4=NC5=CC=CC=C5S4 D07UNH HIGHSTAT Patented D07XVL DRUG__ID D07XVL D07XVL DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D07XVL DRUGTYPE Small molecular drug D07XVL DRUGINCH 1S/C18H18F3N5O2/c1-26(2)14-8-11(18(19,20)21)7-6-10(14)9-22-16(27)23-12-4-3-5-13-15(12)25-17(28)24-13/h3-8H,9H2,1-2H3,(H2,22,23,27)(H2,24,25,28) D07XVL DRUGINKE GUTYAMHQYWODRM-UHFFFAOYSA-N D07XVL DRUGSMIL CN(C)C1=C(C=CC(=C1)C(F)(F)F)CNC(=O)NC2=CC=CC3=C2NC(=O)N3 D07XVL HIGHSTAT Patented D07XZR DRUG__ID D07XZR D07XZR DRUGCOMP Novartis AG D07XZR DRUGTYPE Small molecular drug D07XZR DRUGINCH 1S/C17H16ClN3O/c1-10(2)16-20-15-9-12(19)5-8-14(15)17(22)21(16)13-6-3-11(18)4-7-13/h3-10H,19H2,1-2H3 D07XZR DRUGINKE XBLNKLVBZMWWLK-UHFFFAOYSA-N D07XZR DRUGSMIL CC(C)C1=NC2=C(C=CC(=C2)N)C(=O)N1C3=CC=C(C=C3)Cl D07XZR HIGHSTAT Patented D08BCK DRUG__ID D08BCK D08BCK DRUGCOMP KAINOS MEDICINE, INC D08BCK DRUGTYPE Small molecular drug D08BCK DRUGINCH 1S/C20H19ClN4O4S/c1-12-23-24-20-17(11-29-30(3,26)27)22-19(13-4-6-14(21)7-5-13)16-10-15(28-2)8-9-18(16)25(12)20/h4-10,17H,11H2,1-3H3/t17-/m0/s1 D08BCK DRUGINKE LELNYTXQJUOJKQ-KRWDZBQOSA-N D08BCK DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2COS(=O)(=O)C)C4=CC=C(C=C4)Cl D08BCK HIGHSTAT Patented D08CLA DRUG__ID D08CLA D08CLA DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D08CLA DRUGTYPE Small molecular drug D08CLA DRUGINCH 1S/C21H21F3N4O3/c22-21(23,24)14-7-6-13(17(10-14)28-8-1-2-9-28)11-25-20(30)27-16-5-3-4-15-19(16)31-12-18(29)26-15/h3-7,10H,1-2,8-9,11-12H2,(H,26,29)(H2,25,27,30) D08CLA DRUGINKE ABNCWKBVNWSWPZ-UHFFFAOYSA-N D08CLA DRUGSMIL C1CCN(C1)C2=C(C=CC(=C2)C(F)(F)F)CNC(=O)NC3=CC=CC4=C3OCC(=O)N4 D08CLA HIGHSTAT Patented D08CUF DRUG__ID D08CUF D08CUF DRUGCOMP DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry D08CUF DRUGTYPE Small molecular drug D08CUF DRUGINCH 1S/C18H14FN5O2S/c1-25-9-3-4-11(10(19)7-9)23-17-14-12(21-8-22-17)5-6-13-15(14)27-18(24-13)16(20)26-2/h3-8,20H,1-2H3,(H,21,22,23) D08CUF DRUGINKE RYBNARZBIXTFJS-UHFFFAOYSA-N D08CUF DRUGSMIL COC1=CC(=C(C=C1)NC2=NC=NC3=C2C4=C(C=C3)N=C(S4)C(=N)OC)F D08CUF HIGHSTAT Patented D08CYC DRUG__ID D08CYC D08CYC DRUGCOMP CHDI FOUNDATION, INC D08CYC DRUGTYPE Small molecular drug D08CYC DRUGINCH 1S/C20H23F3N4O2/c1-13(11-27-10-2-7-19(12-27)8-9-19)24-17(28)15-5-3-14(4-6-15)16-25-18(29-26-16)20(21,22)23/h3-6,13H,2,7-12H2,1H3,(H,24,28)/t13-/m1/s1 D08CYC DRUGINKE DPJWEPTZTQMWTC-CYBMUJFWSA-N D08CYC DRUGSMIL CC(CN1CCCC2(C1)CC2)NC(=O)C3=CC=C(C=C3)C4=NOC(=N4)C(F)(F)F D08CYC HIGHSTAT Patented D08DIJ DRUG__ID D08DIJ D08DIJ DRUGCOMP DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry D08DIJ DRUGTYPE Small molecular drug D08DIJ DRUGINCH 1S/C17H11Cl2N5OS/c1-25-15(20)17-24-12-5-4-11-13(14(12)26-17)16(22-7-21-11)23-10-3-2-8(18)6-9(10)19/h2-7,20H,1H3,(H,21,22,23) D08DIJ DRUGINKE QSGKPYRFWJINEH-UHFFFAOYSA-N D08DIJ DRUGSMIL COC(=N)C1=NC2=C(S1)C3=C(C=C2)N=CN=C3NC4=C(C=C(C=C4)Cl)Cl D08DIJ HIGHSTAT Patented D08DMM DRUG__ID D08DMM D08DMM DRUGCOMP VANDERBILT UNIVERSITY D08DMM DRUGTYPE Small molecular drug D08DMM DRUGINCH 1S/C17H10F2N6O2/c18-10-1-2-15(21-6-10)24-17(26)14-4-13(8-25-16(14)22-9-23-25)27-12-3-11(19)5-20-7-12/h1-9H,(H,21,24,26) D08DMM DRUGINKE UQYDLTVGUNGXDW-UHFFFAOYSA-N D08DMM DRUGSMIL C1=CC(=NC=C1F)NC(=O)C2=CC(=CN3C2=NC=N3)OC4=CC(=CN=C4)F D08DMM HIGHSTAT Patented D08DNZ DRUG__ID D08DNZ D08DNZ DRUGCOMP ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely D08DNZ DRUGTYPE Small molecular drug D08DNZ DRUGINCH 1S/C17H12ClN5OS/c18-13-8-25-17(15(13)16-20-9-21-23-16)22-14(24)6-10-2-1-3-11-7-19-5-4-12(10)11/h1-5,7-9H,6H2,(H,22,24)(H,20,21,23) D08DNZ DRUGINKE MYLVKAPPYVXQKQ-UHFFFAOYSA-N D08DNZ DRUGSMIL C1=CC2=C(C=CN=C2)C(=C1)CC(=O)NC3=C(C(=CS3)Cl)C4=NC=NN4 D08DNZ HIGHSTAT Patented D08DPU DRUG__ID D08DPU D08DPU DRUGTYPE Small molecular drug D08DPU DRUGINCH 1S/C22H19N3O2/c1-24(18-10-6-3-7-11-18)21(26)15-25-20-14-17(16-8-4-2-5-9-16)12-13-19(20)23-22(25)27/h2-14H,15H2,1H3,(H,23,27) D08DPU DRUGINKE ORIMXDOWDCMRCI-UHFFFAOYSA-N D08DPU DRUGSMIL CN(C1=CC=CC=C1)C(=O)CN2C3=C(C=CC(=C3)C4=CC=CC=C4)NC2=O D08DPU HIGHSTAT Patented D08DPU COMPCLAS Benzimidazolone acetamide derivatives D08ETA DRUG__ID D08ETA D08ETA DRUGCOMP H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INCH. Lee Moffitt Cancer Center and Research Institute, University of Central Florida Research Foundation D08ETA DRUGTYPE Small molecular drug D08ETA DRUGINCH 1S/C30H34N2O6S/c1-21-8-15-26(16-9-21)39(37,38)31(2)20-29(34)32(25-14-17-28(33)27(18-25)30(35)36)19-22-10-12-24(13-11-22)23-6-4-3-5-7-23/h8-18,23,33H,3-7,19-20H2,1-2H3,(H,35,36) D08ETA DRUGINKE PTAQXAOGPHGSTK-UHFFFAOYSA-N D08ETA DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N(C)CC(=O)N(CC2=CC=C(C=C2)C3CCCCC3)C4=CC(=C(C=C4)O)C(=O)O D08ETA HIGHSTAT Patented D08GBR DRUG__ID D08GBR D08GBR DRUGCOMP KARUS THERAPEUTICS LTD D08GBR DRUGTYPE Small molecular drug D08GBR DRUGINCH 1S/C18H16FN5O3/c1-27-15-3-2-6-22-17(15)24(16-10-20-7-8-21-16)11-13-5-4-12(9-14(13)19)18(25)23-26/h2-10,26H,11H2,1H3,(H,23,25) D08GBR DRUGINKE APGUTSIVBNKJKQ-UHFFFAOYSA-N D08GBR DRUGSMIL COC1=C(N=CC=C1)N(CC2=C(C=C(C=C2)C(=O)NO)F)C3=NC=CN=C3 D08GBR HIGHSTAT Patented D08GQL DRUG__ID D08GQL D08GQL DRUGCOMP KARUS THERAPEUTICS LTD D08GQL DRUGTYPE Small molecular drug D08GQL DRUGINCH 1S/C16H13FN6O2/c17-13-8-11(16(24)22-25)3-4-12(13)10-23(14-2-1-5-20-21-14)15-9-18-6-7-19-15/h1-9,25H,10H2,(H,22,24) D08GQL DRUGINKE JRLWVTOAMRASSS-UHFFFAOYSA-N D08GQL DRUGSMIL C1=CC(=NN=C1)N(CC2=C(C=C(C=C2)C(=O)NO)F)C3=NC=CN=C3 D08GQL HIGHSTAT Patented D08HYS DRUG__ID D08HYS D08HYS DRUGCOMP Takeda Pharmaceutical Co. Ltd D08HYS DRUGTYPE Small molecular drug D08HYS DRUGINCH 1S/C20H20N4O3/c25-20(24-14-3-4-15(24)10-26-9-14)17-6-22-19-16(18-7-21-11-27-18)5-13(8-23(17)19)12-1-2-12/h5-8,11-12,14-15H,1-4,9-10H2 D08HYS DRUGINKE SESFIBLYIKNNRP-UHFFFAOYSA-N D08HYS DRUGSMIL C1CC1C2=CN3C(=CN=C3C(=C2)C4=CN=CO4)C(=O)N5C6CCC5COC6 D08HYS HIGHSTAT Patented D08ICT DRUG__ID D08ICT D08ICT DRUGCOMP ABBVIE INC D08ICT DRUGTYPE Small molecular drug D08ICT DRUGINCH 1S/C22H22FN3O2/c1-26-20-8-4-7-19(17(20)11-12-21(26)27)25-22(28)24-15-10-9-14(13-15)16-5-2-3-6-18(16)23/h2-8,11-12,14-15H,9-10,13H2,1H3,(H2,24,25,28)/t14-,15-/m1/s1 D08ICT DRUGINKE NGJOCHXSRSVEDI-HUUCEWRRSA-N D08ICT DRUGSMIL CN1C(=O)C=CC2=C(C=CC=C21)NC(=O)NC3CCC(C3)C4=CC=CC=C4F D08ICT HIGHSTAT Patented D08IUE DRUG__ID D08IUE D08IUE DRUGCOMP NOVARTIS AG DODD, Stephanie Kay FURET, Pascal GROTZFELD, Robert Martin JAHNKE, Wolfgang JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph D08IUE DRUGTYPE Small molecular drug D08IUE DRUGINCH 1S/C20H17ClF3N5O3/c21-20(23,24)32-14-3-1-12(2-4-14)27-19(31)11-7-15(17-16(22)9-26-28-17)18(25-8-11)29-6-5-13(30)10-29/h1-4,7-9,13,30H,5-6,10H2,(H,26,28)(H,27,31)/t13-/m0/s1 D08IUE DRUGINKE NAXNSUPRCUTVTP-ZDUSSCGKSA-N D08IUE DRUGSMIL C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=C(C=NN4)F D08IUE HIGHSTAT Patented D08JES DRUG__ID D08JES D08JES DRUGTYPE Small molecular drug D08JES DRUGINCH 1S/C19H19N5OS/c25-18(20-16-9-5-2-6-10-16)23-11-13-24(14-12-23)19-21-17(22-26-19)15-7-3-1-4-8-15/h1-10H,11-14H2,(H,20,25) D08JES DRUGINKE BHBOSTKQCZEAJM-UHFFFAOYSA-N D08JES DRUGSMIL C1CN(CCN1C2=NC(=NS2)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 D08JES HIGHSTAT Patented D08JES COMPCLAS Piperazine urea derivatives D08JIS DRUG__ID D08JIS D08JIS DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED YANG, Xiaoqing HADIDA RUAH, Sara, S. GROOTENHUIS, Peter, D.J. VAN GOOR, Fredrick, F. BOTFIELD, Martyn, C. ZLOKARNIK, Gregor D08JIS DRUGTYPE Small molecular drug D08JIS DRUGINCH 1S/C15H12N2O2S2/c16-14(19)11-5-6-20-15(11)17-13(18)7-9-8-21-12-4-2-1-3-10(9)12/h1-6,8H,7H2,(H2,16,19)(H,17,18) D08JIS DRUGINKE ZZKGJVRSUVIYIJ-UHFFFAOYSA-N D08JIS DRUGSMIL C1=CC=C2C(=C1)C(=CS2)CC(=O)NC3=C(C=CS3)C(=O)N D08JIS HIGHSTAT Patented D08JMZ DRUG__ID D08JMZ D08JMZ DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D08JMZ DRUGTYPE Small molecular drug D08JMZ DRUGINCH 1S/C25H23FN4O2/c1-29-22-11-18(5-6-20(22)25-21-7-4-16(28-21)10-23(25)29)30-9-8-19(12-24(30)31)32-14-17-3-2-15(26)13-27-17/h2-3,5-6,8-9,11-13,16,21,28H,4,7,10,14H2,1H3 D08JMZ DRUGINKE WIHBSZQMVJUBGL-UHFFFAOYSA-N D08JMZ DRUGSMIL CN1C2=C(C3CCC(C2)N3)C4=C1C=C(C=C4)N5C=CC(=CC5=O)OCC6=NC=C(C=C6)F D08JMZ HIGHSTAT Patented D08JOC DRUG__ID D08JOC D08JOC DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D08JOC DRUGTYPE Small molecular drug D08JOC DRUGINCH 1S/C25H20N6O2/c1-2-23(32)28-21-7-3-5-17(15-21)24(33)29-19-8-10-20(11-9-19)30-25-27-14-12-22(31-25)18-6-4-13-26-16-18/h2-16H,1H2,(H,28,32)(H,29,33)(H,27,30,31) D08JOC DRUGINKE LUFRTLQRKNBFAZ-UHFFFAOYSA-N D08JOC DRUGSMIL C=CC(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CN=CC=C4 D08JOC HIGHSTAT Patented D08JWY DRUG__ID D08JWY D08JWY DRUGCOMP Incyte Corporation D08JWY DRUGTYPE Small molecule immunotherapy D08JWY DRUGINCH 1S/C21H21N5O/c1-15-18(16-6-3-2-4-7-16)8-5-9-19(15)20-14-26-21(24-20)23-13-17(25-26)12-22-10-11-27/h2-9,13-14,22,27H,10-12H2,1H3 D08JWY DRUGINKE SIYAOZFRXTVXSP-UHFFFAOYSA-N D08JWY DRUGSMIL CC1=C(C=CC=C1C2=CN3C(=N2)N=CC(=N3)CNCCO)C4=CC=CC=C4 D08JWY HIGHSTAT Patented D08KYP DRUG__ID D08KYP D08KYP DRUGTYPE Small molecular drug D08KYP DRUGINCH 1S/C29H36N4O2/c1-31(2)20-21-8-13-32(14-9-21)26-10-15-33(16-11-26)29(35)24-6-3-5-22(17-24)25-18-23-7-4-12-30-28(23)27(34)19-25/h3-7,12,17-19,21,26,34H,8-11,13-16,20H2,1-2H3 D08KYP DRUGINKE CILGUWSVIMKGON-UHFFFAOYSA-N D08KYP DRUGSMIL CN(C)CC1CCN(CC1)C2CCN(CC2)C(=O)C3=CC=CC(=C3)C4=CC(=C5C(=C4)C=CC=N5)O D08KYP HIGHSTAT Patented D08KYP COMPCLAS Hydroxyqunoline analogs D08MXO DRUG__ID D08MXO D08MXO DRUGCOMP EPIZYME, INC D08MXO DRUGTYPE Small molecular drug D08MXO DRUGINCH 1S/C25H31N3O4/c1-15-13-22(31-4)20(24(29)27-15)14-26-25(30)23-17(3)28(21-8-6-5-7-19(21)23)16(2)18-9-11-32-12-10-18/h5-8,13,16,18H,9-12,14H2,1-4H3,(H,26,30)(H,27,29) D08MXO DRUGINKE PFPSFENQCNMITC-UHFFFAOYSA-N D08MXO DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCOCC4)C)OC D08MXO HIGHSTAT Patented D08MYA DRUG__ID D08MYA D08MYA DRUGCOMP SALK INSTITUTE FOR BIOLOGICAL STUDIE D08MYA DRUGTYPE Small molecular drug D08MYA DRUGINCH 1S/C32H31F2N3O3/c1-36-30-12-11-23(16-26(30)19-35-36)24-9-10-25(29(34)17-24)20-37(32(39)22-6-4-3-5-7-22)28-15-21(14-27(33)18-28)8-13-31(38)40-2/h8-19,22H,3-7,20H2,1-2H3/b13-8+/i20D D08MYA DRUGINKE FCAAOLBKZMXHIT-CPVMVVEOSA-N D08MYA DRUGSMIL CN1C2=C(C=C(C=C2)C3=CC(=C(C=C3)CN(C4=CC(=CC(=C4)C=CC(=O)OC)F)C(=O)C5CCCCC5)F)C=N1 D08MYA HIGHSTAT Patented D08QBO DRUG__ID D08QBO D08QBO DRUGCOMP GODAVARI BIOREFINERIES LIMITED D08QBO DRUGTYPE Small molecular drug D08QBO DRUGINCH 1S/C15H19N3O2S/c1-3-20-15(19)12-10(2)11-13(16-9-17-14(11)21-12)18-7-5-4-6-8-18/h9H,3-8H2,1-2H3 D08QBO DRUGINKE GMMKSQFSPZJZPM-UHFFFAOYSA-N D08QBO DRUGSMIL CCOC(=O)C1=C(C2=C(N=CN=C2S1)N3CCCCC3)C D08QBO HIGHSTAT Patented D08QGR DRUG__ID D08QGR D08QGR DRUGCOMP National Cancer Center (S. Korea) D08QGR DRUGTYPE Small molecular drug D08QGR DRUGINCH 1S/C8H6N2S3/c1-5-7(12-13-8(5)11)6-4-9-2-3-10-6/h2-4H,1H3 D08QGR DRUGINKE CKNAQFVBEHDJQV-UHFFFAOYSA-N D08QGR DRUGSMIL CC1=C(SSC1=S)C2=NC=CN=C2 D08QGR HIGHSTAT Patented D08RET DRUG__ID D08RET D08RET DRUGCOMP Incyte Corporation D08RET DRUGTYPE Small molecule immunotherapy D08RET DRUGINCH 1S/C24H25N3O3S/c1-16-19(17-8-3-2-4-9-17)10-7-11-20(16)26-22(28)23-25-14-18(31-23)15-27-13-6-5-12-21(27)24(29)30/h2-4,7-11,14,21H,5-6,12-13,15H2,1H3,(H,26,28)(H,29,30)/t21-/m0/s1 D08RET DRUGINKE UBENHLQYILNMML-NRFANRHFSA-N D08RET DRUGSMIL CC1=C(C=CC=C1NC(=O)C2=NC=C(S2)CN3CCCCC3C(=O)O)C4=CC=CC=C4 D08RET HIGHSTAT Patented D08RTY DRUG__ID D08RTY D08RTY DRUGTYPE Small molecular drug D08RTY DRUGINCH 1S/C21H26N4O/c1-6-24(7-2)19(26)13-18-20(17-10-8-14(3)9-11-17)22-21-15(4)12-16(5)23-25(18)21/h8-12H,6-7,13H2,1-5H3 D08RTY DRUGINKE CUGGTIFWWSZRMG-UHFFFAOYSA-N D08RTY DRUGSMIL CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)C D08RTY HIGHSTAT Patented D08RTY COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D08SEP DRUG__ID D08SEP D08SEP DRUGCOMP The Ohio University D08SEP DRUGTYPE Small molecular drug D08SEP DRUGINCH 1S/C14H9NO5S/c15-21(19,20)10-6-2-4-8-12(10)14(18)7-3-1-5-9(16)11(7)13(8)17/h1-6,16H,(H2,15,19,20) D08SEP DRUGINKE CQBHSRLUQDYPBU-UHFFFAOYSA-N D08SEP DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)N D08SEP HIGHSTAT Patented D08SFW DRUG__ID D08SFW D08SFW DRUGCOMP Janssen Pharmaceutica D08SFW DRUGTYPE Small molecular drug D08SFW DRUGINCH 1S/C19H15ClF3N5O/c1-10-16-12(17(25-9-24-16)14-5-7-26-27-14)6-8-28(10)18(29)11-3-2-4-13(15(11)20)19(21,22)23/h2-5,7,9-10H,6,8H2,1H3,(H,26,27)/t10-/m1/s1 D08SFW DRUGINKE CJGMJEYIRWOWHA-SNVBAGLBSA-N D08SFW DRUGSMIL CC1C2=NC=NC(=C2CCN1C(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl)C4=CC=NN4 D08SFW HIGHSTAT Patented D08UEC DRUG__ID D08UEC D08UEC DRUGCOMP Novartis AG D08UEC DRUGTYPE Small molecular drug D08UEC DRUGINCH 1S/C18H16F3N3O/c1-10(2)16-23-15-9-12(22)5-8-14(15)17(25)24(16)13-6-3-11(4-7-13)18(19,20)21/h3-10H,22H2,1-2H3 D08UEC DRUGINKE BRVXMMDZSNVASE-UHFFFAOYSA-N D08UEC DRUGSMIL CC(C)C1=NC2=C(C=CC(=C2)N)C(=O)N1C3=CC=C(C=C3)C(F)(F)F D08UEC HIGHSTAT Patented D08UPQ DRUG__ID D08UPQ D08UPQ DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D08UPQ DRUGTYPE Small molecular drug D08UPQ DRUGINCH 1S/C61H80FN9O7/c1-36(63-10)53(72)67-51(60(4,5)6)58(77)70-34-43-21-13-12-20-42(43)31-50(70)57(76)69(38(3)45-23-16-17-25-47(45)62)33-39-27-29-41(30-28-39)55(74)65-44-32-49(56(75)66-48-26-18-22-40-19-14-15-24-46(40)48)71(35-44)59(78)52(61(7,8)9)68-54(73)37(2)64-11/h12-17,19-21,23-25,27-30,36-38,44,48-52,63-64H,18,22,26,31-35H2,1-11H3,(H,65,74)(H,66,75)(H,67,72)(H,68,73)/t36-,37-,38+,44-,48+,49-,50-,51+,52+/m0/s1 D08UPQ DRUGINKE SUVGZSPIXFUCLS-NQFXVQPCSA-N D08UPQ DRUGSMIL CC(C1=CC=CC=C1F)N(CC2=CC=C(C=C2)C(=O)NC3CC(N(C3)C(=O)C(C(C)(C)C)NC(=O)C(C)NC)C(=O)NC4CCCC5=CC=CC=C45)C(=O)C6CC7=CC=CC=C7CN6C(=O)C(C(C)(C)C)NC(=O)C(C)NC D08UPQ HIGHSTAT Patented D08VON DRUG__ID D08VON D08VON DRUGCOMP ELARA PHARMACEUTICALS GMBH [DE] D08VON DRUGTYPE Small molecular drug D08VON DRUGINCH 1S/C20H16N2O3S2/c1-14-2-6-17(7-3-14)27(23,24)22-10-11-25-19-8-4-15(12-18(19)22)20-9-5-16(13-21)26-20/h2-9,12H,10-11H2,1H3 D08VON DRUGINKE VIWNRKLYEZMKCY-UHFFFAOYSA-N D08VON DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCOC3=C2C=C(C=C3)C4=CC=C(S4)C#N D08VON HIGHSTAT Patented D08XES DRUG__ID D08XES D08XES DRUGCOMP F. HOFFMANN-LA ROCHE AG BISSANTZ, Caterina DHURWASULU, Baledi GRETHER, Uwe HAZRA, Anindya HEBEISEN, Paul ROEVER, Stephan ROGERS-EVANS, Mark D08XES DRUGTYPE Small molecular drug D08XES DRUGINCH 1S/C19H24F2N4O4/c1-18(12-5-6-12,17(27)28-2)24-15(26)13-7-22-14(25-9-19(20,21)10-25)16(23-13)29-8-11-3-4-11/h7,11-12H,3-6,8-10H2,1-2H3,(H,24,26) D08XES DRUGINKE ZVGNNTZBRRKTHH-UHFFFAOYSA-N D08XES DRUGSMIL CC(C1CC1)(C(=O)OC)NC(=O)C2=CN=C(C(=N2)OCC3CC3)N4CC(C4)(F)F D08XES HIGHSTAT Patented D08XOV DRUG__ID D08XOV D08XOV DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D08XOV DRUGTYPE Small molecular drug D08XOV DRUGINCH 1S/C31H45F2N5O5/c1-4-42-22-15-21-16-38(30(41)27(36-28(39)19(2)34-3)20-9-12-31(32,33)13-10-20)25(18-37(21)17-22)29(40)35-24-11-14-43-26-8-6-5-7-23(24)26/h5-8,19-22,24-25,27,34H,4,9-18H2,1-3H3,(H,35,40)(H,36,39)/t19-,21+,22+,24+,25-,27-/m0/s1 D08XOV DRUGINKE WQLHYSFOEZZZDD-QAPMSZJWSA-N D08XOV DRUGSMIL CCOC1CC2CN(C(CN2C1)C(=O)NC3CCOC4=CC=CC=C34)C(=O)C(C5CCC(CC5)(F)F)NC(=O)C(C)NC D08XOV HIGHSTAT Patented D08XQG DRUG__ID D08XQG D08XQG DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D08XQG DRUGTYPE Small molecular drug D08XQG DRUGINCH 1S/C25H34N4O4/c1-15(2)14-29(18-7-5-4-6-8-18)22-10-9-17(19-13-20(19)24(30)31)12-21(22)26-25(32)27-23-11-16(3)28-33-23/h9-12,15,18-20H,4-8,13-14H2,1-3H3,(H,30,31)(H2,26,27,32)/t19-,20-/m0/s1 D08XQG DRUGINKE JFOVWQVFKHJGRN-PMACEKPBSA-N D08XQG DRUGSMIL CC1=NOC(=C1)NC(=O)NC2=C(C=CC(=C2)C3CC3C(=O)O)N(CC(C)C)C4CCCCC4 D08XQG HIGHSTAT Patented D08YGE DRUG__ID D08YGE D08YGE DRUGCOMP LES LABORATOIRES SERVIER D08YGE DRUGTYPE Small molecular drug D08YGE DRUGINCH 1S/C19H16F2N2O2/c1-19(2,22)10-8-14(20)16(15(21)9-10)17(24)12-4-3-5-13-11(12)6-7-23-18(13)25/h3-9H,22H2,1-2H3,(H,23,25) D08YGE DRUGINKE FBSSVAIINOQLST-UHFFFAOYSA-N D08YGE DRUGSMIL CC(C)(C1=CC(=C(C(=C1)F)C(=O)C2=CC=CC3=C2C=CNC3=O)F)N D08YGE HIGHSTAT Patented D08YYW DRUG__ID D08YYW D08YYW DRUGCOMP NTZ LAB LTD [BG] D08YYW DRUGTYPE Small molecular drug D08YYW DRUGINCH 1S/C16H12Cl2N2O/c1-20-7-6-10-8-11(2-5-15(10)20)16(21)19-12-3-4-13(17)14(18)9-12/h2-9H,1H3,(H,19,21) D08YYW DRUGINKE XHTKCMHMWMUSIE-UHFFFAOYSA-N D08YYW DRUGSMIL CN1C=CC2=C1C=CC(=C2)C(=O)NC3=CC(=C(C=C3)Cl)Cl D08YYW HIGHSTAT Patented D08ZBB DRUG__ID D08ZBB D08ZBB DRUGCOMP Japan Tobacco, Inc D08ZBB DRUGTYPE Small molecular drug D08ZBB DRUGINCH 1S/C22H14Cl2F6N4O3/c23-15-6-1-11(20(36)33-13-2-4-14(5-3-13)37-22(28,29)30)7-17(15)34(10-18(31)35)19-16(24)8-12(9-32-19)21(25,26)27/h1-9H,10H2,(H2,31,35)(H,33,36) D08ZBB DRUGINKE FZDJPSLGLZJDRY-UHFFFAOYSA-N D08ZBB DRUGSMIL C1=CC(=CC=C1NC(=O)C2=CC(=C(C=C2)Cl)N(CC(=O)N)C3=C(C=C(C=N3)C(F)(F)F)Cl)OC(F)(F)F D08ZBB HIGHSTAT Patented D08ZEM DRUG__ID D08ZEM D08ZEM DRUGCOMP NeoPharm Co. Ltd D08ZEM DRUGTYPE Small molecular drug D08ZEM DRUGINCH 1S/C20H14BrN3O3S/c1-27-12-8-9-15(21)14(11-12)19(25)23-24-18(17-7-4-10-28-17)22-16-6-3-2-5-13(16)20(24)26/h2-11H,1H3,(H,23,25) D08ZEM DRUGINKE SIPGYZVTRHQPRD-UHFFFAOYSA-N D08ZEM DRUGSMIL COC1=CC(=C(C=C1)Br)C(=O)NN2C(=NC3=CC=CC=C3C2=O)C4=CC=CS4 D08ZEM HIGHSTAT Patented D09AKT DRUG__ID D09AKT D09AKT DRUGTYPE Small molecular drug D09AKT DRUGINCH 1S/C20H23FN4O/c1-5-24(6-2)18(26)12-17-19(15-7-9-16(21)10-8-15)22-20-13(3)11-14(4)23-25(17)20/h7-11H,5-6,12H2,1-4H3 D09AKT DRUGINKE DARQBLUTJIXEJM-UHFFFAOYSA-N D09AKT DRUGSMIL CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)F D09AKT HIGHSTAT Patented D09AKT COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D09AQZ DRUG__ID D09AQZ D09AQZ DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED RUPRAH, Parminder, Kaur MERCHANT, Kevin, John WALSH, Louise, Marie KERR, Catrina, Morven FIELDHOUSE, Charlotte HARRISSON, David MAINE, Stephanie HAZEL, Katherine D09AQZ DRUGTYPE Small molecular drug D09AQZ DRUGINCH 1S/C20H25N3/c1-22-15-19(14-21-22)18-7-5-16(6-8-18)13-17-9-11-23(12-10-17)20-3-2-4-20/h5-8,13-15,20H,2-4,9-12H2,1H3 D09AQZ DRUGINKE JKRRUTHXHYUIML-UHFFFAOYSA-N D09AQZ DRUGSMIL CN1C=C(C=N1)C2=CC=C(C=C2)C=C3CCN(CC3)C4CCC4 D09AQZ HIGHSTAT Patented D09AVU DRUG__ID D09AVU D09AVU DRUGCOMP MERCK SHARP & DOHME CORP. MANLEY, Peter, J. NANDA, Kausik, K. TROTTER, B. Wesley D09AVU DRUGTYPE Small molecular drug D09AVU DRUGINCH 1S/C23H23ClN2O2/c1-27-19-6-7-20-21(14-19)23(26-11-10-25-22(20)26,15-16-8-12-28-13-9-16)17-2-4-18(24)5-3-17/h2-7,10-11,14,16H,8-9,12-13,15H2,1H3 D09AVU DRUGINKE XRZGTQYRLUSRHL-UHFFFAOYSA-N D09AVU DRUGSMIL COC1=CC2=C(C=C1)C3=NC=CN3C2(CC4CCOCC4)C5=CC=C(C=C5)Cl D09AVU HIGHSTAT Patented D09BOL DRUG__ID D09BOL D09BOL DRUGCOMP BOSTON BIOMEDICAL, INC. JIANG, Zhiwei LI, Chiang, Jia LI, Wei LEGGETT, David D09BOL DRUGTYPE Small molecular drug D09BOL DRUGINCH 1S/C14H8O5/c1-6(15)10-5-8-12(17)7-3-2-4-9(16)11(7)13(18)14(8)19-10/h2-5,16H,1H3 D09BOL DRUGINKE MYDAXHYLQBNETF-UHFFFAOYSA-N D09BOL DRUGSMIL CC(=O)C1=CC2=C(O1)C(=O)C3=C(C2=O)C=CC=C3O D09BOL HIGHSTAT Patented D09BXO DRUG__ID D09BXO D09BXO DRUGCOMP Macau University of Science and Technology, Macau D09BXO DRUGTYPE Small molecular drug D09BXO DRUGINCH 1S/C31H41NO8S/c1-17-13-30(32-9-10-41-30)31(36)26(38-17)39-23-12-19-3-4-22-21(28(19,16-33)14-24(23)40-31)5-7-27(2)20(6-8-29(22,27)35)18-11-25(34)37-15-18/h9,11,16-17,19-24,26,35-36H,3-8,10,12-15H2,1-2H3/t17-,19+,20-,21+,22-,23-,24-,26+,27-,28-,29+,30+,31-/m1/s1 D09BXO DRUGINKE DONIPVCAKBPJLH-IGACXKNBSA-N D09BXO DRUGSMIL CC1CC2(C3(C(O1)OC4CC5CCC6C(C5(CC4O3)C=O)CCC7(C6(CCC7C8=CC(=O)OC8)O)C)O)N=CCS2 D09BXO HIGHSTAT Patented D09CDR DRUG__ID D09CDR D09CDR DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE D09CDR DRUGTYPE Small molecular drug D09CDR DRUGINCH 1S/C17H11N3O/c1-21-12-2-3-14-15(7-12)20-17-13-4-5-19-9-11(13)6-10(8-18)16(14)17/h2-7,9,20H,1H3 D09CDR DRUGINKE UVJQEKJPAVSBTA-UHFFFAOYSA-N D09CDR DRUGSMIL COC1=CC2=C(C=C1)C3=C(C=C4C=NC=CC4=C3N2)C#N D09CDR HIGHSTAT Patented D09CER DRUG__ID D09CER D09CER DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD D09CER DRUGTYPE Small molecular drug D09CER DRUGINCH 1S/C23H27N3O3/c1-29-20-4-2-3-18(14-20)23(28)24-19-9-11-26(12-10-19)15-16-5-6-17-7-8-22(27)25-21(17)13-16/h2-6,13-14,19H,7-12,15H2,1H3,(H,24,28)(H,25,27) D09CER DRUGINKE SWKXQUKCAIDRHK-UHFFFAOYSA-N D09CER DRUGSMIL COC1=CC=CC(=C1)C(=O)NC2CCN(CC2)CC3=CC4=C(CCC(=O)N4)C=C3 D09CER HIGHSTAT Patented D09FGW DRUG__ID D09FGW D09FGW DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D09FGW DRUGTYPE Small molecular drug D09FGW DRUGINCH 1S/C23H20N6O/c24-14-17-11-15(3-6-21(17)29-9-1-2-10-29)20-7-8-25-23(28-20)26-18-4-5-19-16(12-18)13-22(30)27-19/h3-8,11-12H,1-2,9-10,13H2,(H,27,30)(H,25,26,28) D09FGW DRUGINKE DHPSFJYFPJRCTN-UHFFFAOYSA-N D09FGW DRUGSMIL C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC5=C(C=C4)NC(=O)C5)C#N D09FGW HIGHSTAT Patented D09FMS DRUG__ID D09FMS D09FMS DRUGCOMP IKERCHEM S L [ESUNIV DEL PA S VASCO [ES] D09FMS DRUGTYPE Small molecular drug D09FMS DRUGINCH 1S/C23H19NO8/c1-32-11-2-3-12-15(13-4-6-17(25)22(30)20(13)28)9-24(16(12)8-11)10-19(27)14-5-7-18(26)23(31)21(14)29/h2-9,25-26,28-31H,10H2,1H3 D09FMS DRUGINKE SFHIQZITSGPFGB-UHFFFAOYSA-N D09FMS DRUGSMIL COC1=CC2=C(C=C1)C(=CN2CC(=O)C3=C(C(=C(C=C3)O)O)O)C4=C(C(=C(C=C4)O)O)O D09FMS HIGHSTAT Patented D09GFF DRUG__ID D09GFF D09GFF DRUGCOMP EPIZYME, INC D09GFF DRUGTYPE Small molecular drug D09GFF DRUGINCH 1S/C31H38N6O3/c1-6-21(4)37-18-19(2)29-24(30(39)34-17-25-27(38)13-20(3)35-31(25)40-5)14-23(15-26(29)37)22-7-8-28(33-16-22)36-11-9-32-10-12-36/h7-8,13-16,18,21,32H,6,9-12,17H2,1-5H3,(H,34,39)(H,35,38) D09GFF DRUGINKE RKSMELDENOCZPF-UHFFFAOYSA-N D09GFF DRUGSMIL CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(NC(=CC5=O)C)OC)C D09GFF HIGHSTAT Patented D09HVV DRUG__ID D09HVV D09HVV DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D09HVV DRUGTYPE Small molecular drug D09HVV DRUGINCH 1S/C25H30F5N3O3/c1-14(2)12-33(13-15(3)4)22-8-5-16(18(11-23(34)35)25(28,29)30)9-21(22)32-24(36)31-20-7-6-17(26)10-19(20)27/h5-10,14-15,18H,11-13H2,1-4H3,(H,34,35)(H2,31,32,36) D09HVV DRUGINKE LLRWXYAXYSABOE-UHFFFAOYSA-N D09HVV DRUGSMIL CC(C)CN(CC(C)C)C1=C(C=C(C=C1)C(CC(=O)O)C(F)(F)F)NC(=O)NC2=C(C=C(C=C2)F)F D09HVV HIGHSTAT Patented D09IGN DRUG__ID D09IGN D09IGN DRUGCOMP SCHERING CORPORATION GILBERT, Eric, J. MILLER, Michael, W. DEMONG, Duane Eugene STAMFORD, Andrew, W. GREENLEE, William, J D09IGN DRUGTYPE Small molecular drug D09IGN DRUGINCH 1S/C31H28Cl2N2O6S/c1-41-27-7-4-20-12-22(3-2-21(20)15-27)29-16-24(23-13-25(32)17-26(33)14-23)18-35(29)42(39,40)28-8-5-19(6-9-28)31(38)34-11-10-30(36)37/h2-9,12-15,17,24,29H,10-11,16,18H2,1H3,(H,34,38)(H,36,37)/t24-,29-/m1/s1 D09IGN DRUGINKE DOKNZWNPLZNQJB-FUFSCUOVSA-N D09IGN DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3CC(CN3S(=O)(=O)C4=CC=C(C=C4)C(=O)NCCC(=O)O)C5=CC(=CC(=C5)Cl)Cl D09IGN HIGHSTAT Patented D09IKN DRUG__ID D09IKN D09IKN DRUGTYPE Small molecular drug D09IKN DRUGINCH 1S/C24H28ClN5O4/c1-2-3-4-11-29-20(28-12-5-6-19(28)23(34)26-14-22(32)33)13-21(31)30-15-18(27-24(29)30)16-7-9-17(25)10-8-16/h7-10,13,15,19H,2-6,11-12,14H2,1H3,(H,26,34)(H,32,33)/t19-/m0/s1 D09IKN DRUGINKE VHDLUVVGLIPRGY-IBGZPJMESA-N D09IKN DRUGSMIL CCCCCN1C(=CC(=O)N2C1=NC(=C2)C3=CC=C(C=C3)Cl)N4CCCC4C(=O)NCC(=O)O D09IKN HIGHSTAT Patented D09IKN COMPCLAS Imidazopyrimidinone derivatives D09JZA DRUG__ID D09JZA D09JZA DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D09JZA DRUGTYPE Small molecular drug D09JZA DRUGINCH 1S/C20H19F4N5O2/c1-28-8-12(7-26-28)14-6-15(19(25)30)27-18-13(14)3-2-11(17(18)21)9-29-4-5-31-16(10-29)20(22,23)24/h2-3,6-8,16H,4-5,9-10H2,1H3,(H2,25,30)/t16-/m0/s1 D09JZA DRUGINKE GTJVIXLYXAAAKE-INIZCTEOSA-N D09JZA DRUGSMIL CN1C=C(C=N1)C2=CC(=NC3=C2C=CC(=C3F)CN4CCOC(C4)C(F)(F)F)C(=O)N D09JZA HIGHSTAT Patented D09LKN DRUG__ID D09LKN D09LKN DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D09LKN DRUGTYPE Small molecular drug D09LKN DRUGINCH 1S/C28H29FN6O2/c1-3-5-6-11-19-17-20(21-12-7-8-13-22(21)27-32-34-35-33-27)18-25(26(19)37-16-4-2)31-28(36)30-24-15-10-9-14-23(24)29/h5-10,12-15,17-18H,3-4,11,16H2,1-2H3,(H2,30,31,36)(H,32,33,34,35)/b6-5+ D09LKN DRUGINKE KTJPMWGPZICNCM-AATRIKPKSA-N D09LKN DRUGSMIL CCCOC1=C(C=C(C=C1NC(=O)NC2=CC=CC=C2F)C3=CC=CC=C3C4=NNN=N4)CC=CCC D09LKN HIGHSTAT Patented D09NFI DRUG__ID D09NFI D09NFI DRUGCOMP Macau University of Science and Technology, Macau D09NFI DRUGTYPE Small molecular drug D09NFI DRUGINCH 1S/C31H41NO8S/c1-17-13-30(32-9-10-41-30)31(36)26(38-17)39-23-12-19-3-4-22-21(28(19,16-33)14-24(23)40-31)5-7-27(2)20(6-8-29(22,27)35)18-11-25(34)37-15-18/h9,11,16-17,19-24,26,35-36H,3-8,10,12-15H2,1-2H3/t17-,19+,20-,21+,22-,23-,24-,26+,27-,28-,29+,30+,31+/m1/s1 D09NFI DRUGINKE DONIPVCAKBPJLH-NCSQWUIOSA-N D09NFI DRUGSMIL CC1CC2(C3(C(O1)OC4CC5CCC6C(C5(CC4O3)C=O)CCC7(C6(CCC7C8=CC(=O)OC8)O)C)O)N=CCS2 D09NFI HIGHSTAT Patented D09NRH DRUG__ID D09NRH D09NRH DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D09NRH DRUGTYPE Small molecular drug D09NRH DRUGINCH 1S/C20H19F3N4O2S/c1-11-25-8-17(30-11)14-7-16(19(24)28)26-15-6-12(2-3-13(14)15)9-27-4-5-29-18(10-27)20(21,22)23/h2-3,6-8,18H,4-5,9-10H2,1H3,(H2,24,28) D09NRH DRUGINKE QYGZQJAQOQLFSQ-UHFFFAOYSA-N D09NRH DRUGSMIL CC1=NC=C(S1)C2=CC(=NC3=C2C=CC(=C3)CN4CCOC(C4)C(F)(F)F)C(=O)N D09NRH HIGHSTAT Patented D09OQZ DRUG__ID D09OQZ D09OQZ DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia WICHMANN, Juergen WOLTERING, Thomas D09OQZ DRUGTYPE Small molecular drug D09OQZ DRUGINCH 1S/C21H13ClF3N3O2S2/c22-19-8-7-17(31-19)16-11-18(21(23,24)25)28-20(27-16)14-5-1-3-12(9-14)13-4-2-6-15(10-13)32(26,29)30/h1-11H,(H2,26,29,30) D09OQZ DRUGINKE PNTBWHIVXJKWAT-UHFFFAOYSA-N D09OQZ DRUGSMIL C1=CC(=CC(=C1)C2=NC(=CC(=N2)C(F)(F)F)C3=CC=C(S3)Cl)C4=CC(=CC=C4)S(=O)(=O)N D09OQZ HIGHSTAT Patented D09PGW DRUG__ID D09PGW D09PGW DRUGTYPE Small molecular drug D09PGW DRUGINCH 1S/C23H24FN5O4/c24-16-17(25)15-19-21(18(16)28-10-9-27-14-4-1-2-8-26-14)33-11-7-23(5-3-6-23)29(19)12-13(20(15)30)22(31)32/h1-2,4,8,12,28H,3,5-7,9-11,25H2,(H,26,27)(H,31,32) D09PGW DRUGINKE FBGUGRUHZTVCSL-UHFFFAOYSA-N D09PGW DRUGSMIL C1CC2(C1)CCOC3=C4N2C=C(C(=O)C4=C(C(=C3NCCNC5=CC=CC=N5)F)N)C(=O)O D09PGW HIGHSTAT Patented D09PGW COMPCLAS Spiroquinolone derivatives D09PQQ DRUG__ID D09PQQ D09PQQ DRUGCOMP EPIZYME, INC D09PQQ DRUGTYPE Small molecular drug D09PQQ DRUGINCH 1S/C25H31N3O4/c1-15-13-22(31-4)20(24(29)27-15)14-26-25(30)23-17(3)28(21-8-6-5-7-19(21)23)16(2)18-9-11-32-12-10-18/h5-8,13,16,18H,9-12,14H2,1-4H3,(H,26,30)(H,27,29) D09PQQ DRUGINKE PFPSFENQCNMITC-UHFFFAOYSA-N D09PQQ DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCOCC4)C)OC D09PQQ HIGHSTAT Patented D09QCB DRUG__ID D09QCB D09QCB DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED RUPRAH, Parminder, Kaur MERCHANT, Kevin, John WALSH, Louise, Marie KERR, Catrina, Morven FIELDHOUSE, Charlotte HARRISSON, David MAINE, Stephanie HAZEL, Katherine D09QCB DRUGTYPE Small molecular drug D09QCB DRUGINCH 1S/C23H33NO2/c1-26-22-9-13-23(25,14-10-22)20-7-5-18(6-8-20)17-19-11-15-24(16-12-19)21-3-2-4-21/h5-8,17,21-22,25H,2-4,9-16H2,1H3 D09QCB DRUGINKE PTJSNMGOBXREIH-UHFFFAOYSA-N D09QCB DRUGSMIL COC1CCC(CC1)(C2=CC=C(C=C2)C=C3CCN(CC3)C4CCC4)O D09QCB HIGHSTAT Patented D09QKG DRUG__ID D09QKG D09QKG DRUGCOMP F. HOFFMANN-LA ROCHE AG D09QKG DRUGTYPE Small molecular drug D09QKG DRUGINCH 1S/C27H23ClN2O5/c1-35-27(34)24-22(15-17-7-9-18(10-8-17)26(33)29-13-14-31)25(32)21-12-11-19(28)16-23(21)30(24)20-5-3-2-4-6-20/h2-12,16,31H,13-15H2,1H3,(H,29,33) D09QKG DRUGINKE STNCBMGTCZRJPA-UHFFFAOYSA-N D09QKG DRUGSMIL COC(=O)C1=C(C(=O)C2=C(N1C3=CC=CC=C3)C=C(C=C2)Cl)CC4=CC=C(C=C4)C(=O)NCCO D09QKG HIGHSTAT Patented D09QNH DRUG__ID D09QNH D09QNH DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D09QNH DRUGTYPE Small molecular drug D09QNH DRUGINCH 1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13) D09QNH DRUGINKE YAPQBXQYLJRXSA-UHFFFAOYSA-N D09QNH DRUGSMIL CN1C=NC2=C1C(=O)NC(=O)N2C D09QNH HIGHSTAT Patented D09QXC DRUG__ID D09QXC D09QXC DRUGCOMP Japan Tobacco, Inc D09QXC DRUGTYPE Small molecular drug D09QXC DRUGINCH 1S/C21H15Cl2F3N4O2/c22-15-8-3-12(20(32)29-14-6-4-13(5-7-14)21(24,25)26)10-17(15)30(11-18(27)31)19-16(23)2-1-9-28-19/h1-10H,11H2,(H2,27,31)(H,29,32) D09QXC DRUGINKE LLVCZHNGUDERCY-UHFFFAOYSA-N D09QXC DRUGSMIL C1=CC(=C(N=C1)N(CC(=O)N)C2=C(C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(F)(F)F)Cl)Cl D09QXC HIGHSTAT Patented D09REZ DRUG__ID D09REZ D09REZ DRUGCOMP Janssen Pharmaceutica D09REZ DRUGTYPE Small molecular drug D09REZ DRUGINCH 1S/C20H15ClF4N6O/c21-15-12(4-2-5-13(15)20(23,24)25)19(32)31-11-3-1-6-14(31)17-28-29-18(30(17)9-11)16-26-7-10(22)8-27-16/h2,4-5,7-8,11,14H,1,3,6,9H2/t11-,14+/m1/s1 D09REZ DRUGINKE OKEUHBTYCIUVSL-RISCZKNCSA-N D09REZ DRUGSMIL C1CC2CN3C(=NN=C3C4=NC=C(C=N4)F)C(C1)N2C(=O)C5=C(C(=CC=C5)C(F)(F)F)Cl D09REZ HIGHSTAT Patented D09RTV DRUG__ID D09RTV D09RTV DRUGCOMP Takeda Pharmaceutical Co. Ltd D09RTV DRUGTYPE Small molecular drug D09RTV DRUGINCH 1S/C18H11F3N4O2/c19-18(20,21)11-6-13(15-8-22-10-27-15)16-23-7-14(25(16)9-11)17(26)24-12-4-2-1-3-5-12/h1-10H,(H,24,26) D09RTV DRUGINKE SNIXWKGBBMUCPJ-UHFFFAOYSA-N D09RTV DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CN=C3N2C=C(C=C3C4=CN=CO4)C(F)(F)F D09RTV HIGHSTAT Patented D09SMA DRUG__ID D09SMA D09SMA DRUGCOMP Sanofi-Aventis D09SMA DRUGTYPE Small molecular drug D09SMA DRUGINCH 1S/C25H20FN5O/c26-18-3-5-21-17(12-18)13-23(31(21)15-16-7-9-27-10-8-16)25(32)28-19-4-6-22-20(14-19)29-24-2-1-11-30(22)24/h3-10,12-14H,1-2,11,15H2,(H,28,32) D09SMA DRUGINKE GBRKESHSZHLQFC-UHFFFAOYSA-N D09SMA DRUGSMIL C1CC2=NC3=C(N2C1)C=CC(=C3)NC(=O)C4=CC5=C(N4CC6=CC=NC=C6)C=CC(=C5)F D09SMA HIGHSTAT Patented D09STY DRUG__ID D09STY D09STY DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED RUPRAH, Parminder, Kaur MERCHANT, Kevin, John WALSH, Louise, Marie KERR, Catrina, Morven FIELDHOUSE, Charlotte HARRISSON, David MAINE, Stephanie HAZEL, Katherine D09STY DRUGTYPE Small molecular drug D09STY DRUGINCH 1S/C24H35NO2/c1-27-23-11-14-24(26,15-12-23)21-9-7-20(8-10-21)18-19-4-3-16-25(17-13-19)22-5-2-6-22/h7-10,18,22-23,26H,2-6,11-17H2,1H3/b19-18+ D09STY DRUGINKE CVCLZBKTZVQEGU-VHEBQXMUSA-N D09STY DRUGSMIL COC1CCC(CC1)(C2=CC=C(C=C2)C=C3CCCN(CC3)C4CCC4)O D09STY HIGHSTAT Patented D09SYX DRUG__ID D09SYX D09SYX DRUGCOMP BOSTON BIOMEDICAL, INC. JIANG, Zhiwei LI, Chiang, Jia LI, Wei LEGGETT, David D09SYX DRUGTYPE Small molecular drug D09SYX DRUGINCH 1S/C19H10O4S/c20-13-8-4-7-11-15(13)18(23)19-12(17(11)22)9-14(24-19)16(21)10-5-2-1-3-6-10/h1-9,20H D09SYX DRUGINKE FLMLYZNKLBTMFK-UHFFFAOYSA-N D09SYX DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC3=C(S2)C(=O)C4=C(C3=O)C=CC=C4O D09SYX HIGHSTAT Patented D09UNF DRUG__ID D09UNF D09UNF DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE D09UNF DRUGTYPE Small molecular drug D09UNF DRUGINCH 1S/C16H11N3/c17-9-13(8-12-4-3-7-18-10-12)15-11-19-16-6-2-1-5-14(15)16/h1-8,10-11,19H/b13-8+ D09UNF DRUGINKE YMYYQRZCCKBFBE-MDWZMJQESA-N D09UNF DRUGSMIL C1=CC=C2C(=C1)C(=CN2)C(=CC3=CN=CC=C3)C#N D09UNF HIGHSTAT Patented D09UVF DRUG__ID D09UVF D09UVF DRUGCOMP H. LUNDBECK A/S D09UVF DRUGTYPE Small molecular drug D09UVF DRUGINCH 1S/C21H21N3O/c25-19(18-7-2-4-15-23-18)24-21-10-5-9-20(16-21,12-13-21)11-8-17-6-1-3-14-22-17/h1-4,6-7,14-15H,5,9-10,12-13,16H2,(H,24,25)/t20-,21+/m1/s1 D09UVF DRUGINKE ISUZZRVMDCKBEJ-RTWAWAEBSA-N D09UVF DRUGSMIL C1CC2(CCC(C1)(C2)NC(=O)C3=CC=CC=N3)C#CC4=CC=CC=N4 D09UVF HIGHSTAT Patented D09VAX DRUG__ID D09VAX D09VAX DRUGCOMP AVILA THERAPEUTICS, INC. PETTER, Russell C. JEWELL, Charles F. LEE, Kwangho MEDIKONDA, Aravind Prasad NIU, Deqiang QIAO, Lixin SINGH, Juswinder ZHU, Zhendong D09VAX DRUGTYPE Small molecular drug D09VAX DRUGINCH 1S/C25H35N5O4/c1-4-22(31)28-18-9-7-8-17(14-18)15-27-24(33)21-13-12-19-10-5-6-11-20(25(34)30(19)21)29-23(32)16(2)26-3/h4,7-9,14,16,19-21,26H,1,5-6,10-13,15H2,2-3H3,(H,27,33)(H,28,31)(H,29,32)/t16-,19-,20-,21-/m0/s1 D09VAX DRUGINKE KIYJPROOFKKHPR-FIRPJDEBSA-N D09VAX DRUGSMIL CC(C(=O)NC1CCCCC2CCC(N2C1=O)C(=O)NCC3=CC(=CC=C3)NC(=O)C=C)NC D09VAX HIGHSTAT Patented D09VDQ DRUG__ID D09VDQ D09VDQ DRUGTYPE Small molecular drug D09VDQ DRUGINCH 1S/C51H36F6N10O5/c1-29-40(44-17-19-62-66(44)35-13-9-31(25-58)10-14-35)23-42(48(71)64(29)37-7-3-5-33(21-37)50(52,53)54)46(69)60-27-39(68)28-61-47(70)43-24-41(45-18-20-63-67(45)36-15-11-32(26-59)12-16-36)30(2)65(49(43)72)38-8-4-6-34(22-38)51(55,56)57/h3-24,39,68H,27-28H2,1-2H3,(H,60,69)(H,61,70) D09VDQ DRUGINKE KYPHYLQIJUHQAO-UHFFFAOYSA-N D09VDQ DRUGSMIL CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC(CNC(=O)C3=CC(=C(N(C3=O)C4=CC=CC(=C4)C(F)(F)F)C)C5=CC=NN5C6=CC=C(C=C6)C#N)O)C7=CC=NN7C8=CC=C(C=C8)C#N D09VDQ HIGHSTAT Patented D09VDQ COMPCLAS Pyrimidinone derivatives D09VNK DRUG__ID D09VNK D09VNK DRUGCOMP Merz Pharma GmbH & Co KGaA D09VNK DRUGTYPE Small molecular drug D09VNK DRUGINCH 1S/C20H18N4O/c1-23(2)20(25)24-9-8-19-18(14-24)11-17(13-22-19)7-6-15-4-3-5-16(10-15)12-21/h3-5,10-11,13H,8-9,14H2,1-2H3 D09VNK DRUGINKE TUOMBETVTQCJRF-UHFFFAOYSA-N D09VNK DRUGSMIL CN(C)C(=O)N1CCC2=C(C1)C=C(C=N2)C#CC3=CC(=CC=C3)C#N D09VNK HIGHSTAT Patented D09WKF DRUG__ID D09WKF D09WKF DRUGCOMP NOVARTIS AG FURET, Pascal GROTZFELD, Robert Martin JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas MOUSSAOUI, Saliha PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph JAHNKE, Wolfgang D09WKF DRUGTYPE Small molecular drug D09WKF DRUGINCH 1S/C17H10Cl2F2N4O2/c18-15-14(11-6-22-9-23-7-11)5-10(8-24-15)16(26)25-12-1-3-13(4-2-12)27-17(19,20)21/h1-9H,(H,25,26) D09WKF DRUGINKE BHFPNMRGSVUFLM-UHFFFAOYSA-N D09WKF DRUGSMIL C1=CC(=CC=C1NC(=O)C2=CC(=C(N=C2)Cl)C3=CN=CN=C3)OC(F)(F)Cl D09WKF HIGHSTAT Patented D09WTI DRUG__ID D09WTI D09WTI DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D09WTI DRUGTYPE Small molecular drug D09WTI DRUGINCH 1S/C24H27FN8/c1-32(2)12-10-27-23-6-4-20(15-29-23)30-24-28-9-7-21(31-24)17-3-5-22(18(13-17)14-26)33-11-8-19(25)16-33/h3-7,9,13,15,19H,8,10-12,16H2,1-2H3,(H,27,29)(H,28,30,31) D09WTI DRUGINKE NGQHJZXAWIBXQH-UHFFFAOYSA-N D09WTI DRUGSMIL CN(C)CCNC1=NC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)N4CCC(C4)F)C#N D09WTI HIGHSTAT Patented D09WXH DRUG__ID D09WXH D09WXH DRUGCOMP F. HOFFMANN-LA ROCHE AF. Hoffmann-La Roche AG D09WXH DRUGTYPE Small molecular drug D09WXH DRUGINCH 1S/C16H14N2O/c1-11-7-8-13-15(9-11)18-16(19)10-14(17-13)12-5-3-2-4-6-12/h2-9H,10H2,1H3,(H,18,19) D09WXH DRUGINKE SCWDIXHHIUWDED-UHFFFAOYSA-N D09WXH DRUGSMIL CC1=CC2=C(C=C1)N=C(CC(=O)N2)C3=CC=CC=C3 D09WXH HIGHSTAT Patented D09XUJ DRUG__ID D09XUJ D09XUJ DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D09XUJ DRUGTYPE Small molecular drug D09XUJ DRUGINCH 1S/C21H18N4O3/c26-18-12-11-16(22-25(18)14-6-10-19(27)28)20-17-9-4-5-13-24(17)23-21(20)15-7-2-1-3-8-15/h1-5,7-9,11-13H,6,10,14H2,(H,27,28) D09XUJ DRUGINKE FKJPZJACCBMNKZ-UHFFFAOYSA-N D09XUJ DRUGSMIL C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=NN(C(=O)C=C4)CCCC(=O)O D09XUJ HIGHSTAT Patented D09YFD DRUG__ID D09YFD D09YFD DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher Joseph ROSE, Nathan SEKIRNIK, Rok D09YFD DRUGTYPE Small molecular drug D09YFD DRUGINCH 1S/C6H5ClSe/c7-8-6-4-2-1-3-5-6/h1-5H D09YFD DRUGINKE WJCXADMLESSGRI-UHFFFAOYSA-N D09YFD DRUGSMIL C1=CC=C(C=C1)[Se]Cl D09YFD HIGHSTAT Patented D09YKI DRUG__ID D09YKI D09YKI DRUGTYPE Small molecular drug D09YKI DRUGINCH 1S/C24H27NO5/c26-17-2-1-16(20(27)6-17)12-25-23(30)18-7-19(22(29)8-21(18)28)24-9-13-3-14(10-24)5-15(4-13)11-24/h1-2,6-8,13-15,26-29H,3-5,9-12H2,(H,25,30) D09YKI DRUGINKE DHXXJPGHCYCRET-UHFFFAOYSA-N D09YKI DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=C(C(=C4)C(=O)NCC5=C(C=C(C=C5)O)O)O)O D09YKI HIGHSTAT Patented D09YKI COMPCLAS Polyhydroxy benzamide derivatives D09ZAJ DRUG__ID D09ZAJ D09ZAJ DRUGTYPE Small molecular drug D09ZAJ DRUGINCH 1S/C16H23N5O2S/c22-15-13-12-17-16(20-8-10-23-11-9-20)18-14(13)24-21(15)7-6-19-4-2-1-3-5-19/h12H,1-11H2 D09ZAJ DRUGINKE YVQWBBJPPJKQIM-UHFFFAOYSA-N D09ZAJ DRUGSMIL C1CCN(CC1)CCN2C(=O)C3=CN=C(N=C3S2)N4CCOCC4 D09ZAJ HIGHSTAT Patented D09ZAJ COMPCLAS Isothiazolone derivatives D09ZFM DRUG__ID D09ZFM D09ZFM DRUGCOMP NOVARTIS AG FURET, Pascal GROTZFELD, Robert Martin JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas MOUSSAOUI, Saliha PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph JAHNKE, Wolfgang D09ZFM DRUGTYPE Small molecular drug D09ZFM DRUGINCH 1S/C19H14F3N3O2/c1-12-2-3-13(8-17(12)14-9-23-11-24-10-14)18(26)25-15-4-6-16(7-5-15)27-19(20,21)22/h2-11H,1H3,(H,25,26) D09ZFM DRUGINKE CHZIAMJENFGBCI-UHFFFAOYSA-N D09ZFM DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)OC(F)(F)F)C3=CN=CN=C3 D09ZFM HIGHSTAT Patented D09ZWU DRUG__ID D09ZWU D09ZWU DRUGCOMP GRENTHAL GMBH FRANK, Robert BAHRENBERG, Gregor CHRISTOPH, Thomas SCHIENE, Klaus DE VRY, Jean DAMANN, Nils FRORMANN, Sven LESCH, Bernhard LEE, Jeewoo KIM, Yong-Soo KIM, Myeon-Seop D09ZWU DRUGTYPE Small molecular drug D09ZWU DRUGINCH 1S/C21H19ClF4N4O3S/c1-12(13-6-7-18(17(23)8-13)29-34(2,32)33)20(31)27-11-16-10-19(21(24,25)26)28-30(16)15-5-3-4-14(22)9-15/h3-10,12,29H,11H2,1-2H3,(H,27,31)/t12-/m0/s1 D09ZWU DRUGINKE REFSKWWRGFCGDO-LBPRGKRZSA-N D09ZWU DRUGSMIL CC(C1=CC(=C(C=C1)NS(=O)(=O)C)F)C(=O)NCC2=CC(=NN2C3=CC(=CC=C3)Cl)C(F)(F)F D09ZWU HIGHSTAT Patented D0A0RM DRUG__ID D0A0RM D0A0RM DRUGCOMP Boiteau J-G, Barbuis CM, Talano S D0A0RM DRUGTYPE Small molecular drug D0A0RM DRUGINCH 1S/C10H8F2N2OS/c11-9(12)15-7-3-1-6(2-4-7)8-5-13-10(16)14-8/h1-5,9H,(H2,13,14,16) D0A0RM DRUGINKE RSUPNTVGCZRJCF-UHFFFAOYSA-N D0A0RM DRUGSMIL C1=CC(=CC=C1C2=CNC(=S)N2)OC(F)F D0A0RM HIGHSTAT Patented D0A0VH DRUG__ID D0A0VH D0A0VH DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0A0VH DRUGTYPE Small molecular drug D0A0VH DRUGINCH 1S/C23H27ClN2O4/c1-12-7-17(14(3)15-10-30-11-15)21(24)20-16(12)5-6-26(23(20)28)9-18-19(29-4)8-13(2)25-22(18)27/h7-8,14-15H,5-6,9-11H2,1-4H3,(H,25,27) D0A0VH DRUGINKE ZUDMACKBEPQTPV-UHFFFAOYSA-N D0A0VH DRUGSMIL CC1=CC(=C(C2=C1CCN(C2=O)CC3=C(C=C(NC3=O)C)OC)Cl)C(C)C4COC4 D0A0VH HIGHSTAT Patented D0A0YI DRUG__ID D0A0YI D0A0YI DRUGCOMP ABBVIE INC D0A0YI DRUGTYPE Small molecular drug D0A0YI DRUGINCH 1S/C21H21F2N3O3/c1-21(2)10-16(13-6-7-14(22)18(23)19(13)29-21)26-20(28)24-12-5-3-11-4-8-17(27)25-15(11)9-12/h3,5-7,9,16H,4,8,10H2,1-2H3,(H,25,27)(H2,24,26,28)/t16-/m1/s1 D0A0YI DRUGINKE UDVRSQKMFMPYID-MRXNPFEDSA-N D0A0YI DRUGSMIL CC1(CC(C2=C(O1)C(=C(C=C2)F)F)NC(=O)NC3=CC4=C(CCC(=O)N4)C=C3)C D0A0YI HIGHSTAT Patented D0A2NA DRUG__ID D0A2NA D0A2NA DRUGCOMP VIROBAY, INC D0A2NA DRUGTYPE Small molecular drug D0A2NA DRUGINCH 1S/C25H25Cl2F4N3O4/c1-2-18(21(36)24(38)32-15-7-8-15)34-23(37)19(11-12-9-16(26)20(35)17(27)10-12)33-22(25(29,30)31)13-3-5-14(28)6-4-13/h3-6,9-10,15,18-19,22,33,35H,2,7-8,11H2,1H3,(H,32,38)(H,34,37)/t18-,19-,22-/m0/s1 D0A2NA DRUGINKE HNEZRIRYWXIOJA-IPJJNNNSSA-N D0A2NA DRUGSMIL CCC(C(=O)C(=O)NC1CC1)NC(=O)C(CC2=CC(=C(C(=C2)Cl)O)Cl)NC(C3=CC=C(C=C3)F)C(F)(F)F D0A2NA HIGHSTAT Patented D0A2NT DRUG__ID D0A2NT D0A2NT DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED MASADA, Shinichi D0A2NT DRUGTYPE Small molecular drug D0A2NT DRUGINCH 1S/C29H37N3O4/c1-20-26-16-23(18-30-17-21-11-14-34-15-12-21)32(2)28(26)10-9-27(20)31-29(33)22-5-7-24(8-6-22)36-19-25-4-3-13-35-25/h5-10,16,21,25,30H,3-4,11-15,17-19H2,1-2H3,(H,31,33)/t25-/m0/s1 D0A2NT DRUGINKE ODYOYEADBNGJGQ-VWLOTQADSA-N D0A2NT DRUGSMIL CC1=C(C=CC2=C1C=C(N2C)CNCC3CCOCC3)NC(=O)C4=CC=C(C=C4)OCC5CCCO5 D0A2NT HIGHSTAT Patented D0A3XC DRUG__ID D0A3XC D0A3XC DRUGCOMP ABBVIE INC D0A3XC DRUGTYPE Small molecular drug D0A3XC DRUGINCH 1S/C21H22ClFN2O3/c1-21(2)10-17(13-6-7-15(23)18(22)19(13)28-21)25-20(27)24-16-5-3-4-11-8-12(26)9-14(11)16/h3-7,12,17,26H,8-10H2,1-2H3,(H2,24,25,27)/t12-,17-/m1/s1 D0A3XC DRUGINKE NXZOBNXJGCHNTQ-SJKOYZFVSA-N D0A3XC DRUGSMIL CC1(CC(C2=C(O1)C(=C(C=C2)F)Cl)NC(=O)NC3=CC=CC4=C3CC(C4)O)C D0A3XC HIGHSTAT Patented D0A4LL DRUG__ID D0A4LL D0A4LL DRUGCOMP ENANTA PHARMACEUTICALS, INC D0A4LL DRUGTYPE Small molecular drug D0A4LL DRUGINCH 1S/C28H29Cl2N5O5S2/c1-34(2)42(37,38)33-27(36)17-8-9-22-23(14-17)41-28(31-22)35-12-10-18(11-13-35)39-15-19-25(32-40-26(19)16-6-7-16)24-20(29)4-3-5-21(24)30/h3-5,8-9,14,16,18H,6-7,10-13,15H2,1-2H3,(H,33,36) D0A4LL DRUGINKE FJNHJIMGAHRBKJ-UHFFFAOYSA-N D0A4LL DRUGSMIL CN(C)S(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(S2)N3CCC(CC3)OCC4=C(ON=C4C5=C(C=CC=C5Cl)Cl)C6CC6 D0A4LL HIGHSTAT Patented D0A7CE DRUG__ID D0A7CE D0A7CE DRUGCOMP LYTIX BIOPHARMA AS D0A7CE DRUGTYPE Small molecular drug D0A7CE DRUGINCH 1S/C10H10N2O2S/c1-6(13)11-10-12-8-5-7(14-2)3-4-9(8)15-10/h3-5H,1-2H3,(H,11,12,13) D0A7CE DRUGINKE ZKNFVQNHIHCHEW-UHFFFAOYSA-N D0A7CE DRUGSMIL CC(=O)NC1=NC2=C(S1)C=CC(=C2)OC D0A7CE HIGHSTAT Patented D0A7NX DRUG__ID D0A7NX D0A7NX DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0A7NX DRUGTYPE Small molecular drug D0A7NX DRUGINCH 1S/C14H12BrN5O2S/c15-8-6-16-12-5-10(18-20(12)7-8)13(21)19-3-1-9-11(2-4-19)23-14(22)17-9/h5-7H,1-4H2,(H,17,22) D0A7NX DRUGINKE NFUGEPSHTBCNFR-UHFFFAOYSA-N D0A7NX DRUGSMIL C1CN(CCC2=C1NC(=O)S2)C(=O)C3=NN4C=C(C=NC4=C3)Br D0A7NX HIGHSTAT Patented D0A8LU DRUG__ID D0A8LU D0A8LU DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D0A8LU DRUGTYPE Small molecular drug D0A8LU DRUGINCH 1S/C21H20Cl2F3N3O3/c22-17-9-14(1-2-16(17)21(24,25)26)28-20(32)29-5-3-13(4-6-29)19-18(23)8-12(10-27-19)7-15(31)11-30/h1-3,8-10,15,30-31H,4-7,11H2,(H,28,32) D0A8LU DRUGINKE XRTGOKOICCLLQT-UHFFFAOYSA-N D0A8LU DRUGSMIL C1CN(CC=C1C2=C(C=C(C=N2)CC(CO)O)Cl)C(=O)NC3=CC(=C(C=C3)C(F)(F)F)Cl D0A8LU HIGHSTAT Patented D0A8VU DRUG__ID D0A8VU D0A8VU DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED RUPRAH, Parminder, Kaur MERCHANT, Kevin, John WALSH, Louise, Marie KERR, Catrina, Morven FIELDHOUSE, Charlotte HARRISSON, David MAINE, Stephanie HAZEL, Katherine D0A8VU DRUGTYPE Small molecular drug D0A8VU DRUGINCH 1S/C22H31NO/c24-22(19-4-1-2-5-19)20-10-8-17(9-11-20)16-18-12-14-23(15-13-18)21-6-3-7-21/h8-11,16,19,21-22,24H,1-7,12-15H2 D0A8VU DRUGINKE UWSZCEKCJNGAAH-UHFFFAOYSA-N D0A8VU DRUGSMIL C1CCC(C1)C(C2=CC=C(C=C2)C=C3CCN(CC3)C4CCC4)O D0A8VU HIGHSTAT Patented D0A9HR DRUG__ID D0A9HR D0A9HR DRUGCOMP Janssen Pharmaceutica NV D0A9HR DRUGTYPE Small molecular drug D0A9HR DRUGINCH 1S/C14H18N4O/c15-9-10-5-7-18(8-6-10)13-11-3-1-2-4-12(11)14(19)17-16-13/h1-4,10H,5-9,15H2,(H,17,19) D0A9HR DRUGINKE CLUMMMKUUCOEBB-UHFFFAOYSA-N D0A9HR DRUGSMIL C1CN(CCC1CN)C2=NNC(=O)C3=CC=CC=C32 D0A9HR HIGHSTAT Patented D0A9KH DRUG__ID D0A9KH D0A9KH DRUGCOMP Merck Patent GmBH D0A9KH DRUGTYPE Small molecular drug D0A9KH DRUGINCH 1S/C27H39N3O/c1-26(2)12-13-27(3,4)23-20-21(10-11-22(23)26)24-8-7-9-25(28-24)30-17-15-29(16-18-30)14-5-6-19-31/h7-11,20,31H,5-6,12-19H2,1-4H3 D0A9KH DRUGINKE NSOIVUTZXMNIJX-UHFFFAOYSA-N D0A9KH DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C3=NC(=CC=C3)N4CCN(CC4)CCCCO)(C)C)C D0A9KH HIGHSTAT Patented D0AC4P DRUG__ID D0AC4P D0AC4P DRUGTYPE Small molecular drug D0AC4P DRUGINCH 1S/C23H21N3O2/c1-24(19-11-7-4-8-12-19)22(27)16-26-21-15-18(17-9-5-3-6-10-17)13-14-20(21)25(2)23(26)28/h3-15H,16H2,1-2H3 D0AC4P DRUGINKE KWRWRRZPFCLHLS-UHFFFAOYSA-N D0AC4P DRUGSMIL CN1C2=C(C=C(C=C2)C3=CC=CC=C3)N(C1=O)CC(=O)N(C)C4=CC=CC=C4 D0AC4P HIGHSTAT Patented D0AC4P COMPCLAS Benzimidazolone acetamide derivatives D0AE5G DRUG__ID D0AE5G D0AE5G DRUGCOMP Janssen Pharmaceutica NV D0AE5G DRUGTYPE Small molecular drug D0AE5G DRUGINCH 1S/C22H24FN3O3/c23-16-5-7-18(8-6-16)29-14-17(27)13-26-11-9-15(10-12-26)21-19-3-1-2-4-20(19)22(28)25-24-21/h1-8,15,17,27H,9-14H2,(H,25,28) D0AE5G DRUGINKE KVBJGGXSNXZAOH-UHFFFAOYSA-N D0AE5G DRUGSMIL C1CN(CCC1C2=NNC(=O)C3=CC=CC=C32)CC(COC4=CC=C(C=C4)F)O D0AE5G HIGHSTAT Patented D0AE6Y DRUG__ID D0AE6Y D0AE6Y DRUGCOMP UNIVERSITY OF DUNDEE CAMBRIDGE ENTERPRISE LIMITED D0AE6Y DRUGTYPE Small molecular drug D0AE6Y DRUGINCH 1S/C22H21ClN4O3/c1-12(22(28)30-4)19-21-26-25-13(2)27(21)18-10-9-16(29-3)11-17(18)20(24-19)14-5-7-15(23)8-6-14/h5-12,19H,1-4H3/t12-,19+/m1/s1 D0AE6Y DRUGINKE FENXDXHDXYVGRJ-BLVKFPJESA-N D0AE6Y DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2C(C)C(=O)OC)C4=CC=C(C=C4)Cl D0AE6Y HIGHSTAT Patented D0AE8D DRUG__ID D0AE8D D0AE8D DRUGTYPE Small molecular drug D0AE8D DRUGINCH 1S/C13H8ClNO2S/c14-8-2-4-12-9(6-8)15-13(18-12)7-1-3-10(16)11(17)5-7/h1-6,16-17H D0AE8D DRUGINKE XSTUFGUKBUSBMM-UHFFFAOYSA-N D0AE8D DRUGSMIL C1=CC(=C(C=C1C2=NC3=C(S2)C=CC(=C3)Cl)O)O D0AE8D HIGHSTAT Patented D0AE8D COMPCLAS Benzothiazole analogs D0AF7J DRUG__ID D0AF7J D0AF7J DRUGCOMP NTZ LAB LTD [BG] D0AF7J DRUGTYPE Small molecular drug D0AF7J DRUGINCH 1S/C15H11ClFN3O/c1-20-14-5-2-9(6-10(14)8-18-20)15(21)19-11-3-4-13(17)12(16)7-11/h2-8H,1H3,(H,19,21) D0AF7J DRUGINKE ISZVIYGCASWHFG-UHFFFAOYSA-N D0AF7J DRUGSMIL CN1C2=C(C=C(C=C2)C(=O)NC3=CC(=C(C=C3)F)Cl)C=N1 D0AF7J HIGHSTAT Patented D0AJ2T DRUG__ID D0AJ2T D0AJ2T DRUGCOMP REATA PHARMACEUTICALS, INC D0AJ2T DRUGTYPE Small molecular drug D0AJ2T DRUGINCH 1S/C32H43NO5/c1-26(2)11-13-31(25(36)38-8)14-12-30(7)29(6)10-9-20-27(3,4)24(35)19(18-33)16-28(20,5)21(29)15-23(34)32(30,37)22(31)17-26/h15-16,20,22,37H,9-14,17H2,1-8H3/t20-,22?,28-,29+,30-,31-,32+/m0/s1 D0AJ2T DRUGINKE QBHNHKNDTFTWNV-BTIYJVALSA-N D0AJ2T DRUGSMIL CC1(CCC2(CCC3(C4(CCC5C(C(=O)C(=CC5(C4=CC(=O)C3(C2C1)O)C)C#N)(C)C)C)C)C(=O)OC)C D0AJ2T HIGHSTAT Patented D0AJ5T DRUG__ID D0AJ5T D0AJ5T DRUGCOMP LG Life Sciences Ltd D0AJ5T DRUGTYPE Small molecular drug D0AJ5T DRUGINCH 1S/C17H14N4O2/c18-6-12-9-20(8-11-1-2-11)16-4-3-14(5-15(12)16)21-10-13(7-19-21)17(22)23/h3-5,7,9-11H,1-2,8H2,(H,22,23) D0AJ5T DRUGINKE MHZLIWHOFCJYKU-UHFFFAOYSA-N D0AJ5T DRUGSMIL C1CC1CN2C=C(C3=C2C=CC(=C3)N4C=C(C=N4)C(=O)O)C#N D0AJ5T HIGHSTAT Patented D0AK6L DRUG__ID D0AK6L D0AK6L DRUGCOMP PROXIMAGEN LIMITED D0AK6L DRUGTYPE Small molecular drug D0AK6L DRUGINCH 1S/C23H24N4O3S/c1-27(2)31(29,30)21-9-4-3-8-20(21)18-6-5-7-19(14-18)23(28)26-15-16-10-12-17(13-11-16)22(24)25/h3-14H,15H2,1-2H3,(H3,24,25)(H,26,28) D0AK6L DRUGINKE PJHSDMZESVNZHU-UHFFFAOYSA-N D0AK6L DRUGSMIL CN(C)S(=O)(=O)C1=CC=CC=C1C2=CC(=CC=C2)C(=O)NCC3=CC=C(C=C3)C(=N)N D0AK6L HIGHSTAT Patented D0AQ3U DRUG__ID D0AQ3U D0AQ3U DRUGCOMP Amorepacific Corp D0AQ3U DRUGTYPE Small molecular drug D0AQ3U DRUGINCH 1S/C22H16F8N2O4S/c1-10(11-7-15(23)19(16(24)8-11)32-37(2,34)35)31-20(33)18-4-3-17(36-18)12-5-13(21(25,26)27)9-14(6-12)22(28,29)30/h3-10,32H,1-2H3,(H,31,33)/t10-/m1/s1 D0AQ3U DRUGINKE RGPMLUVMZUYQEJ-SNVBAGLBSA-N D0AQ3U DRUGSMIL CC(C1=CC(=C(C(=C1)F)NS(=O)(=O)C)F)NC(=O)C2=CC=C(O2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0AQ3U HIGHSTAT Patented D0AR5O DRUG__ID D0AR5O D0AR5O DRUGCOMP University of Virginia Patent Foundation D0AR5O DRUGTYPE Small molecular drug D0AR5O DRUGINCH 1S/C22H41N3O2/c23-20(24)22(14-15-22)21(26)25-16-10-5-3-1-2-4-6-11-17-27-18-19-12-8-7-9-13-19/h19H,1-18H2,(H3,23,24)(H,25,26) D0AR5O DRUGINKE DCHHZPQOGYUREG-UHFFFAOYSA-N D0AR5O DRUGSMIL C1CCC(CC1)COCCCCCCCCCCNC(=O)C2(CC2)C(=N)N D0AR5O HIGHSTAT Patented D0AT0A DRUG__ID D0AT0A D0AT0A DRUGCOMP MERCK SHARP & DOHME CORP. BARROW, James, C. BILODEAU, Mark, T. COX, Christopher, D. HARTNETT, John, C. KETT, Nathan, R. LI, Yiwei MANLEY, Peter MELAMED, Jeffrey SHIPE, William, D. TROTTER, B. Wesley ZARTMAN, Amy, E D0AT0A DRUGTYPE Small molecular drug D0AT0A DRUGINCH 1S/C30H44N4O2/c1-31-17-19-34(20-18-31)30(15-9-4-10-16-30)23-33(29(36)24-11-5-3-6-12-24)22-26-21-25-13-7-8-14-27(25)32(2)28(26)35/h7-8,13-14,21,24H,3-6,9-12,15-20,22-23H2,1-2H3 D0AT0A DRUGINKE PJVMTTZJMVQBDL-UHFFFAOYSA-N D0AT0A DRUGSMIL CN1CCN(CC1)C2(CCCCC2)CN(CC3=CC4=CC=CC=C4N(C3=O)C)C(=O)C5CCCCC5 D0AT0A HIGHSTAT Patented D0AU8E DRUG__ID D0AU8E D0AU8E DRUGCOMP Kissei Pharmaceutical Co. Ltd D0AU8E DRUGTYPE Small molecular drug D0AU8E DRUGINCH 1S/C17H11N3O2/c18-9-14-10-20(11-15(14)12-4-2-1-3-5-12)16-8-13(17(21)22)6-7-19-16/h1-8,10-11H,(H,21,22) D0AU8E DRUGINKE XMNOTSLRNISRFW-UHFFFAOYSA-N D0AU8E DRUGSMIL C1=CC=C(C=C1)C2=CN(C=C2C#N)C3=NC=CC(=C3)C(=O)O D0AU8E HIGHSTAT Patented D0AW3F DRUG__ID D0AW3F D0AW3F DRUGCOMP CORNELL UNIVERSITY D0AW3F DRUGTYPE Small molecular drug D0AW3F DRUGINCH 1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-15(7-10-17(18)21)19(24)23-16-8-5-14(6-9-16)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26) D0AW3F DRUGINKE SZWKGOZKRMMLAJ-UHFFFAOYSA-N D0AW3F DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)(C)C)C D0AW3F HIGHSTAT Patented D0B0WJ DRUG__ID D0B0WJ D0B0WJ DRUGCOMP GRUENENTHAL GMBH [DE] D0B0WJ DRUGTYPE Small molecular drug D0B0WJ DRUGINCH 1S/C25H29ClN4O2/c1-25(2,3)23-13-19(30(29-23)18-8-5-7-17(26)12-18)15-27-24(32)28-22-9-4-6-16-10-11-20(31)14-21(16)22/h5,7-8,10-14,22,31H,4,6,9,15H2,1-3H3,(H2,27,28,32) D0B0WJ DRUGINKE RUCBWZCSOLTLOQ-UHFFFAOYSA-N D0B0WJ DRUGSMIL CC(C)(C)C1=NN(C(=C1)CNC(=O)NC2CCCC3=C2C=C(C=C3)O)C4=CC(=CC=C4)Cl D0B0WJ HIGHSTAT Patented D0B3CG DRUG__ID D0B3CG D0B3CG DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0B3CG DRUGTYPE Small molecular drug D0B3CG DRUGINCH 1S/C15H14ClN5OS/c1-9-18-11-2-4-20(5-3-13(11)23-9)15(22)12-6-14-17-7-10(16)8-21(14)19-12/h6-8H,2-5H2,1H3 D0B3CG DRUGINKE WOOXFLPCMNOANB-UHFFFAOYSA-N D0B3CG DRUGSMIL CC1=NC2=C(S1)CCN(CC2)C(=O)C3=NN4C=C(C=NC4=C3)Cl D0B3CG HIGHSTAT Patented D0B3QI DRUG__ID D0B3QI D0B3QI DRUGTYPE Small molecular drug D0B3QI DRUGINCH 1S/C20H16F2N6O/c1-28-19(24-9-25-28)17-14(10-2-4-11(21)5-3-10)8-23-15-7-12(22)6-13-16(15)18(17)26-27-20(13)29/h2-7,9,14,17,23H,8H2,1H3,(H,27,29) D0B3QI DRUGINKE BGMPCZSIPWMURU-UHFFFAOYSA-N D0B3QI DRUGSMIL CN1C(=NC=N1)C2C(CNC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F D0B3QI HIGHSTAT Patented D0B3QI COMPCLAS Dihydropyrido phthalazinone derivatives D0B4IH DRUG__ID D0B4IH D0B4IH DRUGCOMP F. HOFFMANN-LA ROCHE AG BOICE, Genevieve N. GONG, Leyi MCCALEB, Kristen Lynn PALMER, Wylie Solang D0B4IH DRUGTYPE Small molecular drug D0B4IH DRUGINCH 1S/C17H24N4O2/c1-12(9-10-22)21-15(23)8-7-13-11-18-17(20-16(13)21)19-14-5-3-2-4-6-14/h7-8,11-12,14,22H,2-6,9-10H2,1H3,(H,18,19,20) D0B4IH DRUGINKE WWOJIYPDCCGHSL-UHFFFAOYSA-N D0B4IH DRUGSMIL CC(CCO)N1C(=O)C=CC2=CN=C(N=C21)NC3CCCCC3 D0B4IH HIGHSTAT Patented D0B4IU DRUG__ID D0B4IU D0B4IU DRUGCOMP Merz Pharma GmbH & Co KGaA D0B4IU DRUGTYPE Small molecular drug D0B4IU DRUGINCH 1S/C19H21N3O/c1-19(2)10-16-15(17(11-19)23-3)9-13(12-21-16)7-8-14-5-4-6-18(20)22-14/h4-6,9,12,17H,10-11H2,1-3H3,(H2,20,22) D0B4IU DRUGINKE MVVPJGFFGSEZEE-UHFFFAOYSA-N D0B4IU DRUGSMIL CC1(CC(C2=C(C1)N=CC(=C2)C#CC3=NC(=CC=C3)N)OC)C D0B4IU HIGHSTAT Patented D0B4NI DRUG__ID D0B4NI D0B4NI DRUGCOMP Japan Tobacco, Inc D0B4NI DRUGTYPE Small molecular drug D0B4NI DRUGINCH 1S/C26H28Cl2N4O4/c1-16(2)15-36-23-9-7-18(14-19(23)26(35)29-3)31-25(34)17-6-8-20(27)22(13-17)32(11-12-33)24-21(28)5-4-10-30-24/h4-10,13-14,16,33H,11-12,15H2,1-3H3,(H,29,35)(H,31,34) D0B4NI DRUGINKE VOVIFBICMYYQQM-UHFFFAOYSA-N D0B4NI DRUGSMIL CC(C)COC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)Cl)N(CCO)C3=C(C=CC=N3)Cl)C(=O)NC D0B4NI HIGHSTAT Patented D0B4TX DRUG__ID D0B4TX D0B4TX DRUGCOMP PFIZER INC D0B4TX DRUGTYPE Small molecular drug D0B4TX DRUGINCH 1S/C22H21Cl2N3O4/c1-10-7-17(30-4)15(21(28)25-10)9-27-6-5-13-16(23)8-14(20(24)19(13)22(27)29)18-11(2)26-31-12(18)3/h7-8H,5-6,9H2,1-4H3,(H,25,28) D0B4TX DRUGINKE HCXPMZKLLCLZQX-UHFFFAOYSA-N D0B4TX DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C4=C(ON=C4C)C)Cl)OC D0B4TX HIGHSTAT Patented D0B5QZ DRUG__ID D0B5QZ D0B5QZ DRUGCOMP Kissei Pharmaceutical Co. Ltd D0B5QZ DRUGTYPE Small molecular drug D0B5QZ DRUGINCH 1S/C16H10N2O4/c17-7-10-8-18(9-13(10)15-2-1-5-22-15)11-3-4-12(16(20)21)14(19)6-11/h1-6,8-9,19H,(H,20,21) D0B5QZ DRUGINKE ZWZQFNSOFGQISH-UHFFFAOYSA-N D0B5QZ DRUGSMIL C1=COC(=C1)C2=CN(C=C2C#N)C3=CC(=C(C=C3)C(=O)O)O D0B5QZ HIGHSTAT Patented D0B6KC DRUG__ID D0B6KC D0B6KC DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED AQUILA, Brian HENNESSY, Edward HIRD, Alexander OZA, Vibha SAEH, Jamal Carlos SHA, Li D0B6KC DRUGTYPE Small molecular drug D0B6KC DRUGINCH 1S/C58H78N8O8/c1-37(59-3)53(67)61-49(39-21-9-7-10-22-39)57(71)65-31-19-29-45(65)55(69)63-51-43-27-15-13-25-41(43)35-47(51)73-33-17-5-6-18-34-74-48-36-42-26-14-16-28-44(42)52(48)64-56(70)46-30-20-32-66(46)58(72)50(40-23-11-8-12-24-40)62-54(68)38(2)60-4/h13-16,25-28,37-40,45-52,59-60H,7-12,19-24,29-36H2,1-4H3,(H,61,67)(H,62,68)(H,63,69)(H,64,70)/t37-,38-,45-,46-,47+,48+,49-,50-,51-,52-/m0/s1 D0B6KC DRUGINKE WLMCRYCCYXHPQF-ZVMUOSSASA-N D0B6KC DRUGSMIL CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C(=O)NC3C(CC4=CC=CC=C34)OCC#CC#CCOC5CC6=CC=CC=C6C5NC(=O)C7CCCN7C(=O)C(C8CCCCC8)NC(=O)C(C)NC)NC D0B6KC HIGHSTAT Patented D0B7CW DRUG__ID D0B7CW D0B7CW DRUGCOMP BIAL-Portela & Ca., S.A D0B7CW DRUGTYPE Small molecular drug D0B7CW DRUGINCH 1S/C17H15F2N3O5/c1-24-6-7-25-15-9-11(3-4-13(15)20)22-17(23)27-16(21-22)26-14-5-2-10(18)8-12(14)19/h2-5,8-9H,6-7,20H2,1H3 D0B7CW DRUGINKE AYJCMQZJZQQNKN-UHFFFAOYSA-N D0B7CW DRUGSMIL COCCOC1=C(C=CC(=C1)N2C(=O)OC(=N2)OC3=C(C=C(C=C3)F)F)N D0B7CW HIGHSTAT Patented D0B7KM DRUG__ID D0B7KM D0B7KM DRUGCOMP AstraZeneca D0B7KM DRUGTYPE Small molecular drug D0B7KM DRUGINCH 1S/C23H30ClN3O3/c1-15-3-2-10-23(30,13-15)14-25-22(29)21-17-4-7-20(26-19(17)6-5-18(21)24)27-11-8-16(28)9-12-27/h4-7,15-16,28,30H,2-3,8-14H2,1H3,(H,25,29)/t15-,23-/m0/s1 D0B7KM DRUGINKE BAHOQKHEWZJWME-WNSKOXEYSA-N D0B7KM DRUGSMIL CC1CCCC(C1)(CNC(=O)C2=C(C=CC3=C2C=CC(=N3)N4CCC(CC4)O)Cl)O D0B7KM HIGHSTAT Patented D0B7LR DRUG__ID D0B7LR D0B7LR DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0B7LR DRUGTYPE Small molecular drug D0B7LR DRUGINCH 1S/C32H27F6N7O2/c1-20-6-11-23(12-7-20)39-30(46)40-27-18-22(25-4-2-3-5-26(25)29-41-43-44-42-29)10-15-28(27)45(17-16-31(33,34)35)19-21-8-13-24(14-9-21)47-32(36,37)38/h2-15,18H,16-17,19H2,1H3,(H2,39,40,46)(H,41,42,43,44) D0B7LR DRUGINKE ZBBKUFMLKWFYDD-UHFFFAOYSA-N D0B7LR DRUGSMIL CC1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)C3=CC=CC=C3C4=NNN=N4)N(CCC(F)(F)F)CC5=CC=C(C=C5)OC(F)(F)F D0B7LR HIGHSTAT Patented D0BI1O DRUG__ID D0BI1O D0BI1O DRUGCOMP WASHINGTON UNIVERSITY D0BI1O DRUGTYPE Small molecular drug D0BI1O DRUGINCH 1S/C53H67N7O7/c1-4-65-49-19-10-9-18-47(49)60-50(55-45-17-8-7-16-44(45)52(60)62)36-57-28-30-58(31-29-57)51(61)37-66-42-23-21-39(22-24-42)35-54-26-11-5-6-12-27-59-40-14-13-15-41(59)34-43(33-40)67-53(63)56-46-32-38(2)20-25-48(46)64-3/h7-10,16-25,32,40-41,43,54H,4-6,11-15,26-31,33-37H2,1-3H3,(H,56,63) D0BI1O DRUGINKE NMJRVPZKOISERX-UHFFFAOYSA-N D0BI1O DRUGSMIL CCOC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)CN4CCN(CC4)C(=O)COC5=CC=C(C=C5)CNCCCCCCN6C7CCCC6CC(C7)OC(=O)NC8=C(C=CC(=C8)C)OC D0BI1O HIGHSTAT Patented D0BJ6M DRUG__ID D0BJ6M D0BJ6M DRUGCOMP SYNTECH SOLUTION LLC CHEN, Yongsheng D0BJ6M DRUGTYPE Small molecular drug D0BJ6M DRUGINCH 1S/C30H24F3N7O/c1-18-4-5-20(11-26(18)39-29-35-10-8-25(38-29)21-3-2-9-34-15-21)28(41)37-23-12-22(30(31,32)33)13-24(14-23)40-16-27(36-17-40)19-6-7-19/h2-5,8-17,19H,6-7H2,1H3,(H,37,41)(H,35,38,39) D0BJ6M DRUGINKE GKVZSPCAKFODTN-UHFFFAOYSA-N D0BJ6M DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C4CC4)NC5=NC=CC(=N5)C6=CN=CC=C6 D0BJ6M HIGHSTAT Patented D0BK6R DRUG__ID D0BK6R D0BK6R DRUGCOMP NOVARTIS AG FURET, Pascal GROTZFELD, Robert Martin JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas MOUSSAOUI, Saliha PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph JAHNKE, Wolfgang D0BK6R DRUGTYPE Small molecular drug D0BK6R DRUGINCH 1S/C18H14F3N3O2/c1-12-2-3-13(10-16(12)24-9-8-22-11-24)17(25)23-14-4-6-15(7-5-14)26-18(19,20)21/h2-11H,1H3,(H,23,25) D0BK6R DRUGINKE VTOBGTLKLODAIL-UHFFFAOYSA-N D0BK6R DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)OC(F)(F)F)N3C=CN=C3 D0BK6R HIGHSTAT Patented D0BP8I DRUG__ID D0BP8I D0BP8I DRUGCOMP THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE D0BP8I DRUGTYPE Small molecular drug D0BP8I DRUGINCH 1S/C25H35N7O3/c1-32-17-26-23-22(32)24(27-18-9-5-4-6-10-18)30-25(29-23)28-19-12-14-20(15-13-19)35-16-8-3-2-7-11-21(33)31-34/h12-15,17-18,34H,2-11,16H2,1H3,(H,31,33)(H2,27,28,29,30) D0BP8I DRUGINKE RYYJQDSPRGRHMH-UHFFFAOYSA-N D0BP8I DRUGSMIL CN1C=NC2=C1C(=NC(=N2)NC3=CC=C(C=C3)OCCCCCCC(=O)NO)NC4CCCCC4 D0BP8I HIGHSTAT Patented D0BR7G DRUG__ID D0BR7G D0BR7G DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PFAU, Roland ARNDT, Kirsten DOODS, Henri HAUEL, Norbert KLINDER, Klaus KUELZER, Raimund D0BR7G DRUGTYPE Small molecular drug D0BR7G DRUGINCH 1S/C20H13Cl2F3N6O/c1-31-15-9-27-14(18(32)29-16-7-10(5-6-26-16)20(23,24)25)8-13(15)28-19(31)30-17-11(21)3-2-4-12(17)22/h2-9H,1H3,(H,28,30)(H,26,29,32) D0BR7G DRUGINKE STCXSHUPLPUMJZ-UHFFFAOYSA-N D0BR7G DRUGSMIL CN1C2=CN=C(C=C2N=C1NC3=C(C=CC=C3Cl)Cl)C(=O)NC4=NC=CC(=C4)C(F)(F)F D0BR7G HIGHSTAT Patented D0BT6Y DRUG__ID D0BT6Y D0BT6Y DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0BT6Y DRUGTYPE Small molecular drug D0BT6Y DRUGINCH 1S/C39H46N6O4/c1-8-25(3)45-23-24(2)35-31(36(46)41-22-32-30-12-10-9-11-29(30)26(4)42-37(32)47)19-28(20-33(35)45)27-13-14-34(40-21-27)43-15-17-44(18-16-43)38(48)49-39(5,6)7/h9-14,19-21,23,25H,8,15-18,22H2,1-7H3,(H,41,46)(H,42,47) D0BT6Y DRUGINKE LTHICEHOVQKREU-UHFFFAOYSA-N D0BT6Y DRUGSMIL CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCN(CC4)C(=O)OC(C)(C)C)C(=O)NCC5=C6C=CC=CC6=C(NC5=O)C)C D0BT6Y HIGHSTAT Patented D0C1MZ DRUG__ID D0C1MZ D0C1MZ DRUGCOMP ABBVIE INC D0C1MZ DRUGTYPE Small molecular drug D0C1MZ DRUGINCH 1S/C22H22FN3O/c1-14-11-19-17(13-24-14)8-10-20(23)21(19)26-22(27)25-18-9-7-16(12-18)15-5-3-2-4-6-15/h2-6,8,10-11,13,16,18H,7,9,12H2,1H3,(H2,25,26,27)/t16-,18-/m1/s1 D0C1MZ DRUGINKE BLFYIBROKHRKEJ-SJLPKXTDSA-N D0C1MZ DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC=CC=C4)F)C=N1 D0C1MZ HIGHSTAT Patented D0C1PB DRUG__ID D0C1PB D0C1PB DRUGCOMP Guangdong Hospital of Traditional Chinese Medicine D0C1PB DRUGTYPE Small molecular drug D0C1PB DRUGINCH 1S/C15H20O5/c1-8-4-5-11-9(2)12(16)17-13-15(11)10(8)6-7-14(3,18-13)19-20-15/h8,10-11,13H,2,4-7H2,1,3H3/t8-,10+,11+,13-,14-,15-/m1/s1 D0C1PB DRUGINKE IGEBZMMCKFUABB-KPHNHPKPSA-N D0C1PB DRUGSMIL CC1CCC2C(=C)C(=O)OC3C24C1CCC(O3)(OO4)C D0C1PB HIGHSTAT Patented D0C2QU DRUG__ID D0C2QU D0C2QU DRUGCOMP National Cancer Center (S. Korea) D0C2QU DRUGTYPE Small molecular drug D0C2QU DRUGINCH 1S/C10H8OS3/c1-11-8-4-2-7(3-5-8)9-6-10(12)14-13-9/h2-6H,1H3 D0C2QU DRUGINKE KYLIZBIRMBGUOP-UHFFFAOYSA-N D0C2QU DRUGSMIL COC1=CC=C(C=C1)C2=CC(=S)SS2 D0C2QU HIGHSTAT Patented D0C3ZN DRUG__ID D0C3ZN D0C3ZN DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PFAU, Roland ARNDT, Kirsten DOODS, Henri HAUEL, Norbert KLINDER, Klaus KUELZER, Raimund D0C3ZN DRUGTYPE Small molecular drug D0C3ZN DRUGINCH 1S/C23H17BrF5N5O2/c1-34-19-17(32-22(34)31-16-5-3-2-4-15(16)23(27,28)29)10-14(21(33-19)36-11-18(25)26)20(35)30-13-8-6-12(24)7-9-13/h2-10,18H,11H2,1H3,(H,30,35)(H,31,32) D0C3ZN DRUGINKE KPWHFPJALLFSPY-UHFFFAOYSA-N D0C3ZN DRUGSMIL CN1C2=C(C=C(C(=N2)OCC(F)F)C(=O)NC3=CC=C(C=C3)Br)N=C1NC4=CC=CC=C4C(F)(F)F D0C3ZN HIGHSTAT Patented D0C5NT DRUG__ID D0C5NT D0C5NT DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D0C5NT DRUGTYPE Small molecular drug D0C5NT DRUGINCH 1S/C20H21ClFN5O3S/c21-15-8-12(7-14(29)11-28)10-23-18(15)26-3-5-27(6-4-26)20(30)25-19-24-16-2-1-13(22)9-17(16)31-19/h1-2,8-10,14,28-29H,3-7,11H2,(H,24,25,30)/t14-/m1/s1 D0C5NT DRUGINKE GUCBTAMMWIOHHO-CQSZACIVSA-N D0C5NT DRUGSMIL C1CN(CCN1C2=C(C=C(C=N2)CC(CO)O)Cl)C(=O)NC3=NC4=C(S3)C=C(C=C4)F D0C5NT HIGHSTAT Patented D0C7ON DRUG__ID D0C7ON D0C7ON DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0C7ON DRUGTYPE Small molecular drug D0C7ON DRUGINCH 1S/C10H14N4O4/c1-12-8-7(9(17)13(2)10(12)18)14(5-11-8)3-6(16)4-15/h5-6,15-16H,3-4H2,1-2H3 D0C7ON DRUGINKE KSCFJBIXMNOVSH-UHFFFAOYSA-N D0C7ON DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O D0C7ON HIGHSTAT Patented D0C8ZZ DRUG__ID D0C8ZZ D0C8ZZ DRUGCOMP ABBVIE INC D0C8ZZ DRUGTYPE Small molecular drug D0C8ZZ DRUGINCH 1S/C22H21F2N3O/c1-13-9-19-16(12-25-13)6-8-20(24)21(19)27-22(28)26-18-7-5-15(11-18)14-3-2-4-17(23)10-14/h2-4,6,8-10,12,15,18H,5,7,11H2,1H3,(H2,26,27,28)/t15-,18-/m1/s1 D0C8ZZ DRUGINKE PAFRMBKESKKSIA-CRAIPNDOSA-N D0C8ZZ DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC(=CC=C4)F)F)C=N1 D0C8ZZ HIGHSTAT Patented D0C9FN DRUG__ID D0C9FN D0C9FN DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D0C9FN DRUGTYPE Small molecular drug D0C9FN DRUGINCH 1S/C21H23F2N3O3/c1-21(2,3)19-16(22)9-14(10-17(19)23)29-8-7-24-20(28)15-11-25-26-13(12-27)5-4-6-18(15)26/h4-6,9-11,27H,7-8,12H2,1-3H3,(H,24,28) D0C9FN DRUGINKE SNBOLRWYZPETPJ-UHFFFAOYSA-N D0C9FN DRUGSMIL CC(C)(C)C1=C(C=C(C=C1F)OCCNC(=O)C2=C3C=CC=C(N3N=C2)CO)F D0C9FN HIGHSTAT Patented D0C9NX DRUG__ID D0C9NX D0C9NX DRUGCOMP REGENACY PHARMACEUTICALS, LLC D0C9NX DRUGTYPE Small molecular drug D0C9NX DRUGINCH 1S/C24H23N5OS/c25-20-6-4-17(23-2-1-11-31-23)14-21(20)28-24(30)22-13-16-3-5-19(12-18(16)15-27-22)29-9-7-26-8-10-29/h1-6,11-15,26H,7-10,25H2,(H,28,30) D0C9NX DRUGINKE SRWKZCCXNJSFMX-UHFFFAOYSA-N D0C9NX DRUGSMIL C1CN(CCN1)C2=CC3=CN=C(C=C3C=C2)C(=O)NC4=C(C=CC(=C4)C5=CC=CS5)N D0C9NX HIGHSTAT Patented D0C9RQ DRUG__ID D0C9RQ D0C9RQ DRUGCOMP KAINOS MEDICINE, INC D0C9RQ DRUGTYPE Small molecular drug D0C9RQ DRUGINCH 1S/C26H26ClN7O4S/c1-16-30-31-26-22(15-38-39(4,36)37)29-25(17-5-8-20(27)9-6-17)21-11-18(7-10-23(21)34(16)26)19-12-28-33(13-19)14-24(35)32(2)3/h5-13,22H,14-15H2,1-4H3/t22-/m0/s1 D0C9RQ DRUGINKE FLSJIUPJVTYGIO-QFIPXVFZSA-N D0C9RQ DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)C4=CN(N=C4)CC(=O)N(C)C)C(=NC2COS(=O)(=O)C)C5=CC=C(C=C5)Cl D0C9RQ HIGHSTAT Patented D0CB8D DRUG__ID D0CB8D D0CB8D DRUGCOMP KYORIN PHARMACEUTICAL CO., LTD D0CB8D DRUGTYPE Small molecular drug D0CB8D DRUGINCH 1S/C29H34N6O4/c1-4-38-25-15-19(28(36)35-13-9-20(18-35)34-11-5-6-12-34)7-8-21(25)31-26-16-23-24(17-30-26)33(3)29(37)27-22(32(23)2)10-14-39-27/h7-8,10,14-17,20H,4-6,9,11-13,18H2,1-3H3,(H,30,31) D0CB8D DRUGINKE MABJPFUJXNIKGP-UHFFFAOYSA-N D0CB8D DRUGSMIL CCOC1=C(C=CC(=C1)C(=O)N2CCC(C2)N3CCCC3)NC4=NC=C5C(=C4)N(C6=C(C(=O)N5C)OC=C6)C D0CB8D HIGHSTAT Patented D0CC6Q DRUG__ID D0CC6Q D0CC6Q DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D0CC6Q DRUGTYPE Small molecular drug D0CC6Q DRUGINCH 1S/C24H21F3N4O/c1-30-21-3-2-9-28-14-19(21)18-6-5-17(12-22(18)30)31-10-8-15(11-23(31)32)20-7-4-16(13-29-20)24(25,26)27/h4-8,10-13,28H,2-3,9,14H2,1H3 D0CC6Q DRUGINKE KTVJCRABCWFUNK-UHFFFAOYSA-N D0CC6Q DRUGSMIL CN1C2=C(CNCCC2)C3=C1C=C(C=C3)N4C=CC(=CC4=O)C5=NC=C(C=C5)C(F)(F)F D0CC6Q HIGHSTAT Patented D0CC7E DRUG__ID D0CC7E D0CC7E DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE D0CC7E DRUGTYPE Small molecular drug D0CC7E DRUGINCH 1S/C18H13N3O2/c1-22-12-3-4-13-14(6-12)21-18-16(13)10(7-19)5-11-8-20-9-15(23-2)17(11)18/h3-6,8-9,21H,1-2H3 D0CC7E DRUGINKE WAJNOEPHTZIWTO-UHFFFAOYSA-N D0CC7E DRUGSMIL COC1=CC2=C(C=C1)C3=C(C=C4C=NC=C(C4=C3N2)OC)C#N D0CC7E HIGHSTAT Patented D0CE7G DRUG__ID D0CE7G D0CE7G DRUGCOMP MERCK PATENT GMBH SHERER, Brian A D0CE7G DRUGTYPE Small molecular drug D0CE7G DRUGINCH 1S/C18H20F2N2O/c19-14-3-1-2-13-16-10-21-11-22(16)15(17(13)14)6-9-18(20)7-4-12(23)5-8-18/h1-3,10-12,15,23H,4-9H2 D0CE7G DRUGINKE AHMWQTITKYANIA-UHFFFAOYSA-N D0CE7G DRUGSMIL C1CC(CCC1O)(CCC2C3=C(C=CC=C3F)C4=CN=CN24)F D0CE7G HIGHSTAT Patented D0CF4R DRUG__ID D0CF4R D0CF4R DRUGTYPE Small molecular drug D0CF4R DRUGINCH 1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14,16,22H,4-7H2,1-3H3/t11-,12-,13-,14-,16+,17-,18-,19+,20+/m1/s1 D0CF4R DRUGINKE DFBIRQPKNDILPW-IJWWASSVSA-N D0CF4R DRUGSMIL CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C D0CF4R HIGHSTAT Patented D0CF4R COMPCLAS Diterpene triepoxide derivatives D0CH4O DRUG__ID D0CH4O D0CH4O DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D0CH4O DRUGTYPE Small molecular drug D0CH4O DRUGINCH 1S/C30H38N8O2/c1-6-7-21-14-20(4)34-30(40)24(21)17-32-29(39)23-15-26(35-28-25(23)18-33-38(28)19(2)3)22-8-9-27(31-16-22)37-12-10-36(5)11-13-37/h8-9,14-16,18-19H,6-7,10-13,17H2,1-5H3,(H,32,39)(H,34,40) D0CH4O DRUGINKE LQTWDAYNGMMHLV-UHFFFAOYSA-N D0CH4O DRUGSMIL CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=CC(=NC3=C2C=NN3C(C)C)C4=CN=C(C=C4)N5CCN(CC5)C D0CH4O HIGHSTAT Patented D0CH7Z DRUG__ID D0CH7Z D0CH7Z DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0CH7Z DRUGTYPE Small molecular drug D0CH7Z DRUGINCH 1S/C17H20N4O2/c1-3-10-20-15-13(16(22)21(11-4-2)17(20)23)18-14(19-15)12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3,(H,18,19) D0CH7Z DRUGINKE CLIGSMOZKDCDRZ-UHFFFAOYSA-N D0CH7Z DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=CC=C3 D0CH7Z HIGHSTAT Patented D0CH8Q DRUG__ID D0CH8Q D0CH8Q DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED GRIGG, Ronald Ernest INMAN, Martyn PACKHAM, Graham D0CH8Q DRUGTYPE Small molecular drug D0CH8Q DRUGINCH 1S/C24H21N3O2/c1-16-14-27(24(29)20-7-3-2-6-19(16)20)15-17-10-12-18(13-11-17)23(28)26-22-9-5-4-8-21(22)25/h2-13H,1,14-15,25H2,(H,26,28) D0CH8Q DRUGINKE GTLTXEIKQVWSRF-UHFFFAOYSA-N D0CH8Q DRUGSMIL C=C1CN(C(=O)C2=CC=CC=C12)CC3=CC=C(C=C3)C(=O)NC4=CC=CC=C4N D0CH8Q HIGHSTAT Patented D0CI3E DRUG__ID D0CI3E D0CI3E DRUGTYPE Small molecular drug D0CI3E DRUGINCH 1S/C15H11FN4O2S/c1-9-7-23-15(19-9)20-14(21)10-2-11(16)4-12(3-10)22-13-5-17-8-18-6-13/h2-8H,1H3,(H,19,20,21) D0CI3E DRUGINKE AXVLPJHYYFHCHK-UHFFFAOYSA-N D0CI3E DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC(=CC(=C2)F)OC3=CN=CN=C3 D0CI3E HIGHSTAT Patented D0CI3E COMPCLAS Bicyclic heteroaryl carboxamide analogs D0CL2E DRUG__ID D0CL2E D0CL2E DRUGTYPE Small molecular drug D0CL2E DRUGINCH 1S/C20H18FIN2O/c1-24(12-4-11-21)20(25)18-13-15-5-2-3-6-17(15)19(23-18)14-7-9-16(22)10-8-14/h2-3,5-10,13H,4,11-12H2,1H3 D0CL2E DRUGINKE QJIFXKOIKACWEI-UHFFFAOYSA-N D0CL2E DRUGSMIL CN(CCCF)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=C(C=C3)I D0CL2E HIGHSTAT Patented D0CL2E COMPCLAS Iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives D0CM5P DRUG__ID D0CM5P D0CM5P DRUGCOMP NeoPharm Co. Ltd D0CM5P DRUGTYPE Small molecular drug D0CM5P DRUGINCH 1S/C22H15BrFN3O3/c1-30-15-10-11-18(23)17(12-15)21(28)26-27-20(13-6-8-14(24)9-7-13)25-19-5-3-2-4-16(19)22(27)29/h2-12H,1H3,(H,26,28) D0CM5P DRUGINKE NCDCVFJWCCFMHL-UHFFFAOYSA-N D0CM5P DRUGSMIL COC1=CC(=C(C=C1)Br)C(=O)NN2C(=NC3=CC=CC=C3C2=O)C4=CC=C(C=C4)F D0CM5P HIGHSTAT Patented D0CR2E DRUG__ID D0CR2E D0CR2E DRUGTYPE Small molecular drug D0CR2E DRUGINCH 1S/C11H12N2O3S/c14-7-6-12-10(15)13(17-11(12)16)8-9-4-2-1-3-5-9/h1-5,14H,6-8H2 D0CR2E DRUGINKE DDYFMVMCMQSWNI-UHFFFAOYSA-N D0CR2E DRUGSMIL C1=CC=C(C=C1)CN2C(=O)N(C(=O)S2)CCO D0CR2E HIGHSTAT Patented D0CR2E COMPCLAS Thiadiazolidindione derivatives D0CV5F DRUG__ID D0CV5F D0CV5F DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0CV5F DRUGTYPE Small molecular drug D0CV5F DRUGINCH 1S/C29H32N2O4/c1-33-28-21-24(11-14-26(28)34-20-19-30-16-5-6-17-30)31-18-15-27(29(31)32)35-25-12-9-23(10-13-25)22-7-3-2-4-8-22/h2-4,7-14,21,27H,5-6,15-20H2,1H3/t27-/m0/s1 D0CV5F DRUGINKE QXWLILWORIGJCR-MHZLTWQESA-N D0CV5F DRUGSMIL COC1=C(C=CC(=C1)N2CCC(C2=O)OC3=CC=C(C=C3)C4=CC=CC=C4)OCCN5CCCC5 D0CV5F HIGHSTAT Patented D0CV9K DRUG__ID D0CV9K D0CV9K DRUGCOMP TETRALOGIC PHARMACEUTICALS CORP. CONDON, Stephen, M. DENG, Yijun LAPORTE, Matthew, G D0CV9K DRUGTYPE Small molecular drug D0CV9K DRUGINCH 1S/C27H38N6O5S/c1-16(28-5)24(34)31-23(27(2,3)4)26(36)32-14-12-20-22(32)18(15-33(20)39(6,37)38)25(35)30-19-11-7-9-17-10-8-13-29-21(17)19/h7-11,13,16,18,20,22-23,28H,12,14-15H2,1-6H3,(H,30,35)(H,31,34)/t16-,18-,20+,22+,23+/m0/s1 D0CV9K DRUGINKE VDNCJSPAMUEWDC-VBEIARHESA-N D0CV9K DRUGSMIL CC(C(=O)NC(C(=O)N1CCC2C1C(CN2S(=O)(=O)C)C(=O)NC3=CC=CC4=C3N=CC=C4)C(C)(C)C)NC D0CV9K HIGHSTAT Patented D0CW1J DRUG__ID D0CW1J D0CW1J DRUGCOMP SANOFI-AVENTIS BARTH, Francis CONGY, Christian JEANJEAN, Audrey RINALDI-CARMONA, Muriell D0CW1J DRUGTYPE Small molecular drug D0CW1J DRUGINCH 1S/C34H36ClFN4O4/c1-39-30(32(42)40-17-15-34(16-18-40,33(37)43)38-22-23-7-11-25(36)12-8-23)21-28(27-5-2-3-6-29(27)35)31(39)24-9-13-26(14-10-24)44-20-4-19-41/h2-3,5-14,21,38,41H,4,15-20,22H2,1H3,(H2,37,43) D0CW1J DRUGINKE QZKLHVGMMWBLEQ-UHFFFAOYSA-N D0CW1J DRUGSMIL CN1C(=CC(=C1C2=CC=C(C=C2)OCCCO)C3=CC=CC=C3Cl)C(=O)N4CCC(CC4)(C(=O)N)NCC5=CC=C(C=C5)F D0CW1J HIGHSTAT Patented D0CW9Q DRUG__ID D0CW9Q D0CW9Q DRUGCOMP H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC D0CW9Q DRUGTYPE Small molecular drug D0CW9Q DRUGINCH 1S/C16H16N4O/c21-16(17-9-8-12-4-2-1-3-5-12)19-14-6-7-15-13(10-14)11-18-20-15/h1-7,10-11H,8-9H2,(H,18,20)(H2,17,19,21) D0CW9Q DRUGINKE XEZOXLSEWZHMQY-UHFFFAOYSA-N D0CW9Q DRUGSMIL C1=CC=C(C=C1)CCNC(=O)NC2=CC3=C(C=C2)NN=C3 D0CW9Q HIGHSTAT Patented D0CX1F DRUG__ID D0CX1F D0CX1F DRUGTYPE Small molecular drug D0CX1F DRUGINCH 1S/C20H25N3O3S/c24-20(21-11-4-1-5-12-21)22-13-15-23(16-14-22)27(25,26)19-10-6-8-17-7-2-3-9-18(17)19/h2-3,6-10H,1,4-5,11-16H2 D0CX1F DRUGINKE FVGJQXBVEVXXEH-UHFFFAOYSA-N D0CX1F DRUGSMIL C1CCN(CC1)C(=O)N2CCN(CC2)S(=O)(=O)C3=CC=CC4=CC=CC=C43 D0CX1F HIGHSTAT Patented D0CX1F COMPCLAS Sulfonylated piperazine derivatives D0CX1Y DRUG__ID D0CX1Y D0CX1Y DRUGCOMP KARUS THERAPEUTICS LTD D0CX1Y DRUGTYPE Small molecular drug D0CX1Y DRUGINCH 1S/C20H20N4O3/c1-14-5-10-18(22-12-14)24(19-17(27-2)4-3-11-21-19)13-15-6-8-16(9-7-15)20(25)23-26/h3-12,26H,13H2,1-2H3,(H,23,25) D0CX1Y DRUGINKE JGXHNVLWEATQAQ-UHFFFAOYSA-N D0CX1Y DRUGSMIL CC1=CN=C(C=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=C(C=CC=N3)OC D0CX1Y HIGHSTAT Patented D0CX4C DRUG__ID D0CX4C D0CX4C DRUGCOMP Japan Tobacco, Inc D0CX4C DRUGTYPE Small molecular drug D0CX4C DRUGINCH 1S/C25H28ClN3O4/c1-17(2)16-33-20-9-7-19(8-10-20)28-25(31)18-6-11-23(32-3)22(15-18)29(13-14-30)24-21(26)5-4-12-27-24/h4-12,15,17,30H,13-14,16H2,1-3H3,(H,28,31) D0CX4C DRUGINKE QGYXTXVZRNIAOQ-UHFFFAOYSA-N D0CX4C DRUGSMIL CC(C)COC1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2)OC)N(CCO)C3=C(C=CC=N3)Cl D0CX4C HIGHSTAT Patented D0D1TS DRUG__ID D0D1TS D0D1TS DRUGCOMP LUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar TALE, Prashant, Vitthalrao CHEEMALA, Narasimha, Murthy MAHANGARE, Sachin, Jaysing VIDHATE, Prashant, Popatrao KULKARNI, Chaitanya, Prabhakar PATEL, Sapana, Suresh PATIL, Amolsing, Dattu ZADE, Seema, Prabhakar SHINDE, Rohan, Mahadev PALLE, Venkata, P. KAMBOJ, Rajender, KumaLUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar MAHANGARE, Sachin, Jaysing TALE, Prashant, Vitthalrao ZADE, Seema, Prabhakar PATIL, Amolsing, Dattu CHEEMALA, Narasimha, Murthy PALLE, Venkata, P. KAMBOJ, Rajender, KumaLUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar TALE, Prashant, Vitthalrao CHEEMALA, Narasimha, Murthy MAHANGARE, Sachin, Jaysing VIDHATE, Prashant, Popatrao KULKARNI, Chaitanya, Prabhakar PATEL, Sapana, Suresh PATIL, Amolsing, Dattu SHINDE, Rohan, Mahadev PALLE, Venkata, P. KAMBOJ, Rajender, Kumar D0D1TS DRUGTYPE Small molecular drug D0D1TS DRUGINCH 1S/C21H20FN3O2/c1-14-4-2-7-17-19(14)18(21(26)25-8-10-27-11-9-25)13-23-20(17)24-16-6-3-5-15(22)12-16/h2-7,12-13H,8-11H2,1H3,(H,23,24) D0D1TS DRUGINKE QKTNWXFWLOHPFJ-UHFFFAOYSA-N D0D1TS DRUGSMIL CC1=C2C(=CC=C1)C(=NC=C2C(=O)N3CCOCC3)NC4=CC(=CC=C4)F D0D1TS HIGHSTAT Patented D0D2CF DRUG__ID D0D2CF D0D2CF DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D0D2CF DRUGTYPE Small molecular drug D0D2CF DRUGINCH 1S/C21H23ClFN5O3S/c1-12-10-27(19-16(22)7-13(9-24-19)6-15(30)11-29)4-5-28(12)21(31)26-20-25-17-3-2-14(23)8-18(17)32-20/h2-3,7-9,12,15,29-30H,4-6,10-11H2,1H3,(H,25,26,31)/t12-,15-/m1/s1 D0D2CF DRUGINKE SRAUTTLRNBOIMG-IUODEOHRSA-N D0D2CF DRUGSMIL CC1CN(CCN1C(=O)NC2=NC3=C(S2)C=C(C=C3)F)C4=C(C=C(C=N4)CC(CO)O)Cl D0D2CF HIGHSTAT Patented D0D2JW DRUG__ID D0D2JW D0D2JW DRUGTYPE Small molecular drug D0D2JW DRUGINCH 1S/C26H31NO5/c1-31-23-10-24(32-2)21(26-11-15-5-16(12-26)7-17(6-15)13-26)9-20(23)25(30)27-14-18-3-4-19(28)8-22(18)29/h3-4,8-10,15-17,28-29H,5-7,11-14H2,1-2H3,(H,27,30) D0D2JW DRUGINKE WDLDXQVTSRCDMN-UHFFFAOYSA-N D0D2JW DRUGSMIL COC1=CC(=C(C=C1C(=O)NCC2=C(C=C(C=C2)O)O)C34CC5CC(C3)CC(C5)C4)OC D0D2JW HIGHSTAT Patented D0D2JW COMPCLAS Polyhydroxy benzamide derivatives D0D2LC DRUG__ID D0D2LC D0D2LC DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D0D2LC DRUGTYPE Small molecular drug D0D2LC DRUGINCH 1S/C22H20N6O/c23-14-17-12-15(6-7-20(17)28-10-1-2-11-28)19-8-9-25-22(27-19)26-18-5-3-4-16(13-18)21(24)29/h3-9,12-13H,1-2,10-11H2,(H2,24,29)(H,25,26,27) D0D2LC DRUGINKE KPMCSBDURLKXIY-UHFFFAOYSA-N D0D2LC DRUGSMIL C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C(=O)N)C#N D0D2LC HIGHSTAT Patented D0D3FB DRUG__ID D0D3FB D0D3FB DRUGCOMP SUN PHARMA ADVANCED RESEARCH COMPANY LTD., SENGUPTA, Prabal PURI, Chetan Surjitsingh CHOKSHI, Hemantkumar CHITTURI, Trinadha Rao THENNATI, Rajamannar D0D3FB DRUGTYPE Small molecular drug D0D3FB DRUGINCH 1S/C25H21ClN6O2/c1-15-8-9-17(23(33)31-32-24(34)22-16(2)5-3-7-19(22)26)13-21(15)30-25-28-12-10-20(29-25)18-6-4-11-27-14-18/h3-14H,1-2H3,(H,31,33)(H,32,34)(H,28,29,30) D0D3FB DRUGINKE RCYQHUIWHIZRQI-UHFFFAOYSA-N D0D3FB DRUGSMIL CC1=C(C(=CC=C1)Cl)C(=O)NNC(=O)C2=CC(=C(C=C2)C)NC3=NC=CC(=N3)C4=CN=CC=C4 D0D3FB HIGHSTAT Patented D0D3RS DRUG__ID D0D3RS D0D3RS DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0D3RS DRUGTYPE Small molecule immunotherapy D0D3RS DRUGINCH 1S/C49H43Cl2N5O8/c1-29-36(26-63-46-15-44(61-24-34-11-32(17-52)19-54-21-34)38(13-42(46)50)23-56-49(4,28-57)48(59)60)7-5-9-39(29)40-10-6-8-37(30(40)2)27-64-47-16-45(41(31(3)58)14-43(47)51)62-25-35-12-33(18-53)20-55-22-35/h5-16,19-22,56-57H,23-28H2,1-4H3,(H,59,60) D0D3RS DRUGINKE LBEJCLGFPBJTDE-UHFFFAOYSA-N D0D3RS DRUGSMIL CC1=C(C=CC=C1C2=CC=CC(=C2C)COC3=C(C=C(C(=C3)OCC4=CC(=CN=C4)C#N)C(=O)C)Cl)COC5=C(C=C(C(=C5)OCC6=CC(=CN=C6)C#N)CNC(C)(CO)C(=O)O)Cl D0D3RS HIGHSTAT Patented D0D4OW DRUG__ID D0D4OW D0D4OW DRUGCOMP ELI LILLY AND COMPANY D0D4OW DRUGTYPE Small molecular drug D0D4OW DRUGINCH 1S/C15H15Cl2NO6/c16-6-2-1-5(3-7(6)17)4-24-12-11(19)8-9(13(20)21)10(8)15(12,18)14(22)23/h1-3,8-12,19H,4,18H2,(H,20,21)(H,22,23)/t8-,9-,10-,11-,12+,15+/m0/s1 D0D4OW DRUGINKE WNOZOUHFGZKGNT-ANYOLZDRSA-N D0D4OW DRUGSMIL C1=CC(=C(C=C1COC2C(C3C(C3C2(C(=O)O)N)C(=O)O)O)Cl)Cl D0D4OW HIGHSTAT Patented D0D4UH DRUG__ID D0D4UH D0D4UH DRUGCOMP PFIZER INC D0D4UH DRUGTYPE Small molecular drug D0D4UH DRUGINCH 1S/C22H21Cl2N3O4/c1-10-6-11(2)25-21(29)15(10)8-27-5-4-13-16(23)7-14(20(24)19(13)22(27)30)18-12(3)31-26-17(18)9-28/h6-7,28H,4-5,8-9H2,1-3H3,(H,25,29) D0D4UH DRUGINKE WZHICSHLNWIANY-UHFFFAOYSA-N D0D4UH DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C4=C(ON=C4CO)C)Cl)C D0D4UH HIGHSTAT Patented D0D5AH DRUG__ID D0D5AH D0D5AH DRUGCOMP AAPA B.V D0D5AH DRUGTYPE Small molecular drug D0D5AH DRUGINCH 1S/C25H32N4O4/c30-25-26-22-3-1-4-23(24(22)33-25)29-12-10-27(11-13-29)9-2-16-32-21-7-5-20(6-8-21)19-28-14-17-31-18-15-28/h1,3-8H,2,9-19H2,(H,26,30) D0D5AH DRUGINKE JHTDAMZJAOPBAK-UHFFFAOYSA-N D0D5AH DRUGSMIL C1CN(CCN1CCCOC2=CC=C(C=C2)CN3CCOCC3)C4=CC=CC5=C4OC(=O)N5 D0D5AH HIGHSTAT Patented D0D7EG DRUG__ID D0D7EG D0D7EG DRUGCOMP ARRAY BIOPHARMA INC D0D7EG DRUGTYPE Small molecular drug D0D7EG DRUGINCH 1S/C28H32FN7O2/c1-19-26(21-15-30-34(2)16-21)33-36(23-7-5-4-6-8-23)27(19)32-28(37)31-25-18-35(13-14-38-3)17-24(25)20-9-11-22(29)12-10-20/h4-12,15-16,24-25H,13-14,17-18H2,1-3H3,(H2,31,32,37)/t24-,25+/m0/s1 D0D7EG DRUGINKE JNTHQYPNOWOSDA-LOSJGSFVSA-N D0D7EG DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC=CC=C3)NC(=O)NC4CN(CC4C5=CC=C(C=C5)F)CCOC D0D7EG HIGHSTAT Patented D0D7ZU DRUG__ID D0D7ZU D0D7ZU DRUGTYPE Small molecular drug D0D7ZU DRUGINCH 1S/C20H17BrCl2N4OSe/c1-10-16(18-24-19(26-28-18)20(2,3)4)25-27(13-6-5-11(22)9-12(13)23)17(10)14-7-8-15(21)29-14/h5-9H,1-4H3 D0D7ZU DRUGINKE YUVJAEGOFXSXNJ-UHFFFAOYSA-N D0D7ZU DRUGSMIL CC1=C(N(N=C1C2=NC(=NO2)C(C)(C)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C([Se]4)Br D0D7ZU HIGHSTAT Patented D0D7ZU COMPCLAS Pyrazole derivatives D0D8IZ DRUG__ID D0D8IZ D0D8IZ DRUGCOMP WYETH KREFT, Anthony, Frank RESNICK, Lynn MAYER, Scott, Christian DIAMANTIDIS, George COLE, Derek, Cecil WANG, Tingzhong GALANTE, Rocco, John HOKE, Molly HARRISON, Boyd, Lynn ZHANG, Minsheng D0D8IZ DRUGTYPE Small molecular drug D0D8IZ DRUGINCH 1S/C9H8ClF6NO3S2/c10-5-1-2-6(21-5)22(19,20)17-4(3-18)7(8(11,12)13)9(14,15)16/h1-2,4,7,17-18H,3H2/t4-/m0/s1 D0D8IZ DRUGINKE PSXOKXJMVRSARX-BYPYZUCNSA-N D0D8IZ DRUGSMIL C1=C(SC(=C1)Cl)S(=O)(=O)NC(CO)C(C(F)(F)F)C(F)(F)F D0D8IZ HIGHSTAT Patented D0D8KO DRUG__ID D0D8KO D0D8KO DRUGCOMP THE JOHNS HOPKINS UNIVERSITY The National Institutes of Health D0D8KO DRUGTYPE Small molecular drug D0D8KO DRUGINCH 1S/C29H25N3O4S/c1-17-5-3-4-6-22(17)28(34)32-12-11-20-15-21(8-9-23(20)32)27-18(2)37-29(31-27)30-26(33)14-19-7-10-24-25(13-19)36-16-35-24/h3-10,13,15H,11-12,14,16H2,1-2H3,(H,30,31,33) D0D8KO DRUGINKE LINHYWKZVCNAMQ-UHFFFAOYSA-N D0D8KO DRUGSMIL CC1=CC=CC=C1C(=O)N2CCC3=C2C=CC(=C3)C4=C(SC(=N4)NC(=O)CC5=CC6=C(C=C5)OCO6)C D0D8KO HIGHSTAT Patented D0DC4O DRUG__ID D0DC4O D0DC4O DRUGCOMP Japan Tobacco, Inc D0DC4O DRUGTYPE Small molecular drug D0DC4O DRUGINCH 1S/C24H25Cl2N3O2/c1-24(2,3)17-7-9-18(10-8-17)28-23(31)16-6-11-19(25)21(15-16)29(13-14-30)22-20(26)5-4-12-27-22/h4-12,15,30H,13-14H2,1-3H3,(H,28,31) D0DC4O DRUGINKE PUELSMJKWSTCFR-UHFFFAOYSA-N D0DC4O DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2)Cl)N(CCO)C3=C(C=CC=N3)Cl D0DC4O HIGHSTAT Patented D0DE5K DRUG__ID D0DE5K D0DE5K DRUGCOMP GRUENENTHAL GMBH [DE] D0DE5K DRUGTYPE Small molecular drug D0DE5K DRUGINCH 1S/C24H30ClN5O3S/c1-16(18-10-8-17(9-11-18)14-28-34(26,32)33)23(31)27-15-21-13-22(24(2,3)4)29-30(21)20-7-5-6-19(25)12-20/h5-13,16,28H,14-15H2,1-4H3,(H,27,31)(H2,26,32,33) D0DE5K DRUGINKE DACXYKBLLKSFLC-UHFFFAOYSA-N D0DE5K DRUGSMIL CC(C1=CC=C(C=C1)CNS(=O)(=O)N)C(=O)NCC2=CC(=NN2C3=CC(=CC=C3)Cl)C(C)(C)C D0DE5K HIGHSTAT Patented D0DF2M DRUG__ID D0DF2M D0DF2M DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0DF2M DRUGTYPE Small molecular drug D0DF2M DRUGINCH 1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9) D0DF2M DRUGINKE ZFXYFBGIUFBOJW-UHFFFAOYSA-N D0DF2M DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC=N2 D0DF2M HIGHSTAT Patented D0DF6B DRUG__ID D0DF6B D0DF6B DRUGTYPE Small molecular drug D0DF6B DRUGINCH 1S/C21H24Cl2N2O2/c1-21(2,3)24-20(26)25-12-18(13-25)27-19(14-4-8-16(22)9-5-14)15-6-10-17(23)11-7-15/h4-11,18-19H,12-13H2,1-3H3,(H,24,26) D0DF6B DRUGINKE JIJVOTYIBJGZDJ-UHFFFAOYSA-N D0DF6B DRUGSMIL CC(C)(C)NC(=O)N1CC(C1)OC(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl D0DF6B HIGHSTAT Patented D0DF6B COMPCLAS Azetidine-1-carboxamide derivatives D0DG7E DRUG__ID D0DG7E D0DG7E DRUGCOMP RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK UNIVERSITY OF STRATHCLYDE BITTMAN, Robert PYNE, Nigel J. PYNE, Susan BAEK, Dong Jae LIU, Zheng BYUN, Hoe Sup D0DG7E DRUGTYPE Small molecular drug D0DG7E DRUGINCH 1S/C25H43NO/c1-2-3-4-5-6-7-8-9-10-11-13-23-15-17-24(18-16-23)19-21-26-20-12-14-25(26)22-27/h15-18,25,27H,2-14,19-22H2,1H3/t25-/m1/s1 D0DG7E DRUGINKE PNEOFQRNMJSTMT-RUZDIDTESA-N D0DG7E DRUGSMIL CCCCCCCCCCCCC1=CC=C(C=C1)CCN2CCCC2CO D0DG7E HIGHSTAT Patented D0DI9S DRUG__ID D0DI9S D0DI9S DRUGCOMP THE GENERAL HOSPITAL CORPORATION D0DI9S DRUGTYPE Small molecular drug D0DI9S DRUGINCH 1S/C22H30N2O2/c1-24(14-17-4-2-16(3-5-17)6-7-21(25)23-26)15-22-11-18-8-19(12-22)10-20(9-18)13-22/h2-7,18-20,26H,8-15H2,1H3,(H,23,25)/b7-6+ D0DI9S DRUGINKE WNIDBXBLQFPAJA-VOTSOKGWSA-N D0DI9S DRUGSMIL CN(CC1=CC=C(C=C1)C=CC(=O)NO)CC23CC4CC(C2)CC(C4)C3 D0DI9S HIGHSTAT Patented D0DK4I DRUG__ID D0DK4I D0DK4I DRUGCOMP NATIONAL CANCER CENTER KIM, Soo Youl LEE, Chang Hoon D0DK4I DRUGTYPE Small molecular drug D0DK4I DRUGINCH 1S/C18H22O4/c1-11(7-13-3-5-15(19)17(21)9-13)12(2)8-14-4-6-16(20)18(22)10-14/h3-6,9-12,19-22H,7-8H2,1-2H3 D0DK4I DRUGINKE HCZKYJDFEPMADG-UHFFFAOYSA-N D0DK4I DRUGSMIL CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O D0DK4I HIGHSTAT Patented D0DM9L DRUG__ID D0DM9L D0DM9L DRUGCOMP NTZ LAB LTD [BG] D0DM9L DRUGTYPE Small molecular drug D0DM9L DRUGINCH 1S/C14H10ClN3O2/c15-11-3-2-10(6-13(11)19)17-14(20)8-1-4-12-9(5-8)7-16-18-12/h1-7,19H,(H,16,18)(H,17,20) D0DM9L DRUGINKE HSMCXXGJZHHZDS-UHFFFAOYSA-N D0DM9L DRUGSMIL C1=CC2=C(C=C1C(=O)NC3=CC(=C(C=C3)Cl)O)C=NN2 D0DM9L HIGHSTAT Patented D0DN8Z DRUG__ID D0DN8Z D0DN8Z DRUGCOMP GLAXOSMITHKLINE LLC CHRISTENSEN, Siegfried, Benjamin, IV QIN, Donghui CHEN, Shenglin HUANG, Xing LI, Di LI, Fei LI, Lei LIN, Xiaojuan LU, Shi LU, Zhen LV, Maoyun WANG, Chuanning WU, Chengde XIAO, Mei YU, Haiyu ZHANG, Weina ZHANG, Zhiliu D0DN8Z DRUGTYPE Small molecular drug D0DN8Z DRUGINCH 1S/C22H26ClN5O2/c1-3-27(4-2)12-10-24-21-8-7-19(15-26-21)28-11-9-20(13-22(28)29)30-16-18-6-5-17(23)14-25-18/h5-9,11,13-15H,3-4,10,12,16H2,1-2H3,(H,24,26) D0DN8Z DRUGINKE QZSXDTLVUJGVDX-UHFFFAOYSA-N D0DN8Z DRUGSMIL CCN(CC)CCNC1=NC=C(C=C1)N2C=CC(=CC2=O)OCC3=NC=C(C=C3)Cl D0DN8Z HIGHSTAT Patented D0DO1U DRUG__ID D0DO1U D0DO1U DRUGCOMP KADMON CORPORATION, LLC D0DO1U DRUGTYPE Small molecular drug D0DO1U DRUGINCH 1S/C25H26N6O2/c1-15-16(2)27-25(30-24(15)29-20-9-10-22-18(11-20)13-26-31-22)17-5-3-8-21(12-17)33-14-23(32)28-19-6-4-7-19/h3,5,8-13,19H,4,6-7,14H2,1-2H3,(H,26,31)(H,28,32)(H,27,29,30) D0DO1U DRUGINKE FFIBTGFOEVIJLU-UHFFFAOYSA-N D0DO1U DRUGSMIL CC1=C(N=C(N=C1NC2=CC3=C(C=C2)NN=C3)C4=CC(=CC=C4)OCC(=O)NC5CCC5)C D0DO1U HIGHSTAT Patented D0DQ6C DRUG__ID D0DQ6C D0DQ6C DRUGCOMP Kissei Pharmaceutical Co. Ltd D0DQ6C DRUGTYPE Small molecular drug D0DQ6C DRUGINCH 1S/C15H11N3O2S/c1-8-13(15(19)20)21-14(17-8)10-5-9-3-4-18(2)12(9)11(6-10)7-16/h3-6H,1-2H3,(H,19,20) D0DQ6C DRUGINKE UKMCFVVQXUWRFF-UHFFFAOYSA-N D0DQ6C DRUGSMIL CC1=C(SC(=N1)C2=CC(=C3C(=C2)C=CN3C)C#N)C(=O)O D0DQ6C HIGHSTAT Patented D0DT5I DRUG__ID D0DT5I D0DT5I DRUGCOMP DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry D0DT5I DRUGTYPE Small molecular drug D0DT5I DRUGINCH 1S/C18H15N5OS/c1-10-3-5-11(6-4-10)22-17-14-12(20-9-21-17)7-8-13-15(14)25-18(23-13)16(19)24-2/h3-9,19H,1-2H3,(H,20,21,22) D0DT5I DRUGINKE AVKKQBJQERVCTD-UHFFFAOYSA-N D0DT5I DRUGSMIL CC1=CC=C(C=C1)NC2=NC=NC3=C2C4=C(C=C3)N=C(S4)C(=N)OC D0DT5I HIGHSTAT Patented D0DT7M DRUG__ID D0DT7M D0DT7M DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D0DT7M DRUGTYPE Small molecular drug D0DT7M DRUGINCH 1S/C22H23F3N4O3/c23-22(24,25)15-8-7-14(18(11-15)29-9-2-1-3-10-29)12-26-21(31)28-17-6-4-5-16-20(17)32-13-19(30)27-16/h4-8,11H,1-3,9-10,12-13H2,(H,27,30)(H2,26,28,31) D0DT7M DRUGINKE FSBAINYERQVPNQ-UHFFFAOYSA-N D0DT7M DRUGSMIL C1CCN(CC1)C2=C(C=CC(=C2)C(F)(F)F)CNC(=O)NC3=CC=CC4=C3OCC(=O)N4 D0DT7M HIGHSTAT Patented D0DW1D DRUG__ID D0DW1D D0DW1D DRUGCOMP THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0DW1D DRUGTYPE Small molecular drug D0DW1D DRUGINCH 1S/C18H25FN2OS/c19-9-5-6-15-7-8-16-17(14-15)23-18(22)21(16)13-12-20-10-3-1-2-4-11-20/h7-8,14H,1-6,9-13H2 D0DW1D DRUGINKE DNGYIBDXSUNKMV-UHFFFAOYSA-N D0DW1D DRUGSMIL C1CCCN(CC1)CCN2C3=C(C=C(C=C3)CCCF)SC2=O D0DW1D HIGHSTAT Patented D0DW4P DRUG__ID D0DW4P D0DW4P DRUGCOMP AUCKLAND UNISERVICES LIMITED D0DW4P DRUGTYPE Small molecular drug D0DW4P DRUGINCH 1S/C15H12ClN3O3/c1-8-11-13(19-22-14(11)17-9(2)12(8)16)18-15(20)21-10-6-4-3-5-7-10/h3-7H,1-2H3,(H,18,19,20) D0DW4P DRUGINKE WUNZBHVIWUQNNS-UHFFFAOYSA-N D0DW4P DRUGSMIL CC1=C2C(=NOC2=NC(=C1Cl)C)NC(=O)OC3=CC=CC=C3 D0DW4P HIGHSTAT Patented D0DZ0M DRUG__ID D0DZ0M D0DZ0M DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D0DZ0M DRUGTYPE Small molecular drug D0DZ0M DRUGINCH 1S/C17H14ClFN2/c18-14-4-3-6-16(12-14)21-11-9-17(19,13-21)8-7-15-5-1-2-10-20-15/h1-6,10,12H,9,11,13H2 D0DZ0M DRUGINKE AHSZAMGYMLYSLL-UHFFFAOYSA-N D0DZ0M DRUGSMIL C1CN(CC1(C#CC2=CC=CC=N2)F)C3=CC(=CC=C3)Cl D0DZ0M HIGHSTAT Patented D0DZ5H DRUG__ID D0DZ5H D0DZ5H DRUGCOMP THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0DZ5H DRUGTYPE Small molecular drug D0DZ5H DRUGINCH 1S/C21H31N3OS/c25-21-24(19-10-4-5-11-20(19)26-21)13-7-6-12-22-14-16-23(17-15-22)18-8-2-1-3-9-18/h4-5,10-11,18H,1-3,6-9,12-17H2 D0DZ5H DRUGINKE ZACKDLLCPUTVQK-UHFFFAOYSA-N D0DZ5H DRUGSMIL C1CCC(CC1)N2CCN(CC2)CCCCN3C4=CC=CC=C4SC3=O D0DZ5H HIGHSTAT Patented D0E0MH DRUG__ID D0E0MH D0E0MH DRUGCOMP INTERCEPT PHARMACEUTICALS, INC. PELLICCIARI, Roberto FIORUCCI, Stefano PRUZANSKI, Mark D0E0MH DRUGTYPE Small molecular drug D0E0MH DRUGINCH 1S/C26H46O5S/c1-5-18-22-15-17(27)10-12-26(22,4)21-11-13-25(3)19(8-9-20(25)23(21)24(18)28)16(2)7-6-14-32(29,30)31/h16-24,27-28H,5-15H2,1-4H3,(H,29,30,31)/t16-,17-,18-,19-,20+,21+,22+,23+,24-,25-,26-/m1/s1 D0E0MH DRUGINKE VJHHZJYLJUGVGO-JDCMAIOWSA-N D0E0MH DRUGSMIL CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCCS(=O)(=O)O)C)C)O D0E0MH HIGHSTAT Patented D0E1KS DRUG__ID D0E1KS D0E1KS DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0E1KS DRUGTYPE Small molecular drug D0E1KS DRUGINCH 1S/C28H30N4O3/c1-2-32-12-4-7-23(32)16-31-27(33)20-6-3-5-19(13-20)15-30-28(34)21-8-9-24-22(14-21)18-35-26-17-29-11-10-25(24)26/h3,5-6,8-11,13-14,17,23H,2,4,7,12,15-16,18H2,1H3,(H,30,34)(H,31,33) D0E1KS DRUGINKE PMNRRBVQSVNKLM-UHFFFAOYSA-N D0E1KS DRUGSMIL CCN1CCCC1CNC(=O)C2=CC=CC(=C2)CNC(=O)C3=CC4=C(C=C3)C5=C(C=NC=C5)OC4 D0E1KS HIGHSTAT Patented D0E4UV DRUG__ID D0E4UV D0E4UV DRUGCOMP INCYTE CORPORATIOIncyte Corporation D0E4UV DRUGTYPE Small molecular drug D0E4UV DRUGINCH 1S/C19H19N3O4/c1-19(2)18(24)21-14-8-10(25-4)7-12(16(14)26-19)13-9-22(3)17(23)15-11(13)5-6-20-15/h5-9,20H,1-4H3,(H,21,24) D0E4UV DRUGINKE YAGDWXZVBYSOAH-UHFFFAOYSA-N D0E4UV DRUGSMIL CC1(C(=O)NC2=CC(=CC(=C2O1)C3=CN(C(=O)C4=C3C=CN4)C)OC)C D0E4UV HIGHSTAT Patented D0E5QO DRUG__ID D0E5QO D0E5QO DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D0E5QO DRUGTYPE Small molecular drug D0E5QO DRUGINCH 1S/C24H19F4N5O/c25-16-4-2-15(3-5-16)18-10-20(23(29)34)30-19-9-14(1-6-17(18)19)11-32-7-8-33-12-21(24(26,27)28)31-22(33)13-32/h1-6,9-10,12H,7-8,11,13H2,(H2,29,34) D0E5QO DRUGINKE CGZZSGTWUICICQ-UHFFFAOYSA-N D0E5QO DRUGSMIL C1CN2C=C(N=C2CN1CC3=CC4=C(C=C3)C(=CC(=N4)C(=O)N)C5=CC=C(C=C5)F)C(F)(F)F D0E5QO HIGHSTAT Patented D0E6EP DRUG__ID D0E6EP D0E6EP DRUGCOMP 4SC AG [DE] D0E6EP DRUGTYPE Small molecular drug D0E6EP DRUGINCH 1S/C23H19N5O3S2/c1-14-4-5-16(25-22(30)20-8-6-17(33-20)7-9-21(29)28-31)11-18(14)26-23-27-19(13-32-23)15-3-2-10-24-12-15/h2-13,31H,1H3,(H,25,30)(H,26,27)(H,28,29)/b9-7+ D0E6EP DRUGINKE DFZFLIGZEDFNOL-VQHVLOKHSA-N D0E6EP DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=C(S2)C=CC(=O)NO)NC3=NC(=CS3)C4=CN=CC=C4 D0E6EP HIGHSTAT Patented D0E6YT DRUG__ID D0E6YT D0E6YT DRUGCOMP ISIS INNOVATION LIMITED D0E6YT DRUGTYPE Small molecular drug D0E6YT DRUGINCH 1S/C21H12N6O2S/c22-11-13-5-1-2-6-14(13)12-30-21-24-19-18(25-26-21)15-7-3-4-8-16(15)27(19)20(28)17-9-10-23-29-17/h1-10H,12H2 D0E6YT DRUGINKE DRIBOKZNLIGADO-UHFFFAOYSA-N D0E6YT DRUGSMIL C1=CC=C(C(=C1)CSC2=NC3=C(C4=CC=CC=C4N3C(=O)C5=CC=NO5)N=N2)C#N D0E6YT HIGHSTAT Patented D0E8UP DRUG__ID D0E8UP D0E8UP DRUGCOMP Japan Tobacco, Inc D0E8UP DRUGTYPE Small molecular drug D0E8UP DRUGINCH 1S/C26H27F2N3O5/c1-15-7-8-22(29-11-15)31-17(12-32)13-35-23-18(5-4-6-21(23)31)25(34)30-16-9-19(27)24(20(28)10-16)36-26(2,3)14-33/h4-11,17,32-33H,12-14H2,1-3H3,(H,30,34)/t17-/m0/s1 D0E8UP DRUGINKE HVUQTZHOXKBNTC-KRWDZBQOSA-N D0E8UP DRUGSMIL CC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C(=O)NC4=CC(=C(C(=C4)F)OC(C)(C)CO)F)CO D0E8UP HIGHSTAT Patented D0E9PE DRUG__ID D0E9PE D0E9PE DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0E9PE DRUGTYPE Small molecular drug D0E9PE DRUGINCH 1S/C20H19N3O2/c1-3-23-18-8-6-5-7-16(18)17-11-15(9-10-19(17)23)22-13-14(12-21)20(24)25-4-2/h5-11,13-14H,3-4H2,1-2H3 D0E9PE DRUGINKE ZCSFFBZXCQGHRG-UHFFFAOYSA-N D0E9PE DRUGSMIL CCN1C2=C(C=C(C=C2)N=CC(C#N)C(=O)OCC)C3=CC=CC=C31 D0E9PE HIGHSTAT Patented D0EA3E DRUG__ID D0EA3E D0EA3E DRUGCOMP National Cancer Center (S. Korea) D0EA3E DRUGTYPE Small molecular drug D0EA3E DRUGINCH 1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1 D0EA3E DRUGINKE WMBWREPUVVBILR-WIYYLYMNSA-N D0EA3E DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O D0EA3E HIGHSTAT Patented D0EA5P DRUG__ID D0EA5P D0EA5P DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D0EA5P DRUGTYPE Small molecular drug D0EA5P DRUGINCH 1S/C17H20N6O2/c18-14(24)11-6-8-23(9-7-11)17-20-10-13(15(19)25)16(22-17)21-12-4-2-1-3-5-12/h1-5,10-11H,6-9H2,(H2,18,24)(H2,19,25)(H,20,21,22) D0EA5P DRUGINKE KEVAFBBLBKUMEB-UHFFFAOYSA-N D0EA5P DRUGSMIL C1CN(CCC1C(=O)N)C2=NC=C(C(=N2)NC3=CC=CC=C3)C(=O)N D0EA5P HIGHSTAT Patented D0EB9M DRUG__ID D0EB9M D0EB9M DRUGCOMP Glenmark Pharmaceuticals S.A D0EB9M DRUGTYPE Small molecular drug D0EB9M DRUGINCH 1S/C28H24ClF4N5O2/c1-27(2,3)26(40)34-13-15-10-11-19(29)21(22(15)30)25(39)38-20-9-5-8-18-23(20)35-14-36-24(18)37-17-7-4-6-16(12-17)28(31,32)33/h4-12,14H,13H2,1-3H3,(H,34,40)(H,38,39)(H,35,36,37) D0EB9M DRUGINKE NPMRJEGXUPKUTE-UHFFFAOYSA-N D0EB9M DRUGSMIL CC(C)(C)C(=O)NCC1=C(C(=C(C=C1)Cl)C(=O)NC2=CC=CC3=C2N=CN=C3NC4=CC=CC(=C4)C(F)(F)F)F D0EB9M HIGHSTAT Patented D0EC3H DRUG__ID D0EC3H D0EC3H DRUGCOMP NeoPharm Co. Ltd D0EC3H DRUGTYPE Small molecular drug D0EC3H DRUGINCH 1S/C19H16BrN3O3/c1-26-12-8-9-15(20)14(10-12)18(24)22-23-17(11-6-7-11)21-16-5-3-2-4-13(16)19(23)25/h2-5,8-11H,6-7H2,1H3,(H,22,24) D0EC3H DRUGINKE OWJRZOOAIAWSHE-UHFFFAOYSA-N D0EC3H DRUGSMIL COC1=CC(=C(C=C1)Br)C(=O)NN2C(=NC3=CC=CC=C3C2=O)C4CC4 D0EC3H HIGHSTAT Patented D0EE5S DRUG__ID D0EE5S D0EE5S DRUGTYPE Small molecular drug D0EE5S DRUGINCH 1S/C25H21F3N6O2/c1-14-19(22-32-24(2,3)13-33(22)17-9-7-15(12-29)8-10-17)31-20(21(30)35)23(36)34(14)18-6-4-5-16(11-18)25(26,27)28/h4-11H,13H2,1-3H3,(H2,30,35) D0EE5S DRUGINKE CMHWRRKHSAWOMT-UHFFFAOYSA-N D0EE5S DRUGSMIL CC1=C(N=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)N)C3=NC(CN3C4=CC=C(C=C4)C#N)(C)C D0EE5S HIGHSTAT Patented D0EE5S COMPCLAS 2-pyrazinone derivatives D0EF5T DRUG__ID D0EF5T D0EF5T DRUGCOMP IRM LLC DING, Qiang SIM, Tae-bo ZHANG, Guobao ADRIAN, Francisco GRAY, Nathanael, S D0EF5T DRUGTYPE Small molecular drug D0EF5T DRUGINCH 1S/C20H17F3N4O3/c21-20(22,23)30-16-6-4-15(5-7-16)27-18-11-17(25-12-26-18)13-2-1-3-14(10-13)19(29)24-8-9-28/h1-7,10-12,28H,8-9H2,(H,24,29)(H,25,26,27) D0EF5T DRUGINKE IIQUYGWWHIHOCF-UHFFFAOYSA-N D0EF5T DRUGSMIL C1=CC(=CC(=C1)C(=O)NCCO)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F D0EF5T HIGHSTAT Patented D0EH2K DRUG__ID D0EH2K D0EH2K DRUGCOMP ACETYLON PHARMACEUTICALS, INC D0EH2K DRUGTYPE Small molecular drug D0EH2K DRUGINCH 1S/C24H26N6O4/c1-34-20-9-7-19(8-10-20)27-23(32)30-13-11-24(12-14-30,18-5-3-2-4-6-18)28-22-25-15-17(16-26-22)21(31)29-33/h2-10,15-16,33H,11-14H2,1H3,(H,27,32)(H,29,31)(H,25,26,28) D0EH2K DRUGINKE LFKIEMRCUDLUJN-UHFFFAOYSA-N D0EH2K DRUGSMIL COC1=CC=C(C=C1)NC(=O)N2CCC(CC2)(C3=CC=CC=C3)NC4=NC=C(C=N4)C(=O)NO D0EH2K HIGHSTAT Patented D0EH2T DRUG__ID D0EH2T D0EH2T DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D0EH2T DRUGTYPE Small molecular drug D0EH2T DRUGINCH 1S/C20H21ClN4O3/c21-14-7-6-13(17(10-14)25-8-1-2-9-25)11-22-20(27)24-16-5-3-4-15-19(16)28-12-18(26)23-15/h3-7,10H,1-2,8-9,11-12H2,(H,23,26)(H2,22,24,27) D0EH2T DRUGINKE IMKHWDHGNGTOSD-UHFFFAOYSA-N D0EH2T DRUGSMIL C1CCN(C1)C2=C(C=CC(=C2)Cl)CNC(=O)NC3=CC=CC4=C3OCC(=O)N4 D0EH2T HIGHSTAT Patented D0EL5B DRUG__ID D0EL5B D0EL5B DRUGTYPE Small molecular drug D0EL5B DRUGINCH 1S/C26H27N7O3S/c1-18-8-10-23(11-9-18)37(35,36)30-22-13-24-25(34)32(15-20-6-3-2-5-19(20)14-27)26(29-33(24)17-22)31-12-4-7-21(28)16-31/h2-3,5-6,8-11,13,17,21,30H,4,7,12,15-16,28H2,1H3/t21-/m1/s1 D0EL5B DRUGINKE ZYJICIOJMGMKDZ-OAQYLSRUSA-N D0EL5B DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CN3C(=C2)C(=O)N(C(=N3)N4CCCC(C4)N)CC5=CC=CC=C5C#N D0EL5B HIGHSTAT Patented D0EL5B COMPCLAS Pyrrolo[1,2-f]triazine derivatives D0EN4B DRUG__ID D0EN4B D0EN4B DRUGCOMP SignalRx Pharmaceuticals, Inc D0EN4B DRUGTYPE Small molecular drug D0EN4B DRUGINCH 1S/C16H16N4O2/c21-14-13-11-17-20(12-7-3-1-4-8-12)15(13)22-16(18-14)19-9-5-2-6-10-19/h1,3-4,7-8,11H,2,5-6,9-10H2 D0EN4B DRUGINKE FXNLCONPKYSXSM-UHFFFAOYSA-N D0EN4B DRUGSMIL C1CCN(CC1)C2=NC(=O)C3=C(O2)N(N=C3)C4=CC=CC=C4 D0EN4B HIGHSTAT Patented D0EP0M DRUG__ID D0EP0M D0EP0M DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED WANG, Rong LU, HongtaGLAXO GROUP LIMITED BAILEY, James, Matthew BRUTON, Gordon HUXLEY, Anthony MILNER, Peter, Henry ORLEK, Barry, Sidney D0EP0M DRUGTYPE Small molecular drug D0EP0M DRUGINCH 1S/C20H29N3O/c1-16(2)22-11-7-19(8-12-22)24-20-9-13-23(14-10-20)18-5-3-17(15-21)4-6-18/h3-6,16,19-20H,7-14H2,1-2H3 D0EP0M DRUGINKE RIRWRSQXDDJXDS-UHFFFAOYSA-N D0EP0M DRUGSMIL CC(C)N1CCC(CC1)OC2CCN(CC2)C3=CC=C(C=C3)C#N D0EP0M HIGHSTAT Patented D0ET4U DRUG__ID D0ET4U D0ET4U DRUGCOMP KARUS THERAPEUTICS LTD D0ET4U DRUGTYPE Small molecular drug D0ET4U DRUGINCH 1S/C21H18FN5O2/c1-26-18-5-3-2-4-17(18)24-21(26)27(19-11-10-16(22)12-23-19)13-14-6-8-15(9-7-14)20(28)25-29/h2-12,29H,13H2,1H3,(H,25,28) D0ET4U DRUGINKE DTDCFCPAKQGZSU-UHFFFAOYSA-N D0ET4U DRUGSMIL CN1C2=CC=CC=C2N=C1N(CC3=CC=C(C=C3)C(=O)NO)C4=NC=C(C=C4)F D0ET4U HIGHSTAT Patented D0EV3G DRUG__ID D0EV3G D0EV3G DRUGCOMP ABBVIE INC D0EV3G DRUGTYPE Small molecular drug D0EV3G DRUGINCH 1S/C22H23F3N2O4/c1-21(2)11-17(14-6-4-8-18(19(14)31-21)30-22(23,24)25)27-20(29)26-16-7-3-5-12-9-13(28)10-15(12)16/h3-8,13,17,28H,9-11H2,1-2H3,(H2,26,27,29)/t13-,17+/m0/s1 D0EV3G DRUGINKE VGEBXDOPNDGVPV-SUMWQHHRSA-N D0EV3G DRUGSMIL CC1(CC(C2=C(O1)C(=CC=C2)OC(F)(F)F)NC(=O)NC3=CC=CC4=C3CC(C4)O)C D0EV3G HIGHSTAT Patented D0EV5U DRUG__ID D0EV5U D0EV5U DRUGCOMP UNIVERSITY OF SOUTH FLORIDA TAN, Jun LUO, Deyan D0EV5U DRUGTYPE Small molecular drug D0EV5U DRUGINCH 1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3 D0EV5U DRUGINKE MBNGWHIJMBWFHU-UHFFFAOYSA-N D0EV5U DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D0EV5U HIGHSTAT Patented D0EX1T DRUG__ID D0EX1T D0EX1T DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH HICKEY, Eugene Richard RIETHER, Doris ERMANN, Monika D0EX1T DRUGTYPE Small molecular drug D0EX1T DRUGINCH 1S/C19H23F3N2O3S2/c1-11-14(17(2,3)4)28-16(23-11)24-15(25)18(5,6)29(26,27)13-9-7-12(8-10-13)19(20,21)22/h7-10H,1-6H3,(H,23,24,25) D0EX1T DRUGINKE GQVUAMKUPFMNNE-UHFFFAOYSA-N D0EX1T DRUGSMIL CC1=C(SC(=N1)NC(=O)C(C)(C)S(=O)(=O)C2=CC=C(C=C2)C(F)(F)F)C(C)(C)C D0EX1T HIGHSTAT Patented D0EY2Q DRUG__ID D0EY2Q D0EY2Q DRUGTYPE Small molecular drug D0EY2Q DRUGINCH 1S/C20H18FIN2O/c1-24(11-5-10-21)20(25)18-13-14-6-2-3-9-17(14)19(23-18)15-7-4-8-16(22)12-15/h2-4,6-9,12-13H,5,10-11H2,1H3 D0EY2Q DRUGINKE KIEVJKCKQLQTJL-UHFFFAOYSA-N D0EY2Q DRUGSMIL CN(CCCF)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC(=CC=C3)I D0EY2Q HIGHSTAT Patented D0EY2Q COMPCLAS Iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives D0EY9Y DRUG__ID D0EY9Y D0EY9Y DRUGCOMP EPITHERAPEUTICS APS D0EY9Y DRUGTYPE Small molecular drug D0EY9Y DRUGINCH 1S/C10H14N2O2S/c1-15-5-4-11-7-9-6-8(10(13)14)2-3-12-9/h2-3,6,11H,4-5,7H2,1H3,(H,13,14) D0EY9Y DRUGINKE RTKPPOFYHYGKKG-UHFFFAOYSA-N D0EY9Y DRUGSMIL CSCCNCC1=NC=CC(=C1)C(=O)O D0EY9Y HIGHSTAT Patented D0EZ5O DRUG__ID D0EZ5O D0EZ5O DRUGCOMP LG Life Sciences Ltd D0EZ5O DRUGTYPE Small molecular drug D0EZ5O DRUGINCH 1S/C16H14N4O2/c1-10(2)19-8-11(6-17)14-5-13(3-4-15(14)19)20-9-12(7-18-20)16(21)22/h3-5,7-10H,1-2H3,(H,21,22) D0EZ5O DRUGINKE JLQQRYOWGCIMMZ-UHFFFAOYSA-N D0EZ5O DRUGSMIL CC(C)N1C=C(C2=C1C=CC(=C2)N3C=C(C=N3)C(=O)O)C#N D0EZ5O HIGHSTAT Patented D0EZ6V DRUG__ID D0EZ6V D0EZ6V DRUGCOMP UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. TURKSON, James HAMILTON, Andrew, D. JOVE, Richard SEBTI, Said, MUniversity of Central Florida research foundation, Inc D0EZ6V DRUGTYPE Small molecular drug D0EZ6V DRUGINCH 1S/C27H29N2O6P/c1-2-3-4-7-17-28-26(30)25-24(18-19-13-15-21(16-14-19)35-36(31,32)33)34-27(29-25)23-12-8-10-20-9-5-6-11-22(20)23/h5-6,8-16H,2-4,7,17-18H2,1H3,(H,28,30)(H2,31,32,33) D0EZ6V DRUGINKE NUEVMWXZKGBDPT-UHFFFAOYSA-N D0EZ6V DRUGSMIL CCCCCCNC(=O)C1=C(OC(=N1)C2=CC=CC3=CC=CC=C32)CC4=CC=C(C=C4)OP(=O)(O)O D0EZ6V HIGHSTAT Patented D0F0VY DRUG__ID D0F0VY D0F0VY DRUGTYPE Small molecular drug D0F0VY DRUGINCH 1S/C26H24Cl2N4O/c1-26(13-5-2-6-14-26)31-25(33)21-16-30-32-23(17-9-11-18(27)12-10-17)20(15-29-24(21)32)19-7-3-4-8-22(19)28/h3-4,7-12,15-16H,2,5-6,13-14H2,1H3,(H,31,33) D0F0VY DRUGINKE UVMYGLSWIQQBTO-UHFFFAOYSA-N D0F0VY DRUGSMIL CC1(CCCCC1)NC(=O)C2=C3N=CC(=C(N3N=C2)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0F0VY HIGHSTAT Patented D0F0VY COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0F1DK DRUG__ID D0F1DK D0F1DK DRUGTYPE Small molecular drug D0F1DK DRUGINCH 1S/C26H20ClN7O2/c1-26(2,3)24-30-22-18(23-31-32-25(35)34(23)24)12-17(20(29-22)16-6-4-5-7-19(16)27)14-8-10-15(11-9-14)21-28-13-36-33-21/h4-13H,1-3H3,(H,32,35) D0F1DK DRUGINKE CHQLSHSXSIIVFC-UHFFFAOYSA-N D0F1DK DRUGSMIL CC(C)(C)C1=NC2=NC(=C(C=C2C3=NNC(=O)N31)C4=CC=C(C=C4)C5=NOC=N5)C6=CC=CC=C6Cl D0F1DK HIGHSTAT Patented D0F1DK COMPCLAS Pyridotriazolopyrimidine derivatives D0F1FD DRUG__ID D0F1FD D0F1FD DRUGCOMP GALAPAGOS NV D0F1FD DRUGTYPE Small molecular drug D0F1FD DRUGINCH 1S/C29H30F2N8O2S/c1-3-23-28(35(2)29-34-26(24(13-32)42-29)18-4-6-19(30)7-5-18)39-14-20(12-22(31)27(39)33-23)37-10-8-36(9-11-37)17-25(41)38-15-21(40)16-38/h4-7,12,14,21,40H,3,8-11,15-17H2,1-2H3 D0F1FD DRUGINKE XWIATKKSLBPZTC-UHFFFAOYSA-N D0F1FD DRUGSMIL CCC1=C(N2C=C(C=C(C2=N1)F)N3CCN(CC3)CC(=O)N4CC(C4)O)N(C)C5=NC(=C(S5)C#N)C6=CC=C(C=C6)F D0F1FD HIGHSTAT Patented D0F2OO DRUG__ID D0F2OO D0F2OO DRUGCOMP GILEAD SCIENCES, INC D0F2OO DRUGTYPE Small molecular drug D0F2OO DRUGINCH 1S/C29H24Cl3N3O5/c30-21-2-1-3-22(31)25(21)26-19(27(40-34-26)16-4-5-16)14-39-18-7-8-20(23(32)12-18)29(38)10-11-35(15-29)24-9-6-17(13-33-24)28(36)37/h1-3,6-9,12-13,16,38H,4-5,10-11,14-15H2,(H,36,37) D0F2OO DRUGINKE YGRGAPWBPFVISR-UHFFFAOYSA-N D0F2OO DRUGSMIL C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CCN(C5)C6=NC=C(C=C6)C(=O)O)O)Cl D0F2OO HIGHSTAT Patented D0F3HP DRUG__ID D0F3HP D0F3HP DRUGCOMP PURDUE PHARMA L.P D0F3HP DRUGTYPE Small molecular drug D0F3HP DRUGINCH 1S/C22H18FN3O3S/c23-17-10-13(9-16(28)12-27)11-24-20(17)14-5-7-15(8-6-14)21(29)26-22-25-18-3-1-2-4-19(18)30-22/h1-8,10-11,16,27-28H,9,12H2,(H,25,26,29)/t16-/m0/s1 D0F3HP DRUGINKE AMBUADZXQKAOQQ-INIZCTEOSA-N D0F3HP DRUGSMIL C1=CC=C2C(=C1)N=C(S2)NC(=O)C3=CC=C(C=C3)C4=C(C=C(C=N4)CC(CO)O)F D0F3HP HIGHSTAT Patented D0F3TB DRUG__ID D0F3TB D0F3TB DRUGCOMP THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0F3TB DRUGTYPE Small molecular drug D0F3TB DRUGINCH 1S/C16H21N3OS/c20-15(12-21)18-10-3-1-2-9-17-14-8-4-6-13-7-5-11-19-16(13)14/h4-8,11,17,21H,1-3,9-10,12H2,(H,18,20) D0F3TB DRUGINKE WCTPLVYFIGGBJC-UHFFFAOYSA-N D0F3TB DRUGSMIL C1=CC2=C(C(=C1)NCCCCCNC(=O)CS)N=CC=C2 D0F3TB HIGHSTAT Patented D0F4DI DRUG__ID D0F4DI D0F4DI DRUGCOMP ABBVIE INC D0F4DI DRUGTYPE Small molecular drug D0F4DI DRUGINCH 1S/C21H22ClFN2O3/c1-21(2)10-17(13-6-7-15(23)18(22)19(13)28-21)25-20(27)24-16-5-3-4-11-8-12(26)9-14(11)16/h3-7,12,17,26H,8-10H2,1-2H3,(H2,24,25,27)/t12-,17+/m0/s1 D0F4DI DRUGINKE NXZOBNXJGCHNTQ-YVEFUNNKSA-N D0F4DI DRUGSMIL CC1(CC(C2=C(O1)C(=C(C=C2)F)Cl)NC(=O)NC3=CC=CC4=C3CC(C4)O)C D0F4DI HIGHSTAT Patented D0F4MN DRUG__ID D0F4MN D0F4MN DRUGCOMP IOMET PHARMA LTD D0F4MN DRUGTYPE Small molecular drug D0F4MN DRUGINCH 1S/C17H14N2O4S/c20-24(21,13-4-5-16-17(10-13)23-9-8-22-16)19-15-3-1-2-12-11-18-7-6-14(12)15/h1-7,10-11,19H,8-9H2 D0F4MN DRUGINKE QYTGSNGNCQHITP-UHFFFAOYSA-N D0F4MN DRUGSMIL C1COC2=C(O1)C=CC(=C2)S(=O)(=O)NC3=CC=CC4=C3C=CN=C4 D0F4MN HIGHSTAT Patented D0F4YX DRUG__ID D0F4YX D0F4YX DRUGCOMP ABBOTT LABORATORIES D0F4YX DRUGTYPE Small molecular drug D0F4YX DRUGINCH 1S/C21H18F3N3O3/c1-12-10-15-13(11-25-12)4-2-6-16(15)26-20(28)27-17-8-9-29-19-14(17)5-3-7-18(19)30-21(22,23)24/h2-7,10-11,17H,8-9H2,1H3,(H2,26,27,28)/t17-/m1/s1 D0F4YX DRUGINKE JPPAKTWQFHCNDQ-QGZVFWFLSA-N D0F4YX DRUGSMIL CC1=CC2=C(C=CC=C2NC(=O)NC3CCOC4=C3C=CC=C4OC(F)(F)F)C=N1 D0F4YX HIGHSTAT Patented D0F5HC DRUG__ID D0F5HC D0F5HC DRUGCOMP NANJING SANHOME PHARMACEUTICAL CO LTD [CN] D0F5HC DRUGTYPE Small molecular drug D0F5HC DRUGINCH 1S/C31H29F6N7O/c1-19-4-5-21(14-20(19)6-9-24-18-43(3)28(39-24)27-38-16-26(41-27)31(35,36)37)29(45)40-23-8-7-22(25(15-23)30(32,33)34)17-44-12-10-42(2)11-13-44/h4-5,7-8,14-16,18H,10-13,17H2,1-3H3,(H,38,41)(H,40,45) D0F5HC DRUGINKE HTQFCQUXHWQFLM-UHFFFAOYSA-N D0F5HC DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN(C(=N4)C5=NC=C(N5)C(F)(F)F)C D0F5HC HIGHSTAT Patented D0F5MF DRUG__ID D0F5MF D0F5MF DRUGCOMP METACRINE, INC D0F5MF DRUGTYPE Small molecular drug D0F5MF DRUGINCH 1S/C34H37N3O2/c1-36(2)31-18-16-27(17-19-31)26-14-12-25(13-15-26)24-37(34(38)28-8-5-4-6-9-28)32-11-7-10-29(20-32)30-21-33(39-3)23-35-22-30/h7,10-23,28H,4-6,8-9,24H2,1-3H3 D0F5MF DRUGINKE GNROXEVONXEHCJ-UHFFFAOYSA-N D0F5MF DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC=CC(=C3)C4=CC(=CN=C4)OC)C(=O)C5CCCCC5 D0F5MF HIGHSTAT Patented D0F5NQ DRUG__ID D0F5NQ D0F5NQ DRUGCOMP GRUENENTHAL GMBH [DE] D0F5NQ DRUGTYPE Small molecular drug D0F5NQ DRUGINCH 1S/C21H27F3N6O2/c1-14-6-9-30(10-7-14)19-15(2-4-17(29-19)21(22,23)24)12-27-20(32)28-16-3-5-18(26-13-16)25-8-11-31/h2-5,13-14,31H,6-12H2,1H3,(H,25,26)(H2,27,28,32) D0F5NQ DRUGINKE YIEBGPCORZIWJQ-UHFFFAOYSA-N D0F5NQ DRUGSMIL CC1CCN(CC1)C2=C(C=CC(=N2)C(F)(F)F)CNC(=O)NC3=CN=C(C=C3)NCCO D0F5NQ HIGHSTAT Patented D0F7DS DRUG__ID D0F7DS D0F7DS DRUGCOMP NOSCIRA, S.A D0F7DS DRUGTYPE Small molecular drug D0F7DS DRUGINCH 1S/C12H9ClN4O/c13-6-1-2-8-7(5-6)10(11(18)16-8)9-3-4-15-12(14)17-9/h1-5,16,18H,(H2,14,15,17) D0F7DS DRUGINKE LHICLFBRLYHBGK-UHFFFAOYSA-N D0F7DS DRUGSMIL C1=CC2=C(C=C1Cl)C(=C(N2)O)C3=NC(=NC=C3)N D0F7DS HIGHSTAT Patented D0F7NL DRUG__ID D0F7NL D0F7NL DRUGCOMP BIOGEN MA INC D0F7NL DRUGTYPE Small molecular drug D0F7NL DRUGINCH 1S/C20H19F6N3O4/c1-2-32-17(30)16-9-15-10-28(4-3-5-29(15)27-16)18(31)33-11-12-6-13(19(21,22)23)8-14(7-12)20(24,25)26/h6-9H,2-5,10-11H2,1H3 D0F7NL DRUGINKE UVKJSSLAVQPIDP-UHFFFAOYSA-N D0F7NL DRUGSMIL CCOC(=O)C1=NN2CCCN(CC2=C1)C(=O)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0F7NL HIGHSTAT Patented D0F7UB DRUG__ID D0F7UB D0F7UB DRUGTYPE Small molecular drug D0F7UB DRUGINCH 1S/C26H31N3OS/c1-20-25(31-26-27-18-22-8-3-4-9-23(22)19-29(20)26)21-10-12-24(13-11-21)30-17-7-16-28-14-5-2-6-15-28/h3-4,8-13H,2,5-7,14-19H2,1H3 D0F7UB DRUGINKE RUTOALHMLUQLAH-UHFFFAOYSA-N D0F7UB DRUGSMIL CC1=C(SC2=NCC3=CC=CC=C3CN12)C4=CC=C(C=C4)OCCCN5CCCCC5 D0F7UB HIGHSTAT Patented D0F7UB COMPCLAS Triazolo-benzodiazepine derivatives D0F8AB DRUG__ID D0F8AB D0F8AB DRUGCOMP PIERRE FABRE MEDICAMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) D0F8AB DRUGTYPE Small molecular drug D0F8AB DRUGINCH 1S/C36H37N7O2/c44-36-30-10-9-27(23-35(30)41-25-43(36)22-18-40-34-12-16-38-32-8-4-2-6-29(32)34)45-24-26-13-19-42(20-14-26)21-17-39-33-11-15-37-31-7-3-1-5-28(31)33/h1-12,15-16,23,25-26H,13-14,17-22,24H2,(H,37,39)(H,38,40) D0F8AB DRUGINKE ZJSGNMNKODEYPA-UHFFFAOYSA-N D0F8AB DRUGSMIL C1CN(CCC1COC2=CC3=C(C=C2)C(=O)N(C=N3)CCNC4=CC=NC5=CC=CC=C54)CCNC6=CC=NC7=CC=CC=C76 D0F8AB HIGHSTAT Patented D0F8KE DRUG__ID D0F8KE D0F8KE DRUGCOMP ELI LILLY AND COMPANY HUGHES, Norman Earle WOODS, Timothy Andrew NORMAN, Bryan Hurst D0F8KE DRUGTYPE Small molecular drug D0F8KE DRUGINCH 1S/C23H22F5N5O2/c1-11(2)20(34)30-10-13-8-16(18(19(24)25)29-9-13)21(35)33-22-31-12(3)17(32-22)14-4-6-15(7-5-14)23(26,27)28/h4-9,11,19H,10H2,1-3H3,(H,30,34)(H2,31,32,33,35) D0F8KE DRUGINKE BZYSILFNUIGABU-UHFFFAOYSA-N D0F8KE DRUGSMIL CC1=C(N=C(N1)NC(=O)C2=C(N=CC(=C2)CNC(=O)C(C)C)C(F)F)C3=CC=C(C=C3)C(F)(F)F D0F8KE HIGHSTAT Patented D0F8XZ DRUG__ID D0F8XZ D0F8XZ DRUGCOMP METASIGNAL THERAPEUTICS INC. SUPURAN, Claudiu DEDHAR, Shoukat CARTA, Fabrizio WINUM, Jean-Yves MCDONALD, Paul C UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES CNRS - DIRE D0F8XZ DRUGTYPE Small molecular drug D0F8XZ DRUGINCH 1S/C9H6OS/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-6H D0F8XZ DRUGINKE FRZDLTCXOSFHJC-UHFFFAOYSA-N D0F8XZ DRUGSMIL C1=CC=C2C(=C1)C=CC(=S)O2 D0F8XZ HIGHSTAT Patented D0F9TY DRUG__ID D0F9TY D0F9TY DRUGTYPE Small molecular drug D0F9TY DRUGINCH 1S/C30H28N6O/c31-20-22-5-10-28-27(19-22)23(21-33-28)3-2-13-34-15-17-35(18-16-34)24-6-8-25(9-7-24)36-14-11-29-26(30(36)37)4-1-12-32-29/h1,4-12,14,19,21,33H,2-3,13,15-18H2 D0F9TY DRUGINKE QGUBOPJCHFVENQ-UHFFFAOYSA-N D0F9TY DRUGSMIL C1CN(CCN1CCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC=C(C=C4)N5C=CC6=C(C5=O)C=CC=N6 D0F9TY HIGHSTAT Patented D0F9TY COMPCLAS Aryl piperazine derivatives D0FC0B DRUG__ID D0FC0B D0FC0B DRUGCOMP ALIOS BIOPHARMA, INC D0FC0B DRUGTYPE Small molecular drug D0FC0B DRUGINCH 1S/C29H22Cl3NO5/c30-21-5-2-6-22(31)25(21)26-20(27(38-33-26)15-7-8-15)14-36-19-12-17-9-10-24(37-28(17)23(32)13-19)16-3-1-4-18(11-16)29(34)35/h1-6,11-13,15,24H,7-10,14H2,(H,34,35) D0FC0B DRUGINKE KCNYPNKMQPDXHA-UHFFFAOYSA-N D0FC0B DRUGSMIL C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC5=C(C(=C4)Cl)OC(CC5)C6=CC(=CC=C6)C(=O)O D0FC0B HIGHSTAT Patented D0FC8P DRUG__ID D0FC8P D0FC8P DRUGTYPE Small molecular drug D0FC8P DRUGINCH 1S/C21H20Cl3N3OS/c1-12-16(11-25-21(28)13-4-2-3-5-13)26-27(17-7-6-14(22)10-15(17)23)20(12)18-8-9-19(24)29-18/h6-10,13H,2-5,11H2,1H3,(H,25,28) D0FC8P DRUGINKE WBIDOYNZOLUBQY-UHFFFAOYSA-N D0FC8P DRUGSMIL CC1=C(N(N=C1CNC(=O)C2CCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(S4)Cl D0FC8P HIGHSTAT Patented D0FC8P COMPCLAS Pyrazole derivatives D0FC9J DRUG__ID D0FC9J D0FC9J DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0FC9J DRUGTYPE Small molecular drug D0FC9J DRUGINCH 1S/C26H31Cl2N3O4/c1-14-11-15(2)29-25(33)20(14)13-31-10-7-18-21(27)12-19(23(28)22(18)26(31)34)24(35-4)17-5-8-30(9-6-17)16(3)32/h11-12,17,24H,5-10,13H2,1-4H3,(H,29,33) D0FC9J DRUGINKE PCBQYEOJXRGLFI-UHFFFAOYSA-N D0FC9J DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C(C4CCN(CC4)C(=O)C)OC)Cl)C D0FC9J HIGHSTAT Patented D0FH5K DRUG__ID D0FH5K D0FH5K DRUGTYPE Small molecular drug D0FH5K DRUGINCH 1S/C23H37N3O3/c1-17-10-11-22(28-2)21(14-17)25-23(27)29-20-15-18-8-7-9-19(16-20)26(18)13-6-4-3-5-12-24/h10-11,14,18-20H,3-9,12-13,15-16,24H2,1-2H3,(H,25,27) D0FH5K DRUGINKE LKFLCBUCBHTSTF-UHFFFAOYSA-N D0FH5K DRUGSMIL CC1=CC(=C(C=C1)OC)NC(=O)OC2CC3CCCC(C2)N3CCCCCCN D0FH5K HIGHSTAT Patented D0FH5K COMPCLAS N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl-phenylcarbamate analogs D0FH6P DRUG__ID D0FH6P D0FH6P DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D0FH6P DRUGTYPE Small molecular drug D0FH6P DRUGINCH 1S/C22H22N2O3/c1-15-3-5-17(6-4-15)7-10-22(26)27-19-8-9-21-20(13-19)18(14-24-21)11-12-23-16(2)25/h3-10,13-14,24H,11-12H2,1-2H3,(H,23,25)/b10-7+ D0FH6P DRUGINKE FKXPVWWTKVQISE-JXMROGBWSA-N D0FH6P DRUGSMIL CC1=CC=C(C=C1)C=CC(=O)OC2=CC3=C(C=C2)NC=C3CCNC(=O)C D0FH6P HIGHSTAT Patented D0FJ1N DRUG__ID D0FJ1N D0FJ1N DRUGCOMP INCYTE CORPORATION D0FJ1N DRUGTYPE Small molecule immunotherapy D0FJ1N DRUGINCH 1S/C26H29N5O2/c1-30-18-19(17-29-30)7-10-28-21-8-11-31(12-9-21)24-4-2-3-22(23(24)16-27)20-5-6-25-26(15-20)33-14-13-32-25/h2-6,15,17-18,21,28H,7-14H2,1H3 D0FJ1N DRUGINKE YIQQKUGTBUPKTJ-UHFFFAOYSA-N D0FJ1N DRUGSMIL CN1C=C(C=N1)CCNC2CCN(CC2)C3=CC=CC(=C3C#N)C4=CC5=C(C=C4)OCCO5 D0FJ1N HIGHSTAT Patented D0FK2Q DRUG__ID D0FK2Q D0FK2Q DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0FK2Q DRUGTYPE Small molecular drug D0FK2Q DRUGINCH 1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14) D0FK2Q DRUGINKE SIQPXVQCUCHWDI-UHFFFAOYSA-N D0FK2Q DRUGSMIL CCCN1C2=C(C(=O)NC1=O)NC=N2 D0FK2Q HIGHSTAT Patented D0FK4P DRUG__ID D0FK4P D0FK4P DRUGCOMP Incyte Corporation D0FK4P DRUGTYPE Small molecule immunotherapy D0FK4P DRUGINCH 1S/C21H24N4O2/c1-15-18(16-7-4-3-5-8-16)9-6-10-19(15)24-21(27)20-23-14-17(25(20)2)13-22-11-12-26/h3-10,14,22,26H,11-13H2,1-2H3,(H,24,27) D0FK4P DRUGINKE NMRCIXCIRVZQNY-UHFFFAOYSA-N D0FK4P DRUGSMIL CC1=C(C=CC=C1NC(=O)C2=NC=C(N2C)CNCCO)C3=CC=CC=C3 D0FK4P HIGHSTAT Patented D0FM3Q DRUG__ID D0FM3Q D0FM3Q DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D0FM3Q DRUGTYPE Small molecular drug D0FM3Q DRUGINCH 1S/C21H20N2O3/c1-15(24)22-12-11-17-14-23-20-9-8-18(13-19(17)20)26-21(25)10-7-16-5-3-2-4-6-16/h2-10,13-14,23H,11-12H2,1H3,(H,22,24)/b10-7+ D0FM3Q DRUGINKE NDJABQJCUZPRSD-JXMROGBWSA-N D0FM3Q DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC(=O)C=CC3=CC=CC=C3 D0FM3Q HIGHSTAT Patented D0FM8Q DRUG__ID D0FM8Q D0FM8Q DRUGCOMP Kissei Pharmaceutical Co. Ltd D0FM8Q DRUGTYPE Small molecular drug D0FM8Q DRUGINCH 1S/C16H10N2O3S/c17-7-10-8-18(9-13(10)15-2-1-5-22-15)11-3-4-12(16(20)21)14(19)6-11/h1-6,8-9,19H,(H,20,21) D0FM8Q DRUGINKE DWSLFJUREKSUNF-UHFFFAOYSA-N D0FM8Q DRUGSMIL C1=CSC(=C1)C2=CN(C=C2C#N)C3=CC(=C(C=C3)C(=O)O)O D0FM8Q HIGHSTAT Patented D0FM9V DRUG__ID D0FM9V D0FM9V DRUGCOMP RIJKSUNIVERSITEIT GRONINGEN D0FM9V DRUGTYPE Small molecule immunotherapy D0FM9V DRUGINCH 1S/C25H30N6O4/c1-17-21(15-28-8-7-27-2)31(9-10-32)24(30-17)16-35-25-20(14-26)19(5-6-29-25)18-3-4-22-23(13-18)34-12-11-33-22/h3-6,13,27-28,32H,7-12,15-16H2,1-2H3 D0FM9V DRUGINKE WQHRKWCRQIAXRG-UHFFFAOYSA-N D0FM9V DRUGSMIL CC1=C(N(C(=N1)COC2=NC=CC(=C2C#N)C3=CC4=C(C=C3)OCCO4)CCO)CNCCNC D0FM9V HIGHSTAT Patented D0FN6F DRUG__ID D0FN6F D0FN6F DRUGCOMP KAINOS MEDICINE, INC D0FN6F DRUGTYPE Small molecular drug D0FN6F DRUGINCH 1S/C21H21ClN4O4S/c1-4-31(27,28)30-12-18-21-25-24-13(2)26(21)19-10-9-16(29-3)11-17(19)20(23-18)14-5-7-15(22)8-6-14/h5-11,18H,4,12H2,1-3H3/t18-/m0/s1 D0FN6F DRUGINKE YVHHEUZAFNGTKI-SFHVURJKSA-N D0FN6F DRUGSMIL CCS(=O)(=O)OCC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C D0FN6F HIGHSTAT Patented D0FN8Y DRUG__ID D0FN8Y D0FN8Y DRUGCOMP NOVARTIS AG BEATTIE, David BAETTIG, Urs LEGRAND, Darren Mark LISTER, Andrew Stuart MCKENNA, Jeffrey PEARCE, David William SANDHAM, David Andrew STEWARD, Oliver Ross THOMSON, Christopher D0FN8Y DRUGTYPE Small molecular drug D0FN8Y DRUGINCH 1S/C25H33F3N8O/c1-18-30-34-36(32-18)17-21-15-22(25(26,27)28)9-7-20(21)8-10-24(37)35-13-11-19(12-14-35)5-3-2-4-6-23-16-29-33-31-23/h7,9,15-16,19H,2-6,8,10-14,17H2,1H3,(H,29,31,33) D0FN8Y DRUGINKE KVDZWWLIQHBBCT-UHFFFAOYSA-N D0FN8Y DRUGSMIL CC1=NN(N=N1)CC2=C(C=CC(=C2)C(F)(F)F)CCC(=O)N3CCC(CC3)CCCCCC4=NNN=C4 D0FN8Y HIGHSTAT Patented D0FQ3D DRUG__ID D0FQ3D D0FQ3D DRUGTYPE Small molecular drug D0FQ3D DRUGINCH 1S/C6H6N2O2/c9-6(8-10)5-2-1-3-7-4-5/h1-4,10H,(H,8,9) D0FQ3D DRUGINKE IYCHDNQCHLMLJZ-UHFFFAOYSA-N D0FQ3D DRUGSMIL C1=CC(=CN=C1)C(=O)NO D0FQ3D HIGHSTAT Patented D0FQ3D COMPCLAS Nicotinyl hydroxamic acid derivatives D0FQ4W DRUG__ID D0FQ4W D0FQ4W DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED JOHANSSON, Lars, Anders, Mikael D0FQ4W DRUGTYPE Small molecular drug D0FQ4W DRUGINCH 1S/C26H28N4O4/c1-18-11-21(8-7-20(18)12-29-15-26(16-29)9-10-32-17-26)33-22-13-30(14-22)25(31)24-28-27-23(34-24)19-5-3-2-4-6-19/h2-8,11,22H,9-10,12-17H2,1H3 D0FQ4W DRUGINKE FMNDCDNBXCVEBC-UHFFFAOYSA-N D0FQ4W DRUGSMIL CC1=C(C=CC(=C1)OC2CN(C2)C(=O)C3=NN=C(O3)C4=CC=CC=C4)CN5CC6(C5)CCOC6 D0FQ4W HIGHSTAT Patented D0FQ6V DRUG__ID D0FQ6V D0FQ6V DRUGCOMP SENEX BIOTECHNOLOGY, INC D0FQ6V DRUGTYPE Small molecular drug D0FQ6V DRUGINCH 1S/C10H10Cl2N2/c11-7-3-8-6(1-2-13)5-14-10(8)9(12)4-7/h3-5,14H,1-2,13H2 D0FQ6V DRUGINKE MOPMGVMKLSZZPB-UHFFFAOYSA-N D0FQ6V DRUGSMIL C1=C(C=C(C2=C1C(=CN2)CCN)Cl)Cl D0FQ6V HIGHSTAT Patented D0FR1Q DRUG__ID D0FR1Q D0FR1Q DRUGTYPE Small molecular drug D0FR1Q DRUGINCH 1S/C19H16F6N2O3S/c20-18(21,22)14-10-15(19(23,24)25)12-16(11-14)31(29,30)27-8-6-26(7-9-27)17(28)13-4-2-1-3-5-13/h1-5,10-12H,6-9H2 D0FR1Q DRUGINKE PIYWKJKVVMSCGG-UHFFFAOYSA-N D0FR1Q DRUGSMIL C1CN(CCN1C(=O)C2=CC=CC=C2)S(=O)(=O)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0FR1Q HIGHSTAT Patented D0FR1Q COMPCLAS Sulfonylated piperazine derivatives D0FS0D DRUG__ID D0FS0D D0FS0D DRUGTYPE Small molecular drug D0FS0D DRUGINCH 1S/C23H15Cl4FN4O/c24-14-3-7-17(19(26)9-14)22-23(18-8-4-15(25)10-20(18)27)31-32(30-22)12-21(33)29-11-13-1-5-16(28)6-2-13/h1-10H,11-12H2,(H,29,33) D0FS0D DRUGINKE MDVQABZPIQBGMA-UHFFFAOYSA-N D0FS0D DRUGSMIL C1=CC(=CC=C1CNC(=O)CN2N=C(C(=N2)C3=C(C=C(C=C3)Cl)Cl)C4=C(C=C(C=C4)Cl)Cl)F D0FS0D HIGHSTAT Patented D0FS0D COMPCLAS 1,2,3-triazole derivatives D0FS2X DRUG__ID D0FS2X D0FS2X DRUGCOMP HEPTARES THERAPEUTICS LIMITED D0FS2X DRUGTYPE Small molecular drug D0FS2X DRUGINCH 1S/C14H8ClN5/c15-12-5-10(8-16)4-11(6-12)13-7-14(18-9-17-13)20-3-1-2-19-20/h1-7,9H D0FS2X DRUGINKE RDPNIWXBEYDORQ-UHFFFAOYSA-N D0FS2X DRUGSMIL C1=CN(N=C1)C2=NC=NC(=C2)C3=CC(=CC(=C3)C#N)Cl D0FS2X HIGHSTAT Patented D0FZ5R DRUG__ID D0FZ5R D0FZ5R DRUGTYPE Small molecular drug D0FZ5R DRUGINCH 1S/C26H26N2O2S/c1-26(2)24(29)28(22-14-9-15-23(17-22)31-3)25(30)27(26)18-21-13-8-7-12-20(21)16-19-10-5-4-6-11-19/h4-15,17H,16,18H2,1-3H3 D0FZ5R DRUGINKE WURWRZROHLTLFU-UHFFFAOYSA-N D0FZ5R DRUGSMIL CC1(C(=O)N(C(=O)N1CC2=CC=CC=C2CC3=CC=CC=C3)C4=CC(=CC=C4)SC)C D0FZ5R HIGHSTAT Patented D0FZ5R COMPCLAS Imidazolidine-2,4-dione derivatives D0G0EG DRUG__ID D0G0EG D0G0EG DRUGCOMP ALVINE PHARMACEUTICALS, INC. PHARMIX CORPORATION GRIFFIN, John LANZA, Guido BOARDMAN, Paul SPENCER, Andrew D0G0EG DRUGTYPE Small molecular drug D0G0EG DRUGINCH 1S/C17H10N2O4/c20-14-10-6-8(1-3-12(10)18-16(14)22)5-9-2-4-13-11(7-9)15(21)17(23)19-13/h1-4,6-7H,5H2,(H,18,20,22)(H,19,21,23) D0G0EG DRUGINKE ZWPNSXUXJWRFIZ-UHFFFAOYSA-N D0G0EG DRUGSMIL C1=CC2=C(C=C1CC3=CC4=C(C=C3)NC(=O)C4=O)C(=O)C(=O)N2 D0G0EG HIGHSTAT Patented D0G2TX DRUG__ID D0G2TX D0G2TX DRUGCOMP GENZYME CORPORATION XIANG, Yibin HIRTH, Bradford KANE, John, L. LIAO, Junkai NOSON, Kevin YEE, Christopher D0G2TX DRUGTYPE Small molecular drug D0G2TX DRUGINCH 1S/C22H30N4O3/c1-14(24-22(28)20-18(27)12-13-23-20)16-7-9-17(10-8-16)21-25-19(29-26-21)11-6-15-4-2-3-5-15/h7-10,14-15,18,20,23,27H,2-6,11-13H2,1H3,(H,24,28)/t14-,18-,20-/m0/s1 D0G2TX DRUGINKE GDJANRNMFHNVOW-DCPHZVHLSA-N D0G2TX DRUGSMIL CC(C1=CC=C(C=C1)C2=NOC(=N2)CCC3CCCC3)NC(=O)C4C(CCN4)O D0G2TX HIGHSTAT Patented D0G3KY DRUG__ID D0G3KY D0G3KY DRUGCOMP INTEKRIN THERAPEUTICS, INC D0G3KY DRUGTYPE Small molecular drug D0G3KY DRUGINCH 1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H D0G3KY DRUGINKE NMRWDFUZLLQSBN-UHFFFAOYSA-N D0G3KY DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)OC3=C(C=C(C=C3Cl)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl)Cl D0G3KY HIGHSTAT Patented D0G3UV DRUG__ID D0G3UV D0G3UV DRUGCOMP GRENTHAL GMBH FRANK, Robert BAHRENBERG, Gregor CHRISTOPH, Thomas SCHIENE, Klaus DE VRY, Jean D0G3UV DRUGTYPE Small molecular drug D0G3UV DRUGINCH 1S/C24H28Cl2N6O/c1-24(2,3)21-15-19(32(29-21)18-7-4-6-17(25)14-18)16-28-23(33)31-12-10-30(11-13-31)22-20(26)8-5-9-27-22/h4-9,14-15H,10-13,16H2,1-3H3,(H,28,33) D0G3UV DRUGINKE UGDIRECFVAQSNI-UHFFFAOYSA-N D0G3UV DRUGSMIL CC(C)(C)C1=NN(C(=C1)CNC(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl)C4=CC(=CC=C4)Cl D0G3UV HIGHSTAT Patented D0G4EK DRUG__ID D0G4EK D0G4EK DRUGCOMP Tsukuba University, JapaKyorin Pharmaceutical Co., Ltd D0G4EK DRUGTYPE Small molecular drug D0G4EK DRUGINCH 1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 D0G4EK DRUGINKE GBFLZEXEOZUWRN-VKHMYHEASA-N D0G4EK DRUGSMIL C(C(C(=O)O)N)SCC(=O)O D0G4EK HIGHSTAT Patented D0G5UR DRUG__ID D0G5UR D0G5UR DRUGCOMP INCYTE CORPORATIOIncyte Corporation D0G5UR DRUGTYPE Small molecular drug D0G5UR DRUGINCH 1S/C22H23N3O4/c1-25-11-16(14-7-8-23-18(14)22(25)27)15-9-13(28-2)10-17-20(15)29-19(21(26)24-17)12-5-3-4-6-12/h7-12,19,23H,3-6H2,1-2H3,(H,24,26) D0G5UR DRUGINKE APVTWFGLNNDNFT-UHFFFAOYSA-N D0G5UR DRUGSMIL CN1C=C(C2=C(C1=O)NC=C2)C3=C4C(=CC(=C3)OC)NC(=O)C(O4)C5CCCC5 D0G5UR HIGHSTAT Patented D0G8LH DRUG__ID D0G8LH D0G8LH DRUGTYPE Small molecular drug D0G8LH DRUGINCH 1S/C23H20Cl2N6O3S/c24-15-9-7-14(8-10-15)20-17(16-5-1-2-6-18(16)25)13-27-21-19(22(32)28-30-11-3-4-12-30)23(29-31(20)21)35(26,33)34/h1-2,5-10,13H,3-4,11-12H2,(H,28,32)(H2,26,33,34) D0G8LH DRUGINKE WHAZINAXCQYHKF-UHFFFAOYSA-N D0G8LH DRUGSMIL C1CCN(C1)NC(=O)C2=C3N=CC(=C(N3N=C2S(=O)(=O)N)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0G8LH HIGHSTAT Patented D0G8LH COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0G9CR DRUG__ID D0G9CR D0G9CR DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0G9CR DRUGTYPE Small molecular drug D0G9CR DRUGINCH 1S/C58H56Br2N8O8/c1-33(61-3)53(69)63-45-31-67(49-13-9-7-11-47(49)65(57(45)73)29-43-41-23-21-39(59)27-37(41)19-25-51(43)75-5)55(71)35-15-17-36(18-16-35)56(72)68-32-46(64-54(70)34(2)62-4)58(74)66(48-12-8-10-14-50(48)68)30-44-42-24-22-40(60)28-38(42)20-26-52(44)76-6/h7-28,33-34,45-46,61-62H,29-32H2,1-6H3,(H,63,69)(H,64,70)/t33-,34-,45-,46-/m0/s1 D0G9CR DRUGINKE PBGWEJJBQUBSJN-MLLHAFNLSA-N D0G9CR DRUGSMIL CC(C(=O)NC1CN(C2=CC=CC=C2N(C1=O)CC3=C(C=CC4=C3C=CC(=C4)Br)OC)C(=O)C5=CC=C(C=C5)C(=O)N6CC(C(=O)N(C7=CC=CC=C76)CC8=C(C=CC9=C8C=CC(=C9)Br)OC)NC(=O)C(C)NC)NC D0G9CR HIGHSTAT Patented D0GH0Z DRUG__ID D0GH0Z D0GH0Z DRUGCOMP RICHTER GEDEON NYRT [HU] D0GH0Z DRUGTYPE Small molecular drug D0GH0Z DRUGINCH 1S/C26H24ClN3O4S/c1-32-22-10-19(6-7-21(22)34-9-8-29-12-26(13-29)14-33-15-26)30-16-28-20-11-23(35-24(20)25(30)31)17-2-4-18(27)5-3-17/h2-7,10-11,16H,8-9,12-15H2,1H3 D0GH0Z DRUGINKE RYWKRAVYOFTFPJ-UHFFFAOYSA-N D0GH0Z DRUGSMIL COC1=C(C=CC(=C1)N2C=NC3=C(C2=O)SC(=C3)C4=CC=C(C=C4)Cl)OCCN5CC6(C5)COC6 D0GH0Z HIGHSTAT Patented D0GN5K DRUG__ID D0GN5K D0GN5K DRUGCOMP GLAXOSMITHKLINE LLC CHRISTENSEN, Siegfried, Benjamin, IV QIN, Donghui CHEN, Shuhui LU, Shi D0GN5K DRUGTYPE Small molecular drug D0GN5K DRUGINCH 1S/C23H22ClN5O3/c24-16-1-2-17(26-12-16)14-32-19-5-10-28(21(30)11-19)18-3-4-20(27-13-18)29-15-23(22(29)31)6-8-25-9-7-23/h1-5,10-13,25H,6-9,14-15H2 D0GN5K DRUGINKE SIMRWGQXBPBXAH-UHFFFAOYSA-N D0GN5K DRUGSMIL C1CNCCC12CN(C2=O)C3=NC=C(C=C3)N4C=CC(=CC4=O)OCC5=NC=C(C=C5)Cl D0GN5K HIGHSTAT Patented D0GQ7L DRUG__ID D0GQ7L D0GQ7L DRUGCOMP BAYER INTELLECTUAL PROPERTY GMBH D0GQ7L DRUGTYPE Small molecular drug D0GQ7L DRUGINCH 1S/C24H21F2N5O2S/c1-34(27,32)14-17-5-3-7-20(11-17)30-24-29-15-28-23(31-24)21-9-8-19(26)12-22(21)33-13-16-4-2-6-18(25)10-16/h2-12,15,27H,13-14H2,1H3,(H,28,29,30,31) D0GQ7L DRUGINKE YPAQXRURXUKFGB-UHFFFAOYSA-N D0GQ7L DRUGSMIL CS(=N)(=O)CC1=CC(=CC=C1)NC2=NC=NC(=N2)C3=C(C=C(C=C3)F)OCC4=CC(=CC=C4)F D0GQ7L HIGHSTAT Patented D0GQ8W DRUG__ID D0GQ8W D0GQ8W DRUGTYPE Small molecular drug D0GQ8W DRUGINCH 1S/C24H30N2O2/c1-3-4-6-15-26-22-12-9-18(24(27)25-13-7-5-8-14-25)16-21(22)20-11-10-19(28-2)17-23(20)26/h9-12,16-17H,3-8,13-15H2,1-2H3 D0GQ8W DRUGINKE LHILAHDXYGCIPJ-UHFFFAOYSA-N D0GQ8W DRUGSMIL CCCCCN1C2=C(C=C(C=C2)C(=O)N3CCCCC3)C4=C1C=C(C=C4)OC D0GQ8W HIGHSTAT Patented D0GQ8W COMPCLAS Carbazole-3-carboxamide analogs D0GT7A DRUG__ID D0GT7A D0GT7A DRUGCOMP EPIZYME, INC D0GT7A DRUGTYPE Small molecular drug D0GT7A DRUGINCH 1S/C31H41N7O2/c1-7-21(4)37-19-20(3)29-25(30(39)34-18-26-22(5)38(8-2)35-31(26)40-6)15-24(16-27(29)37)23-9-10-28(33-17-23)36-13-11-32-12-14-36/h9-10,15-17,19,21,32H,7-8,11-14,18H2,1-6H3,(H,34,39) D0GT7A DRUGINKE NMLLGPWQRDDVGB-UHFFFAOYSA-N D0GT7A DRUGSMIL CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(N(N=C5OC)CC)C)C D0GT7A HIGHSTAT Patented D0GV3X DRUG__ID D0GV3X D0GV3X DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE D0GV3X DRUGTYPE Small molecular drug D0GV3X DRUGINCH 1S/C16H9N3/c17-8-10-7-11-9-18-6-5-12(11)16-15(10)13-3-1-2-4-14(13)19-16/h1-7,9,19H D0GV3X DRUGINKE DCPBIOSSTDLFHO-UHFFFAOYSA-N D0GV3X DRUGSMIL C1=CC=C2C(=C1)C3=C(C=C4C=NC=CC4=C3N2)C#N D0GV3X HIGHSTAT Patented D0GV5G DRUG__ID D0GV5G D0GV5G DRUGCOMP Japan Tobacco, Inc D0GV5G DRUGTYPE Small molecular drug D0GV5G DRUGINCH 1S/C26H27F2N3O4/c1-15-8-9-22(29-12-15)31-17(13-32)14-34-23-18(6-5-7-21(23)31)25(33)30-16-10-19(27)24(20(28)11-16)35-26(2,3)4/h5-12,17,32H,13-14H2,1-4H3,(H,30,33)/t17-/m0/s1 D0GV5G DRUGINKE XZRDDTOOBFNFRB-KRWDZBQOSA-N D0GV5G DRUGSMIL CC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C(=O)NC4=CC(=C(C(=C4)F)OC(C)(C)C)F)CO D0GV5G HIGHSTAT Patented D0GW5H DRUG__ID D0GW5H D0GW5H DRUGTYPE Small molecular drug D0GW5H DRUGINCH 1S/C25H29NO4/c1-30-23-5-3-18(24(29)26-14-19-2-4-20(27)10-22(19)28)9-21(23)25-11-15-6-16(12-25)8-17(7-15)13-25/h2-5,9-10,15-17,27-28H,6-8,11-14H2,1H3,(H,26,29) D0GW5H DRUGINKE MZAJLDVRKVEVKU-UHFFFAOYSA-N D0GW5H DRUGSMIL COC1=C(C=C(C=C1)C(=O)NCC2=C(C=C(C=C2)O)O)C34CC5CC(C3)CC(C5)C4 D0GW5H HIGHSTAT Patented D0GW5H COMPCLAS Polyhydroxy benzamide derivatives D0GW8L DRUG__ID D0GW8L D0GW8L DRUGCOMP SANOFI-AVENTIS BARTH, Francis CONGY, Christian DUCOUX, Jean-Philippe RINALDI-CARMONA, Murielle D0GW8L DRUGTYPE Small molecular drug D0GW8L DRUGINCH 1S/C32H30Cl2N2O4S/c33-23-9-12-25(27(34)19-23)29-26(21-7-10-24(11-8-21)40-18-4-17-37)20-28(41-29)30(38)36-15-13-32(14-16-36,31(35)39)22-5-2-1-3-6-22/h1-3,5-12,19-20,37H,4,13-18H2,(H2,35,39) D0GW8L DRUGINKE WHNYDESPWWLRBM-UHFFFAOYSA-N D0GW8L DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)C(=O)N)C(=O)C3=CC(=C(S3)C4=C(C=C(C=C4)Cl)Cl)C5=CC=C(C=C5)OCCCO D0GW8L HIGHSTAT Patented D0GY4F DRUG__ID D0GY4F D0GY4F DRUGCOMP NTZ LAB LTD [BG] D0GY4F DRUGTYPE Small molecular drug D0GY4F DRUGINCH 1S/C14H9Cl2N3O/c15-10-4-11(16)6-12(5-10)18-14(20)8-1-2-13-9(3-8)7-17-19-13/h1-7H,(H,17,19)(H,18,20) D0GY4F DRUGINKE XXLZLPDHTLLSMN-UHFFFAOYSA-N D0GY4F DRUGSMIL C1=CC2=C(C=C1C(=O)NC3=CC(=CC(=C3)Cl)Cl)C=NN2 D0GY4F HIGHSTAT Patented D0GZ4G DRUG__ID D0GZ4G D0GZ4G DRUGCOMP ABBVIE INC D0GZ4G DRUGTYPE Small molecular drug D0GZ4G DRUGINCH 1S/C19H20N4O/c24-19(22-17-7-4-8-18-16(17)12-20-23-18)21-15-10-9-14(11-15)13-5-2-1-3-6-13/h1-8,12,14-15H,9-11H2,(H,20,23)(H2,21,22,24)/t14-,15+/m1/s1 D0GZ4G DRUGINKE JSEHDPNFIUYQLO-CABCVRRESA-N D0GZ4G DRUGSMIL C1CC(CC1C2=CC=CC=C2)NC(=O)NC3=CC=CC4=C3C=NN4 D0GZ4G HIGHSTAT Patented D0H0CH DRUG__ID D0H0CH D0H0CH DRUGCOMP INCYTE CORPORATION D0H0CH DRUGTYPE Small molecule immunotherapy D0H0CH DRUGINCH 1S/C28H28N2O3/c1-18-15-20(17-30-14-7-6-13-25(30)28(31)32)16-24-26(18)33-27(29-24)23-12-8-11-22(19(23)2)21-9-4-3-5-10-21/h3-5,8-12,15-16,25H,6-7,13-14,17H2,1-2H3,(H,31,32)/t25-/m0/s1 D0H0CH DRUGINKE UWWIGOJLOPXCJZ-VWLOTQADSA-N D0H0CH DRUGSMIL CC1=CC(=CC2=C1OC(=N2)C3=CC=CC(=C3C)C4=CC=CC=C4)CN5CCCCC5C(=O)O D0H0CH HIGHSTAT Patented D0H0LO DRUG__ID D0H0LO D0H0LO DRUGTYPE Small molecular drug D0H0LO DRUGINCH 1S/C28H28N4O4/c33-25-15-14-23(31-25)28(36)32(19-21-11-5-2-6-12-21)24(17-20-9-3-1-4-10-20)26(34)27(35)30-18-22-13-7-8-16-29-22/h1-13,16,23-24H,14-15,17-19H2,(H,30,35)(H,31,33)/t23-,24?/m0/s1 D0H0LO DRUGINKE BRJIMUOJPNOLKS-UXMRNZNESA-N D0H0LO DRUGSMIL C1CC(=O)NC1C(=O)N(CC2=CC=CC=C2)C(CC3=CC=CC=C3)C(=O)C(=O)NCC4=CC=CC=N4 D0H0LO HIGHSTAT Patented D0H0LO COMPCLAS Carboxamide derivatives D0H1BQ DRUG__ID D0H1BQ D0H1BQ DRUGCOMP AJINOMOTO CO., INC D0H1BQ DRUGTYPE Small molecular drug D0H1BQ DRUGINCH 1S/C28H32N2O2/c1-28(2)11-10-27(32)25(16-28)21-6-3-5-19(13-21)20-8-9-26-22(14-20)15-23(29-26)17-30-12-4-7-24(30)18-31/h3,5-6,8-9,13-16,24,29,31H,4,7,10-12,17-18H2,1-2H3/t24-/m1/s1 D0H1BQ DRUGINKE PNODTUCQTPQANY-XMMPIXPASA-N D0H1BQ DRUGSMIL CC1(CCC(=O)C(=C1)C2=CC=CC(=C2)C3=CC4=C(C=C3)NC(=C4)CN5CCCC5CO)C D0H1BQ HIGHSTAT Patented D0H1LQ DRUG__ID D0H1LQ D0H1LQ DRUGCOMP MERCK SHARP & DOHME CORP. MANLEY, Peter, J. NANDA, Kausik, K. TROTTER, B. Wesley D0H1LQ DRUGTYPE Small molecular drug D0H1LQ DRUGINCH 1S/C24H26ClN3O2/c1-4-27(5-2)22(29)12-13-24(17-6-8-18(25)9-7-17)21-16-19(30-3)10-11-20(21)23-26-14-15-28(23)24/h6-11,14-16H,4-5,12-13H2,1-3H3 D0H1LQ DRUGINKE YBMSTCJKQQMCAW-UHFFFAOYSA-N D0H1LQ DRUGSMIL CCN(CC)C(=O)CCC1(C2=C(C=CC(=C2)OC)C3=NC=CN31)C4=CC=C(C=C4)Cl D0H1LQ HIGHSTAT Patented D0H2BU DRUG__ID D0H2BU D0H2BU DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia WICHMANN, Juergen WOLTERING, Thomas D0H2BU DRUGTYPE Small molecular drug D0H2BU DRUGINCH 1S/C23H17F3N4O2S/c1-14-10-17(16-8-9-22(28-13-16)23(24,25)26)12-21(29-14)20-7-3-6-19(30-20)15-4-2-5-18(11-15)33(27,31)32/h2-13H,1H3,(H2,27,31,32) D0H2BU DRUGINKE SNOQZNIOGMOXDJ-UHFFFAOYSA-N D0H2BU DRUGSMIL CC1=CC(=CC(=N1)C2=CC=CC(=N2)C3=CC(=CC=C3)S(=O)(=O)N)C4=CN=C(C=C4)C(F)(F)F D0H2BU HIGHSTAT Patented D0H2DL DRUG__ID D0H2DL D0H2DL DRUGCOMP University of Texas D0H2DL DRUGTYPE Small molecular drug D0H2DL DRUGINCH 1S/C20H16N6O3S/c1-13(27)21-15-8-5-9-16(10-15)26-23-20(22-25-26)30-12-18(28)19-11-17(24-29-19)14-6-3-2-4-7-14/h2-11H,12H2,1H3,(H,21,27) D0H2DL DRUGINKE ZSSIYCOJZBCFEO-UHFFFAOYSA-N D0H2DL DRUGSMIL CC(=O)NC1=CC(=CC=C1)N2N=C(N=N2)SCC(=O)C3=CC(=NO3)C4=CC=CC=C4 D0H2DL HIGHSTAT Patented D0H2LD DRUG__ID D0H2LD D0H2LD DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0H2LD DRUGTYPE Small molecular drug D0H2LD DRUGINCH 1S/C24H15F6N3/c25-23(26,27)19-7-4-14(5-8-19)18-11-20(33-21(12-18)24(28,29)30)16-3-1-2-15(10-16)17-6-9-22(31)32-13-17/h1-13H,(H2,31,32) D0H2LD DRUGINKE VLHFNIFTVTULIS-UHFFFAOYSA-N D0H2LD DRUGSMIL C1=CC(=CC(=C1)C2=NC(=CC(=C2)C3=CC=C(C=C3)C(F)(F)F)C(F)(F)F)C4=CN=C(C=C4)N D0H2LD HIGHSTAT Patented D0H3VI DRUG__ID D0H3VI D0H3VI DRUGCOMP NOVARTIS AG BURGER, Matthew DING, Yu HAN, Wooseok LINDVALL, Mika NISHIGUCHI, Gisele A. RICO, Alice SMITH, Aaron TANNER, Huw WAN, Lifeng D0H3VI DRUGTYPE Small molecular drug D0H3VI DRUGINCH 1S/C24H23N5O3/c1-14-19(30)11-20(32-24(14)8-9-24)16-7-10-26-12-18(16)29-23(31)21-22(25)27-13-17(28-21)15-5-3-2-4-6-15/h2-7,10,12-13,19-20,30H,1,8-9,11H2,(H2,25,27)(H,29,31)/t19-,20-/m0/s1 D0H3VI DRUGINKE WHESOVNDWAKAQI-PMACEKPBSA-N D0H3VI DRUGSMIL C=C1C(CC(OC12CC2)C3=C(C=NC=C3)NC(=O)C4=NC(=CN=C4N)C5=CC=CC=C5)O D0H3VI HIGHSTAT Patented D0H3ZZ DRUG__ID D0H3ZZ D0H3ZZ DRUGCOMP FLEXUS BIOSCIENCES, INC D0H3ZZ DRUGTYPE Small molecular drug D0H3ZZ DRUGINCH 1S/C21H22ClF3N2O/c1-13(20(28)27-18-8-6-17(22)7-9-18)14-2-4-15(5-3-14)16-10-11-26-19(12-16)21(23,24)25/h6-15H,2-5H2,1H3,(H,27,28) D0H3ZZ DRUGINKE WSWKMGSCQQQPBU-UHFFFAOYSA-N D0H3ZZ DRUGSMIL CC(C1CCC(CC1)C2=CC(=NC=C2)C(F)(F)F)C(=O)NC3=CC=C(C=C3)Cl D0H3ZZ HIGHSTAT Patented D0H4HR DRUG__ID D0H4HR D0H4HR DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0H4HR DRUGTYPE Small molecular drug D0H4HR DRUGINCH 1S/C19H21BrN2O3/c1-10-5-11(2)22-18(24)14(10)9-21-17(23)12-6-13-8-19(3,4)25-16(13)15(20)7-12/h5-7H,8-9H2,1-4H3,(H,21,23)(H,22,24) D0H4HR DRUGINKE HDXJPZKHNBTZOX-UHFFFAOYSA-N D0H4HR DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC3=C(C(=C2)Br)OC(C3)(C)C)C D0H4HR HIGHSTAT Patented D0H4TR DRUG__ID D0H4TR D0H4TR DRUGCOMP Japan Tobacco, Inc D0H4TR DRUGTYPE Small molecular drug D0H4TR DRUGINCH 1S/C22H17Cl2F3N4O2/c1-28-19(32)12-31(20-17(24)3-2-10-29-20)18-11-13(4-9-16(18)23)21(33)30-15-7-5-14(6-8-15)22(25,26)27/h2-11H,12H2,1H3,(H,28,32)(H,30,33) D0H4TR DRUGINKE OGONHQFOPUHELI-UHFFFAOYSA-N D0H4TR DRUGSMIL CNC(=O)CN(C1=C(C=CC(=C1)C(=O)NC2=CC=C(C=C2)C(F)(F)F)Cl)C3=C(C=CC=N3)Cl D0H4TR HIGHSTAT Patented D0H6CX DRUG__ID D0H6CX D0H6CX DRUGCOMP Japan Tobacco, Inc D0H6CX DRUGTYPE Small molecular drug D0H6CX DRUGINCH 1S/C23H23Cl2N3O/c1-23(2,3)16-8-10-17(11-9-16)27-22(29)15-7-12-18(24)20(14-15)28(4)21-19(25)6-5-13-26-21/h5-14H,1-4H3,(H,27,29) D0H6CX DRUGINKE KDJDFSOSSGWODT-UHFFFAOYSA-N D0H6CX DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2)Cl)N(C)C3=C(C=CC=N3)Cl D0H6CX HIGHSTAT Patented D0H8IH DRUG__ID D0H8IH D0H8IH DRUGCOMP ARENA PHARMACEUTICALS, INC. SELVEY, Lee, Alani CARLOS, Marlon V. MAFFUID, Paul SHAN, Yun BETTS, William, L., III GIVEN, Deam, Windate, III HART, Ryan, M. SHAO, Zezhi, Jesse D0H8IH DRUGTYPE Small molecular drug D0H8IH DRUGINCH 1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26) D0H8IH DRUGINKE COSPVUFTLGQDQL-UHFFFAOYSA-N D0H8IH DRUGSMIL CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)OC D0H8IH HIGHSTAT Patented D0H9AU DRUG__ID D0H9AU D0H9AU DRUGCOMP Ferring BV D0H9AU DRUGTYPE Small molecular drug D0H9AU DRUGINCH 1S/C24H24ClN5O2/c1-14-9-16(5-6-17(14)11-26-23(31)15-3-4-15)24(32)30-13-18-12-27-29(2)22(18)28-20-10-19(25)7-8-21(20)30/h5-10,12,15,28H,3-4,11,13H2,1-2H3,(H,26,31) D0H9AU DRUGINKE DZLYFDUKRUYUIP-UHFFFAOYSA-N D0H9AU DRUGSMIL CC1=C(C=CC(=C1)C(=O)N2CC3=C(NC4=C2C=CC(=C4)Cl)N(N=C3)C)CNC(=O)C5CC5 D0H9AU HIGHSTAT Patented D0H9IX DRUG__ID D0H9IX D0H9IX DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0H9IX DRUGTYPE Small molecular drug D0H9IX DRUGINCH 1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3 D0H9IX DRUGINKE RYYVLZVUVIJVGH-UHFFFAOYSA-N D0H9IX DRUGSMIL CN1C=NC2=C1C(=O)N(C(=O)N2C)C D0H9IX HIGHSTAT Patented D0HD7S DRUG__ID D0HD7S D0HD7S DRUGCOMP SANOFI-AVENTIS BARTH, Francis BICHON, Daniel CONGY, Christian RINALDI-CARMONA, Muriell D0HD7S DRUGTYPE Small molecular drug D0HD7S DRUGINCH 1S/C32H29Cl4N3O3/c33-21-5-3-20(4-6-21)32(31(37)42)13-15-38(16-14-32)30(41)26-19-29(25-12-9-23(35)18-27(25)36)39(28(26)2-1-17-40)24-10-7-22(34)8-11-24/h3-12,18-19,40H,1-2,13-17H2,(H2,37,42) D0HD7S DRUGINKE VICABLXDCCBPMT-UHFFFAOYSA-N D0HD7S DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Cl)C(=O)N)C(=O)C3=C(N(C(=C3)C4=C(C=C(C=C4)Cl)Cl)C5=CC=C(C=C5)Cl)CCCO D0HD7S HIGHSTAT Patented D0HE7X DRUG__ID D0HE7X D0HE7X DRUGCOMP ABBVIE INC D0HE7X DRUGTYPE Small molecular drug D0HE7X DRUGINCH 1S/C22H21F2N3O/c1-13-10-18-15(12-25-13)7-9-20(24)21(18)27-22(28)26-16-8-6-14(11-16)17-4-2-3-5-19(17)23/h2-5,7,9-10,12,14,16H,6,8,11H2,1H3,(H2,26,27,28)/t14-,16-/m1/s1 D0HE7X DRUGINKE PJVXUKARZNCIRA-GDBMZVCRSA-N D0HE7X DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC=CC=C4F)F)C=N1 D0HE7X HIGHSTAT Patented D0HG1W DRUG__ID D0HG1W D0HG1W DRUGCOMP Korea Institute of Science and Technology D0HG1W DRUGTYPE Small molecular drug D0HG1W DRUGINCH 1S/C17H9N3/c18-12-16-6-3-5-14(19-16)10-11-15-9-8-13-4-1-2-7-17(13)20-15/h1-9H D0HG1W DRUGINKE SAXYXSCAJSSRCR-UHFFFAOYSA-N D0HG1W DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)C#CC3=NC(=CC=C3)C#N D0HG1W HIGHSTAT Patented D0HG2S DRUG__ID D0HG2S D0HG2S DRUGCOMP PFIZER LIMITED D0HG2S DRUGTYPE Small molecular drug D0HG2S DRUGINCH 1S/C19H10ClFN4O3S/c20-17-8-15(3-1-12(17)9-22)28-18-5-4-16(7-13(18)10-23)29(26,27)25-19-6-2-14(21)11-24-19/h1-8,11H,(H,24,25) D0HG2S DRUGINKE ABKCBHGHCYFDNT-UHFFFAOYSA-N D0HG2S DRUGSMIL C1=CC(=C(C=C1OC2=C(C=C(C=C2)S(=O)(=O)NC3=NC=C(C=C3)F)C#N)Cl)C#N D0HG2S HIGHSTAT Patented D0HH1O DRUG__ID D0HH1O D0HH1O DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0HH1O DRUGTYPE Small molecular drug D0HH1O DRUGINCH 1S/C24H26N2O3/c1-18-13-20(15-25(2)3)9-10-22(18)23(27)16-26-12-11-21(14-24(26)28)29-17-19-7-5-4-6-8-19/h4-14H,15-17H2,1-3H3 D0HH1O DRUGINKE QONJYPHKWHUJOW-UHFFFAOYSA-N D0HH1O DRUGSMIL CC1=C(C=CC(=C1)CN(C)C)C(=O)CN2C=CC(=CC2=O)OCC3=CC=CC=C3 D0HH1O HIGHSTAT Patented D0HH5B DRUG__ID D0HH5B D0HH5B DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PFAU, Roland ARNDT, Kirsten DOODS, Henri KLINDER, Klaus KUELZER, Raimund LUBRIKS, Dimitrijs MACK, Juergen PELCMAN, Benjamin PRIEPKE, Henning ROENN, Robert STENKAMP, Dirk SUNA, Edgars D0HH5B DRUGTYPE Small molecular drug D0HH5B DRUGINCH 1S/C30H33F8N5O3/c1-28(2,3)26(45)39-13-15-4-9-19(30(36,37)38)20(10-15)41-27-42-21-11-18(23(12-22(21)43-27)46-14-24(31)32)25(44)40-17-7-5-16(6-8-17)29(33,34)35/h4,9-12,16-17,24H,5-8,13-14H2,1-3H3,(H,39,45)(H,40,44)(H2,41,42,43) D0HH5B DRUGINKE QUJFMVVWDBGGPL-UHFFFAOYSA-N D0HH5B DRUGSMIL CC(C)(C)C(=O)NCC1=CC(=C(C=C1)C(F)(F)F)NC2=NC3=C(N2)C=C(C(=C3)OCC(F)F)C(=O)NC4CCC(CC4)C(F)(F)F D0HH5B HIGHSTAT Patented D0HM6Q DRUG__ID D0HM6Q D0HM6Q DRUGCOMP AJINOMOTO CO., INC D0HM6Q DRUGTYPE Small molecular drug D0HM6Q DRUGINCH 1S/C26H30N2O/c29-18-25-10-5-13-28(25)17-24-16-23-15-22(11-12-26(23)27-24)21-9-4-8-20(14-21)19-6-2-1-3-7-19/h4,6,8-9,11-12,14-16,25,27,29H,1-3,5,7,10,13,17-18H2/t25-/m1/s1 D0HM6Q DRUGINKE VGAFMTJLEJHSLL-RUZDIDTESA-N D0HM6Q DRUGSMIL C1CCC(=CC1)C2=CC=CC(=C2)C3=CC4=C(C=C3)NC(=C4)CN5CCCC5CO D0HM6Q HIGHSTAT Patented D0HY5Q DRUG__ID D0HY5Q D0HY5Q DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN WANG, Shaomeng SUN, Haiying D0HY5Q DRUGTYPE Small molecular drug D0HY5Q DRUGINCH 1S/C62H78N12O7/c1-39(63-3)59(77)67-49-37-71(33-31-43-27-29-51(73(43)61(49)79)57-65-47-23-15-21-45(55(47)69-57)41-17-7-5-8-18-41)53(75)25-11-13-35-81-36-14-12-26-54(76)72-34-32-44-28-30-52(74(44)62(80)50(38-72)68-60(78)40(2)64-4)58-66-48-24-16-22-46(56(48)70-58)42-19-9-6-10-20-42/h5-10,15-24,39-40,43-44,49-52,63-64H,11-14,25-38H2,1-4H3,(H,65,69)(H,66,70)(H,67,77)(H,68,78)/t39-,40-,43+,44+,49-,50-,51-,52-/m0/s1 D0HY5Q DRUGINKE ZPYWWTKXCOYJBE-LLUFGHGUSA-N D0HY5Q DRUGSMIL CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C3=NC4=C(C=CC=C4N3)C5=CC=CC=C5)C(=O)CCCCOCCCCC(=O)N6CCC7CCC(N7C(=O)C(C6)NC(=O)C(C)NC)C8=NC9=C(C=CC=C9N8)C1=CC=CC=C1)NC D0HY5Q HIGHSTAT Patented D0I3KT DRUG__ID D0I3KT D0I3KT DRUGCOMP JOHNSON & JOHNSON CONSUMER COMPANIES, INC D0I3KT DRUGTYPE Small molecular drug D0I3KT DRUGINCH 1S/C22H18O3/c23-20-9-5-16(6-10-20)1-3-18-13-19(15-22(25)14-18)4-2-17-7-11-21(24)12-8-17/h1-15,23-25H/b3-1+,4-2+ D0I3KT DRUGINKE ICUPUOLNNGGWKO-ZPUQHVIOSA-N D0I3KT DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)C=CC3=CC=C(C=C3)O)O D0I3KT HIGHSTAT Patented D0I5DE DRUG__ID D0I5DE D0I5DE DRUGCOMP Boehringer Ingelheim International GMBH D0I5DE DRUGTYPE Small molecular drug D0I5DE DRUGINCH 1S/C31H28Cl2F6N6O/c1-43-26-16-25(45-12-10-44(11-13-45)20-5-3-19(4-6-20)30(34,35)36)22(33)15-24(26)42-28(43)41-23-14-18(2-7-21(23)32)17-40-27(46)29(8-9-29)31(37,38)39/h2-7,14-16H,8-13,17H2,1H3,(H,40,46)(H,41,42) D0I5DE DRUGINKE YVXLODVZVGRVRR-UHFFFAOYSA-N D0I5DE DRUGSMIL CN1C2=CC(=C(C=C2N=C1NC3=C(C=CC(=C3)CNC(=O)C4(CC4)C(F)(F)F)Cl)Cl)N5CCN(CC5)C6=CC=C(C=C6)C(F)(F)F D0I5DE HIGHSTAT Patented D0I5VG DRUG__ID D0I5VG D0I5VG DRUGCOMP HANMI SCIENCE CO., LTD. KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION SON, Jung Beom JUNG, Seung Hyun CHOI, Wha Il JUNG, Young Hee CHOI, Jae Yul SONG, Ji Yeon LEE, Kyu Hang LEE, Jae Chul KIM, Eun Young AHN, Young Gil KIM, Maeng Sup CHOI, Hwan Geun SIM, Tae Bo HAM, Young Jin PARK, Dong-sik KIM, Hwan KIM, Dong-Wook D0I5VG DRUGTYPE Small molecular drug D0I5VG DRUGINCH 1S/C26H22FN7O2S/c1-14-3-8-18(10-20(14)32-25(35)19-12-37-23-22(19)29-13-30-24(23)28)31-26(36)21-9-15(2)33-34(21)11-16-4-6-17(27)7-5-16/h3-10,12-13H,11H2,1-2H3,(H,31,36)(H,32,35)(H2,28,29,30) D0I5VG DRUGINKE XYZZDCAVPVYIRF-UHFFFAOYSA-N D0I5VG DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=NN2CC3=CC=C(C=C3)F)C)NC(=O)C4=CSC5=C4N=CN=C5N D0I5VG HIGHSTAT Patented D0I6CF DRUG__ID D0I6CF D0I6CF DRUGTYPE Small molecular drug D0I6CF DRUGINCH 1S/C20H18FIN2O/c1-24(12-6-11-21)20(25)18-13-14-7-2-3-8-15(14)19(23-18)16-9-4-5-10-17(16)22/h2-5,7-10,13H,6,11-12H2,1H3 D0I6CF DRUGINKE JYVUQBFGPOGZEN-UHFFFAOYSA-N D0I6CF DRUGSMIL CN(CCCF)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3I D0I6CF HIGHSTAT Patented D0I6CF COMPCLAS Iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives D0I6LO DRUG__ID D0I6LO D0I6LO DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0I6LO DRUGTYPE Small molecular drug D0I6LO DRUGINCH 1S/C27H22F3N3O3S/c1-3-26(34)33-37(35,36)22-7-4-6-19(15-22)23-8-5-9-24(32-23)25-16-20(14-17(2)31-25)18-10-12-21(13-11-18)27(28,29)30/h4-16H,3H2,1-2H3,(H,33,34) D0I6LO DRUGINKE OCTDFPIPOMIKKG-UHFFFAOYSA-N D0I6LO DRUGSMIL CCC(=O)NS(=O)(=O)C1=CC=CC(=C1)C2=NC(=CC=C2)C3=NC(=CC(=C3)C4=CC=C(C=C4)C(F)(F)F)C D0I6LO HIGHSTAT Patented D0I8CT DRUG__ID D0I8CT D0I8CT DRUGCOMP LYTIX BIOPHARMA AS D0I8CT DRUGTYPE Small molecular drug D0I8CT DRUGINCH 1S/C9H8N2O2S/c1-5(12)10-9-11-7-4-6(13)2-3-8(7)14-9/h2-4,13H,1H3,(H,10,11,12) D0I8CT DRUGINKE YOMAHEQEXVNJNF-UHFFFAOYSA-N D0I8CT DRUGSMIL CC(=O)NC1=NC2=C(S1)C=CC(=C2)O D0I8CT HIGHSTAT Patented D0I8ZE DRUG__ID D0I8ZE D0I8ZE DRUGCOMP MERCK SHARP & DOHME CORP. BARROW, James, C. BILODEAU, Mark, T. COX, Christopher, D. HARTNETT, John, C. KETT, Nathan, R. LI, Yiwei MANLEY, Peter MELAMED, Jeffrey SHIPE, William, D. TROTTER, B. Wesley ZARTMAN, Amy, E D0I8ZE DRUGTYPE Small molecular drug D0I8ZE DRUGINCH 1S/C29H43N3O2/c1-4-29(2,17-20-31-18-11-6-12-19-31)32(28(34)23-13-7-5-8-14-23)22-25-21-24-15-9-10-16-26(24)30(3)27(25)33/h9-10,15-16,21,23H,4-8,11-14,17-20,22H2,1-3H3 D0I8ZE DRUGINKE LQTUVTFQPOMQHL-UHFFFAOYSA-N D0I8ZE DRUGSMIL CCC(C)(CCN1CCCCC1)N(CC2=CC3=CC=CC=C3N(C2=O)C)C(=O)C4CCCCC4 D0I8ZE HIGHSTAT Patented D0I9BT DRUG__ID D0I9BT D0I9BT DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D0I9BT DRUGTYPE Small molecular drug D0I9BT DRUGINCH 1S/C23H20F3N5O/c1-30-19-7-10-27-9-6-17(19)16-3-2-15(13-20(16)30)31-11-8-14(12-22(31)32)18-4-5-21(29-28-18)23(24,25)26/h2-5,8,11-13,27H,6-7,9-10H2,1H3 D0I9BT DRUGINKE RTHGRJZORFROEE-UHFFFAOYSA-N D0I9BT DRUGSMIL CN1C2=C(CCNCC2)C3=C1C=C(C=C3)N4C=CC(=CC4=O)C5=NN=C(C=C5)C(F)(F)F D0I9BT HIGHSTAT Patented D0IA4G DRUG__ID D0IA4G D0IA4G DRUGCOMP NOVARTIS AG DODD, Stephanie Kay FURET, Pascal GROTZFELD, Robert Martin JAHNKE, Wolfgang JONES, Darryl Brynley MANLEY, Paul MARZINZIK, Andreas PELLE, Xavier Francois Andre SALEM, Bahaa SCHOEPFER, Joseph D0IA4G DRUGTYPE Small molecular drug D0IA4G DRUGINCH 1S/C21H18ClF3N4O3/c22-21(24,25)32-15-4-2-13(3-5-15)27-20(31)12-1-6-18(29-8-7-14(30)11-29)16(9-12)19-17(23)10-26-28-19/h1-6,9-10,14,30H,7-8,11H2,(H,26,28)(H,27,31)/t14-/m1/s1 D0IA4G DRUGINKE XFHOXKYPYFGBCJ-CQSZACIVSA-N D0IA4G DRUGSMIL C1CN(CC1O)C2=C(C=C(C=C2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=C(C=NN4)F D0IA4G HIGHSTAT Patented D0IC3K DRUG__ID D0IC3K D0IC3K DRUGTYPE Small molecular drug D0IC3K DRUGINCH 1S/C23H23Cl3N4O3/c1-2-33-23(32)20-4-3-11-29(20)28-22(31)18-13-21(14-5-7-15(24)8-6-14)30(27-18)19-10-9-16(25)12-17(19)26/h5-10,12,20-21H,2-4,11,13H2,1H3,(H,28,31) D0IC3K DRUGINKE SXZDWKSALIBFCB-UHFFFAOYSA-N D0IC3K DRUGSMIL CCOC(=O)C1CCCN1NC(=O)C2=NN(C(C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl D0IC3K HIGHSTAT Patented D0IC3K COMPCLAS N-phenyl-5-phenyl-pyrazolin-3-yl amide derivatives D0ID4H DRUG__ID D0ID4H D0ID4H DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED YANG, Xiaoqing HADIDA RUAH, Sara, S. GROOTENHUIS, Peter, D.J. VAN GOOR, Fredrick, F. BOTFIELD, Martyn, C. ZLOKARNIK, Gregor D0ID4H DRUGTYPE Small molecular drug D0ID4H DRUGINCH 1S/C19H18N2O2S/c1-11-12(2)24-19(17(11)18(20)23)21-16(22)10-14-8-5-7-13-6-3-4-9-15(13)14/h3-9H,10H2,1-2H3,(H2,20,23)(H,21,22) D0ID4H DRUGINKE WKFBSIRAGVAYFT-UHFFFAOYSA-N D0ID4H DRUGSMIL CC1=C(SC(=C1C(=O)N)NC(=O)CC2=CC=CC3=CC=CC=C32)C D0ID4H HIGHSTAT Patented D0IG6J DRUG__ID D0IG6J D0IG6J DRUGCOMP INTERVET INTERNATIONAL B.V. GILBERT, Eric, J. MILLER, Michael, W. SCOTT, Jack, D. DEMONG, Duane, Eugene STAMFORD, Andrew GREENLEE, William, J. CELLY, Chander, Shekhe D0IG6J DRUGTYPE Small molecular drug D0IG6J DRUGINCH 1S/C24H27Cl2N5O3/c25-18-3-1-17(2-4-18)23-15-29(7-8-30-14-21(24(27)33)28-16-30)9-10-31(23)22-6-5-19(13-20(22)26)34-12-11-32/h1-6,13-14,16,23,32H,7-12,15H2,(H2,27,33)/t23-/m0/s1 D0IG6J DRUGINKE LYKRPBPENHGRNR-QHCPKHFHSA-N D0IG6J DRUGSMIL C1CN(C(CN1CCN2C=C(N=C2)C(=O)N)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)OCCO)Cl D0IG6J HIGHSTAT Patented D0IH3I DRUG__ID D0IH3I D0IH3I DRUGCOMP BOSTON BIOMEDICAL, INC D0IH3I DRUGTYPE Small molecular drug D0IH3I DRUGINCH 1S/C31H33N5O2S/c1-5-36(6-2)15-14-32-30(38)28-19(3)26(33-20(28)4)17-24-23-16-22(12-13-25(23)34-29(24)37)27-18-39-31(35-27)21-10-8-7-9-11-21/h7-13,16-18,33H,5-6,14-15H2,1-4H3,(H,32,38)(H,34,37)/b24-17- D0IH3I DRUGINKE QDWKGEFGLQMDAM-ULJHMMPZSA-N D0IH3I DRUGSMIL CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)C4=CSC(=N4)C5=CC=CC=C5)NC2=O)C D0IH3I HIGHSTAT Patented D0IH3T DRUG__ID D0IH3T D0IH3T DRUGCOMP RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK UNIVERSITY OF STRATHCLYDE BITTMAN, Robert PYNE, Nigel J. PYNE, Susan BAEK, Dong Jae LIU, Zheng BYUN, Hoe Sup D0IH3T DRUGTYPE Small molecular drug D0IH3T DRUGINCH 1S/C20H34NO4P/c1-2-3-4-5-6-7-8-18-9-11-19(12-10-18)13-14-20(21,17-22)15-16-26(23,24)25/h9-12,15-16,22H,2-8,13-14,17,21H2,1H3,(H2,23,24,25)/b16-15+/t20-/m0/s1 D0IH3T DRUGINKE YWQUROWPKWKDNA-APHAIJBRSA-N D0IH3T DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(C=CP(=O)(O)O)N D0IH3T HIGHSTAT Patented D0IK9N DRUG__ID D0IK9N D0IK9N DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0IK9N DRUGTYPE Small molecular drug D0IK9N DRUGINCH 1S/C19H18ClN3O2/c1-19(2)13-25-9-8-23(19)18(24)17-21-11-15(12-22-17)7-6-14-4-3-5-16(20)10-14/h3-5,10-12H,8-9,13H2,1-2H3 D0IK9N DRUGINKE UOYREAVBKXAAFN-UHFFFAOYSA-N D0IK9N DRUGSMIL CC1(COCCN1C(=O)C2=NC=C(C=N2)C#CC3=CC(=CC=C3)Cl)C D0IK9N HIGHSTAT Patented D0IL0U DRUG__ID D0IL0U D0IL0U DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D0IL0U DRUGTYPE Small molecular drug D0IL0U DRUGINCH 1S/C26H27F3N4O3/c1-16(2)13-22(33-23-10-7-19(14-32-23)25(36)30-12-11-24(34)35)18-5-3-17(4-6-18)21-9-8-20(15-31-21)26(27,28)29/h3-10,14-16,22H,11-13H2,1-2H3,(H,30,36)(H,32,33)(H,34,35)/t22-/m0/s1 D0IL0U DRUGINKE MSWXTYSARYGQHP-QFIPXVFZSA-N D0IL0U DRUGSMIL CC(C)CC(C1=CC=C(C=C1)C2=NC=C(C=C2)C(F)(F)F)NC3=NC=C(C=C3)C(=O)NCCC(=O)O D0IL0U HIGHSTAT Patented D0IL4Z DRUG__ID D0IL4Z D0IL4Z DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0IL4Z DRUGTYPE Small molecular drug D0IL4Z DRUGINCH 1S/C14H8ClF3N4/c15-10-3-1-9(2-4-10)11-7-12(14(16,17)18)21-13(20-11)22-6-5-19-8-22/h1-8H D0IL4Z DRUGINKE LXVWPYFCJFOEJE-UHFFFAOYSA-N D0IL4Z DRUGSMIL C1=CC(=CC=C1C2=CC(=NC(=N2)N3C=CN=C3)C(F)(F)F)Cl D0IL4Z HIGHSTAT Patented D0IP5E DRUG__ID D0IP5E D0IP5E DRUGCOMP ABBVIE INC D0IP5E DRUGTYPE Small molecular drug D0IP5E DRUGINCH 1S/C19H19FN4O/c20-14-4-1-3-12(9-14)13-7-8-15(10-13)22-19(25)23-17-5-2-6-18-16(17)11-21-24-18/h1-6,9,11,13,15H,7-8,10H2,(H,21,24)(H2,22,23,25)/t13-,15-/m0/s1 D0IP5E DRUGINKE ROOFFAWDIFZLQB-ZFWWWQNUSA-N D0IP5E DRUGSMIL C1CC(CC1C2=CC(=CC=C2)F)NC(=O)NC3=CC=CC4=C3C=NN4 D0IP5E HIGHSTAT Patented D0IQ8I DRUG__ID D0IQ8I D0IQ8I DRUGCOMP National Cancer Center (S. Korea) D0IQ8I DRUGTYPE Small molecular drug D0IQ8I DRUGINCH 1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-13,22,24-25H,1-2H3/b7-3+,8-4+,16-13- D0IQ8I DRUGINKE ZIUSSTSXXLLKKK-KOBPDPAPSA-N D0IQ8I DRUGSMIL COC1=C(C=CC(=C1)C=CC(=CC(=O)C=CC2=CC(=C(C=C2)O)OC)O)O D0IQ8I HIGHSTAT Patented D0IR7H DRUG__ID D0IR7H D0IR7H DRUGCOMP ABBVIE INC D0IR7H DRUGTYPE Small molecular drug D0IR7H DRUGINCH 1S/C21H21ClF2N2O3/c22-13-4-5-15-18(9-21(10-23,11-24)29-19(15)7-13)26-20(28)25-17-3-1-2-12-6-14(27)8-16(12)17/h1-5,7,14,18,27H,6,8-11H2,(H2,25,26,28)/t14-,18-/m1/s1 D0IR7H DRUGINKE UKGBTQWQSDNAQR-RDTXWAMCSA-N D0IR7H DRUGSMIL C1C(CC2=C1C=CC=C2NC(=O)NC3CC(OC4=C3C=CC(=C4)Cl)(CF)CF)O D0IR7H HIGHSTAT Patented D0IS1M DRUG__ID D0IS1M D0IS1M DRUGCOMP REDX PHARMA PLC D0IS1M DRUGTYPE Small molecular drug D0IS1M DRUGINCH 1S/C17H14N2O/c1-12-6-2-5-9-16(12)20-17-13-7-3-4-8-14(13)19-11-18-10-15(17)19/h2-11,17H,1H3 D0IS1M DRUGINKE OZIYVKPSWZBCSG-UHFFFAOYSA-N D0IS1M DRUGSMIL CC1=CC=CC=C1OC2C3=CC=CC=C3N4C2=CN=C4 D0IS1M HIGHSTAT Patented D0IT3V DRUG__ID D0IT3V D0IT3V DRUGCOMP CURADEV PHARMA PRIVATE LTD D0IT3V DRUGTYPE Small molecular drug D0IT3V DRUGINCH 1S/C13H9ClFN3O/c14-9-5-7(1-2-10(9)15)18-12-8-3-4-17-6-11(8)19-13(12)16/h1-6,18H,16H2 D0IT3V DRUGINKE MAFDXEXXQIAQTR-UHFFFAOYSA-N D0IT3V DRUGSMIL C1=CC(=C(C=C1NC2=C(OC3=C2C=CN=C3)N)Cl)F D0IT3V HIGHSTAT Patented D0IU1H DRUG__ID D0IU1H D0IU1H DRUGCOMP GRUENENTHAL GMBH [DE] D0IU1H DRUGTYPE Small molecular drug D0IU1H DRUGINCH 1S/C22H24F4N6O3S/c1-13(2)14-4-3-5-17(8-14)32-18(10-20(31-32)22(24,25)26)12-28-21(33)30-16-7-6-15(19(23)9-16)11-29-36(27,34)35/h3-10,13,29H,11-12H2,1-2H3,(H2,27,34,35)(H2,28,30,33) D0IU1H DRUGINKE PXYVSPVUKXZTLN-UHFFFAOYSA-N D0IU1H DRUGSMIL CC(C)C1=CC(=CC=C1)N2C(=CC(=N2)C(F)(F)F)CNC(=O)NC3=CC(=C(C=C3)CNS(=O)(=O)N)F D0IU1H HIGHSTAT Patented D0IY1Z DRUG__ID D0IY1Z D0IY1Z DRUGCOMP NEWLINK GENETICS CORPORATION MAUTINO, Mario KUMAR, Sanjeev WALDO, Jesse JAIPURI, Firoz KESHARWANI, Tanay ZHANG, Xiaoxia D0IY1Z DRUGTYPE Small molecular drug D0IY1Z DRUGINCH 1S/C23H23N3O2/c27-22(17-13-25(14-17)23(28)10-16-6-2-1-3-7-16)11-20-18-8-4-5-9-19(18)21-12-24-15-26(20)21/h1-9,12,15,17,20,22,27H,10-11,13-14H2 D0IY1Z DRUGINKE XCPKPBVNKDRBNO-UHFFFAOYSA-N D0IY1Z DRUGSMIL C1C(CN1C(=O)CC2=CC=CC=C2)C(CC3C4=CC=CC=C4C5=CN=CN35)O D0IY1Z HIGHSTAT Patented D0IY8T DRUG__ID D0IY8T D0IY8T DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0IY8T DRUGTYPE Small molecular drug D0IY8T DRUGINCH 1S/C24H18F3N3O2S/c1-15-12-18(16-8-10-19(11-9-16)24(25,26)27)14-23(29-15)22-7-3-6-21(30-22)17-4-2-5-20(13-17)33(28,31)32/h2-14H,1H3,(H2,28,31,32) D0IY8T DRUGINKE DQITWECLUPKXEE-UHFFFAOYSA-N D0IY8T DRUGSMIL CC1=CC(=CC(=N1)C2=CC=CC(=N2)C3=CC(=CC=C3)S(=O)(=O)N)C4=CC=C(C=C4)C(F)(F)F D0IY8T HIGHSTAT Patented D0J0JH DRUG__ID D0J0JH D0J0JH DRUGCOMP National Taiwan University D0J0JH DRUGTYPE Small molecular drug D0J0JH DRUGINCH 1S/C15H12O6/c16-10(9-3-6-12(18)15(21)14(9)20)4-1-8-2-5-11(17)13(19)7-8/h1-7,17-21H/b4-1+ D0J0JH DRUGINKE GSBNFGRTUCCBTK-DAFODLJHSA-N D0J0JH DRUGSMIL C1=CC(=C(C=C1C=CC(=O)C2=C(C(=C(C=C2)O)O)O)O)O D0J0JH HIGHSTAT Patented D0J0WG DRUG__ID D0J0WG D0J0WG DRUGCOMP THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS PRABHAKAR, Bellur, S. ELSHABRAWY, Hatem, A D0J0WG DRUGTYPE Small molecular drug D0J0WG DRUGINCH 1S/C13H21N7O2/c1-8(2)15-11-17-12(16-9(3)4)19-13(18-11)20(7-14)6-10(21)22-5/h8-9H,6H2,1-5H3,(H2,15,16,17,18,19) D0J0WG DRUGINKE QYAYANIDXCPTDU-UHFFFAOYSA-N D0J0WG DRUGSMIL CC(C)NC1=NC(=NC(=N1)N(CC(=O)OC)C#N)NC(C)C D0J0WG HIGHSTAT Patented D0J3OD DRUG__ID D0J3OD D0J3OD DRUGTYPE Small molecular drug D0J3OD DRUGINCH 1S/C25H32N2O3/c1-25(2)18-27(17-19-7-5-4-6-8-19)23-10-9-21(15-22(23)25)30-24(28)26(3)16-20-11-13-29-14-12-20/h4-10,15,20H,11-14,16-18H2,1-3H3 D0J3OD DRUGINKE LZXDNQGOGJJABM-UHFFFAOYSA-N D0J3OD DRUGSMIL CC1(CN(C2=C1C=C(C=C2)OC(=O)N(C)CC3CCOCC3)CC4=CC=CC=C4)C D0J3OD HIGHSTAT Patented D0J3OD COMPCLAS Indoline derivatives D0J4CL DRUG__ID D0J4CL D0J4CL DRUGCOMP SUNSHINE LAKE PHARMA CO., LTD D0J4CL DRUGTYPE Small molecular drug D0J4CL DRUGINCH 1S/C27H19Cl2NO7S/c28-19-2-1-3-20(29)24(19)25-18(26(37-30-25)14-4-5-14)12-35-17-8-9-21-23(11-17)38(33,34)13-16-7-6-15(27(31)32)10-22(16)36-21/h1-3,6-11,14H,4-5,12-13H2,(H,31,32) D0J4CL DRUGINKE LTDMSLKNDBRACZ-UHFFFAOYSA-N D0J4CL DRUGSMIL C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC5=C(C=C4)OC6=C(CS5(=O)=O)C=CC(=C6)C(=O)O D0J4CL HIGHSTAT Patented D0J4GY DRUG__ID D0J4GY D0J4GY DRUGTYPE Small molecular drug D0J4GY DRUGINCH 1S/C19H15F2N7O/c1-28-18(22-8-23-28)15-16(9-2-4-10(20)5-3-9)25-24-13-7-11(21)6-12-14(13)17(15)26-27-19(12)29/h2-8,15-16,24-25H,1H3,(H,27,29) D0J4GY DRUGINKE VGIBCJTZZYLWON-UHFFFAOYSA-N D0J4GY DRUGSMIL CN1C(=NC=N1)C2C(NNC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F D0J4GY HIGHSTAT Patented D0J4GY COMPCLAS Dihydropyrido phthalazinone derivatives D0J4IP DRUG__ID D0J4IP D0J4IP DRUGCOMP Aston University D0J4IP DRUGTYPE Small molecular drug D0J4IP DRUGINCH 1S/C25H30N2O6S/c1-34(2)17-20(28)13-14-21(24(30)31)26-23(29)22(15-18-9-5-3-6-10-18)27-25(32)33-16-19-11-7-4-8-12-19/h3-12,21-22H,13-17H2,1-2H3,(H2-,26,27,29,30,31,32)/p+1/t21-,22-/m0/s1 D0J4IP DRUGINKE MQKDBWQFOOQINN-VXKWHMMOSA-O D0J4IP DRUGSMIL C[S+](C)CC(=O)CCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2 D0J4IP HIGHSTAT Patented D0J4QG DRUG__ID D0J4QG D0J4QG DRUGCOMP SignalRx Pharmaceuticals, Inc D0J4QG DRUGTYPE Small molecular drug D0J4QG DRUGINCH 1S/C16H17N5O/c22-15-13-11-17-21(12-7-3-1-4-8-12)14(13)18-16(19-15)20-9-5-2-6-10-20/h1,3-4,7-8,11H,2,5-6,9-10H2,(H,18,19,22) D0J4QG DRUGINKE ULYRISNPZZRBFO-UHFFFAOYSA-N D0J4QG DRUGSMIL C1CCN(CC1)C2=NC3=C(C=NN3C4=CC=CC=C4)C(=O)N2 D0J4QG HIGHSTAT Patented D0J4YH DRUG__ID D0J4YH D0J4YH DRUGTYPE Small molecular drug D0J4YH DRUGINCH 1S/C19H21NO5/c1-24-17-7-4-14(12-18(17)25-2)9-10-20-19(23)8-5-13-3-6-15(21)16(22)11-13/h3-8,11-12,21-22H,9-10H2,1-2H3,(H,20,23)/b8-5+ D0J4YH DRUGINKE WWELEILTWYPGMY-VMPITWQZSA-N D0J4YH DRUGSMIL COC1=C(C=C(C=C1)CCNC(=O)C=CC2=CC(=C(C=C2)O)O)OC D0J4YH HIGHSTAT Patented D0J4YH COMPCLAS P-coumaric acid derivatives D0J5NB DRUG__ID D0J5NB D0J5NB DRUGTYPE Small molecular drug D0J5NB DRUGINCH 1S/C25H22Cl2N4OS/c1-3-22-28-25(32-30-22)23-15(2)24(31(29-23)20-12-9-17(26)14-19(20)27)21-13-11-18(33-21)10-8-16-6-4-5-7-16/h9,11-14,16H,3-7H2,1-2H3 D0J5NB DRUGINKE NIKGOEACQPFNCK-UHFFFAOYSA-N D0J5NB DRUGSMIL CCC1=NOC(=N1)C2=NN(C(=C2C)C3=CC=C(S3)C#CC4CCCC4)C5=C(C=C(C=C5)Cl)Cl D0J5NB HIGHSTAT Patented D0J5NB COMPCLAS Pyrazole derivatives D0J6MM DRUG__ID D0J6MM D0J6MM DRUGCOMP MERCK SHARP &amDOHME CORP. LIN, Linus SOLL, Richard DONG, Jingchao WU, Hao SUZUKI, Takao HU, Bin LIU, Dejun HAO, Jinglai XU, Ming D0J6MM DRUGTYPE Small molecular drug D0J6MM DRUGINCH 1S/C23H24FNO4/c1-16-12-19(8-9-21(16)29-15-23(2,3)27)25-11-10-20(13-22(25)26)28-14-17-4-6-18(24)7-5-17/h4-13,27H,14-15H2,1-3H3 D0J6MM DRUGINKE WCMFUWBVIKILDJ-UHFFFAOYSA-N D0J6MM DRUGSMIL CC1=C(C=CC(=C1)N2C=CC(=CC2=O)OCC3=CC=C(C=C3)F)OCC(C)(C)O D0J6MM HIGHSTAT Patented D0J6OC DRUG__ID D0J6OC D0J6OC DRUGCOMP EPITHERAPEUTICS APS D0J6OC DRUGTYPE Small molecular drug D0J6OC DRUGINCH 1S/C12H12N2O3/c15-12(16)9-3-4-14-10(6-9)7-13-8-11-2-1-5-17-11/h1-6,13H,7-8H2,(H,15,16) D0J6OC DRUGINKE WAXTXDDUSDCZNA-UHFFFAOYSA-N D0J6OC DRUGSMIL C1=COC(=C1)CNCC2=NC=CC(=C2)C(=O)O D0J6OC HIGHSTAT Patented D0J8DR DRUG__ID D0J8DR D0J8DR DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D0J8DR DRUGTYPE Small molecular drug D0J8DR DRUGINCH 1S/C15H20N6O/c1-21(2)9-8-17-15-18-10-12(13(16)22)14(20-15)19-11-6-4-3-5-7-11/h3-7,10H,8-9H2,1-2H3,(H2,16,22)(H2,17,18,19,20) D0J8DR DRUGINKE GTNNAVLREWBUPQ-UHFFFAOYSA-N D0J8DR DRUGSMIL CN(C)CCNC1=NC=C(C(=N1)NC2=CC=CC=C2)C(=O)N D0J8DR HIGHSTAT Patented D0J9CS DRUG__ID D0J9CS D0J9CS DRUGCOMP GRUENENTHAL GMBH [DE] D0J9CS DRUGTYPE Small molecular drug D0J9CS DRUGINCH 1S/C23H22F4N4O3S/c1-14-4-3-5-15(10-14)21-17(7-9-20(31-21)23(25,26)27)12-28-22(32)30-18-8-6-16(19(24)11-18)13-29-35(2,33)34/h3-11,29H,12-13H2,1-2H3,(H2,28,30,32) D0J9CS DRUGINKE RKDUDSFOPJMGMR-UHFFFAOYSA-N D0J9CS DRUGSMIL CC1=CC(=CC=C1)C2=C(C=CC(=N2)C(F)(F)F)CNC(=O)NC3=CC(=C(C=C3)CNS(=O)(=O)C)F D0J9CS HIGHSTAT Patented D0J9ZG DRUG__ID D0J9ZG D0J9ZG DRUGCOMP ABBVIE INC D0J9ZG DRUGTYPE Small molecular drug D0J9ZG DRUGINCH 1S/C29H32N6O3/c30-28-27-24(32-33-28)16-20(18-26(27)38-22-8-14-37-15-9-22)19-6-7-23(29(31)36)25(17-19)35-12-10-34(11-13-35)21-4-2-1-3-5-21/h1-7,16-18,22H,8-15H2,(H2,31,36)(H3,30,32,33) D0J9ZG DRUGINKE UDESEJHYZQLNDD-UHFFFAOYSA-N D0J9ZG DRUGSMIL C1COCCC1OC2=CC(=CC3=C2C(=NN3)N)C4=CC(=C(C=C4)C(=O)N)N5CCN(CC5)C6=CC=CC=C6 D0J9ZG HIGHSTAT Patented D0JA4K DRUG__ID D0JA4K D0JA4K DRUGCOMP MGI GP, INC. XU, Weizheng DELAHANTY, Greg ZHANG, Jie D0JA4K DRUGTYPE Small molecular drug D0JA4K DRUGINCH 1S/C20H19N3O3/c24-13-6-8-23(9-7-13)11-12-4-5-16-15(10-12)19-18-14(20(25)22-21-19)2-1-3-17(18)26-16/h1-5,10,13,24H,6-9,11H2,(H,22,25) D0JA4K DRUGINKE HAVFFEMDLROBGI-UHFFFAOYSA-N D0JA4K DRUGSMIL C1CN(CCC1O)CC2=CC3=C(C=C2)OC4=CC=CC5=C4C3=NNC5=O D0JA4K HIGHSTAT Patented D0JB1V DRUG__ID D0JB1V D0JB1V DRUGCOMP IOMET PHARMA LTD D0JB1V DRUGTYPE Small molecular drug D0JB1V DRUGINCH 1S/C16H18ClN5O2/c1-15(2)8-22(4-3-16(15)13(23)19-14(24)20-16)12-6-9(17)5-11-10(12)7-18-21-11/h5-7H,3-4,8H2,1-2H3,(H,18,21)(H2,19,20,23,24) D0JB1V DRUGINKE JZDRNRKIZBGYLY-UHFFFAOYSA-N D0JB1V DRUGSMIL CC1(CN(CCC12C(=O)NC(=O)N2)C3=CC(=CC4=C3C=NN4)Cl)C D0JB1V HIGHSTAT Patented D0JD5W DRUG__ID D0JD5W D0JD5W DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0JD5W DRUGTYPE Small molecular drug D0JD5W DRUGINCH 1S/C24H21F2IN4O4S/c25-16-3-1-2-4-19(16)36(34,35)15-10-18(21(32)30-23(13-28)5-6-23)31(12-15)22(33)24(7-8-24)20-17(26)9-14(27)11-29-20/h1-4,9,11,15,18H,5-8,10,12H2,(H,30,32)/t15-,18+/m1/s1 D0JD5W DRUGINKE ZEFHIBBPLAGQMT-QAPCUYQASA-N D0JD5W DRUGSMIL C1CC1(C#N)NC(=O)C2CC(CN2C(=O)C3(CC3)C4=C(C=C(C=N4)I)F)S(=O)(=O)C5=CC=CC=C5F D0JD5W HIGHSTAT Patented D0JD9Z DRUG__ID D0JD9Z D0JD9Z DRUGCOMP PF MEDICAMENT [FR] D0JD9Z DRUGTYPE Small molecular drug D0JD9Z DRUGINCH 1S/C30H33F2N7O2/c1-38-6-8-39(9-7-38)24-2-3-25(27(17-24)34-23-4-10-41-11-5-23)30(40)35-29-26-15-20(18-33-28(26)36-37-29)12-19-13-21(31)16-22(32)14-19/h2-3,13-18,23,34H,4-12H2,1H3,(H2,33,35,36,37,40) D0JD9Z DRUGINKE HHXDZBJLUOYVEU-UHFFFAOYSA-N D0JD9Z DRUGSMIL CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=C4C=C(C=NC4=NN3)CC5=CC(=CC(=C5)F)F)NC6CCOCC6 D0JD9Z HIGHSTAT Patented D0JF6W DRUG__ID D0JF6W D0JF6W DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0JF6W DRUGTYPE Small molecular drug D0JF6W DRUGINCH 1S/C23H23N5O/c1-26-15-12-18(13-16-26)28-21(29)11-10-19(24-28)22-20-9-5-6-14-27(20)25-23(22)17-7-3-2-4-8-17/h2-11,14,18H,12-13,15-16H2,1H3 D0JF6W DRUGINKE YHDRUTMZCJZJAL-UHFFFAOYSA-N D0JF6W DRUGSMIL CN1CCC(CC1)N2C(=O)C=CC(=N2)C3=C4C=CC=CN4N=C3C5=CC=CC=C5 D0JF6W HIGHSTAT Patented D0JK3V DRUG__ID D0JK3V D0JK3V DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeongmin JUNG, Myung Eun KIM, Jong Yup AHN, Kwangwoo SEO, Hee Jeong LEE, Sung-Han LEE, Suk Ho D0JK3V DRUGTYPE Small molecular drug D0JK3V DRUGINCH 1S/C24H15Cl3F3N7O/c25-13-1-4-15(5-2-13)37-18(10-36-12-31-11-32-36)19(33-20(37)16-6-3-14(26)9-17(16)27)21-34-35-22(38-21)23(7-8-23)24(28,29)30/h1-6,9,11-12H,7-8,10H2 D0JK3V DRUGINKE UFJZESYUYSJRPI-UHFFFAOYSA-N D0JK3V DRUGSMIL C1CC1(C2=NN=C(O2)C3=C(N(C(=N3)C4=C(C=C(C=C4)Cl)Cl)C5=CC=C(C=C5)Cl)CN6C=NC=N6)C(F)(F)F D0JK3V HIGHSTAT Patented D0JQ0Z DRUG__ID D0JQ0Z D0JQ0Z DRUGCOMP Department of Health and Human Services (NIH, Bethesda, US) D0JQ0Z DRUGTYPE Small molecular drug D0JQ0Z DRUGINCH 1S/C20H21N3O2/c1-20(2,3)10-21-19-15-8-13(4-6-16(15)22-11-23-19)14-5-7-17-18(9-14)25-12-24-17/h4-9,11H,10,12H2,1-3H3,(H,21,22,23) D0JQ0Z DRUGINKE OSWHZHVVVZAPRN-UHFFFAOYSA-N D0JQ0Z DRUGSMIL CC(C)(C)CNC1=NC=NC2=C1C=C(C=C2)C3=CC4=C(C=C3)OCO4 D0JQ0Z HIGHSTAT Patented D0JR5G DRUG__ID D0JR5G D0JR5G DRUGCOMP INCYTE CORPORATIOIncyte Corporation D0JR5G DRUGTYPE Small molecular drug D0JR5G DRUGINCH 1S/C22H17N3O3/c1-25-12-16(14-10-11-23-18(14)22(25)27)15-8-5-9-17-20(15)28-19(21(26)24-17)13-6-3-2-4-7-13/h2-12,19,23H,1H3,(H,24,26) D0JR5G DRUGINKE DWZVOOLKEMMANA-UHFFFAOYSA-N D0JR5G DRUGSMIL CN1C=C(C2=C(C1=O)NC=C2)C3=C4C(=CC=C3)NC(=O)C(O4)C5=CC=CC=C5 D0JR5G HIGHSTAT Patented D0JR7X DRUG__ID D0JR7X D0JR7X DRUGCOMP HANMI SCIENCE CO., LTD. KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION SON, Jung Beom JUNG, Seung Hyun CHOI, Wha Il JUNG, Young Hee CHOI, Jae Yul SONG, Ji Yeon LEE, Kyu Hang LEE, Jae Chul KIM, Eun Young AHN, Young Gil KIM, Maeng Sup CHOI, Hwan Geun SIM, Tae Bo HAM, Young Jin PARK, Dong-sik KIM, Hwan KIM, Dong-Wook D0JR7X DRUGTYPE Small molecular drug D0JR7X DRUGINCH 1S/C29H32N8O2S/c1-3-36-10-12-37(13-11-36)24-9-8-21(15-30-24)34-28(38)19-5-4-18(2)23(14-19)35-29(39)22-16-40-26-25(22)31-17-32-27(26)33-20-6-7-20/h4-5,8-9,14-17,20H,3,6-7,10-13H2,1-2H3,(H,34,38)(H,35,39)(H,31,32,33) D0JR7X DRUGINKE VVZVKYOPIITGGL-UHFFFAOYSA-N D0JR7X DRUGSMIL CCN1CCN(CC1)C2=NC=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)NC(=O)C4=CSC5=C4N=CN=C5NC6CC6 D0JR7X HIGHSTAT Patented D0JR9L DRUG__ID D0JR9L D0JR9L DRUGCOMP KARUS THERAPEUTICS LTD D0JR9L DRUGTYPE Small molecular drug D0JR9L DRUGINCH 1S/C15H20N6O2/c22-15(20-23)5-3-1-2-4-8-21(13-9-17-12-18-10-13)14-11-16-6-7-19-14/h6-7,9-12,23H,1-5,8H2,(H,20,22) D0JR9L DRUGINKE SQFSXNZGZJNPJZ-UHFFFAOYSA-N D0JR9L DRUGSMIL C1=CN=C(C=N1)N(CCCCCCC(=O)NO)C2=CN=CN=C2 D0JR9L HIGHSTAT Patented D0JT0B DRUG__ID D0JT0B D0JT0B DRUGCOMP PROXIMAGEN LIMITED D0JT0B DRUGTYPE Small molecular drug D0JT0B DRUGINCH 1S/C22H22N4O3S/c1-14-11-19(30(25,28)29)9-10-20(14)17-3-2-4-18(12-17)22(27)26-13-15-5-7-16(8-6-15)21(23)24/h2-12H,13H2,1H3,(H3,23,24)(H,26,27)(H2,25,28,29) D0JT0B DRUGINKE QDCYPEUVWUOSBP-UHFFFAOYSA-N D0JT0B DRUGSMIL CC1=C(C=CC(=C1)S(=O)(=O)N)C2=CC(=CC=C2)C(=O)NCC3=CC=C(C=C3)C(=N)N D0JT0B HIGHSTAT Patented D0JT8B DRUG__ID D0JT8B D0JT8B DRUGCOMP Xention Ltd D0JT8B DRUGTYPE Small molecular drug D0JT8B DRUGINCH 1S/C23H20ClFN2O2/c24-20-10-8-16(12-21(20)25)15-4-1-5-17(11-15)26-23(29)27-22-6-2-3-14-7-9-18(28)13-19(14)22/h1-6,8,10-12,18,28H,7,9,13H2,(H2,26,27,29) D0JT8B DRUGINKE VIQQVXGGWBFLTG-UHFFFAOYSA-N D0JT8B DRUGSMIL C1CC2=C(CC1O)C(=CC=C2)NC(=O)NC3=CC=CC(=C3)C4=CC(=C(C=C4)Cl)F D0JT8B HIGHSTAT Patented D0JU4R DRUG__ID D0JU4R D0JU4R DRUGCOMP ARRAY BIOPHARMA INC D0JU4R DRUGTYPE Small molecular drug D0JU4R DRUGINCH 1S/C25H20F3N7OS/c1-15-19(17-13-29-34(2)14-17)33-35(18-11-7-4-8-12-18)21(15)31-24(36)32-22-20(16-9-5-3-6-10-16)30-23(37-22)25(26,27)28/h3-14H,1-2H3,(H2,31,32,36) D0JU4R DRUGINKE OKQYVMVRBRSVES-UHFFFAOYSA-N D0JU4R DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC=CC=C3)NC(=O)NC4=C(N=C(S4)C(F)(F)F)C5=CC=CC=C5 D0JU4R HIGHSTAT Patented D0JX4I DRUG__ID D0JX4I D0JX4I DRUGCOMP GRUENENTHAL GMBH [DE] D0JX4I DRUGTYPE Small molecular drug D0JX4I DRUGINCH 1S/C21H27F3N6O3S/c1-14-8-10-30(11-9-14)19-16(4-7-18(29-19)21(22,23)24)13-26-20(31)28-17-5-2-15(3-6-17)12-27-34(25,32)33/h2-7,14,27H,8-13H2,1H3,(H2,25,32,33)(H2,26,28,31) D0JX4I DRUGINKE OTVBHAAUANCTTG-UHFFFAOYSA-N D0JX4I DRUGSMIL CC1CCN(CC1)C2=C(C=CC(=N2)C(F)(F)F)CNC(=O)NC3=CC=C(C=C3)CNS(=O)(=O)N D0JX4I HIGHSTAT Patented D0JY1I DRUG__ID D0JY1I D0JY1I DRUGCOMP 4SC AG [DE] D0JY1I DRUGTYPE Small molecular drug D0JY1I DRUGINCH 1S/C25H21N5O3S/c1-16-4-10-20(27-24(32)18-8-5-17(6-9-18)7-11-23(31)30-33)13-21(16)28-25-29-22(15-34-25)19-3-2-12-26-14-19/h2-15,33H,1H3,(H,27,32)(H,28,29)(H,30,31)/b11-7+ D0JY1I DRUGINKE OINCRSHJNMRVSX-YRNVUSSQSA-N D0JY1I DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)C=CC(=O)NO)NC3=NC(=CS3)C4=CN=CC=C4 D0JY1I HIGHSTAT Patented D0JY2I DRUG__ID D0JY2I D0JY2I DRUGCOMP SCHERING CORPORATION GILBERT, Eric, J. MILLER, Michael, W. DEMONG, Duane Eugene STAMFORD, Andrew, W. GREENLEE, William, J D0JY2I DRUGTYPE Small molecular drug D0JY2I DRUGINCH 1S/C33H32Cl2N2O4/c1-20(21-3-5-22(6-4-21)33(40)36-12-11-32(38)39)37-19-27(26-14-28(34)18-29(35)15-26)17-31(37)25-8-7-24-16-30(41-2)10-9-23(24)13-25/h3-10,13-16,18,20,27,31H,11-12,17,19H2,1-2H3,(H,36,40)(H,38,39)/t20?,27-,31-/m1/s1 D0JY2I DRUGINKE MKGXNUKACRIFNF-JOPCKLHNSA-N D0JY2I DRUGSMIL CC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)N2CC(CC2C3=CC4=C(C=C3)C=C(C=C4)OC)C5=CC(=CC(=C5)Cl)Cl D0JY2I HIGHSTAT Patented D0JY4C DRUG__ID D0JY4C D0JY4C DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0JY4C DRUGTYPE Small molecular drug D0JY4C DRUGINCH 1S/C26H30N2O4/c1-30-25-18-21(8-11-23(25)31-17-16-27-13-2-3-14-27)28-15-12-24(26(28)29)32-22-9-6-20(7-10-22)19-4-5-19/h6-12,18-19H,2-5,13-17H2,1H3 D0JY4C DRUGINKE NDQYSDBXPKTXCY-UHFFFAOYSA-N D0JY4C DRUGSMIL COC1=C(C=CC(=C1)N2CC=C(C2=O)OC3=CC=C(C=C3)C4CC4)OCCN5CCCC5 D0JY4C HIGHSTAT Patented D0K0PG DRUG__ID D0K0PG D0K0PG DRUGCOMP Korea Research Institute of Bioscience and Biotechnology Dongguk University Industry-Academic Cooperation Foundation WON, Mi-Sun KIM, Hwan-Mook LEE, Kyeong PARK, Song-Kyu LEE, Ki-Ho LEE, Chang-Woo LEE, Jung-Joon CHUNG, Kyung-Sook KIM, Bo-Kyung JIN, Ying-Lan D0K0PG DRUGTYPE Small molecular drug D0K0PG DRUGINCH 1S/C26H29NO5/c1-31-25(30)19-2-7-23(28)22(11-19)27-24(29)15-32-21-5-3-20(4-6-21)26-12-16-8-17(13-26)10-18(9-16)14-26/h2-7,11,16-18,28H,8-10,12-15H2,1H3,(H,27,29) D0K0PG DRUGINKE BJRPPNOJYFZSLY-UHFFFAOYSA-N D0K0PG DRUGSMIL COC(=O)C1=CC(=C(C=C1)O)NC(=O)COC2=CC=C(C=C2)C34CC5CC(C3)CC(C5)C4 D0K0PG HIGHSTAT Patented D0K0ZI DRUG__ID D0K0ZI D0K0ZI DRUGCOMP Novartis AG D0K0ZI DRUGTYPE Small molecular drug D0K0ZI DRUGINCH 1S/C18H15F3N2O2/c1-10(2)16-22-15-9-13(24)7-8-14(15)17(25)23(16)12-5-3-11(4-6-12)18(19,20)21/h3-10,24H,1-2H3 D0K0ZI DRUGINKE BQCYMHBVGHVCTM-UHFFFAOYSA-N D0K0ZI DRUGSMIL CC(C)C1=NC2=C(C=CC(=C2)O)C(=O)N1C3=CC=C(C=C3)C(F)(F)F D0K0ZI HIGHSTAT Patented D0K0ZX DRUG__ID D0K0ZX D0K0ZX DRUGTYPE Small molecular drug D0K0ZX DRUGINCH 1S/C21H17F4N5O3S/c22-12-30-18(9-6-13-4-7-15(8-5-13)21(23,24)25)17(11-27-30)20-28-19(29-33-20)14-2-1-3-16(10-14)34(26,31)32/h1-5,7-8,10-11H,6,9,12H2,(H2,26,31,32) D0K0ZX DRUGINKE ZBFNZSWRIVRSIR-UHFFFAOYSA-N D0K0ZX DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)C2=NOC(=N2)C3=C(N(N=C3)CF)CCC4=CC=C(C=C4)C(F)(F)F D0K0ZX HIGHSTAT Patented D0K0ZX COMPCLAS Heteroaryl-pyrazole derivatives D0K1RU DRUG__ID D0K1RU D0K1RU DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D0K1RU DRUGTYPE Small molecular drug D0K1RU DRUGINCH 1S/C25H23N3O2/c1-16(12-17-4-3-11-27-15-17)19-7-10-21-22(18-5-8-20(30-2)9-6-18)14-24(25(26)29)28-23(21)13-19/h3-11,13-16H,12H2,1-2H3,(H2,26,29) D0K1RU DRUGINKE SLSRIELIUCLTJB-UHFFFAOYSA-N D0K1RU DRUGSMIL CC(CC1=CN=CC=C1)C2=CC3=C(C=C2)C(=CC(=N3)C(=O)N)C4=CC=C(C=C4)OC D0K1RU HIGHSTAT Patented D0K2BT DRUG__ID D0K2BT D0K2BT DRUGCOMP SAMUMED, LLC D0K2BT DRUGTYPE Small molecular drug D0K2BT DRUGINCH 1S/C27H30N6O2/c1-18(2)35-25-9-7-22(16-29-25)30-27(34)26-23-13-20(6-8-24(23)31-32-26)21-12-19(14-28-15-21)17-33-10-4-3-5-11-33/h6-9,12-16,18H,3-5,10-11,17H2,1-2H3,(H,30,34)(H,31,32) D0K2BT DRUGINKE QWXGMMPJHDIFKI-UHFFFAOYSA-N D0K2BT DRUGSMIL CC(C)OC1=NC=C(C=C1)NC(=O)C2=NNC3=C2C=C(C=C3)C4=CN=CC(=C4)CN5CCCCC5 D0K2BT HIGHSTAT Patented D0K2LB DRUG__ID D0K2LB D0K2LB DRUGCOMP NTZ LAB LTD [BG] D0K2LB DRUGTYPE Small molecular drug D0K2LB DRUGINCH 1S/C13H8Cl2N4O/c14-10-4-9(6-16-12(10)15)18-13(20)7-1-2-11-8(3-7)5-17-19-11/h1-6H,(H,17,19)(H,18,20) D0K2LB DRUGINKE JLABGNSHSHVIHC-UHFFFAOYSA-N D0K2LB DRUGSMIL C1=CC2=C(C=C1C(=O)NC3=CC(=C(N=C3)Cl)Cl)C=NN2 D0K2LB HIGHSTAT Patented D0K3KE DRUG__ID D0K3KE D0K3KE DRUGCOMP Janssen Pharmaceutica NV D0K3KE DRUGTYPE Small molecular drug D0K3KE DRUGINCH 1S/C24H26F3N5/c1-23(2,3)16-6-8-17(9-7-16)31-21-18-10-13-32(14-11-20(18)29-15-30-21)22-19(24(25,26)27)5-4-12-28-22/h4-9,12,15H,10-11,13-14H2,1-3H3,(H,29,30,31) D0K3KE DRUGINKE HUWDXCSRDAPMOC-UHFFFAOYSA-N D0K3KE DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC2=NC=NC3=C2CCN(CC3)C4=C(C=CC=N4)C(F)(F)F D0K3KE HIGHSTAT Patented D0K3KM DRUG__ID D0K3KM D0K3KM DRUGCOMP Xention Ltd D0K3KM DRUGTYPE Small molecular drug D0K3KM DRUGINCH 1S/C23H19F2NO2/c24-20-11-9-17(12-21(20)25)14-4-6-16(7-5-14)23(28)26-22-3-1-2-15-8-10-18(27)13-19(15)22/h1-7,9,11-12,18,27H,8,10,13H2,(H,26,28) D0K3KM DRUGINKE BBXIMYHEGLSHKN-UHFFFAOYSA-N D0K3KM DRUGSMIL C1CC2=C(CC1O)C(=CC=C2)NC(=O)C3=CC=C(C=C3)C4=CC(=C(C=C4)F)F D0K3KM HIGHSTAT Patented D0K3MV DRUG__ID D0K3MV D0K3MV DRUGTYPE Small molecular drug D0K3MV DRUGINCH 1S/C20H24N4O2/c1-5-23(6-2)18(26)12-17-19(15-7-9-16(25)10-8-15)21-20-13(3)11-14(4)22-24(17)20/h7-11,25H,5-6,12H2,1-4H3 D0K3MV DRUGINKE AHZVLZZEKQYWAC-UHFFFAOYSA-N D0K3MV DRUGSMIL CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)O D0K3MV HIGHSTAT Patented D0K3MV COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D0K3UO DRUG__ID D0K3UO D0K3UO DRUGCOMP AKARNA THERAPEUTICS, LTD D0K3UO DRUGTYPE Small molecular drug D0K3UO DRUGINCH 1S/C28H39N4O5/c1-19(2)37-27(34)23-17-31(18-28(4,5)24-20(3)29-30-25(23)24)26(33)21-7-9-22(10-8-21)36-16-13-32(6)11-14-35-15-12-32/h7-10,17,19H,11-16,18H2,1-6H3,(H,29,30)/q+1 D0K3UO DRUGINKE BFMZLOKFIVIHGO-UHFFFAOYSA-N D0K3UO DRUGSMIL CC1=C2C(=NN1)C(=CN(CC2(C)C)C(=O)C3=CC=C(C=C3)OCC[N+]4(CCOCC4)C)C(=O)OC(C)C D0K3UO HIGHSTAT Patented D0K4KM DRUG__ID D0K4KM D0K4KM DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0K4KM DRUGTYPE Small molecular drug D0K4KM DRUGINCH 1S/C25H31ClFN3O4/c1-16(2)14-30(18-6-4-3-5-7-18)23-11-9-19(34-15-24(31)32)13-22(23)29-25(33)28-21-10-8-17(26)12-20(21)27/h8-13,16,18H,3-7,14-15H2,1-2H3,(H,31,32)(H2,28,29,33) D0K4KM DRUGINKE TVQUEBMGNJZEOT-UHFFFAOYSA-N D0K4KM DRUGSMIL CC(C)CN(C1CCCCC1)C2=C(C=C(C=C2)OCC(=O)O)NC(=O)NC3=C(C=C(C=C3)Cl)F D0K4KM HIGHSTAT Patented D0K4LQ DRUG__ID D0K4LQ D0K4LQ DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0K4LQ DRUGTYPE Small molecular drug D0K4LQ DRUGINCH 1S/C14H12ClN5OS/c15-9-6-16-13-5-11(18-20(13)7-9)14(21)19-3-1-10-12(2-4-19)22-8-17-10/h5-8H,1-4H2 D0K4LQ DRUGINKE UNBIVDPTRGTTPR-UHFFFAOYSA-N D0K4LQ DRUGSMIL C1CN(CCC2=C1N=CS2)C(=O)C3=NN4C=C(C=NC4=C3)Cl D0K4LQ HIGHSTAT Patented D0K4VT DRUG__ID D0K4VT D0K4VT DRUGTYPE Small molecular drug D0K4VT DRUGINCH 1S/C21H18N2O3/c1-2-22-21(24)26-20-17-12-8-14-23(17)16-11-6-7-13-18(16)25-19(20)15-9-4-3-5-10-15/h3-14H,2H2,1H3,(H,22,24) D0K4VT DRUGINKE KPYJFQDJNXSVFL-UHFFFAOYSA-N D0K4VT DRUGSMIL CCNC(=O)OC1=C(OC2=CC=CC=C2N3C1=CC=C3)C4=CC=CC=C4 D0K4VT HIGHSTAT Patented D0K4VT COMPCLAS Benzoxazepine analogs D0K4YF DRUG__ID D0K4YF D0K4YF DRUGCOMP IKERCHEM S L [ESUNIV DEL PA S VASCO [ES] D0K4YF DRUGTYPE Small molecular drug D0K4YF DRUGINCH 1S/C23H19NO6/c1-30-15-4-5-16-17(13-2-6-19(25)21(27)8-13)11-24(18(16)10-15)12-23(29)14-3-7-20(26)22(28)9-14/h2-11,25-28H,12H2,1H3 D0K4YF DRUGINKE YPZMHCJTRFQAIG-UHFFFAOYSA-N D0K4YF DRUGSMIL COC1=CC2=C(C=C1)C(=CN2CC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)O D0K4YF HIGHSTAT Patented D0K6CM DRUG__ID D0K6CM D0K6CM DRUGCOMP F. HOFFMANN-LA ROCHE AG KOLCZEWSKI, Sabine PINARD, Emmanuel D0K6CM DRUGTYPE Small molecular drug D0K6CM DRUGINCH 1S/C25H29F3N2O2S/c1-32-19-15-18(25(26,27)28)16-20(33-2)22(19)23(31)29-24(17-9-4-3-5-10-17)12-8-14-30-13-7-6-11-21(24)30/h3-5,9-10,15-16,21H,6-8,11-14H2,1-2H3,(H,29,31)/t21-,24+/m1/s1 D0K6CM DRUGINKE VEQWRPXCFYIVLR-QPPBQGQZSA-N D0K6CM DRUGSMIL COC1=C(C(=CC(=C1)C(F)(F)F)SC)C(=O)NC2(CCCN3C2CCCC3)C4=CC=CC=C4 D0K6CM HIGHSTAT Patented D0K6GI DRUG__ID D0K6GI D0K6GI DRUGCOMP ASTRAZENECA AB BROWN, William PAGE, Daniel SRIVASTAVA, Sanjay WALPOLE, Christopher WEI, Zhong-yong YANG, Hua D0K6GI DRUGTYPE Small molecular drug D0K6GI DRUGINCH 1S/C28H38F2N4O2/c1-27(2,3)26-32-22-16-20(4-7-23(22)34(26)17-18-8-12-28(29,30)13-9-18)25(36)33-14-10-19(11-15-33)24(35)31-21-5-6-21/h4,7,16,18-19,21H,5-6,8-15,17H2,1-3H3,(H,31,35) D0K6GI DRUGINKE XZJQGNKKTKJFJW-UHFFFAOYSA-N D0K6GI DRUGSMIL CC(C)(C)C1=NC2=C(N1CC3CCC(CC3)(F)F)C=CC(=C2)C(=O)N4CCC(CC4)C(=O)NC5CC5 D0K6GI HIGHSTAT Patented D0K6HD DRUG__ID D0K6HD D0K6HD DRUGCOMP Exelixis D0K6HD DRUGTYPE Small molecular drug D0K6HD DRUGINCH 1S/C19H17F3IN3O3/c20-13-3-2-12(19(29)26-8-10(9-26)18(28)24-5-6-27)17(16(13)22)25-15-4-1-11(23)7-14(15)21/h1-4,7,10,25,27H,5-6,8-9H2,(H,24,28) D0K6HD DRUGINKE GNOFJPRIPYVPCR-UHFFFAOYSA-N D0K6HD DRUGSMIL C1C(CN1C(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)F)C(=O)NCCO D0K6HD HIGHSTAT Patented D0K7XA DRUG__ID D0K7XA D0K7XA DRUGTYPE Small molecular drug D0K7XA DRUGINCH 1S/C27H32Cl2N4OS/c1-3-4-6-11-21-13-15-25(35-21)26-18(2)23(17-30-27(34)31-20-9-7-5-8-10-20)32-33(26)24-14-12-19(28)16-22(24)29/h6,11-16,20H,3-5,7-10,17H2,1-2H3,(H2,30,31,34)/b11-6+ D0K7XA DRUGINKE RKQZPZUIJRISOY-IZZDOVSWSA-N D0K7XA DRUGSMIL CCCC=CC1=CC=C(S1)C2=C(C(=NN2C3=C(C=C(C=C3)Cl)Cl)CNC(=O)NC4CCCCC4)C D0K7XA HIGHSTAT Patented D0K7XA COMPCLAS Pyrazole derivatives D0KA7I DRUG__ID D0KA7I D0KA7I DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0KA7I DRUGTYPE Small molecule immunotherapy D0KA7I DRUGINCH 1S/C43H49ClN4O6/c1-29-33(8-5-9-36(29)37-10-6-12-40(30(37)2)52-19-7-15-47-17-13-35(49)14-18-47)28-54-42-22-41(53-27-32-20-31(23-45)24-46-25-32)34(21-38(42)44)26-48-16-4-3-11-39(48)43(50)51/h5-6,8-10,12,20-22,24-25,35,39,49H,3-4,7,11,13-19,26-28H2,1-2H3,(H,50,51) D0KA7I DRUGINKE VDKPFVAEXSRQOY-UHFFFAOYSA-N D0KA7I DRUGSMIL CC1=C(C=CC=C1C2=C(C(=CC=C2)OCCCN3CCC(CC3)O)C)COC4=C(C=C(C(=C4)OCC5=CC(=CN=C5)C#N)CN6CCCCC6C(=O)O)Cl D0KA7I HIGHSTAT Patented D0KB2Z DRUG__ID D0KB2Z D0KB2Z DRUGCOMP ABBVIE INC D0KB2Z DRUGTYPE Small molecular drug D0KB2Z DRUGINCH 1S/C22H22FN3O/c1-14-11-19-17(13-24-14)8-10-20(23)21(19)26-22(27)25-18-9-7-16(12-18)15-5-3-2-4-6-15/h2-6,8,10-11,13,16,18H,7,9,12H2,1H3,(H2,25,26,27)/t16-,18+/m0/s1 D0KB2Z DRUGINKE BLFYIBROKHRKEJ-FUHWJXTLSA-N D0KB2Z DRUGSMIL CC1=CC2=C(C=CC(=C2NC(=O)NC3CCC(C3)C4=CC=CC=C4)F)C=N1 D0KB2Z HIGHSTAT Patented D0KF3A DRUG__ID D0KF3A D0KF3A DRUGCOMP PURDUE PHARMA LP [USSHIONOGI & CO [JPTAFESSE LAYKEA [USANDO SHIGERU [JPKUROSE NORIYUKI [JP] D0KF3A DRUGTYPE Small molecular drug D0KF3A DRUGINCH 1S/C20H21F2N5O3S/c1-11-9-26(18-14(22)6-12(8-23-18)16(29)10-28)4-5-27(11)20(30)25-19-24-15-7-13(21)2-3-17(15)31-19/h2-3,6-8,11,16,28-29H,4-5,9-10H2,1H3,(H,24,25,30)/t11-,16+/m0/s1 D0KF3A DRUGINKE GVENNMJXQHKHOV-MEDUHNTESA-N D0KF3A DRUGSMIL CC1CN(CCN1C(=O)NC2=NC3=C(S2)C=CC(=C3)F)C4=C(C=C(C=N4)C(CO)O)F D0KF3A HIGHSTAT Patented D0KG5I DRUG__ID D0KG5I D0KG5I DRUGTYPE Small molecular drug D0KG5I DRUGINCH 1S/C19H20ClN5OS/c1-3-4-16(25-18(26)19-21-7-8-27-19)13-9-15(20)17(23-10-13)24-14-6-5-12(2)22-11-14/h5-11,16H,3-4H2,1-2H3,(H,23,24)(H,25,26) D0KG5I DRUGINKE QMMHYPPKJAWXON-UHFFFAOYSA-N D0KG5I DRUGSMIL CCCC(C1=CC(=C(N=C1)NC2=CN=C(C=C2)C)Cl)NC(=O)C3=NC=CS3 D0KG5I HIGHSTAT Patented D0KG5I COMPCLAS N-alkylamide derivatives D0KK6L DRUG__ID D0KK6L D0KK6L DRUGCOMP Apotex Inc D0KK6L DRUGTYPE Small molecular drug D0KK6L DRUGINCH 1S/C18H22N6O6S2/c25-16(26)13-22(17-21-31-18-19-10-12-23(17)18)11-6-2-1-5-9-20-32(29,30)15-8-4-3-7-14(15)24(27)28/h3-4,7-8,10,12,20H,1-2,5-6,9,11,13H2,(H,25,26) D0KK6L DRUGINKE NCXBWLQKBKSTHD-UHFFFAOYSA-N D0KK6L DRUGSMIL C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)NCCCCCCN(CC(=O)O)C2=NSC3=NC=CN23 D0KK6L HIGHSTAT Patented D0KL5M DRUG__ID D0KL5M D0KL5M DRUGCOMP ASTAR BIOTECH LLC HUANG, Haihong YU, Chunrong ZHANG, Dongfeng LI, Peng D0KL5M DRUGTYPE Small molecular drug D0KL5M DRUGINCH 1S/C30H28F2N6O/c1-20-5-6-22(16-21(20)7-9-24-19-33-28-4-3-11-34-38(24)28)29(39)35-23-8-10-25-26(17-23)30(31,32)18-27(25)37-14-12-36(2)13-15-37/h3-6,8,10-11,16-17,19,27H,12-15,18H2,1-2H3,(H,35,39) D0KL5M DRUGINKE BPLVEFPXYUJTQJ-UHFFFAOYSA-N D0KL5M DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC3=C(C=C2)C(CC3(F)F)N4CCN(CC4)C)C#CC5=CN=C6N5N=CC=C6 D0KL5M HIGHSTAT Patented D0KM8V DRUG__ID D0KM8V D0KM8V DRUGCOMP TRUSTEES OF BOSTON UNIVERSITY SCHAUS, Scott, E. EASTWOOD, Erin, L D0KM8V DRUGTYPE Small molecular drug D0KM8V DRUGINCH 1S/C11H14N4O2S/c1-2-3-9-18(16,17)11-12-13-14-15(11)10-7-5-4-6-8-10/h4-8H,2-3,9H2,1H3 D0KM8V DRUGINKE FSUGWNZPOPKNAK-UHFFFAOYSA-N D0KM8V DRUGSMIL CCCCS(=O)(=O)C1=NN=NN1C2=CC=CC=C2 D0KM8V HIGHSTAT Patented D0KP0U DRUG__ID D0KP0U D0KP0U DRUGCOMP G. D. SEARLE & CO. GAO, Danchen HLINAK, Anthony, J. MAZHARY, Ahmad, M. TRUELOVE, James, E. VAUGHN, Margaret, B., Woodhull D0KP0U DRUGTYPE Small molecular drug D0KP0U DRUGINCH 1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25) D0KP0U DRUGINKE RZEKVGVHFLEQIL-UHFFFAOYSA-N D0KP0U DRUGSMIL CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F D0KP0U HIGHSTAT Patented D0KP8N DRUG__ID D0KP8N D0KP8N DRUGCOMP THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY IP, Nancy Yuk-Yu IP, Fanny Chui-Fun FU, Wing Yu FU, Guangmiao D0KP8N DRUGTYPE Small molecular drug D0KP8N DRUGINCH 1S/C21H20O11/c1-7-13(25)15(27)17(29)21(30-7)32-19-11(24)6-10(23)12-14(26)16(28)18(31-20(12)19)8-2-4-9(22)5-3-8/h2-7,13,15,17,21-25,27-29H,1H3 D0KP8N DRUGINKE PJZKCQPCHMMPJZ-UHFFFAOYSA-N D0KP8N DRUGSMIL CC1C(C(C(C(O1)OC2=C(C=C(C3=C2OC(=C(C3=O)O)C4=CC=C(C=C4)O)O)O)O)O)O D0KP8N HIGHSTAT Patented D0KR7K DRUG__ID D0KR7K D0KR7K DRUGCOMP NATCO PHARMA LIMITED KOMPELLA, Amala, Kishan RACHAKONDA, Sreenivas ADIBHATLA KALISATYA, Bhujanga, Rao VENKAIAH CHOWDARY, Nannapanen D0KR7K DRUGTYPE Small molecular drug D0KR7K DRUGINCH 1S/C24H18F3N5O3S/c1-15-7-8-18(30-22(33)16-4-2-6-19(12-16)36(34,35)24(25,26)27)13-21(15)32-23-29-11-9-20(31-23)17-5-3-10-28-14-17/h2-14H,1H3,(H,30,33)(H,29,31,32) D0KR7K DRUGINKE SCDUZEXJWFANOL-UHFFFAOYSA-N D0KR7K DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)S(=O)(=O)C(F)(F)F)NC3=NC=CC(=N3)C4=CN=CC=C4 D0KR7K HIGHSTAT Patented D0KT5W DRUG__ID D0KT5W D0KT5W DRUGCOMP PIRAMAL HEALTHCARE LIMITED SIVAKUMAR, Meenakshi JOSHI, Kalpana Sanjay AWARE, Valmik Sopan SARDE, Ankush Gangaram BAGUL, Sandeep Mukunda MANOHAR, Sonal Mohan D0KT5W DRUGTYPE Small molecular drug D0KT5W DRUGINCH 1S/C17H14N2O3/c20-14-8-6-13(10-15(14)21)7-9-17-18-16(19-22-17)11-12-4-2-1-3-5-12/h1-10,20-21H,11H2/b9-7+ D0KT5W DRUGINKE BJLAYSATLVCCDW-VQHVLOKHSA-N D0KT5W DRUGSMIL C1=CC=C(C=C1)CC2=NOC(=N2)C=CC3=CC(=C(C=C3)O)O D0KT5W HIGHSTAT Patented D0KX2W DRUG__ID D0KX2W D0KX2W DRUGTYPE Small molecular drug D0KX2W DRUGINCH 1S/C21H19Cl3N4OS/c1-30-21-18(20(29)26-27-10-2-3-11-27)25-19(16-9-6-14(23)12-17(16)24)28(21)15-7-4-13(22)5-8-15/h4-9,12H,2-3,10-11H2,1H3,(H,26,29) D0KX2W DRUGINKE HYQPTXFCPLFWMJ-UHFFFAOYSA-N D0KX2W DRUGSMIL CSC1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCC4 D0KX2W HIGHSTAT Patented D0KX2W COMPCLAS 1,2,4,5-tetra-substituted imidazole derivatives D0KY1Y DRUG__ID D0KY1Y D0KY1Y DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PFAU, Roland ARNDT, Kirsten DOODS, Henri HAUEL, Norbert KLINDER, Klaus KUELZER, Raimund MACK, Juergen PRIEPKE, Henning STENKAMP, Dirk D0KY1Y DRUGTYPE Small molecular drug D0KY1Y DRUGINCH 1S/C25H30ClFN4O2/c1-14-6-7-17(26)22(21(14)27)30-24-29-18-12-16(20(33-5)13-19(18)31(24)4)23(32)28-15-8-10-25(2,3)11-9-15/h6-7,12-13,15H,8-11H2,1-5H3,(H,28,32)(H,29,30) D0KY1Y DRUGINKE GHWPMCBIOYWZCT-UHFFFAOYSA-N D0KY1Y DRUGSMIL CC1=C(C(=C(C=C1)Cl)NC2=NC3=C(N2C)C=C(C(=C3)C(=O)NC4CCC(CC4)(C)C)OC)F D0KY1Y HIGHSTAT Patented D0KZ6Q DRUG__ID D0KZ6Q D0KZ6Q DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0KZ6Q DRUGTYPE Small molecular drug D0KZ6Q DRUGINCH 1S/C24H14F9N5O/c25-22(26,27)11-39-18-7-13(4-5-16(18)23(28,29)30)17-8-19(24(31,32)33)38-20(37-17)14-3-1-2-12(6-14)15-9-35-21(34)36-10-15/h1-10H,11H2,(H2,34,35,36) D0KZ6Q DRUGINKE YCJPDEUHPPTQFR-UHFFFAOYSA-N D0KZ6Q DRUGSMIL C1=CC(=CC(=C1)C2=NC(=CC(=N2)C(F)(F)F)C3=CC(=C(C=C3)C(F)(F)F)OCC(F)(F)F)C4=CN=C(N=C4)N D0KZ6Q HIGHSTAT Patented D0L1JQ DRUG__ID D0L1JQ D0L1JQ DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D0L1JQ DRUGTYPE Small molecular drug D0L1JQ DRUGINCH 1S/C16H18N2O3/c1-3-4-16(20)21-13-5-6-15-14(9-13)12(10-18-15)7-8-17-11(2)19/h3-6,9-10,18H,7-8H2,1-2H3,(H,17,19)/b4-3+ D0L1JQ DRUGINKE YKWJUNJYDNSFHV-ONEGZZNKSA-N D0L1JQ DRUGSMIL CC=CC(=O)OC1=CC2=C(C=C1)NC=C2CCNC(=O)C D0L1JQ HIGHSTAT Patented D0L1NO DRUG__ID D0L1NO D0L1NO DRUGCOMP CHDI FOUNDATION, INC D0L1NO DRUGTYPE Small molecular drug D0L1NO DRUGINCH 1S/C20H15F2N3O2/c21-15-10-23-18(24-11-15)14-8-6-13(7-9-14)17-16(12-4-2-1-3-5-12)20(17,22)19(26)25-27/h1-11,16-17,27H,(H,25,26)/t16-,17-,20+/m1/s1 D0L1NO DRUGINKE MREATSZIGJDNKB-HLIPFELVSA-N D0L1NO DRUGSMIL C1=CC=C(C=C1)C2C(C2(C(=O)NO)F)C3=CC=C(C=C3)C4=NC=C(C=N4)F D0L1NO HIGHSTAT Patented D0L1PP DRUG__ID D0L1PP D0L1PP DRUGCOMP VIROBAY, INC. HOLSINGER, Lesli D0L1PP DRUGTYPE Small molecular drug D0L1PP DRUGINCH 1S/C40H54N8O7/c1-39(2,3)34(45-38(53)46-40(4,5)6)37(52)47-22-26(55-31-21-32(48-17-9-16-41-48)43-28-19-25(54-7)14-15-27(28)31)20-30(47)35(50)44-29(18-23-10-8-11-23)33(49)36(51)42-24-12-13-24/h9,14-17,19,21,23-24,26,29-30,34H,8,10-13,18,20,22H2,1-7H3,(H,42,51)(H,44,50)(H2,45,46,53)/t26-,29+,30+,34-/m1/s1 D0L1PP DRUGINKE YOTPWZLVXAMQNL-GUXYKIAJSA-N D0L1PP DRUGSMIL CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC(CC2CCC2)C(=O)C(=O)NC3CC3)OC4=CC(=NC5=C4C=CC(=C5)OC)N6C=CC=N6)NC(=O)NC(C)(C)C D0L1PP HIGHSTAT Patented D0L1SV DRUG__ID D0L1SV D0L1SV DRUGTYPE Small molecular drug D0L1SV DRUGINCH 1S/C16H23NO3/c1-11-8-12(10-16(2,3)9-11)20-15(19)17-13-6-4-5-7-14(13)18/h4-7,11-12,18H,8-10H2,1-3H3,(H,17,19) D0L1SV DRUGINKE XMUAVVZKNAMDEP-UHFFFAOYSA-N D0L1SV DRUGSMIL CC1CC(CC(C1)(C)C)OC(=O)NC2=CC=CC=C2O D0L1SV HIGHSTAT Patented D0L1SV COMPCLAS Cyclohexyl carbamate derivatives D0L1TA DRUG__ID D0L1TA D0L1TA DRUGCOMP YUNG SHIN PHARM. IND. CO., LTD D0L1TA DRUGTYPE Small molecular drug D0L1TA DRUGINCH 1S/C19H16N2O2/c22-13-15-10-11-18(23-15)19-16-8-4-5-9-17(16)21(20-19)12-14-6-2-1-3-7-14/h1-11,22H,12-13H2 D0L1TA DRUGINKE OQQVFCKUDYMWGV-UHFFFAOYSA-N D0L1TA DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)C4=CC=C(O4)CO D0L1TA HIGHSTAT Patented D0L2EQ DRUG__ID D0L2EQ D0L2EQ DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D0L2EQ DRUGTYPE Small molecular drug D0L2EQ DRUGINCH 1S/C26H30N4O/c1-28-23-16-20(8-9-21(23)26-22-10-7-19(27-22)15-24(26)28)30-14-13-29(17-25(30)31)12-11-18-5-3-2-4-6-18/h2-6,8-9,16,19,22,27H,7,10-15,17H2,1H3 D0L2EQ DRUGINKE JXBCIEBMTZBYLB-UHFFFAOYSA-N D0L2EQ DRUGSMIL CN1C2=C(C3CCC(C2)N3)C4=C1C=C(C=C4)N5CCN(CC5=O)CCC6=CC=CC=C6 D0L2EQ HIGHSTAT Patented D0L3ZZ DRUG__ID D0L3ZZ D0L3ZZ DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0L3ZZ DRUGTYPE Small molecular drug D0L3ZZ DRUGINCH 1S/C28H29NO5/c1-32-27-17-22(11-14-25(27)33-18-24(30)21-7-8-21)29-16-15-26(28(29)31)34-23-12-9-20(10-13-23)19-5-3-2-4-6-19/h2-6,9-14,17,21,24,26,30H,7-8,15-16,18H2,1H3/t24-,26+/m0/s1 D0L3ZZ DRUGINKE GLIZEOCMOXBOFJ-AZGAKELHSA-N D0L3ZZ DRUGSMIL COC1=C(C=CC(=C1)N2CCC(C2=O)OC3=CC=C(C=C3)C4=CC=CC=C4)OCC(C5CC5)O D0L3ZZ HIGHSTAT Patented D0L4GL DRUG__ID D0L4GL D0L4GL DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0L4GL DRUGTYPE Small molecular drug D0L4GL DRUGINCH 1S/C29H31ClFN3O4/c1-38-16-15-34(21-7-3-2-4-8-21)27-14-11-19(22-9-5-6-10-23(22)28(35)36)17-26(27)33-29(37)32-25-13-12-20(30)18-24(25)31/h5-6,9-14,17-18,21H,2-4,7-8,15-16H2,1H3,(H,35,36)(H2,32,33,37) D0L4GL DRUGINKE KUVXHGKRYSVGPP-UHFFFAOYSA-N D0L4GL DRUGSMIL COCCN(C1CCCCC1)C2=C(C=C(C=C2)C3=CC=CC=C3C(=O)O)NC(=O)NC4=C(C=C(C=C4)Cl)F D0L4GL HIGHSTAT Patented D0L5NZ DRUG__ID D0L5NZ D0L5NZ DRUGCOMP Takeda Pharmaceutical Co. Ltd D0L5NZ DRUGTYPE Small molecular drug D0L5NZ DRUGINCH 1S/C23H23N3O2/c27-22(20-7-4-12-25-21(20)19-8-13-24-14-9-19)26-15-10-23(28,11-16-26)17-18-5-2-1-3-6-18/h1-9,12-14,28H,10-11,15-17H2 D0L5NZ DRUGINKE XKUZMIUSBMCVPP-UHFFFAOYSA-N D0L5NZ DRUGSMIL C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4 D0L5NZ HIGHSTAT Patented D0L6CM DRUG__ID D0L6CM D0L6CM DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D0L6CM DRUGTYPE Small molecular drug D0L6CM DRUGINCH 1S/C26H26ClN5/c27-22-9-7-21(8-10-22)25-30-23(24(31-25)26-28-14-4-15-29-26)20-12-17-32(18-13-20)16-11-19-5-2-1-3-6-19/h1-10,14-15,20H,11-13,16-18H2,(H,30,31) D0L6CM DRUGINKE CQQKTUASFMHQMA-UHFFFAOYSA-N D0L6CM DRUGSMIL C1CN(CCC1C2=C(N=C(N2)C3=CC=C(C=C3)Cl)C4=NC=CC=N4)CCC5=CC=CC=C5 D0L6CM HIGHSTAT Patented D0L7HG DRUG__ID D0L7HG D0L7HG DRUGCOMP CHONG KUN DANG PHARMACEUTICAL CORP D0L7HG DRUGTYPE Small molecular drug D0L7HG DRUGINCH 1S/C25H34N4O3/c30-23(27-32)15-9-1-2-10-16-26-25(31)29-19-17-28(18-20-29)24(21-11-5-3-6-12-21)22-13-7-4-8-14-22/h3-8,11-14,24,32H,1-2,9-10,15-20H2,(H,26,31)(H,27,30) D0L7HG DRUGINKE GFDQSOACLIFRIQ-UHFFFAOYSA-N D0L7HG DRUGSMIL C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NCCCCCCC(=O)NO D0L7HG HIGHSTAT Patented D0L7SK DRUG__ID D0L7SK D0L7SK DRUGCOMP KYORIN PHARMACEUTICAL CO., LTD D0L7SK DRUGTYPE Small molecular drug D0L7SK DRUGINCH 1S/C33H41N7O3/c1-5-43-30-18-22(32(41)40-17-14-24(21-40)35-23-12-15-37(2)16-13-23)10-11-26(30)36-31-19-28-29(20-34-31)39(4)33(42)25-8-6-7-9-27(25)38(28)3/h6-11,18-20,23-24,35H,5,12-17,21H2,1-4H3,(H,34,36)/t24-/m0/s1 D0L7SK DRUGINKE SXKDARBSSREUSH-DEOSSOPVSA-N D0L7SK DRUGSMIL CCOC1=C(C=CC(=C1)C(=O)N2CCC(C2)NC3CCN(CC3)C)NC4=NC=C5C(=C4)N(C6=CC=CC=C6C(=O)N5C)C D0L7SK HIGHSTAT Patented D0L7XM DRUG__ID D0L7XM D0L7XM DRUGCOMP IRM LLC DING, Qiang SIM, Tae-bo ZHANG, Guobao ADRIAN, Francisco GRAY, Nathanael, S D0L7XM DRUGTYPE Small molecular drug D0L7XM DRUGINCH 1S/C18H15F3N4O3S/c1-29(26,27)25-14-4-2-12(3-5-14)16-10-17(23-11-22-16)24-13-6-8-15(9-7-13)28-18(19,20)21/h2-11,25H,1H3,(H,22,23,24) D0L7XM DRUGINKE IQTSERMRWSERDI-UHFFFAOYSA-N D0L7XM DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F D0L7XM HIGHSTAT Patented D0L8KM DRUG__ID D0L8KM D0L8KM DRUGCOMP AUCKLAND UNISERVICES LIMITED D0L8KM DRUGTYPE Small molecular drug D0L8KM DRUGINCH 1S/C8H8ClN3O/c1-3-5-7(10)12-13-8(5)11-4(2)6(3)9/h1-2H3,(H2,10,12) D0L8KM DRUGINKE XEYWCHKONZUDGB-UHFFFAOYSA-N D0L8KM DRUGSMIL CC1=C2C(=NOC2=NC(=C1Cl)C)N D0L8KM HIGHSTAT Patented D0L9BG DRUG__ID D0L9BG D0L9BG DRUGCOMP IOMET PHARMA LTD. MERCK SHARP & DOHME CORP. COWLEY, Phillip, M. WISE, Alan BROWN, Thomas, J. MCGOWAN, Meredeth, A. ZHOU, Hua HAN, Yongxin D0L9BG DRUGTYPE Small molecular drug D0L9BG DRUGINCH 1S/C14H19BrN4O2S/c1-14(2)9-17(4-5-19(14)22(3,20)21)13-7-11(15)6-12-8-16-10-18(12)13/h6-8,10H,4-5,9H2,1-3H3 D0L9BG DRUGINKE MJEJSWKBPXDOCH-UHFFFAOYSA-N D0L9BG DRUGSMIL CC1(CN(CCN1S(=O)(=O)C)C2=CC(=CC3=CN=CN23)Br)C D0L9BG HIGHSTAT Patented D0LB3J DRUG__ID D0LB3J D0LB3J DRUGTYPE Small molecular drug D0LB3J DRUGINCH 1S/C22H27FN4O2/c1-5-26(6-2)20(28)14-19-21(17-7-9-18(10-8-17)29-12-11-23)25-27-16(4)13-15(3)24-22(19)27/h7-10,13H,5-6,11-12,14H2,1-4H3 D0LB3J DRUGINKE FLZZFWBNYJNHMY-UHFFFAOYSA-N D0LB3J DRUGSMIL CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OCCF)C)C D0LB3J HIGHSTAT Patented D0LB3J COMPCLAS Pyrazolopyrimidine acetamide analogs D0LB7I DRUG__ID D0LB7I D0LB7I DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0LB7I DRUGTYPE Small molecular drug D0LB7I DRUGINCH 1S/C23H23N5O/c1-26-15-12-18(13-16-26)28-21(29)11-10-19(24-28)22-20-9-5-6-14-27(20)25-23(22)17-7-3-2-4-8-17/h2-11,14,18H,12-13,15-16H2,1H3 D0LB7I DRUGINKE YHDRUTMZCJZJAL-UHFFFAOYSA-N D0LB7I DRUGSMIL CN1CCC(CC1)N2C(=O)C=CC(=N2)C3=C4C=CC=CN4N=C3C5=CC=CC=C5 D0LB7I HIGHSTAT Patented D0LC2G DRUG__ID D0LC2G D0LC2G DRUGTYPE Small molecular drug D0LC2G DRUGINCH 1S/C13H25NO2/c1-4-5-9-14-13(15)16-12-8-6-7-10(2)11(12)3/h10-12H,4-9H2,1-3H3,(H,14,15) D0LC2G DRUGINKE NRBLABNDLCTIGX-UHFFFAOYSA-N D0LC2G DRUGSMIL CCCCNC(=O)OC1CCCC(C1C)C D0LC2G HIGHSTAT Patented D0LC2G COMPCLAS Cyclohexyl carbamate derivatives D0LI2I DRUG__ID D0LI2I D0LI2I DRUGCOMP VANDERBILT UNIVERSITY D0LI2I DRUGTYPE Small molecular drug D0LI2I DRUGINCH 1S/C16H10FN7O2/c17-10-1-2-14(20-4-10)23-16(25)13-3-11(7-24-15(13)21-9-22-24)26-12-5-18-8-19-6-12/h1-9H,(H,20,23,25) D0LI2I DRUGINKE CBMXXEDRQZKTGZ-UHFFFAOYSA-N D0LI2I DRUGSMIL C1=CC(=NC=C1F)NC(=O)C2=CC(=CN3C2=NC=N3)OC4=CN=CN=C4 D0LI2I HIGHSTAT Patented D0LK4L DRUG__ID D0LK4L D0LK4L DRUGCOMP EURO-CELTIQUE S.A. CRYSTAL BIOPHARMACEUTICALS LLC PURDUE PHARMACEUTICAL PRODUCTS L.P D0LK4L DRUGTYPE Small molecular drug D0LK4L DRUGINCH 1S/C23H28Cl2N4O2S2/c1-23(2,3)18-13-26-20(31-18)15-32-21-14-27-22(33-21)28-19(30)12-16-4-6-17(7-5-16)29(10-8-24)11-9-25/h4-7,13-14H,8-12,15H2,1-3H3,(H,27,28,30) D0LK4L DRUGINKE WETDPIQQVIMQAF-UHFFFAOYSA-N D0LK4L DRUGSMIL CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)CC3=CC=C(C=C3)N(CCCl)CCCl D0LK4L HIGHSTAT Patented D0LN9D DRUG__ID D0LN9D D0LN9D DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0LN9D DRUGTYPE Small molecular drug D0LN9D DRUGINCH 1S/C18H28N4O3/c1-17(2,12-19)14-10-15(25-21-14)20-16(23)18(3,4)22(5)11-13-6-8-24-9-7-13/h10,13H,6-9,11H2,1-5H3,(H,20,23) D0LN9D DRUGINKE OLLDWVBPHQUDHP-UHFFFAOYSA-N D0LN9D DRUGSMIL CC(C)(C#N)C1=NOC(=C1)NC(=O)C(C)(C)N(C)CC2CCOCC2 D0LN9D HIGHSTAT Patented D0LO0I DRUG__ID D0LO0I D0LO0I DRUGCOMP Stanford University D0LO0I DRUGTYPE Small molecular drug D0LO0I DRUGINCH 1S/C23H23BrN4O4/c24-21-11-17(32-28-21)13-26-22(29)20(10-16-12-25-19-9-5-4-8-18(16)19)27-23(30)31-14-15-6-2-1-3-7-15/h1-9,12,17,20,25H,10-11,13-14H2,(H,26,29)(H,27,30)/t17?,20-/m0/s1 D0LO0I DRUGINKE MAQVWGRATZCTBU-OZBJMMHXSA-N D0LO0I DRUGSMIL C1C(ON=C1Br)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4 D0LO0I HIGHSTAT Patented D0LO1Z DRUG__ID D0LO1Z D0LO1Z DRUGCOMP WEIGEL, Ronald J D0LO1Z DRUGTYPE Small molecular drug D0LO1Z DRUGINCH 1S/C22H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-17-15-18-20(23)21(19)22(24)25/h7-8,15,17-18,23H,2-6,9-14,16H2,1H3,(H,24,25)/b8-7- D0LO1Z DRUGINKE YXHVCZZLWZYHSA-FPLPWBNLSA-N D0LO1Z DRUGSMIL CCCCCCC=CCCCCCCCC1=C(C(=CC=C1)O)C(=O)O D0LO1Z HIGHSTAT Patented D0LP1K DRUG__ID D0LP1K D0LP1K DRUGCOMP CHONG KUN DANG PHARMACEUTICAL CORP D0LP1K DRUGTYPE Small molecular drug D0LP1K DRUGINCH 1S/C20H20F3N3O4/c21-20(22,23)16-2-1-3-17(12-16)26(19(28)25-8-10-30-11-9-25)13-14-4-6-15(7-5-14)18(27)24-29/h1-7,12,29H,8-11,13H2,(H,24,27) D0LP1K DRUGINKE SOEPWATUUFBVRJ-UHFFFAOYSA-N D0LP1K DRUGSMIL C1COCCN1C(=O)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC(=C3)C(F)(F)F D0LP1K HIGHSTAT Patented D0LP3P DRUG__ID D0LP3P D0LP3P DRUGCOMP THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0LP3P DRUGTYPE Small molecular drug D0LP3P DRUGINCH 1S/C23H26FN3O3/c1-17(28)18-4-9-21-22(16-18)30-23(29)27(21)11-3-2-10-25-12-14-26(15-13-25)20-7-5-19(24)6-8-20/h4-9,16H,2-3,10-15H2,1H3 D0LP3P DRUGINKE VGDFDVKDWFJQHD-UHFFFAOYSA-N D0LP3P DRUGSMIL CC(=O)C1=CC2=C(C=C1)N(C(=O)O2)CCCCN3CCN(CC3)C4=CC=C(C=C4)F D0LP3P HIGHSTAT Patented D0LR5O DRUG__ID D0LR5O D0LR5O DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0LR5O DRUGTYPE Small molecular drug D0LR5O DRUGINCH 1S/C26H31Cl2N3O6/c1-14-10-20(36-2)18(25(34)29-14)12-31-9-6-16-19(27)11-17(23(28)22(16)26(31)35)24(37-3)15-4-7-30(8-5-15)21(33)13-32/h10-11,15,24,32H,4-9,12-13H2,1-3H3,(H,29,34) D0LR5O DRUGINKE AARGZKBSIZRPJQ-UHFFFAOYSA-N D0LR5O DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C(C4CCN(CC4)C(=O)CO)OC)Cl)OC D0LR5O HIGHSTAT Patented D0LT5Y DRUG__ID D0LT5Y D0LT5Y DRUGCOMP NeoPharm Co. Ltd D0LT5Y DRUGTYPE Small molecular drug D0LT5Y DRUGINCH 1S/C14H25N3O3/c1-12(18)11-14(20)17-9-7-16(8-10-17)13(19)5-3-2-4-6-15/h2-11,15H2,1H3 D0LT5Y DRUGINKE ISBLYNHHDOKBBQ-UHFFFAOYSA-N D0LT5Y DRUGSMIL CC(=O)CC(=O)N1CCN(CC1)C(=O)CCCCCN D0LT5Y HIGHSTAT Patented D0LU7K DRUG__ID D0LU7K D0LU7K DRUGTYPE Small molecular drug D0LU7K DRUGINCH 1S/C24H21Cl2N5O5S2/c1-27-38(35,36)24-20(23(32)29-16-10-11-37(33,34)13-16)22-28-12-18(17-4-2-3-5-19(17)26)21(31(22)30-24)14-6-8-15(25)9-7-14/h2-9,12,16,27H,10-11,13H2,1H3,(H,29,32) D0LU7K DRUGINKE OGXPEWYKDODYIH-UHFFFAOYSA-N D0LU7K DRUGSMIL CNS(=O)(=O)C1=NN2C(=C(C=NC2=C1C(=O)NC3CCS(=O)(=O)C3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl D0LU7K HIGHSTAT Patented D0LU7K COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0LW9K DRUG__ID D0LW9K D0LW9K DRUGCOMP Takeda Pharmaceutical Co. Ltd D0LW9K DRUGTYPE Small molecular drug D0LW9K DRUGINCH 1S/C17H15FN4O3/c18-10-3-13(15-5-19-9-25-15)16-20-4-14(21(16)6-10)17(23)22-11-1-2-12(22)8-24-7-11/h3-6,9,11-12H,1-2,7-8H2 D0LW9K DRUGINKE AVXVHVNSDORSDK-UHFFFAOYSA-N D0LW9K DRUGSMIL C1CC2COCC1N2C(=O)C3=CN=C4N3C=C(C=C4C5=CN=CO5)F D0LW9K HIGHSTAT Patented D0LX9F DRUG__ID D0LX9F D0LX9F DRUGCOMP Baylor College of Medicine D0LX9F DRUGTYPE Small molecular drug D0LX9F DRUGINCH 1S/C7H5NO5/c9-3-4-1-5(8(12)13)7(11)6(10)2-4/h1-3,10-11H D0LX9F DRUGINKE BBFJODMCHICIAA-UHFFFAOYSA-N D0LX9F DRUGSMIL C1=C(C=C(C(=C1[N+](=O)[O-])O)O)C=O D0LX9F HIGHSTAT Patented D0LY6S DRUG__ID D0LY6S D0LY6S DRUGCOMP GLENMARK PHARMACEUTICALS S.A D0LY6S DRUGTYPE Small molecular drug D0LY6S DRUGINCH 1S/C27H19ClF2N4O3/c28-18-2-1-3-19(29)22(18)33-27-32-21-13-17(24-25(23(21)34-27)37-11-10-36-24)26(35)31-16-9-8-15(20(30)12-16)7-6-14-4-5-14/h1-3,8-9,12-14H,4-5,10-11H2,(H,31,35)(H2,32,33,34) D0LY6S DRUGINKE CSOLVYOAIFCMHY-UHFFFAOYSA-N D0LY6S DRUGSMIL C1CC1C#CC2=C(C=C(C=C2)NC(=O)C3=CC4=C(C5=C3OCCO5)N=C(N4)NC6=C(C=CC=C6Cl)F)F D0LY6S HIGHSTAT Patented D0LZ1Z DRUG__ID D0LZ1Z D0LZ1Z DRUGTYPE Small molecular drug D0LZ1Z DRUGINCH 1S/C26H24Cl2N6O4S/c27-16-11-9-15(10-12-16)23-19(18-7-3-4-8-20(18)28)13-30-24-22(25(36)32-17-5-1-2-6-17)26(33-34(23)24)39(37,38)31-14-21(29)35/h3-4,7-13,17,31H,1-2,5-6,14H2,(H2,29,35)(H,32,36) D0LZ1Z DRUGINKE XUKGKEPVXJSMGH-UHFFFAOYSA-N D0LZ1Z DRUGSMIL C1CCC(C1)NC(=O)C2=C3N=CC(=C(N3N=C2S(=O)(=O)NCC(=O)N)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0LZ1Z HIGHSTAT Patented D0LZ1Z COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0M0RE DRUG__ID D0M0RE D0M0RE DRUGCOMP HOCHSCHULE DARMSTADT D0M0RE DRUGTYPE Small molecular drug D0M0RE DRUGINCH 1S/C11H10FN3S/c12-7-2-3-8-9(6-7)16-11(13)15-5-1-4-14-10(8)15/h2-3,6,13H,1,4-5H2 D0M0RE DRUGINKE QEVWRCSULVKULZ-UHFFFAOYSA-N D0M0RE DRUGSMIL C1CN=C2C3=C(C=C(C=C3)F)SC(=N)N2C1 D0M0RE HIGHSTAT Patented D0M0UE DRUG__ID D0M0UE D0M0UE DRUGCOMP CASE WESTERN RESERVE UNIVERSITY D0M0UE DRUGTYPE Small molecular drug D0M0UE DRUGINCH 1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9) D0M0UE DRUGINKE BPBPYQWMFCTCNG-UHFFFAOYSA-N D0M0UE DRUGSMIL CCC(C)SSC1=NC=CN1 D0M0UE HIGHSTAT Patented D0M3EA DRUG__ID D0M3EA D0M3EA DRUGTYPE Small molecular drug D0M3EA DRUGINCH 1S/C26H19N7O2/c1-16-23(22-11-12-29-33(22)20-9-5-17(14-27)6-10-20)31-24(25(34)30-19-7-8-19)26(35)32(16)21-4-2-3-18(13-21)15-28/h2-6,9-13,19H,7-8H2,1H3,(H,30,34) D0M3EA DRUGINKE GJIYKCWSHGJDFQ-UHFFFAOYSA-N D0M3EA DRUGSMIL CC1=C(N=C(C(=O)N1C2=CC=CC(=C2)C#N)C(=O)NC3CC3)C4=CC=NN4C5=CC=C(C=C5)C#N D0M3EA HIGHSTAT Patented D0M3EA COMPCLAS 2-pyrazinone derivatives D0M3VE DRUG__ID D0M3VE D0M3VE DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0M3VE DRUGTYPE Small molecular drug D0M3VE DRUGINCH 1S/C15H14BrN5OS/c1-9-18-11-2-4-20(5-3-13(11)23-9)15(22)12-6-14-17-7-10(16)8-21(14)19-12/h6-8H,2-5H2,1H3 D0M3VE DRUGINKE PPBYGUATKIHBBC-UHFFFAOYSA-N D0M3VE DRUGSMIL CC1=NC2=C(S1)CCN(CC2)C(=O)C3=NN4C=C(C=NC4=C3)Br D0M3VE HIGHSTAT Patented D0M4EQ DRUG__ID D0M4EQ D0M4EQ DRUGCOMP Boiteau JG, Barbuis CM, Bouquet K D0M4EQ DRUGTYPE Small molecular drug D0M4EQ DRUGINCH 1S/C8H8N2S2/c1-5-2-3-7(12-5)6-4-9-8(11)10-6/h2-4H,1H3,(H2,9,10,11) D0M4EQ DRUGINKE VLDBRCXNFRGTRR-UHFFFAOYSA-N D0M4EQ DRUGSMIL CC1=CC=C(S1)C2=CNC(=S)N2 D0M4EQ HIGHSTAT Patented D0M4WY DRUG__ID D0M4WY D0M4WY DRUGCOMP ABBVIE INC D0M4WY DRUGTYPE Small molecular drug D0M4WY DRUGINCH 1S/C21H22F2N2O3/c1-21(2)10-17(13-6-7-15(22)18(23)19(13)28-21)25-20(27)24-16-5-3-4-11-8-12(26)9-14(11)16/h3-7,12,17,26H,8-10H2,1-2H3,(H2,24,25,27)/t12-,17-/m1/s1 D0M4WY DRUGINKE YOPCFYQBNUSQMJ-SJKOYZFVSA-N D0M4WY DRUGSMIL CC1(CC(C2=C(O1)C(=C(C=C2)F)F)NC(=O)NC3=CC=CC4=C3CC(C4)O)C D0M4WY HIGHSTAT Patented D0M4XO DRUG__ID D0M4XO D0M4XO DRUGCOMP Takeda Pharmaceutical Co. Ltd D0M4XO DRUGTYPE Small molecular drug D0M4XO DRUGINCH 1S/C18H15F3N4O3/c19-18(20,21)10-3-13(15-5-22-9-28-15)16-23-4-14(24(16)6-10)17(26)25-11-1-2-12(25)8-27-7-11/h3-6,9,11-12H,1-2,7-8H2 D0M4XO DRUGINKE OANZLTUUAVMTHM-UHFFFAOYSA-N D0M4XO DRUGSMIL C1CC2COCC1N2C(=O)C3=CN=C4N3C=C(C=C4C5=CN=CO5)C(F)(F)F D0M4XO HIGHSTAT Patented D0M5EC DRUG__ID D0M5EC D0M5EC DRUGCOMP CORNELL UNIVERSITY D0M5EC DRUGTYPE Small molecular drug D0M5EC DRUGINCH 1S/C21H26O2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)19-13-15-20(16-14-19)21(22)23/h9-16H,2-8H2,1H3,(H,22,23) D0M5EC DRUGINKE HXBKPYIEQLLNBK-UHFFFAOYSA-N D0M5EC DRUGSMIL CCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)O D0M5EC HIGHSTAT Patented D0M5LL DRUG__ID D0M5LL D0M5LL DRUGCOMP THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0M5LL DRUGTYPE Small molecular drug D0M5LL DRUGINCH 1S/C21H31N3S2/c25-21-24(19-10-4-5-11-20(19)26-21)13-7-6-12-22-14-16-23(17-15-22)18-8-2-1-3-9-18/h4-5,10-11,18H,1-3,6-9,12-17H2 D0M5LL DRUGINKE FJGOTAJCEJCFEV-UHFFFAOYSA-N D0M5LL DRUGSMIL C1CCC(CC1)N2CCN(CC2)CCCCN3C4=CC=CC=C4SC3=S D0M5LL HIGHSTAT Patented D0M6LX DRUG__ID D0M6LX D0M6LX DRUGTYPE Small molecular drug D0M6LX DRUGINCH 1S/C17H12N2O4/c20-17(21)11-4-3-5-12(10-11)18-15-8-9-16(19(22)23)14-7-2-1-6-13(14)15/h1-10,18H,(H,20,21) D0M6LX DRUGINKE ZLIDMWNTWSBTSM-UHFFFAOYSA-N D0M6LX DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2[N+](=O)[O-])NC3=CC=CC(=C3)C(=O)O D0M6LX HIGHSTAT Patented D0M6LX COMPCLAS N-(naphthylamino)-benzoate derivatives D0M6PB DRUG__ID D0M6PB D0M6PB DRUGCOMP SANOFI-AVENTIS BARTH, Francis BICHON, Daniel CONGY, Christian RINALDI-CARMONA, Muriell D0M6PB DRUGTYPE Small molecular drug D0M6PB DRUGINCH 1S/C33H32Cl3N3O3/c34-23-9-12-25(13-10-23)39-29(8-4-5-19-40)27(21-30(39)26-14-11-24(35)20-28(26)36)31(41)38-17-15-33(16-18-38,32(37)42)22-6-2-1-3-7-22/h1-3,6-7,9-14,20-21,40H,4-5,8,15-19H2,(H2,37,42) D0M6PB DRUGINKE JVBKCVQNRQUJHM-UHFFFAOYSA-N D0M6PB DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)C(=O)N)C(=O)C3=C(N(C(=C3)C4=C(C=C(C=C4)Cl)Cl)C5=CC=C(C=C5)Cl)CCCCO D0M6PB HIGHSTAT Patented D0M6WW DRUG__ID D0M6WW D0M6WW DRUGCOMP ARISING INTERNATIONAL, INC D0M6WW DRUGTYPE Small molecule immunotherapy D0M6WW DRUGINCH 1S/C36H44N2O4/c1-25-19-29(21-37-15-17-39)11-13-35(25)41-23-31-7-5-9-33(27(31)3)34-10-6-8-32(28(34)4)24-42-36-14-12-30(20-26(36)2)22-38-16-18-40/h5-14,19-20,37-40H,15-18,21-24H2,1-4H3 D0M6WW DRUGINKE OXBVQSJSNDTUEX-UHFFFAOYSA-N D0M6WW DRUGSMIL CC1=C(C=CC(=C1)CNCCO)OCC2=C(C(=CC=C2)C3=CC=CC(=C3C)COC4=C(C=C(C=C4)CNCCO)C)C D0M6WW HIGHSTAT Patented D0M8AA DRUG__ID D0M8AA D0M8AA DRUGCOMP PFIZER INC D0M8AA DRUGTYPE Small molecular drug D0M8AA DRUGINCH 1S/C19H19N3O3/c1-11-8-12(2)21-18(23)15(11)10-22-7-6-13-4-5-16(25-3)14(9-20)17(13)19(22)24/h4-5,8H,6-7,10H2,1-3H3,(H,21,23) D0M8AA DRUGINKE SJAPTZBKLVFZLU-UHFFFAOYSA-N D0M8AA DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C2=O)C(=C(C=C3)OC)C#N)C D0M8AA HIGHSTAT Patented D0M8IR DRUG__ID D0M8IR D0M8IR DRUGCOMP Merz Pharma GmbH & Co KGaA D0M8IR DRUGTYPE Small molecular drug D0M8IR DRUGINCH 1S/C17H15NO2S/c1-13-3-2-4-14(9-13)5-6-15-10-16-12-21(19,20)8-7-17(16)18-11-15/h2-4,9-11H,7-8,12H2,1H3 D0M8IR DRUGINKE QSNHNADSPWYHPP-UHFFFAOYSA-N D0M8IR DRUGSMIL CC1=CC(=CC=C1)C#CC2=CC3=C(CCS(=O)(=O)C3)N=C2 D0M8IR HIGHSTAT Patented D0M8UO DRUG__ID D0M8UO D0M8UO DRUGTYPE Small molecular drug D0M8UO DRUGINCH 1S/C23H24FN5O/c1-15(25)14-30-20-8-6-17(7-9-20)21-13-26-23-11-10-22(28-29(21)23)27-16(2)18-4-3-5-19(24)12-18/h3-13,15-16H,14,25H2,1-2H3,(H,27,28)/t15-,16+/m0/s1 D0M8UO DRUGINKE HEVHTYMYEMEBPX-JKSUJKDBSA-N D0M8UO DRUGSMIL CC(COC1=CC=C(C=C1)C2=CN=C3N2N=C(C=C3)NC(C)C4=CC(=CC=C4)F)N D0M8UO HIGHSTAT Patented D0M8UO COMPCLAS Imidazo[1,2-b]pyridazine derivatives D0M9BY DRUG__ID D0M9BY D0M9BY DRUGCOMP EPIZYME, INC D0M9BY DRUGTYPE Small molecular drug D0M9BY DRUGINCH 1S/C25H31N3O3/c1-15-13-16(2)27-24(29)21(15)14-26-25(30)23-18(4)28(22-8-6-5-7-20(22)23)17(3)19-9-11-31-12-10-19/h5-8,13,17,19H,9-12,14H2,1-4H3,(H,26,30)(H,27,29) D0M9BY DRUGINKE HFMSKVHOEPULNV-UHFFFAOYSA-N D0M9BY DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCOCC4)C)C D0M9BY HIGHSTAT Patented D0M9JM DRUG__ID D0M9JM D0M9JM DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0M9JM DRUGTYPE Small molecular drug D0M9JM DRUGINCH 1S/C26H27NO5S/c1-19-18-22(10-13-24(19)31-16-17-33(2,29)30)27-15-14-25(26(27)28)32-23-11-8-21(9-12-23)20-6-4-3-5-7-20/h3-13,18,25H,14-17H2,1-2H3/t25-/m1/s1 D0M9JM DRUGINKE FNCUHIWLQCDGMI-RUZDIDTESA-N D0M9JM DRUGSMIL CC1=C(C=CC(=C1)N2CCC(C2=O)OC3=CC=C(C=C3)C4=CC=CC=C4)OCCS(=O)(=O)C D0M9JM HIGHSTAT Patented D0M9LM DRUG__ID D0M9LM D0M9LM DRUGTYPE Small molecular drug D0M9LM DRUGINCH 1S/C32H31N5O/c33-22-24-8-13-31-30(21-24)26(23-34-31)6-3-4-15-35-17-19-36(20-18-35)27-9-11-28(12-10-27)37-16-14-25-5-1-2-7-29(25)32(37)38/h1-2,5,7-14,16,21,23,34H,3-4,6,15,17-20H2 D0M9LM DRUGINKE AMDZNENPETWKSQ-UHFFFAOYSA-N D0M9LM DRUGSMIL C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC=C(C=C4)N5C=CC6=CC=CC=C6C5=O D0M9LM HIGHSTAT Patented D0M9LM COMPCLAS Aryl piperazine derivatives D0M9TG DRUG__ID D0M9TG D0M9TG DRUGCOMP Shanghai Institute of Materia Medica D0M9TG DRUGTYPE Small molecular drug D0M9TG DRUGINCH 1S/C21H14F4N6O3/c22-15-6-5-11(34-18-13-4-2-1-3-12(13)17(32)27-28-18)9-14(15)19(33)30-7-8-31-16(10-30)26-29-20(31)21(23,24)25/h1-6,9H,7-8,10H2,(H,27,32) D0M9TG DRUGINKE MZFDEPWODAICMP-UHFFFAOYSA-N D0M9TG DRUGSMIL C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)OC4=NNC(=O)C5=CC=CC=C54)F D0M9TG HIGHSTAT Patented D0MA9U DRUG__ID D0MA9U D0MA9U DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0MA9U DRUGTYPE Small molecular drug D0MA9U DRUGINCH 1S/C20H16N4O2/c1-14(25)13-24-18(26)11-10-16(21-24)19-17-9-5-6-12-23(17)22-20(19)15-7-3-2-4-8-15/h2-12H,13H2,1H3 D0MA9U DRUGINKE QATXIDMQXCGKIY-UHFFFAOYSA-N D0MA9U DRUGSMIL CC(=O)CN1C(=O)C=CC(=N1)C2=C3C=CC=CN3N=C2C4=CC=CC=C4 D0MA9U HIGHSTAT Patented D0MD6P DRUG__ID D0MD6P D0MD6P DRUGCOMP LABORATORIOS DEL DR. ESTEVE, S.A D0MD6P DRUGTYPE Small molecular drug D0MD6P DRUGINCH 1S/C16H20Cl2N4S/c1-12-19-16(23-10-9-21-7-3-2-4-8-21)20-22(12)13-5-6-14(17)15(18)11-13/h5-6,11H,2-4,7-10H2,1H3 D0MD6P DRUGINKE BCOSIWNFJNBROD-UHFFFAOYSA-N D0MD6P DRUGSMIL CC1=NC(=NN1C2=CC(=C(C=C2)Cl)Cl)SCCN3CCCCC3 D0MD6P HIGHSTAT Patented D0MM1Y DRUG__ID D0MM1Y D0MM1Y DRUGTYPE Small molecular drug D0MM1Y DRUGINCH 1S/C25H29NO5/c1-31-23-9-22(29)19(24(30)26-13-17-2-3-18(27)7-21(17)28)8-20(23)25-10-14-4-15(11-25)6-16(5-14)12-25/h2-3,7-9,14-16,27-29H,4-6,10-13H2,1H3,(H,26,30) D0MM1Y DRUGINKE SQCLSKGGXIWWPU-UHFFFAOYSA-N D0MM1Y DRUGSMIL COC1=C(C=C(C(=C1)O)C(=O)NCC2=C(C=C(C=C2)O)O)C34CC5CC(C3)CC(C5)C4 D0MM1Y HIGHSTAT Patented D0MM1Y COMPCLAS Polyhydroxy benzamide derivatives D0MO3W DRUG__ID D0MO3W D0MO3W DRUGCOMP REDX PHARMA PLC D0MO3W DRUGTYPE Small molecular drug D0MO3W DRUGINCH 1S/C17H21N3O/c21-17(12-4-2-1-3-5-12)8-15-13-6-7-18-9-14(13)16-10-19-11-20(15)16/h6-7,9-12,15,17,21H,1-5,8H2 D0MO3W DRUGINKE PCYLWVWPFZLSAJ-UHFFFAOYSA-N D0MO3W DRUGSMIL C1CCC(CC1)C(CC2C3=C(C=NC=C3)C4=CN=CN24)O D0MO3W HIGHSTAT Patented D0MQ2D DRUG__ID D0MQ2D D0MQ2D DRUGCOMP KARUS THERAPEUTICS LTD D0MQ2D DRUGTYPE Small molecular drug D0MQ2D DRUGINCH 1S/C17H14FN5O2/c18-14-5-6-15(21-9-14)23(16-10-19-7-8-20-16)11-12-1-3-13(4-2-12)17(24)22-25/h1-10,25H,11H2,(H,22,24) D0MQ2D DRUGINKE GEFHLXDMZNZOPQ-UHFFFAOYSA-N D0MQ2D DRUGSMIL C1=CC(=CC=C1CN(C2=NC=C(C=C2)F)C3=NC=CN=C3)C(=O)NO D0MQ2D HIGHSTAT Patented D0MQ3X DRUG__ID D0MQ3X D0MQ3X DRUGCOMP China Pharmaceutical University D0MQ3X DRUGTYPE Small molecular drug D0MQ3X DRUGINCH 1S/C18H14O3/c1-9-4-3-5-12-11(9)6-7-13-15(12)17(20)16(19)14-10(2)8-21-18(13)14/h3-7,10H,8H2,1-2H3 D0MQ3X DRUGINKE HARGZZNYNSYSGJ-UHFFFAOYSA-N D0MQ3X DRUGSMIL CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C(C=CC=C43)C D0MQ3X HIGHSTAT Patented D0MR7U DRUG__ID D0MR7U D0MR7U DRUGCOMP KARUS THERAPEUTICS LTD D0MR7U DRUGTYPE Small molecular drug D0MR7U DRUGINCH 1S/C16H14FN5O2S/c1-10-19-16(25-21-10)22(14-7-6-13(17)8-18-14)9-11-2-4-12(5-3-11)15(23)20-24/h2-8,24H,9H2,1H3,(H,20,23) D0MR7U DRUGINKE RBFLOFRQBMMVRY-UHFFFAOYSA-N D0MR7U DRUGSMIL CC1=NSC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)F D0MR7U HIGHSTAT Patented D0MU3S DRUG__ID D0MU3S D0MU3S DRUGCOMP GRUENENTHAL GMBH [DE] D0MU3S DRUGTYPE Small molecular drug D0MU3S DRUGINCH 1S/C27H20ClF5N4O2/c1-15(16-5-10-22(23(30)11-16)26(39)35-19-8-6-18(29)7-9-19)25(38)34-14-21-13-24(27(31,32)33)36-37(21)20-4-2-3-17(28)12-20/h2-13,15H,14H2,1H3,(H,34,38)(H,35,39) D0MU3S DRUGINKE SRQSJNYCMNVXTK-UHFFFAOYSA-N D0MU3S DRUGSMIL CC(C1=CC(=C(C=C1)C(=O)NC2=CC=C(C=C2)F)F)C(=O)NCC3=CC(=NN3C4=CC(=CC=C4)Cl)C(F)(F)F D0MU3S HIGHSTAT Patented D0MX0Q DRUG__ID D0MX0Q D0MX0Q DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D0MX0Q DRUGTYPE Small molecular drug D0MX0Q DRUGINCH 1S/C22H22N2O4/c1-15(25)23-12-11-17-14-24-21-9-8-19(13-20(17)21)28-22(26)10-5-16-3-6-18(27-2)7-4-16/h3-10,13-14,24H,11-12H2,1-2H3,(H,23,25)/b10-5+ D0MX0Q DRUGINKE XTKZTJVFEUTPPV-BJMVGYQFSA-N D0MX0Q DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC(=O)C=CC3=CC=C(C=C3)OC D0MX0Q HIGHSTAT Patented D0MX5B DRUG__ID D0MX5B D0MX5B DRUGCOMP PFIZER INC D0MX5B DRUGTYPE Small molecular drug D0MX5B DRUGINCH 1S/C22H18N4OS/c1-23-22(27)18-7-2-3-8-21(18)28-16-10-11-17-19(25-26-20(17)14-16)12-9-15-6-4-5-13-24-15/h2-14H,1H3,(H,23,27)(H,25,26)/b12-9+ D0MX5B DRUGINKE RITAVMQDGBJQJZ-FMIVXFBMSA-N D0MX5B DRUGSMIL CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4 D0MX5B HIGHSTAT Patented D0MY3K DRUG__ID D0MY3K D0MY3K DRUGCOMP Purdue Pharma L.P D0MY3K DRUGTYPE Small molecular drug D0MY3K DRUGINCH 1S/C20H23ClN4O/c1-20(2,3)15-4-6-16(7-5-15)24-19(26)25-12-8-14(9-13-25)17-18(21)23-11-10-22-17/h4-8,10-11H,9,12-13H2,1-3H3,(H,24,26) D0MY3K DRUGINKE SOOFDEGWVPVUAQ-UHFFFAOYSA-N D0MY3K DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=O)N2CCC(=CC2)C3=NC=CN=C3Cl D0MY3K HIGHSTAT Patented D0N0FA DRUG__ID D0N0FA D0N0FA DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia WICHMANN, Juergen WOLTERING, Thomas D0N0FA DRUGTYPE Small molecular drug D0N0FA DRUGINCH 1S/C21H12F6N6/c22-20(23,24)16-3-1-13(9-30-16)15-8-17(21(25,26)27)33-19(32-15)11-5-6-29-14(7-11)12-2-4-18(28)31-10-12/h1-10H,(H2,28,31) D0N0FA DRUGINKE XWOLECIBHRHRCW-UHFFFAOYSA-N D0N0FA DRUGSMIL C1=CC(=NC=C1C2=CC(=NC(=N2)C3=CC(=NC=C3)C4=CN=C(C=C4)N)C(F)(F)F)C(F)(F)F D0N0FA HIGHSTAT Patented D0N0QN DRUG__ID D0N0QN D0N0QN DRUGCOMP Xention Ltd D0N0QN DRUGTYPE Small molecular drug D0N0QN DRUGINCH 1S/C26H26N2O4/c1-2-32-25(30)19-11-9-17(10-12-19)20-6-3-7-21(15-20)27-26(31)28-24-8-4-5-18-13-14-22(29)16-23(18)24/h3-12,15,22,29H,2,13-14,16H2,1H3,(H2,27,28,31) D0N0QN DRUGINKE IWMJRJDFRWWJBW-UHFFFAOYSA-N D0N0QN DRUGSMIL CCOC(=O)C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)NC3=CC=CC4=C3CC(CC4)O D0N0QN HIGHSTAT Patented D0N0TF DRUG__ID D0N0TF D0N0TF DRUGCOMP Janssen Pharmaceutica NV D0N0TF DRUGTYPE Small molecular drug D0N0TF DRUGINCH 1S/C27H32F3N5/c1-17(2)23-33-22-13-16-35(25-21(27(28,29)30)7-6-14-31-25)15-12-20(22)24(34-23)32-19-10-8-18(9-11-19)26(3,4)5/h6-11,14,17H,12-13,15-16H2,1-5H3,(H,32,33,34) D0N0TF DRUGINKE KJNMKUGTDFIAPJ-UHFFFAOYSA-N D0N0TF DRUGSMIL CC(C)C1=NC2=C(CCN(CC2)C3=C(C=CC=N3)C(F)(F)F)C(=N1)NC4=CC=C(C=C4)C(C)(C)C D0N0TF HIGHSTAT Patented D0N1CC DRUG__ID D0N1CC D0N1CC DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0N1CC DRUGTYPE Small molecular drug D0N1CC DRUGINCH 1S/C24H18F3N3/c1-15-11-20(16-5-8-21(9-6-16)24(25,26)27)13-22(30-15)18-4-2-3-17(12-18)19-7-10-23(28)29-14-19/h2-14H,1H3,(H2,28,29) D0N1CC DRUGINKE PGUYKLHAVPKWNB-UHFFFAOYSA-N D0N1CC DRUGSMIL CC1=CC(=CC(=N1)C2=CC=CC(=C2)C3=CN=C(C=C3)N)C4=CC=C(C=C4)C(F)(F)F D0N1CC HIGHSTAT Patented D0N1RX DRUG__ID D0N1RX D0N1RX DRUGCOMP KARUS THERAPEUTICS LTD D0N1RX DRUGTYPE Small molecular drug D0N1RX DRUGINCH 1S/C15H13N5O2S/c21-14(19-22)12-6-4-11(5-7-12)9-20(15-18-17-10-23-15)13-3-1-2-8-16-13/h1-8,10,22H,9H2,(H,19,21) D0N1RX DRUGINKE BQMQOALHRWIFDX-UHFFFAOYSA-N D0N1RX DRUGSMIL C1=CC=NC(=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NN=CS3 D0N1RX HIGHSTAT Patented D0N2DJ DRUG__ID D0N2DJ D0N2DJ DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PRIEPKE, Henning DOODS, Henri KUELZER, Raimund PFAU, Roland STENKAMP, Dirk PELCMAN, Benjamin ROENN, Robert D0N2DJ DRUGTYPE Small molecular drug D0N2DJ DRUGINCH 1S/C29H28Cl3F2N5O3/c1-29(2,3)27(41)35-14-15-5-7-18(30)25(24(15)32)38-28-37-21-12-17(23(42-10-9-33)13-22(21)39(28)4)26(40)36-16-6-8-20(34)19(31)11-16/h5-8,11-13H,9-10,14H2,1-4H3,(H,35,41)(H,36,40)(H,37,38) D0N2DJ DRUGINKE MJNRUPMNPGZLRT-UHFFFAOYSA-N D0N2DJ DRUGSMIL CC(C)(C)C(=O)NCC1=C(C(=C(C=C1)Cl)NC2=NC3=C(N2C)C=C(C(=C3)C(=O)NC4=CC(=C(C=C4)F)Cl)OCCF)Cl D0N2DJ HIGHSTAT Patented D0N2DK DRUG__ID D0N2DK D0N2DK DRUGCOMP SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A D0N2DK DRUGTYPE Small molecular drug D0N2DK DRUGINCH 1S/C20H25F3N4O5/c21-20(22,23)12-5-4-6-13(11-12)24-18(30)14(7-2-1-3-8-17(29)27-32)26-19(31)15-9-10-16(28)25-15/h4-6,11,14-15,32H,1-3,7-10H2,(H,24,30)(H,25,28)(H,26,31)(H,27,29)/t14-,15+/m0/s1 D0N2DK DRUGINKE XVGBJXUAVWXLJX-LSDHHAIUSA-N D0N2DK DRUGSMIL C1CC(=O)NC1C(=O)NC(CCCCCC(=O)NO)C(=O)NC2=CC=CC(=C2)C(F)(F)F D0N2DK HIGHSTAT Patented D0N2FN DRUG__ID D0N2FN D0N2FN DRUGCOMP UNIVERSITY OF CONNECTICUT D0N2FN DRUGTYPE Small molecular drug D0N2FN DRUGINCH 1S/C15H22N2O3/c1-2-20-15(19)17-11-6-9-14(18)16-12-10-13-7-4-3-5-8-13/h3-5,7-8H,2,6,9-12H2,1H3,(H,16,18)(H,17,19) D0N2FN DRUGINKE HTOYBIILVCHURC-UHFFFAOYSA-N D0N2FN DRUGSMIL CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1 D0N2FN HIGHSTAT Patented D0N3XY DRUG__ID D0N3XY D0N3XY DRUGTYPE Small molecular drug D0N3XY DRUGINCH 1S/C17H23N3O2/c1-17(2,22)11-12-7-9-20(10-8-12)16(21)15-18-13-5-3-4-6-14(13)19-15/h3-6,12,22H,7-11H2,1-2H3,(H,18,19) D0N3XY DRUGINKE ZCKTVNQIWGZETA-UHFFFAOYSA-N D0N3XY DRUGSMIL CC(C)(CC1CCN(CC1)C(=O)C2=NC3=CC=CC=C3N2)O D0N3XY HIGHSTAT Patented D0N3XY COMPCLAS N-(benzimidazolylcarbonyl)-piperidine derivatives D0N4PL DRUG__ID D0N4PL D0N4PL DRUGCOMP ALIOS BIOPHARMA, INC D0N4PL DRUGTYPE Small molecular drug D0N4PL DRUGINCH 1S/C24H23F2N3O3/c1-13(2)32-23(31)16-11-29(22(30)14-7-8-17(25)18(26)10-14)12-24(3,4)19-15-6-5-9-27-21(15)28-20(16)19/h5-11,13H,12H2,1-4H3,(H,27,28) D0N4PL DRUGINKE PKWPSFIXOLFFPB-UHFFFAOYSA-N D0N4PL DRUGSMIL CC(C)OC(=O)C1=CN(CC(C2=C1NC3=C2C=CC=N3)(C)C)C(=O)C4=CC(=C(C=C4)F)F D0N4PL HIGHSTAT Patented D0N5NV DRUG__ID D0N5NV D0N5NV DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0N5NV DRUGTYPE Small molecule immunotherapy D0N5NV DRUGINCH 1S/C52H50Cl2N6O10/c1-31-37(27-69-47-15-45(67-25-35-11-33(17-55)19-57-21-35)39(13-43(47)53)23-59-51(3,29-61)49(63)64)7-5-9-41(31)42-10-6-8-38(32(42)2)28-70-48-16-46(68-26-36-12-34(18-56)20-58-22-36)40(14-44(48)54)24-60-52(4,30-62)50(65)66/h5-16,19-22,59-62H,23-30H2,1-4H3,(H,63,64)(H,65,66) D0N5NV DRUGINKE JQCFAYBBTOJHLG-UHFFFAOYSA-N D0N5NV DRUGSMIL CC1=C(C=CC=C1C2=CC=CC(=C2C)COC3=C(C=C(C(=C3)OCC4=CC(=CN=C4)C#N)CNC(C)(CO)C(=O)O)Cl)COC5=C(C=C(C(=C5)OCC6=CC(=CN=C6)C#N)CNC(C)(CO)C(=O)O)Cl D0N5NV HIGHSTAT Patented D0N6HP DRUG__ID D0N6HP D0N6HP DRUGTYPE Small molecular drug D0N6HP DRUGINCH 1S/C19H13F2N5OS/c1-11-9-28-18(25-11)26-17(27)15-6-13(5-12-3-2-4-24-16(12)15)19(20,21)14-7-22-10-23-8-14/h2-10H,1H3,(H,25,26,27) D0N6HP DRUGINKE WMANVHZDYKNLDT-UHFFFAOYSA-N D0N6HP DRUGSMIL CC1=CSC(=N1)NC(=O)C2=C3C(=CC(=C2)C(C4=CN=CN=C4)(F)F)C=CC=N3 D0N6HP HIGHSTAT Patented D0N6HP COMPCLAS Bicyclic heteroaryl carboxamide analogs D0N6JH DRUG__ID D0N6JH D0N6JH DRUGTYPE Small molecular drug D0N6JH DRUGINCH 1S/C26H35N3O3/c1-18-8-13-25(31-4)24(14-18)27-26(30)32-23-15-21-6-5-7-22(16-23)29(21)17-19-9-11-20(12-10-19)28(2)3/h8-14,21-23H,5-7,15-17H2,1-4H3,(H,27,30) D0N6JH DRUGINKE LLKXKYKXJPUWCM-UHFFFAOYSA-N D0N6JH DRUGSMIL CC1=CC(=C(C=C1)OC)NC(=O)OC2CC3CCCC(C2)N3CC4=CC=C(C=C4)N(C)C D0N6JH HIGHSTAT Patented D0N6JH COMPCLAS N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl-phenylcarbamate analogs D0N6UO DRUG__ID D0N6UO D0N6UO DRUGCOMP SCIFLUOR LIFE SCIENCES, INC D0N6UO DRUGTYPE Small molecular drug D0N6UO DRUGINCH 1S/C19H23FN2/c20-18(14-6-2-1-3-7-14)11-16-10-15-8-4-5-9-17(15)19-12-21-13-22(16)19/h4-5,8-9,12-14,16,18H,1-3,6-7,10-11H2 D0N6UO DRUGINKE MCRCDKJVHBJTQP-UHFFFAOYSA-N D0N6UO DRUGSMIL C1CCC(CC1)C(CC2CC3=CC=CC=C3C4=CN=CN24)F D0N6UO HIGHSTAT Patented D0N8YJ DRUG__ID D0N8YJ D0N8YJ DRUGCOMP PFIZER INC D0N8YJ DRUGTYPE Small molecular drug D0N8YJ DRUGINCH 1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1 D0N8YJ DRUGINKE IIXWYSCJSQVBQM-LLVKDONJSA-N D0N8YJ DRUGSMIL CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C D0N8YJ HIGHSTAT Patented D0N9DS DRUG__ID D0N9DS D0N9DS DRUGCOMP COCENSYS, INC D0N9DS DRUGTYPE Small molecular drug D0N9DS DRUGINCH 1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3 D0N9DS DRUGINKE AAOVKJBEBIDNHE-UHFFFAOYSA-N D0N9DS DRUGSMIL CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3 D0N9DS HIGHSTAT Patented D0N9FJ DRUG__ID D0N9FJ D0N9FJ DRUGCOMP ABBVIE INC D0N9FJ DRUGTYPE Small molecular drug D0N9FJ DRUGINCH 1S/C19H20N4O/c24-19(22-17-7-4-8-18-16(17)12-20-23-18)21-15-10-9-14(11-15)13-5-2-1-3-6-13/h1-8,12,14-15H,9-11H2,(H,20,23)(H2,21,22,24)/t14-,15-/m0/s1 D0N9FJ DRUGINKE JSEHDPNFIUYQLO-GJZGRUSLSA-N D0N9FJ DRUGSMIL C1CC(CC1C2=CC=CC=C2)NC(=O)NC3=CC=CC4=C3C=NN4 D0N9FJ HIGHSTAT Patented D0N9GH DRUG__ID D0N9GH D0N9GH DRUGCOMP REATA PHARMACEUTICALS, INC. ANDERSON, Eric JIANG, Xin VISNICK, Melean BENDER, Christopher, F. LIU, Xiaofeng D0N9GH DRUGTYPE Small molecular drug D0N9GH DRUGINCH 1S/C30H41NO3/c1-18-20-7-8-28(5)23(27(20,4)14-19(16-31)25(18)34)13-22(33)24-21-15-26(2,3)9-11-30(21,17-32)12-10-29(24,28)6/h13-14,18,20-21,24,32H,7-12,15,17H2,1-6H3/t18-,20-,21?,24?,27-,28+,29+,30+/m0/s1 D0N9GH DRUGINKE UHGNLMUWOYPXQG-WDPAWIMBSA-N D0N9GH DRUGSMIL CC1C2CCC3(C(=CC(=O)C4C3(CCC5(C4CC(CC5)(C)C)CO)C)C2(C=C(C1=O)C#N)C)C D0N9GH HIGHSTAT Patented D0NB2K DRUG__ID D0NB2K D0NB2K DRUGCOMP SANOFI-AVENTIS BARTH, Francis CONGY, Christian JEANJEAN, Audrey RINALDI-CARMONA, Muriell D0NB2K DRUGTYPE Small molecular drug D0NB2K DRUGINCH 1S/C32H30Cl2N4O4/c1-37-27(30(40)38-15-13-32(14-16-38,31(36)41)21-5-3-2-4-6-21)18-25(24-12-9-22(33)17-26(24)34)29(37)20-7-10-23(11-8-20)42-19-28(35)39/h2-12,17-18H,13-16,19H2,1H3,(H2,35,39)(H2,36,41) D0NB2K DRUGINKE LTDLMCVMMICHRM-UHFFFAOYSA-N D0NB2K DRUGSMIL CN1C(=CC(=C1C2=CC=C(C=C2)OCC(=O)N)C3=C(C=C(C=C3)Cl)Cl)C(=O)N4CCC(CC4)(C5=CC=CC=C5)C(=O)N D0NB2K HIGHSTAT Patented D0NB7Z DRUG__ID D0NB7Z D0NB7Z DRUGTYPE Small molecular drug D0NB7Z DRUGINCH 1S/C22H26N2O2/c25-22-10-8-18-7-9-20(15-21(18)23-22)26-14-4-3-12-24-13-11-17-5-1-2-6-19(17)16-24/h1-2,5-7,9,15H,3-4,8,10-14,16H2,(H,23,25) D0NB7Z DRUGINKE WKRADRDLWGKBQG-UHFFFAOYSA-N D0NB7Z DRUGSMIL C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCC4=CC=CC=C4C3 D0NB7Z HIGHSTAT Patented D0NB7Z COMPCLAS Tetra-hydro-isoquinoline derivatives D0NG8Q DRUG__ID D0NG8Q D0NG8Q DRUGCOMP FURMINGER, Vikki HUGHES, Owen LEGRAND, Darren STANLEY, Emily THOMSON, Christopher WILLIAMS, Gareth NOVARTIS ANOVARTIS AG FURMINGER, Vikki HUGHES, Owen THOMSON, Christopher LEGRAND, Darren, Mark STANLEY, Emil D0NG8Q DRUGTYPE Small molecular drug D0NG8Q DRUGINCH 1S/C19H23Cl2N5O3/c20-14-8-13(9-15(21)10-14)12-29-19(28)26-6-4-16(5-7-26)23-18(27)3-1-2-17-11-22-25-24-17/h8-11,16H,1-7,12H2,(H,23,27)(H,22,24,25) D0NG8Q DRUGINKE GAMSNABJTRSYDT-UHFFFAOYSA-N D0NG8Q DRUGSMIL C1CN(CCC1NC(=O)CCCC2=NNN=C2)C(=O)OCC3=CC(=CC(=C3)Cl)Cl D0NG8Q HIGHSTAT Patented D0NG9V DRUG__ID D0NG9V D0NG9V DRUGCOMP CHDI FOUNDATION, INC D0NG9V DRUGTYPE Small molecular drug D0NG9V DRUGINCH 1S/C21H18FN3O2/c1-13-11-23-19(24-12-13)16-9-7-15(8-10-16)18-17(14-5-3-2-4-6-14)21(18,22)20(26)25-27/h2-12,17-18,27H,1H3,(H,25,26)/t17-,18-,21+/m1/s1 D0NG9V DRUGINKE LERFWXLGVNOQCJ-OPYAIIAOSA-N D0NG9V DRUGSMIL CC1=CN=C(N=C1)C2=CC=C(C=C2)C3C(C3(C(=O)NO)F)C4=CC=CC=C4 D0NG9V HIGHSTAT Patented D0NH2M DRUG__ID D0NH2M D0NH2M DRUGCOMP Novartis AG D0NH2M DRUGTYPE Small molecular drug D0NH2M DRUGINCH 1S/C17H14BrClN2O2/c1-9(2)16-20-15-12(7-8-13(22)14(15)18)17(23)21(16)11-5-3-10(19)4-6-11/h3-9,22H,1-2H3 D0NH2M DRUGINKE RGGBBKIVAZMLNK-UHFFFAOYSA-N D0NH2M DRUGSMIL CC(C)C1=NC2=C(C=CC(=C2Br)O)C(=O)N1C3=CC=C(C=C3)Cl D0NH2M HIGHSTAT Patented D0NJ9E DRUG__ID D0NJ9E D0NJ9E DRUGCOMP VANDERBILT UNIVERSITY D0NJ9E DRUGTYPE Small molecular drug D0NJ9E DRUGINCH 1S/C17H10F2N6O2/c18-10-1-2-15(21-6-10)23-17(26)14-4-13(8-25-9-22-24-16(14)25)27-12-3-11(19)5-20-7-12/h1-9H,(H,21,23,26) D0NJ9E DRUGINKE LDLCJJXQJNSUAB-UHFFFAOYSA-N D0NJ9E DRUGSMIL C1=CC(=NC=C1F)NC(=O)C2=CC(=CN3C2=NN=C3)OC4=CC(=CN=C4)F D0NJ9E HIGHSTAT Patented D0NM3D DRUG__ID D0NM3D D0NM3D DRUGCOMP ABBOTT LABORATORIES D0NM3D DRUGTYPE Small molecular drug D0NM3D DRUGINCH 1S/C24H26ClN3O2/c1-4-24(5-2)13-21(18-10-9-17(25)12-22(18)30-24)28-23(29)27-20-8-6-7-16-14-26-15(3)11-19(16)20/h6-12,14,21H,4-5,13H2,1-3H3,(H2,27,28,29)/t21-/m1/s1 D0NM3D DRUGINKE PETMJQMEMLSBKV-OAQYLSRUSA-N D0NM3D DRUGSMIL CCC1(CC(C2=C(O1)C=C(C=C2)Cl)NC(=O)NC3=CC=CC4=C3C=C(N=C4)C)CC D0NM3D HIGHSTAT Patented D0NN4U DRUG__ID D0NN4U D0NN4U DRUGCOMP MEDIVATION TECHNOLOGIES, INC D0NN4U DRUGTYPE Small molecular drug D0NN4U DRUGINCH 1S/C17H17NO3/c1-3-16(20)18(2)14-9-13(10-15(19)11-14)17(21)12-7-5-4-6-8-12/h3-11,17,19,21H,1H2,2H3/t17-/m0/s1 D0NN4U DRUGINKE ISTAOAGDLRWZMS-KRWDZBQOSA-N D0NN4U DRUGSMIL CN(C1=CC(=CC(=C1)C(C2=CC=CC=C2)O)O)C(=O)C=C D0NN4U HIGHSTAT Patented D0NS6I DRUG__ID D0NS6I D0NS6I DRUGCOMP GAMBRO LUNDIA AB [SEJOENSSON LENNART [SENILSSON EDDIE [SESTERNBY JAN [SE] D0NS6I DRUGTYPE Small molecular drug D0NS6I DRUGINCH 1S/C12H11N3O3/c1-15-11(16)8(14-12(15)13)4-7-2-3-9-10(5-7)18-6-17-9/h2-5H,6H2,1H3,(H2,13,14)/b8-4- D0NS6I DRUGINKE PKEDBIGNILOTHW-YWEYNIOJSA-N D0NS6I DRUGSMIL CN1C(=O)C(=CC2=CC3=C(C=C2)OCO3)N=C1N D0NS6I HIGHSTAT Patented D0NV2M DRUG__ID D0NV2M D0NV2M DRUGCOMP Janssen Pharmaceutica NV D0NV2M DRUGTYPE Small molecular drug D0NV2M DRUGINCH 1S/C23H22F6N6/c1-13(2)19-32-17-8-11-35(21-16(23(27,28)29)4-3-9-30-21)10-7-15(17)20(34-19)33-18-6-5-14(12-31-18)22(24,25)26/h3-6,9,12-13H,7-8,10-11H2,1-2H3,(H,31,32,33,34) D0NV2M DRUGINKE NACDTTPBPBGLSZ-UHFFFAOYSA-N D0NV2M DRUGSMIL CC(C)C1=NC2=C(CCN(CC2)C3=C(C=CC=N3)C(F)(F)F)C(=N1)NC4=NC=C(C=C4)C(F)(F)F D0NV2M HIGHSTAT Patented D0O0UG DRUG__ID D0O0UG D0O0UG DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D0O0UG DRUGTYPE Small molecular drug D0O0UG DRUGINCH 1S/C20H21F2N3O2/c1-20(2,3)18-15(21)10-13(11-16(18)22)27-9-7-23-19(26)14-12-24-25-8-5-4-6-17(14)25/h4-6,8,10-12H,7,9H2,1-3H3,(H,23,26) D0O0UG DRUGINKE SDAKWMHNXUGINA-UHFFFAOYSA-N D0O0UG DRUGSMIL CC(C)(C)C1=C(C=C(C=C1F)OCCNC(=O)C2=C3C=CC=CN3N=C2)F D0O0UG HIGHSTAT Patented D0O0YI DRUG__ID D0O0YI D0O0YI DRUGCOMP DECIPHERA PHARMACEUTICALS, LLC PETILLO, Peter, A. KAUFMAN, Michael, D. FLYNN, Daniel, L D0O0YI DRUGTYPE Small molecular drug D0O0YI DRUGINCH 1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40) D0O0YI DRUGINKE WVXNSAVVKYZVOE-UHFFFAOYSA-N D0O0YI DRUGSMIL CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5 D0O0YI HIGHSTAT Patented D0O2DY DRUG__ID D0O2DY D0O2DY DRUGCOMP Astra Zeneca AB D0O2DY DRUGTYPE Small molecular drug D0O2DY DRUGINCH 1S/C18H16ClN3O5S2/c1-27-18-15(19)10-13(11-21-18)12-5-4-6-14(9-12)29(25,26)22-16-7-2-3-8-17(16)28(20,23)24/h2-11,22H,1H3,(H2,20,23,24) D0O2DY DRUGINKE WVXMZKAIOMLXRH-UHFFFAOYSA-N D0O2DY DRUGSMIL COC1=C(C=C(C=N1)C2=CC(=CC=C2)S(=O)(=O)NC3=CC=CC=C3S(=O)(=O)N)Cl D0O2DY HIGHSTAT Patented D0O2EF DRUG__ID D0O2EF D0O2EF DRUGCOMP UNIVERSIT DEGLI STUDI DI BARI [IT] D0O2EF DRUGTYPE Small molecular drug D0O2EF DRUGINCH 1S/C22H20N2O6/c1-28-19-12-16(13-20(29-2)21(19)30-3)23-22(25)17-10-9-15(11-18(17)24(26)27)14-7-5-4-6-8-14/h4-13H,1-3H3,(H,23,25) D0O2EF DRUGINKE RCEYITFFDFXLHB-UHFFFAOYSA-N D0O2EF DRUGSMIL COC1=CC(=CC(=C1OC)OC)NC(=O)C2=C(C=C(C=C2)C3=CC=CC=C3)[N+](=O)[O-] D0O2EF HIGHSTAT Patented D0O3JR DRUG__ID D0O3JR D0O3JR DRUGTYPE Small molecular drug D0O3JR DRUGINCH 1S/C18H19NO5/c1-24-17-11-12(3-6-15(17)21)4-7-18(23)19-9-8-13-2-5-14(20)16(22)10-13/h2-7,10-11,20-22H,8-9H2,1H3,(H,19,23)/b7-4+ D0O3JR DRUGINKE ZRLYUFOWFPPSTD-QPJJXVBHSA-N D0O3JR DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)NCCC2=CC(=C(C=C2)O)O)O D0O3JR HIGHSTAT Patented D0O3JR COMPCLAS P-coumaric acid derivatives D0O3TG DRUG__ID D0O3TG D0O3TG DRUGCOMP Novartis AG D0O3TG DRUGTYPE Small molecular drug D0O3TG DRUGINCH 1S/C17H15Cl2N3O/c1-9(2)16-21-15-12(7-8-13(20)14(15)19)17(23)22(16)11-5-3-10(18)4-6-11/h3-9H,20H2,1-2H3 D0O3TG DRUGINKE KVPDVXGLZNHXJL-UHFFFAOYSA-N D0O3TG DRUGSMIL CC(C)C1=NC2=C(C=CC(=C2Cl)N)C(=O)N1C3=CC=C(C=C3)Cl D0O3TG HIGHSTAT Patented D0O4RN DRUG__ID D0O4RN D0O4RN DRUGTYPE Small molecular drug D0O4RN DRUGINCH 1S/C23H22F6N2O3S/c24-22(25,26)18-5-1-15(2-6-18)11-21(32)30-7-9-31(10-8-30)35(33,34)20-13-17(16-3-4-16)12-19(14-20)23(27,28)29/h1-2,5-6,12-14,16H,3-4,7-11H2 D0O4RN DRUGINKE DVPAFQJRBKXLSG-UHFFFAOYSA-N D0O4RN DRUGSMIL C1CC1C2=CC(=CC(=C2)S(=O)(=O)N3CCN(CC3)C(=O)CC4=CC=C(C=C4)C(F)(F)F)C(F)(F)F D0O4RN HIGHSTAT Patented D0O4RN COMPCLAS Sulfonylated piperazine derivatives D0O5ZK DRUG__ID D0O5ZK D0O5ZK DRUGCOMP THE HAMNER INSTITUTES D0O5ZK DRUGTYPE Small molecular drug D0O5ZK DRUGINCH 1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11) D0O5ZK DRUGINKE AEOCXXJPGCBFJA-UHFFFAOYSA-N D0O5ZK DRUGSMIL CCC1=NC=CC(=C1)C(=S)N D0O5ZK HIGHSTAT Patented D0O6LL DRUG__ID D0O6LL D0O6LL DRUGCOMP University of Texas D0O6LL DRUGTYPE Small molecular drug D0O6LL DRUGINCH 1S/C17H25N3O2S/c1-20(2)16-10-6-9-15-14(16)8-7-11-17(15)23(21,22)19-13-5-3-4-12-18/h6-11,19H,3-5,12-13,18H2,1-2H3 D0O6LL DRUGINKE MLEBFEHOJICQQS-UHFFFAOYSA-N D0O6LL DRUGSMIL CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCCN D0O6LL HIGHSTAT Patented D0O6SJ DRUG__ID D0O6SJ D0O6SJ DRUGCOMP KARUS THERAPEUTICS LTD D0O6SJ DRUGTYPE Small molecular drug D0O6SJ DRUGINCH 1S/C16H14FN5O3/c1-10-19-16(25-21-10)22(14-7-6-13(17)8-18-14)9-11-2-4-12(5-3-11)15(23)20-24/h2-8,24H,9H2,1H3,(H,20,23) D0O6SJ DRUGINKE YHMSVHVCVQHZRX-UHFFFAOYSA-N D0O6SJ DRUGSMIL CC1=NOC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)F D0O6SJ HIGHSTAT Patented D0O7IQ DRUG__ID D0O7IQ D0O7IQ DRUGCOMP ABBVIE INC D0O7IQ DRUGTYPE Small molecular drug D0O7IQ DRUGINCH 1S/C19H19FN4O/c20-14-4-1-3-12(9-14)13-7-8-15(10-13)22-19(25)23-17-5-2-6-18-16(17)11-21-24-18/h1-6,9,11,13,15H,7-8,10H2,(H,21,24)(H2,22,23,25)/t13-,15+/m1/s1 D0O7IQ DRUGINKE ROOFFAWDIFZLQB-HIFRSBDPSA-N D0O7IQ DRUGSMIL C1CC(CC1C2=CC(=CC=C2)F)NC(=O)NC3=CC=CC4=C3C=NN4 D0O7IQ HIGHSTAT Patented D0O9BK DRUG__ID D0O9BK D0O9BK DRUGCOMP DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry D0O9BK DRUGTYPE Small molecular drug D0O9BK DRUGINCH 1S/C17H11ClFN5OS/c1-25-15(20)17-24-12-5-4-11-13(14(12)26-17)16(22-7-21-11)23-10-3-2-8(18)6-9(10)19/h2-7,20H,1H3,(H,21,22,23) D0O9BK DRUGINKE RFRICXRVXVFZMF-UHFFFAOYSA-N D0O9BK DRUGSMIL COC(=N)C1=NC2=C(S1)C3=C(C=C2)N=CN=C3NC4=C(C=C(C=C4)Cl)F D0O9BK HIGHSTAT Patented D0O9GI DRUG__ID D0O9GI D0O9GI DRUGCOMP GRUENENTHAL GMBH [DE] D0O9GI DRUGTYPE Small molecular drug D0O9GI DRUGINCH 1S/C21H26F4N6O3S/c1-13-6-8-31(9-7-13)19-15(3-5-18(30-19)21(23,24)25)11-27-20(32)29-16-4-2-14(17(22)10-16)12-28-35(26,33)34/h2-5,10,13,28H,6-9,11-12H2,1H3,(H2,26,33,34)(H2,27,29,32) D0O9GI DRUGINKE ULLMJBDXTPAPKF-UHFFFAOYSA-N D0O9GI DRUGSMIL CC1CCN(CC1)C2=C(C=CC(=N2)C(F)(F)F)CNC(=O)NC3=CC(=C(C=C3)CNS(=O)(=O)N)F D0O9GI HIGHSTAT Patented D0O9JZ DRUG__ID D0O9JZ D0O9JZ DRUGCOMP University of Texas D0O9JZ DRUGTYPE Small molecular drug D0O9JZ DRUGINCH 1S/C17H14ClFN6O2S/c1-10(26)20-11-3-2-4-13(7-11)25-23-17(22-24-25)28-9-16(27)21-12-5-6-15(19)14(18)8-12/h2-8H,9H2,1H3,(H,20,26)(H,21,27) D0O9JZ DRUGINKE NIWRZNPQACMKRY-UHFFFAOYSA-N D0O9JZ DRUGSMIL CC(=O)NC1=CC(=CC=C1)N2N=C(N=N2)SCC(=O)NC3=CC(=C(C=C3)F)Cl D0O9JZ HIGHSTAT Patented D0O9TL DRUG__ID D0O9TL D0O9TL DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia WICHMANN, Juergen WOLTERING, Thomas D0O9TL DRUGTYPE Small molecular drug D0O9TL DRUGINCH 1S/C22H13F6N5/c23-21(24,25)17-6-4-15(11-30-17)16-9-18(22(26,27)28)33-20(32-16)13-3-1-2-12(8-13)14-5-7-19(29)31-10-14/h1-11H,(H2,29,31) D0O9TL DRUGINKE RUFVODIMOVLNAI-UHFFFAOYSA-N D0O9TL DRUGSMIL C1=CC(=CC(=C1)C2=NC(=CC(=N2)C(F)(F)F)C3=CN=C(C=C3)C(F)(F)F)C4=CN=C(C=C4)N D0O9TL HIGHSTAT Patented D0OA1P DRUG__ID D0OA1P D0OA1P DRUGCOMP GRUENENTHAL GMBH [DE] D0OA1P DRUGTYPE Small molecular drug D0OA1P DRUGINCH 1S/C24H26F4N4O3S/c1-15(2)17-5-4-6-19(11-17)32-20(13-22(31-32)24(26,27)28)14-29-23(33)30-18-8-7-16(21(25)12-18)9-10-36(3,34)35/h4-8,11-13,15H,9-10,14H2,1-3H3,(H2,29,30,33) D0OA1P DRUGINKE XUFAPWVIHXCCMT-UHFFFAOYSA-N D0OA1P DRUGSMIL CC(C)C1=CC(=CC=C1)N2C(=CC(=N2)C(F)(F)F)CNC(=O)NC3=CC(=C(C=C3)CCS(=O)(=O)C)F D0OA1P HIGHSTAT Patented D0OC6A DRUG__ID D0OC6A D0OC6A DRUGCOMP Japan Tobacco, Inc D0OC6A DRUGTYPE Small molecular drug D0OC6A DRUGINCH 1S/C24H25Cl2N3O3/c1-16(2)15-32-19-8-6-18(7-9-19)28-24(31)17-5-10-20(25)22(14-17)29(12-13-30)23-21(26)4-3-11-27-23/h3-11,14,16,30H,12-13,15H2,1-2H3,(H,28,31) D0OC6A DRUGINKE BQRACGGWLNJTKY-UHFFFAOYSA-N D0OC6A DRUGSMIL CC(C)COC1=CC=C(C=C1)NC(=O)C2=CC(=C(C=C2)Cl)N(CCO)C3=C(C=CC=N3)Cl D0OC6A HIGHSTAT Patented D0OE0D DRUG__ID D0OE0D D0OE0D DRUGCOMP C4T S.C. A.R.L D0OE0D DRUGTYPE Small molecular drug D0OE0D DRUGINCH 1S/C24H22FNO5S/c1-16-4-11-20(12-5-16)32(28,29)31-19-10-13-21-22(14-19)30-24(2,3)26(23(21)27)15-17-6-8-18(25)9-7-17/h4-14H,15H2,1-3H3 D0OE0D DRUGINKE RDCDFXNTJYTRNH-UHFFFAOYSA-N D0OE0D DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)OC2=CC3=C(C=C2)C(=O)N(C(O3)(C)C)CC4=CC=C(C=C4)F D0OE0D HIGHSTAT Patented D0OE4F DRUG__ID D0OE4F D0OE4F DRUGCOMP UNIVERSITY OF TAMPERE SUPURAN, Claudiu PARKKILA, Seppo D0OE4F DRUGTYPE Small molecular drug D0OE4F DRUGINCH 1S/C28H29N7O/c1-34-14-16-35(17-15-34)20-21-7-9-22(10-8-21)27(36)31-24-5-2-6-25(18-24)32-28-30-13-11-26(33-28)23-4-3-12-29-19-23/h2-13,18-19H,14-17,20H2,1H3,(H,31,36)(H,30,32,33) D0OE4F DRUGINKE JHMBUEWQJDGKGS-UHFFFAOYSA-N D0OE4F DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)NC4=NC=CC(=N4)C5=CN=CC=C5 D0OE4F HIGHSTAT Patented D0OE6G DRUG__ID D0OE6G D0OE6G DRUGTYPE Small molecular drug D0OE6G DRUGINCH 1S/C24H21FNO4/c1-28-21-8-7-19-20(24(21)29-2)15-30-22(23(19)27)13-16-9-11-26(12-10-16)14-17-3-5-18(25)6-4-17/h3-13H,14-15H2,1-2H3/q+1/b22-13- D0OE6G DRUGINKE WLIFEPXXMAJAQJ-XKZIYDEJSA-N D0OE6G DRUGSMIL COC1=C(C2=C(C=C1)C(=O)C(=CC3=CC=[N+](C=C3)CC4=CC=C(C=C4)F)OC2)OC D0OE6G HIGHSTAT Patented D0OE6G COMPCLAS Isochroman-4-ketone derivatives D0OJ1R DRUG__ID D0OJ1R D0OJ1R DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0OJ1R DRUGTYPE Small molecular drug D0OJ1R DRUGINCH 1S/C23H29N5O4S/c1-15-23(29)27(2)20-8-9-21(25-22(20)28(15)18-10-12-32-13-11-18)24-17-4-3-5-19(14-17)33(30,31)26-16-6-7-16/h3-5,8-9,14-16,18,26H,6-7,10-13H2,1-2H3,(H,24,25)/t15-/m1/s1 D0OJ1R DRUGINKE XMBSYBXAJSVFRE-OAHLLOKOSA-N D0OJ1R DRUGSMIL CC1C(=O)N(C2=C(N1C3CCOCC3)N=C(C=C2)NC4=CC(=CC=C4)S(=O)(=O)NC5CC5)C D0OJ1R HIGHSTAT Patented D0OK1S DRUG__ID D0OK1S D0OK1S DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0OK1S DRUGTYPE Small molecule immunotherapy D0OK1S DRUGINCH 1S/C27H28BrNO3/c1-19-22(10-7-11-23(19)21-8-3-2-4-9-21)18-32-26-14-13-20(16-24(26)28)17-29-15-6-5-12-25(29)27(30)31/h2-4,7-11,13-14,16,25H,5-6,12,15,17-18H2,1H3,(H,30,31) D0OK1S DRUGINKE QRXBPPWUGITQLE-UHFFFAOYSA-N D0OK1S DRUGSMIL CC1=C(C=CC=C1C2=CC=CC=C2)COC3=C(C=C(C=C3)CN4CCCCC4C(=O)O)Br D0OK1S HIGHSTAT Patented D0OM2M DRUG__ID D0OM2M D0OM2M DRUGCOMP SALK INSTITUTE FOR BIOLOGICAL STUDIE D0OM2M DRUGTYPE Small molecular drug D0OM2M DRUGINCH 1S/C33H35FN2O3/c1-35(2)29-13-11-26(12-14-29)25-8-4-22(5-9-25)21-36(33(38)31-19-23-6-10-27(31)16-23)30-18-24(17-28(34)20-30)7-15-32(37)39-3/h4-5,7-9,11-15,17-18,20,23,27,31H,6,10,16,19,21H2,1-3H3/b15-7+/t23-,27+,31?/m0/s1/i21D/t21?,23-,27+,31? D0OM2M DRUGINKE OQLFJJIBJUSVIK-YNEPWPPESA-N D0OM2M DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC(=CC(=C3)C=CC(=O)OC)F)C(=O)C4CC5CCC4C5 D0OM2M HIGHSTAT Patented D0ON4M DRUG__ID D0ON4M D0ON4M DRUGCOMP ABBVIE INC D0ON4M DRUGTYPE Small molecular drug D0ON4M DRUGINCH 1S/C19H19FN4O/c20-16-5-2-1-4-14(16)12-8-9-13(10-12)22-19(25)23-17-6-3-7-18-15(17)11-21-24-18/h1-7,11-13H,8-10H2,(H,21,24)(H2,22,23,25)/t12-,13-/m0/s1 D0ON4M DRUGINKE MNXPYZUSFURMKS-STQMWFEESA-N D0ON4M DRUGSMIL C1CC(CC1C2=CC=CC=C2F)NC(=O)NC3=CC=CC4=C3C=NN4 D0ON4M HIGHSTAT Patented D0OQ2S DRUG__ID D0OQ2S D0OQ2S DRUGCOMP ELARA PHARMACEUTICALS GMBH [DE] D0OQ2S DRUGTYPE Small molecular drug D0OQ2S DRUGINCH 1S/C23H21N3O3S/c1-16-3-4-19(15-24-16)17-5-8-23-22(14-17)26(11-12-29-23)30(27,28)20-6-7-21-18(13-20)9-10-25(21)2/h3-10,13-15H,11-12H2,1-2H3 D0OQ2S DRUGINKE FPMLAMSVUUIGOG-UHFFFAOYSA-N D0OQ2S DRUGSMIL CC1=NC=C(C=C1)C2=CC3=C(C=C2)OCCN3S(=O)(=O)C4=CC5=C(C=C4)N(C=C5)C D0OQ2S HIGHSTAT Patented D0OR4G DRUG__ID D0OR4G D0OR4G DRUGCOMP Arena Pharmaceuticals, Inc D0OR4G DRUGTYPE Small molecular drug D0OR4G DRUGINCH 1S/C16H13BrClN3/c1-21-16(15(17)10-19-21)11-3-2-4-14(9-11)20-13-7-5-12(18)6-8-13/h2-10,20H,1H3 D0OR4G DRUGINKE CEDWMDLRVLLSQK-UHFFFAOYSA-N D0OR4G DRUGSMIL CN1C(=C(C=N1)Br)C2=CC(=CC=C2)NC3=CC=C(C=C3)Cl D0OR4G HIGHSTAT Patented D0OT4O DRUG__ID D0OT4O D0OT4O DRUGCOMP MERCK SHARP & DOHME CORP. BUNGARD, Christopher James CONVERSO, Antonella DE LEON, Pablo HANNEY, Barbara HARTINGH, Timothy John MANIKOWSKI, Jesse Josef MANLEY, Peter, J. MEISSNER, Robert MENG, Zhaoyang PERKINS, James, J. RUDD, Michael, T. SHU, Youheng D0OT4O DRUGTYPE Small molecular drug D0OT4O DRUGINCH 1S/C20H20F3N5O2/c1-27-10-13(8-25-27)15-7-17(19(24)29)26-16-6-12(2-3-14(15)16)9-28-4-5-30-18(11-28)20(21,22)23/h2-3,6-8,10,18H,4-5,9,11H2,1H3,(H2,24,29)/t18-/m1/s1 D0OT4O DRUGINKE PUIAIYDBFPDZPF-GOSISDBHSA-N D0OT4O DRUGSMIL CN1C=C(C=N1)C2=CC(=NC3=C2C=CC(=C3)CN4CCOC(C4)C(F)(F)F)C(=O)N D0OT4O HIGHSTAT Patented D0OT8R DRUG__ID D0OT8R D0OT8R DRUGCOMP SCHERING CORPORATION TING, Pauline, C. LEE, Joe, F. ASLANIAN, Robert, G D0OT8R DRUGTYPE Small molecular drug D0OT8R DRUGINCH 1S/C31H27N3O5/c1-19-24-15-21(20-7-5-4-6-8-20)9-13-26(24)39-28(19)29(35)34-23-11-12-25(32-17-23)22-10-14-27(33-16-22)38-18-31(2,3)30(36)37/h4-17H,18H2,1-3H3,(H,34,35)(H,36,37) D0OT8R DRUGINKE WBSJFAVPZLMOLD-UHFFFAOYSA-N D0OT8R DRUGSMIL CC1=C(OC2=C1C=C(C=C2)C3=CC=CC=C3)C(=O)NC4=CN=C(C=C4)C5=CN=C(C=C5)OCC(C)(C)C(=O)O D0OT8R HIGHSTAT Patented D0OU0J DRUG__ID D0OU0J D0OU0J DRUGCOMP BIOMARIN PHARMACEUTICAL INC D0OU0J DRUGTYPE Small molecular drug D0OU0J DRUGINCH 1S/C26H24N4O/c27-23-3-1-2-4-24(23)29-26(31)22-9-5-18(6-10-22)13-20-16-30(17-20)15-19-7-8-21-11-12-28-25(21)14-19/h1-14,28H,15-17,27H2,(H,29,31) D0OU0J DRUGINKE YLZQVWHBPTVEHO-UHFFFAOYSA-N D0OU0J DRUGSMIL C1C(=CC2=CC=C(C=C2)C(=O)NC3=CC=CC=C3N)CN1CC4=CC5=C(C=C4)C=CN5 D0OU0J HIGHSTAT Patented D0OW2D DRUG__ID D0OW2D D0OW2D DRUGTYPE Small molecular drug D0OW2D DRUGINCH 1S/C17H18F2N4O5S/c1-23(2)29(26,27)22-17(25)21-14-8-10(4-7-15(14)28-3)16(24)20-11-5-6-12(18)13(19)9-11/h4-9H,1-3H3,(H,20,24)(H2,21,22,25) D0OW2D DRUGINKE VUAXXZRGLYBYPO-UHFFFAOYSA-N D0OW2D DRUGSMIL CN(C)S(=O)(=O)NC(=O)NC1=C(C=CC(=C1)C(=O)NC2=CC(=C(C=C2)F)F)OC D0OW2D HIGHSTAT Patented D0OW2D COMPCLAS Tri-substituted benzene derivatives D0OZ8W DRUG__ID D0OZ8W D0OZ8W DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0OZ8W DRUGTYPE Small molecular drug D0OZ8W DRUGINCH 1S/C31H38N6O/c1-6-25(7-2)37(20-21(3)4)29-17-16-24(26-10-8-9-11-27(26)31-33-35-36-34-31)19-28(29)32-30(38)18-23-14-12-22(5)13-15-23/h8-17,19,21,25H,6-7,18,20H2,1-5H3,(H,32,38)(H,33,34,35,36) D0OZ8W DRUGINKE CERFYCIXDOVMJH-UHFFFAOYSA-N D0OZ8W DRUGSMIL CCC(CC)N(CC(C)C)C1=C(C=C(C=C1)C2=CC=CC=C2C3=NNN=N3)NC(=O)CC4=CC=C(C=C4)C D0OZ8W HIGHSTAT Patented D0P0MR DRUG__ID D0P0MR D0P0MR DRUGCOMP Grunenthal GmbH D0P0MR DRUGTYPE Small molecular drug D0P0MR DRUGINCH 1S/C23H28F4N4O3S/c1-15-7-9-31(10-8-15)22-18(5-6-20(30-22)23(25,26)27)13-28-21(32)12-16-3-4-17(19(24)11-16)14-29-35(2,33)34/h3-6,11,15,29H,7-10,12-14H2,1-2H3,(H,28,32) D0P0MR DRUGINKE DAEWVVDOSOXCOU-UHFFFAOYSA-N D0P0MR DRUGSMIL CC1CCN(CC1)C2=C(C=CC(=N2)C(F)(F)F)CNC(=O)CC3=CC(=C(C=C3)CNS(=O)(=O)C)F D0P0MR HIGHSTAT Patented D0P0PT DRUG__ID D0P0PT D0P0PT DRUGTYPE Small molecular drug D0P0PT DRUGINCH 1S/C17H16N4O/c18-17(19-11-13-6-2-1-3-7-13)21-20-12-15-10-14-8-4-5-9-16(14)22-15/h1-10,12H,11H2,(H3,18,19,21)/b20-12+ D0P0PT DRUGINKE BUHIWIPIXBWCOP-UDWIEESQSA-N D0P0PT DRUGSMIL C1=CC=C(C=C1)CN=C(N)NN=CC2=CC3=CC=CC=C3O2 D0P0PT HIGHSTAT Patented D0P0PT COMPCLAS Aromatic hydrazine carboxyimidoamide derivatives D0P1BE DRUG__ID D0P1BE D0P1BE DRUGTYPE Small molecular drug D0P1BE DRUGINCH 1S/C23H26N4O6S2/c1-32-19-10-9-18(14-20(19)33-2)35(30,31)25-23-24-22(16-7-6-8-17(13-16)27(28)29)21(34-23)15-26-11-4-3-5-12-26/h6-10,13-14H,3-5,11-12,15H2,1-2H3,(H,24,25) D0P1BE DRUGINKE AOZLMMDVJOGGEQ-UHFFFAOYSA-N D0P1BE DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)NC2=NC(=C(S2)CN3CCCCC3)C4=CC(=CC=C4)[N+](=O)[O-])OC D0P1BE HIGHSTAT Patented D0P1BE COMPCLAS Benzene sulfonamide derivatives D0P1TH DRUG__ID D0P1TH D0P1TH DRUGTYPE Small molecular drug D0P1TH DRUGINCH 1S/C21H26N4O2/c1-6-24(7-2)19(26)13-18-20(16-8-10-17(27-5)11-9-16)22-21-14(3)12-15(4)23-25(18)21/h8-12H,6-7,13H2,1-5H3 D0P1TH DRUGINKE RGPSCAJBNWAKNP-UHFFFAOYSA-N D0P1TH DRUGSMIL CCN(CC)C(=O)CC1=C(N=C2N1N=C(C=C2C)C)C3=CC=C(C=C3)OC D0P1TH HIGHSTAT Patented D0P1TH COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D0P2BJ DRUG__ID D0P2BJ D0P2BJ DRUGCOMP NeoPharm Co. Ltd D0P2BJ DRUGTYPE Small molecular drug D0P2BJ DRUGINCH 1S/C19H16ClN3O3/c1-26-12-8-9-15(20)14(10-12)18(24)22-23-17(11-6-7-11)21-16-5-3-2-4-13(16)19(23)25/h2-5,8-11H,6-7H2,1H3,(H,22,24) D0P2BJ DRUGINKE PHWRMNPWLIXVPO-UHFFFAOYSA-N D0P2BJ DRUGSMIL COC1=CC(=C(C=C1)Cl)C(=O)NN2C(=NC3=CC=CC=C3C2=O)C4CC4 D0P2BJ HIGHSTAT Patented D0P3VK DRUG__ID D0P3VK D0P3VK DRUGCOMP ARRAY BIOPHARMA INC D0P3VK DRUGTYPE Small molecular drug D0P3VK DRUGINCH 1S/C29H32FN7O2/c1-19-27(22-15-31-20(2)32-16-22)35-37(24-10-5-4-6-11-24)28(19)34-29(38)33-26-18-36(12-13-39-3)17-25(26)21-8-7-9-23(30)14-21/h4-11,14-16,25-26H,12-13,17-18H2,1-3H3,(H2,33,34,38)/t25-,26+/m0/s1 D0P3VK DRUGINKE BGKSBHPSVMJTFL-IZZNHLLZSA-N D0P3VK DRUGSMIL CC1=C(N(N=C1C2=CN=C(N=C2)C)C3=CC=CC=C3)NC(=O)NC4CN(CC4C5=CC(=CC=C5)F)CCOC D0P3VK HIGHSTAT Patented D0P5SB DRUG__ID D0P5SB D0P5SB DRUGCOMP GRUENENTHAL GMBH [DE] D0P5SB DRUGTYPE Small molecular drug D0P5SB DRUGINCH 1S/C20H18ClF3N4O2/c1-12(13-5-6-15(11-29)25-9-13)19(30)26-10-17-8-18(20(22,23)24)27-28(17)16-4-2-3-14(21)7-16/h2-9,12,29H,10-11H2,1H3,(H,26,30) D0P5SB DRUGINKE BPOYGEDVQYUUIM-UHFFFAOYSA-N D0P5SB DRUGSMIL CC(C1=CN=C(C=C1)CO)C(=O)NCC2=CC(=NN2C3=CC(=CC=C3)Cl)C(F)(F)F D0P5SB HIGHSTAT Patented D0P7DA DRUG__ID D0P7DA D0P7DA DRUGCOMP BRAINCELLS, INCBRAINCELLS, INC. BLEICHER, Leo D0P7DA DRUGTYPE Small molecular drug D0P7DA DRUGINCH 1S/C22H28Cl2FNO5/c1-2-3-4-5-6-9-30-20(29)21(25)14-11-17(22(26,18(14)21)19(27)28)31-12-13-7-8-15(23)16(24)10-13/h7-8,10,14,17-18H,2-6,9,11-12,26H2,1H3,(H,27,28)/t14-,17-,18+,21-,22+/m1/s1 D0P7DA DRUGINKE SVZJNGHWEHDHLT-OUSKECTQSA-N D0P7DA DRUGSMIL CCCCCCCOC(=O)C1(C2C1C(C(C2)OCC3=CC(=C(C=C3)Cl)Cl)(C(=O)O)N)F D0P7DA HIGHSTAT Patented D0P8YL DRUG__ID D0P8YL D0P8YL DRUGTYPE Small molecular drug D0P8YL DRUGINCH 1S/C21H23N3O2/c1-24(2)12-4-11-22-21(26)16-9-7-15(8-10-16)18-13-17-5-3-6-19(25)20(17)23-14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,22,26) D0P8YL DRUGINKE USYGLVCNYUDJNL-UHFFFAOYSA-N D0P8YL DRUGSMIL CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CN=C3C(=C2)C=CC=C3O D0P8YL HIGHSTAT Patented D0P8YL COMPCLAS Hydroxyqunoline analogs D0P9PZ DRUG__ID D0P9PZ D0P9PZ DRUGCOMP GENENTECH, INC. BERGERON, Philippe KOEHLER, Michael, F. T D0P9PZ DRUGTYPE Small molecular drug D0P9PZ DRUGINCH 1S/C28H35N5O3/c1-18(29-2)27(34)32-26(20-11-15-36-16-12-20)28(35)33-14-6-9-23(33)22-17-21-10-13-30-24(25(21)31-22)19-7-4-3-5-8-19/h3-5,7-8,10,13,17-18,20,23,26,29,31H,6,9,11-12,14-16H2,1-2H3,(H,32,34)/t18-,23-,26-/m0/s1 D0P9PZ DRUGINKE IKVUPSWUHVVHKV-WMDMVVLCSA-N D0P9PZ DRUGSMIL CC(C(=O)NC(C1CCOCC1)C(=O)N2CCCC2C3=CC4=C(N3)C(=NC=C4)C5=CC=CC=C5)NC D0P9PZ HIGHSTAT Patented D0P9ZD DRUG__ID D0P9ZD D0P9ZD DRUGCOMP THE HAMNER INSTITUTES D0P9ZD DRUGTYPE Small molecular drug D0P9ZD DRUGINCH 1S/C6H14N2/c7-5-6-1-3-8-4-2-6/h6,8H,1-5,7H2 D0P9ZD DRUGINKE LTEKQAPRXFBRNN-UHFFFAOYSA-N D0P9ZD DRUGSMIL C1CNCCC1CN D0P9ZD HIGHSTAT Patented D0PB6T DRUG__ID D0PB6T D0PB6T DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0PB6T DRUGTYPE Small molecular drug D0PB6T DRUGINCH 1S/C23H27Cl2N3O3/c1-12-7-19(31-4)17(22(29)26-12)11-28-6-5-15-18(24)8-16(21(25)20(15)23(28)30)13(2)14-9-27(3)10-14/h7-8,13-14H,5-6,9-11H2,1-4H3,(H,26,29) D0PB6T DRUGINKE YSHFYFJAQGEFJV-UHFFFAOYSA-N D0PB6T DRUGSMIL CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C(C)C4CN(C4)C)Cl)OC D0PB6T HIGHSTAT Patented D0PF9X DRUG__ID D0PF9X D0PF9X DRUGTYPE Small molecular drug D0PF9X DRUGINCH 1S/C21H31FN2/c22-20-9-7-18(8-10-20)21(16-17-5-6-19(21)15-17)23-11-4-14-24-12-2-1-3-13-24/h7-10,17,19,23H,1-6,11-16H2 D0PF9X DRUGINKE DJXNOCLZKSUJMI-UHFFFAOYSA-N D0PF9X DRUGSMIL C1CCN(CC1)CCCNC2(CC3CCC2C3)C4=CC=C(C=C4)F D0PF9X HIGHSTAT Patented D0PF9X COMPCLAS Bicyclo-heptan-2-amine derivatives D0PG5N DRUG__ID D0PG5N D0PG5N DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D0PG5N DRUGTYPE Small molecular drug D0PG5N DRUGINCH 1S/C29H29N7O2/c1-20-8-11-24(18-26(20)35-29-31-16-14-25(34-29)22-6-4-15-30-19-22)33-28(38)21-9-12-23(13-10-21)32-27(37)7-5-17-36(2)3/h4-16,18-19H,17H2,1-3H3,(H,32,37)(H,33,38)(H,31,34,35)/b7-5+ D0PG5N DRUGINKE YFRXAAWSVLQGDR-FNORWQNLSA-N D0PG5N DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)NC(=O)C=CCN(C)C)NC3=NC=CC(=N3)C4=CN=CC=C4 D0PG5N HIGHSTAT Patented D0PI5O DRUG__ID D0PI5O D0PI5O DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0PI5O DRUGTYPE Small molecular drug D0PI5O DRUGINCH 1S/C29H34N4O3/c1-18-13-19(2)32-28(35)25(18)17-31-27(34)21-14-22-16-29(3,4)36-26(22)24(15-21)20-5-7-23(8-6-20)33-11-9-30-10-12-33/h5-8,13-15,30H,9-12,16-17H2,1-4H3,(H,31,34)(H,32,35) D0PI5O DRUGINKE ZIIBOHIVIFEGAI-UHFFFAOYSA-N D0PI5O DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC3=C(C(=C2)C4=CC=C(C=C4)N5CCNCC5)OC(C3)(C)C)C D0PI5O HIGHSTAT Patented D0PJ1W DRUG__ID D0PJ1W D0PJ1W DRUGCOMP DIAXONHIT LEBLOND, Bertrand CASAGRANDE, Anne-Sophie DESIRE, Laurent FOUCOURT, Alicia BESSON, Thierry D0PJ1W DRUGTYPE Small molecular drug D0PJ1W DRUGINCH 1S/C17H11F2N5OS/c1-25-15(20)17-24-12-5-4-11-13(14(12)26-17)16(22-7-21-11)23-10-3-2-8(18)6-9(10)19/h2-7,20H,1H3,(H,21,22,23) D0PJ1W DRUGINKE VONVAHFLRYRXSJ-UHFFFAOYSA-N D0PJ1W DRUGSMIL COC(=N)C1=NC2=C(S1)C3=C(C=C2)N=CN=C3NC4=C(C=C(C=C4)F)F D0PJ1W HIGHSTAT Patented D0PJ8X DRUG__ID D0PJ8X D0PJ8X DRUGCOMP Korea Institute of Science and Technology D0PJ8X DRUGTYPE Small molecular drug D0PJ8X DRUGINCH 1S/C18H13NO/c1-20-18-9-5-8-17-16(18)13-12-15(19-17)11-10-14-6-3-2-4-7-14/h2-9,12-13H,1H3 D0PJ8X DRUGINKE JKTIXUXRNOXCFC-UHFFFAOYSA-N D0PJ8X DRUGSMIL COC1=CC=CC2=C1C=CC(=N2)C#CC3=CC=CC=C3 D0PJ8X HIGHSTAT Patented D0PM1B DRUG__ID D0PM1B D0PM1B DRUGCOMP SAMUMED, LLC D0PM1B DRUGTYPE Small molecular drug D0PM1B DRUGINCH 1S/C25H26N6O/c1-17-9-21(15-26-12-17)28-25(32)24-22-11-19(5-6-23(22)29-30-24)20-10-18(13-27-14-20)16-31-7-3-2-4-8-31/h5-6,9-15H,2-4,7-8,16H2,1H3,(H,28,32)(H,29,30) D0PM1B DRUGINKE LIXXQBRPVXEVJX-UHFFFAOYSA-N D0PM1B DRUGSMIL CC1=CC(=CN=C1)NC(=O)C2=NNC3=C2C=C(C=C3)C4=CN=CC(=C4)CN5CCCCC5 D0PM1B HIGHSTAT Patented D0PN6U DRUG__ID D0PN6U D0PN6U DRUGCOMP Boiteau J-G, Barbuis CM, Talano S D0PN6U DRUGTYPE Small molecular drug D0PN6U DRUGINCH 1S/C10H10N2OS/c1-13-8-4-2-3-7(5-8)9-6-11-10(14)12-9/h2-6H,1H3,(H2,11,12,14) D0PN6U DRUGINKE NAHCKRAVJDCJKM-UHFFFAOYSA-N D0PN6U DRUGSMIL COC1=CC=CC(=C1)C2=CNC(=S)N2 D0PN6U HIGHSTAT Patented D0PT0U DRUG__ID D0PT0U D0PT0U DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D0PT0U DRUGTYPE Small molecular drug D0PT0U DRUGINCH 1S/C21H21ClF3N3O3/c22-18-10-13(9-17(30)12-29)11-26-19(18)14-5-7-28(8-6-14)20(31)27-16-3-1-15(2-4-16)21(23,24)25/h1-5,10-11,17,29-30H,6-9,12H2,(H,27,31) D0PT0U DRUGINKE DMTZGKUBPJHALY-UHFFFAOYSA-N D0PT0U DRUGSMIL C1CN(CC=C1C2=C(C=C(C=N2)CC(CO)O)Cl)C(=O)NC3=CC=C(C=C3)C(F)(F)F D0PT0U HIGHSTAT Patented D0Q1NA DRUG__ID D0Q1NA D0Q1NA DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0Q1NA DRUGTYPE Small molecular drug D0Q1NA DRUGINCH 1S/C21H18FN3O2/c1-14-23-19-8-7-17(11-20(19)24(14)2)25-10-9-18(12-21(25)26)27-13-15-3-5-16(22)6-4-15/h3-12H,13H2,1-2H3 D0Q1NA DRUGINKE WSKXMIQVCMWHGL-UHFFFAOYSA-N D0Q1NA DRUGSMIL CC1=NC2=C(N1C)C=C(C=C2)N3C=CC(=CC3=O)OCC4=CC=C(C=C4)F D0Q1NA HIGHSTAT Patented D0Q1QY DRUG__ID D0Q1QY D0Q1QY DRUGCOMP ACETYLON PHARMACEUTICALS, INC. VIB VZW KATHOLIEKE UNVERSITEIT LEUVEN LIFE SCIENCES RESEARCH PARTNERS VZW D0Q1QY DRUGTYPE Small molecular drug D0Q1QY DRUGINCH 1S/C14H14N4O2/c19-12(18-20)10-8-15-13(16-9-10)17-14(6-7-14)11-4-2-1-3-5-11/h1-5,8-9,20H,6-7H2,(H,18,19)(H,15,16,17) D0Q1QY DRUGINKE LIIWIMDSZVNYHY-UHFFFAOYSA-N D0Q1QY DRUGSMIL C1CC1(C2=CC=CC=C2)NC3=NC=C(C=N3)C(=O)NO D0Q1QY HIGHSTAT Patented D0Q1WV DRUG__ID D0Q1WV D0Q1WV DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D0Q1WV DRUGTYPE Small molecular drug D0Q1WV DRUGINCH 1S/C16H19FN2O2/c1-2-3-12-21-15(20)19-11-9-16(17,13-19)8-7-14-6-4-5-10-18-14/h4-6,10H,2-3,9,11-13H2,1H3 D0Q1WV DRUGINKE NCBPLEITPLWATL-UHFFFAOYSA-N D0Q1WV DRUGSMIL CCCCOC(=O)N1CCC(C1)(C#CC2=CC=CC=N2)F D0Q1WV HIGHSTAT Patented D0Q1XF DRUG__ID D0Q1XF D0Q1XF DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0Q1XF DRUGTYPE Small molecular drug D0Q1XF DRUGINCH 1S/C57H77N9O7Si/c1-35(58-6)51(68)63-46(55(72)66-34-74(8,9)33-48(66)54(71)62-45-23-15-19-40-17-11-13-21-43(40)45)30-38-26-24-37(25-27-38)28-29-49(67)60-41-31-47(53(70)61-44-22-14-18-39-16-10-12-20-42(39)44)65(32-41)56(73)50(57(3,4)5)64-52(69)36(2)59-7/h10-13,16-17,20-21,24-27,35-36,41,44-48,50,58-59H,14-15,18-19,22-23,30-34H2,1-9H3,(H,60,67)(H,61,70)(H,62,71)(H,63,68)(H,64,69)/t35-,36-,41-,44+,45+,46-,47-,48-,50+/m0/s1 D0Q1XF DRUGINKE SOUZAGJRYQSXAP-UZNJVIDBSA-N D0Q1XF DRUGSMIL CC(C(=O)NC(CC1=CC=C(C=C1)C#CC(=O)NC2CC(N(C2)C(=O)C(C(C)(C)C)NC(=O)C(C)NC)C(=O)NC3CCCC4=CC=CC=C34)C(=O)N5C[Si](CC5C(=O)NC6CCCC7=CC=CC=C67)(C)C)NC D0Q1XF HIGHSTAT Patented D0Q3VZ DRUG__ID D0Q3VZ D0Q3VZ DRUGCOMP GAMBRO LUNDIA AB [SEJOENSSON LENNART [SENILSSON EDDIE [SESTERNBY JAN [SE] D0Q3VZ DRUGTYPE Small molecular drug D0Q3VZ DRUGINCH 1S/C17H13N3O3/c21-16-13(8-11-6-7-14-15(9-11)23-10-22-14)19-17(20-16)18-12-4-2-1-3-5-12/h1-9H,10H2,(H2,18,19,20,21)/b13-8- D0Q3VZ DRUGINKE PGPHHJBZEGSUNE-JYRVWZFOSA-N D0Q3VZ DRUGSMIL C1OC2=C(O1)C=C(C=C2)C=C3C(=O)NC(=N3)NC4=CC=CC=C4 D0Q3VZ HIGHSTAT Patented D0Q8LH DRUG__ID D0Q8LH D0Q8LH DRUGTYPE Small molecular drug D0Q8LH DRUGINCH 1S/C24H25N7O/c1-2-21(32)30-10-6-9-19(15-30)29-24-22-20(12-25-23(22)26-16-27-24)18-11-28-31(14-18)13-17-7-4-3-5-8-17/h2-5,7-8,11-12,14,16,19H,1,6,9-10,13,15H2,(H2,25,26,27,29) D0Q8LH DRUGINKE KOFRBWGSVPRLLQ-UHFFFAOYSA-N D0Q8LH DRUGSMIL C=CC(=O)N1CCCC(C1)NC2=NC=NC3=C2C(=CN3)C4=CN(N=C4)CC5=CC=CC=C5 D0Q8LH HIGHSTAT Patented D0Q8LH COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0Q9TO DRUG__ID D0Q9TO D0Q9TO DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH HICKEY, Eugene Richard RIETHER, Doris ERMANN, Monika D0Q9TO DRUGTYPE Small molecular drug D0Q9TO DRUGINCH 1S/C16H27N3O4S2/c1-15(2,3)13-18-19-14(24-13)17-12(20)16(4,5)10-25(21,22)11-6-8-23-9-7-11/h11H,6-10H2,1-5H3,(H,17,19,20) D0Q9TO DRUGINKE YNOMXHGERFXVDK-UHFFFAOYSA-N D0Q9TO DRUGSMIL CC(C)(C)C1=NN=C(S1)NC(=O)C(C)(C)CS(=O)(=O)C2CCOCC2 D0Q9TO HIGHSTAT Patented D0QC5O DRUG__ID D0QC5O D0QC5O DRUGCOMP GSK D0QC5O DRUGTYPE Small molecular drug D0QC5O DRUGINCH 1S/C18H12ClF5N2O2/c19-16-11(2-1-3-12(16)18(22,23)24)17(28)25-6-7-26(15(27)9-25)14-5-4-10(20)8-13(14)21/h1-5,8H,6-7,9H2 D0QC5O DRUGINKE VNEYCAAUOFFQMB-UHFFFAOYSA-N D0QC5O DRUGSMIL C1CN(C(=O)CN1C(=O)C2=C(C(=CC=C2)C(F)(F)F)Cl)C3=C(C=C(C=C3)F)F D0QC5O HIGHSTAT Patented D0QE8S DRUG__ID D0QE8S D0QE8S DRUGTYPE Small molecular drug D0QE8S DRUGINCH 1S/C17H12F2N4O2/c1-10-4-13(25-14-5-12(19)7-20-9-14)6-15(22-10)17(24)23-16-3-2-11(18)8-21-16/h2-9H,1H3,(H,21,23,24) D0QE8S DRUGINKE MBSANIMQXDBICP-UHFFFAOYSA-N D0QE8S DRUGSMIL CC1=CC(=CC(=N1)C(=O)NC2=NC=C(C=C2)F)OC3=CC(=CN=C3)F D0QE8S HIGHSTAT Patented D0QE8S COMPCLAS Bicyclic heteroaryl carboxamide analogs D0QH1J DRUG__ID D0QH1J D0QH1J DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0QH1J DRUGTYPE Small molecular drug D0QH1J DRUGINCH 1S/C37H45FN4O4/c1-4-42(29-12-16-45-17-13-29)34-21-28(27-10-8-26(9-11-27)23-41-14-18-46-19-15-41)20-31(24(34)2)36(43)39-22-32-35-30(6-5-7-33(35)38)25(3)40-37(32)44/h5-11,20-21,25,29,32H,4,12-19,22-23H2,1-3H3,(H,39,43)(H,40,44) D0QH1J DRUGINKE FUYGRYVZMCQDEP-UHFFFAOYSA-N D0QH1J DRUGSMIL CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3C4=C(C=CC=C4F)C(NC3=O)C)C5=CC=C(C=C5)CN6CCOCC6 D0QH1J HIGHSTAT Patented D0QL7B DRUG__ID D0QL7B D0QL7B DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0QL7B DRUGTYPE Small molecular drug D0QL7B DRUGINCH 1S/C8H10N4O2/c1-4-9-5-6(10-4)11(2)8(14)12(3)7(5)13/h1-3H3,(H,9,10) D0QL7B DRUGINKE WZBKGWBHAPBSBF-UHFFFAOYSA-N D0QL7B DRUGSMIL CC1=NC2=C(N1)C(=O)N(C(=O)N2C)C D0QL7B HIGHSTAT Patented D0QP4N DRUG__ID D0QP4N D0QP4N DRUGCOMP Japan Tobacco, Inc D0QP4N DRUGTYPE Small molecular drug D0QP4N DRUGINCH 1S/C22H14Cl2F6N4O2/c23-15-6-1-11(20(36)33-14-4-2-12(3-5-14)21(25,26)27)7-17(15)34(10-18(31)35)19-16(24)8-13(9-32-19)22(28,29)30/h1-9H,10H2,(H2,31,35)(H,33,36) D0QP4N DRUGINKE YLOQUQYZKPTZAV-UHFFFAOYSA-N D0QP4N DRUGSMIL C1=CC(=CC=C1C(F)(F)F)NC(=O)C2=CC(=C(C=C2)Cl)N(CC(=O)N)C3=C(C=C(C=N3)C(F)(F)F)Cl D0QP4N HIGHSTAT Patented D0QR0U DRUG__ID D0QR0U D0QR0U DRUGCOMP University of Texas D0QR0U DRUGTYPE Small molecular drug D0QR0U DRUGINCH 1S/C30H28O8/c1-15-24(33)19(27(36)22(16(2)31)25(15)34)14-20-26(35)18-12-13-30(3,4)38-29(18)23(28(20)37)21(32)11-10-17-8-6-5-7-9-17/h5-13,33-37H,14H2,1-4H3/b11-10+ D0QR0U DRUGINKE DEZFNHCVIZBHBI-ZHACJKMWSA-N D0QR0U DRUGSMIL CC1=C(C(=C(C(=C1O)C(=O)C)O)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C=CC4=CC=CC=C4)O)O D0QR0U HIGHSTAT Patented D0QR1Z DRUG__ID D0QR1Z D0QR1Z DRUGTYPE Small molecular drug D0QR1Z DRUGINCH 1S/C16H18N6O2S/c1-9(2)22-10(3)18-8-12(22)11-6-7-17-16(19-11)20-14-5-4-13(25-14)15(23)21-24/h4-9,24H,1-3H3,(H,21,23)(H,17,19,20) D0QR1Z DRUGINKE CKZXHZVEFKLZPB-UHFFFAOYSA-N D0QR1Z DRUGSMIL CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(S3)C(=O)NO D0QR1Z HIGHSTAT Patented D0QR1Z COMPCLAS Isosteric imidazolyl pyrimidine derivatives D0QT3C DRUG__ID D0QT3C D0QT3C DRUGCOMP MERCK SHARP &amDOHME CORP. DEVITA, Robert, J. YU, Yang LIU, Jian HE, Shuwen KRIKORIAN, Arto, D. MILLER, Daniel, J. WU, Zhicai YANG, Ginger Xu-Qiang HONG, Quingmei LAI, Zhong ZORN, Nicolas TING, Pauline, C D0QT3C DRUGTYPE Small molecular drug D0QT3C DRUGINCH 1S/C23H19ClFN3O3/c1-23(2,22(29)30)12-31-20-8-4-14(11-26-20)13-3-6-16(17(25)9-13)21-27-18-7-5-15(24)10-19(18)28-21/h3-11H,12H2,1-2H3,(H,27,28)(H,29,30) D0QT3C DRUGINKE VDSPJLXCWHECIK-UHFFFAOYSA-N D0QT3C DRUGSMIL CC(C)(COC1=NC=C(C=C1)C2=CC(=C(C=C2)C3=NC4=C(N3)C=C(C=C4)Cl)F)C(=O)O D0QT3C HIGHSTAT Patented D0QT5B DRUG__ID D0QT5B D0QT5B DRUGCOMP AJINOMOTO CO., INC D0QT5B DRUGTYPE Small molecular drug D0QT5B DRUGINCH 1S/C24H30N2O/c1-24(2,3)20-7-4-6-17(13-20)18-9-10-23-19(12-18)14-21(25-23)15-26-11-5-8-22(26)16-27/h4,6-7,9-10,12-14,22,25,27H,5,8,11,15-16H2,1-3H3/t22-/m1/s1 D0QT5B DRUGINKE WJXINPLKVRUVDV-JOCHJYFZSA-N D0QT5B DRUGSMIL CC(C)(C)C1=CC=CC(=C1)C2=CC3=C(C=C2)NC(=C3)CN4CCCC4CO D0QT5B HIGHSTAT Patented D0QX3G DRUG__ID D0QX3G D0QX3G DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH BRESLOW, Ronald MARKS, Paul, A D0QX3G DRUGTYPE Small molecular drug D0QX3G DRUGINCH 1S/C17H18N2O4/c20-11-10-19(15-4-2-1-3-5-15)16(21)12-13-6-8-14(9-7-13)17(22)18-23/h1-9,20,23H,10-12H2,(H,18,22) D0QX3G DRUGINKE RFAZNTABYJYOAR-UHFFFAOYSA-N D0QX3G DRUGSMIL C1=CC=C(C=C1)N(CCO)C(=O)CC2=CC=C(C=C2)C(=O)NO D0QX3G HIGHSTAT Patented D0QY4O DRUG__ID D0QY4O D0QY4O DRUGCOMP Kissei Pharmaceutical Co. Ltd D0QY4O DRUGTYPE Small molecular drug D0QY4O DRUGINCH 1S/C18H12N2O3/c19-9-13-10-20(11-16(13)12-4-2-1-3-5-12)14-6-7-15(18(22)23)17(21)8-14/h1-8,10-11,21H,(H,22,23) D0QY4O DRUGINKE KTIOENPGGRVZED-UHFFFAOYSA-N D0QY4O DRUGSMIL C1=CC=C(C=C1)C2=CN(C=C2C#N)C3=CC(=C(C=C3)C(=O)O)O D0QY4O HIGHSTAT Patented D0R0YB DRUG__ID D0R0YB D0R0YB DRUGCOMP ALBANY MOLECULAR RESEARCH, INC D0R0YB DRUGTYPE Small molecular drug D0R0YB DRUGINCH 1S/C25H21F3N4O/c1-31-20-12-17(4-5-18(20)24-19-6-3-16(30-19)11-21(24)31)32-9-8-14(10-23(32)33)15-2-7-22(29-13-15)25(26,27)28/h2,4-5,7-10,12-13,16,19,30H,3,6,11H2,1H3 D0R0YB DRUGINKE NAYVWRUHNOMLBF-UHFFFAOYSA-N D0R0YB DRUGSMIL CN1C2=C(C3CCC(C2)N3)C4=C1C=C(C=C4)N5C=CC(=CC5=O)C6=CN=C(C=C6)C(F)(F)F D0R0YB HIGHSTAT Patented D0R2QV DRUG__ID D0R2QV D0R2QV DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D0R2QV DRUGTYPE Small molecular drug D0R2QV DRUGINCH 1S/C19H19F3N4O3/c1-26(2)15-8-12(19(20,21)22)7-6-11(15)9-23-18(28)25-14-5-3-4-13-17(14)29-10-16(27)24-13/h3-8H,9-10H2,1-2H3,(H,24,27)(H2,23,25,28) D0R2QV DRUGINKE NEPJFAHBBJEELA-UHFFFAOYSA-N D0R2QV DRUGSMIL CN(C)C1=C(C=CC(=C1)C(F)(F)F)CNC(=O)NC2=CC=CC3=C2OCC(=O)N3 D0R2QV HIGHSTAT Patented D0R2TH DRUG__ID D0R2TH D0R2TH DRUGTYPE Small molecular drug D0R2TH DRUGINCH 1S/C22H15ClF3N5O2/c1-12-18(17-9-10-28-31(17)15-7-5-14(23)6-8-15)29-19(20(27)32)21(33)30(12)16-4-2-3-13(11-16)22(24,25)26/h2-11H,1H3,(H2,27,32) D0R2TH DRUGINKE CESXSDAPOCNYPG-UHFFFAOYSA-N D0R2TH DRUGSMIL CC1=C(N=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)N)C3=CC=NN3C4=CC=C(C=C4)Cl D0R2TH HIGHSTAT Patented D0R2TH COMPCLAS 2-pyrazinone derivatives D0R3RJ DRUG__ID D0R3RJ D0R3RJ DRUGCOMP THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0R3RJ DRUGTYPE Small molecular drug D0R3RJ DRUGINCH 1S/C16H17N3O2/c20-16(18-21)13-7-5-12(6-8-13)11-19-10-9-17-14-3-1-2-4-15(14)19/h1-8,17,21H,9-11H2,(H,18,20) D0R3RJ DRUGINKE RGVWNOQFULPCMK-UHFFFAOYSA-N D0R3RJ DRUGSMIL C1CN(C2=CC=CC=C2N1)CC3=CC=C(C=C3)C(=O)NO D0R3RJ HIGHSTAT Patented D0R3YM DRUG__ID D0R3YM D0R3YM DRUGCOMP PHARMASCIENCE INC. LAURENT, Alain PROULX, Melanie ROSE, Yannick DENISSOVA, Irina DAIRI, Kenza JARVIS, Scott JAQUITH, James, B D0R3YM DRUGTYPE Small molecular drug D0R3YM DRUGINCH 1S/C30H40FN7O3/c1-20(32-5)26(39)35-25(30(2,3)4)28(41)38-16-6-8-23(38)18-36(17-13-21-9-11-22(31)12-10-21)27(40)24-19-37-15-7-14-33-29(37)34-24/h7,9-12,14-15,19-20,23,25,32H,6,8,13,16-18H2,1-5H3,(H,35,39)/t20-,23-,25+/m0/s1 D0R3YM DRUGINKE HWFGTCIBSHAQOY-GRYUFTJMSA-N D0R3YM DRUGSMIL CC(C(=O)NC(C(=O)N1CCCC1CN(CCC2=CC=C(C=C2)F)C(=O)C3=CN4C=CC=NC4=N3)C(C)(C)C)NC D0R3YM HIGHSTAT Patented D0R6KH DRUG__ID D0R6KH D0R6KH DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0R6KH DRUGTYPE Small molecular drug D0R6KH DRUGINCH 1S/C25H34N6O3S/c1-18-25(32)29(3)22-9-10-23(27-24(22)31(18)20-11-15-28(2)16-12-20)26-19-7-6-8-21(17-19)35(33,34)30-13-4-5-14-30/h6-10,17-18,20H,4-5,11-16H2,1-3H3,(H,26,27)/t18-/m1/s1 D0R6KH DRUGINKE IIDSCXUAKMUCPQ-GOSISDBHSA-N D0R6KH DRUGSMIL CC1C(=O)N(C2=C(N1C3CCN(CC3)C)N=C(C=C2)NC4=CC(=CC=C4)S(=O)(=O)N5CCCC5)C D0R6KH HIGHSTAT Patented D0R6LF DRUG__ID D0R6LF D0R6LF DRUGTYPE Small molecular drug D0R6LF DRUGINCH 1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3 D0R6LF DRUGINKE WSEQXVZVJXJVFP-UHFFFAOYSA-N D0R6LF DRUGSMIL CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F D0R6LF HIGHSTAT Patented D0R6LF COMPCLAS Citalopram derivatives D0R6RT DRUG__ID D0R6RT D0R6RT DRUGTYPE Small molecular drug D0R6RT DRUGINCH 1S/C24H30N2O2/c27-24-12-10-20-9-11-22(17-23(20)25-24)28-16-6-2-1-5-14-26-15-13-19-7-3-4-8-21(19)18-26/h3-4,7-9,11,17H,1-2,5-6,10,12-16,18H2,(H,25,27) D0R6RT DRUGINKE BIIFFVLUGVJJJX-UHFFFAOYSA-N D0R6RT DRUGSMIL C1CC(=O)NC2=C1C=CC(=C2)OCCCCCCN3CCC4=CC=CC=C4C3 D0R6RT HIGHSTAT Patented D0R6RT COMPCLAS Tetra-hydro-isoquinoline derivatives D0R7YI DRUG__ID D0R7YI D0R7YI DRUGCOMP POLARIS PHARMACEUTICALS, INC D0R7YI DRUGTYPE Small molecule immunotherapy D0R7YI DRUGINCH 1S/C42H46Br2N2O6/c1-27-31(25-51-39-17-15-29(21-35(39)43)23-45-19-5-3-13-37(45)41(47)48)9-7-11-33(27)34-12-8-10-32(28(34)2)26-52-40-18-16-30(22-36(40)44)24-46-20-6-4-14-38(46)42(49)50/h7-12,15-18,21-22,37-38H,3-6,13-14,19-20,23-26H2,1-2H3,(H,47,48)(H,49,50)/t37-,38-/m0/s1 D0R7YI DRUGINKE SDCCYXRWWJGRKC-UWXQCODUSA-N D0R7YI DRUGSMIL CC1=C(C=CC=C1C2=CC=CC(=C2C)COC3=C(C=C(C=C3)CN4CCCCC4C(=O)O)Br)COC5=C(C=C(C=C5)CN6CCCCC6C(=O)O)Br D0R7YI HIGHSTAT Patented D0R8CR DRUG__ID D0R8CR D0R8CR DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0R8CR DRUGTYPE Small molecular drug D0R8CR DRUGINCH 1S/C26H33F3N6O4S/c1-18-25(36)32(2)22-6-7-23(31-24(22)35(18)20-8-14-39-15-9-20)30-19-4-3-5-21(16-19)40(37,38)34-12-10-33(11-13-34)17-26(27,28)29/h3-7,16,18,20H,8-15,17H2,1-2H3,(H,30,31)/t18-/m1/s1 D0R8CR DRUGINKE DRCMYKRSYNVVMM-GOSISDBHSA-N D0R8CR DRUGSMIL CC1C(=O)N(C2=C(N1C3CCOCC3)N=C(C=C2)NC4=CC(=CC=C4)S(=O)(=O)N5CCN(CC5)CC(F)(F)F)C D0R8CR HIGHSTAT Patented D0R8GA DRUG__ID D0R8GA D0R8GA DRUGCOMP ABBVIE INC D0R8GA DRUGTYPE Small molecular drug D0R8GA DRUGINCH 1S/C19H19FN4O/c20-16-5-2-1-4-14(16)12-8-9-13(10-12)22-19(25)23-17-6-3-7-18-15(17)11-21-24-18/h1-7,11-13H,8-10H2,(H,21,24)(H2,22,23,25)/t12-,13-/m1/s1 D0R8GA DRUGINKE MNXPYZUSFURMKS-CHWSQXEVSA-N D0R8GA DRUGSMIL C1CC(CC1C2=CC=CC=C2F)NC(=O)NC3=CC=CC4=C3C=NN4 D0R8GA HIGHSTAT Patented D0R8GK DRUG__ID D0R8GK D0R8GK DRUGCOMP PHENEX PHARMACEUTICALS AG KREMOSER, Claus ABEL, Ulrich STEENECK, Christoph KINZEL, Olaf D0R8GK DRUGTYPE Small molecular drug D0R8GK DRUGINCH 1S/C29H22Cl3NO4/c30-23-2-1-3-24(31)26(23)27-22(28(37-33-27)16-6-7-16)14-36-18-10-11-19(25(32)12-18)21-13-20(21)15-4-8-17(9-5-15)29(34)35/h1-5,8-12,16,20-21H,6-7,13-14H2,(H,34,35) D0R8GK DRUGINKE XBUXXJUEBFDQHD-UHFFFAOYSA-N D0R8GK DRUGSMIL C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5CC5C6=CC=C(C=C6)C(=O)O)Cl D0R8GK HIGHSTAT Patented D0R8OW DRUG__ID D0R8OW D0R8OW DRUGCOMP IOMET PHARMA LTD D0R8OW DRUGTYPE Small molecular drug D0R8OW DRUGINCH 1S/C15H12N2O3S/c18-21(19,13-9-5-2-6-10-13)17-15-14(11-16-20-15)12-7-3-1-4-8-12/h1-11,17H D0R8OW DRUGINKE KJPWMAIBFGUKIA-UHFFFAOYSA-N D0R8OW DRUGSMIL C1=CC=C(C=C1)C2=C(ON=C2)NS(=O)(=O)C3=CC=CC=C3 D0R8OW HIGHSTAT Patented D0RD9V DRUG__ID D0RD9V D0RD9V DRUGTYPE Small molecular drug D0RD9V DRUGINCH 1S/C15H10F3N5O/c16-15(17,18)9-1-2-11-10(7-9)12(3-4-20-11)22-14(24)23-13-8-19-5-6-21-13/h1-8H,(H2,20,21,22,23,24) D0RD9V DRUGINKE GHAZVJQMLWOQLP-UHFFFAOYSA-N D0RD9V DRUGSMIL C1=CC2=NC=CC(=C2C=C1C(F)(F)F)NC(=O)NC3=NC=CN=C3 D0RD9V HIGHSTAT Patented D0RD9V COMPCLAS Quinolinyl pyrazinyl urea derivatives D0RE9W DRUG__ID D0RE9W D0RE9W DRUGCOMP ALMAC DISCOVERY LIMITED HARRISON, Timothy BURKAMP, Frank JORDAN, Linda BELL, Mark JANSSEN, Dominic MIEL, Hugues MCFARLAND, Mary D0RE9W DRUGTYPE Small molecular drug D0RE9W DRUGINCH 1S/C25H28N4/c1-24(2)12-13-25(3,4)20-15-18(9-10-19(20)24)21-11-14-28-23(29-21)17-7-5-16(6-8-17)22(26)27/h5-11,14-15H,12-13H2,1-4H3,(H3,26,27) D0RE9W DRUGINKE HBVOXJWWSHTROQ-UHFFFAOYSA-N D0RE9W DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C3=NC(=NC=C3)C4=CC=C(C=C4)C(=N)N)(C)C)C D0RE9W HIGHSTAT Patented D0RF1Z DRUG__ID D0RF1Z D0RF1Z DRUGCOMP IRBM - SCIENCE PARK S.P.A. C.N.C.C.S. SCARL COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING D0RF1Z DRUGTYPE Small molecular drug D0RF1Z DRUGINCH 1S/C27H34N4O4/c1-4-20(32)11-6-5-7-13-23(29-25(33)19-16-31(2)17-19)27-28-15-24(35-27)21-14-18-10-8-9-12-22(18)30-26(21)34-3/h8-10,12,14-15,19,23H,4-7,11,13,16-17H2,1-3H3,(H,29,33)/t23-/m0/s1 D0RF1Z DRUGINKE YOCBGMVQRJHNRU-QHCPKHFHSA-N D0RF1Z DRUGSMIL CCC(=O)CCCCCC(C1=NC=C(O1)C2=CC3=CC=CC=C3N=C2OC)NC(=O)C4CN(C4)C D0RF1Z HIGHSTAT Patented D0RG1T DRUG__ID D0RG1T D0RG1T DRUGCOMP SIRTRIS PHARMACEUTICALS, INC. PERNI, Robert, B. BEMIS, Jean NUNES, Joseph, J. SZCZEPANKIEWICZ, Bruce, G D0RG1T DRUGTYPE Small molecular drug D0RG1T DRUGINCH 1S/C12H13NO2S/c1-3-13-10-7-9(15)4-5-11(10)16-12(13)6-8(2)14/h4-7,15H,3H2,1-2H3/b12-6- D0RG1T DRUGINKE GCSZJMUFYOAHFY-SDQBBNPISA-N D0RG1T DRUGSMIL CCN1C2=C(C=CC(=C2)O)SC1=CC(=O)C D0RG1T HIGHSTAT Patented D0RG9J DRUG__ID D0RG9J D0RG9J DRUGCOMP HUA MEDICINE (SHANGHAI) LTD D0RG9J DRUGTYPE Small molecular drug D0RG9J DRUGINCH 1S/C18H14FN3/c19-18(8-7-16-5-1-2-10-21-16)9-11-22(14-18)17-6-3-4-15(12-17)13-20/h1-6,10,12H,9,11,14H2 D0RG9J DRUGINKE NHUYADGCDLCNRQ-UHFFFAOYSA-N D0RG9J DRUGSMIL C1CN(CC1(C#CC2=CC=CC=N2)F)C3=CC=CC(=C3)C#N D0RG9J HIGHSTAT Patented D0RH9K DRUG__ID D0RH9K D0RH9K DRUGCOMP BEIGENE, LTD. WANG, Hexiang D0RH9K DRUGTYPE Small molecular drug D0RH9K DRUGINCH 1S/C18H22N2O/c21-18(15-8-11-1-2-13(15)7-11)17-14(12-3-4-12)5-6-20-10-19-9-16(17)20/h5-6,9-13,15,18,21H,1-4,7-8H2/t11?,13?,15?,18-/m0/s1 D0RH9K DRUGINKE AYNGHFYFVHELEJ-NNIVULJMSA-N D0RH9K DRUGSMIL C1CC1C2=C(C3=CN=CN3C=C2)C(C4CC5CCC4C5)O D0RH9K HIGHSTAT Patented D0RM4V DRUG__ID D0RM4V D0RM4V DRUGCOMP REATA PHARMACEUTICALS, INC D0RM4V DRUGTYPE Small molecular drug D0RM4V DRUGINCH 1S/C32H44N2O3/c1-19(35)34-32-13-11-27(2,3)17-21(32)25-22(36)15-24-29(6)16-20(18-33)26(37)28(4,5)23(29)9-10-30(24,7)31(25,8)12-14-32/h15-16,21,23,25H,9-14,17H2,1-8H3,(H,34,35)/t21?,23-,25?,29-,30+,31+,32-/m0/s1 D0RM4V DRUGINKE MXZQJSKPUZWONN-CCCNGEJOSA-N D0RM4V DRUGSMIL CC(=O)NC12CCC(CC1C3C(=O)C=C4C(C3(CC2)C)(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C D0RM4V HIGHSTAT Patented D0RN2X DRUG__ID D0RN2X D0RN2X DRUGCOMP Korea Bio Health Co. Ltd D0RN2X DRUGTYPE Small molecular drug D0RN2X DRUGINCH 1S/C19H20O5/c1-11(2)7-18(21)23-16-9-13-8-12-5-6-17(20)22-14(12)10-15(13)24-19(16,3)4/h5-8,10,16H,9H2,1-4H3/t16-/m0/s1 D0RN2X DRUGINKE CUKSFECWKQBVED-INIZCTEOSA-N D0RN2X DRUGSMIL CC(=CC(=O)OC1CC2=C(C=C3C(=C2)C=CC(=O)O3)OC1(C)C)C D0RN2X HIGHSTAT Patented D0RO7A DRUG__ID D0RO7A D0RO7A DRUGCOMP THE HAMNER INSTITUTES D0RO7A DRUGTYPE Small molecular drug D0RO7A DRUGINCH 1S/C7H9N3O/c8-6-3-1-5(2-4-6)7(11)10-9/h1-4H,8-9H2,(H,10,11) D0RO7A DRUGINKE WPBZMCGPFHZRHJ-UHFFFAOYSA-N D0RO7A DRUGSMIL C1=CC(=CC=C1C(=O)NN)N D0RO7A HIGHSTAT Patented D0RP1J DRUG__ID D0RP1J D0RP1J DRUGCOMP AAPA B.V D0RP1J DRUGTYPE Small molecular drug D0RP1J DRUGINCH 1S/C27H34N4O3/c32-27-28-24-5-2-6-25(26(24)34-27)31-17-15-29(16-18-31)19-20-7-9-22(10-8-20)33-23-11-13-30(14-12-23)21-3-1-4-21/h2,5-10,21,23H,1,3-4,11-19H2,(H,28,32) D0RP1J DRUGINKE MCJUAFCGICUNIN-UHFFFAOYSA-N D0RP1J DRUGSMIL C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)CN4CCN(CC4)C5=CC=CC6=C5OC(=O)N6 D0RP1J HIGHSTAT Patented D0RT6C DRUG__ID D0RT6C D0RT6C DRUGCOMP IKERCHEM S L [ESUNIV DEL PA S VASCO [ES] D0RT6C DRUGTYPE Small molecular drug D0RT6C DRUGINCH 1S/C24H21NO7/c1-31-15-9-17-24(23(10-15)32-2)16(13-3-5-18(26)20(28)7-13)11-25(17)12-22(30)14-4-6-19(27)21(29)8-14/h3-11,26-29H,12H2,1-2H3 D0RT6C DRUGINKE VZIMIRNNOGRJFC-UHFFFAOYSA-N D0RT6C DRUGSMIL COC1=CC2=C(C(=C1)OC)C(=CN2CC(=O)C3=CC(=C(C=C3)O)O)C4=CC(=C(C=C4)O)O D0RT6C HIGHSTAT Patented D0RT8M DRUG__ID D0RT8M D0RT8M DRUGCOMP ZHANG, Dawei D0RT8M DRUGTYPE Small molecular drug D0RT8M DRUGINCH 1S/C29H30FN7O/c1-20-25(30)16-24(17-27(20)35-29-32-11-9-26(34-29)23-4-3-10-31-18-23)33-28(38)22-7-5-21(6-8-22)19-37-14-12-36(2)13-15-37/h3-11,16-18H,12-15,19H2,1-2H3,(H,33,38)(H,32,34,35) D0RT8M DRUGINKE ZRPUCWORBBVKGL-UHFFFAOYSA-N D0RT8M DRUGSMIL CC1=C(C=C(C=C1F)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 D0RT8M HIGHSTAT Patented D0RV0O DRUG__ID D0RV0O D0RV0O DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED WANG, Rong LU, HongtaGLAXO GROUP LIMITED BAMFORD, Mark, James DEAN, David, Kenneth SEHMI, Sanjeet, Singh WILSON, David, Matthew WITHERINGTON, Jason D0RV0O DRUGTYPE Small molecular drug D0RV0O DRUGINCH 1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2 D0RV0O DRUGINKE YFRBKEVUUCQYOW-UHFFFAOYSA-N D0RV0O DRUGSMIL C1CC(C1)N2CCC3=C(CC2)C=C(C=C3)OC4=NC=C(C=C4)N5CCCC5=O D0RV0O HIGHSTAT Patented D0RV2Z DRUG__ID D0RV2Z D0RV2Z DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi JAHANGIR, Alam REUTER, Deborah Carol D0RV2Z DRUGTYPE Small molecular drug D0RV2Z DRUGINCH 1S/C20H23N9O2S/c1-13-16(12-22-25-13)15-4-3-5-17-19(15)26-27-29(17)18-6-9-21-20(24-18)23-14-7-10-28(11-8-14)32(2,30)31/h3-6,9,12,14H,7-8,10-11H2,1-2H3,(H,22,25)(H,21,23,24) D0RV2Z DRUGINKE VBKBWWKTPBEGBH-UHFFFAOYSA-N D0RV2Z DRUGSMIL CC1=C(C=NN1)C2=C3C(=CC=C2)N(N=N3)C4=NC(=NC=C4)NC5CCN(CC5)S(=O)(=O)C D0RV2Z HIGHSTAT Patented D0RV9D DRUG__ID D0RV9D D0RV9D DRUGCOMP IMPACT THERAPEUTICS, INC. CAI, Suixiong TIAN, Ye Edward WANG, Xiaozhu XIE, Kai LI, Sicun YU, Zenghui GU, Chengyun LIU, Lijun D0RV9D DRUGTYPE Small molecular drug D0RV9D DRUGINCH 1S/C26H24ClN5O3/c1-14(2)35-16-6-8-21-22(11-16)32-26(31-21)18-9-15(5-7-20(18)27)30-25-19-10-17(33-3)12-23(34-4)24(19)28-13-29-25/h5-14H,1-4H3,(H,31,32)(H,28,29,30) D0RV9D DRUGINKE UTABPCPBPRTBQJ-UHFFFAOYSA-N D0RV9D DRUGSMIL CC(C)OC1=CC2=C(C=C1)N=C(N2)C3=C(C=CC(=C3)NC4=NC=NC5=C4C=C(C=C5OC)OC)Cl D0RV9D HIGHSTAT Patented D0RX0M DRUG__ID D0RX0M D0RX0M DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0RX0M DRUGTYPE Small molecular drug D0RX0M DRUGINCH 1S/C19H11ClF3N5O3S/c20-12-6-4-10(5-7-12)14-9-15(19(21,22)23)26-16(25-14)17-27-18(31-28-17)11-2-1-3-13(8-11)32(24,29)30/h1-9H,(H2,24,29,30) D0RX0M DRUGINKE BODKDPJDJKXVIU-UHFFFAOYSA-N D0RX0M DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)C2=NC(=NO2)C3=NC(=CC(=N3)C(F)(F)F)C4=CC=C(C=C4)Cl D0RX0M HIGHSTAT Patented D0RX2U DRUG__ID D0RX2U D0RX2U DRUGCOMP GLAXOSMITHKLINE LLC QIN, Donghui CHRISTENSEN, IV, Siegfried Benjamin WU, Chengde ZHANG, Zhiliu YU, Haiyu YUAN, Jiangxing LIN, Xiaojuan XU, Shanli LV, Maoyun YAO, Chen LI, Lei HUANG, Xing GAO, Min D0RX2U DRUGTYPE Small molecular drug D0RX2U DRUGINCH 1S/C28H32ClN3O2/c1-20(2)31-13-12-30-18-22-3-6-24-16-26(10-7-23(24)15-22)32-14-11-27(17-28(32)33)34-19-21-4-8-25(29)9-5-21/h3-6,8-9,11,14-17,20,30-31H,7,10,12-13,18-19H2,1-2H3 D0RX2U DRUGINKE SCTPFHKOHPCDLG-UHFFFAOYSA-N D0RX2U DRUGSMIL CC(C)NCCNCC1=CC2=C(C=C1)C=C(CC2)N3C=CC(=CC3=O)OCC4=CC=C(C=C4)Cl D0RX2U HIGHSTAT Patented D0RY9R DRUG__ID D0RY9R D0RY9R DRUGCOMP Takeda Pharmaceutical Co. Ltd D0RY9R DRUGTYPE Small molecular drug D0RY9R DRUGINCH 1S/C18H12F3N5O2/c19-18(20,21)12-6-13(14-8-22-10-28-14)15-24-25-16(26(15)9-12)17(27)23-7-11-4-2-1-3-5-11/h1-6,8-10H,7H2,(H,23,27) D0RY9R DRUGINKE QZZRSTUQIGEDKT-UHFFFAOYSA-N D0RY9R DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=NN=C3N2C=C(C=C3C4=CN=CO4)C(F)(F)F D0RY9R HIGHSTAT Patented D0S0EM DRUG__ID D0S0EM D0S0EM DRUGCOMP National Taiwan University D0S0EM DRUGTYPE Small molecular drug D0S0EM DRUGINCH 1S/C15H10O7/c16-8-3-1-6(5-10(8)18)14-13(21)11(19)7-2-4-9(17)12(20)15(7)22-14/h1-5,16-18,20-21H D0S0EM DRUGINKE RHTZDFORBKRGQU-UHFFFAOYSA-N D0S0EM DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3)O)O)O)O)O D0S0EM HIGHSTAT Patented D0S0VF DRUG__ID D0S0VF D0S0VF DRUGCOMP LES LABORATOIRES SERVIER D0S0VF DRUGTYPE Small molecular drug D0S0VF DRUGINCH 1S/C18H14F2N2O/c1-10(21)12-7-15(19)17(16(20)8-12)18(23)14-4-2-3-11-9-22-6-5-13(11)14/h2-10H,21H2,1H3 D0S0VF DRUGINKE MZQREGYHCORZLY-UHFFFAOYSA-N D0S0VF DRUGSMIL CC(C1=CC(=C(C(=C1)F)C(=O)C2=CC=CC3=C2C=CN=C3)F)N D0S0VF HIGHSTAT Patented D0S2SS DRUG__ID D0S2SS D0S2SS DRUGCOMP TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED D0S2SS DRUGTYPE Small molecular drug D0S2SS DRUGINCH 1S/C19H19N3O2/c1-3-22(4-2)19(23)24-18-15-12-8-9-13-16(15)20-17(21-18)14-10-6-5-7-11-14/h5-13H,3-4H2,1-2H3 D0S2SS DRUGINKE VZRHWILGJDZNKG-UHFFFAOYSA-N D0S2SS DRUGSMIL CCN(CC)C(=O)OC1=NC(=NC2=CC=CC=C21)C3=CC=CC=C3 D0S2SS HIGHSTAT Patented D0S3RX DRUG__ID D0S3RX D0S3RX DRUGTYPE Small molecular drug D0S3RX DRUGINCH 1S/C20H17Cl4N3O2/c1-2-3-8-29-18(28)11-27-25-19(14-6-4-12(21)9-16(14)23)20(26-27)15-7-5-13(22)10-17(15)24/h4-7,9-10H,2-3,8,11H2,1H3 D0S3RX DRUGINKE JHYLDWFPNBXQGK-UHFFFAOYSA-N D0S3RX DRUGSMIL CCCCOC(=O)CN1N=C(C(=N1)C2=C(C=C(C=C2)Cl)Cl)C3=C(C=C(C=C3)Cl)Cl D0S3RX HIGHSTAT Patented D0S3RX COMPCLAS 1,2,3-triazole derivatives D0S4OP DRUG__ID D0S4OP D0S4OP DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0S4OP DRUGTYPE Small molecular drug D0S4OP DRUGINCH 1S/C33H38N6O2/c1-21(2)39-20-25-8-6-4-5-7-23-15-22(3)37-33(41)28(23)19-36-32(40)27-16-26(17-29(39)31(25)27)24-9-10-30(35-18-24)38-13-11-34-12-14-38/h4,6,9-10,15-18,20-21,34H,5,7-8,11-14,19H2,1-3H3,(H,36,40)(H,37,41)/b6-4+ D0S4OP DRUGINKE GMAFAVDEQFGQCC-GQCTYLIASA-N D0S4OP DRUGSMIL CC1=CC2=C(CNC(=O)C3=C4C(=CN(C4=CC(=C3)C5=CN=C(C=C5)N6CCNCC6)C(C)C)CC=CCC2)C(=O)N1 D0S4OP HIGHSTAT Patented D0S5NS DRUG__ID D0S5NS D0S5NS DRUGTYPE Small molecular drug D0S5NS DRUGINCH 1S/C22H20Cl2N4OS/c1-5-6-15-8-10-18(30-15)20-13(4)19(22-25-21(12(2)3)27-29-22)26-28(20)17-9-7-14(23)11-16(17)24/h5-12H,1-4H3/b6-5+ D0S5NS DRUGINKE WDHLKRONMIKUBC-AATRIKPKSA-N D0S5NS DRUGSMIL CC=CC1=CC=C(S1)C2=C(C(=NN2C3=C(C=C(C=C3)Cl)Cl)C4=NC(=NO4)C(C)C)C D0S5NS HIGHSTAT Patented D0S5NS COMPCLAS Pyrazole derivatives D0S6DD DRUG__ID D0S6DD D0S6DD DRUGCOMP MERCK SHARP &amDOHME CORP. LIN, Linus SOLL, Richard DONG, Jingchao WU, Hao SUZUKI, Takao HU, Bin LIU, Dejun HAO, Jinglai XU, Ming D0S6DD DRUGTYPE Small molecular drug D0S6DD DRUGINCH 1S/C23H22FNO4/c1-16-12-19(6-7-21(16)29-15-23(27)9-10-23)25-11-8-20(13-22(25)26)28-14-17-2-4-18(24)5-3-17/h2-8,11-13,27H,9-10,14-15H2,1H3 D0S6DD DRUGINKE DSXGYSJOEHCCMA-UHFFFAOYSA-N D0S6DD DRUGSMIL CC1=C(C=CC(=C1)N2C=CC(=CC2=O)OCC3=CC=C(C=C3)F)OCC4(CC4)O D0S6DD HIGHSTAT Patented D0S9NB DRUG__ID D0S9NB D0S9NB DRUGTYPE Small molecular drug D0S9NB DRUGINCH 1S/C21H14ClF3N6O2/c1-11-17(15-7-8-28-31(15)16-6-5-13(22)10-27-16)29-18(19(26)32)20(33)30(11)14-4-2-3-12(9-14)21(23,24)25/h2-10H,1H3,(H2,26,32) D0S9NB DRUGINKE DZKSYFBPXVHKDO-UHFFFAOYSA-N D0S9NB DRUGSMIL CC1=C(N=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)N)C3=CC=NN3C4=NC=C(C=C4)Cl D0S9NB HIGHSTAT Patented D0S9NB COMPCLAS 2-pyrazinone derivatives D0SA1N DRUG__ID D0SA1N D0SA1N DRUGCOMP FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA UNIVERSIDAD AUTONOMA DE MADRID DNS NEUROSCIENCE D0SA1N DRUGTYPE Small molecular drug D0SA1N DRUGINCH 1S/C21H19N3O5/c1-14(25)22-11-10-16-13-23-20-8-7-18(12-19(16)20)29-21(26)9-4-15-2-5-17(6-3-15)24(27)28/h2-9,12-13,23H,10-11H2,1H3,(H,22,25)/b9-4+ D0SA1N DRUGINKE HAJBAZSPWITWPC-RUDMXATFSA-N D0SA1N DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC(=O)C=CC3=CC=C(C=C3)[N+](=O)[O-] D0SA1N HIGHSTAT Patented D0SB3H DRUG__ID D0SB3H D0SB3H DRUGCOMP KYORIN PHARMACEUTICAL CO., LTD D0SB3H DRUGTYPE Small molecular drug D0SB3H DRUGINCH 1S/C32H38N6O3/c1-4-41-29-19-22(31(39)38-17-13-23(14-18-38)37-15-7-8-16-37)11-12-25(29)34-30-20-27-28(21-33-30)36(3)32(40)24-9-5-6-10-26(24)35(27)2/h5-6,9-12,19-21,23H,4,7-8,13-18H2,1-3H3,(H,33,34) D0SB3H DRUGINKE CBWCJYFVVHOTAZ-UHFFFAOYSA-N D0SB3H DRUGSMIL CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCCC3)NC4=NC=C5C(=C4)N(C6=CC=CC=C6C(=O)N5C)C D0SB3H HIGHSTAT Patented D0SD4G DRUG__ID D0SD4G D0SD4G DRUGCOMP ABBOTT LABORATORIES D0SD4G DRUGTYPE Small molecular drug D0SD4G DRUGINCH 1S/C23H20F5N3O3/c1-13-8-16-14(10-29-13)4-2-6-17(16)30-21(32)31-18-9-22(11-24,12-25)34-20-15(18)5-3-7-19(20)33-23(26,27)28/h2-8,10,18H,9,11-12H2,1H3,(H2,30,31,32)/t18-/m1/s1 D0SD4G DRUGINKE NCTHKPLEGMZRNY-GOSISDBHSA-N D0SD4G DRUGSMIL CC1=CC2=C(C=CC=C2NC(=O)NC3CC(OC4=C3C=CC=C4OC(F)(F)F)(CF)CF)C=N1 D0SD4G HIGHSTAT Patented D0SD9L DRUG__ID D0SD9L D0SD9L DRUGCOMP UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette D0SD9L DRUGTYPE Small molecular drug D0SD9L DRUGINCH 1S/C14H23NO2/c1-11(2)7-8-15-10-12-5-6-13(16-3)14(9-12)17-4/h5-6,9,11,15H,7-8,10H2,1-4H3 D0SD9L DRUGINKE BDUIJHAHSRAUGH-UHFFFAOYSA-N D0SD9L DRUGSMIL CC(C)CCNCC1=CC(=C(C=C1)OC)OC D0SD9L HIGHSTAT Patented D0SF6C DRUG__ID D0SF6C D0SF6C DRUGTYPE Small molecular drug D0SF6C DRUGINCH 1S/C17H17NO5/c19-13-4-1-11(9-15(13)21)3-6-17(23)18-8-7-12-2-5-14(20)16(22)10-12/h1-6,9-10,19-22H,7-8H2,(H,18,23)/b6-3+ D0SF6C DRUGINKE FSMGGLPUXCKRGT-ZZXKWVIFSA-N D0SF6C DRUGSMIL C1=CC(=C(C=C1CCNC(=O)C=CC2=CC(=C(C=C2)O)O)O)O D0SF6C HIGHSTAT Patented D0SF6C COMPCLAS P-coumaric acid derivatives D0SG8X DRUG__ID D0SG8X D0SG8X DRUGCOMP LAUNIER, Benoi D0SG8X DRUGTYPE Small molecular drug D0SG8X DRUGINCH 1S/C17H28N2O/c1-3-4-5-8-11-18-12-14-19(15-13-18)16-9-6-7-10-17(16)20-2/h6-7,9-10H,3-5,8,11-15H2,1-2H3 D0SG8X DRUGINKE QLLNEODTUOCQKR-UHFFFAOYSA-N D0SG8X DRUGSMIL CCCCCCN1CCN(CC1)C2=CC=CC=C2OC D0SG8X HIGHSTAT Patented D0SG9W DRUG__ID D0SG9W D0SG9W DRUGCOMP COGNITION THERAPEUTICS, INC. CATALANO, Susan, M. RISHTON, Gilbert IZZO, Nicholas, J D0SG9W DRUGTYPE Small molecular drug D0SG9W DRUGINCH 1S/C19H22F3NO2/c1-13(3-4-14-7-10-17(24)18(11-14)25-2)23-12-15-5-8-16(9-6-15)19(20,21)22/h5-11,13,23-24H,3-4,12H2,1-2H3 D0SG9W DRUGINKE JWMMMNZRBWMHKZ-UHFFFAOYSA-N D0SG9W DRUGSMIL CC(CCC1=CC(=C(C=C1)O)OC)NCC2=CC=C(C=C2)C(F)(F)F D0SG9W HIGHSTAT Patented D0SJ4S DRUG__ID D0SJ4S D0SJ4S DRUGTYPE Small molecular drug D0SJ4S DRUGINCH 1S/C17H17NO4/c19-14-5-1-12(2-6-14)9-10-18-17(22)8-4-13-3-7-15(20)16(21)11-13/h1-8,11,19-21H,9-10H2,(H,18,22)/b8-4+ D0SJ4S DRUGINKE VSHUQLRHTJOKTA-XBXARRHUSA-N D0SJ4S DRUGSMIL C1=CC(=CC=C1CCNC(=O)C=CC2=CC(=C(C=C2)O)O)O D0SJ4S HIGHSTAT Patented D0SJ4S COMPCLAS P-coumaric acid derivatives D0SM9Y DRUG__ID D0SM9Y D0SM9Y DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D0SM9Y DRUGTYPE Small molecular drug D0SM9Y DRUGINCH 1S/C21H19N7O2/c1-13(29)25-20-5-3-16(10-24-20)26-21-23-7-6-18(27-21)14-2-4-19(15(8-14)9-22)28-11-17(30)12-28/h2-8,10,17,30H,11-12H2,1H3,(H,23,26,27)(H,24,25,29) D0SM9Y DRUGINKE ULOABNKVPRZZBK-UHFFFAOYSA-N D0SM9Y DRUGSMIL CC(=O)NC1=NC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)N4CC(C4)O)C#N D0SM9Y HIGHSTAT Patented D0SP7T DRUG__ID D0SP7T D0SP7T DRUGCOMP CHDI FOUNDATION, INC D0SP7T DRUGTYPE Small molecular drug D0SP7T DRUGINCH 1S/C21H15F4N3O2/c22-20(19(29)28-30)16(12-4-2-1-3-5-12)17(20)13-6-8-14(9-7-13)18-26-11-10-15(27-18)21(23,24)25/h1-11,16-17,30H,(H,28,29)/t16-,17-,20+/m1/s1 D0SP7T DRUGINKE DDTXYXHMSVMLET-HLIPFELVSA-N D0SP7T DRUGSMIL C1=CC=C(C=C1)C2C(C2(C(=O)NO)F)C3=CC=C(C=C3)C4=NC=CC(=N4)C(F)(F)F D0SP7T HIGHSTAT Patented D0SQ0F DRUG__ID D0SQ0F D0SQ0F DRUGCOMP SignalRx Pharmaceuticals, Inc D0SQ0F DRUGTYPE Small molecular drug D0SQ0F DRUGINCH 1S/C16H14N4O3/c21-13-8-4-5-9-19(13)16-18-14(22)12-10-17-20(15(12)23-16)11-6-2-1-3-7-11/h1-3,6-7,10H,4-5,8-9H2 D0SQ0F DRUGINKE GHCGOVANSHYUTA-UHFFFAOYSA-N D0SQ0F DRUGSMIL C1CCN(C(=O)C1)C2=NC(=O)C3=C(O2)N(N=C3)C4=CC=CC=C4 D0SQ0F HIGHSTAT Patented D0SR0U DRUG__ID D0SR0U D0SR0U DRUGTYPE Small molecular drug D0SR0U DRUGINCH 1S/C37H34F5N7O3/c38-24-13-25(27(18-50)31(14-24)49-9-10-52-32-12-23(22-2-3-22)11-28(39)33(32)36(49)51)34-26-15-30(46-35(26)45-20-44-34)29-4-1-21(16-43-29)17-47-5-7-48(8-6-47)19-37(40,41)42/h1,4,11-16,20,22,50H,2-3,5-10,17-19H2,(H,44,45,46) D0SR0U DRUGINKE TYFKEORPONMRPY-UHFFFAOYSA-N D0SR0U DRUGSMIL C1CC1C2=CC3=C(C(=C2)F)C(=O)N(CCO3)C4=CC(=CC(=C4CO)C5=C6C=C(NC6=NC=N5)C7=NC=C(C=C7)CN8CCN(CC8)CC(F)(F)F)F D0SR0U HIGHSTAT Patented D0SR0U COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0SV2E DRUG__ID D0SV2E D0SV2E DRUGCOMP LEAD DISCOVERY CENTER GMBH MAX-PLANCK-GESELLSCHAFT ZUR FDERUNG DER WISSENSCHAFTEN E.V. CHOIDAS, Axel KLEBL, Bert HABENBERGER, Peter EICKHOFF, Jan THOMAS, Roman HEUCKMANN, Johannes D0SV2E DRUGTYPE Small molecular drug D0SV2E DRUGINCH 1S/C17H17N5O3S/c1-25-15-8-3-2-7-14(15)16-19-11-20-17(22-16)21-13-6-4-5-12(9-13)10-26(18,23)24/h2-9,11H,10H2,1H3,(H2,18,23,24)(H,19,20,21,22) D0SV2E DRUGINKE BQJUSTFHSZCQFK-UHFFFAOYSA-N D0SV2E DRUGSMIL COC1=CC=CC=C1C2=NC(=NC=N2)NC3=CC=CC(=C3)CS(=O)(=O)N D0SV2E HIGHSTAT Patented D0SY6J DRUG__ID D0SY6J D0SY6J DRUGCOMP Kissei Pharmaceutical Co. Ltd D0SY6J DRUGTYPE Small molecular drug D0SY6J DRUGINCH 1S/C14H11N3O4S/c1-7-12(14(18)19)22-13(15-7)9-5-8-3-4-16(2)11(8)10(6-9)17(20)21/h3-6H,1-2H3,(H,18,19) D0SY6J DRUGINKE YGQCHVOXQFVYAB-UHFFFAOYSA-N D0SY6J DRUGSMIL CC1=C(SC(=N1)C2=CC(=C3C(=C2)C=CN3C)[N+](=O)[O-])C(=O)O D0SY6J HIGHSTAT Patented D0SZ5A DRUG__ID D0SZ5A D0SZ5A DRUGCOMP MERZ PHARMA GMBH & CO. KGAA RUSS, Hermann BORTA, Andreas HEERS, Cara HAUPTMEIER, Bernhard BODERKE, Peter PURMANN, Brigitte TARDT, AxeMERZ PHARMA GMBH & CO. KGAA DANYSZ, Wojciech DEKUNDY, Andrzej HECHENBERGER, Mirko HENRICH, Markus JATZKE, Claudia NAGEL, Jens PARSONS, Christopher Graham Raphael WEIL, Tanja MLER, Sibylle FOTINS, Juris GUTCAITS, Aleksandra ZEMRIBO, Ronalds KAUSS, Valerjans KAULINA, Larisa ERDMANE, Elina D0SZ5A DRUGTYPE Small molecular drug D0SZ5A DRUGINCH 1S/C17H15BrN4O/c1-11-14-5-3-2-4-12(14)6-7-21(11)17(23)15-8-16-19-9-13(18)10-22(16)20-15/h2-5,8-11H,6-7H2,1H3/t11-/m1/s1 D0SZ5A DRUGINKE TUYZYSNXXSTKQX-LLVKDONJSA-N D0SZ5A DRUGSMIL CC1C2=CC=CC=C2CCN1C(=O)C3=NN4C=C(C=NC4=C3)Br D0SZ5A HIGHSTAT Patented D0T0RV DRUG__ID D0T0RV D0T0RV DRUGCOMP AMAKEM NV D0T0RV DRUGTYPE Small molecular drug D0T0RV DRUGINCH 1S/C30H25FN4O4S/c31-25-17-33-12-10-26(25)35-29(37)20-4-5-21(16-32)24(15-20)19-2-1-3-22(14-19)34-28(36)18-6-8-23(9-7-18)40-27-11-13-39-30(27)38/h1-10,12,14-15,17,27H,11,13,16,32H2,(H,34,36)(H,33,35,37) D0T0RV DRUGINKE QKLHHIYLYLZRFM-UHFFFAOYSA-N D0T0RV DRUGSMIL C1COC(=O)C1SC2=CC=C(C=C2)C(=O)NC3=CC=CC(=C3)C4=C(C=CC(=C4)C(=O)NC5=C(C=NC=C5)F)CN D0T0RV HIGHSTAT Patented D0T1JN DRUG__ID D0T1JN D0T1JN DRUGCOMP AXXAM S.P.A D0T1JN DRUGTYPE Small molecular drug D0T1JN DRUGINCH 1S/C18H20ClF2N3OS/c1-12-3-2-4-13(19)16(12)17(25)23-9-14(15-10-22-11-26-15)24-7-5-18(20,21)6-8-24/h2-4,10-11,14H,5-9H2,1H3,(H,23,25) D0T1JN DRUGINKE WADLCIPMWTXETG-UHFFFAOYSA-N D0T1JN DRUGSMIL CC1=C(C(=CC=C1)Cl)C(=O)NCC(C2=CN=CS2)N3CCC(CC3)(F)F D0T1JN HIGHSTAT Patented D0T2LN DRUG__ID D0T2LN D0T2LN DRUGCOMP THE JOHNS HOPKINS UNIVERSITY The National Institutes of Health D0T2LN DRUGTYPE Small molecular drug D0T2LN DRUGINCH 1S/C22H14F3N3O4S/c23-22(24,25)15-6-4-13(5-7-15)10-17-12-26-21(33-17)27-20(29)19-9-8-18(32-19)14-2-1-3-16(11-14)28(30)31/h1-9,11-12H,10H2,(H,26,27,29) D0T2LN DRUGINKE GIUVRWFYNOIRLR-UHFFFAOYSA-N D0T2LN DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC=C(O2)C(=O)NC3=NC=C(S3)CC4=CC=C(C=C4)C(F)(F)F D0T2LN HIGHSTAT Patented D0T2OX DRUG__ID D0T2OX D0T2OX DRUGCOMP ABBVIE INC D0T2OX DRUGTYPE Small molecular drug D0T2OX DRUGINCH 1S/C27H27F3N6O2/c1-16(27(28,29)30)38-23-15-18(13-21-24(23)25(31)34-33-21)17-7-8-20(26(32)37)22(14-17)36-11-9-35(10-12-36)19-5-3-2-4-6-19/h2-8,13-16H,9-12H2,1H3,(H2,32,37)(H3,31,33,34) D0T2OX DRUGINKE NRNLAILVLWFKCG-UHFFFAOYSA-N D0T2OX DRUGSMIL CC(C(F)(F)F)OC1=CC(=CC2=C1C(=NN2)N)C3=CC(=C(C=C3)C(=O)N)N4CCN(CC4)C5=CC=CC=C5 D0T2OX HIGHSTAT Patented D0T3TZ DRUG__ID D0T3TZ D0T3TZ DRUGCOMP TESARO, INCAMGEN INC. BOEZIO, Christiane M. CHENG, Alan, C. CHOQUETTE, Deborah LEWIS, Richard, T. POTASHMAN, Michele, H. ROMERO, Karina STELLWAGEN, John, C. WHITTINGTON, Douglas, A D0T3TZ DRUGTYPE Small molecular drug D0T3TZ DRUGINCH 1S/C33H44FN5O3/c1-21(2)35-30(40)24-8-12-27(13-9-24)39-29-19-22(20-38-17-15-25(16-18-38)33(3,4)42)5-14-28(29)36-32(39)37-31(41)23-6-10-26(34)11-7-23/h5-7,10-11,14,19,21,24-25,27,42H,8-9,12-13,15-18,20H2,1-4H3,(H,35,40)(H,36,37,41) D0T3TZ DRUGINKE WSTUJEXAPHIEIM-UHFFFAOYSA-N D0T3TZ DRUGSMIL CC(C)NC(=O)C1CCC(CC1)N2C3=C(C=CC(=C3)CN4CCC(CC4)C(C)(C)O)N=C2NC(=O)C5=CC=C(C=C5)F D0T3TZ HIGHSTAT Patented D0T5OF DRUG__ID D0T5OF D0T5OF DRUGCOMP ARRAY BIOPHARMA INC D0T5OF DRUGTYPE Small molecular drug D0T5OF DRUGINCH 1S/C29H31F2N7O2/c1-18-27(21-14-32-19(2)33-15-21)36-38(22-7-5-4-6-8-22)28(18)35-29(39)34-26-17-37(11-12-40-3)16-23(26)20-9-10-24(30)25(31)13-20/h4-10,13-15,23,26H,11-12,16-17H2,1-3H3,(H2,34,35,39)/t23-,26+/m0/s1 D0T5OF DRUGINKE HMZMJVUIFWVPPL-JYFHCDHNSA-N D0T5OF DRUGSMIL CC1=C(N(N=C1C2=CN=C(N=C2)C)C3=CC=CC=C3)NC(=O)NC4CN(CC4C5=CC(=C(C=C5)F)F)CCOC D0T5OF HIGHSTAT Patented D0T6SP DRUG__ID D0T6SP D0T6SP DRUGCOMP NEOPHARM CO.,LTD. ( ) GWAK, Hyung Sub KIM, Yong Zu KIM, Uk Il PARK, Byeong Deog PARK, Tae Kyo WOO, Sung Ho D0T6SP DRUGTYPE Small molecular drug D0T6SP DRUGINCH 1S/C21H23N3O/c1-15-7-6-8-17(13-15)20-16(2)22-19-10-9-18(14-24(19)20)21(25)23-11-4-3-5-12-23/h6-10,13-14H,3-5,11-12H2,1-2H3 D0T6SP DRUGINKE RKISYXMPLQOYPU-UHFFFAOYSA-N D0T6SP DRUGSMIL CC1=CC(=CC=C1)C2=C(N=C3N2C=C(C=C3)C(=O)N4CCCCC4)C D0T6SP HIGHSTAT Patented D0T6UX DRUG__ID D0T6UX D0T6UX DRUGCOMP GLAXOSMITHKLINE LLC QIN, Donghui CHRISTENSEN, Sieg WU, Chengde ZHANG, Zhiliu YU, Haiyu YUAN, Jiangxing D0T6UX DRUGTYPE Small molecular drug D0T6UX DRUGINCH 1S/C26H29N3O4S2/c1-18-17-34-25(28-18)16-33-24-6-9-29(26(30)14-24)23-5-4-20-12-19(2-3-21(20)13-23)15-27-22-7-10-35(31,32)11-8-22/h2-3,6,9,12-14,17,22,27H,4-5,7-8,10-11,15-16H2,1H3 D0T6UX DRUGINKE XVQJOVCBLFUQMO-UHFFFAOYSA-N D0T6UX DRUGSMIL CC1=CSC(=N1)COC2=CC(=O)N(C=C2)C3=CC4=C(CC3)C=C(C=C4)CNC5CCS(=O)(=O)CC5 D0T6UX HIGHSTAT Patented D0T7HK DRUG__ID D0T7HK D0T7HK DRUGTYPE Small molecular drug D0T7HK DRUGINCH 1S/C31H30N6O/c32-21-23-6-11-29-28(20-23)24(22-34-29)4-1-2-14-35-16-18-36(19-17-35)25-7-9-26(10-8-25)37-15-12-30-27(31(37)38)5-3-13-33-30/h3,5-13,15,20,22,34H,1-2,4,14,16-19H2 D0T7HK DRUGINKE FGYLPIJGSRWQAL-UHFFFAOYSA-N D0T7HK DRUGSMIL C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC=C(C=C4)N5C=CC6=C(C5=O)C=CC=N6 D0T7HK HIGHSTAT Patented D0T7HK COMPCLAS Aryl piperazine derivatives D0T8VE DRUG__ID D0T8VE D0T8VE DRUGTYPE Small molecular drug D0T8VE DRUGINCH 1S/C26H24Cl2F2N2O4S/c1-3-36-26(33)25-23(32(37(2,34)35)22-13-20(29)12-21(30)14-22)15-31(25)24(16-4-8-18(27)9-5-16)17-6-10-19(28)11-7-17/h4-14,23-25H,3,15H2,1-2H3 D0T8VE DRUGINKE LOJPJQZCZJCZBS-UHFFFAOYSA-N D0T8VE DRUGSMIL CCOC(=O)C1C(CN1C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)N(C4=CC(=CC(=C4)F)F)S(=O)(=O)C D0T8VE HIGHSTAT Patented D0T8VE COMPCLAS Aminoazetidine derivatives D0T8XD DRUG__ID D0T8XD D0T8XD DRUGTYPE Small molecular drug D0T8XD DRUGINCH 1S/C24H24FN5O/c1-16(18-3-2-4-19(25)13-18)28-23-9-10-24-27-14-22(30(24)29-23)17-5-7-21(8-6-17)31-15-20-11-12-26-20/h2-10,13-14,16,20,26H,11-12,15H2,1H3,(H,28,29)/t16-,20+/m1/s1 D0T8XD DRUGINKE FQCGOBGLJQWKJA-UZLBHIALSA-N D0T8XD DRUGSMIL CC(C1=CC(=CC=C1)F)NC2=NN3C(=NC=C3C4=CC=C(C=C4)OCC5CCN5)C=C2 D0T8XD HIGHSTAT Patented D0T8XD COMPCLAS Imidazo[1,2-b]pyridazine derivatives D0T9ZO DRUG__ID D0T9ZO D0T9ZO DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0T9ZO DRUGTYPE Small molecular drug D0T9ZO DRUGINCH 1S/C26H36N6O4S/c1-18-26(33)31(3)23-7-8-24(28-25(23)32(18)21-11-15-36-16-12-21)27-20-5-4-6-22(17-20)37(34,35)29-19-9-13-30(2)14-10-19/h4-8,17-19,21,29H,9-16H2,1-3H3,(H,27,28)/t18-/m1/s1 D0T9ZO DRUGINKE NYFZHTKDUXWZDU-GOSISDBHSA-N D0T9ZO DRUGSMIL CC1C(=O)N(C2=C(N1C3CCOCC3)N=C(C=C2)NC4=CC(=CC=C4)S(=O)(=O)NC5CCN(CC5)C)C D0T9ZO HIGHSTAT Patented D0TA4N DRUG__ID D0TA4N D0TA4N DRUGCOMP EPIZYME, INC D0TA4N DRUGTYPE Small molecular drug D0TA4N DRUGINCH 1S/C30H39N7O2/c1-6-20(4)36-18-19(3)28-24(29(38)33-17-25-21(5)37(7-2)34-30(25)39)14-23(15-26(28)36)22-8-9-27(32-16-22)35-12-10-31-11-13-35/h8-9,14-16,18,20,31H,6-7,10-13,17H2,1-5H3,(H,33,38)(H,34,39) D0TA4N DRUGINKE MQDSSXUQHUNJLJ-UHFFFAOYSA-N D0TA4N DRUGSMIL CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(N(NC5=O)CC)C)C D0TA4N HIGHSTAT Patented D0TB2L DRUG__ID D0TB2L D0TB2L DRUGCOMP BAYER SCHERING PHARMA AKTIENGESELLSCHAFT LEHMANN, Lutz THIELE, Andrea HEINRICH, Tobias VOLLMER, Sonja D0TB2L DRUGTYPE Small molecular drug D0TB2L DRUGINCH 1S/C25H27FN2O4/c1-17-7-5-9-23(18(17)2)32-25-22(8-6-13-27-25)28(19(3)29)16-20-15-21(30-4)10-11-24(20)31-14-12-26/h5-11,13,15H,12,14,16H2,1-4H3/i26-1 D0TB2L DRUGINKE JBDICOKSGXRRSY-KPVNRNJOSA-N D0TB2L DRUGSMIL CC1=C(C(=CC=C1)OC2=C(C=CC=N2)N(CC3=C(C=CC(=C3)OC)OCCF)C(=O)C)C D0TB2L HIGHSTAT Patented D0TC7X DRUG__ID D0TC7X D0TC7X DRUGCOMP LUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar TALE, Prashant, Vitthalrao CHEEMALA, Narasimha, Murthy MAHANGARE, Sachin, Jaysing VIDHATE, Prashant, Popatrao KULKARNI, Chaitanya, Prabhakar PATEL, Sapana, Suresh PATIL, Amolsing, Dattu ZADE, Seema, Prabhakar SHINDE, Rohan, Mahadev PALLE, Venkata, P. KAMBOJ, Rajender, KumaLUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar MAHANGARE, Sachin, Jaysing TALE, Prashant, Vitthalrao ZADE, Seema, Prabhakar PATIL, Amolsing, Dattu CHEEMALA, Narasimha, Murthy PALLE, Venkata, P. KAMBOJ, Rajender, KumaLUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar TALE, Prashant, Vitthalrao CHEEMALA, Narasimha, Murthy MAHANGARE, Sachin, Jaysing VIDHATE, Prashant, Popatrao KULKARNI, Chaitanya, Prabhakar PATEL, Sapana, Suresh PATIL, Amolsing, Dattu SHINDE, Rohan, Mahadev PALLE, Venkata, P. KAMBOJ, Rajender, Kumar D0TC7X DRUGTYPE Small molecular drug D0TC7X DRUGINCH 1S/C22H22ClN3O/c1-15-7-5-10-18-20(15)19(22(27)26-11-3-2-4-12-26)14-24-21(18)25-17-9-6-8-16(23)13-17/h5-10,13-14H,2-4,11-12H2,1H3,(H,24,25) D0TC7X DRUGINKE RSQQKPIPFGRLQX-UHFFFAOYSA-N D0TC7X DRUGSMIL CC1=C2C(=CC=C1)C(=NC=C2C(=O)N3CCCCC3)NC4=CC(=CC=C4)Cl D0TC7X HIGHSTAT Patented D0TE2D DRUG__ID D0TE2D D0TE2D DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED WANG, Rong LU, Hongtao D0TE2D DRUGTYPE Small molecular drug D0TE2D DRUGINCH 1S/C19H23N3O3/c1-2-15(3-1)22-8-6-13(7-9-22)10-18-20-19(21-25-18)14-4-5-16-17(11-14)24-12-23-16/h4-5,11,13,15H,1-3,6-10,12H2 D0TE2D DRUGINKE ATGQONNRRWKPGJ-UHFFFAOYSA-N D0TE2D DRUGSMIL C1CC(C1)N2CCC(CC2)CC3=NC(=NO3)C4=CC5=C(C=C4)OCO5 D0TE2D HIGHSTAT Patented D0TH3L DRUG__ID D0TH3L D0TH3L DRUGCOMP KARUS THERAPEUTICS LTD D0TH3L DRUGTYPE Small molecular drug D0TH3L DRUGINCH 1S/C16H11F4N5O2S/c17-11-5-6-12(21-7-11)25(15-22-14(24-28-15)16(18,19)20)8-9-1-3-10(4-2-9)13(26)23-27/h1-7,27H,8H2,(H,23,26) D0TH3L DRUGINKE XGHLBDLYNQPBIS-UHFFFAOYSA-N D0TH3L DRUGSMIL C1=CC(=CC=C1CN(C2=NC=C(C=C2)F)C3=NC(=NS3)C(F)(F)F)C(=O)NO D0TH3L HIGHSTAT Patented D0TH5W DRUG__ID D0TH5W D0TH5W DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0TH5W DRUGTYPE Small molecular drug D0TH5W DRUGINCH 1S/C25H25N3O3/c26-14-18-1-3-20-13-22(5-4-19(20)12-18)28-10-9-27(15-24(28)29)8-7-17-2-6-23-21(11-17)16-31-25(23)30/h1-3,6,11-12,22H,4-5,7-10,13,15-16H2 D0TH5W DRUGINKE IXHFMRBAJKIWFU-UHFFFAOYSA-N D0TH5W DRUGSMIL C1CC2=C(CC1N3CCN(CC3=O)CCC4=CC5=C(C=C4)C(=O)OC5)C=CC(=C2)C#N D0TH5W HIGHSTAT Patented D0TH6M DRUG__ID D0TH6M D0TH6M DRUGCOMP ELI LILLY AND COMPANY GENIN, Michael, James AGEJAS-CHICHARRO, Francisco, Javier BUENO MELENDO, Ana, Belen MANNINEN, Peter, Rudolph WARSHAWSKY, Alan, M D0TH6M DRUGTYPE Small molecular drug D0TH6M DRUGINCH 1S/C28H27Cl2N3O4/c1-32-14-20(28(34)35)19-8-7-17(13-24(19)32)33-11-9-18(10-12-33)36-15-21-26(31-37-27(21)16-5-6-16)25-22(29)3-2-4-23(25)30/h2-4,7-8,13-14,16,18H,5-6,9-12,15H2,1H3,(H,34,35) D0TH6M DRUGINKE RPVDFHPBGBMWID-UHFFFAOYSA-N D0TH6M DRUGSMIL CN1C=C(C2=C1C=C(C=C2)N3CCC(CC3)OCC4=C(ON=C4C5=C(C=CC=C5Cl)Cl)C6CC6)C(=O)O D0TH6M HIGHSTAT Patented D0TI0R DRUG__ID D0TI0R D0TI0R DRUGTYPE Small molecular drug D0TI0R DRUGINCH 1S/C36H34FN7O4/c1-2-32(46)42-10-4-5-24(18-42)44-17-23(16-40-44)29-15-26-34(38-20-39-35(26)41-29)25-6-3-7-30(27(25)19-45)43-11-12-48-31-14-22(21-8-9-21)13-28(37)33(31)36(43)47/h2-3,6-7,13-17,20-21,24,45H,1,4-5,8-12,18-19H2,(H,38,39,41) D0TI0R DRUGINKE SGCPAQMSTLOCLE-UHFFFAOYSA-N D0TI0R DRUGSMIL C=CC(=O)N1CCCC(C1)N2C=C(C=N2)C3=CC4=C(N=CN=C4N3)C5=C(C(=CC=C5)N6CCOC7=C(C6=O)C(=CC(=C7)C8CC8)F)CO D0TI0R HIGHSTAT Patented D0TI0R COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0TI3Q DRUG__ID D0TI3Q D0TI3Q DRUGTYPE Small molecular drug D0TI3Q DRUGINCH 1S/C22H21Cl3N4O3S/c1-33(31,32)22-19(21(30)27-28-11-3-2-4-12-28)26-20(17-10-7-15(24)13-18(17)25)29(22)16-8-5-14(23)6-9-16/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D0TI3Q DRUGINKE XHUGETFAQBCPHR-UHFFFAOYSA-N D0TI3Q DRUGSMIL CS(=O)(=O)C1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCCC4 D0TI3Q HIGHSTAT Patented D0TI3Q COMPCLAS 1,2,4,5-tetra-substituted imidazole derivatives D0TJ4D DRUG__ID D0TJ4D D0TJ4D DRUGCOMP Incyte Corporation D0TJ4D DRUGTYPE Small molecule immunotherapy D0TJ4D DRUGINCH 1S/C28H28N4O2/c1-19-22(20-8-3-2-4-9-20)10-7-11-24(19)31-27-26-23(14-16-30-27)21(13-15-29-26)18-32-17-6-5-12-25(32)28(33)34/h2-4,7-11,13-16,25H,5-6,12,17-18H2,1H3,(H,30,31)(H,33,34) D0TJ4D DRUGINKE PDWPVFMFNAKOIU-UHFFFAOYSA-N D0TJ4D DRUGSMIL CC1=C(C=CC=C1NC2=NC=CC3=C(C=CN=C32)CN4CCCCC4C(=O)O)C5=CC=CC=C5 D0TJ4D HIGHSTAT Patented D0TK2N DRUG__ID D0TK2N D0TK2N DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED MASADA, Shinichi D0TK2N DRUGTYPE Small molecular drug D0TK2N DRUGINCH 1S/C26H33N3O3/c1-17-22-13-20(14-27-16-26(2,3)31)29(4)24(22)12-11-23(17)28-25(30)19-7-9-21(10-8-19)32-15-18-5-6-18/h7-13,18,27,31H,5-6,14-16H2,1-4H3,(H,28,30) D0TK2N DRUGINKE LYUFDXWEPKVSLW-UHFFFAOYSA-N D0TK2N DRUGSMIL CC1=C(C=CC2=C1C=C(N2C)CNCC(C)(C)O)NC(=O)C3=CC=C(C=C3)OCC4CC4 D0TK2N HIGHSTAT Patented D0TN6E DRUG__ID D0TN6E D0TN6E DRUGCOMP KARUS THERAPEUTICS LTD D0TN6E DRUGTYPE Small molecular drug D0TN6E DRUGINCH 1S/C18H16N4O2/c23-18(21-24)15-9-7-14(8-10-15)13-22(16-5-1-3-11-19-16)17-6-2-4-12-20-17/h1-12,24H,13H2,(H,21,23) D0TN6E DRUGINKE FWQCLQYFYHSYHY-UHFFFAOYSA-N D0TN6E DRUGSMIL C1=CC=NC(=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC=N3 D0TN6E HIGHSTAT Patented D0TO3O DRUG__ID D0TO3O D0TO3O DRUGCOMP FORMA THERAPEUTICS, INC D0TO3O DRUGTYPE Small molecular drug D0TO3O DRUGINCH 1S/C22H24N2O3/c25-20(23-27)18-7-8-19-14-22(11-9-17(19)13-18)10-4-12-24(21(22)26)15-16-5-2-1-3-6-16/h1-3,5-8,13,27H,4,9-12,14-15H2,(H,23,25) D0TO3O DRUGINKE PRTQLYSHPNDHIG-UHFFFAOYSA-N D0TO3O DRUGSMIL C1CC2(CCC3=C(C2)C=CC(=C3)C(=O)NO)C(=O)N(C1)CC4=CC=CC=C4 D0TO3O HIGHSTAT Patented D0TP7S DRUG__ID D0TP7S D0TP7S DRUGCOMP TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED D0TP7S DRUGTYPE Small molecular drug D0TP7S DRUGINCH 1S/C18H16ClN3O2/c1-3-22(2)18(23)24-17-13-9-5-7-11-15(13)20-16(21-17)12-8-4-6-10-14(12)19/h4-11H,3H2,1-2H3 D0TP7S DRUGINKE PBHDUERHMVFHLD-UHFFFAOYSA-N D0TP7S DRUGSMIL CCN(C)C(=O)OC1=NC(=NC2=CC=CC=C21)C3=CC=CC=C3Cl D0TP7S HIGHSTAT Patented D0TR9T DRUG__ID D0TR9T D0TR9T DRUGCOMP GENZYME CORPORATION XIANG, Yibin HIRTH, Bradford KANE, John, L. LIAO, Junkai NOSON, Kevin YEE, Christopher D0TR9T DRUGTYPE Small molecular drug D0TR9T DRUGINCH 1S/C21H30N4O3/c1-2-3-4-5-6-7-18-24-20(25-28-18)16-10-8-15(9-11-16)14-23-21(27)19-17(26)12-13-22-19/h8-11,17,19,22,26H,2-7,12-14H2,1H3,(H,23,27)/t17-,19-/m0/s1 D0TR9T DRUGINKE CMLALAZUOVTKKV-HKUYNNGSSA-N D0TR9T DRUGSMIL CCCCCCCC1=NC(=NO1)C2=CC=C(C=C2)CNC(=O)C3C(CCN3)O D0TR9T HIGHSTAT Patented D0TT4A DRUG__ID D0TT4A D0TT4A DRUGCOMP UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION D0TT4A DRUGTYPE Small molecular drug D0TT4A DRUGINCH 1S/C10H12O2S/c11-10(12)7-4-8-13-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12) D0TT4A DRUGINKE HHZVQLOVHIDMBD-UHFFFAOYSA-N D0TT4A DRUGSMIL C1=CC=C(C=C1)SCCCC(=O)O D0TT4A HIGHSTAT Patented D0TU0X DRUG__ID D0TU0X D0TU0X DRUGCOMP H. Lee Moffitt Cancer Center and Research Institute, University of Central Florida Research Foundation D0TU0X DRUGTYPE Small molecular drug D0TU0X DRUGINCH 1S/C16H15NO7S/c1-10-2-5-12(6-3-10)25(22,23)24-9-15(19)17-11-4-7-13(16(20)21)14(18)8-11/h2-8,18H,9H2,1H3,(H,17,19)(H,20,21) D0TU0X DRUGINKE HWNUSGNZBAISFM-UHFFFAOYSA-N D0TU0X DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)OCC(=O)NC2=CC(=C(C=C2)C(=O)O)O D0TU0X HIGHSTAT Patented D0TU6D DRUG__ID D0TU6D D0TU6D DRUGCOMP ABIDE THERAPEUTICS, INC D0TU6D DRUGTYPE Small molecular drug D0TU6D DRUGINCH 1S/C23H22F6N2O2/c24-22(25,26)20(23(27,28)29)33-21(32)31-13-18-11-30(12-19(18)14-31)10-15-6-8-17(9-7-15)16-4-2-1-3-5-16/h1-9,18-20H,10-14H2 D0TU6D DRUGINKE YPFURSFOBNHDRO-UHFFFAOYSA-N D0TU6D DRUGSMIL C1C2CN(CC2CN1CC3=CC=C(C=C3)C4=CC=CC=C4)C(=O)OC(C(F)(F)F)C(F)(F)F D0TU6D HIGHSTAT Patented D0TW7K DRUG__ID D0TW7K D0TW7K DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0TW7K DRUGTYPE Small molecular drug D0TW7K DRUGINCH 1S/C27H24F3N5O2S/c28-27(29,30)19-1-3-20(4-2-19)34-8-7-18-13-21(5-6-24(18)34)35-15-22(14-25(35)36)32-9-11-33(12-10-32)26(37)23-16-38-17-31-23/h1-8,13,16-17,22H,9-12,14-15H2/t22-/m1/s1 D0TW7K DRUGINKE ACWGPXVJPMRMHD-JOCHJYFZSA-N D0TW7K DRUGSMIL C1CN(CCN1C2CC(=O)N(C2)C3=CC4=C(C=C3)N(C=C4)C5=CC=C(C=C5)C(F)(F)F)C(=O)C6=CSC=N6 D0TW7K HIGHSTAT Patented D0TX1S DRUG__ID D0TX1S D0TX1S DRUGCOMP PF MEDICAMENT [FR] D0TX1S DRUGTYPE Small molecular drug D0TX1S DRUGINCH 1S/C29H31F2N7O2S/c1-37-6-8-38(9-7-37)21-2-3-24(26(15-21)33-20-4-10-40-11-5-20)29(39)34-28-25-16-23(17-32-27(25)35-36-28)41-22-13-18(30)12-19(31)14-22/h2-3,12-17,20,33H,4-11H2,1H3,(H2,32,34,35,36,39) D0TX1S DRUGINKE DNSGDBHRFQIANM-UHFFFAOYSA-N D0TX1S DRUGSMIL CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=C4C=C(C=NC4=NN3)SC5=CC(=CC(=C5)F)F)NC6CCOCC6 D0TX1S HIGHSTAT Patented D0TY8S DRUG__ID D0TY8S D0TY8S DRUGCOMP GLAXOSMITHKLINE LLC CHRISTENSEN, Siegfried, Benjamin, IV QIN, Donghui LU, Shi WEI, Shuai YANG, Nianyong ZHANG, Zhiliu D0TY8S DRUGTYPE Small molecular drug D0TY8S DRUGINCH 1S/C23H24ClN5O2/c1-22-13-23(22,25-2)15-28(14-22)20-6-5-18(11-27-20)29-8-7-19(9-21(29)30)31-12-17-4-3-16(24)10-26-17/h3-11,25H,12-15H2,1-2H3/t22-,23-/m0/s1 D0TY8S DRUGINKE KROAARZZGJOXPL-GOTSBHOMSA-N D0TY8S DRUGSMIL CC12CC1(CN(C2)C3=NC=C(C=C3)N4C=CC(=CC4=O)OCC5=NC=C(C=C5)Cl)NC D0TY8S HIGHSTAT Patented D0TZ2W DRUG__ID D0TZ2W D0TZ2W DRUGCOMP GRUENENTHAL GMBH [DE] D0TZ2W DRUGTYPE Small molecular drug D0TZ2W DRUGINCH 1S/C23H17Cl2F3N4O/c1-13(18-7-2-4-14-11-29-21(25)10-19(14)18)22(33)30-12-17-9-20(23(26,27)28)31-32(17)16-6-3-5-15(24)8-16/h2-11,13H,12H2,1H3,(H,30,33) D0TZ2W DRUGINKE IMGRGGRJBGEWLE-UHFFFAOYSA-N D0TZ2W DRUGSMIL CC(C1=CC=CC2=CN=C(C=C21)Cl)C(=O)NCC3=CC(=NN3C4=CC(=CC=C4)Cl)C(F)(F)F D0TZ2W HIGHSTAT Patented D0U2LO DRUG__ID D0U2LO D0U2LO DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA DAR, Arvin SHOKAT, Kevan M D0U2LO DRUGTYPE Small molecular drug D0U2LO DRUGINCH 1S/C26H24F3N7O2/c1-14(2)36-23-20(22(30-13-31-23)34-24(37)16-6-7-16)21(35-36)15-8-10-18(11-9-15)32-25(38)33-19-5-3-4-17(12-19)26(27,28)29/h3-5,8-14,16H,6-7H2,1-2H3,(H2,32,33,38)(H,30,31,34,37) D0U2LO DRUGINKE UNZJMBBOGIRTFD-UHFFFAOYSA-N D0U2LO DRUGSMIL CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F)NC(=O)C5CC5 D0U2LO HIGHSTAT Patented D0U3KX DRUG__ID D0U3KX D0U3KX DRUGCOMP FLEXUS BIOSCIENCES, INC D0U3KX DRUGTYPE Small molecular drug D0U3KX DRUGINCH 1S/C23H23ClFN3O2/c1-15(23(29)27-18-5-2-16(24)3-6-18)28-12-9-19(10-13-28)30-22-8-11-26-21-7-4-17(25)14-20(21)22/h2-8,11,14-15,19H,9-10,12-13H2,1H3,(H,27,29) D0U3KX DRUGINKE JOMPEBQANPZAPO-UHFFFAOYSA-N D0U3KX DRUGSMIL CC(C(=O)NC1=CC=C(C=C1)Cl)N2CCC(CC2)OC3=C4C=C(C=CC4=NC=C3)F D0U3KX HIGHSTAT Patented D0U3VU DRUG__ID D0U3VU D0U3VU DRUGTYPE Small molecular drug D0U3VU DRUGINCH 1S/C24H23Cl2F2N2O2S/c1-30(24(16-3-7-18(25)8-4-16)17-5-9-19(26)10-6-17)14-23(15-30)29(33(2,31)32)22-12-20(27)11-21(28)13-22/h3-13,23-24H,14-15H2,1-2H3/q+1 D0U3VU DRUGINKE DQQUOWSXOJKTEJ-UHFFFAOYSA-N D0U3VU DRUGSMIL C[N+]1(CC(C1)N(C2=CC(=CC(=C2)F)F)S(=O)(=O)C)C(C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl D0U3VU HIGHSTAT Patented D0U3VU COMPCLAS Aminoazetidine derivatives D0U4LI DRUG__ID D0U4LI D0U4LI DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0U4LI DRUGTYPE Small molecular drug D0U4LI DRUGINCH 1S/C23H21N3O3/c1-2-25-22(27)16-5-3-4-15(10-16)12-26-23(28)17-6-7-19-18(11-17)14-29-21-13-24-9-8-20(19)21/h3-11,13H,2,12,14H2,1H3,(H,25,27)(H,26,28) D0U4LI DRUGINKE YKJXZODWOQJHCQ-UHFFFAOYSA-N D0U4LI DRUGSMIL CCNC(=O)C1=CC=CC(=C1)CNC(=O)C2=CC3=C(C=C2)C4=C(C=NC=C4)OC3 D0U4LI HIGHSTAT Patented D0U5CQ DRUG__ID D0U5CQ D0U5CQ DRUGCOMP GRUENENTHAL GMBH [DE] D0U5CQ DRUGTYPE Small molecular drug D0U5CQ DRUGINCH 1S/C24H27ClFN5O2/c1-24(2,3)22-11-18(31(29-22)17-6-4-5-15(25)9-17)12-27-23(33)28-16-7-8-21(20(26)10-16)30-13-19(32)14-30/h4-11,19,32H,12-14H2,1-3H3,(H2,27,28,33) D0U5CQ DRUGINKE BLMVABKWVMAQJO-UHFFFAOYSA-N D0U5CQ DRUGSMIL CC(C)(C)C1=NN(C(=C1)CNC(=O)NC2=CC(=C(C=C2)N3CC(C3)O)F)C4=CC(=CC=C4)Cl D0U5CQ HIGHSTAT Patented D0U5ON DRUG__ID D0U5ON D0U5ON DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D0U5ON DRUGTYPE Small molecular drug D0U5ON DRUGINCH 1S/C19H20ClN5O2/c20-13-7-6-12(16(10-13)25-8-1-2-9-25)11-21-18(26)22-14-4-3-5-15-17(14)24-19(27)23-15/h3-7,10H,1-2,8-9,11H2,(H2,21,22,26)(H2,23,24,27) D0U5ON DRUGINKE HZDOWKSLUNQEPU-UHFFFAOYSA-N D0U5ON DRUGSMIL C1CCN(C1)C2=C(C=CC(=C2)Cl)CNC(=O)NC3=CC=CC4=C3NC(=O)N4 D0U5ON HIGHSTAT Patented D0U5TX DRUG__ID D0U5TX D0U5TX DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0U5TX DRUGTYPE Small molecular drug D0U5TX DRUGINCH 1S/C25H30F2N4O3/c1-14(28-5)22(32)30-21(25(2,3)4)24(34)31-13-15-9-6-7-10-16(15)20(31)23(33)29-19-17(26)11-8-12-18(19)27/h6-12,14,20-21,28H,13H2,1-5H3,(H,29,33)(H,30,32)/t14-,20-,21+/m0/s1 D0U5TX DRUGINKE YVSLGVHZPIUKJU-SZFUDVHCSA-N D0U5TX DRUGSMIL CC(C(=O)NC(C(=O)N1CC2=CC=CC=C2C1C(=O)NC3=C(C=CC=C3F)F)C(C)(C)C)NC D0U5TX HIGHSTAT Patented D0U6PA DRUG__ID D0U6PA D0U6PA DRUGTYPE Small molecular drug D0U6PA DRUGINCH 1S/C25H19Cl2N7O3S/c1-33(20-8-4-5-13-29-20)31-24(35)21-23-30-14-18(17-6-2-3-7-19(17)27)22(15-9-11-16(26)12-10-15)34(23)32-25(21)38(28,36)37/h2-14H,1H3,(H,31,35)(H2,28,36,37) D0U6PA DRUGINKE SIHKCQZRSPKPIN-UHFFFAOYSA-N D0U6PA DRUGSMIL CN(C1=CC=CC=N1)NC(=O)C2=C3N=CC(=C(N3N=C2S(=O)(=O)N)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0U6PA HIGHSTAT Patented D0U6PA COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0U8BD DRUG__ID D0U8BD D0U8BD DRUGCOMP X-RX, INC D0U8BD DRUGTYPE Small molecular drug D0U8BD DRUGINCH 1S/C28H27F7N4O5/c1-15(2)21(36-22(40)19-14-16(27(30,31)32)4-9-20(19)29)23(41)38-12-10-26(11-13-38)24(42)37(3)25(43)39(26)17-5-7-18(8-6-17)44-28(33,34)35/h4-9,14-15,21H,10-13H2,1-3H3,(H,36,40)/t21-/m1/s1 D0U8BD DRUGINKE BYITUQUWMVRENA-OAQYLSRUSA-N D0U8BD DRUGSMIL CC(C)C(C(=O)N1CCC2(CC1)C(=O)N(C(=O)N2C3=CC=C(C=C3)OC(F)(F)F)C)NC(=O)C4=C(C=CC(=C4)C(F)(F)F)F D0U8BD HIGHSTAT Patented D0U8YZ DRUG__ID D0U8YZ D0U8YZ DRUGCOMP GRUENENTHAL GMBH [DE] D0U8YZ DRUGTYPE Small molecular drug D0U8YZ DRUGINCH 1S/C25H27F4N3O2/c1-15(2)18-5-4-6-20(11-18)32-21(13-23(31-32)25(27,28)29)14-30-24(34)16(3)19-8-7-17(9-10-33)22(26)12-19/h4-8,11-13,15-16,33H,9-10,14H2,1-3H3,(H,30,34) D0U8YZ DRUGINKE VKEXSUFTMBHDFU-UHFFFAOYSA-N D0U8YZ DRUGSMIL CC(C)C1=CC(=CC=C1)N2C(=CC(=N2)C(F)(F)F)CNC(=O)C(C)C3=CC(=C(C=C3)CCO)F D0U8YZ HIGHSTAT Patented D0U9OH DRUG__ID D0U9OH D0U9OH DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0U9OH DRUGTYPE Small molecular drug D0U9OH DRUGINCH 1S/C20H21BrN2O3/c1-11-4-5-26-18-14(6-11)8-15(9-17(18)21)19(24)22-10-16-12(2)7-13(3)23-20(16)25/h4,7-9H,5-6,10H2,1-3H3,(H,22,24)(H,23,25) D0U9OH DRUGINKE FKDNRFGIZCNPMK-UHFFFAOYSA-N D0U9OH DRUGSMIL CC1=CCOC2=C(C1)C=C(C=C2Br)C(=O)NCC3=C(C=C(NC3=O)C)C D0U9OH HIGHSTAT Patented D0UC8I DRUG__ID D0UC8I D0UC8I DRUGCOMP Abbott D0UC8I DRUGTYPE Small molecular drug D0UC8I DRUGINCH 1S/C23H29Cl2FN8/c1-23(2,3)15-32-10-5-11-33(13-12-32)21-16(6-4-9-27-21)14-28-22-29-30-31-34(22)18-8-7-17(26)19(24)20(18)25/h4,6-9H,5,10-15H2,1-3H3,(H,28,29,31) D0UC8I DRUGINKE JYRXOWVYFHHKEV-UHFFFAOYSA-N D0UC8I DRUGSMIL CC(C)(C)CN1CCCN(CC1)C2=C(C=CC=N2)CNC3=NN=NN3C4=C(C(=C(C=C4)F)Cl)Cl D0UC8I HIGHSTAT Patented D0UD6X DRUG__ID D0UD6X D0UD6X DRUGTYPE Small molecular drug D0UD6X DRUGINCH 1S/C22H20ClF3N4O3/c1-2-33-21(32)14-7-9-29(10-8-14)20(31)17-12-19-27-16(13-3-5-15(23)6-4-13)11-18(22(24,25)26)30(19)28-17/h3-6,11-12,14H,2,7-10H2,1H3 D0UD6X DRUGINKE GQAPMAOCKZPCGZ-UHFFFAOYSA-N D0UD6X DRUGSMIL CCOC(=O)C1CCN(CC1)C(=O)C2=NN3C(=CC(=NC3=C2)C4=CC=C(C=C4)Cl)C(F)(F)F D0UD6X HIGHSTAT Patented D0UD6X COMPCLAS Imidazopyridazine derivatives D0UE9B DRUG__ID D0UE9B D0UE9B DRUGCOMP CHDI FOUNDATION, INC D0UE9B DRUGTYPE Small molecular drug D0UE9B DRUGINCH 1S/C18H13N3O2S/c22-18(20-23)16-11-15(19-21(16)13-6-2-1-3-7-13)14-8-4-5-12-9-10-24-17(12)14/h1-11,23H,(H,20,22) D0UE9B DRUGINKE OYRFBDZKQFEJSC-UHFFFAOYSA-N D0UE9B DRUGSMIL C1=CC=C(C=C1)N2C(=CC(=N2)C3=CC=CC4=C3SC=C4)C(=O)NO D0UE9B HIGHSTAT Patented D0UE9K DRUG__ID D0UE9K D0UE9K DRUGCOMP Japan Tobacco, Inc D0UE9K DRUGTYPE Small molecular drug D0UE9K DRUGINCH 1S/C21H15Cl2F3N4O3/c22-15-8-3-12(20(32)29-13-4-6-14(7-5-13)33-21(24,25)26)10-17(15)30(11-18(27)31)19-16(23)2-1-9-28-19/h1-10H,11H2,(H2,27,31)(H,29,32) D0UE9K DRUGINKE OHISWWFMRZTNTO-UHFFFAOYSA-N D0UE9K DRUGSMIL C1=CC(=C(N=C1)N(CC(=O)N)C2=C(C=CC(=C2)C(=O)NC3=CC=C(C=C3)OC(F)(F)F)Cl)Cl D0UE9K HIGHSTAT Patented D0UK7K DRUG__ID D0UK7K D0UK7K DRUGCOMP Wisconsin-Alumni-Research-Foundation D0UK7K DRUGTYPE Small molecular drug D0UK7K DRUGINCH 1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22?,23-,24+,25+,27+/m0/s1 D0UK7K DRUGINKE UHMPCVGLSKFXHR-NFZXMVPNSA-N D0UK7K DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(=C)C(C3)O)O)C D0UK7K HIGHSTAT Patented D0UL2R DRUG__ID D0UL2R D0UL2R DRUGCOMP NTZ LAB LTD [BG] D0UL2R DRUGTYPE Small molecular drug D0UL2R DRUGINCH 1S/C17H15Cl2N3O2/c1-24-7-6-22-16-5-2-11(8-12(16)10-20-22)17(23)21-13-3-4-14(18)15(19)9-13/h2-5,8-10H,6-7H2,1H3,(H,21,23) D0UL2R DRUGINKE CTHLAPNHCMOVBE-UHFFFAOYSA-N D0UL2R DRUGSMIL COCCN1C2=C(C=C(C=C2)C(=O)NC3=CC(=C(C=C3)Cl)Cl)C=N1 D0UL2R HIGHSTAT Patented D0UR1H DRUG__ID D0UR1H D0UR1H DRUGCOMP DOMINGUEZ, Celia PRIME, Michael MARSTON, Richard BROOKFIELD, Frederick, A. COURTNEY, Stephen, M. MACDONALD, Douglas WITYAK, John YARNOLD, Christopher, John VAIDYA, Darshan D0UR1H DRUGTYPE Small molecular drug D0UR1H DRUGINCH 1S/C27H33ClN4O4/c1-2-25(33)29-15-9-8-13-23(30-27(35)36-20-21-10-4-3-5-11-21)26(34)32-18-16-31(17-19-32)24-14-7-6-12-22(24)28/h2-7,10-12,14,23H,1,8-9,13,15-20H2,(H,29,33)(H,30,35)/t23-/m0/s1 D0UR1H DRUGINKE KYVYJVRZPFRADU-QHCPKHFHSA-N D0UR1H DRUGSMIL C=CC(=O)NCCCCC(C(=O)N1CCN(CC1)C2=CC=CC=C2Cl)NC(=O)OCC3=CC=CC=C3 D0UR1H HIGHSTAT Patented D0UT9H DRUG__ID D0UT9H D0UT9H DRUGTYPE Small molecular drug D0UT9H DRUGINCH 1S/C14H27NO3/c1-11-8-12(10-14(2,3)9-11)18-13(16)15-6-5-7-17-4/h11-12H,5-10H2,1-4H3,(H,15,16) D0UT9H DRUGINKE XKPVQQCVMUKNEK-UHFFFAOYSA-N D0UT9H DRUGSMIL CC1CC(CC(C1)(C)C)OC(=O)NCCCOC D0UT9H HIGHSTAT Patented D0UT9H COMPCLAS Cyclohexyl carbamate derivatives D0UU7G DRUG__ID D0UU7G D0UU7G DRUGCOMP HANMI SCIENCE CO., LTD. BAE, In Hwan BYUN, Eun Young JU, Hae Kyoung SONG, Ji Young JUNG, Seung Hyun JUN, Seung Ah KIM, Ho Seok JUNG, Young Hee SHIM, Mi Yon AHN, Young Gil KIM, Maeng Sup D0UU7G DRUGTYPE Small molecular drug D0UU7G DRUGINCH 1S/C30H36ClF2N7O4/c1-15(34-5)27(41)39-25(30(2,3)4)29(43)40-11-7-8-21(40)28(42)38-20-12-16-19(13-22(20)44-6)35-14-36-26(16)37-18-10-9-17(32)23(31)24(18)33/h9-10,12-15,21,25,34H,7-8,11H2,1-6H3,(H,38,42)(H,39,41)(H,35,36,37)/t15-,21-,25+/m0/s1 D0UU7G DRUGINKE KJLMHHDQQFRBTF-HHCYOLOASA-N D0UU7G DRUGSMIL CC(C(=O)NC(C(=O)N1CCCC1C(=O)NC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=C(C=C4)F)Cl)F)OC)C(C)(C)C)NC D0UU7G HIGHSTAT Patented D0UW5J DRUG__ID D0UW5J D0UW5J DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0UW5J DRUGTYPE Small molecular drug D0UW5J DRUGINCH 1S/C19H26N2O2/c1-3-19(4-2)12-23-18(21-19)16-9-17(22-11-13-5-6-13)15(10-20-16)14-7-8-14/h9-10,13-14H,3-8,11-12H2,1-2H3 D0UW5J DRUGINKE NMHFZCVAQZPHOP-UHFFFAOYSA-N D0UW5J DRUGSMIL CCC1(COC(=N1)C2=NC=C(C(=C2)OCC3CC3)C4CC4)CC D0UW5J HIGHSTAT Patented D0UW8Q DRUG__ID D0UW8Q D0UW8Q DRUGCOMP METACRINE, INC D0UW8Q DRUGTYPE Small molecular drug D0UW8Q DRUGINCH 1S/C30H34N2O3/c1-30(2,3)29(34)32(27-9-7-8-22(20-27)12-19-28(33)35-6)21-23-10-13-24(14-11-23)25-15-17-26(18-16-25)31(4)5/h7-20H,21H2,1-6H3/b19-12+ D0UW8Q DRUGINKE CROILKLCCCWJNU-XDHOZWIPSA-N D0UW8Q DRUGSMIL CC(C)(C)C(=O)N(CC1=CC=C(C=C1)C2=CC=C(C=C2)N(C)C)C3=CC=CC(=C3)C=CC(=O)OC D0UW8Q HIGHSTAT Patented D0UX4J DRUG__ID D0UX4J D0UX4J DRUGTYPE Small molecular drug D0UX4J DRUGINCH 1S/C12H12N2O3S/c1-16-8-3-7(4-9(6-8)17-2)5-10-11(15)14-12(18)13-10/h3-6H,1-2H3,(H2,13,14,15,18)/b10-5- D0UX4J DRUGINKE SXBGOUWIALXAOL-YHYXMXQVSA-N D0UX4J DRUGSMIL COC1=CC(=CC(=C1)C=C2C(=O)NC(=S)N2)OC D0UX4J HIGHSTAT Patented D0UX4J COMPCLAS Dimethoxybenzylidene-2-thio-imidazole-4-one derivatives D0UY7A DRUG__ID D0UY7A D0UY7A DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY HUANG, Yanting SUN, Chongqing LAWRENCE, R., Michael EWING, William, R. TURDI, Huji D0UY7A DRUGTYPE Small molecular drug D0UY7A DRUGINCH 1S/C20H19F3N4O3/c1-27(10-11-29-2)15-9-8-14(12-24-15)25-18(28)16-17(20(21,22)23)30-19(26-16)13-6-4-3-5-7-13/h3-9,12H,10-11H2,1-2H3,(H,25,28) D0UY7A DRUGINKE QEZWDFXCTTZZRI-UHFFFAOYSA-N D0UY7A DRUGSMIL CN(CCOC)C1=NC=C(C=C1)NC(=O)C2=C(OC(=N2)C3=CC=CC=C3)C(F)(F)F D0UY7A HIGHSTAT Patented D0UY9Y DRUG__ID D0UY9Y D0UY9Y DRUGCOMP ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely D0UY9Y DRUGTYPE Small molecular drug D0UY9Y DRUGINCH 1S/C16H14N2O3S/c1-20-12-4-2-11(3-5-12)10-14(19)18-13-6-9-22-15(13)16-17-7-8-21-16/h2-9H,10H2,1H3,(H,18,19) D0UY9Y DRUGINKE KSZHRLGDJPCAID-UHFFFAOYSA-N D0UY9Y DRUGSMIL COC1=CC=C(C=C1)CC(=O)NC2=C(SC=C2)C3=NC=CO3 D0UY9Y HIGHSTAT Patented D0UZ7I DRUG__ID D0UZ7I D0UZ7I DRUGTYPE Small molecular drug D0UZ7I DRUGINCH 1S/C18H16N2O/c21-18(19-13-14-7-2-1-3-8-14)20-17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2,(H2,19,20,21) D0UZ7I DRUGINKE FWIZGBBRZIIRBG-UHFFFAOYSA-N D0UZ7I DRUGSMIL C1=CC=C(C=C1)CNC(=O)NC2=CC=CC3=CC=CC=C32 D0UZ7I HIGHSTAT Patented D0UZ7I COMPCLAS N-naphtyl-N-benzylurea derivatives D0V0UW DRUG__ID D0V0UW D0V0UW DRUGTYPE Small molecular drug D0V0UW DRUGINCH 1S/C24H19Cl2N5O/c1-24(2,3)22-28-20-17(21-29-30-23(32)31(21)22)12-16(13-8-10-14(25)11-9-13)19(27-20)15-6-4-5-7-18(15)26/h4-12H,1-3H3,(H,30,32) D0V0UW DRUGINKE RCDDRZOJAVJMCL-UHFFFAOYSA-N D0V0UW DRUGSMIL CC(C)(C)C1=NC2=NC(=C(C=C2C3=NNC(=O)N31)C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl D0V0UW HIGHSTAT Patented D0V0UW COMPCLAS Pyridotriazolopyrimidine derivatives D0V0WT DRUG__ID D0V0WT D0V0WT DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D0V0WT DRUGTYPE Small molecular drug D0V0WT DRUGINCH 1S/C16H15N7O/c1-10-7-8-18-15(20-10)23-16-19-9-12(13(17)24)14(22-16)21-11-5-3-2-4-6-11/h2-9H,1H3,(H2,17,24)(H2,18,19,20,21,22,23) D0V0WT DRUGINKE YVTIEYHXPXUHLT-UHFFFAOYSA-N D0V0WT DRUGSMIL CC1=NC(=NC=C1)NC2=NC=C(C(=N2)NC3=CC=CC=C3)C(=O)N D0V0WT HIGHSTAT Patented D0V3KH DRUG__ID D0V3KH D0V3KH DRUGCOMP MERCK PATENT GMBH SHERER, Brian A D0V3KH DRUGTYPE Small molecular drug D0V3KH DRUGINCH 1S/C17H20FN3O/c18-17-6-12-13(8-20-17)15-9-19-10-21(15)14(12)7-16(22)11-4-2-1-3-5-11/h6,8-11,14,16,22H,1-5,7H2 D0V3KH DRUGINKE QUDWXPLDIKCCKW-UHFFFAOYSA-N D0V3KH DRUGSMIL C1CCC(CC1)C(CC2C3=CC(=NC=C3C4=CN=CN24)F)O D0V3KH HIGHSTAT Patented D0V3PI DRUG__ID D0V3PI D0V3PI DRUGCOMP ABBVIE INC D0V3PI DRUGTYPE Small molecular drug D0V3PI DRUGINCH 1S/C20H20FN3O4/c1-20(2)9-15(13-5-3-11(21)7-17(13)28-20)24-19(26)22-12-4-6-16-14(8-12)23-18(25)10-27-16/h3-8,15H,9-10H2,1-2H3,(H,23,25)(H2,22,24,26)/t15-/m1/s1 D0V3PI DRUGINKE GBNGQHMENHKOCY-OAHLLOKOSA-N D0V3PI DRUGSMIL CC1(CC(C2=C(O1)C=C(C=C2)F)NC(=O)NC3=CC4=C(C=C3)OCC(=O)N4)C D0V3PI HIGHSTAT Patented D0V4KJ DRUG__ID D0V4KJ D0V4KJ DRUGTYPE Small molecular drug D0V4KJ DRUGINCH 1S/C21H24BrNO/c22-18-8-4-7-16(11-18)21(24)14-23-19-9-10-20(23)13-17(12-19)15-5-2-1-3-6-15/h1-8,11,17,19-21,24H,9-10,12-14H2/t17?,19?,20?,21-/m0/s1 D0V4KJ DRUGINKE OPZPEBWJFYVOEI-SLQSYFLNSA-N D0V4KJ DRUGSMIL C1CC2CC(CC1N2CC(C3=CC(=CC=C3)Br)O)C4=CC=CC=C4 D0V4KJ HIGHSTAT Patented D0V4KJ COMPCLAS N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl-phenylcarbamate analogs D0V5AG DRUG__ID D0V5AG D0V5AG DRUGCOMP ABBVIE INC D0V5AG DRUGTYPE Small molecular drug D0V5AG DRUGINCH 1S/C30H40N6O3/c1-32-30(37)24-8-7-20(18-26(24)36-13-11-35(12-14-36)22-5-3-2-4-6-22)21-17-25-28(29(31)34-33-25)27(19-21)39-23-9-15-38-16-10-23/h7-8,17-19,22-23H,2-6,9-16H2,1H3,(H,32,37)(H3,31,33,34) D0V5AG DRUGINKE QLRPXVWKEWQCQV-UHFFFAOYSA-N D0V5AG DRUGSMIL CNC(=O)C1=C(C=C(C=C1)C2=CC3=C(C(=C2)OC4CCOCC4)C(=NN3)N)N5CCN(CC5)C6CCCCC6 D0V5AG HIGHSTAT Patented D0V5BV DRUG__ID D0V5BV D0V5BV DRUGCOMP ASTRAZENECA AB BROWN, William PAGE, Daniel SRIVASTAVA, Sanjay WALPOLE, Christopher WEI, Zhong-yong YANG, Hua D0V5BV DRUGTYPE Small molecular drug D0V5BV DRUGINCH 1S/C28H40N4O2/c1-28(2,3)27-30-23-17-21(9-12-24(23)32(27)18-19-7-5-4-6-8-19)26(34)31-15-13-20(14-16-31)25(33)29-22-10-11-22/h9,12,17,19-20,22H,4-8,10-11,13-16,18H2,1-3H3,(H,29,33) D0V5BV DRUGINKE UNNYHANBNOQKCU-UHFFFAOYSA-N D0V5BV DRUGSMIL CC(C)(C)C1=NC2=C(N1CC3CCCCC3)C=CC(=C2)C(=O)N4CCC(CC4)C(=O)NC5CC5 D0V5BV HIGHSTAT Patented D0V5IQ DRUG__ID D0V5IQ D0V5IQ DRUGCOMP CHARIT UNIVERSIT TSMEDIZIN BERLIN [DEUNIVERSIT T BAYREUTH [DE] D0V5IQ DRUGTYPE Small molecular drug D0V5IQ DRUGINCH 1S/C21H21N3O3/c1-3-24-14-22-20(16-9-11-18(27-2)12-10-16)21(24)17-7-4-15(5-8-17)6-13-19(25)23-26/h4-14,26H,3H2,1-2H3,(H,23,25)/b13-6+ D0V5IQ DRUGINKE JRABOCDIAYUFQB-AWNIVKPZSA-N D0V5IQ DRUGSMIL CCN1C=NC(=C1C2=CC=C(C=C2)C=CC(=O)NO)C3=CC=C(C=C3)OC D0V5IQ HIGHSTAT Patented D0V6OK DRUG__ID D0V6OK D0V6OK DRUGCOMP KADMON CORPORATION, LLC D0V6OK DRUGTYPE Small molecular drug D0V6OK DRUGINCH 1S/C20H18N6O/c1-27-17-4-2-13-11-26(12-15(13)9-17)20-21-7-6-19(24-20)23-16-3-5-18-14(8-16)10-22-25-18/h2-10H,11-12H2,1H3,(H,22,25)(H,21,23,24) D0V6OK DRUGINKE SWHUIIODYNUMNO-UHFFFAOYSA-N D0V6OK DRUGSMIL COC1=CC2=C(CN(C2)C3=NC=CC(=N3)NC4=CC5=C(C=C4)NN=C5)C=C1 D0V6OK HIGHSTAT Patented D0V7HS DRUG__ID D0V7HS D0V7HS DRUGCOMP BOSTON BIOMEDICAL, INC. JIANG, Zhiwei LI, Chiang, Jia LI, Wei LEGGETT, David D0V7HS DRUGTYPE Small molecular drug D0V7HS DRUGINCH 1S/C14H7ClO4/c1-6(16)11-5-10-12(17)8-3-2-7(15)4-9(8)13(18)14(10)19-11/h2-5H,1H3 D0V7HS DRUGINKE RVIUPSHRLLQFOH-UHFFFAOYSA-N D0V7HS DRUGSMIL CC(=O)C1=CC2=C(O1)C(=O)C3=C(C2=O)C=CC(=C3)Cl D0V7HS HIGHSTAT Patented D0V7NH DRUG__ID D0V7NH D0V7NH DRUGCOMP UNIVERSITY OF SOUTH FLORIDA TAN, Jun LUO, Deyan D0V7NH DRUGTYPE Small molecular drug D0V7NH DRUGINCH 1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H D0V7NH DRUGINKE IQPNAANSBPBGFQ-UHFFFAOYSA-N D0V7NH DRUGSMIL C1=CC(=C(C=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O)O D0V7NH HIGHSTAT Patented D0V7OU DRUG__ID D0V7OU D0V7OU DRUGCOMP Ildong Pharmaceutical Co., Ltd., S. Korea D0V7OU DRUGTYPE Small molecular drug D0V7OU DRUGINCH 1S/C18H22O3/c19-17(20)11-21-16-3-1-15(2-4-16)18-8-12-5-13(9-18)7-14(6-12)10-18/h1-4,12-14H,5-11H2,(H,19,20) D0V7OU DRUGINKE WIWCHWGNONICJI-UHFFFAOYSA-N D0V7OU DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=CC=C(C=C4)OCC(=O)O D0V7OU HIGHSTAT Patented D0V7UQ DRUG__ID D0V7UQ D0V7UQ DRUGCOMP UNIVERSIT DEGLI STUDI DI BARI [IT] D0V7UQ DRUGTYPE Small molecular drug D0V7UQ DRUGINCH 1S/C22H18F2N2O6/c1-30-19-9-14(10-20(31-2)21(19)32-3)22(27)25-17-5-4-12(8-18(17)26(28)29)13-6-15(23)11-16(24)7-13/h4-11H,1-3H3,(H,25,27) D0V7UQ DRUGINKE UCSAAECBPXPZFV-UHFFFAOYSA-N D0V7UQ DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)NC2=C(C=C(C=C2)C3=CC(=CC(=C3)F)F)[N+](=O)[O-] D0V7UQ HIGHSTAT Patented D0VB2X DRUG__ID D0VB2X D0VB2X DRUGCOMP RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK UNIVERSITY OF STRATHCLYDE BITTMAN, Robert PYNE, Nigel J. PYNE, Susan BAEK, Dong Jae LIU, Zheng BYUN, Hoe Sup D0VB2X DRUGTYPE Small molecular drug D0VB2X DRUGINCH 1S/C21H36N2/c1-2-3-4-5-6-7-8-19-9-11-20(12-10-19)13-16-23-17-14-21(22)15-18-23/h9-12,21H,2-8,13-18,22H2,1H3 D0VB2X DRUGINKE ILDHJXNNCSUCMI-UHFFFAOYSA-N D0VB2X DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCN2CCC(CC2)N D0VB2X HIGHSTAT Patented D0VB3P DRUG__ID D0VB3P D0VB3P DRUGCOMP KYORIN PHARMACEUTICAL CO., LTD D0VB3P DRUGTYPE Small molecular drug D0VB3P DRUGINCH 1S/C34H43N7O3/c1-5-44-31-21-24(33(42)41-17-13-25(14-18-41)40-16-8-15-37(2)19-20-40)11-12-27(31)36-32-22-29-30(23-35-32)39(4)34(43)26-9-6-7-10-28(26)38(29)3/h6-7,9-12,21-23,25H,5,8,13-20H2,1-4H3,(H,35,36) D0VB3P DRUGINKE YZJHEYIGGRFZOH-UHFFFAOYSA-N D0VB3P DRUGSMIL CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCCN(CC3)C)NC4=NC=C5C(=C4)N(C6=CC=CC=C6C(=O)N5C)C D0VB3P HIGHSTAT Patented D0VI4S DRUG__ID D0VI4S D0VI4S DRUGTYPE Small molecular drug D0VI4S DRUGINCH 1S/C22H24N4O7S2/c1-31-18-7-6-17(13-19(18)32-2)35(29,30)24-22-23-21(15-4-3-5-16(12-15)26(27)28)20(34-22)14-25-8-10-33-11-9-25/h3-7,12-13H,8-11,14H2,1-2H3,(H,23,24) D0VI4S DRUGINKE GOWBSGKWACGSGN-UHFFFAOYSA-N D0VI4S DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)NC2=NC(=C(S2)CN3CCOCC3)C4=CC(=CC=C4)[N+](=O)[O-])OC D0VI4S HIGHSTAT Patented D0VI4S COMPCLAS Benzene sulfonamide derivatives D0VK6S DRUG__ID D0VK6S D0VK6S DRUGCOMP KADMON CORPORATION, LLC D0VK6S DRUGTYPE Small molecular drug D0VK6S DRUGINCH 1S/C22H20N6O/c1-29-20-7-4-16-13-28(14-17(16)10-20)22-23-9-8-21(27-22)26-19-5-2-15(3-6-19)18-11-24-25-12-18/h2-12H,13-14H2,1H3,(H,24,25)(H,23,26,27) D0VK6S DRUGINKE QWVKCTINPBKQMS-UHFFFAOYSA-N D0VK6S DRUGSMIL COC1=CC2=C(CN(C2)C3=NC=CC(=N3)NC4=CC=C(C=C4)C5=CNN=C5)C=C1 D0VK6S HIGHSTAT Patented D0VN2U DRUG__ID D0VN2U D0VN2U DRUGCOMP PROXIMAGEN LIMITED D0VN2U DRUGTYPE Small molecular drug D0VN2U DRUGINCH 1S/C22H21N3O/c1-15-19(17-6-3-2-4-7-17)8-5-9-20(15)22(26)25-14-16-10-12-18(13-11-16)21(23)24/h2-13H,14H2,1H3,(H3,23,24)(H,25,26) D0VN2U DRUGINKE RNDNSLVKMYCGOO-UHFFFAOYSA-N D0VN2U DRUGSMIL CC1=C(C=CC=C1C(=O)NCC2=CC=C(C=C2)C(=N)N)C3=CC=CC=C3 D0VN2U HIGHSTAT Patented D0VS3A DRUG__ID D0VS3A D0VS3A DRUGTYPE Small molecular drug D0VS3A DRUGINCH 1S/C21H23N3O2/c1-24(2)12-4-11-23-21(26)16-8-6-15(7-9-16)18-13-17-5-3-10-22-20(17)19(25)14-18/h3,5-10,13-14,25H,4,11-12H2,1-2H3,(H,23,26) D0VS3A DRUGINKE QDBVSOZTVKXUES-UHFFFAOYSA-N D0VS3A DRUGSMIL CN(C)CCCNC(=O)C1=CC=C(C=C1)C2=CC(=C3C(=C2)C=CC=N3)O D0VS3A HIGHSTAT Patented D0VS3A COMPCLAS Hydroxyqunoline analogs D0W0MT DRUG__ID D0W0MT D0W0MT DRUGCOMP Incyte Corporation D0W0MT DRUGTYPE Small molecule immunotherapy D0W0MT DRUGINCH 1S/C22H18N4O3S/c23-11-15-14(13-4-5-18-19(10-13)29-9-8-28-18)2-1-3-16(15)25-21(27)22-26-17-6-7-24-12-20(17)30-22/h1-5,10,24H,6-9,12H2,(H,25,27) D0W0MT DRUGINKE CJCNMXQYXKRQRK-UHFFFAOYSA-N D0W0MT DRUGSMIL C1CNCC2=C1N=C(S2)C(=O)NC3=CC=CC(=C3C#N)C4=CC5=C(C=C4)OCCO5 D0W0MT HIGHSTAT Patented D0W4AA DRUG__ID D0W4AA D0W4AA DRUGCOMP ABBVIE INC D0W4AA DRUGTYPE Small molecular drug D0W4AA DRUGINCH 1S/C21H21F3N4O3/c1-20(21(22,23)24)10-16(14-5-3-4-6-17(14)31-20)26-18(29)25-13-8-7-12-11-28(2)19(30)27-15(12)9-13/h3-9,16H,10-11H2,1-2H3,(H,27,30)(H2,25,26,29)/t16-,20-/m1/s1 D0W4AA DRUGINKE OFCQSAHGUNDUTK-OXQOHEQNSA-N D0W4AA DRUGSMIL CC1(CC(C2=CC=CC=C2O1)NC(=O)NC3=CC4=C(CN(C(=O)N4)C)C=C3)C(F)(F)F D0W4AA HIGHSTAT Patented D0W7MG DRUG__ID D0W7MG D0W7MG DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BEAUCHAMPS, Marie, Georges HARRIS, Louise, Michelle KOTHARE, Mohit, Atul SAINDANE, Manohar, T D0W7MG DRUGTYPE Small molecular drug D0W7MG DRUGINCH 1S/C23H23FN6O/c1-31-17-12-10-15(11-13-17)26-22-25-14-20-21(29-22)30(16-6-2-3-7-16)23(28-20)27-19-9-5-4-8-18(19)24/h4-5,8-14,16H,2-3,6-7H2,1H3,(H,27,28)(H,25,26,29) D0W7MG DRUGINKE IMFVPVKPQOQCBY-UHFFFAOYSA-N D0W7MG DRUGSMIL COC1=CC=C(C=C1)NC2=NC=C3C(=N2)N(C(=N3)NC4=CC=CC=C4F)C5CCCC5 D0W7MG HIGHSTAT Patented D0W8BL DRUG__ID D0W8BL D0W8BL DRUGCOMP ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely D0W8BL DRUGTYPE Small molecular drug D0W8BL DRUGINCH 1S/C18H11BrF3N5O2S/c19-11-7-30-17(15(11)16-23-8-24-26-16)25-13(28)6-27-12-3-2-10(18(20,21)22)5-9(12)1-4-14(27)29/h1-5,7-8H,6H2,(H,25,28)(H,23,24,26) D0W8BL DRUGINKE CRWXJGJNJZPMRW-UHFFFAOYSA-N D0W8BL DRUGSMIL C1=CC2=C(C=CC(=O)N2CC(=O)NC3=C(C(=CS3)Br)C4=NC=NN4)C=C1C(F)(F)F D0W8BL HIGHSTAT Patented D0W9PY DRUG__ID D0W9PY D0W9PY DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0W9PY DRUGTYPE Small molecular drug D0W9PY DRUGINCH 1S/C19H25F2N3O2/c1-18(2)8-3-9-24(18)17(25)14-6-7-15(23-11-19(20,21)12-23)16(22-14)26-10-13-4-5-13/h6-7,13H,3-5,8-12H2,1-2H3 D0W9PY DRUGINKE AOQJVECXJNNKAZ-UHFFFAOYSA-N D0W9PY DRUGSMIL CC1(CCCN1C(=O)C2=NC(=C(C=C2)N3CC(C3)(F)F)OCC4CC4)C D0W9PY HIGHSTAT Patented D0WA9U DRUG__ID D0WA9U D0WA9U DRUGCOMP INTERCEPT PHARMACEUTICALS, INC D0WA9U DRUGTYPE Small molecular drug D0WA9U DRUGINCH 1S/C26H44O4/c1-5-16-18-8-6-7-13-25(18,3)23-20(27)14-26(4)17(15(2)9-12-21(28)29)10-11-19(26)22(23)24(16)30/h15-20,22-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18+,19?,20+,22?,23?,24-,25+,26-/m1/s1 D0WA9U DRUGINKE IMDDBKRWRHUMNT-QAUCXMOESA-N D0WA9U DRUGSMIL CCC1C2CCCCC2(C3C(CC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)O)C D0WA9U HIGHSTAT Patented D0WC8M DRUG__ID D0WC8M D0WC8M DRUGCOMP Arena Pharmaceuticals, Inc D0WC8M DRUGTYPE Small molecular drug D0WC8M DRUGINCH 1S/C17H13BrF3N3/c1-24-16(15(18)10-22-24)11-3-2-4-14(9-11)23-13-7-5-12(6-8-13)17(19,20)21/h2-10,23H,1H3 D0WC8M DRUGINKE ZAIICAYGFBFTHL-UHFFFAOYSA-N D0WC8M DRUGSMIL CN1C(=C(C=N1)Br)C2=CC(=CC=C2)NC3=CC=C(C=C3)C(F)(F)F D0WC8M HIGHSTAT Patented D0WD0M DRUG__ID D0WD0M D0WD0M DRUGCOMP UNIV WARSZAWSKI [PLCT MEDYCZNE KSZTALCENIA PODYPLOMOWEGO [PL] D0WD0M DRUGTYPE Small molecular drug D0WD0M DRUGINCH 1S/C33H41N5O3/c1-22(39)35-18-15-23(20-31(41-33(34)40)25-13-14-28-24(21-25)16-19-36-28)8-6-7-17-37-32-26-9-2-4-11-29(26)38-30-12-5-3-10-27(30)32/h2,4,9,11,13-14,16,19,21,23,31,36H,3,5-8,10,12,15,17-18,20H2,1H3,(H2,34,40)(H,35,39)(H,37,38) D0WD0M DRUGINKE YSPYIIMVNQAFBG-UHFFFAOYSA-N D0WD0M DRUGSMIL CC(=O)NCCC(CCCCNC1=C2CCCCC2=NC3=CC=CC=C31)CC(C4=CC5=C(C=C4)NC=C5)OC(=O)N D0WD0M HIGHSTAT Patented D0WD8Z DRUG__ID D0WD8Z D0WD8Z DRUGCOMP BIOGEN MA INC D0WD8Z DRUGTYPE Small molecular drug D0WD8Z DRUGINCH 1S/C28H44N2O3/c1-2-3-4-5-6-7-22-33-25-10-8-24(9-11-25)30-20-18-29(19-21-30)23-27-12-15-28(16-13-27,17-14-27)26(31)32/h8-11H,2-7,12-23H2,1H3,(H,31,32) D0WD8Z DRUGINKE BBLBOXJIVAKNRT-UHFFFAOYSA-N D0WD8Z DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)N2CCN(CC2)CC34CCC(CC3)(CC4)C(=O)O D0WD8Z HIGHSTAT Patented D0WG5P DRUG__ID D0WG5P D0WG5P DRUGCOMP EBERHARD KARLS UNIVERSIT TINGEN WERZ, Oliver KOEBERLE, Andreas D0WG5P DRUGTYPE Small molecular drug D0WG5P DRUGINCH 1S/C38H52O10/c1-15(2)18(22-29(43)35(7,8)33(47)36(9,10)30(22)44)20-26(40)21(28(42)24(27(20)41)25(39)17(5)6)19(16(3)4)23-31(45)37(11,12)34(48)38(13,14)32(23)46/h15-19,40-43,45H,1-14H3 D0WG5P DRUGINKE BIHONVMOJSPPFL-UHFFFAOYSA-N D0WG5P DRUGSMIL CC(C)C(C1=C(C(=C(C(=C1O)C(=O)C(C)C)O)C(C2=C(C(C(=O)C(C2=O)(C)C)(C)C)O)C(C)C)O)C3=C(C(C(=O)C(C3=O)(C)C)(C)C)O D0WG5P HIGHSTAT Patented D0WH1K DRUG__ID D0WH1K D0WH1K DRUGCOMP PROXIMAGEN LIMITED D0WH1K DRUGTYPE Small molecular drug D0WH1K DRUGINCH 1S/C21H18ClN3O/c22-19-17(15-5-2-1-3-6-15)7-4-8-18(19)21(26)25-13-14-9-11-16(12-10-14)20(23)24/h1-12H,13H2,(H3,23,24)(H,25,26) D0WH1K DRUGINKE HZBJZCWAIZICKW-UHFFFAOYSA-N D0WH1K DRUGSMIL C1=CC=C(C=C1)C2=C(C(=CC=C2)C(=O)NCC3=CC=C(C=C3)C(=N)N)Cl D0WH1K HIGHSTAT Patented D0WI0P DRUG__ID D0WI0P D0WI0P DRUGCOMP MERCK SHARP & DOHME CORP. BARROW, James, C. BILODEAU, Mark, T. COX, Christopher, D. HARTNETT, John, C. KETT, Nathan, R. LI, Yiwei MANLEY, Peter MELAMED, Jeffrey SHIPE, William, D. TROTTER, B. Wesley ZARTMAN, Amy, E D0WI0P DRUGTYPE Small molecular drug D0WI0P DRUGINCH 1S/C28H41N3O3/c1-4-28(2,14-15-30-16-18-34-19-17-30)31(27(33)22-10-6-5-7-11-22)21-24-20-23-12-8-9-13-25(23)29(3)26(24)32/h8-9,12-13,20,22H,4-7,10-11,14-19,21H2,1-3H3 D0WI0P DRUGINKE FWHNGUFKFXDMER-UHFFFAOYSA-N D0WI0P DRUGSMIL CCC(C)(CCN1CCOCC1)N(CC2=CC3=CC=CC=C3N(C2=O)C)C(=O)C4CCCCC4 D0WI0P HIGHSTAT Patented D0WI9M DRUG__ID D0WI9M D0WI9M DRUGCOMP GSK D0WI9M DRUGTYPE Small molecular drug D0WI9M DRUGINCH 1S/C17H15ClF3N5O2/c1-25-12(9-26(16(25)28)15-22-6-3-7-23-15)14(27)24-8-10-4-2-5-11(13(10)18)17(19,20)21/h2-7,12H,8-9H2,1H3,(H,24,27) D0WI9M DRUGINKE VEJSCJTUSBXATQ-UHFFFAOYSA-N D0WI9M DRUGSMIL CN1C(CN(C1=O)C2=NC=CC=N2)C(=O)NCC3=C(C(=CC=C3)C(F)(F)F)Cl D0WI9M HIGHSTAT Patented D0WK8I DRUG__ID D0WK8I D0WK8I DRUGTYPE Small molecular drug D0WK8I DRUGINCH 1S/C23H28N2O3S/c26-23(18-8-2-1-3-9-18)25-19-13-14-20(25)16-24(15-19)29(27,28)22-12-6-10-17-7-4-5-11-21(17)22/h4-7,10-12,18-20H,1-3,8-9,13-16H2 D0WK8I DRUGINKE REHIEVFQRQVSNB-UHFFFAOYSA-N D0WK8I DRUGSMIL C1CCC(CC1)C(=O)N2C3CCC2CN(C3)S(=O)(=O)C4=CC=CC5=CC=CC=C54 D0WK8I HIGHSTAT Patented D0WK8I COMPCLAS Sulfonylated piperazine derivatives D0WL1U DRUG__ID D0WL1U D0WL1U DRUGCOMP ARIAD PHARMACEUTICALS, INC. HUANG, Wei-sheng RIVERA, Victor, M. CLACKSON, Timothy, P. SHAKESPEARE, William, C. SQUILLACE, Rachel, M. GOZGIT, Joseph, M D0WL1U DRUGTYPE Small molecular drug D0WL1U DRUGINCH 1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) D0WL1U DRUGINKE PHXJVRSECIGDHY-UHFFFAOYSA-N D0WL1U DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5 D0WL1U HIGHSTAT Patented D0WN1Y DRUG__ID D0WN1Y D0WN1Y DRUGCOMP REATA PHARMACEUTICALS, INC D0WN1Y DRUGTYPE Small molecular drug D0WN1Y DRUGINCH 1S/C33H46N2O3/c1-9-25(37)35-33-14-12-28(2,3)18-21(33)26-22(36)16-24-30(6)17-20(19-34)27(38)29(4,5)23(30)10-11-31(24,7)32(26,8)13-15-33/h16-17,21,23,26H,9-15,18H2,1-8H3,(H,35,37)/t21?,23-,26?,30-,31+,32+,33-/m0/s1 D0WN1Y DRUGINKE GTBWGDPMQABIQD-RYMYCHIXSA-N D0WN1Y DRUGSMIL CCC(=O)NC12CCC(CC1C3C(=O)C=C4C(C3(CC2)C)(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C D0WN1Y HIGHSTAT Patented D0WQ9X DRUG__ID D0WQ9X D0WQ9X DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0WQ9X DRUGTYPE Small molecule immunotherapy D0WQ9X DRUGINCH 1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29) D0WQ9X DRUGINKE JEDPSOYOYVELLZ-UHFFFAOYSA-N D0WQ9X DRUGSMIL CC1=C(C=CC=C1C2=CC=CC=C2)COC3=NC(=C(C=C3)CNCCNC(=O)C)OC D0WQ9X HIGHSTAT Patented D0WR0Q DRUG__ID D0WR0Q D0WR0Q DRUGCOMP GLENMARK PHARMACEUTICALS S.A D0WR0Q DRUGTYPE Small molecular drug D0WR0Q DRUGINCH 1S/C22H19ClF4N4O2/c1-21(2,3)19(32)29-10-12-4-6-13(23)17(18(12)24)15-8-14(30-20(33)31-15)11-5-7-16(28-9-11)22(25,26)27/h4-9H,10H2,1-3H3,(H,29,32)(H,30,31,33) D0WR0Q DRUGINKE CHFIXQQTHCXPKE-UHFFFAOYSA-N D0WR0Q DRUGSMIL CC(C)(C)C(=O)NCC1=C(C(=C(C=C1)Cl)C2=CC(=NC(=O)N2)C3=CN=C(C=C3)C(F)(F)F)F D0WR0Q HIGHSTAT Patented D0WT1C DRUG__ID D0WT1C D0WT1C DRUGTYPE Small molecular drug D0WT1C DRUGINCH 1S/C14H8F3NO2S/c15-14(16,17)7-1-4-12-10(5-7)18-13(21-12)9-3-2-8(19)6-11(9)20/h1-6,19-20H D0WT1C DRUGINKE XQUCXFZBRZZCKD-UHFFFAOYSA-N D0WT1C DRUGSMIL C1=CC2=C(C=C1C(F)(F)F)N=C(S2)C3=C(C=C(C=C3)O)O D0WT1C HIGHSTAT Patented D0WT1C COMPCLAS Benzothiazole analogs D0WT1W DRUG__ID D0WT1W D0WT1W DRUGCOMP Sanofi D0WT1W DRUGTYPE Small molecular drug D0WT1W DRUGINCH 1S/C25H21F4N5O/c26-19-5-3-4-16(10-19)15-34-21(12-17-11-18(25(27,28)29)13-31-23(17)34)24(35)32-20-6-7-22(30-14-20)33-8-1-2-9-33/h3-7,10-14H,1-2,8-9,15H2,(H,32,35) D0WT1W DRUGINKE IZIWMKBKLZPSFO-UHFFFAOYSA-N D0WT1W DRUGSMIL C1CCN(C1)C2=NC=C(C=C2)NC(=O)C3=CC4=CC(=CN=C4N3CC5=CC(=CC=C5)F)C(F)(F)F D0WT1W HIGHSTAT Patented D0WW1Z DRUG__ID D0WW1Z D0WW1Z DRUGCOMP BOSTON BIOMEDICAL, INC. JIANG, Zhiwei LI, Chiang, Jia LI, Wei LEGGETT, David D0WW1Z DRUGTYPE Small molecular drug D0WW1Z DRUGINCH 1S/C14H7FO4/c1-6(16)11-5-10-12(17)8-3-2-7(15)4-9(8)13(18)14(10)19-11/h2-5H,1H3 D0WW1Z DRUGINKE RPCXZIRGAHYOKZ-UHFFFAOYSA-N D0WW1Z DRUGSMIL CC(=O)C1=CC2=C(O1)C(=O)C3=C(C2=O)C=CC(=C3)F D0WW1Z HIGHSTAT Patented D0WX4W DRUG__ID D0WX4W D0WX4W DRUGCOMP PHARMESTE S.R.L. NAPOLETANO, Mauro TREVISANI, Marcello PAVANI, Maria Giovanna FRUTTAROLO, Francesca D0WX4W DRUGTYPE Small molecular drug D0WX4W DRUGINCH 1S/C20H20F3N5O2/c21-20(22,23)13-7-6-12(16(10-13)28-8-1-2-9-28)11-24-18(29)25-14-4-3-5-15-17(14)27-19(30)26-15/h3-7,10H,1-2,8-9,11H2,(H2,24,25,29)(H2,26,27,30) D0WX4W DRUGINKE GUWJRCUFOIXCMK-UHFFFAOYSA-N D0WX4W DRUGSMIL C1CCN(C1)C2=C(C=CC(=C2)C(F)(F)F)CNC(=O)NC3=CC=CC4=C3NC(=O)N4 D0WX4W HIGHSTAT Patented D0X0RV DRUG__ID D0X0RV D0X0RV DRUGCOMP Boiteau JG, Barbuis CM, Bouquet K D0X0RV DRUGTYPE Small molecular drug D0X0RV DRUGINCH 1S/C8H8N2S2/c1-5-2-7(12-4-5)6-3-9-8(11)10-6/h2-4H,1H3,(H2,9,10,11) D0X0RV DRUGINKE KEJRMOMLDKMMDC-UHFFFAOYSA-N D0X0RV DRUGSMIL CC1=CSC(=C1)C2=CNC(=S)N2 D0X0RV HIGHSTAT Patented D0X0VH DRUG__ID D0X0VH D0X0VH DRUGCOMP ZHANG, Dawei D0X0VH DRUGTYPE Small molecular drug D0X0VH DRUGINCH 1S/C31H31F4N7O/c1-3-41-11-13-42(14-12-41)19-23-7-6-21(15-25(23)31(33,34)35)29(43)38-24-16-26(32)20(2)28(17-24)40-30-37-10-8-27(39-30)22-5-4-9-36-18-22/h4-10,15-18H,3,11-14,19H2,1-2H3,(H,38,43)(H,37,39,40) D0X0VH DRUGINKE CQBGILGFZXYQMT-UHFFFAOYSA-N D0X0VH DRUGSMIL CCN1CCN(CC1)CC2=C(C=C(C=C2)C(=O)NC3=CC(=C(C(=C3)F)C)NC4=NC=CC(=N4)C5=CN=CC=C5)C(F)(F)F D0X0VH HIGHSTAT Patented D0X0ZC DRUG__ID D0X0ZC D0X0ZC DRUGCOMP LYTIX BIOPHARMA AS D0X0ZC DRUGTYPE Small molecular drug D0X0ZC DRUGINCH 1S/C9H7N3O3S/c1-5(13)10-9-11-7-3-2-6(12(14)15)4-8(7)16-9/h2-4H,1H3,(H,10,11,13) D0X0ZC DRUGINKE XARDSBCDZPSYTN-UHFFFAOYSA-N D0X0ZC DRUGSMIL CC(=O)NC1=NC2=C(S1)C=C(C=C2)[N+](=O)[O-] D0X0ZC HIGHSTAT Patented D0X1MK DRUG__ID D0X1MK D0X1MK DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0X1MK DRUGTYPE Small molecular drug D0X1MK DRUGINCH 1S/C21H29N5O2/c1-5-12-25(6-2)13-14-26-17(15-16-10-8-7-9-11-16)22-19-18(26)20(27)24(4)21(28)23(19)3/h7-11H,5-6,12-15H2,1-4H3 D0X1MK DRUGINKE PKUZGRWGAWHGEF-UHFFFAOYSA-N D0X1MK DRUGSMIL CCCN(CC)CCN1C(=NC2=C1C(=O)N(C(=O)N2C)C)CC3=CC=CC=C3 D0X1MK HIGHSTAT Patented D0X1OO DRUG__ID D0X1OO D0X1OO DRUGCOMP GRUENENTHAL GMBH [DE] D0X1OO DRUGTYPE Small molecular drug D0X1OO DRUGINCH 1S/C23H20ClF3N4O2/c1-13(19-12-30(2)20-7-6-17(32)10-18(19)20)22(33)28-11-16-9-21(23(25,26)27)29-31(16)15-5-3-4-14(24)8-15/h3-10,12-13,32H,11H2,1-2H3,(H,28,33) D0X1OO DRUGINKE OSCHEDGPGHRWRA-UHFFFAOYSA-N D0X1OO DRUGSMIL CC(C1=CN(C2=C1C=C(C=C2)O)C)C(=O)NCC3=CC(=NN3C4=CC(=CC=C4)Cl)C(F)(F)F D0X1OO HIGHSTAT Patented D0X2AU DRUG__ID D0X2AU D0X2AU DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher Joseph ROSE, Nathan SEKIRNIK, Rok D0X2AU DRUGTYPE Small molecular drug D0X2AU DRUGINCH 1S/C6H6O2Se/c7-9(8)6-4-2-1-3-5-6/h1-5H,(H,7,8) D0X2AU DRUGINKE WIHKGDVGLJJAMC-UHFFFAOYSA-N D0X2AU DRUGSMIL C1=CC=C(C=C1)[Se](=O)O D0X2AU HIGHSTAT Patented D0X5MW DRUG__ID D0X5MW D0X5MW DRUGCOMP CENTRE NAT RECH SCIENT [FRUNIV ORLEANS [FRROUTIER SYLVAIN [FRGUILLAUMET GERALD [FRTIKAD ABDELLATIF [BEDEHBI OUSSAMA [FR] D0X5MW DRUGTYPE Small molecular drug D0X5MW DRUGINCH 1S/C18H16N4O2/c23-14-6-4-12(5-7-14)18-20-11-16-15(21-18)9-13(10-19-16)22-8-2-1-3-17(22)24/h4-7,9-11,23H,1-3,8H2 D0X5MW DRUGINKE GIUNPBXEXJKOFE-UHFFFAOYSA-N D0X5MW DRUGSMIL C1CCN(C(=O)C1)C2=CC3=NC(=NC=C3N=C2)C4=CC=C(C=C4)O D0X5MW HIGHSTAT Patented D0X5VH DRUG__ID D0X5VH D0X5VH DRUGCOMP UNILEVER PLC UNILEVER N.V. HINDUSTAN UNILEVER LIMITED ROSA, Jose, Guillermo HARICHIAN, Bijan DRENNAN, Diana, Jean BAJOR, John, Steven BOSKO, Carol, Annette D0X5VH DRUGTYPE Small molecular drug D0X5VH DRUGINCH 1S/C17H21NO2/c1-19-16-8-9-17(20-2)15(12-16)13-18-11-10-14-6-4-3-5-7-14/h3-9,12,18H,10-11,13H2,1-2H3 D0X5VH DRUGINKE IAEIRIQVUSGNFI-UHFFFAOYSA-N D0X5VH DRUGSMIL COC1=CC(=C(C=C1)OC)CNCCC2=CC=CC=C2 D0X5VH HIGHSTAT Patented D0X5ZS DRUG__ID D0X5ZS D0X5ZS DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0X5ZS DRUGTYPE Small molecular drug D0X5ZS DRUGINCH 1S/C19H33N3O4/c1-18(2,13-24-6)15-11-16(26-21-15)20-17(23)19(3,4)22(5)12-14-7-9-25-10-8-14/h11,14H,7-10,12-13H2,1-6H3,(H,20,23) D0X5ZS DRUGINKE FTTMRXSESRGDGE-UHFFFAOYSA-N D0X5ZS DRUGSMIL CC(C)(COC)C1=NOC(=C1)NC(=O)C(C)(C)N(C)CC2CCOCC2 D0X5ZS HIGHSTAT Patented D0X6SJ DRUG__ID D0X6SJ D0X6SJ DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher Joseph ROSE, Nathan SEKIRNIK, Rok D0X6SJ DRUGTYPE Small molecular drug D0X6SJ DRUGINCH 1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H D0X6SJ DRUGINKE DYEFUKCXAQOFHX-UHFFFAOYSA-N D0X6SJ DRUGSMIL C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2 D0X6SJ HIGHSTAT Patented D0X7OF DRUG__ID D0X7OF D0X7OF DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED YANG, Xiaoqing HADIDA RUAH, Sara, S. GROOTENHUIS, Peter, D.J. VAN GOOR, Fredrick, F. BOTFIELD, Martyn, C. ZLOKARNIK, Gregor D0X7OF DRUGTYPE Small molecular drug D0X7OF DRUGINCH 1S/C15H16N2O2S/c1-9-5-10(2)7-11(6-9)8-13(18)17-15-12(14(16)19)3-4-20-15/h3-7H,8H2,1-2H3,(H2,16,19)(H,17,18) D0X7OF DRUGINKE DXUHHRPREFMGHI-UHFFFAOYSA-N D0X7OF DRUGSMIL CC1=CC(=CC(=C1)CC(=O)NC2=C(C=CS2)C(=O)N)C D0X7OF HIGHSTAT Patented D0X8NN DRUG__ID D0X8NN D0X8NN DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) UNIVERSITE DE REIMS CHAMPAGNE-ARDENNE UNIVERSITE PARIS DIDEROT PARIS 7 D0X8NN DRUGTYPE Small molecular drug D0X8NN DRUGINCH 1S/C19H14N2O3/c22-14-4-1-11(2-5-14)16-10-21-19-15(16)7-13(9-20-19)12-3-6-17(23)18(24)8-12/h1-10,22-24H,(H,20,21) D0X8NN DRUGINKE HBCKPNCVCXUSEU-UHFFFAOYSA-N D0X8NN DRUGSMIL C1=CC(=CC=C1C2=CNC3=C2C=C(C=N3)C4=CC(=C(C=C4)O)O)O D0X8NN HIGHSTAT Patented D0X8TY DRUG__ID D0X8TY D0X8TY DRUGTYPE Small molecular drug D0X8TY DRUGINCH 1S/C43H52N8O4/c1-9-48(10-2)38(52)26-36-40(46-50-30(7)24-28(5)44-42(36)50)32-14-18-34(19-15-32)54-22-13-23-55-35-20-16-33(17-21-35)41-37(27-39(53)49(11-3)12-4)43-45-29(6)25-31(8)51(43)47-41/h14-21,24-25H,9-13,22-23,26-27H2,1-8H3 D0X8TY DRUGINKE NTCLVQPBPKMEFJ-UHFFFAOYSA-N D0X8TY DRUGSMIL CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OCCCOC4=CC=C(C=C4)C5=NN6C(=CC(=NC6=C5CC(=O)N(CC)CC)C)C)C)C D0X8TY HIGHSTAT Patented D0X8TY COMPCLAS Bidentate pyrazolopyrimidine acetamide analogs D0XB1S DRUG__ID D0XB1S D0XB1S DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D0XB1S DRUGTYPE Small molecular drug D0XB1S DRUGINCH 1S/C17H19N5/c18-11-13-12-19-17(21-15-9-5-2-6-10-15)22-16(13)20-14-7-3-1-4-8-14/h1,3-4,7-8,12,15H,2,5-6,9-10H2,(H2,19,20,21,22) D0XB1S DRUGINKE HKWATPBSDKRVFA-UHFFFAOYSA-N D0XB1S DRUGSMIL C1CCC(CC1)NC2=NC=C(C(=N2)NC3=CC=CC=C3)C#N D0XB1S HIGHSTAT Patented D0XH9K DRUG__ID D0XH9K D0XH9K DRUGCOMP F. HOFFMANN-LA ROCHE AG D0XH9K DRUGTYPE Small molecular drug D0XH9K DRUGINCH 1S/C26H23ClN4O2/c27-20-9-10-22-23(14-20)31(21-6-2-1-3-7-21)17-19(25(22)32)16-29-26(33)18-8-11-24(28-15-18)30-12-4-5-13-30/h1-3,6-11,14-15,17H,4-5,12-13,16H2,(H,29,33) D0XH9K DRUGINKE RUQWOHJJIMCQMH-UHFFFAOYSA-N D0XH9K DRUGSMIL C1CCN(C1)C2=NC=C(C=C2)C(=O)NCC3=CN(C4=C(C3=O)C=CC(=C4)Cl)C5=CC=CC=C5 D0XH9K HIGHSTAT Patented D0XM8B DRUG__ID D0XM8B D0XM8B DRUGCOMP KAINOS MEDICINE, INC D0XM8B DRUGTYPE Small molecular drug D0XM8B DRUGINCH 1S/C24H22ClN7O4S/c1-14-29-30-24-20(13-36-37(2,34)35)28-23(15-3-6-18(25)7-4-15)19-9-16(5-8-21(19)32(14)24)17-10-27-31(11-17)12-22(26)33/h3-11,20H,12-13H2,1-2H3,(H2,26,33)/t20-/m0/s1 D0XM8B DRUGINKE ZZJJMUOPZJGNMG-FQEVSTJZSA-N D0XM8B DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)C4=CN(N=C4)CC(=O)N)C(=NC2COS(=O)(=O)C)C5=CC=C(C=C5)Cl D0XM8B HIGHSTAT Patented D0XQ3F DRUG__ID D0XQ3F D0XQ3F DRUGCOMP UNIVERSITY OF SOUTH FLORIDA TURKSON, James JOVE, Richard SEBTI, Said, M. HAMILTON, Andrew, D D0XQ3F DRUGTYPE Small molecular drug D0XQ3F DRUGINCH 1S/C23H26N3O8P/c1-14(2)11-20(23(29)30)26-22(28)19(25-21(27)17-7-3-16(13-24)4-8-17)12-15-5-9-18(10-6-15)34-35(31,32)33/h3-10,14,19-20H,11-12H2,1-2H3,(H,25,27)(H,26,28)(H,29,30)(H2,31,32,33)/t19-,20-/m0/s1 D0XQ3F DRUGINKE HXSAWUQKNZJUNW-PMACEKPBSA-N D0XQ3F DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C2=CC=C(C=C2)C#N D0XQ3F HIGHSTAT Patented D0XQ5F DRUG__ID D0XQ5F D0XQ5F DRUGCOMP SUN PHARMA ADVANCED RESEARCH COMPANY LTD., SENGUPTA, Prabal PURI, Chetan Surjitsingh CHOKSHI, Hemantkumar CHITTURI, Trinadha Rao THENNATI, Rajamannar D0XQ5F DRUGTYPE Small molecular drug D0XQ5F DRUGINCH 1S/C25H21IN6O2/c1-15-8-9-17(23(33)31-32-24(34)22-16(2)5-3-7-19(22)26)13-21(15)30-25-28-12-10-20(29-25)18-6-4-11-27-14-18/h3-14H,1-2H3,(H,31,33)(H,32,34)(H,28,29,30) D0XQ5F DRUGINKE KRUFMIXJJSFERC-UHFFFAOYSA-N D0XQ5F DRUGSMIL CC1=C(C(=CC=C1)I)C(=O)NNC(=O)C2=CC(=C(C=C2)C)NC3=NC=CC(=N3)C4=CN=CC=C4 D0XQ5F HIGHSTAT Patented D0XS3N DRUG__ID D0XS3N D0XS3N DRUGTYPE Small molecular drug D0XS3N DRUGINCH 1S/C24H27F2NO3/c1-29-20-12-18-14-24(26,22(28)19(18)13-21(20)30-2)16-23(25)8-10-27(11-9-23)15-17-6-4-3-5-7-17/h3-7,12-13H,8-11,14-16H2,1-2H3 D0XS3N DRUGINKE FMFDCMLVUWZCIV-UHFFFAOYSA-N D0XS3N DRUGSMIL COC1=C(C=C2C(=C1)CC(C2=O)(CC3(CCN(CC3)CC4=CC=CC=C4)F)F)OC D0XS3N HIGHSTAT Patented D0XS3N COMPCLAS Fluorinated donepezil derivatives D0XT4V DRUG__ID D0XT4V D0XT4V DRUGCOMP AUCKLAND UNISERVICES LIMITED D0XT4V DRUGTYPE Small molecular drug D0XT4V DRUGINCH 1S/C6H3ClFN3O/c7-4-3(8)1-2-5(9)11-12-6(2)10-4/h1H,(H2,9,11) D0XT4V DRUGINKE MTIDNIWREKNKHM-UHFFFAOYSA-N D0XT4V DRUGSMIL C1=C2C(=NOC2=NC(=C1F)Cl)N D0XT4V HIGHSTAT Patented D0XU3A DRUG__ID D0XU3A D0XU3A DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA DAR, Arvin SHOKAT, Kevan M D0XU3A DRUGTYPE Small molecular drug D0XU3A DRUGINCH 1S/C28H28F3N7O2/c1-16(2)38-25-22(24(32-15-33-25)36-26(39)18-6-3-4-7-18)23(37-38)17-10-12-20(13-11-17)34-27(40)35-21-9-5-8-19(14-21)28(29,30)31/h5,8-16,18H,3-4,6-7H2,1-2H3,(H2,34,35,40)(H,32,33,36,39) D0XU3A DRUGINKE HXLONDQXUGAZKS-UHFFFAOYSA-N D0XU3A DRUGSMIL CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F)NC(=O)C5CCCC5 D0XU3A HIGHSTAT Patented D0XV2A DRUG__ID D0XV2A D0XV2A DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0XV2A DRUGTYPE Small molecular drug D0XV2A DRUGINCH 1S/C16H14O2/c17-16(12-11-14-7-3-1-4-8-14)18-13-15-9-5-2-6-10-15/h1-12H,13H2/b12-11+ D0XV2A DRUGINKE NGHOLYJTSCBCGC-VAWYXSNFSA-N D0XV2A DRUGSMIL C1=CC=C(C=C1)COC(=O)C=CC2=CC=CC=C2 D0XV2A HIGHSTAT Patented D0Y0PE DRUG__ID D0Y0PE D0Y0PE DRUGCOMP TERRABAY PHARMACEUTICALS, INC D0Y0PE DRUGTYPE Small molecular drug D0Y0PE DRUGINCH 1S/C31H24F5N7O/c1-18-4-5-19(9-26(18)42-29-38-8-6-25(41-29)20-3-2-7-37-15-20)28(44)40-23-10-22(31(34,35)36)11-24(12-23)43-16-27(39-17-43)21-13-30(32,33)14-21/h2-12,15-17,21H,13-14H2,1H3,(H,40,44)(H,38,41,42) D0Y0PE DRUGINKE FHMNIXSTLJZGDP-UHFFFAOYSA-N D0Y0PE DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C4CC(C4)(F)F)NC5=NC=CC(=N5)C6=CN=CC=C6 D0Y0PE HIGHSTAT Patented D0Y0RS DRUG__ID D0Y0RS D0Y0RS DRUGCOMP GLAXOSMITHKLINE LLC CHRISTENSEN, Siegfried, Benjamin, IV QIN, Donghui CHEN, Shenglin HUANG, Xing LI, Di LI, Fei LIN, Xiaojuan LU, Shi LV, Maoyun WU, Chengde XU, Weiliang YAN, Gang YUAN, Jianxing ZHANG, Weina ZHANG, Zhiliu D0Y0RS DRUGTYPE Small molecular drug D0Y0RS DRUGINCH 1S/C21H21ClN4O3/c22-15-3-4-16(23-11-15)14-29-19-7-9-26(21(28)10-19)17-5-6-20(24-12-17)25-8-1-2-18(25)13-27/h3-7,9-12,18,27H,1-2,8,13-14H2/t18-/m1/s1 D0Y0RS DRUGINKE FLLZLALIXHIFNL-GOSISDBHSA-N D0Y0RS DRUGSMIL C1CC(N(C1)C2=NC=C(C=C2)N3C=CC(=CC3=O)OCC4=NC=C(C=C4)Cl)CO D0Y0RS HIGHSTAT Patented D0Y1SI DRUG__ID D0Y1SI D0Y1SI DRUGCOMP PURDUE PHARMA LP [USSHIONOGI & CO [JPTAFESSE LAYKEA [USANDO SHIGERU [JPKUROSE NORIYUKI [JP] D0Y1SI DRUGTYPE Small molecular drug D0Y1SI DRUGINCH 1S/C20H21F2N5O3S/c1-11-9-26(18-14(22)6-12(8-23-18)16(29)10-28)4-5-27(11)20(30)25-19-24-15-7-13(21)2-3-17(15)31-19/h2-3,6-8,11,16,28-29H,4-5,9-10H2,1H3,(H,24,25,30)/t11-,16+/m0/s1 D0Y1SI DRUGINKE GVENNMJXQHKHOV-MEDUHNTESA-N D0Y1SI DRUGSMIL CC1CN(CCN1C(=O)NC2=NC3=C(S2)C=CC(=C3)F)C4=C(C=C(C=N4)C(CO)O)F D0Y1SI HIGHSTAT Patented D0Y2QO DRUG__ID D0Y2QO D0Y2QO DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0Y2QO DRUGTYPE Small molecular drug D0Y2QO DRUGINCH 1S/C20H16N4O2/c1-14(25)13-24-18(26)11-10-16(21-24)19-17-9-5-6-12-23(17)22-20(19)15-7-3-2-4-8-15/h2-12H,13H2,1H3 D0Y2QO DRUGINKE QATXIDMQXCGKIY-UHFFFAOYSA-N D0Y2QO DRUGSMIL CC(=O)CN1C(=O)C=CC(=N1)C2=C3C=CC=CN3N=C2C4=CC=CC=C4 D0Y2QO HIGHSTAT Patented D0Y3DN DRUG__ID D0Y3DN D0Y3DN DRUGCOMP UNIVERSITY OF SOUTH FLORIDA TAN, Jun LUO, Deyan D0Y3DN DRUGTYPE Small molecular drug D0Y3DN DRUGINCH 1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H D0Y3DN DRUGINKE REFJWTPEDVJJIY-UHFFFAOYSA-N D0Y3DN DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O D0Y3DN HIGHSTAT Patented D0Y3NZ DRUG__ID D0Y3NZ D0Y3NZ DRUGCOMP NOVARTIS AG CHIANELLI, Donatella LIU, Xiaodong MOLTENI, Valentina NELSON, John ROLAND, Jason RUCKER, Paul Vincent TULLY, David Charles D0Y3NZ DRUGTYPE Small molecular drug D0Y3NZ DRUGINCH 1S/C25H24ClFN4O3/c1-30-24-18-10-17(26)8-9-21(18)34-14-19(24)23(29-30)25(33)31(12-16-4-2-3-5-20(16)27)13-22(32)28-11-15-6-7-15/h2-5,8-10,15H,6-7,11-14H2,1H3,(H,28,32) D0Y3NZ DRUGINKE CQPYMJNUAFOXPI-UHFFFAOYSA-N D0Y3NZ DRUGSMIL CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC=CC=C4F)CC(=O)NCC5CC5 D0Y3NZ HIGHSTAT Patented D0Y4EU DRUG__ID D0Y4EU D0Y4EU DRUGCOMP CURIS, INC D0Y4EU DRUGTYPE Small molecular drug D0Y4EU DRUGINCH 1S/C24H31ClN8O3S/c1-15-7-6-8-17(25)22(15)32-23(35)18-14-28-24(37-18)31-20-13-19(29-16(2)30-20)27-12-11-26-10-5-3-4-9-21(34)33-36/h6-8,13-14,26,36H,3-5,9-12H2,1-2H3,(H,32,35)(H,33,34)(H2,27,28,29,30,31) D0Y4EU DRUGINKE FVPJJDVBEPNQCD-UHFFFAOYSA-N D0Y4EU DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)NCCNCCCCCC(=O)NO)C D0Y4EU HIGHSTAT Patented D0Y4HR DRUG__ID D0Y4HR D0Y4HR DRUGCOMP F. HOFFMANN-LA ROCHE AG D0Y4HR DRUGTYPE Small molecular drug D0Y4HR DRUGINCH 1S/C32H23ClN4O4/c33-23-11-12-25-27(18-23)37(24-9-5-2-6-10-24)29(32-34-14-16-41-32)26(30(25)39)19-35-31(40)22-13-15-36(28(38)17-22)20-21-7-3-1-4-8-21/h1-18H,19-20H2,(H,35,40) D0Y4HR DRUGINKE CDEQUNLOBIAUNN-UHFFFAOYSA-N D0Y4HR DRUGSMIL C1=CC=C(C=C1)CN2C=CC(=CC2=O)C(=O)NCC3=C(N(C4=C(C3=O)C=CC(=C4)Cl)C5=CC=CC=C5)C6=NC=CO6 D0Y4HR HIGHSTAT Patented D0Y6TX DRUG__ID D0Y6TX D0Y6TX DRUGCOMP Aston University D0Y6TX DRUGTYPE Small molecular drug D0Y6TX DRUGINCH 1S/C21H28N2O6S/c1-30(2)14-16(24)10-11-17(20(26)27)22-19(25)18-9-6-12-23(18)21(28)29-13-15-7-4-3-5-8-15/h3-5,7-8,17-18H,6,9-14H2,1-2H3,(H-,22,25,26,27)/p+1/t17-,18-/m0/s1 D0Y6TX DRUGINKE SKEWALVSEUJDCH-ROUUACIJSA-O D0Y6TX DRUGSMIL C[S+](C)CC(=O)CCC(C(=O)O)NC(=O)C1CCCN1C(=O)OCC2=CC=CC=C2 D0Y6TX HIGHSTAT Patented D0Y9TP DRUG__ID D0Y9TP D0Y9TP DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0Y9TP DRUGTYPE Small molecular drug D0Y9TP DRUGINCH 1S/C20H18N4O/c1-2-13-24-18(25)12-11-16(21-24)19-17-10-6-7-14-23(17)22-20(19)15-8-4-3-5-9-15/h3-12,14H,2,13H2,1H3 D0Y9TP DRUGINKE ATTQDJZYFIDUQX-UHFFFAOYSA-N D0Y9TP DRUGSMIL CCCN1C(=O)C=CC(=N1)C2=C3C=CC=CN3N=C2C4=CC=CC=C4 D0Y9TP HIGHSTAT Patented D0YC2M DRUG__ID D0YC2M D0YC2M DRUGCOMP KARUS THERAPEUTICS LTD D0YC2M DRUGTYPE Small molecular drug D0YC2M DRUGINCH 1S/C20H15FN4O3/c21-15-9-10-18(22-11-15)25(20-23-16-3-1-2-4-17(16)28-20)12-13-5-7-14(8-6-13)19(26)24-27/h1-11,27H,12H2,(H,24,26) D0YC2M DRUGINKE CJXJBYDELMRNKR-UHFFFAOYSA-N D0YC2M DRUGSMIL C1=CC=C2C(=C1)N=C(O2)N(CC3=CC=C(C=C3)C(=O)NO)C4=NC=C(C=C4)F D0YC2M HIGHSTAT Patented D0YD7B DRUG__ID D0YD7B D0YD7B DRUGCOMP KARUS THERAPEUTICS LTD D0YD7B DRUGTYPE Small molecular drug D0YD7B DRUGINCH 1S/C15H21N5O2S/c1-12-17-15(23-19-12)20(13-8-5-6-10-16-13)11-7-3-2-4-9-14(21)18-22/h5-6,8,10,22H,2-4,7,9,11H2,1H3,(H,18,21) D0YD7B DRUGINKE OMIWXFMPPYEWJD-UHFFFAOYSA-N D0YD7B DRUGSMIL CC1=NSC(=N1)N(CCCCCCC(=O)NO)C2=CC=CC=N2 D0YD7B HIGHSTAT Patented D0YK6K DRUG__ID D0YK6K D0YK6K DRUGCOMP IKERCHEM S L [ESUNIV DEL PA S VASCO [ES] D0YK6K DRUGTYPE Small molecular drug D0YK6K DRUGINCH 1S/C32H29NO11/c1-17(34)41-27-9-7-21(11-29(27)43-19(3)36)24-15-33(25-13-23(39-5)14-31(40-6)32(24)25)16-26(38)22-8-10-28(42-18(2)35)30(12-22)44-20(4)37/h7-15H,16H2,1-6H3 D0YK6K DRUGINKE NMWWCTXMWYUUNT-UHFFFAOYSA-N D0YK6K DRUGSMIL CC(=O)OC1=C(C=C(C=C1)C2=CN(C3=C2C(=CC(=C3)OC)OC)CC(=O)C4=CC(=C(C=C4)OC(=O)C)OC(=O)C)OC(=O)C D0YK6K HIGHSTAT Patented D0YK9Q DRUG__ID D0YK9Q D0YK9Q DRUGCOMP ALIOS BIOPHARMA, INC D0YK9Q DRUGTYPE Small molecular drug D0YK9Q DRUGINCH 1S/C24H23F2N3O3/c1-13(2)32-23(31)15-11-29(22(30)14-7-8-16(25)17(26)10-14)12-24(3,4)19-20(15)28-18-6-5-9-27-21(18)19/h5-11,13,28H,12H2,1-4H3 D0YK9Q DRUGINKE LHMOWNHVOCSXKQ-UHFFFAOYSA-N D0YK9Q DRUGSMIL CC(C)OC(=O)C1=CN(CC(C2=C1NC3=C2N=CC=C3)(C)C)C(=O)C4=CC(=C(C=C4)F)F D0YK9Q HIGHSTAT Patented D0YM1M DRUG__ID D0YM1M D0YM1M DRUGCOMP Japan Tobacco, Inc D0YM1M DRUGTYPE Small molecular drug D0YM1M DRUGINCH 1S/C25H25F2N3O4/c1-14(2)34-24-19(26)9-16(10-20(24)27)29-25(32)18-5-4-6-21-23(18)33-13-17(12-31)30(21)22-8-7-15(3)11-28-22/h4-11,14,17,31H,12-13H2,1-3H3,(H,29,32)/t17-/m0/s1 D0YM1M DRUGINKE IUQNHNNDFBOZEL-KRWDZBQOSA-N D0YM1M DRUGSMIL CC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C(=O)NC4=CC(=C(C(=C4)F)OC(C)C)F)CO D0YM1M HIGHSTAT Patented D0YM2S DRUG__ID D0YM2S D0YM2S DRUGCOMP ARRAY BIOPHARMA INC D0YM2S DRUGTYPE Small molecular drug D0YM2S DRUGINCH 1S/C25H25F3N6O2/c1-16-22(19-13-30-33(2)14-19)32-34(20-7-5-4-6-8-20)23(16)31-24(35)29-12-18-11-17(15-36-3)9-10-21(18)25(26,27)28/h4-11,13-14H,12,15H2,1-3H3,(H2,29,31,35) D0YM2S DRUGINKE SBSBZPNKXQZAIG-UHFFFAOYSA-N D0YM2S DRUGSMIL CC1=C(N(N=C1C2=CN(N=C2)C)C3=CC=CC=C3)NC(=O)NCC4=C(C=CC(=C4)COC)C(F)(F)F D0YM2S HIGHSTAT Patented D0YN1X DRUG__ID D0YN1X D0YN1X DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN D0YN1X DRUGTYPE Small molecular drug D0YN1X DRUGINCH 1S/C62H74N12O8/c1-39(63-3)55(75)67-49-37-71(35-33-47-29-31-51(73(47)59(49)79)57(77)69-53(41-17-9-5-10-18-41)42-19-11-6-12-20-42)61(81)65-45-25-27-46(28-26-45)66-62(82)72-36-34-48-30-32-52(74(48)60(80)50(38-72)68-56(76)40(2)64-4)58(78)70-54(43-21-13-7-14-22-43)44-23-15-8-16-24-44/h5-28,39-40,47-54,63-64H,29-38H2,1-4H3,(H,65,81)(H,66,82)(H,67,75)(H,68,76)(H,69,77)(H,70,78)/t39-,40-,47+,48+,49-,50-,51-,52-/m0/s1 D0YN1X DRUGINKE SGWUDLNUDPDRSR-CEQBHCGOSA-N D0YN1X DRUGSMIL CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)NC5=CC=C(C=C5)NC(=O)N6CCC7CCC(N7C(=O)C(C6)NC(=O)C(C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC D0YN1X HIGHSTAT Patented D0YN2T DRUG__ID D0YN2T D0YN2T DRUGCOMP CHDI FOUNDATION, INC D0YN2T DRUGTYPE Small molecular drug D0YN2T DRUGINCH 1S/C19H16FN3O2/c1-12-21-10-15(11-22-12)13-6-8-14(9-7-13)18(19(24)23-25)16-4-2-3-5-17(16)20/h2-11,18,25H,1H3,(H,23,24) D0YN2T DRUGINKE SFXMVIQZYOMYOF-UHFFFAOYSA-N D0YN2T DRUGSMIL CC1=NC=C(C=N1)C2=CC=C(C=C2)C(C3=CC=CC=C3F)C(=O)NO D0YN2T HIGHSTAT Patented D0YT8O DRUG__ID D0YT8O D0YT8O DRUGCOMP AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH D0YT8O DRUGTYPE Small molecular drug D0YT8O DRUGINCH 1S/C26H35N7O4/c1-18(2)33-17-27-24-23(29-26(30-25(24)33)32-12-14-37-15-13-32)19-8-7-9-20(16-19)28-21(34)10-5-3-4-6-11-22(35)31-36/h7-9,16-18,36H,3-6,10-15H2,1-2H3,(H,28,34)(H,31,35) D0YT8O DRUGINKE QWBHGNUFZYWTSG-UHFFFAOYSA-N D0YT8O DRUGSMIL CC(C)N1C=NC2=C(N=C(N=C21)N3CCOCC3)C4=CC(=CC=C4)NC(=O)CCCCCCC(=O)NO D0YT8O HIGHSTAT Patented D0YU2R DRUG__ID D0YU2R D0YU2R DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D0YU2R DRUGTYPE Small molecular drug D0YU2R DRUGINCH 1S/C24H25N7O/c25-16-19-15-18(3-5-22(19)30-9-1-2-10-30)21-7-8-26-24(29-21)28-20-4-6-23(27-17-20)31-11-13-32-14-12-31/h3-8,15,17H,1-2,9-14H2,(H,26,28,29) D0YU2R DRUGINKE BEWCKABPPSBSRH-UHFFFAOYSA-N D0YU2R DRUGSMIL C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CN=C(C=C4)N5CCOCC5)C#N D0YU2R HIGHSTAT Patented D0YU9B DRUG__ID D0YU9B D0YU9B DRUGCOMP Amorepacific Corp D0YU9B DRUGTYPE Small molecular drug D0YU9B DRUGINCH 1S/C22H21F2N3O4S/c1-12(16-9-17(23)20(18(24)10-16)27-32(2,29)30)25-21(28)19-11-31-22(26-19)15-5-3-4-14(8-15)13-6-7-13/h3-5,8-13,27H,6-7H2,1-2H3,(H,25,28)/t12-/m1/s1 D0YU9B DRUGINKE PCQJGNGGTPQUOG-GFCCVEGCSA-N D0YU9B DRUGSMIL CC(C1=CC(=C(C(=C1)F)NS(=O)(=O)C)F)NC(=O)C2=COC(=N2)C3=CC(=CC=C3)C4CC4 D0YU9B HIGHSTAT Patented D0YV6S DRUG__ID D0YV6S D0YV6S DRUGCOMP KADMON CORPORATION, LLC D0YV6S DRUGTYPE Small molecular drug D0YV6S DRUGINCH 1S/C22H24N6O/c1-15(2)23-10-11-29-19-5-3-4-16(13-19)22-24-9-8-21(27-22)26-18-6-7-20-17(12-18)14-25-28-20/h3-9,12-15,23H,10-11H2,1-2H3,(H,25,28)(H,24,26,27) D0YV6S DRUGINKE CBUNAFRZRCOJEX-UHFFFAOYSA-N D0YV6S DRUGSMIL CC(C)NCCOC1=CC=CC(=C1)C2=NC=CC(=N2)NC3=CC4=C(C=C3)NN=C4 D0YV6S HIGHSTAT Patented D0YW4T DRUG__ID D0YW4T D0YW4T DRUGTYPE Small molecular drug D0YW4T DRUGINCH 1S/C13H16BrFN6O3S/c1-16-25(2,23)6-5-17-12-11(20-24-21-12)13(19-22)18-8-3-4-10(15)9(14)7-8/h3-4,7,22H,5-6H2,1-2H3,(H,17,21)(H,18,19) D0YW4T DRUGINKE LLCCKYPCVYUSQH-UHFFFAOYSA-N D0YW4T DRUGSMIL CN=S(=O)(C)CCNC1=NON=C1C(=NC2=CC(=C(C=C2)F)Br)NO D0YW4T HIGHSTAT Patented D0YW4T COMPCLAS Aryl sulphoxide imine derivatives D0YX0S DRUG__ID D0YX0S D0YX0S DRUGCOMP Kissei Pharmaceutical Co. Ltd D0YX0S DRUGTYPE Small molecular drug D0YX0S DRUGINCH 1S/C16H16N2O3/c1-2-3-4-11-9-18(10-12(11)8-17)13-5-6-14(16(20)21)15(19)7-13/h5-7,9-10,19H,2-4H2,1H3,(H,20,21) D0YX0S DRUGINKE IFZIPYWLVUUWDL-UHFFFAOYSA-N D0YX0S DRUGSMIL CCCCC1=CN(C=C1C#N)C2=CC(=C(C=C2)C(=O)O)O D0YX0S HIGHSTAT Patented D0YY4R DRUG__ID D0YY4R D0YY4R DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0YY4R DRUGTYPE Small molecular drug D0YY4R DRUGINCH 1S/C27H28BrFN6O2/c1-3-9-18(10-4-2)37-25-21(28)15-17(19-11-5-6-12-20(19)26-32-34-35-33-26)16-24(25)31-27(36)30-23-14-8-7-13-22(23)29/h5-8,11-16,18H,3-4,9-10H2,1-2H3,(H2,30,31,36)(H,32,33,34,35) D0YY4R DRUGINKE RCDIDCDPBBVKLP-UHFFFAOYSA-N D0YY4R DRUGSMIL CCCC(CCC)OC1=C(C=C(C=C1Br)C2=CC=CC=C2C3=NNN=N3)NC(=O)NC4=CC=CC=C4F D0YY4R HIGHSTAT Patented D0YZ1B DRUG__ID D0YZ1B D0YZ1B DRUGCOMP EPITHERAPEUTICS APS D0YZ1B DRUGTYPE Small molecular drug D0YZ1B DRUGINCH 1S/C13H16N4O2/c18-13(19)11-2-4-16-12(8-11)9-14-3-1-6-17-7-5-15-10-17/h2,4-5,7-8,10,14H,1,3,6,9H2,(H,18,19) D0YZ1B DRUGINKE HGXLVPBZRFKRHK-UHFFFAOYSA-N D0YZ1B DRUGSMIL C1=CN=C(C=C1C(=O)O)CNCCCN2C=CN=C2 D0YZ1B HIGHSTAT Patented D0YZ7D DRUG__ID D0YZ7D D0YZ7D DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia WICHMANN, Juergen WOLTERING, Thomas D0YZ7D DRUGTYPE Small molecular drug D0YZ7D DRUGINCH 1S/C20H13F5N6O2S/c21-18(22)15-7-14(12-4-5-17(27-8-12)20(23,24)25)29-19(30-15)31-9-16(28-10-31)11-2-1-3-13(6-11)34(26,32)33/h1-10,18H,(H2,26,32,33) D0YZ7D DRUGINKE OGTCWWKKFTYEFV-UHFFFAOYSA-N D0YZ7D DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)C2=CN(C=N2)C3=NC(=CC(=N3)C(F)F)C4=CN=C(C=C4)C(F)(F)F D0YZ7D HIGHSTAT Patented D0Z0DX DRUG__ID D0Z0DX D0Z0DX DRUGTYPE Small molecular drug D0Z0DX DRUGINCH 1S/C17H14ClNO3S/c1-17(2,16(20)21)22-12-6-3-10(4-7-12)15-19-13-9-11(18)5-8-14(13)23-15/h3-9H,1-2H3,(H,20,21) D0Z0DX DRUGINKE HJOJVKDSEPDKSE-UHFFFAOYSA-N D0Z0DX DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)C2=NC3=C(S2)C=CC(=C3)Cl D0Z0DX HIGHSTAT Patented D0Z0DX COMPCLAS Benzothiazole analogs D0Z0NC DRUG__ID D0Z0NC D0Z0NC DRUGCOMP EPIZYME, INC D0Z0NC DRUGTYPE Small molecular drug D0Z0NC DRUGINCH 1S/C31H38N6O2/c1-6-21(4)37-18-19(2)30-25(31(39)34-17-26-22(5)35-20(3)13-28(26)38)14-24(15-27(30)37)23-7-8-29(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,21,32H,6,9-12,17H2,1-5H3,(H,34,39)(H,35,38) D0Z0NC DRUGINKE GSJUSSJURDTFPS-UHFFFAOYSA-N D0Z0NC DRUGSMIL CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(NC(=CC5=O)C)C)C D0Z0NC HIGHSTAT Patented D0Z2IO DRUG__ID D0Z2IO D0Z2IO DRUGCOMP LG Life Sciences Ltd D0Z2IO DRUGTYPE Small molecular drug D0Z2IO DRUGINCH 1S/C19H15N3O2/c20-9-15-11-22(10-12-1-2-12)18-4-3-13(7-16(15)18)17-8-14(19(23)24)5-6-21-17/h3-8,11-12H,1-2,10H2,(H,23,24) D0Z2IO DRUGINKE MHJSHOXSYFENTO-UHFFFAOYSA-N D0Z2IO DRUGSMIL C1CC1CN2C=C(C3=C2C=CC(=C3)C4=NC=CC(=C4)C(=O)O)C#N D0Z2IO HIGHSTAT Patented D0Z2PC DRUG__ID D0Z2PC D0Z2PC DRUGTYPE Small molecular drug D0Z2PC DRUGINCH 1S/C24H23N5O4/c1-3-21(30)26-17-5-4-6-19(15-17)33-23-20-11-12-25-22(20)28-24(29-23)27-16-7-9-18(10-8-16)32-14-13-31-2/h3-12,15H,1,13-14H2,2H3,(H,26,30)(H2,25,27,28,29) D0Z2PC DRUGINKE GVVINAQSLGCCRZ-UHFFFAOYSA-N D0Z2PC DRUGSMIL COCCOC1=CC=C(C=C1)NC2=NC3=C(C=CN3)C(=N2)OC4=CC=CC(=C4)NC(=O)C=C D0Z2PC HIGHSTAT Patented D0Z2PC COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0Z4SW DRUG__ID D0Z4SW D0Z4SW DRUGCOMP NEOPHARM CO.,LTD. ( ) GWAK, Hyung Sub KIM, Yong Zu KIM, Uk Il PARK, Byeong Deog PARK, Tae Kyo WOO, Sung Ho D0Z4SW DRUGTYPE Small molecular drug D0Z4SW DRUGINCH 1S/C22H25N3O/c1-16-7-6-8-18(13-16)15-25-17(2)23-20-14-19(9-10-21(20)25)22(26)24-11-4-3-5-12-24/h6-10,13-14H,3-5,11-12,15H2,1-2H3 D0Z4SW DRUGINKE FWLBCCWBWAZRLY-UHFFFAOYSA-N D0Z4SW DRUGSMIL CC1=CC(=CC=C1)CN2C(=NC3=C2C=CC(=C3)C(=O)N4CCCCC4)C D0Z4SW HIGHSTAT Patented D0Z5HH DRUG__ID D0Z5HH D0Z5HH DRUGCOMP DAEWOONG PHARMACEUTICAL CO., LTD. KIM, Ji Duck YOON, Hong Chul KIM, In Woo CHO, Min Jae LEE, In Young LEE, Sang Ho PARK, Eun Kyung LIM, Kwon Jo NAM, Sang Hyun D0Z5HH DRUGTYPE Small molecular drug D0Z5HH DRUGINCH 1S/C22H18ClFN4O3/c1-30-13-5-6-20(25-9-13)28-12(10-29)11-31-21-14(3-2-4-19(21)28)22-26-17-7-15(23)16(24)8-18(17)27-22/h2-9,12,29H,10-11H2,1H3,(H,26,27)/t12-/m0/s1 D0Z5HH DRUGINKE KALRQYKXWDYSRI-LBPRGKRZSA-N D0Z5HH DRUGSMIL COC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C4=NC5=CC(=C(C=C5N4)F)Cl)CO D0Z5HH HIGHSTAT Patented D0Z5PM DRUG__ID D0Z5PM D0Z5PM DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0Z5PM DRUGTYPE Small molecular drug D0Z5PM DRUGINCH 1S/C11H13ClN4O/c1-17-5-4-8-6-9(12)2-3-10(8)14-11-7-13-16-15-11/h2-3,6-7H,4-5H2,1H3,(H2,13,14,15,16) D0Z5PM DRUGINKE ZVGDDDHHESZRQT-UHFFFAOYSA-N D0Z5PM DRUGSMIL COCCC1=C(C=CC(=C1)Cl)NC2=NNN=C2 D0Z5PM HIGHSTAT Patented D0Z7DA DRUG__ID D0Z7DA D0Z7DA DRUGCOMP IRM LLC HUANG, Shenlin LIU, Zuosheng ALBAUGH, Pamela, A. WANG, Xing PAN, Shifeng XIE, Yongping ZHANG, Guobao D0Z7DA DRUGTYPE Small molecular drug D0Z7DA DRUGINCH 1S/C22H19F3N8O/c1-13-6-7-16(31-20(34)14-4-3-5-15(8-14)22(23,24)25)9-17(13)32-21-29-12-30-33(21)19-10-18(26-2)27-11-28-19/h3-12H,1-2H3,(H,31,34)(H,26,27,28)(H,29,30,32) D0Z7DA DRUGINKE ZHABTPLXVWUNPN-UHFFFAOYSA-N D0Z7DA DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)NC3=NC=NN3C4=NC=NC(=C4)NC D0Z7DA HIGHSTAT Patented D0Z7EV DRUG__ID D0Z7EV D0Z7EV DRUGTYPE Small molecular drug D0Z7EV DRUGINCH 1S/C21H22Cl2N4O/c22-16-9-10-19(17(23)13-16)27-20(15-7-3-1-4-8-15)14-18(24-27)21(28)25-26-11-5-2-6-12-26/h1,3-4,7-10,13,20H,2,5-6,11-12,14H2,(H,25,28) D0Z7EV DRUGINKE IAMSOYSVSFMFLR-UHFFFAOYSA-N D0Z7EV DRUGSMIL C1CCN(CC1)NC(=O)C2=NN(C(C2)C3=CC=CC=C3)C4=C(C=C(C=C4)Cl)Cl D0Z7EV HIGHSTAT Patented D0Z7EV COMPCLAS Carboxamide derivatives D0Z8WF DRUG__ID D0Z8WF D0Z8WF DRUGTYPE Small molecular drug D0Z8WF DRUGINCH 1S/C25H18Cl2N6O/c1-25(2,3)23-30-21-18(22-31-32-24(34)33(22)23)11-17(14-5-7-15(26)8-6-14)20(29-21)16-9-4-13(12-28)10-19(16)27/h4-11H,1-3H3,(H,32,34) D0Z8WF DRUGINKE CSEQBOCMDXHKIF-UHFFFAOYSA-N D0Z8WF DRUGSMIL CC(C)(C)C1=NC2=NC(=C(C=C2C3=NNC(=O)N31)C4=CC=C(C=C4)Cl)C5=C(C=C(C=C5)C#N)Cl D0Z8WF HIGHSTAT Patented D0Z8WF COMPCLAS Pyridotriazolopyrimidine derivatives D0ZE8B DRUG__ID D0ZE8B D0ZE8B DRUGTYPE Small molecular drug D0ZE8B DRUGINCH 1S/C22H23BrF4N2O2/c1-21(2,3)28-20(30)29-11-14(12-29)31-19(16-9-8-13(23)10-18(16)24)15-6-4-5-7-17(15)22(25,26)27/h4-10,14,19H,11-12H2,1-3H3,(H,28,30) D0ZE8B DRUGINKE PTVKXSFBTUPKHX-UHFFFAOYSA-N D0ZE8B DRUGSMIL CC(C)(C)NC(=O)N1CC(C1)OC(C2=C(C=C(C=C2)Br)F)C3=CC=CC=C3C(F)(F)F D0ZE8B HIGHSTAT Patented D0ZE8B COMPCLAS Azetidine-1-carboxamide derivatives D0ZG3D DRUG__ID D0ZG3D D0ZG3D DRUGCOMP SALK INSTITUTE FOR BIOLOGICAL STUDIE D0ZG3D DRUGTYPE Small molecular drug D0ZG3D DRUGINCH 1S/C32H32FN3O3/c1-35-30-15-14-24(18-27(30)20-34-35)25-12-13-26(29(33)19-25)21-36(32(38)23-8-4-3-5-9-23)28-10-6-7-22(17-28)11-16-31(37)39-2/h6-7,10-20,23H,3-5,8-9,21H2,1-2H3/b16-11+/i21D D0ZG3D DRUGINKE NOJHCAUXLPQOOD-STTMTRHISA-N D0ZG3D DRUGSMIL CN1C2=C(C=C(C=C2)C3=CC(=C(C=C3)CN(C4=CC=CC(=C4)C=CC(=O)OC)C(=O)C5CCCCC5)F)C=N1 D0ZG3D HIGHSTAT Patented D0ZG7E DRUG__ID D0ZG7E D0ZG7E DRUGCOMP Whitehead Institute for Biomedical Research D0ZG7E DRUGTYPE Small molecular drug D0ZG7E DRUGINCH 1S/C25H23N5O2S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32) D0ZG7E DRUGINKE DSXXEELGXBCYNQ-UHFFFAOYSA-N D0ZG7E DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N D0ZG7E HIGHSTAT Patented D0ZH4I DRUG__ID D0ZH4I D0ZH4I DRUGCOMP AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (A*STAR) D0ZH4I DRUGTYPE Small molecular drug D0ZH4I DRUGINCH 1S/C27H29F3N4O2/c1-2-33-12-14-34(15-13-33)18-22-5-8-23(16-25(22)27(28,29)30)32-26(35)19-36-24-9-6-20(7-10-24)21-4-3-11-31-17-21/h3-11,16-17H,2,12-15,18-19H2,1H3,(H,32,35) D0ZH4I DRUGINKE UXNUQVZRIJPJBL-UHFFFAOYSA-N D0ZH4I DRUGSMIL CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)COC3=CC=C(C=C3)C4=CN=CC=C4)C(F)(F)F D0ZH4I HIGHSTAT Patented D0ZM1H DRUG__ID D0ZM1H D0ZM1H DRUGCOMP LUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar TALE, Prashant, Vitthalrao CHEEMALA, Narasimha, Murthy MAHANGARE, Sachin, Jaysing VIDHATE, Prashant, Popatrao KULKARNI, Chaitanya, Prabhakar PATEL, Sapana, Suresh PATIL, Amolsing, Dattu ZADE, Seema, Prabhakar SHINDE, Rohan, Mahadev PALLE, Venkata, P. KAMBOJ, Rajender, KumaLUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar MAHANGARE, Sachin, Jaysing TALE, Prashant, Vitthalrao ZADE, Seema, Prabhakar PATIL, Amolsing, Dattu CHEEMALA, Narasimha, Murthy PALLE, Venkata, P. KAMBOJ, Rajender, KumaLUPIN LIMITED KULKARNI, Sanjeev, Anant MADAN, Sachin JANA, Nirmal, Kumar TALE, Prashant, Vitthalrao CHEEMALA, Narasimha, Murthy MAHANGARE, Sachin, Jaysing VIDHATE, Prashant, Popatrao KULKARNI, Chaitanya, Prabhakar PATEL, Sapana, Suresh PATIL, Amolsing, Dattu SHINDE, Rohan, Mahadev PALLE, Venkata, P. KAMBOJ, Rajender, Kumar D0ZM1H DRUGTYPE Small molecular drug D0ZM1H DRUGINCH 1S/C22H20F3N3O2/c1-14-4-2-7-17-19(14)18(21(29)28-8-10-30-11-9-28)13-26-20(17)27-16-6-3-5-15(12-16)22(23,24)25/h2-7,12-13H,8-11H2,1H3,(H,26,27) D0ZM1H DRUGINKE GPXLPNZECOPGPJ-UHFFFAOYSA-N D0ZM1H DRUGSMIL CC1=C2C(=CC=C1)C(=NC=C2C(=O)N3CCOCC3)NC4=CC=CC(=C4)C(F)(F)F D0ZM1H HIGHSTAT Patented D0ZM8H DRUG__ID D0ZM8H D0ZM8H DRUGCOMP ABBOTT LABORATORIES D0ZM8H DRUGTYPE Small molecular drug D0ZM8H DRUGINCH 1S/C24H26FN3O2/c1-4-24(5-2)13-21(17-9-7-10-19(25)22(17)30-24)28-23(29)27-20-11-6-8-16-14-26-15(3)12-18(16)20/h6-12,14,21H,4-5,13H2,1-3H3,(H2,27,28,29)/t21-/m1/s1 D0ZM8H DRUGINKE KRCMLCOREROPCP-OAQYLSRUSA-N D0ZM8H DRUGSMIL CCC1(CC(C2=C(O1)C(=CC=C2)F)NC(=O)NC3=CC=CC4=C3C=C(N=C4)C)CC D0ZM8H HIGHSTAT Patented D0ZP2C DRUG__ID D0ZP2C D0ZP2C DRUGCOMP Purdue Pharma L.P D0ZP2C DRUGTYPE Small molecular drug D0ZP2C DRUGINCH 1S/C20H18Cl2F3N3O3/c21-15-8-13(1-2-14(15)20(23,24)25)27-19(31)28-5-3-11(4-6-28)18-16(22)7-12(9-26-18)17(30)10-29/h1-3,7-9,17,29-30H,4-6,10H2,(H,27,31)/t17-/m1/s1 D0ZP2C DRUGINKE CJDYNMVVGNTWLD-QGZVFWFLSA-N D0ZP2C DRUGSMIL C1CN(CC=C1C2=C(C=C(C=N2)C(CO)O)Cl)C(=O)NC3=CC(=C(C=C3)C(F)(F)F)Cl D0ZP2C HIGHSTAT Patented D0ZQ0X DRUG__ID D0ZQ0X D0ZQ0X DRUGCOMP CORNELL UNIVERSITY GUDAS, Lorraine J TANG, Xiao-Han OSEI-SARFO, Kwame URVALEK, Aliso D0ZQ0X DRUGTYPE Small molecular drug D0ZQ0X DRUGINCH 1S/C27H26O3/c28-25-12-22-6-5-21(19-1-3-20(4-2-19)26(29)30)10-23(22)11-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30) D0ZQ0X DRUGINKE VCQGNUWOMLYNNG-UHFFFAOYSA-N D0ZQ0X DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=C5C=CC(=CC5=C4)C6=CC=C(C=C6)C(=O)O)O D0ZQ0X HIGHSTAT Patented D0ZS3E DRUG__ID D0ZS3E D0ZS3E DRUGCOMP Amorepacific Corp D0ZS3E DRUGTYPE Small molecular drug D0ZS3E DRUGINCH 1S/C21H17F5N2O4S/c1-11(13-9-15(22)19(16(23)10-13)28-33(2,30)31)27-20(29)18-7-6-17(32-18)12-4-3-5-14(8-12)21(24,25)26/h3-11,28H,1-2H3,(H,27,29)/t11-/m1/s1 D0ZS3E DRUGINKE UBEWFMQQEXOLKY-LLVKDONJSA-N D0ZS3E DRUGSMIL CC(C1=CC(=C(C(=C1)F)NS(=O)(=O)C)F)NC(=O)C2=CC=C(O2)C3=CC(=CC=C3)C(F)(F)F D0ZS3E HIGHSTAT Patented D0ZT9I DRUG__ID D0ZT9I D0ZT9I DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0ZT9I DRUGTYPE Small molecular drug D0ZT9I DRUGINCH 1S/C31H35Cl2F5N6O2/c1-29(2,3)27(46)39-15-16-5-6-20(32)25(24(16)33)42-28-41-21-11-19(26(45)40-18-13-30(34,35)14-18)22(12-23(21)43(28)4)44-9-7-17(8-10-44)31(36,37)38/h5-6,11-12,17-18H,7-10,13-15H2,1-4H3,(H,39,46)(H,40,45)(H,41,42) D0ZT9I DRUGINKE WROFUPVHFCAUPE-UHFFFAOYSA-N D0ZT9I DRUGSMIL CC(C)(C)C(=O)NCC1=C(C(=C(C=C1)Cl)NC2=NC3=C(N2C)C=C(C(=C3)C(=O)NC4CC(C4)(F)F)N5CCC(CC5)C(F)(F)F)Cl D0ZT9I HIGHSTAT Patented D0ZU8L DRUG__ID D0ZU8L D0ZU8L DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D0ZU8L DRUGTYPE Small molecular drug D0ZU8L DRUGINCH 1S/C36H32N8O2/c1-43(2)22-9-15-32(45)38-29-13-8-12-26(24-29)35(46)39-27-16-18-28(19-17-27)40-36-37-21-20-30(41-36)33-31-14-6-7-23-44(31)42-34(33)25-10-4-3-5-11-25/h3-21,23-24H,22H2,1-2H3,(H,38,45)(H,39,46)(H,37,40,41)/b15-9+ D0ZU8L DRUGINKE OCZDPFMSAKKNRH-OQLLNIDSSA-N D0ZU8L DRUGSMIL CN(C)CC=CC(=O)NC1=CC=CC(=C1)C(=O)NC2=CC=C(C=C2)NC3=NC=CC(=N3)C4=C5C=CC=CN5N=C4C6=CC=CC=C6 D0ZU8L HIGHSTAT Patented D0ZV6F DRUG__ID D0ZV6F D0ZV6F DRUGCOMP BEIGENE, LTD. WANG, Hexiang D0ZV6F DRUGTYPE Small molecular drug D0ZV6F DRUGINCH 1S/C14H17ClN2O/c15-11-6-12-8-16-9-17(12)13(7-11)14(18)10-4-2-1-3-5-10/h6-10,14,18H,1-5H2/t14-/m0/s1 D0ZV6F DRUGINKE AVJCRIIDMDBAQC-AWEZNQCLSA-N D0ZV6F DRUGSMIL C1CCC(CC1)C(C2=CC(=CC3=CN=CN23)Cl)O D0ZV6F HIGHSTAT Patented D0ZZ8F DRUG__ID D0ZZ8F D0ZZ8F DRUGCOMP Japan Tobacco, Inc D0ZZ8F DRUGTYPE Small molecular drug D0ZZ8F DRUGINCH 1S/C24H20F5N3O4/c1-13-5-6-20(30-9-13)32-15(10-33)11-35-21-16(3-2-4-19(21)32)23(34)31-14-7-17(25)22(18(26)8-14)36-12-24(27,28)29/h2-9,15,33H,10-12H2,1H3,(H,31,34)/t15-/m0/s1 D0ZZ8F DRUGINKE RPAMBIQBMQRYLH-HNNXBMFYSA-N D0ZZ8F DRUGSMIL CC1=CN=C(C=C1)N2C(COC3=C(C=CC=C32)C(=O)NC4=CC(=C(C(=C4)F)OCC(F)(F)F)F)CO D0ZZ8F HIGHSTAT Patented D00BRD DRUG__ID D00BRD D00BRD DRUGTYPE Small molecular drug D00BRD DRUGINCH 1S/C7H6O2/c8-5-6-1-3-7(9)4-2-6/h1-5,9H D00BRD DRUGINKE RGHHSNMVTDWUBI-UHFFFAOYSA-N D00BRD DRUGSMIL C1=CC(=CC=C1C=O)O D00BRD HIGHSTAT Patented D00CAO DRUG__ID D00CAO D00CAO DRUGTYPE Small molecular drug D00CAO DRUGINCH 1S/C21H18F3N3O6/c22-21(23,24)13-3-6-16(25-9-13)33-14-4-1-12(2-5-14)11-27-8-7-15(28)18(20(27)32)19(31)26-10-17(29)30/h1-6,9,28H,7-8,10-11H2,(H,26,31)(H,29,30) D00CAO DRUGINKE OAYSSFWXQZDVKQ-UHFFFAOYSA-N D00CAO DRUGSMIL C1CN(C(=O)C(=C1O)C(=O)NCC(=O)O)CC2=CC=C(C=C2)OC3=NC=C(C=C3)C(F)(F)F D00CAO HIGHSTAT Patented D00ECX DRUG__ID D00ECX D00ECX DRUGTYPE Small molecular drug D00ECX DRUGINCH 1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-2-4-11(16)5-3-9/h2-7,19H,8H2,1H3,(H,18,21) D00ECX DRUGINKE BYGKIXAXITXFDW-UHFFFAOYSA-N D00ECX DRUGSMIL COC(=O)CNC(=O)C1=C(C=C(C=N1)C2=CC=C(C=C2)Cl)O D00ECX HIGHSTAT Patented D00HBJ DRUG__ID D00HBJ D00HBJ DRUGTYPE Small molecular drug D00HBJ DRUGINCH 1S/C20H21F3N6O3/c1-28-7-10-31-16-15(28)17(24-13-5-8-30-9-6-13)27-29-18(25-26-19(16)29)12-3-2-4-14(11-12)32-20(21,22)23/h2-4,11,13H,5-10H2,1H3,(H,24,27) D00HBJ DRUGINKE DKFWOQOORFAKNT-UHFFFAOYSA-N D00HBJ DRUGSMIL CN1CCOC2=C1C(=NN3C2=NN=C3C4=CC(=CC=C4)OC(F)(F)F)NC5CCOCC5 D00HBJ HIGHSTAT Patented D00HGD DRUG__ID D00HGD D00HGD DRUGTYPE Small molecular drug D00HGD DRUGINCH 1S/C24H21ClN4O2/c25-20-4-2-1-3-19(20)21-15-16-9-10-26-24(30)22(16)23(28-21)27-17-5-7-18(8-6-17)29-11-13-31-14-12-29/h1-10,15H,11-14H2,(H,26,30)(H,27,28) D00HGD DRUGINKE BMPOWIIBXCMAFL-UHFFFAOYSA-N D00HGD DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC3=C4C(=CC(=N3)C5=CC=CC=C5Cl)C=CNC4=O D00HGD HIGHSTAT Patented D00HQJ DRUG__ID D00HQJ D00HQJ DRUGTYPE Small molecular drug D00HQJ DRUGINCH 1S/C23H23F2N7O2/c1-34-22-21(28-19-9-16(24)17(25)10-20(19)29-22)30-23(33)27-15-4-6-32(7-5-15)12-13-2-3-14-11-26-31-18(14)8-13/h2-3,8-11,15H,4-7,12H2,1H3,(H,26,31)(H2,27,28,30,33) D00HQJ DRUGINKE XSQADOWIAZCVIY-UHFFFAOYSA-N D00HQJ DRUGSMIL COC1=NC2=CC(=C(C=C2N=C1NC(=O)NC3CCN(CC3)CC4=CC5=C(C=C4)C=NN5)F)F D00HQJ HIGHSTAT Patented D00IKR DRUG__ID D00IKR D00IKR DRUGTYPE Small molecular drug D00IKR DRUGINCH 1S/C22H28ClN3O4/c1-22(2,3)30-21(29)25-12-10-24(11-13-25)15-17-8-9-26(20(28)19(17)27)14-16-4-6-18(23)7-5-16/h4-9,27H,10-15H2,1-3H3 D00IKR DRUGINKE UPJZLOCUUOIMNC-UHFFFAOYSA-N D00IKR DRUGSMIL CC(C)(C)OC(=O)N1CCN(CC1)CC2=C(C(=O)N(C=C2)CC3=CC=C(C=C3)Cl)O D00IKR HIGHSTAT Patented D00JQA DRUG__ID D00JQA D00JQA DRUGTYPE Small molecular drug D00JQA DRUGINCH 1S/C13H10N2O2/c16-8-5-6-9(12(17)7-8)13-14-10-3-1-2-4-11(10)15-13/h1-7,16-17H,(H,14,15) D00JQA DRUGINKE MTDSHRDWHUXPQH-UHFFFAOYSA-N D00JQA DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=C(C=C(C=C3)O)O D00JQA HIGHSTAT Patented D00LHT DRUG__ID D00LHT D00LHT DRUGTYPE Small molecular drug D00LHT DRUGINCH 1S/C17H20ClF2N3O2S/c1-11-16(12(2)22-21-11)26(24,25)23-7-5-17(20,6-8-23)10-13-3-4-14(18)9-15(13)19/h3-4,9H,5-8,10H2,1-2H3,(H,21,22) D00LHT DRUGINKE RXIULEDXXPGKEE-UHFFFAOYSA-N D00LHT DRUGSMIL CC1=C(C(=NN1)C)S(=O)(=O)N2CCC(CC2)(CC3=C(C=C(C=C3)Cl)F)F D00LHT HIGHSTAT Patented D00LVD DRUG__ID D00LVD D00LVD DRUGTYPE Small molecular drug D00LVD DRUGINCH 1S/C30H33F2N7O2/c1-6-41-29-24(8-7-13-33-29)25-14-26(28-27(35-25)20(4)36-39(28)19(2)3)37(16-21-9-11-23(40-5)12-10-21)17-22-15-34-38(18-22)30(31)32/h7-15,18-19,30H,6,16-17H2,1-5H3 D00LVD DRUGINKE UXTFTMXAFOTATJ-UHFFFAOYSA-N D00LVD DRUGSMIL CCOC1=C(C=CC=N1)C2=NC3=C(C(=C2)N(CC4=CC=C(C=C4)OC)CC5=CN(N=C5)C(F)F)N(N=C3C)C(C)C D00LVD HIGHSTAT Patented D00MFW DRUG__ID D00MFW D00MFW DRUGTYPE Small molecular drug D00MFW DRUGINCH 1S/C19H13N3O7S2/c23-19-16(10-17(31(27,28)29)15-2-1-7-20-18(15)19)22-21-13-5-3-12-9-14(30(24,25)26)6-4-11(12)8-13/h1-10,23H,(H,24,25,26)(H,27,28,29) D00MFW DRUGINKE XGMFVZOKHBRUTL-UHFFFAOYSA-N D00MFW DRUGSMIL C1=CC2=C(C=C(C(=C2N=C1)O)N=NC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)S(=O)(=O)O D00MFW HIGHSTAT Patented D00OUG DRUG__ID D00OUG D00OUG DRUGTYPE Small molecular drug D00OUG DRUGINCH 1S/C16H9BrO4/c17-11-4-1-9(2-5-11)12-7-10-3-6-14(19)13(8-18)15(10)21-16(12)20/h1-8,19H D00OUG DRUGINKE DJSPMRZGTUKARX-UHFFFAOYSA-N D00OUG DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C(=C(C=C3)O)C=O)OC2=O)Br D00OUG HIGHSTAT Patented D00OWF DRUG__ID D00OWF D00OWF DRUGTYPE Small molecular drug D00OWF DRUGINCH 1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3 D00OWF DRUGINKE BXNJHAXVSOCGBA-UHFFFAOYSA-N D00OWF DRUGSMIL CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC D00OWF HIGHSTAT Patented D00PES DRUG__ID D00PES D00PES DRUGTYPE Small molecular drug D00PES DRUGINCH 1S/C15H20N2O2/c18-15(19)5-3-4-13-6-7-14(16-12-13)8-11-17-9-1-2-10-17/h3-4,6-7,12H,1-2,5,8-11H2,(H,18,19)/b4-3+ D00PES DRUGINKE YAJGYOKZMAZQGT-ONEGZZNKSA-N D00PES DRUGSMIL C1CCN(C1)CCC2=NC=C(C=C2)C=CCC(=O)O D00PES HIGHSTAT Patented D00PVE DRUG__ID D00PVE D00PVE DRUGTYPE Small molecular drug D00PVE DRUGINCH 1S/C17H13NO6S/c1-25(20,21)15-5-3-2-4-10(15)16-18-12-9-14-13(22-6-7-23-14)8-11(12)17(19)24-16/h2-5,8-9H,6-7H2,1H3 D00PVE DRUGINKE NYGGGQOBPHOCIJ-UHFFFAOYSA-N D00PVE DRUGSMIL CS(=O)(=O)C1=CC=CC=C1C2=NC3=CC4=C(C=C3C(=O)O2)OCCO4 D00PVE HIGHSTAT Patented D00PWQ DRUG__ID D00PWQ D00PWQ DRUGTYPE Small molecular drug D00PWQ DRUGINCH 1S/C16H11BrN2O/c17-9-5-6-14-11(7-9)12-8-15(20)18-13-4-2-1-3-10(13)16(12)19-14/h1-7,19H,8H2,(H,18,20) D00PWQ DRUGINKE QQUXFYAWXPMDOE-UHFFFAOYSA-N D00PWQ DRUGSMIL C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)Br D00PWQ HIGHSTAT Patented D00QNV DRUG__ID D00QNV D00QNV DRUGTYPE Small molecular drug D00QNV DRUGINCH 1S/C20H29N7O/c1-5-15(16(28)6-2)24-20-25-18(22-11-14-8-7-9-21-10-14)17-19(26-20)27(12-23-17)13(3)4/h7-10,12-13,15-16,28H,5-6,11H2,1-4H3,(H2,22,24,25,26)/t15-,16?/m1/s1 D00QNV DRUGINKE VFEDEOUBYBLDKN-AAFJCEBUSA-N D00QNV DRUGSMIL CCC(C(CC)O)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CN=CC=C3 D00QNV HIGHSTAT Patented D00QVY DRUG__ID D00QVY D00QVY DRUGTYPE Small molecular drug D00QVY DRUGINCH 1S/C11H16O2/c1-3-4-5-10-8(2)6-9(12)7-11(10)13/h6-7,12-13H,3-5H2,1-2H3 D00QVY DRUGINKE IYOQFZBJNROXMO-UHFFFAOYSA-N D00QVY DRUGSMIL CCCCC1=C(C=C(C=C1C)O)O D00QVY HIGHSTAT Patented D00RJA DRUG__ID D00RJA D00RJA DRUGTYPE Small molecular drug D00RJA DRUGINCH 1S/C23H25N5O4/c1-4-20(10-11-24)32-23(30)26-15(2)16-6-5-7-18(12-16)27-22(29)28-19-9-8-17(14-25)21(13-19)31-3/h5-9,12-13,15,20H,4,10H2,1-3H3,(H,26,30)(H2,27,28,29)/t15-,20?/m0/s1 D00RJA DRUGINKE PJFQWSNOXLEDDZ-OOJLDXBWSA-N D00RJA DRUGSMIL CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C#N)OC D00RJA HIGHSTAT Patented D00RNS DRUG__ID D00RNS D00RNS DRUGTYPE Small molecular drug D00RNS DRUGINCH 1S/C21H25BrN4O2S/c1-26(2)14-4-3-5-19(27)23-17-10-12-18(13-11-17)24-21(29)25-20(28)15-6-8-16(22)9-7-15/h6-13H,3-5,14H2,1-2H3,(H,23,27)(H2,24,25,28,29) D00RNS DRUGINKE NWWFPYSNQAXIIL-UHFFFAOYSA-N D00RNS DRUGSMIL CN(C)CCCCC(=O)NC1=CC=C(C=C1)NC(=S)NC(=O)C2=CC=C(C=C2)Br D00RNS HIGHSTAT Patented D00RUE DRUG__ID D00RUE D00RUE DRUGTYPE Small molecular drug D00RUE DRUGINCH 1S/C26H27N3O3S/c1-31-23-17-20(10-11-22(23)32-16-15-28-13-5-6-14-28)29-18-19-9-12-24(27-25(19)26(29)30)33-21-7-3-2-4-8-21/h2-4,7-12,17H,5-6,13-16,18H2,1H3 D00RUE DRUGINKE PULOMQYOCPKDEH-UHFFFAOYSA-N D00RUE DRUGSMIL COC1=C(C=CC(=C1)N2CC3=C(C2=O)N=C(C=C3)SC4=CC=CC=C4)OCCN5CCCC5 D00RUE HIGHSTAT Patented D00SDR DRUG__ID D00SDR D00SDR DRUGTYPE Small molecular drug D00SDR DRUGINCH 1S/C15H13N3O/c1-19-12-4-2-3-10(7-12)11-5-6-14-13(8-11)15(16)18-9-17-14/h2-9H,1H3,(H2,16,17,18) D00SDR DRUGINKE HAFNABUNLVCDOP-UHFFFAOYSA-N D00SDR DRUGSMIL COC1=CC=CC(=C1)C2=CC3=C(C=C2)N=CN=C3N D00SDR HIGHSTAT Patented D00SUC DRUG__ID D00SUC D00SUC DRUGTYPE Small molecular drug D00SUC DRUGINCH 1S/C17H14ClN3O3/c1-11-8-14(18)3-2-13(11)10-24-16-5-7-20-21(16)15-9-12(17(22)23)4-6-19-15/h2-9H,10H2,1H3,(H,22,23) D00SUC DRUGINKE PSOBPHXKKHPWMU-UHFFFAOYSA-N D00SUC DRUGSMIL CC1=C(C=CC(=C1)Cl)COC2=CC=NN2C3=NC=CC(=C3)C(=O)O D00SUC HIGHSTAT Patented D00TBI DRUG__ID D00TBI D00TBI DRUGTYPE Small molecular drug D00TBI DRUGINCH 1S/C26H25Cl2N7O/c1-18-24(26(36)33(2)34-15-4-3-5-16-34)31-25(22-13-10-20(27)17-23(22)28)35(18)21-11-8-19(9-12-21)7-6-14-30-32-29/h8-13,17H,3-5,14-16H2,1-2H3 D00TBI DRUGINKE ZHBIOSWRXRWSAO-UHFFFAOYSA-N D00TBI DRUGSMIL CC1=C(N=C(N1C2=CC=C(C=C2)C#CCN=[N+]=[N-])C3=C(C=C(C=C3)Cl)Cl)C(=O)N(C)N4CCCCC4 D00TBI HIGHSTAT Patented D00UAQ DRUG__ID D00UAQ D00UAQ DRUGTYPE Small molecular drug D00UAQ DRUGINCH 1S/C26H29Cl2F3N4O5S/c1-2-41(39,40)21-6-5-16(27)10-15(21)12-35-24(37)18-11-20(26(29,30)31)19(22(28)23(18)33-25(35)38)14-34-8-3-4-17(13-34)32-7-9-36/h5-6,10-11,17,32,36H,2-4,7-9,12-14H2,1H3,(H,33,38)/t17-/m0/s1 D00UAQ DRUGINKE YWUVDJQWNVIFHU-KRWDZBQOSA-N D00UAQ DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CN2C(=O)C3=CC(=C(C(=C3NC2=O)Cl)CN4CCCC(C4)NCCO)C(F)(F)F D00UAQ HIGHSTAT Patented D00XHH DRUG__ID D00XHH D00XHH DRUGTYPE Small molecular drug D00XHH DRUGINCH 1S/C16H15NO4/c1-10-2-4-11(5-3-10)12-6-7-13(14(18)8-12)16(21)17-9-15(19)20/h2-8,18H,9H2,1H3,(H,17,21)(H,19,20) D00XHH DRUGINKE POKDHYRFSOQLCV-UHFFFAOYSA-N D00XHH DRUGSMIL CC1=CC=C(C=C1)C2=CC(=C(C=C2)C(=O)NCC(=O)O)O D00XHH HIGHSTAT Patented D00XMF DRUG__ID D00XMF D00XMF DRUGTYPE Small molecular drug D00XMF DRUGINCH 1S/C11H9Cl2NO3/c12-8-2-1-6(3-9(8)13)11-7(4-10(15)16)5-17-14-11/h1-3,7H,4-5H2,(H,15,16) D00XMF DRUGINKE JUWLIQWWDGCIRH-UHFFFAOYSA-N D00XMF DRUGSMIL C1C(C(=NO1)C2=CC(=C(C=C2)Cl)Cl)CC(=O)O D00XMF HIGHSTAT Patented D00YYO DRUG__ID D00YYO D00YYO DRUGTYPE Small molecular drug D00YYO DRUGINCH 1S/C27H21F3N6O3/c1-13-23(26(38)34-16-6-8-22-15(9-16)11-32-36-22)24(35-27(39)33-13)14-5-7-21(30)17(10-14)25(37)31-12-18-19(28)3-2-4-20(18)29/h2-11,24H,12H2,1H3,(H,31,37)(H,32,36)(H,34,38)(H2,33,35,39) D00YYO DRUGINKE YJQKIQOVJOGHMP-UHFFFAOYSA-N D00YYO DRUGSMIL CC1=C(C(NC(=O)N1)C2=CC(=C(C=C2)F)C(=O)NCC3=C(C=CC=C3F)F)C(=O)NC4=CC5=C(C=C4)NN=C5 D00YYO HIGHSTAT Patented D01BXA DRUG__ID D01BXA D01BXA DRUGTYPE Small molecular drug D01BXA DRUGINCH 1S/C23H20FNO4/c24-15-22(26)25(16-17-7-6-12-21-23(17)28-14-13-27-21)19-10-4-5-11-20(19)29-18-8-2-1-3-9-18/h1-12H,13-16H2/i24-1 D01BXA DRUGINKE UDPFMHCLCUMIOF-MIGPCILRSA-N D01BXA DRUGSMIL C1COC2=C(C=CC=C2O1)CN(C3=CC=CC=C3OC4=CC=CC=C4)C(=O)CF D01BXA HIGHSTAT Patented D01BXV DRUG__ID D01BXV D01BXV DRUGTYPE Small molecular drug D01BXV DRUGINCH 1S/C5H8Br2O2/c1-9-5(8)4(2-6)3-7/h4H,2-3H2,1H3 D01BXV DRUGINKE USXVPPOARMSYGY-UHFFFAOYSA-N D01BXV DRUGSMIL COC(=O)C(CBr)CBr D01BXV HIGHSTAT Patented D01CDK DRUG__ID D01CDK D01CDK DRUGTYPE Small molecular drug D01CDK DRUGINCH 1S/C22H19F3N6/c23-22(24,25)15-9-10-17-16(13-15)18(14-7-3-1-4-8-14)19(20-27-29-30-28-20)21(26-17)31-11-5-2-6-12-31/h1,3-4,7-10,13H,2,5-6,11-12H2,(H,27,28,29,30) D01CDK DRUGINKE SUXQAVNHOCPUSH-UHFFFAOYSA-N D01CDK DRUGSMIL C1CCN(CC1)C2=NC3=C(C=C(C=C3)C(F)(F)F)C(=C2C4=NNN=N4)C5=CC=CC=C5 D01CDK HIGHSTAT Patented D01DYO DRUG__ID D01DYO D01DYO DRUGTYPE Small molecular drug D01DYO DRUGINCH 1S/C21H19F5N4O2S/c1-29-11-20(27-12-29)33(31,32)30-9-16(13-2-4-14(22)5-3-13)19(10-30)28-15-6-7-18(23)17(8-15)21(24,25)26/h2-8,11-12,16,19,28H,9-10H2,1H3/t16-,19+/m1/s1 D01DYO DRUGINKE QHYIYIVWHBQJLT-APWZRJJASA-N D01DYO DRUGSMIL CN1C=C(N=C1)S(=O)(=O)N2CC(C(C2)NC3=CC(=C(C=C3)F)C(F)(F)F)C4=CC=C(C=C4)F D01DYO HIGHSTAT Patented D01ENV DRUG__ID D01ENV D01ENV DRUGTYPE Small molecular drug D01ENV DRUGINCH 1S/C14H20N2O2/c1-2-18-14(17)12-5-6-13(15-11-12)7-10-16-8-3-4-9-16/h5-6,11H,2-4,7-10H2,1H3 D01ENV DRUGINKE MBNVMBKJYZXTNI-UHFFFAOYSA-N D01ENV DRUGSMIL CCOC(=O)C1=CN=C(C=C1)CCN2CCCC2 D01ENV HIGHSTAT Patented D01EUT DRUG__ID D01EUT D01EUT DRUGTYPE Small molecular drug D01EUT DRUGINCH 1S/C24H21F2N7O2/c1-4-35-16-9-19(25)18(20(26)10-16)13-33-14(2)17(11-27)22(32-33)24-29-12-21(34-3)23(31-24)30-15-5-7-28-8-6-15/h5-10,12H,4,13H2,1-3H3,(H,28,29,30,31) D01EUT DRUGINKE VNVLBWOVSDGPGB-UHFFFAOYSA-N D01EUT DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C(=C(C(=N2)C3=NC=C(C(=N3)NC4=CC=NC=C4)OC)C#N)C)F D01EUT HIGHSTAT Patented D01EVP DRUG__ID D01EVP D01EVP DRUGTYPE Small molecular drug D01EVP DRUGINCH 1S/C15H16O2/c1-11(9-12-5-3-2-4-6-12)14-8-7-13(16)10-15(14)17/h2-8,10-11,16-17H,9H2,1H3 D01EVP DRUGINKE NGQMLDWNBTVAAC-UHFFFAOYSA-N D01EVP DRUGSMIL CC(CC1=CC=CC=C1)C2=C(C=C(C=C2)O)O D01EVP HIGHSTAT Patented D01GFH DRUG__ID D01GFH D01GFH DRUGTYPE Small molecular drug D01GFH DRUGINCH 1S/C11H8BrNO2/c12-9-6-10(14)13(11(9)15)7-8-4-2-1-3-5-8/h1-6H,7H2 D01GFH DRUGINKE LLBVECSKMXUDOT-UHFFFAOYSA-N D01GFH DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C=C(C2=O)Br D01GFH HIGHSTAT Patented D01GOO DRUG__ID D01GOO D01GOO DRUGTYPE Small molecular drug D01GOO DRUGINCH 1S/C19H17ClN6/c1-3-26(2)19-17(18-22-24-25-23-18)16(12-7-5-4-6-8-12)14-11-13(20)9-10-15(14)21-19/h4-11H,3H2,1-2H3,(H,22,23,24,25) D01GOO DRUGINKE DNKGOGCNEVPJAB-UHFFFAOYSA-N D01GOO DRUGSMIL CCN(C)C1=NC2=C(C=C(C=C2)Cl)C(=C1C3=NNN=N3)C4=CC=CC=C4 D01GOO HIGHSTAT Patented D01IOH DRUG__ID D01IOH D01IOH DRUGTYPE Small molecular drug D01IOH DRUGINCH 1S/C19H18N4O3/c1-26-17-11-14(5-7-20-17)22-18(24)13-4-3-12-9-16-19(25)21-6-2-8-23(16)15(12)10-13/h3-5,7,9-11H,2,6,8H2,1H3,(H,21,25)(H,20,22,24) D01IOH DRUGINKE IGJVUIUYHUKAST-UHFFFAOYSA-N D01IOH DRUGSMIL COC1=NC=CC(=C1)NC(=O)C2=CC3=C(C=C2)C=C4N3CCCNC4=O D01IOH HIGHSTAT Patented D01IXT DRUG__ID D01IXT D01IXT DRUGTYPE Small molecular drug D01IXT DRUGINCH 1S/C18H17NO6/c1-21-10-5-6-11(14(7-10)22-2)17-19-13-9-16(24-4)15(23-3)8-12(13)18(20)25-17/h5-9H,1-4H3 D01IXT DRUGINKE JCFSQIOFMQLSPV-UHFFFAOYSA-N D01IXT DRUGSMIL COC1=CC(=C(C=C1)C2=NC3=CC(=C(C=C3C(=O)O2)OC)OC)OC D01IXT HIGHSTAT Patented D01KCA DRUG__ID D01KCA D01KCA DRUGTYPE Small molecular drug D01KCA DRUGINCH 1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5- D01KCA DRUGINKE XFWLTFZLLXVKDY-WAYWQWQTSA-N D01KCA DRUGSMIL CCNCCCNCC=CCNCCCNCC D01KCA HIGHSTAT Patented D01KKC DRUG__ID D01KKC D01KKC DRUGTYPE Small molecular drug D01KKC DRUGINCH 1S/C17H25N3O3/c1-17(2,3)13-6-4-5-7-14(13)19-8-10-20(11-9-19)16(23)18-12-15(21)22/h4-7H,8-12H2,1-3H3,(H,18,23)(H,21,22) D01KKC DRUGINKE BAZIXHMBHKLDIK-UHFFFAOYSA-N D01KKC DRUGSMIL CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)NCC(=O)O D01KKC HIGHSTAT Patented D01MPC DRUG__ID D01MPC D01MPC DRUGTYPE Small molecular drug D01MPC DRUGINCH 1S/C24H30FN3O5S/c1-3-24(4-2,23(32)28-12-6-5-7-20(29)30)14-16-9-11-19(34-16)22(31)33-18-10-8-15(21(26)27)13-17(18)25/h8-11,13H,3-7,12,14H2,1-2H3,(H3,26,27)(H,28,32)(H,29,30) D01MPC DRUGINKE JBHHRVQRHSBNTN-UHFFFAOYSA-N D01MPC DRUGSMIL CCC(CC)(CC1=CC=C(S1)C(=O)OC2=C(C=C(C=C2)C(=N)N)F)C(=O)NCCCCC(=O)O D01MPC HIGHSTAT Patented D01NJW DRUG__ID D01NJW D01NJW DRUGTYPE Small molecular drug D01NJW DRUGINCH 1S/C11H14O2S/c12-9-1-2-10(11(13)7-9)8-3-5-14-6-4-8/h1-2,7-8,12-13H,3-6H2 D01NJW DRUGINKE OLWFCALCIRMVMM-UHFFFAOYSA-N D01NJW DRUGSMIL C1CSCCC1C2=C(C=C(C=C2)O)O D01NJW HIGHSTAT Patented D01NVM DRUG__ID D01NVM D01NVM DRUGTYPE Small molecular drug D01NVM DRUGINCH 1S/C23H28N6O/c1-15-13-16(9-12-24-15)19-17-7-3-2-4-8-18(17)25-21(20(19)22-26-28-29-27-22)23(14-30)10-5-6-11-23/h9,12-13,30H,2-8,10-11,14H2,1H3,(H,26,27,28,29) D01NVM DRUGINKE JDONBBWFRSZVOY-UHFFFAOYSA-N D01NVM DRUGSMIL CC1=NC=CC(=C1)C2=C(C(=NC3=C2CCCCC3)C4(CCCC4)CO)C5=NNN=N5 D01NVM HIGHSTAT Patented D01OFO DRUG__ID D01OFO D01OFO DRUGTYPE Small molecular drug D01OFO DRUGINCH 1S/C16H21N5O2/c17-15-2-1-11(8-19-15)7-13(16(22)23)14-9-21(10-20-14)12-3-5-18-6-4-12/h1-2,8-10,12-13,18H,3-7H2,(H2,17,19)(H,22,23) D01OFO DRUGINKE ZPMPWZIJWOLMHZ-UHFFFAOYSA-N D01OFO DRUGSMIL C1CNCCC1N2C=C(N=C2)C(CC3=CN=C(C=C3)N)C(=O)O D01OFO HIGHSTAT Patented D01OZO DRUG__ID D01OZO D01OZO DRUGTYPE Small molecular drug D01OZO DRUGINCH 1S/C26H31N5O3S/c1-29-16-26(27-18-29)35(32,33)28-20-14-31(15-20)21-8-9-25-23(13-21)22(12-19-6-3-2-4-7-19)24(17-34-25)30-10-5-11-30/h2-4,6-9,13,16,18,20,22,24,28H,5,10-12,14-15,17H2,1H3 D01OZO DRUGINKE LMBGMNQXZDWDDD-UHFFFAOYSA-N D01OZO DRUGSMIL CN1C=C(N=C1)S(=O)(=O)NC2CN(C2)C3=CC4=C(C=C3)OCC(C4CC5=CC=CC=C5)N6CCC6 D01OZO HIGHSTAT Patented D01PPR DRUG__ID D01PPR D01PPR DRUGTYPE Small molecular drug D01PPR DRUGINCH 1S/C20H26N2O2/c1-15-7-9-18(10-8-15)21-13-17-11-12-22(20(24)19(17)23)14-16-5-3-2-4-6-16/h2-6,11-12,15,18,21,23H,7-10,13-14H2,1H3 D01PPR DRUGINKE VJHCNYYTYSQTGD-UHFFFAOYSA-N D01PPR DRUGSMIL CC1CCC(CC1)NCC2=C(C(=O)N(C=C2)CC3=CC=CC=C3)O D01PPR HIGHSTAT Patented D01QPX DRUG__ID D01QPX D01QPX DRUGTYPE Small molecular drug D01QPX DRUGINCH 1S/C18H14N10/c1-27-15-5-4-11(6-13(15)14(8-20)25-27)23-18-24-16(22-10-2-3-10)17-21-9-12(7-19)28(17)26-18/h4-6,9-10H,2-3H2,1H3,(H2,22,23,24,26) D01QPX DRUGINKE JAQNOWSPKHFMOW-UHFFFAOYSA-N D01QPX DRUGSMIL CN1C2=C(C=C(C=C2)NC3=NN4C(=CN=C4C(=N3)NC5CC5)C#N)C(=N1)C#N D01QPX HIGHSTAT Patented D01QYA DRUG__ID D01QYA D01QYA DRUGTYPE Small molecular drug D01QYA DRUGINCH 1S/C19H26N2/c1-17-9-11-19(12-10-17)16-21(14-13-20(2)3)15-18-7-5-4-6-8-18/h4-12H,13-16H2,1-3H3 D01QYA DRUGINKE FAKZYZYSFVGBEY-UHFFFAOYSA-N D01QYA DRUGSMIL CC1=CC=C(C=C1)CN(CCN(C)C)CC2=CC=CC=C2 D01QYA HIGHSTAT Patented D01RQE DRUG__ID D01RQE D01RQE DRUGTYPE Small molecular drug D01RQE DRUGINCH 1S/C28H35N5O2S/c1-21(34)29-24-7-4-6-23(20-24)22-10-14-31(15-11-22)12-5-13-33-28(35)26-9-3-2-8-25(26)27(30-33)32-16-18-36-19-17-32/h2-4,6-9,20,22H,5,10-19H2,1H3,(H,29,34) D01RQE DRUGINKE XXBGKRFICBGOCH-UHFFFAOYSA-N D01RQE DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCCN3C(=O)C4=CC=CC=C4C(=N3)N5CCSCC5 D01RQE HIGHSTAT Patented D01RXV DRUG__ID D01RXV D01RXV DRUGTYPE Small molecular drug D01RXV DRUGINCH 1S/C24H21N7/c1-2-4-22-20(3-1)19(7-8-26-22)21-15-29-31-16-18(14-28-24(21)31)17-5-6-23(27-13-17)30-11-9-25-10-12-30/h1-8,13-16,25H,9-12H2 D01RXV DRUGINKE YTUZELSDHUVEFM-UHFFFAOYSA-N D01RXV DRUGSMIL C1CN(CCN1)C2=NC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3 D01RXV HIGHSTAT Patented D01UIJ DRUG__ID D01UIJ D01UIJ DRUGTYPE Small molecular drug D01UIJ DRUGINCH 1S/C29H30N6O5/c1-16-32-22-9-7-17(13-24(22)39-16)20-15-31-26-25(20)28(40-19-5-3-4-6-19)35-29(34-26)33-21-10-8-18(14-23(21)38-2)27(37)30-11-12-36/h7-10,13-15,19,36H,3-6,11-12H2,1-2H3,(H,30,37)(H2,31,33,34,35) D01UIJ DRUGINKE DUZMKFLMNMTYDM-UHFFFAOYSA-N D01UIJ DRUGSMIL CC1=NC2=C(O1)C=C(C=C2)C3=CNC4=C3C(=NC(=N4)NC5=C(C=C(C=C5)C(=O)NCCO)OC)OC6CCCC6 D01UIJ HIGHSTAT Patented D01UPA DRUG__ID D01UPA D01UPA DRUGTYPE Small molecular drug D01UPA DRUGINCH 1S/C8H6Br2O3/c1-13-6-2-5(9)7(10)4(3-11)8(6)12/h2-3,12H,1H3 D01UPA DRUGINKE NEQRDPRMCZPVJM-UHFFFAOYSA-N D01UPA DRUGSMIL COC1=CC(=C(C(=C1O)C=O)Br)Br D01UPA HIGHSTAT Patented D01WAJ DRUG__ID D01WAJ D01WAJ DRUGTYPE Small molecular drug D01WAJ DRUGINCH 1S/C18H15N3O2/c19-9-10-4-6-14-12(8-10)17(18(23)21-14)15-7-5-11-13(20-15)2-1-3-16(11)22/h4-8,16-17,22H,1-3H2,(H,21,23) D01WAJ DRUGINKE XZWVOUQIYLZUCJ-UHFFFAOYSA-N D01WAJ DRUGSMIL C1CC(C2=C(C1)N=C(C=C2)C3C4=C(C=CC(=C4)C#N)NC3=O)O D01WAJ HIGHSTAT Patented D01WHH DRUG__ID D01WHH D01WHH DRUGTYPE Small molecular drug D01WHH DRUGINCH 1S/C18H17FN6O/c1-11(2)9-25-16-4-3-12(19)7-14(16)17(24-25)23-15-8-21-6-5-13(15)18(26)22-10-20/h3-8,11H,9H2,1-2H3,(H,22,26)(H,23,24) D01WHH DRUGINKE HHHITATYTCPWBZ-UHFFFAOYSA-N D01WHH DRUGSMIL CC(C)CN1C2=C(C=C(C=C2)F)C(=N1)NC3=C(C=CN=C3)C(=O)NC#N D01WHH HIGHSTAT Patented D01XRW DRUG__ID D01XRW D01XRW DRUGTYPE Small molecular drug D01XRW DRUGINCH 1S/C14H15Cl2NO3/c1-3-8-6-5-7-9(4-2)12(8)17-13(18)10(15)11(16)14(19)20/h5-7H,3-4H2,1-2H3,(H,17,18)(H,19,20)/b11-10+ D01XRW DRUGINKE JDSFJBVJTZVNIT-ZHACJKMWSA-N D01XRW DRUGSMIL CCC1=C(C(=CC=C1)CC)NC(=O)C(=C(C(=O)O)Cl)Cl D01XRW HIGHSTAT Patented D01XTB DRUG__ID D01XTB D01XTB DRUGTYPE Small molecular drug D01XTB DRUGINCH 1S/C17H22N4O2/c18-16-7-6-12(9-19-16)8-14(17(22)23)15-10-21(11-20-15)13-4-2-1-3-5-13/h6-7,9-11,13-14H,1-5,8H2,(H2,18,19)(H,22,23) D01XTB DRUGINKE XHKJBNCTUYFLDC-UHFFFAOYSA-N D01XTB DRUGSMIL C1CCC(CC1)N2C=C(N=C2)C(CC3=CN=C(C=C3)N)C(=O)O D01XTB HIGHSTAT Patented D01XZT DRUG__ID D01XZT D01XZT DRUGTYPE Small molecular drug D01XZT DRUGINCH 1S/C15H14N2O4/c1-9-2-4-10(5-3-9)11-6-12(18)14(16-7-11)15(21)17-8-13(19)20/h2-7,18H,8H2,1H3,(H,17,21)(H,19,20) D01XZT DRUGINKE VBNCAZJDNCXKIO-UHFFFAOYSA-N D01XZT DRUGSMIL CC1=CC=C(C=C1)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O D01XZT HIGHSTAT Patented D01ZCC DRUG__ID D01ZCC D01ZCC DRUGTYPE Small molecular drug D01ZCC DRUGINCH 1S/C15H30N2O3/c1-17(2)13-9-12-16-14(18)10-7-5-3-4-6-8-11-15(19)20/h3-13H2,1-2H3,(H,16,18)(H,19,20) D01ZCC DRUGINKE GWKPWGKMVDEOGQ-UHFFFAOYSA-N D01ZCC DRUGSMIL CN(C)CCCNC(=O)CCCCCCCCC(=O)O D01ZCC HIGHSTAT Patented D02AAR DRUG__ID D02AAR D02AAR DRUGTYPE Small molecular drug D02AAR DRUGINCH 1S/C23H17F2N3O3S/c1-31-21-6-5-12(18-10-14-8-16(24)17(25)11-19(14)27-18)9-20(21)28-23(32)26-15-4-2-3-13(7-15)22(29)30/h2-11,27H,1H3,(H,29,30)(H2,26,28,32) D02AAR DRUGINKE WDBLIHVXAGLYCZ-UHFFFAOYSA-N D02AAR DRUGSMIL COC1=C(C=C(C=C1)C2=CC3=CC(=C(C=C3N2)F)F)NC(=S)NC4=CC=CC(=C4)C(=O)O D02AAR HIGHSTAT Patented D02CJU DRUG__ID D02CJU D02CJU DRUGTYPE Small molecular drug D02CJU DRUGINCH 1S/C41H53F2N4O11P/c1-24(26-13-16-29(17-14-26)41(42,43)59(54,57-22-55-37(52)39(3,4)5)58-23-56-38(53)40(6,7)8)20-33(49)46-30-18-15-27-10-9-11-28-21-31(47(34(27)28)36(30)51)35(50)45-25(2)12-19-32(44)48/h9-11,13-14,16-17,20,25,30-31H,12,15,18-19,21-23H2,1-8H3,(H2,44,48)(H,45,50)(H,46,49)/b24-20+/t25-,30+,31+/m1/s1 D02CJU DRUGINKE FPJJYMKTWVMUCU-GCFVZNOFSA-N D02CJU DRUGSMIL CC(CCC(=O)N)NC(=O)C1CC2=CC=CC3=C2N1C(=O)C(CC3)NC(=O)C=C(C)C4=CC=C(C=C4)C(F)(F)P(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C D02CJU HIGHSTAT Patented D02CXZ DRUG__ID D02CXZ D02CXZ DRUGTYPE Small molecular drug D02CXZ DRUGINCH 1S/C22H23N/c23-18-10-17-22(19-11-4-1-5-12-19,20-13-6-2-7-14-20)21-15-8-3-9-16-21/h1-9,11-16H,10,17-18,23H2 D02CXZ DRUGINKE PVCHAKQXNCGVFU-UHFFFAOYSA-N D02CXZ DRUGSMIL C1=CC=C(C=C1)C(CCCN)(C2=CC=CC=C2)C3=CC=CC=C3 D02CXZ HIGHSTAT Patented D02DJP DRUG__ID D02DJP D02DJP DRUGTYPE Small molecular drug D02DJP DRUGINCH 1S/C26H26N6O2/c1-2-22(33)30-18-10-12-19(13-11-18)32-26-23(25(27)28-16-29-26)24(31-32)17-8-14-21(15-9-17)34-20-6-4-3-5-7-20/h2-9,14-16,18-19H,1,10-13H2,(H,30,33)(H2,27,28,29) D02DJP DRUGINKE SSDFTYWIYVWCIE-UHFFFAOYSA-N D02DJP DRUGSMIL C=CC(=O)NC1CCC(CC1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N D02DJP HIGHSTAT Patented D02IRO DRUG__ID D02IRO D02IRO DRUGTYPE Small molecular drug D02IRO DRUGINCH 1S/C26H20F3N3O5/c27-26(28,29)19-9-5-4-8-16(19)17-12-18-20(32(25(17)37)14-15-6-2-1-3-7-15)13-31-22(23(18)35)24(36)30-11-10-21(33)34/h1-9,12-13,35H,10-11,14H2,(H,30,36)(H,33,34) D02IRO DRUGINKE VSKYLKKDQYXUIH-UHFFFAOYSA-N D02IRO DRUGSMIL C1=CC=C(C=C1)CN2C3=CN=C(C(=C3C=C(C2=O)C4=CC=CC=C4C(F)(F)F)O)C(=O)NCCC(=O)O D02IRO HIGHSTAT Patented D02JVX DRUG__ID D02JVX D02JVX DRUGTYPE Small molecular drug D02JVX DRUGINCH 1S/C11H10O3/c12-9-4-3-8(11(13)7-9)6-10-2-1-5-14-10/h1-5,7,12-13H,6H2 D02JVX DRUGINKE UGOKFADRDRUFRJ-UHFFFAOYSA-N D02JVX DRUGSMIL C1=COC(=C1)CC2=C(C=C(C=C2)O)O D02JVX HIGHSTAT Patented D02LNB DRUG__ID D02LNB D02LNB DRUGTYPE Small molecular drug D02LNB DRUGINCH 1S/C13H21N3O/c14-9-11-7-4-8-16(11)13(17)12(15)10-5-2-1-3-6-10/h10-12H,1-8,15H2 D02LNB DRUGINKE SXNUNNAPZNTPQV-UHFFFAOYSA-N D02LNB DRUGSMIL C1CCC(CC1)C(C(=O)N2CCCC2C#N)N D02LNB HIGHSTAT Patented D02NNZ DRUG__ID D02NNZ D02NNZ DRUGTYPE Small molecular drug D02NNZ DRUGINCH 1S/C19H16Cl3N5O/c20-13-5-3-12(4-6-13)18-23-17(19(28)25-26-9-1-2-10-26)24-27(18)16-8-7-14(21)11-15(16)22/h3-8,11H,1-2,9-10H2,(H,25,28) D02NNZ DRUGINKE ONYKENLNZNVNBN-UHFFFAOYSA-N D02NNZ DRUGSMIL C1CCN(C1)NC(=O)C2=NN(C(=N2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl D02NNZ HIGHSTAT Patented D02NRD DRUG__ID D02NRD D02NRD DRUGTYPE Small molecular drug D02NRD DRUGINCH 1S/C22H26N4O3/c1-22(2)19(26-18-20(23)24-12-25-21(18)29-22)16-9-7-15(8-10-16)14-5-3-13(4-6-14)11-17(27)28/h7-10,12-14H,3-6,11H2,1-2H3,(H,27,28)(H2,23,24,25) D02NRD DRUGINKE FUIYMYNYUHVDPT-UHFFFAOYSA-N D02NRD DRUGSMIL CC1(C(=NC2=C(N=CN=C2O1)N)C3=CC=C(C=C3)C4CCC(CC4)CC(=O)O)C D02NRD HIGHSTAT Patented D02QTG DRUG__ID D02QTG D02QTG DRUGTYPE Small molecular drug D02QTG DRUGINCH 1S/C27H40N10O4S/c1-16(2)22(37-42(40,41)15-18-7-11-20(12-8-18)24(30)31)26(39)36-21(4-3-13-34-27(32)33)25(38)35-14-17-5-9-19(10-6-17)23(28)29/h5-12,16,21-22,37H,3-4,13-15H2,1-2H3,(H3,28,29)(H3,30,31)(H,35,38)(H,36,39)(H4,32,33,34)/t21-,22-/m0/s1 D02QTG DRUGINKE PRSVXIFOXDFBKT-VXKWHMMOSA-N D02QTG DRUGSMIL CC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)NCC1=CC=C(C=C1)C(=N)N)NS(=O)(=O)CC2=CC=C(C=C2)C(=N)N D02QTG HIGHSTAT Patented D02TPQ DRUG__ID D02TPQ D02TPQ DRUGTYPE Small molecular drug D02TPQ DRUGINCH 1S/C22H22F8N4O/c23-15-2-1-13(17(18(15)24)22(28,29)30)12-3-8-34(9-4-12)20(35)19-14-11-33(10-6-21(25,26)27)7-5-16(14)31-32-19/h1-2,12H,3-11H2,(H,31,32) D02TPQ DRUGINKE GUCHXVVEHJYGON-UHFFFAOYSA-N D02TPQ DRUGSMIL C1CN(CCC1C2=C(C(=C(C=C2)F)F)C(F)(F)F)C(=O)C3=NNC4=C3CN(CC4)CCC(F)(F)F D02TPQ HIGHSTAT Patented D02WJB DRUG__ID D02WJB D02WJB DRUGTYPE Small molecular drug D02WJB DRUGINCH 1S/C24H25N/c1-5-13-21(14-6-1)24(22-15-7-2-8-16-22,23-17-9-3-10-18-23)25-19-11-4-12-20-25/h1-3,5-10,13-18H,4,11-12,19-20H2 D02WJB DRUGINKE ZDTBBCYZMFEIHU-UHFFFAOYSA-N D02WJB DRUGSMIL C1CCN(CC1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D02WJB HIGHSTAT Patented D02WVW DRUG__ID D02WVW D02WVW DRUGTYPE Small molecular drug D02WVW DRUGINCH 1S/C22H36NO4P/c1-2-3-4-5-6-17-7-8-19-14-20(10-9-18(19)13-17)21-11-12-22(23,15-21)16-27-28(24,25)26/h9-10,14,17,21H,2-8,11-13,15-16,23H2,1H3,(H2,24,25,26)/t17-,21-,22+/m1/s1 D02WVW DRUGINKE BWKSEIHXZRSETR-YHYVQYDKSA-N D02WVW DRUGSMIL CCCCCCC1CCC2=C(C1)C=CC(=C2)C3CCC(C3)(COP(=O)(O)O)N D02WVW HIGHSTAT Patented D02XAR DRUG__ID D02XAR D02XAR DRUGTYPE Small molecular drug D02XAR DRUGINCH 1S/C25H29N3O5S/c29-25(27-30)24(28-14-4-1-5-15-28)17-26-34(31,32)23-12-10-22(11-13-23)33-18-19-8-9-20-6-2-3-7-21(20)16-19/h2-3,6-13,16,24,26,30H,1,4-5,14-15,17-18H2,(H,27,29)/t24-/m0/s1 D02XAR DRUGINKE OPHJLUDAYHJCPN-DEOSSOPVSA-N D02XAR DRUGSMIL C1CCN(CC1)C(CNS(=O)(=O)C2=CC=C(C=C2)OCC3=CC4=CC=CC=C4C=C3)C(=O)NO D02XAR HIGHSTAT Patented D03DSN DRUG__ID D03DSN D03DSN DRUGTYPE Small molecular drug D03DSN DRUGINCH 1S/C24H23N5O2S/c1-28-20(17-11-6-3-7-12-17)27-22-19(23(28)31)26-24(32-22)29-14-8-13-18(29)21(30)25-15-16-9-4-2-5-10-16/h2-7,9-12,18H,8,13-15H2,1H3,(H,25,30)/t18-/m1/s1 D03DSN DRUGINKE LYGQOCVESZDBMV-GOSISDBHSA-N D03DSN DRUGSMIL CN1C(=NC2=C(C1=O)N=C(S2)N3CCCC3C(=O)NCC4=CC=CC=C4)C5=CC=CC=C5 D03DSN HIGHSTAT Patented D03DZQ DRUG__ID D03DZQ D03DZQ DRUGTYPE Small molecular drug D03DZQ DRUGINCH 1S/C25H24F2N2O3/c1-14(2)32-24(31)17-12-29(23(30)15-9-10-18(26)19(27)11-15)13-25(3,4)21-16-7-5-6-8-20(16)28-22(17)21/h5-12,14,28H,13H2,1-4H3 D03DZQ DRUGINKE INASOKQDNHHMRE-UHFFFAOYSA-N D03DZQ DRUGSMIL CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F D03DZQ HIGHSTAT Patented D03ETN DRUG__ID D03ETN D03ETN DRUGTYPE Small molecular drug D03ETN DRUGINCH 1S/C16H16ClN5/c1-9-8-14(22-21-9)19-15-10(2)11(3)18-16(20-15)12-6-4-5-7-13(12)17/h4-8H,1-3H3,(H2,18,19,20,21,22) D03ETN DRUGINKE ONBXAMQNBSFIQS-UHFFFAOYSA-N D03ETN DRUGSMIL CC1=CC(=NN1)NC2=NC(=NC(=C2C)C)C3=CC=CC=C3Cl D03ETN HIGHSTAT Patented D03FDN DRUG__ID D03FDN D03FDN DRUGTYPE Small molecular drug D03FDN DRUGINCH 1S/C24H17Cl3N2O/c1-15-23(22(30)13-16-5-3-2-4-6-16)28-29(21-12-11-19(26)14-20(21)27)24(15)17-7-9-18(25)10-8-17/h2-12,14H,13H2,1H3 D03FDN DRUGINKE GTXRPIMCNZXFIC-UHFFFAOYSA-N D03FDN DRUGSMIL CC1=C(N(N=C1C(=O)CC2=CC=CC=C2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D03FDN HIGHSTAT Patented D03GTM DRUG__ID D03GTM D03GTM DRUGTYPE Small molecular drug D03GTM DRUGINCH 1S/C18H16ClN5OS/c1-22-7-6-13-14(9-22)26-17-15(13)16-20-10-21-24(16)18(25)23(17)8-11-2-4-12(19)5-3-11/h2-5,10H,6-9H2,1H3 D03GTM DRUGINKE AXPVGJNPJSMCLA-UHFFFAOYSA-N D03GTM DRUGSMIL CN1CCC2=C(C1)SC3=C2C4=NC=NN4C(=O)N3CC5=CC=C(C=C5)Cl D03GTM HIGHSTAT Patented D03MKE DRUG__ID D03MKE D03MKE DRUGTYPE Small molecular drug D03MKE DRUGINCH 1S/C17H20O4/c1-11-16(20-2)9-7-13(17(11)21-3)5-4-12-6-8-14(18)10-15(12)19/h6-10,18-19H,4-5H2,1-3H3 D03MKE DRUGINKE IUYGPVSGZMZJPS-UHFFFAOYSA-N D03MKE DRUGSMIL CC1=C(C=CC(=C1OC)CCC2=C(C=C(C=C2)O)O)OC D03MKE HIGHSTAT Patented D03NCL DRUG__ID D03NCL D03NCL DRUGTYPE Small molecular drug D03NCL DRUGINCH 1S/C11H9NO4S/c1-16-8-3-2-6(4-7(8)13)5-9-10(14)12-11(15)17-9/h2-5,13H,1H3,(H,12,14,15)/b9-5- D03NCL DRUGINKE MHRJJGJJVMGLRQ-UITAMQMPSA-N D03NCL DRUGSMIL COC1=C(C=C(C=C1)C=C2C(=O)NC(=O)S2)O D03NCL HIGHSTAT Patented D03OBN DRUG__ID D03OBN D03OBN DRUGTYPE Small molecular drug D03OBN DRUGINCH 1S/C17H18F3N3OS/c1-22-6-8-23(9-7-22)14-5-4-12(17(18,19)20)11-13(14)21-16(24)15-3-2-10-25-15/h2-5,10-11H,6-9H2,1H3,(H,21,24) D03OBN DRUGINKE ZMQGTVWBYJXOLY-UHFFFAOYSA-N D03OBN DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)C(F)(F)F)NC(=O)C3=CC=CS3 D03OBN HIGHSTAT Patented D03OLC DRUG__ID D03OLC D03OLC DRUGTYPE Small molecular drug D03OLC DRUGINCH 1S/C21H18N4O/c1-25-19(26)21(24-20(25)22,17-9-3-2-4-10-17)18-11-5-7-15(13-18)16-8-6-12-23-14-16/h2-14H,1H3,(H2,22,24) D03OLC DRUGINKE PNSQCPQDRVOKMA-UHFFFAOYSA-N D03OLC DRUGSMIL CN1C(=O)C(N=C1N)(C2=CC=CC=C2)C3=CC=CC(=C3)C4=CN=CC=C4 D03OLC HIGHSTAT Patented D03PGC DRUG__ID D03PGC D03PGC DRUGTYPE Small molecular drug D03PGC DRUGINCH 1S/C19H22N4O2/c24-18-17(13-20-8-4-10-22-12-9-21-15-22)7-11-23(19(18)25)14-16-5-2-1-3-6-16/h1-3,5-7,9,11-12,15,20,24H,4,8,10,13-14H2 D03PGC DRUGINKE VKLSJRDNBKOSAR-UHFFFAOYSA-N D03PGC DRUGSMIL C1=CC=C(C=C1)CN2C=CC(=C(C2=O)O)CNCCCN3C=CN=C3 D03PGC HIGHSTAT Patented D03POM DRUG__ID D03POM D03POM DRUGTYPE Small molecular drug D03POM DRUGINCH 1S/C15H22N4O2/c1-9(2)12-7-13(18-17-12)15(21)19-6-5-11(8-19)16-14(20)10-3-4-10/h7,9-11H,3-6,8H2,1-2H3,(H,16,20)(H,17,18) D03POM DRUGINKE CXEXTVGTDZRKJS-UHFFFAOYSA-N D03POM DRUGSMIL CC(C)C1=CC(=NN1)C(=O)N2CCC(C2)NC(=O)C3CC3 D03POM HIGHSTAT Patented D03PTY DRUG__ID D03PTY D03PTY DRUGTYPE Small molecular drug D03PTY DRUGINCH 1S/C22H18FNO4/c23-13-21(25)24(14-16-7-6-12-20-22(16)27-15-26-20)18-10-4-5-11-19(18)28-17-8-2-1-3-9-17/h1-12H,13-15H2/i23-1 D03PTY DRUGINKE JHMUPOREYLLSRB-VNRZBHCFSA-N D03PTY DRUGSMIL C1OC2=CC=CC(=C2O1)CN(C3=CC=CC=C3OC4=CC=CC=C4)C(=O)CF D03PTY HIGHSTAT Patented D03PZZ DRUG__ID D03PZZ D03PZZ DRUGTYPE Small molecular drug D03PZZ DRUGINCH 1S/C11H9NO4/c13-8-2-1-6(9(14)5-8)3-7-4-10(15)12-11(7)16/h1-3,5,13-14H,4H2,(H,12,15,16)/b7-3+ D03PZZ DRUGINKE PTHHGONJHHJYIU-XVNBXDOJSA-N D03PZZ DRUGSMIL C1C(=CC2=C(C=C(C=C2)O)O)C(=O)NC1=O D03PZZ HIGHSTAT Patented D03RBY DRUG__ID D03RBY D03RBY DRUGTYPE Small molecular drug D03RBY DRUGINCH 1S/C24H25F2N7O2/c1-5-35-16-10-18(25)17(19(26)11-16)13-33-14-20(32(2)3)22(31-33)24-28-12-21(34-4)23(30-24)29-15-6-8-27-9-7-15/h6-12,14H,5,13H2,1-4H3,(H,27,28,29,30) D03RBY DRUGINKE TYXHNCNKIXBYQD-UHFFFAOYSA-N D03RBY DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C=C(C(=N2)C3=NC=C(C(=N3)NC4=CC=NC=C4)OC)N(C)C)F D03RBY HIGHSTAT Patented D03RHV DRUG__ID D03RHV D03RHV DRUGTYPE Small molecular drug D03RHV DRUGINCH 1S/C17H25N5O/c1-2-3-9-20-17-21-13-14(15-8-4-5-10-18-15)16(22-17)19-11-6-7-12-23/h4-5,8,10,13,23H,2-3,6-7,9,11-12H2,1H3,(H2,19,20,21,22) D03RHV DRUGINKE KKAICBOHJLVDCE-UHFFFAOYSA-N D03RHV DRUGSMIL CCCCNC1=NC=C(C(=N1)NCCCCO)C2=CC=CC=N2 D03RHV HIGHSTAT Patented D03SHV DRUG__ID D03SHV D03SHV DRUGTYPE Small molecular drug D03SHV DRUGINCH 1S/C18H14FN3O4S/c19-12-8-10(16(20)21)3-5-14(12)26-18(25)15-6-4-11(27-15)9-22-7-1-2-13(22)17(23)24/h1-8H,9H2,(H3,20,21)(H,23,24) D03SHV DRUGINKE FIQOBFTVRYSLKW-UHFFFAOYSA-N D03SHV DRUGSMIL C1=CN(C(=C1)C(=O)O)CC2=CC=C(S2)C(=O)OC3=C(C=C(C=C3)C(=N)N)F D03SHV HIGHSTAT Patented D03SLR DRUG__ID D03SLR D03SLR DRUGTYPE Small molecular drug D03SLR DRUGINCH 1S/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+ D03SLR DRUGINKE KSEBMYQBYZTDHS-HWKANZROSA-N D03SLR DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)O)O D03SLR HIGHSTAT Patented D03TFJ DRUG__ID D03TFJ D03TFJ DRUGTYPE Small molecular drug D03TFJ DRUGINCH 1S/C7H6N2/c1-2-4-7-6(3-1)8-5-9-7/h1-5H,(H,8,9) D03TFJ DRUGINKE HYZJCKYKOHLVJF-UHFFFAOYSA-N D03TFJ DRUGSMIL C1=CC=C2C(=C1)NC=N2 D03TFJ HIGHSTAT Patented D03TKM DRUG__ID D03TKM D03TKM DRUGTYPE Small molecular drug D03TKM DRUGINCH 1S/C16H13N3O2/c1-11-2-4-12(5-3-11)14-7-9-18-19(14)15-10-13(16(20)21)6-8-17-15/h2-10H,1H3,(H,20,21) D03TKM DRUGINKE LKBZHRSAENXIOI-UHFFFAOYSA-N D03TKM DRUGSMIL CC1=CC=C(C=C1)C2=CC=NN2C3=NC=CC(=C3)C(=O)O D03TKM HIGHSTAT Patented D03TTE DRUG__ID D03TTE D03TTE DRUGTYPE Small molecular drug D03TTE DRUGINCH 1S/C28H26O8/c1-9(2)17-21-13(7-15(29)27(17)35)25(33)19(11(5)23(21)31)20-12(6)24(32)22-14(26(20)34)8-16(30)28(36)18(22)10(3)4/h7-10,29,31,33,35H,1-6H3 D03TTE DRUGINKE PXSGRWNXASCGTJ-UHFFFAOYSA-N D03TTE DRUGSMIL CC1=C(C(=O)C2=CC(=O)C(=O)C(=C2C1=O)C(C)C)C3=C(C4=CC(=C(C(=C4C(=C3C)O)C(C)C)O)O)O D03TTE HIGHSTAT Patented D03UAE DRUG__ID D03UAE D03UAE DRUGTYPE Small molecular drug D03UAE DRUGINCH 1S/C22H26F3N5O3S/c1-12(2)17-19-27-15-7-6-13(34(5,32)33)10-16(15)29(19)8-9-30(17)20-26-11-14(21(3,4)31)18(28-20)22(23,24)25/h6-7,10-12,17,31H,8-9H2,1-5H3 D03UAE DRUGINKE LOFRRPNYSLDHRM-UHFFFAOYSA-N D03UAE DRUGSMIL CC(C)C1C2=NC3=C(N2CCN1C4=NC=C(C(=N4)C(F)(F)F)C(C)(C)O)C=C(C=C3)S(=O)(=O)C D03UAE HIGHSTAT Patented D03VKC DRUG__ID D03VKC D03VKC DRUGTYPE Small molecular drug D03VKC DRUGINCH 1S/C12H11NO2S/c1-15-12(14)10-9(7-16-11(10)13)8-5-3-2-4-6-8/h2-7H,13H2,1H3 D03VKC DRUGINKE KHNSKPUYBBZGLW-UHFFFAOYSA-N D03VKC DRUGSMIL COC(=O)C1=C(SC=C1C2=CC=CC=C2)N D03VKC HIGHSTAT Patented D03VOJ DRUG__ID D03VOJ D03VOJ DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D03VOJ DRUGINCH 1S/C7H6O3/c8-4-5-1-2-6(9)7(10)3-5/h1-4,9-10H D03VOJ DRUGINKE IBGBGRVKPALMCQ-UHFFFAOYSA-N D03VOJ DRUGSMIL C1=CC(=C(C=C1C=O)O)O D03VOJ HIGHSTAT Patented D03YWY DRUG__ID D03YWY D03YWY DRUGTYPE Small molecular drug D03YWY DRUGINCH 1S/C21H26F2N2O/c1-26-18-17-14-3-2-13(4-14)16(17)15(8-24-18)25-21-7-12-5-19(22,10-21)9-20(23,6-12)11-21/h8,12-14,25H,2-7,9-11H2,1H3 D03YWY DRUGINKE YKIONNFZUQIKPS-UHFFFAOYSA-N D03YWY DRUGSMIL COC1=NC=C(C2=C1C3CCC2C3)NC45CC6CC(C4)(CC(C6)(C5)F)F D03YWY HIGHSTAT Patented D03ZOH DRUG__ID D03ZOH D03ZOH DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D03ZOH DRUGINCH 1S/C6H8O3/c1-3-5(7)6(8)4(2)9-3/h3,8H,1-2H3 D03ZOH DRUGINKE INAXVXBDKKUCGI-UHFFFAOYSA-N D03ZOH DRUGSMIL CC1C(=O)C(=C(O1)C)O D03ZOH HIGHSTAT Patented D04AFR DRUG__ID D04AFR D04AFR DRUGTYPE Small molecular drug D04AFR DRUGINCH 1S/C21H28N4O5/c1-14-2-4-16(5-3-14)30-17-6-7-24-15(10-17)11-21(28,20(26)27)18(22)13-29-19-12-23-8-9-25-19/h6-10,12,14,16,18,28H,2-5,11,13,22H2,1H3,(H,26,27)/t14?,16?,18-,21+/m0/s1 D04AFR DRUGINKE GDORSLXMLRLKBT-MAQYLPRKSA-N D04AFR DRUGSMIL CC1CCC(CC1)OC2=CC(=NC=C2)CC(C(COC3=NC=CN=C3)N)(C(=O)O)O D04AFR HIGHSTAT Patented D04BAA DRUG__ID D04BAA D04BAA DRUGTYPE Small molecular drug D04BAA DRUGINCH 1S/C22H22F6N4O2/c1-12(33)32-7-4-17-18(11-32)29-30-19(17)20(34)31-5-2-13(3-6-31)14-8-15(21(23,24)25)10-16(9-14)22(26,27)28/h8-10,13H,2-7,11H2,1H3,(H,29,30) D04BAA DRUGINKE UYJQGBUMNGFPIF-UHFFFAOYSA-N D04BAA DRUGSMIL CC(=O)N1CCC2=C(C1)NN=C2C(=O)N3CCC(CC3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D04BAA HIGHSTAT Patented D04BTN DRUG__ID D04BTN D04BTN DRUGTYPE Small molecular drug D04BTN DRUGINCH 1S/C18H14FN3O5/c1-9-15-12(17(25)16(21-9)18(26)20-8-14(23)24)6-7-13(22-15)27-11-4-2-10(19)3-5-11/h2-7,25H,8H2,1H3,(H,20,26)(H,23,24) D04BTN DRUGINKE ZGAARGWNIMGZMM-UHFFFAOYSA-N D04BTN DRUGSMIL CC1=C2C(=C(C(=N1)C(=O)NCC(=O)O)O)C=CC(=N2)OC3=CC=C(C=C3)F D04BTN HIGHSTAT Patented D04FAS DRUG__ID D04FAS D04FAS DRUGTYPE Small molecular drug D04FAS DRUGINCH 1S/C26H32N2O4/c29-25(9-11-27-13-17-31-18-14-27)23-5-1-21(2-6-23)22-3-7-24(8-4-22)26(30)10-12-28-15-19-32-20-16-28/h1-8H,9-20H2 D04FAS DRUGINKE UKUXOYHUMOANRU-UHFFFAOYSA-N D04FAS DRUGSMIL C1COCCN1CCC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)CCN4CCOCC4 D04FAS HIGHSTAT Patented D04HEW DRUG__ID D04HEW D04HEW DRUGTYPE Small molecular drug D04HEW DRUGINCH 1S/C16H21NO4S/c1-3-12(2)11-22(20,21)17-8-6-13(7-9-17)15-5-4-14(18)10-16(15)19/h3-5,10,13,18-19H,1-2,6-9,11H2 D04HEW DRUGINKE JCJFASCAOSDZDC-UHFFFAOYSA-N D04HEW DRUGSMIL C=CC(=C)CS(=O)(=O)N1CCC(CC1)C2=C(C=C(C=C2)O)O D04HEW HIGHSTAT Patented D04JJM DRUG__ID D04JJM D04JJM DRUGTYPE Small molecular drug D04JJM DRUGINCH 1S/C27H24N4O3/c1-28-16-11-19-30-17-9-5-4-8-14(17)21-22-15(12-29-26(22)32)20-13-7-3-6-10-18(13)31(23(20)24(21)30)27(34-19)25(16)33-2/h3-10,16,19,25,27-28H,11-12H2,1-2H3,(H,29,32)/t16-,19?,25-,27?/m1/s1 D04JJM DRUGINKE YISMQBFJYDFMAL-AESIHLKFSA-N D04JJM DRUGSMIL CNC1CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)C(C1OC)O2)CNC6=O D04JJM HIGHSTAT Patented D04JZE DRUG__ID D04JZE D04JZE DRUGTYPE Small molecular drug D04JZE DRUGINCH 1S/C21H16N2O2S/c24-18-11-10-13-6-4-5-9-15(13)16(18)12-17-19(14-7-2-1-3-8-14)22-21(26)23-20(17)25/h1-11,24H,12H2,(H2,22,23,25,26) D04JZE DRUGINKE RVNSQVIUFZVNAU-UHFFFAOYSA-N D04JZE DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)NC(=S)N2)CC3=C(C=CC4=CC=CC=C43)O D04JZE HIGHSTAT Patented D04KXV DRUG__ID D04KXV D04KXV DRUGTYPE Small molecular drug D04KXV DRUGINCH 1S/C23H23ClF3N5O7/c24-13-1-11(4-17(5-13)39-23(25,26)27)18(7-20(36)37)32-19(35)10-28-21(38)12-2-14(6-15(33)3-12)31-22-29-8-16(34)9-30-22/h1-6,16,18,33-34H,7-10H2,(H,28,38)(H,32,35)(H,36,37)(H2,29,30,31)/t18-/m0/s1 D04KXV DRUGINKE BQYBIJDRTDZCAJ-SFHVURJKSA-N D04KXV DRUGSMIL C1C(CN=C(N1)NC2=CC(=CC(=C2)C(=O)NCC(=O)NC(CC(=O)O)C3=CC(=CC(=C3)Cl)OC(F)(F)F)O)O D04KXV HIGHSTAT Patented D04LJF DRUG__ID D04LJF D04LJF DRUGTYPE Small molecular drug D04LJF DRUGINCH 1S/C16H20FN3O3S/c1-11-16(12(2)19-18-11)24(21,22)20-9-7-13(8-10-20)23-15-6-4-3-5-14(15)17/h3-6,13H,7-10H2,1-2H3,(H,18,19) D04LJF DRUGINKE LSJGWMPNBWLCRK-UHFFFAOYSA-N D04LJF DRUGSMIL CC1=C(C(=NN1)C)S(=O)(=O)N2CCC(CC2)OC3=CC=CC=C3F D04LJF HIGHSTAT Patented D04LWZ DRUG__ID D04LWZ D04LWZ DRUGTYPE Small molecular drug D04LWZ DRUGINCH 1S/C18H16N2/c1-12-5-2-8-14(11-12)18-19-15-9-3-6-13-7-4-10-16(20-18)17(13)15/h2-11,18-20H,1H3 D04LWZ DRUGINKE HPFJVSRZYNTHHT-UHFFFAOYSA-N D04LWZ DRUGSMIL CC1=CC(=CC=C1)C2NC3=CC=CC4=C3C(=CC=C4)N2 D04LWZ HIGHSTAT Patented D04MAZ DRUG__ID D04MAZ D04MAZ DRUGTYPE Small molecular drug D04MAZ DRUGINCH 1S/C23H24ClN5O2/c1-2-3-11-28-21(27-10-4-5-18(25)14-27)13-22(30)29(23(28)31)15-19-9-7-16-6-8-17(24)12-20(16)26-19/h6-9,12-13,18H,4-5,10-11,14-15,25H2,1H3/t18-/m1/s1 D04MAZ DRUGINKE MRWKTDPDQXVRSA-GOSISDBHSA-N D04MAZ DRUGSMIL CC#CCN1C(=CC(=O)N(C1=O)CC2=NC3=C(C=CC(=C3)Cl)C=C2)N4CCCC(C4)N D04MAZ HIGHSTAT Patented D04MCF DRUG__ID D04MCF D04MCF DRUGTYPE Small molecular drug D04MCF DRUGINCH 1S/C20H18F3N5OS/c21-11-5-7-28(9-14(11)24)17-4-6-25-8-15(17)26-19(29)16-10-30-20(27-16)18-12(22)2-1-3-13(18)23/h1-4,6,8,10-11,14H,5,7,9,24H2,(H,26,29)/t11-,14-/m1/s1 D04MCF DRUGINKE QQRNXNZMTIFVNK-BXUZGUMPSA-N D04MCF DRUGSMIL C1CN(CC(C1F)N)C2=C(C=NC=C2)NC(=O)C3=CSC(=N3)C4=C(C=CC=C4F)F D04MCF HIGHSTAT Patented D04NEO DRUG__ID D04NEO D04NEO DRUGTYPE Small molecular drug D04NEO DRUGINCH 1S/C27H36N4O5/c1-6-18(7-2)23-12-21(10-17(5)29-23)27-30-26(31-36-27)20-9-16(4)25(19(8-3)11-20)35-15-22(33)13-28-24(34)14-32/h9-12,18,22,32-33H,6-8,13-15H2,1-5H3,(H,28,34)/t22-/m0/s1 D04NEO DRUGINKE CHIUPZSZKBJIHD-QFIPXVFZSA-N D04NEO DRUGSMIL CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)C)C(CC)CC)C)OCC(CNC(=O)CO)O D04NEO HIGHSTAT Patented D04NQY DRUG__ID D04NQY D04NQY DRUGTYPE Small molecular drug D04NQY DRUGINCH 1S/C32H29F5N4O6S/c1-38-29(42)27-24-17-23(20-4-3-5-21(16-20)30(43)39-12-14-40(15-13-39)31(44)32(35,36)37)25(41(11-10-33)48(2,45)46)18-26(24)47-28(27)19-6-8-22(34)9-7-19/h3-9,16-18H,10-15H2,1-2H3,(H,38,42) D04NQY DRUGINKE QALVUUHEMYLFBN-UHFFFAOYSA-N D04NQY DRUGSMIL CNC(=O)C1=C(OC2=CC(=C(C=C21)C3=CC(=CC=C3)C(=O)N4CCN(CC4)C(=O)C(F)(F)F)N(CCF)S(=O)(=O)C)C5=CC=C(C=C5)F D04NQY HIGHSTAT Patented D04SWX DRUG__ID D04SWX D04SWX DRUGTYPE Small molecular drug D04SWX DRUGINCH 1S/C20H12Cl3FN4/c21-13-9-15(22)19(16(23)10-13)28-20(25)17(11-1-3-14(24)4-2-11)18(27-28)12-5-7-26-8-6-12/h1-10H,25H2 D04SWX DRUGINKE MOHYPRXHKRXDSE-UHFFFAOYSA-N D04SWX DRUGSMIL C1=CC(=CC=C1C2=C(N(N=C2C3=CC=NC=C3)C4=C(C=C(C=C4Cl)Cl)Cl)N)F D04SWX HIGHSTAT Patented D04UXN DRUG__ID D04UXN D04UXN DRUGTYPE Small molecular drug D04UXN DRUGINCH 1S/C23H28N6O/c1-15-9-20-17(12-26-28-20)10-19(15)27-23(30)21-11-22(25-14-24-21)29(13-16-7-8-16)18-5-3-2-4-6-18/h9-12,14,16,18H,2-8,13H2,1H3,(H,26,28)(H,27,30) D04UXN DRUGINKE YYDJCLCSBYCSCO-UHFFFAOYSA-N D04UXN DRUGSMIL CC1=CC2=C(C=C1NC(=O)C3=CC(=NC=N3)N(CC4CC4)C5CCCCC5)C=NN2 D04UXN HIGHSTAT Patented D04UXO DRUG__ID D04UXO D04UXO DRUGTYPE Small molecular drug D04UXO DRUGINCH 1S/C32H23F3N6O2/c1-20-18-41(19-38-20)24-15-22(32(33,34)35)14-23(16-24)39-31(42)28-6-4-5-21-13-25(8-9-27(21)28)43-26-10-12-37-30(17-26)40-29-7-2-3-11-36-29/h2-19H,1H3,(H,39,42)(H,36,37,40) D04UXO DRUGINKE YLFSQHDNZXYOOB-UHFFFAOYSA-N D04UXO DRUGSMIL CC1=CN(C=N1)C2=CC(=CC(=C2)NC(=O)C3=CC=CC4=C3C=CC(=C4)OC5=CC(=NC=C5)NC6=CC=CC=N6)C(F)(F)F D04UXO HIGHSTAT Patented D04VGR DRUG__ID D04VGR D04VGR DRUGTYPE Small molecular drug D04VGR DRUGINCH 1S/C28H30N4O2/c1-20(2)17-26(28(34)32(4)31(3)19-29)30-27(33)25-12-8-11-24(18-25)23-15-13-22(14-16-23)21-9-6-5-7-10-21/h5-16,18,20,26H,17H2,1-4H3,(H,30,33) D04VGR DRUGINKE PYEQDWCBKMTPFO-UHFFFAOYSA-N D04VGR DRUGSMIL CC(C)CC(C(=O)N(C)N(C)C#N)NC(=O)C1=CC=CC(=C1)C2=CC=C(C=C2)C3=CC=CC=C3 D04VGR HIGHSTAT Patented D04VJX DRUG__ID D04VJX D04VJX DRUGTYPE Small molecular drug D04VJX DRUGINCH 1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23) D04VJX DRUGINKE YDADFGXXCHDXFC-UHFFFAOYSA-N D04VJX DRUGSMIL C1CC1NC(=O)C2=C(N3C(=N2)C=CC=N3)C4=CN=C(C=C4)C#N D04VJX HIGHSTAT Patented D04VSB DRUG__ID D04VSB D04VSB DRUGTYPE Small molecular drug D04VSB DRUGINCH 1S/C18H17N7OS/c19-18-24-23-17(27-18)11-1-2-14-12(7-11)13(8-21-14)15-9-20-10-16(22-15)25-3-5-26-6-4-25/h1-2,7-10,21H,3-6H2,(H2,19,24) D04VSB DRUGINKE JHCXRIDGVGVKMB-UHFFFAOYSA-N D04VSB DRUGSMIL C1COCCN1C2=NC(=CN=C2)C3=CNC4=C3C=C(C=C4)C5=NN=C(S5)N D04VSB HIGHSTAT Patented D04WNI DRUG__ID D04WNI D04WNI DRUGTYPE Small molecular drug D04WNI DRUGINCH 1S/C16H17BFNO3/c1-9-14(5-4-12-8-21-17(20)16(9)12)22-15-6-3-11(10(2)19)7-13(15)18/h3-7,10,20H,8,19H2,1-2H3 D04WNI DRUGINKE LKHWQSZVOZRQIZ-UHFFFAOYSA-N D04WNI DRUGSMIL B1(C2=C(CO1)C=CC(=C2C)OC3=C(C=C(C=C3)C(C)N)F)O D04WNI HIGHSTAT Patented D04XHJ DRUG__ID D04XHJ D04XHJ DRUGTYPE Small molecular drug D04XHJ DRUGINCH 1S/C22H24N6/c23-21-20-19(12-17-6-3-5-16-4-1-2-7-18(16)17)27-28(22(20)26-14-25-21)13-15-8-10-24-11-9-15/h1-7,14-15,24H,8-13H2,(H2,23,25,26) D04XHJ DRUGINKE MMRLNUFECMEMSQ-UHFFFAOYSA-N D04XHJ DRUGSMIL C1CNCCC1CN2C3=NC=NC(=C3C(=N2)CC4=CC=CC5=CC=CC=C54)N D04XHJ HIGHSTAT Patented D04XII DRUG__ID D04XII D04XII DRUGTYPE Small molecular drug D04XII DRUGINCH 1S/C21H27F3N4O4S/c1-13(2)17-10-27(16-5-4-14(11-29)18(8-16)33(3,31)32)6-7-28(17)20-25-9-15(12-30)19(26-20)21(22,23)24/h4-5,8-9,13,17,29-30H,6-7,10-12H2,1-3H3/t17-/m1/s1 D04XII DRUGINKE FPVIRRAMNBCEDK-QGZVFWFLSA-N D04XII DRUGSMIL CC(C)C1CN(CCN1C2=NC=C(C(=N2)C(F)(F)F)CO)C3=CC(=C(C=C3)CO)S(=O)(=O)C D04XII HIGHSTAT Patented D04YMG DRUG__ID D04YMG D04YMG DRUGTYPE Small molecular drug D04YMG DRUGINCH 1S/C19H17N3O5/c1-11-7-13-14(22(19(11)27)10-12-5-3-2-4-6-12)8-20-16(17(13)25)18(26)21-9-15(23)24/h2-8,25H,9-10H2,1H3,(H,21,26)(H,23,24) D04YMG DRUGINKE WGLKJEAEYYHYAM-UHFFFAOYSA-N D04YMG DRUGSMIL CC1=CC2=C(C(=NC=C2N(C1=O)CC3=CC=CC=C3)C(=O)NCC(=O)O)O D04YMG HIGHSTAT Patented D04ZZM DRUG__ID D04ZZM D04ZZM DRUGTYPE Small molecular drug D04ZZM DRUGINCH 1S/C17H20O4/c1-20-15-8-12(9-16(11-15)21-2)4-3-5-13-6-7-14(18)10-17(13)19/h6-11,18-19H,3-5H2,1-2H3 D04ZZM DRUGINKE FKEXLBVQKBTEJO-UHFFFAOYSA-N D04ZZM DRUGSMIL COC1=CC(=CC(=C1)CCCC2=C(C=C(C=C2)O)O)OC D04ZZM HIGHSTAT Patented D05AFD DRUG__ID D05AFD D05AFD DRUGTYPE Small molecular drug D05AFD DRUGINCH 1S/C23H17ClN6OS/c1-12-5-6-16-15(7-8-26-22(16)29-14-4-2-3-13(24)9-14)18(12)30-23(31)17-10-32-20-19(17)27-11-28-21(20)25/h2-11H,1H3,(H,26,29)(H,30,31)(H2,25,27,28) D05AFD DRUGINKE RFEWCQAWLXXDQI-UHFFFAOYSA-N D05AFD DRUGSMIL CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC(=CC=C3)Cl)NC(=O)C4=CSC5=C4N=CN=C5N D05AFD HIGHSTAT Patented D05AIC DRUG__ID D05AIC D05AIC DRUGTYPE Small molecular drug D05AIC DRUGINCH 1S/C18H20ClFN4O/c19-16-12(2-1-3-14(16)20)11-5-8-24(9-6-11)18(25)17-13-4-7-21-10-15(13)22-23-17/h1-3,11,21H,4-10H2,(H,22,23) D05AIC DRUGINKE PJUXIWWOLCCJBG-UHFFFAOYSA-N D05AIC DRUGSMIL C1CN(CCC1C2=C(C(=CC=C2)F)Cl)C(=O)C3=NNC4=C3CCNC4 D05AIC HIGHSTAT Patented D05CCY DRUG__ID D05CCY D05CCY DRUGTYPE Small molecular drug D05CCY DRUGINCH 1S/C17H22N2O2/c20-16(21)14-1-2-18-9-15(14)19-10-17-6-11-3-12(7-17)5-13(4-11)8-17/h1-2,9,11-13,19H,3-8,10H2,(H,20,21) D05CCY DRUGINKE TUXVCHDESZTZON-UHFFFAOYSA-N D05CCY DRUGSMIL C1C2CC3CC1CC(C2)(C3)CNC4=C(C=CN=C4)C(=O)O D05CCY HIGHSTAT Patented D05CDF DRUG__ID D05CDF D05CDF DRUGTYPE Small molecular drug D05CDF DRUGINCH 1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37) D05CDF DRUGINKE MVCOAUNKQVWQHZ-UHFFFAOYSA-N D05CDF DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5 D05CDF HIGHSTAT Patented D05CJM DRUG__ID D05CJM D05CJM DRUGTYPE Small molecular drug D05CJM DRUGINCH 1S/C16H10ClNO4/c17-11-4-2-1-3-9(11)15-18-12-8-14-13(20-5-6-21-14)7-10(12)16(19)22-15/h1-4,7-8H,5-6H2 D05CJM DRUGINKE RMEUFAVEIHZTRM-UHFFFAOYSA-N D05CJM DRUGSMIL C1COC2=C(O1)C=C3C(=C2)N=C(OC3=O)C4=CC=CC=C4Cl D05CJM HIGHSTAT Patented D05CNJ DRUG__ID D05CNJ D05CNJ DRUGTYPE Small molecular drug D05CNJ DRUGINCH 1S/C16H20N2OS/c19-15(11-4-2-1-3-5-11)8-13-16-12(6-7-20-16)14-9-17-10-18(13)14/h6-7,9-11,13,15,19H,1-5,8H2 D05CNJ DRUGINKE ZPMZNNITKQQNAG-UHFFFAOYSA-N D05CNJ DRUGSMIL C1CCC(CC1)C(CC2C3=C(C=CS3)C4=CN=CN24)O D05CNJ HIGHSTAT Patented D05EHX DRUG__ID D05EHX D05EHX DRUGTYPE Small molecular drug D05EHX DRUGINCH 1S/C21H19FN2O6/c22-15-3-1-2-4-17(15)30-14-7-5-13(6-8-14)12-24-10-9-16(25)19(21(24)29)20(28)23-11-18(26)27/h1-8,25H,9-12H2,(H,23,28)(H,26,27) D05EHX DRUGINKE FFAFLVNMXIWUFY-UHFFFAOYSA-N D05EHX DRUGSMIL C1CN(C(=O)C(=C1O)C(=O)NCC(=O)O)CC2=CC=C(C=C2)OC3=CC=CC=C3F D05EHX HIGHSTAT Patented D05EMC DRUG__ID D05EMC D05EMC DRUGTYPE Small molecular drug D05EMC DRUGINCH 1S/C27H31Cl2FN2O4S/c1-27(2,17-10-18(28)12-19(29)11-17)32-9-3-4-20(15-32)36-25-14-24(30)23(13-22(25)16-5-6-16)26(33)31-37(34,35)21-7-8-21/h10-14,16,20-21H,3-9,15H2,1-2H3,(H,31,33)/t20-/m1/s1 D05EMC DRUGINKE OCNOGKDYKRVBCZ-HXUWFJFHSA-N D05EMC DRUGSMIL CC(C)(C1=CC(=CC(=C1)Cl)Cl)N2CCCC(C2)OC3=CC(=C(C=C3C4CC4)C(=O)NS(=O)(=O)C5CC5)F D05EMC HIGHSTAT Patented D05ETL DRUG__ID D05ETL D05ETL DRUGTYPE Small molecular drug D05ETL DRUGINCH 1S/C36H38FN5O7S/c1-7-42(50(6,46)47)29-19-30-28(31(33(43)39-5)32(48-30)22-11-13-25(37)14-12-22)18-27(29)23-9-8-10-24(17-23)34(44)41-16-15-40(21-26(41)20-38)35(45)49-36(2,3)4/h8-14,17-19,26H,7,15-16,21H2,1-6H3,(H,39,43)/t26-/m1/s1 D05ETL DRUGINKE MBGMGMOYLOFWNU-AREMUKBSSA-N D05ETL DRUGSMIL CCN(C1=C(C=C2C(=C1)OC(=C2C(=O)NC)C3=CC=C(C=C3)F)C4=CC(=CC=C4)C(=O)N5CCN(CC5C#N)C(=O)OC(C)(C)C)S(=O)(=O)C D05ETL HIGHSTAT Patented D05FDR DRUG__ID D05FDR D05FDR DRUGTYPE Small molecular drug D05FDR DRUGINCH 1S/C18H15N3O5/c1-10-15-12(17(24)16(20-10)18(25)19-9-14(22)23)7-8-13(21-15)26-11-5-3-2-4-6-11/h2-8,24H,9H2,1H3,(H,19,25)(H,22,23) D05FDR DRUGINKE FMQZRTFVSFAASE-UHFFFAOYSA-N D05FDR DRUGSMIL CC1=C2C(=C(C(=N1)C(=O)NCC(=O)O)O)C=CC(=N2)OC3=CC=CC=C3 D05FDR HIGHSTAT Patented D05FMP DRUG__ID D05FMP D05FMP DRUGTYPE Small molecular drug D05FMP DRUGINCH 1S/C18H15F2N3O2/c19-18(20)8-13(9-21)23(11-18)16(24)10-22-17(25)15-7-3-5-12-4-1-2-6-14(12)15/h1-7,13H,8,10-11H2,(H,22,25)/t13-/m0/s1 D05FMP DRUGINKE YJNMDFARAFJSEZ-ZDUSSCGKSA-N D05FMP DRUGSMIL C1C(N(CC1(F)F)C(=O)CNC(=O)C2=CC=CC3=CC=CC=C32)C#N D05FMP HIGHSTAT Patented D05GPF DRUG__ID D05GPF D05GPF DRUGTYPE Small molecular drug D05GPF DRUGINCH 1S/C25H19F4N7O2/c26-21-9-6-19(25(27,28)29)13-22(21)32-24(38)31-20-7-4-16(5-8-20)2-3-17-12-18(15-30-14-17)23-33-35-36(34-23)10-1-11-37/h4-9,12-15,37H,1,10-11H2,(H2,31,32,38) D05GPF DRUGINKE LOBSULBGQKFHGX-UHFFFAOYSA-N D05GPF DRUGSMIL C1=CC(=CC=C1C#CC2=CC(=CN=C2)C3=NN(N=N3)CCCO)NC(=O)NC4=C(C=CC(=C4)C(F)(F)F)F D05GPF HIGHSTAT Patented D05HHG DRUG__ID D05HHG D05HHG DRUGTYPE Small molecular drug D05HHG DRUGINCH 1S/C11H9Cl2NO3/c1-6-2-4-7(5-3-6)14-10(15)8(12)9(13)11(16)17/h2-5H,1H3,(H,14,15)(H,16,17)/b9-8+ D05HHG DRUGINKE LYXYEAXSHFSVNI-CMDGGOBGSA-N D05HHG DRUGSMIL CC1=CC=C(C=C1)NC(=O)C(=C(C(=O)O)Cl)Cl D05HHG HIGHSTAT Patented D05HMS DRUG__ID D05HMS D05HMS DRUGTYPE Small molecular drug D05HMS DRUGINCH 1S/C25H24ClFN2O4S/c1-34(31,32)28-25(30)20-12-21(26)23(13-22(20)27)33-16-17-14-29(15-17)24(18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-13,17,24H,14-16H2,1H3,(H,28,30) D05HMS DRUGINKE YUDSOPSBYJDZMS-UHFFFAOYSA-N D05HMS DRUGSMIL CS(=O)(=O)NC(=O)C1=CC(=C(C=C1F)OCC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)Cl D05HMS HIGHSTAT Patented D05NHA DRUG__ID D05NHA D05NHA DRUGTYPE Small molecular drug D05NHA DRUGINCH 1S/C11H16O3/c12-7-3-1-2-4-9-5-6-10(13)8-11(9)14/h5-6,8,12-14H,1-4,7H2 D05NHA DRUGINKE ZZBHJCFPTVMPAC-UHFFFAOYSA-N D05NHA DRUGSMIL C1=CC(=C(C=C1O)O)CCCCCO D05NHA HIGHSTAT Patented D05OIU DRUG__ID D05OIU D05OIU DRUGTYPE Small molecular drug D05OIU DRUGINCH 1S/C23H27F2N3O2S2/c1-3-4-20(23(24,25)30-17-7-9-18(31-2)10-8-17)27-19(14-32-13-16-5-6-16)21(29)28-22(15-26)11-12-22/h7-10,16,19-20,27H,5-6,11-14H2,1-2H3,(H,28,29)/t19-,20-/m0/s1 D05OIU DRUGINKE UKRDTRXIEUADJU-PMACEKPBSA-N D05OIU DRUGSMIL CC#CC(C(OC1=CC=C(C=C1)SC)(F)F)NC(CSCC2CC2)C(=O)NC3(CC3)C#N D05OIU HIGHSTAT Patented D05PTF DRUG__ID D05PTF D05PTF DRUGTYPE Small molecular drug D05PTF DRUGINCH 1S/C29H21F7N6O3/c1-13-23(26(44)40-19-3-5-22-16(8-19)12-38-42-22)24(41-27(45)39-13)15-2-4-21(30)20(9-15)25(43)37-11-14-6-17(28(31,32)33)10-18(7-14)29(34,35)36/h2-10,12,24H,11H2,1H3,(H,37,43)(H,38,42)(H,40,44)(H2,39,41,45) D05PTF DRUGINKE VUCAOBMPSJTWFL-UHFFFAOYSA-N D05PTF DRUGSMIL CC1=C(C(NC(=O)N1)C2=CC(=C(C=C2)F)C(=O)NCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)NC4=CC5=C(C=C4)NN=C5 D05PTF HIGHSTAT Patented D05SRL DRUG__ID D05SRL D05SRL DRUGTYPE Small molecular drug D05SRL DRUGINCH 1S/C31H34F2N4O4/c32-16-26(17-33)41-25-7-9-29-28(15-25)30(39)36(31(40)37(29)24-10-12-35(20-38)13-11-24)19-21-6-8-27(23(14-21)18-34)22-4-2-1-3-5-22/h1-6,8,14,20,24-26,28-29H,7,9-13,15-17,19H2 D05SRL DRUGINKE FDTVWOHILNTAPC-UHFFFAOYSA-N D05SRL DRUGSMIL C1CC2C(CC1OC(CF)CF)C(=O)N(C(=O)N2C3CCN(CC3)C=O)CC4=CC(=C(C=C4)C5=CC=CC=C5)C#N D05SRL HIGHSTAT Patented D05TQB DRUG__ID D05TQB D05TQB DRUGTYPE Small molecular drug D05TQB DRUGINCH 1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24) D05TQB DRUGINKE KZFDLYSKEWBCTB-UHFFFAOYSA-N D05TQB DRUGSMIL C1CC1NC(=O)C2=C(N3C(=N2)C=CC=N3)C4=CN5C(=NC=N5)C=C4 D05TQB HIGHSTAT Patented D05TTX DRUG__ID D05TTX D05TTX DRUGTYPE Small molecular drug D05TTX DRUGINCH 1S/C18H14BrN3O5/c1-9-15-12(17(25)16(21-9)18(26)20-8-14(23)24)6-7-13(22-15)27-11-4-2-10(19)3-5-11/h2-7,25H,8H2,1H3,(H,20,26)(H,23,24) D05TTX DRUGINKE PKTKHEQNIDLMBW-UHFFFAOYSA-N D05TTX DRUGSMIL CC1=C2C(=C(C(=N1)C(=O)NCC(=O)O)O)C=CC(=N2)OC3=CC=C(C=C3)Br D05TTX HIGHSTAT Patented D05WXM DRUG__ID D05WXM D05WXM DRUGTYPE Small molecular drug D05WXM DRUGINCH 1S/C21H19ClFN5/c1-3-12(4-2)20-19(21-25-27-28-26-21)18(13-8-6-5-7-9-13)14-10-15(22)16(23)11-17(14)24-20/h5-12H,3-4H2,1-2H3,(H,25,26,27,28) D05WXM DRUGINKE OTAAEQZYEFGHGG-UHFFFAOYSA-N D05WXM DRUGSMIL CCC(CC)C1=NC2=CC(=C(C=C2C(=C1C3=NNN=N3)C4=CC=CC=C4)Cl)F D05WXM HIGHSTAT Patented D05YDJ DRUG__ID D05YDJ D05YDJ DRUGTYPE Small molecular drug D05YDJ DRUGINCH 1S/C21H23FN2O6S2/c1-31(26,27)23-21(25)18-9-17(15-7-8-15)20(10-19(18)22)30-13-14-11-24(12-14)32(28,29)16-5-3-2-4-6-16/h2-6,9-10,14-15H,7-8,11-13H2,1H3,(H,23,25) D05YDJ DRUGINKE SPEKXWKFVSKSOS-UHFFFAOYSA-N D05YDJ DRUGSMIL CS(=O)(=O)NC(=O)C1=C(C=C(C(=C1)C2CC2)OCC3CN(C3)S(=O)(=O)C4=CC=CC=C4)F D05YDJ HIGHSTAT Patented D05YMG DRUG__ID D05YMG D05YMG DRUGTYPE Small molecular drug D05YMG DRUGINCH 1S/C26H23N5/c1-2-4-25-23(3-1)22(11-14-28-25)24-16-30-31-17-21(15-29-26(24)31)19-7-5-18(6-8-19)20-9-12-27-13-10-20/h1-8,11,14-17,20,27H,9-10,12-13H2 D05YMG DRUGINKE WTMROIBZVGJXRP-UHFFFAOYSA-N D05YMG DRUGSMIL C1CNCCC1C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3 D05YMG HIGHSTAT Patented D05ZAV DRUG__ID D05ZAV D05ZAV DRUGTYPE Small molecular drug D05ZAV DRUGINCH 1S/C21H25IN4O2/c1-6-25(7-2)19(27)12-16-20(15-8-9-18(28-5)17(22)11-15)24-26-14(4)10-13(3)23-21(16)26/h8-11H,6-7,12H2,1-5H3/i22-2 D05ZAV DRUGINKE TYBYEGAEDKDDES-ONBQKKEBSA-N D05ZAV DRUGSMIL CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC(=C(C=C3)OC)I)C)C D05ZAV HIGHSTAT Patented D05ZEZ DRUG__ID D05ZEZ D05ZEZ DRUGTYPE Small molecular drug D05ZEZ DRUGINCH 1S/C19H30N2O4/c1-12(2)8-17(20)19(24,18(22)23)11-15-10-16(6-7-21-15)25-13(3)9-14-4-5-14/h6-7,10,12-14,17,24H,4-5,8-9,11,20H2,1-3H3,(H,22,23)/t13-,17+,19-/m1/s1 D05ZEZ DRUGINKE YLKHAUHZCVMCJX-XVGQJIODSA-N D05ZEZ DRUGSMIL CC(C)CC(C(CC1=NC=CC(=C1)OC(C)CC2CC2)(C(=O)O)O)N D05ZEZ HIGHSTAT Patented D05ZQI DRUG__ID D05ZQI D05ZQI DRUGTYPE Small molecular drug D05ZQI DRUGINCH 1S/C24H29N7O3/c1-15-13-31(14-17(25)23(15)32)22-4-5-26-12-21(22)29-24(33)19-3-2-18-20(28-19)10-16(11-27-18)30-6-8-34-9-7-30/h2-5,10-12,15,17,23,32H,6-9,13-14,25H2,1H3,(H,29,33)/t15-,17+,23+/m0/s1 D05ZQI DRUGINKE SSNIKHVUFVVWIH-XSSDXNQZSA-N D05ZQI DRUGSMIL CC1CN(CC(C1O)N)C2=C(C=NC=C2)NC(=O)C3=NC4=C(C=C3)N=CC(=C4)N5CCOCC5 D05ZQI HIGHSTAT Patented D06BHM DRUG__ID D06BHM D06BHM DRUGTYPE Small molecular drug D06BHM DRUGINCH 1S/C8H7ClN6/c9-7-3-1-6(2-4-7)5-10-11-8-12-14-15-13-8/h1-5H,(H2,11,12,13,14,15)/b10-5+ D06BHM DRUGINKE SZFUMFNPTAQHAI-BJMVGYQFSA-N D06BHM DRUGSMIL C1=CC(=CC=C1C=NNC2=NNN=N2)Cl D06BHM HIGHSTAT Patented D06DRH DRUG__ID D06DRH D06DRH DRUGTYPE Small molecular drug D06DRH DRUGINCH 1S/C25H18F3N3O5/c26-25(27,28)19-20(14-4-2-1-3-5-14)29-36-23(19)22-17-12-34-18-8-13(6-7-16(18)21(17)30-35-22)9-31-10-15(11-31)24(32)33/h1-8,15H,9-12H2,(H,32,33) D06DRH DRUGINKE QUYMGOJIHUGBPQ-UHFFFAOYSA-N D06DRH DRUGSMIL C1C(CN1CC2=CC3=C(C=C2)C4=NOC(=C4CO3)C5=C(C(=NO5)C6=CC=CC=C6)C(F)(F)F)C(=O)O D06DRH HIGHSTAT Patented D06GXM DRUG__ID D06GXM D06GXM DRUGTYPE Small molecular drug D06GXM DRUGINCH 1S/C22H33N7O/c1-7-16(18(30)22(4,5)6)26-21-27-19(24-12-15-9-8-10-23-11-15)17-20(28-21)29(13-25-17)14(2)3/h8-11,13-14,16,18,30H,7,12H2,1-6H3,(H2,24,26,27,28)/t16-,18?/m1/s1 D06GXM DRUGINKE XHPNYYOUZWOWNT-PYUWXLGESA-N D06GXM DRUGSMIL CCC(C(C(C)(C)C)O)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CN=CC=C3 D06GXM HIGHSTAT Patented D06JEA DRUG__ID D06JEA D06JEA DRUGTYPE Small molecular drug D06JEA DRUGINCH 1S/C20H18ClFN6/c1-3-28(4-2)20-18(19-24-26-27-25-19)17(12-8-6-5-7-9-12)13-10-14(21)15(22)11-16(13)23-20/h5-11H,3-4H2,1-2H3,(H,24,25,26,27) D06JEA DRUGINKE CVFVCWWTTQCZRK-UHFFFAOYSA-N D06JEA DRUGSMIL CCN(CC)C1=NC2=CC(=C(C=C2C(=C1C3=NNN=N3)C4=CC=CC=C4)Cl)F D06JEA HIGHSTAT Patented D06JLW DRUG__ID D06JLW D06JLW DRUGTYPE Small molecular drug D06JLW DRUGINCH 1S/C22H28FN3O5/c1-14-2-5-17(6-3-14)31-18-8-9-25-16(10-18)11-22(29,21(27)28)19(24)13-30-20-7-4-15(23)12-26-20/h4,7-10,12,14,17,19,29H,2-3,5-6,11,13,24H2,1H3,(H,27,28)/t14?,17?,19-,22+/m0/s1 D06JLW DRUGINKE AOFAGXGTSSPBTM-UCQMRJNNSA-N D06JLW DRUGSMIL CC1CCC(CC1)OC2=CC(=NC=C2)CC(C(COC3=NC=C(C=C3)F)N)(C(=O)O)O D06JLW HIGHSTAT Patented D06KNK DRUG__ID D06KNK D06KNK DRUGTYPE Small molecular drug D06KNK DRUGINCH 1S/C10H10N2O2S/c1-11-9(13)12(10(14)15-11)7-8-5-3-2-4-6-8/h2-6H,7H2,1H3 D06KNK DRUGINKE JDSJDASOXWCHPN-UHFFFAOYSA-N D06KNK DRUGSMIL CN1C(=O)N(C(=O)S1)CC2=CC=CC=C2 D06KNK HIGHSTAT Patented D06MBI DRUG__ID D06MBI D06MBI DRUGTYPE Small molecular drug D06MBI DRUGINCH 1S/C13H15NO2S/c1-4-14-11-8-10(16-3)5-6-12(11)17-13(14)7-9(2)15/h5-8H,4H2,1-3H3/b13-7- D06MBI DRUGINKE BGVLELSCIHASRV-QPEQYQDCSA-N D06MBI DRUGSMIL CCN1C2=C(C=CC(=C2)OC)SC1=CC(=O)C D06MBI HIGHSTAT Patented D06OKT DRUG__ID D06OKT D06OKT DRUGTYPE Small molecular drug D06OKT DRUGINCH 1S/C23H25F2N3O2/c24-18-5-1-16(2-6-18)20-15-27-22(30)23(20)9-12-28(13-10-23)14-11-26-21(29)17-3-7-19(25)8-4-17/h1-8,20H,9-15H2,(H,26,29)(H,27,30) D06OKT DRUGINKE BPCQYJWHRHUHQC-UHFFFAOYSA-N D06OKT DRUGSMIL C1CN(CCC12C(CNC2=O)C3=CC=C(C=C3)F)CCNC(=O)C4=CC=C(C=C4)F D06OKT HIGHSTAT Patented D06OKX DRUG__ID D06OKX D06OKX DRUGTYPE Small molecular drug D06OKX DRUGINCH 1S/C20H21N7S/c21-20-27-26-19(28-20)12-6-7-16-14(8-12)15(9-23-16)17-10-22-11-18(25-17)24-13-4-2-1-3-5-13/h6-11,13,23H,1-5H2,(H2,21,27)(H,24,25) D06OKX DRUGINKE NZRCHCMMQGWKLZ-UHFFFAOYSA-N D06OKX DRUGSMIL C1CCC(CC1)NC2=NC(=CN=C2)C3=CNC4=C3C=C(C=C4)C5=NN=C(S5)N D06OKX HIGHSTAT Patented D06RNU DRUG__ID D06RNU D06RNU DRUGTYPE Small molecular drug D06RNU DRUGINCH 1S/C17H15N3O2/c1-20(2)17(21)22-16-13-10-6-7-11-14(13)18-15(19-16)12-8-4-3-5-9-12/h3-11H,1-2H3 D06RNU DRUGINKE NAXSAPGEPBKPDD-UHFFFAOYSA-N D06RNU DRUGSMIL CN(C)C(=O)OC1=NC(=NC2=CC=CC=C21)C3=CC=CC=C3 D06RNU HIGHSTAT Patented D06RWL DRUG__ID D06RWL D06RWL DRUGTYPE Small molecular drug D06RWL DRUGINCH 1S/C19H15ClN4O2/c1-12-15(20)8-5-9-16(12)26-11-14-10-17(25)24-19(21-14)22-18(23-24)13-6-3-2-4-7-13/h2-10H,11H2,1H3,(H,21,22,23) D06RWL DRUGINKE DHVPJCVPOZYDTH-UHFFFAOYSA-N D06RWL DRUGSMIL CC1=C(C=CC=C1Cl)OCC2=CC(=O)N3C(=N2)N=C(N3)C4=CC=CC=C4 D06RWL HIGHSTAT Patented D06TGF DRUG__ID D06TGF D06TGF DRUGTYPE Small molecular drug D06TGF DRUGINCH 1S/C14H9BrN2/c15-9-2-4-12-11(7-9)10-3-1-8-5-6-16-13(8)14(10)17-12/h1-7,16-17H D06TGF DRUGINKE JRPUZUBQJFQSQO-UHFFFAOYSA-N D06TGF DRUGSMIL C1=CC2=C(C3=C1C=CN3)NC4=C2C=C(C=C4)Br D06TGF HIGHSTAT Patented D06TKT DRUG__ID D06TKT D06TKT DRUGTYPE Small molecular drug D06TKT DRUGINCH 1S/C14H11ClN4O2/c1-19-12-3-2-8(15)6-10(12)13(18-19)17-11-7-16-5-4-9(11)14(20)21/h2-7H,1H3,(H,17,18)(H,20,21) D06TKT DRUGINKE TXMBUJQSVXBAFZ-UHFFFAOYSA-N D06TKT DRUGSMIL CN1C2=C(C=C(C=C2)Cl)C(=N1)NC3=C(C=CN=C3)C(=O)O D06TKT HIGHSTAT Patented D06TXN DRUG__ID D06TXN D06TXN DRUGTYPE Small molecular drug D06TXN DRUGINCH 1S/C13H20N5O6P/c1-2-24-10(19)7-17(5-6-25(21,22)23)3-4-18-9-16-11-12(18)14-8-15-13(11)20/h8-9,11H,2-7H2,1H3,(H2,21,22,23) D06TXN DRUGINKE ISSPDMWVBYSPCQ-UHFFFAOYSA-N D06TXN DRUGSMIL CCOC(=O)CN(CCN1C=NC2C1=NC=NC2=O)CCP(=O)(O)O D06TXN HIGHSTAT Patented D06WEY DRUG__ID D06WEY D06WEY DRUGTYPE Small molecular drug D06WEY DRUGINCH 1S/C24H30FN3O3S/c1-26-22-14-31-24-11-21(25)23(10-20(24)19(22)9-16-5-3-2-4-6-16)28-12-18(13-28)27-32(29,30)15-17-7-8-17/h2-6,10-11,17-19,22,26-27H,7-9,12-15H2,1H3/t19-,22+/m0/s1 D06WEY DRUGINKE BOABKZGNZKTRFI-SIKLNZKXSA-N D06WEY DRUGSMIL CNC1COC2=CC(=C(C=C2C1CC3=CC=CC=C3)N4CC(C4)NS(=O)(=O)CC5CC5)F D06WEY HIGHSTAT Patented D06WGO DRUG__ID D06WGO D06WGO DRUGTYPE Small molecular drug D06WGO DRUGINCH 1S/C12H11NO2/c14-11-4-3-10(12(15)7-11)6-9-2-1-5-13-8-9/h1-5,7-8,14-15H,6H2 D06WGO DRUGINKE ZWKHYPPKPLXBIY-UHFFFAOYSA-N D06WGO DRUGSMIL C1=CC(=CN=C1)CC2=C(C=C(C=C2)O)O D06WGO HIGHSTAT Patented D06WJK DRUG__ID D06WJK D06WJK DRUGTYPE Small molecular drug D06WJK DRUGINCH 1S/C24H32N4O3S/c1-7-30-24-18(9-8-11-25-24)19-13-20(32-12-10-21(29)31-14-15(2)3)23-22(26-19)17(6)27-28(23)16(4)5/h8-9,11,13,15-16H,7,10,12,14H2,1-6H3 D06WJK DRUGINKE HVDCJFCTBUPVCE-UHFFFAOYSA-N D06WJK DRUGSMIL CCOC1=C(C=CC=N1)C2=NC3=C(C(=C2)SCCC(=O)OCC(C)C)N(N=C3C)C(C)C D06WJK HIGHSTAT Patented D07FAF DRUG__ID D07FAF D07FAF DRUGTYPE Small molecular drug D07FAF DRUGINCH 1S/C24H26N6O/c1-2-11-31-20-6-5-17-12-19(4-3-18(17)13-20)22-21-23(25)27-15-28-24(21)30(29-22)14-16-7-9-26-10-8-16/h2-6,12-13,15-16,26H,1,7-11,14H2,(H2,25,27,28) D07FAF DRUGINKE LQRGSXMDDSWGQL-UHFFFAOYSA-N D07FAF DRUGSMIL C=CCOC1=CC2=C(C=C1)C=C(C=C2)C3=NN(C4=NC=NC(=C34)N)CC5CCNCC5 D07FAF HIGHSTAT Patented D07GJH DRUG__ID D07GJH D07GJH DRUGTYPE Small molecular drug D07GJH DRUGINCH 1S/C24H23Cl3N2O/c1-15-23(22(30)13-16-5-3-2-4-6-16)28-29(21-12-11-19(26)14-20(21)27)24(15)17-7-9-18(25)10-8-17/h7-12,14,16H,2-6,13H2,1H3 D07GJH DRUGINKE XMPCPPFFIBUKLW-UHFFFAOYSA-N D07GJH DRUGSMIL CC1=C(N(N=C1C(=O)CC2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl D07GJH HIGHSTAT Patented D07IHT DRUG__ID D07IHT D07IHT DRUGTYPE Small molecular drug D07IHT DRUGINCH 1S/C25H27N3O2/c1-28(2)22-15-13-21(14-16-22)25(26-23(29)17-19-9-5-3-6-10-19)27-24(30)18-20-11-7-4-8-12-20/h3-16,25H,17-18H2,1-2H3,(H,26,29)(H,27,30) D07IHT DRUGINKE XZLHEBHGANHBEG-UHFFFAOYSA-N D07IHT DRUGSMIL CN(C)C1=CC=C(C=C1)C(NC(=O)CC2=CC=CC=C2)NC(=O)CC3=CC=CC=C3 D07IHT HIGHSTAT Patented D07JBL DRUG__ID D07JBL D07JBL DRUGTYPE Small molecular drug D07JBL DRUGINCH 1S/C13H14N4O2/c14-11-6-10-8-16(7-9-4-2-1-3-5-9)15-12(10)17(19)13(11)18/h1-5,8,11,19H,6-7,14H2/t11-/m0/s1 D07JBL DRUGINKE YEHNWRNMGIYLAL-NSHDSACASA-N D07JBL DRUGSMIL C1C(C(=O)N(C2=NN(C=C21)CC3=CC=CC=C3)O)N D07JBL HIGHSTAT Patented D07JHU DRUG__ID D07JHU D07JHU DRUGTYPE Small molecular drug D07JHU DRUGINCH 1S/C18H18N4O3/c1-25-13-4-5-16-15(9-13)14(6-7-20-16)18(24)21-11-17(23)22-8-2-3-12(22)10-19/h4-7,9,12H,2-3,8,11H2,1H3,(H,21,24)/t12-/m0/s1 D07JHU DRUGINKE YPWQFVMQCFSLCP-LBPRGKRZSA-N D07JHU DRUGSMIL COC1=CC2=C(C=CN=C2C=C1)C(=O)NCC(=O)N3CCCC3C#N D07JHU HIGHSTAT Patented D07JOR DRUG__ID D07JOR D07JOR DRUGTYPE Small molecular drug D07JOR DRUGINCH 1S/C24H24ClNO4/c1-16(24(27)28)13-26-11-10-22-19(14-26)12-23(30-22)18-4-8-21(9-5-18)29-15-17-2-6-20(25)7-3-17/h2-9,12,16H,10-11,13-15H2,1H3,(H,27,28) D07JOR DRUGINKE YVXSDYLDIVRURS-UHFFFAOYSA-N D07JOR DRUGSMIL CC(CN1CCC2=C(C1)C=C(O2)C3=CC=C(C=C3)OCC4=CC=C(C=C4)Cl)C(=O)O D07JOR HIGHSTAT Patented D07NKC DRUG__ID D07NKC D07NKC DRUGTYPE Small molecular drug D07NKC DRUGINCH 1S/C21H25BrN4O2S/c1-26(2)13-4-3-8-19(27)23-17-9-11-18(12-10-17)24-21(29)25-20(28)15-6-5-7-16(22)14-15/h5-7,9-12,14H,3-4,8,13H2,1-2H3,(H,23,27)(H2,24,25,28,29) D07NKC DRUGINKE UZNNTHWEMCFBAY-UHFFFAOYSA-N D07NKC DRUGSMIL CN(C)CCCCC(=O)NC1=CC=C(C=C1)NC(=S)NC(=O)C2=CC(=CC=C2)Br D07NKC HIGHSTAT Patented D07PDQ DRUG__ID D07PDQ D07PDQ DRUGTYPE Small molecular drug D07PDQ DRUGINCH 1S/C34H36N6O4/c1-22-10-12-24(13-11-22)40-31(19-29(39-40)34(2,3)4)38-33(42)36-27-14-15-28(26-9-7-6-8-25(26)27)44-20-23-16-17-35-30(18-23)37-32(41)21-43-5/h6-19H,20-21H2,1-5H3,(H,35,37,41)(H2,36,38,42) D07PDQ DRUGINKE RTDCVLCTBQDLBW-UHFFFAOYSA-N D07PDQ DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCC5=CC(=NC=C5)NC(=O)COC D07PDQ HIGHSTAT Patented D07PLJ DRUG__ID D07PLJ D07PLJ DRUGTYPE Small molecular drug D07PLJ DRUGINCH 1S/C21H19F3N6/c1-3-30(4-2)20-18(19-26-28-29-27-19)17(13-8-6-5-7-9-13)15-12-14(21(22,23)24)10-11-16(15)25-20/h5-12H,3-4H2,1-2H3,(H,26,27,28,29) D07PLJ DRUGINKE RVTWZFXKPCJMAI-UHFFFAOYSA-N D07PLJ DRUGSMIL CCN(CC)C1=NC2=C(C=C(C=C2)C(F)(F)F)C(=C1C3=NNN=N3)C4=CC=CC=C4 D07PLJ HIGHSTAT Patented D07PNX DRUG__ID D07PNX D07PNX DRUGTYPE Small molecular drug D07PNX DRUGINCH 1S/C17H34N2O3/c1-14(2)19(15(3)4)13-12-18-16(20)10-8-6-5-7-9-11-17(21)22/h14-15H,5-13H2,1-4H3,(H,18,20)(H,21,22) D07PNX DRUGINKE LAOKJSWBEZVBIK-UHFFFAOYSA-N D07PNX DRUGSMIL CC(C)N(CCNC(=O)CCCCCCCC(=O)O)C(C)C D07PNX HIGHSTAT Patented D07PSJ DRUG__ID D07PSJ D07PSJ DRUGTYPE Small molecular drug D07PSJ DRUGINCH 1S/C13H20O2/c1-3-4-5-6-7-12-10(2)8-11(14)9-13(12)15/h8-9,14-15H,3-7H2,1-2H3 D07PSJ DRUGINKE VCKRCCNBIYKEFP-UHFFFAOYSA-N D07PSJ DRUGSMIL CCCCCCC1=C(C=C(C=C1C)O)O D07PSJ HIGHSTAT Patented D07QIZ DRUG__ID D07QIZ D07QIZ DRUGTYPE Small molecular drug D07QIZ DRUGINCH 1S/C20H22F3N5O3S/c1-11(2)17-18-25-13-8-12(10-29)15(32(3,30)31)9-14(13)27(18)6-7-28(17)19-24-5-4-16(26-19)20(21,22)23/h4-5,8-9,11,17,29H,6-7,10H2,1-3H3/t17-/m0/s1 D07QIZ DRUGINKE CABUZECPUSGGRX-KRWDZBQOSA-N D07QIZ DRUGSMIL CC(C)C1C2=NC3=C(N2CCN1C4=NC=CC(=N4)C(F)(F)F)C=C(C(=C3)CO)S(=O)(=O)C D07QIZ HIGHSTAT Patented D07QYV DRUG__ID D07QYV D07QYV DRUGTYPE Small molecular drug D07QYV DRUGINCH 1S/C21H22F3N5O3S/c1-11(2)17-19-26-15-6-5-13(33(4,31)32)9-16(15)28(19)7-8-29(17)20-25-10-14(12(3)30)18(27-20)21(22,23)24/h5-6,9-11,17H,7-8H2,1-4H3 D07QYV DRUGINKE UVRFHLLVIGMMMM-UHFFFAOYSA-N D07QYV DRUGSMIL CC(C)C1C2=NC3=C(N2CCN1C4=NC=C(C(=N4)C(F)(F)F)C(=O)C)C=C(C=C3)S(=O)(=O)C D07QYV HIGHSTAT Patented D07RJD DRUG__ID D07RJD D07RJD DRUGTYPE Small molecular drug D07RJD DRUGINCH 1S/C10H14O2/c1-6(2)10-7(3)4-8(11)5-9(10)12/h4-6,11-12H,1-3H3 D07RJD DRUGINKE FBSIDCYWGKQYRW-UHFFFAOYSA-N D07RJD DRUGSMIL CC1=CC(=CC(=C1C(C)C)O)O D07RJD HIGHSTAT Patented D07RUH DRUG__ID D07RUH D07RUH DRUGTYPE Small molecular drug D07RUH DRUGINCH 1S/C17H16BrNO3/c18-14-5-1-12(2-6-14)9-10-19-17(22)8-4-13-3-7-15(20)16(21)11-13/h1-8,11,20-21H,9-10H2,(H,19,22)/b8-4+ D07RUH DRUGINKE QIQBGDXOXRDDBP-XBXARRHUSA-N D07RUH DRUGSMIL C1=CC(=CC=C1CCNC(=O)C=CC2=CC(=C(C=C2)O)O)Br D07RUH HIGHSTAT Patented D07SHE DRUG__ID D07SHE D07SHE DRUGTYPE Small molecular drug D07SHE DRUGINCH 1S/C21H18N8/c1-2-16-13-23-14-18(26-16)17-10-19-15(11-24-17)12-25-29(19)21-5-3-4-20(27-21)28-8-6-22-7-9-28/h1,3-5,10-14,22H,6-9H2 D07SHE DRUGINKE LBSWUVMKCABART-UHFFFAOYSA-N D07SHE DRUGSMIL C#CC1=CN=CC(=N1)C2=NC=C3C=NN(C3=C2)C4=NC(=CC=C4)N5CCNCC5 D07SHE HIGHSTAT Patented D07YHN DRUG__ID D07YHN D07YHN DRUGTYPE Small molecular drug D07YHN DRUGINCH 1S/C12H9N5O2S/c1-16-7-14-15-12(16)20-10-5-4-9(17(18)19)8-3-2-6-13-11(8)10/h2-7H,1H3 D07YHN DRUGINKE RMYCZXRLBFQOFF-UHFFFAOYSA-N D07YHN DRUGSMIL CN1C=NN=C1SC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC=N3 D07YHN HIGHSTAT Patented D07ZDJ DRUG__ID D07ZDJ D07ZDJ DRUGTYPE Small molecular drug D07ZDJ DRUGINCH 1S/C31H35F3N4O3/c1-20-17-25(38-19-22-5-2-3-7-27(22)36-38)12-13-26(20)28(14-15-31(32,33)34)35-24-10-8-21(9-11-24)29(39)37-16-4-6-23(18-37)30(40)41/h8-13,17,19,23,28,35H,2-7,14-16,18H2,1H3,(H,40,41)/t23-,28?/m1/s1 D07ZDJ DRUGINKE ZEUDUNQWXOYIFC-YFIOFSHDSA-N D07ZDJ DRUGSMIL CC1=C(C=CC(=C1)N2C=C3CCCCC3=N2)C(CCC(F)(F)F)NC4=CC=C(C=C4)C(=O)N5CCCC(C5)C(=O)O D07ZDJ HIGHSTAT Patented D08BFF DRUG__ID D08BFF D08BFF DRUGTYPE Small molecular drug D08BFF DRUGINCH 1S/C24H27ClFNO3S/c1-2-16-4-3-5-19(25)17(16)14-31-20-7-6-18-23(22(20)26)30-15-24(18)9-12-27(13-10-24)11-8-21(28)29/h3-7H,2,8-15H2,1H3,(H,28,29) D08BFF DRUGINKE QTCUMVXBAZTPSZ-UHFFFAOYSA-N D08BFF DRUGSMIL CCC1=C(C(=CC=C1)Cl)CSC2=C(C3=C(C=C2)C4(CCN(CC4)CCC(=O)O)CO3)F D08BFF HIGHSTAT Patented D08BVX DRUG__ID D08BVX D08BVX DRUGTYPE Small molecular drug D08BVX DRUGINCH 1S/C10H7N5O3/c1-14-7-5-3-2-4-6(7)8(12-13-11)9(10(14)16)15(17)18/h2-5H,1H3 D08BVX DRUGINKE PVHDZPYQHVOXSW-UHFFFAOYSA-N D08BVX DRUGSMIL CN1C2=CC=CC=C2C(=C(C1=O)[N+](=O)[O-])N=[N+]=[N-] D08BVX HIGHSTAT Patented D08CWE DRUG__ID D08CWE D08CWE DRUGTYPE Small molecular drug D08CWE DRUGINCH 1S/C21H19N9/c1-13-9-19(30-28-13)26-21-25-18(10-14-5-3-2-4-6-14)24-20(27-21)23-16-8-7-15-12-22-29-17(15)11-16/h2-9,11-12H,10H2,1H3,(H,22,29)(H3,23,24,25,26,27,28,30) D08CWE DRUGINKE OKPNIPFZIIYESG-UHFFFAOYSA-N D08CWE DRUGSMIL CC1=CC(=NN1)NC2=NC(=NC(=N2)NC3=CC4=C(C=C3)C=NN4)CC5=CC=CC=C5 D08CWE HIGHSTAT Patented D08ETC DRUG__ID D08ETC D08ETC DRUGTYPE Small molecular drug D08ETC DRUGINCH 1S/C19H19F2N5O2S/c1-25-15(14(20)21)24-17-13(18(25)28)23-19(29-17)26-9-5-8-12(26)16(27)22-10-11-6-3-2-4-7-11/h2-4,6-7,12,14H,5,8-10H2,1H3,(H,22,27)/t12-/m1/s1 D08ETC DRUGINKE VIBFDLHDQBMSOA-GFCCVEGCSA-N D08ETC DRUGSMIL CN1C(=O)C2=C(N=C1C(F)F)SC(=N2)N3CCCC3C(=O)NCC4=CC=CC=C4 D08ETC HIGHSTAT Patented D08FOG DRUG__ID D08FOG D08FOG DRUGTYPE Small molecular drug D08FOG DRUGINCH 1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5+ D08FOG DRUGINKE XFWLTFZLLXVKDY-AATRIKPKSA-N D08FOG DRUGSMIL CCNCCCNCC=CCNCCCNCC D08FOG HIGHSTAT Patented D08HOV DRUG__ID D08HOV D08HOV DRUGTYPE Small molecular drug D08HOV DRUGINCH 1S/C22H24N4O2/c1-20(2)16-10-13-6-5-9-26(13)17(11-23)21(16)12-22(28-19(27)25-21)14-7-3-4-8-15(14)24-18(20)22/h3-4,7-8,13,16-17H,5-6,9-10,12H2,1-2H3,(H,25,27)/t13-,16-,17-,21+,22+/m0/s1 D08HOV DRUGINKE MJAHQBSZAYUSFL-MKGFCTCPSA-N D08HOV DRUGSMIL CC1(C2CC3CCCN3C(C24CC5(C1=NC6=CC=CC=C65)OC(=O)N4)C#N)C D08HOV HIGHSTAT Patented D08IIV DRUG__ID D08IIV D08IIV DRUGTYPE Small molecular drug D08IIV DRUGINCH 1S/C23H25F3N6/c1-13-11-15(9-10-27-13)19-17-12-16(23(24,25)26)7-8-18(17)28-21(14-5-3-2-4-6-14)20(19)22-29-31-32-30-22/h9-11,14,16H,2-8,12H2,1H3,(H,29,30,31,32) D08IIV DRUGINKE ALFQKPZYXQRVDU-UHFFFAOYSA-N D08IIV DRUGSMIL CC1=NC=CC(=C1)C2=C(C(=NC3=C2CC(CC3)C(F)(F)F)C4CCCCC4)C5=NNN=N5 D08IIV HIGHSTAT Patented D08JKR DRUG__ID D08JKR D08JKR DRUGTYPE Small molecular drug D08JKR DRUGINCH 1S/C23H22N4O2/c1-26-20-9-11-24-14-19(20)18-7-8-21(25-23(18)26)27-12-10-17(13-22(27)28)29-15-16-5-3-2-4-6-16/h2-8,10,12-13,24H,9,11,14-15H2,1H3 D08JKR DRUGINKE SXWOYRGICAISET-UHFFFAOYSA-N D08JKR DRUGSMIL CN1C2=C(CNCC2)C3=C1N=C(C=C3)N4C=CC(=CC4=O)OCC5=CC=CC=C5 D08JKR HIGHSTAT Patented D08JUU DRUG__ID D08JUU D08JUU DRUGTYPE Small molecular drug D08JUU DRUGINCH 1S/C20H19N5OS/c21-20-25-24-19(27-20)12-8-9-16-14(10-12)15(11-22-16)17-6-3-7-18(23-17)26-13-4-1-2-5-13/h3,6-11,13,22H,1-2,4-5H2,(H2,21,25) D08JUU DRUGINKE PNAYFCPGKVJMMN-UHFFFAOYSA-N D08JUU DRUGSMIL C1CCC(C1)OC2=CC=CC(=N2)C3=CNC4=C3C=C(C=C4)C5=NN=C(S5)N D08JUU HIGHSTAT Patented D08KCW DRUG__ID D08KCW D08KCW DRUGTYPE Small molecular drug D08KCW DRUGINCH 1S/C21H20F3N3O4S/c1-8-12(9-2-3-9)15(17-26-20(27-31-17)21(22,23)24)18(32-8)25-16(28)13-10-4-6-11(7-5-10)14(13)19(29)30/h9-11H,2-7H2,1H3,(H,25,28)(H,29,30) D08KCW DRUGINKE HXCOCQVXJUKVAX-UHFFFAOYSA-N D08KCW DRUGSMIL CC1=C(C(=C(S1)NC(=O)C2=C(C3CCC2CC3)C(=O)O)C4=NC(=NO4)C(F)(F)F)C5CC5 D08KCW HIGHSTAT Patented D08LBW DRUG__ID D08LBW D08LBW DRUGTYPE Small molecular drug D08LBW DRUGINCH 1S/C25H27NO2/c1-4-6-20(25(27)28)22-16(3)26-21-14-13-17-7-5-8-19(17)24(21)23(22)18-11-9-15(2)10-12-18/h9-14,20H,4-8H2,1-3H3,(H,27,28) D08LBW DRUGINKE MNMDSGXKGOEYSF-UHFFFAOYSA-N D08LBW DRUGSMIL CCCC(C1=C(N=C2C=CC3=C(C2=C1C4=CC=C(C=C4)C)CCC3)C)C(=O)O D08LBW HIGHSTAT Patented D08NHT DRUG__ID D08NHT D08NHT DRUGTYPE Small molecular drug D08NHT DRUGINCH 1S/C24H27NO4/c1-14-4-7-17(10-15(14)2)25(13-16-5-6-16)18-8-9-19(22(11-18)29-3)23(26)20-12-21(20)24(27)28/h4,7-11,16,20-21H,5-6,12-13H2,1-3H3,(H,27,28) D08NHT DRUGINKE HYAQXBPDSJIQND-UHFFFAOYSA-N D08NHT DRUGSMIL CC1=C(C=C(C=C1)N(CC2CC2)C3=CC(=C(C=C3)C(=O)C4CC4C(=O)O)OC)C D08NHT HIGHSTAT Patented D08OEW DRUG__ID D08OEW D08OEW DRUGTYPE Small molecular drug D08OEW DRUGINCH 1S/C19H28N6/c1-2-3-9-22-19-24-14-16(17-6-4-5-10-21-17)18(25-19)23-13-15-7-11-20-12-8-15/h4-6,10,14-15,20H,2-3,7-9,11-13H2,1H3,(H2,22,23,24,25) D08OEW DRUGINKE HVIDXJFXDHKCMO-UHFFFAOYSA-N D08OEW DRUGSMIL CCCCNC1=NC=C(C(=N1)NCC2CCNCC2)C3=CC=CC=N3 D08OEW HIGHSTAT Patented D08PYU DRUG__ID D08PYU D08PYU DRUGTYPE Small molecular drug D08PYU DRUGINCH 1S/C17H23NO4/c1-17(2,3)13-6-4-5-7-14(13)22-12-10-18(11-12)15(19)8-9-16(20)21/h4-7,12H,8-11H2,1-3H3,(H,20,21) D08PYU DRUGINKE PSHYFYJKCNFREU-UHFFFAOYSA-N D08PYU DRUGSMIL CC(C)(C)C1=CC=CC=C1OC2CN(C2)C(=O)CCC(=O)O D08PYU HIGHSTAT Patented D08RPE DRUG__ID D08RPE D08RPE DRUGTYPE Small molecular drug D08RPE DRUGINCH 1S/C21H15F3N4O2S/c22-21(23,24)14-7-5-13(6-8-14)19-17-3-1-2-4-18(17)20(28-27-19)26-15-9-11-16(12-10-15)31(25,29)30/h1-12H,(H,26,28)(H2,25,29,30) D08RPE DRUGINKE DXRJQXFJLLMHKO-UHFFFAOYSA-N D08RPE DRUGSMIL C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)S(=O)(=O)N)C4=CC=C(C=C4)C(F)(F)F D08RPE HIGHSTAT Patented D08SLU DRUG__ID D08SLU D08SLU DRUGTYPE Small molecular drug D08SLU DRUGINCH 1S/C26H27FN4O2/c27-22-6-3-7-23(17-22)31-25(33)29-18-26(31)10-13-30(14-11-26)15-12-28-24(32)21-9-8-19-4-1-2-5-20(19)16-21/h1-9,16-17H,10-15,18H2,(H,28,32)(H,29,33) D08SLU DRUGINKE BYFCBILNFVVIKQ-UHFFFAOYSA-N D08SLU DRUGSMIL C1CN(CCC12CNC(=O)N2C3=CC(=CC=C3)F)CCNC(=O)C4=CC5=CC=CC=C5C=C4 D08SLU HIGHSTAT Patented D08SNH DRUG__ID D08SNH D08SNH DRUGTYPE Small molecular drug D08SNH DRUGINCH 1S/C22H19ClN4OS/c23-15-9-10-17-16(13-15)18(14-7-3-1-4-8-14)19(21-25-26-22(29)28-21)20(24-17)27-11-5-2-6-12-27/h1,3-4,7-10,13H,2,5-6,11-12H2,(H,26,29) D08SNH DRUGINKE QNSIEZUINFOQFH-UHFFFAOYSA-N D08SNH DRUGSMIL C1CCN(CC1)C2=NC3=C(C=C(C=C3)Cl)C(=C2C4=NNC(=S)O4)C5=CC=CC=C5 D08SNH HIGHSTAT Patented D08VSV DRUG__ID D08VSV D08VSV DRUGTYPE Small molecular drug D08VSV DRUGINCH 1S/C18H20N2O5/c1-10(2)19-8-11-5-16(24-3)17(25-4)6-12(11)14-7-15(21)13(18(22)23)9-20(14)19/h5-7,9-10H,8H2,1-4H3,(H,22,23) D08VSV DRUGINKE PURJTKDWCZADSM-UHFFFAOYSA-N D08VSV DRUGSMIL CC(C)N1CC2=CC(=C(C=C2C3=CC(=O)C(=CN31)C(=O)O)OC)OC D08VSV HIGHSTAT Patented D08YMT DRUG__ID D08YMT D08YMT DRUGTYPE Small molecular drug D08YMT DRUGINCH 1S/C21H26N4O3/c1-28-19-7-3-2-5-17(19)18-6-4-12-25(18)20(26)14-24-21(27)23-13-15-8-10-16(22)11-9-15/h2-3,5,7-11,18H,4,6,12-14,22H2,1H3,(H2,23,24,27) D08YMT DRUGINKE VJEMAKQKNYWEFQ-UHFFFAOYSA-N D08YMT DRUGSMIL COC1=CC=CC=C1C2CCCN2C(=O)CNC(=O)NCC3=CC=C(C=C3)N D08YMT HIGHSTAT Patented D09AXR DRUG__ID D09AXR D09AXR DRUGTYPE Small molecular drug D09AXR DRUGINCH 1S/C8H6ClN5O/c9-5-1-2-7(10-3-5)12-8(15)6-4-11-14-13-6/h1-4H,(H,10,12,15)(H,11,13,14) D09AXR DRUGINKE RVQBIGKKUXHYRZ-UHFFFAOYSA-N D09AXR DRUGSMIL C1=CC(=NC=C1Cl)NC(=O)C2=NNN=C2 D09AXR HIGHSTAT Patented D09BSA DRUG__ID D09BSA D09BSA DRUGTYPE Small molecular drug D09BSA DRUGINCH 1S/C24H27F2N3O2/c1-16(28-22(30)18-4-8-20(26)9-5-18)15-29-12-10-24(11-13-29)21(14-27-23(24)31)17-2-6-19(25)7-3-17/h2-9,16,21H,10-15H2,1H3,(H,27,31)(H,28,30)/t16-,21?/m0/s1 D09BSA DRUGINKE ZRRZCDIHCHFDRR-BJQOMGFOSA-N D09BSA DRUGSMIL CC(CN1CCC2(CC1)C(CNC2=O)C3=CC=C(C=C3)F)NC(=O)C4=CC=C(C=C4)F D09BSA HIGHSTAT Patented D09CKU DRUG__ID D09CKU D09CKU DRUGTYPE Small molecular drug D09CKU DRUGINCH 1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1 D09CKU DRUGINKE WMBWREPUVVBILR-WIYYLYMNSA-N D09CKU DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O D09CKU HIGHSTAT Patented D09CNM DRUG__ID D09CNM D09CNM DRUGTYPE Small molecular drug D09CNM DRUGINCH 1S/C17H12F2N4OS/c1-24-12-7-13-11(6-10(12)19)21-17(25-13)14-15(22-23-16(14)20)8-4-2-3-5-9(8)18/h2-7H,1H3,(H3,20,22,23) D09CNM DRUGINKE YMZGLBIKIDCVFV-UHFFFAOYSA-N D09CNM DRUGSMIL COC1=C(C=C2C(=C1)SC(=N2)C3=C(NN=C3N)C4=CC=CC=C4F)F D09CNM HIGHSTAT Patented D09CWB DRUG__ID D09CWB D09CWB DRUGTYPE Small molecular drug D09CWB DRUGINCH 1S/C19H16N2O2/c22-19(23)17-10-11-20-13-18(17)21-12-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-11,13,21H,12H2,(H,22,23) D09CWB DRUGINKE RNBCOBWQQCESLL-UHFFFAOYSA-N D09CWB DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CNC3=C(C=CN=C3)C(=O)O D09CWB HIGHSTAT Patented D09EFW DRUG__ID D09EFW D09EFW DRUGTYPE Small molecular drug D09EFW DRUGINCH 1S/C16H15NO4/c1-21-13-6-4-12(5-7-13)17-16(20)9-3-11-2-8-14(18)15(19)10-11/h2-10,18-19H,1H3,(H,17,20)/b9-3+ D09EFW DRUGINKE MGXQKQSEWXXTPE-YCRREMRBSA-N D09EFW DRUGSMIL COC1=CC=C(C=C1)NC(=O)C=CC2=CC(=C(C=C2)O)O D09EFW HIGHSTAT Patented D09FOM DRUG__ID D09FOM D09FOM DRUGTYPE Small molecular drug D09FOM DRUGINCH 1S/C22H23F2N3O3/c1-12(2)30-21(29)15-10-27(20(28)13-5-6-17(23)18(24)7-13)11-22(3,4)16-8-14(9-25)26-19(15)16/h5-8,12,15,26H,10-11H2,1-4H3 D09FOM DRUGINKE JTWLRQHGXNKRJB-UHFFFAOYSA-N D09FOM DRUGSMIL CC(C)OC(=O)C1CN(CC(C2=C1NC(=C2)C#N)(C)C)C(=O)C3=CC(=C(C=C3)F)F D09FOM HIGHSTAT Patented D09FPV DRUG__ID D09FPV D09FPV DRUGTYPE Small molecular drug D09FPV DRUGINCH 1S/C13H14FN3O2S/c14-10-1-2-11-12(8-16-13(11)7-10)9-3-5-17(6-4-9)20(15,18)19/h1-3,7-8,16H,4-6H2,(H2,15,18,19) D09FPV DRUGINKE JQVNNQIVDXRAAV-UHFFFAOYSA-N D09FPV DRUGSMIL C1CN(CC=C1C2=CNC3=C2C=CC(=C3)F)S(=O)(=O)N D09FPV HIGHSTAT Patented D09GMS DRUG__ID D09GMS D09GMS DRUGTYPE Small molecular drug D09GMS DRUGINCH 1S/C28H29ClN4O8/c29-19-3-1-2-18(14-19)16-4-6-17(7-5-16)23-15-20(41-33-23)8-11-24(34)31-22(10-13-26(37)38)28(40)32-21(27(30)39)9-12-25(35)36/h1-7,14-15,21-22H,8-13H2,(H2,30,39)(H,31,34)(H,32,40)(H,35,36)(H,37,38)/t21-,22-/m0/s1 D09GMS DRUGINKE KOVQMCGGWATESY-VXKWHMMOSA-N D09GMS DRUGSMIL C1=CC(=CC(=C1)Cl)C2=CC=C(C=C2)C3=NOC(=C3)CCC(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N D09GMS HIGHSTAT Patented D09JLP DRUG__ID D09JLP D09JLP DRUGTYPE Small molecular drug D09JLP DRUGINCH 1S/C10H7NO3S2/c12-6-2-1-5(7(13)4-6)3-8-9(14)11-10(15)16-8/h1-4,12-13H,(H,11,14,15)/b8-3- D09JLP DRUGINKE GZGFGVYXIOPNPH-BAQGIRSFSA-N D09JLP DRUGSMIL C1=CC(=C(C=C1O)O)C=C2C(=O)NC(=S)S2 D09JLP HIGHSTAT Patented D09JPJ DRUG__ID D09JPJ D09JPJ DRUGTYPE Small molecular drug D09JPJ DRUGINCH 1S/C12H12N4O2/c13-9-6-10-11(16(18)12(9)17)7-15(14-10)8-4-2-1-3-5-8/h1-5,7,9,18H,6,13H2/t9-/m0/s1 D09JPJ DRUGINKE LHLQHHDRLPOVCF-VIFPVBQESA-N D09JPJ DRUGSMIL C1C(C(=O)N(C2=CN(N=C21)C3=CC=CC=C3)O)N D09JPJ HIGHSTAT Patented D09KTX DRUG__ID D09KTX D09KTX DRUGTYPE Small molecular drug D09KTX DRUGINCH 1S/C19H20N4O8/c1-23(19(29)22-13(17(26)27)8-15(24)25)9-12-6-7-14(30-12)18(28)31-11-4-2-10(3-5-11)16(20)21/h2-7,13H,8-9H2,1H3,(H3,20,21)(H,22,29)(H,24,25)(H,26,27)/t13-/m0/s1 D09KTX DRUGINKE IPAMUZPOGLKECI-ZDUSSCGKSA-N D09KTX DRUGSMIL CN(CC1=CC=C(O1)C(=O)OC2=CC=C(C=C2)C(=N)N)C(=O)NC(CC(=O)O)C(=O)O D09KTX HIGHSTAT Patented D09LDU DRUG__ID D09LDU D09LDU DRUGTYPE Small molecular drug D09LDU DRUGINCH 1S/C17H19ClN4O2/c18-13-8-12(23)6-7-14(13)22-17(24)15-9-16(20-10-19-15)21-11-4-2-1-3-5-11/h6-11,23H,1-5H2,(H,22,24)(H,19,20,21) D09LDU DRUGINKE JCXGHZCWAHCYGY-UHFFFAOYSA-N D09LDU DRUGSMIL C1CCC(CC1)NC2=NC=NC(=C2)C(=O)NC3=C(C=C(C=C3)O)Cl D09LDU HIGHSTAT Patented D09MHU DRUG__ID D09MHU D09MHU DRUGTYPE Small molecular drug D09MHU DRUGINCH 1S/C11H10N2O4/c1-17-9-3-2-6(5-8(9)14)4-7-10(15)13-11(16)12-7/h2-5,14H,1H3,(H2,12,13,15,16)/b7-4- D09MHU DRUGINKE CVEPZWFFKVWAMM-DAXSKMNVSA-N D09MHU DRUGSMIL COC1=C(C=C(C=C1)C=C2C(=O)NC(=O)N2)O D09MHU HIGHSTAT Patented D09NCT DRUG__ID D09NCT D09NCT DRUGTYPE Small molecular drug D09NCT DRUGINCH 1S/C27H29N3O6/c31-25(14-15-26(32)33)30(35)17-4-3-16-28-18-20-10-12-21(13-11-20)19-36-27(34)29-24-9-5-7-22-6-1-2-8-23(22)24/h1-2,5-15,28,35H,3-4,16-19H2,(H,29,34)(H,32,33)/b15-14+ D09NCT DRUGINKE FOJNYQXAAPCEPX-CCEZHUSRSA-N D09NCT DRUGSMIL C1=CC=C2C(=C1)C=CC=C2NC(=O)OCC3=CC=C(C=C3)CNCCCCN(C(=O)C=CC(=O)O)O D09NCT HIGHSTAT Patented D09OGH DRUG__ID D09OGH D09OGH DRUGTYPE Small molecular drug D09OGH DRUGINCH 1S/C24H22N4O2/c29-24-22-18(10-11-25-24)16-21(17-4-2-1-3-5-17)27-23(22)26-19-6-8-20(9-7-19)28-12-14-30-15-13-28/h1-11,16H,12-15H2,(H,25,29)(H,26,27) D09OGH DRUGINKE UNLNOESEDGPPCS-UHFFFAOYSA-N D09OGH DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC3=C4C(=CC(=N3)C5=CC=CC=C5)C=CNC4=O D09OGH HIGHSTAT Patented D09RDP DRUG__ID D09RDP D09RDP DRUGTYPE Small molecular drug D09RDP DRUGINCH 1S/C25H17F4N3O4/c26-17-9-16-13(8-18(17)32-10-14(11-32)24(33)34)6-7-15-21(16)31-35-22(15)23-19(25(27,28)29)20(30-36-23)12-4-2-1-3-5-12/h1-5,8-9,14H,6-7,10-11H2,(H,33,34) D09RDP DRUGINKE TTXDTJUDJNHFLR-UHFFFAOYSA-N D09RDP DRUGSMIL C1CC2=C(ON=C2C3=CC(=C(C=C31)N4CC(C4)C(=O)O)F)C5=C(C(=NO5)C6=CC=CC=C6)C(F)(F)F D09RDP HIGHSTAT Patented D09SDN DRUG__ID D09SDN D09SDN DRUGTYPE Small molecular drug D09SDN DRUGINCH 1S/C27H31NO3/c1-16-10-12-18(13-11-16)24-21-14-19-8-6-7-9-20(19)15-22(21)28-17(2)23(24)25(26(29)30)31-27(3,4)5/h10-15,25H,6-9H2,1-5H3,(H,29,30) D09SDN DRUGINKE NWMYEMJIPIXUNW-UHFFFAOYSA-N D09SDN DRUGSMIL CC1=CC=C(C=C1)C2=C3C=C4CCCCC4=CC3=NC(=C2C(C(=O)O)OC(C)(C)C)C D09SDN HIGHSTAT Patented D09SKG DRUG__ID D09SKG D09SKG DRUGTYPE Small molecular drug D09SKG DRUGINCH 1S/C21H34NO5P/c1-2-26-11-3-4-16-5-6-18-13-19(8-7-17(18)12-16)20-9-10-21(22,14-20)15-27-28(23,24)25/h7-8,13,16,20H,2-6,9-12,14-15,22H2,1H3,(H2,23,24,25)/t16?,20-,21+/m0/s1 D09SKG DRUGINKE VHKORLDZIRFKDI-KCECWRNFSA-N D09SKG DRUGSMIL CCOCCCC1CCC2=C(C1)C=CC(=C2)C3CCC(C3)(COP(=O)(O)O)N D09SKG HIGHSTAT Patented D09SWE DRUG__ID D09SWE D09SWE DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D09SWE DRUGINCH 1S/C8H8O2/c1-10-8-4-2-7(6-9)3-5-8/h2-6H,1H3 D09SWE DRUGINKE ZRSNZINYAWTAHE-UHFFFAOYSA-N D09SWE DRUGSMIL COC1=CC=C(C=C1)C=O D09SWE HIGHSTAT Patented D09UGQ DRUG__ID D09UGQ D09UGQ DRUGTYPE Small molecular drug D09UGQ DRUGINCH 1S/C33H32N4O3/c1-22(38)36-27-6-4-5-25(19-27)23-11-16-37(17-12-23)18-15-35-33(39)31-21-26-20-30(24-9-13-34-14-10-24)28-7-2-3-8-29(28)32(26)40-31/h2-10,13-14,19-21,23H,11-12,15-18H2,1H3,(H,35,39)(H,36,38) D09UGQ DRUGINKE KFXQNHZULSOCEW-UHFFFAOYSA-N D09UGQ DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCNC(=O)C3=CC4=C(O3)C5=CC=CC=C5C(=C4)C6=CC=NC=C6 D09UGQ HIGHSTAT Patented D09VFP DRUG__ID D09VFP D09VFP DRUGTYPE Small molecular drug D09VFP DRUGINCH 1S/C22H23FN4O7S/c23-13-8-11(19(24)25)3-5-16(13)34-22(33)17-6-4-12(35-17)10-27-7-1-2-15(27)20(30)26-14(21(31)32)9-18(28)29/h3-6,8,14-15H,1-2,7,9-10H2,(H3,24,25)(H,26,30)(H,28,29)(H,31,32)/t14-,15+/m0/s1 D09VFP DRUGINKE CEBSLTBKCPYKRD-LSDHHAIUSA-N D09VFP DRUGSMIL C1CC(N(C1)CC2=CC=C(S2)C(=O)OC3=C(C=C(C=C3)C(=N)N)F)C(=O)NC(CC(=O)O)C(=O)O D09VFP HIGHSTAT Patented D09VOD DRUG__ID D09VOD D09VOD DRUGTYPE Small molecular drug D09VOD DRUGINCH 1S/C19H14ClNO2/c20-13-8-9-15-14(10-13)16(11-4-2-1-3-5-11)17(19(22)23)18(21-15)12-6-7-12/h1-5,8-10,12H,6-7H2,(H,22,23) D09VOD DRUGINKE OKOHKZNRTKWMBM-UHFFFAOYSA-N D09VOD DRUGSMIL C1CC1C2=NC3=C(C=C(C=C3)Cl)C(=C2C(=O)O)C4=CC=CC=C4 D09VOD HIGHSTAT Patented D09YFJ DRUG__ID D09YFJ D09YFJ DRUGTYPE Small molecular drug D09YFJ DRUGINCH 1S/C27H26O3/c28-25-6-5-22(20-1-2-21-11-23(26(29)30)4-3-19(21)10-20)12-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30) D09YFJ DRUGINKE LDGIHZJOIQSHPB-UHFFFAOYSA-N D09YFJ DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC6=C(C=C5)C=C(C=C6)C(=O)O)O D09YFJ HIGHSTAT Patented D09YHB DRUG__ID D09YHB D09YHB DRUGTYPE Small molecular drug D09YHB DRUGINCH 1S/C28H32F3N5O4S2/c1-4-42(38,39)22-6-5-21(32-16-22)15-33-25(37)23-12-19-11-17(2)40-27(24(19)41-23)7-9-36(10-8-27)18(3)20-13-34-26(35-14-20)28(29,30)31/h5-6,12-14,16-18H,4,7-11,15H2,1-3H3,(H,33,37)/t17-,18?/m1/s1 D09YHB DRUGINKE ILXLMNLDODDHOQ-QNSVNVJESA-N D09YHB DRUGSMIL CCS(=O)(=O)C1=CN=C(C=C1)CNC(=O)C2=CC3=C(S2)C4(CCN(CC4)C(C)C5=CN=C(N=C5)C(F)(F)F)OC(C3)C D09YHB HIGHSTAT Patented D0A0BS DRUG__ID D0A0BS D0A0BS DRUGTYPE Small molecular drug D0A0BS DRUGINCH 1S/C18H12FN3OS2/c19-10-3-1-4-11(9-10)21-17(23)16-15(20)12-6-7-13(22-18(12)25-16)14-5-2-8-24-14/h1-9H,20H2,(H,21,23) D0A0BS DRUGINKE UCTSEHMMSSIODN-UHFFFAOYSA-N D0A0BS DRUGSMIL C1=CC(=CC(=C1)F)NC(=O)C2=C(C3=C(S2)N=C(C=C3)C4=CC=CS4)N D0A0BS HIGHSTAT Patented D0A0ND DRUG__ID D0A0ND D0A0ND DRUGTYPE Small molecular drug D0A0ND DRUGINCH 1S/C27H33N5O2S/c1-30-18-27(28-19-30)35(33,34)29-22-16-32(17-22)23-10-8-21-9-11-26(31-12-5-13-31)25(24(21)15-23)14-20-6-3-2-4-7-20/h2-4,6-8,10,15,18-19,22,25-26,29H,5,9,11-14,16-17H2,1H3/t25-,26+/m1/s1 D0A0ND DRUGINKE OLRHCKCMIVFULU-FTJBHMTQSA-N D0A0ND DRUGSMIL CN1C=C(N=C1)S(=O)(=O)NC2CN(C2)C3=CC4=C(CCC(C4CC5=CC=CC=C5)N6CCC6)C=C3 D0A0ND HIGHSTAT Patented D0A0VI DRUG__ID D0A0VI D0A0VI DRUGTYPE Small molecular drug D0A0VI DRUGINCH 1S/C24H30N4O5/c1-3-31-20-8-6-18(12-21(20)32-4-2)23-26-22(27-33-23)17-5-7-19-16(11-17)9-10-28(19)13-24(25,14-29)15-30/h5-8,11-12,29-30H,3-4,9-10,13-15,25H2,1-2H3 D0A0VI DRUGINKE ARJYSAJMGKMECN-UHFFFAOYSA-N D0A0VI DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=NO2)C3=CC4=C(C=C3)N(CC4)CC(CO)(CO)N)OCC D0A0VI HIGHSTAT Patented D0A0ZU DRUG__ID D0A0ZU D0A0ZU DRUGTYPE Small molecular drug D0A0ZU DRUGINCH 1S/C16H18N2OS2/c1-3-11(2)21-16-17-13-9-10-20-14(13)15(19)18(16)12-7-5-4-6-8-12/h4-8,11H,3,9-10H2,1-2H3 D0A0ZU DRUGINKE UWXVMIBCJRNBBP-UHFFFAOYSA-N D0A0ZU DRUGSMIL CCC(C)SC1=NC2=C(C(=O)N1C3=CC=CC=C3)SCC2 D0A0ZU HIGHSTAT Patented D0A2RI DRUG__ID D0A2RI D0A2RI DRUGTYPE Small molecular drug D0A2RI DRUGINCH 1S/C22H22O3/c1-24-21-14-12-20(13-15-21)22(25-17-16-23,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-15,23H,16-17H2,1H3 D0A2RI DRUGINKE JOXFVFZKGOUGOT-UHFFFAOYSA-N D0A2RI DRUGSMIL COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCCO D0A2RI HIGHSTAT Patented D0A3MV DRUG__ID D0A3MV D0A3MV DRUGTYPE Small molecular drug D0A3MV DRUGINCH 1S/C12H12N4O4S/c1-20-9-4-2-8(3-5-9)6-13-11(17)15-12-14-7-10(21-12)16(18)19/h2-5,7H,6H2,1H3,(H2,13,14,15,17) D0A3MV DRUGINKE YAEMHJKFIIIULI-UHFFFAOYSA-N D0A3MV DRUGSMIL COC1=CC=C(C=C1)CNC(=O)NC2=NC=C(S2)[N+](=O)[O-] D0A3MV HIGHSTAT Patented D0A5JS DRUG__ID D0A5JS D0A5JS DRUGTYPE Small molecular drug D0A5JS DRUGINCH 1S/C32H44F2N4O7/c1-43-29-15-22(5-8-28(29)44-20-30(40)36-11-3-2-4-12-36)19-37-31(41)26-16-24(45-25(17-33)18-34)6-7-27(26)38(32(37)42)23-9-13-35(21-39)14-10-23/h5,8,15,21,23-27H,2-4,6-7,9-14,16-20H2,1H3 D0A5JS DRUGINKE NIQRJBGTHGXCJU-UHFFFAOYSA-N D0A5JS DRUGSMIL COC1=C(C=CC(=C1)CN2C(=O)C3CC(CCC3N(C2=O)C4CCN(CC4)C=O)OC(CF)CF)OCC(=O)N5CCCCC5 D0A5JS HIGHSTAT Patented D0A5NU DRUG__ID D0A5NU D0A5NU DRUGTYPE Small molecular drug D0A5NU DRUGINCH 1S/C13H20N5O6P/c1-24-10(19)2-3-17(6-7-25(21,22)23)4-5-18-9-16-11-12(18)14-8-15-13(11)20/h8-9,11H,2-7H2,1H3,(H2,21,22,23) D0A5NU DRUGINKE VXLAMFCNIGSKKO-UHFFFAOYSA-N D0A5NU DRUGSMIL COC(=O)CCN(CCN1C=NC2C1=NC=NC2=O)CCP(=O)(O)O D0A5NU HIGHSTAT Patented D0A5QV DRUG__ID D0A5QV D0A5QV DRUGTYPE Small molecular drug D0A5QV DRUGINCH 1S/C21H24N6O/c1-14-10-18(26-9-5-8-17(23)13-26)19-20(24-14)25(2)21(28)27(19)12-16-7-4-3-6-15(16)11-22/h3-4,6-7,10,17H,5,8-9,12-13,23H2,1-2H3 D0A5QV DRUGINKE UWSKGQJKQNVRJZ-UHFFFAOYSA-N D0A5QV DRUGSMIL CC1=CC(=C2C(=N1)N(C(=O)N2CC3=CC=CC=C3C#N)C)N4CCCC(C4)N D0A5QV HIGHSTAT Patented D0A8UJ DRUG__ID D0A8UJ D0A8UJ DRUGTYPE Small molecular drug D0A8UJ DRUGINCH 1S/C11H8N2O4S/c14-7-2-1-5(4-8(7)15)3-6-9(16)12-11(18)13-10(6)17/h1-4,14-15H,(H2,12,13,16,17,18) D0A8UJ DRUGINKE DELWWBDBFMAAMG-UHFFFAOYSA-N D0A8UJ DRUGSMIL C1=CC(=C(C=C1C=C2C(=O)NC(=S)NC2=O)O)O D0A8UJ HIGHSTAT Patented D0A9KU DRUG__ID D0A9KU D0A9KU DRUGTYPE Small molecular drug D0A9KU DRUGINCH 1S/C28H32F3N5O4S2/c1-4-42(38,39)22-6-5-21(32-16-22)15-33-25(37)23-12-19-11-17(2)40-27(24(19)41-23)7-9-36(10-8-27)18(3)20-13-34-26(35-14-20)28(29,30)31/h5-6,12-14,16-18H,4,7-11,15H2,1-3H3,(H,33,37)/t17-,18-/m0/s1 D0A9KU DRUGINKE ILXLMNLDODDHOQ-ROUUACIJSA-N D0A9KU DRUGSMIL CCS(=O)(=O)C1=CN=C(C=C1)CNC(=O)C2=CC3=C(S2)C4(CCN(CC4)C(C)C5=CN=C(N=C5)C(F)(F)F)OC(C3)C D0A9KU HIGHSTAT Patented D0AB5X DRUG__ID D0AB5X D0AB5X DRUGTYPE Small molecular drug D0AB5X DRUGINCH 1S/C26H24O11/c1-31-17-6-12-13(7-18(17)32-2)24(37-26-23(29)22(28)15(27)9-34-26)14-8-33-25(30)21(14)20(12)11-3-4-16-19(5-11)36-10-35-16/h3-7,15,22-23,26-29H,8-10H2,1-2H3 D0AB5X DRUGINKE AVYGDWFATMFGNJ-UHFFFAOYSA-N D0AB5X DRUGSMIL COC1=C(C=C2C(=C1)C(=C3C(=C2OC4C(C(C(CO4)O)O)O)COC3=O)C5=CC6=C(C=C5)OCO6)OC D0AB5X HIGHSTAT Patented D0AK7K DRUG__ID D0AK7K D0AK7K DRUGTYPE Small molecular drug D0AK7K DRUGINCH 1S/C23H23F3N2O/c24-23(25,26)19-11-7-8-17(16-19)21-27-20(29-28-21)12-15-22(13-5-2-6-14-22)18-9-3-1-4-10-18/h1,3-4,7-11,16H,2,5-6,12-15H2 D0AK7K DRUGINKE QEEBNTVAPQWKOQ-UHFFFAOYSA-N D0AK7K DRUGSMIL C1CCC(CC1)(CCC2=NC(=NO2)C3=CC(=CC=C3)C(F)(F)F)C4=CC=CC=C4 D0AK7K HIGHSTAT Patented D0AV6X DRUG__ID D0AV6X D0AV6X DRUGTYPE Small molecular drug D0AV6X DRUGINCH 1S/C19H14O4/c1-23-19(22)15-4-2-3-12(10-15)13-5-7-16-14(9-13)6-8-18(21)17(16)11-20/h2-11,21H,1H3 D0AV6X DRUGINKE WXSWAZIIQXYJAM-UHFFFAOYSA-N D0AV6X DRUGSMIL COC(=O)C1=CC=CC(=C1)C2=CC3=C(C=C2)C(=C(C=C3)O)C=O D0AV6X HIGHSTAT Patented D0AY2N DRUG__ID D0AY2N D0AY2N DRUGTYPE Small molecular drug D0AY2N DRUGINCH 1S/C20H19FN2O/c1-12-3-4-14-7-10-17-19(18(14)11-12)22-23(13(2)24)20(17)15-5-8-16(21)9-6-15/h3-6,8-9,11,17,20H,7,10H2,1-2H3 D0AY2N DRUGINKE KSFRHQFENHYLGG-UHFFFAOYSA-N D0AY2N DRUGSMIL CC1=CC2=C(CCC3C2=NN(C3C4=CC=C(C=C4)F)C(=O)C)C=C1 D0AY2N HIGHSTAT Patented D0AZ6X DRUG__ID D0AZ6X D0AZ6X DRUGTYPE Small molecular drug D0AZ6X DRUGINCH 1S/C20H19FN4O/c1-13-23-10-14(11-24-13)16-9-20(25-18-7-3-2-5-15(16)18)26-12-19-17(21)6-4-8-22-19/h4,6,8-11H,2-3,5,7,12H2,1H3 D0AZ6X DRUGINKE SPNLLZYJQZRTPY-UHFFFAOYSA-N D0AZ6X DRUGSMIL CC1=NC=C(C=N1)C2=CC(=NC3=C2CCCC3)OCC4=C(C=CC=N4)F D0AZ6X HIGHSTAT Patented D0B1UL DRUG__ID D0B1UL D0B1UL DRUGTYPE Small molecular drug D0B1UL DRUGINCH 1S/C38H26O10/c1-17-27(35(45)21-15-25(41)37(47)31(29(21)33(17)43)23(39)13-19-9-5-3-6-10-19)28-18(2)34(44)30-22(36(28)46)16-26(42)38(48)32(30)24(40)14-20-11-7-4-8-12-20/h3-12,15-16,41,43,45,47H,13-14H2,1-2H3 D0B1UL DRUGINKE SAXRAWJDCMFHQD-UHFFFAOYSA-N D0B1UL DRUGSMIL CC1=C(C(=O)C2=CC(=O)C(=O)C(=C2C1=O)C(=O)CC3=CC=CC=C3)C4=C(C5=CC(=C(C(=C5C(=C4C)O)C(=O)CC6=CC=CC=C6)O)O)O D0B1UL HIGHSTAT Patented D0B4VO DRUG__ID D0B4VO D0B4VO DRUGTYPE Small molecular drug D0B4VO DRUGINCH 1S/C22H35N3O5/c26-20(24-19-11-5-3-6-12-19)13-7-4-9-17-23-16-8-1-2-10-18-25(30)21(27)14-15-22(28)29/h3,5-6,11-12,23,30H,1-2,4,7-10,13-18H2,(H,24,26)(H,28,29) D0B4VO DRUGINKE FJNPYJKFIGGTME-UHFFFAOYSA-N D0B4VO DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCNCCCCCCN(C(=O)CCC(=O)O)O D0B4VO HIGHSTAT Patented D0B5FA DRUG__ID D0B5FA D0B5FA DRUGTYPE Small molecular drug D0B5FA DRUGINCH 1S/C13H10BrN5O/c14-8-2-1-3-9(6-8)18-12(19-20)10-4-5-15-13-11(10)16-7-17-13/h1-7,20H,(H,18,19)(H,15,16,17) D0B5FA DRUGINKE UPPKJOIPXZWQCK-UHFFFAOYSA-N D0B5FA DRUGSMIL C1=CC(=CC(=C1)Br)N=C(C2=C3C(=NC=C2)N=CN3)NO D0B5FA HIGHSTAT Patented D0B5YS DRUG__ID D0B5YS D0B5YS DRUGTYPE Small molecular drug D0B5YS DRUGINCH 1S/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H3 D0B5YS DRUGINKE MWOOGOJBHIARFG-UHFFFAOYSA-N D0B5YS DRUGSMIL COC1=C(C=CC(=C1)C=O)O D0B5YS HIGHSTAT Patented D0B6VY DRUG__ID D0B6VY D0B6VY DRUGTYPE Small molecular drug D0B6VY DRUGINCH 1S/C21H31N7O/c1-6-16(18(29)13(2)3)25-21-26-19(23-11-15-8-7-9-22-10-15)17-20(27-21)28(12-24-17)14(4)5/h7-10,12-14,16,18,29H,6,11H2,1-5H3,(H2,23,25,26,27)/t16-,18?/m1/s1 D0B6VY DRUGINKE AGGGWZCOULSEER-PYUWXLGESA-N D0B6VY DRUGSMIL CCC(C(C(C)C)O)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CN=CC=C3 D0B6VY HIGHSTAT Patented D0B7VP DRUG__ID D0B7VP D0B7VP DRUGTYPE Small molecular drug D0B7VP DRUGINCH 1S/C32H31N7O3/c1-19-10-12-20(13-11-19)39-27(18-26(37-39)32(2,3)4)35-30(40)34-23-14-15-24(22-9-7-6-8-21(22)23)42-25-16-17-33-29-28(25)38(5)31(41)36-29/h6-18H,1-5H3,(H,33,36,41)(H2,34,35,40) D0B7VP DRUGINKE JIFZZVZROIFPKB-UHFFFAOYSA-N D0B7VP DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OC5=C6C(=NC=C5)NC(=O)N6C D0B7VP HIGHSTAT Patented D0B9TI DRUG__ID D0B9TI D0B9TI DRUGTYPE Small molecular drug D0B9TI DRUGINCH 1S/C22H28N2O2/c1-23(2)15-13-21(25)19-9-5-17(6-10-19)18-7-11-20(12-8-18)22(26)14-16-24(3)4/h5-12H,13-16H2,1-4H3 D0B9TI DRUGINKE KDKCLSBOSGNKSF-UHFFFAOYSA-N D0B9TI DRUGSMIL CN(C)CCC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCN(C)C D0B9TI HIGHSTAT Patented D0BB4J DRUG__ID D0BB4J D0BB4J DRUGTYPE Small molecular drug D0BB4J DRUGINCH 1S/C2H6N2O2/c3-4-1-2(5)6/h4H,1,3H2,(H,5,6) D0BB4J DRUGINKE RRBZUCWNYQUCTR-UHFFFAOYSA-N D0BB4J DRUGSMIL C(C(=O)O)NN D0BB4J HIGHSTAT Patented D0BJ3R DRUG__ID D0BJ3R D0BJ3R DRUGTYPE Small molecular drug D0BJ3R DRUGINCH 1S/C21H19ClF4N4O2S/c1-29-11-20(27-12-29)33(31,32)30-9-16(13-2-4-14(23)5-3-13)19(10-30)28-15-6-7-18(22)17(8-15)21(24,25)26/h2-8,11-12,16,19,28H,9-10H2,1H3/t16-,19+/m1/s1 D0BJ3R DRUGINKE VSJNRQGUSYDZJE-APWZRJJASA-N D0BJ3R DRUGSMIL CN1C=C(N=C1)S(=O)(=O)N2CC(C(C2)NC3=CC(=C(C=C3)Cl)C(F)(F)F)C4=CC=C(C=C4)F D0BJ3R HIGHSTAT Patented D0BR6D DRUG__ID D0BR6D D0BR6D DRUGTYPE Small molecular drug D0BR6D DRUGINCH 1S/C27H29N3O/c1-20(2)17-26(27(31)30(4)29(3)19-28)25-12-8-11-24(18-25)23-15-13-22(14-16-23)21-9-6-5-7-10-21/h5-16,18,20,26H,17H2,1-4H3 D0BR6D DRUGINKE VUAQQIIYDSXRAP-UHFFFAOYSA-N D0BR6D DRUGSMIL CC(C)CC(C1=CC=CC(=C1)C2=CC=C(C=C2)C3=CC=CC=C3)C(=O)N(C)N(C)C#N D0BR6D HIGHSTAT Patented D0BU1L DRUG__ID D0BU1L D0BU1L DRUGTYPE Small molecular drug D0BU1L DRUGINCH 1S/C24H20N2O/c27-24(21-12-5-4-10-18(21)17-8-2-1-3-9-17)26-15-14-20-19-11-6-7-13-22(19)25-23(20)16-26/h1-13,25H,14-16H2 D0BU1L DRUGINKE UCWAWBWZKYMCRY-UHFFFAOYSA-N D0BU1L DRUGSMIL C1CN(CC2=C1C3=CC=CC=C3N2)C(=O)C4=CC=CC=C4C5=CC=CC=C5 D0BU1L HIGHSTAT Patented D0BW9L DRUG__ID D0BW9L D0BW9L DRUGTYPE Small molecular drug D0BW9L DRUGINCH 1S/C25H20N6O2S/c1-13-3-8-18-17(9-10-27-24(18)30-16-6-4-15(5-7-16)14(2)32)20(13)31-25(33)19-11-34-22-21(19)28-12-29-23(22)26/h3-12H,1-2H3,(H,27,30)(H,31,33)(H2,26,28,29) D0BW9L DRUGINKE VDPIYNSZQSYYGQ-UHFFFAOYSA-N D0BW9L DRUGSMIL CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC=C(C=C3)C(=O)C)NC(=O)C4=CSC5=C4N=CN=C5N D0BW9L HIGHSTAT Patented D0C4AW DRUG__ID D0C4AW D0C4AW DRUGTYPE Small molecular drug D0C4AW DRUGINCH 1S/C34H39FN2O6/c1-3-23(4-2)22-33(41)15-17-37(18-16-33)32(40)36-26-19-29(21-30(20-26)43-28-11-7-25(35)8-12-28)42-27-9-5-24(6-10-27)34(13-14-34)31(38)39/h5-12,19-21,23,41H,3-4,13-18,22H2,1-2H3,(H,36,40)(H,38,39) D0C4AW DRUGINKE UZPSRIVFHKJDOL-UHFFFAOYSA-N D0C4AW DRUGSMIL CCC(CC)CC1(CCN(CC1)C(=O)NC2=CC(=CC(=C2)OC3=CC=C(C=C3)F)OC4=CC=C(C=C4)C5(CC5)C(=O)O)O D0C4AW HIGHSTAT Patented D0C4PD DRUG__ID D0C4PD D0C4PD DRUGTYPE Small molecular drug D0C4PD DRUGINCH 1S/C32H30F3N7O3/c1-20-3-4-21(18-42-13-15-44-16-14-42)17-26(20)38-30(43)23-5-9-24(10-6-23)37-31-39-27(28-29(40-31)41(2)19-36-28)22-7-11-25(12-8-22)45-32(33,34)35/h3-12,17,19H,13-16,18H2,1-2H3,(H,38,43)(H,37,39,40) D0C4PD DRUGINKE RXPJNNAJKCJKEX-UHFFFAOYSA-N D0C4PD DRUGSMIL CC1=C(C=C(C=C1)CN2CCOCC2)NC(=O)C3=CC=C(C=C3)NC4=NC(=C5C(=N4)N(C=N5)C)C6=CC=C(C=C6)OC(F)(F)F D0C4PD HIGHSTAT Patented D0C5RD DRUG__ID D0C5RD D0C5RD DRUGTYPE Small molecular drug D0C5RD DRUGINCH 1S/C28H31N3O3/c1-3-20-6-8-21(9-7-20)24-12-10-22-19-31(28(32)27(22)29-24)23-11-13-25(26(18-23)33-2)34-17-16-30-14-4-5-15-30/h6-13,18H,3-5,14-17,19H2,1-2H3 D0C5RD DRUGINKE JRDLEMTYNVKHFV-UHFFFAOYSA-N D0C5RD DRUGSMIL CCC1=CC=C(C=C1)C2=NC3=C(CN(C3=O)C4=CC(=C(C=C4)OCCN5CCCC5)OC)C=C2 D0C5RD HIGHSTAT Patented D0C6NX DRUG__ID D0C6NX D0C6NX DRUGTYPE Small molecular drug D0C6NX DRUGINCH 1S/C17H15ClN4O2/c18-11-3-4-13-14(5-6-20-15(13)8-11)17(24)21-10-16(23)22-7-1-2-12(22)9-19/h3-6,8,12H,1-2,7,10H2,(H,21,24)/t12-/m0/s1 D0C6NX DRUGINKE NERXNBIHCGOYFQ-LBPRGKRZSA-N D0C6NX DRUGSMIL C1CC(N(C1)C(=O)CNC(=O)C2=C3C=CC(=CC3=NC=C2)Cl)C#N D0C6NX HIGHSTAT Patented D0C9ZW DRUG__ID D0C9ZW D0C9ZW DRUGTYPE Small molecular drug D0C9ZW DRUGINCH 1S/C22H15F3N6/c23-22(24,25)14-4-1-3-13(9-14)10-28-21-29-11-17-15-6-8-26-12-18(15)30-20-16(19(17)31-21)5-2-7-27-20/h1-9,11-12H,10H2,(H,27,30)(H,28,29,31) D0C9ZW DRUGINKE BJNZVGIKBDSXJO-UHFFFAOYSA-N D0C9ZW DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)CNC2=NC=C3C4=C(C=NC=C4)NC5=C(C3=N2)C=CC=N5 D0C9ZW HIGHSTAT Patented D0CD5P DRUG__ID D0CD5P D0CD5P DRUGTYPE Small molecular drug D0CD5P DRUGINCH 1S/C22H28N2O7S/c1-14(2)11-23-12-15-8-21(31-6-5-7-32(4,28)29)20(30-3)9-16(15)18-10-19(25)17(22(26)27)13-24(18)23/h8-10,13-14H,5-7,11-12H2,1-4H3,(H,26,27) D0CD5P DRUGINKE RECMZXKLBVQDRN-UHFFFAOYSA-N D0CD5P DRUGSMIL CC(C)CN1CC2=CC(=C(C=C2C3=CC(=O)C(=CN31)C(=O)O)OC)OCCCS(=O)(=O)C D0CD5P HIGHSTAT Patented D0CH3F DRUG__ID D0CH3F D0CH3F DRUGTYPE Small molecular drug D0CH3F DRUGINCH 1S/C14H16O3/c1-2-12-7-8-13(17-12)6-4-10-3-5-11(15)9-14(10)16/h3,5,7-9,15-16H,2,4,6H2,1H3 D0CH3F DRUGINKE UPOWUYPZHMWQPH-UHFFFAOYSA-N D0CH3F DRUGSMIL CCC1=CC=C(O1)CCC2=C(C=C(C=C2)O)O D0CH3F HIGHSTAT Patented D0CI3N DRUG__ID D0CI3N D0CI3N DRUGTYPE Small molecular drug D0CI3N DRUGINCH 1S/C23H17ClN6OS/c1-12-2-7-16-15(8-9-26-22(16)29-14-5-3-13(24)4-6-14)18(12)30-23(31)17-10-32-20-19(17)27-11-28-21(20)25/h2-11H,1H3,(H,26,29)(H,30,31)(H2,25,27,28) D0CI3N DRUGINKE FHPTWZJZWOYCKG-UHFFFAOYSA-N D0CI3N DRUGSMIL CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC=C(C=C3)Cl)NC(=O)C4=CSC5=C4N=CN=C5N D0CI3N HIGHSTAT Patented D0CI4A DRUG__ID D0CI4A D0CI4A DRUGTYPE Small molecular drug D0CI4A DRUGINCH 1S/C25H26N4O2/c30-24(20-10-9-18-5-1-2-6-19(18)17-20)26-13-16-28-14-11-21(12-15-28)29-23-8-4-3-7-22(23)27-25(29)31/h1-10,17,21H,11-16H2,(H,26,30)(H,27,31) D0CI4A DRUGINKE IXLLRNNFUYEADZ-UHFFFAOYSA-N D0CI4A DRUGSMIL C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCNC(=O)C4=CC5=CC=CC=C5C=C4 D0CI4A HIGHSTAT Patented D0CI9L DRUG__ID D0CI9L D0CI9L DRUGTYPE Small molecular drug D0CI9L DRUGINCH 1S/C18H15FN4O/c19-15-4-2-6-22-17(15)10-24-18-7-14(12-8-20-11-21-9-12)13-3-1-5-16(13)23-18/h2,4,6-9,11H,1,3,5,10H2 D0CI9L DRUGINKE JQPYBOWMLVSYFJ-UHFFFAOYSA-N D0CI9L DRUGSMIL C1CC2=C(C1)N=C(C=C2C3=CN=CN=C3)OCC4=C(C=CC=N4)F D0CI9L HIGHSTAT Patented D0CN2Q DRUG__ID D0CN2Q D0CN2Q DRUGTYPE Small molecular drug D0CN2Q DRUGINCH 1S/C34H43N5O5S/c1-3-44-29-15-13-26(14-16-29)27-9-6-11-30(23-27)45(42,43)38-31(22-25-8-4-10-28(21-25)33(35)36)34(41)39-19-17-24(18-20-39)7-5-12-32(40)37-2/h4,6,8-11,13-16,21,23-24,31,38H,3,5,7,12,17-20,22H2,1-2H3,(H3,35,36)(H,37,40)/t31-/m0/s1 D0CN2Q DRUGINKE XXQHDBAWRGBXGY-HKBQPEDESA-N D0CN2Q DRUGSMIL CCOC1=CC=C(C=C1)C2=CC(=CC=C2)S(=O)(=O)NC(CC3=CC(=CC=C3)C(=N)N)C(=O)N4CCC(CC4)CCCC(=O)NC D0CN2Q HIGHSTAT Patented D0CR9A DRUG__ID D0CR9A D0CR9A DRUGTYPE Small molecular drug D0CR9A DRUGINCH 1S/C30H30O8/c1-11(2)7-15-23-17(9-19(31)27(15)35)29(37)21(13(5)25(23)33)22-14(6)26(34)24-16(8-12(3)4)28(36)20(32)10-18(24)30(22)38/h9-12,31,33,35,37H,7-8H2,1-6H3 D0CR9A DRUGINKE WDQZGCJOCKBUQY-UHFFFAOYSA-N D0CR9A DRUGSMIL CC1=C(C(=O)C2=CC(=O)C(=O)C(=C2C1=O)CC(C)C)C3=C(C4=CC(=C(C(=C4C(=C3C)O)CC(C)C)O)O)O D0CR9A HIGHSTAT Patented D0CT4T DRUG__ID D0CT4T D0CT4T DRUGTYPE Small molecular drug D0CT4T DRUGINCH 1S/C24H28N2O4/c1-14-5-4-6-17(15(14)2)13-26(12-16-7-8-16)18-9-21(30-3)22(25-11-18)23(27)19-10-20(19)24(28)29/h4-6,9,11,16,19-20H,7-8,10,12-13H2,1-3H3,(H,28,29) D0CT4T DRUGINKE LRXJWJPKMGAWTD-UHFFFAOYSA-N D0CT4T DRUGSMIL CC1=C(C(=CC=C1)CN(CC2CC2)C3=CC(=C(N=C3)C(=O)C4CC4C(=O)O)OC)C D0CT4T HIGHSTAT Patented D0CT9O DRUG__ID D0CT9O D0CT9O DRUGTYPE Small molecular drug D0CT9O DRUGINCH 1S/C28H37N5O/c1-3-4-6-11-20-14-15-23-22(18-20)24(21-12-7-5-8-13-21)25(27-30-32-33-31-27)26(29-23)28(19-34-2)16-9-10-17-28/h5,7-8,12-13,20H,3-4,6,9-11,14-19H2,1-2H3,(H,30,31,32,33) D0CT9O DRUGINKE OGYHUAQNUJEKHA-UHFFFAOYSA-N D0CT9O DRUGSMIL CCCCCC1CCC2=C(C1)C(=C(C(=N2)C3(CCCC3)COC)C4=NNN=N4)C5=CC=CC=C5 D0CT9O HIGHSTAT Patented D0CV8R DRUG__ID D0CV8R D0CV8R DRUGTYPE Small molecular drug D0CV8R DRUGINCH 1S/C29H30F2N2O2/c1-18(2)28-27(29(34)32-16-21-10-13-24(30)25(31)14-21)23-12-11-22(35-19(3)4)15-26(23)33(28)17-20-8-6-5-7-9-20/h5-15,18-19H,16-17H2,1-4H3,(H,32,34) D0CV8R DRUGINKE UJUPJZYUKBFHHO-UHFFFAOYSA-N D0CV8R DRUGSMIL CC(C)C1=C(C2=C(N1CC3=CC=CC=C3)C=C(C=C2)OC(C)C)C(=O)NCC4=CC(=C(C=C4)F)F D0CV8R HIGHSTAT Patented D0CV8T DRUG__ID D0CV8T D0CV8T DRUGTYPE Small molecular drug D0CV8T DRUGINCH 1S/C16H19NO4S/c1-9(2)21-16(18)14-11(8-22-15(14)17)10-5-6-12(19-3)13(7-10)20-4/h5-9H,17H2,1-4H3 D0CV8T DRUGINKE WEHPOCNINSGWET-UHFFFAOYSA-N D0CV8T DRUGSMIL CC(C)OC(=O)C1=C(SC=C1C2=CC(=C(C=C2)OC)OC)N D0CV8T HIGHSTAT Patented D0CW5D DRUG__ID D0CW5D D0CW5D DRUGTYPE Small molecular drug D0CW5D DRUGINCH 1S/C46H62F2N5O9P/c1-5-31-15-19-34(20-16-31)43(56)50-24-10-9-13-37(42(49)55)52-45(58)39(27-33-17-21-35(22-18-33)46(47,48)63(59,60)61)53-44(57)38(26-32-11-7-6-8-12-32)51-41(54)28-62-40-25-30(4)14-23-36(40)29(2)3/h6-8,11-12,15-22,29-30,36-40H,5,9-10,13-14,23-28H2,1-4H3,(H2,49,55)(H,50,56)(H,51,54)(H,52,58)(H,53,57)(H2,59,60,61) D0CW5D DRUGINKE DZZMIHDOJVEPRL-UHFFFAOYSA-N D0CW5D DRUGSMIL CCC1=CC=C(C=C1)C(=O)NCCCCC(C(=O)N)NC(=O)C(CC2=CC=C(C=C2)C(F)(F)P(=O)(O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)COC4CC(CCC4C(C)C)C D0CW5D HIGHSTAT Patented D0CW9H DRUG__ID D0CW9H D0CW9H DRUGTYPE Small molecular drug D0CW9H DRUGINCH 1S/C23H26N6O2/c1-3-4-12-28-21(27-11-7-8-17(24)14-27)13-22(30)29(23(28)31)15-20-25-16(2)18-9-5-6-10-19(18)26-20/h5-6,9-10,13,17H,7-8,11-12,14-15,24H2,1-2H3/t17-/m1/s1 D0CW9H DRUGINKE GHHYMLIQMIXJDE-QGZVFWFLSA-N D0CW9H DRUGSMIL CC#CCN1C(=CC(=O)N(C1=O)CC2=NC3=CC=CC=C3C(=N2)C)N4CCCC(C4)N D0CW9H HIGHSTAT Patented D0D0WQ DRUG__ID D0D0WQ D0D0WQ DRUGTYPE Small molecular drug D0D0WQ DRUGINCH 1S/C14H11F2N5OS/c1-21-6-7(5-18-21)19-13(22)11-12(17)23-14(20-11)10-8(15)3-2-4-9(10)16/h2-6H,17H2,1H3,(H,19,22) D0D0WQ DRUGINKE NJUKVCLHVLPDAP-UHFFFAOYSA-N D0D0WQ DRUGSMIL CN1C=C(C=N1)NC(=O)C2=C(SC(=N2)C3=C(C=CC=C3F)F)N D0D0WQ HIGHSTAT Patented D0D1JC DRUG__ID D0D1JC D0D1JC DRUGTYPE Small molecular drug D0D1JC DRUGINCH 1S/C28H30F2N6O5S/c29-17-8-3-1-6-15(17)19-12-35(33-31-19)21-10-5-11-23(25(21)38)42-28-27(40)24(26(39)22(14-37)41-28)36-13-20(32-34-36)16-7-2-4-9-18(16)30/h1-4,6-9,12-13,21-28,37-40H,5,10-11,14H2/t21?,22?,23-,24+,25?,26+,27?,28+/m1/s1 D0D1JC DRUGINKE BJVVNEYHVCHMBX-NJCBQTTNSA-N D0D1JC DRUGSMIL C1CC(C(C(C1)SC2C(C(C(C(O2)CO)O)N3C=C(N=N3)C4=CC=CC=C4F)O)O)N5C=C(N=N5)C6=CC=CC=C6F D0D1JC HIGHSTAT Patented D0D2CR DRUG__ID D0D2CR D0D2CR DRUGTYPE Small molecular drug D0D2CR DRUGINCH 1S/C22H21ClN10/c1-31-9-22(10-31)11-32(12-22)17-5-13(6-24)4-16(18(17)23)28-21-29-19(27-14-2-3-14)20-26-8-15(7-25)33(20)30-21/h4-5,8,14H,2-3,9-12H2,1H3,(H2,27,28,29,30) D0D2CR DRUGINKE UGYSMTLFOSQOTN-UHFFFAOYSA-N D0D2CR DRUGSMIL CN1CC2(C1)CN(C2)C3=CC(=CC(=C3Cl)NC4=NN5C(=CN=C5C(=N4)NC6CC6)C#N)C#N D0D2CR HIGHSTAT Patented D0D4NX DRUG__ID D0D4NX D0D4NX DRUGTYPE Small molecular drug D0D4NX DRUGINCH 1S/C20H24ClN3OSi/c1-26(2,3)17-8-6-16(7-9-17)23-20(25)15-10-13-24(14-11-15)19-18(21)5-4-12-22-19/h4-10,12H,11,13-14H2,1-3H3,(H,23,25) D0D4NX DRUGINKE DYKDTFQPEROGHZ-UHFFFAOYSA-N D0D4NX DRUGSMIL C[Si](C)(C)C1=CC=C(C=C1)NC(=O)C2=CCN(CC2)C3=C(C=CC=N3)Cl D0D4NX HIGHSTAT Patented D0D5AI DRUG__ID D0D5AI D0D5AI DRUGTYPE Small molecular drug D0D5AI DRUGINCH 1S/C17H24N2O3/c1-17(2,3)13-6-4-5-7-14(13)18-8-10-19(11-9-18)15(20)12-16(21)22/h4-7H,8-12H2,1-3H3,(H,21,22) D0D5AI DRUGINKE BJJSTQNQWBMPNN-UHFFFAOYSA-N D0D5AI DRUGSMIL CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)CC(=O)O D0D5AI HIGHSTAT Patented D0D5PL DRUG__ID D0D5PL D0D5PL DRUGTYPE Small molecular drug D0D5PL DRUGINCH 1S/C24H23N3O2S/c28-20-6-2-5-19(14-20)26-21-7-8-25-22-15-23(30-24(21)22)18-4-1-3-17(13-18)16-27-9-11-29-12-10-27/h1-8,13-15,28H,9-12,16H2,(H,25,26) D0D5PL DRUGINKE ZCWXCBKGPJOAFQ-UHFFFAOYSA-N D0D5PL DRUGSMIL C1COCCN1CC2=CC(=CC=C2)C3=CC4=NC=CC(=C4S3)NC5=CC(=CC=C5)O D0D5PL HIGHSTAT Patented D0D5YG DRUG__ID D0D5YG D0D5YG DRUGTYPE Small molecular drug D0D5YG DRUGINCH 1S/C15H10N2O3S/c1-8-4-12-14(21-8)9(6-16)7-17(12)10-2-3-11(15(19)20)13(18)5-10/h2-5,7,18H,1H3,(H,19,20) D0D5YG DRUGINKE CBQIUEMJMYALSV-UHFFFAOYSA-N D0D5YG DRUGSMIL CC1=CC2=C(S1)C(=CN2C3=CC(=C(C=C3)C(=O)O)O)C#N D0D5YG HIGHSTAT Patented D0D8AV DRUG__ID D0D8AV D0D8AV DRUGTYPE Small molecular drug D0D8AV DRUGINCH 1S/C19H16N2O5/c1-11-14-8-7-13(26-12-5-3-2-4-6-12)9-15(14)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23) D0D8AV DRUGINKE ZLDYCVXVGXUSBB-UHFFFAOYSA-N D0D8AV DRUGSMIL CC1=C2C=CC(=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3 D0D8AV HIGHSTAT Patented D0DA4Y DRUG__ID D0DA4Y D0DA4Y DRUGTYPE Small molecular drug D0DA4Y DRUGINCH 1S/C17H15ClF3NO3S/c1-2-26(24,25)15-7-6-14(18)9-12(15)10-22-16(23)11-4-3-5-13(8-11)17(19,20)21/h3-9H,2,10H2,1H3,(H,22,23) D0DA4Y DRUGINKE YHSRDHPSFFNXQB-UHFFFAOYSA-N D0DA4Y DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CNC(=O)C2=CC(=CC=C2)C(F)(F)F D0DA4Y HIGHSTAT Patented D0DB8G DRUG__ID D0DB8G D0DB8G DRUGTYPE Small molecular drug D0DB8G DRUGINCH 1S/C25H19ClN2O4/c1-30-23-12-18(6-7-21(23)31-15-25(14-27)9-10-25)28-11-8-20-19(24(28)29)13-22(32-20)16-2-4-17(26)5-3-16/h2-8,11-13H,9-10,15H2,1H3 D0DB8G DRUGINKE RMJJVTXKEKNHEK-UHFFFAOYSA-N D0DB8G DRUGSMIL COC1=C(C=CC(=C1)N2C=CC3=C(C2=O)C=C(O3)C4=CC=C(C=C4)Cl)OCC5(CC5)C#N D0DB8G HIGHSTAT Patented D0DQ6N DRUG__ID D0DQ6N D0DQ6N DRUGTYPE Small molecular drug D0DQ6N DRUGINCH 1S/C27H33F3N4O3/c1-16-13-23(37-4)21(25(35)32-16)14-31-26(36)24-18(3)34(22-8-6-5-7-20(22)24)17(2)19-9-11-33(12-10-19)15-27(28,29)30/h5-8,13,17,19H,9-12,14-15H2,1-4H3,(H,31,36)(H,32,35) D0DQ6N DRUGINKE HPODOLXTMDHLLC-UHFFFAOYSA-N D0DQ6N DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCN(CC4)CC(F)(F)F)C)OC D0DQ6N HIGHSTAT Patented D0DR0S DRUG__ID D0DR0S D0DR0S DRUGTYPE Small molecular drug D0DR0S DRUGINCH 1S/C20H17N5O/c21-10-19-23-11-14(12-24-19)17-9-20(25-18-7-2-1-6-16(17)18)26-13-15-5-3-4-8-22-15/h3-5,8-9,11-12H,1-2,6-7,13H2 D0DR0S DRUGINKE SBDHHIXJPZSGIC-UHFFFAOYSA-N D0DR0S DRUGSMIL C1CCC2=C(C1)C(=CC(=N2)OCC3=CC=CC=N3)C4=CN=C(N=C4)C#N D0DR0S HIGHSTAT Patented D0DT0E DRUG__ID D0DT0E D0DT0E DRUGTYPE Small molecular drug D0DT0E DRUGINCH 1S/C20H23F2N7OS/c1-29-18(25-9-11-5-7-24-8-6-11)14(10-26-29)27-19(30)16-17(23)31-20(28-16)15-12(21)3-2-4-13(15)22/h2-4,10-11,24-25H,5-9,23H2,1H3,(H,27,30) D0DT0E DRUGINKE QVHWRVHLJFUJKP-UHFFFAOYSA-N D0DT0E DRUGSMIL CN1C(=C(C=N1)NC(=O)C2=C(SC(=N2)C3=C(C=CC=C3F)F)N)NCC4CCNCC4 D0DT0E HIGHSTAT Patented D0DV4H DRUG__ID D0DV4H D0DV4H DRUGTYPE Small molecular drug D0DV4H DRUGINCH 1S/C26H21NO3/c1-27(16-18-5-3-2-4-6-18)26(30)20-9-7-19(8-10-20)21-11-13-23-22(15-21)12-14-25(29)24(23)17-28/h2-15,17,29H,16H2,1H3 D0DV4H DRUGINKE VYGZNGAQJYQSJI-UHFFFAOYSA-N D0DV4H DRUGSMIL CN(CC1=CC=CC=C1)C(=O)C2=CC=C(C=C2)C3=CC4=C(C=C3)C(=C(C=C4)O)C=O D0DV4H HIGHSTAT Patented D0DW3Z DRUG__ID D0DW3Z D0DW3Z DRUGTYPE Small molecular drug D0DW3Z DRUGINCH 1S/C13H16F2O6/c14-13(15)8(5-16)9(18)10(19)11(20)12(13)21-7-3-1-6(17)2-4-7/h1-4,8-12,16-20H,5H2/t8-,9-,10+,11-,12+/m1/s1 D0DW3Z DRUGINKE PIRSYSBZACJVMC-ZIQFBCGOSA-N D0DW3Z DRUGSMIL C1=CC(=CC=C1O)OC2C(C(C(C(C2(F)F)CO)O)O)O D0DW3Z HIGHSTAT Patented D0E0YY DRUG__ID D0E0YY D0E0YY DRUGTYPE Small molecular drug D0E0YY DRUGINCH 1S/C21H15ClFN7/c1-11(29-21-19-20(25-9-24-19)26-10-27-21)15-8-16(22)14-5-6-28-30-18(14)17(15)12-3-2-4-13(23)7-12/h2-11H,1H3,(H2,24,25,26,27,29) D0E0YY DRUGINKE KRDULPYOVRWKMA-UHFFFAOYSA-N D0E0YY DRUGSMIL CC(C1=CC(=C2C=CN=NC2=C1C3=CC(=CC=C3)F)Cl)NC4=NC=NC5=C4NC=N5 D0E0YY HIGHSTAT Patented D0E2AD DRUG__ID D0E2AD D0E2AD DRUGTYPE Small molecular drug D0E2AD DRUGINCH 1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3 D0E2AD DRUGINKE OGQICQVSFDPSEI-UHFFFAOYSA-N D0E2AD DRUGSMIL CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C D0E2AD HIGHSTAT Patented D0E3OT DRUG__ID D0E3OT D0E3OT DRUGTYPE Small molecular drug D0E3OT DRUGINCH 1S/C25H33FN2O4/c1-18-6-7-22(32-13-9-26)21(14-18)25(29)27-10-4-5-11-28-12-8-19-15-23(30-2)24(31-3)16-20(19)17-28/h6-7,14-16H,4-5,8-13,17H2,1-3H3,(H,27,29)/i26-1 D0E3OT DRUGINKE QVRVXSZKCXFBTE-KPVNRNJOSA-N D0E3OT DRUGSMIL CC1=CC(=C(C=C1)OCCF)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC D0E3OT HIGHSTAT Patented D0E5OA DRUG__ID D0E5OA D0E5OA DRUGTYPE Small molecular drug D0E5OA DRUGINCH 1S/C20H32NO7P/c1-2-3-4-9-25-12-17-13-26-19-10-15(5-6-18(19)28-17)16-7-8-20(21,11-16)14-27-29(22,23)24/h5-6,10,16-17H,2-4,7-9,11-14,21H2,1H3,(H2,22,23,24)/t16-,17+,20+/m0/s1 D0E5OA DRUGINKE XFNWLBLKUWRFPE-SQGPQFPESA-N D0E5OA DRUGSMIL CCCCCOCC1COC2=C(O1)C=CC(=C2)C3CCC(C3)(COP(=O)(O)O)N D0E5OA HIGHSTAT Patented D0E6LU DRUG__ID D0E6LU D0E6LU DRUGTYPE Small molecular drug D0E6LU DRUGINCH 1S/C13H13NO3/c1-17-13-10(3-2-6-14-13)7-9-4-5-11(15)8-12(9)16/h2-6,8,15-16H,7H2,1H3 D0E6LU DRUGINKE DRCOSVLHATXBGT-UHFFFAOYSA-N D0E6LU DRUGSMIL COC1=C(C=CC=N1)CC2=C(C=C(C=C2)O)O D0E6LU HIGHSTAT Patented D0E6VS DRUG__ID D0E6VS D0E6VS DRUGTYPE Small molecular drug D0E6VS DRUGINCH 1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1 D0E6VS DRUGINKE CQOQDQWUFQDJMK-SSTWWWIQSA-N D0E6VS DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O D0E6VS HIGHSTAT Patented D0E7TM DRUG__ID D0E7TM D0E7TM DRUGTYPE Small molecular drug D0E7TM DRUGINCH 1S/C11H18N3O15P3/c1-10(18)8(16)6(4-26-31(22,23)29-32(24,25)28-30(19,20)21)27-11(10,5-12)14-3-2-7(15)13-9(14)17/h6,8,16,18H,2-4H2,1H3,(H,22,23)(H,24,25)(H,13,15,17)(H2,19,20,21)/t6-,8-,10-,11-/m0/s1 D0E7TM DRUGINKE OIFHDPSGRVTKRS-SEZOGAINSA-N D0E7TM DRUGSMIL CC1(C(C(OC1(C#N)N2CCC(=O)NC2=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D0E7TM HIGHSTAT Patented D0E7ZS DRUG__ID D0E7ZS D0E7ZS DRUGTYPE Small molecular drug D0E7ZS DRUGINCH 1S/C21H25N7O3/c1-2-31-21(30)27-15-5-3-14(4-6-15)26-20(29)16-11-17(13-7-9-23-10-8-13)28-18(16)19(22)24-12-25-28/h7-12,14-15H,2-6H2,1H3,(H,26,29)(H,27,30)(H2,22,24,25) D0E7ZS DRUGINKE JJHBNGJYDQCBGI-UHFFFAOYSA-N D0E7ZS DRUGSMIL CCOC(=O)NC1CCC(CC1)NC(=O)C2=C3C(=NC=NN3C(=C2)C4=CC=NC=C4)N D0E7ZS HIGHSTAT Patented D0E9JC DRUG__ID D0E9JC D0E9JC DRUGTYPE Small molecular drug D0E9JC DRUGINCH 1S/C25H25FN6O2/c1-15(33)17-7-5-16(6-8-17)13-32-21(27-19-11-9-18(26)10-12-19)20-22(29-32)31-14-25(2,3)28-24(31)30(4)23(20)34/h5-12,27H,13-14H2,1-4H3 D0E9JC DRUGINKE RKEUHNQOPBPRQD-UHFFFAOYSA-N D0E9JC DRUGSMIL CC(=O)C1=CC=C(C=C1)CN2C(=C3C(=N2)N4CC(N=C4N(C3=O)C)(C)C)NC5=CC=C(C=C5)F D0E9JC HIGHSTAT Patented D0E9JL DRUG__ID D0E9JL D0E9JL DRUGTYPE Small molecular drug D0E9JL DRUGINCH 1S/C18H15NO2/c1-13-7-9-15(10-8-13)16-11-17(20)19(18(16)21)12-14-5-3-2-4-6-14/h2-11H,12H2,1H3 D0E9JL DRUGINKE PLQCDKKQKRJJDK-UHFFFAOYSA-N D0E9JL DRUGSMIL CC1=CC=C(C=C1)C2=CC(=O)N(C2=O)CC3=CC=CC=C3 D0E9JL HIGHSTAT Patented D0E9VJ DRUG__ID D0E9VJ D0E9VJ DRUGTYPE Small molecular drug D0E9VJ DRUGINCH 1S/C27H31ClFN5O3/c1-16(2)19-15-33-23(18-12-17(28)6-7-21(18)29)13-24(19)34-22-8-9-30-14-20(22)25(35)31-10-11-32-26(36)37-27(3,4)5/h6-9,12-16H,10-11H2,1-5H3,(H,31,35)(H,32,36)(H,30,33,34) D0E9VJ DRUGINKE NUVPAWNZKYSCFY-UHFFFAOYSA-N D0E9VJ DRUGSMIL CC(C)C1=CN=C(C=C1NC2=C(C=NC=C2)C(=O)NCCNC(=O)OC(C)(C)C)C3=C(C=CC(=C3)Cl)F D0E9VJ HIGHSTAT Patented D0EC1A DRUG__ID D0EC1A D0EC1A DRUGTYPE Small molecular drug D0EC1A DRUGINCH 1S/CH4N6/c2-3-1-4-6-7-5-1/h2H2,(H2,3,4,5,6,7) D0EC1A DRUGINKE FXYYVODGZXUHLT-UHFFFAOYSA-N D0EC1A DRUGSMIL C1(=NNN=N1)NN D0EC1A HIGHSTAT Patented D0EF6R DRUG__ID D0EF6R D0EF6R DRUGTYPE Small molecular drug D0EF6R DRUGINCH 1S/C26H35F2N3O6/c1-35-23-6-3-17(11-24(23)36-2)15-30-25(33)21-12-19(37-20(13-27)14-28)4-5-22(21)31(26(30)34)18-7-9-29(16-32)10-8-18/h3,6,11,16,18-22H,4-5,7-10,12-15H2,1-2H3 D0EF6R DRUGINKE QZWWBGKSFBRQGT-UHFFFAOYSA-N D0EF6R DRUGSMIL COC1=C(C=C(C=C1)CN2C(=O)C3CC(CCC3N(C2=O)C4CCN(CC4)C=O)OC(CF)CF)OC D0EF6R HIGHSTAT Patented D0EH4P DRUG__ID D0EH4P D0EH4P DRUGTYPE Small molecular drug D0EH4P DRUGINCH 1S/C14H28N2O3/c1-16(2)12-11-15-13(17)9-7-5-3-4-6-8-10-14(18)19/h3-12H2,1-2H3,(H,15,17)(H,18,19) D0EH4P DRUGINKE RGOJAAXJOLYDHR-UHFFFAOYSA-N D0EH4P DRUGSMIL CN(C)CCNC(=O)CCCCCCCCC(=O)O D0EH4P HIGHSTAT Patented D0EH6G DRUG__ID D0EH6G D0EH6G DRUGTYPE Small molecular drug D0EH6G DRUGINCH 1S/C19H19F3N6O2/c1-27-7-8-29-15-14(27)16(23-10-11-5-6-11)26-28-17(24-25-18(15)28)12-3-2-4-13(9-12)30-19(20,21)22/h2-4,9,11H,5-8,10H2,1H3,(H,23,26) D0EH6G DRUGINKE RTBZFULAXSZFTC-UHFFFAOYSA-N D0EH6G DRUGSMIL CN1CCOC2=C1C(=NN3C2=NN=C3C4=CC(=CC=C4)OC(F)(F)F)NCC5CC5 D0EH6G HIGHSTAT Patented D0EN2M DRUG__ID D0EN2M D0EN2M DRUGTYPE Small molecular drug D0EN2M DRUGINCH 1S/C25H23ClN2O5S/c1-5-32-24(15-6-8-16(9-7-15)25-28-27-14(2)34-25)23(29)19-11-10-18(33-19)17-12-20(30-3)22(26)21(13-17)31-4/h6-13,24H,5H2,1-4H3 D0EN2M DRUGINKE QQHJRLKSCSRMEM-UHFFFAOYSA-N D0EN2M DRUGSMIL CCOC(C1=CC=C(C=C1)C2=NN=C(S2)C)C(=O)C3=CC=C(O3)C4=CC(=C(C(=C4)OC)Cl)OC D0EN2M HIGHSTAT Patented D0EP8Y DRUG__ID D0EP8Y D0EP8Y DRUGTYPE Small molecular drug D0EP8Y DRUGINCH 1S/C26H34N4O5/c1-5-18-11-20(10-17(4)24(18)34-15-22(32)13-28-23(33)14-31)25-29-26(35-30-25)19-8-9-27-21(12-19)7-6-16(2)3/h8-12,16,22,31-32H,5-7,13-15H2,1-4H3,(H,28,33)/t22-/m0/s1 D0EP8Y DRUGINKE PFJWQQDDQKRIRR-QFIPXVFZSA-N D0EP8Y DRUGSMIL CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC=C3)CCC(C)C)C)OCC(CNC(=O)CO)O D0EP8Y HIGHSTAT Patented D0EQ3V DRUG__ID D0EQ3V D0EQ3V DRUGTYPE Small molecular drug D0EQ3V DRUGINCH 1S/C13H12O3/c1-16-11-5-2-9(3-6-11)12-7-4-10(14)8-13(12)15/h2-8,14-15H,1H3 D0EQ3V DRUGINKE QYQMHWNFXIXZGS-UHFFFAOYSA-N D0EQ3V DRUGSMIL COC1=CC=C(C=C1)C2=C(C=C(C=C2)O)O D0EQ3V HIGHSTAT Patented D0F0DX DRUG__ID D0F0DX D0F0DX DRUGTYPE Small molecular drug D0F0DX DRUGINCH 1S/C16H16N2O5/c1-9-3-4-13(10(2)5-9)23-11-6-12(19)15(17-7-11)16(22)18-8-14(20)21/h3-7,19H,8H2,1-2H3,(H,18,22)(H,20,21) D0F0DX DRUGINKE NRYBEIHDIVNLGM-UHFFFAOYSA-N D0F0DX DRUGSMIL CC1=CC(=C(C=C1)OC2=CC(=C(N=C2)C(=O)NCC(=O)O)O)C D0F0DX HIGHSTAT Patented D0F3TL DRUG__ID D0F3TL D0F3TL DRUGTYPE Small molecular drug D0F3TL DRUGINCH 1S/C15H10BrN3O2/c16-12-3-1-10(2-4-12)13-6-8-18-19(13)14-9-11(15(20)21)5-7-17-14/h1-9H,(H,20,21) D0F3TL DRUGINKE MITOFELVTHNBGA-UHFFFAOYSA-N D0F3TL DRUGSMIL C1=CC(=CC=C1C2=CC=NN2C3=NC=CC(=C3)C(=O)O)Br D0F3TL HIGHSTAT Patented D0F4TB DRUG__ID D0F4TB D0F4TB DRUGTYPE Small molecular drug D0F4TB DRUGINCH 1S/C21H23N2O3P/c24-27(25,26)15-7-14-22-16-19-12-13-20(17-8-3-1-4-9-17)21(23-19)18-10-5-2-6-11-18/h1-6,8-13,22H,7,14-16H2,(H2,24,25,26) D0F4TB DRUGINKE PKIXUSGPPGWLFE-UHFFFAOYSA-N D0F4TB DRUGSMIL C1=CC=C(C=C1)C2=C(N=C(C=C2)CNCCCP(=O)(O)O)C3=CC=CC=C3 D0F4TB HIGHSTAT Patented D0F6NT DRUG__ID D0F6NT D0F6NT DRUGTYPE Small molecular drug D0F6NT DRUGINCH 1S/C22H19N3OS/c1-4-10-18(11-5-1)17-27-22-24-23-21(16-26-20-14-8-3-9-15-20)25(22)19-12-6-2-7-13-19/h1-15H,16-17H2 D0F6NT DRUGINKE SSZGXGUFAAHHAF-UHFFFAOYSA-N D0F6NT DRUGSMIL C1=CC=C(C=C1)CSC2=NN=C(N2C3=CC=CC=C3)COC4=CC=CC=C4 D0F6NT HIGHSTAT Patented D0F7CA DRUG__ID D0F7CA D0F7CA DRUGTYPE Small molecular drug D0F7CA DRUGINCH 1S/C26H25N7/c1-17-11-27-12-18(2)33(17)25-8-7-19(13-29-25)20-14-30-26-23(15-31-32(26)16-20)21-9-10-28-24-6-4-3-5-22(21)24/h3-10,13-18,27H,11-12H2,1-2H3/t17-,18+ D0F7CA DRUGINKE OVXMCCQKIOSDGE-HDICACEKSA-N D0F7CA DRUGSMIL CC1CNCC(N1C2=NC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3)C D0F7CA HIGHSTAT Patented D0FA3G DRUG__ID D0FA3G D0FA3G DRUGTYPE Small molecular drug D0FA3G DRUGINCH 1S/C25H34FN3O/c1-27(2)12-4-11-25(22-6-8-23(26)9-7-22)24-10-5-20(17-21(24)19-30-25)18-29-15-13-28(3)14-16-29/h5-10,17H,4,11-16,18-19H2,1-3H3 D0FA3G DRUGINKE SJDALWQXTPZZQB-UHFFFAOYSA-N D0FA3G DRUGSMIL CN1CCN(CC1)CC2=CC3=C(C=C2)C(OC3)(CCCN(C)C)C4=CC=C(C=C4)F D0FA3G HIGHSTAT Patented D0FA5D DRUG__ID D0FA5D D0FA5D DRUGTYPE Small molecular drug D0FA5D DRUGINCH 1S/C29H28F6N4O3/c1-17-13-19(25-36-14-21(15-37-25)29(33,34)35)6-9-23(17)24(10-11-28(30,31)32)38-22-7-4-18(5-8-22)26(40)39-12-2-3-20(16-39)27(41)42/h4-9,13-15,20,24,38H,2-3,10-12,16H2,1H3,(H,41,42)/t20-,24?/m1/s1 D0FA5D DRUGINKE HYBIWCXMSAEBQK-CGHJUBPDSA-N D0FA5D DRUGSMIL CC1=C(C=CC(=C1)C2=NC=C(C=N2)C(F)(F)F)C(CCC(F)(F)F)NC3=CC=C(C=C3)C(=O)N4CCCC(C4)C(=O)O D0FA5D HIGHSTAT Patented D0FL7J DRUG__ID D0FL7J D0FL7J DRUGTYPE Small molecular drug D0FL7J DRUGINCH 1S/C15H14N6S/c1-2-4-13-12(3-1)20-15(22-13)11-8-19-21-14(11)17-6-5-10-7-16-9-18-10/h1-4,7-9H,5-6H2,(H,16,18)(H2,17,19,21) D0FL7J DRUGINKE SKFIGKZRFZMUKR-UHFFFAOYSA-N D0FL7J DRUGSMIL C1=CC=C2C(=C1)N=C(S2)C3=C(NN=C3)NCCC4=CN=CN4 D0FL7J HIGHSTAT Patented D0FW5U DRUG__ID D0FW5U D0FW5U DRUGTYPE Small molecular drug D0FW5U DRUGINCH 1S/C24H25F3N6O3/c25-24(26,27)19-13-33(14-31-19)23-29-11-18(12-30-23)32-21(15-3-1-2-4-15)16-5-7-17(8-6-16)22(36)28-10-9-20(34)35/h5-8,11-15,21,32H,1-4,9-10H2,(H,28,36)(H,34,35) D0FW5U DRUGINKE KUIQXXFGGIPRIS-UHFFFAOYSA-N D0FW5U DRUGSMIL C1CCC(C1)C(C2=CC=C(C=C2)C(=O)NCCC(=O)O)NC3=CN=C(N=C3)N4C=C(N=C4)C(F)(F)F D0FW5U HIGHSTAT Patented D0G1CF DRUG__ID D0G1CF D0G1CF DRUGTYPE Small molecular drug D0G1CF DRUGINCH 1S/C23H25ClN6O2/c1-3-4-10-29-21(28-9-5-6-17(25)13-28)12-22(31)30(23(29)32)14-20-26-15(2)18-11-16(24)7-8-19(18)27-20/h7-8,11-12,17H,5-6,9-10,13-14,25H2,1-2H3/t17-/m1/s1 D0G1CF DRUGINKE NESYRYDEOFUJRC-QGZVFWFLSA-N D0G1CF DRUGSMIL CC#CCN1C(=CC(=O)N(C1=O)CC2=NC(=C3C=C(C=CC3=N2)Cl)C)N4CCCC(C4)N D0G1CF HIGHSTAT Patented D0G1LL DRUG__ID D0G1LL D0G1LL DRUGTYPE Small molecular drug D0G1LL DRUGINCH 1S/C20H22F3N3O3/c21-20(22,23)14-5-1-11(2-6-14)9-15(12-3-4-12)16(27)24-10-19(13-7-8-13)17(28)25-18(29)26-19/h1-2,5-6,12-13,15H,3-4,7-10H2,(H,24,27)(H2,25,26,28,29)/t15-,19-/m0/s1 D0G1LL DRUGINKE JHOUEQAOHDTLPY-KXBFYZLASA-N D0G1LL DRUGSMIL C1CC1C(CC2=CC=C(C=C2)C(F)(F)F)C(=O)NCC3(C(=O)NC(=O)N3)C4CC4 D0G1LL HIGHSTAT Patented D0G2TL DRUG__ID D0G2TL D0G2TL DRUGTYPE Small molecular drug D0G2TL DRUGINCH 1S/C19H19N3O7/c1-10(17(24)22-14(9-23)18(25)26)8-13-6-7-15(28-13)19(27)29-12-4-2-11(3-5-12)16(20)21/h2-8,14,23H,9H2,1H3,(H3,20,21)(H,22,24)(H,25,26)/b10-8+/t14-/m0/s1 D0G2TL DRUGINKE NRFIREHTDRUARE-PLWJUESGSA-N D0G2TL DRUGSMIL CC(=CC1=CC=C(O1)C(=O)OC2=CC=C(C=C2)C(=N)N)C(=O)NC(CO)C(=O)O D0G2TL HIGHSTAT Patented D0G4IS DRUG__ID D0G4IS D0G4IS DRUGTYPE Small molecular drug D0G4IS DRUGINCH 1S/C14H20N2O3/c1-2-19-14(17)12-3-4-13(15-11-12)5-6-16-7-9-18-10-8-16/h3-4,11H,2,5-10H2,1H3 D0G4IS DRUGINKE XIDYSJNRQHEJQG-UHFFFAOYSA-N D0G4IS DRUGSMIL CCOC(=O)C1=CN=C(C=C1)CCN2CCOCC2 D0G4IS HIGHSTAT Patented D0G4LV DRUG__ID D0G4LV D0G4LV DRUGTYPE Small molecular drug D0G4LV DRUGINCH 1S/C32H32FN5O7S2/c1-5-37(46(3,41)42)27-17-28-26(29(31(39)35-2)30(45-28)20-9-11-23(33)12-10-20)16-25(27)21-7-6-8-22(15-21)32(40)36-13-14-38(47(4,43)44)24(18-34)19-36/h6-12,15-17,24H,5,13-14,19H2,1-4H3,(H,35,39) D0G4LV DRUGINKE WEBAERCGMUCGLL-UHFFFAOYSA-N D0G4LV DRUGSMIL CCN(C1=C(C=C2C(=C1)OC(=C2C(=O)NC)C3=CC=C(C=C3)F)C4=CC(=CC=C4)C(=O)N5CCN(C(C5)C#N)S(=O)(=O)C)S(=O)(=O)C D0G4LV HIGHSTAT Patented D0G4ZU DRUG__ID D0G4ZU D0G4ZU DRUGTYPE Small molecular drug D0G4ZU DRUGINCH 1S/C20H21N3O8/c1-11(19(28)23(9-16(24)25)10-17(26)27)8-14-6-7-15(30-14)20(29)31-13-4-2-12(3-5-13)18(21)22/h2-7,11H,8-10H2,1H3,(H3,21,22)(H,24,25)(H,26,27) D0G4ZU DRUGINKE GTJNXXKNXAEKAD-UHFFFAOYSA-N D0G4ZU DRUGSMIL CC(CC1=CC=C(O1)C(=O)OC2=CC=C(C=C2)C(=N)N)C(=O)N(CC(=O)O)CC(=O)O D0G4ZU HIGHSTAT Patented D0G7XW DRUG__ID D0G7XW D0G7XW DRUGTYPE Small molecular drug D0G7XW DRUGINCH 1S/C10H7NO4S/c12-6-2-1-5(7(13)4-6)3-8-9(14)11-10(15)16-8/h1-4,12-13H,(H,11,14,15)/b8-3- D0G7XW DRUGINKE CPVBTHMWQGHRIR-BAQGIRSFSA-N D0G7XW DRUGSMIL C1=CC(=C(C=C1O)O)C=C2C(=O)NC(=O)S2 D0G7XW HIGHSTAT Patented D0G8QR DRUG__ID D0G8QR D0G8QR DRUGTYPE Small molecular drug D0G8QR DRUGINCH 1S/C18H17FN4O2/c19-11-5-6-16-14(9-11)17(22-23(16)12-3-1-2-4-12)21-15-10-20-8-7-13(15)18(24)25/h5-10,12H,1-4H2,(H,21,22)(H,24,25) D0G8QR DRUGINKE LJHFNRZRNINLGH-UHFFFAOYSA-N D0G8QR DRUGSMIL C1CCC(C1)N2C3=C(C=C(C=C3)F)C(=N2)NC4=C(C=CN=C4)C(=O)O D0G8QR HIGHSTAT Patented D0GH8J DRUG__ID D0GH8J D0GH8J DRUGTYPE Small molecular drug D0GH8J DRUGINCH 1S/C16H12ClN3O3/c17-13-3-1-11(2-4-13)10-23-15-6-8-19-20(15)14-9-12(16(21)22)5-7-18-14/h1-9H,10H2,(H,21,22) D0GH8J DRUGINKE SMXDPQZYSIFABV-UHFFFAOYSA-N D0GH8J DRUGSMIL C1=CC(=CC=C1COC2=CC=NN2C3=NC=CC(=C3)C(=O)O)Cl D0GH8J HIGHSTAT Patented D0GK1K DRUG__ID D0GK1K D0GK1K DRUGTYPE Small molecular drug D0GK1K DRUGINCH 1S/C20H17NO3/c1-21(2)20(24)16-5-3-4-13(11-16)14-6-8-17-15(10-14)7-9-19(23)18(17)12-22/h3-12,23H,1-2H3 D0GK1K DRUGINKE NWWPDKVVFKCCIV-UHFFFAOYSA-N D0GK1K DRUGSMIL CN(C)C(=O)C1=CC=CC(=C1)C2=CC3=C(C=C2)C(=C(C=C3)O)C=O D0GK1K HIGHSTAT Patented D0GL1X DRUG__ID D0GL1X D0GL1X DRUGTYPE Small molecular drug D0GL1X DRUGINCH 1S/C14H12Cl2N2O2/c1-20-13-5-2-8(6-12(13)17)14(19)18-9-3-4-10(15)11(16)7-9/h2-7H,17H2,1H3,(H,18,19) D0GL1X DRUGINKE ZKXFJDCWWSKUHN-UHFFFAOYSA-N D0GL1X DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)Cl)N D0GL1X HIGHSTAT Patented D0GS6T DRUG__ID D0GS6T D0GS6T DRUGTYPE Small molecular drug D0GS6T DRUGINCH 1S/C17H14N6OS/c1-10-3-4-18-6-14(10)12-5-13(15-19-9-20-23(15)7-12)16(24)22-17-21-11(2)8-25-17/h3-9H,1-2H3,(H,21,22,24) D0GS6T DRUGINKE BKRWMNODROTBAW-UHFFFAOYSA-N D0GS6T DRUGSMIL CC1=C(C=NC=C1)C2=CN3C(=NC=N3)C(=C2)C(=O)NC4=NC(=CS4)C D0GS6T HIGHSTAT Patented D0GT9T DRUG__ID D0GT9T D0GT9T DRUGTYPE Small molecular drug D0GT9T DRUGINCH 1S/C31H31F3N6O2S/c1-2-39-12-14-40(15-13-39)18-22-8-9-23(17-24(22)31(32,33)34)35-28(42)21-5-3-4-20(16-21)25-10-11-26-29(36-25)43-30(37-26)38-27(41)19-6-7-19/h3-5,8-11,16-17,19H,2,6-7,12-15,18H2,1H3,(H,35,42)(H,37,38,41) D0GT9T DRUGINKE VTWWRKFUHCSCEW-UHFFFAOYSA-N D0GT9T DRUGSMIL CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC=CC(=C3)C4=NC5=C(C=C4)N=C(S5)NC(=O)C6CC6)C(F)(F)F D0GT9T HIGHSTAT Patented D0GV1S DRUG__ID D0GV1S D0GV1S DRUGTYPE Small molecular drug D0GV1S DRUGINCH 1S/C24H22F2N6O/c25-15-4-2-5-16(26)22(15)24-29-11-14-3-1-6-18(23(14)31-24)30-19-12-28-9-7-20(19)32-10-8-21(33)17(27)13-32/h1-7,9,11-12,17,21,30,33H,8,10,13,27H2/t17-,21+/m1/s1 D0GV1S DRUGINKE WAISNUDWNYJNMT-UTKZUKDTSA-N D0GV1S DRUGSMIL C1CN(CC(C1O)N)C2=C(C=NC=C2)NC3=CC=CC4=CN=C(N=C43)C5=C(C=CC=C5F)F D0GV1S HIGHSTAT Patented D0H0GL DRUG__ID D0H0GL D0H0GL DRUGTYPE Small molecular drug D0H0GL DRUGINCH 1S/C24H25Cl2F3N4O4S/c1-2-38(36,37)19-6-5-14(25)8-13(19)10-33-22(34)16-9-18(24(27,28)29)17(20(26)21(16)31-23(33)35)12-32-7-3-4-15(30)11-32/h5-6,8-9,15H,2-4,7,10-12,30H2,1H3,(H,31,35)/t15-/m1/s1 D0H0GL DRUGINKE ASAFNJMZLYOBFG-OAHLLOKOSA-N D0H0GL DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CN2C(=O)C3=CC(=C(C(=C3NC2=O)Cl)CN4CCCC(C4)N)C(F)(F)F D0H0GL HIGHSTAT Patented D0H0SM DRUG__ID D0H0SM D0H0SM DRUGTYPE Small molecular drug D0H0SM DRUGINCH 1S/C35H33N7O2/c1-23-14-16-25(17-15-23)42-31(22-30(41-42)35(2,3)4)39-34(43)38-28-18-19-29(27-13-9-8-12-26(27)28)44-32-20-21-36-33(40-32)37-24-10-6-5-7-11-24/h5-22H,1-4H3,(H,36,37,40)(H2,38,39,43) D0H0SM DRUGINKE DBXJNQABFNNKPN-UHFFFAOYSA-N D0H0SM DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OC5=NC(=NC=C5)NC6=CC=CC=C6 D0H0SM HIGHSTAT Patented D0H0UC DRUG__ID D0H0UC D0H0UC DRUGTYPE Small molecular drug D0H0UC DRUGINCH 1S/C8H9FO2/c1-2-6-7(9)3-5(10)4-8(6)11/h3-4,10-11H,2H2,1H3 D0H0UC DRUGINKE GJVVTWQXSOPPFB-UHFFFAOYSA-N D0H0UC DRUGSMIL CCC1=C(C=C(C=C1F)O)O D0H0UC HIGHSTAT Patented D0H2GT DRUG__ID D0H2GT D0H2GT DRUGTYPE Small molecular drug D0H2GT DRUGINCH 1S/C32H31ClN2O4S/c33-27-10-5-4-9-25(27)29-26(22-11-13-24(14-12-22)39-20-6-19-36)21-28(40-29)30(37)35-17-15-32(16-18-35,31(34)38)23-7-2-1-3-8-23/h1-5,7-14,21,36H,6,15-20H2,(H2,34,38) D0H2GT DRUGINKE MWPKIBLLWUZVNJ-UHFFFAOYSA-N D0H2GT DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)C(=O)N)C(=O)C3=CC(=C(S3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)OCCCO D0H2GT HIGHSTAT Patented D0H4IY DRUG__ID D0H4IY D0H4IY DRUGTYPE Small molecular drug D0H4IY DRUGINCH 1S/C20H21N3O2/c1-23-18(24)20(15-9-10-15,22-19(23)21)16-7-3-5-13(11-16)14-6-4-8-17(12-14)25-2/h3-8,11-12,15H,9-10H2,1-2H3,(H2,21,22) D0H4IY DRUGINKE NCNMSGOJBLVCOM-UHFFFAOYSA-N D0H4IY DRUGSMIL CN1C(=O)C(N=C1N)(C2CC2)C3=CC=CC(=C3)C4=CC(=CC=C4)OC D0H4IY HIGHSTAT Patented D0H5FI DRUG__ID D0H5FI D0H5FI DRUGTYPE Small molecular drug D0H5FI DRUGINCH 1S/C28H24F3NO6/c1-16-23(14-18-5-4-6-21(13-18)37-17(2)27(34)35)24-15-22(38-28(29,30)31)11-12-25(24)32(16)26(33)19-7-9-20(36-3)10-8-19/h4-13,15,17H,14H2,1-3H3,(H,34,35)/t17-/m0/s1 D0H5FI DRUGINKE OFCWBJAYEIROGZ-KRWDZBQOSA-N D0H5FI DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)OC)C=CC(=C2)OC(F)(F)F)CC4=CC(=CC=C4)OC(C)C(=O)O D0H5FI HIGHSTAT Patented D0H5GP DRUG__ID D0H5GP D0H5GP DRUGTYPE Small molecular drug D0H5GP DRUGINCH 1S/C17H22N2O5/c20-16(18-22)13-2-3-14-11-19(6-1-7-24-15(14)10-13)17(21)12-4-8-23-9-5-12/h2-3,10,12,22H,1,4-9,11H2,(H,18,20) D0H5GP DRUGINKE UIDRHDHNNBIRIS-UHFFFAOYSA-N D0H5GP DRUGSMIL C1CN(CC2=C(C=C(C=C2)C(=O)NO)OC1)C(=O)C3CCOCC3 D0H5GP HIGHSTAT Patented D0H6DS DRUG__ID D0H6DS D0H6DS DRUGTYPE Small molecular drug D0H6DS DRUGINCH 1S/C18H19FN6O2/c19-15-7-10(5-6-21-15)14-8-13(16-17(20)22-9-23-25(14)16)18(27)24-11-1-3-12(26)4-2-11/h5-9,11-12,26H,1-4H2,(H,24,27)(H2,20,22,23) D0H6DS DRUGINKE DZUXIHIXWCKJDW-UHFFFAOYSA-N D0H6DS DRUGSMIL C1CC(CCC1NC(=O)C2=C3C(=NC=NN3C(=C2)C4=CC(=NC=C4)F)N)O D0H6DS HIGHSTAT Patented D0H6LK DRUG__ID D0H6LK D0H6LK DRUGTYPE Small molecular drug D0H6LK DRUGINCH 1S/C42H45BrF2IN6O11P/c1-23-8-12-27(21-30(23)43)39(57)51-32(17-24-9-13-28(14-10-24)42(44,45)64(60,61)62)41(59)50-31(7-4-16-48-38(56)26-5-3-6-29(46)20-26)40(58)52-33(37(47)55)22-49-36(54)19-25-11-15-34(53)35(18-25)63-2/h3,5-6,8-15,18,20-21,31-33,53H,4,7,16-17,19,22H2,1-2H3,(H2,47,55)(H,48,56)(H,49,54)(H,50,59)(H,51,57)(H,52,58)(H2,60,61,62) D0H6LK DRUGINKE PXNYEUGGRMYQLD-UHFFFAOYSA-N D0H6LK DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)C(F)(F)P(=O)(O)O)C(=O)NC(CCCNC(=O)C3=CC(=CC=C3)I)C(=O)NC(CNC(=O)CC4=CC(=C(C=C4)O)OC)C(=O)N)Br D0H6LK HIGHSTAT Patented D0HH4L DRUG__ID D0HH4L D0HH4L DRUGTYPE Small molecular drug D0HH4L DRUGINCH 1S/C10H11NO3S/c12-7-3-1-6(2-4-7)9-11-8(5-15-9)10(13)14/h1-4,8-9,11-12H,5H2,(H,13,14)/t8-,9?/m0/s1 D0HH4L DRUGINKE TWPYJYQNZHPNGQ-IENPIDJESA-N D0HH4L DRUGSMIL C1C(NC(S1)C2=CC=C(C=C2)O)C(=O)O D0HH4L HIGHSTAT Patented D0HK8C DRUG__ID D0HK8C D0HK8C DRUGTYPE Small molecular drug D0HK8C DRUGINCH 1S/C14H11N3/c15-14-12-8-11(10-4-2-1-3-5-10)6-7-13(12)16-9-17-14/h1-9H,(H2,15,16,17) D0HK8C DRUGINKE KLSNPRMSQXGJND-UHFFFAOYSA-N D0HK8C DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(C=C2)N=CN=C3N D0HK8C HIGHSTAT Patented D0HN5O DRUG__ID D0HN5O D0HN5O DRUGTYPE Small molecular drug D0HN5O DRUGINCH 1S/C21H22N2O2/c1-16(18-10-6-3-7-11-18)22-14-19-12-13-23(21(25)20(19)24)15-17-8-4-2-5-9-17/h2-13,16,22,24H,14-15H2,1H3 D0HN5O DRUGINKE VGDRCKOTQHHWTA-UHFFFAOYSA-N D0HN5O DRUGSMIL CC(C1=CC=CC=C1)NCC2=C(C(=O)N(C=C2)CC3=CC=CC=C3)O D0HN5O HIGHSTAT Patented D0HO0I DRUG__ID D0HO0I D0HO0I DRUGTYPE Small molecular drug D0HO0I DRUGINCH 1S/C11H10N2O3S/c1-16-8-3-2-6(4-7(8)14)5-9-10(15)13-11(12)17-9/h2-5,14H,1H3,(H2,12,13,15)/b9-5- D0HO0I DRUGINKE WCHCAGWRYJMMPY-UITAMQMPSA-N D0HO0I DRUGSMIL COC1=C(C=C(C=C1)C=C2C(=O)N=C(S2)N)O D0HO0I HIGHSTAT Patented D0HO1Q DRUG__ID D0HO1Q D0HO1Q DRUGTYPE Small molecular drug D0HO1Q DRUGINCH 1S/C25H27FN6O2/c1-15(33)17-7-5-16(6-8-17)13-32-21(27-19-11-9-18(26)10-12-19)20-22(29-32)31-14-25(2,3)28-24(31)30(4)23(20)34/h5-12,15,27,33H,13-14H2,1-4H3 D0HO1Q DRUGINKE PSUHAEXBWCRQED-UHFFFAOYSA-N D0HO1Q DRUGSMIL CC(C1=CC=C(C=C1)CN2C(=C3C(=N2)N4CC(N=C4N(C3=O)C)(C)C)NC5=CC=C(C=C5)F)O D0HO1Q HIGHSTAT Patented D0HO8O DRUG__ID D0HO8O D0HO8O DRUGTYPE Small molecular drug D0HO8O DRUGINCH 1S/C19H26N2O4S/c1-24-18(22)19(23,17(20)11-26-2)10-15-14-9-13(6-5-12-3-4-12)25-16(14)7-8-21-15/h7-9,12,17,23H,3-6,10-11,20H2,1-2H3/t17-,19+/m0/s1 D0HO8O DRUGINKE GTBZNNHYIZEBEO-PKOBYXMFSA-N D0HO8O DRUGSMIL COC(=O)C(CC1=NC=CC2=C1C=C(O2)CCC3CC3)(C(CSC)N)O D0HO8O HIGHSTAT Patented D0HT9Q DRUG__ID D0HT9Q D0HT9Q DRUGTYPE Small molecular drug D0HT9Q DRUGINCH 1S/C12H12N2O2S/c1-8-2-3-9(17-8)6-14-11-7-13-5-4-10(11)12(15)16/h2-5,7,14H,6H2,1H3,(H,15,16) D0HT9Q DRUGINKE RFUZGPWCXINBNW-UHFFFAOYSA-N D0HT9Q DRUGSMIL CC1=CC=C(S1)CNC2=C(C=CN=C2)C(=O)O D0HT9Q HIGHSTAT Patented D0HW8T DRUG__ID D0HW8T D0HW8T DRUGTYPE Small molecular drug D0HW8T DRUGINCH 1S/C25H32N4O5/c1-5-17-10-19(9-16(4)23(17)33-14-21(31)12-27-22(32)13-30)24-28-25(34-29-24)18-6-7-26-20(11-18)8-15(2)3/h6-7,9-11,15,21,30-31H,5,8,12-14H2,1-4H3,(H,27,32)/t21-/m0/s1 D0HW8T DRUGINKE FIZLCOHGMMUGTO-NRFANRHFSA-N D0HW8T DRUGSMIL CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC=C3)CC(C)C)C)OCC(CNC(=O)CO)O D0HW8T HIGHSTAT Patented D0I0CN DRUG__ID D0I0CN D0I0CN DRUGTYPE Small molecular drug D0I0CN DRUGINCH 1S/C19H22FN7OS/c1-26-19(27-8-4-5-11(21)10-27)14(9-23-26)24-17(28)15-16(22)29-18(25-15)12-6-2-3-7-13(12)20/h2-3,6-7,9,11H,4-5,8,10,21-22H2,1H3,(H,24,28)/t11-/m0/s1 D0I0CN DRUGINKE OEPCHHARAQRIEP-NSHDSACASA-N D0I0CN DRUGSMIL CN1C(=C(C=N1)NC(=O)C2=C(SC(=N2)C3=CC=CC=C3F)N)N4CCCC(C4)N D0I0CN HIGHSTAT Patented D0I1LE DRUG__ID D0I1LE D0I1LE DRUGTYPE Small molecular drug D0I1LE DRUGINCH 1S/C16H21NO4/c1-16(2,3)12-6-4-5-7-13(12)21-11-9-17(10-11)14(18)8-15(19)20/h4-7,11H,8-10H2,1-3H3,(H,19,20) D0I1LE DRUGINKE VZDYQTRPYQHMNA-UHFFFAOYSA-N D0I1LE DRUGSMIL CC(C)(C)C1=CC=CC=C1OC2CN(C2)C(=O)CC(=O)O D0I1LE HIGHSTAT Patented D0I2AN DRUG__ID D0I2AN D0I2AN DRUGTYPE Small molecular drug D0I2AN DRUGINCH 1S/C28H20IN3O5S/c1-32-22-13-23(33)21(28(36)37)12-20(22)24(29)25(32)16-3-2-4-19(11-16)31-27(35)26(34)30-18-7-5-15(6-8-18)17-9-10-38-14-17/h2-14,33H,1H3,(H,30,34)(H,31,35)(H,36,37) D0I2AN DRUGINKE WILZWITYAQZYKV-UHFFFAOYSA-N D0I2AN DRUGSMIL CN1C2=CC(=C(C=C2C(=C1C3=CC(=CC=C3)NC(=O)C(=O)NC4=CC=C(C=C4)C5=CSC=C5)I)C(=O)O)O D0I2AN HIGHSTAT Patented D0I3PZ DRUG__ID D0I3PZ D0I3PZ DRUGTYPE Small molecular drug D0I3PZ DRUGINCH 1S/C26H25F3N6O4/c1-5-38-15-9-18(27)17(19(28)10-15)13-35-14(3)22(29)23(34-35)25-31-12-21(37-4)24(33-25)32-20-7-8-30-11-16(20)26(36)39-6-2/h7-12H,5-6,13H2,1-4H3,(H,30,31,32,33) D0I3PZ DRUGINKE GCVMXSOKVYMCOA-UHFFFAOYSA-N D0I3PZ DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C(=C(C(=N2)C3=NC=C(C(=N3)NC4=C(C=NC=C4)C(=O)OCC)OC)F)C)F D0I3PZ HIGHSTAT Patented D0I4PX DRUG__ID D0I4PX D0I4PX DRUGTYPE Small molecular drug D0I4PX DRUGINCH 1S/C31H26N4O5/c36-25(37)13-15-33-30(39)27-29(38)24-17-23(16-20-8-3-1-4-9-20)31(40)35(19-21-10-5-2-6-11-21)28(24)26(34-27)22-12-7-14-32-18-22/h1-12,14,17-18,38H,13,15-16,19H2,(H,33,39)(H,36,37) D0I4PX DRUGINKE DKTMWXXXKCITJR-UHFFFAOYSA-N D0I4PX DRUGSMIL C1=CC=C(C=C1)CC2=CC3=C(C(=NC(=C3O)C(=O)NCCC(=O)O)C4=CN=CC=C4)N(C2=O)CC5=CC=CC=C5 D0I4PX HIGHSTAT Patented D0I5SD DRUG__ID D0I5SD D0I5SD DRUGTYPE Small molecular drug D0I5SD DRUGINCH 1S/C23H21Cl2FN2O2S/c1-15-22(27-31(29,30)21-12-10-20(26)11-13-21)14-28(15)23(16-2-6-18(24)7-3-16)17-4-8-19(25)9-5-17/h2-13,15,22-23,27H,14H2,1H3/t15-,22?/m0/s1 D0I5SD DRUGINKE BNBGRXOGPFOPLL-UEDXYCIISA-N D0I5SD DRUGSMIL CC1C(CN1C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)NS(=O)(=O)C4=CC=C(C=C4)F D0I5SD HIGHSTAT Patented D0I5TH DRUG__ID D0I5TH D0I5TH DRUGTYPE Small molecular drug D0I5TH DRUGINCH 1S/C18H25N5O3S/c1-4-8-23(9-5-2)17-11-16(20-12-21-17)18(24)22-15-7-6-14(10-13(15)3)27(19,25)26/h6-7,10-12H,4-5,8-9H2,1-3H3,(H,22,24)(H2,19,25,26) D0I5TH DRUGINKE MHHFJYABEVJNEG-UHFFFAOYSA-N D0I5TH DRUGSMIL CCCN(CCC)C1=NC=NC(=C1)C(=O)NC2=C(C=C(C=C2)S(=O)(=O)N)C D0I5TH HIGHSTAT Patented D0IA4F DRUG__ID D0IA4F D0IA4F DRUGTYPE Small molecular drug D0IA4F DRUGINCH 1S/C17H14N4O3S2/c1-24-14-7-6-11(16-19-12-4-2-8-18-17(12)20-16)10-13(14)21-26(22,23)15-5-3-9-25-15/h2-10,21H,1H3,(H,18,19,20) D0IA4F DRUGINKE WCSLLVSWFDOVCR-UHFFFAOYSA-N D0IA4F DRUGSMIL COC1=C(C=C(C=C1)C2=NC3=C(N2)C=CC=N3)NS(=O)(=O)C4=CC=CS4 D0IA4F HIGHSTAT Patented D0IA7H DRUG__ID D0IA7H D0IA7H DRUGTYPE Small molecular drug D0IA7H DRUGINCH 1S/C24H25ClFN5O3/c25-15-3-4-19(26)17(9-15)21-10-22(23(12-28-21)31-7-1-2-8-31)30-20-5-6-27-11-18(20)24(34)29-16(13-32)14-33/h3-6,9-12,16,32-33H,1-2,7-8,13-14H2,(H,29,34)(H,27,28,30) D0IA7H DRUGINKE FDMRIXRWLAMVEF-UHFFFAOYSA-N D0IA7H DRUGSMIL C1CCN(C1)C2=CN=C(C=C2NC3=C(C=NC=C3)C(=O)NC(CO)CO)C4=C(C=CC(=C4)Cl)F D0IA7H HIGHSTAT Patented D0IB3Z DRUG__ID D0IB3Z D0IB3Z DRUGTYPE Small molecular drug D0IB3Z DRUGINCH 1S/C12H15NO4S/c1-16-7-3-4-8(10(5-7)17-2)11-13-9(6-18-11)12(14)15/h3-5,9,11,13H,6H2,1-2H3,(H,14,15)/t9-,11?/m0/s1 D0IB3Z DRUGINKE GXPHSEXJDZAWQX-FTNKSUMCSA-N D0IB3Z DRUGSMIL COC1=CC(=C(C=C1)C2NC(CS2)C(=O)O)OC D0IB3Z HIGHSTAT Patented D0IC5Y DRUG__ID D0IC5Y D0IC5Y DRUGTYPE Small molecular drug D0IC5Y DRUGINCH 1S/C21H30N2O4S/c1-13(2)11-28-12-19(22)21(26,20(24)25)10-17-16-9-15(6-5-14-3-4-14)27-18(16)7-8-23-17/h7-9,13-14,19,26H,3-6,10-12,22H2,1-2H3,(H,24,25)/t19-,21+/m0/s1 D0IC5Y DRUGINKE HMDRAHWGUKKPQA-PZJWPPBQSA-N D0IC5Y DRUGSMIL CC(C)CSCC(C(CC1=NC=CC2=C1C=C(O2)CCC3CC3)(C(=O)O)O)N D0IC5Y HIGHSTAT Patented D0IH6G DRUG__ID D0IH6G D0IH6G DRUGTYPE Small molecular drug D0IH6G DRUGINCH 1S/C13H15F3O2/c14-13(15,16)10-6-9(17)7-11(18)12(10)8-4-2-1-3-5-8/h6-8,17-18H,1-5H2 D0IH6G DRUGINKE BYAFHGYCRSXCQR-UHFFFAOYSA-N D0IH6G DRUGSMIL C1CCC(CC1)C2=C(C=C(C=C2O)O)C(F)(F)F D0IH6G HIGHSTAT Patented D0IL0J DRUG__ID D0IL0J D0IL0J DRUGTYPE Small molecular drug D0IL0J DRUGINCH 1S/C21H34NO5P/c1-2-26-11-3-4-16-5-6-18-13-19(8-7-17(18)12-16)20-9-10-21(22,14-20)15-27-28(23,24)25/h7-8,13,16,20H,2-6,9-12,14-15,22H2,1H3,(H2,23,24,25)/t16-,20+,21-/m1/s1 D0IL0J DRUGINKE VHKORLDZIRFKDI-TYCQWZJGSA-N D0IL0J DRUGSMIL CCOCCCC1CCC2=C(C1)C=CC(=C2)C3CCC(C3)(COP(=O)(O)O)N D0IL0J HIGHSTAT Patented D0IQ6R DRUG__ID D0IQ6R D0IQ6R DRUGTYPE Small molecular drug D0IQ6R DRUGINCH 1S/C26H34F3N7O2/c1-4-20-24(37)34(3)21-16-30-25(32-23(21)36(20)17-7-5-6-8-17)31-19-15-18(35-13-11-33(2)12-14-35)9-10-22(19)38-26(27,28)29/h9-10,15-17,20H,4-8,11-14H2,1-3H3,(H,30,31,32)/t20-/m1/s1 D0IQ6R DRUGINKE UKDYPCZCLRCOMP-HXUWFJFHSA-N D0IQ6R DRUGSMIL CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=CC(=C4)N5CCN(CC5)C)OC(F)(F)F)C D0IQ6R HIGHSTAT Patented D0IV0E DRUG__ID D0IV0E D0IV0E DRUGTYPE Small molecular drug D0IV0E DRUGINCH 1S/C18H24N4O/c1-18(2,3)14-6-4-5-7-16(14)21-8-10-22(11-9-21)17(23)15-12-19-13-20-15/h4-7,12-13H,8-11H2,1-3H3,(H,19,20) D0IV0E DRUGINKE DISALCDEOIPUGE-UHFFFAOYSA-N D0IV0E DRUGSMIL CC(C)(C)C1=CC=CC=C1N2CCN(CC2)C(=O)C3=CN=CN3 D0IV0E HIGHSTAT Patented D0J0BB DRUG__ID D0J0BB D0J0BB DRUGTYPE Small molecular drug D0J0BB DRUGINCH 1S/C11H9NO3S2/c1-15-8-3-2-6(4-7(8)13)5-9-10(14)12-11(16)17-9/h2-5,13H,1H3,(H,12,14,16)/b9-5- D0J0BB DRUGINKE PCTZLDOIVAVMME-UITAMQMPSA-N D0J0BB DRUGSMIL COC1=C(C=C(C=C1)C=C2C(=O)NC(=S)S2)O D0J0BB HIGHSTAT Patented D0J0UN DRUG__ID D0J0UN D0J0UN DRUGTYPE Small molecular drug D0J0UN DRUGINCH 1S/C23H26N6O2/c1-3-4-12-28-21(27-11-7-8-17(24)14-27)13-22(30)29(23(28)31)15-20-25-16(2)18-9-5-6-10-19(18)26-20/h5-6,9-10,13,17H,7-8,11-12,14-15,24H2,1-2H3/t17-/m1/s1 D0J0UN DRUGINKE GHHYMLIQMIXJDE-QGZVFWFLSA-N D0J0UN DRUGSMIL CC#CCN1C(=CC(=O)N(C1=O)CC2=NC3=CC=CC=C3C(=N2)C)N4CCCC(C4)N D0J0UN HIGHSTAT Patented D0J1LK DRUG__ID D0J1LK D0J1LK DRUGTYPE Small molecular drug D0J1LK DRUGINCH 1S/C21H18ClN5O2S/c22-14-5-1-12(2-6-14)9-26-20-17(18-23-11-24-27(18)21(26)29)15-7-8-25(10-16(15)30-20)19(28)13-3-4-13/h1-2,5-6,11,13H,3-4,7-10H2 D0J1LK DRUGINKE FYTZTJBBBNSPSE-UHFFFAOYSA-N D0J1LK DRUGSMIL C1CC1C(=O)N2CCC3=C(C2)SC4=C3C5=NC=NN5C(=O)N4CC6=CC=C(C=C6)Cl D0J1LK HIGHSTAT Patented D0J5XM DRUG__ID D0J5XM D0J5XM DRUGTYPE Small molecular drug D0J5XM DRUGINCH 1S/C23H19Cl3N4/c1-23(2,3)22-29-20(27)17-11-16(12-4-6-13(24)7-5-12)19(28-21(17)30-22)15-9-8-14(25)10-18(15)26/h4-11H,1-3H3,(H2,27,28,29,30) D0J5XM DRUGINKE QVFUKBUINZLPLW-UHFFFAOYSA-N D0J5XM DRUGSMIL CC(C)(C)C1=NC2=NC(=C(C=C2C(=N1)N)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl D0J5XM HIGHSTAT Patented D0J5YV DRUG__ID D0J5YV D0J5YV DRUGTYPE Small molecular drug D0J5YV DRUGINCH 1S/C19H20Cl2N6O2/c1-5-6-27-18-17(11(4)25-27)13(10(2)3)9-16(24-18)29-26-19(28)22-12-7-14(20)23-15(21)8-12/h5,7-10H,1,6H2,2-4H3,(H2,22,23,26,28) D0J5YV DRUGINKE GSDSPSURUKLGBL-UHFFFAOYSA-N D0J5YV DRUGSMIL CC1=NN(C2=C1C(=CC(=N2)ONC(=O)NC3=CC(=NC(=C3)Cl)Cl)C(C)C)CC=C D0J5YV HIGHSTAT Patented D0J6BK DRUG__ID D0J6BK D0J6BK DRUGTYPE Small molecular drug D0J6BK DRUGINCH 1S/C12H19N6O6P/c13-12-15-10-9(11(21)16-12)14-7-18(10)4-3-17(2-1-8(19)20)5-6-25(22,23)24/h7,9H,1-6H2,(H,19,20)(H2,13,16,21)(H2,22,23,24) D0J6BK DRUGINKE LUBVDKAUBOMGNH-UHFFFAOYSA-N D0J6BK DRUGSMIL C1=NC2C(=NC(=NC2=O)N)N1CCN(CCC(=O)O)CCP(=O)(O)O D0J6BK HIGHSTAT Patented D0J6DS DRUG__ID D0J6DS D0J6DS DRUGTYPE Small molecular drug D0J6DS DRUGINCH 1S/C10H11NO4S/c12-5-1-2-6(8(13)3-5)9-11-7(4-16-9)10(14)15/h1-3,7,9,11-13H,4H2,(H,14,15)/t7-,9?/m0/s1 D0J6DS DRUGINKE GYBITJROHWLVSE-JAVCKPHESA-N D0J6DS DRUGSMIL C1C(NC(S1)C2=C(C=C(C=C2)O)O)C(=O)O D0J6DS HIGHSTAT Patented D0J6HN DRUG__ID D0J6HN D0J6HN DRUGTYPE Small molecular drug D0J6HN DRUGINCH 1S/C23H22F3N5O2/c1-12-10-31(11-16(27)22(12)32)19-7-8-28-9-18(19)30-23(33)17-6-5-15(26)21(29-17)20-13(24)3-2-4-14(20)25/h2-9,12,16,22,32H,10-11,27H2,1H3,(H,30,33)/t12-,16+,22+/m0/s1 D0J6HN DRUGINKE ODZZYKUYGVLOTQ-ONJZCGHCSA-N D0J6HN DRUGSMIL CC1CN(CC(C1O)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F D0J6HN HIGHSTAT Patented D0J9YV DRUG__ID D0J9YV D0J9YV DRUGTYPE Small molecular drug D0J9YV DRUGINCH 1S/C19H21FN2O2/c1-19(2,3)15-10-13(20)7-8-17(15)24-14-11-22(12-14)18(23)16-6-4-5-9-21-16/h4-10,14H,11-12H2,1-3H3 D0J9YV DRUGINKE NKBTZZMPHFITPK-UHFFFAOYSA-N D0J9YV DRUGSMIL CC(C)(C)C1=C(C=CC(=C1)F)OC2CN(C2)C(=O)C3=CC=CC=N3 D0J9YV HIGHSTAT Patented D0J9YX DRUG__ID D0J9YX D0J9YX DRUGTYPE Small molecular drug D0J9YX DRUGINCH 1S/C16H13N7O2/c1-25-11-5-3-10(4-6-11)23-13(24)9-12-14(22-23)15(21-20-12)19-16-17-7-2-8-18-16/h2-9,20H,1H3,(H,17,18,19,21) D0J9YX DRUGINKE SSEXHPVKWUREDI-UHFFFAOYSA-N D0J9YX DRUGSMIL COC1=CC=C(C=C1)N2C(=O)C=C3C(=N2)C(=NN3)NC4=NC=CC=N4 D0J9YX HIGHSTAT Patented D0JA0A DRUG__ID D0JA0A D0JA0A DRUGTYPE Small molecular drug D0JA0A DRUGINCH 1S/C27H31N3O4/c1-2-5-25(19-8-10-20(11-9-19)27(33)28-17-16-26(31)32)34-23-14-12-22(13-15-23)30-18-21-6-3-4-7-24(21)29-30/h8-15,18,25H,2-7,16-17H2,1H3,(H,28,33)(H,31,32) D0JA0A DRUGINKE BFFBGZWQVKRFRU-UHFFFAOYSA-N D0JA0A DRUGSMIL CCCC(C1=CC=C(C=C1)C(=O)NCCC(=O)O)OC2=CC=C(C=C2)N3C=C4CCCCC4=N3 D0JA0A HIGHSTAT Patented D0JC3U DRUG__ID D0JC3U D0JC3U DRUGTYPE Small molecular drug D0JC3U DRUGINCH 1S/C12H12O3/c13-10-5-3-9(12(14)8-10)4-6-11-2-1-7-15-11/h1-3,5,7-8,13-14H,4,6H2 D0JC3U DRUGINKE DRPCFXFFIMCRRN-UHFFFAOYSA-N D0JC3U DRUGSMIL C1=COC(=C1)CCC2=C(C=C(C=C2)O)O D0JC3U HIGHSTAT Patented D0JL8G DRUG__ID D0JL8G D0JL8G DRUGTYPE Small molecular drug D0JL8G DRUGINCH 1S/C21H23N9/c1-2-24-19-14-23-13-17(27-19)16-10-18-15(11-25-16)12-26-30(18)21-5-3-4-20(28-21)29-8-6-22-7-9-29/h3-5,10-14,22H,2,6-9H2,1H3,(H,24,27) D0JL8G DRUGINKE XXIAOEADCPRWAT-UHFFFAOYSA-N D0JL8G DRUGSMIL CCNC1=NC(=CN=C1)C2=NC=C3C=NN(C3=C2)C4=NC(=CC=C4)N5CCNCC5 D0JL8G HIGHSTAT Patented D0JR0P DRUG__ID D0JR0P D0JR0P DRUGTYPE Small molecular drug D0JR0P DRUGINCH 1S/C11H8N2O5/c14-7-2-1-5(4-8(7)15)3-6-9(16)12-11(18)13-10(6)17/h1-4,14-15H,(H2,12,13,16,17,18) D0JR0P DRUGINKE PJCLRLDOILEINS-UHFFFAOYSA-N D0JR0P DRUGSMIL C1=CC(=C(C=C1C=C2C(=O)NC(=O)NC2=O)O)O D0JR0P HIGHSTAT Patented D0JR2Q DRUG__ID D0JR2Q D0JR2Q DRUGTYPE Small molecular drug D0JR2Q DRUGINCH 1S/C14H12N2O5/c17-11-6-10(21-9-4-2-1-3-5-9)7-15-13(11)14(20)16-8-12(18)19/h1-7,17H,8H2,(H,16,20)(H,18,19) D0JR2Q DRUGINKE SUWPOWJCFOLJFD-UHFFFAOYSA-N D0JR2Q DRUGSMIL C1=CC=C(C=C1)OC2=CC(=C(N=C2)C(=O)NCC(=O)O)O D0JR2Q HIGHSTAT Patented D0JW7T DRUG__ID D0JW7T D0JW7T DRUGTYPE Small molecular drug D0JW7T DRUGINCH 1S/C22H22Cl3N3O/c1-3-4-5-12-26-22(29)20-14(2)21(15-6-8-16(23)9-7-15)28(27-20)19-11-10-17(24)13-18(19)25/h6-11,13H,3-5,12H2,1-2H3,(H,26,29) D0JW7T DRUGINKE JDBOTXIRNSWBCG-UHFFFAOYSA-N D0JW7T DRUGSMIL CCCCCNC(=O)C1=NN(C(=C1C)C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl D0JW7T HIGHSTAT Patented D0K0IZ DRUG__ID D0K0IZ D0K0IZ DRUGTYPE Small molecular drug D0K0IZ DRUGINCH 1S/C20H18F5N5O/c21-14-2-1-12(16(17(14)22)20(23,24)25)11-3-7-30(8-4-11)19(31)18-13-5-6-29(10-26)9-15(13)27-28-18/h1-2,11H,3-9H2,(H,27,28) D0K0IZ DRUGINKE TXJTYIKCTGYLBH-UHFFFAOYSA-N D0K0IZ DRUGSMIL C1CN(CCC1C2=C(C(=C(C=C2)F)F)C(F)(F)F)C(=O)C3=NNC4=C3CCN(C4)C#N D0K0IZ HIGHSTAT Patented D0K2YO DRUG__ID D0K2YO D0K2YO DRUGTYPE Small molecular drug D0K2YO DRUGINCH 1S/C17H19NO2S2/c19-22(20,16-6-3-9-21-16)18-17-14-7-8-15(17)11-13-5-2-1-4-12(13)10-14/h1-6,9,14-15,17-18H,7-8,10-11H2 D0K2YO DRUGINKE IFPBWXNUXWIDSN-UHFFFAOYSA-N D0K2YO DRUGSMIL C1CC2CC3=CC=CC=C3CC1C2NS(=O)(=O)C4=CC=CS4 D0K2YO HIGHSTAT Patented D0K3BR DRUG__ID D0K3BR D0K3BR DRUGTYPE Small molecular drug D0K3BR DRUGINCH 1S/C21H15ClN6/c22-14-5-3-13(4-6-14)10-25-21-26-11-17-15-7-9-23-12-18(15)27-20-16(19(17)28-21)2-1-8-24-20/h1-9,11-12H,10H2,(H,24,27)(H,25,26,28) D0K3BR DRUGINKE PBJUHSSYAPBPIB-UHFFFAOYSA-N D0K3BR DRUGSMIL C1=CC2=C(NC3=C(C=CN=C3)C4=CN=C(N=C24)NCC5=CC=C(C=C5)Cl)N=C1 D0K3BR HIGHSTAT Patented D0K3FJ DRUG__ID D0K3FJ D0K3FJ DRUGTYPE Small molecular drug D0K3FJ DRUGINCH 1S/C23H23Cl2IN4O/c1-14-21(29-23(31)27-17-5-3-2-4-6-17)28-22(19-12-7-15(24)13-20(19)25)30(14)18-10-8-16(26)9-11-18/h7-13,17H,2-6H2,1H3,(H2,27,29,31) D0K3FJ DRUGINKE KINYNFFISOBDBZ-UHFFFAOYSA-N D0K3FJ DRUGSMIL CC1=C(N=C(N1C2=CC=C(C=C2)I)C3=C(C=C(C=C3)Cl)Cl)NC(=O)NC4CCCCC4 D0K3FJ HIGHSTAT Patented D0K3IO DRUG__ID D0K3IO D0K3IO DRUGTYPE Small molecular drug D0K3IO DRUGINCH 1S/C20H22FN3O6S/c1-20(2,19(29)24-13(9-25)17(26)27)8-11-4-6-15(31-11)18(28)30-14-5-3-10(16(22)23)7-12(14)21/h3-7,13,25H,8-9H2,1-2H3,(H3,22,23)(H,24,29)(H,26,27)/t13-/m0/s1 D0K3IO DRUGINKE PGOXWLZRNRRTHV-ZDUSSCGKSA-N D0K3IO DRUGSMIL CC(C)(CC1=CC=C(S1)C(=O)OC2=C(C=C(C=C2)C(=N)N)F)C(=O)NC(CO)C(=O)O D0K3IO HIGHSTAT Patented D0K4BI DRUG__ID D0K4BI D0K4BI DRUGTYPE Small molecular drug D0K4BI DRUGINCH 1S/C17H19Cl2N7O/c1-8(2)11-7-14(22-16-15(11)9(3)25-26(16)4)23-24-17(27)20-10-5-12(18)21-13(19)6-10/h5-8H,1-4H3,(H,22,23)(H2,20,21,24,27) D0K4BI DRUGINKE RNSLRQNDXRSASX-UHFFFAOYSA-N D0K4BI DRUGSMIL CC1=NN(C2=C1C(=CC(=N2)NNC(=O)NC3=CC(=NC(=C3)Cl)Cl)C(C)C)C D0K4BI HIGHSTAT Patented D0K4LW DRUG__ID D0K4LW D0K4LW DRUGTYPE Small molecular drug D0K4LW DRUGINCH 1S/C18H16FN3O4/c19-15-3-1-12(2-4-15)11-26-17-14(6-8-23)10-21-22(17)16-9-13(18(24)25)5-7-20-16/h1-5,7,9-10,23H,6,8,11H2,(H,24,25) D0K4LW DRUGINKE MAYCQAAYKTWJKJ-UHFFFAOYSA-N D0K4LW DRUGSMIL C1=CC(=CC=C1COC2=C(C=NN2C3=NC=CC(=C3)C(=O)O)CCO)F D0K4LW HIGHSTAT Patented D0K5JG DRUG__ID D0K5JG D0K5JG DRUGTYPE Small molecular drug D0K5JG DRUGINCH 1S/C11H8N2O5/c14-6-2-1-5(8(15)4-6)3-7-9(16)12-11(18)13-10(7)17/h1-4,14-15H,(H2,12,13,16,17,18) D0K5JG DRUGINKE XGRANFKYXNDTDO-UHFFFAOYSA-N D0K5JG DRUGSMIL C1=CC(=C(C=C1O)O)C=C2C(=O)NC(=O)NC2=O D0K5JG HIGHSTAT Patented D0K5UR DRUG__ID D0K5UR D0K5UR DRUGTYPE Small molecular drug D0K5UR DRUGINCH 1S/C21H21N3O6/c1-13-2-7-17(22-10-13)30-15-5-3-14(4-6-15)12-24-9-8-16(25)19(21(24)29)20(28)23-11-18(26)27/h2-7,10,25H,8-9,11-12H2,1H3,(H,23,28)(H,26,27) D0K5UR DRUGINKE FHMUUXWOUSOEJQ-UHFFFAOYSA-N D0K5UR DRUGSMIL CC1=CN=C(C=C1)OC2=CC=C(C=C2)CN3CCC(=C(C3=O)C(=O)NCC(=O)O)O D0K5UR HIGHSTAT Patented D0K6TN DRUG__ID D0K6TN D0K6TN DRUGTYPE Small molecular drug D0K6TN DRUGINCH 1S/C13H18O2/c1-9-7-11(14)8-12(15)13(9)10-5-3-2-4-6-10/h7-8,10,14-15H,2-6H2,1H3 D0K6TN DRUGINKE NZLWYNBRWDATJO-UHFFFAOYSA-N D0K6TN DRUGSMIL CC1=CC(=CC(=C1C2CCCCC2)O)O D0K6TN HIGHSTAT Patented D0K8EF DRUG__ID D0K8EF D0K8EF DRUGTYPE Small molecular drug D0K8EF DRUGINCH 1S/C33H39FN8O3/c1-4-5-10-29-27(17-22-12-11-21(18-28(22)34)25-8-6-7-9-26(25)30-37-39-40-38-30)31(43)41(32-35-20-36-42(29)32)23-13-15-24(16-14-23)45-19-33(2,3)44/h6-9,11-12,18,20,23-24,44H,4-5,10,13-17,19H2,1-3H3,(H,37,38,39,40) D0K8EF DRUGINKE LXXPRMLBRPJLIY-UHFFFAOYSA-N D0K8EF DRUGSMIL CCCCC1=C(C(=O)N(C2=NC=NN12)C3CCC(CC3)OCC(C)(C)O)CC4=C(C=C(C=C4)C5=CC=CC=C5C6=NNN=N6)F D0K8EF HIGHSTAT Patented D0K8FK DRUG__ID D0K8FK D0K8FK DRUGTYPE Small molecular drug D0K8FK DRUGINCH 1S/C29H30F2N2O2/c1-4-14-35-22-11-12-23-26(16-22)33(18-20-8-6-5-7-9-20)28(19(2)3)27(23)29(34)32-17-21-10-13-24(30)25(31)15-21/h5-13,15-16,19H,4,14,17-18H2,1-3H3,(H,32,34) D0K8FK DRUGINKE AFDUGVKJXKJJMO-UHFFFAOYSA-N D0K8FK DRUGSMIL CCCOC1=CC2=C(C=C1)C(=C(N2CC3=CC=CC=C3)C(C)C)C(=O)NCC4=CC(=C(C=C4)F)F D0K8FK HIGHSTAT Patented D0K8GC DRUG__ID D0K8GC D0K8GC DRUGTYPE Small molecular drug D0K8GC DRUGINCH 1S/C19H20F3N5O2S/c1-11(2)16-17-24-13-5-4-12(30(3,28)29)10-14(13)26(17)8-9-27(16)18-23-7-6-15(25-18)19(20,21)22/h4-7,10-11,16H,8-9H2,1-3H3 D0K8GC DRUGINKE SEQLXXRHDQNPMX-UHFFFAOYSA-N D0K8GC DRUGSMIL CC(C)C1C2=NC3=C(N2CCN1C4=NC=CC(=N4)C(F)(F)F)C=C(C=C3)S(=O)(=O)C D0K8GC HIGHSTAT Patented D0KF0D DRUG__ID D0KF0D D0KF0D DRUGTYPE Small molecular drug D0KF0D DRUGINCH 1S/C11H7BrO4/c1-5-6-2-3-8(14)7(4-13)10(6)16-11(15)9(5)12/h2-4,14H,1H3 D0KF0D DRUGINKE YMUFHKSSNMFQIZ-UHFFFAOYSA-N D0KF0D DRUGSMIL CC1=C(C(=O)OC2=C1C=CC(=C2C=O)O)Br D0KF0D HIGHSTAT Patented D0KG9M DRUG__ID D0KG9M D0KG9M DRUGTYPE Small molecular drug D0KG9M DRUGINCH 1S/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12H D0KG9M DRUGINKE RJIWZDNTCBHXAL-UHFFFAOYSA-N D0KG9M DRUGSMIL C1=CC2=C(C=CC(=C2N=C1)O)[N+](=O)[O-] D0KG9M HIGHSTAT Patented D0KJ9U DRUG__ID D0KJ9U D0KJ9U DRUGTYPE Small molecular drug D0KJ9U DRUGINCH 1S/C23H26ClN3O4/c1-28-21-14-18(6-9-20(21)30-13-12-27-10-2-3-11-27)23-25-22(31-26-23)16-29-15-17-4-7-19(24)8-5-17/h4-9,14H,2-3,10-13,15-16H2,1H3 D0KJ9U DRUGINKE KTSBQVGVFAEOBK-UHFFFAOYSA-N D0KJ9U DRUGSMIL COC1=C(C=CC(=C1)C2=NOC(=N2)COCC3=CC=C(C=C3)Cl)OCCN4CCCC4 D0KJ9U HIGHSTAT Patented D0KO5D DRUG__ID D0KO5D D0KO5D DRUGTYPE Small molecular drug D0KO5D DRUGINCH 1S/C20H23ClN4O2/c21-17-5-2-1-4-16(17)18-6-3-11-25(18)19(26)13-24-20(27)23-12-14-7-9-15(22)10-8-14/h1-2,4-5,7-10,18H,3,6,11-13,22H2,(H2,23,24,27) D0KO5D DRUGINKE HPUOXERGZUDYRB-UHFFFAOYSA-N D0KO5D DRUGSMIL C1CC(N(C1)C(=O)CNC(=O)NCC2=CC=C(C=C2)N)C3=CC=CC=C3Cl D0KO5D HIGHSTAT Patented D0KU5J DRUG__ID D0KU5J D0KU5J DRUGTYPE Small molecular drug D0KU5J DRUGINCH 1S/C12H10O4/c13-7-1-3-9(11(15)5-7)10-4-2-8(14)6-12(10)16/h1-6,13-16H D0KU5J DRUGINKE CFGDTWRKBRQUFB-UHFFFAOYSA-N D0KU5J DRUGSMIL C1=CC(=C(C=C1O)O)C2=C(C=C(C=C2)O)O D0KU5J HIGHSTAT Patented D0KZ0M DRUG__ID D0KZ0M D0KZ0M DRUGTYPE Small molecular drug D0KZ0M DRUGINCH 1S/C29H31N3O7S/c30-28(38)22(11-14-26(34)35)32-29(39)23(12-15-27(36)37)31-25(33)13-8-18-6-9-20(10-7-18)24-16-21(17-40-24)19-4-2-1-3-5-19/h1-7,9-10,16-17,22-23H,8,11-15H2,(H2,30,38)(H,31,33)(H,32,39)(H,34,35)(H,36,37)/t22-,23-/m0/s1 D0KZ0M DRUGINKE MMIHYNVQXYWTFM-GOTSBHOMSA-N D0KZ0M DRUGSMIL C1=CC=C(C=C1)C2=CSC(=C2)C3=CC=C(C=C3)CCC(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N D0KZ0M HIGHSTAT Patented D0L0CV DRUG__ID D0L0CV D0L0CV DRUGTYPE Small molecular drug D0L0CV DRUGINCH 1S/C18H24N2/c1-19(2)13-14-20(15-17-9-5-3-6-10-17)16-18-11-7-4-8-12-18/h3-12H,13-16H2,1-2H3 D0L0CV DRUGINKE XFOYZAKVZYMLET-UHFFFAOYSA-N D0L0CV DRUGSMIL CN(C)CCN(CC1=CC=CC=C1)CC2=CC=CC=C2 D0L0CV HIGHSTAT Patented D0L2FW DRUG__ID D0L2FW D0L2FW DRUGTYPE Small molecular drug D0L2FW DRUGINCH 1S/C15H13N3O/c1-19-14-5-3-2-4-11(14)10-6-7-13-12(8-10)15(16)18-9-17-13/h2-9H,1H3,(H2,16,17,18) D0L2FW DRUGINKE CUSAKFRCIPMPMS-UHFFFAOYSA-N D0L2FW DRUGSMIL COC1=CC=CC=C1C2=CC3=C(C=C2)N=CN=C3N D0L2FW HIGHSTAT Patented D0L3TL DRUG__ID D0L3TL D0L3TL DRUGTYPE Small molecular drug D0L3TL DRUGINCH 1S/C11H17N4O14P3/c1-10(18)8(16)6(4-26-31(22,23)29-32(24,25)28-30(19,20)21)27-11(10,5-12)15-3-2-7(13)14-9(15)17/h2-3,6,8,16,18H,4H2,1H3,(H,22,23)(H,24,25)(H2,13,14,17)(H2,19,20,21)/t6-,8-,10-,11-/m0/s1 D0L3TL DRUGINKE KAONGDYMRWWDBJ-SEZOGAINSA-N D0L3TL DRUGSMIL CC1(C(C(OC1(C#N)N2C=CC(=NC2=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D0L3TL HIGHSTAT Patented D0L4EU DRUG__ID D0L4EU D0L4EU DRUGTYPE Small molecular drug D0L4EU DRUGINCH 1S/C20H18ClN3O3/c21-13-6-3-5-12(11-13)18(25)16-9-4-10-24(16)20(27)17-19(26)23-15-8-2-1-7-14(15)22-17/h1-3,5-8,11,16,18,25H,4,9-10H2,(H,23,26) D0L4EU DRUGINKE FORQANAYPSMAGB-UHFFFAOYSA-N D0L4EU DRUGSMIL C1CC(N(C1)C(=O)C2=NC3=CC=CC=C3NC2=O)C(C4=CC(=CC=C4)Cl)O D0L4EU HIGHSTAT Patented D0L5AE DRUG__ID D0L5AE D0L5AE DRUGTYPE Small molecular drug D0L5AE DRUGINCH 1S/C28H34N6O2S/c1-32-18-28(29-31-32)37(35,36)30-23-16-33(17-23)24-9-7-20-8-10-27(34-14-21-12-22(21)15-34)26(25(20)13-24)11-19-5-3-2-4-6-19/h2-7,9,13,18,21-23,26-27,30H,8,10-12,14-17H2,1H3/t21?,22?,26-,27+/m1/s1 D0L5AE DRUGINKE RWNRNSRLIFLPBC-PGJSQRTPSA-N D0L5AE DRUGSMIL CN1C=C(N=N1)S(=O)(=O)NC2CN(C2)C3=CC4=C(CCC(C4CC5=CC=CC=C5)N6CC7CC7C6)C=C3 D0L5AE HIGHSTAT Patented D0L5RA DRUG__ID D0L5RA D0L5RA DRUGTYPE Small molecular drug D0L5RA DRUGINCH 1S/C28H31N3O6/c1-36-27(33)16-15-26(32)31(35)18-5-4-17-29-19-21-11-13-22(14-12-21)20-37-28(34)30-25-10-6-8-23-7-2-3-9-24(23)25/h2-3,6-16,29,35H,4-5,17-20H2,1H3,(H,30,34)/b16-15+ D0L5RA DRUGINKE MUJOCHRZXRZONW-FOCLMDBBSA-N D0L5RA DRUGSMIL COC(=O)C=CC(=O)N(CCCCNCC1=CC=C(C=C1)COC(=O)NC2=CC=CC3=CC=CC=C32)O D0L5RA HIGHSTAT Patented D0L5VH DRUG__ID D0L5VH D0L5VH DRUGTYPE Small molecular drug D0L5VH DRUGINCH 1S/C22H20ClF3N2O4/c1-32-17-8-14(10-27-18(17)19(29)15-9-16(15)21(30)31)28(13-6-4-12(23)5-7-13)20(11-2-3-11)22(24,25)26/h4-8,10-11,15-16,20H,2-3,9H2,1H3,(H,30,31) D0L5VH DRUGINKE LWAUMGSKFOFDCB-UHFFFAOYSA-N D0L5VH DRUGSMIL COC1=C(N=CC(=C1)N(C2=CC=C(C=C2)Cl)C(C3CC3)C(F)(F)F)C(=O)C4CC4C(=O)O D0L5VH HIGHSTAT Patented D0L7YW DRUG__ID D0L7YW D0L7YW DRUGTYPE Small molecular drug D0L7YW DRUGINCH 1S/C19H16FN3O/c20-19-15(7-4-10-22-19)16-11-18(23-17-8-3-6-14(16)17)24-12-13-5-1-2-9-21-13/h1-2,4-5,7,9-11H,3,6,8,12H2 D0L7YW DRUGINKE NKDIYHWBHMMBTN-UHFFFAOYSA-N D0L7YW DRUGSMIL C1CC2=C(C1)N=C(C=C2C3=C(N=CC=C3)F)OCC4=CC=CC=N4 D0L7YW HIGHSTAT Patented D0L8BY DRUG__ID D0L8BY D0L8BY DRUGTYPE Small molecular drug D0L8BY DRUGINCH 1S/C20H20FN3O7S/c1-9-6-15(20(30)31-13-3-2-10(18(22)23)7-11(13)21)32-14(9)4-5-16(25)24-12(19(28)29)8-17(26)27/h2-3,6-7,12H,4-5,8H2,1H3,(H3,22,23)(H,24,25)(H,26,27)(H,28,29)/t12-/m0/s1 D0L8BY DRUGINKE KUFWXCZSAUGMIW-LBPRGKRZSA-N D0L8BY DRUGSMIL CC1=C(SC(=C1)C(=O)OC2=C(C=C(C=C2)C(=N)N)F)CCC(=O)NC(CC(=O)O)C(=O)O D0L8BY HIGHSTAT Patented D0L9XU DRUG__ID D0L9XU D0L9XU DRUGTYPE Small molecular drug D0L9XU DRUGINCH 1S/C22H22N2O7/c1-30-16-3-2-4-17(11-16)31-15-7-5-14(6-8-15)13-24-10-9-18(25)20(22(24)29)21(28)23-12-19(26)27/h2-8,11,25H,9-10,12-13H2,1H3,(H,23,28)(H,26,27) D0L9XU DRUGINKE ZKPWKTAYUOZETR-UHFFFAOYSA-N D0L9XU DRUGSMIL COC1=CC(=CC=C1)OC2=CC=C(C=C2)CN3CCC(=C(C3=O)C(=O)NCC(=O)O)O D0L9XU HIGHSTAT Patented D0LA9D DRUG__ID D0LA9D D0LA9D DRUGTYPE Small molecular drug D0LA9D DRUGINCH 1S/C17H17F3N2O3/c1-11-2-5-15(25-11)16(23)21-13-10-12(17(18,19)20)3-4-14(13)22-6-8-24-9-7-22/h2-5,10H,6-9H2,1H3,(H,21,23) D0LA9D DRUGINKE FZCPNRVICXFZJR-UHFFFAOYSA-N D0LA9D DRUGSMIL CC1=CC=C(O1)C(=O)NC2=C(C=CC(=C2)C(F)(F)F)N3CCOCC3 D0LA9D HIGHSTAT Patented D0LF0B DRUG__ID D0LF0B D0LF0B DRUGTYPE Small molecular drug D0LF0B DRUGINCH 1S/C13H13N3O2/c1-16-12(17)11(15-13(16)18)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,11,14H,6H2,1H3,(H,15,18) D0LF0B DRUGINKE PANAMPMZPUJRLL-UHFFFAOYSA-N D0LF0B DRUGSMIL CN1C(=O)C(NC1=O)CC2=CNC3=CC=CC=C32 D0LF0B HIGHSTAT Patented D0LG1I DRUG__ID D0LG1I D0LG1I DRUGTYPE Small molecular drug D0LG1I DRUGINCH 1S/C25H25N5O2/c26-17-20-4-3-15-30(20)25(31)23(27)16-18-6-10-21(11-7-18)32-22-12-8-19(9-13-22)29-24-5-1-2-14-28-24/h1-2,5-14,20,23H,3-4,15-16,27H2,(H,28,29)/t20?,23-/m0/s1 D0LG1I DRUGINKE UTSGGYFCIGGJDF-AKRCKQFNSA-N D0LG1I DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)OC3=CC=C(C=C3)NC4=CC=CC=N4)N)C#N D0LG1I HIGHSTAT Patented D0LK3O DRUG__ID D0LK3O D0LK3O DRUGTYPE Small molecular drug D0LK3O DRUGINCH 1S/C30H33F3N4O4/c1-16-11-17(12-23(34)28(16)40-2)19-5-8-35-15-25(19)37-29(38)24-4-3-20(31)27(36-24)26-21(32)13-18(14-22(26)33)30(39)6-9-41-10-7-30/h3-5,8,13-17,23,28,39H,6-7,9-12,34H2,1-2H3,(H,37,38)/t16-,17+,23+,28+/m0/s1 D0LK3O DRUGINKE KRXHIAQHNCEJEE-XCPDJCNPSA-N D0LK3O DRUGSMIL CC1CC(CC(C1OC)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=C(C=C4F)C5(CCOCC5)O)F D0LK3O HIGHSTAT Patented D0LL1P DRUG__ID D0LL1P D0LL1P DRUGTYPE Small molecular drug D0LL1P DRUGINCH 1S/C23H27ClF3N3O3S/c1-3-34(32,33)21-7-6-19(24)12-18(21)14-28-22(31)16-4-5-17(20(13-16)23(25,26)27)15-30-10-8-29(2)9-11-30/h4-7,12-13H,3,8-11,14-15H2,1-2H3,(H,28,31) D0LL1P DRUGINKE VAPBGCRAUJRZPO-UHFFFAOYSA-N D0LL1P DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CNC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F D0LL1P HIGHSTAT Patented D0LO2C DRUG__ID D0LO2C D0LO2C DRUGTYPE Small molecular drug D0LO2C DRUGINCH 1S/C20H18N2O6/c1-11-16-9-14(28-13-5-3-12(27-2)4-6-13)7-8-15(16)19(25)18(22-11)20(26)21-10-17(23)24/h3-9,25H,10H2,1-2H3,(H,21,26)(H,23,24) D0LO2C DRUGINKE JPXYINYXIDIDQY-UHFFFAOYSA-N D0LO2C DRUGSMIL CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=C(C=C3)OC D0LO2C HIGHSTAT Patented D0LS4Y DRUG__ID D0LS4Y D0LS4Y DRUGTYPE Small molecular drug D0LS4Y DRUGINCH 1S/C14H11BrClNO3S/c1-8-2-4-10(11(15)6-8)14(18)9-3-5-12(16)13(7-9)21(17,19)20/h2-7H,1H3,(H2,17,19,20) D0LS4Y DRUGINKE IWYFDCPQQNBMTJ-UHFFFAOYSA-N D0LS4Y DRUGSMIL CC1=CC(=C(C=C1)C(=O)C2=CC(=C(C=C2)Cl)S(=O)(=O)N)Br D0LS4Y HIGHSTAT Patented D0LT2N DRUG__ID D0LT2N D0LT2N DRUGTYPE Small molecular drug D0LT2N DRUGINCH 1S/C20H26N4O2/c1-3-24(15-7-5-4-6-8-15)19-12-18(21-13-22-19)20(26)23-17-10-9-16(25)11-14(17)2/h9-13,15,25H,3-8H2,1-2H3,(H,23,26) D0LT2N DRUGINKE ZNFTXQFGUIKQQE-UHFFFAOYSA-N D0LT2N DRUGSMIL CCN(C1CCCCC1)C2=NC=NC(=C2)C(=O)NC3=C(C=C(C=C3)O)C D0LT2N HIGHSTAT Patented D0LT5U DRUG__ID D0LT5U D0LT5U DRUGTYPE Small molecular drug D0LT5U DRUGINCH 1S/C23H24FNO3/c24-20-4-2-1-3-18(20)7-5-17-6-8-19-21(15-17)28-16-23(19)10-13-25(14-11-23)12-9-22(26)27/h1-8,15H,9-14,16H2,(H,26,27)/b7-5+ D0LT5U DRUGINKE SWXZUILIRNOBES-FNORWQNLSA-N D0LT5U DRUGSMIL C1CN(CCC12COC3=C2C=CC(=C3)C=CC4=CC=CC=C4F)CCC(=O)O D0LT5U HIGHSTAT Patented D0LX6X DRUG__ID D0LX6X D0LX6X DRUGTYPE Small molecular drug D0LX6X DRUGINCH 1S/C18H10N2O/c21-18-13-6-2-4-8-15(13)20-10-9-12-11-5-1-3-7-14(11)19-16(12)17(18)20/h1-10H/p+1 D0LX6X DRUGINKE WYQIPCUPNMRAKP-UHFFFAOYSA-O D0LX6X DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C4=[N+](C=C3)C5=CC=CC=C5C4=O D0LX6X HIGHSTAT Patented D0M0TH DRUG__ID D0M0TH D0M0TH DRUGTYPE Small molecular drug D0M0TH DRUGINCH 1S/C21H12F2N2O/c22-13-2-3-14(18(23)8-13)11-1-6-19-17(7-11)16-5-4-15-12(10-26)9-24-20(15)21(16)25-19/h1-10,24-25H D0M0TH DRUGINKE BFWHRHJPPAUSLJ-UHFFFAOYSA-N D0M0TH DRUGSMIL C1=CC2=C(C=C1C3=C(C=C(C=C3)F)F)C4=C(N2)C5=C(C=C4)C(=CN5)C=O D0M0TH HIGHSTAT Patented D0M2OY DRUG__ID D0M2OY D0M2OY DRUGTYPE Small molecular drug D0M2OY DRUGINCH 1S/C12H17N3O3/c1-2-18-11(16)8-15-12(17)14-7-9-3-5-10(13)6-4-9/h3-6H,2,7-8,13H2,1H3,(H2,14,15,17) D0M2OY DRUGINKE UCMPTJMHPJQEED-UHFFFAOYSA-N D0M2OY DRUGSMIL CCOC(=O)CNC(=O)NCC1=CC=C(C=C1)N D0M2OY HIGHSTAT Patented D0M2TO DRUG__ID D0M2TO D0M2TO DRUGTYPE Small molecular drug D0M2TO DRUGINCH 1S/C10H16N4O/c15-9(13-10-11-7-12-14-10)6-8-4-2-1-3-5-8/h7-8H,1-6H2,(H2,11,12,13,14,15) D0M2TO DRUGINKE WOQYWVDZSFPTSS-UHFFFAOYSA-N D0M2TO DRUGSMIL C1CCC(CC1)CC(=O)NC2=NC=NN2 D0M2TO HIGHSTAT Patented D0M6CN DRUG__ID D0M6CN D0M6CN DRUGTYPE Small molecular drug D0M6CN DRUGINCH 1S/C21H26F5N5O3/c22-20(23)6-4-15(32)31(19(20)34)9-12(27)8-16(33)30-7-5-13-14(10-30)28-18(11-2-1-3-11)29-17(13)21(24,25)26/h11-12,19,34H,1-10,27H2/t12-,19?/m0/s1 D0M6CN DRUGINKE OPWLXRFLOSHBNJ-HSLMYDHPSA-N D0M6CN DRUGSMIL C1CC(C1)C2=NC3=C(CCN(C3)C(=O)CC(CN4C(C(CCC4=O)(F)F)O)N)C(=N2)C(F)(F)F D0M6CN HIGHSTAT Patented D0M6MM DRUG__ID D0M6MM D0M6MM DRUGTYPE Small molecular drug D0M6MM DRUGINCH 1S/C21H24N2O3/c24-21(26-20-7-5-16-2-1-3-17(16)14-20)18-4-6-19(22-15-18)8-9-23-10-12-25-13-11-23/h4-7,14-15H,1-3,8-13H2 D0M6MM DRUGINKE YBXFSMTZUPPQRJ-UHFFFAOYSA-N D0M6MM DRUGSMIL C1CC2=C(C1)C=C(C=C2)OC(=O)C3=CN=C(C=C3)CCN4CCOCC4 D0M6MM HIGHSTAT Patented D0M7WS DRUG__ID D0M7WS D0M7WS DRUGTYPE Small molecular drug D0M7WS DRUGINCH 1S/C15H11NO7/c1-8-6-13(19)14(15(20)23-8)12(18)5-3-9-2-4-11(17)10(7-9)16(21)22/h2-7,17,19H,1H3/b5-3+ D0M7WS DRUGINKE QYYBACCETRXSEX-HWKANZROSA-N D0M7WS DRUGSMIL CC1=CC(=C(C(=O)O1)C(=O)C=CC2=CC(=C(C=C2)O)[N+](=O)[O-])O D0M7WS HIGHSTAT Patented D0M8KC DRUG__ID D0M8KC D0M8KC DRUGTYPE Small molecular drug D0M8KC DRUGINCH 1S/C24H22ClNO5/c1-24(2,28)14-30-20-9-8-17(12-22(20)29-3)26-11-10-19-18(23(26)27)13-21(31-19)15-4-6-16(25)7-5-15/h4-13,28H,14H2,1-3H3 D0M8KC DRUGINKE UBVMNCOEYQICSI-UHFFFAOYSA-N D0M8KC DRUGSMIL CC(C)(COC1=C(C=C(C=C1)N2C=CC3=C(C2=O)C=C(O3)C4=CC=C(C=C4)Cl)OC)O D0M8KC HIGHSTAT Patented D0M9TR DRUG__ID D0M9TR D0M9TR DRUGTYPE Small molecular drug D0M9TR DRUGINCH 1S/C16H23N5O/c1-2-3-8-19-16-20-12-13(14-7-4-5-9-17-14)15(21-16)18-10-6-11-22/h4-5,7,9,12,22H,2-3,6,8,10-11H2,1H3,(H2,18,19,20,21) D0M9TR DRUGINKE BQWLIDAUTKRGNB-UHFFFAOYSA-N D0M9TR DRUGSMIL CCCCNC1=NC=C(C(=N1)NCCCO)C2=CC=CC=N2 D0M9TR HIGHSTAT Patented D0MA7A DRUG__ID D0MA7A D0MA7A DRUGTYPE Small molecular drug D0MA7A DRUGINCH 1S/C17H15NO/c18-15-8-3-5-13(11-15)12-19-17-10-4-7-14-6-1-2-9-16(14)17/h1-11H,12,18H2 D0MA7A DRUGINKE OPMLHBFHZXOITN-UHFFFAOYSA-N D0MA7A DRUGSMIL C1=CC=C2C(=C1)C=CC=C2OCC3=CC(=CC=C3)N D0MA7A HIGHSTAT Patented D0MA8T DRUG__ID D0MA8T D0MA8T DRUGTYPE Small molecular drug D0MA8T DRUGINCH 1S/C24H44O2/c1-21-22(24(2,3)19-18-23(21)26)17-15-13-11-9-7-5-4-6-8-10-12-14-16-20-25/h25H,4-20H2,1-3H3 D0MA8T DRUGINKE FGMAOXGOTRUOKJ-UHFFFAOYSA-N D0MA8T DRUGSMIL CC1=C(C(CCC1=O)(C)C)CCCCCCCCCCCCCCCO D0MA8T HIGHSTAT Patented D0MC3J DRUG__ID D0MC3J D0MC3J DRUGTYPE Small molecular drug D0MC3J DRUGINCH 1S/C23H26FNO4/c1-22(2)9-10-23(3,4)16-11-13(5-7-15(16)22)19(26)20(27)25-18-8-6-14(21(28)29)12-17(18)24/h5-8,11-12,19,26H,9-10H2,1-4H3,(H,25,27)(H,28,29)/t19-/m1/s1 D0MC3J DRUGINKE AANFHDFOMFRLLR-LJQANCHMSA-N D0MC3J DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(C(=O)NC3=C(C=C(C=C3)C(=O)O)F)O)(C)C)C D0MC3J HIGHSTAT Patented D0MF7O DRUG__ID D0MF7O D0MF7O DRUGTYPE Small molecular drug D0MF7O DRUGINCH 1S/C21H22F5N5O4/c22-20(23)5-3-15(32)31(19(20)34)9-11(27)8-16(33)30-6-4-12-13(10-30)28-18(14-2-1-7-35-14)29-17(12)21(24,25)26/h1-2,7,11,19,34H,3-6,8-10,27H2/t11-,19-/m0/s1 D0MF7O DRUGINKE QGMCXZMURXFXMP-WLRWDXFRSA-N D0MF7O DRUGSMIL C1CC(C(N(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C4=CC=CO4)N)O)(F)F D0MF7O HIGHSTAT Patented D0MH3Y DRUG__ID D0MH3Y D0MH3Y DRUGTYPE Small molecular drug D0MH3Y DRUGINCH 1S/C24H30N4O5/c1-3-31-20-9-8-16(12-21(20)32-4-2)23-26-22(27-33-23)18-6-5-7-19-17(18)10-11-28(19)13-24(25,14-29)15-30/h5-9,12,29-30H,3-4,10-11,13-15,25H2,1-2H3 D0MH3Y DRUGINKE KBLICPOFCCULHE-UHFFFAOYSA-N D0MH3Y DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCN(C4=CC=C3)CC(CO)(CO)N)OCC D0MH3Y HIGHSTAT Patented D0MK8L DRUG__ID D0MK8L D0MK8L DRUGTYPE Small molecular drug D0MK8L DRUGINCH 1S/C22H26N4O8/c23-21(32)15(7-10-19(28)29)25-22(33)16(8-11-20(30)31)24-18(27)9-6-14-12-17(26-34-14)13-4-2-1-3-5-13/h1-5,12,15-16H,6-11H2,(H2,23,32)(H,24,27)(H,25,33)(H,28,29)(H,30,31)/t15-,16-/m0/s1 D0MK8L DRUGINKE LIIRZRQVACDFBI-HOTGVXAUSA-N D0MK8L DRUGSMIL C1=CC=C(C=C1)C2=NOC(=C2)CCC(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N D0MK8L HIGHSTAT Patented D0MM7U DRUG__ID D0MM7U D0MM7U DRUGTYPE Small molecular drug D0MM7U DRUGINCH 1S/C18H19N3O3S2/c1-8-13(17-19-9(2)21-26-17)16(25-14(8)10-6-7-10)20-15(22)11-4-3-5-12(11)18(23)24/h10H,3-7H2,1-2H3,(H,20,22)(H,23,24) D0MM7U DRUGINKE PPVLCUXVOGWJMY-UHFFFAOYSA-N D0MM7U DRUGSMIL CC1=C(SC(=C1C2=NC(=NS2)C)NC(=O)C3=C(CCC3)C(=O)O)C4CC4 D0MM7U HIGHSTAT Patented D0MN6V DRUG__ID D0MN6V D0MN6V DRUGTYPE Small molecular drug D0MN6V DRUGINCH 1S/C19H25N3O/c1-11-15-16(12-7-5-4-6-8-12)17-13(20-18(15)22-21-11)9-19(2,3)10-14(17)23/h4-8,11,15-16,18,20-22H,9-10H2,1-3H3/t11?,15?,16-,18?/m0/s1 D0MN6V DRUGINKE RWOOXYWACRLYJU-RQWZRZRSSA-N D0MN6V DRUGSMIL CC1C2C(C3=C(CC(CC3=O)(C)C)NC2NN1)C4=CC=CC=C4 D0MN6V HIGHSTAT Patented D0MS5W DRUG__ID D0MS5W D0MS5W DRUGTYPE Small molecular drug D0MS5W DRUGINCH 1S/C20H18N2O6/c1-11-15-8-7-14(28-13-5-3-12(27-2)4-6-13)9-16(15)19(25)18(22-11)20(26)21-10-17(23)24/h3-9,25H,10H2,1-2H3,(H,21,26)(H,23,24) D0MS5W DRUGINKE MHMUTVWPLKKCIN-UHFFFAOYSA-N D0MS5W DRUGSMIL CC1=C2C=CC(=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=C(C=C3)OC D0MS5W HIGHSTAT Patented D0MT3J DRUG__ID D0MT3J D0MT3J DRUGTYPE Small molecular drug D0MT3J DRUGINCH 1S/C15H14N2O3/c1-19-12-7-9(8-13(20-2)14(12)18)15-16-10-5-3-4-6-11(10)17-15/h3-8,18H,1-2H3,(H,16,17) D0MT3J DRUGINKE LEEVVCNLICRBQX-UHFFFAOYSA-N D0MT3J DRUGSMIL COC1=CC(=CC(=C1O)OC)C2=NC3=CC=CC=C3N2 D0MT3J HIGHSTAT Patented D0MT7T DRUG__ID D0MT7T D0MT7T DRUGTYPE Small molecular drug D0MT7T DRUGINCH 1S/C24H18ClN3O2/c1-14-23(16-2-3-16)26-22-9-8-18(13-28(14)22)27-11-10-20-19(24(27)29)12-21(30-20)15-4-6-17(25)7-5-15/h4-13,16H,2-3H2,1H3 D0MT7T DRUGINKE FBRSISPMXWGFQN-UHFFFAOYSA-N D0MT7T DRUGSMIL CC1=C(N=C2N1C=C(C=C2)N3C=CC4=C(C3=O)C=C(O4)C5=CC=C(C=C5)Cl)C6CC6 D0MT7T HIGHSTAT Patented D0MW0K DRUG__ID D0MW0K D0MW0K DRUGTYPE Small molecular drug D0MW0K DRUGINCH 1S/C33H49N3O3S/c1-2-3-4-5-6-7-8-9-10-11-18-26-31(40)34-27-20-19-25-30(32(37)35-28-21-14-12-15-22-28)36-33(38)39-29-23-16-13-17-24-29/h12-17,21-24,30H,2-11,18-20,25-27H2,1H3,(H,34,40)(H,35,37)(H,36,38) D0MW0K DRUGINKE KNGBKXOOWUXHDK-UHFFFAOYSA-N D0MW0K DRUGSMIL CCCCCCCCCCCCCC(=S)NCCCCC(C(=O)NC1=CC=CC=C1)NC(=O)OC2=CC=CC=C2 D0MW0K HIGHSTAT Patented D0N0DD DRUG__ID D0N0DD D0N0DD DRUGTYPE Small molecular drug D0N0DD DRUGINCH 1S/C7H14O6/c1-12-7-6(11)5(10)4(9)3(2-8)13-7/h3-11H,2H2,1H3/t3?,4-,5-,6?,7+/m0/s1 D0N0DD DRUGINKE HOVAGTYPODGVJG-FSUQTPNVSA-N D0N0DD DRUGSMIL COC1C(C(C(C(O1)CO)O)O)O D0N0DD HIGHSTAT Patented D0N3SU DRUG__ID D0N3SU D0N3SU DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0N3SU DRUGINCH 1S/C8H6O3/c9-4-6-1-2-7-8(3-6)11-5-10-7/h1-4H,5H2 D0N3SU DRUGINKE SATCULPHIDQDRE-UHFFFAOYSA-N D0N3SU DRUGSMIL C1OC2=C(O1)C=C(C=C2)C=O D0N3SU HIGHSTAT Patented D0N5RH DRUG__ID D0N5RH D0N5RH DRUGTYPE Small molecular drug D0N5RH DRUGINCH 1S/C15H27NO11/c1-5(19)16-8-10(21)13(7(4-18)26-14(8)24-2)27-15-12(23)11(22)9(20)6(3-17)25-15/h6-15,17-18,20-23H,3-4H2,1-2H3,(H,16,19)/t6?,7?,8?,9-,10+,11-,12?,13+,14+,15-/m0/s1 D0N5RH DRUGINKE PKPZITUQXLANSE-IFUIUTNGSA-N D0N5RH DRUGSMIL CC(=O)NC1C(C(C(OC1OC)CO)OC2C(C(C(C(O2)CO)O)O)O)O D0N5RH HIGHSTAT Patented D0N6ZA DRUG__ID D0N6ZA D0N6ZA DRUGTYPE Small molecular drug D0N6ZA DRUGINCH 1S/C20H24F3N3O3/c1-11(2)15(9-12-3-5-14(6-4-12)20(21,22)23)16(27)24-10-19(13-7-8-13)17(28)25-18(29)26-19/h3-6,11,13,15H,7-10H2,1-2H3,(H,24,27)(H2,25,26,28,29)/t15-,19-/m0/s1 D0N6ZA DRUGINKE VXXYNKXMRXANKX-KXBFYZLASA-N D0N6ZA DRUGSMIL CC(C)C(CC1=CC=C(C=C1)C(F)(F)F)C(=O)NCC2(C(=O)NC(=O)N2)C3CC3 D0N6ZA HIGHSTAT Patented D0N6ZR DRUG__ID D0N6ZR D0N6ZR DRUGTYPE Small molecular drug D0N6ZR DRUGINCH 1S/C8H12N3O5P/c9-7-1-2-11(8(12)10-7)3-6-4-16-17(13,14)5-15-6/h1-2,6H,3-5H2,(H,13,14)(H2,9,10,12) D0N6ZR DRUGINKE YXQUGSXUDFTPLL-UHFFFAOYSA-N D0N6ZR DRUGSMIL C1C(OCP(=O)(O1)O)CN2C=CC(=NC2=O)N D0N6ZR HIGHSTAT Patented D0N7BW DRUG__ID D0N7BW D0N7BW DRUGTYPE Small molecular drug D0N7BW DRUGINCH 1S/C10H7NO3S/c12-7-3-1-6(2-4-7)5-8-9(13)11-10(14)15-8/h1-5,12H,(H,11,13,14)/b8-5- D0N7BW DRUGINKE ARHIHDVVUHVQCP-YVMONPNESA-N D0N7BW DRUGSMIL C1=CC(=CC=C1C=C2C(=O)NC(=O)S2)O D0N7BW HIGHSTAT Patented D0N8CI DRUG__ID D0N8CI D0N8CI DRUGTYPE Small molecular drug D0N8CI DRUGINCH 1S/C23H21ClN2O4S/c1-23(2,28)13-30-18-9-8-17(11-19(18)29-3)26-22(27)21-15(12-25-26)10-20(31-21)14-4-6-16(24)7-5-14/h4-12,28H,13H2,1-3H3 D0N8CI DRUGINKE QOXWOBOEWLTLQE-UHFFFAOYSA-N D0N8CI DRUGSMIL CC(C)(COC1=C(C=C(C=C1)N2C(=O)C3=C(C=C(S3)C4=CC=C(C=C4)Cl)C=N2)OC)O D0N8CI HIGHSTAT Patented D0N8QO DRUG__ID D0N8QO D0N8QO DRUGTYPE Small molecular drug D0N8QO DRUGINCH 1S/C27H25F4N9O/c28-18-1-2-22(21(11-18)27(29,30)31)37-25(41)38-9-4-19(5-10-38)39-14-26(15-39,6-7-32)40-13-17(12-36-40)23-20-3-8-33-24(20)35-16-34-23/h1-3,8,11-13,16,19H,4-6,9-10,14-15H2,(H,37,41)(H,33,34,35) D0N8QO DRUGINKE RZUCZMLSGAQMJN-UHFFFAOYSA-N D0N8QO DRUGSMIL C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)NC6=C(C=C(C=C6)F)C(F)(F)F D0N8QO HIGHSTAT Patented D0N9CV DRUG__ID D0N9CV D0N9CV DRUGTYPE Small molecular drug D0N9CV DRUGINCH 1S/C19H26N6O/c20-8-16-2-1-3-25(16)17(26)9-22-19-6-14-4-15(19)7-18(5-14,10-19)11-24-13-21-12-23-24/h12-16,22H,1-7,9-11H2/t14?,15?,16-,18?,19?/m0/s1 D0N9CV DRUGINKE IGRDXWYZILJAIK-YYSDWXCKSA-N D0N9CV DRUGSMIL C1CC(N(C1)C(=O)CNC23CC4CC2CC(C4)(C3)CN5C=NC=N5)C#N D0N9CV HIGHSTAT Patented D0N9JJ DRUG__ID D0N9JJ D0N9JJ DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0N9JJ DRUGINCH 1S/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3 D0N9JJ DRUGINKE CBOQJANXLMLOSS-UHFFFAOYSA-N D0N9JJ DRUGSMIL CCOC1=C(C=CC(=C1)C=O)O D0N9JJ HIGHSTAT Patented D0N9JZ DRUG__ID D0N9JZ D0N9JZ DRUGTYPE Small molecular drug D0N9JZ DRUGINCH 1S/C13H13N3O3/c17-12(16-5-1-2-6-16)10-7-9-11(15-10)8(13(18)19)3-4-14-9/h3-4,7,15H,1-2,5-6H2,(H,18,19) D0N9JZ DRUGINKE YVSBFLGSNJSZJQ-UHFFFAOYSA-N D0N9JZ DRUGSMIL C1CCN(C1)C(=O)C2=CC3=NC=CC(=C3N2)C(=O)O D0N9JZ HIGHSTAT Patented D0ND3H DRUG__ID D0ND3H D0ND3H DRUGTYPE Small molecular drug D0ND3H DRUGINCH 1S/C19H16Cl2N2O2/c1-3-23(2)18-16(19(24)25)15(11-7-5-4-6-8-11)13-9-12(20)10-14(21)17(13)22-18/h4-10H,3H2,1-2H3,(H,24,25) D0ND3H DRUGINKE RNRWKMXASDHXSW-UHFFFAOYSA-N D0ND3H DRUGSMIL CCN(C)C1=C(C(=C2C=C(C=C(C2=N1)Cl)Cl)C3=CC=CC=C3)C(=O)O D0ND3H HIGHSTAT Patented D0ND9W DRUG__ID D0ND9W D0ND9W DRUGTYPE Small molecular drug D0ND9W DRUGINCH 1S/C18H11ClFN3OS2/c19-9-3-5-12(11(20)8-9)22-17(24)16-15(21)10-4-6-13(23-18(10)26-16)14-2-1-7-25-14/h1-8H,21H2,(H,22,24) D0ND9W DRUGINKE NSFJHJZRXLGMGP-UHFFFAOYSA-N D0ND9W DRUGSMIL C1=CSC(=C1)C2=NC3=C(C=C2)C(=C(S3)C(=O)NC4=C(C=C(C=C4)Cl)F)N D0ND9W HIGHSTAT Patented D0NE0N DRUG__ID D0NE0N D0NE0N DRUGTYPE Small molecular drug D0NE0N DRUGINCH 1S/C15H11N3O/c16-15(19)11-7-17-13-10(11)6-5-9-8-3-1-2-4-12(8)18-14(9)13/h1-7,17-18H,(H2,16,19) D0NE0N DRUGINKE MXZKCOUOYWSEKW-UHFFFAOYSA-N D0NE0N DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C4=C(C=C3)C(=CN4)C(=O)N D0NE0N HIGHSTAT Patented D0NG8M DRUG__ID D0NG8M D0NG8M DRUGTYPE Small molecular drug D0NG8M DRUGINCH 1S/C14H14N2O3/c1-19-11-4-2-10(3-5-11)8-16-13-9-15-7-6-12(13)14(17)18/h2-7,9,16H,8H2,1H3,(H,17,18) D0NG8M DRUGINKE XKZFNTZMCLZYHZ-UHFFFAOYSA-N D0NG8M DRUGSMIL COC1=CC=C(C=C1)CNC2=C(C=CN=C2)C(=O)O D0NG8M HIGHSTAT Patented D0NH9P DRUG__ID D0NH9P D0NH9P DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0NH9P DRUGINCH 1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10) D0NH9P DRUGINKE FJKROLUGYXJWQN-UHFFFAOYSA-N D0NH9P DRUGSMIL C1=CC(=CC=C1C(=O)O)O D0NH9P HIGHSTAT Patented D0NI7A DRUG__ID D0NI7A D0NI7A DRUGTYPE Small molecular drug D0NI7A DRUGINCH 1S/C18H15ClN4OS/c19-13-7-3-1-5-11(13)9-22-17-15(12-6-2-4-8-14(12)25-17)16-20-10-21-23(16)18(22)24/h1,3,5,7,10H,2,4,6,8-9H2 D0NI7A DRUGINKE CXMQSCNDPBVQEJ-UHFFFAOYSA-N D0NI7A DRUGSMIL C1CCC2=C(C1)C3=C(S2)N(C(=O)N4C3=NC=N4)CC5=CC=CC=C5Cl D0NI7A HIGHSTAT Patented D0NM3B DRUG__ID D0NM3B D0NM3B DRUGTYPE Small molecular drug D0NM3B DRUGINCH 1S/C20H27N5O2/c1-12(2)16-10-18(23-22-16)20(27)25-7-6-14(11-25)17-9-15(8-13(3)21-17)19(26)24(4)5/h8-10,12,14H,6-7,11H2,1-5H3,(H,22,23) D0NM3B DRUGINKE YAVZAMCCDJRPBX-UHFFFAOYSA-N D0NM3B DRUGSMIL CC1=CC(=CC(=N1)C2CCN(C2)C(=O)C3=NNC(=C3)C(C)C)C(=O)N(C)C D0NM3B HIGHSTAT Patented D0NM6I DRUG__ID D0NM6I D0NM6I DRUGTYPE Small molecular drug D0NM6I DRUGINCH 1S/C22H27N7O4/c1-3-33-22(31)28-15-6-4-14(5-7-15)27-21(30)16-11-17(13-8-9-24-18(10-13)32-2)29-19(16)20(23)25-12-26-29/h8-12,14-15H,3-7H2,1-2H3,(H,27,30)(H,28,31)(H2,23,25,26) D0NM6I DRUGINKE UOUCFNDSPAGXJQ-UHFFFAOYSA-N D0NM6I DRUGSMIL CCOC(=O)NC1CCC(CC1)NC(=O)C2=C3C(=NC=NN3C(=C2)C4=CC(=NC=C4)OC)N D0NM6I HIGHSTAT Patented D0NO7V DRUG__ID D0NO7V D0NO7V DRUGTYPE Small molecular drug D0NO7V DRUGINCH 1S/C20H17FN4O2/c21-15-4-1-3-14-17(7-10-22-19(14)15)24-20(26)25-18-6-2-5-16(23-18)13-8-11-27-12-9-13/h1-8,10H,9,11-12H2,(H2,22,23,24,25,26) D0NO7V DRUGINKE BYKSEVADXIBXTH-UHFFFAOYSA-N D0NO7V DRUGSMIL C1COCC=C1C2=NC(=CC=C2)NC(=O)NC3=C4C=CC=C(C4=NC=C3)F D0NO7V HIGHSTAT Patented D0NR2A DRUG__ID D0NR2A D0NR2A DRUGTYPE Small molecular drug D0NR2A DRUGINCH 1S/C14H12O4/c15-11-3-2-10(12(16)7-11)5-9-1-4-13-14(6-9)18-8-17-13/h1-4,6-7,15-16H,5,8H2 D0NR2A DRUGINKE KUMBCKZCFIONIT-UHFFFAOYSA-N D0NR2A DRUGSMIL C1OC2=C(O1)C=C(C=C2)CC3=C(C=C(C=C3)O)O D0NR2A HIGHSTAT Patented D0NT3V DRUG__ID D0NT3V D0NT3V DRUGTYPE Small molecular drug D0NT3V DRUGINCH 1S/C24H31N3O2S/c1-30(28,29)25-20-16-27(17-20)21-10-8-19-9-11-24(26-12-5-13-26)23(22(19)15-21)14-18-6-3-2-4-7-18/h2-4,6-8,10,15,20,23-25H,5,9,11-14,16-17H2,1H3/t23-,24+/m1/s1 D0NT3V DRUGINKE DTCYWONIILSWPE-RPWUZVMVSA-N D0NT3V DRUGSMIL CS(=O)(=O)NC1CN(C1)C2=CC3=C(CCC(C3CC4=CC=CC=C4)N5CCC5)C=C2 D0NT3V HIGHSTAT Patented D0NW8W DRUG__ID D0NW8W D0NW8W DRUGTYPE Small molecular drug D0NW8W DRUGINCH 1S/C21H26FN3O5S/c22-17-6-4-16(5-7-17)15-30-18-8-10-19(11-9-18)31(28,29)23-14-20(21(26)24-27)25-12-2-1-3-13-25/h4-11,20,23,27H,1-3,12-15H2,(H,24,26)/t20-/m0/s1 D0NW8W DRUGINKE PDOPZKWZZGOMJC-FQEVSTJZSA-N D0NW8W DRUGSMIL C1CCN(CC1)C(CNS(=O)(=O)C2=CC=C(C=C2)OCC3=CC=C(C=C3)F)C(=O)NO D0NW8W HIGHSTAT Patented D0NX6B DRUG__ID D0NX6B D0NX6B DRUGTYPE Small molecular drug D0NX6B DRUGINCH 1S/C29H35FN8O4/c1-15(2)34-27(39)17-5-6-19(30)18(11-17)22-8-7-20(31)26(35-22)28(40)36-23-12-33-10-9-24(23)38-13-16(3)25(21(32)14-38)37-29(41)42-4/h5-12,15-16,21,25H,13-14,31-32H2,1-4H3,(H,34,39)(H,36,40)(H,37,41)/t16-,21+,25-/m0/s1 D0NX6B DRUGINKE FGLBTUNMAVXKMV-LMNXFLSBSA-N D0NX6B DRUGSMIL CC1CN(CC(C1NC(=O)OC)N)C2=C(C=NC=C2)NC(=O)C3=C(C=CC(=N3)C4=C(C=CC(=C4)C(=O)NC(C)C)F)N D0NX6B HIGHSTAT Patented D0NY4A DRUG__ID D0NY4A D0NY4A DRUGTYPE Small molecular drug D0NY4A DRUGINCH 1S/C25H28F3N5O2/c1-31(2)11-12-32-13-15-33(16-14-32)21-4-3-19(25(26,27)28)17-20(21)30-24(34)23-6-5-22(35-23)18-7-9-29-10-8-18/h3-10,17H,11-16H2,1-2H3,(H,30,34) D0NY4A DRUGINKE ALLIMXLDTJFWHR-UHFFFAOYSA-N D0NY4A DRUGSMIL CN(C)CCN1CCN(CC1)C2=C(C=C(C=C2)C(F)(F)F)NC(=O)C3=CC=C(O3)C4=CC=NC=C4 D0NY4A HIGHSTAT Patented D0O1NA DRUG__ID D0O1NA D0O1NA DRUGTYPE Small molecular drug D0O1NA DRUGINCH 1S/C21H27N3O5S/c25-21(23-26)20(24-13-5-2-6-14-24)15-22-30(27,28)19-11-9-18(10-12-19)29-16-17-7-3-1-4-8-17/h1,3-4,7-12,20,22,26H,2,5-6,13-16H2,(H,23,25)/t20-/m0/s1 D0O1NA DRUGINKE MVDTXPPSDKEWJP-FQEVSTJZSA-N D0O1NA DRUGSMIL C1CCN(CC1)C(CNS(=O)(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3)C(=O)NO D0O1NA HIGHSTAT Patented D0O4QB DRUG__ID D0O4QB D0O4QB DRUGTYPE Small molecular drug D0O4QB DRUGINCH 1S/C10H12O2/c1-3-4-8-5-6-9(11)10(7-8)12-2/h3,5-7,11H,1,4H2,2H3 D0O4QB DRUGINKE RRAFCDWBNXTKKO-UHFFFAOYSA-N D0O4QB DRUGSMIL COC1=C(C=CC(=C1)CC=C)O D0O4QB HIGHSTAT Patented D0O4RX DRUG__ID D0O4RX D0O4RX DRUGTYPE Small molecular drug D0O4RX DRUGINCH 1S/C23H23Cl2NO3/c24-18-2-1-3-19(25)22(18)16-11-15(16)14-4-5-17-20(10-14)29-13-23(17)6-8-26(9-7-23)12-21(27)28/h1-5,10,15-16H,6-9,11-13H2,(H,27,28) D0O4RX DRUGINKE UTYPIEPGWJMTNG-UHFFFAOYSA-N D0O4RX DRUGSMIL C1CN(CCC12COC3=C2C=CC(=C3)C4CC4C5=C(C=CC=C5Cl)Cl)CC(=O)O D0O4RX HIGHSTAT Patented D0OE2R DRUG__ID D0OE2R D0OE2R DRUGTYPE Small molecular drug D0OE2R DRUGINCH 1S/C15H15BFNO3/c1-9-13(5-3-11-8-20-16(19)15(9)11)21-14-4-2-10(7-18)6-12(14)17/h2-6,19H,7-8,18H2,1H3 D0OE2R DRUGINKE ZCITXZXBLWIHHP-UHFFFAOYSA-N D0OE2R DRUGSMIL B1(C2=C(CO1)C=CC(=C2C)OC3=C(C=C(C=C3)CN)F)O D0OE2R HIGHSTAT Patented D0OH0T DRUG__ID D0OH0T D0OH0T DRUGTYPE Small molecular drug D0OH0T DRUGINCH 1S/C23H30NO6PS/c24-23(16-30-31(25,26)27)11-10-21(14-23)20-9-8-18-12-17(6-7-19(18)13-20)15-32(28,29)22-4-2-1-3-5-22/h1-5,8-9,13,17,21H,6-7,10-12,14-16,24H2,(H2,25,26,27)/t17-,21-,23+/m0/s1 D0OH0T DRUGINKE UIXJBOOFWQSQAS-JWNTYJGQSA-N D0OH0T DRUGSMIL C1CC2=C(CC1CS(=O)(=O)C3=CC=CC=C3)C=CC(=C2)C4CCC(C4)(COP(=O)(O)O)N D0OH0T HIGHSTAT Patented D0OR4X DRUG__ID D0OR4X D0OR4X DRUGTYPE Small molecular drug D0OR4X DRUGINCH 1S/C16H16N2O5/c1-9-4-3-5-13(10(9)2)23-11-6-12(19)15(17-7-11)16(22)18-8-14(20)21/h3-7,19H,8H2,1-2H3,(H,18,22)(H,20,21) D0OR4X DRUGINKE FSLSXJQWQVETMM-UHFFFAOYSA-N D0OR4X DRUGSMIL CC1=C(C(=CC=C1)OC2=CC(=C(N=C2)C(=O)NCC(=O)O)O)C D0OR4X HIGHSTAT Patented D0OS2I DRUG__ID D0OS2I D0OS2I DRUGTYPE Small molecular drug D0OS2I DRUGINCH 1S/C23H23F3N6O2/c1-11-9-32(10-16(28)22(11)33)18-5-6-29-8-17(18)30-23(34)21-15(27)7-14(26)20(31-21)19-12(24)3-2-4-13(19)25/h2-8,11,16,22,33H,9-10,27-28H2,1H3,(H,30,34)/t11-,16+,22+/m0/s1 D0OS2I DRUGINKE QJWGSVNGDURFSA-CNUNAPQTSA-N D0OS2I DRUGSMIL CC1CN(CC(C1O)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3N)F)C4=C(C=CC=C4F)F D0OS2I HIGHSTAT Patented D0OW3S DRUG__ID D0OW3S D0OW3S DRUGTYPE Small molecular drug D0OW3S DRUGINCH 1S/C21H23N3O/c1-3-9-18(10-4-1)21(12-5-2-6-13-21)14-11-19-23-20(24-25-19)17-8-7-15-22-16-17/h1,3-4,7-10,15-16H,2,5-6,11-14H2 D0OW3S DRUGINKE UAUQCABEJBRLRC-UHFFFAOYSA-N D0OW3S DRUGSMIL C1CCC(CC1)(CCC2=NC(=NO2)C3=CN=CC=C3)C4=CC=CC=C4 D0OW3S HIGHSTAT Patented D0OX9E DRUG__ID D0OX9E D0OX9E DRUGTYPE Small molecular drug D0OX9E DRUGINCH 1S/C27H29FN4O2/c1-18(31-25(33)21-14-20-4-2-3-5-24(20)29-15-21)17-32-12-10-27(11-13-32)23(16-30-26(27)34)19-6-8-22(28)9-7-19/h2-9,14-15,18,23H,10-13,16-17H2,1H3,(H,30,34)(H,31,33)/t18-,23+/m0/s1 D0OX9E DRUGINKE VALMDDHRZJXVOR-FDDCHVKYSA-N D0OX9E DRUGSMIL CC(CN1CCC2(CC1)C(CNC2=O)C3=CC=C(C=C3)F)NC(=O)C4=CC5=CC=CC=C5N=C4 D0OX9E HIGHSTAT Patented D0OY0U DRUG__ID D0OY0U D0OY0U DRUGTYPE Small molecular drug D0OY0U DRUGINCH 1S/C21H14F2N6/c22-16-4-3-12(8-17(16)23)9-26-21-27-10-15-13-5-7-24-11-18(13)28-20-14(19(15)29-21)2-1-6-25-20/h1-8,10-11H,9H2,(H,25,28)(H,26,27,29) D0OY0U DRUGINKE HIVDOLJVFRYLKP-UHFFFAOYSA-N D0OY0U DRUGSMIL C1=CC2=C(NC3=C(C=CN=C3)C4=CN=C(N=C24)NCC5=CC(=C(C=C5)F)F)N=C1 D0OY0U HIGHSTAT Patented D0P0OH DRUG__ID D0P0OH D0P0OH DRUGTYPE Small molecular drug D0P0OH DRUGINCH 1S/C16H12INO4/c1-20-13-7-10-12(8-14(13)21-2)18-15(22-16(10)19)9-5-3-4-6-11(9)17/h3-8H,1-2H3 D0P0OH DRUGINKE HKRJBRGRGFMQJI-UHFFFAOYSA-N D0P0OH DRUGSMIL COC1=C(C=C2C(=C1)C(=O)OC(=N2)C3=CC=CC=C3I)OC D0P0OH HIGHSTAT Patented D0P3PT DRUG__ID D0P3PT D0P3PT DRUGTYPE Small molecular drug D0P3PT DRUGINCH 1S/C24H25N5O5S/c25-35(32,33)34-14-18-12-20(24(31)23(18)30)27-21-9-10-26-22-13-19(28-29(21)22)17-8-4-7-16(11-17)15-5-2-1-3-6-15/h1-11,13,18,20,23-24,27,30-31H,12,14H2,(H2,25,32,33)/t18-,20-,23-,24+/m1/s1 D0P3PT DRUGINKE OHUBWOCZKZLWIV-ILEGPTGMSA-N D0P3PT DRUGSMIL C1C(C(C(C1NC2=CC=NC3=CC(=NN23)C4=CC=CC(=C4)C5=CC=CC=C5)O)O)COS(=O)(=O)N D0P3PT HIGHSTAT Patented D0P4NQ DRUG__ID D0P4NQ D0P4NQ DRUGTYPE Small molecular drug D0P4NQ DRUGINCH 1S/C23H21F2N7/c24-16-6-2-7-17(25)20(16)22-28-10-14-4-1-8-18(21(14)31-22)30-19-11-27-13-29-23(19)32-9-3-5-15(26)12-32/h1-2,4,6-8,10-11,13,15,30H,3,5,9,12,26H2/t15-/m0/s1 D0P4NQ DRUGINKE XPBFQTIASOFUJQ-HNNXBMFYSA-N D0P4NQ DRUGSMIL C1CC(CN(C1)C2=NC=NC=C2NC3=CC=CC4=CN=C(N=C43)C5=C(C=CC=C5F)F)N D0P4NQ HIGHSTAT Patented D0P6ZB DRUG__ID D0P6ZB D0P6ZB DRUGTYPE Small molecular drug D0P6ZB DRUGINCH 1S/C14H14O4/c15-11-5-3-9(13(17)7-11)1-2-10-4-6-12(16)8-14(10)18/h3-8,15-18H,1-2H2 D0P6ZB DRUGINKE WKIFTWPZTZUMRN-UHFFFAOYSA-N D0P6ZB DRUGSMIL C1=CC(=C(C=C1O)O)CCC2=C(C=C(C=C2)O)O D0P6ZB HIGHSTAT Patented D0P7LP DRUG__ID D0P7LP D0P7LP DRUGTYPE Small molecular drug D0P7LP DRUGINCH 1S/C28H28Cl2F3N3O4S/c1-17(16-37)34-27(38)20-11-21(28(31,32)33)13-24(12-20)36(41(2,39)40)25-14-35(15-25)26(18-3-7-22(29)8-4-18)19-5-9-23(30)10-6-19/h3-13,17,25-26,37H,14-16H2,1-2H3,(H,34,38) D0P7LP DRUGINKE CVPMSFUZFFYDBR-UHFFFAOYSA-N D0P7LP DRUGSMIL CC(CO)NC(=O)C1=CC(=CC(=C1)N(C2CN(C2)C(C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl)S(=O)(=O)C)C(F)(F)F D0P7LP HIGHSTAT Patented D0P8RK DRUG__ID D0P8RK D0P8RK DRUGTYPE Small molecular drug D0P8RK DRUGINCH 1S/C14H8Cl3F3N4OS/c15-6-1-4-26-11(6)9-7(16)8-10(12(17)23-5-22-8)24(9)3-2-21-13(25)14(18,19)20/h1,4-5H,2-3H2,(H,21,25) D0P8RK DRUGINKE OHSATPMXJJAETD-UHFFFAOYSA-N D0P8RK DRUGSMIL C1=CSC(=C1Cl)C2=C(C3=C(N2CCNC(=O)C(F)(F)F)C(=NC=N3)Cl)Cl D0P8RK HIGHSTAT Patented D0P9UF DRUG__ID D0P9UF D0P9UF DRUGTYPE Small molecular drug D0P9UF DRUGINCH 1S/C20H19F2N5OS/c21-13-4-1-5-14(22)18(13)20-26-16(11-29-20)19(28)25-15-9-24-7-6-17(15)27-8-2-3-12(23)10-27/h1,4-7,9,11-12H,2-3,8,10,23H2,(H,25,28)/t12-/m0/s1 D0P9UF DRUGINKE DRSGGAHSPDXOOW-LBPRGKRZSA-N D0P9UF DRUGSMIL C1CC(CN(C1)C2=C(C=NC=C2)NC(=O)C3=CSC(=N3)C4=C(C=CC=C4F)F)N D0P9UF HIGHSTAT Patented D0PF2F DRUG__ID D0PF2F D0PF2F DRUGTYPE Small molecular drug D0PF2F DRUGINCH 1S/C31H24F3N5O3/c1-17-36-16-27(37-17)20-11-21(31(32,33)34)14-22(12-20)38-30(41)26-4-2-3-19-13-23(7-8-25(19)26)42-24-9-10-35-28(15-24)39-29(40)18-5-6-18/h2-4,7-16,18H,5-6H2,1H3,(H,36,37)(H,38,41)(H,35,39,40) D0PF2F DRUGINKE LFBDVPDAUGENGX-UHFFFAOYSA-N D0PF2F DRUGSMIL CC1=NC=C(N1)C2=CC(=CC(=C2)NC(=O)C3=CC=CC4=C3C=CC(=C4)OC5=CC(=NC=C5)NC(=O)C6CC6)C(F)(F)F D0PF2F HIGHSTAT Patented D0PF2W DRUG__ID D0PF2W D0PF2W DRUGTYPE Small molecular drug D0PF2W DRUGINCH 1S/C24H26N6O2/c1-2-3-12-29-21(28-11-5-7-17(25)14-28)13-22(31)30(24(29)32)15-20-26-18-8-4-6-16-9-10-19(27-20)23(16)18/h4,6,8,13,17H,5,7,9-12,14-15,25H2,1H3/t17-/m1/s1 D0PF2W DRUGINKE VRAJXOQRFSNNNZ-QGZVFWFLSA-N D0PF2W DRUGSMIL CC#CCN1C(=CC(=O)N(C1=O)CC2=NC3=CC=CC4=C3C(=N2)CC4)N5CCCC(C5)N D0PF2W HIGHSTAT Patented D0PG7W DRUG__ID D0PG7W D0PG7W DRUGTYPE Small molecular drug D0PG7W DRUGINCH 1S/C15H14N2O5/c1-21-13-3-8-6-16-17-7-10(15(19)20)12(18)5-11(17)9(8)4-14(13)22-2/h3-5,7,16H,6H2,1-2H3,(H,19,20) D0PG7W DRUGINKE BPBHVSAWZGGVPZ-UHFFFAOYSA-N D0PG7W DRUGSMIL COC1=C(C=C2C(=C1)CNN3C2=CC(=O)C(=C3)C(=O)O)OC D0PG7W HIGHSTAT Patented D0PI1Z DRUG__ID D0PI1Z D0PI1Z DRUGTYPE Small molecular drug D0PI1Z DRUGINCH 1S/C15H14O4/c16-12-5-4-11(13(17)8-12)3-1-10-2-6-14-15(7-10)19-9-18-14/h2,4-8,16-17H,1,3,9H2 D0PI1Z DRUGINKE WYCYXIGYEQHUEJ-UHFFFAOYSA-N D0PI1Z DRUGSMIL C1OC2=C(O1)C=C(C=C2)CCC3=C(C=C(C=C3)O)O D0PI1Z HIGHSTAT Patented D0PL1I DRUG__ID D0PL1I D0PL1I DRUGTYPE Small molecular drug D0PL1I DRUGINCH 1S/C21H25N3O3S/c1-16(28)22-15-9-8-14-19(20(25)23-17-10-4-2-5-11-17)24-21(26)27-18-12-6-3-7-13-18/h2-7,10-13,19H,8-9,14-15H2,1H3,(H,22,28)(H,23,25)(H,24,26) D0PL1I DRUGINKE KPDAUKDFHIWNQM-UHFFFAOYSA-N D0PL1I DRUGSMIL CC(=S)NCCCCC(C(=O)NC1=CC=CC=C1)NC(=O)OC2=CC=CC=C2 D0PL1I HIGHSTAT Patented D0PO7F DRUG__ID D0PO7F D0PO7F DRUGTYPE Small molecular drug D0PO7F DRUGINCH 1S/C28H24F3NO6/c1-16-22(14-19-6-4-5-7-25(19)37-17(2)27(34)35)23-15-21(38-28(29,30)31)12-13-24(23)32(16)26(33)18-8-10-20(36-3)11-9-18/h4-13,15,17H,14H2,1-3H3,(H,34,35)/t17-/m0/s1 D0PO7F DRUGINKE BWTOBMCYVACNJZ-KRWDZBQOSA-N D0PO7F DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)OC)C=CC(=C2)OC(F)(F)F)CC4=CC=CC=C4OC(C)C(=O)O D0PO7F HIGHSTAT Patented D0PO8N DRUG__ID D0PO8N D0PO8N DRUGTYPE Small molecular drug D0PO8N DRUGINCH 1S/C28H28N6O4/c1-15-31-21-10-8-16(12-23(21)37-15)19-14-30-25-24(19)27(38-18-6-4-5-7-18)34-28(33-25)32-20-11-9-17(26(35)29-2)13-22(20)36-3/h8-14,18H,4-7H2,1-3H3,(H,29,35)(H2,30,32,33,34) D0PO8N DRUGINKE CWJLAVRXVFHDSJ-UHFFFAOYSA-N D0PO8N DRUGSMIL CC1=NC2=C(O1)C=C(C=C2)C3=CNC4=C3C(=NC(=N4)NC5=C(C=C(C=C5)C(=O)NC)OC)OC6CCCC6 D0PO8N HIGHSTAT Patented D0PQ5P DRUG__ID D0PQ5P D0PQ5P DRUGTYPE Small molecular drug D0PQ5P DRUGINCH 1S/C18H17ClN2O3/c1-2-9-24-17(11-5-3-4-6-13(11)19)15-10-14-16(21-15)12(18(22)23)7-8-20-14/h3-8,10,17,21H,2,9H2,1H3,(H,22,23) D0PQ5P DRUGINKE NXCXDWJNFKFGCO-UHFFFAOYSA-N D0PQ5P DRUGSMIL CCCOC(C1=CC=CC=C1Cl)C2=CC3=NC=CC(=C3N2)C(=O)O D0PQ5P HIGHSTAT Patented D0PT8T DRUG__ID D0PT8T D0PT8T DRUGTYPE Small molecular drug D0PT8T DRUGINCH 1S/C14H19NO/c1-10-6-7-13(11(2)8-10)14(16)12(3)9-15(4)5/h6-8H,3,9H2,1-2,4-5H3 D0PT8T DRUGINKE QXLQZLBNPTZMRK-UHFFFAOYSA-N D0PT8T DRUGSMIL CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C D0PT8T HIGHSTAT Patented D0PW0R DRUG__ID D0PW0R D0PW0R DRUGTYPE Small molecular drug D0PW0R DRUGINCH 1S/C31H26F2N2O6/c32-22-5-3-21(4-6-22)31(39)13-15-35(16-14-31)30(38)34-24-17-27(40-25-9-1-20(2-10-25)29(36)37)19-28(18-24)41-26-11-7-23(33)8-12-26/h1-12,17-19,39H,13-16H2,(H,34,38)(H,36,37) D0PW0R DRUGINKE PZFBUIYFAFMDBM-UHFFFAOYSA-N D0PW0R DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)F)O)C(=O)NC3=CC(=CC(=C3)OC4=CC=C(C=C4)F)OC5=CC=C(C=C5)C(=O)O D0PW0R HIGHSTAT Patented D0PX1D DRUG__ID D0PX1D D0PX1D DRUGTYPE Small molecular drug D0PX1D DRUGINCH 1S/C24H24N4O/c1-24(29)14-19(15-24)23-27-20(21-22(25)26-11-12-28(21)23)18-9-7-17(8-10-18)13-16-5-3-2-4-6-16/h2-12,19,29H,13-15H2,1H3,(H2,25,26) D0PX1D DRUGINKE ZSKAHJMMVVSPKI-UHFFFAOYSA-N D0PX1D DRUGSMIL CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)CC5=CC=CC=C5)O D0PX1D HIGHSTAT Patented D0PY4S DRUG__ID D0PY4S D0PY4S DRUGTYPE Small molecular drug D0PY4S DRUGINCH 1S/C28H35N7O3S/c29-12-9-19-10-13-35(14-11-19)28(36)25(16-20-3-1-5-22(15-20)27(31)32)34-39(37,38)24-6-2-4-21(17-24)23-7-8-26(30)33-18-23/h1-8,15,17-19,25,34H,9-14,16,29H2,(H2,30,33)(H3,31,32) D0PY4S DRUGINKE YXXOMQLSCCTIBA-UHFFFAOYSA-N D0PY4S DRUGSMIL C1CN(CCC1CCN)C(=O)C(CC2=CC(=CC=C2)C(=N)N)NS(=O)(=O)C3=CC=CC(=C3)C4=CN=C(C=C4)N D0PY4S HIGHSTAT Patented D0Q1HU DRUG__ID D0Q1HU D0Q1HU DRUGTYPE Small molecular drug D0Q1HU DRUGINCH 1S/C9H9F3O2/c1-5-2-6(13)3-8(14)7(5)4-9(10,11)12/h2-3,13-14H,4H2,1H3 D0Q1HU DRUGINKE JMBGLSBPUYZWGE-UHFFFAOYSA-N D0Q1HU DRUGSMIL CC1=CC(=CC(=C1CC(F)(F)F)O)O D0Q1HU HIGHSTAT Patented D0Q1NF DRUG__ID D0Q1NF D0Q1NF DRUGTYPE Small molecular drug D0Q1NF DRUGINCH 1S/C17H21NO/c1-3-18(4-2)16-10-8-9-15(13-16)14-19-17-11-6-5-7-12-17/h5-13H,3-4,14H2,1-2H3 D0Q1NF DRUGINKE NRJLSCXDEWCXHU-UHFFFAOYSA-N D0Q1NF DRUGSMIL CCN(CC)C1=CC=CC(=C1)COC2=CC=CC=C2 D0Q1NF HIGHSTAT Patented D0Q3SU DRUG__ID D0Q3SU D0Q3SU DRUGTYPE Small molecular drug D0Q3SU DRUGINCH 1S/C20H20ClF3N6O2/c1-32-11-8-30(9-11)5-4-25-20-27-17-12(7-15(23)16(24)18(17)28-20)19(29-31)26-10-2-3-14(22)13(21)6-10/h2-3,6-7,11,31H,4-5,8-9H2,1H3,(H,26,29)(H2,25,27,28) D0Q3SU DRUGINKE DZOQWZPMCBWTQQ-UHFFFAOYSA-N D0Q3SU DRUGSMIL COC1CN(C1)CCNC2=NC3=C(N2)C(=CC(=C3F)F)C(=NC4=CC(=C(C=C4)F)Cl)NO D0Q3SU HIGHSTAT Patented D0Q4XE DRUG__ID D0Q4XE D0Q4XE DRUGTYPE Small molecular drug D0Q4XE DRUGINCH 1S/C23H22FNO4/c24-20-4-2-1-3-17(20)15-28-19-7-5-16(6-8-19)22-13-18-14-25(12-10-23(26)27)11-9-21(18)29-22/h1-8,13H,9-12,14-15H2,(H,26,27) D0Q4XE DRUGINKE TUHBOROWRALEDS-UHFFFAOYSA-N D0Q4XE DRUGSMIL C1CN(CC2=C1OC(=C2)C3=CC=C(C=C3)OCC4=CC=CC=C4F)CCC(=O)O D0Q4XE HIGHSTAT Patented D0Q6PR DRUG__ID D0Q6PR D0Q6PR DRUGTYPE Small molecular drug D0Q6PR DRUGINCH 1S/C4H10O6S4.2Na/c5-13(6,7)3-1-11-12-2-4-14(8,9)10;;/h1-4H2,(H,5,6,7)(H,8,9,10);;/q;2*+1 D0Q6PR DRUGINKE KQYGMURBTJPBPQ-UHFFFAOYSA-N D0Q6PR DRUGSMIL C(CS(=O)(=O)O)SSCCS(=O)(=O)O.[Na+].[Na+] D0Q6PR HIGHSTAT Patented D0Q7KI DRUG__ID D0Q7KI D0Q7KI DRUGTYPE Small molecular drug D0Q7KI DRUGINCH 1S/C10H8FN5O2S2/c11-5-1-6-7(2-8(5)20(13,17)18)19-10(15-6)4-3-14-16-9(4)12/h1-3H,(H3,12,14,16)(H2,13,17,18) D0Q7KI DRUGINKE MJSWBRWBMZMVTH-UHFFFAOYSA-N D0Q7KI DRUGSMIL C1=C2C(=CC(=C1F)S(=O)(=O)N)SC(=N2)C3=C(NN=C3)N D0Q7KI HIGHSTAT Patented D0Q9AF DRUG__ID D0Q9AF D0Q9AF DRUGTYPE Small molecular drug D0Q9AF DRUGINCH 1S/C15H13ClN2O4/c1-22-13(20)8-18-15(21)14-12(19)6-10(7-17-14)9-3-2-4-11(16)5-9/h2-7,19H,8H2,1H3,(H,18,21) D0Q9AF DRUGINKE LQWXMRRGVHUWEN-UHFFFAOYSA-N D0Q9AF DRUGSMIL COC(=O)CNC(=O)C1=C(C=C(C=N1)C2=CC(=CC=C2)Cl)O D0Q9AF HIGHSTAT Patented D0QE9Q DRUG__ID D0QE9Q D0QE9Q DRUGTYPE Small molecular drug D0QE9Q DRUGINCH 1S/C20H20F3N5O3S/c21-20(22,23)18-26-16-14(17(31)28(18)9-10-29)25-19(32-16)27-8-4-7-13(27)15(30)24-11-12-5-2-1-3-6-12/h1-3,5-6,13,29H,4,7-11H2,(H,24,30)/t13-/m1/s1 D0QE9Q DRUGINKE SXQHHSSAGQUGBT-CYBMUJFWSA-N D0QE9Q DRUGSMIL C1CC(N(C1)C2=NC3=C(S2)N=C(N(C3=O)CCO)C(F)(F)F)C(=O)NCC4=CC=CC=C4 D0QE9Q HIGHSTAT Patented D0QG9P DRUG__ID D0QG9P D0QG9P DRUGTYPE Small molecular drug D0QG9P DRUGINCH 1S/C22H23Br2N5O6/c23-13-1-11(2-14(24)5-13)18(7-20(33)34)29-19(32)10-25-21(35)12-3-15(6-16(30)4-12)28-22-26-8-17(31)9-27-22/h1-6,17-18,30-31H,7-10H2,(H,25,35)(H,29,32)(H,33,34)(H2,26,27,28)/t18-/m0/s1 D0QG9P DRUGINKE BWAUVRFZNDRMLY-SFHVURJKSA-N D0QG9P DRUGSMIL C1C(CN=C(N1)NC2=CC(=CC(=C2)C(=O)NCC(=O)NC(CC(=O)O)C3=CC(=CC(=C3)Br)Br)O)O D0QG9P HIGHSTAT Patented D0QI0J DRUG__ID D0QI0J D0QI0J DRUGTYPE Small molecular drug D0QI0J DRUGINCH 1S/C14H10F2N2O5/c15-8-2-1-3-10(12(8)16)23-7-4-9(19)13(17-5-7)14(22)18-6-11(20)21/h1-5,19H,6H2,(H,18,22)(H,20,21) D0QI0J DRUGINKE CTRIOCMSHSAPNW-UHFFFAOYSA-N D0QI0J DRUGSMIL C1=CC(=C(C(=C1)F)F)OC2=CC(=C(N=C2)C(=O)NCC(=O)O)O D0QI0J HIGHSTAT Patented D0QQ3B DRUG__ID D0QQ3B D0QQ3B DRUGTYPE Small molecular drug D0QQ3B DRUGINCH 1S/C19H23N5O5S/c1-11-7-16(22-15-8-13(18(25)19(15)26)10-29-30(20,27)28)24-17(21-11)9-14(23-24)12-5-3-2-4-6-12/h2-7,9,13,15,18-19,22,25-26H,8,10H2,1H3,(H2,20,27,28)/t13-,15-,18-,19+/m1/s1 D0QQ3B DRUGINKE LFVBSFKFKWBKIB-LRHNDGHRSA-N D0QQ3B DRUGSMIL CC1=NC2=CC(=NN2C(=C1)NC3CC(C(C3O)O)COS(=O)(=O)N)C4=CC=CC=C4 D0QQ3B HIGHSTAT Patented D0QR0E DRUG__ID D0QR0E D0QR0E DRUGTYPE Small molecular drug D0QR0E DRUGINCH 1S/C9H9F3O2/c1-2-6-7(9(10,11)12)3-5(13)4-8(6)14/h3-4,13-14H,2H2,1H3 D0QR0E DRUGINKE KNSOMAAWMTUOTF-UHFFFAOYSA-N D0QR0E DRUGSMIL CCC1=C(C=C(C=C1O)O)C(F)(F)F D0QR0E HIGHSTAT Patented D0QU3G DRUG__ID D0QU3G D0QU3G DRUGTYPE Small molecular drug D0QU3G DRUGINCH 1S/C22H26N2/c1-23(2)14-15-24(17-19-8-4-3-5-9-19)18-20-12-13-21-10-6-7-11-22(21)16-20/h3-13,16H,14-15,17-18H2,1-2H3 D0QU3G DRUGINKE MOXMQBPFKXNWCD-UHFFFAOYSA-N D0QU3G DRUGSMIL CN(C)CCN(CC1=CC=CC=C1)CC2=CC3=CC=CC=C3C=C2 D0QU3G HIGHSTAT Patented D0QU7N DRUG__ID D0QU7N D0QU7N DRUGTYPE Small molecular drug D0QU7N DRUGINCH 1S/C26H31N5O3/c1-16-14-31(15-20(27)25(16)32)24-6-9-28-13-23(24)30-26(33)21-5-4-18-2-3-19(12-22(18)29-21)17-7-10-34-11-8-17/h2-6,9,12-13,16-17,20,25,32H,7-8,10-11,14-15,27H2,1H3,(H,30,33)/t16-,20+,25+/m0/s1 D0QU7N DRUGINKE ZCIAXCLJCAUHGJ-CQSIOLINSA-N D0QU7N DRUGSMIL CC1CN(CC(C1O)N)C2=C(C=NC=C2)NC(=O)C3=NC4=C(C=CC(=C4)C5CCOCC5)C=C3 D0QU7N HIGHSTAT Patented D0QU9I DRUG__ID D0QU9I D0QU9I DRUGTYPE Small molecular drug D0QU9I DRUGINCH 1S/C22H30ClN7O3/c1-6-9-33-19-11-15(10-17(23)25-19)24-22(32)28-30(7-8-31)18-12-16(13(2)3)20-14(4)27-29(5)21(20)26-18/h10-13,31H,6-9H2,1-5H3,(H2,24,25,28,32) D0QU9I DRUGINKE GOQBSVFOBGVWTA-UHFFFAOYSA-N D0QU9I DRUGSMIL CCCOC1=NC(=CC(=C1)NC(=O)NN(CCO)C2=NC3=C(C(=NN3C)C)C(=C2)C(C)C)Cl D0QU9I HIGHSTAT Patented D0QX1S DRUG__ID D0QX1S D0QX1S DRUGTYPE Small molecular drug D0QX1S DRUGINCH 1S/C23H21N3O2/c1-26-21(27)23(25-22(26)24,18-10-4-3-5-11-18)19-12-6-8-16(14-19)17-9-7-13-20(15-17)28-2/h3-15H,1-2H3,(H2,24,25) D0QX1S DRUGINKE LRYKHTDVFXMHEH-UHFFFAOYSA-N D0QX1S DRUGSMIL CN1C(=O)C(N=C1N)(C2=CC=CC=C2)C3=CC=CC(=C3)C4=CC(=CC=C4)OC D0QX1S HIGHSTAT Patented D0QX2U DRUG__ID D0QX2U D0QX2U DRUGTYPE Small molecular drug D0QX2U DRUGINCH 1S/C17H15FN4O2/c18-11-3-4-15-14(8-11)13(5-6-20-15)17(24)21-10-16(23)22-7-1-2-12(22)9-19/h3-6,8,12H,1-2,7,10H2,(H,21,24)/t12-/m0/s1 D0QX2U DRUGINKE CRWCYVOHVXAEMF-LBPRGKRZSA-N D0QX2U DRUGSMIL C1CC(N(C1)C(=O)CNC(=O)C2=C3C=C(C=CC3=NC=C2)F)C#N D0QX2U HIGHSTAT Patented D0QZ4B DRUG__ID D0QZ4B D0QZ4B DRUGTYPE Small molecular drug D0QZ4B DRUGINCH 1S/C22H14ClF3N8OS/c23-16-3-1-13(8-15(16)22(24,25)26)30-21(35)29-12-2-4-17-10(5-12)7-18(36-17)14-6-11(9-28-19(14)27)20-31-33-34-32-20/h1-9H,(H2,27,28)(H2,29,30,35)(H,31,32,33,34) D0QZ4B DRUGINKE LHUVPYZTQHNXRU-UHFFFAOYSA-N D0QZ4B DRUGSMIL C1=CC2=C(C=C1NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)C=C(S2)C4=C(N=CC(=C4)C5=NNN=N5)N D0QZ4B HIGHSTAT Patented D0R2GT DRUG__ID D0R2GT D0R2GT DRUGTYPE Small molecular drug D0R2GT DRUGINCH 1S/C14H10N2O2/c17-14(18)10-6-7-15-12-8-11(16-13(10)12)9-4-2-1-3-5-9/h1-8,16H,(H,17,18) D0R2GT DRUGINKE FEZIKLVLFANZBD-UHFFFAOYSA-N D0R2GT DRUGSMIL C1=CC=C(C=C1)C2=CC3=NC=CC(=C3N2)C(=O)O D0R2GT HIGHSTAT Patented D0R2VB DRUG__ID D0R2VB D0R2VB DRUGTYPE Small molecular drug D0R2VB DRUGINCH 1S/C19H25ClN4OSi/c1-26(2,3)16-8-6-15(7-9-16)22-19(25)24-13-11-23(12-14-24)18-17(20)5-4-10-21-18/h4-10H,11-14H2,1-3H3,(H,22,25) D0R2VB DRUGINKE VOWXQOSAQUYVQK-UHFFFAOYSA-N D0R2VB DRUGSMIL C[Si](C)(C)C1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl D0R2VB HIGHSTAT Patented D0R4CX DRUG__ID D0R4CX D0R4CX DRUGTYPE Small molecular drug D0R4CX DRUGINCH 1S/C26H21N3O5/c1-26(2,25(32)33)14-28-24(31)22-23(30)19-10-9-18(12-20(19)21(13-27)29-22)34-17-8-7-15-5-3-4-6-16(15)11-17/h3-12,30H,14H2,1-2H3,(H,28,31)(H,32,33) D0R4CX DRUGINKE QBSUFMQXFVGWJT-UHFFFAOYSA-N D0R4CX DRUGSMIL CC(C)(CNC(=O)C1=C(C2=C(C=C(C=C2)OC3=CC4=CC=CC=C4C=C3)C(=N1)C#N)O)C(=O)O D0R4CX HIGHSTAT Patented D0R7ED DRUG__ID D0R7ED D0R7ED DRUGTYPE Small molecular drug D0R7ED DRUGINCH 1S/C26H32N4O5/c1-3-17-11-20(10-16(2)24(17)34-15-21(32)13-28-23(33)14-31)25-29-26(35-30-25)19-8-9-27-22(12-19)18-6-4-5-7-18/h8-12,18,21,31-32H,3-7,13-15H2,1-2H3,(H,28,33)/t21-/m0/s1 D0R7ED DRUGINKE XRJPXSNXMMSPIZ-NRFANRHFSA-N D0R7ED DRUGSMIL CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC=C3)C4CCCC4)C)OCC(CNC(=O)CO)O D0R7ED HIGHSTAT Patented D0R9MA DRUG__ID D0R9MA D0R9MA DRUGTYPE Small molecular drug D0R9MA DRUGINCH 1S/C31H45FN12O4/c1-16(2)25(44-28(47)23(41-17(3)45)5-4-12-39-30(35)36)29(48)43-24(13-18-6-10-21(11-7-18)42-31(37)38)27(46)40-15-20-9-8-19(26(33)34)14-22(20)32/h6-11,14,16,23-25H,4-5,12-13,15H2,1-3H3,(H3,33,34)(H,40,46)(H,41,45)(H,43,48)(H,44,47)(H4,35,36,39)(H4,37,38,42)/t23-,24-,25-/m0/s1 D0R9MA DRUGINKE HYFZTDZJLMLSBP-SDHOMARFSA-N D0R9MA DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)N=C(N)N)C(=O)NCC2=C(C=C(C=C2)C(=N)N)F)NC(=O)C(CCCN=C(N)N)NC(=O)C D0R9MA HIGHSTAT Patented D0R9RK DRUG__ID D0R9RK D0R9RK DRUGTYPE Small molecular drug D0R9RK DRUGINCH 1S/C22H26N6/c1-13-7-8-18-17(11-13)19(16-9-10-23-14(2)12-16)20(22-25-27-28-26-22)21(24-18)15-5-3-4-6-15/h9-10,12-13,15H,3-8,11H2,1-2H3,(H,25,26,27,28) D0R9RK DRUGINKE LSPFDXQDUWKIKF-UHFFFAOYSA-N D0R9RK DRUGSMIL CC1CCC2=C(C1)C(=C(C(=N2)C3CCCC3)C4=NNN=N4)C5=CC(=NC=C5)C D0R9RK HIGHSTAT Patented D0RA0D DRUG__ID D0RA0D D0RA0D DRUGTYPE Small molecular drug D0RA0D DRUGINCH 1S/C14H11N3O3S/c18-12(16-20)10-5-3-9(4-6-10)8-17-14(19)11-2-1-7-15-13(11)21-17/h1-7,20H,8H2,(H,16,18) D0RA0D DRUGINKE VLJAVCKTTLIBDT-UHFFFAOYSA-N D0RA0D DRUGSMIL C1=CC2=C(N=C1)SN(C2=O)CC3=CC=C(C=C3)C(=O)NO D0RA0D HIGHSTAT Patented D0RC5I DRUG__ID D0RC5I D0RC5I DRUGTYPE Small molecular drug D0RC5I DRUGINCH 1S/C29H30Cl2F3N3O5S/c1-28(16-38,17-39)35-27(40)20-11-21(29(32,33)34)13-24(12-20)37(43(2,41)42)25-14-36(15-25)26(18-3-7-22(30)8-4-18)19-5-9-23(31)10-6-19/h3-13,25-26,38-39H,14-17H2,1-2H3,(H,35,40) D0RC5I DRUGINKE OMKQCMZJBZXEKN-UHFFFAOYSA-N D0RC5I DRUGSMIL CC(CO)(CO)NC(=O)C1=CC(=CC(=C1)N(C2CN(C2)C(C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl)S(=O)(=O)C)C(F)(F)F D0RC5I HIGHSTAT Patented D0RC7R DRUG__ID D0RC7R D0RC7R DRUGTYPE Small molecular drug D0RC7R DRUGINCH 1S/C11H10O3/c12-10-2-1-9(11(13)6-10)5-8-3-4-14-7-8/h1-4,6-7,12-13H,5H2 D0RC7R DRUGINKE LOAGBHXAWVQEGF-UHFFFAOYSA-N D0RC7R DRUGSMIL C1=CC(=C(C=C1O)O)CC2=COC=C2 D0RC7R HIGHSTAT Patented D0RL7G DRUG__ID D0RL7G D0RL7G DRUGTYPE Small molecular drug D0RL7G DRUGINCH 1S/C28H24F2N4O2/c1-17(2)26-25(27(35)31-14-19-8-11-22(29)23(30)12-19)21-10-9-20(28-33-32-16-36-28)13-24(21)34(26)15-18-6-4-3-5-7-18/h3-13,16-17H,14-15H2,1-2H3,(H,31,35) D0RL7G DRUGINKE JRPPHTCHABUGFY-UHFFFAOYSA-N D0RL7G DRUGSMIL CC(C)C1=C(C2=C(N1CC3=CC=CC=C3)C=C(C=C2)C4=NN=CO4)C(=O)NCC5=CC(=C(C=C5)F)F D0RL7G HIGHSTAT Patented D0RN9V DRUG__ID D0RN9V D0RN9V DRUGTYPE Small molecular drug D0RN9V DRUGINCH 1S/C34H43N5O4S/c1-3-24-13-15-27(16-14-24)28-9-6-11-30(23-28)44(42,43)38-31(22-26-8-4-10-29(21-26)33(35)36)34(41)39-19-17-25(18-20-39)7-5-12-32(40)37-2/h4,6,8-11,13-16,21,23,25,31,38H,3,5,7,12,17-20,22H2,1-2H3,(H3,35,36)(H,37,40)/t31-/m0/s1 D0RN9V DRUGINKE CGNCDGWBKGYOAP-HKBQPEDESA-N D0RN9V DRUGSMIL CCC1=CC=C(C=C1)C2=CC(=CC=C2)S(=O)(=O)NC(CC3=CC(=CC=C3)C(=N)N)C(=O)N4CCC(CC4)CCCC(=O)NC D0RN9V HIGHSTAT Patented D0RP0H DRUG__ID D0RP0H D0RP0H DRUGTYPE Small molecular drug D0RP0H DRUGINCH 1S/C23H23N3O2/c1-4-7-18(23(27)28)20-15(3)24-22-17-8-5-6-9-19(17)25-26(22)21(20)16-12-10-14(2)11-13-16/h5-6,8-13,18H,4,7H2,1-3H3,(H,27,28) D0RP0H DRUGINKE ZCHVIKJTLWPNBL-UHFFFAOYSA-N D0RP0H DRUGSMIL CCCC(C1=C(N2C(=C3C=CC=CC3=N2)N=C1C)C4=CC=C(C=C4)C)C(=O)O D0RP0H HIGHSTAT Patented D0RQ0B DRUG__ID D0RQ0B D0RQ0B DRUGTYPE Small molecular drug D0RQ0B DRUGINCH 1S/C26H26Cl2N4O/c27-23-24(28)32(18-29-23)17-19-8-7-9-20(16-19)25-30-22(33-31-25)12-15-26(13-5-2-6-14-26)21-10-3-1-4-11-21/h1,3-4,7-11,16,18H,2,5-6,12-15,17H2 D0RQ0B DRUGINKE TVHRMMKSOSXQRC-UHFFFAOYSA-N D0RQ0B DRUGSMIL C1CCC(CC1)(CCC2=NC(=NO2)C3=CC=CC(=C3)CN4C=NC(=C4Cl)Cl)C5=CC=CC=C5 D0RQ0B HIGHSTAT Patented D0RR5C DRUG__ID D0RR5C D0RR5C DRUGTYPE Small molecular drug D0RR5C DRUGINCH 1S/C7H10N4O2/c1-10-6-4(3-9-10)2-5(8)7(12)11(6)13/h3,5,13H,2,8H2,1H3/t5-/m0/s1 D0RR5C DRUGINKE OETBHDOEBPITJA-YFKPBYRVSA-N D0RR5C DRUGSMIL CN1C2=C(CC(C(=O)N2O)N)C=N1 D0RR5C HIGHSTAT Patented D0RS6O DRUG__ID D0RS6O D0RS6O DRUGTYPE Small molecular drug D0RS6O DRUGINCH 1S/C28H36N2O2/c31-27(15-21-29-17-3-1-4-18-29)25-11-7-23(8-12-25)24-9-13-26(14-10-24)28(32)16-22-30-19-5-2-6-20-30/h7-14H,1-6,15-22H2 D0RS6O DRUGINKE OEJCMWCXCHXDOS-UHFFFAOYSA-N D0RS6O DRUGSMIL C1CCN(CC1)CCC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)CCN4CCCCC4 D0RS6O HIGHSTAT Patented D0RZ9C DRUG__ID D0RZ9C D0RZ9C DRUGTYPE Small molecular drug D0RZ9C DRUGINCH 1S/C21H18ClFN6/c22-15-11-14-17(12-16(15)23)24-21(29-9-5-2-6-10-29)19(20-25-27-28-26-20)18(14)13-7-3-1-4-8-13/h1,3-4,7-8,11-12H,2,5-6,9-10H2,(H,25,26,27,28) D0RZ9C DRUGINKE APFHIGYPDALGOX-UHFFFAOYSA-N D0RZ9C DRUGSMIL C1CCN(CC1)C2=NC3=CC(=C(C=C3C(=C2C4=NNN=N4)C5=CC=CC=C5)Cl)F D0RZ9C HIGHSTAT Patented D0S0MC DRUG__ID D0S0MC D0S0MC DRUGTYPE Small molecular drug D0S0MC DRUGINCH 1S/C28H28F2N2O2/c1-4-34-21-11-12-22-25(15-21)32(17-19-8-6-5-7-9-19)27(18(2)3)26(22)28(33)31-16-20-10-13-23(29)24(30)14-20/h5-15,18H,4,16-17H2,1-3H3,(H,31,33) D0S0MC DRUGINKE HYKLZEZGHJEJET-UHFFFAOYSA-N D0S0MC DRUGSMIL CCOC1=CC2=C(C=C1)C(=C(N2CC3=CC=CC=C3)C(C)C)C(=O)NCC4=CC(=C(C=C4)F)F D0S0MC HIGHSTAT Patented D0S2ED DRUG__ID D0S2ED D0S2ED DRUGTYPE Small molecular drug D0S2ED DRUGINCH 1S/C31H30N4O3/c1-21(36)34-28-4-2-3-25(18-28)24-11-14-35(15-12-24)16-13-33-31(37)30-19-27-17-26(9-10-29(27)38-30)23-7-5-22(20-32)6-8-23/h2-10,17-19,24H,11-16H2,1H3,(H,33,37)(H,34,36) D0S2ED DRUGINKE FYWPSNHXRLJIKV-UHFFFAOYSA-N D0S2ED DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCNC(=O)C3=CC4=C(O3)C=CC(=C4)C5=CC=C(C=C5)C#N D0S2ED HIGHSTAT Patented D0S3QX DRUG__ID D0S3QX D0S3QX DRUGTYPE Small molecular drug D0S3QX DRUGINCH 1S/C22H14O6/c1-9-7-11-12(23)3-4-13(24)19(11)22(28)18(9)17-10(2)8-16(27)20-14(25)5-6-15(26)21(17)20/h3-8,27-28H,1-2H3 D0S3QX DRUGINKE OEEOHKZVBKYMBA-UHFFFAOYSA-N D0S3QX DRUGSMIL CC1=CC2=C(C(=O)C=CC2=O)C(=C1C3=C4C(=O)C=CC(=O)C4=C(C=C3C)O)O D0S3QX HIGHSTAT Patented D0S7BW DRUG__ID D0S7BW D0S7BW DRUGTYPE Small molecular drug D0S7BW DRUGINCH 1S/C18H22N2O/c21-18(13-6-2-1-3-7-13)10-15-14-8-4-5-9-16(14)20-12-19-11-17(15)20/h4-5,8-9,11-13,15,18,21H,1-3,6-7,10H2 D0S7BW DRUGINKE MENMLCRHDMAGQE-UHFFFAOYSA-N D0S7BW DRUGSMIL C1CCC(CC1)C(CC2C3=CC=CC=C3N4C2=CN=C4)O D0S7BW HIGHSTAT Patented D0S8CH DRUG__ID D0S8CH D0S8CH DRUGTYPE Small molecular drug D0S8CH DRUGINCH 1S/C18H19F8N5O3/c19-16(20)3-1-11(32)31(15(16)34)6-8(27)5-12(33)30-4-2-9-10(7-30)28-14(18(24,25)26)29-13(9)17(21,22)23/h8,15,34H,1-7,27H2/t8-,15-/m0/s1 D0S8CH DRUGINKE DMXWXVXGQLCKOY-AYVTZFPOSA-N D0S8CH DRUGSMIL C1CC(C(N(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)O)(F)F D0S8CH HIGHSTAT Patented D0SG9Q DRUG__ID D0SG9Q D0SG9Q DRUGTYPE Small molecular drug D0SG9Q DRUGINCH 1S/C20H20Cl2N2O2/c1-20(2,3)18-11-17(15-9-6-13(21)10-16(15)22)24(23-18)14-7-4-12(5-8-14)19(25)26/h4-10,17H,11H2,1-3H3,(H,25,26) D0SG9Q DRUGINKE DIZHQHRVPINGBC-UHFFFAOYSA-N D0SG9Q DRUGSMIL CC(C)(C)C1=NN(C(C1)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)C(=O)O D0SG9Q HIGHSTAT Patented D0SH7F DRUG__ID D0SH7F D0SH7F DRUGTYPE Small molecular drug D0SH7F DRUGINCH 1S/C25H19FN4/c1-17-7-5-6-10-22(17)29-24-23-21(18-8-3-2-4-9-18)15-30(25(23)28-16-27-24)20-13-11-19(26)12-14-20/h2-16H,1H3,(H,27,28,29) D0SH7F DRUGINKE KCNWFXKVXRZIGO-UHFFFAOYSA-N D0SH7F DRUGSMIL CC1=CC=CC=C1NC2=C3C(=CN(C3=NC=N2)C4=CC=C(C=C4)F)C5=CC=CC=C5 D0SH7F HIGHSTAT Patented D0SH7G DRUG__ID D0SH7G D0SH7G DRUGTYPE Small molecular drug D0SH7G DRUGINCH 1S/C22H23F5N6O3/c23-21(24)5-1-16(34)33(20(21)36)10-13(28)9-17(35)32-8-4-14-15(11-32)30-19(12-2-6-29-7-3-12)31-18(14)22(25,26)27/h2-3,6-7,13,20,36H,1,4-5,8-11,28H2/t13-,20-/m0/s1 D0SH7G DRUGINKE JLAXABGHGCBAGV-RBZFPXEDSA-N D0SH7G DRUGSMIL C1CC(C(N(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C4=CC=NC=C4)N)O)(F)F D0SH7G HIGHSTAT Patented D0SJ1U DRUG__ID D0SJ1U D0SJ1U DRUGTYPE Small molecular drug D0SJ1U DRUGINCH 1S/C12H11NO4/c1-17-10-3-2-7(5-9(10)14)4-8-6-11(15)13-12(8)16/h2-5,14H,6H2,1H3,(H,13,15,16)/b8-4+ D0SJ1U DRUGINKE NXKPYDPDZWALNH-XBXARRHUSA-N D0SJ1U DRUGSMIL COC1=C(C=C(C=C1)C=C2CC(=O)NC2=O)O D0SJ1U HIGHSTAT Patented D0SK3V DRUG__ID D0SK3V D0SK3V DRUGTYPE Small molecular drug D0SK3V DRUGINCH 1S/C28H32F3N5O4S2/c1-4-42(38,39)22-6-5-21(32-16-22)15-33-25(37)23-12-19-11-17(2)40-27(24(19)41-23)7-9-36(10-8-27)18(3)20-13-34-26(35-14-20)28(29,30)31/h5-6,12-14,16-18H,4,7-11,15H2,1-3H3,(H,33,37)/t17-,18+/m0/s1 D0SK3V DRUGINKE ILXLMNLDODDHOQ-ZWKOTPCHSA-N D0SK3V DRUGSMIL CCS(=O)(=O)C1=CN=C(C=C1)CNC(=O)C2=CC3=C(S2)C4(CCN(CC4)C(C)C5=CN=C(N=C5)C(F)(F)F)OC(C3)C D0SK3V HIGHSTAT Patented D0SM8Z DRUG__ID D0SM8Z D0SM8Z DRUGTYPE Small molecular drug D0SM8Z DRUGINCH 1S/C20H17FN2O4/c21-15-6-3-12(4-7-15)13-5-8-16-14(10-13)11-23-18(19(16)26)20(27)22-9-1-2-17(24)25/h3-8,10-11,26H,1-2,9H2,(H,22,27)(H,24,25) D0SM8Z DRUGINKE ZCPXHSRUGVQBOS-UHFFFAOYSA-N D0SM8Z DRUGSMIL C1=CC(=CC=C1C2=CC3=CN=C(C(=C3C=C2)O)C(=O)NCCCC(=O)O)F D0SM8Z HIGHSTAT Patented D0SZ3I DRUG__ID D0SZ3I D0SZ3I DRUGTYPE Small molecular drug D0SZ3I DRUGINCH 1S/C25H26N4O2/c1-24(30)14-17(15-24)23-28-20(21-22(26)27-12-13-29(21)23)16-8-10-19(11-9-16)25(2,31)18-6-4-3-5-7-18/h3-13,17,30-31H,14-15H2,1-2H3,(H2,26,27) D0SZ3I DRUGINKE MUKLAWDKMYGQSN-UHFFFAOYSA-N D0SZ3I DRUGSMIL CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(C)(C5=CC=CC=C5)O)O D0SZ3I HIGHSTAT Patented D0SZ7H DRUG__ID D0SZ7H D0SZ7H DRUGTYPE Small molecular drug D0SZ7H DRUGINCH 1S/C12H12N4O2/c13-10-6-8-7-15(9-4-2-1-3-5-9)14-11(8)16(18)12(10)17/h1-5,7,10,18H,6,13H2/t10-/m0/s1 D0SZ7H DRUGINKE AUAOKUNOKVGYJP-JTQLQIEISA-N D0SZ7H DRUGSMIL C1C(C(=O)N(C2=NN(C=C21)C3=CC=CC=C3)O)N D0SZ7H HIGHSTAT Patented D0T0YA DRUG__ID D0T0YA D0T0YA DRUGTYPE Small molecular drug D0T0YA DRUGINCH 1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16) D0T0YA DRUGINKE IAVUPMFITXYVAF-UHFFFAOYSA-N D0T0YA DRUGSMIL CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C D0T0YA HIGHSTAT Patented D0T2KT DRUG__ID D0T2KT D0T2KT DRUGTYPE Small molecular drug D0T2KT DRUGINCH 1S/C22H16FN5OS/c1-28-20-14(11-19(21(28)29)30-17-5-2-15(23)3-6-17)12-25-22(27-20)26-16-4-7-18-13(10-16)8-9-24-18/h2-12,24H,1H3,(H,25,26,27) D0T2KT DRUGINKE FJECSOOLAWUZAB-UHFFFAOYSA-N D0T2KT DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)SC3=CC=C(C=C3)F)NC4=CC5=C(C=C4)NC=C5 D0T2KT HIGHSTAT Patented D0T4SV DRUG__ID D0T4SV D0T4SV DRUGTYPE Small molecular drug D0T4SV DRUGINCH 1S/C27H19F3N4O4/c28-27(29,30)19-21(34-37-23(19)14-4-2-1-3-5-14)24-18-9-6-15-12-16(7-8-17(15)20(18)33-38-24)22(35)25(36)32-26(13-31)10-11-26/h1-5,7-8,12,22,35H,6,9-11H2,(H,32,36) D0T4SV DRUGINKE XVGCLGONKUIZED-UHFFFAOYSA-N D0T4SV DRUGSMIL C1CC2=C(ON=C2C3=C1C=C(C=C3)C(C(=O)NC4(CC4)C#N)O)C5=NOC(=C5C(F)(F)F)C6=CC=CC=C6 D0T4SV HIGHSTAT Patented D0T6SD DRUG__ID D0T6SD D0T6SD DRUGTYPE Small molecular drug D0T6SD DRUGINCH 1S/C28H26N10O2/c1-2-3-13-36-24-25(34-27(36)35-12-6-9-21(31)18-35)37(16-19-7-4-10-32-22(19)14-29)28(40)38(26(24)39)17-20-8-5-11-33-23(20)15-30/h4-5,7-8,10-11,21H,6,9,12-13,16-18,31H2,1H3/t21-/m1/s1 D0T6SD DRUGINKE BQCBNCZDTPPBMN-OAQYLSRUSA-N D0T6SD DRUGSMIL CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=C(N=CC=C4)C#N)CC5=C(N=CC=C5)C#N D0T6SD HIGHSTAT Patented D0T7OQ DRUG__ID D0T7OQ D0T7OQ DRUGTYPE Small molecular drug D0T7OQ DRUGINCH 1S/C17H10F3N3O2/c18-17(19,20)16-21-14(22-25-16)10-6-7-13-11(8-10)9-23(15(13)24)12-4-2-1-3-5-12/h1-8H,9H2 D0T7OQ DRUGINKE FROSXYATWLHDNN-UHFFFAOYSA-N D0T7OQ DRUGSMIL C1C2=C(C=CC(=C2)C3=NOC(=N3)C(F)(F)F)C(=O)N1C4=CC=CC=C4 D0T7OQ HIGHSTAT Patented D0T8BO DRUG__ID D0T8BO D0T8BO DRUGTYPE Small molecular drug D0T8BO DRUGINCH 1S/C23H16ClFN6OS/c1-11-2-4-14-13(6-7-27-22(14)30-12-3-5-17(25)16(24)8-12)18(11)31-23(32)15-9-33-20-19(15)28-10-29-21(20)26/h2-10H,1H3,(H,27,30)(H,31,32)(H2,26,28,29) D0T8BO DRUGINKE GNDBDDNLWIOKDN-UHFFFAOYSA-N D0T8BO DRUGSMIL CC1=C(C2=C(C=C1)C(=NC=C2)NC3=CC(=C(C=C3)F)Cl)NC(=O)C4=CSC5=C4N=CN=C5N D0T8BO HIGHSTAT Patented D0T8FV DRUG__ID D0T8FV D0T8FV DRUGTYPE Small molecular drug D0T8FV DRUGINCH 1S/C24H31FN2O3/c1-3-18(4-2)17-24(29)12-14-27(15-13-24)23(28)26-20-6-5-7-22(16-20)30-21-10-8-19(25)9-11-21/h5-11,16,18,29H,3-4,12-15,17H2,1-2H3,(H,26,28) D0T8FV DRUGINKE QDTNDGDKXXSUJU-UHFFFAOYSA-N D0T8FV DRUGSMIL CCC(CC)CC1(CCN(CC1)C(=O)NC2=CC(=CC=C2)OC3=CC=C(C=C3)F)O D0T8FV HIGHSTAT Patented D0T8YT DRUG__ID D0T8YT D0T8YT DRUGTYPE Small molecular drug D0T8YT DRUGINCH 1S/C16H24N4O2/c1-10(2)13-8-14(19-18-13)16(22)20-7-6-12(9-20)17-15(21)11-4-3-5-11/h8,10-12H,3-7,9H2,1-2H3,(H,17,21)(H,18,19) D0T8YT DRUGINKE WFZQSICPYNAMNU-UHFFFAOYSA-N D0T8YT DRUGSMIL CC(C)C1=CC(=NN1)C(=O)N2CCC(C2)NC(=O)C3CCC3 D0T8YT HIGHSTAT Patented D0T9IR DRUG__ID D0T9IR D0T9IR DRUGTYPE Small molecular drug D0T9IR DRUGINCH 1S/C15H13N7OS/c1-9-7-24-15(19-9)20-14(23)11-5-10(12-3-4-17-21(12)2)6-22-13(11)16-8-18-22/h3-8H,1-2H3,(H,19,20,23) D0T9IR DRUGINKE POJPLPZXVLFMAM-UHFFFAOYSA-N D0T9IR DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC(=CN3C2=NC=N3)C4=CC=NN4C D0T9IR HIGHSTAT Patented D0T9JA DRUG__ID D0T9JA D0T9JA DRUGTYPE Small molecular drug D0T9JA DRUGINCH 1S/C24H22F2N4O/c1-23(31)13-16(14-23)22-29-19(20-21(27)28-11-12-30(20)22)15-7-9-18(10-8-15)24(25,26)17-5-3-2-4-6-17/h2-12,16,31H,13-14H2,1H3,(H2,27,28) D0T9JA DRUGINKE QXYZHRYXSNHAFM-UHFFFAOYSA-N D0T9JA DRUGSMIL CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(C5=CC=CC=C5)(F)F)O D0T9JA HIGHSTAT Patented D0TA9C DRUG__ID D0TA9C D0TA9C DRUGTYPE Small molecular drug D0TA9C DRUGINCH 1S/C21H19NO3/c1-13(2)22-21(25)17-5-3-4-14(11-17)15-6-8-18-16(10-15)7-9-20(24)19(18)12-23/h3-13,24H,1-2H3,(H,22,25) D0TA9C DRUGINKE LCESLTUVSXEGCC-UHFFFAOYSA-N D0TA9C DRUGSMIL CC(C)NC(=O)C1=CC=CC(=C1)C2=CC3=C(C=C2)C(=C(C=C3)O)C=O D0TA9C HIGHSTAT Patented D0TG1V DRUG__ID D0TG1V D0TG1V DRUGTYPE Small molecular drug D0TG1V DRUGINCH 1S/C19H22F4N4O2S/c1-12(2)15-11-26(13-4-5-14(20)16(10-13)30(3,28)29)8-9-27(15)18-24-7-6-17(25-18)19(21,22)23/h4-7,10,12,15H,8-9,11H2,1-3H3/t15-/m0/s1 D0TG1V DRUGINKE YTEDTWJJQBCOTI-HNNXBMFYSA-N D0TG1V DRUGSMIL CC(C)C1CN(CCN1C2=NC=CC(=N2)C(F)(F)F)C3=CC(=C(C=C3)F)S(=O)(=O)C D0TG1V HIGHSTAT Patented D0TI5Y DRUG__ID D0TI5Y D0TI5Y DRUGTYPE Small molecular drug D0TI5Y DRUGINCH 1S/C34H40N8O3/c1-6-9-28-27(20-22-12-14-23(15-13-22)25-10-7-8-11-26(25)29-37-39-40-38-29)30(43)41(31-35-21-36-42(28)31)24-16-18-34(19-17-24)44-32(2,3)33(4,5)45-34/h7-8,10-15,21,24H,6,9,16-20H2,1-5H3,(H,37,38,39,40) D0TI5Y DRUGINKE QMZXPLFRIAZTAV-UHFFFAOYSA-N D0TI5Y DRUGSMIL CCCC1=C(C(=O)N(C2=NC=NN12)C3CCC4(CC3)OC(C(O4)(C)C)(C)C)CC5=CC=C(C=C5)C6=CC=CC=C6C7=NNN=N7 D0TI5Y HIGHSTAT Patented D0TL2C DRUG__ID D0TL2C D0TL2C DRUGTYPE Small molecular drug D0TL2C DRUGINCH 1S/C18H22O5/c1-21-14-10-17(22-2)15(18(11-14)23-3)6-4-5-12-7-8-13(19)9-16(12)20/h7-11,19-20H,4-6H2,1-3H3 D0TL2C DRUGINKE BLSIHFDETVSCHH-UHFFFAOYSA-N D0TL2C DRUGSMIL COC1=CC(=C(C(=C1)OC)CCCC2=C(C=C(C=C2)O)O)OC D0TL2C HIGHSTAT Patented D0U2EG DRUG__ID D0U2EG D0U2EG DRUGTYPE Small molecular drug D0U2EG DRUGINCH 1S/C20H22F3N5O3S/c1-11(2)17-18-25-13-8-12(10-29)15(32(3,30)31)9-14(13)27(18)6-7-28(17)19-24-5-4-16(26-19)20(21,22)23/h4-5,8-9,11,17,29H,6-7,10H2,1-3H3/t17-/m1/s1 D0U2EG DRUGINKE CABUZECPUSGGRX-QGZVFWFLSA-N D0U2EG DRUGSMIL CC(C)C1C2=NC3=C(N2CCN1C4=NC=CC(=N4)C(F)(F)F)C=C(C(=C3)CO)S(=O)(=O)C D0U2EG HIGHSTAT Patented D0U2SI DRUG__ID D0U2SI D0U2SI DRUGTYPE Small molecular drug D0U2SI DRUGINCH 1S/C22H26N6/c1-3-7-16(8-4-1)21-20(22-25-27-28-26-22)19(15-11-13-23-14-12-15)17-9-5-2-6-10-18(17)24-21/h11-14,16H,1-10H2,(H,25,26,27,28) D0U2SI DRUGINKE FMTDJMYDWZGVPK-UHFFFAOYSA-N D0U2SI DRUGSMIL C1CCC(CC1)C2=NC3=C(CCCCC3)C(=C2C4=NNN=N4)C5=CC=NC=C5 D0U2SI HIGHSTAT Patented D0U4EO DRUG__ID D0U4EO D0U4EO DRUGTYPE Small molecular drug D0U4EO DRUGINCH 1S/C28H39N7O3S/c29-12-9-19-10-13-35(14-11-19)28(36)25(16-20-3-1-5-22(15-20)27(31)32)34-39(37,38)24-6-2-4-21(17-24)23-7-8-26(30)33-18-23/h1-6,15,17,19,23,25,34H,7-14,16,18,29H2,(H2,30,33)(H3,31,32) D0U4EO DRUGINKE JLKDEEFFWQESQM-UHFFFAOYSA-N D0U4EO DRUGSMIL C1CC(=NCC1C2=CC(=CC=C2)S(=O)(=O)NC(CC3=CC(=CC=C3)C(=N)N)C(=O)N4CCC(CC4)CCN)N D0U4EO HIGHSTAT Patented D0U4IE DRUG__ID D0U4IE D0U4IE DRUGTYPE Small molecular drug D0U4IE DRUGINCH 1S/C26H34N4O3/c1-3-6-18-10-11-20(14-19(18)7-4-2)25-28-24(29-33-25)22-8-5-9-23-21(22)12-13-30(23)15-26(27,16-31)17-32/h5,8-11,14,31-32H,3-4,6-7,12-13,15-17,27H2,1-2H3 D0U4IE DRUGINKE KVXIWHRSUIQTTC-UHFFFAOYSA-N D0U4IE DRUGSMIL CCCC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCN(C4=CC=C3)CC(CO)(CO)N)CCC D0U4IE HIGHSTAT Patented D0U5GU DRUG__ID D0U5GU D0U5GU DRUGTYPE Small molecular drug D0U5GU DRUGINCH 1S/C23H23N/c1-4-12-20(13-5-1)23(24-18-10-11-19-24,21-14-6-2-7-15-21)22-16-8-3-9-17-22/h1-9,12-17H,10-11,18-19H2 D0U5GU DRUGINKE DVFDHIZVAQOEMX-UHFFFAOYSA-N D0U5GU DRUGSMIL C1CCN(C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D0U5GU HIGHSTAT Patented D0U5IW DRUG__ID D0U5IW D0U5IW DRUGTYPE Small molecular drug D0U5IW DRUGINCH 1S/C30H29FN6O3/c1-16-5-4-6-17(2)23(16)15-32-26(38)13-20-11-19(7-9-24(20)31)28-27(18(3)34-30(40)36-28)29(39)35-22-8-10-25-21(12-22)14-33-37-25/h4-12,14,28H,13,15H2,1-3H3,(H,32,38)(H,33,37)(H,35,39)(H2,34,36,40) D0U5IW DRUGINKE IDOAXNXBZZZOFX-UHFFFAOYSA-N D0U5IW DRUGSMIL CC1=C(C(=CC=C1)C)CNC(=O)CC2=C(C=CC(=C2)C3C(=C(NC(=O)N3)C)C(=O)NC4=CC5=C(C=C4)NN=C5)F D0U5IW HIGHSTAT Patented D0U5VO DRUG__ID D0U5VO D0U5VO DRUGTYPE Small molecular drug D0U5VO DRUGINCH 1S/C18H24ClN3O4S/c1-12-17(13(2)21-20-12)27(24,25)22-8-6-18(23,7-9-22)11-14-4-5-15(19)10-16(14)26-3/h4-5,10,23H,6-9,11H2,1-3H3,(H,20,21) D0U5VO DRUGINKE JDTHPTFPMSSAJL-UHFFFAOYSA-N D0U5VO DRUGSMIL CC1=C(C(=NN1)C)S(=O)(=O)N2CCC(CC2)(CC3=C(C=C(C=C3)Cl)OC)O D0U5VO HIGHSTAT Patented D0UB5E DRUG__ID D0UB5E D0UB5E DRUGTYPE Small molecular drug D0UB5E DRUGINCH 1S/C23H26ClN5O6/c1-12-2-13(4-15(24)3-12)19(8-21(33)34)29-20(32)11-25-22(35)14-5-16(7-17(30)6-14)28-23-26-9-18(31)10-27-23/h2-7,18-19,30-31H,8-11H2,1H3,(H,25,35)(H,29,32)(H,33,34)(H2,26,27,28)/t19-/m0/s1 D0UB5E DRUGINKE UCBYYQWMMNUSGH-IBGZPJMESA-N D0UB5E DRUGSMIL CC1=CC(=CC(=C1)Cl)C(CC(=O)O)NC(=O)CNC(=O)C2=CC(=CC(=C2)O)NC3=NCC(CN3)O D0UB5E HIGHSTAT Patented D0UF5V DRUG__ID D0UF5V D0UF5V DRUGTYPE Small molecular drug D0UF5V DRUGINCH 1S/C25H20ClN3O2/c26-19-8-5-9-20(15-19)28-24(30)12-13-25(31)29-27-16-23-21-10-3-1-6-17(21)14-18-7-2-4-11-22(18)23/h1-11,14-16H,12-13H2,(H,28,30)(H,29,31)/b27-16+ D0UF5V DRUGINKE OJLFRDWWYAPUAJ-JVWAILMASA-N D0UF5V DRUGSMIL C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C=NNC(=O)CCC(=O)NC4=CC(=CC=C4)Cl D0UF5V HIGHSTAT Patented D0UM5R DRUG__ID D0UM5R D0UM5R DRUGTYPE Small molecular drug D0UM5R DRUGINCH 1S/C19H22F3N3O3/c1-17(2,9-11-3-5-13(6-4-11)19(20,21)22)14(26)23-10-18(12-7-8-12)15(27)24-16(28)25-18/h3-6,12H,7-10H2,1-2H3,(H,23,26)(H2,24,25,27,28)/t18-/m0/s1 D0UM5R DRUGINKE FJEJHTFPLBTMLO-SFHVURJKSA-N D0UM5R DRUGSMIL CC(C)(CC1=CC=C(C=C1)C(F)(F)F)C(=O)NCC2(C(=O)NC(=O)N2)C3CC3 D0UM5R HIGHSTAT Patented D0UZ6C DRUG__ID D0UZ6C D0UZ6C DRUGTYPE Small molecular drug D0UZ6C DRUGINCH 1S/C16H19FN2S/c17-16(6-2-1-3-7-16)8-4-13-15-12(5-9-20-15)14-10-18-11-19(13)14/h5,9-11,13H,1-4,6-8H2 D0UZ6C DRUGINKE AQNGWMVFAXPUTC-UHFFFAOYSA-N D0UZ6C DRUGSMIL C1CCC(CC1)(CCC2C3=C(C=CS3)C4=CN=CN24)F D0UZ6C HIGHSTAT Patented D0V1PW DRUG__ID D0V1PW D0V1PW DRUGTYPE Small molecular drug D0V1PW DRUGINCH 1S/C20H19F4N5O2S/c1-28-11-19(25-12-28)32(30,31)29-9-15(13-5-7-14(21)8-6-13)16(10-29)26-18-4-2-3-17(27-18)20(22,23)24/h2-8,11-12,15-16H,9-10H2,1H3,(H,26,27)/t15-,16+/m1/s1 D0V1PW DRUGINKE QHPPCJNRRPMMDC-CVEARBPZSA-N D0V1PW DRUGSMIL CN1C=C(N=C1)S(=O)(=O)N2CC(C(C2)NC3=CC=CC(=N3)C(F)(F)F)C4=CC=C(C=C4)F D0V1PW HIGHSTAT Patented D0V2UZ DRUG__ID D0V2UZ D0V2UZ DRUGTYPE Small molecular drug D0V2UZ DRUGINCH 1S/C24H32N4O2S/c1-17(2)18-8-10-19(11-9-18)23(30)27-24(31)26-21-14-12-20(13-15-21)25-22(29)7-5-6-16-28(3)4/h8-15,17H,5-7,16H2,1-4H3,(H,25,29)(H2,26,27,30,31) D0V2UZ DRUGINKE UTQHGPPEEJLEOE-UHFFFAOYSA-N D0V2UZ DRUGSMIL CC(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)NC(=O)CCCCN(C)C D0V2UZ HIGHSTAT Patented D0V2VM DRUG__ID D0V2VM D0V2VM DRUGTYPE Small molecular drug D0V2VM DRUGINCH 1S/C20H19FN4O/c1-13-10-22-11-18(24-13)15-9-20(25-17-7-3-2-5-14(15)17)26-12-19-16(21)6-4-8-23-19/h4,6,8-11H,2-3,5,7,12H2,1H3 D0V2VM DRUGINKE NVOTVOBVLQBYNP-UHFFFAOYSA-N D0V2VM DRUGSMIL CC1=CN=CC(=N1)C2=CC(=NC3=C2CCCC3)OCC4=C(C=CC=N4)F D0V2VM HIGHSTAT Patented D0V3OD DRUG__ID D0V3OD D0V3OD DRUGTYPE Small molecular drug D0V3OD DRUGINCH 1S/C30H30F2N4O2/c1-20(37)33-24-7-4-6-22(18-24)21-12-16-35(17-13-21)14-5-15-36-30(38)26-9-3-2-8-25(26)29(34-36)23-10-11-27(31)28(32)19-23/h2-4,6-11,18-19,21H,5,12-17H2,1H3,(H,33,37) D0V3OD DRUGINKE YVVMAGRTTSOPEO-UHFFFAOYSA-N D0V3OD DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCCN3C(=O)C4=CC=CC=C4C(=N3)C5=CC(=C(C=C5)F)F D0V3OD HIGHSTAT Patented D0V3SA DRUG__ID D0V3SA D0V3SA DRUGTYPE Small molecular drug D0V3SA DRUGINCH 1S/C20H16N4O/c21-9-14-4-6-15(7-5-14)12-25-20-8-18(16-10-22-13-23-11-16)17-2-1-3-19(17)24-20/h4-8,10-11,13H,1-3,12H2 D0V3SA DRUGINKE CZFKXGVEBISLMB-UHFFFAOYSA-N D0V3SA DRUGSMIL C1CC2=C(C1)N=C(C=C2C3=CN=CN=C3)OCC4=CC=C(C=C4)C#N D0V3SA HIGHSTAT Patented D0V4YX DRUG__ID D0V4YX D0V4YX DRUGTYPE Small molecular drug D0V4YX DRUGINCH 1S/C20H28N2O4S/c1-2-9-27-12-18(21)20(25,19(23)24)11-16-15-10-14(6-5-13-3-4-13)26-17(15)7-8-22-16/h7-8,10,13,18,25H,2-6,9,11-12,21H2,1H3,(H,23,24)/t18-,20+/m0/s1 D0V4YX DRUGINKE ZJHMLTXEBYSRTJ-AZUAARDMSA-N D0V4YX DRUGSMIL CCCSCC(C(CC1=NC=CC2=C1C=C(O2)CCC3CC3)(C(=O)O)O)N D0V4YX HIGHSTAT Patented D0V5JW DRUG__ID D0V5JW D0V5JW DRUGTYPE Small molecular drug D0V5JW DRUGINCH 1S/C21H24F3N7O2/c1-29-8-6-14(7-9-29)25-18-16-17(32-11-10-30(16)2)20-27-26-19(31(20)28-18)13-4-3-5-15(12-13)33-21(22,23)24/h3-5,12,14H,6-11H2,1-2H3,(H,25,28) D0V5JW DRUGINKE OIOYUXMGVUEQPH-UHFFFAOYSA-N D0V5JW DRUGSMIL CN1CCC(CC1)NC2=NN3C(=NN=C3C4=C2N(CCO4)C)C5=CC(=CC=C5)OC(F)(F)F D0V5JW HIGHSTAT Patented D0V6AZ DRUG__ID D0V6AZ D0V6AZ DRUGTYPE Small molecular drug D0V6AZ DRUGINCH 1S/C19H14F2N2O5/c1-9-15-7-12(28-13-5-10(20)4-11(21)6-13)2-3-14(15)18(26)17(23-9)19(27)22-8-16(24)25/h2-7,26H,8H2,1H3,(H,22,27)(H,24,25) D0V6AZ DRUGINKE AWHJVFRHVNXXDF-UHFFFAOYSA-N D0V6AZ DRUGSMIL CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC(=CC(=C3)F)F D0V6AZ HIGHSTAT Patented D0V6RN DRUG__ID D0V6RN D0V6RN DRUGTYPE Small molecular drug D0V6RN DRUGINCH 1S/C27H26N2O4/c1-33-23-11-18(13-28-25(23)26(30)20-12-21(20)27(31)32)29(14-15-5-6-15)22-10-8-17-4-2-3-16-7-9-19(22)24(16)17/h2-4,8,10-11,13,15,20-21H,5-7,9,12,14H2,1H3,(H,31,32) D0V6RN DRUGINKE VUVDRPVJLHQYMJ-UHFFFAOYSA-N D0V6RN DRUGSMIL COC1=C(N=CC(=C1)N(CC2CC2)C3=C4CCC5=CC=CC(=C54)C=C3)C(=O)C6CC6C(=O)O D0V6RN HIGHSTAT Patented D0V8FC DRUG__ID D0V8FC D0V8FC DRUGTYPE Small molecular drug D0V8FC DRUGINCH 1S/C26H26FN3O3S/c1-32-23-16-20(7-10-22(23)33-15-14-29-12-2-3-13-29)30-17-18-4-11-24(28-25(18)26(30)31)34-21-8-5-19(27)6-9-21/h4-11,16H,2-3,12-15,17H2,1H3 D0V8FC DRUGINKE IOVNPTLMMFSPCO-UHFFFAOYSA-N D0V8FC DRUGSMIL COC1=C(C=CC(=C1)N2CC3=C(C2=O)N=C(C=C3)SC4=CC=C(C=C4)F)OCCN5CCCC5 D0V8FC HIGHSTAT Patented D0V8ZY DRUG__ID D0V8ZY D0V8ZY DRUGTYPE Small molecular drug D0V8ZY DRUGINCH 1S/C21H25N7O2/c1-6-29-21-15(8-7-9-22-21)16-10-17(23-11-18-26-25-14(5)30-18)20-19(24-16)13(4)27-28(20)12(2)3/h7-10,12H,6,11H2,1-5H3,(H,23,24) D0V8ZY DRUGINKE XEBJMVLHZBRKST-UHFFFAOYSA-N D0V8ZY DRUGSMIL CCOC1=C(C=CC=N1)C2=NC3=C(C(=C2)NCC4=NN=C(O4)C)N(N=C3C)C(C)C D0V8ZY HIGHSTAT Patented D0V9WU DRUG__ID D0V9WU D0V9WU DRUGTYPE Small molecular drug D0V9WU DRUGINCH 1S/C24H21N3O5/c25-13-19-18-12-16(32-15-6-2-1-3-7-15)8-9-17(18)21(28)20(27-19)22(29)26-14-24(23(30)31)10-4-5-11-24/h1-3,6-9,12,28H,4-5,10-11,14H2,(H,26,29)(H,30,31) D0V9WU DRUGINKE JSYWJICQZNCWHF-UHFFFAOYSA-N D0V9WU DRUGSMIL C1CCC(C1)(CNC(=O)C2=C(C3=C(C=C(C=C3)OC4=CC=CC=C4)C(=N2)C#N)O)C(=O)O D0V9WU HIGHSTAT Patented D0VE2A DRUG__ID D0VE2A D0VE2A DRUGTYPE Small molecular drug D0VE2A DRUGINCH 1S/C21H25N5O2/c22-8-1-2-17-14-15-7-9-23-21(27)19(15)20(25-17)24-16-3-5-18(6-4-16)26-10-12-28-13-11-26/h3-7,9,14H,1-2,8,10-13,22H2,(H,23,27)(H,24,25) D0VE2A DRUGINKE MKILIVUEQNFIIU-UHFFFAOYSA-N D0VE2A DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC3=C4C(=CC(=N3)CCCN)C=CNC4=O D0VE2A HIGHSTAT Patented D0VE7D DRUG__ID D0VE7D D0VE7D DRUGTYPE Small molecular drug D0VE7D DRUGINCH 1S/C19H20FN3O5S/c1-19(2,18(27)23-9-15(24)25)8-11-4-6-14(29-11)17(26)28-13-5-3-10(16(21)22)7-12(13)20/h3-7H,8-9H2,1-2H3,(H3,21,22)(H,23,27)(H,24,25) D0VE7D DRUGINKE FBFZNZYSXBOYCU-UHFFFAOYSA-N D0VE7D DRUGSMIL CC(C)(CC1=CC=C(S1)C(=O)OC2=C(C=C(C=C2)C(=N)N)F)C(=O)NCC(=O)O D0VE7D HIGHSTAT Patented D0VI2M DRUG__ID D0VI2M D0VI2M DRUGTYPE Small molecular drug D0VI2M DRUGINCH 1S/C22H23N3O5/c1-12-18-15(20(28)19(24-12)21(29)23-11-17(26)27)8-9-16(25-18)30-14-7-5-6-13(10-14)22(2,3)4/h5-10,28H,11H2,1-4H3,(H,23,29)(H,26,27) D0VI2M DRUGINKE NYGCHYPUCCYURU-UHFFFAOYSA-N D0VI2M DRUGSMIL CC1=C2C(=C(C(=N1)C(=O)NCC(=O)O)O)C=CC(=N2)OC3=CC=CC(=C3)C(C)(C)C D0VI2M HIGHSTAT Patented D0VJ8Y DRUG__ID D0VJ8Y D0VJ8Y DRUGTYPE Small molecular drug D0VJ8Y DRUGINCH 1S/C23H25N3O6/c1-3-29-18-8-6-15(10-19(18)30-4-2)22-25-21(26-32-22)14-5-7-17-16(9-14)11-20(31-17)23(24,12-27)13-28/h5-11,27-28H,3-4,12-13,24H2,1-2H3 D0VJ8Y DRUGINKE YPBZKICXUPGWLN-UHFFFAOYSA-N D0VJ8Y DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=NO2)C3=CC4=C(C=C3)OC(=C4)C(CO)(CO)N)OCC D0VJ8Y HIGHSTAT Patented D0VK5C DRUG__ID D0VK5C D0VK5C DRUGTYPE Small molecular drug D0VK5C DRUGINCH 1S/C26H22FN3O5/c1-26(2,25(33)34)14-29-24(32)22-23(31)19-9-8-18(35-17-6-4-3-5-7-17)11-20(19)21(30-22)15-10-16(27)13-28-12-15/h3-13,31H,14H2,1-2H3,(H,29,32)(H,33,34) D0VK5C DRUGINKE WTLXLQBMAJRSSQ-UHFFFAOYSA-N D0VK5C DRUGSMIL CC(C)(CNC(=O)C1=C(C2=C(C=C(C=C2)OC3=CC=CC=C3)C(=N1)C4=CC(=CN=C4)F)O)C(=O)O D0VK5C HIGHSTAT Patented D0VP7R DRUG__ID D0VP7R D0VP7R DRUGTYPE Small molecular drug D0VP7R DRUGINCH 1S/C11H8N2O2/c14-6-9-3-8(1-2-11(9)15)10-4-12-7-13-5-10/h1-7,15H D0VP7R DRUGINKE HPQAHGRGPPOWML-UHFFFAOYSA-N D0VP7R DRUGSMIL C1=CC(=C(C=C1C2=CN=CN=C2)C=O)O D0VP7R HIGHSTAT Patented D0VQ2N DRUG__ID D0VQ2N D0VQ2N DRUGTYPE Small molecular drug D0VQ2N DRUGINCH 1S/C26H36N2O2/c1-5-27(6-2)19-17-25(29)23-13-9-21(10-14-23)22-11-15-24(16-12-22)26(30)18-20-28(7-3)8-4/h9-16H,5-8,17-20H2,1-4H3 D0VQ2N DRUGINKE BFCHHHLQSJIBJK-UHFFFAOYSA-N D0VQ2N DRUGSMIL CCN(CC)CCC(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCN(CC)CC D0VQ2N HIGHSTAT Patented D0VX6P DRUG__ID D0VX6P D0VX6P DRUGTYPE Small molecular drug D0VX6P DRUGINCH 1S/C25H33FN2O/c1-27(2)14-6-13-25(22-8-10-23(26)11-9-22)24-12-7-20(17-21(24)19-29-25)18-28-15-4-3-5-16-28/h7-12,17H,3-6,13-16,18-19H2,1-2H3 D0VX6P DRUGINKE UWNUOIHSSBTGRY-UHFFFAOYSA-N D0VX6P DRUGSMIL CN(C)CCCC1(C2=C(CO1)C=C(C=C2)CN3CCCCC3)C4=CC=C(C=C4)F D0VX6P HIGHSTAT Patented D0VZ5E DRUG__ID D0VZ5E D0VZ5E DRUGTYPE Small molecular drug D0VZ5E DRUGINCH 1S/C14H12N4O2/c1-18-12-5-3-2-4-10(12)13(17-18)16-11-8-15-7-6-9(11)14(19)20/h2-8H,1H3,(H,16,17)(H,19,20) D0VZ5E DRUGINKE CPZUCKVTDNNRCJ-UHFFFAOYSA-N D0VZ5E DRUGSMIL CN1C2=CC=CC=C2C(=N1)NC3=C(C=CN=C3)C(=O)O D0VZ5E HIGHSTAT Patented D0W1XE DRUG__ID D0W1XE D0W1XE DRUGTYPE Small molecular drug D0W1XE DRUGINCH 1S/C21H27F3N4O4S/c1-13(2)17-10-27(16-5-4-14(11-29)18(8-16)33(3,31)32)6-7-28(17)20-25-9-15(12-30)19(26-20)21(22,23)24/h4-5,8-9,13,17,29-30H,6-7,10-12H2,1-3H3/t17-/m0/s1 D0W1XE DRUGINKE FPVIRRAMNBCEDK-KRWDZBQOSA-N D0W1XE DRUGSMIL CC(C)C1CN(CCN1C2=NC=C(C(=N2)C(F)(F)F)CO)C3=CC(=C(C=C3)CO)S(=O)(=O)C D0W1XE HIGHSTAT Patented D0W2BO DRUG__ID D0W2BO D0W2BO DRUGTYPE Small molecular drug D0W2BO DRUGINCH 1S/C31H45FN12O4/c1-16(2)25(44-28(47)23(41-17(3)45)5-4-12-39-30(35)36)29(48)43-24(14-18-6-9-20(10-7-18)42-31(37)38)27(46)40-15-19-8-11-21(26(33)34)22(32)13-19/h6-11,13,16,23-25H,4-5,12,14-15H2,1-3H3,(H3,33,34)(H,40,46)(H,41,45)(H,43,48)(H,44,47)(H4,35,36,39)(H4,37,38,42)/t23-,24-,25-/m0/s1 D0W2BO DRUGINKE STWIQLJAZUCKRU-SDHOMARFSA-N D0W2BO DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)N=C(N)N)C(=O)NCC2=CC(=C(C=C2)C(=N)N)F)NC(=O)C(CCCN=C(N)N)NC(=O)C D0W2BO HIGHSTAT Patented D0W2KL DRUG__ID D0W2KL D0W2KL DRUGTYPE Small molecular drug D0W2KL DRUGINCH 1S/C27H34F2N4O3/c1-16-13-23(36-4)21(26(34)31-16)14-30-27(35)25-18(3)33(22-8-6-5-7-20(22)25)17(2)19-9-11-32(12-10-19)15-24(28)29/h5-8,13,17,19,24H,9-12,14-15H2,1-4H3,(H,30,35)(H,31,34) D0W2KL DRUGINKE RQOXQFWLPWTPPB-UHFFFAOYSA-N D0W2KL DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCN(CC4)CC(F)F)C)OC D0W2KL HIGHSTAT Patented D0W2OT DRUG__ID D0W2OT D0W2OT DRUGTYPE Small molecular drug D0W2OT DRUGINCH 1S/C24H40O5/c1-3-14-24(15-9-16-24)22(27)12-8-11-19-18(20(25)17-21(19)26)10-6-4-5-7-13-23(28)29-2/h8,11,18-19,21-22,26-27H,3-7,9-10,12-17H2,1-2H3/b11-8+/t18-,19-,21-,22-/m1/s1 D0W2OT DRUGINKE XRISENIKJUKIHD-LHQZMKCDSA-N D0W2OT DRUGSMIL CCCC1(CCC1)C(CC=CC2C(CC(=O)C2CCCCCCC(=O)OC)O)O D0W2OT HIGHSTAT Patented D0W5OE DRUG__ID D0W5OE D0W5OE DRUGTYPE Small molecular drug D0W5OE DRUGINCH 1S/2C16H28NP.2ClH.Pd/c2*1-15(2,3)18(16(4,5)6)14-11-9-13(10-12-14)17(7)8;;;/h2*9-12H,1-8H3;2*1H;/q;;;;+2 D0W5OE DRUGINKE DWOZNANUEDYIOF-UHFFFAOYSA-N D0W5OE DRUGSMIL CC(C)(C)[PH+](C1=CC=C(C=C1)N(C)C)C(C)(C)C.CC(C)(C)[PH+](C1=CC=C(C=C1)N(C)C)C(C)(C)C.Cl[Pd]Cl D0W5OE HIGHSTAT Patented D0W6MZ DRUG__ID D0W6MZ D0W6MZ DRUGTYPE Small molecular drug D0W6MZ DRUGINCH 1S/C22H22FN3O7S/c23-13-8-11(18(24)25)2-4-15(13)33-20(31)16-5-3-12(34-16)10-22(6-1-7-22)21(32)26-14(19(29)30)9-17(27)28/h2-5,8,14H,1,6-7,9-10H2,(H3,24,25)(H,26,32)(H,27,28)(H,29,30)/t14-/m0/s1 D0W6MZ DRUGINKE CHAXFLSDNLDWPP-AWEZNQCLSA-N D0W6MZ DRUGSMIL C1CC(C1)(CC2=CC=C(S2)C(=O)OC3=C(C=C(C=C3)C(=N)N)F)C(=O)NC(CC(=O)O)C(=O)O D0W6MZ HIGHSTAT Patented D0W6ZO DRUG__ID D0W6ZO D0W6ZO DRUGTYPE Small molecular drug D0W6ZO DRUGINCH 1S/C11H14O3/c12-9-1-2-10(11(13)7-9)8-3-5-14-6-4-8/h1-2,7-8,12-13H,3-6H2 D0W6ZO DRUGINKE YVJHGULPEXKTIJ-UHFFFAOYSA-N D0W6ZO DRUGSMIL C1COCCC1C2=C(C=C(C=C2)O)O D0W6ZO HIGHSTAT Patented D0W8JK DRUG__ID D0W8JK D0W8JK DRUGTYPE Small molecular drug D0W8JK DRUGINCH 1S/C28H28O3/c1-31-26-7-6-23(21-2-3-22-12-24(27(29)30)5-4-20(22)11-21)13-25(26)28-14-17-8-18(15-28)10-19(9-17)16-28/h2-7,11-13,17-19H,8-10,14-16H2,1H3,(H,29,30) D0W8JK DRUGINKE LZCDAPDGXCYOEH-UHFFFAOYSA-N D0W8JK DRUGSMIL COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5 D0W8JK HIGHSTAT Patented D0W8RV DRUG__ID D0W8RV D0W8RV DRUGTYPE Small molecular drug D0W8RV DRUGINCH 1S/C14H28N2O3/c1-16(2)12-8-11-15-13(17)9-6-4-3-5-7-10-14(18)19/h3-12H2,1-2H3,(H,15,17)(H,18,19) D0W8RV DRUGINKE GACCFZXBPOHVCL-UHFFFAOYSA-N D0W8RV DRUGSMIL CN(C)CCCNC(=O)CCCCCCCC(=O)O D0W8RV HIGHSTAT Patented D0W9OC DRUG__ID D0W9OC D0W9OC DRUGTYPE Small molecular drug D0W9OC DRUGINCH 1S/C28H32ClN3O3/c29-20-11-12-22-24(18-20)32-23-8-4-3-7-21(23)28(22)31-16-6-2-1-5-15-30-27(35)14-10-19-9-13-25(33)26(34)17-19/h9-14,17-18,33-34H,1-8,15-16H2,(H,30,35)(H,31,32)/b14-10+ D0W9OC DRUGINKE PBISLIYZMJMPKF-GXDHUFHOSA-N D0W9OC DRUGSMIL C1CCC2=NC3=C(C=CC(=C3)Cl)C(=C2C1)NCCCCCCNC(=O)C=CC4=CC(=C(C=C4)O)O D0W9OC HIGHSTAT Patented D0WA4F DRUG__ID D0WA4F D0WA4F DRUGTYPE Small molecular drug D0WA4F DRUGINCH 1S/C26H22F3N3O4/c1-25(30,24(33)34)12-11-14-7-9-17-16(13-14)8-10-18-20(17)31-36-23(18)21-19(26(27,28)29)22(35-32-21)15-5-3-2-4-6-15/h2-7,9,13H,8,10-12,30H2,1H3,(H,33,34) D0WA4F DRUGINKE HJNGPEXUUTVSJW-UHFFFAOYSA-N D0WA4F DRUGSMIL CC(CCC1=CC2=C(C=C1)C3=NOC(=C3CC2)C4=NOC(=C4C(F)(F)F)C5=CC=CC=C5)(C(=O)O)N D0WA4F HIGHSTAT Patented D0WC1D DRUG__ID D0WC1D D0WC1D DRUGTYPE Small molecular drug D0WC1D DRUGINCH 1S/C24H25NO4/c1-17(13-24(26)27)25-12-11-22-20(15-25)14-23(29-22)19-7-9-21(10-8-19)28-16-18-5-3-2-4-6-18/h2-10,14,17H,11-13,15-16H2,1H3,(H,26,27) D0WC1D DRUGINKE OBUYLWCGRDYKEQ-UHFFFAOYSA-N D0WC1D DRUGSMIL CC(CC(=O)O)N1CCC2=C(C1)C=C(O2)C3=CC=C(C=C3)OCC4=CC=CC=C4 D0WC1D HIGHSTAT Patented D0WH9N DRUG__ID D0WH9N D0WH9N DRUGTYPE Small molecular drug D0WH9N DRUGINCH 1S/C18H19F2N7OS/c19-10-4-1-5-11(20)13(10)18-25-14(15(22)29-18)17(28)24-12-7-23-26-16(12)27-6-2-3-9(21)8-27/h1,4-5,7,9H,2-3,6,8,21-22H2,(H,23,26)(H,24,28)/t9-/m0/s1 D0WH9N DRUGINKE NVTPYRCDKQXUGU-VIFPVBQESA-N D0WH9N DRUGSMIL C1CC(CN(C1)C2=C(C=NN2)NC(=O)C3=C(SC(=N3)C4=C(C=CC=C4F)F)N)N D0WH9N HIGHSTAT Patented D0WJ3F DRUG__ID D0WJ3F D0WJ3F DRUGTYPE Small molecular drug D0WJ3F DRUGINCH 1S/C25H30N2O3S/c1-5-26(6-2)22-13-9-21(10-14-22)19-27(23-11-7-20(3)8-12-23)31(28,29)25-17-15-24(30-4)16-18-25/h7-18H,5-6,19H2,1-4H3 D0WJ3F DRUGINKE FKEFNETYRMRPCY-UHFFFAOYSA-N D0WJ3F DRUGSMIL CCN(CC)C1=CC=C(C=C1)CN(C2=CC=C(C=C2)C)S(=O)(=O)C3=CC=C(C=C3)OC D0WJ3F HIGHSTAT Patented D0WO4T DRUG__ID D0WO4T D0WO4T DRUGTYPE Small molecular drug D0WO4T DRUGINCH 1S/C20H32/c1-14(2)15-7-9-17-16(13-15)8-10-18-19(3,4)11-6-12-20(17,18)5/h7,14,18H,6,8-13H2,1-5H3/t18?,20-/m1/s1 D0WO4T DRUGINKE BGVUIJDZTQIJIO-ROPPNANJSA-N D0WO4T DRUGSMIL CC(C)C1=CCC2=C(C1)CCC3C2(CCCC3(C)C)C D0WO4T HIGHSTAT Patented D0WS3T DRUG__ID D0WS3T D0WS3T DRUGTYPE Small molecular drug D0WS3T DRUGINCH 1S/C24H26FN5O3S/c1-32-17-3-2-16(19(25)10-17)12-29-23-21(22-26-14-27-30(22)24(29)31)18-4-7-28(13-20(18)34-23)11-15-5-8-33-9-6-15/h2-3,10,14-15H,4-9,11-13H2,1H3 D0WS3T DRUGINKE FOZFBBKUKXGMND-UHFFFAOYSA-N D0WS3T DRUGSMIL COC1=CC(=C(C=C1)CN2C3=C(C4=C(S3)CN(CC4)CC5CCOCC5)C6=NC=NN6C2=O)F D0WS3T HIGHSTAT Patented D0WU1C DRUG__ID D0WU1C D0WU1C DRUGTYPE Small molecular drug D0WU1C DRUGINCH 1S/C26H27F3N4O4S/c1-14-11-15(12-20(30)25(14)38(36,37)10-9-34)16-7-8-31-13-22(16)33-26(35)21-6-5-19(29)24(32-21)23-17(27)3-2-4-18(23)28/h2-8,13-15,20,25,34H,9-12,30H2,1H3,(H,33,35)/t14-,15+,20+,25-/m0/s1 D0WU1C DRUGINKE XQMOXTIXSKOQJT-LCNIEQOASA-N D0WU1C DRUGSMIL CC1CC(CC(C1S(=O)(=O)CCO)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F D0WU1C HIGHSTAT Patented D0WX0K DRUG__ID D0WX0K D0WX0K DRUGTYPE Small molecular drug D0WX0K DRUGINCH 1S/C23H26F2N4O2/c1-31-12-11-29-9-7-15(8-10-29)14-26-23(30)22-18-13-16(5-6-20(18)27-28-22)17-3-2-4-19(24)21(17)25/h2-6,13,15H,7-12,14H2,1H3,(H,26,30)(H,27,28) D0WX0K DRUGINKE QCLXNOBXQUWUEW-UHFFFAOYSA-N D0WX0K DRUGSMIL COCCN1CCC(CC1)CNC(=O)C2=NNC3=C2C=C(C=C3)C4=C(C(=CC=C4)F)F D0WX0K HIGHSTAT Patented D0X0BB DRUG__ID D0X0BB D0X0BB DRUGTYPE Small molecular drug D0X0BB DRUGINCH 1S/C24H33N5O2/c1-14-11-16(12-19(26)23(14)30)17-9-10-27-13-21(17)29-24(31)22-18(25)7-8-20(28-22)15-5-3-2-4-6-15/h7-10,13-16,19,23,30H,2-6,11-12,25-26H2,1H3,(H,29,31)/t14-,16+,19+,23+/m0/s1 D0X0BB DRUGINKE JMHGWOVBMIFUIZ-CBAWVIOQSA-N D0X0BB DRUGSMIL CC1CC(CC(C1O)N)C2=C(C=NC=C2)NC(=O)C3=C(C=CC(=N3)C4CCCCC4)N D0X0BB HIGHSTAT Patented D0X0NV DRUG__ID D0X0NV D0X0NV DRUGTYPE Small molecular drug D0X0NV DRUGINCH 1S/C25H29BrN4O2/c1-16(27-24(31)21-14-20(21)17-5-3-2-4-6-17)15-29-11-9-19(10-12-29)30-23-8-7-18(26)13-22(23)28-25(30)32/h2-8,13,16,19-21H,9-12,14-15H2,1H3,(H,27,31)(H,28,32)/t16-,20+,21+/m0/s1 D0X0NV DRUGINKE JSVNNLRZCJAYTQ-ZLGUVYLKSA-N D0X0NV DRUGSMIL CC(CN1CCC(CC1)N2C3=C(C=C(C=C3)Br)NC2=O)NC(=O)C4CC4C5=CC=CC=C5 D0X0NV HIGHSTAT Patented D0X1ZY DRUG__ID D0X1ZY D0X1ZY DRUGTYPE Small molecular drug D0X1ZY DRUGINCH 1S/C17H23N3O3S/c1-13-17(14(2)19(3)18-13)24(21,22)20-11-9-16(10-12-20)23-15-7-5-4-6-8-15/h4-8,16H,9-12H2,1-3H3 D0X1ZY DRUGINKE UOPFZPMEKNDBSU-UHFFFAOYSA-N D0X1ZY DRUGSMIL CC1=C(C(=NN1C)C)S(=O)(=O)N2CCC(CC2)OC3=CC=CC=C3 D0X1ZY HIGHSTAT Patented D0X2XN DRUG__ID D0X2XN D0X2XN DRUGTYPE Small molecular drug D0X2XN DRUGINCH 1S/C17H24N2O3S2/c1-3-4-5-11-8-12-13(19-7-6-14(12)24-11)9-17(22,16(20)21)15(18)10-23-2/h6-8,15,22H,3-5,9-10,18H2,1-2H3,(H,20,21)/t15-,17+/m0/s1 D0X2XN DRUGINKE DBCFIUMQYJLFBC-DOTOQJQBSA-N D0X2XN DRUGSMIL CCCCC1=CC2=C(S1)C=CN=C2CC(C(CSC)N)(C(=O)O)O D0X2XN HIGHSTAT Patented D0X5XB DRUG__ID D0X5XB D0X5XB DRUGTYPE Small molecular drug D0X5XB DRUGINCH 1S/C17H26N4O/c1-3-13(4-2)21-16-14(11-18-21)17(22)20-15(19-16)10-12-8-6-5-7-9-12/h11-13H,3-10H2,1-2H3,(H,19,20,22) D0X5XB DRUGINKE GXWSVMJGLJNVHK-UHFFFAOYSA-N D0X5XB DRUGSMIL CCC(CC)N1C2=C(C=N1)C(=O)NC(=N2)CC3CCCCC3 D0X5XB HIGHSTAT Patented D0X7BT DRUG__ID D0X7BT D0X7BT DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0X7BT DRUGINCH 1S/C7H8O2/c8-5-6-1-3-7(9)4-2-6/h1-4,8-9H,5H2 D0X7BT DRUGINKE BVJSUAQZOZWCKN-UHFFFAOYSA-N D0X7BT DRUGSMIL C1=CC(=CC=C1CO)O D0X7BT HIGHSTAT Patented D0X7EQ DRUG__ID D0X7EQ D0X7EQ DRUGTYPE Small molecular drug D0X7EQ DRUGINCH 1S/C15H16O4/c16-12-5-4-11(15(19)9-12)3-1-2-10-6-13(17)8-14(18)7-10/h4-9,16-19H,1-3H2 D0X7EQ DRUGINKE NQTJPTOXNAMXIJ-UHFFFAOYSA-N D0X7EQ DRUGSMIL C1=CC(=C(C=C1O)O)CCCC2=CC(=CC(=C2)O)O D0X7EQ HIGHSTAT Patented D0X7WG DRUG__ID D0X7WG D0X7WG DRUGTYPE Small molecular drug D0X7WG DRUGINCH 1S/C32H36F3N9O2/c33-32(34,35)27-12-21(17-43-9-1-2-23(43)19-45)13-28(41-27)46-25-4-10-42(11-5-25)24-14-31(15-24,6-7-36)44-18-22(16-40-44)29-26-3-8-37-30(26)39-20-38-29/h3,8,12-13,16,18,20,23-25,45H,1-2,4-6,9-11,14-15,17,19H2,(H,37,38,39)/t23-,24?,31?/m0/s1 D0X7WG DRUGINKE WQXUGBZSZWSUTM-VVTYCJQISA-N D0X7WG DRUGSMIL C1CC(N(C1)CC2=CC(=NC(=C2)OC3CCN(CC3)C4CC(C4)(CC#N)N5C=C(C=N5)C6=C7C=CNC7=NC=N6)C(F)(F)F)CO D0X7WG HIGHSTAT Patented D0X7ZB DRUG__ID D0X7ZB D0X7ZB DRUGTYPE Small molecular drug D0X7ZB DRUGINCH 1S/C22H21N7O2/c1-13-9-24-22(31)19-8-15-4-7-18(27-20(15)29(13)19)21(30)26-17-10-25-28(12-17)11-14-2-5-16(23)6-3-14/h2-8,10,12-13H,9,11,23H2,1H3,(H,24,31)(H,26,30)/t13-/m1/s1 D0X7ZB DRUGINKE IBOJVZMIACTCIV-CYBMUJFWSA-N D0X7ZB DRUGSMIL CC1CNC(=O)C2=CC3=C(N12)N=C(C=C3)C(=O)NC4=CN(N=C4)CC5=CC=C(C=C5)N D0X7ZB HIGHSTAT Patented D0X9SE DRUG__ID D0X9SE D0X9SE DRUGTYPE Small molecular drug D0X9SE DRUGINCH 1S/C23H29N3O3S/c1-2-11-21(30)24-17-10-9-16-20(22(27)25-18-12-5-3-6-13-18)26-23(28)29-19-14-7-4-8-15-19/h3-8,12-15,20H,2,9-11,16-17H2,1H3,(H,24,30)(H,25,27)(H,26,28) D0X9SE DRUGINKE WGKXXIZEWYTERA-UHFFFAOYSA-N D0X9SE DRUGSMIL CCCC(=S)NCCCCC(C(=O)NC1=CC=CC=C1)NC(=O)OC2=CC=CC=C2 D0X9SE HIGHSTAT Patented D0X9VS DRUG__ID D0X9VS D0X9VS DRUGTYPE Small molecular drug D0X9VS DRUGINCH 1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24) D0X9VS DRUGINKE MYQAUKPBNJWPIE-UHFFFAOYSA-N D0X9VS DRUGSMIL COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC D0X9VS HIGHSTAT Patented D0XA0Y DRUG__ID D0XA0Y D0XA0Y DRUGTYPE Small molecular drug D0XA0Y DRUGINCH 1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16) D0XA0Y DRUGINKE VWFCHDSQECPREK-UHFFFAOYSA-N D0XA0Y DRUGSMIL C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O D0XA0Y HIGHSTAT Patented D0XB2W DRUG__ID D0XB2W D0XB2W DRUGTYPE Small molecular drug D0XB2W DRUGINCH 1S/C15H13N7OS/c1-8-3-12(21-20-8)10-4-11(13-16-7-17-22(13)5-10)14(23)19-15-18-9(2)6-24-15/h3-7H,1-2H3,(H,20,21)(H,18,19,23) D0XB2W DRUGINKE VNZBTWWCDKRKLN-UHFFFAOYSA-N D0XB2W DRUGSMIL CC1=CC(=NN1)C2=CN3C(=NC=N3)C(=C2)C(=O)NC4=NC(=CS4)C D0XB2W HIGHSTAT Patented D0XF1S DRUG__ID D0XF1S D0XF1S DRUGTYPE Small molecular drug D0XF1S DRUGINCH 1S/C28H30N6O4/c1-29-25(35)17-10-8-16(9-11-17)20-15-31-24-23(20)27(38-19-6-4-5-7-19)34-28(33-24)32-21-13-12-18(26(36)30-2)14-22(21)37-3/h8-15,19H,4-7H2,1-3H3,(H,29,35)(H,30,36)(H2,31,32,33,34) D0XF1S DRUGINKE YMYOREROCXXANC-UHFFFAOYSA-N D0XF1S DRUGSMIL CNC(=O)C1=CC=C(C=C1)C2=CNC3=C2C(=NC(=N3)NC4=C(C=C(C=C4)C(=O)NC)OC)OC5CCCC5 D0XF1S HIGHSTAT Patented D0XG7K DRUG__ID D0XG7K D0XG7K DRUGTYPE Small molecular drug D0XG7K DRUGINCH 1S/C18H14F6N2O4S/c19-17(20,21)29-12-3-1-2-11(7-12)26-13-8-25-16(30-31(27,28)18(22,23)24)15-10-5-4-9(6-10)14(13)15/h1-3,7-10,26H,4-6H2 D0XG7K DRUGINKE DQBACBSLAAPBLG-UHFFFAOYSA-N D0XG7K DRUGSMIL C1CC2CC1C3=C2C(=NC=C3NC4=CC(=CC=C4)OC(F)(F)F)OS(=O)(=O)C(F)(F)F D0XG7K HIGHSTAT Patented D0XH0I DRUG__ID D0XH0I D0XH0I DRUGTYPE Small molecular drug D0XH0I DRUGINCH 1S/C17H15NO3S/c19-15(13-7-4-8-14(13)17(20)21)18-16-12(9-10-22-16)11-5-2-1-3-6-11/h1-3,5-6,9-10H,4,7-8H2,(H,18,19)(H,20,21) D0XH0I DRUGINKE WTIMMZFOZTXDOY-UHFFFAOYSA-N D0XH0I DRUGSMIL C1CC(=C(C1)C(=O)O)C(=O)NC2=C(C=CS2)C3=CC=CC=C3 D0XH0I HIGHSTAT Patented D0XJ2J DRUG__ID D0XJ2J D0XJ2J DRUGTYPE Small molecular drug D0XJ2J DRUGINCH 1S/C25H21F2N5/c26-19-7-3-8-20(27)23(19)25-30-13-16-5-2-9-21(24(16)32-25)31-22-14-29-11-10-18(22)15-4-1-6-17(28)12-15/h2-3,5,7-14,17,31H,1,4,6,28H2 D0XJ2J DRUGINKE VWDOGNVHWKGFOS-UHFFFAOYSA-N D0XJ2J DRUGSMIL C1CC(C=C(C1)C2=C(C=NC=C2)NC3=CC=CC4=CN=C(N=C43)C5=C(C=CC=C5F)F)N D0XJ2J HIGHSTAT Patented D0XV4L DRUG__ID D0XV4L D0XV4L DRUGTYPE Small molecular drug D0XV4L DRUGINCH 1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9) D0XV4L DRUGINKE BPBPYQWMFCTCNG-UHFFFAOYSA-N D0XV4L DRUGSMIL CCC(C)SSC1=NC=CN1 D0XV4L HIGHSTAT Patented D0XX5N DRUG__ID D0XX5N D0XX5N DRUGTYPE Small molecular drug D0XX5N DRUGINCH 1S/C21H20N2O4/c1-22-8-10-23(11-9-22)21(26)20-7-6-19(27-20)15-2-4-16-14(12-15)3-5-18(25)17(16)13-24/h2-7,12-13,25H,8-11H2,1H3 D0XX5N DRUGINKE XYOMDLUIYINLEM-UHFFFAOYSA-N D0XX5N DRUGSMIL CN1CCN(CC1)C(=O)C2=CC=C(O2)C3=CC4=C(C=C3)C(=C(C=C4)O)C=O D0XX5N HIGHSTAT Patented D0XY1Z DRUG__ID D0XY1Z D0XY1Z DRUGTYPE Small molecular drug D0XY1Z DRUGINCH 1S/C20H18ClN9O/c21-17-15(5-11(7-22)6-16(17)29-4-3-14(31)10-29)26-20-27-18(25-12-1-2-12)19-24-9-13(8-23)30(19)28-20/h5-6,9,12,14,31H,1-4,10H2,(H2,25,26,27,28) D0XY1Z DRUGINKE XMYPWCUEOAYOMV-UHFFFAOYSA-N D0XY1Z DRUGSMIL C1CC1NC2=NC(=NN3C2=NC=C3C#N)NC4=C(C(=CC(=C4)C#N)N5CCC(C5)O)Cl D0XY1Z HIGHSTAT Patented D0Y0OQ DRUG__ID D0Y0OQ D0Y0OQ DRUGTYPE Small molecular drug D0Y0OQ DRUGINCH 1S/C30H34N2O6S/c1-21-8-15-26(16-9-21)39(37,38)31(2)20-29(34)32(25-14-17-27(30(35)36)28(33)18-25)19-22-10-12-24(13-11-22)23-6-4-3-5-7-23/h8-18,23,33H,3-7,19-20H2,1-2H3,(H,35,36) D0Y0OQ DRUGINKE DMZMMAPPHDCECB-UHFFFAOYSA-N D0Y0OQ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N(C)CC(=O)N(CC2=CC=C(C=C2)C3CCCCC3)C4=CC(=C(C=C4)C(=O)O)O D0Y0OQ HIGHSTAT Patented D0Y1WA DRUG__ID D0Y1WA D0Y1WA DRUGTYPE Small molecular drug D0Y1WA DRUGINCH 1S/C22H18N4O3S/c27-26(28)19-13-11-17(12-14-19)16-30-22-24-23-21(15-29-20-9-5-2-6-10-20)25(22)18-7-3-1-4-8-18/h1-14H,15-16H2 D0Y1WA DRUGINKE WMFDORZAJHGLBJ-UHFFFAOYSA-N D0Y1WA DRUGSMIL C1=CC=C(C=C1)N2C(=NN=C2SCC3=CC=C(C=C3)[N+](=O)[O-])COC4=CC=CC=C4 D0Y1WA HIGHSTAT Patented D0Y2ZS DRUG__ID D0Y2ZS D0Y2ZS DRUGTYPE Small molecular drug D0Y2ZS DRUGINCH 1S/C23H20FNO3/c24-15-22(26)25(16-18-8-6-7-17-13-14-27-23(17)18)20-11-4-5-12-21(20)28-19-9-2-1-3-10-19/h1-12H,13-16H2/i24-1 D0Y2ZS DRUGINKE RDJNEDDYELAPBM-MIGPCILRSA-N D0Y2ZS DRUGSMIL C1COC2=C1C=CC=C2CN(C3=CC=CC=C3OC4=CC=CC=C4)C(=O)CF D0Y2ZS HIGHSTAT Patented D0Y3AM DRUG__ID D0Y3AM D0Y3AM DRUGTYPE Small molecular drug D0Y3AM DRUGINCH 1S/C22H23F3N6O2/c23-22(24,25)12-2-1-3-13(8-12)31-19-14(20(32)30-21(31)33)10-27-16-6-5-15(29-18(16)19)11-4-7-17(26)28-9-11/h1-4,7-9,14-16,18-19,27,29H,5-6,10H2,(H2,26,28)(H,30,32,33) D0Y3AM DRUGINKE PPLLDCXSMMXDPV-UHFFFAOYSA-N D0Y3AM DRUGSMIL C1CC(NC2C1NCC3C2N(C(=O)NC3=O)C4=CC=CC(=C4)C(F)(F)F)C5=CN=C(C=C5)N D0Y3AM HIGHSTAT Patented D0Y3FD DRUG__ID D0Y3FD D0Y3FD DRUGTYPE Small molecular drug D0Y3FD DRUGINCH 1S/C23H23Cl2F3N4O4S/c1-2-37(35,36)18-4-3-14(24)9-13(18)11-32-21(33)15-10-17(23(26,27)28)16(12-31-7-5-29-6-8-31)19(25)20(15)30-22(32)34/h3-4,9-10,19,29H,2,5-8,11-12H2,1H3 D0Y3FD DRUGINKE MFENBMQVIBVYSX-UHFFFAOYSA-N D0Y3FD DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CN2C(=O)C3=CC(=C(C(C3=NC2=O)Cl)CN4CCNCC4)C(F)(F)F D0Y3FD HIGHSTAT Patented D0Y3NI DRUG__ID D0Y3NI D0Y3NI DRUGTYPE Small molecular drug D0Y3NI DRUGINCH 1S/C27H25N3O5/c31-23(32)13-14-28-26(34)24-25(33)21-15-20(12-11-18-7-3-1-4-8-18)27(35)30(22(21)16-29-24)17-19-9-5-2-6-10-19/h1-10,15-16,33H,11-14,17H2,(H,28,34)(H,31,32) D0Y3NI DRUGINKE CJDQJFHCXLGXOK-UHFFFAOYSA-N D0Y3NI DRUGSMIL C1=CC=C(C=C1)CCC2=CC3=C(C(=NC=C3N(C2=O)CC4=CC=CC=C4)C(=O)NCCC(=O)O)O D0Y3NI HIGHSTAT Patented D0Y4TK DRUG__ID D0Y4TK D0Y4TK DRUGTYPE Small molecular drug D0Y4TK DRUGINCH 1S/C33H34N6O4/c1-21-10-12-22(13-11-21)39-30(19-28(38-39)33(2,3)4)37-32(41)35-26-14-15-27(25-9-7-6-8-24(25)26)43-23-16-17-34-29(18-23)36-31(40)20-42-5/h6-19H,20H2,1-5H3,(H,34,36,40)(H2,35,37,41) D0Y4TK DRUGINKE AVUUHIYJPTWYNX-UHFFFAOYSA-N D0Y4TK DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OC5=CC(=NC=C5)NC(=O)COC D0Y4TK HIGHSTAT Patented D0Y5DU DRUG__ID D0Y5DU D0Y5DU DRUGTYPE Small molecular drug D0Y5DU DRUGINCH 1S/C28H28ClF3N4O3/c1-17-13-19(25-33-14-21(29)15-34-25)6-9-23(17)24(10-11-28(30,31)32)35-22-7-4-18(5-8-22)26(37)36-12-2-3-20(16-36)27(38)39/h4-9,13-15,20,24,35H,2-3,10-12,16H2,1H3,(H,38,39)/t20-,24?/m1/s1 D0Y5DU DRUGINKE IDBHHYNBIVBFSI-CGHJUBPDSA-N D0Y5DU DRUGSMIL CC1=C(C=CC(=C1)C2=NC=C(C=N2)Cl)C(CCC(F)(F)F)NC3=CC=C(C=C3)C(=O)N4CCCC(C4)C(=O)O D0Y5DU HIGHSTAT Patented D0Y6FF DRUG__ID D0Y6FF D0Y6FF DRUGTYPE Small molecular drug D0Y6FF DRUGINCH 1S/C26H31N5O3S/c1-29-17-22(14-27-29)35(32,33)28-20-15-31(16-20)21-8-9-26-24(13-21)23(12-19-6-3-2-4-7-19)25(18-34-26)30-10-5-11-30/h2-4,6-9,13-14,17,20,23,25,28H,5,10-12,15-16,18H2,1H3 D0Y6FF DRUGINKE WCDMIBGCPCYAHS-UHFFFAOYSA-N D0Y6FF DRUGSMIL CN1C=C(C=N1)S(=O)(=O)NC2CN(C2)C3=CC4=C(C=C3)OCC(C4CC5=CC=CC=C5)N6CCC6 D0Y6FF HIGHSTAT Patented D0Y7KX DRUG__ID D0Y7KX D0Y7KX DRUGTYPE Small molecular drug D0Y7KX DRUGINCH 1S/C20H19NO4S/c1-23-16-9-8-14(10-17(16)24-2)15-12-26-19(21)18(15)20(22)25-11-13-6-4-3-5-7-13/h3-10,12H,11,21H2,1-2H3 D0Y7KX DRUGINKE DXFCCKZJJXVRFH-UHFFFAOYSA-N D0Y7KX DRUGSMIL COC1=C(C=C(C=C1)C2=CSC(=C2C(=O)OCC3=CC=CC=C3)N)OC D0Y7KX HIGHSTAT Patented D0Y7ZA DRUG__ID D0Y7ZA D0Y7ZA DRUGTYPE Small molecular drug D0Y7ZA DRUGINCH 1S/C22H24F3N5O4S/c1-5-34-20(31)14-11-26-21(28-18(14)22(23,24)25)30-9-8-29-16-10-13(35(4,32)33)6-7-15(16)27-19(29)17(30)12(2)3/h6-7,10-12,17H,5,8-9H2,1-4H3 D0Y7ZA DRUGINKE VWVWWPZPLJBDBN-UHFFFAOYSA-N D0Y7ZA DRUGSMIL CCOC(=O)C1=CN=C(N=C1C(F)(F)F)N2CCN3C4=C(C=CC(=C4)S(=O)(=O)C)N=C3C2C(C)C D0Y7ZA HIGHSTAT Patented D0Y9PK DRUG__ID D0Y9PK D0Y9PK DRUGTYPE Small molecular drug D0Y9PK DRUGINCH 1S/C23H26N6O/c1-2-30-19-6-5-16-11-18(4-3-17(16)12-19)21-20-22(24)26-14-27-23(20)29(28-21)13-15-7-9-25-10-8-15/h3-6,11-12,14-15,25H,2,7-10,13H2,1H3,(H2,24,26,27) D0Y9PK DRUGINKE DLMBMHOJKBPKLK-UHFFFAOYSA-N D0Y9PK DRUGSMIL CCOC1=CC2=C(C=C1)C=C(C=C2)C3=NN(C4=NC=NC(=C34)N)CC5CCNCC5 D0Y9PK HIGHSTAT Patented D0YB5B DRUG__ID D0YB5B D0YB5B DRUGTYPE Small molecular drug D0YB5B DRUGINCH 1S/C15H15BFNO3/c1-9(18)10-3-5-15(14(17)6-10)21-12-4-2-11-8-20-16(19)13(11)7-12/h2-7,9,19H,8,18H2,1H3 D0YB5B DRUGINKE AKFFDQJZYBSJJA-UHFFFAOYSA-N D0YB5B DRUGSMIL B1(C2=C(CO1)C=CC(=C2)OC3=C(C=C(C=C3)C(C)N)F)O D0YB5B HIGHSTAT Patented D0YD7S DRUG__ID D0YD7S D0YD7S DRUGTYPE Small molecular drug D0YD7S DRUGINCH 1S/C27H24FN7O3/c1-15-23(26(37)33-19-3-5-22-18(12-19)14-31-35-22)24(34-27(38)32-15)17-2-4-21(28)20(13-17)25(36)30-11-8-16-6-9-29-10-7-16/h2-7,9-10,12-14,24H,8,11H2,1H3,(H,30,36)(H,31,35)(H,33,37)(H2,32,34,38) D0YD7S DRUGINKE GJTSGDBPSODHKH-UHFFFAOYSA-N D0YD7S DRUGSMIL CC1=C(C(NC(=O)N1)C2=CC(=C(C=C2)F)C(=O)NCCC3=CC=NC=C3)C(=O)NC4=CC5=C(C=C4)NN=C5 D0YD7S HIGHSTAT Patented D0YE0V DRUG__ID D0YE0V D0YE0V DRUGTYPE Small molecular drug D0YE0V DRUGINCH 1S/C22H23N5O5S/c23-33(30,31)32-12-14-10-18(22(29)21(14)28)25-19-8-9-24-20-11-17(26-27(19)20)16-7-3-5-13-4-1-2-6-15(13)16/h1-9,11,14,18,21-22,25,28-29H,10,12H2,(H2,23,30,31)/t14-,18-,21-,22+/m1/s1 D0YE0V DRUGINKE QCPOIDRINIAUKU-SRBBEKPSSA-N D0YE0V DRUGSMIL C1C(C(C(C1NC2=CC=NC3=CC(=NN23)C4=CC=CC5=CC=CC=C54)O)O)COS(=O)(=O)N D0YE0V HIGHSTAT Patented D0YI7A DRUG__ID D0YI7A D0YI7A DRUGTYPE Small molecular drug D0YI7A DRUGINCH 1S/C16H20N4O2/c17-15-6-5-11(8-18-15)7-13(16(21)22)14-9-20(10-19-14)12-3-1-2-4-12/h5-6,8-10,12-13H,1-4,7H2,(H2,17,18)(H,21,22) D0YI7A DRUGINKE IQZKZQSOVLMDRA-UHFFFAOYSA-N D0YI7A DRUGSMIL C1CCC(C1)N2C=C(N=C2)C(CC3=CN=C(C=C3)N)C(=O)O D0YI7A HIGHSTAT Patented D0YK9D DRUG__ID D0YK9D D0YK9D DRUGTYPE Small molecular drug D0YK9D DRUGINCH 1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32) D0YK9D DRUGINKE AQGNHMOJWBZFQQ-UHFFFAOYSA-N D0YK9D DRUGSMIL CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N D0YK9D HIGHSTAT Patented D0YP0T DRUG__ID D0YP0T D0YP0T DRUGTYPE Small molecular drug D0YP0T DRUGINCH 1S/C23H26FNO4/c1-22(2)9-10-23(3,4)16-11-13(5-7-15(16)22)19(26)20(27)25-18-8-6-14(21(28)29)12-17(18)24/h5-8,11-12,19,26H,9-10H2,1-4H3,(H,25,27)(H,28,29)/t19-/m1/s1 D0YP0T DRUGINKE AANFHDFOMFRLLR-LJQANCHMSA-N D0YP0T DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(C(=O)NC3=C(C=C(C=C3)C(=O)O)F)O)(C)C)C D0YP0T HIGHSTAT Patented D0YU9U DRUG__ID D0YU9U D0YU9U DRUGTYPE Small molecular drug D0YU9U DRUGINCH 1S/C21H22F4N4O2/c1-12(30)29-10-7-15-17(11-29)26-27-19(15)20(31)28-8-5-13(6-9-28)14-3-2-4-16(22)18(14)21(23,24)25/h2-4,13H,5-11H2,1H3,(H,26,27) D0YU9U DRUGINKE VICXOPXLVAUSNR-UHFFFAOYSA-N D0YU9U DRUGSMIL CC(=O)N1CCC2=C(C1)NN=C2C(=O)N3CCC(CC3)C4=C(C(=CC=C4)F)C(F)(F)F D0YU9U HIGHSTAT Patented D0YX1C DRUG__ID D0YX1C D0YX1C DRUGTYPE Small molecular drug D0YX1C DRUGINCH 1S/C10H7NO4S/c12-5-1-2-6(8(13)3-5)9-11-7(4-16-9)10(14)15/h1-4,12-13H,(H,14,15) D0YX1C DRUGINKE ANYJSBBMNGTYRM-UHFFFAOYSA-N D0YX1C DRUGSMIL C1=CC(=C(C=C1O)O)C2=NC(=CS2)C(=O)O D0YX1C HIGHSTAT Patented D0YX2B DRUG__ID D0YX2B D0YX2B DRUGTYPE Small molecular drug D0YX2B DRUGINCH 1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12- D0YX2B DRUGINKE WINHZLLDWRZWRT-ATVHPVEESA-N D0YX2B DRUGSMIL CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C D0YX2B HIGHSTAT Patented D0YY5J DRUG__ID D0YY5J D0YY5J DRUGTYPE Small molecular drug D0YY5J DRUGINCH 1S/C18H17N3O5/c22-14-7-6-12-13(21(14)10-11-4-2-1-3-5-11)8-19-16(17(12)25)18(26)20-9-15(23)24/h1-5,8,25H,6-7,9-10H2,(H,20,26)(H,23,24) D0YY5J DRUGINKE RKTAODJRDMTRFE-UHFFFAOYSA-N D0YY5J DRUGSMIL C1CC(=O)N(C2=CN=C(C(=C21)O)C(=O)NCC(=O)O)CC3=CC=CC=C3 D0YY5J HIGHSTAT Patented D0YZ8I DRUG__ID D0YZ8I D0YZ8I DRUGTYPE Small molecular drug D0YZ8I DRUGINCH 1S/C23H21NO/c1-3-15-24-16(2)22(20-12-6-7-14-21(20)24)23(25)19-13-8-10-17-9-4-5-11-18(17)19/h4-14H,3,15H2,1-2H3 D0YZ8I DRUGINKE LJSBBBWQTLXQEN-UHFFFAOYSA-N D0YZ8I DRUGSMIL CCCN1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43)C D0YZ8I HIGHSTAT Patented D0Z0BQ DRUG__ID D0Z0BQ D0Z0BQ DRUGTYPE Small molecular drug D0Z0BQ DRUGINCH 1S/C23H20N6O3/c1-16-8-11-32-21(16)23(31)25-20-5-2-4-17(13-20)6-7-18-12-19(15-24-14-18)22-26-28-29(27-22)9-3-10-30/h2,4-5,8,11-15,30H,3,9-10H2,1H3,(H,25,31) D0Z0BQ DRUGINKE OGVARLFWIBVKET-UHFFFAOYSA-N D0Z0BQ DRUGSMIL CC1=C(OC=C1)C(=O)NC2=CC=CC(=C2)C#CC3=CC(=CN=C3)C4=NN(N=N4)CCCO D0Z0BQ HIGHSTAT Patented D0Z1CK DRUG__ID D0Z1CK D0Z1CK DRUGTYPE Small molecular drug D0Z1CK DRUGINCH 1S/C25H24F2N6O2/c1-14(34)16-7-5-15(6-8-16)12-33-21(28-17-9-10-18(26)19(27)11-17)20-22(30-33)32-13-25(2,3)29-24(32)31(4)23(20)35/h5-11,28H,12-13H2,1-4H3 D0Z1CK DRUGINKE ITYGOFCAYSOSFS-UHFFFAOYSA-N D0Z1CK DRUGSMIL CC(=O)C1=CC=C(C=C1)CN2C(=C3C(=N2)N4CC(N=C4N(C3=O)C)(C)C)NC5=CC(=C(C=C5)F)F D0Z1CK HIGHSTAT Patented D0Z5GO DRUG__ID D0Z5GO D0Z5GO DRUGTYPE Small molecular drug D0Z5GO DRUGINCH 1S/C31H31N9O2/c1-2-5-27-26(16-20-8-10-21(11-9-20)24-6-3-4-7-25(24)29-35-37-38-36-29)30(41)39(31-33-18-34-40(27)31)23-14-12-22(13-15-23)28-17-32-19-42-28/h3-4,6-11,17-19,22-23H,2,5,12-16H2,1H3,(H,35,36,37,38) D0Z5GO DRUGINKE IFFXJMQHLNIFIO-UHFFFAOYSA-N D0Z5GO DRUGSMIL CCCC1=C(C(=O)N(C2=NC=NN12)C3CCC(CC3)C4=CN=CO4)CC5=CC=C(C=C5)C6=CC=CC=C6C7=NNN=N7 D0Z5GO HIGHSTAT Patented D0Z6IH DRUG__ID D0Z6IH D0Z6IH DRUGTYPE Small molecular drug D0Z6IH DRUGINCH 1S/C23H21N5O2/c1-15-11-24-23(30)21-10-17-9-19(7-8-20(17)28(15)21)26-22(29)18-12-25-27(14-18)13-16-5-3-2-4-6-16/h2-10,12,14-15H,11,13H2,1H3,(H,24,30)(H,26,29)/t15-/m1/s1 D0Z6IH DRUGINKE DWRUMXZDNGCUDK-OAHLLOKOSA-N D0Z6IH DRUGSMIL CC1CNC(=O)C2=CC3=C(N12)C=CC(=C3)NC(=O)C4=CN(N=C4)CC5=CC=CC=C5 D0Z6IH HIGHSTAT Patented D0Z7FD DRUG__ID D0Z7FD D0Z7FD DRUGTYPE Small molecular drug D0Z7FD DRUGINCH 1S/C20H25N3O5S/c24-20(22-25)19(23-12-4-5-13-23)14-21-29(26,27)18-10-8-17(9-11-18)28-15-16-6-2-1-3-7-16/h1-3,6-11,19,21,25H,4-5,12-15H2,(H,22,24)/t19-/m0/s1 D0Z7FD DRUGINKE NOUZHOVZVQEFTM-IBGZPJMESA-N D0Z7FD DRUGSMIL C1CCN(C1)C(CNS(=O)(=O)C2=CC=C(C=C2)OCC3=CC=CC=C3)C(=O)NO D0Z7FD HIGHSTAT Patented D0Z7YQ DRUG__ID D0Z7YQ D0Z7YQ DRUGTYPE Small molecular drug D0Z7YQ DRUGINCH 1S/C16H18N2O2S2/c1-3-9-22-16-17-11-8-10-21-14(11)15(19)18(16)12-6-4-5-7-13(12)20-2/h4-7H,3,8-10H2,1-2H3 D0Z7YQ DRUGINKE MXDVDZKXHJWBLR-UHFFFAOYSA-N D0Z7YQ DRUGSMIL CCCSC1=NC2=C(C(=O)N1C3=CC=CC=C3OC)SCC2 D0Z7YQ HIGHSTAT Patented D0Z9FM DRUG__ID D0Z9FM D0Z9FM DRUGTYPE Small molecular drug D0Z9FM DRUGINCH 1S/C22H22ClFN4O2/c1-3-14-11-26-21(16-8-15(23)4-5-18(16)24)9-20(14)28-19-6-7-25-12-17(19)22(30)27-10-13(2)29/h4-9,11-13,29H,3,10H2,1-2H3,(H,27,30)(H,25,26,28)/t13-/m0/s1 D0Z9FM DRUGINKE OGPVQKHTKOAKDQ-ZDUSSCGKSA-N D0Z9FM DRUGSMIL CCC1=CN=C(C=C1NC2=C(C=NC=C2)C(=O)NCC(C)O)C3=C(C=CC(=C3)Cl)F D0Z9FM HIGHSTAT Patented D0ZC0E DRUG__ID D0ZC0E D0ZC0E DRUGTYPE Small molecular drug D0ZC0E DRUGINCH 1S/C20H19F2N5O2S/c21-11-2-1-3-12(22)18(11)20-26-15(10-30-20)19(29)25-14-8-24-6-4-16(14)27-7-5-17(28)13(23)9-27/h1-4,6,8,10,13,17,28H,5,7,9,23H2,(H,25,29)/t13-,17-/m1/s1 D0ZC0E DRUGINKE LQASHUDUJOBHMP-CXAGYDPISA-N D0ZC0E DRUGSMIL C1CN(CC(C1O)N)C2=C(C=NC=C2)NC(=O)C3=CSC(=N3)C4=C(C=CC=C4F)F D0ZC0E HIGHSTAT Patented D0ZC2K DRUG__ID D0ZC2K D0ZC2K DRUGTYPE Small molecular drug D0ZC2K DRUGINCH 1S/C12H16N2O3/c15-12(16)10-1-2-11(13-9-10)3-4-14-5-7-17-8-6-14/h1-2,9H,3-8H2,(H,15,16) D0ZC2K DRUGINKE IAYFDTNYXBOKKE-UHFFFAOYSA-N D0ZC2K DRUGSMIL C1COCCN1CCC2=NC=C(C=C2)C(=O)O D0ZC2K HIGHSTAT Patented D0ZE1M DRUG__ID D0ZE1M D0ZE1M DRUGTYPE Small molecular drug D0ZE1M DRUGINCH 1S/C22H21F3N2OSi/c1-29(2,3)18-12-10-17(11-13-18)27-21(28)16-8-6-15(7-9-16)20-19(22(23,24)25)5-4-14-26-20/h4-14H,1-3H3,(H,27,28) D0ZE1M DRUGINKE ATDYJIBFGKJFQE-UHFFFAOYSA-N D0ZE1M DRUGSMIL C[Si](C)(C)C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)C3=C(C=CC=N3)C(F)(F)F D0ZE1M HIGHSTAT Patented D0ZG5X DRUG__ID D0ZG5X D0ZG5X DRUGTYPE Small molecular drug D0ZG5X DRUGINCH 1S/C26H25N3O3/c1-2-24-27-23-13-10-20(16-19-8-11-21(12-9-19)25(30)28-32)17-22(23)26(31)29(24)15-14-18-6-4-3-5-7-18/h3-13,17,32H,2,14-16H2,1H3,(H,28,30) D0ZG5X DRUGINKE VLBQAJZSHGGUBQ-UHFFFAOYSA-N D0ZG5X DRUGSMIL CCC1=NC2=C(C=C(C=C2)CC3=CC=C(C=C3)C(=O)NO)C(=O)N1CCC4=CC=CC=C4 D0ZG5X HIGHSTAT Patented D0ZJ0Z DRUG__ID D0ZJ0Z D0ZJ0Z DRUGTYPE Small molecular drug D0ZJ0Z DRUGINCH 1S/C8H5ClN2O2/c9-5-3-11-6-4(8(12)13)1-2-10-7(5)6/h1-3,11H,(H,12,13) D0ZJ0Z DRUGINKE UAFNSWUBMGTOQA-UHFFFAOYSA-N D0ZJ0Z DRUGSMIL C1=CN=C2C(=CNC2=C1C(=O)O)Cl D0ZJ0Z HIGHSTAT Patented D0ZJ4M DRUG__ID D0ZJ4M D0ZJ4M DRUGTYPE Small molecular drug D0ZJ4M DRUGINCH 1S/C11H9NO2/c13-9-3-4-10(11(14)6-9)8-2-1-5-12-7-8/h1-7,13-14H D0ZJ4M DRUGINKE QGIIUQKOKJXLED-UHFFFAOYSA-N D0ZJ4M DRUGSMIL C1=CC(=CN=C1)C2=C(C=C(C=C2)O)O D0ZJ4M HIGHSTAT Patented D0ZK2Q DRUG__ID D0ZK2Q D0ZK2Q DRUGTYPE Small molecular drug D0ZK2Q DRUGINCH 1S/C21H20N2O3/c1-16(24)23(15-17-8-6-7-11-20(17)25-2)19-14-22-13-12-21(19)26-18-9-4-3-5-10-18/h3-14H,15H2,1-2H3 D0ZK2Q DRUGINKE DHZBNHMEIOBPAE-UHFFFAOYSA-N D0ZK2Q DRUGSMIL CC(=O)N(CC1=CC=CC=C1OC)C2=C(C=CN=C2)OC3=CC=CC=C3 D0ZK2Q HIGHSTAT Patented D0ZK5P DRUG__ID D0ZK5P D0ZK5P DRUGTYPE Small molecular drug D0ZK5P DRUGINCH 1S/C17H14BrClF3NO3S/c1-2-27(25,26)15-4-3-14(19)7-11(15)9-23-16(24)10-5-12(17(20,21)22)8-13(18)6-10/h3-8H,2,9H2,1H3,(H,23,24) D0ZK5P DRUGINKE ZJRYMLPPVADAGI-UHFFFAOYSA-N D0ZK5P DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CNC(=O)C2=CC(=CC(=C2)Br)C(F)(F)F D0ZK5P HIGHSTAT Patented D0ZN0D DRUG__ID D0ZN0D D0ZN0D DRUGTYPE Small molecular drug D0ZN0D DRUGINCH 1S/C23H24FN3O7S/c24-14-9-12(19(25)26)3-5-16(14)34-21(32)17-6-4-13(35-17)11-23(7-1-2-8-23)22(33)27-15(20(30)31)10-18(28)29/h3-6,9,15H,1-2,7-8,10-11H2,(H3,25,26)(H,27,33)(H,28,29)(H,30,31)/t15-/m0/s1 D0ZN0D DRUGINKE HXDKJHJAMFQXBA-HNNXBMFYSA-N D0ZN0D DRUGSMIL C1CCC(C1)(CC2=CC=C(S2)C(=O)OC3=C(C=C(C=C3)C(=N)N)F)C(=O)NC(CC(=O)O)C(=O)O D0ZN0D HIGHSTAT Patented D0ZN3M DRUG__ID D0ZN3M D0ZN3M DRUGTYPE Small molecular drug D0ZN3M DRUGINCH 1S/C30H33BrN2O6S/c1-22(2)19-26(17-18-40(36,37)39-27-15-13-25(31)14-16-27)32-29(34)28(20-23-9-5-3-6-10-23)33-30(35)38-21-24-11-7-4-8-12-24/h3-18,22,26,28H,19-21H2,1-2H3,(H,32,34)(H,33,35)/b18-17+/t26-,28+/m1/s1 D0ZN3M DRUGINKE FMZWJWZKFKZMSS-FMPLDUIVSA-N D0ZN3M DRUGSMIL CC(C)CC(C=CS(=O)(=O)OC1=CC=C(C=C1)Br)NC(=O)C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3 D0ZN3M HIGHSTAT Patented D0ZP0G DRUG__ID D0ZP0G D0ZP0G DRUGTYPE Small molecular drug D0ZP0G DRUGINCH 1S/C19H23NO7/c1-4-20-16(23)6-5-12-11(2)17-15(26-8-7-25-3)9-14(22)13(10-21)18(17)27-19(12)24/h9-10,22H,4-8H2,1-3H3,(H,20,23) D0ZP0G DRUGINKE LPHJXGTWAKQUGZ-UHFFFAOYSA-N D0ZP0G DRUGSMIL CCNC(=O)CCC1=C(C2=C(C=C(C(=C2OC1=O)C=O)O)OCCOC)C D0ZP0G HIGHSTAT Patented D0ZS0I DRUG__ID D0ZS0I D0ZS0I DRUGTYPE Small molecular drug D0ZS0I DRUGINCH 1S/C20H23BFNO5/c1-12-15(9-8-14-11-26-21(25)17(12)14)27-16-7-5-6-13(18(16)22)10-23-19(24)28-20(2,3)4/h5-9,25H,10-11H2,1-4H3,(H,23,24) D0ZS0I DRUGINKE LHNSCZROXVKHFK-UHFFFAOYSA-N D0ZS0I DRUGSMIL B1(C2=C(CO1)C=CC(=C2C)OC3=CC=CC(=C3F)CNC(=O)OC(C)(C)C)O D0ZS0I HIGHSTAT Patented D0ZT3U DRUG__ID D0ZT3U D0ZT3U DRUGTYPE Small molecular drug D0ZT3U DRUGINCH 1S/C14H14O2/c1-10-7-12(15)9-14(16)13(10)8-11-5-3-2-4-6-11/h2-7,9,15-16H,8H2,1H3 D0ZT3U DRUGINKE VPHJXVVCNGTIMH-UHFFFAOYSA-N D0ZT3U DRUGSMIL CC1=CC(=CC(=C1CC2=CC=CC=C2)O)O D0ZT3U HIGHSTAT Patented D0ZX6M DRUG__ID D0ZX6M D0ZX6M DRUGTYPE Small molecular drug D0ZX6M DRUGINCH 1S/C28H32F3N5O4S2/c1-4-42(38,39)22-6-5-21(32-16-22)15-33-25(37)23-12-19-11-17(2)40-27(24(19)41-23)7-9-36(10-8-27)18(3)20-13-34-26(35-14-20)28(29,30)31/h5-6,12-14,16-18H,4,7-11,15H2,1-3H3,(H,33,37) D0ZX6M DRUGINKE ILXLMNLDODDHOQ-UHFFFAOYSA-N D0ZX6M DRUGSMIL CCS(=O)(=O)C1=CN=C(C=C1)CNC(=O)C2=CC3=C(S2)C4(CCN(CC4)C(C)C5=CN=C(N=C5)C(F)(F)F)OC(C3)C D0ZX6M HIGHSTAT Patented D0ZY3D DRUG__ID D0ZY3D D0ZY3D DRUGTYPE Small molecular drug D0ZY3D DRUGINCH 1S/C24H25N7O/c1-16-13-30(6-5-26-16)23-3-2-4-24(29-23)31-22-8-21(27-11-19(22)12-28-31)18-7-17(9-25-10-18)20-14-32-15-20/h2-4,7-12,16,20,26H,5-6,13-15H2,1H3/t16-/m0/s1 D0ZY3D DRUGINKE AWEQRQAMCRCOJY-INIZCTEOSA-N D0ZY3D DRUGSMIL CC1CN(CCN1)C2=CC=CC(=N2)N3C4=CC(=NC=C4C=N3)C5=CC(=CN=C5)C6COC6 D0ZY3D HIGHSTAT Patented D0ZY9S DRUG__ID D0ZY9S D0ZY9S DRUGTYPE Small molecular drug D0ZY9S DRUGINCH 1S/C25H22FN9O/c1-28-18-2-3-20(22(26)12-18)25(36)34-10-8-33(9-11-34)15-19(4-6-27)35-14-17(13-32-35)23-21-5-7-29-24(21)31-16-30-23/h2-3,5,7,12-14,16,19H,4,8-11,15H2,(H,29,30,31) D0ZY9S DRUGINKE VCJFOLMEZCAWFO-UHFFFAOYSA-N D0ZY9S DRUGSMIL [C-]#[N+]C1=CC(=C(C=C1)C(=O)N2CCN(CC2)CC(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)F D0ZY9S HIGHSTAT Patented D00COH DRUG__ID D00COH D00COH DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D00COH DRUGTYPE Carbohydrates D00COH HIGHSTAT Patented D00COH COMPCLAS Biaryl mannoside derivatives D00DFK DRUG__ID D00DFK D00DFK DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D00DFK DRUGTYPE Small molecular drug D00DFK HIGHSTAT Patented D00DFK COMPCLAS Heteroaryl-azepine derivatives D00FKF DRUG__ID D00FKF D00FKF DRUGCOMP H. LUNDBECK A/S VERNALIS (R&D) LTD D00FKF DRUGTYPE Small molecular drug D00FKF HIGHSTAT Patented D00FKF COMPCLAS Pyrrolo-pyridine derivatives D00GJY DRUG__ID D00GJY D00GJY DRUGCOMP INCYTE CORPORATION RODGERS, James D. ARVANITIS, Argyrios G D00GJY DRUGTYPE Small molecular drug D00GJY HIGHSTAT Patented D00GJY COMPCLAS Cyclohexyl azetidine derivatives D00GSF DRUG__ID D00GSF D00GSF DRUGCOMP UNIVERZA V LJUBLJANI [SI] D00GSF DRUGTYPE Small molecular drug D00GSF HIGHSTAT Patented D00GSF COMPCLAS Di-substituted piperidine derivatives D00IPI DRUG__ID D00IPI D00IPI DRUGCOMP NORTHEASTERN UNIVERSITY D00IPI DRUGTYPE Small molecular drug D00IPI HIGHSTAT Patented D00IPI COMPCLAS Carbamide derivatives D00JUI DRUG__ID D00JUI D00JUI DRUGCOMP F.HOFFMANN-LA ROCHE AG GENENTECH, INC LI, Wei D00JUI DRUGTYPE Small molecular drug D00JUI HIGHSTAT Patented D00JUI COMPCLAS Triazolo-pyridine derivatives D00MLJ DRUG__ID D00MLJ D00MLJ DRUGCOMP The Ohio State University Research Foundation D00MLJ DRUGTYPE Small molecular drug D00MLJ HIGHSTAT Patented D00MLJ COMPCLAS Pyrazole derivatives D00ODC DRUG__ID D00ODC D00ODC DRUGCOMP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES MARUGAN, Juan J. PATNAIK, Samarjit HEILIG, Markus A. SOUTHALL, Noel T. ZHENG, Wei D00ODC DRUGTYPE Small molecular drug D00ODC HIGHSTAT Patented D00ODC COMPCLAS Imidazo pyridine derivatives D00PHK DRUG__ID D00PHK D00PHK DRUGCOMP ELI LILLY AND COMPANY D00PHK DRUGTYPE Small molecular drug D00PHK HIGHSTAT Patented D00PHK COMPCLAS Carboxylic acid derivatives D00PLP DRUG__ID D00PLP D00PLP DRUGCOMP Arena Pharmaceuticals, Inc D00PLP DRUGTYPE Small molecular drug D00PLP HIGHSTAT Patented D00PLP COMPCLAS Pyrazole derivatives D00PTE DRUG__ID D00PTE D00PTE DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D00PTE DRUGTYPE Small molecular drug D00PTE HIGHSTAT Patented D00PTE COMPCLAS Imidazopyridazine derivatives D00RKV DRUG__ID D00RKV D00RKV DRUGCOMP Astellas Pharma Inc. AOKI, Satoshi MUNAKATA, Ryosuke KAWANO, Noriyuki D00RKV DRUGTYPE Small molecular drug D00RKV HIGHSTAT Patented D00RKV COMPCLAS Carbamate derivatives D00RQW DRUG__ID D00RQW D00RQW DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D00RQW DRUGTYPE Carbohydrates D00RQW HIGHSTAT Patented D00RQW COMPCLAS Biaryl mannoside derivatives D00RRB DRUG__ID D00RRB D00RRB DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D00RRB DRUGTYPE Small molecular drug D00RRB HIGHSTAT Patented D00RRB COMPCLAS Isoflavone derivatives D00WDA DRUG__ID D00WDA D00WDA DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D00WDA DRUGTYPE Small molecular drug D00WDA HIGHSTAT Patented D00WDA COMPCLAS Indazole amide derivatives D00XDN DRUG__ID D00XDN D00XDN DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D00XDN DRUGTYPE Small molecular drug D00XDN HIGHSTAT Patented D00XDN COMPCLAS Pyrazole derivatives D00XEM DRUG__ID D00XEM D00XEM DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D00XEM DRUGTYPE Carbohydrates D00XEM HIGHSTAT Patented D00XEM COMPCLAS Beta-cyclodextrin conjugate derivatives D00YOY DRUG__ID D00YOY D00YOY DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D00YOY DRUGTYPE Small molecular drug D00YOY HIGHSTAT Patented D00YOY COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D00YRD DRUG__ID D00YRD D00YRD DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D00YRD DRUGTYPE Small molecular drug D00YRD HIGHSTAT Patented D00YRD COMPCLAS Heteroaryl-azepine derivatives D00YYA DRUG__ID D00YYA D00YYA DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D00YYA DRUGTYPE Small molecular drug D00YYA HIGHSTAT Patented D00YYA COMPCLAS Cyclopentane carboxamide derivatives D00ZAI DRUG__ID D00ZAI D00ZAI DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D00ZAI DRUGTYPE Small molecular drug D00ZAI HIGHSTAT Patented D00ZAI COMPCLAS Isoquinolinone derivatives D00ZCD DRUG__ID D00ZCD D00ZCD DRUGCOMP JANSEN PHARMACEUTICA NV HAWRYLUK, Natalie, A D00ZCD DRUGTYPE Small molecular drug D00ZCD HIGHSTAT Patented D00ZCD COMPCLAS Piperazine urea derivatives D00ZFY DRUG__ID D00ZFY D00ZFY DRUGCOMP SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY ZHANG, Qingwen D00ZFY DRUGTYPE Small molecular drug D00ZFY HIGHSTAT Patented D00ZFY COMPCLAS Carbamide derivatives D00ZRO DRUG__ID D00ZRO D00ZRO DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D00ZRO DRUGTYPE Small molecule immunotherapy D00ZRO HIGHSTAT Patented D00ZRO COMPCLAS Macrocycle derivatives D01AJO DRUG__ID D01AJO D01AJO DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D01AJO DRUGTYPE Small molecular drug D01AJO HIGHSTAT Patented D01AJO COMPCLAS Imidazo bicyclic iminium derivatives D01AYP DRUG__ID D01AYP D01AYP DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D01AYP DRUGTYPE Small molecule immunotherapy D01AYP HIGHSTAT Patented D01AYP COMPCLAS Bromo benzyl ether derivatives D01BGG DRUG__ID D01BGG D01BGG DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D01BGG DRUGTYPE Small molecular drug D01BGG HIGHSTAT Patented D01BGG COMPCLAS Isoflavone derivatives D01BMX DRUG__ID D01BMX D01BMX DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA MOUNT SINAI SCHOOL OF MEDICINE DAR, Arvin, C. DAS, Tirtha, K. SOS, Martin BIVONA, Trever, G. SHOKAT, Kevan, M. CAGAN, Ross, LUniversity of California and Icahn School of Medicine at Mount Sinai D01BMX DRUGTYPE Small molecular drug D01BMX HIGHSTAT Patented D01BMX COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D01BVU DRUG__ID D01BVU D01BVU DRUGCOMP H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE TURKSON, James JOVE, Richard SEBTI, Said D01BVU DRUGTYPE Small molecular drug D01BVU HIGHSTAT Patented D01BVU COMPCLAS Platinum IV complexes D01CIK DRUG__ID D01CIK D01CIK DRUGCOMP ORYZON GENOMICS SA [ESORYZON GENOMICS S.A. BAKER, Jonathan, Alleman CASTRO PALOMINO, Julio FYFE, Matthew, Colin, Thor MAES, Tamara MARTINELL PEDEMONTE, MarORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D01CIK DRUGTYPE Small molecular drug D01CIK HIGHSTAT Patented D01CIK COMPCLAS Heteroaryl-cyclopropylamine derivatives D01CKB DRUG__ID D01CKB D01CKB DRUGCOMP ASCEPION PHARMACEUTICALS, INC. JIANG, Shan GAO, Xiaoyong WANG, Qishan D01CKB DRUGTYPE Small molecular drug D01CKB HIGHSTAT Patented D01CKB COMPCLAS Carbamide derivatives D01DJZ DRUG__ID D01DJZ D01DJZ DRUGCOMP KBP BIOSCIENCES CO., LTD D01DJZ DRUGTYPE Small molecular drug D01DJZ HIGHSTAT Patented D01DJZ COMPCLAS Indoline derivatives D01EIT DRUG__ID D01EIT D01EIT DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED GLAXOSMITHKLINE (CHINA) R&D COMPANY LIMITED D01EIT DRUGTYPE Small molecular drug D01EIT HIGHSTAT Patented D01EIT COMPCLAS Pyrrolo-pyrimidine derivatives D01EVT DRUG__ID D01EVT D01EVT DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. NAKAMURA Toshio SAKAGAMI Kazunari KONISHI Kazuhide YAMAMOTO Kanako MASUDA Seiji D01EVT DRUGTYPE Small molecular drug D01EVT HIGHSTAT Patented D01EVT COMPCLAS Ethinyl-pyrazole derivatives D01EYJ DRUG__ID D01EYJ D01EYJ DRUGCOMP JIN, Bohan D01EYJ DRUGTYPE Small molecular drug D01EYJ HIGHSTAT Patented D01EYJ COMPCLAS Ruxolitinib derivatives D01GEE DRUG__ID D01GEE D01GEE DRUGCOMP MERCK SHARP &amDOHME CORP. GRAHAM, Thomas, H. SHEN, Dong-Ming SHU, Min D01GEE DRUGTYPE Small molecular drug D01GEE HIGHSTAT Patented D01GEE COMPCLAS Piperidinyl pyrazole derivatives D01GNL DRUG__ID D01GNL D01GNL DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D01GNL DRUGTYPE Small molecular drug D01GNL HIGHSTAT Patented D01GNL COMPCLAS Pyrazolopyridine derivatives D01IRA DRUG__ID D01IRA D01IRA DRUGCOMP PFIZER INC. HELAL, Christopher J. CHAPPIE, Thomas Allen HUMPHREY, John M D01IRA DRUGTYPE Small molecular drug D01IRA HIGHSTAT Patented D01IRA COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D01IYF DRUG__ID D01IYF D01IYF DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D01IYF DRUGTYPE Small molecular drug D01IYF HIGHSTAT Patented D01IYF COMPCLAS N-oxalylglycine derivatives D01KFW DRUG__ID D01KFW D01KFW DRUGCOMP Nerviano Medical Sciences S.r.l D01KFW DRUGTYPE Small molecular drug D01KFW HIGHSTAT Patented D01KFW COMPCLAS 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives D01MZI DRUG__ID D01MZI D01MZI DRUGCOMP China Pharmaceutical University D01MZI DRUGTYPE Small molecular drug D01MZI HIGHSTAT Patented D01MZI COMPCLAS Pyrazino[2,1-a]isoquinolin derivatives D01PBX DRUG__ID D01PBX D01PBX DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D01PBX DRUGTYPE Carbohydrates D01PBX HIGHSTAT Patented D01PBX COMPCLAS Biphenyl mannoside derivatives D01PFZ DRUG__ID D01PFZ D01PFZ DRUGCOMP Oscotec, Inc., S. Korea. assignee D01PFZ DRUGTYPE Small molecular drug D01PFZ HIGHSTAT Patented D01PFZ COMPCLAS Pyridopyrimidinone derivatives D01PJZ DRUG__ID D01PJZ D01PJZ DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D01PJZ DRUGTYPE Small molecule immunotherapy D01PJZ HIGHSTAT Patented D01PJZ COMPCLAS Cyclic peptidomimetic derivatives D01PYO DRUG__ID D01PYO D01PYO DRUGCOMP Angion Biomedica Corp D01PYO DRUGTYPE Small molecular drug D01PYO HIGHSTAT Patented D01PYO COMPCLAS Benzimidazole carboxamide derivatives D01RJL DRUG__ID D01RJL D01RJL DRUGCOMP MERCK SHARP & DOHME CORP. HO, Ginny, D. TULSHIAN, Deen HEAP, Charles, R D01RJL DRUGTYPE Small molecular drug D01RJL HIGHSTAT Patented D01RJL COMPCLAS Cyclopropyl-spiro piperidine derivatives D01RZG DRUG__ID D01RZG D01RZG DRUGCOMP HUMAN BIOMOLECULAR RESEARCH INSTITUTE CASHMAN, John, R. KALISIAK, Jaroslaw D01RZG DRUGTYPE Small molecular drug D01RZG HIGHSTAT Patented D01RZG COMPCLAS Amidine oxime derivatives D01TDT DRUG__ID D01TDT D01TDT DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D01TDT DRUGTYPE Small molecular drug D01TDT HIGHSTAT Patented D01TDT COMPCLAS Aryl pyrimidine derivatives D01WWN DRUG__ID D01WWN D01WWN DRUGCOMP RESEARCH TRIANGLE INSTITUTE FULP, Alan Bradley MAITRA, Rangan ZHANG, Yanan SELTZMAN, Herbert H D01WWN DRUGTYPE Small molecular drug D01WWN HIGHSTAT Patented D01WWN COMPCLAS Pyrazole derivatives D01XFM DRUG__ID D01XFM D01XFM DRUGCOMP Merck Patent GmBH D01XFM DRUGTYPE Small molecular drug D01XFM HIGHSTAT Patented D01XFM COMPCLAS 2-piperidine thiazole derivatives D01XUI DRUG__ID D01XUI D01XUI DRUGCOMP CELLTECH R&D LIMITED DYKE, Hazel, Joan RICHARD, Marianna, Dilani HAUGHAN, Alan, Findlay SHARPE, Andrew D01XUI DRUGTYPE Small molecular drug D01XUI HIGHSTAT Patented D01XUI COMPCLAS Carbamide derivatives D01XVK DRUG__ID D01XVK D01XVK DRUGCOMP JENRIN DISCOVERY MCELROY, John CHORVAT, Rober D01XVK DRUGTYPE Small molecular drug D01XVK HIGHSTAT Patented D01XVK COMPCLAS Pyrazoline derivatives D01ZKE DRUG__ID D01ZKE D01ZKE DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D01ZKE DRUGTYPE Carbohydrates D01ZKE HIGHSTAT Patented D01ZKE COMPCLAS Biaryl mannoside derivatives D02AAD DRUG__ID D02AAD D02AAD DRUGCOMP WASHINGTON UNIVERSITY D02AAD DRUGTYPE Carbohydrates D02AAD HIGHSTAT Patented D02AAD COMPCLAS Biaryl mannoside derivatives D02BPJ DRUG__ID D02BPJ D02BPJ DRUGCOMP RESEARCH TRIANGLE INSTITUTE D02BPJ DRUGTYPE Small molecular drug D02BPJ HIGHSTAT Patented D02BPJ COMPCLAS 4,5,6,7-tetrahydrofuro[3,4-c]pyridine-1(3H)-one derivatives D02CIX DRUG__ID D02CIX D02CIX DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D02CIX DRUGTYPE Small molecular drug D02CIX HIGHSTAT Patented D02CIX COMPCLAS Cyclopropylamine derivatives D02CTG DRUG__ID D02CTG D02CTG DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY HUANG, Yanting SUN, Chongqing LAWRENCE, R., Michael EWING, William, R. TURDI, Huji D02CTG DRUGTYPE Small molecular drug D02CTG HIGHSTAT Patented D02CTG COMPCLAS Carbamide derivatives D02DFJ DRUG__ID D02DFJ D02DFJ DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D02DFJ DRUGTYPE Carbohydrates D02DFJ HIGHSTAT Patented D02DFJ COMPCLAS Biaryl mannoside derivatives D02DXA DRUG__ID D02DXA D02DXA DRUGCOMP GLENMARK PHARMACEUTICALS S.A D02DXA DRUGTYPE Small molecular drug D02DXA HIGHSTAT Patented D02DXA COMPCLAS Benzamide derivatives D02GCY DRUG__ID D02GCY D02GCY DRUGCOMP MERCK SHARP & DOHME CORP. HO, Ginny, D. TULSHIAN, Deen HEAP, Charles, R D02GCY DRUGTYPE Small molecular drug D02GCY HIGHSTAT Patented D02GCY COMPCLAS Cyclopropyl-spiro piperidine derivatives D02GTU DRUG__ID D02GTU D02GTU DRUGCOMP F. HOFFMANN-LA ROCHE AG GOBBI, Luca JAESCHKE, Georg RODRIGUEZ SARMIENTO, Rosa Maria STEWARD, LucindHoffmann-La Roche Inc D02GTU DRUGTYPE Small molecular drug D02GTU HIGHSTAT Patented D02GTU COMPCLAS Benzoyl-piperidine derivatives D02HPF DRUG__ID D02HPF D02HPF DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D02HPF DRUGTYPE Carbohydrates D02HPF HIGHSTAT Patented D02HPF COMPCLAS Biaryl mannoside derivatives D02IXA DRUG__ID D02IXA D02IXA DRUGCOMP D2 BIOSCIENCE GROUP LTD. BAYERL, Thoma D02IXA DRUGTYPE Small molecular drug D02IXA HIGHSTAT Patented D02IXA COMPCLAS Uracil derivatives D02JPV DRUG__ID D02JPV D02JPV DRUGCOMP ASTELLAS PHARMA INC. FURUTANI, Takashi ENJO, Kentaro KIKUCHI, AyaAstellas Pharma Inc. KAKEFUDA, Akio KONDOH, Yutaka HIRANO, Masaak D02JPV DRUGTYPE Small molecular drug D02JPV HIGHSTAT Patented D02JPV COMPCLAS N-(benzimidazole/indole) benzoic acid derivatives D02ODA DRUG__ID D02ODA D02ODA DRUGCOMP ARIZONA BOARD OF REGENTS, ACTING ON BEHALF OF THE UNIVERSITY OF ARIZONA UNIVERSITY OF PITTSBURGH POWIS, Garth WIPF, Pete D02ODA DRUGTYPE Small molecular drug D02ODA HIGHSTAT Patented D02ODA COMPCLAS Palmarumycin derivatives D02QFM DRUG__ID D02QFM D02QFM DRUGCOMP Nerviano Medical Sciences S.r.l D02QFM DRUGTYPE Small molecular drug D02QFM HIGHSTAT Patented D02QFM COMPCLAS 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives D02RRE DRUG__ID D02RRE D02RRE DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. MASUDA Seiji MATSUDA Yohei SAKAGAMI Kazunari KONISHI Kazuhide URABE Hiroki SHIMONO Rie OKADA Kumiko D02RRE DRUGTYPE Small molecular drug D02RRE HIGHSTAT Patented D02RRE COMPCLAS Pyrazole derivatives D02SUS DRUG__ID D02SUS D02SUS DRUGCOMP SHANGHAI FOCHON PHARMACEUTICAL CO LTD WANG, Weibo ZHAO, Xingdong LEI, Ming ZHANG, Huajie WANG, Longcheng ZHANG, Jian FANG, Bo LIU, Xia ZHOU, Zuwen D02SUS DRUGTYPE Small molecular drug D02SUS HIGHSTAT Patented D02SUS COMPCLAS Imidazo cyclohexylamine derivatives D02URA DRUG__ID D02URA D02URA DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D02URA DRUGTYPE Small molecular drug D02URA HIGHSTAT Patented D02URA COMPCLAS Pyridine-2,4-dicarboxylic acid derivatives D02USA DRUG__ID D02USA D02USA DRUGCOMP SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. JIANGSU HENGRUI MEDICINE CO., LTD D02USA DRUGTYPE Small molecular drug D02USA HIGHSTAT Patented D02USA COMPCLAS Cycloalkyl acid derivatives D02UTG DRUG__ID D02UTG D02UTG DRUGCOMP THE UNIVERSITY OF HONG KON D02UTG DRUGTYPE Small molecular drug D02UTG HIGHSTAT Patented D02UTG COMPCLAS Binuclear gold(I) compounds D02VGC DRUG__ID D02VGC D02VGC DRUGCOMP CELLZOME LIMITED OXENFORD, Sally HOBSON, Andrew OLIVER, Kathryn RATCLIFFE, Andrew RAMSDEN, Nigel D02VGC DRUGTYPE Small molecular drug D02VGC HIGHSTAT Patented D02VGC COMPCLAS Pyrazolopyridine derivatives D02VRI DRUG__ID D02VRI D02VRI DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D02VRI DRUGTYPE Small molecular drug D02VRI HIGHSTAT Patented D02VRI COMPCLAS Tricyclic indole compounds D02WWT DRUG__ID D02WWT D02WWT DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D02WWT DRUGTYPE Carbohydrates D02WWT HIGHSTAT Patented D02WWT COMPCLAS Aryl mannoside derivatives D02XNH DRUG__ID D02XNH D02XNH DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D02XNH DRUGTYPE Carbohydrates D02XNH HIGHSTAT Patented D02XNH COMPCLAS C-linked disaccharide biphenyl mannoside derivatives D02YNU DRUG__ID D02YNU D02YNU DRUGCOMP Keio University D02YNU DRUGTYPE Small molecular drug D02YNU HIGHSTAT Patented D02YNU COMPCLAS 2-hydroxybenzamide derivatives D02YTB DRUG__ID D02YTB D02YTB DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED GLAXOSMITHKLINE (CHINA) R&D COMPANY LIMITED D02YTB DRUGTYPE Small molecular drug D02YTB HIGHSTAT Patented D02YTB COMPCLAS Pyrrolo-pyrimidine derivatives D02ZPG DRUG__ID D02ZPG D02ZPG DRUGCOMP PFIZER INC. FAY, Lorraine Kathleen JOHNSON, Douglas Scott MEYERS, Marvin Jay THORARENSEN, Atli WANG, Lijuan Jane D02ZPG DRUGTYPE Small molecular drug D02ZPG HIGHSTAT Patented D02ZPG COMPCLAS Aryl urea derivatives D02ZUW DRUG__ID D02ZUW D02ZUW DRUGCOMP NORTHEASTERN UNIVERSITY D02ZUW DRUGTYPE Small molecular drug D02ZUW HIGHSTAT Patented D02ZUW COMPCLAS Carbamide derivatives D02ZYV DRUG__ID D02ZYV D02ZYV DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D02ZYV DRUGTYPE Carbohydrates D02ZYV HIGHSTAT Patented D02ZYV COMPCLAS Biaryl mannoside derivatives D03BCV DRUG__ID D03BCV D03BCV DRUGCOMP BRISTOL-MYERS SQUIBB COMPANBristol-Myers Squibb Company D03BCV DRUGTYPE Small molecule immunotherapy D03BCV HIGHSTAT Patented D03BCV COMPCLAS Macrocycle derivatives D03BPZ DRUG__ID D03BPZ D03BPZ DRUGCOMP ISIS INNOVATION LIMITED LOWE, Gordon D03BPZ DRUGTYPE Small molecular drug D03BPZ HIGHSTAT Patented D03BPZ COMPCLAS Terpyridineplatinum(II) complexes D03CTH DRUG__ID D03CTH D03CTH DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D03CTH DRUGTYPE Carbohydrates D03CTH HIGHSTAT Patented D03CTH COMPCLAS Biphenyl mannoside derivatives D03DNE DRUG__ID D03DNE D03DNE DRUGCOMP Washington University D03DNE DRUGTYPE Small molecular drug D03DNE HIGHSTAT Patented D03DNE COMPCLAS Benzamide derivatives D03EOJ DRUG__ID D03EOJ D03EOJ DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D03EOJ DRUGTYPE Small molecular drug D03EOJ HIGHSTAT Patented D03EOJ COMPCLAS N-oxalyl-D-tyrosine derivatives D03FZI DRUG__ID D03FZI D03FZI DRUGCOMP ABBOTT LABORATORIES WENDT, Michael, D. SHEN, Wang DICKMAN, Daniel, A. DING, Hong THOMAS, Sheela, A. AUGERI, David ELMORE, Steven, W D03FZI DRUGTYPE Small molecular drug D03FZI HIGHSTAT Patented D03FZI COMPCLAS Biphenyl carboxylic acid derivatives D03GDC DRUG__ID D03GDC D03GDC DRUGCOMP H. LUNDBECK A/S VERNALIS (R&D) LTD D03GDC DRUGTYPE Small molecular drug D03GDC HIGHSTAT Patented D03GDC COMPCLAS Pyrrolo-pyridine derivatives D03GFB DRUG__ID D03GFB D03GFB DRUGCOMP SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. CALVANI, Menotti D'IDDIO, Stefania BENATTI, Paola D03GFB DRUGTYPE Small molecular drug D03GFB HIGHSTAT Patented D03GFB COMPCLAS Spirolaxine derivatives D03GFZ DRUG__ID D03GFZ D03GFZ DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED DALY, Kevin HERON, Nicola HIRD, Alexander IOANNIDIS, Stephanos JANETKA, James, Walter LYNE, Paul SCOTT, Jamie TOADER, Dorin VASBINDER, Melissa YU, Dingwei YU, Yan D03GFZ DRUGTYPE Small molecular drug D03GFZ HIGHSTAT Patented D03GFZ COMPCLAS Thieno[3,2-c]pyridine-7-carboxamide derivatives D03HHD DRUG__ID D03HHD D03HHD DRUGCOMP JENRIN DISCOVERY MCELROY, John CHORVAT, Robert D03HHD DRUGTYPE Small molecular drug D03HHD HIGHSTAT Patented D03HHD COMPCLAS Pyrazoline derivatives D03HNU DRUG__ID D03HNU D03HNU DRUGCOMP ELAN PHARMACEUTICALS, LLC D03HNU DRUGTYPE Small molecular drug D03HNU HIGHSTAT Patented D03HNU COMPCLAS Hydrazide derivatives D03HPW DRUG__ID D03HPW D03HPW DRUGCOMP HUNAN NONFERROUS METALS GROUP CHEMBIO PHARMACY CO., LTD D03HPW DRUGTYPE Small molecular drug D03HPW HIGHSTAT Patented D03HPW COMPCLAS Indoline derivatives D03IAB DRUG__ID D03IAB D03IAB DRUGCOMP ARENA PHARMACEUTICALS, INC. XIONG, Yifeng CHERRIER, Martin, C. CHOI, Jin Sun, Karoline DOSA, Peter, I. SMITH, Brian, M. STRAH-PLEYNET, Sonja ULLMAN, Bret TEEGARDEN, Bradley D03IAB DRUGTYPE Small molecular drug D03IAB HIGHSTAT Patented D03IAB COMPCLAS Pyrazole derivatives D03ITZ DRUG__ID D03ITZ D03ITZ DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D03ITZ DRUGTYPE Carbohydrates D03ITZ HIGHSTAT Patented D03ITZ COMPCLAS Aryl mannoside derivatives D03IZY DRUG__ID D03IZY D03IZY DRUGCOMP ARENA PHARMACEUTICALS, INC D03IZY DRUGTYPE Small molecular drug D03IZY HIGHSTAT Patented D03IZY COMPCLAS Benzazepine derivatives D03JZP DRUG__ID D03JZP D03JZP DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEGlaxoSmithKline D03JZP DRUGTYPE Small molecular drug D03JZP HIGHSTAT Patented D03JZP COMPCLAS Dihydropyridine compounds D03KAV DRUG__ID D03KAV D03KAV DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D03KAV DRUGTYPE Carbohydrates D03KAV HIGHSTAT Patented D03KAV COMPCLAS Biphenyl mannoside derivatives D03MCC DRUG__ID D03MCC D03MCC DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D03MCC DRUGTYPE Small molecular drug D03MCC HIGHSTAT Patented D03MCC COMPCLAS Tetra-hydro-naphthalene derivatives D03MKY DRUG__ID D03MKY D03MKY DRUGCOMP UNIVERSITE DE LILLE 2 DROIT ET SANTE CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) D03MKY DRUGTYPE Small molecular drug D03MKY HIGHSTAT Patented D03MKY COMPCLAS Benzamide derivatives D03MMZ DRUG__ID D03MMZ D03MMZ DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA MOUNT SINAI SCHOOL OF MEDICINE DAR, Arvin, C. DAS, Tirtha, K. SOS, Martin BIVONA, Trever, G. SHOKAT, Kevan, M. CAGAN, Ross, LUniversity of California and Icahn School of Medicine at Mount Sinai D03MMZ DRUGTYPE Small molecular drug D03MMZ HIGHSTAT Patented D03MMZ COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D03NHO DRUG__ID D03NHO D03NHO DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D03NHO DRUGTYPE Small molecular drug D03NHO HIGHSTAT Patented D03NHO COMPCLAS Monoaryl-1,2-diamine derivatives D03ORX DRUG__ID D03ORX D03ORX DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEGlaxoSmithKline D03ORX DRUGTYPE Small molecular drug D03ORX HIGHSTAT Patented D03ORX COMPCLAS Dihydropyridine compounds D03PBI DRUG__ID D03PBI D03PBI DRUGCOMP MERCK SHARP & DOHME [US] D03PBI DRUGTYPE Small molecular drug D03PBI HIGHSTAT Patented D03PBI COMPCLAS Pyrrolo-pyridone derivatives D03PSA DRUG__ID D03PSA D03PSA DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D03PSA DRUGTYPE Small molecule immunotherapy D03PSA HIGHSTAT Patented D03PSA COMPCLAS 1,2,4-oxadiazole derivatives D03PZX DRUG__ID D03PZX D03PZX DRUGCOMP Shenyang Pharmaceutical University and Santa (ZhangJiakou) Pharmaceutical Co., Ltd D03PZX DRUGTYPE Small molecular drug D03PZX HIGHSTAT Patented D03PZX COMPCLAS 2-ethyl-3-(4-hydroxy) benzoyl benzofuran derivatives D03QAY DRUG__ID D03QAY D03QAY DRUGCOMP PFIZER INC D03QAY DRUGTYPE Small molecular drug D03QAY HIGHSTAT Patented D03QAY COMPCLAS Pyrazolopyridine derivatives D03QGH DRUG__ID D03QGH D03QGH DRUGCOMP ARDEA BIOSCIENCES, INC. OUK, Samedy VERNIER, Jean-michel GUNIC, Esmir CHEN, Chixu D03QGH DRUGTYPE Small molecular drug D03QGH HIGHSTAT Patented D03QGH COMPCLAS Tihoacetate derivatives D03ROY DRUG__ID D03ROY D03ROY DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D03ROY DRUGTYPE Small molecular drug D03ROY HIGHSTAT Patented D03ROY COMPCLAS Aryl pyrimidine derivatives D03RXE DRUG__ID D03RXE D03RXE DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D03RXE DRUGTYPE Carbohydrates D03RXE HIGHSTAT Patented D03RXE COMPCLAS Biphenyl mannoside derivatives D03SZN DRUG__ID D03SZN D03SZN DRUGCOMP HUNAN NONFERROUS METALS GROUP CHEMBIO PHARMACY CO., LTD. ZHANG, Shixi D03SZN DRUGTYPE Small molecular drug D03SZN HIGHSTAT Patented D03SZN COMPCLAS Carbamide derivatives D03TEE DRUG__ID D03TEE D03TEE DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED BENNANI, Yousseff WANG, Tiansheng SALITURO, Francesco DUFFY, John D03TEE DRUGTYPE Small molecular drug D03TEE HIGHSTAT Patented D03TEE COMPCLAS Tricyclic heterocycle derivatives D03VUN DRUG__ID D03VUN D03VUN DRUGCOMP Kunming Inst Botany CN ACAD D03VUN DRUGTYPE Small molecular drug D03VUN HIGHSTAT Patented D03VUN COMPCLAS Lycorine dimer salt derivatives D03VXQ DRUG__ID D03VXQ D03VXQ DRUGCOMP NEW HOPE R & D BIOSCIENCE, INC. CHEN, Xiao-Tao D03VXQ DRUGTYPE Small molecular drug D03VXQ HIGHSTAT Patented D03VXQ COMPCLAS Oxetane 3,3-dicarboxamide compounds D03WBS DRUG__ID D03WBS D03WBS DRUGCOMP RAQUALIA PHARMA INC. YAMAGISHI, Tatsuya ARANO, Yoshimasa MORITA, Mikio INOUE, Tadashi D03WBS DRUGTYPE Small molecular drug D03WBS HIGHSTAT Patented D03WBS COMPCLAS Aryl carboxamide derivatives D03WCJ DRUG__ID D03WCJ D03WCJ DRUGCOMP LABORATORIOS DEL DR. ESTEVE, S. A. VELA HERNANDEZ, Jose, Miguel YENES MINGUEZ, Susan D03WCJ DRUGTYPE Small molecular drug D03WCJ HIGHSTAT Patented D03WCJ COMPCLAS 4-methyl-4,5-dihydro-1H-pyrazole-3-carboxamide derivatives D03WJB DRUG__ID D03WJB D03WJB DRUGCOMP WASHINGTON UNIVERSITY D03WJB DRUGTYPE Carbohydrates D03WJB HIGHSTAT Patented D03WJB COMPCLAS Biphenyl mannoside derivatives D03WXM DRUG__ID D03WXM D03WXM DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D03WXM DRUGTYPE Carbohydrates D03WXM HIGHSTAT Patented D03WXM COMPCLAS C-linked disaccharide biphenyl mannoside derivatives D03XZT DRUG__ID D03XZT D03XZT DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D03XZT DRUGTYPE Small molecule immunotherapy D03XZT HIGHSTAT Patented D03XZT COMPCLAS Macrocycle derivatives D04BSD DRUG__ID D04BSD D04BSD DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D04BSD DRUGTYPE Small molecular drug D04BSD HIGHSTAT Patented D04BSD COMPCLAS Piperazinyl norbenzomorphane compounds D04BYB DRUG__ID D04BYB D04BYB DRUGCOMP CHDI FOUNDATION, INC D04BYB DRUGTYPE Small molecular drug D04BYB HIGHSTAT Patented D04BYB COMPCLAS Cyclopropane 1-carboxylic acid derivatives D04BZI DRUG__ID D04BZI D04BZI DRUGCOMP CURADEV PHARMA PRIVATE LTD D04BZI DRUGTYPE Small molecular drug D04BZI HIGHSTAT Patented D04BZI COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D04DCO DRUG__ID D04DCO D04DCO DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D04DCO DRUGTYPE Small molecular drug D04DCO HIGHSTAT Patented D04DCO COMPCLAS 1,2-diamino cyclopentane-based derivatives D04IFL DRUG__ID D04IFL D04IFL DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D04IFL DRUGTYPE Small molecular drug D04IFL HIGHSTAT Patented D04IFL COMPCLAS Isoflavone derivatives D04KQB DRUG__ID D04KQB D04KQB DRUGCOMP ARRAY BIOPHARMA INC. HAAS, Julia ANDREWS, Steven, W. JIANG, Yutong ZHANG, Gan D04KQB DRUGTYPE Small molecular drug D04KQB HIGHSTAT Patented D04KQB COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D04MQF DRUG__ID D04MQF D04MQF DRUGCOMP PRESIDENT AND FELLOWS OF HARVARD COLLEGE FINLEY, Daniel KING, Randall, W. LEE, Byung-Hoon LEE, Min, Jae GAHMAN, Timothy, C D04MQF DRUGTYPE Small molecular drug D04MQF HIGHSTAT Patented D04MQF COMPCLAS Tricyclic heterocycle derivatives D04OHC DRUG__ID D04OHC D04OHC DRUGCOMP UNIV ROMA [ITFOND IEO [ITUNIV PAVIA [ITUNIV DEGLI STUDI MILANO [ITMINUCCI SAVERIO [ITMAI ANTONELLO [ITMATTEVI ANDREA [IT] D04OHC DRUGTYPE Small molecular drug D04OHC HIGHSTAT Patented D04OHC COMPCLAS Tarnylcypromine derivatives D04ONQ DRUG__ID D04ONQ D04ONQ DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D04ONQ DRUGTYPE Small molecular drug D04ONQ HIGHSTAT Patented D04ONQ COMPCLAS 4-aryl quinol derivatives D04PCA DRUG__ID D04PCA D04PCA DRUGCOMP ESTEVE LABOR DR [ES] D04PCA DRUGTYPE Small molecular drug D04PCA HIGHSTAT Patented D04PCA COMPCLAS Pyrazole derivatives D04PDM DRUG__ID D04PDM D04PDM DRUGCOMP Washington University D04PDM DRUGTYPE Small molecular drug D04PDM HIGHSTAT Patented D04PDM COMPCLAS Benzamide derivatives D04PWX DRUG__ID D04PWX D04PWX DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D04PWX DRUGTYPE Small molecular drug D04PWX HIGHSTAT Patented D04PWX COMPCLAS Cyclopropylamine derivatives D04SWU DRUG__ID D04SWU D04SWU DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D04SWU DRUGTYPE Small molecular drug D04SWU HIGHSTAT Patented D04SWU COMPCLAS Tricyclic indole compounds D04TLQ DRUG__ID D04TLQ D04TLQ DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D04TLQ DRUGTYPE Small molecule immunotherapy D04TLQ HIGHSTAT Patented D04TLQ COMPCLAS Cyclic peptidomimetic derivatives D04UIH DRUG__ID D04UIH D04UIH DRUGCOMP MERCK SHARP & DOHME CORP. SEGANISH, W. Michael MCELROY, William, T. BRUMFIELD, Stephanie HERR, R. Jason YET, Larry YANG, Jinhai HARDING, James, P., III HO, Ginny Dai TULSHIAN, Deen, B. YU, Wensheng WONG, Michael, K. C. LAVEY, Brian, J. KOZLOWSKI, Joseph, A D04UIH DRUGTYPE Small molecular drug D04UIH HIGHSTAT Patented D04UIH COMPCLAS Amidopyrazole derivatives D04UKD DRUG__ID D04UKD D04UKD DRUGCOMP JIANGSU SIMCERE PHARMACEUTICAL CO LTD [CN] D04UKD DRUGTYPE Small molecular drug D04UKD HIGHSTAT Patented D04UKD COMPCLAS 1,6-naphyridine-4-ketone fused heterocyclic derivatives D04ULX DRUG__ID D04ULX D04ULX DRUGCOMP Yuanqiang Z D04ULX DRUGTYPE Small molecular drug D04ULX HIGHSTAT Patented D04ULX COMPCLAS Succinamide derivatives D04USU DRUG__ID D04USU D04USU DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, J., Guy KEITH, John, M. TICHENOR, Mark, S. CHAMBERS, Alison, L. JONES, William, M. HAWRYLUK, Natalie, A. TIMMONS, Amy, K. MERIT, Jeffrey, E. SEIERSTAD, Mark, JJanssen Pharmaceutica N.V D04USU DRUGTYPE Small molecular drug D04USU HIGHSTAT Patented D04USU COMPCLAS Heteroaryl-substituted urea derivatives D04UXC DRUG__ID D04UXC D04UXC DRUGCOMP SHANGHAI FOCHON PHARMACEUTICAL CO LTD WANG, Weibo ZHAO, Xingdong LEI, Ming ZHANG, Huajie WANG, Longcheng ZHANG, Jian FANG, Bo LIU, Xia ZHOU, Zuwen D04UXC DRUGTYPE Small molecular drug D04UXC HIGHSTAT Patented D04UXC COMPCLAS Imidazo cyclohexylamine derivatives D04VDD DRUG__ID D04VDD D04VDD DRUGCOMP UNIVERSITY OF SOUTH AUSTRALIA CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC D04VDD DRUGTYPE Small molecular drug D04VDD HIGHSTAT Patented D04VDD COMPCLAS Methylbenzenesulfonamide derivatives D04WCW DRUG__ID D04WCW D04WCW DRUGCOMP INCYTE CORPORATIOINCYTE HOLDINGS CORPORATION D04WCW DRUGTYPE Small molecular drug D04WCW HIGHSTAT Patented D04WCW COMPCLAS Hydoxyamidine derivatives D04WKL DRUG__ID D04WKL D04WKL DRUGCOMP WASHINGTON UNIVERSITY D04WKL DRUGTYPE Small molecular drug D04WKL HIGHSTAT Patented D04WKL COMPCLAS Piperazinyl methyl quinazolinone derivatives D04WND DRUG__ID D04WND D04WND DRUGCOMP Oscotec, Inc., S. Korea. assignee D04WND DRUGTYPE Small molecular drug D04WND HIGHSTAT Patented D04WND COMPCLAS Pyridopyrimidinone derivatives D04XNL DRUG__ID D04XNL D04XNL DRUGCOMP CONCERT PHARMACEUTICALS, INC D04XNL DRUGTYPE Small molecular drug D04XNL HIGHSTAT Patented D04XNL COMPCLAS Ruxolitinib derivatives D04ZEX DRUG__ID D04ZEX D04ZEX DRUGCOMP ABIDE THERAPEUTICS, INC D04ZEX DRUGTYPE Small molecular drug D04ZEX HIGHSTAT Patented D04ZEX COMPCLAS Pyrazole derivatives D05AXE DRUG__ID D05AXE D05AXE DRUGCOMP SAREUM LIMITED D05AXE DRUGTYPE Small molecular drug D05AXE HIGHSTAT Patented D05AXE COMPCLAS Aminooxazole carboxamide derivatives D05AZE DRUG__ID D05AZE D05AZE DRUGCOMP WASHINGTON UNIVERSITY D05AZE DRUGTYPE Carbohydrates D05AZE HIGHSTAT Patented D05AZE COMPCLAS Biphenyl mannoside derivatives D05BUD DRUG__ID D05BUD D05BUD DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D05BUD DRUGTYPE Carbohydrates D05BUD HIGHSTAT Patented D05BUD COMPCLAS Mannoside derivatives D05BYE DRUG__ID D05BYE D05BYE DRUGCOMP JIANGSU HENGRUI MEDICINE CO., LTD. SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD D05BYE DRUGTYPE Small molecular drug D05BYE HIGHSTAT Patented D05BYE COMPCLAS Hydroxy amidine derivatives D05CEL DRUG__ID D05CEL D05CEL DRUGCOMP NORTHEASTERN UNIVERSITY D05CEL DRUGTYPE Small molecular drug D05CEL HIGHSTAT Patented D05CEL COMPCLAS 2-cycloalkyl resorcinol cannabinoid ligand derivatives D05DBG DRUG__ID D05DBG D05DBG DRUGCOMP PFIZER INC D05DBG DRUGTYPE Small molecular drug D05DBG HIGHSTAT Patented D05DBG COMPCLAS Carbamate derivatives D05GEL DRUG__ID D05GEL D05GEL DRUGCOMP MERCK SHARP & DOHME [US] D05GEL DRUGTYPE Small molecular drug D05GEL HIGHSTAT Patented D05GEL COMPCLAS Cyclic cyanoethypypazole derivatives D05GKS DRUG__ID D05GKS D05GKS DRUGCOMP EXXONMOBIL RESEARCH AND ENGINEERING COMPANY OLIVERI, Christopher, G. LAI, Wenyih, Frank DANDEKAR, Ajit, B. WEIGEL, Scott, J. KAY, Robert, Ellis WU, Jianxin, Jaso D05GKS DRUGTYPE Small molecular drug D05GKS HIGHSTAT Patented D05GKS COMPCLAS N-(phenylamino)-benzoate derivatives D05GMT DRUG__ID D05GMT D05GMT DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH ENGELHARDT, Harald BOEHMELT, Guido KOFINK, Christiane KUHN, Daniel MCCONNELL, Darryl STADTMUELLER, Heinz D05GMT DRUGTYPE Small molecular drug D05GMT HIGHSTAT Patented D05GMT COMPCLAS Pyridinone carboxamide derivatives D05HBM DRUG__ID D05HBM D05HBM DRUGCOMP THE JOHNS HOPKINS UNIVERSITY CASERO, Robert, A. BYTHEWAY, Ian WOSTER, Patrick, M D05HBM DRUGTYPE Small molecular drug D05HBM HIGHSTAT Patented D05HBM COMPCLAS Benzenamine derivatives D05HYJ DRUG__ID D05HYJ D05HYJ DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA MOUNT SINAI SCHOOL OF MEDICINE DAR, Arvin, C. DAS, Tirtha, K. SOS, Martin BIVONA, Trever, G. SHOKAT, Kevan, M. CAGAN, Ross, LUniversity of California and Icahn School of Medicine at Mount Sinai D05HYJ DRUGTYPE Small molecular drug D05HYJ HIGHSTAT Patented D05HYJ COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D05JAS DRUG__ID D05JAS D05JAS DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D05JAS DRUGTYPE Carbohydrates D05JAS HIGHSTAT Patented D05JAS COMPCLAS Biphenyl mannoside derivatives D05KHT DRUG__ID D05KHT D05KHT DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, Wade CONDROSKI, Kevin, Ronald HAAS, Julia JIANG, Yutong KOLAKOWSKI, Gabrielle, R. SEO, Jeongbeob YANG, Hong-Woon ZHAO, Qian D05KHT DRUGTYPE Small molecular drug D05KHT HIGHSTAT Patented D05KHT COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D05NBB DRUG__ID D05NBB D05NBB DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D05NBB DRUGTYPE Small molecular drug D05NBB HIGHSTAT Patented D05NBB COMPCLAS Pyrrolo-pyridinone derivatives D05NRG DRUG__ID D05NRG D05NRG DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D05NRG DRUGTYPE Small molecular drug D05NRG HIGHSTAT Patented D05NRG COMPCLAS Isoflavone derivatives D05NUN DRUG__ID D05NUN D05NUN DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D05NUN DRUGTYPE Small molecular drug D05NUN HIGHSTAT Patented D05NUN COMPCLAS Pyrazole derivatives D05PMY DRUG__ID D05PMY D05PMY DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D05PMY DRUGTYPE Small molecular drug D05PMY HIGHSTAT Patented D05PMY COMPCLAS 1,2-diamino cyclopentane-based derivatives D05QAL DRUG__ID D05QAL D05QAL DRUGCOMP JIANGSU HENGRUI MEDICINE CO., LTD. SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD D05QAL DRUGTYPE Small molecular drug D05QAL HIGHSTAT Patented D05QAL COMPCLAS Hydroxy amidine derivatives D05QVX DRUG__ID D05QVX D05QVX DRUGCOMP Univ China Pharma D05QVX DRUGTYPE Small molecular drug D05QVX HIGHSTAT Patented D05QVX COMPCLAS Tacrine-indole hybrid derivatives D05SHW DRUG__ID D05SHW D05SHW DRUGCOMP ISIS INNOVATION LIMITED LOWE, Gordon D05SHW DRUGTYPE Small molecular drug D05SHW HIGHSTAT Patented D05SHW COMPCLAS Terpyridineplatinum(II) complexes D05SOY DRUG__ID D05SOY D05SOY DRUGCOMP BEIJING LABWORLD BIO MEDICINE TECHNOLOGY CO LTD D05SOY DRUGTYPE Small molecular drug D05SOY HIGHSTAT Patented D05SOY COMPCLAS Hexahydro naphthalene derivatives D05SWA DRUG__ID D05SWA D05SWA DRUGCOMP INSERM INST NAT DE LA SANT ET DE LA RECH M DICALE [FRUNIVERSIT PARIS DIDEROT PARIS 7 [FRCENTRE NAT RECH SCIENT [FR] D05SWA DRUGTYPE Small molecular drug D05SWA HIGHSTAT Patented D05SWA COMPCLAS Azetidinyl-piperidine derivatives D05TIP DRUG__ID D05TIP D05TIP DRUGCOMP CURADEV PHARMA PRIVATE LTD D05TIP DRUGTYPE Small molecular drug D05TIP HIGHSTAT Patented D05TIP COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D05UNO DRUG__ID D05UNO D05UNO DRUGCOMP Pfizer Incorporated D05UNO DRUGTYPE Small molecular drug D05UNO HIGHSTAT Patented D05UNO COMPCLAS Imidazo triazine derivatives D05WDQ DRUG__ID D05WDQ D05WDQ DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D05WDQ DRUGTYPE Small molecular drug D05WDQ HIGHSTAT Patented D05WDQ COMPCLAS 1,2-diamino cyclopentane-based derivatives D05WPG DRUG__ID D05WPG D05WPG DRUGCOMP Univ Sun Yat Sen D05WPG DRUGTYPE Small molecular drug D05WPG HIGHSTAT Patented D05WPG COMPCLAS Tacrine-caffeic acid hybrid derivatives D05WTW DRUG__ID D05WTW D05WTW DRUGCOMP Kala Pharmaceuticals, Inc D05WTW DRUGTYPE Small molecular drug D05WTW HIGHSTAT Patented D05WTW COMPCLAS Carbamide derivatives D05WWX DRUG__ID D05WWX D05WWX DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D05WWX DRUGTYPE Carbohydrates D05WWX HIGHSTAT Patented D05WWX COMPCLAS Biphenyl mannoside derivatives D05YFF DRUG__ID D05YFF D05YFF DRUGCOMP UNIVERSITE DE LILLE 2 DROIT ET SANTE CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) D05YFF DRUGTYPE Small molecular drug D05YFF HIGHSTAT Patented D05YFF COMPCLAS Benzamide derivatives D05ZGX DRUG__ID D05ZGX D05ZGX DRUGCOMP CURADEV PHARMA PRIVATE LTD D05ZGX DRUGTYPE Small molecular drug D05ZGX HIGHSTAT Patented D05ZGX COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D06BNK DRUG__ID D06BNK D06BNK DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA MOUNT SINAI SCHOOL OF MEDICINE DAR, Arvin, C. DAS, Tirtha, K. SOS, Martin BIVONA, Trever, G. SHOKAT, Kevan, M. CAGAN, Ross, LUniversity of California and Icahn School of Medicine at Mount Sinai D06BNK DRUGTYPE Small molecular drug D06BNK HIGHSTAT Patented D06BNK COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D06BSG DRUG__ID D06BSG D06BSG DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED DALY, Kevin HERON, Nicola HIRD, Alexander IOANNIDIS, Stephanos JANETKA, James, Walter LYNE, Paul SCOTT, Jamie TOADER, Dorin VASBINDER, Melissa YU, Dingwei YU, Yan D06BSG DRUGTYPE Small molecular drug D06BSG HIGHSTAT Patented D06BSG COMPCLAS Thieno[3,2-c]pyridine-7-carboxamide derivatives D06FUK DRUG__ID D06FUK D06FUK DRUGCOMP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES MARUGAN, Juan J. PATNAIK, Samarjit HEILIG, Markus A. SOUTHALL, Noel T. ZHENG, Wei D06FUK DRUGTYPE Small molecular drug D06FUK HIGHSTAT Patented D06FUK COMPCLAS Imidazo pyridine derivatives D06IPV DRUG__ID D06IPV D06IPV DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori SHIRAI, Kimihiro OI, Marik D06IPV DRUGTYPE Small molecular drug D06IPV HIGHSTAT Patented D06IPV COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D06JCF DRUG__ID D06JCF D06JCF DRUGCOMP ABBVIE DEUTSCHLAND [DEABBVIE INC [US] D06JCF DRUGTYPE Small molecular drug D06JCF HIGHSTAT Patented D06JCF COMPCLAS Carboxamide derivatives D06KXL DRUG__ID D06KXL D06KXL DRUGCOMP CELLTECH R&D LIMITED HAUGHAN, Alan, Findlay BUCKLEY, George, Martin DAVIES, Natasha DYKE, Hazel, Joan HANNAH, Duncan, Robert MORGAN, Trevor RICHARD, Marianna, Dilani SHARPE, Andrew WILLIAMS, Sophie, Caroline D06KXL DRUGTYPE Small molecular drug D06KXL HIGHSTAT Patented D06KXL COMPCLAS Quinazolinone derivatives D06LEF DRUG__ID D06LEF D06LEF DRUGCOMP China Pharmaceutical University D06LEF DRUGTYPE Small molecular drug D06LEF HIGHSTAT Patented D06LEF COMPCLAS Pyrazino[2,1-a]isoquinolin derivatives D06MHK DRUG__ID D06MHK D06MHK DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D06MHK DRUGTYPE Small molecular drug D06MHK HIGHSTAT Patented D06MHK COMPCLAS N-oxalyl-D-tyrosine derivatives D06MIW DRUG__ID D06MIW D06MIW DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D06MIW DRUGTYPE Small molecular drug D06MIW HIGHSTAT Patented D06MIW COMPCLAS Pyrazole derivatives D06MPH DRUG__ID D06MPH D06MPH DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeong Min CHANG, Chong-Hwan Jonathan LEE, Suk Ho SEO, Hee Jeong KANG, Suk Youn SONG, Kwang-Seop KIM, Jong Yup KIM, Min Ju LEE, Sung-Han AHN, Kwang-Woo JUNG, Myung Eu D06MPH DRUGTYPE Small molecular drug D06MPH HIGHSTAT Patented D06MPH COMPCLAS Pyrazole derivatives D06MQB DRUG__ID D06MQB D06MQB DRUGCOMP MERCK SHARP & DOHME CORP. DINSMORE, Christopher FULLER, Peter GUERIN, David THOMPSON, Christopher F. PU, Qinglin SCOTT, Mark E. KATZ, Jason David KURUKULASURIYA, Ravi CLOSE, Joshua T. FALCONE, Danielle BRUBAKER, Jason ZENG, Hongbo BAI, Yunfeng FU, Jianmin KONG, Norman LIU, Yumei ZHENG, Zhixiang D06MQB DRUGTYPE Small molecular drug D06MQB HIGHSTAT Patented D06MQB COMPCLAS Pyrrolo-pyridone derivatives D06PIO DRUG__ID D06PIO D06PIO DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D06PIO DRUGTYPE Small molecular drug D06PIO HIGHSTAT Patented D06PIO COMPCLAS Indoline derivatives D06PNN DRUG__ID D06PNN D06PNN DRUGCOMP WASHINGTON UNIVERSITY D06PNN DRUGTYPE Carbohydrates D06PNN HIGHSTAT Patented D06PNN COMPCLAS Biaryl mannoside derivatives D06QWY DRUG__ID D06QWY D06QWY DRUGCOMP PFIZER LIMITED ICAGEN, INC. MARKWORTH, Christopher John MARRON, Brian Edward RAWSON, David James STORER, Robert Ian SWAIN, Nigel Alan WEST, Christopher William ZHOU, Shulan D06QWY DRUGTYPE Small molecular drug D06QWY HIGHSTAT Patented D06QWY COMPCLAS Benzene sulfonamide derivatives D06RFO DRUG__ID D06RFO D06RFO DRUGCOMP J-PHARMA CO., LTD. WEMPE, Michael, F. ENDOU, Hitoshi D06RFO DRUGTYPE Small molecular drug D06RFO HIGHSTAT Patented D06RFO COMPCLAS Benzofurans derivatives D06SWT DRUG__ID D06SWT D06SWT DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D06SWT DRUGTYPE Carbohydrates D06SWT HIGHSTAT Patented D06SWT COMPCLAS Aryl mannoside derivatives D06VJM DRUG__ID D06VJM D06VJM DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D06VJM DRUGTYPE Small molecular drug D06VJM HIGHSTAT Patented D06VJM COMPCLAS Heteroaryl-azepine derivatives D06VMN DRUG__ID D06VMN D06VMN DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, CarloORYZON GENOMICS SA [ES] D06VMN DRUGTYPE Small molecular drug D06VMN HIGHSTAT Patented D06VMN COMPCLAS Heteroaryl-cyclopropylamine derivatives D06VTI DRUG__ID D06VTI D06VTI DRUGCOMP Bristol-Myers Squibb Company D06VTI DRUGTYPE Small molecule immunotherapy D06VTI HIGHSTAT Patented D06VTI COMPCLAS Macrocycle derivatives D06VYB DRUG__ID D06VYB D06VYB DRUGCOMP RAQUALIA PHARMA INC D06VYB DRUGTYPE Small molecular drug D06VYB HIGHSTAT Patented D06VYB COMPCLAS Pyrrolo-pyridinone derivatives D06WUT DRUG__ID D06WUT D06WUT DRUGCOMP COCENSYS, INC D06WUT DRUGTYPE Small molecular drug D06WUT HIGHSTAT Patented D06WUT COMPCLAS Quinoline carboxamide derivatives D06ZAE DRUG__ID D06ZAE D06ZAE DRUGCOMP BIOGEN MA INC D06ZAE DRUGTYPE Small molecular drug D06ZAE HIGHSTAT Patented D06ZAE COMPCLAS Pyrazolo[3,4-c]pyridine derivatives D06ZPF DRUG__ID D06ZPF D06ZPF DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D06ZPF DRUGTYPE Small molecular drug D06ZPF HIGHSTAT Patented D06ZPF COMPCLAS Pyridine-2,4-dicarboxylic acid analogs D07AMZ DRUG__ID D07AMZ D07AMZ DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D07AMZ DRUGTYPE Small molecular drug D07AMZ HIGHSTAT Patented D07AMZ COMPCLAS Spiroimidazolone derivatives D07BND DRUG__ID D07BND D07BND DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D07BND DRUGTYPE Small molecular drug D07BND HIGHSTAT Patented D07BND COMPCLAS Imidazopyridazine derivatives D07DIJ DRUG__ID D07DIJ D07DIJ DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D07DIJ DRUGTYPE Small molecular drug D07DIJ HIGHSTAT Patented D07DIJ COMPCLAS Cyclopropylamine derivatives D07GAN DRUG__ID D07GAN D07GAN DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D07GAN DRUGTYPE Carbohydrates D07GAN HIGHSTAT Patented D07GAN COMPCLAS Biaryl mannoside derivatives D07GAP DRUG__ID D07GAP D07GAP DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D07GAP DRUGTYPE Small molecular drug D07GAP HIGHSTAT Patented D07GAP COMPCLAS N-oxalylglycine derivatives D07HOP DRUG__ID D07HOP D07HOP DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D07HOP DRUGTYPE Carbohydrates D07HOP HIGHSTAT Patented D07HOP COMPCLAS Alkyl mannoside derivatives D07IAO DRUG__ID D07IAO D07IAO DRUGCOMP Duke University, USA D07IAO DRUGTYPE Small molecular drug D07IAO HIGHSTAT Patented D07IAO COMPCLAS Aryl cyclopropylamine derivatives D07JTE DRUG__ID D07JTE D07JTE DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D07JTE DRUGTYPE Small molecular drug D07JTE HIGHSTAT Patented D07JTE COMPCLAS Tetra-hydro-pyrazolopyrazine derivatives D07KCA DRUG__ID D07KCA D07KCA DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D07KCA DRUGTYPE Carbohydrates D07KCA HIGHSTAT Patented D07KCA COMPCLAS Aryl mannoside derivatives D07KER DRUG__ID D07KER D07KER DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D07KER DRUGTYPE Small molecular drug D07KER HIGHSTAT Patented D07KER COMPCLAS Tetra-hydro-pyrazolopyrazine derivatives D07KNI DRUG__ID D07KNI D07KNI DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason LouiMerck & Co., Inc., Kenilworth, NJ, USA D07KNI DRUGTYPE Small molecular drug D07KNI HIGHSTAT Patented D07KNI COMPCLAS Benzodihydroisofuran derivatives D07KTM DRUG__ID D07KTM D07KTM DRUGCOMP COCENSYS, INC D07KTM DRUGTYPE Small molecular drug D07KTM HIGHSTAT Patented D07KTM COMPCLAS Quinoline carboxamide derivatives D07KZR DRUG__ID D07KZR D07KZR DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D07KZR DRUGTYPE Small molecular drug D07KZR HIGHSTAT Patented D07KZR COMPCLAS Heteroaryl-azepine derivatives D07MIY DRUG__ID D07MIY D07MIY DRUGCOMP PFIZER INC D07MIY DRUGTYPE Small molecular drug D07MIY HIGHSTAT Patented D07MIY COMPCLAS Aryl urea derivatives D07MRK DRUG__ID D07MRK D07MRK DRUGCOMP ELARA PHARMACEUTICALS GMBH MCLAUGHLIN, Fiona LEWIS, Joe D07MRK DRUGTYPE Small molecular drug D07MRK HIGHSTAT Patented D07MRK COMPCLAS Tlouidine sulfonamide derivatives D07NQG DRUG__ID D07NQG D07NQG DRUGCOMP PFIZER LIMITED D07NQG DRUGTYPE Small molecular drug D07NQG HIGHSTAT Patented D07NQG COMPCLAS Methylsulfonylbenzamide derivatives D07NRP DRUG__ID D07NRP D07NRP DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D07NRP DRUGTYPE Small molecular drug D07NRP HIGHSTAT Patented D07NRP COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D07NTA DRUG__ID D07NTA D07NTA DRUGCOMP ORYZON GENOMICS, S.AORYZON GENOMICS SA [ES] D07NTA DRUGTYPE Small molecular drug D07NTA HIGHSTAT Patented D07NTA COMPCLAS Heteroaryl-cyclopropylamine derivatives D07OLQ DRUG__ID D07OLQ D07OLQ DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D07OLQ DRUGTYPE Small molecular drug D07OLQ HIGHSTAT Patented D07OLQ COMPCLAS Pyrrolo-pyrimidine derivatives D07OOA DRUG__ID D07OOA D07OOA DRUGCOMP PFIZER INC. HELAL, Christopher J. CHAPPIE, Thomas Allen HUMPHREY, John M D07OOA DRUGTYPE Small molecular drug D07OOA HIGHSTAT Patented D07OOA COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D07PIH DRUG__ID D07PIH D07PIH DRUGCOMP RESEARCH TRIANGLE INSTITUTE FULP, Alan Bradley MAITRA, Rangan ZHANG, Yanan SELTZMAN, Herbert H D07PIH DRUGTYPE Small molecular drug D07PIH HIGHSTAT Patented D07PIH COMPCLAS Pyrazole derivatives D07PJR DRUG__ID D07PJR D07PJR DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D07PJR DRUGTYPE Small molecule immunotherapy D07PJR HIGHSTAT Patented D07PJR COMPCLAS Macrocycle derivatives D07POS DRUG__ID D07POS D07POS DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D07POS DRUGTYPE Carbohydrates D07POS HIGHSTAT Patented D07POS COMPCLAS Alkyl mannoside derivatives D07PVX DRUG__ID D07PVX D07PVX DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D07PVX DRUGTYPE Carbohydrates D07PVX HIGHSTAT Patented D07PVX COMPCLAS Aryl mannoside derivatives D07QAH DRUG__ID D07QAH D07QAH DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D07QAH DRUGTYPE Carbohydrates D07QAH HIGHSTAT Patented D07QAH COMPCLAS Biaryl mannoside derivatives D07QKP DRUG__ID D07QKP D07QKP DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D07QKP DRUGTYPE Small molecular drug D07QKP HIGHSTAT Patented D07QKP COMPCLAS Pyrrolo-pyridinone derivatives D07RQA DRUG__ID D07RQA D07RQA DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D07RQA DRUGTYPE Carbohydrates D07RQA HIGHSTAT Patented D07RQA COMPCLAS Alkyl mannoside derivatives D07SEG DRUG__ID D07SEG D07SEG DRUGCOMP CONSEJO SUPERIOR INVESTIGACION [ES] D07SEG DRUGTYPE Small molecular drug D07SEG HIGHSTAT Patented D07SEG COMPCLAS Oxindole derivatives D07VNW DRUG__ID D07VNW D07VNW DRUGCOMP SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. MINETTI, Patrizia CABRI, Walter DALLAVALLE, Sabrina MERLINI, Lucio PENCO, Sergio BORSINI, Franco CAPRIOLI, Antonio MACCARRONE, Mauro D07VNW DRUGTYPE Small molecular drug D07VNW HIGHSTAT Patented D07VNW COMPCLAS Enol carbamate derivatives D07VPQ DRUG__ID D07VPQ D07VPQ DRUGCOMP NOVARTIS AG BARSANTI, Paul A. HU, Cheng PFISTER, Keith B. SENDZIK, Martin SUTTON, James D07VPQ DRUGTYPE Small molecular drug D07VPQ HIGHSTAT Patented D07VPQ COMPCLAS Pyrazinylpyridine derivatives D07WNO DRUG__ID D07WNO D07WNO DRUGCOMP Hoffmann-La Roche, Inc D07WNO DRUGTYPE Small molecular drug D07WNO HIGHSTAT Patented D07WNO COMPCLAS Tetra-azabenzo[e]azulene derivatives D07XVQ DRUG__ID D07XVQ D07XVQ DRUGCOMP UNIVERSITA' DEGLI STUDI DI PAVIA D07XVQ DRUGTYPE Small molecular drug D07XVQ HIGHSTAT Patented D07XVQ COMPCLAS Aryl alkanolamine derivatives D07YWQ DRUG__ID D07YWQ D07YWQ DRUGCOMP PFIZER INC. HELAL, Christopher J. CHAPPIE, Thomas Allen HUMPHREY, John M D07YWQ DRUGTYPE Small molecular drug D07YWQ HIGHSTAT Patented D07YWQ COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D07ZQS DRUG__ID D07ZQS D07ZQS DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D07ZQS DRUGTYPE Small molecule immunotherapy D07ZQS HIGHSTAT Patented D07ZQS COMPCLAS Macrocycle derivatives D07ZTT DRUG__ID D07ZTT D07ZTT DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D07ZTT DRUGTYPE Small molecular drug D07ZTT HIGHSTAT Patented D07ZTT COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D08BLZ DRUG__ID D08BLZ D08BLZ DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D08BLZ DRUGTYPE Carbohydrates D08BLZ HIGHSTAT Patented D08BLZ COMPCLAS Aryl mannoside derivatives D08BNB DRUG__ID D08BNB D08BNB DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D08BNB DRUGTYPE Carbohydrates D08BNB HIGHSTAT Patented D08BNB COMPCLAS Biaryl mannoside derivatives D08CEK DRUG__ID D08CEK D08CEK DRUGCOMP Pfizer Incorporated D08CEK DRUGTYPE Small molecular drug D08CEK HIGHSTAT Patented D08CEK COMPCLAS Imidazo triazine derivatives D08EHL DRUG__ID D08EHL D08EHL DRUGCOMP Bristol-Myers Squibb Company D08EHL DRUGTYPE Small molecule immunotherapy D08EHL HIGHSTAT Patented D08EHL COMPCLAS Macrocycle derivatives D08EIA DRUG__ID D08EIA D08EIA DRUGCOMP Bristol-Myers Squibb Co D08EIA DRUGTYPE Small molecular drug D08EIA HIGHSTAT Patented D08EIA COMPCLAS Carbamide derivatives D08HTR DRUG__ID D08HTR D08HTR DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L. CALDARELLI, Marina BERIA, Italo COLOMBO, Nicoletta PIUTTI, Claudia SALSA, Matteo TRAQUANDI, Gabriella D08HTR DRUGTYPE Small molecular drug D08HTR HIGHSTAT Patented D08HTR COMPCLAS Tricyclic isoxazoloquinazoline derivatives D08IOP DRUG__ID D08IOP D08IOP DRUGCOMP ORYZON GENOMICS SA [ESOryzon Genomics S.A., Spain D08IOP DRUGTYPE Small molecular drug D08IOP HIGHSTAT Patented D08IOP COMPCLAS N-(2-phenylcyclopropyl) amino acid derivatives D08JPW DRUG__ID D08JPW D08JPW DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD D08JPW DRUGTYPE Small molecular drug D08JPW HIGHSTAT Patented D08JPW COMPCLAS N-substituted pyrazole derivatives D08LCQ DRUG__ID D08LCQ D08LCQ DRUGCOMP Chugai Pharmaceutical D08LCQ DRUGTYPE Small molecular drug D08LCQ HIGHSTAT Patented D08LCQ COMPCLAS Benzo(b)carbazol-11-one compounds D08OXD DRUG__ID D08OXD D08OXD DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D08OXD DRUGTYPE Carbohydrates D08OXD HIGHSTAT Patented D08OXD COMPCLAS Mannoside derivatives D08SMT DRUG__ID D08SMT D08SMT DRUGCOMP NORTHEASTERN UNIVERSITY D08SMT DRUGTYPE Small molecular drug D08SMT HIGHSTAT Patented D08SMT COMPCLAS Carbamate derivatives D08WMK DRUG__ID D08WMK D08WMK DRUGCOMP THE JOHNS HOPKINS UNIVERSITY CASERO, Robert, A. BYTHEWAY, Ian WOSTER, Patrick, M D08WMK DRUGTYPE Small molecular drug D08WMK HIGHSTAT Patented D08WMK COMPCLAS Benzenamine derivatives D08WTW DRUG__ID D08WTW D08WTW DRUGCOMP 7TM PHARMA A/S COOPER, Martin RECEVEUR, Jean-Marie HOEGBERG, Thomas NIELSEN, Peter, Aadal LINGET, Jean-Michel NOEREGAARD, Pia, Karina D08WTW DRUGTYPE Small molecular drug D08WTW HIGHSTAT Patented D08WTW COMPCLAS Pyrazole derivatives D08WVK DRUG__ID D08WVK D08WVK DRUGCOMP CONSEJO SUPERIOR INVESTIGACION [ES] D08WVK DRUGTYPE Small molecular drug D08WVK HIGHSTAT Patented D08WVK COMPCLAS Oxindole derivatives D08XDA DRUG__ID D08XDA D08XDA DRUGCOMP Allergan, Inc D08XDA DRUGTYPE Small molecular drug D08XDA HIGHSTAT Patented D08XDA COMPCLAS Carbamide derivatives D08YPU DRUG__ID D08YPU D08YPU DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D08YPU DRUGTYPE Small molecular drug D08YPU HIGHSTAT Patented D08YPU COMPCLAS 4-Carboxamido-isoindolinone derivatives D08ZRN DRUG__ID D08ZRN D08ZRN DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D08ZRN DRUGTYPE Small molecular drug D08ZRN HIGHSTAT Patented D08ZRN COMPCLAS 1,2-diamino cyclopentane-based derivatives D09ALF DRUG__ID D09ALF D09ALF DRUGCOMP GALAPAGOS NV D09ALF DRUGTYPE Small molecular drug D09ALF HIGHSTAT Patented D09ALF COMPCLAS Aminotriazolopyridine derivatives D09BGB DRUG__ID D09BGB D09BGB DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D09BGB DRUGTYPE Carbohydrates D09BGB HIGHSTAT Patented D09BGB COMPCLAS Aryl mannoside derivatives D09CGG DRUG__ID D09CGG D09CGG DRUGCOMP ABBVIE DEUTSCHLAND [DEABBVIE INC [US] D09CGG DRUGTYPE Small molecular drug D09CGG HIGHSTAT Patented D09CGG COMPCLAS Carboxamide derivatives D09EIQ DRUG__ID D09EIQ D09EIQ DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D09EIQ DRUGTYPE Carbohydrates D09EIQ HIGHSTAT Patented D09EIQ COMPCLAS Biaryl mannoside derivatives D09EPG DRUG__ID D09EPG D09EPG DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D09EPG DRUGTYPE Small molecular drug D09EPG HIGHSTAT Patented D09EPG COMPCLAS Heteroaryl-azepine derivatives D09FBJ DRUG__ID D09FBJ D09FBJ DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D09FBJ DRUGTYPE Small molecular drug D09FBJ HIGHSTAT Patented D09FBJ COMPCLAS Pyrrolo-pyrimidine derivatives D09GXN DRUG__ID D09GXN D09GXN DRUGCOMP Eisai R & D Management Co., Ltd., Japan D09GXN DRUGTYPE Small molecular drug D09GXN HIGHSTAT Patented D09GXN COMPCLAS Benzanilide compounds D09HUV DRUG__ID D09HUV D09HUV DRUGCOMP Nerviano Medical Sciences S.r.l D09HUV DRUGTYPE Small molecular drug D09HUV HIGHSTAT Patented D09HUV COMPCLAS 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives D09IYH DRUG__ID D09IYH D09IYH DRUGCOMP RESEARCH TRIANGLE INSTITUTE FULP, Alan Bradley MAITRA, Rangan ZHANG, Yanan SELTZMAN, Herbert H D09IYH DRUGTYPE Small molecular drug D09IYH HIGHSTAT Patented D09IYH COMPCLAS Pyrazole derivatives D09LWZ DRUG__ID D09LWZ D09LWZ DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D09LWZ DRUGTYPE Carbohydrates D09LWZ HIGHSTAT Patented D09LWZ COMPCLAS Mannoside derivatives D09OXG DRUG__ID D09OXG D09OXG DRUGCOMP DONG-A PHARM. CO., LTD. YUHAN CO., LTD. MOON, Ho-Sang YOO, Moo-Hi KIM, Soon-Hoe LIM, Joong-In SON, Moon-Ho KIM, Mi-Kyung SHIN, Chang-Yell KIM, Jin-Kwan PARK, Sang-Kuk CHAE, Yu-Na SHIM, Hyun-Joo JEON, Sun-Ho KIM, Hae-Sun WIE, Gil-Tae KIM, Dong-Hwan LEE, Byung-Kyu PARK, Chan-Sun AHN, Byung-Nak KIM, Eunkyung BAE, Myung-Ho SHIN, Young-Ah HUR, Youn LEE, Chun-Ho CHOI, Hyun-Ho KIM, Bongtae CHONG, Wonee KANG, So Mi D09OXG DRUGTYPE Small molecular drug D09OXG HIGHSTAT Patented D09OXG COMPCLAS Phenylpropionic acid derivatives D09PGP DRUG__ID D09PGP D09PGP DRUGCOMP NOVARTIS AG ANTONIOS-MCCREA, William R. BARSANTI, Paul A. HU, Cheng JIN, Xianming MARTIN, Eric J. PAN, Yue PFISTER, Keith B. SENDZIK, Martin SUTTON, James WAN, Lifeng D09PGP DRUGTYPE Small molecular drug D09PGP HIGHSTAT Patented D09PGP COMPCLAS Phenylpyridine derivatives D09RGE DRUG__ID D09RGE D09RGE DRUGCOMP NORTHEASTERN UNIVERSITY D09RGE DRUGTYPE Small molecular drug D09RGE HIGHSTAT Patented D09RGE COMPCLAS Carbamide derivatives D09RTW DRUG__ID D09RTW D09RTW DRUGCOMP DEBIOPHARM SA [CHAURIGENE DISCOVERY TECH LTD [IN] D09RTW DRUGTYPE Small molecular drug D09RTW HIGHSTAT Patented D09RTW COMPCLAS Aromatic bicyclic compounds D09SGU DRUG__ID D09SGU D09SGU DRUGCOMP ABBOTT LABORATORIES WENDT, Michael, D. SHEN, Wang DICKMAN, Daniel, A. DING, Hong THOMAS, Sheela, A. AUGERI, David ELMORE, Steven, W D09SGU DRUGTYPE Small molecular drug D09SGU HIGHSTAT Patented D09SGU COMPCLAS Biphenyl carboxylic acid derivatives D09SLI DRUG__ID D09SLI D09SLI DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D09SLI DRUGTYPE Carbohydrates D09SLI HIGHSTAT Patented D09SLI COMPCLAS Aryl mannoside derivatives D09TKO DRUG__ID D09TKO D09TKO DRUGCOMP PHARMACYCLICS, INC D09TKO DRUGTYPE Small molecular drug D09TKO HIGHSTAT Patented D09TKO COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D09TKY DRUG__ID D09TKY D09TKY DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D09TKY DRUGTYPE Carbohydrates D09TKY HIGHSTAT Patented D09TKY COMPCLAS Biaryl mannoside derivatives D09UBE DRUG__ID D09UBE D09UBE DRUGCOMP JIANGSU HENGRUI MEDICINE CO [CNSHANGHAI HENGRUI PHARM CO LTD [CN] D09UBE DRUGTYPE Small molecular drug D09UBE HIGHSTAT Patented D09UBE COMPCLAS Pyrrole six-membered heteroaryl ring derivatives D09VIE DRUG__ID D09VIE D09VIE DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D09VIE DRUGTYPE Small molecular drug D09VIE HIGHSTAT Patented D09VIE COMPCLAS Isoflavone derivatives D09WFK DRUG__ID D09WFK D09WFK DRUGCOMP Arena Pharmaceuticals, Inc D09WFK DRUGTYPE Small molecular drug D09WFK HIGHSTAT Patented D09WFK COMPCLAS Pyrazole derivatives D09YJV DRUG__ID D09YJV D09YJV DRUGCOMP RAQUALIA PHARMA INC D09YJV DRUGTYPE Small molecular drug D09YJV HIGHSTAT Patented D09YJV COMPCLAS Pyrrolo-pyridinone derivatives D09ZCA DRUG__ID D09ZCA D09ZCA DRUGCOMP WASHINGTON UNIVERSITY D09ZCA DRUGTYPE Carbohydrates D09ZCA HIGHSTAT Patented D09ZCA COMPCLAS Biphenyl mannoside derivatives D09ZIM DRUG__ID D09ZIM D09ZIM DRUGCOMP Nerviano Medical Sciences S.r.l D09ZIM DRUGTYPE Small molecular drug D09ZIM HIGHSTAT Patented D09ZIM COMPCLAS 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives D09ZXW DRUG__ID D09ZXW D09ZXW DRUGCOMP REDX PHARMA LIMITED LINDSAY, Derek JACKSON, PeteREDX PHARMA LIMITED LINDSAY, Derek JACKSON, Peter HINDLEY, Stephen BHAMRA, IndeREDX PHARMA LTD [GB]BRADFORD PHARMA LTD [GBREDX PHARMA LTD [GBBRADFORD PHARMA LTD [GB]REDX PHARMA LTBRADFORD PHARMA LTD D09ZXW DRUGTYPE Small molecular drug D09ZXW HIGHSTAT Patented D09ZXW COMPCLAS Atorvastatin lactole derivatives D0A0DV DRUG__ID D0A0DV D0A0DV DRUGCOMP Wisconsin Alumni Research Foundation D0A0DV DRUGTYPE Small molecular drug D0A0DV HIGHSTAT Patented D0A0DV COMPCLAS Phenylpropylamine derivatives D0A0QQ DRUG__ID D0A0QQ D0A0QQ DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0A0QQ DRUGTYPE Small molecular drug D0A0QQ HIGHSTAT Patented D0A0QQ COMPCLAS Piperidinyl triazole derivatives D0A2BX DRUG__ID D0A2BX D0A2BX DRUGCOMP Astellas Pharma Inc. INAMI, Hiroshi MIZUTANI, Tsuyoshi MAEDA, Junko USUDA, Hiroyuki NAGASHIMA, Shinya ITO, Tomonori AOYAMA, Naohiro D0A2BX DRUGTYPE Small molecular drug D0A2BX HIGHSTAT Patented D0A2BX COMPCLAS Amidopyrazole derivatives D0A2PY DRUG__ID D0A2PY D0A2PY DRUGCOMP 7TM PHARMA A/S RECEVEUR, Jean-Marie NIELSEN, Peter, Aadal HOEGBERG, Thomas LINGET, Jean-Michel COOPER, Martin NOERREGAARD, Pia, Karina D0A2PY DRUGTYPE Small molecular drug D0A2PY HIGHSTAT Patented D0A2PY COMPCLAS Pyrazole derivatives D0A3PP DRUG__ID D0A3PP D0A3PP DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0A3PP DRUGTYPE Carbohydrates D0A3PP HIGHSTAT Patented D0A3PP COMPCLAS Biphenyl mannoside derivatives D0A5FR DRUG__ID D0A5FR D0A5FR DRUGCOMP ARENA PHARMACEUTICALS, INC D0A5FR DRUGTYPE Small molecular drug D0A5FR HIGHSTAT Patented D0A5FR COMPCLAS Benzazepine derivatives D0A5NC DRUG__ID D0A5NC D0A5NC DRUGCOMP BETA PHARMA CANADA INC. WANG, Zhaoyin YU, Chunrong D0A5NC DRUGTYPE Small molecular drug D0A5NC HIGHSTAT Patented D0A5NC COMPCLAS Carbamide derivatives D0A6RR DRUG__ID D0A6RR D0A6RR DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEGlaxoSmithKline D0A6RR DRUGTYPE Small molecular drug D0A6RR HIGHSTAT Patented D0A6RR COMPCLAS Dihydropyridine compounds D0A8RV DRUG__ID D0A8RV D0A8RV DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0A8RV DRUGTYPE Carbohydrates D0A8RV HIGHSTAT Patented D0A8RV COMPCLAS Biaryl mannoside derivatives D0A8SH DRUG__ID D0A8SH D0A8SH DRUGCOMP SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD D0A8SH DRUGTYPE Small molecular drug D0A8SH HIGHSTAT Patented D0A8SH COMPCLAS Indoline derivatives D0AA9F DRUG__ID D0AA9F D0AA9F DRUGCOMP ATHERSYS, INC.ATHERSYS, INC. BENNANI, Youssef, L. BOM, David, C. ROBARGE, Michael, J D0AA9F DRUGTYPE Small molecular drug D0AA9F HIGHSTAT Patented D0AA9F COMPCLAS Tricyclic pyrrolidine derivatives D0AB3D DRUG__ID D0AB3D D0AB3D DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0AB3D DRUGTYPE Small molecular drug D0AB3D HIGHSTAT Patented D0AB3D COMPCLAS Imidazo bicyclic iminium derivatives D0AI1I DRUG__ID D0AI1I D0AI1I DRUGCOMP Roche D0AI1I DRUGTYPE Small molecular drug D0AI1I HIGHSTAT Patented D0AI1I COMPCLAS Fused triazoloamino-phenyl analogs D0AI8S DRUG__ID D0AI8S D0AI8S DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0AI8S DRUGTYPE Small molecular drug D0AI8S HIGHSTAT Patented D0AI8S COMPCLAS Heteroaryl-azepine derivatives D0AJ0O DRUG__ID D0AJ0O D0AJ0O DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0AJ0O DRUGTYPE Small molecular drug D0AJ0O HIGHSTAT Patented D0AJ0O COMPCLAS Heteroaryl-azepine derivatives D0AK5Y DRUG__ID D0AK5Y D0AK5Y DRUGCOMP PFIZER PRODUCTS INC. CHAMBERS, Robert, James LAM, Kelvin, T D0AK5Y DRUGTYPE Small molecular drug D0AK5Y HIGHSTAT Patented D0AK5Y COMPCLAS Oxindole derivatives D0AM0A DRUG__ID D0AM0A D0AM0A DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0AM0A DRUGTYPE Carbohydrates D0AM0A HIGHSTAT Patented D0AM0A COMPCLAS Aryl mannoside derivatives D0AM1D DRUG__ID D0AM1D D0AM1D DRUGCOMP INTERVET INTERNATIONAL B.V. DEMONG, Duane, Eugene MILLER, Michael, W. GILBERT, Eric, J. SCOTT, Jack, D. STAMFORD, Andrew GREENLEE, William, J. CELLY, Chander, Shekher D0AM1D DRUGTYPE Small molecular drug D0AM1D HIGHSTAT Patented D0AM1D COMPCLAS Diaryl piperazine derivatives D0AQ1T DRUG__ID D0AQ1T D0AQ1T DRUGCOMP Arena Pharmaceuticals, Inc D0AQ1T DRUGTYPE Small molecular drug D0AQ1T HIGHSTAT Patented D0AQ1T COMPCLAS Pyrazole derivatives D0AT9E DRUG__ID D0AT9E D0AT9E DRUGCOMP WASHINGTON UNIVERSITY D0AT9E DRUGTYPE Small molecular drug D0AT9E HIGHSTAT Patented D0AT9E COMPCLAS Piperazinyl methyl quinazolinone derivatives D0AU3O DRUG__ID D0AU3O D0AU3O DRUGCOMP ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI D0AU3O DRUGTYPE Small molecular drug D0AU3O HIGHSTAT Patented D0AU3O COMPCLAS Aminocyclopentenone compounds D0AV8R DRUG__ID D0AV8R D0AV8R DRUGCOMP ATHERSYS, INC.ATHERSYS, INC. BENNANI, Youssef, L. BOM, David, C. ROBARGE, Michael, J D0AV8R DRUGTYPE Small molecular drug D0AV8R HIGHSTAT Patented D0AV8R COMPCLAS Tricyclic pyrrolidine derivatives D0AW8P DRUG__ID D0AW8P D0AW8P DRUGCOMP COCENSYS, INC D0AW8P DRUGTYPE Small molecular drug D0AW8P HIGHSTAT Patented D0AW8P COMPCLAS Quinoline carboxamide derivatives D0AY4N DRUG__ID D0AY4N D0AY4N DRUGCOMP RedX Pharma Limited (Manchester, GB) D0AY4N DRUGTYPE Small molecular drug D0AY4N HIGHSTAT Patented D0AY4N COMPCLAS Lactol derivatives D0AZ8T DRUG__ID D0AZ8T D0AZ8T DRUGCOMP China Pharmaceutical University D0AZ8T DRUGTYPE Small molecular drug D0AZ8T HIGHSTAT Patented D0AZ8T COMPCLAS Pyrazino[2,1-a]isoquinolin derivatives D0B1HT DRUG__ID D0B1HT D0B1HT DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0B1HT DRUGTYPE Carbohydrates D0B1HT HIGHSTAT Patented D0B1HT COMPCLAS Biaryl mannoside derivatives D0B3CU DRUG__ID D0B3CU D0B3CU DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0B3CU DRUGTYPE Carbohydrates D0B3CU HIGHSTAT Patented D0B3CU COMPCLAS C-linked disaccharide biphenyl mannoside derivatives D0B3XW DRUG__ID D0B3XW D0B3XW DRUGCOMP NANT HOLDINGS IP, LLC D0B3XW DRUGTYPE Small molecular drug D0B3XW HIGHSTAT Patented D0B3XW COMPCLAS Cyclic sulfonamide derivatives D0B5BT DRUG__ID D0B5BT D0B5BT DRUGCOMP JANSSEN PHARMACEUTICA NV FLORES, Christopher, M. NELEN, Marina, I. NULTON, Erica, L. PROUTY, Stephen TODD, Matthew ZHANG, Sui-PJANSSEN PHARMACEUTICA NV CHEVALIER, Kristen, M. DAX, Scott, L. FLORES, Christopher, M. LIU, Li MACIELAG, Mark, J. MCDONNELL, Mark, E. NELEN, Marina, I. PROUTY, Stephen TODD, Matthew ZHANG, Sui-Po ZHU, Bin NULTON, Erica, L. CLEMENTE, Jose D0B5BT DRUGTYPE Small molecular drug D0B5BT HIGHSTAT Patented D0B5BT COMPCLAS Azetidinyl-piperazine derivatives D0B5WF DRUG__ID D0B5WF D0B5WF DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0B5WF DRUGTYPE Small molecular drug D0B5WF HIGHSTAT Patented D0B5WF COMPCLAS Pyridine-2,4-dicarboxylic acid derivatives D0B6GK DRUG__ID D0B6GK D0B6GK DRUGCOMP ORYZON GENOMICS SA [ESORYZON GENOMICS S.A D0B6GK DRUGTYPE Small molecular drug D0B6GK HIGHSTAT Patented D0B6GK COMPCLAS Cyclopropylamine derivatives D0B7GQ DRUG__ID D0B7GQ D0B7GQ DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0B7GQ DRUGTYPE Small molecular drug D0B7GQ HIGHSTAT Patented D0B7GQ COMPCLAS 2,2-bipyridyl derivatives D0B7JY DRUG__ID D0B7JY D0B7JY DRUGCOMP ELI LILLY AND COMPANY D0B7JY DRUGTYPE Small molecular drug D0B7JY HIGHSTAT Patented D0B7JY COMPCLAS Phenylmethanesulfonamide derivatives D0B8RU DRUG__ID D0B8RU D0B8RU DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0B8RU DRUGTYPE Carbohydrates D0B8RU HIGHSTAT Patented D0B8RU COMPCLAS Aryl mannoside derivatives D0BD3M DRUG__ID D0BD3M D0BD3M DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0BD3M DRUGTYPE Small molecular drug D0BD3M HIGHSTAT Patented D0BD3M COMPCLAS Heteroaryl-azepine derivatives D0BE4Z DRUG__ID D0BE4Z D0BE4Z DRUGCOMP IMAGO BIOSCIENCEKYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY EDUCATIONAL CORPORATION KANSAI BUNRI SOUGOUGAKUEN FRONTIER PHARMA INC. KYOTO UNIVERSITY D0BE4Z DRUGTYPE Small molecular drug D0BE4Z HIGHSTAT Patented D0BE4Z COMPCLAS N6-cyclopropyllydine derivatives D0BG7B DRUG__ID D0BG7B D0BG7B DRUGCOMP UNIV ROMA [ITFOND IEO [ITUNIV PAVIA [ITUNIV DEGLI STUDI MILANO [ITMINUCCI SAVERIO [ITMAI ANTONELLO [ITMATTEVI ANDREA [IT] D0BG7B DRUGTYPE Small molecular drug D0BG7B HIGHSTAT Patented D0BG7B COMPCLAS Tarnylcypromine derivatives D0BH7X DRUG__ID D0BH7X D0BH7X DRUGCOMP ZENITH EPIGENETICS CORP D0BH7X DRUGTYPE Small molecular drug D0BH7X HIGHSTAT Patented D0BH7X COMPCLAS Isoxazole-based bicyclic compounds D0BI5I DRUG__ID D0BI5I D0BI5I DRUGCOMP ARRAY BIOPHARMA INC. ALLEN, Shelley ANDREWS, Steven S. CONDROSKI, Kevin Ronald HAAS, Julia HUANG, Lily JIANG, Yutong KERCHER, Timothy SEO, Jeongbeob D0BI5I DRUGTYPE Small molecular drug D0BI5I HIGHSTAT Patented D0BI5I COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0BN7S DRUG__ID D0BN7S D0BN7S DRUGCOMP VERNALIS (R&D) LTD. ROUGHLEY, Stephen WALLS, Steven HART, Terrence PARSONS, Rachel BROUGH, Paul GRAHAM, Christopher MACIAS, Alba D0BN7S DRUGTYPE Small molecular drug D0BN7S HIGHSTAT Patented D0BN7S COMPCLAS Azetidine urea derivatives D0BR9C DRUG__ID D0BR9C D0BR9C DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, CorinnTHE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0BR9C DRUGTYPE Carbohydrates D0BR9C HIGHSTAT Patented D0BR9C COMPCLAS Biphenyl mannoside derivatives D0BS0K DRUG__ID D0BS0K D0BS0K DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0BS0K DRUGTYPE Small molecular drug D0BS0K HIGHSTAT Patented D0BS0K COMPCLAS Tetra-hydro-pyrazolopyrazine derivatives D0BS3E DRUG__ID D0BS3E D0BS3E DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0BS3E DRUGTYPE Carbohydrates D0BS3E HIGHSTAT Patented D0BS3E COMPCLAS Biphenyl mannoside derivatives D0BS8I DRUG__ID D0BS8I D0BS8I DRUGCOMP UNIVERZA V LJUBLJANI [SI] D0BS8I DRUGTYPE Small molecular drug D0BS8I HIGHSTAT Patented D0BS8I COMPCLAS Di-substituted piperidine derivatives D0BU6K DRUG__ID D0BU6K D0BU6K DRUGCOMP ARENA PHARMACEUTICALS, INC D0BU6K DRUGTYPE Small molecular drug D0BU6K HIGHSTAT Patented D0BU6K COMPCLAS Aryl piperazine derivatives D0BU9N DRUG__ID D0BU9N D0BU9N DRUGCOMP CHDI FOUNDATION, INC D0BU9N DRUGTYPE Small molecular drug D0BU9N HIGHSTAT Patented D0BU9N COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0C0PK DRUG__ID D0C0PK D0C0PK DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED JOHNSON, Neil, W. KASPAREC, Jiri MILLER, William, Henry ROUSE, Meagan, B. SUAREZ, Dominic TIAN, Xinrong D0C0PK DRUGTYPE Small molecular drug D0C0PK HIGHSTAT Patented D0C0PK COMPCLAS Cyclopropylamine derivatives D0C1CV DRUG__ID D0C1CV D0C1CV DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0C1CV DRUGTYPE Small molecular drug D0C1CV HIGHSTAT Patented D0C1CV COMPCLAS Pyridine-2,4-dicarboxylic acid derivatives D0C1HS DRUG__ID D0C1HS D0C1HS DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0C1HS DRUGTYPE Small molecular drug D0C1HS HIGHSTAT Patented D0C1HS COMPCLAS Dihydropyrido pyrazinone compounds D0C1TH DRUG__ID D0C1TH D0C1TH DRUGCOMP Duke University, USA D0C1TH DRUGTYPE Small molecular drug D0C1TH HIGHSTAT Patented D0C1TH COMPCLAS Aryl cyclopropylamine derivatives D0C1UA DRUG__ID D0C1UA D0C1UA DRUGCOMP JIANGSU SIMCERE PHARMACEUTICAL R&D CO., LTD CHEN, Rong LIU, Fei CONG, Xin D0C1UA DRUGTYPE Small molecular drug D0C1UA HIGHSTAT Patented D0C1UA COMPCLAS Tacrine-dihydropyridine hybrid derivatives D0C3OH DRUG__ID D0C3OH D0C3OH DRUGCOMP SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. MINETTI, Patrizia CABRI, Walter BORSINI, Franco CAPRIOLI, Antonio PENCO, Sergio DALLAVALLE, Sabrina MERLINI, Lucio MACCARRONE, Mauro D0C3OH DRUGTYPE Small molecular drug D0C3OH HIGHSTAT Patented D0C3OH COMPCLAS Carbamoyl oxime derivatives D0C5HR DRUG__ID D0C5HR D0C5HR DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED GLAXOSMITHKLINE (CHINA) R&D COMPANY LIMITED D0C5HR DRUGTYPE Small molecular drug D0C5HR HIGHSTAT Patented D0C5HR COMPCLAS Pyrrolo-pyrimidine derivatives D0C5SQ DRUG__ID D0C5SQ D0C5SQ DRUGCOMP PFIZER INC D0C5SQ DRUGTYPE Small molecular drug D0C5SQ HIGHSTAT Patented D0C5SQ COMPCLAS Carbamate derivatives D0C7LB DRUG__ID D0C7LB D0C7LB DRUGCOMP University Zhejiang Technology D0C7LB DRUGTYPE Small molecular drug D0C7LB HIGHSTAT Patented D0C7LB COMPCLAS Lazabemide analogs D0C8GW DRUG__ID D0C8GW D0C8GW DRUGCOMP Celltech R&D Ltd D0C8GW DRUGTYPE Small molecular drug D0C8GW HIGHSTAT Patented D0C8GW COMPCLAS Quinolone derivatives D0CD6Y DRUG__ID D0CD6Y D0CD6Y DRUGCOMP ENDO PHARMACEUTICALS INC. VENKATESAN, Aranapakam SMITH, Roger, Astbury HOSAHALLI, Subramanya POTLURI, Vijay PANIGRAHI, Sunil, Kumar BASETTI, Vishnu KUNTU, Karunasree D0CD6Y DRUGTYPE Small molecular drug D0CD6Y HIGHSTAT Patented D0CD6Y COMPCLAS Pyrimidopyridazinone derivatives D0CD7Q DRUG__ID D0CD7Q D0CD7Q DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D0CD7Q DRUGTYPE Carbohydrates D0CD7Q HIGHSTAT Patented D0CD7Q COMPCLAS Beta-cyclodextrin conjugate derivatives D0CE7X DRUG__ID D0CE7X D0CE7X DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED RUPRAH, Parminder, Kaur MERCHANT, Kevin, John WALSH, Louise, Marie KERR, Catrina, Morven FIELDHOUSE, Charlotte HARRISSON, David MAINE, Stephanie HAZEL, Katherine D0CE7X DRUGTYPE Small molecular drug D0CE7X HIGHSTAT Patented D0CE7X COMPCLAS 4-benzylidene-1-(cyclobutylo)piperidine derivatives D0CF8Y DRUG__ID D0CF8Y D0CF8Y DRUGCOMP JENRIN DISCOVERY MCELROY, John CHORVAT, Robert D0CF8Y DRUGTYPE Small molecular drug D0CF8Y HIGHSTAT Patented D0CF8Y COMPCLAS Pyrazoline derivatives D0CG0D DRUG__ID D0CG0D D0CG0D DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0CG0D DRUGTYPE Small molecular drug D0CG0D HIGHSTAT Patented D0CG0D COMPCLAS 1,2-diamino cyclopentane-based derivatives D0CG3V DRUG__ID D0CG3V D0CG3V DRUGCOMP MERCK SHARP & DOHME CORP. MERCK SHARP &amDOHME B.V. DE MAN, Adrianus P.A. STERRENBURG, Jan-Gerard RAAIJMAKERS, Hans C.A. KAPTEIN, Allard OUBRIE, Arthur REWINKEL, Johannes B.M. JANS, Christiaan G.J.M. WIJKMANS, Jacobus C.H.M BARF, Tjeerd A. COOPER, Alan B. KIM, Ronald M. BOGA, Sobhana Babu ZHU, Hugh Y. GAO, Xiaolei YAO, Xin ANAND, Rajan WU, Hao LIU, Shilan YANG, Chundao ALHASSAN, Abdul-Basit WANG, James YU, Younong LIU, Jian VACCARO, Henry M D0CG3V DRUGTYPE Small molecular drug D0CG3V HIGHSTAT Patented D0CG3V COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0CH8E DRUG__ID D0CH8E D0CH8E DRUGCOMP Aurigene Discovery Technologies Limited D0CH8E DRUGTYPE Small molecule immunotherapy D0CH8E HIGHSTAT Patented D0CH8E COMPCLAS Macrocycle derivatives D0CK1D DRUG__ID D0CK1D D0CK1D DRUGCOMP WELLSTAT THERAPEUTICS CORPORATION SHARMA, Shalini VON BORSTEL, Reid, W D0CK1D DRUGTYPE Small molecular drug D0CK1D HIGHSTAT Patented D0CK1D COMPCLAS 3-benzyloxyphenyloxoacetic acid derivatives D0CK6M DRUG__ID D0CK6M D0CK6M DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0CK6M DRUGTYPE Small molecular drug D0CK6M HIGHSTAT Patented D0CK6M COMPCLAS Fused aryl carbocycle derivatives D0CM4R DRUG__ID D0CM4R D0CM4R DRUGCOMP REDX PHARMA LIMITED LINDSAY, Derek JACKSON, PeteREDX PHARMA LIMITED LINDSAY, Derek JACKSON, Peter HINDLEY, Stephen BHAMRA, IndeREDX PHARMA LTD [GBREDX PHARMA LTD [GB]BRADFORD PHARMA LTD [GBBRADFORD PHARMA LTREDX PHARMA LTD D0CM4R DRUGTYPE Small molecular drug D0CM4R HIGHSTAT Patented D0CM4R COMPCLAS Lactol derivatives D0CO2G DRUG__ID D0CO2G D0CO2G DRUGCOMP ABBVIE DEUTSCHLAND [DEABBVIE INC [US] D0CO2G DRUGTYPE Small molecular drug D0CO2G HIGHSTAT Patented D0CO2G COMPCLAS Carboxamide derivatives D0CQ1M DRUG__ID D0CQ1M D0CQ1M DRUGCOMP Sunesis & Biogen D0CQ1M DRUGTYPE Small molecular drug D0CQ1M HIGHSTAT Patented D0CQ1M COMPCLAS Heterocyclic-carboxamide derivatives D0CR8J DRUG__ID D0CR8J D0CR8J DRUGCOMP WASHINGTON UNIVERSITY D0CR8J DRUGTYPE Carbohydrates D0CR8J HIGHSTAT Patented D0CR8J COMPCLAS Biphenyl mannoside derivatives D0CY3L DRUG__ID D0CY3L D0CY3L DRUGCOMP ZENITH EPIGENETICS CORP D0CY3L DRUGTYPE Small molecular drug D0CY3L HIGHSTAT Patented D0CY3L COMPCLAS Isoxazole-based bicyclic compounds D0CY9X DRUG__ID D0CY9X D0CY9X DRUGCOMP ZENITH EPIGENETICS CORP D0CY9X DRUGTYPE Small molecular drug D0CY9X HIGHSTAT Patented D0CY9X COMPCLAS Isoxazole-based bicyclic compounds D0CZ6T DRUG__ID D0CZ6T D0CZ6T DRUGCOMP EISAI R&D MANAGEMENT CO., LTD D0CZ6T DRUGTYPE Small molecular drug D0CZ6T HIGHSTAT Patented D0CZ6T COMPCLAS Tetra-hydro-imidazo[1,5-d][1,4]oxazepin-3-yl derivatives D0D0WU DRUG__ID D0D0WU D0D0WU DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0D0WU DRUGTYPE Small molecular drug D0D0WU HIGHSTAT Patented D0D0WU COMPCLAS Pyridine-2,4-dicarboxylic acid analogs D0D1QH DRUG__ID D0D1QH D0D1QH DRUGCOMP CELLZOME LIMITED OXENFORD, Sally HOBSON, Andrew OLIVER, Kathryn RATCLIFFE, Andrew RAMSDEN, Nigel D0D1QH DRUGTYPE Small molecular drug D0D1QH HIGHSTAT Patented D0D1QH COMPCLAS Pyrazolopyridine derivatives D0D4YR DRUG__ID D0D4YR D0D4YR DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0D4YR DRUGTYPE Small molecular drug D0D4YR HIGHSTAT Patented D0D4YR COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D0D5YE DRUG__ID D0D5YE D0D5YE DRUGCOMP KUTUSHOV MIKHAIL VLADIMIROVICH [RUGERMANOV EVGENY PAVLOVICH [RU] D0D5YE DRUGTYPE Small molecular drug D0D5YE HIGHSTAT Patented D0D5YE COMPCLAS Imidazo quinoline derivatives D0D6DN DRUG__ID D0D6DN D0D6DN DRUGCOMP LUNDBECK & CO AS H [DKVERNALIS R & D LTD [GB] D0D6DN DRUGTYPE Small molecular drug D0D6DN HIGHSTAT Patented D0D6DN COMPCLAS Aminopyridine derivatives D0D6HS DRUG__ID D0D6HS D0D6HS DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0D6HS DRUGTYPE Carbohydrates D0D6HS HIGHSTAT Patented D0D6HS COMPCLAS Mannoside derivatives D0D6OM DRUG__ID D0D6OM D0D6OM DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0D6OM DRUGTYPE Carbohydrates D0D6OM HIGHSTAT Patented D0D6OM COMPCLAS Alkyl mannoside derivatives D0D8NX DRUG__ID D0D8NX D0D8NX DRUGCOMP MERCK SHARP & DOHME CORP. HO, Ginny, D. TULSHIAN, Deen HEAP, Charles, R D0D8NX DRUGTYPE Small molecular drug D0D8NX HIGHSTAT Patented D0D8NX COMPCLAS Cyclopropyl-spiro piperidine derivatives D0D9MV DRUG__ID D0D9MV D0D9MV DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0D9MV DRUGTYPE Carbohydrates D0D9MV HIGHSTAT Patented D0D9MV COMPCLAS Aryl mannoside derivatives D0DB7W DRUG__ID D0DB7W D0DB7W DRUGCOMP CHDI FOUNDATION, INC D0DB7W DRUGTYPE Small molecular drug D0DB7W HIGHSTAT Patented D0DB7W COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0DC8B DRUG__ID D0DC8B D0DC8B DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0DC8B DRUGTYPE Small molecular drug D0DC8B HIGHSTAT Patented D0DC8B COMPCLAS Indazole amide derivatives D0DD7K DRUG__ID D0DD7K D0DD7K DRUGCOMP PFIZER INC. LONG, Scott Allen MEYERS, Marvin Jay PELC, Matthew James SCHWEITZER, Barbara Ann THORARENSEN, Atli WANG, Lijuan Jane D0DD7K DRUGTYPE Small molecular drug D0DD7K HIGHSTAT Patented D0DD7K COMPCLAS Aryl urea derivatives D0DE0Y DRUG__ID D0DE0Y D0DE0Y DRUGCOMP THE JOHNS HOPKINS UNIVERSITY The National Institutes of Health D0DE0Y DRUGTYPE Small molecular drug D0DE0Y HIGHSTAT Patented D0DE0Y COMPCLAS Benzamide derivatives D0DH0Y DRUG__ID D0DH0Y D0DH0Y DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0DH0Y DRUGTYPE Carbohydrates D0DH0Y HIGHSTAT Patented D0DH0Y COMPCLAS Aryl mannoside derivatives D0DI1T DRUG__ID D0DI1T D0DI1T DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0DI1T DRUGTYPE Carbohydrates D0DI1T HIGHSTAT Patented D0DI1T COMPCLAS Biaryl mannoside derivatives D0DI5S DRUG__ID D0DI5S D0DI5S DRUGCOMP SHANGHAI INSITITUTE OF PHARMACEUTICAL INDUSTRY ZHANG, Qingwen D0DI5S DRUGTYPE Small molecular drug D0DI5S HIGHSTAT Patented D0DI5S COMPCLAS Carbamide derivatives D0DI6U DRUG__ID D0DI6U D0DI6U DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0DI6U DRUGTYPE Carbohydrates D0DI6U HIGHSTAT Patented D0DI6U COMPCLAS Alkyl mannoside derivatives D0DK0R DRUG__ID D0DK0R D0DK0R DRUGCOMP BIOGEN MA INC D0DK0R DRUGTYPE Small molecular drug D0DK0R HIGHSTAT Patented D0DK0R COMPCLAS Macrolactam derivatives D0DM2G DRUG__ID D0DM2G D0DM2G DRUGCOMP ELI LILLY AND COMPANY GRAFF, Jeremy, Richard D0DM2G DRUGTYPE Small molecular drug D0DM2G HIGHSTAT Patented D0DM2G COMPCLAS Bis-indolylmaleimide derivatives D0DO4I DRUG__ID D0DO4I D0DO4I DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, W. HAAS, Julia JIANG, Yutong ZHANG, Gan D0DO4I DRUGTYPE Small molecular drug D0DO4I HIGHSTAT Patented D0DO4I COMPCLAS Imidazo[1,2-b]pyridazine derivatives D0DO4J DRUG__ID D0DO4J D0DO4J DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0DO4J DRUGTYPE Small molecular drug D0DO4J HIGHSTAT Patented D0DO4J COMPCLAS 1,2-diamino cyclopentane-based derivatives D0DS9D DRUG__ID D0DS9D D0DS9D DRUGCOMP SUVEN LIFE SCIENCES LIMITED D0DS9D DRUGTYPE Small molecular drug D0DS9D HIGHSTAT Patented D0DS9D COMPCLAS Acrylamide compounds D0DW6V DRUG__ID D0DW6V D0DW6V DRUGCOMP ARENA PHARMACEUTICALS, INC. XIONG, Yifeng CHERRIER, Martin, C. CHOI, Jin Sun, Karoline DOSA, Peter, I. SMITH, Brian, M. STRAH-PLEYNET, Sonja ULLMAN, Bret TEEGARDEN, Bradley D0DW6V DRUGTYPE Small molecular drug D0DW6V HIGHSTAT Patented D0DW6V COMPCLAS Pyrazole derivatives D0DY3E DRUG__ID D0DY3E D0DY3E DRUGCOMP GLAXOSMITHKLINE LLC AXTEN, Jeffrey, Michael GRANT, Seth, Wilson HEERDING, Dirk, A. MEDINA, Jesus, Raul ROMERIL, Stuart, Paul TANG, Jun D0DY3E DRUGTYPE Small molecular drug D0DY3E HIGHSTAT Patented D0DY3E COMPCLAS Indoline derivatives D0E0EF DRUG__ID D0E0EF D0E0EF DRUGCOMP ISIS INNOVATION LIMITED LOWE, Gordon D0E0EF DRUGTYPE Small molecular drug D0E0EF HIGHSTAT Patented D0E0EF COMPCLAS Terpyridineplatinum(II) complexes D0E3DS DRUG__ID D0E3DS D0E3DS DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0E3DS DRUGTYPE Carbohydrates D0E3DS HIGHSTAT Patented D0E3DS COMPCLAS Alkyl mannoside derivatives D0E4BN DRUG__ID D0E4BN D0E4BN DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0E4BN DRUGTYPE Small molecular drug D0E4BN HIGHSTAT Patented D0E4BN COMPCLAS Monoaryl-1,2-diamine derivatives D0E5IJ DRUG__ID D0E5IJ D0E5IJ DRUGCOMP NEKTAR THERAPEUTICS RIGGS-SAUTHIER, Jennifer ALLUMS-DONALD, Stephanie CULBERTSON, Sean, M D0E5IJ DRUGTYPE Small molecular drug D0E5IJ HIGHSTAT Patented D0E5IJ COMPCLAS Indoline derivatives D0E6TQ DRUG__ID D0E6TQ D0E6TQ DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0E6TQ DRUGTYPE Small molecular drug D0E6TQ HIGHSTAT Patented D0E6TQ COMPCLAS Tricyclic indole compounds D0E8XV DRUG__ID D0E8XV D0E8XV DRUGCOMP CURADEV PHARMA PRIVATE LTD D0E8XV DRUGTYPE Small molecular drug D0E8XV HIGHSTAT Patented D0E8XV COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D0E9CV DRUG__ID D0E9CV D0E9CV DRUGCOMP Washington University D0E9CV DRUGTYPE Small molecular drug D0E9CV HIGHSTAT Patented D0E9CV COMPCLAS Benzamide derivatives D0E9GD DRUG__ID D0E9GD D0E9GD DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0E9GD DRUGTYPE Carbohydrates D0E9GD HIGHSTAT Patented D0E9GD COMPCLAS Biphenyl mannoside derivatives D0E9JI DRUG__ID D0E9JI D0E9JI DRUGCOMP China Pharmaceutical University D0E9JI DRUGTYPE Small molecular drug D0E9JI HIGHSTAT Patented D0E9JI COMPCLAS Tricyclic indole compounds D0E9ZW DRUG__ID D0E9ZW D0E9ZW DRUGCOMP Amgen, Inc D0E9ZW DRUGTYPE Small molecular drug D0E9ZW HIGHSTAT Patented D0E9ZW COMPCLAS Tarizine derivatives D0EA9Y DRUG__ID D0EA9Y D0EA9Y DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0EA9Y DRUGTYPE Carbohydrates D0EA9Y HIGHSTAT Patented D0EA9Y COMPCLAS Biaryl mannoside derivatives D0EI2Q DRUG__ID D0EI2Q D0EI2Q DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0EI2Q DRUGTYPE Small molecular drug D0EI2Q HIGHSTAT Patented D0EI2Q COMPCLAS Tricyclic indole compounds D0EI4B DRUG__ID D0EI4B D0EI4B DRUGCOMP INCYTE CORPORATION D0EI4B DRUGTYPE Small molecule immunotherapy D0EI4B HIGHSTAT Patented D0EI4B COMPCLAS N-phenyl-pyridine-2-carboxamide derivatives D0EK3Z DRUG__ID D0EK3Z D0EK3Z DRUGCOMP COGNITION THERAPEUTICS, INC D0EK3Z DRUGTYPE Small molecular drug D0EK3Z HIGHSTAT Patented D0EK3Z COMPCLAS Isoindoline derivatives D0ET2A DRUG__ID D0ET2A D0ET2A DRUGCOMP Pfizer Incorporated D0ET2A DRUGTYPE Small molecular drug D0ET2A HIGHSTAT Patented D0ET2A COMPCLAS Imidazo triazine derivatives D0ET9M DRUG__ID D0ET9M D0ET9M DRUGCOMP WASHINGTON UNIVERSITY D0ET9M DRUGTYPE Carbohydrates D0ET9M HIGHSTAT Patented D0ET9M COMPCLAS Biaryl mannoside derivatives D0ET9U DRUG__ID D0ET9U D0ET9U DRUGCOMP JENRIN DISCOVERY MCELROY, John CHORVAT, Rober D0ET9U DRUGTYPE Small molecular drug D0ET9U HIGHSTAT Patented D0ET9U COMPCLAS Pyrazoline derivatives D0EW3O DRUG__ID D0EW3O D0EW3O DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0EW3O DRUGTYPE Small molecule immunotherapy D0EW3O HIGHSTAT Patented D0EW3O COMPCLAS Cyclic peptidomimetic derivatives D0EX5C DRUG__ID D0EX5C D0EX5C DRUGCOMP PFIZER INC D0EX5C DRUGTYPE Small molecular drug D0EX5C HIGHSTAT Patented D0EX5C COMPCLAS Pyrrolo-pyrazine derivatives D0EY5F DRUG__ID D0EY5F D0EY5F DRUGCOMP Roche D0EY5F DRUGTYPE Small molecular drug D0EY5F HIGHSTAT Patented D0EY5F COMPCLAS Isoindole 1,3-dione analogs D0F0XC DRUG__ID D0F0XC D0F0XC DRUGCOMP ASTRAZENECA AB ASTRAZENECA UK LIMITED BIRCH, Alan Martin PAL, Sharmistha PETTERSEN, Anna TOMKINSON, Gary Peter D0F0XC DRUGTYPE Small molecular drug D0F0XC HIGHSTAT Patented D0F0XC COMPCLAS 4-oxadiazole derivatives D0F1CT DRUG__ID D0F1CT D0F1CT DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED JOHNSON, Neil, W. KASPAREC, Jiri MILLER, William, Henry ROUSE, Meagan, B. SUAREZ, Dominic TIAN, Xinrong D0F1CT DRUGTYPE Small molecular drug D0F1CT HIGHSTAT Patented D0F1CT COMPCLAS Cyclopropylamine derivatives D0F2KN DRUG__ID D0F2KN D0F2KN DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0F2KN DRUGTYPE Small molecular drug D0F2KN HIGHSTAT Patented D0F2KN COMPCLAS Dihydropyrimidinone derivatives D0F3BO DRUG__ID D0F3BO D0F3BO DRUGCOMP THE UNIVERSITY OF HONG KON D0F3BO DRUGTYPE Small molecular drug D0F3BO HIGHSTAT Patented D0F3BO COMPCLAS Binuclear gold(I) compounds D0F3GC DRUG__ID D0F3GC D0F3GC DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0F3GC DRUGTYPE Small molecular drug D0F3GC HIGHSTAT Patented D0F3GC COMPCLAS Dihydropyrido pyrazinone compounds D0F4VD DRUG__ID D0F4VD D0F4VD DRUGCOMP CURADEV PHARMA PRIVATE LTD D0F4VD DRUGTYPE Small molecular drug D0F4VD HIGHSTAT Patented D0F4VD COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D0F6TN DRUG__ID D0F6TN D0F6TN DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0F6TN DRUGTYPE Carbohydrates D0F6TN HIGHSTAT Patented D0F6TN COMPCLAS Mannoside derivatives D0FC0Z DRUG__ID D0FC0Z D0FC0Z DRUGCOMP ZENITH EPIGENETICS CORP D0FC0Z DRUGTYPE Small molecular drug D0FC0Z HIGHSTAT Patented D0FC0Z COMPCLAS Isoxazole-based bicyclic compounds D0FF5C DRUG__ID D0FF5C D0FF5C DRUGCOMP COCENSYS, INC D0FF5C DRUGTYPE Small molecular drug D0FF5C HIGHSTAT Patented D0FF5C COMPCLAS Quinoline carboxamide derivatives D0FF6H DRUG__ID D0FF6H D0FF6H DRUGCOMP CURADEV PHARMA PRIVATE LTD D0FF6H DRUGTYPE Small molecular drug D0FF6H HIGHSTAT Patented D0FF6H COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D0FG4C DRUG__ID D0FG4C D0FG4C DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0FG4C DRUGTYPE Small molecular drug D0FG4C HIGHSTAT Patented D0FG4C COMPCLAS Epoxysuccinate derivatives D0FH4G DRUG__ID D0FH4G D0FH4G DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM PRIEBE, Waldemar KATO, Takayuki FOKT, Izabela CONRAD, Charles MADDEN, Timothy SKORA, Stanislaw D0FH4G DRUGTYPE Small molecular drug D0FH4G HIGHSTAT Patented D0FH4G COMPCLAS Gold-complexed thiosaccharide derivatives D0FI3Q DRUG__ID D0FI3Q D0FI3Q DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0FI3Q DRUGTYPE Carbohydrates D0FI3Q HIGHSTAT Patented D0FI3Q COMPCLAS Biaryl mannoside derivatives D0FK7E DRUG__ID D0FK7E D0FK7E DRUGCOMP PFIZER INC D0FK7E DRUGTYPE Small molecular drug D0FK7E HIGHSTAT Patented D0FK7E COMPCLAS Carbamate derivatives D0FL0T DRUG__ID D0FL0T D0FL0T DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITThe Board of Trustees of the Leland Stanford Junior University D0FL0T DRUGTYPE Small molecular drug D0FL0T HIGHSTAT Patented D0FL0T COMPCLAS Imidazo bicyclic iminium derivatives D0FO4C DRUG__ID D0FO4C D0FO4C DRUGCOMP ELI LILLY AND COMPANY D0FO4C DRUGTYPE Small molecular drug D0FO4C HIGHSTAT Patented D0FO4C COMPCLAS Dihydropyrido pyrimidine derivatives D0FQ4Z DRUG__ID D0FQ4Z D0FQ4Z DRUGCOMP PFIZER INC D0FQ4Z DRUGTYPE Small molecular drug D0FQ4Z HIGHSTAT Patented D0FQ4Z COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0FR1P DRUG__ID D0FR1P D0FR1P DRUGCOMP F. HOFFMANN-LA ROCHE AG GOBBI, Luca JAESCHKE, Georg RODRIGUEZ SARMIENTO, Rosa Maria STEWARD, LucindHoffmann-La Roche Inc D0FR1P DRUGTYPE Small molecular drug D0FR1P HIGHSTAT Patented D0FR1P COMPCLAS Benzoyl-piperidine derivatives D0FR3Z DRUG__ID D0FR3Z D0FR3Z DRUGCOMP NOVARTIS AG D0FR3Z DRUGTYPE Small molecular drug D0FR3Z HIGHSTAT Patented D0FR3Z COMPCLAS Aminoarylpyridine derivatives D0FS1J DRUG__ID D0FS1J D0FS1J DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0FS1J DRUGTYPE Small molecular drug D0FS1J HIGHSTAT Patented D0FS1J COMPCLAS Imidazo bicyclic iminium derivatives D0FS3J DRUG__ID D0FS3J D0FS3J DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0FS3J DRUGTYPE Small molecular drug D0FS3J HIGHSTAT Patented D0FS3J COMPCLAS Heteroaryl-azepine derivatives D0FS9X DRUG__ID D0FS9X D0FS9X DRUGCOMP MERCK SHARP & DOHME CORP D0FS9X DRUGTYPE Small molecular drug D0FS9X HIGHSTAT Patented D0FS9X COMPCLAS Fused thiophene derivatives D0FT4P DRUG__ID D0FT4P D0FT4P DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0FT4P DRUGTYPE Carbohydrates D0FT4P HIGHSTAT Patented D0FT4P COMPCLAS Aryl mannoside derivatives D0FU0I DRUG__ID D0FU0I D0FU0I DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0FU0I DRUGTYPE Small molecular drug D0FU0I HIGHSTAT Patented D0FU0I COMPCLAS Pyrrolo-pyrimidine derivatives D0FV3G DRUG__ID D0FV3G D0FV3G DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0FV3G DRUGTYPE Small molecular drug D0FV3G HIGHSTAT Patented D0FV3G COMPCLAS 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives D0FW5Q DRUG__ID D0FW5Q D0FW5Q DRUGCOMP CHDI FOUNDATION, INC D0FW5Q DRUGTYPE Small molecular drug D0FW5Q HIGHSTAT Patented D0FW5Q COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0FX7I DRUG__ID D0FX7I D0FX7I DRUGCOMP MEDSHINE DISCOVERY INC D0FX7I DRUGTYPE Small molecular drug D0FX7I HIGHSTAT Patented D0FX7I COMPCLAS Isoquinoline sulfonyl derivatives D0FX9D DRUG__ID D0FX9D D0FX9D DRUGCOMP Yuanqiang Z D0FX9D DRUGTYPE Small molecular drug D0FX9D HIGHSTAT Patented D0FX9D COMPCLAS Tetrazole acetic acid derivatives D0FY8B DRUG__ID D0FY8B D0FY8B DRUGCOMP Bristol-Myers Squibb Co D0FY8B DRUGTYPE Small molecular drug D0FY8B HIGHSTAT Patented D0FY8B COMPCLAS Carbamide derivatives D0G1LS DRUG__ID D0G1LS D0G1LS DRUGCOMP CUREVEDA, LLC D0G1LS DRUGTYPE Small molecular drug D0G1LS HIGHSTAT Patented D0G1LS COMPCLAS Chalcone derivatives D0G3NC DRUG__ID D0G3NC D0G3NC DRUGCOMP MERCK SHARP & DOHME CORP. SEGANISH, W. Michael MCELROY, William, T. BRUMFIELD, Stephanie HERR, R. Jason YET, Larry YANG, Jinhai HARDING, James, P., III HO, Ginny Dai TULSHIAN, Deen, B. YU, Wensheng WONG, Michael, K. C. LAVEY, Brian, J. KOZLOWSKI, Joseph, A D0G3NC DRUGTYPE Small molecular drug D0G3NC HIGHSTAT Patented D0G3NC COMPCLAS Amidopyrazole derivatives D0G3QD DRUG__ID D0G3QD D0G3QD DRUGCOMP Toray Industries, Inc D0G3QD DRUGTYPE Small molecular drug D0G3QD HIGHSTAT Patented D0G3QD COMPCLAS Chalcone derivatives D0G7GN DRUG__ID D0G7GN D0G7GN DRUGCOMP Wisconsin Alumni Research Foundation D0G7GN DRUGTYPE Small molecular drug D0G7GN HIGHSTAT Patented D0G7GN COMPCLAS Phenylpropylamine derivatives D0G8CF DRUG__ID D0G8CF D0G8CF DRUGCOMP Korea Institute of Radiological & Medical Sciences, S D0G8CF DRUGTYPE Small molecular drug D0G8CF HIGHSTAT Patented D0G8CF COMPCLAS Benzo[d]oxazole derivatives D0G8HX DRUG__ID D0G8HX D0G8HX DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0G8HX DRUGTYPE Small molecular drug D0G8HX HIGHSTAT Patented D0G8HX COMPCLAS 3-phenyl isoquinolin-1(2H) derivatives D0G8IM DRUG__ID D0G8IM D0G8IM DRUGCOMP ZENITH EPIGENETICS CORP D0G8IM DRUGTYPE Small molecular drug D0G8IM HIGHSTAT Patented D0G8IM COMPCLAS Isoxazole-based bicyclic compounds D0G8JX DRUG__ID D0G8JX D0G8JX DRUGCOMP the Shanghai Institute of Technology and the Shanghai Ecust Biomedicine Company D0G8JX DRUGTYPE Small molecular drug D0G8JX HIGHSTAT Patented D0G8JX COMPCLAS Pitavastatin derivatives D0G8SB DRUG__ID D0G8SB D0G8SB DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0G8SB DRUGTYPE Small molecular drug D0G8SB HIGHSTAT Patented D0G8SB COMPCLAS 2,2-bipyridyl derivatives D0G9KS DRUG__ID D0G9KS D0G9KS DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0G9KS DRUGTYPE Carbohydrates D0G9KS HIGHSTAT Patented D0G9KS COMPCLAS Aryl mannoside derivatives D0GA8C DRUG__ID D0GA8C D0GA8C DRUGCOMP BIOGEN MA INC D0GA8C DRUGTYPE Small molecular drug D0GA8C HIGHSTAT Patented D0GA8C COMPCLAS Macrolactam derivatives D0GB3P DRUG__ID D0GB3P D0GB3P DRUGCOMP CEPHALON, INC. BIERLMAIER, Stephen HALTIWANGER, Ralph, Curtis JACOBS, Martin, JCEPHALON, INC. HUDKINS, Robert, L. JOSEF, Kurt, A. TAO, Ming BECKNELL, Nadine, C. HOSTETLER, Greg KNUTSON, Lars, J., S. ZULLI, Allison, L D0GB3P DRUGTYPE Small molecular drug D0GB3P HIGHSTAT Patented D0GB3P COMPCLAS Pyridazin-3(2H)-one derivatives D0GH4V DRUG__ID D0GH4V D0GH4V DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0GH4V DRUGTYPE Small molecular drug D0GH4V HIGHSTAT Patented D0GH4V COMPCLAS 4-Carboxamido-isoindolinone derivatives D0GI7I DRUG__ID D0GI7I D0GI7I DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, Guy, J. KEITH, John, M. JONES, William, M D0GI7I DRUGTYPE Small molecular drug D0GI7I HIGHSTAT Patented D0GI7I COMPCLAS Spirocyclic diamine urea derivatives D0GJ4G DRUG__ID D0GJ4G D0GJ4G DRUGCOMP Pfizer Inc., USA. Assignee D0GJ4G DRUGTYPE Small molecular drug D0GJ4G HIGHSTAT Patented D0GJ4G COMPCLAS Pyrrolo-pyrimidine derivatives D0GM6O DRUG__ID D0GM6O D0GM6O DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0GM6O DRUGTYPE Carbohydrates D0GM6O HIGHSTAT Patented D0GM6O COMPCLAS Biphenyl mannoside derivatives D0GQ2Z DRUG__ID D0GQ2Z D0GQ2Z DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0GQ2Z DRUGTYPE Small molecular drug D0GQ2Z HIGHSTAT Patented D0GQ2Z COMPCLAS Tetra-hydro-oxazolopyridine derivatives D0GR3C DRUG__ID D0GR3C D0GR3C DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D0GR3C DRUGTYPE Carbohydrates D0GR3C HIGHSTAT Patented D0GR3C COMPCLAS Biphenyl mannoside derivatives D0GS2P DRUG__ID D0GS2P D0GS2P DRUGCOMP Merck Patent GmBH D0GS2P DRUGTYPE Small molecular drug D0GS2P HIGHSTAT Patented D0GS2P COMPCLAS 2-piperidine thiazole derivatives D0GT5M DRUG__ID D0GT5M D0GT5M DRUGCOMP Hoffmann-La Roche, Inc D0GT5M DRUGTYPE Small molecular drug D0GT5M HIGHSTAT Patented D0GT5M COMPCLAS Tetra-azabenzo[e]azulene derivatives D0GV9F DRUG__ID D0GV9F D0GV9F DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0GV9F DRUGTYPE Carbohydrates D0GV9F HIGHSTAT Patented D0GV9F COMPCLAS Biaryl mannoside derivatives D0GW5F DRUG__ID D0GW5F D0GW5F DRUGCOMP ARENA PHARMACEUTICALS, INC D0GW5F DRUGTYPE Small molecular drug D0GW5F HIGHSTAT Patented D0GW5F COMPCLAS Benzazepine derivatives D0H0XC DRUG__ID D0H0XC D0H0XC DRUGCOMP NORTHEASTERN UNIVERSITY D0H0XC DRUGTYPE Small molecular drug D0H0XC HIGHSTAT Patented D0H0XC COMPCLAS 2-cycloalkyl resorcinol cannabinoid ligand derivatives D0H1BZ DRUG__ID D0H1BZ D0H1BZ DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0H1BZ DRUGTYPE Carbohydrates D0H1BZ HIGHSTAT Patented D0H1BZ COMPCLAS Biaryl mannoside derivatives D0H1IX DRUG__ID D0H1IX D0H1IX DRUGCOMP Mitsubishi Tanabe Pharma Corporation MORITANI, Yasunori IMASHIRO, Ritsuo SATO, Atsush D0H1IX DRUGTYPE Small molecular drug D0H1IX HIGHSTAT Patented D0H1IX COMPCLAS Pyrazole derivatives D0H1JS DRUG__ID D0H1JS D0H1JS DRUGCOMP PROXIMAGEN LTD. BOYD, Joe William MEO, Paul HIGGINBOTTOM, Michael SIMPSON, Iain MOUNTFORD, David Mark SAVORY, Edward Daniel D0H1JS DRUGTYPE Small molecular drug D0H1JS HIGHSTAT Patented D0H1JS COMPCLAS Piperazine urea derivatives D0H3KF DRUG__ID D0H3KF D0H3KF DRUGCOMP INCYTE CORPORATION D0H3KF DRUGTYPE Small molecular drug D0H3KF HIGHSTAT Patented D0H3KF COMPCLAS Bipyrazole derivatives D0H4CL DRUG__ID D0H4CL D0H4CL DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0H4CL DRUGTYPE Carbohydrates D0H4CL HIGHSTAT Patented D0H4CL COMPCLAS C-linked disaccharide biphenyl mannoside derivatives D0H4LG DRUG__ID D0H4LG D0H4LG DRUGCOMP DART NEUROSCIENCE (CAYMAN) LTD D0H4LG DRUGTYPE Small molecular drug D0H4LG HIGHSTAT Patented D0H4LG COMPCLAS 1,2,4-triazole [1,5-a]pyrimidin-7-yl derivatives D0H5XC DRUG__ID D0H5XC D0H5XC DRUGCOMP Arena Pharmaceuticals, Inc D0H5XC DRUGTYPE Small molecular drug D0H5XC HIGHSTAT Patented D0H5XC COMPCLAS Pyrazole derivatives D0H6XN DRUG__ID D0H6XN D0H6XN DRUGCOMP MERCK SHARP & DOHME CORP. CHILDERS, Matthew L. FULLER, Peter H. GUERIN, David J. KATZ, Jason David MARTINEZ, Michelle PU, Qinglin SCOTT, Mark E. THOMPSON, Christopher F. CAI, Jiaqiang KONG, Norman LIU, Yumei D0H6XN DRUGTYPE Small molecular drug D0H6XN HIGHSTAT Patented D0H6XN COMPCLAS Geminally-substituted cyanoethylpypazolo pyridone derivatives D0H7UR DRUG__ID D0H7UR D0H7UR DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0H7UR DRUGTYPE Carbohydrates D0H7UR HIGHSTAT Patented D0H7UR COMPCLAS Mannoside derivatives D0HC5P DRUG__ID D0HC5P D0HC5P DRUGCOMP DART NEUROSCIENCE (CAYMAN) LTD D0HC5P DRUGTYPE Small molecular drug D0HC5P HIGHSTAT Patented D0HC5P COMPCLAS 1,2,4-triazole [1,5-a]pyrimidin-7-yl derivatives D0HD8F DRUG__ID D0HD8F D0HD8F DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. MASUDA Seiji MATSUDA Yohei SAKAGAMI Kazunari KONISHI Kazuhide URABE Hiroki SHIMONO Rie OKADA Kumiko D0HD8F DRUGTYPE Small molecular drug D0HD8F HIGHSTAT Patented D0HD8F COMPCLAS Pyrazole derivatives D0HE3B DRUG__ID D0HE3B D0HE3B DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0HE3B DRUGTYPE Carbohydrates D0HE3B HIGHSTAT Patented D0HE3B COMPCLAS Biphenyl mannoside derivatives D0HF7V DRUG__ID D0HF7V D0HF7V DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0HF7V DRUGTYPE Peptide D0HF7V DRUGSMIL C(CCN)CC(C(=O)O)NC(=O)NC(CC(=O)N)C(=O)NNC(=O)C(CO)N D0HF7V HIGHSTAT Patented D0HG0F DRUG__ID D0HG0F D0HG0F DRUGCOMP SANOFI D0HG0F DRUGTYPE Small molecular drug D0HG0F HIGHSTAT Patented D0HG0F COMPCLAS 1,3,5-triazine derivatives D0HJ2J DRUG__ID D0HJ2J D0HJ2J DRUGCOMP ONCOIMMUNE INC. SUNVITA THERAPEUTICS, D0HJ2J DRUGTYPE Small molecular drug D0HJ2J HIGHSTAT Patented D0HJ2J COMPCLAS Cyclic octapeptide derivatives D0HO5B DRUG__ID D0HO5B D0HO5B DRUGCOMP BETA PHARMA, INC. ZHANG, Don XIE, Guojian D0HO5B DRUGTYPE Small molecular drug D0HO5B HIGHSTAT Patented D0HO5B COMPCLAS Indoline derivatives D0HS9X DRUG__ID D0HS9X D0HS9X DRUGCOMP DAINIPPON SUMITOMO PHARMA CO [JPDAINIPPON SUMITOMO PHARMA CO., LTD. FUJII, Akihito NIIDOME, Kazumi MIGIHASHI, Chiaki D0HS9X DRUGTYPE Small molecular drug D0HS9X HIGHSTAT Patented D0HS9X COMPCLAS 3-substituted-2-furancarboxylic acid hydrazide derivatives D0HV0D DRUG__ID D0HV0D D0HV0D DRUGCOMP ARENA PHARMACEUTICALS, INC D0HV0D DRUGTYPE Small molecular drug D0HV0D HIGHSTAT Patented D0HV0D COMPCLAS Aryl piperazine derivatives D0HV0Y DRUG__ID D0HV0Y D0HV0Y DRUGCOMP CURADEV PHARMA PRIVATE LTD D0HV0Y DRUGTYPE Small molecular drug D0HV0Y HIGHSTAT Patented D0HV0Y COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D0HY0H DRUG__ID D0HY0H D0HY0H DRUGCOMP ELAN PHARMACEUTICALS, LLC D0HY0H DRUGTYPE Small molecular drug D0HY0H HIGHSTAT Patented D0HY0H COMPCLAS Hydrazide derivatives D0HY3K DRUG__ID D0HY3K D0HY3K DRUGCOMP Arena Pharmaceuticals, Inc D0HY3K DRUGTYPE Small molecular drug D0HY3K HIGHSTAT Patented D0HY3K COMPCLAS 3-phenyl pyrazole derivatives D0HY9M DRUG__ID D0HY9M D0HY9M DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0HY9M DRUGTYPE Small molecular drug D0HY9M HIGHSTAT Patented D0HY9M COMPCLAS Fused aryl carbocycle derivatives D0I0MT DRUG__ID D0I0MT D0I0MT DRUGCOMP AMGEN INC. BREGMAN, Howard BUCHANAN, John, L. CHAKKA, Nagasree DIMAURO, Erin, F. DU, Bingfan NGUYEN, Hanh, Nho ZHENG, Xiao, Mei D0I0MT DRUGTYPE Small molecular drug D0I0MT HIGHSTAT Patented D0I0MT COMPCLAS Aryl carboxamide derivatives D0I2FM DRUG__ID D0I2FM D0I2FM DRUGCOMP Univ Hefei Technology D0I2FM DRUGTYPE Small molecular drug D0I2FM HIGHSTAT Patented D0I2FM COMPCLAS Tacrine-phenothiazine hybrid derivatives D0I2RF DRUG__ID D0I2RF D0I2RF DRUGCOMP KATHOLIEKE UNIVERSITEIT LEUVEN VRIJE UNIVERSITEIT BRUSSEL UNIVERSITY OF STRATHCLYDE SALAMA NEUROSCIENCE CENTRCELLARTIS AB [SESTEM CELLS FOR SAFER MEDICINES LIMITED BONE, Heather Karyn TOSH, David WELHAM, Melanie Joann D0I2RF DRUGTYPE Small molecular drug D0I2RF HIGHSTAT Patented D0I2RF COMPCLAS Indirubin derivatives D0I3QY DRUG__ID D0I3QY D0I3QY DRUGCOMP ARENA PHARMACEUTICALS, INC D0I3QY DRUGTYPE Small molecular drug D0I3QY HIGHSTAT Patented D0I3QY COMPCLAS Benzazepine derivatives D0I5KI DRUG__ID D0I5KI D0I5KI DRUGCOMP Wyeth D0I5KI DRUGTYPE Small molecular drug D0I5KI HIGHSTAT Patented D0I5KI COMPCLAS Dibenzo [c,f]-[2,7]naphthyridine derivatives D0I5UY DRUG__ID D0I5UY D0I5UY DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael S. ERDEI, James Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0I5UY DRUGTYPE Small molecular drug D0I5UY HIGHSTAT Patented D0I5UY COMPCLAS Imidazo[5,1-c][1,2,4]benzotriazine derivatives D0I6HB DRUG__ID D0I6HB D0I6HB DRUGCOMP ZENITH EPIGENETICS CORP D0I6HB DRUGTYPE Small molecular drug D0I6HB HIGHSTAT Patented D0I6HB COMPCLAS Quinazolinone derivatives D0I6VK DRUG__ID D0I6VK D0I6VK DRUGCOMP SANOFI D0I6VK DRUGTYPE Small molecular drug D0I6VK HIGHSTAT Patented D0I6VK COMPCLAS Carbamate derivatives D0I6WJ DRUG__ID D0I6WJ D0I6WJ DRUGCOMP Allergan, Inc D0I6WJ DRUGTYPE Small molecular drug D0I6WJ HIGHSTAT Patented D0I6WJ COMPCLAS Carbamide derivatives D0II7X DRUG__ID D0II7X D0II7X DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITThe Board of Trustees of the Leland Stanford Junior University D0II7X DRUGTYPE Small molecular drug D0II7X HIGHSTAT Patented D0II7X COMPCLAS Imidazo bicyclic iminium derivatives D0IK9V DRUG__ID D0IK9V D0IK9V DRUGCOMP Janssen Pharmaceutica N.V D0IK9V DRUGTYPE Small molecular drug D0IK9V HIGHSTAT Patented D0IK9V COMPCLAS Ketoheterocycle derivatives D0IO8Y DRUG__ID D0IO8Y D0IO8Y DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0IO8Y DRUGTYPE Small molecular drug D0IO8Y HIGHSTAT Patented D0IO8Y COMPCLAS Epoxysuccinate derivatives D0IR8B DRUG__ID D0IR8B D0IR8B DRUGCOMP WYETH WISSNER, Allan FLOYD, Middleton, Brawner, Jr. DUSHIN, Russell FRASER, Heidi, L. HU, Yongbo MADERNA, Andreas NITTOLI, Thomas WANG, Yanong, Daniel D0IR8B DRUGTYPE Small molecular drug D0IR8B HIGHSTAT Patented D0IR8B COMPCLAS Benzonaphthyridine derivatives D0IW7A DRUG__ID D0IW7A D0IW7A DRUGCOMP NANT HOLDINGS IP, LLC D0IW7A DRUGTYPE Small molecular drug D0IW7A HIGHSTAT Patented D0IW7A COMPCLAS Cyclic sulfonamide derivatives D0J0UC DRUG__ID D0J0UC D0J0UC DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0J0UC DRUGTYPE Small molecular drug D0J0UC HIGHSTAT Patented D0J0UC COMPCLAS Azetidine-benzoxazin-3(4H)-one derivatives D0J1OK DRUG__ID D0J1OK D0J1OK DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0J1OK DRUGTYPE Small molecular drug D0J1OK HIGHSTAT Patented D0J1OK COMPCLAS N-oxalylglycine derivatives D0J1RB DRUG__ID D0J1RB D0J1RB DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D0J1RB DRUGTYPE Small molecular drug D0J1RB HIGHSTAT Patented D0J1RB COMPCLAS Isoflavone derivatives D0J1US DRUG__ID D0J1US D0J1US DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM PRIEBE, Waldemar KATO, Takayuki FOKT, Izabela CONRAD, Charles MADDEN, Timothy SKORA, Stanislaw D0J1US DRUGTYPE Small molecular drug D0J1US HIGHSTAT Patented D0J1US COMPCLAS Gold-complexed thiosaccharide derivatives D0J4AZ DRUG__ID D0J4AZ D0J4AZ DRUGCOMP H. LUNDBECK A/S HOLM, Ren BRUUN, LonH. Lundbeck A/S D0J4AZ DRUGTYPE Small molecular drug D0J4AZ HIGHSTAT Patented D0J4AZ COMPCLAS L-piperazino-3-phenyl-indane derivatives D0J4PE DRUG__ID D0J4PE D0J4PE DRUGCOMP INST CHEMII ORGANICZNEJ POLSKIEJ AKADEMII NAUK [PLWARSZAWSKI UNIV MEDYCZNY [PL] D0J4PE DRUGTYPE Small molecular drug D0J4PE HIGHSTAT Patented D0J4PE COMPCLAS Acyl oxymethyl acrylamide ester derivatives D0J4UO DRUG__ID D0J4UO D0J4UO DRUGCOMP Bristol-Myers Squibb Company D0J4UO DRUGTYPE Small molecule immunotherapy D0J4UO HIGHSTAT Patented D0J4UO COMPCLAS Macrocycle derivatives D0J6KS DRUG__ID D0J6KS D0J6KS DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GmbH D0J6KS DRUGTYPE Small molecular drug D0J6KS HIGHSTAT Patented D0J6KS COMPCLAS 1,2,4-triazole [4,3-a]quinoxaline derivatives D0J8YF DRUG__ID D0J8YF D0J8YF DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0J8YF DRUGTYPE Small molecular drug D0J8YF HIGHSTAT Patented D0J8YF COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D0JB7I DRUG__ID D0JB7I D0JB7I DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D0JB7I DRUGTYPE Small molecular drug D0JB7I HIGHSTAT Patented D0JB7I COMPCLAS 7-azaindole derivatives D0JC8E DRUG__ID D0JC8E D0JC8E DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L. CALDARELLI, Marina BERIA, Italo COLOMBO, Nicoletta PIUTTI, Claudia SALSA, Matteo TRAQUANDI, Gabriella D0JC8E DRUGTYPE Small molecular drug D0JC8E HIGHSTAT Patented D0JC8E COMPCLAS Tricyclic isoxazoloquinazoline derivatives D0JE6I DRUG__ID D0JE6I D0JE6I DRUGCOMP Duke University, USA D0JE6I DRUGTYPE Small molecular drug D0JE6I HIGHSTAT Patented D0JE6I COMPCLAS Aryl cyclopropylamine derivatives D0JJ1N DRUG__ID D0JJ1N D0JJ1N DRUGCOMP Office of Research Affairs/UIF, Yonsei University, S. Korea D0JJ1N DRUGTYPE Small molecular drug D0JJ1N HIGHSTAT Patented D0JJ1N COMPCLAS Matairesinol derivatives D0JJ8K DRUG__ID D0JJ8K D0JJ8K DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0JJ8K DRUGTYPE Small molecular drug D0JJ8K HIGHSTAT Patented D0JJ8K COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D0JM7W DRUG__ID D0JM7W D0JM7W DRUGCOMP ARDEA BIOSCIENCES, INC. OUK, Samedy VERNIER, Jean-michel GUNIC, Esmir D0JM7W DRUGTYPE Small molecular drug D0JM7W HIGHSTAT Patented D0JM7W COMPCLAS Phenylthioacetate derivatives D0JU1R DRUG__ID D0JU1R D0JU1R DRUGCOMP F. HOFFMANN-LA ROCHE AG CHEN, Shaoqing DE VICENTE FIDALGO, Javier HAMILTON, Matthew Michael HERMANN, Johannes Cornelius KENNEDY-SMITH, Joshua LI, Hongju LOVEY, Allen John LUCAS, Matthew C. LUK, Kin-Chun Thomas LYNCH, Stephen M. O'YANG, Counde PADILLA, Fernando SCHOENFELD, Ryan Craig SIDDURI, Achyutharao SOTH, Michael WANG, Ce WOVKULICH, Peter Michael ZHANG, Xiaohu D0JU1R DRUGTYPE Small molecular drug D0JU1R HIGHSTAT Patented D0JU1R COMPCLAS Pyrrolo-pyrazine derivatives D0JY0L DRUG__ID D0JY0L D0JY0L DRUGCOMP SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A D0JY0L DRUGTYPE Small molecular drug D0JY0L HIGHSTAT Patented D0JY0L COMPCLAS 7-azaindole derivatives D0JY9S DRUG__ID D0JY9S D0JY9S DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEGlaxoSmithKline D0JY9S DRUGTYPE Small molecular drug D0JY9S HIGHSTAT Patented D0JY9S COMPCLAS Dihydropyridine compounds D0JZ2B DRUG__ID D0JZ2B D0JZ2B DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0JZ2B DRUGTYPE Small molecular drug D0JZ2B HIGHSTAT Patented D0JZ2B COMPCLAS Alkynyl-substituted pyrimidinyl-pyrrole derivatives D0JZ9L DRUG__ID D0JZ9L D0JZ9L DRUGCOMP CHDI FOUNDATION, INC D0JZ9L DRUGTYPE Small molecular drug D0JZ9L HIGHSTAT Patented D0JZ9L COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0K2AA DRUG__ID D0K2AA D0K2AA DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0K2AA DRUGTYPE Carbohydrates D0K2AA HIGHSTAT Patented D0K2AA COMPCLAS Biaryl mannoside derivatives D0K2FK DRUG__ID D0K2FK D0K2FK DRUGCOMP NANT HOLDINGS IP, LLC D0K2FK DRUGTYPE Small molecular drug D0K2FK HIGHSTAT Patented D0K2FK COMPCLAS Cyclic sulfonamide derivatives D0K2OT DRUG__ID D0K2OT D0K2OT DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0K2OT DRUGTYPE Small molecular drug D0K2OT HIGHSTAT Patented D0K2OT COMPCLAS 2,2-bipyridyl derivatives D0K2RW DRUG__ID D0K2RW D0K2RW DRUGCOMP MERCK SHARP & DOHME CORP. BRUBAKER, Jason CHILDERS, Matthew Lloyd CHRISTOPHER, Matthew CLOSE, Joshua, T. KATZ, Jason David JUNG, Joon PETERSON, Scott SILIPHAIVANH, Phieng SIU, Tony SMITH, Graham Frank TORRES, Luis, E. WOO, Hyun Chong YOUNG, Jonathan, R. ZHANG, Hongjun D0K2RW DRUGTYPE Small molecular drug D0K2RW HIGHSTAT Patented D0K2RW COMPCLAS Cyanomethyl pypazole carboxamide derivatives D0K2WP DRUG__ID D0K2WP D0K2WP DRUGCOMP PFIZER INC D0K2WP DRUGTYPE Small molecular drug D0K2WP HIGHSTAT Patented D0K2WP COMPCLAS Aryl urea derivatives D0K3EB DRUG__ID D0K3EB D0K3EB DRUGCOMP UNIVERZA V LJUBLJANI [SI] D0K3EB DRUGTYPE Small molecular drug D0K3EB HIGHSTAT Patented D0K3EB COMPCLAS Di-substituted piperidine derivatives D0K3QR DRUG__ID D0K3QR D0K3QR DRUGCOMP ALTANA PHARMA AG TENOR, Hermann BAER, Thomas HATZELMANN, Armin D0K3QR DRUGTYPE Small molecular drug D0K3QR HIGHSTAT Patented D0K3QR COMPCLAS Purin-6-one derivatives D0K3QX DRUG__ID D0K3QX D0K3QX DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0K3QX DRUGTYPE Small molecular drug D0K3QX HIGHSTAT Patented D0K3QX COMPCLAS Tricyclic indole compounds D0K7CD DRUG__ID D0K7CD D0K7CD DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0K7CD DRUGTYPE Small molecular drug D0K7CD HIGHSTAT Patented D0K7CD COMPCLAS Fused aryl carbocycle derivatives D0K7OV DRUG__ID D0K7OV D0K7OV DRUGCOMP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES MARUGAN, Juan J. PATNAIK, Samarjit HEILIG, Markus A. SOUTHALL, Noel T. ZHENG, Wei D0K7OV DRUGTYPE Small molecular drug D0K7OV HIGHSTAT Patented D0K7OV COMPCLAS Imidazo pyridine derivatives D0K7TE DRUG__ID D0K7TE D0K7TE DRUGCOMP WASHINGTON UNIVERSITY D0K7TE DRUGTYPE Carbohydrates D0K7TE HIGHSTAT Patented D0K7TE COMPCLAS Biaryl mannoside derivatives D0K8NP DRUG__ID D0K8NP D0K8NP DRUGCOMP ISIS INNOVATION LIMITED LOWE, Gordon D0K8NP DRUGTYPE Small molecular drug D0K8NP HIGHSTAT Patented D0K8NP COMPCLAS Terpyridineplatinum(II) complexes D0K9MH DRUG__ID D0K9MH D0K9MH DRUGCOMP SUVEN LIFE SCIENCES LIMITED D0K9MH DRUGTYPE Small molecular drug D0K9MH HIGHSTAT Patented D0K9MH COMPCLAS Acrylamide compounds D0KA3X DRUG__ID D0KA3X D0KA3X DRUGCOMP KARUS THERAPEUTICS LIMITED SHUTTLEWORTH, Stephen Joseph TOMASSI, Cyrille Davy D0KA3X DRUGTYPE Small molecular drug D0KA3X HIGHSTAT Patented D0KA3X COMPCLAS Diaryl amine derivatives D0KD6U DRUG__ID D0KD6U D0KD6U DRUGCOMP WELLSTAT THERAPEUTICS CORPORATION SHARMA, Shalini VON BORSTEL, Reid, W D0KD6U DRUGTYPE Small molecular drug D0KD6U HIGHSTAT Patented D0KD6U COMPCLAS Benzoic acid derivatives D0KE8U DRUG__ID D0KE8U D0KE8U DRUGCOMP SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. CABRI, Walter MINETTI, Patrizia CAMPIANI, Giuseppe BUTINI, Stefania D0KE8U DRUGTYPE Small molecular drug D0KE8U HIGHSTAT Patented D0KE8U COMPCLAS Carbamate derivatives D0KH5D DRUG__ID D0KH5D D0KH5D DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITEGLAXOSMITHKLINE LLC AXTEN, Jeffrey, Michael GRANT, Seth, Wilson HEERDING, Dirk, A. MEDINA, Jesus, Raul ROMERIL, Stuart, Paul TANG, Jun D0KH5D DRUGTYPE Small molecular drug D0KH5D HIGHSTAT Patented D0KH5D COMPCLAS Indoline derivatives D0KI5F DRUG__ID D0KI5F D0KI5F DRUGCOMP MERCK SHARP & DOHME CORP. CHILDERS, Matthew L. FULLER, Peter H. GUERIN, David J. KATZ, Jason David MARTINEZ, Michelle PU, Qinglin SCOTT, Mark E. THOMPSON, Christopher F. CAI, Jiaqiang KONG, Norman LIU, Yumei D0KI5F DRUGTYPE Small molecular drug D0KI5F HIGHSTAT Patented D0KI5F COMPCLAS Geminally-substituted cyanoethylpypazolo pyridone derivatives D0KL3B DRUG__ID D0KL3B D0KL3B DRUGCOMP PFIZER INC D0KL3B DRUGTYPE Small molecular drug D0KL3B HIGHSTAT Patented D0KL3B COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0KM0T DRUG__ID D0KM0T D0KM0T DRUGCOMP Arena Pharmaceuticals, Inc D0KM0T DRUGTYPE Small molecular drug D0KM0T HIGHSTAT Patented D0KM0T COMPCLAS Pyrazole derivatives D0KN3S DRUG__ID D0KN3S D0KN3S DRUGCOMP Bristol-Myers Squibb Co D0KN3S DRUGTYPE Small molecular drug D0KN3S HIGHSTAT Patented D0KN3S COMPCLAS Carbamide derivatives D0KO2E DRUG__ID D0KO2E D0KO2E DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0KO2E DRUGTYPE Small molecular drug D0KO2E HIGHSTAT Patented D0KO2E COMPCLAS Heteroaryl-azepine derivatives D0KP0I DRUG__ID D0KP0I D0KP0I DRUGCOMP NOVARTIS AG AUBERSON, Yves BOCK, Mark Gary BRAGA, Dario CURZI, Marco DODD, Stephanie Kay GIAFFREDA, Stefano Luca JIANG, Haiyang KARPINSKI, Piotr TROXLER, Thomas J. WANG, Tielin WANG, Xiaoyang ZHANG, XuechuNOVARTIS AG D0KP0I DRUGTYPE Small molecular drug D0KP0I HIGHSTAT Patented D0KP0I COMPCLAS Piperazine carbamate/urea derivatives D0KR0I DRUG__ID D0KR0I D0KR0I DRUGCOMP THE JOHNS HOPKINS UNIVERSITY CASERO, Robert, A. BYTHEWAY, Ian WOSTER, Patrick, M D0KR0I DRUGTYPE Small molecular drug D0KR0I HIGHSTAT Patented D0KR0I COMPCLAS Benzenamine derivatives D0KS8Y DRUG__ID D0KS8Y D0KS8Y DRUGCOMP SHANGHAI FOCHON PHARMACEUTICAL CO LTD WANG, Weibo ZHAO, Xingdong LEI, Ming ZHANG, Huajie WANG, Longcheng ZHANG, Jian FANG, Bo LIU, Xia ZHOU, Zuwen D0KS8Y DRUGTYPE Small molecular drug D0KS8Y HIGHSTAT Patented D0KS8Y COMPCLAS Imidazo cyclohexylamine derivatives D0KV2U DRUG__ID D0KV2U D0KV2U DRUGCOMP JIANGSU HENGRUI MEDICINE CO., LTD D0KV2U DRUGTYPE Small molecular drug D0KV2U HIGHSTAT Patented D0KV2U COMPCLAS P-toluenesulfonate derivatives D0KX1A DRUG__ID D0KX1A D0KX1A DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0KX1A DRUGTYPE Carbohydrates D0KX1A HIGHSTAT Patented D0KX1A COMPCLAS Aryl mannoside derivatives D0KX5G DRUG__ID D0KX5G D0KX5G DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0KX5G DRUGTYPE Small molecular drug D0KX5G HIGHSTAT Patented D0KX5G COMPCLAS Imidazo bicyclic iminium derivatives D0KZ5Q DRUG__ID D0KZ5Q D0KZ5Q DRUGCOMP Pfizer Incorporated D0KZ5Q DRUGTYPE Small molecular drug D0KZ5Q HIGHSTAT Patented D0KZ5Q COMPCLAS Imidazo triazine derivatives D0KZ5T DRUG__ID D0KZ5T D0KZ5T DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED JOHNSON, Neil, W. KASPAREC, Jiri MILLER, William, Henry ROUSE, Meagan, B. SUAREZ, Dominic TIAN, Xinrong D0KZ5T DRUGTYPE Small molecular drug D0KZ5T HIGHSTAT Patented D0KZ5T COMPCLAS Cyclopropylamine derivatives D0L0MI DRUG__ID D0L0MI D0L0MI DRUGCOMP BAYER AG [DE] D0L0MI DRUGTYPE Small molecular drug D0L0MI HIGHSTAT Patented D0L0MI COMPCLAS Imidazotriazinone derivatives D0L1PO DRUG__ID D0L1PO D0L1PO DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0L1PO DRUGTYPE Carbohydrates D0L1PO HIGHSTAT Patented D0L1PO COMPCLAS Alkyl mannoside derivatives D0L2QZ DRUG__ID D0L2QZ D0L2QZ DRUGCOMP WASHINGTON UNIVERSITY D0L2QZ DRUGTYPE Carbohydrates D0L2QZ HIGHSTAT Patented D0L2QZ COMPCLAS Biphenyl mannoside derivatives D0L3BE DRUG__ID D0L3BE D0L3BE DRUGCOMP Academia Sinica (Taipei, TW), National Taiwan University (Taipei, TW) D0L3BE DRUGTYPE Small molecular drug D0L3BE HIGHSTAT Patented D0L3BE COMPCLAS Hexahydro naphthalene derivatives D0L3JL DRUG__ID D0L3JL D0L3JL DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0L3JL DRUGTYPE Carbohydrates D0L3JL HIGHSTAT Patented D0L3JL COMPCLAS Aryl mannoside derivatives D0L3RN DRUG__ID D0L3RN D0L3RN DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0L3RN DRUGTYPE Small molecular drug D0L3RN HIGHSTAT Patented D0L3RN COMPCLAS Epoxysuccinate derivatives D0L4UC DRUG__ID D0L4UC D0L4UC DRUGCOMP ARENA PHARMACEUTICALS, INC D0L4UC DRUGTYPE Small molecular drug D0L4UC HIGHSTAT Patented D0L4UC COMPCLAS Benzazepine derivatives D0L5EG DRUG__ID D0L5EG D0L5EG DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexande D0L5EG DRUGTYPE Small molecular drug D0L5EG HIGHSTAT Patented D0L5EG COMPCLAS Tricyclic indole compounds D0L6AM DRUG__ID D0L6AM D0L6AM DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael S. ERDEI, James Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0L6AM DRUGTYPE Small molecular drug D0L6AM HIGHSTAT Patented D0L6AM COMPCLAS Imidazo[5,1-c][1,2,4]benzotriazine derivatives D0L7HC DRUG__ID D0L7HC D0L7HC DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0L7HC DRUGTYPE Small molecular drug D0L7HC HIGHSTAT Patented D0L7HC COMPCLAS N-oxalyl-D-tyrosine derivatives D0L7OR DRUG__ID D0L7OR D0L7OR DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0L7OR DRUGTYPE Small molecular drug D0L7OR HIGHSTAT Patented D0L7OR COMPCLAS Diaminopyridine analogs D0L9FL DRUG__ID D0L9FL D0L9FL DRUGCOMP University Hefei Technology D0L9FL DRUGTYPE Small molecular drug D0L9FL HIGHSTAT Patented D0L9FL COMPCLAS Coumarin/resveratrol hybrid derivatives D0LB8Y DRUG__ID D0LB8Y D0LB8Y DRUGCOMP JANSSEN PHARMACEUTICA NV BREITENBUCHER, J., Guy KEITH, John, M. TICHENOR, Mark, S. CHAMBERS, Alison, L. JONES, William, M. HAWRYLUK, Natalie, A. TIMMONS, Amy, K. MERIT, Jeffrey, E. SEIERSTAD, Mark, JJanssen Pharmaceutica N.V D0LB8Y DRUGTYPE Small molecular drug D0LB8Y HIGHSTAT Patented D0LB8Y COMPCLAS Heteroaryl-substituted urea derivatives D0LH0O DRUG__ID D0LH0O D0LH0O DRUGCOMP CELLTECH R&D LIMITED DYKE, Hazel, Joan RICHARD, Marianna, Dilani HAUGHAN, Alan, Findlay SHARPE, Andrew D0LH0O DRUGTYPE Small molecular drug D0LH0O HIGHSTAT Patented D0LH0O COMPCLAS Carbamide derivatives D0LH6R DRUG__ID D0LH6R D0LH6R DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0LH6R DRUGTYPE Small molecular drug D0LH6R HIGHSTAT Patented D0LH6R COMPCLAS Imidazo bicyclic iminium derivatives D0LI6Z DRUG__ID D0LI6Z D0LI6Z DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0LI6Z DRUGTYPE Small molecular drug D0LI6Z HIGHSTAT Patented D0LI6Z COMPCLAS 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives D0LJ0M DRUG__ID D0LJ0M D0LJ0M DRUGCOMP the Shanghai Institute of Pharmaceutical Industry D0LJ0M DRUGTYPE Small molecular drug D0LJ0M HIGHSTAT Patented D0LJ0M COMPCLAS 2-cyclopropyl-4-substituted-phenoxy-quinoline derivatives D0LK8A DRUG__ID D0LK8A D0LK8A DRUGCOMP ORYZON GENOMICS SA [ES] D0LK8A DRUGTYPE Small molecular drug D0LK8A HIGHSTAT Patented D0LK8A COMPCLAS Heteroaryl-cyclopropylamine derivatives D0LL0X DRUG__ID D0LL0X D0LL0X DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D0LL0X DRUGTYPE Small molecular drug D0LL0X HIGHSTAT Patented D0LL0X COMPCLAS Pyrazole derivatives D0LN2J DRUG__ID D0LN2J D0LN2J DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0LN2J DRUGTYPE Small molecular drug D0LN2J HIGHSTAT Patented D0LN2J COMPCLAS Fused aryl carbocycle derivatives D0LR6D DRUG__ID D0LR6D D0LR6D DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED JOHNSON, Neil, W. KASPAREC, Jiri MILLER, William, Henry ROUSE, Meagan, B. SUAREZ, Dominic TIAN, Xinrong D0LR6D DRUGTYPE Small molecular drug D0LR6D HIGHSTAT Patented D0LR6D COMPCLAS Cyclopropylamine derivatives D0LR6J DRUG__ID D0LR6J D0LR6J DRUGCOMP CELLZOME LIMITED HOBSON, Andrew ADDISON, Glynn RAMSDEN, Nigel HARRISON, John D0LR6J DRUGTYPE Small molecular drug D0LR6J HIGHSTAT Patented D0LR6J COMPCLAS Bis-aminopyrimidine derivatives D0LR7Z DRUG__ID D0LR7Z D0LR7Z DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA UNIVERSITA DEGLI STUDI DI URBINO "CARLO BO&quoUNIVERSITA DEGLI STUDI DI PARMA PIOMELLI, Daniele CLAPPER, Jason, R. MORENO-SANZ, Guillermo DURANTI, Andrea TONTINI, Andrea MOR, Marco TARZIA, Giorgio D0LR7Z DRUGTYPE Small molecular drug D0LR7Z HIGHSTAT Patented D0LR7Z COMPCLAS Carbamate derivatives D0LU7U DRUG__ID D0LU7U D0LU7U DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0LU7U DRUGTYPE Small molecular drug D0LU7U HIGHSTAT Patented D0LU7U COMPCLAS N-oxalyl-D-tyrosine derivatives D0LV1G DRUG__ID D0LV1G D0LV1G DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0LV1G DRUGTYPE Small molecular drug D0LV1G HIGHSTAT Patented D0LV1G COMPCLAS Piperazinyl norbenzomorphane compounds D0LZ8I DRUG__ID D0LZ8I D0LZ8I DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D0LZ8I DRUGTYPE Small molecular drug D0LZ8I HIGHSTAT Patented D0LZ8I COMPCLAS Tetra-hydro-naphthalene derivatives D0M0WS DRUG__ID D0M0WS D0M0WS DRUGCOMP Nerviano Medical Sciences S.r.l D0M0WS DRUGTYPE Small molecular drug D0M0WS HIGHSTAT Patented D0M0WS COMPCLAS 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives D0M1RM DRUG__ID D0M1RM D0M1RM DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0M1RM DRUGTYPE Small molecular drug D0M1RM HIGHSTAT Patented D0M1RM COMPCLAS Heterocyclic-tetracyclic tetrahydrofuran derivatives D0M1UF DRUG__ID D0M1UF D0M1UF DRUGCOMP SHANGHAI INST PHARM INDUSTRY [CNCAI ZHENGYAN [CNZHOU WEICHENG [CNHAO QUN [CN D0M1UF DRUGTYPE Small molecular drug D0M1UF HIGHSTAT Patented D0M1UF COMPCLAS Aryl piperazine derivatives D0M2OK DRUG__ID D0M2OK D0M2OK DRUGCOMP CELLZOME LIMITED HARRISON, Richard John RAMSDEN, Nigel MAJOR, Jeremy MOREL, Adeline CONVERY, Laura SUNOSE, Mihiro LYNCH, Rosemary ADREGO, Rita JONES, Alison D0M2OK DRUGTYPE Small molecular drug D0M2OK HIGHSTAT Patented D0M2OK COMPCLAS Bis-aminopyrimidine derivatives D0M2WA DRUG__ID D0M2WA D0M2WA DRUGCOMP F. HOFFMANN-LA ROCHE AG HURLEY, Christopher KULAGOWSKI, Janusz ZAK, Mark D0M2WA DRUGTYPE Small molecular drug D0M2WA HIGHSTAT Patented D0M2WA COMPCLAS Tricyclic heterocycle derivatives D0M4RD DRUG__ID D0M4RD D0M4RD DRUGCOMP MERCK & CO., INC. LEYES, Aquiles, E D0M4RD DRUGTYPE Small molecular drug D0M4RD HIGHSTAT Patented D0M4RD COMPCLAS Crystalline anhydrous toluene derivatives D0M5AG DRUG__ID D0M5AG D0M5AG DRUGCOMP DEBIOPHARM SA [CHAURIGENE DISCOVERY TECH LTD [IN] D0M5AG DRUGTYPE Small molecular drug D0M5AG HIGHSTAT Patented D0M5AG COMPCLAS Aromatic bicyclic compounds D0M7XB DRUG__ID D0M7XB D0M7XB DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D0M7XB DRUGTYPE Carbohydrates D0M7XB HIGHSTAT Patented D0M7XB COMPCLAS Beta-cyclodextrin conjugate derivatives D0M8WO DRUG__ID D0M8WO D0M8WO DRUGCOMP RAQUALIA PHARMA INC. INOUE, Tadashi WATANABE, Shuzo YAMAGISHI, Tatsuya ARANO, Yoshimasa MORITA, Mikio SHIMADA, Kaoru D0M8WO DRUGTYPE Small molecular drug D0M8WO HIGHSTAT Patented D0M8WO COMPCLAS Aryl carboxamide derivatives D0M9YZ DRUG__ID D0M9YZ D0M9YZ DRUGCOMP DEBIOPHARM SA [CHAURIGENE DISCOVERY TECH LTD [IN] D0M9YZ DRUGTYPE Small molecular drug D0M9YZ HIGHSTAT Patented D0M9YZ COMPCLAS Aromatic bicyclic compounds D0MA2R DRUG__ID D0MA2R D0MA2R DRUGCOMP ALTANA PHARMA AG [DEALTANA PHARMA AG SCHMIDT, Beate WEINBRENNER, Steffen FLOCKERZI, Dieter KUELZER, Raimund TENOR, Hermann KLEY, Hans-Peter D0MA2R DRUGTYPE Small molecular drug D0MA2R HIGHSTAT Patented D0MA2R COMPCLAS Triazolo-phthalazine derivatives D0MH7K DRUG__ID D0MH7K D0MH7K DRUGCOMP MSD K.K. ARAKAWA, Keisuke ITO, Yoshiki KAWAMOTO, Hiroshi SAKAKI, Junichi SHIMAMURA, Tadashi D0MH7K DRUGTYPE Small molecular drug D0MH7K HIGHSTAT Patented D0MH7K COMPCLAS Pyrimidine-4(3H)-one derivatives D0MK2F DRUG__ID D0MK2F D0MK2F DRUGCOMP Aurigene Discovery Technologies Limited D0MK2F DRUGTYPE Small molecule immunotherapy D0MK2F HIGHSTAT Patented D0MK2F COMPCLAS Macrocycle derivatives D0MK7X DRUG__ID D0MK7X D0MK7X DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael S. ERDEI, James Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0MK7X DRUGTYPE Small molecular drug D0MK7X HIGHSTAT Patented D0MK7X COMPCLAS Imidazo[5,1-c][1,2,4]benzotriazine derivatives D0MO0Z DRUG__ID D0MO0Z D0MO0Z DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0MO0Z DRUGTYPE Carbohydrates D0MO0Z HIGHSTAT Patented D0MO0Z COMPCLAS Alkyl mannoside derivatives D0MP4W DRUG__ID D0MP4W D0MP4W DRUGCOMP LUPIN LIMITED D0MP4W DRUGTYPE Small molecular drug D0MP4W HIGHSTAT Patented D0MP4W COMPCLAS Tetra-hydro-quinoline derivatives D0MQ7F DRUG__ID D0MQ7F D0MQ7F DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0MQ7F DRUGTYPE Small molecular drug D0MQ7F HIGHSTAT Patented D0MQ7F COMPCLAS Heteroaryl-azepine derivatives D0MS7G DRUG__ID D0MS7G D0MS7G DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED ASTEX THERAPEUTICS LIMITED D0MS7G DRUGTYPE Small molecular drug D0MS7G HIGHSTAT Patented D0MS7G COMPCLAS 3-phenyl propanoic derivatives D0MV3E DRUG__ID D0MV3E D0MV3E DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0MV3E DRUGTYPE Small molecular drug D0MV3E HIGHSTAT Patented D0MV3E COMPCLAS Aryl pyrimidine derivatives D0MX7B DRUG__ID D0MX7B D0MX7B DRUGCOMP ASTELLAS PHARMA INC. KOTOBUKI PHARMACEUTICAL CO., LTD. SHIMADA, Itsuro MATSUYA, Takahiro KUROSAWA, Kazuo IIKUBO, Kazuhiko KAMIKAWA, Akio KUROMITSU, Sadao SHINDOU, Nobuaki D0MX7B DRUGTYPE Small molecular drug D0MX7B HIGHSTAT Patented D0MX7B COMPCLAS Carboxamide derivatives D0N0YE DRUG__ID D0N0YE D0N0YE DRUGCOMP MEDSHINE DISCOVERY INC D0N0YE DRUGTYPE Small molecular drug D0N0YE HIGHSTAT Patented D0N0YE COMPCLAS Isoquinoline sulfonamide derivatives D0N2AI DRUG__ID D0N2AI D0N2AI DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0N2AI DRUGTYPE Carbohydrates D0N2AI HIGHSTAT Patented D0N2AI COMPCLAS Biphenyl mannoside derivatives D0N4TO DRUG__ID D0N4TO D0N4TO DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0N4TO DRUGTYPE Carbohydrates D0N4TO HIGHSTAT Patented D0N4TO COMPCLAS Biphenyl mannoside derivatives D0N4TZ DRUG__ID D0N4TZ D0N4TZ DRUGCOMP BRISTOL-MYERS SQUIBB COMPANBristol-Myers Squibb Company D0N4TZ DRUGTYPE Small molecule immunotherapy D0N4TZ HIGHSTAT Patented D0N4TZ COMPCLAS Macrocycle derivatives D0N4ZM DRUG__ID D0N4ZM D0N4ZM DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0N4ZM DRUGTYPE Small molecular drug D0N4ZM HIGHSTAT Patented D0N4ZM COMPCLAS Amidopyrazole derivatives D0N5WE DRUG__ID D0N5WE D0N5WE DRUGCOMP BIOGEN MA INC D0N5WE DRUGTYPE Small molecular drug D0N5WE HIGHSTAT Patented D0N5WE COMPCLAS Macrolactam derivatives D0N6NA DRUG__ID D0N6NA D0N6NA DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0N6NA DRUGTYPE Small molecule immunotherapy D0N6NA HIGHSTAT Patented D0N6NA COMPCLAS 1,3,4-thiadiazole derivatives D0N8PF DRUG__ID D0N8PF D0N8PF DRUGCOMP Arena Pharmaceuticals, Inc D0N8PF DRUGTYPE Small molecular drug D0N8PF HIGHSTAT Patented D0N8PF COMPCLAS Pyrazole derivatives D0NA2Q DRUG__ID D0NA2Q D0NA2Q DRUGCOMP JANSSEN PHARMACEUTICA NV D0NA2Q DRUGTYPE Small molecular drug D0NA2Q HIGHSTAT Patented D0NA2Q COMPCLAS Indoline derivatives D0NB5P DRUG__ID D0NB5P D0NB5P DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0NB5P DRUGTYPE Carbohydrates D0NB5P HIGHSTAT Patented D0NB5P COMPCLAS Biphenyl mannoside derivatives D0NB7Y DRUG__ID D0NB7Y D0NB7Y DRUGCOMP CENTRE NAT RECH SCIENT [FR D0NB7Y DRUGTYPE Small molecular drug D0NB7Y HIGHSTAT Patented D0NB7Y COMPCLAS Pyrazolo[1,5-a]-1,3,5-triazine derivatives D0NF3Y DRUG__ID D0NF3Y D0NF3Y DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0NF3Y DRUGTYPE Small molecular drug D0NF3Y HIGHSTAT Patented D0NF3Y COMPCLAS Tricyclic indole compounds D0NG2F DRUG__ID D0NG2F D0NG2F DRUGCOMP STEM CELLS FOR SAFER MEDICINES LIMITED BONE, Heather Karyn TOSH, David WELHAM, Melanie Joanne D0NG2F DRUGTYPE Small molecular drug D0NG2F HIGHSTAT Patented D0NG2F COMPCLAS Maleimides derivatives D0NI2B DRUG__ID D0NI2B D0NI2B DRUGCOMP BRISTOL-MYERS SQUIBB COMPANBristol-Myers Squibb Company D0NI2B DRUGTYPE Small molecule immunotherapy D0NI2B HIGHSTAT Patented D0NI2B COMPCLAS Macrocycle derivatives D0NJ6B DRUG__ID D0NJ6B D0NJ6B DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED JOHNSON, Neil, W. KASPAREC, Jiri MILLER, William, Henry ROUSE, Meagan, B. SUAREZ, Dominic TIAN, Xinrong D0NJ6B DRUGTYPE Small molecular drug D0NJ6B HIGHSTAT Patented D0NJ6B COMPCLAS Cyclopropylamine derivatives D0NK4T DRUG__ID D0NK4T D0NK4T DRUGCOMP PFIZER INC D0NK4T DRUGTYPE Small molecular drug D0NK4T HIGHSTAT Patented D0NK4T COMPCLAS Carbamate derivatives D0NK9Y DRUG__ID D0NK9Y D0NK9Y DRUGCOMP CELLTECH R&D LIMITED HAUGHAN, Alan, Findlay BUCKLEY, George, Martin DAVIES, Natasha DYKE, Hazel, Joan HANNAH, Duncan, Robert MORGAN, Trevor RICHARD, Marianna, Dilani SHARPE, Andrew WILLIAMS, Sophie, Caroline D0NK9Y DRUGTYPE Small molecular drug D0NK9Y HIGHSTAT Patented D0NK9Y COMPCLAS Quinazolinone derivatives D0NT8U DRUG__ID D0NT8U D0NT8U DRUGCOMP MERCK SERONO S.A. JORAND-LEBRUN, Catherine CROSIGNANI, Stefano DORBAIS, Jerome GRIPPI-VALLOTTON, Tania PRETRE, Adeline D0NT8U DRUGTYPE Small molecular drug D0NT8U HIGHSTAT Patented D0NT8U COMPCLAS Indazoletriazolephenyl derivatives D0O0DJ DRUG__ID D0O0DJ D0O0DJ DRUGCOMP MERCK SHARP & DOHME CORP. DEMONG, Duane, E. MILLER, Michael, W. DAI, Xing WONG, Michael, K. LAVEY, Brian, J. YU, Wensheng ZHOU, Guowei STAMFORD, Andrew, W. KOZLOWSKI, Joseph, A. GREENLEE, William, J. ZHAO, He CHEN, Ping LIN, Peishan DAI, Peng DAVIS, Jason Louis D0O0DJ DRUGTYPE Small molecular drug D0O0DJ HIGHSTAT Patented D0O0DJ COMPCLAS Spiroimidazolone derivatives D0O6GQ DRUG__ID D0O6GQ D0O6GQ DRUGCOMP MERCK SERONO S.A. JORAND-LEBRUN, Catherine CROSIGNANI, Stefano DORBAIS, Jerome GRIPPI-VALLOTTON, Tania PRETRE, Adeline D0O6GQ DRUGTYPE Small molecular drug D0O6GQ HIGHSTAT Patented D0O6GQ COMPCLAS Indazoletriazolephenyl derivatives D0O6SK DRUG__ID D0O6SK D0O6SK DRUGCOMP SHANGHAI FOCHON PHARMACEUTICAL CO LTD WANG, Weibo ZHAO, Xingdong YUAN, Quan LIU, Caiping LUO, Lian SHI, Hailong ZOU, Chunlan YAN, Chengyi D0O6SK DRUGTYPE Small molecular drug D0O6SK HIGHSTAT Patented D0O6SK COMPCLAS Triazolo-pyrimidinedione derivatives D0O7IH DRUG__ID D0O7IH D0O7IH DRUGCOMP UNIV ROMA [ITFOND IEO [ITUNIV PAVIA [ITUNIV DEGLI STUDI MILANO [ITMINUCCI SAVERIO [ITMAI ANTONELLO [ITMATTEVI ANDREA [IT] D0O7IH DRUGTYPE Small molecular drug D0O7IH HIGHSTAT Patented D0O7IH COMPCLAS Tarnylcypromine derivatives D0O8DL DRUG__ID D0O8DL D0O8DL DRUGCOMP Evotec D0O8DL DRUGTYPE Small molecular drug D0O8DL HIGHSTAT Patented D0O8DL COMPCLAS Dihydroisoquinoline carboxamide analogs D0O8FI DRUG__ID D0O8FI D0O8FI DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0O8FI DRUGTYPE Small molecule immunotherapy D0O8FI HIGHSTAT Patented D0O8FI COMPCLAS 1,3-dihydroxy phenyl derivatives D0O8MJ DRUG__ID D0O8MJ D0O8MJ DRUGCOMP CHDI FOUNDATION, INC D0O8MJ DRUGTYPE Small molecular drug D0O8MJ HIGHSTAT Patented D0O8MJ COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0O8RZ DRUG__ID D0O8RZ D0O8RZ DRUGCOMP KBP BIOSCIENCES CO., LTD D0O8RZ DRUGTYPE Small molecular drug D0O8RZ HIGHSTAT Patented D0O8RZ COMPCLAS Indoline derivatives D0O9DS DRUG__ID D0O9DS D0O9DS DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D0O9DS DRUGTYPE Small molecular drug D0O9DS HIGHSTAT Patented D0O9DS COMPCLAS Pyrazole derivatives D0O9FC DRUG__ID D0O9FC D0O9FC DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0O9FC DRUGTYPE Small molecular drug D0O9FC HIGHSTAT Patented D0O9FC COMPCLAS 4-Carboxamido-isoindolinone derivatives D0O9IS DRUG__ID D0O9IS D0O9IS DRUGCOMP CHDI FOUNDATION, INC D0O9IS DRUGTYPE Small molecular drug D0O9IS HIGHSTAT Patented D0O9IS COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0O9JD DRUG__ID D0O9JD D0O9JD DRUGCOMP Chugai Pharmaceutical D0O9JD DRUGTYPE Small molecular drug D0O9JD HIGHSTAT Patented D0O9JD COMPCLAS Benzo(b)carbazol-11-one compounds D0O9WS DRUG__ID D0O9WS D0O9WS DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0O9WS DRUGTYPE Small molecular drug D0O9WS HIGHSTAT Patented D0O9WS COMPCLAS Pyridine-2,4-dicarboxylic acid analogs D0OA6W DRUG__ID D0OA6W D0OA6W DRUGCOMP ARENA PHARMACEUTICALS, INC D0OA6W DRUGTYPE Small molecular drug D0OA6W HIGHSTAT Patented D0OA6W COMPCLAS Aryl piperazine derivatives D0OB0Q DRUG__ID D0OB0Q D0OB0Q DRUGCOMP COCENSYS, INC D0OB0Q DRUGTYPE Small molecular drug D0OB0Q HIGHSTAT Patented D0OB0Q COMPCLAS Quinoline carboxamide derivatives D0OC1S DRUG__ID D0OC1S D0OC1S DRUGCOMP PFIZER PRODUCTS INC. BEYER, Thomas, Arthur CHAMBERS, Robert, James LAM, Kelvin LI, Mei MORRELL, Andrew, Ian THOMPSON, David, Duane D0OC1S DRUGTYPE Small molecular drug D0OC1S HIGHSTAT Patented D0OC1S COMPCLAS Pyrido[2,3-d]pyrimidine-2,4-diamine derivatives D0OI2F DRUG__ID D0OI2F D0OI2F DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0OI2F DRUGTYPE Small molecular drug D0OI2F HIGHSTAT Patented D0OI2F COMPCLAS Epoxysuccinate derivatives D0OK3K DRUG__ID D0OK3K D0OK3K DRUGCOMP JANSSEN PHARMACEUTICA NV D0OK3K DRUGTYPE Small molecular drug D0OK3K HIGHSTAT Patented D0OK3K COMPCLAS Azetidinyl-piperazine derivatives D0OM6D DRUG__ID D0OM6D D0OM6D DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0OM6D DRUGTYPE Small molecular drug D0OM6D HIGHSTAT Patented D0OM6D COMPCLAS Pyrimidine benzenesulfonamide derivatives D0OP5F DRUG__ID D0OP5F D0OP5F DRUGCOMP RAQUALIA PHARMA INC. INOUE, Tadashi WATANABE, Shuzo YAMAGISHI, Tatsuya ARANO, Yoshimasa MORITA, Mikio SHIMADA, Kaoru D0OP5F DRUGTYPE Small molecular drug D0OP5F HIGHSTAT Patented D0OP5F COMPCLAS Aryl carboxamide derivatives D0OQ2R DRUG__ID D0OQ2R D0OQ2R DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0OQ2R DRUGTYPE Carbohydrates D0OQ2R HIGHSTAT Patented D0OQ2R COMPCLAS Mannoside derivatives D0OR0K DRUG__ID D0OR0K D0OR0K DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0OR0K DRUGTYPE Small molecular drug D0OR0K HIGHSTAT Patented D0OR0K COMPCLAS Pyridine-2,4-dicarboxylic acid analogs D0OS9O DRUG__ID D0OS9O D0OS9O DRUGCOMP MEDSHINE DISCOVERY INC D0OS9O DRUGTYPE Small molecular drug D0OS9O HIGHSTAT Patented D0OS9O COMPCLAS Isoquinoline sulfonamide derivatives D0OT3G DRUG__ID D0OT3G D0OT3G DRUGCOMP MITSUBISHI TANABE PHARMA CORPORATION TANIMOTO, Koichi OI, Mariko TSUBOI, Yasunori MORITANI, Yasunor D0OT3G DRUGTYPE Small molecular drug D0OT3G HIGHSTAT Patented D0OT3G COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0OW1V DRUG__ID D0OW1V D0OW1V DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0OW1V DRUGTYPE Carbohydrates D0OW1V HIGHSTAT Patented D0OW1V COMPCLAS Biaryl mannoside derivatives D0OX5S DRUG__ID D0OX5S D0OX5S DRUGCOMP MERCK SHARP & DOHME CORP. HO, Ginny, D. TULSHIAN, Deen HEAP, Charles, R D0OX5S DRUGTYPE Small molecular drug D0OX5S HIGHSTAT Patented D0OX5S COMPCLAS Cyclopropyl-spiro piperidine derivatives D0P1AH DRUG__ID D0P1AH D0P1AH DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0P1AH DRUGTYPE Small molecular drug D0P1AH HIGHSTAT Patented D0P1AH COMPCLAS Pyrrolo-pyrimidine derivatives D0P1VT DRUG__ID D0P1VT D0P1VT DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH ENGELHARDT, Harald BOEHMELT, Guido KOFINK, Christiane KUHN, Daniel McCONNELL, Darryl STADTMUELLER, Heinz D0P1VT DRUGTYPE Small molecular drug D0P1VT HIGHSTAT Patented D0P1VT COMPCLAS Pyrimidinone derivatives D0P3MU DRUG__ID D0P3MU D0P3MU DRUGCOMP INFINITY PHARMACEUTICALS, INC BEHNKE, Mark, L. CASTRO, Alfredo, C. EVANS, Catherine, A. GRENIER, Louis GROGAN, Michael, J. LIU, Tao SNYDER, Daniel, A. TIBBITTS, Thomas, T D0P3MU DRUGTYPE Small molecular drug D0P3MU HIGHSTAT Patented D0P3MU COMPCLAS Boronic acid derivatives D0P5MY DRUG__ID D0P5MY D0P5MY DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0P5MY DRUGTYPE Small molecular drug D0P5MY HIGHSTAT Patented D0P5MY COMPCLAS N-oxalyl-D-tyrosine derivatives D0P6WN DRUG__ID D0P6WN D0P6WN DRUGCOMP CELLTECH R&D LIMITED DYKE, Hazel, Joan RICHARD, Marianna, Dilani HAUGHAN, Alan, Findlay SHARPE, Andrew D0P6WN DRUGTYPE Small molecular drug D0P6WN HIGHSTAT Patented D0P6WN COMPCLAS Carbamide derivatives D0P7QA DRUG__ID D0P7QA D0P7QA DRUGCOMP 7TM PHARMA A/S COOPER, Martin RECEVEUR, Jean-Marie HOEGBERG, Thomas NIELSEN, Peter, Aadal LINGET, Jean-Michel NOEREGAARD, Pia, Karina D0P7QA DRUGTYPE Small molecular drug D0P7QA HIGHSTAT Patented D0P7QA COMPCLAS Pyrazole derivatives D0P7ZY DRUG__ID D0P7ZY D0P7ZY DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0P7ZY DRUGTYPE Small molecular drug D0P7ZY HIGHSTAT Patented D0P7ZY COMPCLAS N-oxalyl-D-tyrosine derivatives D0P8PE DRUG__ID D0P8PE D0P8PE DRUGCOMP ZENITH EPIGENETICS CORP D0P8PE DRUGTYPE Small molecular drug D0P8PE HIGHSTAT Patented D0P8PE COMPCLAS Isoxazole-based bicyclic compounds D0PB5X DRUG__ID D0PB5X D0PB5X DRUGCOMP MERCK SHARP & DOHME CORP. CHILDERS, Matthew Lloyd DINSMORE, Christopher FULLER, Peter GUERIN, David KATZ, Jason David PU, Qinglin SCOTT, Mark E. THOMPSON, Christopher F. ZHANG, Hongjun FALCONE, Danielle TORRES, Luis BRUBAKER, Jason ZENG, Hongbo CAI, Jiaqiang DU, Xiaoxing WANG, Chonggang BAI, Yunfeng KONG, Norman LIU, Yumei ZHENG, Zhixiang D0PB5X DRUGTYPE Small molecular drug D0PB5X HIGHSTAT Patented D0PB5X COMPCLAS Cycloalkyl nitrile pyrazolo pyridone derivatives D0PE1K DRUG__ID D0PE1K D0PE1K DRUGCOMP COCENSYS, INC D0PE1K DRUGTYPE Small molecular drug D0PE1K HIGHSTAT Patented D0PE1K COMPCLAS Quinoline carboxamide derivatives D0PI7V DRUG__ID D0PI7V D0PI7V DRUGCOMP CHDI FOUNDATION, INC D0PI7V DRUGTYPE Small molecular drug D0PI7V HIGHSTAT Patented D0PI7V COMPCLAS Cyclopropane 1-carboxylic acid derivatives D0PJ7M DRUG__ID D0PJ7M D0PJ7M DRUGCOMP GLAXOSMITHKLINE LLC AXTEN, Jeffrey, Michael BRADY, Gerald, Patrick, Jr. GALLAGHER, Timothy, Francis HEERDING, Dirk, A. MEDINA, Jesus, Raul ROMERIL, Stuart, Paul D0PJ7M DRUGTYPE Small molecular drug D0PJ7M HIGHSTAT Patented D0PJ7M COMPCLAS 1,2-dihydroindazolo[4,3-bc][1,5]benzoxazepine derivatives D0PM4N DRUG__ID D0PM4N D0PM4N DRUGCOMP SHANGHAI FOCHON PHARMACEUTICAL CO LTD WANG, Weibo ZHAO, Xingdong YUAN, Quan LIU, Caiping LUO, Lian SHI, Hailong ZOU, Chunlan YAN, Chengyi D0PM4N DRUGTYPE Small molecular drug D0PM4N HIGHSTAT Patented D0PM4N COMPCLAS Triazolo-pyrimidinedione derivatives D0PP8O DRUG__ID D0PP8O D0PP8O DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael, S. ERDEI, James, Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0PP8O DRUGTYPE Small molecular drug D0PP8O HIGHSTAT Patented D0PP8O COMPCLAS Imidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine derivatives D0Q4OB DRUG__ID D0Q4OB D0Q4OB DRUGCOMP PFIZER INC D0Q4OB DRUGTYPE Small molecular drug D0Q4OB HIGHSTAT Patented D0Q4OB COMPCLAS Carbamate derivatives D0Q4XV DRUG__ID D0Q4XV D0Q4XV DRUGCOMP ORIBASE PHARMA D0Q4XV DRUGTYPE Small molecular drug D0Q4XV HIGHSTAT Patented D0Q4XV COMPCLAS Indoline derivatives D0Q5JO DRUG__ID D0Q5JO D0Q5JO DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0Q5JO DRUGTYPE Small molecular drug D0Q5JO HIGHSTAT Patented D0Q5JO COMPCLAS Tricyclic indole compounds D0Q5JV DRUG__ID D0Q5JV D0Q5JV DRUGCOMP DEBIOPHARM SA [CHAURIGENE DISCOVERY TECH LTD [IN] D0Q5JV DRUGTYPE Small molecular drug D0Q5JV HIGHSTAT Patented D0Q5JV COMPCLAS Aromatic bicyclic compounds D0Q6VL DRUG__ID D0Q6VL D0Q6VL DRUGCOMP PFIZER INC D0Q6VL DRUGTYPE Small molecular drug D0Q6VL HIGHSTAT Patented D0Q6VL COMPCLAS Pyrrolo-pyridazine derivatives D0Q7QK DRUG__ID D0Q7QK D0Q7QK DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0Q7QK DRUGTYPE Carbohydrates D0Q7QK HIGHSTAT Patented D0Q7QK COMPCLAS Mannoside derivatives D0Q7ZF DRUG__ID D0Q7ZF D0Q7ZF DRUGCOMP BIOGEN MA INC D0Q7ZF DRUGTYPE Small molecular drug D0Q7ZF HIGHSTAT Patented D0Q7ZF COMPCLAS Macrolactam derivatives D0Q8JZ DRUG__ID D0Q8JZ D0Q8JZ DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED ASTEX THERAPEUTICS LIMITED D0Q8JZ DRUGTYPE Small molecular drug D0Q8JZ HIGHSTAT Patented D0Q8JZ COMPCLAS 3-phenyl propanoic derivatives D0Q9AD DRUG__ID D0Q9AD D0Q9AD DRUGCOMP RESEARCH TRIANGLE INSTITUTE FULP, Alan Bradley MAITRA, Rangan ZHANG, Yanan SELTZMAN, Herbert H D0Q9AD DRUGTYPE Small molecular drug D0Q9AD HIGHSTAT Patented D0Q9AD COMPCLAS Pyrazole derivatives D0QA4O DRUG__ID D0QA4O D0QA4O DRUGCOMP ZENITH EPIGENETICS CORP D0QA4O DRUGTYPE Small molecular drug D0QA4O HIGHSTAT Patented D0QA4O COMPCLAS Isoxazole-based bicyclic compounds D0QE7X DRUG__ID D0QE7X D0QE7X DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0QE7X DRUGTYPE Small molecular drug D0QE7X HIGHSTAT Patented D0QE7X COMPCLAS 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives D0QF4W DRUG__ID D0QF4W D0QF4W DRUGCOMP BRISTOL-MYERS SQUIBB COMPANBristol-Myers Squibb Company D0QF4W DRUGTYPE Small molecule immunotherapy D0QF4W HIGHSTAT Patented D0QF4W COMPCLAS Macrocycle derivatives D0QI8G DRUG__ID D0QI8G D0QI8G DRUGCOMP STANGE, Hans LANGEN, Barbara EGERLAND, Ute HOEFGEN, Norbert PRIEBS, Martina MALAMAS, Michael S. ERDEI, James Joseph NI, Yike BIOTIE THERAPIES GMBH WYETH D0QI8G DRUGTYPE Small molecular drug D0QI8G HIGHSTAT Patented D0QI8G COMPCLAS Imidazo[5,1-c][1,2,4]benzotriazine derivatives D0QK7K DRUG__ID D0QK7K D0QK7K DRUGCOMP CONSEJO SUPERIOR INVESTIGACION [ES] D0QK7K DRUGTYPE Small molecular drug D0QK7K HIGHSTAT Patented D0QK7K COMPCLAS Oxindole derivatives D0QL0X DRUG__ID D0QL0X D0QL0X DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0QL0X DRUGTYPE Carbohydrates D0QL0X HIGHSTAT Patented D0QL0X COMPCLAS Biaryl mannoside derivatives D0QM9Q DRUG__ID D0QM9Q D0QM9Q DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0QM9Q DRUGTYPE Small molecular drug D0QM9Q HIGHSTAT Patented D0QM9Q COMPCLAS Cyclohexane carboxamide derivatives D0QN7I DRUG__ID D0QN7I D0QN7I DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D0QN7I DRUGTYPE Small molecular drug D0QN7I HIGHSTAT Patented D0QN7I COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D0QQ5W DRUG__ID D0QQ5W D0QQ5W DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D0QQ5W DRUGTYPE Carbohydrates D0QQ5W HIGHSTAT Patented D0QQ5W COMPCLAS Beta-cyclodextrin conjugate derivatives D0QV0P DRUG__ID D0QV0P D0QV0P DRUGCOMP RICHTER GEDEON NYRT D0QV0P DRUGTYPE Small molecular drug D0QV0P HIGHSTAT Patented D0QV0P COMPCLAS Phenoxypiperidine derivatives D0QY6M DRUG__ID D0QY6M D0QY6M DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0QY6M DRUGTYPE Small molecular drug D0QY6M HIGHSTAT Patented D0QY6M COMPCLAS Pyrrolo-pyridinone derivatives D0R0OA DRUG__ID D0R0OA D0R0OA DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0R0OA DRUGTYPE Small molecular drug D0R0OA HIGHSTAT Patented D0R0OA COMPCLAS Tricyclic indole compounds D0R0PO DRUG__ID D0R0PO D0R0PO DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0R0PO DRUGTYPE Small molecular drug D0R0PO HIGHSTAT Patented D0R0PO COMPCLAS 4-Carboxamido-isoindolinone derivatives D0R0QY DRUG__ID D0R0QY D0R0QY DRUGCOMP EMCURE PHARMACEUTICALS LIMITED D0R0QY DRUGTYPE Small molecular drug D0R0QY HIGHSTAT Patented D0R0QY COMPCLAS Pyrrolo[1,2-c]pyrazole derivatives D0R1GD DRUG__ID D0R1GD D0R1GD DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0R1GD DRUGTYPE Carbohydrates D0R1GD HIGHSTAT Patented D0R1GD COMPCLAS Aryl mannoside derivatives D0R1OG DRUG__ID D0R1OG D0R1OG DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0R1OG DRUGTYPE Small molecular drug D0R1OG HIGHSTAT Patented D0R1OG COMPCLAS 2,2-bipyridyl derivatives D0R1PX DRUG__ID D0R1PX D0R1PX DRUGCOMP MERCK & CO., INC. DEBENHAM, John, S. HALE, Jeffrey, J. HUO, Pei MADSEN-DUGGAN, Christina, B. WALSH, Thomas, F. YAN, Li D0R1PX DRUGTYPE Small molecular drug D0R1PX HIGHSTAT Patented D0R1PX COMPCLAS Pyrano[2,3-b]pyridine derivatives D0R1QI DRUG__ID D0R1QI D0R1QI DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0R1QI DRUGTYPE Small molecular drug D0R1QI HIGHSTAT Patented D0R1QI COMPCLAS Aryl azepine derivatives D0R1SQ DRUG__ID D0R1SQ D0R1SQ DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0R1SQ DRUGTYPE Carbohydrates D0R1SQ HIGHSTAT Patented D0R1SQ COMPCLAS Biaryl mannoside derivatives D0R2GA DRUG__ID D0R2GA D0R2GA DRUGCOMP WASHINGTON UNIVERSITY D0R2GA DRUGTYPE Carbohydrates D0R2GA HIGHSTAT Patented D0R2GA COMPCLAS Biaryl mannoside derivatives D0R2YA DRUG__ID D0R2YA D0R2YA DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0R2YA DRUGTYPE Small molecular drug D0R2YA HIGHSTAT Patented D0R2YA COMPCLAS Cyclopropylamine derivatives D0R3WH DRUG__ID D0R3WH D0R3WH DRUGCOMP MERCK SHARP &amDOHME CORP. GRAHAM, Thomas, H. SHEN, Dong-Ming SHU, Min D0R3WH DRUGTYPE Small molecular drug D0R3WH HIGHSTAT Patented D0R3WH COMPCLAS Piperidinyl pyrazole derivatives D0R5DH DRUG__ID D0R5DH D0R5DH DRUGCOMP Yuanqiang Z D0R5DH DRUGTYPE Small molecular drug D0R5DH HIGHSTAT Patented D0R5DH COMPCLAS Triazole propanedioic acid derivatives D0R6EF DRUG__ID D0R6EF D0R6EF DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0R6EF DRUGTYPE Small molecular drug D0R6EF HIGHSTAT Patented D0R6EF COMPCLAS Heteroaryl-azepine derivatives D0R6FO DRUG__ID D0R6FO D0R6FO DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0R6FO DRUGTYPE Carbohydrates D0R6FO HIGHSTAT Patented D0R6FO COMPCLAS Aryl mannoside derivatives D0R6HF DRUG__ID D0R6HF D0R6HF DRUGCOMP Arena Pharmaceuticals, Inc D0R6HF DRUGTYPE Small molecular drug D0R6HF HIGHSTAT Patented D0R6HF COMPCLAS Pyrazole derivatives D0R7CP DRUG__ID D0R7CP D0R7CP DRUGCOMP INST OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCES [CN] D0R7CP DRUGTYPE Small molecule immunotherapy D0R7CP HIGHSTAT Patented D0R7CP COMPCLAS Bromo benzyl ether derivatives D0R7JW DRUG__ID D0R7JW D0R7JW DRUGCOMP BRISTOL-MYERS SQUIBB COMPANBristol-Myers Squibb Company D0R7JW DRUGTYPE Small molecule immunotherapy D0R7JW HIGHSTAT Patented D0R7JW COMPCLAS Macrocycle derivatives D0R7RY DRUG__ID D0R7RY D0R7RY DRUGCOMP Incyte Corporation, USA D0R7RY DRUGTYPE Small molecular drug D0R7RY HIGHSTAT Patented D0R7RY COMPCLAS Cyclopropylamine derivatives D0R7YN DRUG__ID D0R7YN D0R7YN DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0R7YN DRUGTYPE Carbohydrates D0R7YN HIGHSTAT Patented D0R7YN COMPCLAS Mannoside derivatives D0R8DW DRUG__ID D0R8DW D0R8DW DRUGCOMP Array BioPharma D0R8DW DRUGTYPE Small molecular drug D0R8DW HIGHSTAT Patented D0R8DW COMPCLAS Benzoimidazole derivatives D0RA7I DRUG__ID D0RA7I D0RA7I DRUGCOMP CURADEV PHARMA PRIVATE LTDCuradev Pharma Private Ltd D0RA7I DRUGTYPE Small molecular drug D0RA7I HIGHSTAT Patented D0RA7I COMPCLAS 2,3-diamino-benzo[b]thiophene derivatives D0RC4W DRUG__ID D0RC4W D0RC4W DRUGCOMP DAINIPPON SUMITOMO PHARMA CO [JP] D0RC4W DRUGTYPE Small molecular drug D0RC4W HIGHSTAT Patented D0RC4W COMPCLAS Bicyclic pyrimidine derivatives D0RE0F DRUG__ID D0RE0F D0RE0F DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, CorinnTHE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0RE0F DRUGTYPE Carbohydrates D0RE0F HIGHSTAT Patented D0RE0F COMPCLAS Biphenyl mannoside derivatives D0RE1D DRUG__ID D0RE1D D0RE1D DRUGCOMP ISIS INNOVATION LIMITED LOWE, Gordon D0RE1D DRUGTYPE Small molecular drug D0RE1D HIGHSTAT Patented D0RE1D COMPCLAS Terpyridineplatinum(II) complexes D0RG1Z DRUG__ID D0RG1Z D0RG1Z DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0RG1Z DRUGTYPE Carbohydrates D0RG1Z HIGHSTAT Patented D0RG1Z COMPCLAS Biaryl mannoside derivatives D0RK1R DRUG__ID D0RK1R D0RK1R DRUGCOMP Kissei Pharmaceutical Co. Ltd D0RK1R DRUGTYPE Small molecular drug D0RK1R HIGHSTAT Patented D0RK1R COMPCLAS Azaindole derivatives D0RK3P DRUG__ID D0RK3P D0RK3P DRUGCOMP UNIVERSITY OF SUNDERLAND D0RK3P DRUGTYPE Small molecular drug D0RK3P HIGHSTAT Patented D0RK3P COMPCLAS Bis-sulfonamide derivatives D0RK4V DRUG__ID D0RK4V D0RK4V DRUGCOMP UANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD [CN] D0RK4V DRUGTYPE Small molecule immunotherapy D0RK4V HIGHSTAT Patented D0RK4V COMPCLAS Aromatic acetylene derivatives D0RS2J DRUG__ID D0RS2J D0RS2J DRUGCOMP UNIVERSITE DE LILLE 2 DROIT ET SANTE CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (CHRU) D0RS2J DRUGTYPE Small molecular drug D0RS2J HIGHSTAT Patented D0RS2J COMPCLAS Benzamide derivatives D0RT5D DRUG__ID D0RT5D D0RT5D DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0RT5D DRUGTYPE Small molecular drug D0RT5D HIGHSTAT Patented D0RT5D COMPCLAS Tricyclic indole compounds D0RW8J DRUG__ID D0RW8J D0RW8J DRUGCOMP the Shanghai Institute of Technology and the Shanghai Ecust Biomedicine Company D0RW8J DRUGTYPE Small molecular drug D0RW8J HIGHSTAT Patented D0RW8J COMPCLAS Poly-substituted azoles statin lactone derivatives D0RY6M DRUG__ID D0RY6M D0RY6M DRUGCOMP Merck & Co., Inc D0RY6M DRUGTYPE Small molecular drug D0RY6M HIGHSTAT Patented D0RY6M COMPCLAS Heterocyclic-carboxamide derivatives D0RZ5E DRUG__ID D0RZ5E D0RZ5E DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0RZ5E DRUGTYPE Carbohydrates D0RZ5E HIGHSTAT Patented D0RZ5E COMPCLAS Biphenyl mannoside derivatives D0S0HQ DRUG__ID D0S0HQ D0S0HQ DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT D0S0HQ DRUGTYPE Small molecular drug D0S0HQ HIGHSTAT Patented D0S0HQ COMPCLAS Dihydropyrido pyrazinone compounds D0S0OF DRUG__ID D0S0OF D0S0OF DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0S0OF DRUGTYPE Small molecule immunotherapy D0S0OF HIGHSTAT Patented D0S0OF COMPCLAS Macrocycle derivatives D0S0UL DRUG__ID D0S0UL D0S0UL DRUGCOMP MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH D0S0UL DRUGTYPE Small molecular drug D0S0UL HIGHSTAT Patented D0S0UL COMPCLAS Pyrazole derivatives D0S1AT DRUG__ID D0S1AT D0S1AT DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D0S1AT DRUGTYPE Small molecular drug D0S1AT HIGHSTAT Patented D0S1AT COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D0S2JF DRUG__ID D0S2JF D0S2JF DRUGCOMP ABIDE THERAPEUTICS, INC D0S2JF DRUGTYPE Small molecular drug D0S2JF HIGHSTAT Patented D0S2JF COMPCLAS Pyrazole derivatives D0S2ME DRUG__ID D0S2ME D0S2ME DRUGCOMP JENRIN DISCOVERY MCELROY, John CHORVAT, Robert D0S2ME DRUGTYPE Small molecular drug D0S2ME HIGHSTAT Patented D0S2ME COMPCLAS Pyrazoline derivatives D0S3TL DRUG__ID D0S3TL D0S3TL DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED Fukatsu, Kohji Nakayama, Yutaka Tarui, Naoki Mori, Masaaki Matsumoto, Hirokazu Kurasawa, Osamu Banno, Hiroshi D0S3TL DRUGTYPE Small molecular drug D0S3TL HIGHSTAT Patented D0S3TL COMPCLAS Oxazolo[3,4-a]pyrazine derivatives D0S4IB DRUG__ID D0S4IB D0S4IB DRUGCOMP Oscotec, Inc., S. Korea. assignee D0S4IB DRUGTYPE Small molecular drug D0S4IB HIGHSTAT Patented D0S4IB COMPCLAS Pyridopyrimidinone derivatives D0S4TH DRUG__ID D0S4TH D0S4TH DRUGCOMP MERCK SHARP & DOHME CORP. CHILDERS, Matthew L. DINSMORE, Christopher FULLER, Peter H. GUERIN, David J. KATZ, Jason David PU, Qinglin SCOTT, Mark E. THOMPSON, Christopher F. ZHANG, Hongjun CAI, Jiaqiang DU, Xiaoxing WANG, Chonggang KONG, Norman LIU, Yumei D0S4TH DRUGTYPE Small molecular drug D0S4TH HIGHSTAT Patented D0S4TH COMPCLAS Cycloalkyl nitrile pyrazolo pyridone derivatives D0S4XV DRUG__ID D0S4XV D0S4XV DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, CangminMerck & Co., Inc., Kenilworth, NJ, USA D0S4XV DRUGTYPE Small molecular drug D0S4XV HIGHSTAT Patented D0S4XV COMPCLAS Piperidinyl triazole derivatives D0S5SK DRUG__ID D0S5SK D0S5SK DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. MASUDA Seiji MATSUDA Yohei SAKAGAMI Kazunari KONISHI Kazuhide URABE Hiroki SHIMONO Rie OKADA Kumiko D0S5SK DRUGTYPE Small molecular drug D0S5SK HIGHSTAT Patented D0S5SK COMPCLAS Pyrazole derivatives D0S6TL DRUG__ID D0S6TL D0S6TL DRUGCOMP ASTELLAS PHARMA INC. FURUTANI, Takashi ENJO, Kentaro KIKUCHI, AyaAstellas Pharma Inc. KAKEFUDA, Akio KONDOH, Yutaka HIRANO, Masaak D0S6TL DRUGTYPE Small molecular drug D0S6TL HIGHSTAT Patented D0S6TL COMPCLAS N-(benzimidazole/indole) benzoic acid derivatives D0S6XT DRUG__ID D0S6XT D0S6XT DRUGCOMP CELLZOME LIMITED HOBSON, Andrew ADDISON, Glynn RAMSDEN, Nigel HARRISON, John D0S6XT DRUGTYPE Small molecular drug D0S6XT HIGHSTAT Patented D0S6XT COMPCLAS Bis-aminopyrimidine derivatives D0S7NE DRUG__ID D0S7NE D0S7NE DRUGCOMP PRESIDENT AND FELLOWS OF HARVARD COLLEGE DANA-FARBER CANCER INSTITUTE, INC. TANG, Weiping BRADNER, James, Elliot SCHREIBER, Stuart, L D0S7NE DRUGTYPE Small molecular drug D0S7NE HIGHSTAT Patented D0S7NE COMPCLAS Diaryl amine derivatives D0S8TB DRUG__ID D0S8TB D0S8TB DRUGCOMP FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA D0S8TB DRUGTYPE Small molecular drug D0S8TB HIGHSTAT Patented D0S8TB COMPCLAS Carbamate derivatives D0S9MR DRUG__ID D0S9MR D0S9MR DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0S9MR DRUGTYPE Small molecular drug D0S9MR HIGHSTAT Patented D0S9MR COMPCLAS Azetidine-benzoxazin-3(4H)-one derivatives D0SA6K DRUG__ID D0SA6K D0SA6K DRUGCOMP JANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj GRECO, Michael, N. SHOOK, Brian XU, Guozhang ZHANG, RuJANSSEN PHARMACEUTICA NV CHAKRAVARTY, Devraj KREUTTER, Kevin POWELL, Mark SHOOK, Brian SONG, Fengbin XU, Guozhang YANG, Shyh-ming ZHANG, Rui ZHAO, Bao-pin D0SA6K DRUGTYPE Small molecular drug D0SA6K HIGHSTAT Patented D0SA6K COMPCLAS Biphenyl carboxamidopropanoic acid derivatives D0SC3B DRUG__ID D0SC3B D0SC3B DRUGCOMP ARIZONA BOARD OF REGENTS, ACTING ON BEHALF OF THE UNIVERSITY OF ARIZONA UNIVERSITY OF PITTSBURGH POWIS, Garth WIPF, Pete D0SC3B DRUGTYPE Small molecular drug D0SC3B HIGHSTAT Patented D0SC3B COMPCLAS Palmarumycin derivatives D0SD4Q DRUG__ID D0SD4Q D0SD4Q DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0SD4Q DRUGTYPE Carbohydrates D0SD4Q HIGHSTAT Patented D0SD4Q COMPCLAS Aryl mannoside derivatives D0SE7V DRUG__ID D0SE7V D0SE7V DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0SE7V DRUGTYPE Carbohydrates D0SE7V HIGHSTAT Patented D0SE7V COMPCLAS Alkyl mannoside derivatives D0SJ1Q DRUG__ID D0SJ1Q D0SJ1Q DRUGCOMP CELLZOME LIMITED HOBSON, Andrew ADDISON, Glynn RAMSDEN, Nigel HARRISON, John D0SJ1Q DRUGTYPE Small molecular drug D0SJ1Q HIGHSTAT Patented D0SJ1Q COMPCLAS Bis-aminopyrimidine derivatives D0SO0F DRUG__ID D0SO0F D0SO0F DRUGCOMP ATHERSYS, INC.ATHERSYS, INC. BENNANI, Youssef, L. BOM, David, C. ROBARGE, Michael, J D0SO0F DRUGTYPE Small molecular drug D0SO0F HIGHSTAT Patented D0SO0F COMPCLAS Tricyclic pyrrolidine derivatives D0SO4O DRUG__ID D0SO4O D0SO4O DRUGCOMP AAPA B.V D0SO4O DRUGTYPE Small molecular drug D0SO4O HIGHSTAT Patented D0SO4O COMPCLAS Benzo[d]oxazol-2(3H)-one derivatives D0SS2O DRUG__ID D0SS2O D0SS2O DRUGCOMP BeiGene Ltd D0SS2O DRUGTYPE Small molecular drug D0SS2O HIGHSTAT Patented D0SS2O COMPCLAS Dihydrodiazepinocarbazolone derivatives D0SU0E DRUG__ID D0SU0E D0SU0E DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, CorinnTHE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0SU0E DRUGTYPE Carbohydrates D0SU0E HIGHSTAT Patented D0SU0E COMPCLAS Biphenyl mannoside derivatives D0SV1I DRUG__ID D0SV1I D0SV1I DRUGCOMP LUNDBECK & CO AS H [DKJOERGENSEN MORTEN [DKBRUUN ANNE TECHAU [DKRASMUSSEN LARS KYHN [DK] D0SV1I DRUGTYPE Small molecular drug D0SV1I HIGHSTAT Patented D0SV1I COMPCLAS Pyrido[1,2,4]triazolo[4,3-a]pyrazine derivatives D0SV6U DRUG__ID D0SV6U D0SV6U DRUGCOMP Galderma Research & Development D0SV6U DRUGTYPE Small molecular drug D0SV6U HIGHSTAT Patented D0SV6U COMPCLAS 3-phenyl acrylic acid derivatives D0SW0V DRUG__ID D0SW0V D0SW0V DRUGCOMP Univ Sun Yat Sen D0SW0V DRUGTYPE Small molecular drug D0SW0V HIGHSTAT Patented D0SW0V COMPCLAS Tacrine-caffeic acid hybrid derivatives D0T5ER DRUG__ID D0T5ER D0T5ER DRUGCOMP ARENA PHARMACEUTICALS, INC D0T5ER DRUGTYPE Small molecular drug D0T5ER HIGHSTAT Patented D0T5ER COMPCLAS Benzazepine derivatives D0T6CY DRUG__ID D0T6CY D0T6CY DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0T6CY DRUGTYPE Small molecular drug D0T6CY HIGHSTAT Patented D0T6CY COMPCLAS Pyrrolo-pyridone derivatives D0T6IZ DRUG__ID D0T6IZ D0T6IZ DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D0T6IZ DRUGTYPE Small molecular drug D0T6IZ HIGHSTAT Patented D0T6IZ COMPCLAS 7-azaindole derivatives D0T6NX DRUG__ID D0T6NX D0T6NX DRUGCOMP WASHINGTON UNIVERSITY D0T6NX DRUGTYPE Carbohydrates D0T6NX HIGHSTAT Patented D0T6NX COMPCLAS Biphenyl mannoside derivatives D0T7VN DRUG__ID D0T7VN D0T7VN DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0T7VN DRUGTYPE Carbohydrates D0T7VN HIGHSTAT Patented D0T7VN COMPCLAS Aryl mannoside derivatives D0T8DH DRUG__ID D0T8DH D0T8DH DRUGCOMP ZENITH EPIGENETICS CORP D0T8DH DRUGTYPE Small molecular drug D0T8DH HIGHSTAT Patented D0T8DH COMPCLAS Isoxazole-based bicyclic compounds D0T8MJ DRUG__ID D0T8MJ D0T8MJ DRUGCOMP DART NEUROSCIENCE (CAYMAN) LTD D0T8MJ DRUGTYPE Small molecular drug D0T8MJ HIGHSTAT Patented D0T8MJ COMPCLAS 1,2,4-triazole [1,5-a]pyrimidin-7-yl derivatives D0T8PK DRUG__ID D0T8PK D0T8PK DRUGCOMP City of Hope, Durate, CA D0T8PK DRUGTYPE Small molecular drug D0T8PK HIGHSTAT Patented D0T8PK COMPCLAS Indirubin derivatives D0T9JB DRUG__ID D0T9JB D0T9JB DRUGCOMP University Guangdong Technology D0T9JB DRUGTYPE Small molecular drug D0T9JB HIGHSTAT Patented D0T9JB COMPCLAS Tacrine-coumarin hybrid derivatives D0TA8W DRUG__ID D0TA8W D0TA8W DRUGCOMP XENON PHARMACEUTICALS INC D0TA8W DRUGTYPE Small molecular drug D0TA8W HIGHSTAT Patented D0TA8W COMPCLAS Benzene sulfonamide derivatives D0TH7T DRUG__ID D0TH7T D0TH7T DRUGCOMP NOVARTIS AG BARSANTI, Paul A. HU, Cheng JIN, Xianming NG, Simon C. PFISTER, Keith B. SENDZIK, Martin SUTTON, James D0TH7T DRUGTYPE Small molecular drug D0TH7T HIGHSTAT Patented D0TH7T COMPCLAS Bipyridine derivatives D0TK5G DRUG__ID D0TK5G D0TK5G DRUGCOMP NEURO3D UNIVERSITE LOUIS PASTEUR CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE FORENAP BOURGUIGNON, Jean-Jacques LUGNIER, Claire ABARGHAZ, Mustapha LAGOUGE, Yan WAGNER, Patrick MONDADORI, Cesare MACHER, Jean-Paul SCHULTZ, Dominique RABOISSON, PierrNeuro3d D0TK5G DRUGTYPE Small molecular drug D0TK5G HIGHSTAT Patented D0TK5G COMPCLAS Benzodiazepine derivatives D0TP0S DRUG__ID D0TP0S D0TP0S DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D0TP0S DRUGTYPE Small molecular drug D0TP0S HIGHSTAT Patented D0TP0S COMPCLAS Isoflavone derivatives D0TQ8V DRUG__ID D0TQ8V D0TQ8V DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0TQ8V DRUGTYPE Small molecular drug D0TQ8V HIGHSTAT Patented D0TQ8V COMPCLAS Tricyclic indole compounds D0TV9G DRUG__ID D0TV9G D0TV9G DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0TV9G DRUGTYPE Small molecular drug D0TV9G HIGHSTAT Patented D0TV9G COMPCLAS Amidopyrazole derivatives D0TY1Q DRUG__ID D0TY1Q D0TY1Q DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0TY1Q DRUGTYPE Carbohydrates D0TY1Q HIGHSTAT Patented D0TY1Q COMPCLAS Mannoside derivatives D0U1DY DRUG__ID D0U1DY D0U1DY DRUGCOMP THE JOHNS HOPKINS UNIVERSITY CASERO, Robert, A. BYTHEWAY, Ian WOSTER, Patrick, M D0U1DY DRUGTYPE Small molecular drug D0U1DY HIGHSTAT Patented D0U1DY COMPCLAS Benzenamine derivatives D0U2GJ DRUG__ID D0U2GJ D0U2GJ DRUGCOMP CMG PHARMACEUTICAL CO., LTD. HANDOK INC D0U2GJ DRUGTYPE Small molecular drug D0U2GJ HIGHSTAT Patented D0U2GJ COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0U2JU DRUG__ID D0U2JU D0U2JU DRUGCOMP UNIV ALCALA HENARES [ES] D0U2JU DRUGTYPE Small molecular drug D0U2JU HIGHSTAT Patented D0U2JU COMPCLAS 5-azolone derivatives D0U2WQ DRUG__ID D0U2WQ D0U2WQ DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0U2WQ DRUGTYPE Small molecular drug D0U2WQ HIGHSTAT Patented D0U2WQ COMPCLAS Dihydropyrimidinone derivatives D0U3IS DRUG__ID D0U3IS D0U3IS DRUGCOMP WYETH WISSNER, Allan VENKATESAN, Aranapakam, M D0U3IS DRUGTYPE Small molecular drug D0U3IS HIGHSTAT Patented D0U3IS COMPCLAS Benzonaphthyridine derivatives D0U3KV DRUG__ID D0U3KV D0U3KV DRUGCOMP LUNDBECK & CO AS H [DK] D0U3KV DRUGTYPE Small molecular drug D0U3KV HIGHSTAT Patented D0U3KV COMPCLAS Triazolo-pyridine derivatives D0U3YY DRUG__ID D0U3YY D0U3YY DRUGCOMP MERCK & CO., INC. DEBENHAM, John, S. HALE, Jeffrey, J. HUO, Pei MADSEN-DUGGAN, Christina, B. WALSH, Thomas, F. YAN, Li D0U3YY DRUGTYPE Small molecular drug D0U3YY HIGHSTAT Patented D0U3YY COMPCLAS Pyrano[2,3-b]pyridine derivatives D0U5BE DRUG__ID D0U5BE D0U5BE DRUGCOMP FORMA THERAPEUTICS INC D0U5BE DRUGTYPE Small molecular drug D0U5BE HIGHSTAT Patented D0U5BE COMPCLAS Tetra-hydro-quinoline derivatives D0U5FZ DRUG__ID D0U5FZ D0U5FZ DRUGCOMP PFIZER INC D0U5FZ DRUGTYPE Small molecular drug D0U5FZ HIGHSTAT Patented D0U5FZ COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0U8IL DRUG__ID D0U8IL D0U8IL DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0U8IL DRUGTYPE Small molecular drug D0U8IL HIGHSTAT Patented D0U8IL COMPCLAS Phenylpyrrolidinone derivatives D0U9WX DRUG__ID D0U9WX D0U9WX DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0U9WX DRUGTYPE Small molecular drug D0U9WX HIGHSTAT Patented D0U9WX COMPCLAS 1,2-diamino cyclopentane-based derivatives D0UA6W DRUG__ID D0UA6W D0UA6W DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa SEO, Hee Jeong KIM, Min-Ah KIM, Jeongmin LEE, Sung-Han JUNG, Myung Eun KIM, Mi-Soo D0UA6W DRUGTYPE Small molecular drug D0UA6W HIGHSTAT Patented D0UA6W COMPCLAS Pyrazole derivatives D0UB8U DRUG__ID D0UB8U D0UB8U DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0UB8U DRUGTYPE Carbohydrates D0UB8U HIGHSTAT Patented D0UB8U COMPCLAS Alkyl mannoside derivatives D0UD4X DRUG__ID D0UD4X D0UD4X DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D0UD4X DRUGTYPE Small molecular drug D0UD4X HIGHSTAT Patented D0UD4X COMPCLAS Ketoheterocycle derivatives D0UE3F DRUG__ID D0UE3F D0UE3F DRUGCOMP WASHINGTON UNIVERSITY D0UE3F DRUGTYPE Carbohydrates D0UE3F HIGHSTAT Patented D0UE3F COMPCLAS Biphenyl mannoside derivatives D0UF8Z DRUG__ID D0UF8Z D0UF8Z DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0UF8Z DRUGTYPE Small molecular drug D0UF8Z HIGHSTAT Patented D0UF8Z COMPCLAS Aryl pyrimidine derivatives D0UG8S DRUG__ID D0UG8S D0UG8S DRUGCOMP F. HOFFMANN-LA ROCHE AG GENENTECH, INC D0UG8S DRUGTYPE Small molecular drug D0UG8S HIGHSTAT Patented D0UG8S COMPCLAS Thiazolopyridine derivatives D0UG9S DRUG__ID D0UG9S D0UG9S DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0UG9S DRUGTYPE Carbohydrates D0UG9S HIGHSTAT Patented D0UG9S COMPCLAS Biphenyl mannoside derivatives D0UI9T DRUG__ID D0UI9T D0UI9T DRUGCOMP FLEXUS BIOSCIENCES, INC D0UI9T DRUGTYPE Small molecular drug D0UI9T HIGHSTAT Patented D0UI9T COMPCLAS Carbamide derivatives D0UL9U DRUG__ID D0UL9U D0UL9U DRUGCOMP ORYZON GENOMICS SA [ESOryzon Genomics S.A., Spain D0UL9U DRUGTYPE Small molecular drug D0UL9U HIGHSTAT Patented D0UL9U COMPCLAS N-(2-phenylcyclopropyl) amino acid derivatives D0UL9W DRUG__ID D0UL9W D0UL9W DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0UL9W DRUGTYPE Small molecular drug D0UL9W HIGHSTAT Patented D0UL9W COMPCLAS Heteroaryl-azepine derivatives D0UQ2R DRUG__ID D0UQ2R D0UQ2R DRUGCOMP EPITHERAPEUTICS APS LABELLE, Marc MONTALBETTI, Christian A.G.N. MEARS, Richard John VILE, Julia GELMAN, Danny M. GAI, Xinjie BARKER, Oliver Robin DEBOVES, Herv Jean Claude EAST, Stephen Peter BOESEN, Thomas D0UQ2R DRUGTYPE Small molecular drug D0UQ2R HIGHSTAT Patented D0UQ2R COMPCLAS Pyrido[1,2-a]indole-1.-carboxylic acid analogs D0UR7K DRUG__ID D0UR7K D0UR7K DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0UR7K DRUGTYPE Small molecular drug D0UR7K HIGHSTAT Patented D0UR7K COMPCLAS 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives D0US5I DRUG__ID D0US5I D0US5I DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0US5I DRUGTYPE Carbohydrates D0US5I HIGHSTAT Patented D0US5I COMPCLAS C-linked disaccharide biphenyl mannoside derivatives D0UU2U DRUG__ID D0UU2U D0UU2U DRUGCOMP ZENITH EPIGENETICS CORP D0UU2U DRUGTYPE Small molecular drug D0UU2U HIGHSTAT Patented D0UU2U COMPCLAS Isoxazole-based bicyclic compounds D0UV3I DRUG__ID D0UV3I D0UV3I DRUGCOMP SHANGHAI FOCHON PHARMACEUTICAL CO LTD WANG, Weibo ZHAO, Xingdong ZOU, Chunlan ZHANG, Huajie ZHANG, Weipeng LIU, Caiping TIAN, Qiang D0UV3I DRUGTYPE Small molecular drug D0UV3I HIGHSTAT Patented D0UV3I COMPCLAS Imidazo pyridine derivatives D0V0BC DRUG__ID D0V0BC D0V0BC DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD D0V0BC DRUGTYPE Small molecular drug D0V0BC HIGHSTAT Patented D0V0BC COMPCLAS N-substituted pyrazole derivatives D0V0KI DRUG__ID D0V0KI D0V0KI DRUGCOMP MERCK SHARP & DOHME CORP. BRUBAKER, Jason DINSMORE, Christopher J. HOFFMAN, Dawn Marie JUNG, Joon LIU, Duan PETERSON, Scott SIU, Tony TORRES, Luis E. ZHANG, Hongjun WEI, Zhongyong SHI, Feng D0V0KI DRUGTYPE Small molecular drug D0V0KI HIGHSTAT Patented D0V0KI COMPCLAS Cycloalkyl nitrile pyrazole carboxamide derivatives D0V1VT DRUG__ID D0V1VT D0V1VT DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D0V1VT DRUGTYPE Small molecular drug D0V1VT HIGHSTAT Patented D0V1VT COMPCLAS Tetra-hydro-naphthalene derivatives D0V2WE DRUG__ID D0V2WE D0V2WE DRUGCOMP RICHTER GEDEON NYRT [HU] D0V2WE DRUGTYPE Small molecular drug D0V2WE HIGHSTAT Patented D0V2WE COMPCLAS Steroidal carboxamide derivatives D0V5GR DRUG__ID D0V5GR D0V5GR DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0V5GR DRUGTYPE Small molecular drug D0V5GR HIGHSTAT Patented D0V5GR COMPCLAS Tetra-hydro-pyrazolopyrazine derivatives D0V6LW DRUG__ID D0V6LW D0V6LW DRUGCOMP PFIZER INC. HELAL, Christopher J. CHAPPIE, Thomas Allen HUMPHREY, John M D0V6LW DRUGTYPE Small molecular drug D0V6LW HIGHSTAT Patented D0V6LW COMPCLAS Pyrazolo[3,4-d]pyrimidine derivatives D0V9AB DRUG__ID D0V9AB D0V9AB DRUGCOMP NANT HOLDINGS IP, LLC D0V9AB DRUGTYPE Small molecular drug D0V9AB HIGHSTAT Patented D0V9AB COMPCLAS Cyclic sulfonamide derivatives D0VA1D DRUG__ID D0VA1D D0VA1D DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0VA1D DRUGTYPE Small molecular drug D0VA1D HIGHSTAT Patented D0VA1D COMPCLAS Alkyl mannoside derivatives D0VA2G DRUG__ID D0VA2G D0VA2G DRUGCOMP China Pharmaceutical University D0VA2G DRUGTYPE Small molecular drug D0VA2G HIGHSTAT Patented D0VA2G COMPCLAS Pyrazino[2,1-a]isoquinolin derivatives D0VB2M DRUG__ID D0VB2M D0VB2M DRUGCOMP ELI LILLY AND COMPANY SCHAUS, John, Mehner D0VB2M DRUGTYPE Small molecular drug D0VB2M HIGHSTAT Patented D0VB2M COMPCLAS 1,5-diphenylpyrrolidin-2-one derivatives D0VB4T DRUG__ID D0VB4T D0VB4T DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0VB4T DRUGTYPE Carbohydrates D0VB4T HIGHSTAT Patented D0VB4T COMPCLAS Aryl mannoside derivatives D0VD3P DRUG__ID D0VD3P D0VD3P DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0VD3P DRUGTYPE Small molecular drug D0VD3P HIGHSTAT Patented D0VD3P COMPCLAS Amidopyrazole derivatives D0VD5I DRUG__ID D0VD5I D0VD5I DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0VD5I DRUGTYPE Small molecular drug D0VD5I HIGHSTAT Patented D0VD5I COMPCLAS Aminopyrimidine derivatives D0VE8R DRUG__ID D0VE8R D0VE8R DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0VE8R DRUGTYPE Small molecular drug D0VE8R HIGHSTAT Patented D0VE8R COMPCLAS Fused aryl carbocycle derivatives D0VG0F DRUG__ID D0VG0F D0VG0F DRUGCOMP WASHINGTON UNIVERSITY D0VG0F DRUGTYPE Carbohydrates D0VG0F HIGHSTAT Patented D0VG0F COMPCLAS Biphenyl mannoside derivatives D0VQ7P DRUG__ID D0VQ7P D0VQ7P DRUGCOMP INCYTE CORPORATION D0VQ7P DRUGTYPE Small molecular drug D0VQ7P HIGHSTAT Patented D0VQ7P COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0VR1O DRUG__ID D0VR1O D0VR1O DRUGCOMP EISAI R & D MANAGEMENT CO. LTD GRACZYK, Piotr BHATIA, Gurpreet, SingEISAI R&D MANAGEMENT CO. LTD D0VR1O DRUGTYPE Small molecular drug D0VR1O HIGHSTAT Patented D0VR1O COMPCLAS 7-azaindole derivatives D0VR8N DRUG__ID D0VR8N D0VR8N DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0VR8N DRUGTYPE Small molecular drug D0VR8N HIGHSTAT Patented D0VR8N COMPCLAS Imidazo bicyclic iminium derivatives D0VS7X DRUG__ID D0VS7X D0VS7X DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0VS7X DRUGTYPE Small molecular drug D0VS7X HIGHSTAT Patented D0VS7X COMPCLAS Azetidine-benzoxazin-3(4H)-one derivatives D0VW9H DRUG__ID D0VW9H D0VW9H DRUGCOMP Keio University D0VW9H DRUGTYPE Small molecular drug D0VW9H HIGHSTAT Patented D0VW9H COMPCLAS 2-hydroxybenzamide derivatives D0VX5Y DRUG__ID D0VX5Y D0VX5Y DRUGCOMP BETA PHARMA, INC. ZHANG, Don XIE, Guojian D0VX5Y DRUGTYPE Small molecular drug D0VX5Y HIGHSTAT Patented D0VX5Y COMPCLAS Indoline derivatives D0VY1Y DRUG__ID D0VY1Y D0VY1Y DRUGCOMP XENON PHARMACEUTICALS INC D0VY1Y DRUGTYPE Small molecular drug D0VY1Y HIGHSTAT Patented D0VY1Y COMPCLAS Benzene sulfonamide derivatives D0W0PC DRUG__ID D0W0PC D0W0PC DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0W0PC DRUGTYPE Small molecule immunotherapy D0W0PC HIGHSTAT Patented D0W0PC COMPCLAS 1,2,4-oxadiazole derivatives D0W0UF DRUG__ID D0W0UF D0W0UF DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, W. HAAS, Julia JIANG, Yutong ZHANG, Gan D0W0UF DRUGTYPE Small molecular drug D0W0UF HIGHSTAT Patented D0W0UF COMPCLAS Imidazo[1,2-b]pyridazine derivatives D0W3NX DRUG__ID D0W3NX D0W3NX DRUGCOMP ZENITH EPIGENETICS CORP D0W3NX DRUGTYPE Small molecular drug D0W3NX HIGHSTAT Patented D0W3NX COMPCLAS Isoxazole-based bicyclic compounds D0W3RA DRUG__ID D0W3RA D0W3RA DRUGCOMP OXYGEN HEALTHCARE RESEARCH PVT. LTD SHIRSATH, Vikas S. PATEL, Shailesh M SHETH, Nehal M. SINGH, Jitendra K. PATIL, Pawan D. PAWAR, Anil D. MOTIVARAS, Jitendra D D0W3RA DRUGTYPE Small molecular drug D0W3RA HIGHSTAT Patented D0W3RA COMPCLAS Phenylsulfonyl derivatives D0W3TL DRUG__ID D0W3TL D0W3TL DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED ANIMA, Boruah HOSAHALLI, Subramanya SUBHENDU, Mukherjee D0W3TL DRUGTYPE Small molecular drug D0W3TL HIGHSTAT Patented D0W3TL COMPCLAS Fused benzoheterocycle amide derivatives D0W6ZS DRUG__ID D0W6ZS D0W6ZS DRUGCOMP SCHERING CORPORATION HO, Ginny, D. TULSHIAN, Deen HEAP, Charles, R. EARLEY, William, G. COURNEYA, Brandy D0W6ZS DRUGTYPE Small molecular drug D0W6ZS HIGHSTAT Patented D0W6ZS COMPCLAS Pyrrolo-benzo-diazine derivatives D0W7VE DRUG__ID D0W7VE D0W7VE DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0W7VE DRUGTYPE Carbohydrates D0W7VE HIGHSTAT Patented D0W7VE COMPCLAS Biphenyl mannoside derivatives D0W8EC DRUG__ID D0W8EC D0W8EC DRUGCOMP BIOMARIN PHARMACEUTICAL INC. FENG, Ying GUTIERREZ, Andres, A. SHEN, Yuqiao WANG, Evelyn, W. OKHAMAFE, Augustus, O. PRICE, Christopher, P. CHOU, TianweBIOMARIN PHARMACEUTICAL INC. WANG, Bing CHU, Daniel D0W8EC DRUGTYPE Small molecular drug D0W8EC HIGHSTAT Patented D0W8EC COMPCLAS Dihydropyrido phthalazinone derivatives D0W9AB DRUG__ID D0W9AB D0W9AB DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0W9AB DRUGTYPE Small molecular drug D0W9AB HIGHSTAT Patented D0W9AB COMPCLAS Imidazopyridazine derivatives D0W9GL DRUG__ID D0W9GL D0W9GL DRUGCOMP Astellas Pharma Inc. AOKI, Satoshi MUNAKATA, Ryosuke KAWANO, Noriyuki D0W9GL DRUGTYPE Small molecular drug D0W9GL HIGHSTAT Patented D0W9GL COMPCLAS Carbamate derivatives D0W9VF DRUG__ID D0W9VF D0W9VF DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0W9VF DRUGTYPE Small molecular drug D0W9VF HIGHSTAT Patented D0W9VF COMPCLAS Cyclopropylamine derivatives D0W9ZU DRUG__ID D0W9ZU D0W9ZU DRUGCOMP Univ East China Science & Tech D0W9ZU DRUGTYPE Small molecular drug D0W9ZU HIGHSTAT Patented D0W9ZU COMPCLAS Galantamine analogs D0WA1V DRUG__ID D0WA1V D0WA1V DRUGCOMP ELI LILLY AND COMPANENDO PHARMACEUTICALS INC. VENKATESAN, Aranapakam SMITH, Roger, Astbury HOSAHALLI, Subramanya POTLURI, Vijay PANIGRAHI, Sunil, Kumar BASETTI, Vishnu KUNTU, Karunasree D0WA1V DRUGTYPE Small molecular drug D0WA1V HIGHSTAT Patented D0WA1V COMPCLAS Pyrimidopyridazinone derivatives D0WE5J DRUG__ID D0WE5J D0WE5J DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0WE5J DRUGTYPE Small molecular drug D0WE5J HIGHSTAT Patented D0WE5J COMPCLAS Aryl azepine derivatives D0WI1G DRUG__ID D0WI1G D0WI1G DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D0WI1G DRUGTYPE Small molecular drug D0WI1G HIGHSTAT Patented D0WI1G COMPCLAS Isoflavone derivatives D0WJ0T DRUG__ID D0WJ0T D0WJ0T DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D0WJ0T DRUGTYPE Small molecular drug D0WJ0T HIGHSTAT Patented D0WJ0T COMPCLAS Ketoheterocycle derivatives D0WK2S DRUG__ID D0WK2S D0WK2S DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L. CALDARELLI, Marina BERIA, Italo COLOMBO, Nicoletta PIUTTI, Claudia SALSA, Matteo TRAQUANDI, Gabriella D0WK2S DRUGTYPE Small molecular drug D0WK2S HIGHSTAT Patented D0WK2S COMPCLAS Tricyclic isoxazoloquinazoline derivatives D0WK9J DRUG__ID D0WK9J D0WK9J DRUGCOMP THE UNIVERSITY OF HONG KON D0WK9J DRUGTYPE Small molecular drug D0WK9J HIGHSTAT Patented D0WK9J COMPCLAS Binuclear gold(I) compounds D0WL7F DRUG__ID D0WL7F D0WL7F DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0WL7F DRUGTYPE Small molecular drug D0WL7F HIGHSTAT Patented D0WL7F COMPCLAS Tricyclic indole compounds D0WR1I DRUG__ID D0WR1I D0WR1I DRUGCOMP RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY THE BROAD INSTITUTE, INC D0WR1I DRUGTYPE Small molecular drug D0WR1I HIGHSTAT Patented D0WR1I COMPCLAS 1,2,3,4-tetrahydroisoquinoline derivatives D0WR6N DRUG__ID D0WR6N D0WR6N DRUGCOMP GLAXOSMITHKLINE LLGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED QIN, Donghui CHEUNG, Mui JOSHI, Hemant TANGIRALA, Raghuram BETHI, Sridhar, Reddy D0WR6N DRUGTYPE Small molecular drug D0WR6N HIGHSTAT Patented D0WR6N COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0WR7F DRUG__ID D0WR7F D0WR7F DRUGCOMP WYETH HEFFERNAN, Gavin, David STACK, Gary, Paul GROSS, Jonathan, Laird ZHOU, Dahui GAO, Hong D0WR7F DRUGTYPE Small molecular drug D0WR7F HIGHSTAT Patented D0WR7F COMPCLAS Chromene derivatives D0WS6Y DRUG__ID D0WS6Y D0WS6Y DRUGCOMP ATHERSYS, INC.ATHERSYS, INC. BENNANI, Youssef, L. BOM, David, C. ROBARGE, Michael, J D0WS6Y DRUGTYPE Small molecular drug D0WS6Y HIGHSTAT Patented D0WS6Y COMPCLAS Tricyclic pyrrolidine derivatives D0WV9J DRUG__ID D0WV9J D0WV9J DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE NANTES UNIVERSITE DE PICARDIE JULES VERNE UNIVERSITE LILLE 1 SCIENCES ET TECHNOLOGIES INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) UNIVERSITE D'AUVERGNE - CLERMONT-FERRAND 1 D0WV9J DRUGTYPE Carbohydrates D0WV9J HIGHSTAT Patented D0WV9J COMPCLAS Beta-cyclodextrin conjugate derivatives D0WW9B DRUG__ID D0WW9B D0WW9B DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0WW9B DRUGTYPE Carbohydrates D0WW9B HIGHSTAT Patented D0WW9B COMPCLAS Aryl mannoside derivatives D0WX1B DRUG__ID D0WX1B D0WX1B DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0WX1B DRUGTYPE Small molecular drug D0WX1B HIGHSTAT Patented D0WX1B COMPCLAS 1,2-diamino cyclopentane-based derivatives D0X1FD DRUG__ID D0X1FD D0X1FD DRUGCOMP NISSAN CHEMICAL INDUSTRIES, LTD. HAYASHI, Keishi WATANABE, Tsuneo TOYAMA, Koji KAMON, Junji MINAMI, Masataka UNI, Miyuki NASU, Mariko D0X1FD DRUGTYPE Small molecular drug D0X1FD HIGHSTAT Patented D0X1FD COMPCLAS Tricyclic heterocycle derivatives D0X2MF DRUG__ID D0X2MF D0X2MF DRUGCOMP SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD D0X2MF DRUGTYPE Small molecular drug D0X2MF HIGHSTAT Patented D0X2MF COMPCLAS Indoline derivatives D0X2UO DRUG__ID D0X2UO D0X2UO DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0X2UO DRUGTYPE Small molecular drug D0X2UO HIGHSTAT Patented D0X2UO COMPCLAS 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives D0X7IS DRUG__ID D0X7IS D0X7IS DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEGlaxoSmithKline D0X7IS DRUGTYPE Small molecular drug D0X7IS HIGHSTAT Patented D0X7IS COMPCLAS Dihydropyridine compounds D0X8AB DRUG__ID D0X8AB D0X8AB DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0X8AB DRUGTYPE Carbohydrates D0X8AB HIGHSTAT Patented D0X8AB COMPCLAS Mannoside derivatives D0X8LX DRUG__ID D0X8LX D0X8LX DRUGCOMP LUNDBECK & CO AS H [DKVERNALIS R & D LTD [GB] D0X8LX DRUGTYPE Small molecular drug D0X8LX HIGHSTAT Patented D0X8LX COMPCLAS Aminopyridine derivatives D0X9GC DRUG__ID D0X9GC D0X9GC DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D0X9GC DRUGTYPE Small molecular drug D0X9GC HIGHSTAT Patented D0X9GC COMPCLAS Pyrazole derivatives D0X9GL DRUG__ID D0X9GL D0X9GL DRUGCOMP SANOFI-AVENTIS ABOUABDELLAH, Ahmed CHEREZE, Nathalie FAYOL, Aude SAADY, Mourad VACHE, Julien VERONIQUE, Corinne YAICHE, Philippe D0X9GL DRUGTYPE Small molecular drug D0X9GL HIGHSTAT Patented D0X9GL COMPCLAS Carbamate derivatives D0XB0Q DRUG__ID D0XB0Q D0XB0Q DRUGCOMP MERCK SHARP & DOHME CORP. BIFTU, Tesfaye KHAN, Tanweer, A D0XB0Q DRUGTYPE Small molecular drug D0XB0Q HIGHSTAT Patented D0XB0Q COMPCLAS Dihydropyrrolopyrazole derivatives D0XB2O DRUG__ID D0XB2O D0XB2O DRUGCOMP GE HEALTHCARE LIMITED JONES, Paul, Alexander D0XB2O DRUGTYPE Small molecular drug D0XB2O HIGHSTAT Patented D0XB2O COMPCLAS Tricyclic indole compounds D0XH4K DRUG__ID D0XH4K D0XH4K DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0XH4K DRUGTYPE Carbohydrates D0XH4K HIGHSTAT Patented D0XH4K COMPCLAS C-linked disaccharide biphenyl mannoside derivatives D0XH5O DRUG__ID D0XH5O D0XH5O DRUGCOMP THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D0XH5O DRUGTYPE Small molecular drug D0XH5O HIGHSTAT Patented D0XH5O COMPCLAS Imidazo bicyclic iminium derivatives D0XH7H DRUG__ID D0XH7H D0XH7H DRUGCOMP NOVARTIS TIERGESUNDHEIT AG D0XH7H DRUGTYPE Small molecular drug D0XH7H HIGHSTAT Patented D0XH7H COMPCLAS N-methylmethanesulfonamide derivatives D0XH9M DRUG__ID D0XH9M D0XH9M DRUGCOMP ORYZON GENOMICS SA [ESOryzon Genomics S.A., Spain D0XH9M DRUGTYPE Small molecular drug D0XH9M HIGHSTAT Patented D0XH9M COMPCLAS N-(2-phenylcyclopropyl) amino acid derivatives D0XJ0B DRUG__ID D0XJ0B D0XJ0B DRUGCOMP MERCK SHARP &amDOHME CORP. LAYTON, Mark, E. PERO, Joseph, E. FIJI, Hannah KELLY, Michael, J., III DE LEON, Pablo ROSSI, Michael, A. GILBERT, Kevin, F. ROECKER, Anthony, J. ZHAO, Zhijian MERCER, Swati Pal WOLKENBERG, Scott MULHEARN, James ZHAO, Lianyun LI, Dansu D0XJ0B DRUGTYPE Small molecular drug D0XJ0B HIGHSTAT Patented D0XJ0B COMPCLAS Enzoxazolinone sulfonamide derivatives D0XJ4J DRUG__ID D0XJ4J D0XJ4J DRUGCOMP JANSSEN PHARMACEUTICA NV [BE] D0XJ4J DRUGTYPE Small molecular drug D0XJ4J HIGHSTAT Patented D0XJ4J COMPCLAS 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives D0XM9M DRUG__ID D0XM9M D0XM9M DRUGCOMP ELI LILLY AND COMPANY D0XM9M DRUGTYPE Small molecular drug D0XM9M HIGHSTAT Patented D0XM9M COMPCLAS Methyl-piperidine compounds D0XN2W DRUG__ID D0XN2W D0XN2W DRUGCOMP MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH D0XN2W DRUGTYPE Small molecular drug D0XN2W HIGHSTAT Patented D0XN2W COMPCLAS Diaryl amine derivatives D0XP5X DRUG__ID D0XP5X D0XP5X DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0XP5X DRUGTYPE Carbohydrates D0XP5X HIGHSTAT Patented D0XP5X COMPCLAS Mannoside derivatives D0XQ4B DRUG__ID D0XQ4B D0XQ4B DRUGCOMP PFIZER INC D0XQ4B DRUGTYPE Small molecular drug D0XQ4B HIGHSTAT Patented D0XQ4B COMPCLAS Aryl urea derivatives D0XR0Z DRUG__ID D0XR0Z D0XR0Z DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0XR0Z DRUGTYPE Small molecular drug D0XR0Z HIGHSTAT Patented D0XR0Z COMPCLAS Aryl pyrimidine derivatives D0XR1C DRUG__ID D0XR1C D0XR1C DRUGCOMP WASHINGTON UNIVERSITY D0XR1C DRUGTYPE Carbohydrates D0XR1C HIGHSTAT Patented D0XR1C COMPCLAS Biaryl mannoside derivatives D0XR9O DRUG__ID D0XR9O D0XR9O DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0XR9O DRUGTYPE Small molecular drug D0XR9O HIGHSTAT Patented D0XR9O COMPCLAS Pyrrolo-pyridinone derivatives D0XS0Z DRUG__ID D0XS0Z D0XS0Z DRUGCOMP HUNAN NONFERROUS METALS GROUP CHEMBIO PHARMACY CO., LTD D0XS0Z DRUGTYPE Small molecular drug D0XS0Z HIGHSTAT Patented D0XS0Z COMPCLAS Carbamide derivatives D0XY1J DRUG__ID D0XY1J D0XY1J DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED GLAXOSMITHKLINE (CHINA) R&D COMPANY LIMITED D0XY1J DRUGTYPE Small molecular drug D0XY1J HIGHSTAT Patented D0XY1J COMPCLAS Pyrrolo-pyrimidine derivatives D0Y0FR DRUG__ID D0Y0FR D0Y0FR DRUGCOMP COCENSYS, INC D0Y0FR DRUGTYPE Small molecular drug D0Y0FR HIGHSTAT Patented D0Y0FR COMPCLAS Quinoline carboxamide derivatives D0Y0SI DRUG__ID D0Y0SI D0Y0SI DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0Y0SI DRUGTYPE Carbohydrates D0Y0SI HIGHSTAT Patented D0Y0SI COMPCLAS Aryl mannoside derivatives D0Y2IM DRUG__ID D0Y2IM D0Y2IM DRUGCOMP CADILA HEALTHCARE LIMITED D0Y2IM DRUGTYPE Small molecular drug D0Y2IM HIGHSTAT Patented D0Y2IM COMPCLAS N-(cyanomethyl)-4-(2-(phenylamino)pyrimidin-4-yl)benzamide derivatives D0Y6ON DRUG__ID D0Y6ON D0Y6ON DRUGCOMP F. HOFFMANN-LA ROCHE AG CHEN, Shaoqing DE VICENTE FIDALGO, Javier HAMILTON, Matthew Michael HERMANN, Johannes Cornelius KENNEDY-SMITH, Joshua LI, Hongju LOVEY, Allen John LUCAS, Matthew C. LUK, Kin-Chun Thomas LYNCH, Stephen M. O'YANG, Counde PADILLA, Fernando SCHOENFELD, Ryan Craig SIDDURI, Achyutharao SOTH, Michael WANG, Ce WOVKULICH, Peter Michael ZHANG, Xiaohu D0Y6ON DRUGTYPE Small molecular drug D0Y6ON HIGHSTAT Patented D0Y6ON COMPCLAS Pyrrolo-pyrazine derivatives D0Y7LM DRUG__ID D0Y7LM D0Y7LM DRUGCOMP PFIZER INC D0Y7LM DRUGTYPE Small molecular drug D0Y7LM HIGHSTAT Patented D0Y7LM COMPCLAS Carbamate derivatives D0Y7MC DRUG__ID D0Y7MC D0Y7MC DRUGCOMP DAEWOONG PHARMACEUTICAL CO., LTD D0Y7MC DRUGTYPE Small molecular drug D0Y7MC HIGHSTAT Patented D0Y7MC COMPCLAS Benzene sulfonamide derivatives D0Y7XJ DRUG__ID D0Y7XJ D0Y7XJ DRUGCOMP GTX, INC D0Y7XJ DRUGTYPE Small molecular drug D0Y7XJ HIGHSTAT Patented D0Y7XJ COMPCLAS Isoquinolone derivatives D0YA6M DRUG__ID D0YA6M D0YA6M DRUGCOMP Suzhou Kangrun Pharmaceutical Inc D0YA6M DRUGTYPE Small molecular drug D0YA6M HIGHSTAT Patented D0YA6M COMPCLAS Aza-phenalene-3-ketone derivatives D0YC7C DRUG__ID D0YC7C D0YC7C DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITEGlaxoSmithKline D0YC7C DRUGTYPE Small molecular drug D0YC7C HIGHSTAT Patented D0YC7C COMPCLAS Dihydropyridine compounds D0YF2M DRUG__ID D0YF2M D0YF2M DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0YF2M DRUGTYPE Small molecular drug D0YF2M HIGHSTAT Patented D0YF2M COMPCLAS N-oxalyl-D-tyrosine derivatives D0YF6E DRUG__ID D0YF6E D0YF6E DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED ANIMA, Boruah HOSAHALLI, Subramanya SUBHENDU, Mukherjee D0YF6E DRUGTYPE Small molecular drug D0YF6E HIGHSTAT Patented D0YF6E COMPCLAS Fused benzoheterocycle amide derivatives D0YF7Q DRUG__ID D0YF7Q D0YF7Q DRUGCOMP JANSSEN PHARMACEUTICA NV D0YF7Q DRUGTYPE Small molecular drug D0YF7Q HIGHSTAT Patented D0YF7Q COMPCLAS Indoline derivatives D0YI3Z DRUG__ID D0YI3Z D0YI3Z DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0YI3Z DRUGTYPE Small molecular drug D0YI3Z HIGHSTAT Patented D0YI3Z COMPCLAS 1,2-diamino cyclopentane-based derivatives D0YM0G DRUG__ID D0YM0G D0YM0G DRUGCOMP ABIDE THERAPEUTICS, INC D0YM0G DRUGTYPE Small molecular drug D0YM0G HIGHSTAT Patented D0YM0G COMPCLAS Pyrazole derivatives D0YO2O DRUG__ID D0YO2O D0YO2O DRUGCOMP ATHERSYS, INC. BENNANI, Youssef, L. ROBARGE, Michael, J. BOM, David, C. VARGA, Norbert TUMEY, Lawrence, NBIOVITRUM AB [SENILSSON BJOERN [SE] D0YO2O DRUGTYPE Small molecular drug D0YO2O HIGHSTAT Patented D0YO2O COMPCLAS Heteroaryl-azepine derivatives D0Z0SY DRUG__ID D0Z0SY D0Z0SY DRUGCOMP NEKTAR THERAPEUTICS RIGGS-SAUTHIER, Jennifer ALLUMS-DONALD, Stephanie CULBERTSON, Sean, M D0Z0SY DRUGTYPE Small molecular drug D0Z0SY HIGHSTAT Patented D0Z0SY COMPCLAS Indoline derivatives D0Z1YF DRUG__ID D0Z1YF D0Z1YF DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0Z1YF DRUGTYPE Carbohydrates D0Z1YF HIGHSTAT Patented D0Z1YF COMPCLAS Biphenyl mannoside derivatives D0Z1ZA DRUG__ID D0Z1ZA D0Z1ZA DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0Z1ZA DRUGTYPE Carbohydrates D0Z1ZA HIGHSTAT Patented D0Z1ZA COMPCLAS Mannoside derivatives D0Z2JJ DRUG__ID D0Z2JJ D0Z2JJ DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0Z2JJ DRUGTYPE Small molecular drug D0Z2JJ HIGHSTAT Patented D0Z2JJ COMPCLAS Aryl pyrimidine derivatives D0Z5DI DRUG__ID D0Z5DI D0Z5DI DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0Z5DI DRUGTYPE Small molecular drug D0Z5DI HIGHSTAT Patented D0Z5DI COMPCLAS 4-Carboxamido-isoindolinone derivatives D0Z5MJ DRUG__ID D0Z5MJ D0Z5MJ DRUGCOMP Janssen Pharmaceutica N.V D0Z5MJ DRUGTYPE Small molecular drug D0Z5MJ HIGHSTAT Patented D0Z5MJ COMPCLAS Ketoheterocycle derivatives D0Z5PA DRUG__ID D0Z5PA D0Z5PA DRUGCOMP ARRAY BIOPHARMA INC. ANDREWS, Steven, Wade CONDROSKI, Kevin, Ronald HAAS, Julia JIANG, Yutong KOLAKOWSKI, Gabrielle, R. SEO, Jeongbeob YANG, Hong-Woon ZHAO, Qian D0Z5PA DRUGTYPE Small molecular drug D0Z5PA HIGHSTAT Patented D0Z5PA COMPCLAS Pyrazolo[1,5-a]pyrimidine derivatives D0Z5VD DRUG__ID D0Z5VD D0Z5VD DRUGCOMP University Hefei Technology D0Z5VD DRUGTYPE Small molecular drug D0Z5VD HIGHSTAT Patented D0Z5VD COMPCLAS Coumarin/resveratrol hybrid derivatives D0Z6IS DRUG__ID D0Z6IS D0Z6IS DRUGCOMP UNIVERSITA' DEGLI STUDI DI SIENA,UNIVERSITA' DEGLI STUDI DI ROMA "LA SAPIENZA" D0Z6IS DRUGTYPE Small molecular drug D0Z6IS HIGHSTAT Patented D0Z6IS COMPCLAS Isoflavone derivatives D0Z6PF DRUG__ID D0Z6PF D0Z6PF DRUGCOMP VIB vzw VRIJE UNIVERSITEIT BRUSSEL D0Z6PF DRUGTYPE Small molecular drug D0Z6PF HIGHSTAT Patented D0Z6PF COMPCLAS Alkyl mannoside derivatives D0Z8IR DRUG__ID D0Z8IR D0Z8IR DRUGCOMP BeiGene Ltd D0Z8IR DRUGTYPE Small molecular drug D0Z8IR HIGHSTAT Patented D0Z8IR COMPCLAS Tetra-cyclic pyridophthalazinone derivatives D0Z8VY DRUG__ID D0Z8VY D0Z8VY DRUGCOMP LUNDBECK & CO AS H [DK] D0Z8VY DRUGTYPE Small molecular drug D0Z8VY HIGHSTAT Patented D0Z8VY COMPCLAS Triazolo-pyridine derivatives D0Z9WY DRUG__ID D0Z9WY D0Z9WY DRUGCOMP SHANGHAI INST PHARM INDUSTRY [CNCAI ZHENGYAN [CNZHOU WEICHENG [CNHAO QUN [CN D0Z9WY DRUGTYPE Small molecular drug D0Z9WY HIGHSTAT Patented D0Z9WY COMPCLAS Aryl piperazine derivatives D0ZB9T DRUG__ID D0ZB9T D0ZB9T DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0ZB9T DRUGTYPE Small molecular drug D0ZB9T HIGHSTAT Patented D0ZB9T COMPCLAS Aryl pyrimidine derivatives D0ZD6N DRUG__ID D0ZD6N D0ZD6N DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0ZD6N DRUGTYPE Carbohydrates D0ZD6N HIGHSTAT Patented D0ZD6N COMPCLAS Biaryl mannoside derivatives D0ZE2J DRUG__ID D0ZE2J D0ZE2J DRUGCOMP NEW HOPE R & D BIOSCIENCE, INC. CHEN, Xiao-Tao D0ZE2J DRUGTYPE Small molecular drug D0ZE2J HIGHSTAT Patented D0ZE2J COMPCLAS Oxetane 3,3-dicarboxamide compounds D0ZL9P DRUG__ID D0ZL9P D0ZL9P DRUGCOMP The J. David Gladstone InstitutUniversity of Maryland D0ZL9P DRUGTYPE Small molecular drug D0ZL9P HIGHSTAT Patented D0ZL9P COMPCLAS Benzene sulfonamide derivatives D0ZO0D DRUG__ID D0ZO0D D0ZO0D DRUGCOMP VIVACELL BIOTECHNOLOGY ESPANA S L [ES] D0ZO0D DRUGTYPE Small molecular drug D0ZO0D HIGHSTAT Patented D0ZO0D COMPCLAS Cannabinoid quinone derivatives D0ZO9C DRUG__ID D0ZO9C D0ZO9C DRUGCOMP TAKEDA CAMBRIDGE LIMITED TAKEDA PHARMACEUTICAL COMPANY LIMITED D0ZO9C DRUGTYPE Small molecular drug D0ZO9C HIGHSTAT Patented D0ZO9C COMPCLAS 1,2-diamino cyclopentane-based derivatives D0ZR2O DRUG__ID D0ZR2O D0ZR2O DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0ZR2O DRUGTYPE Carbohydrates D0ZR2O HIGHSTAT Patented D0ZR2O COMPCLAS Biaryl mannoside derivatives D0ZU3R DRUG__ID D0ZU3R D0ZU3R DRUGCOMP SANOFI-AVENTIS D0ZU3R DRUGTYPE Small molecular drug D0ZU3R HIGHSTAT Patented D0ZU3R COMPCLAS Carbamate derivatives D0ZV9P DRUG__ID D0ZV9P D0ZV9P DRUGCOMP GLAXOSMITHKLINE LLC ATKINSON, Francis, Louis AXTEN, Jeffrey, Michael CICHY-KNIGHT, Maria MOORE, Michael, Lee PATEI, Vipulkumar, Kantibhai TIAN, Xinrong WELLAWAY, Christopher, Roland DUNN, Allison, K D0ZV9P DRUGTYPE Small molecular drug D0ZV9P HIGHSTAT Patented D0ZV9P COMPCLAS Pyrido[4,3-d]pyrimidin-5(6H)-one derivatives D0ZW5H DRUG__ID D0ZW5H D0ZW5H DRUGCOMP ISIS INNOVATION LIMITED SCHOFIELD, Christopher, Joseph MCDONOUGH, Michael ROSE, Nathan THALHAMMER, Armin D0ZW5H DRUGTYPE Small molecular drug D0ZW5H HIGHSTAT Patented D0ZW5H COMPCLAS 2,2-bipyridyl derivatives D0ZY4T DRUG__ID D0ZY4T D0ZY4T DRUGCOMP COURTNEY, Stephen Martin PRIME, Michael MITCHELL, William BROWN, Christopher John DE AGUIAR PENA, Paula C. JOHNSON, Peter DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia M. MUNOZ, Ignacio D0ZY4T DRUGTYPE Small molecular drug D0ZY4T HIGHSTAT Patented D0ZY4T COMPCLAS Aryl pyrimidine derivatives D0ZY5M DRUG__ID D0ZY5M D0ZY5M DRUGCOMP ACTELION PHARMACEUTICALS LTD D0ZY5M DRUGTYPE Small molecular drug D0ZY5M HIGHSTAT Patented D0ZY5M COMPCLAS Indole carboxamide derivatives D00ALX DRUG__ID D00ALX D00ALX DRUGCOMP Merck Sharp & Dohme Corp D00ALX DRUGTYPE Small molecular drug D00ALX HIGHSTAT Patented D00AQW DRUG__ID D00AQW D00AQW DRUGCOMP Zhejiang University D00AQW DRUGTYPE Small molecular drug D00AQW HIGHSTAT Patented D00BEJ DRUG__ID D00BEJ D00BEJ DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHGIAN NIKOLOVSKA-COLESKA, Zaneta SHOWALTER, Hollis D. LIAO, Chenzhong MOHAMMAD, Ramzi ABULWERDI, Fardokht WAYNE STATE UNIVERSITY D00BEJ DRUGTYPE Small molecular drug D00BEJ HIGHSTAT Patented D00BYK DRUG__ID D00BYK D00BYK DRUGCOMP BEIJING HANMI PHARMACEUTICAL CO., LTD D00BYK DRUGTYPE Small molecular drug D00BYK HIGHSTAT Patented D00CLK DRUG__ID D00CLK D00CLK DRUGCOMP THE UNIVERSITY OF HONG KON D00CLK DRUGTYPE Small molecular drug D00CLK HIGHSTAT Patented D00CMX DRUG__ID D00CMX D00CMX DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00CMX DRUGTYPE Small molecular drug D00CMX HIGHSTAT Patented D00EBN DRUG__ID D00EBN D00EBN DRUGTYPE Small molecular drug D00EBN HIGHSTAT Patented D00EBN COMPCLAS Imidazopyridine acetamide analogs D00FJH DRUG__ID D00FJH D00FJH DRUGCOMP PFIZER LIMITED D00FJH HIGHSTAT Patented D00FJH COMPCLAS N-acylpiperidine ether derivatives D00GGB DRUG__ID D00GGB D00GGB DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY D00GGB DRUGTYPE Small molecular drug D00GGB HIGHSTAT Patented D00GLJ DRUG__ID D00GLJ D00GLJ DRUGCOMP KARUS THERAPEUTICS LTD D00GLJ DRUGTYPE Small molecular drug D00GLJ HIGHSTAT Patented D00GNP DRUG__ID D00GNP D00GNP DRUGTYPE Small molecular drug D00GNP HIGHSTAT Patented D00GNP COMPCLAS Triazole piperazine derivatives D00GWE DRUG__ID D00GWE D00GWE DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D00GWE DRUGTYPE Small molecular drug D00GWE HIGHSTAT Patented D00ITT DRUG__ID D00ITT D00ITT DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D00ITT DRUGTYPE Small molecular drug D00ITT HIGHSTAT Patented D00IVM DRUG__ID D00IVM D00IVM DRUGCOMP MERCK SHARP & DOHME CORP. MANLEY, Peter, J. NANDA, Kausik, K. TROTTER, B. Wesley D00IVM DRUGTYPE Small molecular drug D00IVM HIGHSTAT Patented D00JEC DRUG__ID D00JEC D00JEC DRUGCOMP ABBOTT GMBH &amCO. KG ABBOTT LABORATORIES AMBERG, Wilhelm OCHSE, Michael LANGE, Udo BEHL, Berthold HORNBERGER, Wilfried MEZLER, Mario POHLKI, Frauke TURNER, Sean HUTCHINS, Charles D00JEC DRUGTYPE Small molecular drug D00JEC HIGHSTAT Patented D00JGN DRUG__ID D00JGN D00JGN DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D00JGN DRUGTYPE Small molecular drug D00JGN HIGHSTAT Patented D00JLX DRUG__ID D00JLX D00JLX DRUGCOMP FLEXUS BIOSCIENCES, INC D00JLX DRUGTYPE Small molecular drug D00JLX HIGHSTAT Patented D00JVQ DRUG__ID D00JVQ D00JVQ DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00JVQ DRUGTYPE Small molecular drug D00JVQ HIGHSTAT Patented D00KGL DRUG__ID D00KGL D00KGL DRUGCOMP F. HOFFMANN-LA ROCHE AG BANNER, David CECCARELLI, Simona M. GRETHER, Uwe HAAP, Wolfgang HILPERT, Hans KUEHNE, Holger MAUSER, Harald PLANCHER, Jean-Marc SANCHEZ, Rub Alvare D00KGL DRUGTYPE Small molecular drug D00KGL HIGHSTAT Patented D00KKD DRUG__ID D00KKD D00KKD DRUGCOMP WASHINGTON UNIVERSITY D00KKD DRUGTYPE Carbohydrates D00KKD HIGHSTAT Patented D00KTI DRUG__ID D00KTI D00KTI DRUGCOMP NTZ LAB LTD [BG] D00KTI DRUGTYPE Small molecular drug D00KTI HIGHSTAT Patented D00KXJ DRUG__ID D00KXJ D00KXJ DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNITHE REGENTS OF THE UNIVERSITY OF CALIFORNIA HE, Biao FUJII, Naoaki YOU, Liang XU, Zhidong JABLONS, David M D00KXJ DRUGTYPE Small molecular drug D00KXJ HIGHSTAT Patented D00LBC DRUG__ID D00LBC D00LBC DRUGTYPE Small molecular drug D00LBC HIGHSTAT Patented D00LBC COMPCLAS Triazole gold complexes D00LLN DRUG__ID D00LLN D00LLN DRUGCOMP KARUS THERAPEUTICS LTD D00LLN DRUGTYPE Small molecular drug D00LLN HIGHSTAT Patented D00LMA DRUG__ID D00LMA D00LMA DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D00LMA HIGHSTAT Patented D00LMA COMPCLAS Heteroaryl-carboxamide derivatives D00LWY DRUG__ID D00LWY D00LWY DRUGCOMP X-RX DISCOVERY, INC D00LWY DRUGTYPE Small molecular drug D00LWY HIGHSTAT Patented D00ODY DRUG__ID D00ODY D00ODY DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D00ODY DRUGTYPE Small molecular drug D00ODY HIGHSTAT Patented D00OLY DRUG__ID D00OLY D00OLY DRUGCOMP Xention Ltd D00OLY DRUGTYPE Small molecular drug D00OLY HIGHSTAT Patented D00PEV DRUG__ID D00PEV D00PEV DRUGCOMP DEBRECENI EGYETEM D00PEV DRUGTYPE Carbohydrates D00PEV HIGHSTAT Patented D00PFS DRUG__ID D00PFS D00PFS DRUGTYPE Small molecular drug D00PFS HIGHSTAT Patented D00PFS COMPCLAS Azetidinyl-piperidine derivatives D00QEZ DRUG__ID D00QEZ D00QEZ DRUGCOMP GRUENENTHAL GMBH [DE] D00QEZ DRUGTYPE Small molecular drug D00QEZ HIGHSTAT Patented D00RDO DRUG__ID D00RDO D00RDO DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D00RDO DRUGTYPE Carbohydrates D00RDO HIGHSTAT Patented D00SAR DRUG__ID D00SAR D00SAR DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D00SAR DRUGTYPE Small molecular drug D00SAR HIGHSTAT Patented D00SLD DRUG__ID D00SLD D00SLD DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00SLD DRUGTYPE Small molecular drug D00SLD HIGHSTAT Patented D00THJ DRUG__ID D00THJ D00THJ DRUGTYPE Small molecular drug D00THJ HIGHSTAT Patented D00THJ COMPCLAS 1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivatives D00TIB DRUG__ID D00TIB D00TIB DRUGCOMP C4T S.C. A.R.L D00TIB DRUGTYPE Small molecular drug D00TIB HIGHSTAT Patented D00TVG DRUG__ID D00TVG D00TVG DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D00TVG DRUGTYPE Small molecular drug D00TVG HIGHSTAT Patented D00UDJ DRUG__ID D00UDJ D00UDJ DRUGCOMP GE HEALTHCARE LIMITED D00UDJ DRUGTYPE Small molecular drug D00UDJ HIGHSTAT Patented D00VBP DRUG__ID D00VBP D00VBP DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D00VBP DRUGTYPE Small molecular drug D00VBP HIGHSTAT Patented D00VSX DRUG__ID D00VSX D00VSX DRUGCOMP NTZ LAB LTD [BG] D00VSX DRUGTYPE Small molecular drug D00VSX HIGHSTAT Patented D00WHH DRUG__ID D00WHH D00WHH DRUGTYPE Small molecular drug D00WHH HIGHSTAT Patented D00WHH COMPCLAS 4-pyridone derivatives D00WZH DRUG__ID D00WZH D00WZH DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D00WZH DRUGTYPE Small molecular drug D00WZH HIGHSTAT Patented D00XFT DRUG__ID D00XFT D00XFT DRUGTYPE Small molecular drug D00XFT HIGHSTAT Patented D00XFT COMPCLAS Pyrazole derivatives D00XKE DRUG__ID D00XKE D00XKE DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D00XKE DRUGTYPE Carbohydrates D00XKE HIGHSTAT Patented D00XRN DRUG__ID D00XRN D00XRN DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D00XRN DRUGTYPE Small molecular drug D00XRN HIGHSTAT Patented D00XWZ DRUG__ID D00XWZ D00XWZ DRUGCOMP KARUS THERAPEUTICS LTD D00XWZ DRUGTYPE Small molecular drug D00XWZ HIGHSTAT Patented D00XXZ DRUG__ID D00XXZ D00XXZ DRUGCOMP PFIZER LIMITED D00XXZ HIGHSTAT Patented D00XXZ COMPCLAS N-acylpiperidine ether derivatives D00YBT DRUG__ID D00YBT D00YBT DRUGCOMP NTZ LAB LTD [BG] D00YBT DRUGTYPE Small molecular drug D00YBT HIGHSTAT Patented D00YGY DRUG__ID D00YGY D00YGY DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D00YGY DRUGTYPE Small molecular drug D00YGY HIGHSTAT Patented D00YVL DRUG__ID D00YVL D00YVL DRUGCOMP the Shanghai Institute of Technology together with the East China University of Science and Technology D00YVL DRUGTYPE Small molecular drug D00YVL HIGHSTAT Patented D00YXL DRUG__ID D00YXL D00YXL DRUGTYPE Small molecular drug D00YXL HIGHSTAT Patented D00YXL COMPCLAS 2-pyrazinone derivatives D00ZGG DRUG__ID D00ZGG D00ZGG DRUGCOMP MERCK SHARP &amDOHME CORP. LIN, Linus, S. CHIODA, Marc, D. LIU, Ping NARGUND, Ravi, P D00ZGG DRUGTYPE Small molecular drug D00ZGG HIGHSTAT Patented D00ZVY DRUG__ID D00ZVY D00ZVY DRUGCOMP LIGAND PHARMACEUTICALS INCORPORATED COLE, Andrew, G. JAMES, Ray, A. SHAO, Yuefei LETOURNEAU, Jeffrey, J. QUINTERO, Jorge, G. RIVIELLO, Christopher, Mark ZHI, Lin D00ZVY HIGHSTAT Patented D00ZVY COMPCLAS Pyrazolopyridine derivatives D00ZXR DRUG__ID D00ZXR D00ZXR DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D00ZXR HIGHSTAT Patented D00ZXR COMPCLAS Heteroaryl-carboxamide derivatives D00ZZJ DRUG__ID D00ZZJ D00ZZJ DRUGCOMP RANBAXY LABORATORIES LIMITED KHERA, Manoj Kumar PALLE, Venkata P. SATTIGERI, Viswajanani SATTIGERI, Jitendra SONI, Ajay RAUF, Abdul Rehman Abdul SIVAKUMAR, R. REDDY, Ranadheer R. MUSIB, Arpita CLIFFE, Ian A. BHATNAGAR, Pradip Kumar RAY, Abhijit SRIVASTAVA, Punit DASTIDAR, Sunanda Ghosh D00ZZJ DRUGTYPE Small molecular drug D00ZZJ HIGHSTAT Patented D01ADE DRUG__ID D01ADE D01ADE DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D01ADE DRUGTYPE Small molecular drug D01ADE HIGHSTAT Patented D01AWH DRUG__ID D01AWH D01AWH DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D01AWH DRUGTYPE Small molecular drug D01AWH HIGHSTAT Patented D01AXK DRUG__ID D01AXK D01AXK DRUGCOMP KADMON CORPORATION, LLC D01AXK DRUGTYPE Antibody D01AXK HIGHSTAT Patented D01BSX DRUG__ID D01BSX D01BSX DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D01BSX DRUGTYPE Small molecular drug D01BSX HIGHSTAT Patented D01CGQ DRUG__ID D01CGQ D01CGQ DRUGCOMP NEW ENGLAND BIOLABS INC D01CGQ DRUGTYPE Nucleotide D01CGQ HIGHSTAT Patented D01CND DRUG__ID D01CND D01CND DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D01CND DRUGTYPE Carbohydrates D01CND HIGHSTAT Patented D01CRX DRUG__ID D01CRX D01CRX DRUGCOMP GALAPAGOS NV D01CRX DRUGTYPE Small molecular drug D01CRX HIGHSTAT Patented D01DBB DRUG__ID D01DBB D01DBB DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D01DBB DRUGTYPE Small molecular drug D01DBB HIGHSTAT Patented D01DWN DRUG__ID D01DWN D01DWN DRUGCOMP Owen D, Wilkins M D01DWN DRUGTYPE Small molecular drug D01DWN HIGHSTAT Patented D01DXB DRUG__ID D01DXB D01DXB DRUGCOMP DEBRECENI EGYETEM D01DXB DRUGTYPE Carbohydrates D01DXB HIGHSTAT Patented D01EEY DRUG__ID D01EEY D01EEY DRUGCOMP Takeda Pharmaceutical Co. Ltd D01EEY DRUGTYPE Small molecular drug D01EEY HIGHSTAT Patented D01EGC DRUG__ID D01EGC D01EGC DRUGCOMP Southwest Res Inst D01EGC DRUGTYPE Small molecular drug D01EGC HIGHSTAT Patented D01EWH DRUG__ID D01EWH D01EWH DRUGCOMP PFIZER INC. DIDIUK, Mary FILIPSKI, Kevin J. GUZMAN-PEREZ, Angel LEE, Esther C. PFEFFERKORN, Jeffrey A. STEVENS, Benjamin TU, Meihua D01EWH DRUGTYPE Small molecular drug D01EWH HIGHSTAT Patented D01FIM DRUG__ID D01FIM D01FIM DRUGCOMP EMORY UNIVERSITY JIANG, Jianxiong GANESH, Thota DU, Yuhong THEPCHATRI, Pahk QUAN, Yi DINGLEDINE, Ray J D01FIM DRUGTYPE Small molecular drug D01FIM HIGHSTAT Patented D01FMW DRUG__ID D01FMW D01FMW DRUGCOMP Kissei Pharmaceutical Co. Ltd D01FMW DRUGTYPE Small molecular drug D01FMW HIGHSTAT Patented D01FPR DRUG__ID D01FPR D01FPR DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D01FPR DRUGTYPE Small molecular drug D01FPR HIGHSTAT Patented D01FRI DRUG__ID D01FRI D01FRI DRUGCOMP Centrum Medyczne D01FRI DRUGTYPE Small molecular drug D01FRI HIGHSTAT Patented D01FTR DRUG__ID D01FTR D01FTR DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi TAN, Yun-chou D01FTR DRUGTYPE Small molecular drug D01FTR HIGHSTAT Patented D01FVC DRUG__ID D01FVC D01FVC DRUGCOMP CELLZOME LIMITED FREEMAN, Jay READER, Valerie ADDISON, Glynn RAMSDEN, Nigel SCANLON, Jane Elizabeth HARRISON, Richard John D01FVC HIGHSTAT Patented D01FVC COMPCLAS Bis-aminopyrimidine derivatives D01GON DRUG__ID D01GON D01GON DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY D01GON DRUGTYPE Small molecular drug D01GON HIGHSTAT Patented D01GSU DRUG__ID D01GSU D01GSU DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D01GSU DRUGTYPE Small molecular drug D01GSU HIGHSTAT Patented D01IFD DRUG__ID D01IFD D01IFD DRUGCOMP AFFIBODY AB D01IFD DRUGTYPE Antibody D01IFD HIGHSTAT Patented D01IPU DRUG__ID D01IPU D01IPU DRUGTYPE Small molecular drug D01IPU HIGHSTAT Patented D01IPU COMPCLAS Triazole gold complexes D01JCZ DRUG__ID D01JCZ D01JCZ DRUGCOMP Merck Sharp & Dohme Corp D01JCZ DRUGTYPE Small molecular drug D01JCZ HIGHSTAT Patented D01JDK DRUG__ID D01JDK D01JDK DRUGCOMP NTZ LAB LTD [BG] D01JDK DRUGTYPE Small molecular drug D01JDK HIGHSTAT Patented D01JJN DRUG__ID D01JJN D01JJN DRUGCOMP BAYER SCHERING PHARMA AG [DE] D01JJN DRUGTYPE Small molecular drug D01JJN HIGHSTAT Patented D01JPM DRUG__ID D01JPM D01JPM DRUGCOMP KARUS THERAPEUTICS LTD D01JPM DRUGTYPE Small molecular drug D01JPM HIGHSTAT Patented D01LCZ DRUG__ID D01LCZ D01LCZ DRUGCOMP KARUS THERAPEUTICS LTD D01LCZ DRUGTYPE Small molecular drug D01LCZ HIGHSTAT Patented D01LDP DRUG__ID D01LDP D01LDP DRUGTYPE Small molecular drug D01LDP HIGHSTAT Patented D01LDP COMPCLAS Ampicidin analogs D01LGQ DRUG__ID D01LGQ D01LGQ DRUGCOMP PURDUE PHARMA L.P D01LGQ DRUGTYPE Small molecular drug D01LGQ HIGHSTAT Patented D01LSP DRUG__ID D01LSP D01LSP DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D01LSP DRUGTYPE Small molecular drug D01LSP HIGHSTAT Patented D01LVT DRUG__ID D01LVT D01LVT DRUGCOMP WYETH RAMAMOORTHY, Sivaramakrishnan, P D01LVT DRUGTYPE Small molecular drug D01LVT HIGHSTAT Patented D01MKD DRUG__ID D01MKD D01MKD DRUGTYPE Small molecular drug D01MKD HIGHSTAT Patented D01MKD COMPCLAS Phenylalanine derivatives D01NCJ DRUG__ID D01NCJ D01NCJ DRUGCOMP ONYX THERAPEUTICS, INC D01NCJ DRUGTYPE Small molecular drug D01NCJ HIGHSTAT Patented D01OBB DRUG__ID D01OBB D01OBB DRUGCOMP PROTEOLIX, INC. BENNETT, Mark, K. BUCHHOLZ, Tonia, J. DEMO, Susan LAIDIG, Guy, J. LEWIS, Evan, R. SMYTH, Mark, S D01OBB DRUGTYPE Small molecular drug D01OBB HIGHSTAT Patented D01OGR DRUG__ID D01OGR D01OGR DRUGCOMP University Zhejiang Technology D01OGR DRUGTYPE Small molecular drug D01OGR HIGHSTAT Patented D01OIQ DRUG__ID D01OIQ D01OIQ DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D01OIQ DRUGTYPE Small molecular drug D01OIQ HIGHSTAT Patented D01OOO DRUG__ID D01OOO D01OOO DRUGCOMP PROTEOLIX, INC. BENNETT, Mark, K. BUCHHOLZ, Tonia, J. DEMO, Susan LAIDIG, Guy, J. LEWIS, Evan, R. SMYTH, Mark, S D01OOO DRUGTYPE Small molecular drug D01OOO HIGHSTAT Patented D01PAP DRUG__ID D01PAP D01PAP DRUGCOMP Apotex Pharmachem IncTeva Pharmaceutical Industries LtdSynthon Ip IncU & I Pharmaceuticals, LtdGeneva Pharmaceuticals, IncEli Lilly and CompanLilly Industries LimitedKRKA, Tovarna Zdravil, D.D D01PAP DRUGTYPE Small molecular drug D01PAP HIGHSTAT Patented D01PCI DRUG__ID D01PCI D01PCI DRUGCOMP NTZ LAB LTD [BG] D01PCI DRUGTYPE Small molecular drug D01PCI HIGHSTAT Patented D01PLJ DRUG__ID D01PLJ D01PLJ DRUGCOMP GRUENENTHAL GMBH [DE] D01PLJ DRUGTYPE Small molecular drug D01PLJ HIGHSTAT Patented D01PXI DRUG__ID D01PXI D01PXI DRUGCOMP GE HEALTHCARE LIMITED D01PXI DRUGTYPE Small molecular drug D01PXI HIGHSTAT Patented D01PZZ DRUG__ID D01PZZ D01PZZ DRUGCOMP ELI LILLY AND COMPANY D01PZZ DRUGTYPE Small molecular drug D01PZZ HIGHSTAT Patented D01QNX DRUG__ID D01QNX D01QNX DRUGCOMP ENANTA PHARMACEUTICALS, INC D01QNX DRUGTYPE Small molecular drug D01QNX HIGHSTAT Patented D01RHK DRUG__ID D01RHK D01RHK DRUGCOMP WASHINGTON UNIVERSITY D01RHK DRUGTYPE Carbohydrates D01RHK HIGHSTAT Patented D01RUI DRUG__ID D01RUI D01RUI DRUGCOMP CORNELL UNIVERSITY ITHACA COLLEGE D01RUI DRUGTYPE Small molecular drug D01RUI HIGHSTAT Patented D01SYN DRUG__ID D01SYN D01SYN DRUGCOMP MERCK SHARP & DOHME CORP. MSD K.K. LIN, Linus, S. SUZUKI, Takao D01SYN DRUGTYPE Small molecular drug D01SYN HIGHSTAT Patented D01VHD DRUG__ID D01VHD D01VHD DRUGCOMP University of Kentucky Research Foundation D01VHD DRUGTYPE Small molecular drug D01VHD HIGHSTAT Patented D01VJR DRUG__ID D01VJR D01VJR DRUGCOMP Merck Sharp & Dohme D01VJR DRUGTYPE Small molecular drug D01VJR HIGHSTAT Patented D01VMN DRUG__ID D01VMN D01VMN DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D01VMN DRUGTYPE Small molecular drug D01VMN HIGHSTAT Patented D01WQX DRUG__ID D01WQX D01WQX DRUGCOMP AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION THE UNIVERSITY OF SYDNEY D01WQX DRUGTYPE Small molecular drug D01WQX HIGHSTAT Patented D01YHY DRUG__ID D01YHY D01YHY DRUGCOMP IPSEN PHARMA S.A.S. ONCODESIGN S.A D01YHY DRUGTYPE Small molecular drug D01YHY HIGHSTAT Patented D02CAU DRUG__ID D02CAU D02CAU DRUGCOMP Ixchelsis Limited D02CAU DRUGTYPE Small molecular drug D02CAU HIGHSTAT Patented D02CQG DRUG__ID D02CQG D02CQG DRUGCOMP UNIV DARMSTADT TECH [DECHARITE UNIVERSITAETSMEDIZIN [DE] D02CQG DRUGTYPE Small molecular drug D02CQG HIGHSTAT Patented D02DBH DRUG__ID D02DBH D02DBH DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. HIGGINS, Jonathan PATNAIK, Debasis ULYANOVA, Natalia STEIN, Ross L. XIAN, Jun GLICKSMAN, Marcie CUNY, Gregory D D02DBH DRUGTYPE Small molecular drug D02DBH HIGHSTAT Patented D02DOE DRUG__ID D02DOE D02DOE DRUGCOMP UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG D02DOE DRUGTYPE miRNA D02DOE HIGHSTAT Patented D02EGY DRUG__ID D02EGY D02EGY DRUGTYPE Small molecular drug D02EGY HIGHSTAT Patented D02EGY COMPCLAS Aromatic hydrazine carboxyimidoamide derivatives D02EHR DRUG__ID D02EHR D02EHR DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D02EHR DRUGTYPE Small molecular drug D02EHR HIGHSTAT Patented D02GCZ DRUG__ID D02GCZ D02GCZ DRUGCOMP Univ Lanzhou Tech D02GCZ DRUGTYPE Small molecular drug D02GCZ HIGHSTAT Patented D02HOM DRUG__ID D02HOM D02HOM DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D02HOM DRUGTYPE Small molecular drug D02HOM HIGHSTAT Patented D02IET DRUG__ID D02IET D02IET DRUGCOMP ARRIEN PHARMACEUTICALS LLC D02IET DRUGTYPE Small molecular drug D02IET HIGHSTAT Patented D02IVA DRUG__ID D02IVA D02IVA DRUGCOMP ASTRAZENECA AB CANCER RESEARCH TECHNOLOGY LIMITED D02IVA DRUGTYPE Small molecular drug D02IVA HIGHSTAT Patented D02JFV DRUG__ID D02JFV D02JFV DRUGCOMP China Pharmaceutical University D02JFV DRUGTYPE Small molecular drug D02JFV HIGHSTAT Patented D02KDA DRUG__ID D02KDA D02KDA DRUGCOMP UNIVERSITY OF SOUTH FLORIDA TAN, Jun LUO, Deyan D02KDA DRUGTYPE Small molecular drug D02KDA HIGHSTAT Patented D02KPK DRUG__ID D02KPK D02KPK DRUGCOMP UNIVERZA V LJUBLJANI D02KPK DRUGTYPE Small molecular drug D02KPK HIGHSTAT Patented D02KWX DRUG__ID D02KWX D02KWX DRUGCOMP GILEAD SCIENCES, INC. GRAUPE, Michael VENKATARAMANI, Chandrasekar D02KWX DRUGTYPE Small molecular drug D02KWX HIGHSTAT Patented D02KWZ DRUG__ID D02KWZ D02KWZ DRUGCOMP DEBRECENI EGYETEM D02KWZ DRUGTYPE Carbohydrates D02KWZ HIGHSTAT Patented D02LAD DRUG__ID D02LAD D02LAD DRUGCOMP Merck Sharp & DohmMerck Sharp & Dohme D02LAD DRUGTYPE Small molecular drug D02LAD HIGHSTAT Patented D02MAG DRUG__ID D02MAG D02MAG DRUGCOMP THOMAS JEFFERSON UNIVERSITY D02MAG DRUGTYPE Small molecular drug D02MAG HIGHSTAT Patented D02MGJ DRUG__ID D02MGJ D02MGJ DRUGCOMP UNIVERSITEIT ANTWERPESIXERA PHARMA AUNIVERSITE PIERRE ET MARIE CURIE (PARIS 6QUEENSLAND UNIVERSITY OF TECHNOLOGY HARRIS, Jonathan Malcolm DE VEER, Simon John SWEDBERG, Joakim Erik D02MGJ HIGHSTAT Patented D02MGJ COMPCLAS Benzoxazinone derivatives D02MMG DRUG__ID D02MMG D02MMG DRUGCOMP MERCK PATENT GMBH WUCHERER-PLIETKER, Margarita ESDAR, Christina D02MMG DRUGTYPE Small molecular drug D02MMG HIGHSTAT Patented D02MTQ DRUG__ID D02MTQ D02MTQ DRUGCOMP MERCK SHARP & DOHME CORP. MSD K.K. LIN, Linus, S. SUZUKI, Takao D02MTQ DRUGTYPE Small molecular drug D02MTQ HIGHSTAT Patented D02NDP DRUG__ID D02NDP D02NDP DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D02NDP DRUGTYPE Carbohydrates D02NDP HIGHSTAT Patented D02NYT DRUG__ID D02NYT D02NYT DRUGTYPE Small molecular drug D02NYT HIGHSTAT Patented D02NYT COMPCLAS Golden phosphorous acetyletic compounds D02OAH DRUG__ID D02OAH D02OAH DRUGCOMP ABBVIE INC D02OAH DRUGTYPE Small molecular drug D02OAH HIGHSTAT Patented D02OBW DRUG__ID D02OBW D02OBW DRUGTYPE Small molecular drug D02OBW HIGHSTAT Patented D02OBW COMPCLAS Aminoazetidine derivatives D02OJH DRUG__ID D02OJH D02OJH DRUGCOMP ENANTA PHARMACEUTICALS, INC D02OJH DRUGTYPE Small molecular drug D02OJH HIGHSTAT Patented D02OLJ DRUG__ID D02OLJ D02OLJ DRUGCOMP PFIZER INC D02OLJ HIGHSTAT Patented D02OLJ COMPCLAS N-acylpiperidine ether derivatives D02OXG DRUG__ID D02OXG D02OXG DRUGCOMP Syntex, Inc D02OXG DRUGTYPE Small molecular drug D02OXG HIGHSTAT Patented D02PFE DRUG__ID D02PFE D02PFE DRUGCOMP SRI INTERNATIONAL ZHOU, Wei SAMBUCETTI, LidiSRI International, USA D02PFE DRUGTYPE Small molecular drug D02PFE HIGHSTAT Patented D02PFP DRUG__ID D02PFP D02PFP DRUGCOMP LUNDBECK & CO AS H [DK] D02PFP DRUGTYPE Small molecular drug D02PFP HIGHSTAT Patented D02PJI DRUG__ID D02PJI D02PJI DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D02PJI DRUGTYPE Small molecular drug D02PJI HIGHSTAT Patented D02QJE DRUG__ID D02QJE D02QJE DRUGCOMP ABBOTT LABORATORIES D02QJE DRUGTYPE Small molecular drug D02QJE HIGHSTAT Patented D02SES DRUG__ID D02SES D02SES DRUGCOMP Aurigene Discovery Technologies Limited D02SES DRUGTYPE Peptide D02SES HIGHSTAT Patented D02SKQ DRUG__ID D02SKQ D02SKQ DRUGCOMP ARENA PHARMACEUTICALS, INC D02SKQ DRUGTYPE Small molecular drug D02SKQ HIGHSTAT Patented D02SQQ DRUG__ID D02SQQ D02SQQ DRUGCOMP Centrum Medyczne D02SQQ DRUGTYPE Small molecular drug D02SQQ HIGHSTAT Patented D02SYR DRUG__ID D02SYR D02SYR DRUGCOMP CORNELL UNIVERSITY D02SYR DRUGTYPE Small molecular drug D02SYR HIGHSTAT Patented D02TZT DRUG__ID D02TZT D02TZT DRUGCOMP F. HOFFMANN-LA ROCHE AG D02TZT DRUGTYPE Small molecular drug D02TZT HIGHSTAT Patented D02UCA DRUG__ID D02UCA D02UCA DRUGCOMP CHIESI FARMACEUTICI S.p.A. EDWARDS, Christine KULAGOWSKI, Janusz FINCH, Harry D02UCA DRUGTYPE Small molecular drug D02UCA HIGHSTAT Patented D02UDO DRUG__ID D02UDO D02UDO DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D02UDO DRUGTYPE Carbohydrates D02UDO HIGHSTAT Patented D02VIR DRUG__ID D02VIR D02VIR DRUGCOMP METASIGNAL THERAPEUTICS INC. SUPURAN, Claudiu DEDHAR, Shoukat CARTA, Fabrizio WINUM, Jean-Yves MCDONALD, Paul C UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES CNRS - DIRE D02VIR DRUGTYPE Small molecular drug D02VIR HIGHSTAT Patented D02WRM DRUG__ID D02WRM D02WRM DRUGCOMP METHEOR THERAPEUTICS CORPORATION SLEDZIEWSKI, Andrew, Z. DEVOS, Theodore KOLE, Ryszard D02WRM DRUGTYPE Nucleotide D02WRM HIGHSTAT Patented D02XDG DRUG__ID D02XDG D02XDG DRUGCOMP Merck & Co., Inc D02XDG DRUGTYPE Small molecular drug D02XDG HIGHSTAT Patented D02YCN DRUG__ID D02YCN D02YCN DRUGCOMP UNIVERSITY OF NOTRE DAME DU LAC CHANG, Mayland MOBASHERY, Shahriar LEE, Mijoon D02YCN DRUGTYPE Small molecular drug D02YCN HIGHSTAT Patented D02YDG DRUG__ID D02YDG D02YDG DRUGCOMP KARUS THERAPEUTICS LTD D02YDG DRUGTYPE Small molecular drug D02YDG HIGHSTAT Patented D02YGX DRUG__ID D02YGX D02YGX DRUGCOMP MUSC FOUNDATION FOR RESEARCH DEVELOPMENT D02YGX DRUGTYPE Small molecular drug D02YGX HIGHSTAT Patented D02ZGO DRUG__ID D02ZGO D02ZGO DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D02ZGO DRUGTYPE Small molecular drug D02ZGO HIGHSTAT Patented D02ZGY DRUG__ID D02ZGY D02ZGY DRUGCOMP THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY D02ZGY DRUGTYPE Small molecular drug D02ZGY HIGHSTAT Patented D02ZHC DRUG__ID D02ZHC D02ZHC DRUGCOMP ASTEX THERAPEUTICS LIMITED D02ZHC DRUGTYPE Small molecular drug D02ZHC HIGHSTAT Patented D03AOX DRUG__ID D03AOX D03AOX DRUGCOMP Ixchelsis Limited D03AOX DRUGTYPE Small molecular drug D03AOX HIGHSTAT Patented D03BAY DRUG__ID D03BAY D03BAY DRUGCOMP PFIZER LIMITED D03BAY HIGHSTAT Patented D03BAY COMPCLAS N-acylpiperidine ether derivatives D03BRP DRUG__ID D03BRP D03BRP DRUGTYPE Small molecular drug D03BRP HIGHSTAT Patented D03BRP COMPCLAS Aromatic hydrazine carboxyimidoamide derivatives D03CMD DRUG__ID D03CMD D03CMD DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D03CMD DRUGTYPE Small molecular drug D03CMD HIGHSTAT Patented D03CQQ DRUG__ID D03CQQ D03CQQ DRUGCOMP THE UNIVERSITY OF HONG KON D03CQQ DRUGTYPE Small molecular drug D03CQQ HIGHSTAT Patented D03DIQ DRUG__ID D03DIQ D03DIQ DRUGCOMP Univ Guangzhou Chinese Medicine D03DIQ DRUGTYPE Small molecular drug D03DIQ HIGHSTAT Patented D03EUD DRUG__ID D03EUD D03EUD DRUGCOMP KARUS THERAPEUTICS LTD D03EUD DRUGTYPE Small molecular drug D03EUD HIGHSTAT Patented D03GLK DRUG__ID D03GLK D03GLK DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeongmin JUNG, Myung Eun KIM, Jong Yup AHN, Kwangwoo SEO, Hee Jeong LEE, Sung-Han LEE, Suk Ho D03GLK DRUGTYPE Small molecular drug D03GLK HIGHSTAT Patented D03GPV DRUG__ID D03GPV D03GPV DRUGCOMP RAQUALIA PHARMA INC D03GPV DRUGTYPE Small molecular drug D03GPV HIGHSTAT Patented D03GSK DRUG__ID D03GSK D03GSK DRUGTYPE Small molecular drug D03GSK HIGHSTAT Patented D03GSK COMPCLAS Carbamide derivatives D03HHG DRUG__ID D03HHG D03HHG DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D03HHG DRUGTYPE Carbohydrates D03HHG HIGHSTAT Patented D03HHN DRUG__ID D03HHN D03HHN DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D03HHN DRUGTYPE Small molecular drug D03HHN HIGHSTAT Patented D03HKN DRUG__ID D03HKN D03HKN DRUGCOMP the Shanghai Institute of Pharmaceutical Industry D03HKN DRUGTYPE Small molecular drug D03HKN HIGHSTAT Patented D03IKW DRUG__ID D03IKW D03IKW DRUGCOMP EMORY UNIVERSITY JIANG, Jianxiong GANESH, Thota DU, Yuhong THEPCHATRI, Pahk QUAN, Yi DINGLEDINE, Ray J D03IKW DRUGTYPE Small molecular drug D03IKW HIGHSTAT Patented D03JCI DRUG__ID D03JCI D03JCI DRUGCOMP N Zyme Biotech GmbH D03JCI DRUGTYPE Small molecular drug D03JCI HIGHSTAT Patented D03JCN DRUG__ID D03JCN D03JCN DRUGCOMP Merck Sharp & Dohme Corp D03JCN DRUGTYPE Small molecular drug D03JCN HIGHSTAT Patented D03JFJ DRUG__ID D03JFJ D03JFJ DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D03JFJ DRUGTYPE Carbohydrates D03JFJ HIGHSTAT Patented D03JFK DRUG__ID D03JFK D03JFK DRUGCOMP UNIVERSITY OF LAUSANNE BONNY, Christophe D03JFK DRUGTYPE Peptide D03JFK HIGHSTAT Patented D03JHD DRUG__ID D03JHD D03JHD DRUGCOMP SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE D03JHD DRUGTYPE Small molecular drug D03JHD HIGHSTAT Patented D03JMZ DRUG__ID D03JMZ D03JMZ DRUGCOMP CORNELL UNIVERSITY D03JMZ DRUGTYPE Small molecular drug D03JMZ HIGHSTAT Patented D03JWM DRUG__ID D03JWM D03JWM DRUGCOMP University of Kentucky Research Foundation D03JWM DRUGTYPE Small molecular drug D03JWM HIGHSTAT Patented D03JXD DRUG__ID D03JXD D03JXD DRUGCOMP UNIVERSITA' DEGLI STUDI DI PADOVA CHILIN, Adriana MARZARO, Giovanni GUIOTTO, Adriano CONCONI, Maria Teresa CASTAGLIUOLO, Ignazio D03JXD DRUGTYPE Small molecular drug D03JXD HIGHSTAT Patented D03KFN DRUG__ID D03KFN D03KFN DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D03KFN DRUGTYPE Small molecular drug D03KFN HIGHSTAT Patented D03KOH DRUG__ID D03KOH D03KOH DRUGCOMP CHDI FOUNDATION, INC D03KOH DRUGTYPE Small molecular drug D03KOH HIGHSTAT Patented D03KUD DRUG__ID D03KUD D03KUD DRUGCOMP SCHERING CORPORATION GILBERT, Eric, J. MILLER, Michael, W. DEMONG, Duane Eugene STAMFORD, Andrew, W. GREENLEE, William, J D03KUD DRUGTYPE Small molecular drug D03KUD HIGHSTAT Patented D03LKM DRUG__ID D03LKM D03LKM DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D03LKM DRUGTYPE Small molecular drug D03LKM HIGHSTAT Patented D03MPD DRUG__ID D03MPD D03MPD DRUGCOMP ORYZON GENOMICS SA [ES] D03MPD DRUGTYPE Small molecular drug D03MPD HIGHSTAT Patented D03MTX DRUG__ID D03MTX D03MTX DRUGCOMP UNIVERSITY OF LAUSANNE BONNY, Christophe D03MTX DRUGTYPE Peptide D03MTX HIGHSTAT Patented D03PQS DRUG__ID D03PQS D03PQS DRUGCOMP DART NEUROSCIENCE (CAYMAN) LTD D03PQS DRUGTYPE Small molecular drug D03PQS HIGHSTAT Patented D03PRT DRUG__ID D03PRT D03PRT DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D03PRT DRUGTYPE Small molecular drug D03PRT HIGHSTAT Patented D03PTG DRUG__ID D03PTG D03PTG DRUGCOMP TETRALOGIC PHARMACEUTICALS CORP. CONDON, Stephen, M. DENG, Yijun LAPORTE, Matthew, G D03PTG DRUGTYPE Small molecular drug D03PTG HIGHSTAT Patented D03QAU DRUG__ID D03QAU D03QAU DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D03QAU DRUGTYPE Small molecular drug D03QAU HIGHSTAT Patented D03QAW DRUG__ID D03QAW D03QAW DRUGCOMP GRUENENTHAL GMBH [DE] D03QAW DRUGTYPE Small molecular drug D03QAW HIGHSTAT Patented D03QMA DRUG__ID D03QMA D03QMA DRUGCOMP Changzhou Kelixin Medical Devices CO LTD D03QMA DRUGTYPE Small molecular drug D03QMA HIGHSTAT Patented D03SHM DRUG__ID D03SHM D03SHM DRUGCOMP SNU R&DB Foundation D03SHM DRUGTYPE Small molecular drug D03SHM HIGHSTAT Patented D03SNE DRUG__ID D03SNE D03SNE DRUGCOMP UNIVERSITAET BASEL D03SNE DRUGTYPE Small molecular drug D03SNE HIGHSTAT Patented D03TGG DRUG__ID D03TGG D03TGG DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D03TGG DRUGTYPE Small molecular drug D03TGG HIGHSTAT Patented D03TLQ DRUG__ID D03TLQ D03TLQ DRUGCOMP Ferring BV D03TLQ DRUGTYPE Small molecular drug D03TLQ HIGHSTAT Patented D03TQU DRUG__ID D03TQU D03TQU DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D03TQU DRUGTYPE Small molecular drug D03TQU HIGHSTAT Patented D03TWD DRUG__ID D03TWD D03TWD DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D03TWD DRUGTYPE Small molecule immunotherapy D03TWD HIGHSTAT Patented D03TZE DRUG__ID D03TZE D03TZE DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED D03TZE DRUGTYPE Small molecular drug D03TZE HIGHSTAT Patented D03WFE DRUG__ID D03WFE D03WFE DRUGCOMP Asana Biosciences D03WFE DRUGTYPE Small molecular drug D03WFE HIGHSTAT Patented D03WFI DRUG__ID D03WFI D03WFI DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D03WFI HIGHSTAT Patented D03WFI COMPCLAS Heteroaryl-carboxamide derivatives D03WGA DRUG__ID D03WGA D03WGA DRUGCOMP Univ Lanzhou Tech D03WGA DRUGTYPE Small molecular drug D03WGA HIGHSTAT Patented D03WPO DRUG__ID D03WPO D03WPO DRUGCOMP DEBRECENI EGYETEM D03WPO DRUGTYPE Carbohydrates D03WPO HIGHSTAT Patented D03XKM DRUG__ID D03XKM D03XKM DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D03XKM DRUGTYPE Small molecular drug D03XKM HIGHSTAT Patented D03YAA DRUG__ID D03YAA D03YAA DRUGCOMP BAYER INTELLECTUAL PROPERTY GMBH KOCH, Markus WOLF, Siegmund BUCHMANN, Bernd FUHRMANN, Ulrike DROESCHER, Peter ZOLLNER, Thomas D03YAA DRUGTYPE Small molecular drug D03YAA HIGHSTAT Patented D03ZGF DRUG__ID D03ZGF D03ZGF DRUGCOMP Obseva SA D03ZGF DRUGTYPE Small molecular drug D03ZGF HIGHSTAT Patented D03ZOZ DRUG__ID D03ZOZ D03ZOZ DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D03ZOZ DRUGTYPE Small molecular drug D03ZOZ HIGHSTAT Patented D03ZXP DRUG__ID D03ZXP D03ZXP DRUGCOMP CYTOCHROMA INC. JOHNS HOPKINS UNIVERSITY POSNER, Gary, H. HESS, Lindsey, C. KALINDA, Alvin, S. SLACK, Rachel, D. SAHA, Uttam PETKOVICH, P., Martin D03ZXP DRUGTYPE Small molecular drug D03ZXP HIGHSTAT Patented D04AMI DRUG__ID D04AMI D04AMI DRUGCOMP KARUS THERAPEUTICS LTD D04AMI DRUGTYPE Small molecular drug D04AMI HIGHSTAT Patented D04BAQ DRUG__ID D04BAQ D04BAQ DRUGCOMP Kissei Pharmaceutical Co. Ltd D04BAQ DRUGTYPE Small molecular drug D04BAQ HIGHSTAT Patented D04BBA DRUG__ID D04BBA D04BBA DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D04BBA HIGHSTAT Patented D04BBA COMPCLAS Thiazole carboxamide derivatives D04BOW DRUG__ID D04BOW D04BOW DRUGTYPE Small molecular drug D04BOW HIGHSTAT Patented D04BOW COMPCLAS Tricyclic pyrrolopyridine compounds D04CCX DRUG__ID D04CCX D04CCX DRUGCOMP POLARIS PHARMACEUTICALS, INC D04CCX DRUGTYPE Small molecule immunotherapy D04CCX HIGHSTAT Patented D04DRI DRUG__ID D04DRI D04DRI DRUGCOMP Gilead Sciences Inc D04DRI DRUGTYPE Small molecular drug D04DRI HIGHSTAT Patented D04FJY DRUG__ID D04FJY D04FJY DRUGCOMP NTZ LAB LTD [BG] D04FJY DRUGTYPE Small molecular drug D04FJY HIGHSTAT Patented D04GCC DRUG__ID D04GCC D04GCC DRUGCOMP PFIZER LIMITED D04GCC HIGHSTAT Patented D04GCC COMPCLAS N-acylpiperidine ether derivatives D04HCS DRUG__ID D04HCS D04HCS DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D04HCS DRUGTYPE Small molecular drug D04HCS HIGHSTAT Patented D04HMP DRUG__ID D04HMP D04HMP DRUGCOMP MERCK PATENT GMBH D04HMP DRUGTYPE Small molecular drug D04HMP HIGHSTAT Patented D04HPR DRUG__ID D04HPR D04HPR DRUGCOMP UNIV DARMSTADT TECH [DECHARITE UNIVERSITAETSMEDIZIN [DE] D04HPR DRUGTYPE Small molecular drug D04HPR HIGHSTAT Patented D04HQH DRUG__ID D04HQH D04HQH DRUGCOMP KYORIN SEIYAKU KK [JPTAKAHASHI HIROYASU [JPHIGUCHI HIROMI [JP] D04HQH HIGHSTAT Patented D04HQH COMPCLAS Dihydrothieno [2,3-e]indazole derivatives D04JUD DRUG__ID D04JUD D04JUD DRUGCOMP F. HOFFMANN-LA ROCHE AG BUETTELMANN, Bernd GOYAL, Bindu PALMER, Wylie Solang D04JUD DRUGTYPE Small molecular drug D04JUD HIGHSTAT Patented D04JWR DRUG__ID D04JWR D04JWR DRUGCOMP UNIVERSITE PARIS-SUD CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) D04JWR DRUGTYPE Small molecular drug D04JWR HIGHSTAT Patented D04KIH DRUG__ID D04KIH D04KIH DRUGCOMP UNIVERSITY OF COPENHAGEN D04KIH DRUGTYPE Peptide D04KIH HIGHSTAT Patented D04LBL DRUG__ID D04LBL D04LBL DRUGCOMP METHEOR THERAPEUTICS CORPORATION SLEDZIEWSKI, Andrew, Z. DEVOS, Theodore KOLE, Ryszard D04LBL DRUGTYPE Nucleotide D04LBL HIGHSTAT Patented D04MFJ DRUG__ID D04MFJ D04MFJ DRUGCOMP the Shanghai Institute of Pharmaceutical Industry D04MFJ DRUGTYPE Small molecular drug D04MFJ HIGHSTAT Patented D04MIQ DRUG__ID D04MIQ D04MIQ DRUGCOMP CURADEV PHARMA PRIVATE LTDCuradev Pharma Private Ltd D04MIQ DRUGTYPE Small molecular drug D04MIQ HIGHSTAT Patented D04MVN DRUG__ID D04MVN D04MVN DRUGCOMP KARUS THERAPEUTICS LTD D04MVN DRUGTYPE Small molecular drug D04MVN HIGHSTAT Patented D04NKE DRUG__ID D04NKE D04NKE DRUGCOMP SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY INDUSTRIAL COOPERATION FOUNDATION JEON, Raok D04NKE HIGHSTAT Patented D04NKE COMPCLAS Tihourea derivatives D04NXG DRUG__ID D04NXG D04NXG DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D04NXG DRUGTYPE Carbohydrates D04NXG HIGHSTAT Patented D04OCD DRUG__ID D04OCD D04OCD DRUGCOMP F. HOFFMANN-LA ROCHE AG GENENTECH, INC D04OCD DRUGTYPE Small molecular drug D04OCD HIGHSTAT Patented D04OEV DRUG__ID D04OEV D04OEV DRUGCOMP MUSC Foundation for Research Development, USA D04OEV DRUGTYPE Peptide D04OEV HIGHSTAT Patented D04OXI DRUG__ID D04OXI D04OXI DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D04OXI DRUGTYPE Small molecular drug D04OXI HIGHSTAT Patented D04PCT DRUG__ID D04PCT D04PCT DRUGCOMP ARISING INTERNATIONAL, INC D04PCT DRUGTYPE Small molecule immunotherapy D04PCT HIGHSTAT Patented D04PCW DRUG__ID D04PCW D04PCW DRUGCOMP EPIZYME, INC D04PCW DRUGTYPE Small molecular drug D04PCW HIGHSTAT Patented D04PKQ DRUG__ID D04PKQ D04PKQ DRUGCOMP UNIV MAINZ JOHANNES GUTENBERG [DE] D04PKQ DRUGTYPE Small molecular drug D04PKQ HIGHSTAT Patented D04PKX DRUG__ID D04PKX D04PKX DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D04PKX DRUGTYPE Carbohydrates D04PKX HIGHSTAT Patented D04QRX DRUG__ID D04QRX D04QRX DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D04QRX HIGHSTAT Patented D04QRX COMPCLAS Thiazole carboxamide derivatives D04RXX DRUG__ID D04RXX D04RXX DRUGCOMP PFIZER LIMITED D04RXX HIGHSTAT Patented D04RXX COMPCLAS N-acylpiperidine ether derivatives D04SYJ DRUG__ID D04SYJ D04SYJ DRUGCOMP KYOTO UNIVERSITY D04SYJ DRUGTYPE Small molecular drug D04SYJ HIGHSTAT Patented D04TGG DRUG__ID D04TGG D04TGG DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -,HOSPICES CIVILS DE LYON,ECOLE NORMALE SUPERIEURE DE LYON,UNIVERSITE CLAUDE BERNARD LYON 1,UNIVERSITE DE MONTPELLIER D04TGG DRUGTYPE Small molecular drug D04TGG HIGHSTAT Patented D04TGJ DRUG__ID D04TGJ D04TGJ DRUGCOMP INSA (INSTITUT NATIONAL DES SCIENCES APPLIQUS) DE ROUEN CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) UNIVERSITE DE ROUEN VFP THAPIES D04TGJ DRUGTYPE Small molecular drug D04TGJ HIGHSTAT Patented D04TUG DRUG__ID D04TUG D04TUG DRUGCOMP NOVARTIS AG BEATTIE, David BAETTIG, Urs LEGRAND, Darren Mark LISTER, Andrew Stuart MCKENNA, Jeffrey PEARCE, David William SANDHAM, David Andrew STEWARD, Oliver Ross THOMSON, Christopher D04TUG DRUGTYPE Small molecular drug D04TUG HIGHSTAT Patented D04UGJ DRUG__ID D04UGJ D04UGJ DRUGCOMP INCYTE CORPORATION D04UGJ DRUGTYPE Small molecular drug D04UGJ HIGHSTAT Patented D04UHW DRUG__ID D04UHW D04UHW DRUGCOMP Novartis D04UHW DRUGTYPE Small molecular drug D04UHW HIGHSTAT Patented D04VUH DRUG__ID D04VUH D04VUH DRUGCOMP EMCURE PHARMACEUTICALS LIMITED D04VUH DRUGTYPE Small molecular drug D04VUH HIGHSTAT Patented D04XHE DRUG__ID D04XHE D04XHE DRUGCOMP Kunming Inst Botany CN ACAD D04XHE DRUGTYPE Small molecular drug D04XHE HIGHSTAT Patented D04YKO DRUG__ID D04YKO D04YKO DRUGCOMP PROXIMAGEN LTD. BOYD, Joe William MEO, Paul HIGGINBOTTOM, Michael SIMPSON, Iain MOUNTFORD, David Mark SAVORY, Edward Daniel D04YKO DRUGTYPE Small molecular drug D04YKO HIGHSTAT Patented D05AJX DRUG__ID D05AJX D05AJX DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D05AJX DRUGTYPE Small molecular drug D05AJX HIGHSTAT Patented D05AUY DRUG__ID D05AUY D05AUY DRUGCOMP PUSAN NAT UNIVERSITY INDUSTRYUNIVERSITY [KR] D05AUY DRUGTYPE Small molecular drug D05AUY HIGHSTAT Patented D05BGS DRUG__ID D05BGS D05BGS DRUGCOMP Vertex Pharmaceuticals, Inc D05BGS DRUGTYPE Small molecular drug D05BGS HIGHSTAT Patented D05BTL DRUG__ID D05BTL D05BTL DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D05BTL DRUGTYPE Carbohydrates D05BTL HIGHSTAT Patented D05CBP DRUG__ID D05CBP D05CBP DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D05CBP DRUGTYPE Carbohydrates D05CBP HIGHSTAT Patented D05CWM DRUG__ID D05CWM D05CWM DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D05CWM DRUGTYPE Small molecular drug D05CWM HIGHSTAT Patented D05CXZ DRUG__ID D05CXZ D05CXZ DRUGCOMP HANGZHOU GAMMA BIOTECH CO., LTD D05CXZ DRUGTYPE Small molecular drug D05CXZ HIGHSTAT Patented D05EMI DRUG__ID D05EMI D05EMI DRUGCOMP THE HAMNER INSTITUTES D05EMI DRUGTYPE Small molecular drug D05EMI HIGHSTAT Patented D05FVW DRUG__ID D05FVW D05FVW DRUGCOMP UNIVERSITY OF UTAUNIVERSITY OF UTAH RESEARCH FOUNDATIOUNIVERSITY OF UTAH RESEARCH FOUNDATION VANKAYALAPATI, Hariprasad SORNA, Venkataswamy WARNER, Steve, L. BEARSS, David, J. SHARMA, Sunil STEPHENS, BreUniversity of Utah, USA D05FVW DRUGTYPE Small molecular drug D05FVW HIGHSTAT Patented D05GVV DRUG__ID D05GVV D05GVV DRUGCOMP Allergan, Inc D05GVV DRUGTYPE Small molecular drug D05GVV HIGHSTAT Patented D05HBS DRUG__ID D05HBS D05HBS DRUGTYPE Small molecular drug D05HBS HIGHSTAT Patented D05HBS COMPCLAS Hydroxamate analogs D05HKC DRUG__ID D05HKC D05HKC DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D05HKC DRUGTYPE Carbohydrates D05HKC HIGHSTAT Patented D05IZN DRUG__ID D05IZN D05IZN DRUGCOMP MERCK SHARP & DOHME CORP. WALJI, Abbas, M. NANTERMET, Philippe, G. MOORE, Keith, P. STORR, Rachel Anne VASSALLO, Laura KREATSOULAS, Constantine D05IZN DRUGTYPE Small molecular drug D05IZN HIGHSTAT Patented D05LBH DRUG__ID D05LBH D05LBH DRUGCOMP ANGION BIOMEDICA CORP D05LBH DRUGTYPE Small molecular drug D05LBH HIGHSTAT Patented D05LBM DRUG__ID D05LBM D05LBM DRUGCOMP MERCK SHARP &amDOHME CORP. LIU, Ping DEVITA, Robert, J. LIN, Linus, S. CHIODA, Marc, D. HAMILL, Terence, G. LI, Wenping D05LBM DRUGTYPE Small molecular drug D05LBM HIGHSTAT Patented D05MAR DRUG__ID D05MAR D05MAR DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D05MAR DRUGTYPE Small molecular drug D05MAR HIGHSTAT Patented D05MST DRUG__ID D05MST D05MST DRUGCOMP THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA D05MST DRUGTYPE Small molecular drug D05MST HIGHSTAT Patented D05MVF DRUG__ID D05MVF D05MVF DRUGCOMP CORNELL UNIVERSITY D05MVF DRUGTYPE Small molecular drug D05MVF HIGHSTAT Patented D05NMG DRUG__ID D05NMG D05NMG DRUGCOMP BETH ISRAEL DEACONESS MEDICAL CENTER, INC. DIRUSCIO, Annalisa EBRALIDZE, Alexander, K. TENEN, Daniel, G. LEONE, Giuseppe UNIVERSITA CATTOLICA DEL SACRO CUOR D05NMG DRUGTYPE siRNA drug D05NMG HIGHSTAT Patented D05OEZ DRUG__ID D05OEZ D05OEZ DRUGTYPE Small molecular drug D05OEZ HIGHSTAT Patented D05OEZ COMPCLAS Hexahydro azepinone derivatives D05OKZ DRUG__ID D05OKZ D05OKZ DRUGCOMP Chong Kun Dang Pharmaceutical Corp D05OKZ DRUGTYPE Small molecular drug D05OKZ HIGHSTAT Patented D05OMO DRUG__ID D05OMO D05OMO DRUGCOMP CENTRE NAT RECH SCIENT [FRUNIV D AUVERGNE [FRUNIV LILLE SCIENCES TECH [FRUNIV NANTES [FRINST NAT SANTE RECH MED [FR] D05OMO DRUGTYPE Carbohydrates D05OMO HIGHSTAT Patented D05PRG DRUG__ID D05PRG D05PRG DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D05PRG DRUGTYPE Small molecular drug D05PRG HIGHSTAT Patented D05QMA DRUG__ID D05QMA D05QMA DRUGCOMP CELLTECH R & D LIMITED DYKE, Hazel, Joan BUCKLEY, George, Martin D05QMA DRUGTYPE Small molecular drug D05QMA HIGHSTAT Patented D05QYN DRUG__ID D05QYN D05QYN DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D05QYN DRUGTYPE Small molecular drug D05QYN HIGHSTAT Patented D05RJG DRUG__ID D05RJG D05RJG DRUGCOMP University China Pharma D05RJG DRUGTYPE Small molecular drug D05RJG HIGHSTAT Patented D05RUG DRUG__ID D05RUG D05RUG DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D05RUG DRUGTYPE Small molecular drug D05RUG HIGHSTAT Patented D05TBZ DRUG__ID D05TBZ D05TBZ DRUGCOMP CALITHERA BIOSCIENCES, INC D05TBZ DRUGTYPE Small molecular drug D05TBZ HIGHSTAT Patented D05UGL DRUG__ID D05UGL D05UGL DRUGTYPE Small molecular drug D05UGL HIGHSTAT Patented D05UGL COMPCLAS 1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivatives D05UNM DRUG__ID D05UNM D05UNM DRUGCOMP NTZ LAB LTD [BG] D05UNM DRUGTYPE Small molecular drug D05UNM HIGHSTAT Patented D05VVZ DRUG__ID D05VVZ D05VVZ DRUGCOMP Novartis D05VVZ DRUGTYPE Small molecular drug D05VVZ HIGHSTAT Patented D05VWD DRUG__ID D05VWD D05VWD DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D05VWD DRUGTYPE Small molecular drug D05VWD HIGHSTAT Patented D05WCW DRUG__ID D05WCW D05WCW DRUGCOMP BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA NATARAJAN, Amarnath CHEN, Qianyi BRYANT, Vashti, C. RAJULE, Rajkumar D05WCW HIGHSTAT Patented D05WCW COMPCLAS Quinoxaline derivatives D05XGH DRUG__ID D05XGH D05XGH DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D05XGH DRUGTYPE Carbohydrates D05XGH HIGHSTAT Patented D05YHV DRUG__ID D05YHV D05YHV DRUGCOMP Gilead Sciences Inc D05YHV DRUGTYPE Small molecular drug D05YHV HIGHSTAT Patented D05ZHZ DRUG__ID D05ZHZ D05ZHZ DRUGCOMP WASHINGTON UNIVERSITY D05ZHZ DRUGTYPE Carbohydrates D05ZHZ HIGHSTAT Patented D05ZTV DRUG__ID D05ZTV D05ZTV DRUGCOMP Aston University D05ZTV DRUGTYPE Small molecular drug D05ZTV HIGHSTAT Patented D05ZWR DRUG__ID D05ZWR D05ZWR DRUGCOMP SNU R&DB Foundation D05ZWR DRUGTYPE Small molecular drug D05ZWR HIGHSTAT Patented D06ARD DRUG__ID D06ARD D06ARD DRUGCOMP NEUPHARMA, INC. ZHU, Yong-liang QIAN, Xiangping D06ARD DRUGTYPE Small molecular drug D06ARD HIGHSTAT Patented D06BTN DRUG__ID D06BTN D06BTN DRUGCOMP KALA PHARMACEUTICALS, INC D06BTN DRUGTYPE Small molecular drug D06BTN HIGHSTAT Patented D06CGQ DRUG__ID D06CGQ D06CGQ DRUGCOMP Merck Sharp & Dohme Corp D06CGQ DRUGTYPE Small molecular drug D06CGQ HIGHSTAT Patented D06EDH DRUG__ID D06EDH D06EDH DRUGCOMP DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia, M. COURTNEY, Stephen, Martin PRIME, Michael MITCHELL, William BROWN, Christopher, John DE AGUIAR PENA, Paula, C. JOHNSON, Peter D06EDH DRUGTYPE Small molecular drug D06EDH HIGHSTAT Patented D06FIH DRUG__ID D06FIH D06FIH DRUGCOMP Genentech, Inc., USA. assignee D06FIH DRUGTYPE Small molecular drug D06FIH HIGHSTAT Patented D06FLB DRUG__ID D06FLB D06FLB DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D06FLB DRUGTYPE Small molecular drug D06FLB HIGHSTAT Patented D06GDM DRUG__ID D06GDM D06GDM DRUGCOMP ONYX THERAPEUTICS, INC. SHENK, Kevin D. PARLATI, Francesco BENNETT, Mark K D06GDM DRUGTYPE Small molecular drug D06GDM HIGHSTAT Patented D06GSR DRUG__ID D06GSR D06GSR DRUGCOMP THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK D06GSR DRUGTYPE Small molecular drug D06GSR HIGHSTAT Patented D06HEO DRUG__ID D06HEO D06HEO DRUGCOMP Hutchison MediPharma Enterprises Limited, Bahamas D06HEO DRUGTYPE Small molecular drug D06HEO HIGHSTAT Patented D06HJX DRUG__ID D06HJX D06HJX DRUGTYPE Small molecular drug D06HJX HIGHSTAT Patented D06HJX COMPCLAS Thiomorpholine derivatives D06HLW DRUG__ID D06HLW D06HLW DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D06HLW DRUGTYPE Small molecular drug D06HLW HIGHSTAT Patented D06HRI DRUG__ID D06HRI D06HRI DRUGCOMP WASHINGTON UNIVERSITY D06HRI DRUGTYPE Small molecular drug D06HRI HIGHSTAT Patented D06IVC DRUG__ID D06IVC D06IVC DRUGCOMP VAXINNATE CORPORATION NEW YORK UNIVERSITY POWELL, Thomas, J. NAKAAR, Valerian MCDONALD, William, F. NARDIN, Elizabeth, H D06IVC DRUGTYPE Vaccine D06IVC HIGHSTAT Patented D06JRV DRUG__ID D06JRV D06JRV DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BEAUCHAMPS, Marie, Georges HARRIS, Louise, Michelle KOTHARE, Mohit, Atul SAINDANE, Manohar, T D06JRV DRUGTYPE Small molecular drug D06JRV HIGHSTAT Patented D06LCB DRUG__ID D06LCB D06LCB DRUGCOMP Schering Corp D06LCB HIGHSTAT Patented D06LCB COMPCLAS Thiazole carboxamide derivatives D06LHV DRUG__ID D06LHV D06LHV DRUGCOMP UNIVERSITA' DEGLI STUDI DI PADOVA CHILIN, Adriana MARZARO, Giovanni GUIOTTO, Adriano CONCONI, Maria Teresa CASTAGLIUOLO, Ignazio D06LHV DRUGTYPE Small molecular drug D06LHV HIGHSTAT Patented D06LLS DRUG__ID D06LLS D06LLS DRUGCOMP NOVARTIS AG JAIN, Rama LIN, Xiaodong NG, Simon C. PFISTER, Keith B. RAMURTHY, Savithri RICO, Alice SUBRAMANIAN, Sharadha WANG, Xiaojing Michael D06LLS DRUGTYPE Small molecular drug D06LLS HIGHSTAT Patented D06LLT DRUG__ID D06LLT D06LLT DRUGCOMP THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA D06LLT DRUGTYPE Small molecular drug D06LLT HIGHSTAT Patented D06LLY DRUG__ID D06LLY D06LLY DRUGTYPE Small molecular drug D06LLY HIGHSTAT Patented D06LLY COMPCLAS Sulfonamide-thiadiazole derivatives D06MSZ DRUG__ID D06MSZ D06MSZ DRUGCOMP Actelion pharmaceuticals Ltd D06MSZ DRUGTYPE Small molecular drug D06MSZ HIGHSTAT Patented D06NBL DRUG__ID D06NBL D06NBL DRUGCOMP IMPACT THERAPEUTICS, INC. CAI, Suixiong TIAN, Ye Edward WANG, Xiaozhu XIE, Kai LI, Sicun YU, Zenghui GU, Chengyun LIU, Lijun D06NBL DRUGTYPE Small molecular drug D06NBL HIGHSTAT Patented D06OXO DRUG__ID D06OXO D06OXO DRUGCOMP CORNELL UNIVERSITY D06OXO DRUGTYPE Small molecular drug D06OXO HIGHSTAT Patented D06PPD DRUG__ID D06PPD D06PPD DRUGTYPE Small molecular drug D06PPD HIGHSTAT Patented D06PPD COMPCLAS Imidazopyridine acetamide analogs D06PSM DRUG__ID D06PSM D06PSM DRUGCOMP DEBRECENI EGYETEM D06PSM DRUGTYPE Carbohydrates D06PSM HIGHSTAT Patented D06PTW DRUG__ID D06PTW D06PTW DRUGCOMP Schering Corp D06PTW HIGHSTAT Patented D06PTW COMPCLAS Thiazole carboxamide derivatives D06RBE DRUG__ID D06RBE D06RBE DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D06RBE DRUGTYPE Small molecular drug D06RBE HIGHSTAT Patented D06RGW DRUG__ID D06RGW D06RGW DRUGCOMP Vernalis Cambridge Ltd D06RGW DRUGTYPE Small molecular drug D06RGW HIGHSTAT Patented D06RIO DRUG__ID D06RIO D06RIO DRUGCOMP F. HOFFMANN-LA ROCHE AG GOBBI, Luca JAESCHKE, Georg RODRIGUEZ SARMIENTO, Rosa Maria STEWARD, LucindHoffmann-La Roche Inc D06RIO DRUGTYPE Small molecular drug D06RIO HIGHSTAT Patented D06SJU DRUG__ID D06SJU D06SJU DRUGCOMP CORNELL UNIVERSITY D06SJU DRUGTYPE Small molecular drug D06SJU HIGHSTAT Patented D06SKI DRUG__ID D06SKI D06SKI DRUGTYPE Small molecular drug D06SKI HIGHSTAT Patented D06SKI COMPCLAS Sulfamic acid ester derivatives D06TPB DRUG__ID D06TPB D06TPB DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D06TPB DRUGTYPE Small molecular drug D06TPB HIGHSTAT Patented D06TXR DRUG__ID D06TXR D06TXR DRUGCOMP ALVINE PHARMACEUTICALS, INC. PHARMIX CORPORATION GRIFFIN, John LANZA, Guido BOARDMAN, Paul SPENCER, Andrew D06TXR DRUGTYPE Small molecular drug D06TXR HIGHSTAT Patented D06UKM DRUG__ID D06UKM D06UKM DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D06UKM DRUGTYPE Small molecular drug D06UKM HIGHSTAT Patented D06UXE DRUG__ID D06UXE D06UXE DRUGCOMP Medshine Discovery Inc D06UXE DRUGTYPE Small molecular drug D06UXE HIGHSTAT Patented D06WAN DRUG__ID D06WAN D06WAN DRUGCOMP MERCK PATENT GMBH D06WAN DRUGTYPE Small molecular drug D06WAN HIGHSTAT Patented D06WXJ DRUG__ID D06WXJ D06WXJ DRUGCOMP Schering Corp D06WXJ HIGHSTAT Patented D06WXJ COMPCLAS Thiazole carboxamide derivatives D06XCD DRUG__ID D06XCD D06XCD DRUGCOMP VIROBAY, INC. BOOTH, Rober D06XCD DRUGTYPE Small molecular drug D06XCD HIGHSTAT Patented D06XEU DRUG__ID D06XEU D06XEU DRUGCOMP IEO - ISTITUTO EUROPEO DI ONCOLOGIA S.R.L D06XEU DRUGTYPE Small molecular drug D06XEU HIGHSTAT Patented D06XTA DRUG__ID D06XTA D06XTA DRUGCOMP THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA DIAMOND, Scott, L. BEAVERS, Mary, Pat HURYN, Donna MYERS, Michael, C. SMITH, Amos, B. SHAH, Parag, P. LIU, Zhuqin D06XTA DRUGTYPE Small molecular drug D06XTA HIGHSTAT Patented D06XWQ DRUG__ID D06XWQ D06XWQ DRUGCOMP Amorepacific Corp D06XWQ DRUGTYPE Small molecular drug D06XWQ HIGHSTAT Patented D06YAB DRUG__ID D06YAB D06YAB DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D06YAB DRUGTYPE Small molecular drug D06YAB HIGHSTAT Patented D06YCW DRUG__ID D06YCW D06YCW DRUGCOMP LUNDBECK & CO AS H [DK] D06YCW DRUGTYPE Small molecular drug D06YCW HIGHSTAT Patented D06YEK DRUG__ID D06YEK D06YEK DRUGTYPE Small molecular drug D06YEK HIGHSTAT Patented D06YEK COMPCLAS 1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivatives D07AJO DRUG__ID D07AJO D07AJO DRUGCOMP MERCK SHARP & DOHME CORP D07AJO HIGHSTAT Patented D07AJO COMPCLAS Bicyclic heteroaryl benzamide derivatives D07AVU DRUG__ID D07AVU D07AVU DRUGCOMP ALLERGAN, INC D07AVU DRUGTYPE Small molecular drug D07AVU HIGHSTAT Patented D07AVV DRUG__ID D07AVV D07AVV DRUGCOMP UNIVERSITY OF COPENHAGEN D07AVV DRUGTYPE Peptide D07AVV HIGHSTAT Patented D07AXK DRUG__ID D07AXK D07AXK DRUGCOMP Peptron Inc D07AXK DRUGTYPE Small molecular drug D07AXK HIGHSTAT Patented D07BIQ DRUG__ID D07BIQ D07BIQ DRUGCOMP DUKE UNIVERSITY D07BIQ DRUGTYPE Small molecular drug D07BIQ HIGHSTAT Patented D07CMZ DRUG__ID D07CMZ D07CMZ DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D07CMZ DRUGTYPE Small molecular drug D07CMZ HIGHSTAT Patented D07CPL DRUG__ID D07CPL D07CPL DRUGCOMP MERCK SHARP & DOHME CORP D07CPL HIGHSTAT Patented D07CPL COMPCLAS Bicyclic heteroaryl benzamide derivatives D07CZI DRUG__ID D07CZI D07CZI DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D07CZI DRUGTYPE Small molecular drug D07CZI HIGHSTAT Patented D07DBU DRUG__ID D07DBU D07DBU DRUGCOMP KYORIN SEIYAKU KK [JPTAKAHASHI HIROYASU [JPHIGUCHI HIROMI [JP] D07DBU HIGHSTAT Patented D07DBU COMPCLAS Dihydrothieno [2,3-e]indazole derivatives D07DFC DRUG__ID D07DFC D07DFC DRUGTYPE Small molecular drug D07DFC HIGHSTAT Patented D07DFC COMPCLAS Aromatic hydrazine carboxyimidoamide derivatives D07DGA DRUG__ID D07DGA D07DGA DRUGCOMP UNIVERSITY OF TAMPERE SUPURAN, Claudiu PARKKILA, Seppo D07DGA DRUGTYPE Small molecular drug D07DGA HIGHSTAT Patented D07DJR DRUG__ID D07DJR D07DJR DRUGCOMP BIONOMICS LIMITED D07DJR DRUGTYPE Small molecular drug D07DJR HIGHSTAT Patented D07EFT DRUG__ID D07EFT D07EFT DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D07EFT DRUGTYPE Small molecular drug D07EFT HIGHSTAT Patented D07ESG DRUG__ID D07ESG D07ESG DRUGCOMP NOVARTIS AG ARTMAN III, Gerald David ELLIOTT, Jason Matthew JI, Nan LIU, Donglei MA, Fupeng MAINOLFI, Nello MEREDITH, Erik MIRANDA, Karl POWERS, James J. RAO, Chang D07ESG DRUGTYPE Small molecular drug D07ESG HIGHSTAT Patented D07FFA DRUG__ID D07FFA D07FFA DRUGCOMP ORIGENIS GMBH D07FFA DRUGTYPE Small molecular drug D07FFA HIGHSTAT Patented D07FWF DRUG__ID D07FWF D07FWF DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D07FWF DRUGTYPE Small molecular drug D07FWF HIGHSTAT Patented D07GSH DRUG__ID D07GSH D07GSH DRUGCOMP ABBVIE DEUTSCHLAND GMBH & CO. KG ABBVIE INC D07GSH DRUGTYPE Small molecular drug D07GSH HIGHSTAT Patented D07GZU DRUG__ID D07GZU D07GZU DRUGCOMP NTZ LAB LTD [BG] D07GZU DRUGTYPE Small molecular drug D07GZU HIGHSTAT Patented D07HNU DRUG__ID D07HNU D07HNU DRUGCOMP Univ Shenyang Chemical Tech D07HNU DRUGTYPE Small molecular drug D07HNU HIGHSTAT Patented D07IOO DRUG__ID D07IOO D07IOO DRUGCOMP Bristol-Myers Squibb Co D07IOO DRUGTYPE Small molecular drug D07IOO HIGHSTAT Patented D07IQM DRUG__ID D07IQM D07IQM DRUGCOMP HANGZHOU GAMMA BIOTECH CO., LTD D07IQM DRUGTYPE Small molecular drug D07IQM HIGHSTAT Patented D07JNJ DRUG__ID D07JNJ D07JNJ DRUGCOMP ABBOTT LABORATORIES D07JNJ DRUGTYPE Small molecular drug D07JNJ HIGHSTAT Patented D07JQX DRUG__ID D07JQX D07JQX DRUGCOMP F. HOFFMANN-LA ROCHE AG BOICE, Genevieve N. GONG, Leyi MCCALEB, Kristen Lynn PALMER, Wylie Solang D07JQX DRUGTYPE Small molecular drug D07JQX HIGHSTAT Patented D07KON DRUG__ID D07KON D07KON DRUGCOMP ASTRAZENECA AB CANCER RESEARCH TECHNOLOGY LIMITED D07KON DRUGTYPE Small molecular drug D07KON HIGHSTAT Patented D07KVU DRUG__ID D07KVU D07KVU DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi TAN, Yun-chou D07KVU DRUGTYPE Small molecular drug D07KVU HIGHSTAT Patented D07LKA DRUG__ID D07LKA D07LKA DRUGCOMP CELGENE QUANTICEL RESEARCH, INC D07LKA DRUGTYPE Small molecular drug D07LKA HIGHSTAT Patented D07MQD DRUG__ID D07MQD D07MQD DRUGCOMP ORYZON GENOMICS SA [ESORYZON GENOMICS S.A. BAKER, Jonathan, Alleman CASTRO PALOMINO, Julio FYFE, Matthew, Colin, Thor MAES, Tamara MARTINELL PEDEMONTE, MarORYZON GENOMICS, S.A. BAKER, Jonathan, Alleman FYFE, Matthew, Colin Thor D07MQD DRUGTYPE Small molecular drug D07MQD HIGHSTAT Patented D07MSB DRUG__ID D07MSB D07MSB DRUGCOMP Schering Corp D07MSB HIGHSTAT Patented D07MSB COMPCLAS Thiazole carboxamide derivatives D07NDT DRUG__ID D07NDT D07NDT DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D07NDT DRUGTYPE Small molecular drug D07NDT HIGHSTAT Patented D07NTP DRUG__ID D07NTP D07NTP DRUGCOMP ENANTA PHARMACEUTICALS, INC D07NTP DRUGTYPE Small molecular drug D07NTP HIGHSTAT Patented D07OVM DRUG__ID D07OVM D07OVM DRUGCOMP Amorepacific Corp D07OVM DRUGTYPE Small molecular drug D07OVM HIGHSTAT Patented D07POD DRUG__ID D07POD D07POD DRUGCOMP DEBRECENI EGYETEM D07POD DRUGTYPE Carbohydrates D07POD HIGHSTAT Patented D07PTU DRUG__ID D07PTU D07PTU DRUGCOMP GALAPAGOS NV D07PTU DRUGTYPE Small molecular drug D07PTU HIGHSTAT Patented D07RAA DRUG__ID D07RAA D07RAA DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D07RAA DRUGTYPE Carbohydrates D07RAA HIGHSTAT Patented D07RRL DRUG__ID D07RRL D07RRL DRUGCOMP Verleye M, Guern MEL, Girard P, et al D07RRL DRUGTYPE Small molecular drug D07RRL HIGHSTAT Patented D07RRV DRUG__ID D07RRV D07RRV DRUGCOMP CHIESI FARMACEUTICI S.p.A. BLENCH, Toby Jonathan EDWARDS, Christine HEALD, Robert Andrew KULAGOWSKI, Janusz Jozef SUTTON, Jonathan Mark CAPALDI, CarmelidBoehringer Ingelheim International GmbBayer Intellectual Property GmbH D07RRV HIGHSTAT Patented D07RRV COMPCLAS Tetra-hydro-triazolopyrimidine derivatives D07SSO DRUG__ID D07SSO D07SSO DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D07SSO DRUGTYPE Small molecular drug D07SSO HIGHSTAT Patented D07SSU DRUG__ID D07SSU D07SSU DRUGCOMP CORNELL UNIVERSITY D07SSU DRUGTYPE Small molecular drug D07SSU HIGHSTAT Patented D07TUN DRUG__ID D07TUN D07TUN DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D07TUN DRUGTYPE Small molecular drug D07TUN HIGHSTAT Patented D07UBZ DRUG__ID D07UBZ D07UBZ DRUGTYPE Small molecular drug D07UBZ HIGHSTAT Patented D07UBZ COMPCLAS Thiazoline derivatives D07UJJ DRUG__ID D07UJJ D07UJJ DRUGCOMP UNIVERSITA' DEGLI STUDI DI PADOVA CHILIN, Adriana MARZARO, Giovanni GUIOTTO, Adriano CONCONI, Maria Teresa CASTAGLIUOLO, Ignazio D07UJJ DRUGTYPE Small molecular drug D07UJJ HIGHSTAT Patented D07VUL DRUG__ID D07VUL D07VUL DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D07VUL DRUGTYPE Small molecular drug D07VUL HIGHSTAT Patented D07WAT DRUG__ID D07WAT D07WAT DRUGCOMP SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A D07WAT DRUGTYPE Small molecular drug D07WAT HIGHSTAT Patented D07WXU DRUG__ID D07WXU D07WXU DRUGCOMP Vertex Pharmaceuticals, Inc D07WXU DRUGTYPE Small molecular drug D07WXU HIGHSTAT Patented D07XPI DRUG__ID D07XPI D07XPI DRUGCOMP ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY SCHUSTER, Victor, L. CHI, Yuling WASMUTH, Andrew, S. POTTORF, Richard, S. OLSON, Gary, L D07XPI DRUGTYPE Small molecular drug D07XPI HIGHSTAT Patented D07XYI DRUG__ID D07XYI D07XYI DRUGCOMP CEPHALON, INC D07XYI DRUGTYPE Small molecular drug D07XYI HIGHSTAT Patented D07YPE DRUG__ID D07YPE D07YPE DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D07YPE DRUGTYPE Small molecular drug D07YPE HIGHSTAT Patented D07YWE DRUG__ID D07YWE D07YWE DRUGCOMP INSERM INST NAT DE LA SANT ET DE LA RECH M DICALE [FRUNIVERSIT PARIS DIDEROT PARIS 7 [FRCENTRE NAT RECH SCIENT [FR] D07YWE DRUGTYPE Small molecular drug D07YWE HIGHSTAT Patented D07ZCP DRUG__ID D07ZCP D07ZCP DRUGTYPE Small molecular drug D07ZCP HIGHSTAT Patented D07ZCP COMPCLAS Carbamide derivatives D07ZMG DRUG__ID D07ZMG D07ZMG DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D07ZMG HIGHSTAT Patented D07ZMG COMPCLAS Thiazole carboxamide derivatives D07ZUO DRUG__ID D07ZUO D07ZUO DRUGCOMP IMPACT THERAPEUTICS, INC D07ZUO DRUGTYPE Small molecular drug D07ZUO HIGHSTAT Patented D08BIH DRUG__ID D08BIH D08BIH DRUGCOMP PFIZER INC D08BIH HIGHSTAT Patented D08BIH COMPCLAS N-acylpyrrolidine ether derivatives D08DJY DRUG__ID D08DJY D08DJY DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D08DJY DRUGTYPE Small molecular drug D08DJY HIGHSTAT Patented D08EGT DRUG__ID D08EGT D08EGT DRUGCOMP SUNESIS PHARMACEUTICALS BIOGEN IDEC MA INC. LIND, Kenneth, Egnard CAO, Kathy LIN, Edward, Yin-shiang NGUYEN, Thinh, Ba TANGONAN, Bradley, T. ERLANSON, Daniel, A. GUCKIAN, Kevin SIMMONS, Robert, Lowell LEE, Wen-cherng BIOGEN IDEC, INC. SUN, Lihong HANSEN, Stig PATHAN, Nuzhat ZHANG, Lei D08EGT DRUGTYPE Small molecular drug D08EGT HIGHSTAT Patented D08FMC DRUG__ID D08FMC D08FMC DRUGCOMP UNIV BEIJING PEKING WBL BIOTECH CO LTD [CN] D08FMC DRUGTYPE Small molecular drug D08FMC HIGHSTAT Patented D08FVR DRUG__ID D08FVR D08FVR DRUGCOMP THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION on behalf of THE UNIVERSITY OF NEVADA, LAS VEGAS D08FVR DRUGTYPE Small molecular drug D08FVR HIGHSTAT Patented D08GSN DRUG__ID D08GSN D08GSN DRUGCOMP DEBRECENI EGYETEM D08GSN DRUGTYPE Carbohydrates D08GSN HIGHSTAT Patented D08GXR DRUG__ID D08GXR D08GXR DRUGCOMP F. HOFFMANN-LA ROCHE AG D08GXR DRUGTYPE Small molecular drug D08GXR HIGHSTAT Patented D08HBF DRUG__ID D08HBF D08HBF DRUGCOMP Merck Sharp & Dohme Corp D08HBF DRUGTYPE Small molecular drug D08HBF HIGHSTAT Patented D08HPR DRUG__ID D08HPR D08HPR DRUGCOMP ARES TRADING S.A D08HPR DRUGTYPE Small molecular drug D08HPR HIGHSTAT Patented D08INZ DRUG__ID D08INZ D08INZ DRUGCOMP BORYUNG PHARMACEUTICAL CO., LTD. KIM, Ji Han KIM, Je Hak LEE, Joon Kwang JUNG, Hahn-Sun HAN, Nam Seok PARK, Yong D08INZ DRUGTYPE Small molecular drug D08INZ HIGHSTAT Patented D08KAT DRUG__ID D08KAT D08KAT DRUGCOMP Kissei Pharmaceutical Co. Ltd D08KAT DRUGTYPE Small molecular drug D08KAT HIGHSTAT Patented D08LIB DRUG__ID D08LIB D08LIB DRUGCOMP INTERCEPT PHARMACEUTICALS, INC. PELLICCIARI, Roberto FIORUCCI, Stefano PRUZANSKI, Mark D08LIB DRUGTYPE Small molecular drug D08LIB HIGHSTAT Patented D08LPX DRUG__ID D08LPX D08LPX DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -,HOSPICES CIVILS DE LYON,ECOLE NORMALE SUPERIEURE DE LYON,UNIVERSITE CLAUDE BERNARD LYON 1,UNIVERSITE DE MONTPELLIER D08LPX DRUGTYPE Small molecular drug D08LPX HIGHSTAT Patented D08MBD DRUG__ID D08MBD D08MBD DRUGCOMP Gilead Sciences D08MBD DRUGTYPE Small molecular drug D08MBD HIGHSTAT Patented D08NNH DRUG__ID D08NNH D08NNH DRUGCOMP Merck Sharp & Dohme D08NNH DRUGTYPE Small molecular drug D08NNH HIGHSTAT Patented D08OJQ DRUG__ID D08OJQ D08OJQ DRUGCOMP SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE PELLECCHIA, Maurizio D08OJQ DRUGTYPE Small molecular drug D08OJQ HIGHSTAT Patented D08OXH DRUG__ID D08OXH D08OXH DRUGCOMP Sunshine Lake Pharma Co., LtdCalitor Sciences, LLC D08OXH DRUGTYPE Small molecular drug D08OXH HIGHSTAT Patented D08PHH DRUG__ID D08PHH D08PHH DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D08PHH DRUGTYPE Small molecular drug D08PHH HIGHSTAT Patented D08PQU DRUG__ID D08PQU D08PQU DRUGCOMP Aventis Pharmaceuticals, Inc D08PQU DRUGTYPE Small molecular drug D08PQU HIGHSTAT Patented D08RNV DRUG__ID D08RNV D08RNV DRUGTYPE Small molecular drug D08RNV HIGHSTAT Patented D08RNV COMPCLAS Aryl oxyanilide derivatives D08RUG DRUG__ID D08RUG D08RUG DRUGCOMP LABORATORIOS DEL DR. ESTEVE, S.A D08RUG DRUGTYPE Small molecular drug D08RUG HIGHSTAT Patented D08RXZ DRUG__ID D08RXZ D08RXZ DRUGCOMP PRINCIPIA BIOPHARMA INC D08RXZ DRUGTYPE Small molecular drug D08RXZ HIGHSTAT Patented D08SNJ DRUG__ID D08SNJ D08SNJ DRUGCOMP KARUS THERAPEUTICS LTD D08SNJ DRUGTYPE Small molecular drug D08SNJ HIGHSTAT Patented D08SNT DRUG__ID D08SNT D08SNT DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D08SNT HIGHSTAT Patented D08SNT COMPCLAS Heteroaryl-carboxamide derivatives D08TDJ DRUG__ID D08TDJ D08TDJ DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D08TDJ DRUGTYPE Small molecular drug D08TDJ HIGHSTAT Patented D08TOM DRUG__ID D08TOM D08TOM DRUGCOMP GLAXOSMITHKLINE BIOLOGICALS S.A D08TOM DRUGTYPE Vaccine D08TOM HIGHSTAT Patented D08UCB DRUG__ID D08UCB D08UCB DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY HUANG, Yanting SUN, Chongqing LAWRENCE, R., Michael EWING, William, R. TURDI, Huji D08UCB DRUGTYPE Small molecular drug D08UCB HIGHSTAT Patented D08UFW DRUG__ID D08UFW D08UFW DRUGCOMP Leland Stanford Junior University D08UFW DRUGTYPE Small molecular drug D08UFW HIGHSTAT Patented D08UQK DRUG__ID D08UQK D08UQK DRUGCOMP ABBVIE DEUTSCHLAND GMBH &amCO. KG ABBVIE INC D08UQK DRUGTYPE Small molecular drug D08UQK HIGHSTAT Patented D08UXR DRUG__ID D08UXR D08UXR DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D08UXR DRUGTYPE Small molecular drug D08UXR HIGHSTAT Patented D08VBG DRUG__ID D08VBG D08VBG DRUGCOMP ORIGENIS GMBH D08VBG DRUGTYPE Small molecular drug D08VBG HIGHSTAT Patented D08VDV DRUG__ID D08VDV D08VDV DRUGCOMP CHEMOCENTRYX, INC D08VDV DRUGTYPE Small molecule immunotherapy D08VDV HIGHSTAT Patented D08VTV DRUG__ID D08VTV D08VTV DRUGCOMP WONKWANG UNIVERSITY CENTER FOR INDUSTRY-ACADEMY COOPERATION D08VTV DRUGTYPE Small molecular drug D08VTV HIGHSTAT Patented D08WPB DRUG__ID D08WPB D08WPB DRUGCOMP SHANGHAI YUNYI HEALTHCARE MANAGEMENT CO., LTD CHINA GATEWAY TECHNOLOGY DEVELOPMENT D08WPB DRUGTYPE Small molecular drug D08WPB HIGHSTAT Patented D08WZC DRUG__ID D08WZC D08WZC DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D08WZC DRUGTYPE Carbohydrates D08WZC HIGHSTAT Patented D08XAY DRUG__ID D08XAY D08XAY DRUGCOMP SUZHOU INSTITUTE OF NANO-TECH AND NANO-BIONICS(SINANO), CAS D08XAY DRUGTYPE Antibody D08XAY HIGHSTAT Patented D08XLK DRUG__ID D08XLK D08XLK DRUGCOMP KARUS THERAPEUTICS LTD D08XLK DRUGTYPE Small molecular drug D08XLK HIGHSTAT Patented D08YAL DRUG__ID D08YAL D08YAL DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D08YAL DRUGTYPE Small molecular drug D08YAL HIGHSTAT Patented D08YMD DRUG__ID D08YMD D08YMD DRUGCOMP BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA NATARAJAN, Amarnath CHEN, Qianyi BRYANT, Vashti, C. RAJULE, Rajkumar D08YMD HIGHSTAT Patented D08YMD COMPCLAS Quinoxaline derivatives D08YPQ DRUG__ID D08YPQ D08YPQ DRUGCOMP Schering Corp D08YPQ HIGHSTAT Patented D08YPQ COMPCLAS Thiazole carboxamide derivatives D08ZAW DRUG__ID D08ZAW D08ZAW DRUGCOMP ENANTA PHARMACEUTICALS, INC D08ZAW DRUGTYPE Small molecular drug D08ZAW HIGHSTAT Patented D08ZDR DRUG__ID D08ZDR D08ZDR DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS -,HOSPICES CIVILS DE LYON,ECOLE NORMALE SUPERIEURE DE LYON,UNIVERSITE CLAUDE BERNARD LYON 1,UNIVERSITE DE MONTPELLIER D08ZDR DRUGTYPE Small molecular drug D08ZDR HIGHSTAT Patented D08ZHA DRUG__ID D08ZHA D08ZHA DRUGCOMP BIOCODEX D08ZHA DRUGTYPE Small molecular drug D08ZHA HIGHSTAT Patented D08ZJZ DRUG__ID D08ZJZ D08ZJZ DRUGCOMP KARUS THERAPEUTICS LTD D08ZJZ DRUGTYPE Small molecular drug D08ZJZ HIGHSTAT Patented D09ACU DRUG__ID D09ACU D09ACU DRUGCOMP CENTRE NAT RECH SCIENT [FR D09ACU DRUGTYPE Small molecular drug D09ACU HIGHSTAT Patented D09ATD DRUG__ID D09ATD D09ATD DRUGCOMP RANBAXY LABORATORIES LIMITED KHERA, Manoj, Kumar SATTIGERI, Jitendra SATTIGERI, Viswajanani YADAV, Neeraj, Kumar KUMAR, Kewal RAUF, Abdul, Rehman, Abdul CLIFFE, Ian, A. BHATNAGAR, Pradip, Kumar RAY, Abhijit SRIVASTAVA, Punit DASTIDAR, Sunanda, Ghosh D09ATD DRUGTYPE Small molecular drug D09ATD HIGHSTAT Patented D09BCJ DRUG__ID D09BCJ D09BCJ DRUGCOMP INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK,UNIWERSYTET JAGIELLO SKI D09BCJ DRUGTYPE Small molecular drug D09BCJ HIGHSTAT Patented D09EGD DRUG__ID D09EGD D09EGD DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D09EGD DRUGTYPE Small molecular drug D09EGD HIGHSTAT Patented D09EIX DRUG__ID D09EIX D09EIX DRUGCOMP THE UNIVERSITY OF QUEENSLAND FAIRLIE, David Paul LIU, Ligong YAU, Mei-Kwan SUEN, Jacky Yung REID, Robert LOHMAN, Rink-Jan IYER, Abishek Venkatasubramanian LIM, Junxian BROWN, Lindsay CharleThe University of Queensland D09EIX DRUGTYPE Small molecular drug D09EIX HIGHSTAT Patented D09EPZ DRUG__ID D09EPZ D09EPZ DRUGTYPE Small molecular drug D09EPZ HIGHSTAT Patented D09EPZ COMPCLAS 4-pyridone derivatives D09EWC DRUG__ID D09EWC D09EWC DRUGCOMP SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE PELLECCHIA, Maurizio D09EWC DRUGTYPE Small molecular drug D09EWC HIGHSTAT Patented D09EXQ DRUG__ID D09EXQ D09EXQ DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D09EXQ DRUGTYPE Carbohydrates D09EXQ HIGHSTAT Patented D09GWR DRUG__ID D09GWR D09GWR DRUGCOMP NATIONAL UNIVERSITY OF SINGAPORE RAGHUNATH, Michael BLOCKI, Anna D09GWR DRUGTYPE Antibody D09GWR HIGHSTAT Patented D09HTY DRUG__ID D09HTY D09HTY DRUGCOMP Bristol-Myers Squibb Co D09HTY DRUGTYPE Small molecular drug D09HTY HIGHSTAT Patented D09ISI DRUG__ID D09ISI D09ISI DRUGCOMP ANYGEN CO., LTD. KIM, Yong-Chul KIM, Jae-Il BAN, Soo-Ho JEONG, Soon-Young CHOI, Soo-Jeong LEE, Jung-Eun D09ISI DRUGTYPE Small molecular drug D09ISI HIGHSTAT Patented D09JDV DRUG__ID D09JDV D09JDV DRUGCOMP WASHINGTON UNIVERSITY D09JDV DRUGTYPE Carbohydrates D09JDV HIGHSTAT Patented D09JLL DRUG__ID D09JLL D09JLL DRUGCOMP PRINCIPIA BIOPHARMA INC D09JLL DRUGTYPE Small molecular drug D09JLL HIGHSTAT Patented D09JTT DRUG__ID D09JTT D09JTT DRUGCOMP TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED D09JTT DRUGTYPE Small molecular drug D09JTT HIGHSTAT Patented D09KCN DRUG__ID D09KCN D09KCN DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D09KCN DRUGTYPE Small molecular drug D09KCN HIGHSTAT Patented D09KWM DRUG__ID D09KWM D09KWM DRUGCOMP Wisconsin-Alumni-Research-Foundation D09KWM DRUGTYPE Small molecular drug D09KWM HIGHSTAT Patented D09KYB DRUG__ID D09KYB D09KYB DRUGCOMP Allergan, Inc D09KYB DRUGTYPE Small molecular drug D09KYB HIGHSTAT Patented D09LAD DRUG__ID D09LAD D09LAD DRUGCOMP ABIDE THERAPEUTICS, INC D09LAD DRUGTYPE Small molecular drug D09LAD HIGHSTAT Patented D09LWP DRUG__ID D09LWP D09LWP DRUGCOMP WASHINGTON UNIVERSITY D09LWP DRUGTYPE Carbohydrates D09LWP HIGHSTAT Patented D09OMM DRUG__ID D09OMM D09OMM DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. SHI, Yujiang Geno LIAN, Christine Guo D09OMM DRUGTYPE Small molecular drug D09OMM HIGHSTAT Patented D09OSS DRUG__ID D09OSS D09OSS DRUGTYPE Small molecular drug D09OSS HIGHSTAT Patented D09OSS COMPCLAS Dihydropyrido phthalazinone derivatives D09PAZ DRUG__ID D09PAZ D09PAZ DRUGCOMP DEBRECENI EGYETEM D09PAZ DRUGTYPE Carbohydrates D09PAZ HIGHSTAT Patented D09PIS DRUG__ID D09PIS D09PIS DRUGCOMP CELLZOME LIMITED RAMSDEN, Nigel DAGOSTIN, Claudio D09PIS HIGHSTAT Patented D09PIS COMPCLAS Pyrazolo[4,3-c]pyridine derivatives D09PVH DRUG__ID D09PVH D09PVH DRUGCOMP CHONG KUN DANG PHARMACEUTICAL CORP D09PVH DRUGTYPE Small molecular drug D09PVH HIGHSTAT Patented D09RUN DRUG__ID D09RUN D09RUN DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D09RUN HIGHSTAT Patented D09RUN COMPCLAS Pyrazolopyridine derivatives D09RWM DRUG__ID D09RWM D09RWM DRUGCOMP LUNDBECK & CO AS H [DK] D09RWM DRUGTYPE Small molecular drug D09RWM HIGHSTAT Patented D09SSG DRUG__ID D09SSG D09SSG DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D09SSG DRUGTYPE Small molecular drug D09SSG HIGHSTAT Patented D09SWG DRUG__ID D09SWG D09SWG DRUGCOMP MERCK SHARP &amDOHME CORP. LIN, Linus, S. CHANG, Linda, L. CHOBANIAN, Harry NARGUND, Ravi, P D09SWG DRUGTYPE Small molecular drug D09SWG HIGHSTAT Patented D09UJB DRUG__ID D09UJB D09UJB DRUGCOMP PFIZER PRODUCTS INC. BRODNEY, Michael, Aaron CHEN, Yuhpyng, Liang COFFMAN, Karen, Jean KLEINMAN, Edward, Fox O'NEILL, Brian, Thomas D09UJB DRUGTYPE Small molecular drug D09UJB HIGHSTAT Patented D09VRO DRUG__ID D09VRO D09VRO DRUGTYPE Small molecular drug D09VRO HIGHSTAT Patented D09VRO COMPCLAS Cyclohexyl carbamate derivatives D09WPA DRUG__ID D09WPA D09WPA DRUGCOMP NORTHEASTERN UNIVERSITY D09WPA DRUGTYPE Small molecular drug D09WPA HIGHSTAT Patented D09WRT DRUG__ID D09WRT D09WRT DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D09WRT DRUGTYPE Small molecular drug D09WRT HIGHSTAT Patented D09WUW DRUG__ID D09WUW D09WUW DRUGCOMP ARES TRADING S.A D09WUW DRUGTYPE Small molecular drug D09WUW HIGHSTAT Patented D09XWR DRUG__ID D09XWR D09XWR DRUGCOMP AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH NATIONAL UNIVERSITY OF SINGAPORE CHAI, Christina, L., L. BERNARDO, Paul, H. XU, Jin YU, Victor, C. WAN, Kah-Fei MOK, Henry, Y., K. SIVARAMAN, Thirunavukkarasu KJRISHNAMOORTHY, Janarthanan D09XWR DRUGTYPE Small molecular drug D09XWR HIGHSTAT Patented D0A0UX DRUG__ID D0A0UX D0A0UX DRUGCOMP MERCK SHARP &amDOHME CORP. PISSARNITSKI, Dmitri ZHAO, Zhiqiang D0A0UX DRUGTYPE Small molecular drug D0A0UX HIGHSTAT Patented D0A0VU DRUG__ID D0A0VU D0A0VU DRUGCOMP UNIVERZA V LJUBLJANI D0A0VU DRUGTYPE Small molecular drug D0A0VU HIGHSTAT Patented D0A1DV DRUG__ID D0A1DV D0A1DV DRUGCOMP THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA D0A1DV DRUGTYPE Small molecular drug D0A1DV HIGHSTAT Patented D0A6EX DRUG__ID D0A6EX D0A6EX DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0A6EX DRUGTYPE Small molecular drug D0A6EX HIGHSTAT Patented D0A6RG DRUG__ID D0A6RG D0A6RG DRUGCOMP ALMIRALL SA [ESEASTWOOD PAUL ROBERT [ESBACH TANA JORDI [ESPAGES SANTACANA LLUIS MIQUEL [ES] D0A6RG DRUGTYPE Small molecular drug D0A6RG HIGHSTAT Patented D0A6TU DRUG__ID D0A6TU D0A6TU DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D0A6TU DRUGTYPE Small molecular drug D0A6TU HIGHSTAT Patented D0A8BV DRUG__ID D0A8BV D0A8BV DRUGCOMP TOLERO PHARMACEUTICALS, INC D0A8BV DRUGTYPE Small molecular drug D0A8BV HIGHSTAT Patented D0A8EN DRUG__ID D0A8EN D0A8EN DRUGCOMP VIVOLUX AB LINDER, Stig LARSSON, Rolf D0A8EN DRUGTYPE Small molecular drug D0A8EN HIGHSTAT Patented D0A8GW DRUG__ID D0A8GW D0A8GW DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0A8GW DRUGTYPE Carbohydrates D0A8GW HIGHSTAT Patented D0A9OC DRUG__ID D0A9OC D0A9OC DRUGCOMP Merck & Co., Inc D0A9OC DRUGTYPE Small molecular drug D0A9OC HIGHSTAT Patented D0A9RY DRUG__ID D0A9RY D0A9RY DRUGCOMP CISEN PHARMACEUTICAL CO., LTD. SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY LI, Jianqi WANG, Wenya ZHOU, Bin XIE, Peng DU, Zhenxin LU, Xiulian WENG, Zhijie ZHANG, Qingwei HUANG, Daowei D0A9RY DRUGTYPE Small molecular drug D0A9RY HIGHSTAT Patented D0AA3P DRUG__ID D0AA3P D0AA3P DRUGCOMP INTERCEPT PHARMACEUTICALS, INC D0AA3P DRUGTYPE Small molecular drug D0AA3P HIGHSTAT Patented D0AC8H DRUG__ID D0AC8H D0AC8H DRUGCOMP NOVARTIS AG STRAUB, Christopher Sean CHEN, Zhuoliang D0AC8H DRUGTYPE Small molecular drug D0AC8H HIGHSTAT Patented D0AE0M DRUG__ID D0AE0M D0AE0M DRUGCOMP TOLERO PHARMACEUTICALS, INC D0AE0M DRUGTYPE Small molecular drug D0AE0M HIGHSTAT Patented D0AF4A DRUG__ID D0AF4A D0AF4A DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0AF4A DRUGTYPE Small molecular drug D0AF4A HIGHSTAT Patented D0AG2A DRUG__ID D0AG2A D0AG2A DRUGCOMP PFIZER LIMITED ANDREWS, Mark David BAGAL, Sharanjeet Kaur GIBSON, Karl Richard OMOTO, Kiyoyuki RYCKMANS, Thomas SKERRATT, Sarah Elizabeth STUPPLE, Paul Anthony D0AG2A HIGHSTAT Patented D0AG2A COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0AH3R DRUG__ID D0AH3R D0AH3R DRUGTYPE Small molecular drug D0AH3R HIGHSTAT Patented D0AH3R COMPCLAS Fluorinated donepezil derivatives D0AJ3H DRUG__ID D0AJ3H D0AJ3H DRUGCOMP DEBRECENI EGYETEM D0AJ3H DRUGTYPE Carbohydrates D0AJ3H HIGHSTAT Patented D0AK1F DRUG__ID D0AK1F D0AK1F DRUGCOMP YM BIOSCIENCES AUSTRALIA PTY [AU] D0AK1F DRUGTYPE Small molecular drug D0AK1F HIGHSTAT Patented D0AK2Y DRUG__ID D0AK2Y D0AK2Y DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0AK2Y DRUGTYPE Carbohydrates D0AK2Y HIGHSTAT Patented D0AP1F DRUG__ID D0AP1F D0AP1F DRUGCOMP RICHTER GEDEON NYRT D0AP1F DRUGTYPE Small molecular drug D0AP1F HIGHSTAT Patented D0AP6V DRUG__ID D0AP6V D0AP6V DRUGTYPE Small molecular drug D0AP6V HIGHSTAT Patented D0AP6V COMPCLAS Poly-substituted azoles statin lactone derivatives D0AR6B DRUG__ID D0AR6B D0AR6B DRUGCOMP ONYX THERAPEUTICS, INC D0AR6B DRUGTYPE Small molecular drug D0AR6B HIGHSTAT Patented D0AU4G DRUG__ID D0AU4G D0AU4G DRUGCOMP NERVIANO MEDICAL D0AU4G HIGHSTAT Patented D0AU4G COMPCLAS 3-amino-5-benzyl-substituted indazole derivatives D0AV1B DRUG__ID D0AV1B D0AV1B DRUGCOMP Kissei Pharmaceutical Co. Ltd D0AV1B DRUGTYPE Small molecular drug D0AV1B HIGHSTAT Patented D0AX4Q DRUG__ID D0AX4Q D0AX4Q DRUGCOMP REATA PHARMACEUTICALS, INC D0AX4Q DRUGTYPE Small molecular drug D0AX4Q HIGHSTAT Patented D0AX9N DRUG__ID D0AX9N D0AX9N DRUGCOMP ARENA PHARMACEUTICALS, INC D0AX9N DRUGTYPE Small molecular drug D0AX9N HIGHSTAT Patented D0AY0H DRUG__ID D0AY0H D0AY0H DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0AY0H DRUGTYPE Carbohydrates D0AY0H HIGHSTAT Patented D0B0AS DRUG__ID D0B0AS D0B0AS DRUGCOMP GAMBRO LUNDIA AB [SEJOENSSON LENNART [SENILSSON EDDIE [SESTERNBY JAN [SE] D0B0AS DRUGTYPE Small molecular drug D0B0AS HIGHSTAT Patented D0B0GG DRUG__ID D0B0GG D0B0GG DRUGCOMP THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL MOUNT SINAL SCHOOL OF MEDICINE ORLOWSKI, Robert, Z. ORLOWSKI, Marian D0B0GG DRUGTYPE Small molecular drug D0B0GG HIGHSTAT Patented D0B0VK DRUG__ID D0B0VK D0B0VK DRUGCOMP CORNELL UNIVERSITY D0B0VK DRUGTYPE Small molecular drug D0B0VK HIGHSTAT Patented D0B2GM DRUG__ID D0B2GM D0B2GM DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0B2GM HIGHSTAT Patented D0B2GM COMPCLAS Thiazole carboxamide derivatives D0B2NV DRUG__ID D0B2NV D0B2NV DRUGCOMP LES LABORATOIRES SERVIELES LABORATOIRES SERVIER ROBERT, Nicolas LERESTIF, Jean-Michel LECOUVE, Jean-Pierre GAILLARD, Marina DELCROIX - MEUNIER, Julie LETELLIER, Philippe BOIRET, MathieLES LABORATOIRES SERVIER TROCME-THIBIERGE, Caryn SORS, Aurore KEIME GUIBERT, FlorencLES LABORATOIRES SERVIER CASARA, Patrick CHOLLET, Anne-Marie DHAINAUT, Alain BERT, Lionel LESTAGE, Pierre LOCKHART, Brian D0B2NV DRUGTYPE Small molecular drug D0B2NV HIGHSTAT Patented D0B2YJ DRUG__ID D0B2YJ D0B2YJ DRUGCOMP NTZ LAB LTD [BG] D0B2YJ DRUGTYPE Small molecular drug D0B2YJ HIGHSTAT Patented D0B3GX DRUG__ID D0B3GX D0B3GX DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D0B3GX DRUGTYPE Small molecular drug D0B3GX HIGHSTAT Patented D0B3RK DRUG__ID D0B3RK D0B3RK DRUGCOMP GE HEALTHCARE LIMITED D0B3RK DRUGTYPE Small molecular drug D0B3RK HIGHSTAT Patented D0B5NJ DRUG__ID D0B5NJ D0B5NJ DRUGCOMP TAISHO PHARMA CO LTD [JP] D0B5NJ DRUGTYPE Small molecular drug D0B5NJ HIGHSTAT Patented D0B5QU DRUG__ID D0B5QU D0B5QU DRUGTYPE Small molecular drug D0B5QU HIGHSTAT Patented D0B5QU COMPCLAS 2-pyrazinone derivatives D0B7FH DRUG__ID D0B7FH D0B7FH DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0B7FH DRUGTYPE Small molecular drug D0B7FH HIGHSTAT Patented D0B7KP DRUG__ID D0B7KP D0B7KP DRUGCOMP BIOGEN MA INC D0B7KP DRUGTYPE Small molecular drug D0B7KP HIGHSTAT Patented D0B7NS DRUG__ID D0B7NS D0B7NS DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D0B7NS DRUGTYPE Small molecular drug D0B7NS HIGHSTAT Patented D0B9LM DRUG__ID D0B9LM D0B9LM DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0B9LM DRUGTYPE Carbohydrates D0B9LM HIGHSTAT Patented D0B9ML DRUG__ID D0B9ML D0B9ML DRUGCOMP IMPACT THERAPEUTICS, INC. CAI, Suixiong TIAN, Ye Edward WANG, Xiaozhu XIE, Kai LI, Sicun YU, Zenghui GU, Chengyun LIU, Lijun D0B9ML DRUGTYPE Small molecular drug D0B9ML HIGHSTAT Patented D0B9TH DRUG__ID D0B9TH D0B9TH DRUGCOMP INCYTE CORPORATION D0B9TH DRUGTYPE Small molecular drug D0B9TH HIGHSTAT Patented D0BA5J DRUG__ID D0BA5J D0BA5J DRUGCOMP METHYLGENE INC D0BA5J DRUGTYPE Small molecular drug D0BA5J HIGHSTAT Patented D0BI0F DRUG__ID D0BI0F D0BI0F DRUGCOMP GREEN CROSS CORPORATION LEE, Jinhwa KIM, Jeongmin JUNG, Myung Eun KIM, Jong Yup AHN, Kwangwoo SEO, Hee Jeong LEE, Sung-Han LEE, Suk Ho D0BI0F DRUGTYPE Small molecular drug D0BI0F HIGHSTAT Patented D0BK2I DRUG__ID D0BK2I D0BK2I DRUGCOMP CURADEV PHARMA PVT. LTD D0BK2I DRUGTYPE Small molecular drug D0BK2I HIGHSTAT Patented D0BL4H DRUG__ID D0BL4H D0BL4H DRUGCOMP NEUPHARMA, INC. QIAN, Xiangping ZHU, Yong-liang D0BL4H DRUGTYPE Small molecular drug D0BL4H HIGHSTAT Patented D0BL8W DRUG__ID D0BL8W D0BL8W DRUGCOMP EPIZYME, INC D0BL8W DRUGTYPE Small molecular drug D0BL8W HIGHSTAT Patented D0BN9E DRUG__ID D0BN9E D0BN9E DRUGCOMP ENANTA PHARMACEUTICALS, INC D0BN9E DRUGTYPE Small molecular drug D0BN9E HIGHSTAT Patented D0BU3L DRUG__ID D0BU3L D0BU3L DRUGCOMP Obseva SA D0BU3L DRUGTYPE Small molecular drug D0BU3L HIGHSTAT Patented D0BV4M DRUG__ID D0BV4M D0BV4M DRUGCOMP CHDI FOUNDATION, INC D0BV4M DRUGTYPE Small molecular drug D0BV4M HIGHSTAT Patented D0BW2B DRUG__ID D0BW2B D0BW2B DRUGCOMP VIEVAX CORP. MAHAIRAS, Gregory, G D0BW2B DRUGTYPE Vaccine D0BW2B HIGHSTAT Patented D0BY1R DRUG__ID D0BY1R D0BY1R DRUGCOMP KARUS THERAPEUTICS LTD D0BY1R DRUGTYPE Small molecular drug D0BY1R HIGHSTAT Patented D0C0BP DRUG__ID D0C0BP D0C0BP DRUGCOMP F. HOFFMANN-LA ROCHE AG LUK, Kin-Chun Thomas D0C0BP DRUGTYPE Small molecular drug D0C0BP HIGHSTAT Patented D0C0KI DRUG__ID D0C0KI D0C0KI DRUGTYPE Small molecular drug D0C0KI HIGHSTAT Patented D0C0KI COMPCLAS Aminoazetidine derivatives D0C0LQ DRUG__ID D0C0LQ D0C0LQ DRUGCOMP University of Iowa Research Foundation D0C0LQ DRUGTYPE Small molecular drug D0C0LQ HIGHSTAT Patented D0C2DV DRUG__ID D0C2DV D0C2DV DRUGCOMP VANDERBILT UNIVERSITY D0C2DV DRUGTYPE Small molecular drug D0C2DV HIGHSTAT Patented D0C2EW DRUG__ID D0C2EW D0C2EW DRUGCOMP NTZ LAB LTD [BG] D0C2EW DRUGTYPE Small molecular drug D0C2EW HIGHSTAT Patented D0C2MH DRUG__ID D0C2MH D0C2MH DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0C2MH DRUGTYPE Small molecular drug D0C2MH HIGHSTAT Patented D0C2UP DRUG__ID D0C2UP D0C2UP DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0C2UP DRUGTYPE Small molecular drug D0C2UP HIGHSTAT Patented D0C3HN DRUG__ID D0C3HN D0C3HN DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0C3HN DRUGTYPE Small molecular drug D0C3HN HIGHSTAT Patented D0C3RK DRUG__ID D0C3RK D0C3RK DRUGCOMP PFIZER INC D0C3RK HIGHSTAT Patented D0C3RK COMPCLAS N-(phenylpyrazolyl)benzamide derivatives D0C4BJ DRUG__ID D0C4BJ D0C4BJ DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0C4BJ DRUGTYPE Small molecular drug D0C4BJ HIGHSTAT Patented D0C4JQ DRUG__ID D0C4JQ D0C4JQ DRUGCOMP ONYX THERAPEUTICS, INC. PHIASIVONGSA, Pasit SEHL, Louis, C D0C4JQ DRUGTYPE Small molecular drug D0C4JQ HIGHSTAT Patented D0C4TB DRUG__ID D0C4TB D0C4TB DRUGTYPE Small molecular drug D0C4TB HIGHSTAT Patented D0C4TB COMPCLAS Pyrazole derivatives D0C4VR DRUG__ID D0C4VR D0C4VR DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D0C4VR DRUGTYPE Small molecular drug D0C4VR HIGHSTAT Patented D0C6OW DRUG__ID D0C6OW D0C6OW DRUGCOMP WYETH KREFT, Anthony, Frank RESNICK, Lynn MAYER, Scott, Christian DIAMANTIDIS, George COLE, Derek, Cecil WANG, Tingzhong GALANTE, Rocco, John HOKE, Molly HARRISON, Boyd, Lynn ZHANG, Minsheng D0C6OW DRUGTYPE Small molecular drug D0C6OW HIGHSTAT Patented D0C6VX DRUG__ID D0C6VX D0C6VX DRUGCOMP MERCK PATENT GMBH DORSCH, Dieter WUCHERER-PLIETKER, Margarita MUELLER, Thomas, J., J. MERKUL, Eugen D0C6VX DRUGTYPE Small molecular drug D0C6VX HIGHSTAT Patented D0C7HZ DRUG__ID D0C7HZ D0C7HZ DRUGCOMP Janssen Pharmaceutica NV D0C7HZ DRUGTYPE Small molecular drug D0C7HZ HIGHSTAT Patented D0C8EB DRUG__ID D0C8EB D0C8EB DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0C8EB DRUGTYPE Carbohydrates D0C8EB HIGHSTAT Patented D0CB1C DRUG__ID D0CB1C D0CB1C DRUGTYPE Small molecular drug D0CB1C HIGHSTAT Patented D0CB1C COMPCLAS Tacrine heterodimer derivatives D0CC7A DRUG__ID D0CC7A D0CC7A DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0CC7A DRUGTYPE Small molecular drug D0CC7A HIGHSTAT Patented D0CD8G DRUG__ID D0CD8G D0CD8G DRUGCOMP IMPACT THERAPEUTICS, INC. CAI, Suixiong TIAN, Ye Edward WANG, Xiaozhu XIE, Kai LI, Sicun YU, Zenghui GU, Chengyun LIU, Lijun D0CD8G DRUGTYPE Small molecular drug D0CD8G HIGHSTAT Patented D0CE1R DRUG__ID D0CE1R D0CE1R DRUGCOMP KADMON CORPORATION, LLC D0CE1R DRUGTYPE Antibody D0CE1R HIGHSTAT Patented D0CE8B DRUG__ID D0CE8B D0CE8B DRUGCOMP METASIGNAL THERAPEUTICS INC. SUPURAN, Claudiu DEDHAR, Shoukat CARTA, Fabrizio WINUM, Jean-Yves MCDONALD, Paul C UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES CNRS - DIRE D0CE8B DRUGTYPE Small molecular drug D0CE8B HIGHSTAT Patented D0CG8N DRUG__ID D0CG8N D0CG8N DRUGCOMP MERCK SHARP & DOHME CORP D0CG8N HIGHSTAT Patented D0CG8N COMPCLAS Tri-substituted urea derivatives D0CH4M DRUG__ID D0CH4M D0CH4M DRUGCOMP KARUS THERAPEUTICS LTD D0CH4M DRUGTYPE Small molecular drug D0CH4M HIGHSTAT Patented D0CI2I DRUG__ID D0CI2I D0CI2I DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0CI2I DRUGTYPE Small molecular drug D0CI2I HIGHSTAT Patented D0CI6Y DRUG__ID D0CI6Y D0CI6Y DRUGCOMP Merck Sharp & Dohme Corp D0CI6Y DRUGTYPE Small molecular drug D0CI6Y HIGHSTAT Patented D0CK8H DRUG__ID D0CK8H D0CK8H DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED BINCH, Hayley BRENCHLEY, Guy GOLEC, Julian, M., C. KNEGTEL, Ronald MORTIMORE, Michael PATEL, Sanjay RUTHERFORD, Alistair D0CK8H DRUGTYPE Small molecular drug D0CK8H HIGHSTAT Patented D0CN6Q DRUG__ID D0CN6Q D0CN6Q DRUGCOMP WASHINGTON UNIVERSITY D0CN6Q DRUGTYPE Carbohydrates D0CN6Q HIGHSTAT Patented D0CN7A DRUG__ID D0CN7A D0CN7A DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0CN7A DRUGTYPE Carbohydrates D0CN7A HIGHSTAT Patented D0CR0H DRUG__ID D0CR0H D0CR0H DRUGCOMP Novartis AG D0CR0H DRUGTYPE Small molecular drug D0CR0H HIGHSTAT Patented D0CS9R DRUG__ID D0CS9R D0CS9R DRUGCOMP F. HOFFMANN-LA ROCHE AG ARZENO, Humberto, Bartolome FILONOVA, Lubov GOLDSTEIN, David, Michael GONG, Leyi LOE, Bradley, E. O'BRIEN, Erin, M. PALMER, Wylie, Solang ROTSTEIN, David, Mark SILVA, Tania TAN, Yun-chou D0CS9R DRUGTYPE Small molecular drug D0CS9R HIGHSTAT Patented D0CV1Q DRUG__ID D0CV1Q D0CV1Q DRUGCOMP CENTRE NAT RECH SCIENT [FR D0CV1Q DRUGTYPE Small molecular drug D0CV1Q HIGHSTAT Patented D0CW2F DRUG__ID D0CW2F D0CW2F DRUGTYPE Small molecular drug D0CW2F HIGHSTAT Patented D0CW2F COMPCLAS Poly-substituted miazine derivatives D0D0AX DRUG__ID D0D0AX D0D0AX DRUGCOMP VEGENICS PTY LIMITED D0D0AX DRUGTYPE Antibody D0D0AX HIGHSTAT Patented D0D2BV DRUG__ID D0D2BV D0D2BV DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-EMERY, Fabienne JAKOB-ROETNE, Rolan D0D2BV DRUGTYPE Small molecular drug D0D2BV HIGHSTAT Patented D0D2PS DRUG__ID D0D2PS D0D2PS DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0D2PS DRUGTYPE Small molecular drug D0D2PS HIGHSTAT Patented D0D2PU DRUG__ID D0D2PU D0D2PU DRUGCOMP Peptron Inc D0D2PU DRUGTYPE Small molecular drug D0D2PU HIGHSTAT Patented D0D2QE DRUG__ID D0D2QE D0D2QE DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0D2QE DRUGTYPE Carbohydrates D0D2QE HIGHSTAT Patented D0D2YG DRUG__ID D0D2YG D0D2YG DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0D2YG DRUGTYPE Small molecular drug D0D2YG HIGHSTAT Patented D0D3BL DRUG__ID D0D3BL D0D3BL DRUGTYPE Small molecular drug D0D3BL HIGHSTAT Patented D0D3BL COMPCLAS Pyrazole-3-carboxamide derivatives D0D4BP DRUG__ID D0D4BP D0D4BP DRUGTYPE Small molecular drug D0D4BP HIGHSTAT Patented D0D4BP COMPCLAS Thiomorpholine derivatives D0D5YK DRUG__ID D0D5YK D0D5YK DRUGCOMP Bristol-Myers Squibb Co D0D5YK DRUGTYPE Small molecular drug D0D5YK HIGHSTAT Patented D0D7AI DRUG__ID D0D7AI D0D7AI DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0D7AI DRUGTYPE Small molecular drug D0D7AI HIGHSTAT Patented D0D7AJ DRUG__ID D0D7AJ D0D7AJ DRUGTYPE Small molecular drug D0D7AJ HIGHSTAT Patented D0D7AJ COMPCLAS Pyrazoline derivatives D0D7SL DRUG__ID D0D7SL D0D7SL DRUGCOMP Allergan, Inc D0D7SL DRUGTYPE Small molecular drug D0D7SL HIGHSTAT Patented D0D8MK DRUG__ID D0D8MK D0D8MK DRUGCOMP SUPERGEN, INC. VANKAYALAPATI, Hariprasad LIU, Xiao-hui BEARSS, David, J D0D8MK DRUGTYPE Small molecular drug D0D8MK HIGHSTAT Patented D0D8PF DRUG__ID D0D8PF D0D8PF DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0D8PF HIGHSTAT Patented D0D8PF COMPCLAS Thiazole carboxamide derivatives D0D9CK DRUG__ID D0D9CK D0D9CK DRUGCOMP UNIVERSITY OF CANBERRKYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY EDUCATIONAL CORPORATION KANSAI BUNRI SOUGOUGAKUEN FRONTIER PHARMA INC. KYOTO UNIVERSITY D0D9CK DRUGTYPE Small molecular drug D0D9CK HIGHSTAT Patented D0DA6B DRUG__ID D0DA6B D0DA6B DRUGCOMP CISEN PHARMACEUTICAL CO., LTD. SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY D0DA6B DRUGTYPE Small molecular drug D0DA6B HIGHSTAT Patented D0DC7I DRUG__ID D0DC7I D0DC7I DRUGCOMP CURIS, INC D0DC7I DRUGTYPE Small molecular drug D0DC7I HIGHSTAT Patented D0DD4I DRUG__ID D0DD4I D0DD4I DRUGCOMP NEVADA CANCER INSTITUTE SHENZHEN GRADUATE SCHOOL OF PEKING UNIVERSITY ZHANG, Hui YE, Tao QUAN, Junmin WANG, Jing D0DD4I DRUGTYPE Small molecular drug D0DD4I HIGHSTAT Patented D0DE5I DRUG__ID D0DE5I D0DE5I DRUGCOMP Japan Tobacco, Inc D0DE5I DRUGTYPE Small molecular drug D0DE5I HIGHSTAT Patented D0DG0F DRUG__ID D0DG0F D0DG0F DRUGCOMP ABBOTT LABORATORIES D0DG0F DRUGTYPE Small molecular drug D0DG0F HIGHSTAT Patented D0DG4A DRUG__ID D0DG4A D0DG4A DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0DG4A DRUGTYPE Small molecular drug D0DG4A HIGHSTAT Patented D0DH0O DRUG__ID D0DH0O D0DH0O DRUGCOMP IMPACT THERAPEUTICS, INC D0DH0O DRUGTYPE Small molecular drug D0DH0O HIGHSTAT Patented D0DH7R DRUG__ID D0DH7R D0DH7R DRUGCOMP KARUS THERAPEUTICS LTD D0DH7R DRUGTYPE Small molecular drug D0DH7R HIGHSTAT Patented D0DI1R DRUG__ID D0DI1R D0DI1R DRUGCOMP Sanofi-Aventis D0DI1R DRUGTYPE Small molecular drug D0DI1R HIGHSTAT Patented D0DK3R DRUG__ID D0DK3R D0DK3R DRUGCOMP PRINCIPIA BIOPHARMA INC D0DK3R DRUGTYPE Small molecular drug D0DK3R HIGHSTAT Patented D0DL5J DRUG__ID D0DL5J D0DL5J DRUGCOMP MCCORD, Darlene E. KARAGIANNIS, Thomas D0DL5J DRUGTYPE Small molecular drug D0DL5J HIGHSTAT Patented D0DN3Q DRUG__ID D0DN3Q D0DN3Q DRUGCOMP DR. REDDY'S LABORATORIES LTD D0DN3Q HIGHSTAT Patented D0DN3Q COMPCLAS Pyrazolo[1,5-a]pyridine derivatives D0DO6K DRUG__ID D0DO6K D0DO6K DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0DO6K HIGHSTAT Patented D0DO6K COMPCLAS Thiazole carboxamide derivatives D0DP6U DRUG__ID D0DP6U D0DP6U DRUGCOMP Genentech, Inc., USA. assignee D0DP6U DRUGTYPE Small molecular drug D0DP6U HIGHSTAT Patented D0DP8E DRUG__ID D0DP8E D0DP8E DRUGCOMP Incyte Corporation D0DP8E DRUGTYPE Small molecule immunotherapy D0DP8E HIGHSTAT Patented D0DU4H DRUG__ID D0DU4H D0DU4H DRUGCOMP ONYX THERAPEUTICS, INC D0DU4H DRUGTYPE Small molecular drug D0DU4H HIGHSTAT Patented D0DV4X DRUG__ID D0DV4X D0DV4X DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED D0DV4X DRUGTYPE Small molecular drug D0DV4X HIGHSTAT Patented D0DW5P DRUG__ID D0DW5P D0DW5P DRUGCOMP University China Pharma D0DW5P DRUGTYPE Small molecular drug D0DW5P HIGHSTAT Patented D0DW7A DRUG__ID D0DW7A D0DW7A DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0DW7A DRUGTYPE Carbohydrates D0DW7A HIGHSTAT Patented D0DX8P DRUG__ID D0DX8P D0DX8P DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0DX8P DRUGTYPE Small molecular drug D0DX8P HIGHSTAT Patented D0DY3A DRUG__ID D0DY3A D0DY3A DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY D0DY3A DRUGTYPE Small molecular drug D0DY3A HIGHSTAT Patented D0DY5R DRUG__ID D0DY5R D0DY5R DRUGCOMP MERCK SHARP & DOHME CORP D0DY5R HIGHSTAT Patented D0DY5R COMPCLAS Bicyclic heteroaryl benzamide derivatives D0E0SA DRUG__ID D0E0SA D0E0SA DRUGCOMP Shionogi & Co., Ltd. KUROSE, Noriyuki D0E0SA DRUGTYPE Small molecular drug D0E0SA HIGHSTAT Patented D0E1GC DRUG__ID D0E1GC D0E1GC DRUGCOMP WASHINGTON UNIVERSITY D0E1GC DRUGTYPE Carbohydrates D0E1GC HIGHSTAT Patented D0E2AF DRUG__ID D0E2AF D0E2AF DRUGCOMP MERCK FROSST CANADA LTD. GAUTHIER, Jacques-Yves TRUONG, Vouy-Lin D0E2AF DRUGTYPE Small molecular drug D0E2AF HIGHSTAT Patented D0E2VI DRUG__ID D0E2VI D0E2VI DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH GIOVANNINI, Riccardo BERTANI, Barbara FERRARA, Marco LINGARD, Iain MAZZAFERRO, Rocco ROSENBROCK, Holger D0E2VI DRUGTYPE Small molecular drug D0E2VI HIGHSTAT Patented D0E2WK DRUG__ID D0E2WK D0E2WK DRUGCOMP MERCK SHARP &amDOHME CORP. AHEARN, Sean, P. CHRISTOPHER, Matthew JUNG, Joon PU, Qinglin RIVKIN, Alexey SCOTT, Mark, E. WITTER, David, J. WOO, Hyun Chong CASH, Brandon DINSMORE, Christopher GUERIN, David D0E2WK DRUGTYPE Small molecular drug D0E2WK HIGHSTAT Patented D0E2WS DRUG__ID D0E2WS D0E2WS DRUGCOMP Merck Sharp & Dohme Corp D0E2WS DRUGTYPE Small molecular drug D0E2WS HIGHSTAT Patented D0E2XN DRUG__ID D0E2XN D0E2XN DRUGCOMP BIO IMAGING KOREA CO., LTD D0E2XN DRUGTYPE Small molecular drug D0E2XN HIGHSTAT Patented D0E4TO DRUG__ID D0E4TO D0E4TO DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D0E4TO DRUGTYPE Small molecular drug D0E4TO HIGHSTAT Patented D0E5AT DRUG__ID D0E5AT D0E5AT DRUGCOMP F. HOFFMANN-LA ROCHE AG ARORA, Nidhi CHEN, Shaoqing HERMANN, Johannes, Cornelius KUGLSTATTER, Andreas LABADIE, Sharada, Shenvi LIN, Clara Jeou Jen LUCAS, Matthew, C. MOORE, Amy, Geraldine PAPP, Eva TALAMAS, Francisco, Xavier WANNER, Jutta ZHAI, Yansheng D0E5AT DRUGTYPE Small molecular drug D0E5AT HIGHSTAT Patented D0E5CO DRUG__ID D0E5CO D0E5CO DRUGCOMP KARUS THERAPEUTICS LTD D0E5CO DRUGTYPE Small molecular drug D0E5CO HIGHSTAT Patented D0E5ED DRUG__ID D0E5ED D0E5ED DRUGCOMP INTERCEPT PHARMACEUTICALS, INC D0E5ED DRUGTYPE Small molecular drug D0E5ED HIGHSTAT Patented D0E5WC DRUG__ID D0E5WC D0E5WC DRUGCOMP UNIVERZA V LJUBLJANI D0E5WC DRUGTYPE Small molecular drug D0E5WC HIGHSTAT Patented D0E6ED DRUG__ID D0E6ED D0E6ED DRUGCOMP ONYX THERAPEUTICS, INC D0E6ED DRUGTYPE Small molecular drug D0E6ED HIGHSTAT Patented D0E7FT DRUG__ID D0E7FT D0E7FT DRUGCOMP NEUROLIXIS UNIVERSITE JAGELLONNE D0E7FT DRUGTYPE Small molecular drug D0E7FT HIGHSTAT Patented D0E7OA DRUG__ID D0E7OA D0E7OA DRUGCOMP NEW ENGLAND BIOLABS INC D0E7OA DRUGTYPE Nucleotide D0E7OA HIGHSTAT Patented D0E7TU DRUG__ID D0E7TU D0E7TU DRUGCOMP CHDI FOUNDATION, INC D0E7TU DRUGTYPE Small molecular drug D0E7TU HIGHSTAT Patented D0EA6L DRUG__ID D0EA6L D0EA6L DRUGCOMP PFIZER PRODUCTS INC. HUANG, Liming LIU, Song LUNNEY, Elizabeth, Ann PLANKEN, Simon, Paul D0EA6L DRUGTYPE Small molecular drug D0EA6L HIGHSTAT Patented D0EB7G DRUG__ID D0EB7G D0EB7G DRUGCOMP INTERCEPT PHARMACEUTICALS, INC D0EB7G DRUGTYPE Small molecular drug D0EB7G HIGHSTAT Patented D0EC3Z DRUG__ID D0EC3Z D0EC3Z DRUGCOMP Japan Tobacco, Inc D0EC3Z DRUGTYPE Small molecular drug D0EC3Z HIGHSTAT Patented D0EE3P DRUG__ID D0EE3P D0EE3P DRUGCOMP CISEN PHARMACEUTICAL CO., LTD. SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY D0EE3P DRUGTYPE Small molecular drug D0EE3P HIGHSTAT Patented D0EF0P DRUG__ID D0EF0P D0EF0P DRUGCOMP ALBANY MOLECULAR RESEARCH, INC. CIOFFI, Christopher, L. WOLF, Mark, A. GUZZO, Peter, R. LIU, Shuang SADALAPURE, Kashinath PARTHASARATHY, Visweswaren MAENG, Jun-ho D0EF0P DRUGTYPE Small molecular drug D0EF0P HIGHSTAT Patented D0EF9J DRUG__ID D0EF9J D0EF9J DRUGCOMP the Shanghai Institute of Pharmaceutical Industry D0EF9J DRUGTYPE Small molecular drug D0EF9J HIGHSTAT Patented D0EG4F DRUG__ID D0EG4F D0EG4F DRUGTYPE Small molecular drug D0EG4F HIGHSTAT Patented D0EG4F COMPCLAS Imidazopyridine acetamide analogs D0EM8D DRUG__ID D0EM8D D0EM8D DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN DONATO, Nicholas, J. WOBUS, Christiane SHOWALTER, H. D. Hollis TALPAZ, Moshe PERRY, Jeffrey, William SORENSON, Roderick, Joseph O'RIORDAN, Mary, Xuan Dziem JIN, Yafei D0EM8D DRUGTYPE Small molecular drug D0EM8D HIGHSTAT Patented D0EO1L DRUG__ID D0EO1L D0EO1L DRUGCOMP NORTHWESTERN UNIVERSITY ONCOTHYREON INC. GORDON, Leo I. EVENS, Andrew PESTANO, Linda FOWLER, Kerry PETERSON, Scott D0EO1L DRUGTYPE Small molecular drug D0EO1L HIGHSTAT Patented D0EO8F DRUG__ID D0EO8F D0EO8F DRUGCOMP UNIV RIO DE JANEIRO [BRUNIAO BRASILIENSE DE EDUCACAO E CULTURA UBEC [BR D0EO8F DRUGTYPE Small molecular drug D0EO8F HIGHSTAT Patented D0EO9Z DRUG__ID D0EO9Z D0EO9Z DRUGCOMP VAMVAKIDES, Alexandre D0EO9Z DRUGTYPE Small molecular drug D0EO9Z HIGHSTAT Patented D0EU5A DRUG__ID D0EU5A D0EU5A DRUGCOMP KARUS THERAPEUTICS LTD D0EU5A DRUGTYPE Small molecular drug D0EU5A HIGHSTAT Patented D0EW9W DRUG__ID D0EW9W D0EW9W DRUGCOMP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES TARASOVA, Nadya I. TRINCHIERI, Giorgio YOUNG, Howard A. STEWART, C. Andrew CARDONE, Marco A. PERANTONI, Alan O D0EW9W DRUGTYPE Small molecular drug D0EW9W HIGHSTAT Patented D0EX3N DRUG__ID D0EX3N D0EX3N DRUGCOMP REGENTS OF THE UNIVERSITY OF MINNESOTA PANKIEWICZ, Krzysztof CHEN, Liqiang VINCE, Robert D0EX3N DRUGTYPE Small molecular drug D0EX3N HIGHSTAT Patented D0EX5A DRUG__ID D0EX5A D0EX5A DRUGCOMP KYORIN SEIYAKU KK [JPTAKAHASHI HIROYASU [JPHIGUCHI HIROMI [JP] D0EX5A HIGHSTAT Patented D0EX5A COMPCLAS Dihydrothieno [2,3-e]indazole derivatives D0EX9E DRUG__ID D0EX9E D0EX9E DRUGCOMP Merck Sharp & Dohme Corp D0EX9E DRUGTYPE Small molecular drug D0EX9E HIGHSTAT Patented D0EZ6C DRUG__ID D0EZ6C D0EZ6C DRUGCOMP NATIONAL CANCER CENTER KIM, Soo Youl LEE, Chang Hoon D0EZ6C DRUGTYPE Small molecular drug D0EZ6C HIGHSTAT Patented D0EZ9G DRUG__ID D0EZ9G D0EZ9G DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0EZ9G DRUGTYPE Small molecular drug D0EZ9G HIGHSTAT Patented D0F0TY DRUG__ID D0F0TY D0F0TY DRUGCOMP Merck Sharp & Dohme Corp D0F0TY DRUGTYPE Small molecular drug D0F0TY HIGHSTAT Patented D0F2NW DRUG__ID D0F2NW D0F2NW DRUGCOMP F. HOFFMANN-LA ROCHE AG ARORA, Nidhi CHEN, Shaoqing HERMANN, Johannes, Cornelius KUGLSTATTER, Andreas LABADIE, Sharada, Shenvi LIN, Clara Jeou Jen LUCAS, Matthew, C. MOORE, Amy, Geraldine PAPP, Eva TALAMAS, Francisco, Xavier WANNER, Jutta ZHAI, Yansheng D0F2NW DRUGTYPE Small molecular drug D0F2NW HIGHSTAT Patented D0F3BK DRUG__ID D0F3BK D0F3BK DRUGCOMP CALITOR SCIENCES, LLC SUNSHINE LAKE PHARMA CO., LTD D0F3BK DRUGTYPE Small molecular drug D0F3BK HIGHSTAT Patented D0F3HA DRUG__ID D0F3HA D0F3HA DRUGTYPE Small molecular drug D0F3HA HIGHSTAT Patented D0F3HA COMPCLAS Cyclohexyl carbamate derivatives D0F3SQ DRUG__ID D0F3SQ D0F3SQ DRUGCOMP INTERCEPT PHARMACEUTICALS, INC D0F3SQ DRUGTYPE Small molecular drug D0F3SQ HIGHSTAT Patented D0F4NB DRUG__ID D0F4NB D0F4NB DRUGCOMP INSTYTUT FARMAKOLOGII POLSKIEJ AKADEMII NAUK,UNIWERSYTET JAGIELLO SKI D0F4NB DRUGTYPE Small molecular drug D0F4NB HIGHSTAT Patented D0F8BF DRUG__ID D0F8BF D0F8BF DRUGCOMP MERCK SHARP & DOHME CORP D0F8BF HIGHSTAT Patented D0F8BF COMPCLAS Bicyclic heteroaryl benzamide derivatives D0F8LE DRUG__ID D0F8LE D0F8LE DRUGCOMP VANDERBILT UNIVERSITY D0F8LE DRUGTYPE Small molecular drug D0F8LE HIGHSTAT Patented D0F8PG DRUG__ID D0F8PG D0F8PG DRUGCOMP SANOFSANOFI LANGEVIN, Beverly C. FARR, Robert Allan SHAH, Dinubhai H. SHERER, DanieSANOFI-AVENTIS DIAZ MARTIN, Juan Antonio JIMENEZ BARGUENO, Maria Dolores D0F8PG DRUGTYPE Small molecular drug D0F8PG HIGHSTAT Patented D0F9QC DRUG__ID D0F9QC D0F9QC DRUGCOMP AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH NATIONAL UNIVERSITY OF SINGAPORE CHAI, Christina, L., L. BERNARDO, Paul, H. XU, Jin YU, Victor, C. WAN, Kah-Fei MOK, Henry, Y., K. SIVARAMAN, Thirunavukkarasu KJRISHNAMOORTHY, Janarthanan D0F9QC DRUGTYPE Small molecular drug D0F9QC HIGHSTAT Patented D0FB1Q DRUG__ID D0FB1Q D0FB1Q DRUGCOMP NOVARTIS AG BURGER, Matthew DING, Yu HAN, Wooseok LINDVALL, Mika NISHIGUCHI, Gisele A. RICO, Alice SMITH, Aaron TANNER, Huw WAN, Lifeng D0FB1Q DRUGTYPE Small molecular drug D0FB1Q HIGHSTAT Patented D0FC5J DRUG__ID D0FC5J D0FC5J DRUGCOMP Merck Sharp & Dohme Corp D0FC5J DRUGTYPE Small molecular drug D0FC5J HIGHSTAT Patented D0FG2H DRUG__ID D0FG2H D0FG2H DRUGCOMP ABBVIE DEUTSCHLAND [DEABBVIE INC [US] D0FG2H DRUGTYPE Small molecular drug D0FG2H HIGHSTAT Patented D0FI3A DRUG__ID D0FI3A D0FI3A DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0FI3A DRUGTYPE Small molecular drug D0FI3A HIGHSTAT Patented D0FJ4A DRUG__ID D0FJ4A D0FJ4A DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0FJ4A HIGHSTAT Patented D0FJ4A COMPCLAS Thiazole carboxamide derivatives D0FJ8E DRUG__ID D0FJ8E D0FJ8E DRUGCOMP University of Kentucky Research Foundation D0FJ8E DRUGTYPE Small molecular drug D0FJ8E HIGHSTAT Patented D0FK5P DRUG__ID D0FK5P D0FK5P DRUGCOMP Allergan, Inc D0FK5P DRUGTYPE Small molecular drug D0FK5P HIGHSTAT Patented D0FK6N DRUG__ID D0FK6N D0FK6N DRUGCOMP Aurigene Discovery Technologies Limited D0FK6N DRUGTYPE Peptide D0FK6N HIGHSTAT Patented D0FK6Y DRUG__ID D0FK6Y D0FK6Y DRUGCOMP KALA PHARMACEUTICALS, INC D0FK6Y DRUGTYPE Small molecular drug D0FK6Y HIGHSTAT Patented D0FL3H DRUG__ID D0FL3H D0FL3H DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0FL3H DRUGTYPE Carbohydrates D0FL3H HIGHSTAT Patented D0FL6P DRUG__ID D0FL6P D0FL6P DRUGCOMP UNIVERSIDADE FEDERAL DO RIO DE JANEIRO D0FL6P DRUGTYPE Small molecular drug D0FL6P HIGHSTAT Patented D0FM6Y DRUG__ID D0FM6Y D0FM6Y DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0FM6Y DRUGTYPE Small molecular drug D0FM6Y HIGHSTAT Patented D0FS9V DRUG__ID D0FS9V D0FS9V DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0FS9V DRUGTYPE Carbohydrates D0FS9V HIGHSTAT Patented D0FU2M DRUG__ID D0FU2M D0FU2M DRUGTYPE Small molecular drug D0FU2M HIGHSTAT Patented D0FU2M COMPCLAS Bicyclo-heptan-2-amine derivatives D0FV9R DRUG__ID D0FV9R D0FV9R DRUGCOMP WONKWANG UNIVERSITY CENTER FOR INDUSTRY-ACADEMY COOPERATION D0FV9R DRUGTYPE Small molecular drug D0FV9R HIGHSTAT Patented D0FY1Q DRUG__ID D0FY1Q D0FY1Q DRUGCOMP KYOWA HAKKO KIRIN CO., LTD D0FY1Q DRUGTYPE Small molecular drug D0FY1Q HIGHSTAT Patented D0FY2Q DRUG__ID D0FY2Q D0FY2Q DRUGCOMP HUNAN NONFERROUS METALS GROUP CHEMBIO PHARMACY CO., LTD. ZHANG, Shixi D0FY2Q DRUGTYPE Small molecular drug D0FY2Q HIGHSTAT Patented D0FZ1H DRUG__ID D0FZ1H D0FZ1H DRUGCOMP Gilead Sciences Inc D0FZ1H DRUGTYPE Small molecular drug D0FZ1H HIGHSTAT Patented D0G0FK DRUG__ID D0G0FK D0G0FK DRUGCOMP ALMIRALL, S.AABBVIE INC D0G0FK DRUGTYPE Small molecular drug D0G0FK HIGHSTAT Patented D0G1JR DRUG__ID D0G1JR D0G1JR DRUGCOMP ELI LILLY AND COMPANY D0G1JR DRUGTYPE Small molecular drug D0G1JR HIGHSTAT Patented D0G1YI DRUG__ID D0G1YI D0G1YI DRUGCOMP NOVARTIS AG GLAENZEL, Ulrike NUFER, Robert D0G1YI DRUGTYPE Small molecular drug D0G1YI HIGHSTAT Patented D0G2EP DRUG__ID D0G2EP D0G2EP DRUGCOMP PROXIMAGEN LIMITED D0G2EP DRUGTYPE Small molecular drug D0G2EP HIGHSTAT Patented D0G3IL DRUG__ID D0G3IL D0G3IL DRUGCOMP Sunshine Lake Pharma Co., Ltd D0G3IL DRUGTYPE Small molecular drug D0G3IL HIGHSTAT Patented D0G4YS DRUG__ID D0G4YS D0G4YS DRUGCOMP Mississippi State University D0G4YS DRUGTYPE Small molecular drug D0G4YS HIGHSTAT Patented D0G5FS DRUG__ID D0G5FS D0G5FS DRUGTYPE Small molecular drug D0G5FS HIGHSTAT Patented D0G5FS COMPCLAS Bidentate pyrazolopyrimidine acetamide analogs D0G6IQ DRUG__ID D0G6IQ D0G6IQ DRUGCOMP DAEWOONG PHARMACEUTICAL CO., LTD. KIM, Ji Duck YOON, Hong Chul KIM, In Woo CHO, Min Jae LEE, In Young LEE, Sang Ho PARK, Eun Kyung LIM, Kwon Jo NAM, Sang Hyun D0G6IQ DRUGTYPE Small molecular drug D0G6IQ HIGHSTAT Patented D0G6ON DRUG__ID D0G6ON D0G6ON DRUGCOMP NEW ENGLAND BIOLABS INC D0G6ON DRUGTYPE Nucleotide D0G6ON HIGHSTAT Patented D0G6QW DRUG__ID D0G6QW D0G6QW DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L. ZAMPIERI, Massimo VANOTTI, Ermes CIVAROLI, Paola FORNARETTO, Maria, Gioia D0G6QW DRUGTYPE Small molecular drug D0G6QW HIGHSTAT Patented D0G6UA DRUG__ID D0G6UA D0G6UA DRUGCOMP EMORY UNIVERSITY JIANG, Jianxiong GANESH, Thota DU, Yuhong THEPCHATRI, Pahk QUAN, Yi DINGLEDINE, Ray J D0G6UA DRUGTYPE Small molecular drug D0G6UA HIGHSTAT Patented D0G7LB DRUG__ID D0G7LB D0G7LB DRUGCOMP SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE PELLECCHIA, Maurizio D0G7LB DRUGTYPE Small molecular drug D0G7LB HIGHSTAT Patented D0G9BO DRUG__ID D0G9BO D0G9BO DRUGCOMP Gilead Sciences Inc D0G9BO DRUGTYPE Small molecular drug D0G9BO HIGHSTAT Patented D0G9MM DRUG__ID D0G9MM D0G9MM DRUGCOMP ZHEJIANG DTRM BIOPHARMA [CN] D0G9MM DRUGTYPE Small molecular drug D0G9MM HIGHSTAT Patented D0G9NQ DRUG__ID D0G9NQ D0G9NQ DRUGCOMP INFINITY PHARMACEUTICALS, INC D0G9NQ DRUGTYPE Small molecular drug D0G9NQ HIGHSTAT Patented D0G9OT DRUG__ID D0G9OT D0G9OT DRUGCOMP Kissei Pharmaceutical Co. Ltd D0G9OT DRUGTYPE Small molecular drug D0G9OT HIGHSTAT Patented D0G9QO DRUG__ID D0G9QO D0G9QO DRUGCOMP CENTRE NAT RECH SCIENT [FR D0G9QO DRUGTYPE Small molecular drug D0G9QO HIGHSTAT Patented D0GA7D DRUG__ID D0GA7D D0GA7D DRUGCOMP UNIVERSITY OF UTAH RESEARCH FOUNDATIOUniversity of Utah, USA D0GA7D DRUGTYPE Small molecular drug D0GA7D HIGHSTAT Patented D0GB6Y DRUG__ID D0GB6Y D0GB6Y DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0GB6Y DRUGTYPE Carbohydrates D0GB6Y HIGHSTAT Patented D0GB7G DRUG__ID D0GB7G D0GB7G DRUGCOMP CALITOR SCIENCES, LLC SUNSHINE LAKE PHARMA CO., LTD D0GB7G DRUGTYPE Small molecular drug D0GB7G HIGHSTAT Patented D0GD6R DRUG__ID D0GD6R D0GD6R DRUGCOMP UNIVERSITY OF CONNECTICUT D0GD6R DRUGTYPE Small molecular drug D0GD6R HIGHSTAT Patented D0GE4F DRUG__ID D0GE4F D0GE4F DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE D0GE4F DRUGTYPE Small molecular drug D0GE4F HIGHSTAT Patented D0GE6F DRUG__ID D0GE6F D0GE6F DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0GE6F HIGHSTAT Patented D0GE6F COMPCLAS Thiazole carboxamide derivatives D0GF3P DRUG__ID D0GF3P D0GF3P DRUGCOMP NOVARTIS AG STRAUB, Christopher Sean CHEN, Zhuoliang PALERMO, Mark G D0GF3P DRUGTYPE Small molecular drug D0GF3P HIGHSTAT Patented D0GG5K DRUG__ID D0GG5K D0GG5K DRUGCOMP PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED FINCH, Harry FOX, Craig D0GG5K DRUGTYPE Small molecular drug D0GG5K HIGHSTAT Patented D0GH8D DRUG__ID D0GH8D D0GH8D DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0GH8D DRUGTYPE Small molecular drug D0GH8D HIGHSTAT Patented D0GH9W DRUG__ID D0GH9W D0GH9W DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D0GH9W HIGHSTAT Patented D0GH9W COMPCLAS Heteroaryl-carboxamide derivatives D0GI4S DRUG__ID D0GI4S D0GI4S DRUGCOMP MERCK PATENT GMBH D0GI4S DRUGTYPE Small molecular drug D0GI4S HIGHSTAT Patented D0GP7L DRUG__ID D0GP7L D0GP7L DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0GP7L DRUGTYPE Carbohydrates D0GP7L HIGHSTAT Patented D0GQ0V DRUG__ID D0GQ0V D0GQ0V DRUGCOMP Astellas Pharma Inc D0GQ0V DRUGTYPE Small molecular drug D0GQ0V HIGHSTAT Patented D0GR7W DRUG__ID D0GR7W D0GR7W DRUGCOMP Gilead Sciences Inc D0GR7W DRUGTYPE Small molecular drug D0GR7W HIGHSTAT Patented D0GT0I DRUG__ID D0GT0I D0GT0I DRUGCOMP ABIDE THERAPEUTICS, INC D0GT0I DRUGTYPE Small molecular drug D0GT0I HIGHSTAT Patented D0GX7W DRUG__ID D0GX7W D0GX7W DRUGCOMP ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely D0GX7W DRUGTYPE Small molecular drug D0GX7W HIGHSTAT Patented D0GY8G DRUG__ID D0GY8G D0GY8G DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0GY8G HIGHSTAT Patented D0GY8G COMPCLAS Thiazole carboxamide derivatives D0H0QR DRUG__ID D0H0QR D0H0QR DRUGCOMP Ixchelsis Ltd D0H0QR DRUGTYPE Small molecular drug D0H0QR HIGHSTAT Patented D0H2KL DRUG__ID D0H2KL D0H2KL DRUGCOMP GLAXO GROUP LIMITED BRADLEY, Daniel, Marcus BRANCH, Clive, Leslie CHAN, Wai, Ngor COULTON, Steven GILPIN, Martin, Leonard HARRIS, Andrew, Jonathan JAXA-CHAMIEC, Albert, Andrzej LAI, Justine, Yeun, Quai MARSHALL, Howard, Robert MACRITCHIE, Jacqueline, Anne NASH, David, John PORTER, Roderick, Alan SPADA, Simone THEWLIS, Kevin, Michael WARD, Simon, Edward D0H2KL DRUGTYPE Small molecular drug D0H2KL HIGHSTAT Patented D0H2RG DRUG__ID D0H2RG D0H2RG DRUGTYPE Small molecular drug D0H2RG HIGHSTAT Patented D0H2RG COMPCLAS Phenylpurine acetamide analogs D0H2UJ DRUG__ID D0H2UJ D0H2UJ DRUGTYPE Small molecular drug D0H2UJ HIGHSTAT Patented D0H2UJ COMPCLAS Ampicidin analogs D0H3NO DRUG__ID D0H3NO D0H3NO DRUGCOMP ABBOTT LABORATORIES D0H3NO DRUGTYPE Small molecular drug D0H3NO HIGHSTAT Patented D0H3YG DRUG__ID D0H3YG D0H3YG DRUGCOMP UNIV WARSZAWSKI [PLCT MEDYCZNE KSZTALCENIA PODYPLOMOWEGO [PL] D0H3YG DRUGTYPE Small molecular drug D0H3YG HIGHSTAT Patented D0H4HD DRUG__ID D0H4HD D0H4HD DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi JAHANGIR, Alam REUTER, Deborah CaroF. HOFFMANN-LA ROCHE AG GOLDSTEIN, David Michael GONG, Leyi MICHOUD, Christophe PALMER, Wylie Solang SIDDURI, Achyutharao D0H4HD DRUGTYPE Small molecular drug D0H4HD HIGHSTAT Patented D0H4LK DRUG__ID D0H4LK D0H4LK DRUGTYPE Small molecular drug D0H4LK HIGHSTAT Patented D0H4LK COMPCLAS Thiazoline derivatives D0H4PF DRUG__ID D0H4PF D0H4PF DRUGCOMP Aston University D0H4PF DRUGTYPE Small molecular drug D0H4PF HIGHSTAT Patented D0H4SE DRUG__ID D0H4SE D0H4SE DRUGCOMP Amorepacific Corp D0H4SE DRUGTYPE Small molecular drug D0H4SE HIGHSTAT Patented D0H4WT DRUG__ID D0H4WT D0H4WT DRUGCOMP University of Southern California, USNew York University D0H4WT DRUGTYPE Small molecular drug D0H4WT HIGHSTAT Patented D0H5UL DRUG__ID D0H5UL D0H5UL DRUGCOMP Vertex Pharmaceuticals Inc D0H5UL DRUGTYPE Small molecular drug D0H5UL HIGHSTAT Patented D0H5VO DRUG__ID D0H5VO D0H5VO DRUGCOMP ABBVIE DEUTSCHLAND GMBH &amCO. KG ABBVIE INC. AMBERG, Wilhelm LANGE, Udo OCHSE, Michael POHLKI, Frauke BEHL, Berthold MEZLER, Mario HORNBERGER, Wilfried HUTCHINS, Charles W D0H5VO DRUGTYPE Small molecular drug D0H5VO HIGHSTAT Patented D0H6AF DRUG__ID D0H6AF D0H6AF DRUGCOMP Schering Corp D0H6AF HIGHSTAT Patented D0H6AF COMPCLAS Thiazole carboxamide derivatives D0H7SO DRUG__ID D0H7SO D0H7SO DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D0H7SO HIGHSTAT Patented D0H7SO COMPCLAS Heteroaryl-carboxamide derivatives D0H9SD DRUG__ID D0H9SD D0H9SD DRUGCOMP ARTIFICIAL CELL TECHNOLOGIES, INC D0H9SD DRUGTYPE Vaccine D0H9SD HIGHSTAT Patented D0HA0J DRUG__ID D0HA0J D0HA0J DRUGCOMP METHEOR THERAPEUTICS CORPORATION SLEDZIEWSKI, Andrew, Z. DEVOS, Theodore KOLE, Ryszard D0HA0J DRUGTYPE Nucleotide D0HA0J HIGHSTAT Patented D0HC9K DRUG__ID D0HC9K D0HC9K DRUGCOMP INCYTE CORPORATION D0HC9K DRUGTYPE Small molecule immunotherapy D0HC9K HIGHSTAT Patented D0HD6C DRUG__ID D0HD6C D0HD6C DRUGTYPE Small molecular drug D0HD6C HIGHSTAT Patented D0HD6C COMPCLAS Tetra-hydro-1H-1,2,6-triazaazulene derivatives D0HF1A DRUG__ID D0HF1A D0HF1A DRUGCOMP MERCK SHARP & DOHME CORP D0HF1A HIGHSTAT Patented D0HF1A COMPCLAS Bicyclic heteroaryl benzamide derivatives D0HI1R DRUG__ID D0HI1R D0HI1R DRUGCOMP Southwest Res Inst D0HI1R DRUGTYPE Small molecular drug D0HI1R HIGHSTAT Patented D0HK3A DRUG__ID D0HK3A D0HK3A DRUGCOMP ARTIFICIAL CELL TECHNOLOGIES, INC D0HK3A DRUGTYPE Vaccine D0HK3A HIGHSTAT Patented D0HL6X DRUG__ID D0HL6X D0HL6X DRUGCOMP MERCK SHARP & DOHME CORP. WU, Wen-Lian BURNETT, Duane, A D0HL6X DRUGTYPE Small molecular drug D0HL6X HIGHSTAT Patented D0HM4V DRUG__ID D0HM4V D0HM4V DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0HM4V DRUGTYPE Small molecular drug D0HM4V HIGHSTAT Patented D0HM6Y DRUG__ID D0HM6Y D0HM6Y DRUGCOMP KARUS THERAPEUTICS LTD D0HM6Y DRUGTYPE Small molecular drug D0HM6Y HIGHSTAT Patented D0HO8C DRUG__ID D0HO8C D0HO8C DRUGCOMP Bristol-Myers Squibb Co D0HO8C DRUGTYPE Small molecular drug D0HO8C HIGHSTAT Patented D0HP8K DRUG__ID D0HP8K D0HP8K DRUGCOMP Schering Corp D0HP8K HIGHSTAT Patented D0HP8K COMPCLAS Thiazole carboxamide derivatives D0HQ8X DRUG__ID D0HQ8X D0HQ8X DRUGTYPE Small molecular drug D0HQ8X HIGHSTAT Patented D0HQ8X COMPCLAS Azepan-4-one derivatives D0HR6P DRUG__ID D0HR6P D0HR6P DRUGCOMP NTZ LAB LTD [BG] D0HR6P DRUGTYPE Small molecular drug D0HR6P HIGHSTAT Patented D0HR8Y DRUG__ID D0HR8Y D0HR8Y DRUGCOMP ENANTA PHARMACEUTICALS, INC D0HR8Y DRUGTYPE Small molecular drug D0HR8Y HIGHSTAT Patented D0HS1D DRUG__ID D0HS1D D0HS1D DRUGCOMP ABBOTT LABORATORIES D0HS1D DRUGTYPE Small molecular drug D0HS1D HIGHSTAT Patented D0HS2J DRUG__ID D0HS2J D0HS2J DRUGCOMP CELON PHARMA S.A D0HS2J DRUGTYPE Small molecular drug D0HS2J HIGHSTAT Patented D0HS8T DRUG__ID D0HS8T D0HS8T DRUGCOMP AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION THE UNIVERSITY OF SYDNE D0HS8T DRUGTYPE Small molecular drug D0HS8T HIGHSTAT Patented D0HT9C DRUG__ID D0HT9C D0HT9C DRUGCOMP PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED RAMDAS, Vidya FINCH, Harry FOX, Craig D0HT9C DRUGTYPE Small molecular drug D0HT9C HIGHSTAT Patented D0HU0O DRUG__ID D0HU0O D0HU0O DRUGTYPE Small molecular drug D0HU0O HIGHSTAT Patented D0HU0O COMPCLAS Tetra-hydro-pyrrolopyrimidinedione derivatives D0HV3N DRUG__ID D0HV3N D0HV3N DRUGCOMP MERCK PATENT GMBH D0HV3N DRUGTYPE Small molecular drug D0HV3N HIGHSTAT Patented D0HW6Y DRUG__ID D0HW6Y D0HW6Y DRUGCOMP Huawei Technologies Co., Ltd D0HW6Y DRUGTYPE Small molecular drug D0HW6Y HIGHSTAT Patented D0HX9S DRUG__ID D0HX9S D0HX9S DRUGCOMP KTB TUMORFORSCHUNGSGESELLSCHAFT MBH D0HX9S DRUGTYPE Small molecular drug D0HX9S HIGHSTAT Patented D0I1GO DRUG__ID D0I1GO D0I1GO DRUGCOMP NOVASAID AB [SE] D0I1GO DRUGTYPE Small molecular drug D0I1GO HIGHSTAT Patented D0I1YQ DRUG__ID D0I1YQ D0I1YQ DRUGCOMP MERCK SHARP & DOHME CORP. MSD K.K. KATZ, Jason JEWELL, James JUNG, Joon KATTAR, Solomon HOU, Yongquan MACCOSS, Rachel ITO, Satoru D0I1YQ DRUGTYPE Small molecular drug D0I1YQ HIGHSTAT Patented D0I2MR DRUG__ID D0I2MR D0I2MR DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0I2MR DRUGTYPE Carbohydrates D0I2MR HIGHSTAT Patented D0I2RS DRUG__ID D0I2RS D0I2RS DRUGCOMP THE UNIVERSITY OF QUEENSLAND FAIRLIE, David Paul LIU, Ligong YAU, Mei-Kwan SUEN, Jacky Yung REID, Robert LOHMAN, Rink-Jan IYER, Abishek Venkatasubramanian LIM, Junxian BROWN, Lindsay CharleThe University of Queensland D0I2RS DRUGTYPE Small molecular drug D0I2RS HIGHSTAT Patented D0I3LY DRUG__ID D0I3LY D0I3LY DRUGCOMP TRANSLATIONAL GENOMICS RESEARCH INSTITUTE DUNCKLEY, Travis D0I3LY DRUGTYPE Small molecular drug D0I3LY HIGHSTAT Patented D0I3NS DRUG__ID D0I3NS D0I3NS DRUGCOMP SIGNAL PHARMACEUTICALS, LLC BENNETT, Brydon, L. ELSNER, Jan ERDMAN, Paul HILGRAF, Robert LEBRUN, Laurie, Ann MCCARRICK, Meg MOGHADDAM, Mehran, F. NAGY, Mark, A. NORRIS, Stephen PAISNER, David, A. SLOSS, Marianne ROMANOW, William, J. SATOH, Yoshitaka TIKHE, Jayashree YOON, Won, Hyung DELGADO, Mercedes D0I3NS DRUGTYPE Small molecular drug D0I3NS HIGHSTAT Patented D0I3ZW DRUG__ID D0I3ZW D0I3ZW DRUGCOMP Janssen Pharmaceutica NV D0I3ZW DRUGTYPE Small molecular drug D0I3ZW HIGHSTAT Patented D0I6IR DRUG__ID D0I6IR D0I6IR DRUGCOMP UNIVERSITY OF NOTRE DAME DU LAC D0I6IR DRUGTYPE Small molecular drug D0I6IR HIGHSTAT Patented D0I6YT DRUG__ID D0I6YT D0I6YT DRUGCOMP OMORI, Naoki et al D0I6YT DRUGTYPE Small molecular drug D0I6YT HIGHSTAT Patented D0I7UZ DRUG__ID D0I7UZ D0I7UZ DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0I7UZ DRUGTYPE Peptide D0I7UZ HIGHSTAT Patented D0I8RK DRUG__ID D0I8RK D0I8RK DRUGTYPE Small molecular drug D0I8RK HIGHSTAT Patented D0I8RK COMPCLAS Bicyclic hexapeptide derivatives D0I8RX DRUG__ID D0I8RX D0I8RX DRUGCOMP UNIVERSITY OF SOUTH AUSTRALIA CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC D0I8RX DRUGTYPE Small molecular drug D0I8RX HIGHSTAT Patented D0I9FU DRUG__ID D0I9FU D0I9FU DRUGCOMP MERCK SHARP & DOHME CORP D0I9FU HIGHSTAT Patented D0I9FU COMPCLAS Bicyclic heteroaryl benzamide derivatives D0I9PC DRUG__ID D0I9PC D0I9PC DRUGCOMP VANDERBILT UNIVERSITY D0I9PC DRUGTYPE Small molecular drug D0I9PC HIGHSTAT Patented D0I9QC DRUG__ID D0I9QC D0I9QC DRUGCOMP THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION on behalf of THE UNIVERSITY OF NEVADA, LAS VEGAS D0I9QC DRUGTYPE Small molecular drug D0I9QC HIGHSTAT Patented D0IB3R DRUG__ID D0IB3R D0IB3R DRUGCOMP F. HOFFMANN-LA ROCHE AG LAI, Yingjie LIANG, Jun MAGNUSON, Steven, R. ROBARGE, Kirk, D. TSUI, Vickie, Hsaio-Wei ZHANG, Birong D0IB3R DRUGTYPE Small molecular drug D0IB3R HIGHSTAT Patented D0IB8D DRUG__ID D0IB8D D0IB8D DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corrine D0IB8D DRUGTYPE Carbohydrates D0IB8D HIGHSTAT Patented D0ID3R DRUG__ID D0ID3R D0ID3R DRUGCOMP ASTEX THERAPEUTICS LIMITED D0ID3R DRUGTYPE Small molecular drug D0ID3R HIGHSTAT Patented D0IE9E DRUG__ID D0IE9E D0IE9E DRUGCOMP Merck & Co., Inc D0IE9E DRUGTYPE Small molecular drug D0IE9E HIGHSTAT Patented D0IF3G DRUG__ID D0IF3G D0IF3G DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D0IF3G DRUGTYPE Small molecular drug D0IF3G HIGHSTAT Patented D0IF4J DRUG__ID D0IF4J D0IF4J DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0IF4J DRUGTYPE Carbohydrates D0IF4J HIGHSTAT Patented D0IF5M DRUG__ID D0IF5M D0IF5M DRUGCOMP AMAKEM NV D0IF5M DRUGTYPE Small molecular drug D0IF5M HIGHSTAT Patented D0IH8R DRUG__ID D0IH8R D0IH8R DRUGCOMP GLAXOSMITHKLINE BIOLOGICALS S.A. THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY COHEN, Joseph D MARCHAND, Martine OCKENHOUSE, Christian F YADAVA, Anjali D0IH8R DRUGTYPE Vaccine D0IH8R HIGHSTAT Patented D0IK1S DRUG__ID D0IK1S D0IK1S DRUGCOMP PURDUE PHARMA L.P D0IK1S DRUGTYPE Small molecular drug D0IK1S HIGHSTAT Patented D0IL3B DRUG__ID D0IL3B D0IL3B DRUGCOMP Santen Pharmaceutical Co D0IL3B DRUGTYPE Small molecular drug D0IL3B HIGHSTAT Patented D0IL3C DRUG__ID D0IL3C D0IL3C DRUGCOMP BeiGene Ltd D0IL3C DRUGTYPE Small molecular drug D0IL3C HIGHSTAT Patented D0IN5E DRUG__ID D0IN5E D0IN5E DRUGCOMP GRUENENTHAL GMBH [DE] D0IN5E DRUGTYPE Small molecular drug D0IN5E HIGHSTAT Patented D0IQ5V DRUG__ID D0IQ5V D0IQ5V DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0IQ5V DRUGTYPE Small molecular drug D0IQ5V HIGHSTAT Patented D0IQ6G DRUG__ID D0IQ6G D0IQ6G DRUGCOMP MERCK SHARP & DOHME CORP. BUTCHER, John, W. WITTER, David DINSMORE, Christopher KIM, June HENDRIX, John ARCHARYA, Raksha AHEARN, Sean, P. JUNG, Joon RIVKIN, Alexey JONES, Philip D0IQ6G DRUGTYPE Small molecular drug D0IQ6G HIGHSTAT Patented D0IS8R DRUG__ID D0IS8R D0IS8R DRUGCOMP VANDERBILT UNIVERSITY D0IS8R DRUGTYPE Small molecular drug D0IS8R HIGHSTAT Patented D0IT4N DRUG__ID D0IT4N D0IT4N DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D0IT4N DRUGTYPE Small molecular drug D0IT4N HIGHSTAT Patented D0IV8T DRUG__ID D0IV8T D0IV8T DRUGCOMP ABBOTT LABORATORIES D0IV8T DRUGTYPE Small molecular drug D0IV8T HIGHSTAT Patented D0IY5H DRUG__ID D0IY5H D0IY5H DRUGCOMP BAYER SCHERING PHARMA AKTIENGESELLSCHAFT LEHMANN, Lutz THIELE, Andrea HEINRICH, Tobias VOLLMER, Sonja D0IY5H DRUGTYPE Small molecular drug D0IY5H HIGHSTAT Patented D0IZ8B DRUG__ID D0IZ8B D0IZ8B DRUGCOMP CANCER RESEARCH TECHNOLOGY LIMITED INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) D0IZ8B DRUGTYPE Small molecular drug D0IZ8B HIGHSTAT Patented D0J0AT DRUG__ID D0J0AT D0J0AT DRUGCOMP IMPACT THERAPEUTICS, INC D0J0AT DRUGTYPE Small molecular drug D0J0AT HIGHSTAT Patented D0J0EP DRUG__ID D0J0EP D0J0EP DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0J0EP DRUGTYPE Small molecular drug D0J0EP HIGHSTAT Patented D0J0LC DRUG__ID D0J0LC D0J0LC DRUGCOMP THE WASHINGTON UNIVERSITY JANETKA, James W. HAN, Zhenfu HULTGREN, Scott PINKNER, Jerry CUSUMANO, Corinne D0J0LC DRUGTYPE Carbohydrates D0J0LC HIGHSTAT Patented D0J0NM DRUG__ID D0J0NM D0J0NM DRUGCOMP UNIVERSITY OF CANBERRA D0J0NM DRUGTYPE Small molecular drug D0J0NM HIGHSTAT Patented D0J1HQ DRUG__ID D0J1HQ D0J1HQ DRUGCOMP UNIVERSITY OF UTAH D0J1HQ DRUGTYPE Small molecular drug D0J1HQ HIGHSTAT Patented D0J2HH DRUG__ID D0J2HH D0J2HH DRUGTYPE Small molecular drug D0J2HH HIGHSTAT Patented D0J2HH COMPCLAS Cyclohexyl carbamate derivatives D0J2VS DRUG__ID D0J2VS D0J2VS DRUGTYPE Small molecular drug D0J2VS HIGHSTAT Patented D0J2VS COMPCLAS 1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivatives D0J3JY DRUG__ID D0J3JY D0J3JY DRUGCOMP NTZ LAB LTD [BG] D0J3JY DRUGTYPE Small molecular drug D0J3JY HIGHSTAT Patented D0J4CI DRUG__ID D0J4CI D0J4CI DRUGCOMP Gilead Sciences Inc D0J4CI DRUGTYPE Small molecular drug D0J4CI HIGHSTAT Patented D0J4LV DRUG__ID D0J4LV D0J4LV DRUGCOMP INCYTE CORPORATION D0J4LV DRUGTYPE Small molecule immunotherapy D0J4LV HIGHSTAT Patented D0J5AB DRUG__ID D0J5AB D0J5AB DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D0J5AB DRUGTYPE Small molecular drug D0J5AB HIGHSTAT Patented D0J5EW DRUG__ID D0J5EW D0J5EW DRUGTYPE Small molecular drug D0J5EW HIGHSTAT Patented D0J5EW COMPCLAS Pyrimidinedione derivatives D0J5GC DRUG__ID D0J5GC D0J5GC DRUGCOMP FURMINGER, Vikki HUGHES, Owen LEGRAND, Darren STANLEY, Emily THOMSON, Christopher WILLIAMS, Gareth NOVARTIS ANOVARTIS AG FURMINGER, Vikki HUGHES, Owen THOMSON, Christopher LEGRAND, Darren, Mark STANLEY, Emil D0J5GC DRUGTYPE Small molecular drug D0J5GC HIGHSTAT Patented D0J5IB DRUG__ID D0J5IB D0J5IB DRUGCOMP Obseva SA D0J5IB DRUGTYPE Small molecular drug D0J5IB HIGHSTAT Patented D0J5QP DRUG__ID D0J5QP D0J5QP DRUGCOMP Ixchelsis Limited D0J5QP DRUGTYPE Small molecular drug D0J5QP HIGHSTAT Patented D0J6LT DRUG__ID D0J6LT D0J6LT DRUGCOMP UNIVERZA V LJUBLJANI D0J6LT DRUGTYPE Small molecular drug D0J6LT HIGHSTAT Patented D0J6TA DRUG__ID D0J6TA D0J6TA DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D0J6TA DRUGTYPE Small molecular drug D0J6TA HIGHSTAT Patented D0J6UW DRUG__ID D0J6UW D0J6UW DRUGCOMP RUDD, Christopher D0J6UW HIGHSTAT Patented D0J6UW COMPCLAS Maleimides derivatives D0J7DA DRUG__ID D0J7DA D0J7DA DRUGCOMP Allomek Therapeutics D0J7DA DRUGTYPE Small molecular drug D0J7DA HIGHSTAT Patented D0J7HR DRUG__ID D0J7HR D0J7HR DRUGCOMP University Zhejiang Technology D0J7HR DRUGTYPE Small molecular drug D0J7HR HIGHSTAT Patented D0J7SD DRUG__ID D0J7SD D0J7SD DRUGCOMP F. HOFFMANN-LA ROCHE AG GOBBI, Luca JAESCHKE, Georg RODRIGUEZ SARMIENTO, Rosa Maria STEWARD, LucindHoffmann-La Roche Inc D0J7SD DRUGTYPE Small molecular drug D0J7SD HIGHSTAT Patented D0J8GO DRUG__ID D0J8GO D0J8GO DRUGTYPE Small molecular drug D0J8GO HIGHSTAT Patented D0J8GO COMPCLAS Aminoazetidine derivatives D0J8HJ DRUG__ID D0J8HJ D0J8HJ DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0J8HJ DRUGTYPE Carbohydrates D0J8HJ HIGHSTAT Patented D0J8PJ DRUG__ID D0J8PJ D0J8PJ DRUGCOMP F. HOFFMANN-LA ROCHE AG ARZENO, Humberto, Bartolome FILONOVA, Lubov GOLDSTEIN, David, Michael GONG, Leyi LOE, Bradley, E. O'BRIEN, Erin, M. PALMER, Wylie, Solang ROTSTEIN, David, Mark SILVA, Tania TAN, Yun-chou D0J8PJ DRUGTYPE Small molecular drug D0J8PJ HIGHSTAT Patented D0J9FN DRUG__ID D0J9FN D0J9FN DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN D0J9FN DRUGTYPE Small molecular drug D0J9FN HIGHSTAT Patented D0J9JB DRUG__ID D0J9JB D0J9JB DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0J9JB DRUGTYPE Small molecular drug D0J9JB HIGHSTAT Patented D0J9JS DRUG__ID D0J9JS D0J9JS DRUGCOMP ZHANG, Xiaohu D0J9JS DRUGTYPE Small molecular drug D0J9JS HIGHSTAT Patented D0J9SL DRUG__ID D0J9SL D0J9SL DRUGCOMP Merk Patent GMBH D0J9SL DRUGTYPE Small molecular drug D0J9SL HIGHSTAT Patented D0J9WP DRUG__ID D0J9WP D0J9WP DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0J9WP DRUGTYPE Small molecular drug D0J9WP HIGHSTAT Patented D0JA5B DRUG__ID D0JA5B D0JA5B DRUGCOMP ABBOTT LABORATORIES D0JA5B DRUGTYPE Small molecular drug D0JA5B HIGHSTAT Patented D0JB4S DRUG__ID D0JB4S D0JB4S DRUGCOMP UWM RESEARCH FOUNDATION, INC D0JB4S DRUGTYPE Small molecular drug D0JB4S HIGHSTAT Patented D0JC8L DRUG__ID D0JC8L D0JC8L DRUGCOMP ABBVIE INC D0JC8L DRUGTYPE Small molecular drug D0JC8L HIGHSTAT Patented D0JC8M DRUG__ID D0JC8M D0JC8M DRUGCOMP CYTOCHROMA INC. JOHNS HOPKINS UNIVERSITY POSNER, Gary, H. HESS, Lindsey, C. KALINDA, Alvin, S. SLACK, Rachel, D. SAHA, Uttam PETKOVICH, P., Martin D0JC8M DRUGTYPE Small molecular drug D0JC8M HIGHSTAT Patented D0JD0G DRUG__ID D0JD0G D0JD0G DRUGCOMP INTERCEPT PHARMACEUTICALS, INC D0JD0G DRUGTYPE Small molecular drug D0JD0G HIGHSTAT Patented D0JF5K DRUG__ID D0JF5K D0JF5K DRUGCOMP THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES TARASOVA, Nadya I. TRINCHIERI, Giorgio YOUNG, Howard A. STEWART, C. Andrew CARDONE, Marco A. PERANTONI, Alan O D0JF5K DRUGTYPE Small molecular drug D0JF5K HIGHSTAT Patented D0JH7Q DRUG__ID D0JH7Q D0JH7Q DRUGCOMP GLENMARK PHARMACEUTICALS S.A D0JH7Q DRUGTYPE Small molecular drug D0JH7Q HIGHSTAT Patented D0JH8Z DRUG__ID D0JH8Z D0JH8Z DRUGCOMP Chengdu Sourcebio Limited Liability Company, Peop. Rep. China.Zhenjiang Shengan Pharmaceutical Co., Ltd., Peop. Rep. China D0JH8Z DRUGTYPE Small molecular drug D0JH8Z HIGHSTAT Patented D0JI3T DRUG__ID D0JI3T D0JI3T DRUGCOMP THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK D0JI3T DRUGTYPE Small molecular drug D0JI3T HIGHSTAT Patented D0JI5X DRUG__ID D0JI5X D0JI5X DRUGCOMP ARES TRADING S.A D0JI5X DRUGTYPE Small molecular drug D0JI5X HIGHSTAT Patented D0JK0Y DRUG__ID D0JK0Y D0JK0Y DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY D0JK0Y DRUGTYPE Small molecular drug D0JK0Y HIGHSTAT Patented D0JK2N DRUG__ID D0JK2N D0JK2N DRUGCOMP ABBOTT LABORATORIES D0JK2N DRUGTYPE Small molecular drug D0JK2N HIGHSTAT Patented D0JN0A DRUG__ID D0JN0A D0JN0A DRUGCOMP KARUS THERAPEUTICS LTD D0JN0A DRUGTYPE Small molecular drug D0JN0A HIGHSTAT Patented D0JN7L DRUG__ID D0JN7L D0JN7L DRUGCOMP BIOCODEX D0JN7L DRUGTYPE Small molecular drug D0JN7L HIGHSTAT Patented D0JO2A DRUG__ID D0JO2A D0JO2A DRUGCOMP DEBRECENI EGYETEM D0JO2A DRUGTYPE Small molecular drug D0JO2A HIGHSTAT Patented D0JP6A DRUG__ID D0JP6A D0JP6A DRUGCOMP CADILA HEALTHCARE LIMITED PANDEY, Bipin DAVE, Mayank, Ghanshyambhai KOTHARI, Himanshu, M. SHUKLA, Bhavin, Shriprasad D0JP6A DRUGTYPE Small molecular drug D0JP6A HIGHSTAT Patented D0JR0F DRUG__ID D0JR0F D0JR0F DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0JR0F HIGHSTAT Patented D0JR0F COMPCLAS Thiazole carboxamide derivatives D0JR2C DRUG__ID D0JR2C D0JR2C DRUGCOMP NEWLINK GENETICS CORPORATION MAUTINO, Mario KUMAR, Sanjeev WALDO, Jesse JAIPURI, Firoz KESHARWANI, Tanay ZHANG, Xiaoxia D0JR2C DRUGTYPE Small molecular drug D0JR2C HIGHSTAT Patented D0JT3F DRUG__ID D0JT3F D0JT3F DRUGCOMP ARENA PHARMACEUTICALS, INC. TEEGARDEN, Bradley JAYAKUMAR, Honnappa LI, Hongmei STRAH-PLEYNET, Sonja DOSA, Peter, Ian D0JT3F DRUGTYPE Small molecular drug D0JT3F HIGHSTAT Patented D0JU4Z DRUG__ID D0JU4Z D0JU4Z DRUGTYPE Small molecular drug D0JU4Z HIGHSTAT Patented D0JU4Z COMPCLAS 4-amino-3,5-di-substituted-thiazole derivatives D0JU7T DRUG__ID D0JU7T D0JU7T DRUGCOMP DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan D0JU7T DRUGTYPE Small molecular drug D0JU7T HIGHSTAT Patented D0JU8E DRUG__ID D0JU8E D0JU8E DRUGCOMP NOVARTIS AG GLAENZEL, Ulrike NUFER, Robert D0JU8E DRUGTYPE Small molecular drug D0JU8E HIGHSTAT Patented D0JZ4W DRUG__ID D0JZ4W D0JZ4W DRUGCOMP AMGEN INC D0JZ4W DRUGTYPE Small molecular drug D0JZ4W HIGHSTAT Patented D0K0DV DRUG__ID D0K0DV D0K0DV DRUGTYPE Small molecular drug D0K0DV HIGHSTAT Patented D0K0DV COMPCLAS N-phenyl-5-phenyl-pyrazolin-3-yl amide derivatives D0K0GJ DRUG__ID D0K0GJ D0K0GJ DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0K0GJ DRUGTYPE Small molecular drug D0K0GJ HIGHSTAT Patented D0K1PP DRUG__ID D0K1PP D0K1PP DRUGTYPE Small molecular drug D0K1PP HIGHSTAT Patented D0K1PP COMPCLAS Hydroxamate analogs D0K2PK DRUG__ID D0K2PK D0K2PK DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY D0K2PK DRUGTYPE Small molecular drug D0K2PK HIGHSTAT Patented D0K2UF DRUG__ID D0K2UF D0K2UF DRUGCOMP KARUS THERAPEUTICS LTD D0K2UF DRUGTYPE Small molecular drug D0K2UF HIGHSTAT Patented D0K3DA DRUG__ID D0K3DA D0K3DA DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0K3DA DRUGTYPE Carbohydrates D0K3DA HIGHSTAT Patented D0K3ZB DRUG__ID D0K3ZB D0K3ZB DRUGCOMP TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED D0K3ZB DRUGTYPE Small molecular drug D0K3ZB HIGHSTAT Patented D0K4AQ DRUG__ID D0K4AQ D0K4AQ DRUGCOMP Gilead Sciences Inc D0K4AQ DRUGTYPE Small molecular drug D0K4AQ HIGHSTAT Patented D0K4CX DRUG__ID D0K4CX D0K4CX DRUGCOMP ALTIMMUNE INC D0K4CX DRUGTYPE Vaccine D0K4CX HIGHSTAT Patented D0K4SZ DRUG__ID D0K4SZ D0K4SZ DRUGCOMP GRUENENTHAL GMBH [DE] D0K4SZ DRUGTYPE Small molecular drug D0K4SZ HIGHSTAT Patented D0K4UF DRUG__ID D0K4UF D0K4UF DRUGTYPE Small molecular drug D0K4UF HIGHSTAT Patented D0K4UF COMPCLAS Imidazopyridine acetamide analogs D0K5YJ DRUG__ID D0K5YJ D0K5YJ DRUGCOMP MERCK SHARP & DOHME CORP. BIFTU, Tesfaye D0K5YJ DRUGTYPE Small molecular drug D0K5YJ HIGHSTAT Patented D0K6SZ DRUG__ID D0K6SZ D0K6SZ DRUGCOMP Aston University D0K6SZ DRUGTYPE Small molecular drug D0K6SZ HIGHSTAT Patented D0K6XL DRUG__ID D0K6XL D0K6XL DRUGCOMP IMPACT THERAPEUTICS, INC D0K6XL DRUGTYPE Small molecular drug D0K6XL HIGHSTAT Patented D0K7NC DRUG__ID D0K7NC D0K7NC DRUGCOMP CHEMOCENTRYX, INC D0K7NC DRUGTYPE Small molecule immunotherapy D0K7NC HIGHSTAT Patented D0K8EV DRUG__ID D0K8EV D0K8EV DRUGCOMP IOMET PHARMA LTD. MERCK SHARP & DOHME CORP. COWLEY, Phillip, M. WISE, Alan BROWN, Thomas, J. MCGOWAN, Meredeth, A. ZHOU, Hua HAN, Yongxin D0K8EV DRUGTYPE Small molecular drug D0K8EV HIGHSTAT Patented D0K8XT DRUG__ID D0K8XT D0K8XT DRUGCOMP Schering Corp D0K8XT HIGHSTAT Patented D0K8XT COMPCLAS Thiazole carboxamide derivatives D0K9QH DRUG__ID D0K9QH D0K9QH DRUGCOMP Amorepacific Corp D0K9QH DRUGTYPE Small molecular drug D0K9QH HIGHSTAT Patented D0KB4T DRUG__ID D0KB4T D0KB4T DRUGCOMP CITY OF HOPE FOREMAN, Barry D0KB4T DRUGTYPE Small molecular drug D0KB4T HIGHSTAT Patented D0KC6Y DRUG__ID D0KC6Y D0KC6Y DRUGCOMP IMPACT THERAPEUTICS, INC. CAI, Suixiong TIAN, Ye Edward WANG, Xiaozhu XIE, Kai LI, Sicun YU, Zenghui GU, Chengyun LIU, Lijun D0KC6Y DRUGTYPE Small molecular drug D0KC6Y HIGHSTAT Patented D0KC8X DRUG__ID D0KC8X D0KC8X DRUGCOMP MERCK SHARP & DOHME CORP D0KC8X HIGHSTAT Patented D0KC8X COMPCLAS Bicyclic heteroaryl benzamide derivatives D0KE4E DRUG__ID D0KE4E D0KE4E DRUGCOMP NEW ENGLAND BIOLABS INC D0KE4E DRUGTYPE Nucleotide D0KE4E HIGHSTAT Patented D0KE8Q DRUG__ID D0KE8Q D0KE8Q DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0KE8Q DRUGTYPE Carbohydrates D0KE8Q HIGHSTAT Patented D0KF8H DRUG__ID D0KF8H D0KF8H DRUGCOMP CELON PHARMA S.A D0KF8H DRUGTYPE Small molecular drug D0KF8H HIGHSTAT Patented D0KG5U DRUG__ID D0KG5U D0KG5U DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0KG5U DRUGTYPE Carbohydrates D0KG5U HIGHSTAT Patented D0KK0E DRUG__ID D0KK0E D0KK0E DRUGCOMP DEBRECENI EGYETEM D0KK0E DRUGTYPE Carbohydrates D0KK0E HIGHSTAT Patented D0KM0W DRUG__ID D0KM0W D0KM0W DRUGCOMP Novartis AG D0KM0W DRUGTYPE Small molecular drug D0KM0W HIGHSTAT Patented D0KM7V DRUG__ID D0KM7V D0KM7V DRUGCOMP UNIVERSITA' DEGLI STUDI DI PADOVA CHILIN, Adriana MARZARO, Giovanni GUIOTTO, Adriano CONCONI, Maria Teresa CASTAGLIUOLO, Ignazio D0KM7V DRUGTYPE Small molecular drug D0KM7V HIGHSTAT Patented D0KN6L DRUG__ID D0KN6L D0KN6L DRUGCOMP UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION CORNELL UNIVERSITY D0KN6L DRUGTYPE Small molecular drug D0KN6L HIGHSTAT Patented D0KN7T DRUG__ID D0KN7T D0KN7T DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0KN7T HIGHSTAT Patented D0KN7T COMPCLAS Thiazole carboxamide derivatives D0KO3I DRUG__ID D0KO3I D0KO3I DRUGCOMP KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY RHO, Mun Chual LEE, Woo Song OH, Hyun Mee KIM, Young Min D0KO3I HIGHSTAT Patented D0KO3I COMPCLAS Olenolic acid acetate derivatives D0KP4J DRUG__ID D0KP4J D0KP4J DRUGCOMP BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM D0KP4J DRUGTYPE Small molecular drug D0KP4J HIGHSTAT Patented D0KR2T DRUG__ID D0KR2T D0KR2T DRUGCOMP EPIZYME, INC D0KR2T DRUGTYPE Small molecular drug D0KR2T HIGHSTAT Patented D0KR7R DRUG__ID D0KR7R D0KR7R DRUGCOMP Sunshine Lake Pharma Co., Ltd D0KR7R DRUGTYPE Small molecular drug D0KR7R HIGHSTAT Patented D0KS3G DRUG__ID D0KS3G D0KS3G DRUGCOMP ARCUS BIOSCIENCES, INCVITAE PHARMACEUTICALS, INC D0KS3G DRUGTYPE Small molecular drug D0KS3G HIGHSTAT Patented D0KU2T DRUG__ID D0KU2T D0KU2T DRUGTYPE Small molecular drug D0KU2T HIGHSTAT Patented D0KU2T COMPCLAS Pravastatin derivatives D0KV5Z DRUG__ID D0KV5Z D0KV5Z DRUGTYPE Small molecular drug D0KV5Z HIGHSTAT Patented D0KV5Z COMPCLAS Benzisoselenazolone difluorocytidine derivatives D0KV7D DRUG__ID D0KV7D D0KV7D DRUGCOMP ELI LILLY AND COMPANY D0KV7D DRUGTYPE Small molecular drug D0KV7D HIGHSTAT Patented D0KW0F DRUG__ID D0KW0F D0KW0F DRUGCOMP CISEN PHARMACEUTICAL CO., LTD. SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY D0KW0F DRUGTYPE Small molecular drug D0KW0F HIGHSTAT Patented D0KX0J DRUG__ID D0KX0J D0KX0J DRUGCOMP TRUSTEES OF DARTMOUTH COLLEGE D0KX0J DRUGTYPE Small molecular drug D0KX0J HIGHSTAT Patented D0KZ5O DRUG__ID D0KZ5O D0KZ5O DRUGTYPE Small molecular drug D0KZ5O HIGHSTAT Patented D0KZ5O COMPCLAS Bidentate pyrazolopyrimidine acetamide analogs D0KZ6T DRUG__ID D0KZ6T D0KZ6T DRUGCOMP Leland Stanford Junior University D0KZ6T DRUGTYPE Small molecular drug D0KZ6T HIGHSTAT Patented D0L0DT DRUG__ID D0L0DT D0L0DT DRUGCOMP CELGENE QUANTICEL RESEARCH, INC D0L0DT DRUGTYPE Small molecular drug D0L0DT HIGHSTAT Patented D0L1TT DRUG__ID D0L1TT D0L1TT DRUGCOMP ONYX THERAPEUTICS, INC. SHENK, Kevin D. PARLATI, Francesco BENNETT, Mark K D0L1TT DRUGTYPE Small molecular drug D0L1TT HIGHSTAT Patented D0L2KM DRUG__ID D0L2KM D0L2KM DRUGCOMP AstraZeneca D0L2KM DRUGTYPE Small molecular drug D0L2KM HIGHSTAT Patented D0L2MS DRUG__ID D0L2MS D0L2MS DRUGCOMP ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely D0L2MS DRUGTYPE Small molecular drug D0L2MS HIGHSTAT Patented D0L2XV DRUG__ID D0L2XV D0L2XV DRUGCOMP SERVIER LAB [FRVERNALIS (R&D) LTD [GB] D0L2XV DRUGTYPE Small molecular drug D0L2XV HIGHSTAT Patented D0L3CU DRUG__ID D0L3CU D0L3CU DRUGCOMP KARUS THERAPEUTICS LTD D0L3CU DRUGTYPE Small molecular drug D0L3CU HIGHSTAT Patented D0L4OH DRUG__ID D0L4OH D0L4OH DRUGCOMP IEO - ISTITUTO EUROPEO DI ONCOLOGIA S.R.L D0L4OH DRUGTYPE Small molecular drug D0L4OH HIGHSTAT Patented D0L5DV DRUG__ID D0L5DV D0L5DV DRUGCOMP PFIZER INC D0L5DV DRUGTYPE Small molecular drug D0L5DV HIGHSTAT Patented D0L5OP DRUG__ID D0L5OP D0L5OP DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0L5OP DRUGTYPE Carbohydrates D0L5OP HIGHSTAT Patented D0L5UM DRUG__ID D0L5UM D0L5UM DRUGCOMP Bristol-Myers Squibb Co D0L5UM DRUGTYPE Small molecular drug D0L5UM HIGHSTAT Patented D0L6HL DRUG__ID D0L6HL D0L6HL DRUGCOMP RANBAXY LABORATORIES LIMITED KHERA, Manoj Kumar SONI, Ajay SATTIGERI, Jitendra SATTIGERI, Viswajanani DAS, Biswajit CLIFFE, Ian A. BHATNAGAR, Pradip Kumar RAUF, Abdul Rehman Abdul MUSIB, Arpita SAHA, Subham YADAV, Neeraj Kumar AHAMMED, Sabir REDDY, Ranadheer R. RAY, Abhijit SRIVASTAVA, Punit DASTIDAR, Sunanda Ghosh D0L6HL DRUGTYPE Small molecular drug D0L6HL HIGHSTAT Patented D0L7QE DRUG__ID D0L7QE D0L7QE DRUGCOMP Gilead Sciences Inc D0L7QE DRUGTYPE Small molecular drug D0L7QE HIGHSTAT Patented D0L8FE DRUG__ID D0L8FE D0L8FE DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0L8FE DRUGTYPE Small molecular drug D0L8FE HIGHSTAT Patented D0L8QD DRUG__ID D0L8QD D0L8QD DRUGCOMP Nissan chemical industries, Ltd D0L8QD DRUGTYPE Small molecular drug D0L8QD HIGHSTAT Patented D0LA0Q DRUG__ID D0LA0Q D0LA0Q DRUGCOMP Janssen Pharmaceutica NV D0LA0Q DRUGTYPE Small molecular drug D0LA0Q HIGHSTAT Patented D0LA2R DRUG__ID D0LA2R D0LA2R DRUGTYPE Small molecular drug D0LA2R HIGHSTAT Patented D0LA2R COMPCLAS Dihydroxyfumaric acid derivatives D0LA6O DRUG__ID D0LA6O D0LA6O DRUGCOMP KOWA COMPANY, LTD. MIURA, Toru ONOGI, Kazuhiro TAGASHIRA, Junya D0LA6O DRUGTYPE Small molecular drug D0LA6O HIGHSTAT Patented D0LB6Q DRUG__ID D0LB6Q D0LB6Q DRUGCOMP THE UNIVERSITY OF HONG KON D0LB6Q DRUGTYPE Small molecular drug D0LB6Q HIGHSTAT Patented D0LC5Y DRUG__ID D0LC5Y D0LC5Y DRUGCOMP ABIDE THERAPEUTICS, INCABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D0LC5Y DRUGTYPE Small molecular drug D0LC5Y HIGHSTAT Patented D0LE6B DRUG__ID D0LE6B D0LE6B DRUGCOMP Verleye M, Guern MEL, Girard P, et alMsn Laboratories Limited, India D0LE6B DRUGTYPE Small molecular drug D0LE6B HIGHSTAT Patented D0LH9E DRUG__ID D0LH9E D0LH9E DRUGTYPE Small molecular drug D0LH9E HIGHSTAT Patented D0LH9E COMPCLAS Imidazolidine-2,4-dione derivatives D0LK4R DRUG__ID D0LK4R D0LK4R DRUGCOMP NEW ENGLAND BIOLABS INC D0LK4R DRUGTYPE Nucleotide D0LK4R HIGHSTAT Patented D0LL7V DRUG__ID D0LL7V D0LL7V DRUGCOMP China Pharmaceutical University D0LL7V DRUGTYPE Small molecular drug D0LL7V HIGHSTAT Patented D0LM5V DRUG__ID D0LM5V D0LM5V DRUGTYPE Small molecular drug D0LM5V HIGHSTAT Patented D0LM5V COMPCLAS Benzene sulfonamide derivatives D0LN1T DRUG__ID D0LN1T D0LN1T DRUGCOMP THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS D0LN1T DRUGTYPE Small molecular drug D0LN1T HIGHSTAT Patented D0LO7X DRUG__ID D0LO7X D0LO7X DRUGCOMP DANA FARBER CANCER INSTITUTE, INCDANA-FARBER CANCER INSTITUTE, INC WALENSKY, Loren, D. STEWART, Michelle, L. COHEN, Nicole D0LO7X DRUGTYPE Small molecular drug D0LO7X HIGHSTAT Patented D0LP0D DRUG__ID D0LP0D D0LP0D DRUGCOMP RANBAXY LABORATORIES LIMITED KHERA, Manoj Kumar SATTIGERI, Jitendra YADAV, Neeraj Kumar RAUF, Abdul Rehman Abdul CLIFFE, Ian A. BHATNAGAR, Pradip Kumar RAY, Abhijit SRIVASTAVA, Punit DASTIDAR, Sunanda Ghosh D0LP0D DRUGTYPE Small molecular drug D0LP0D HIGHSTAT Patented D0LS1O DRUG__ID D0LS1O D0LS1O DRUGCOMP F. HOFFMANN-LA ROCHE AG BERGERON, Philippe BODIL VAN NIEL, Monique DRAGOVICH, Peter HURLEY, Christopher KULAGOWSKI, Janusz LABADIE, Sharada MCLEAN, Neville James MENDONCA, Rohan PULK, Rebecca ZAK, Mark D0LS1O DRUGTYPE Small molecular drug D0LS1O HIGHSTAT Patented D0LV6K DRUG__ID D0LV6K D0LV6K DRUGCOMP KARUS THERAPEUTICS LTD D0LV6K DRUGTYPE Small molecular drug D0LV6K HIGHSTAT Patented D0LW9R DRUG__ID D0LW9R D0LW9R DRUGCOMP Obseva SA D0LW9R DRUGTYPE Small molecular drug D0LW9R HIGHSTAT Patented D0LX2Y DRUG__ID D0LX2Y D0LX2Y DRUGTYPE Small molecular drug D0LX2Y HIGHSTAT Patented D0LX2Y COMPCLAS Aminoazetidine derivatives D0LZ1W DRUG__ID D0LZ1W D0LZ1W DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0LZ1W DRUGTYPE Carbohydrates D0LZ1W HIGHSTAT Patented D0LZ4V DRUG__ID D0LZ4V D0LZ4V DRUGCOMP Merck Sharp & Dohme D0LZ4V DRUGTYPE Small molecular drug D0LZ4V HIGHSTAT Patented D0LZ5Q DRUG__ID D0LZ5Q D0LZ5Q DRUGCOMP Hoffmann-La Roche Ag D0LZ5Q DRUGTYPE Small molecular drug D0LZ5Q HIGHSTAT Patented D0M1TG DRUG__ID D0M1TG D0M1TG DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0M1TG DRUGTYPE Small molecular drug D0M1TG HIGHSTAT Patented D0M2JK DRUG__ID D0M2JK D0M2JK DRUGTYPE Small molecular drug D0M2JK HIGHSTAT Patented D0M2JK COMPCLAS Aminopyridine derivatives D0M2XJ DRUG__ID D0M2XJ D0M2XJ DRUGCOMP TIANJIN LONGBOGEN PHARMACEUTICAL CO., LTD D0M2XJ DRUGTYPE Small molecular drug D0M2XJ HIGHSTAT Patented D0M3BY DRUG__ID D0M3BY D0M3BY DRUGCOMP TETRALOGIC PHARMACEUTICALS CORP. CONDON, Stephen, M. LAPORTE, Matthew, G D0M3BY DRUGTYPE Small molecular drug D0M3BY HIGHSTAT Patented D0M3CB DRUG__ID D0M3CB D0M3CB DRUGCOMP JIANGSU CAREFREE PHARMACEUTICAL CO., LTD D0M3CB DRUGTYPE Small molecular drug D0M3CB HIGHSTAT Patented D0M4KF DRUG__ID D0M4KF D0M4KF DRUGCOMP HEPTARES THERAPEUTICS LIMITED D0M4KF DRUGTYPE Small molecular drug D0M4KF HIGHSTAT Patented D0M4LK DRUG__ID D0M4LK D0M4LK DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFT THE BROAD INSTITUTE INC D0M4LK DRUGTYPE Small molecular drug D0M4LK HIGHSTAT Patented D0M5BR DRUG__ID D0M5BR D0M5BR DRUGCOMP ONCODESIGN S.A. IPSEN PHARMA S.A.S D0M5BR DRUGTYPE Small molecular drug D0M5BR HIGHSTAT Patented D0M5YQ DRUG__ID D0M5YQ D0M5YQ DRUGCOMP Okayama University D0M5YQ DRUGTYPE Small molecular drug D0M5YQ HIGHSTAT Patented D0M6JD DRUG__ID D0M6JD D0M6JD DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0M6JD DRUGTYPE Small molecular drug D0M6JD HIGHSTAT Patented D0M6MP DRUG__ID D0M6MP D0M6MP DRUGCOMP SERVIER LAB [FRVERNALIS R & D LTD [GB] D0M6MP DRUGTYPE Small molecular drug D0M6MP HIGHSTAT Patented D0M7GG DRUG__ID D0M7GG D0M7GG DRUGCOMP CHDI FOUNDATION, INC D0M7GG DRUGTYPE Small molecular drug D0M7GG HIGHSTAT Patented D0M7XL DRUG__ID D0M7XL D0M7XL DRUGCOMP KARUS THERAPEUTICS LTD D0M7XL DRUGTYPE Small molecular drug D0M7XL HIGHSTAT Patented D0M8KB DRUG__ID D0M8KB D0M8KB DRUGCOMP FLEXUS BIOSCIENCES, INC D0M8KB DRUGTYPE Small molecular drug D0M8KB HIGHSTAT Patented D0M8YW DRUG__ID D0M8YW D0M8YW DRUGTYPE Small molecular drug D0M8YW HIGHSTAT Patented D0M8YW COMPCLAS Aminopyrimidine derivatives D0M9KZ DRUG__ID D0M9KZ D0M9KZ DRUGCOMP ASINEX LTD [RUKAZULKIN DENIS NIKOLAEVICH [RUKOCHUBEY VALERIY SERGEEVICH [RU] D0M9KZ DRUGTYPE Small molecular drug D0M9KZ HIGHSTAT Patented D0M9PB DRUG__ID D0M9PB D0M9PB DRUGTYPE Small molecular drug D0M9PB HIGHSTAT Patented D0M9PB COMPCLAS Imidazo[1,2-b]pyridazine acetamide derivatives D0M9ZW DRUG__ID D0M9ZW D0M9ZW DRUGTYPE Small molecular drug D0M9ZW HIGHSTAT Patented D0M9ZW COMPCLAS Hexahydro naphthalene derivatives D0MA2H DRUG__ID D0MA2H D0MA2H DRUGCOMP Syntex, Inc D0MA2H DRUGTYPE Small molecular drug D0MA2H HIGHSTAT Patented D0MA6I DRUG__ID D0MA6I D0MA6I DRUGCOMP Development Center for Biotechnology D0MA6I DRUGTYPE Small molecular drug D0MA6I HIGHSTAT Patented D0MB0V DRUG__ID D0MB0V D0MB0V DRUGCOMP Korea Institute of Science and Technology D0MB0V DRUGTYPE Small molecular drug D0MB0V HIGHSTAT Patented D0MF2V DRUG__ID D0MF2V D0MF2V DRUGCOMP National Cancer Center (S. Korea) D0MF2V DRUGTYPE Small molecular drug D0MF2V HIGHSTAT Patented D0MG4D DRUG__ID D0MG4D D0MG4D DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D0MG4D HIGHSTAT Patented D0MG4D COMPCLAS Heteroaryl-carboxamide derivatives D0MH4B DRUG__ID D0MH4B D0MH4B DRUGCOMP TETRALOGIC PHARMACEUTICALS CORP. CONDON, Stephen, M. LAPORTE, Matthew, G D0MH4B DRUGTYPE Small molecular drug D0MH4B HIGHSTAT Patented D0MH8G DRUG__ID D0MH8G D0MH8G DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0MH8G DRUGTYPE Small molecular drug D0MH8G HIGHSTAT Patented D0MI3E DRUG__ID D0MI3E D0MI3E DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0MI3E DRUGTYPE Small molecular drug D0MI3E HIGHSTAT Patented D0MI7K DRUG__ID D0MI7K D0MI7K DRUGCOMP H. LUNDBECK A/S D0MI7K DRUGTYPE Small molecular drug D0MI7K HIGHSTAT Patented D0MJ4L DRUG__ID D0MJ4L D0MJ4L DRUGTYPE Small molecular drug D0MJ4L HIGHSTAT Patented D0MJ4L COMPCLAS Hydroxamate analogs D0MO2X DRUG__ID D0MO2X D0MO2X DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0MO2X DRUGTYPE Small molecular drug D0MO2X HIGHSTAT Patented D0MO5Y DRUG__ID D0MO5Y D0MO5Y DRUGCOMP UNIVERSITY OF UTAH D0MO5Y DRUGTYPE Small molecular drug D0MO5Y HIGHSTAT Patented D0MP8N DRUG__ID D0MP8N D0MP8N DRUGCOMP SNU R&DB FOUNDATION KIM, Hyun Kee D0MP8N DRUGTYPE Antibody D0MP8N HIGHSTAT Patented D0MQ6T DRUG__ID D0MQ6T D0MQ6T DRUGCOMP Hoffmann-La Roche Ag D0MQ6T DRUGTYPE Small molecular drug D0MQ6T HIGHSTAT Patented D0MR8D DRUG__ID D0MR8D D0MR8D DRUGTYPE Small molecular drug D0MR8D HIGHSTAT Patented D0MR8D COMPCLAS Imidazopyridine acetamide analogs D0MR9V DRUG__ID D0MR9V D0MR9V DRUGCOMP GRUENENTHAL GMBH [DE D0MR9V DRUGTYPE Small molecular drug D0MR9V HIGHSTAT Patented D0MT4C DRUG__ID D0MT4C D0MT4C DRUGCOMP GLAXO GROUP LIMITED BLUNT, Richard EATHERTON, Andrew John GARZYA, Vincenzo HEALY, Mark Patrick MYATT, James PORTER, Roderick Alan D0MT4C DRUGTYPE Small molecular drug D0MT4C HIGHSTAT Patented D0MT6D DRUG__ID D0MT6D D0MT6D DRUGCOMP DEBRECENI EGYETEM D0MT6D DRUGTYPE Carbohydrates D0MT6D HIGHSTAT Patented D0MW7D DRUG__ID D0MW7D D0MW7D DRUGCOMP F. HOFFMANN-LA ROCHE AG D0MW7D DRUGTYPE Small molecular drug D0MW7D HIGHSTAT Patented D0MW7L DRUG__ID D0MW7L D0MW7L DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D0MW7L HIGHSTAT Patented D0MW7L COMPCLAS Heteroaryl-carboxamide derivatives D0MX3Y DRUG__ID D0MX3Y D0MX3Y DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY HUANG, Yanting SUN, Chongqing LAWRENCE, R., Michael EWING, William, R. TURDI, Huji D0MX3Y DRUGTYPE Small molecular drug D0MX3Y HIGHSTAT Patented D0MZ7I DRUG__ID D0MZ7I D0MZ7I DRUGCOMP VANDERBILT UNIVERSITY D0MZ7I DRUGTYPE Small molecular drug D0MZ7I HIGHSTAT Patented D0MZ7K DRUG__ID D0MZ7K D0MZ7K DRUGCOMP MERCK SHARP & DOHME CORP D0MZ7K HIGHSTAT Patented D0MZ7K COMPCLAS Triazolo[4,3-b]pyridazine derivatives D0MZ8D DRUG__ID D0MZ8D D0MZ8D DRUGCOMP CONSTELLATION PHARMACEUTICALS, INC D0MZ8D DRUGTYPE Small molecular drug D0MZ8D HIGHSTAT Patented D0MZ8J DRUG__ID D0MZ8J D0MZ8J DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0MZ8J DRUGTYPE Carbohydrates D0MZ8J HIGHSTAT Patented D0N0MV DRUG__ID D0N0MV D0N0MV DRUGCOMP Kissei Pharmaceutical Co. Ltd D0N0MV DRUGTYPE Small molecular drug D0N0MV HIGHSTAT Patented D0N1CF DRUG__ID D0N1CF D0N1CF DRUGTYPE Small molecular drug D0N1CF HIGHSTAT Patented D0N1CF COMPCLAS Imidazo[1,2-b]pyridazine derivatives D0N1IA DRUG__ID D0N1IA D0N1IA DRUGCOMP DEBRECENI EGYETEM D0N1IA DRUGTYPE Carbohydrates D0N1IA HIGHSTAT Patented D0N1VC DRUG__ID D0N1VC D0N1VC DRUGCOMP China Medical University D0N1VC DRUGTYPE Small molecular drug D0N1VC HIGHSTAT Patented D0N2QZ DRUG__ID D0N2QZ D0N2QZ DRUGCOMP CELGENE QUANTICEL RESEARCH, INC D0N2QZ DRUGTYPE Small molecular drug D0N2QZ HIGHSTAT Patented D0N2UQ DRUG__ID D0N2UQ D0N2UQ DRUGCOMP AbbVie, Inc D0N2UQ DRUGTYPE Small molecular drug D0N2UQ HIGHSTAT Patented D0N2VA DRUG__ID D0N2VA D0N2VA DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D0N2VA DRUGTYPE Small molecular drug D0N2VA HIGHSTAT Patented D0N4DY DRUG__ID D0N4DY D0N4DY DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0N4DY DRUGTYPE Small molecular drug D0N4DY HIGHSTAT Patented D0N4RI DRUG__ID D0N4RI D0N4RI DRUGCOMP Obseva SA D0N4RI DRUGTYPE Small molecular drug D0N4RI HIGHSTAT Patented D0N4WW DRUG__ID D0N4WW D0N4WW DRUGCOMP WASHINGTON UNIVERSITY D0N4WW DRUGTYPE Carbohydrates D0N4WW HIGHSTAT Patented D0N5JQ DRUG__ID D0N5JQ D0N5JQ DRUGCOMP COGNITION THERAPEUTICS, INC. CATALANO, Susan, M. RISHTON, Gilbert IZZO, Nicholas, J D0N5JQ DRUGTYPE Small molecular drug D0N5JQ HIGHSTAT Patented D0N5LW DRUG__ID D0N5LW D0N5LW DRUGTYPE Small molecular drug D0N5LW HIGHSTAT Patented D0N5LW COMPCLAS Phenylpurine acetamide analogs D0N6GL DRUG__ID D0N6GL D0N6GL DRUGTYPE Small molecular drug D0N6GL HIGHSTAT Patented D0N6GL COMPCLAS Pyrazoline derivatives D0N6NG DRUG__ID D0N6NG D0N6NG DRUGCOMP MERCK SHARP & DOHME CORP D0N6NG HIGHSTAT Patented D0N6NG COMPCLAS Bicyclic heteroaryl benzamide derivatives D0N9WZ DRUG__ID D0N9WZ D0N9WZ DRUGTYPE Small molecular drug D0N9WZ HIGHSTAT Patented D0N9WZ COMPCLAS Benzene sulfonamide derivatives D0NA4O DRUG__ID D0NA4O D0NA4O DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D0NA4O DRUGTYPE Small molecular drug D0NA4O HIGHSTAT Patented D0NB1V DRUG__ID D0NB1V D0NB1V DRUGCOMP YM BIOSCIENCES AUSTRALIA PTY [AU] D0NB1V DRUGTYPE Small molecular drug D0NB1V HIGHSTAT Patented D0NB4O DRUG__ID D0NB4O D0NB4O DRUGCOMP N Zyme Biotech GmbH D0NB4O DRUGTYPE Small molecular drug D0NB4O HIGHSTAT Patented D0NB5M DRUG__ID D0NB5M D0NB5M DRUGCOMP ABBVIE INC D0NB5M DRUGTYPE Small molecular drug D0NB5M HIGHSTAT Patented D0NC3Q DRUG__ID D0NC3Q D0NC3Q DRUGCOMP Merck Sharp & Dohme D0NC3Q DRUGTYPE Small molecular drug D0NC3Q HIGHSTAT Patented D0NE8M DRUG__ID D0NE8M D0NE8M DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0NE8M DRUGTYPE Small molecular drug D0NE8M HIGHSTAT Patented D0NF8V DRUG__ID D0NF8V D0NF8V DRUGTYPE Small molecular drug D0NF8V HIGHSTAT Patented D0NF8V COMPCLAS Phenylpyridine derivatives D0NK1R DRUG__ID D0NK1R D0NK1R DRUGCOMP HANMI PHARM CO., LTD D0NK1R DRUGTYPE Small molecular drug D0NK1R HIGHSTAT Patented D0NM0B DRUG__ID D0NM0B D0NM0B DRUGCOMP CENTRE NAT RECH SCIENT [FR D0NM0B DRUGTYPE Small molecular drug D0NM0B HIGHSTAT Patented D0NN4P DRUG__ID D0NN4P D0NN4P DRUGCOMP Bristol-Myers Squibb Co D0NN4P DRUGTYPE Small molecular drug D0NN4P HIGHSTAT Patented D0NO3H DRUG__ID D0NO3H D0NO3H DRUGCOMP ONYX THERAPEUTICS, INC. PHIASIVONGSA, PasiPROTEOLIX, INC. SHENK, Kevin, D. PARLATI, Francesco ZHOU, Han-jie SYLVAIN, Catherine SMYTH, Mark, S. BENNETT, Mark, K. LAIDIG, Guy, J D0NO3H DRUGTYPE Small molecular drug D0NO3H HIGHSTAT Patented D0NO4O DRUG__ID D0NO4O D0NO4O DRUGCOMP Genentech, Inc., USA. assignee D0NO4O DRUGTYPE Small molecular drug D0NO4O HIGHSTAT Patented D0NP2W DRUG__ID D0NP2W D0NP2W DRUGCOMP CEPHALON, INC D0NP2W DRUGTYPE Small molecular drug D0NP2W HIGHSTAT Patented D0NQ6N DRUG__ID D0NQ6N D0NQ6N DRUGCOMP EMORY UNIVERSITY JIANG, Jianxiong GANESH, Thota DU, Yuhong THEPCHATRI, Pahk QUAN, Yi DINGLEDINE, Ray J D0NQ6N DRUGTYPE Small molecular drug D0NQ6N HIGHSTAT Patented D0NS7W DRUG__ID D0NS7W D0NS7W DRUGCOMP Kissei Pharmaceutical Co. Ltd D0NS7W DRUGTYPE Small molecular drug D0NS7W HIGHSTAT Patented D0NS8V DRUG__ID D0NS8V D0NS8V DRUGTYPE Small molecular drug D0NS8V HIGHSTAT Patented D0NS8V COMPCLAS Dihydropyrimidinone derivatives D0NT2S DRUG__ID D0NT2S D0NT2S DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN NIKOLOVSKA-COLESKA, Zaneta BAJWA, Naval LIAO, Chenzhong MIAO, Lei D0NT2S DRUGTYPE Small molecular drug D0NT2S HIGHSTAT Patented D0NX1O DRUG__ID D0NX1O D0NX1O DRUGCOMP NATIONAL CANCER CENTER KIM, Soo Youl D0NX1O DRUGTYPE Small molecular drug D0NX1O HIGHSTAT Patented D0NX8E DRUG__ID D0NX8E D0NX8E DRUGTYPE Small molecular drug D0NX8E HIGHSTAT Patented D0NX8E COMPCLAS Triazole gold complexes D0NY3W DRUG__ID D0NY3W D0NY3W DRUGTYPE Small molecular drug D0NY3W HIGHSTAT Patented D0NY3W COMPCLAS N-containing heterocyclic derivatives D0NY6M DRUG__ID D0NY6M D0NY6M DRUGCOMP NIMBUS LAKSHMI, INC D0NY6M DRUGTYPE Small molecular drug D0NY6M HIGHSTAT Patented D0O0AW DRUG__ID D0O0AW D0O0AW DRUGCOMP YM BIOSCIENCES AUSTRALIA PTY [AU] D0O0AW DRUGTYPE Small molecular drug D0O0AW HIGHSTAT Patented D0O0GZ DRUG__ID D0O0GZ D0O0GZ DRUGCOMP MERCK SHARP & DOHME CORP D0O0GZ HIGHSTAT Patented D0O0GZ COMPCLAS Bicyclic heteroaryl benzamide derivatives D0O0OD DRUG__ID D0O0OD D0O0OD DRUGCOMP BEIJING WBL PEKING UNIV BIOTEC D0O0OD DRUGTYPE Small molecular drug D0O0OD HIGHSTAT Patented D0O1LX DRUG__ID D0O1LX D0O1LX DRUGCOMP CHDI FOUNDATION, INC D0O1LX DRUGTYPE Small molecular drug D0O1LX HIGHSTAT Patented D0O1RL DRUG__ID D0O1RL D0O1RL DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0O1RL DRUGTYPE Small molecular drug D0O1RL HIGHSTAT Patented D0O2EN DRUG__ID D0O2EN D0O2EN DRUGCOMP EMORY UNIVERSITY JIANG, Jianxiong GANESH, Thota DU, Yuhong THEPCHATRI, Pahk QUAN, Yi DINGLEDINE, Ray J D0O2EN DRUGTYPE Small molecular drug D0O2EN HIGHSTAT Patented D0O2HK DRUG__ID D0O2HK D0O2HK DRUGCOMP UNIV SANTIAGO COMPOSTELA [ESUNIV DA CORU A [ESSERVIZO GALEGO DE SAUDE SERGAS [ES] D0O2HK DRUGTYPE Small molecular drug D0O2HK HIGHSTAT Patented D0O2TY DRUG__ID D0O2TY D0O2TY DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH HICKEY, Eugene Richard RIETHER, Doris ERMANN, Monika D0O2TY DRUGTYPE Small molecular drug D0O2TY HIGHSTAT Patented D0O2WW DRUG__ID D0O2WW D0O2WW DRUGCOMP ORYZON GENOMICS SA [ES] D0O2WW DRUGTYPE Small molecular drug D0O2WW HIGHSTAT Patented D0O3BR DRUG__ID D0O3BR D0O3BR DRUGCOMP Arena Pharmaceuticals, Inc D0O3BR DRUGTYPE Small molecular drug D0O3BR HIGHSTAT Patented D0O3KN DRUG__ID D0O3KN D0O3KN DRUGCOMP China Pharmaceutical University D0O3KN DRUGTYPE Small molecular drug D0O3KN HIGHSTAT Patented D0O4KM DRUG__ID D0O4KM D0O4KM DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0O4KM DRUGTYPE Small molecular drug D0O4KM HIGHSTAT Patented D0O4TA DRUG__ID D0O4TA D0O4TA DRUGCOMP YM BIOSCIENCES AUSTRALIA PTY [AU] D0O4TA DRUGTYPE Small molecular drug D0O4TA HIGHSTAT Patented D0O4TC DRUG__ID D0O4TC D0O4TC DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0O4TC DRUGTYPE Carbohydrates D0O4TC HIGHSTAT Patented D0O5IA DRUG__ID D0O5IA D0O5IA DRUGCOMP Development Center for Biotechnology D0O5IA DRUGTYPE Small molecular drug D0O5IA HIGHSTAT Patented D0O5IN DRUG__ID D0O5IN D0O5IN DRUGCOMP THE UNIVERSITY OF SYDNEY HIBBS, David, Edward SALAM, Noeris, Kris ROUBIN, Rebecca MATIN, Azadeh GAVANDE, Navnath, S D0O5IN DRUGTYPE Small molecular drug D0O5IN HIGHSTAT Patented D0O6QC DRUG__ID D0O6QC D0O6QC DRUGTYPE Small molecular drug D0O6QC HIGHSTAT Patented D0O6QC COMPCLAS Heteroaryl-pyrazole derivatives D0O6VU DRUG__ID D0O6VU D0O6VU DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D0O6VU DRUGTYPE Small molecular drug D0O6VU HIGHSTAT Patented D0O7BH DRUG__ID D0O7BH D0O7BH DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D0O7BH DRUGTYPE Small molecular drug D0O7BH HIGHSTAT Patented D0O8AP DRUG__ID D0O8AP D0O8AP DRUGCOMP ORIGENIS GMBH D0O8AP DRUGTYPE Small molecular drug D0O8AP HIGHSTAT Patented D0O8EX DRUG__ID D0O8EX D0O8EX DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0O8EX DRUGTYPE Carbohydrates D0O8EX HIGHSTAT Patented D0O8PR DRUG__ID D0O8PR D0O8PR DRUGCOMP Galderma Researh & Development D0O8PR DRUGTYPE Small molecular drug D0O8PR HIGHSTAT Patented D0O8RQ DRUG__ID D0O8RQ D0O8RQ DRUGCOMP PHARMAHUNGARY 2000 KFT [HUINFARMATIK KFT [HUTARGETEX KFT [HU] D0O8RQ DRUGTYPE Small molecular drug D0O8RQ HIGHSTAT Patented D0O8SX DRUG__ID D0O8SX D0O8SX DRUGCOMP NERVIANO MEDICAL D0O8SX HIGHSTAT Patented D0O8SX COMPCLAS Pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives D0O9WA DRUG__ID D0O9WA D0O9WA DRUGCOMP MEDIPROPHARMA, INC. SHCHERBAKOVA, Irina NIKOLICH, Karoly NIKOLYUKIN, Yuri D0O9WA DRUGTYPE Small molecular drug D0O9WA HIGHSTAT Patented D0O9YJ DRUG__ID D0O9YJ D0O9YJ DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0O9YJ DRUGTYPE Small molecular drug D0O9YJ HIGHSTAT Patented D0OE9W DRUG__ID D0OE9W D0OE9W DRUGCOMP MEDEON PHARMACEUTICALS GMBH UNIVERSIT TINGEN WERZ, Oliver KOEBERLE, Andreas SCHUBERT-ZSILAVECZ, Manfred POPESCU, Laura SYHA, Yvonne D0OE9W DRUGTYPE Small molecular drug D0OE9W HIGHSTAT Patented D0OG8Z DRUG__ID D0OG8Z D0OG8Z DRUGCOMP Univ California, Scripps Research Inst D0OG8Z DRUGTYPE Small molecular drug D0OG8Z HIGHSTAT Patented D0OH5L DRUG__ID D0OH5L D0OH5L DRUGTYPE Small molecular drug D0OH5L HIGHSTAT Patented D0OH5L COMPCLAS N-alkylamide derivatives D0OI4X DRUG__ID D0OI4X D0OI4X DRUGCOMP Biota Inc D0OI4X DRUGTYPE Small molecular drug D0OI4X HIGHSTAT Patented D0OL7Q DRUG__ID D0OL7Q D0OL7Q DRUGCOMP WYETH KREFT, Anthony, Frank RESNICK, Lynn MAYER, Scott, Christian DIAMANTIDIS, George COLE, Derek, Cecil WANG, Tingzhong GALANTE, Rocco, John HOKE, Molly HARRISON, Boyd, Lynn ZHANG, Minshen D0OL7Q DRUGTYPE Small molecular drug D0OL7Q HIGHSTAT Patented D0OS1N DRUG__ID D0OS1N D0OS1N DRUGCOMP INCYTE CORPORATION D0OS1N DRUGTYPE Small molecular drug D0OS1N HIGHSTAT Patented D0OS2M DRUG__ID D0OS2M D0OS2M DRUGCOMP Gilead Sciences Inc D0OS2M DRUGTYPE Small molecular drug D0OS2M HIGHSTAT Patented D0OW6O DRUG__ID D0OW6O D0OW6O DRUGCOMP CENTRE NAT RECH SCIENT [FRUNIV D AUVERGNE [FRUNIV LILLE SCIENCES TECH [FRUNIV NANTES [FRINST NAT SANTE RECH MED [FR] D0OW6O DRUGTYPE Carbohydrates D0OW6O HIGHSTAT Patented D0OY0Q DRUG__ID D0OY0Q D0OY0Q DRUGTYPE Small molecular drug D0OY0Q HIGHSTAT Patented D0OY0Q COMPCLAS Tihotungstate derivatives D0P1HR DRUG__ID D0P1HR D0P1HR DRUGCOMP MERCK SHARP &amDOHME CORP. HAN, Yongxin ACHAB, Abdelghani BIJU, Purakkattle DENG, Yongqi FRADERA, Xavier GUO, Liangqin HE, Shuwen KOZLOWSKI, Joseph KURUKULASURIYA, Ravi LIU, Kun MCGOWAN, Meredeth, A. PU, Qinglin SCIAMMETTA, Nunzio ZHANG, Hongjun ZHOU, Hua D0P1HR DRUGTYPE Small molecular drug D0P1HR HIGHSTAT Patented D0P1KV DRUG__ID D0P1KV D0P1KV DRUGCOMP Nanjing-University-of-Science-and-Technology D0P1KV DRUGTYPE Small molecular drug D0P1KV HIGHSTAT Patented D0P2AB DRUG__ID D0P2AB D0P2AB DRUGCOMP MERCK SHARP & DOHME CORP. YANG, ZhiQiang NANTERMET, Philippe, G. KREATSOULAS, Constantine MOORE, Keith, P. SHALEN, Evan Foster D0P2AB DRUGTYPE Small molecular drug D0P2AB HIGHSTAT Patented D0P3DS DRUG__ID D0P3DS D0P3DS DRUGTYPE Small molecular drug D0P3DS HIGHSTAT Patented D0P3DS COMPCLAS Pyrrolo[1,2-f]triazine derivatives D0P3SL DRUG__ID D0P3SL D0P3SL DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0P3SL DRUGTYPE Carbohydrates D0P3SL HIGHSTAT Patented D0P3UH DRUG__ID D0P3UH D0P3UH DRUGCOMP HANMI PHARM. CO., LTD D0P3UH DRUGTYPE Small molecular drug D0P3UH HIGHSTAT Patented D0P4NF DRUG__ID D0P4NF D0P4NF DRUGCOMP MCCORD, Darlene E. KARAGIANNIS, Thomas D0P4NF DRUGTYPE Small molecular drug D0P4NF HIGHSTAT Patented D0P6PT DRUG__ID D0P6PT D0P6PT DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0P6PT HIGHSTAT Patented D0P6PT COMPCLAS Thiazole carboxamide derivatives D0P7QO DRUG__ID D0P7QO D0P7QO DRUGCOMP F. HOFFMANN-LA ROCHE AG LIU, Wenjian LUK, Kin-Chun Thomas ZHANG, Xiaoh D0P7QO DRUGTYPE Small molecular drug D0P7QO HIGHSTAT Patented D0P7UB DRUG__ID D0P7UB D0P7UB DRUGCOMP Amorepacific Corp D0P7UB DRUGTYPE Small molecular drug D0P7UB HIGHSTAT Patented D0P8CM DRUG__ID D0P8CM D0P8CM DRUGCOMP Wisconsin-Alumni-Research-Foundation D0P8CM DRUGTYPE Small molecular drug D0P8CM HIGHSTAT Patented D0P8IR DRUG__ID D0P8IR D0P8IR DRUGTYPE Small molecular drug D0P8IR HIGHSTAT Patented D0P8IR COMPCLAS Bicyclic hexapeptide derivatives D0P8VL DRUG__ID D0P8VL D0P8VL DRUGCOMP PROTEOLIX, INC. SHENK, Kevin, D. PARLATI, Francesco ZHOU, Han-jie SYLVAIN, Catherine SMYTH, Mark, S. BENNETT, Mark, K. LAIDIG, Guy, J D0P8VL DRUGTYPE Small molecular drug D0P8VL HIGHSTAT Patented D0P8WC DRUG__ID D0P8WC D0P8WC DRUGCOMP Brandeis University and The Brigham and Womens Hospital, Inc D0P8WC DRUGTYPE Small molecular drug D0P8WC HIGHSTAT Patented D0P9KJ DRUG__ID D0P9KJ D0P9KJ DRUGCOMP GRUENENTHAL GMBH [DE] D0P9KJ DRUGTYPE Small molecular drug D0P9KJ HIGHSTAT Patented D0P9VX DRUG__ID D0P9VX D0P9VX DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D0P9VX DRUGTYPE Small molecular drug D0P9VX HIGHSTAT Patented D0P9YR DRUG__ID D0P9YR D0P9YR DRUGCOMP CORNELL UNIVERSITY D0P9YR DRUGTYPE Small molecular drug D0P9YR HIGHSTAT Patented D0PD2I DRUG__ID D0PD2I D0PD2I DRUGCOMP Schering Corp D0PD2I HIGHSTAT Patented D0PD2I COMPCLAS Thiazole carboxamide derivatives D0PE8E DRUG__ID D0PE8E D0PE8E DRUGCOMP THE TRUSTEES OF PRINCETON UNIVERSITY SHENK, Thomas KOYUNCU, Emre CRISTEA, Ileana D0PE8E DRUGTYPE RNA D0PE8E HIGHSTAT Patented D0PF4H DRUG__ID D0PF4H D0PF4H DRUGCOMP THE HAMNER INSTITUTES D0PF4H DRUGTYPE Small molecular drug D0PF4H HIGHSTAT Patented D0PF7S DRUG__ID D0PF7S D0PF7S DRUGCOMP HANMI HOLDINGS CO., LTD. BAE, In Hwan JUN, Mi Ae SONG, Ji Young JU, Hae Kyoung SONG, Tae Hun CHO, Ju Hyun KWEON, Eun Kyung AHN, Young Gil KIM, Cheol Kyung KIM, Maeng Sup D0PF7S DRUGTYPE Small molecular drug D0PF7S HIGHSTAT Patented D0PG2V DRUG__ID D0PG2V D0PG2V DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. WOLFE, Michael, S D0PG2V DRUGTYPE Peptide D0PG2V HIGHSTAT Patented D0PI1W DRUG__ID D0PI1W D0PI1W DRUGCOMP BAYER PHARMA AKTIENGESELLSCHAFBAYER INTELLECTUAL PROPERTY GMBH BAYER PHARMA AKTIENGESELLSCHAFT D0PI1W DRUGTYPE Small molecular drug D0PI1W HIGHSTAT Patented D0PI2I DRUG__ID D0PI2I D0PI2I DRUGCOMP BIOGEN MA INC D0PI2I DRUGTYPE Small molecular drug D0PI2I HIGHSTAT Patented D0PJ2C DRUG__ID D0PJ2C D0PJ2C DRUGCOMP Nanjing-University-of-Science-and-Technology D0PJ2C DRUGTYPE Small molecular drug D0PJ2C HIGHSTAT Patented D0PJ8O DRUG__ID D0PJ8O D0PJ8O DRUGCOMP Sanofi-Aventis D0PJ8O DRUGTYPE Small molecular drug D0PJ8O HIGHSTAT Patented D0PK0R DRUG__ID D0PK0R D0PK0R DRUGCOMP INTERVET INTERNATIONAL B.V. GILBERT, Eric, J. MILLER, Michael, W. SCOTT, Jack, D. DEMONG, Duane, Eugene STAMFORD, Andrew GREENLEE, William, J. CELLY, Chander, Shekhe D0PK0R DRUGTYPE Small molecular drug D0PK0R HIGHSTAT Patented D0PN7H DRUG__ID D0PN7H D0PN7H DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0PN7H DRUGTYPE Small molecular drug D0PN7H HIGHSTAT Patented D0PO3M DRUG__ID D0PO3M D0PO3M DRUGTYPE Small molecular drug D0PO3M HIGHSTAT Patented D0PO3M COMPCLAS Imidazopyridine acetamide analogs D0PS0J DRUG__ID D0PS0J D0PS0J DRUGCOMP PFIZER PRODUCTS INC. BRODNEY, Michael, Aaron CHEN, Yuhpyng, Liang COFFMAN, Karen, Jean KLEINMAN, Edward, Fox O'NEILL, Brian, Thomas D0PS0J DRUGTYPE Small molecular drug D0PS0J HIGHSTAT Patented D0PU1L DRUG__ID D0PU1L D0PU1L DRUGCOMP CORNELL UNIVERSITY D0PU1L DRUGTYPE Small molecular drug D0PU1L HIGHSTAT Patented D0PY0H DRUG__ID D0PY0H D0PY0H DRUGTYPE Small molecular drug D0PY0H HIGHSTAT Patented D0PY0H COMPCLAS Azepan-4-one derivatives D0Q0XC DRUG__ID D0Q0XC D0Q0XC DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0Q0XC DRUGTYPE Carbohydrates D0Q0XC HIGHSTAT Patented D0Q0XN DRUG__ID D0Q0XN D0Q0XN DRUGCOMP University of Kentucky Research Foundation D0Q0XN DRUGTYPE Small molecular drug D0Q0XN HIGHSTAT Patented D0Q1MN DRUG__ID D0Q1MN D0Q1MN DRUGCOMP NTZ LAB LTD [BG] D0Q1MN DRUGTYPE Small molecular drug D0Q1MN HIGHSTAT Patented D0Q1SX DRUG__ID D0Q1SX D0Q1SX DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0Q1SX DRUGTYPE Carbohydrates D0Q1SX HIGHSTAT Patented D0Q4WA DRUG__ID D0Q4WA D0Q4WA DRUGCOMP XIGEN S.A. COMBETTE, Jean-Marc DELOCHE, Catherine D0Q4WA DRUGTYPE Peptide D0Q4WA HIGHSTAT Patented D0Q5FS DRUG__ID D0Q5FS D0Q5FS DRUGTYPE Small molecular drug D0Q5FS HIGHSTAT Patented D0Q5FS COMPCLAS Pyrazole derivatives D0Q6RC DRUG__ID D0Q6RC D0Q6RC DRUGCOMP Schering Corp D0Q6RC HIGHSTAT Patented D0Q6RC COMPCLAS Thiazole carboxamide derivatives D0Q8CR DRUG__ID D0Q8CR D0Q8CR DRUGCOMP SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE PELLECCHIA, Maurizio D0Q8CR DRUGTYPE Small molecular drug D0Q8CR HIGHSTAT Patented D0Q8JK DRUG__ID D0Q8JK D0Q8JK DRUGCOMP Schering Corp D0Q8JK HIGHSTAT Patented D0Q8JK COMPCLAS Thiazole carboxamide derivatives D0Q8MQ DRUG__ID D0Q8MQ D0Q8MQ DRUGCOMP Amorepacific Corp D0Q8MQ DRUGTYPE Small molecular drug D0Q8MQ HIGHSTAT Patented D0Q9XK DRUG__ID D0Q9XK D0Q9XK DRUGCOMP KARUS THERAPEUTICS LTD D0Q9XK DRUGTYPE Small molecular drug D0Q9XK HIGHSTAT Patented D0QA8T DRUG__ID D0QA8T D0QA8T DRUGCOMP Bristol-Myers Squibb Co D0QA8T DRUGTYPE Small molecular drug D0QA8T HIGHSTAT Patented D0QA9Q DRUG__ID D0QA9Q D0QA9Q DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D0QA9Q DRUGTYPE Small molecular drug D0QA9Q HIGHSTAT Patented D0QC6H DRUG__ID D0QC6H D0QC6H DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHIGAN GLICK, Gary D D0QC6H DRUGTYPE Small molecular drug D0QC6H HIGHSTAT Patented D0QE2H DRUG__ID D0QE2H D0QE2H DRUGTYPE Small molecular drug D0QE2H HIGHSTAT Patented D0QE2H COMPCLAS Thiadiazolidindione derivatives D0QE9E DRUG__ID D0QE9E D0QE9E DRUGCOMP DANA FARBER CANCER INSTITUTE, INCDANA-FARBER CANCER INSTITUTE, INC WALENSKY, Loren, D. STEWART, Michelle, L. COHEN, Nicole D0QE9E DRUGTYPE Small molecular drug D0QE9E HIGHSTAT Patented D0QF0Y DRUG__ID D0QF0Y D0QF0Y DRUGCOMP KARUS THERAPEUTICS LTD D0QF0Y DRUGTYPE Small molecular drug D0QF0Y HIGHSTAT Patented D0QF4V DRUG__ID D0QF4V D0QF4V DRUGCOMP AMAKEM NV D0QF4V DRUGTYPE Small molecular drug D0QF4V HIGHSTAT Patented D0QH5I DRUG__ID D0QH5I D0QH5I DRUGTYPE Small molecular drug D0QH5I HIGHSTAT Patented D0QH5I COMPCLAS N-phenyl-5-phenyl-pyrazolin-3-yl amide derivatives D0QH9W DRUG__ID D0QH9W D0QH9W DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBNOVARTIS AKalvista Pharmaceuticals LimiteRa Rharmaceuticals Inc D0QH9W HIGHSTAT Patented D0QH9W COMPCLAS Heteroaryl-carboxamide derivatives D0QJ5H DRUG__ID D0QJ5H D0QJ5H DRUGCOMP Centrum Medyczne D0QJ5H DRUGTYPE Small molecular drug D0QJ5H HIGHSTAT Patented D0QK6D DRUG__ID D0QK6D D0QK6D DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi TAN, Yun-chou D0QK6D DRUGTYPE Small molecular drug D0QK6D HIGHSTAT Patented D0QL7J DRUG__ID D0QL7J D0QL7J DRUGCOMP ABBVIE INC. WISHART, Neil BONAFOUX, Dominique F. FRANK, Kristine E. HOBSON, Adrian D. KONOPACKI, Donald B, MARTINEZ, Gloria Y. WANG, Lu D0QL7J DRUGTYPE Small molecular drug D0QL7J HIGHSTAT Patented D0QL7X DRUG__ID D0QL7X D0QL7X DRUGCOMP Bristol-Myers Squibb Co D0QL7X DRUGTYPE Small molecular drug D0QL7X HIGHSTAT Patented D0QM2O DRUG__ID D0QM2O D0QM2O DRUGCOMP WASHINGTON UNIVERSITY D0QM2O DRUGTYPE Carbohydrates D0QM2O HIGHSTAT Patented D0QN8W DRUG__ID D0QN8W D0QN8W DRUGCOMP KARUS THERAPEUTICS LTD D0QN8W DRUGTYPE Small molecular drug D0QN8W HIGHSTAT Patented D0QO1Y DRUG__ID D0QO1Y D0QO1Y DRUGCOMP IMPACT THERAPEUTICS, INC. CAI, Suixiong TIAN, Ye Edward WANG, Xiaozhu XIE, Kai LI, Sicun YU, Zenghui GU, Chengyun LIU, Lijun D0QO1Y DRUGTYPE Small molecular drug D0QO1Y HIGHSTAT Patented D0QU6N DRUG__ID D0QU6N D0QU6N DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0QU6N DRUGTYPE Carbohydrates D0QU6N HIGHSTAT Patented D0QV1E DRUG__ID D0QV1E D0QV1E DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0QV1E HIGHSTAT Patented D0QV1E COMPCLAS Thiazole carboxamide derivatives D0QW0C DRUG__ID D0QW0C D0QW0C DRUGCOMP INFECTIOUS DISEASE RESEARCH INSTITUTE D0QW0C DRUGTYPE Vaccine D0QW0C HIGHSTAT Patented D0QW6B DRUG__ID D0QW6B D0QW6B DRUGCOMP RUDD, ChristopheChung-Ang University D0QW6B HIGHSTAT Patented D0QW6B COMPCLAS Maleimides derivatives D0QW7F DRUG__ID D0QW7F D0QW7F DRUGCOMP SHANGHAI INST PHARM INDUSTRY [CNCAI ZHENGYAN [CNZHOU WEICHENG [CNHAO QUN [CN]the Shanghai Institute of Pharmaceutical Industry D0QW7F DRUGTYPE Small molecular drug D0QW7F HIGHSTAT Patented D0QX0O DRUG__ID D0QX0O D0QX0O DRUGCOMP KADMON CORPORATION, LLC D0QX0O DRUGTYPE Small molecular drug D0QX0O HIGHSTAT Patented D0QY0N DRUG__ID D0QY0N D0QY0N DRUGCOMP METHEOR THERAPEUTICS CORPORATION SLEDZIEWSKI, Andrew, Z. DEVOS, Theodore KOLE, Ryszard D0QY0N DRUGTYPE Nucleotide D0QY0N HIGHSTAT Patented D0R0DW DRUG__ID D0R0DW D0R0DW DRUGTYPE Small molecular drug D0R0DW HIGHSTAT Patented D0R0DW COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0R2TQ DRUG__ID D0R2TQ D0R2TQ DRUGCOMP EPIZYME, INC D0R2TQ DRUGTYPE Small molecular drug D0R2TQ HIGHSTAT Patented D0R3JM DRUG__ID D0R3JM D0R3JM DRUGTYPE Small molecular drug D0R3JM HIGHSTAT Patented D0R3JM COMPCLAS Benzene sulfonamide derivatives D0R3QC DRUG__ID D0R3QC D0R3QC DRUGCOMP REGENTS OF THE UNIVERSITY OF MINNESOTA PANKIEWICZ, Krzysztof CHEN, Liqiang VINCE, Robert D0R3QC DRUGTYPE Small molecular drug D0R3QC HIGHSTAT Patented D0R3VG DRUG__ID D0R3VG D0R3VG DRUGCOMP Schering Corp D0R3VG HIGHSTAT Patented D0R3VG COMPCLAS Thiazole carboxamide derivatives D0R5FU DRUG__ID D0R5FU D0R5FU DRUGCOMP THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL MOUNT SINAL SCHOOL OF MEDICINE ORLOWSKI, Robert, Z. ORLOWSKI, Marian D0R5FU DRUGTYPE Small molecular drug D0R5FU HIGHSTAT Patented D0R8UO DRUG__ID D0R8UO D0R8UO DRUGCOMP IMPACT THERAPEUTICS, INC D0R8UO DRUGTYPE Small molecular drug D0R8UO HIGHSTAT Patented D0R8XD DRUG__ID D0R8XD D0R8XD DRUGCOMP ONYX THERAPEUTICS, INC D0R8XD DRUGTYPE Small molecular drug D0R8XD HIGHSTAT Patented D0R9PD DRUG__ID D0R9PD D0R9PD DRUGTYPE Small molecular drug D0R9PD HIGHSTAT Patented D0R9PD COMPCLAS Hydrazide derivatives D0R9RP DRUG__ID D0R9RP D0R9RP DRUGCOMP ABBVIE INC D0R9RP DRUGTYPE Small molecular drug D0R9RP HIGHSTAT Patented D0RB6K DRUG__ID D0RB6K D0RB6K DRUGTYPE Small molecular drug D0RB6K HIGHSTAT Patented D0RB6K COMPCLAS Tetra-hydro-carboline derivatives D0RC0G DRUG__ID D0RC0G D0RC0G DRUGCOMP UNIVERSITY OF UTAH D0RC0G DRUGTYPE Small molecular drug D0RC0G HIGHSTAT Patented D0RC7L DRUG__ID D0RC7L D0RC7L DRUGCOMP Novartis AG D0RC7L DRUGTYPE Small molecular drug D0RC7L HIGHSTAT Patented D0RD5P DRUG__ID D0RD5P D0RD5P DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0RD5P DRUGTYPE Small molecular drug D0RD5P HIGHSTAT Patented D0RD7T DRUG__ID D0RD7T D0RD7T DRUGCOMP KARUS THERAPEUTICS LTD D0RD7T DRUGTYPE Small molecular drug D0RD7T HIGHSTAT Patented D0RF1V DRUG__ID D0RF1V D0RF1V DRUGCOMP Ixchelsis Limited D0RF1V DRUGTYPE Small molecular drug D0RF1V HIGHSTAT Patented D0RF5E DRUG__ID D0RF5E D0RF5E DRUGCOMP University of Kentucky Research Foundation D0RF5E DRUGTYPE Small molecular drug D0RF5E HIGHSTAT Patented D0RH3O DRUG__ID D0RH3O D0RH3O DRUGCOMP IMPACT THERAPEUTICS, INC D0RH3O DRUGTYPE Small molecular drug D0RH3O HIGHSTAT Patented D0RH7L DRUG__ID D0RH7L D0RH7L DRUGCOMP Dainippon Pharmaceutical Co., Ltd D0RH7L DRUGTYPE Small molecular drug D0RH7L HIGHSTAT Patented D0RJ1U DRUG__ID D0RJ1U D0RJ1U DRUGCOMP ABBOTT LABORATORIES D0RJ1U DRUGTYPE Small molecular drug D0RJ1U HIGHSTAT Patented D0RJ3W DRUG__ID D0RJ3W D0RJ3W DRUGCOMP YM BIOSCIENCES AUSTRALIA PTY LTD D0RJ3W DRUGTYPE Small molecular drug D0RJ3W HIGHSTAT Patented D0RK3S DRUG__ID D0RK3S D0RK3S DRUGCOMP Kissei Pharmaceutical Co. Ltd D0RK3S DRUGTYPE Small molecular drug D0RK3S HIGHSTAT Patented D0RK3U DRUG__ID D0RK3U D0RK3U DRUGCOMP MERCK PATENT GMBH D0RK3U DRUGTYPE Small molecular drug D0RK3U HIGHSTAT Patented D0RK6W DRUG__ID D0RK6W D0RK6W DRUGCOMP PFIZER LIMITED D0RK6W HIGHSTAT Patented D0RK6W COMPCLAS Pyrazolo[4,3-c]pyridine derivatives D0RL3M DRUG__ID D0RL3M D0RL3M DRUGCOMP METACRINE, INC D0RL3M DRUGTYPE Small molecular drug D0RL3M HIGHSTAT Patented D0RM6C DRUG__ID D0RM6C D0RM6C DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0RM6C DRUGTYPE Small molecular drug D0RM6C HIGHSTAT Patented D0RP4U DRUG__ID D0RP4U D0RP4U DRUGCOMP SGX PHARMACEUTICALS, INC. ARNOLD, William, D. GOSBERG, Andreas LI, Zhe STEENSMA, Ruo, W. WILSON, Mark, E D0RP4U DRUGTYPE Small molecular drug D0RP4U HIGHSTAT Patented D0RQ8Q DRUG__ID D0RQ8Q D0RQ8Q DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D0RQ8Q DRUGTYPE Small molecular drug D0RQ8Q HIGHSTAT Patented D0RR2D DRUG__ID D0RR2D D0RR2D DRUGTYPE Small molecular drug D0RR2D HIGHSTAT Patented D0RR2D COMPCLAS Golden phosphorous acetyletic compounds D0RV2E DRUG__ID D0RV2E D0RV2E DRUGTYPE Small molecular drug D0RV2E HIGHSTAT Patented D0RV2E COMPCLAS Pyrazole derivatives D0RY9I DRUG__ID D0RY9I D0RY9I DRUGCOMP MERCK PATENT GMBH D0RY9I DRUGTYPE Small molecular drug D0RY9I HIGHSTAT Patented D0RZ4M DRUG__ID D0RZ4M D0RZ4M DRUGCOMP NORTHEASTERN UNIVERSITY D0RZ4M DRUGTYPE Small molecular drug D0RZ4M HIGHSTAT Patented D0S0DL DRUG__ID D0S0DL D0S0DL DRUGTYPE Small molecular drug D0S0DL HIGHSTAT Patented D0S0DL COMPCLAS Benzene sulfonamide derivatives D0S0II DRUG__ID D0S0II D0S0II DRUGCOMP PFIZER LIMITED ANDREWS, Mark David BAGAL, Sharanjeet Kaur GIBSON, Karl Richard OMOTO, Kiyoyuki RYCKMANS, Thomas SKERRATT, Sarah Elizabeth STUPPLE, Paul Anthony D0S0II HIGHSTAT Patented D0S0II COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0S0XT DRUG__ID D0S0XT D0S0XT DRUGCOMP ENSEMBLE THERAPEUTICS CORPORATION D0S0XT DRUGTYPE Small molecular drug D0S0XT HIGHSTAT Patented D0S1OV DRUG__ID D0S1OV D0S1OV DRUGCOMP F. HOFFMANN-LA ROCHE AG BUETTELMANN, Bernd GOYAL, Bindu PALMER, Wylie Solang D0S1OV DRUGTYPE Small molecular drug D0S1OV HIGHSTAT Patented D0S2AY DRUG__ID D0S2AY D0S2AY DRUGCOMP CENTRE NAT RECH SCIENT [FR D0S2AY DRUGTYPE Small molecular drug D0S2AY HIGHSTAT Patented D0S2LV DRUG__ID D0S2LV D0S2LV DRUGCOMP NTZ LAB LTD [BG] D0S2LV DRUGTYPE Small molecular drug D0S2LV HIGHSTAT Patented D0S2UD DRUG__ID D0S2UD D0S2UD DRUGCOMP GLENMARK PHARMACEUTICALS S.A D0S2UD DRUGTYPE Small molecular drug D0S2UD HIGHSTAT Patented D0S3BE DRUG__ID D0S3BE D0S3BE DRUGCOMP HANS JOACHIM [DEGROTHE TORSTEN [DEWOEHRLE INGO [DEMOLDENHAUER JANA [DEKOEPCKE BAERBEL [DEKUEPER THOMAS [DEBITZER JENS [DEREINHARDT KATHRIN [DE D0S3BE DRUGTYPE Small molecular drug D0S3BE HIGHSTAT Patented D0S3ZB DRUG__ID D0S3ZB D0S3ZB DRUGCOMP KARUS THERAPEUTICS LTD D0S3ZB DRUGTYPE Small molecular drug D0S3ZB HIGHSTAT Patented D0S4XH DRUG__ID D0S4XH D0S4XH DRUGCOMP METHYLGENE INC D0S4XH DRUGTYPE Small molecular drug D0S4XH HIGHSTAT Patented D0S4YD DRUG__ID D0S4YD D0S4YD DRUGCOMP Zedira GmbH D0S4YD DRUGTYPE Small molecular drug D0S4YD HIGHSTAT Patented D0S5BD DRUG__ID D0S5BD D0S5BD DRUGCOMP MERCK SHARP &amDOHME LIMITED CHURCHER, Ian HARRISON, Timothy KERRAD, Sonia NADIN, Alan, John OWENS, Andrew, Pate SHAW, Duncan, Edward THOMSON, Joanne WILLIAMS, Susannah D0S5BD DRUGTYPE Small molecular drug D0S5BD HIGHSTAT Patented D0S6IA DRUG__ID D0S6IA D0S6IA DRUGCOMP NOVARTIS AG BRUCE, Ian CHAMOIN, Sylvie COLLINGWOOD, Stephen Paul FURET, Pascal FURMINGER, Vikki LEWIS, Sarah LOREN, Jon LV, Lin MOLTENI, Valentina SAUNDERS, Alex Michael SHAW, Duncan TURNER, Roy YEH, Vince D0S6IA DRUGTYPE Small molecular drug D0S6IA HIGHSTAT Patented D0S6SJ DRUG__ID D0S6SJ D0S6SJ DRUGCOMP PROXIMAGEN LTD. BOYD, Joe William MEO, Paul HIGGINBOTTOM, Michael SIMPSON, Iain MOUNTFORD, David Mark SAVORY, Edward Daniel D0S6SJ DRUGTYPE Small molecular drug D0S6SJ HIGHSTAT Patented D0S7VL DRUG__ID D0S7VL D0S7VL DRUGCOMP Bristol-Myers Squibb Co D0S7VL DRUGTYPE Small molecular drug D0S7VL HIGHSTAT Patented D0S8AZ DRUG__ID D0S8AZ D0S8AZ DRUGCOMP Kenhavns Universitet CLOOS, Paul AGGER, Karl CHRISTENSEN, Jesper HANSEN, Klaus H. HELIN, Kristian D0S8AZ DRUGTYPE Small molecular drug D0S8AZ HIGHSTAT Patented D0S8EH DRUG__ID D0S8EH D0S8EH DRUGCOMP BIOGEN IDEC MA INC D0S8EH DRUGTYPE Small molecular drug D0S8EH HIGHSTAT Patented D0S9HE DRUG__ID D0S9HE D0S9HE DRUGCOMP Evotec D0S9HE DRUGTYPE Small molecular drug D0S9HE HIGHSTAT Patented D0SB1W DRUG__ID D0SB1W D0SB1W DRUGCOMP F. HOFFMANN-LA ROCHE AG LUK, Kin-Chun Thomas D0SB1W DRUGTYPE Small molecular drug D0SB1W HIGHSTAT Patented D0SE9K DRUG__ID D0SE9K D0SE9K DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D0SE9K DRUGTYPE Small molecular drug D0SE9K HIGHSTAT Patented D0SF1E DRUG__ID D0SF1E D0SF1E DRUGCOMP ELI LILLY AND COMPANY D0SF1E DRUGTYPE Small molecular drug D0SF1E HIGHSTAT Patented D0SF8N DRUG__ID D0SF8N D0SF8N DRUGCOMP KARUS THERAPEUTICS LTD D0SF8N DRUGTYPE Small molecular drug D0SF8N HIGHSTAT Patented D0SG2L DRUG__ID D0SG2L D0SG2L DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0SG2L DRUGTYPE Small molecular drug D0SG2L HIGHSTAT Patented D0SH0L DRUG__ID D0SH0L D0SH0L DRUGCOMP the Shanghai Institute of Technology D0SH0L DRUGTYPE Small molecular drug D0SH0L HIGHSTAT Patented D0SH2Y DRUG__ID D0SH2Y D0SH2Y DRUGCOMP KALA PHARMACEUTICALS, INC D0SH2Y DRUGTYPE Small molecular drug D0SH2Y HIGHSTAT Patented D0SK3R DRUG__ID D0SK3R D0SK3R DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0SK3R DRUGTYPE Small molecular drug D0SK3R HIGHSTAT Patented D0SK9K DRUG__ID D0SK9K D0SK9K DRUGCOMP KARUS THERAPEUTICS LTD D0SK9K DRUGTYPE Small molecular drug D0SK9K HIGHSTAT Patented D0SL0K DRUG__ID D0SL0K D0SL0K DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED TAWARAISHI, Taisuke IMOTO, Hiroshi CHO, Nobuo D0SL0K DRUGTYPE Small molecular drug D0SL0K HIGHSTAT Patented D0SO6T DRUG__ID D0SO6T D0SO6T DRUGCOMP MEMORIAL SLOAN-KETTERING CANCER CENTER THE ROCKEFELLER UNIVERSITY D0SO6T DRUGTYPE Small molecular drug D0SO6T HIGHSTAT Patented D0SO8W DRUG__ID D0SO8W D0SO8W DRUGCOMP KARUS THERAPEUTICS LTD D0SO8W DRUGTYPE Small molecular drug D0SO8W HIGHSTAT Patented D0SQ1R DRUG__ID D0SQ1R D0SQ1R DRUGCOMP EPIZYME, INC D0SQ1R DRUGTYPE Small molecular drug D0SQ1R HIGHSTAT Patented D0SQ4B DRUG__ID D0SQ4B D0SQ4B DRUGCOMP Takeda Pharmaceutical Co. Ltd D0SQ4B DRUGTYPE Small molecular drug D0SQ4B HIGHSTAT Patented D0SR5L DRUG__ID D0SR5L D0SR5L DRUGCOMP ARENA PHARMACEUTICALS, INC. BLACKBURN, Anthony C. HAN, Sangdon JONES, Robert M. MONTALBAN, Anthony Garrido PAL, Biman B. RUETER, Jaimie Karyn D0SR5L DRUGTYPE Small molecular drug D0SR5L HIGHSTAT Patented D0SR8I DRUG__ID D0SR8I D0SR8I DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0SR8I DRUGTYPE Carbohydrates D0SR8I HIGHSTAT Patented D0SV0D DRUG__ID D0SV0D D0SV0D DRUGCOMP THE SCRIPPS RESEARCH INSTITUTE D0SV0D DRUGTYPE Small molecular drug D0SV0D HIGHSTAT Patented D0SW2Q DRUG__ID D0SW2Q D0SW2Q DRUGTYPE Small molecular drug D0SW2Q HIGHSTAT Patented D0SW2Q COMPCLAS Tetra-hydro-1H-1,2,6-triazaazulene derivatives D0SY6P DRUG__ID D0SY6P D0SY6P DRUGCOMP EPIZYME, INC D0SY6P DRUGTYPE Small molecular drug D0SY6P HIGHSTAT Patented D0SZ1L DRUG__ID D0SZ1L D0SZ1L DRUGTYPE Small molecular drug D0SZ1L HIGHSTAT Patented D0SZ1L COMPCLAS Triazolo-benzodiazepine derivatives D0T0CB DRUG__ID D0T0CB D0T0CB DRUGCOMP COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH D0T0CB DRUGTYPE Small molecular drug D0T0CB HIGHSTAT Patented D0T0OQ DRUG__ID D0T0OQ D0T0OQ DRUGTYPE Small molecular drug D0T0OQ HIGHSTAT Patented D0T0OQ COMPCLAS Furopyridine derivatives D0T1BE DRUG__ID D0T1BE D0T1BE DRUGCOMP TAISHO PHARMACEUTICAL CO., LTD. YASUHARA, Akito SAKAGAMI, Kazunari OHTA, Hiroshi HAYASHI, Masato SHIRASAKI, Yoshihisa YAMAMOTO, Shuji SHIMAZAKI, Youichi ARAKI, Yuko ABE, Kumi SUN, Xiang-Min D0T1BE DRUGTYPE Small molecular drug D0T1BE HIGHSTAT Patented D0T1GB DRUG__ID D0T1GB D0T1GB DRUGCOMP BOSTON BIOMEDICAL, INC. JIANG, Zhiwei LI, Chiang, Jia LI, Wei LEGGETT, David D0T1GB DRUGTYPE Small molecular drug D0T1GB HIGHSTAT Patented D0T1GG DRUG__ID D0T1GG D0T1GG DRUGCOMP ALLERGAN, INC D0T1GG DRUGTYPE Small molecular drug D0T1GG HIGHSTAT Patented D0T1MA DRUG__ID D0T1MA D0T1MA DRUGCOMP KYORIN SEIYAKU KK [JPTAKAHASHI HIROYASU [JPHIGUCHI HIROMI [JP] D0T1MA HIGHSTAT Patented D0T1MA COMPCLAS Dihydrothieno [2,3-e]indazole derivatives D0T1UU DRUG__ID D0T1UU D0T1UU DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PFAU, Roland ARNDT, Kirsten DOODS, Henri HAUEL, Norbert KLINDER, Klaus KUELZER, Raimund MACK, Juergen STENKAMP, Dirk D0T1UU DRUGTYPE Small molecular drug D0T1UU HIGHSTAT Patented D0T1YB DRUG__ID D0T1YB D0T1YB DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0T1YB DRUGTYPE Small molecular drug D0T1YB HIGHSTAT Patented D0T2CA DRUG__ID D0T2CA D0T2CA DRUGTYPE Small molecular drug D0T2CA HIGHSTAT Patented D0T2CA COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0T2QP DRUG__ID D0T2QP D0T2QP DRUGCOMP ALBANY MOLECULAR RESEARCH, INC. CIOFFI, Christopher, L. WOLF, Mark, A. GUZZO, Peter, R. LIU, Shuang SADALAPURE, Kashinath PARTHASARATHY, Visweswaren MAENG, Jun-ho D0T2QP DRUGTYPE Small molecular drug D0T2QP HIGHSTAT Patented D0T5AF DRUG__ID D0T5AF D0T5AF DRUGCOMP CADILA HEALTHCARE LIMITED THOMBARE, Pravin, S. ARGADE, Anil JAIN, Mukul, R. GITE, Sanjay D0T5AF DRUGTYPE Small molecular drug D0T5AF HIGHSTAT Patented D0T5SO DRUG__ID D0T5SO D0T5SO DRUGCOMP Merk Patent GMBH D0T5SO DRUGTYPE Small molecular drug D0T5SO HIGHSTAT Patented D0T7BE DRUG__ID D0T7BE D0T7BE DRUGCOMP YM BIOSCIENCES AUSTRALIA PTY [AU] D0T7BE DRUGTYPE Small molecular drug D0T7BE HIGHSTAT Patented D0T7RJ DRUG__ID D0T7RJ D0T7RJ DRUGCOMP KARUS THERAPEUTICS LTD D0T7RJ DRUGTYPE Small molecular drug D0T7RJ HIGHSTAT Patented D0T8QL DRUG__ID D0T8QL D0T8QL DRUGCOMP EPIZYME, INC D0T8QL DRUGTYPE Small molecular drug D0T8QL HIGHSTAT Patented D0T8WU DRUG__ID D0T8WU D0T8WU DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH D0T8WU DRUGTYPE Small molecular drug D0T8WU HIGHSTAT Patented D0T8XY DRUG__ID D0T8XY D0T8XY DRUGCOMP GLAXOSMITHKLINE BIOLOGICALS S.A. UNITED STATES DEPARTMENT OF THE ARMY, AS REPRESENTED BY THE SECRETARY OF THE US ARMY D0T8XY DRUGTYPE Vaccine D0T8XY HIGHSTAT Patented D0T9DV DRUG__ID D0T9DV D0T9DV DRUGCOMP THE JOHNS HOPKINS UNIVERSITY LIU, Jun, O. SHI, Wei PASUNOOTI, Kalyan, Kumar D0T9DV DRUGTYPE Small molecular drug D0T9DV HIGHSTAT Patented D0TB2H DRUG__ID D0TB2H D0TB2H DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D0TB2H HIGHSTAT Patented D0TB2H COMPCLAS Heteroaryl-carboxamide derivatives D0TK0L DRUG__ID D0TK0L D0TK0L DRUGCOMP F. HOFFMANN-LA ROCHE AG D0TK0L DRUGTYPE Small molecular drug D0TK0L HIGHSTAT Patented D0TK2O DRUG__ID D0TK2O D0TK2O DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D0TK2O DRUGTYPE Small molecular drug D0TK2O HIGHSTAT Patented D0TK3S DRUG__ID D0TK3S D0TK3S DRUGCOMP OMORI, Naoki et al D0TK3S DRUGTYPE Small molecular drug D0TK3S HIGHSTAT Patented D0TL1G DRUG__ID D0TL1G D0TL1G DRUGCOMP NORTHEASTERN UNIVERSITY D0TL1G DRUGTYPE Small molecular drug D0TL1G HIGHSTAT Patented D0TL4F DRUG__ID D0TL4F D0TL4F DRUGCOMP Gilead Sciences D0TL4F DRUGTYPE Small molecular drug D0TL4F HIGHSTAT Patented D0TO9J DRUG__ID D0TO9J D0TO9J DRUGCOMP Merck Sharp & Dohme Corp D0TO9J DRUGTYPE Small molecular drug D0TO9J HIGHSTAT Patented D0TP8T DRUG__ID D0TP8T D0TP8T DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0TP8T DRUGTYPE Carbohydrates D0TP8T HIGHSTAT Patented D0TR5T DRUG__ID D0TR5T D0TR5T DRUGCOMP PFIZER INC. ASPNES, Gary, Erik DIDIUK, Mary, Theresa FILIPSKI, Kevin, James GUZMAN-PEREZ, Angel PFEFFERKORN, Jeffrey, Allen STEVENS, Benjamin, Dawson TU, Meihua, Mik D0TR5T DRUGTYPE Small molecular drug D0TR5T HIGHSTAT Patented D0TT7U DRUG__ID D0TT7U D0TT7U DRUGCOMP TAKEDA PHARMACEUTICAL COMPANY LIMITED D0TT7U DRUGTYPE Small molecular drug D0TT7U HIGHSTAT Patented D0TU3N DRUG__ID D0TU3N D0TU3N DRUGCOMP THE REGENTS OF THE UNIVERSITY OF MICHGIAN NIKOLOVSKA-COLESKA, Zaneta SHOWALTER, Hollis D. LIAO, Chenzhong MOHAMMAD, Ramzi ABULWERDI, Fardokht WAYNE STATE UNIVERSITY D0TU3N DRUGTYPE Small molecular drug D0TU3N HIGHSTAT Patented D0TU5R DRUG__ID D0TU5R D0TU5R DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0TU5R DRUGTYPE Small molecular drug D0TU5R HIGHSTAT Patented D0TV9B DRUG__ID D0TV9B D0TV9B DRUGCOMP Ferring BV D0TV9B DRUGTYPE Small molecular drug D0TV9B HIGHSTAT Patented D0TX2G DRUG__ID D0TX2G D0TX2G DRUGCOMP ZHEJIANG DTRM BIOPHARMA [CN] D0TX2G DRUGTYPE Small molecular drug D0TX2G HIGHSTAT Patented D0TY4L DRUG__ID D0TY4L D0TY4L DRUGCOMP DEBRECENI EGYETEM D0TY4L DRUGTYPE Carbohydrates D0TY4L HIGHSTAT Patented D0TZ1Y DRUG__ID D0TZ1Y D0TZ1Y DRUGCOMP Gilead Sciences Inc D0TZ1Y DRUGTYPE Small molecular drug D0TZ1Y HIGHSTAT Patented D0U0CC DRUG__ID D0U0CC D0U0CC DRUGCOMP ENANTA PHARMACEUTICALS, INC D0U0CC DRUGTYPE Small molecular drug D0U0CC HIGHSTAT Patented D0U0IH DRUG__ID D0U0IH D0U0IH DRUGCOMP GE HEALTHCARE LIMITED WADSWORTH, Harry, John SHAN, Bo O'SHEA, Dennis PASSMORE, Joanna, Marie TRIGG, William, John D0U0IH DRUGTYPE Small molecular drug D0U0IH HIGHSTAT Patented D0U0ZN DRUG__ID D0U0ZN D0U0ZN DRUGCOMP Merck Sharp & Dohme Corp D0U0ZN DRUGTYPE Small molecular drug D0U0ZN HIGHSTAT Patented D0U1HA DRUG__ID D0U1HA D0U1HA DRUGCOMP ARRAY BIOPHARMA INC D0U1HA DRUGTYPE Small molecular drug D0U1HA HIGHSTAT Patented D0U2CK DRUG__ID D0U2CK D0U2CK DRUGCOMP the Shanghai Institute of Pharmaceutical Industry D0U2CK DRUGTYPE Small molecular drug D0U2CK HIGHSTAT Patented D0U2YE DRUG__ID D0U2YE D0U2YE DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0U2YE DRUGTYPE Small molecular drug D0U2YE HIGHSTAT Patented D0U3KT DRUG__ID D0U3KT D0U3KT DRUGCOMP EPITHERAPEUTICS APS D0U3KT DRUGTYPE Small molecular drug D0U3KT HIGHSTAT Patented D0U4DT DRUG__ID D0U4DT D0U4DT DRUGCOMP THE JOHNS HOPKINS UNIVERSITY INTONATION RESEARCH LABORATORIES D0U4DT DRUGTYPE Small molecular drug D0U4DT HIGHSTAT Patented D0U4ZO DRUG__ID D0U4ZO D0U4ZO DRUGCOMP SCHERING CORPORATION PARUCH, Kamil GUZI, Timothy J. DWYER, Michael P D0U4ZO DRUGTYPE Small molecular drug D0U4ZO HIGHSTAT Patented D0U5CK DRUG__ID D0U5CK D0U5CK DRUGCOMP METHEOR THERAPEUTICS CORPORATION SLEDZIEWSKI, Andrew, Z. DEVOS, Theodore KOLE, Ryszard D0U5CK DRUGTYPE Nucleotide D0U5CK HIGHSTAT Patented D0U5HB DRUG__ID D0U5HB D0U5HB DRUGCOMP Schering Corp D0U5HB HIGHSTAT Patented D0U5HB COMPCLAS Thiazole carboxamide derivatives D0U6AW DRUG__ID D0U6AW D0U6AW DRUGCOMP KOWA COMPANY, LTD. MIURA, Toru YAMADA, Hajime TAGASHIRA, Junya WATANABE, Gen D0U6AW DRUGTYPE Small molecular drug D0U6AW HIGHSTAT Patented D0U6CU DRUG__ID D0U6CU D0U6CU DRUGCOMP CHDI Foundation, Inc D0U6CU DRUGTYPE Small molecular drug D0U6CU HIGHSTAT Patented D0U6PW DRUG__ID D0U6PW D0U6PW DRUGCOMP PHARMABCINE INC D0U6PW DRUGTYPE Antibody D0U6PW HIGHSTAT Patented D0U7LW DRUG__ID D0U7LW D0U7LW DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0U7LW HIGHSTAT Patented D0U7LW COMPCLAS Thiazole carboxamide derivatives D0U9LS DRUG__ID D0U9LS D0U9LS DRUGCOMP GLENMARK PHARMACEUTICALS S.A. GHARAT, Laxmikant Atmaram GAJERA, Jitendra Maganbhai NARAYANA, Lakshminarayana KHAIRATKAR-JOSHI, Neelima KATTIGE, Vidya Ganapati D0U9LS DRUGTYPE Small molecular drug D0U9LS HIGHSTAT Patented D0U9UH DRUG__ID D0U9UH D0U9UH DRUGCOMP JANSSEN PHARMACEUTICA N.V. DVORAK, Curt, A. RUDOLPH, Dale, A. SHIREMAN, Brock, TJanssen Pharmaceutica NV D0U9UH DRUGTYPE Small molecular drug D0U9UH HIGHSTAT Patented D0UD3K DRUG__ID D0UD3K D0UD3K DRUGCOMP Bristol-Myers Squibb Co D0UD3K DRUGTYPE Small molecular drug D0UD3K HIGHSTAT Patented D0UD9R DRUG__ID D0UD9R D0UD9R DRUGCOMP BIOMARIN PHARMACEUTICAL INC D0UD9R DRUGTYPE Small molecular drug D0UD9R HIGHSTAT Patented D0UE4K DRUG__ID D0UE4K D0UE4K DRUGCOMP ORYZON GENOMICS SA [ESORYZON GENOMICS S.A. BAKER, Jonathan, Alleman CASTRO PALOMINO, Julio FYFE, Matthew, Colin, Thor MAES, Tamara MARTINELL PEDEMONTE, MarORYZON GENOMICS, S.A. BAKER, Jonathan, Alleman FYFE, Matthew, Colin Thor D0UE4K DRUGTYPE Small molecular drug D0UE4K HIGHSTAT Patented D0UG1W DRUG__ID D0UG1W D0UG1W DRUGCOMP MERCK & CO., INC. MEINKE, Peter, T. DENKER, Andrew MEININGER, Gary, E. UEMURA, Naoto WAGNER, John, A. CHARNICK, Steven D0UG1W DRUGTYPE Small molecular drug D0UG1W HIGHSTAT Patented D0UG5O DRUG__ID D0UG5O D0UG5O DRUGCOMP EPIZYME, INC D0UG5O DRUGTYPE Small molecular drug D0UG5O HIGHSTAT Patented D0UG5Q DRUG__ID D0UG5Q D0UG5Q DRUGCOMP UNIVERSITY OF UTAH RESEARCH FOUNDATIOUniversity of Utah, USA D0UG5Q DRUGTYPE Small molecular drug D0UG5Q HIGHSTAT Patented D0UH5B DRUG__ID D0UH5B D0UH5B DRUGCOMP METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC TANIS, Steven, P. PARKER, Timothy GADWOOD, Robert, C. ZELLER, James, R. ARTMAN, Gerald, D., III LARSEN, Scott, D D0UH5B DRUGTYPE Small molecular drug D0UH5B HIGHSTAT Patented D0UH8J DRUG__ID D0UH8J D0UH8J DRUGCOMP BEIJING HANMI PHARMACEUTICAL CO., LTD D0UH8J DRUGTYPE Small molecular drug D0UH8J HIGHSTAT Patented D0UJ5D DRUG__ID D0UJ5D D0UJ5D DRUGCOMP BOEHRINGER INGELHEIM INTERNATIONAL GMBH PRIEPKE, Henning DOODS, Henri KUELZER, Raimund PFAU, Roland STENKAMP, Dirk PELCMAN, Benjamin ROENN, Robert LUBRIKS, Dimitrijs SUNA, Edgars D0UJ5D DRUGTYPE Small molecular drug D0UJ5D HIGHSTAT Patented D0UK1S DRUG__ID D0UK1S D0UK1S DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0UK1S DRUGTYPE Carbohydrates D0UK1S HIGHSTAT Patented D0UL0K DRUG__ID D0UL0K D0UL0K DRUGCOMP AMGEN INC D0UL0K DRUGTYPE Small molecular drug D0UL0K HIGHSTAT Patented D0UQ2G DRUG__ID D0UQ2G D0UQ2G DRUGCOMP MERCK SHARP & DOHME CORP D0UQ2G HIGHSTAT Patented D0UQ2G COMPCLAS Tri-substituted urea derivatives D0UT0X DRUG__ID D0UT0X D0UT0X DRUGTYPE Small molecular drug D0UT0X HIGHSTAT Patented D0UT0X COMPCLAS Aromatic hydrazine carboxyimidoamide derivatives D0UT1G DRUG__ID D0UT1G D0UT1G DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0UT1G DRUGTYPE Small molecular drug D0UT1G HIGHSTAT Patented D0UU5N DRUG__ID D0UU5N D0UU5N DRUGCOMP The Regents of the University of Michigan D0UU5N DRUGTYPE Small molecular drug D0UU5N HIGHSTAT Patented D0UW6S DRUG__ID D0UW6S D0UW6S DRUGCOMP INSERM INST NAT DE LA SANT ET DE LA RECH M DICALE [FRUNIVERSIT PARIS DIDEROT PARIS 7 [FRCENTRE NAT RECH SCIENT [FR] D0UW6S DRUGTYPE Small molecular drug D0UW6S HIGHSTAT Patented D0UX1S DRUG__ID D0UX1S D0UX1S DRUGCOMP HEPTARES THERAPEUTICS LIMITED D0UX1S DRUGTYPE Small molecular drug D0UX1S HIGHSTAT Patented D0UX5I DRUG__ID D0UX5I D0UX5I DRUGCOMP Centrum Medyczne D0UX5I DRUGTYPE Small molecular drug D0UX5I HIGHSTAT Patented D0UY1A DRUG__ID D0UY1A D0UY1A DRUGCOMP Merck Sharp & Dohme Corp D0UY1A DRUGTYPE Small molecular drug D0UY1A HIGHSTAT Patented D0UY3J DRUG__ID D0UY3J D0UY3J DRUGCOMP CYTOCHROMA INC. JOHNS HOPKINS UNIVERSITY POSNER, Gary, H. HESS, Lindsey, C. KALINDA, Alvin, S. SLACK, Rachel, D. SAHA, Uttam PETKOVICH, P., Martin D0UY3J DRUGTYPE Small molecular drug D0UY3J HIGHSTAT Patented D0UY8K DRUG__ID D0UY8K D0UY8K DRUGCOMP Department of Health and Human Services (NIH, Bethesda, US) D0UY8K DRUGTYPE Small molecular drug D0UY8K HIGHSTAT Patented D0UZ2S DRUG__ID D0UZ2S D0UZ2S DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0UZ2S DRUGTYPE Carbohydrates D0UZ2S HIGHSTAT Patented D0UZ4S DRUG__ID D0UZ4S D0UZ4S DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0UZ4S DRUGTYPE Small molecular drug D0UZ4S HIGHSTAT Patented D0V0JN DRUG__ID D0V0JN D0V0JN DRUGCOMP Sanofi-Aventis D0V0JN DRUGTYPE Small molecular drug D0V0JN HIGHSTAT Patented D0V0OD DRUG__ID D0V0OD D0V0OD DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0V0OD DRUGTYPE Small molecular drug D0V0OD HIGHSTAT Patented D0V1CB DRUG__ID D0V1CB D0V1CB DRUGCOMP F. HOFFMANN-LA ROCHE AG BUETTELMANN, Bernd GOYAL, Bindu PALMER, Wylie Solang D0V1CB DRUGTYPE Small molecular drug D0V1CB HIGHSTAT Patented D0V2JR DRUG__ID D0V2JR D0V2JR DRUGCOMP Univ Lanzhou Tech D0V2JR DRUGTYPE Small molecular drug D0V2JR HIGHSTAT Patented D0V2NC DRUG__ID D0V2NC D0V2NC DRUGCOMP NTZ LAB LTD [BG] D0V2NC DRUGTYPE Small molecular drug D0V2NC HIGHSTAT Patented D0V3HE DRUG__ID D0V3HE D0V3HE DRUGCOMP Brandeis University, University of Georgia Research Foundation, Inc., and The Brigham and Womens Hospital, Inc D0V3HE DRUGTYPE Small molecular drug D0V3HE HIGHSTAT Patented D0V3MX DRUG__ID D0V3MX D0V3MX DRUGCOMP Novartis D0V3MX DRUGTYPE Small molecular drug D0V3MX HIGHSTAT Patented D0V5KY DRUG__ID D0V5KY D0V5KY DRUGCOMP TAISHO PHARMA CO LTD [JP] D0V5KY DRUGTYPE Small molecular drug D0V5KY HIGHSTAT Patented D0V5NK DRUG__ID D0V5NK D0V5NK DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0V5NK DRUGTYPE Small molecular drug D0V5NK HIGHSTAT Patented D0V7OE DRUG__ID D0V7OE D0V7OE DRUGCOMP ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC D0V7OE DRUGTYPE Small molecular drug D0V7OE HIGHSTAT Patented D0V7OF DRUG__ID D0V7OF D0V7OF DRUGCOMP Allergan, Inc D0V7OF DRUGTYPE Small molecular drug D0V7OF HIGHSTAT Patented D0V7PO DRUG__ID D0V7PO D0V7PO DRUGCOMP DR. AUGUST WOLFF GMBH &amCO. KG ARZNEIMITTEL D0V7PO DRUGTYPE Small molecular drug D0V7PO HIGHSTAT Patented D0V8XG DRUG__ID D0V8XG D0V8XG DRUGCOMP ORIGENIS GMBH D0V8XG DRUGTYPE Small molecular drug D0V8XG HIGHSTAT Patented D0V9GL DRUG__ID D0V9GL D0V9GL DRUGTYPE Small molecular drug D0V9GL HIGHSTAT Patented D0V9GL COMPCLAS Imidazopyridine acetamide analogs D0V9RM DRUG__ID D0V9RM D0V9RM DRUGCOMP SNU R&DB Foundation D0V9RM DRUGTYPE Small molecular drug D0V9RM HIGHSTAT Patented D0V9ZJ DRUG__ID D0V9ZJ D0V9ZJ DRUGCOMP DR. REDDY'S LABORATORIES LTD D0V9ZJ HIGHSTAT Patented D0V9ZJ COMPCLAS Pyrazolo[1,5-a]pyridine derivatives D0VB7F DRUG__ID D0VB7F D0VB7F DRUGCOMP NEVADA CANCER INSTITUTE SHENZHEN GRADUATE SCHOOL OF PEKING UNIVERSITY ZHANG, Hui YE, Tao QUAN, Junmin WANG, Jing D0VB7F DRUGTYPE Small molecular drug D0VB7F HIGHSTAT Patented D0VB9M DRUG__ID D0VB9M D0VB9M DRUGCOMP Aurigene Discovery Technologies Limited D0VB9M DRUGTYPE Peptide D0VB9M HIGHSTAT Patented D0VE3Y DRUG__ID D0VE3Y D0VE3Y DRUGCOMP F. HOFFMANN-LA ROCHE AG GONG, Leyi JAHANGIR, Alam REUTER, Deborah Carol D0VE3Y DRUGTYPE Small molecular drug D0VE3Y HIGHSTAT Patented D0VF0M DRUG__ID D0VF0M D0VF0M DRUGCOMP EPIZYME, INC D0VF0M DRUGTYPE Small molecular drug D0VF0M HIGHSTAT Patented D0VF5B DRUG__ID D0VF5B D0VF5B DRUGCOMP WASHINGTON UNIVERSITY D0VF5B DRUGTYPE Carbohydrates D0VF5B HIGHSTAT Patented D0VJ0N DRUG__ID D0VJ0N D0VJ0N DRUGCOMP DEBRECENI EGYETEM D0VJ0N DRUGTYPE Small molecular drug D0VJ0N HIGHSTAT Patented D0VJ1R DRUG__ID D0VJ1R D0VJ1R DRUGCOMP GALAPAGOS NV D0VJ1R DRUGTYPE Small molecular drug D0VJ1R HIGHSTAT Patented D0VJ5M DRUG__ID D0VJ5M D0VJ5M DRUGCOMP LIGAND PHARMACEUTICALS INCORPORATED COLE, Andrew, G. JAMES, Ray, A. SHAO, Yuefei LETOURNEAU, Jeffrey, J. QUINTERO, Jorge, G. RIVIELLO, Christopher, Mark ZHI, Lin D0VJ5M HIGHSTAT Patented D0VJ5M COMPCLAS Pyrazolopyridine derivatives D0VL5E DRUG__ID D0VL5E D0VL5E DRUGTYPE Small molecular drug D0VL5E HIGHSTAT Patented D0VL5E COMPCLAS Aminoazetidine derivatives D0VM5Z DRUG__ID D0VM5Z D0VM5Z DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0VM5Z DRUGTYPE Small molecular drug D0VM5Z HIGHSTAT Patented D0VR6E DRUG__ID D0VR6E D0VR6E DRUGTYPE Small molecular drug D0VR6E HIGHSTAT Patented D0VR6E COMPCLAS Pyrrolo-pyridine derivatives D0VU3I DRUG__ID D0VU3I D0VU3I DRUGTYPE Small molecular drug D0VU3I HIGHSTAT Patented D0VU3I COMPCLAS Hypersulfated disaccharide compounds D0VY7R DRUG__ID D0VY7R D0VY7R DRUGTYPE Small molecular drug D0VY7R HIGHSTAT Patented D0VY7R COMPCLAS Azetidinyl-piperidine derivatives D0W1AX DRUG__ID D0W1AX D0W1AX DRUGCOMP KARUS THERAPEUTICS LTD D0W1AX DRUGTYPE Small molecular drug D0W1AX HIGHSTAT Patented D0W1DK DRUG__ID D0W1DK D0W1DK DRUGTYPE Small molecular drug D0W1DK HIGHSTAT Patented D0W1DK COMPCLAS Golden phosphorous acetyletic compounds D0W1RQ DRUG__ID D0W1RQ D0W1RQ DRUGCOMP Incyte Corporation D0W1RQ DRUGTYPE Small molecule immunotherapy D0W1RQ HIGHSTAT Patented D0W1SE DRUG__ID D0W1SE D0W1SE DRUGCOMP WASHINGTON UNIVERSITY D0W1SE DRUGTYPE Carbohydrates D0W1SE HIGHSTAT Patented D0W3KK DRUG__ID D0W3KK D0W3KK DRUGCOMP Hoffmann-La Roche Inc D0W3KK DRUGTYPE Small molecular drug D0W3KK HIGHSTAT Patented D0W4MW DRUG__ID D0W4MW D0W4MW DRUGCOMP EPIZYME, INC D0W4MW DRUGTYPE Small molecular drug D0W4MW HIGHSTAT Patented D0W5DU DRUG__ID D0W5DU D0W5DU DRUGCOMP DEBRECENI EGYETEM D0W5DU DRUGTYPE Carbohydrates D0W5DU HIGHSTAT Patented D0W5GX DRUG__ID D0W5GX D0W5GX DRUGCOMP THOMAS JEFFERSON UNIVERSITY D0W5GX DRUGTYPE Small molecular drug D0W5GX HIGHSTAT Patented D0W5ZQ DRUG__ID D0W5ZQ D0W5ZQ DRUGCOMP Merck Sharp & DohmeMerck Sharp & Dohme D0W5ZQ DRUGTYPE Small molecular drug D0W5ZQ HIGHSTAT Patented D0W6PE DRUG__ID D0W6PE D0W6PE DRUGTYPE Small molecular drug D0W6PE HIGHSTAT Patented D0W6PE COMPCLAS Dihydropyrimidinone derivatives D0W7FS DRUG__ID D0W7FS D0W7FS DRUGCOMP ALBANY MOLECULAR RESEARCH, INC. CIOFFI, Christopher, L. WOLF, Mark, A. GUZZO, Peter, R. LIU, Shuang SADALAPURE, Kashinath PARTHASARATHY, Visweswaren MAENG, Jun-ho D0W7FS DRUGTYPE Small molecular drug D0W7FS HIGHSTAT Patented D0W8DN DRUG__ID D0W8DN D0W8DN DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0W8DN DRUGTYPE Small molecular drug D0W8DN HIGHSTAT Patented D0W8XM DRUG__ID D0W8XM D0W8XM DRUGCOMP MUSC FOUNDATION FOR RESEARCH DEVELOPMENT D0W8XM DRUGTYPE Small molecular drug D0W8XM HIGHSTAT Patented D0W9RH DRUG__ID D0W9RH D0W9RH DRUGCOMP ARRAY BIOPHARMA INC D0W9RH DRUGTYPE Small molecular drug D0W9RH HIGHSTAT Patented D0W9VU DRUG__ID D0W9VU D0W9VU DRUGTYPE Small molecular drug D0W9VU HIGHSTAT Patented D0W9VU COMPCLAS Sulfonamide-thiadiazole derivatives D0W9VZ DRUG__ID D0W9VZ D0W9VZ DRUGCOMP METHEOR THERAPEUTICS CORPORATION SLEDZIEWSKI, Andrew, Z. DEVOS, Theodore KOLE, Ryszard D0W9VZ DRUGTYPE Nucleotide D0W9VZ HIGHSTAT Patented D0WB5U DRUG__ID D0WB5U D0WB5U DRUGCOMP MERCK SHARP &amDOHME CORP. AHEARN, Sean, P. CHRISTOPHER, Matthew JUNG, Joon PU, Qinglin RIVKIN, Alexey SCOTT, Mark, E. WITTER, David, J. WOO, Hyun Chong CASH, Brandon DINSMORE, Christopher GUERIN, David D0WB5U DRUGTYPE Small molecular drug D0WB5U HIGHSTAT Patented D0WF1F DRUG__ID D0WF1F D0WF1F DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0WF1F DRUGTYPE Small molecular drug D0WF1F HIGHSTAT Patented D0WI7N DRUG__ID D0WI7N D0WI7N DRUGCOMP DR. REDDY'S LABORATORIES LTD D0WI7N HIGHSTAT Patented D0WI7N COMPCLAS Imidazo pyridine derivatives D0WJ3T DRUG__ID D0WJ3T D0WJ3T DRUGCOMP KEZAR LIFE SCIENCES D0WJ3T DRUGTYPE Small molecular drug D0WJ3T HIGHSTAT Patented D0WJ8R DRUG__ID D0WJ8R D0WJ8R DRUGCOMP SNU R&DB Foundation D0WJ8R DRUGTYPE Small molecular drug D0WJ8R HIGHSTAT Patented D0WL5E DRUG__ID D0WL5E D0WL5E DRUGCOMP BIOGEN MA INC D0WL5E DRUGTYPE Small molecular drug D0WL5E HIGHSTAT Patented D0WL5P DRUG__ID D0WL5P D0WL5P DRUGCOMP TRUSTEES OF BOSTON UNIVERSITY D0WL5P DRUGTYPE Antibody D0WL5P HIGHSTAT Patented D0WO2I DRUG__ID D0WO2I D0WO2I DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat D0WO2I DRUGTYPE Carbohydrates D0WO2I HIGHSTAT Patented D0WO5W DRUG__ID D0WO5W D0WO5W DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. SHI, Yujiang Geno LIAN, Christine Guo D0WO5W DRUGTYPE Small molecular drug D0WO5W HIGHSTAT Patented D0WO6C DRUG__ID D0WO6C D0WO6C DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0WO6C DRUGTYPE Carbohydrates D0WO6C HIGHSTAT Patented D0WP1P DRUG__ID D0WP1P D0WP1P DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0WP1P DRUGTYPE Small molecular drug D0WP1P HIGHSTAT Patented D0WR9T DRUG__ID D0WR9T D0WR9T DRUGTYPE Small molecular drug D0WR9T HIGHSTAT Patented D0WR9T COMPCLAS Oxime derivatives D0WT1Z DRUG__ID D0WT1Z D0WT1Z DRUGCOMP UNIVERSITY OF UTAUNIVERSITY OF UTAH RESEARCH FOUNDATIOUNIVERSITY OF UTAH RESEARCH FOUNDATION VANKAYALAPATI, Hariprasad SORNA, Venkataswamy WARNER, Steve, L. BEARSS, David, J. SHARMA, Sunil STEPHENS, BreUniversity of Utah, USA D0WT1Z DRUGTYPE Small molecular drug D0WT1Z HIGHSTAT Patented D0WT3F DRUG__ID D0WT3F D0WT3F DRUGCOMP DART NEUROSCIENCE (CAYMAN) LTD D0WT3F DRUGTYPE Small molecular drug D0WT3F HIGHSTAT Patented D0WT4I DRUG__ID D0WT4I D0WT4I DRUGCOMP UNIV SANTIAGO COMPOSTELA [ESUNIV DA CORU A [ESSERVIZO GALEGO DE SAUDE SERGAS [ES] D0WT4I DRUGTYPE Small molecular drug D0WT4I HIGHSTAT Patented D0WT7M DRUG__ID D0WT7M D0WT7M DRUGCOMP AKARNA THERAPEUTICS, LTDAKARNA THERAPEUTICS, LTD. PRATT, Benjamin Anthony D0WT7M DRUGTYPE Small molecular drug D0WT7M HIGHSTAT Patented D0WT9J DRUG__ID D0WT9J D0WT9J DRUGCOMP MERCK SHARP & DOHME CORP. PALIWAL, Sunil TSUI, Hon-Chung GAO, Xiaolei KIM, Hyunjin, M. CAPLEN, Mary Ann FISCHMANN, Thierry, O. DUCA, Jose, S D0WT9J HIGHSTAT Patented D0WT9J COMPCLAS Heteroaryl-carboxamide derivatives D0WV1W DRUG__ID D0WV1W D0WV1W DRUGCOMP Wisconsin-Alumni-Research-Foundation D0WV1W DRUGTYPE Small molecular drug D0WV1W HIGHSTAT Patented D0WW2H DRUG__ID D0WW2H D0WW2H DRUGCOMP GLAXOSMITHKLINE LLC BLUM, Charles, A. SPRINGER, Stephanie, K. VU, Chi, B D0WW2H HIGHSTAT Patented D0WW2H COMPCLAS Triazolo[4,3-b]pyridazine derivatives D0WX4U DRUG__ID D0WX4U D0WX4U DRUGCOMP Merck Sharp & Dohme Corp D0WX4U DRUGTYPE Small molecular drug D0WX4U HIGHSTAT Patented D0WX7F DRUG__ID D0WX7F D0WX7F DRUGCOMP BIOGEN IDEC MA INC D0WX7F DRUGTYPE Small molecular drug D0WX7F HIGHSTAT Patented D0WZ8N DRUG__ID D0WZ8N D0WZ8N DRUGCOMP DANA-FARBER CANCER INSTITUTE, INC D0WZ8N DRUGTYPE Small molecular drug D0WZ8N HIGHSTAT Patented D0X1AF DRUG__ID D0X1AF D0X1AF DRUGCOMP F. HOFFMANN-LA ROCHE AG ALVAREZ SANCHEZ, Ruben BANNER, David CECCARELLI, Simona M. GRETHER, Uwe HAAP, Wolfgang HARTMAN, Peter HARTMANN, Guido HILPERT, Hans KUEHNE, Holger MAUSER, Harald PLANCHER, Jean-Mar D0X1AF DRUGTYPE Small molecular drug D0X1AF HIGHSTAT Patented D0X1LP DRUG__ID D0X1LP D0X1LP DRUGCOMP PFIZER LIMITED D0X1LP HIGHSTAT Patented D0X1LP COMPCLAS N-acylpiperidine ether derivatives D0X1MJ DRUG__ID D0X1MJ D0X1MJ DRUGTYPE Small molecular drug D0X1MJ HIGHSTAT Patented D0X1MJ COMPCLAS Bidentate pyrazolopyrimidine acetamide analogs D0X1ZA DRUG__ID D0X1ZA D0X1ZA DRUGCOMP ABBOTT GMBH & CO. KG LANGE, Udo HEUTLING, Andreas AMBERG, Wilhelm OCHSE, Michael BEHL, Berthold HORNBERGER, Wilfried MEZLER, Mario D0X1ZA DRUGTYPE Small molecular drug D0X1ZA HIGHSTAT Patented D0X2BP DRUG__ID D0X2BP D0X2BP DRUGCOMP TUBITAK ERDAG, Berrin D0X2BP DRUGTYPE Antibody D0X2BP HIGHSTAT Patented D0X2SG DRUG__ID D0X2SG D0X2SG DRUGCOMP ELAN PHARMACEUTICALS, INC. SHAM, Hing, L. KONRADI, Andrei, W. HOM, Roy, K. PROBST, Gary, D. BOWERS, Simeon TRUONG, Anh NEITZ, R., Jeffrey SEALY, Jennifer TOTH, Gergely D0X2SG DRUGTYPE Small molecular drug D0X2SG HIGHSTAT Patented D0X4HJ DRUG__ID D0X4HJ D0X4HJ DRUGCOMP F. HOFFMANN-LA ROCHE AG HOFFMANN-LA ROCHE INC D0X4HJ DRUGTYPE Small molecular drug D0X4HJ HIGHSTAT Patented D0X4LA DRUG__ID D0X4LA D0X4LA DRUGCOMP PFIZER INC D0X4LA HIGHSTAT Patented D0X4LA COMPCLAS N-acylpyrrolidine ether derivatives D0X4TV DRUG__ID D0X4TV D0X4TV DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0X4TV DRUGTYPE Carbohydrates D0X4TV HIGHSTAT Patented D0X5FS DRUG__ID D0X5FS D0X5FS DRUGCOMP Australian Nuclear Science & Technology Organisation D0X5FS DRUGTYPE Small molecular drug D0X5FS HIGHSTAT Patented D0X5KA DRUG__ID D0X5KA D0X5KA DRUGCOMP UNIVERSITE DE STRASBOURG COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE ROUEN L'ETAT (MINISTE DE LA DENSE), REPRENT PAR LE DIRECTEUR CENTRAL DU SERVICE DE SANT DES ARMS D0X5KA DRUGTYPE Small molecular drug D0X5KA HIGHSTAT Patented D0X5OC DRUG__ID D0X5OC D0X5OC DRUGCOMP DOMINGUEZ, Celia TOLEDO-SHERMAN, Leticia, M. COURTNEY, Stephen, Martin PRIME, Michael MITCHELL, William BROWN, Christopher, John DE AGUIAR PENA, Paula, C. JOHNSON, Peter D0X5OC DRUGTYPE Small molecular drug D0X5OC HIGHSTAT Patented D0X6DL DRUG__ID D0X6DL D0X6DL DRUGCOMP PRINCIPIA BIOPHARMA INC D0X6DL DRUGTYPE Small molecular drug D0X6DL HIGHSTAT Patented D0X6FX DRUG__ID D0X6FX D0X6FX DRUGCOMP Brandeis University and University of Georgia Research Foundation, Inc D0X6FX DRUGTYPE Small molecular drug D0X6FX HIGHSTAT Patented D0X6GG DRUG__ID D0X6GG D0X6GG DRUGCOMP PHARMAHUNGARY 2000 KFT [HUINFARMATIK KFT [HUTARGETEX KFT [HU] D0X6GG DRUGTYPE Small molecular drug D0X6GG HIGHSTAT Patented D0X7HN DRUG__ID D0X7HN D0X7HN DRUGCOMP UNIVERSITY OF BASEL ERNST, Beat HEROLD, Janno D0X7HN DRUGTYPE Carbohydrates D0X7HN HIGHSTAT Patented D0X8JD DRUG__ID D0X8JD D0X8JD DRUGCOMP MERCK SHARP & DOHME CORP. BARROW, James, C. BILODEAU, Mark, T. COX, Christopher, D. HARTNETT, John, C. KETT, Nathan, R. LI, Yiwei MANLEY, Peter MELAMED, Jeffrey SHIPE, William, D. TROTTER, B. Wesley ZARTMAN, Amy, E D0X8JD DRUGTYPE Small molecular drug D0X8JD HIGHSTAT Patented D0X8YT DRUG__ID D0X8YT D0X8YT DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0X8YT DRUGTYPE Small molecular drug D0X8YT HIGHSTAT Patented D0X8YV DRUG__ID D0X8YV D0X8YV DRUGTYPE Small molecular drug D0X8YV HIGHSTAT Patented D0X8YV COMPCLAS Pyrrolo[2,3-d]pyrimidine derivatives D0X8ZF DRUG__ID D0X8ZF D0X8ZF DRUGCOMP MERCK SHARP & DOHME CORP. HALE, Jeffrey, J. JIANG, Jinlong SHEN, Dong-Ming SHI, Zhi-Cai SHU, Min WU, Zhicai YANG, Cangming D0X8ZF DRUGTYPE Small molecular drug D0X8ZF HIGHSTAT Patented D0X9CR DRUG__ID D0X9CR D0X9CR DRUGCOMP FARGEM FARMAS T K ARA TIRMA GEL T RME MERKEZ SANAY VE T&Id [TR] D0X9CR DRUGTYPE Small molecular drug D0X9CR HIGHSTAT Patented D0X9RA DRUG__ID D0X9RA D0X9RA DRUGCOMP Australian Nuclear Science & Technology Organisation D0X9RA DRUGTYPE Small molecular drug D0X9RA HIGHSTAT Patented D0XC2D DRUG__ID D0XC2D D0XC2D DRUGTYPE Small molecular drug D0XC2D HIGHSTAT Patented D0XC2D COMPCLAS Carboxamide derivatives D0XJ3S DRUG__ID D0XJ3S D0XJ3S DRUGCOMP Takeda Pharmaceutical Co. Ltd D0XJ3S DRUGTYPE Small molecular drug D0XJ3S HIGHSTAT Patented D0XK7H DRUG__ID D0XK7H D0XK7H DRUGCOMP Merck Sharp & Dohme Corp D0XK7H DRUGTYPE Small molecular drug D0XK7H HIGHSTAT Patented D0XL2V DRUG__ID D0XL2V D0XL2V DRUGTYPE Small molecular drug D0XL2V HIGHSTAT Patented D0XL2V COMPCLAS Trepenoid derivatives D0XM8F DRUG__ID D0XM8F D0XM8F DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0XM8F DRUGTYPE Small molecular drug D0XM8F HIGHSTAT Patented D0XQ3W DRUG__ID D0XQ3W D0XQ3W DRUGCOMP Gilead Sciences Inc D0XQ3W DRUGTYPE Small molecular drug D0XQ3W HIGHSTAT Patented D0XQ4T DRUG__ID D0XQ4T D0XQ4T DRUGCOMP Korea Institute of Science and Technology D0XQ4T DRUGTYPE Small molecular drug D0XQ4T HIGHSTAT Patented D0XQ5E DRUG__ID D0XQ5E D0XQ5E DRUGCOMP BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA NATARAJAN, Amarnath CHEN, Qianyi BRYANT, Vashti, C. RAJULE, Rajkumar D0XQ5E HIGHSTAT Patented D0XQ5E COMPCLAS Quinoxaline derivatives D0XS1I DRUG__ID D0XS1I D0XS1I DRUGCOMP TAISHO PHARMA CO LTD [JP] D0XS1I DRUGTYPE Small molecular drug D0XS1I HIGHSTAT Patented D0XX8R DRUG__ID D0XX8R D0XX8R DRUGCOMP Janssen Pharmaceutica NV D0XX8R DRUGTYPE Small molecular drug D0XX8R HIGHSTAT Patented D0Y0LI DRUG__ID D0Y0LI D0Y0LI DRUGCOMP AKARNA THERAPEUTICS, LTD D0Y0LI DRUGTYPE Small molecular drug D0Y0LI HIGHSTAT Patented D0Y1NH DRUG__ID D0Y1NH D0Y1NH DRUGCOMP PIERRE FABRE MEDICAMENT D0Y1NH HIGHSTAT Patented D0Y1NH COMPCLAS Azaindazole amide derivatives D0Y2IV DRUG__ID D0Y2IV D0Y2IV DRUGCOMP PHARMABCINE INC. SAMSUNG LIFE PUBLIC WELFARE FOUNDATION YOO, Jin San LEE, Sang Hoon LEE, Weon Sup KIM, Sung-Woo SHIM, Sang Ryeol YOO, Jin Sang KIM, Yeun Ju SHIN, Hee Young KIM, Joong Kyu NAM, Ju Ryung D0Y2IV DRUGTYPE Antibody D0Y2IV HIGHSTAT Patented D0Y2NR DRUG__ID D0Y2NR D0Y2NR DRUGTYPE Small molecular drug D0Y2NR HIGHSTAT Patented D0Y2NR COMPCLAS Bicyclo-heptan-2-amine derivatives D0Y3UB DRUG__ID D0Y3UB D0Y3UB DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0Y3UB DRUGTYPE Carbohydrates D0Y3UB HIGHSTAT Patented D0Y3YK DRUG__ID D0Y3YK D0Y3YK DRUGCOMP Merck & Co., Inc D0Y3YK DRUGTYPE Small molecular drug D0Y3YK HIGHSTAT Patented D0Y4CG DRUG__ID D0Y4CG D0Y4CG DRUGTYPE Small molecular drug D0Y4CG HIGHSTAT Patented D0Y4CG COMPCLAS Decyle nelycorine dibromo salt derivatives D0Y4KU DRUG__ID D0Y4KU D0Y4KU DRUGCOMP F. HOFFMANN-LA ROCHE AG ARZENO, Humberto, Bartolome FILONOVA, Lubov GOLDSTEIN, David, Michael GONG, Leyi LOE, Bradley, E. O'BRIEN, Erin, M. PALMER, Wylie, Solang ROTSTEIN, David, Mark SILVA, Tania TAN, Yun-chou D0Y4KU DRUGTYPE Small molecular drug D0Y4KU HIGHSTAT Patented D0Y5DN DRUG__ID D0Y5DN D0Y5DN DRUGCOMP F. HOFFMANN-LA ROCHE AG GATTI MCARTHUR, Silvia GOETSCHI, Erwin WICHMANN, Juergen WOLTERING, Thomas Johannes D0Y5DN DRUGTYPE Small molecular drug D0Y5DN HIGHSTAT Patented D0Y6EY DRUG__ID D0Y6EY D0Y6EY DRUGCOMP DUKE UNIVERSITY D0Y6EY DRUGTYPE Small molecular drug D0Y6EY HIGHSTAT Patented D0Y7FK DRUG__ID D0Y7FK D0Y7FK DRUGCOMP Zedira GmbH D0Y7FK DRUGTYPE Small molecular drug D0Y7FK HIGHSTAT Patented D0Y7QW DRUG__ID D0Y7QW D0Y7QW DRUGCOMP PFIZER PRODUCTS INC. HUANG, Liming LIU, Song LUNNEY, Elizabeth, Ann PLANKEN, Simon, Paul D0Y7QW DRUGTYPE Small molecular drug D0Y7QW HIGHSTAT Patented D0Y9FA DRUG__ID D0Y9FA D0Y9FA DRUGCOMP F. HOFFMANN-LA ROCHE AG KOLCZEWSKI, Sabine PINARD, Emmanuel D0Y9FA DRUGTYPE Small molecular drug D0Y9FA HIGHSTAT Patented D0Y9ST DRUG__ID D0Y9ST D0Y9ST DRUGCOMP GRUENENTHAL GMBH [DE] D0Y9ST DRUGTYPE Small molecular drug D0Y9ST HIGHSTAT Patented D0Y9UV DRUG__ID D0Y9UV D0Y9UV DRUGCOMP The University of Queensland D0Y9UV DRUGTYPE Small molecular drug D0Y9UV HIGHSTAT Patented D0Y9XS DRUG__ID D0Y9XS D0Y9XS DRUGCOMP ACTELION PHARMACEUTICALS LTD FRETZ, Heinz GATFIELD, John ISLER, Markus KIMMERLIN, Thierry KOBERSTEIN, Ralf LYOTHIER, Isabelle MONNIER, Lucile POTHIER, Julien VALDENAIRE, Anja D0Y9XS DRUGTYPE Small molecular drug D0Y9XS HIGHSTAT Patented D0YD1Q DRUG__ID D0YD1Q D0YD1Q DRUGCOMP Phosphosites GmbH D0YD1Q DRUGTYPE Small molecular drug D0YD1Q HIGHSTAT Patented D0YE0P DRUG__ID D0YE0P D0YE0P DRUGCOMP CORNELL UNIVERSITY ITHACA COLLEGE D0YE0P DRUGTYPE Small molecular drug D0YE0P HIGHSTAT Patented D0YE8Q DRUG__ID D0YE8Q D0YE8Q DRUGCOMP DEBRECENI EGYETEM D0YE8Q DRUGTYPE Small molecular drug D0YE8Q HIGHSTAT Patented D0YF7A DRUG__ID D0YF7A D0YF7A DRUGCOMP Univ Shenyang Chemical Tech D0YF7A DRUGTYPE Small molecular drug D0YF7A HIGHSTAT Patented D0YI0V DRUG__ID D0YI0V D0YI0V DRUGCOMP ORYZON GENOMICS, S.A. BAKER, Jonathan, A. FYFE, Matthew, Colin, ThoORYZON GENOMICS, S.A. BAKER, Jonathan, Alleman FYFE, Matthew, Colin Thor D0YI0V DRUGTYPE Small molecular drug D0YI0V HIGHSTAT Patented D0YJ1O DRUG__ID D0YJ1O D0YJ1O DRUGCOMP MERCK SHARP & DOHME [US] D0YJ1O DRUGTYPE Small molecular drug D0YJ1O HIGHSTAT Patented D0YJ4D DRUG__ID D0YJ4D D0YJ4D DRUGCOMP NERVIANO MEDICAL SCIENCES S.R.L D0YJ4D DRUGTYPE Small molecular drug D0YJ4D HIGHSTAT Patented D0YR4E DRUG__ID D0YR4E D0YR4E DRUGCOMP ABBOTT LABORATORIES D0YR4E DRUGTYPE Small molecular drug D0YR4E HIGHSTAT Patented D0YR8S DRUG__ID D0YR8S D0YR8S DRUGCOMP GALAPAGOS NV D0YR8S DRUGTYPE Small molecular drug D0YR8S HIGHSTAT Patented D0YT1S DRUG__ID D0YT1S D0YT1S DRUGCOMP SERVIER LAB [FRVERNALIS (R&D) LTD [GB] D0YT1S DRUGTYPE Small molecular drug D0YT1S HIGHSTAT Patented D0YU5R DRUG__ID D0YU5R D0YU5R DRUGCOMP MERCK SHARP & DOHME CORP. MANLEY, Peter, J. NANDA, Kausik, K. TROTTER, B. Wesley D0YU5R DRUGTYPE Small molecular drug D0YU5R HIGHSTAT Patented D0YV6X DRUG__ID D0YV6X D0YV6X DRUGCOMP FLEXUS BIOSCIENCES, INC D0YV6X DRUGTYPE Small molecular drug D0YV6X HIGHSTAT Patented D0YW3K DRUG__ID D0YW3K D0YW3K DRUGTYPE Small molecular drug D0YW3K HIGHSTAT Patented D0YW3K COMPCLAS Pyrazole derivatives D0YX4L DRUG__ID D0YX4L D0YX4L DRUGCOMP VERTEX PHARMACEUTICALS INCORPORATED D0YX4L DRUGTYPE Carbohydrates D0YX4L HIGHSTAT Patented D0YX4R DRUG__ID D0YX4R D0YX4R DRUGCOMP NEVADA CANCER INSTITUTE SHENZHEN GRADUATE SCHOOL OF PEKING UNIVERSITY ZHANG, Hui YE, Tao QUAN, Junmin WANG, Jing D0YX4R DRUGTYPE Small molecular drug D0YX4R HIGHSTAT Patented D0YY8N DRUG__ID D0YY8N D0YY8N DRUGCOMP THE JOHNS HOPKINS UNIVERSITY COLE, Philip A. BARNETT, Bradley P. HWANG, Yousang BOEKE, Jef D D0YY8N DRUGTYPE Small molecular drug D0YY8N HIGHSTAT Patented D0YZ3U DRUG__ID D0YZ3U D0YZ3U DRUGCOMP BEIJING PEKING UNIVERSITY WBL BIOTECH CO., LTD. DUAN, ZhenwenUNIV BEIJING PEKING WBL BIOTECH CO LTD [CN] D0YZ3U DRUGTYPE Small molecular drug D0YZ3U HIGHSTAT Patented D0Z0FP DRUG__ID D0Z0FP D0Z0FP DRUGCOMP METACRINE, INC D0Z0FP DRUGTYPE Small molecular drug D0Z0FP HIGHSTAT Patented D0Z0QS DRUG__ID D0Z0QS D0Z0QS DRUGCOMP EPIZYME, INC D0Z0QS DRUGTYPE Small molecular drug D0Z0QS HIGHSTAT Patented D0Z1VM DRUG__ID D0Z1VM D0Z1VM DRUGCOMP Leland Stanford Junior University D0Z1VM DRUGTYPE Small molecular drug D0Z1VM HIGHSTAT Patented D0Z3HW DRUG__ID D0Z3HW D0Z3HW DRUGCOMP MERCK SHARP & DOHME CORP. TSUI, Hon-Chung PALIWAL, Sunil FISCHMANN, Thierry Olivier D0Z3HW HIGHSTAT Patented D0Z3HW COMPCLAS Thiazole carboxamide derivatives D0Z4QJ DRUG__ID D0Z4QJ D0Z4QJ DRUGCOMP NOVARTIS AG BRUCE, Ian CHAMOIN, Sylvie COLLINGWOOD, Stephen Paul FURET, Pascal FURMINGER, Vikki LEWIS, Sarah LOREN, Jon LV, Lin MOLTENI, Valentina SAUNDERS, Alex Michael SHAW, Duncan TURNER, Roy YEH, Vince D0Z4QJ DRUGTYPE Small molecular drug D0Z4QJ HIGHSTAT Patented D0Z4QQ DRUG__ID D0Z4QQ D0Z4QQ DRUGCOMP Janssen Pharmaceutica NV D0Z4QQ DRUGTYPE Small molecular drug D0Z4QQ HIGHSTAT Patented D0Z4RS DRUG__ID D0Z4RS D0Z4RS DRUGCOMP KITASATO INST [JPOMURA SATOSHI [JPTOMODA HIROSHI [JPMASUMA ROKURO [JP] D0Z4RS DRUGTYPE Small molecular drug D0Z4RS HIGHSTAT Patented D0Z5HL DRUG__ID D0Z5HL D0Z5HL DRUGCOMP Schering Corp D0Z5HL HIGHSTAT Patented D0Z5HL COMPCLAS Thiazole carboxamide derivatives D0Z6ZH DRUG__ID D0Z6ZH D0Z6ZH DRUGCOMP NTZ LAB LTD [BG] D0Z6ZH DRUGTYPE Small molecular drug D0Z6ZH HIGHSTAT Patented D0Z7FL DRUG__ID D0Z7FL D0Z7FL DRUGCOMP ABIDE THERAPEUTICS, INC. THE SCRIPPS RESEARCH INSTITUTE D0Z7FL DRUGTYPE Small molecular drug D0Z7FL HIGHSTAT Patented D0Z7GN DRUG__ID D0Z7GN D0Z7GN DRUGCOMP GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED D0Z7GN DRUGTYPE Small molecular drug D0Z7GN HIGHSTAT Patented D0Z7HE DRUG__ID D0Z7HE D0Z7HE DRUGCOMP THE BRIGHAM AND WOMEN'S HOSPITAL, INC. SHI, Yujiang Geno LIAN, Christine Guo D0Z7HE DRUGTYPE Small molecular drug D0Z7HE HIGHSTAT Patented D0Z7QI DRUG__ID D0Z7QI D0Z7QI DRUGCOMP CHARIT UNIVERSIT TSMEDIZIN BERLIN [DEUNIVERSIT T BAYREUTH [DE] D0Z7QI DRUGTYPE Small molecular drug D0Z7QI HIGHSTAT Patented D0Z7SK DRUG__ID D0Z7SK D0Z7SK DRUGCOMP Bristol-Myers Squibb Co D0Z7SK DRUGTYPE Small molecular drug D0Z7SK HIGHSTAT Patented D0Z7VF DRUG__ID D0Z7VF D0Z7VF DRUGCOMP BRISTOL-MYERS SQUIBB COMPANY HUANG, Yanting SUN, Chongqing LAWRENCE, R., Michael EWING, William, R. TURDI, Huji D0Z7VF DRUGTYPE Small molecular drug D0Z7VF HIGHSTAT Patented D0Z8BD DRUG__ID D0Z8BD D0Z8BD DRUGCOMP UNIVERSITY OF SOUTH FLORIDA TAN, Jun LUO, Deyan D0Z8BD DRUGTYPE Small molecular drug D0Z8BD HIGHSTAT Patented D0Z9UJ DRUG__ID D0Z9UJ D0Z9UJ DRUGCOMP AURIGENE DISCOVERY TECHNOLOGIES LIMITED D0Z9UJ DRUGTYPE Peptide D0Z9UJ HIGHSTAT Patented D0ZF0Z DRUG__ID D0ZF0Z D0ZF0Z DRUGCOMP ARENA PHARMACEUTICALS, INC. TEEGARDEN, Bradley JAYAKUMAR, Honnappa LI, Hongmei STRAH-PLEYNET, Sonja DOSA, Peter, Ian D0ZF0Z DRUGTYPE Small molecular drug D0ZF0Z HIGHSTAT Patented D0ZF1N DRUG__ID D0ZF1N D0ZF1N DRUGCOMP CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE UNIVERSITE DE STRASBOURG RUAT, Martial FAURE, Hélène ROUDAUT, Hermine HOCH, Lucile SCHOENFELDER, Angèle TADDEI, Maurizio MANN, André D0ZF1N DRUGTYPE Small molecular drug D0ZF1N HIGHSTAT Patented D0ZG0K DRUG__ID D0ZG0K D0ZG0K DRUGCOMP Schering Corp D0ZG0K HIGHSTAT Patented D0ZG0K COMPCLAS Thiazole carboxamide derivatives D0ZH3O DRUG__ID D0ZH3O D0ZH3O DRUGCOMP University of Kentucky Research Foundation D0ZH3O DRUGTYPE Small molecular drug D0ZH3O HIGHSTAT Patented D0ZQ2W DRUG__ID D0ZQ2W D0ZQ2W DRUGCOMP GLAXO GROUP LIMITED BIGGADIKE, Keith BIRAULT, Veronique CHAMPIGNY, Aurelie Cecile COE, Diane Mary HUGHES, Owen Rhys NEEDHAM, Deborah TAPE, Daniel Terence D0ZQ2W DRUGTYPE Small molecular drug D0ZQ2W HIGHSTAT Patented D0ZQ8T DRUG__ID D0ZQ8T D0ZQ8T DRUGCOMP OTSUKA PHARMACEUTICAL CO., LTD. SEKIGUCHI, Kazuo SUZUKI, Takashi OHBUCHI, Yutaka OKUNO, Mitsuhiro OHI, Naoto OHNISHI, Kenji MOTOYAMA, Masaaki YOSHIDA, Kenji KODAMA, Takeshi SUGIYAMA, Kazuhisa AKAMATSU, Seiji KIYONO, Kunihiko YANAGIHARA, Yasuo WATANABE, Takashi HAYASHI, Kazuhiko TANAKA, Hideo SUMIDA, Takumi D0ZQ8T DRUGTYPE Small molecular drug D0ZQ8T HIGHSTAT Patented D0ZS8Q DRUG__ID D0ZS8Q D0ZS8Q DRUGCOMP Meiji Dairies Corporation D0ZS8Q DRUGTYPE Small molecular drug D0ZS8Q HIGHSTAT Patented D0ZW5B DRUG__ID D0ZW5B D0ZW5B DRUGCOMP Genentech, Inc., USA. assignee D0ZW5B DRUGTYPE Small molecular drug D0ZW5B HIGHSTAT Patented D0ZX6S DRUG__ID D0ZX6S D0ZX6S DRUGCOMP MERCK SHARP & DOHME CORP. PASTERNAK, Alexander DEJESUS, Reynalda, K. ZHU, Yuping YANG, Lihu WALSH, Shawn PIO, Barbara SHAHRIPOUR, Aurash TANG, Haifeng BELYK, Kevin KIM, Dooseop D0ZX6S DRUGTYPE Small molecular drug D0ZX6S HIGHSTAT Patented D0ZX8C DRUG__ID D0ZX8C D0ZX8C DRUGCOMP JIANGSU SIMCERE PHARMACEUTICAL CO., LTD D0ZX8C DRUGTYPE Small molecular drug D0ZX8C HIGHSTAT Patented D00CDI DRUG__ID D00CDI D00CDI DRUGTYPE Peptide D00CDI HIGHSTAT Patented D00EUL DRUG__ID D00EUL D00EUL DRUGCOMP MERCK SHARP & DOHME CORP D00EUL HIGHSTAT Patented D00GMI DRUG__ID D00GMI D00GMI DRUGTYPE Small molecular drug D00GMI HIGHSTAT Patented D00KII DRUG__ID D00KII D00KII DRUGTYPE Small molecular drug D00KII HIGHSTAT Patented D00LSQ DRUG__ID D00LSQ D00LSQ DRUGTYPE Small molecular drug D00LSQ HIGHSTAT Patented D00MGO DRUG__ID D00MGO D00MGO DRUGCOMP MERCK SHARP & DOHME CORP D00MGO HIGHSTAT Patented D00NVU DRUG__ID D00NVU D00NVU DRUGTYPE Small molecular drug D00NVU HIGHSTAT Patented D00RPW DRUG__ID D00RPW D00RPW DRUGTYPE Small molecular drug D00RPW HIGHSTAT Patented D00SVK DRUG__ID D00SVK D00SVK DRUGCOMP MERCK SHARP & DOHME CORP. KEENAN, Kevin, A. NORTHRUP, Alan, B D00SVK HIGHSTAT Patented D00TCL DRUG__ID D00TCL D00TCL DRUGTYPE Small molecular drug D00TCL HIGHSTAT Patented D00TFF DRUG__ID D00TFF D00TFF DRUGCOMP F. HOFFMANN-LA ROCHE AG ANDERSON, Kevin William CHEN, Yi CHEN, Zhi LUK, Kin-Chun Thomas ROSSMAN, Pamela Loreen SUN, Hongmao WOVKULICH, Peter Michael D00TFF HIGHSTAT Patented D00YRS DRUG__ID D00YRS D00YRS DRUGTYPE Small molecular drug D00YRS HIGHSTAT Patented D01ERV DRUG__ID D01ERV D01ERV DRUGTYPE Small molecular drug D01ERV HIGHSTAT Patented D01IJO DRUG__ID D01IJO D01IJO DRUGTYPE Small molecular drug D01IJO HIGHSTAT Patented D01KYS DRUG__ID D01KYS D01KYS DRUGTYPE Small molecular drug D01KYS HIGHSTAT Patented D01LTK DRUG__ID D01LTK D01LTK DRUGCOMP KOREA OCEAN RESEARCH AND DEVELOPMENT INSITUTE YIM, Joung Han KIM, Il Chan LEE, Sung Gu KIM, Doc Kyu HAN, Se Jong LEE, Hyoung Seok D01LTK HIGHSTAT Patented D01OYE DRUG__ID D01OYE D01OYE DRUGTYPE Small molecular drug D01OYE HIGHSTAT Patented D01YQE DRUG__ID D01YQE D01YQE DRUGTYPE Small molecular drug D01YQE HIGHSTAT Patented D02ABC DRUG__ID D02ABC D02ABC DRUGTYPE Small molecular drug D02ABC HIGHSTAT Patented D02CEY DRUG__ID D02CEY D02CEY DRUGCOMP REVERAGEN BIOPHARMA, INC D02CEY HIGHSTAT Patented D02ETU DRUG__ID D02ETU D02ETU DRUGCOMP MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED D02ETU HIGHSTAT Patented D02IBX DRUG__ID D02IBX D02IBX DRUGCOMP PLEXXIKON, INC. VISOR, Gary Conard IBRAHIM, Prabha N. SPEVAK, Wayne CHO, Hanna SHI, Songyuan WU, Guoxian D02IBX HIGHSTAT Patented D02JSW DRUG__ID D02JSW D02JSW DRUGTYPE Small molecular drug D02JSW HIGHSTAT Patented D02QKC DRUG__ID D02QKC D02QKC DRUGCOMP THE TRUSTEES OF PRINCETON UNIVERSITY SHENK, Thomas KOYUNCU, Emre CRISTEA, Ileana D02QKC HIGHSTAT Patented D02UOW DRUG__ID D02UOW D02UOW DRUGTYPE Peptide D02UOW HIGHSTAT Patented D02USE DRUG__ID D02USE D02USE DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D02USE HIGHSTAT Patented D02WOW DRUG__ID D02WOW D02WOW DRUGCOMP VALIDUS BIOPHARMA MCCALL, John, M. HOFFMAN, Eric NAGARAJU, Kanneboyina D02WOW HIGHSTAT Patented D02WXS DRUG__ID D02WXS D02WXS DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D02WXS HIGHSTAT Patented D02ZQN DRUG__ID D02ZQN D02ZQN DRUGCOMP MERCK SHARP & DOHME CORP D02ZQN HIGHSTAT Patented D03EHC DRUG__ID D03EHC D03EHC DRUGCOMP Varinel, Inc D03EHC HIGHSTAT Patented D03EML DRUG__ID D03EML D03EML DRUGTYPE Peptide D03EML HIGHSTAT Patented D03EYJ DRUG__ID D03EYJ D03EYJ DRUGTYPE Small molecular drug D03EYJ HIGHSTAT Patented D03FQY DRUG__ID D03FQY D03FQY DRUGTYPE Small molecular drug D03FQY HIGHSTAT Patented D03HEK DRUG__ID D03HEK D03HEK DRUGTYPE Small molecular drug D03HEK HIGHSTAT Patented D03HMW DRUG__ID D03HMW D03HMW DRUGTYPE Small molecular drug D03HMW HIGHSTAT Patented D03JDH DRUG__ID D03JDH D03JDH DRUGTYPE Small molecular drug D03JDH HIGHSTAT Patented D03SCM DRUG__ID D03SCM D03SCM DRUGTYPE Small molecular drug D03SCM HIGHSTAT Patented D03TDK DRUG__ID D03TDK D03TDK DRUGTYPE Small molecular drug D03TDK HIGHSTAT Patented D03VGN DRUG__ID D03VGN D03VGN DRUGCOMP Varinel, Inc D03VGN HIGHSTAT Patented D03VMP DRUG__ID D03VMP D03VMP DRUGTYPE Small molecular drug D03VMP HIGHSTAT Patented D03WHA DRUG__ID D03WHA D03WHA HIGHSTAT Patented D03WHA COMPCLAS N-quinolin-benzene sulphonamide derivatives D04BBT DRUG__ID D04BBT D04BBT DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D04BBT HIGHSTAT Patented D04BRW DRUG__ID D04BRW D04BRW DRUGCOMP MERCK SHARP & DOHME CORP D04BRW HIGHSTAT Patented D04GMP DRUG__ID D04GMP D04GMP HIGHSTAT Patented D04GMP COMPCLAS N-quinolin-benzene sulphonamide derivatives D04JCD DRUG__ID D04JCD D04JCD DRUGCOMP MERCK SHARP & DOHME CORP D04JCD HIGHSTAT Patented D04KUJ DRUG__ID D04KUJ D04KUJ DRUGTYPE Small molecular drug D04KUJ HIGHSTAT Patented D04MHV DRUG__ID D04MHV D04MHV DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D04MHV HIGHSTAT Patented D04MTT DRUG__ID D04MTT D04MTT DRUGCOMP CORNELL UNIVERSITY LIN, Hening D04MTT HIGHSTAT Patented D04NCC DRUG__ID D04NCC D04NCC DRUGTYPE Small molecular drug D04NCC HIGHSTAT Patented D04NMJ DRUG__ID D04NMJ D04NMJ DRUGTYPE Small molecular drug D04NMJ HIGHSTAT Patented D04OXC DRUG__ID D04OXC D04OXC DRUGTYPE Small molecular drug D04OXC HIGHSTAT Patented D04RDR DRUG__ID D04RDR D04RDR DRUGTYPE Small molecular drug D04RDR HIGHSTAT Patented D04XXF DRUG__ID D04XXF D04XXF DRUGTYPE Peptide D04XXF HIGHSTAT Patented D05AQT DRUG__ID D05AQT D05AQT DRUGCOMP ARRAY BIOPHARMA INC D05AQT HIGHSTAT Patented D05CGR DRUG__ID D05CGR D05CGR DRUGCOMP REVERAGEN BIOPHARMA, INC D05CGR HIGHSTAT Patented D05CLL DRUG__ID D05CLL D05CLL DRUGCOMP F. HOFFMANN-LA ROCHE AG DOMINIQUE, Romyr LUK, Kin-Chun Thomas QIAO, Qi ROSSMAN, Pamela Loreen D05CLL HIGHSTAT Patented D05GAP DRUG__ID D05GAP D05GAP DRUGTYPE Small molecular drug D05GAP HIGHSTAT Patented D05GEY DRUG__ID D05GEY D05GEY DRUGTYPE Peptide D05GEY HIGHSTAT Patented D05HBW DRUG__ID D05HBW D05HBW DRUGTYPE Small molecular drug D05HBW HIGHSTAT Patented D05LJQ DRUG__ID D05LJQ D05LJQ DRUGTYPE Peptide D05LJQ HIGHSTAT Patented D05MIG DRUG__ID D05MIG D05MIG DRUGTYPE Small molecular drug D05MIG HIGHSTAT Patented D05MRY DRUG__ID D05MRY D05MRY DRUGCOMP MERCK SHARP & DOHME CORP D05MRY HIGHSTAT Patented D05QCM DRUG__ID D05QCM D05QCM DRUGTYPE Small molecular drug D05QCM HIGHSTAT Patented D05UGS DRUG__ID D05UGS D05UGS DRUGTYPE Small molecular drug D05UGS HIGHSTAT Patented D06BUG DRUG__ID D06BUG D06BUG DRUGTYPE Small molecular drug D06BUG HIGHSTAT Patented D06CEA DRUG__ID D06CEA D06CEA DRUGTYPE Small molecular drug D06CEA HIGHSTAT Patented D06ELK DRUG__ID D06ELK D06ELK DRUGTYPE Small molecular drug D06ELK HIGHSTAT Patented D06FOF DRUG__ID D06FOF D06FOF DRUGTYPE Small molecular drug D06FOF HIGHSTAT Patented D06FUM DRUG__ID D06FUM D06FUM DRUGTYPE Small molecular drug D06FUM HIGHSTAT Patented D06GOT DRUG__ID D06GOT D06GOT DRUGCOMP PLEXXIKON, INC. ZHANG, Chao ZHANG, Jiazhong IBRAHIM, Prabha N. ARTIS, Dean R. BREMER, Ryan WU, Guoxian ZHU, Hongyao NESPI, Marika D06GOT HIGHSTAT Patented D06GQG DRUG__ID D06GQG D06GQG DRUGTYPE Small molecular drug D06GQG HIGHSTAT Patented D06IHB DRUG__ID D06IHB D06IHB DRUGCOMP THE TRUSTEES OF PRINCETON UNIVERSITY SHENK, Thomas KOYUNCU, Emre CRISTEA, Ileana D06IHB HIGHSTAT Patented D06KBT DRUG__ID D06KBT D06KBT DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D06KBT HIGHSTAT Patented D06KFU DRUG__ID D06KFU D06KFU DRUGTYPE Small molecular drug D06KFU HIGHSTAT Patented D06MXI DRUG__ID D06MXI D06MXI DRUGTYPE Small molecular drug D06MXI HIGHSTAT Patented D06OSE DRUG__ID D06OSE D06OSE DRUGTYPE Small molecular drug D06OSE HIGHSTAT Patented D06PDK DRUG__ID D06PDK D06PDK DRUGTYPE Small molecular drug D06PDK HIGHSTAT Patented D06STK DRUG__ID D06STK D06STK DRUGTYPE Small molecular drug D06STK HIGHSTAT Patented D06TPL DRUG__ID D06TPL D06TPL DRUGTYPE Nucleotide D06TPL HIGHSTAT Patented D06XWC DRUG__ID D06XWC D06XWC DRUGCOMP THE REGENTS OF THE UNIVERSITY OF CALIFORNIA D06XWC HIGHSTAT Patented D06YKN DRUG__ID D06YKN D06YKN DRUGTYPE Small molecular drug D06YKN HIGHSTAT Patented D06ZEI DRUG__ID D06ZEI D06ZEI DRUGTYPE Small molecular drug D06ZEI HIGHSTAT Patented D07CDS DRUG__ID D07CDS D07CDS DRUGTYPE Small molecular drug D07CDS HIGHSTAT Patented D07IZC DRUG__ID D07IZC D07IZC DRUGTYPE Small molecular drug D07IZC HIGHSTAT Patented D07JJT DRUG__ID D07JJT D07JJT DRUGTYPE Small molecular drug D07JJT HIGHSTAT Patented D07KVL DRUG__ID D07KVL D07KVL DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D07KVL HIGHSTAT Patented D07NCJ DRUG__ID D07NCJ D07NCJ DRUGCOMP Korea Ocean Research and Development Institute D07NCJ HIGHSTAT Patented D07NEI DRUG__ID D07NEI D07NEI DRUGTYPE Vaccine D07NEI HIGHSTAT Patented D07QBF DRUG__ID D07QBF D07QBF DRUGTYPE Small molecular drug D07QBF HIGHSTAT Patented D07TVO DRUG__ID D07TVO D07TVO DRUGTYPE Small molecular drug D07TVO HIGHSTAT Patented D07UZL DRUG__ID D07UZL D07UZL DRUGTYPE Small molecular drug D07UZL HIGHSTAT Patented D07VFQ DRUG__ID D07VFQ D07VFQ DRUGCOMP MERCK SHARP & DOHME CORP D07VFQ HIGHSTAT Patented D08CZY DRUG__ID D08CZY D08CZY DRUGCOMP MERCK SHARP & DOHME CORP D08CZY HIGHSTAT Patented D08HBW DRUG__ID D08HBW D08HBW DRUGTYPE Peptide D08HBW HIGHSTAT Patented D08KMR DRUG__ID D08KMR D08KMR DRUGTYPE Nucleotide D08KMR HIGHSTAT Patented D08LBZ DRUG__ID D08LBZ D08LBZ DRUGTYPE Small molecular drug D08LBZ HIGHSTAT Patented D08NGV DRUG__ID D08NGV D08NGV DRUGTYPE Small molecular drug D08NGV HIGHSTAT Patented D08OJB DRUG__ID D08OJB D08OJB DRUGTYPE Peptide D08OJB HIGHSTAT Patented D08QMJ DRUG__ID D08QMJ D08QMJ DRUGTYPE Small molecular drug D08QMJ HIGHSTAT Patented D08RCV DRUG__ID D08RCV D08RCV DRUGTYPE Small molecular drug D08RCV HIGHSTAT Patented D08RUK DRUG__ID D08RUK D08RUK DRUGCOMP VALIDUS BIOPHARMA MCCALL, John, M. HOFFMAN, Eric NAGARAJU, Kanneboyina D08RUK HIGHSTAT Patented D08SLP DRUG__ID D08SLP D08SLP DRUGTYPE Small molecular drug D08SLP HIGHSTAT Patented D08VQU DRUG__ID D08VQU D08VQU DRUGTYPE Small molecular drug D08VQU HIGHSTAT Patented D08WJG DRUG__ID D08WJG D08WJG DRUGTYPE Small molecular drug D08WJG HIGHSTAT Patented D09GSO DRUG__ID D09GSO D09GSO DRUGTYPE Small molecular drug D09GSO HIGHSTAT Patented D09OGV DRUG__ID D09OGV D09OGV DRUGCOMP VALIDUS BIOPHARMA MCCALL, John, M. HOFFMAN, Eric NAGARAJU, Kanneboyina D09OGV HIGHSTAT Patented D09PMC DRUG__ID D09PMC D09PMC DRUGTYPE Small molecular drug D09PMC HIGHSTAT Patented D09QZB DRUG__ID D09QZB D09QZB DRUGTYPE Small molecular drug D09QZB HIGHSTAT Patented D09VXA DRUG__ID D09VXA D09VXA HIGHSTAT Patented D09VXA COMPCLAS Quinoxaline derivatives D09YEH DRUG__ID D09YEH D09YEH DRUGTYPE Small molecular drug D09YEH HIGHSTAT Patented D09YQO DRUG__ID D09YQO D09YQO DRUGTYPE Nucleotide D09YQO HIGHSTAT Patented D09ZUJ DRUG__ID D09ZUJ D09ZUJ DRUGTYPE Peptide D09ZUJ HIGHSTAT Patented D0A2UR DRUG__ID D0A2UR D0A2UR DRUGTYPE Small molecular drug D0A2UR HIGHSTAT Patented D0A2VQ DRUG__ID D0A2VQ D0A2VQ DRUGTYPE Small molecular drug D0A2VQ HIGHSTAT Patented D0A4QD DRUG__ID D0A4QD D0A4QD DRUGTYPE Small molecular drug D0A4QD HIGHSTAT Patented D0A5RG DRUG__ID D0A5RG D0A5RG DRUGTYPE Small molecular drug D0A5RG HIGHSTAT Patented D0A5YE DRUG__ID D0A5YE D0A5YE DRUGTYPE Small molecular drug D0A5YE HIGHSTAT Patented D0A6AJ DRUG__ID D0A6AJ D0A6AJ DRUGTYPE Peptide D0A6AJ HIGHSTAT Patented D0A9ZW DRUG__ID D0A9ZW D0A9ZW DRUGTYPE Small molecular drug D0A9ZW HIGHSTAT Patented D0AA7U DRUG__ID D0AA7U D0AA7U DRUGTYPE Small molecular drug D0AA7U HIGHSTAT Patented D0AF4V DRUG__ID D0AF4V D0AF4V DRUGTYPE Vaccine D0AF4V HIGHSTAT Patented D0AG7M DRUG__ID D0AG7M D0AG7M DRUGTYPE Peptide D0AG7M HIGHSTAT Patented D0AH9P DRUG__ID D0AH9P D0AH9P DRUGTYPE Small molecular drug D0AH9P HIGHSTAT Patented D0AI6J DRUG__ID D0AI6J D0AI6J DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D0AI6J HIGHSTAT Patented D0AM2B DRUG__ID D0AM2B D0AM2B DRUGTYPE Small molecular drug D0AM2B HIGHSTAT Patented D0B3FN DRUG__ID D0B3FN D0B3FN DRUGTYPE Small molecular drug D0B3FN HIGHSTAT Patented D0B4CH DRUG__ID D0B4CH D0B4CH DRUGTYPE Peptide D0B4CH HIGHSTAT Patented D0B6GA DRUG__ID D0B6GA D0B6GA DRUGTYPE Small molecular drug D0B6GA HIGHSTAT Patented D0B8IQ DRUG__ID D0B8IQ D0B8IQ DRUGCOMP F. HOFFMANN-LA ROCHE AG ANDERSON, Kevin William CHEN, Yi CHEN, Zhi LUK, Kin-Chun Thomas ROSSMAN, Pamela Loreen SUN, Hongmao WOVKULICH, Peter Michael D0B8IQ HIGHSTAT Patented D0B8OB DRUG__ID D0B8OB D0B8OB DRUGCOMP MERCK SHARP & DOHME CORP. KEENAN, Kevin, A. NORTHRUP, Alan, B D0B8OB HIGHSTAT Patented D0BJ2X DRUG__ID D0BJ2X D0BJ2X DRUGTYPE Small molecular drug D0BJ2X HIGHSTAT Patented D0BL3X DRUG__ID D0BL3X D0BL3X DRUGTYPE Small molecular drug D0BL3X HIGHSTAT Patented D0BN4A DRUG__ID D0BN4A D0BN4A DRUGTYPE Small molecular drug D0BN4A HIGHSTAT Patented D0BO1H DRUG__ID D0BO1H D0BO1H DRUGCOMP MERCK SHARP & DOHME CORP D0BO1H HIGHSTAT Patented D0BP6J DRUG__ID D0BP6J D0BP6J DRUGCOMP F. HOFFMANN-LA ROCHE AG DOMINIQUE, Romyr LUK, Kin-Chun Thomas QIAO, Qi ROSSMAN, Pamela Loreen D0BP6J HIGHSTAT Patented D0BQ7K DRUG__ID D0BQ7K D0BQ7K DRUGTYPE Small molecular drug D0BQ7K HIGHSTAT Patented D0BQ8A DRUG__ID D0BQ8A D0BQ8A DRUGTYPE Small molecular drug D0BQ8A HIGHSTAT Patented D0BT3Y DRUG__ID D0BT3Y D0BT3Y DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0BT3Y HIGHSTAT Patented D0BY2H DRUG__ID D0BY2H D0BY2H DRUGTYPE Peptide D0BY2H HIGHSTAT Patented D0CI2U DRUG__ID D0CI2U D0CI2U DRUGTYPE Peptide D0CI2U HIGHSTAT Patented D0CJ7F DRUG__ID D0CJ7F D0CJ7F DRUGTYPE Small molecular drug D0CJ7F HIGHSTAT Patented D0CP6B DRUG__ID D0CP6B D0CP6B DRUGTYPE Small molecular drug D0CP6B HIGHSTAT Patented D0CR0Y DRUG__ID D0CR0Y D0CR0Y DRUGTYPE Small molecular drug D0CR0Y HIGHSTAT Patented D0CY3U DRUG__ID D0CY3U D0CY3U DRUGCOMP MERCK SHARP & DOHME CORP D0CY3U HIGHSTAT Patented D0D0PF DRUG__ID D0D0PF D0D0PF DRUGTYPE Small molecular drug D0D0PF HIGHSTAT Patented D0D1LI DRUG__ID D0D1LI D0D1LI DRUGTYPE Small molecular drug D0D1LI HIGHSTAT Patented D0D1QD DRUG__ID D0D1QD D0D1QD DRUGTYPE Small molecular drug D0D1QD HIGHSTAT Patented D0DB0Z DRUG__ID D0DB0Z D0DB0Z DRUGTYPE Small molecular drug D0DB0Z HIGHSTAT Patented D0DC2P DRUG__ID D0DC2P D0DC2P DRUGCOMP UNIVERSITY OF UTAH RESEARCH FOUNDATION BEARSS, David, J. VANKAYALAPATI, Hariprasad SORNA, Venkataswamy WARNER, Steven, L. SHARMA, Sunil D0DC2P HIGHSTAT Patented D0DL3R DRUG__ID D0DL3R D0DL3R DRUGTYPE Small molecular drug D0DL3R HIGHSTAT Patented D0DQ5G DRUG__ID D0DQ5G D0DQ5G DRUGCOMP PFIZER LIMITED D0DQ5G HIGHSTAT Patented D0E7OQ DRUG__ID D0E7OQ D0E7OQ DRUGCOMP Nanjing Guangkangxie Biolog. Medical Technology CO LTD D0E7OQ HIGHSTAT Patented D0E7SF DRUG__ID D0E7SF D0E7SF DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D0E7SF HIGHSTAT Patented D0E7ZN DRUG__ID D0E7ZN D0E7ZN DRUGTYPE Small molecular drug D0E7ZN HIGHSTAT Patented D0E8WW DRUG__ID D0E8WW D0E8WW DRUGTYPE Peptide D0E8WW HIGHSTAT Patented D0E9GF DRUG__ID D0E9GF D0E9GF DRUGTYPE Small molecular drug D0E9GF HIGHSTAT Patented D0E9IY DRUG__ID D0E9IY D0E9IY DRUGTYPE Small molecular drug D0E9IY HIGHSTAT Patented D0E9MO DRUG__ID D0E9MO D0E9MO DRUGTYPE Small molecular drug D0E9MO HIGHSTAT Patented D0EC4Z DRUG__ID D0EC4Z D0EC4Z DRUGCOMP MERCK SHARP & DOHME CORP D0EC4Z HIGHSTAT Patented D0ED5S DRUG__ID D0ED5S D0ED5S DRUGCOMP Korea Ocean Research and Development Institute D0ED5S HIGHSTAT Patented D0EG8Y DRUG__ID D0EG8Y D0EG8Y DRUGTYPE Small molecular drug D0EG8Y HIGHSTAT Patented D0EH9Z DRUG__ID D0EH9Z D0EH9Z DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D0EH9Z HIGHSTAT Patented D0EV6V DRUG__ID D0EV6V D0EV6V DRUGTYPE Small molecular drug D0EV6V HIGHSTAT Patented D0F0VF DRUG__ID D0F0VF D0F0VF DRUGTYPE Peptide D0F0VF HIGHSTAT Patented D0F2BF DRUG__ID D0F2BF D0F2BF DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D0F2BF HIGHSTAT Patented D0F4GT DRUG__ID D0F4GT D0F4GT DRUGTYPE Small molecular drug D0F4GT HIGHSTAT Patented D0F5ND DRUG__ID D0F5ND D0F5ND DRUGCOMP GLAXOSMITHKLINE LLC BLUM, Charles, A. DISCH, Jeremy, S. SPRINGER, Stephanie, K D0F5ND HIGHSTAT Patented D0F5TR DRUG__ID D0F5TR D0F5TR DRUGTYPE Small molecular drug D0F5TR HIGHSTAT Patented D0F9GL DRUG__ID D0F9GL D0F9GL DRUGTYPE Small molecular drug D0F9GL HIGHSTAT Patented D0FA2L DRUG__ID D0FA2L D0FA2L DRUGTYPE Small molecular drug D0FA2L HIGHSTAT Patented D0FL1E DRUG__ID D0FL1E D0FL1E DRUGTYPE Small molecular drug D0FL1E HIGHSTAT Patented D0FL8A DRUG__ID D0FL8A D0FL8A DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D0FL8A HIGHSTAT Patented D0FM6W DRUG__ID D0FM6W D0FM6W DRUGTYPE Small molecular drug D0FM6W HIGHSTAT Patented D0FT1X DRUG__ID D0FT1X D0FT1X DRUGTYPE Small molecular drug D0FT1X HIGHSTAT Patented D0FW3M DRUG__ID D0FW3M D0FW3M DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D0FW3M HIGHSTAT Patented D0G3TH DRUG__ID D0G3TH D0G3TH DRUGCOMP Nanjing Zhengliang Med. Tech. CO D0G3TH HIGHSTAT Patented D0G4YI DRUG__ID D0G4YI D0G4YI DRUGTYPE Small molecular drug D0G4YI HIGHSTAT Patented D0G5CV DRUG__ID D0G5CV D0G5CV DRUGTYPE Small molecular drug D0G5CV HIGHSTAT Patented D0GA6X DRUG__ID D0GA6X D0GA6X DRUGTYPE Small molecular drug D0GA6X HIGHSTAT Patented D0GD7H DRUG__ID D0GD7H D0GD7H DRUGCOMP GLAXOSMITHKLINE LLC BLUM, Charles, A. DISCH, Jeremy, S. SPRINGER, Stephanie, K D0GD7H HIGHSTAT Patented D0GN7U DRUG__ID D0GN7U D0GN7U DRUGTYPE Small molecular drug D0GN7U HIGHSTAT Patented D0GX8J DRUG__ID D0GX8J D0GX8J DRUGTYPE Small molecular drug D0GX8J HIGHSTAT Patented D0H0XX DRUG__ID D0H0XX D0H0XX DRUGTYPE Nucleotide D0H0XX HIGHSTAT Patented D0H3ZG DRUG__ID D0H3ZG D0H3ZG DRUGCOMP MERCK SHARP & DOHME CORP D0H3ZG HIGHSTAT Patented D0H5WE DRUG__ID D0H5WE D0H5WE DRUGTYPE Small molecular drug D0H5WE HIGHSTAT Patented D0H6QG DRUG__ID D0H6QG D0H6QG DRUGTYPE Small molecular drug D0H6QG HIGHSTAT Patented D0H7HH DRUG__ID D0H7HH D0H7HH DRUGCOMP Nanjing Guangkangxie Biolog. Medical Technology CO LTD D0H7HH HIGHSTAT Patented D0H8VN DRUG__ID D0H8VN D0H8VN DRUGTYPE Small molecular drug D0H8VN HIGHSTAT Patented D0HI8X DRUG__ID D0HI8X D0HI8X DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D0HI8X HIGHSTAT Patented D0HJ1O DRUG__ID D0HJ1O D0HJ1O DRUGTYPE Small molecular drug D0HJ1O HIGHSTAT Patented D0I3YK DRUG__ID D0I3YK D0I3YK DRUGTYPE Small molecular drug D0I3YK HIGHSTAT Patented D0I6UA DRUG__ID D0I6UA D0I6UA DRUGTYPE Small molecular drug D0I6UA HIGHSTAT Patented D0I7AJ DRUG__ID D0I7AJ D0I7AJ DRUGTYPE Small molecular drug D0I7AJ HIGHSTAT Patented D0I9CK DRUG__ID D0I9CK D0I9CK DRUGCOMP Nanjing Zhengliang Med. Tech. CO D0I9CK HIGHSTAT Patented D0I9JE DRUG__ID D0I9JE D0I9JE DRUGTYPE Small molecular drug D0I9JE HIGHSTAT Patented D0I9VU DRUG__ID D0I9VU D0I9VU DRUGTYPE Small molecular drug D0I9VU HIGHSTAT Patented D0IG7E DRUG__ID D0IG7E D0IG7E DRUGCOMP CORNELL UNIVERSITY LIN, Hening CERIONE, Richard D0IG7E HIGHSTAT Patented D0IL0Y DRUG__ID D0IL0Y D0IL0Y DRUGTYPE Peptide D0IL0Y HIGHSTAT Patented D0IO0M DRUG__ID D0IO0M D0IO0M DRUGTYPE Peptide D0IO0M HIGHSTAT Patented D0IO2A DRUG__ID D0IO2A D0IO2A DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D0IO2A HIGHSTAT Patented D0IO2X DRUG__ID D0IO2X D0IO2X DRUGCOMP MERCK SHARP & DOHME CORP. KEENAN, Kevin, A. NORTHRUP, Alan, B D0IO2X HIGHSTAT Patented D0IS8B DRUG__ID D0IS8B D0IS8B DRUGTYPE Small molecular drug D0IS8B HIGHSTAT Patented D0J4CA DRUG__ID D0J4CA D0J4CA DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D0J4CA HIGHSTAT Patented D0J4KQ DRUG__ID D0J4KQ D0J4KQ DRUGTYPE Peptide D0J4KQ HIGHSTAT Patented D0J4PC DRUG__ID D0J4PC D0J4PC DRUGTYPE Small molecular drug D0J4PC HIGHSTAT Patented D0JE1M DRUG__ID D0JE1M D0JE1M DRUGTYPE Small molecular drug D0JE1M HIGHSTAT Patented D0K0IO DRUG__ID D0K0IO D0K0IO DRUGTYPE Small molecular drug D0K0IO HIGHSTAT Patented D0K0TL DRUG__ID D0K0TL D0K0TL DRUGCOMP REVERAGEN BIOPHARMA, INC D0K0TL HIGHSTAT Patented D0K1UO DRUG__ID D0K1UO D0K1UO DRUGTYPE Small molecular drug D0K1UO HIGHSTAT Patented D0K2GG DRUG__ID D0K2GG D0K2GG DRUGTYPE Small molecular drug D0K2GG HIGHSTAT Patented D0K2RX DRUG__ID D0K2RX D0K2RX DRUGTYPE Peptide D0K2RX HIGHSTAT Patented D0K2XK DRUG__ID D0K2XK D0K2XK DRUGTYPE Small molecular drug D0K2XK HIGHSTAT Patented D0K6IM DRUG__ID D0K6IM D0K6IM DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D0K6IM HIGHSTAT Patented D0K7LI DRUG__ID D0K7LI D0K7LI DRUGTYPE Small molecular drug D0K7LI HIGHSTAT Patented D0K8HU DRUG__ID D0K8HU D0K8HU DRUGTYPE Small molecular drug D0K8HU HIGHSTAT Patented D0KF0X DRUG__ID D0KF0X D0KF0X DRUGTYPE Small molecular drug D0KF0X HIGHSTAT Patented D0KH7Q DRUG__ID D0KH7Q D0KH7Q DRUGTYPE Small molecular drug D0KH7Q HIGHSTAT Patented D0KI1H DRUG__ID D0KI1H D0KI1H DRUGTYPE Small molecular drug D0KI1H HIGHSTAT Patented D0KN9S DRUG__ID D0KN9S D0KN9S DRUGTYPE Small molecular drug D0KN9S HIGHSTAT Patented D0KR9E DRUG__ID D0KR9E D0KR9E DRUGTYPE Small molecular drug D0KR9E HIGHSTAT Patented D0KS3J DRUG__ID D0KS3J D0KS3J DRUGTYPE Small molecular drug D0KS3J HIGHSTAT Patented D0L2LF DRUG__ID D0L2LF D0L2LF DRUGTYPE Small molecular drug D0L2LF HIGHSTAT Patented D0L9AS DRUG__ID D0L9AS D0L9AS DRUGTYPE Peptide D0L9AS HIGHSTAT Patented D0LK8E DRUG__ID D0LK8E D0LK8E DRUGCOMP MERCK SHARP & DOHME CORP D0LK8E HIGHSTAT Patented D0LT6Z DRUG__ID D0LT6Z D0LT6Z DRUGTYPE Small molecular drug D0LT6Z HIGHSTAT Patented D0LZ2M DRUG__ID D0LZ2M D0LZ2M DRUGCOMP Nanjing Zhengliang Med. Tech. CO D0LZ2M HIGHSTAT Patented D0M0AK DRUG__ID D0M0AK D0M0AK DRUGTYPE Small molecular drug D0M0AK HIGHSTAT Patented D0M0EP DRUG__ID D0M0EP D0M0EP DRUGCOMP Nanjing Guangkangxie Biolog. Medical Technology CO LTD D0M0EP HIGHSTAT Patented D0M3NR DRUG__ID D0M3NR D0M3NR DRUGTYPE Peptide D0M3NR HIGHSTAT Patented D0M6PI DRUG__ID D0M6PI D0M6PI DRUGTYPE Small molecular drug D0M6PI HIGHSTAT Patented D0M6WD DRUG__ID D0M6WD D0M6WD DRUGTYPE Peptide D0M6WD HIGHSTAT Patented D0M8VS DRUG__ID D0M8VS D0M8VS DRUGCOMP MERCK SHARP & DOHME CORP D0M8VS HIGHSTAT Patented D0M9JE DRUG__ID D0M9JE D0M9JE DRUGTYPE Small molecular drug D0M9JE HIGHSTAT Patented D0ME4N DRUG__ID D0ME4N D0ME4N DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0ME4N HIGHSTAT Patented D0MH5C DRUG__ID D0MH5C D0MH5C DRUGTYPE Small molecular drug D0MH5C HIGHSTAT Patented D0MO1P DRUG__ID D0MO1P D0MO1P DRUGTYPE Small molecular drug D0MO1P HIGHSTAT Patented D0MZ9P DRUG__ID D0MZ9P D0MZ9P DRUGTYPE Small molecular drug D0MZ9P HIGHSTAT Patented D0N6WW DRUG__ID D0N6WW D0N6WW DRUGTYPE Small molecular drug D0N6WW HIGHSTAT Patented D0NB0V DRUG__ID D0NB0V D0NB0V DRUGTYPE Small molecular drug D0NB0V HIGHSTAT Patented D0ND5K DRUG__ID D0ND5K D0ND5K DRUGTYPE Small molecular drug D0ND5K HIGHSTAT Patented D0ND8U DRUG__ID D0ND8U D0ND8U DRUGTYPE Small molecular drug D0ND8U HIGHSTAT Patented D0NF2E DRUG__ID D0NF2E D0NF2E DRUGTYPE Small molecular drug D0NF2E HIGHSTAT Patented D0NU8U DRUG__ID D0NU8U D0NU8U DRUGTYPE Small molecular drug D0NU8U HIGHSTAT Patented D0O2HW DRUG__ID D0O2HW D0O2HW DRUGTYPE Small molecular drug D0O2HW HIGHSTAT Patented D0O5TC DRUG__ID D0O5TC D0O5TC HIGHSTAT Patented D0O5TC COMPCLAS Quinoxaline derivatives D0O6TG DRUG__ID D0O6TG D0O6TG DRUGTYPE Small molecular drug D0O6TG HIGHSTAT Patented D0O8MI DRUG__ID D0O8MI D0O8MI DRUGTYPE Peptide D0O8MI HIGHSTAT Patented D0O8ZD DRUG__ID D0O8ZD D0O8ZD DRUGTYPE Small molecular drug D0O8ZD HIGHSTAT Patented D0OQ7S DRUG__ID D0OQ7S D0OQ7S DRUGCOMP GLAXOSMITHKLINE LLC CASAUBON, Rebecca, L. NARAYAN, Radha OALMANN, Christopher VU, Chi, B D0OQ7S HIGHSTAT Patented D0P0ES DRUG__ID D0P0ES D0P0ES DRUGTYPE Small molecular drug D0P0ES HIGHSTAT Patented D0P0KY DRUG__ID D0P0KY D0P0KY DRUGCOMP VALIDUS BIOPHARMA MCCALL, John, M. HOFFMAN, Eric NAGARAJU, Kanneboyina D0P0KY HIGHSTAT Patented D0P0WF DRUG__ID D0P0WF D0P0WF DRUGCOMP MERCK SHARP & DOHME CORP. KEENAN, Kevin, A. NORTHRUP, Alan, B D0P0WF HIGHSTAT Patented D0P8SR DRUG__ID D0P8SR D0P8SR DRUGCOMP PLEXXIKON, INC. ZHANG, Chao ZHANG, Jiazhong IBRAHIM, Prabha N. ARTIS, Dean R. BREMER, Ryan WU, Guoxian ZHU, Hongyao NESPI, Marika D0P8SR HIGHSTAT Patented D0P8VT DRUG__ID D0P8VT D0P8VT DRUGTYPE Vaccine D0P8VT HIGHSTAT Patented D0PB2J DRUG__ID D0PB2J D0PB2J DRUGCOMP REVERAGEN BIOPHARMA, INC D0PB2J HIGHSTAT Patented D0PG1G DRUG__ID D0PG1G D0PG1G DRUGTYPE Small molecular drug D0PG1G HIGHSTAT Patented D0PM2S DRUG__ID D0PM2S D0PM2S DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D0PM2S HIGHSTAT Patented D0PM8K DRUG__ID D0PM8K D0PM8K DRUGCOMP CALITOR SCIENCES, LLC SUNSHINE LAKE PHARMA CO., LTD D0PM8K HIGHSTAT Patented D0PT1W DRUG__ID D0PT1W D0PT1W DRUGTYPE Peptide D0PT1W HIGHSTAT Patented D0PY0G DRUG__ID D0PY0G D0PY0G DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D0PY0G HIGHSTAT Patented D0Q1EG DRUG__ID D0Q1EG D0Q1EG DRUGCOMP ORYZON GENOMICS S.A. MAES, Tamara BUESA ARJOL, Carlos D0Q1EG HIGHSTAT Patented D0Q4QB DRUG__ID D0Q4QB D0Q4QB DRUGTYPE Small molecular drug D0Q4QB HIGHSTAT Patented D0Q5YJ DRUG__ID D0Q5YJ D0Q5YJ DRUGTYPE Small molecular drug D0Q5YJ HIGHSTAT Patented D0Q6JK DRUG__ID D0Q6JK D0Q6JK HIGHSTAT Patented D0Q6JK COMPCLAS Quinoxaline derivatives D0Q7NM DRUG__ID D0Q7NM D0Q7NM DRUGTYPE Small molecular drug D0Q7NM HIGHSTAT Patented D0Q8VI DRUG__ID D0Q8VI D0Q8VI DRUGCOMP GLAXOSMITHKLINE LLC CASAUBON, Rebecca, L. NARAYAN, Radha OALMANN, Christopher VU, Chi, B D0Q8VI HIGHSTAT Patented D0Q9LM DRUG__ID D0Q9LM D0Q9LM DRUGTYPE Small molecular drug D0Q9LM HIGHSTAT Patented D0QA9N DRUG__ID D0QA9N D0QA9N DRUGTYPE Small molecular drug D0QA9N HIGHSTAT Patented D0QC9I DRUG__ID D0QC9I D0QC9I DRUGTYPE Peptide D0QC9I HIGHSTAT Patented D0QE8Z DRUG__ID D0QE8Z D0QE8Z DRUGTYPE Peptide D0QE8Z HIGHSTAT Patented D0QR1I DRUG__ID D0QR1I D0QR1I DRUGTYPE Small molecular drug D0QR1I HIGHSTAT Patented D0QT8L DRUG__ID D0QT8L D0QT8L DRUGCOMP ONO PHARMACEUTICAL CO., LTD D0QT8L HIGHSTAT Patented D0R0SJ DRUG__ID D0R0SJ D0R0SJ DRUGCOMP UNIVERSITY OF UTAH RESEARCH FOUNDATION BEARSS, David, J. VANKAYALAPATI, Hariprasad SORNA, Venkataswamy WARNER, Steven, L. SHARMA, Sunil D0R0SJ HIGHSTAT Patented D0R3UI DRUG__ID D0R3UI D0R3UI DRUGTYPE Small molecular drug D0R3UI HIGHSTAT Patented D0R7UI DRUG__ID D0R7UI D0R7UI DRUGTYPE Small molecular drug D0R7UI HIGHSTAT Patented D0RC5J DRUG__ID D0RC5J D0RC5J DRUGTYPE Small molecular drug D0RC5J HIGHSTAT Patented D0RD5O DRUG__ID D0RD5O D0RD5O DRUGTYPE Small molecular drug D0RD5O HIGHSTAT Patented D0RH6G DRUG__ID D0RH6G D0RH6G DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D0RH6G HIGHSTAT Patented D0RR8O DRUG__ID D0RR8O D0RR8O DRUGCOMP MERCK SHARP & DOHME CORP D0RR8O HIGHSTAT Patented D0RT1R DRUG__ID D0RT1R D0RT1R DRUGTYPE Small molecular drug D0RT1R HIGHSTAT Patented D0S3AP DRUG__ID D0S3AP D0S3AP DRUGTYPE Small molecular drug D0S3AP HIGHSTAT Patented D0S3PN DRUG__ID D0S3PN D0S3PN DRUGTYPE Small molecular drug D0S3PN HIGHSTAT Patented D0S5CP DRUG__ID D0S5CP D0S5CP DRUGTYPE Nucleotide D0S5CP HIGHSTAT Patented D0S6BG DRUG__ID D0S6BG D0S6BG DRUGTYPE Small molecular drug D0S6BG HIGHSTAT Patented D0S7KA DRUG__ID D0S7KA D0S7KA DRUGCOMP BRANDON UNIVERSITY D0S7KA HIGHSTAT Patented D0SK0L DRUG__ID D0SK0L D0SK0L DRUGTYPE Small molecular drug D0SK0L HIGHSTAT Patented D0ST2K DRUG__ID D0ST2K D0ST2K DRUGTYPE Small molecular drug D0ST2K HIGHSTAT Patented D0SX1B DRUG__ID D0SX1B D0SX1B DRUGCOMP LIGAND PHARMACEUTICALS INCORPORATED COLE, Andrew, G. JAMES, Ray, A. SHAO, Yuefei LETOURNEAU, Jeffrey, J. QUINTERO, Jorge, G. RIVIELLO, Christopher, Mark ZHI, Lin D0SX1B HIGHSTAT Patented D0T0HM DRUG__ID D0T0HM D0T0HM DRUGCOMP VM PHARMA LLC WU, Jay Jie-Qiang WANG, Ling D0T0HM HIGHSTAT Patented D0T1WB DRUG__ID D0T1WB D0T1WB DRUGTYPE Small molecular drug D0T1WB HIGHSTAT Patented D0T4CF DRUG__ID D0T4CF D0T4CF DRUGCOMP MERCK SHARP & DOHME CORP D0T4CF HIGHSTAT Patented D0T7BH DRUG__ID D0T7BH D0T7BH DRUGTYPE Small molecular drug D0T7BH HIGHSTAT Patented D0T9XC DRUG__ID D0T9XC D0T9XC DRUGTYPE Small molecular drug D0T9XC HIGHSTAT Patented D0TE4S DRUG__ID D0TE4S D0TE4S DRUGTYPE Nucleotide D0TE4S HIGHSTAT Patented D0TH2W DRUG__ID D0TH2W D0TH2W DRUGTYPE Small molecular drug D0TH2W HIGHSTAT Patented D0TK3W DRUG__ID D0TK3W D0TK3W DRUGTYPE Small molecular drug D0TK3W HIGHSTAT Patented D0TP0X DRUG__ID D0TP0X D0TP0X DRUGTYPE Peptide D0TP0X HIGHSTAT Patented D0TR7N DRUG__ID D0TR7N D0TR7N DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0TR7N HIGHSTAT Patented D0TT0B DRUG__ID D0TT0B D0TT0B DRUGTYPE Small molecular drug D0TT0B HIGHSTAT Patented D0TZ6J DRUG__ID D0TZ6J D0TZ6J DRUGTYPE Small molecular drug D0TZ6J HIGHSTAT Patented D0U3RD DRUG__ID D0U3RD D0U3RD DRUGCOMP MERCK SHARP & DOHME CORP D0U3RD HIGHSTAT Patented D0U5XI DRUG__ID D0U5XI D0U5XI DRUGCOMP MERCK SHARP & DOHME CORP D0U5XI HIGHSTAT Patented D0U7WQ DRUG__ID D0U7WQ D0U7WQ DRUGTYPE Nucleotide D0U7WQ HIGHSTAT Patented D0UA3V DRUG__ID D0UA3V D0UA3V DRUGCOMP UNILEVER PLC UNILEVER N.V. CONOPCO, INC., D/B/A UNILEVER D0UA3V HIGHSTAT Patented D0UA4Y DRUG__ID D0UA4Y D0UA4Y DRUGTYPE Small molecular drug D0UA4Y HIGHSTAT Patented D0UC2S DRUG__ID D0UC2S D0UC2S DRUGTYPE Small molecular drug D0UC2S HIGHSTAT Patented D0UK9U DRUG__ID D0UK9U D0UK9U DRUGTYPE Small molecular drug D0UK9U HIGHSTAT Patented D0UL2V DRUG__ID D0UL2V D0UL2V DRUGTYPE Small molecular drug D0UL2V HIGHSTAT Patented D0UN4M DRUG__ID D0UN4M D0UN4M DRUGCOMP MERCK SHARP & DOHME CORP D0UN4M HIGHSTAT Patented D0V1XY DRUG__ID D0V1XY D0V1XY DRUGTYPE Small molecular drug D0V1XY HIGHSTAT Patented D0VD5J DRUG__ID D0VD5J D0VD5J DRUGCOMP MERCK SHARP & DOHME CORP D0VD5J HIGHSTAT Patented D0VI3F DRUG__ID D0VI3F D0VI3F DRUGTYPE Small molecular drug D0VI3F HIGHSTAT Patented D0VK1L DRUG__ID D0VK1L D0VK1L DRUGTYPE Small molecular drug D0VK1L HIGHSTAT Patented D0VM8G DRUG__ID D0VM8G D0VM8G DRUGTYPE Small molecular drug D0VM8G HIGHSTAT Patented D0VY9O DRUG__ID D0VY9O D0VY9O DRUGTYPE Small molecular drug D0VY9O HIGHSTAT Patented D0W2YK DRUG__ID D0W2YK D0W2YK DRUGTYPE Small molecular drug D0W2YK HIGHSTAT Patented D0W3EJ DRUG__ID D0W3EJ D0W3EJ DRUGTYPE Peptide D0W3EJ HIGHSTAT Patented D0W4MN DRUG__ID D0W4MN D0W4MN HIGHSTAT Patented D0W4MN COMPCLAS Isoquinoline 1,3-dione derivatives D0W6HL DRUG__ID D0W6HL D0W6HL DRUGTYPE Peptide D0W6HL HIGHSTAT Patented D0W7HO DRUG__ID D0W7HO D0W7HO DRUGTYPE Small molecular drug D0W7HO HIGHSTAT Patented D0WB2S DRUG__ID D0WB2S D0WB2S DRUGTYPE Small molecular drug D0WB2S HIGHSTAT Patented D0WE8K DRUG__ID D0WE8K D0WE8K DRUGTYPE Peptide D0WE8K HIGHSTAT Patented D0WJ3W DRUG__ID D0WJ3W D0WJ3W DRUGTYPE Small molecular drug D0WJ3W HIGHSTAT Patented D0WL1Z DRUG__ID D0WL1Z D0WL1Z DRUGTYPE Small molecular drug D0WL1Z HIGHSTAT Patented D0WX4H DRUG__ID D0WX4H D0WX4H DRUGCOMP BEHEERSMAATSCHAPPIJ G.A.CH.M. JENTJENS B.V. ILMER, Wilhelmus, Antonius, Maria THOONSEN, Paulus, Johannes, Maria D0WX4H HIGHSTAT Patented D0X2BO DRUG__ID D0X2BO D0X2BO DRUGCOMP THE UNIVERSITY OF SYDNEY DUKE, Colin Charles TRAN, Van Hoan DUKE, Rujee Kyokajee D0X2BO HIGHSTAT Patented D0X2ZY DRUG__ID D0X2ZY D0X2ZY HIGHSTAT Patented D0X2ZY COMPCLAS N-quinolin-benzene sulphonamide derivatives D0X4EC DRUG__ID D0X4EC D0X4EC DRUGTYPE Peptide D0X4EC HIGHSTAT Patented D0X5VI DRUG__ID D0X5VI D0X5VI DRUGTYPE Small molecular drug D0X5VI HIGHSTAT Patented D0X6QQ DRUG__ID D0X6QQ D0X6QQ DRUGTYPE Small molecular drug D0X6QQ HIGHSTAT Patented D0XG8H DRUG__ID D0XG8H D0XG8H DRUGTYPE Small molecular drug D0XG8H HIGHSTAT Patented D0XN3O DRUG__ID D0XN3O D0XN3O DRUGTYPE Small molecular drug D0XN3O HIGHSTAT Patented D0XO4I DRUG__ID D0XO4I D0XO4I DRUGTYPE Small molecular drug D0XO4I HIGHSTAT Patented D0XT3V DRUG__ID D0XT3V D0XT3V DRUGTYPE Small molecular drug D0XT3V HIGHSTAT Patented D0Y0XJ DRUG__ID D0Y0XJ D0Y0XJ DRUGCOMP MERCK SHARP & DOHME CORP D0Y0XJ HIGHSTAT Patented D0Y1LO DRUG__ID D0Y1LO D0Y1LO DRUGTYPE Small molecular drug D0Y1LO HIGHSTAT Patented D0Y2RN DRUG__ID D0Y2RN D0Y2RN DRUGTYPE Small molecular drug D0Y2RN HIGHSTAT Patented D0Y4KB DRUG__ID D0Y4KB D0Y4KB DRUGTYPE Nucleotide D0Y4KB HIGHSTAT Patented D0Y8GN DRUG__ID D0Y8GN D0Y8GN DRUGTYPE Small molecular drug D0Y8GN HIGHSTAT Patented D0Y8JF DRUG__ID D0Y8JF D0Y8JF DRUGTYPE Small molecular drug D0Y8JF HIGHSTAT Patented D0Y8SC DRUG__ID D0Y8SC D0Y8SC DRUGTYPE Small molecular drug D0Y8SC HIGHSTAT Patented D0YN0I DRUG__ID D0YN0I D0YN0I DRUGCOMP ARRAY BIOPHARMA INC D0YN0I HIGHSTAT Patented D0YX0O DRUG__ID D0YX0O D0YX0O DRUGTYPE Small molecular drug D0YX0O HIGHSTAT Patented D0Z1LJ DRUG__ID D0Z1LJ D0Z1LJ DRUGTYPE Small molecular drug D0Z1LJ HIGHSTAT Patented D0ZA3S DRUG__ID D0ZA3S D0ZA3S DRUGTYPE Peptide D0ZA3S HIGHSTAT Patented D0ZE6H DRUG__ID D0ZE6H D0ZE6H DRUGCOMP MERCK SHARP & DOHME CORP D0ZE6H HIGHSTAT Patented D0ZT9N DRUG__ID D0ZT9N D0ZT9N DRUGTYPE Small molecular drug D0ZT9N HIGHSTAT Patented D0ZW9O DRUG__ID D0ZW9O D0ZW9O DRUGTYPE Small molecular drug D0ZW9O HIGHSTAT Patented D03YOU DRUG__ID D03YOU D03YOU HIGHSTAT Patented D04EDM DRUG__ID D04EDM D04EDM HIGHSTAT Patented D05GWJ DRUG__ID D05GWJ D05GWJ HIGHSTAT Patented D05MYL DRUG__ID D05MYL D05MYL HIGHSTAT Patented D05OTD DRUG__ID D05OTD D05OTD HIGHSTAT Patented D06LSZ DRUG__ID D06LSZ D06LSZ HIGHSTAT Patented D07FMW DRUG__ID D07FMW D07FMW HIGHSTAT Patented D07HOA DRUG__ID D07HOA D07HOA HIGHSTAT Patented D07IQE DRUG__ID D07IQE D07IQE HIGHSTAT Patented D07MEE DRUG__ID D07MEE D07MEE HIGHSTAT Patented D07XBA DRUG__ID D07XBA D07XBA HIGHSTAT Patented D07ZKE DRUG__ID D07ZKE D07ZKE HIGHSTAT Patented D09BNP DRUG__ID D09BNP D09BNP HIGHSTAT Patented D09FQP DRUG__ID D09FQP D09FQP HIGHSTAT Patented D09HHL DRUG__ID D09HHL D09HHL HIGHSTAT Patented D0AM2D DRUG__ID D0AM2D D0AM2D HIGHSTAT Patented D0B2AE DRUG__ID D0B2AE D0B2AE HIGHSTAT Patented D0D0ML DRUG__ID D0D0ML D0D0ML HIGHSTAT Patented D0D6DE DRUG__ID D0D6DE D0D6DE HIGHSTAT Patented D0D7MV DRUG__ID D0D7MV D0D7MV HIGHSTAT Patented D0FU6L DRUG__ID D0FU6L D0FU6L HIGHSTAT Patented D0I2OO DRUG__ID D0I2OO D0I2OO HIGHSTAT Patented D0I5DV DRUG__ID D0I5DV D0I5DV HIGHSTAT Patented D0J9DI DRUG__ID D0J9DI D0J9DI HIGHSTAT Patented D0JA8J DRUG__ID D0JA8J D0JA8J HIGHSTAT Patented D0JN5O DRUG__ID D0JN5O D0JN5O HIGHSTAT Patented D0K3UV DRUG__ID D0K3UV D0K3UV HIGHSTAT Patented D0KW7O DRUG__ID D0KW7O D0KW7O HIGHSTAT Patented D0N0WE DRUG__ID D0N0WE D0N0WE HIGHSTAT Patented D0N1CG DRUG__ID D0N1CG D0N1CG HIGHSTAT Patented D0N9RD DRUG__ID D0N9RD D0N9RD HIGHSTAT Patented D0P1PC DRUG__ID D0P1PC D0P1PC HIGHSTAT Patented D0R2YC DRUG__ID D0R2YC D0R2YC HIGHSTAT Patented D0R4RV DRUG__ID D0R4RV D0R4RV HIGHSTAT Patented D0RE3R DRUG__ID D0RE3R D0RE3R HIGHSTAT Patented D0SB4A DRUG__ID D0SB4A D0SB4A HIGHSTAT Patented D0TX9E DRUG__ID D0TX9E D0TX9E HIGHSTAT Patented D0V6TF DRUG__ID D0V6TF D0V6TF HIGHSTAT Patented D0W3JC DRUG__ID D0W3JC D0W3JC HIGHSTAT Patented D0XY6I DRUG__ID D0XY6I D0XY6I HIGHSTAT Patented D0Y0RG DRUG__ID D0Y0RG D0Y0RG HIGHSTAT Patented D0Y9VB DRUG__ID D0Y9VB D0Y9VB HIGHSTAT Patented D01VAB DRUG__ID D01VAB D01VAB DRUGCOMP AstraZeneca D01VAB THERCLAS Antiarrhythmic Agents D01VAB DRUGTYPE Small molecular drug D01VAB DRUGINCH 1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3 D01VAB DRUGINKE PAZJSJFMUHDSTF-UHFFFAOYSA-N D01VAB DRUGSMIL CC(C)NCC(COC1=CC=CC=C1CC=C)O D01VAB HIGHSTAT Withdrawn from market D07XPE DRUG__ID D07XPE D07XPE DRUGCOMP Eli Lilly D07XPE THERCLAS Hypoglycemic Agents D07XPE DRUGTYPE Small molecular drug D07XPE DRUGINCH 1S/C10H15N5/c11-9(12)15-10(13)14-7-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H6,11,12,13,14,15) D07XPE DRUGINKE ICFJFFQQTFMIBG-UHFFFAOYSA-N D07XPE DRUGSMIL C1=CC=C(C=C1)CCN=C(N)N=C(N)N D07XPE HIGHSTAT Withdrawn from market D08SOF DRUG__ID D08SOF D08SOF DRUGCOMP Marion Merrell. Dow, Inc. D08SOF THERCLAS Antihistamines D08SOF DRUGTYPE Small molecular drug D08SOF DRUGINCH 1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3 D08SOF DRUGINKE GUGOEEXESWIERI-UHFFFAOYSA-N D08SOF DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O D08SOF HIGHSTAT Withdrawn from market D09JXM DRUG__ID D09JXM D09JXM DRUGCOMP Cipla phamaceuticals D09JXM THERCLAS Appetite Depressants D09JXM DRUGTYPE Small molecular drug D09JXM DRUGINCH 1S/C9H13NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7,9,11H,10H2,1H3/t7-,9-/m1/s1 D09JXM DRUGINKE DLNKOYKMWOXYQA-VXNVDRBHSA-N D09JXM DRUGSMIL CC(C(C1=CC=CC=C1)O)N D09JXM HIGHSTAT Withdrawn from market D0D2RN DRUG__ID D0D2RN D0D2RN DRUGCOMP Lederle Laboratories D0D2RN THERCLAS Anticancer Agents D0D2RN DRUGTYPE Small molecular drug D0D2RN DRUGINCH 1S/C19H20N8O5/c20-15-14-16(27-19(21)26-15)23-8-11(24-14)7-22-10-3-1-9(2-4-10)17(30)25-12(18(31)32)5-6-13(28)29/h1-4,8,12,22H,5-7H2,(H,25,30)(H,28,29)(H,31,32)(H4,20,21,23,26,27)/t12-/m0/s1 D0D2RN DRUGINKE TVZGACDUOSZQKY-LBPRGKRZSA-N D0D2RN DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N D0D2RN HIGHSTAT Withdrawn from market D0F9SG DRUG__ID D0F9SG D0F9SG DRUGCOMP Wyeth Pharmaceuticals D0F9SG THERCLAS Appetite Depressants D0F9SG DRUGTYPE Small molecular drug D0F9SG DRUGINCH 1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3/t9-/m0/s1 D0F9SG DRUGINKE DBGIVFWFUFKIQN-VIFPVBQESA-N D0F9SG DRUGSMIL CCNC(C)CC1=CC(=CC=C1)C(F)(F)F D0F9SG HIGHSTAT Withdrawn from market D0JQ7Y DRUG__ID D0JQ7Y D0JQ7Y DRUGCOMP AstraZeneca D0JQ7Y THERCLAS Anticoagulants D0JQ7Y DRUGTYPE Small molecular drug D0JQ7Y DRUGINCH 1S/C24H35N5O5/c1-2-34-20(30)15-26-21(17-6-4-3-5-7-17)24(32)29-13-12-19(29)23(31)27-14-16-8-10-18(11-9-16)22(25)28-33/h8-11,17,19,21,26,33H,2-7,12-15H2,1H3,(H2,25,28)(H,27,31)/t19-,21+/m0/s1 D0JQ7Y DRUGINKE ZXIBCJHYVWYIKI-PZJWPPBQSA-N D0JQ7Y DRUGSMIL CCOC(=O)CNC(C1CCCCC1)C(=O)N2CCC2C(=O)NCC3=CC=C(C=C3)C(=NO)N D0JQ7Y HIGHSTAT Withdrawn from market D0OC3J DRUG__ID D0OC3J D0OC3J DRUGCOMP Lundbeck Inc D0OC3J THERCLAS Antipsychotic Agents D0OC3J DRUGTYPE Small molecular drug D0OC3J DRUGINCH 1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2/b18-5- D0OC3J DRUGINKE NJMYODHXAKYRHW-DVZOWYKESA-N D0OC3J DRUGSMIL C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO D0OC3J HIGHSTAT Withdrawn from market D0Y2HR DRUG__ID D0Y2HR D0Y2HR DRUGCOMP Janssen Pharmaceutica D0Y2HR THERCLAS Antiallergic Agents D0Y2HR DRUGTYPE Small molecular drug D0Y2HR DRUGINCH 1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31) D0Y2HR DRUGINKE GXDALQBWZGODGZ-UHFFFAOYSA-N D0Y2HR DRUGSMIL COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F D0Y2HR HIGHSTAT Withdrawn from market D0Y4FL DRUG__ID D0Y4FL D0Y4FL DRUGCOMP Sanofi-Aventis D0Y4FL THERCLAS Antibiotics D0Y4FL DRUGTYPE Small molecular drug D0Y4FL DRUGINCH 1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1 D0Y4FL DRUGINKE RXZBMPWDPOLZGW-XMRMVWPWSA-N D0Y4FL DRUGSMIL CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O D0Y4FL HIGHSTAT Withdrawn from market D00CCI DRUG__ID D00CCI D00CCI DRUGCOMP Eli Lilly D00CCI DRUGTYPE Small molecular drug D00CCI DRUGINCH 1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20) D00CCI DRUGINKE MITFXPHMIHQXPI-UHFFFAOYSA-N D00CCI DRUGSMIL CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O D00CCI HIGHSTAT Withdrawn from market D00ZGA DRUG__ID D00ZGA D00ZGA DRUGCOMP GlaxoSmithKline D00ZGA DRUGTYPE Small molecular drug D00ZGA DRUGINCH 1S/C30H35F7N4O2/c1-18-13-24(31)5-6-26(18)27-17-25(40-11-9-39(10-12-40)20(3)42)7-8-41(27)28(43)38(4)19(2)21-14-22(29(32,33)34)16-23(15-21)30(35,36)37/h5-6,13-16,19,25,27H,7-12,17H2,1-4H3/t19-,25+,27-/m1/s1 D00ZGA DRUGINKE XGGTZCKQRWXCHW-WMTVXVAQSA-N D00ZGA DRUGSMIL CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C D00ZGA HIGHSTAT Withdrawn from market D01PIL DRUG__ID D01PIL D01PIL THERCLAS Antipsychotic Agents D01PIL DRUGTYPE Small molecular drug D01PIL DRUGINCH 1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1 D01PIL DRUGINKE GUJRSXAPGDDABA-NSHDSACASA-N D01PIL DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2OC)Br)OC D01PIL HIGHSTAT Withdrawn from market D04SBX DRUG__ID D04SBX D04SBX DRUGCOMP Abbott Laboratories D04SBX DRUGTYPE Small molecular drug D04SBX DRUGINCH 1S/C21H18F3N3O3/c1-11-9-26(5-4-25-11)19-8-18-13(7-16(19)24)20(28)14(21(29)30)10-27(18)17-3-2-12(22)6-15(17)23/h2-3,6-8,10-11,25H,4-5,9H2,1H3,(H,29,30) D04SBX DRUGINKE QKDHBVNJCZBTMR-UHFFFAOYSA-N D04SBX DRUGSMIL CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F D04SBX HIGHSTAT Withdrawn from market D06BPG DRUG__ID D06BPG D06BPG DRUGCOMP Uihlein D06BPG DRUGTYPE Small molecular drug D06BPG DRUGINCH 1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3 D06BPG DRUGINKE XXPANQJNYNUNES-UHFFFAOYSA-N D06BPG DRUGSMIL CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3 D06BPG HIGHSTAT Withdrawn from market D06JRD DRUG__ID D06JRD D06JRD DRUGCOMP Aventis SA D06JRD DRUGTYPE Small molecular drug D06JRD DRUGINCH 1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20) D06JRD DRUGINKE LVWZTYCIRDMTEY-UHFFFAOYSA-N D06JRD DRUGSMIL CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)O D06JRD HIGHSTAT Withdrawn from market D06PAZ DRUG__ID D06PAZ D06PAZ THERCLAS Antiarrhythmic Agents D06PAZ DRUGTYPE Small molecular drug D06PAZ DRUGINCH 1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25) D06PAZ DRUGINKE PJWPNDMDCLXCOM-UHFFFAOYSA-N D06PAZ DRUGSMIL CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC D06PAZ HIGHSTAT Withdrawn from market D08QUV DRUG__ID D08QUV D08QUV DRUGCOMP Roche D08QUV DRUGTYPE Small molecular drug D08QUV DRUGINCH 1S/C22H27NO2/c24-21(25)13-3-1-2-8-16-23-22-19-11-6-4-9-17(19)14-15-18-10-5-7-12-20(18)22/h4-7,9-12,22-23H,1-3,8,13-16H2,(H,24,25) D08QUV DRUGINKE ONNOFKFOZAJDHT-UHFFFAOYSA-N D08QUV DRUGSMIL C1CC2=CC=CC=C2C(C3=CC=CC=C31)NCCCCCCC(=O)O D08QUV HIGHSTAT Withdrawn from market D0EC5X DRUG__ID D0EC5X D0EC5X DRUGCOMP May & Baker D0EC5X DRUGTYPE Small molecular drug D0EC5X DRUGINCH 1S/C23H38O5/c1-5-6-15-23(2,3)21(26)14-13-18-17(19(24)16-20(18)25)11-9-7-8-10-12-22(27)28-4/h10,12-14,17-18,20-21,25-26H,5-9,11,15-16H2,1-4H3/b12-10+,14-13+/t17-,18-,20-,21-/m1/s1 D0EC5X DRUGINKE KYBOHGVERHWSSV-VNIVIJDLSA-N D0EC5X DRUGSMIL CCCCC(C)(C)C(C=CC1C(CC(=O)C1CCCCC=CC(=O)OC)O)O D0EC5X HIGHSTAT Withdrawn from market D0F0OK DRUG__ID D0F0OK D0F0OK THERCLAS Antiinfective Agents D0F0OK DRUGTYPE Small molecular drug D0F0OK DRUGINCH 1S/C11H12N4O3S/c1-18-11-10(13-6-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) D0F0OK DRUGINKE KXRZBTAEDBELFD-UHFFFAOYSA-N D0F0OK DRUGSMIL COC1=NC=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N D0F0OK HIGHSTAT Withdrawn from market D0JP4H DRUG__ID D0JP4H D0JP4H THERCLAS Antihypertensive Agents D0JP4H DRUGTYPE Small molecular drug D0JP4H DRUGINCH 1S/C10H15N3/c1-11-10(12-2)13-8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3,(H2,11,12,13) D0JP4H DRUGINKE NIVZHWNOUVJHKV-UHFFFAOYSA-N D0JP4H DRUGSMIL CNC(=NC)NCC1=CC=CC=C1 D0JP4H HIGHSTAT Withdrawn from market D0OS6O DRUG__ID D0OS6O D0OS6O THERCLAS Antipsychotic Agents D0OS6O DRUGTYPE Small molecular drug D0OS6O DRUGINCH 1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31) D0OS6O DRUGINKE GZKLJWGUPQBVJQ-UHFFFAOYSA-N D0OS6O DRUGSMIL C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O D0OS6O HIGHSTAT Withdrawn from market D0P3DM DRUG__ID D0P3DM D0P3DM THERCLAS Central Nervous System Stimulants D0P3DM DRUGTYPE Small molecular drug D0P3DM DRUGINCH 1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3 D0P3DM DRUGINKE IKFBPFGUINLYQI-UHFFFAOYSA-N D0P3DM DRUGSMIL CCNC1C2CCC(C2)C1C3=CC=CC=C3 D0P3DM HIGHSTAT Withdrawn from market D0R6AB DRUG__ID D0R6AB D0R6AB DRUGCOMP Esteve D0R6AB DRUGTYPE Small molecular drug D0R6AB DRUGINCH 1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3 D0R6AB DRUGINKE OEHFRZLKGRKFAS-UHFFFAOYSA-N D0R6AB DRUGSMIL CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4 D0R6AB HIGHSTAT Withdrawn from market D0R8FM DRUG__ID D0R8FM D0R8FM DRUGCOMP Ferrer Internacional SA D0R8FM DRUGTYPE Small molecular drug D0R8FM DRUGINCH 1S/C14H17BrN6O2S3/c15-10-1-3-12(4-2-10)26(22,23)19-9-18-5-6-24-7-11-8-25-14(20-11)21-13(16)17/h1-4,8-9H,5-7H2,(H,18,19)(H4,16,17,20,21) D0R8FM DRUGINKE ZQHFZHPUZXNPMF-UHFFFAOYSA-N D0R8FM DRUGSMIL C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br D0R8FM HIGHSTAT Withdrawn from market D0T1RG DRUG__ID D0T1RG D0T1RG DRUGCOMP Encysive D0T1RG DRUGTYPE Small molecular drug D0T1RG DRUGINCH 1S/C18H15ClN2O6S2/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h3-5,7,21H,6,8H2,1-2H3 D0T1RG DRUGINKE PHWXUGHIIBDVKD-UHFFFAOYSA-N D0T1RG DRUGSMIL CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2 D0T1RG HIGHSTAT Withdrawn from market D0X0KJ DRUG__ID D0X0KJ D0X0KJ THERCLAS Anticancer Agents D0X0KJ DRUGTYPE Small molecular drug D0X0KJ DRUGINCH 1S/C23H21ClO3/c1-25-19-10-4-16(5-11-19)22(17-6-12-20(26-2)13-7-17)23(24)18-8-14-21(27-3)15-9-18/h4-15H,1-3H3 D0X0KJ DRUGINKE BFPSDSIWYFKGBC-UHFFFAOYSA-N D0X0KJ DRUGSMIL COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC D0X0KJ HIGHSTAT Withdrawn from market D0Y8UB DRUG__ID D0Y8UB D0Y8UB DRUGCOMP Servier D0Y8UB DRUGTYPE Small molecular drug D0Y8UB DRUGINCH 1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17) D0Y8UB DRUGINKE YJYPHIXNFHFHND-UHFFFAOYSA-N D0Y8UB DRUGSMIL CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC D0Y8UB HIGHSTAT Withdrawn from market D00IKH DRUG__ID D00IKH D00IKH DRUGTYPE Small molecular drug D00IKH DRUGINCH 1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18) D00IKH DRUGINKE AOCCBINRVIKJHY-UHFFFAOYSA-N D00IKH DRUGSMIL CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F D00IKH HIGHSTAT Withdrawn from market D01EQG DRUG__ID D01EQG D01EQG DRUGTYPE Small molecular drug D01EQG DRUGINCH 1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3 D01EQG DRUGINKE MPHPHYZQRGLTBO-UHFFFAOYSA-N D01EQG DRUGSMIL CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C D01EQG HIGHSTAT Withdrawn from market D01MXV DRUG__ID D01MXV D01MXV DRUGTYPE Small molecular drug D01MXV DRUGINCH 1S/C10H15NO2/c1-2-11-7-10(13)8-4-3-5-9(12)6-8/h3-6,10-13H,2,7H2,1H3 D01MXV DRUGINKE SQVIAVUSQAWMKL-UHFFFAOYSA-N D01MXV DRUGSMIL CCNCC(C1=CC(=CC=C1)O)O D01MXV HIGHSTAT Withdrawn from market D02EAS DRUG__ID D02EAS D02EAS DRUGTYPE Small molecular drug D02EAS DRUGINCH 1S/C20H27N3O.C4H4O4/c1-3-24-19-10-7-13-21-20(19)22(2)18-11-14-23(15-12-18)16-17-8-5-4-6-9-17;5-3(6)1-2-4(7)8/h4-10,13,18H,3,11-12,14-16H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D02EAS DRUGINKE ADAMULBLHXHVFN-BTJKTKAUSA-N D02EAS DRUGSMIL CCOC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=CC=C3.C(=CC(=O)O)C(=O)O D02EAS HIGHSTAT Withdrawn from market D02FEA DRUG__ID D02FEA D02FEA DRUGTYPE Small molecular drug D02FEA DRUGINCH 1S/C23H25N/c1-19(20-11-5-2-6-12-20)24-18-17-23(21-13-7-3-8-14-21)22-15-9-4-10-16-22/h2-16,19,23-24H,17-18H2,1H3 D02FEA DRUGINKE NMKSAYKQLCHXDK-UHFFFAOYSA-N D02FEA DRUGSMIL CC(C1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3 D02FEA HIGHSTAT Withdrawn from market D02LHR DRUG__ID D02LHR D02LHR DRUGTYPE Small molecular drug D02LHR DRUGINCH 1S/C22H25N3O/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21/h1-9,16,19,23H,10-15H2,(H,24,26) D02LHR DRUGINKE JXZZEXZZKAWDSP-UHFFFAOYSA-N D02LHR DRUGSMIL C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43 D02LHR HIGHSTAT Withdrawn from market D03FDT DRUG__ID D03FDT D03FDT DRUGTYPE Small molecular drug D03FDT DRUGINCH 1S/C20H14O4/c21-15-9-5-13(6-10-15)20(14-7-11-16(22)12-8-14)18-4-2-1-3-17(18)19(23)24-20/h1-12,21-22H D03FDT DRUGINKE KJFMBFZCATUALV-UHFFFAOYSA-N D03FDT DRUGSMIL C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O D03FDT HIGHSTAT Withdrawn from market D03JPH DRUG__ID D03JPH D03JPH DRUGTYPE Small molecular drug D03JPH DRUGINCH 1S/C14H13N3O5S/c1-8-7-11(16-22-8)15-14(19)12-13(18)9-5-3-4-6-10(9)23(20,21)17(12)2/h3-7,18H,1-2H3,(H,15,16,19) D03JPH DRUGINKE YYUAYBYLJSNDCX-UHFFFAOYSA-N D03JPH DRUGSMIL CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O D03JPH HIGHSTAT Withdrawn from market D04YCE DRUG__ID D04YCE D04YCE DRUGTYPE Small molecular drug D04YCE DRUGINCH 1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1 D04YCE DRUGINKE UUTKICFRNVKFRG-WDSKDSINSA-N D04YCE DRUGSMIL C1CC(=O)NC1C(=O)N2CSCC2C(=O)O D04YCE HIGHSTAT Withdrawn from market D05RUM DRUG__ID D05RUM D05RUM DRUGTYPE Small molecular drug D05RUM DRUGINCH 1S/C16H22FNO/c1-13-8-11-18(12-9-13)10-2-3-16(19)14-4-6-15(17)7-5-14/h4-7,13H,2-3,8-12H2,1H3 D05RUM DRUGINKE DKMFBWQBDIGMHM-UHFFFAOYSA-N D05RUM DRUGSMIL CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F D05RUM HIGHSTAT Withdrawn from market D06ABW DRUG__ID D06ABW D06ABW DRUGTYPE Small molecular drug D06ABW DRUGINCH 1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H D06ABW DRUGINKE QCDFBFJGMNKBDO-UHFFFAOYSA-N D06ABW DRUGSMIL C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1 D06ABW HIGHSTAT Withdrawn from market D06UWD DRUG__ID D06UWD D06UWD DRUGTYPE Small molecular drug D06UWD DRUGINCH 1S/C14H22ClNO/c1-11(10-16(3)4)14(2,17)9-12-5-7-13(15)8-6-12/h5-8,11,17H,9-10H2,1-4H3 D06UWD DRUGINKE KVHHQGIIZCJATJ-UHFFFAOYSA-N D06UWD DRUGSMIL CC(CN(C)C)C(C)(CC1=CC=C(C=C1)Cl)O D06UWD HIGHSTAT Withdrawn from market D07KDE DRUG__ID D07KDE D07KDE DRUGTYPE Small molecular drug D07KDE DRUGINCH 1S/C33H57N3O9/c1-16(2)22-31(40)43-26(20(9)10)29(38)35(14)24(18(5)6)33(42)45-27(21(11)12)30(39)36(15)23(17(3)4)32(41)44-25(19(7)8)28(37)34(22)13/h16-27H,1-15H3/t22-,23-,24-,25?,26?,27?/m0/s1 D07KDE DRUGINKE MIZMDSVSLSIMSC-OGLSAIDSSA-N D07KDE DRUGSMIL CC(C)C1C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C D07KDE HIGHSTAT Withdrawn from market D07KYU DRUG__ID D07KYU D07KYU DRUGTYPE Small molecular drug D07KYU DRUGINCH 1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,23H,3-4,15-16H2,1-2H3 D07KYU DRUGINKE IVQOFBKHQCTVQV-UHFFFAOYSA-N D07KYU DRUGSMIL CCN(CC)CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O D07KYU HIGHSTAT Withdrawn from market D07XCF DRUG__ID D07XCF D07XCF DRUGTYPE Small molecular drug D07XCF DRUGINCH 1S/C19H20F3NO2/c1-14(12-15-6-5-9-17(13-15)19(20,21)22)23-10-11-25-18(24)16-7-3-2-4-8-16/h2-9,13-14,23H,10-12H2,1H3 D07XCF DRUGINKE CJAVTWRYCDNHSM-UHFFFAOYSA-N D07XCF DRUGSMIL CC(CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C2=CC=CC=C2 D07XCF HIGHSTAT Withdrawn from market D0A4BR DRUG__ID D0A4BR D0A4BR DRUGTYPE Small molecular drug D0A4BR DRUGINCH 1S/C6H12O5S.Au/c7-1-2-3(8)4(9)5(10)6(12)11-2;/h2-10,12H,1H2;/q;+1/p-1/t2-,3-,4+,5-,6?;/m1./s1 D0A4BR DRUGINKE XHVAWZZCDCWGBK-BMZZJELJSA-M D0A4BR DRUGSMIL C(C1C(C(C(C(O1)[S-])O)O)O)O.[Au+] D0A4BR HIGHSTAT Withdrawn from market D0AK5R DRUG__ID D0AK5R D0AK5R DRUGTYPE Small molecular drug D0AK5R DRUGINCH 1S/C20H17F3N2O4/c21-20(22,23)15-6-3-5-13-17(8-9-24-18(13)15)25-16-7-2-1-4-14(16)19(28)29-11-12(27)10-26/h1-9,12,26-27H,10-11H2,(H,24,25) D0AK5R DRUGINKE APQPGQGAWABJLN-UHFFFAOYSA-N D0AK5R DRUGSMIL C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC=C(C3=NC=C2)C(F)(F)F D0AK5R HIGHSTAT Withdrawn from market D0B6PZ DRUG__ID D0B6PZ D0B6PZ DRUGTYPE Small molecular drug D0B6PZ DRUGINCH 1S/C19H26O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,22H,3-10H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1 D0B6PZ DRUGINKE OSVMTWJCGUFAOD-KZQROQTASA-N D0B6PZ DRUGSMIL CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O D0B6PZ HIGHSTAT Withdrawn from market D0C1XS DRUG__ID D0C1XS D0C1XS DRUGTYPE Small molecular drug D0C1XS DRUGINCH 1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9- D0C1XS DRUGINKE OYPPVKRFBIWMSX-SXGWCWSVSA-N D0C1XS DRUGSMIL CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2 D0C1XS HIGHSTAT Withdrawn from market D0C4FT DRUG__ID D0C4FT D0C4FT DRUGTYPE Small molecular drug D0C4FT DRUGINCH 1S/C18H22O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,17-20H,3-4H2,1-2H3 D0C4FT DRUGINKE PBBGSZCBWVPOOL-UHFFFAOYSA-N D0C4FT DRUGSMIL CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O D0C4FT HIGHSTAT Withdrawn from market D0F8IO DRUG__ID D0F8IO D0F8IO DRUGTYPE Small molecular drug D0F8IO DRUGINCH 1S/C19H17N3O4S2/c23-14(9-13-5-4-8-27-13)20-15-17(24)22-16(19(25)26)12(11-28-18(15)22)10-21-6-2-1-3-7-21/h1-8,15,18H,9-11H2,(H-,20,23,25,26)/t15-,18-/m1/s1 D0F8IO DRUGINKE CZTQZXZIADLWOZ-CRAIPNDOSA-N D0F8IO DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CS3)C(=O)[O-])C[N+]4=CC=CC=C4 D0F8IO HIGHSTAT Withdrawn from market D0J0EL DRUG__ID D0J0EL D0J0EL DRUGTYPE Small molecular drug D0J0EL DRUGINCH 1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H D0J0EL DRUGINKE QBPFLULOKWLNNW-UHFFFAOYSA-N D0J0EL DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=CC=C3O D0J0EL HIGHSTAT Withdrawn from market D0M7LV DRUG__ID D0M7LV D0M7LV DRUGTYPE Small molecular drug D0M7LV DRUGINCH 1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1 D0M7LV DRUGINKE VAYOSLLFUXYJDT-RDTXWAMCSA-N D0M7LV DRUGSMIL CCN(CC)C(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C D0M7LV HIGHSTAT Withdrawn from market D0O2IE DRUG__ID D0O2IE D0O2IE DRUGTYPE Small molecular drug D0O2IE DRUGINCH 1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12) D0O2IE DRUGINKE CPJSUEIXXCENMM-UHFFFAOYSA-N D0O2IE DRUGSMIL CCOC1=CC=C(C=C1)NC(=O)C D0O2IE HIGHSTAT Withdrawn from market D0O8OB DRUG__ID D0O8OB D0O8OB DRUGTYPE Small molecular drug D0O8OB DRUGINCH 1S/C18H23NO3/c1-13(12-22-17-6-4-3-5-7-17)19-14(2)18(21)15-8-10-16(20)11-9-15/h3-11,13-14,18-21H,12H2,1-2H3 D0O8OB DRUGINKE BMUKKTUHUDJSNZ-UHFFFAOYSA-N D0O8OB DRUGSMIL CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O D0O8OB HIGHSTAT Withdrawn from market D0Q5PL DRUG__ID D0Q5PL D0Q5PL DRUGTYPE Small molecular drug D0Q5PL DRUGINCH 1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21) D0Q5PL DRUGINKE RJMIEHBSYVWVIN-UHFFFAOYSA-N D0Q5PL DRUGSMIL CC(C1=CC=C(C=C1)N2CC3=CC=CC=C3C2=O)C(=O)O D0Q5PL HIGHSTAT Withdrawn from market D0QQ1J DRUG__ID D0QQ1J D0QQ1J DRUGTYPE Small molecular drug D0QQ1J DRUGINCH 1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H D0QQ1J DRUGINKE JFIOVJDNOJYLKP-UHFFFAOYSA-N D0QQ1J DRUGSMIL C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)O)O)Cl)Cl D0QQ1J HIGHSTAT Withdrawn from market D0SU1G DRUG__ID D0SU1G D0SU1G DRUGTYPE Small molecular drug D0SU1G DRUGINCH 1S/C15H14ClNO3/c1-9-7-12(8-13(18)19)17(2)14(9)15(20)10-3-5-11(16)6-4-10/h3-7H,8H2,1-2H3,(H,18,19) D0SU1G DRUGINKE ZXVNMYWKKDOREA-UHFFFAOYSA-N D0SU1G DRUGSMIL CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl D0SU1G HIGHSTAT Withdrawn from market D0T0TZ DRUG__ID D0T0TZ D0T0TZ DRUGTYPE Small molecular drug D0T0TZ DRUGINCH 1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17) D0T0TZ DRUGINKE AGHANLSBXUWXTB-UHFFFAOYSA-N D0T0TZ DRUGSMIL C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl D0T0TZ HIGHSTAT Withdrawn from market D0T7XI DRUG__ID D0T7XI D0T7XI DRUGTYPE Small molecular drug D0T7XI DRUGINCH 1S/C16H14N2O/c1-11-7-3-6-10-15(11)18-12(2)17-14-9-5-4-8-13(14)16(18)19/h3-10H,1-2H3 D0T7XI DRUGINKE JEYCTXHKTXCGPB-UHFFFAOYSA-N D0T7XI DRUGSMIL CC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)C D0T7XI HIGHSTAT Withdrawn from market D0U2CB DRUG__ID D0U2CB D0U2CB DRUGTYPE Small molecular drug D0U2CB DRUGINCH 1S/C13H19NO2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(15)14-16/h4-7,9-10,16H,8H2,1-3H3,(H,14,15) D0U2CB DRUGINKE BYPIURIATSUHDW-UHFFFAOYSA-N D0U2CB DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)NO D0U2CB HIGHSTAT Withdrawn from market D0G1GP DRUG__ID D0G1GP D0G1GP DRUGCOMP Isis Pharmaceuticals D0G1GP DRUGTYPE Antisense drug D0G1GP HIGHSTAT Withdrawn from market D03CGS DRUG__ID D03CGS D03CGS DRUGCOMP Chiesi Pharmaceuticals Inc D03CGS HIGHSTAT Withdrawn from market D05TLR DRUG__ID D05TLR D05TLR DRUGCOMP Lederle Laboratories D05TLR HIGHSTAT Withdrawn from market D0QU8H DRUG__ID D0QU8H D0QU8H DRUGCOMP Sanofi-Aventis D0QU8H DRUGTYPE Small molecular drug D0QU8H DRUGINCH 1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)/t12-/m0/s1 D0QU8H DRUGINKE NTJOBXMMWNYJFB-LBPRGKRZSA-N D0QU8H DRUGSMIL CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC D0QU8H HIGHSTAT Discontinued in Phase 4 D05HDX DRUG__ID D05HDX D05HDX DRUGTYPE Small molecular drug D05HDX DRUGINCH 1S/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27) D05HDX DRUGINKE YDBLKRPLXZNVNB-UHFFFAOYSA-N D05HDX DRUGSMIL CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O D05HDX HIGHSTAT Discontinued in Phase 4 D00KOV DRUG__ID D00KOV D00KOV DRUGCOMP Dainippon Pharmaceutical Co Ltd D00KOV DRUGTYPE Small molecular drug D00KOV DRUGINCH 1S/C28H30FN3OS.C4H4O4/c29-22-11-13-23(14-12-22)32-18-16-31(17-19-32)15-5-10-27(33)30-28-24-7-2-1-6-21(24)20-34-26-9-4-3-8-25(26)28;5-3(6)1-2-4(7)8/h1-4,6-9,11-14,28H,5,10,15-20H2,(H,30,33);1-2H,(H,5,6)(H,7,8)/b;2-1- D00KOV DRUGINKE ZDZXCYHMVFLGMT-BTJKTKAUSA-N D00KOV DRUGSMIL C1CN(CCN1CCCC(=O)NC2C3=CC=CC=C3CSC4=CC=CC=C24)C5=CC=C(C=C5)F.C(=CC(=O)O)C(=O)O D00KOV HIGHSTAT Discontinued in Preregistration D01HRR DRUG__ID D01HRR D01HRR DRUGCOMP Shionogi & Co Ltd D01HRR DRUGTYPE Small molecular drug D01HRR DRUGINCH 1S/C20H27NO4S/c22-19(23)11-7-2-1-6-10-18-15-12-13-16(14-15)20(18)21-26(24,25)17-8-4-3-5-9-17/h1,3-6,8-9,15-16,18,20-21H,2,7,10-14H2,(H,22,23)/b6-1-/t15-,16+,18+,20+/m1/s1 D01HRR DRUGINKE PWTCIBWRMQFJBC-ZEMKZVSASA-N D01HRR DRUGSMIL C1CC2CC1C(C2NS(=O)(=O)C3=CC=CC=C3)CC=CCCCC(=O)O D01HRR HIGHSTAT Discontinued in Preregistration D01IRW DRUG__ID D01IRW D01IRW DRUGCOMP Dainippon Pharmaceutical Co Ltd D01IRW DRUGTYPE Small molecular drug D01IRW DRUGINCH 1S/C18H16O4/c1-10-3-5-16-13(7-10)9-15(19)14-8-12(11(2)18(20)21)4-6-17(14)22-16/h3-8,11H,9H2,1-2H3,(H,20,21) D01IRW DRUGINKE REHLODZXMGOGQP-UHFFFAOYSA-N D01IRW DRUGSMIL CC1=CC2=C(C=C1)OC3=C(C=C(C=C3)C(C)C(=O)O)C(=O)C2 D01IRW HIGHSTAT Discontinued in Preregistration D02HKL DRUG__ID D02HKL D02HKL DRUGCOMP Rhone-Poulenc SA D02HKL DRUGTYPE Small molecular drug D02HKL DRUGINCH 1S/C20H20ClN5O3S2/c1-24-6-8-25(9-7-24)20(28)29-19-16-15(30-10-11-31-16)18(27)26(19)14-5-3-12-2-4-13(21)22-17(12)23-14/h2-5,19H,6-11H2,1H3 D02HKL DRUGINKE RMXOUBDDDQUBKD-UHFFFAOYSA-N D02HKL DRUGSMIL CN1CCN(CC1)C(=O)OC2C3=C(C(=O)N2C4=NC5=C(C=C4)C=CC(=N5)Cl)SCCS3 D02HKL HIGHSTAT Discontinued in Preregistration D03DSB DRUG__ID D03DSB D03DSB DRUGCOMP Pharmacia & Upjohn Co D03DSB DRUGTYPE Small molecular drug D03DSB DRUGINCH 1S/C17H30N2O7/c1-4-5-6-8-7-9(20)17(23)16(24-8)25-15-13(22)10(18-2)12(21)11(19-3)14(15)26-17/h8,10-16,18-19,21-23H,4-7H2,1-3H3/t8-,10-,11+,12+,13+,14-,15-,16+,17+/m1/s1 D03DSB DRUGINKE KHAUBYTYGDOYRU-IRXASZMISA-N D03DSB DRUGSMIL CCCCC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O D03DSB HIGHSTAT Discontinued in Preregistration D05RQX DRUG__ID D05RQX D05RQX DRUGCOMP Eisai Co Ltd D05RQX DRUGTYPE Small molecular drug D05RQX DRUGINCH 1S/C21H26N8O6S2/c1-35-26-11(14-25-20(23)37-27-14)15(30)24-12-16(31)28-13(18(32)33)10(9-36-17(12)28)8-29-5-2-21(3-6-29,4-7-29)19(22)34/h12,17H,2-9H2,1H3,(H5-,22,23,24,25,27,30,32,33,34)/b26-11-/t12-,17-,21?,29?/m1/s1 D05RQX DRUGINKE JUVHVMCKLDZLGN-TVNFHGJBSA-N D05RQX DRUGSMIL CON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]45CCC(CC4)(CC5)C(=O)N)C(=O)[O-] D05RQX HIGHSTAT Discontinued in Preregistration D06LDC DRUG__ID D06LDC D06LDC DRUGCOMP Teijin Ltd D06LDC DRUGTYPE Small molecular drug D06LDC DRUGINCH 1S/C29H34FN3O6.ClH/c1-18-24(27(34)38-6)26(22-14-21(33(36)37)12-13-23(22)30)25(19(2)31-18)28(35)39-17-29(3,4)16-32(5)15-20-10-8-7-9-11-20;/h7-14,26,31H,15-17H2,1-6H3;1H D06LDC DRUGINKE OQHXRVQARZHYGQ-UHFFFAOYSA-N D06LDC DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC(C)(C)CN(C)CC2=CC=CC=C2)C3=C(C=CC(=C3)[N+](=O)[O-])F)C(=O)OC.Cl D06LDC HIGHSTAT Discontinued in Preregistration D06TVG DRUG__ID D06TVG D06TVG DRUGCOMP Hokuriku Seiyaku KK D06TVG DRUGTYPE Small molecular drug D06TVG DRUGINCH 1S/C16H23NO/c1-3-14-6-8-15(9-7-14)16(18)13(2)12-17-10-4-5-11-17/h6-9,13H,3-5,10-12H2,1-2H3 D06TVG DRUGINKE VNFAARJCGSAROU-UHFFFAOYSA-N D06TVG DRUGSMIL CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCC2 D06TVG HIGHSTAT Discontinued in Preregistration D07EGW DRUG__ID D07EGW D07EGW DRUGCOMP Mitsubishi Pharma Corp D07EGW DRUGTYPE Small molecular drug D07EGW DRUGINCH 1S/C41H42N4O6/c1-28-36(40(46)50-3)38(33-15-10-16-35(27-33)45(48)49)37(29(2)42-28)41(47)51-26-21-30-17-19-34(20-18-30)43-22-24-44(25-23-43)39(31-11-6-4-7-12-31)32-13-8-5-9-14-32/h4-20,27,38-39,46H,21-26H2,1-3H3 D07EGW DRUGINKE VPQACPHDDSSGPL-UHFFFAOYSA-N D07EGW DRUGSMIL CC1=C(C(C(=C([O-])OC)C(=N1)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCC3=CC=C(C=C3)[NH+]4CCN(CC4)C(C5=CC=CC=C5)C6=CC=CC=C6 D07EGW HIGHSTAT Discontinued in Preregistration D07MEL DRUG__ID D07MEL D07MEL DRUGCOMP Greenwich Pharmaceuticals Inc D07MEL DRUGTYPE Small molecular drug D07MEL DRUGINCH 1S/C14H27NO6/c1-14(2)20-12-11(18-7-5-6-15(3)4)10(9(17)8-16)19-13(12)21-14/h9-13,16-17H,5-8H2,1-4H3/t9-,10-,11+,12-,13-/m1/s1 D07MEL DRUGINKE YXBQLONCIPUQKO-UJPOAAIJSA-N D07MEL DRUGSMIL CC1(OC2C(C(OC2O1)C(CO)O)OCCCN(C)C)C D07MEL HIGHSTAT Discontinued in Preregistration D0E0JF DRUG__ID D0E0JF D0E0JF DRUGCOMP Bayer Schering Pharma AG D0E0JF DRUGTYPE Small molecular drug D0E0JF DRUGINCH 1S/C17H12ClFN2O2/c18-12-3-1-11(2-4-12)15-10-21(20-16(15)9-17(22)23)14-7-5-13(19)6-8-14/h1-8,10H,9H2,(H,22,23) D0E0JF DRUGINKE YAMFWQIVVMITPG-UHFFFAOYSA-N D0E0JF DRUGSMIL C1=CC(=CC=C1C2=CN(N=C2CC(=O)O)C3=CC=C(C=C3)F)Cl D0E0JF HIGHSTAT Discontinued in Preregistration D0FX4J DRUG__ID D0FX4J D0FX4J DRUGCOMP ALTANA Pharma AG D0FX4J DRUGTYPE Small molecular drug D0FX4J DRUGINCH 1S/C19H22N4O2S/c1-13-18-14(12-26-13)19(25)20-15-5-3-4-6-16(15)23(18)17(24)11-22-9-7-21(2)8-10-22/h3-6,12H,7-11H2,1-2H3,(H,20,25) D0FX4J DRUGINKE VSWPGAIWKHPTKX-UHFFFAOYSA-N D0FX4J DRUGSMIL CC1=C2C(=CS1)C(=O)NC3=CC=CC=C3N2C(=O)CN4CCN(CC4)C D0FX4J HIGHSTAT Discontinued in Preregistration D0KT8U DRUG__ID D0KT8U D0KT8U DRUGCOMP Santen Pharmaceutical Co Ltd D0KT8U DRUGTYPE Small molecular drug D0KT8U DRUGINCH 1S/C29H32N2O6S/c1-30(14-16-34-21-10-12-25-26(18-21)37-19-36-25)13-6-15-35-24-11-9-20(33-3)17-22(24)28-29(32)31(2)23-7-4-5-8-27(23)38-28/h4-5,7-12,17-18,28H,6,13-16,19H2,1-3H3/t28-/m1/s1 D0KT8U DRUGINKE RKXVEXUAWGRFNP-MUUNZHRXSA-N D0KT8U DRUGSMIL CN1C2=CC=CC=C2SC(C1=O)C3=C(C=CC(=C3)OC)OCCCN(C)CCOC4=CC5=C(C=C4)OCO5 D0KT8U HIGHSTAT Discontinued in Preregistration D0L0MO DRUG__ID D0L0MO D0L0MO DRUGCOMP Eisai Co Ltd D0L0MO DRUGTYPE Small molecular drug D0L0MO DRUGINCH 1S/C20H19NO4/c1-24-17-8-3-14(4-9-17)20(16(13-21)7-12-19(22)23)15-5-10-18(25-2)11-6-15/h3-6,8-11H,7,12H2,1-2H3,(H,22,23) D0L0MO DRUGINKE GRVCTHTXJDYIHB-UHFFFAOYSA-N D0L0MO DRUGSMIL COC1=CC=C(C=C1)C(=C(CCC(=O)O)C#N)C2=CC=C(C=C2)OC D0L0MO HIGHSTAT Discontinued in Preregistration D0NS0S DRUG__ID D0NS0S D0NS0S DRUGCOMP OmniChem SA D0NS0S DRUGTYPE Small molecular drug D0NS0S DRUGINCH 1S/C18H20N2O2/c1-3-19-11-10-13-12-6-4-5-7-14(12)20-16(18(21)22-2)9-8-15(19)17(13)20/h4-7,9,15H,3,8,10-11H2,1-2H3 D0NS0S DRUGINKE JWOSSISWAJNJIA-UHFFFAOYSA-N D0NS0S DRUGSMIL CCN1CCC2=C3C1CC=C(N3C4=CC=CC=C24)C(=O)OC D0NS0S HIGHSTAT Discontinued in Preregistration D0OO6A DRUG__ID D0OO6A D0OO6A DRUGCOMP Takeda Pharmaceutical Co Ltd D0OO6A DRUGTYPE Small molecular drug D0OO6A DRUGINCH 1S/C18H19NO2/c20-18(21)12-6-2-5-11-17(15-8-3-1-4-9-15)16-10-7-13-19-14-16/h1,3-4,7-11,13-14H,2,5-6,12H2,(H,20,21)/b17-11+ D0OO6A DRUGINKE UWPBQLKEHGGKKD-GZTJUZNOSA-N D0OO6A DRUGSMIL C1=CC=C(C=C1)C(=CCCCCC(=O)O)C2=CN=CC=C2 D0OO6A HIGHSTAT Discontinued in Preregistration D0P0TR DRUG__ID D0P0TR D0P0TR DRUGCOMP Hokuriku Seiyaku KK D0P0TR DRUGTYPE Small molecular drug D0P0TR DRUGINCH 1S/C12H18ClNO2/c1-12(2,3)14-7-11(16)9-5-4-8(15)6-10(9)13/h4-6,11,14-16H,7H2,1-3H3/t11-/m0/s1 D0P0TR DRUGINKE LIXBJWRFCNRAPA-NSHDSACASA-N D0P0TR DRUGSMIL CC(C)(C)NCC(C1=C(C=C(C=C1)O)Cl)O D0P0TR HIGHSTAT Discontinued in Preregistration D0X8DU DRUG__ID D0X8DU D0X8DU DRUGCOMP Teijin Ltd D0X8DU DRUGTYPE Small molecular drug D0X8DU DRUGINCH 1S/C22H36O4/c1-3-4-5-9-18(23)11-12-19-20-14-16(13-17(20)15-21(19)24)8-6-7-10-22(25)26-2/h11-13,17-21,23-24H,3-10,14-15H2,1-2H3/b12-11+/t17-,18-,19+,20-,21+/m0/s1 D0X8DU DRUGINKE QIGRQPVOWVHYBT-KABTVRTISA-N D0X8DU DRUGSMIL CCCCCC(C=CC1C(CC2C1CC(=C2)CCCCC(=O)OC)O)O D0X8DU HIGHSTAT Discontinued in Preregistration D0Y0GG DRUG__ID D0Y0GG D0Y0GG DRUGCOMP Imperial Chemical Industries Plc D0Y0GG DRUGTYPE Small molecular drug D0Y0GG DRUGINCH 1S/C20H23N3O4/c21-12-16-3-1-2-4-19(16)27-14-18(25)13-22-9-10-23-20(26)11-15-5-7-17(24)8-6-15/h1-8,18,22,24-25H,9-11,13-14H2,(H,23,26) D0Y0GG DRUGINKE YARKMNAWFIMDKV-UHFFFAOYSA-N D0Y0GG DRUGSMIL C1=CC=C(C(=C1)C#N)OCC(CNCCNC(=O)CC2=CC=C(C=C2)O)O D0Y0GG HIGHSTAT Discontinued in Preregistration D0Y0ZQ DRUG__ID D0Y0ZQ D0Y0ZQ DRUGCOMP Daiichi Seiyaku Co Ltd D0Y0ZQ DRUGTYPE Small molecular drug D0Y0ZQ DRUGINCH 1S/C20H25N3O4/c1-21-20(25)15-5-4-6-16(12-15)23-13-19(24)22-10-9-14-7-8-17(26-2)18(11-14)27-3/h4-8,11-12,23H,9-10,13H2,1-3H3,(H,21,25)(H,22,24) D0Y0ZQ DRUGINKE JTAGHJPZEDNHHA-UHFFFAOYSA-N D0Y0ZQ DRUGSMIL CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC D0Y0ZQ HIGHSTAT Discontinued in Preregistration D05NBD DRUG__ID D05NBD D05NBD DRUGTYPE Small molecular drug D05NBD DRUGINCH 1S/C17H24N6O4S.4H2O/c1-9-15(25)22-12(7-28-9)16(26)21-11(5-10-6-19-8-20-10)17(27)23-4-2-3-13(23)14(18)24;;;;/h6,8-9,11-13H,2-5,7H2,1H3,(H2,18,24)(H,19,20)(H,21,26)(H,22,25);4*1H2/t9-,11+,12+,13+;;;;/m1..../s1 D05NBD DRUGINKE LYTHVCBIYIODIA-UVZXXTSMSA-N D05NBD DRUGSMIL CC1C(=O)NC(CS1)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N.O.O.O.O D05NBD HIGHSTAT Discontinued in Preregistration D08DKA DRUG__ID D08DKA D08DKA DRUGTYPE Small molecular drug D08DKA DRUGINCH 1S/C16H18N2O3/c1-16(2)15(20)14(18-7-3-4-13(18)19)11-8-10(9-17)5-6-12(11)21-16/h5-6,8,14-15,20H,3-4,7H2,1-2H3/t14-,15+/m1/s1 D08DKA DRUGINKE TVZCRIROJQEVOT-CABCVRRESA-N D08DKA DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N3CCCC3=O)O)C D08DKA HIGHSTAT Discontinued in Preregistration D08LDS DRUG__ID D08LDS D08LDS DRUGTYPE Small molecular drug D08LDS DRUGINCH 1S/C22H25F2N3O2S/c1-26(22-25-20-4-2-3-5-21(20)30-22)15-8-10-27(11-9-15)13-16(28)14-29-17-6-7-18(23)19(24)12-17/h2-7,12,15-16,28H,8-11,13-14H2,1H3/t16-/m0/s1 D08LDS DRUGINKE OZFSWVOEXHGDES-INIZCTEOSA-N D08LDS DRUGSMIL CN(C1CCN(CC1)CC(COC2=CC(=C(C=C2)F)F)O)C3=NC4=CC=CC=C4S3 D08LDS HIGHSTAT Discontinued in Preregistration D0I5UU DRUG__ID D0I5UU D0I5UU DRUGTYPE Small molecular drug D0I5UU DRUGINCH 1S/C19H21FN4/c20-15-7-5-14(6-8-15)13-24-18-4-2-1-3-17(18)23-19(24)22-16-9-11-21-12-10-16/h1-8,16,21H,9-13H2,(H,22,23) D0I5UU DRUGINKE SFOVDSLXFUGAIV-UHFFFAOYSA-N D0I5UU DRUGSMIL C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F D0I5UU HIGHSTAT Discontinued in Preregistration D0QZ4S DRUG__ID D0QZ4S D0QZ4S DRUGTYPE Small molecular drug D0QZ4S DRUGINCH 1S/C19H23N3OS/c1-14(2)12-22(3)18-11-7-4-8-15(18)13-24(23)19-20-16-9-5-6-10-17(16)21-19/h4-11,14H,12-13H2,1-3H3,(H,20,21) D0QZ4S DRUGINKE PSIREIZGKQBEEO-UHFFFAOYSA-N D0QZ4S DRUGSMIL CC(C)CN(C)C1=CC=CC=C1CS(=O)C2=NC3=CC=CC=C3N2 D0QZ4S HIGHSTAT Discontinued in Preregistration D0TR0Z DRUG__ID D0TR0Z D0TR0Z DRUGTYPE Small molecular drug D0TR0Z DRUGINCH 1S/C16H21NO5S/c1-3-21-16(19)10-14(18)17-8-9-23-15(17)11-22-13-7-5-4-6-12(13)20-2/h4-7,15H,3,8-11H2,1-2H3 D0TR0Z DRUGINKE WSYVIAQNTFPTBI-UHFFFAOYSA-N D0TR0Z DRUGSMIL CCOC(=O)CC(=O)N1CCSC1COC2=CC=CC=C2OC D0TR0Z HIGHSTAT Discontinued in Preregistration D0U2CT DRUG__ID D0U2CT D0U2CT DRUGTYPE Small molecular drug D0U2CT DRUGINCH 1S/C28H19FN4O8/c1-2-39-16-32-15-21(29)25(35)33(28(32)38)24(34)18-9-6-10-19(13-18)27(37)41-23-20(14-30)11-12-22(31-23)40-26(36)17-7-4-3-5-8-17/h3-13,15H,2,16H2,1H3 D0U2CT DRUGINKE WTSKMKRYHATLLL-UHFFFAOYSA-N D0U2CT DRUGSMIL CCOCN1C=C(C(=O)N(C1=O)C(=O)C2=CC(=CC=C2)C(=O)OC3=C(C=CC(=N3)OC(=O)C4=CC=CC=C4)C#N)F D0U2CT HIGHSTAT Discontinued in Preregistration D00CIT DRUG__ID D00CIT D00CIT DRUGCOMP Teijin Ltd D00CIT DRUGTYPE Monoclonal antibody D00CIT HIGHSTAT Discontinued in Preregistration D0K1ZD DRUG__ID D0K1ZD D0K1ZD DRUGCOMP XOMA Ltd D0K1ZD DRUGTYPE Monoclonal antibody D0K1ZD HIGHSTAT Discontinued in Preregistration D00FCW DRUG__ID D00FCW D00FCW DRUGCOMP King Pharmaceuticals R&D Inc D00FCW HIGHSTAT Discontinued in Preregistration D01KKB DRUG__ID D01KKB D01KKB DRUGCOMP Penwest Pharmaceuticals D01KKB HIGHSTAT Discontinued in Preregistration D01LPK DRUG__ID D01LPK D01LPK DRUGCOMP Victory Pharma Inc D01LPK HIGHSTAT Discontinued in Preregistration D03UFM DRUG__ID D03UFM D03UFM DRUGCOMP Wyeth D03UFM HIGHSTAT Discontinued in Preregistration D04DAL DRUG__ID D04DAL D04DAL DRUGCOMP Almirall Prodesfarma SA D04DAL HIGHSTAT Discontinued in Preregistration D06HPA DRUG__ID D06HPA D06HPA DRUGCOMP Telios Pharmaceuticals Inc D06HPA HIGHSTAT Discontinued in Preregistration D06IVN DRUG__ID D06IVN D06IVN DRUGCOMP Protherics plc D06IVN HIGHSTAT Discontinued in Preregistration D08OAS DRUG__ID D08OAS D08OAS DRUGCOMP Robert-Koch-Instituts D08OAS HIGHSTAT Discontinued in Preregistration D0D4DY DRUG__ID D0D4DY D0D4DY DRUGCOMP Wyeth D0D4DY HIGHSTAT Discontinued in Preregistration D0F1JB DRUG__ID D0F1JB D0F1JB DRUGCOMP GlaxoSmithKline plc D0F1JB HIGHSTAT Discontinued in Preregistration D0G9SD DRUG__ID D0G9SD D0G9SD DRUGCOMP Efamol D0G9SD HIGHSTAT Discontinued in Preregistration D0I8LS DRUG__ID D0I8LS D0I8LS DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0I8LS HIGHSTAT Discontinued in Preregistration D0R6IF DRUG__ID D0R6IF D0R6IF DRUGCOMP Scotia Pharmaceuticals D0R6IF HIGHSTAT Discontinued in Preregistration D00RSK DRUG__ID D00RSK D00RSK DRUGCOMP GlaxoSmithKline D00RSK THERCLAS Analgesics D00RSK DRUGTYPE Small molecular drug D00RSK DRUGINCH 1S/C21H19N3O3S/c1-3-27-17-10-6-16(7-11-17)21-20(19-5-4-14-22-24(19)23-21)15-8-12-18(13-9-15)28(2,25)26/h4-14H,3H2,1-2H3 D00RSK DRUGINKE NXMZBNYLCVTRGB-UHFFFAOYSA-N D00RSK DRUGSMIL CCOC1=CC=C(C=C1)C2=NN3C(=C2C4=CC=C(C=C4)S(=O)(=O)C)C=CC=N3 D00RSK HIGHSTAT Discontinued in Phase 3 D01EUF DRUG__ID D01EUF D01EUF DRUGCOMP Bristol Myers Squibb; Celltech Group D01EUF THERCLAS Anticancer Agents D01EUF DRUGTYPE Small molecular drug D01EUF DRUGINCH 1S/C23H41N5O5S/c1-13(2)12-14(17(29)26-19(31)16(24-8)22(3,4)5)25-18(30)15(34)10-11-28-20(32)23(6,7)27(9)21(28)33/h13-16,24,34H,10-12H2,1-9H3,(H,25,30)(H,26,29,31)/t14-,15-,16+/m0/s1 D01EUF DRUGINKE BWLOJMZLTBBDHA-HRCADAONSA-N D01EUF DRUGSMIL CC(C)CC(C(=O)NC(=O)C(C(C)(C)C)NC)NC(=O)C(CCN1C(=O)C(N(C1=O)C)(C)C)S D01EUF HIGHSTAT Discontinued in Phase 3 D06DCL DRUG__ID D06DCL D06DCL DRUGCOMP Eli Lilly D06DCL THERCLAS Anticancer Agents D06DCL DRUGTYPE Small molecular drug D06DCL DRUGINCH 1S/C32H31F2N3O2.3ClH/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27;;;/h1-14,21,29-31,38H,15-20H2;3*1H/t21-,29-,30+,31?;;;/m1.../s1 D06DCL DRUGINKE ZPFVQKPWGDRLHL-ZLYBXYBFSA-N D06DCL DRUGSMIL C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C4C5=CC=CC=C5C6C(C6(F)F)C7=CC=CC=C47.Cl.Cl.Cl D06DCL HIGHSTAT Discontinued in Phase 3 D08YYY DRUG__ID D08YYY D08YYY DRUGCOMP Dov Pharmaceutical D08YYY THERCLAS Psychiatric D08YYY DRUGTYPE Small molecular drug D08YYY DRUGINCH 1S/C17H11N5O/c23-16(14-3-1-2-7-19-14)13-11-21-22-15(6-10-20-17(13)22)12-4-8-18-9-5-12/h1-11H D08YYY DRUGINKE OQJFBUOFGHPMSR-UHFFFAOYSA-N D08YYY DRUGSMIL C1=CC=NC(=C1)C(=O)C2=C3N=CC=C(N3N=C2)C4=CC=NC=C4 D08YYY HIGHSTAT Discontinued in Phase 3 D0P4BQ DRUG__ID D0P4BQ D0P4BQ DRUGCOMP Eli Lilly D0P4BQ THERCLAS Psychiatric D0P4BQ DRUGTYPE Small molecular drug D0P4BQ DRUGINCH 1S/C11H16N2O5/c1-4(12)8(14)13-11(10(17)18)3-2-5-6(7(5)11)9(15)16/h4-7H,2-3,12H2,1H3,(H,13,14)(H,15,16)(H,17,18)/t4-,5-,6-,7-,11-/m0/s1 D0P4BQ DRUGINKE UPSXYNJDCKOCFD-QIMCWZKGSA-N D0P4BQ DRUGSMIL CC(C(=O)NC1(CCC2C1C2C(=O)O)C(=O)O)N D0P4BQ HIGHSTAT Discontinued in Phase 3 D0Q1CD DRUG__ID D0Q1CD D0Q1CD DRUGCOMP Bayer D0Q1CD THERCLAS Anticancer Agents D0Q1CD DRUGTYPE Small molecular drug D0Q1CD DRUGINCH 1S/C23H19ClO3S/c24-20-12-10-17(11-13-20)16-6-8-18(9-7-16)22(25)14-19(23(26)27)15-28-21-4-2-1-3-5-21/h1-13,19H,14-15H2,(H,26,27)/t19-/m1/s1 D0Q1CD DRUGINKE JXAGDPXECXQWBC-LJQANCHMSA-N D0Q1CD DRUGSMIL C1=CC=C(C=C1)SCC(CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)Cl)C(=O)O D0Q1CD HIGHSTAT Discontinued in Phase 3 D00DQX DRUG__ID D00DQX D00DQX DRUGCOMP Amgen D00DQX DRUGTYPE Small molecular drug D00DQX DRUGINCH 1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28) D00DQX DRUGINKE RAHBGWKEPAQNFF-UHFFFAOYSA-N D00DQX DRUGSMIL CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C D00DQX HIGHSTAT Discontinued in Phase 3 D00KEF DRUG__ID D00KEF D00KEF DRUGCOMP Organon BioSciences D00KEF DRUGTYPE Small molecular drug D00KEF DRUGINCH 1S/C40H55N9O11S/c1-61(59,60)19-17-28(42)35(52)45-30(15-16-34(50)51)37(54)48-32(22-27-23-43-24-44-27)39(56)47-31(20-25-10-4-2-5-11-25)38(55)46-29(14-8-9-18-41)36(53)49-33(40(57)58)21-26-12-6-3-7-13-26/h2-7,10-13,23-24,28-33H,8-9,14-22,41-42H2,1H3,(H,43,44)(H,45,52)(H,46,55)(H,47,56)(H,48,54)(H,49,53)(H,50,51)(H,57,58)/t28-,29+,30-,31-,32-,33-/m0/s1 D00KEF DRUGINKE QUCFVNGGGFLOES-ACQYNFKHSA-N D00KEF DRUGSMIL CS(=O)(=O)CCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=CC=C3)C(=O)O)N D00KEF HIGHSTAT Discontinued in Phase 3 D00LVA DRUG__ID D00LVA D00LVA DRUGCOMP Sanofi-Aventis D00LVA DRUGTYPE Small molecular drug D00LVA DRUGINCH 1S/C13H16N2O/c1-2-11-10(14-5-1)8-13-4-7-15(9-13)6-3-12(13)16-11/h1-2,5,12H,3-4,6-9H2/t12-,13+/m0/s1 D00LVA DRUGINKE SUPRUPHAEXPGPF-QWHCGFSZSA-N D00LVA DRUGSMIL C1CN2CCC3(C2)C1OC4=C(C3)N=CC=C4 D00LVA HIGHSTAT Discontinued in Phase 3 D00LWS DRUG__ID D00LWS D00LWS DRUGCOMP Ono Pharmaceutical Co Ltd D00LWS DRUGTYPE Small molecular drug D00LWS DRUGINCH 1S/C21H32O4/c22-19(15-6-2-3-7-15)10-9-17-18-12-14(5-1-4-8-21(24)25)11-16(18)13-20(17)23/h5,9-10,15-20,22-23H,1-4,6-8,11-13H2,(H,24,25)/b10-9+,14-5+/t16-,17+,18-,19+,20+/m0/s1 D00LWS DRUGINKE DKLGLHQHLFISGJ-YLBFUXKPSA-N D00LWS DRUGSMIL C1CCC(C1)C(C=CC2C(CC3C2CC(=CCCCC(=O)O)C3)O)O D00LWS HIGHSTAT Discontinued in Phase 3 D00NGN DRUG__ID D00NGN D00NGN DRUGCOMP Janssen Pharmaceutica NV D00NGN DRUGTYPE Small molecular drug D00NGN DRUGINCH 1S/C22H26FN3O2S/c1-25(22-24-20-4-2-3-5-21(20)29-22)17-10-12-26(13-11-17)14-18(27)15-28-19-8-6-16(23)7-9-19/h2-9,17-18,27H,10-15H2,1H3 D00NGN DRUGINKE IGMKTIJBFUMVIN-UHFFFAOYSA-N D00NGN DRUGSMIL CN(C1CCN(CC1)CC(COC2=CC=C(C=C2)F)O)C3=NC4=CC=CC=C4S3 D00NGN HIGHSTAT Discontinued in Phase 3 D00QFY DRUG__ID D00QFY D00QFY DRUGCOMP Astellas D00QFY DRUGTYPE Small molecular drug D00QFY DRUGINCH 1S/C24H30O5.Na/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28;/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28);/q;+1/p-1/b13-12+; D00QFY DRUGINKE YTCZZXIRLARSET-UEIGIMKUSA-M D00QFY DRUGSMIL CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)[O-])O)O.[Na+] D00QFY HIGHSTAT Discontinued in Phase 3 D00YSJ DRUG__ID D00YSJ D00YSJ DRUGCOMP CV Therapeutics D00YSJ DRUGTYPE Small molecular drug D00YSJ DRUGINCH 1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1 D00YSJ DRUGINKE OESBDSFYJMDRJY-BAYCTPFLSA-N D00YSJ DRUGSMIL C1COCC1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D00YSJ HIGHSTAT Discontinued in Phase 3 D01BPF DRUG__ID D01BPF D01BPF DRUGCOMP Bristol-Myers Squibb Co D01BPF DRUGTYPE Small molecular drug D01BPF DRUGINCH 1S/C22H30N6O3S/c1-23-32(29,30)15-17-5-6-20-19(12-17)18(13-25-20)4-3-7-27-8-10-28(11-9-27)22-21(31-2)14-24-16-26-22/h5-6,12-14,16,23,25H,3-4,7-11,15H2,1-2H3 D01BPF DRUGINKE WRZVGHXUPBWIOO-UHFFFAOYSA-N D01BPF DRUGSMIL CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC D01BPF HIGHSTAT Discontinued in Phase 3 D01DAW DRUG__ID D01DAW D01DAW DRUGCOMP Solvay D01DAW DRUGTYPE Small molecular drug D01DAW DRUGINCH 1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28) D01DAW DRUGINKE CYGODHVAJQTCBG-UHFFFAOYSA-N D01DAW DRUGSMIL C1CN(CCN1CC2=CC(=CC=C2)C3=CC=CC=C3)C4=CC=CC5=C4OC(=O)N5 D01DAW HIGHSTAT Discontinued in Phase 3 D01TVR DRUG__ID D01TVR D01TVR DRUGCOMP Spherix D01TVR DRUGTYPE Small molecular drug D01TVR DRUGINCH 1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4+,5+,6?/m1/s1 D01TVR DRUGINKE LKDRXBCSQODPBY-OEXCPVAWSA-N D01TVR DRUGSMIL C1C(C(C(C(O1)(CO)O)O)O)O D01TVR HIGHSTAT Discontinued in Phase 3 D01YDF DRUG__ID D01YDF D01YDF DRUGCOMP Ikeda Mohando Co Ltd D01YDF DRUGTYPE Small molecular drug D01YDF DRUGINCH 1S/C19H24N4O3/c20-16-17(19(25)18(16)24)22-7-2-5-11-26-15-12-14(6-8-21-15)13-23-9-3-1-4-10-23/h2,5-6,8,12,22H,1,3-4,7,9-11,13,20H2/b5-2- D01YDF DRUGINKE XMDYZASWLGWIPL-DJWKRKHSSA-N D01YDF DRUGSMIL C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC3=C(C(=O)C3=O)N D01YDF HIGHSTAT Discontinued in Phase 3 D01YOC DRUG__ID D01YOC D01YOC DRUGCOMP Bristol-Myers Squibb Co; Skybridge Pharmaceuticals Inc D01YOC DRUGTYPE Small molecular drug D01YOC DRUGINCH 1S/C18H22F2N4O/c19-15-5-3-14(4-6-15)17(25)2-1-7-23-8-10-24(11-9-23)18-21-12-16(20)13-22-18/h3-6,12-13,17,25H,1-2,7-11H2 D01YOC DRUGINKE ZXUYYZPJUGQHLQ-UHFFFAOYSA-N D01YOC DRUGSMIL C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F D01YOC HIGHSTAT Discontinued in Phase 3 D02EMR DRUG__ID D02EMR D02EMR DRUGCOMP GlaxoSmithKline D02EMR DRUGTYPE Small molecular drug D02EMR DRUGINCH 1S/C20H25NO4/c1-24-17-7-6-15(12-18(17)25-16-4-2-3-5-16)20(13-21)10-8-14(9-11-20)19(22)23/h6-7,12,14,16H,2-5,8-11H2,1H3,(H,22,23) D02EMR DRUGINKE CFBUZOUXXHZCFB-UHFFFAOYSA-N D02EMR DRUGSMIL COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3 D02EMR HIGHSTAT Discontinued in Phase 3 D02FXU DRUG__ID D02FXU D02FXU DRUGCOMP Takeda Chemical Industries D02FXU DRUGTYPE Small molecular drug D02FXU DRUGINCH 1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-10,16,21,27,30H,11-15,17-19H2,1-5H3,(H,39,40)/t27-,30-/m1/s1 D02FXU DRUGINKE CMLUGNQVANVZHY-POURPWNDSA-N D02FXU DRUGSMIL CC(=O)OCC(C)(C)CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)N3CCC(CC3)CC(=O)O)C4=C(C(=CC=C4)OC)OC D02FXU HIGHSTAT Discontinued in Phase 3 D02HVW DRUG__ID D02HVW D02HVW DRUGCOMP AstraZeneca D02HVW DRUGTYPE Small molecular drug D02HVW DRUGINCH 1S/C19H16N6O4S/c1-12-10-21-17(19(23-12)28-2)25-30(26,27)15-4-3-9-20-16(15)13-5-7-14(8-6-13)18-24-22-11-29-18/h3-11H,1-2H3,(H,21,25) D02HVW DRUGINKE FJHHZXWJVIEFGJ-UHFFFAOYSA-N D02HVW DRUGSMIL CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4 D02HVW HIGHSTAT Discontinued in Phase 3 D02THB DRUG__ID D02THB D02THB DRUGCOMP SmithKline Beecham plc D02THB DRUGTYPE Small molecular drug D02THB DRUGINCH 1S/C21H22N2O2/c1-4-8-18(24)16-13-22-21-15(10-7-12-19(21)25-3)20(16)23-17-11-6-5-9-14(17)2/h5-7,9-13H,4,8H2,1-3H3,(H,22,23) D02THB DRUGINKE MAVJDLHBPIXVJL-UHFFFAOYSA-N D02THB DRUGSMIL CCCC(=O)C1=CN=C2C(=C1NC3=CC=CC=C3C)C=CC=C2OC D02THB HIGHSTAT Discontinued in Phase 3 D02VFB DRUG__ID D02VFB D02VFB DRUGCOMP Taiho Pharmaceutical Co Ltd D02VFB DRUGTYPE Small molecular drug D02VFB DRUGINCH 1S/C29H35NO2/c1-6-28(23-9-7-22(8-10-23)21(2)3)29(24-11-15-26(31)16-12-24)25-13-17-27(18-14-25)32-20-19-30(4)5/h7-18,21,31H,6,19-20H2,1-5H3/b29-28- D02VFB DRUGINKE FVVPWVFWOOMXEZ-ZIADKAODSA-N D02VFB DRUGSMIL CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCCN(C)C)C3=CC=C(C=C3)C(C)C D02VFB HIGHSTAT Discontinued in Phase 3 D02VZP DRUG__ID D02VZP D02VZP DRUGCOMP Solvay Pharmaceuticals BV D02VZP DRUGTYPE Small molecular drug D02VZP DRUGINCH 1S/C22H26FN3O4/c23-17-6-4-16(5-7-17)22(28)24-8-9-25-10-12-26(13-11-25)19-2-1-3-20-21(19)29-15-18(14-27)30-20/h1-7,18,27H,8-15H2,(H,24,28)/t18-/m0/s1 D02VZP DRUGINKE NYSDRDDQELAVKP-SFHVURJKSA-N D02VZP DRUGSMIL C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=C4C(=CC=C3)OC(CO4)CO D02VZP HIGHSTAT Discontinued in Phase 3 D02WGY DRUG__ID D02WGY D02WGY DRUGCOMP Karo Bio D02WGY DRUGTYPE Small molecular drug D02WGY DRUGINCH 1S/C18H17Br2NO5/c1-9(2)12-7-11(3-4-15(12)22)26-18-13(19)5-10(6-14(18)20)21-16(23)8-17(24)25/h3-7,9,22H,8H2,1-2H3,(H,21,23)(H,24,25) D02WGY DRUGINKE VPCSYAVXDAUHLT-UHFFFAOYSA-N D02WGY DRUGSMIL CC(C)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Br)NC(=O)CC(=O)O)Br)O D02WGY HIGHSTAT Discontinued in Phase 3 D03GYK DRUG__ID D03GYK D03GYK DRUGCOMP Merck D03GYK DRUGTYPE Small molecular drug D03GYK DRUGINCH 1S/C21H19ClFNO4S.C6H5NO2/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12;8-6(9)5-2-1-3-7-4-5/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26);1-4H,(H,8,9)/t13-;/m1./s1 D03GYK DRUGINKE ZZRFQBQNZLFESZ-BTQNPOSSSA-N D03GYK DRUGSMIL CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F.C1=CC(=CN=C1)C(=O)O D03GYK HIGHSTAT Discontinued in Phase 3 D03HVN DRUG__ID D03HVN D03HVN DRUGCOMP Phytopharm plc D03HVN DRUGTYPE Small molecular drug D03HVN DRUGINCH 1S/C14H21NO3.ClH/c1-3-15(4-2)8-9-16-12-6-5-7-13-14(12)18-11-10-17-13;/h5-7H,3-4,8-11H2,1-2H3;1H D03HVN DRUGINKE ACLBTXLOASZGRX-UHFFFAOYSA-N D03HVN DRUGSMIL CCN(CC)CCOC1=CC=CC2=C1OCCO2.Cl D03HVN HIGHSTAT Discontinued in Phase 3 D03LQQ DRUG__ID D03LQQ D03LQQ DRUGCOMP Boehringer Ingelheim Corp D03LQQ DRUGTYPE Small molecular drug D03LQQ DRUGINCH 1S/C12H13Cl2N3/c1-2-8-17(12-15-6-7-16-12)11-9(13)4-3-5-10(11)14/h2-5H,1,6-8H2,(H,15,16) D03LQQ DRUGINKE OXTYVEUAQHPPMV-UHFFFAOYSA-N D03LQQ DRUGSMIL C=CCN(C1=C(C=CC=C1Cl)Cl)C2=NCCN2 D03LQQ HIGHSTAT Discontinued in Phase 3 D04BQR DRUG__ID D04BQR D04BQR DRUGCOMP King Pharmaceuticals R&D Inc D04BQR DRUGTYPE Small molecular drug D04BQR DRUGINCH 1S/C15H23N3O2/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19) D04BQR DRUGINKE KEECCEWTUVWFCV-UHFFFAOYSA-N D04BQR DRUGSMIL CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C D04BQR HIGHSTAT Discontinued in Phase 3 D04DZD DRUG__ID D04DZD D04DZD DRUGCOMP GD Searle & Co D04DZD DRUGTYPE Small molecular drug D04DZD DRUGINCH 1S/C22H34ClN3O2/c1-17(2)26(18(3)27)16-12-22(21(24)28,19-9-5-6-10-20(19)23)11-15-25-13-7-4-8-14-25/h5-6,9-10,17H,4,7-8,11-16H2,1-3H3,(H2,24,28) D04DZD DRUGINKE GTEPPJFJSNSNIH-UHFFFAOYSA-N D04DZD DRUGSMIL CC(C)N(CCC(CCN1CCCCC1)(C2=CC=CC=C2Cl)C(=O)N)C(=O)C D04DZD HIGHSTAT Discontinued in Phase 3 D04KKE DRUG__ID D04KKE D04KKE DRUGCOMP Medimmune Oncology Inc D04KKE DRUGTYPE Small molecular drug D04KKE DRUGINCH 1S/C16H20N4O6/c1-3-25-15(23)17-9-11(19-5-6-19)14(22)10(18-16(24)26-4-2)12(13(9)21)20-7-8-20/h3-8H2,1-2H3,(H,17,23)(H,18,24) D04KKE DRUGINKE WVYXNIXAMZOZFK-UHFFFAOYSA-N D04KKE DRUGSMIL CCOC(=O)NC1=C(C(=O)C(=C(C1=O)N2CC2)NC(=O)OCC)N3CC3 D04KKE HIGHSTAT Discontinued in Phase 3 D04SPK DRUG__ID D04SPK D04SPK DRUGCOMP Takeda Pharma D04SPK DRUGTYPE Small molecular drug D04SPK DRUGINCH 1S/C22H26O4/c1-14-15(2)22(26)20(16(3)21(14)25)18(17-10-6-4-7-11-17)12-8-5-9-13-19(23)24/h4,6-7,10-11,18H,5,8-9,12-13H2,1-3H3,(H,23,24) D04SPK DRUGINKE ZBVKEHDGYSLCCC-UHFFFAOYSA-N D04SPK DRUGSMIL CC1=C(C(=O)C(=C(C1=O)C)C(CCCCCC(=O)O)C2=CC=CC=C2)C D04SPK HIGHSTAT Discontinued in Phase 3 D05WEP DRUG__ID D05WEP D05WEP DRUGCOMP Sanofi-Synthelabo D05WEP DRUGTYPE Small molecular drug D05WEP DRUGINCH 1S/C15H18F3NO5/c1-22-9-12-8-19(14(21)24-12)10-2-4-11(5-3-10)23-7-6-13(20)15(16,17)18/h2-5,12-13,20H,6-9H2,1H3/t12-,13-/m1/s1 D05WEP DRUGINKE IALVDLPLCLFBCF-CHWSQXEVSA-N D05WEP DRUGSMIL COCC1CN(C(=O)O1)C2=CC=C(C=C2)OCCC(C(F)(F)F)O D05WEP HIGHSTAT Discontinued in Phase 3 D05WJQ DRUG__ID D05WJQ D05WJQ DRUGCOMP Sanofi-aventis D05WJQ DRUGTYPE Small molecular drug D05WJQ DRUGINCH 1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1 D05WJQ DRUGINKE PGKXDIMONUAMFR-AREMUKBSSA-N D05WJQ DRUGSMIL CC(=O)NC1(CCN(CC1)CCC(CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4 D05WJQ HIGHSTAT Discontinued in Phase 3 D05YIX DRUG__ID D05YIX D05YIX DRUGCOMP Immunomedics D05YIX DRUGTYPE Small molecular drug D05YIX DRUGINCH 1S/3S.2Sb D05YIX DRUGINKE IHBMMJGTJFPEQY-UHFFFAOYSA-N D05YIX DRUGSMIL S=[Sb]S[Sb]=S D05YIX HIGHSTAT Discontinued in Phase 3 D06SEY DRUG__ID D06SEY D06SEY DRUGCOMP Hebrew University of Jerusalem; NeuroDerm Ltd D06SEY DRUGTYPE Small molecular drug D06SEY DRUGINCH 1S/C11H15NO4/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7/h3-4,6,8,13-14H,2,5,12H2,1H3/t8-/m0/s1 D06SEY DRUGINKE NULMGOSOSZBEQL-QMMMGPOBSA-N D06SEY DRUGSMIL CCOC(=O)C(CC1=CC(=C(C=C1)O)O)N D06SEY HIGHSTAT Discontinued in Phase 3 D06TGE DRUG__ID D06TGE D06TGE DRUGCOMP Merck D06TGE DRUGTYPE Small molecular drug D06TGE DRUGINCH 1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1 D06TGE DRUGINKE QLYKJCMUNUWAGO-GAJHUEQPSA-N D06TGE DRUGSMIL CC(C(CC1=CC=C(C=C1)Cl)C2=CC=CC(=C2)C#N)NC(=O)C(C)(C)OC3=NC=C(C=C3)C(F)(F)F D06TGE HIGHSTAT Discontinued in Phase 3 D06YXD DRUG__ID D06YXD D06YXD DRUGCOMP Grunenthal GmbH D06YXD DRUGTYPE Small molecular drug D06YXD DRUGINCH 1S/C24H30O5/c25-21(16-6-2-1-3-7-16)10-9-19-20-13-18(29-23(20)14-22(19)26)12-15-5-4-8-17(11-15)24(27)28/h4-5,8-12,16,19-23,25-26H,1-3,6-7,13-14H2,(H,27,28)/b10-9+,18-12-/t19-,20-,21-,22-,23+/m1/s1 D06YXD DRUGINKE ZLJOKYGJNOQXDP-OZUBPDBUSA-N D06YXD DRUGSMIL C1CCC(CC1)C(C=CC2C(CC3C2CC(=CC4=CC(=CC=C4)C(=O)O)O3)O)O D06YXD HIGHSTAT Discontinued in Phase 3 D07ESH DRUG__ID D07ESH D07ESH DRUGCOMP Pfizer D07ESH DRUGTYPE Small molecular drug D07ESH DRUGINCH 1S/C18H15N7O/c19-18-22-16-13(11-20-24(16)9-8-12-5-2-1-3-6-12)17-21-15(23-25(17)18)14-7-4-10-26-14/h1-7,10-11H,8-9H2,(H2,19,22) D07ESH DRUGINKE UTLPKQYUXOEJIL-UHFFFAOYSA-N D07ESH DRUGSMIL C1=CC=C(C=C1)CCN2C3=C(C=N2)C4=NC(=NN4C(=N3)N)C5=CC=CO5 D07ESH HIGHSTAT Discontinued in Phase 3 D07OGZ DRUG__ID D07OGZ D07OGZ DRUGCOMP Astellas Pharma D07OGZ DRUGTYPE Small molecular drug D07OGZ DRUGINCH 1S/C27H30N4O4.C4H4O4/c1-30-15-4-16-31(18-17-30)21-11-7-19(8-12-21)27(34)29-25-23(5-3-6-24(25)32)28-26(33)20-9-13-22(35-2)14-10-20;5-3(6)1-2-4(7)8/h3,5-14,32H,4,15-18H2,1-2H3,(H,28,33)(H,29,34);1-2H,(H,5,6)(H,7,8)/b;2-1- D07OGZ DRUGINKE WHMPMUVISXATBH-BTJKTKAUSA-N D07OGZ DRUGSMIL CN1CCCN(CC1)C2=CC=C(C=C2)C(=O)NC3=C(C=CC=C3O)NC(=O)C4=CC=C(C=C4)OC.C(=CC(=O)O)C(=O)O D07OGZ HIGHSTAT Discontinued in Phase 3 D07RPR DRUG__ID D07RPR D07RPR DRUGCOMP Pharmacia & Upjohn Inc D07RPR DRUGTYPE Small molecular drug D07RPR DRUGINCH 1S/C10H8BrN3O/c11-7-8(6-4-2-1-3-5-6)13-10(12)14-9(7)15/h1-5H,(H3,12,13,14,15) D07RPR DRUGINKE CIUUIPMOFZIWIZ-UHFFFAOYSA-N D07RPR DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)NC(=N2)N)Br D07RPR HIGHSTAT Discontinued in Phase 3 D07VZV DRUG__ID D07VZV D07VZV DRUGCOMP Aderis Pharmaceuticals Inc D07VZV DRUGTYPE Small molecular drug D07VZV DRUGINCH 1S/C13H17N5/c1-18-7-16-11-12(14-6-15-13(11)18)17-10-5-8-2-3-9(10)4-8/h6-10H,2-5H2,1H3,(H,14,15,17)/t8-,9+,10-/m1/s1 D07VZV DRUGINKE MTQYIGCUBBMQCJ-KXUCPTDWSA-N D07VZV DRUGSMIL CN1C=NC2=C(N=CN=C21)NC3CC4CCC3C4 D07VZV HIGHSTAT Discontinued in Phase 3 D08FOX DRUG__ID D08FOX D08FOX DRUGCOMP Hoechst Marion Roussel Inc D08FOX DRUGTYPE Small molecular drug D08FOX DRUGINCH 1S/C11H11N3O2/c1-2-8-9(14-11(16)13-8)10(15)7-3-5-12-6-4-7/h3-6H,2H2,1H3,(H2,13,14,16) D08FOX DRUGINKE OQGWJZOWLHWFME-UHFFFAOYSA-N D08FOX DRUGSMIL CCC1=C(NC(=O)N1)C(=O)C2=CC=NC=C2 D08FOX HIGHSTAT Discontinued in Phase 3 D08LIF DRUG__ID D08LIF D08LIF DRUGCOMP Bayer AG D08LIF DRUGTYPE Small molecular drug D08LIF DRUGINCH 1S/C16H25N3O.C4H4O4/c1-3-16(20)19(15-9-5-6-10-17-15)14(2)13-18-11-7-4-8-12-18;5-3(6)1-2-4(7)8/h5-6,9-10,14H,3-4,7-8,11-13H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D08LIF DRUGINKE WQTLOZFMTGYQDX-WLHGVMLRSA-N D08LIF DRUGSMIL CCC(=O)N(C1=CC=CC=N1)C(C)CN2CCCCC2.C(=CC(=O)O)C(=O)O D08LIF HIGHSTAT Discontinued in Phase 3 D08MTG DRUG__ID D08MTG D08MTG DRUGCOMP York Pharma D08MTG DRUGTYPE Small molecular drug D08MTG DRUGINCH 1S/C21H22N4OS/c1-14-8-9-18(15(2)12-14)26-19-7-4-3-6-16(19)17-13-27-21(24-17)25-20-22-10-5-11-23-20/h3-4,6-9,12-13H,5,10-11H2,1-2H3,(H2,22,23,24,25) D08MTG DRUGINKE TYBHXIFFPVFXQW-UHFFFAOYSA-N D08MTG DRUGSMIL CC1=CC(=C(C=C1)OC2=CC=CC=C2C3=CSC(=N3)NC4=NCCCN4)C D08MTG HIGHSTAT Discontinued in Phase 3 D08NLQ DRUG__ID D08NLQ D08NLQ DRUGCOMP Novartis D08NLQ DRUGTYPE Small molecular drug D08NLQ DRUGINCH 1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19) D08NLQ DRUGINKE BMPDWHIDQYTSHX-UHFFFAOYSA-N D08NLQ DRUGSMIL C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O D08NLQ HIGHSTAT Discontinued in Phase 3 D08OJE DRUG__ID D08OJE D08OJE DRUGCOMP Pfizer Inc D08OJE DRUGTYPE Small molecular drug D08OJE DRUGINCH 1S/C20H25NO2/c1-21-13-12-20(16-6-4-3-5-7-16)17(14-21)15-23-19-10-8-18(22-2)9-11-19/h3-11,17,20H,12-15H2,1-2H3/t17-,20-/m1/s1 D08OJE DRUGINKE OJSFTALXCYKKFQ-YLJYHZDGSA-N D08OJE DRUGSMIL CN1CCC(C(C1)COC2=CC=C(C=C2)OC)C3=CC=CC=C3 D08OJE HIGHSTAT Discontinued in Phase 3 D09DIG DRUG__ID D09DIG D09DIG DRUGCOMP Roche Holding AG D09DIG DRUGTYPE Small molecular drug D09DIG DRUGINCH 1S/C28H34O8/c1-4-8-21-23(12-10-20(17(2)29)27(21)31)34-13-6-5-7-14-35-26-16-25-19(15-22(26)18(3)30)9-11-24(36-25)28(32)33/h10,12,15-16,24,31H,4-9,11,13-14H2,1-3H3,(H,32,33) D09DIG DRUGINKE FGGYJWZYDAROFF-UHFFFAOYSA-N D09DIG DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCCOC2=C(C=C3CCC(OC3=C2)C(=O)O)C(=O)C D09DIG HIGHSTAT Discontinued in Phase 3 D09ESW DRUG__ID D09ESW D09ESW DRUGCOMP Knoll GmbH D09ESW DRUGTYPE Small molecular drug D09ESW DRUGINCH 1S/C34H52N2O2/c1-5-6-7-8-9-10-11-12-13-14-23-34(29-35,31-19-16-21-33(28-31)38-4)24-17-25-36(2)26-22-30-18-15-20-32(27-30)37-3/h15-16,18-21,27-28H,5-14,17,22-26H2,1-4H3 D09ESW DRUGINKE PHFDAOXXIZOUIX-UHFFFAOYSA-N D09ESW DRUGSMIL CCCCCCCCCCCCC(CCCN(C)CCC1=CC(=CC=C1)OC)(C#N)C2=CC(=CC=C2)OC D09ESW HIGHSTAT Discontinued in Phase 3 D09GGJ DRUG__ID D09GGJ D09GGJ DRUGCOMP CV Therapeutics D09GGJ DRUGTYPE Small molecular drug D09GGJ DRUGINCH 1S/C18H24N4O3/c1-3-5-21-16-12(17(23)22(6-4-2)18(21)24)19-15(20-16)11-8-9-7-10(11)14-13(9)25-14/h9-11,13-14H,3-8H2,1-2H3,(H,19,20)/t9-,10+,11+,13-,14+/m1/s1 D09GGJ DRUGINKE OQCJPFYWFGUHIN-GJKBLCTNSA-N D09GGJ DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CC4CC3C5C4O5 D09GGJ HIGHSTAT Discontinued in Phase 3 D09SIR DRUG__ID D09SIR D09SIR DRUGCOMP Threshold Pharma D09SIR DRUGTYPE Small molecular drug D09SIR DRUGINCH 1S/C15H10Cl2N2O2/c16-10-6-5-9(12(17)7-10)8-19-13-4-2-1-3-11(13)14(18-19)15(20)21/h1-7H,8H2,(H,20,21) D09SIR DRUGINKE WDRYRZXSPDWGEB-UHFFFAOYSA-N D09SIR DRUGSMIL C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O D09SIR HIGHSTAT Discontinued in Phase 3 D09TGX DRUG__ID D09TGX D09TGX DRUGCOMP Novartis D09TGX DRUGTYPE Small molecular drug D09TGX DRUGINCH 1S/C63H111N11O12/c1-26-27-28-41(16)53(76)52-57(80)67-49(38(10)11)61(84)68(19)33-48(75)69(20)44(29-34(2)3)56(79)66-50(39(12)13)62(85)70(21)45(30-35(4)5)55(78)64-42(17)54(77)65-43(18)58(81)71(22)46(31-36(6)7)59(82)72(23)47(32-37(8)9)60(83)73(24)51(40(14)15)63(86)74(52)25/h26-27,34-47,49-52H,28-33H2,1-25H3,(H,64,78)(H,65,77)(H,66,79)(H,67,80)/b27-26+/t41-,42+,43-,44+,45+,46+,47+,49+,50+,51+,52+/m1/s1 D09TGX DRUGINKE YJDYDFNKCBANTM-QCWCSKBGSA-N D09TGX DRUGSMIL CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C D09TGX HIGHSTAT Discontinued in Phase 3 D09YTY DRUG__ID D09YTY D09YTY DRUGCOMP Toyama Chemical Co Ltd D09YTY DRUGTYPE Small molecular drug D09YTY DRUGINCH 1S/C19H28N4O5S2/c1-20-11-16-7-8-17(28-16)13-29-10-9-21-19(23-30(2,26)27)22-12-18(25)14-3-5-15(24)6-4-14/h3-8,18,20,24-25H,9-13H2,1-2H3,(H2,21,22,23) D09YTY DRUGINKE GZPOYVTZKHVRHE-UHFFFAOYSA-N D09YTY DRUGSMIL CNCC1=CC=C(O1)CSCCNC(=NCC(C2=CC=C(C=C2)O)O)NS(=O)(=O)C D09YTY HIGHSTAT Discontinued in Phase 3 D0A2IH DRUG__ID D0A2IH D0A2IH DRUGCOMP Kyorin Pharmaceutical Co Ltd D0A2IH DRUGTYPE Small molecular drug D0A2IH DRUGINCH 1S/C18H29N3O2/c1-2-19-18(22)20-10-7-13-23-17-9-6-8-16(14-17)15-21-11-4-3-5-12-21/h6,8-9,14H,2-5,7,10-13,15H2,1H3,(H2,19,20,22) D0A2IH DRUGINKE SVCQBXMFONNZHX-UHFFFAOYSA-N D0A2IH DRUGSMIL CCNC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2 D0A2IH HIGHSTAT Discontinued in Phase 3 D0AM8W DRUG__ID D0AM8W D0AM8W DRUGCOMP Takeda Pharmaceutical Co Ltd D0AM8W DRUGTYPE Small molecular drug D0AM8W DRUGINCH 1S/C25H32N2O/c28-25(23-11-10-22-8-4-5-15-26-24(22)18-23)12-9-20-13-16-27(17-14-20)19-21-6-2-1-3-7-21/h1-3,6-7,10-11,18,20,26H,4-5,8-9,12-17,19H2 D0AM8W DRUGINKE PMBLXLOXUGVTGB-UHFFFAOYSA-N D0AM8W DRUGSMIL C1CCNC2=C(C1)C=CC(=C2)C(=O)CCC3CCN(CC3)CC4=CC=CC=C4 D0AM8W HIGHSTAT Discontinued in Phase 3 D0B1WU DRUG__ID D0B1WU D0B1WU DRUGCOMP CepTor D0B1WU DRUGTYPE Small molecular drug D0B1WU DRUGINCH 1S/2C8H16O2.Co/c2*1-3-5-6-7(4-2)8(9)10;/h2*7H,3-6H2,1-2H3,(H,9,10);/q;;+2/p-2 D0B1WU DRUGINKE QAEKNCDIHIGLFI-UHFFFAOYSA-L D0B1WU DRUGSMIL CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Co+2] D0B1WU HIGHSTAT Discontinued in Phase 3 D0B9EN DRUG__ID D0B9EN D0B9EN DRUGCOMP Roche D0B9EN DRUGTYPE Small molecular drug D0B9EN DRUGINCH 1S/C24H23NO5S/c1-15-19(25-23(30-15)16-6-4-3-5-7-16)10-12-29-20-9-8-17(14-21(28-2)24(26)27)22-18(20)11-13-31-22/h3-9,11,13,21H,10,12,14H2,1-2H3,(H,26,27)/t21-/m0/s1 D0B9EN DRUGINKE DAYKLWSKQJBGCS-NRFANRHFSA-N D0B9EN DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=C4C=CSC4=C(C=C3)CC(C(=O)O)OC D0B9EN HIGHSTAT Discontinued in Phase 3 D0B9GM DRUG__ID D0B9GM D0B9GM DRUGCOMP GlaxoSmithKline D0B9GM DRUGTYPE Small molecular drug D0B9GM DRUGINCH 1S/C12H15N3O3/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16) D0B9GM DRUGINKE RAOCRURYZCVHMG-UHFFFAOYSA-N D0B9GM DRUGSMIL CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC D0B9GM HIGHSTAT Discontinued in Phase 3 D0C5PA DRUG__ID D0C5PA D0C5PA DRUGCOMP AstraZeneca D0C5PA DRUGTYPE Small molecular drug D0C5PA DRUGINCH 1S/C22H28N2O5S2/c25-19-8-7-18(21-20(19)24-22(26)30-21)9-11-23-12-16-31(27,28)15-4-13-29-14-10-17-5-2-1-3-6-17/h1-3,5-8,23,25H,4,9-16H2,(H,24,26) D0C5PA DRUGINKE DBCKRBGYGMVSTI-UHFFFAOYSA-N D0C5PA DRUGSMIL C1=CC=C(C=C1)CCOCCCS(=O)(=O)CCNCCC2=C3C(=C(C=C2)O)NC(=O)S3 D0C5PA HIGHSTAT Discontinued in Phase 3 D0C8RH DRUG__ID D0C8RH D0C8RH DRUGCOMP Jouveinal SA D0C8RH DRUGTYPE Small molecular drug D0C8RH DRUGINCH 1S/C12H17Cl2NO/c1-12(8-16,15(2)3)7-9-4-5-10(13)11(14)6-9/h4-6,16H,7-8H2,1-3H3 D0C8RH DRUGINKE FWYRGHMKHZXXQX-UHFFFAOYSA-N D0C8RH DRUGSMIL CC(CC1=CC(=C(C=C1)Cl)Cl)(CO)N(C)C D0C8RH HIGHSTAT Discontinued in Phase 3 D0CY3A DRUG__ID D0CY3A D0CY3A DRUGCOMP Sanofi-Aventis D0CY3A DRUGTYPE Small molecular drug D0CY3A DRUGINCH 1S/C38H64O49S7/c1-64-15-12(9-72-88(43,44)45)76-35(27(68-5)18(15)65-2)80-21-19(66-3)28(69-6)37(82-25(21)32(39)40)79-17-14(11-74-90(49,50)51)77-38(31(87-94(61,62)63)24(17)85-92(55,56)57)81-22-20(67-4)29(70-7)36(83-26(22)33(41)42)78-16-13(10-73-89(46,47)48)75-34(71-8)30(86-93(58,59)60)23(16)84-91(52,53)54/h12-31,34-38H,9-11H2,1-8H3,(H,39,40)(H,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)(H,55,56,57)(H,58,59,60)(H,61,62,63)/t12-,13-,14-,15-,16-,17-,18+,19+,20+,21+,22+,23+,24+,25+,26-,27-,28-,29-,30-,31-,34+,35-,36-,37-,38-/m1/s1 D0CY3A DRUGINKE AJBMORBNKXNZSF-COSHMZDQSA-N D0CY3A DRUGSMIL COC1C(OC(C(C1OC)OC)OC2C(C(C(OC2C(=O)O)OC3C(OC(C(C3OS(=O)(=O)O)OS(=O)(=O)O)OC4C(C(C(OC4C(=O)O)OC5C(OC(C(C5OS(=O)(=O)O)OS(=O)(=O)O)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O D0CY3A HIGHSTAT Discontinued in Phase 3 D0D3PX DRUG__ID D0D3PX D0D3PX DRUGCOMP Schering-Plough D0D3PX DRUGTYPE Small molecular drug D0D3PX DRUGINCH 1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1 D0D3PX DRUGINKE PIMQWRZWLQKKBJ-SFHVURJKSA-N D0D3PX DRUGSMIL CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO D0D3PX HIGHSTAT Discontinued in Phase 3 D0D5ZX DRUG__ID D0D5ZX D0D5ZX DRUGCOMP Rhone-Poulenc SA D0D5ZX DRUGTYPE Small molecular drug D0D5ZX DRUGINCH 1S/C20H25ClN2O2/c21-13-9-15-14-3-1-2-4-18(14)25-19(15)16(10-13)20(24)22-17-11-23-7-5-12(17)6-8-23/h9-10,12,14,17-18H,1-8,11H2,(H,22,24) D0D5ZX DRUGINKE LDYMIBZOCSHLBG-UHFFFAOYSA-N D0D5ZX DRUGSMIL C1CCC2C(C1)C3=C(O2)C(=CC(=C3)Cl)C(=O)NC4CN5CCC4CC5 D0D5ZX HIGHSTAT Discontinued in Phase 3 D0D6ZK DRUG__ID D0D6ZK D0D6ZK DRUGCOMP Alcon Inc D0D6ZK DRUGTYPE Small molecular drug D0D6ZK DRUGINCH 1S/C20H32O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-5,8-11,14,17,19,21H,2-3,6-7,12-13,15-16,18H2,1H3,(H,22,23)/b5-4-,10-8-,11-9-,17-14+/t19-/m0/s1 D0D6ZK DRUGINKE JSFATNQSLKRBCI-VAEKSGALSA-N D0D6ZK DRUGSMIL CCCCCC(C=CC=CCC=CCC=CCCCC(=O)O)O D0D6ZK HIGHSTAT Discontinued in Phase 3 D0E2MJ DRUG__ID D0E2MJ D0E2MJ DRUGCOMP Sanofi-Aventis D0E2MJ DRUGTYPE Small molecular drug D0E2MJ DRUGINCH 1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1 D0E2MJ DRUGINKE PFGVNLZDWRZPJW-OPAMFIHVSA-N D0E2MJ DRUGSMIL CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-] D0E2MJ HIGHSTAT Discontinued in Phase 3 D0E6UA DRUG__ID D0E6UA D0E6UA DRUGCOMP EGIS Gyogyszergyar RT D0E6UA DRUGTYPE Small molecular drug D0E6UA DRUGINCH 1S/C20H31NO/c1-18(2)17-11-12-19(18,3)20(15-17,22-14-13-21(4)5)16-9-7-6-8-10-16/h6-10,17H,11-15H2,1-5H3/t17-,19-,20+/m1/s1 D0E6UA DRUGINKE QOBGWWQAMAPULA-RLLQIKCJSA-N D0E6UA DRUGSMIL CC1(C2CCC1(C(C2)(C3=CC=CC=C3)OCCN(C)C)C)C D0E6UA HIGHSTAT Discontinued in Phase 3 D0E8CZ DRUG__ID D0E8CZ D0E8CZ DRUGCOMP Sanofi-Aventis; Eli Lilly D0E8CZ DRUGTYPE Small molecular drug D0E8CZ DRUGINCH 1S/C22H26ClNO4/c1-2-27-22(26)14-28-20-9-7-15-6-8-19(11-17(15)12-20)24-13-21(25)16-4-3-5-18(23)10-16/h3-5,7,9-10,12,19,21,24-25H,2,6,8,11,13-14H2,1H3/t19-,21-/m0/s1 D0E8CZ DRUGINKE RDJQCOBTKKAQAH-FPOVZHCZSA-N D0E8CZ DRUGSMIL CCOC(=O)COC1=CC2=C(CCC(C2)NCC(C3=CC(=CC=C3)Cl)O)C=C1 D0E8CZ HIGHSTAT Discontinued in Phase 3 D0FQ6O DRUG__ID D0FQ6O D0FQ6O DRUGCOMP Roche Holding AG D0FQ6O DRUGTYPE Small molecular drug D0FQ6O DRUGINCH 1S/C25H32O2S/c1-7-28(26,27)21-11-8-19(9-12-21)16-18(2)20-10-13-22-23(17-20)25(5,6)15-14-24(22,3)4/h8-13,16-17H,7,14-15H2,1-6H3/b18-16+ D0FQ6O DRUGINKE UDAZCXVIYSIEFX-FBMGVBCBSA-N D0FQ6O DRUGSMIL CCS(=O)(=O)C1=CC=C(C=C1)C=C(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C D0FQ6O HIGHSTAT Discontinued in Phase 3 D0G2XN DRUG__ID D0G2XN D0G2XN DRUGCOMP Servier D0G2XN DRUGTYPE Small molecular drug D0G2XN DRUGINCH 1S/C22H28Cl2N2O6.C4H6O6/c1-4-32-22(28)19-16(12-31-11-10-30-9-8-25)26-13(2)17(21(27)29-3)18(19)14-6-5-7-15(23)20(14)24;5-1(3(7)8)2(6)4(9)10/h5-7,18,26H,4,8-12,25H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 D0G2XN DRUGINKE LKFLYCNXQSCXIV-LREBCSMRSA-N D0G2XN DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)COCCOCCN.C(C(C(=O)O)O)(C(=O)O)O D0G2XN HIGHSTAT Discontinued in Phase 3 D0G6SZ DRUG__ID D0G6SZ D0G6SZ DRUGCOMP GlaxoSmithKline D0G6SZ DRUGTYPE Small molecular drug D0G6SZ DRUGINCH 1S/C33H43N3O6/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40)/t28-,29-/m1/s1 D0G6SZ DRUGINKE GWNOTCOIYUNTQP-FQLXRVMXSA-N D0G6SZ DRUGSMIL CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)C(C5CCCCC5)O D0G6SZ HIGHSTAT Discontinued in Phase 3 D0G6ZW DRUG__ID D0G6ZW D0G6ZW DRUGCOMP BioDelivery Sciences International D0G6ZW DRUGTYPE Small molecular drug D0G6ZW DRUGINCH 1S/C34H50O7.2Na/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6;;/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40);;/q;2*+1/p-2/t21-,23-,24-,27+,30+,31-,32-,33+,34+;;/m0../s1 D0G6ZW DRUGINKE BQENDLAVTKRQMS-SBBGFIFASA-L D0G6ZW DRUGSMIL CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)[O-])C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Na+].[Na+] D0G6ZW HIGHSTAT Discontinued in Phase 3 D0GR2J DRUG__ID D0GR2J D0GR2J DRUGCOMP Institute of Cancer Research UK D0GR2J DRUGTYPE Small molecular drug D0GR2J DRUGINCH 1S/C28H30INO/c1-2-27(22-8-4-3-5-9-22)28(23-10-14-25(29)15-11-23)24-12-16-26(17-13-24)31-21-20-30-18-6-7-19-30/h3-5,8-17H,2,6-7,18-21H2,1H3/b28-27- D0GR2J DRUGINKE JJKOTMDDZAJTGQ-DQSJHHFOSA-N D0GR2J DRUGSMIL CCC(=C(C1=CC=C(C=C1)OCCN2CCCC2)C3=CC=C(C=C3)I)C4=CC=CC=C4 D0GR2J HIGHSTAT Discontinued in Phase 3 D0HK7R DRUG__ID D0HK7R D0HK7R DRUGCOMP BTG plc D0HK7R DRUGTYPE Small molecular drug D0HK7R DRUGINCH 1S/C8H15N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h1,5,7,9H,2-4,6H2,(H,11,12)(H2,13,14,15)/b5-1+/t7-/m1/s1 D0HK7R DRUGINKE VZXMZMJSGLFKQI-ABVWVHJUSA-N D0HK7R DRUGSMIL C1CN(CC(N1)C(=O)O)CC=CP(=O)(O)O D0HK7R HIGHSTAT Discontinued in Phase 3 D0J0AE DRUG__ID D0J0AE D0J0AE DRUGCOMP Pfizer D0J0AE DRUGTYPE Small molecular drug D0J0AE DRUGINCH 1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35) D0J0AE DRUGINKE UNAZAADNBYXMIV-UHFFFAOYSA-N D0J0AE DRUGSMIL CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N D0J0AE HIGHSTAT Discontinued in Phase 3 D0J0RV DRUG__ID D0J0RV D0J0RV DRUGCOMP Sanofi-Aventis D0J0RV DRUGTYPE Small molecular drug D0J0RV DRUGINCH 1S/C45H53NO14/c1-23-29(57-39(52)33(49)32(26-15-11-9-12-16-26)46-40(53)60-41(4,5)6)21-45(54)37(58-38(51)27-17-13-10-14-18-27)35-43(36(50)34(56-24(2)47)31(23)42(45,7)8)20-28(43)19-30-44(35,22-55-30)59-25(3)48/h9-18,28-30,32-35,37,49,54H,19-22H2,1-8H3,(H,46,53)/t28-,29+,30-,32+,33-,34-,35+,37+,43-,44+,45-/m1/s1 D0J0RV DRUGINKE DXOJIXGRFSHVKA-BZVZGCBYSA-N D0J0RV DRUGSMIL CC1=C2C(C(=O)C34CC3CC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=CC=CC=C6)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)OC(=O)C D0J0RV HIGHSTAT Discontinued in Phase 3 D0J6TN DRUG__ID D0J6TN D0J6TN DRUGCOMP LEO Pharma A/S D0J6TN DRUGTYPE Small molecular drug D0J6TN DRUGINCH 1S/C22H29N3O6S.C8H10BrNO3S/c1-21(2,3)20(29)31-11-30-19(28)15-22(4,5)32-18-14(17(27)25(15)18)24-16(26)13(23)12-9-7-6-8-10-12;1-8(2)4(7(12)13)10-5(11)3(9)6(10)14-8/h6-10,13-15,18H,11,23H2,1-5H3,(H,24,26);3-4,6H,1-2H3,(H,12,13)/t13-,14+,15-,18+;3-,4+,6-/m01/s1 D0J6TN DRUGINKE NSZOIZOWOWUYKG-VKICDOHCSA-N D0J6TN DRUGSMIL CC1(C(N2C(S1)C(C2=O)Br)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)[NH3+])C(=O)OCOC(=O)C(C)(C)C)C D0J6TN HIGHSTAT Discontinued in Phase 3 D0J8RM DRUG__ID D0J8RM D0J8RM DRUGCOMP Gedeon Richter Ltd D0J8RM DRUGTYPE Small molecular drug D0J8RM DRUGINCH 1S/C17H28N4O4/c1-10(2)9-12(17(25)21-8-4-6-13(21)15(18)23)20-16(24)11-5-3-7-14(22)19-11/h10-13H,3-9H2,1-2H3,(H2,18,23)(H,19,22)(H,20,24)/t11-,12-,13-/m0/s1 D0J8RM DRUGINKE DPNGIIPSQYKWQA-AVGNSLFASA-N D0J8RM DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)N)NC(=O)C2CCCC(=O)N2 D0J8RM HIGHSTAT Discontinued in Phase 3 D0K0ZB DRUG__ID D0K0ZB D0K0ZB DRUGCOMP Fournier Pharma D0K0ZB DRUGTYPE Small molecular drug D0K0ZB DRUGINCH 1S/C17H37N7O3/c18-8-7-10-21-9-5-6-13-24-17(26)27-14-15(25)22-11-3-1-2-4-12-23-16(19)20/h21H,1-14,18H2,(H,22,25)(H,24,26)(H4,19,20,23) D0K0ZB DRUGINKE LVBMFPUTQOHXQE-UHFFFAOYSA-N D0K0ZB DRUGSMIL C(CCCN=C(N)N)CCNC(=O)COC(=O)NCCCCNCCCN D0K0ZB HIGHSTAT Discontinued in Phase 3 D0K1HO DRUG__ID D0K1HO D0K1HO DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D0K1HO DRUGTYPE Small molecular drug D0K1HO DRUGINCH 1S/C12H10O4/c1-12(8-5-3-2-4-6-8)10(13)7-9(16-12)11(14)15/h2-7H,1H3,(H,14,15) D0K1HO DRUGINKE DFDGRKNOFOJBAJ-UHFFFAOYSA-N D0K1HO DRUGSMIL CC1(C(=O)C=C(O1)C(=O)O)C2=CC=CC=C2 D0K1HO HIGHSTAT Discontinued in Phase 3 D0L5BK DRUG__ID D0L5BK D0L5BK DRUGCOMP Kyowa Hakko Kogyo Co Ltd D0L5BK DRUGTYPE Small molecular drug D0L5BK DRUGINCH 1S/C24H34N6O8S2/c1-11-17(28-6-8-40-39-7-5-27-15(31)4-3-13(25)22(34)35)20(33)16-12(10-38-23(26)36)24(37-2)21-14(29-21)9-30(24)18(16)19(11)32/h12-14,21,28-29H,3-10,25H2,1-2H3,(H2,26,36)(H,27,31)(H,34,35)/t12-,13+,14+,21+,24-/m1/s1 D0L5BK DRUGINKE BIOSTZMAOGCGSC-CYUGEGSCSA-N D0L5BK DRUGSMIL CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)NCCSSCCNC(=O)CCC(C(=O)O)N D0L5BK HIGHSTAT Discontinued in Phase 3 D0L5UO DRUG__ID D0L5UO D0L5UO DRUGCOMP GlaxoSmithKline D0L5UO DRUGTYPE Small molecular drug D0L5UO DRUGINCH 1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3 D0L5UO DRUGINKE WDPFJWLDPVQCAJ-UHFFFAOYSA-N D0L5UO DRUGSMIL CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F D0L5UO HIGHSTAT Discontinued in Phase 3 D0L7SY DRUG__ID D0L7SY D0L7SY DRUGCOMP Roche Bioscience D0L7SY DRUGTYPE Small molecular drug D0L7SY DRUGINCH 1S/C18H26N2O3S.ClH/c1-23-15-5-6-16-13(10-15)7-9-19-12-14-4-3-8-20(24(2,21)22)17(14)11-18(16)19;/h5-6,10,14,17-18H,3-4,7-9,11-12H2,1-2H3;1H/t14-,17+,18+;/m1./s1 D0L7SY DRUGINKE ITJOISLXCMAIOC-CVLULELNSA-N D0L7SY DRUGSMIL COC1=CC2=C(C=C1)C3CC4C(CCCN4S(=O)(=O)C)CN3CC2.Cl D0L7SY HIGHSTAT Discontinued in Phase 3 D0L8ZX DRUG__ID D0L8ZX D0L8ZX DRUGCOMP NicOx SA D0L8ZX DRUGTYPE Small molecular drug D0L8ZX DRUGINCH 1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H D0L8ZX DRUGINKE PGLIUCLTXOYQMV-UHFFFAOYSA-N D0L8ZX DRUGSMIL C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl D0L8ZX HIGHSTAT Discontinued in Phase 3 D0L9AJ DRUG__ID D0L9AJ D0L9AJ DRUGCOMP UCB Pharma D0L9AJ DRUGTYPE Small molecular drug D0L9AJ DRUGINCH 1S/C10H14F2N2O2/c1-2-7(10(13)16)14-5-6(3-8(11)12)4-9(14)15/h3,6-7H,2,4-5H2,1H3,(H2,13,16)/t6-,7+/m1/s1 D0L9AJ DRUGINKE ANWPENAPCIFDSZ-RQJHMYQMSA-N D0L9AJ DRUGSMIL CCC(C(=O)N)N1CC(CC1=O)C=C(F)F D0L9AJ HIGHSTAT Discontinued in Phase 3 D0LA5G DRUG__ID D0LA5G D0LA5G DRUGCOMP Schering-Plough D0LA5G DRUGTYPE Small molecular drug D0LA5G DRUGINCH 1S/C70H97Cl2NO38/c1-24-15-31(74)16-32(75)40(24)61(82)100-36-22-94-70(60-53(36)92-23-93-60)108-37-21-91-63(46(79)52(37)109-70)106-65-56(89-13)45(78)51(35(101-65)20-86-10)104-64-47(80)55(50(87-11)27(4)97-64)105-66-57(81)68(9)59(30(7)98-66)110-69(111-68)18-33(76)48(28(5)107-69)102-38-17-34(99-39-19-67(8,73(84)85)58(90-14)29(6)96-39)49(26(3)95-38)103-62(83)41-25(2)42(71)44(77)43(72)54(41)88-12/h15-16,26-30,33-39,45-53,55-60,63-66,74-81H,17-23H2,1-14H3/t26-,27-,28-,29+,30-,33-,34-,35-,36-,37+,38+,39+,45+,46-,47-,48-,49-,50+,51-,52-,53+,55-,56+,57-,58+,59-,60-,63+,64+,65+,66+,67+,68-,69-,70-/m1/s1 D0LA5G DRUGINKE UPADRKHAIMTUCC-OWALTSPQSA-N D0LA5G DRUGSMIL CC1C(C(CC(O1)OC2C(OC3(CC2O)OC4C(OC(C(C4(O3)C)O)OC5C(C(OC(C5OC)C)OC6C(OC(C(C6O)OC)OC7C(C8C(CO7)OC9(O8)C1C(C(CO9)OC(=O)C2=C(C=C(C=C2C)O)O)OCO1)O)COC)O)C)C)OC1CC(C(C(O1)C)OC)(C)[N+](=O)[O-])OC(=O)C1=C(C(=C(C(=C1OC)Cl)O)Cl)C D0LA5G HIGHSTAT Discontinued in Phase 3 D0N1FR DRUG__ID D0N1FR D0N1FR DRUGCOMP Exelixis D0N1FR DRUGTYPE Small molecular drug D0N1FR DRUGINCH 1S/C33H34Cl2N4O7/c1-4-37(5-2)12-13-38-31(43)22-20-15-8-6-10-17(34)24(15)36-25(20)27-21(23(22)32(38)44)16-9-7-11-18(35)26(16)39(27)33-29(42)28(41)30(45-3)19(14-40)46-33/h6-11,19,28-30,33,36,40-42H,4-5,12-14H2,1-3H3/t19-,28-,29-,30-,33-/m1/s1 D0N1FR DRUGINKE JSKFWUPVIZYJMR-UDOAKELVSA-N D0N1FR DRUGSMIL CCN(CC)CCN1C(=O)C2=C3C4=C(C(=CC=C4)Cl)NC3=C5C(=C2C1=O)C6=C(N5C7C(C(C(C(O7)CO)OC)O)O)C(=CC=C6)Cl D0N1FR HIGHSTAT Discontinued in Phase 3 D0N7WR DRUG__ID D0N7WR D0N7WR DRUGCOMP Taiho Pharmaceutical Co Ltd D0N7WR DRUGTYPE Small molecular drug D0N7WR DRUGINCH 1S/C21H19N5O2.CH4O3S/c22-19(23)16-2-1-15-12-18(8-5-14(15)11-16)28-20(27)13-3-6-17(7-4-13)26-21-24-9-10-25-21;1-5(2,3)4/h1-8,11-12H,9-10H2,(H3,22,23)(H2,24,25,26);1H3,(H,2,3,4) D0N7WR DRUGINKE NAMGRNXMZHEICS-UHFFFAOYSA-N D0N7WR DRUGSMIL CS(=O)(=O)O.C1CN=C(N1)NC2=CC=C(C=C2)C(=O)OC3=CC4=C(C=C3)C=C(C=C4)C(=N)N D0N7WR HIGHSTAT Discontinued in Phase 3 D0OR2S DRUG__ID D0OR2S D0OR2S DRUGCOMP Zambon Co SpA D0OR2S DRUGTYPE Small molecular drug D0OR2S DRUGINCH 1S/C9H15BrN2O2/c1-9(2,3)11-5-6(13)7-4-8(10)12-14-7/h4,6,11,13H,5H2,1-3H3 D0OR2S DRUGINKE JBRBWHCVRGURBA-UHFFFAOYSA-N D0OR2S DRUGSMIL CC(C)(C)NCC(C1=CC(=NO1)Br)O D0OR2S HIGHSTAT Discontinued in Phase 3 D0P8EU DRUG__ID D0P8EU D0P8EU DRUGCOMP Gedeon Richter Ltd D0P8EU DRUGTYPE Small molecular drug D0P8EU DRUGINCH 1S/C21H40N8O7/c1-11(2)16(20(35)36)29-19(34)14(10-15(30)31)28-18(33)13(7-3-4-8-22)27-17(32)12(23)6-5-9-26-21(24)25/h11-14,16H,3-10,22-23H2,1-2H3,(H,27,32)(H,28,33)(H,29,34)(H,30,31)(H,35,36)(H4,24,25,26)/t12-,13-,14-,16-/m0/s1 D0P8EU DRUGINKE COIXXKVZEXZCLU-YXWQFLTLSA-N D0P8EU DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N D0P8EU HIGHSTAT Discontinued in Phase 3 D0Q6SD DRUG__ID D0Q6SD D0Q6SD DRUGCOMP AstraZeneca & NewBiotics D0Q6SD DRUGTYPE Small molecular drug D0Q6SD DRUGINCH 1S/C26H19Cl3N2O6S2/c27-14-3-5-18(17(29)8-14)37-19-6-4-15(28)9-20(19)36-11-13-12-39-25-22(24(33)31(25)23(13)26(34)35)30-21(32)10-16-2-1-7-38-16/h1-9,22,25H,10-12H2,(H,30,32)(H,34,35)/t22-,25-/m1/s1 D0Q6SD DRUGINKE XKYWDADJBIQZBT-RCZVLFRGSA-N D0Q6SD DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CS3)C(=O)O)COC4=C(C=CC(=C4)Cl)OC5=C(C=C(C=C5)Cl)Cl D0Q6SD HIGHSTAT Discontinued in Phase 3 D0QE5B DRUG__ID D0QE5B D0QE5B DRUGCOMP Dainippon Pharmaceutical Co Ltd D0QE5B DRUGTYPE Small molecular drug D0QE5B DRUGINCH 1S/C30H36N4O/c1-25-14-15-26(24-32-25)16-17-29(35)31-18-8-9-19-33-20-22-34(23-21-33)30(27-10-4-2-5-11-27)28-12-6-3-7-13-28/h2-7,10-17,24,30H,8-9,18-23H2,1H3,(H,31,35)/b17-16+ D0QE5B DRUGINKE DVYCNKDRINREMB-WUKNDPDISA-N D0QE5B DRUGSMIL CC1=NC=C(C=C1)C=CC(=O)NCCCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4 D0QE5B HIGHSTAT Discontinued in Phase 3 D0S4LL DRUG__ID D0S4LL D0S4LL DRUGCOMP Glaxo Wellcome plc D0S4LL DRUGTYPE Small molecular drug D0S4LL DRUGINCH 1S/C14H19NO5/c1-6(16)9-11-7-4-3-5-8(20-2)10(7)12(14(18)19)15(11)13(9)17/h6-9,11,16H,3-5H2,1-2H3,(H,18,19)/t6-,7+,8+,9-,11-/m1/s1 D0S4LL DRUGINKE ICFDDEJRXZSWTA-KJFVXYAMSA-N D0S4LL DRUGSMIL CC(C1C2C3CCCC(C3=C(N2C1=O)C(=O)O)OC)O D0S4LL HIGHSTAT Discontinued in Phase 3 D0S6VB DRUG__ID D0S6VB D0S6VB DRUGCOMP DeCODE genetics D0S6VB DRUGTYPE Small molecular drug D0S6VB DRUGINCH 1S/C23H23NO3/c25-23(26)22(17-6-1-2-7-17)18-10-13-20(14-11-18)27-15-19-12-9-16-5-3-4-8-21(16)24-19/h3-5,8-14,17,22H,1-2,6-7,15H2,(H,25,26)/t22-/m1/s1 D0S6VB DRUGINKE ZEYYDOLCHFETHQ-JOCHJYFZSA-N D0S6VB DRUGSMIL C1CCC(C1)C(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O D0S6VB HIGHSTAT Discontinued in Phase 3 D0UX0T DRUG__ID D0UX0T D0UX0T DRUGCOMP Pfizer Inc D0UX0T DRUGTYPE Small molecular drug D0UX0T DRUGINCH 1S/C8H14N2O/c1-10-5-3-4-8(7-10)6-9-11-2/h4,6H,3,5,7H2,1-2H3/b9-6+ D0UX0T DRUGINKE YMMXHEYLRHNXAB-RMKNXTFCSA-N D0UX0T DRUGSMIL CN1CCC=C(C1)C=NOC D0UX0T HIGHSTAT Discontinued in Phase 3 D0V3RZ DRUG__ID D0V3RZ D0V3RZ DRUGCOMP Glaxo Wellcome plc D0V3RZ DRUGTYPE Small molecular drug D0V3RZ DRUGINCH 1S/C23H23NO2/c1-23(14-25,15-26)24-13-17-12-22-18-7-3-2-6-16(18)10-11-21(22)20-9-5-4-8-19(17)20/h2-12,24-26H,13-15H2,1H3 D0V3RZ DRUGINKE SBRXTSOCZITGQG-UHFFFAOYSA-N D0V3RZ DRUGSMIL CC(CO)(CO)NCC1=CC2=C(C=CC3=CC=CC=C32)C4=CC=CC=C41 D0V3RZ HIGHSTAT Discontinued in Phase 3 D0V4RH DRUG__ID D0V4RH D0V4RH DRUGCOMP Bristol-Myers Squibb D0V4RH DRUGTYPE Small molecular drug D0V4RH DRUGINCH 1S/C11H15N5O3/c12-11-14-9-8(10(19)15-11)13-4-16(9)7-1-5(2-17)6(7)3-18/h4-7,17-18H,1-3H2,(H3,12,14,15,19)/t5-,6-,7-/m1/s1 D0V4RH DRUGINKE GWFOVSGRNGAGDL-FSDSQADBSA-N D0V4RH DRUGSMIL C1C(C(C1N2C=NC3=C2N=C(NC3=O)N)CO)CO D0V4RH HIGHSTAT Discontinued in Phase 3 D0W5RL DRUG__ID D0W5RL D0W5RL DRUGCOMP Bayer D0W5RL DRUGTYPE Small molecular drug D0W5RL DRUGINCH 1S/C28H35NO4/c1-27-15-24(19-6-4-18(5-7-19)16-29-31)26-22-11-9-21(30)14-20(22)8-10-23(26)25(27)12-13-28(27,33-3)17-32-2/h4-7,14,16,23-25,31H,8-13,15,17H2,1-3H3/b29-16+/t23-,24+,25-,27-,28+/m0/s1 D0W5RL DRUGINKE GJMNAFGEUJBOCE-MEQIQULJSA-N D0W5RL DRUGSMIL CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(COC)OC)C5=CC=C(C=C5)C=NO D0W5RL HIGHSTAT Discontinued in Phase 3 D0W7UO DRUG__ID D0W7UO D0W7UO DRUGCOMP Servier D0W7UO DRUGTYPE Small molecular drug D0W7UO DRUGINCH 1S/C26H29N5O2S.ClH/c27-25-22-9-3-4-10-23(22)30-26(31-25)28-16-18-12-14-19(15-13-18)17-29-34(32,33)24-11-5-7-20-6-1-2-8-21(20)24;/h1-11,18-19,29H,12-17H2,(H3,27,28,30,31);1H D0W7UO DRUGINKE DIQDKUNCSVFGHH-UHFFFAOYSA-N D0W7UO DRUGSMIL C1CC(CCC1CNC2=NC3=CC=CC=C3C(=N2)N)CNS(=O)(=O)C4=CC=CC5=CC=CC=C54.Cl D0W7UO HIGHSTAT Discontinued in Phase 3 D0X9VP DRUG__ID D0X9VP D0X9VP DRUGCOMP Cermol SA D0X9VP DRUGTYPE Small molecular drug D0X9VP DRUGINCH 1S/C21H24N2O7/c1-12-17(20(24)28-3)19(15-8-4-5-9-16(15)23(26)27)18(13(2)22-12)21(25)30-11-14-7-6-10-29-14/h4-5,8-9,14,19,22H,6-7,10-11H2,1-3H3 D0X9VP DRUGINKE GGVUNNUOJDGCBK-UHFFFAOYSA-N D0X9VP DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC2CCCO2)C3=CC=CC=C3[N+](=O)[O-])C(=O)OC D0X9VP HIGHSTAT Discontinued in Phase 3 D0Y0RW DRUG__ID D0Y0RW D0Y0RW DRUGCOMP Janssen-Cilag Ltd D0Y0RW DRUGTYPE Small molecular drug D0Y0RW DRUGINCH 1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1 D0Y0RW DRUGINKE QVSXOXCYXPQXMF-OAHLLOKOSA-N D0Y0RW DRUGSMIL C1CNC(=NC1)NCCCNCC2CCC3=CC=CC=C3O2 D0Y0RW HIGHSTAT Discontinued in Phase 3 D0Y9XD DRUG__ID D0Y9XD D0Y9XD DRUGCOMP Rhone-Poulenc SA D0Y9XD DRUGTYPE Small molecular drug D0Y9XD DRUGINCH 1S/C24H31FO3/c1-15-10-16(6-9-21(15)25)19-13-23(2,3)14-24(4,5)20(19)8-7-18-11-17(26)12-22(27)28-18/h6-10,17-18,26H,11-14H2,1-5H3/b8-7+/t17-,18-/m0/s1 D0Y9XD DRUGINKE VDSBXXDKCUBMQC-VUOWKATKSA-N D0Y9XD DRUGSMIL CC1=C(C=CC(=C1)C2=C(C(CC(C2)(C)C)(C)C)C=CC3CC(CC(=O)O3)O)F D0Y9XD HIGHSTAT Discontinued in Phase 3 D0YE2N DRUG__ID D0YE2N D0YE2N DRUGCOMP Pharmacia & Upjohn Co D0YE2N DRUGTYPE Small molecular drug D0YE2N DRUGINCH 1S/C18H23FN4O5/c1-12(25)20-9-14-10-23(18(27)28-14)13-2-3-16(15(19)8-13)21-4-6-22(7-5-21)17(26)11-24/h2-3,8,14,24H,4-7,9-11H2,1H3,(H,20,25)/t14-/m0/s1 D0YE2N DRUGINKE SIMWTRCFFSTNMG-AWEZNQCLSA-N D0YE2N DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C(=O)CO)F D0YE2N HIGHSTAT Discontinued in Phase 3 D0Z5VQ DRUG__ID D0Z5VQ D0Z5VQ DRUGCOMP Servier D0Z5VQ DRUGTYPE Small molecular drug D0Z5VQ DRUGINCH 1S/C20H22ClNO4S.Na/c1-13-2-3-14-12-16(6-9-19(14)18(13)10-11-20(23)24)22-27(25,26)17-7-4-15(21)5-8-17;/h2-5,7-8,16,22H,6,9-12H2,1H3,(H,23,24);/q;+1/p-1/t16-;/m1./s1 D0Z5VQ DRUGINKE BQMSKINGUUUIHE-PKLMIRHRSA-M D0Z5VQ DRUGSMIL CC1=C(C2=C(CC(CC2)NS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1)CCC(=O)[O-].[Na+] D0Z5VQ HIGHSTAT Discontinued in Phase 3 D0Z7FU DRUG__ID D0Z7FU D0Z7FU DRUGCOMP Inspire Pharmaceuticals D0Z7FU DRUGTYPE Small molecular drug D0Z7FU DRUGINCH 1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D0Z7FU DRUGINKE PGAVKCOVUIYSFO-XVFCMESISA-N D0Z7FU DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D0Z7FU HIGHSTAT Discontinued in Phase 3 D00LBD DRUG__ID D00LBD D00LBD DRUGTYPE Small molecular drug D00LBD DRUGINCH 1S/C18H25N5O4/c1-11(25-2)17(24)22-5-7-23(8-6-22)18-20-13-10-15(27-4)14(26-3)9-12(13)16(19)21-18/h9-11H,5-8H2,1-4H3,(H2,19,20,21) D00LBD DRUGINKE YEOTYALSMRNXLJ-UHFFFAOYSA-N D00LBD DRUGSMIL CC(C(=O)N1CCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC)OC D00LBD HIGHSTAT Discontinued in Phase 3 D00USX DRUG__ID D00USX D00USX DRUGTYPE Small molecular drug D00USX DRUGINCH 1S/C15H14N8O5S4.ClH.H2O/c16-15-18-5(2-30-15)8(21-28)11(24)19-9-12(25)23-10(14(26)27)6(3-29-13(9)23)31-4-32-7-1-17-22-20-7;;/h1-2,9,13,28H,3-4H2,(H2,16,18)(H,19,24)(H,26,27)(H,17,20,22);1H;1H2/b21-8-;;/t9-,13-;;/m1../s1 D00USX DRUGINKE LBWIJMWZWJRRMO-AWXOXGPMSA-N D00USX DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)C(=O)O)SCSC4=NNN=C4.O.Cl D00USX HIGHSTAT Discontinued in Phase 3 D00VAJ DRUG__ID D00VAJ D00VAJ DRUGTYPE Small molecular drug D00VAJ DRUGINCH 1S/C17H23N5O4/c1-2-26-14(23)7-9-20-17(25)21-13-8-10-22(16(13)24)12-5-3-11(4-6-12)15(18)19/h3-6,13H,2,7-10H2,1H3,(H3,18,19)(H2,20,21,25)/t13-/m0/s1 D00VAJ DRUGINKE VJDOPFARMOLELX-ZDUSSCGKSA-N D00VAJ DRUGSMIL CCOC(=O)CCNC(=O)NC1CCN(C1=O)C2=CC=C(C=C2)C(=N)N D00VAJ HIGHSTAT Discontinued in Phase 3 D01LAC DRUG__ID D01LAC D01LAC DRUGTYPE Small molecular drug D01LAC DRUGINCH 1S/C11H13F2N/c12-7-10(8-14)2-1-9-3-5-11(13)6-4-9/h3-7H,1-2,8,14H2/b10-7+ D01LAC DRUGINKE VXLBSYHAEKDUSU-JXMROGBWSA-N D01LAC DRUGSMIL C1=CC(=CC=C1CCC(=CF)CN)F D01LAC HIGHSTAT Discontinued in Phase 3 D01QQM DRUG__ID D01QQM D01QQM DRUGTYPE Small molecular drug D01QQM DRUGINCH 1S/C24H28N4O6/c25-22(26)16-3-5-17(6-4-16)23(32)27-20(13-15-1-7-18(29)8-2-15)24(33)28-11-9-19(10-12-28)34-14-21(30)31/h1-8,19-20,29H,9-14H2,(H3,25,26)(H,27,32)(H,30,31)/t20-/m0/s1 D01QQM DRUGINKE FPKOGTAFKSLZLD-FQEVSTJZSA-N D01QQM DRUGSMIL C1CN(CCC1OCC(=O)O)C(=O)C(CC2=CC=C(C=C2)O)NC(=O)C3=CC=C(C=C3)C(=N)N D01QQM HIGHSTAT Discontinued in Phase 3 D01RCS DRUG__ID D01RCS D01RCS DRUGTYPE Small molecular drug D01RCS DRUGINCH 1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2 D01RCS DRUGINKE ZFZPJDFBJFHYIV-UHFFFAOYSA-N D01RCS DRUGSMIL C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54 D01RCS HIGHSTAT Discontinued in Phase 3 D02ALD DRUG__ID D02ALD D02ALD DRUGTYPE Small molecular drug D02ALD DRUGINCH 1S/C19H27NO4.ClH/c1-11(2)18(21)23-16-9-6-13-10-14(20-5)7-8-15(13)17(16)24-19(22)12(3)4;/h6,9,11-12,14,20H,7-8,10H2,1-5H3;1H D02ALD DRUGINKE TWTMQRXNAZGSCE-UHFFFAOYSA-N D02ALD DRUGSMIL CC(C)C(=O)OC1=C(C2=C(CC(CC2)NC)C=C1)OC(=O)C(C)C.Cl D02ALD HIGHSTAT Discontinued in Phase 3 D02JUT DRUG__ID D02JUT D02JUT DRUGTYPE Small molecular drug D02JUT DRUGINCH 1S/C5H7ClN2O3/c6-3-1-2(11-8-3)4(7)5(9)10/h2,4H,1,7H2,(H,9,10)/t2-,4-/m0/s1 D02JUT DRUGINKE QAWIHIJWNYOLBE-OKKQSCSOSA-N D02JUT DRUGSMIL C1C(ON=C1Cl)C(C(=O)O)N D02JUT HIGHSTAT Discontinued in Phase 3 D02VCK DRUG__ID D02VCK D02VCK DRUGTYPE Small molecular drug D02VCK DRUGINCH 1S/C10H10FNO2/c11-6-2-1-3-7-10(6)14-9-5-12-4-8(9)13-7/h1-3,8-9,12H,4-5H2/t8-,9-/m0/s1 D02VCK DRUGINKE XSOUHEXVEOQRKJ-IUCAKERBSA-N D02VCK DRUGSMIL C1C2C(CN1)OC3=C(O2)C=CC=C3F D02VCK HIGHSTAT Discontinued in Phase 3 D03ITI DRUG__ID D03ITI D03ITI DRUGTYPE Small molecular drug D03ITI DRUGINCH 1S/C17H23N5O2/c23-15-4-5-16(24)22(15)11-13-2-3-14-12-21(9-8-20(14)10-13)17-18-6-1-7-19-17/h1,6-7,13-14H,2-5,8-12H2/t13-,14-/m0/s1 D03ITI DRUGINKE UXWBIYCPUVWKHP-KBPBESRZSA-N D03ITI DRUGSMIL C1CC2CN(CCN2CC1CN3C(=O)CCC3=O)C4=NC=CC=N4 D03ITI HIGHSTAT Discontinued in Phase 3 D03MCV DRUG__ID D03MCV D03MCV DRUGCOMP Regado Biosci D03MCV DRUGINCH 1S/C20H40N3O11P.Na/c1-30-13-15-32-19(25)22-11-7-5-9-17(23-20(26)33-16-14-31-2)18(24)21-10-6-3-4-8-12-34-35(27,28)29;/h17H,3-16H2,1-2H3,(H,21,24)(H,22,25)(H,23,26)(H2,27,28,29);/q;+1/p-1 D03MCV DRUGINKE AYPFBAOWSFOSKF-UHFFFAOYSA-M D03MCV DRUGSMIL COCCOC(=O)NCCCCC(C(=O)NCCCCCCOP(=O)(O)[O-])NC(=O)OCCOC.[Na+] D03MCV HIGHSTAT Discontinued in Phase 3 D03QGL DRUG__ID D03QGL D03QGL DRUGTYPE Small molecular drug D03QGL DRUGINCH 1S/C16H16ClNO4S/c17-14-5-7-15(8-6-14)23(21,22)18-10-9-12-1-3-13(4-2-12)11-16(19)20/h1-8,18H,9-11H2,(H,19,20) D03QGL DRUGINKE IULOBWFWYDMECP-UHFFFAOYSA-N D03QGL DRUGSMIL C1=CC(=CC=C1CCNS(=O)(=O)C2=CC=C(C=C2)Cl)CC(=O)O D03QGL HIGHSTAT Discontinued in Phase 3 D03VTN DRUG__ID D03VTN D03VTN DRUGTYPE Small molecular drug D03VTN DRUGINCH 1S/C23H38O4/c1-5-6-15-23(3,4)21(25)14-13-18-17(2)16-20(24)19(18)11-9-7-8-10-12-22(26)27/h7,9,13-14,17-19,21,25H,5-6,8,10-12,15-16H2,1-4H3,(H,26,27)/b9-7-,14-13+/t17-,18+,19-,21-/m1/s1 D03VTN DRUGINKE OOAHNJDZICJECC-BHWPLRMJSA-N D03VTN DRUGSMIL CCCCC(C)(C)C(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)C)O D03VTN HIGHSTAT Discontinued in Phase 3 D04KHH DRUG__ID D04KHH D04KHH DRUGTYPE Small molecular drug D04KHH DRUGINCH 1S/C27H27N5O9S3.ClH/c1-12(28)24(35)41-20(15-7-5-4-6-8-15)21(33)29-18-22(34)32-19(25(36)38-9-17-13(2)39-27(37)40-17)16(10-42-23(18)32)11-43-26-31-30-14(3)44-26;/h4-8,12,18,20,23H,9-11,28H2,1-3H3,(H,29,33);1H/t12-,18+,20+,23+;/m0./s1 D04KHH DRUGINKE HFVATKYQUGKLGL-PCQLZLFJSA-N D04KHH DRUGSMIL CC1=C(OC(=O)O1)COC(=O)C2=C(CSC3N2C(=O)C3NC(=O)C(C4=CC=CC=C4)OC(=O)C(C)N)CSC5=NN=C(S5)C.Cl D04KHH HIGHSTAT Discontinued in Phase 3 D04SBH DRUG__ID D04SBH D04SBH DRUGTYPE Small molecular drug D04SBH DRUGINCH 1S/C27H29NO3/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2/t24-/m1/s1 D04SBH DRUGINKE BDNFQGRSKSQXRI-XMMPIXPASA-N D04SBH DRUGSMIL C1CC(CN(C1)CCC2=CC3=C(C=C2)OCO3)OC(C4=CC=CC=C4)C5=CC=CC=C5 D04SBH HIGHSTAT Discontinued in Phase 3 D05MFO DRUG__ID D05MFO D05MFO DRUGTYPE Small molecular drug D05MFO DRUGINCH 1S/C20H25NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19-20,22H,11-16H2 D05MFO DRUGINKE AXNGJCOYCMDPQG-UHFFFAOYSA-N D05MFO DRUGSMIL C1CN(CCC1C(C2=CC=CC=C2)O)CCC3=CC=CC=C3 D05MFO HIGHSTAT Discontinued in Phase 3 D05YUK DRUG__ID D05YUK D05YUK DRUGTYPE Small molecular drug D05YUK DRUGINCH 1S/C28H40N4S/c1-19(2)23-14-24(20(3)4)27(25(15-23)21(5)6)26-18-33-28(30-26)32(13-12-31(7)8)17-22-10-9-11-29-16-22/h9-11,14-16,18-21H,12-13,17H2,1-8H3 D05YUK DRUGINKE VVBFISAUNSXQGZ-UHFFFAOYSA-N D05YUK DRUGSMIL CC(C)C1=CC(=C(C(=C1)C(C)C)C2=CSC(=N2)N(CCN(C)C)CC3=CN=CC=C3)C(C)C D05YUK HIGHSTAT Discontinued in Phase 3 D07EXV DRUG__ID D07EXV D07EXV DRUGTYPE Small molecular drug D07EXV DRUGINCH 1S/C18H22N4O4/c1-3-13(11-17(25)26-4-2)21-15(23)9-10-16(24)22-14-7-5-12(6-8-14)18(19)20/h1,5-8,13H,4,9-11H2,2H3,(H3,19,20)(H,21,23)(H,22,24)/t13-/m1/s1 D07EXV DRUGINKE ZHCINJQZDFCSEL-CYBMUJFWSA-N D07EXV DRUGSMIL CCOC(=O)CC(C#C)NC(=O)CCC(=O)NC1=CC=C(C=C1)C(=N)N D07EXV HIGHSTAT Discontinued in Phase 3 D08JCL DRUG__ID D08JCL D08JCL DRUGTYPE Small molecular drug D08JCL DRUGINCH 1S/C31H37NO5/c1-20(2)19-24-12-14-25(15-13-24)23(5)37-28-17-16-26(21(3)22(28)4)31(35)32-27-9-6-7-10-29(27)36-18-8-11-30(33)34/h6-7,9-10,12-17,20,23H,8,11,18-19H2,1-5H3,(H,32,35)(H,33,34)/t23-/m0/s1 D08JCL DRUGINKE XWNSOVPLENXWNU-QHCPKHFHSA-N D08JCL DRUGSMIL CC1=C(C=CC(=C1C)OC(C)C2=CC=C(C=C2)CC(C)C)C(=O)NC3=CC=CC=C3OCCCC(=O)O D08JCL HIGHSTAT Discontinued in Phase 3 D0B3LP DRUG__ID D0B3LP D0B3LP DRUGTYPE Small molecular drug D0B3LP DRUGINCH 1S/C19H20BrN3O3/c1-19(2,3)26-18(25)15-16-13-8-5-9-22(13)17(24)14-11(20)6-4-7-12(14)23(16)10-21-15/h4,6-7,10,13H,5,8-9H2,1-3H3/t13-/m0/s1 D0B3LP DRUGINKE LWUDDYHYYNNIQI-ZDUSSCGKSA-N D0B3LP DRUGSMIL CC(C)(C)OC(=O)C1=C2C3CCCN3C(=O)C4=C(N2C=N1)C=CC=C4Br D0B3LP HIGHSTAT Discontinued in Phase 3 D0B8YZ DRUG__ID D0B8YZ D0B8YZ DRUGTYPE Small molecular drug D0B8YZ DRUGINCH 1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15-,16+,17-,18+,19+,20+,21-/m1/s1 D0B8YZ DRUGINKE AURFZBICLPNKBZ-YZRLXODZSA-N D0B8YZ DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D0B8YZ HIGHSTAT Discontinued in Phase 3 D0C1QB DRUG__ID D0C1QB D0C1QB DRUGTYPE Small molecular drug D0C1QB DRUGINCH 1S/C12H11ClO4/c1-16-9-6-10(14)17-12(9)11(15)7-4-2-3-5-8(7)13/h2-6,11-12,15H,1H3 D0C1QB DRUGINKE ICDNYWJQGWNLFP-UHFFFAOYSA-N D0C1QB DRUGSMIL COC1=CC(=O)OC1C(C2=CC=CC=C2Cl)O D0C1QB HIGHSTAT Discontinued in Phase 3 D0C9JL DRUG__ID D0C9JL D0C9JL DRUGTYPE Small molecular drug D0C9JL DRUGINCH 1S/C18H13ClN2O2S/c19-13-5-7-14(8-6-13)21-17(22)11-12-9-10-24(23)16-4-2-1-3-15(16)18(12)20-21/h1-8,11H,9-10H2 D0C9JL DRUGINKE WHMCSFWQVGJBGM-UHFFFAOYSA-N D0C9JL DRUGSMIL C1CS(=O)C2=CC=CC=C2C3=NN(C(=O)C=C31)C4=CC=C(C=C4)Cl D0C9JL HIGHSTAT Discontinued in Phase 3 D0CV7Z DRUG__ID D0CV7Z D0CV7Z DRUGTYPE Small molecular drug D0CV7Z DRUGINCH 1S/C27H41NO6S/c1-15-9-8-10-27(7)22(34-27)12-20(16(2)11-19-14-35-18(4)28-19)33-23(30)13-21(29)26(5,6)25(32)17(3)24(15)31/h11,14-15,17,20-22,24,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,20-,21-,22-,24-,27+/m0/s1 D0CV7Z DRUGINKE QXRSDHAAWVKZLJ-PVYNADRNSA-N D0CV7Z DRUGSMIL CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C D0CV7Z HIGHSTAT Discontinued in Phase 3 D0G2RE DRUG__ID D0G2RE D0G2RE DRUGTYPE Small molecular drug D0G2RE DRUGINCH 1S/C26H23ClN6OS2/c1-15-30-31-22-13-28-24(18-5-3-4-6-20(18)27)23-19-11-12-32(14-21(19)36-25(23)33(15)22)26(35)29-16-7-9-17(34-2)10-8-16/h3-10H,11-14H2,1-2H3,(H,29,35) D0G2RE DRUGINKE WBGAFGNZNGJVNW-UHFFFAOYSA-N D0G2RE DRUGSMIL CC1=NN=C2N1C3=C(C4=C(S3)CN(CC4)C(=S)NC5=CC=C(C=C5)OC)C(=NC2)C6=CC=CC=C6Cl D0G2RE HIGHSTAT Discontinued in Phase 3 D0H0EM DRUG__ID D0H0EM D0H0EM DRUGTYPE Small molecular drug D0H0EM DRUGINCH 1S/C30H31N3O3.C4H4O4/c34-25(22-36-28-15-7-14-27-26(28)13-8-16-31-27)21-32-17-19-33(20-18-32)30(35)29(23-9-3-1-4-10-23)24-11-5-2-6-12-24;5-3(6)1-2-4(7)8/h1-16,25,29,34H,17-22H2;1-2H,(H,5,6)(H,7,8)/b;2-1+ D0H0EM DRUGINKE QIAVTDQTRFYXSD-WLHGVMLRSA-N D0H0EM DRUGSMIL C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5.C(=CC(=O)O)C(=O)O D0H0EM HIGHSTAT Discontinued in Phase 3 D0H1FV DRUG__ID D0H1FV D0H1FV DRUGTYPE Small molecular drug D0H1FV DRUGINCH 1S/C7H14NO5P/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8H,1-4H2,(H,9,10)(H2,11,12,13)/t5-,6+/m1/s1 D0H1FV DRUGINKE LPMRCCNDNGONCD-RITPCOANSA-N D0H1FV DRUGSMIL C1CNC(CC1CP(=O)(O)O)C(=O)O D0H1FV HIGHSTAT Discontinued in Phase 3 D0HQ3A DRUG__ID D0HQ3A D0HQ3A DRUGTYPE Small molecular drug D0HQ3A DRUGINCH 1S/C29H33FN2O6.ClH/c1-17(2)38-29(34)25-19(4)31-18(3)24(26(25)22-7-6-8-23-27(22)37-16-36-23)28(33)35-14-13-32(5)15-20-9-11-21(30)12-10-20;/h6-12,17,26,31H,13-16H2,1-5H3;1H D0HQ3A DRUGINKE JBKDMKOYLBVOOR-UHFFFAOYSA-N D0HQ3A DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=C3C(=CC=C2)OCO3)C(=O)OCCN(C)CC4=CC=C(C=C4)F.Cl D0HQ3A HIGHSTAT Discontinued in Phase 3 D0J6JZ DRUG__ID D0J6JZ D0J6JZ DRUGTYPE Small molecular drug D0J6JZ DRUGINCH 1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27) D0J6JZ DRUGINKE BMHZAHGTGIZZCT-UHFFFAOYSA-N D0J6JZ DRUGSMIL C1C(=O)NC(=O)C12C3=C(C=CC(=C3)F)C(=O)N(C2=O)CC4=C(C=C(C=C4)Br)F D0J6JZ HIGHSTAT Discontinued in Phase 3 D0JB7Z DRUG__ID D0JB7Z D0JB7Z DRUGCOMP Spectrum Pharmaceuticals D0JB7Z DRUGINCH 1S/C15H20N6O3/c22-11(16-5-2-7-20-6-1-3-12(20)23)4-8-21-10-19-13-14(21)17-9-18-15(13)24/h9-10H,1-8H2,(H,16,22)(H,17,18,24) D0JB7Z DRUGINKE FBVDVFULNXWYRF-UHFFFAOYSA-N D0JB7Z DRUGSMIL C1CC(=O)N(C1)CCCNC(=O)CCN2C=NC3=C2N=CNC3=O D0JB7Z HIGHSTAT Discontinued in Phase 3 D0K1QO DRUG__ID D0K1QO D0K1QO DRUGTYPE Small molecular drug D0K1QO DRUGINCH 1S/C20H17N5O9S2/c21-20-22-8(6-36-20)12(24-34-14(19(32)33)7-1-2-10(26)11(27)5-7)15(28)23-13-16(29)25-9(18(30)31)3-4-35-17(13)25/h1-3,5-6,13-14,17,26-27H,4H2,(H2,21,22)(H,23,28)(H,30,31)(H,32,33)/b24-12+/t13-,14+,17-/m1/s1 D0K1QO DRUGINKE ILZCDOYRDFDUPN-UITOYEBDSA-N D0K1QO DRUGSMIL C1C=C(N2C(S1)C(C2=O)NC(=O)C(=NOC(C3=CC(=C(C=C3)O)O)C(=O)O)C4=CSC(=N4)N)C(=O)O D0K1QO HIGHSTAT Discontinued in Phase 3 D0K8NW DRUG__ID D0K8NW D0K8NW DRUGTYPE Small molecular drug D0K8NW DRUGINCH 1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3 D0K8NW DRUGINKE JUQLTPCYUFPYKE-UHFFFAOYSA-N D0K8NW DRUGSMIL CC1=C(C(=O)N2C=CSC2=N1)CCN3CCC(=C(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F)CC3 D0K8NW HIGHSTAT Discontinued in Phase 3 D0L8QQ DRUG__ID D0L8QQ D0L8QQ DRUGTYPE Small molecular drug D0L8QQ DRUGINCH 1S/C13H14N2O/c14-13-8-4-1-2-5-9(8)15-10-6-3-7-11(16)12(10)13/h1-2,4-5,11,16H,3,6-7H2,(H2,14,15) D0L8QQ DRUGINKE HLVVITIHAZBPKB-UHFFFAOYSA-N D0L8QQ DRUGSMIL C1CC(C2=C(C3=CC=CC=C3N=C2C1)N)O D0L8QQ HIGHSTAT Discontinued in Phase 3 D0M8HH DRUG__ID D0M8HH D0M8HH DRUGTYPE Small molecular drug D0M8HH DRUGINCH 1S/C19H22N4O2/c1-12-7-5-8-16(22-19(24)25-4)15(12)11-20-17-9-6-10-23-14(3)13(2)21-18(17)23/h5-10,20H,11H2,1-4H3,(H,22,24) D0M8HH DRUGINKE NZQTVUWEPPDOKK-UHFFFAOYSA-N D0M8HH DRUGSMIL CC1=C(C(=CC=C1)NC(=O)OC)CNC2=CC=CN3C2=NC(=C3C)C D0M8HH HIGHSTAT Discontinued in Phase 3 D0MU0S DRUG__ID D0MU0S D0MU0S DRUGTYPE Small molecular drug D0MU0S DRUGINCH 1S/C39H47NO6/c1-26-32-20-19-31(45-37(42)39(5,6)7)25-33(32)46-35(34(26)27-11-17-30(18-12-27)44-36(41)38(2,3)4)28-13-15-29(16-14-28)43-24-23-40-21-9-8-10-22-40/h11-20,25,35H,8-10,21-24H2,1-7H3/t35-/m0/s1 D0MU0S DRUGINKE OEKMGABCSLYWOP-DHUJRADRSA-N D0MU0S DRUGSMIL CC1=C(C(OC2=C1C=CC(=C2)OC(=O)C(C)(C)C)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)OC(=O)C(C)(C)C D0MU0S HIGHSTAT Discontinued in Phase 3 D0N0BI DRUG__ID D0N0BI D0N0BI DRUGTYPE Small molecular drug D0N0BI DRUGINCH 1S/C20H28N4O6/c1-3-29-17(25)12-30-16-8-10-24(11-9-16)20(27)13(2)22-19(26)15-6-4-14(5-7-15)18(21)23-28/h4-7,13,16,28H,3,8-12H2,1-2H3,(H2,21,23)(H,22,26)/t13-/m0/s1 D0N0BI DRUGINKE WBNUCLPUOSXSNJ-ZDUSSCGKSA-N D0N0BI DRUGSMIL CCOC(=O)COC1CCN(CC1)C(=O)C(C)NC(=O)C2=CC=C(C=C2)C(=NO)N D0N0BI HIGHSTAT Discontinued in Phase 3 D0NJ1A DRUG__ID D0NJ1A D0NJ1A DRUGTYPE Small molecular drug D0NJ1A DRUGINCH 1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1 D0NJ1A DRUGINKE SRVFFFJZQVENJC-IHRRRGAJSA-N D0NJ1A DRUGSMIL CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C D0NJ1A HIGHSTAT Discontinued in Phase 3 D0O1KX DRUG__ID D0O1KX D0O1KX DRUGTYPE Small molecular drug D0O1KX DRUGINCH 1S/C29H43NO4S/c1-17(2)22-14-25(20(7)8)27(26(15-22)21(9)10)16-28(31)30-35(32,33)34-29-23(18(3)4)12-11-13-24(29)19(5)6/h11-15,17-21H,16H2,1-10H3,(H,30,31) D0O1KX DRUGINKE PTQXTEKSNBVPQJ-UHFFFAOYSA-N D0O1KX DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C D0O1KX HIGHSTAT Discontinued in Phase 3 D0O4EV DRUG__ID D0O4EV D0O4EV DRUGCOMP Phoenix Pharmacologies D0O4EV DRUGINCH 1S/C14H25NO11/c1-4(18)15-7-10(21)8(19)5(2-16)25-14(7)26-12-9(20)6(3-17)24-13(23)11(12)22/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8+,9+,10-,11-,12+,13?,14-/m1/s1 D0O4EV DRUGINKE IXWNIYCPCRHGAE-DFZOHVKFSA-N D0O4EV DRUGSMIL CC(=O)NC1C(C(C(OC1OC2C(C(OC(C2O)O)CO)O)CO)O)O D0O4EV HIGHSTAT Discontinued in Phase 3 D0PS2W DRUG__ID D0PS2W D0PS2W DRUGTYPE Small molecular drug D0PS2W DRUGINCH 1S/C20H22N2O4/c1-12-5-6-15-10-16-9-14(7-8-17(16)26-19(15)21-12)13(2)20(24)25-11-18(23)22(3)4/h5-9,13H,10-11H2,1-4H3 D0PS2W DRUGINKE ZAKRMJAETCUYKK-UHFFFAOYSA-N D0PS2W DRUGSMIL CC1=NC2=C(CC3=C(O2)C=CC(=C3)C(C)C(=O)OCC(=O)N(C)C)C=C1 D0PS2W HIGHSTAT Discontinued in Phase 3 D0Q0SZ DRUG__ID D0Q0SZ D0Q0SZ DRUGTYPE Small molecular drug D0Q0SZ DRUGINCH 1S/C20H23FN4O3.CH4O3S/c1-9-16-13(18(26)11(19(27)28)6-25(16)10-2-3-10)15(23)14(21)17(9)24-7-12(22)20(8-24)4-5-20;1-5(2,3)4/h6,10,12H,2-5,7-8,22-23H2,1H3,(H,27,28);1H3,(H,2,3,4)/t12-;/m1./s1 D0Q0SZ DRUGINKE QCRMQMNCFYYEFX-UTONKHPSSA-N D0Q0SZ DRUGSMIL CC1=C2C(=C(C(=C1N3CC(C4(C3)CC4)N)F)N)C(=O)C(=CN2C5CC5)C(=O)O.CS(=O)(=O)O D0Q0SZ HIGHSTAT Discontinued in Phase 3 D0Q7AW DRUG__ID D0Q7AW D0Q7AW DRUGTYPE Small molecular drug D0Q7AW DRUGINCH 1S/C15H8F2N2O2/c16-7-1-3-9-10-4-2-8(17)6-12(10)15(11(9)5-7)13(20)18-14(21)19-15/h1-6H,(H2,18,19,20,21) D0Q7AW DRUGINKE QCCHBHSAIQIQGO-UHFFFAOYSA-N D0Q7AW DRUGSMIL C1=CC2=C(C=C1F)C3(C4=C2C=CC(=C4)F)C(=O)NC(=O)N3 D0Q7AW HIGHSTAT Discontinued in Phase 3 D0R9ON DRUG__ID D0R9ON D0R9ON DRUGTYPE Small molecular drug D0R9ON DRUGINCH 1S/C12H13NO3S3/c1-7(19-12(16)9-3-2-5-17-9)10(14)13-8-4-6-18-11(8)15/h2-3,5,7-8H,4,6H2,1H3,(H,13,14) D0R9ON DRUGINKE MKTVMEMIKNBVHI-UHFFFAOYSA-N D0R9ON DRUGSMIL CC(C(=O)NC1CCSC1=O)SC(=O)C2=CC=CS2 D0R9ON HIGHSTAT Discontinued in Phase 3 D0RJ0J DRUG__ID D0RJ0J D0RJ0J DRUGTYPE Small molecular drug D0RJ0J DRUGINCH 1S/C14H14O2S/c1-9-7-8-17-13(9)12-5-3-11(4-6-12)10(2)14(15)16/h3-8,10H,1-2H3,(H,15,16) D0RJ0J DRUGINKE DTOPKPBTCXKNFF-UHFFFAOYSA-N D0RJ0J DRUGSMIL CC1=C(SC=C1)C2=CC=C(C=C2)C(C)C(=O)O D0RJ0J HIGHSTAT Discontinued in Phase 3 D0RT5T DRUG__ID D0RT5T D0RT5T DRUGTYPE Small molecular drug D0RT5T DRUGINCH 1S/C7H13N3O6/c1-10(9-15)7(14)8-6-5(13)4(12)3(11)2-16-6/h3-6,11-13H,2H2,1H3,(H,8,14)/t3-,4-,5+,6+/m0/s1 D0RT5T DRUGINKE BADMGRJDJPQBLS-UNTFVMJOSA-N D0RT5T DRUGSMIL CN(C(=O)NC1C(C(C(CO1)O)O)O)N=O D0RT5T HIGHSTAT Discontinued in Phase 3 D0S6GJ DRUG__ID D0S6GJ D0S6GJ DRUGTYPE Small molecular drug D0S6GJ DRUGINCH 1S/C14H15N3O/c1-10-13(12-6-2-3-8-17(12)16-10)14(18)11-5-4-7-15-9-11/h2-3,6,8-9,15H,4-5,7H2,1H3 D0S6GJ DRUGINKE SLMUMPSLUWOXAO-UHFFFAOYSA-N D0S6GJ DRUGSMIL CC1=NN2C=CC=CC2=C1C(=O)C3=CNCCC3 D0S6GJ HIGHSTAT Discontinued in Phase 3 D0S6QR DRUG__ID D0S6QR D0S6QR DRUGTYPE Small molecular drug D0S6QR DRUGINCH 1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1 D0S6QR DRUGINKE ULYONBAOIMCNEH-HNNXBMFYSA-N D0S6QR DRUGSMIL COC1=C(C=C(C=C1)Cl)C2(C3=C(C=C(C=C3)C(F)(F)F)NC2=O)F D0S6QR HIGHSTAT Discontinued in Phase 3 D0SV7D DRUG__ID D0SV7D D0SV7D DRUGTYPE Small molecular drug D0SV7D DRUGINCH 1S/C23H32N4O4/c1-26-14-18-12-17(2-3-19(18)25-20(23(26)31)13-21(28)29)22(30)27-10-6-16(7-11-27)15-4-8-24-9-5-15/h2-3,12,15-16,20,24-25H,4-11,13-14H2,1H3,(H,28,29)/t20-/m0/s1 D0SV7D DRUGINKE PYZOVVQJTLOHDG-FQEVSTJZSA-N D0SV7D DRUGSMIL CN1CC2=C(C=CC(=C2)C(=O)N3CCC(CC3)C4CCNCC4)NC(C1=O)CC(=O)O D0SV7D HIGHSTAT Discontinued in Phase 3 D0U9TM DRUG__ID D0U9TM D0U9TM DRUGTYPE Small molecular drug D0U9TM DRUGINCH 1S/C17H12BrFN2O3/c18-11-6-5-10(14(19)7-11)9-21-17(24)13-4-2-1-3-12(13)15(20-21)8-16(22)23/h1-7H,8-9H2,(H,22,23) D0U9TM DRUGINKE LKBFFDOJUKLQNY-UHFFFAOYSA-N D0U9TM DRUGSMIL C1=CC=C2C(=C1)C(=NN(C2=O)CC3=C(C=C(C=C3)Br)F)CC(=O)O D0U9TM HIGHSTAT Discontinued in Phase 3 D0V1RX DRUG__ID D0V1RX D0V1RX DRUGTYPE Small molecular drug D0V1RX DRUGINCH 1S/C11H11N3O2/c12-11(16)9-3-1-2-7(10(9)15)4-8-5-13-6-14-8/h1-3,5-6,15H,4H2,(H2,12,16)(H,13,14) D0V1RX DRUGINKE RLHGFJMGWQXPBW-UHFFFAOYSA-N D0V1RX DRUGSMIL C1=CC(=C(C(=C1)C(=O)N)O)CC2=CN=CN2 D0V1RX HIGHSTAT Discontinued in Phase 3 D0V3GT DRUG__ID D0V3GT D0V3GT DRUGTYPE Small molecular drug D0V3GT DRUGINCH 1S/C15H17Cl2NO2/c1-18-12-2-3-13(18)8-14(7-12)20-15(19)9-4-10(16)6-11(17)5-9/h4-6,12-14H,2-3,7-8H2,1H3/t12-,13+,14? D0V3GT DRUGINKE MNJNPLVXBISNSX-PBWFPOADSA-N D0V3GT DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C3=CC(=CC(=C3)Cl)Cl D0V3GT HIGHSTAT Discontinued in Phase 3 D0V7HI DRUG__ID D0V7HI D0V7HI DRUGTYPE Small molecular drug D0V7HI DRUGINCH 1S/C15H13N3O2.C4H11NO3/c1-18-9-5-8-13(18)14(19)12(10-16)15(20)17-11-6-3-2-4-7-11;5-4(1-6,2-7)3-8/h2-9,12H,1H3,(H,17,20);6-8H,1-3,5H2 D0V7HI DRUGINKE CPUJDORGQAJDCT-UHFFFAOYSA-N D0V7HI DRUGSMIL CN1C=CC=C1C(=O)C(C#N)C(=O)NC2=CC=CC=C2.C(C(CO)(CO)N)O D0V7HI HIGHSTAT Discontinued in Phase 3 D0Y4AZ DRUG__ID D0Y4AZ D0Y4AZ DRUGTYPE Small molecular drug D0Y4AZ DRUGINCH 1S/C19H22FN3O8/c1-8-13(24)14(25)18(31-8)23-7-10(20)16(22-19(23)27)21-17(26)9-5-11(28-2)15(30-4)12(6-9)29-3/h5-8,13-14,18,24-25H,1-4H3,(H,21,22,26,27)/t8-,13-,14-,18-/m1/s1 D0Y4AZ DRUGINKE TVYPSLDUBVTDIS-FUOMVGGVSA-N D0Y4AZ DRUGSMIL CC1C(C(C(O1)N2C=C(C(=NC2=O)NC(=O)C3=CC(=C(C(=C3)OC)OC)OC)F)O)O D0Y4AZ HIGHSTAT Discontinued in Phase 3 D0Z0CH DRUG__ID D0Z0CH D0Z0CH DRUGTYPE Small molecular drug D0Z0CH DRUGINCH 1S/C18H28N2O3S/c1-3-11-24(22)12-5-10-20(4-2)14-17(21)15-23-18-8-6-16(13-19)7-9-18/h6-9,17,21H,3-5,10-12,14-15H2,1-2H3 D0Z0CH DRUGINKE ZMHOBBKJBYLXFR-UHFFFAOYSA-N D0Z0CH DRUGSMIL CCCS(=O)CCCN(CC)CC(COC1=CC=C(C=C1)C#N)O D0Z0CH HIGHSTAT Discontinued in Phase 3 D0Z2WQ DRUG__ID D0Z2WQ D0Z2WQ DRUGTYPE Small molecular drug D0Z2WQ DRUGINCH 1S/C14H22N4/c1-2-5-18-6-3-4-10-7-12-11(8-13(10)18)9-16-14(15)17-12/h9-10,13H,2-8H2,1H3,(H2,15,16,17)/t10-,13-/m1/s1 D0Z2WQ DRUGINKE TUFADSGTJUOBEH-ZWNOBZJWSA-N D0Z2WQ DRUGSMIL CCCN1CCCC2C1CC3=CN=C(N=C3C2)N D0Z2WQ HIGHSTAT Discontinued in Phase 3 D0ZE9C DRUG__ID D0ZE9C D0ZE9C DRUGTYPE Small molecular drug D0ZE9C DRUGINCH 1S/C25H23ClN4O4/c26-20-7-5-16-6-8-21(28-23(16)27-20)30-19(17-3-1-2-4-18(17)24(30)32)15-22(31)29-11-9-25(10-12-29)33-13-14-34-25/h1-8,19H,9-15H2 D0ZE9C DRUGINKE DPGKFACWOCLTCA-UHFFFAOYSA-N D0ZE9C DRUGSMIL C1CN(CCC12OCCO2)C(=O)CC3C4=CC=CC=C4C(=O)N3C5=NC6=C(C=C5)C=CC(=N6)Cl D0ZE9C HIGHSTAT Discontinued in Phase 3 D06NHK DRUG__ID D06NHK D06NHK DRUGCOMP Merck D06NHK DRUGTYPE Combination drug D06NHK DRUGSMIL failed D06NHK HIGHSTAT Discontinued in Phase 3 D0YG4I DRUG__ID D0YG4I D0YG4I DRUGCOMP Opko Health D0YG4I THERCLAS siRNA D0YG4I DRUGTYPE siRNA drug D0YG4I HIGHSTAT Discontinued in Phase 3 D03GAI DRUG__ID D03GAI D03GAI DRUGCOMP Immune Response BioPharma Inc D03GAI DRUGTYPE Vaccine D03GAI HIGHSTAT Discontinued in Phase 3 D04NCK DRUG__ID D04NCK D04NCK THERCLAS Antiviral Agents D04NCK DRUGTYPE Protein/peptide drug D04NCK HIGHSTAT Discontinue in Phase 3 Trial D06IQE DRUG__ID D06IQE D06IQE DRUGCOMP Green Cross Corp D06IQE DRUGTYPE Vaccine D06IQE HIGHSTAT Discontinued in Phase 3 D06VJK DRUG__ID D06VJK D06VJK DRUGCOMP Akela Pharma D06VJK DRUGTYPE Vaccine D06VJK HIGHSTAT Discontinued in Phase 3 D07AWM DRUG__ID D07AWM D07AWM DRUGCOMP Abbott Laboratories D07AWM DRUGTYPE Antibody D07AWM HIGHSTAT Discontinued in Phase 3 D0N5AY DRUG__ID D0N5AY D0N5AY DRUGCOMP NovaRx Corp D0N5AY DRUGTYPE Vaccine D0N5AY HIGHSTAT Discontinued in Phase 3 D0P6MB DRUG__ID D0P6MB D0P6MB DRUGCOMP Alexion Pharmaceuticals D0P6MB DRUGTYPE Antibody D0P6MB HIGHSTAT Discontinued in Phase 3 D0VE6X DRUG__ID D0VE6X D0VE6X DRUGCOMP Antisoma D0VE6X DRUGTYPE Monoclonal antibody D0VE6X HIGHSTAT Discontinued in Phase 3 D0VW2Z DRUG__ID D0VW2Z D0VW2Z DRUGCOMP Chiron Corp D0VW2Z DRUGTYPE Monoclonal antibody D0VW2Z HIGHSTAT Discontinued in Phase 3 D00BVF DRUG__ID D00BVF D00BVF DRUGCOMP Iroko Pharmaceuticals D00BVF HIGHSTAT Discontinued in Phase 3 D00OEG DRUG__ID D00OEG D00OEG DRUGCOMP Pharmacia; Pfizer D00OEG HIGHSTAT Discontinued in Phase 3 D00XPA DRUG__ID D00XPA D00XPA DRUGCOMP Merck D00XPA HIGHSTAT Discontinued in Phase 3 D01GFU DRUG__ID D01GFU D01GFU DRUGCOMP Gliatech Inc D01GFU HIGHSTAT Discontinued in Phase 3 D01MSJ DRUG__ID D01MSJ D01MSJ DRUGCOMP Inhibitex D01MSJ HIGHSTAT Discontinued in Phase 3 D01OML DRUG__ID D01OML D01OML DRUGCOMP Symbollon Pharmaceuticals D01OML HIGHSTAT Discontinued in Phase 3 D01OSN DRUG__ID D01OSN D01OSN DRUGCOMP Sanofi-aventis D01OSN HIGHSTAT Discontinued in Phase 3 D02SDC DRUG__ID D02SDC D02SDC DRUGCOMP Panacos D02SDC HIGHSTAT Discontinued in Phase 3 D02XHD DRUG__ID D02XHD D02XHD DRUGCOMP Kuhnil Pharmaceutical Co Ltd D02XHD HIGHSTAT Discontinued in Phase 3 D02YWW DRUG__ID D02YWW D02YWW DRUGCOMP IDM Pharma D02YWW HIGHSTAT Discontinued in Phase 3 D03IKZ DRUG__ID D03IKZ D03IKZ DRUGCOMP Weizmann Institute of Science D03IKZ HIGHSTAT Discontinued in Phase 3 D03SKF DRUG__ID D03SKF D03SKF DRUGCOMP Scotia Pharmaceuticals D03SKF HIGHSTAT Discontinued in Phase 3 D05KFA DRUG__ID D05KFA D05KFA DRUGCOMP Bioglan Labs Ltd D05KFA HIGHSTAT Discontinued in Phase 3 D05VYJ DRUG__ID D05VYJ D05VYJ DRUGCOMP Sun pharma advanced research D05VYJ HIGHSTAT Discontinued in Phase 3 D06FBB DRUG__ID D06FBB D06FBB DRUGCOMP Pfizer D06FBB HIGHSTAT Discontinued in Phase 3 D06USG DRUG__ID D06USG D06USG DRUGCOMP Hayashibara Co Ltd D06USG HIGHSTAT Discontinued in Phase 3 D06XVF DRUG__ID D06XVF D06XVF DRUGCOMP National Institutes of Health Clinical Center (CC) D06XVF HIGHSTAT Discontinued in Phase 3 D07FGV DRUG__ID D07FGV D07FGV DRUGCOMP Lupin Ltd D07FGV HIGHSTAT Discontinued in Phase 3 D07UQR DRUG__ID D07UQR D07UQR DRUGCOMP Intracel D07UQR HIGHSTAT Discontinued in Phase 3 D09EDW DRUG__ID D09EDW D09EDW DRUGCOMP Aeolus Pharmaceuticals D09EDW HIGHSTAT Discontinued in Phase 3 D09KIP DRUG__ID D09KIP D09KIP DRUGCOMP Curis D09KIP HIGHSTAT Discontinued in Phase 3 D09LPI DRUG__ID D09LPI D09LPI DRUGCOMP Nventa BioPharma D09LPI HIGHSTAT Discontinued in Phase 3 D0AF7N DRUG__ID D0AF7N D0AF7N DRUGCOMP Draxis D0AF7N HIGHSTAT Discontinued in Phase 3 D0AK5G DRUG__ID D0AK5G D0AK5G DRUGCOMP ICOS Corp D0AK5G HIGHSTAT Discontinued in Phase 3 D0B1GX DRUG__ID D0B1GX D0B1GX DRUGCOMP Ventrus Biosciences D0B1GX HIGHSTAT Discontinued in Phase 3 D0B4GZ DRUG__ID D0B4GZ D0B4GZ DRUGCOMP Eisai D0B4GZ HIGHSTAT Discontinued in Phase 3 D0B7MU DRUG__ID D0B7MU D0B7MU DRUGCOMP Hawker Resources Inc D0B7MU HIGHSTAT Discontinued in Phase 3 D0BQ5X DRUG__ID D0BQ5X D0BQ5X DRUGCOMP Sanofi Pasteur D0BQ5X HIGHSTAT Discontinued in Phase 3 D0BT2P DRUG__ID D0BT2P D0BT2P DRUGCOMP BioMS Medical D0BT2P HIGHSTAT Discontinued in Phase 3 D0CZ0D DRUG__ID D0CZ0D D0CZ0D DRUGCOMP Scotia Holdings plc D0CZ0D HIGHSTAT Discontinued in Phase 3 D0DQ7T DRUG__ID D0DQ7T D0DQ7T DRUGCOMP Let's Talk Recovery Inc D0DQ7T HIGHSTAT Discontinued in Phase 3 D0E3SA DRUG__ID D0E3SA D0E3SA DRUGCOMP Alpha-Beta Technology Inc D0E3SA HIGHSTAT Discontinued in Phase 3 D0G2SZ DRUG__ID D0G2SZ D0G2SZ DRUGCOMP SyntheMed Inc D0G2SZ HIGHSTAT Discontinued in Phase 3 D0G6EO DRUG__ID D0G6EO D0G6EO DRUGCOMP Ajinomoto Co Inc D0G6EO HIGHSTAT Discontinued in Phase 3 D0G9LP DRUG__ID D0G9LP D0G9LP DRUGCOMP IBEX Technologies Inc D0G9LP HIGHSTAT Discontinued in Phase 3 D0H6CA DRUG__ID D0H6CA D0H6CA DRUGCOMP Roche Holding AG D0H6CA HIGHSTAT Discontinued in Phase 3 D0I0VY DRUG__ID D0I0VY D0I0VY DRUGCOMP Dong-A D0I0VY HIGHSTAT Discontinued in Phase 3 D0I5OM DRUG__ID D0I5OM D0I5OM DRUGCOMP Innovata plc D0I5OM HIGHSTAT Discontinued in Phase 3 D0I8TF DRUG__ID D0I8TF D0I8TF DRUGCOMP Exocell D0I8TF HIGHSTAT Discontinued in Phase 3 D0I9LH DRUG__ID D0I9LH D0I9LH DRUGCOMP Phytomedics D0I9LH HIGHSTAT Discontinued in Phase 3 D0J6GO DRUG__ID D0J6GO D0J6GO DRUGCOMP Shire Pharmaceuticals D0J6GO HIGHSTAT Discontinued in Phase 3 D0K0GN DRUG__ID D0K0GN D0K0GN DRUGCOMP Milkhaus Laboratory Inc D0K0GN HIGHSTAT Discontinued in Phase 3 D0K8MQ DRUG__ID D0K8MQ D0K8MQ DRUGCOMP FemmePharma D0K8MQ HIGHSTAT Discontinued in Phase 3 D0L4UN DRUG__ID D0L4UN D0L4UN DRUGCOMP Nabi Biopharmaceuticals D0L4UN HIGHSTAT Discontinued in Phase 3 D0M5VS DRUG__ID D0M5VS D0M5VS DRUGCOMP Berna Biotech AG D0M5VS HIGHSTAT Discontinued in Phase 3 D0M9ZT DRUG__ID D0M9ZT D0M9ZT DRUGCOMP Tsumura & Co D0M9ZT HIGHSTAT Discontinued in Phase 3 D0N1KC DRUG__ID D0N1KC D0N1KC DRUGCOMP Teva Pharmaceuticals USA D0N1KC HIGHSTAT Discontinued in Phase 3 D0N5BC DRUG__ID D0N5BC D0N5BC DRUGCOMP Cellcor Inc D0N5BC HIGHSTAT Discontinued in Phase 3 D0O9JI DRUG__ID D0O9JI D0O9JI DRUGCOMP GE Healthcare D0O9JI HIGHSTAT Discontinued in Phase 3 D0PE0D DRUG__ID D0PE0D D0PE0D DRUGCOMP 3SBio Inc D0PE0D HIGHSTAT Discontinued in Phase 3 D0T0LE DRUG__ID D0T0LE D0T0LE DRUGCOMP Io Therapeutics Inc D0T0LE HIGHSTAT Discontinued in Phase 3 D0T9YF DRUG__ID D0T9YF D0T9YF DRUGCOMP Abbott Laboratories D0T9YF HIGHSTAT Discontinued in Phase 3 D0U0AM DRUG__ID D0U0AM D0U0AM DRUGCOMP Viral Genetics Inc D0U0AM HIGHSTAT Discontinued in Phase 3 D0W8RX DRUG__ID D0W8RX D0W8RX DRUGCOMP Ark Therapeutics D0W8RX HIGHSTAT Discontinued in Phase 3 D0WR3D DRUG__ID D0WR3D D0WR3D DRUGCOMP La Jolla Pharmaceutical D0WR3D HIGHSTAT Discontinued in Phase 3 D0X0OT DRUG__ID D0X0OT D0X0OT DRUGCOMP Intercell USA D0X0OT HIGHSTAT Discontinued in Phase 3 D0XV3Z DRUG__ID D0XV3Z D0XV3Z DRUGCOMP ImmuLogic Pharmaceutical Corp D0XV3Z HIGHSTAT Discontinued in Phase 3 D0Y0UK DRUG__ID D0Y0UK D0Y0UK DRUGCOMP Maxia Pharmaceuticals Inc D0Y0UK HIGHSTAT Discontinued in Phase 3 D0Y1MK DRUG__ID D0Y1MK D0Y1MK DRUGCOMP CIS Bio international D0Y1MK HIGHSTAT Discontinued in Phase 3 D0Y4EM DRUG__ID D0Y4EM D0Y4EM DRUGCOMP Mochida Pharmaceutical Co Ltd D0Y4EM HIGHSTAT Discontinued in Phase 3 D0Z5SR DRUG__ID D0Z5SR D0Z5SR DRUGCOMP University of Mississippi D0Z5SR HIGHSTAT Discontinued in Phase 3 D0ZI7Q DRUG__ID D0ZI7Q D0ZI7Q DRUGCOMP Chugai Pharmaceutical Co Ltd D0ZI7Q HIGHSTAT Discontinued in Phase 3 D01OKS DRUG__ID D01OKS D01OKS HIGHSTAT Discontinued in Phase 3 D03PJP DRUG__ID D03PJP D03PJP HIGHSTAT Discontinued in Phase 3 D0S2GT DRUG__ID D0S2GT D0S2GT HIGHSTAT Discontinued in Phase 3 D0K6SM DRUG__ID D0K6SM D0K6SM DRUGCOMP Sanofi-Aventis D0K6SM DRUGINCH 1S/C22H28N2O5S/c1-12(2)19(30-13(3)25)20(26)23-16-11-14-7-4-5-8-15(14)17-9-6-10-18(22(28)29)24(17)21(16)27/h4-5,7-8,12,16-19H,6,9-11H2,1-3H3,(H,23,26)(H,28,29)/t16-,17+,18-,19-/m0/s1 D0K6SM DRUGINKE FXKFFTMLFPWYFH-RDGPPVDQSA-N D0K6SM DRUGSMIL CC(C)C(C(=O)NC1CC2=CC=CC=C2C3CCCC(N3C1=O)C(=O)O)SC(=O)C D0K6SM HIGHSTAT Discontinued in Phase 2/3 D0J3YX DRUG__ID D0J3YX D0J3YX DRUGCOMP Bayer HealthCare Pharmaceuticals D0J3YX HIGHSTAT Discontinued in Phase 2/3 D0YW4R DRUG__ID D0YW4R D0YW4R DRUGCOMP IDM Pharma D0YW4R HIGHSTAT Discontinued in Phase 2/3 D0IP6X DRUG__ID D0IP6X D0IP6X DRUGCOMP Sanofi-aventis D0IP6X DRUGTYPE Small molecular drug D0IP6X DRUGINCH 1S/C35H41Cl2N3O2/c1-27(41)38(2)35(29-13-7-4-8-14-29)19-23-39(24-20-35)21-9-17-34(30-15-16-31(36)32(37)25-30)18-10-22-40(26-34)33(42)28-11-5-3-6-12-28/h3-8,11-16,25H,9-10,17-24,26H2,1-2H3/t34-/m0/s1 D0IP6X DRUGINKE DZOJBGLFWINFBF-UMSFTDKQSA-N D0IP6X DRUGSMIL CC(=O)N(C)C1(CCN(CC1)CCCC2(CCCN(C2)C(=O)C3=CC=CC=C3)C4=CC(=C(C=C4)Cl)Cl)C5=CC=CC=C5 D0IP6X HIGHSTAT Discontinued in Phase 2b D0L9YS DRUG__ID D0L9YS D0L9YS DRUGCOMP Sanofi-aventis D0L9YS DRUGTYPE Small molecular drug D0L9YS DRUGINCH 1S/C8H11NO2/c9-5-8(11)6-1-3-7(10)4-2-6/h1-4,8,10-11H,5,9H2 D0L9YS DRUGINKE QHGUCRYDKWKLMG-UHFFFAOYSA-N D0L9YS DRUGSMIL C1=CC(=CC=C1C(CN)O)O D0L9YS HIGHSTAT Discontinued in Phase 2a D00GNK DRUG__ID D00GNK D00GNK DRUGCOMP Sawyer & Brooks D00GNK THERCLAS Anticancer Agents D00GNK DRUGTYPE Small molecular drug D00GNK DRUGINCH 1S/C33H33FO6/c1-3-9-25-29(12-7-13-30(25)40-31-11-6-5-10-26(31)33(36)37)38-18-8-19-39-32-21-28(35)27(20-22(32)4-2)23-14-16-24(34)17-15-23/h5-7,10-17,20-21,35H,3-4,8-9,18-19H2,1-2H3,(H,36,37) D00GNK DRUGINKE YFIZRWPXUYFCSN-UHFFFAOYSA-N D00GNK DRUGSMIL CCCC1=C(C=CC=C1OC2=CC=CC=C2C(=O)O)OCCCOC3=CC(=C(C=C3CC)C4=CC=C(C=C4)F)O D00GNK HIGHSTAT Discontinued in Phase 2 D01ESB DRUG__ID D01ESB D01ESB DRUGCOMP Yamanouchi D01ESB THERCLAS Psychiatric D01ESB DRUGTYPE Small molecular drug D01ESB DRUGINCH 1S/C14H18FNO2.ClH/c15-13-4-5-14(12-3-1-2-11(12)13)18-9-10-8-16-6-7-17-10;/h4-5,10,16H,1-3,6-9H2;1H/t10-;/m0./s1 D01ESB DRUGINKE HWEMEKZYQCJVEZ-PPHPATTJSA-N D01ESB DRUGSMIL C1CC2=C(C=CC(=C2C1)F)OCC3CNCCO3.Cl D01ESB HIGHSTAT Discontinued in Phase 2 D01NAM DRUG__ID D01NAM D01NAM DRUGCOMP Elbion AG; 4AZA Bioscience D01NAM THERCLAS Psychiatric D01NAM DRUGTYPE Small molecular drug D01NAM DRUGINCH 1S/C14H16ClN3O/c15-11-4-6-12(7-5-11)18-10-13(16-14(18)19)17-8-2-1-3-9-17/h4-7H,1-3,8-10H2 D01NAM DRUGINKE YGXIELIREXEJQN-UHFFFAOYSA-N D01NAM DRUGSMIL C1CCN(CC1)C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl D01NAM HIGHSTAT Discontinued in Phase 2 D01ZXW DRUG__ID D01ZXW D01ZXW DRUGCOMP Sanofi-aventis D01ZXW THERCLAS Anticancer Agents D01ZXW DRUGTYPE Small molecular drug D01ZXW DRUGINCH 1S/C20H14ClN3O3S/c21-14-7-3-2-6-13(14)15-11-28-20(22-15)23-19(27)17-9-12-5-1-4-8-16(12)24(17)10-18(25)26/h1-9,11H,10H2,(H,25,26)(H,22,23,27) D01ZXW DRUGINKE ILNRQFBVVQUOLP-UHFFFAOYSA-N D01ZXW DRUGSMIL C1=CC=C2C(=C1)C=C(N2CC(=O)O)C(=O)NC3=NC(=CS3)C4=CC=CC=C4Cl D01ZXW HIGHSTAT Discontinued in Phase 2 D02VJY DRUG__ID D02VJY D02VJY DRUGCOMP Vertex Pharmaceuticals D02VJY THERCLAS Anticancer Agents D02VJY DRUGTYPE Small molecular drug D02VJY DRUGINCH 1S/C34H41N3O7/c1-41-29-20-26(21-30(42-2)32(29)43-3)31(38)33(39)37-19-5-4-16-28(37)34(40)44-27(14-6-10-24-12-8-17-35-22-24)15-7-11-25-13-9-18-36-23-25/h8-9,12-13,17-18,20-23,27-28H,4-7,10-11,14-16,19H2,1-3H3/t28-/m0/s1 D02VJY DRUGINKE CGVWPQOFHSAKRR-NDEPHWFRSA-N D02VJY DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)C(=O)N2CCCCC2C(=O)OC(CCCC3=CN=CC=C3)CCCC4=CN=CC=C4 D02VJY HIGHSTAT Discontinued in Phase 2 D04PMM DRUG__ID D04PMM D04PMM DRUGCOMP AstraZeneca D04PMM THERCLAS Analgesics D04PMM DRUGTYPE Small molecular drug D04PMM DRUGINCH 1S/C19H13ClF3N3O3/c1-9-5-12(20)7-13-14(9)26(16(28)18(13)15(27)24-17(29)25-18)8-10-3-2-4-11(6-10)19(21,22)23/h2-7H,8H2,1H3,(H2,24,25,27,29) D04PMM DRUGINKE DXDVSYALLVVBOV-UHFFFAOYSA-N D04PMM DRUGSMIL CC1=CC(=CC2=C1N(C(=O)C23C(=O)NC(=O)N3)CC4=CC(=CC=C4)C(F)(F)F)Cl D04PMM HIGHSTAT Discontinued in Phase 2 D05HVY DRUG__ID D05HVY D05HVY DRUGCOMP GlaxoSmithKline D05HVY THERCLAS Analgesics D05HVY DRUGTYPE Small molecular drug D05HVY DRUGINCH 1S/C14H12F3N3O5.C10H24N2O2/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11;1-3-9(7-13)11-5-6-12-10(4-2)8-14/h1-4,6,11H,5,7-8H2;9-14H,3-8H2,1-2H3/t11-;9-,10-/m00/s1 D05HVY DRUGINKE CSKKOIQIXPTXLB-MZEPSHEKSA-N D05HVY DRUGSMIL CCC(CO)NCCNC(CC)CO.C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F D05HVY HIGHSTAT Discontinued in Phase 2 D06FJO DRUG__ID D06FJO D06FJO DRUGCOMP Camurus D06FJO THERCLAS Analgesics D06FJO DRUGTYPE Small molecular drug D06FJO DRUGINCH 1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3 D06FJO DRUGINKE CNBGNNVCVSKAQZ-UHFFFAOYSA-N D06FJO DRUGSMIL CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3 D06FJO HIGHSTAT Discontinued in Phase 2 D09DJU DRUG__ID D09DJU D09DJU DRUGCOMP Pfizer D09DJU THERCLAS Anticancer Agents D09DJU DRUGTYPE Small molecular drug D09DJU DRUGINCH 1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,21,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10-/t16-,21?/m0/s1 D09DJU DRUGINKE XWPFYHDOZULRTD-ROUJOJKSSA-N D09DJU DRUGSMIL CC1=C(N=C(C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O D09DJU HIGHSTAT Discontinued in Phase 2 D09GPB DRUG__ID D09GPB D09GPB DRUGCOMP AstraZeneca D09GPB THERCLAS Analgesics D09GPB DRUGTYPE Small molecular drug D09GPB DRUGINCH 1S/C19H16ClN5O2/c1-12(16-11-17(27-24-16)14-4-3-5-15(20)10-14)26-19-23-22-18(25(19)2)13-6-8-21-9-7-13/h3-12H,1-2H3/t12-/m1/s1 D09GPB DRUGINKE SXWHYTICXCLKDG-GFCCVEGCSA-N D09GPB DRUGSMIL CC(C1=NOC(=C1)C2=CC(=CC=C2)Cl)OC3=NN=C(N3C)C4=CC=NC=C4 D09GPB HIGHSTAT Discontinued in Phase 2 D0A5TS DRUG__ID D0A5TS D0A5TS DRUGCOMP Roche D0A5TS THERCLAS Neurodegenerative D0A5TS DRUGTYPE Small molecular drug D0A5TS DRUGINCH 1S/C16H13F3N4.2ClH/c1-10-20-4-5-23(10)9-13-6-12(8-21-22-13)11-2-3-15(17)14(7-11)16(18)19;;/h2-8,16H,9H2,1H3;2*1H D0A5TS DRUGINKE OJBLXSPBJMGZDN-UHFFFAOYSA-N D0A5TS DRUGSMIL CC1=NC=CN1CC2=NN=CC(=C2)C3=CC(=C(C=C3)F)C(F)F.Cl.Cl D0A5TS HIGHSTAT Discontinued in Phase 2 D0G0IZ DRUG__ID D0G0IZ D0G0IZ DRUGCOMP Alkermes D0G0IZ THERCLAS Anticancer Agents D0G0IZ DRUGTYPE Small molecular drug D0G0IZ DRUGINCH 1S/C49H75N15O12S/c1-76-31-14-12-28(13-15-31)21-29(24-57-34(47(74)75)9-3-17-56-49(53)54)59-43(70)37-10-4-18-62(37)45(72)36(27-65)61-41(68)35(23-32-7-6-20-77-32)60-40(67)25-58-42(69)39-22-30(66)26-64(39)46(73)38-11-5-19-63(38)44(71)33(50)8-2-16-55-48(51)52/h6-7,12-15,20,29-30,33-39,57,65-66H,2-5,8-11,16-19,21-27,50H2,1H3,(H,58,69)(H,59,70)(H,60,67)(H,61,68)(H,74,75)(H4,51,52,55)(H4,53,54,56)/t29-,30+,33-,34-,35-,36-,37-,38-,39-/m0/s1 D0G0IZ DRUGINKE IDXCXSCCZNCXCL-XMADEQCMSA-N D0G0IZ DRUGSMIL COC1=CC=C(C=C1)CC(CNC(CCCN=C(N)N)C(=O)O)NC(=O)C2CCCN2C(=O)C(CO)NC(=O)C(CC3=CC=CS3)NC(=O)CNC(=O)C4CC(CN4C(=O)C5CCCN5C(=O)C(CCCN=C(N)N)N)O D0G0IZ HIGHSTAT Discontinued in Phase 2 D0IT6Q DRUG__ID D0IT6Q D0IT6Q DRUGCOMP Millenium; Takeda D0IT6Q THERCLAS Anticancer Agents D0IT6Q DRUGTYPE Small molecular drug D0IT6Q DRUGINCH 1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38) D0IT6Q DRUGINKE UXXQOJXBIDBUAC-UHFFFAOYSA-N D0IT6Q DRUGSMIL CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5 D0IT6Q HIGHSTAT Discontinued in Phase 2 D0M0HJ DRUG__ID D0M0HJ D0M0HJ DRUGCOMP Shionogi D0M0HJ THERCLAS Neurodegenerative D0M0HJ DRUGTYPE Small molecular drug D0M0HJ DRUGINCH 1S/C10H12N2O2S/c13-15(14)9-5-2-1-4-8(9)12-7-3-6-10(12)11-15/h1-2,4-5,10-11H,3,6-7H2/t10-/m1/s1 D0M0HJ DRUGINKE MNTIJYGEITVWHU-SNVBAGLBSA-N D0M0HJ DRUGSMIL C1CC2NS(=O)(=O)C3=CC=CC=C3N2C1 D0M0HJ HIGHSTAT Discontinued in Phase 2 D0UH4T DRUG__ID D0UH4T D0UH4T DRUGCOMP GlaxoSmithKline D0UH4T THERCLAS Analgesics D0UH4T DRUGTYPE Small molecular drug D0UH4T DRUGINCH 1S/C21H21ClFN7O4/c1-21(2,3)20-29-28-18(34-20)15-13(31)14(32)19(33-15)30-8-26-12-16(24-7-25-17(12)30)27-11-5-4-9(22)6-10(11)23/h4-8,13-15,19,31-32H,1-3H3,(H,24,25,27)/t13-,14+,15-,19+/m0/s1 D0UH4T DRUGINKE ZQYJPMPXQLNTPQ-QCUYGVNKSA-N D0UH4T DRUGSMIL CC(C)(C)C1=NN=C(O1)C2C(C(C(O2)N3C=NC4=C(N=CN=C43)NC5=C(C=C(C=C5)Cl)F)O)O D0UH4T HIGHSTAT Discontinued in Phase 2 D0Z0PB DRUG__ID D0Z0PB D0Z0PB DRUGCOMP Neurogen Corp D0Z0PB THERCLAS Analgesics D0Z0PB DRUGTYPE Small molecular drug D0Z0PB DRUGINCH 1S/C21H12F6N4/c22-20(23,24)13-4-6-14(7-5-13)31-19-15-8-3-12(10-17(15)29-11-30-19)18-16(21(25,26)27)2-1-9-28-18/h1-11H,(H,29,30,31) D0Z0PB DRUGINKE VTANGSDRFFLTSQ-UHFFFAOYSA-N D0Z0PB DRUGSMIL C1=CC(=C(N=C1)C2=CC3=C(C=C2)C(=NC=N3)NC4=CC=C(C=C4)C(F)(F)F)C(F)(F)F D0Z0PB HIGHSTAT Discontinued in Phase 2 D0Z7MJ DRUG__ID D0Z7MJ D0Z7MJ DRUGCOMP Alizyme D0Z7MJ THERCLAS Anticancer Agents D0Z7MJ DRUGTYPE Small molecular drug D0Z7MJ DRUGINCH 1S/C28H32O9S.Na/c1-26-10-8-18(29)13-17(26)6-7-20-21-9-11-28(33,27(21,2)14-22(30)24(20)26)23(31)15-37-25(32)16-4-3-5-19(12-16)38(34,35)36;/h3-5,8,10,12-13,20-22,24,30,33H,6-7,9,11,14-15H2,1-2H3,(H,34,35,36);/q;+1/p-1/t20-,21-,22-,24+,26-,27-,28-;/m0./s1 D0Z7MJ DRUGINKE RWFZSORKWFPGNE-VDYYWZOJSA-M D0Z7MJ DRUGSMIL CC12CC(C3C(C1CCC2(C(=O)COC(=O)C4=CC(=CC=C4)S(=O)(=O)[O-])O)CCC5=CC(=O)C=CC35C)O.[Na+] D0Z7MJ HIGHSTAT Discontinued in Phase 2 D00CFB DRUG__ID D00CFB D00CFB DRUGCOMP Lederle Laboratories D00CFB DRUGTYPE Small molecular drug D00CFB DRUGINCH 1S/C6H8O4.C5H12N2O2.Pt/c7-4(8)6(5(9)10)2-1-3-6;6-1-5(2-7,3-8)4-9;/h1-3H2,(H,7,8)(H,9,10);6-9H,1-4H2;/q;-2;+4/p-2 D00CFB DRUGINKE QPWBZVAOCWJTFK-UHFFFAOYSA-L D00CFB DRUGSMIL C1CC(C1)(C(=O)[O-])C(=O)[O-].C(C(C[NH-])(CO)CO)[NH-].[Pt+4] D00CFB HIGHSTAT Discontinued in Phase 2 D00DBH DRUG__ID D00DBH D00DBH DRUGCOMP NPS Pharmaceuticals D00DBH DRUGTYPE Small molecular drug D00DBH DRUGINCH 1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7) D00DBH DRUGINKE SANOUVWGPVYVAV-UHFFFAOYSA-N D00DBH DRUGSMIL CC(C)CC(=O)N D00DBH HIGHSTAT Discontinued in Phase 2 D00EBH DRUG__ID D00EBH D00EBH DRUGCOMP Zeneca Group plc D00EBH DRUGTYPE Small molecular drug D00EBH DRUGINCH 1S/C21H24N2S.ClH/c1-21(2,23(3)4)15-24-20-18(16-10-6-5-7-11-16)14-17-12-8-9-13-19(17)22-20;/h5-14H,15H2,1-4H3;1H D00EBH DRUGINKE HVIXPSLXHVWFAU-UHFFFAOYSA-N D00EBH DRUGSMIL CC(C)(CSC1=NC2=CC=CC=C2C=C1C3=CC=CC=C3)N(C)C.Cl D00EBH HIGHSTAT Discontinued in Phase 2 D00ECB DRUG__ID D00ECB D00ECB DRUGCOMP Taisho Pharmaceutical Co Ltd D00ECB DRUGTYPE Small molecular drug D00ECB DRUGINCH 1S/C21H24N4O12/c1-12(37-25(32)33)11-35-21(27)18-14(3)22-13(2)17(20(26)34-8-5-9-36-24(30)31)19(18)15-6-4-7-16(10-15)23(28)29/h4,6-7,10,12,19,22H,5,8-9,11H2,1-3H3 D00ECB DRUGINKE QSTCLWROWBZZLA-UHFFFAOYSA-N D00ECB DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC(C)O[N+](=O)[O-])C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCCO[N+](=O)[O-] D00ECB HIGHSTAT Discontinued in Phase 2 D00EZE DRUG__ID D00EZE D00EZE DRUGCOMP Merck KGaA D00EZE DRUGTYPE Small molecular drug D00EZE DRUGINCH 1S/C23H26N2O6/c1-28-18-5-3-17(4-6-18)25-14-19(31-22(25)26)13-24-10-8-23(27,9-11-24)16-2-7-20-21(12-16)30-15-29-20/h2-7,12,19,27H,8-11,13-15H2,1H3/t19-/m0/s1 D00EZE DRUGINKE NINYZUDVKTUKIA-IBGZPJMESA-N D00EZE DRUGSMIL COC1=CC=C(C=C1)N2CC(OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O D00EZE HIGHSTAT Discontinued in Phase 2 D00FHI DRUG__ID D00FHI D00FHI DRUGCOMP Servier D00FHI DRUGTYPE Small molecular drug D00FHI DRUGINCH 1S/C21H28N2O5/c1-13(22-17(20(25)26)12-7-14-5-3-2-4-6-14)19(24)23-16-10-8-15(9-11-16)18(23)21(27)28/h2-6,13,15-18,22H,7-12H2,1H3,(H,25,26)(H,27,28)/t13-,15?,16?,17-,18-/m0/s1 D00FHI DRUGINKE HBZJVGFXZTUXNI-XMQLQKOFSA-N D00FHI DRUGSMIL CC(C(=O)N1C2CCC(C1C(=O)O)CC2)NC(CCC3=CC=CC=C3)C(=O)O D00FHI HIGHSTAT Discontinued in Phase 2 D00HFD DRUG__ID D00HFD D00HFD DRUGCOMP Eisai Co Ltd D00HFD DRUGTYPE Small molecular drug D00HFD DRUGINCH 1S/C17H19N3O3S2.ClH/c1-9-10(2)15(21)11(3)16-14(9)20-17(24-16)19-8-12-4-6-13(7-5-12)25(18,22)23;/h4-7,21H,8H2,1-3H3,(H,19,20)(H2,18,22,23);1H D00HFD DRUGINKE WLODMDLNSQYBMG-UHFFFAOYSA-N D00HFD DRUGSMIL CC1=C(C(=C(C2=C1N=C(S2)NCC3=CC=C(C=C3)S(=O)(=O)N)C)O)C.Cl D00HFD HIGHSTAT Discontinued in Phase 2 D00LWF DRUG__ID D00LWF D00LWF DRUGCOMP LEO Pharma A/S D00LWF DRUGTYPE Small molecular drug D00LWF DRUGINCH 1S/C12H17N5/c1-4-12(2,3)17-11(15-9-13)16-10-6-5-7-14-8-10/h5-8H,4H2,1-3H3,(H2,15,16,17) D00LWF DRUGINKE HKZNADVVGXKQDL-UHFFFAOYSA-N D00LWF DRUGSMIL CCC(C)(C)N=C(NC#N)NC1=CN=CC=C1 D00LWF HIGHSTAT Discontinued in Phase 2 D00QXV DRUG__ID D00QXV D00QXV DRUGCOMP Bristol-Myers Squibb Co D00QXV DRUGTYPE Small molecular drug D00QXV DRUGINCH 1S/C20H24FN5O/c1-27-19-13-22-14-24-20(19)26-9-7-25(8-10-26)6-2-3-15-12-23-18-5-4-16(21)11-17(15)18/h4-5,11-14,23H,2-3,6-10H2,1H3 D00QXV DRUGINKE NRLXAYBZNVHRFL-UHFFFAOYSA-N D00QXV DRUGSMIL COC1=CN=CN=C1N2CCN(CC2)CCCC3=CNC4=C3C=C(C=C4)F D00QXV HIGHSTAT Discontinued in Phase 2 D00RMD DRUG__ID D00RMD D00RMD DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00RMD DRUGTYPE Small molecular drug D00RMD DRUGINCH 1S/C13H16FN3O2/c1-10(18)16-6-8-17(9-7-16)15-13(19)11-2-4-12(14)5-3-11/h2-5H,6-9H2,1H3,(H,15,19) D00RMD DRUGINKE XTOKQKWTUYYVAO-UHFFFAOYSA-N D00RMD DRUGSMIL CC(=O)N1CCN(CC1)NC(=O)C2=CC=C(C=C2)F D00RMD HIGHSTAT Discontinued in Phase 2 D00SPK DRUG__ID D00SPK D00SPK DRUGCOMP Eisai Co Ltd D00SPK DRUGTYPE Small molecular drug D00SPK DRUGINCH 1S/C22H21ClN4O4.Na/c23-15-2-3-17-16(10-15)20(24-11-13-1-4-18-19(9-13)31-12-30-18)26-22(25-17)27-7-5-14(6-8-27)21(28)29;/h1-4,9-10,14H,5-8,11-12H2,(H,28,29)(H,24,25,26);/q;+1/p-1 D00SPK DRUGINKE LDYABEHPDDRNAF-UHFFFAOYSA-M D00SPK DRUGSMIL C1CN(CCC1C(=O)[O-])C2=NC3=C(C=C(C=C3)Cl)C(=N2)NCC4=CC5=C(C=C4)OCO5.[Na+] D00SPK HIGHSTAT Discontinued in Phase 2 D00VZF DRUG__ID D00VZF D00VZF DRUGCOMP Uniroyal Chemical Co Inc D00VZF DRUGTYPE Small molecular drug D00VZF DRUGINCH 1S/C11H9N3O3S/c15-8(12-6-4-2-1-3-5-6)7-9(16)13-11(18)14-10(7)17/h1-5,7H,(H,12,15)(H2,13,14,16,17,18) D00VZF DRUGINKE JARCFMKMOFFIGZ-UHFFFAOYSA-N D00VZF DRUGSMIL C1=CC=C(C=C1)NC(=O)C2C(=O)NC(=S)NC2=O D00VZF HIGHSTAT Discontinued in Phase 2 D00ZKC DRUG__ID D00ZKC D00ZKC DRUGCOMP Triangle Pharmaceuticals Inc D00ZKC DRUGTYPE Small molecular drug D00ZKC DRUGINCH 1S/C10H14N6O3/c1-5-3-16(10(18)13-9(5)11)8-2-6(14-15-12)7(4-17)19-8/h3,6-8,17H,2,4H2,1H3,(H2,11,13,18)/t6-,7+,8+/m0/s1 D00ZKC DRUGINKE GZSDAHQGNUAEBC-XLPZGREQSA-N D00ZKC DRUGSMIL CC1=CN(C(=O)N=C1N)C2CC(C(O2)CO)N=[N+]=[N-] D00ZKC HIGHSTAT Discontinued in Phase 2 D01BBR DRUG__ID D01BBR D01BBR DRUGCOMP A H Robins Co Inc D01BBR DRUGTYPE Small molecular drug D01BBR DRUGINCH 1S/C11H11F3N2O2/c12-11(13,14)7-2-1-3-8(4-7)18-9-5-16(6-9)10(15)17/h1-4,9H,5-6H2,(H2,15,17) D01BBR DRUGINKE LIAILJLSVRAGSM-UHFFFAOYSA-N D01BBR DRUGSMIL C1C(CN1C(=O)N)OC2=CC=CC(=C2)C(F)(F)F D01BBR HIGHSTAT Discontinued in Phase 2 D01DAD DRUG__ID D01DAD D01DAD DRUGCOMP Pfizer D01DAD DRUGTYPE Small molecular drug D01DAD DRUGINCH 1S/C22H23N3O2S/c1-16-24-11-12-25(16)18-5-7-19(8-6-18)28-20-4-2-3-17(15-20)22(21(23)26)9-13-27-14-10-22/h2-8,11-12,15H,9-10,13-14H2,1H3,(H2,23,26) D01DAD DRUGINKE VPTONMHDLLMOOV-UHFFFAOYSA-N D01DAD DRUGSMIL CC1=NC=CN1C2=CC=C(C=C2)SC3=CC=CC(=C3)C4(CCOCC4)C(=O)N D01DAD HIGHSTAT Discontinued in Phase 2 D01EBJ DRUG__ID D01EBJ D01EBJ DRUGCOMP Glaxo Wellcome plc D01EBJ DRUGTYPE Small molecular drug D01EBJ DRUGINCH 1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22)/t12?,13-,14?/m0/s1 D01EBJ DRUGINKE JLDUTSKKXXJGGG-MOKVOYLWSA-N D01EBJ DRUGSMIL CN(C)C1CC(C1)C2=CNC3=C2C=C(C=C3)CC4COC(=O)N4 D01EBJ HIGHSTAT Discontinued in Phase 2 D01FCK DRUG__ID D01FCK D01FCK DRUGCOMP Sigma-Tau SpA D01FCK DRUGTYPE Small molecular drug D01FCK DRUGINCH 1S/C22H45N3O3/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-23-22(28)24-20(18-21(26)27)19-25(2,3)4/h20H,5-19H2,1-4H3,(H2-,23,24,26,27,28)/t20-/m1/s1 D01FCK DRUGINKE BMZYTDRMCBZVNH-HXUWFJFHSA-N D01FCK DRUGSMIL CCCCCCCCCCCCCCNC(=O)NC(CC(=O)[O-])C[N+](C)(C)C D01FCK HIGHSTAT Discontinued in Phase 2 D01FEC DRUG__ID D01FEC D01FEC DRUGCOMP Capstone Therapeutics D01FEC DRUGTYPE Small molecular drug D01FEC DRUGINCH 1S/C97H146N28O36S.C2H4O2/c1-48(2)79(96(160)161)123-91(155)60(35-51-15-6-5-7-16-51)119-93(157)66-20-13-33-124(66)73(133)45-104-68(128)40-106-85(149)64(46-126)121-89(153)62(38-77(140)141)114-72(132)44-109-84(148)57(27-29-75(136)137)117-92(156)65(47-162)122-81(145)50(4)110-87(151)61(37-76(138)139)113-71(131)43-107-82(146)54(19-12-32-103-97(101)102)115-86(150)55(17-8-10-30-98)111-69(129)42-108-83(147)56(26-28-74(134)135)116-90(154)63(39-78(142)143)120-94(158)67-21-14-34-125(67)95(159)58(18-9-11-31-99)118-88(152)59(36-52-22-24-53(127)25-23-52)112-70(130)41-105-80(144)49(3)100;1-2(3)4/h5-7,15-16,22-25,48-50,54-67,79,126-127,162H,8-14,17-21,26-47,98-100H2,1-4H3,(H,104,128)(H,105,144)(H,106,149)(H,107,146)(H,108,147)(H,109,148)(H,110,151)(H,111,129)(H,112,130)(H,113,131)(H,114,132)(H,115,150)(H,116,154)(H,117,156)(H,118,152)(H,119,157)(H,120,158)(H,121,153)(H,122,145)(H,123,155)(H,134,135)(H,136,137)(H,138,139)(H,140,141)(H,142,143)(H,160,161)(H4,101,102,103);1H3,(H,3,4)/t49-,50-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,79-;/m0./s1 D01FEC DRUGINKE NYKOSFMXGHDHHF-NJTUGBEZSA-N D01FEC DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2CCCN2C(=O)CNC(=O)CNC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)N.CC(=O)O D01FEC HIGHSTAT Discontinued in Phase 2 D01FUB DRUG__ID D01FUB D01FUB DRUGCOMP AstraZeneca D01FUB DRUGTYPE Small molecular drug D01FUB DRUGINCH 1S/C24H24F3N5O3/c1-15-10-17(22-29-20(30-35-22)14-31-8-6-28-7-9-31)11-18-13-32(23(33)21(15)18)12-16-2-4-19(5-3-16)34-24(25,26)27/h2-5,10-11,28H,6-9,12-14H2,1H3 D01FUB DRUGINKE IPCYZQQFECEHLI-UHFFFAOYSA-N D01FUB DRUGSMIL CC1=CC(=CC2=C1C(=O)N(C2)CC3=CC=C(C=C3)OC(F)(F)F)C4=NC(=NO4)CN5CCNCC5 D01FUB HIGHSTAT Discontinued in Phase 2 D01IDE DRUG__ID D01IDE D01IDE DRUGCOMP Eisai Co Ltd D01IDE DRUGTYPE Small molecular drug D01IDE DRUGINCH 1S/C26H34N4O2/c1-4-6-16-27-26(31)29-24-20(3)12-10-15-23(24)32-18-11-17-30-19-28-25(22(30)5-2)21-13-8-7-9-14-21/h7-10,12-15,19H,4-6,11,16-18H2,1-3H3,(H2,27,29,31) D01IDE DRUGINKE NQZTZGNLFLQHKG-UHFFFAOYSA-N D01IDE DRUGSMIL CCCCNC(=O)NC1=C(C=CC=C1OCCCN2C=NC(=C2CC)C3=CC=CC=C3)C D01IDE HIGHSTAT Discontinued in Phase 2 D01JGG DRUG__ID D01JGG D01JGG DRUGCOMP GlaxoSmithKline D01JGG DRUGTYPE Small molecular drug D01JGG DRUGINCH 1S/C23H21F4NO3S2/c1-12-9-15(6-8-18(12)31-22(3,4)21(29)30)32-11-19-13(2)28-20(33-19)16-7-5-14(10-17(16)24)23(25,26)27/h5-10H,11H2,1-4H3,(H,29,30) D01JGG DRUGINKE ZUGQWAYOWCBWGM-UHFFFAOYSA-N D01JGG DRUGSMIL CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=C(C=C(C=C3)C(F)(F)F)F)C)OC(C)(C)C(=O)O D01JGG HIGHSTAT Discontinued in Phase 2 D01JOJ DRUG__ID D01JOJ D01JOJ DRUGCOMP Reckitt; Colman plc D01JOJ DRUGTYPE Small molecular drug D01JOJ DRUGINCH 1S/C18H26N6O4/c1-18(2)5-6-24(14(18)15(19)26)17(28)12(7-10-8-20-9-21-10)23-16(27)11-3-4-13(25)22-11/h8-9,11-12,14H,3-7H2,1-2H3,(H2,19,26)(H,20,21)(H,22,25)(H,23,27)/t11-,12-,14+/m0/s1 D01JOJ DRUGINKE ZEQAPQNFHVYDEL-SGMGOOAPSA-N D01JOJ DRUGSMIL CC1(CCN(C1C(=O)N)C(=O)C(CC2=CN=CN2)NC(=O)C3CCC(=O)N3)C D01JOJ HIGHSTAT Discontinued in Phase 2 D01KKE DRUG__ID D01KKE D01KKE DRUGCOMP GSK D01KKE DRUGTYPE Small molecular drug D01KKE DRUGINCH 1S/C22H24N6O2/c1-14-12-16(30-3)4-5-18(14)26-9-6-17-19(13-15(2)24-21(17)26)28-10-7-20(25-28)27-11-8-23-22(27)29/h4-5,7,10,12-13H,6,8-9,11H2,1-3H3,(H,23,29) D01KKE DRUGINKE JFHJGXQFESYQGY-UHFFFAOYSA-N D01KKE DRUGSMIL CC1=CC(=C2CCN(C2=N1)C3=C(C=C(C=C3)OC)C)N4C=CC(=N4)N5CCNC5=O D01KKE HIGHSTAT Discontinued in Phase 2 D01KZC DRUG__ID D01KZC D01KZC DRUGCOMP Eisai Co Ltd D01KZC DRUGTYPE Small molecular drug D01KZC DRUGINCH 1S/C46H72N4O9.ClH/c1-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-31-47-44(52)59-39-29-33-49(34-30-39)45(53)57-36-40(55-3)37-58-46(54)50(35-38-26-23-25-32-48(38)6-2)43(51)41-27-21-22-28-42(41)56-4;/h21-23,25-28,32,39-40H,5-20,24,29-31,33-37H2,1-4H3;1H/t40-;/m1./s1 D01KZC DRUGINKE IXRMFSBOHHRXSS-YPMTVOEDSA-N D01KZC DRUGSMIL CCCCCCCCCCCCCCCCCCNC(=O)OC1CCN(CC1)C(=O)OCC(COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C3=CC=CC=C3OC)OC.[Cl-] D01KZC HIGHSTAT Discontinued in Phase 2 D01LNG DRUG__ID D01LNG D01LNG DRUGCOMP Novartis D01LNG DRUGTYPE Small molecular drug D01LNG DRUGINCH 1S/C23H33N5O2/c1-2-14-27-15-17-28(18-16-27)20-8-6-19(7-9-20)21(29)26-23(10-4-3-5-11-23)22(30)25-13-12-24/h6-9H,2-5,10-11,13-18H2,1H3,(H,25,30)(H,26,29) D01LNG DRUGINKE LLCRBOWRJOUJAE-UHFFFAOYSA-N D01LNG DRUGSMIL CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N D01LNG HIGHSTAT Discontinued in Phase 2 D01LPX DRUG__ID D01LPX D01LPX DRUGCOMP Nycomed AS D01LPX DRUGTYPE Small molecular drug D01LPX DRUGINCH 1S/C14H15NO5S2/c16-13(17)10-20-14-7-6-11(21-14)8-9-15-22(18,19)12-4-2-1-3-5-12/h1-7,15H,8-10H2,(H,16,17) D01LPX DRUGINKE ISSKMEQROMFEHL-UHFFFAOYSA-N D01LPX DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NCCC2=CC=C(S2)OCC(=O)O D01LPX HIGHSTAT Discontinued in Phase 2 D01LQC DRUG__ID D01LQC D01LQC DRUGCOMP Phytopharm D01LQC DRUGTYPE Small molecular drug D01LQC DRUGINCH 1S/C19H14ClN7/c20-15-8-6-13(7-9-15)11-22-18-25-17-14(10-21)12-23-27(17)19(26-18)24-16-4-2-1-3-5-16/h1-9,12H,11H2,(H2,22,24,25,26) D01LQC DRUGINKE QCVULERVJOYHCP-UHFFFAOYSA-N D01LQC DRUGSMIL C1=CC=C(C=C1)NC2=NC(=NC3=C(C=NN32)C#N)NCC4=CC=C(C=C4)Cl D01LQC HIGHSTAT Discontinued in Phase 2 D01NJT DRUG__ID D01NJT D01NJT DRUGCOMP Pfizer D01NJT DRUGTYPE Small molecular drug D01NJT DRUGINCH 1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1 D01NJT DRUGINKE CBQGYUDMJHNJBX-OALUTQOASA-N D01NJT DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3 D01NJT HIGHSTAT Discontinued in Phase 2 D01SGM DRUG__ID D01SGM D01SGM DRUGCOMP Fujisawa Pharmaceutical Co Ltd D01SGM DRUGTYPE Small molecular drug D01SGM DRUGINCH 1S/C40H63N7O7.ClH/c1-29(2)16-17-35(48)33(24-30-12-8-6-9-13-30)43-37(49)34(26-32-27-41-28-42-32)46(5)38(50)36(25-31-14-10-7-11-15-31)54-40(52)45(4)19-18-44(3)39(51)47-20-22-53-23-21-47;/h7,10-11,14-15,27-30,33-36,48H,6,8-9,12-13,16-26H2,1-5H3,(H,41,42)(H,43,49);1H/t33-,34-,35-,36-;/m0./s1 D01SGM DRUGINKE MBTHCNKHNNGZGE-GIOOZNHKSA-N D01SGM DRUGSMIL CC(C)CCC(C(CC1CCCCC1)NC(=O)C(CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)OC(=O)N(C)CCN(C)C(=O)N4CCOCC4)O.Cl D01SGM HIGHSTAT Discontinued in Phase 2 D01SJC DRUG__ID D01SJC D01SJC DRUGCOMP Durect D01SJC DRUGTYPE Small molecular drug D01SJC DRUGINCH 1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D01SJC DRUGINKE OJCZPLDERGDQRJ-UHFFFAOYSA-N D01SJC DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D01SJC HIGHSTAT Discontinued in Phase 2 D01SPI DRUG__ID D01SPI D01SPI DRUGCOMP Akela Pharma D01SPI DRUGTYPE Small molecular drug D01SPI DRUGINCH 1S/C163H273N51O49S2/c1-73(2)52-97(186-116(226)65-179-131(233)82(18)183-139(241)98(53-74(3)4)193-137(239)94(44-35-49-176-162(171)172)188-142(244)101(57-91-62-175-72-182-91)199-159(261)128(88(24)221)213-156(258)123(79(13)14)207-151(253)110(71-265)204-160(262)126(86(22)219)210-133(235)84(20)185-157(259)125(85(21)218)211-147(249)105(61-119(229)230)198-150(252)109(70-264)203-130(232)81(17)166)140(242)194-99(54-75(5)6)141(243)202-108(69-217)149(251)190-95(45-36-50-177-163(173)174)138(240)201-106(67-215)134(236)180-63-115(225)178-64-118(228)205-121(77(9)10)155(257)208-122(78(11)12)154(256)191-93(43-32-34-48-165)136(238)196-102(58-112(167)222)144(246)197-103(59-113(168)223)143(245)195-100(56-90-40-29-26-30-41-90)145(247)209-124(80(15)16)161(263)214-51-37-46-111(214)152(254)212-127(87(23)220)158(260)200-104(60-114(169)224)146(248)206-120(76(7)8)153(255)181-66-117(227)187-107(68-216)148(250)189-92(42-31-33-47-164)135(237)184-83(19)132(234)192-96(129(170)231)55-89-38-27-25-28-39-89/h25-30,38-41,73-88,91-111,120-128,175,182,215-221,264-265H,31-37,42-72,164-166H2,1-24H3,(H2,167,222)(H2,168,223)(H2,169,224)(H2,170,231)(H,178,225)(H,179,233)(H,180,236)(H,181,255)(H,183,241)(H,184,237)(H,185,259)(H,186,226)(H,187,227)(H,188,244)(H,189,250)(H,190,251)(H,191,256)(H,192,234)(H,193,239)(H,194,242)(H,195,245)(H,196,238)(H,197,246)(H,198,252)(H,199,261)(H,200,260)(H,201,240)(H,202,243)(H,203,232)(H,204,262)(H,205,228)(H,206,248)(H,207,253)(H,208,257)(H,209,247)(H,210,235)(H,211,249)(H,212,254)(H,213,258)(H,229,230)(H4,171,172,176)(H4,173,174,177) D01SPI DRUGINKE JAPBQZADVRUIIO-UHFFFAOYSA-N D01SPI DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4CNCN4)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(CS)NC(=O)C(C)N D01SPI HIGHSTAT Discontinued in Phase 2 D01SWK DRUG__ID D01SWK D01SWK DRUGCOMP Dainippon Pharmaceutical Co Ltd D01SWK DRUGTYPE Small molecular drug D01SWK DRUGINCH 1S/C21H23ClN2O4/c1-13(23-11-18(25)14-4-2-5-16(22)9-14)8-15-10-24-21-17(15)6-3-7-19(21)28-12-20(26)27/h2-7,9-10,13,18,23-25H,8,11-12H2,1H3,(H,26,27)/t13-,18+/m1/s1 D01SWK DRUGINKE FHEYFIGWYQJVDR-ACJLOTCBSA-N D01SWK DRUGSMIL CC(CC1=CNC2=C1C=CC=C2OCC(=O)O)NCC(C3=CC(=CC=C3)Cl)O D01SWK HIGHSTAT Discontinued in Phase 2 D01TBN DRUG__ID D01TBN D01TBN DRUGCOMP Pfizer D01TBN DRUGTYPE Small molecular drug D01TBN DRUGINCH 1S/C31H38N2O/c1-22(2)26-14-15-28(34-3)27(20-26)21-32-30-25-16-18-33(19-17-25)31(30)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-15,20,22,25,29-32H,16-19,21H2,1-3H3/t30-,31-/m0/s1 D01TBN DRUGINKE XPNMCDYOYIKVGB-CONSDPRKSA-N D01TBN DRUGSMIL CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3 D01TBN HIGHSTAT Discontinued in Phase 2 D01VPR DRUG__ID D01VPR D01VPR DRUGCOMP Roche Holding AG D01VPR DRUGTYPE Small molecular drug D01VPR DRUGINCH 1S/C20H24N6O2/c1-21-6-7-24-15-2-3-16-18-17(15)20(28)13-4-5-23-12-14(13)19(18)25-26(16)10-8-22-9-11-27/h2-5,12,21-22,24,27H,6-11H2,1H3 D01VPR DRUGINKE PMGQHDIXCJMHRO-UHFFFAOYSA-N D01VPR DRUGSMIL CNCCNC1=C2C3=C(C=C1)N(N=C3C4=C(C2=O)C=CN=C4)CCNCCO D01VPR HIGHSTAT Discontinued in Phase 2 D01XGX DRUG__ID D01XGX D01XGX DRUGCOMP Japan Tobacco Inc D01XGX DRUGTYPE Small molecular drug D01XGX DRUGINCH 1S/C19H25N3O4/c23-13-17(24)15-8-4-10-21(15)18(25)16-9-5-11-22(16)19(26)20-12-14-6-2-1-3-7-14/h1-3,6-7,15-16,23H,4-5,8-13H2,(H,20,26)/t15-,16-/m0/s1 D01XGX DRUGINKE ICULFJDHZQTNRB-HOTGVXAUSA-N D01XGX DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)NCC3=CC=CC=C3)C(=O)CO D01XGX HIGHSTAT Discontinued in Phase 2 D02BGL DRUG__ID D02BGL D02BGL DRUGCOMP National Institutes of Health D02BGL DRUGTYPE Small molecular drug D02BGL DRUGINCH 1S/C8H14N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h3-6,13-15H,1-2H2,(H3,9,10,11,16) D02BGL DRUGINKE LJIRBXZDQGQUOO-UHFFFAOYSA-N D02BGL DRUGSMIL C1N=C(NC(=O)N1C2C(C(C(O2)CO)O)O)N D02BGL HIGHSTAT Discontinued in Phase 2 D02CQL DRUG__ID D02CQL D02CQL DRUGCOMP Innodia D02CQL DRUGTYPE Small molecular drug D02CQL DRUGINCH 1S/C6H13NO3/c1-3(4(2)8)5(7)6(9)10/h3-5,8H,7H2,1-2H3,(H,9,10)/t3-,4-,5-/m0/s1 D02CQL DRUGINKE OSCCDBFHNMXNME-YUPRTTJUSA-N D02CQL DRUGSMIL CC(C(C)O)C(C(=O)O)N D02CQL HIGHSTAT Discontinued in Phase 2 D02FIJ DRUG__ID D02FIJ D02FIJ DRUGCOMP Fujisawa Pharmaceutical Co Ltd D02FIJ DRUGTYPE Small molecular drug D02FIJ DRUGINCH 1S/C54H72N8O13/c1-7-8-10-17-36-18-13-14-19-37(36)22-25-45(67)60-47-33(5)75-54(74)42(30-63)59-49(69)41(29-44(55)66)58-52(72)46(32(4)64)61-50(70)40(27-34-15-11-9-12-16-34)56-48(68)39(26-31(2)3)57-51(71)43(62(6)53(47)73)28-35-20-23-38(65)24-21-35/h9,11-16,18-21,23-24,28,31-33,39-42,46-47,63-65H,7-8,10,17,22,25-27,29-30H2,1-6H3,(H2,55,66)(H,56,68)(H,57,71)(H,58,72)(H,59,69)(H,60,67)(H,61,70)/b43-28- D02FIJ DRUGINKE BEWCDVTWUFJSSM-MBMPTNJISA-N D02FIJ DRUGSMIL CCCCCC1=CC=CC=C1CCC(=O)NC2C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(=CC3=CC=C(C=C3)O)N(C2=O)C)CC(C)C)CC4=CC=CC=C4)C(C)O)CC(=O)N)CO)C D02FIJ HIGHSTAT Discontinued in Phase 2 D02GMT DRUG__ID D02GMT D02GMT DRUGCOMP Organon BioSciences D02GMT DRUGTYPE Small molecular drug D02GMT DRUGINCH 1S/C19H27NO2.C4H4O4/c1-19-8-7-14-13-6-4-12(21)9-11(13)3-5-15(14)16(19)10-17(22)18(19)20-2;5-3(6)1-2-4(7)8/h4,6,9,14-18,20-22H,3,5,7-8,10H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,15-,16+,17-,18+,19+;/m1./s1 D02GMT DRUGINKE UDCGSEPMGRJOAG-IQQQYFTASA-N D02GMT DRUGSMIL CC12CCC3C(C1CC(C2NC)O)CCC4=C3C=CC(=C4)O.C(=CC(=O)O)C(=O)O D02GMT HIGHSTAT Discontinued in Phase 2 D02JMI DRUG__ID D02JMI D02JMI DRUGCOMP Solvay Pharma D02JMI DRUGTYPE Small molecular drug D02JMI DRUGINCH 1S/C25H24FN3O2/c26-18-7-8-23-21(15-18)22(16-27-23)17-9-13-28(14-10-17)11-3-4-12-29-24(30)19-5-1-2-6-20(19)25(29)31/h1-2,5-9,15-16,27H,3-4,10-14H2 D02JMI DRUGINKE NECJNLXOJRDELU-UHFFFAOYSA-N D02JMI DRUGSMIL C1CN(CC=C1C2=CNC3=C2C=C(C=C3)F)CCCCN4C(=O)C5=CC=CC=C5C4=O D02JMI HIGHSTAT Discontinued in Phase 2 D02KMG DRUG__ID D02KMG D02KMG DRUGCOMP GSK D02KMG DRUGTYPE Small molecular drug D02KMG DRUGINCH 1S/C25H29N3O4/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29)/t24-,25-/m0/s1 D02KMG DRUGINKE BMKINZUHKYLSKI-DQEYMECFSA-N D02KMG DRUGSMIL C1=CC=C(C=C1)C(CNC2=CC=C(C=C2)CCNCC(C3=CC(=C(C=C3)O)NC=O)O)O D02KMG HIGHSTAT Discontinued in Phase 2 D02LCL DRUG__ID D02LCL D02LCL DRUGCOMP Toyama Chemical D02LCL DRUGTYPE Small molecular drug D02LCL DRUGINCH 1S/C29H27NO8/c31-24-15-21(37-20-3-1-2-4-20)8-10-22(24)28(34)19-6-11-25(18(14-19)7-12-27(32)33)36-16-17-5-9-23-26(13-17)38-30-29(23)35/h5-6,8-11,13-15,20,31H,1-4,7,12,16H2,(H,30,35)(H,32,33) D02LCL DRUGINKE DALCQQSLNPLQFZ-UHFFFAOYSA-N D02LCL DRUGSMIL C1CCC(C1)OC2=CC(=C(C=C2)C(=O)C3=CC(=C(C=C3)OCC4=CC5=C(C=C4)C(=O)NO5)CCC(=O)O)O D02LCL HIGHSTAT Discontinued in Phase 2 D02RAU DRUG__ID D02RAU D02RAU DRUGCOMP Merck D02RAU DRUGTYPE Small molecular drug D02RAU DRUGINCH 1S/C20H17F3N2O4S/c1-29-15-7-4-12(9-16-18(27)25-19(28)30-16)8-14(15)17(26)24-10-11-2-5-13(6-3-11)20(21,22)23/h2-8,16H,9-10H2,1H3,(H,24,26)(H,25,27,28) D02RAU DRUGINKE NFFXEUUOMTXWCX-UHFFFAOYSA-N D02RAU DRUGSMIL COC1=C(C=C(C=C1)CC2C(=O)NC(=O)S2)C(=O)NCC3=CC=C(C=C3)C(F)(F)F D02RAU HIGHSTAT Discontinued in Phase 2 D02RVE DRUG__ID D02RVE D02RVE DRUGCOMP Tanabe Seiyaku Co Ltd D02RVE DRUGTYPE Small molecular drug D02RVE DRUGINCH 1S/C25H26O10/c1-29-14-9-8-12(10-15(14)30-2)17-18-13(11-16(31-3)22(32-4)23(18)33-5)21(26)20(25(28)35-7)19(17)24(27)34-6/h8-11,26H,1-7H3 D02RVE DRUGINKE DTCYXOLBEPGOHV-UHFFFAOYSA-N D02RVE DRUGSMIL COC1=C(C=C(C=C1)C2=C(C(=C(C3=CC(=C(C(=C32)OC)OC)OC)O)C(=O)OC)C(=O)OC)OC D02RVE HIGHSTAT Discontinued in Phase 2 D02VUX DRUG__ID D02VUX D02VUX DRUGCOMP Pfizer D02VUX DRUGTYPE Small molecular drug D02VUX DRUGINCH 1S/C26H30N4O2/c31-24-12-10-21-11-13-25(28-26(21)27-24)32-19-4-3-14-29-15-17-30(18-16-29)23-9-5-7-20-6-1-2-8-22(20)23/h1-2,5-9,11,13H,3-4,10,12,14-19H2,(H,27,28,31) D02VUX DRUGINKE QGNOXTFZOLDODX-UHFFFAOYSA-N D02VUX DRUGSMIL C1CC(=O)NC2=C1C=CC(=N2)OCCCCN3CCN(CC3)C4=CC=CC5=CC=CC=C54 D02VUX HIGHSTAT Discontinued in Phase 2 D02YBP DRUG__ID D02YBP D02YBP DRUGCOMP Laboratorio Guidotti SpA D02YBP DRUGTYPE Small molecular drug D02YBP DRUGINCH 1S/C21H25N2S.HI/c1-23-12-10-16(11-13-23)17(15-23)14-22-18-6-2-4-8-20(18)24-21-9-5-3-7-19(21)22;/h2-9,16-17H,10-15H2,1H3;1H/q+1;/p-1 D02YBP DRUGINKE SWVANDLDSRKJFI-UHFFFAOYSA-M D02YBP DRUGSMIL C[N+]12CCC(CC1)C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53.[I-] D02YBP HIGHSTAT Discontinued in Phase 2 D02ZLM DRUG__ID D02ZLM D02ZLM DRUGCOMP Universiteit Utrecht D02ZLM DRUGTYPE Small molecular drug D02ZLM DRUGINCH 1S/C43H60N14O11S2/c1-21(2)8-31(43(67)68)54-41(65)33(17-69)57-42(66)34(18-70)56-39(63)29(10-24-13-45-19-49-24)51-35(59)15-48-37(61)32(16-58)55-38(62)28(9-23-12-47-27-7-5-4-6-26(23)27)53-40(64)30(52-36(60)22(3)44)11-25-14-46-20-50-25/h4-7,12-14,19-22,28-34,47,58,69-70H,8-11,15-18,44H2,1-3H3,(H,45,49)(H,46,50)(H,48,61)(H,51,59)(H,52,60)(H,53,64)(H,54,65)(H,55,62)(H,56,63)(H,57,66)(H,67,68)/t22-,28-,29-,30-,31-,32-,33-,34-/m0/s1 D02ZLM DRUGINKE BWCARSGBKSFOCL-OSTURJEUSA-N D02ZLM DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CS)NC(=O)C(CS)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(CO)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C(C)N D02ZLM HIGHSTAT Discontinued in Phase 2 D02ZSU DRUG__ID D02ZSU D02ZSU DRUGCOMP Nippon Shinyaku Co Ltd D02ZSU DRUGTYPE Small molecular drug D02ZSU DRUGINCH 1S/C9H13FN2O3S/c1-16(14,15)12-6-2-3-8(10)7(4-6)9(13)5-11/h2-4,9,12-13H,5,11H2,1H3/t9-/m0/s1 D02ZSU DRUGINKE XYLJNMCMDOOJRW-VIFPVBQESA-N D02ZSU DRUGSMIL CS(=O)(=O)NC1=CC(=C(C=C1)F)C(CN)O D02ZSU HIGHSTAT Discontinued in Phase 2 D03ABH DRUG__ID D03ABH D03ABH DRUGCOMP Synthelabo D03ABH DRUGTYPE Small molecular drug D03ABH DRUGINCH 1S/C16H21N3/c1-2-7-16(15-17-8-9-18-15)11-13-5-3-4-12-6-10-19(16)14(12)13/h3-5H,2,6-11H2,1H3,(H,17,18) D03ABH DRUGINKE BADQRNHAZHSOKC-UHFFFAOYSA-N D03ABH DRUGSMIL CCCC1(CC2=CC=CC3=C2N1CC3)C4=NCCN4 D03ABH HIGHSTAT Discontinued in Phase 2 D03ACT DRUG__ID D03ACT D03ACT DRUGCOMP Pharmos D03ACT DRUGTYPE Small molecular drug D03ACT DRUGINCH 1S/C27H42O3/c1-8-9-10-11-12-26(2,3)19-14-23(29-6)25(24(15-19)30-7)20-13-18(17-28)21-16-22(20)27(21,4)5/h13-15,20-22,28H,8-12,16-17H2,1-7H3/t20-,21-,22+/m0/s1 D03ACT DRUGINKE CFMRIVODIXTERW-FDFHNCONSA-N D03ACT DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C(=C1)OC)C2C=C(C3CC2C3(C)C)CO)OC D03ACT HIGHSTAT Discontinued in Phase 2 D03BHO DRUG__ID D03BHO D03BHO DRUGCOMP Japan Tobacco Inc D03BHO DRUGTYPE Small molecular drug D03BHO DRUGINCH 1S/C18H25N5O4/c1-10-5-12(24)7-13(10)17(26)22-14(6-11-8-20-9-21-11)18(27)23-4-2-3-15(23)16(19)25/h8-10,13-15H,2-7H2,1H3,(H2,19,25)(H,20,21)(H,22,26)/t10-,13+,14+,15+/m1/s1 D03BHO DRUGINKE MVRLGJKFVUDFCR-KJEVXHAQSA-N D03BHO DRUGSMIL CC1CC(=O)CC1C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N D03BHO HIGHSTAT Discontinued in Phase 2 D03CFJ DRUG__ID D03CFJ D03CFJ DRUGCOMP NicOx SA D03CFJ DRUGTYPE Small molecular drug D03CFJ DRUGINCH 1S/C12H14N2O6/c1-9(15)13-10-4-6-11(7-5-10)20-12(16)3-2-8-19-14(17)18/h4-7H,2-3,8H2,1H3,(H,13,15) D03CFJ DRUGINKE XTMOQAKCOFLCRZ-UHFFFAOYSA-N D03CFJ DRUGSMIL CC(=O)NC1=CC=C(C=C1)OC(=O)CCCO[N+](=O)[O-] D03CFJ HIGHSTAT Discontinued in Phase 2 D03CVV DRUG__ID D03CVV D03CVV DRUGCOMP Fournier Pharma D03CVV DRUGTYPE Small molecular drug D03CVV DRUGINCH 1S/C18H39N7O3/c1-15(19)8-13-22-9-6-7-12-25-18(27)28-14-16(26)23-10-4-2-3-5-11-24-17(20)21/h15,22H,2-14,19H2,1H3,(H,23,26)(H,25,27)(H4,20,21,24)/t15-/m1/s1 D03CVV DRUGINKE PZDPVSFZTKORSP-OAHLLOKOSA-N D03CVV DRUGSMIL CC(CCNCCCCNC(=O)OCC(=O)NCCCCCCN=C(N)N)N D03CVV HIGHSTAT Discontinued in Phase 2 D03FFY DRUG__ID D03FFY D03FFY DRUGCOMP AstraZeneca D03FFY DRUGTYPE Small molecular drug D03FFY DRUGINCH 1S/C3H7FNO2P/c4-3(1-5)2-8(6)7/h3H,1-2,5H2/p+1/t3-/m1/s1 D03FFY DRUGINKE WVTGPBOMAQLPCP-GSVOUGTGSA-O D03FFY DRUGSMIL C(C(C[P+](=O)O)F)N D03FFY HIGHSTAT Discontinued in Phase 2 D03GAY DRUG__ID D03GAY D03GAY DRUGCOMP AstraZeneca plc D03GAY DRUGTYPE Small molecular drug D03GAY DRUGINCH 1S/C28H33N5O3/c1-19(20-14-16-23(34)17-15-20)32-26(35)24(13-8-18-31-28(29)30)33-27(36)25(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-7,9-12,14-17,19,24-25,34H,8,13,18H2,1H3,(H,32,35)(H,33,36)(H4,29,30,31)/t19-,24-/m1/s1 D03GAY DRUGINKE AOUQZUZEYSDMEZ-NTKDMRAZSA-N D03GAY DRUGSMIL CC(C1=CC=C(C=C1)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3 D03GAY HIGHSTAT Discontinued in Phase 2 D03JHJ DRUG__ID D03JHJ D03JHJ DRUGCOMP Fujisawa Pharmaceutical Co Ltd D03JHJ DRUGTYPE Small molecular drug D03JHJ DRUGINCH 1S/C23H23N3O3/c27-21(25-14-6-4-10-18(25)16-22(28)29)13-12-19-20-11-5-7-15-26(20)24-23(19)17-8-2-1-3-9-17/h1-3,5,7-9,11-13,15,18H,4,6,10,14,16H2,(H,28,29)/b13-12+/t18-/m1/s1 D03JHJ DRUGINKE UWTYIJJJSYDUQM-QFQMRYFISA-N D03JHJ DRUGSMIL C1CCN(C(C1)CC(=O)O)C(=O)C=CC2=C3C=CC=CN3N=C2C4=CC=CC=C4 D03JHJ HIGHSTAT Discontinued in Phase 2 D03OKG DRUG__ID D03OKG D03OKG DRUGCOMP Fujisawa Pharmaceutical Co Ltd D03OKG DRUGTYPE Small molecular drug D03OKG DRUGINCH 1S/C24H22N7.Na/c1-2-3-10-22-26-21-9-6-15-25-24(21)31(22)16-17-11-13-18(14-12-17)19-7-4-5-8-20(19)23-27-29-30-28-23;/h4-9,11-15H,2-3,10,16H2,1H3;/q-1;+1 D03OKG DRUGINKE YFABTKCYNBWJHS-UHFFFAOYSA-N D03OKG DRUGSMIL CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=N[N-]5)N=CC=C2.[Na+] D03OKG HIGHSTAT Discontinued in Phase 2 D03PHU DRUG__ID D03PHU D03PHU DRUGCOMP Hoechst Marion Roussel Inc D03PHU DRUGTYPE Small molecular drug D03PHU DRUGINCH 1S/C10H6N8.C7H17NO5.H2O/c1-2-4-8-6(3-1)5-7(9-11-14-15-12-9)10-13-16-17-18(8)10;1-8-2-4(10)6(12)7(13)5(11)3-9;/h1-5H,(H,11,12,14,15);4-13H,2-3H2,1H3;1H2/t;4-,5+,6+,7+;/m.0./s1 D03PHU DRUGINKE PXORXOKNKGCVHI-BMWGJIJESA-N D03PHU DRUGSMIL CNCC(C(C(C(CO)O)O)O)O.C1=CC=C2C(=C1)C=C(C3=NN=NN23)C4=NNN=N4.O D03PHU HIGHSTAT Discontinued in Phase 2 D03PKI DRUG__ID D03PKI D03PKI DRUGCOMP Fermentek D03PKI DRUGTYPE Small molecular drug D03PKI DRUGINCH 1S/C29H40N2O9/c1-15-11-19-25(34)20(14-21(32)27(19)39-7)31-28(35)16(2)9-8-10-22(37-5)26(40-29(30)36)18(4)13-17(3)24(33)23(12-15)38-6/h8-10,13-15,17,22-24,26,33H,11-12H2,1-7H3,(H2,30,36)(H,31,35)/b10-8-,16-9+,18-13+/t15-,17+,22+,23+,24-,26+/m1/s1 D03PKI DRUGINKE QTQAWLPCGQOSGP-KSRBKZBZSA-N D03PKI DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)C)OC)OC(=O)N)C)C)O)OC D03PKI HIGHSTAT Discontinued in Phase 2 D03SFN DRUG__ID D03SFN D03SFN DRUGCOMP Pfizer D03SFN DRUGTYPE Small molecular drug D03SFN DRUGINCH 1S/C22H23Cl2N3OS.ClH/c1-25-8-10-26(11-9-25)20-5-3-2-4-16(20)14-21-22(28)27(12-13-29-21)17-6-7-18(23)19(24)15-17;/h2-7,14-15H,8-13H2,1H3;1H/b21-14-; D03SFN DRUGINKE NMTRXBJYASHMND-UXTSPRGOSA-N D03SFN DRUGSMIL CN1CCN(CC1)C2=CC=CC=C2C=C3C(=O)N(CCS3)C4=CC(=C(C=C4)Cl)Cl.Cl D03SFN HIGHSTAT Discontinued in Phase 2 D03SWH DRUG__ID D03SWH D03SWH DRUGCOMP Pharmacia & Upjohn Inc D03SWH DRUGTYPE Small molecular drug D03SWH DRUGINCH 1S/C24H30N4O3/c1-26-24(30)19-4-7-21-18(16-19)9-15-31-22(21)8-10-27-11-13-28(14-12-27)20-5-2-17(3-6-20)23(25)29/h2-7,16,22H,8-15H2,1H3,(H2,25,29)(H,26,30)/t22-/m0/s1 D03SWH DRUGINKE PNTVCCRNJOGKGA-QFIPXVFZSA-N D03SWH DRUGSMIL CNC(=O)C1=CC2=C(C=C1)C(OCC2)CCN3CCN(CC3)C4=CC=C(C=C4)C(=O)N D03SWH HIGHSTAT Discontinued in Phase 2 D03TIJ DRUG__ID D03TIJ D03TIJ DRUGCOMP Medac GmbH D03TIJ DRUGTYPE Small molecular drug D03TIJ DRUGINCH 1S/2C5H5.2ClH.Ti/c2*1-2-4-5-3-1;;;/h2*1-5H;2*1H;/q2*-1;;;+4/p-2 D03TIJ DRUGINKE YMNCCEXICREQQV-UHFFFAOYSA-L D03TIJ DRUGSMIL [CH-]1C=CC=C1.[CH-]1C=CC=C1.[Cl-].[Cl-].[Ti+4] D03TIJ HIGHSTAT Discontinued in Phase 2 D03UYI DRUG__ID D03UYI D03UYI DRUGCOMP Takeda Pharmaceutical Co Ltd D03UYI DRUGTYPE Small molecular drug D03UYI DRUGINCH 1S/C31H37N5O3/c1-31(2,30(37)38)26-22-36-28(33-26)15-14-27(34-36)32-18-9-19-35-20-16-25(17-21-35)39-29(23-10-5-3-6-11-23)24-12-7-4-8-13-24/h3-8,10-15,22,25,29H,9,16-21H2,1-2H3,(H,32,34)(H,37,38) D03UYI DRUGINKE WTBRUSNNZKWTMI-UHFFFAOYSA-N D03UYI DRUGSMIL CC(C)(C1=CN2C(=N1)C=CC(=N2)NCCCN3CCC(CC3)OC(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)O D03UYI HIGHSTAT Discontinued in Phase 2 D03WPI DRUG__ID D03WPI D03WPI DRUGCOMP Taisho Pharmaceutical Co Ltd D03WPI DRUGTYPE Small molecular drug D03WPI DRUGINCH 1S/C23H22N4O5.Na/c1-27(2)9-8-24-22(29)18-20-19(12-6-4-5-7-13(12)21(18)28)25-16-11-17(32-3)14(23(30)31)10-15(16)26-20;/h4-7,10-11,28H,8-9H2,1-3H3,(H,24,29)(H,30,31);/q;+1/p-1 D03WPI DRUGINKE GHPJVVCCBMRQAR-UHFFFAOYSA-M D03WPI DRUGSMIL CN(C)CCNC(=O)C1=C(C2=CC=CC=C2C3=NC4=C(C=C(C(=C4)OC)C(=O)[O-])N=C13)O.[Na+] D03WPI HIGHSTAT Discontinued in Phase 2 D03XDX DRUG__ID D03XDX D03XDX DRUGCOMP Solvay Pharma D03XDX DRUGTYPE Small molecular drug D03XDX DRUGINCH 1S/C28H24N4O2/c1-31-22-15-6-5-14-21(22)24(18-9-3-2-4-10-18)29-26(28(31)34)30-27(33)23-17-20-12-7-11-19-13-8-16-32(23)25(19)20/h2-7,9-12,14-15,17,26H,8,13,16H2,1H3,(H,30,33)/t26-/m1/s1 D03XDX DRUGINKE CZPILLBHPRAPCB-AREMUKBSSA-N D03XDX DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C3=CC4=C5N3CCCC5=CC=C4)C6=CC=CC=C6 D03XDX HIGHSTAT Discontinued in Phase 2 D03ZKE DRUG__ID D03ZKE D03ZKE DRUGCOMP Sankyo D03ZKE DRUGTYPE Small molecular drug D03ZKE DRUGINCH 1S/C34H38Cl2N2O6S.ClH/c1-41-29-18-24(19-30(42-2)31(29)43-3)32(39)38-16-17-44-33(22-38,25-8-9-27(35)28(36)20-25)10-13-37-14-11-34(12-15-37)26-7-5-4-6-23(26)21-45(34)40;/h4-9,18-20H,10-17,21-22H2,1-3H3;1H/t33-,45-;/m0./s1 D03ZKE DRUGINKE IHDDYKNRVLPVEV-FFKPOUSOSA-N D03ZKE DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)N2CCOC(C2)(CCN3CCC4(CC3)C5=CC=CC=C5CS4=O)C6=CC(=C(C=C6)Cl)Cl.Cl D03ZKE HIGHSTAT Discontinued in Phase 2 D04DMQ DRUG__ID D04DMQ D04DMQ DRUGCOMP Fujisawa Pharmaceutical Co Ltd D04DMQ DRUGTYPE Small molecular drug D04DMQ DRUGINCH 1S/C18H19N3O/c1-11-14-5-3-4-6-17(14)21-16(11)8-7-13(18(21)22)9-15-12(2)19-10-20-15/h3-6,10,13H,7-9H2,1-2H3,(H,19,20)/t13-/m1/s1 D04DMQ DRUGINKE AEKQMJRJRAHOAP-CYBMUJFWSA-N D04DMQ DRUGSMIL CC1=C2CCC(C(=O)N2C3=CC=CC=C13)CC4=C(NC=N4)C D04DMQ HIGHSTAT Discontinued in Phase 2 D04DUJ DRUG__ID D04DUJ D04DUJ DRUGCOMP Shionogi & Co Ltd D04DUJ DRUGTYPE Small molecular drug D04DUJ DRUGINCH 1S/C20H31NO3S/c1-8-21-10-9-15(25(21,23)24)11-14-12-16(19(2,3)4)18(22)17(13-14)20(5,6)7/h11-13,22H,8-10H2,1-7H3 D04DUJ DRUGINKE HFWZBWTWCKQUCB-UHFFFAOYSA-N D04DUJ DRUGSMIL CCN1CCC(=CC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C)S1(=O)=O D04DUJ HIGHSTAT Discontinued in Phase 2 D04GWY DRUG__ID D04GWY D04GWY DRUGCOMP GD Searle & Co D04GWY DRUGTYPE Small molecular drug D04GWY DRUGINCH 1S/C33H44N6O5/c1-21(2)19-39(32(44)38-33(3,4)5)20-28(40)26(17-22-11-7-6-8-12-22)36-31(43)27(18-29(34)41)37-30(42)25-16-15-23-13-9-10-14-24(23)35-25/h6-16,21,26-28,40H,17-20H2,1-5H3,(H2,34,41)(H,36,43)(H,37,42)(H,38,44)/t26-,27-,28+/m0/s1 D04GWY DRUGINKE ZILOOGIOHVCEKS-HZFUHODCSA-N D04GWY DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(CC(=O)N)NC(=O)C2=NC3=CC=CC=C3C=C2)O)C(=O)NC(C)(C)C D04GWY HIGHSTAT Discontinued in Phase 2 D04HIZ DRUG__ID D04HIZ D04HIZ DRUGCOMP Chugai Pharmaceutical Co Ltd D04HIZ DRUGTYPE Small molecular drug D04HIZ DRUGINCH 1S/C26H44O2/c1-9-11-13-15-26(16-14-12-10-2)18-19-21(28-26)17-20(24(3,4)5)23(27)22(19)25(6,7)8/h17,27H,9-16,18H2,1-8H3 D04HIZ DRUGINKE AGURKSYKTJQPNA-UHFFFAOYSA-N D04HIZ DRUGSMIL CCCCCC1(CC2=C(O1)C=C(C(=C2C(C)(C)C)O)C(C)(C)C)CCCCC D04HIZ HIGHSTAT Discontinued in Phase 2 D04HVB DRUG__ID D04HVB D04HVB DRUGCOMP EGIS Gyogyszergyar RT D04HVB DRUGTYPE Small molecular drug D04HVB DRUGINCH 1S/C25H24F3NO2/c26-25(27,28)24(21-9-5-2-6-10-21)23(19-7-3-1-4-8-19)20-11-13-22(14-12-20)31-18-16-29-15-17-30/h1-14,29-30H,15-18H2/b24-23+ D04HVB DRUGINKE MHXVDXXARZCVRK-WCWDXBQESA-N D04HVB DRUGSMIL C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C(F)(F)F)C3=CC=C(C=C3)OCCNCCO D04HVB HIGHSTAT Discontinued in Phase 2 D04HXS DRUG__ID D04HXS D04HXS DRUGCOMP Recordati SpA D04HXS DRUGTYPE Small molecular drug D04HXS DRUGINCH 1S/C26H34N4O4/c1-34-25-14-8-7-13-24(25)28-18-15-27(16-19-28)17-20-29(26(31)21-9-3-2-4-10-21)22-11-5-6-12-23(22)30(32)33/h5-8,11-14,21H,2-4,9-10,15-20H2,1H3 D04HXS DRUGINKE HVMKWKIPLGPYAR-UHFFFAOYSA-N D04HXS DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=C3[N+](=O)[O-])C(=O)C4CCCCC4 D04HXS HIGHSTAT Discontinued in Phase 2 D04IFU DRUG__ID D04IFU D04IFU DRUGCOMP GSK D04IFU DRUGTYPE Small molecular drug D04IFU DRUGINCH 1S/C40H46N4O6.C2HF3O2/c1-25-21-37(45)50-36-23-27(18-19-28(25)36)42-38(46)34(17-9-10-20-41)43-39(47)35(22-26-11-3-2-4-12-26)44-40(48)49-24-33-31-15-7-5-13-29(31)30-14-6-8-16-32(30)33;3-2(4,5)1(6)7/h5-8,13-16,18-19,21,23,26,33-35H,2-4,9-12,17,20,22,24,41H2,1H3,(H,42,46)(H,43,47)(H,44,48);(H,6,7)/t34-,35-;/m0./s1 D04IFU DRUGINKE NLKOPSMADZXEPE-WDAFUDAASA-N D04IFU DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CCCCN)NC(=O)C(CC3CCCCC3)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46.C(=O)(C(F)(F)F)O D04IFU HIGHSTAT Discontinued in Phase 2 D04MOF DRUG__ID D04MOF D04MOF DRUGCOMP GlaxoSmithKline D04MOF DRUGTYPE Small molecular drug D04MOF DRUGINCH 1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14?,16+,17+,19+,20+,21+,22+/m1/s1 D04MOF DRUGINKE MGNNYOODZCAHBA-AZYZPMHWSA-N D04MOF DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F D04MOF HIGHSTAT Discontinued in Phase 2 D04OCC DRUG__ID D04OCC D04OCC DRUGCOMP Organon BioSciences D04OCC DRUGTYPE Small molecular drug D04OCC DRUGINCH 1S/C36H61N2O4.BrH/c1-6-13-33(40)42-34-31(38(5)20-11-8-12-21-38)23-29-27-15-14-26-22-32(41-25(2)39)30(37-18-9-7-10-19-37)24-36(26,4)28(27)16-17-35(29,34)3;/h26-32,34H,6-24H2,1-5H3;1H/q+1;/p-1/t26-,27+,28-,29-,30-,31-,32-,34+,35-,36-;/m0./s1 D04OCC DRUGINKE ZFJFKPJKLLLVSR-HELRLQSOSA-M D04OCC DRUGSMIL CCCC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)OC(=O)C)N5CCCCC5)C)C)[N+]6(CCCCC6)C.[Br-] D04OCC HIGHSTAT Discontinued in Phase 2 D04OXU DRUG__ID D04OXU D04OXU DRUGCOMP Eisai Co Ltd D04OXU DRUGTYPE Small molecular drug D04OXU DRUGINCH 1S/C50H81N15O9/c1-8-56-44(70)37(24-30(2)3)64-47(73)40(17-13-23-58-50(53)54)65(7)48(74)35(16-12-22-57-49(51)52)62-45(71)38(25-31(4)5)63-46(72)39(27-32-14-10-9-11-15-32)61-42(68)29-59-41(67)28-60-43(69)36(55-6)26-33-18-20-34(66)21-19-33/h9-11,14-15,18-21,30-31,35-40,55,66H,8,12-13,16-17,22-29H2,1-7H3,(H,56,70)(H,59,67)(H,60,69)(H,61,68)(H,62,71)(H,63,72)(H,64,73)(H4,51,52,57)(H4,53,54,58)/t35-,36-,37+,38-,39-,40-/m0/s1 D04OXU DRUGINKE JENWDDCMEATQSR-ONSKYXJOSA-N D04OXU DRUGSMIL CCNC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)N(C)C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC D04OXU HIGHSTAT Discontinued in Phase 2 D04RLX DRUG__ID D04RLX D04RLX DRUGCOMP Xenova Group Ltd. D04RLX DRUGTYPE Small molecular drug D04RLX DRUGINCH 1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43) D04RLX DRUGINKE LGGHDPFKSSRQNS-UHFFFAOYSA-N D04RLX DRUGSMIL COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC D04RLX HIGHSTAT Discontinued in Phase 2 D04SOS DRUG__ID D04SOS D04SOS DRUGCOMP Bristol-Myers Squibb Co D04SOS DRUGTYPE Small molecular drug D04SOS DRUGINCH 1S/C15H19F3N4O/c16-15(17,18)14-19-6-3-12(20-14)21-8-4-11(5-9-21)10-22-7-1-2-13(22)23/h3,6,11H,1-2,4-5,7-10H2 D04SOS DRUGINKE KEWFMWJJMGQBAN-UHFFFAOYSA-N D04SOS DRUGSMIL C1CC(=O)N(C1)CC2CCN(CC2)C3=NC(=NC=C3)C(F)(F)F D04SOS HIGHSTAT Discontinued in Phase 2 D05ACQ DRUG__ID D05ACQ D05ACQ DRUGCOMP Titan Pharmaceuticals; Geomed Inc D05ACQ DRUGTYPE Small molecular drug D05ACQ DRUGINCH 1S/3C6H6O3.Ga/c3*1-4-6(8)5(7)2-3-9-4;/h3*2-3,8H,1H3;/q;;;+3/p-3 D05ACQ DRUGINKE ASYYOZSDALANRF-UHFFFAOYSA-K D05ACQ DRUGSMIL CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].[Ga+3] D05ACQ HIGHSTAT Discontinued in Phase 2 D05DDN DRUG__ID D05DDN D05DDN DRUGCOMP ViroPharma; Wyeth D05DDN DRUGTYPE Small molecular drug D05DDN DRUGINCH 1S/C22H23FN2O5S/c1-24-22(27)20-17-11-16(13-3-4-13)18(25(9-10-26)31(2,28)29)12-19(17)30-21(20)14-5-7-15(23)8-6-14/h5-8,11-13,26H,3-4,9-10H2,1-2H3,(H,24,27) D05DDN DRUGINKE WTDWVLJJJOTABN-UHFFFAOYSA-N D05DDN DRUGSMIL CNC(=O)C1=C(OC2=CC(=C(C=C21)C3CC3)N(CCO)S(=O)(=O)C)C4=CC=C(C=C4)F D05DDN HIGHSTAT Discontinued in Phase 2 D05ERT DRUG__ID D05ERT D05ERT DRUGCOMP Glaxo Wellcome plc D05ERT DRUGTYPE Small molecular drug D05ERT DRUGINCH 1S/C20H14Cl2N2O3/c21-12-9-15(22)17-14(18(20(26)27)23-16(17)10-12)8-11-6-7-24(19(11)25)13-4-2-1-3-5-13/h1-5,8-10,23H,6-7H2,(H,26,27)/b11-8+ D05ERT DRUGINKE VDIRQCDDCGAGET-DHZHZOJOSA-N D05ERT DRUGSMIL C1CN(C(=O)C1=CC2=C(NC3=C2C(=CC(=C3)Cl)Cl)C(=O)O)C4=CC=CC=C4 D05ERT HIGHSTAT Discontinued in Phase 2 D05MCS DRUG__ID D05MCS D05MCS DRUGCOMP GSK D05MCS DRUGTYPE Small molecular drug D05MCS DRUGINCH 1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43) D05MCS DRUGINKE DFQGDHBGRSTTHX-UHFFFAOYSA-N D05MCS DRUGSMIL CCOC1=NC=C(C=C1)C2=CC=C(C=C2)CN3C4=C(C=C(C=C4)OCC5=NC=C(C=C5)C)C(=C3CC(C)(C)C(=O)O)SC(C)(C)C D05MCS HIGHSTAT Discontinued in Phase 2 D05NRI DRUG__ID D05NRI D05NRI DRUGCOMP Bristol-Myers Squibb Co D05NRI DRUGTYPE Small molecular drug D05NRI DRUGINCH 1S/C21H33N2O6P/c22-14-6-4-13-19(20(24)23-15-8-12-18(23)21(25)26)29-30(27,28)16-7-5-11-17-9-2-1-3-10-17/h1-3,9-10,18-19H,4-8,11-16,22H2,(H,25,26)(H,27,28)/t18-,19-/m0/s1 D05NRI DRUGINKE IFYLTXNCFVRALQ-OALUTQOASA-N D05NRI DRUGSMIL C1CC(N(C1)C(=O)C(CCCCN)OP(=O)(CCCCC2=CC=CC=C2)O)C(=O)O D05NRI HIGHSTAT Discontinued in Phase 2 D05RZI DRUG__ID D05RZI D05RZI DRUGCOMP Chugai Pharmaceutical Co Ltd D05RZI DRUGTYPE Small molecular drug D05RZI DRUGINCH 1S/C16H10ClNO4/c17-11-6-9-13(8-4-2-1-3-5-8)18-22-14(9)10-7-12(16(19)20)21-15(10)11/h1-6,12H,7H2,(H,19,20) D05RZI DRUGINKE RVKIPRIYUGLRFF-UHFFFAOYSA-N D05RZI DRUGSMIL C1C(OC2=C(C=C3C(=C21)ON=C3C4=CC=CC=C4)Cl)C(=O)O D05RZI HIGHSTAT Discontinued in Phase 2 D05UKK DRUG__ID D05UKK D05UKK DRUGCOMP Fujisawa Pharmaceutical Co Ltd D05UKK DRUGTYPE Small molecular drug D05UKK DRUGINCH 1S/C36H36N4O4/c1-38-23-30(29-14-8-9-15-32(29)38)35(43)40-22-28(41)20-33(40)34(42)37-31(36(44)39(2)21-24-10-4-3-5-11-24)19-25-16-17-26-12-6-7-13-27(26)18-25/h3-18,23,28,31,33,41H,19-22H2,1-2H3,(H,37,42)/t28-,31+,33+/m1/s1 D05UKK DRUGINKE BFNKQTIJVFGCKQ-PDJGWCFMSA-N D05UKK DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)N3CC(CC3C(=O)NC(CC4=CC5=CC=CC=C5C=C4)C(=O)N(C)CC6=CC=CC=C6)O D05UKK HIGHSTAT Discontinued in Phase 2 D05UXF DRUG__ID D05UXF D05UXF DRUGCOMP Dainippon; Novartis D05UXF DRUGTYPE Small molecular drug D05UXF DRUGINCH 1S/C23H23N5O2/c1-3-27(15-17-10-6-4-7-11-17)20(29)16-28-22-19(26(2)23(28)30)14-24-21(25-22)18-12-8-5-9-13-18/h4-14H,3,15-16H2,1-2H3 D05UXF DRUGINKE NBMBIEOUVBHEBM-UHFFFAOYSA-N D05UXF DRUGSMIL CCN(CC1=CC=CC=C1)C(=O)CN2C3=NC(=NC=C3N(C2=O)C)C4=CC=CC=C4 D05UXF HIGHSTAT Discontinued in Phase 2 D05VAA DRUG__ID D05VAA D05VAA DRUGCOMP The Menarini Group D05VAA DRUGTYPE Small molecular drug D05VAA DRUGINCH 1S/C11H16N4O2/c1-7(2)5-15-6-12-9-8(15)10(16)14(4)11(17)13(9)3/h6-7H,5H2,1-4H3 D05VAA DRUGINKE WHUWQSQEVISUMC-UHFFFAOYSA-N D05VAA DRUGSMIL CC(C)CN1C=NC2=C1C(=O)N(C(=O)N2C)C D05VAA HIGHSTAT Discontinued in Phase 2 D05WTZ DRUG__ID D05WTZ D05WTZ DRUGCOMP Dong-A Pharmaceutical Co Ltd D05WTZ DRUGTYPE Small molecular drug D05WTZ DRUGINCH 1S/C30H32FNO13/c1-11-23(35)28(40)22(31)29(44-11)45-15-9-30(41,16(33)10-43-17(34)6-7-32)8-13-19(15)27(39)21-20(25(13)37)24(36)12-4-3-5-14(42-2)18(12)26(21)38/h3-5,11,15,22-23,28-29,35,37,39-41H,6-10,32H2,1-2H3/t11-,15-,22+,23+,28-,29-,30-/m0/s1 D05WTZ DRUGINKE CKXIPXAIFMTQCS-LRDUUELOSA-N D05WTZ DRUGSMIL CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CCN)O)F)O)O D05WTZ HIGHSTAT Discontinued in Phase 2 D05YAS DRUG__ID D05YAS D05YAS DRUGCOMP ALTANA Pharma AG D05YAS DRUGTYPE Small molecular drug D05YAS DRUGINCH 1S/C28H31N3O4S/c1-18-5-11-21(12-6-18)36(32,33)30-20-9-7-19(8-10-20)28-23-16-27(35-4)26(34-3)15-22(23)24-17-31(2)14-13-25(24)29-28/h5-12,15-16,24-25,30H,13-14,17H2,1-4H3/t24-,25-/m0/s1 D05YAS DRUGINKE FVZJIAUYFDQQKJ-DQEYMECFSA-N D05YAS DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C3=NC4CCN(CC4C5=CC(=C(C=C53)OC)OC)C D05YAS HIGHSTAT Discontinued in Phase 2 D06EIO DRUG__ID D06EIO D06EIO DRUGCOMP Institute of Cancer Research UK D06EIO DRUGTYPE Small molecular drug D06EIO DRUGINCH 1S/C9H18N6O3/c1-13(4-16)7-10-8(14(2)5-17)12-9(11-7)15(3)6-18/h16-18H,4-6H2,1-3H3 D06EIO DRUGINKE MHVFYGIQJNFWGQ-UHFFFAOYSA-N D06EIO DRUGSMIL CN(CO)C1=NC(=NC(=N1)N(C)CO)N(C)CO D06EIO HIGHSTAT Discontinued in Phase 2 D06FSC DRUG__ID D06FSC D06FSC THERCLAS Analgesics D06FSC DRUGTYPE Small molecular drug D06FSC DRUGINCH 1S/C32H32N2O/c35-31(25-30(26-13-5-1-6-14-26)27-15-7-2-8-16-27)33-21-23-34(24-22-33)32(28-17-9-3-10-18-28)29-19-11-4-12-20-29/h1-20,30,32H,21-25H2 D06FSC DRUGINKE VCPMZDWBEWTGNW-UHFFFAOYSA-N D06FSC DRUGSMIL C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)CC(C4=CC=CC=C4)C5=CC=CC=C5 D06FSC HIGHSTAT Discontinued in Phase 2 D06GDH DRUG__ID D06GDH D06GDH DRUGCOMP Dong-A D06GDH DRUGTYPE Small molecular drug D06GDH DRUGINCH 1S/C22H30N2O3.ClH/c1-16-6-7-18(13-17(16)2)5-4-11-24-22(25)15-19-8-9-20(27-12-10-23)21(14-19)26-3;/h6-9,13-14H,4-5,10-12,15,23H2,1-3H3,(H,24,25);1H D06GDH DRUGINKE OUEKLNJUMVZULZ-UHFFFAOYSA-N D06GDH DRUGSMIL CC1=C(C=C(C=C1)CCCNC(=O)CC2=CC(=C(C=C2)OCCN)OC)C.Cl D06GDH HIGHSTAT Discontinued in Phase 2 D06HIO DRUG__ID D06HIO D06HIO DRUGCOMP Sigma-Tau Pharmaceuticals D06HIO DRUGTYPE Small molecular drug D06HIO DRUGINCH 1S/C21H32N2O3/c1-20-7-5-13(23-26-10-9-22)11-17(20)18(24)12-14-15-3-4-19(25)21(15,2)8-6-16(14)20/h14-17H,3-12,22H2,1-2H3/b23-13+/t14-,15-,16-,17+,20+,21-/m0/s1 D06HIO DRUGINKE MPYLDWFDPHRTEG-PAAYLBSLSA-N D06HIO DRUGSMIL CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C D06HIO HIGHSTAT Discontinued in Phase 2 D06HKB DRUG__ID D06HKB D06HKB DRUGCOMP National Cancer Institute D06HKB DRUGTYPE Small molecular drug D06HKB DRUGINCH 1S/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1 D06HKB DRUGINKE KBEMFSMODRNJHE-JFWOZONXSA-N D06HKB DRUGSMIL C1C(OC(C1F)N2C=NC3=C(N=CN=C32)N)CO D06HKB HIGHSTAT Discontinued in Phase 2 D06ODM DRUG__ID D06ODM D06ODM DRUGCOMP Boehringer D06ODM DRUGTYPE Small molecular drug D06ODM DRUGINCH 1S/C10H15NO.C4H4O4/c1-2-7-12-10-8-11-5-3-9(10)4-6-11;5-3(6)1-2-4(7)8/h1,9-10H,3-8H2;1-2H,(H,5,6)(H,7,8)/b;2-1+/t10-;/m0./s1 D06ODM DRUGINKE SBCXBWBXWKVIFK-PBBCPHEYSA-N D06ODM DRUGSMIL C#CCOC1CN2CCC1CC2.C(=CC(=O)O)C(=O)O D06ODM HIGHSTAT Discontinued in Phase 2 D06PKS DRUG__ID D06PKS D06PKS DRUGCOMP Ono Pharmaceutical Co Ltd D06PKS DRUGTYPE Small molecular drug D06PKS DRUGINCH 1S/C50H79NO12S.Na/c1-2-3-4-5-6-7-8-15-26-35-42(60-45(54)36-27-16-11-9-13-20-29-40-31-22-18-23-32-40)38-44(53)51-47-49(48(63-64(57,58)59)43(39-52)61-50(47)56)62-46(55)37-28-17-12-10-14-21-30-41-33-24-19-25-34-41;/h18-19,22-25,31-34,42-43,47-50,52,56H,2-17,20-21,26-30,35-39H2,1H3,(H,51,53)(H,57,58,59);/q;+1/p-1/t42-,43+,47+,48+,49+,50?;/m0./s1 D06PKS DRUGINKE KSLCVWMGAOQHEA-TZBBHZOSSA-M D06PKS DRUGSMIL CCCCCCCCCCCC(CC(=O)NC1C(C(C(OC1O)CO)OS(=O)(=O)[O-])OC(=O)CCCCCCCCC2=CC=CC=C2)OC(=O)CCCCCCCCC3=CC=CC=C3.[Na+] D06PKS HIGHSTAT Discontinued in Phase 2 D06PQR DRUG__ID D06PQR D06PQR DRUGCOMP Otsuka Pharmaceutical Co Ltd D06PQR DRUGTYPE Small molecular drug D06PQR DRUGINCH 1S/C24H27N3O3.C6H8O7/c28-22(18-5-2-1-3-6-18)7-4-12-26-13-15-27(16-14-26)24(30)20-8-10-21-19(17-20)9-11-23(29)25-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h1-3,5-6,8,10,17H,4,7,9,11-16H2,(H,25,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D06PQR DRUGINKE ONELTIQETCJUSG-UHFFFAOYSA-N D06PQR DRUGSMIL C1CC(=O)NC2=C1C=C(C=C2)C(=O)N3CCN(CC3)CCCC(=O)C4=CC=CC=C4.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D06PQR HIGHSTAT Discontinued in Phase 2 D06QHT DRUG__ID D06QHT D06QHT DRUGCOMP Wyeth D06QHT DRUGTYPE Small molecular drug D06QHT DRUGINCH 1S/C15H27N3O4S2/c1-12(2)16-10-11-18(13(3)4)24(21,22)15-8-6-14(7-9-15)17-23(5,19)20/h6-9,12-13,16-17H,10-11H2,1-5H3 D06QHT DRUGINKE GLIRXHQYWRYQDV-UHFFFAOYSA-N D06QHT DRUGSMIL CC(C)NCCN(C(C)C)S(=O)(=O)C1=CC=C(C=C1)NS(=O)(=O)C D06QHT HIGHSTAT Discontinued in Phase 2 D06QOF DRUG__ID D06QOF D06QOF DRUGCOMP Roche D06QOF DRUGTYPE Small molecular drug D06QOF DRUGINCH 1S/C18H26FN3O6/c1-9(2)14(23)26-8-11-13(28-15(24)10(3)4)18(5,19)16(27-11)22-7-6-12(20)21-17(22)25/h6-7,9-11,13,16H,8H2,1-5H3,(H2,20,21,25)/t11-,13-,16-,18-/m1/s1 D06QOF DRUGINKE MLESJYFEMSJZLZ-MAAOGQSESA-N D06QOF DRUGSMIL CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C D06QOF HIGHSTAT Discontinued in Phase 2 D06QOJ DRUG__ID D06QOJ D06QOJ DRUGCOMP Sankyo Co Ltd D06QOJ DRUGTYPE Small molecular drug D06QOJ DRUGINCH 1S/C14H12N4O/c15-7-9-1-3-10(4-2-9)18-14-11-5-6-12(19)13(11)16-8-17-14/h1-4,8,12,19H,5-6H2,(H,16,17,18) D06QOJ DRUGINKE YKTSVZRWKHWINV-UHFFFAOYSA-N D06QOJ DRUGSMIL C1CC2=C(C1O)N=CN=C2NC3=CC=C(C=C3)C#N D06QOJ HIGHSTAT Discontinued in Phase 2 D06SBK DRUG__ID D06SBK D06SBK DRUGCOMP LEO Pharma A/S D06SBK DRUGTYPE Small molecular drug D06SBK DRUGINCH 1S/C32H46O4/c1-21(19-36-20-23-8-6-10-26(16-23)31(3,4)35)28-13-14-29-24(9-7-15-32(28,29)5)11-12-25-17-27(33)18-30(34)22(25)2/h6,8,10-12,16,21,27-30,33-35H,2,7,9,13-15,17-20H2,1,3-5H3/b24-11+,25-12-/t21-,27+,28+,29-,30-,32+/m0/s1 D06SBK DRUGINKE CFIFSLBCJAXYTC-FJLAUVHZSA-N D06SBK DRUGSMIL CC(COCC1=CC(=CC=C1)C(C)(C)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D06SBK HIGHSTAT Discontinued in Phase 2 D06TAL DRUG__ID D06TAL D06TAL DRUGCOMP Eli Lilly & Co D06TAL DRUGTYPE Small molecular drug D06TAL DRUGINCH 1S/C18H27NO2S/c1-17(2,3)12-7-11(9-14-16(21)19-10-22-14)8-13(15(12)20)18(4,5)6/h7-8,14,20H,9-10H2,1-6H3,(H,19,21) D06TAL DRUGINKE ILMMRHUILQOQGP-UHFFFAOYSA-N D06TAL DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NCS2 D06TAL HIGHSTAT Discontinued in Phase 2 D06TVC DRUG__ID D06TVC D06TVC DRUGCOMP Laboratories UPSA D06TVC DRUGTYPE Small molecular drug D06TVC DRUGINCH 1S/C21H28N2O5S/c1-5-27-20(26)16-11-14(23-19(25)18-7-6-10-29-18)8-9-17(16)28-13-15(24)12-22-21(2,3)4/h6-11,15,22,24H,5,12-13H2,1-4H3,(H,23,25) D06TVC DRUGINKE PHMRLCQEIQGCHH-UHFFFAOYSA-N D06TVC DRUGSMIL CCOC(=O)C1=C(C=CC(=C1)NC(=O)C2=CC=CS2)OCC(CNC(C)(C)C)O D06TVC HIGHSTAT Discontinued in Phase 2 D06UVO DRUG__ID D06UVO D06UVO DRUGCOMP Bristol-Myers Squibb Pharma Co D06UVO DRUGTYPE Small molecular drug D06UVO DRUGINCH 1S/C17H14O/c18-17-15(12-13-6-2-1-3-7-13)11-10-14-8-4-5-9-16(14)17/h1-11,18H,12H2 D06UVO DRUGINKE CZTSOXCSVFEFIK-UHFFFAOYSA-N D06UVO DRUGSMIL C1=CC=C(C=C1)CC2=C(C3=CC=CC=C3C=C2)O D06UVO HIGHSTAT Discontinued in Phase 2 D06UYI DRUG__ID D06UYI D06UYI DRUGCOMP Amira Pharma. D06UYI DRUGTYPE Small molecular drug D06UYI DRUGINCH 1S/C22H20N4O3/c1-14(27)8-18-9-16-10-19(11-24-22(16)26(18)12-21(23)28)29-13-17-7-6-15-4-2-3-5-20(15)25-17/h2-7,9-11H,8,12-13H2,1H3,(H2,23,28) D06UYI DRUGINKE NNJQMAFPENKSQD-UHFFFAOYSA-N D06UYI DRUGSMIL CC(=O)CC1=CC2=CC(=CN=C2N1CC(=O)N)OCC3=NC4=CC=CC=C4C=C3 D06UYI HIGHSTAT Discontinued in Phase 2 D06WJI DRUG__ID D06WJI D06WJI DRUGCOMP Otsuka America Pharmaceutical D06WJI DRUGTYPE Small molecular drug D06WJI DRUGINCH 1S/C26H35N3O2/c1-5-24(30)27-25-19(2)17-22(18-20(25)3)26(31)29-15-12-23(13-16-29)28(4)14-11-21-9-7-6-8-10-21/h6-10,17-18,23H,5,11-16H2,1-4H3,(H,27,30) D06WJI DRUGINKE BESKMDLUOAVUJF-UHFFFAOYSA-N D06WJI DRUGSMIL CCC(=O)NC1=C(C=C(C=C1C)C(=O)N2CCC(CC2)N(C)CCC3=CC=CC=C3)C D06WJI HIGHSTAT Discontinued in Phase 2 D06WOJ DRUG__ID D06WOJ D06WOJ DRUGCOMP Japan Tobacco Inc D06WOJ DRUGTYPE Small molecular drug D06WOJ DRUGINCH 1S/C24H35NO4.2C4H4O4/c1-14(2)19-12-21(26)15(3)11-22(19)29-10-9-25(7)13-20-18(6)23(27)16(4)17(5)24(20)28-8;2*5-3(6)1-2-4(7)8/h11-12,14,26-27H,9-10,13H2,1-8H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+ D06WOJ DRUGINKE SZSMNSNVWDKMMN-LVEZLNDCSA-N D06WOJ DRUGSMIL CC1=CC(=C(C=C1O)C(C)C)OCCN(C)CC2=C(C(=C(C(=C2C)O)C)C)OC.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O D06WOJ HIGHSTAT Discontinued in Phase 2 D06XEL DRUG__ID D06XEL D06XEL DRUGCOMP DeCODE genetics D06XEL DRUGTYPE Small molecular drug D06XEL DRUGINCH 1S/C21H24ClNO4.ClH/c22-16-5-7-19(8-6-16)27-20-11-9-18(10-12-20)26-15-17-3-1-13-23(17)14-2-4-21(24)25;/h5-12,17H,1-4,13-15H2,(H,24,25);1H/t17-;/m0./s1 D06XEL DRUGINKE UCPVOTSNNAVKNE-LMOVPXPDSA-N D06XEL DRUGSMIL C1CC(N(C1)CCCC(=O)O)COC2=CC=C(C=C2)OC3=CC=C(C=C3)Cl.Cl D06XEL HIGHSTAT Discontinued in Phase 2 D07AOY DRUG__ID D07AOY D07AOY DRUGCOMP Furiex pharmaceuticals D07AOY DRUGTYPE Small molecular drug D07AOY DRUGINCH 1S/C21H23F2N3O4/c1-30-20-17-13(19(27)14(21(28)29)10-26(17)12-4-5-12)7-15(22)18(20)25-6-2-3-11(9-25)16(23)8-24/h7,10,12H,2-6,8-9,24H2,1H3,(H,28,29)/b16-11+ D07AOY DRUGINKE VMKVDAAFMQKZJS-LFIBNONCSA-N D07AOY DRUGSMIL COC1=C2C(=CC(=C1N3CCCC(=C(CN)F)C3)F)C(=O)C(=CN2C4CC4)C(=O)O D07AOY HIGHSTAT Discontinued in Phase 2 D07BDY DRUG__ID D07BDY D07BDY DRUGCOMP Bayer Schering Pharma AG D07BDY DRUGTYPE Small molecular drug D07BDY DRUGINCH 1S/C31H48O5/c1-19(2)36-29(35)30(5,6)28(34)15-10-20(3)25-13-14-26-22(9-8-16-31(25,26)7)11-12-23-17-24(32)18-27(33)21(23)4/h10-12,15,19-20,24-28,32-34H,4,8-9,13-14,16-18H2,1-3,5-7H3/b15-10+,22-11+,23-12-/t20-,24-,25-,26+,27+,28-,31-/m1/s1 D07BDY DRUGINKE AUMBXYDXKLLKEK-BGMQPCSBSA-N D07BDY DRUGSMIL CC(C)OC(=O)C(C)(C)C(C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O D07BDY HIGHSTAT Discontinued in Phase 2 D07BKL DRUG__ID D07BKL D07BKL DRUGCOMP Kyowa Hakko Kogyo Co Ltd D07BKL DRUGTYPE Small molecular drug D07BKL DRUGINCH 1S/C20H23N5O4.2ClH/c21-6-1-7-23-12-3-2-11-13(10-22-8-9-26)24-25-18(11)16(12)20(29)17-14(27)4-5-15(28)19(17)25;;/h2-5,22-23,26,28-29H,1,6-10,21H2;2*1H D07BKL DRUGINKE FSJDQJHSJAGEJV-UHFFFAOYSA-N D07BKL DRUGSMIL C1=CC(=C2C3=C1C(=NN3C4=C(C=CC(=O)C4=C2O)O)CNCCO)NCCCN.Cl.Cl D07BKL HIGHSTAT Discontinued in Phase 2 D07FNG DRUG__ID D07FNG D07FNG THERCLAS Analgesics D07FNG DRUGTYPE Small molecular drug D07FNG DRUGINCH 1S/C107H179N35O36S7/c1-51(2)33-64(129-91(163)62(20-11-15-30-111)127-100(172)71(44-147)135-103(175)73(47-181)137-93(165)60(18-9-13-28-109)124-85(157)53(5)121-77(150)36-117-87(159)58(17-8-12-27-108)126-99(171)70(43-146)134-92(164)61(19-10-14-29-110)125-86(158)57(112)45-179)95(167)128-63(26-32-185-7)94(166)130-65(34-55-22-24-56(149)25-23-55)96(168)131-66(35-81(154)155)97(169)138-76(50-184)104(176)140-75(49-183)102(174)133-67(40-143)88(160)118-37-79(152)123-69(42-145)98(170)139-74(48-182)101(173)132-68(41-144)89(161)119-39-80(153)141-83(54(6)148)106(178)142-82(52(3)4)105(177)120-38-78(151)122-59(21-16-31-116-107(114)115)90(162)136-72(46-180)84(113)156/h22-25,46,48-49,51-54,57-76,82-83,143-149,179,181,184H,8-21,26-45,47,50,108-112H2,1-7H3,(H2,113,156)(H,117,159)(H,118,160)(H,119,161)(H,120,177)(H,121,150)(H,122,151)(H,123,152)(H,124,157)(H,125,158)(H,126,171)(H,127,172)(H,128,167)(H,129,163)(H,130,166)(H,131,168)(H,132,173)(H,133,174)(H,134,164)(H,135,175)(H,136,162)(H,137,165)(H,138,169)(H,139,170)(H,140,176)(H,141,153)(H,142,178)(H,154,155)(H4,114,115,116)/t53-,54+,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,82-,83-/m0/s1 D07FNG DRUGINKE HBMCYCKNGADUQP-CFIKXUEXSA-N D07FNG DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)O)C(=O)NC(CS)C(=O)NC(C=S)C(=O)NC(CO)C(=O)NCC(=O)NC(CO)C(=O)NC(C=S)C(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(C=S)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CS)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CS)N D07FNG HIGHSTAT Discontinued in Phase 2 D07GDN DRUG__ID D07GDN D07GDN DRUGCOMP Pfizer D07GDN DRUGTYPE Small molecular drug D07GDN DRUGINCH 1S/C26H25F9N2O4/c1-4-18-12-21(19-11-15(24(27,28)29)6-7-20(19)37(18)23(39)41-5-2)36(22(38)40-3)13-14-8-16(25(30,31)32)10-17(9-14)26(33,34)35/h6-11,18,21H,4-5,12-13H2,1-3H3/t18-,21+/m1/s1 D07GDN DRUGINKE CMSGWTNRGKRWGS-NQIIRXRSSA-N D07GDN DRUGSMIL CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC D07GDN HIGHSTAT Discontinued in Phase 2 D07GLF DRUG__ID D07GLF D07GLF DRUGCOMP Tetragenex Pharmaceuticals D07GLF DRUGTYPE Small molecular drug D07GLF DRUGINCH 1S/C33H43FN10O6/c34-20-9-7-18(8-10-20)12-23(35)32(50)44-17-21(45)14-27(44)31(49)43-25(6-3-11-39-33(37)38)30(48)41-16-28(46)42-26(29(36)47)13-19-15-40-24-5-2-1-4-22(19)24/h1-2,4-5,7-10,15,21,23,25-27,40,45H,3,6,11-14,16-17,35H2,(H2,36,47)(H,41,48)(H,42,46)(H,43,49)(H4,37,38,39)/t21-,23+,25+,26+,27+/m1/s1 D07GLF DRUGINKE SGXPTOACEHQGHL-RCNLLYRESA-N D07GLF DRUGSMIL C1C(CN(C1C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)N)C(=O)C(CC4=CC=C(C=C4)F)N)O D07GLF HIGHSTAT Discontinued in Phase 2 D07HTX DRUG__ID D07HTX D07HTX DRUGCOMP University of North Carolina D07HTX DRUGTYPE Small molecular drug D07HTX DRUGINCH 1S/C27H24N2O9/c1-34-21-7-13(8-22(35-2)26(21)30)23-16-9-19-20(38-12-37-19)10-17(16)25(18-11-36-27(31)24(18)23)28-14-3-5-15(6-4-14)29(32)33/h3-10,18,23-25,28,30H,11-12H2,1-2H3/t18-,23+,24-,25+/m0/s1 D07HTX DRUGINKE DLROLUIVVKTFPW-LVEBQJTPSA-N D07HTX DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)NC6=CC=C(C=C6)[N+](=O)[O-] D07HTX HIGHSTAT Discontinued in Phase 2 D07MPJ DRUG__ID D07MPJ D07MPJ DRUGCOMP Abbott Laboratories D07MPJ DRUGTYPE Small molecular drug D07MPJ DRUGINCH 1S/C44H54N4O8/c1-29(2)37(47-43(53)55-27-33-21-13-7-14-22-33)41(51)45-35(25-31-17-9-5-10-18-31)39(49)40(50)36(26-32-19-11-6-12-20-32)46-42(52)38(30(3)4)48-44(54)56-28-34-23-15-8-16-24-34/h5-24,29-30,35-40,49-50H,25-28H2,1-4H3,(H,45,51)(H,46,52)(H,47,53)(H,48,54)/t35-,36-,37-,38-,39+,40+/m0/s1 D07MPJ DRUGINKE TZRRVSCDIPHXHN-RRUVMKMCSA-N D07MPJ DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(C(C(CC2=CC=CC=C2)NC(=O)C(C(C)C)NC(=O)OCC3=CC=CC=C3)O)O)NC(=O)OCC4=CC=CC=C4 D07MPJ HIGHSTAT Discontinued in Phase 2 D07RUV DRUG__ID D07RUV D07RUV DRUGCOMP Recordati SpA D07RUV DRUGTYPE Small molecular drug D07RUV DRUGINCH 1S/C26H29NO4/c1-18-22(28)20-13-10-14-21(24(20)30-23(18)19-11-6-4-7-12-19)25(29)31-26(2,3)17-27-15-8-5-9-16-27/h4,6-7,10-14H,5,8-9,15-17H2,1-3H3 D07RUV DRUGINKE VQTYZZPDAFGNCK-UHFFFAOYSA-N D07RUV DRUGSMIL CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OC(C)(C)CN3CCCCC3)C4=CC=CC=C4 D07RUV HIGHSTAT Discontinued in Phase 2 D07RYX DRUG__ID D07RYX D07RYX DRUGCOMP Merck Serono SA D07RYX DRUGTYPE Small molecular drug D07RYX DRUGINCH 1S/C82H108ClN17O14/c1-50(2)41-65(76(108)95-64(26-11-12-37-88-51(3)4)82(114)100-40-18-27-70(100)81(113)91-52(5)71(84)103)96-75(107)63(25-10-14-39-90-73(105)60-23-17-36-87-48-60)93-74(106)62(24-9-13-38-89-72(104)59-22-16-35-86-47-59)94-80(112)69(49-101)99-79(111)68(45-56-19-15-34-85-46-56)98-78(110)67(43-54-29-32-61(83)33-30-54)97-77(109)66(92-53(6)102)44-55-28-31-57-20-7-8-21-58(57)42-55/h7-8,15-17,19-23,28-36,42,46-48,50-52,62-70,88,101H,9-14,18,24-27,37-41,43-45,49H2,1-6H3,(H2,84,103)(H,89,104)(H,90,105)(H,91,113)(H,92,102)(H,93,106)(H,94,112)(H,95,108)(H,96,107)(H,97,109)(H,98,110)(H,99,111)/t52-,62+,63-,64+,65+,66-,67-,68-,69+,70+/m1/s1 D07RYX DRUGINKE QRYFGTULTGLGHU-NBERXCRTSA-N D07RYX DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=O)C2=CN=CC=C2)NC(=O)C(CCCCNC(=O)C3=CN=CC=C3)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D07RYX HIGHSTAT Discontinued in Phase 2 D07XDS DRUG__ID D07XDS D07XDS DRUGCOMP Sankyo Co Ltd D07XDS DRUGTYPE Small molecular drug D07XDS DRUGINCH 1S/C23H35N7O6S/c1-10-17-16(11(2)31)21(34)30(17)18(22(35)36)19(10)37-13-6-14(28(3)9-13)20(33)29-5-4-12(8-29)27-15(32)7-26-23(24)25/h10-14,16-17,31H,4-9H2,1-3H3,(H,27,32)(H,35,36)(H4,24,25,26)/t10-,11-,12+,13+,14+,16-,17-/m1/s1 D07XDS DRUGINKE KEDAXBWZURNCHS-GPODMPQUSA-N D07XDS DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC(N(C3)C)C(=O)N4CCC(C4)NC(=O)CN=C(N)N)C(=O)O)C(C)O D07XDS HIGHSTAT Discontinued in Phase 2 D07XPT DRUG__ID D07XPT D07XPT DRUGCOMP GSK D07XPT DRUGTYPE Small molecular drug D07XPT DRUGINCH 1S/C25H31F2NO4/c1-25(2,13-17-9-18-5-3-4-6-19(18)10-17)28-14-20(29)15-32-22-12-16(7-8-23(30)31)11-21(26)24(22)27/h3-6,11-12,17,20,28-29H,7-10,13-15H2,1-2H3,(H,30,31)/t20-/m1/s1 D07XPT DRUGINKE FQJISUPNMFRIFZ-HXUWFJFHSA-N D07XPT DRUGSMIL CC(C)(CC1CC2=CC=CC=C2C1)NCC(COC3=C(C(=CC(=C3)CCC(=O)O)F)F)O D07XPT HIGHSTAT Discontinued in Phase 2 D07YHT DRUG__ID D07YHT D07YHT DRUGCOMP GlaxoSmithKline D07YHT DRUGTYPE Small molecular drug D07YHT DRUGINCH 1S/C29H30O8/c1-3-11-34-19-6-7-20-22(14-19)27(21-8-5-18(33-2)15-24(21)35-12-10-30)28(29(31)32)26(20)17-4-9-23-25(13-17)37-16-36-23/h4-9,13-15,26-28,30H,3,10-12,16H2,1-2H3,(H,31,32)/t26-,27+,28+/m0/s1 D07YHT DRUGINKE GLCKXJLCYIJMRB-UPRLRBBYSA-N D07YHT DRUGSMIL CCCOC1=CC2=C(C=C1)C(C(C2C3=C(C=C(C=C3)OC)OCCO)C(=O)O)C4=CC5=C(C=C4)OCO5 D07YHT HIGHSTAT Discontinued in Phase 2 D08AWI DRUG__ID D08AWI D08AWI DRUGCOMP Epix D08AWI DRUGTYPE Small molecular drug D08AWI DRUGINCH 1S/C23H38N4O3S/c1-20(28)25-22-10-7-11-23(18-22)27-16-14-26(15-17-27)13-6-5-12-24-31(29,30)19-21-8-3-2-4-9-21/h7,10-11,18,21,24H,2-6,8-9,12-17,19H2,1H3,(H,25,28) D08AWI DRUGINKE SPWZXWDPAWDKQE-UHFFFAOYSA-N D08AWI DRUGSMIL CC(=O)NC1=CC(=CC=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3 D08AWI HIGHSTAT Discontinued in Phase 2 D08CLN DRUG__ID D08CLN D08CLN DRUGCOMP Hoechst Marion Roussel Inc D08CLN DRUGTYPE Small molecular drug D08CLN DRUGINCH 1S/C10H10FN3S/c1-13-9(12-14(2)10(13)15)7-4-3-5-8(11)6-7/h3-6H,1-2H3 D08CLN DRUGINKE IWDUZEHNLHFBRZ-UHFFFAOYSA-N D08CLN DRUGSMIL CN1C(=NN(C1=S)C)C2=CC(=CC=C2)F D08CLN HIGHSTAT Discontinued in Phase 2 D08DBE DRUG__ID D08DBE D08DBE DRUGCOMP Rigel Pharmaceuticals Inc D08DBE DRUGTYPE Small molecular drug D08DBE DRUGINCH 1S/C21H17F3N6O4/c1-25-17(31)10-33-13-4-2-3-11(7-13)28-20-26-9-14(22)18(30-20)27-12-5-6-16-15(8-12)29-19(32)21(23,24)34-16/h2-9H,10H2,1H3,(H,25,31)(H,29,32)(H2,26,27,28,30) D08DBE DRUGINKE MOXXQFNQDDSJHT-UHFFFAOYSA-N D08DBE DRUGSMIL CNC(=O)COC1=CC=CC(=C1)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(C(=O)N4)(F)F)F D08DBE HIGHSTAT Discontinued in Phase 2 D08DWH DRUG__ID D08DWH D08DWH DRUGCOMP Laboratorio Guidotti SpA D08DWH DRUGTYPE Small molecular drug D08DWH DRUGINCH 1S/C11H18N2O5/c1-13(6-9(14)12-18)10(15)7-4-2-3-5-8(7)11(16)17/h7-8,18H,2-6H2,1H3,(H,12,14)(H,16,17)/t7-,8+/m1/s1 D08DWH DRUGINKE QKIVRALZQSUWHH-SFYZADRCSA-N D08DWH DRUGSMIL CN(CC(=O)NO)C(=O)C1CCCCC1C(=O)O D08DWH HIGHSTAT Discontinued in Phase 2 D08GRF DRUG__ID D08GRF D08GRF DRUGCOMP Ligand Pharmaceuticals D08GRF DRUGTYPE Small molecular drug D08GRF DRUGINCH 1S/C23H32O2/c1-16(12-21(24)25)10-9-11-17(2)18-13-19(22(3,4)5)15-20(14-18)23(6,7)8/h9-15H,1-8H3,(H,24,25)/b10-9+,16-12+,17-11+ D08GRF DRUGINKE JMPZTWDLOGTBPM-OUQSKUGOSA-N D08GRF DRUGSMIL CC(=CC(=O)O)C=CC=C(C)C1=CC(=CC(=C1)C(C)(C)C)C(C)(C)C D08GRF HIGHSTAT Discontinued in Phase 2 D08HFA DRUG__ID D08HFA D08HFA DRUGCOMP Mitsubishi Pharma Corp D08HFA DRUGTYPE Small molecular drug D08HFA DRUGINCH 1S/C21H22N2O4/c1-14(24)23(26-13-15-7-5-4-6-8-15)19-17-11-16(12-22)9-10-18(17)27-21(2,3)20(19)25/h4-11,19-20,25H,13H2,1-3H3/t19-,20+/m1/s1 D08HFA DRUGINKE RHFUXPCCELGMFC-UXHICEINSA-N D08HFA DRUGSMIL CC(=O)N(C1C(C(OC2=C1C=C(C=C2)C#N)(C)C)O)OCC3=CC=CC=C3 D08HFA HIGHSTAT Discontinued in Phase 2 D08HGY DRUG__ID D08HGY D08HGY DRUGCOMP ARYx Therapeutics D08HGY DRUGTYPE Small molecular drug D08HGY DRUGINCH 1S/C27H41ClN4O5/c1-35-23-15-21(29)20(28)14-19(23)27(34)30-22-9-13-31(17-25(22)36-2)10-5-3-4-6-26(33)37-24-16-32-11-7-18(24)8-12-32/h14-15,18,22,24-25H,3-13,16-17,29H2,1-2H3,(H,30,34)/t22-,24+,25+/m1/s1 D08HGY DRUGINKE VGDDOIZXGFJDRC-VJTSUQJLSA-N D08HGY DRUGSMIL COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)OC3CN4CCC3CC4 D08HGY HIGHSTAT Discontinued in Phase 2 D08LVF DRUG__ID D08LVF D08LVF DRUGCOMP Orion Corp D08LVF DRUGTYPE Small molecular drug D08LVF DRUGINCH 1S/C12H11NO6/c1-6(14)9(7(2)15)3-8-4-10(13(18)19)12(17)11(16)5-8/h3-5,16-17H,1-2H3 D08LVF DRUGINKE UPMRZALMHVUCIN-UHFFFAOYSA-N D08LVF DRUGSMIL CC(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C(=O)C D08LVF HIGHSTAT Discontinued in Phase 2 D08ODH DRUG__ID D08ODH D08ODH DRUGCOMP Chugai Pharmaceutical Co Ltd D08ODH DRUGTYPE Small molecular drug D08ODH DRUGINCH 1S/C31H34N6O6/c1-4-6-7-11-36-17-33-21-9-8-10-22-26(21)28(36)18-14-37-23(27(18)34-22)12-20-19(29(37)40)16-42-30(41)31(20,5-2)43-25(39)15-35(3)24(38)13-32/h8-10,12,17H,4-7,11,13-16,32H2,1-3H3/t31-/m0/s1 D08ODH DRUGINKE CWJSAEZZZABNRI-HKBQPEDESA-N D08ODH DRUGSMIL CCCCCN1C=NC2=CC=CC3=C2C1=C4CN5C(=CC6=C(C5=O)COC(=O)C6(CC)OC(=O)CN(C)C(=O)CN)C4=N3 D08ODH HIGHSTAT Discontinued in Phase 2 D08OQQ DRUG__ID D08OQQ D08OQQ DRUGCOMP GlaxoSmithKline plc D08OQQ DRUGTYPE Small molecular drug D08OQQ DRUGINCH 1S/C19H29N5O2/c1-23-19(21-18(15-25)22-23)20-9-6-12-26-17-8-5-7-16(13-17)14-24-10-3-2-4-11-24/h5,7-8,13,25H,2-4,6,9-12,14-15H2,1H3,(H,20,21,22) D08OQQ DRUGINKE VTLNPNNUIJHJQB-UHFFFAOYSA-N D08OQQ DRUGSMIL CN1C(=NC(=N1)CO)NCCCOC2=CC=CC(=C2)CN3CCCCC3 D08OQQ HIGHSTAT Discontinued in Phase 2 D08PNQ DRUG__ID D08PNQ D08PNQ DRUGCOMP Alter SA D08PNQ DRUGTYPE Small molecular drug D08PNQ DRUGINCH 1S/C21H24N2O7S/c1-5-29-20(25)17-12(2)18(14(4)22-13(17)3)21(26)30-11-10-23-19(24)15-8-6-7-9-16(15)31(23,27)28/h6-9,12,22H,5,10-11H2,1-4H3 D08PNQ DRUGINKE MCNAAGLIGWJLQX-UHFFFAOYSA-N D08PNQ DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C)C(=O)OCCN2C(=O)C3=CC=CC=C3S2(=O)=O)C)C D08PNQ HIGHSTAT Discontinued in Phase 2 D08QHS DRUG__ID D08QHS D08QHS DRUGCOMP DeCODE genetics D08QHS DRUGTYPE Small molecular drug D08QHS DRUGINCH 1S/C23H15Cl4FN2O3S2/c1-12-10-30(11-14-2-4-15(24)7-18(14)25)22-13(6-16(28)8-17(12)22)3-5-20(31)29-35(32,33)21-9-19(26)23(27)34-21/h2-10H,11H2,1H3,(H,29,31)/b5-3+ D08QHS DRUGINKE BFBTVZNKWXWKNZ-HWKANZROSA-N D08QHS DRUGSMIL CC1=CN(C2=C(C=C(C=C12)F)C=CC(=O)NS(=O)(=O)C3=CC(=C(S3)Cl)Cl)CC4=C(C=C(C=C4)Cl)Cl D08QHS HIGHSTAT Discontinued in Phase 2 D08SNL DRUG__ID D08SNL D08SNL THERCLAS Analgesics D08SNL DRUGTYPE Small molecular drug D08SNL DRUGINCH 1S/C26H25N3O2.ClH/c1-3-18-8-11-21(12-9-18)31-16-19-6-4-5-7-22(19)26(30)29-20-10-13-25-23(15-20)24(27)14-17(2)28-25;/h4-15H,3,16H2,1-2H3,(H2,27,28)(H,29,30);1H D08SNL DRUGINKE NQLIYKXNAXKMBL-UHFFFAOYSA-N D08SNL DRUGSMIL CCC1=CC=C(C=C1)OCC2=CC=CC=C2C(=O)NC3=CC4=C(C=C(N=C4C=C3)C)N.Cl D08SNL HIGHSTAT Discontinued in Phase 2 D08UHN DRUG__ID D08UHN D08UHN DRUGCOMP Janssen Pharmaceutica NV D08UHN DRUGTYPE Small molecular drug D08UHN DRUGINCH 1S/C18H16N4/c1-13-20-16-8-7-15(11-17(16)21-13)18(22-10-9-19-12-22)14-5-3-2-4-6-14/h2-12,18H,1H3,(H,20,21) D08UHN DRUGINKE DCGOMTSIZLGUOK-UHFFFAOYSA-N D08UHN DRUGSMIL CC1=NC2=C(N1)C=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4 D08UHN HIGHSTAT Discontinued in Phase 2 D08WCU DRUG__ID D08WCU D08WCU DRUGCOMP Bristol-Myers Squibb Co D08WCU DRUGTYPE Small molecular drug D08WCU DRUGINCH 1S/C20H18ClN5O2/c1-20(2)18(27)17(15-9-12(10-22)3-8-16(15)28-20)26-19(24-11-23)25-14-6-4-13(21)5-7-14/h3-9,17-18,27H,1-2H3,(H2,24,25,26)/t17-,18+/m1/s1 D08WCU DRUGINKE VLICJSLDCJXZBG-MSOLQXFVSA-N D08WCU DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N=C(NC#N)NC3=CC=C(C=C3)Cl)O)C D08WCU HIGHSTAT Discontinued in Phase 2 D08XQA DRUG__ID D08XQA D08XQA DRUGCOMP University of British Columbia D08XQA DRUGTYPE Small molecular drug D08XQA DRUGINCH 1S/C21H28N2OS/c1-22(18-8-2-3-9-19(18)23-12-4-5-13-23)21(24)15-16-7-6-10-20-17(16)11-14-25-20/h6-7,10-11,14,18-19H,2-5,8-9,12-13,15H2,1H3/t18-,19-/m1/s1 D08XQA DRUGINKE SYHJZCCNQDFHJQ-RTBURBONSA-N D08XQA DRUGSMIL CN(C1CCCCC1N2CCCC2)C(=O)CC3=C4C=CSC4=CC=C3 D08XQA HIGHSTAT Discontinued in Phase 2 D08ZKN DRUG__ID D08ZKN D08ZKN DRUGCOMP Pharmagenesis D08ZKN DRUGTYPE Small molecular drug D08ZKN DRUGINCH 1S/C24H27N3O7S/c1-33-20-9-5-18(6-10-20)23(28)25-19-7-11-21(12-8-19)35(31,32)26-22(24(29)30)4-2-3-13-27-14-16-34-17-15-27/h5-12,22,26H,4,13-17H2,1H3,(H,25,28)(H,29,30) D08ZKN DRUGINKE JAYVKNDQKXUNOJ-UHFFFAOYSA-N D08ZKN DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC(CC#CCN3CCOCC3)C(=O)O D08ZKN HIGHSTAT Discontinued in Phase 2 D09AFJ DRUG__ID D09AFJ D09AFJ DRUGCOMP Sanofi-Synthelabo D09AFJ DRUGTYPE Small molecular drug D09AFJ DRUGINCH 1S/C27H37N5O6S/c1-4-36-23(33)13-16-32(21-11-14-31(15-12-21)17-24(34)37-5-2)26-29-22(18-39-26)19-7-9-20(10-8-19)25(28)30-27(35)38-6-3/h7-10,18,21H,4-6,11-17H2,1-3H3,(H2,28,30,35) D09AFJ DRUGINKE WJMRSKGCJGOLKV-UHFFFAOYSA-N D09AFJ DRUGSMIL CCOC(=O)CCN(C1CCN(CC1)CC(=O)OCC)C2=NC(=CS2)C3=CC=C(C=C3)C(=NC(=O)OCC)N D09AFJ HIGHSTAT Discontinued in Phase 2 D09AUP DRUG__ID D09AUP D09AUP DRUGCOMP Glaxo Wellcome plc D09AUP DRUGTYPE Small molecular drug D09AUP DRUGINCH 1S/C25H30F2O6S/c1-12-8-14-15-10-17(26)16-9-13(28)4-6-22(16,2)24(15,27)19(29)11-23(14,3)25(12,32)21(31)34-18-5-7-33-20(18)30/h4,6,9,12,14-15,17-19,29,32H,5,7-8,10-11H2,1-3H3/t12-,14?,15+,17+,18-,19+,22+,23+,24?,25+/m1/s1 D09AUP DRUGINKE OJRPWVDDBGJONP-RCWMBTMBSA-N D09AUP DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SC5CCOC5=O)O)C)O)F)C)F D09AUP HIGHSTAT Discontinued in Phase 2 D09EEV DRUG__ID D09EEV D09EEV DRUGCOMP OXiGENE Inc D09EEV DRUGTYPE Small molecular drug D09EEV DRUGINCH 1S/C13H20ClN3O/c1-3-17(4-2)8-7-16-13(18)10-5-6-12(15)11(14)9-10/h5-6,9H,3-4,7-8,15H2,1-2H3,(H,16,18) D09EEV DRUGINKE YEYAKZXEBSVURO-UHFFFAOYSA-N D09EEV DRUGSMIL CCN(CC)CCNC(=O)C1=CC(=C(C=C1)N)Cl D09EEV HIGHSTAT Discontinued in Phase 2 D09EVZ DRUG__ID D09EVZ D09EVZ DRUGCOMP Bristol-Myers Squibb D09EVZ DRUGTYPE Small molecular drug D09EVZ DRUGINCH 1S/C22H22N4O5/c1-30-16-13-24-20(31-2)18-17(16)15(12-23-18)19(27)22(29)26-10-8-25(9-11-26)21(28)14-6-4-3-5-7-14/h3-7,12-13,23H,8-11H2,1-2H3 D09EVZ DRUGINKE DBPMWRYLTBNCCE-UHFFFAOYSA-N D09EVZ DRUGSMIL COC1=CN=C(C2=C1C(=CN2)C(=O)C(=O)N3CCN(CC3)C(=O)C4=CC=CC=C4)OC D09EVZ HIGHSTAT Discontinued in Phase 2 D09JVV DRUG__ID D09JVV D09JVV DRUGCOMP Calabar AB D09JVV DRUGTYPE Small molecular drug D09JVV DRUGINCH 1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1 D09JVV DRUGINKE PIJVFDBKTWXHHD-HIFRSBDPSA-N D09JVV DRUGSMIL CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC)C)C D09JVV HIGHSTAT Discontinued in Phase 2 D09OHP DRUG__ID D09OHP D09OHP DRUGCOMP Plexxikon D09OHP DRUGTYPE Small molecular drug D09OHP DRUGINCH 1S/C19H19NO6S/c1-25-14-4-7-16(8-5-14)27(23,24)20-12-13(3-10-19(21)22)17-11-15(26-2)6-9-18(17)20/h4-9,11-12H,3,10H2,1-2H3,(H,21,22) D09OHP DRUGINKE YMPALHOKRBVHOJ-UHFFFAOYSA-N D09OHP DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)N2C=C(C3=C2C=CC(=C3)OC)CCC(=O)O D09OHP HIGHSTAT Discontinued in Phase 2 D09PGM DRUG__ID D09PGM D09PGM DRUGCOMP Chugai Pharmaceutical Co Ltd D09PGM DRUGTYPE Small molecular drug D09PGM DRUGINCH 1S/C16H13NO4/c1-9-12-5-4-11(20-2)8-15(12)21-14-6-3-10(16(18)19)7-13(14)17-9/h3-8H,1-2H3,(H,18,19) D09PGM DRUGINKE JTZGDJSJVQONAV-UHFFFAOYSA-N D09PGM DRUGSMIL CC1=NC2=C(C=CC(=C2)C(=O)O)OC3=C1C=CC(=C3)OC D09PGM HIGHSTAT Discontinued in Phase 2 D09PTA DRUG__ID D09PTA D09PTA DRUGCOMP Astra AB; Hoechst AG D09PTA DRUGTYPE Small molecular drug D09PTA DRUGINCH 1S/C23H27N3O2/c1-23-11-13-24(2)21(23)25(3)20-9-8-18(14-19(20)23)28-22(27)26-12-10-16-6-4-5-7-17(16)15-26/h4-9,14,21H,10-13,15H2,1-3H3/t21-,23+/m1/s1 D09PTA DRUGINKE IIFRKALDATVOJE-GGAORHGYSA-N D09PTA DRUGSMIL CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)N4CCC5=CC=CC=C5C4)C)C D09PTA HIGHSTAT Discontinued in Phase 2 D09PYD DRUG__ID D09PYD D09PYD DRUGCOMP Novartis AG D09PYD DRUGTYPE Small molecular drug D09PYD DRUGINCH 1S/C31H31N2O6P/c34-30(35)20-21-32-31(36)29(22-24-16-18-26(19-17-24)25-10-4-1-5-11-25)33-23-40(37,38-27-12-6-2-7-13-27)39-28-14-8-3-9-15-28/h1-19,29,33H,20-23H2,(H,32,36)(H,34,35)/t29-/m0/s1 D09PYD DRUGINKE JTQWXNZXTRVPHN-LJAQVGFWSA-N D09PYD DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC(C(=O)NCCC(=O)O)NCP(=O)(OC3=CC=CC=C3)OC4=CC=CC=C4 D09PYD HIGHSTAT Discontinued in Phase 2 D09RGW DRUG__ID D09RGW D09RGW DRUGCOMP AstraZeneca plc D09RGW DRUGTYPE Small molecular drug D09RGW DRUGINCH 1S/C24H29Cl2N3O4S/c1-17-2-5-21(6-3-17)34(31,32)27-24(30)29-12-8-18(9-13-29)28-14-10-19(11-15-28)33-20-4-7-22(25)23(26)16-20/h2-7,16,18-19H,8-15H2,1H3,(H,27,30) D09RGW DRUGINKE QVLZVRFIGXNZMN-UHFFFAOYSA-N D09RGW DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(=O)N2CCC(CC2)N3CCC(CC3)OC4=CC(=C(C=C4)Cl)Cl D09RGW HIGHSTAT Discontinued in Phase 2 D09TGZ DRUG__ID D09TGZ D09TGZ DRUGCOMP Mediolanum Farmaceutici SpA D09TGZ DRUGTYPE Small molecular drug D09TGZ DRUGINCH 1S/C47H58N12O6/c1-27-34(33-15-7-9-17-37(33)54-27)23-41(58-44(62)35(49)22-31-25-51-26-53-31)45(63)55-28(2)43(61)57-40(21-30-24-52-36-16-8-6-14-32(30)36)47(65)59-39(20-29-12-4-3-5-13-29)46(64)56-38(42(50)60)18-10-11-19-48/h3-9,12-17,24-26,28,35,38-41,52,54H,10-11,18-23,48-49H2,1-2H3,(H2,50,60)(H,51,53)(H,55,63)(H,56,64)(H,57,61)(H,58,62)(H,59,65)/t28-,35-,38-,39+,40-,41+/m0/s1 D09TGZ DRUGINKE RVWNMGKSNGWLOL-GIIHNPQRSA-N D09TGZ DRUGSMIL CC1=C(C2=CC=CC=C2N1)CC(C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CN=CN6)N D09TGZ HIGHSTAT Discontinued in Phase 2 D09TYS DRUG__ID D09TYS D09TYS DRUGCOMP Janssen Pharmaceutica NV D09TYS DRUGTYPE Small molecular drug D09TYS DRUGINCH 1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23) D09TYS DRUGINKE CJPLEFFCVDQQFZ-UHFFFAOYSA-N D09TYS DRUGSMIL CC1=CC(=C(C=C1)C(=O)C)NC(C2=C(C=CC=C2Cl)Cl)C(=O)N D09TYS HIGHSTAT Discontinued in Phase 2 D09UFV DRUG__ID D09UFV D09UFV DRUGCOMP AstraZeneca plc D09UFV DRUGTYPE Small molecular drug D09UFV DRUGINCH 1S/C25H21F4N3O3/c1-15(31-24(33)25(27,28)29)23(16-4-3-5-20(12-16)34-2)35-21-10-11-22-17(13-21)14-30-32(22)19-8-6-18(26)7-9-19/h3-15,23H,1-2H3,(H,31,33)/t15-,23-/m0/s1 D09UFV DRUGINKE FCNQMDSJHADDFT-WNSKOXEYSA-N D09UFV DRUGSMIL CC(C(C1=CC(=CC=C1)OC)OC2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)NC(=O)C(F)(F)F D09UFV HIGHSTAT Discontinued in Phase 2 D09WCE DRUG__ID D09WCE D09WCE DRUGCOMP Immunotech SA D09WCE DRUGTYPE Small molecular drug D09WCE DRUGINCH 1S/C23H27N5O5/c1-13(29)28-20(23(32)27-12-22(25)31)8-14-2-3-16(30)9-21(14)33-17-4-5-19-18(10-17)15(6-7-24)11-26-19/h2-5,9-11,20,26,30H,6-8,12,24H2,1H3,(H2,25,31)(H,27,32)(H,28,29)/t20-/m0/s1 D09WCE DRUGINKE AUJLCXYDDFMYCQ-FQEVSTJZSA-N D09WCE DRUGSMIL CC(=O)NC(CC1=C(C=C(C=C1)O)OC2=CC3=C(C=C2)NC=C3CCN)C(=O)NCC(=O)N D09WCE HIGHSTAT Discontinued in Phase 2 D0A5RD DRUG__ID D0A5RD D0A5RD DRUGCOMP GlaxoSmithKline D0A5RD DRUGTYPE Small molecular drug D0A5RD DRUGINCH 1S/C13H18ClNO2/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3/t9-,13+/m0/s1 D0A5RD DRUGINKE RCOBKSKAZMVBHT-TVQRCGJNSA-N D0A5RD DRUGSMIL CC1C(OCC(N1)(C)C)(C2=CC(=CC=C2)Cl)O D0A5RD HIGHSTAT Discontinued in Phase 2 D0A5TM DRUG__ID D0A5TM D0A5TM DRUGCOMP Chugai Pharmaceutical Co Ltd D0A5TM DRUGTYPE Small molecular drug D0A5TM DRUGINCH 1S/C21H24N4O3.ClH/c1-28-19-9-5-4-8-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-6-2-3-7-17(16)22-21(25)27;/h2-9H,10-15H2,1H3,(H,22,27);1H D0A5TM DRUGINKE NPNDIKQZGVCHMQ-UHFFFAOYSA-N D0A5TM DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=CC=CC=C4NC3=O.Cl D0A5TM HIGHSTAT Discontinued in Phase 2 D0A9CY DRUG__ID D0A9CY D0A9CY DRUGCOMP Sanofi D0A9CY DRUGTYPE Small molecular drug D0A9CY DRUGINCH 1S/C19H33N3O/c1-14(2)13-19(18(20)23,17-9-7-8-11-21-17)10-12-22(15(3)4)16(5)6/h7-9,11,14-16H,10,12-13H2,1-6H3,(H2,20,23) D0A9CY DRUGINKE ZZOZYGHXNQPIPS-UHFFFAOYSA-N D0A9CY DRUGSMIL CC(C)CC(CCN(C(C)C)C(C)C)(C1=CC=CC=N1)C(=O)N D0A9CY HIGHSTAT Discontinued in Phase 2 D0A9OR DRUG__ID D0A9OR D0A9OR DRUGCOMP Solvay Pharmaceuticals D0A9OR DRUGTYPE Small molecular drug D0A9OR DRUGINCH 1S/C23H20Cl2N4O2S/c1-26-23(28-32(30,31)20-13-11-19(25)12-14-20)29-15-21(16-5-3-2-4-6-16)22(27-29)17-7-9-18(24)10-8-17/h2-14,21H,15H2,1H3,(H,26,28) D0A9OR DRUGINKE AXJQVVLKUYCICH-UHFFFAOYSA-N D0A9OR DRUGSMIL CN=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4 D0A9OR HIGHSTAT Discontinued in Phase 2 D0AB4Q DRUG__ID D0AB4Q D0AB4Q DRUGCOMP AstraZeneca D0AB4Q DRUGTYPE Small molecular drug D0AB4Q DRUGINCH 1S/C14H22N2O/c1-11(2)17-14-8-13(9-16-10-14)7-5-6-12(3)15-4/h5,7-12,15H,6H2,1-4H3/b7-5+/t12-/m0/s1 D0AB4Q DRUGINKE RPCVIAXDAUMJJP-PZBABLGHSA-N D0AB4Q DRUGSMIL CC(C)OC1=CN=CC(=C1)C=CCC(C)NC D0AB4Q HIGHSTAT Discontinued in Phase 2 D0B1KK DRUG__ID D0B1KK D0B1KK DRUGCOMP AstraZeneca D0B1KK DRUGTYPE Small molecular drug D0B1KK DRUGINCH 1S/C22H23ClF2N4O5/c1-33-28-19(26)13-4-2-12(3-5-13)11-27-20(31)17-6-7-29(17)21(32)18(30)14-8-15(23)10-16(9-14)34-22(24)25/h2-5,8-10,17-18,22,30H,6-7,11H2,1H3,(H2,26,28)(H,27,31)/t17-,18+/m0/s1 D0B1KK DRUGINKE XSNMGLZVFNDDPW-ZWKOTPCHSA-N D0B1KK DRUGSMIL CON=C(C1=CC=C(C=C1)CNC(=O)C2CCN2C(=O)C(C3=CC(=CC(=C3)Cl)OC(F)F)O)N D0B1KK HIGHSTAT Discontinued in Phase 2 D0B1MJ DRUG__ID D0B1MJ D0B1MJ DRUGCOMP ALTANA Pharma AG D0B1MJ DRUGTYPE Small molecular drug D0B1MJ DRUGINCH 1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m1/s1 D0B1MJ DRUGINKE SVJMLYUFVDMUHP-MGBGTMOVSA-N D0B1MJ DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC D0B1MJ HIGHSTAT Discontinued in Phase 2 D0B2WQ DRUG__ID D0B2WQ D0B2WQ DRUGCOMP Cancer Research Campaign D0B2WQ DRUGTYPE Small molecular drug D0B2WQ DRUGINCH 1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16) D0B2WQ DRUGINKE JUJPKFNFCWJBCX-UHFFFAOYSA-N D0B2WQ DRUGSMIL C1=C(SC=C1Br)COC2=NC(=NC3=C2NC=N3)N D0B2WQ HIGHSTAT Discontinued in Phase 2 D0B3IC DRUG__ID D0B3IC D0B3IC DRUGCOMP Riom Laboratories D0B3IC DRUGTYPE Small molecular drug D0B3IC DRUGINCH 1S/C20H35NO2/c1-4-10-20(11-6-5-7-12-20)23-17-19(16-22-15-18(2)3)21-13-8-9-14-21/h18-19H,5-9,11-17H2,1-3H3 D0B3IC DRUGINKE FITWYAUFKJXWPL-UHFFFAOYSA-N D0B3IC DRUGSMIL CC#CC1(CCCCC1)OCC(COCC(C)C)N2CCCC2 D0B3IC HIGHSTAT Discontinued in Phase 2 D0B5KE DRUG__ID D0B5KE D0B5KE DRUGCOMP LEO Pharma A/S D0B5KE DRUGTYPE Small molecular drug D0B5KE DRUGINCH 1S/C7H17NO7P2/c9-7(16(10,11)12,17(13,14)15)3-6-8-4-1-2-5-8/h9H,1-6H2,(H2,10,11,12)(H2,13,14,15) D0B5KE DRUGINKE PMXAPNNYCFBALB-UHFFFAOYSA-N D0B5KE DRUGSMIL C1CCN(C1)CCC(O)(P(=O)(O)O)P(=O)(O)O D0B5KE HIGHSTAT Discontinued in Phase 2 D0B6EU DRUG__ID D0B6EU D0B6EU DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D0B6EU DRUGTYPE Small molecular drug D0B6EU DRUGINCH 1S/C21H20N6O4/c1-3-5-15-17(8-7-14(12(2)28)18(15)29)31-11-13-6-4-9-27-20(13)22-10-16(21(27)30)19-23-25-26-24-19/h4,6-10,29H,3,5,11H2,1-2H3,(H,23,24,25,26) D0B6EU DRUGINKE RVRGDCZGEKSIRW-UHFFFAOYSA-N D0B6EU DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCC2=CC=CN3C2=NC=C(C3=O)C4=NNN=N4 D0B6EU HIGHSTAT Discontinued in Phase 2 D0B7HX DRUG__ID D0B7HX D0B7HX DRUGCOMP Santen Pharmaceutical Co Ltd D0B7HX DRUGTYPE Small molecular drug D0B7HX DRUGINCH 1S/C29H32N2O6S/c1-30(14-16-34-21-10-12-25-26(18-21)37-19-36-25)13-6-15-35-24-11-9-20(33-3)17-22(24)28-29(32)31(2)23-7-4-5-8-27(23)38-28/h4-5,7-12,17-18,28H,6,13-16,19H2,1-3H3/t28-/m0/s1 D0B7HX DRUGINKE RKXVEXUAWGRFNP-NDEPHWFRSA-N D0B7HX DRUGSMIL CN1C2=CC=CC=C2SC(C1=O)C3=C(C=CC(=C3)OC)OCCCN(C)CCOC4=CC5=C(C=C4)OCO5 D0B7HX HIGHSTAT Discontinued in Phase 2 D0B7QP DRUG__ID D0B7QP D0B7QP DRUGCOMP 7TMPharma. D0B7QP DRUGTYPE Small molecular drug D0B7QP DRUGINCH 1S/C185H286N52O58S2/c1-20-92(10)144(172(282)222-122(83-136(189)246)161(271)213-115(64-75-297-19)158(268)218-120(78-90(6)7)163(273)229-146(99(17)239)181(292)295-231-117(33-24-68-202-185(197)198)175(285)236-72-27-36-131(236)167(277)214-110(32-23-67-201-184(195)196)154(264)224-126(178(288)289)81-102-43-51-106(242)52-44-102)227-164(274)121(79-100-39-47-104(240)48-40-100)220-153(263)109(31-22-66-200-183(193)194)209-152(262)108(30-21-65-199-182(191)192)210-159(269)118(76-88(2)3)219-162(272)123(85-141(253)254)217-148(258)94(12)204-150(260)97(15)230-293-179(290)127(82-103-45-53-107(243)54-46-103)225-157(267)111(55-59-134(187)244)208-147(257)95(13)205-151(261)114(63-74-296-18)212-155(265)112(56-60-135(188)245)211-156(266)113(57-61-139(249)250)215-168(278)132-37-29-73-237(132)177(287)145(98(16)238)228-149(259)96(14)206-165(275)124(84-137(190)247)232-294-180(291)128(86-142(255)256)207-138(248)87-203-166(276)129-34-25-70-234(129)176(286)125(80-101-41-49-105(241)50-42-101)223-171(281)143(91(8)9)226-170(280)133-38-28-71-235(133)174(284)116(58-62-140(251)252)216-160(270)119(77-89(4)5)221-169(279)130-35-26-69-233(130)173(283)93(11)186/h39-54,88-99,108-133,143-146,230-232,238-243H,20-38,55-87,186H2,1-19H3,(H2,187,244)(H2,188,245)(H2,189,246)(H2,190,247)(H,203,276)(H,204,260)(H,205,261)(H,206,275)(H,207,248)(H,208,257)(H,209,262)(H,210,269)(H,211,266)(H,212,265)(H,213,271)(H,214,277)(H,215,278)(H,216,270)(H,217,258)(H,218,268)(H,219,272)(H,220,263)(H,221,279)(H,222,282)(H,223,281)(H,224,264)(H,225,267)(H,226,280)(H,227,274)(H,228,259)(H,229,273)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,288,289)(H4,191,192,199)(H4,193,194,200)(H4,195,196,201)(H4,197,198,202) D0B7QP DRUGINKE ZECLZCGVVAIWHI-UHFFFAOYSA-N D0B7QP DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CCSC)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)ONC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(CCCNC(=N)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(C)NOC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C5CCCN5C(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(=O)N)NOC(=O)C(CC(=O)O)NC(=O)CNC(=O)C6CCCN6C(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)C)NC(=O)C8CCCN8C(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C9CCCN9C(=O)C(C)N D0B7QP HIGHSTAT Discontinued in Phase 2 D0B7SP DRUG__ID D0B7SP D0B7SP DRUGCOMP GSK D0B7SP DRUGTYPE Small molecular drug D0B7SP DRUGINCH 1S/C25H29N5O/c1-19-8-9-22-23(27-19)6-3-7-24(22)29-16-14-28(15-17-29)12-10-20-4-2-5-21(18-20)30-13-11-26-25(30)31/h2-9,18H,10-17H2,1H3,(H,26,31) D0B7SP DRUGINKE ANGUXJDGJCHGOG-UHFFFAOYSA-N D0B7SP DRUGSMIL CC1=NC2=C(C=C1)C(=CC=C2)N3CCN(CC3)CCC4=CC(=CC=C4)N5CCNC5=O D0B7SP HIGHSTAT Discontinued in Phase 2 D0B9EH DRUG__ID D0B9EH D0B9EH DRUGCOMP Arriva Pharma D0B9EH DRUGTYPE Small molecular drug D0B9EH DRUGINCH 1S/C27H31NOS2/c1-5-28(14-8-6-7-13-27(2,3)4)18-22-10-9-11-25(16-22)29-19-26-17-24(21-31-26)23-12-15-30-20-23/h6,8-12,15-17,20-21H,5,14,18-19H2,1-4H3 D0B9EH DRUGINKE KIRGLCXNEVICOG-UHFFFAOYSA-N D0B9EH DRUGSMIL CCN(CC=CC#CC(C)(C)C)CC1=CC(=CC=C1)OCC2=CC(=CS2)C3=CSC=C3 D0B9EH HIGHSTAT Discontinued in Phase 2 D0B9NA DRUG__ID D0B9NA D0B9NA DRUGCOMP Zeneca Group plc D0B9NA DRUGTYPE Small molecular drug D0B9NA DRUGINCH 1S/C22H23ClO5/c23-18-11-6-4-9-16(18)22-27-14-15(8-2-1-3-13-20(25)26)21(28-22)17-10-5-7-12-19(17)24/h1-2,4-7,9-12,15,21-22,24H,3,8,13-14H2,(H,25,26)/b2-1-/t15-,21+,22+/m0/s1 D0B9NA DRUGINKE WHUIENZXNGAHQI-YGPRPMEGSA-N D0B9NA DRUGSMIL C1C(C(OC(O1)C2=CC=CC=C2Cl)C3=CC=CC=C3O)CC=CCCC(=O)O D0B9NA HIGHSTAT Discontinued in Phase 2 D0BC4Q DRUG__ID D0BC4Q D0BC4Q DRUGCOMP Klinge Pharma GmbH D0BC4Q DRUGTYPE Small molecular drug D0BC4Q DRUGINCH 1S/C21H26O4/c1-21(2,3)17-9-4-15(5-10-17)6-11-18(22)14-25-19-12-7-16(8-13-19)20(23)24/h4-5,7-10,12-13,18,22H,6,11,14H2,1-3H3,(H,23,24) D0BC4Q DRUGINKE LNXBEIZREVRNTF-UHFFFAOYSA-N D0BC4Q DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CCC(COC2=CC=C(C=C2)C(=O)O)O D0BC4Q HIGHSTAT Discontinued in Phase 2 D0BQ8M DRUG__ID D0BQ8M D0BQ8M DRUGCOMP Novartis AG D0BQ8M DRUGTYPE Small molecular drug D0BQ8M DRUGINCH 1S/C19H18N2/c1-21-11-12-5-2-3-6-14(12)19-15-7-4-8-16-18(15)13(10-20-16)9-17(19)21/h2-8,10,17,19-20H,9,11H2,1H3/t17-,19-/m1/s1 D0BQ8M DRUGINKE WRNKIDLXXXIELU-IEBWSBKVSA-N D0BQ8M DRUGSMIL CN1CC2=CC=CC=C2C3C1CC4=CNC5=CC=CC3=C45 D0BQ8M HIGHSTAT Discontinued in Phase 2 D0C6HM DRUG__ID D0C6HM D0C6HM DRUGCOMP Novartis AG D0C6HM DRUGTYPE Small molecular drug D0C6HM DRUGINCH 1S/C16H18ClN3O3/c17-13-3-1-11(2-4-13)12-7-15(22)20(8-12)10-16(23)19-6-5-18-14(21)9-19/h1-4,12H,5-10H2,(H,18,21) D0C6HM DRUGINKE QPKMIYNBZGPJAR-UHFFFAOYSA-N D0C6HM DRUGSMIL C1CN(CC(=O)N1)C(=O)CN2CC(CC2=O)C3=CC=C(C=C3)Cl D0C6HM HIGHSTAT Discontinued in Phase 2 D0C9FF DRUG__ID D0C9FF D0C9FF DRUGCOMP Novartis D0C9FF DRUGTYPE Small molecular drug D0C9FF DRUGINCH 1S/C27H25Cl2F6N3O3/c1-38(25(41)16-12-17(26(30,31)32)14-18(13-16)27(33,34)35)19(10-15-5-7-20(28)21(29)11-15)6-8-23(39)37-22-4-2-3-9-36-24(22)40/h5-8,11-14,19,22H,2-4,9-10H2,1H3,(H,36,40)(H,37,39)/b8-6+/t19-,22+/m0/s1 D0C9FF DRUGINKE BHCJHYIMNHXLOM-WVDRJWPYSA-N D0C9FF DRUGSMIL CN(C(CC1=CC(=C(C=C1)Cl)Cl)C=CC(=O)NC2CCCCNC2=O)C(=O)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0C9FF HIGHSTAT Discontinued in Phase 2 D0CB8W DRUG__ID D0CB8W D0CB8W DRUGCOMP Santen Pharmaceutical Co Ltd D0CB8W DRUGTYPE Small molecular drug D0CB8W DRUGINCH 1S/C22H22ClN5O2S/c1-14-25-26-19-13-24-21(16-4-2-3-5-18(16)23)17-12-15(31-22(17)28(14)19)6-7-20(29)27-8-10-30-11-9-27/h2-5,12H,6-11,13H2,1H3 D0CB8W DRUGINKE JGPJQFOROWSRRS-UHFFFAOYSA-N D0CB8W DRUGSMIL CC1=NN=C2N1C3=C(C=C(S3)CCC(=O)N4CCOCC4)C(=NC2)C5=CC=CC=C5Cl D0CB8W HIGHSTAT Discontinued in Phase 2 D0CE6T DRUG__ID D0CE6T D0CE6T DRUGCOMP GE Healthcare D0CE6T DRUGTYPE Small molecular drug D0CE6T DRUGINCH 1S/C27H28ClN6O5.K/c1-4-6-11-22-29-24(28)23(26(35)38-17(3)39-27(36)37-5-2)34(22)16-18-12-14-19(15-13-18)20-9-7-8-10-21(20)25-30-32-33-31-25;/h7-10,12-15,17H,4-6,11,16H2,1-3H3;/q-1;+1 D0CE6T DRUGINKE LWBGIHXLGBYBNG-UHFFFAOYSA-N D0CE6T DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)C(=O)OC(C)OC(=O)OCC)Cl.[K+] D0CE6T HIGHSTAT Discontinued in Phase 2 D0CO2M DRUG__ID D0CO2M D0CO2M DRUGCOMP Servier D0CO2M DRUGTYPE Small molecular drug D0CO2M DRUGINCH 1S/C28H33F2N7/c1-3-15-31-26-34-27(32-16-4-2)36-28(35-26)37-17-13-24(14-18-37)33-19-25(20-5-9-22(29)10-6-20)21-7-11-23(30)12-8-21/h3-12,24-25,33H,1-2,13-19H2,(H2,31,32,34,35,36) D0CO2M DRUGINKE GERNFWKTMKWULM-UHFFFAOYSA-N D0CO2M DRUGSMIL C=CCNC1=NC(=NC(=N1)N2CCC(CC2)NCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C D0CO2M HIGHSTAT Discontinued in Phase 2 D0D1YY DRUG__ID D0D1YY D0D1YY DRUGCOMP Ikeda Mohando Co Ltd D0D1YY DRUGTYPE Small molecular drug D0D1YY DRUGINCH 1S/C22H30N4O2.2ClH/c1-17-18(2)24-22(25-21(17)27)23-11-4-7-14-28-20-10-8-9-19(15-20)16-26-12-5-3-6-13-26;;/h4,7-10,15H,3,5-6,11-14,16H2,1-2H3,(H2,23,24,25,27);2*1H/b7-4-;; D0D1YY DRUGINKE NTLKFRQIRDDXCH-XIFWRFGDSA-N D0D1YY DRUGSMIL CC1=C(N=C(NC1=O)NCC=CCOC2=CC=CC(=C2)CN3CCCCC3)C.Cl.Cl D0D1YY HIGHSTAT Discontinued in Phase 2 D0D3JQ DRUG__ID D0D3JQ D0D3JQ DRUGCOMP Paion D0D3JQ DRUGTYPE Small molecular drug D0D3JQ DRUGINCH 1S/C27H36BN3O7/c1-37-17-9-15-24(28(35)36)30-25(32)23-14-8-16-31(23)26(33)22(18-20-10-4-2-5-11-20)29-27(34)38-19-21-12-6-3-7-13-21/h2-7,10-13,22-24,35-36H,8-9,14-19H2,1H3,(H,29,34)(H,30,32)/t22-,23+,24+/m1/s1 D0D3JQ DRUGINKE PAOGOXGDGABPSC-SGNDLWITSA-N D0D3JQ DRUGSMIL B(C(CCCOC)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)(O)O D0D3JQ HIGHSTAT Discontinued in Phase 2 D0D3KY DRUG__ID D0D3KY D0D3KY DRUGCOMP Scotia Holdings plc D0D3KY DRUGTYPE Small molecular drug D0D3KY DRUGINCH 1S/C15H17N5O4/c1-2-10(7-13(22)23)19-12(21)8-18-14(24)9-4-3-5-11(6-9)20-15(16)17/h1,3-6,10H,7-8H2,(H,18,24)(H,19,21)(H,22,23)(H4,16,17,20)/t10-/m0/s1 D0D3KY DRUGINKE IABCGGIFHPDBCJ-JTQLQIEISA-N D0D3KY DRUGSMIL C#CC(CC(=O)O)NC(=O)CNC(=O)C1=CC(=CC=C1)N=C(N)N D0D3KY HIGHSTAT Discontinued in Phase 2 D0D3PB DRUG__ID D0D3PB D0D3PB DRUGCOMP Bayer HealthCare Pharmaceuticals D0D3PB DRUGTYPE Small molecular drug D0D3PB DRUGINCH 1S/C19H17FN8O2/c1-30-19(29)24-14-15(21)25-17(26-16(14)22)13-11-6-4-8-23-18(11)28(27-13)9-10-5-2-3-7-12(10)20/h2-8H,9H2,1H3,(H,24,29)(H4,21,22,25,26) D0D3PB DRUGINKE FTQHGWIXJSSWOY-UHFFFAOYSA-N D0D3PB DRUGSMIL COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N D0D3PB HIGHSTAT Discontinued in Phase 2 D0D5RH DRUG__ID D0D5RH D0D5RH DRUGCOMP Takeda D0D5RH DRUGTYPE Small molecular drug D0D5RH DRUGINCH 1S/C22H26ClN3O5S/c23-17-4-2-16-13-19(5-3-15(16)12-17)32(30,31)14-20(27)21(28)25-10-6-18(7-11-25)26-9-1-8-24-22(26)29/h2-5,12-13,18,20,27H,1,6-11,14H2,(H,24,29)/t20-/m1/s1 D0D5RH DRUGINKE GEHAEMCVKDPMKO-HXUWFJFHSA-N D0D5RH DRUGSMIL C1CNC(=O)N(C1)C2CCN(CC2)C(=O)C(CS(=O)(=O)C3=CC4=C(C=C3)C=C(C=C4)Cl)O D0D5RH HIGHSTAT Discontinued in Phase 2 D0D5ZR DRUG__ID D0D5ZR D0D5ZR DRUGCOMP Trophos SA D0D5ZR DRUGTYPE Small molecular drug D0D5ZR DRUGINCH 1S/C26H47NO2/c1-18(2)8-6-9-19(3)21-11-12-22-20-10-13-24(27-29)26(5,15-7-17-28)23(20)14-16-25(21,22)4/h18-23,28-29H,6-17H2,1-5H3/b27-24-/t19-,20+,21-,22+,23+,25-,26-/m1/s1 D0D5ZR DRUGINKE OBKBVSFXEIFOMS-GHCPFUIOSA-N D0D5ZR DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC(=NO)C3(C)CCCO)C D0D5ZR HIGHSTAT Discontinued in Phase 2 D0DT2P DRUG__ID D0DT2P D0DT2P DRUGCOMP Daiichi Seiyaku Co Ltd D0DT2P DRUGTYPE Small molecular drug D0DT2P DRUGINCH 1S/C15H16N2O2/c18-15(19)14-4-3-12-7-11(1-2-13(12)8-14)9-17-6-5-16-10-17/h3-6,8,10-11H,1-2,7,9H2,(H,18,19) D0DT2P DRUGINKE VJJHOPPXRPHVCA-UHFFFAOYSA-N D0DT2P DRUGSMIL C1CC2=C(CC1CN3C=CN=C3)C=CC(=C2)C(=O)O D0DT2P HIGHSTAT Discontinued in Phase 2 D0E3XG DRUG__ID D0E3XG D0E3XG DRUGCOMP Glaxo Wellcome plc D0E3XG DRUGTYPE Small molecular drug D0E3XG DRUGINCH 1S/C24H20BrClN6O3/c1-2-3-8-18-27-22(26)20(24(33)34)32(18)12-13-9-10-17-16(11-13)19(25)21(35-17)14-6-4-5-7-15(14)23-28-30-31-29-23/h4-7,9-11H,2-3,8,12H2,1H3,(H,33,34)(H,28,29,30,31) D0E3XG DRUGINKE FIKYECRHLXONOX-UHFFFAOYSA-N D0E3XG DRUGSMIL CCCCC1=NC(=C(N1CC2=CC3=C(C=C2)OC(=C3Br)C4=CC=CC=C4C5=NNN=N5)C(=O)O)Cl D0E3XG HIGHSTAT Discontinued in Phase 2 D0E4FG DRUG__ID D0E4FG D0E4FG DRUGCOMP Bristol-Myers Squibb D0E4FG DRUGTYPE Small molecular drug D0E4FG DRUGINCH 1S/C33H36N4O3/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26/h1-18,29-32,38-39H,19-22,34-35H2/t29-,30-,31+,32+/m1/s1 D0E4FG DRUGINKE KYRSNWPSSXSNEP-ZRTHHSRSSA-N D0E4FG DRUGSMIL C1=CC=C(C=C1)CC2C(C(C(N(C(=O)N2CC3=CC(=CC=C3)N)CC4=CC(=CC=C4)N)CC5=CC=CC=C5)O)O D0E4FG HIGHSTAT Discontinued in Phase 2 D0E5YG DRUG__ID D0E5YG D0E5YG DRUGCOMP AstraZeneca D0E5YG DRUGTYPE Small molecular drug D0E5YG DRUGINCH 1S/C15H19ClN4O5S/c1-15(13(21)18-14(22)19-15)9-26(23,24)20-6-4-11(5-7-20)25-12-3-2-10(16)8-17-12/h2-3,8,11H,4-7,9H2,1H3,(H2,18,19,21,22)/t15-/m1/s1 D0E5YG DRUGINKE SFJFBTPHDHUUPU-OAHLLOKOSA-N D0E5YG DRUGSMIL CC1(C(=O)NC(=O)N1)CS(=O)(=O)N2CCC(CC2)OC3=NC=C(C=C3)Cl D0E5YG HIGHSTAT Discontinued in Phase 2 D0E6DI DRUG__ID D0E6DI D0E6DI DRUGCOMP Amgen D0E6DI DRUGTYPE Small molecular drug D0E6DI DRUGINCH 1S/C12H10N4O2/c13-9-1-3-10(4-2-9)14-15-11-5-7-12(8-6-11)16(17)18/h1-8H,13H2 D0E6DI DRUGINKE UNBOSJFEZZJZLR-UHFFFAOYSA-N D0E6DI DRUGSMIL C1=CC(=CC=C1N)N=NC2=CC=C(C=C2)[N+](=O)[O-] D0E6DI HIGHSTAT Discontinued in Phase 2 D0E6FO DRUG__ID D0E6FO D0E6FO DRUGCOMP Japan Tobacco Inc D0E6FO DRUGTYPE Small molecular drug D0E6FO DRUGINCH 1S/C25H31Cl2N3O5.2ClH/c1-3-34-25(33)20(15-17-7-5-4-6-8-17)28-24(32)18-16-19(26)23(21(27)22(18)31)35-14-13-30-11-9-29(2)10-12-30;;/h4-8,16,20,31H,3,9-15H2,1-2H3,(H,28,32);2*1H/t20-;;/m0../s1 D0E6FO DRUGINKE JUJAUEQJEWIWCQ-FJSYBICCSA-N D0E6FO DRUGSMIL CCOC(=O)C(CC1=CC=CC=C1)NC(=O)C2=CC(=C(C(=C2O)Cl)OCCN3CCN(CC3)C)Cl.Cl.Cl D0E6FO HIGHSTAT Discontinued in Phase 2 D0E6NR DRUG__ID D0E6NR D0E6NR DRUGCOMP Bayer AG D0E6NR DRUGTYPE Small molecular drug D0E6NR DRUGINCH 1S/C20H21ClFN3O3/c21-16-17-12(19(26)13(20(27)28)8-25(17)11-3-4-11)6-14(22)18(16)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1 D0E6NR DRUGINKE VRXORHRXNRJZCQ-ZUZCIYMTSA-N D0E6NR DRUGSMIL C1CC2CN(CC2NC1)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5)F D0E6NR HIGHSTAT Discontinued in Phase 2 D0E8JO DRUG__ID D0E8JO D0E8JO DRUGCOMP Daiichi Fine Chemicals Co Ltd D0E8JO DRUGTYPE Small molecular drug D0E8JO DRUGINCH 1S/C14H20FN3O7.ClH/c1-5(2)8(16)13(22)24-4-7-9(19)10(20)12(25-7)18-3-6(15)11(21)17-14(18)23;/h3,5,7-10,12,19-20H,4,16H2,1-2H3,(H,17,21,23);1H/t7-,8+,9-,10-,12-;/m1./s1 D0E8JO DRUGINKE HMYHLEZOXXVLBU-LNKDGEPZSA-N D0E8JO DRUGSMIL CC(C)C(C(=O)OCC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O)N.Cl D0E8JO HIGHSTAT Discontinued in Phase 2 D0E8UV DRUG__ID D0E8UV D0E8UV DRUGCOMP Sankyo D0E8UV DRUGTYPE Small molecular drug D0E8UV DRUGINCH 1S/C35H40N2O6/c1-3-41-35(39)43-31-19-18-27(26-32(31)40-2)12-10-11-17-33(38)36-22-25-37-23-20-30(21-24-37)42-34(28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-19,26,30,34H,3,20-25H2,1-2H3,(H,36,38)/b12-10+,17-11+ D0E8UV DRUGINKE LUOUCHOLMUUZBO-SVSXJNCISA-N D0E8UV DRUGSMIL CCOC(=O)OC1=C(C=C(C=C1)C=CC=CC(=O)NCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4)OC D0E8UV HIGHSTAT Discontinued in Phase 2 D0E9IT DRUG__ID D0E9IT D0E9IT DRUGCOMP Astra AB D0E9IT DRUGTYPE Small molecular drug D0E9IT DRUGINCH 1S/C10H16N2O6S2/c1-5(13)11-7(9(15)16)3-19-20-4-8(10(17)18)12-6(2)14/h7-8H,3-4H2,1-2H3,(H,11,13)(H,12,14)(H,15,16)(H,17,18)/t7-,8-/m0/s1 D0E9IT DRUGINKE YTPQSLLEROSACP-YUMQZZPRSA-N D0E9IT DRUGSMIL CC(=O)NC(CSSCC(C(=O)O)NC(=O)C)C(=O)O D0E9IT HIGHSTAT Discontinued in Phase 2 D0EG5A DRUG__ID D0EG5A D0EG5A DRUGCOMP Infinity Pharmaceuticals D0EG5A DRUGTYPE Small molecular drug D0EG5A DRUGINCH 1S/C31H45N3O8/c1-8-12-33-26-21-13-17(2)14-25(41-7)27(36)19(4)15-20(5)29(42-31(32)39)24(40-6)11-9-10-18(3)30(38)34-22(28(21)37)16-23(26)35/h8-11,15-17,19,24-25,27,29,33,35-37H,1,12-14H2,2-7H3,(H2,32,39)(H,34,38)/b11-9-,18-10+,20-15+/t17-,19+,24+,25+,27-,29+/m1/s1 D0EG5A DRUGINKE OAKGNIRUXAZDQF-TXHRRWQRSA-N D0EG5A DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=C(C(=C2O)C1)NCC=C)O)C)OC)OC(=O)N)C)C)O)OC D0EG5A HIGHSTAT Discontinued in Phase 2 D0F3FB DRUG__ID D0F3FB D0F3FB DRUGCOMP Servier D0F3FB DRUGTYPE Small molecular drug D0F3FB DRUGINCH 1S/C20H33N7O3.ClH/c1-6-26(7-2)20(30)27-13-11-25(12-14-27)10-8-9-15-21-17-16(22(15)3)18(28)24(5)19(29)23(17)4;/h6-14H2,1-5H3;1H D0F3FB DRUGINKE GVHZRDKDUVIRNY-UHFFFAOYSA-N D0F3FB DRUGSMIL CCN(CC)C(=O)N1CCN(CC1)CCCC2=NC3=C(N2C)C(=O)N(C(=O)N3C)C.Cl D0F3FB HIGHSTAT Discontinued in Phase 2 D0F4IG DRUG__ID D0F4IG D0F4IG DRUGCOMP Daiichi Seiyaku Co Ltd D0F4IG DRUGTYPE Small molecular drug D0F4IG DRUGINCH 1S/C13H16N6OS/c20-12-10-11(16-18-15-10)14-13-19(12)17-9(21-13)7-6-8-4-2-1-3-5-8/h8H,1-7H2,(H,15,16,18) D0F4IG DRUGINKE ASIFEXZWAKYMRM-UHFFFAOYSA-N D0F4IG DRUGSMIL C1CCC(CC1)CCC2=NN3C(=O)C4=NNN=C4N=C3S2 D0F4IG HIGHSTAT Discontinued in Phase 2 D0F6CT DRUG__ID D0F6CT D0F6CT DRUGCOMP GlaxoSmithKline D0F6CT DRUGTYPE Small molecular drug D0F6CT DRUGINCH 1S/C34H31N5O6/c1-22(2)38(25-14-5-3-6-15-25)29(40)21-37-27-18-9-10-19-28(27)39(26-16-7-4-8-17-26)32(42)30(31(37)41)36-34(45)35-24-13-11-12-23(20-24)33(43)44/h3-20,22,30H,21H2,1-2H3,(H,43,44)(H2,35,36,45)/t30-/m0/s1 D0F6CT DRUGINKE CABBMMXFOOZVMS-PMERELPUSA-N D0F6CT DRUGSMIL CC(C)N(C1=CC=CC=C1)C(=O)CN2C3=CC=CC=C3N(C(=O)C(C2=O)NC(=O)NC4=CC=CC(=C4)C(=O)O)C5=CC=CC=C5 D0F6CT HIGHSTAT Discontinued in Phase 2 D0F7FX DRUG__ID D0F7FX D0F7FX DRUGCOMP AstraZeneca D0F7FX DRUGTYPE Small molecular drug D0F7FX DRUGINCH 1S/C10H14N2O2S/c1-6(15)8(10(13)14)4-7-2-3-9(11)12-5-7/h2-3,5-6,8,15H,4H2,1H3,(H2,11,12)(H,13,14)/t6-,8-/m1/s1 D0F7FX DRUGINKE GYIYAOUGKJSCCG-HTRCEHHLSA-N D0F7FX DRUGSMIL CC(C(CC1=CN=C(C=C1)N)C(=O)O)S D0F7FX HIGHSTAT Discontinued in Phase 2 D0F7WQ DRUG__ID D0F7WQ D0F7WQ DRUGCOMP Colthurst Ltd D0F7WQ DRUGTYPE Small molecular drug D0F7WQ DRUGINCH 1S/C19H29BrO2/c1-18-7-5-12(21)9-11(18)3-4-13-14(18)6-8-19(2)15(13)10-16(20)17(19)22/h11-16,21H,3-10H2,1-2H3/t11-,12-,13+,14-,15-,16+,18-,19-/m0/s1 D0F7WQ DRUGINKE CWVMWSZEMZOUPC-JUAXIXHSSA-N D0F7WQ DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3CC(C4=O)Br)C)O D0F7WQ HIGHSTAT Discontinued in Phase 2 D0G0LH DRUG__ID D0G0LH D0G0LH DRUGCOMP Shionogi & Co Ltd D0G0LH DRUGTYPE Small molecular drug D0G0LH DRUGINCH 1S/C20H22N2O4S/c1-11(2)8-14-10-27-19-18(14)17(16(12(3)21-19)20(23)26-4)13-6-5-7-15(9-13)22(24)25/h5-7,9-11,17,21H,8H2,1-4H3/t17-/m0/s1 D0G0LH DRUGINKE UTLPUICHKZBRCI-KRWDZBQOSA-N D0G0LH DRUGSMIL CC1=C(C(C2=C(N1)SC=C2CC(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC D0G0LH HIGHSTAT Discontinued in Phase 2 D0G1RH DRUG__ID D0G1RH D0G1RH DRUGCOMP NPS Pharmaceuticals D0G1RH DRUGTYPE Small molecular drug D0G1RH DRUGINCH 1S/C24H25ClN2O2/c1-24(2,13-17-10-11-18-6-3-4-7-19(18)12-17)27-15-20(28)16-29-23-9-5-8-22(25)21(23)14-26/h3-12,20,27-28H,13,15-16H2,1-2H3/t20-/m1/s1 D0G1RH DRUGINKE PZUJQWHTIRWCID-HXUWFJFHSA-N D0G1RH DRUGSMIL CC(C)(CC1=CC2=CC=CC=C2C=C1)NCC(COC3=C(C(=CC=C3)Cl)C#N)O D0G1RH HIGHSTAT Discontinued in Phase 2 D0G1YN DRUG__ID D0G1YN D0G1YN DRUGCOMP Enhance Biotech D0G1YN DRUGTYPE Small molecular drug D0G1YN DRUGINCH 1S/C30H34FN3O2/c1-5-15-33-19-22(3)34(20-21(33)2)29(24-10-7-14-28(35)17-24)23-9-6-11-25(16-23)30(36)32(4)27-13-8-12-26(31)18-27/h5-14,16-18,21-22,29,35H,1,15,19-20H2,2-4H3/t21-,22+,29-/m1/s1 D0G1YN DRUGINKE LZXRQLIIMYJZDA-UETOGOEVSA-N D0G1YN DRUGSMIL CC1CN(C(CN1C(C2=CC(=CC=C2)C(=O)N(C)C3=CC(=CC=C3)F)C4=CC(=CC=C4)O)C)CC=C D0G1YN HIGHSTAT Discontinued in Phase 2 D0G2GR DRUG__ID D0G2GR D0G2GR DRUGCOMP Ono Pharmaceutical Co Ltd D0G2GR DRUGTYPE Small molecular drug D0G2GR DRUGINCH 1S/C25H41NO4/c1-3-6-17-9-11-18(12-10-17)23(27)14-13-20-21-15-19(26-22(21)16-24(20)28)7-4-5-8-25(29)30-2/h13-14,17-18,20-24,27-28H,3-12,15-16H2,1-2H3/b14-13+/t17?,18?,20-,21-,22+,23-,24-/m1/s1 D0G2GR DRUGINKE UQEOPLABKYFAJH-FPNSLHOUSA-N D0G2GR DRUGSMIL CCCC1CCC(CC1)C(C=CC2C(CC3C2CC(=N3)CCCCC(=O)OC)O)O D0G2GR HIGHSTAT Discontinued in Phase 2 D0G5TU DRUG__ID D0G5TU D0G5TU DRUGCOMP Esteve Group D0G5TU DRUGTYPE Small molecular drug D0G5TU DRUGINCH 1S/C15H21ClN6.2ClH/c16-14-12-19-22(13-14)7-2-1-6-20-8-10-21(11-9-20)15-17-4-3-5-18-15;;/h3-5,12-13H,1-2,6-11H2;2*1H D0G5TU DRUGINKE RGDLQJUAYQRGBC-UHFFFAOYSA-N D0G5TU DRUGSMIL C1CN(CCN1CCCCN2C=C(C=N2)Cl)C3=NC=CC=N3.Cl.Cl D0G5TU HIGHSTAT Discontinued in Phase 2 D0G8UG DRUG__ID D0G8UG D0G8UG DRUGCOMP Eli Lilly & Co D0G8UG DRUGTYPE Small molecular drug D0G8UG DRUGINCH 1S/C25H36N4O3S/c1-2-3-4-5-6-7-8-9-10-11-12-16-22(33-18-17-23(30)31)24(32)20-14-13-15-21(19-20)25-26-28-29-27-25/h10-16,19,22,24,32H,2-9,17-18H2,1H3,(H,30,31)(H,26,27,28,29)/b11-10-,16-12+/t22-,24+/m1/s1 D0G8UG DRUGINKE YPHOSUPSOWQQCB-AFOLHBCXSA-N D0G8UG DRUGSMIL CCCCCCCCCC=CC=CC(C(C1=CC=CC(=C1)C2=NNN=N2)O)SCCC(=O)O D0G8UG HIGHSTAT Discontinued in Phase 2 D0G9FP DRUG__ID D0G9FP D0G9FP DRUGCOMP AstraZeneca plc D0G9FP DRUGTYPE Small molecular drug D0G9FP DRUGINCH 1S/C25H34F2O6/c1-4-5-21-32-20-10-14-15-9-17(26)16-8-13(29)6-7-22(16,2)24(15,27)18(30)11-23(14,3)25(20,33-21)19(31)12-28/h8,14-15,17-18,20-21,28,30H,4-7,9-12H2,1-3H3/t14-,15-,17-,18-,20+,21+,22-,23-,24-,25+/m0/s1 D0G9FP DRUGINKE IXTCZMJQGGONPY-XJAYAHQCSA-N D0G9FP DRUGSMIL CCCC1OC2CC3C4CC(C5=CC(=O)CCC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F D0G9FP HIGHSTAT Discontinued in Phase 2 D0GP4R DRUG__ID D0GP4R D0GP4R DRUGCOMP Glaxo Wellcome plc D0GP4R DRUGTYPE Small molecular drug D0GP4R DRUGINCH 1S/C21H29Cl2N3O2/c22-18-13-16(14-19(23)21(18)24)20(27)15-25-9-4-1-2-6-11-28-12-8-17-7-3-5-10-26-17/h3,5,7,10,13-14,20,25,27H,1-2,4,6,8-9,11-12,15,24H2/t20-/m0/s1 D0GP4R DRUGINKE NUBLQEKABJXICM-FQEVSTJZSA-N D0GP4R DRUGSMIL C1=CC=NC(=C1)CCOCCCCCCNCC(C2=CC(=C(C(=C2)Cl)N)Cl)O D0GP4R HIGHSTAT Discontinued in Phase 2 D0GT4N DRUG__ID D0GT4N D0GT4N DRUGCOMP SmithKline Beecham plc D0GT4N DRUGTYPE Small molecular drug D0GT4N DRUGINCH 1S/C18H20F5NO3/c1-16(2)15(26)14(24-8-4-3-5-13(24)25)11-9-10(6-7-12(11)27-16)17(19,20)18(21,22)23/h6-7,9,14-15,26H,3-5,8H2,1-2H3/t14-,15+/m1/s1 D0GT4N DRUGINKE ZSUFQZNGDIXQAD-CABCVRRESA-N D0GT4N DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C(C(F)(F)F)(F)F)N3CCCCC3=O)O)C D0GT4N HIGHSTAT Discontinued in Phase 2 D0GY4V DRUG__ID D0GY4V D0GY4V DRUGCOMP Toa Eiyo KK D0GY4V DRUGTYPE Small molecular drug D0GY4V DRUGINCH 1S/C18H20N3O2S.Na/c1-23-15-10-11-19-17-12(15)6-2-5-9-16(17)24(22)18-20-13-7-3-4-8-14(13)21-18;/h3-4,7-8,10,16H,2,5-6,9,11H2,1H3,(H,20,21);/q-1;+1 D0GY4V DRUGINKE IPAJARTUAXFVLF-UHFFFAOYSA-N D0GY4V DRUGSMIL COC1=CC[N-]C2=C1CCCCC2S(=O)C3=NC4=CC=CC=C4N3.[Na+] D0GY4V HIGHSTAT Discontinued in Phase 2 D0H1GF DRUG__ID D0H1GF D0H1GF DRUGCOMP Schering-Plough Corp D0H1GF DRUGTYPE Small molecular drug D0H1GF DRUGINCH 1S/C27H34N2O7/c1-27(2)35-18-21(36-27)17-34-26(33)23(16-20-11-7-4-8-12-20)29-22(15-19-9-5-3-6-10-19)25(32)28-14-13-24(30)31/h3-12,21-23,29H,13-18H2,1-2H3,(H,28,32)(H,30,31)/t21?,22-,23?/m0/s1 D0H1GF DRUGINKE GWLFRMJMKXSMSR-KOENEWCDSA-N D0H1GF DRUGSMIL CC1(OCC(O1)COC(=O)C(CC2=CC=CC=C2)NC(CC3=CC=CC=C3)C(=O)NCCC(=O)O)C D0H1GF HIGHSTAT Discontinued in Phase 2 D0H3JF DRUG__ID D0H3JF D0H3JF DRUGCOMP VentiRx Pharmaceuticals D0H3JF DRUGTYPE Small molecular drug D0H3JF DRUGINCH 1S/C28H34N4O2/c1-3-13-31(14-4-2)28(34)24-17-23-12-11-22(18-25(23)30-26(29)19-24)20-7-9-21(10-8-20)27(33)32-15-5-6-16-32/h7-12,17-18H,3-6,13-16,19H2,1-2H3,(H2,29,30) D0H3JF DRUGINKE QSPOQCXMGPDIHI-UHFFFAOYSA-N D0H3JF DRUGSMIL CCCN(CCC)C(=O)C1=CC2=C(C=C(C=C2)C3=CC=C(C=C3)C(=O)N4CCCC4)N=C(C1)N D0H3JF HIGHSTAT Discontinued in Phase 2 D0H7WA DRUG__ID D0H7WA D0H7WA DRUGCOMP Forbes Medi-Tech Inc D0H7WA DRUGTYPE Small molecular drug D0H7WA DRUGINCH 1S/C20H25ClN2O5.C6H6O3S/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21;7-10(8,9)6-4-2-1-3-5-6/h5-8,17,23H,4,9-11,22H2,1-3H3;1-5H,(H,7,8,9) D0H7WA DRUGINKE ZPBWCRDSRKPIDG-UHFFFAOYSA-N D0H7WA DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O D0H7WA HIGHSTAT Discontinued in Phase 2 D0H9DE DRUG__ID D0H9DE D0H9DE DRUGCOMP Sankyo Co Ltd D0H9DE DRUGTYPE Small molecular drug D0H9DE DRUGINCH 1S/C16H19ClN2O4.ClH/c17-14-15(12-4-2-1-3-5-12)23-19(16(14)21)11-13(20)10-18-6-8-22-9-7-18;/h1-5,13,20H,6-11H2;1H/t13-;/m1./s1 D0H9DE DRUGINKE KIWUOCZHZROUNT-BTQNPOSSSA-N D0H9DE DRUGSMIL C1COCCN1CC(CN2C(=O)C(=C(O2)C3=CC=CC=C3)Cl)O.Cl D0H9DE HIGHSTAT Discontinued in Phase 2 D0H9GQ DRUG__ID D0H9GQ D0H9GQ DRUGCOMP DOV D0H9GQ DRUGTYPE Small molecular drug D0H9GQ DRUGINCH 1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2 D0H9GQ DRUGINKE BSMNRYCSBFHEMQ-UHFFFAOYSA-N D0H9GQ DRUGSMIL C1C2C1(CNC2)C3=CC(=C(C=C3)Cl)Cl D0H9GQ HIGHSTAT Discontinued in Phase 2 D0I3BB DRUG__ID D0I3BB D0I3BB DRUGCOMP Kyowa Hakko D0I3BB DRUGTYPE Small molecular drug D0I3BB DRUGINCH 1S/C16H12F3NO5S2/c1-15(23,16(17,18)19)14(22)20-9-3-2-4-10-11(9)12(21)13-8(5-6-26-13)7-27(10,24)25/h2-6,23H,7H2,1H3,(H,20,22)/t15-/m0/s1 D0I3BB DRUGINKE NAFSYPCVPLWHFY-HNNXBMFYSA-N D0I3BB DRUGSMIL CC(C(=O)NC1=C2C(=CC=C1)S(=O)(=O)CC3=C(C2=O)SC=C3)(C(F)(F)F)O D0I3BB HIGHSTAT Discontinued in Phase 2 D0I3EI DRUG__ID D0I3EI D0I3EI DRUGCOMP Nyken BV D0I3EI DRUGTYPE Small molecular drug D0I3EI DRUGINCH 1S/C18H35N3O12/c19-2-6-8(23)10(25)12(27)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)11(26)9(24)7(3-22)31-18/h4-18,22-29H,1-3,19-21H2/t4-,5+,6-,7-,8-,9-,10+,11+,12-,13-,14-,15+,16-,17-,18-/m1/s1 D0I3EI DRUGINKE NZCOZAMBHLSNDW-GUKOCFKPSA-N D0I3EI DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)O)O)OC3C(C(C(C(O3)CN)O)O)O)N D0I3EI HIGHSTAT Discontinued in Phase 2 D0I4GI DRUG__ID D0I4GI D0I4GI DRUGCOMP BioXell D0I4GI DRUGTYPE Small molecular drug D0I4GI DRUGINCH 1S/C29H43FO2/c1-6-29(32,7-2)17-8-10-20(3)25-14-15-26-22(11-9-16-28(25,26)5)12-13-23-18-24(31)19-27(30)21(23)4/h8,12-14,17,20,24,26-27,31-32H,4,6-7,9-11,15-16,18-19H2,1-3,5H3/b17-8+,22-12+,23-13-/t20-,24+,26-,27-,28+/m0/s1 D0I4GI DRUGINKE LRLWXBHFPGSUOX-GJQYOBCGSA-N D0I4GI DRUGSMIL CCC(CC)(C=CCC(C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)F)O)C)O D0I4GI HIGHSTAT Discontinued in Phase 2 D0I6UU DRUG__ID D0I6UU D0I6UU DRUGCOMP Pfizer Ltd D0I6UU DRUGTYPE Small molecular drug D0I6UU DRUGINCH 1S/C34H29ClN6O3/c1-4-44-34(43)31-30(24-9-5-6-10-25(24)35)29(33(42)40-28-11-7-8-17-37-28)20(2)38-32(31)22-12-14-23(15-13-22)41-21(3)39-26-19-36-18-16-27(26)41/h5-19,30,38H,4H2,1-3H3,(H,37,40,42) D0I6UU DRUGINKE ODRYSCQFUGFOSU-UHFFFAOYSA-N D0I6UU DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)NC3=CC=CC=N3)C)C4=CC=C(C=C4)N5C(=NC6=C5C=CN=C6)C D0I6UU HIGHSTAT Discontinued in Phase 2 D0IJ2H DRUG__ID D0IJ2H D0IJ2H DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0IJ2H DRUGTYPE Small molecular drug D0IJ2H DRUGINCH 1S/C21H25N/c1-20(2,3)22-19-14-15-21(16-19,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-15,19,22H,16H2,1-3H3/t19-/m1/s1 D0IJ2H DRUGINKE QMTVTICJRCJOFZ-LJQANCHMSA-N D0IJ2H DRUGSMIL CC(C)(C)NC1CC(C=C1)(C2=CC=CC=C2)C3=CC=CC=C3 D0IJ2H HIGHSTAT Discontinued in Phase 2 D0IZ1D DRUG__ID D0IZ1D D0IZ1D DRUGCOMP Novartis AG D0IZ1D DRUGTYPE Small molecular drug D0IZ1D DRUGINCH 1S/C14H16BrNO2/c1-17-11-6-10-7-13(9-2-4-16-5-3-9)18-14(10)12(15)8-11/h6-9,16H,2-5H2,1H3 D0IZ1D DRUGINKE WZXHSWVDAYOFPE-UHFFFAOYSA-N D0IZ1D DRUGSMIL COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br D0IZ1D HIGHSTAT Discontinued in Phase 2 D0J1TS DRUG__ID D0J1TS D0J1TS DRUGCOMP AstraZeneca D0J1TS DRUGTYPE Small molecular drug D0J1TS DRUGINCH 1S/C22H20Cl2F2N4O3/c1-14(15-5-4-6-16(23)11-15)28-21(31)12-18-17(24)8-9-20(30(18)33)27-13-22(25,26)19-7-2-3-10-29(19)32/h2-11,14,33H,12-13H2,1H3,(H-,28,31,32)/p+2/t14-/m1/s1 D0J1TS DRUGINKE GNYWBETUYIZBHL-CQSZACIVSA-P D0J1TS DRUGSMIL CC(C1=CC(=CC=C1)Cl)NC(=O)CC2=C(C=CC(=[N+]2O)NCC(C3=CC=CC=[N+]3O)(F)F)Cl D0J1TS HIGHSTAT Discontinued in Phase 2 D0J2IH DRUG__ID D0J2IH D0J2IH DRUGCOMP Speedel D0J2IH DRUGTYPE Small molecular drug D0J2IH DRUGINCH 1S/C23H21N5O5S/c1-15-8-9-19(25-14-15)34(29,30)28-22-20(33-18-7-5-4-6-17(18)31-2)23(32-3)27-21(26-22)16-10-12-24-13-11-16/h4-14H,1-3H3,(H,26,27,28) D0J2IH DRUGINKE YBWLTKFZAOSWSM-UHFFFAOYSA-N D0J2IH DRUGSMIL CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC=NC=C3)OC)OC4=CC=CC=C4OC D0J2IH HIGHSTAT Discontinued in Phase 2 D0J2NB DRUG__ID D0J2NB D0J2NB DRUGCOMP Wakunaga Pharmaceutical Co Ltd D0J2NB DRUGTYPE Small molecular drug D0J2NB DRUGINCH 1S/C25H23N7O3S.K/c1-2-21-29-32(25(36-21)26-23(33)19-8-5-9-20(19)24(34)35)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-30-31-28-22;/h3-4,6-7,10-13H,2,5,8-9,14H2,1H3,(H,34,35)(H,27,28,30,31);/q;+1/p-1 D0J2NB DRUGINKE IYBVDYGNSNOZHQ-UHFFFAOYSA-M D0J2NB DRUGSMIL CCC1=NN(C(=NC(=O)C2=C(CCC2)C(=O)[O-])S1)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5.[K+] D0J2NB HIGHSTAT Discontinued in Phase 2 D0J3TP DRUG__ID D0J3TP D0J3TP DRUGCOMP Zeneca Group plc D0J3TP DRUGTYPE Small molecular drug D0J3TP DRUGINCH 1S/C24H20F6N6O2/c25-17-4-7-19(20(26)9-17)23(37,10-35-14-31-13-33-35)11-36-15-32-21(34-36)8-3-16-1-5-18(6-2-16)38-12-24(29,30)22(27)28/h1-9,13-15,22,37H,10-12H2/b8-3+/t23-/m1/s1 D0J3TP DRUGINKE FZEJTXCSLUORDW-DHXBXMGCSA-N D0J3TP DRUGSMIL C1=CC(=CC=C1C=CC2=NN(C=N2)CC(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)O)OCC(C(F)F)(F)F D0J3TP HIGHSTAT Discontinued in Phase 2 D0J5CX DRUG__ID D0J5CX D0J5CX DRUGCOMP Takeda D0J5CX DRUGTYPE Small molecular drug D0J5CX DRUGINCH 1S/C30H25F6N3O2/c1-17-5-7-20(8-6-17)24-23-4-3-10-37-25(23)27(40)39-11-9-18(2)15-38(28(41)26(24)39)16-19-12-21(29(31,32)33)14-22(13-19)30(34,35)36/h3-8,10,12-14,18H,9,11,15-16H2,1-2H3/t18-/m1/s1 D0J5CX DRUGINKE LDXQLWNPGRANTO-GOSISDBHSA-N D0J5CX DRUGSMIL CC1CCN2C(=C(C3=C(C2=O)N=CC=C3)C4=CC=C(C=C4)C)C(=O)N(C1)CC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F D0J5CX HIGHSTAT Discontinued in Phase 2 D0J9AK DRUG__ID D0J9AK D0J9AK DRUGCOMP Merck & Co Inc D0J9AK DRUGTYPE Small molecular drug D0J9AK DRUGINCH 1S/C39H48N4O5/c1-39(2,3)41-38(47)33-25-42(24-31-21-28-14-8-10-16-35(28)48-31)17-18-43(33)23-30(44)20-29(19-26-11-5-4-6-12-26)37(46)40-36-32-15-9-7-13-27(32)22-34(36)45/h4-16,21,29-30,33-34,36,44-45H,17-20,22-25H2,1-3H3,(H,40,46)(H,41,47)/t29-,30+,33+,34-,36+/m1/s1 D0J9AK DRUGINKE AOMZDQMIOCTPQP-QHQMVRJISA-N D0J9AK DRUGSMIL CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CC6=CC=CC=C6O5 D0J9AK HIGHSTAT Discontinued in Phase 2 D0JY4Y DRUG__ID D0JY4Y D0JY4Y DRUGCOMP Eisai Co Ltd D0JY4Y DRUGTYPE Small molecular drug D0JY4Y DRUGINCH 1S/C16H17N3OS/c1-9-12(7-11-5-4-6-18-8-11)13-15(10(2)14(9)20)21-16(17-3)19-13/h4-6,8,20H,7H2,1-3H3,(H,17,19) D0JY4Y DRUGINKE IONAQTGMWFXHIX-UHFFFAOYSA-N D0JY4Y DRUGSMIL CC1=C(C2=C(C(=C1O)C)SC(=N2)NC)CC3=CN=CC=C3 D0JY4Y HIGHSTAT Discontinued in Phase 2 D0K1DC DRUG__ID D0K1DC D0K1DC DRUGCOMP Pharmacia & Upjohn AB D0K1DC DRUGTYPE Small molecular drug D0K1DC DRUGINCH 1S/C20H22N4O2/c1-23-8-12(9-24-10-18(25)22-19(26)11-24)5-15-14-3-2-4-16-20(14)13(7-21-16)6-17(15)23/h2-5,7,12,17,21H,6,8-11H2,1H3,(H,22,25,26)/t12-,17-/m1/s1 D0K1DC DRUGINKE RJCXNCSJGRUWRW-SJKOYZFVSA-N D0K1DC DRUGSMIL CN1CC(C=C2C1CC3=CNC4=CC=CC2=C34)CN5CC(=O)NC(=O)C5 D0K1DC HIGHSTAT Discontinued in Phase 2 D0K4ED DRUG__ID D0K4ED D0K4ED DRUGCOMP Roche D0K4ED DRUGTYPE Small molecular drug D0K4ED DRUGINCH 1S/C31H31F3N8O8S2/c1-39-5-7-40(8-6-39)24-17(33)9-15-23(19(24)34)41(4-3-32)10-16(25(15)43)30(48)50-11-14-12-51-28-21(27(45)42(28)22(14)29(46)47)37-26(44)20(38-49-2)18-13-52-31(35)36-18/h9-10,13,21,28H,3-8,11-12H2,1-2H3,(H2,35,36)(H,37,44)(H,46,47)/b38-20+/t21-,28-/m1/s1 D0K4ED DRUGINKE IKYGJSBKPPIKJK-YZURVANNSA-N D0K4ED DRUGSMIL CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)OCC4=C(N5C(C(C5=O)NC(=O)C(=NOC)C6=CSC(=N6)N)SC4)C(=O)O)CCF)F D0K4ED HIGHSTAT Discontinued in Phase 2 D0K4NZ DRUG__ID D0K4NZ D0K4NZ DRUGCOMP Shionogi & Co Ltd D0K4NZ DRUGTYPE Small molecular drug D0K4NZ DRUGINCH 1S/C17H24F3N3O3S/c1-16(2,3)27(25,26)23-13-7-4-11(5-8-13)15(24)22-14-9-6-12(10-21-14)17(18,19)20/h6,9-11,13,23H,4-5,7-8H2,1-3H3,(H,21,22,24) D0K4NZ DRUGINKE WGEWUYACXPEFPO-UHFFFAOYSA-N D0K4NZ DRUGSMIL CC(C)(C)S(=O)(=O)NC1CCC(CC1)C(=O)NC2=NC=C(C=C2)C(F)(F)F D0K4NZ HIGHSTAT Discontinued in Phase 2 D0K4UW DRUG__ID D0K4UW D0K4UW DRUGCOMP Sankyo Co Ltd D0K4UW DRUGTYPE Small molecular drug D0K4UW DRUGINCH 1S/C13H12N2O2S/c16-13(17)10-2-1-9-5-11(18-12(9)6-10)7-15-4-3-14-8-15/h3-6,8H,1-2,7H2,(H,16,17) D0K4UW DRUGINKE KRBSZXUPPSXPAN-UHFFFAOYSA-N D0K4UW DRUGSMIL C1CC2=C(C=C1C(=O)O)SC(=C2)CN3C=CN=C3 D0K4UW HIGHSTAT Discontinued in Phase 2 D0KV4Z DRUG__ID D0KV4Z D0KV4Z DRUGCOMP Dura Pharmaceuticals Inc D0KV4Z DRUGTYPE Small molecular drug D0KV4Z DRUGINCH 1S/C20H20N6O3/c1-12(2)29-18-15-11-14(28-3)9-10-16(15)26(13-7-5-4-6-8-13)17(18)19(27)21-20-22-24-25-23-20/h4-12H,1-3H3,(H2,21,22,23,24,25,27) D0KV4Z DRUGINKE JPTSIWRGXIZEOO-UHFFFAOYSA-N D0KV4Z DRUGSMIL CC(C)OC1=C(N(C2=C1C=C(C=C2)OC)C3=CC=CC=C3)C(=O)NC4=NNN=N4 D0KV4Z HIGHSTAT Discontinued in Phase 2 D0L1DP DRUG__ID D0L1DP D0L1DP DRUGCOMP Abbott Laboratories D0L1DP DRUGTYPE Small molecular drug D0L1DP DRUGINCH 1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1 D0L1DP DRUGINKE YRVIKLBSVVNSHF-JTQLQIEISA-N D0L1DP DRUGSMIL CC1=C(C=CC=N1)OCC2CCCN2 D0L1DP HIGHSTAT Discontinued in Phase 2 D0L1JE DRUG__ID D0L1JE D0L1JE DRUGCOMP ConjuChem Biotechnologies Inc D0L1JE DRUGTYPE Small molecular drug D0L1JE DRUGINCH 1S/C168H254N44O52/c1-17-89(10)137(165(260)188-93(14)144(239)197-118(72-99-75-180-104-38-25-24-37-102(99)104)155(250)199-114(68-86(4)5)156(251)208-135(87(6)7)163(258)196-106(40-26-29-58-169)146(241)181-77-125(221)189-107(42-32-61-179-168(174)175)150(245)191-105(140(173)235)39-28-31-60-177-128(224)83-264-66-65-263-64-62-178-124(220)57-63-212-129(225)52-53-130(212)226)210-157(252)116(69-96-33-20-18-21-34-96)200-152(247)112(50-56-133(231)232)195-151(246)108(41-27-30-59-170)192-142(237)91(12)185-141(236)90(11)187-149(244)111(47-51-123(172)219)190-126(222)78-182-148(243)110(49-55-132(229)230)194-153(248)113(67-85(2)3)198-154(249)115(71-98-43-45-101(218)46-44-98)201-160(255)120(80-213)204-162(257)122(82-215)205-164(259)136(88(8)9)209-159(254)119(74-134(233)234)202-161(256)121(81-214)206-167(262)139(95(16)217)211-158(253)117(70-97-35-22-19-23-36-97)203-166(261)138(94(15)216)207-127(223)79-183-147(242)109(48-54-131(227)228)193-143(238)92(13)186-145(240)103(171)73-100-76-176-84-184-100/h18-25,33-38,43-46,52-53,75-76,84-95,103,105-122,135-139,180,213-218H,17,26-32,39-42,47-51,54-74,77-83,169-171H2,1-16H3,(H2,172,219)(H2,173,235)(H,176,184)(H,177,224)(H,178,220)(H,181,241)(H,182,243)(H,183,242)(H,185,236)(H,186,240)(H,187,244)(H,188,260)(H,189,221)(H,190,222)(H,191,245)(H,192,237)(H,193,238)(H,194,248)(H,195,246)(H,196,258)(H,197,239)(H,198,249)(H,199,250)(H,200,247)(H,201,255)(H,202,256)(H,203,261)(H,204,257)(H,205,259)(H,206,262)(H,207,223)(H,208,251)(H,209,254)(H,210,252)(H,211,253)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H4,174,175,179)/t89-,90-,91-,92+,93-,94+,95+,103-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,135-,136-,137-,138-,139-/m0/s1 D0L1JE DRUGINKE AIWAEWBZDJARBJ-PXUUZXDZSA-N D0L1JE DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)CCN3C(=O)C=CC3=O)C(=O)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC7=CNC=N7)N D0L1JE HIGHSTAT Discontinued in Phase 2 D0L1LJ DRUG__ID D0L1LJ D0L1LJ DRUGCOMP Merck Sante SA D0L1LJ DRUGTYPE Small molecular drug D0L1LJ DRUGINCH 1S/C28H31FO5/c1-2-33-26(32)18-22(31)17-21(30)13-14-24-27(19-9-11-20(29)12-10-19)23-7-3-4-8-25(23)34-28(24)15-5-6-16-28/h3-4,7-14,21-22,30-31H,2,5-6,15-18H2,1H3/b14-13+/t21-,22-/m0/s1 D0L1LJ DRUGINKE ZADJRRFMOOACHL-WQICJITCSA-N D0L1LJ DRUGSMIL CCOC(=O)CC(CC(C=CC1=C(C2=CC=CC=C2OC13CCCC3)C4=CC=C(C=C4)F)O)O D0L1LJ HIGHSTAT Discontinued in Phase 2 D0L4PY DRUG__ID D0L4PY D0L4PY DRUGCOMP Kanebo KK D0L4PY DRUGTYPE Small molecular drug D0L4PY DRUGINCH 1S/C23H30N2O6.C4H4O4/c1-27-18-5-7-19(8-6-18)31-22(26)16-25-11-9-24(10-12-25)15-17-13-20(28-2)23(30-4)21(14-17)29-3;5-3(6)1-2-4(7)8/h5-8,13-14H,9-12,15-16H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D0L4PY DRUGINKE JUOYRBCKLAPYBI-WLHGVMLRSA-N D0L4PY DRUGSMIL COC1=CC=C(C=C1)OC(=O)CN2CCN(CC2)CC3=CC(=C(C(=C3)OC)OC)OC.C(=CC(=O)O)C(=O)O D0L4PY HIGHSTAT Discontinued in Phase 2 D0M0QX DRUG__ID D0M0QX D0M0QX DRUGCOMP Merck D0M0QX DRUGTYPE Small molecular drug D0M0QX DRUGINCH 1S/C34H35ClN2O3S.Na/c1-33(2,3)41-31-27-18-26(40-21-25-15-12-23-8-6-7-9-28(23)36-25)16-17-29(27)37(20-22-10-13-24(35)14-11-22)30(31)19-34(4,5)32(38)39;/h6-18H,19-21H2,1-5H3,(H,38,39);/q;+1/p-1 D0M0QX DRUGINKE YPURUCMVRRNPHJ-UHFFFAOYSA-M D0M0QX DRUGSMIL CC(C)(C)SC1=C(N(C2=C1C=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)CC5=CC=C(C=C5)Cl)CC(C)(C)C(=O)[O-].[Na+] D0M0QX HIGHSTAT Discontinued in Phase 2 D0M7PS DRUG__ID D0M7PS D0M7PS DRUGCOMP Eisai Co Ltd D0M7PS DRUGTYPE Small molecular drug D0M7PS DRUGINCH 1S/C24H21N3O2/c1-15-12-13-25-23-21(15)26-22(18-10-11-18)27(23)14-16-6-8-17(9-7-16)19-4-2-3-5-20(19)24(28)29/h2-9,12-13,18H,10-11,14H2,1H3,(H,28,29) D0M7PS DRUGINKE VWWMGPCUZVOLLK-UHFFFAOYSA-N D0M7PS DRUGSMIL CC1=C2C(=NC=C1)N(C(=N2)C3CC3)CC4=CC=C(C=C4)C5=CC=CC=C5C(=O)O D0M7PS HIGHSTAT Discontinued in Phase 2 D0MM2K DRUG__ID D0MM2K D0MM2K DRUGCOMP Pfizer Inc D0MM2K DRUGTYPE Small molecular drug D0MM2K DRUGINCH 1S/C24H19F3O4/c25-24(26,27)17-7-9-18(23(29)30)20(12-17)15-6-8-19-21(11-15)31-13-16(22(19)28)10-14-4-2-1-3-5-14/h1-9,11-12,16,22,28H,10,13H2,(H,29,30)/t16-,22+/m0/s1 D0MM2K DRUGINKE NZQDWKCNBOELAI-KSFYIVLOSA-N D0MM2K DRUGSMIL C1C(C(C2=C(O1)C=C(C=C2)C3=C(C=CC(=C3)C(F)(F)F)C(=O)O)O)CC4=CC=CC=C4 D0MM2K HIGHSTAT Discontinued in Phase 2 D0MP2U DRUG__ID D0MP2U D0MP2U DRUGCOMP Anacor Pharma. D0MP2U DRUGTYPE Small molecular drug D0MP2U DRUGINCH 1S/C10H18O4/c1-5-6-8(11)13-7-14-9(12)10(2,3)4/h5-7H2,1-4H3 D0MP2U DRUGINKE GYKLFBYWXZYSOW-UHFFFAOYSA-N D0MP2U DRUGSMIL CCCC(=O)OCOC(=O)C(C)(C)C D0MP2U HIGHSTAT Discontinued in Phase 2 D0N0PU DRUG__ID D0N0PU D0N0PU DRUGCOMP Novartis D0N0PU DRUGTYPE Small molecular drug D0N0PU DRUGINCH 1S/C26H37N3O4.C4H4O4/c1-18(2)29(19(3)4)26(30)21-11-14-23(24(17-21)31-5)33-16-8-6-7-15-32-22-12-9-20(10-13-22)25(27)28;5-3(6)1-2-4(7)8/h9-14,17-19H,6-8,15-16H2,1-5H3,(H3,27,28);1-2H,(H,5,6)(H,7,8)/b;2-1- D0N0PU DRUGINKE BUMMZWFWCNQFPS-BTJKTKAUSA-N D0N0PU DRUGSMIL CC(C)N(C(C)C)C(=O)C1=CC(=C(C=C1)OCCCCCOC2=CC=C(C=C2)C(=N)N)OC.C(=CC(=O)O)C(=O)O D0N0PU HIGHSTAT Discontinued in Phase 2 D0N1HL DRUG__ID D0N1HL D0N1HL DRUGCOMP Shire plc D0N1HL DRUGTYPE Small molecular drug D0N1HL DRUGINCH 1S/C30H34FN5O5/c1-18(34-29(40)24(32)15-20-9-13-23(37)14-10-20)28(39)36-26(17-21-7-11-22(31)12-8-21)30(41)35-25(27(33)38)16-19-5-3-2-4-6-19/h2-14,18,24-26,37H,15-17,32H2,1H3,(H2,33,38)(H,34,40)(H,35,41)(H,36,39)/t18-,24+,25+,26+/m1/s1 D0N1HL DRUGINKE GTPHQORJKFJIRB-JTQLPTLWSA-N D0N1HL DRUGSMIL CC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CC3=CC=C(C=C3)O)N D0N1HL HIGHSTAT Discontinued in Phase 2 D0N1PA DRUG__ID D0N1PA D0N1PA DRUGCOMP Novartis AG D0N1PA DRUGTYPE Small molecular drug D0N1PA DRUGINCH 1S/C31H33N3O/c1-22-16-23(2)18-26(17-22)31(35)34-15-13-27(20-28(34)19-24-8-4-3-5-9-24)33-21-25-12-14-32-30-11-7-6-10-29(25)30/h3-12,14,16-18,27-28,33H,13,15,19-21H2,1-2H3/t27-,28+/m0/s1 D0N1PA DRUGINKE WQZUOBIIPDZRJP-WUFINQPMSA-N D0N1PA DRUGSMIL CC1=CC(=CC(=C1)C(=O)N2CCC(CC2CC3=CC=CC=C3)NCC4=CC=NC5=CC=CC=C45)C D0N1PA HIGHSTAT Discontinued in Phase 2 D0N2FI DRUG__ID D0N2FI D0N2FI DRUGCOMP GlaxoSmithKline plc D0N2FI DRUGTYPE Small molecular drug D0N2FI DRUGINCH 1S/C21H24Cl2N4O3/c22-18-6-3-15(9-19(18)23)12-27-7-8-30-17(13-27)11-26-21(29)25-10-14-1-4-16(5-2-14)20(24)28/h1-6,9,17H,7-8,10-13H2,(H2,24,28)(H2,25,26,29)/t17-/m0/s1 D0N2FI DRUGINKE GPLUUMAKBFSDIE-KRWDZBQOSA-N D0N2FI DRUGSMIL C1COC(CN1CC2=CC(=C(C=C2)Cl)Cl)CNC(=O)NCC3=CC=C(C=C3)C(=O)N D0N2FI HIGHSTAT Discontinued in Phase 2 D0N2YN DRUG__ID D0N2YN D0N2YN DRUGCOMP Unimed Pharmaceuticals Inc D0N2YN DRUGTYPE Small molecular drug D0N2YN DRUGINCH 1S/C17H36GeN2.2ClH/c1-5-18(6-2)11-8-17(9-12-18)10-15-20(16-17)14-7-13-19(3)4;;/h5-16H2,1-4H3;2*1H D0N2YN DRUGINKE GRLUHXSUZYFZCW-UHFFFAOYSA-N D0N2YN DRUGSMIL CC[Ge]1(CCC2(CCN(C2)CCCN(C)C)CC1)CC.Cl.Cl D0N2YN HIGHSTAT Discontinued in Phase 2 D0N4YX DRUG__ID D0N4YX D0N4YX DRUGCOMP Wyeth D0N4YX DRUGTYPE Small molecular drug D0N4YX DRUGINCH 1S/C9H13N2O5P/c12-8-6-7(9(8)13)11(3-1-2-10-6)4-5-17(14,15)16/h10H,1-5H2,(H2,14,15,16) D0N4YX DRUGINKE BDABGOLMYNHHTR-UHFFFAOYSA-N D0N4YX DRUGSMIL C1CNC2=C(C(=O)C2=O)N(C1)CCP(=O)(O)O D0N4YX HIGHSTAT Discontinued in Phase 2 D0N5HN DRUG__ID D0N5HN D0N5HN DRUGCOMP Aventis Pharma D0N5HN DRUGTYPE Small molecular drug D0N5HN DRUGINCH 1S/C26H28N2O5S/c1-16(29)34-23(14-17-8-3-2-4-9-17)24(30)27-20-15-18-10-5-6-11-19(18)21-12-7-13-22(26(32)33)28(21)25(20)31/h2-6,8-11,20-23H,7,12-15H2,1H3,(H,27,30)(H,32,33)/t20-,21+,22-,23-/m0/s1 D0N5HN DRUGINKE AIEZUMPHACQOGT-BJESRGMDSA-N D0N5HN DRUGSMIL CC(=O)SC(CC1=CC=CC=C1)C(=O)NC2CC3=CC=CC=C3C4CCCC(N4C2=O)C(=O)O D0N5HN HIGHSTAT Discontinued in Phase 2 D0N5HO DRUG__ID D0N5HO D0N5HO DRUGCOMP Bristol-Myers Squibb Co D0N5HO DRUGTYPE Small molecular drug D0N5HO DRUGINCH 1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/b14-9+,15-11+ D0N5HO DRUGINKE VWFJDQUYCIWHTN-YFVJMOTDSA-N D0N5HO DRUGSMIL CC(=CCCC(=CCCC(=CCOP(=O)(O)OP(=O)(O)O)C)C)C D0N5HO HIGHSTAT Discontinued in Phase 2 D0N7SG DRUG__ID D0N7SG D0N7SG DRUGCOMP Sankyo Co Ltd D0N7SG DRUGTYPE Small molecular drug D0N7SG DRUGINCH 1S/C19H24Cl2N2OS.ClH/c20-17-9-13-3-4-15(16(13)10-18(17)21)19(24)23-7-8-25-12-14(23)11-22-5-1-2-6-22;/h9-10,14-15H,1-8,11-12H2;1H/t14-,15+;/m1./s1 D0N7SG DRUGINKE KSUNRZWFIKXTKO-LIOBNPLQSA-N D0N7SG DRUGSMIL C1CCN(C1)CC2CSCCN2C(=O)C3CCC4=CC(=C(C=C34)Cl)Cl.Cl D0N7SG HIGHSTAT Discontinued in Phase 2 D0N8MQ DRUG__ID D0N8MQ D0N8MQ DRUGCOMP GlaxoSmithKline D0N8MQ DRUGTYPE Small molecular drug D0N8MQ DRUGINCH 1S/C25H29N3O4.ClH/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19;/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29);1H/t24-,25-;/m0./s1 D0N8MQ DRUGINKE QQPHRRSYJMOQOC-DKIIUIKKSA-N D0N8MQ DRUGSMIL C1=CC=C(C=C1)C(CNC2=CC=C(C=C2)CCNCC(C3=CC(=C(C=C3)O)NC=O)O)O.Cl D0N8MQ HIGHSTAT Discontinued in Phase 2 D0NA8W DRUG__ID D0NA8W D0NA8W DRUGCOMP AstraZeneca plc D0NA8W DRUGTYPE Small molecular drug D0NA8W DRUGINCH 1S/C13H25N3O5/c1-6(2)5-9(14)11(18)16-10(8(4)17)12(19)15-7(3)13(20)21/h6-10,17H,5,14H2,1-4H3,(H,15,19)(H,16,18)(H,20,21)/t7-,8+,9-,10-/m0/s1 D0NA8W DRUGINKE ZJZNLRVCZWUONM-JXUBOQSCSA-N D0NA8W DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(C)C(=O)O)N D0NA8W HIGHSTAT Discontinued in Phase 2 D0NF0Q DRUG__ID D0NF0Q D0NF0Q DRUGCOMP AstraZeneca plc D0NF0Q DRUGTYPE Small molecular drug D0NF0Q DRUGINCH 1S/C17H13F3N2O/c18-17(19,20)15-8-12(11-4-1-3-10(7-11)9-21)16-13(22-15)5-2-6-14(16)23/h1,3-4,7-8,12,22H,2,5-6H2/t12-/m0/s1 D0NF0Q DRUGINKE RUVMMEREJMHLOS-LBPRGKRZSA-N D0NF0Q DRUGSMIL C1CC2=C(C(C=C(N2)C(F)(F)F)C3=CC=CC(=C3)C#N)C(=O)C1 D0NF0Q HIGHSTAT Discontinued in Phase 2 D0NV9O DRUG__ID D0NV9O D0NV9O DRUGCOMP Bayer healthcare pharmaceuticals D0NV9O DRUGTYPE Small molecular drug D0NV9O DRUGINCH 1S/C18H21F3N4O3S/c1-10(26)11(2)28-16-15(18(19,20)21)9-23-17(25-16)24-12-3-5-13(6-4-12)29(22,27)14-7-8-14/h3-6,9-11,14,22,26H,7-8H2,1-2H3,(H,23,24,25)/t10-,11-,29?/m1/s1 D0NV9O DRUGINKE UELYDGOOJPRWGF-MFOHZAOFSA-N D0NV9O DRUGSMIL CC(C(C)OC1=NC(=NC=C1C(F)(F)F)NC2=CC=C(C=C2)S(=N)(=O)C3CC3)O D0NV9O HIGHSTAT Discontinued in Phase 2 D0O0DF DRUG__ID D0O0DF D0O0DF DRUGCOMP Roche Holding AG D0O0DF DRUGTYPE Small molecular drug D0O0DF DRUGINCH 1S/C26H25ClN2O3/c1-2-32-20-11-12-28(16-20)25(30)23-15-22(17-6-4-3-5-7-17)26(31)29-13-10-18-8-9-19(27)14-21(18)24(23)29/h3-9,14-15,20H,2,10-13,16H2,1H3/t20-/m0/s1 D0O0DF DRUGINKE CBSWRAUYCIIUEI-FQEVSTJZSA-N D0O0DF DRUGSMIL CCOC1CCN(C1)C(=O)C2=C3C4=C(CCN3C(=O)C(=C2)C5=CC=CC=C5)C=CC(=C4)Cl D0O0DF HIGHSTAT Discontinued in Phase 2 D0O0FF DRUG__ID D0O0FF D0O0FF DRUGCOMP GlaxoSmithKline D0O0FF DRUGTYPE Small molecular drug D0O0FF DRUGINCH 1S/C20H17ClN2O3/c21-12-6-7-14-16(11-18(20(25)26)22-17(14)10-12)15-8-9-23(19(15)24)13-4-2-1-3-5-13/h1-7,10,18,22H,8-9,11H2,(H,25,26)/b16-15+ D0O0FF DRUGINKE XDKRVNKVAKCFGW-FOCLMDBBSA-N D0O0FF DRUGSMIL C1CN(C(=O)C1=C2CC(NC3=C2C=CC(=C3)Cl)C(=O)O)C4=CC=CC=C4 D0O0FF HIGHSTAT Discontinued in Phase 2 D0O4XW DRUG__ID D0O4XW D0O4XW DRUGCOMP Novartis D0O4XW DRUGTYPE Small molecular drug D0O4XW DRUGINCH 1S/C24H34O6S/c1-29-16-18-6-3-5-17(13-18)14-19(25)8-9-20-21(23(27)15-22(20)26)10-12-31-11-4-7-24(28)30-2/h3,5-6,8-9,13,19-22,25-26H,4,7,10-12,14-16H2,1-2H3/b9-8+/t19-,20-,21-,22-/m1/s1 D0O4XW DRUGINKE FBQUXLIJKPWCAO-AZIFJQEOSA-N D0O4XW DRUGSMIL COCC1=CC=CC(=C1)CC(C=CC2C(CC(=O)C2CCSCCCC(=O)OC)O)O D0O4XW HIGHSTAT Discontinued in Phase 2 D0O6QW DRUG__ID D0O6QW D0O6QW DRUGCOMP Glaxo Wellcome plc D0O6QW DRUGTYPE Small molecular drug D0O6QW DRUGINCH 1S/C12H15F2NO2/c1-7-6-17-12(16,8(2)15-7)9-3-10(13)5-11(14)4-9/h3-5,7-8,15-16H,6H2,1-2H3/t7-,8+,12-/m1/s1 D0O6QW DRUGINKE OZGPVYJHWWPEFT-RGNHYFCHSA-N D0O6QW DRUGSMIL CC1COC(C(N1)C)(C2=CC(=CC(=C2)F)F)O D0O6QW HIGHSTAT Discontinued in Phase 2 D0O7XO DRUG__ID D0O7XO D0O7XO DRUGCOMP Monash University/Metabolic Pharmaceuticals D0O7XO DRUGTYPE Small molecular drug D0O7XO DRUGINCH 1S/C78H125N23O23S2/c1-9-41(8)62(101-68(115)47(18-14-28-86-78(83)84)91-63(110)45(79)29-38(2)3)75(122)100-61(40(6)7)74(121)94-49(23-25-56(80)105)67(114)98-55(37-126)72(119)92-46(17-13-27-85-77(81)82)66(113)96-53(35-103)71(118)99-60(39(4)5)73(120)93-48(24-26-59(108)109)64(111)87-33-58(107)90-52(34-102)70(117)97-54(36-125)65(112)88-32-57(106)89-50(30-42-15-11-10-12-16-42)69(116)95-51(76(123)124)31-43-19-21-44(104)22-20-43/h10-12,15-16,19-22,38-41,45-55,60-62,102-104,125-126H,9,13-14,17-18,23-37,79H2,1-8H3,(H2,80,105)(H,87,111)(H,88,112)(H,89,106)(H,90,107)(H,91,110)(H,92,119)(H,93,120)(H,94,121)(H,95,116)(H,96,113)(H,97,117)(H,98,114)(H,99,118)(H,100,122)(H,101,115)(H,108,109)(H,123,124)(H4,81,82,85)(H4,83,84,86)/t41-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,60-,61-,62-/m0/s1 D0O7XO DRUGINKE GNOVCDMBTHSXBH-BPXGDYAESA-N D0O7XO DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CS)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(CO)C(=O)NC(CS)C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)N D0O7XO HIGHSTAT Discontinued in Phase 2 D0OK9X DRUG__ID D0OK9X D0OK9X DRUGCOMP AstraZeneca D0OK9X DRUGTYPE Small molecular drug D0OK9X DRUGINCH 1S/C13H14N2/c14-13(11-6-2-1-3-7-11)10-12-8-4-5-9-15-12/h1-9,13H,10,14H2/t13-/m0/s1 D0OK9X DRUGINKE FWUQWDCOOWEXRY-ZDUSSCGKSA-N D0OK9X DRUGSMIL C1=CC=C(C=C1)C(CC2=CC=CC=N2)N D0OK9X HIGHSTAT Discontinued in Phase 2 D0OM0M DRUG__ID D0OM0M D0OM0M DRUGCOMP Sanofi-Aventis D0OM0M DRUGTYPE Small molecular drug D0OM0M DRUGINCH 1S/C23H20Cl2F2N2O2S/c1-32(30,31)29(21-11-19(26)10-20(27)12-21)22-13-28(14-22)23(15-2-6-17(24)7-3-15)16-4-8-18(25)9-5-16/h2-12,22-23H,13-14H2,1H3 D0OM0M DRUGINKE IQQBRKLVEALROM-UHFFFAOYSA-N D0OM0M DRUGSMIL CS(=O)(=O)N(C1CN(C1)C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)C4=CC(=CC(=C4)F)F D0OM0M HIGHSTAT Discontinued in Phase 2 D0P0DT DRUG__ID D0P0DT D0P0DT DRUGCOMP Takeda Pharmaceutical Co Ltd D0P0DT DRUGTYPE Small molecular drug D0P0DT DRUGINCH 1S/C45H53N9O11S.2Na/c1-25(2)19-30-40(60)47-31(20-26-24-46-29-12-7-6-11-28(26)29)41(61)49-33(22-37(56)57)43(63)48-32(21-36(55)54-16-14-53(15-17-54)27-9-4-3-5-10-27)42(62)50-34(23-38(58)59)44(64)52-39(45(65)51-30)35-13-8-18-66-35;;/h3-13,18,24-25,30-34,39,46H,14-17,19-23H2,1-2H3,(H,47,60)(H,48,63)(H,49,61)(H,50,62)(H,51,65)(H,52,64)(H,56,57)(H,58,59);;/q;2*+1/p-2/t30-,31+,32-,33+,34-,39+;;/m0../s1 D0P0DT DRUGINKE UWHBIISPHYTOGL-PFSAEEMXSA-L D0P0DT DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C2=CC=CS2)CC(=O)[O-])CC(=O)N3CCN(CC3)C4=CC=CC=C4)CC(=O)[O-])CC5=CNC6=CC=CC=C65.[Na+].[Na+] D0P0DT HIGHSTAT Discontinued in Phase 2 D0P1LR DRUG__ID D0P1LR D0P1LR DRUGCOMP Wyeth D0P1LR DRUGTYPE Small molecular drug D0P1LR DRUGINCH 1S/C22H23NO3/c1-2-22(13-19(24)25)21-20(17-10-6-7-11-18(17)23-21)16(14-26-22)12-15-8-4-3-5-9-15/h3-11,16,23H,2,12-14H2,1H3,(H,24,25)/t16-,22-/m0/s1 D0P1LR DRUGINKE BUUODSZYUAZDIF-AOMKIAJQSA-N D0P1LR DRUGSMIL CCC1(C2=C(C(CO1)CC3=CC=CC=C3)C4=CC=CC=C4N2)CC(=O)O D0P1LR HIGHSTAT Discontinued in Phase 2 D0P1QW DRUG__ID D0P1QW D0P1QW DRUGCOMP Novartis D0P1QW DRUGTYPE Small molecular drug D0P1QW DRUGINCH 1S/C10H11N4O7P/c15-9-10(16)13-8-5(3-11-4-22(19,20)21)1-6(14(17)18)2-7(8)12-9/h1-2,11H,3-4H2,(H,12,15)(H,13,16)(H2,19,20,21) D0P1QW DRUGINKE ABFMMCZFKUIJGQ-UHFFFAOYSA-N D0P1QW DRUGSMIL C1=C(C=C2C(=C1CNCP(=O)(O)O)NC(=O)C(=O)N2)[N+](=O)[O-] D0P1QW HIGHSTAT Discontinued in Phase 2 D0P1TZ DRUG__ID D0P1TZ D0P1TZ DRUGCOMP PharmaEngine D0P1TZ DRUGTYPE Small molecular drug D0P1TZ DRUGINCH 1S/C16H19FN2O4/c17-12-4-6-13(7-5-12)22-11-15-9-8-14(23-15)3-1-2-10-19(21)16(18)20/h4-7,14-15,21H,2,8-11H2,(H2,18,20)/t14-,15+/m1/s1 D0P1TZ DRUGINKE YANONWCPCKIWEC-CABCVRRESA-N D0P1TZ DRUGSMIL C1CC(OC1COC2=CC=C(C=C2)F)C#CCCN(C(=O)N)O D0P1TZ HIGHSTAT Discontinued in Phase 2 D0P7WJ DRUG__ID D0P7WJ D0P7WJ DRUGCOMP OSI Pharma D0P7WJ DRUGTYPE Small molecular drug D0P7WJ DRUGINCH 1S/C25H30ClFN6O2/c1-31(2)7-8-32-9-11-33(12-10-32)25(35)21(13-17-3-5-19(27)6-4-17)30-24(34)20-14-18-15-23(26)28-16-22(18)29-20/h3-6,14-16,21,29H,7-13H2,1-2H3,(H,30,34)/t21-/m0/s1 D0P7WJ DRUGINKE RDFYSUFNGGYNSK-NRFANRHFSA-N D0P7WJ DRUGSMIL CN(C)CCN1CCN(CC1)C(=O)C(CC2=CC=C(C=C2)F)NC(=O)C3=CC4=CC(=NC=C4N3)Cl D0P7WJ HIGHSTAT Discontinued in Phase 2 D0P9FT DRUG__ID D0P9FT D0P9FT DRUGCOMP Recordati SpA D0P9FT DRUGTYPE Small molecular drug D0P9FT DRUGINCH 1S/C31H33N3O4/c1-22-28(35)24-12-8-13-25(30(24)38-29(22)23-10-4-3-5-11-23)31(36)32-16-9-17-33-18-20-34(21-19-33)26-14-6-7-15-27(26)37-2/h3-8,10-15H,9,16-21H2,1-2H3,(H,32,36) D0P9FT DRUGINKE DUCNHKDCVVSJLG-UHFFFAOYSA-N D0P9FT DRUGSMIL CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OC)C5=CC=CC=C5 D0P9FT HIGHSTAT Discontinued in Phase 2 D0Q0AJ DRUG__ID D0Q0AJ D0Q0AJ DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D0Q0AJ DRUGTYPE Small molecular drug D0Q0AJ DRUGINCH 1S/C18H17FN2S/c1-12(17-11-22-18(20-2)21-17)14-8-9-15(16(19)10-14)13-6-4-3-5-7-13/h3-12H,1-2H3,(H,20,21) D0Q0AJ DRUGINKE ZTFDMDJGJVUYQE-UHFFFAOYSA-N D0Q0AJ DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C3=CSC(=N3)NC D0Q0AJ HIGHSTAT Discontinued in Phase 2 D0Q3WN DRUG__ID D0Q3WN D0Q3WN DRUGCOMP Roche Holding AG D0Q3WN DRUGTYPE Small molecular drug D0Q3WN DRUGINCH 1S/C26H34N6O6S/c27-26(28)31-11-3-4-17(15-31)14-29-23(33)13-22(25(36)32(16-24(34)35)20-8-9-20)30-39(37,38)21-10-7-18-5-1-2-6-19(18)12-21/h1-2,5-7,10,12,17,20,22,30H,3-4,8-9,11,13-16H2,(H3,27,28)(H,29,33)(H,34,35)/t17-,22-/m0/s1 D0Q3WN DRUGINKE BYDKEYCXCIVOOV-JTSKRJEESA-N D0Q3WN DRUGSMIL C1CC(CN(C1)C(=N)N)CNC(=O)CC(C(=O)N(CC(=O)O)C2CC2)NS(=O)(=O)C3=CC4=CC=CC=C4C=C3 D0Q3WN HIGHSTAT Discontinued in Phase 2 D0Q4UY DRUG__ID D0Q4UY D0Q4UY DRUGCOMP CJ Corp D0Q4UY DRUGTYPE Small molecular drug D0Q4UY DRUGINCH 1S/C19H21FN4O3.ClH/c1-19-5-14(21)12(19)7-23(8-19)17-13(20)4-10-15(25)11(18(26)27)6-24(9-2-3-9)16(10)22-17;/h4,6,9,12,14H,2-3,5,7-8,21H2,1H3,(H,26,27);1H/t12-,14-,19-;/m0./s1 D0Q4UY DRUGINKE OTJVJUVCWOCNQA-ZJKXRWPCSA-N D0Q4UY DRUGSMIL CC12CC(C1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5CC5)C(=O)O)F)N.Cl D0Q4UY HIGHSTAT Discontinued in Phase 2 D0Q5YF DRUG__ID D0Q5YF D0Q5YF DRUGCOMP Gliatech D0Q5YF DRUGTYPE Small molecular drug D0Q5YF DRUGINCH 1S/C14H20N2/c1-14(2,3)7-5-4-6-11-8-12(11)13-9-15-10-16-13/h9-12H,5,7-8H2,1-3H3,(H,15,16)/t11-,12-/m1/s1 D0Q5YF DRUGINKE CVKJAXCQPFOAIN-VXGBXAGGSA-N D0Q5YF DRUGSMIL CC(C)(C)CCC#CC1CC1C2=CN=CN2 D0Q5YF HIGHSTAT Discontinued in Phase 2 D0Q7FC DRUG__ID D0Q7FC D0Q7FC DRUGCOMP Glaxo Inc D0Q7FC DRUGTYPE Small molecular drug D0Q7FC DRUGINCH 1S/C28H30N4O6/c1-3-28(35)20-11-22-25-18(14-32(22)26(33)19(20)15-38-27(28)34)17(13-31-6-4-30(2)5-7-31)16-10-23-24(12-21(16)29-25)37-9-8-36-23/h10-12,35H,3-9,13-15H2,1-2H3/t28-/m0/s1 D0Q7FC DRUGINKE RVFGKBWWUQOIOU-NDEPHWFRSA-N D0Q7FC DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC6=C(C=C5N=C4C3=C2)OCCO6)CN7CCN(CC7)C)O D0Q7FC HIGHSTAT Discontinued in Phase 2 D0Q9RR DRUG__ID D0Q9RR D0Q9RR DRUGCOMP AstraZeneca D0Q9RR DRUGTYPE Small molecular drug D0Q9RR DRUGINCH 1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h1-2,5,11H,3-4,6-9H2/t13-/m0/s1 D0Q9RR DRUGINKE OCKIPDMKGPYYJS-ZDUSSCGKSA-N D0Q9RR DRUGSMIL C1CN2CCC1C3(C2)CC4=C(O3)N=CC=C4 D0Q9RR HIGHSTAT Discontinued in Phase 2 D0Q9ZD DRUG__ID D0Q9ZD D0Q9ZD DRUGCOMP AtheroGenics Inc D0Q9ZD DRUGTYPE Small molecular drug D0Q9ZD DRUGINCH 1S/C33H50O4S2/c1-29(2,3)22-15-20(16-23(27(22)36)30(4,5)6)38-33(13,14)39-21-17-24(31(7,8)9)28(37-19-26(34)35)25(18-21)32(10,11)12/h15-18,36H,19H2,1-14H3,(H,34,35) D0Q9ZD DRUGINKE FGBGXESDYFKUFX-UHFFFAOYSA-N D0Q9ZD DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)OCC(=O)O)C(C)(C)C D0Q9ZD HIGHSTAT Discontinued in Phase 2 D0R2JS DRUG__ID D0R2JS D0R2JS DRUGCOMP Klinge Pharma GmbH D0R2JS DRUGTYPE Small molecular drug D0R2JS DRUGINCH 1S/C26H29NO2/c1-4-25(20-9-6-5-7-10-20)26(22-11-8-12-23(28)19-22)21-13-15-24(16-14-21)29-18-17-27(2)3/h5-16,19,28H,4,17-18H2,1-3H3/b26-25+ D0R2JS DRUGINKE ZQZFYGIXNQKOAV-OCEACIFDSA-N D0R2JS DRUGSMIL CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC(=CC=C2)O)C3=CC=CC=C3 D0R2JS HIGHSTAT Discontinued in Phase 2 D0R2KV DRUG__ID D0R2KV D0R2KV DRUGCOMP Pfizer D0R2KV DRUGTYPE Small molecular drug D0R2KV DRUGINCH 1S/C21H29NO2/c1-8-18(9-2)23-19-12-16(6)22-21(17(19)7)24-20-14(4)10-13(3)11-15(20)5/h10-12,18H,8-9H2,1-7H3 D0R2KV DRUGINKE ZSEJGVQTBLJRCQ-UHFFFAOYSA-N D0R2KV DRUGSMIL CCC(CC)OC1=C(C(=NC(=C1)C)OC2=C(C=C(C=C2C)C)C)C D0R2KV HIGHSTAT Discontinued in Phase 2 D0R3EL DRUG__ID D0R3EL D0R3EL DRUGCOMP GSK D0R3EL DRUGTYPE Small molecular drug D0R3EL DRUGINCH 1S/C12H18N2O3/c1-7(2)5-9-11(15)14(17)12(16)10(13-9)6-8(3)4/h5,7-8,17H,6H2,1-4H3/b9-5- D0R3EL DRUGINKE SIXHCCPAJIVTOY-UITAMQMPSA-N D0R3EL DRUGSMIL CC(C)CC1=NC(=CC(C)C)C(=O)N(C1=O)O D0R3EL HIGHSTAT Discontinued in Phase 2 D0R4ML DRUG__ID D0R4ML D0R4ML DRUGCOMP Ipsat Therapies Oy D0R4ML DRUGTYPE Small molecular drug D0R4ML DRUGINCH 1S/C27H44O6/c1-15(2)6-7-23(31)26(5,32)22-9-11-27(33)17-12-19(28)18-13-20(29)21(30)14-24(18,3)16(17)8-10-25(22,27)4/h12,15-16,18,20-23,29-33H,6-11,13-14H2,1-5H3/t16-,18-,20+,21-,22-,23+,24+,25+,26+,27+/m0/s1 D0R4ML DRUGINKE PJYYBCXMCWDUAZ-JJJZTNILSA-N D0R4ML DRUGSMIL CC(C)CCC(C(C)(C1CCC2(C1(CCC3C2=CC(=O)C4C3(CC(C(C4)O)O)C)C)O)O)O D0R4ML HIGHSTAT Discontinued in Phase 2 D0R5UZ DRUG__ID D0R5UZ D0R5UZ DRUGCOMP Hoechst Marion Roussel Inc D0R5UZ DRUGTYPE Small molecular drug D0R5UZ DRUGINCH 1S/C6H11N3O4/c1-4(10)9(5(11)7-2)13-6(12)8-3/h1-3H3,(H,7,11)(H,8,12) D0R5UZ DRUGINKE JURAJLFHWXNPHG-UHFFFAOYSA-N D0R5UZ DRUGSMIL CC(=O)N(C(=O)NC)OC(=O)NC D0R5UZ HIGHSTAT Discontinued in Phase 2 D0R6MH DRUG__ID D0R6MH D0R6MH DRUGCOMP Sankyo Co Ltd D0R6MH DRUGTYPE Small molecular drug D0R6MH DRUGINCH 1S/C19H20F3N3O4/c1-9-7-24(5-4-23-9)15-13(20)6-11-14(17(15)29-19(21)22)25(10-2-3-10)8-12(16(11)26)18(27)28/h6,8-10,19,23H,2-5,7H2,1H3,(H,27,28)/t9-/m0/s1 D0R6MH DRUGINKE QBDBUKJBJJWZMG-VIFPVBQESA-N D0R6MH DRUGSMIL CC1CN(CCN1)C2=C(C=C3C(=C2OC(F)F)N(C=C(C3=O)C(=O)O)C4CC4)F D0R6MH HIGHSTAT Discontinued in Phase 2 D0R8TB DRUG__ID D0R8TB D0R8TB DRUGCOMP Wyeth D0R8TB DRUGTYPE Small molecular drug D0R8TB DRUGINCH 1S/C29H32N2O3/c1-21-27-19-25(33)11-14-28(27)31(29(21)23-7-9-24(32)10-8-23)20-22-5-12-26(13-6-22)34-18-17-30-15-3-2-4-16-30/h5-14,19,32-33H,2-4,15-18,20H2,1H3 D0R8TB DRUGINKE JICOGKJOQXTAIP-UHFFFAOYSA-N D0R8TB DRUGSMIL CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O D0R8TB HIGHSTAT Discontinued in Phase 2 D0RF9T DRUG__ID D0RF9T D0RF9T DRUGCOMP LEO Pharma A/S D0RF9T DRUGTYPE Small molecular drug D0RF9T DRUGINCH 1S/C29H48O4/c1-6-29(32,7-2)16-9-17-33-21(4)25-13-14-26-22(10-8-15-28(25,26)5)11-12-23-18-24(30)19-27(31)20(23)3/h11-12,21,24-27,30-32H,3,6-10,13-19H2,1-2,4-5H3/b22-11+,23-12-/t21-,24-,25-,26+,27+,28-/m1/s1 D0RF9T DRUGINKE KLZOTDOJMRMLDX-YBBVPDDNSA-N D0RF9T DRUGSMIL CCC(CC)(CCCOC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O D0RF9T HIGHSTAT Discontinued in Phase 2 D0RW4F DRUG__ID D0RW4F D0RW4F DRUGCOMP StemCells Inc D0RW4F DRUGTYPE Small molecular drug D0RW4F DRUGINCH 1S/C150H230N44O39S/c1-80(2)120(190-139(224)112-40-26-62-192(112)144(229)101(35-17-21-58-154)173-115(200)75-168-125(210)106(69-87-72-166-93-31-13-12-30-91(87)93)184-129(214)98(37-23-60-164-149(158)159)177-134(219)105(66-84-28-10-9-11-29-84)183-136(221)107(70-88-73-162-79-170-88)185-130(215)99(50-52-117(202)203)178-131(216)100(54-65-234-8)179-137(222)110(78-196)188-135(220)104(182-124(209)92(155)77-195)67-85-42-46-89(197)47-43-85)141(226)169-76-114(199)172-94(32-14-18-55-151)126(211)175-95(33-15-19-56-152)127(212)176-97(36-22-59-163-148(156)157)128(213)181-102(38-24-61-165-150(160)161)145(230)193-63-27-41-113(193)140(225)191-122(82(5)6)142(227)180-96(34-16-20-57-153)132(217)189-121(81(3)4)143(228)187-109(68-86-44-48-90(198)49-45-86)146(231)194-64-25-39-111(194)138(223)186-108(71-119(206)207)133(218)171-83(7)123(208)167-74-116(201)174-103(147(232)233)51-53-118(204)205/h9-13,28-31,42-49,72-73,79-83,92,94-113,120-122,166,195-198H,14-27,32-41,50-71,74-78,151-155H2,1-8H3,(H,162,170)(H,167,208)(H,168,210)(H,169,226)(H,171,218)(H,172,199)(H,173,200)(H,174,201)(H,175,211)(H,176,212)(H,177,219)(H,178,216)(H,179,222)(H,180,227)(H,181,213)(H,182,209)(H,183,221)(H,184,214)(H,185,215)(H,186,223)(H,187,228)(H,188,220)(H,189,217)(H,190,224)(H,191,225)(H,202,203)(H,204,205)(H,206,207)(H,232,233)(H4,156,157,163)(H4,158,159,164)(H4,160,161,165)/t83-,92-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,120-,121-,122-/m0/s1 D0RW4F DRUGINKE VDBFSWDFTQMVDA-GDNBNFDOSA-N D0RW4F DRUGSMIL CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N D0RW4F HIGHSTAT Discontinued in Phase 2 D0S1AD DRUG__ID D0S1AD D0S1AD DRUGCOMP GLYCODesign Inc D0S1AD DRUGTYPE Small molecular drug D0S1AD DRUGINCH 1S/C8H15NO3/c10-5-2-1-3-9-4-6(11)8(12)7(5)9/h5-8,10-12H,1-4H2/t5-,6-,7-,8-/m1/s1 D0S1AD DRUGINKE FXUAIOOAOAVCGD-WCTZXXKLSA-N D0S1AD DRUGSMIL C1CC(C2C(C(CN2C1)O)O)O D0S1AD HIGHSTAT Discontinued in Phase 2 D0S2HO DRUG__ID D0S2HO D0S2HO DRUGCOMP University of Wisconsin-Madison D0S2HO DRUGTYPE Small molecular drug D0S2HO DRUGINCH 1S/C10H16O/c1-8(2)10-5-3-9(7-11)4-6-10/h3,10-11H,1,4-7H2,2H3 D0S2HO DRUGINKE NDTYTMIUWGWIMO-UHFFFAOYSA-N D0S2HO DRUGSMIL CC(=C)C1CCC(=CC1)CO D0S2HO HIGHSTAT Discontinued in Phase 2 D0S4JY DRUG__ID D0S4JY D0S4JY DRUGCOMP Roche Holding AG D0S4JY DRUGTYPE Small molecular drug D0S4JY DRUGINCH 1S/C31H20ClN5OS/c1-19-34-35-28-18-33-29(24-13-4-6-14-26(24)32)25-17-20(39-31(25)37(19)28)9-8-16-36-27-15-7-5-11-22(27)21-10-2-3-12-23(21)30(36)38/h2-7,10-15,17H,16,18H2,1H3 D0S4JY DRUGINKE MPMZSZMDCRPSRF-UHFFFAOYSA-N D0S4JY DRUGSMIL CC1=NN=C2N1C3=C(C=C(S3)C#CCN4C5=CC=CC=C5C6=CC=CC=C6C4=O)C(=NC2)C7=CC=CC=C7Cl D0S4JY HIGHSTAT Discontinued in Phase 2 D0S6KX DRUG__ID D0S6KX D0S6KX DRUGCOMP GSK D0S6KX DRUGTYPE Small molecular drug D0S6KX DRUGINCH 1S/C34H36F3N3O4S2/c1-4-33(5-2,32(41)42)44-27-14-16-28(17-15-27)45-22-29-30(38-31(46-29)23-6-8-24(9-7-23)34(35,36)37)40-20-18-39(19-21-40)25-10-12-26(43-3)13-11-25/h6-17H,4-5,18-22H2,1-3H3,(H,41,42) D0S6KX DRUGINKE COHCTXOFKQXTRQ-UHFFFAOYSA-N D0S6KX DRUGSMIL CCC(CC)(C(=O)O)OC1=CC=C(C=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)N4CCN(CC4)C5=CC=C(C=C5)OC D0S6KX HIGHSTAT Discontinued in Phase 2 D0S6SU DRUG__ID D0S6SU D0S6SU DRUGCOMP Kirin Brewery Co Ltd D0S6SU DRUGTYPE Small molecular drug D0S6SU DRUGINCH 1S/C9H9N5O3.CH4O3S/c10-7-13-9(8-2-1-3-11-6-8)12-4-5-17-14(15)16;1-5(2,3)4/h1-3,6H,4-5H2,(H,12,13);1H3,(H,2,3,4) D0S6SU DRUGINKE BIBJJSCMCXFMML-UHFFFAOYSA-N D0S6SU DRUGSMIL CS(=O)(=O)O.C1=CC(=CN=C1)C(=NCCO[N+](=O)[O-])NC#N D0S6SU HIGHSTAT Discontinued in Phase 2 D0S7IZ DRUG__ID D0S7IZ D0S7IZ DRUGCOMP Tragara Pharmaceuticals D0S7IZ DRUGTYPE Small molecular drug D0S7IZ DRUGINCH 1S/C19H20N2O3S/c1-3-24-17-8-4-15(5-9-17)19-12-14(2)13-21(19)16-6-10-18(11-7-16)25(20,22)23/h4-13H,3H2,1-2H3,(H2,20,22,23) D0S7IZ DRUGINKE JTMITOKKUMVWRT-UHFFFAOYSA-N D0S7IZ DRUGSMIL CCOC1=CC=C(C=C1)C2=CC(=CN2C3=CC=C(C=C3)S(=O)(=O)N)C D0S7IZ HIGHSTAT Discontinued in Phase 2 D0S8RY DRUG__ID D0S8RY D0S8RY DRUGCOMP PeriCor Therapeutics D0S8RY DRUGTYPE Small molecular drug D0S8RY DRUGINCH 1S/C16H21N5O4/c17-14-11(15(18)24)20-8-21(14)16-13(23)12(22)10(25-16)7-19-6-9-4-2-1-3-5-9/h1-5,8,10,12-13,16,19,22-23H,6-7,17H2,(H2,18,24)/t10-,12-,13-,16-/m1/s1 D0S8RY DRUGINKE LECUGLHMNZTZQB-XNIJJKJLSA-N D0S8RY DRUGSMIL C1=CC=C(C=C1)CNCC2C(C(C(O2)N3C=NC(=C3N)C(=O)N)O)O D0S8RY HIGHSTAT Discontinued in Phase 2 D0SB6K DRUG__ID D0SB6K D0SB6K DRUGCOMP Dainippon Pharmaceutical Co Ltd D0SB6K DRUGTYPE Small molecular drug D0SB6K DRUGINCH 1S/C22H27N5O.2ClH/c1-16-6-5-7-17(12-16)13-27-11-10-26(2)14-18(15-27)23-22(28)21-19-8-3-4-9-20(19)24-25-21;;/h3-9,12,18H,10-11,13-15H2,1-2H3,(H,23,28)(H,24,25);2*1H/t18-;;/m1../s1 D0SB6K DRUGINKE BDHAPQXDDJQQBI-JPKZNVRTSA-N D0SB6K DRUGSMIL CC1=CC(=CC=C1)CN2CCN(CC(C2)NC(=O)C3=NNC4=CC=CC=C43)C.Cl.Cl D0SB6K HIGHSTAT Discontinued in Phase 2 D0SH5O DRUG__ID D0SH5O D0SH5O DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0SH5O DRUGTYPE Small molecular drug D0SH5O DRUGINCH 1S/C19H21N3O8/c1-9(24)22-14-6-21-13-4-11(7-23)5-15(27-3)16(13)12(8-28-18(20)26)19(30-21,17(14)22)29-10(2)25/h4-5,7,12,14,17H,6,8H2,1-3H3,(H2,20,26) D0SH5O DRUGINKE BUZDGGFWWPZBIN-UHFFFAOYSA-N D0SH5O DRUGSMIL CC(=O)N1C2C1C3(C(C4=C(C=C(C=C4OC)C=O)N(C2)O3)COC(=O)N)OC(=O)C D0SH5O HIGHSTAT Discontinued in Phase 2 D0SK2J DRUG__ID D0SK2J D0SK2J DRUGCOMP Taisho Pharmaceutical D0SK2J DRUGTYPE Small molecular drug D0SK2J DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1 D0SK2J DRUGINKE GMVPRGQOIOIIMI-DODZYUBVSA-N D0SK2J DRUGSMIL CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O D0SK2J HIGHSTAT Discontinued in Phase 2 D0SX3X DRUG__ID D0SX3X D0SX3X DRUGCOMP Teijin Ltd D0SX3X DRUGTYPE Small molecular drug D0SX3X DRUGINCH 1S/C22H38O5S/c1-4-5-9-16(2)14-17(23)11-12-18-19(24)15-20(25)22(18)28-13-8-6-7-10-21(26)27-3/h11-12,16-19,22-24H,4-10,13-15H2,1-3H3/b12-11+/t16-,17?,18+,19-,22-/m1/s1 D0SX3X DRUGINKE KMYUINCCFSNYPC-VPTZPLTNSA-N D0SX3X DRUGSMIL CCCCC(C)CC(C=CC1C(CC(=O)C1SCCCCCC(=O)OC)O)O D0SX3X HIGHSTAT Discontinued in Phase 2 D0T1MP DRUG__ID D0T1MP D0T1MP DRUGCOMP Glaxo Wellcome plc D0T1MP DRUGTYPE Small molecular drug D0T1MP DRUGINCH 1S/C17H17FN4O/c1-10-13(20-9-19-10)8-22-7-6-14-15(17(22)23)11-4-3-5-12(18)16(11)21(14)2/h3-5,9H,6-8H2,1-2H3,(H,19,20) D0T1MP DRUGINKE NUMKWGDDRWJQMY-UHFFFAOYSA-N D0T1MP DRUGSMIL CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=C(N3C)C(=CC=C4)F D0T1MP HIGHSTAT Discontinued in Phase 2 D0T1YN DRUG__ID D0T1YN D0T1YN DRUGCOMP Pfizer Inc D0T1YN DRUGTYPE Small molecular drug D0T1YN DRUGINCH 1S/C39H64O13/c1-18-7-12-39(47-17-18)19(2)28-25(52-39)14-24-22-6-5-20-13-21(8-10-37(20,3)23(22)9-11-38(24,28)4)48-35-33(46)31(44)34(27(16-41)50-35)51-36-32(45)30(43)29(42)26(15-40)49-36/h18-36,40-46H,5-17H2,1-4H3/t18-,19+,20+,21+,22-,23+,24+,25+,26-,27-,28+,29-,30+,31-,32-,33-,34-,35-,36+,37+,38+,39-/m1/s1 D0T1YN DRUGINKE GUSVHVVOABZHAH-OPZWKQDFSA-N D0T1YN DRUGSMIL CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)O)O)O)O)C)C)C)OC1 D0T1YN HIGHSTAT Discontinued in Phase 2 D0T2LP DRUG__ID D0T2LP D0T2LP DRUGCOMP Armgo pharma D0T2LP DRUGTYPE Small molecular drug D0T2LP DRUGINCH 1S/C12H13NO4S/c1-17-9-2-3-10-8(6-9)7-13(4-5-18-10)11(14)12(15)16/h2-3,6H,4-5,7H2,1H3,(H,15,16) D0T2LP DRUGINKE FPWBHFYYVSNIFZ-UHFFFAOYSA-N D0T2LP DRUGSMIL COC1=CC2=C(C=C1)SCCN(C2)C(=O)C(=O)O D0T2LP HIGHSTAT Discontinued in Phase 2 D0T3VO DRUG__ID D0T3VO D0T3VO DRUGCOMP Daiichi Seiyaku Co Ltd D0T3VO DRUGTYPE Small molecular drug D0T3VO DRUGINCH 1S/C21H24FN3O4/c1-29-19-15(24-7-4-11(9-24)21(23)5-6-21)3-2-12-17(19)25(16-8-14(16)22)10-13(18(12)26)20(27)28/h2-3,10-11,14,16H,4-9,23H2,1H3,(H,27,28)/t11-,14+,16-/m1/s1 D0T3VO DRUGINKE ZLICIITZJTYKAQ-DIOULYMOSA-N D0T3VO DRUGSMIL COC1=C(C=CC2=C1N(C=C(C2=O)C(=O)O)C3CC3F)N4CCC(C4)C5(CC5)N D0T3VO HIGHSTAT Discontinued in Phase 2 D0T4OT DRUG__ID D0T4OT D0T4OT DRUGCOMP Pronova BioPharma ASA D0T4OT DRUGTYPE Small molecular drug D0T4OT DRUGINCH 1S/C13H12O6/c14-9-10(15)12(16)19-11(9)8-6-17-13(18-8)7-4-2-1-3-5-7/h1-5,8,11,13-15H,6H2/t8-,11+,13?/m0/s1/i13D D0T4OT DRUGINKE SWTGJCNCBUCXSS-GUFVNPKRSA-N D0T4OT DRUGSMIL C1C(OC(O1)C2=CC=CC=C2)C3C(=C(C(=O)O3)O)O D0T4OT HIGHSTAT Discontinued in Phase 2 D0T4UL DRUG__ID D0T4UL D0T4UL DRUGCOMP Pfizer D0T4UL DRUGTYPE Small molecular drug D0T4UL DRUGINCH 1S/C24H22ClFN4O4/c1-34-18-13-21(30(14-18)24(33)27-16-7-5-15(25)6-8-16)23(32)28-20-10-9-17(12-19(20)26)29-11-3-2-4-22(29)31/h2-12,18,21H,13-14H2,1H3,(H,27,33)(H,28,32)/t18-,21-/m1/s1 D0T4UL DRUGINKE QQBKAVAGLMGMHI-WIYYLYMNSA-N D0T4UL DRUGSMIL COC1CC(N(C1)C(=O)NC2=CC=C(C=C2)Cl)C(=O)NC3=C(C=C(C=C3)N4C=CC=CC4=O)F D0T4UL HIGHSTAT Discontinued in Phase 2 D0T5NI DRUG__ID D0T5NI D0T5NI DRUGCOMP Janssen Pharmaceutica NV D0T5NI DRUGTYPE Small molecular drug D0T5NI DRUGINCH 1S/C35H38F2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3 D0T5NI DRUGINKE HUADITLKOCMHSB-UHFFFAOYSA-N D0T5NI DRUGSMIL CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F D0T5NI HIGHSTAT Discontinued in Phase 2 D0T5PH DRUG__ID D0T5PH D0T5PH DRUGCOMP GlaxoSmithKline D0T5PH DRUGTYPE Small molecular drug D0T5PH DRUGINCH 1S/C27H32N4O6S/c1-17(2)14-21(30-27(34)24-15-19-8-4-5-9-23(19)37-24)26(33)29-20-12-11-18(3)31(16-22(20)32)38(35,36)25-10-6-7-13-28-25/h4-10,13,15,17-18,20-21H,11-12,14,16H2,1-3H3,(H,29,33)(H,30,34)/t18-,20+,21+/m1/s1 D0T5PH DRUGINKE BWYBBMQLUKXECQ-GIVPXCGWSA-N D0T5PH DRUGSMIL CC1CCC(C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)C(CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3 D0T5PH HIGHSTAT Discontinued in Phase 2 D0TH1Z DRUG__ID D0TH1Z D0TH1Z DRUGCOMP Merck & Co Inc D0TH1Z DRUGTYPE Small molecular drug D0TH1Z DRUGINCH 1S/C15H21NO2/c1-2-7-16-8-9-18-15-13-10-12(17)5-3-11(13)4-6-14(15)16/h3,5,10,14-15,17H,2,4,6-9H2,1H3/t14-,15-/m1/s1 D0TH1Z DRUGINKE JCSREICEMHWFAY-HUUCEWRRSA-N D0TH1Z DRUGSMIL CCCN1CCOC2C1CCC3=C2C=C(C=C3)O D0TH1Z HIGHSTAT Discontinued in Phase 2 D0U1SI DRUG__ID D0U1SI D0U1SI DRUGCOMP CytRx; Biorex Research and Development Co D0U1SI DRUGTYPE Small molecular drug D0U1SI DRUGINCH 1S/C14H20ClN3O2/c15-14(12-5-4-6-16-9-12)17-20-11-13(19)10-18-7-2-1-3-8-18/h4-6,9,13,19H,1-3,7-8,10-11H2/b17-14- D0U1SI DRUGINKE NMOVJBAGBXIKCG-VKAVYKQESA-N D0U1SI DRUGSMIL C1CCN(CC1)CC(CON=C(C2=CN=CC=C2)Cl)O D0U1SI HIGHSTAT Discontinued in Phase 2 D0U3DX DRUG__ID D0U3DX D0U3DX DRUGCOMP Santa Cruz Biotechnology D0U3DX DRUGTYPE Small molecular drug D0U3DX DRUGINCH 1S/C6H12O6.H3O4P/c7-1-3(9)5(11)6(12)4(10)2-8;1-5(2,3)4/h1,3-6,8-12H,2H2;(H3,1,2,3,4)/t3-,4-,5-,6-;/m1./s1 D0U3DX DRUGINKE NDVRKEKNSBMTAX-MVNLRXSJSA-N D0U3DX DRUGSMIL C(C(C(C(C(C=O)O)O)O)O)O.OP(=O)(O)O D0U3DX HIGHSTAT Discontinued in Phase 2 D0U5CS DRUG__ID D0U5CS D0U5CS DRUGCOMP Eli Lilly D0U5CS DRUGTYPE Small molecular drug D0U5CS DRUGINCH 1S/C8H11NO4/c9-8(7(12)13)2-1-3-4(5(3)8)6(10)11/h3-5H,1-2,9H2,(H,10,11)(H,12,13)/t3-,4-,5-,8-/m0/s1 D0U5CS DRUGINKE VTAARTQTOOYTES-RGDLXGNYSA-N D0U5CS DRUGSMIL C1CC(C2C1C2C(=O)O)(C(=O)O)N D0U5CS HIGHSTAT Discontinued in Phase 2 D0U5EU DRUG__ID D0U5EU D0U5EU DRUGCOMP GD Searle & Co D0U5EU DRUGTYPE Small molecular drug D0U5EU DRUGINCH 1S/C20H32O4S/c1-12(24-11-17(21)22)13(2)25-14-9-15(19(3,4)5)18(23)16(10-14)20(6,7)8/h9-10,12-13,23H,11H2,1-8H3,(H,21,22)/t12-,13+/m1/s1 D0U5EU DRUGINKE ADVNUIUADIXWMI-OLZOCXBDSA-N D0U5EU DRUGSMIL CC(C(C)SC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)OCC(=O)O D0U5EU HIGHSTAT Discontinued in Phase 2 D0U7PS DRUG__ID D0U7PS D0U7PS DRUGCOMP GSK D0U7PS DRUGTYPE Small molecular drug D0U7PS DRUGINCH 1S/C27H26N4O5S/c1-16-11-21(37(34,35)20-10-5-7-17(12-20)27(33)31(2)3)14-22-24(16)29-15-23(26(28)32)25(22)30-18-8-6-9-19(13-18)36-4/h5-15H,1-4H3,(H2,28,32)(H,29,30) D0U7PS DRUGINKE JFHROPTYMMSOLG-UHFFFAOYSA-N D0U7PS DRUGSMIL CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)C D0U7PS HIGHSTAT Discontinued in Phase 2 D0U9JL DRUG__ID D0U9JL D0U9JL DRUGCOMP Eli Lilly & Co D0U9JL DRUGTYPE Small molecular drug D0U9JL DRUGINCH 1S/C30H30O7/c1-36-26-14-10-21(11-15-26)7-4-2-3-5-18-37-27-16-12-24(19-22(27)13-17-28(31)32)29(33)23-8-6-9-25(20-23)30(34)35/h4,6-12,14-16,19-20H,2-3,5,13,17-18H2,1H3,(H,31,32)(H,34,35)/b7-4+ D0U9JL DRUGINKE SYZSSLLFRVDRHL-QPJJXVBHSA-N D0U9JL DRUGSMIL COC1=CC=C(C=C1)C=CCCCCOC2=C(C=C(C=C2)C(=O)C3=CC(=CC=C3)C(=O)O)CCC(=O)O D0U9JL HIGHSTAT Discontinued in Phase 2 D0UT3F DRUG__ID D0UT3F D0UT3F DRUGCOMP Sanofi-Synthelabo; Sanofi-aventis D0UT3F DRUGTYPE Small molecular drug D0UT3F DRUGINCH 1S/C37H45Cl2N2O2.C6H6O3S/c1-28(2)43-32-11-6-8-29(24-32)25-35(42)40-19-7-14-37(27-40,31-12-13-33(38)34(39)26-31)18-23-41-20-15-36(16-21-41,17-22-41)30-9-4-3-5-10-30;7-10(8,9)6-4-2-1-3-5-6/h3-6,8-13,24,26,28H,7,14-23,25,27H2,1-2H3;1-5H,(H,7,8,9)/q+1;/p-1/t36?,37-,41?;/m1./s1 D0UT3F DRUGINKE PQRLQZNKDQQMBC-LSYPWIJNSA-M D0UT3F DRUGSMIL CC(C)OC1=CC=CC(=C1)CC(=O)N2CCCC(C2)(CC[N+]34CCC(CC3)(CC4)C5=CC=CC=C5)C6=CC(=C(C=C6)Cl)Cl.C1=CC=C(C=C1)S(=O)(=O)[O-] D0UT3F HIGHSTAT Discontinued in Phase 2 D0V7GC DRUG__ID D0V7GC D0V7GC DRUGCOMP Pharmacia & Upjohn AB D0V7GC DRUGTYPE Small molecular drug D0V7GC DRUGINCH 1S/C14H12N2O2/c17-14(18)11-2-1-10-3-4-13(8-12(10)7-11)16-6-5-15-9-16/h1-2,5-9H,3-4H2,(H,17,18) D0V7GC DRUGINKE DQEDSIVMYUUZCK-UHFFFAOYSA-N D0V7GC DRUGSMIL C1CC(=CC2=C1C=CC(=C2)C(=O)O)N3C=CN=C3 D0V7GC HIGHSTAT Discontinued in Phase 2 D0V7IS DRUG__ID D0V7IS D0V7IS DRUGCOMP ALTANA Pharma AG D0V7IS DRUGTYPE Small molecular drug D0V7IS DRUGINCH 1S/C29H39N3O3/c1-8-35-27-15-22-23(16-26(27)34-7)28(30-25-13-14-31(6)17-24(22)25)20-9-11-21(12-10-20)29(33)32(18(2)3)19(4)5/h9-12,15-16,18-19,24-25H,8,13-14,17H2,1-7H3/t24-,25-/m1/s1 D0V7IS DRUGINKE CVDXFPBVOIERBH-JWQCQUIFSA-N D0V7IS DRUGSMIL CCOC1=C(C=C2C(=C1)C3CN(CCC3N=C2C4=CC=C(C=C4)C(=O)N(C(C)C)C(C)C)C)OC D0V7IS HIGHSTAT Discontinued in Phase 2 D0V9HH DRUG__ID D0V9HH D0V9HH DRUGCOMP Pfizer Inc D0V9HH DRUGTYPE Small molecular drug D0V9HH DRUGINCH 1S/C25H26N6O4S/c1-34-20-13-19-22(21(23(20)35-2)18-8-4-5-11-27-18)24(26)29-25(28-19)31-12-10-16-15(14-31)7-6-9-17(16)30-36(3,32)33/h4-9,11,13,30H,10,12,14H2,1-3H3,(H2,26,28,29) D0V9HH DRUGINKE OLYXPBZBZBVRGD-UHFFFAOYSA-N D0V9HH DRUGSMIL COC1=C(C(=C2C(=C1)N=C(N=C2N)N3CCC4=C(C3)C=CC=C4NS(=O)(=O)C)C5=CC=CC=N5)OC D0V9HH HIGHSTAT Discontinued in Phase 2 D0W0ED DRUG__ID D0W0ED D0W0ED DRUGCOMP Pierre Fabre SA D0W0ED DRUGTYPE Small molecular drug D0W0ED DRUGINCH 1S/C29H43NO2S/c1-5-6-7-8-9-10-11-12-13-17-20-33-28(25-18-15-14-16-19-25)29(32)30-26-21-22(2)27(31)24(4)23(26)3/h14-16,18-19,21,28,31H,5-13,17,20H2,1-4H3,(H,30,32)/t28-/m0/s1 D0W0ED DRUGINKE ZXEIEKDGPVTZLD-NDEPHWFRSA-N D0W0ED DRUGSMIL CCCCCCCCCCCCSC(C1=CC=CC=C1)C(=O)NC2=C(C(=C(C(=C2)C)O)C)C D0W0ED HIGHSTAT Discontinued in Phase 2 D0W2UY DRUG__ID D0W2UY D0W2UY DRUGCOMP Eisai Co Ltd D0W2UY DRUGTYPE Small molecular drug D0W2UY DRUGINCH 1S/C21H35NO2/c1-16(2)6-5-7-17(3)14-19-8-10-20(11-9-19)18(4)15-21(24)22-12-13-23/h8-11,16-18,23H,5-7,12-15H2,1-4H3,(H,22,24) D0W2UY DRUGINKE SRKIBXBMSGIQFP-UHFFFAOYSA-N D0W2UY DRUGSMIL CC(C)CCCC(C)CC1=CC=C(C=C1)C(C)CC(=O)NCCO D0W2UY HIGHSTAT Discontinued in Phase 2 D0W6XL DRUG__ID D0W6XL D0W6XL DRUGCOMP SmithKline Beecham plc D0W6XL DRUGTYPE Small molecular drug D0W6XL DRUGINCH 1S/C29H28O9/c1-3-10-35-18-6-7-19-21(12-18)27(20-8-5-17(34-2)13-23(20)36-14-25(30)31)28(29(32)33)26(19)16-4-9-22-24(11-16)38-15-37-22/h4-9,11-13,26-28H,3,10,14-15H2,1-2H3,(H,30,31)(H,32,33)/t26-,27+,28+/m0/s1 D0W6XL DRUGINKE UUAVCCWBNUITBB-UPRLRBBYSA-N D0W6XL DRUGSMIL CCCOC1=CC2=C(C=C1)C(C(C2C3=C(C=C(C=C3)OC)OCC(=O)O)C(=O)O)C4=CC5=C(C=C4)OCO5 D0W6XL HIGHSTAT Discontinued in Phase 2 D0W7IR DRUG__ID D0W7IR D0W7IR DRUGCOMP Bristol-Myers Squibb Pharma Co D0W7IR DRUGTYPE Small molecular drug D0W7IR DRUGINCH 1S/C26H18F2N2O/c27-23-13-17(9-11-29-23)15-26(16-18-10-12-30-24(28)14-18)21-7-3-1-5-19(21)25(31)20-6-2-4-8-22(20)26/h1-14H,15-16H2 D0W7IR DRUGINKE MUJBUUDUXGDXLW-UHFFFAOYSA-N D0W7IR DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2(CC4=CC(=NC=C4)F)CC5=CC(=NC=C5)F D0W7IR HIGHSTAT Discontinued in Phase 2 D0W8VY DRUG__ID D0W8VY D0W8VY DRUGCOMP Abbott Laboratories D0W8VY DRUGTYPE Small molecular drug D0W8VY DRUGINCH 1S/C18H20FN3O3.ClH.H2O/c1-9-15-12(10-2-3-10)6-13(18(24)25)17(23)22(15)8-14(19)16(9)21-5-4-11(20)7-21;;/h6,8,10-11H,2-5,7,20H2,1H3,(H,24,25);1H;1H2/t11-;;/m0../s1 D0W8VY DRUGINKE HOXFHPNUPIUHBB-IDMXKUIJSA-N D0W8VY DRUGSMIL CC1=C(C(=CN2C1=C(C=C(C2=O)C(=O)O)C3CC3)F)N4CCC(C4)N.O.Cl D0W8VY HIGHSTAT Discontinued in Phase 2 D0W9NH DRUG__ID D0W9NH D0W9NH DRUGCOMP National Cancer Institute (NCI) D0W9NH DRUGTYPE Small molecular drug D0W9NH DRUGINCH 1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20) D0W9NH DRUGINKE VAZAPHZUAVEOMC-UHFFFAOYSA-N D0W9NH DRUGSMIL CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N D0W9NH HIGHSTAT Discontinued in Phase 2 D0W9ZY DRUG__ID D0W9ZY D0W9ZY DRUGCOMP Pfizer Inc D0W9ZY DRUGTYPE Small molecular drug D0W9ZY DRUGINCH 1S/C37H34N6O2/c1-25(2)41(23-26-13-5-3-6-14-26)34(44)24-42-32-19-11-12-20-33(32)43-35(27-15-7-4-8-16-27)39-40-36(43)30(37(42)45)21-28-22-38-31-18-10-9-17-29(28)31/h3-20,22,25,30,38H,21,23-24H2,1-2H3/t30-/m0/s1 D0W9ZY DRUGINKE UBNMGTSDHSQBEL-PMERELPUSA-N D0W9ZY DRUGSMIL CC(C)N(CC1=CC=CC=C1)C(=O)CN2C3=CC=CC=C3N4C(=NN=C4C5=CC=CC=C5)C(C2=O)CC6=CNC7=CC=CC=C76 D0W9ZY HIGHSTAT Discontinued in Phase 2 D0WF1S DRUG__ID D0WF1S D0WF1S DRUGCOMP Bayer AG D0WF1S DRUGTYPE Small molecular drug D0WF1S DRUGINCH 1S/C23H27N3O4S/c1-23(2,15-27)22(28)24-16-11-13-17(14-12-16)25-31(29,30)21-10-6-7-18-19(21)8-5-9-20(18)26(3)4/h5-14,25,27H,15H2,1-4H3,(H,24,28) D0WF1S DRUGINKE OSQAKHSYTKBSPB-UHFFFAOYSA-N D0WF1S DRUGSMIL CC(C)(CO)C(=O)NC1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C D0WF1S HIGHSTAT Discontinued in Phase 2 D0X1YF DRUG__ID D0X1YF D0X1YF DRUGCOMP Tanabe Seiyaku Co Ltd D0X1YF DRUGTYPE Small molecular drug D0X1YF DRUGINCH 1S/C26H28O11/c1-13-9-17(28)21(16(27)5-3-14-4-6-18-15(11-14)7-8-34-18)19(10-13)36-25-24(31)23(30)22(29)20(37-25)12-35-26(32)33-2/h4,6-11,20,22-25,28-31H,3,5,12H2,1-2H3/t20-,22-,23+,24-,25-/m1/s1 D0X1YF DRUGINKE BXNCIERBDJYIQT-PRDVQWLOSA-N D0X1YF DRUGSMIL CC1=CC(=C(C(=C1)OC2C(C(C(C(O2)COC(=O)OC)O)O)O)C(=O)CCC3=CC4=C(C=C3)OC=C4)O D0X1YF HIGHSTAT Discontinued in Phase 2 D0X2TO DRUG__ID D0X2TO D0X2TO DRUGCOMP Wyeth D0X2TO DRUGTYPE Small molecular drug D0X2TO DRUGINCH 1S/C21H31N5O/c27-19(21-13-16-10-17(14-21)12-18(11-16)15-21)22-4-5-25-6-8-26(9-7-25)20-23-2-1-3-24-20/h1-3,16-18H,4-15H2,(H,22,27) D0X2TO DRUGINKE HPFLVTSWRFCPCV-UHFFFAOYSA-N D0X2TO DRUGSMIL C1CN(CCN1CCNC(=O)C23CC4CC(C2)CC(C4)C3)C5=NC=CC=N5 D0X2TO HIGHSTAT Discontinued in Phase 2 D0X3LD DRUG__ID D0X3LD D0X3LD DRUGCOMP Idenix Pharmaceuticals D0X3LD DRUGTYPE Small molecular drug D0X3LD DRUGINCH 1S/C14H22N4O5/c1-7(2)12(16)13(20)23-8-5-11(22-9(8)6-19)18-4-3-10(15)17-14(18)21/h3-4,7-9,11-12,19H,5-6,16H2,1-2H3,(H2,15,17,21)/t8-,9+,11+,12+/m1/s1 D0X3LD DRUGINKE VFCYZPOEGWLYRM-QCZKYFFMSA-N D0X3LD DRUGSMIL CC(C)C(C(=O)OC1CC(OC1CO)N2C=CC(=NC2=O)N)N D0X3LD HIGHSTAT Discontinued in Phase 2 D0X4IA DRUG__ID D0X4IA D0X4IA DRUGCOMP Astellas D0X4IA DRUGTYPE Small molecular drug D0X4IA DRUGINCH 1S/C14H10F3N3O2/c15-14(16,17)9-3-5-10(6-4-9)20-13(22)11(8-19)12(21)2-1-7-18/h3-6,21H,1-2H2,(H,20,22)/b12-11- D0X4IA DRUGINKE OQUXVPJVBSENGK-QXMHVHEDSA-N D0X4IA DRUGSMIL C1=CC(=CC=C1C(F)(F)F)NC(=O)C(=C(CCC#N)O)C#N D0X4IA HIGHSTAT Discontinued in Phase 2 D0X7HV DRUG__ID D0X7HV D0X7HV DRUGCOMP AstraZeneca plc D0X7HV DRUGTYPE Small molecular drug D0X7HV DRUGINCH 1S/C17H14F3NO3/c1-16(24,17(18,19)20)15(23)21-13-9-7-12(8-10-13)14(22)11-5-3-2-4-6-11/h2-10,24H,1H3,(H,21,23)/t16-/m0/s1 D0X7HV DRUGINKE LVEDGSIMCSQNNX-INIZCTEOSA-N D0X7HV DRUGSMIL CC(C(=O)NC1=CC=C(C=C1)C(=O)C2=CC=CC=C2)(C(F)(F)F)O D0X7HV HIGHSTAT Discontinued in Phase 2 D0X9PW DRUG__ID D0X9PW D0X9PW DRUGCOMP YM Biosciences D0X9PW DRUGTYPE Small molecular drug D0X9PW DRUGINCH 1S/C19H25NO/c1-3-20(4-2)14-15-21-19-12-10-18(11-13-19)16-17-8-6-5-7-9-17/h5-13H,3-4,14-16H2,1-2H3 D0X9PW DRUGINKE NFIXBCVWIPOYCD-UHFFFAOYSA-N D0X9PW DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)CC2=CC=CC=C2 D0X9PW HIGHSTAT Discontinued in Phase 2 D0XE5L DRUG__ID D0XE5L D0XE5L DRUGCOMP Merck & Co Inc D0XE5L DRUGTYPE Small molecular drug D0XE5L DRUGINCH 1S/C19H20N4O2/c1-22-11-5-6-13(12-22)19(25)23-16-9-3-2-8-15(16)21-18(24)14-7-4-10-20-17(14)23/h2-4,7-10,13H,5-6,11-12H2,1H3,(H,21,24) D0XE5L DRUGINKE LPLNSPKKMWHFAU-UHFFFAOYSA-N D0XE5L DRUGSMIL CN1CCCC(C1)C(=O)N2C3=CC=CC=C3NC(=O)C4=C2N=CC=C4 D0XE5L HIGHSTAT Discontinued in Phase 2 D0XT1M DRUG__ID D0XT1M D0XT1M DRUGCOMP Teva Pharmaceutical Industries D0XT1M DRUGTYPE Small molecular drug D0XT1M DRUGINCH 1S/C10H20N2O2/c1-3-5-8(6-4-2)10(14)12-7-9(11)13/h8H,3-7H2,1-2H3,(H2,11,13)(H,12,14) D0XT1M DRUGINKE RALGCAOVRLYSMA-UHFFFAOYSA-N D0XT1M DRUGSMIL CCCC(CCC)C(=O)NCC(=O)N D0XT1M HIGHSTAT Discontinued in Phase 2 D0Z3UP DRUG__ID D0Z3UP D0Z3UP DRUGCOMP Roche D0Z3UP DRUGTYPE Small molecular drug D0Z3UP DRUGINCH 1S/C12H16ClN3O3S/c1-8-10(19-7-11-14-5-6-15-11)4-3-9(13)12(8)16-20(2,17)18/h3-4,16H,5-7H2,1-2H3,(H,14,15) D0Z3UP DRUGINKE FOYWMEJSRSBQGB-UHFFFAOYSA-N D0Z3UP DRUGSMIL CC1=C(C=CC(=C1NS(=O)(=O)C)Cl)OCC2=NCCN2 D0Z3UP HIGHSTAT Discontinued in Phase 2 D0ZF1D DRUG__ID D0ZF1D D0ZF1D DRUGCOMP BASF AG D0ZF1D DRUGTYPE Small molecular drug D0ZF1D DRUGINCH 1S/C21H25N3O/c22-20-8-6-19(7-9-20)21(25)24-14-17-10-18(15-24)13-23(12-17)11-16-4-2-1-3-5-16/h1-9,17-18H,10-15,22H2 D0ZF1D DRUGINKE DLNAKYFPFYUBDR-UHFFFAOYSA-N D0ZF1D DRUGSMIL C1C2CN(CC1CN(C2)C(=O)C3=CC=C(C=C3)N)CC4=CC=CC=C4 D0ZF1D HIGHSTAT Discontinued in Phase 2 D0ZX7I DRUG__ID D0ZX7I D0ZX7I DRUGCOMP Sanofi D0ZX7I DRUGTYPE Small molecular drug D0ZX7I DRUGINCH 1S/C10H14ClN3/c11-9-2-1-3-10(13-9)14-6-4-8(12)5-7-14/h1-3,8H,4-7,12H2 D0ZX7I DRUGINKE WPVVMKYQOMJPIN-UHFFFAOYSA-N D0ZX7I DRUGSMIL C1CN(CCC1N)C2=NC(=CC=C2)Cl D0ZX7I HIGHSTAT Discontinued in Phase 2 D1SWN3 DRUG__ID D1SWN3 D1SWN3 DRUGCOMP Amicus Therapeutics D1SWN3 DRUGTYPE Small molecular drug D1SWN3 DRUGINCH 1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m1/s1 D1SWN3 DRUGINKE QPYJXFZUIJOGNX-HSUXUTPPSA-N D1SWN3 DRUGSMIL C1C(C(C(CN1)O)O)CO D1SWN3 HIGHSTAT Discontinued in Phase 2 DM3J5I DRUG__ID DM3J5I DM3J5I DRUGCOMP Boehringer Ingelheim DM3J5I DRUGTYPE Small molecular drug DM3J5I DRUGINCH 1S/C15H21FN2O2.ClH/c1-15(2,3)18-14(19)12-4-6-13(7-5-12)20-10-11(8-16)9-17;/h4-8H,9-10,17H2,1-3H3,(H,18,19);1H/b11-8+; DM3J5I DRUGINKE AEMZEDNMNLIDSL-YGCVIUNWSA-N DM3J5I DRUGSMIL CC(C)(C)NC(=O)C1=CC=C(C=C1)OCC(=CF)CN.Cl DM3J5I HIGHSTAT Discontinued in Phase 2 D00CQW DRUG__ID D00CQW D00CQW DRUGTYPE Small molecular drug D00CQW DRUGINCH 1S/C21H24N6O5/c22-17-16-13(10-24-18(16)27-21(23)26-17)3-1-2-11-4-6-12(7-5-11)19(30)25-14(20(31)32)8-9-15(28)29/h4-7,10,14H,1-3,8-9H2,(H,25,30)(H,28,29)(H,31,32)(H5,22,23,24,26,27)/t14-/m0/s1 D00CQW DRUGINKE WLGCEMWNUHSIIS-AWEZNQCLSA-N D00CQW DRUGSMIL C1=CC(=CC=C1CCCC2=CNC3=NC(=NC(=C23)N)N)C(=O)NC(CCC(=O)O)C(=O)O D00CQW HIGHSTAT Discontinued in Phase 2 D00DBE DRUG__ID D00DBE D00DBE DRUGTYPE Small molecular drug D00DBE DRUGINCH 1S/C24H20N4O2/c1-15-13-18-9-12-28-21(18)19(14-15)20(16-5-3-2-4-6-16)26-22(24(28)30)27-23(29)17-7-10-25-11-8-17/h2-8,10-11,13-14,22H,9,12H2,1H3,(H,27,29)/t22-/m0/s1 D00DBE DRUGINKE KYFWUBJMTHVBIF-QFIPXVFZSA-N D00DBE DRUGSMIL CC1=CC2=C3C(=C1)C(=NC(C(=O)N3CC2)NC(=O)C4=CC=NC=C4)C5=CC=CC=C5 D00DBE HIGHSTAT Discontinued in Phase 2 D00ECO DRUG__ID D00ECO D00ECO DRUGTYPE Small molecular drug D00ECO DRUGINCH 1S/C13H19NOS/c1-14-9-2-3-11(14)8-10-16-13-6-4-12(15)5-7-13/h4-7,11,15H,2-3,8-10H2,1H3 D00ECO DRUGINKE NVZGJSVPOOILDI-UHFFFAOYSA-N D00ECO DRUGSMIL CN1CCCC1CCSC2=CC=C(C=C2)O D00ECO HIGHSTAT Discontinued in Phase 2 D00FMV DRUG__ID D00FMV D00FMV DRUGTYPE Small molecular drug D00FMV DRUGINCH 1S/C4H12N2/c5-3-1-2-4-6/h1-6H2 D00FMV DRUGINKE KIDHWZJUCRJVML-UHFFFAOYSA-N D00FMV DRUGSMIL C(CCN)CN D00FMV HIGHSTAT Discontinued in Phase 2 D00FQP DRUG__ID D00FQP D00FQP DRUGTYPE Small molecular drug D00FQP DRUGINCH 1S/C33H58N10O9/c1-17(2)25(41-28(47)20-10-7-15-37-20)31(50)42-26(19(4)44)32(51)40-22(9-5-6-14-34)33(52)43-16-8-11-23(43)30(49)39-21(12-13-24(35)45)29(48)38-18(3)27(36)46/h17-23,25-26,37,44H,5-16,34H2,1-4H3,(H2,35,45)(H2,36,46)(H,38,48)(H,39,49)(H,40,51)(H,41,47)(H,42,50)/t18-,19-,20+,21+,22+,23+,25+,26+/m1/s1 D00FQP DRUGINKE WNDMGDURKQLJNM-DHCXFDNTSA-N D00FQP DRUGSMIL CC(C)C(C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)N)NC(=O)C2CCCN2 D00FQP HIGHSTAT Discontinued in Phase 2 D00FYF DRUG__ID D00FYF D00FYF DRUGTYPE Small molecular drug D00FYF DRUGINCH 1S/C15H18N6O/c16-8-12-3-4-14(20-10-12)19-6-5-18-11-15(22)21-7-1-2-13(21)9-17/h3-4,10,13,18H,1-2,5-7,11H2,(H,19,20)/t13-/m0/s1 D00FYF DRUGINKE VFFZWMWTUSXDCB-ZDUSSCGKSA-N D00FYF DRUGSMIL C1CC(N(C1)C(=O)CNCCNC2=NC=C(C=C2)C#N)C#N D00FYF HIGHSTAT Discontinued in Phase 2 D00PMA DRUG__ID D00PMA D00PMA DRUGTYPE Small molecular drug D00PMA DRUGINCH 1S/C27H35N3O2.3ClH/c1-3-11-29(12-4-1)15-17-31-24-9-7-22-19-23-8-10-25(21-27(23)28-26(22)20-24)32-18-16-30-13-5-2-6-14-30;;;/h7-10,19-21H,1-6,11-18H2;3*1H D00PMA DRUGINKE IXDXMHOJTVBKJI-UHFFFAOYSA-N D00PMA DRUGSMIL C1CCN(CC1)CCOC2=CC3=C(C=C2)C=C4C=CC(=CC4=N3)OCCN5CCCCC5.Cl.Cl.Cl D00PMA HIGHSTAT Discontinued in Phase 2 D00QCB DRUG__ID D00QCB D00QCB DRUGTYPE Small molecular drug D00QCB DRUGINCH 1S/C29H60NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-24-33-27-29(22-21-25-34-29)28-36-37(31,32)35-26-23-30(2,3)4/h5-28H2,1-4H3 D00QCB DRUGINKE OEWZGBLJCYAMEG-UHFFFAOYSA-N D00QCB DRUGSMIL CCCCCCCCCCCCCCCCCCOCC1(CCCO1)COP(=O)([O-])OCC[N+](C)(C)C D00QCB HIGHSTAT Discontinued in Phase 2 D00TNC DRUG__ID D00TNC D00TNC DRUGTYPE Small molecular drug D00TNC DRUGINCH 1S/C12H10N4O2/c1-3-17-6-7-8(1)13-5-10-11(7)15-12(14-10)9-2-4-18-16-9/h2,4-5H,1,3,6H2,(H,14,15) D00TNC DRUGINKE ITPFSYAYHHPKRT-UHFFFAOYSA-N D00TNC DRUGSMIL C1COCC2=C3C(=CN=C21)NC(=N3)C4=NOC=C4 D00TNC HIGHSTAT Discontinued in Phase 2 D00VPV DRUG__ID D00VPV D00VPV DRUGTYPE Small molecular drug D00VPV DRUGINCH 1S/C36H31F2N5O4S/c1-41(20-23-10-5-3-6-11-23)21-28-31-33(44)43(26-12-7-4-8-13-26)36(46)42(22-27-29(37)14-9-15-30(27)38)34(31)48-32(28)24-16-18-25(19-17-24)39-35(45)40-47-2/h3-19H,20-22H2,1-2H3,(H2,39,40,45) D00VPV DRUGINKE UCQSBGOFELXYIN-UHFFFAOYSA-N D00VPV DRUGSMIL CN(CC1=CC=CC=C1)CC2=C(SC3=C2C(=O)N(C(=O)N3CC4=C(C=CC=C4F)F)C5=CC=CC=C5)C6=CC=C(C=C6)NC(=O)NOC D00VPV HIGHSTAT Discontinued in Phase 2 D00VQI DRUG__ID D00VQI D00VQI DRUGTYPE Small molecular drug D00VQI DRUGINCH 1S/C23H38N2O5/c1-2-3-4-8-11-21(26)25-16-22(27)24-15-18-17(19-13-14-20(18)30-19)10-7-5-6-9-12-23(28)29/h5,7,17-20H,2-4,6,8-16H2,1H3,(H,24,27)(H,25,26)(H,28,29)/b7-5-/t17-,18+,19+,20-/m1/s1 D00VQI DRUGINKE OPZODFCEYJMBAM-OXVBEWKXSA-N D00VQI DRUGSMIL CCCCCCC(=O)NCC(=O)NCC1C2CCC(C1CC=CCCCC(=O)O)O2 D00VQI HIGHSTAT Discontinued in Phase 2 D00WJE DRUG__ID D00WJE D00WJE DRUGCOMP Sun Pharmaceutical Industries Ltd D00WJE DRUGINCH 1S/C23H26F2N2O3.2ClH/c24-20-7-3-18(4-8-20)23(19-5-9-21(25)10-6-19)27-14-12-26(13-15-27)11-1-2-16-30-17-22(28)29;;/h1-10,23H,11-17H2,(H,28,29);2*1H/b2-1+;; D00WJE DRUGINKE KAQMKGKFTBFMGE-SEPHDYHBSA-N D00WJE DRUGSMIL C1CN(CCN1CC=CCOCC(=O)O)C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F.Cl.Cl D00WJE HIGHSTAT Discontinued in Phase 2 D00ZUU DRUG__ID D00ZUU D00ZUU DRUGCOMP Ono Pharmaceutical Co Ltd D00ZUU DRUGINCH 1S/C21H34N4O4S/c1-14-13-30-21(25(14)2)24-23-20(28)18(26)17(15-9-11-29-12-10-15)22-19(27)16-7-5-3-4-6-8-16/h14-17H,3-13H2,1-2H3,(H,22,27)(H,23,28)/b24-21-/t14-,17+/m1/s1 D00ZUU DRUGINKE BTZCSXIUAFVRTE-CHGLIHOBSA-N D00ZUU DRUGSMIL CC1CSC(=NNC(=O)C(=O)C(C2CCOCC2)NC(=O)C3CCCCCC3)N1C D00ZUU HIGHSTAT Discontinued in Phase 2 D01HBE DRUG__ID D01HBE D01HBE DRUGTYPE Small molecular drug D01HBE DRUGINCH 1S/C35H47NO9/c1-19(13-25-18-41-23(5)36-25)9-8-10-21(3)32(40-7)22(4)27-17-29(37)35(6)30(45-35)12-11-20(2)26-14-24(16-31(38)42-26)15-28-33(43-28)34(39)44-27/h8-13,18,20,22,24,26-30,32-33,37H,14-17H2,1-7H3/b9-8+,12-11+,19-13+,21-10+/t20-,22+,24+,26-,27+,28+,29+,30-,32+,33-,35-/m1/s1 D01HBE DRUGINKE OWPCHSCAPHNHAV-QIPOKPRISA-N D01HBE DRUGSMIL CC1C=CC2C(O2)(C(CC(OC(=O)C3C(O3)CC4CC1OC(=O)C4)C(C)C(C(=CC=CC(=CC5=COC(=N5)C)C)C)OC)O)C D01HBE HIGHSTAT Discontinued in Phase 2 D01IPI DRUG__ID D01IPI D01IPI DRUGTYPE Small molecular drug D01IPI DRUGINCH 1S/C19H26N2O4S/c1-19(2)10-6-9-14(18(25)21(19)12-16(22)23)20-17(24)15(26)11-13-7-4-3-5-8-13/h3-5,7-8,14-15,26H,6,9-12H2,1-2H3,(H,20,24)(H,22,23)/t14-,15-/m0/s1 D01IPI DRUGINKE YRSVDSQRGBYVIY-GJZGRUSLSA-N D01IPI DRUGSMIL CC1(CCCC(C(=O)N1CC(=O)O)NC(=O)C(CC2=CC=CC=C2)S)C D01IPI HIGHSTAT Discontinued in Phase 2 D01NMN DRUG__ID D01NMN D01NMN DRUGTYPE Small molecular drug D01NMN DRUGINCH 1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15) D01NMN DRUGINKE ZUQSGZULKDDMEW-UHFFFAOYSA-N D01NMN DRUGSMIL CC1=CC(=C(N1CCNC(=O)C)C)C=O D01NMN HIGHSTAT Discontinued in Phase 2 D01ORM DRUG__ID D01ORM D01ORM DRUGTYPE Small molecular drug D01ORM DRUGINCH 1S/C16H15N3O4/c1-17(2)6-7-18-15(20)12-5-3-4-10-8-11(19(22)23)9-13(14(10)12)16(18)21/h3-5,8-9H,6-7H2,1-2H3 D01ORM DRUGINKE XXVLKDRPHSFIIB-UHFFFAOYSA-N D01ORM DRUGSMIL CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)[N+](=O)[O-] D01ORM HIGHSTAT Discontinued in Phase 2 D01QKR DRUG__ID D01QKR D01QKR DRUGTYPE Small molecular drug D01QKR DRUGINCH 1S/C26H38N2O4/c1-3-13-27(20-16-21-22(31-2)9-8-10-23(21)32-19-20)14-6-7-15-28-24(29)17-26(18-25(28)30)11-4-5-12-26/h8-10,20H,3-7,11-19H2,1-2H3/t20-/m0/s1 D01QKR DRUGINKE DLLULNTXJPATBC-FQEVSTJZSA-N D01QKR DRUGSMIL CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C3CC4=C(C=CC=C4OC)OC3 D01QKR HIGHSTAT Discontinued in Phase 2 D01VPK DRUG__ID D01VPK D01VPK DRUGTYPE Small molecular drug D01VPK DRUGINCH 1S/C23H25N3O2/c27-17-14-19-10-4-6-15-25(19)22(28)13-12-20-21-11-5-7-16-26(21)24-23(20)18-8-2-1-3-9-18/h1-3,5,7-9,11-13,16,19,27H,4,6,10,14-15,17H2/b13-12+/t19-/m1/s1 D01VPK DRUGINKE OPLOPFHUHFGKMJ-JXOMPUQVSA-N D01VPK DRUGSMIL C1CCN(C(C1)CCO)C(=O)C=CC2=C3C=CC=CN3N=C2C4=CC=CC=C4 D01VPK HIGHSTAT Discontinued in Phase 2 D01VWR DRUG__ID D01VWR D01VWR DRUGTYPE Small molecular drug D01VWR DRUGINCH 1S/C36H35F3N2O4/c1-44-33(26-7-6-8-27(21-26)36(37,38)39)23-40-19-20-45-35(43)25-15-13-24(14-16-25)17-18-41-34(42)22-32-30-11-4-2-9-28(30)29-10-3-5-12-31(29)32/h2-16,21,32-33,40H,17-20,22-23H2,1H3,(H,41,42) D01VWR DRUGINKE ASWYZRRXMGAWGN-UHFFFAOYSA-N D01VWR DRUGSMIL COC(CNCCOC(=O)C1=CC=C(C=C1)CCNC(=O)CC2C3=CC=CC=C3C4=CC=CC=C24)C5=CC(=CC=C5)C(F)(F)F D01VWR HIGHSTAT Discontinued in Phase 2 D01WJZ DRUG__ID D01WJZ D01WJZ DRUGTYPE Small molecular drug D01WJZ DRUGINCH 1S/C26H35N3O2/c1-21(2)31-25-12-5-4-11-24(25)28-17-15-27(16-18-28)20-22-9-8-10-23(19-22)26(30)29-13-6-3-7-14-29/h4-5,8-12,19,21H,3,6-7,13-18,20H2,1-2H3 D01WJZ DRUGINKE ZKZFPRUSWCYSGT-UHFFFAOYSA-N D01WJZ DRUGSMIL CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CC=C3)C(=O)N4CCCCC4 D01WJZ HIGHSTAT Discontinued in Phase 2 D01WQO DRUG__ID D01WQO D01WQO DRUGCOMP BoehringerIngelheim D01WQO DRUGINCH 1S/C23H20Cl2F3N5O5S/c1-12(19(29)34)31-39(36,37)18-11-30-21-32(16-8-14(24)7-15(25)9-16)20(35)22(2,33(18)21)10-13-3-5-17(6-4-13)38-23(26,27)28/h3-9,11-12,31H,10H2,1-2H3,(H2,29,34)/t12-,22+/m0/s1 D01WQO DRUGINKE QSNSVPRLHYSSQG-AMXDTQDGSA-N D01WQO DRUGSMIL CC(C(=O)N)NS(=O)(=O)C1=CN=C2N1C(C(=O)N2C3=CC(=CC(=C3)Cl)Cl)(C)CC4=CC=C(C=C4)OC(F)(F)F D01WQO HIGHSTAT Discontinued in Phase 2 D02GVH DRUG__ID D02GVH D02GVH DRUGTYPE Small molecular drug D02GVH DRUGINCH 1S/C21H27N3O3/c1-3-26-21(25)18-5-7-19(8-6-18)27-15-12-17-10-13-24(14-11-17)20-9-4-16(2)22-23-20/h4-9,17H,3,10-15H2,1-2H3 D02GVH DRUGINKE KCHIOGFOPPOUJC-UHFFFAOYSA-N D02GVH DRUGSMIL CCOC(=O)C1=CC=C(C=C1)OCCC2CCN(CC2)C3=NN=C(C=C3)C D02GVH HIGHSTAT Discontinued in Phase 2 D02HBW DRUG__ID D02HBW D02HBW DRUGTYPE Small molecular drug D02HBW DRUGINCH 1S/C21H24N2O5/c24-19(25)11-12-22-20(26)17(13-15-7-3-1-4-8-15)23-18(21(27)28)14-16-9-5-2-6-10-16/h1-10,17-18,23H,11-14H2,(H,22,26)(H,24,25)(H,27,28)/t17-,18-/m0/s1 D02HBW DRUGINKE WOVRTBFSWOVRST-ROUUACIJSA-N D02HBW DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCCC(=O)O)NC(CC2=CC=CC=C2)C(=O)O D02HBW HIGHSTAT Discontinued in Phase 2 D02IRL DRUG__ID D02IRL D02IRL DRUGCOMP Idenix D02IRL DRUGINCH 1S/C24H37N4O6PS/c1-9-34-35(31)17-14-15(27-36(8,32)33)10-11-16(17)25-21(26-35)18-19(29)20(24(5,6)7)28(22(18)30)13-12-23(2,3)4/h10-11,14,20,27,29H,9,12-13H2,1-8H3,(H,25,26,31)/t20-,35+/m1/s1 D02IRL DRUGINKE FKLYVKZFUGOUQH-GOKJBEJGSA-N D02IRL DRUGSMIL CCOP1(=O)C2=C(C=CC(=C2)NS(=O)(=O)C)NC(=N1)C3=C(C(N(C3=O)CCC(C)(C)C)C(C)(C)C)O D02IRL HIGHSTAT Discontinued in Phase 2 D02KKQ DRUG__ID D02KKQ D02KKQ DRUGTYPE Small molecular drug D02KKQ DRUGINCH 1S/C18H21N5/c1-22-8-12(9-23-11-19-10-21-23)5-15-14-3-2-4-16-18(14)13(7-20-16)6-17(15)22/h2-4,7,10-12,15,17,20H,5-6,8-9H2,1H3/t12-,15?,17-/m1/s1 D02KKQ DRUGINKE AIBHLZVVPXCTKY-XURPUJGUSA-N D02KKQ DRUGSMIL CN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CN5C=NC=N5 D02KKQ HIGHSTAT Discontinued in Phase 2 D02NGR DRUG__ID D02NGR D02NGR DRUGTYPE Small molecular drug D02NGR DRUGINCH 1S/C25H29N3O4S/c1-33(30,31)27-20-5-7-24-22(14-20)23(29)15-25(32-24)8-10-28(11-9-25)21-6-4-18-12-17(16-26)2-3-19(18)13-21/h2-3,5,7,12,14,21,23,27,29H,4,6,8-11,13,15H2,1H3/t21-,23-/m1/s1 D02NGR DRUGINKE NIYGLRKUBPNXQS-FYYLOGMGSA-N D02NGR DRUGSMIL CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)C4CCC5=C(C4)C=CC(=C5)C#N)CC2O D02NGR HIGHSTAT Discontinued in Phase 2 D02RHV DRUG__ID D02RHV D02RHV DRUGTYPE Small molecular drug D02RHV DRUGINCH 1S/C17H25N3O5.ClH/c1-17(2,3)18-9-12(21)10-23-13-7-5-6-8-14(13)24-11-15-19-16(22-4)20-25-15;/h5-8,12,18,21H,9-11H2,1-4H3;1H D02RHV DRUGINKE IQEOUWNTUSFDSZ-UHFFFAOYSA-N D02RHV DRUGSMIL CC(C)(C)NCC(COC1=CC=CC=C1OCC2=NC(=NO2)OC)O.Cl D02RHV HIGHSTAT Discontinued in Phase 2 D02SKA DRUG__ID D02SKA D02SKA DRUGTYPE Small molecular drug D02SKA DRUGINCH 1S/C19H22N4O2/c1-22-8-11(9-23-10-17(24)21-19(23)25)5-14-13-3-2-4-15-18(13)12(7-20-15)6-16(14)22/h2-4,7,11,14,16,20H,5-6,8-10H2,1H3,(H,21,24,25)/t11-,14-,16-/m1/s1 D02SKA DRUGINKE VXIHQTMCLKWCBN-DJSGYFEHSA-N D02SKA DRUGSMIL CN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CN5CC(=O)NC5=O D02SKA HIGHSTAT Discontinued in Phase 2 D02TTF DRUG__ID D02TTF D02TTF DRUGTYPE Small molecular drug D02TTF DRUGINCH 1S/C11H7N5O4.ClH/c17-10-11(18)14-7-4-9(16(19)20)8(3-6(7)13-10)15-2-1-12-5-15;/h1-5H,(H,13,17)(H,14,18);1H D02TTF DRUGINKE UMLFDVOHVJPDIZ-UHFFFAOYSA-N D02TTF DRUGSMIL C1=CN(C=N1)C2=C(C=C3C(=C2)NC(=O)C(=O)N3)[N+](=O)[O-].Cl D02TTF HIGHSTAT Discontinued in Phase 2 D02WGN DRUG__ID D02WGN D02WGN DRUGTYPE Small molecular drug D02WGN DRUGINCH 1S/C16H17N3O.ClH/c20-16(12-5-6-13-14(9-12)18-10-17-13)19-8-7-11-3-1-2-4-15(11)19;/h1-4,10,12H,5-9H2,(H,17,18);1H/t12-;/m1./s1 D02WGN DRUGINKE GZXONPGTMHLBKQ-UTONKHPSSA-N D02WGN DRUGSMIL C1CC2=C(CC1C(=O)N3CCC4=CC=CC=C43)NC=N2.Cl D02WGN HIGHSTAT Discontinued in Phase 2 D02ZEM DRUG__ID D02ZEM D02ZEM DRUGTYPE Small molecular drug D02ZEM DRUGINCH 1S/C25H30ClN5O3/c1-16-10-23(33)30-31-24(16)17-5-8-20(9-6-17)28-15-25(2,3)29-13-21(32)14-34-22-11-19(26)7-4-18(22)12-27/h4-9,11,16,21,28-29,32H,10,13-15H2,1-3H3,(H,30,33) D02ZEM DRUGINKE SHAJOALCPZUGLR-UHFFFAOYSA-N D02ZEM DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)NCC(C)(C)NCC(COC3=C(C=CC(=C3)Cl)C#N)O D02ZEM HIGHSTAT Discontinued in Phase 2 D03BOZ DRUG__ID D03BOZ D03BOZ DRUGTYPE Small molecular drug D03BOZ DRUGINCH 1S/C19H20ClNO6S/c20-14-1-3-15(4-2-14)27-16-5-7-17(8-6-16)28(24,25)13-19(18(22)21-23)9-11-26-12-10-19/h1-8,23H,9-13H2,(H,21,22) D03BOZ DRUGINKE ROSNVSQTEGHUKU-UHFFFAOYSA-N D03BOZ DRUGSMIL C1COCCC1(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C(=O)NO D03BOZ HIGHSTAT Discontinued in Phase 2 D03DRW DRUG__ID D03DRW D03DRW DRUGTYPE Small molecular drug D03DRW DRUGINCH 1S/C22H31N3O5S/c1-6-30-20(29)16(13-12-15-10-8-7-9-11-15)23-14(2)17(26)25-18(19(27)28)31-21(24-25)22(3,4)5/h7-11,14,16,18,23H,6,12-13H2,1-5H3,(H,27,28)/t14-,16-,18-/m0/s1 D03DRW DRUGINKE FTYVYAGWBXTWTN-ZVZYQTTQSA-N D03DRW DRUGSMIL CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(SC(=N2)C(C)(C)C)C(=O)O D03DRW HIGHSTAT Discontinued in Phase 2 D03EZB DRUG__ID D03EZB D03EZB DRUGCOMP AstraZeneca plc D03EZB DRUGINCH 1S/C20H24N4O/c1-5-15-8-6-7-12(2)17(15)10-22-18-9-16(19(21)25)11-24-14(4)13(3)23-20(18)24/h6-9,11,22H,5,10H2,1-4H3,(H2,21,25) D03EZB DRUGINKE IDSZXCFCCNVXER-UHFFFAOYSA-N D03EZB DRUGSMIL CCC1=CC=CC(=C1CNC2=CC(=CN3C2=NC(=C3C)C)C(=O)N)C D03EZB HIGHSTAT Discontinued in Phase 2 D03GAX DRUG__ID D03GAX D03GAX DRUGCOMP Takeda Pharmaceutical Co Ltd D03GAX DRUGINCH 1S/C26H29FN2O2/c27-23-3-1-2-19(14-23)17-28-11-8-18(9-12-28)4-6-24(30)22-15-20-5-7-25(31)29-13-10-21(16-22)26(20)29/h1-3,14-16,18H,4-13,17H2 D03GAX DRUGINKE RAYMNBAAUXRZHA-UHFFFAOYSA-N D03GAX DRUGSMIL C1CN(CCC1CCC(=O)C2=CC3=C4C(=C2)CCN4C(=O)CC3)CC5=CC(=CC=C5)F D03GAX HIGHSTAT Discontinued in Phase 2 D03LFR DRUG__ID D03LFR D03LFR DRUGCOMP GlaxoSmithKline D03LFR DRUGINCH 1S/C21H28N2O8S2/c1-28-18-8-6-16(14-20(18)30-3)32(24,25)22-10-5-11-23(13-12-22)33(26,27)17-7-9-19(29-2)21(15-17)31-4/h6-9,14-15H,5,10-13H2,1-4H3 D03LFR DRUGINKE GJUFPAZNBPFNRI-UHFFFAOYSA-N D03LFR DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)N2CCCN(CC2)S(=O)(=O)C3=CC(=C(C=C3)OC)OC)OC D03LFR HIGHSTAT Discontinued in Phase 2 D03NZM DRUG__ID D03NZM D03NZM DRUGTYPE Small molecular drug D03NZM DRUGINCH 1S/C16H23NO2S.ClH/c1-3-17(4-2)8-9-19-12-15(18)13-5-6-16-14(11-13)7-10-20-16;/h5-7,10-11,15,18H,3-4,8-9,12H2,1-2H3;1H/t15-;/m0./s1 D03NZM DRUGINKE BKMCUGFGPQNYHG-RSAXXLAASA-N D03NZM DRUGSMIL CCN(CC)CCOCC(C1=CC2=C(C=C1)SC=C2)O.Cl D03NZM HIGHSTAT Discontinued in Phase 2 D03PIB DRUG__ID D03PIB D03PIB DRUGTYPE Small molecular drug D03PIB DRUGINCH 1S/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17) D03PIB DRUGINKE GCUCIFQCGJIRNT-UHFFFAOYSA-N D03PIB DRUGSMIL C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CC(=O)O D03PIB HIGHSTAT Discontinued in Phase 2 D03RCP DRUG__ID D03RCP D03RCP DRUGCOMP Nissin Foods Holdings Co Ltd D03RCP DRUGINCH 1S/C60H62F2O13/c1-32-8-16-37(17-9-32)53(66)70-31-47-50(73-54(67)38-18-10-33(2)11-19-38)51(74-55(68)39-20-12-34(3)13-21-39)52(75-56(69)40-22-14-35(4)15-23-40)57(72-47)71-30-46(64)49-36(5)26-42-43-28-45(61)44-27-41(63)24-25-59(44,7)60(43,62)48(65)29-58(42,49)6/h8-25,27,36,42-43,45,47-52,57,65H,26,28-31H2,1-7H3/t36-,42+,43+,45+,47-,48+,49-,50-,51+,52-,57-,58+,59+,60+/m1/s1 D03RCP DRUGINKE BVEAZFTXNPWHMR-QBKHVOGRSA-N D03RCP DRUGSMIL CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)COC5C(C(C(C(O5)COC(=O)C6=CC=C(C=C6)C)OC(=O)C7=CC=C(C=C7)C)OC(=O)C8=CC=C(C=C8)C)OC(=O)C9=CC=C(C=C9)C)C)O)F)C)F D03RCP HIGHSTAT Discontinued in Phase 2 D03REC DRUG__ID D03REC D03REC DRUGTYPE Small molecular drug D03REC DRUGINCH 1S/C21H18N8O8S4.2Na/c22-21-24-10(7-40-21)14(26-37-4-9-1-11(30)12(31)3-28(9)36)17(32)25-15-18(33)29-16(20(34)35)8(6-39-19(15)29)5-38-13-2-23-27-41-13;;/h1-3,7,15,19,31,36H,4-6H2,(H2,22,24)(H,25,32)(H,34,35);;/q;2*+1/p-2/b26-14-;;/t15-,19-;;/m1../s1 D03REC DRUGINKE RNPRGWFDYQHVDK-PUZJMABTSA-L D03REC DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NOCC3=CC(=O)C(=CN3O)[O-])C4=CSC(=N4)N)C(=O)[O-])CSC5=CN=NS5.[Na+].[Na+] D03REC HIGHSTAT Discontinued in Phase 2 D03RNX DRUG__ID D03RNX D03RNX DRUGTYPE Small molecular drug D03RNX DRUGINCH 1S/C35H57O10P.K/c1-21(2)12-9-13-22(3)14-10-15-23(4)16-11-18-35(8)19-17-27-26(7)30(24(5)25(6)31(27)43-35)44-46(40,41)45-33-29(38)32(28(37)20-36)42-34(33)39;/h21-23,28,32,36-38H,9-20H2,1-8H3,(H,40,41);/q;+1/p-1/t22-,23-,28+,32-,35-;/m1./s1 D03RNX DRUGINKE VIHIKSJKXIMMLV-FZTHFCCHSA-M D03RNX DRUGSMIL CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OP(=O)([O-])OC3=C(C(OC3=O)C(CO)O)O)C.[K+] D03RNX HIGHSTAT Discontinued in Phase 2 D03STA DRUG__ID D03STA D03STA DRUGCOMP GSK D03STA DRUGINCH 1S/C24H29N2/c1-26(2)22-13-14-23(26)16-19(15-22)17-24(18-25,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,19,22-23H,13-17H2,1-2H3/q+1/t19?,22-,23+ D03STA DRUGINKE BKLAJZNVMHLXAP-VKGMXUHCSA-N D03STA DRUGSMIL C[N+]1(C2CCC1CC(C2)CC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)C D03STA HIGHSTAT Discontinued in Phase 2 D03TNA DRUG__ID D03TNA D03TNA DRUGTYPE Small molecular drug D03TNA DRUGINCH 1S/C17H19N5/c1-2-6-15-14(5-1)19-16(20-15)13-21-9-11-22(12-10-21)17-7-3-4-8-18-17/h1-8H,9-13H2,(H,19,20) D03TNA DRUGINKE FRPJGTNLZNXQEX-UHFFFAOYSA-N D03TNA DRUGSMIL C1CN(CCN1CC2=NC3=CC=CC=C3N2)C4=CC=CC=N4 D03TNA HIGHSTAT Discontinued in Phase 2 D03UID DRUG__ID D03UID D03UID DRUGTYPE Small molecular drug D03UID DRUGINCH 1S/C10H14N2/c1-11-7-3-2-5-10-6-4-8-12-9-10/h2,4-6,8-9,11H,3,7H2,1H3/b5-2+ D03UID DRUGINKE JUOSGGQXEBBCJB-GORDUTHDSA-N D03UID DRUGSMIL CNCCC=CC1=CN=CC=C1 D03UID HIGHSTAT Discontinued in Phase 2 D03VAR DRUG__ID D03VAR D03VAR DRUGCOMP Idera Pharmaceuticals Inc D03VAR DRUGINCH 1S/C237H310N72O131P24S24/c1-100-61-298(229(335)276-205(100)312)172-36-109(311)135(393-172)71-368-441(344,465)418-111-38-174(286-24-11-160(239)262-217(286)323)394-136(111)72-373-454(357,478)435-128-55-191(304-67-106(7)211(318)282-235(304)341)412-154(128)90-387-461(364,485)437-130-57-193(306-69-108(9)213(320)284-237(306)343)411-153(130)89-386-446(349,470)422-115-42-178(290-28-15-164(243)266-221(290)327)396-138(115)74-371-444(347,468)420-113-40-176(288-26-13-162(241)264-219(288)325)398-140(113)76-375-456(359,480)431-124-51-187(300-63-102(3)207(314)278-231(300)337)407-149(124)85-383-448(351,472)424-117-44-180(292-30-17-166(245)268-223(292)329)400-142(117)78-376-457(360,481)432-125-52-188(301-64-103(4)208(315)279-232(301)338)408-150(125)86-384-449(352,473)425-118-45-181(293-31-18-167(246)269-224(293)330)401-143(118)79-377-458(361,482)433-126-53-189(302-65-104(5)209(316)280-233(302)339)409-151(126)87-385-450(353,474)426-119-46-182(294-32-19-168(247)270-225(294)331)402-144(119)80-378-460(363,484)436-129-56-192(305-68-107(8)212(319)283-236(305)342)413-155(129)91-388-464(367,488)439-132-59-195(308-98-259-198-201(252)255-96-257-203(198)308)415-157(132)93-390-451(354,475)427-120-47-183(295-33-20-169(248)271-226(295)332)397-139(120)75-372-443(346,467)419-112-39-175(287-25-12-161(240)263-218(287)324)395-137(112)73-370-445(348,469)421-114-41-177(289-27-14-163(242)265-220(289)326)404-146(114)82-380-462(365,486)438-131-58-194(307-97-258-197-200(251)254-95-256-202(197)307)414-156(131)92-389-452(355,476)428-122-49-185(297-35-22-171(250)273-228(297)334)405-147(122)83-381-463(366,487)440-133-60-196(309-99-260-199-204(309)274-215(253)275-214(199)321)416-158(133)94-391-453(356,477)429-121-48-184(296-34-21-170(249)272-227(296)333)403-145(121)81-379-459(362,483)434-127-54-190(303-66-105(6)210(317)281-234(303)340)410-152(127)88-382-447(350,471)423-116-43-179(291-29-16-165(244)267-222(291)328)399-141(116)77-374-455(358,479)430-123-50-186(299-62-101(2)206(313)277-230(299)336)406-148(123)84-369-442(345,466)417-110-37-173(392-134(110)70-310)285-23-10-159(238)261-216(285)322/h10-35,61-69,95-99,109-158,172-196,310-311H,36-60,70-94H2,1-9H3,(H,344,465)(H,345,466)(H,346,467)(H,347,468)(H,348,469)(H,349,470)(H,350,471)(H,351,472)(H,352,473)(H,353,474)(H,354,475)(H,355,476)(H,356,477)(H,357,478)(H,358,479)(H,359,480)(H,360,481)(H,361,482)(H,362,483)(H,363,484)(H,364,485)(H,365,486)(H,366,487)(H,367,488)(H2,238,261,322)(H2,239,262,323)(H2,240,263,324)(H2,241,264,325)(H2,242,265,326)(H2,243,266,327)(H2,244,267,328)(H2,245,268,329)(H2,246,269,330)(H2,247,270,331)(H2,248,271,332)(H2,249,272,333)(H2,250,273,334)(H2,251,254,256)(H2,252,255,257)(H,276,312,335)(H,277,313,336)(H,278,314,337)(H,279,315,338)(H,280,316,339)(H,281,317,340)(H,282,318,341)(H,283,319,342)(H,284,320,343)(H3,253,274,275,321) D03VAR DRUGINKE MTLZEBXFKNNOHO-UHFFFAOYSA-N D03VAR DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=O)(OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)S)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)O D03VAR HIGHSTAT Discontinued in Phase 2 D03XIS DRUG__ID D03XIS D03XIS DRUGTYPE Small molecular drug D03XIS DRUGINCH 1S/C18H22ClNO.ClH/c1-14(16-8-5-10-17(13-16)21-2)20-12-6-9-15-7-3-4-11-18(15)19;/h3-5,7-8,10-11,13-14,20H,6,9,12H2,1-2H3;1H/t14-;/m1./s1 D03XIS DRUGINKE YJXUXANREVNZLH-PFEQFJNWSA-N D03XIS DRUGSMIL CC(C1=CC(=CC=C1)OC)NCCCC2=CC=CC=C2Cl.Cl D03XIS HIGHSTAT Discontinued in Phase 2 D03ZBM DRUG__ID D03ZBM D03ZBM DRUGTYPE Small molecular drug D03ZBM DRUGINCH 1S/C60H87N19O13/c61-39(20-10-24-68-58(62)63)49(83)73-40(21-11-25-69-59(64)65)55(89)78-27-13-23-46(78)56(90)79-33-38(81)31-47(79)54(88)71-32-48(82)72-42(28-35-14-4-1-5-15-35)50(84)77-45(34-80)53(87)76-44(30-37-18-8-3-9-19-37)52(86)75-43(29-36-16-6-2-7-17-36)51(85)74-41(57(91)92)22-12-26-70-60(66)67/h1-9,14-19,38-47,80-81H,10-13,20-34,61H2,(H,71,88)(H,72,82)(H,73,83)(H,74,85)(H,75,86)(H,76,87)(H,77,84)(H,91,92)(H4,62,63,68)(H4,64,65,69)(H4,66,67,70)/t38-,39-,40+,41+,42+,43+,44-,45+,46+,47+/m1/s1 D03ZBM DRUGINKE RBIXVHPHNGXTCI-QJTYZATASA-N D03ZBM DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O)O D03ZBM HIGHSTAT Discontinued in Phase 2 D03ZVD DRUG__ID D03ZVD D03ZVD DRUGCOMP Kyowa Hakko Kogyo Co Ltd D03ZVD DRUGINCH 1S/C17H19NO5/c1-21-13-3-2-12(14-15(13)23-9-8-22-14)17(10-18)6-4-11(5-7-17)16(19)20/h2-3,11H,4-9H2,1H3,(H,19,20) D03ZVD DRUGINKE SBCKAEJLDHJBNZ-UHFFFAOYSA-N D03ZVD DRUGSMIL COC1=C2C(=C(C=C1)C3(CCC(CC3)C(=O)O)C#N)OCCO2 D03ZVD HIGHSTAT Discontinued in Phase 2 D04ENK DRUG__ID D04ENK D04ENK DRUGTYPE Small molecular drug D04ENK DRUGINCH 1S/C30H33BrN4O4.NO3/c1-2-15-33-20-25(19-26(31)22-33)29(37)35(27-10-4-3-5-11-27)17-13-28(36)32-14-18-39-30(38)34-16-12-23-8-6-7-9-24(23)21-34;2-1(3)4/h3-11,19-20,22H,2,12-18,21H2,1H3;/q;-1/p+1 D04ENK DRUGINKE DVGLBKDNVHDMTD-UHFFFAOYSA-O D04ENK DRUGSMIL CCC[N+]1=CC(=CC(=C1)Br)C(=O)N(CCC(=O)NCCOC(=O)N2CCC3=CC=CC=C3C2)C4=CC=CC=C4.[N+](=O)([O-])[O-] D04ENK HIGHSTAT Discontinued in Phase 2 D04FXS DRUG__ID D04FXS D04FXS DRUGTYPE Small molecular drug D04FXS DRUGINCH 1S/C7H7NO4/c9-5-2-1-4(3-6(5)10)7(11)8-12/h1-3,9-10,12H,(H,8,11) D04FXS DRUGINKE QJMCKEPOKRERLN-UHFFFAOYSA-N D04FXS DRUGSMIL C1=CC(=C(C=C1C(=O)NO)O)O D04FXS HIGHSTAT Discontinued in Phase 2 D04HYP DRUG__ID D04HYP D04HYP DRUGTYPE Small molecular drug D04HYP DRUGINCH 1S/C9H11ClN2O/c10-9-2-1-8(5-12-9)13-6-7-3-4-11-7/h1-2,5,7,11H,3-4,6H2/t7-/m1/s1 D04HYP DRUGINKE MKTAGSRKQIGEBH-SSDOTTSWSA-N D04HYP DRUGSMIL C1CNC1COC2=CN=C(C=C2)Cl D04HYP HIGHSTAT Discontinued in Phase 2 D04IME DRUG__ID D04IME D04IME DRUGTYPE Small molecular drug D04IME DRUGINCH 1S/C26H27NO3/c1-29-22-15-11-20(12-16-22)25-24(10-6-9-19-7-4-3-5-8-19)26(28)27(25)21-13-17-23(30-2)18-14-21/h3-5,7-8,11-18,24-25H,6,9-10H2,1-2H3/t24-,25-/m1/s1 D04IME DRUGINKE IMNTVVOUWFPRSB-JWQCQUIFSA-N D04IME DRUGSMIL COC1=CC=C(C=C1)C2C(C(=O)N2C3=CC=C(C=C3)OC)CCCC4=CC=CC=C4 D04IME HIGHSTAT Discontinued in Phase 2 D04JFT DRUG__ID D04JFT D04JFT DRUGCOMP Kyowa Hakko Kogyo Co Ltd D04JFT DRUGINCH 1S/C121H190N34O35/c1-10-65(8)98(153-115(185)87-32-23-53-155(87)118(188)97(64(6)7)152-100(170)71(124)56-67-24-13-11-14-25-67)116(186)151-85(57-68-26-15-12-16-27-68)114(184)154-99(66(9)156)117(187)150-84(58-69-33-35-70(157)36-34-69)102(172)136-60-92(162)137-76(40-46-94(164)165)106(176)148-83(55-63(4)5)112(182)145-77(37-43-88(125)158)107(177)141-74(30-21-51-133-120(129)130)104(174)147-82(54-62(2)3)111(181)146-78(38-44-89(126)159)108(178)144-80(42-48-96(168)169)109(179)140-73(29-18-20-50-123)103(173)143-79(41-47-95(166)167)110(180)142-75(31-22-52-134-121(131)132)105(175)149-86(59-91(128)161)113(183)139-72(28-17-19-49-122)101(171)135-61-93(163)138-81(119(189)190)39-45-90(127)160/h11-16,24-27,33-36,62-66,71-87,97-99,156-157H,10,17-23,28-32,37-61,122-124H2,1-9H3,(H2,125,158)(H2,126,159)(H2,127,160)(H2,128,161)(H,135,171)(H,136,172)(H,137,162)(H,138,163)(H,139,183)(H,140,179)(H,141,177)(H,142,180)(H,143,173)(H,144,178)(H,145,182)(H,146,181)(H,147,174)(H,148,176)(H,149,175)(H,150,187)(H,151,186)(H,152,170)(H,153,185)(H,154,184)(H,164,165)(H,166,167)(H,168,169)(H,189,190)(H4,129,130,133)(H4,131,132,134)/t65-,66+,71-,72-,73-,74-,75+,76-,77-,78-,79-,80-,81+,82-,83-,84-,85-,86+,87-,97-,98-,99-/m0/s1 D04JFT DRUGINKE GFOZQXMKARUPQI-DFIBRNPJSA-N D04JFT DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C3CCCN3C(=O)C(C(C)C)NC(=O)C(CC4=CC=CC=C4)N D04JFT HIGHSTAT Discontinued in Phase 2 D04MRV DRUG__ID D04MRV D04MRV DRUGTYPE Small molecular drug D04MRV DRUGINCH 1S/C16H19FN4O3/c1-18-21-9-11(16(23)24)15(22)10-7-12(17)14(8-13(10)21)20-5-3-19(2)4-6-20/h7-9,18H,3-6H2,1-2H3,(H,23,24) D04MRV DRUGINKE RUXPNBWPIRDVTH-UHFFFAOYSA-N D04MRV DRUGSMIL CNN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O D04MRV HIGHSTAT Discontinued in Phase 2 D04NCJ DRUG__ID D04NCJ D04NCJ DRUGTYPE Small molecular drug D04NCJ DRUGINCH 1S/C23H22F2N4O4.Na/c1-29-23(26-27-28-29)20(11-10-18(30)12-19(31)13-21(32)33)22(14-2-6-16(24)7-3-14)15-4-8-17(25)9-5-15;/h2-11,18-19,30-31H,12-13H2,1H3,(H,32,33);/q;+1/p-1/b11-10+;/t18-,19-;/m0./s1 D04NCJ DRUGINKE NTDIRNUKAZNMSW-IYVGUKHKSA-M D04NCJ DRUGSMIL CN1C(=NN=N1)C(=C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C=CC(CC(CC(=O)[O-])O)O.[Na+] D04NCJ HIGHSTAT Discontinued in Phase 2 D04NWP DRUG__ID D04NWP D04NWP DRUGTYPE Small molecular drug D04NWP DRUGINCH 1S/C30H33Cl2F2N5O2/c31-25-15-23(35)16-26(32)29(25)37-28(40)18-39-14-13-38(17-27(39)30(36)41)12-2-1-3-24(19-4-8-21(33)9-5-19)20-6-10-22(34)11-7-20/h4-11,15-16,24,27H,1-3,12-14,17-18,35H2,(H2,36,41)(H,37,40) D04NWP DRUGINKE IWMYIWLIESDFRZ-UHFFFAOYSA-N D04NWP DRUGSMIL C1CN(C(CN1CCCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C(=O)N)CC(=O)NC4=C(C=C(C=C4Cl)N)Cl D04NWP HIGHSTAT Discontinued in Phase 2 D04PSL DRUG__ID D04PSL D04PSL DRUGTYPE Small molecular drug D04PSL DRUGINCH 1S/C18H15FN4O/c19-16-7-3-13(4-8-16)9-17(24)18(23-12-21-11-22-23)15-5-1-14(10-20)2-6-15/h1-8,11-12,17-18,24H,9H2/t17-,18+/m0/s1 D04PSL DRUGINKE SLJZVZKQYSKYNV-ZWKOTPCHSA-N D04PSL DRUGSMIL C1=CC(=CC=C1CC(C(C2=CC=C(C=C2)C#N)N3C=NC=N3)O)F D04PSL HIGHSTAT Discontinued in Phase 2 D04VIP DRUG__ID D04VIP D04VIP DRUGTYPE Small molecular drug D04VIP DRUGINCH 1S/C11H9Cl2FN4/c12-6-3-1-2-5(9(6)13)8-7(4-14)17-11(16)18-10(8)15/h1-3H,4H2,(H4,15,16,17,18) D04VIP DRUGINKE GKBLWFDYSYTVEA-UHFFFAOYSA-N D04VIP DRUGSMIL C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=C2N)N)CF D04VIP HIGHSTAT Discontinued in Phase 2 D04VJH DRUG__ID D04VJH D04VJH DRUGTYPE Small molecular drug D04VJH DRUGINCH 1S/C15H14ClN3O6/c1-8(20)24-6-13(22)18-11-3-10(5-17)4-12(15(11)16)19-14(23)7-25-9(2)21/h3-4H,6-7H2,1-2H3,(H,18,22)(H,19,23) D04VJH DRUGINKE VNVBCWREJHKWSG-UHFFFAOYSA-N D04VJH DRUGSMIL CC(=O)OCC(=O)NC1=CC(=CC(=C1Cl)NC(=O)COC(=O)C)C#N D04VJH HIGHSTAT Discontinued in Phase 2 D04WCI DRUG__ID D04WCI D04WCI DRUGTYPE Small molecular drug D04WCI DRUGINCH 1S/C19H20F2N4O4/c1-25-17-11(10-22-19(24-17)23-13(4-6-26)5-7-27)8-16(18(25)28)29-15-3-2-12(20)9-14(15)21/h2-3,8-10,13,26-27H,4-7H2,1H3,(H,22,23,24) D04WCI DRUGINKE JYYLVUFNAHSSFE-UHFFFAOYSA-N D04WCI DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)OC3=C(C=C(C=C3)F)F)NC(CCO)CCO D04WCI HIGHSTAT Discontinued in Phase 2 D04WHX DRUG__ID D04WHX D04WHX DRUGCOMP EMD Lexigen Research Center Corp D04WHX DRUGINCH 1S/C42H28Cl4N6O18S4.4Na/c1-69-30-16-27(50-52-38-33(74(66,67)68)11-18-9-21(72(60,61)62)14-29(35(18)40(38)54)48-42(56)23-4-3-5-24(44)36(23)46)31(70-2)15-26(30)49-51-37-32(73(63,64)65)10-17-8-20(71(57,58)59)13-28(34(17)39(37)53)47-41(55)22-7-6-19(43)12-25(22)45;;;;/h3-16,49-50H,1-2H3,(H,47,55)(H,48,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;/q;4*+1/p-4/b51-37-,52-38-;;;; D04WHX DRUGINKE ZHLWZRQBFUUDMG-PWABEOQWSA-J D04WHX DRUGSMIL COC1=CC(=C(C=C1NN=C2C(=CC3=C(C2=O)C(=CC(=C3)S(=O)(=O)[O-])NC(=O)C4=C(C(=CC=C4)Cl)Cl)S(=O)(=O)[O-])OC)NN=C5C(=CC6=C(C5=O)C(=CC(=C6)S(=O)(=O)[O-])NC(=O)C7=C(C=C(C=C7)Cl)Cl)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+] D04WHX HIGHSTAT Discontinued in Phase 2 D04ZLJ DRUG__ID D04ZLJ D04ZLJ DRUGTYPE Small molecular drug D04ZLJ DRUGINCH 1S/C22H27N5O4/c28-12-9-23-6-7-25-15-4-5-16-20-19(15)22(31)18-14(2-1-3-17(18)30)21(20)26-27(16)11-8-24-10-13-29/h1-5,23-25,28-30H,6-13H2 D04ZLJ DRUGINKE YROQEQPFUCPDCP-UHFFFAOYSA-N D04ZLJ DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C=CC4=C3C2=NN4CCNCCO)NCCNCCO D04ZLJ HIGHSTAT Discontinued in Phase 2 D04ZOZ DRUG__ID D04ZOZ D04ZOZ DRUGTYPE Small molecular drug D04ZOZ DRUGINCH 1S/C18H22N2O2.ClH/c1-2-14(13-20-10-6-7-11-20)18(21)17-12-16(19-22-17)15-8-4-3-5-9-15;/h3-5,8-9,12,14H,2,6-7,10-11,13H2,1H3;1H D04ZOZ DRUGINKE DGJPRBXSVZULQO-UHFFFAOYSA-N D04ZOZ DRUGSMIL CCC(CN1CCCC1)C(=O)C2=CC(=NO2)C3=CC=CC=C3.Cl D04ZOZ HIGHSTAT Discontinued in Phase 2 D05BTR DRUG__ID D05BTR D05BTR DRUGTYPE Small molecular drug D05BTR DRUGINCH 1S/C32H38Cl2N10O4/c1-41-18-22(14-25(41)30(46)37-11-8-28(35)36)39-32(48)27-16-23(19-43(27)3)40-31(47)26-15-21(17-42(26)2)38-29(45)20-4-6-24(7-5-20)44(12-9-33)13-10-34/h4-7,14-19H,8-13H2,1-3H3,(H3,35,36)(H,37,46)(H,38,45)(H,39,48)(H,40,47) D05BTR DRUGINKE ARKYUICTMUZVEW-UHFFFAOYSA-N D05BTR DRUGSMIL CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCC(=N)N)C)C)NC(=O)C4=CC=C(C=C4)N(CCCl)CCCl D05BTR HIGHSTAT Discontinued in Phase 2 D05HZI DRUG__ID D05HZI D05HZI DRUGTYPE Small molecular drug D05HZI DRUGINCH 1S/C10H12FN3O4/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17/h1-3,6,8-9,15-16H,4H2,(H2,12,13,17)/b5-3+/t6-,8+,9-/m1/s1 D05HZI DRUGINKE GFFXZLZWLOBBLO-ASKVSEFXSA-N D05HZI DRUGSMIL C1=CN(C(=O)N=C1N)C2C(=CF)C(C(O2)CO)O D05HZI HIGHSTAT Discontinued in Phase 2 D05KQE DRUG__ID D05KQE D05KQE DRUGTYPE Small molecular drug D05KQE DRUGINCH 1S/C25H34O9S/c1-6-10-33-25-22(31-4)14-17(15-23(25)35(27,28)11-9-26)19-8-7-18(34-19)16-12-20(29-2)24(32-5)21(13-16)30-3/h12-15,18-19,26H,6-11H2,1-5H3/t18-,19-/m0/s1 D05KQE DRUGINKE WXIDMVGKJBAEFP-OALUTQOASA-N D05KQE DRUGSMIL CCCOC1=C(C=C(C=C1S(=O)(=O)CCO)C2CCC(O2)C3=CC(=C(C(=C3)OC)OC)OC)OC D05KQE HIGHSTAT Discontinued in Phase 2 D05OVC DRUG__ID D05OVC D05OVC DRUGTYPE Small molecular drug D05OVC DRUGINCH 1S/C14H16N2/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14/h3-6,9-10H,2,7-8H2,1H3,(H,15,16) D05OVC DRUGINKE HSWPZIDYAHLZDD-UHFFFAOYSA-N D05OVC DRUGSMIL CCC1(CC2=CC=CC=C2C1)C3=CN=CN3 D05OVC HIGHSTAT Discontinued in Phase 2 D05SFD DRUG__ID D05SFD D05SFD DRUGTYPE Small molecular drug D05SFD DRUGINCH 1S/C14H10ClF3N2O/c15-9-3-4-11-10(7-9)13(14(16,17)18,20-12(21)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H2,19,20,21)/t13-/m0/s1 D05SFD DRUGINKE JJWJSIAJLBEMEN-ZDUSSCGKSA-N D05SFD DRUGSMIL C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)N2)C(F)(F)F D05SFD HIGHSTAT Discontinued in Phase 2 D05UHJ DRUG__ID D05UHJ D05UHJ DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D05UHJ DRUGINCH 1S/C14H13FN2.C6H8O7/c15-10-2-1-3-11-12(10)13(16)9-6-7-4-8(5-7)14(9)17-11;7-3(8)1-6(13,5(11)12)2-4(9)10/h1-3,7-8H,4-6H2,(H2,16,17);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D05UHJ DRUGINKE ZCELBELLETVSEJ-UHFFFAOYSA-N D05UHJ DRUGSMIL C1C2CC1C3=NC4=C(C(=CC=C4)F)C(=C3C2)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D05UHJ HIGHSTAT Discontinued in Phase 2 D05UIL DRUG__ID D05UIL D05UIL DRUGCOMP Teva D05UIL DRUGINCH 1S/C111H149N27O28/c1-5-59(3)94(107(163)123-57-93(150)151)135-103(159)82(49-64-53-119-72-22-11-8-19-69(64)72)131-99(155)77(38-41-92(148)149)127-98(154)76(37-40-91(146)147)125-89(144)55-121-96(152)74(24-13-14-42-112)124-90(145)56-122-106(162)85-26-16-44-137(85)110(166)86-27-17-45-138(86)109(165)78(36-39-87(114)142)129-97(153)75(25-15-43-117-111(115)116)128-108(164)95(60(4)6-2)136-104(160)83(50-65-54-120-73-23-12-9-20-70(65)73)133-105(161)84(58-139)134-102(158)81(48-63-52-118-71-21-10-7-18-68(63)71)132-101(157)80(47-62-30-34-67(141)35-31-62)130-100(156)79(126-88(143)51-113)46-61-28-32-66(140)33-29-61/h7-12,18-23,28-35,52-54,59-60,74-86,94-95,118-120,139-141H,5-6,13-17,24-27,36-51,55-58,112-113H2,1-4H3,(H2,114,142)(H,121,152)(H,122,162)(H,123,163)(H,124,145)(H,125,144)(H,126,143)(H,127,154)(H,128,164)(H,129,153)(H,130,156)(H,131,155)(H,132,157)(H,133,161)(H,134,158)(H,135,159)(H,136,160)(H,146,147)(H,148,149)(H,150,151)(H4,115,116,117)/t59-,60-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,94-,95-/m0/s1 D05UIL DRUGINKE VXXZQHUWZSRPAM-CDJUQFLLSA-N D05UIL DRUGSMIL CCC(C)C(C(=O)NCC(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CCCCN)NC(=O)CNC(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)CC)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CO)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CN D05UIL HIGHSTAT Discontinued in Phase 2 D05UMD DRUG__ID D05UMD D05UMD DRUGTYPE Small molecular drug D05UMD DRUGINCH 1S/C32H39N7O6/c1-32(2,3)38-30(44)25-14-9-15-39(25)31(45)27(41)22(16-19-10-5-4-6-11-19)36-28(42)23(17-26(33)40)37-29(43)24-18-34-20-12-7-8-13-21(20)35-24/h4-8,10-13,18,22-23,25,27,41H,9,14-17H2,1-3H3,(H2,33,40)(H,36,42)(H,37,43)(H,38,44)/t22-,23-,25-,27-/m0/s1 D05UMD DRUGINKE UYZMZENNYRSFDS-QNWDWTFCSA-N D05UMD DRUGSMIL CC(C)(C)NC(=O)C1CCCN1C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CC(=O)N)NC(=O)C3=NC4=CC=CC=C4N=C3)O D05UMD HIGHSTAT Discontinued in Phase 2 D05UZO DRUG__ID D05UZO D05UZO DRUGTYPE Small molecular drug D05UZO DRUGINCH 1S/C17H19N5O2.C2H6O4S/c1-3-24-17(23)21-13-9-12-15(16(18)20-13)22-14(10(2)19-12)11-7-5-4-6-8-11;3-1-2-7(4,5)6/h4-10,19H,3H2,1-2H3,(H3,18,20,21,23);3H,1-2H2,(H,4,5,6)/t10-;/m0./s1 D05UZO DRUGINKE JEFPWOBULVSOTM-PPHPATTJSA-N D05UZO DRUGSMIL CCOC(=O)NC1=NC(=C2C(=C1)NC(C(=N2)C3=CC=CC=C3)C)N.C(CS(=O)(=O)O)O D05UZO HIGHSTAT Discontinued in Phase 2 D05VZJ DRUG__ID D05VZJ D05VZJ DRUGTYPE Small molecular drug D05VZJ DRUGINCH 1S/C31H33NO7/c1-4-5-6-20-8-10-23-26(18-7-12-24-25(15-18)39-16-38-24)28(31(35)36)27(29(23)32-20)22-11-9-21(37-3)14-19(22)13-17(2)30(33)34/h7-12,14-15,17,26-28H,4-6,13,16H2,1-3H3,(H,33,34)(H,35,36)/t17-,26-,27-,28+/m0/s1 D05VZJ DRUGINKE IUHMIOAKWHUFKU-YINIXLNUSA-N D05VZJ DRUGSMIL CCCCC1=NC2=C(C=C1)C(C(C2C3=C(C=C(C=C3)OC)CC(C)C(=O)O)C(=O)O)C4=CC5=C(C=C4)OCO5 D05VZJ HIGHSTAT Discontinued in Phase 2 D05YLL DRUG__ID D05YLL D05YLL DRUGTYPE Small molecular drug D05YLL DRUGINCH 1S/C18H26O4S/c1-14(2)12-15-8-10-16(11-9-15)18(19)13-22-23(20,21)17-6-4-3-5-7-17/h3-7,14-16H,8-13H2,1-2H3 D05YLL DRUGINKE RLVLLBHWAQWLKL-UHFFFAOYSA-N D05YLL DRUGSMIL CC(C)CC1CCC(CC1)C(=O)COS(=O)(=O)C2=CC=CC=C2 D05YLL HIGHSTAT Discontinued in Phase 2 D05ZQC DRUG__ID D05ZQC D05ZQC DRUGTYPE Small molecular drug D05ZQC DRUGINCH 1S/C11H18N2O/c1-8(2)13-9(3)6-10-4-5-11(14)7-12-10/h4-5,7-9,13-14H,6H2,1-3H3 D05ZQC DRUGINKE WQRPBKUCJBWQRT-UHFFFAOYSA-N D05ZQC DRUGSMIL CC(C)NC(C)CC1=NC=C(C=C1)O D05ZQC HIGHSTAT Discontinued in Phase 2 D05ZQV DRUG__ID D05ZQV D05ZQV DRUGTYPE Small molecular drug D05ZQV DRUGINCH 1S/C31H37NO12.ClH/c1-13-38-11-22-29(42-13)27(34)25(32(2)3)31(43-22)44-28-16-9-19-18(40-12-41-19)8-15(16)23(24-17(28)10-39-30(24)35)14-6-20(36-4)26(33)21(7-14)37-5;/h6-9,13,17,22-25,27-29,31,33-34H,10-12H2,1-5H3;1H D05ZQV DRUGINKE PYLTTZZOZBYUEI-UHFFFAOYSA-N D05ZQV DRUGSMIL CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)N(C)C)O.Cl D05ZQV HIGHSTAT Discontinued in Phase 2 D06DWQ DRUG__ID D06DWQ D06DWQ DRUGTYPE Small molecular drug D06DWQ DRUGINCH 1S/C21H26N6O2.2ClH/c1-26(2)10-8-24-16-3-4-17-19-18(16)21(29)14-5-6-23-13-15(14)20(19)25-27(17)11-7-22-9-12-28;;/h3-6,13,22,24,28H,7-12H2,1-2H3;2*1H D06DWQ DRUGINKE CQZQVNJGECUKMB-UHFFFAOYSA-N D06DWQ DRUGSMIL CN(C)CCNC1=C2C3=C(C=C1)N(N=C3C4=C(C2=O)C=CN=C4)CCNCCO.Cl.Cl D06DWQ HIGHSTAT Discontinued in Phase 2 D06EDT DRUG__ID D06EDT D06EDT DRUGTYPE Small molecular drug D06EDT DRUGINCH 1S/C19H12F3N3O3S/c20-19(21,22)10-5-6-15-14(7-10)23-16(29-15)9-25-18(28)12-4-2-1-3-11(12)13(24-25)8-17(26)27/h1-7H,8-9H2,(H,26,27) D06EDT DRUGINKE BCSVCWVQNOXFGL-UHFFFAOYSA-N D06EDT DRUGSMIL C1=CC=C2C(=C1)C(=NN(C2=O)CC3=NC4=C(S3)C=CC(=C4)C(F)(F)F)CC(=O)O D06EDT HIGHSTAT Discontinued in Phase 2 D06KOL DRUG__ID D06KOL D06KOL DRUGTYPE Small molecular drug D06KOL DRUGINCH 1S/C22H25NO2/c1-2-5-16(6-3-1)17-11-12-23(13-17)14-18-7-4-8-20-19(18)9-10-21-22(20)25-15-24-21/h1-3,5-6,9-10,17-18H,4,7-8,11-15H2 D06KOL DRUGINKE HAEPGZUGYMHCJE-UHFFFAOYSA-N D06KOL DRUGSMIL C1CC(C2=C(C1)C3=C(C=C2)OCO3)CN4CCC(C4)C5=CC=CC=C5 D06KOL HIGHSTAT Discontinued in Phase 2 D06LGC DRUG__ID D06LGC D06LGC DRUGTYPE Small molecular drug D06LGC DRUGINCH 1S/C20H25N3O3/c1-16(14-20(24)25)15-26-19-4-2-17(3-5-19)22-10-12-23(13-11-22)18-6-8-21-9-7-18/h2-9,16H,10-15H2,1H3,(H,24,25)/t16-/m1/s1 D06LGC DRUGINKE RVVTUJLHUHZYOD-MRXNPFEDSA-N D06LGC DRUGSMIL CC(CC(=O)O)COC1=CC=C(C=C1)N2CCN(CC2)C3=CC=NC=C3 D06LGC HIGHSTAT Discontinued in Phase 2 D06NOR DRUG__ID D06NOR D06NOR DRUGCOMP Sanofi-Aventis D06NOR DRUGINCH 1S/C31H36N4O8/c1-20-7-5-6-8-23(20)33-31(40)34-24-11-9-21(15-26(24)42-3)17-28(36)32-18-29(37)35(14-13-30(38)39)19-22-10-12-25(41-2)27(16-22)43-4/h5-12,15-16H,13-14,17-19H2,1-4H3,(H,32,36)(H,38,39)(H2,33,34,40) D06NOR DRUGINKE WZFRNNCNGXELDE-UHFFFAOYSA-N D06NOR DRUGSMIL CC1=CC=CC=C1NC(=O)NC2=C(C=C(C=C2)CC(=O)NCC(=O)N(CCC(=O)O)CC3=CC(=C(C=C3)OC)OC)OC D06NOR HIGHSTAT Discontinued in Phase 2 D06NPB DRUG__ID D06NPB D06NPB DRUGCOMP Johnson&Johnson D06NPB DRUGINCH 1S/C24H26N8O2/c1-14(2)30-10-19-8-18(30)11-31(19)17-5-3-16(4-6-17)29-23-24-27-13-28-32(24)20(9-26-23)15-7-21(22(25)33)34-12-15/h3-7,9,12-14,18-19H,8,10-11H2,1-2H3,(H2,25,33)(H,26,29)/t18-,19-/m0/s1 D06NPB DRUGINKE YBFGSJUVEOYPIS-OALUTQOASA-N D06NPB DRUGSMIL CC(C)N1CC2CC1CN2C3=CC=C(C=C3)NC4=NC=C(N5C4=NC=N5)C6=COC(=C6)C(=O)N D06NPB HIGHSTAT Discontinued in Phase 2 D06PTT DRUG__ID D06PTT D06PTT DRUGTYPE Small molecular drug D06PTT DRUGINCH 1S/C10H11N3O/c1-8-4-6-12-13(8)10(14)9-3-2-5-11-7-9/h2-3,5-8H,4H2,1H3 D06PTT DRUGINKE KKMMIKKVFRCZBO-UHFFFAOYSA-N D06PTT DRUGSMIL CC1CC=NN1C(=O)C2=CN=CC=C2 D06PTT HIGHSTAT Discontinued in Phase 2 D06TZT DRUG__ID D06TZT D06TZT DRUGTYPE Small molecular drug D06TZT DRUGINCH 1S/C23H22N8O/c1-3-6-20-19(22-25-23(32)28-31(22)14(2)24-20)13-15-9-11-16(12-10-15)17-7-4-5-8-18(17)21-26-29-30-27-21/h4-5,7-12H,3,6,13H2,1-2H3,(H,28,32)(H,26,27,29,30) D06TZT DRUGINKE OLJAPHMBAMBVKL-UHFFFAOYSA-N D06TZT DRUGSMIL CCCC1=C(C2=NC(=O)NN2C(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D06TZT HIGHSTAT Discontinued in Phase 2 D06UCV DRUG__ID D06UCV D06UCV DRUGTYPE Small molecular drug D06UCV DRUGINCH 1S/C18H18ClNO4S.Na/c19-16-3-5-17(6-4-16)25(23,24)20-11-13-8-14-2-1-12(10-18(21)22)7-15(14)9-13;/h1-7,13,20H,8-11H2,(H,21,22);/q;+1/p-1 D06UCV DRUGINKE UEPBEZPJELQKJV-UHFFFAOYSA-M D06UCV DRUGSMIL C1C(CC2=C1C=CC(=C2)CC(=O)[O-])CNS(=O)(=O)C3=CC=C(C=C3)Cl.[Na+] D06UCV HIGHSTAT Discontinued in Phase 2 D07DBS DRUG__ID D07DBS D07DBS DRUGCOMP Rhone-Poulenc SA D07DBS DRUGINCH 1S/C29H42N2O3S/c1-4-6-8-9-10-11-12-13-21-34-25-17-14-23(15-18-25)29(33)31-26-22-24(16-19-27(26)35-3)28(32)30-20-7-5-2/h14-19,22H,4-13,20-21H2,1-3H3,(H,30,32)(H,31,33) D07DBS DRUGINKE OZMWNRSILHTVFV-UHFFFAOYSA-N D07DBS DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C(=O)NCCCC)SC D07DBS HIGHSTAT Discontinued in Phase 2 D07FJM DRUG__ID D07FJM D07FJM DRUGTYPE Small molecular drug D07FJM DRUGINCH 1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1 D07FJM DRUGINKE JORVRJNILJXMMG-OLNQLETPSA-N D07FJM DRUGSMIL CC1=NC(=CS1)COC2=CC=C(C=C2)CC(C(CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)OC5COC6C5CCO6 D07FJM HIGHSTAT Discontinued in Phase 2 D07GFF DRUG__ID D07GFF D07GFF DRUGTYPE Small molecular drug D07GFF DRUGINCH 1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1 D07GFF DRUGINKE XRYJULCDUUATMC-CYBMUJFWSA-N D07GFF DRUGSMIL CC(C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O D07GFF HIGHSTAT Discontinued in Phase 2 D07GTB DRUG__ID D07GTB D07GTB DRUGTYPE Small molecular drug D07GTB DRUGINCH 1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/p-1/b10-6+ D07GTB DRUGINKE AXUZQJFHDNNPFG-UXBLZVDNSA-M D07GTB DRUGSMIL CN(C)C(=O)CCSC(C1=CC=CC(=C1)C=CC2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)[O-] D07GTB HIGHSTAT Discontinued in Phase 2 D07HBI DRUG__ID D07HBI D07HBI DRUGTYPE Small molecular drug D07HBI DRUGINCH 1S/C23H24FNO4/c1-25-21-5-3-16(11-17(21)4-6-22(25)26)15-29-20-13-18(12-19(24)14-20)23(27-2)7-9-28-10-8-23/h3-6,11-14H,7-10,15H2,1-2H3 D07HBI DRUGINKE SLZBEPLWGGRZAY-UHFFFAOYSA-N D07HBI DRUGSMIL CN1C2=C(C=CC1=O)C=C(C=C2)COC3=CC(=CC(=C3)C4(CCOCC4)OC)F D07HBI HIGHSTAT Discontinued in Phase 2 D07OMK DRUG__ID D07OMK D07OMK DRUGTYPE Small molecular drug D07OMK DRUGINCH 1S/C21H25FN6O2/c1-4-8-27(9-5-2)12-18-24-20(25-30-18)19-17-11-26(3)21(29)15-10-14(22)6-7-16(15)28(17)13-23-19/h6-7,10,13H,4-5,8-9,11-12H2,1-3H3 D07OMK DRUGINKE NOQIYRGMEFBZTI-UHFFFAOYSA-N D07OMK DRUGSMIL CCCN(CCC)CC1=NC(=NO1)C2=C3CN(C(=O)C4=C(N3C=N2)C=CC(=C4)F)C D07OMK HIGHSTAT Discontinued in Phase 2 D07QAA DRUG__ID D07QAA D07QAA DRUGTYPE Small molecular drug D07QAA DRUGINCH 1S/C19H27N3O/c1-19(2)12-22(17-7-5-4-6-16(17)19)18(23)20-13-10-14-8-9-15(11-13)21(14)3/h4-7,13-15H,8-12H2,1-3H3,(H,20,23)/t13?,14-,15+ D07QAA DRUGINKE ILXWRFDRNAKTDD-GOOCMWNKSA-N D07QAA DRUGSMIL CC1(CN(C2=CC=CC=C21)C(=O)NC3CC4CCC(C3)N4C)C D07QAA HIGHSTAT Discontinued in Phase 2 D07QWZ DRUG__ID D07QWZ D07QWZ DRUGTYPE Small molecular drug D07QWZ DRUGINCH 1S/C20H24N9O9P/c1-10-5-28(20(32)25-18(10)30)15-4-12(26-27-21)13(38-15)7-36-39(33,34)35-6-11-2-3-14(37-11)29-9-24-16-17(29)22-8-23-19(16)31/h5,8-9,11-15H,2-4,6-7H2,1H3,(H,33,34)(H,22,23,31)(H,25,30,32)/t11-,12-,13+,14+,15+/m0/s1 D07QWZ DRUGINKE XURFYCWNUGWGDL-VQJWOFKYSA-N D07QWZ DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OCC3CCC(O3)N4C=NC5=C4N=CNC5=O)N=[N+]=[N-] D07QWZ HIGHSTAT Discontinued in Phase 2 D07VPG DRUG__ID D07VPG D07VPG DRUGTYPE Small molecular drug D07VPG DRUGINCH 1S/C21H21NO2.ClH/c1-21(12-23,13-24)22-11-14-9-10-19-17-6-3-2-5-16(17)18-8-4-7-15(14)20(18)19;/h2-10,22-24H,11-13H2,1H3;1H D07VPG DRUGINKE XPSPHVAGYMFPFA-UHFFFAOYSA-N D07VPG DRUGSMIL CC(CO)(CO)NCC1=C2C=CC=C3C2=C(C=C1)C4=CC=CC=C43.Cl D07VPG HIGHSTAT Discontinued in Phase 2 D07YCR DRUG__ID D07YCR D07YCR DRUGTYPE Small molecular drug D07YCR DRUGINCH 1S/C22H24N4O2.2ClH/c1-13-15-7-8-23-20(22(28)24-9-10-25(2)3)17(15)12-18-16-11-14(27)5-6-19(16)26(4)21(13)18;;/h5-8,11-12,27H,9-10H2,1-4H3,(H,24,28);2*1H D07YCR DRUGINKE DSJBVXJNKBKZSB-UHFFFAOYSA-N D07YCR DRUGSMIL CC1=C2C=CN=C(C2=CC3=C1N(C4=C3C=C(C=C4)O)C)C(=O)NCCN(C)C.Cl.Cl D07YCR HIGHSTAT Discontinued in Phase 2 D07ZHV DRUG__ID D07ZHV D07ZHV DRUGTYPE Small molecular drug D07ZHV DRUGINCH 1S/C9H8N4O5/c10-9(14)5-3-7(11-1-2-11)8(13(17)18)4-6(5)12(15)16/h3-4H,1-2H2,(H2,10,14) D07ZHV DRUGINKE WOCXQMCIOTUMJV-UHFFFAOYSA-N D07ZHV DRUGSMIL C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])[N+](=O)[O-] D07ZHV HIGHSTAT Discontinued in Phase 2 D08CKJ DRUG__ID D08CKJ D08CKJ DRUGCOMP Hoechst Marion Roussel Inc; Hoechst AG D08CKJ DRUGINCH 1S/C26H32N4O5S2.2K/c1-4-6-11-22-28-24(36-3)23(25(31)32)30(22)17-18-12-14-19(15-13-18)20-9-7-8-10-21(20)37(34,35)29-26(33)27-16-5-2;;/h7-10,12-15H,4-6,11,16-17H2,1-3H3,(H,31,32)(H2,27,29,33);;/q;2*+1/p-2 D08CKJ DRUGINKE WGZNJDWXOFLZKQ-UHFFFAOYSA-L D08CKJ DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3S(=O)(=O)NC(=NCCC)[O-])C(=O)[O-])SC.[K+].[K+] D08CKJ HIGHSTAT Discontinued in Phase 2 D08FGX DRUG__ID D08FGX D08FGX DRUGTYPE Small molecular drug D08FGX DRUGINCH 1S/C25H30N4O2/c1-19-17-23(21-9-5-6-10-22(21)27-19)28-24(30)26-13-16-29-14-11-25(31,12-15-29)18-20-7-3-2-4-8-20/h2-10,17,31H,11-16,18H2,1H3,(H2,26,27,28,30) D08FGX DRUGINKE WYJCYXOCHXWTHG-UHFFFAOYSA-N D08FGX DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)NC(=O)NCCN3CCC(CC3)(CC4=CC=CC=C4)O D08FGX HIGHSTAT Discontinued in Phase 2 D08JAP DRUG__ID D08JAP D08JAP DRUGTYPE Small molecular drug D08JAP DRUGINCH 1S/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1 D08JAP DRUGINKE MQTUXRKNJYPMCG-CYBMUJFWSA-N D08JAP DRUGSMIL C1CC(C1)N(C2CCC2)C3CC4=C(C=CC(=C4OC3)F)C(=O)N D08JAP HIGHSTAT Discontinued in Phase 2 D08LQD DRUG__ID D08LQD D08LQD DRUGTYPE Small molecular drug D08LQD DRUGINCH 1S/C18H14N4O3/c1-10-20-17(22-25-10)14-9-13-15(21-18(14)23)6-7-19-16(13)11-4-3-5-12(8-11)24-2/h3-9H,1-2H3,(H,21,23) D08LQD DRUGINKE JQOFKKWHXGQABB-UHFFFAOYSA-N D08LQD DRUGSMIL CC1=NC(=NO1)C2=CC3=C(C=CN=C3C4=CC(=CC=C4)OC)NC2=O D08LQD HIGHSTAT Discontinued in Phase 2 D08LZI DRUG__ID D08LZI D08LZI DRUGTYPE Small molecular drug D08LZI DRUGINCH 1S/C21H27NO5/c1-14-8-10-17(11-9-14)19-22-18(15(2)27-19)7-5-4-6-16-12-25-21(3,20(23)24)26-13-16/h8-11,16H,4-7,12-13H2,1-3H3,(H,23,24) D08LZI DRUGINKE IMYPSTHZBIWMNA-UHFFFAOYSA-N D08LZI DRUGSMIL CC1=CC=C(C=C1)C2=NC(=C(O2)C)CCCCC3COC(OC3)(C)C(=O)O D08LZI HIGHSTAT Discontinued in Phase 2 D08MYL DRUG__ID D08MYL D08MYL DRUGCOMP Novartis AG D08MYL DRUGINCH 1S/C62H111N11O12/c1-25-28-29-40(15)52(75)51-56(79)65-43(27-3)58(81)67(18)33-47(74)71(22)50(39(14)26-2)55(78)66-48(37(10)11)61(84)68(19)44(30-34(4)5)54(77)63-41(16)53(76)64-42(17)57(80)69(20)45(31-35(6)7)59(82)70(21)46(32-36(8)9)60(83)72(23)49(38(12)13)62(85)73(51)24/h25,28,34-46,48-52,75H,26-27,29-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b28-25+/t39-,40+,41-,42+,43-,44-,45-,46-,48-,49-,50-,51-,52+/m0/s1 D08MYL DRUGINKE RPJPZDVUUKWPGT-FOIHOXPVSA-N D08MYL DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)CC)C)C D08MYL HIGHSTAT Discontinued in Phase 2 D08ORO DRUG__ID D08ORO D08ORO DRUGTYPE Small molecular drug D08ORO DRUGINCH 1S/C26H31N3O4/c1-19(30)27-15-4-18-33-23-10-7-21(8-11-23)26(32)28-16-13-22(14-17-28)29-24-6-3-2-5-20(24)9-12-25(29)31/h2-3,5-8,10-11,22H,4,9,12-18H2,1H3,(H,27,30) D08ORO DRUGINKE KSNUCNRMDYJBKT-UHFFFAOYSA-N D08ORO DRUGSMIL CC(=O)NCCCOC1=CC=C(C=C1)C(=O)N2CCC(CC2)N3C(=O)CCC4=CC=CC=C43 D08ORO HIGHSTAT Discontinued in Phase 2 D08RZV DRUG__ID D08RZV D08RZV DRUGTYPE Small molecular drug D08RZV DRUGINCH 1S/C21H21FN2O3.2H2O/c22-16-3-4-17-18(12-16)27-13-15-2-1-8-23-21(15)20(17)14-5-9-24(10-6-14)11-7-19(25)26;;/h1-4,8,12H,5-7,9-11,13H2,(H,25,26);2*1H2 D08RZV DRUGINKE CWNCDQYLHMXURI-UHFFFAOYSA-N D08RZV DRUGSMIL C1CN(CCC1=C2C3=C(C=C(C=C3)F)OCC4=C2N=CC=C4)CCC(=O)O.O.O D08RZV HIGHSTAT Discontinued in Phase 2 D08SNX DRUG__ID D08SNX D08SNX DRUGCOMP Napp Pharmaceutical Group Ltd D08SNX DRUGINCH 1S/C23H31N5O2/c1-5-24-22-20-23(27-21(26-20)15(2)3)28(14-25-22)13-16-10-11-18(29-4)19(12-16)30-17-8-6-7-9-17/h10-12,14-15,17H,5-9,13H2,1-4H3,(H,26,27) D08SNX DRUGINKE KLPQJJKXRIDASJ-UHFFFAOYSA-N D08SNX DRUGSMIL CCN=C1C2=C(N=C(N2)C(C)C)N(C=N1)CC3=CC(=C(C=C3)OC)OC4CCCC4 D08SNX HIGHSTAT Discontinued in Phase 2 D08UDF DRUG__ID D08UDF D08UDF DRUGTYPE Small molecular drug D08UDF DRUGINCH 1S/C24H29NO4/c26-23(27)19-29-18-17-28-16-15-25-13-11-22(12-14-25)24(20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-10H,11-19H2,(H,26,27) D08UDF DRUGINKE KMUBBNQZNBTUSH-UHFFFAOYSA-N D08UDF DRUGSMIL C1CN(CCC1=C(C2=CC=CC=C2)C3=CC=CC=C3)CCOCCOCC(=O)O D08UDF HIGHSTAT Discontinued in Phase 2 D08WSW DRUG__ID D08WSW D08WSW DRUGTYPE Small molecular drug D08WSW DRUGINCH 1S/C29H35N3O7.ClH/c1-30(18-15-21-7-13-25(36-2)27(19-21)38-4)16-6-17-31(24-12-14-26(37-3)28(20-24)39-5)29(33)22-8-10-23(11-9-22)32(34)35;/h7-14,19-20H,6,15-18H2,1-5H3;1H D08WSW DRUGINKE CMKVOHIRMCFVBJ-UHFFFAOYSA-N D08WSW DRUGSMIL CN(CCCN(C1=CC(=C(C=C1)OC)OC)C(=O)C2=CC=C(C=C2)[N+](=O)[O-])CCC3=CC(=C(C=C3)OC)OC.Cl D08WSW HIGHSTAT Discontinued in Phase 2 D09ADT DRUG__ID D09ADT D09ADT DRUGTYPE Small molecular drug D09ADT DRUGINCH 1S/C9H14N2O/c1-7-6-9(12-10-7)8-4-3-5-11(8)2/h6,8H,3-5H2,1-2H3/t8-/m0/s1 D09ADT DRUGINKE ILLGYRJAYAAAEW-QMMMGPOBSA-N D09ADT DRUGSMIL CC1=NOC(=C1)C2CCCN2C D09ADT HIGHSTAT Discontinued in Phase 2 D09CFM DRUG__ID D09CFM D09CFM DRUGTYPE Small molecular drug D09CFM DRUGINCH 1S/C19H20FN3O3/c1-21-7-12-4-11(21)8-22(12)17-6-16-13(5-15(17)20)18(24)14(19(25)26)9-23(16)10-2-3-10/h5-6,9-12H,2-4,7-8H2,1H3,(H,25,26)/t11-,12-/m0/s1 D09CFM DRUGINKE QMLVECGLEOSESV-RYUDHWBXSA-N D09CFM DRUGSMIL CN1CC2CC1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F D09CFM HIGHSTAT Discontinued in Phase 2 D09ELW DRUG__ID D09ELW D09ELW DRUGTYPE Small molecular drug D09ELW DRUGINCH 1S/C35H56N6O6/c1-22(2)15-30(42)32(44)27(16-23-9-7-6-8-10-23)40-34(46)29(18-25-20-37-21-38-25)41-33(45)28(39-31(43)19-35(3,4)36)17-24-11-13-26(47-5)14-12-24/h11-14,20-23,27-30,32,42,44H,6-10,15-19,36H2,1-5H3,(H,37,38)(H,39,43)(H,40,46)(H,41,45)/t27-,28-,29-,30-,32+/m0/s1 D09ELW DRUGINKE KQXVERRYBYGQJZ-WRPDIKACSA-N D09ELW DRUGSMIL CC(C)CC(C(C(CC1CCCCC1)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=C(C=C3)OC)NC(=O)CC(C)(C)N)O)O D09ELW HIGHSTAT Discontinued in Phase 2 D09JXL DRUG__ID D09JXL D09JXL DRUGTYPE Small molecular drug D09JXL DRUGINCH 1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1 D09JXL DRUGINKE NPJIOCBFOAHEDO-AVWFULIKSA-N D09JXL DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)C(C)C)CCCCN)CC3=CNC4=CC=CC=C43)CC5=CC=C(C=C5)O D09JXL HIGHSTAT Discontinued in Phase 2 D09NYB DRUG__ID D09NYB D09NYB DRUGTYPE Small molecular drug D09NYB DRUGINCH 1S/C8H15NO4/c10-4-1-2-9-3-5(11)7(12)8(13)6(4)9/h4-8,10-13H,1-3H2/t4-,5-,6+,7+,8+/m0/s1 D09NYB DRUGINKE JDVVGAQPNNXQDW-TVNFTVLESA-N D09NYB DRUGSMIL C1CN2CC(C(C(C2C1O)O)O)O D09NYB HIGHSTAT Discontinued in Phase 2 D09OAQ DRUG__ID D09OAQ D09OAQ DRUGTYPE Small molecular drug D09OAQ DRUGINCH 1S/C19H28ClNO6/c1-11(2)5-6-13-18(3,27-13)16-15(24-4)12(7-8-19(16)10-25-19)26-17(23)21-14(22)9-20/h5,12-13,15-16H,6-10H2,1-4H3,(H,21,22,23)/t12-,13-,15-,16-,18+,19+/m1/s1 D09OAQ DRUGINKE MSHZHSPISPJWHW-PVDLLORBSA-N D09OAQ DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)NC(=O)CCl)OC)C D09OAQ HIGHSTAT Discontinued in Phase 2 D09ORU DRUG__ID D09ORU D09ORU DRUGTYPE Small molecular drug D09ORU DRUGINCH 1S/C15H15NO4.ClH/c17-12-3-1-8(5-14(12)19)10-6-16-7-11-9(10)2-4-13(18)15(11)20;/h1-5,10,16-20H,6-7H2;1H/t10-;/m0./s1 D09ORU DRUGINKE NHCWZEQEFHNLBQ-PPHPATTJSA-N D09ORU DRUGSMIL C1C(C2=C(CN1)C(=C(C=C2)O)O)C3=CC(=C(C=C3)O)O.Cl D09ORU HIGHSTAT Discontinued in Phase 2 D09PKU DRUG__ID D09PKU D09PKU DRUGTYPE Small molecular drug D09PKU DRUGINCH 1S/C24H27N3O5S/c1-3-30-23(28)26-19-6-10-22(11-7-19)33-15-21-14-31-24(32-21,16-27-13-12-25-17-27)18-4-8-20(29-2)9-5-18/h4-13,17,21H,3,14-16H2,1-2H3,(H,26,28)/t21-,24+/m1/s1 D09PKU DRUGINKE KLEPCGBEXOCIGS-QPPBQGQZSA-N D09PKU DRUGSMIL CCOC(=O)NC1=CC=C(C=C1)SCC2COC(O2)(CN3C=CN=C3)C4=CC=C(C=C4)OC D09PKU HIGHSTAT Discontinued in Phase 2 D09RON DRUG__ID D09RON D09RON DRUGCOMP Eli Lilly & Co D09RON DRUGINCH 1S/C26H26O6/c1-3-5-22-23(13-12-21(16(2)27)25(22)29)32-15-17-8-10-18(11-9-17)24(28)19-6-4-7-20(14-19)26(30)31/h4,6-14,24,28-29H,3,5,15H2,1-2H3,(H,30,31)/t24-/m0/s1 D09RON DRUGINKE DWQVYDLTPMGYNE-DEOSSOPVSA-N D09RON DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCC2=CC=C(C=C2)C(C3=CC(=CC=C3)C(=O)O)O D09RON HIGHSTAT Discontinued in Phase 2 D09TEI DRUG__ID D09TEI D09TEI DRUGCOMP Novo Nordisk Pharmaceuticals Ltd D09TEI DRUGINCH 1S/C24H27NO2/c26-24(27)20-9-5-15-25(17-20)16-6-12-23-21-10-3-1-7-18(21)13-14-19-8-2-4-11-22(19)23/h1-4,7-8,10-12,20H,5-6,9,13-17H2,(H,26,27)/t20-/m1/s1 D09TEI DRUGINKE RXWDEUWOJGGNHU-HXUWFJFHSA-N D09TEI DRUGSMIL C1CC(CN(C1)CCC=C2C3=CC=CC=C3CCC4=CC=CC=C42)C(=O)O D09TEI HIGHSTAT Discontinued in Phase 2 D09TXG DRUG__ID D09TXG D09TXG DRUGTYPE Small molecular drug D09TXG DRUGINCH 1S/C35H56N6O5.ClH/c1-22(2)28(37-32(43)29(23(3)4)38(7)8)34(45)39(9)30(24(5)6)35(46)41-20-14-18-27(41)33(44)40-19-13-17-26(40)31(42)36-21-25-15-11-10-12-16-25;/h10-12,15-16,22-24,26-30H,13-14,17-21H2,1-9H3,(H,36,42)(H,37,43);1H/t26-,27-,28-,29-,30-;/m0./s1 D09TXG DRUGINKE MRJQTLJSMQOFTP-JGTKTWDESA-N D09TXG DRUGSMIL CC(C)C(C(=O)N(C)C(C(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NCC3=CC=CC=C3)NC(=O)C(C(C)C)N(C)C.Cl D09TXG HIGHSTAT Discontinued in Phase 2 D09UGP DRUG__ID D09UGP D09UGP DRUGCOMP Aventis Pharma AG D09UGP DRUGINCH 1S/C24H34F2O4S/c1-5-6-20-29-19-11-14-15-10-17(25)16-9-13(27)7-8-21(16,2)23(15,26)18(28)12-22(14,3)24(19,30-20)31-4/h9,14-15,17-20,28H,5-8,10-12H2,1-4H3/t14-,15-,17-,18-,19+,20+,21-,22-,23-,24-/m0/s1 D09UGP DRUGINKE QGBIFMJAQARMNQ-QISPFCDLSA-N D09UGP DRUGSMIL CCCC1OC2CC3C4CC(C5=CC(=O)CCC5(C4(C(CC3(C2(O1)SC)C)O)F)C)F D09UGP HIGHSTAT Discontinued in Phase 2 D09URT DRUG__ID D09URT D09URT DRUGTYPE Small molecular drug D09URT DRUGINCH 1S/C19H21NO4/c1-13(2)14-3-5-15(6-4-14)18(21)20-11-12-24-17-9-7-16(8-10-17)19(22)23/h3-10,13H,11-12H2,1-2H3,(H,20,21)(H,22,23) D09URT DRUGINKE ODLDHXPJRGNTPC-UHFFFAOYSA-N D09URT DRUGSMIL CC(C)C1=CC=C(C=C1)C(=O)NCCOC2=CC=C(C=C2)C(=O)O D09URT HIGHSTAT Discontinued in Phase 2 D09WFI DRUG__ID D09WFI D09WFI DRUGTYPE Small molecular drug D09WFI DRUGINCH 1S/C8H12N2/c1-5-6(2)10-8(4)7(3)9-5/h1-4H3 D09WFI DRUGINKE FINHMKGKINIASC-UHFFFAOYSA-N D09WFI DRUGSMIL CC1=C(N=C(C(=N1)C)C)C D09WFI HIGHSTAT Discontinued in Phase 2 D09WYC DRUG__ID D09WYC D09WYC DRUGTYPE Small molecular drug D09WYC DRUGINCH 1S/C18H19F2N3O4/c19-13-5-11-15(14(20)16(13)22-3-4-27-10(6-21)7-22)23(9-1-2-9)8-12(17(11)24)18(25)26/h5,8-10H,1-4,6-7,21H2,(H,25,26) D09WYC DRUGINKE MVKGRIHKSLEKTE-UHFFFAOYSA-N D09WYC DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)F)N4CCOC(C4)CN)F)C(=O)O D09WYC HIGHSTAT Discontinued in Phase 2 D09XVQ DRUG__ID D09XVQ D09XVQ DRUGCOMP Competitive Technologies Inc D09XVQ DRUGINCH 1S/C14H20N2O2/c15-13-7-2-1-6-12(13)14(17)18-10-8-11-5-3-4-9-16-11/h1-2,6-7,11,16H,3-5,8-10,15H2 D09XVQ DRUGINKE BMIJYAZXNZEMLI-UHFFFAOYSA-N D09XVQ DRUGSMIL C1CCNC(C1)CCOC(=O)C2=CC=CC=C2N D09XVQ HIGHSTAT Discontinued in Phase 2 D09ZQX DRUG__ID D09ZQX D09ZQX DRUGTYPE Small molecular drug D09ZQX DRUGINCH 1S/C23H25ClN4O4/c24-18-14-17(20-21(19(18)25)31-13-12-30-20)22-26-28(23(29)32-22)16-7-10-27(11-8-16)9-6-15-4-2-1-3-5-15/h1-5,14,16H,6-13,25H2 D09ZQX DRUGINKE MDBNTXARNGRHEV-UHFFFAOYSA-N D09ZQX DRUGSMIL C1CN(CCC1N2C(=O)OC(=N2)C3=CC(=C(C4=C3OCCO4)N)Cl)CCC5=CC=CC=C5 D09ZQX HIGHSTAT Discontinued in Phase 2 D09ZYW DRUG__ID D09ZYW D09ZYW DRUGCOMP Inex Pharmaceuticals Corp D09ZYW DRUGINCH 1S/C18H40O4P2/c1-5-19-9-13-23(14-10-20-6-2)17-18-24(15-11-21-7-3)16-12-22-8-4/h5-18H2,1-4H3 D09ZYW DRUGINKE QCWJONLQSHEGEJ-UHFFFAOYSA-N D09ZYW DRUGSMIL CCOCCP(CCOCC)CCP(CCOCC)CCOCC D09ZYW HIGHSTAT Discontinued in Phase 2 D0A0MU DRUG__ID D0A0MU D0A0MU DRUGTYPE Small molecular drug D0A0MU DRUGINCH 1S/C35H64N5O8PS/c1-4-6-8-10-12-14-15-17-19-21-23-50-28-30(45-22-20-18-16-13-11-9-7-5-2)26-46-49(43,44)47-27-32-31(38-39-36)24-33(48-32)40-25-29(3)34(41)37-35(40)42/h25,30-33H,4-24,26-28H2,1-3H3,(H,43,44)(H,37,41,42)/t30?,31-,32+,33+/m0/s1 D0A0MU DRUGINKE IBHARWXWOCPXCR-WELGVCPWSA-N D0A0MU DRUGSMIL CCCCCCCCCCCCSCC(COP(=O)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)N=[N+]=[N-])OCCCCCCCCCC D0A0MU HIGHSTAT Discontinued in Phase 2 D0A2OW DRUG__ID D0A2OW D0A2OW DRUGTYPE Small molecular drug D0A2OW DRUGINCH 1S/C24H31N5O2/c1-3-27(4-2)16-18-10-7-8-15-28(18)17-22(30)29-21-13-6-5-11-19(21)24(31)26-20-12-9-14-25-23(20)29/h5-6,9,11-14,18H,3-4,7-8,10,15-17H2,1-2H3,(H,26,31) D0A2OW DRUGINKE UBRKDAVQCKZSPO-UHFFFAOYSA-N D0A2OW DRUGSMIL CCN(CC)CC1CCCCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 D0A2OW HIGHSTAT Discontinued in Phase 2 D0A4OT DRUG__ID D0A4OT D0A4OT DRUGTYPE Small molecular drug D0A4OT DRUGINCH 1S/C27H32N2O3.2ClH/c1-31-25-14-13-23(19-26(25)32-2)24(30)20-28-15-17-29(18-16-28)27(21-9-5-3-6-10-21)22-11-7-4-8-12-22;;/h3-14,19,24,27,30H,15-18,20H2,1-2H3;2*1H D0A4OT DRUGINKE ZIGNSXDSBVYYFD-UHFFFAOYSA-N D0A4OT DRUGSMIL COC1=C(C=C(C=C1)C(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O)OC.Cl.Cl D0A4OT HIGHSTAT Discontinued in Phase 2 D0A5MI DRUG__ID D0A5MI D0A5MI DRUGTYPE Small molecular drug D0A5MI DRUGINCH 1S/C37H36N4O3/c1-43-37(42)34-24-38-36-35(32-8-4-2-6-27(32)19-23-41(34)36)29-17-21-40(22-18-29)20-16-26-10-14-31(15-11-26)44-25-30-13-12-28-7-3-5-9-33(28)39-30/h2-15,24H,16-23,25H2,1H3 D0A5MI DRUGINKE TULGGJGJQXESOO-UHFFFAOYSA-N D0A5MI DRUGSMIL COC(=O)C1=CN=C2N1CCC3=CC=CC=C3C2=C4CCN(CC4)CCC5=CC=C(C=C5)OCC6=NC7=CC=CC=C7C=C6 D0A5MI HIGHSTAT Discontinued in Phase 2 D0A6VE DRUG__ID D0A6VE D0A6VE DRUGTYPE Small molecular drug D0A6VE DRUGINCH 1S/C30H29N5O4S.ClH/c1-38-22-10-7-11-23-24(22)20-16-34(15-19(20)17-39-23)12-5-6-13-35-29(36)27-25(33-30(35)37)26-28(40-27)31-14-21(32-26)18-8-3-2-4-9-18;/h2-4,7-11,14,19-20H,5-6,12-13,15-17H2,1H3,(H,33,37);1H/t19-,20-;/m1./s1 D0A6VE DRUGINKE OFPMGRPQOZABPO-GZJHNZOKSA-N D0A6VE DRUGSMIL COC1=CC=CC2=C1C3CN(CC3CO2)CCCCN4C(=O)C5=C(C6=NC(=CN=C6S5)C7=CC=CC=C7)NC4=O.Cl D0A6VE HIGHSTAT Discontinued in Phase 2 D0A9BX DRUG__ID D0A9BX D0A9BX DRUGTYPE Small molecular drug D0A9BX DRUGINCH 1S/C30H28N4O3S/c1-4-27-32-28-20(2)18-21(3)31-29(28)34(27)19-22-14-16-23(17-15-22)25-12-8-9-13-26(25)38(36,37)33-30(35)24-10-6-5-7-11-24/h5-18H,4,19H2,1-3H3,(H,33,35) D0A9BX DRUGINKE LIUNMFCWFYFUGQ-UHFFFAOYSA-N D0A9BX DRUGSMIL CCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC(=O)C5=CC=CC=C5)N=C(C=C2C)C D0A9BX HIGHSTAT Discontinued in Phase 2 D0AF7D DRUG__ID D0AF7D D0AF7D DRUGCOMP Novartis AG D0AF7D DRUGINCH 1S/C114H156N24O28/c1-64(2)96(114(166)123-67(5)98(150)125-83(48-50-93(143)144)105(157)126-80(41-23-27-53-117)104(156)133-86(57-71-33-15-9-16-34-71)107(159)128-79(40-22-26-52-116)103(155)130-82(47-49-92(141)142)102(154)122-65(3)99(151)131-84(97(119)149)55-69-29-11-7-12-30-69)138-106(158)81(42-24-28-54-118)129-113(165)91(62-95(147)148)137-110(162)88(59-73-43-45-75(140)46-44-73)134-109(161)85(56-70-31-13-8-14-32-70)132-100(152)66(4)121-101(153)78(39-21-25-51-115)127-108(160)87(58-72-35-17-10-18-36-72)135-111(163)89(60-74-63-120-77-38-20-19-37-76(74)77)136-112(164)90(61-94(145)146)124-68(6)139/h7-20,29-38,43-46,63-67,78-91,96,120,140H,21-28,39-42,47-62,115-118H2,1-6H3,(H2,119,149)(H,121,153)(H,122,154)(H,123,166)(H,124,139)(H,125,150)(H,126,157)(H,127,160)(H,128,159)(H,129,165)(H,130,155)(H,131,151)(H,132,152)(H,133,156)(H,134,161)(H,135,163)(H,136,164)(H,137,162)(H,138,158)(H,141,142)(H,143,144)(H,145,146)(H,147,148)/t65-,66-,67-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,96-/m0/s1 D0AF7D DRUGINKE ZKKBZMXTFBAQLP-PINGPBTISA-N D0AF7D DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)C(CC(=O)O)NC(=O)C D0AF7D HIGHSTAT Discontinued in Phase 2 D0AQ3H DRUG__ID D0AQ3H D0AQ3H DRUGCOMP Pfizer Inc D0AQ3H DRUGINCH 1S/C34H39N3O6S/c1-34(2,36-22-32(40)28-12-15-31(39)30(19-28)37-44(3,42)43)20-24-7-4-6-23(16-24)18-33(41)35-21-25-8-5-9-27(17-25)26-10-13-29(38)14-11-26/h4-17,19,32,36-40H,18,20-22H2,1-3H3,(H,35,41)/t32-/m0/s1 D0AQ3H DRUGINKE YPHDIMUXXABSSO-YTTGMZPUSA-N D0AQ3H DRUGSMIL CC(C)(CC1=CC=CC(=C1)CC(=O)NCC2=CC(=CC=C2)C3=CC=C(C=C3)O)NCC(C4=CC(=C(C=C4)O)NS(=O)(=O)C)O D0AQ3H HIGHSTAT Discontinued in Phase 2 D0B2BQ DRUG__ID D0B2BQ D0B2BQ DRUGTYPE Small molecular drug D0B2BQ DRUGINCH 1S/C23H25N3O2.C4H4O4/c27-23-13-18-12-19-20(25-28-22(19)14-21(18)24-23)7-6-16-8-10-26(11-9-16)15-17-4-2-1-3-5-17;5-3(6)1-2-4(7)8/h1-5,12,14,16H,6-11,13,15H2,(H,24,27);1-2H,(H,5,6)(H,7,8)/b;2-1- D0B2BQ DRUGINKE CTYSKGVFLJLGGX-BTJKTKAUSA-N D0B2BQ DRUGSMIL C1CN(CCC1CCC2=NOC3=C2C=C4CC(=O)NC4=C3)CC5=CC=CC=C5.C(=CC(=O)O)C(=O)O D0B2BQ HIGHSTAT Discontinued in Phase 2 D0B2OL DRUG__ID D0B2OL D0B2OL DRUGTYPE Small molecular drug D0B2OL DRUGINCH 1S/C15H23N5O4/c1-5-7-9-18-12-10(13(21)19(8-6-2)14(18)22)11(16-3)20(17-12)15(23)24-4/h16H,5-9H2,1-4H3 D0B2OL DRUGINKE AKJPAUXGPOUISG-UHFFFAOYSA-N D0B2OL DRUGSMIL CCCCN1C2=NN(C(=C2C(=O)N(C1=O)CCC)NC)C(=O)OC D0B2OL HIGHSTAT Discontinued in Phase 2 D0B4EV DRUG__ID D0B4EV D0B4EV DRUGTYPE Small molecular drug D0B4EV DRUGINCH 1S/C22H34N2O2/c1-18(2)17-20-21(19-11-6-5-7-12-19)26-22(25)24(20)16-10-15-23-13-8-3-4-9-14-23/h5-7,11-12,18,20-21H,3-4,8-10,13-17H2,1-2H3/t20-,21+/m0/s1 D0B4EV DRUGINKE DQNMZSIJHFEYTM-LEWJYISDSA-N D0B4EV DRUGSMIL CC(C)CC1C(OC(=O)N1CCCN2CCCCCC2)C3=CC=CC=C3 D0B4EV HIGHSTAT Discontinued in Phase 2 D0B4JL DRUG__ID D0B4JL D0B4JL DRUGTYPE Small molecular drug D0B4JL DRUGINCH 1S/C22H23N3O2.ClH/c1-23-11-12-24-17-9-5-3-7-15(17)13-25-18-10-6-4-8-16(18)20(22(26)27-2)21(25)19(24)14-23;/h3-10,19H,11-14H2,1-2H3;1H D0B4JL DRUGINKE YEITZTKANLXOTH-UHFFFAOYSA-N D0B4JL DRUGSMIL CN1CCN2C(C1)C3=C(C4=CC=CC=C4N3CC5=CC=CC=C52)C(=O)OC.Cl D0B4JL HIGHSTAT Discontinued in Phase 2 D0B5PU DRUG__ID D0B5PU D0B5PU DRUGTYPE Small molecular drug D0B5PU DRUGINCH 1S/C20H17N3O4S/c1-13-14(2)22-27-19(13)23-28(24,25)18-6-4-3-5-17(18)15-7-9-16(10-8-15)20-21-11-12-26-20/h3-12,23H,1-2H3 D0B5PU DRUGINKE LJGUZUROJOJEMI-UHFFFAOYSA-N D0B5PU DRUGSMIL CC1=C(ON=C1C)NS(=O)(=O)C2=CC=CC=C2C3=CC=C(C=C3)C4=NC=CO4 D0B5PU HIGHSTAT Discontinued in Phase 2 D0B6GJ DRUG__ID D0B6GJ D0B6GJ DRUGTYPE Small molecular drug D0B6GJ DRUGINCH 1S/C23H40FN2O8P.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-32-35(30,31)33-17-20-19(27)15-21(34-20)26-16-18(24)22(28)25-23(26)29;/h16,19-21,27H,2-15,17H2,1H3,(H,30,31)(H,25,28,29);/q;+1/p-1/t19-,20+,21+;/m0./s1 D0B6GJ DRUGINKE YUGLAGAQPWTRTP-HWAJWLCKSA-M D0B6GJ DRUGSMIL CCCCCCCCCCCCCCOP(=O)([O-])OCC1C(CC(O1)N2C=C(C(=O)NC2=O)F)O.[Na+] D0B6GJ HIGHSTAT Discontinued in Phase 2 D0B6JV DRUG__ID D0B6JV D0B6JV DRUGTYPE Small molecular drug D0B6JV DRUGINCH 1S/C32H37NO6S/c1-38-28-15-12-24(13-16-28)9-6-4-2-3-5-7-20-39-30-18-14-27(33-29(30)17-19-31(34)35)23-40-22-25-10-8-11-26(21-25)32(36)37/h8,10-19,21H,2-7,9,20,22-23H2,1H3,(H,34,35)(H,36,37)/b19-17+ D0B6JV DRUGINKE QQUXZUFSDIOIFJ-HTXNQAPBSA-N D0B6JV DRUGSMIL COC1=CC=C(C=C1)CCCCCCCCOC2=C(N=C(C=C2)CSCC3=CC(=CC=C3)C(=O)O)C=CC(=O)O D0B6JV HIGHSTAT Discontinued in Phase 2 D0B8JQ DRUG__ID D0B8JQ D0B8JQ DRUGCOMP Kyorin Pharmaceutical Co Ltd D0B8JQ DRUGINCH 1S/C26H26FNO5/c1-3-19(26(30)31)14-18-6-13-24(32-2)23(15-18)25(29)28-16-17-4-9-21(10-5-17)33-22-11-7-20(27)8-12-22/h4-13,15,19H,3,14,16H2,1-2H3,(H,28,29)(H,30,31)/t19-/m0/s1 D0B8JQ DRUGINKE VRHOBXXCNBZJRX-IBGZPJMESA-N D0B8JQ DRUGSMIL CCC(CC1=CC(=C(C=C1)OC)C(=O)NCC2=CC=C(C=C2)OC3=CC=C(C=C3)F)C(=O)O D0B8JQ HIGHSTAT Discontinued in Phase 2 D0B8SC DRUG__ID D0B8SC D0B8SC DRUGTYPE Small molecular drug D0B8SC DRUGINCH 1S/C18H14N4O3S.Na/c1-25-15-9-12(14-10-21-22-17(14)19-11-20-18(22)23)7-8-16(15)26(24)13-5-3-2-4-6-13;/h2-11H,1H3,(H,19,20,21,23);/q;+1/p-1 D0B8SC DRUGINKE FRSOALVXQKHLLF-UHFFFAOYSA-M D0B8SC DRUGSMIL COC1=C(C=CC(=C1)C2=C3[N-]C=NC(=O)N3N=C2)S(=O)C4=CC=CC=C4.[Na+] D0B8SC HIGHSTAT Discontinued in Phase 2 D0BB1T DRUG__ID D0BB1T D0BB1T DRUGCOMP Roche Bioscience D0BB1T DRUGINCH 1S/C175H300N56O51/c1-24-93(20)138(230-169(279)127(80-233)227-143(253)101(37-26-30-56-177)201-130(237)78-196-142(252)100(36-25-29-55-176)202-165(275)124(73-135(246)247)226-164(274)122(71-98-76-191-82-198-98)223-162(272)120(69-91(16)17)220-160(270)117(66-88(10)11)216-151(261)107(43-49-128(181)235)209-163(273)121(70-97-75-190-81-197-97)222-154(264)112(48-54-134(244)245)212-168(278)126(79-232)228-170(280)137(92(18)19)229-141(251)94(21)180)171(281)213-108(44-50-129(182)236)152(262)225-125(74-136(248)249)166(276)221-113(62-84(2)3)155(265)207-106(42-35-61-195-175(188)189)145(255)205-104(40-33-59-193-173(184)185)144(254)206-105(41-34-60-194-174(186)187)146(256)208-111(47-53-133(242)243)153(263)217-118(67-89(12)13)159(269)219-115(64-86(6)7)157(267)211-109(45-51-131(238)239)149(259)203-102(38-27-31-57-178)147(257)214-116(65-87(8)9)158(268)218-114(63-85(4)5)156(266)210-110(46-52-132(240)241)150(260)204-103(39-28-32-58-179)148(258)215-119(68-90(14)15)161(271)224-123(72-99-77-192-83-199-99)167(277)231-139(96(23)234)172(282)200-95(22)140(183)250/h75-77,81-96,100-127,137-139,232-234H,24-74,78-80,176-180H2,1-23H3,(H2,181,235)(H2,182,236)(H2,183,250)(H,190,197)(H,191,198)(H,192,199)(H,196,252)(H,200,282)(H,201,237)(H,202,275)(H,203,259)(H,204,260)(H,205,255)(H,206,254)(H,207,265)(H,208,256)(H,209,273)(H,210,266)(H,211,267)(H,212,278)(H,213,281)(H,214,257)(H,215,258)(H,216,261)(H,217,263)(H,218,268)(H,219,269)(H,220,270)(H,221,276)(H,222,264)(H,223,272)(H,224,271)(H,225,262)(H,226,274)(H,227,253)(H,228,280)(H,229,251)(H,230,279)(H,231,277)(H,238,239)(H,240,241)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H4,184,185,193)(H4,186,187,194)(H4,188,189,195)/t93-,94-,95-,96+,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,137-,138-,139-/m0/s1 D0BB1T DRUGINKE BLQSIKSVAXFNRH-ZMWZJJJDSA-N D0BB1T DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(C)N D0BB1T HIGHSTAT Discontinued in Phase 2 D0BK6B DRUG__ID D0BK6B D0BK6B DRUGTYPE Small molecular drug D0BK6B DRUGINCH 1S/C14H14N4O/c1-10-8-13(19)16-17-14(10)11-2-4-12(5-3-11)18-7-6-15-9-18/h2-7,9-10H,8H2,1H3,(H,16,19) D0BK6B DRUGINKE AEZZPAQOEUQNBB-UHFFFAOYSA-N D0BK6B DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3 D0BK6B HIGHSTAT Discontinued in Phase 2 D0C1SI DRUG__ID D0C1SI D0C1SI DRUGTYPE Small molecular drug D0C1SI DRUGINCH 1S/C28H49NO/c1-18(2)9-8-10-19(3)21-11-12-22-26-20(4)17-24-28(6,16-14-25(30)29(24)7)23(26)13-15-27(21,22)5/h18-24,26H,8-17H2,1-7H3/t19-,20+,21-,22+,23+,24-,26+,27-,28-/m1/s1 D0C1SI DRUGINKE XUTZDXHKQDPUMA-MVJJLJOTSA-N D0C1SI DRUGSMIL CC1CC2C(CCC(=O)N2C)(C3C1C4CCC(C4(CC3)C)C(C)CCCC(C)C)C D0C1SI HIGHSTAT Discontinued in Phase 2 D0C1TJ DRUG__ID D0C1TJ D0C1TJ DRUGCOMP Nycomed AS D0C1TJ DRUGINCH 1S/C12H11N3O2S2/c1-17-9-8(19(2)16)6-18-10(9)12-14-7-4-3-5-13-11(7)15-12/h3-6H,1-2H3,(H,13,14,15) D0C1TJ DRUGINKE WUXLGRPRVSOZPL-UHFFFAOYSA-N D0C1TJ DRUGSMIL COC1=C(SC=C1S(=O)C)C2=NC3=C(N2)C=CC=N3 D0C1TJ HIGHSTAT Discontinued in Phase 2 D0C2CH DRUG__ID D0C2CH D0C2CH DRUGCOMP Oxford GlycoSciences plc D0C2CH DRUGINCH 1S/C10H13FN2O7/c11-3-1-13(10(19)12-8(3)18)9-7(17)6(16)5(15)4(2-14)20-9/h1,4-7,9,14-17H,2H2,(H,12,18,19)/t4-,5+,6+,7-,9-/m1/s1 D0C2CH DRUGINKE YHWGRVDTEORPPJ-WENHOLORSA-N D0C2CH DRUGSMIL C1=C(C(=O)NC(=O)N1C2C(C(C(C(O2)CO)O)O)O)F D0C2CH HIGHSTAT Discontinued in Phase 2 D0C2HR DRUG__ID D0C2HR D0C2HR DRUGTYPE Small molecular drug D0C2HR DRUGINCH 1S/C31H53N2O4/c1-21(34)37-29-27(33(4)14-6-5-7-15-33)19-25-23-9-8-22-18-28(35)26(32-12-16-36-17-13-32)20-31(22,3)24(23)10-11-30(25,29)2/h22-29,35H,5-20H2,1-4H3/q+1/t22-,23?,24?,25?,26-,27-,28-,29-,30-,31-/m0/s1 D0C2HR DRUGINKE DHYOZTTVCWLBTR-JHKQNVCFSA-N D0C2HR DRUGSMIL CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCCC6)C D0C2HR HIGHSTAT Discontinued in Phase 2 D0C5KG DRUG__ID D0C5KG D0C5KG DRUGTYPE Small molecular drug D0C5KG DRUGINCH 1S/C30H34O3/c1-18-13-15-33-30(18)14-12-27-25-10-8-22-16-23(32)9-11-24(22)28(25)26(17-29(27,30)3)21-6-4-20(5-7-21)19(2)31/h4-7,16,25-27H,1,8-15,17H2,2-3H3/t25-,26+,27-,29-,30+/m0/s1 D0C5KG DRUGINKE YNWTZVKFWBTFFE-ONBAZCQBSA-N D0C5KG DRUGSMIL CC(=O)C1=CC=C(C=C1)C2CC3(C(CCC34C(=C)CCO4)C5C2=C6CCC(=O)C=C6CC5)C D0C5KG HIGHSTAT Discontinued in Phase 2 D0C9EE DRUG__ID D0C9EE D0C9EE DRUGTYPE Small molecular drug D0C9EE DRUGINCH 1S/C22H27N5/c1-4-27(5-2)12-6-9-24-22-18-13-17-19-14-23-10-8-20(19)26-21(17)15(3)16(18)7-11-25-22/h7-8,10-11,13-14,26H,4-6,9,12H2,1-3H3,(H,24,25) D0C9EE DRUGINKE LPHSYQSMAGVYNT-UHFFFAOYSA-N D0C9EE DRUGSMIL CCN(CC)CCCNC1=NC=CC2=C(C3=C(C=C21)C4=C(N3)C=CN=C4)C D0C9EE HIGHSTAT Discontinued in Phase 2 D0D1XG DRUG__ID D0D1XG D0D1XG DRUGTYPE Small molecular drug D0D1XG DRUGINCH 1S/C23H39NO4/c1-7-8-9-10-11-12-13-14-15-23(2,3)22(25)24-21-19(27-5)16-18(26-4)17-20(21)28-6/h16-17H,7-15H2,1-6H3,(H,24,25) D0D1XG DRUGINKE WAFNZAURAWBNDZ-UHFFFAOYSA-N D0D1XG DRUGSMIL CCCCCCCCCCC(C)(C)C(=O)NC1=C(C=C(C=C1OC)OC)OC D0D1XG HIGHSTAT Discontinued in Phase 2 D0D3BO DRUG__ID D0D3BO D0D3BO DRUGTYPE Small molecular drug D0D3BO DRUGINCH 1S/C18H23NO3.ClH/c1-14(13-22-16-10-6-3-7-11-16)19-17(12-20)18(21)15-8-4-2-5-9-15;/h2-11,14,17-21H,12-13H2,1H3;1H/t14-,17-,18+;/m0./s1 D0D3BO DRUGINKE ZERZMJPMHWGYET-QSCFYETBSA-N D0D3BO DRUGSMIL CC(COC1=CC=CC=C1)NC(CO)C(C2=CC=CC=C2)O.Cl D0D3BO HIGHSTAT Discontinued in Phase 2 D0D3PF DRUG__ID D0D3PF D0D3PF DRUGTYPE Small molecular drug D0D3PF DRUGINCH 1S/C16H13ClN6/c1-22-15-8-12(4-7-14(15)20-21-22)16(23-10-18-9-19-23)11-2-5-13(17)6-3-11/h2-10,16H,1H3/t16-/m0/s1 D0D3PF DRUGINKE XLMPPFTZALNBFS-INIZCTEOSA-N D0D3PF DRUGSMIL CN1C2=C(C=CC(=C2)C(C3=CC=C(C=C3)Cl)N4C=NC=N4)N=N1 D0D3PF HIGHSTAT Discontinued in Phase 2 D0D3VA DRUG__ID D0D3VA D0D3VA DRUGTYPE Small molecular drug D0D3VA DRUGINCH 1S/C8H13NO3/c1-2-3-7(10)9-6-4-5-12-8(6)11/h6H,2-5H2,1H3,(H,9,10) D0D3VA DRUGINKE VFFNZZXXTGXBOG-UHFFFAOYSA-N D0D3VA DRUGSMIL CCCC(=O)NC1CCOC1=O D0D3VA HIGHSTAT Discontinued in Phase 2 D0D5CJ DRUG__ID D0D5CJ D0D5CJ DRUGCOMP Novartis AG D0D5CJ DRUGINCH 1S/C18H20O5/c1-21-14-7-9-17(22-2)13(11-14)6-4-12-5-8-16(19)15(10-12)18(20)23-3/h5,7-11,19H,4,6H2,1-3H3 D0D5CJ DRUGINKE GZOFTOHENYHNMS-UHFFFAOYSA-N D0D5CJ DRUGSMIL COC1=CC(=C(C=C1)OC)CCC2=CC(=C(C=C2)O)C(=O)OC D0D5CJ HIGHSTAT Discontinued in Phase 2 D0D5DE DRUG__ID D0D5DE D0D5DE DRUGTYPE Small molecular drug D0D5DE DRUGINCH 1S/C15H22N2O2.ClH/c1-4-7-13-8-5-6-9-15(13)19-11-14(17-18)10-16-12(2)3;/h4-6,8-9,12,16,18H,1,7,10-11H2,2-3H3;1H D0D5DE DRUGINKE ZFLRDGZJSCQDSR-UHFFFAOYSA-N D0D5DE DRUGSMIL CC(C)NCC(=NO)COC1=CC=CC=C1CC=C.Cl D0D5DE HIGHSTAT Discontinued in Phase 2 D0D7XW DRUG__ID D0D7XW D0D7XW DRUGTYPE Small molecular drug D0D7XW DRUGINCH 1S/C10H10N2O5/c13-10-8-3-1-2-4-9(8)16-7-11(10)5-6-17-12(14)15/h1-4H,5-7H2 D0D7XW DRUGINKE POVFCWQCRHXYAB-UHFFFAOYSA-N D0D7XW DRUGSMIL C1N(C(=O)C2=CC=CC=C2O1)CCO[N+](=O)[O-] D0D7XW HIGHSTAT Discontinued in Phase 2 D0DL2S DRUG__ID D0DL2S D0DL2S DRUGTYPE Small molecular drug D0DL2S DRUGINCH 1S/C30H30N6O3S/c1-4-5-10-26-25(29(37)36(19(2)31-26)18-27-24(15-16-40-27)30(38)39-3)17-20-11-13-21(14-12-20)22-8-6-7-9-23(22)28-32-34-35-33-28/h6-9,11-16H,4-5,10,17-18H2,1-3H3,(H,32,33,34,35) D0DL2S DRUGINKE QVFVAKQHELFATN-UHFFFAOYSA-N D0DL2S DRUGSMIL CCCCC1=C(C(=O)N(C(=N1)C)CC2=C(C=CS2)C(=O)OC)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D0DL2S HIGHSTAT Discontinued in Phase 2 D0E2CZ DRUG__ID D0E2CZ D0E2CZ DRUGTYPE Small molecular drug D0E2CZ DRUGINCH 1S/C12H17NO.CH4O3S/c1-4-14-9-5-6-10-11(7-9)13-8-12(10,2)3;1-5(2,3)4/h5-7,13H,4,8H2,1-3H3;1H3,(H,2,3,4) D0E2CZ DRUGINKE QZTLHRAONHZQNK-UHFFFAOYSA-N D0E2CZ DRUGSMIL CCOC1=CC2=C(C=C1)C(CN2)(C)C.CS(=O)(=O)O D0E2CZ HIGHSTAT Discontinued in Phase 2 D0E2PX DRUG__ID D0E2PX D0E2PX DRUGTYPE Small molecular drug D0E2PX DRUGINCH 1S/C21H27N3O3S.2ClH/c1-16-4-3-5-19(22-16)12-15-24-13-10-18(11-14-24)21(25)17-6-8-20(9-7-17)23-28(2,26)27;;/h3-9,18,23H,10-15H2,1-2H3;2*1H D0E2PX DRUGINKE ZQBNWMFBOSOOLX-UHFFFAOYSA-N D0E2PX DRUGSMIL CC1=NC(=CC=C1)CCN2CCC(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C.Cl.Cl D0E2PX HIGHSTAT Discontinued in Phase 2 D0E3NZ DRUG__ID D0E3NZ D0E3NZ DRUGTYPE Small molecular drug D0E3NZ DRUGINCH 1S/C17H18N2O2/c1-3-12-10-13(17(20)18-11(12)2)8-9-16-19-14-6-4-5-7-15(14)21-16/h4-7,10H,3,8-9H2,1-2H3,(H,18,20) D0E3NZ DRUGINKE MHUVLRNBDLFMHQ-UHFFFAOYSA-N D0E3NZ DRUGSMIL CCC1=C(NC(=O)C(=C1)CCC2=NC3=CC=CC=C3O2)C D0E3NZ HIGHSTAT Discontinued in Phase 2 D0E4FM DRUG__ID D0E4FM D0E4FM DRUGTYPE Small molecular drug D0E4FM DRUGINCH 1S/C16H17N3O3/c1-16(2,3)10-22-14-5-4-13(6-11(14)7-17)19-9-12(8-18-19)15(20)21/h4-6,8-9H,10H2,1-3H3,(H,20,21) D0E4FM DRUGINKE AETHRPHBGJAIBT-UHFFFAOYSA-N D0E4FM DRUGSMIL CC(C)(C)COC1=C(C=C(C=C1)N2C=C(C=N2)C(=O)O)C#N D0E4FM HIGHSTAT Discontinued in Phase 2 D0E6UD DRUG__ID D0E6UD D0E6UD DRUGTYPE Small molecular drug D0E6UD DRUGINCH 1S/C24H29N3O3/c1-8-27-19(18-9-10-20(29-6)21(13-18)30-7)14-22(26(5)24(27)28)25-23-16(3)11-15(2)12-17(23)4/h9-14H,8H2,1-7H3 D0E6UD DRUGINKE OYGHXRNCHYRYRR-UHFFFAOYSA-N D0E6UD DRUGSMIL CCN1C(=CC(=NC2=C(C=C(C=C2C)C)C)N(C1=O)C)C3=CC(=C(C=C3)OC)OC D0E6UD HIGHSTAT Discontinued in Phase 2 D0E7YQ DRUG__ID D0E7YQ D0E7YQ DRUGTYPE Small molecular drug D0E7YQ DRUGINCH 1S/C27H49N5O8/c1-3-4-5-6-7-8-9-10-11-15-22(33)30-18(2)25(36)32-21(27(39)40)16-17-23(34)31-20(26(37)38)14-12-13-19(28)24(29)35/h18-21H,3-17,28H2,1-2H3,(H2,29,35)(H,30,33)(H,31,34)(H,32,36)(H,37,38)(H,39,40)/t18-,19-,20-,21+/m0/s1 D0E7YQ DRUGINKE TUNXCNXMSJZNPO-XSDIEEQYSA-N D0E7YQ DRUGSMIL CCCCCCCCCCCC(=O)NC(C)C(=O)NC(CCC(=O)NC(CCCC(C(=O)N)N)C(=O)O)C(=O)O D0E7YQ HIGHSTAT Discontinued in Phase 2 D0EC2K DRUG__ID D0EC2K D0EC2K DRUGTYPE Small molecular drug D0EC2K DRUGINCH 1S/C15H16Cl3N5/c1-22-2-4-23(5-3-22)15-20-8-11(14(19)21-15)10-6-9(16)7-12(17)13(10)18/h6-8H,2-5H2,1H3,(H2,19,20,21) D0EC2K DRUGINKE PDOCBJADCWMDGL-UHFFFAOYSA-N D0EC2K DRUGSMIL CN1CCN(CC1)C2=NC=C(C(=N2)N)C3=C(C(=CC(=C3)Cl)Cl)Cl D0EC2K HIGHSTAT Discontinued in Phase 2 D0EE6L DRUG__ID D0EE6L D0EE6L DRUGTYPE Small molecular drug D0EE6L DRUGINCH 1S/C26H31N3O2/c1-31-25-11-5-4-10-24(25)29-18-16-28(17-19-29)15-7-6-14-27-26(30)23-13-12-21-8-2-3-9-22(21)20-23/h2-5,8-13,20H,6-7,14-19H2,1H3,(H,27,30) D0EE6L DRUGINKE MNHDKMDLOJSCGN-UHFFFAOYSA-N D0EE6L DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCCCNC(=O)C3=CC4=CC=CC=C4C=C3 D0EE6L HIGHSTAT Discontinued in Phase 2 D0EK6D DRUG__ID D0EK6D D0EK6D DRUGTYPE Small molecular drug D0EK6D DRUGINCH 1S/C21H18N4O3/c26-18-12-11-16(22-25(18)14-6-10-19(27)28)20-17-9-4-5-13-24(17)23-21(20)15-7-2-1-3-8-15/h1-5,7-9,11-13H,6,10,14H2,(H,27,28) D0EK6D DRUGINKE FKJPZJACCBMNKZ-UHFFFAOYSA-N D0EK6D DRUGSMIL C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=NN(C(=O)C=C4)CCCC(=O)O D0EK6D HIGHSTAT Discontinued in Phase 2 D0EO6S DRUG__ID D0EO6S D0EO6S DRUGCOMP SmithKline Beecham plc D0EO6S DRUGINCH 1S/C48H74N12O22/c49-19-5-3-9-29(47(79)80)57-39(71)23(53-45(77)31(21-37(67)68)59-43(75)27(13-17-35(63)64)55-41(73)25-11-15-33(61)51-25)7-1-2-8-24(40(72)58-30(48(81)82)10-4-6-20-50)54-46(78)32(22-38(69)70)60-44(76)28(14-18-36(65)66)56-42(74)26-12-16-34(62)52-26/h23-32H,1-22,49-50H2,(H,51,61)(H,52,62)(H,53,77)(H,54,78)(H,55,73)(H,56,74)(H,57,71)(H,58,72)(H,59,75)(H,60,76)(H,63,64)(H,65,66)(H,67,68)(H,69,70)(H,79,80)(H,81,82)/t23-,24-,25-,26-,27-,28-,29-,30-,31-,32-/m0/s1 D0EO6S DRUGINKE CNYIEQNFOBBXCP-CJMGQXRASA-N D0EO6S DRUGSMIL C1CC(=O)NC1C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCC(C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C2CCC(=O)N2)C(=O)NC(CCCCN)C(=O)O D0EO6S HIGHSTAT Discontinued in Phase 2 D0F1VQ DRUG__ID D0F1VQ D0F1VQ DRUGTYPE Small molecular drug D0F1VQ DRUGINCH 1S/C11H13F3OSi/c1-16(2,3)9-6-4-5-8(7-9)10(15)11(12,13)14/h4-7H,1-3H3 D0F1VQ DRUGINKE GAPOASFZXBWUGS-UHFFFAOYSA-N D0F1VQ DRUGSMIL C[Si](C)(C)C1=CC=CC(=C1)C(=O)C(F)(F)F D0F1VQ HIGHSTAT Discontinued in Phase 2 D0F2HA DRUG__ID D0F2HA D0F2HA DRUGCOMP Zeneca Group plc D0F2HA DRUGINCH 1S/C25H21N5O/c1-2-19-15-24(22-9-5-6-10-23(22)26-19)31-16-17-11-13-18(14-12-17)20-7-3-4-8-21(20)25-27-29-30-28-25/h3-15H,2,16H2,1H3,(H,27,28,29,30) D0F2HA DRUGINKE FSJCYXPMWQPVOS-UHFFFAOYSA-N D0F2HA DRUGSMIL CCC1=NC2=CC=CC=C2C(=C1)OCC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D0F2HA HIGHSTAT Discontinued in Phase 2 D0F8BS DRUG__ID D0F8BS D0F8BS DRUGTYPE Small molecular drug D0F8BS DRUGINCH 1S/C11H19NO/c1-9-8-11(13-10(9)2)4-6-12(3)7-5-11/h10H,1,4-8H2,2-3H3/t10-/m1/s1 D0F8BS DRUGINKE HDTOQYUZMCNTBZ-SNVBAGLBSA-N D0F8BS DRUGSMIL CC1C(=C)CC2(O1)CCN(CC2)C D0F8BS HIGHSTAT Discontinued in Phase 2 D0F9QP DRUG__ID D0F9QP D0F9QP DRUGCOMP GlaxoSmithKline plc D0F9QP DRUGINCH 1S/C31H40N4O8/c1-19(2)16-24(33-27(36)18-42-26-7-5-4-6-20(26)3)29(38)34-25(30(39)40)17-21-8-10-23(11-9-21)43-31(41)35-14-12-22(13-15-35)28(32)37/h4-11,19,22,24-25H,12-18H2,1-3H3,(H2,32,37)(H,33,36)(H,34,38)(H,39,40)/t24-,25-/m0/s1 D0F9QP DRUGINKE RZMCXMNNXGCFQG-DQEYMECFSA-N D0F9QP DRUGSMIL CC1=CC=CC=C1OCC(=O)NC(CC(C)C)C(=O)NC(CC2=CC=C(C=C2)OC(=O)N3CCC(CC3)C(=O)N)C(=O)O D0F9QP HIGHSTAT Discontinued in Phase 2 D0F9WF DRUG__ID D0F9WF D0F9WF DRUGTYPE Small molecular drug D0F9WF DRUGINCH 1S/C19H23NO4/c1-20-7-6-19-10-14(21)16(24-3)9-12(19)13(20)8-11-4-5-15(23-2)18(22)17(11)19/h4-5,9,12-13,22H,6-8,10H2,1-3H3/t12-,13+,19-/m1/s1 D0F9WF DRUGINKE INYYVPJSBIVGPH-QHRIQVFBSA-N D0F9WF DRUGSMIL CN1CCC23CC(=O)C(=CC2C1CC4=C3C(=C(C=C4)OC)O)OC D0F9WF HIGHSTAT Discontinued in Phase 2 D0FH3X DRUG__ID D0FH3X D0FH3X DRUGTYPE Small molecular drug D0FH3X DRUGINCH 1S/C20H27F3N6OS/c1-19(2,3)17-25-14(20(21,22)23)13-15(26-17)29-10-8-28(9-11-29)7-4-12-31-18-24-6-5-16(30)27-18/h5-6,13H,4,7-12H2,1-3H3,(H,24,27,30) D0FH3X DRUGINKE KXVAICSRMHXLJN-UHFFFAOYSA-N D0FH3X DRUGSMIL CC(C)(C)C1=NC(=CC(=N1)N2CCN(CC2)CCCSC3=NC=CC(=O)N3)C(F)(F)F D0FH3X HIGHSTAT Discontinued in Phase 2 D0G0CX DRUG__ID D0G0CX D0G0CX DRUGTYPE Small molecular drug D0G0CX DRUGINCH 1S/C39H68N2O8/c1-22(2)9-8-10-23(3)28-13-14-29-27-12-11-25-19-26(15-17-37(25,5)30(27)16-18-38(28,29)6)41-36(47)39(48-7)20-31(44)33(40-24(4)43)35(49-39)34(46)32(45)21-42/h22-23,25-35,42,44-46H,8-21H2,1-7H3,(H,40,43)(H,41,47)/t23-,25+,26-,27+,28-,29+,30+,31+,32-,33-,34-,35-,37+,38-,39-/m1/s1 D0G0CX DRUGINKE CHMRTBYTCBDIRG-JQZMMWJVSA-N D0G0CX DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)NC(=O)C5(CC(C(C(O5)C(C(CO)O)O)NC(=O)C)O)OC)C)C D0G0CX HIGHSTAT Discontinued in Phase 2 D0G1EE DRUG__ID D0G1EE D0G1EE DRUGTYPE Small molecular drug D0G1EE DRUGINCH 1S/C6H15O15P3/c7-1-2(8)4(19-22(10,11)12)6(21-24(16,17)18)5(3(1)9)20-23(13,14)15/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1?,2-,3+,4-,5-,6?/m1/s1 D0G1EE DRUGINKE GKDKOMAJZATYAY-GCVPSNMTSA-N D0G1EE DRUGSMIL C1(C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O)O D0G1EE HIGHSTAT Discontinued in Phase 2 D0G3OF DRUG__ID D0G3OF D0G3OF DRUGCOMP Schering-Plough Corp D0G3OF DRUGINCH 1S/C21H17Cl3O3/c1-25-16-9-10-20(19(24)11-16)26-12-14-5-7-15(8-6-14)13-27-21-17(22)3-2-4-18(21)23/h2-11H,12-13H2,1H3 D0G3OF DRUGINKE XXMDDBVNWRWNCW-UHFFFAOYSA-N D0G3OF DRUGSMIL COC1=CC(=C(C=C1)OCC2=CC=C(C=C2)COC3=C(C=CC=C3Cl)Cl)Cl D0G3OF HIGHSTAT Discontinued in Phase 2 D0G5GJ DRUG__ID D0G5GJ D0G5GJ DRUGTYPE Small molecular drug D0G5GJ DRUGINCH 1S/C23H28N4O2S/c1-4-26-22(30)27(21(29)23(26,2)3)19-7-5-17(6-8-19)24-13-15-25(16-14-24)18-9-11-20(28)12-10-18/h5-12,28H,4,13-16H2,1-3H3 D0G5GJ DRUGINKE AHWDHLCCXRVAIC-UHFFFAOYSA-N D0G5GJ DRUGSMIL CCN1C(=S)N(C(=O)C1(C)C)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)O D0G5GJ HIGHSTAT Discontinued in Phase 2 D0GT8W DRUG__ID D0GT8W D0GT8W DRUGCOMP Bristol Myers Squibb D0GT8W DRUGINCH 1S/C26H20Cl2N4O4S/c1-30-25(36)32(20-8-18(27)7-19(28)9-20)24(35)26(30)14-31(11-21-6-17(13-37-21)23(33)34)12-22(26)16-4-2-15(10-29)3-5-16/h2-9,13,22H,11-12,14H2,1H3,(H,33,34)/t22-,26+/m0/s1 D0GT8W DRUGINKE NXNKJLOEGWSJGI-BKMJKUGQSA-N D0GT8W DRUGSMIL CN1C(=O)N(C(=O)C12CN(CC2C3=CC=C(C=C3)C#N)CC4=CC(=CS4)C(=O)O)C5=CC(=CC(=C5)Cl)Cl D0GT8W HIGHSTAT Discontinued in Phase 2 D0H4TC DRUG__ID D0H4TC D0H4TC DRUGCOMP Amylin Pharmaceuticals Inc D0H4TC DRUGINCH 1S/C152H248N50O49S2/c1-66(2)48-91(189-143(245)113(70(9)10)195-140(242)103-64-253-252-63-102(193-122(224)83(154)24-18-19-43-153)139(241)188-97(56-108(158)216)135(237)200-115(73(13)206)144(246)174-71(11)121(223)196-116(74(14)207)148(250)194-103)123(225)171-59-110(218)175-84(25-20-44-168-150(161)162)124(226)183-94(51-69(7)8)132(234)192-101(62-204)138(240)180-87(37-40-105(155)213)126(228)178-89(39-42-112(220)221)127(229)185-93(50-68(5)6)131(233)186-95(54-80-58-167-65-173-80)133(235)177-85(26-21-45-169-151(163)164)125(227)184-92(49-67(3)4)130(232)179-88(38-41-106(156)214)129(231)199-119(77(17)210)147(249)191-99(53-79-31-35-82(212)36-32-79)149(251)202-47-23-28-104(202)141(243)181-86(27-22-46-170-152(165)166)128(230)198-118(76(16)209)146(248)190-98(57-109(159)217)136(238)197-114(72(12)205)142(244)172-60-111(219)176-100(61-203)137(239)187-96(55-107(157)215)134(236)201-117(75(15)208)145(247)182-90(120(160)222)52-78-29-33-81(211)34-30-78/h29-36,58,65-77,83-104,113-119,203-212H,18-28,37-57,59-64,153-154H2,1-17H3,(H2,155,213)(H2,156,214)(H2,157,215)(H2,158,216)(H2,159,217)(H2,160,222)(H,167,173)(H,171,225)(H,172,244)(H,174,246)(H,175,218)(H,176,219)(H,177,235)(H,178,228)(H,179,232)(H,180,240)(H,181,243)(H,182,247)(H,183,226)(H,184,227)(H,185,229)(H,186,233)(H,187,239)(H,188,241)(H,189,245)(H,190,248)(H,191,249)(H,192,234)(H,193,224)(H,194,250)(H,195,242)(H,196,223)(H,197,238)(H,198,230)(H,199,231)(H,200,237)(H,201,236)(H,220,221)(H4,161,162,168)(H4,163,164,169)(H4,165,166,170)/t71-,72+,73+,74+,75+,76+,77+,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,113-,114-,115-,116-,117-,118-,119-/m0/s1 D0H4TC DRUGINKE SLYFITHISHUGLZ-QPMCIWSFSA-N D0H4TC DRUGSMIL CC1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CN=CN2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N)C(C)O D0H4TC HIGHSTAT Discontinued in Phase 2 D0H4UJ DRUG__ID D0H4UJ D0H4UJ DRUGTYPE Small molecular drug D0H4UJ DRUGINCH 1S/C21H38N6O4/c22-21(23)25-11-6-10-24-19(30)17-9-4-5-12-27(17)20(31)16(26-14-18(28)29)13-15-7-2-1-3-8-15/h15-17,26H,1-14H2,(H,24,30)(H,28,29)(H4,22,23,25)/t16-,17+/m1/s1 D0H4UJ DRUGINKE CDPROXZBMHOBTQ-SJORKVTESA-N D0H4UJ DRUGSMIL C1CCC(CC1)CC(C(=O)N2CCCCC2C(=O)NCCCN=C(N)N)NCC(=O)O D0H4UJ HIGHSTAT Discontinued in Phase 2 D0H6PN DRUG__ID D0H6PN D0H6PN DRUGTYPE Small molecular drug D0H6PN DRUGINCH 1S/C10H6Cl3N3/c11-7-1-2-8(9(12)3-7)10(13)4-16-6-14-5-15-16/h1-6H/b10-4- D0H6PN DRUGINKE XGLHZTBDUXXHOM-WMZJFQQLSA-N D0H6PN DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C(=CN2C=NC=N2)Cl D0H6PN HIGHSTAT Discontinued in Phase 2 D0H6PX DRUG__ID D0H6PX D0H6PX DRUGCOMP Takeda Pharmaceutical Co Ltd D0H6PX DRUGINCH 1S/C25H26N4O6/c1-6-35-25(30)24-18(12-29-14-26-13-27-29)28-17-11-22(34-5)21(33-4)10-16(17)23(24)15-7-8-19(31-2)20(9-15)32-3/h7-11,13-14H,6,12H2,1-5H3 D0H6PX DRUGINKE CLQRMSBSMHXMMC-UHFFFAOYSA-N D0H6PX DRUGSMIL CCOC(=O)C1=C(C2=CC(=C(C=C2N=C1CN3C=NC=N3)OC)OC)C4=CC(=C(C=C4)OC)OC D0H6PX HIGHSTAT Discontinued in Phase 2 D0H7GH DRUG__ID D0H7GH D0H7GH DRUGTYPE Small molecular drug D0H7GH DRUGINCH 1S/C31H25FN2O3/c32-26-6-3-4-23(18-26)20-34(19-22-8-10-25(11-9-22)31(35)36)28-14-16-29(17-15-28)37-21-27-13-12-24-5-1-2-7-30(24)33-27/h1-18H,19-21H2,(H,35,36) D0H7GH DRUGINKE KRCUWCAUDKTMPB-UHFFFAOYSA-N D0H7GH DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=C(C=C3)N(CC4=CC=C(C=C4)C(=O)O)CC5=CC(=CC=C5)F D0H7GH HIGHSTAT Discontinued in Phase 2 D0H9KW DRUG__ID D0H9KW D0H9KW DRUGTYPE Small molecular drug D0H9KW DRUGINCH 1S/C15H20N2O4/c1-10(17-21-15(16)18)11-7-8-13(19-2)14(9-11)20-12-5-3-4-6-12/h7-9,12H,3-6H2,1-2H3,(H2,16,18)/b17-10+ D0H9KW DRUGINKE STTRYQAGHGJXJJ-LICLKQGHSA-N D0H9KW DRUGSMIL CC(=NOC(=O)N)C1=CC(=C(C=C1)OC)OC2CCCC2 D0H9KW HIGHSTAT Discontinued in Phase 2 D0H9WO DRUG__ID D0H9WO D0H9WO DRUGTYPE Small molecular drug D0H9WO DRUGINCH 1S/C21H29N5O6/c1-3-31-18(27)14-25-10-8-24(9-11-25)12-17-13-26(21(29)32-17)16-6-4-15(5-7-16)19(22)23-20(28)30-2/h4-7,17H,3,8-14H2,1-2H3,(H2,22,23,28)/t17-/m1/s1 D0H9WO DRUGINKE YNBHAPKHWDNTMZ-QGZVFWFLSA-N D0H9WO DRUGSMIL CCOC(=O)CN1CCN(CC1)CC2CN(C(=O)O2)C3=CC=C(C=C3)C(=N)NC(=O)OC D0H9WO HIGHSTAT Discontinued in Phase 2 D0HV6X DRUG__ID D0HV6X D0HV6X DRUGCOMP Toray Industries Inc D0HV6X DRUGINCH 1S/C28H28N2O5/c31-20-8-7-16-13-21-28(34)10-9-19(30-25(32)17-3-1-2-4-18(17)26(30)33)24-27(28,22(16)23(20)35-24)11-12-29(21)14-15-5-6-15/h1-4,7-8,15,19,21,24,31,34H,5-6,9-14H2/t19-,21?,24?,27+,28-/m1/s1 D0HV6X DRUGINKE DHAITNWJDOSRBU-RCSSWNHXSA-N D0HV6X DRUGSMIL C1CC1CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)N7C(=O)C8=CC=CC=C8C7=O D0HV6X HIGHSTAT Discontinued in Phase 2 D0I0GM DRUG__ID D0I0GM D0I0GM DRUGCOMP Bayer Schering Pharma AG D0I0GM DRUGINCH 1S/C14H19NO4/c1-4-7-18-12-8-10(5-6-11(12)17-3)14(2)9-15-13(16)19-14/h5-6,8H,4,7,9H2,1-3H3,(H,15,16)/t14-/m0/s1 D0I0GM DRUGINKE PCCPERGCFKIYIS-AWEZNQCLSA-N D0I0GM DRUGSMIL CCCOC1=C(C=CC(=C1)C2(CNC(=O)O2)C)OC D0I0GM HIGHSTAT Discontinued in Phase 2 D0I7RO DRUG__ID D0I7RO D0I7RO DRUGTYPE Small molecular drug D0I7RO DRUGINCH 1S/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1 D0I7RO DRUGINKE HEEWEZGQMLZMFE-RKGINYAYSA-N D0I7RO DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C2CCCN2C(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCC(=O)O)NC(=O)CN D0I7RO HIGHSTAT Discontinued in Phase 2 D0IW4R DRUG__ID D0IW4R D0IW4R DRUGTYPE Small molecular drug D0IW4R DRUGINCH 1S/C25H31FN6O2.ClH/c1-3-23(33)32(22-13-9-8-12-21(22)26)25(20-10-6-5-7-11-20)14-16-29(17-15-25)18-19-31-24(34)30(4-2)27-28-31;/h5-13H,3-4,14-19H2,1-2H3;1H D0IW4R DRUGINKE YMRJQYDWCFOMRR-UHFFFAOYSA-N D0IW4R DRUGSMIL CCC(=O)N(C1=CC=CC=C1F)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)C4=CC=CC=C4.Cl D0IW4R HIGHSTAT Discontinued in Phase 2 D0J0PR DRUG__ID D0J0PR D0J0PR DRUGTYPE Small molecular drug D0J0PR DRUGINCH 1S/C32H36BrN5O8.ClH/c1-16-23(31(40)45-6)25-24-18(14-33)15-38(20(24)13-21(27(25)34-16)46-32(41)37-9-7-36(2)8-10-37)30(39)19-11-17-12-22(42-3)28(43-4)29(44-5)26(17)35-19;/h11-13,18,34-35H,7-10,14-15H2,1-6H3;1H/t18-;/m1./s1 D0J0PR DRUGINKE LXRTZQKDZOKJRQ-GMUIIQOCSA-N D0J0PR DRUGSMIL CC1=C(C2=C3C(CN(C3=CC(=C2N1)OC(=O)N4CCN(CC4)C)C(=O)C5=CC6=CC(=C(C(=C6N5)OC)OC)OC)CBr)C(=O)OC.Cl D0J0PR HIGHSTAT Discontinued in Phase 2 D0J5DL DRUG__ID D0J5DL D0J5DL DRUGTYPE Small molecular drug D0J5DL DRUGINCH 1S/C5H12N2O3/c6-1-2-10-3-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1 D0J5DL DRUGINKE SLTGLTLBIVDQKE-BYPYZUCNSA-N D0J5DL DRUGSMIL C(COCC(C(=O)O)N)N D0J5DL HIGHSTAT Discontinued in Phase 2 D0J5GT DRUG__ID D0J5GT D0J5GT DRUGTYPE Small molecular drug D0J5GT DRUGINCH 1S/C35H55N5O6S2/c1-25(2)18-32(41)33(42)30(20-27-12-8-5-9-13-27)37-35(44)31(21-29-22-47-24-36-29)38-34(43)28(19-26-10-6-4-7-11-26)23-48(45,46)40-16-14-39(3)15-17-40/h4,6-7,10-11,22,24-25,27-28,30-33,41-42H,5,8-9,12-21,23H2,1-3H3,(H,37,44)(H,38,43)/t28-,30+,31+,32+,33-/m1/s1 D0J5GT DRUGINKE YFDSDRDMDDGDFC-HOQQKOLYSA-N D0J5GT DRUGSMIL CC(C)CC(C(C(CC1CCCCC1)NC(=O)C(CC2=CSC=N2)NC(=O)C(CC3=CC=CC=C3)CS(=O)(=O)N4CCN(CC4)C)O)O D0J5GT HIGHSTAT Discontinued in Phase 2 D0JH6W DRUG__ID D0JH6W D0JH6W DRUGTYPE Small molecular drug D0JH6W DRUGINCH 1S/C26H28N4O3.ClH.5H2O/c1-16(27)30-11-10-23(15-30)33-22-8-6-19(7-9-22)24(26(31)32)13-17-2-3-18-4-5-20(25(28)29)14-21(18)12-17;;;;;;/h2-9,12,14,23-24,27H,10-11,13,15H2,1H3,(H3,28,29)(H,31,32);1H;5*1H2/t23-,24-;;;;;;/m0....../s1 D0JH6W DRUGINKE LJCBAPRMNYSDOP-LVCYMWGESA-N D0JH6W DRUGSMIL CC(=N)N1CCC(C1)OC2=CC=C(C=C2)C(CC3=CC4=C(C=C3)C=CC(=C4)C(=N)N)C(=O)O.O.O.O.O.O.Cl D0JH6W HIGHSTAT Discontinued in Phase 2 D0K0VH DRUG__ID D0K0VH D0K0VH DRUGTYPE Small molecular drug D0K0VH DRUGINCH 1S/C25H31NO4S/c1-25(2)16-11-15(7-5-3-4-6-8-22(28)29)23(20(25)12-16)26-24(30)19-14-31-21-10-9-17(27)13-18(19)21/h3,5,9-10,13-16,20,23,27H,4,6-8,11-12H2,1-2H3,(H,26,30)(H,28,29)/b5-3-/t15-,16-,20-,23+/m0/s1 D0K0VH DRUGINKE ZXBHFWFKSIYJEK-MFJOXFORSA-N D0K0VH DRUGSMIL CC1(C2CC(C(C1C2)NC(=O)C3=CSC4=C3C=C(C=C4)O)CC=CCCCC(=O)O)C D0K0VH HIGHSTAT Discontinued in Phase 2 D0K1SZ DRUG__ID D0K1SZ D0K1SZ DRUGTYPE Small molecular drug D0K1SZ DRUGINCH 1S/C14H20ClN3O3/c1-20-12-6-10(16)9(15)5-8(12)14(19)18-11-3-4-17-7-13(11)21-2/h5-6,11,13,17H,3-4,7,16H2,1-2H3,(H,18,19) D0K1SZ DRUGINKE OMLDMGPCWMBPAN-UHFFFAOYSA-N D0K1SZ DRUGSMIL COC1CNCCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl D0K1SZ HIGHSTAT Discontinued in Phase 2 D0K2BQ DRUG__ID D0K2BQ D0K2BQ DRUGTYPE Small molecular drug D0K2BQ DRUGINCH 1S/C13H17N5O2/c14-12-15-9-10(16-12)17(5-7-1-2-7)13(20)18(11(9)19)6-8-3-4-8/h7-8H,1-6H2,(H3,14,15,16) D0K2BQ DRUGINKE KSPYMJJKQMWWNB-UHFFFAOYSA-N D0K2BQ DRUGSMIL C1CC1CN2C3=C(C(=O)N(C2=O)CC4CC4)NC(=N3)N D0K2BQ HIGHSTAT Discontinued in Phase 2 D0K2ER DRUG__ID D0K2ER D0K2ER DRUGTYPE Small molecular drug D0K2ER DRUGINCH 1S/C27H34ClNO2S/c1-17(2)19-10-13-22-21(14-19)24(32-26(3,4)5)23(15-27(6,7)25(30)31)29(22)16-18-8-11-20(28)12-9-18/h8-14,17H,15-16H2,1-7H3,(H,30,31) D0K2ER DRUGINKE QAOAOVKBIIKRNL-UHFFFAOYSA-N D0K2ER DRUGSMIL CC(C)C1=CC2=C(C=C1)N(C(=C2SC(C)(C)C)CC(C)(C)C(=O)O)CC3=CC=C(C=C3)Cl D0K2ER HIGHSTAT Discontinued in Phase 2 D0K2PH DRUG__ID D0K2PH D0K2PH DRUGTYPE Small molecular drug D0K2PH DRUGINCH 1S/C9H10FN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h1-3,5,7,14H,4H2,(H2,11,12,15)/t5-,7+/m1/s1 D0K2PH DRUGINKE HSBKFSPNDWWPSL-VDTYLAMSSA-N D0K2PH DRUGSMIL C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F D0K2PH HIGHSTAT Discontinued in Phase 2 D0K2QG DRUG__ID D0K2QG D0K2QG DRUGTYPE Small molecular drug D0K2QG DRUGINCH 1S/C22H28BrN5O5/c1-3-26-20(31)18-19(27(9-10-29)22(26)32)25-21(24-15-5-4-6-16(15)30)28(18)12-13-7-8-17(33-2)14(23)11-13/h7-8,11,15-16,29-30H,3-6,9-10,12H2,1-2H3,(H,24,25)/t15-,16-/m1/s1 D0K2QG DRUGINKE RCJYGWGQCPDYSL-HZPDHXFCSA-N D0K2QG DRUGSMIL CCN1C(=O)C2=C(N=C(N2CC3=CC(=C(C=C3)OC)Br)NC4CCCC4O)N(C1=O)CCO D0K2QG HIGHSTAT Discontinued in Phase 2 D0KX9Z DRUG__ID D0KX9Z D0KX9Z DRUGCOMP Servier D0KX9Z DRUGINCH 1S/C51H72N5O10P.H2O4S/c1-10-47(60)27-32-28-50(46(59)64-9,40-34(19-23-55(29-32)30-47)33-17-14-15-18-37(33)52-40)36-25-35-38(26-39(36)63-8)54(7)43-49(35)21-24-56-22-16-20-48(11-2,42(49)56)44(57)51(43,61)45(58)53-41(31(5)6)67(62,65-12-3)66-13-4;1-5(2,3)4/h14-18,20,25-26,31-32,41-44,52,57,60-61H,10-13,19,21-24,27-30H2,1-9H3,(H,53,58);(H2,1,2,3,4)/t32-,41+,42+,43-,44-,47+,48-,49-,50+,51+;/m1./s1 D0KX9Z DRUGINKE BZUUMJJIORUJAU-XFLWUYJZSA-N D0KX9Z DRUGSMIL CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)NC(C(C)C)P(=O)(OCC)OCC)O)O)CC)OC)C(=O)OC)O.OS(=O)(=O)O D0KX9Z HIGHSTAT Discontinued in Phase 2 D0L2IQ DRUG__ID D0L2IQ D0L2IQ DRUGTYPE Small molecular drug D0L2IQ DRUGINCH 1S/C23H25NO6S/c1-15(23(27)28-12-17-6-4-3-5-7-17)24-22(26)19(13-31-16(2)25)10-18-8-9-20-21(11-18)30-14-29-20/h3-9,11,15,19H,10,12-14H2,1-2H3,(H,24,26)/t15-,19+/m0/s1 D0L2IQ DRUGINKE KKBIUAUSZKGNOA-HNAYVOBHSA-N D0L2IQ DRUGSMIL CC(C(=O)OCC1=CC=CC=C1)NC(=O)C(CC2=CC3=C(C=C2)OCO3)CSC(=O)C D0L2IQ HIGHSTAT Discontinued in Phase 2 D0L8GO DRUG__ID D0L8GO D0L8GO DRUGTYPE Small molecular drug D0L8GO DRUGINCH 1S/C8H11N3O4/c12-5-1-2-6-15-7-10-4-3-9-8(10)11(13)14/h1-4,12H,5-7H2/b2-1+ D0L8GO DRUGINKE OGIXVTVGRBZYJM-OWOJBTEDSA-N D0L8GO DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])COCC=CCO D0L8GO HIGHSTAT Discontinued in Phase 2 D0LC2B DRUG__ID D0LC2B D0LC2B DRUGTYPE Small molecular drug D0LC2B DRUGINCH 1S/C17H19N3O2/c1-10-9-16(22)19-20-17(10)12-3-5-13(6-4-12)18-14-7-8-15(21)11(14)2/h3-6,10,18H,7-9H2,1-2H3,(H,19,22) D0LC2B DRUGINKE DSRIICXPBQXOKK-UHFFFAOYSA-N D0LC2B DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)NC3=C(C(=O)CC3)C D0LC2B HIGHSTAT Discontinued in Phase 2 D0LI3C DRUG__ID D0LI3C D0LI3C DRUGTYPE Small molecular drug D0LI3C DRUGINCH 1S/C35H43ClN2O8/c1-20(2)16-29-35(42)44-27(22(4)31-32(46-31)24-10-7-6-8-11-24)12-9-13-30(39)38-26(33(40)37-19-21(3)34(41)45-29)18-23-14-15-28(43-5)25(36)17-23/h6-11,13-15,17,20-22,26-27,29,31-32H,12,16,18-19H2,1-5H3,(H,37,40)(H,38,39)/b13-9+/t21-,22+,26-,27+,29+,31-,32-/m1/s1 D0LI3C DRUGINKE PSNOPSMXOBPNNV-VVCTWANISA-N D0LI3C DRUGSMIL CC1CNC(=O)C(NC(=O)C=CCC(OC(=O)C(OC1=O)CC(C)C)C(C)C2C(O2)C3=CC=CC=C3)CC4=CC(=C(C=C4)OC)Cl D0LI3C HIGHSTAT Discontinued in Phase 2 D0LK8O DRUG__ID D0LK8O D0LK8O DRUGTYPE Small molecular drug D0LK8O DRUGINCH 1S/C29H32N4/c1-22-13-15-26(16-14-22)29-30-23(2)27(31-29)21-32-17-19-33(20-18-32)28(24-9-5-3-6-10-24)25-11-7-4-8-12-25/h3-16,28H,17-21H2,1-2H3,(H,30,31) D0LK8O DRUGINKE HTDFEXRUDGWNHA-UHFFFAOYSA-N D0LK8O DRUGSMIL CC1=CC=C(C=C1)C2=NC(=C(N2)C)CN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5 D0LK8O HIGHSTAT Discontinued in Phase 2 D0LL9K DRUG__ID D0LL9K D0LL9K DRUGTYPE Small molecular drug D0LL9K DRUGINCH 1S/C28H33F2N5O5/c1-39-17-23-24(26(36)40-2)25(19-7-8-20(29)21(30)16-19)35(28(38)33-23)27(37)32-12-5-13-34-14-9-18(10-15-34)22-6-3-4-11-31-22/h3-4,6-8,11,16,18,25H,5,9-10,12-15,17H2,1-2H3,(H,32,37)(H,33,38)/t25-/m0/s1 D0LL9K DRUGINKE FFXFCSQUTLDLAR-VWLOTQADSA-N D0LL9K DRUGSMIL COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)C3=CC=CC=N3)C4=CC(=C(C=C4)F)F)C(=O)OC D0LL9K HIGHSTAT Discontinued in Phase 2 D0M0RN DRUG__ID D0M0RN D0M0RN DRUGTYPE Small molecular drug D0M0RN DRUGINCH 1S/C20H29NO4S2/c1-5-25-20(24)18(10-11-26-4)21-19(23)17(13-27-15(3)22)12-16-9-7-6-8-14(16)2/h6-9,17-18H,5,10-13H2,1-4H3,(H,21,23)/t17-,18+/m1/s1 D0M0RN DRUGINKE ZVQXPUMRSJGLSF-MSOLQXFVSA-N D0M0RN DRUGSMIL CCOC(=O)C(CCSC)NC(=O)C(CC1=CC=CC=C1C)CSC(=O)C D0M0RN HIGHSTAT Discontinued in Phase 2 D0M0VN DRUG__ID D0M0VN D0M0VN DRUGTYPE Small molecular drug D0M0VN DRUGINCH 1S/C32H28N6O8.2CH4O3S/c1-17(35-29(39)23-7-3-5-19-11-21(37(43)44)13-25(27(19)23)31(35)41)15-33-9-10-34-16-18(2)36-30(40)24-8-4-6-20-12-22(38(45)46)14-26(28(20)24)32(36)42;2*1-5(2,3)4/h3-8,11-14,17-18,33-34H,9-10,15-16H2,1-2H3;2*1H3,(H,2,3,4)/t17-,18-;;/m1../s1 D0M0VN DRUGINKE KPQJSSLKKBKWEW-RKDOVGOJSA-N D0M0VN DRUGSMIL CC(CNCCNCC(C)N1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)[N+](=O)[O-])N4C(=O)C5=CC=CC6=CC(=CC(=C65)C4=O)[N+](=O)[O-].CS(=O)(=O)O.CS(=O)(=O)O D0M0VN HIGHSTAT Discontinued in Phase 2 D0M4LW DRUG__ID D0M4LW D0M4LW DRUGTYPE Small molecular drug D0M4LW DRUGINCH 1S/C54H67N11O9S2/c1-32(66)46-54(74)63-43(27-35-19-9-4-10-20-35)52(72)64-45(47(57)67)31-76-75-30-38(56)48(68)60-41(25-33-15-5-2-6-16-33)50(70)61-42(26-34-17-7-3-8-18-34)51(71)62-44(28-36-29-58-39-22-12-11-21-37(36)39)53(73)59-40(49(69)65-46)23-13-14-24-55/h2-12,15-22,29,32,38,40-46,58,66H,13-14,23-28,30-31,55-56H2,1H3,(H2,57,67)(H,59,73)(H,60,68)(H,61,70)(H,62,71)(H,63,74)(H,64,72)(H,65,69)/t32-,38+,40+,41+,42+,43+,44-,45+,46+/m1/s1 D0M4LW DRUGINKE JNMPZUZCPFIJGJ-OCZUONHDSA-N D0M4LW DRUGSMIL CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)N)C(=O)N)CC6=CC=CC=C6)O D0M4LW HIGHSTAT Discontinued in Phase 2 D0ML9K DRUG__ID D0ML9K D0ML9K DRUGTYPE Small molecular drug D0ML9K DRUGINCH 1S/C32H55FN3O9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-30(37)45-27-23-29(35-24-26(33)31(38)34-32(35)39)44-28(27)25-43-46(40,41)42-22-21-36(2,3)4/h12-13,24,27-29H,5-11,14-23,25H2,1-4H3,(H-,34,38,39,40,41)/b13-12+ D0ML9K DRUGINKE JLGWAGKPIWGUEH-OUKQBFOZSA-N D0ML9K DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OC1CC(OC1COP(=O)([O-])OCC[N+](C)(C)C)N2C=C(C(=O)NC2=O)F D0ML9K HIGHSTAT Discontinued in Phase 2 D0N1EC DRUG__ID D0N1EC D0N1EC DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D0N1EC DRUGINCH 1S/C14H13N3O2S/c1-19-11-4-2-3-10(7-11)9-20(18)14-16-12-5-6-15-8-13(12)17-14/h2-8H,9H2,1H3,(H,16,17) D0N1EC DRUGINKE SWPJMIZLPONDGF-UHFFFAOYSA-N D0N1EC DRUGSMIL COC1=CC=CC(=C1)CS(=O)C2=NC3=C(N2)C=NC=C3 D0N1EC HIGHSTAT Discontinued in Phase 2 D0N4OZ DRUG__ID D0N4OZ D0N4OZ DRUGTYPE Small molecular drug D0N4OZ DRUGINCH 1S/C27H41NO5S/c1-16-9-8-10-17(2)25(31)19(4)26(32)27(6,7)23(29)14-24(30)33-22(12-11-16)18(3)13-21-15-34-20(5)28-21/h11,13,15,17,19,22-23,25,29,31H,8-10,12,14H2,1-7H3/b16-11-,18-13+/t17-,19+,22-,23-,25-/m0/s1 D0N4OZ DRUGINKE XOZIUKBZLSUILX-GIQCAXHBSA-N D0N4OZ DRUGSMIL CC1CCCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=CSC(=N2)C)C)C D0N4OZ HIGHSTAT Discontinued in Phase 2 D0N5JJ DRUG__ID D0N5JJ D0N5JJ DRUGTYPE Small molecular drug D0N5JJ DRUGINCH 1S/C22H25NO4S.ClH/c1-4-5-15-9-17-21(28-15)11-23-18-7-6-14-8-19(26-12(2)24)20(27-13(3)25)10-16(14)22(17)18;/h8-10,18,22-23H,4-7,11H2,1-3H3;1H/t18-,22+;/m1./s1 D0N5JJ DRUGINKE NPEZSCRKHFTLPE-MYXGOWFTSA-N D0N5JJ DRUGSMIL CCCC1=CC2=C(S1)CNC3C2C4=CC(=C(C=C4CC3)OC(=O)C)OC(=O)C.Cl D0N5JJ HIGHSTAT Discontinued in Phase 2 D0N6PV DRUG__ID D0N6PV D0N6PV DRUGTYPE Small molecular drug D0N6PV DRUGINCH 1S/C34H47N9O12S3/c1-16(44)38-22-13-57-58-14-23(33(54)55)42-29(50)20(10-26(47)48)39-25(46)12-37-28(49)19(8-17-4-6-18(11-35)7-5-17)40-31(52)27-34(2,3)56-15-43(27)32(53)21(9-24(36)45)41-30(22)51/h4-7,19-23,27H,8-15,35H2,1-3H3,(H2,36,45)(H,37,49)(H,38,44)(H,39,46)(H,40,52)(H,41,51)(H,42,50)(H,47,48)(H,54,55)/t19?,20-,21-,22+,23+,27-/m0/s1 D0N6PV DRUGINKE IHTQUFFCUYSOIH-JUXWROAHSA-N D0N6PV DRUGSMIL CC(=O)NC1CSSCC(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C2C(SCN2C(=O)C(NC1=O)CC(=O)N)(C)C)CC3=CC=C(C=C3)CN)CC(=O)O)C(=O)O D0N6PV HIGHSTAT Discontinued in Phase 2 D0N8NC DRUG__ID D0N8NC D0N8NC DRUGTYPE Small molecular drug D0N8NC DRUGINCH 1S/C25H26N2O.CH4O3S/c26-16-19-9-10-25-23(15-19)21-12-14-27(17-18-5-1-2-6-18)13-11-20(21)22-7-3-4-8-24(22)28-25;1-5(2,3)4/h3-4,7-10,15,18H,1-2,5-6,11-14,17H2;1H3,(H,2,3,4) D0N8NC DRUGINKE PDYLRPIUJQGVNY-UHFFFAOYSA-N D0N8NC DRUGSMIL CS(=O)(=O)O.C1CCC(C1)CN2CCC3=C(CC2)C4=C(C=CC(=C4)C#N)OC5=CC=CC=C35 D0N8NC HIGHSTAT Discontinued in Phase 2 D0N8QQ DRUG__ID D0N8QQ D0N8QQ DRUGTYPE Small molecular drug D0N8QQ DRUGINCH 1S/C12H17N3O3S/c1-7(2)9-5-4-8(11(16)15-12(13)14)6-10(9)19(3,17)18/h4-7H,1-3H3,(H4,13,14,15,16) D0N8QQ DRUGINKE IWXNYAIICFKCTM-UHFFFAOYSA-N D0N8QQ DRUGSMIL CC(C)C1=C(C=C(C=C1)C(=O)N=C(N)N)S(=O)(=O)C D0N8QQ HIGHSTAT Discontinued in Phase 2 D0N9WB DRUG__ID D0N9WB D0N9WB DRUGTYPE Small molecular drug D0N9WB DRUGINCH 1S/C22H28N6O4.ClH/c23-19(30)17-8-4-12-28(17)21(32)16(7-3-11-26-22(24)25)27-20(31)15-10-9-13-5-1-2-6-14(13)18(15)29;/h1-2,5-6,9-10,16-17,29H,3-4,7-8,11-12H2,(H2,23,30)(H,27,31)(H4,24,25,26);1H/t16-,17-;/m0./s1 D0N9WB DRUGINKE IZLPTTJTHFFFJF-QJHJCNPRSA-N D0N9WB DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C2=C(C3=CC=CC=C3C=C2)O)C(=O)N.Cl D0N9WB HIGHSTAT Discontinued in Phase 2 D0O0AH DRUG__ID D0O0AH D0O0AH DRUGTYPE Small molecular drug D0O0AH DRUGINCH 1S/C22H24N4O2.ClH/c27-22(20-7-4-16-28-20)26(21-17-23-11-12-24-21)19-9-14-25(15-10-19)13-8-18-5-2-1-3-6-18;/h1-7,11-12,16-17,19H,8-10,13-15H2;1H D0O0AH DRUGINKE KVCOVXMNIYUKBS-UHFFFAOYSA-N D0O0AH DRUGSMIL C1CN(CCC1N(C2=NC=CN=C2)C(=O)C3=CC=CO3)CCC4=CC=CC=C4.Cl D0O0AH HIGHSTAT Discontinued in Phase 2 D0O1MP DRUG__ID D0O1MP D0O1MP DRUGTYPE Small molecular drug D0O1MP DRUGINCH 1S/C41H37ClN6O5/c1-4-47(5-2)29-13-11-24-17-35(52-33(24)18-29)39(49)44-28-12-14-30-25(15-28)16-31(46-30)40(50)48-22-26(20-42)37-32(48)19-34(38-36(37)23(3)21-43-38)53-41(51)45-27-9-7-6-8-10-27/h6-19,21,26,43,46H,4-5,20,22H2,1-3H3,(H,44,49)(H,45,51)/t26-/m1/s1 D0O1MP DRUGINKE BBZDXMBRAFTCAA-AREMUKBSSA-N D0O1MP DRUGSMIL CCN(CC)C1=CC2=C(C=C1)C=C(O2)C(=O)NC3=CC4=C(C=C3)NC(=C4)C(=O)N5CC(C6=C7C(=CNC7=C(C=C65)OC(=O)NC8=CC=CC=C8)C)CCl D0O1MP HIGHSTAT Discontinued in Phase 2 D0O2ET DRUG__ID D0O2ET D0O2ET DRUGTYPE Small molecular drug D0O2ET DRUGINCH 1S/C16H21NO3S/c1-9(2)11-6-5-7-12-15(11)20-14(10(3)4)16(21)17(12)8-13(18)19/h5-7,9-10,14H,8H2,1-4H3,(H,18,19) D0O2ET DRUGINKE CLDJCRWXLDLJLO-UHFFFAOYSA-N D0O2ET DRUGSMIL CC(C)C1C(=S)N(C2=CC=CC(=C2O1)C(C)C)CC(=O)O D0O2ET HIGHSTAT Discontinued in Phase 2 D0O4LU DRUG__ID D0O4LU D0O4LU DRUGCOMP Sanwa Kagaku Kenkyusho Co Ltd D0O4LU DRUGINCH 1S/C125H197N35O37/c1-10-67(8)101(158-119(192)90-32-23-54-160(90)122(195)100(66(6)7)157-103(176)73(128)58-69-24-13-11-14-25-69)120(193)156-88(59-70-26-15-12-16-27-70)118(191)159-102(68(9)162)121(194)155-87(60-71-33-35-72(163)36-34-71)105(178)140-63-96(169)142-79(40-46-97(170)171)110(183)153-86(57-65(4)5)116(189)149-80(38-44-92(130)165)111(184)145-76(30-21-52-137-124(133)134)107(180)152-85(56-64(2)3)115(188)150-81(39-45-93(131)166)112(185)148-83(42-48-99(174)175)113(186)144-75(29-18-20-51-127)106(179)147-82(41-47-98(172)173)114(187)146-77(31-22-53-138-125(135)136)108(181)154-89(61-94(132)167)117(190)143-74(28-17-19-50-126)104(177)139-62-95(168)141-78(37-43-91(129)164)109(182)151-84(49-55-161)123(196)197/h11-16,24-27,33-36,64-68,73-90,100-102,161-163H,10,17-23,28-32,37-63,126-128H2,1-9H3,(H2,129,164)(H2,130,165)(H2,131,166)(H2,132,167)(H,139,177)(H,140,178)(H,141,168)(H,142,169)(H,143,190)(H,144,186)(H,145,184)(H,146,187)(H,147,179)(H,148,185)(H,149,189)(H,150,188)(H,151,182)(H,152,180)(H,153,183)(H,154,181)(H,155,194)(H,156,193)(H,157,176)(H,158,192)(H,159,191)(H,170,171)(H,172,173)(H,174,175)(H,196,197)(H4,133,134,137)(H4,135,136,138)/t67-,68+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,100-,101-,102-/m0/s1 D0O4LU DRUGINKE MQCKZUPRTHWQQQ-IOQNLEIOSA-N D0O4LU DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CCO)C(=O)O)NC(=O)C3CCCN3C(=O)C(C(C)C)NC(=O)C(CC4=CC=CC=C4)N D0O4LU HIGHSTAT Discontinued in Phase 2 D0O6AQ DRUG__ID D0O6AQ D0O6AQ DRUGTYPE Small molecular drug D0O6AQ DRUGINCH 1S/C18H12Cl2N2O3/c19-10-8-13(20)16-12(17(18(24)25)22-14(16)9-10)6-7-15(23)21-11-4-2-1-3-5-11/h1-9,22H,(H,21,23)(H,24,25)/b7-6+ D0O6AQ DRUGINKE WZBNEZWCNKUOSM-VOTSOKGWSA-N D0O6AQ DRUGSMIL C1=CC=C(C=C1)NC(=O)C=CC2=C(NC3=C2C(=CC(=C3)Cl)Cl)C(=O)O D0O6AQ HIGHSTAT Discontinued in Phase 2 D0O7DZ DRUG__ID D0O7DZ D0O7DZ DRUGTYPE Small molecular drug D0O7DZ DRUGINCH 1S/C16H20N4O/c1-13-4-3-5-14(12-13)19-8-10-20(11-9-19)15-6-7-16(21-2)18-17-15/h3-7,12H,8-11H2,1-2H3 D0O7DZ DRUGINKE DDOAUTHWSCUHQA-UHFFFAOYSA-N D0O7DZ DRUGSMIL CC1=CC(=CC=C1)N2CCN(CC2)C3=NN=C(C=C3)OC D0O7DZ HIGHSTAT Discontinued in Phase 2 D0O8LW DRUG__ID D0O8LW D0O8LW DRUGTYPE Small molecular drug D0O8LW DRUGINCH 1S/C15H10O6.ClH.H2O/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7;;/h1-6H,(H4-,16,17,18,19,20);1H;1H2 D0O8LW DRUGINKE ROFFNEFHTNKURQ-UHFFFAOYSA-N D0O8LW DRUGSMIL C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O)O.O.[Cl-] D0O8LW HIGHSTAT Discontinued in Phase 2 D0OQ3L DRUG__ID D0OQ3L D0OQ3L DRUGTYPE Small molecular drug D0OQ3L DRUGINCH 1S/C24H24FN5O2S/c25-17-1-2-18-16(13-23(32)30(15-22(26)31)20(18)14-17)4-7-28-8-10-29(11-9-28)24-19-5-12-33-21(19)3-6-27-24/h1-3,5-6,12-14H,4,7-11,15H2,(H2,26,31) D0OQ3L DRUGINKE JDLYOFUDIKMYBL-UHFFFAOYSA-N D0OQ3L DRUGSMIL C1CN(CCN1CCC2=CC(=O)N(C3=C2C=CC(=C3)F)CC(=O)N)C4=NC=CC5=C4C=CS5 D0OQ3L HIGHSTAT Discontinued in Phase 2 D0P3KA DRUG__ID D0P3KA D0P3KA DRUGTYPE Small molecular drug D0P3KA DRUGINCH 1S/C20H28O2/c1-8-9-10-11-17(21)14-12-15(19(2,3)4)18(22)16(13-14)20(5,6)7/h1,12-13,22H,9-11H2,2-7H3 D0P3KA DRUGINKE ZHXUEUKVDMWSKV-UHFFFAOYSA-N D0P3KA DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)CCCC#C D0P3KA HIGHSTAT Discontinued in Phase 2 D0P3TF DRUG__ID D0P3TF D0P3TF DRUGCOMP Tamarkin Pharmaceutical Innovation Ltd D0P3TF DRUGINCH 1S/C27H32O8/c1-3-32-26(30)20-14-10-12-16-22(20)34-24(28)18-8-6-5-7-9-19-25(29)35-23-17-13-11-15-21(23)27(31)33-4-2/h10-17H,3-9,18-19H2,1-2H3 D0P3TF DRUGINKE LIBAUACOIKWWKP-UHFFFAOYSA-N D0P3TF DRUGSMIL CCOC(=O)C1=CC=CC=C1OC(=O)CCCCCCCC(=O)OC2=CC=CC=C2C(=O)OCC D0P3TF HIGHSTAT Discontinued in Phase 2 D0P4IK DRUG__ID D0P4IK D0P4IK DRUGTYPE Small molecular drug D0P4IK DRUGINCH 1S/C26H33F3N4O7.Na/c1-13(2)19(21(36)26(27,28)29)31-24(39)17-6-5-11-33(17)25(40)20(14(3)4)32-23(38)16-9-7-15(8-10-16)22(37)30-12-18(34)35;/h7-10,13-14,17,19-20H,5-6,11-12H2,1-4H3,(H,30,37)(H,31,39)(H,32,38)(H,34,35);/q;+1/p-1/t17-,19?,20-;/m0./s1 D0P4IK DRUGINKE DNTYCMNNMGACPR-JSAITXCESA-M D0P4IK DRUGSMIL CC(C)C(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C2=CC=C(C=C2)C(=O)NCC(=O)[O-].[Na+] D0P4IK HIGHSTAT Discontinued in Phase 2 D0PW0G DRUG__ID D0PW0G D0PW0G DRUGCOMP Roche D0PW0G DRUGINCH 1S/C30H32Cl3N3O4/c1-4-36(5-2)16-17-40-30(39)25(35-28(37)26-19(3)8-6-9-22(26)31)18-20-12-14-21(15-13-20)34-29(38)27-23(32)10-7-11-24(27)33/h6-15,25H,4-5,16-18H2,1-3H3,(H,34,38)(H,35,37)/t25-/m0/s1 D0PW0G DRUGINKE VZVNFRFMDNFPOM-VWLOTQADSA-N D0PW0G DRUGSMIL CCN(CC)CCOC(=O)C(CC1=CC=C(C=C1)NC(=O)C2=C(C=CC=C2Cl)Cl)NC(=O)C3=C(C=CC=C3Cl)C D0PW0G HIGHSTAT Discontinued in Phase 2 D0Q0YN DRUG__ID D0Q0YN D0Q0YN DRUGTYPE Small molecular drug D0Q0YN DRUGINCH 1S/C21H25N3O3/c1-13-14(2)24-10-9-16-18(21(24)22-13)23-17(15-7-5-4-6-8-15)19(25)20(16)27-12-11-26-3/h4-10,17,19-20,23,25H,11-12H2,1-3H3/t17-,19-,20-/m1/s1 D0Q0YN DRUGINKE PWILYDZRJORZDR-MISYRCLQSA-N D0Q0YN DRUGSMIL CC1=C(N2C=CC3=C(C2=N1)NC(C(C3OCCOC)O)C4=CC=CC=C4)C D0Q0YN HIGHSTAT Discontinued in Phase 2 D0Q1HG DRUG__ID D0Q1HG D0Q1HG DRUGCOMP Bristol-Myers Squibb Co D0Q1HG DRUGINCH 1S/C19H17N7O10S2/c1-6-13(17(30)26(6)38(33,34)35)24-16(29)14(10-5-37-19(20)23-10)25-36-4-9-15(18(31)32)22-8-3-12(28)11(27)2-7(8)21-9/h2-3,5-6,13,27-28H,4H2,1H3,(H2,20,23)(H,24,29)(H,31,32)(H,33,34,35)/b25-14-/t6-,13+/m1/s1 D0Q1HG DRUGINKE FAUHVXXXXAHABE-VHLYPECSSA-N D0Q1HG DRUGSMIL CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOCC2=NC3=CC(=C(C=C3N=C2C(=O)O)O)O)C4=CSC(=N4)N D0Q1HG HIGHSTAT Discontinued in Phase 2 D0Q1KP DRUG__ID D0Q1KP D0Q1KP DRUGCOMP Janssen Pharmaceutica NV D0Q1KP DRUGINCH 1S/C14H11Cl2N3O3/c15-8-4-3-5-9(16)12(8)13(14(17)20)18-10-6-1-2-7-11(10)19(21)22/h1-7,13,18H,(H2,17,20) D0Q1KP DRUGINKE BSFPWNBIKBSHRL-UHFFFAOYSA-N D0Q1KP DRUGSMIL C1=CC=C(C(=C1)NC(C2=C(C=CC=C2Cl)Cl)C(=O)N)[N+](=O)[O-] D0Q1KP HIGHSTAT Discontinued in Phase 2 D0Q8UU DRUG__ID D0Q8UU D0Q8UU DRUGTYPE Small molecular drug D0Q8UU DRUGINCH 1S/C18H25Cl3O2/c19-16-12-10-15(11-13-16)9-7-5-3-1-2-4-6-8-14-18(20,21)17(22)23/h10-13H,1-9,14H2,(H,22,23) D0Q8UU DRUGINKE GPCJDSXBRMKASP-UHFFFAOYSA-N D0Q8UU DRUGSMIL C1=CC(=CC=C1CCCCCCCCCCC(C(=O)O)(Cl)Cl)Cl D0Q8UU HIGHSTAT Discontinued in Phase 2 D0R0EV DRUG__ID D0R0EV D0R0EV DRUGTYPE Small molecular drug D0R0EV DRUGINCH 1S/C23H22ClN5OS/c1-12-21-27-26-13(2)29(21)23-19(20(25-12)15-5-3-4-6-17(15)24)16-9-10-28(11-18(16)31-23)22(30)14-7-8-14/h3-6,12,14H,7-11H2,1-2H3/t12-/m0/s1 D0R0EV DRUGINKE JEQVYSUCZLYBRQ-LBPRGKRZSA-N D0R0EV DRUGSMIL CC1C2=NN=C(N2C3=C(C4=C(S3)CN(CC4)C(=O)C5CC5)C(=N1)C6=CC=CC=C6Cl)C D0R0EV HIGHSTAT Discontinued in Phase 2 D0R0TF DRUG__ID D0R0TF D0R0TF DRUGTYPE Small molecular drug D0R0TF DRUGINCH 1S/C26H23ClN6O2S/c1-15-30-31-22-13-28-24(18-5-3-4-6-20(18)27)23-19-11-12-32(14-21(19)36-25(23)33(15)22)26(34)29-16-7-9-17(35-2)10-8-16/h3-10H,11-14H2,1-2H3,(H,29,34) D0R0TF DRUGINKE DDJKTQDAEYPACV-UHFFFAOYSA-N D0R0TF DRUGSMIL CC1=NN=C2N1C3=C(C4=C(S3)CN(CC4)C(=O)NC5=CC=C(C=C5)OC)C(=NC2)C6=CC=CC=C6Cl D0R0TF HIGHSTAT Discontinued in Phase 2 D0R1LT DRUG__ID D0R1LT D0R1LT DRUGTYPE Small molecular drug D0R1LT DRUGINCH 1S/C23H29NO3S.ClH/c1-4-7-11-19-22(17-10-8-9-12-18(17)27-19)23(25)20-13-14-21(28-20)26-16-15-24(5-2)6-3;/h8-10,12-14H,4-7,11,15-16H2,1-3H3;1H D0R1LT DRUGINKE CNLJBVCZDLFMKQ-UHFFFAOYSA-N D0R1LT DRUGSMIL CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(S3)OCCN(CC)CC.Cl D0R1LT HIGHSTAT Discontinued in Phase 2 D0R2CM DRUG__ID D0R2CM D0R2CM DRUGTYPE Small molecular drug D0R2CM DRUGINCH 1S/C21H17ClN2.ClH/c22-18-13-11-17(12-14-18)21-23-19(15-7-3-1-4-8-15)20(24-21)16-9-5-2-6-10-16;/h1-14,19-20H,(H,23,24);1H/t19-,20+; D0R2CM DRUGINKE BRBLXQRJSVLYHU-AMDBCLDASA-N D0R2CM DRUGSMIL C1=CC=C(C=C1)C2C(N=C(N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.Cl D0R2CM HIGHSTAT Discontinued in Phase 2 D0R3WG DRUG__ID D0R3WG D0R3WG DRUGTYPE Small molecular drug D0R3WG DRUGINCH 1S/C15H24FNSi.ClH/c1-18(2,13-17-10-4-3-5-11-17)12-14-6-8-15(16)9-7-14;/h6-9H,3-5,10-13H2,1-2H3;1H D0R3WG DRUGINKE VGKGHWXDGBFJTP-UHFFFAOYSA-N D0R3WG DRUGSMIL C[Si](C)(CC1=CC=C(C=C1)F)CN2CCCCC2.Cl D0R3WG HIGHSTAT Discontinued in Phase 2 D0R5QQ DRUG__ID D0R5QQ D0R5QQ DRUGCOMP Genfit SA D0R5QQ DRUGINCH 1S/C22H23NO5/c1-16-7-5-10-18(20(16)22(24)25)13-26-11-6-12-27-14-19-15-28-21(23-19)17-8-3-2-4-9-17/h2-5,7-10,15H,6,11-14H2,1H3,(H,24,25) D0R5QQ DRUGINKE WLHOBCUVPMOXAT-UHFFFAOYSA-N D0R5QQ DRUGSMIL CC1=C(C(=CC=C1)COCCCOCC2=COC(=N2)C3=CC=CC=C3)C(=O)O D0R5QQ HIGHSTAT Discontinued in Phase 2 D0RL4M DRUG__ID D0RL4M D0RL4M DRUGTYPE Small molecular drug D0RL4M DRUGINCH 1S/C26H19FN4O2/c27-19-10-3-2-8-17(19)22-18-9-5-7-15-12-13-31(23(15)18)26(33)24(29-22)30-25(32)21-14-16-6-1-4-11-20(16)28-21/h1-11,14,24,28H,12-13H2,(H,30,32)/t24-/m1/s1 D0RL4M DRUGINKE WKJDXKWFGJWGAS-XMMPIXPASA-N D0RL4M DRUGSMIL C1CN2C(=O)C(N=C(C3=CC=CC1=C32)C4=CC=CC=C4F)NC(=O)C5=CC6=CC=CC=C6N5 D0RL4M HIGHSTAT Discontinued in Phase 2 D0S3RB DRUG__ID D0S3RB D0S3RB DRUGTYPE Small molecular drug D0S3RB DRUGINCH 1S/C22H32N4O4/c27-20(6-5-16-7-10-23-11-8-16)26-12-2-4-18(15-26)22(30)25-19(13-21(28)29)17-3-1-9-24-14-17/h1,3,9,14,16,18-19,23H,2,4-8,10-13,15H2,(H,25,30)(H,28,29)/t18-,19+/m1/s1 D0S3RB DRUGINKE ABNXKGFLZFSILK-MOPGFXCFSA-N D0S3RB DRUGSMIL C1CC(CN(C1)C(=O)CCC2CCNCC2)C(=O)NC(CC(=O)O)C3=CN=CC=C3 D0S3RB HIGHSTAT Discontinued in Phase 2 D0S5FQ DRUG__ID D0S5FQ D0S5FQ DRUGTYPE Small molecular drug D0S5FQ DRUGINCH 1S/C10H11ClO3/c1-6-5-8(11)3-4-9(6)14-7(2)10(12)13/h3-5,7H,1-2H3,(H,12,13) D0S5FQ DRUGINKE WNTGYJSOUMFZEP-UHFFFAOYSA-N D0S5FQ DRUGSMIL CC1=C(C=CC(=C1)Cl)OC(C)C(=O)O D0S5FQ HIGHSTAT Discontinued in Phase 2 D0S5ZJ DRUG__ID D0S5ZJ D0S5ZJ DRUGTYPE Small molecular drug D0S5ZJ DRUGINCH 1S/C26H36N2O3.C4H4O4/c1-16(2)28-15-17-13-24-22(21-6-5-7-23(28)25(17)21)12-18(14-27(24)3)26(29)31-20-10-8-19(30-4)9-11-20;5-3(6)1-2-4(7)8/h5-7,15-16,18-20,22,24H,8-14H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t18-,19?,20?,22-,24-;/m1./s1 D0S5ZJ DRUGINKE AWRYUNKJBYLYFR-VRUJKGOYSA-N D0S5ZJ DRUGSMIL CC(C)N1C=C2CC3C(CC(CN3C)C(=O)OC4CCC(CC4)OC)C5=C2C1=CC=C5.C(=CC(=O)O)C(=O)O D0S5ZJ HIGHSTAT Discontinued in Phase 2 D0SU1F DRUG__ID D0SU1F D0SU1F DRUGTYPE Small molecular drug D0SU1F DRUGINCH 1S/C16H23N3O2S/c1-17-22(20,21)11-12-5-6-16-15(8-12)13(10-18-16)9-14-4-3-7-19(14)2/h5-6,8,10,14,17-18H,3-4,7,9,11H2,1-2H3/t14-/m1/s1 D0SU1F DRUGINKE BWQZTHPHLITOOZ-CQSZACIVSA-N D0SU1F DRUGSMIL CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CC3CCCN3C D0SU1F HIGHSTAT Discontinued in Phase 2 D0SW2H DRUG__ID D0SW2H D0SW2H DRUGCOMP Takeda Pharmaceutical Co Ltd D0SW2H DRUGINCH 1S/C24H28NO7PS/c1-4-31-33(28,32-5-2)13-16-6-8-18(9-7-16)25-24(27)22-11-17-10-20-21(30-14-29-20)12-19(17)23(26)15(3)34-22/h6-10,12,15,22H,4-5,11,13-14H2,1-3H3,(H,25,27)/t15-,22+/m0/s1 D0SW2H DRUGINKE WXACSCNLLDFZHE-OYHNWAKOSA-N D0SW2H DRUGSMIL CCOP(=O)(CC1=CC=C(C=C1)NC(=O)C2CC3=CC4=C(C=C3C(=O)C(S2)C)OCO4)OCC D0SW2H HIGHSTAT Discontinued in Phase 2 D0SX4K DRUG__ID D0SX4K D0SX4K DRUGTYPE Small molecular drug D0SX4K DRUGINCH 1S/C15H13F3N2O2/c1-8-6-10(4-5-12(8)15(16,17)18)20-14(22)11(7-19)13(21)9-2-3-9/h4-6,9,21H,2-3H2,1H3,(H,20,22) D0SX4K DRUGINKE GDHFOVCRYCPOTK-UHFFFAOYSA-N D0SX4K DRUGSMIL CC1=C(C=CC(=C1)NC(=O)C(=C(C2CC2)O)C#N)C(F)(F)F D0SX4K HIGHSTAT Discontinued in Phase 2 D0SX7F DRUG__ID D0SX7F D0SX7F DRUGTYPE Small molecular drug D0SX7F DRUGINCH 1S/C22H24ClN3O2S/c23-18-3-1-17(2-4-18)9-10-22(15-26-12-11-25-16-26)27-13-20(28-22)14-29-21-7-5-19(24)6-8-21/h1-8,11-12,16,20H,9-10,13-15,24H2/t20-,22-/m0/s1 D0SX7F DRUGINKE VYNIUBZKEWJOJP-UNMCSNQZSA-N D0SX7F DRUGSMIL C1C(OC(O1)(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)CSC4=CC=C(C=C4)N D0SX7F HIGHSTAT Discontinued in Phase 2 D0T2EP DRUG__ID D0T2EP D0T2EP DRUGTYPE Small molecular drug D0T2EP DRUGINCH 1S/C8H8ClN5OS/c9-1-2-10-8(15)16-7-5-6(12-3-11-5)13-4-14-7/h3-4H,1-2H2,(H,10,15)(H,11,12,13,14) D0T2EP DRUGINKE OQBORDVFGPUGDV-UHFFFAOYSA-N D0T2EP DRUGSMIL C1=NC2=C(N1)C(=NC=N2)SC(=O)NCCCl D0T2EP HIGHSTAT Discontinued in Phase 2 D0T3ZL DRUG__ID D0T3ZL D0T3ZL DRUGCOMP Cyclis Pharmaceuticals D0T3ZL DRUGINCH 1S/C102H193N2O21P/c1-7-13-19-25-31-37-40-42-43-45-48-54-60-65-71-77-92(109)120-85(74-68-62-56-50-35-29-23-17-11-5)80-90(107)104-96-100(124-94(111)81-86(75-69-63-57-51-36-30-24-18-12-6)121-93(110)78-72-66-58-52-46-39-33-27-21-15-9-3)99(125-126(115,116)117)87(82-105)123-102(96)118-83-88-97(112)98(113)95(101(114)122-88)103-89(106)79-84(73-67-61-55-49-34-28-22-16-10-4)119-91(108)76-70-64-59-53-47-44-41-38-32-26-20-14-8-2/h84-88,95-102,105,112-114H,7-83H2,1-6H3,(H,103,106)(H,104,107)(H2,115,116,117)/t84-,85-,86-,87-,88-,95-,96-,97-,98-,99-,100-,101?,102-/m1/s1 D0T3ZL DRUGINKE JWBXGVSYUHYUJY-MOYMLGNLSA-N D0T3ZL DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCCCC)CC(=O)NC1C(C(C(OC1OCC2C(C(C(C(O2)O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)O)O)CO)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC D0T3ZL HIGHSTAT Discontinued in Phase 2 D0T5GT DRUG__ID D0T5GT D0T5GT DRUGTYPE Small molecular drug D0T5GT DRUGINCH 1S/C36H42O12S2.2Na/c1-33(2,29(37)38)21-49(43,44)27-17-13-25(14-18-27)47-31(41)35(5,6)23-9-11-24(12-10-23)36(7,8)32(42)48-26-15-19-28(20-16-26)50(45,46)22-34(3,4)30(39)40;;/h9-20H,21-22H2,1-8H3,(H,37,38)(H,39,40);;/q;2*+1/p-2 D0T5GT DRUGINKE HTARXGMNANKUGQ-UHFFFAOYSA-L D0T5GT DRUGSMIL CC(C)(CS(=O)(=O)C1=CC=C(C=C1)OC(=O)C(C)(C)C2=CC=C(C=C2)C(C)(C)C(=O)OC3=CC=C(C=C3)S(=O)(=O)CC(C)(C)C(=O)[O-])C(=O)[O-].[Na+].[Na+] D0T5GT HIGHSTAT Discontinued in Phase 2 D0T9HG DRUG__ID D0T9HG D0T9HG DRUGTYPE Small molecular drug D0T9HG DRUGINCH 1S/C20H28N4O4/c1-12(2)8-13(10-18(25)24-28)19(26)23-17(20(27)21-3)9-14-11-22-16-7-5-4-6-15(14)16/h4-7,11-13,17,22,28H,8-10H2,1-3H3,(H,21,27)(H,23,26)(H,24,25)/t13-,17+/m1/s1 D0T9HG DRUGINKE NITYDPDXAAFEIT-DYVFJYSZSA-N D0T9HG DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC D0T9HG HIGHSTAT Discontinued in Phase 2 D0TM0C DRUG__ID D0TM0C D0TM0C DRUGTYPE Small molecular drug D0TM0C DRUGINCH 1S/C8H13NO3S2/c1-8(2)4-14-13-3-5(6(10)11)9-7(8)12/h5H,3-4H2,1-2H3,(H,9,12)(H,10,11)/t5-/m0/s1 D0TM0C DRUGINKE PTARWFJHCZHOGS-YFKPBYRVSA-N D0TM0C DRUGSMIL CC1(CSSCC(NC1=O)C(=O)O)C D0TM0C HIGHSTAT Discontinued in Phase 2 D0TX8Z DRUG__ID D0TX8Z D0TX8Z DRUGTYPE Small molecular drug D0TX8Z DRUGINCH 1S/C26H34F3N3O3S/c1-19(2)18-35-25(34)31(14-13-30(3)4)17-24(33)32(22-11-6-7-12-23(22)36-5)16-20-9-8-10-21(15-20)26(27,28)29/h6-12,15,19H,13-14,16-18H2,1-5H3 D0TX8Z DRUGINKE MJOGWNMYQLVUOU-UHFFFAOYSA-N D0TX8Z DRUGSMIL CC(C)COC(=O)N(CCN(C)C)CC(=O)N(CC1=CC(=CC=C1)C(F)(F)F)C2=CC=CC=C2SC D0TX8Z HIGHSTAT Discontinued in Phase 2 D0U0QI DRUG__ID D0U0QI D0U0QI DRUGTYPE Small molecular drug D0U0QI DRUGINCH 1S/C16H19N3O3/c20-16-7-3-9-18-19(16)10-4-8-17-11-13-12-21-14-5-1-2-6-15(14)22-13/h1-3,5-7,9,13,17H,4,8,10-12H2/t13-/m1/s1 D0U0QI DRUGINKE FJNRJBQUOQLUNQ-CYBMUJFWSA-N D0U0QI DRUGSMIL C1C(OC2=CC=CC=C2O1)CNCCCN3C(=O)C=CC=N3 D0U0QI HIGHSTAT Discontinued in Phase 2 D0U4FW DRUG__ID D0U4FW D0U4FW DRUGTYPE Small molecular drug D0U4FW DRUGINCH 1S/C23H26ClN3O5S/c24-17-15-19(22-20(16-17)31-13-14-32-22)26-11-9-25(10-12-26)7-3-4-8-27-23(28)18-5-1-2-6-21(18)33(27,29)30/h1-2,5-6,15-16H,3-4,7-14H2 D0U4FW DRUGINKE LYXKFNHUJJDTIA-UHFFFAOYSA-N D0U4FW DRUGSMIL C1CN(CCN1CCCCN2C(=O)C3=CC=CC=C3S2(=O)=O)C4=C5C(=CC(=C4)Cl)OCCO5 D0U4FW HIGHSTAT Discontinued in Phase 2 D0U5NU DRUG__ID D0U5NU D0U5NU DRUGTYPE Small molecular drug D0U5NU DRUGINCH 1S/C27H26FNO3/c1-17(2)27-23(13-12-22-14-21(30)15-26(31)32-22)24(18-8-10-20(28)11-9-18)16-25(29-27)19-6-4-3-5-7-19/h3-13,16-17,21-22,30H,14-15H2,1-2H3/b13-12+/t21-,22-/m1/s1 D0U5NU DRUGINKE LJIZUXQINHXGAO-ITWZMISCSA-N D0U5NU DRUGSMIL CC(C)C1=C(C(=CC(=N1)C2=CC=CC=C2)C3=CC=C(C=C3)F)C=CC4CC(CC(=O)O4)O D0U5NU HIGHSTAT Discontinued in Phase 2 D0U7DI DRUG__ID D0U7DI D0U7DI DRUGTYPE Small molecular drug D0U7DI DRUGINCH 1S/C10H12N2OS.ClH/c1-7-9(13)12(2)10(14-7)8-4-3-5-11-6-8;/h3-7,10H,1-2H3;1H/t7-,10+;/m0./s1 D0U7DI DRUGINKE CXHDSLQCNYLQND-XQRIHRDZSA-N D0U7DI DRUGSMIL CC1C(=O)N(C(S1)C2=CN=CC=C2)C.Cl D0U7DI HIGHSTAT Discontinued in Phase 2 D0U9LL DRUG__ID D0U9LL D0U9LL DRUGTYPE Small molecular drug D0U9LL DRUGINCH 1S/C19H24O4/c1-17-6-3-11(20)9-14(17)15(21)10-13-12(17)4-7-18(2)16(22)5-8-19(13,18)23/h9,12-13,23H,3-8,10H2,1-2H3/t12-,13+,17+,18+,19+/m0/s1 D0U9LL DRUGINKE UKVVNEHFNYKGMX-KIVPVIKRSA-N D0U9LL DRUGSMIL CC12CCC(=O)C=C1C(=O)CC3C2CCC4(C3(CCC4=O)O)C D0U9LL HIGHSTAT Discontinued in Phase 2 D0UG4T DRUG__ID D0UG4T D0UG4T DRUGTYPE Small molecular drug D0UG4T DRUGINCH 1S/C25H27NO2/c1-27-24-12-11-21(18-25(24)28-22-9-5-6-10-22)23(20-7-3-2-4-8-20)17-19-13-15-26-16-14-19/h2-4,7-8,11-16,18,22-23H,5-6,9-10,17H2,1H3/t23-/m1/s1 D0UG4T DRUGINKE UTUUPXBCDMQYRR-HSZRJFAPSA-N D0UG4T DRUGSMIL COC1=C(C=C(C=C1)C(CC2=CC=NC=C2)C3=CC=CC=C3)OC4CCCC4 D0UG4T HIGHSTAT Discontinued in Phase 2 D0UO2N DRUG__ID D0UO2N D0UO2N DRUGTYPE Small molecular drug D0UO2N DRUGINCH 1S/C25H36O5S/c1-4-5-21(29)30-25(20(28)14-31)11-9-18-17-7-6-15-12-16(26)8-10-23(15,2)22(17)19(27)13-24(18,25)3/h12,17-19,22,27,31H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1 D0UO2N DRUGINKE HOAKOHHSHOCDLI-TUFAYURCSA-N D0UO2N DRUGSMIL CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CS D0UO2N HIGHSTAT Discontinued in Phase 2 D0V3CM DRUG__ID D0V3CM D0V3CM DRUGTYPE Small molecular drug D0V3CM DRUGINCH 1S/C14H17FN2O3/c1-4-11-13(18)16-10-6-5-9(15)7-12(10)17(11)14(19)20-8(2)3/h5-8,11H,4H2,1-3H3,(H,16,18)/t11-/m0/s1 D0V3CM DRUGINKE KELNNWMENBUHNS-NSHDSACASA-N D0V3CM DRUGSMIL CCC1C(=O)NC2=C(N1C(=O)OC(C)C)C=C(C=C2)F D0V3CM HIGHSTAT Discontinued in Phase 2 D0V3HG DRUG__ID D0V3HG D0V3HG DRUGTYPE Small molecular drug D0V3HG DRUGINCH 1S/C15H15NO2/c1-9-10(2)15(18)13(11(3)14(9)17)7-12-5-4-6-16-8-12/h4-6,8H,7H2,1-3H3 D0V3HG DRUGINKE IPGAFOVEIIWXFR-UHFFFAOYSA-N D0V3HG DRUGSMIL CC1=C(C(=O)C(=C(C1=O)C)CC2=CN=CC=C2)C D0V3HG HIGHSTAT Discontinued in Phase 2 D0V7MA DRUG__ID D0V7MA D0V7MA DRUGTYPE Small molecular drug D0V7MA DRUGINCH 1S/C25H35N3O/c1-16(2)28-15-17-13-23-21(20-10-7-11-22(28)24(17)20)12-18(14-27(23)3)25(29)26-19-8-5-4-6-9-19/h7,10-11,15-16,18-19,21,23H,4-6,8-9,12-14H2,1-3H3,(H,26,29)/t18-,21-,23-/m1/s1 D0V7MA DRUGINKE KEMOOQHMCGCZKH-JMUQELJHSA-N D0V7MA DRUGSMIL CC(C)N1C=C2CC3C(CC(CN3C)C(=O)NC4CCCCC4)C5=C2C1=CC=C5 D0V7MA HIGHSTAT Discontinued in Phase 2 D0V9OL DRUG__ID D0V9OL D0V9OL DRUGCOMP Burroughs Wellcome Inc D0V9OL DRUGINCH 1S/C12H9F2N5.ClH/c13-8-2-1-3-9(14)7(8)6-19-10-4-5-16-12(15)11(10)17-18-19;/h1-5H,6H2,(H2,15,16);1H D0V9OL DRUGINKE JKXUBXRPDZPXOD-UHFFFAOYSA-N D0V9OL DRUGSMIL C1=CC(=C(C(=C1)F)CN2C3=C(C(=NC=C3)N)N=N2)F.Cl D0V9OL HIGHSTAT Discontinued in Phase 2 D0V9RU DRUG__ID D0V9RU D0V9RU DRUGTYPE Small molecular drug D0V9RU DRUGINCH 1S/C14H16N4O3S/c1-9-7-11(18-5-3-4-6-18)12(22(2,20)21)8-10(9)13(19)17-14(15)16/h3-8H,1-2H3,(H4,15,16,17,19) D0V9RU DRUGINKE UADMBZFZZOBWBB-UHFFFAOYSA-N D0V9RU DRUGSMIL CC1=CC(=C(C=C1C(=O)N=C(N)N)S(=O)(=O)C)N2C=CC=C2 D0V9RU HIGHSTAT Discontinued in Phase 2 D0W1MX DRUG__ID D0W1MX D0W1MX DRUGTYPE Small molecular drug D0W1MX DRUGINCH 1S/C16H19O7PS/c17-24(18,19)16(25(20,21)22)11-5-7-13-6-4-10-15(12-13)23-14-8-2-1-3-9-14/h1-4,6,8-10,12,16H,5,7,11H2,(H2,17,18,19)(H,20,21,22)/t16-/m0/s1 D0W1MX DRUGINKE RCGCZPXSRLLKCK-INIZCTEOSA-N D0W1MX DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CCCC(P(=O)(O)O)S(=O)(=O)O D0W1MX HIGHSTAT Discontinued in Phase 2 D0W4OL DRUG__ID D0W4OL D0W4OL DRUGTYPE Small molecular drug D0W4OL DRUGINCH 1S/C20H28N4O7/c1-11(2)17(20(29)30)24-19(28)14(10-16(26)27)23-15(25)4-3-9-31-13-7-5-12(6-8-13)18(21)22/h5-8,11,14,17H,3-4,9-10H2,1-2H3,(H3,21,22)(H,23,25)(H,24,28)(H,26,27)(H,29,30)/t14-,17-/m0/s1 D0W4OL DRUGINKE JFCXCBBSUORTNS-YOEHRIQHSA-N D0W4OL DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)CCCOC1=CC=C(C=C1)C(=N)N D0W4OL HIGHSTAT Discontinued in Phase 2 D0W7KD DRUG__ID D0W7KD D0W7KD DRUGTYPE Small molecular drug D0W7KD DRUGINCH 1S/C20H18F2N4O3.ClH/c1-24-4-6-25(7-5-24)17-9-16-13(8-15(17)22)19(27)14(20(28)29)11-26(16)18-3-2-12(21)10-23-18;/h2-3,8-11H,4-7H2,1H3,(H,28,29);1H D0W7KD DRUGINKE UPCHGBDAUCFDMW-UHFFFAOYSA-N D0W7KD DRUGSMIL CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=NC=C(C=C4)F)F.Cl D0W7KD HIGHSTAT Discontinued in Phase 2 D0W8QV DRUG__ID D0W8QV D0W8QV DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0W8QV DRUGINCH 1S/C18H22N4O2S2/c1-26(23,24)21-18-20-14(12-25-18)11-22-8-6-13(7-9-22)16-10-19-17-5-3-2-4-15(16)17/h2-5,10,12-13,19H,6-9,11H2,1H3,(H,20,21) D0W8QV DRUGINKE XLFASBVDVQTBES-UHFFFAOYSA-N D0W8QV DRUGSMIL CS(=O)(=O)NC1=NC(=CS1)CN2CCC(CC2)C3=CNC4=CC=CC=C43 D0W8QV HIGHSTAT Discontinued in Phase 2 D0W9JH DRUG__ID D0W9JH D0W9JH DRUGTYPE Small molecular drug D0W9JH DRUGINCH 1S/C28H35NO3/c1-20(12-17-26-22(3)11-8-18-28(26,5)6)9-7-10-21(2)19-27(31)32-25-15-13-24(14-16-25)29-23(4)30/h7,9-10,12-17,19H,8,11,18H2,1-6H3,(H,29,30)/b10-7+,17-12+,20-9+,21-19+ D0W9JH DRUGINKE LQBHPDDJEMOJQA-ABRSJASVSA-N D0W9JH DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)OC2=CC=C(C=C2)NC(=O)C)C)C D0W9JH HIGHSTAT Discontinued in Phase 2 D0W9PG DRUG__ID D0W9PG D0W9PG DRUGCOMP Sparta Pharmaceuticals Inc D0W9PG DRUGINCH 1S/C6H7N5O/c7-6(8)11-5(12)4-3-9-1-2-10-4/h1-3H,(H4,7,8,11,12) D0W9PG DRUGINKE WNBSDCKJFDZMHT-UHFFFAOYSA-N D0W9PG DRUGSMIL C1=CN=C(C=N1)C(=O)N=C(N)N D0W9PG HIGHSTAT Discontinued in Phase 2 D0W9SZ DRUG__ID D0W9SZ D0W9SZ DRUGCOMP Amgen D0W9SZ DRUGINCH 1S/C20H14N2O5S.Na/c23-17-11-18(28(25,26)27)14-7-3-4-8-15(14)19(17)22-21-16-10-9-12-5-1-2-6-13(12)20(16)24;/h1-11,23-24H,(H,25,26,27);/q;+1/p-1 D0W9SZ DRUGINKE HOWITLLZNKSJOJ-UHFFFAOYSA-M D0W9SZ DRUGSMIL C1=CC=C2C(=C1)C=CC(=C2O)N=NC3=C(C=C(C4=CC=CC=C43)S(=O)(=O)[O-])O.[Na+] D0W9SZ HIGHSTAT Discontinued in Phase 2 D0WL7V DRUG__ID D0WL7V D0WL7V DRUGCOMP Meiji Seika Kaisha Ltd D0WL7V DRUGINCH 1S/C31H52O3/c1-26(2)17-21-20-9-10-23-28(4)13-12-24(33)29(5,19-32)22(28)11-14-31(23,7)30(20,6)16-15-27(21,3)25(18-26)34-8/h9,21-25,32-33H,10-19H2,1-8H3/t21-,22+,23+,24-,25+,27+,28-,29+,30+,31+/m0/s1 D0WL7V DRUGINKE PKYIOGUKISFMKN-NUKYOBHGSA-N D0WL7V DRUGSMIL CC1(CC2C3=CCC4C5(CCC(C(C5CCC4(C3(CCC2(C(C1)OC)C)C)C)(C)CO)O)C)C D0WL7V HIGHSTAT Discontinued in Phase 2 D0X1EX DRUG__ID D0X1EX D0X1EX DRUGTYPE Small molecular drug D0X1EX DRUGINCH 1S/C13H14O4S/c1-3-16-9-5-8-6-12(13(14)15)18-11(8)7-10(9)17-4-2/h5-7H,3-4H2,1-2H3,(H,14,15) D0X1EX DRUGINKE PDUXMHXBBXXJFQ-UHFFFAOYSA-N D0X1EX DRUGSMIL CCOC1=C(C=C2C(=C1)C=C(S2)C(=O)O)OCC D0X1EX HIGHSTAT Discontinued in Phase 2 D0X2PQ DRUG__ID D0X2PQ D0X2PQ DRUGCOMP Sandoz AG D0X2PQ DRUGINCH 1S/C16H12O3S/c1-19-14-8-10-4-2-3-5-11(10)13(9-15(17)18)12-6-7-20-16(12)14/h2-9H,1H3,(H,17,18)/b13-9- D0X2PQ DRUGINKE XIKRQPKFOKKGGW-LCYFTJDESA-N D0X2PQ DRUGSMIL COC1=CC2=CC=CC=C2C(=CC(=O)O)C3=C1SC=C3 D0X2PQ HIGHSTAT Discontinued in Phase 2 D0X4AV DRUG__ID D0X4AV D0X4AV DRUGTYPE Small molecular drug D0X4AV DRUGINCH 1S/C33H34N4O3/c38-30-29(35-32(40)34-25-9-3-1-4-10-25)31(39)37(26-11-5-2-6-12-26)28-14-8-7-13-27(28)36(30)21-33-18-22-15-23(19-33)17-24(16-22)20-33/h1-14,22-24,29H,15-21H2,(H2,34,35,40)/t22?,23?,24?,29-,33?/m1/s1 D0X4AV DRUGINKE RZERRLOTRSJIAW-NEPGVILWSA-N D0X4AV DRUGSMIL C1C2CC3CC1CC(C2)(C3)CN4C5=CC=CC=C5N(C(=O)C(C4=O)NC(=O)NC6=CC=CC=C6)C7=CC=CC=C7 D0X4AV HIGHSTAT Discontinued in Phase 2 D0X5UH DRUG__ID D0X5UH D0X5UH DRUGTYPE Small molecular drug D0X5UH DRUGINCH 1S/C30H22N4O4/c1-15-13-31-27-22(35)11-25-30(26(15)27)12-18(30)14-34(25)29(37)21-9-17-8-19(6-7-20(17)33-21)32-28(36)24-10-16-4-2-3-5-23(16)38-24/h2-11,13,18,31,33H,12,14H2,1H3,(H,32,36)/t18-,30+/m1/s1 D0X5UH DRUGINKE BYRVKDUQDLJUBX-JJCDCTGGSA-N D0X5UH DRUGSMIL CC1=CNC2=C1C34CC3CN(C4=CC2=O)C(=O)C5=CC6=C(N5)C=CC(=C6)NC(=O)C7=CC8=CC=CC=C8O7 D0X5UH HIGHSTAT Discontinued in Phase 2 D0X8GJ DRUG__ID D0X8GJ D0X8GJ DRUGTYPE Small molecular drug D0X8GJ DRUGINCH 1S/C16H16N2O6S/c1-8(19)11-14(21)18-12(16(22)24-7-23-9(2)20)13(25-15(11)18)10-4-3-5-17-6-10/h3-6,8,11,15,19H,7H2,1-2H3/t8-,11+,15-/m1/s1 D0X8GJ DRUGINKE SFIPPEJRUGDKRJ-OTDPEBBPSA-N D0X8GJ DRUGSMIL CC(C1C2N(C1=O)C(=C(S2)C3=CN=CC=C3)C(=O)OCOC(=O)C)O D0X8GJ HIGHSTAT Discontinued in Phase 2 D0X8QP DRUG__ID D0X8QP D0X8QP DRUGTYPE Small molecular drug D0X8QP DRUGINCH 1S/C9H14NO5P/c1-10-5-4-7-2-3-9(8(11)6-7)15-16(12,13)14/h2-3,6,10-11H,4-5H2,1H3,(H2,12,13,14) D0X8QP DRUGINKE WHEGQKBWPSOMHG-UHFFFAOYSA-N D0X8QP DRUGSMIL CNCCC1=CC(=C(C=C1)OP(=O)(O)O)O D0X8QP HIGHSTAT Discontinued in Phase 2 D0XJ0S DRUG__ID D0XJ0S D0XJ0S DRUGTYPE Small molecular drug D0XJ0S DRUGINCH 1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21?,22?,24?,25?,29-,32?,35+/m0/s1 D0XJ0S DRUGINKE FVQSSYMRZKLFDR-ZABPBAJSSA-N D0XJ0S DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC(C3=CC=CC=C3)NC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0XJ0S HIGHSTAT Discontinued in Phase 2 D0XK4R DRUG__ID D0XK4R D0XK4R DRUGTYPE Small molecular drug D0XK4R DRUGINCH 1S/C21H24F2N2O3/c22-18-5-1-16(2-6-18)21(17-3-7-19(23)8-4-17)25-11-9-24(10-12-25)13-14-28-15-20(26)27/h1-8,21H,9-15H2,(H,26,27) D0XK4R DRUGINKE BAWMMJAUVBLLEE-UHFFFAOYSA-N D0XK4R DRUGSMIL C1CN(CCN1CCOCC(=O)O)C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D0XK4R HIGHSTAT Discontinued in Phase 2 D0Y0SY DRUG__ID D0Y0SY D0Y0SY DRUGCOMP Eisai Co Ltd D0Y0SY DRUGINCH 1S/C20H26ClN3O2.ClH/c1-4-5-12(2)26-19-11-18(22)17(21)10-16(19)20(25)23-13-8-14-6-7-15(9-13)24(14)3;/h10-15H,6-9,22H2,1-3H3,(H,23,25);1H/t12-,13?,14-,15+;/m0./s1 D0Y0SY DRUGINKE GMHMNKHDLXRRGF-LZMJSSQSSA-N D0Y0SY DRUGSMIL CC#CC(C)OC1=CC(=C(C=C1C(=O)NC2CC3CCC(C2)N3C)Cl)N.Cl D0Y0SY HIGHSTAT Discontinued in Phase 2 D0Y1YP DRUG__ID D0Y1YP D0Y1YP DRUGTYPE Small molecular drug D0Y1YP DRUGINCH 1S/C13H8N2O3/c16-12-9-7-8(13(17)18)4-5-10(9)14-11-3-1-2-6-15(11)12/h1-7H,(H,17,18) D0Y1YP DRUGINKE HMZDSBSMNLBGIW-UHFFFAOYSA-N D0Y1YP DRUGSMIL C1=CC2=NC3=C(C=C(C=C3)C(=O)O)C(=O)N2C=C1 D0Y1YP HIGHSTAT Discontinued in Phase 2 D0Y2IP DRUG__ID D0Y2IP D0Y2IP DRUGTYPE Small molecular drug D0Y2IP DRUGINCH 1S/C53H90N20O16/c1-26(2)20-34(46(84)68-31(9-6-18-63-52(58)59)43(81)65-24-40(77)66-37(50(88)89)22-28-11-13-29(75)14-12-28)70-48(86)36(23-39(55)76)72-44(82)32(10-7-19-64-53(60)61)69-47(85)35(21-27(3)4)71-49(87)38(25-74)73-45(83)33(15-16-41(78)79)67-42(80)30(54)8-5-17-62-51(56)57/h11-14,26-27,30-38,74-75H,5-10,15-25,54H2,1-4H3,(H2,55,76)(H,65,81)(H,66,77)(H,67,80)(H,68,84)(H,69,85)(H,70,86)(H,71,87)(H,72,82)(H,73,83)(H,78,79)(H,88,89)(H4,56,57,62)(H4,58,59,63)(H4,60,61,64)/t30-,31-,32-,33-,34-,35-,36-,37-,38-/m0/s1 D0Y2IP DRUGINKE KXASYRUYKYOKGG-IWLMWFOOSA-N D0Y2IP DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CCCN=C(N)N)N D0Y2IP HIGHSTAT Discontinued in Phase 2 D0Y2OG DRUG__ID D0Y2OG D0Y2OG DRUGTYPE Small molecular drug D0Y2OG DRUGINCH 1S/C16H12BrN5/c17-15-5-1-14(2-6-15)10-22(21-11-19-20-12-21)16-7-3-13(9-18)4-8-16/h1-8,11-12H,10H2 D0Y2OG DRUGINKE GGPPBTSXFROGAE-UHFFFAOYSA-N D0Y2OG DRUGSMIL C1=CC(=CC=C1CN(C2=CC=C(C=C2)C#N)N3C=NN=C3)Br D0Y2OG HIGHSTAT Discontinued in Phase 2 D0Y4LU DRUG__ID D0Y4LU D0Y4LU DRUGTYPE Small molecular drug D0Y4LU DRUGINCH 1S/C20H25N3O2/c1-21-11-8-20(22(2)19(21)24)9-12-23-10-7-15-14-5-3-4-6-17(14)25-18(15)16(23)13-20/h3-6,16H,7-13H2,1-2H3/t16-,20+/m0/s1 D0Y4LU DRUGINKE JRDUBBHIPPPSLP-OXJNMPFZSA-N D0Y4LU DRUGSMIL CN1CCC2(CCN3CCC4=C(C3C2)OC5=CC=CC=C45)N(C1=O)C D0Y4LU HIGHSTAT Discontinued in Phase 2 D0Y8SK DRUG__ID D0Y8SK D0Y8SK DRUGTYPE Small molecular drug D0Y8SK DRUGINCH 1S/C99H155N31O23/c1-7-55(6)81(129-86(142)66(28-18-40-112-98(107)108)118-83(139)65(27-17-39-111-97(105)106)120-88(144)70(44-54(4)5)125-89(145)71(46-56-21-9-8-10-22-56)117-79(135)52-115-78(134)51-116-82(138)61(102)45-57-31-33-59(131)34-32-57)94(150)122-67(29-19-41-113-99(109)110)95(151)130-42-20-30-75(130)93(149)121-64(26-14-16-38-101)85(141)124-69(43-53(2)3)87(143)119-63(25-13-15-37-100)84(140)126-72(47-58-50-114-62-24-12-11-23-60(58)62)90(146)128-74(49-80(136)137)92(148)127-73(48-77(104)133)91(147)123-68(96(152)153)35-36-76(103)132/h8-12,21-24,31-34,50,53-55,61,63-75,81,114,131H,7,13-20,25-30,35-49,51-52,100-102H2,1-6H3,(H2,103,132)(H2,104,133)(H,115,134)(H,116,138)(H,117,135)(H,118,139)(H,119,143)(H,120,144)(H,121,149)(H,122,150)(H,123,147)(H,124,141)(H,125,145)(H,126,140)(H,127,148)(H,128,146)(H,129,142)(H,136,137)(H,152,153)(H4,105,106,111)(H4,107,108,112)(H4,109,110,113)/t55-,61-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,81-/m0/s1 D0Y8SK DRUGINKE JMNJYGMAUMANNW-FIXZTSJVSA-N D0Y8SK DRUGSMIL CCC(C)C(C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)CNC(=O)C(CC5=CC=C(C=C5)O)N D0Y8SK HIGHSTAT Discontinued in Phase 2 D0Z0OT DRUG__ID D0Z0OT D0Z0OT DRUGTYPE Small molecular drug D0Z0OT DRUGINCH 1S/C27H34O7/c1-32-22-15-13-21(14-16-22)9-4-2-3-6-19-33-24-10-8-11-25(23(24)17-18-27(30)31)34-20-7-5-12-26(28)29/h4,8-11,13-16H,2-3,5-7,12,17-20H2,1H3,(H,28,29)(H,30,31)/b9-4+ D0Z0OT DRUGINKE JOPSSWGWLCLPPF-RUDMXATFSA-N D0Z0OT DRUGSMIL COC1=CC=C(C=C1)C=CCCCCOC2=C(C(=CC=C2)OCCCCC(=O)O)CCC(=O)O D0Z0OT HIGHSTAT Discontinued in Phase 2 D0Z1RQ DRUG__ID D0Z1RQ D0Z1RQ DRUGTYPE Small molecular drug D0Z1RQ DRUGINCH 1S/C24H22N4O2/c1-16-9-8-12-18(15-16)25-24(30)27-22-23(29)28(2)20-14-7-6-13-19(20)21(26-22)17-10-4-3-5-11-17/h3-15,22H,1-2H3,(H2,25,27,30)/t22-/m0/s1 D0Z1RQ DRUGINKE KDFQABSFVYLGPM-QFIPXVFZSA-N D0Z1RQ DRUGSMIL CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)C D0Z1RQ HIGHSTAT Discontinued in Phase 2 D0Z5LZ DRUG__ID D0Z5LZ D0Z5LZ DRUGTYPE Small molecular drug D0Z5LZ DRUGINCH 1S/C16H19FN2O3S/c1-10-19-15(11-5-3-2-4-6-11)16(22-10)12-7-8-14(13(17)9-12)23(18,20)21/h7-9,11H,2-6H2,1H3,(H2,18,20,21) D0Z5LZ DRUGINKE MIMJSJSRRDZIPW-UHFFFAOYSA-N D0Z5LZ DRUGSMIL CC1=NC(=C(O1)C2=CC(=C(C=C2)S(=O)(=O)N)F)C3CCCCC3 D0Z5LZ HIGHSTAT Discontinued in Phase 2 D0ZC7P DRUG__ID D0ZC7P D0ZC7P DRUGTYPE Small molecular drug D0ZC7P DRUGINCH 1S/C16H21N3O3/c1-3-10-19-14-9-5-4-7-12(14)18-13(15(19)20)8-6-11-22-16(21)17-2/h4-5,7,9H,3,6,8,10-11H2,1-2H3,(H,17,21) D0ZC7P DRUGINKE HNQSZPBGDAJIJO-UHFFFAOYSA-N D0ZC7P DRUGSMIL CCCN1C2=CC=CC=C2N=C(C1=O)CCCOC(=O)NC D0ZC7P HIGHSTAT Discontinued in Phase 2 D0ZL4F DRUG__ID D0ZL4F D0ZL4F DRUGTYPE Small molecular drug D0ZL4F DRUGINCH 1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)/t11-/m1/s1 D0ZL4F DRUGINKE DKYWVDODHFEZIM-LLVKDONJSA-N D0ZL4F DRUGSMIL CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O D0ZL4F HIGHSTAT Discontinued in Phase 2 D0ZM5W DRUG__ID D0ZM5W D0ZM5W DRUGTYPE Small molecular drug D0ZM5W DRUGINCH 1S/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3 D0ZM5W DRUGINKE CHDGAVDQRSPBTA-UHFFFAOYSA-N D0ZM5W DRUGSMIL CCS(=O)(=O)OC1=CC2=C(C=C1)C(=C(C(=O)O2)C)C D0ZM5W HIGHSTAT Discontinued in Phase 2 D00AKY DRUG__ID D00AKY D00AKY DRUGINCH 1S/C26H34O4S/c27-25(28)17-18-31-24(20-26(29)30)23-16-10-15-22(19-23)14-7-4-2-1-3-6-11-21-12-8-5-9-13-21/h5,8-10,12-13,15-16,19,24H,1-4,6-7,11,14,17-18,20H2,(H,27,28)(H,29,30)/t24-/m0/s1 D00AKY DRUGINKE IEOUXQMKLRALNJ-DEOSSOPVSA-N D00AKY DRUGSMIL C1=CC=C(C=C1)CCCCCCCCC2=CC(=CC=C2)C(CC(=O)O)SCCC(=O)O D00AKY HIGHSTAT Discontinued in Phase 2 D02JUM DRUG__ID D02JUM D02JUM DRUGINCH 1S/C12H19NO4S/c1-8-4-3-5-10(12(16)17)13(8)11(15)6-7-18-9(2)14/h8,10H,3-7H2,1-2H3,(H,16,17)/t8-,10-/m0/s1 D02JUM DRUGINKE JHFOAISYWJRTIM-WPRPVWTQSA-N D02JUM DRUGSMIL CC1CCCC(N1C(=O)CCSC(=O)C)C(=O)O D02JUM HIGHSTAT Discontinued in Phase 2 D02QWJ DRUG__ID D02QWJ D02QWJ DRUGINCH 1S/C73H89ClN10O26/c1-27(2)16-39(78-7)64(95)83-54-56(90)32-11-15-43(38(74)18-32)106-45-20-33-19-44(60(45)110-71-61(58(92)57(91)46(26-85)107-71)109-49-25-73(6,77)63(94)29(4)104-49)105-35-12-8-30(9-13-35)59(108-48-24-72(5,76)62(93)28(3)103-48)55-69(100)82-53(70(101)102)37-21-34(86)22-42(88)50(37)36-17-31(10-14-41(36)87)51(66(97)84-55)81-67(98)52(33)80-65(96)40(23-47(75)89)79-68(54)99/h8-15,17-22,27-29,39-40,46,48-49,51-59,61-63,71,78,85-88,90-94H,16,23-26,76-77H2,1-7H3,(H2,75,89)(H,79,99)(H,80,96)(H,81,98)(H,82,100)(H,83,95)(H,84,97)(H,101,102)/t28-,29-,39+,40-,46+,48-,49-,51+,52+,53-,54+,55-,56+,57+,58-,59+,61+,62-,63-,71-,72-,73-/m0/s1 D02QWJ DRUGINKE UECIPBUIMXSXEI-BNSVOVDNSA-N D02QWJ DRUGSMIL CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC=C(O4)C=C1)OC1CC(C(C(O1)C)O)(C)N)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O D02QWJ HIGHSTAT Discontinued in Phase 2 D03MUM DRUG__ID D03MUM D03MUM DRUGINCH 1S/C28H32N4O5S.H2O/c1-18-19(2)37-30-26(18)31-38(34,35)24-10-8-7-9-23(24)22-12-11-20(27-29-13-14-36-27)15-21(22)17-32(6)25(33)16-28(3,4)5;/h7-15H,16-17H2,1-6H3,(H,30,31);1H2 D03MUM DRUGINKE VRUJTPHFVRXEPB-UHFFFAOYSA-N D03MUM DRUGSMIL CC1=C(ON=C1NS(=O)(=O)C2=CC=CC=C2C3=C(C=C(C=C3)C4=NC=CO4)CN(C)C(=O)CC(C)(C)C)C.O D03MUM HIGHSTAT Discontinued in Phase 2 D05DON DRUG__ID D05DON D05DON DRUGINCH 1S/C19H25N3O.C4H6O6/c1-14-7-4-8-15(2)18(14)22(19(23)16(3)20)12-6-10-17-9-5-11-21-13-17;5-1(3(7)8)2(6)4(9)10/h4-5,7-9,11,13,16H,6,10,12,20H2,1-3H3;1-2,5-6H,(H,7,8)(H,9,10)/t16-;1-,2-/m10/s1 D05DON DRUGINKE UKFWRCBTXJZERY-ZKBHHEPKSA-N D05DON DRUGSMIL CC1=C(C(=CC=C1)C)N(CCCC2=CN=CC=C2)C(=O)C(C)N.C(C(C(=O)O)O)(C(=O)O)O D05DON HIGHSTAT Discontinued in Phase 2 D08NYL DRUG__ID D08NYL D08NYL DRUGCOMP Allergan D08NYL THERCLAS siRNA D08NYL DRUGTYPE siRNA drug D08NYL HIGHSTAT Discontinued in Phase 2 D08ZCW DRUG__ID D08ZCW D08ZCW DRUGINCH 1S/C18H28F3N3O5/c1-9(2)12(14(25)18(19,20)21)22-15(26)11-7-6-8-24(11)16(27)13(10(3)4)23-17(28)29-5/h9-13H,6-8H2,1-5H3,(H,22,26)(H,23,28)/t11-,12-,13-/m0/s1 D08ZCW DRUGINKE ZYLBZJKJNAYAFU-AVGNSLFASA-N D08ZCW DRUGSMIL CC(C)C(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)OC D08ZCW HIGHSTAT Discontinued in Phase 2 D0B2BY DRUG__ID D0B2BY D0B2BY DRUGINCH 1S/C13H21N5O3S/c1-9(2)10-5-11-15-8-16-18(11)17-12(10)21-6-13(3,4)7-22(14,19)20/h5,8-9H,6-7H2,1-4H3,(H2,14,19,20) D0B2BY DRUGINKE ABSYJOKYMQTMMK-UHFFFAOYSA-N D0B2BY DRUGSMIL CC(C)C1=CC2=NC=NN2N=C1OCC(C)(C)CS(=O)(=O)N D0B2BY HIGHSTAT Discontinued in Phase 2 D0E1UZ DRUG__ID D0E1UZ D0E1UZ DRUGINCH 1S/C28H41ClN2O/c1-6-7-8-9-10-17-31(20-25-15-13-24(14-16-25)12-11-21(2)3)28(32)30-27-22(4)18-26(29)19-23(27)5/h13-16,18-19,21H,6-12,17,20H2,1-5H3,(H,30,32) D0E1UZ DRUGINKE YQFGILAFZYCULR-UHFFFAOYSA-N D0E1UZ DRUGSMIL CCCCCCCN(CC1=CC=C(C=C1)CCC(C)C)C(=O)NC2=C(C=C(C=C2C)Cl)C D0E1UZ HIGHSTAT Discontinued in Phase 2 D0FX3P DRUG__ID D0FX3P D0FX3P DRUGCOMP Isis Pharmaceuticals D0FX3P THERCLAS Antisense D0FX3P DRUGTYPE Antisense drug D0FX3P HIGHSTAT Discontinued in Phase 2 D0G6PG DRUG__ID D0G6PG D0G6PG DRUGINCH 1S/C17H19NO9/c1-7(20)18-14-16(24)15(23)12(6-19)27-17(14)26-11-4-8-2-3-13(22)25-10(8)5-9(11)21/h2-5,12,14-17,19,21,23-24H,6H2,1H3,(H,18,20)/t12-,14-,15-,16-,17-/m1/s1 D0G6PG DRUGINKE OTXAWKXSJDFGID-LMHBHQSJSA-N D0G6PG DRUGSMIL CC(=O)NC1C(C(C(OC1OC2=C(C=C3C(=C2)C=CC(=O)O3)O)CO)O)O D0G6PG HIGHSTAT Discontinued in Phase 2 D0H2JQ DRUG__ID D0H2JQ D0H2JQ DRUGINCH 1S/C27H22N4O10/c32-7-13-22(36)23(37)24(38)27(41-13)30-20-10(4-2-6-12(20)35)15-17-16(25(39)31(26(17)40)28-8-33)14-9-3-1-5-11(34)18(9)29-19(14)21(15)30/h1-6,8,13,22-24,27,29,32,34-38H,7H2,(H,28,33)/t13-,22-,23+,24-,27-/m1/s1 D0H2JQ DRUGINKE WHTCLLAVOBBKHK-ISCYQWKGSA-N D0H2JQ DRUGSMIL C1=CC2=C(C(=C1)O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC=O)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C(=CC=C6)O D0H2JQ HIGHSTAT Discontinued in Phase 2 D0KL3K DRUG__ID D0KL3K D0KL3K DRUGINCH 1S/C22H20N4O8/c27-19-23-21(29)33-25(19)13-15-3-7-17(8-4-15)31-11-1-2-12-32-18-9-5-16(6-10-18)14-26-20(28)24-22(30)34-26/h1-10H,11-14H2,(H,23,27,29)(H,24,28,30)/b2-1- D0KL3K DRUGINKE LUACLLSCZRRTIH-UPHRSURJSA-N D0KL3K DRUGSMIL C1=CC(=CC=C1CN2C(=O)NC(=O)O2)OCC=CCOC3=CC=C(C=C3)CN4C(=O)NC(=O)O4 D0KL3K HIGHSTAT Discontinued in Phase 2 D0NC9Y DRUG__ID D0NC9Y D0NC9Y DRUGCOMP Isis Pharmaceuticals D0NC9Y DRUGTYPE Antisense drug D0NC9Y DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)OP(=S)([O-])OCC3C(CC(O3)N4C=C(C(=O)NC4=O)C)OP(=S)([O-])OCC5C(CC(O5)N6C=NC7=C6N=C(NC7=O)N)OP(=S)([O-])OCC8C(CC(O8)N9C=CC(=NC9=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0NC9Y HIGHSTAT Discontinued in Phase 2 D0P2MH DRUG__ID D0P2MH D0P2MH DRUGINCH 1S/C13H20N4O.C4H4O4/c1-16(2)13(14)15-11-5-3-4-6-12(11)17-7-9-18-10-8-17;5-3(6)1-2-4(7)8/h3-6H,7-10H2,1-2H3,(H2,14,15);1-2H,(H,5,6)(H,7,8)/b;2-1+ D0P2MH DRUGINKE FFEKJBVVAJTQST-WLHGVMLRSA-N D0P2MH DRUGSMIL CN(C)C(=NC1=CC=CC=C1N2CCOCC2)N.C(=CC(=O)O)C(=O)O D0P2MH HIGHSTAT Discontinued in Phase 2 D0VB9J DRUG__ID D0VB9J D0VB9J DRUGCOMP Isis Pharmaceuticals D0VB9J THERCLAS Antisense D0VB9J DRUGTYPE Antisense drug D0VB9J HIGHSTAT Discontinued in Phase 2 D0W7VG DRUG__ID D0W7VG D0W7VG DRUGCOMP Amgen D0W7VG DRUGTYPE Small molecular drug D0W7VG DRUGSMIL C1=C(C2=C(N1)C(=O)N=CN2)C3C(C(C(N3)CO)O)O D0W7VG HIGHSTAT Discontinued in Phase 2 D0X0EU DRUG__ID D0X0EU D0X0EU DRUGINCH 1S/C73H136N2O22P2/c1-7-12-17-22-25-28-31-36-40-45-58(77)53-63(79)74-66-70(90-51-49-57(76)44-39-34-20-15-10-4)68(82)61(94-73(66)97-99(86,87)88)56-92-72-67(75-64(80)54-59(78)46-41-37-32-29-26-23-18-13-8-2)71(69(96-98(83,84)85)62(95-72)55-89-6)91-52-50-60(47-42-35-21-16-11-5)93-65(81)48-43-38-33-30-27-24-19-14-9-3/h30,33,57,60-62,66-73,76,82H,7-29,31-32,34-56H2,1-6H3,(H,74,79)(H,75,80)(H2,83,84,85)(H2,86,87,88)/b33-30-/t57-,60-,61-,62-,66-,67-,68-,69-,70-,71-,72-,73-/m1/s1 D0X0EU DRUGINKE GDODKYPBSZCPOO-XFMGTHRKSA-N D0X0EU DRUGSMIL CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC(=O)CCCC=CCCCCCC)NC(=O)CC(=O)CCCCCCCCCCC)O)OCCC(CCCCCCC)O D0X0EU HIGHSTAT Discontinued in Phase 2 D00BPE DRUG__ID D00BPE D00BPE DRUGCOMP ImmunoGen Inc D00BPE DRUGTYPE Antibody D00BPE HIGHSTAT Discontinued in Phase 2 D00PFW DRUG__ID D00PFW D00PFW DRUGCOMP AstraZeneca D00PFW DRUGTYPE Small molecular drug D00PFW HIGHSTAT Discontinued in Phase 2 D00WOT DRUG__ID D00WOT D00WOT DRUGCOMP UCB Celltech D00WOT DRUGTYPE Antibody D00WOT HIGHSTAT Discontinued in Phase 2 D01RNL DRUG__ID D01RNL D01RNL DRUGCOMP PDL BioPharma Inc; Seattle Genetics D01RNL DRUGTYPE Antibody D01RNL HIGHSTAT Discontinued in Phase 2 D02ESK DRUG__ID D02ESK D02ESK DRUGCOMP GlaxoSmithKline plc D02ESK DRUGTYPE Vaccine D02ESK HIGHSTAT Discontinued in Phase 2 D03VCF DRUG__ID D03VCF D03VCF DRUGCOMP Teijin Ltd D03VCF DRUGTYPE Antibody D03VCF HIGHSTAT Discontinued in Phase 2 D03ZHE DRUG__ID D03ZHE D03ZHE DRUGCOMP Medarex D03ZHE DRUGTYPE Antibody D03ZHE HIGHSTAT Discontinued in Phase 2 D04DDM DRUG__ID D04DDM D04DDM THERCLAS Antisense D04DDM DRUGTYPE Antisense drug D04DDM HIGHSTAT Discontinued in Phase 2 D04NKJ DRUG__ID D04NKJ D04NKJ THERCLAS Antiviral Agents D04NKJ DRUGTYPE Protein/peptide drug D04NKJ HIGHSTAT Discontinue in Phase 2 Trial D04RZZ DRUG__ID D04RZZ D04RZZ DRUGTYPE Small molecular drug D04RZZ DRUGSMIL C1C(C1(CN2C=NC3=C2NC(=NC3=O)N)CO)CO D04RZZ HIGHSTAT Discontinued in Phase 2 D04ZLG DRUG__ID D04ZLG D04ZLG DRUGCOMP Biogen Idec D04ZLG DRUGTYPE Antibody D04ZLG HIGHSTAT Discontinued in Phase 2 D05PWZ DRUG__ID D05PWZ D05PWZ DRUGCOMP Life Science Pharmaceuticals D05PWZ DRUGTYPE Monoclonal antibody D05PWZ HIGHSTAT Discontinued in Phase 2 D05RUJ DRUG__ID D05RUJ D05RUJ DRUGCOMP Genta Inc D05RUJ DRUGTYPE Antisense drug D05RUJ HIGHSTAT Discontinued in Phase 2 D05YLO DRUG__ID D05YLO D05YLO DRUGCOMP Roger Williams Medical Center D05YLO DRUGTYPE Antibody D05YLO HIGHSTAT Discontinued in Phase 2 D06BVT DRUG__ID D06BVT D06BVT DRUGCOMP AFFiRiS AG D06BVT DRUGTYPE Vaccine D06BVT HIGHSTAT Discontinued in Phase 2 D06UDV DRUG__ID D06UDV D06UDV DRUGCOMP AstraZeneca D06UDV THERCLAS Analgesics D06UDV HIGHSTAT Discontinued in Phase 2 D06UPS DRUG__ID D06UPS D06UPS DRUGCOMP Symphogen A/S D06UPS DRUGTYPE Antibody D06UPS HIGHSTAT Discontinued in Phase 2 D07AOO DRUG__ID D07AOO D07AOO DRUGCOMP Amgen D07AOO DRUGTYPE Antibody D07AOO HIGHSTAT Discontinued in Phase 2 D08PIJ DRUG__ID D08PIJ D08PIJ DRUGCOMP Japan Tobacco Inc D08PIJ DRUGTYPE Small molecular drug D08PIJ HIGHSTAT Discontinued in Phase 2 D0C1EO DRUG__ID D0C1EO D0C1EO DRUGCOMP Sanofi Pasteur D0C1EO DRUGTYPE Vaccine D0C1EO HIGHSTAT Discontinued in Phase 2 D0C7OQ DRUG__ID D0C7OQ D0C7OQ DRUGCOMP Boehringer Ingelheim Corp D0C7OQ DRUGTYPE Vaccine D0C7OQ HIGHSTAT Discontinued in Phase 2 D0EI1U DRUG__ID D0EI1U D0EI1U DRUGCOMP Genentech D0EI1U DRUGTYPE Antibody D0EI1U HIGHSTAT Discontinued in Phase 2 D0J4KC DRUG__ID D0J4KC D0J4KC DRUGCOMP Celldex Therapeutics Inc D0J4KC DRUGTYPE Vaccine D0J4KC HIGHSTAT Discontinued in Phase 2 D0J9KC DRUG__ID D0J9KC D0J9KC DRUGCOMP Igeneon GmbH D0J9KC DRUGTYPE Vaccine D0J9KC HIGHSTAT Discontinued in Phase 2 D0N4ND DRUG__ID D0N4ND D0N4ND DRUGCOMP PDL Biopharma D0N4ND DRUGTYPE Antibody D0N4ND HIGHSTAT Discontinued in Phase 2 D0O2QB DRUG__ID D0O2QB D0O2QB DRUGCOMP XOMA Ltd D0O2QB DRUGTYPE Monoclonal antibody D0O2QB HIGHSTAT Discontinued in Phase 2 D0P9LO DRUG__ID D0P9LO D0P9LO DRUGTYPE Small molecular drug D0P9LO DRUGSMIL CC(CC1=CN=CN1)NC(=C2C=CC=CC2=O)C3=CC=CC=C3 D0P9LO HIGHSTAT Discontinued in Phase 2 D0QH0B DRUG__ID D0QH0B D0QH0B THERCLAS Antisense D0QH0B DRUGTYPE Antisense drug D0QH0B HIGHSTAT Discontinued in Phase 2 D0VO9O DRUG__ID D0VO9O D0VO9O DRUGCOMP Tanox D0VO9O DRUGTYPE Monoclonal antibody D0VO9O HIGHSTAT Discontinued in Phase 2 D0X9RN DRUG__ID D0X9RN D0X9RN DRUGCOMP Merck D0X9RN DRUGTYPE Monoclonal antibody D0X9RN HIGHSTAT Discontinued in Phase 2 D00AJI DRUG__ID D00AJI D00AJI DRUGCOMP Pfizer Inc D00AJI HIGHSTAT Discontinued in Phase 2 D00DBU DRUG__ID D00DBU D00DBU DRUGCOMP Inhibitex Inc D00DBU HIGHSTAT Discontinued in Phase 2 D00FBM DRUG__ID D00FBM D00FBM DRUGCOMP Medical Biology Institute D00FBM HIGHSTAT Discontinued in Phase 2 D00FJC DRUG__ID D00FJC D00FJC DRUGCOMP Procter & Gamble Pharmaceuticals Inc D00FJC HIGHSTAT Discontinued in Phase 2 D00KUD DRUG__ID D00KUD D00KUD DRUGCOMP Adolor D00KUD HIGHSTAT Discontinued in Phase 2 D00LLI DRUG__ID D00LLI D00LLI DRUGCOMP Let's Talk Recovery Inc D00LLI HIGHSTAT Discontinued in Phase 2 D00LXD DRUG__ID D00LXD D00LXD DRUGCOMP Intarcia Therapeutics D00LXD HIGHSTAT Discontinued in Phase 2 D00NTW DRUG__ID D00NTW D00NTW DRUGCOMP Boehringer Ingelheim Corp D00NTW HIGHSTAT Discontinued in Phase 2 D00NWT DRUG__ID D00NWT D00NWT DRUGCOMP Glaxo Wellcome plc D00NWT HIGHSTAT Discontinued in Phase 2 D00PZK DRUG__ID D00PZK D00PZK DRUGCOMP Acacia Pharma Ltd D00PZK HIGHSTAT Discontinued in Phase 2 D00TQN DRUG__ID D00TQN D00TQN DRUGCOMP Japan Tobacco Inc D00TQN HIGHSTAT Discontinued in Phase 2 D00YFP DRUG__ID D00YFP D00YFP DRUGCOMP Roche D00YFP HIGHSTAT Discontinued in Phase 2 D00YUB DRUG__ID D00YUB D00YUB DRUGCOMP Takeda Pharmaceutical Co Ltd D00YUB HIGHSTAT Discontinued in Phase 2 D00ZGE DRUG__ID D00ZGE D00ZGE DRUGCOMP Poniard Pharmaceuticals Inc D00ZGE HIGHSTAT Discontinued in Phase 2 D01AFG DRUG__ID D01AFG D01AFG DRUGCOMP Genentech D01AFG HIGHSTAT Discontinued in Phase 2 D01AXT DRUG__ID D01AXT D01AXT DRUGCOMP Nascent Pharmaceuticals D01AXT HIGHSTAT Discontinued in Phase 2 D01IDQ DRUG__ID D01IDQ D01IDQ DRUGCOMP Innate, Pharma D01IDQ HIGHSTAT Discontinued in Phase 2 D01IYQ DRUG__ID D01IYQ D01IYQ DRUGCOMP Meiji Dairies Corp D01IYQ HIGHSTAT Discontinued in Phase 2 D01LFA DRUG__ID D01LFA D01LFA DRUGCOMP Ambrx Inc D01LFA HIGHSTAT Discontinued in Phase 2 D01MFA DRUG__ID D01MFA D01MFA DRUGCOMP Cypress Bioscience Inc D01MFA HIGHSTAT Discontinued in Phase 2 D01MVK DRUG__ID D01MVK D01MVK DRUGCOMP Calydon Inc; Cell Genesys D01MVK HIGHSTAT Discontinued in Phase 2 D01MYN DRUG__ID D01MYN D01MYN DRUGCOMP Eli Lilly & Co D01MYN HIGHSTAT Discontinued in Phase 2 D01NUG DRUG__ID D01NUG D01NUG DRUGCOMP GlaxoSmithKline D01NUG HIGHSTAT Discontinued in Phase 2 D01PCE DRUG__ID D01PCE D01PCE DRUGCOMP Shire BioChem Inc D01PCE HIGHSTAT Discontinued in Phase 2 D01PSI DRUG__ID D01PSI D01PSI DRUGCOMP Meiji Seika Kaisha Ltd D01PSI HIGHSTAT Discontinued in Phase 2 D01XDN DRUG__ID D01XDN D01XDN DRUGTYPE Antisense drug D01XDN HIGHSTAT Discontinued in Phase 2 D01YLF DRUG__ID D01YLF D01YLF DRUGCOMP Pain Therapeutics D01YLF HIGHSTAT Discontinued in Phase 2 D02GSA DRUG__ID D02GSA D02GSA DRUGCOMP PPD Wilmington D02GSA HIGHSTAT Discontinued in Phase 2 D02HLL DRUG__ID D02HLL D02HLL DRUGCOMP RaQualia Pharma Inc D02HLL HIGHSTAT Discontinued in Phase 2 D02JNX DRUG__ID D02JNX D02JNX DRUGCOMP Endo Pharmaceuticals D02JNX HIGHSTAT Discontinued in Phase 2 D02TYL DRUG__ID D02TYL D02TYL DRUGCOMP Hermo Pharma Oy Ltd D02TYL HIGHSTAT Discontinued in Phase 2 D02UAR DRUG__ID D02UAR D02UAR DRUGCOMP ImmuCell Corp D02UAR HIGHSTAT Discontinued in Phase 2 D02ZKL DRUG__ID D02ZKL D02ZKL DRUGCOMP Pfizer D02ZKL HIGHSTAT Discontinued in Phase 2 D03AUN DRUG__ID D03AUN D03AUN DRUGCOMP Roche D03AUN HIGHSTAT Discontinued in Phase 2 D03CKX DRUG__ID D03CKX D03CKX DRUGCOMP Millennium Pharmaceuticals D03CKX HIGHSTAT Discontinued in Phase 2 D03KJV DRUG__ID D03KJV D03KJV DRUGCOMP Innovata plc D03KJV HIGHSTAT Discontinued in Phase 2 D03MWM DRUG__ID D03MWM D03MWM DRUGCOMP Dana-Farber Cancer Institute Inc D03MWM HIGHSTAT Discontinued in Phase 2 D03NDI DRUG__ID D03NDI D03NDI DRUGCOMP Novartis AG D03NDI HIGHSTAT Discontinued in Phase 2 D03PVY DRUG__ID D03PVY D03PVY DRUGCOMP Neose Technologies D03PVY HIGHSTAT Discontinued in Phase 2 D03USI DRUG__ID D03USI D03USI DRUGCOMP Synthelabo D03USI HIGHSTAT Discontinued in Phase 2 D03WRN DRUG__ID D03WRN D03WRN DRUGCOMP Avontec GmbH D03WRN HIGHSTAT Discontinued in Phase 2 D03WSE DRUG__ID D03WSE D03WSE DRUGCOMP XOMA Ltd D03WSE HIGHSTAT Discontinued in Phase 2 D04BIG DRUG__ID D04BIG D04BIG DRUGCOMP Sanofi-Synthelabo D04BIG HIGHSTAT Discontinued in Phase 2 D04CON DRUG__ID D04CON D04CON DRUGCOMP Synthelabo D04CON HIGHSTAT Discontinued in Phase 2 D04HHW DRUG__ID D04HHW D04HHW DRUGCOMP Fujisawa Pharmaceutical Co Ltd D04HHW HIGHSTAT Discontinued in Phase 2 D04IBA DRUG__ID D04IBA D04IBA DRUGCOMP Suntory Ltd D04IBA HIGHSTAT Discontinued in Phase 2 D04MNL DRUG__ID D04MNL D04MNL DRUGCOMP Hoechst Marion Roussel Inc D04MNL HIGHSTAT Discontinued in Phase 2 D04NPP DRUG__ID D04NPP D04NPP DRUGCOMP Kadmon Pharmaceuticals; Nano Terra D04NPP HIGHSTAT Discontinued in Phase 2 D04PLC DRUG__ID D04PLC D04PLC DRUGCOMP Sanofi D04PLC HIGHSTAT Discontinued in Phase 2 D04QVN DRUG__ID D04QVN D04QVN DRUGCOMP Fisons plc D04QVN HIGHSTAT Discontinued in Phase 2 D04VKO DRUG__ID D04VKO D04VKO DRUGCOMP Aton Pharma Inc D04VKO HIGHSTAT Discontinued in Phase 2 D04YPZ DRUG__ID D04YPZ D04YPZ DRUGCOMP BTG plc D04YPZ HIGHSTAT Discontinued in Phase 2 D04ZWH DRUG__ID D04ZWH D04ZWH DRUGCOMP Corvas D04ZWH HIGHSTAT Discontinued in Phase 2 D05AHK DRUG__ID D05AHK D05AHK DRUGCOMP Introgen Therapeutics Inc D05AHK HIGHSTAT Discontinued in Phase 2 D05BWX DRUG__ID D05BWX D05BWX DRUGCOMP KS Biomedix Holdings plc D05BWX HIGHSTAT Discontinued in Phase 2 D05CKF DRUG__ID D05CKF D05CKF DRUGCOMP Ajinomoto; Daiichi Sanko D05CKF HIGHSTAT Discontinued in Phase 2 D05DBZ DRUG__ID D05DBZ D05DBZ DRUGCOMP Astellas D05DBZ HIGHSTAT Discontinued in Phase 2 D05EEJ DRUG__ID D05EEJ D05EEJ DRUGCOMP Maret Pharmaceuticals Inc D05EEJ HIGHSTAT Discontinued in Phase 2 D05HYC DRUG__ID D05HYC D05HYC DRUGCOMP Pierre Fabre SA D05HYC HIGHSTAT Discontinued in Phase 2 D05ILZ DRUG__ID D05ILZ D05ILZ DRUGCOMP Novo Nordisk D05ILZ HIGHSTAT Discontinued in Phase 2 D05JCG DRUG__ID D05JCG D05JCG DRUGCOMP KS Biomedix Ltd D05JCG HIGHSTAT Discontinued in Phase 2 D05LSY DRUG__ID D05LSY D05LSY DRUGCOMP Akesis Pharmaceuticals D05LSY HIGHSTAT Discontinued in Phase 2 D05MEL DRUG__ID D05MEL D05MEL DRUGCOMP Novozymes GroPep Limited D05MEL HIGHSTAT Discontinued in Phase 2 D05MWY DRUG__ID D05MWY D05MWY DRUGCOMP SuperGen Inc D05MWY HIGHSTAT Discontinued in Phase 2 D05OFO DRUG__ID D05OFO D05OFO DRUGCOMP Targacept D05OFO HIGHSTAT Discontinued in Phase 2 D05PZZ DRUG__ID D05PZZ D05PZZ DRUGCOMP Dynogen D05PZZ HIGHSTAT Discontinued in Phase 2 D05RBO DRUG__ID D05RBO D05RBO DRUGCOMP Bionetworks GmbH D05RBO HIGHSTAT Discontinued in Phase 2 D05TGV DRUG__ID D05TGV D05TGV DRUGCOMP InterMune D05TGV HIGHSTAT Discontinued in Phase 2 D05VFQ DRUG__ID D05VFQ D05VFQ DRUGCOMP Protherics plc D05VFQ HIGHSTAT Discontinued in Phase 2 D06AVN DRUG__ID D06AVN D06AVN DRUGCOMP Sankyo Co Ltd D06AVN HIGHSTAT Discontinued in Phase 2 D06BHQ DRUG__ID D06BHQ D06BHQ DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D06BHQ HIGHSTAT Discontinued in Phase 2 D06GCP DRUG__ID D06GCP D06GCP DRUGCOMP Roche Bioscience D06GCP HIGHSTAT Discontinued in Phase 2 D06HUF DRUG__ID D06HUF D06HUF DRUGCOMP Zenyth Therapeutics Ltd D06HUF HIGHSTAT Discontinued in Phase 2 D06KRZ DRUG__ID D06KRZ D06KRZ DRUGCOMP Medicure D06KRZ HIGHSTAT Discontinued in Phase 2 D06NEU DRUG__ID D06NEU D06NEU DRUGCOMP Pfizer Inc D06NEU HIGHSTAT Discontinued in Phase 2 D06PYP DRUG__ID D06PYP D06PYP DRUGCOMP Japan Tobacco D06PYP HIGHSTAT Discontinued in Phase 2 D06SNS DRUG__ID D06SNS D06SNS DRUGCOMP Human Genome Sciences D06SNS HIGHSTAT Discontinued in Phase 2 D06XRA DRUG__ID D06XRA D06XRA DRUGCOMP Lundbeck D06XRA HIGHSTAT Discontinued in Phase 2 D07AIE DRUG__ID D07AIE D07AIE DRUGCOMP Basilea Pharmaceutica International Ltd D07AIE HIGHSTAT Discontinued in Phase 2 D07ATG DRUG__ID D07ATG D07ATG DRUGCOMP GlaxoSmithKline D07ATG HIGHSTAT Discontinued in Phase 2 D07BEE DRUG__ID D07BEE D07BEE DRUGCOMP Corixa Corp D07BEE HIGHSTAT Discontinued in Phase 2 D07EIJ DRUG__ID D07EIJ D07EIJ DRUGCOMP EpiGenesis Pharmaceuticals D07EIJ HIGHSTAT Discontinued in Phase 2 D07FDV DRUG__ID D07FDV D07FDV DRUGCOMP Oncolix inc D07FDV HIGHSTAT Discontinued in Phase 2 D07HAD DRUG__ID D07HAD D07HAD DRUGCOMP Genentech D07HAD HIGHSTAT Discontinued in Phase 2 D07MZC DRUG__ID D07MZC D07MZC DRUGCOMP Vascular Therapeutics Inc D07MZC HIGHSTAT Discontinued in Phase 2 D07QKM DRUG__ID D07QKM D07QKM DRUGCOMP Handok Pharmaceuticals D07QKM HIGHSTAT Discontinued in Phase 2 D07SCN DRUG__ID D07SCN D07SCN DRUGCOMP Solvay SA D07SCN HIGHSTAT Discontinued in Phase 2 D07SWU DRUG__ID D07SWU D07SWU DRUGCOMP 7TMPharma. D07SWU HIGHSTAT Discontinued in Phase 2 D07VSA DRUG__ID D07VSA D07VSA DRUGCOMP Keryx Biopharmaceuticals D07VSA HIGHSTAT Discontinued in Phase 2 D07VTD DRUG__ID D07VTD D07VTD DRUGCOMP Chiron Corp D07VTD HIGHSTAT Discontinued in Phase 2 D07WMH DRUG__ID D07WMH D07WMH DRUGCOMP GelTex Pharmaceuticals Inc D07WMH HIGHSTAT Discontinued in Phase 2 D07XMG DRUG__ID D07XMG D07XMG DRUGCOMP Flamel Technologies D07XMG HIGHSTAT Discontinued in Phase 2 D08BVM DRUG__ID D08BVM D08BVM DRUGCOMP TransTech Pharma Inc D08BVM HIGHSTAT Discontinued in Phase 2 D08CCC DRUG__ID D08CCC D08CCC DRUGCOMP Immunomedics D08CCC HIGHSTAT Discontinued in Phase 2 D08CCF DRUG__ID D08CCF D08CCF DRUGCOMP Impax pharmaceuticals D08CCF HIGHSTAT Discontinued in Phase 2 D08CPT DRUG__ID D08CPT D08CPT DRUGCOMP Amylkin; Takeda D08CPT HIGHSTAT Discontinued in Phase 2 D08CSZ DRUG__ID D08CSZ D08CSZ DRUGCOMP Aventis Pharma AG D08CSZ HIGHSTAT Discontinued in Phase 2 D08FZT DRUG__ID D08FZT D08FZT DRUGCOMP Gilead Sciences D08FZT HIGHSTAT Discontinued in Phase 2 D08GEX DRUG__ID D08GEX D08GEX DRUGCOMP Trilex Pharmaceuticals Inc D08GEX HIGHSTAT Discontinued in Phase 2 D08JNE DRUG__ID D08JNE D08JNE DRUGCOMP Roche D08JNE HIGHSTAT Discontinued in Phase 2 D08KWQ DRUG__ID D08KWQ D08KWQ DRUGCOMP Brookhaven National Laboratory D08KWQ HIGHSTAT Discontinued in Phase 2 D08NJQ DRUG__ID D08NJQ D08NJQ DRUGCOMP Tsumura & Co D08NJQ HIGHSTAT Discontinued in Phase 2 D08NNR DRUG__ID D08NNR D08NNR DRUGCOMP Strakan Group plc D08NNR HIGHSTAT Discontinued in Phase 2 D08OJU DRUG__ID D08OJU D08OJU DRUGCOMP Arachnova Therapeutics Ltd D08OJU HIGHSTAT Discontinued in Phase 2 D08PAV DRUG__ID D08PAV D08PAV DRUGCOMP ZymoGenetics Inc D08PAV HIGHSTAT Discontinued in Phase 2 D08RGA DRUG__ID D08RGA D08RGA DRUGCOMP AstraZeneca D08RGA HIGHSTAT Discontinued in Phase 2 D08RMH DRUG__ID D08RMH D08RMH DRUGCOMP Celera South San Francisco D08RMH HIGHSTAT Discontinued in Phase 2 D08TKV DRUG__ID D08TKV D08TKV DRUGCOMP SmithKline Beecham plc D08TKV HIGHSTAT Discontinued in Phase 2 D08VMO DRUG__ID D08VMO D08VMO DRUGCOMP Japan Tobacco Inc D08VMO HIGHSTAT Discontinued in Phase 2 D08WGZ DRUG__ID D08WGZ D08WGZ DRUGCOMP Taisho Pharmaceutical Co Ltd D08WGZ HIGHSTAT Discontinued in Phase 2 D08XRX DRUG__ID D08XRX D08XRX DRUGCOMP Angiogenix Inc D08XRX HIGHSTAT Discontinued in Phase 2 D09BLW DRUG__ID D09BLW D09BLW DRUGCOMP Targeted Genetics Corp D09BLW HIGHSTAT Discontinued in Phase 2 D09DYT DRUG__ID D09DYT D09DYT DRUGCOMP Endotis Pharma D09DYT HIGHSTAT Discontinued in Phase 2 D09EQA DRUG__ID D09EQA D09EQA DRUGCOMP Canopus BioPharma D09EQA HIGHSTAT Discontinued in Phase 2 D09FEN DRUG__ID D09FEN D09FEN DRUGCOMP Cypress Bioscience D09FEN HIGHSTAT Discontinued in Phase 2 D09IZX DRUG__ID D09IZX D09IZX DRUGCOMP Glaxo Wellcome plc D09IZX HIGHSTAT Discontinued in Phase 2 D09MTC DRUG__ID D09MTC D09MTC DRUGCOMP Eli Lilly & Co D09MTC HIGHSTAT Discontinued in Phase 2 D09NEE DRUG__ID D09NEE D09NEE DRUGCOMP Biovitrum D09NEE HIGHSTAT Discontinued in Phase 2 D09OXR DRUG__ID D09OXR D09OXR DRUGCOMP Let's Talk Recovery Inc D09OXR HIGHSTAT Discontinued in Phase 2 D09RNP DRUG__ID D09RNP D09RNP DRUGCOMP GlaxoSmithKline D09RNP HIGHSTAT Discontinued in Phase 2 D09VLQ DRUG__ID D09VLQ D09VLQ DRUGCOMP ViroPharma Inc D09VLQ HIGHSTAT Discontinued in Phase 2 D0A0ZX DRUG__ID D0A0ZX D0A0ZX DRUGCOMP University of New South Wales D0A0ZX HIGHSTAT Discontinued in Phase 2 D0A4HD DRUG__ID D0A4HD D0A4HD DRUGCOMP SangStat Medical Corp D0A4HD HIGHSTAT Discontinued in Phase 2 D0A9CV DRUG__ID D0A9CV D0A9CV DRUGCOMP Thomas Jefferson University D0A9CV HIGHSTAT Discontinued in Phase 2 D0AL3O DRUG__ID D0AL3O D0AL3O DRUGCOMP Vertex Pharmaceuticals Inc D0AL3O HIGHSTAT Discontinued in Phase 2 D0B1NA DRUG__ID D0B1NA D0B1NA DRUGCOMP Silence Therapeutics plc D0B1NA HIGHSTAT Discontinued in Phase 2 D0B2HE DRUG__ID D0B2HE D0B2HE DRUGCOMP Avecia Biologics Ltd D0B2HE HIGHSTAT Discontinued in Phase 2 D0B2OC DRUG__ID D0B2OC D0B2OC DRUGCOMP Sepracor D0B2OC HIGHSTAT Discontinued in Phase 2 D0B3DX DRUG__ID D0B3DX D0B3DX DRUGCOMP YM Biosciences D0B3DX HIGHSTAT Discontinued in Phase 2 D0B3MX DRUG__ID D0B3MX D0B3MX DRUGCOMP Neurocrine Biosciences D0B3MX HIGHSTAT Discontinued in Phase 2 D0B4XU DRUG__ID D0B4XU D0B4XU DRUGCOMP Takeda Pharmaceutical Co Ltd D0B4XU HIGHSTAT Discontinued in Phase 2 D0BB9M DRUG__ID D0BB9M D0BB9M DRUGCOMP Neose Technologies D0BB9M HIGHSTAT Discontinued in Phase 2 D0BZ1Q DRUG__ID D0BZ1Q D0BZ1Q DRUGCOMP CombinatoRx D0BZ1Q HIGHSTAT Discontinued in Phase 2 D0C0EV DRUG__ID D0C0EV D0C0EV DRUGCOMP Acambis plc D0C0EV HIGHSTAT Discontinued in Phase 2 D0C2KV DRUG__ID D0C2KV D0C2KV DRUGCOMP Amylin Pharmaceuticals D0C2KV HIGHSTAT Discontinued in Phase 2 D0C2QJ DRUG__ID D0C2QJ D0C2QJ DRUGCOMP Sepsicure LLC; Glaxo Wellcome plc D0C2QJ HIGHSTAT Discontinued in Phase 2 D0C9HE DRUG__ID D0C9HE D0C9HE DRUGCOMP BioPort Corporation D0C9HE HIGHSTAT Discontinued in Phase 2 D0CC1Y DRUG__ID D0CC1Y D0CC1Y DRUGCOMP University of Strathclyde D0CC1Y HIGHSTAT Discontinued in Phase 2 D0D0WP DRUG__ID D0D0WP D0D0WP DRUGCOMP Orfagen D0D0WP HIGHSTAT Discontinued in Phase 2 D0D2SG DRUG__ID D0D2SG D0D2SG DRUGCOMP Draxis D0D2SG HIGHSTAT Discontinued in Phase 2 D0D2SX DRUG__ID D0D2SX D0D2SX DRUGCOMP Innogenetics NV D0D2SX HIGHSTAT Discontinued in Phase 2 D0D5FQ DRUG__ID D0D5FQ D0D5FQ DRUGCOMP Pfizer D0D5FQ HIGHSTAT Discontinued in Phase 2 D0D6EW DRUG__ID D0D6EW D0D6EW DRUGCOMP Neuren Pharmaceuticals D0D6EW HIGHSTAT Discontinued in Phase 2 D0D8UH DRUG__ID D0D8UH D0D8UH DRUGCOMP BTG plc D0D8UH HIGHSTAT Discontinued in Phase 2 D0E0FY DRUG__ID D0E0FY D0E0FY DRUGCOMP Cobra Biomanufacturing plc D0E0FY HIGHSTAT Discontinued in Phase 2 D0E0QS DRUG__ID D0E0QS D0E0QS DRUGCOMP OsteoArthritis Sciences Inc D0E0QS HIGHSTAT Discontinued in Phase 2 D0E2CQ DRUG__ID D0E2CQ D0E2CQ DRUGCOMP Roche D0E2CQ HIGHSTAT Discontinued in Phase 2 D0E2ED DRUG__ID D0E2ED D0E2ED DRUGCOMP CellGenix Technologie Transfer GmbH D0E2ED HIGHSTAT Discontinued in Phase 2 D0E3EK DRUG__ID D0E3EK D0E3EK DRUGCOMP Biophysica Inc D0E3EK HIGHSTAT Discontinued in Phase 2 D0E4EZ DRUG__ID D0E4EZ D0E4EZ DRUGCOMP Roche D0E4EZ HIGHSTAT Discontinued in Phase 2 D0E5MJ DRUG__ID D0E5MJ D0E5MJ DRUGCOMP Incyte D0E5MJ HIGHSTAT Discontinued in Phase 2 D0E9XG DRUG__ID D0E9XG D0E9XG DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0E9XG HIGHSTAT Discontinued in Phase 2 D0EY5A DRUG__ID D0EY5A D0EY5A DRUGCOMP Valentis Inc D0EY5A HIGHSTAT Discontinued in Phase 2 D0F0YL DRUG__ID D0F0YL D0F0YL DRUGCOMP Sanofi-Synthelabo D0F0YL HIGHSTAT Discontinued in Phase 2 D0F1MU DRUG__ID D0F1MU D0F1MU DRUGCOMP Merck Sante SA D0F1MU HIGHSTAT Discontinued in Phase 2 D0F2IC DRUG__ID D0F2IC D0F2IC DRUGCOMP Stem Cell Therapeutics Corp D0F2IC HIGHSTAT Discontinued in Phase 2 D0F3BY DRUG__ID D0F3BY D0F3BY DRUGCOMP GSK; Elbion D0F3BY HIGHSTAT Discontinued in Phase 2 D0F3EH DRUG__ID D0F3EH D0F3EH DRUGCOMP Sankyo Co Ltd D0F3EH HIGHSTAT Discontinued in Phase 2 D0F6JI DRUG__ID D0F6JI D0F6JI DRUGCOMP AstraZeneca plc D0F6JI HIGHSTAT Discontinued in Phase 2 D0F8EU DRUG__ID D0F8EU D0F8EU DRUGCOMP Molecular Biosystems Inc D0F8EU HIGHSTAT Discontinued in Phase 2 D0F9ND DRUG__ID D0F9ND D0F9ND DRUGCOMP Washington University in St Louis D0F9ND HIGHSTAT Discontinued in Phase 2 D0FD0B DRUG__ID D0FD0B D0FD0B DRUGCOMP OSI Pharmaceuticals D0FD0B HIGHSTAT Discontinued in Phase 2 D0FN6D DRUG__ID D0FN6D D0FN6D DRUGCOMP Neurogen Corp D0FN6D HIGHSTAT Discontinued in Phase 2 D0G2CQ DRUG__ID D0G2CQ D0G2CQ DRUGCOMP AstraZeneca D0G2CQ HIGHSTAT Discontinued in Phase 2 D0G2GT DRUG__ID D0G2GT D0G2GT DRUGCOMP Russian Academy of Sciences D0G2GT HIGHSTAT Discontinued in Phase 2 D0G4OT DRUG__ID D0G4OT D0G4OT DRUGCOMP Exelixis D0G4OT HIGHSTAT Discontinued in Phase 2 D0G6ES DRUG__ID D0G6ES D0G6ES DRUGCOMP TAP Pharmaceuticals Inc D0G6ES HIGHSTAT Discontinued in Phase 2 D0GA1Q DRUG__ID D0GA1Q D0GA1Q DRUGCOMP AstraZeneca plc D0GA1Q HIGHSTAT Discontinued in Phase 2 D0GY1D DRUG__ID D0GY1D D0GY1D DRUGCOMP Faust Pharmaceuticals D0GY1D HIGHSTAT Discontinued in Phase 2 D0H0VW DRUG__ID D0H0VW D0H0VW DRUGCOMP Dana-Farber Cancer Institute Inc D0H0VW HIGHSTAT Discontinued in Phase 2 D0H0ZU DRUG__ID D0H0ZU D0H0ZU DRUGCOMP Mitsubishi Tanabe Pharma Corp D0H0ZU HIGHSTAT Discontinued in Phase 2 D0H2KV DRUG__ID D0H2KV D0H2KV DRUGCOMP Alantos Pharmaceuticals D0H2KV HIGHSTAT Discontinued in Phase 2 D0HB4E DRUG__ID D0HB4E D0HB4E DRUGCOMP Incyte D0HB4E HIGHSTAT Discontinued in Phase 2 D0I2MA DRUG__ID D0I2MA D0I2MA DRUGCOMP Nissin Foods Holdings Co Ltd D0I2MA HIGHSTAT Discontinued in Phase 2 D0I4PL DRUG__ID D0I4PL D0I4PL DRUGCOMP Bristol-Myers Squibb D0I4PL HIGHSTAT Discontinued in Phase 2 D0I5QL DRUG__ID D0I5QL D0I5QL DRUGCOMP Liponex Inc D0I5QL HIGHSTAT Discontinued in Phase 2 D0I7LB DRUG__ID D0I7LB D0I7LB DRUGCOMP AstraZeneca plc D0I7LB HIGHSTAT Discontinued in Phase 2 D0I7OE DRUG__ID D0I7OE D0I7OE DRUGCOMP ImmuCell Corp D0I7OE HIGHSTAT Discontinued in Phase 2 D0I8GU DRUG__ID D0I8GU D0I8GU DRUGCOMP Enhance Biotech D0I8GU HIGHSTAT Discontinued in Phase 2 D0I9MG DRUG__ID D0I9MG D0I9MG DRUGCOMP Immuron Ltd D0I9MG HIGHSTAT Discontinued in Phase 2 D0ID2I DRUG__ID D0ID2I D0ID2I DRUGCOMP Emergent BioSolutions D0ID2I HIGHSTAT Discontinued in Phase 2 D0IL2B DRUG__ID D0IL2B D0IL2B DRUGCOMP King's College London D0IL2B HIGHSTAT Discontinued in Phase 2 D0J0KX DRUG__ID D0J0KX D0J0KX DRUGCOMP Pfizer Inc D0J0KX HIGHSTAT Discontinued in Phase 2 D0J2BH DRUG__ID D0J2BH D0J2BH DRUGCOMP Cancer Research Campaign Technology Ltd D0J2BH HIGHSTAT Discontinued in Phase 2 D0J3CC DRUG__ID D0J3CC D0J3CC DRUGCOMP Praecis Pharmaceuticals Inc D0J3CC HIGHSTAT Discontinued in Phase 2 D0J7EP DRUG__ID D0J7EP D0J7EP DRUGCOMP Avineuro Pharmaceuticals D0J7EP HIGHSTAT Discontinued in Phase 2 D0J8WJ DRUG__ID D0J8WJ D0J8WJ DRUGCOMP Akela Pharma Inc D0J8WJ HIGHSTAT Discontinued in Phase 2 D0J8WO DRUG__ID D0J8WO D0J8WO DRUGCOMP Takeda Pharmaceuticals U.S.A. D0J8WO HIGHSTAT Discontinued in Phase 2 D0J9NJ DRUG__ID D0J9NJ D0J9NJ DRUGCOMP Calyx Therapeutics D0J9NJ HIGHSTAT Discontinued in Phase 2 D0J9UB DRUG__ID D0J9UB D0J9UB DRUGCOMP Seattle Genetics; Roche D0J9UB HIGHSTAT Discontinued in Phase 2 D0JA1Z DRUG__ID D0JA1Z D0JA1Z DRUGCOMP GlaxoSmithKline plc D0JA1Z HIGHSTAT Discontinued in Phase 2 D0K0FV DRUG__ID D0K0FV D0K0FV DRUGCOMP Quigley Pharma D0K0FV HIGHSTAT Discontinued in Phase 2 D0K1LO DRUG__ID D0K1LO D0K1LO DRUGCOMP Roche Holding AG D0K1LO HIGHSTAT Discontinued in Phase 2 D0K3LX DRUG__ID D0K3LX D0K3LX DRUGCOMP Dendreon San Diego LLC D0K3LX HIGHSTAT Discontinued in Phase 2 D0K5LT DRUG__ID D0K5LT D0K5LT DRUGCOMP StemCyte D0K5LT HIGHSTAT Discontinued in Phase 2 D0KF6X DRUG__ID D0KF6X D0KF6X DRUGCOMP Millenium Pharmacenticals; Sanofi Aventis D0KF6X HIGHSTAT Discontinued in Phase 2 D0KY4O DRUG__ID D0KY4O D0KY4O DRUGCOMP Astion D0KY4O HIGHSTAT Discontinued in Phase 2 D0L1DU DRUG__ID D0L1DU D0L1DU DRUGCOMP Genzyme D0L1DU HIGHSTAT Discontinued in Phase 2 D0L3MZ DRUG__ID D0L3MZ D0L3MZ DRUGCOMP Sirna Therapeutics Inc D0L3MZ HIGHSTAT Discontinued in Phase 2 D0L7MA DRUG__ID D0L7MA D0L7MA DRUGCOMP Acorda therapeutics D0L7MA HIGHSTAT Discontinued in Phase 2 D0L7OY DRUG__ID D0L7OY D0L7OY DRUGCOMP Astra AB D0L7OY HIGHSTAT Discontinued in Phase 2 D0L8CJ DRUG__ID D0L8CJ D0L8CJ DRUGCOMP Miravant Medical Technologies D0L8CJ HIGHSTAT Discontinued in Phase 2 D0L8WA DRUG__ID D0L8WA D0L8WA DRUGCOMP SR Pharma D0L8WA HIGHSTAT Discontinued in Phase 2 D0LF5B DRUG__ID D0LF5B D0LF5B DRUGCOMP Bayer AG D0LF5B HIGHSTAT Discontinued in Phase 2 D0LU6N DRUG__ID D0LU6N D0LU6N DRUGCOMP Shire Pharmaceuticals; Knoll Pharmaceuticals Co D0LU6N HIGHSTAT Discontinued in Phase 2 D0M4RX DRUG__ID D0M4RX D0M4RX DRUGCOMP Roche D0M4RX HIGHSTAT Discontinued in Phase 2 D0M5CU DRUG__ID D0M5CU D0M5CU DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0M5CU HIGHSTAT Discontinued in Phase 2 D0M5XE DRUG__ID D0M5XE D0M5XE DRUGCOMP Piramal Life Sciences Ltd D0M5XE HIGHSTAT Discontinued in Phase 2 D0M8PL DRUG__ID D0M8PL D0M8PL DRUGCOMP Sirna Therapeutics Inc D0M8PL HIGHSTAT Discontinued in Phase 2 D0M9LB DRUG__ID D0M9LB D0M9LB DRUGCOMP NeuroSearch A/S D0M9LB HIGHSTAT Discontinued in Phase 2 D0MF3C DRUG__ID D0MF3C D0MF3C DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D0MF3C HIGHSTAT Discontinued in Phase 2 D0N0OG DRUG__ID D0N0OG D0N0OG DRUGCOMP Japan Polio; Takeda D0N0OG HIGHSTAT Discontinued in Phase 2 D0N2RF DRUG__ID D0N2RF D0N2RF DRUGCOMP Novartis AG D0N2RF HIGHSTAT Discontinued in Phase 2 D0N4JG DRUG__ID D0N4JG D0N4JG DRUGCOMP IDM Pharma D0N4JG HIGHSTAT Discontinued in Phase 2 D0N5BL DRUG__ID D0N5BL D0N5BL DRUGCOMP Ajinomoto Co Inc D0N5BL HIGHSTAT Discontinued in Phase 2 D0N7DW DRUG__ID D0N7DW D0N7DW DRUGCOMP Intercell USA D0N7DW HIGHSTAT Discontinued in Phase 2 D0N7ML DRUG__ID D0N7ML D0N7ML DRUGCOMP Novozymes GroPep Limited D0N7ML HIGHSTAT Discontinued in Phase 2 D0N8JA DRUG__ID D0N8JA D0N8JA DRUGCOMP Genencor International Inc D0N8JA HIGHSTAT Discontinued in Phase 2 D0N8JB DRUG__ID D0N8JB D0N8JB DRUGCOMP Japan Tobacco Inc D0N8JB HIGHSTAT Discontinued in Phase 2 D0NN0I DRUG__ID D0NN0I D0NN0I DRUGCOMP Dendreon D0NN0I HIGHSTAT Discontinued in Phase 2 D0NO8S DRUG__ID D0NO8S D0NO8S DRUGCOMP Acambis D0NO8S HIGHSTAT Discontinued in Phase 2 D0O0VW DRUG__ID D0O0VW D0O0VW DRUGCOMP CEL-SCI D0O0VW HIGHSTAT Discontinued in Phase 2 D0O1YF DRUG__ID D0O1YF D0O1YF DRUGCOMP Taizhou Fudan-Zhangjiang Pharmaceutical Co Ltd D0O1YF HIGHSTAT Discontinued in Phase 2 D0O2FF DRUG__ID D0O2FF D0O2FF DRUGCOMP Cerus D0O2FF HIGHSTAT Discontinued in Phase 2 D0O6WZ DRUG__ID D0O6WZ D0O6WZ DRUGCOMP Telios Pharmaceuticals Inc D0O6WZ HIGHSTAT Discontinued in Phase 2 D0O8HL DRUG__ID D0O8HL D0O8HL DRUGCOMP Merck Sante SA D0O8HL HIGHSTAT Discontinued in Phase 2 D0P0RP DRUG__ID D0P0RP D0P0RP DRUGCOMP Demegen D0P0RP HIGHSTAT Discontinued in Phase 2 D0P4RA DRUG__ID D0P4RA D0P4RA DRUGCOMP Human Genome Sciences Inc D0P4RA HIGHSTAT Discontinued in Phase 2 D0P5NY DRUG__ID D0P5NY D0P5NY DRUGCOMP Shire Pharmaceuticals D0P5NY HIGHSTAT Discontinued in Phase 2 D0P8MG DRUG__ID D0P8MG D0P8MG DRUGCOMP Kadmus Pharmaceuticals D0P8MG HIGHSTAT Discontinued in Phase 2 D0PB1C DRUG__ID D0PB1C D0PB1C DRUGCOMP Phosphagenics D0PB1C HIGHSTAT Discontinued in Phase 2 D0PH0M DRUG__ID D0PH0M D0PH0M DRUGCOMP IDM Pharma D0PH0M HIGHSTAT Discontinued in Phase 2 D0PU5L DRUG__ID D0PU5L D0PU5L DRUGCOMP Pharmos Corp D0PU5L HIGHSTAT Discontinued in Phase 2 D0Q0JJ DRUG__ID D0Q0JJ D0Q0JJ DRUGCOMP Emergent BioSolutions D0Q0JJ HIGHSTAT Discontinued in Phase 2 D0Q1IH DRUG__ID D0Q1IH D0Q1IH DRUGCOMP Kythera Biopharmaceuticals D0Q1IH HIGHSTAT Discontinued in Phase 2 D0Q1KN DRUG__ID D0Q1KN D0Q1KN DRUGCOMP SR Pharma D0Q1KN HIGHSTAT Discontinued in Phase 2 D0Q2BG DRUG__ID D0Q2BG D0Q2BG DRUGCOMP The Medicines Company D0Q2BG HIGHSTAT Discontinued in Phase 2 D0Q2JB DRUG__ID D0Q2JB D0Q2JB DRUGCOMP Pfizer Inc D0Q2JB HIGHSTAT Discontinued in Phase 2 D0Q2RF DRUG__ID D0Q2RF D0Q2RF DRUGCOMP Ariel pharmaceuticals D0Q2RF HIGHSTAT Discontinued in Phase 2 D0Q6FV DRUG__ID D0Q6FV D0Q6FV DRUGCOMP Tsumura & Co D0Q6FV HIGHSTAT Discontinued in Phase 2 D0Q8OW DRUG__ID D0Q8OW D0Q8OW DRUGCOMP Corixa Corp D0Q8OW HIGHSTAT Discontinued in Phase 2 D0Q9HT DRUG__ID D0Q9HT D0Q9HT DRUGCOMP Eli Lilly & Co D0Q9HT HIGHSTAT Discontinued in Phase 2 D0R3RO DRUG__ID D0R3RO D0R3RO DRUGCOMP AstraZeneca plc D0R3RO HIGHSTAT Discontinued in Phase 2 D0R4DN DRUG__ID D0R4DN D0R4DN DRUGCOMP Neurotech Pharmaceuticals Inc D0R4DN HIGHSTAT Discontinued in Phase 2 D0R4GM DRUG__ID D0R4GM D0R4GM DRUGCOMP Medarex D0R4GM HIGHSTAT Discontinued in Phase 2 D0R6RB DRUG__ID D0R6RB D0R6RB DRUGCOMP Queen's University at Kingston D0R6RB HIGHSTAT Discontinued in Phase 2 D0R6RM DRUG__ID D0R6RM D0R6RM DRUGCOMP Collegium Pharmaceuticals D0R6RM HIGHSTAT Discontinued in Phase 2 D0R7OZ DRUG__ID D0R7OZ D0R7OZ DRUGCOMP BTG International D0R7OZ HIGHSTAT Discontinued in Phase 2 D0R8CE DRUG__ID D0R8CE D0R8CE DRUGCOMP Medivir AB D0R8CE HIGHSTAT Discontinued in Phase 2 D0S0GM DRUG__ID D0S0GM D0S0GM DRUGCOMP Addex Pharmaceuticals; Novo Nordisk A/S D0S0GM HIGHSTAT Discontinued in Phase 2 D0S1PM DRUG__ID D0S1PM D0S1PM DRUGCOMP Ranbaxy Laboratories Ltd D0S1PM HIGHSTAT Discontinued in Phase 2 D0S2LQ DRUG__ID D0S2LQ D0S2LQ DRUGCOMP Nastech; Merck D0S2LQ HIGHSTAT Discontinued in Phase 2 D0S3MY DRUG__ID D0S3MY D0S3MY DRUGCOMP Pfizer D0S3MY HIGHSTAT Discontinued in Phase 2 D0S3XA DRUG__ID D0S3XA D0S3XA DRUGCOMP Louisiana State University Medical Center Foundation D0S3XA HIGHSTAT Discontinued in Phase 2 D0S7EQ DRUG__ID D0S7EQ D0S7EQ DRUGCOMP Panacos Pharmaceuticals Inc D0S7EQ HIGHSTAT Discontinued in Phase 2 D0S8DB DRUG__ID D0S8DB D0S8DB DRUGCOMP Organon BioSciences D0S8DB HIGHSTAT Discontinued in Phase 2 D0S8VG DRUG__ID D0S8VG D0S8VG DRUGCOMP PregLem Holding SA D0S8VG HIGHSTAT Discontinued in Phase 2 D0S9KM DRUG__ID D0S9KM D0S9KM DRUGCOMP Neurogen Corporation D0S9KM HIGHSTAT Discontinued in Phase 2 D0ST5P DRUG__ID D0ST5P D0ST5P DRUGCOMP Tanabe Seiyaku Co Ltd D0ST5P HIGHSTAT Discontinued in Phase 2 D0T1ZJ DRUG__ID D0T1ZJ D0T1ZJ DRUGCOMP Vical Inc D0T1ZJ HIGHSTAT Discontinued in Phase 2 D0T3CE DRUG__ID D0T3CE D0T3CE DRUGCOMP Diatos SA D0T3CE HIGHSTAT Discontinued in Phase 2 D0T4XQ DRUG__ID D0T4XQ D0T4XQ DRUGCOMP Sunovion Pharmaceuticals Inc D0T4XQ HIGHSTAT Discontinued in Phase 2 D0T5MB DRUG__ID D0T5MB D0T5MB DRUGCOMP H Lundbeck A/S D0T5MB HIGHSTAT Discontinued in Phase 2 D0T6MM DRUG__ID D0T6MM D0T6MM DRUGCOMP Zenyth Therapeutics Ltd D0T6MM HIGHSTAT Discontinued in Phase 2 D0U1IR DRUG__ID D0U1IR D0U1IR DRUGCOMP Access Pharmaceuticals Inc D0U1IR HIGHSTAT Discontinued in Phase 2 D0U8MF DRUG__ID D0U8MF D0U8MF DRUGCOMP Epimmune Inc D0U8MF HIGHSTAT Discontinued in Phase 2 D0UG4P DRUG__ID D0UG4P D0UG4P DRUGCOMP Archemix D0UG4P HIGHSTAT Discontinued in Phase 2 D0V0FQ DRUG__ID D0V0FQ D0V0FQ DRUGCOMP Regeneron Pharmaceuticals D0V0FQ HIGHSTAT Discontinued in Phase 2 D0V2CN DRUG__ID D0V2CN D0V2CN DRUGCOMP Almirall Prodesfarma SA D0V2CN HIGHSTAT Discontinued in Phase 2 D0V2OS DRUG__ID D0V2OS D0V2OS DRUGCOMP Daiichi Sankyo Co Ltd D0V2OS HIGHSTAT Discontinued in Phase 2 D0V4CL DRUG__ID D0V4CL D0V4CL DRUGCOMP Welfide Corp D0V4CL HIGHSTAT Discontinued in Phase 2 D0V5GO DRUG__ID D0V5GO D0V5GO DRUGCOMP IsoTis OrthoBiologics D0V5GO HIGHSTAT Discontinued in Phase 2 D0VA2I DRUG__ID D0VA2I D0VA2I DRUGCOMP CombinatoRx D0VA2I HIGHSTAT Discontinued in Phase 2 D0VO3H DRUG__ID D0VO3H D0VO3H DRUGCOMP Cell Genesys D0VO3H HIGHSTAT Discontinued in Phase 2 D0VT0T DRUG__ID D0VT0T D0VT0T DRUGCOMP Neurologix Inc D0VT0T HIGHSTAT Discontinued in Phase 2 D0W2EA DRUG__ID D0W2EA D0W2EA DRUGCOMP Epimmune Inc D0W2EA HIGHSTAT Discontinued in Phase 2 D0W2IU DRUG__ID D0W2IU D0W2IU DRUGCOMP Genfit SA D0W2IU HIGHSTAT Discontinued in Phase 2 D0W5KA DRUG__ID D0W5KA D0W5KA DRUGCOMP Daiichi Seiyaku Co Ltd D0W5KA HIGHSTAT Discontinued in Phase 2 D0W6AB DRUG__ID D0W6AB D0W6AB DRUGCOMP GE Healthcare D0W6AB HIGHSTAT Discontinued in Phase 2 D0W7GH DRUG__ID D0W7GH D0W7GH DRUGCOMP ICOS Corp D0W7GH HIGHSTAT Discontinued in Phase 2 D0WL0G DRUG__ID D0WL0G D0WL0G DRUGCOMP Phynova Group plc D0WL0G HIGHSTAT Discontinued in Phase 2 D0WU3G DRUG__ID D0WU3G D0WU3G DRUGCOMP Resolution Pharmaceuticals Inc D0WU3G HIGHSTAT Discontinued in Phase 2 D0X1LO DRUG__ID D0X1LO D0X1LO DRUGCOMP Merck KGaA D0X1LO HIGHSTAT Discontinued in Phase 2 D0X2KY DRUG__ID D0X2KY D0X2KY DRUGCOMP North American Scientific D0X2KY HIGHSTAT Discontinued in Phase 2 D0X4IV DRUG__ID D0X4IV D0X4IV DRUGCOMP Metris Therapeutics Ltd D0X4IV HIGHSTAT Discontinued in Phase 2 D0X6XF DRUG__ID D0X6XF D0X6XF DRUGCOMP Vitae Pharmaceuticals D0X6XF HIGHSTAT Discontinued in Phase 2 D0X7IW DRUG__ID D0X7IW D0X7IW DRUGCOMP Acambis plc D0X7IW HIGHSTAT Discontinued in Phase 2 D0X7NT DRUG__ID D0X7NT D0X7NT DRUGCOMP Novartis AG D0X7NT HIGHSTAT Discontinued in Phase 2 D0XH1P DRUG__ID D0XH1P D0XH1P DRUGCOMP Zalicus D0XH1P HIGHSTAT Discontinued in Phase 2 D0XJ4G DRUG__ID D0XJ4G D0XJ4G DRUGCOMP Pfizer New York, NY D0XJ4G HIGHSTAT Discontinued in Phase 2 D0XQ6J DRUG__ID D0XQ6J D0XQ6J DRUGCOMP GE Healthcare D0XQ6J HIGHSTAT Discontinued in Phase 2 D0Y1VZ DRUG__ID D0Y1VZ D0Y1VZ DRUGCOMP Peptimmune D0Y1VZ HIGHSTAT Discontinued in Phase 2 D0Y2HH DRUG__ID D0Y2HH D0Y2HH DRUGCOMP Kemia D0Y2HH HIGHSTAT Discontinued in Phase 2 D0Y3RY DRUG__ID D0Y3RY D0Y3RY DRUGCOMP Abiocode; Hoffmann-La Roche AG D0Y3RY HIGHSTAT Discontinued in Phase 2 D0Y6ZS DRUG__ID D0Y6ZS D0Y6ZS DRUGCOMP Entropin Inc D0Y6ZS HIGHSTAT Discontinued in Phase 2 D0Y9NE DRUG__ID D0Y9NE D0Y9NE DRUGCOMP NextWave Pharmaceuticals Inc D0Y9NE HIGHSTAT Discontinued in Phase 2 D0YA0N DRUG__ID D0YA0N D0YA0N DRUGCOMP Genentech; Biogen Idec D0YA0N HIGHSTAT Discontinued in Phase 2 D0YL3E DRUG__ID D0YL3E D0YL3E DRUGCOMP GSK D0YL3E HIGHSTAT Discontinued in Phase 2 D0YQ3M DRUG__ID D0YQ3M D0YQ3M DRUGCOMP Epix Pharmaceutical D0YQ3M HIGHSTAT Discontinued in Phase 2 D0YS0B DRUG__ID D0YS0B D0YS0B DRUGCOMP Dompe SpA D0YS0B HIGHSTAT Discontinued in Phase 2 D0Z1VS DRUG__ID D0Z1VS D0Z1VS DRUGCOMP Pfizer D0Z1VS HIGHSTAT Discontinued in Phase 2 D0Z5AC DRUG__ID D0Z5AC D0Z5AC DRUGCOMP Aphton D0Z5AC HIGHSTAT Discontinued in Phase 2 D0Z5LB DRUG__ID D0Z5LB D0Z5LB DRUGCOMP Altea Therapeutics D0Z5LB HIGHSTAT Discontinued in Phase 2 D0Z8UQ DRUG__ID D0Z8UQ D0Z8UQ DRUGCOMP DiaMedica Inc D0Z8UQ HIGHSTAT Discontinued in Phase 2 D0Z9MR DRUG__ID D0Z9MR D0Z9MR DRUGCOMP Transgene SA D0Z9MR HIGHSTAT Discontinued in Phase 2 D0Z9OS DRUG__ID D0Z9OS D0Z9OS DRUGCOMP Dynport vaccine D0Z9OS HIGHSTAT Discontinued in Phase 2 D0ZI0K DRUG__ID D0ZI0K D0ZI0K DRUGCOMP NitroMed D0ZI0K HIGHSTAT Discontinued in Phase 2 D0ZR3N DRUG__ID D0ZR3N D0ZR3N DRUGCOMP Progenics D0ZR3N HIGHSTAT Discontinued in Phase 2 D0ZW5Y DRUG__ID D0ZW5Y D0ZW5Y DRUGCOMP Therion Biologics Corp D0ZW5Y HIGHSTAT Discontinued in Phase 2 D0ZY9U DRUG__ID D0ZY9U D0ZY9U DRUGCOMP Solvay SA D0ZY9U HIGHSTAT Discontinued in Phase 2 D00ZNP DRUG__ID D00ZNP D00ZNP HIGHSTAT Discontinued in Phase 2 D01EDS DRUG__ID D01EDS D01EDS HIGHSTAT Discontinued in Phase 2 D01XAR DRUG__ID D01XAR D01XAR HIGHSTAT Discontinued in Phase 2 D03FVI DRUG__ID D03FVI D03FVI HIGHSTAT Discontinued in Phase 2 D04HLE DRUG__ID D04HLE D04HLE HIGHSTAT Discontinued in Phase 2 D06DUO DRUG__ID D06DUO D06DUO HIGHSTAT Discontinued in Phase 2 D08VGT DRUG__ID D08VGT D08VGT HIGHSTAT Discontinued in Phase 2 D09WRI DRUG__ID D09WRI D09WRI HIGHSTAT Discontinued in Phase 2 D0A6YN DRUG__ID D0A6YN D0A6YN HIGHSTAT Discontinued in Phase 2 D0D9KQ DRUG__ID D0D9KQ D0D9KQ HIGHSTAT Discontinued in Phase 2 D0H4NQ DRUG__ID D0H4NQ D0H4NQ HIGHSTAT Discontinued in Phase 2 D0K4WT DRUG__ID D0K4WT D0K4WT HIGHSTAT Discontinued in Phase 2 D0P3TT DRUG__ID D0P3TT D0P3TT HIGHSTAT Discontinued in Phase 2 D0S8YV DRUG__ID D0S8YV D0S8YV HIGHSTAT Discontinued in Phase 2 D0T2TK DRUG__ID D0T2TK D0T2TK HIGHSTAT Discontinued in Phase 2 D0VS3J DRUG__ID D0VS3J D0VS3J HIGHSTAT Discontinued in Phase 2 D00PDG DRUG__ID D00PDG D00PDG DRUGCOMP Corcept Therapeutics D00PDG DRUGTYPE Small molecular drug D00PDG DRUGINCH 1S/C26H25F4N3O3S/c1-2-36-17-25-14-18-15-31-33(22-7-5-21(27)6-8-22)24(18)13-20(25)11-12-32(16-25)37(34,35)23-9-3-19(4-10-23)26(28,29)30/h3-10,13,15H,2,11-12,14,16-17H2,1H3/t25-/m1/s1 D00PDG DRUGINKE SLKURXRZHJOZOD-RUZDIDTESA-N D00PDG DRUGSMIL CCOCC12CC3=C(C=C1CCN(C2)S(=O)(=O)C4=CC=C(C=C4)C(F)(F)F)N(N=C3)C5=CC=C(C=C5)F D00PDG HIGHSTAT Discontinued in Phase 1/2 D00VLF DRUG__ID D00VLF D00VLF DRUGCOMP Okairos D00VLF DRUGTYPE Small molecular drug D00VLF DRUGINCH 1S/C15H27N3O6S/c1-8(2)12(15(23)24)18-13(20)10(6-7-25)17-11(19)5-3-4-9(16)14(21)22/h8-10,12,25H,3-7,16H2,1-2H3,(H,17,19)(H,18,20)(H,21,22)(H,23,24)/t9-,10-,12+/m0/s1 D00VLF DRUGINKE WDPVNDRNBJNETA-JBLDHEPKSA-N D00VLF DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CCS)NC(=O)CCCC(C(=O)O)N D00VLF HIGHSTAT Discontinued in Phase 1/2 D08INO DRUG__ID D08INO D08INO DRUGCOMP Wilex D08INO DRUGTYPE Small molecular drug D08INO DRUGINCH 1S/C32H47N5O5S/c1-8-42-32(39)37-14-12-36(13-15-37)31(38)28(17-23-10-9-11-24(16-23)30(33)34)35-43(40,41)29-26(21(4)5)18-25(20(2)3)19-27(29)22(6)7/h9-11,16,18-22,28,35H,8,12-15,17H2,1-7H3,(H3,33,34) D08INO DRUGINKE ISJSHQTWOHGCMM-UHFFFAOYSA-N D08INO DRUGSMIL CCOC(=O)N1CCN(CC1)C(=O)C(CC2=CC(=CC=C2)C(=N)N)NS(=O)(=O)C3=C(C=C(C=C3C(C)C)C(C)C)C(C)C D08INO HIGHSTAT Discontinued in Phase 1/2 D08KVK DRUG__ID D08KVK D08KVK DRUGCOMP Cytos Biotechnology D08KVK DRUGTYPE Small molecular drug D08KVK DRUGINCH 1S/C21H30N7O17P3.C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32;22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35);1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t2*10-,11-,13-,14-,15-,16-,20-,21-/m11/s1 D08KVK DRUGINKE HDXXPHUBUBEPGJ-JJVDBIKMSA-N D08KVK DRUGSMIL C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O.C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O D08KVK HIGHSTAT Discontinued in Phase 1/2 D09VTB DRUG__ID D09VTB D09VTB DRUGCOMP Idenix Pharmaceuticals Inc D09VTB DRUGTYPE Small molecular drug D09VTB DRUGINCH 1S/C37H43F3N6O7S2/c1-21-27(52-4)11-10-24-28(18-25(41-30(21)24)32-42-29(20-54-32)37(38,39)40)53-23-12-16-46-26(17-23)31(47)43-36(33(48)44-55(50,51)35(2)13-14-35)19-22(36)9-7-5-6-8-15-45(3)34(46)49/h7,9-11,18,20,22-23,26H,5-6,8,12-17,19H2,1-4H3,(H,43,47)(H,44,48)/b9-7+/t22-,23+,26+,36-/m1/s1 D09VTB DRUGINKE YEPBUHWNLNKZBW-FDVAVYTKSA-N D09VTB DRUGSMIL CC1=C(C=CC2=C1N=C(C=C2OC3CCN4C(C3)C(=O)NC5(CC5C=CCCCCN(C4=O)C)C(=O)NS(=O)(=O)C6(CC6)C)C7=NC(=CS7)C(F)(F)F)OC D09VTB HIGHSTAT Discontinued in Phase 1/2 D0A9JW DRUG__ID D0A9JW D0A9JW DRUGCOMP Tripep D0A9JW DRUGTYPE Small molecular drug D0A9JW DRUGINCH 1S/C22H29N10O10P/c23-21-27-17-11(19(37)29-21)25-5-31(17)9-2-8(13(34)14(9)35)4-41-43(39,40)42-16-7(3-33)1-10(15(16)36)32-6-26-12-18(32)28-22(24)30-20(12)38/h5-10,13-16,33-36H,1-4H2,(H,39,40)(H3,23,27,29,37)(H3,24,28,30,38)/t7-,8-,9-,10-,13-,14+,15+,16-/m1/s1 D0A9JW DRUGINKE WGYAYVXBDYHRBW-QPVXRGBGSA-N D0A9JW DRUGSMIL C1C(C(C(C1N2C=NC3=C2N=C(NC3=O)N)O)OP(=O)(O)OCC4CC(C(C4O)O)N5C=NC6=C5N=C(NC6=O)N)CO D0A9JW HIGHSTAT Discontinued in Phase 1/2 D0K1VK DRUG__ID D0K1VK D0K1VK DRUGCOMP AstraZeneca D0K1VK DRUGTYPE Small molecular drug D0K1VK DRUGINCH 1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1 D0K1VK DRUGINKE KVLFRAWTRWDEDF-IRXDYDNUSA-N D0K1VK DRUGSMIL CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C D0K1VK HIGHSTAT Discontinued in Phase 1/2 D0M2SR DRUG__ID D0M2SR D0M2SR DRUGCOMP Rigel Pharmaceuticals Inc D0M2SR DRUGTYPE Small molecular drug D0M2SR DRUGINCH 1S/C17H14O3/c1-11(17(18)19)13-8-5-9-14-15(10-20-16(13)14)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19) D0M2SR DRUGINKE ODZUWQAFWMLWCF-UHFFFAOYSA-N D0M2SR DRUGSMIL CC(C1=CC=CC2=C1OC=C2C3=CC=CC=C3)C(=O)O D0M2SR HIGHSTAT Discontinued in Phase 1/2 D0N5SC DRUG__ID D0N5SC D0N5SC DRUGCOMP Pfizer D0N5SC DRUGTYPE Small molecular drug D0N5SC DRUGINCH 1S/C23H33N7O5S/c1-5-18-19-20(27-30(18)12-13-34-4)22(31)26-21(25-19)17-14-16(15-24-23(17)35-7-3)36(32,33)29-10-8-28(6-2)9-11-29/h14-15H,5-13H2,1-4H3,(H,25,26,31) D0N5SC DRUGINKE YPFZMBHKIVDSNR-UHFFFAOYSA-N D0N5SC DRUGSMIL CCC1=C2C(=NN1CCOC)C(=O)NC(=N2)C3=C(N=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC D0N5SC HIGHSTAT Discontinued in Phase 1/2 D0NK6Z DRUG__ID D0NK6Z D0NK6Z DRUGCOMP LifeTime Pharmaceuticals D0NK6Z DRUGTYPE Small molecular drug D0NK6Z DRUGINCH 1S/C10H22N4O2S2/c11-3-1-9(15)13-5-7-17-18-8-6-14-10(16)2-4-12/h1-8,11-12H2,(H,13,15)(H,14,16) D0NK6Z DRUGINKE WELIVEBWRWAGOM-UHFFFAOYSA-N D0NK6Z DRUGSMIL C(CN)C(=O)NCCSSCCNC(=O)CCN D0NK6Z HIGHSTAT Discontinued in Phase 1/2 D0S7LN DRUG__ID D0S7LN D0S7LN DRUGCOMP Achillion Pharmaceuticals Inc D0S7LN DRUGTYPE Small molecular drug D0S7LN DRUGINCH 1S/C19H20F3N3O2S/c1-2-3-4-10-27-16-8-7-14(11-15(16)19(20,21)22)24-18(28)25-17(26)13-6-5-9-23-12-13/h5-9,11-12H,2-4,10H2,1H3,(H2,24,25,26,28) D0S7LN DRUGINKE WJSGOXONRXFGRY-UHFFFAOYSA-N D0S7LN DRUGSMIL CCCCCOC1=C(C=C(C=C1)NC(=S)NC(=O)C2=CN=CC=C2)C(F)(F)F D0S7LN HIGHSTAT Discontinued in Phase 1/2 D07MVE DRUG__ID D07MVE D07MVE DRUGTYPE Small molecular drug D07MVE DRUGINCH 1S/C16H18N2O2/c1-19-15-6-2-4-13(10-15)5-3-9-20-17-16-12-18-8-7-14(16)11-18/h2,4,6,10,14H,7-9,11-12H2,1H3/b17-16+/t14-/m1/s1 D07MVE DRUGINKE FXBXWJPMXQHOGD-UVTIVQHFSA-N D07MVE DRUGSMIL COC1=CC=CC(=C1)C#CCON=C2CN3CCC2C3 D07MVE HIGHSTAT Discontinued in Phase 1/2 D09HEV DRUG__ID D09HEV D09HEV DRUGCOMP Gilead Sciences Inc D09HEV DRUGINCH 1S/C29H34N6O/c1-33-15-17-34(18-16-33)22-9-11-23(12-10-22)35-19-26(27-28(30)31-20-32-29(27)35)21-7-13-25(14-8-21)36-24-5-3-2-4-6-24/h2-8,13-14,19-20,22-23H,9-12,15-18H2,1H3,(H2,30,31,32) D09HEV DRUGINKE FDVSOQRNTAPCHB-UHFFFAOYSA-N D09HEV DRUGSMIL CN1CCN(CC1)C2CCC(CC2)N3C=C(C4=C(N=CN=C43)N)C5=CC=C(C=C5)OC6=CC=CC=C6 D09HEV HIGHSTAT Discontinued in Phase 1/2 D0M3OR DRUG__ID D0M3OR D0M3OR DRUGCOMP Kyowa Hakko Kirin Pharma D0M3OR DRUGINCH 1S/C28H29N5O3S.C7H8O3S/c1-19-10-15-37-27(19)28(36)29-25-16-20(17-32-11-13-33(14-12-32)26(35)18-34)6-7-21(25)8-9-24-22-4-2-3-5-23(22)30-31-24;1-6-2-4-7(5-3-6)11(8,9)10/h2-10,15-16,34H,11-14,17-18H2,1H3,(H,29,36)(H,30,31);2-5H,1H3,(H,8,9,10)/b9-8+; D0M3OR DRUGINKE SIJKXSMUXNJNQM-HRNDJLQDSA-N D0M3OR DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CC1=C(SC=C1)C(=O)NC2=C(C=CC(=C2)CN3CCN(CC3)C(=O)CO)C=CC4=NNC5=CC=CC=C54 D0M3OR HIGHSTAT Discontinued in Phase 1/2 D0WY0N DRUG__ID D0WY0N D0WY0N DRUGTYPE Small molecular drug D0WY0N DRUGINCH 1S/C27H49N3O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-28-23-18-20-30(27(34)29-23)26-25(33)24(32)22(21-31)35-26/h18,20,22,24-26,31-33H,2-17,19,21H2,1H3,(H,28,29,34)/t22-,24-,25+,26-/m1/s1 D0WY0N DRUGINKE HQHQCEKUGWOYPS-URBBEOKESA-N D0WY0N DRUGSMIL CCCCCCCCCCCCCCCCCCNC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O D0WY0N HIGHSTAT Discontinued in Phase 1/2 D0W8KT DRUG__ID D0W8KT D0W8KT DRUGCOMP AVI BioPharma D0W8KT THERCLAS Antisense D0W8KT DRUGTYPE Antisense drug D0W8KT HIGHSTAT Discontinued in Phase 1/2 D01MQH DRUG__ID D01MQH D01MQH DRUGCOMP BioTie Therapies Corp D01MQH DRUGTYPE Monoclonal antibody D01MQH HIGHSTAT Discontinued in Phase 1/2 D05RTF DRUG__ID D05RTF D05RTF DRUGCOMP Applied Molecular Evoltion D05RTF DRUGTYPE Antibody D05RTF HIGHSTAT Discontinued in Phase 1/2 D08PXM DRUG__ID D08PXM D08PXM DRUGCOMP Medarex Inc D08PXM DRUGTYPE Antibody D08PXM HIGHSTAT Discontinued in Phase 1/2 D0S0DU DRUG__ID D0S0DU D0S0DU DRUGCOMP YM Biosciences D0S0DU DRUGTYPE Antibody D0S0DU HIGHSTAT Discontinued in Phase 1/2 D0S1LE DRUG__ID D0S1LE D0S1LE DRUGCOMP Actinium Pharmaceuticals D0S1LE DRUGTYPE Monoclonal antibody D0S1LE HIGHSTAT Discontinued in Phase 1/2 D00NSM DRUG__ID D00NSM D00NSM DRUGCOMP CellMed AG D00NSM HIGHSTAT Discontinued in Phase 1/2 D01CEQ DRUG__ID D01CEQ D01CEQ DRUGCOMP Cerenis D01CEQ HIGHSTAT Discontinued in Phase 1/2 D01RLU DRUG__ID D01RLU D01RLU DRUGCOMP Ark Therapeutics Group plc D01RLU HIGHSTAT Discontinued in Phase 1/2 D02FEJ DRUG__ID D02FEJ D02FEJ DRUGCOMP Baylor Research Institute D02FEJ HIGHSTAT Discontinued in Phase 1/2 D02XBY DRUG__ID D02XBY D02XBY DRUGCOMP Argos Therapeutics D02XBY HIGHSTAT Discontinued in Phase 1/2 D03OCG DRUG__ID D03OCG D03OCG DRUGCOMP Eli Lilly & Co D03OCG HIGHSTAT Discontinued in Phase 1/2 D03RUL DRUG__ID D03RUL D03RUL DRUGCOMP Access Pharmaceuticals D03RUL HIGHSTAT Discontinued in Phase 1/2 D04VGY DRUG__ID D04VGY D04VGY DRUGCOMP Cytos Biotechnology D04VGY HIGHSTAT Discontinued in Phase 1/2 D04WVL DRUG__ID D04WVL D04WVL DRUGCOMP SonneMed LLC D04WVL HIGHSTAT Discontinued in Phase 1/2 D05FVX DRUG__ID D05FVX D05FVX DRUGCOMP UCB Celltech D05FVX HIGHSTAT Discontinued in Phase 1/2 D05PYB DRUG__ID D05PYB D05PYB DRUGCOMP Bavarian Nordic A/S D05PYB HIGHSTAT Discontinued in Phase 1/2 D05VEU DRUG__ID D05VEU D05VEU DRUGCOMP Avigen D05VEU HIGHSTAT Discontinued in Phase 1/2 D06CMW DRUG__ID D06CMW D06CMW DRUGCOMP BN ImmunoTherapeutics D06CMW HIGHSTAT Discontinued in Phase 1/2 D06FSD DRUG__ID D06FSD D06FSD DRUGCOMP Novo Nordisk D06FSD HIGHSTAT Discontinued in Phase 1/2 D06YFO DRUG__ID D06YFO D06YFO DRUGCOMP Sosei R&D Ltd D06YFO HIGHSTAT Discontinued in Phase 1/2 D07EFA DRUG__ID D07EFA D07EFA DRUGCOMP Pyrenees Pharmaceuticals Inc D07EFA HIGHSTAT Discontinued in Phase 1/2 D08JRT DRUG__ID D08JRT D08JRT DRUGCOMP Amgen D08JRT HIGHSTAT Discontinued in Phase 1/2 D08RPV DRUG__ID D08RPV D08RPV DRUGCOMP IDM Pharma D08RPV HIGHSTAT Discontinued in Phase 1/2 D09GDY DRUG__ID D09GDY D09GDY DRUGCOMP Okairos D09GDY HIGHSTAT Discontinued in Phase 1/2 D09QUE DRUG__ID D09QUE D09QUE DRUGCOMP Bavarian Nordic D09QUE HIGHSTAT Discontinued in Phase 1/2 D09SAV DRUG__ID D09SAV D09SAV DRUGCOMP Genzyme Molecular Oncology D09SAV HIGHSTAT Discontinued in Phase 1/2 D0B5TO DRUG__ID D0B5TO D0B5TO DRUGCOMP Onyvax Ltd; Onyvax D0B5TO HIGHSTAT Discontinued in Phase 1/2 D0BH8C DRUG__ID D0BH8C D0BH8C DRUGCOMP MacroGenics Inc D0BH8C HIGHSTAT Discontinued in Phase 1/2 D0D0XF DRUG__ID D0D0XF D0D0XF DRUGCOMP Antigenics D0D0XF HIGHSTAT Discontinued in Phase 1/2 D0E6QN DRUG__ID D0E6QN D0E6QN DRUGCOMP GlaxoSmithKline D0E6QN HIGHSTAT Discontinued in Phase 1/2 D0H3HB DRUG__ID D0H3HB D0H3HB DRUGCOMP Ark Therapeutics Group plc D0H3HB HIGHSTAT Discontinued in Phase 1/2 D0H4XV DRUG__ID D0H4XV D0H4XV DRUGCOMP Idera pharmaceuticals D0H4XV HIGHSTAT Discontinued in Phase 1/2 D0IJ1D DRUG__ID D0IJ1D D0IJ1D DRUGCOMP PDL BioPharma Inc D0IJ1D HIGHSTAT Discontinued in Phase 1/2 D0N6PB DRUG__ID D0N6PB D0N6PB DRUGCOMP ViroMed Co Ltd D0N6PB HIGHSTAT Discontinued in Phase 1/2 D0Q2BM DRUG__ID D0Q2BM D0Q2BM DRUGCOMP ViaCell Inc D0Q2BM HIGHSTAT Discontinued in Phase 1/2 D0X5ES DRUG__ID D0X5ES D0X5ES DRUGCOMP NicOx SA D0X5ES HIGHSTAT Discontinued in Phase 1/2 D0Y4GJ DRUG__ID D0Y4GJ D0Y4GJ DRUGCOMP Aventis SA D0Y4GJ HIGHSTAT Discontinued in Phase 1/2 D0Z2KU DRUG__ID D0Z2KU D0Z2KU DRUGCOMP OncoTherapy Science Inc D0Z2KU HIGHSTAT Discontinued in Phase 1/2 D05UGJ DRUG__ID D05UGJ D05UGJ DRUGCOMP Exelixis D05UGJ THERCLAS Anticancer Agents D05UGJ DRUGTYPE Small molecular drug D05UGJ DRUGINCH 1S/C14H17N5O2/c15-6-3-9-21-12-5-2-1-4-11(12)18-14(20)19-13-10-16-7-8-17-13/h1-2,4-5,7-8,10H,3,6,9,15H2,(H2,17,18,19,20) D05UGJ DRUGINKE UVSSZSQSZGKMAL-UHFFFAOYSA-N D05UGJ DRUGSMIL C1=CC=C(C(=C1)NC(=O)NC2=NC=CN=C2)OCCCN D05UGJ HIGHSTAT Discontinued in Phase 1 D0A9OV DRUG__ID D0A9OV D0A9OV DRUGCOMP Takeda Pharmaceuticals D0A9OV THERCLAS Anticancer Agents D0A9OV DRUGTYPE Small molecular drug D0A9OV DRUGINCH 1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+ D0A9OV DRUGINKE ZTFBIUXIQYRUNT-MDWZMJQESA-N D0A9OV DRUGSMIL C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F D0A9OV HIGHSTAT Discontinued in Phase 1 D0E3SD DRUG__ID D0E3SD D0E3SD DRUGCOMP AstraZeneca D0E3SD THERCLAS Analgesics D0E3SD DRUGTYPE Small molecular drug D0E3SD DRUGINCH 1S/C14H6F2N4O/c15-10-1-2-12(18-7-10)13-19-14(21-20-13)9-3-8(6-17)4-11(16)5-9/h1-5,7H D0E3SD DRUGINKE RBSPCALDSNXWEP-UHFFFAOYSA-N D0E3SD DRUGSMIL C1=CC(=NC=C1F)C2=NOC(=N2)C3=CC(=CC(=C3)C#N)F D0E3SD HIGHSTAT Discontinued in Phase 1 D0E9EE DRUG__ID D0E9EE D0E9EE DRUGCOMP Sanofi-aventis D0E9EE THERCLAS Analgesics D0E9EE DRUGTYPE Small molecular drug D0E9EE DRUGINCH 1S/C33H38F2N4O3/c1-37(2)31(41)36-32(26-11-7-4-8-12-26)15-18-38(19-16-32)20-17-33(27-13-14-28(34)29(35)23-27)24-39(21-22-42-33)30(40)25-9-5-3-6-10-25/h3-14,23H,15-22,24H2,1-2H3,(H,36,41) D0E9EE DRUGINKE QNLIUVLFRVYNCV-UHFFFAOYSA-N D0E9EE DRUGSMIL CN(C)C(=O)NC1(CCN(CC1)CCC2(CN(CCO2)C(=O)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5 D0E9EE HIGHSTAT Discontinued in Phase 1 D0L3YX DRUG__ID D0L3YX D0L3YX DRUGCOMP King Pharmaceuticals D0L3YX THERCLAS Analgesics D0L3YX DRUGTYPE Small molecular drug D0L3YX DRUGINCH 1S/C15H14ClNOS/c16-10-7-5-9(6-8-10)14(18)13-11-3-1-2-4-12(11)19-15(13)17/h5-8H,1-4,17H2 D0L3YX DRUGINKE OTZVBZFYMFTYKH-UHFFFAOYSA-N D0L3YX DRUGSMIL C1CCC2=C(C1)C(=C(S2)N)C(=O)C3=CC=C(C=C3)Cl D0L3YX HIGHSTAT Discontinued in Phase 1 D0L5XI DRUG__ID D0L5XI D0L5XI DRUGCOMP Amgen D0L5XI THERCLAS Analgesics D0L5XI DRUGTYPE Small molecular drug D0L5XI DRUGINCH 1S/C20H13F3N4O2S/c1-11(28)26-19-27-18-15(3-2-4-16(18)30-19)29-17-9-14(24-10-25-17)12-5-7-13(8-6-12)20(21,22)23/h2-10H,1H3,(H,26,27,28) D0L5XI DRUGINKE YUTIXVXZQIQWGY-UHFFFAOYSA-N D0L5XI DRUGSMIL CC(=O)NC1=NC2=C(C=CC=C2S1)OC3=NC=NC(=C3)C4=CC=C(C=C4)C(F)(F)F D0L5XI HIGHSTAT Discontinued in Phase 1 D0R7ID DRUG__ID D0R7ID D0R7ID DRUGCOMP Nippon Shinyaku D0R7ID THERCLAS Anticancer Agents D0R7ID DRUGTYPE Small molecular drug D0R7ID DRUGINCH 1S/C22H20N2O5S/c1-17(25)24(30(27,28)21-11-9-20(29-2)10-12-21)22-6-4-3-5-19(22)8-7-18-13-15-23(26)16-14-18/h3-16H,1-2H3/b8-7+ D0R7ID DRUGINKE OCKHRKSTDPOHEN-BQYQJAHWSA-N D0R7ID DRUGSMIL CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC D0R7ID HIGHSTAT Discontinued in Phase 1 D00ACC DRUG__ID D00ACC D00ACC DRUGCOMP Neuro3d D00ACC DRUGTYPE Small molecular drug D00ACC DRUGINCH 1S/C26H31N3O/c30-25-26(29(18-27-25)21-9-2-1-3-10-21)14-16-28(17-15-26)23-13-12-20-7-4-6-19-8-5-11-22(23)24(19)20/h1-3,5,8-11,20,23H,4,6-7,12-18H2,(H,27,30)/t20-,23-/m0/s1 D00ACC DRUGINKE JLFMYEAXZNPWBK-REWPJTCUSA-N D00ACC DRUGSMIL C1CC2CCC(C3=CC=CC(=C23)C1)N4CCC5(CC4)C(=O)NCN5C6=CC=CC=C6 D00ACC HIGHSTAT Discontinued in Phase 1 D00BIY DRUG__ID D00BIY D00BIY DRUGCOMP Novartis AG D00BIY DRUGTYPE Small molecular drug D00BIY DRUGINCH 1S/C26H30N6O/c1-3-5-11-23-22(26(33)28-24(27-23)12-6-4-2)17-18-13-15-19(16-14-18)20-9-7-8-10-21(20)25-29-31-32-30-25/h7-10,13-16H,3-6,11-12,17H2,1-2H3,(H,27,28,33)(H,29,30,31,32) D00BIY DRUGINKE UKEZYWUWLICNPR-UHFFFAOYSA-N D00BIY DRUGSMIL CCCCC1=C(C(=O)NC(=N1)CCCC)CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4 D00BIY HIGHSTAT Discontinued in Phase 1 D00CGU DRUG__ID D00CGU D00CGU DRUGCOMP Inotek Pharmaceuticals D00CGU DRUGTYPE Small molecular drug D00CGU DRUGINCH 1S/C4H10O3S/c1-4(2)7-8(3,5)6/h4H,1-3H3 D00CGU DRUGINKE SWWHCQCMVCPLEQ-UHFFFAOYSA-N D00CGU DRUGSMIL CC(C)OS(=O)(=O)C D00CGU HIGHSTAT Discontinued in Phase 1 D00JNT DRUG__ID D00JNT D00JNT DRUGCOMP ViroPharma; ViroPharma Inc D00JNT DRUGTYPE Small molecular drug D00JNT DRUGINCH 1S/C20H21FN2O5S/c1-11(2)27-17-9-14-16(10-15(17)23-29(4,25)26)28-19(18(14)20(24)22-3)12-5-7-13(21)8-6-12/h5-11,23H,1-4H3,(H,22,24) D00JNT DRUGINKE VBRUONUESYTIDA-UHFFFAOYSA-N D00JNT DRUGSMIL CC(C)OC1=C(C=C2C(=C1)C(=C(O2)C3=CC=C(C=C3)F)C(=O)NC)NS(=O)(=O)C D00JNT HIGHSTAT Discontinued in Phase 1 D00PIE DRUG__ID D00PIE D00PIE DRUGCOMP KuDOS Pharmaceuticals; Novacea D00PIE DRUGTYPE Small molecular drug D00PIE DRUGINCH 1S/C22H28N4O6/c1-25(2,31)11-9-23-13-5-6-14(24-10-12-26(3,4)32)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30/h5-8,23-24,27-28H,9-12H2,1-4H3 D00PIE DRUGINKE YZBAXVICWUUHGG-UHFFFAOYSA-N D00PIE DRUGSMIL C[N+](C)(CCNC1=C2C(=C(C=C1)NCC[N+](C)(C)[O-])C(=O)C3=C(C=CC(=C3C2=O)O)O)[O-] D00PIE HIGHSTAT Discontinued in Phase 1 D00VBT DRUG__ID D00VBT D00VBT DRUGCOMP Schering AG D00VBT DRUGTYPE Small molecular drug D00VBT DRUGINCH 1S/C22H29ClN6O2/c1-28-7-9-29(10-8-28)18-12-15(11-16(23)13-18)21(30)26-19-14-24-27-20(19)22(31)25-17-5-3-2-4-6-17/h11-14,17H,2-10H2,1H3,(H,24,27)(H,25,31)(H,26,30) D00VBT DRUGINKE OALDDSAHYZPJQM-UHFFFAOYSA-N D00VBT DRUGSMIL CN1CCN(CC1)C2=CC(=CC(=C2)C(=O)NC3=C(NN=C3)C(=O)NC4CCCCC4)Cl D00VBT HIGHSTAT Discontinued in Phase 1 D01AUL DRUG__ID D01AUL D01AUL DRUGCOMP Merck & Co Inc D01AUL DRUGTYPE Small molecular drug D01AUL DRUGINCH 1S/C18H21N3O2/c1-5-13-8-14(18(22)20-12(13)4)19-9-15-21-16-10(2)6-7-11(3)17(16)23-15/h6-8,19H,5,9H2,1-4H3,(H,20,22) D01AUL DRUGINKE VDZJXIOFISBBLT-UHFFFAOYSA-N D01AUL DRUGSMIL CCC1=C(NC(=O)C(=C1)NCC2=NC3=C(C=CC(=C3O2)C)C)C D01AUL HIGHSTAT Discontinued in Phase 1 D01CBV DRUG__ID D01CBV D01CBV DRUGCOMP Merck & Co Inc D01CBV DRUGTYPE Small molecular drug D01CBV DRUGINCH 1S/C4H4ClNS.ClH/c5-1-4-2-7-3-6-4;/h2-3H,1H2;1H D01CBV DRUGINKE NVTBASMQHFMANH-UHFFFAOYSA-N D01CBV DRUGSMIL C1=C(N=CS1)CCl.Cl D01CBV HIGHSTAT Discontinued in Phase 1 D01GDH DRUG__ID D01GDH D01GDH DRUGCOMP Xenova Ltd D01GDH DRUGTYPE Small molecular drug D01GDH DRUGINCH 1S/C39H38N4O5/c1-42-34(22-27-8-5-4-6-9-27)38(45)41-33(39(42)46)21-28-10-7-11-30(20-28)37(44)40-32-14-12-26(13-15-32)16-18-43-19-17-29-23-35(47-2)36(48-3)24-31(29)25-43/h4-15,20-24H,16-19,25H2,1-3H3,(H,40,44)(H,41,45)/b33-21-,34-22- D01GDH DRUGINKE RTIZZWMBGKGLFO-YWQXDYITSA-N D01GDH DRUGSMIL CN1C(=CC2=CC=CC=C2)C(=O)NC(=CC3=CC(=CC=C3)C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC)C1=O D01GDH HIGHSTAT Discontinued in Phase 1 D01IBO DRUG__ID D01IBO D01IBO DRUGCOMP BioCryst Pharmaceuticals Inc D01IBO DRUGTYPE Small molecular drug D01IBO DRUGINCH 1S/C14H10N2O2S2/c15-13(16)12-6-8-3-4-9(7-11(8)20-12)18-14(17)10-2-1-5-19-10/h1-7H,(H3,15,16) D01IBO DRUGINKE OTGQTQBPQCRNRG-UHFFFAOYSA-N D01IBO DRUGSMIL C1=CSC(=C1)C(=O)OC2=CC3=C(C=C2)C=C(S3)C(=N)N D01IBO HIGHSTAT Discontinued in Phase 1 D01KHX DRUG__ID D01KHX D01KHX DRUGCOMP Hoechst AG D01KHX DRUGTYPE Small molecular drug D01KHX DRUGINCH 1S/C21H23NO5S/c1-21(2)20(24)19(22-12-6-9-18(22)23)16-13-15(10-11-17(16)27-21)28(25,26)14-7-4-3-5-8-14/h3-5,7-8,10-11,13,19-20,24H,6,9,12H2,1-2H3/t19-,20+/m1/s1 D01KHX DRUGINKE LKAQWOWWTKFLNX-UXHICEINSA-N D01KHX DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)S(=O)(=O)C3=CC=CC=C3)N4CCCC4=O)O)C D01KHX HIGHSTAT Discontinued in Phase 1 D01KIS DRUG__ID D01KIS D01KIS DRUGCOMP Novartis AG D01KIS DRUGTYPE Small molecular drug D01KIS DRUGINCH 1S/C42H56N4O7/c1-29(2)37(39(49)43-35(27-32-19-13-8-14-20-32)40(50)46-21-23-52-24-22-46)45-38(48)33(25-30-15-9-6-10-16-30)28-36(47)34(26-31-17-11-7-12-18-31)44-41(51)53-42(3,4)5/h6-20,29,33-37,47H,21-28H2,1-5H3,(H,43,49)(H,44,51)(H,45,48)/t33-,34+,35+,36+,37+/m1/s1 D01KIS DRUGINKE NAJDZKGRZBLNON-RKGCBODKSA-N D01KIS DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)N2CCOCC2)NC(=O)C(CC3=CC=CC=C3)CC(C(CC4=CC=CC=C4)NC(=O)OC(C)(C)C)O D01KIS HIGHSTAT Discontinued in Phase 1 D01OLO DRUG__ID D01OLO D01OLO DRUGCOMP Merck D01OLO DRUGTYPE Small molecular drug D01OLO DRUGINCH 1S/C18H14N4O3S/c1-10-9-14(23)22(18(10)24)21-17-15-11(5-3-6-12(15)25-2)19-16(20-17)13-7-4-8-26-13/h3-9H,1-2H3,(H,19,20,21) D01OLO DRUGINKE GZGLPBNOIFLLRE-UHFFFAOYSA-N D01OLO DRUGSMIL CC1=CC(=O)N(C1=O)NC2=NC(=NC3=C2C(=CC=C3)OC)C4=CC=CS4 D01OLO HIGHSTAT Discontinued in Phase 1 D01RVS DRUG__ID D01RVS D01RVS DRUGCOMP AstraZeneca D01RVS DRUGTYPE Small molecular drug D01RVS DRUGINCH 1S/C22H28N6O3S.C16H15Cl2N3O2/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-3-9-6-12(16(22)20-8(9)2)19-7-13-21-14-10(17)4-5-11(18)15(14)23-13/h4-8,13-15,24-26H,9-12H2,1-3H3;4-6,19H,3,7H2,1-2H3,(H,20,22) D01RVS DRUGINKE XOJHGEHJHFRZRW-UHFFFAOYSA-N D01RVS DRUGSMIL CCC1=C(NC(=O)C(=C1)NCC2=NC3=C(C=CC(=C3O2)Cl)Cl)C.CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C D01RVS HIGHSTAT Discontinued in Phase 1 D01WOD DRUG__ID D01WOD D01WOD DRUGCOMP Pfizer Inc D01WOD DRUGTYPE Small molecular drug D01WOD DRUGINCH 1S/C19H27NO8S3/c1-5-28-19(3,4)18(24)27-9-26-16(23)13-17(29-11-6-7-31(25)8-11)30-15-12(10(2)21)14(22)20(13)15/h10-12,15,21H,5-9H2,1-4H3/t10-,11+,12+,15-,31-/m1/s1 D01WOD DRUGINKE QBQVJZKXORIDPB-QAMFZHPYSA-N D01WOD DRUGSMIL CCOC(C)(C)C(=O)OCOC(=O)C1=C(SC2N1C(=O)C2C(C)O)SC3CCS(=O)C3 D01WOD HIGHSTAT Discontinued in Phase 1 D01ZGH DRUG__ID D01ZGH D01ZGH DRUGCOMP Japan Tobacco Inc D01ZGH DRUGTYPE Small molecular drug D01ZGH DRUGINCH 1S/C28H23F7N6O4S2/c29-19-11-15(1-8-21(19)45-28(33,34)35)12-37-25(42)20-14-40(26-39-24-22(46-26)13-36-23(38-24)16-2-3-16)9-10-41(20)47(43,44)18-6-4-17(5-7-18)27(30,31)32/h1,4-8,11,13,16,20H,2-3,9-10,12,14H2,(H,37,42)/t20-/m1/s1 D01ZGH DRUGINKE JQLOVYLALGSISI-HXUWFJFHSA-N D01ZGH DRUGSMIL C1CC1C2=NC=C3C(=N2)N=C(S3)N4CCN(C(C4)C(=O)NCC5=CC(=C(C=C5)OC(F)(F)F)F)S(=O)(=O)C6=CC=C(C=C6)C(F)(F)F D01ZGH HIGHSTAT Discontinued in Phase 1 D01ZJM DRUG__ID D01ZJM D01ZJM DRUGCOMP Roche Holding AG D01ZJM DRUGTYPE Small molecular drug D01ZJM DRUGINCH 1S/C9H12N6O5/c10-4-1-2-15(8(19)12-4)7-5(17)6(18)9(3-16,20-7)13-14-11/h1-2,5-7,16-18H,3H2,(H2,10,12,19)/t5-,6+,7-,9-/m1/s1 D01ZJM DRUGINKE ODLGMSQBFONGNG-JVZYCSMKSA-N D01ZJM DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)O D01ZJM HIGHSTAT Discontinued in Phase 1 D02RZL DRUG__ID D02RZL D02RZL DRUGCOMP AstraZeneca D02RZL DRUGTYPE Small molecular drug D02RZL DRUGINCH 1S/C28H27NO3S/c30-28(31)20-33-27(12-6-9-21-7-2-1-3-8-21)23-14-17-25(18-15-23)32-19-24-16-13-22-10-4-5-11-26(22)29-24/h1-5,7-8,10-11,13-18,27H,6,9,12,19-20H2,(H,30,31) D02RZL DRUGINKE JOIXGLLMSDPZDN-UHFFFAOYSA-N D02RZL DRUGSMIL C1=CC=C(C=C1)CCCC(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)SCC(=O)O D02RZL HIGHSTAT Discontinued in Phase 1 D03AZU DRUG__ID D03AZU D03AZU DRUGCOMP Organon BioSciences D03AZU DRUGTYPE Small molecular drug D03AZU DRUGINCH 1S/C30H39NO2/c1-19-16-25-27-12-14-30(13-5-15-33-30)29(27,2)18-26(20-6-8-21(9-7-20)31(3)4)28(25)23-11-10-22(32)17-24(19)23/h6-9,17,19,25-27H,5,10-16,18H2,1-4H3/t19-,25+,26-,27+,29+,30+/m1/s1 D03AZU DRUGINKE HFDGABTZPISMDD-IEVXGSBISA-N D03AZU DRUGSMIL CC1CC2C3CCC4(C3(CC(C2=C5C1=CC(=O)CC5)C6=CC=C(C=C6)N(C)C)C)CCCO4 D03AZU HIGHSTAT Discontinued in Phase 1 D03DXS DRUG__ID D03DXS D03DXS DRUGCOMP Novo Nordisk A/S D03DXS DRUGTYPE Small molecular drug D03DXS DRUGINCH 1S/C19H20ClNO2/c1-21-7-5-13-9-17(20)18(22)10-15(13)16(11-21)14-4-2-3-12-6-8-23-19(12)14/h2-4,9-10,16,22H,5-8,11H2,1H3/t16-/m1/s1 D03DXS DRUGINKE SKMVRXPBCSTNKE-MRXNPFEDSA-N D03DXS DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC4=C3OCC4)O)Cl D03DXS HIGHSTAT Discontinued in Phase 1 D03ESW DRUG__ID D03ESW D03ESW DRUGCOMP Esteve D03ESW DRUGTYPE Small molecular drug D03ESW DRUGINCH 1S/C20H16F3N3O3/c1-9-15(24)8-25(9)18-6-17-11(5-14(18)23)19(27)12(20(28)29)7-26(17)16-3-2-10(21)4-13(16)22/h2-7,9,15H,8,24H2,1H3,(H,28,29)/t9-,15+/m0/s1 D03ESW DRUGINKE LTDOHCZUKCZDEQ-BJOHPYRUSA-N D03ESW DRUGSMIL CC1C(CN1C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F)N D03ESW HIGHSTAT Discontinued in Phase 1 D03JSS DRUG__ID D03JSS D03JSS DRUGCOMP SmithKline Beecham plc D03JSS DRUGTYPE Small molecular drug D03JSS DRUGINCH 1S/C20H19F2NO4/c1-10(24)11-4-5-16-15(8-11)17(18(25)20(2,3)27-16)23-19(26)12-6-13(21)9-14(22)7-12/h4-9,17-18,25H,1-3H3,(H,23,26)/t17-,18+/m0/s1 D03JSS DRUGINKE NWHCDESSIHFNIJ-ZWKOTPCHSA-N D03JSS DRUGSMIL CC(=O)C1=CC2=C(C=C1)OC(C(C2NC(=O)C3=CC(=CC(=C3)F)F)O)(C)C D03JSS HIGHSTAT Discontinued in Phase 1 D03KTE DRUG__ID D03KTE D03KTE DRUGCOMP Ligand Pharmaceuticals D03KTE DRUGTYPE Small molecular drug D03KTE DRUGINCH 1S/C17H16F6N2O2/c1-8-2-5-13(15(27)17(21,22)23)25(8)9-3-4-12-10(6-9)11(16(18,19)20)7-14(26)24-12/h3-4,6-8,13,15,27H,2,5H2,1H3,(H,24,26)/t8-,13-,15-/m1/s1 D03KTE DRUGINKE HWLLYFXDDGGHOE-BCSUUIJWSA-N D03KTE DRUGSMIL CC1CCC(N1C2=CC3=C(C=C2)NC(=O)C=C3C(F)(F)F)C(C(F)(F)F)O D03KTE HIGHSTAT Discontinued in Phase 1 D03KWN DRUG__ID D03KWN D03KWN DRUGCOMP AstraZeneca plc D03KWN DRUGTYPE Small molecular drug D03KWN DRUGINCH 1S/C24H27N5O2/c1-16-3-4-17(23(30)26-18-5-6-18)13-22(16)29-15-25-21-8-7-19(14-20(21)24(29)31)28-11-9-27(2)10-12-28/h3-4,7-8,13-15,18H,5-6,9-12H2,1-2H3,(H,26,30) D03KWN DRUGINKE ZMAZXHICVRYLQN-UHFFFAOYSA-N D03KWN DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2CC2)N3C=NC4=C(C3=O)C=C(C=C4)N5CCN(CC5)C D03KWN HIGHSTAT Discontinued in Phase 1 D03MAD DRUG__ID D03MAD D03MAD DRUGCOMP Pfizer D03MAD DRUGTYPE Small molecular drug D03MAD DRUGINCH 1S/C26H23ClF7NO3/c1-2-17-12-20(9-10-22(17)27)37-19-7-4-6-18(13-19)35(15-23(36)25(30,31)32)14-16-5-3-8-21(11-16)38-26(33,34)24(28)29/h3-13,23-24,36H,2,14-15H2,1H3/t23-/m1/s1 D03MAD DRUGINKE VHSPKQAESIGBIC-HSZRJFAPSA-N D03MAD DRUGSMIL CCC1=C(C=CC(=C1)OC2=CC=CC(=C2)N(CC3=CC(=CC=C3)OC(C(F)F)(F)F)CC(C(F)(F)F)O)Cl D03MAD HIGHSTAT Discontinued in Phase 1 D03PDY DRUG__ID D03PDY D03PDY DRUGCOMP GlaxoSmithKline D03PDY DRUGTYPE Small molecular drug D03PDY DRUGINCH 1S/C13H10Cl3N3O4S/c14-6-2-1-3-8(10(6)16)18-13(21)19-9-5-4-7(15)12(11(9)20)24(17,22)23/h1-5,20H,(H2,17,22,23)(H2,18,19,21) D03PDY DRUGINKE WTLRWOHEKQGKDS-UHFFFAOYSA-N D03PDY DRUGSMIL C1=CC(=C(C(=C1)Cl)Cl)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)N)O D03PDY HIGHSTAT Discontinued in Phase 1 D03QZB DRUG__ID D03QZB D03QZB DRUGCOMP Fujirebio KK D03QZB DRUGTYPE Small molecular drug D03QZB DRUGINCH 1S/C33H61N3O6/c1-9-10-11-12-13-14-17-22-36(23-31(2,3)4)30(39)35-25-18-15-16-19-26(25)41-27(37)20-21-34-29(38)28-32(5,6)24-40-33(7,8)42-28/h25-26,28H,9-24H2,1-8H3,(H,34,38)(H,35,39)/t25-,26-,28?/m0/s1 D03QZB DRUGINKE NWLFOBZKYXKBOF-QIELNMHASA-N D03QZB DRUGSMIL CCCCCCCCCN(CC(C)(C)C)C(=O)NC1CCCCC1OC(=O)CCNC(=O)C2C(COC(O2)(C)C)(C)C D03QZB HIGHSTAT Discontinued in Phase 1 D03ZZH DRUG__ID D03ZZH D03ZZH DRUGCOMP Solvay Pharma D03ZZH DRUGTYPE Small molecular drug D03ZZH DRUGINCH 1S/C24H24FN3O2/c25-21-6-4-19(5-7-21)20-14-18(15-26-16-20)17-27-8-10-28(11-9-27)22-2-1-3-23-24(22)30-13-12-29-23/h1-7,14-16H,8-13,17H2 D03ZZH DRUGINKE IUVSEUFHPNITEQ-UHFFFAOYSA-N D03ZZH DRUGSMIL C1CN(CCN1CC2=CC(=CN=C2)C3=CC=C(C=C3)F)C4=C5C(=CC=C4)OCCO5 D03ZZH HIGHSTAT Discontinued in Phase 1 D04FHB DRUG__ID D04FHB D04FHB DRUGCOMP Hoffmann CLa Roche D04FHB DRUGTYPE Small molecular drug D04FHB DRUGINCH 1S/C18H21F2N5O4S/c1-29-13-4-3-12(19)15(20)14(13)16(26)11-9-22-18(24-17(11)21)23-10-5-7-25(8-6-10)30(2,27)28/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24) D04FHB DRUGINKE JRNJNYBQQYBCLE-UHFFFAOYSA-N D04FHB DRUGSMIL COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C D04FHB HIGHSTAT Discontinued in Phase 1 D04JGA DRUG__ID D04JGA D04JGA DRUGCOMP Bristol-Myers Squibb Co D04JGA DRUGTYPE Small molecular drug D04JGA DRUGINCH 1S/C22H21ClN4O2/c1-22(2)21(28)20(17-11-14(12-24)3-8-18(17)29-22)27(13-19-25-9-10-26-19)16-6-4-15(23)5-7-16/h3-11,20-21,28H,13H2,1-2H3,(H,25,26)/t20-,21+/m0/s1 D04JGA DRUGINKE SMIKIPXIDLITMP-LEWJYISDSA-N D04JGA DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N(CC3=NC=CN3)C4=CC=C(C=C4)Cl)O)C D04JGA HIGHSTAT Discontinued in Phase 1 D04KCT DRUG__ID D04KCT D04KCT DRUGCOMP Organon BioSciences D04KCT DRUGTYPE Small molecular drug D04KCT DRUGINCH 1S/C27H43NO4/c1-16(29)19-8-9-20-18-7-6-17-12-22(30)21(28-10-11-32-25(2,3)15-28)13-26(17,4)24(18)23(31)14-27(19,20)5/h17-22,24,30H,6-15H2,1-5H3/t17-,18-,19+,20-,21-,22-,24+,26-,27+/m0/s1 D04KCT DRUGINKE HQEJMKVZYCQIIH-JJLPOIBOSA-N D04KCT DRUGSMIL CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CC(C(C4)O)N5CCOC(C5)(C)C)C)C D04KCT HIGHSTAT Discontinued in Phase 1 D04RUP DRUG__ID D04RUP D04RUP DRUGCOMP Novartis AG D04RUP DRUGTYPE Small molecular drug D04RUP DRUGINCH 1S/C33H33N5O5/c1-36(22-23-10-3-2-4-11-23)32(40)28(21-24-17-18-25-12-5-6-13-26(25)20-24)34-31(39)30-16-9-19-37(30)33(41)35-27-14-7-8-15-29(27)38(42)43/h2-8,10-15,17-18,20,28,30H,9,16,19,21-22H2,1H3,(H,34,39)(H,35,41)/t28-,30-/m0/s1 D04RUP DRUGINKE PCVSIMQAFWRUEC-JDXGNMNLSA-N D04RUP DRUGSMIL CN(CC1=CC=CC=C1)C(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C4CCCN4C(=O)NC5=CC=CC=C5[N+](=O)[O-] D04RUP HIGHSTAT Discontinued in Phase 1 D04TJP DRUG__ID D04TJP D04TJP DRUGCOMP GSK D04TJP DRUGTYPE Small molecular drug D04TJP DRUGINCH 1S/C25H22N8O2/c1-14-10-11-19(12-15(14)2)33-25(35)22(16(3)30-33)27-26-21-9-5-8-20(23(21)34)17-6-4-7-18(13-17)24-28-31-32-29-24/h4-13,22,34H,1-3H3,(H,28,29,31,32) D04TJP DRUGINKE KWJKFQSAMABKBG-UHFFFAOYSA-N D04TJP DRUGSMIL CC1=C(C=C(C=C1)N2C(=O)C(C(=N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C5=NNN=N5)C D04TJP HIGHSTAT Discontinued in Phase 1 D04XJM DRUG__ID D04XJM D04XJM DRUGCOMP Roche D04XJM DRUGTYPE Small molecular drug D04XJM DRUGINCH 1S/C9H10O3/c1-7-2-4-8(5-3-7)12-6-9(10)11/h2-5H,6H2,1H3,(H,10,11) D04XJM DRUGINKE SFTDDFBJWUWKMN-UHFFFAOYSA-N D04XJM DRUGSMIL CC1=CC=C(C=C1)OCC(=O)O D04XJM HIGHSTAT Discontinued in Phase 1 D04YHW DRUG__ID D04YHW D04YHW DRUGCOMP Roche Holding AG D04YHW DRUGTYPE Small molecular drug D04YHW DRUGINCH 1S/C19H18F2N4O3/c1-25-17-11(10-22-19(24-17)23-13-4-6-27-7-5-13)8-16(18(25)26)28-15-3-2-12(20)9-14(15)21/h2-3,8-10,13H,4-7H2,1H3,(H,22,23,24) D04YHW DRUGINKE KKKRKRMVJRHDMG-UHFFFAOYSA-N D04YHW DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)OC3=C(C=C(C=C3)F)F)NC4CCOCC4 D04YHW HIGHSTAT Discontinued in Phase 1 D05AAW DRUG__ID D05AAW D05AAW DRUGCOMP Vectura Group plc D05AAW DRUGTYPE Small molecular drug D05AAW DRUGINCH 1S/C19H23ClN2.ClH/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22;/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3;1H D05AAW DRUGINKE WIMWMKZEIBHDTH-UHFFFAOYSA-N D05AAW DRUGSMIL CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl D05AAW HIGHSTAT Discontinued in Phase 1 D05BCA DRUG__ID D05BCA D05BCA DRUGCOMP MitoKor; Migenix D05BCA DRUGTYPE Small molecular drug D05BCA DRUGINCH 1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17-,18+/m1/s1 D05BCA DRUGINKE VOXZDWNPVJITMN-SFFUCWETSA-N D05BCA DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O D05BCA HIGHSTAT Discontinued in Phase 1 D05DSK DRUG__ID D05DSK D05DSK DRUGCOMP Eisai Co. Ltd. D05DSK DRUGTYPE Small molecular drug D05DSK DRUGINCH 1S/C24H28FN3O/c1-26-24(29)17-18-6-7-20-9-15-28(23(20)16-18)21-10-13-27(14-11-21)12-8-19-4-2-3-5-22(19)25/h2-7,9,15-16,21H,8,10-14,17H2,1H3,(H,26,29) D05DSK DRUGINKE CQEOXWCXSBFJMB-UHFFFAOYSA-N D05DSK DRUGSMIL CNC(=O)CC1=CC2=C(C=C1)C=CN2C3CCN(CC3)CCC4=CC=CC=C4F D05DSK HIGHSTAT Discontinued in Phase 1 D05OEG DRUG__ID D05OEG D05OEG DRUGCOMP Eisai Co Ltd D05OEG DRUGTYPE Small molecular drug D05OEG DRUGINCH 1S/C24H22FNO2.ClH/c25-22-9-7-18(8-10-22)24(28)19-11-13-26(14-12-19)16-23(27)21-6-5-17-3-1-2-4-20(17)15-21;/h1-10,15,19H,11-14,16H2;1H D05OEG DRUGINKE WCHMXQYBLWIZCL-UHFFFAOYSA-N D05OEG DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CC(=O)C3=CC4=CC=CC=C4C=C3.Cl D05OEG HIGHSTAT Discontinued in Phase 1 D06ABM DRUG__ID D06ABM D06ABM DRUGCOMP Biochemie GmbH D06ABM DRUGTYPE Small molecular drug D06ABM DRUGINCH 1S/C19H24FN11O5S2/c1-29(19(22)30-4-2-23-3-5-30)24-6-9-7-37-16-11(15(33)31(16)12(9)17(34)35)25-14(32)10(27-36-8-20)13-26-18(21)38-28-13/h6,11,16,22-23H,2-5,7-8H2,1H3,(H,25,32)(H,34,35)(H2,21,26,28)/b22-19?,24-6+,27-10-/t11-,16-/m1/s1 D06ABM DRUGINKE VNZAURNTTOSQRE-XQMVPPGESA-N D06ABM DRUGSMIL CN(C(=N)N1CCNCC1)N=CC2=C(N3C(C(C3=O)NC(=O)C(=NOCF)C4=NSC(=N4)N)SC2)C(=O)O D06ABM HIGHSTAT Discontinued in Phase 1 D06BYS DRUG__ID D06BYS D06BYS DRUGCOMP ASTA Medica AG D06BYS DRUGTYPE Small molecular drug D06BYS DRUGINCH 1S/C13H14ClN3O2/c14-10-1-3-11(4-2-10)17-9-12(15-13(17)18)16-5-7-19-8-6-16/h1-4H,5-9H2 D06BYS DRUGINKE IQHYCZKIFIHTAI-UHFFFAOYSA-N D06BYS DRUGSMIL C1COCCN1C2=NC(=O)N(C2)C3=CC=C(C=C3)Cl D06BYS HIGHSTAT Discontinued in Phase 1 D06DLQ DRUG__ID D06DLQ D06DLQ DRUGCOMP Novartis AG D06DLQ DRUGTYPE Small molecular drug D06DLQ DRUGINCH 1S/C6H12NO5P/c1-4(3-13(10,11)12)2-5(7)6(8)9/h2,5H,3,7H2,1H3,(H,8,9)(H2,10,11,12)/b4-2+ D06DLQ DRUGINKE BDYHNCZIGYIOGJ-DUXPYHPUSA-N D06DLQ DRUGSMIL CC(=CC(C(=O)O)N)CP(=O)(O)O D06DLQ HIGHSTAT Discontinued in Phase 1 D06FCR DRUG__ID D06FCR D06FCR DRUGCOMP Lederle Laboratories D06FCR DRUGTYPE Small molecular drug D06FCR DRUGINCH 1S/C26H36F2N2O/c1-5-6-7-8-9-16-30(25(31)29-24-15-14-22(27)17-23(24)28)19-21-12-10-20(11-13-21)18-26(2,3)4/h10-15,17H,5-9,16,18-19H2,1-4H3,(H,29,31) D06FCR DRUGINKE QKJLDOBXDUVGEE-UHFFFAOYSA-N D06FCR DRUGSMIL CCCCCCCN(CC1=CC=C(C=C1)CC(C)(C)C)C(=O)NC2=C(C=C(C=C2)F)F D06FCR HIGHSTAT Discontinued in Phase 1 D06HCD DRUG__ID D06HCD D06HCD DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D06HCD DRUGTYPE Small molecular drug D06HCD DRUGINCH 1S/C26H27N5O5/c1-16-22(25-28-21(29-36-25)15-30(3)14-18-9-6-5-7-10-18)24(23(17(2)27-16)26(32)35-4)19-11-8-12-20(13-19)31(33)34/h5-13,24,27H,14-15H2,1-4H3 D06HCD DRUGINKE HHVCXSOKQHQGFB-UHFFFAOYSA-N D06HCD DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C3=NC(=NO3)CN(C)CC4=CC=CC=C4 D06HCD HIGHSTAT Discontinued in Phase 1 D06JWO DRUG__ID D06JWO D06JWO DRUGCOMP Kotobuki Pharmaceutical Co Ltd D06JWO DRUGTYPE Small molecular drug D06JWO DRUGINCH 1S/C22H28N2O3S.C4H4O4/c1-26-19-9-8-17(16-20(19)27-2)10-12-23-13-11-22(25)24-14-5-15-28-21-7-4-3-6-18(21)24;5-3(6)1-2-4(7)8/h3-4,6-9,16,23H,5,10-15H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D06JWO DRUGINKE YIVXAQUBENUHJC-WLHGVMLRSA-N D06JWO DRUGSMIL COC1=C(C=C(C=C1)CCNCCC(=O)N2CCCSC3=CC=CC=C32)OC.C(=CC(=O)O)C(=O)O D06JWO HIGHSTAT Discontinued in Phase 1 D06KPW DRUG__ID D06KPW D06KPW DRUGCOMP Upjohn Co Ltd D06KPW DRUGTYPE Small molecular drug D06KPW DRUGINCH 1S/C28H28N2O5S/c29-17-18-10-14-22(15-11-18)36(33,34)30-21-7-5-6-20(16-21)25(19-12-13-19)26-27(31)23-8-3-1-2-4-9-24(23)35-28(26)32/h5-7,10-11,14-16,19,25,30-31H,1-4,8-9,12-13H2 D06KPW DRUGINKE VCYQENLVFRTJIC-UHFFFAOYSA-N D06KPW DRUGSMIL C1CCCC2=C(CC1)C(=C(C(=O)O2)C(C3CC3)C4=CC(=CC=C4)NS(=O)(=O)C5=CC=C(C=C5)C#N)O D06KPW HIGHSTAT Discontinued in Phase 1 D06RCS DRUG__ID D06RCS D06RCS THERCLAS Neurodegenerative D06RCS DRUGTYPE Small molecular drug D06RCS DRUGINCH 1S/C21H23FN2O3S/c22-17-3-1-15(2-4-17)13-16-7-9-24(10-8-16)11-12-28(26)18-5-6-19-20(14-18)27-21(25)23-19/h1-6,14,16H,7-13H2,(H,23,25) D06RCS DRUGINKE FCBQJNCAKZSIAH-UHFFFAOYSA-N D06RCS DRUGSMIL C1CN(CCC1CC2=CC=C(C=C2)F)CCS(=O)C3=CC4=C(C=C3)NC(=O)O4 D06RCS HIGHSTAT Discontinued in Phase 1 D06ZWG DRUG__ID D06ZWG D06ZWG DRUGCOMP Sanofi-Aventis D06ZWG DRUGTYPE Small molecular drug D06ZWG DRUGINCH 1S/C25H29F3N4OS/c1-18-4-7-20(8-5-18)30-24(33)29-10-2-3-11-31-12-14-32(15-13-31)22-17-34-23-16-19(25(26,27)28)6-9-21(22)23/h4-9,16-17H,2-3,10-15H2,1H3,(H2,29,30,33) D06ZWG DRUGINKE XVFIYMFVLGFALY-UHFFFAOYSA-N D06ZWG DRUGSMIL CC1=CC=C(C=C1)NC(=O)NCCCCN2CCN(CC2)C3=CSC4=C3C=CC(=C4)C(F)(F)F D06ZWG HIGHSTAT Discontinued in Phase 1 D06ZYC DRUG__ID D06ZYC D06ZYC DRUGCOMP Takeda D06ZYC DRUGTYPE Small molecular drug D06ZYC DRUGINCH 1S/C26H32ClN5O4.CH4O3S/c1-15-10-31(11-16(2)36-15)23(33)12-32-14-26(3,4)35-13-22(32)25(34)30-20-8-17(27)7-19-18-5-6-28-9-21(18)29-24(19)20;1-5(2,3)4/h5-9,15-16,22,29H,10-14H2,1-4H3,(H,30,34);1H3,(H,2,3,4)/t15-,16+,22-;/m0./s1 D06ZYC DRUGINKE VCONVNPAMVXEOA-ZOPSOCCDSA-N D06ZYC DRUGSMIL CC1CN(CC(O1)C)C(=O)CN2CC(OCC2C(=O)NC3=CC(=CC4=C3NC5=C4C=CN=C5)Cl)(C)C.CS(=O)(=O)O D06ZYC HIGHSTAT Discontinued in Phase 1 D07SGB DRUG__ID D07SGB D07SGB DRUGCOMP Abbott Laboratories D07SGB DRUGTYPE Small molecular drug D07SGB DRUGINCH 1S/C32H28FN4O4S.ClH/c1-20(38)41-19-35-13-4-5-23(16-35)31-36-14-12-26(29(36)18-42-31)30(39)27-17-37(32(40)34(2)3)28-15-22(8-11-25(27)28)21-6-9-24(33)10-7-21;/h4-17,31H,18-19H2,1-3H3;1H/q+1;/p-1/t31-;/m1./s1 D07SGB DRUGINKE NKIONDJYXPXFFL-JSSVAETHSA-M D07SGB DRUGSMIL CC(=O)OC[N+]1=CC=CC(=C1)C2N3C=CC(=C3CS2)C(=O)C4=CN(C5=C4C=CC(=C5)C6=CC=C(C=C6)F)C(=O)N(C)C.[Cl-] D07SGB HIGHSTAT Discontinued in Phase 1 D07YHY DRUG__ID D07YHY D07YHY DRUGCOMP Rotta Research Lab SpA D07YHY DRUGTYPE Small molecular drug D07YHY DRUGINCH 1S/C18H25ClN2O4/c1-18(2,3)9-10-20-17(25)14(7-8-15(22)23)21-16(24)12-5-4-6-13(19)11-12/h4-6,11,14H,7-10H2,1-3H3,(H,20,25)(H,21,24)(H,22,23)/t14-/m1/s1 D07YHY DRUGINKE VUYSXYHJEIPUTG-CQSZACIVSA-N D07YHY DRUGSMIL CC(C)(C)CCNC(=O)C(CCC(=O)O)NC(=O)C1=CC(=CC=C1)Cl D07YHY HIGHSTAT Discontinued in Phase 1 D08DZZ DRUG__ID D08DZZ D08DZZ DRUGCOMP Hollis-Eden Pharmaceuticals D08DZZ DRUGTYPE Small molecular drug D08DZZ DRUGINCH 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1 D08DZZ DRUGINKE QADHLRWLCPCEKT-LOVVWNRFSA-N D08DZZ DRUGSMIL CC12CCC3C(C1CCC2O)CC=C4C3(CCC(C4)O)C D08DZZ HIGHSTAT Discontinued in Phase 1 D08GRY DRUG__ID D08GRY D08GRY THERCLAS Analgesics D08GRY DRUGTYPE Small molecular drug D08GRY DRUGINCH 1S/C17H12BrFO2S2/c1-23(20,21)14-8-4-11(5-9-14)15-10-16(18)22-17(15)12-2-6-13(19)7-3-12/h2-10H,1H3 D08GRY DRUGINKE AJFTZWGGHJXZOB-UHFFFAOYSA-N D08GRY DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=C(SC(=C2)Br)C3=CC=C(C=C3)F D08GRY HIGHSTAT Discontinued in Phase 1 D08VUJ DRUG__ID D08VUJ D08VUJ DRUGCOMP NeuroSearch A/S D08VUJ DRUGTYPE Small molecular drug D08VUJ DRUGINCH 1S/C9H13N3/c10-8-3-5-12(7-8)9-2-1-4-11-6-9/h1-2,4,6,8H,3,5,7,10H2 D08VUJ DRUGINKE LVGMMVAWLISWJD-UHFFFAOYSA-N D08VUJ DRUGSMIL C1CN(CC1N)C2=CN=CC=C2 D08VUJ HIGHSTAT Discontinued in Phase 1 D08WVA DRUG__ID D08WVA D08WVA DRUGCOMP Pfizer Inc D08WVA DRUGTYPE Small molecular drug D08WVA DRUGINCH 1S/C24H35Cl2N5O3S/c25-21-4-3-19(13-22(21)26)24(6-5-23(32)30(17-24)14-18-1-2-18)7-8-28-15-20(16-28)29-9-11-31(12-10-29)35(27,33)34/h3-4,13,18,20H,1-2,5-12,14-17H2,(H2,27,33,34)/t24-/m1/s1 D08WVA DRUGINKE OQXJUJDDCWHRLA-XMMPIXPASA-N D08WVA DRUGSMIL C1CC1CN2CC(CCC2=O)(CCN3CC(C3)N4CCN(CC4)S(=O)(=O)N)C5=CC(=C(C=C5)Cl)Cl D08WVA HIGHSTAT Discontinued in Phase 1 D08XWZ DRUG__ID D08XWZ D08XWZ DRUGCOMP NPS Allelix Corp D08XWZ DRUGTYPE Small molecular drug D08XWZ DRUGINCH 1S/C18H25N3/c1-20(2)9-6-16-13-19-18-5-4-15(12-17(16)18)14-7-10-21(3)11-8-14/h4-5,7,12-13,19H,6,8-11H2,1-3H3 D08XWZ DRUGINKE RQTZMTMTBWAQAI-UHFFFAOYSA-N D08XWZ DRUGSMIL CN1CCC(=CC1)C2=CC3=C(C=C2)NC=C3CCN(C)C D08XWZ HIGHSTAT Discontinued in Phase 1 D08ZBT DRUG__ID D08ZBT D08ZBT DRUGCOMP Novartis AG D08ZBT DRUGTYPE Small molecular drug D08ZBT DRUGINCH 1S/C17H25N5O4/c1-25-14-13(24)11(7-23)26-17(14)22-9-20-12-15(18-8-19-16(12)22)21-10-5-3-2-4-6-10/h8-11,13-14,17,23-24H,2-7H2,1H3,(H,18,19,21)/t11-,13-,14-,17-/m1/s1 D08ZBT DRUGINKE JAKAFSGZUXCHLF-LSCFUAHRSA-N D08ZBT DRUGSMIL COC1C(C(OC1N2C=NC3=C(N=CN=C32)NC4CCCCC4)CO)O D08ZBT HIGHSTAT Discontinued in Phase 1 D09CAC DRUG__ID D09CAC D09CAC DRUGCOMP Pharmacia & Upjohn Co D09CAC DRUGTYPE Small molecular drug D09CAC DRUGINCH 1S/C24H26O3/c1-3-18(15-17-11-7-5-8-12-17)22-16-21(25)23(24(26)27-22)20(4-2)19-13-9-6-10-14-19/h5-14,16,18,20,25H,3-4,15H2,1-2H3 D09CAC DRUGINKE HALPINAQGOXQAN-UHFFFAOYSA-N D09CAC DRUGSMIL CCC(CC1=CC=CC=C1)C2=CC(=C(C(=O)O2)C(CC)C3=CC=CC=C3)O D09CAC HIGHSTAT Discontinued in Phase 1 D09GHB DRUG__ID D09GHB D09GHB DRUGCOMP F Hoffmann-La Roche Ltd D09GHB DRUGTYPE Small molecular drug D09GHB DRUGINCH 1S/C20H19F3IN3O5/c21-14-9-12(24)3-4-15(14)25-19-13(20(30)26-31-7-5-28)8-11(17(22)18(19)23)10-27-16(29)2-1-6-32-27/h3-4,8-9,25,28H,1-2,5-7,10H2,(H,26,30) D09GHB DRUGINKE FIMYFEGKMOCQKT-UHFFFAOYSA-N D09GHB DRUGSMIL C1CC(=O)N(OC1)CC2=CC(=C(C(=C2F)F)NC3=C(C=C(C=C3)I)F)C(=O)NOCCO D09GHB HIGHSTAT Discontinued in Phase 1 D09LMX DRUG__ID D09LMX D09LMX DRUGCOMP Pfizer D09LMX DRUGTYPE Small molecular drug D09LMX DRUGINCH 1S/C19H27NO4S/c1-25(23)12-9-19(14-21,16-5-3-2-4-6-16)18(22)24-17-13-20-10-7-15(17)8-11-20/h2-6,15,17,21H,7-14H2,1H3/t17-,19-,25-/m0/s1 D09LMX DRUGINKE VGXACJMXDYPFDB-KMEZTADASA-N D09LMX DRUGSMIL CS(=O)CCC(CO)(C1=CC=CC=C1)C(=O)OC2CN3CCC2CC3 D09LMX HIGHSTAT Discontinued in Phase 1 D09TMV DRUG__ID D09TMV D09TMV DRUGCOMP AstraZeneca plc D09TMV DRUGTYPE Small molecular drug D09TMV DRUGINCH 1S/C27H30O6S2/c1-20-3-5-22(6-4-20)16-18-34-26(27(28)29)19-23-9-7-21(8-10-23)15-17-32-24-11-13-25(14-12-24)33-35(2,30)31/h3-14,26H,15-19H2,1-2H3,(H,28,29) D09TMV DRUGINKE CIHMPKKTGUOBBS-UHFFFAOYSA-N D09TMV DRUGSMIL CC1=CC=C(C=C1)CCSC(CC2=CC=C(C=C2)CCOC3=CC=C(C=C3)OS(=O)(=O)C)C(=O)O D09TMV HIGHSTAT Discontinued in Phase 1 D09XHI DRUG__ID D09XHI D09XHI DRUGCOMP AstraZeneca plc D09XHI DRUGTYPE Small molecular drug D09XHI DRUGINCH 1S/C15H6FN5O/c16-12-4-10(7-18)3-11(5-12)15-20-14(21-22-15)13-2-1-9(6-17)8-19-13/h1-5,8H D09XHI DRUGINKE PBVKGEMPZBKZOA-UHFFFAOYSA-N D09XHI DRUGSMIL C1=CC(=NC=C1C#N)C2=NOC(=N2)C3=CC(=CC(=C3)C#N)F D09XHI HIGHSTAT Discontinued in Phase 1 D0A1NU DRUG__ID D0A1NU D0A1NU DRUGCOMP Abbott Lab D0A1NU DRUGTYPE Small molecular drug D0A1NU DRUGINCH 1S/C21H25N5O3/c1-3-16-4-5-17(13-22)26(16)19(27)14-24-21(2)7-10-25(11-8-21)18-12-15(20(28)29)6-9-23-18/h1,6,9,12,16-17,24H,4-5,7-8,10-11,14H2,2H3,(H,28,29)/t16-,17-/m0/s1 D0A1NU DRUGINKE FIMRNLAKAARHPD-IRXDYDNUSA-N D0A1NU DRUGSMIL CC1(CCN(CC1)C2=NC=CC(=C2)C(=O)O)NCC(=O)N3C(CCC3C#N)C#C D0A1NU HIGHSTAT Discontinued in Phase 1 D0A8IE DRUG__ID D0A8IE D0A8IE DRUGCOMP ACADIA Pharmaceuticals D0A8IE DRUGTYPE Small molecular drug D0A8IE DRUGINCH 1S/C7H13NO3.ClH/c1-10-6(9)7(8)2-4-11-5-3-7;/h2-5,8H2,1H3;1H D0A8IE DRUGINKE VNPBPEQYIQVYDP-UHFFFAOYSA-N D0A8IE DRUGSMIL COC(=O)C1(CCOCC1)N.Cl D0A8IE HIGHSTAT Discontinued in Phase 1 D0A8ZD DRUG__ID D0A8ZD D0A8ZD DRUGCOMP Sanofi D0A8ZD DRUGTYPE Small molecular drug D0A8ZD DRUGINCH 1S/C32H40N2O5S/c1-23(2)31-27-10-7-8-11-28(27)34(4)32(31)40(35,36)26-15-13-25(14-16-26)39-21-9-19-33(3)20-18-24-12-17-29(37-5)30(22-24)38-6/h7-8,10-17,22-23H,9,18-21H2,1-6H3 D0A8ZD DRUGINKE GCVFQRRBTCHIPK-UHFFFAOYSA-N D0A8ZD DRUGSMIL CC(C)C1=C(N(C2=CC=CC=C21)C)S(=O)(=O)C3=CC=C(C=C3)OCCCN(C)CCC4=CC(=C(C=C4)OC)OC D0A8ZD HIGHSTAT Discontinued in Phase 1 D0AM1S DRUG__ID D0AM1S D0AM1S DRUGCOMP Purdue Neuroscience Corp D0AM1S DRUGTYPE Small molecular drug D0AM1S DRUGINCH 1S/C22H33F3O2/c1-13(26)16-6-7-17-15-5-4-14-12-21(27,22(23,24)25)11-10-19(14,2)18(15)8-9-20(16,17)3/h14-18,27H,4-12H2,1-3H3/t14-,15-,16+,17-,18-,19-,20+,21-/m0/s1 D0AM1S DRUGINKE BLMOPJSSNJGYSZ-PECKBWEZSA-N D0AM1S DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C(F)(F)F)O)C)C D0AM1S HIGHSTAT Discontinued in Phase 1 D0AV0O DRUG__ID D0AV0O D0AV0O DRUGCOMP Otsuka America Pharmaceutical; Sosei D0AV0O DRUGTYPE Small molecular drug D0AV0O DRUGINCH 1S/C26H32ClN3O2/c1-18(2)28-25(31)16-19-8-7-15-30(24-10-4-3-9-21(19)24)26(32)22-12-11-20(17-23(22)27)29-13-5-6-14-29/h3-4,9-12,17-19H,5-8,13-16H2,1-2H3,(H,28,31)/t19-/m1/s1 D0AV0O DRUGINKE INGXCNVWWKKWOO-LJQANCHMSA-N D0AV0O DRUGSMIL CC(C)NC(=O)CC1CCCN(C2=CC=CC=C12)C(=O)C3=C(C=C(C=C3)N4CCCC4)Cl D0AV0O HIGHSTAT Discontinued in Phase 1 D0B0EB DRUG__ID D0B0EB D0B0EB DRUGCOMP Ligand Pharmaceuticals Inc D0B0EB DRUGTYPE Small molecular drug D0B0EB DRUGINCH 1S/C26H25NO5S/c1-18-22(27-24(31-18)23-9-6-16-33-23)14-15-30-20-12-10-19(11-13-20)17-26(2,25(28)29)32-21-7-4-3-5-8-21/h3-13,16H,14-15,17H2,1-2H3,(H,28,29)/t26-/m0/s1 D0B0EB DRUGINKE KWSPYUOBNIMILB-SANMLTNESA-N D0B0EB DRUGSMIL CC1=C(N=C(O1)C2=CC=CS2)CCOC3=CC=C(C=C3)CC(C)(C(=O)O)OC4=CC=CC=C4 D0B0EB HIGHSTAT Discontinued in Phase 1 D0B0MA DRUG__ID D0B0MA D0B0MA DRUGCOMP Pierre Fabre SA D0B0MA DRUGTYPE Small molecular drug D0B0MA DRUGINCH 1S/C12H10F3N3O/c1-7-5-10(19)11(16)17-18(7)9-4-2-3-8(6-9)12(13,14)15/h2-6H,1H3,(H2,16,17) D0B0MA DRUGINKE MRMGTEKECRMLOG-UHFFFAOYSA-N D0B0MA DRUGSMIL CC1=CC(=O)C(=NN1C2=CC=CC(=C2)C(F)(F)F)N D0B0MA HIGHSTAT Discontinued in Phase 1 D0B4TT DRUG__ID D0B4TT D0B4TT DRUGCOMP GSK D0B4TT DRUGTYPE Small molecular drug D0B4TT DRUGINCH 1S/C39H49ClN4O2/c40-33-19-15-32(16-20-33)29-38-36-13-3-4-14-37(36)39(45)44(41-38)30-34-12-9-27-43(34)26-8-5-11-31-17-21-35(22-18-31)46-28-10-25-42-23-6-1-2-7-24-42/h3-4,13-22,34H,1-2,5-12,23-30H2/t34-/m1/s1 D0B4TT DRUGINKE YANGEESWIGIKOP-UUWRZZSWSA-N D0B4TT DRUGSMIL C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCCC3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl D0B4TT HIGHSTAT Discontinued in Phase 1 D0B6ER DRUG__ID D0B6ER D0B6ER DRUGCOMP Roche Holding AG D0B6ER DRUGTYPE Small molecular drug D0B6ER DRUGINCH 1S/C17H14N2O2/c1-17(2)10-14(15-5-3-4-8-19(15)20)13-9-12(11-18)6-7-16(13)21-17/h3-10H,1-2H3 D0B6ER DRUGINKE PQVILGHAVGQHRP-UHFFFAOYSA-N D0B6ER DRUGSMIL CC1(C=C(C2=C(O1)C=CC(=C2)C#N)C3=CC=CC=[N+]3[O-])C D0B6ER HIGHSTAT Discontinued in Phase 1 D0B7CZ DRUG__ID D0B7CZ D0B7CZ DRUGCOMP Parke-Davis & Co D0B7CZ DRUGTYPE Small molecular drug D0B7CZ DRUGINCH 1S/C21H25N5O4/c1-22-6-7-24-12-2-3-13-17-16(12)21(30)19-15(29)5-4-14(28)18(19)20(17)25-26(13)10-8-23-9-11-27/h2-5,22-23,25,27,29-30H,6-11H2,1H3 D0B7CZ DRUGINKE WOPAVGQTOMNFGS-UHFFFAOYSA-N D0B7CZ DRUGSMIL CNCCN=C1C=CC2=C3C1=C(C4=C(C=CC(=O)C4=C3NN2CCNCCO)O)O D0B7CZ HIGHSTAT Discontinued in Phase 1 D0BM6S DRUG__ID D0BM6S D0BM6S DRUGCOMP AstraZeneca D0BM6S DRUGTYPE Small molecular drug D0BM6S DRUGINCH 1S/C28H39N3O8/c1-14-10-18-23(29)20(32)13-19(25(18)34)31-27(35)15(2)8-7-9-21(37-5)26(39-28(30)36)17(4)12-16(3)24(33)22(11-14)38-6/h7-9,12-14,16,21-22,24,26,33H,10-11,29H2,1-6H3,(H2,30,36)(H,31,35)/b9-7-,15-8+,17-12+/t14-,16+,21+,22+,24-,26+/m1/s1 D0BM6S DRUGINKE XYFFWTYOFPSZRM-TWNAANEASA-N D0BM6S DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)N)C)OC)OC(=O)N)C)C)O)OC D0BM6S HIGHSTAT Discontinued in Phase 1 D0BN4Y DRUG__ID D0BN4Y D0BN4Y DRUGCOMP Astra AB D0BN4Y DRUGTYPE Small molecular drug D0BN4Y DRUGINCH 1S/C19H30N2O2/c1-6-10-21(14(4)5)15-11-17-16(19(22)20-13(2)3)8-7-9-18(17)23-12-15/h7-9,13-15H,6,10-12H2,1-5H3,(H,20,22)/t15-/m1/s1 D0BN4Y DRUGINKE UEAKCKJAKUFIQP-OAHLLOKOSA-N D0BN4Y DRUGSMIL CCCN(C1CC2=C(C=CC=C2OC1)C(=O)NC(C)C)C(C)C D0BN4Y HIGHSTAT Discontinued in Phase 1 D0C3CF DRUG__ID D0C3CF D0C3CF DRUGCOMP Novartis AG D0C3CF DRUGTYPE Small molecular drug D0C3CF DRUGINCH 1S/C15H21NO2S/c1-16-6-7-18-14-9-11-10(8-12(14)16)13(17-2)4-5-15(11)19-3/h4-5,12,14H,6-9H2,1-3H3/t12-,14-/m1/s1 D0C3CF DRUGINKE SLMAGYSTRWJTMF-TZMCWYRMSA-N D0C3CF DRUGSMIL CN1CCOC2C1CC3=C(C=CC(=C3C2)SC)OC D0C3CF HIGHSTAT Discontinued in Phase 1 D0C4YA DRUG__ID D0C4YA D0C4YA DRUGCOMP Agouron Pharmaceuticals Inc D0C4YA DRUGTYPE Small molecular drug D0C4YA DRUGINCH 1S/C23H24N4O3S/c1-26(21-10-9-20-22-18(21)3-2-4-19(22)23(24)25-20)15-16-5-7-17(8-6-16)31(28,29)27-11-13-30-14-12-27/h2-10H,11-15H2,1H3,(H2,24,25) D0C4YA DRUGINKE CVEGTZWWWRJCFK-UHFFFAOYSA-N D0C4YA DRUGSMIL CN(CC1=CC=C(C=C1)S(=O)(=O)N2CCOCC2)C3=C4C=CC=C5C4=C(C=C3)N=C5N D0C4YA HIGHSTAT Discontinued in Phase 1 D0D9AD DRUG__ID D0D9AD D0D9AD DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0D9AD DRUGTYPE Small molecular drug D0D9AD DRUGINCH 1S/C31H36N2O/c1-21-16-22(2)30(23(3)17-21)32-31(34)33(27-11-6-4-5-7-12-27)20-24-14-15-29-26(18-24)19-25-10-8-9-13-28(25)29/h8-10,13-18,27H,4-7,11-12,19-20H2,1-3H3,(H,32,34) D0D9AD DRUGINKE FMLJREWZCZHGGW-UHFFFAOYSA-N D0D9AD DRUGSMIL CC1=CC(=C(C(=C1)C)NC(=O)N(CC2=CC3=C(C=C2)C4=CC=CC=C4C3)C5CCCCCC5)C D0D9AD HIGHSTAT Discontinued in Phase 1 D0E8MW DRUG__ID D0E8MW D0E8MW DRUGCOMP UCB Celltech D0E8MW DRUGTYPE Small molecular drug D0E8MW DRUGINCH 1S/C12H25BO2/c1-10(2,3)8-9-13-14-11(4,5)12(6,7)15-13/h8-9H2,1-7H3 D0E8MW DRUGINKE JAHKBUBFJVAEDA-UHFFFAOYSA-N D0E8MW DRUGSMIL B1(OC(C(O1)(C)C)(C)C)CCC(C)(C)C D0E8MW HIGHSTAT Discontinued in Phase 1 D0FD2I DRUG__ID D0FD2I D0FD2I DRUGCOMP Harbor Branch Oceanographic Institute Inc D0FD2I DRUGTYPE Small molecular drug D0FD2I DRUGINCH 1S/C33H55NO8/c1-10-11-12-20(4)31(42-33(34)40)24(8)29(37)22(6)16-18(2)15-21(5)28(36)19(3)13-14-26(35)17-27-23(7)30(38)25(9)32(39)41-27/h10-15,19-31,35-38H,1,16-17H2,2-9H3,(H2,34,40)/b12-11-,14-13-,18-15-/t19-,20-,21-,22-,23-,24-,25+,26+,27-,28-,29+,30-,31-/m0/s1 D0FD2I DRUGINKE AADVCYNFEREWOS-OBRABYBLSA-N D0FD2I DRUGSMIL CC1C(OC(=O)C(C1O)C)CC(C=CC(C)C(C(C)C=C(C)CC(C)C(C(C)C(C(C)C=CC=C)OC(=O)N)O)O)O D0FD2I HIGHSTAT Discontinued in Phase 1 D0FY6Q DRUG__ID D0FY6Q D0FY6Q DRUGCOMP Japan Tobacco Inc D0FY6Q DRUGTYPE Small molecular drug D0FY6Q DRUGINCH 1S/C27H26N2O3/c30-27(31)21-13-16-25-24(17-21)28-26(29(25)22-9-5-2-6-10-22)20-11-14-23(15-12-20)32-18-19-7-3-1-4-8-19/h1,3-4,7-8,11-17,22H,2,5-6,9-10,18H2,(H,30,31) D0FY6Q DRUGINKE GWCTUYUNVJTNJR-UHFFFAOYSA-N D0FY6Q DRUGSMIL C1CCC(CC1)N2C3=C(C=C(C=C3)C(=O)O)N=C2C4=CC=C(C=C4)OCC5=CC=CC=C5 D0FY6Q HIGHSTAT Discontinued in Phase 1 D0G1NW DRUG__ID D0G1NW D0G1NW DRUGCOMP Pfizer Inc D0G1NW DRUGTYPE Small molecular drug D0G1NW DRUGINCH 1S/C35H34N2O4/c1-23-30(14-9-17-36-23)37-32(39)25-15-16-29-28(18-25)31(38)19-27-21-35(41,26-12-7-4-8-13-26)33(2,40)22-34(27,29)20-24-10-5-3-6-11-24/h3-18,27,40-41H,19-22H2,1-2H3,(H,37,39)/t27-,33-,34-,35-/m1/s1 D0G1NW DRUGINKE GZOXYYZSDATUNP-WHQVQTAISA-N D0G1NW DRUGSMIL CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)C4(CC(C(CC4CC3=O)(C5=CC=CC=C5)O)(C)O)CC6=CC=CC=C6 D0G1NW HIGHSTAT Discontinued in Phase 1 D0G1RA DRUG__ID D0G1RA D0G1RA DRUGCOMP Huntington Medical Research Institutes D0G1RA DRUGTYPE Small molecular drug D0G1RA DRUGINCH 1S/C21H16N2O3.ClH/c1-25-21(24)15-5-3-2-4-14(15)20-16-8-6-12(22)10-18(16)26-19-11-13(23)7-9-17(19)20;/h2-11,22H,23H2,1H3;1H D0G1RA DRUGINKE MYFATKRONKHHQL-UHFFFAOYSA-N D0G1RA DRUGSMIL COC(=O)C1=CC=CC=C1C2=C3C=CC(=N)C=C3OC4=C2C=CC(=C4)N.Cl D0G1RA HIGHSTAT Discontinued in Phase 1 D0G6JE DRUG__ID D0G6JE D0G6JE DRUGCOMP Schering-Plough D0G6JE DRUGTYPE Small molecular drug D0G6JE DRUGINCH 1S/C28H37BrN4O3/c1-5-36-30-26(22-6-8-24(29)9-7-22)23-11-15-32(16-12-23)28(4)13-18-31(19-14-28)27(34)25-20(2)10-17-33(35)21(25)3/h6-10,17,23H,5,11-16,18-19H2,1-4H3/b30-26+ D0G6JE DRUGINKE ZGDKVKUWTCGYOA-URGPHPNLSA-N D0G6JE DRUGSMIL CCON=C(C1CCN(CC1)C2(CCN(CC2)C(=O)C3=C(C=C[N+](=C3C)[O-])C)C)C4=CC=C(C=C4)Br D0G6JE HIGHSTAT Discontinued in Phase 1 D0G6RU DRUG__ID D0G6RU D0G6RU DRUGCOMP Neose Technologies Inc D0G6RU DRUGTYPE Small molecular drug D0G6RU DRUGINCH 1S/C37H62N2O29/c1-10(46)38-19-12(48)3-37(36(59)60,67-30(19)22(53)14(50)5-41)68-32-24(55)17(8-44)62-35(27(32)58)65-29-18(9-45)63-33(20(25(29)56)39-11(2)47)66-31-23(54)16(7-43)61-34(26(31)57)64-28(15(51)6-42)21(52)13(49)4-40/h4,12-35,41-45,48-58H,3,5-9H2,1-2H3,(H,38,46)(H,39,47)(H,59,60)/t12-,13-,14+,15+,16+,17+,18+,19+,20+,21+,22+,23-,24-,25+,26+,27+,28+,29+,30+,31-,32?,33-,34-,35-,37-/m0/s1 D0G6RU DRUGINKE ILRKELAUAFUGGJ-XLXDPAEISA-N D0G6RU DRUGSMIL CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OC2C(C(OC(C2O)OC3C(OC(C(C3O)NC(=O)C)OC4C(C(OC(C4O)OC(C(CO)O)C(C(C=O)O)O)CO)O)CO)CO)O)O D0G6RU HIGHSTAT Discontinued in Phase 1 D0G9ZW DRUG__ID D0G9ZW D0G9ZW DRUGCOMP Pharmacia & Upjohn AB D0G9ZW DRUGTYPE Small molecular drug D0G9ZW DRUGINCH 1S/C18H16N2O3/c1-19(12-8-4-3-5-9-12)17(22)15-16(21)13-10-6-7-11-14(13)20(2)18(15)23/h3-11,21H,1-2H3 D0G9ZW DRUGINKE SGOOQMRIPALTEL-UHFFFAOYSA-N D0G9ZW DRUGSMIL CN1C2=CC=CC=C2C(=C(C1=O)C(=O)N(C)C3=CC=CC=C3)O D0G9ZW HIGHSTAT Discontinued in Phase 1 D0H1FL DRUG__ID D0H1FL D0H1FL DRUGCOMP Pfizer Inc D0H1FL DRUGTYPE Small molecular drug D0H1FL DRUGINCH 1S/C21H17Cl2F2N3O2/c1-21(24,25)12-27-10-11-30-19-17(20(27)29)26-28(16-5-3-2-4-15(16)23)18(19)13-6-8-14(22)9-7-13/h2-9H,10-12H2,1H3 D0H1FL DRUGINKE FJMQJSUOOGOWBD-UHFFFAOYSA-N D0H1FL DRUGSMIL CC(CN1CCOC2=C(N(N=C2C1=O)C3=CC=CC=C3Cl)C4=CC=C(C=C4)Cl)(F)F D0H1FL HIGHSTAT Discontinued in Phase 1 D0H5KO DRUG__ID D0H5KO D0H5KO DRUGCOMP Kyowa Hakko Kogyo Co Ltd D0H5KO DRUGTYPE Small molecular drug D0H5KO DRUGINCH 1S/C26H22N2O3.Na/c1-16-11-23-24(12-17(16)2)28(15-27-23)10-9-21-20-6-4-3-5-19(20)14-31-25-8-7-18(26(29)30)13-22(21)25;/h3-9,11-13,15H,10,14H2,1-2H3,(H,29,30);/q;+1/p-1/b21-9+; D0H5KO DRUGINKE KWELWDMCBFWKQN-CSFJJMQLSA-M D0H5KO DRUGSMIL CC1=CC2=C(C=C1C)N(C=N2)CC=C3C4=CC=CC=C4COC5=C3C=C(C=C5)C(=O)[O-].[Na+] D0H5KO HIGHSTAT Discontinued in Phase 1 D0H5LC DRUG__ID D0H5LC D0H5LC DRUGCOMP Gilead Sciences Inc D0H5LC DRUGTYPE Small molecular drug D0H5LC DRUGINCH 1S/C8H12N3O5P/c9-7-1-2-11(8(12)10-7)3-6-4-16-17(13,14)5-15-6/h1-2,6H,3-5H2,(H,13,14)(H2,9,10,12)/t6-/m0/s1 D0H5LC DRUGINKE YXQUGSXUDFTPLL-LURJTMIESA-N D0H5LC DRUGSMIL C1C(OCP(=O)(O1)O)CN2C=CC(=NC2=O)N D0H5LC HIGHSTAT Discontinued in Phase 1 D0H5MX DRUG__ID D0H5MX D0H5MX DRUGCOMP Isotechnika Pharma Inc; Isotechnika D0H5MX DRUGTYPE Small molecular drug D0H5MX DRUGINCH 1S/C55H86N2O14.CH4O3S/c1-33-18-14-13-15-19-34(2)45(66-10)30-41-23-21-39(7)55(65,71-41)52(62)53(63)57-25-17-16-20-42(57)54(64)69-46(36(4)28-40-22-24-43(58)47(29-40)67-11)31-44(59)35(3)27-38(6)50(70-48(60)32-56(8)9)51(68-12)49(61)37(5)26-33;1-5(2,3)4/h13-15,18-19,27,33,35-37,39-43,45-47,50-51,58,65H,16-17,20-26,28-32H2,1-12H3;1H3,(H,2,3,4)/b15-13+,18-14+,34-19-,38-27?;/t33?,35?,36?,37?,39?,40?,41?,42?,43?,45?,46?,47?,50?,51?,55-;/m0./s1 D0H5MX DRUGINKE XVNMRKHCSMPLOF-CPNVPWJOSA-N D0H5MX DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)OC(=O)CN(C)C)OC)C)C)C)OC.CS(=O)(=O)O D0H5MX HIGHSTAT Discontinued in Phase 1 D0H5NX DRUG__ID D0H5NX D0H5NX DRUGCOMP Taiho Pharmaceutical Co Ltd D0H5NX DRUGTYPE Small molecular drug D0H5NX DRUGINCH 1S/C28H36N2O7/c1-29(2)8-9-30(3)7-6-17-18-12-21-22(37-15-36-21)13-19(18)25(26-20(17)14-35-28(26)32)16-10-23(33-4)27(31)24(11-16)34-5/h10-13,17,20,25-26,31H,6-9,14-15H2,1-5H3/t17-,20-,25-,26+/m1/s1 D0H5NX DRUGINKE KLCCMMSKRMSMKI-QVNMXXJYSA-N D0H5NX DRUGSMIL CN(C)CCN(C)CCC1C2COC(=O)C2C(C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)O)OC D0H5NX HIGHSTAT Discontinued in Phase 1 D0H7AC DRUG__ID D0H7AC D0H7AC DRUGCOMP Pfizer D0H7AC DRUGTYPE Small molecular drug D0H7AC DRUGINCH 1S/C23H25F3N6O2/c1-12(33)27-11-20(34)32-18-7-8-19(32)16-9-14(5-6-15(16)18)30-22-28-10-17(23(24,25)26)21(31-22)29-13-3-2-4-13/h5-6,9-10,13,18-19H,2-4,7-8,11H2,1H3,(H,27,33)(H2,28,29,30,31)/t18-,19+/m0/s1 D0H7AC DRUGINKE RYYNGWLOYLRZLK-RBUKOAKNSA-N D0H7AC DRUGSMIL CC(=O)NCC(=O)N1C2CCC1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F D0H7AC HIGHSTAT Discontinued in Phase 1 D0H9FX DRUG__ID D0H9FX D0H9FX DRUGCOMP ViroPharma Inc D0H9FX DRUGTYPE Small molecular drug D0H9FX DRUGINCH 1S/C18H20N2O3/c1-3-7-18(9-14(21)22)17-13(6-8-23-18)15-12(10-19)5-4-11(2)16(15)20-17/h4-5,20H,3,6-9H2,1-2H3,(H,21,22)/t18-/m1/s1 D0H9FX DRUGINKE JXZYSNWHGBGZAI-GOSISDBHSA-N D0H9FX DRUGSMIL CCCC1(C2=C(CCO1)C3=C(C=CC(=C3N2)C)C#N)CC(=O)O D0H9FX HIGHSTAT Discontinued in Phase 1 D0I3PG DRUG__ID D0I3PG D0I3PG DRUGCOMP Sandoz Research Institute D0I3PG DRUGTYPE Small molecular drug D0I3PG DRUGINCH 1S/C21H44NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-27-29(25,26)28-20(18-21(23)24)19-22(2,3)4/h20H,5-19H2,1-4H3,(H-,23,24,25,26)/t20-/m1/s1 D0I3PG DRUGINKE HSNUXANXVHLGQT-HXUWFJFHSA-N D0I3PG DRUGSMIL CCCCCCCCCCCCCCOP(=O)([O-])OC(CC(=O)O)C[N+](C)(C)C D0I3PG HIGHSTAT Discontinued in Phase 1 D0IZ7T DRUG__ID D0IZ7T D0IZ7T DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0IZ7T DRUGTYPE Small molecular drug D0IZ7T DRUGINCH 1S/C40H56N6O2.2ClH/c1-43(2)35-24-20-33(21-25-35)41-39(47)45(37-16-9-5-6-10-17-37)29-31-14-13-15-32(28-31)30-46(38-18-11-7-8-12-19-38)40(48)42-34-22-26-36(27-23-34)44(3)4;;/h13-15,20-28,37-38H,5-12,16-19,29-30H2,1-4H3,(H,41,47)(H,42,48);2*1H D0IZ7T DRUGINKE AKJWTZIUYIFCCS-UHFFFAOYSA-N D0IZ7T DRUGSMIL CN(C)C1=CC=C(C=C1)NC(=O)N(CC2=CC(=CC=C2)CN(C3CCCCCC3)C(=O)NC4=CC=C(C=C4)N(C)C)C5CCCCCC5.Cl.Cl D0IZ7T HIGHSTAT Discontinued in Phase 1 D0J5WI DRUG__ID D0J5WI D0J5WI DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0J5WI DRUGTYPE Small molecular drug D0J5WI DRUGINCH 1S/C21H25N9O8S2.ClH/c1-21(2,19(36)37)38-26-11(14-25-20(23)40-27-14)15(32)24-12-16(33)30-13(18(34)35)9(8-39-17(12)30)7-28-4-3-10(22)29(28)5-6-31;/h3-4,12,17,22,31H,5-8H2,1-2H3,(H5,23,24,25,27,32,34,35,36,37);1H/b26-11-;/t12-,17-;/m1./s1 D0J5WI DRUGINKE ZUDLGKOSFNRQKN-RUBGNBDQSA-N D0J5WI DRUGSMIL CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=C(N4CCO)N)C(=O)O.[Cl-] D0J5WI HIGHSTAT Discontinued in Phase 1 D0J6PR DRUG__ID D0J6PR D0J6PR DRUGCOMP Acologix D0J6PR DRUGTYPE Small molecular drug D0J6PR DRUGINCH 1S/C8H9BO2/c10-9(11)8-4-3-6-1-2-7(6)5-8/h3-5,10-11H,1-2H2 D0J6PR DRUGINKE UTCPXUQYTYNXQT-UHFFFAOYSA-N D0J6PR DRUGSMIL B(C1=CC2=C(CC2)C=C1)(O)O D0J6PR HIGHSTAT Discontinued in Phase 1 D0JF6O DRUG__ID D0JF6O D0JF6O DRUGCOMP ALTANA Pharma AG D0JF6O DRUGTYPE Small molecular drug D0JF6O DRUGINCH 1S/C12H9Cl2NO2S/c13-8-2-1-3-9(14)12(8)15-10-6-18-5-7(10)4-11(16)17/h1-3,5-6,15H,4H2,(H,16,17) D0JF6O DRUGINKE AELILMBZWCGOSB-UHFFFAOYSA-N D0JF6O DRUGSMIL C1=CC(=C(C(=C1)Cl)NC2=CSC=C2CC(=O)O)Cl D0JF6O HIGHSTAT Discontinued in Phase 1 D0JJ1B DRUG__ID D0JJ1B D0JJ1B DRUGCOMP Pharmacia & Upjohn Co D0JJ1B DRUGTYPE Small molecular drug D0JJ1B DRUGINCH 1S/C19H34N2O3S/c1-4-6-14-21(15-7-5-2)16-8-9-19(22)17-10-12-18(13-11-17)20-25(3,23)24/h10-13,19-20,22H,4-9,14-16H2,1-3H3/t19-/m1/s1 D0JJ1B DRUGINKE UAARDOOBGJGDJV-LJQANCHMSA-N D0JJ1B DRUGSMIL CCCCN(CCCC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O D0JJ1B HIGHSTAT Discontinued in Phase 1 D0K1OA DRUG__ID D0K1OA D0K1OA DRUGCOMP Chiroscience R&D Ltd D0K1OA DRUGTYPE Small molecular drug D0K1OA DRUGINCH 1S/C16H11Cl2N3O2/c1-23-13-5-4-11(10-3-2-6-19-14(10)13)16(22)21-12-7-9(17)8-20-15(12)18/h2-8H,1H3,(H,21,22) D0K1OA DRUGINKE FSDOTMQXIKBFKJ-UHFFFAOYSA-N D0K1OA DRUGSMIL COC1=C2C(=C(C=C1)C(=O)NC3=C(N=CC(=C3)Cl)Cl)C=CC=N2 D0K1OA HIGHSTAT Discontinued in Phase 1 D0L0ZC DRUG__ID D0L0ZC D0L0ZC DRUGCOMP GlaxoSmithKline D0L0ZC DRUGTYPE Small molecular drug D0L0ZC DRUGINCH 1S/C18H11N3O2S/c22-17-16(24-18(23)21-17)10-11-1-2-15-14(9-11)13(5-8-20-15)12-3-6-19-7-4-12/h1-10H,(H,21,22,23)/b16-10- D0L0ZC DRUGINKE QDITZBLZQQZVEE-YBEGLDIGSA-N D0L0ZC DRUGSMIL C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4 D0L0ZC HIGHSTAT Discontinued in Phase 1 D0L7BV DRUG__ID D0L7BV D0L7BV DRUGCOMP Wyeth; Wyeth-Ayerst Pharmaceuticals Inc D0L7BV DRUGTYPE Small molecular drug D0L7BV DRUGINCH 1S/C19H20FN3/c20-15-5-6-18-16(11-15)17-13-23(10-7-19(17)22-18)9-2-4-14-3-1-8-21-12-14/h1,3,5-6,8,11-12,22H,2,4,7,9-10,13H2 D0L7BV DRUGINKE RZXHTPCHKSYGIB-UHFFFAOYSA-N D0L7BV DRUGSMIL C1CN(CC2=C1NC3=C2C=C(C=C3)F)CCCC4=CN=CC=C4 D0L7BV HIGHSTAT Discontinued in Phase 1 D0LE7P DRUG__ID D0LE7P D0LE7P DRUGCOMP Novartis AG D0LE7P DRUGTYPE Small molecular drug D0LE7P DRUGINCH 1S/C20H24N2S/c1-22-13-15(14-23-20-8-4-5-9-21-20)10-18-11-16-6-2-3-7-17(16)12-19(18)22/h2-9,15,18-19H,10-14H2,1H3/t15-,18-,19-/m1/s1 D0LE7P DRUGINKE JVCCQRRESBKGJS-ATZDWAIDSA-N D0LE7P DRUGSMIL CN1CC(CC2C1CC3=CC=CC=C3C2)CSC4=CC=CC=N4 D0LE7P HIGHSTAT Discontinued in Phase 1 D0LG4V DRUG__ID D0LG4V D0LG4V DRUGCOMP Sanofi D0LG4V DRUGTYPE Small molecular drug D0LG4V DRUGINCH 1S/C17H14N4O3/c1-17(2)10-14(20-8-4-3-5-16(20)19-11-18)13-9-12(21(22)23)6-7-15(13)24-17/h3-10H,1-2H3 D0LG4V DRUGINKE ZOHLDHMGABPLCB-UHFFFAOYSA-N D0LG4V DRUGSMIL CC1(C=C(C2=C(O1)C=CC(=C2)[N+](=O)[O-])N3C=CC=CC3=NC#N)C D0LG4V HIGHSTAT Discontinued in Phase 1 D0M6YW DRUG__ID D0M6YW D0M6YW DRUGCOMP Gedeon Richter Ltd D0M6YW DRUGTYPE Small molecular drug D0M6YW DRUGINCH 1S/C16H19N3O3.ClH/c20-16-7-3-9-18-19(16)10-4-8-17-11-13-12-21-14-5-1-2-6-15(14)22-13;/h1-3,5-7,9,13,17H,4,8,10-12H2;1H D0M6YW DRUGINKE WJDFSAOMSJHHCG-UHFFFAOYSA-N D0M6YW DRUGSMIL C1C(OC2=CC=CC=C2O1)CNCCCN3C(=O)C=CC=N3.Cl D0M6YW HIGHSTAT Discontinued in Phase 1 D0M7LQ DRUG__ID D0M7LQ D0M7LQ DRUGCOMP GW Pharmaceuticals D0M7LQ DRUGTYPE Small molecular drug D0M7LQ DRUGINCH 1S/C33H53NO3/c1-7-10-11-12-13-18-25(4)26-23-29(36-31(35)21-16-17-22-34(8-2)9-3)32-27-19-14-15-20-28(27)33(5,6)37-30(32)24-26/h23-25H,7-22H2,1-6H3 D0M7LQ DRUGINKE LKZQTNSAWVCNMU-UHFFFAOYSA-N D0M7LQ DRUGSMIL CCCCCCCC(C)C1=CC2=C(C3=C(CCCC3)C(O2)(C)C)C(=C1)OC(=O)CCCCN(CC)CC D0M7LQ HIGHSTAT Discontinued in Phase 1 D0MC0O DRUG__ID D0MC0O D0MC0O DRUGCOMP AstraZeneca plc D0MC0O DRUGTYPE Small molecular drug D0MC0O DRUGINCH 1S/C19H18N4O2/c20-10-13-1-3-16-15(9-13)18(19(24)22-16)17-4-2-14(11-21-17)12-23-5-7-25-8-6-23/h1-4,9,11,22,24H,5-8,12H2 D0MC0O DRUGINKE BLTVBQXJFVRPFK-UHFFFAOYSA-N D0MC0O DRUGSMIL C1COCCN1CC2=CN=C(C=C2)C3=C(NC4=C3C=C(C=C4)C#N)O D0MC0O HIGHSTAT Discontinued in Phase 1 D0MF9H DRUG__ID D0MF9H D0MF9H DRUGCOMP NPS Pharmaceuticals Inc D0MF9H DRUGTYPE Small molecular drug D0MF9H DRUGINCH 1S/C16H17F2N/c1-19-9-8-16(12-4-2-6-14(17)10-12)13-5-3-7-15(18)11-13/h2-7,10-11,16,19H,8-9H2,1H3 D0MF9H DRUGINKE MUGNLPWYHGOJEG-UHFFFAOYSA-N D0MF9H DRUGSMIL CNCCC(C1=CC(=CC=C1)F)C2=CC(=CC=C2)F D0MF9H HIGHSTAT Discontinued in Phase 1 D0ML0L DRUG__ID D0ML0L D0ML0L DRUGCOMP Array BioPharma D0ML0L DRUGTYPE Small molecular drug D0ML0L DRUGINCH 1S/C31H33FN6O3/c1-20-5-8-24(9-6-20)38-29(17-28(36-38)31(2,3)4)35-30(40)33-18-22-15-23(32)7-12-27(22)41-25-10-11-26-21(16-25)19-34-37(26)13-14-39/h5-12,15-17,19,39H,13-14,18H2,1-4H3,(H2,33,35,40) D0ML0L DRUGINKE LNMRSSIMGCDUTP-UHFFFAOYSA-N D0ML0L DRUGSMIL CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NCC3=C(C=CC(=C3)F)OC4=CC5=C(C=C4)N(N=C5)CCO D0ML0L HIGHSTAT Discontinued in Phase 1 D0MT0A DRUG__ID D0MT0A D0MT0A DRUGCOMP ChemoCentryx D0MT0A DRUGTYPE Small molecular drug D0MT0A DRUGINCH 1S/C17H16ClNO4/c1-23-15-7-6-13(18)10-14(15)16(20)19-9-8-11-2-4-12(5-3-11)17(21)22/h2-7,10H,8-9H2,1H3,(H,19,20)(H,21,22) D0MT0A DRUGINKE SWLAMJPTOQZTAE-UHFFFAOYSA-N D0MT0A DRUGSMIL COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)C(=O)O D0MT0A HIGHSTAT Discontinued in Phase 1 D0N0KR DRUG__ID D0N0KR D0N0KR DRUGCOMP Merck KGaA D0N0KR DRUGTYPE Small molecular drug D0N0KR DRUGINCH 1S/C17H16N2O3/c1-17(2)16(21)15(19-8-4-3-5-14(19)20)12-9-11(10-18)6-7-13(12)22-17/h3-9,15-16,21H,1-2H3/t15-,16+/m1/s1 D0N0KR DRUGINKE MMSFHQSHXRMPLJ-CVEARBPZSA-N D0N0KR DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N3C=CC=CC3=O)O)C D0N0KR HIGHSTAT Discontinued in Phase 1 D0N1AS DRUG__ID D0N1AS D0N1AS DRUGCOMP Neurogen Corp D0N1AS DRUGTYPE Small molecular drug D0N1AS DRUGINCH 1S/C19H24BrN3O3/c1-24-16-6-4-14(12-17(16)25-2)13-22-8-10-23(11-9-22)18-7-5-15(20)19(21-18)26-3/h4-7,12H,8-11,13H2,1-3H3 D0N1AS DRUGINKE VAKYVNYLCIABRV-UHFFFAOYSA-N D0N1AS DRUGSMIL COC1=C(C=C(C=C1)CN2CCN(CC2)C3=NC(=C(C=C3)Br)OC)OC D0N1AS HIGHSTAT Discontinued in Phase 1 D0N1EW DRUG__ID D0N1EW D0N1EW DRUGCOMP Bristol-Myers Squibb Pharma Co D0N1EW DRUGTYPE Small molecular drug D0N1EW DRUGINCH 1S/C23H19F5N6O2/c1-2-5-17-29-19(22(24,25)23(26,27)28)18(21(35)36)34(17)12-13-8-10-14(11-9-13)15-6-3-4-7-16(15)20-30-32-33-31-20/h3-4,6-11H,2,5,12H2,1H3,(H,35,36)(H,30,31,32,33) D0N1EW DRUGINKE RQGDXPDTZWGCQI-UHFFFAOYSA-N D0N1EW DRUGSMIL CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C(F)(F)F)(F)F D0N1EW HIGHSTAT Discontinued in Phase 1 D0N1SU DRUG__ID D0N1SU D0N1SU DRUGCOMP Merckle GmbH D0N1SU DRUGTYPE Small molecular drug D0N1SU DRUGINCH 1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27) D0N1SU DRUGINKE UAWXGRJVZSAUSZ-UHFFFAOYSA-N D0N1SU DRUGSMIL CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C D0N1SU HIGHSTAT Discontinued in Phase 1 D0N2HF DRUG__ID D0N2HF D0N2HF DRUGCOMP National Institute on Drug Abuse D0N2HF DRUGTYPE Small molecular drug D0N2HF DRUGINCH 1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-15,28H,4,7,16-22H2 D0N2HF DRUGINKE NAUWTFJOPJWYOT-UHFFFAOYSA-N D0N2HF DRUGSMIL C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0N2HF HIGHSTAT Discontinued in Phase 1 D0N3SH DRUG__ID D0N3SH D0N3SH DRUGCOMP National Cancer Institute (NCI) D0N3SH DRUGTYPE Small molecular drug D0N3SH DRUGINCH 1S/C13H19N3O3/c17-12(15-11-6-5-9-14-10-11)7-3-1-2-4-8-13(18)16-19/h5-6,9-10,19H,1-4,7-8H2,(H,15,17)(H,16,18) D0N3SH DRUGINKE PTJGLFIIZFVFJV-UHFFFAOYSA-N D0N3SH DRUGSMIL C1=CC(=CN=C1)NC(=O)CCCCCCC(=O)NO D0N3SH HIGHSTAT Discontinued in Phase 1 D0N3TO DRUG__ID D0N3TO D0N3TO DRUGCOMP Terumo Corp D0N3TO DRUGTYPE Small molecular drug D0N3TO DRUGINCH 1S/C27H36N4O4S/c32-26(9-5-12-29-27(36)30-22-10-11-24-25(18-22)35-20-34-24)28-13-6-16-33-23-8-4-7-21(17-23)19-31-14-2-1-3-15-31/h4,7-8,10-11,17-18H,1-3,5-6,9,12-16,19-20H2,(H,28,32)(H2,29,30,36) D0N3TO DRUGINKE DZSMTMGGLVZZLW-UHFFFAOYSA-N D0N3TO DRUGSMIL C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CCCNC(=S)NC3=CC4=C(C=C3)OCO4 D0N3TO HIGHSTAT Discontinued in Phase 1 D0N8JP DRUG__ID D0N8JP D0N8JP DRUGCOMP Japan Tobacco Inc D0N8JP DRUGTYPE Small molecular drug D0N8JP DRUGINCH 1S/C22H27N5O3.CH4O3S/c23-21(24)27-10-5-16-1-2-19(13-17(16)14-27)30-15-22(20(28)29)6-11-26(12-7-22)18-3-8-25-9-4-18;1-5(2,3)4/h1-4,8-9,13H,5-7,10-12,14-15H2,(H3,23,24)(H,28,29);1H3,(H,2,3,4) D0N8JP DRUGINKE NOBZETMXGVAWIM-UHFFFAOYSA-N D0N8JP DRUGSMIL CS(=O)(=O)O.C1CN(CC2=C1C=CC(=C2)OCC3(CCN(CC3)C4=CC=NC=C4)C(=O)O)C(=N)N D0N8JP HIGHSTAT Discontinued in Phase 1 D0NK2U DRUG__ID D0NK2U D0NK2U DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0NK2U DRUGTYPE Small molecular drug D0NK2U DRUGINCH 1S/C20H21N3O9/c1-9(25)23-15-6-22-14-4-12(7-24)5-16(30-10(2)26)17(14)13(8-29-19(21)28)20(32-22,18(15)23)31-11(3)27/h4-5,7,13,15,18H,6,8H2,1-3H3,(H2,21,28)/t13-,15-,18-,20?,23?/m0/s1 D0NK2U DRUGINKE FBXPCVIKIBWXAE-GFUNNECNSA-N D0NK2U DRUGSMIL CC(=O)N1C2C1C3(C(C4=C(C=C(C=C4OC(=O)C)C=O)N(C2)O3)COC(=O)N)OC(=O)C D0NK2U HIGHSTAT Discontinued in Phase 1 D0O9EM DRUG__ID D0O9EM D0O9EM DRUGCOMP Pierre Fabre SA D0O9EM DRUGTYPE Small molecular drug D0O9EM DRUGINCH 1S/C16H23N7O2/c1-20-14(24)13-19-23(16(20)25)8-3-2-7-21-9-11-22(12-10-21)15-17-5-4-6-18-15/h4-6,13H,2-3,7-12H2,1H3 D0O9EM DRUGINKE NMYAHEULKSYAPP-UHFFFAOYSA-N D0O9EM DRUGSMIL CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=NC=CC=N3 D0O9EM HIGHSTAT Discontinued in Phase 1 D0OB7J DRUG__ID D0OB7J D0OB7J DRUGCOMP Scios Inc D0OB7J DRUGTYPE Small molecular drug D0OB7J DRUGINCH 1S/C23H27NO4/c1-13(2)9-21(22(25)26)24-23(27)28-12-20-18-10-14(3)5-7-16(18)17-8-6-15(4)11-19(17)20/h5-8,10-11,13,20-21H,9,12H2,1-4H3,(H,24,27)(H,25,26)/t21-/m0/s1 D0OB7J DRUGINKE SEHPSBSPFWAVPK-NRFANRHFSA-N D0OB7J DRUGSMIL CC1=CC2=C(C=C1)C3=C(C2COC(=O)NC(CC(C)C)C(=O)O)C=C(C=C3)C D0OB7J HIGHSTAT Discontinued in Phase 1 D0OZ4F DRUG__ID D0OZ4F D0OZ4F DRUGCOMP A Carlsson Research AB D0OZ4F DRUGTYPE Small molecular drug D0OZ4F DRUGINCH 1S/C14H20FNO2S/c1-3-16-9-7-11(8-10-16)12-5-4-6-13(14(12)15)19(2,17)18/h4-6,11H,3,7-10H2,1-2H3 D0OZ4F DRUGINKE UKUPJASJNQDHPH-UHFFFAOYSA-N D0OZ4F DRUGSMIL CCN1CCC(CC1)C2=C(C(=CC=C2)S(=O)(=O)C)F D0OZ4F HIGHSTAT Discontinued in Phase 1 D0P0HI DRUG__ID D0P0HI D0P0HI DRUGCOMP AstraZeneca D0P0HI DRUGTYPE Small molecular drug D0P0HI DRUGINCH 1S/C16H17FIN3O4/c1-9-7-11(15(23)20-25-6-5-22)14(21(2)16(9)24)19-13-4-3-10(18)8-12(13)17/h3-4,7-8,19,22H,5-6H2,1-2H3,(H,20,23) D0P0HI DRUGINKE RWEVIPRMPFNTLO-UHFFFAOYSA-N D0P0HI DRUGSMIL CC1=CC(=C(N(C1=O)C)NC2=C(C=C(C=C2)I)F)C(=O)NOCCO D0P0HI HIGHSTAT Discontinued in Phase 1 D0P9KL DRUG__ID D0P9KL D0P9KL DRUGCOMP Takeda D0P9KL DRUGTYPE Small molecular drug D0P9KL DRUGINCH 1S/C64H83N17O13/c1-34(2)26-48(57(88)73-46(20-13-25-69-63(67)68-5)56(87)74-47(55(66)86)29-39-32-70-44-18-11-9-16-42(39)44)78-64(94)81-80-61(92)50(27-37-14-7-6-8-15-37)77-62(93)54(35(3)82)79-60(91)52(31-53(65)85)76-59(90)51(30-40-33-71-45-19-12-10-17-43(40)45)75-58(89)49(72-36(4)83)28-38-21-23-41(84)24-22-38/h6-12,14-19,21-24,32-35,46-52,54,70-71,82,84H,13,20,25-31H2,1-5H3,(H2,65,85)(H2,66,86)(H,72,83)(H,73,88)(H,74,87)(H,75,89)(H,76,90)(H,77,93)(H,79,91)(H,80,92)(H3,67,68,69)(H2,78,81,94)/t35-,46+,47+,48+,49-,50+,51-,52+,54+/m1/s1 D0P9KL DRUGINKE BDPDXFSIFWZPCE-PHOVXGMNSA-N D0P9KL DRUGSMIL CC(C)CC(C(=O)NC(CCCNC(=NC)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N)NC(=O)NNC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C D0P9KL HIGHSTAT Discontinued in Phase 1 D0PB4P DRUG__ID D0PB4P D0PB4P DRUGCOMP Bristol-Myers Squibb Pharma Co D0PB4P DRUGTYPE Small molecular drug D0PB4P DRUGINCH 1S/C35H38N2O5/c38-23-29-15-11-27(12-16-29)21-36-31(19-25-7-3-1-4-8-25)33(40)34(41)32(20-26-9-5-2-6-10-26)37(35(36)42)22-28-13-17-30(24-39)18-14-28/h1-18,31-34,38-41H,19-24H2/t31-,32-,33+,34+/m1/s1 D0PB4P DRUGINKE XCVGQMUMMDXKCY-WZJLIZBTSA-N D0PB4P DRUGSMIL C1=CC=C(C=C1)CC2C(C(C(N(C(=O)N2CC3=CC=C(C=C3)CO)CC4=CC=C(C=C4)CO)CC5=CC=CC=C5)O)O D0PB4P HIGHSTAT Discontinued in Phase 1 D0Q3ES DRUG__ID D0Q3ES D0Q3ES DRUGCOMP Arena Pharma. D0Q3ES DRUGTYPE Small molecular drug D0Q3ES DRUGINCH 1S/C21H24FN5O5S/c1-13(2)31-21(28)26-8-6-14(7-9-26)32-20-16-11-25-27(19(16)23-12-24-20)18-5-4-15(10-17(18)22)33(3,29)30/h4-5,10-14H,6-9H2,1-3H3 D0Q3ES DRUGINKE XTRUQJBVQBUKSQ-UHFFFAOYSA-N D0Q3ES DRUGSMIL CC(C)OC(=O)N1CCC(CC1)OC2=NC=NC3=C2C=NN3C4=C(C=C(C=C4)S(=O)(=O)C)F D0Q3ES HIGHSTAT Discontinued in Phase 1 D0Q4YP DRUG__ID D0Q4YP D0Q4YP DRUGCOMP Takeda D0Q4YP DRUGTYPE Small molecular drug D0Q4YP DRUGINCH 1S/C22H30N2O2/c1-6-18-16(11-20(25)26)21(15-9-7-14(2)8-10-15)17(13-23)19(24-18)12-22(3,4)5/h7-10H,6,11-13,23H2,1-5H3,(H,25,26) D0Q4YP DRUGINKE HQVOROHHYWZJLD-UHFFFAOYSA-N D0Q4YP DRUGSMIL CCC1=C(C(=C(C(=N1)CC(C)(C)C)CN)C2=CC=C(C=C2)C)CC(=O)O D0Q4YP HIGHSTAT Discontinued in Phase 1 D0Q8RX DRUG__ID D0Q8RX D0Q8RX DRUGCOMP Merck & Co Inc D0Q8RX DRUGTYPE Small molecular drug D0Q8RX DRUGINCH 1S/C26H42N4O5S2/c1-19-7-5-6-8-22(19)29-12-14-30(15-13-29)37(34,35)18-26-11-9-20(25(26,2)3)17-23(26)28-24(31)21(27)10-16-36(4,32)33/h5-8,20-21,23H,9-18,27H2,1-4H3,(H,28,31)/t20-,21+,23+,26-/m1/s1 D0Q8RX DRUGINKE MWIASLNTAGRGGA-ZJPWWDJASA-N D0Q8RX DRUGSMIL CC1=CC=CC=C1N2CCN(CC2)S(=O)(=O)CC34CCC(C3(C)C)CC4NC(=O)C(CCS(=O)(=O)C)N D0Q8RX HIGHSTAT Discontinued in Phase 1 D0QW7D DRUG__ID D0QW7D D0QW7D DRUGCOMP Daiichi Seiyaku Co Ltd D0QW7D DRUGTYPE Small molecular drug D0QW7D DRUGINCH 1S/C20H21F2N3O4/c1-29-18-15-9(17(26)10(19(27)28)6-25(15)13-5-11(13)21)4-12(22)16(18)24-7-14(23)20(8-24)2-3-20/h4,6,11,13-14H,2-3,5,7-8,23H2,1H3,(H,27,28)/t11-,13+,14+/m0/s1 D0QW7D DRUGINKE JYRHGXXQSIPDDP-IACUBPJLSA-N D0QW7D DRUGSMIL COC1=C2C(=CC(=C1N3CC(C4(C3)CC4)N)F)C(=O)C(=CN2C5CC5F)C(=O)O D0QW7D HIGHSTAT Discontinued in Phase 1 D0R2EY DRUG__ID D0R2EY D0R2EY DRUGCOMP SmithKline Beecham plc D0R2EY DRUGTYPE Small molecular drug D0R2EY DRUGINCH 1S/C22H24N2O3/c1-3-7-19(26)17-14-23-22-16(9-6-11-20(22)27-13-12-25)21(17)24-18-10-5-4-8-15(18)2/h4-6,8-11,14,25H,3,7,12-13H2,1-2H3,(H,23,24) D0R2EY DRUGINKE BMCBJKLELCZGBF-UHFFFAOYSA-N D0R2EY DRUGSMIL CCCC(=O)C1=CN=C2C(=C1NC3=CC=CC=C3C)C=CC=C2OCCO D0R2EY HIGHSTAT Discontinued in Phase 1 D0R3HX DRUG__ID D0R3HX D0R3HX DRUGCOMP BTG plc D0R3HX DRUGTYPE Small molecular drug D0R3HX DRUGINCH 1S/C8H13BrN4O3.BrH/c9-1-2-10-5-7(14)6-12-4-3-11-8(12)13(15)16;/h3-4,7,10,14H,1-2,5-6H2;1H D0R3HX DRUGINKE XPBJPGMCFKYBBV-UHFFFAOYSA-N D0R3HX DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])CC(CNCCBr)O.Br D0R3HX HIGHSTAT Discontinued in Phase 1 D0S2WC DRUG__ID D0S2WC D0S2WC DRUGCOMP EGIS Gyogyszergyar RT D0S2WC DRUGTYPE Small molecular drug D0S2WC DRUGINCH 1S/C18H19N3O2/c1-11-8-13-9-16(22-2)17(23-3)10-15(13)18(21-20-11)12-4-6-14(19)7-5-12/h4-7,9-10H,8,19H2,1-3H3 D0S2WC DRUGINKE WWQDEXGFYVSTCX-UHFFFAOYSA-N D0S2WC DRUGSMIL CC1=NN=C(C2=CC(=C(C=C2C1)OC)OC)C3=CC=C(C=C3)N D0S2WC HIGHSTAT Discontinued in Phase 1 D0S2YX DRUG__ID D0S2YX D0S2YX DRUGCOMP Roche Holding AG D0S2YX DRUGTYPE Small molecular drug D0S2YX DRUGINCH 1S/C29H39NO2/c1-22(24-8-11-26-27(21-24)29(4,5)13-12-28(26,2)3)20-23-6-9-25(10-7-23)32-19-16-30-14-17-31-18-15-30/h6-11,20-21H,12-19H2,1-5H3/b22-20+ D0S2YX DRUGINKE OUQPTBCOEKUHBH-LSDHQDQOSA-N D0S2YX DRUGSMIL CC(=CC1=CC=C(C=C1)OCCN2CCOCC2)C3=CC4=C(C=C3)C(CCC4(C)C)(C)C D0S2YX HIGHSTAT Discontinued in Phase 1 D0S4AR DRUG__ID D0S4AR D0S4AR DRUGCOMP Chugai Pharmaceutical Co Ltd D0S4AR DRUGTYPE Small molecular drug D0S4AR DRUGINCH 1S/C22H24N8O5S/c23-18-17-19(29-22(24)28-18)25-9-12(26-17)10-30-6-7-36-15-8-11(4-5-14(15)30)20(33)27-13(21(34)35)2-1-3-16(31)32/h4-5,8-9,13H,1-3,6-7,10H2,(H,27,33)(H,31,32)(H,34,35)(H4,23,24,25,28,29)/t13-/m0/s1 D0S4AR DRUGINKE WEEYASWRWODDTJ-ZDUSSCGKSA-N D0S4AR DRUGSMIL C1CSC2=C(N1CC3=CN=C4C(=N3)C(=NC(=N4)N)N)C=CC(=C2)C(=O)NC(CCCC(=O)O)C(=O)O D0S4AR HIGHSTAT Discontinued in Phase 1 D0SR4G DRUG__ID D0SR4G D0SR4G DRUGCOMP Ontogen Corp D0SR4G DRUGTYPE Small molecular drug D0SR4G DRUGINCH 1S/C32H38N4O/c1-6-37-21-7-8-24-9-11-27(12-10-24)32-35-30(25-13-17-28(18-14-25)33-22(2)3)31(36-32)26-15-19-29(20-16-26)34-23(4)5/h7-20,22-23,33-34H,6,21H2,1-5H3,(H,35,36)/b8-7+ D0SR4G DRUGINKE RSJCLODJSVZNQA-BQYQJAHWSA-N D0SR4G DRUGSMIL CCOCC=CC1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=C(C=C3)NC(C)C)C4=CC=C(C=C4)NC(C)C D0SR4G HIGHSTAT Discontinued in Phase 1 D0T3EV DRUG__ID D0T3EV D0T3EV DRUGCOMP Sanofi-Synthelabo D0T3EV DRUGTYPE Small molecular drug D0T3EV DRUGINCH 1S/C32H36ClN3O5S/c1-18-12-19(2)30-21(13-18)14-24(36(30)17-28(37)38)31(39)35-32-34-29(22-15-26(41-4)23(33)16-25(22)40-3)27(42-32)11-10-20-8-6-5-7-9-20/h12-16,20H,5-11,17H2,1-4H3,(H,37,38)(H,34,35,39) D0T3EV DRUGINKE NFDFTMICKVDYLQ-UHFFFAOYSA-N D0T3EV DRUGSMIL CC1=CC(=C2C(=C1)C=C(N2CC(=O)O)C(=O)NC3=NC(=C(S3)CCC4CCCCC4)C5=CC(=C(C=C5OC)Cl)OC)C D0T3EV HIGHSTAT Discontinued in Phase 1 D0T5SZ DRUG__ID D0T5SZ D0T5SZ DRUGCOMP Pharmacia & Upjohn Inc D0T5SZ DRUGTYPE Small molecular drug D0T5SZ DRUGINCH 1S/C13H11ClN4OS/c1-7(20-13-17-11(14)5-12(15)18-13)9-4-8-2-3-19-10(8)6-16-9/h2-7H,1H3,(H2,15,17,18)/t7-/m0/s1 D0T5SZ DRUGINKE ATCRIOJPQXDFNY-ZETCQYMHSA-N D0T5SZ DRUGSMIL CC(C1=NC=C2C(=C1)C=CO2)SC3=NC(=CC(=N3)Cl)N D0T5SZ HIGHSTAT Discontinued in Phase 1 D0T8KF DRUG__ID D0T8KF D0T8KF DRUGCOMP Suntory Ltd D0T8KF DRUGTYPE Small molecular drug D0T8KF DRUGINCH 1S/C21H25N5O3/c27-19-16-29-18-7-2-1-6-17(18)20(28)26(19)11-4-3-10-24-12-14-25(15-13-24)21-22-8-5-9-23-21/h1-2,5-9H,3-4,10-16H2 D0T8KF DRUGINKE ITTHDTFPCPHJOU-UHFFFAOYSA-N D0T8KF DRUGSMIL C1CN(CCN1CCCCN2C(=O)COC3=CC=CC=C3C2=O)C4=NC=CC=N4 D0T8KF HIGHSTAT Discontinued in Phase 1 D0U0TD DRUG__ID D0U0TD D0U0TD DRUGCOMP Bayer Schering Pharma AG D0U0TD DRUGTYPE Small molecular drug D0U0TD DRUGINCH 1S/C23H21ClN2O4/c1-13(2)29-23(27)22-16(12-28-3)20-18(11-25-22)26-17-5-4-6-19(21(17)20)30-15-9-7-14(24)8-10-15/h4-11,13,26H,12H2,1-3H3 D0U0TD DRUGINKE SLYDYLLJUXFULK-UHFFFAOYSA-N D0U0TD DRUGSMIL CC(C)OC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC=C3OC4=CC=C(C=C4)Cl D0U0TD HIGHSTAT Discontinued in Phase 1 D0U7WN DRUG__ID D0U7WN D0U7WN DRUGCOMP Abbott Laboratories D0U7WN DRUGTYPE Small molecular drug D0U7WN DRUGINCH 1S/C37H43N5O6/c1-26(2)34(42-37(46)48-25-30-17-9-10-19-39-30)35(44)41-32(21-28-14-7-4-8-15-28)33(43)22-31(20-27-12-5-3-6-13-27)40-36(45)47-24-29-16-11-18-38-23-29/h3-19,23,26,31-34,43H,20-22,24-25H2,1-2H3,(H,40,45)(H,41,44)(H,42,46)/t31-,32-,33-,34-/m0/s1 D0U7WN DRUGINKE SSIBMWPFXYSVEK-CUPIEXAXSA-N D0U7WN DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(CC(CC2=CC=CC=C2)NC(=O)OCC3=CN=CC=C3)O)NC(=O)OCC4=CC=CC=N4 D0U7WN HIGHSTAT Discontinued in Phase 1 D0U8IJ DRUG__ID D0U8IJ D0U8IJ DRUGCOMP Novartis AG D0U8IJ DRUGTYPE Small molecular drug D0U8IJ DRUGINCH 1S/C17H17NO4/c1-17(2)16(20)15(21-12-5-4-11(19)8-12)13-7-10(9-18)3-6-14(13)22-17/h3,6-8,15-16,20H,4-5H2,1-2H3/t15-,16+/m1/s1 D0U8IJ DRUGINKE WJBHHTPFTVKZCV-CVEARBPZSA-N D0U8IJ DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)OC3=CC(=O)CC3)O)C D0U8IJ HIGHSTAT Discontinued in Phase 1 D0U9IQ DRUG__ID D0U9IQ D0U9IQ DRUGCOMP Pfizer D0U9IQ DRUGTYPE Small molecular drug D0U9IQ DRUGINCH 1S/C22H25N7O2/c1-29-11-13(9-25-29)20-16-10-24-28-21(30)15-7-14(8-17(27-20)18(15)16)26-22(31)19(23)12-5-3-2-4-6-12/h7-12,19,27H,2-6,23H2,1H3,(H,26,31)(H,28,30)/t19-/m1/s1 D0U9IQ DRUGINKE NDEXUOWTGYUVGA-LJQANCHMSA-N D0U9IQ DRUGSMIL CN1C=C(C=N1)C2=C3C=NNC(=O)C4=C3C(=CC(=C4)NC(=O)C(C5CCCCC5)N)N2 D0U9IQ HIGHSTAT Discontinued in Phase 1 D0V5BJ DRUG__ID D0V5BJ D0V5BJ DRUGCOMP Taro Pharmaceutical Industries Ltd D0V5BJ DRUGTYPE Small molecular drug D0V5BJ DRUGINCH 1S/C20H20N2O5/c1-26-13-21-17(23)20(15-9-5-3-6-10-15,16-11-7-4-8-12-16)18(24)22(14-27-2)19(21)25/h3-12H,13-14H2,1-2H3 D0V5BJ DRUGINKE RRFBTKHQZRCRSS-UHFFFAOYSA-N D0V5BJ DRUGSMIL COCN1C(=O)C(C(=O)N(C1=O)COC)(C2=CC=CC=C2)C3=CC=CC=C3 D0V5BJ HIGHSTAT Discontinued in Phase 1 D0V5DX DRUG__ID D0V5DX D0V5DX DRUGCOMP Glaxo Group Research Ltd D0V5DX DRUGTYPE Small molecular drug D0V5DX DRUGINCH 1S/C15H21N5O5/c21-4-9-11(23)12(24)15(25-9)20-6-18-10-13(16-5-17-14(10)20)19-7-2-1-3-8(7)22/h5-9,11-12,15,21-24H,1-4H2,(H,16,17,19)/t7-,8-,9+,11+,12+,15+/m0/s1 D0V5DX DRUGINKE GYWXTRVEUURNEW-TVDBPQCTSA-N D0V5DX DRUGSMIL C1CC(C(C1)O)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D0V5DX HIGHSTAT Discontinued in Phase 1 D0V7PY DRUG__ID D0V7PY D0V7PY DRUGCOMP Rhone-Poulenc SA D0V7PY DRUGTYPE Small molecular drug D0V7PY DRUGINCH 1S/C6H11ClN4O/c7-3(1-8)5(12)4-2-10-6(9)11-4/h2-3,5,12H,1,8H2,(H3,9,10,11)/t3-,5+/m0/s1 D0V7PY DRUGINKE YILCGOCHVFQMTC-WVZVXSGGSA-N D0V7PY DRUGSMIL C1=C(NC(=N1)N)C(C(CN)Cl)O D0V7PY HIGHSTAT Discontinued in Phase 1 D0W2SO DRUG__ID D0W2SO D0W2SO DRUGCOMP Orion Corp D0W2SO DRUGTYPE Small molecular drug D0W2SO DRUGINCH 1S/C13H14O4S/c1-9(14)13(10(2)15)8-11-4-6-12(7-5-11)18(3,16)17/h4-8H,1-3H3 D0W2SO DRUGINKE CAWYWWPWSAMGBV-UHFFFAOYSA-N D0W2SO DRUGSMIL CC(=O)C(=CC1=CC=C(C=C1)S(=O)(=O)C)C(=O)C D0W2SO HIGHSTAT Discontinued in Phase 1 D0W8QH DRUG__ID D0W8QH D0W8QH DRUGCOMP Ono Pharmaceutical Co Ltd D0W8QH DRUGTYPE Small molecular drug D0W8QH DRUGINCH 1S/C22H28N2O6/c1-3-28-15-29-14-18(13-16(2)21(25)24-27)23-22(26)17-9-11-20(12-10-17)30-19-7-5-4-6-8-19/h4-12,16,18,27H,3,13-15H2,1-2H3,(H,23,26)(H,24,25)/t16-,18-/m0/s1 D0W8QH DRUGINKE HDWWQELUBWGQGA-WMZOPIPTSA-N D0W8QH DRUGSMIL CCOCOCC(CC(C)C(=O)NO)NC(=O)C1=CC=C(C=C1)OC2=CC=CC=C2 D0W8QH HIGHSTAT Discontinued in Phase 1 D0X1BJ DRUG__ID D0X1BJ D0X1BJ DRUGCOMP Angiogene Pharmaceuticals Ltd D0X1BJ DRUGTYPE Small molecular drug D0X1BJ DRUGINCH 1S/C18H19N5O3S/c1-10(19)16(24)20-11-3-5-12(6-4-11)27-13-7-8-14-15(9-13)22-17(21-14)23-18(25)26-2/h3-10H,19H2,1-2H3,(H,20,24)(H2,21,22,23,25)/t10-/m0/s1 D0X1BJ DRUGINKE GAOHLWCIAJNSEE-JTQLQIEISA-N D0X1BJ DRUGSMIL CC(C(=O)NC1=CC=C(C=C1)SC2=CC3=C(C=C2)N=C(N3)NC(=O)OC)N D0X1BJ HIGHSTAT Discontinued in Phase 1 D0X4MC DRUG__ID D0X4MC D0X4MC DRUGCOMP Amgen D0X4MC DRUGTYPE Small molecular drug D0X4MC DRUGINCH 1S/C26H33F3N2O2.C6H6O3S/c1-16-20-15-31(12-10-25(24(32)33)8-3-2-4-9-25)11-7-17(20)13-22-23(16)19-14-18(26(27,28)29)5-6-21(19)30-22;7-10(8,9)6-4-2-1-3-5-6/h5-6,14,16-17,20,30H,2-4,7-13,15H2,1H3,(H,32,33);1-5H,(H,7,8,9)/t16-,17-,20-;/m1./s1 D0X4MC DRUGINKE IBDOVKSLMMFQPJ-IUPOGUASSA-N D0X4MC DRUGSMIL CC1C2CN(CCC2CC3=C1C4=C(N3)C=CC(=C4)C(F)(F)F)CCC5(CCCCC5)C(=O)O.C1=CC=C(C=C1)S(=O)(=O)O D0X4MC HIGHSTAT Discontinued in Phase 1 D0X5ZO DRUG__ID D0X5ZO D0X5ZO DRUGCOMP Sanofi-Aventis D0X5ZO DRUGTYPE Small molecular drug D0X5ZO DRUGINCH 1S/C27H33N5O2/c1-17(2)13-15-31-24-26(29-25(31)21-10-11-22-20(21)12-14-28-22)30(4)18(3)32(27(24)34)16-23(33)19-8-6-5-7-9-19/h5-9,13,20-22,28H,3,10-12,14-16H2,1-2,4H3/t20-,21?,22+/m0/s1 D0X5ZO DRUGINKE PBLJWGCWKPKYPH-JAFNVKOHSA-N D0X5ZO DRUGSMIL CC(=CCN1C(=NC2=C1C(=O)N(C(=C)N2C)CC(=O)C3=CC=CC=C3)C4CCC5C4CCN5)C D0X5ZO HIGHSTAT Discontinued in Phase 1 D0X8MI DRUG__ID D0X8MI D0X8MI DRUGCOMP Novo Nordisk A/S D0X8MI DRUGTYPE Small molecular drug D0X8MI DRUGINCH 1S/C19H19BrClNO2/c1-22-4-2-11-7-17(21)18(23)9-14(11)16(10-22)15-8-13(20)6-12-3-5-24-19(12)15/h6-9,16,23H,2-5,10H2,1H3/t16-/m0/s1 D0X8MI DRUGINKE DIKLCFJDIZFAOM-INIZCTEOSA-N D0X8MI DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC(=CC4=C3OCC4)Br)O)Cl D0X8MI HIGHSTAT Discontinued in Phase 1 D0Y3LJ DRUG__ID D0Y3LJ D0Y3LJ DRUGCOMP AstraZeneca D0Y3LJ DRUGTYPE Small molecular drug D0Y3LJ DRUGINCH 1S/C10H12N4O2S/c15-9-7-8(12-5-11-7)14(10(17)13-9)4-6-2-1-3-16-6/h5-6H,1-4H2,(H,11,12)(H,13,15,17)/t6-/m1/s1 D0Y3LJ DRUGINKE RSPDBEVKURKEII-ZCFIWIBFSA-N D0Y3LJ DRUGSMIL C1CC(OC1)CN2C3=C(C(=O)NC2=S)NC=N3 D0Y3LJ HIGHSTAT Discontinued in Phase 1 D0Y8PM DRUG__ID D0Y8PM D0Y8PM DRUGCOMP La Jolla Pharmaceutical D0Y8PM DRUGTYPE Small molecular drug D0Y8PM DRUGINCH 1S/C23H30N6O/c1-5-29(6-2)13-7-8-16(3)25-23-19-11-9-17(27-28-24)14-22(19)26-21-12-10-18(30-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26) D0Y8PM DRUGINKE OJZRYFDOXJOKNZ-UHFFFAOYSA-N D0Y8PM DRUGSMIL CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)N=[N+]=[N-])OC D0Y8PM HIGHSTAT Discontinued in Phase 1 D0YO4D DRUG__ID D0YO4D D0YO4D DRUGCOMP Ligand Pharmaceuticals D0YO4D DRUGTYPE Small molecular drug D0YO4D DRUGINCH 1S/C24H29NO2/c1-15-12-18-19(23(4,5)9-8-22(18,2)3)13-17(15)24(10-11-24)20-7-6-16(14-25-20)21(26)27/h6-7,12-14H,8-11H2,1-5H3,(H,26,27) D0YO4D DRUGINKE SLXTWXQUEZSSTJ-UHFFFAOYSA-N D0YO4D DRUGSMIL CC1=CC2=C(C=C1C3(CC3)C4=NC=C(C=C4)C(=O)O)C(CCC2(C)C)(C)C D0YO4D HIGHSTAT Discontinued in Phase 1 D0YT6Z DRUG__ID D0YT6Z D0YT6Z DRUGCOMP Wyeth D0YT6Z DRUGTYPE Small molecular drug D0YT6Z DRUGINCH 1S/C24H31N3O2.C4H4O4/c1-26-18-11-12-19(26)14-16(13-18)25-24(29)21-15-27(17-7-3-2-4-8-17)22-10-6-5-9-20(22)23(21)28;5-3(6)1-2-4(7)8/h5-6,9-10,15-19H,2-4,7-8,11-14H2,1H3,(H,25,29);1-2H,(H,5,6)(H,7,8)/b;2-1-/t16?,18-,19+; D0YT6Z DRUGINKE OQIHDZMOAKTHKW-WPJOOPQGSA-N D0YT6Z DRUGSMIL CN1C2CCC1CC(C2)NC(=O)C3=CN(C4=CC=CC=C4C3=O)C5CCCCC5.C(=CC(=O)O)C(=O)O D0YT6Z HIGHSTAT Discontinued in Phase 1 D0Z0LJ DRUG__ID D0Z0LJ D0Z0LJ DRUGCOMP NeuroSearch A/S D0Z0LJ DRUGTYPE Small molecular drug D0Z0LJ DRUGINCH 1S/C19H20N4O/c1-2-16-15(5-8-20-16)11-14(1)17-3-4-19(22-21-17)24-18-12-23-9-6-13(18)7-10-23/h1-5,8,11,13,18,20H,6-7,9-10,12H2/t18-/m0/s1 D0Z0LJ DRUGINKE LUKNJAQKVPBDSC-SFHVURJKSA-N D0Z0LJ DRUGSMIL C1CN2CCC1C(C2)OC3=NN=C(C=C3)C4=CC5=C(C=C4)NC=C5 D0Z0LJ HIGHSTAT Discontinued in Phase 1 D0Z2UD DRUG__ID D0Z2UD D0Z2UD DRUGCOMP Roche Bioscience D0Z2UD DRUGTYPE Small molecular drug D0Z2UD DRUGINCH 1S/C20H24F4N4O3/c1-14-12-25-19(30)28(18(14)29)6-2-5-26-7-9-27(10-8-26)16-4-3-15(21)11-17(16)31-13-20(22,23)24/h3-4,11-12H,2,5-10,13H2,1H3,(H,25,30) D0Z2UD DRUGINKE WEZFJPKJUIGDPS-UHFFFAOYSA-N D0Z2UD DRUGSMIL CC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F D0Z2UD HIGHSTAT Discontinued in Phase 1 D0Z4KX DRUG__ID D0Z4KX D0Z4KX DRUGCOMP Cortex Pharmaceuticals D0Z4KX DRUGTYPE Small molecular drug D0Z4KX DRUGINCH 1S/C12H13N3O2/c16-12(15-6-2-1-3-7-15)9-4-5-10-11(8-9)14-17-13-10/h4-5,8H,1-3,6-7H2 D0Z4KX DRUGINKE XFVRBYKKGGDPAJ-UHFFFAOYSA-N D0Z4KX DRUGSMIL C1CCN(CC1)C(=O)C2=CC3=NON=C3C=C2 D0Z4KX HIGHSTAT Discontinued in Phase 1 D0Z6AX DRUG__ID D0Z6AX D0Z6AX DRUGCOMP Bayer AG D0Z6AX DRUGTYPE Small molecular drug D0Z6AX DRUGINCH 1S/C23H31FO/c1-7-8-19-20(14(2)3)13-21(15(4)5)22(16(6)25)23(19)17-9-11-18(24)12-10-17/h9-16,25H,7-8H2,1-6H3 D0Z6AX DRUGINKE VDTWKXAPIQBOMO-UHFFFAOYSA-N D0Z6AX DRUGSMIL CCCC1=C(C(=C(C=C1C(C)C)C(C)C)C(C)O)C2=CC=C(C=C2)F D0Z6AX HIGHSTAT Discontinued in Phase 1 D0Z8LA DRUG__ID D0Z8LA D0Z8LA DRUGCOMP Repligen Corp D0Z8LA DRUGTYPE Small molecular drug D0Z8LA DRUGINCH 1S/C5H9N3O2/c6-5-7-1-2-8(5)3-4(9)10/h1-3H2,(H2,6,7)(H,9,10) D0Z8LA DRUGINKE AMHZIUVRYRVYBA-UHFFFAOYSA-N D0Z8LA DRUGSMIL C1CN(C(=N1)N)CC(=O)O D0Z8LA HIGHSTAT Discontinued in Phase 1 D0Z9HW DRUG__ID D0Z9HW D0Z9HW DRUGCOMP AstraZeneca D0Z9HW DRUGTYPE Small molecular drug D0Z9HW DRUGINCH 1S/C20H22N4O3/c1-4-10-22-20(25)19-17(21)14-7-5-6-13(18(14)23-24-19)15-11-12(26-2)8-9-16(15)27-3/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,25) D0Z9HW DRUGINKE NVWCZRPXYVDQEE-UHFFFAOYSA-N D0Z9HW DRUGSMIL CCCNC(=O)C1=NN=C2C(=C1N)C=CC=C2C3=C(C=CC(=C3)OC)OC D0Z9HW HIGHSTAT Discontinued in Phase 1 D0ZM5B DRUG__ID D0ZM5B D0ZM5B DRUGCOMP Agouron; Pfizer D0ZM5B DRUGTYPE Small molecular drug D0ZM5B DRUGINCH 1S/C27H31ClN4O5S/c1-15-11-16(2)32-25(29-15)30-26(31-32)38-23-20(33)14-27(37-24(23)34,18-7-5-6-8-18)10-9-17-12-19(28)22(36-4)13-21(17)35-3/h11-13,18,33H,5-10,14H2,1-4H3 D0ZM5B DRUGINKE MKOFABQFNUCNTD-UHFFFAOYSA-N D0ZM5B DRUGSMIL CC1=CC(=NC2=NC(=NN12)SC3=C(CC(OC3=O)(CCC4=CC(=C(C=C4OC)OC)Cl)C5CCCC5)O)C D0ZM5B HIGHSTAT Discontinued in Phase 1 D00CIF DRUG__ID D00CIF D00CIF DRUGCOMP Merck KGaA D00CIF DRUGINCH 1S/C22H23ClN4O5/c23-14-1-3-16(4-2-14)25-22(31)27-12-18(28)11-19(27)21(30)24-15-5-7-17(8-6-15)26-9-10-32-13-20(26)29/h1-8,18-19,28H,9-13H2,(H,24,30)(H,25,31)/t18-,19-/m1/s1 D00CIF DRUGINKE DMYZJLOWGSRVKP-RTBURBONSA-N D00CIF DRUGSMIL C1COCC(=O)N1C2=CC=C(C=C2)NC(=O)C3CC(CN3C(=O)NC4=CC=C(C=C4)Cl)O D00CIF HIGHSTAT Discontinued in Phase 1 D00LCT DRUG__ID D00LCT D00LCT DRUGCOMP Merck KGaA D00LCT DRUGINCH 1S/C17H17N3O4/c1-17(2)16(22)15(23-13-6-7-14(21)20(3)19-13)11-8-10(9-18)4-5-12(11)24-17/h4-8,15-16,22H,1-3H3 D00LCT DRUGINKE RIBYSHCVSQIIJE-UHFFFAOYSA-N D00LCT DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)OC3=NN(C(=O)C=C3)C)O)C D00LCT HIGHSTAT Discontinued in Phase 1 D00ROV DRUG__ID D00ROV D00ROV DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00ROV DRUGINCH 1S/C16H15N7O5S3/c17-16-20-7(4-31-16)9(22-28)12(24)21-10-13(25)23-11(15(26)27)8(5-30-14(10)23)29-3-6-1-18-19-2-6/h1-2,4,10,14,28H,3,5H2,(H2,17,20)(H,18,19)(H,21,24)(H,26,27)/b22-9+/t10-,14-/m1/s1 D00ROV DRUGINKE RNWMKMFWVBYAMX-KXDGEKGBSA-N D00ROV DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)C(=O)O)SCC4=CNN=C4 D00ROV HIGHSTAT Discontinued in Phase 1 D00TLD DRUG__ID D00TLD D00TLD DRUGTYPE Small molecular drug D00TLD DRUGINCH 1S/C21H31N3O12S/c1-9(25)22-18(21(6,7)37-24-31)19(30)23-15-17(34-12(4)28)16(33-11(3)27)14(8-32-10(2)26)36-20(15)35-13(5)29/h14-18,20H,8H2,1-7H3,(H,22,25)(H,23,30)/t14-,15-,16-,17-,18+,20-/m1/s1 D00TLD DRUGINKE VISYVRBZWPNIOD-GFJCLWMYSA-N D00TLD DRUGSMIL CC(=O)NC(C(=O)NC1C(C(C(OC1OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C(C)(C)SN=O D00TLD HIGHSTAT Discontinued in Phase 1 D00UCC DRUG__ID D00UCC D00UCC DRUGTYPE Small molecular drug D00UCC DRUGINCH 1S/C21H22F3NO8S/c1-20(2)30-11-19(33-20)18(25(27)13-26)12-34(28,29)17-9-7-15(8-10-17)31-14-3-5-16(6-4-14)32-21(22,23)24/h3-10,13,18-19,27H,11-12H2,1-2H3/t18-,19-/m1/s1 D00UCC DRUGINKE IVPPTWCRAFCOFJ-RTBURBONSA-N D00UCC DRUGSMIL CC1(OCC(O1)C(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)OC(F)(F)F)N(C=O)O)C D00UCC HIGHSTAT Discontinued in Phase 1 D00UCW DRUG__ID D00UCW D00UCW DRUGTYPE Small molecular drug D00UCW DRUGINCH 1S/C26H35F2NO7/c1-5-11-32-13-15-34-24(30)21-17(3)29-18(4)22(25(31)35-16-14-33-12-6-2)23(21)19-9-7-8-10-20(19)36-26(27)28/h7-10,23,26,29H,5-6,11-16H2,1-4H3 D00UCW DRUGINKE ASCWBYZMMHUZMQ-UHFFFAOYSA-N D00UCW DRUGSMIL CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2OC(F)F)C(=O)OCCOCCC)C)C D00UCW HIGHSTAT Discontinued in Phase 1 D00WWU DRUG__ID D00WWU D00WWU DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D00WWU DRUGINCH 1S/C23H26FN5O2S/c1-25-22(30)26-9-10-29-21(16-32-23(29)27-19-4-2-3-18(24)15-19)17-5-7-20(8-6-17)28-11-13-31-14-12-28/h2-8,15-16H,9-14H2,1H3,(H2,25,26,30) D00WWU DRUGINKE NBGPMRBRSOZDOV-UHFFFAOYSA-N D00WWU DRUGSMIL CNC(=O)NCCN1C(=CSC1=NC2=CC(=CC=C2)F)C3=CC=C(C=C3)N4CCOCC4 D00WWU HIGHSTAT Discontinued in Phase 1 D01DPD DRUG__ID D01DPD D01DPD DRUGTYPE Small molecular drug D01DPD DRUGINCH 1S/C16H17N3O3/c1-2-5-16(20)18-14-8-7-12(15(11-14)19(21)22)10-13-6-3-4-9-17-13/h3-4,6-9,11H,2,5,10H2,1H3,(H,18,20) D01DPD DRUGINKE CZKQVCYQBJJAGG-UHFFFAOYSA-N D01DPD DRUGSMIL CCCC(=O)NC1=CC(=C(C=C1)CC2=CC=CC=N2)[N+](=O)[O-] D01DPD HIGHSTAT Discontinued in Phase 1 D01FXD DRUG__ID D01FXD D01FXD DRUGTYPE Small molecular drug D01FXD DRUGINCH 1S/C17H10Cl2F3N3O3/c1-28-12-4-2-9(8-3-5-13(17(20,21)22)23-14(8)12)16(26)24-15-10(18)6-25(27)7-11(15)19/h2-7,27H,1H3 D01FXD DRUGINKE NPGREARFJMFTDF-UHFFFAOYSA-N D01FXD DRUGSMIL COC1=C2C(=C(C=C1)C(=O)N=C3C(=CN(C=C3Cl)O)Cl)C=CC(=N2)C(F)(F)F D01FXD HIGHSTAT Discontinued in Phase 1 D01GIF DRUG__ID D01GIF D01GIF DRUGTYPE Small molecular drug D01GIF DRUGINCH 1S/C19H28N6O2S/c20-14-22-19(24-16-9-5-2-6-10-16)25-28(26,27)18-13-21-12-11-17(18)23-15-7-3-1-4-8-15/h11-13,15-16H,1-10H2,(H,21,23)(H2,22,24,25) D01GIF DRUGINKE XLBWPHZAHLZGNJ-UHFFFAOYSA-N D01GIF DRUGSMIL C1CCC(CC1)NC2=C(C=NC=C2)S(=O)(=O)NC(=NC3CCCCC3)NC#N D01GIF HIGHSTAT Discontinued in Phase 1 D01PLH DRUG__ID D01PLH D01PLH DRUGCOMP Burroughs Wellcome Inc D01PLH DRUGINCH 1S/C22H24N2O2/c1-22(13-25,14-26)23-12-15-7-9-19-18(11-15)21-17-6-4-3-5-16(17)8-10-20(21)24(19)2/h3-11,23,25-26H,12-14H2,1-2H3 D01PLH DRUGINKE JVMISFXHWOKYOX-UHFFFAOYSA-N D01PLH DRUGSMIL CC(CO)(CO)NCC1=CC2=C(C=C1)N(C3=C2C4=CC=CC=C4C=C3)C D01PLH HIGHSTAT Discontinued in Phase 1 D01XUG DRUG__ID D01XUG D01XUG DRUGCOMP Astellas D01XUG DRUGINCH 1S/C26H32N4O6S2.K/c1-5-27-38(33,34)29-25(31)21-17-37-24(28-21)16-30(13-9-12-19-10-7-6-8-11-19)26(32)20-14-22(35-3)18(2)23(15-20)36-4;/h6-8,10-11,14-15,17,27H,5,9,12-13,16H2,1-4H3,(H,29,31);/q;+1/p-1 D01XUG DRUGINKE WKYBXXHNGOTYDD-UHFFFAOYSA-M D01XUG DRUGSMIL CCNS(=O)(=O)[N-]C(=O)C1=CSC(=N1)CN(CCCC2=CC=CC=C2)C(=O)C3=CC(=C(C(=C3)OC)C)OC.[K+] D01XUG HIGHSTAT Discontinued in Phase 1 D02ANJ DRUG__ID D02ANJ D02ANJ DRUGTYPE Small molecular drug D02ANJ DRUGINCH 1S/C14H16BrN3O3/c1-3-21-12-6-9(4-5-11(12)20-2)7-16-10-8-17-18-14(19)13(10)15/h4-6,8H,3,7H2,1-2H3,(H2,16,18,19) D02ANJ DRUGINKE KNIKAZNCSPYOED-UHFFFAOYSA-N D02ANJ DRUGSMIL CCOC1=C(C=CC(=C1)CNC2=C(C(=O)NN=C2)Br)OC D02ANJ HIGHSTAT Discontinued in Phase 1 D02MHE DRUG__ID D02MHE D02MHE DRUGCOMP Dendreon San Diego LLC D02MHE DRUGINCH 1S/C24H42N6O6/c1-4-8-16(9-5-2)21(33)29-18(14-20(32)36-3)23(35)30-13-7-11-19(30)22(34)28-17(15-31)10-6-12-27-24(25)26/h15-19H,4-14H2,1-3H3,(H,28,34)(H,29,33)(H4,25,26,27)/t17-,18-,19-/m0/s1 D02MHE DRUGINKE ICMSWQUELAGTTR-FHWLQOOXSA-N D02MHE DRUGSMIL CCCC(CCC)C(=O)NC(CC(=O)OC)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C=O D02MHE HIGHSTAT Discontinued in Phase 1 D02OHR DRUG__ID D02OHR D02OHR DRUGTYPE Small molecular drug D02OHR DRUGINCH 1S/C18H17FO2S/c1-22(20,21)16-11-7-14(8-12-16)18-4-2-3-17(18)13-5-9-15(19)10-6-13/h5-12H,2-4H2,1H3 D02OHR DRUGINKE GJGZQTGPOKPFES-UHFFFAOYSA-N D02OHR DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=C(CCC2)C3=CC=C(C=C3)F D02OHR HIGHSTAT Discontinued in Phase 1 D02PIH DRUG__ID D02PIH D02PIH DRUGTYPE Small molecular drug D02PIH DRUGINCH 1S/C18H11BrClN5O5/c19-10-8-21-18(22-9-10)30-15-6-5-11(7-13(15)20)23-17(27)24-16(26)12-3-1-2-4-14(12)25(28)29/h1-9H,(H2,23,24,26,27) D02PIH DRUGINKE WKXWMGOTZJGIIK-UHFFFAOYSA-N D02PIH DRUGSMIL C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC(=C(C=C2)OC3=NC=C(C=N3)Br)Cl)[N+](=O)[O-] D02PIH HIGHSTAT Discontinued in Phase 1 D02QBJ DRUG__ID D02QBJ D02QBJ DRUGTYPE Small molecular drug D02QBJ DRUGINCH 1S/C24H16F3NO4/c25-24(26,27)32-18-9-6-16(7-10-18)17-8-11-21-19(12-17)20(22(29)23(30)31)14-28(21)13-15-4-2-1-3-5-15/h1-12,14H,13H2,(H,30,31) D02QBJ DRUGINKE ODXQFEWQSHNQNI-UHFFFAOYSA-N D02QBJ DRUGSMIL C1=CC=C(C=C1)CN2C=C(C3=C2C=CC(=C3)C4=CC=C(C=C4)OC(F)(F)F)C(=O)C(=O)O D02QBJ HIGHSTAT Discontinued in Phase 1 D02QMQ DRUG__ID D02QMQ D02QMQ DRUGCOMP Shionogi & Co Ltd D02QMQ DRUGINCH 1S/C24H34N10O4S2/c1-3-38-30-17(19-29-24(25)40-31-19)21(35)28-15-11-34-18(23(36)37)14(12-39-22(15)34)10-32-8-4-6-16-20(32)27-13-33(16)9-5-7-26-2/h4,6,8,13-15,18,22,24,26H,3,5,7,9-12,25H2,1-2H3,(H2-,28,29,31,35,36,37)/p+1/b30-17-/t14?,15-,18?,22-,24?/m1/s1 D02QMQ DRUGINKE AHETYSDJHPTUGM-VOMUDFFDSA-O D02QMQ DRUGSMIL CCON=C(C1=NC(SN1)N)C(=O)NC2CN3C2SCC(C3C(=O)O)C[N+]4=CC=CC5=C4N=CN5CCCNC D02QMQ HIGHSTAT Discontinued in Phase 1 D02QQB DRUG__ID D02QQB D02QQB DRUGTYPE Small molecular drug D02QQB DRUGINCH 1S/C30H48N2O6.ClH/c1-7-10-13-31(14-11-8-2)26(33)19-32-18-22(21-15-24(36-6)28-25(16-21)37-20-38-28)27(29(34)35)23(32)17-30(4,5)12-9-3;/h15-16,22-23,27H,7-14,17-20H2,1-6H3,(H,34,35);1H/t22-,23+,27-;/m1./s1 D02QQB DRUGINKE KMKKFZCVBRAWNX-KQQHTNMISA-N D02QQB DRUGSMIL CCCCN(CCCC)C(=O)CN1CC(C(C1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3.Cl D02QQB HIGHSTAT Discontinued in Phase 1 D02VIP DRUG__ID D02VIP D02VIP DRUGTYPE Small molecular drug D02VIP DRUGINCH 1S/C22H24F3N3O4/c23-22(24,25)14-28-13-17-11-18(32-9-3-8-27-19-4-1-2-7-26-19)6-5-15(17)10-16(21(28)31)12-20(29)30/h1-2,4-7,11,16H,3,8-10,12-14H2,(H,26,27)(H,29,30)/t16-/m0/s1 D02VIP DRUGINKE PVDGZHKJXXVONO-INIZCTEOSA-N D02VIP DRUGSMIL C1C(C(=O)N(CC2=C1C=CC(=C2)OCCCNC3=CC=CC=N3)CC(F)(F)F)CC(=O)O D02VIP HIGHSTAT Discontinued in Phase 1 D02WII DRUG__ID D02WII D02WII DRUGTYPE Small molecular drug D02WII DRUGINCH 1S/C24H21Cl2NO5/c1-31-19-7-4-8-20(32-2)21(19)15-11-9-14(10-12-15)13-18(24(29)30)27-23(28)22-16(25)5-3-6-17(22)26/h3-12,18H,13H2,1-2H3,(H,27,28)(H,29,30)/t18-/m0/s1 D02WII DRUGINKE DRSJLVGDSNWQBI-SFHVURJKSA-N D02WII DRUGSMIL COC1=C(C(=CC=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3Cl)Cl D02WII HIGHSTAT Discontinued in Phase 1 D02WQZ DRUG__ID D02WQZ D02WQZ DRUGCOMP Luitpold Pharma GmbH D02WQZ DRUGINCH 1S/C27H50N2O70S16.16Na/c30-24(20(96-112(68,69)70)16(92-108(56,57)58)12(10(88-104(44,45)46)6-82-102(38,39)40)86-26-22(98-114(74,75)76)18(94-110(62,63)64)14(90-106(50,51)52)8(84-26)4-80-100(32,33)34)28-2-1-3-29-25(31)21(97-113(71,72)73)17(93-109(59,60)61)13(11(89-105(47,48)49)7-83-103(41,42)43)87-27-23(99-115(77,78)79)19(95-111(65,66)67)15(91-107(53,54)55)9(85-27)5-81-101(35,36)37;;;;;;;;;;;;;;;;/h8-23,26-27H,1-7H2,(H,28,30)(H,29,31)(H,32,33,34)(H,35,36,37)(H,38,39,40)(H,41,42,43)(H,44,45,46)(H,47,48,49)(H,50,51,52)(H,53,54,55)(H,56,57,58)(H,59,60,61)(H,62,63,64)(H,65,66,67)(H,68,69,70)(H,71,72,73)(H,74,75,76)(H,77,78,79);;;;;;;;;;;;;;;;/q;16*+1/p-16/t8-,9-,10-,11-,12-,13-,14+,15+,16+,17+,18+,19+,20-,21-,22-,23-,26+,27+;;;;;;;;;;;;;;;;/m1................/s1 D02WQZ DRUGINKE CXKOATPJKFZCEL-HPXJARCXSA-A D02WQZ DRUGSMIL C(CNC(=O)C(C(C(C(COS(=O)(=O)[O-])OS(=O)(=O)[O-])OC1C(C(C(C(O1)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])CNC(=O)C(C(C(C(COS(=O)(=O)[O-])OS(=O)(=O)[O-])OC2C(C(C(C(O2)COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D02WQZ HIGHSTAT Discontinued in Phase 1 D03FPA DRUG__ID D03FPA D03FPA DRUGCOMP Bruin Pharma Inc D03FPA DRUGINCH 1S/C114H156N24O28/c1-64(2)96(114(166)123-67(5)98(150)125-83(48-50-93(143)144)105(157)126-80(41-23-27-53-117)104(156)133-86(57-71-33-15-9-16-34-71)107(159)128-79(40-22-26-52-116)103(155)130-82(47-49-92(141)142)102(154)122-65(3)99(151)131-84(97(119)149)55-69-29-11-7-12-30-69)138-106(158)81(42-24-28-54-118)129-113(165)91(62-95(147)148)137-110(162)88(59-73-43-45-75(140)46-44-73)134-109(161)85(56-70-31-13-8-14-32-70)132-100(152)66(4)121-101(153)78(39-21-25-51-115)127-108(160)87(58-72-35-17-10-18-36-72)135-111(163)89(60-74-63-120-77-38-20-19-37-76(74)77)136-112(164)90(61-94(145)146)124-68(6)139/h7-20,29-38,43-46,63-67,78-91,96,120,140H,21-28,39-42,47-62,115-118H2,1-6H3,(H2,119,149)(H,121,153)(H,122,154)(H,123,166)(H,124,139)(H,125,150)(H,126,157)(H,127,160)(H,128,159)(H,129,165)(H,130,155)(H,131,151)(H,132,152)(H,133,156)(H,134,161)(H,135,163)(H,136,164)(H,137,162)(H,138,158)(H,141,142)(H,143,144)(H,145,146)(H,147,148)/t65-,66-,67-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,96-/m1/s1 D03FPA DRUGINKE ZKKBZMXTFBAQLP-INNXVHPBSA-N D03FPA DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)C(CC(=O)O)NC(=O)C D03FPA HIGHSTAT Discontinued in Phase 1 D03ISE DRUG__ID D03ISE D03ISE DRUGTYPE Small molecular drug D03ISE DRUGINCH 1S/C18H31N3O3/c1-13(2)20-11-16(22)12-24-17-7-5-15(6-8-17)9-10-19-18(23)21-14(3)4/h5-8,13-14,16,20,22H,9-12H2,1-4H3,(H2,19,21,23) D03ISE DRUGINKE PKWZWSXSCKVUJB-UHFFFAOYSA-N D03ISE DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CCNC(=O)NC(C)C)O D03ISE HIGHSTAT Discontinued in Phase 1 D03JSO DRUG__ID D03JSO D03JSO DRUGCOMP Astellas Pharma Inc D03JSO DRUGINCH 1S/C22H18N6O/c1-14(2)21-24-25-22(28(21)19-10-6-9-18-20(19)27-29-26-18)16-11-12-17(23-13-16)15-7-4-3-5-8-15/h3-14H,1-2H3 D03JSO DRUGINKE FQGLDGKVKDPVLO-UHFFFAOYSA-N D03JSO DRUGSMIL CC(C)C1=NN=C(N1C2=CC=CC3=NON=C32)C4=CN=C(C=C4)C5=CC=CC=C5 D03JSO HIGHSTAT Discontinued in Phase 1 D03KST DRUG__ID D03KST D03KST DRUGTYPE Small molecular drug D03KST DRUGINCH 1S/C23H26ClNO5S2.Na/c1-16(2)17-6-12-21-18(15-23(32(28,29)30)22(21)13-7-17)5-3-4-14-25-31(26,27)20-10-8-19(24)9-11-20;/h6-13,15-16,25H,3-5,14H2,1-2H3,(H,28,29,30);/q;+1/p-1 D03KST DRUGINKE QIBQVFYOTMPEIP-UHFFFAOYSA-M D03KST DRUGSMIL CC(C)C1=CC=C2C(=C(C=C2S(=O)(=O)[O-])CCCCNS(=O)(=O)C3=CC=C(C=C3)Cl)C=C1.[Na+] D03KST HIGHSTAT Discontinued in Phase 1 D03LXJ DRUG__ID D03LXJ D03LXJ DRUGCOMP Kanebo KK D03LXJ DRUGINCH 1S/C16H13NO2S/c1-10-6-8-12(9-7-10)16-17-15-13(19-11(2)18)4-3-5-14(15)20-16/h3-9H,1-2H3 D03LXJ DRUGINKE RBCGOSAFAPGFGD-UHFFFAOYSA-N D03LXJ DRUGSMIL CC1=CC=C(C=C1)C2=NC3=C(C=CC=C3S2)OC(=O)C D03LXJ HIGHSTAT Discontinued in Phase 1 D03QJN DRUG__ID D03QJN D03QJN DRUGTYPE Small molecular drug D03QJN DRUGINCH 1S/C25H20F4N4O3S/c1-37(35,36)22-8-3-2-7-18(22)16-9-10-20(19(26)12-16)31-24(34)21-13-23(25(27,28)29)32-33(21)17-6-4-5-15(11-17)14-30/h2-13H,14,30H2,1H3,(H,31,34) D03QJN DRUGINKE ZLUOAFAJSUPHOG-UHFFFAOYSA-N D03QJN DRUGSMIL CS(=O)(=O)C1=CC=CC=C1C2=CC(=C(C=C2)NC(=O)C3=CC(=NN3C4=CC=CC(=C4)CN)C(F)(F)F)F D03QJN HIGHSTAT Discontinued in Phase 1 D03RYS DRUG__ID D03RYS D03RYS DRUGTYPE Small molecular drug D03RYS DRUGINCH 1S/C23H19ClN4O/c1-16-10-12-28(25-16)18-8-9-20(21(24)13-18)23(29)27-15-19-6-4-11-26(19)14-17-5-2-3-7-22(17)27/h2-13H,14-15H2,1H3 D03RYS DRUGINKE JXKQHDZUZGKDGO-UHFFFAOYSA-N D03RYS DRUGSMIL CC1=NN(C=C1)C2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl D03RYS HIGHSTAT Discontinued in Phase 1 D03VHI DRUG__ID D03VHI D03VHI DRUGTYPE Small molecular drug D03VHI DRUGINCH 1S/C43H64FN5O10/c1-12-32-43(8)35(49(40(54)59-43)19-14-13-18-48-23-30(46-24-48)29-16-15-17-45-22-29)27(4)33(50)25(2)21-41(6,55-11)37(28(5)36(52)42(7,44)39(53)57-32)58-38-34(51)31(47(9)10)20-26(3)56-38/h15-17,22-28,31-32,34-35,37-38,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,31+,32-,34-,35-,37-,38+,41-,42+,43-/m1/s1 D03VHI DRUGINKE RSIQCUSPSFSWMQ-XXTFOGKVSA-N D03VHI DRUGSMIL CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)(C)F)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C D03VHI HIGHSTAT Discontinued in Phase 1 D04KXF DRUG__ID D04KXF D04KXF DRUGTYPE Small molecular drug D04KXF DRUGINCH 1S/C24H30N8O7S2/c1-5-6-13(22(35)38-8-12(2)3)9-39-23(36)18-14(7-27-31-26)10-40-21-17(20(34)32(18)21)29-19(33)16(30-37-4)15-11-41-24(25)28-15/h6,11-12,17,21H,5,7-10H2,1-4H3,(H2,25,28)(H,29,33)/b13-6-,30-16+/t17-,21-/m1/s1 D04KXF DRUGINKE FHPWLEQQFDSPCU-SVEZEBCVSA-N D04KXF DRUGSMIL CCC=C(COC(=O)C1=C(CSC2N1C(=O)C2NC(=O)C(=NOC)C3=CSC(=N3)N)CN=[N+]=[N-])C(=O)OCC(C)C D04KXF HIGHSTAT Discontinued in Phase 1 D04KZN DRUG__ID D04KZN D04KZN DRUGCOMP Concert pharmaceuticals D04KZN DRUGINCH 1S/C19H19F2N7O/c1-19(2,3)13-8-15-24-25-17(12-7-11(20)5-6-14(12)21)28(15)26-18(13)29-9-16-22-10-23-27(16)4/h5-8,10H,9H2,1-4H3/i1D3,2D3,3D3 D04KZN DRUGINKE BQDUNOMMYOKHEP-GQALSZNTSA-N D04KZN DRUGSMIL CC(C)(C)C1=CC2=NN=C(N2N=C1OCC3=NC=NN3C)C4=C(C=CC(=C4)F)F D04KZN HIGHSTAT Discontinued in Phase 1 D04LAQ DRUG__ID D04LAQ D04LAQ DRUGTYPE Small molecular drug D04LAQ DRUGINCH 1S/C20H33NO7/c1-27-10-11-28-13-15(18(24)25)12-20(8-2-3-9-20)19(26)21-16-6-4-14(5-7-16)17(22)23/h14-16H,2-13H2,1H3,(H,21,26)(H,22,23)(H,24,25)/t14?,15-,16?/m0/s1 D04LAQ DRUGINKE ACZWIDANLCXHBM-PCKAHOCUSA-N D04LAQ DRUGSMIL COCCOCC(CC1(CCCC1)C(=O)NC2CCC(CC2)C(=O)O)C(=O)O D04LAQ HIGHSTAT Discontinued in Phase 1 D04NPX DRUG__ID D04NPX D04NPX DRUGCOMP AstraZeneca plc D04NPX DRUGINCH 1S/C22H24N4O5S/c1-14-13-24-19(20(25-14)31-4)26-32(29,30)17-6-5-11-23-18(17)16-9-7-15(8-10-16)12-22(2,3)21(27)28/h5-11,13H,12H2,1-4H3,(H,24,26)(H,27,28) D04NPX DRUGINKE CDBNTQYPMBJKQZ-UHFFFAOYSA-N D04NPX DRUGSMIL CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)CC(C)(C)C(=O)O D04NPX HIGHSTAT Discontinued in Phase 1 D04NXR DRUG__ID D04NXR D04NXR DRUGTYPE Small molecular drug D04NXR DRUGINCH 1S/C27H32N2O3/c1-20(12-13-21-14-16-24(17-15-21)27(28)32)29(18-25(30)22-8-4-2-5-9-22)19-26(31)23-10-6-3-7-11-23/h2-11,14-17,20,25-26,30-31H,12-13,18-19H2,1H3,(H2,28,32) D04NXR DRUGINKE OPPQEWZOPDBGAS-UHFFFAOYSA-N D04NXR DRUGSMIL CC(CCC1=CC=C(C=C1)C(=O)N)N(CC(C2=CC=CC=C2)O)CC(C3=CC=CC=C3)O D04NXR HIGHSTAT Discontinued in Phase 1 D04ODQ DRUG__ID D04ODQ D04ODQ DRUGCOMP GlaxoSmithKline Inc D04ODQ DRUGINCH 1S/C27H38F2N2O/c1-5-6-7-8-9-16-30-26(32)31-25-22(17-23(28)18-24(25)29)15-14-20-10-12-21(13-11-20)19-27(2,3)4/h10-13,17-18H,5-9,14-16,19H2,1-4H3,(H2,30,31,32) D04ODQ DRUGINKE XWWXRQIQZOTQGF-UHFFFAOYSA-N D04ODQ DRUGSMIL CCCCCCCNC(=O)NC1=C(C=C(C=C1F)F)CCC2=CC=C(C=C2)CC(C)(C)C D04ODQ HIGHSTAT Discontinued in Phase 1 D04OIF DRUG__ID D04OIF D04OIF DRUGCOMP Takeda Pharmaceutical Co Ltd D04OIF DRUGINCH 1S/C14H13Cl2N3O3S/c1-23(21,22)12-3-2-9(15)4-8(12)6-19-7-10(16)5-11(13(19)17)14(18)20/h2-5,7,17H,6H2,1H3,(H2,18,20) D04OIF DRUGINKE CVBJUEIAUOTXLV-UHFFFAOYSA-N D04OIF DRUGSMIL CS(=O)(=O)C1=C(C=C(C=C1)Cl)CN2C=C(C=C(C2=N)C(=O)N)Cl D04OIF HIGHSTAT Discontinued in Phase 1 D04ONP DRUG__ID D04ONP D04ONP DRUGTYPE Small molecular drug D04ONP DRUGINCH 1S/C13H20N4O3/c1-13(2,20)6-4-5-7-17-11(18)9-10(15-8-14-9)16(3)12(17)19/h8,20H,4-7H2,1-3H3,(H,14,15) D04ONP DRUGINKE NWXULHNEYYFVMF-UHFFFAOYSA-N D04ONP DRUGSMIL CC(C)(CCCCN1C(=O)C2=C(N=CN2)N(C1=O)C)O D04ONP HIGHSTAT Discontinued in Phase 1 D05AAM DRUG__ID D05AAM D05AAM DRUGTYPE Small molecular drug D05AAM DRUGINCH 1S/C20H26N2O4.CH4O3S/c23-18-11-20(7-3-4-8-20)12-19(24)22(18)10-9-21-13-15-14-25-16-5-1-2-6-17(16)26-15;1-5(2,3)4/h1-2,5-6,15,21H,3-4,7-14H2;1H3,(H,2,3,4) D05AAM DRUGINKE JXBLEDCYKVWLJI-UHFFFAOYSA-N D05AAM DRUGSMIL CS(=O)(=O)O.C1CCC2(C1)CC(=O)N(C(=O)C2)CCNCC3COC4=CC=CC=C4O3 D05AAM HIGHSTAT Discontinued in Phase 1 D05EVI DRUG__ID D05EVI D05EVI DRUGTYPE Small molecular drug D05EVI DRUGINCH 1S/C18H17N5O2/c1-10(2)23-13-6-4-3-5-12(13)22-9-19-14(15(22)18(23)24)16-20-17(25-21-16)11-7-8-11/h3-6,9-11H,7-8H2,1-2H3 D05EVI DRUGINKE ZGEGOFCLSWVVKG-UHFFFAOYSA-N D05EVI DRUGSMIL CC(C)N1C2=CC=CC=C2N3C=NC(=C3C1=O)C4=NOC(=N4)C5CC5 D05EVI HIGHSTAT Discontinued in Phase 1 D05HIJ DRUG__ID D05HIJ D05HIJ DRUGCOMP Sanofi D05HIJ DRUGINCH 1S/C19H22N4O3/c1-13-10-14-4-2-3-5-15(14)23(13)19(25)11-16-20-17(12-18(24)21-16)22-6-8-26-9-7-22/h2-5,12-13H,6-11H2,1H3,(H,20,21,24)/t13-/m0/s1 D05HIJ DRUGINKE UAXHPOBBKRWJGA-ZDUSSCGKSA-N D05HIJ DRUGSMIL CC1CC2=CC=CC=C2N1C(=O)CC3=NC(=CC(=O)N3)N4CCOCC4 D05HIJ HIGHSTAT Discontinued in Phase 1 D05HSI DRUG__ID D05HSI D05HSI DRUGTYPE Small molecular drug D05HSI DRUGINCH 1S/C29H27FN2O5/c1-37-21-12-13-22-25(17-21)32(24-9-5-4-8-23(24)30)28(36)29(22,15-14-26(33)34)31-27(35)20-11-10-18-6-2-3-7-19(18)16-20/h2-9,12-13,17,20H,10-11,14-16H2,1H3,(H,31,35)(H,33,34)/t20?,29-/m0/s1 D05HSI DRUGINKE RORYEMYJJAIHBK-PRTIIRGTSA-N D05HSI DRUGSMIL COC1=CC2=C(C=C1)C(C(=O)N2C3=CC=CC=C3F)(CCC(=O)O)NC(=O)C4CCC5=CC=CC=C5C4 D05HSI HIGHSTAT Discontinued in Phase 1 D05JXR DRUG__ID D05JXR D05JXR DRUGTYPE Small molecular drug D05JXR DRUGINCH 1S/C25H30N4O6/c26-23(27)18-12-10-16(11-13-18)6-4-5-9-21(30)28-19(15-22(31)32)24(33)29-20(25(34)35)14-17-7-2-1-3-8-17/h1-3,7-8,10-13,19-20H,4-6,9,14-15H2,(H3,26,27)(H,28,30)(H,29,33)(H,31,32)(H,34,35)/t19-,20-/m0/s1 D05JXR DRUGINKE VUUBSMRWDWDDPT-PMACEKPBSA-N D05JXR DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)CCCCC2=CC=C(C=C2)C(=N)N D05JXR HIGHSTAT Discontinued in Phase 1 D05QMG DRUG__ID D05QMG D05QMG DRUGTYPE Small molecular drug D05QMG DRUGINCH 1S/C24H18FN5O2.H2O4S/c25-19-8-6-17(7-9-19)21-20(16-10-12-26-13-11-16)23-28-30(15-14-29(23)27-21)24(32)22(31)18-4-2-1-3-5-18;1-5(2,3)4/h1-13,28H,14-15H2;(H2,1,2,3,4) D05QMG DRUGINKE KCPHXRBKBLJJJJ-UHFFFAOYSA-N D05QMG DRUGSMIL C1CN(NC2=C(C(=NN21)C3=CC=C(C=C3)F)C4=CC=NC=C4)C(=O)C(=O)C5=CC=CC=C5.OS(=O)(=O)O D05QMG HIGHSTAT Discontinued in Phase 1 D05QMJ DRUG__ID D05QMJ D05QMJ DRUGTYPE Small molecular drug D05QMJ DRUGINCH 1S/C20H26N6O4S/c1-11(27)26-10-12(28)9-15(26)18(30)24-14(6-4-8-23-20(21)22)17(29)19-25-13-5-2-3-7-16(13)31-19/h2-3,5,7,12,14-15,28H,4,6,8-10H2,1H3,(H,24,30)(H4,21,22,23)/t12-,14+,15+/m1/s1 D05QMJ DRUGINKE VXDAVYUFYPFGDX-SNPRPXQTSA-N D05QMJ DRUGSMIL CC(=O)N1CC(CC1C(=O)NC(CCCN=C(N)N)C(=O)C2=NC3=CC=CC=C3S2)O D05QMJ HIGHSTAT Discontinued in Phase 1 D05RQB DRUG__ID D05RQB D05RQB DRUGTYPE Small molecular drug D05RQB DRUGINCH 1S/C20H34O4/c1-17(11-21)15-4-3-13-9-14-10-19(13,7-8-20(14,24)12-22)18(15,2)6-5-16(17)23/h13-16,21-24H,3-12H2,1-2H3/t13-,14+,15-,16+,17-,18-,19-,20-/m0/s1 D05RQB DRUGINKE NOFOAYPPHIUXJR-APNQCZIXSA-N D05RQB DRUGSMIL CC12CCC(C(C1CCC3C24CCC(C(C3)C4)(CO)O)(C)CO)O D05RQB HIGHSTAT Discontinued in Phase 1 D05UPB DRUG__ID D05UPB D05UPB DRUGTYPE Small molecular drug D05UPB DRUGINCH 1S/C11H11N5OS.ClH/c12-9-6(3-5-1-2-18-4-5)7-8(14-9)10(17)16-11(13)15-7;/h1-2,4,14H,3,12H2,(H3,13,15,16,17);1H D05UPB DRUGINKE SLNICZJKQXPOJA-UHFFFAOYSA-N D05UPB DRUGSMIL C1=CSC=C1CC2=C(NC3=C2N=C(NC3=O)N)N.Cl D05UPB HIGHSTAT Discontinued in Phase 1 D05XYC DRUG__ID D05XYC D05XYC DRUGTYPE Small molecular drug D05XYC DRUGINCH 1S/C17H29NO/c1-8-18-11-12-9-13(16(2,3)4)15(19)14(10-12)17(5,6)7/h9-10,18-19H,8,11H2,1-7H3 D05XYC DRUGINKE WQNYIWJBDGLKEB-UHFFFAOYSA-N D05XYC DRUGSMIL CCNCC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C D05XYC HIGHSTAT Discontinued in Phase 1 D06AGD DRUG__ID D06AGD D06AGD DRUGTYPE Small molecular drug D06AGD DRUGINCH 1S/C23H35NO2/c1-14(2)13-19(25)18-7-6-16-15-5-8-20-23(4,12-10-21(26)24-20)17(15)9-11-22(16,18)3/h10,12,14-18,20H,5-9,11,13H2,1-4H3,(H,24,26)/t15-,16-,17-,18+,20+,22-,23+/m0/s1 D06AGD DRUGINKE RDPJISLOFXUIDK-RLAPWRJVSA-N D06AGD DRUGSMIL CC(C)CC(=O)C1CCC2C1(CCC3C2CCC4C3(C=CC(=O)N4)C)C D06AGD HIGHSTAT Discontinued in Phase 1 D06DET DRUG__ID D06DET D06DET DRUGTYPE Small molecular drug D06DET DRUGINCH 1S/C23H34F3N5O7/c1-12(2)17(19(35)23(24,25)26)28-20(36)14-6-5-7-31(14)21(37)18(13(3)4)27-15(32)10-29-8-9-30(22(29)38)11-16(33)34/h12-14,17-18H,5-11H2,1-4H3,(H,27,32)(H,28,36)(H,33,34)/t14-,17-,18-/m0/s1 D06DET DRUGINKE DHQQXRRWRZFGDW-WBAXXEDZSA-N D06DET DRUGSMIL CC(C)C(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)CN2CCN(C2=O)CC(=O)O D06DET HIGHSTAT Discontinued in Phase 1 D06PHO DRUG__ID D06PHO D06PHO DRUGCOMP Eisai Co Ltd D06PHO DRUGINCH 1S/2C22H23ClFNO5.Ca/c2*1-14(2)30-21(22(26)27)9-15-4-3-5-19(8-15)28-12-18(24)13-29-20-7-6-17(23)10-16(20)11-25;/h2*3-8,10,14,18,21H,9,12-13H2,1-2H3,(H,26,27);/q;;+2/p-2/t2*18-,21-;/m00./s1 D06PHO DRUGINKE QBPOEQDRFVFZRI-ATAMATRTSA-L D06PHO DRUGSMIL CC(C)OC(CC1=CC(=CC=C1)OCC(COC2=C(C=C(C=C2)Cl)C#N)F)C(=O)[O-].CC(C)OC(CC1=CC(=CC=C1)OCC(COC2=C(C=C(C=C2)Cl)C#N)F)C(=O)[O-].[Ca+2] D06PHO HIGHSTAT Discontinued in Phase 1 D06WEB DRUG__ID D06WEB D06WEB DRUGCOMP Novartis Institutes for BioMedical Research Inc D06WEB DRUGINCH 1S/C25H42N2O8/c1-25(2,3)13-12-18(28)19(29)20(30)21(34-4)23(32)27-17-11-10-16(14-26-22(17)31)35-24(33)15-8-6-5-7-9-15/h12-13,15-21,28-30H,5-11,14H2,1-4H3,(H,26,31)(H,27,32)/b13-12+/t16-,17+,18-,19+,20-,21-/m1/s1 D06WEB DRUGINKE XSYJUVKQRPLTAU-BKMGADMVSA-N D06WEB DRUGSMIL CC(C)(C)C=CC(C(C(C(C(=O)NC1CCC(CNC1=O)OC(=O)C2CCCCC2)OC)O)O)O D06WEB HIGHSTAT Discontinued in Phase 1 D06ZVC DRUG__ID D06ZVC D06ZVC DRUGTYPE Small molecular drug D06ZVC DRUGINCH 1S/C15H13ClN4O2S2/c16-13-14(19-7-8-23-15(19)18-13)24(21,22)20-9-10(5-6-17)11-3-1-2-4-12(11)20/h1-4,7-9H,5-6,17H2 D06ZVC DRUGINKE RYBOXBBYCVOYNO-UHFFFAOYSA-N D06ZVC DRUGSMIL C1=CC=C2C(=C1)C(=CN2S(=O)(=O)C3=C(N=C4N3C=CS4)Cl)CCN D06ZVC HIGHSTAT Discontinued in Phase 1 D07BUO DRUG__ID D07BUO D07BUO DRUGCOMP AstraZeneca plc D07BUO DRUGINCH 1S/C26H34N4O4/c1-28-9-11-30(12-10-28)23-18-22(32-2)17-19-3-8-24(34-25(19)23)26(31)27-20-4-6-21(7-5-20)29-13-15-33-16-14-29/h4-7,17-18,24H,3,8-16H2,1-2H3,(H,27,31)/t24-/m1/s1 D07BUO DRUGINKE SKOWCFJEXPLGNE-XMMPIXPASA-N D07BUO DRUGSMIL CN1CCN(CC1)C2=CC(=CC3=C2OC(CC3)C(=O)NC4=CC=C(C=C4)N5CCOCC5)OC D07BUO HIGHSTAT Discontinued in Phase 1 D07CIB DRUG__ID D07CIB D07CIB DRUGCOMP Parke-Davis & Co D07CIB DRUGINCH 1S/C26H32N2O6S2/c1-5-15(3)21(25(31)32)27-23(29)17-11-7-9-13-19(17)35-36-20-14-10-8-12-18(20)24(30)28-22(26(33)34)16(4)6-2/h7-16,21-22H,5-6H2,1-4H3,(H,27,29)(H,28,30)(H,31,32)(H,33,34)/t15-,16-,21-,22-/m0/s1 D07CIB DRUGINKE SUQDXZBTWJQATJ-QDGJQWLKSA-N D07CIB DRUGSMIL CCC(C)C(C(=O)O)NC(=O)C1=CC=CC=C1SSC2=CC=CC=C2C(=O)NC(C(C)CC)C(=O)O D07CIB HIGHSTAT Discontinued in Phase 1 D07EBU DRUG__ID D07EBU D07EBU DRUGTYPE Small molecular drug D07EBU DRUGINCH 1S/C14H22N2OS/c1-8(2)14(3)12(17)16-13(18-14)15-11-7-9-4-5-10(11)6-9/h8-11H,4-7H2,1-3H3,(H,15,16,17)/t9-,10+,11+,14+/m1/s1 D07EBU DRUGINKE YCNCXQNUXCHRRX-ZHPDPMBESA-N D07EBU DRUGSMIL CC(C)C1(C(=O)NC(=NC2CC3CCC2C3)S1)C D07EBU HIGHSTAT Discontinued in Phase 1 D07EQF DRUG__ID D07EQF D07EQF DRUGTYPE Small molecular drug D07EQF DRUGINCH 1S/C14H12FN3O2/c15-11-3-7-13(8-4-11)20-12-5-1-10(2-6-12)9-17-18-14(16)19/h1-9H,(H3,16,18,19)/b17-9+ D07EQF DRUGINKE MHUUDVZSPFRUSK-RQZCQDPDSA-N D07EQF DRUGSMIL C1=CC(=CC=C1C=NNC(=O)N)OC2=CC=C(C=C2)F D07EQF HIGHSTAT Discontinued in Phase 1 D07FHW DRUG__ID D07FHW D07FHW DRUGTYPE Small molecular drug D07FHW DRUGINCH 1S/C18H14N4O2S/c19-12-13-4-6-14(7-5-13)15-8-10-16(11-9-15)25(23,24)22-18-3-1-2-17(20)21-18/h1-11H,(H3,20,21,22) D07FHW DRUGINKE ZESFDAKNYJQYKO-UHFFFAOYSA-N D07FHW DRUGSMIL C1=CC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C#N)N D07FHW HIGHSTAT Discontinued in Phase 1 D07IIX DRUG__ID D07IIX D07IIX DRUGTYPE Small molecular drug D07IIX DRUGINCH 1S/C15H16N2O/c1-10-4-3-5-11(2)14(10)17-15(18)12-6-8-13(16)9-7-12/h3-9H,16H2,1-2H3,(H,17,18) D07IIX DRUGINKE HZIWGOAXOBPQGY-UHFFFAOYSA-N D07IIX DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C2=CC=C(C=C2)N D07IIX HIGHSTAT Discontinued in Phase 1 D07JHJ DRUG__ID D07JHJ D07JHJ DRUGTYPE Small molecular drug D07JHJ DRUGINCH 1S/C28H38N4O6.2ClH/c1-7-11-30-12-14-31(15-13-30)17-28(4,5)18-38-27(34)24-20(3)29-19(2)23(26(33)37-6)25(24)21-9-8-10-22(16-21)32(35)36;;/h7-10,16,25,29H,1,11-15,17-18H2,2-6H3;2*1H D07JHJ DRUGINKE PJGTYHKZUAHNHC-UHFFFAOYSA-N D07JHJ DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC(C)(C)CN2CCN(CC2)CC=C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl.Cl D07JHJ HIGHSTAT Discontinued in Phase 1 D07JJC DRUG__ID D07JJC D07JJC DRUGTYPE Small molecular drug D07JJC DRUGINCH 1S/C35H48FN5O5S/c1-24(2)22-41(47(45,46)29-16-14-28(37)15-17-29)23-31(42)30(19-25-10-7-6-8-11-25)39-34(44)33(35(3,4)5)40-32(43)21-38-20-26-12-9-13-27(36)18-26/h6-18,24,30-31,33,38,42H,19-23,37H2,1-5H3,(H,39,44)(H,40,43)/t30-,31-,33+/m0/s1 D07JJC DRUGINKE IXZYCIFRVZKVRJ-MZSJJGOWSA-N D07JJC DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)(C)C)NC(=O)CNCC2=CC(=CC=C2)F)O)S(=O)(=O)C3=CC=C(C=C3)N D07JJC HIGHSTAT Discontinued in Phase 1 D07NTN DRUG__ID D07NTN D07NTN DRUGTYPE Small molecular drug D07NTN DRUGINCH 1S/C25H34N2O3.C4H4O4/c1-3-20(2)28-18-23(26-13-7-8-14-26)17-27(16-21-9-5-4-6-10-21)22-11-12-24-25(15-22)30-19-29-24;5-3(6)1-2-4(7)8/h4-6,9-12,15,20,23H,3,7-8,13-14,16-19H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D07NTN DRUGINKE RDZJRZMQCVQTSK-WLHGVMLRSA-N D07NTN DRUGSMIL CCC(C)OCC(CN(CC1=CC=CC=C1)C2=CC3=C(C=C2)OCO3)N4CCCC4.C(=CC(=O)O)C(=O)O D07NTN HIGHSTAT Discontinued in Phase 1 D07RVP DRUG__ID D07RVP D07RVP DRUGTYPE Small molecular drug D07RVP DRUGINCH 1S/C34H37NO8/c36-26(22-41-27-13-7-4-8-14-27)23-42-33-29(30(37)21-31(33)38)15-9-1-2-10-16-32(39)43-28-19-17-25(18-20-28)35-34(40)24-11-5-3-6-12-24/h1-8,11-14,17-20,26,29,31,33,36,38H,9-10,15-16,21-23H2,(H,35,40)/b2-1-/t26?,29-,31+,33+/m0/s1 D07RVP DRUGINKE QQTQLHVRUZWVQZ-WYFSZTNASA-N D07RVP DRUGSMIL C1C(C(C(C1=O)CCC=CCCC(=O)OC2=CC=C(C=C2)NC(=O)C3=CC=CC=C3)OCC(COC4=CC=CC=C4)O)O D07RVP HIGHSTAT Discontinued in Phase 1 D07UOS DRUG__ID D07UOS D07UOS DRUGTYPE Small molecular drug D07UOS DRUGINCH 1S/C25H31NO2/c1-24-14-12-19-17(8-11-21-25(19,2)15-13-22(27)26-21)18(24)9-10-20(24)23(28)16-6-4-3-5-7-16/h3-7,13,15,17-21H,8-12,14H2,1-2H3,(H,26,27)/t17-,18-,19-,20+,21+,24-,25+/m0/s1 D07UOS DRUGINKE ZYTQEOWFSVTRLX-QKONGSNMSA-N D07UOS DRUGSMIL CC12CCC3C(C1CCC2C(=O)C4=CC=CC=C4)CCC5C3(C=CC(=O)N5)C D07UOS HIGHSTAT Discontinued in Phase 1 D08AFD DRUG__ID D08AFD D08AFD DRUGTYPE Small molecular drug D08AFD DRUGINCH 1S/C26H35N3O5/c1-4-5-6-7-8-11-16-34-26(31)23-18(3)27-17(2)22(25(30)28-19-14-15-19)24(23)20-12-9-10-13-21(20)29(32)33/h9-10,12-13,19,24,27H,4-8,11,14-16H2,1-3H3,(H,28,30) D08AFD DRUGINKE IAWVGADTHVEXRD-UHFFFAOYSA-N D08AFD DRUGSMIL CCCCCCCCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2[N+](=O)[O-])C(=O)NC3CC3)C)C D08AFD HIGHSTAT Discontinued in Phase 1 D08AMQ DRUG__ID D08AMQ D08AMQ DRUGTYPE Small molecular drug D08AMQ DRUGINCH 1S/C34H34N2O9/c1-4-5-12-36-32(27-11-10-25(41-2)16-29(27)43-19-21-8-6-7-9-26(21)34(39)40)24(18-35-36)14-23(33(37)38)13-22-15-30-31(45-20-44-30)17-28(22)42-3/h6-11,14-18H,4-5,12-13,19-20H2,1-3H3,(H,37,38)(H,39,40)/b23-14+ D08AMQ DRUGINKE MCHCGWZNXSZKJY-OEAKJJBVSA-N D08AMQ DRUGSMIL CCCCN1C(=C(C=N1)C=C(CC2=CC3=C(C=C2OC)OCO3)C(=O)O)C4=C(C=C(C=C4)OC)OCC5=CC=CC=C5C(=O)O D08AMQ HIGHSTAT Discontinued in Phase 1 D08HIH DRUG__ID D08HIH D08HIH DRUGCOMP Wyeth D08HIH DRUGINCH 1S/C17H10FNO2/c18-16-7-10(2-4-17(16)21)12-5-11-1-3-14(20)8-15(11)13(6-12)9-19/h1-8,20-21H D08HIH DRUGINKE NSSOSHDCWCMNDM-UHFFFAOYSA-N D08HIH DRUGSMIL C1=CC(=CC2=C(C=C(C=C21)C3=CC(=C(C=C3)O)F)C#N)O D08HIH HIGHSTAT Discontinued in Phase 1 D08NES DRUG__ID D08NES D08NES DRUGCOMP Shionogi & Co Ltd D08NES DRUGINCH 1S/C10H9NO/c1-12-10-3-2-9-7-11-5-4-8(9)6-10/h2-7H,1H3 D08NES DRUGINKE XZNUJESLPUNSNO-UHFFFAOYSA-N D08NES DRUGSMIL COC1=CC2=C(C=C1)C=NC=C2 D08NES HIGHSTAT Discontinued in Phase 1 D08RUX DRUG__ID D08RUX D08RUX DRUGTYPE Small molecular drug D08RUX DRUGINCH 1S/C19H24N2O2S/c22-18(11-14-9-15-5-1-2-6-16(15)10-14)21-13-24-12-17(21)19(23)20-7-3-4-8-20/h1-2,5-6,14,17H,3-4,7-13H2/t17-/m0/s1 D08RUX DRUGINKE GDOVFSONSLOIAK-KRWDZBQOSA-N D08RUX DRUGSMIL C1CCN(C1)C(=O)C2CSCN2C(=O)CC3CC4=CC=CC=C4C3 D08RUX HIGHSTAT Discontinued in Phase 1 D08SUQ DRUG__ID D08SUQ D08SUQ DRUGCOMP PharmaMar SA D08SUQ DRUGINCH 1S/C18H39NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18(20)17(2)19/h17-18,20H,3-16,19H2,1-2H3/t17-,18+/m0/s1 D08SUQ DRUGINKE YRYJJIXWWQLGGV-ZWKOTPCHSA-N D08SUQ DRUGSMIL CCCCCCCCCCCCCCCC(C(C)N)O D08SUQ HIGHSTAT Discontinued in Phase 1 D08YVT DRUG__ID D08YVT D08YVT DRUGTYPE Small molecular drug D08YVT DRUGINCH 1S/C31H36ClN3O3S/c1-22-4-2-7-29(30(22)33)31(36)35-18-14-26(15-19-35)34-16-12-24(13-17-34)20-23-8-10-27(11-9-23)39(37,38)28-6-3-5-25(32)21-28/h2-11,21,24,26H,12-20,33H2,1H3 D08YVT DRUGINKE VMJKUCKTXMESQR-UHFFFAOYSA-N D08YVT DRUGSMIL CC1=C(C(=CC=C1)C(=O)N2CCC(CC2)N3CCC(CC3)CC4=CC=C(C=C4)S(=O)(=O)C5=CC(=CC=C5)Cl)N D08YVT HIGHSTAT Discontinued in Phase 1 D09ADN DRUG__ID D09ADN D09ADN DRUGTYPE Small molecular drug D09ADN DRUGINCH 1S/C16H20N2OS/c1-18-8-11(9-20-2)19-16-12-4-3-5-13-15(12)10(7-17-13)6-14(16)18/h3-5,7,11,14,16-17H,6,8-9H2,1-2H3/t11?,14-,16-/m1/s1 D09ADN DRUGINKE GYUHVILBXXBZDS-PXFYRTPJSA-N D09ADN DRUGSMIL CN1CC(OC2C1CC3=CNC4=CC=CC2=C34)CSC D09ADN HIGHSTAT Discontinued in Phase 1 D09CKF DRUG__ID D09CKF D09CKF DRUGTYPE Small molecular drug D09CKF DRUGINCH 1S/C8H3Cl2N3O4/c9-2-1-3-5(6(4(2)10)13(16)17)12-8(15)7(14)11-3/h1H,(H,11,14)(H,12,15) D09CKF DRUGINKE CHFSOFHQIZKQCR-UHFFFAOYSA-N D09CKF DRUGSMIL C1=C2C(=C(C(=C1Cl)Cl)[N+](=O)[O-])NC(=O)C(=O)N2 D09CKF HIGHSTAT Discontinued in Phase 1 D09FGX DRUG__ID D09FGX D09FGX DRUGTYPE Small molecular drug D09FGX DRUGINCH 1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38) D09FGX DRUGINKE OSFCMRGOZNQUSW-UHFFFAOYSA-N D09FGX DRUGSMIL COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC D09FGX HIGHSTAT Discontinued in Phase 1 D09FYQ DRUG__ID D09FYQ D09FYQ DRUGTYPE Small molecular drug D09FYQ DRUGINCH 1S/C10H15N3O/c1-14-12-10(6-11)9-7-13-4-2-8(9)3-5-13/h8-9H,2-5,7H2,1H3/b12-10+/t9-/m0/s1 D09FYQ DRUGINKE IQWCBYSUUOFOMF-QTLFRQQHSA-N D09FYQ DRUGSMIL CON=C(C#N)C1CN2CCC1CC2 D09FYQ HIGHSTAT Discontinued in Phase 1 D09FZI DRUG__ID D09FZI D09FZI DRUGTYPE Small molecular drug D09FZI DRUGINCH 1S/C27H43N3O4/c1-17(2)20(16-18(3)25(33)34)30(10)24(32)22(26(4,5)6)29-23(31)21(28-9)27(7,8)19-14-12-11-13-15-19/h11-17,20-22,28H,1-10H3,(H,29,31)(H,33,34)/b18-16+/t20-,21-,22-/m1/s1 D09FZI DRUGINKE CNTMOLDWXSVYKD-PSRNMDMQSA-N D09FZI DRUGSMIL CC(C)C(C=C(C)C(=O)O)N(C)C(=O)C(C(C)(C)C)NC(=O)C(C(C)(C)C1=CC=CC=C1)NC D09FZI HIGHSTAT Discontinued in Phase 1 D09GUI DRUG__ID D09GUI D09GUI DRUGTYPE Small molecular drug D09GUI DRUGINCH 1S/C49H66N12O6S/c1-28(2)22-40(60-47(66)41(24-31-26-55-37-13-7-5-10-33(31)37)59-44(63)36(51)23-30-17-15-29(3)16-18-30)46(65)57-39(19-21-68-4)45(64)61-48(67)42(25-32-27-56-38-14-8-6-11-34(32)38)58-43(62)35(50)12-9-20-54-49(52)53/h5-8,10-11,13-18,26-28,35-36,39-42,55-56H,9,12,19-25,50-51H2,1-4H3,(H,57,65)(H,58,62)(H,59,63)(H,60,66)(H4,52,53,54)(H,61,64,67)/t35-,36-,39-,40-,41+,42+/m0/s1 D09GUI DRUGINKE XYWLXVYDTHKSAT-ZZDDQDSOSA-N D09GUI DRUGSMIL CC1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCN=C(N)N)N)N D09GUI HIGHSTAT Discontinued in Phase 1 D09KXA DRUG__ID D09KXA D09KXA DRUGTYPE Small molecular drug D09KXA DRUGINCH 1S/C19H22FN5O4/c1-9(21)18(27)22-10-4-5-24(7-10)17-14(20)6-12-15(26)13(19(28)29)8-25(11-2-3-11)16(12)23-17/h6,8-11H,2-5,7,21H2,1H3,(H,22,27)(H,28,29)/t9-,10-/m0/s1 D09KXA DRUGINKE ZVZRDFTXNAZBOX-UWVGGRQHSA-N D09KXA DRUGSMIL CC(C(=O)NC1CCN(C1)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F)N D09KXA HIGHSTAT Discontinued in Phase 1 D09LZA DRUG__ID D09LZA D09LZA DRUGCOMP Daiichi Sankyo D09LZA DRUGINCH 1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3 D09LZA DRUGINKE PHIQHXFUZVPYII-UHFFFAOYSA-N D09LZA DRUGSMIL C[N+](C)(C)CC(CC(=O)[O-])O D09LZA HIGHSTAT Discontinued in Phase 1 D09MAS DRUG__ID D09MAS D09MAS DRUGCOMP Fujisawa Pharmaceutical Co Ltd D09MAS DRUGINCH 1S/C20H31N2O6P/c1-21-14-10-20-8-7-18(28-29(24,25)26)16(11-20)19(23)17(22(20)12-14)9-13-3-5-15(27-2)6-4-13/h3-6,14,16-19,21,23H,7-12H2,1-2H3,(H2,24,25,26)/t14-,16-,17-,18-,19-,20+/m0/s1 D09MAS DRUGINKE CIISYBZFZSWZLX-KKMIJOEASA-N D09MAS DRUGSMIL CNC1CC23CCC(C(C2)C(C(N3C1)CC4=CC=C(C=C4)OC)O)OP(=O)(O)O D09MAS HIGHSTAT Discontinued in Phase 1 D09MON DRUG__ID D09MON D09MON DRUGCOMP Abbott Laboratories D09MON DRUGINCH 1S/C80H104ClN15O14/c1-46(2)38-63(73(103)90-62(20-10-17-59(82)47(3)4)80(110)96-37-13-21-68(96)77(107)87-48(5)71(84)101)91-72(102)61(19-11-18-60(83)70(100)55-32-35-85-36-33-55)89-78(108)69(43-51-25-30-58(99)31-26-51)95(7)79(109)67(45-97)94-76(106)66(42-53-14-12-34-86-44-53)93-75(105)65(40-50-23-28-57(81)29-24-50)92-74(104)64(88-49(6)98)41-52-22-27-54-15-8-9-16-56(54)39-52/h8-9,12,14-16,22-36,39,44,46-48,59-69,97,99H,10-11,13,17-21,37-38,40-43,45,82-83H2,1-7H3,(H2,84,101)(H,87,107)(H,88,98)(H,89,108)(H,90,103)(H,91,102)(H,92,104)(H,93,105)(H,94,106)/t48-,59?,60?,61-,62-,63-,64-,65-,66-,67-,68+,69-/m0/s1 D09MON DRUGINKE WGWPBHBZVYAVTQ-HQDLIPOVSA-N D09MON DRUGSMIL CC(C)CC(C(=O)NC(CCCC(C(C)C)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCC(C(=O)C2=CC=NC=C2)N)NC(=O)C(CC3=CC=C(C=C3)O)N(C)C(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D09MON HIGHSTAT Discontinued in Phase 1 D09NBM DRUG__ID D09NBM D09NBM DRUGCOMP GlaxoSmithKline plc D09NBM DRUGINCH 1S/C38H40F4N6O2S/c1-4-46(5-2)18-19-47(23-27-6-10-30(11-7-27)31-12-14-33(15-13-31)38(40,41)42)35(49)25-48-24-32(20-29-21-43-45(3)22-29)36(50)44-37(48)51-26-28-8-16-34(39)17-9-28/h6-17,21-22,24H,4-5,18-20,23,25-26H2,1-3H3 D09NBM DRUGINKE VGIQUSQBXZXBGW-UHFFFAOYSA-N D09NBM DRUGSMIL CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C=C(C(=O)N=C3SCC4=CC=C(C=C4)F)CC5=CN(N=C5)C D09NBM HIGHSTAT Discontinued in Phase 1 D09PSB DRUG__ID D09PSB D09PSB DRUGTYPE Small molecular drug D09PSB DRUGINCH 1S/C14H11F5N2O/c15-8-3-4-9-10(11(8)16)13(14(17,18)19,21-12(22)20-9)6-5-7-1-2-7/h3-7H,1-2H2,(H2,20,21,22)/b6-5+/t13-/m0/s1 D09PSB DRUGINKE JUCDJPCFPITYRP-GFUIURDCSA-N D09PSB DRUGSMIL C1CC1C=CC2(C3=C(C=CC(=C3F)F)NC(=O)N2)C(F)(F)F D09PSB HIGHSTAT Discontinued in Phase 1 D09SFH DRUG__ID D09SFH D09SFH DRUGTYPE Small molecular drug D09SFH DRUGINCH 1S/C16H21N3S/c1-11(2)7-8-18-10-13-5-4-6-14-15(13)19(9-12(18)3)16(20)17-14/h4-7,12H,8-10H2,1-3H3,(H,17,20)/t12-/m0/s1 D09SFH DRUGINKE WTTIBCHOELPGFK-LBPRGKRZSA-N D09SFH DRUGSMIL CC1CN2C3=C(CN1CC=C(C)C)C=CC=C3NC2=S D09SFH HIGHSTAT Discontinued in Phase 1 D09WHM DRUG__ID D09WHM D09WHM DRUGCOMP Solvay Pharmaceuticals BV D09WHM DRUGINCH 1S/C23H22FN3O/c24-19-6-4-17(5-7-19)21-9-8-20(25-21)16-26-11-13-27(14-12-26)22-3-1-2-18-10-15-28-23(18)22/h1-10,15,25H,11-14,16H2 D09WHM DRUGINKE PGNHBJGIQAEIHD-UHFFFAOYSA-N D09WHM DRUGSMIL C1CN(CCN1CC2=CC=C(N2)C3=CC=C(C=C3)F)C4=CC=CC5=C4OC=C5 D09WHM HIGHSTAT Discontinued in Phase 1 D09ZPX DRUG__ID D09ZPX D09ZPX DRUGTYPE Small molecular drug D09ZPX DRUGINCH 1S/C10H12N8O/c19-9(13-10-14-16-17-15-10)7-5-11-6-8(12-7)18-3-1-2-4-18/h5-6H,1-4H2,(H2,13,14,15,16,17,19) D09ZPX DRUGINKE LUJDHCXCWJFNOJ-UHFFFAOYSA-N D09ZPX DRUGSMIL C1CCN(C1)C2=NC(=CN=C2)C(=O)NC3=NNN=N3 D09ZPX HIGHSTAT Discontinued in Phase 1 D0A0FG DRUG__ID D0A0FG D0A0FG DRUGTYPE Small molecular drug D0A0FG DRUGINCH 1S/C23H33NO2/c1-22(2,3)19-13-17(14-20(21(19)25)23(4,5)6)10-8-12-26-16-18-9-7-11-24-15-18/h7,9,11,13-15,25H,8,10,12,16H2,1-6H3 D0A0FG DRUGINKE YNBBIPPQHYZTQF-UHFFFAOYSA-N D0A0FG DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CCCOCC2=CN=CC=C2 D0A0FG HIGHSTAT Discontinued in Phase 1 D0A1KU DRUG__ID D0A1KU D0A1KU DRUGTYPE Small molecular drug D0A1KU DRUGINCH 1S/C19H19ClFN5O3/c1-27-11-17-23-24-19(26(17)13-4-6-18(28-2)22-8-13)25-9-14(10-25)29-16-5-3-12(21)7-15(16)20/h3-8,14H,9-11H2,1-2H3 D0A1KU DRUGINKE HNIFCPBQMKPRCX-UHFFFAOYSA-N D0A1KU DRUGSMIL COCC1=NN=C(N1C2=CN=C(C=C2)OC)N3CC(C3)OC4=C(C=C(C=C4)F)Cl D0A1KU HIGHSTAT Discontinued in Phase 1 D0A8FD DRUG__ID D0A8FD D0A8FD DRUGCOMP Servier D0A8FD DRUGINCH 1S/C23H25FN4O2/c24-18-6-7-20-21(16-18)30-25-22(20)17-8-10-26(11-9-17)12-13-27-14-15-28(23(27)29)19-4-2-1-3-5-19/h1-7,16-17H,8-15H2 D0A8FD DRUGINKE ULCAXFRFGIKHRG-UHFFFAOYSA-N D0A8FD DRUGSMIL C1CN(CCC1C2=NOC3=C2C=CC(=C3)F)CCN4CCN(C4=O)C5=CC=CC=C5 D0A8FD HIGHSTAT Discontinued in Phase 1 D0A9KI DRUG__ID D0A9KI D0A9KI DRUGTYPE Small molecular drug D0A9KI DRUGINCH 1S/C19H20FN5O/c1-26-19-22-11-8-16(24-19)18-17(13-2-4-14(20)5-3-13)23-12-25(18)15-6-9-21-10-7-15/h2-5,8,11-12,15,21H,6-7,9-10H2,1H3 D0A9KI DRUGINKE PDTYLGXVBIWRIM-UHFFFAOYSA-N D0A9KI DRUGSMIL COC1=NC=CC(=N1)C2=C(N=CN2C3CCNCC3)C4=CC=C(C=C4)F D0A9KI HIGHSTAT Discontinued in Phase 1 D0B0UN DRUG__ID D0B0UN D0B0UN DRUGCOMP Roche D0B0UN DRUGINCH 1S/C7H9ClN2O/c1-4-6(7(8)11)5(2)10(3)9-4/h1-3H3 D0B0UN DRUGINKE UFNVZQRBSDFSPY-UHFFFAOYSA-N D0B0UN DRUGSMIL CC1=C(C(=NN1C)C)C(=O)Cl D0B0UN HIGHSTAT Discontinued in Phase 1 D0B3CY DRUG__ID D0B3CY D0B3CY DRUGTYPE Small molecular drug D0B3CY DRUGINCH 1S/C29H31N7O2/c1-29(2,30)17-26(37)31-24-16-15-21-7-3-6-10-25(21)36(28(24)38)18-19-11-13-20(14-12-19)22-8-4-5-9-23(22)27-32-34-35-33-27/h3-14,24H,15-18,30H2,1-2H3,(H,31,37)(H,32,33,34,35)/t24-/m1/s1 D0B3CY DRUGINKE SBJLJOFPWOYATP-XMMPIXPASA-N D0B3CY DRUGSMIL CC(C)(CC(=O)NC1CCC2=CC=CC=C2N(C1=O)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)N D0B3CY HIGHSTAT Discontinued in Phase 1 D0B7KF DRUG__ID D0B7KF D0B7KF DRUGTYPE Small molecular drug D0B7KF DRUGINCH 1S/C20H19N5O2/c1-2-8-19-15(5-1)10-11-16(21-19)14-27-18-7-3-6-17(13-18)26-12-4-9-20-22-24-25-23-20/h1-3,5-8,10-11,13H,4,9,12,14H2,(H,22,23,24,25) D0B7KF DRUGINKE XDPLTERFGJAMRU-UHFFFAOYSA-N D0B7KF DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=CC(=C3)OCCCC4=NNN=N4 D0B7KF HIGHSTAT Discontinued in Phase 1 D0B9SR DRUG__ID D0B9SR D0B9SR DRUGCOMP SmithKline Beecham plc D0B9SR DRUGINCH 1S/C22H24F3N3O4/c1-26-19-4-2-3-17(27-19)7-8-32-18-6-5-14-9-15(11-20(29)30)21(31)28(12-16(14)10-18)13-22(23,24)25/h2-6,10,15H,7-9,11-13H2,1H3,(H,26,27)(H,29,30)/t15-/m0/s1 D0B9SR DRUGINKE KSSPHFGIOASRDE-HNNXBMFYSA-N D0B9SR DRUGSMIL CNC1=CC=CC(=N1)CCOC2=CC3=C(CC(C(=O)N(C3)CC(F)(F)F)CC(=O)O)C=C2 D0B9SR HIGHSTAT Discontinued in Phase 1 D0C0EO DRUG__ID D0C0EO D0C0EO DRUGTYPE Small molecular drug D0C0EO DRUGINCH 1S/C28H28O4/c29-26-22(16-19-8-10-21(11-9-19)20-6-2-1-3-7-20)18-32-25-17-23(12-13-24(25)26)28(27(30)31)14-4-5-15-28/h1-3,6-13,17,22,26,29H,4-5,14-16,18H2,(H,30,31)/t22-,26+/m0/s1 D0C0EO DRUGINKE KMNLXCBYBKHKSK-BKMJKUGQSA-N D0C0EO DRUGSMIL C1CCC(C1)(C2=CC3=C(C=C2)C(C(CO3)CC4=CC=C(C=C4)C5=CC=CC=C5)O)C(=O)O D0C0EO HIGHSTAT Discontinued in Phase 1 D0C2IA DRUG__ID D0C2IA D0C2IA DRUGCOMP Bristol-Myers Squibb Pharma Co D0C2IA DRUGINCH 1S/C28H36FN3O2/c1-20(33)23-8-4-9-26(17-23)30-28(34)31-27-10-3-2-7-24(27)19-32-15-5-6-22(18-32)16-21-11-13-25(29)14-12-21/h4,8-9,11-14,17,22,24,27H,2-3,5-7,10,15-16,18-19H2,1H3,(H2,30,31,34)/t22-,24?,27+/m0/s1 D0C2IA DRUGINKE ASRDPULQBHFPGU-RJCBHOSBSA-N D0C2IA DRUGSMIL CC(=O)C1=CC(=CC=C1)NC(=O)NC2CCCCC2CN3CCCC(C3)CC4=CC=C(C=C4)F D0C2IA HIGHSTAT Discontinued in Phase 1 D0C3AN DRUG__ID D0C3AN D0C3AN DRUGTYPE Small molecular drug D0C3AN DRUGINCH 1S/C35H42Cl2N4O2/c1-39(2)33(43)38-35(28-13-7-4-8-14-28)19-23-40(24-20-35)21-9-17-34(29-15-16-30(36)31(37)25-29)18-10-22-41(26-34)32(42)27-11-5-3-6-12-27/h3-8,11-16,25H,9-10,17-24,26H2,1-2H3,(H,38,43)/t34-/m0/s1 D0C3AN DRUGINKE XWPBINGFFFZAOZ-UMSFTDKQSA-N D0C3AN DRUGSMIL CN(C)C(=O)NC1(CCN(CC1)CCCC2(CCCN(C2)C(=O)C3=CC=CC=C3)C4=CC(=C(C=C4)Cl)Cl)C5=CC=CC=C5 D0C3AN HIGHSTAT Discontinued in Phase 1 D0C7JH DRUG__ID D0C7JH D0C7JH DRUGTYPE Small molecular drug D0C7JH DRUGINCH 1S/C45H69N17O14S2/c1-22(63)55-31-21-78-77-20-30(36(47)68)61-38(70)26(7-4-14-53-45(50)51)57-39(71)27(16-23-9-11-24(76-2)12-10-23)59-40(72)28(18-35(66)67)56-34(65)19-54-37(69)25(6-3-13-52-44(48)49)58-42(74)32-8-5-15-62(32)43(75)29(17-33(46)64)60-41(31)73/h9-12,25-32H,3-8,13-21H2,1-2H3,(H2,46,64)(H2,47,68)(H,54,69)(H,55,63)(H,56,65)(H,57,71)(H,58,74)(H,59,72)(H,60,73)(H,61,70)(H,66,67)(H4,48,49,52)(H4,50,51,53)/t25-,26-,27-,28-,29-,30-,31-,32-/m0/s1 D0C7JH DRUGINKE RRPUNOOJZOAZNU-ALERXTORSA-N D0C7JH DRUGSMIL CC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C2CCCN2C(=O)C(NC1=O)CC(=O)N)CCCN=C(N)N)CC(=O)O)CC3=CC=C(C=C3)OC)CCCN=C(N)N)C(=O)N D0C7JH HIGHSTAT Discontinued in Phase 1 D0C7JT DRUG__ID D0C7JT D0C7JT DRUGTYPE Small molecular drug D0C7JT DRUGINCH 1S/C17H16ClN3O/c1-3-13-8-9-14-15(11-6-5-7-12(18)10-11)20-17(22)21(4-2)16(14)19-13/h5-10H,3-4H2,1-2H3 D0C7JT DRUGINKE MNHXYNNKDDXKNP-UHFFFAOYSA-N D0C7JT DRUGSMIL CCC1=NC2=C(C=C1)C(=NC(=O)N2CC)C3=CC(=CC=C3)Cl D0C7JT HIGHSTAT Discontinued in Phase 1 D0C7LF DRUG__ID D0C7LF D0C7LF DRUGTYPE Small molecular drug D0C7LF DRUGINCH 1S/C12H11N3OS/c13-11(16)9-3-5-15-10(9)7-17-12(15)8-2-1-4-14-6-8/h1-6,12H,7H2,(H2,13,16)/t12-/m1/s1 D0C7LF DRUGINKE ARFOASMERCHFBY-GFCCVEGCSA-N D0C7LF DRUGSMIL C1C2=C(C=CN2C(S1)C3=CN=CC=C3)C(=O)N D0C7LF HIGHSTAT Discontinued in Phase 1 D0C7UR DRUG__ID D0C7UR D0C7UR DRUGCOMP AtheroGenics D0C7UR DRUGINCH 1S/C35H54O4S2/c1-31(2,3)24-18-22(19-25(29(24)38)32(4,5)6)40-35(13,14)41-23-20-26(33(7,8)9)30(27(21-23)34(10,11)12)39-17-15-16-28(36)37/h18-21,38H,15-17H2,1-14H3,(H,36,37) D0C7UR DRUGINKE YHFUPQNXMNMQAK-UHFFFAOYSA-N D0C7UR DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)OCCCC(=O)O)C(C)(C)C D0C7UR HIGHSTAT Discontinued in Phase 1 D0D1LG DRUG__ID D0D1LG D0D1LG DRUGCOMP AstraZeneca plc D0D1LG DRUGINCH 1S/C21H27Cl2N5O6S/c1-9(8-33-3)24-19(30)16-17(20(31)32)35-21(27-16)28-6-5-11(12(7-28)34-4)26-18(29)15-14(23)13(22)10(2)25-15/h9,11-12,25H,5-8H2,1-4H3,(H,24,30)(H,26,29)(H,31,32)/t9-,11+,12-/m0/s1 D0D1LG DRUGINKE KGZHRAVDXGQUQM-WCQGTBRESA-N D0D1LG DRUGSMIL CC1=C(C(=C(N1)C(=O)NC2CCN(CC2OC)C3=NC(=C(S3)C(=O)O)C(=O)NC(C)COC)Cl)Cl D0D1LG HIGHSTAT Discontinued in Phase 1 D0D1VJ DRUG__ID D0D1VJ D0D1VJ DRUGCOMP Novartis AG D0D1VJ DRUGINCH 1S/C9H17NO2/c1-8-11-7-9(12-8)3-5-10(2)6-4-9/h8H,3-7H2,1-2H3/t8-/m0/s1 D0D1VJ DRUGINKE VHBBMEXIWWKUNY-QMMMGPOBSA-N D0D1VJ DRUGSMIL CC1OCC2(O1)CCN(CC2)C D0D1VJ HIGHSTAT Discontinued in Phase 1 D0D3ZP DRUG__ID D0D3ZP D0D3ZP DRUGTYPE Small molecular drug D0D3ZP DRUGINCH 1S/C27H24F3N3O3/c1-16-24(18-10-6-13-23(36-2)25(18)30)26(34)33(15-22(31)17-8-4-3-5-9-17)27(35)32(16)14-19-20(28)11-7-12-21(19)29/h3-13,22H,14-15,31H2,1-2H3/t22-/m0/s1 D0D3ZP DRUGINKE CJUWBZDJMYYRDG-QFIPXVFZSA-N D0D3ZP DRUGSMIL CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)F)CC(C3=CC=CC=C3)N)C4=C(C(=CC=C4)OC)F D0D3ZP HIGHSTAT Discontinued in Phase 1 D0D7GE DRUG__ID D0D7GE D0D7GE DRUGCOMP Takeda Pharmaceutical Co Ltd D0D7GE DRUGINCH 1S/C19H23N5O7/c1-31-16(28)8-13-19(30)23(10-15(26)27)6-7-24(13)14(25)9-22-18(29)12-4-2-11(3-5-12)17(20)21/h2-5,13H,6-10H2,1H3,(H3,20,21)(H,22,29)(H,26,27)/t13-/m0/s1 D0D7GE DRUGINKE CRFQJHNXTNBRQR-ZDUSSCGKSA-N D0D7GE DRUGSMIL COC(=O)CC1C(=O)N(CCN1C(=O)CNC(=O)C2=CC=C(C=C2)C(=N)N)CC(=O)O D0D7GE HIGHSTAT Discontinued in Phase 1 D0E7OL DRUG__ID D0E7OL D0E7OL DRUGCOMP Genentech D0E7OL DRUGINCH 1S/C7H3F3N2/c8-7(9,10)6-3-5(4-11)1-2-12-6/h1-3H D0E7OL DRUGINKE MLFFNKLBERSEPF-UHFFFAOYSA-N D0E7OL DRUGSMIL C1=CN=C(C=C1C#N)C(F)(F)F D0E7OL HIGHSTAT Discontinued in Phase 1 D0E8UJ DRUG__ID D0E8UJ D0E8UJ DRUGTYPE Small molecular drug D0E8UJ DRUGINCH 1S/C14H12O3S/c1-2-10-6-5-8-12-14(10)18(15,16)13-9-4-3-7-11(13)17-12/h3-9H,2H2,1H3 D0E8UJ DRUGINKE HQSRQKBSOOZLHH-UHFFFAOYSA-N D0E8UJ DRUGSMIL CCC1=C2C(=CC=C1)OC3=CC=CC=C3S2(=O)=O D0E8UJ HIGHSTAT Discontinued in Phase 1 D0F8QM DRUG__ID D0F8QM D0F8QM DRUGTYPE Small molecular drug D0F8QM DRUGINCH 1S/C24H35N5O8S/c1-15(2)21(24(34)29-9-12-38(35,36)13-10-29)28-23(33)18(14-20(31)32)27-19(30)4-3-11-37-17-7-5-16(6-8-17)22(25)26/h5-8,15,18,21H,3-4,9-14H2,1-2H3,(H3,25,26)(H,27,30)(H,28,33)(H,31,32)/t18-,21-/m0/s1 D0F8QM DRUGINKE FPOQHPVEVPIFME-RXVVDRJESA-N D0F8QM DRUGSMIL CC(C)C(C(=O)N1CCS(=O)(=O)CC1)NC(=O)C(CC(=O)O)NC(=O)CCCOC2=CC=C(C=C2)C(=N)N D0F8QM HIGHSTAT Discontinued in Phase 1 D0F8XI DRUG__ID D0F8XI D0F8XI DRUGCOMP Daiichi Sankyo D0F8XI DRUGINCH 1S/C10H7NO2/c12-10(13)9-3-1-2-7-6-11-5-4-8(7)9/h1-6H,(H,12,13) D0F8XI DRUGINKE ZIPLFLRGHZAXSJ-UHFFFAOYSA-N D0F8XI DRUGSMIL C1=CC2=C(C=CN=C2)C(=C1)C(=O)O D0F8XI HIGHSTAT Discontinued in Phase 1 D0FL6X DRUG__ID D0FL6X D0FL6X DRUGCOMP Daiichi Sankyo D0FL6X DRUGINCH 1S/C21H22F3N3O3.ClH.2H2O/c1-10-16-11(18(28)12(19(29)30)7-27(16)15-6-13(15)22)5-14(23)17(10)26-8-20(24)3-2-4-21(20,25)9-26;;;/h5,7,13,15H,2-4,6,8-9,25H2,1H3,(H,29,30);1H;2*1H2/t13-,15+,20-,21+;;;/m0.../s1 D0FL6X DRUGINKE WDCLSNJDBKODOF-JNEZQIAFSA-N D0FL6X DRUGSMIL CC1=C2C(=CC(=C1N3CC4(CCCC4(C3)F)N)F)C(=O)C(=CN2C5CC5F)C(=O)O.O.O.Cl D0FL6X HIGHSTAT Discontinued in Phase 1 D0FT2Z DRUG__ID D0FT2Z D0FT2Z DRUGTYPE Small molecular drug D0FT2Z DRUGINCH 1S/C10H11N/c11-9-5-4-8-10-6-2-1-3-7-10/h1-3,6-7H,4-5,8H2 D0FT2Z DRUGINKE ICMVGKQFVMTRLB-UHFFFAOYSA-N D0FT2Z DRUGSMIL C1=CC=C(C=C1)CCCC#N D0FT2Z HIGHSTAT Discontinued in Phase 1 D0G0XN DRUG__ID D0G0XN D0G0XN DRUGTYPE Small molecular drug D0G0XN DRUGINCH 1S/C27H33N5O5S/c1-17-9-12-32(24(13-17)27(34)35)26(33)23(14-18-3-5-20(6-4-18)25(28)29)30-38(36,37)22-8-7-19-10-11-31(2)16-21(19)15-22/h3-9,15,23-24,30H,10-14,16H2,1-2H3,(H3,28,29)(H,34,35)/t23-,24+/m0/s1 D0G0XN DRUGINKE ZDHBBBQAVLNJBL-BJKOFHAPSA-N D0G0XN DRUGSMIL CC1=CCN(C(C1)C(=O)O)C(=O)C(CC2=CC=C(C=C2)C(=N)N)NS(=O)(=O)C3=CC4=C(CCN(C4)C)C=C3 D0G0XN HIGHSTAT Discontinued in Phase 1 D0G5ZL DRUG__ID D0G5ZL D0G5ZL DRUGTYPE Small molecular drug D0G5ZL DRUGINCH 1S/C16H22N2O/c1-2-9-18-10-8-12-14(18)7-6-11-4-3-5-13(15(11)12)16(17)19/h3-5,12,14H,2,6-10H2,1H3,(H2,17,19)/t12-,14-/m1/s1 D0G5ZL DRUGINKE JSZBRMZCAIJCKB-TZMCWYRMSA-N D0G5ZL DRUGSMIL CCCN1CCC2C1CCC3=C2C(=CC=C3)C(=O)N D0G5ZL HIGHSTAT Discontinued in Phase 1 D0G6XC DRUG__ID D0G6XC D0G6XC DRUGTYPE Small molecular drug D0G6XC DRUGINCH 1S/C21H27N3O3S2/c1-4-24(5-2)13-12-22-17-11-10-15(14-23-29(3,26)27)21-19(17)20(25)16-8-6-7-9-18(16)28-21/h6-11,22-23H,4-5,12-14H2,1-3H3 D0G6XC DRUGINKE NAMOLZVVTPNNTE-UHFFFAOYSA-N D0G6XC DRUGSMIL CCN(CC)CCNC1=C2C(=C(C=C1)CNS(=O)(=O)C)SC3=CC=CC=C3C2=O D0G6XC HIGHSTAT Discontinued in Phase 1 D0GC8F DRUG__ID D0GC8F D0GC8F DRUGTYPE Small molecular drug D0GC8F DRUGINCH 1S/C24H25N5O5/c1-15-5-7-16(8-6-15)21(31)18-10-9-17(26(18)2)13-19(30)34-12-11-29-14-25-22-20(29)23(32)28(4)24(33)27(22)3/h5-10,14H,11-13H2,1-4H3 D0GC8F DRUGINKE TYIRBZOAKBEYEJ-UHFFFAOYSA-N D0GC8F DRUGSMIL CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)OCCN3C=NC4=C3C(=O)N(C(=O)N4C)C D0GC8F HIGHSTAT Discontinued in Phase 1 D0GZ3J DRUG__ID D0GZ3J D0GZ3J DRUGCOMP Sigea SrL D0GZ3J DRUGINCH 1S/2C3H4N2.C2H6OS.4ClH.Ru/c2*1-2-5-3-4-1;1-4(2)3;;;;;/h2*1-3H,(H,4,5);1-2H3;4*1H;/q;;;;;;;+3/p-3 D0GZ3J DRUGINKE RJZBTXZRLXLLKO-UHFFFAOYSA-K D0GZ3J DRUGSMIL CS(=O)C.C1=C[NH+]=CN1.C1=CN=CN1.[Cl-].[Cl-].[Cl-].[Cl-].[Ru+3] D0GZ3J HIGHSTAT Discontinued in Phase 1 D0H5PG DRUG__ID D0H5PG D0H5PG DRUGTYPE Small molecular drug D0H5PG DRUGINCH 1S/C22H29ClN2O4S/c23-20-10-12-21(13-11-20)30(28,29)25-16-2-1-5-18(9-14-22(26)27)6-3-7-19-8-4-15-24-17-19/h4,8,10-13,15,17-18,25H,1-3,5-7,9,14,16H2,(H,26,27) D0H5PG DRUGINKE ISMHAZMNDUAHLK-UHFFFAOYSA-N D0H5PG DRUGSMIL C1=CC(=CN=C1)CCCC(CCCCNS(=O)(=O)C2=CC=C(C=C2)Cl)CCC(=O)O D0H5PG HIGHSTAT Discontinued in Phase 1 D0I3VP DRUG__ID D0I3VP D0I3VP DRUGTYPE Small molecular drug D0I3VP DRUGINCH 1S/C16H15ClN2O3S/c17-13-5-7-14(8-6-13)18-16(20)19-23(21,22)15-9-4-11-2-1-3-12(11)10-15/h4-10H,1-3H2,(H2,18,19,20) D0I3VP DRUGINKE JQJSFAJISYZPER-UHFFFAOYSA-N D0I3VP DRUGSMIL C1CC2=C(C1)C=C(C=C2)S(=O)(=O)NC(=O)NC3=CC=C(C=C3)Cl D0I3VP HIGHSTAT Discontinued in Phase 1 D0I5PM DRUG__ID D0I5PM D0I5PM DRUGCOMP Pharmacopeia Inc D0I5PM DRUGINCH 1S/C31H35Cl2N3O6.Na/c1-35-16-24(23-5-3-4-6-28(23)35)30(38)34-27-14-25(32)19(11-26(27)33)12-29(37)36-15-22(41-2)13-20(36)17-42-21-9-7-18(8-10-21)31(39)40;/h3-6,11,14,16,18,20-22H,7-10,12-13,15,17H2,1-2H3,(H,34,38)(H,39,40);/q;+1/p-1/t18?,20-,21?,22-;/m0./s1 D0I5PM DRUGINKE YWWOTADRIASLGN-VMAKYHEJSA-M D0I5PM DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)NC3=C(C=C(C(=C3)Cl)CC(=O)N4CC(CC4COC5CCC(CC5)C(=O)[O-])OC)Cl.[Na+] D0I5PM HIGHSTAT Discontinued in Phase 1 D0IE4H DRUG__ID D0IE4H D0IE4H DRUGTYPE Small molecular drug D0IE4H DRUGINCH 1S/C14H23N3S2/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3 D0IE4H DRUGINKE XUHMGFKQBWZWPO-UHFFFAOYSA-N D0IE4H DRUGSMIL CCCCCCSC1=NSN=C1C2=CCCN(C2)C D0IE4H HIGHSTAT Discontinued in Phase 1 D0II5S DRUG__ID D0II5S D0II5S DRUGTYPE Small molecular drug D0II5S DRUGINCH 1S/C25H36N8O7.CH4O3S/c1-3-16-24(40)33(2)18(8-5-9-28-25(26)27)23(39)30-13-19(34)31-17(11-20(35)36)22(38)29-12-14-6-4-7-15(10-14)21(37)32-16;1-5(2,3)4/h4,6-7,10,16-18H,3,5,8-9,11-13H2,1-2H3,(H,29,38)(H,30,39)(H,31,34)(H,32,37)(H,35,36)(H4,26,27,28);1H3,(H,2,3,4)/t16-,17+,18+;/m1./s1 D0II5S DRUGINKE CSRWGJAILKTYLJ-PWGAQZMISA-N D0II5S DRUGSMIL CCC1C(=O)N(C(C(=O)NCC(=O)NC(C(=O)NCC2=CC(=CC=C2)C(=O)N1)CC(=O)O)CCCN=C(N)N)C.CS(=O)(=O)O D0II5S HIGHSTAT Discontinued in Phase 1 D0JN3M DRUG__ID D0JN3M D0JN3M DRUGTYPE Small molecular drug D0JN3M DRUGINCH 1S/C14H15ClN2O3/c1-19-16-9-11-3-2-8-17(10-11)14(18)20-13-6-4-12(15)5-7-13/h3-7,9H,2,8,10H2,1H3/b16-9+ D0JN3M DRUGINKE CTVQNEVLCGSTKL-CXUHLZMHSA-N D0JN3M DRUGSMIL CON=CC1=CCCN(C1)C(=O)OC2=CC=C(C=C2)Cl D0JN3M HIGHSTAT Discontinued in Phase 1 D0K0NP DRUG__ID D0K0NP D0K0NP DRUGTYPE Small molecular drug D0K0NP DRUGINCH 1S/C20H24N6O7S/c1-10-18(11(2)32-24-10)34(30,31)26-16(20(28)29)9-23-17(27)8-14-7-15(25-33-14)12-3-5-13(6-4-12)19(21)22/h3-6,14,16,26H,7-9H2,1-2H3,(H3,21,22)(H,23,27)(H,28,29)/t14-,16+/m1/s1 D0K0NP DRUGINKE XKFYFSNOQRUIAO-ZBFHGGJFSA-N D0K0NP DRUGSMIL CC1=C(C(=NO1)C)S(=O)(=O)NC(CNC(=O)CC2CC(=NO2)C3=CC=C(C=C3)C(=N)N)C(=O)O D0K0NP HIGHSTAT Discontinued in Phase 1 D0K7TX DRUG__ID D0K7TX D0K7TX DRUGTYPE Small molecular drug D0K7TX DRUGINCH 1S/C31H48N2O5.C4H4O4/c1-4-6-7-8-9-13-21-38-31(36)28-22-25-17-14-18-27(25)33(28)29(34)23(3)32-26(30(35)37-5-2)20-19-24-15-11-10-12-16-24;5-3(6)1-2-4(7)8/h10-12,15-16,23,25-28,32H,4-9,13-14,17-22H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t23-,25-,26-,27-,28-;/m0./s1 D0K7TX DRUGINKE RCEDCOCCCMIKCY-ZVCJTHDASA-N D0K7TX DRUGSMIL CCCCCCCCOC(=O)C1CC2CCCC2N1C(=O)C(C)NC(CCC3=CC=CC=C3)C(=O)OCC.C(=CC(=O)O)C(=O)O D0K7TX HIGHSTAT Discontinued in Phase 1 D0K8HF DRUG__ID D0K8HF D0K8HF DRUGTYPE Small molecular drug D0K8HF DRUGINCH 1S/C10H17N.2C2H4O2.2ClH.H3N.Pt/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;2*1-2(3)4;;;;/h7-9H,1-6,11H2;2*1H3,(H,3,4);2*1H;1H3;/q;;;;;;+4/p-4 D0K8HF DRUGINKE RGCIZXNKLJAKIS-UHFFFAOYSA-J D0K8HF DRUGSMIL CC(=O)[O-].CC(=O)[O-].C1C2CC3CC1CC(C2)(C3)N.N.[Cl-].[Cl-].[Pt+4] D0K8HF HIGHSTAT Discontinued in Phase 1 D0L3EW DRUG__ID D0L3EW D0L3EW DRUGCOMP Zeneca Group plc D0L3EW DRUGINCH 1S/C25H25N5O.ClH/c1-2-19-15-24(22-9-5-6-10-23(22)26-19)31-16-17-11-13-18(14-12-17)20-7-3-4-8-21(20)25-27-29-30-28-25;/h3-4,7-8,11-15H,2,5-6,9-10,16H2,1H3,(H,27,28,29,30);1H D0L3EW DRUGINKE RPRNBLHRKYAXSM-UHFFFAOYSA-N D0L3EW DRUGSMIL CCC1=CC(=C2CCCCC2=N1)OCC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5.Cl D0L3EW HIGHSTAT Discontinued in Phase 1 D0L5KF DRUG__ID D0L5KF D0L5KF DRUGTYPE Small molecular drug D0L5KF DRUGINCH 1S/C17H18F3N3O3/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3 D0L5KF DRUGINKE ARBYGDBJECGMGA-UHFFFAOYSA-N D0L5KF DRUGSMIL CC1(C(=O)N(C(=O)N1CCCCO)C2=CC(=C(C=C2)C#N)C(F)(F)F)C D0L5KF HIGHSTAT Discontinued in Phase 1 D0L8EQ DRUG__ID D0L8EQ D0L8EQ DRUGCOMP Cubist Pharmaceuticals Inc D0L8EQ DRUGINCH 1S/C54H86ClN17O13/c1-28(2)26-40-50(81)64-34(14-20-56)44(75)63-37(17-23-59)48(79)71-42(29(3)73)52(83)61-25-19-39(47(78)62-35(15-21-57)46(77)68-41(51(82)67-40)27-31-10-6-5-7-11-31)65-45(76)36(16-22-58)66-53(84)43(30(4)74)72-49(80)38(18-24-60)70-54(85)69-33-13-9-8-12-32(33)55/h5-13,28-30,34-43,73-74H,14-27,56-60H2,1-4H3,(H,61,83)(H,62,78)(H,63,75)(H,64,81)(H,65,76)(H,66,84)(H,67,82)(H,68,77)(H,71,79)(H,72,80)(H2,69,70,85)/t29-,30-,34+,35+,36+,37+,38+,39+,40+,41+,42+,43+/m1/s1 D0L8EQ DRUGINKE OINMSSZOBLWDTB-SHGLBBHXSA-N D0L8EQ DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CCN)NC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)NC3=CC=CC=C3Cl)C(C)O)CCN)CCN D0L8EQ HIGHSTAT Discontinued in Phase 1 D0L9PF DRUG__ID D0L9PF D0L9PF DRUGTYPE Small molecular drug D0L9PF DRUGINCH 1S/C12H13N3S2/c16-11(15-12-14-8-9-17-12)13-7-6-10-4-2-1-3-5-10/h1-5,8-9H,6-7H2,(H2,13,14,15,16) D0L9PF DRUGINKE ANUSGJXVCFPWMQ-UHFFFAOYSA-N D0L9PF DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC=CS2 D0L9PF HIGHSTAT Discontinued in Phase 1 D0L9PY DRUG__ID D0L9PY D0L9PY DRUGTYPE Small molecular drug D0L9PY DRUGINCH 1S/C13H20N6S/c1-3-4-5-6-15-12(14)19-13-18-11(8-20-13)10-7-16-9(2)17-10/h7-8H,3-6H2,1-2H3,(H,16,17)(H3,14,15,18,19) D0L9PY DRUGINKE OZSXWXGDJLBJQO-UHFFFAOYSA-N D0L9PY DRUGSMIL CCCCCN=C(N)NC1=NC(=CS1)C2=CN=C(N2)C D0L9PY HIGHSTAT Discontinued in Phase 1 D0M0KB DRUG__ID D0M0KB D0M0KB DRUGCOMP Vertex Pharmaceuticals Inc D0M0KB DRUGINCH 1S/C25H26ClF2N7O2/c1-14-8-21(33-32-14)29-20-10-22(35-12-25(28,13-35)15-2-3-15)31-24(30-20)37-17-6-7-34(11-17)23(36)18-9-16(26)4-5-19(18)27/h4-5,8-10,15,17H,2-3,6-7,11-13H2,1H3,(H2,29,30,31,32,33)/t17-/m0/s1 D0M0KB DRUGINKE SLUHYAXFRJQTGB-KRWDZBQOSA-N D0M0KB DRUGSMIL CC1=CC(=NN1)NC2=CC(=NC(=N2)OC3CCN(C3)C(=O)C4=C(C=CC(=C4)Cl)F)N5CC(C5)(C6CC6)F D0M0KB HIGHSTAT Discontinued in Phase 1 D0MC3R DRUG__ID D0MC3R D0MC3R DRUGTYPE Small molecular drug D0MC3R DRUGINCH 1S/C40H39F5N4O3/c1-52-23-22-47-20-17-32(18-21-47)48(25-27-7-9-28(10-8-27)29-11-14-31(15-12-29)40(43,44)45)37(51)26-49-33(16-13-30-4-2-6-35(41)38(30)42)24-36(50)34-5-3-19-46-39(34)49/h2-12,14-15,19,24,32H,13,16-18,20-23,25-26H2,1H3 D0MC3R DRUGINKE OBJKLVFDRLAGJI-UHFFFAOYSA-N D0MC3R DRUGSMIL COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C(=CC(=O)C5=C4N=CC=C5)CCC6=C(C(=CC=C6)F)F D0MC3R HIGHSTAT Discontinued in Phase 1 D0MF7U DRUG__ID D0MF7U D0MF7U DRUGTYPE Small molecular drug D0MF7U DRUGINCH 1S/C28H34FN3O5.Na/c1-17(2)26-24(13-12-22(33)14-23(34)15-25(35)36)32(21-10-8-20(29)9-11-21)31-27(26)28(37)30-16-19-6-4-18(3)5-7-19;/h4-11,17,22-23,33-34H,12-16H2,1-3H3,(H,30,37)(H,35,36);/q;+1/p-1/t22-,23-;/m1./s1 D0MF7U DRUGINKE VEGKDAAILHTMLD-OHIDFYLOSA-M D0MF7U DRUGSMIL CC1=CC=C(C=C1)CNC(=O)C2=NN(C(=C2C(C)C)CCC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+] D0MF7U HIGHSTAT Discontinued in Phase 1 D0N3ZY DRUG__ID D0N3ZY D0N3ZY DRUGTYPE Small molecular drug D0N3ZY DRUGINCH 1S/C35H48FN5O5S/c1-24(2)22-41(47(45,46)29-16-10-15-28(37)19-29)23-31(42)30(18-25-11-7-6-8-12-25)39-34(44)33(35(3,4)5)40-32(43)21-38-20-26-13-9-14-27(36)17-26/h6-17,19,24,30-31,33,38,42H,18,20-23,37H2,1-5H3,(H,39,44)(H,40,43)/t30-,31+,33+/m0/s1 D0N3ZY DRUGINKE PNIFFZXGBAYVMQ-RKKDRKJOSA-N D0N3ZY DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)(C)C)NC(=O)CNCC2=CC(=CC=C2)F)O)S(=O)(=O)C3=CC=CC(=C3)N D0N3ZY HIGHSTAT Discontinued in Phase 1 D0N5SS DRUG__ID D0N5SS D0N5SS DRUGCOMP AstraZeneca D0N5SS DRUGINCH 1S/C25H25Cl2F3N4O4S/c1-16-22(24(35)32-33-12-3-2-4-13-33)31-34(21-10-7-18(26)15-20(21)27)23(16)17-5-8-19(9-6-17)38-39(36,37)14-11-25(28,29)30/h5-10,15H,2-4,11-14H2,1H3,(H,32,35) D0N5SS DRUGINKE AUAVZPQYSXVTLQ-UHFFFAOYSA-N D0N5SS DRUGSMIL CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)OS(=O)(=O)CCC(F)(F)F D0N5SS HIGHSTAT Discontinued in Phase 1 D0P8JX DRUG__ID D0P8JX D0P8JX DRUGTYPE Small molecular drug D0P8JX DRUGINCH 1S/C18H31N3O4/c1-13(11-17(23)24)20-16(22)12-21-10-2-3-15(18(21)25)5-4-14-6-8-19-9-7-14/h13-15,19H,2-12H2,1H3,(H,20,22)(H,23,24)/t13-,15+/m1/s1 D0P8JX DRUGINKE SFFMYDBKYYBJRY-HIFRSBDPSA-N D0P8JX DRUGSMIL CC(CC(=O)O)NC(=O)CN1CCCC(C1=O)CCC2CCNCC2 D0P8JX HIGHSTAT Discontinued in Phase 1 D0P9EL DRUG__ID D0P9EL D0P9EL DRUGTYPE Small molecular drug D0P9EL DRUGINCH 1S/C15H17NO/c1-10-3-5-14-12(9-10)4-6-13-11(2)15(17)7-8-16(13)14/h3,5,9H,4,6-8H2,1-2H3 D0P9EL DRUGINKE SNEPAAKJPPNOQM-UHFFFAOYSA-N D0P9EL DRUGSMIL CC1=CC2=C(C=C1)N3CCC(=O)C(=C3CC2)C D0P9EL HIGHSTAT Discontinued in Phase 1 D0Q5AS DRUG__ID D0Q5AS D0Q5AS DRUGTYPE Small molecular drug D0Q5AS DRUGINCH 1S/C18H15Cl2N3O.CH4O3S/c1-13(16-4-2-3-5-17(16)20)18(24,10-23-12-21-11-22-23)14-6-8-15(19)9-7-14;1-5(2,3)4/h2-9,11-12,24H,1,10H2;1H3,(H,2,3,4) D0Q5AS DRUGINKE YGEWFSCDLQLUFV-UHFFFAOYSA-N D0Q5AS DRUGSMIL CS(=O)(=O)O.C=C(C1=CC=CC=C1Cl)C(CN2C=NC=N2)(C3=CC=C(C=C3)Cl)O D0Q5AS HIGHSTAT Discontinued in Phase 1 D0Q7HO DRUG__ID D0Q7HO D0Q7HO DRUGTYPE Small molecular drug D0Q7HO DRUGINCH 1S/C16H14BrN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20) D0Q7HO DRUGINKE LSPANGZZENHZNJ-UHFFFAOYSA-N D0Q7HO DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OC D0Q7HO HIGHSTAT Discontinued in Phase 1 D0Q9UO DRUG__ID D0Q9UO D0Q9UO DRUGTYPE Small molecular drug D0Q9UO DRUGINCH 1S/C19H31N3O4S/c1-14(2)17-18-15(22(19(17)24)27(3,25)26)9-13-21(18)16(23)8-7-12-20-10-5-4-6-11-20/h7-8,14-15,17-18H,4-6,9-13H2,1-3H3/b8-7+/t15-,17+,18-/m1/s1 D0Q9UO DRUGINKE NDNKNUMSTIMSHQ-URZKGLGPSA-N D0Q9UO DRUGSMIL CC(C)C1C2C(CCN2C(=O)C=CCN3CCCCC3)N(C1=O)S(=O)(=O)C D0Q9UO HIGHSTAT Discontinued in Phase 1 D0QF4Z DRUG__ID D0QF4Z D0QF4Z DRUGTYPE Small molecular drug D0QF4Z DRUGINCH 1S/C17H16FN3/c1-10(2)15-9-16(21-17(19)20-15)13-7-8-14(18)12-6-4-3-5-11(12)13/h3-10H,1-2H3,(H2,19,20,21) D0QF4Z DRUGINKE ZZZQXCUPAJFVBN-UHFFFAOYSA-N D0QF4Z DRUGSMIL CC(C)C1=NC(=NC(=C1)C2=CC=C(C3=CC=CC=C32)F)N D0QF4Z HIGHSTAT Discontinued in Phase 1 D0R0OC DRUG__ID D0R0OC D0R0OC DRUGTYPE Small molecular drug D0R0OC DRUGINCH 1S/C24H32N6O.ClH/c1-2-8-20-19(7-1)21-22(28-9-3-4-10-28)25-24(29-11-5-6-12-29)26-23(21)30(20)14-13-27-15-17-31-18-16-27;/h1-2,7-8H,3-6,9-18H2;1H D0R0OC DRUGINKE OTTSSGXCAVAVKV-UHFFFAOYSA-N D0R0OC DRUGSMIL C1CCN(C1)C2=NC(=NC3=C2C4=CC=CC=C4N3CCN5CCOCC5)N6CCCC6.Cl D0R0OC HIGHSTAT Discontinued in Phase 1 D0R2QB DRUG__ID D0R2QB D0R2QB DRUGCOMP Mitsubishi Tanabe Pharma Development America D0R2QB DRUGINCH 1S/C27H28N4O2.ClH.H2O/c1-28-25(32)17-30-22-10-2-3-11-23(22)31(27(30)33)20-12-14-29(15-13-20)24-16-19-8-4-6-18-7-5-9-21(24)26(18)19;;/h2-11,20,24H,12-17H2,1H3,(H,28,32);1H;1H2/t24-;;/m1../s1 D0R2QB DRUGINKE NZSPJWUQIIWTKM-PPLJNSMQSA-N D0R2QB DRUGSMIL CNC(=O)CN1C2=CC=CC=C2N(C1=O)C3CCN(CC3)C4CC5=CC=CC6=C5C4=CC=C6.O.Cl D0R2QB HIGHSTAT Discontinued in Phase 1 D0R5AU DRUG__ID D0R5AU D0R5AU DRUGTYPE Small molecular drug D0R5AU DRUGINCH 1S/C35H53N3O9/c1-22(2)29(33(41)36-17-18-43-6)38-32(40)25(20-24-15-16-28(44-7)31(46-9)30(24)45-8)21-27(39)26(19-23-13-11-10-12-14-23)37-34(42)47-35(3,4)5/h10-16,22,25-27,29,39H,17-21H2,1-9H3,(H,36,41)(H,37,42)(H,38,40)/t25-,26+,27+,29+/m1/s1 D0R5AU DRUGINKE BEUUJDAEPJZWHM-COROXYKFSA-N D0R5AU DRUGSMIL CC(C)C(C(=O)NCCOC)NC(=O)C(CC1=C(C(=C(C=C1)OC)OC)OC)CC(C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C)O D0R5AU HIGHSTAT Discontinued in Phase 1 D0R5XK DRUG__ID D0R5XK D0R5XK DRUGTYPE Small molecular drug D0R5XK DRUGINCH 1S/C7H11ClN2.ClH/c1-3-2-4(9)10-7-5(3)6(7)8;/h3,5-7H,2H2,1H3,(H2,9,10);1H/t3-,5-,6+,7-;/m0./s1 D0R5XK DRUGINKE IZIZKGZAEABSET-IEUZAGAGSA-N D0R5XK DRUGSMIL CC1CC(=NC2C1C2Cl)N.Cl D0R5XK HIGHSTAT Discontinued in Phase 1 D0R7GH DRUG__ID D0R7GH D0R7GH DRUGCOMP Sankyo Co Ltd D0R7GH DRUGINCH 1S/C20H22FN3O/c1-12-8-16(12)10-24-14(3)13(2)18-9-22-23-20(19(18)24)25-11-15-4-6-17(21)7-5-15/h4-7,9,12,16H,8,10-11H2,1-3H3/t12-,16+/m0/s1 D0R7GH DRUGINKE NXPLYKRKIFPEOA-BLLLJJGKSA-N D0R7GH DRUGSMIL CC1CC1CN2C(=C(C3=CN=NC(=C32)OCC4=CC=C(C=C4)F)C)C D0R7GH HIGHSTAT Discontinued in Phase 1 D0S0XS DRUG__ID D0S0XS D0S0XS DRUGTYPE Small molecular drug D0S0XS DRUGINCH 1S/C22H27N3O3S/c1-4-25(5-2)11-10-24-18-8-6-15(13-23-14-26)22-20(18)21(27)17-12-16(28-3)7-9-19(17)29-22/h6-9,12,14,24H,4-5,10-11,13H2,1-3H3,(H,23,26) D0S0XS DRUGINKE GWLFIMOOGVXSMZ-UHFFFAOYSA-N D0S0XS DRUGSMIL CCN(CC)CCNC1=C2C(=C(C=C1)CNC=O)SC3=C(C2=O)C=C(C=C3)OC D0S0XS HIGHSTAT Discontinued in Phase 1 D0S6AQ DRUG__ID D0S6AQ D0S6AQ DRUGCOMP Aventis Pharma AG D0S6AQ DRUGINCH 1S/C74H95ClN16O18/c1-38(2)29-52(63(98)82-51(15-9-27-79-73(76)77)71(106)91-28-10-16-59(91)70(105)89-90-74(78)107)83-69(104)58(37-108-72-62(97)61(96)60(95)39(3)109-72)88-66(101)55(32-42-20-25-48(94)26-21-42)85-68(103)57(36-92)87-67(102)56(34-46-35-80-50-14-8-7-13-49(46)50)86-65(100)54(31-41-18-23-47(75)24-19-41)84-64(99)53(81-40(4)93)33-43-17-22-44-11-5-6-12-45(44)30-43/h5-8,11-14,17-26,30,35,38-39,51-62,72,80,92,94-97H,9-10,15-16,27-29,31-34,36-37H2,1-4H3,(H,81,93)(H,82,98)(H,83,104)(H,84,99)(H,85,103)(H,86,100)(H,87,102)(H,88,101)(H,89,105)(H4,76,77,79)(H3,78,90,107)/t39-,51-,52-,53+,54+,55-,56+,57-,58+,59-,60-,61+,62+,72+/m0/s1 D0S6AQ DRUGINKE WDYSQADGBBEGRQ-APSDYLPASA-N D0S6AQ DRUGSMIL CC1C(C(C(C(O1)OCC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)N2CCCC2C(=O)NNC(=O)N)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CO)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C)O)O)O D0S6AQ HIGHSTAT Discontinued in Phase 1 D0S7UU DRUG__ID D0S7UU D0S7UU DRUGCOMP PharmacoFore Inc D0S7UU DRUGINCH 1S/C14H14N4O2S/c1-10-8-17-21(19,20)18(9-10)12-2-3-13-11(6-12)4-5-16-14(13)7-15/h2-6,10,17H,8-9H2,1H3/t10-/m1/s1 D0S7UU DRUGINKE ZKAVFOXYJCREBQ-SNVBAGLBSA-N D0S7UU DRUGSMIL CC1CNS(=O)(=O)N(C1)C2=CC3=C(C=C2)C(=NC=C3)C#N D0S7UU HIGHSTAT Discontinued in Phase 1 D0S7VZ DRUG__ID D0S7VZ D0S7VZ DRUGTYPE Small molecular drug D0S7VZ DRUGINCH 1S/C20H27N3O3/c1-23-15-8-9-16(23)11-14(10-15)21-20(25)22-19(24)17-4-2-3-5-18(17)26-12-13-6-7-13/h2-5,13-16H,6-12H2,1H3,(H2,21,22,24,25)/t14?,15-,16+ D0S7VZ DRUGINKE VFRIHPWRNNTKEX-MQVJKMGUSA-N D0S7VZ DRUGSMIL CN1C2CCC1CC(C2)NC(=O)NC(=O)C3=CC=CC=C3OCC4CC4 D0S7VZ HIGHSTAT Discontinued in Phase 1 D0T1GV DRUG__ID D0T1GV D0T1GV DRUGTYPE Small molecular drug D0T1GV DRUGINCH 1S/C13H11ClN4/c14-11-1-3-12(4-2-11)18-13(9-16-17-18)10-5-7-15-8-6-10/h1-8,13H,9H2 D0T1GV DRUGINKE VVRREURVTJNTQQ-UHFFFAOYSA-N D0T1GV DRUGSMIL C1C(N(N=N1)C2=CC=C(C=C2)Cl)C3=CC=NC=C3 D0T1GV HIGHSTAT Discontinued in Phase 1 D0T2MN DRUG__ID D0T2MN D0T2MN DRUGTYPE Small molecular drug D0T2MN DRUGINCH 1S/C19H30N2O3S/c22-11-13-25-16-19(23)20-8-5-12-24-18-7-4-6-17(14-18)15-21-9-2-1-3-10-21/h4,6-7,14,22H,1-3,5,8-13,15-16H2,(H,20,23) D0T2MN DRUGINKE ZRVDLLKTYZXNAD-UHFFFAOYSA-N D0T2MN DRUGSMIL C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CSCCO D0T2MN HIGHSTAT Discontinued in Phase 1 D0T6PV DRUG__ID D0T6PV D0T6PV DRUGTYPE Small molecular drug D0T6PV DRUGINCH 1S/C20H22FN3O4/c1-10-8-28-18-15-11(17(25)12(19(26)27)6-24(10)15)5-13(21)16(18)23-7-14(22)20(9-23)3-2-4-20/h5-6,10,14H,2-4,7-9,22H2,1H3,(H,26,27)/t10-,14+/m0/s1 D0T6PV DRUGINKE UGGPRXAHUOKTKV-IINYFYTJSA-N D0T6PV DRUGSMIL CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CC(C5(C4)CCC5)N)F)C(=O)O D0T6PV HIGHSTAT Discontinued in Phase 1 D0T8VV DRUG__ID D0T8VV D0T8VV DRUGTYPE Small molecular drug D0T8VV DRUGINCH 1S/C19H31NO2/c1-3-4-5-6-7-8-9-10-11-12-18(20-22)17-15-16(2)13-14-19(17)21/h13-15,21-22H,3-12H2,1-2H3/b20-18- D0T8VV DRUGINKE OOXQDZTUGOJLHK-ZZEZOPTASA-N D0T8VV DRUGSMIL CCCCCCCCCCCC(=NO)C1=C(C=CC(=C1)C)O D0T8VV HIGHSTAT Discontinued in Phase 1 D0TY6Y DRUG__ID D0TY6Y D0TY6Y DRUGCOMP AVI BioPharma D0TY6Y DRUGINCH 1S/C20H14NO4/c1-21-8-12-5-17-18(24-10-23-17)6-14(12)13-3-2-11-4-16-19(25-9-22-16)7-15(11)20(13)21/h2-8H,9-10H2,1H3/q+1 D0TY6Y DRUGINKE IUMDBPMWPHHBDU-UHFFFAOYSA-N D0TY6Y DRUGSMIL C[N+]1=CC2=CC3=C(C=C2C4=C1C5=CC6=C(C=C5C=C4)OCO6)OCO3 D0TY6Y HIGHSTAT Discontinued in Phase 1 D0U5NY DRUG__ID D0U5NY D0U5NY DRUGCOMP Japan Tobacco Inc D0U5NY DRUGINCH 1S/C25H27F3N4O3/c1-23(2)19(30-18-20(29)31-22(25(26,27)28)32-21(18)35-23)15-3-4-16-14(12-15)7-10-24(16)8-5-13(6-9-24)11-17(33)34/h3-4,12-13H,5-11H2,1-2H3,(H,33,34)(H2,29,31,32) D0U5NY DRUGINKE YFJNLPDVCDNOMJ-UHFFFAOYSA-N D0U5NY DRUGSMIL CC1(C(=NC2=C(N=C(N=C2O1)C(F)(F)F)N)C3=CC4=C(C=C3)C5(CCC(CC5)CC(=O)O)CC4)C D0U5NY HIGHSTAT Discontinued in Phase 1 D0U7VZ DRUG__ID D0U7VZ D0U7VZ DRUGCOMP Theravance D0U7VZ DRUGINCH 1S/C26H38N6O2/c1-18(2)32-24-7-5-4-6-23(24)25(28-32)26(34)27-20-16-21-8-9-22(17-20)31(21)15-12-29-10-13-30(14-11-29)19(3)33/h4-7,18,20-22H,8-17H2,1-3H3,(H,27,34)/t20?,21-,22+ D0U7VZ DRUGINKE ZQMXTDPQEHZTBG-FRIKZZABSA-N D0U7VZ DRUGSMIL CC(C)N1C2=CC=CC=C2C(=N1)C(=O)NC3CC4CCC(C3)N4CCN5CCN(CC5)C(=O)C D0U7VZ HIGHSTAT Discontinued in Phase 1 D0U8AR DRUG__ID D0U8AR D0U8AR DRUGTYPE Small molecular drug D0U8AR DRUGINCH 1S/C31H37N5O3/c1-2-3-16-35-26(18-21-10-6-4-7-11-21)28(37)29(38)27(19-22-12-8-5-9-13-22)36(31(35)39)20-23-14-15-25-24(17-23)30(32)34-33-25/h4-15,17,26-29,37-38H,2-3,16,18-20H2,1H3,(H3,32,33,34)/t26-,27-,28+,29+/m1/s1 D0U8AR DRUGINKE CGEJBZXGNPASAG-GKQHHHCTSA-N D0U8AR DRUGSMIL CCCCN1C(C(C(C(N(C1=O)CC2=CC3=C(C=C2)NN=C3N)CC4=CC=CC=C4)O)O)CC5=CC=CC=C5 D0U8AR HIGHSTAT Discontinued in Phase 1 D0UZ1I DRUG__ID D0UZ1I D0UZ1I DRUGTYPE Small molecular drug D0UZ1I DRUGINCH 1S/C22H23N3O2/c1-15(26)24-19-5-2-16(3-6-19)8-9-25-12-18-14-27-22-7-4-17(11-23)10-20(22)21(18)13-25/h2-7,10,18,21H,8-9,12-14H2,1H3,(H,24,26)/t18-,21+/m0/s1 D0UZ1I DRUGINKE ZDZWIQDJFWTDAM-GHTZIAJQSA-N D0UZ1I DRUGSMIL CC(=O)NC1=CC=C(C=C1)CCN2CC3COC4=C(C3C2)C=C(C=C4)C#N D0UZ1I HIGHSTAT Discontinued in Phase 1 D0V6HS DRUG__ID D0V6HS D0V6HS DRUGTYPE Small molecular drug D0V6HS DRUGINCH 1S/C16H20ClN3S/c1-10(2)4-5-19-9-12-6-13(17)7-14-15(12)20(8-11(19)3)16(21)18-14/h4,6-7,11H,5,8-9H2,1-3H3,(H,18,21)/t11-/m0/s1 D0V6HS DRUGINKE RCSLUNOLLUVOOG-NSHDSACASA-N D0V6HS DRUGSMIL CC1CN2C3=C(CN1CC=C(C)C)C=C(C=C3NC2=S)Cl D0V6HS HIGHSTAT Discontinued in Phase 1 D0V7XC DRUG__ID D0V7XC D0V7XC DRUGCOMP Roche Holding AG D0V7XC DRUGINCH 1S/C13H21N5O6.ClH/c1-5(2)7(14)13(22)23-3-6-8(19)9(20)12(24-6)18-4-16-11(17-18)10(15)21;/h4-9,12,19-20H,3,14H2,1-2H3,(H2,15,21);1H/t6-,7-,8-,9-,12-;/m0./s1 D0V7XC DRUGINKE BZAMJGAXDMZZKX-JSNLFJDGSA-N D0V7XC DRUGSMIL CC(C)C(C(=O)OCC1C(C(C(O1)N2C=NC(=N2)C(=O)N)O)O)N.Cl D0V7XC HIGHSTAT Discontinued in Phase 1 D0VP2T DRUG__ID D0VP2T D0VP2T DRUGTYPE Small molecular drug D0VP2T DRUGINCH 1S/C8H10F2N4O4/c9-8(10,6(16)11-2-4-15)5-13-3-1-12-7(13)14(17)18/h1,3,15H,2,4-5H2,(H,11,16) D0VP2T DRUGINKE VOXUFOPZGRTSJY-UHFFFAOYSA-N D0VP2T DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])CC(C(=O)NCCO)(F)F D0VP2T HIGHSTAT Discontinued in Phase 1 D0VR5T DRUG__ID D0VR5T D0VR5T DRUGTYPE Small molecular drug D0VR5T DRUGINCH 1S/C17H40N4/c1-3-18-14-10-16-20-12-8-6-5-7-9-13-21-17-11-15-19-4-2/h18-21H,3-17H2,1-2H3 D0VR5T DRUGINKE WIOJAQYPAPCEMC-UHFFFAOYSA-N D0VR5T DRUGSMIL CCNCCCNCCCCCCCNCCCNCC D0VR5T HIGHSTAT Discontinued in Phase 1 D0W0AM DRUG__ID D0W0AM D0W0AM DRUGTYPE Small molecular drug D0W0AM DRUGINCH 1S/C19H19FN4/c20-16-3-1-14(2-4-16)18-19(15-5-9-21-10-6-15)24(13-23-18)17-7-11-22-12-8-17/h1-6,9-10,13,17,22H,7-8,11-12H2 D0W0AM DRUGINKE QBACMJFLMUCPNA-UHFFFAOYSA-N D0W0AM DRUGSMIL C1CNCCC1N2C=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F D0W0AM HIGHSTAT Discontinued in Phase 1 D0W0TH DRUG__ID D0W0TH D0W0TH DRUGTYPE Small molecular drug D0W0TH DRUGINCH 1S/C26H29N5O3/c1-30(21-10-6-3-7-11-21)24(33)17-34-29-25(18-8-4-2-5-9-18)19-12-13-22-20(14-19)15-31-16-23(32)28-26(31)27-22/h2,4-5,8-9,12-14,21H,3,6-7,10-11,15-17H2,1H3,(H,27,28,32)/b29-25+ D0W0TH DRUGINKE VHDUUXNHZLBGHQ-XLVZBRSZSA-N D0W0TH DRUGSMIL CN(C1CCCCC1)C(=O)CON=C(C2=CC=CC=C2)C3=CC4=C(C=C3)N=C5NC(=O)CN5C4 D0W0TH HIGHSTAT Discontinued in Phase 1 D0W2PK DRUG__ID D0W2PK D0W2PK DRUGCOMP Adolor Corp; Organon BioSciences D0W2PK DRUGINCH 1S/C19H21NO2/c1-13-6-5-7-14-16-12-20(2)11-10-19(16,21)15-8-3-4-9-17(15)22-18(13)14/h3-9,16,21H,10-12H2,1-2H3/t16-,19-/m0/s1 D0W2PK DRUGINKE RPMDQAYGQBREBS-LPHOPBHVSA-N D0W2PK DRUGSMIL CC1=C2C(=CC=C1)C3CN(CCC3(C4=CC=CC=C4O2)O)C D0W2PK HIGHSTAT Discontinued in Phase 1 D0WY9H DRUG__ID D0WY9H D0WY9H DRUGTYPE Small molecular drug D0WY9H DRUGINCH 1S/C24H32F3N3O5/c1-13(2)18(20(31)24(25,26)27)28-22(33)17-7-6-12-30(17)23(34)19(14(3)4)29-21(32)15-8-10-16(35-5)11-9-15/h8-11,13-14,17-19H,6-7,12H2,1-5H3,(H,28,33)(H,29,32)/t17-,18-,19-/m0/s1 D0WY9H DRUGINKE PNILZVBINXNWHW-FHWLQOOXSA-N D0WY9H DRUGSMIL CC(C)C(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C2=CC=C(C=C2)OC D0WY9H HIGHSTAT Discontinued in Phase 1 D0X5LG DRUG__ID D0X5LG D0X5LG DRUGCOMP Novartis AG D0X5LG DRUGINCH 1S/C27H41NO6S2/c1-15-9-8-10-27(6)21(34-27)12-19(16(2)11-18-14-36-25(28-18)35-7)33-22(30)13-20(29)26(4,5)24(32)17(3)23(15)31/h11,14-15,17,19-21,23,29,31H,8-10,12-13H2,1-7H3/b16-11+/t15-,17+,19-,20-,21-,23-,27+/m0/s1 D0X5LG DRUGINKE FODFUEDBIXOGNY-AKXQMUJXSA-N D0X5LG DRUGSMIL CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)SC)C)C D0X5LG HIGHSTAT Discontinued in Phase 1 D0X8AU DRUG__ID D0X8AU D0X8AU DRUGTYPE Small molecular drug D0X8AU DRUGINCH 1S/C32H37N3O5S/c1-20-11-8-9-14-23(20)18-33-30(39)28-32(3,4)41-19-35(28)31(40)27(37)25(17-22-12-6-5-7-13-22)34-29(38)24-15-10-16-26(36)21(24)2/h5-16,25,27-28,36-37H,17-19H2,1-4H3,(H,33,39)(H,34,38)/t25-,27-,28+/m0/s1 D0X8AU DRUGINKE CUFQBQOBLVLKRF-RZDMPUFOSA-N D0X8AU DRUGSMIL CC1=CC=CC=C1CNC(=O)C2C(SCN2C(=O)C(C(CC3=CC=CC=C3)NC(=O)C4=C(C(=CC=C4)O)C)O)(C)C D0X8AU HIGHSTAT Discontinued in Phase 1 D0XK1F DRUG__ID D0XK1F D0XK1F DRUGTYPE Small molecular drug D0XK1F DRUGINCH 1S/C41H71NO6/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-31-39(43)46-35-38(36-47-41(45)37-30-29-33-42-34-37)48-40(44)32-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h29-30,33-34,38H,3-28,31-32,35-36H2,1-2H3 D0XK1F DRUGINKE HOTHIZPJZICUAJ-UHFFFAOYSA-N D0XK1F DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)C1=CN=CC=C1)OC(=O)CCCCCCCCCCCCCCC D0XK1F HIGHSTAT Discontinued in Phase 1 D0XQ1W DRUG__ID D0XQ1W D0XQ1W DRUGTYPE Small molecular drug D0XQ1W DRUGINCH 1S/C22H23N3.2ClH/c1-4-13-24(14-5-1)19-10-8-17(9-11-19)21-16-18-6-2-3-7-20(18)22-23-12-15-25(21)22;;/h2-3,6-11,16H,1,4-5,12-15H2;2*1H D0XQ1W DRUGINKE BKOQATFPPHQOQH-UHFFFAOYSA-N D0XQ1W DRUGSMIL C1CCN(CC1)C2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35.Cl.Cl D0XQ1W HIGHSTAT Discontinued in Phase 1 D0Y2YV DRUG__ID D0Y2YV D0Y2YV DRUGTYPE Small molecular drug D0Y2YV DRUGINCH 1S/C12H13NO3S2/c13-5-7-1-3-8(4-2-7)18-12-11(16)10(15)9(14)6-17-12/h1-4,9-12,14-16H,6H2/t9-,10+,11-,12+/m1/s1 D0Y2YV DRUGINKE LVFZTPIRDLQIGF-KXNHARMFSA-N D0Y2YV DRUGSMIL C1C(C(C(C(S1)SC2=CC=C(C=C2)C#N)O)O)O D0Y2YV HIGHSTAT Discontinued in Phase 1 D0Y3RN DRUG__ID D0Y3RN D0Y3RN DRUGCOMP Bayer AG D0Y3RN DRUGINCH 1S/C26H30N2O4S/c1-33(30,31)28-26(29)25(20-9-4-2-3-5-10-20)21-13-16-23(17-14-21)32-18-22-15-12-19-8-6-7-11-24(19)27-22/h6-8,11-17,20,25H,2-5,9-10,18H2,1H3,(H,28,29)/t25-/m1/s1 D0Y3RN DRUGINKE YAWBFCPZMALJCE-RUZDIDTESA-N D0Y3RN DRUGSMIL CS(=O)(=O)NC(=O)C(C1CCCCCC1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3 D0Y3RN HIGHSTAT Discontinued in Phase 1 D0Y6HV DRUG__ID D0Y6HV D0Y6HV DRUGTYPE Small molecular drug D0Y6HV DRUGINCH 1S/C22H23N3O4S/c1-13-20(23-24-22(27)30-13)15-6-8-17-14(11-15)5-4-10-25(17)21(26)16-7-9-18(28-2)19(12-16)29-3/h6-9,11-13H,4-5,10H2,1-3H3,(H,24,27) D0Y6HV DRUGINKE IZLRMTJLQCLMKF-UHFFFAOYSA-N D0Y6HV DRUGSMIL CC1C(=NNC(=O)S1)C2=CC3=C(C=C2)N(CCC3)C(=O)C4=CC(=C(C=C4)OC)OC D0Y6HV HIGHSTAT Discontinued in Phase 1 D0YP6F DRUG__ID D0YP6F D0YP6F DRUGCOMP AstraZeneca plc D0YP6F DRUGINCH 1S/C36H39F2N3O7S/c37-25-10-6-23(7-11-25)30(42)21-49-34-33(41(35(34)45)27-14-12-26(38)13-15-27)24-8-16-28(17-9-24)48-20-32(44)39-19-31(43)40-29(36(46)47)18-22-4-2-1-3-5-22/h6-17,22,29-30,33-34,42H,1-5,18-21H2,(H,39,44)(H,40,43)(H,46,47)/t29-,30+,33-,34-/m1/s1 D0YP6F DRUGINKE FNTLQLXIDNNELB-GBWWDHKLSA-N D0YP6F DRUGSMIL C1CCC(CC1)CC(C(=O)O)NC(=O)CNC(=O)COC2=CC=C(C=C2)C3C(C(=O)N3C4=CC=C(C=C4)F)SCC(C5=CC=C(C=C5)F)O D0YP6F HIGHSTAT Discontinued in Phase 1 D0Z2QR DRUG__ID D0Z2QR D0Z2QR DRUGCOMP Daiichi Sankyo D0Z2QR DRUGINCH 1S/C12H16ClNO/c13-11-3-1-10(2-4-11)12(6-8-15)5-7-14-9-12/h1-4,14-15H,5-9H2 D0Z2QR DRUGINKE ILTULPUUFNFODT-UHFFFAOYSA-N D0Z2QR DRUGSMIL C1CNCC1(CCO)C2=CC=C(C=C2)Cl D0Z2QR HIGHSTAT Discontinued in Phase 1 D0Z4QV DRUG__ID D0Z4QV D0Z4QV DRUGTYPE Small molecular drug D0Z4QV DRUGINCH 1S/C17H22FNO.BrH/c18-16-5-3-15(4-6-16)17(20)11-13-7-9-19(10-8-13)12-14-1-2-14;/h3-6,13-14H,1-2,7-12H2;1H D0Z4QV DRUGINKE QLZIAKMYJFJBKA-UHFFFAOYSA-N D0Z4QV DRUGSMIL C1CC1CN2CCC(CC2)CC(=O)C3=CC=C(C=C3)F.Br D0Z4QV HIGHSTAT Discontinued in Phase 1 D0ZA2L DRUG__ID D0ZA2L D0ZA2L DRUGTYPE Small molecular drug D0ZA2L DRUGINCH 1S/C19H29N3O5S.ClH/c1-8-14-13(9(2)23)18(25)22(14)15(19(26)27)17(8)28-11-5-12(21-7-11)16(24)10-3-4-20-6-10;/h8-14,16,20-21,23-24H,3-7H2,1-2H3,(H,26,27);1H/t8-,9-,10-,11+,12+,13-,14-,16-;/m1./s1 D0ZA2L DRUGINKE WRVJTXDJDKITNK-XNGFCKKMSA-N D0ZA2L DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(C4CCNC4)O)C(=O)O)C(C)O.Cl D0ZA2L HIGHSTAT Discontinued in Phase 1 D0ZM2S DRUG__ID D0ZM2S D0ZM2S DRUGCOMP Roche D0ZM2S DRUGINCH 1S/C11H14O/c1-7-5-8(2)11(10(4)12)9(3)6-7/h5-6H,1-4H3 D0ZM2S DRUGINKE XWCIICLTKWRWCI-UHFFFAOYSA-N D0ZM2S DRUGSMIL CC1=CC(=C(C(=C1)C)C(=O)C)C D0ZM2S HIGHSTAT Discontinued in Phase 1 D04DGE DRUG__ID D04DGE D04DGE DRUGINCH 1S/C22H19F3N4O2/c1-14-10-15-7-9-29(19(15)11-18(14)22(23,24)25)21(30)28-16-5-6-20(27-12-16)31-13-17-4-2-3-8-26-17/h2-6,8,10-12H,7,9,13H2,1H3,(H,28,30) D04DGE DRUGINKE KLAHZRONIHBPPB-UHFFFAOYSA-N D04DGE DRUGSMIL CC1=CC2=C(C=C1C(F)(F)F)N(CC2)C(=O)NC3=CN=C(C=C3)OCC4=CC=CC=N4 D04DGE HIGHSTAT Discontinued in Phase 1 D06IYV DRUG__ID D06IYV D06IYV DRUGINCH 1S/C37H35F2N3O4S/c1-22(2)32(43)28-21-42(20-26-29(38)10-7-11-30(26)39)35-31(33(28)44)27(19-41(3)18-23-8-5-4-6-9-23)34(47-35)24-12-14-25(15-13-24)40-36(45)37(46)16-17-37/h4-15,21-22,46H,16-20H2,1-3H3,(H,40,45) D06IYV DRUGINKE NWNSIURBDQNMCZ-UHFFFAOYSA-N D06IYV DRUGSMIL CC(C)C(=O)C1=CN(C2=C(C1=O)C(=C(S2)C3=CC=C(C=C3)NC(=O)C4(CC4)O)CN(C)CC5=CC=CC=C5)CC6=C(C=CC=C6F)F D06IYV HIGHSTAT Discontinued in Phase 1 D06LBV DRUG__ID D06LBV D06LBV DRUGINCH 1S/C17H17ClFN3O3/c1-7-12(20)6-21(7)15-11(19)4-9-14(13(15)18)22(8-2-3-8)5-10(16(9)23)17(24)25/h4-5,7-8,12H,2-3,6,20H2,1H3,(H,24,25)/t7-,12+/m0/s1 D06LBV DRUGINKE FGAPXYWEQVSGDJ-JVXZTZIISA-N D06LBV DRUGSMIL CC1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F)N D06LBV HIGHSTAT Discontinued in Phase 1 D07NGJ DRUG__ID D07NGJ D07NGJ DRUGINCH 1S/C28H27NO7/c1-14(30)34-26-23-21(36-28(3,4)27(26)35-15(2)31)13-20(33-6)22-24(23)29(5)19-12-17-10-8-7-9-16(17)11-18(19)25(22)32/h7-13,26-27H,1-6H3/t26-,27-/m0/s1 D07NGJ DRUGINKE OASYWNFOHKQIGI-SVBPBHIXSA-N D07NGJ DRUGSMIL CC(=O)OC1C(C(OC2=CC(=C3C(=C12)N(C4=CC5=CC=CC=C5C=C4C3=O)C)OC)(C)C)OC(=O)C D07NGJ HIGHSTAT Discontinued in Phase 1 D07RUC DRUG__ID D07RUC D07RUC DRUGINCH 1S/C16H12F5N3O2S/c17-9-1-6-12(13(18)7-9)14-8-15(16(19,20)21)23-24(14)10-2-4-11(5-3-10)27(22,25)26/h1-7,14H,8H2,(H2,22,25,26) D07RUC DRUGINKE ZZMJXWXXMAAPLI-UHFFFAOYSA-N D07RUC DRUGSMIL C1C(N(N=C1C(F)(F)F)C2=CC=C(C=C2)S(=O)(=O)N)C3=C(C=C(C=C3)F)F D07RUC HIGHSTAT Discontinued in Phase 1 D0AP4O DRUG__ID D0AP4O D0AP4O DRUGCOMP Idera Pharmaceuticals D0AP4O THERCLAS Antisense D0AP4O DRUGTYPE Antisense drug D0AP4O HIGHSTAT Discontinued in Phase 1 D0B1PC DRUG__ID D0B1PC D0B1PC DRUGINCH 1S/C64H115N11O14/c1-24-26-27-42(15)54(78)53-58(82)66-44(25-2)59(83)69(17)34-50(77)70(18)46(30-36(3)4)57(81)68-51(40(11)12)63(87)71(19)47(31-37(5)6)56(80)65-43(16)55(79)67-45(35-89-29-28-76)60(84)72(20)48(32-38(7)8)61(85)73(21)49(33-39(9)10)62(86)74(22)52(41(13)14)64(88)75(53)23/h24,26,36-49,51-54,76,78H,25,27-35H2,1-23H3,(H,65,80)(H,66,82)(H,67,79)(H,68,81)/b26-24+/t42-,43+,44+,45-,46+,47+,48+,49+,51+,52+,53+,54-/m1/s1 D0B1PC DRUGINKE XZDDMPMZGYEESG-VNHFGJPGSA-N D0B1PC DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)COCCO)C)CC(C)C)C)C(C)C)CC(C)C)C)C D0B1PC HIGHSTAT Discontinued in Phase 1 D0B6SO DRUG__ID D0B6SO D0B6SO DRUGINCH 1S/C19H25N5O5S2.Na/c1-19(2)14(17(27)28)24-12(25)7-10(16(24)31-19)21-15(26)13(11-8-30-18(20)22-11)23-29-9-5-3-4-6-9;/h8-10,14,16H,3-7H2,1-2H3,(H2,20,22)(H,21,26)(H,27,28);/q;+1/p-1/t10?,14?,16-;/m0./s1 D0B6SO DRUGINKE YNLKSESNCYDAMV-UNXXQQGRSA-M D0B6SO DRUGSMIL CC1(C(N2C(S1)C(CC2=O)NC(=O)C(=NOC3CCCC3)C4=CSC(=N4)N)C(=O)[O-])C.[Na+] D0B6SO HIGHSTAT Discontinued in Phase 1 D0C9AQ DRUG__ID D0C9AQ D0C9AQ DRUGCOMP Migenix D0C9AQ THERCLAS Antisense D0C9AQ DRUGTYPE Antisense drug D0C9AQ HIGHSTAT Discontinued in Phase 1 D0G6UP DRUG__ID D0G6UP D0G6UP DRUGINCH 1S/C27H31N5O5S.CH4O3S/c1-18(28)31-12-10-25(11-13-31)37-24-8-6-23(7-9-24)32(38(35,36)17-26(33)34)16-19-2-3-20-4-5-21(27(29)30)15-22(20)14-19;1-5(2,3)4/h2-9,14-15,25,28H,10-13,16-17H2,1H3,(H3,29,30)(H,33,34);1H3,(H,2,3,4) D0G6UP DRUGINKE YRIFGKTUAWTSFP-UHFFFAOYSA-N D0G6UP DRUGSMIL CC(=N)N1CCC(CC1)OC2=CC=C(C=C2)N(CC3=CC4=C(C=C3)C=CC(=C4)C(=N)N)S(=O)(=O)CC(=O)O.CS(=O)(=O)O D0G6UP HIGHSTAT Discontinued in Phase 1 D0H1PN DRUG__ID D0H1PN D0H1PN DRUGINCH 1S/C20H20N2O8S/c23-13(8-22-20(28)17-6-12-7-21-4-3-16(12)31-17)11-1-2-14(29-9-18(24)25)15(5-11)30-10-19(26)27/h1-2,5-6,21H,3-4,7-10H2,(H,22,28)(H,24,25)(H,26,27) D0H1PN DRUGINKE NCPUFPHVKAPNOO-UHFFFAOYSA-N D0H1PN DRUGSMIL C1CNCC2=C1SC(=C2)C(=O)NCC(=O)C3=CC(=C(C=C3)OCC(=O)O)OCC(=O)O D0H1PN HIGHSTAT Discontinued in Phase 1 D0H2ZQ DRUG__ID D0H2ZQ D0H2ZQ DRUGINCH 1S/C23H37BN6O5/c1-16(31)28-19(14-17-8-3-2-4-9-17)22(33)30(18-10-5-6-11-18)15-21(32)29-20(24(34)35)12-7-13-27-23(25)26/h2-4,8-9,18-20,34-35H,5-7,10-15H2,1H3,(H,28,31)(H,29,32)(H4,25,26,27)/t19-,20+/m1/s1 D0H2ZQ DRUGINKE XSHCQGJMSFRKKN-UXHICEINSA-N D0H2ZQ DRUGSMIL B(C(CCCN=C(N)N)NC(=O)CN(C1CCCC1)C(=O)C(CC2=CC=CC=C2)NC(=O)C)(O)O D0H2ZQ HIGHSTAT Discontinued in Phase 1 D0LR1M DRUG__ID D0LR1M D0LR1M DRUGINCH 1S/C32H42N6O4/c1-31(2,33)29(40)35-26(14-10-13-23-11-6-5-7-12-23)28(39)36-27-21-38(22-34-27)32(3,30(41)37-19-8-9-20-37)24-15-17-25(42-4)18-16-24/h5-7,11-12,15-18,21-22,26H,8-10,13-14,19-20,33H2,1-4H3,(H,35,40)(H,36,39)/t26-,32-/m1/s1 D0LR1M DRUGINKE MJUQKUGRKDKGBY-HVIPQOSHSA-N D0LR1M DRUGSMIL CC(C)(C(=O)NC(CCCC1=CC=CC=C1)C(=O)NC2=CN(C=N2)C(C)(C3=CC=C(C=C3)OC)C(=O)N4CCCC4)N D0LR1M HIGHSTAT Discontinued in Phase 1 D0MT9G DRUG__ID D0MT9G D0MT9G DRUGINCH 1S/C22H26FN5O2/c1-4-8-27(9-5-2)12-16-11-24-21(30-16)20-19-13-26(3)22(29)17-10-15(23)6-7-18(17)28(19)14-25-20/h6-7,10-11,14H,4-5,8-9,12-13H2,1-3H3 D0MT9G DRUGINKE YKKLHEHNUYCLQQ-UHFFFAOYSA-N D0MT9G DRUGSMIL CCCN(CCC)CC1=CN=C(O1)C2=C3CN(C(=O)C4=C(N3C=N2)C=CC(=C4)F)C D0MT9G HIGHSTAT Discontinued in Phase 1 D0N1DQ DRUG__ID D0N1DQ D0N1DQ DRUGINCH 1S/C30H53N2O2.C6H6O3S/c1-23(33)34-30(22-31-18-8-6-7-9-19-31)17-16-28(2)24(21-30)12-13-25-26(28)14-15-29(3)27(25)11-10-20-32(29,4)5;7-10(8,9)6-4-2-1-3-5-6/h24-27H,6-22H2,1-5H3;1-5H,(H,7,8,9)/q+1;/p-1/t24-,25+,26-,27-,28-,29-,30+;/m0./s1 D0N1DQ DRUGINKE MUVZCNJMKMCHMD-IBSDALFFSA-M D0N1DQ DRUGSMIL CC(=O)OC1(CCC2(C(C1)CCC3C2CCC4(C3CCC[N+]4(C)C)C)C)CN5CCCCCC5.C1=CC=C(C=C1)S(=O)(=O)[O-] D0N1DQ HIGHSTAT Discontinued in Phase 1 D0Q8DM DRUG__ID D0Q8DM D0Q8DM DRUGINCH 1S/C49H63F5N12O10/c1-21(2)14-34(49(75)76-7)65-47(73)33(16-26-19-57-20-59-26)63-42(68)23(5)61-48(74)41(22(3)4)66-43(69)24(6)60-46(72)32(15-25-18-58-30-11-9-8-10-27(25)30)64-45(71)31(12-13-35(56)67)62-44(70)29(55)17-28-36(50)38(52)40(54)39(53)37(28)51/h8-11,18-24,29,31-34,41,58H,12-17,55H2,1-7H3,(H2,56,67)(H,57,59)(H,60,72)(H,61,74)(H,62,70)(H,63,68)(H,64,71)(H,65,73)(H,66,69)/t23-,24+,29-,31+,32+,33+,34+,41+/m1/s1 D0Q8DM DRUGINKE ZCTCXFYZJYFGAQ-ZZXDJSGYSA-N D0Q8DM DRUGSMIL CC(C)CC(C(=O)OC)NC(=O)C(CC1=CN=CN1)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=C(C(=C(C(=C4F)F)F)F)F)N D0Q8DM HIGHSTAT Discontinued in Phase 1 D0V8RY DRUG__ID D0V8RY D0V8RY DRUGINCH 1S/C17H18N2O6/c1-17(16-23-7-8-24-16)10-13(18-6-2-3-15(18)20)12-9-11(19(21)22)4-5-14(12)25-17/h4-5,9-10,16H,2-3,6-8H2,1H3/t17-/m1/s1 D0V8RY DRUGINKE NJJPKIPOZSWUHV-QGZVFWFLSA-N D0V8RY DRUGSMIL CC1(C=C(C2=C(O1)C=CC(=C2)[N+](=O)[O-])N3CCCC3=O)C4OCCO4 D0V8RY HIGHSTAT Discontinued in Phase 1 D0YJ9T DRUG__ID D0YJ9T D0YJ9T DRUGINCH 1S/C16H19N3O4S/c1-7-12-11(8(2)20)15(21)19(12)13(16(22)23)14(7)24-9-5-10-17-3-4-18(10)6-9/h3-4,7-9,11-12,20H,5-6H2,1-2H3,(H,22,23)/t7-,8-,9+,11-,12+/m1/s1 D0YJ9T DRUGINKE SYFIHQJVKJGGGB-VZSYODPGSA-N D0YJ9T DRUGSMIL CC1C2C(C(=O)N2C(=C1SC3CC4=NC=CN4C3)C(=O)O)C(C)O D0YJ9T HIGHSTAT Discontinued in Phase 1 D00MMV DRUG__ID D00MMV D00MMV DRUGCOMP Regeneron pharmaceuticals D00MMV DRUGTYPE Monoclonal antibody D00MMV HIGHSTAT Discontinued in Phase 1 D00PNU DRUG__ID D00PNU D00PNU DRUGCOMP TeGenero ImmunoTherapeutics AG D00PNU DRUGTYPE Antibody D00PNU HIGHSTAT Discontinued in Phase 1 D01BUS DRUG__ID D01BUS D01BUS DRUGCOMP MorphoSys AG D01BUS DRUGTYPE Antibody D01BUS HIGHSTAT Discontinued in Phase 1 D01KSL DRUG__ID D01KSL D01KSL THERCLAS Antiviral Agents D01KSL DRUGTYPE Combination drug D01KSL HIGHSTAT Discontinue in Phase 1 Trial D04LPZ DRUG__ID D04LPZ D04LPZ THERCLAS Antiviral Agents D04LPZ DRUGTYPE Polyclonal antibody D04LPZ HIGHSTAT Discontinue in Phase 1 Trial D04MYO DRUG__ID D04MYO D04MYO DRUGCOMP Novartis AG D04MYO DRUGTYPE Antibody D04MYO HIGHSTAT Discontinued in Phase 1 D05CHR DRUG__ID D05CHR D05CHR DRUGCOMP Novartis AG D05CHR DRUGTYPE Antibody D05CHR HIGHSTAT Discontinued in Phase 1 D06CZS DRUG__ID D06CZS D06CZS DRUGCOMP Vernalis D06CZS THERCLAS Antiinflammatory Agents D06CZS HIGHSTAT Discontinued in Phase 1 D06JBA DRUG__ID D06JBA D06JBA DRUGCOMP Kirin Brewery Co Ltd D06JBA DRUGTYPE Antibody D06JBA HIGHSTAT Discontinued in Phase 1 D07JQO DRUG__ID D07JQO D07JQO DRUGCOMP GlaxoSmithKline D07JQO DRUGTYPE Antibody D07JQO HIGHSTAT Discontinued in Phase 1 D07NYF DRUG__ID D07NYF D07NYF DRUGCOMP LeukoSite Inc D07NYF DRUGTYPE Antibody D07NYF HIGHSTAT Discontinued in Phase 1 D07TRV DRUG__ID D07TRV D07TRV DRUGCOMP Celldex Therapeutics Inc D07TRV DRUGTYPE Vaccine D07TRV HIGHSTAT Discontinued in Phase 1 D08WTE DRUG__ID D08WTE D08WTE DRUGCOMP Seattle Genetics D08WTE DRUGTYPE Antibody D08WTE HIGHSTAT Discontinued in Phase 1 D09CKG DRUG__ID D09CKG D09CKG THERCLAS Antiviral Agents D09CKG DRUGTYPE Vaccine D09CKG HIGHSTAT Discontinue in Phase 1 Trial D09CLG DRUG__ID D09CLG D09CLG THERCLAS Antiviral Agents D09CLG DRUGTYPE Vaccine D09CLG HIGHSTAT Discontinue in Phase 1 Trial D09FFI DRUG__ID D09FFI D09FFI THERCLAS Antiviral Agents D09FFI DRUGTYPE Vaccine D09FFI HIGHSTAT Discontinue in Phase 1 Trial D09FGV DRUG__ID D09FGV D09FGV THERCLAS Antiviral Agents D09FGV DRUGTYPE Vaccine D09FGV HIGHSTAT Discontinue in Phase 1 Trial D09YUK DRUG__ID D09YUK D09YUK DRUGCOMP National Cancer Institute D09YUK DRUGTYPE Antibody D09YUK HIGHSTAT Discontinued in Phase 1 D0A2NH DRUG__ID D0A2NH D0A2NH DRUGCOMP Biogen Idec D0A2NH DRUGTYPE Antibody D0A2NH HIGHSTAT Discontinued in Phase 1 D0B7PY DRUG__ID D0B7PY D0B7PY DRUGCOMP United Biomedical Inc D0B7PY DRUGTYPE Vaccine D0B7PY HIGHSTAT Discontinued in Phase 1 D0C1NZ DRUG__ID D0C1NZ D0C1NZ THERCLAS Antiviral Agents D0C1NZ DRUGTYPE Monoclonal antibody D0C1NZ HIGHSTAT Discontinue in Phase 1 Trial D0C4AY DRUG__ID D0C4AY D0C4AY THERCLAS Antiviral Agents D0C4AY DRUGTYPE Monoclonal antibody D0C4AY HIGHSTAT Discontinue in Phase 1 Trial D0DC1I DRUG__ID D0DC1I D0DC1I DRUGCOMP ARIUS Research Inc D0DC1I DRUGTYPE Antibody D0DC1I HIGHSTAT Discontinued in Phase 1 D0G7YG DRUG__ID D0G7YG D0G7YG DRUGCOMP Abgenix Inc D0G7YG DRUGTYPE Antibody D0G7YG HIGHSTAT Discontinued in Phase 1 D0G9ZJ DRUG__ID D0G9ZJ D0G9ZJ DRUGCOMP Genentech D0G9ZJ DRUGTYPE Antibody D0G9ZJ HIGHSTAT Discontinued in Phase 1 D0J5XZ DRUG__ID D0J5XZ D0J5XZ DRUGCOMP Indevus Pharmaceuticals D0J5XZ DRUGTYPE Antibody D0J5XZ HIGHSTAT Discontinued in Phase 1 D0J8JF DRUG__ID D0J8JF D0J8JF DRUGCOMP Roche Holding AG D0J8JF DRUGTYPE Antibody D0J8JF HIGHSTAT Discontinued in Phase 1 D0K4OL DRUG__ID D0K4OL D0K4OL DRUGCOMP Lorus Therapeutics Inc D0K4OL DRUGTYPE Antisense drug D0K4OL HIGHSTAT Discontinued in Phase 1 D0P0QG DRUG__ID D0P0QG D0P0QG DRUGCOMP Toagosei Co Ltd D0P0QG DRUGTYPE Antibody D0P0QG HIGHSTAT Discontinued in Phase 1 D0U6KH DRUG__ID D0U6KH D0U6KH DRUGCOMP Pfizer D0U6KH DRUGTYPE Monoclonal antibody D0U6KH HIGHSTAT Discontinued in Phase 1 D0W5XT DRUG__ID D0W5XT D0W5XT DRUGCOMP Archemix; Archemix Corp D0W5XT DRUGTYPE Aptamer D0W5XT HIGHSTAT Discontinued in Phase 1 DFU4B0 DRUG__ID DFU4B0 DFU4B0 DRUGCOMP Roche DFU4B0 DRUGTYPE Antibody DFU4B0 HIGHSTAT Discontinued in Phase 1 D00ABW DRUG__ID D00ABW D00ABW DRUGCOMP MacroChem Corporation D00ABW HIGHSTAT Discontinued in Phase 1 D00BKV DRUG__ID D00BKV D00BKV DRUGCOMP Asahi Kasei Pharma D00BKV HIGHSTAT Discontinued in Phase 1 D00CVT DRUG__ID D00CVT D00CVT DRUGCOMP Theravance Inc D00CVT HIGHSTAT Discontinued in Phase 1 D00EEP DRUG__ID D00EEP D00EEP DRUGCOMP Teikoku Chemical Industries Co Ltd D00EEP HIGHSTAT Discontinued in Phase 1 D00FGY DRUG__ID D00FGY D00FGY DRUGCOMP Pfizer Inc D00FGY HIGHSTAT Discontinued in Phase 1 D00HIC DRUG__ID D00HIC D00HIC DRUGCOMP Provalis plc D00HIC HIGHSTAT Discontinued in Phase 1 D00HMQ DRUG__ID D00HMQ D00HMQ DRUGCOMP Pharmacia & Upjohn Co D00HMQ HIGHSTAT Discontinued in Phase 1 D00RIB DRUG__ID D00RIB D00RIB DRUGCOMP Questcor Pharmaceuticals Inc D00RIB HIGHSTAT Discontinued in Phase 1 D00RXR DRUG__ID D00RXR D00RXR DRUGCOMP Amylin Pharmaceuticals Inc D00RXR HIGHSTAT Discontinued in Phase 1 D00TAP DRUG__ID D00TAP D00TAP DRUGCOMP BioPort Corporation D00TAP HIGHSTAT Discontinued in Phase 1 D00UOZ DRUG__ID D00UOZ D00UOZ DRUGCOMP MedImmune D00UOZ HIGHSTAT Discontinued in Phase 1 D00VPU DRUG__ID D00VPU D00VPU DRUGCOMP Solvay D00VPU HIGHSTAT Discontinued in Phase 1 D00XZP DRUG__ID D00XZP D00XZP DRUGCOMP Grupo Uriach D00XZP HIGHSTAT Discontinued in Phase 1 D00YZP DRUG__ID D00YZP D00YZP DRUGCOMP Emergent Europe Ltd D00YZP HIGHSTAT Discontinued in Phase 1 D01CAJ DRUG__ID D01CAJ D01CAJ DRUGCOMP AstraZeneca plc D01CAJ HIGHSTAT Discontinued in Phase 1 D01DOY DRUG__ID D01DOY D01DOY DRUGCOMP Glaxo Group Research Ltd D01DOY HIGHSTAT Discontinued in Phase 1 D01DQR DRUG__ID D01DQR D01DQR DRUGCOMP Alkermes D01DQR HIGHSTAT Discontinued in Phase 1 D01EDO DRUG__ID D01EDO D01EDO DRUGCOMP Glaxo Wellcome plc D01EDO HIGHSTAT Discontinued in Phase 1 D01GTB DRUG__ID D01GTB D01GTB DRUGCOMP AstraZeneca plc D01GTB HIGHSTAT Discontinued in Phase 1 D01JOA DRUG__ID D01JOA D01JOA DRUGCOMP Chiroscience R&D Ltd D01JOA HIGHSTAT Discontinued in Phase 1 D01LQZ DRUG__ID D01LQZ D01LQZ DRUGCOMP Transgene SA D01LQZ HIGHSTAT Discontinued in Phase 1 D01MNV DRUG__ID D01MNV D01MNV DRUGCOMP Ohio State University D01MNV HIGHSTAT Discontinued in Phase 1 D01NGT DRUG__ID D01NGT D01NGT DRUGCOMP Roche Holding AG D01NGT HIGHSTAT Discontinued in Phase 1 D01OWJ DRUG__ID D01OWJ D01OWJ DRUGCOMP Transgene SA; Transgene D01OWJ HIGHSTAT Discontinued in Phase 1 D01OYR DRUG__ID D01OYR D01OYR DRUGCOMP AstraZeneca plc D01OYR HIGHSTAT Discontinued in Phase 1 D01RKY DRUG__ID D01RKY D01RKY DRUGCOMP Novartis AG D01RKY HIGHSTAT Discontinued in Phase 1 D01TYB DRUG__ID D01TYB D01TYB DRUGCOMP Flamel Technologies D01TYB HIGHSTAT Discontinued in Phase 1 D01VCB DRUG__ID D01VCB D01VCB DRUGCOMP Achillion Pharmaceuticals Inc D01VCB HIGHSTAT Discontinued in Phase 1 D01VSK DRUG__ID D01VSK D01VSK DRUGCOMP Tanabe Seiyaku Co Ltd D01VSK HIGHSTAT Discontinued in Phase 1 D02DVB DRUG__ID D02DVB D02DVB DRUGCOMP Roche Holding AG D02DVB HIGHSTAT Discontinued in Phase 1 D02EVT DRUG__ID D02EVT D02EVT DRUGCOMP Sanofi D02EVT HIGHSTAT Discontinued in Phase 1 D02KEY DRUG__ID D02KEY D02KEY DRUGCOMP Speedel Holding AG D02KEY HIGHSTAT Discontinued in Phase 1 D02LCI DRUG__ID D02LCI D02LCI DRUGCOMP Tanabe Seiyaku Co Ltd D02LCI HIGHSTAT Discontinued in Phase 1 D02UQG DRUG__ID D02UQG D02UQG DRUGCOMP Ardea Biosciences Inc D02UQG HIGHSTAT Discontinued in Phase 1 D02YOQ DRUG__ID D02YOQ D02YOQ DRUGCOMP Nucleonics Inc D02YOQ HIGHSTAT Discontinued in Phase 1 D03APL DRUG__ID D03APL D03APL DRUGCOMP Antisoma plc D03APL HIGHSTAT Discontinued in Phase 1 D03BDE DRUG__ID D03BDE D03BDE DRUGCOMP ILEX Oncology Inc D03BDE HIGHSTAT Discontinued in Phase 1 D03CFR DRUG__ID D03CFR D03CFR DRUGCOMP Sunovion Pharmaceuticals Inc D03CFR HIGHSTAT Discontinued in Phase 1 D03CHE DRUG__ID D03CHE D03CHE DRUGCOMP Pfizer Inc D03CHE HIGHSTAT Discontinued in Phase 1 D03EIC DRUG__ID D03EIC D03EIC DRUGCOMP Zeneca Group plc D03EIC HIGHSTAT Discontinued in Phase 1 D03GNR DRUG__ID D03GNR D03GNR DRUGCOMP Anadys Pharmaceuticals Inc D03GNR HIGHSTAT Discontinued in Phase 1 D03JIH DRUG__ID D03JIH D03JIH DRUGCOMP Sanofi-Synthelabo D03JIH HIGHSTAT Discontinued in Phase 1 D03JQR DRUG__ID D03JQR D03JQR DRUGCOMP Hoffmann-La Roche D03JQR HIGHSTAT Discontinued in Phase 1 D03KTK DRUG__ID D03KTK D03KTK DRUGCOMP Takeda Pharmaceutical Co Ltd D03KTK HIGHSTAT Discontinued in Phase 1 D03LSO DRUG__ID D03LSO D03LSO DRUGCOMP Shire plc D03LSO HIGHSTAT Discontinued in Phase 1 D03MGV DRUG__ID D03MGV D03MGV DRUGCOMP Astellas D03MGV HIGHSTAT Discontinued in Phase 1 D03MIP DRUG__ID D03MIP D03MIP DRUGCOMP Sequoia Pharmaceuticals Inc D03MIP HIGHSTAT Discontinued in Phase 1 D03MNS DRUG__ID D03MNS D03MNS DRUGCOMP Adolor Corp D03MNS HIGHSTAT Discontinued in Phase 1 D03SHP DRUG__ID D03SHP D03SHP DRUGCOMP Glaxosmithkline D03SHP HIGHSTAT Discontinued in Phase 1 D03VLS DRUG__ID D03VLS D03VLS DRUGCOMP H Lundbeck A/S D03VLS HIGHSTAT Discontinued in Phase 1 D03WMK DRUG__ID D03WMK D03WMK DRUGCOMP Amylin D03WMK HIGHSTAT Discontinued in Phase 1 D03ZCG DRUG__ID D03ZCG D03ZCG DRUGCOMP Medlmmune LLC D03ZCG HIGHSTAT Discontinued in Phase 1 D03ZHN DRUG__ID D03ZHN D03ZHN DRUGCOMP Sanofi-Synthelabo D03ZHN HIGHSTAT Discontinued in Phase 1 D04FRB DRUG__ID D04FRB D04FRB DRUGCOMP Ciba-Geigy AG D04FRB HIGHSTAT Discontinued in Phase 1 D04FTB DRUG__ID D04FTB D04FTB DRUGCOMP AstraZeneca plc D04FTB HIGHSTAT Discontinued in Phase 1 D04GVN DRUG__ID D04GVN D04GVN DRUGCOMP Pfizer Inc D04GVN HIGHSTAT Discontinued in Phase 1 D04HZX DRUG__ID D04HZX D04HZX DRUGCOMP ChemoCentryx Inc D04HZX HIGHSTAT Discontinued in Phase 1 D04LEK DRUG__ID D04LEK D04LEK DRUGCOMP GSK D04LEK HIGHSTAT Discontinued in Phase 1 D04LSH DRUG__ID D04LSH D04LSH DRUGCOMP Sanofi D04LSH HIGHSTAT Discontinued in Phase 1 D04MRA DRUG__ID D04MRA D04MRA DRUGCOMP Bayer AG D04MRA HIGHSTAT Discontinued in Phase 1 D04NMF DRUG__ID D04NMF D04NMF DRUGCOMP Cantab Biopharmaceuticals Ltd D04NMF HIGHSTAT Discontinued in Phase 1 D04QCY DRUG__ID D04QCY D04QCY DRUGCOMP Burzynski Research Institute D04QCY HIGHSTAT Discontinued in Phase 1 D04TYP DRUG__ID D04TYP D04TYP DRUGCOMP Genentech D04TYP HIGHSTAT Discontinued in Phase 1 D04UHX DRUG__ID D04UHX D04UHX DRUGCOMP Intracel Corp D04UHX HIGHSTAT Discontinued in Phase 1 D04UKJ DRUG__ID D04UKJ D04UKJ DRUGCOMP Noscira SA D04UKJ HIGHSTAT Discontinued in Phase 1 D04VTV DRUG__ID D04VTV D04VTV DRUGCOMP Roche Holding AG D04VTV HIGHSTAT Discontinued in Phase 1 D04VUY DRUG__ID D04VUY D04VUY DRUGCOMP Roche Holding AG D04VUY HIGHSTAT Discontinued in Phase 1 D04XEO DRUG__ID D04XEO D04XEO DRUGCOMP Immusol D04XEO HIGHSTAT Discontinued in Phase 1 D04ZNG DRUG__ID D04ZNG D04ZNG DRUGCOMP Fournier Pharma D04ZNG HIGHSTAT Discontinued in Phase 1 D05AQP DRUG__ID D05AQP D05AQP DRUGCOMP Astellas Pharma Inc D05AQP HIGHSTAT Discontinued in Phase 1 D05CDG DRUG__ID D05CDG D05CDG DRUGCOMP Roche Holding AG D05CDG HIGHSTAT Discontinued in Phase 1 D05JXM DRUG__ID D05JXM D05JXM DRUGCOMP Pfizer Inc D05JXM HIGHSTAT Discontinued in Phase 1 D05KTK DRUG__ID D05KTK D05KTK DRUGCOMP ConjuChem Biotechnologies Inc D05KTK HIGHSTAT Discontinued in Phase 1 D05MXK DRUG__ID D05MXK D05MXK DRUGCOMP Glaxo Wellcome plc D05MXK HIGHSTAT Discontinued in Phase 1 D05NUT DRUG__ID D05NUT D05NUT DRUGCOMP Apollo Life Sciences Pty Ltd D05NUT HIGHSTAT Discontinued in Phase 1 D05PQF DRUG__ID D05PQF D05PQF DRUGCOMP Ono Pharmaceutical Co Ltd D05PQF HIGHSTAT Discontinued in Phase 1 D05WFF DRUG__ID D05WFF D05WFF DRUGCOMP Genencor International Inc D05WFF HIGHSTAT Discontinued in Phase 1 D06AQI DRUG__ID D06AQI D06AQI DRUGCOMP Novo Nordisk D06AQI HIGHSTAT Discontinued in Phase 1 D06BUI DRUG__ID D06BUI D06BUI DRUGCOMP Paracelsian Inc D06BUI HIGHSTAT Discontinued in Phase 1 D06EMW DRUG__ID D06EMW D06EMW DRUGCOMP AstraZeneca D06EMW HIGHSTAT Discontinued in Phase 1 D06GMJ DRUG__ID D06GMJ D06GMJ DRUGCOMP GSK D06GMJ HIGHSTAT Discontinued in Phase 1 D06JVV DRUG__ID D06JVV D06JVV DRUGCOMP Aldagen Durham, NC D06JVV HIGHSTAT Discontinued in Phase 1 D06KEJ DRUG__ID D06KEJ D06KEJ DRUGCOMP GroPep D06KEJ HIGHSTAT Discontinued in Phase 1 D06LEJ DRUG__ID D06LEJ D06LEJ DRUGCOMP H. Lundbeck A/S D06LEJ HIGHSTAT Discontinued in Phase 1 D06MXY DRUG__ID D06MXY D06MXY DRUGCOMP Bioglan Pharmaceuticals Co D06MXY HIGHSTAT Discontinued in Phase 1 D06QAJ DRUG__ID D06QAJ D06QAJ DRUGCOMP Pharmacopeia D06QAJ HIGHSTAT Discontinued in Phase 1 D06QPI DRUG__ID D06QPI D06QPI DRUGCOMP PowderMed D06QPI HIGHSTAT Discontinued in Phase 1 D06UJO DRUG__ID D06UJO D06UJO DRUGCOMP Poniard Pharmaceuticals Inc D06UJO HIGHSTAT Discontinued in Phase 1 D06VOM DRUG__ID D06VOM D06VOM DRUGCOMP Stegram Pharmaceuticals Ltd D06VOM HIGHSTAT Discontinued in Phase 1 D06VPE DRUG__ID D06VPE D06VPE DRUGCOMP H Lundbeck A/S D06VPE HIGHSTAT Discontinued in Phase 1 D06WGQ DRUG__ID D06WGQ D06WGQ DRUGCOMP Vical D06WGQ HIGHSTAT Discontinued in Phase 1 D06WSQ DRUG__ID D06WSQ D06WSQ DRUGCOMP ASTA Medica AG D06WSQ HIGHSTAT Discontinued in Phase 1 D06XSG DRUG__ID D06XSG D06XSG DRUGCOMP AstraZeneca D06XSG HIGHSTAT Discontinued in Phase 1 D06XZM DRUG__ID D06XZM D06XZM DRUGCOMP Grannus BioSciences Ltd D06XZM HIGHSTAT Discontinued in Phase 1 D07CQJ DRUG__ID D07CQJ D07CQJ DRUGCOMP Pierre Fabre SA D07CQJ HIGHSTAT Discontinued in Phase 1 D07EQJ DRUG__ID D07EQJ D07EQJ DRUGCOMP Genentech Inc D07EQJ HIGHSTAT Discontinued in Phase 1 D07GZL DRUG__ID D07GZL D07GZL DRUGCOMP Roche Holding AG D07GZL HIGHSTAT Discontinued in Phase 1 D07IMX DRUG__ID D07IMX D07IMX DRUGCOMP Isis Pharmaceuticals D07IMX HIGHSTAT Discontinued in Phase 1 D07IXD DRUG__ID D07IXD D07IXD DRUGCOMP Pharmacia & Upjohn AB D07IXD HIGHSTAT Discontinued in Phase 1 D07KGW DRUG__ID D07KGW D07KGW DRUGCOMP Pfizer Inc D07KGW HIGHSTAT Discontinued in Phase 1 D07KOR DRUG__ID D07KOR D07KOR DRUGCOMP Targent Inc D07KOR HIGHSTAT Discontinued in Phase 1 D07TTI DRUG__ID D07TTI D07TTI DRUGCOMP AstraZeneca plc D07TTI HIGHSTAT Discontinued in Phase 1 D07TUD DRUG__ID D07TUD D07TUD DRUGCOMP Pfizer Inc D07TUD HIGHSTAT Discontinued in Phase 1 D07VXT DRUG__ID D07VXT D07VXT DRUGCOMP Incyte D07VXT HIGHSTAT Discontinued in Phase 1 D07WSR DRUG__ID D07WSR D07WSR DRUGCOMP Taisho Pharmaceutical Co Ltd D07WSR HIGHSTAT Discontinued in Phase 1 D07YKJ DRUG__ID D07YKJ D07YKJ DRUGCOMP Roche Holding AG D07YKJ HIGHSTAT Discontinued in Phase 1 D07ZXE DRUG__ID D07ZXE D07ZXE DRUGCOMP Jiangsu Institute of Microbiology D07ZXE HIGHSTAT Discontinued in Phase 1 D08CQE DRUG__ID D08CQE D08CQE DRUGCOMP Aventis SA D08CQE HIGHSTAT Discontinued in Phase 1 D08DOQ DRUG__ID D08DOQ D08DOQ DRUGCOMP Igeneon D08DOQ HIGHSTAT Discontinued in Phase 1 D08GKD DRUG__ID D08GKD D08GKD DRUGCOMP AstraZeneca plc D08GKD HIGHSTAT Discontinued in Phase 1 D08HMK DRUG__ID D08HMK D08HMK DRUGCOMP Esperion Therapeutics Inc D08HMK HIGHSTAT Discontinued in Phase 1 D08HVD DRUG__ID D08HVD D08HVD DRUGCOMP Poniard Pharmaceuticals Inc D08HVD HIGHSTAT Discontinued in Phase 1 D08JOE DRUG__ID D08JOE D08JOE DRUGCOMP Anadys Pharmaceutical D08JOE HIGHSTAT Discontinued in Phase 1 D08JTU DRUG__ID D08JTU D08JTU DRUGCOMP Roche Products Ltd D08JTU HIGHSTAT Discontinued in Phase 1 D08KZR DRUG__ID D08KZR D08KZR DRUGCOMP Roche Holding AG D08KZR HIGHSTAT Discontinued in Phase 1 D08LDV DRUG__ID D08LDV D08LDV DRUGCOMP Panacos D08LDV HIGHSTAT Discontinued in Phase 1 D08ORV DRUG__ID D08ORV D08ORV DRUGCOMP AstraZeneca plc D08ORV HIGHSTAT Discontinued in Phase 1 D08PKF DRUG__ID D08PKF D08PKF DRUGCOMP AMAG Pharmaceuticals Inc D08PKF HIGHSTAT Discontinued in Phase 1 D08UNQ DRUG__ID D08UNQ D08UNQ DRUGCOMP NeuroSearch A/S D08UNQ HIGHSTAT Discontinued in Phase 1 D08YFD DRUG__ID D08YFD D08YFD DRUGCOMP Wyeth D08YFD HIGHSTAT Discontinued in Phase 1 D09AYS DRUG__ID D09AYS D09AYS DRUGCOMP Burzynski Research Institute D09AYS HIGHSTAT Discontinued in Phase 1 D09CQB DRUG__ID D09CQB D09CQB DRUGCOMP Chugai Pharmaceutical Co Ltd D09CQB HIGHSTAT Discontinued in Phase 1 D09GAG DRUG__ID D09GAG D09GAG DRUGCOMP Daiichi Seiyaku Co Ltd D09GAG HIGHSTAT Discontinued in Phase 1 D09HAL DRUG__ID D09HAL D09HAL DRUGCOMP Japan Tobacco Inc D09HAL HIGHSTAT Discontinued in Phase 1 D09LEB DRUG__ID D09LEB D09LEB DRUGCOMP Roche D09LEB HIGHSTAT Discontinued in Phase 1 D09MKQ DRUG__ID D09MKQ D09MKQ DRUGCOMP Amgen D09MKQ HIGHSTAT Discontinued in Phase 1 D09QIJ DRUG__ID D09QIJ D09QIJ DRUGCOMP Pfizer Inc D09QIJ HIGHSTAT Discontinued in Phase 1 D09RDT DRUG__ID D09RDT D09RDT DRUGCOMP Genset SA D09RDT HIGHSTAT Discontinued in Phase 1 D09SLU DRUG__ID D09SLU D09SLU DRUGCOMP Ligand Pharmaceuticals Inc D09SLU HIGHSTAT Discontinued in Phase 1 D09UIM DRUG__ID D09UIM D09UIM DRUGCOMP LXR Biotechnology Inc D09UIM HIGHSTAT Discontinued in Phase 1 D09UXP DRUG__ID D09UXP D09UXP DRUGCOMP AstraZeneca plc D09UXP HIGHSTAT Discontinued in Phase 1 D09WTQ DRUG__ID D09WTQ D09WTQ DRUGCOMP Novo Nordisk A/S D09WTQ HIGHSTAT Discontinued in Phase 1 D0A1KR DRUG__ID D0A1KR D0A1KR DRUGCOMP Japan Tobacco Inc D0A1KR HIGHSTAT Discontinued in Phase 1 D0A2XD DRUG__ID D0A2XD D0A2XD DRUGCOMP Takeda Pharmaceutical Co Ltd D0A2XD HIGHSTAT Discontinued in Phase 1 D0A7UT DRUG__ID D0A7UT D0A7UT DRUGCOMP Pfizer New York, NY D0A7UT HIGHSTAT Discontinued in Phase 1 D0A8EG DRUG__ID D0A8EG D0A8EG DRUGCOMP Takeda D0A8EG HIGHSTAT Discontinued in Phase 1 D0AL0S DRUG__ID D0AL0S D0AL0S DRUGCOMP GlaxoSmithKline plc D0AL0S HIGHSTAT Discontinued in Phase 1 D0B4ZQ DRUG__ID D0B4ZQ D0B4ZQ DRUGCOMP Synthelabo D0B4ZQ HIGHSTAT Discontinued in Phase 1 D0B6HS DRUG__ID D0B6HS D0B6HS DRUGCOMP Shire Pharmaceutical Development Ltd D0B6HS HIGHSTAT Discontinued in Phase 1 D0B6XE DRUG__ID D0B6XE D0B6XE DRUGCOMP Astellas D0B6XE HIGHSTAT Discontinued in Phase 1 D0B8CK DRUG__ID D0B8CK D0B8CK DRUGCOMP Pfizer D0B8CK HIGHSTAT Discontinued in Phase 1 D0BJ5O DRUG__ID D0BJ5O D0BJ5O DRUGCOMP Astellas D0BJ5O HIGHSTAT Discontinued in Phase 1 D0BZ1L DRUG__ID D0BZ1L D0BZ1L DRUGCOMP Schering-Plough D0BZ1L HIGHSTAT Discontinued in Phase 1 D0C1CU DRUG__ID D0C1CU D0C1CU DRUGCOMP Suntory Ltd D0C1CU HIGHSTAT Discontinued in Phase 1 D0C2HF DRUG__ID D0C2HF D0C2HF DRUGCOMP Glaxo Wellcome plc D0C2HF HIGHSTAT Discontinued in Phase 1 D0C3HS DRUG__ID D0C3HS D0C3HS DRUGCOMP Duke University D0C3HS HIGHSTAT Discontinued in Phase 1 D0CA3J DRUG__ID D0CA3J D0CA3J DRUGCOMP GlaxoSmithKline D0CA3J HIGHSTAT Discontinued in Phase 1 D0D2GW DRUG__ID D0D2GW D0D2GW DRUGCOMP Enzo Biochem D0D2GW HIGHSTAT Discontinued in Phase 1 D0D3HM DRUG__ID D0D3HM D0D3HM DRUGCOMP Roche D0D3HM HIGHSTAT Discontinued in Phase 1 D0D3KG DRUG__ID D0D3KG D0D3KG DRUGCOMP Hoffmann-La Roche D0D3KG HIGHSTAT Discontinued in Phase 1 D0D6DB DRUG__ID D0D6DB D0D6DB DRUGCOMP Integrated BioPharma D0D6DB HIGHSTAT Discontinued in Phase 1 D0DI0B DRUG__ID D0DI0B D0DI0B DRUGCOMP Orexo D0DI0B HIGHSTAT Discontinued in Phase 1 D0DQ9N DRUG__ID D0DQ9N D0DQ9N DRUGCOMP Cytokine PharmaSciences Inc D0DQ9N HIGHSTAT Discontinued in Phase 1 D0E2KT DRUG__ID D0E2KT D0E2KT DRUGCOMP Shionogi & Co Ltd D0E2KT HIGHSTAT Discontinued in Phase 1 D0E3BJ DRUG__ID D0E3BJ D0E3BJ DRUGCOMP Solvay SA D0E3BJ HIGHSTAT Discontinued in Phase 1 D0E3JL DRUG__ID D0E3JL D0E3JL DRUGCOMP Sanofi-Synthelabo D0E3JL HIGHSTAT Discontinued in Phase 1 D0E3VF DRUG__ID D0E3VF D0E3VF DRUGCOMP ProdiGene D0E3VF HIGHSTAT Discontinued in Phase 1 D0E4EP DRUG__ID D0E4EP D0E4EP DRUGCOMP Dana-Farber Cancer Institute Inc D0E4EP HIGHSTAT Discontinued in Phase 1 D0E8VF DRUG__ID D0E8VF D0E8VF DRUGTYPE Antibody D0E8VF HIGHSTAT Discontinued in Phase 1 D0F0MU DRUG__ID D0F0MU D0F0MU DRUGCOMP Biolex D0F0MU HIGHSTAT Discontinued in Phase 1 D0F0OJ DRUG__ID D0F0OJ D0F0OJ DRUGCOMP Japan Tobacco Inc D0F0OJ HIGHSTAT Discontinued in Phase 1 D0F0PG DRUG__ID D0F0PG D0F0PG DRUGCOMP AstraZeneca plc D0F0PG HIGHSTAT Discontinued in Phase 1 D0F6GU DRUG__ID D0F6GU D0F6GU DRUGCOMP Pfizer Inc D0F6GU HIGHSTAT Discontinued in Phase 1 D0F8RK DRUG__ID D0F8RK D0F8RK DRUGCOMP Eli Lilly D0F8RK HIGHSTAT Discontinued in Phase 1 D0F8TS DRUG__ID D0F8TS D0F8TS DRUGCOMP Myriad Genetics D0F8TS HIGHSTAT Discontinued in Phase 1 D0G1MZ DRUG__ID D0G1MZ D0G1MZ DRUGCOMP Epimmune Inc D0G1MZ HIGHSTAT Discontinued in Phase 1 D0G1YR DRUG__ID D0G1YR D0G1YR DRUGCOMP Roche Holding AG D0G1YR HIGHSTAT Discontinued in Phase 1 D0G6LR DRUG__ID D0G6LR D0G6LR DRUGCOMP Pain therapeutics D0G6LR HIGHSTAT Discontinued in Phase 1 D0G6NA DRUG__ID D0G6NA D0G6NA DRUGCOMP Renovis Inc D0G6NA HIGHSTAT Discontinued in Phase 1 D0GT0Y DRUG__ID D0GT0Y D0GT0Y DRUGCOMP Mitsubishi Pharma Corp D0GT0Y HIGHSTAT Discontinued in Phase 1 D0H2DN DRUG__ID D0H2DN D0H2DN DRUGCOMP Daiichi Seiyaku Co Ltd D0H2DN HIGHSTAT Discontinued in Phase 1 D0H3JR DRUG__ID D0H3JR D0H3JR DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D0H3JR HIGHSTAT Discontinued in Phase 1 D0H4ZD DRUG__ID D0H4ZD D0H4ZD DRUGCOMP Novopharm Biotech D0H4ZD HIGHSTAT Discontinued in Phase 1 D0H5KK DRUG__ID D0H5KK D0H5KK DRUGCOMP SmithKline Beecham plc D0H5KK HIGHSTAT Discontinued in Phase 1 D0H7ZB DRUG__ID D0H7ZB D0H7ZB DRUGCOMP Scotia Holdings plc D0H7ZB HIGHSTAT Discontinued in Phase 1 D0HY3P DRUG__ID D0HY3P D0HY3P DRUGCOMP Bristol-Myers Squibb Co D0HY3P HIGHSTAT Discontinued in Phase 1 D0I1BQ DRUG__ID D0I1BQ D0I1BQ DRUGCOMP Yeda; Merck Serono D0I1BQ HIGHSTAT Discontinued in Phase 1 D0I4FL DRUG__ID D0I4FL D0I4FL DRUGCOMP NanoScan Imaging LLC; NanoScan Imaging; IMCOR Pharmaceutical Co D0I4FL HIGHSTAT Discontinued in Phase 1 D0I5LM DRUG__ID D0I5LM D0I5LM DRUGCOMP Vernalis Group plc D0I5LM HIGHSTAT Discontinued in Phase 1 D0I8TJ DRUG__ID D0I8TJ D0I8TJ DRUGCOMP Epimmune Inc D0I8TJ HIGHSTAT Discontinued in Phase 1 D0J0IJ DRUG__ID D0J0IJ D0J0IJ DRUGCOMP Roche D0J0IJ HIGHSTAT Discontinued in Phase 1 D0J4WW DRUG__ID D0J4WW D0J4WW DRUGCOMP Nissan Chemical Industries Ltd D0J4WW HIGHSTAT Discontinued in Phase 1 D0J5FU DRUG__ID D0J5FU D0J5FU DRUGCOMP Medivir D0J5FU HIGHSTAT Discontinued in Phase 1 D0J6EQ DRUG__ID D0J6EQ D0J6EQ DRUGCOMP Maruho Co Ltd D0J6EQ HIGHSTAT Discontinued in Phase 1 D0JT1P DRUG__ID D0JT1P D0JT1P DRUGCOMP Sidney Kimmel Cancer Center D0JT1P HIGHSTAT Discontinued in Phase 1 D0K0XW DRUG__ID D0K0XW D0K0XW DRUGCOMP Merck & Co Inc D0K0XW HIGHSTAT Discontinued in Phase 1 D0K3GU DRUG__ID D0K3GU D0K3GU DRUGCOMP Pfizer D0K3GU HIGHSTAT Discontinued in Phase 1 D0K3SV DRUG__ID D0K3SV D0K3SV DRUGCOMP Wyeth D0K3SV HIGHSTAT Discontinued in Phase 1 D0K5HD DRUG__ID D0K5HD D0K5HD DRUGCOMP Eli Lilly & Co D0K5HD HIGHSTAT Discontinued in Phase 1 D0KM3P DRUG__ID D0KM3P D0KM3P DRUGCOMP Stanford University D0KM3P HIGHSTAT Discontinued in Phase 1 D0L2RV DRUG__ID D0L2RV D0L2RV DRUGCOMP Pfizer Inc D0L2RV HIGHSTAT Discontinued in Phase 1 D0L3VA DRUG__ID D0L3VA D0L3VA DRUGCOMP Novartis AG D0L3VA HIGHSTAT Discontinued in Phase 1 D0L3XV DRUG__ID D0L3XV D0L3XV DRUGCOMP PDL BioPharma Inc D0L3XV HIGHSTAT Discontinued in Phase 1 D0L4PM DRUG__ID D0L4PM D0L4PM DRUGCOMP Sanofi-Aventis D0L4PM HIGHSTAT Discontinued in Phase 1 D0L4SB DRUG__ID D0L4SB D0L4SB DRUGCOMP Dana-Farber Cancer Institute Inc D0L4SB HIGHSTAT Discontinued in Phase 1 D0L4VZ DRUG__ID D0L4VZ D0L4VZ DRUGCOMP Speedel Holding AG D0L4VZ HIGHSTAT Discontinued in Phase 1 D0L8OE DRUG__ID D0L8OE D0L8OE DRUGCOMP Amylin Pharmaceuticals D0L8OE HIGHSTAT Discontinued in Phase 1 D0L9ZK DRUG__ID D0L9ZK D0L9ZK DRUGCOMP Roche Holding AG D0L9ZK HIGHSTAT Discontinued in Phase 1 D0LJ0L DRUG__ID D0LJ0L D0LJ0L DRUGCOMP H. Lundbeck A/S D0LJ0L HIGHSTAT Discontinued in Phase 1 D0LX8D DRUG__ID D0LX8D D0LX8D DRUGCOMP AstraZeneca D0LX8D HIGHSTAT Discontinued in Phase 1 D0M4UY DRUG__ID D0M4UY D0M4UY DRUGCOMP Biowest Therapeutics Inc D0M4UY HIGHSTAT Discontinued in Phase 1 D0M5OI DRUG__ID D0M5OI D0M5OI DRUGCOMP Biogen Idec D0M5OI HIGHSTAT Discontinued in Phase 1 D0MH1R DRUG__ID D0MH1R D0MH1R DRUGCOMP BioInvent; Genentech D0MH1R HIGHSTAT Discontinued in Phase 1 D0MT7W DRUG__ID D0MT7W D0MT7W DRUGCOMP Novo Nordisk D0MT7W HIGHSTAT Discontinued in Phase 1 D0MV3Q DRUG__ID D0MV3Q D0MV3Q DRUGCOMP Axovan AG D0MV3Q HIGHSTAT Discontinued in Phase 1 D0MY6Q DRUG__ID D0MY6Q D0MY6Q DRUGCOMP BioMarin Pharmaceuticals D0MY6Q HIGHSTAT Discontinued in Phase 1 D0N0UY DRUG__ID D0N0UY D0N0UY DRUGCOMP AstraZeneca D0N0UY HIGHSTAT Discontinued in Phase 1 D0N2LY DRUG__ID D0N2LY D0N2LY DRUGCOMP Novo Nordisk A/S D0N2LY HIGHSTAT Discontinued in Phase 1 D0N3IT DRUG__ID D0N3IT D0N3IT DRUGCOMP Mucosal Therapeutics LLC D0N3IT HIGHSTAT Discontinued in Phase 1 D0N8AB DRUG__ID D0N8AB D0N8AB DRUGCOMP Pfizer Inc D0N8AB HIGHSTAT Discontinued in Phase 1 D0N9AS DRUG__ID D0N9AS D0N9AS DRUGCOMP Glaxo Wellcome plc D0N9AS HIGHSTAT Discontinued in Phase 1 D0N9BU DRUG__ID D0N9BU D0N9BU DRUGCOMP Sanofi D0N9BU HIGHSTAT Discontinued in Phase 1 D0N9SJ DRUG__ID D0N9SJ D0N9SJ DRUGCOMP Altus Pharmaceuticals Inc D0N9SJ HIGHSTAT Discontinued in Phase 1 D0NH5E DRUG__ID D0NH5E D0NH5E DRUGCOMP Cobra Biomanufacturing plc D0NH5E HIGHSTAT Discontinued in Phase 1 D0NQ5R DRUG__ID D0NQ5R D0NQ5R DRUGCOMP AstraZeneca plc D0NQ5R HIGHSTAT Discontinued in Phase 1 D0O1UC DRUG__ID D0O1UC D0O1UC DRUGCOMP Bristol-Myers Squibb; Nissan Chemical; Teijin Pharma D0O1UC HIGHSTAT Discontinued in Phase 1 D0O2EB DRUG__ID D0O2EB D0O2EB DRUGCOMP Pierre Fabre SA D0O2EB HIGHSTAT Discontinued in Phase 1 D0O3KA DRUG__ID D0O3KA D0O3KA DRUGCOMP Array BioPharma; Roche D0O3KA HIGHSTAT Discontinued in Phase 1 D0O5QL DRUG__ID D0O5QL D0O5QL DRUGCOMP Dart neuroscience D0O5QL HIGHSTAT Discontinued in Phase 1 D0O9UG DRUG__ID D0O9UG D0O9UG DRUGCOMP Zeneca Group plc D0O9UG HIGHSTAT Discontinued in Phase 1 D0P1WB DRUG__ID D0P1WB D0P1WB DRUGCOMP Roche Holding AG D0P1WB HIGHSTAT Discontinued in Phase 1 D0P1YH DRUG__ID D0P1YH D0P1YH DRUGCOMP Shionogi & Co Ltd D0P1YH HIGHSTAT Discontinued in Phase 1 D0P3CF DRUG__ID D0P3CF D0P3CF DRUGCOMP AstraZeneca plc D0P3CF HIGHSTAT Discontinued in Phase 1 D0PF9G DRUG__ID D0PF9G D0PF9G DRUGCOMP Novo Nordisk A/S D0PF9G HIGHSTAT Discontinued in Phase 1 D0PG5J DRUG__ID D0PG5J D0PG5J DRUGCOMP AstraZeneca plc D0PG5J HIGHSTAT Discontinued in Phase 1 D0PZ4Y DRUG__ID D0PZ4Y D0PZ4Y DRUGCOMP Pfizer Inc D0PZ4Y HIGHSTAT Discontinued in Phase 1 D0Q0OP DRUG__ID D0Q0OP D0Q0OP DRUGCOMP Millennium Pharmaceuticals D0Q0OP HIGHSTAT Discontinued in Phase 1 D0Q1NI DRUG__ID D0Q1NI D0Q1NI DRUGCOMP Therion Biologics Corp D0Q1NI HIGHSTAT Discontinued in Phase 1 D0Q5YH DRUG__ID D0Q5YH D0Q5YH DRUGCOMP Neurogen Corp D0Q5YH HIGHSTAT Discontinued in Phase 1 D0Q8CW DRUG__ID D0Q8CW D0Q8CW DRUGCOMP Pfizer Inc D0Q8CW HIGHSTAT Discontinued in Phase 1 D0Q9EH DRUG__ID D0Q9EH D0Q9EH DRUGCOMP Novogen D0Q9EH HIGHSTAT Discontinued in Phase 1 D0Q9NJ DRUG__ID D0Q9NJ D0Q9NJ DRUGCOMP Amylin Pharmaceuticals Inc D0Q9NJ HIGHSTAT Discontinued in Phase 1 D0Q9WN DRUG__ID D0Q9WN D0Q9WN DRUGCOMP Merck Serono SA D0Q9WN HIGHSTAT Discontinued in Phase 1 D0QA6Q DRUG__ID D0QA6Q D0QA6Q DRUGCOMP Novartis AG D0QA6Q HIGHSTAT Discontinued in Phase 1 D0QH7G DRUG__ID D0QH7G D0QH7G DRUGCOMP Roche Holding AG D0QH7G HIGHSTAT Discontinued in Phase 1 D0QX0K DRUG__ID D0QX0K D0QX0K DRUGCOMP Flamel Technologies SA D0QX0K HIGHSTAT Discontinued in Phase 1 D0R2LR DRUG__ID D0R2LR D0R2LR DRUGCOMP Glaxo Group Research Ltd D0R2LR HIGHSTAT Discontinued in Phase 1 D0R6EL DRUG__ID D0R6EL D0R6EL DRUGCOMP Pfizer D0R6EL HIGHSTAT Discontinued in Phase 1 D0R8LW DRUG__ID D0R8LW D0R8LW DRUGCOMP Organon D0R8LW HIGHSTAT Discontinued in Phase 1 D0RJ2P DRUG__ID D0RJ2P D0RJ2P DRUGCOMP Vernalis plc D0RJ2P HIGHSTAT Discontinued in Phase 1 D0RV7J DRUG__ID D0RV7J D0RV7J DRUGCOMP Roche Holding AG D0RV7J HIGHSTAT Discontinued in Phase 1 D0S3BR DRUG__ID D0S3BR D0S3BR DRUGCOMP Genentech D0S3BR HIGHSTAT Discontinued in Phase 1 D0S3WK DRUG__ID D0S3WK D0S3WK DRUGCOMP Ontario Inc D0S3WK HIGHSTAT Discontinued in Phase 1 D0S4XX DRUG__ID D0S4XX D0S4XX DRUGCOMP Faustus Forschungs Cie Translational Cancer Research GmbH D0S4XX HIGHSTAT Discontinued in Phase 1 D0S5AL DRUG__ID D0S5AL D0S5AL DRUGCOMP XTL Biopharmaceutical D0S5AL HIGHSTAT Discontinued in Phase 1 D0S5UB DRUG__ID D0S5UB D0S5UB DRUGCOMP Schering-Plough D0S5UB HIGHSTAT Discontinued in Phase 1 D0S7YU DRUG__ID D0S7YU D0S7YU DRUGCOMP Cytomedix D0S7YU HIGHSTAT Discontinued in Phase 1 D0S9XR DRUG__ID D0S9XR D0S9XR DRUGCOMP TauRx Therapeutics Pte Ltd D0S9XR HIGHSTAT Discontinued in Phase 1 D0SN2Q DRUG__ID D0SN2Q D0SN2Q DRUGCOMP Astra zeneca D0SN2Q HIGHSTAT Discontinued in Phase 1 D0SS4I DRUG__ID D0SS4I D0SS4I DRUGCOMP Astellas Pharma Inc D0SS4I HIGHSTAT Discontinued in Phase 1 D0SS6J DRUG__ID D0SS6J D0SS6J DRUGCOMP Glaxo Wellcome plc D0SS6J HIGHSTAT Discontinued in Phase 1 D0T0SO DRUG__ID D0T0SO D0T0SO DRUGCOMP Pfizer D0T0SO HIGHSTAT Discontinued in Phase 1 D0T2QN DRUG__ID D0T2QN D0T2QN DRUGCOMP Pfizer Inc D0T2QN HIGHSTAT Discontinued in Phase 1 D0T4SO DRUG__ID D0T4SO D0T4SO DRUGCOMP Progenics Pharmaceuticals Inc D0T4SO HIGHSTAT Discontinued in Phase 1 D0T7CM DRUG__ID D0T7CM D0T7CM DRUGCOMP University College London D0T7CM HIGHSTAT Discontinued in Phase 1 D0T8NS DRUG__ID D0T8NS D0T8NS DRUGCOMP AstraZeneca plc D0T8NS HIGHSTAT Discontinued in Phase 1 D0T8YV DRUG__ID D0T8YV D0T8YV DRUGCOMP Human Genome Sciences Inc D0T8YV HIGHSTAT Discontinued in Phase 1 D0T9MQ DRUG__ID D0T9MQ D0T9MQ DRUGCOMP Grunenthal GmbH D0T9MQ HIGHSTAT Discontinued in Phase 1 D0TN3D DRUG__ID D0TN3D D0TN3D DRUGCOMP AstraZeneca plc D0TN3D HIGHSTAT Discontinued in Phase 1 D0U2WO DRUG__ID D0U2WO D0U2WO DRUGCOMP Ono Pharmaceutical Co Ltd D0U2WO HIGHSTAT Discontinued in Phase 1 D0U6DC DRUG__ID D0U6DC D0U6DC DRUGCOMP Pfizer D0U6DC HIGHSTAT Discontinued in Phase 1 D0U7CO DRUG__ID D0U7CO D0U7CO DRUGCOMP Cermol SA D0U7CO HIGHSTAT Discontinued in Phase 1 D0U7GW DRUG__ID D0U7GW D0U7GW DRUGCOMP Pfizer Inc D0U7GW HIGHSTAT Discontinued in Phase 1 D0U9VO DRUG__ID D0U9VO D0U9VO DRUGCOMP Pfizer Inc D0U9VO HIGHSTAT Discontinued in Phase 1 D0UF5I DRUG__ID D0UF5I D0UF5I DRUGCOMP Myriad Genetics D0UF5I HIGHSTAT Discontinued in Phase 1 D0UI8K DRUG__ID D0UI8K D0UI8K DRUGCOMP Alexion Pharmaceuticals Inc D0UI8K HIGHSTAT Discontinued in Phase 1 D0V0IO DRUG__ID D0V0IO D0V0IO DRUGCOMP Novo Nordisk D0V0IO HIGHSTAT Discontinued in Phase 1 D0V4LG DRUG__ID D0V4LG D0V4LG DRUGCOMP Sankyo Co Ltd D0V4LG HIGHSTAT Discontinued in Phase 1 D0V6LF DRUG__ID D0V6LF D0V6LF DRUGCOMP Novo nordisk D0V6LF HIGHSTAT Discontinued in Phase 1 D0W0IN DRUG__ID D0W0IN D0W0IN DRUGCOMP Novo Nordisk D0W0IN HIGHSTAT Discontinued in Phase 1 D0W1HB DRUG__ID D0W1HB D0W1HB DRUGCOMP Millennium Pharmaceuticals Inc D0W1HB HIGHSTAT Discontinued in Phase 1 D0W2FG DRUG__ID D0W2FG D0W2FG DRUGCOMP Ophidian Pharmaceuticals Inc D0W2FG HIGHSTAT Discontinued in Phase 1 D0W2JY DRUG__ID D0W2JY D0W2JY DRUGCOMP Intercell AG D0W2JY HIGHSTAT Discontinued in Phase 1 D0W3AX DRUG__ID D0W3AX D0W3AX DRUGCOMP GlaxoSmithKline plc D0W3AX HIGHSTAT Discontinued in Phase 1 D0W3YW DRUG__ID D0W3YW D0W3YW DRUGCOMP Dr. Reddy's Laboratories D0W3YW HIGHSTAT Discontinued in Phase 1 D0W6WD DRUG__ID D0W6WD D0W6WD DRUGCOMP KemPharm D0W6WD HIGHSTAT Discontinued in Phase 1 D0W7ZN DRUG__ID D0W7ZN D0W7ZN DRUGCOMP ArQule Inc D0W7ZN HIGHSTAT Discontinued in Phase 1 D0WY2L DRUG__ID D0WY2L D0WY2L DRUGCOMP GSK D0WY2L HIGHSTAT Discontinued in Phase 1 D0X2YI DRUG__ID D0X2YI D0X2YI DRUGCOMP Inflazyme Pharmaceuticals D0X2YI HIGHSTAT Discontinued in Phase 1 D0X4OM DRUG__ID D0X4OM D0X4OM DRUGCOMP Shire plc D0X4OM HIGHSTAT Discontinued in Phase 1 D0X7WK DRUG__ID D0X7WK D0X7WK DRUGCOMP AstraZeneca plc D0X7WK HIGHSTAT Discontinued in Phase 1 D0XT5F DRUG__ID D0XT5F D0XT5F DRUGCOMP Onyvax D0XT5F HIGHSTAT Discontinued in Phase 1 D0Y0QB DRUG__ID D0Y0QB D0Y0QB DRUGCOMP PowderJect Pharmaceuticals plc D0Y0QB HIGHSTAT Discontinued in Phase 1 D0Y2XQ DRUG__ID D0Y2XQ D0Y2XQ DRUGCOMP Pfizer Inc D0Y2XQ HIGHSTAT Discontinued in Phase 1 D0Y7HW DRUG__ID D0Y7HW D0Y7HW DRUGCOMP Xanthus Life Sciences D0Y7HW HIGHSTAT Discontinued in Phase 1 D0Y8IS DRUG__ID D0Y8IS D0Y8IS DRUGCOMP Vasogen D0Y8IS HIGHSTAT Discontinued in Phase 1 D0Z3XO DRUG__ID D0Z3XO D0Z3XO DRUGCOMP Mitsubishi Tanabe Pharma D0Z3XO HIGHSTAT Discontinued in Phase 1 D0Z3YP DRUG__ID D0Z3YP D0Z3YP DRUGCOMP Bridge Pharmaceuticals Inc D0Z3YP HIGHSTAT Discontinued in Phase 1 D0Z5BD DRUG__ID D0Z5BD D0Z5BD DRUGCOMP Cerenis Therapeutics D0Z5BD HIGHSTAT Discontinued in Phase 1 D0Z6NK DRUG__ID D0Z6NK D0Z6NK DRUGCOMP ViRexx Medical Corp D0Z6NK HIGHSTAT Discontinued in Phase 1 D0Z6OI DRUG__ID D0Z6OI D0Z6OI DRUGCOMP Daiichi Sankyo D0Z6OI HIGHSTAT Discontinued in Phase 1 D0Z7AM DRUG__ID D0Z7AM D0Z7AM DRUGCOMP The Liposome Company Inc D0Z7AM HIGHSTAT Discontinued in Phase 1 D0ZD6Y DRUG__ID D0ZD6Y D0ZD6Y DRUGCOMP Dr. Reddy's Laboratories D0ZD6Y HIGHSTAT Discontinued in Phase 1 D0ZG1Y DRUG__ID D0ZG1Y D0ZG1Y DRUGCOMP Chugai Pharmaceutical Co Ltd D0ZG1Y HIGHSTAT Discontinued in Phase 1 D0ZY0Z DRUG__ID D0ZY0Z D0ZY0Z DRUGCOMP Abbott Laboratories D0ZY0Z HIGHSTAT Discontinued in Phase 1 D03PTZ DRUG__ID D03PTZ D03PTZ HIGHSTAT Discontinued in Phase 1 D04MDJ DRUG__ID D04MDJ D04MDJ HIGHSTAT Discontinued in Phase 1 D04ZJP DRUG__ID D04ZJP D04ZJP HIGHSTAT Discontinued in Phase 1 D05TLM DRUG__ID D05TLM D05TLM HIGHSTAT Discontinued in Phase 1 D06SSR DRUG__ID D06SSR D06SSR HIGHSTAT Discontinued in Phase 1 D09ANC DRUG__ID D09ANC D09ANC HIGHSTAT Discontinued in Phase 1 D0F5NB DRUG__ID D0F5NB D0F5NB HIGHSTAT Discontinued in Phase 1 D0GB3A DRUG__ID D0GB3A D0GB3A HIGHSTAT Discontinued in Phase 1 D0I4OX DRUG__ID D0I4OX D0I4OX HIGHSTAT Discontinued in Phase 1 D0J0AH DRUG__ID D0J0AH D0J0AH HIGHSTAT Discontinued in Phase 1 D0KX1E DRUG__ID D0KX1E D0KX1E HIGHSTAT Discontinued in Phase 1 D0L6JX DRUG__ID D0L6JX D0L6JX HIGHSTAT Discontinued in Phase 1 D0P6OS DRUG__ID D0P6OS D0P6OS HIGHSTAT Discontinued in Phase 1 D0R1XI DRUG__ID D0R1XI D0R1XI HIGHSTAT Discontinued in Phase 1 D0V9ZL DRUG__ID D0V9ZL D0V9ZL HIGHSTAT Discontinued in Phase 1 D0W5OV DRUG__ID D0W5OV D0W5OV HIGHSTAT Discontinued in Phase 1 D04YZS DRUG__ID D04YZS D04YZS DRUGCOMP Kitov Pharmaceuticals Tel Aviv, Israel D04YZS DRUGINCH 1S/C17H10O5/c18-15(10-5-7-11(8-6-10)16(19)20)14-9-22-17(21)13-4-2-1-3-12(13)14/h1-9H,(H,19,20) D04YZS DRUGINKE DBUCIYXZJLGTJN-UHFFFAOYSA-N D04YZS DRUGSMIL C1=CC=C2C(=C1)C(=COC2=O)C(=O)C3=CC=C(C=C3)C(=O)O D04YZS HIGHSTAT Application submitted D07WPQ DRUG__ID D07WPQ D07WPQ DRUGCOMP Intellipharmaceutics International Toronto, Canada D07WPQ DRUGINCH 1S/C18H21NO4.ClH/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;/h3-4,13,16,21H,5-9H2,1-2H3;1H/t13-,16+,17+,18-;/m1./s1 D07WPQ DRUGINKE MUZQPDBAOYKNLO-RKXJKUSZSA-N D07WPQ DRUGSMIL CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.Cl D07WPQ HIGHSTAT Application submitted D0CU1O DRUG__ID D0CU1O D0CU1O DRUGCOMP Janssen Research & Development Raritan, NJ; ViiV Healthcare Research Triangle Park, NC D0CU1O DRUGINCH 1S/C22H18N6.C20H19F2N3O5/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19;1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h3-9,11-13H,1-2H3,(H2,25,26,27,28);2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/b4-3+;/t;10-,15+/m.1/s1 D0CU1O DRUGINKE LONQNVJNDYLYLN-JMQGDYTKSA-N D0CU1O DRUGSMIL CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O.CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N D0CU1O HIGHSTAT Application submitted D0FU5Y DRUG__ID D0FU5Y D0FU5Y DRUGCOMP Elite Pharmaceuticals Northvale, NJ D0FU5Y DRUGINCH 1S/C20H23NO4.C18H21NO4.2ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10;;/h3-4,11,15,18,22,24H,1-2,5-10H2;3-4,13,16,21H,5-9H2,1-2H3;2*1H/t15-,18+,19+,20-;13-,16+,17+,18-;;/m11../s1 D0FU5Y DRUGINKE FRJHGZQFCBEKSU-UBVCJSOXSA-N D0FU5Y DRUGSMIL CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O.C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl.Cl D0FU5Y HIGHSTAT Application submitted D0HD0G DRUG__ID D0HD0G D0HD0G DRUGCOMP Samsung Bioepis Incheon, South Korea D0HD0G DRUGINCH 1S/Sb/q+3 D0HD0G DRUGINKE FAWGZAFXDJGWBB-UHFFFAOYSA-N D0HD0G DRUGSMIL [Sb+3] D0HD0G HIGHSTAT Application submitted D0NE5B DRUG__ID D0NE5B D0NE5B DRUGCOMP Hemispherx Biopharma Philadelphia, PA D0NE5B DRUGINCH 1S/C10H13N4O8P.C9H14N3O8P.C9H13N2O9P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17;10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18;12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20);1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18);1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,10-;2*4-,6-,7-,8-/m111/s1 D0NE5B DRUGINKE KNUXHTWUIVMBBY-JRJYXWDASA-N D0NE5B DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O D0NE5B HIGHSTAT Application submitted D08RFA DRUG__ID D08RFA D08RFA DRUGCOMP Novartis; Takeda D08RFA DRUGTYPE Vaccine D08RFA HIGHSTAT Application submitted D00NUO DRUG__ID D00NUO D00NUO DRUGCOMP Ortho Dermatologics Raleigh, NC D00NUO HIGHSTAT Application submitted D05IBP DRUG__ID D05IBP D05IBP DRUGCOMP Promius Pharma Princeton, NJ D05IBP HIGHSTAT Application submitted D05QKI DRUG__ID D05QKI D05QKI DRUGCOMP Sanofi US Bridgewater, NJ D05QKI HIGHSTAT Application submitted D06KVU DRUG__ID D06KVU D06KVU DRUGCOMP AllerganParsippany, NJAmgenThousand Oaks, CA D06KVU HIGHSTAT Application submitted D06QMV DRUG__ID D06QMV D06QMV DRUGCOMP Evolus Irvine, CA D06QMV HIGHSTAT Application submitted D08WCY DRUG__ID D08WCY D08WCY DRUGCOMP Allergan Parsippany, NJ D08WCY HIGHSTAT Application submitted D0A6SD DRUG__ID D0A6SD D0A6SD DRUGCOMP Cutanea Wayne, PA D0A6SD HIGHSTAT Application submitted D0B7VH DRUG__ID D0B7VH D0B7VH DRUGCOMP Pain Therapeutics Austin, TX D0B7VH HIGHSTAT Application submitted D0C7LD DRUG__ID D0C7LD D0C7LD DRUGCOMP Eagle Pharmaceuticals Woodcliff Lake, NJ D0C7LD HIGHSTAT Application submitted D0CW3U DRUG__ID D0CW3U D0CW3U DRUGCOMP AllerganMadison, NJAmgenThousand Oaks, CA D0CW3U HIGHSTAT Application submitted D0EF9B DRUG__ID D0EF9B D0EF9B DRUGCOMP Promius Pharma Princeton, NJ D0EF9B HIGHSTAT Application submitted D0EH9A DRUG__ID D0EH9A D0EH9A DRUGCOMP Allergan Parsippany, NJ D0EH9A HIGHSTAT Application submitted D0H8ZY DRUG__ID D0H8ZY D0H8ZY DRUGCOMP Dynavax Technologies Berkeley, CA D0H8ZY HIGHSTAT Application submitted D0HR7X DRUG__ID D0HR7X D0HR7X DRUGCOMP Avedro, Waltham, MA D0HR7X HIGHSTAT Application submitted D0K5NG DRUG__ID D0K5NG D0K5NG DRUGCOMP Highland Therapeutics Toronto, Canada Ironshore Pharmaceuticals Toronto, Canada D0K5NG HIGHSTAT Application submitted D0K9SS DRUG__ID D0K9SS D0K9SS DRUGCOMP SandozHolzkirchen, Germany D0K9SS HIGHSTAT Application submitted D0R6YZ DRUG__ID D0R6YZ D0R6YZ DRUGCOMP Novo Nordisk Plainsboro, NJ D0R6YZ HIGHSTAT Application submitted D0T4MK DRUG__ID D0T4MK D0T4MK DRUGCOMP Portola Pharmaceuticals South San Francisco, CA D0T4MK HIGHSTAT Application submitted D0UM3M DRUG__ID D0UM3M D0UM3M DRUGCOMP Aquestive Therapeutics Warren, NJ D0UM3M HIGHSTAT Application submitted D0V6BS DRUG__ID D0V6BS D0V6BS DRUGCOMP Ortho Dermatologics Raleigh, NC D0V6BS HIGHSTAT Application submitted D0VO7K DRUG__ID D0VO7K D0VO7K DRUGCOMP Spectrum Pharmaceuticals Henderson, NV D0VO7K HIGHSTAT Application submitted D0X7GU DRUG__ID D0X7GU D0X7GU DRUGCOMP IntelGenx Quebec, Canada D0X7GU HIGHSTAT Application submitted D05OEO DRUG__ID D05OEO D05OEO DRUGINCH 1S/C109H159N25O32S5/c1-12-56(9)87(107(163)125-76(109(165)166)39-60-43-113-65-24-18-17-23-63(60)65)134-108(164)88(57(10)13-2)133-99(155)75(42-85(143)144)123-94(150)70(36-54(5)6)118-97(153)73(40-61-44-112-52-114-61)121-103(159)80-49-169-168-48-64(111)89(145)126-77(45-135)102(158)131-81-50-170-171-51-82(105(161)132-86(55(7)8)106(162)124-72(38-59-26-28-62(138)29-27-59)95(151)120-71(96(152)130-80)37-58-21-15-14-16-22-58)129-91(147)67(30-31-83(139)140)116-90(146)66(25-19-20-33-110)115-98(154)74(41-84(141)142)122-92(148)68(32-34-167-11)117-93(149)69(35-53(3)4)119-100(156)78(46-136)127-101(157)79(47-137)128-104(81)160/h14-18,21-24,26-29,43-44,52-57,64,66-82,86-88,113,135-138H,12-13,19-20,25,30-42,45-51,110-111H2,1-11H3,(H,112,114)(H,115,154)(H,116,146)(H,117,149)(H,118,153)(H,119,156)(H,120,151)(H,121,159)(H,122,148)(H,123,150)(H,124,162)(H,125,163)(H,126,145)(H,127,157)(H,128,160)(H,129,147)(H,130,152)(H,131,158)(H,132,161)(H,133,155)(H,134,164)(H,139,140)(H,141,142)(H,143,144)(H,165,166)/t56-,57-,64-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,86-,87-,88-/m0/s1 D05OEO DRUGINKE ZUBDGKVDJUIMQQ-ZTNLKOGPSA-N D05OEO DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CO)CO)CC(C)C)CCSC)CC(=O)O)CCCCN)CCC(=O)O)CO)N D05OEO HIGHSTAT Phase 0 D0G5SK DRUG__ID D0G5SK D0G5SK DRUGCOMP University of Pennsylvania D0G5SK DRUGTYPE CAR T Cell Therapy D0G5SK HIGHSTAT Phase 0 D0H8UT DRUG__ID D0H8UT D0H8UT DRUGCOMP University of Pennsylvania D0H8UT DRUGTYPE CAR T Cell Therapy D0H8UT HIGHSTAT Phase 0 D0P4KP DRUG__ID D0P4KP D0P4KP DRUGCOMP University of Pennsylvania D0P4KP DRUGTYPE CAR T Cell Therapy D0P4KP HIGHSTAT Phase 0 D01QLM DRUG__ID D01QLM D01QLM DRUGCOMP Janssen Alzheimer Immunotherapy; Pfizer D01QLM HIGHSTAT Phase 0 D0P7BA DRUG__ID D0P7BA D0P7BA DRUGCOMP Impel NeuroPharma Seattle, WA D0P7BA HIGHSTAT Phase 0 D0YM4F DRUG__ID D0YM4F D0YM4F DRUGCOMP Janssen Alzheimer Immunotherapy; Pfizer D0YM4F HIGHSTAT Phase 0 D00JRS DRUG__ID D00JRS D00JRS DRUGCOMP Abbott Laboratories D00JRS THERCLAS Antiviral Agents D00JRS DRUGTYPE Small molecular drug D00JRS DRUGINCH 1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1 D00JRS DRUGINKE KJHKTHWMRKYKJE-SUGCFTRWSA-N D00JRS DRUGSMIL CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O D00JRS HIGHSTAT Preclinical D00OCB DRUG__ID D00OCB D00OCB DRUGCOMP Vernalis; Novartis D00OCB THERCLAS Anticancer Agents D00OCB DRUGTYPE Small molecular drug D00OCB DRUGINCH 1S/C20H20N2O4/c1-3-12-8-14(16(24)10-15(12)23)20-19(11(2)21-22-20)13-4-5-17-18(9-13)26-7-6-25-17/h4-5,8-10,23-24H,3,6-7H2,1-2H3,(H,21,22) D00OCB DRUGINKE OWPMENVYXDJDOW-UHFFFAOYSA-N D00OCB DRUGSMIL CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C D00OCB HIGHSTAT Preclinical D07LRT DRUG__ID D07LRT D07LRT DRUGCOMP Abbott D07LRT THERCLAS Analgesics D07LRT DRUGTYPE Small molecular drug D07LRT DRUGINCH 1S/C18H14F3N3O/c19-18(20,21)14-6-4-12(5-7-14)10-23-17(25)24-16-3-1-2-13-11-22-9-8-15(13)16/h1-9,11H,10H2,(H2,23,24,25) D07LRT DRUGINKE SJGVXVZUSQLLJB-UHFFFAOYSA-N D07LRT DRUGSMIL C1=CC2=C(C=CN=C2)C(=C1)NC(=O)NCC3=CC=C(C=C3)C(F)(F)F D07LRT HIGHSTAT Preclinical D07RMX DRUG__ID D07RMX D07RMX DRUGCOMP Bayer Schering Pharma. D07RMX THERCLAS Anticancer Agents D07RMX DRUGTYPE Small molecular drug D07RMX DRUGINCH 1S/C23H30F3N5O2S/c1-2-31-21(33)19(34-22(31)18(13-27)20(32)29-15-23(24,25)26)14-28-17-7-5-6-16(12-17)8-11-30-9-3-4-10-30/h5-7,12,18-19,22,28H,2-4,8-11,14-15H2,1H3,(H,29,32) D07RMX DRUGINKE WFZRONKPJVZNAO-UHFFFAOYSA-N D07RMX DRUGSMIL CCN1C(SC(C1=O)CNC2=CC=CC(=C2)CCN3CCCC3)C(C#N)C(=O)NCC(F)(F)F D07RMX HIGHSTAT Preclinical D08BMO DRUG__ID D08BMO D08BMO DRUGCOMP Sirtris Pharma D08BMO THERCLAS Antiviral Agents D08BMO DRUGTYPE Small molecular drug D08BMO DRUGINCH 1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+ D08BMO DRUGINKE LUKBXSAWLPMMSZ-OWOJBTEDSA-N D08BMO DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O D08BMO HIGHSTAT Preclinical D0AJ3K DRUG__ID D0AJ3K D0AJ3K DRUGCOMP Eli Lilly D0AJ3K THERCLAS Antiviral Agents D0AJ3K DRUGTYPE Small molecular drug D0AJ3K DRUGINCH 1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1 D0AJ3K DRUGINKE SDUQYLNIPVEERB-QPPQHZFASA-N D0AJ3K DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F D0AJ3K HIGHSTAT Preclinical D0BK1N DRUG__ID D0BK1N D0BK1N DRUGCOMP Glaxo Smith Kline Pharmaceuticals D0BK1N THERCLAS Antiviral Agents D0BK1N DRUGTYPE Small molecular drug D0BK1N DRUGINCH 1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11) D0BK1N DRUGINKE WYWHKKSPHMUBEB-UHFFFAOYSA-N D0BK1N DRUGSMIL C1=NC2=C(N1)C(=S)N=C(N2)N D0BK1N HIGHSTAT Preclinical D0SD1L DRUG__ID D0SD1L D0SD1L DRUGCOMP Novopharm D0SD1L THERCLAS Antiviral Agents D0SD1L DRUGTYPE Small molecular drug D0SD1L DRUGINCH 1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) D0SD1L DRUGINKE GLVAUDGFNGKCSF-UHFFFAOYSA-N D0SD1L DRUGSMIL C1=NC2=C(N1)C(=S)N=CN2 D0SD1L HIGHSTAT Preclinical D0SR3J DRUG__ID D0SR3J D0SR3J DRUGCOMP Janssen Pharmaceutica D0SR3J THERCLAS Antiviral Agents D0SR3J DRUGTYPE Small molecular drug D0SR3J DRUGINCH 1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3 D0SR3J DRUGINKE RDOIQAHITMMDAJ-UHFFFAOYSA-N D0SR3J DRUGSMIL CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4 D0SR3J HIGHSTAT Preclinical D0WZ4J DRUG__ID D0WZ4J D0WZ4J DRUGCOMP Cyclacel D0WZ4J THERCLAS Anticancer Agents D0WZ4J DRUGTYPE Small molecular drug D0WZ4J DRUGINCH 1S/C15H13FO2.C6H12O6/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11;7-1-2(8)4(10)6(12)5(11)3(1)9/h2-10H,1H3,(H,17,18);1-12H/t10-;/m1./s1 D0WZ4J DRUGINKE XXWQLQXGYRVJNJ-HNCPQSOCSA-N D0WZ4J DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O.C1(C(C(C(C(C1O)O)O)O)O)O D0WZ4J HIGHSTAT Preclinical D00IYM DRUG__ID D00IYM D00IYM DRUGCOMP AEterna Zentaris Inc D00IYM DRUGTYPE Small molecular drug D00IYM DRUGINCH 1S/C27H56NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-26-31-33(29,30)32-27-25-28(2,3)4/h12-13H,5-11,14-27H2,1-4H3/p+1 D00IYM DRUGINKE KCRSJPCXPQESIU-UHFFFAOYSA-O D00IYM DRUGSMIL CCCCCCCCC=CCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C D00IYM HIGHSTAT Preclinical D00KVE DRUG__ID D00KVE D00KVE DRUGCOMP Santen Pharmaceutical Co Ltd D00KVE DRUGTYPE Small molecular drug D00KVE DRUGINCH 1S/C23H32N2O2/c1-26-22-11-10-21(19-23(22)27-2)12-14-25-17-15-24(16-18-25)13-6-9-20-7-4-3-5-8-20/h3-5,7-8,10-11,19H,6,9,12-18H2,1-2H3 D00KVE DRUGINKE UVSWWUWQVAQPJR-UHFFFAOYSA-N D00KVE DRUGSMIL COC1=C(C=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3)OC D00KVE HIGHSTAT Preclinical D00MQS DRUG__ID D00MQS D00MQS DRUGCOMP Pfizer D00MQS DRUGTYPE Small molecular drug D00MQS DRUGINCH 1S/C18H18N2O2/c21-18-9-8-15-7-6-14(12-17(15)22-18)13-19-10-11-20-16-4-2-1-3-5-16/h1-9,12,19-20H,10-11,13H2 D00MQS DRUGINKE RNNKCHJUBXFBQB-UHFFFAOYSA-N D00MQS DRUGSMIL C1=CC=C(C=C1)NCCNCC2=CC3=C(C=C2)C=CC(=O)O3 D00MQS HIGHSTAT Preclinical D00VPT DRUG__ID D00VPT D00VPT DRUGCOMP GlaxoSmithKline D00VPT DRUGTYPE Small molecular drug D00VPT DRUGINCH 1S/C26H24N2O/c1-3-22(19-12-6-4-7-13-19)28-26(29)24-18(2)25(20-14-8-5-9-15-20)27-23-17-11-10-16-21(23)24/h4-17,22H,3H2,1-2H3,(H,28,29)/t22-/m0/s1 D00VPT DRUGINKE MQNYRKWJSMQECI-QFIPXVFZSA-N D00VPT DRUGSMIL CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)C D00VPT HIGHSTAT Preclinical D01WVJ DRUG__ID D01WVJ D01WVJ DRUGCOMP Enhance Biotech D01WVJ DRUGTYPE Small molecular drug D01WVJ DRUGINCH 1S/C22H32Cl2N2O4/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16/h9-10,15,19H,3-8,11-14H2,1-2H3,(H,25,29)(H,27,28)/p-1 D01WVJ DRUGINKE IEKOTSCYBBDIJC-UHFFFAOYSA-M D01WVJ DRUGSMIL CCCCCN(CCCCC)C(=O)C(CCC(=O)[O-])NC(=O)C1=CC(=C(C=C1)Cl)Cl D01WVJ HIGHSTAT Preclinical D02NMG DRUG__ID D02NMG D02NMG DRUGCOMP Solvay D02NMG DRUGTYPE Small molecular drug D02NMG DRUGINCH 1S/C23H32N2O2S.C7H7NO3/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4;8-4-1-2-5(7(10)11)6(9)3-4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28);1-3,9H,8H2,(H,10,11) D02NMG DRUGINKE HHBOLVQEBVCBNA-UHFFFAOYSA-N D02NMG DRUGSMIL CC(C)CCOC1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)OCCC(C)C.C1=CC(=C(C=C1N)O)C(=O)O D02NMG HIGHSTAT Preclinical D02NMO DRUG__ID D02NMO D02NMO DRUGCOMP Fujisawa D02NMO DRUGTYPE Small molecular drug D02NMO DRUGINCH 1S/C15H13N3/c1-11-14(13-8-5-9-16-10-13)18-15(17-11)12-6-3-2-4-7-12/h2-10H,1H3,(H,17,18) D02NMO DRUGINKE CAQAIFUDUGDPFB-UHFFFAOYSA-N D02NMO DRUGSMIL CC1=C(N=C(N1)C2=CC=CC=C2)C3=CN=CC=C3 D02NMO HIGHSTAT Preclinical D02TNS DRUG__ID D02TNS D02TNS DRUGCOMP Johnson & Johnson D02TNS DRUGTYPE Small molecular drug D02TNS DRUGINCH 1S/C32H42N6O3/c1-23-6-9-26(5-3-16-39)28(19-23)34-21-25-8-10-27-30(20-25)38(22-29-31(40)11-7-24(2)35-29)32(36-27)33-12-4-13-37-14-17-41-18-15-37/h6-11,19-20,34,39-40H,3-5,12-18,21-22H2,1-2H3,(H,33,36) D02TNS DRUGINKE DKORMNNYNRPTBJ-UHFFFAOYSA-N D02TNS DRUGSMIL CC1=CC(=C(C=C1)CCCO)NCC2=CC3=C(C=C2)N=C(N3CC4=C(C=CC(=N4)C)O)NCCCN5CCOCC5 D02TNS HIGHSTAT Preclinical D03BNU DRUG__ID D03BNU D03BNU DRUGCOMP Exelixis Inc D03BNU DRUGTYPE Small molecular drug D03BNU DRUGINCH 1S/C23H22FN3O4S/c1-14-18(5-7-20(22(14)24)32(2,29)30)23(28)27-9-10-31-19-6-3-15(11-17(19)13-27)16-4-8-21(25)26-12-16/h3-8,11-12H,9-10,13H2,1-2H3,(H2,25,26) D03BNU DRUGINKE LNFBAYSBVQBKFR-UHFFFAOYSA-N D03BNU DRUGSMIL CC1=C(C=CC(=C1F)S(=O)(=O)C)C(=O)N2CCOC3=C(C2)C=C(C=C3)C4=CN=C(C=C4)N D03BNU HIGHSTAT Preclinical D03ESO DRUG__ID D03ESO D03ESO DRUGCOMP GlaxoSmithKline D03ESO DRUGTYPE Small molecular drug D03ESO DRUGINCH 1S/C22H36N4O4/c1-7-16(6)19(22(29)24-18-10-8-9-11-23-18)25-21(28)17(12-14(2)3)20(15(4)5)26(30)13-27/h8-11,13-17,19-20,30H,7,12H2,1-6H3,(H,25,28)(H,23,24,29)/t16-,17+,19-,20-/m0/s1 D03ESO DRUGINKE SMZPWUUYPYYHIV-HNJRGHQBSA-N D03ESO DRUGSMIL CCC(C)C(C(=O)NC1=CC=CC=N1)NC(=O)C(CC(C)C)C(C(C)C)N(C=O)O D03ESO HIGHSTAT Preclinical D04EIL DRUG__ID D04EIL D04EIL DRUGCOMP Astellas D04EIL DRUGTYPE Small molecular drug D04EIL DRUGINCH 1S/C29H31FN4O3/c1-20-3-2-11-34(37)28(20)29(36)33-13-8-21(9-14-33)16-27(35)31-26-10-12-32(19-26)18-22-4-5-24-17-25(30)7-6-23(24)15-22/h2-7,11,15-17,26H,8-10,12-14,18-19H2,1H3,(H,31,35) D04EIL DRUGINKE AINQBHMFEKHERT-UHFFFAOYSA-N D04EIL DRUGSMIL CC1=C([N+](=CC=C1)[O-])C(=O)N2CCC(=CC(=O)NC3CCN(C3)CC4=CC5=C(C=C4)C=C(C=C5)F)CC2 D04EIL HIGHSTAT Preclinical D04MMJ DRUG__ID D04MMJ D04MMJ DRUGCOMP Addex D04MMJ DRUGTYPE Small molecular drug D04MMJ DRUGINCH 1S/C20H26N2O.BrH/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19;/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3;1H D04MMJ DRUGINKE NVBHPBGGYJRLTF-UHFFFAOYSA-N D04MMJ DRUGSMIL CCC1CC2CC3C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC.Br D04MMJ HIGHSTAT Preclinical D04PVN DRUG__ID D04PVN D04PVN DRUGCOMP Spectrum Pharmaceuticals D04PVN DRUGTYPE Small molecular drug D04PVN DRUGINCH 1S/C20H24ClN3O/c21-16-3-1-4-17(15-16)23-12-9-22(10-13-23)11-14-24-8-7-18-19(24)5-2-6-20(18)25/h1,3-4,7-8,15H,2,5-6,9-14H2 D04PVN DRUGINKE CQSQHUPRBBCQRE-UHFFFAOYSA-N D04PVN DRUGSMIL C1CC2=C(C=CN2CCN3CCN(CC3)C4=CC(=CC=C4)Cl)C(=O)C1 D04PVN HIGHSTAT Preclinical D04UXX DRUG__ID D04UXX D04UXX DRUGCOMP Pfizer D04UXX DRUGTYPE Small molecular drug D04UXX DRUGINCH 1S/C22H31N5/c1-2-5-21(6-3-1)27-17-15-26(16-18-27)14-11-19-7-9-20(10-8-19)25-22-23-12-4-13-24-22/h1-6,12-13,19-20H,7-11,14-18H2,(H,23,24,25) D04UXX DRUGINKE OUUMPVSFLSOGJZ-UHFFFAOYSA-N D04UXX DRUGSMIL C1CC(CCC1CCN2CCN(CC2)C3=CC=CC=C3)NC4=NC=CC=N4 D04UXX HIGHSTAT Preclinical D05DDZ DRUG__ID D05DDZ D05DDZ DRUGCOMP Miravant Pharmaceuticals Inc D05DDZ DRUGTYPE Small molecular drug D05DDZ DRUGINCH 1S/C34H35N4O3.ClH.In/c1-8-20-16(3)24-13-26-18(5)22(10-11-31(40)41-7)33(37-26)23-12-30(39)32-19(6)27(38-34(23)32)15-29-21(9-2)17(4)25(36-29)14-28(20)35-24;;/h8,13-15,18,22H,1,9-12H2,2-7H3,(H-,35,36,37,38,39);1H;/q-1;;+3/p-2/t18-,22-;;/m0../s1 D05DDZ DRUGINKE JNKZEAZXVUNYPF-BZKLBDBUSA-L D05DDZ DRUGSMIL CCC1=C(C2=NC1=CC3=C(C4=C5N3[In](N6C(=CC7=NC(=C5CC4=O)C(C7C)CCC(=O)OC)C(=C(C6=C2)C=C)C)Cl)C)C D05DDZ HIGHSTAT Preclinical D05GQD DRUG__ID D05GQD D05GQD DRUGCOMP Brigham Young University D05GQD DRUGTYPE Small molecular drug D05GQD DRUGINCH 1S/C41H80N4O3/c1-5-6-7-8-9-10-23-45-24-11-15-31(2)34-16-17-35-39-36(30-38(41(34,35)4)48-27-14-22-44)40(3)19-18-33(46-25-12-20-42)28-32(40)29-37(39)47-26-13-21-43/h31-39,45H,5-30,42-44H2,1-4H3/t31-,32+,33-,34-,35+,36+,37-,38+,39+,40+,41-/m1/s1 D05GQD DRUGINKE YDYLISNLJUDIGF-GXDYCHSMSA-N D05GQD DRUGSMIL CCCCCCCCNCCCC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)OCCCN)C)OCCCN)OCCCN)C D05GQD HIGHSTAT Preclinical D05QXT DRUG__ID D05QXT D05QXT DRUGCOMP Bayer AG D05QXT DRUGTYPE Small molecular drug D05QXT DRUGINCH 1S/C29H28F5NO/c1-16(2)27-25(26(31)18-4-8-19(9-5-18)29(32,33)34)23(17-6-10-20(30)11-7-17)24-21(35-27)14-28(12-3-13-28)15-22(24)36/h4-11,16,22,26,36H,3,12-15H2,1-2H3/t22-,26-/m0/s1 D05QXT DRUGINKE HNPNOKPKJPAVPV-NVQXNPDNSA-N D05QXT DRUGSMIL CC(C)C1=NC2=C(C(CC3(C2)CCC3)O)C(=C1C(C4=CC=C(C=C4)C(F)(F)F)F)C5=CC=C(C=C5)F D05QXT HIGHSTAT Preclinical D05ZCQ DRUG__ID D05ZCQ D05ZCQ DRUGCOMP RottaPharma D05ZCQ THERCLAS Anticancer Agents D05ZCQ DRUGINCH 1S/C25H20N6O4/c1-16(32)27-18-11-13-19(14-12-18)28-25-26-15-22(31(34)35)24(30-25)29-21-10-6-5-9-20(21)23(33)17-7-3-2-4-8-17/h2-15H,1H3,(H,27,32)(H2,26,28,29,30) D05ZCQ DRUGINKE LOMJSEHTDFISSP-UHFFFAOYSA-N D05ZCQ DRUGSMIL CC(=O)NC1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC=CC=C3C(=O)C4=CC=CC=C4)[N+](=O)[O-] D05ZCQ HIGHSTAT Preclinical D06DPS DRUG__ID D06DPS D06DPS DRUGCOMP Pfizer D06DPS DRUGTYPE Small molecular drug D06DPS DRUGINCH 1S/C38H49N5O6/c1-23-9-3-5-12-31(23)42-36(47)39-14-8-7-10-29(20-33(44)45)41-35(46)38(2,21-28-22-40-32-13-6-4-11-30(28)32)43-37(48)49-34-26-16-24-15-25(18-26)19-27(34)17-24/h3-6,9,11-13,22,24-27,29,34,40H,7-8,10,14-21H2,1-2H3,(H,41,46)(H,43,48)(H,44,45)(H2,39,42,47)/t24?,25?,26?,27?,29-,34?,38+/m0/s1 D06DPS DRUGINKE LMIPXHAXVWAMTP-VUFPLIBQSA-N D06DPS DRUGSMIL CC1=CC=CC=C1NC(=O)NCCCCC(CC(=O)O)NC(=O)C(C)(CC2=CNC3=CC=CC=C32)NC(=O)OC4C5CC6CC(C5)CC4C6 D06DPS HIGHSTAT Preclinical D06LYZ DRUG__ID D06LYZ D06LYZ DRUGCOMP Abbott Laboratories D06LYZ DRUGTYPE Small molecular drug D06LYZ DRUGINCH 1S/C17H21N5OS/c1-20(2)12-7-8-18-16-13(12)14-15(24-16)17(23)22(11-19-14)21-9-5-3-4-6-10-21/h7-8,11H,3-6,9-10H2,1-2H3 D06LYZ DRUGINKE GYWGXEGOXODOQU-UHFFFAOYSA-N D06LYZ DRUGSMIL CN(C)C1=C2C3=C(C(=O)N(C=N3)N4CCCCCC4)SC2=NC=C1 D06LYZ HIGHSTAT Preclinical D06PXT DRUG__ID D06PXT D06PXT DRUGCOMP Can-Fite BioPharm D06PXT DRUGTYPE Small molecular drug D06PXT DRUGINCH 1S/C22H21Cl2N3O/c23-17-11-10-15(12-18(17)24)25-21-13-20(16-8-4-5-9-19(16)26-21)27-22(28)14-6-2-1-3-7-14/h4-5,8-14H,1-3,6-7H2,(H2,25,26,27,28) D06PXT DRUGINKE UWEIQVQNNLVOEI-UHFFFAOYSA-N D06PXT DRUGSMIL C1CCC(CC1)C(=O)NC2=CC(=NC3=CC=CC=C32)NC4=CC(=C(C=C4)Cl)Cl D06PXT HIGHSTAT Preclinical D06RQU DRUG__ID D06RQU D06RQU THERCLAS Anticancer Agents D06RQU DRUGTYPE Small molecular drug D06RQU DRUGINCH 1S/C21H32N4O6/c1-12-18(27)22-13(2)19(28)24-14(7-4-3-5-9-16(26)17-11-31-17)21(30)25-10-6-8-15(25)20(29)23-12/h12-15,17H,3-11H2,1-2H3,(H,22,27)(H,23,29)(H,24,28)/t12-,13+,14-,15+,17?/m0/s1 D06RQU DRUGINKE GNYCTMYOHGBSBI-KVUCBBCISA-N D06RQU DRUGSMIL CC1C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C)CCCCCC(=O)C3CO3 D06RQU HIGHSTAT Preclinical D06SBS DRUG__ID D06SBS D06SBS DRUGCOMP Sanofi-Aventis D06SBS DRUGTYPE Small molecular drug D06SBS DRUGINCH 1S/C20H20ClF3N2O/c21-17-14(9-6-10-15(17)20(22,23)24)19(27)26-18(13-7-2-1-3-8-13)16-11-4-5-12-25-16/h1-3,6-10,16,18,25H,4-5,11-12H2,(H,26,27)/t16-,18-/m0/s1 D06SBS DRUGINKE MEZRZVWPLXVLSO-WMZOPIPTSA-N D06SBS DRUGSMIL C1CCNC(C1)C(C2=CC=CC=C2)NC(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl D06SBS HIGHSTAT Preclinical D06XGC DRUG__ID D06XGC D06XGC DRUGCOMP Bristol-myers squibb; Amira Pharmaceuticals Inc D06XGC DRUGTYPE Small molecular drug D06XGC DRUGINCH 1S/C29H26N2O5/c1-18-25(30-28(34)35-19(2)20-6-4-3-5-7-20)26(36-31-18)23-10-8-21(9-11-23)22-12-14-24(15-13-22)29(16-17-29)27(32)33/h3-15,19H,16-17H2,1-2H3,(H,30,34)(H,32,33)/t19-/m0/s1 D06XGC DRUGINKE GQBRZBHEPUQRPL-IBGZPJMESA-N D06XGC DRUGSMIL CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O D06XGC HIGHSTAT Preclinical D07PNC DRUG__ID D07PNC D07PNC DRUGCOMP Akzo Nobel D07PNC DRUGTYPE Small molecular drug D07PNC DRUGINCH 1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16-,17+,18+,19-,20-,21-/m0/s1 D07PNC DRUGINKE ATXHVCQZZJYMCF-XUDSTZEESA-N D07PNC DRUGSMIL CC12CCC3C(C1CCC2(CC=C)O)CCC4=CCCCC34 D07PNC HIGHSTAT Preclinical D07YLK DRUG__ID D07YLK D07YLK DRUGCOMP Sanofi-Aventis D07YLK DRUGTYPE Small molecular drug D07YLK DRUGINCH 1S/C20H22N2/c1-22-12-10-15-6-2-3-7-16(15)14-20-18(11-13-22)17-8-4-5-9-19(17)21-20/h2-9,21H,10-14H2,1H3 D07YLK DRUGINKE YEWGIGCYIAMFMA-UHFFFAOYSA-N D07YLK DRUGSMIL CN1CCC2=CC=CC=C2CC3=C(CC1)C4=CC=CC=C4N3 D07YLK HIGHSTAT Preclinical D08ECB DRUG__ID D08ECB D08ECB DRUGCOMP Almirall Prodesfarma SA D08ECB DRUGTYPE Small molecular drug D08ECB DRUGINCH 1S/C17H12N6O/c1-3-12(9-18-6-1)22-17-20-10-13(14-5-7-19-11-21-14)16(23-17)15-4-2-8-24-15/h1-11H,(H,20,22,23) D08ECB DRUGINKE YRPIMMMBNUUYLG-UHFFFAOYSA-N D08ECB DRUGSMIL C1=CC(=CN=C1)NC2=NC=C(C(=N2)C3=CC=CO3)C4=NC=NC=C4 D08ECB HIGHSTAT Preclinical D08GNX DRUG__ID D08GNX D08GNX DRUGCOMP Fisons D08GNX DRUGTYPE Small molecular drug D08GNX DRUGINCH 1S/C45H56N8O13S3/c1-46-35(21-27-9-5-4-6-10-27)43(60)53-45(62)37(24-40(56)57)52-42(59)34(18-20-68-3)51-44(61)36(23-29-25-47-32-12-8-7-11-31(29)32)50-39(55)26-48-41(58)33(17-19-67-2)49-38(54)22-28-13-15-30(16-14-28)66-69(63,64)65/h4-16,25,33-37,46-47H,17-24,26H2,1-3H3,(H,48,58)(H,49,54)(H,50,55)(H,51,61)(H,52,59)(H,56,57)(H,53,60,62)(H,63,64,65)/t33-,34-,35-,36-,37-/m0/s1 D08GNX DRUGINKE PKMRCHBERGHHNY-LTLCPEALSA-N D08GNX DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)NC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CCSC)NC(=O)CC4=CC=C(C=C4)OS(=O)(=O)O D08GNX HIGHSTAT Preclinical D08IMD DRUG__ID D08IMD D08IMD DRUGCOMP AstraZeneca plc D08IMD DRUGTYPE Small molecular drug D08IMD DRUGINCH 1S/C23H25F2N5O2/c1-3-32-21-12-19-15(11-20(21)30-8-6-29(2)7-9-30)22(16(13-27-19)23(26)31)28-18-5-4-14(24)10-17(18)25/h4-5,10-13H,3,6-9H2,1-2H3,(H2,26,31)(H,27,28) D08IMD DRUGINKE IBHNEKVLDKCEQY-UHFFFAOYSA-N D08IMD DRUGSMIL CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=C(C=C(C=C3)F)F)C(=O)N)N4CCN(CC4)C D08IMD HIGHSTAT Preclinical D08RUW DRUG__ID D08RUW D08RUW DRUGCOMP Parke-Davis & Co D08RUW DRUGTYPE Small molecular drug D08RUW DRUGINCH 1S/C27H25N5O4S/c1-31(2)11-6-12-32-15-20(26(34)35)25(33)19-10-9-18(13-23(19)32)28-27-29-22(16-37-27)24-14-21(30-36-24)17-7-4-3-5-8-17/h3-5,7-10,13-16H,6,11-12H2,1-2H3,(H,28,29)(H,34,35) D08RUW DRUGINKE ZFKADILIBQJDGL-UHFFFAOYSA-N D08RUW DRUGSMIL CN(C)CCCN1C=C(C(=O)C2=C1C=C(C=C2)NC3=NC(=CS3)C4=CC(=NO4)C5=CC=CC=C5)C(=O)O D08RUW HIGHSTAT Preclinical D09IJP DRUG__ID D09IJP D09IJP DRUGCOMP Abbott D09IJP DRUGTYPE Small molecular drug D09IJP DRUGINCH 1S/C48H62N8O13S/c1-5-7-16-38(53-41(57)24-21-31-19-22-34(23-20-31)69-70(66,67)68)45(62)51-28-42(58)56(29-33-27-50-37-18-12-11-14-35(33)37)48(65)54-39(17-8-6-2)46(63)55-44(61)36-15-10-9-13-32(36)25-30(3)52-47(64)40(49-4)26-43(59)60/h9-15,18-20,22-23,27,30,38-40,49-50H,5-8,16-17,21,24-26,28-29H2,1-4H3,(H,51,62)(H,52,64)(H,53,57)(H,54,65)(H,59,60)(H,55,61,63)(H,66,67,68)/t30-,38+,39+,40+/m1/s1 D09IJP DRUGINKE DLOJBPLQFCFYKX-QQYYTUMTSA-N D09IJP DRUGSMIL CCCCC(C(=O)NCC(=O)N(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(=O)C3=CC=CC=C3CC(C)NC(=O)C(CC(=O)O)NC)NC(=O)CCC4=CC=C(C=C4)OS(=O)(=O)O D09IJP HIGHSTAT Preclinical D0AG8C DRUG__ID D0AG8C D0AG8C THERCLAS Antiviral Agents D0AG8C DRUGTYPE Small molecular drug D0AG8C DRUGINCH 1S/C21H31N3O8S.Na/c1-13(2)10-16(24-21(28)32-12-14-6-4-3-5-7-14)19(26)23-17(20(27)33(29,30)31)11-15-8-9-22-18(15)25;/h3-7,13,15-17,20,27H,8-12H2,1-2H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31);/q;+1/p-1/t15?,16-,17-,20?;/m0./s1 D0AG8C DRUGINKE BSPJDKCMFIPBAW-JPBGFCRCSA-M D0AG8C DRUGSMIL CC(C)CC(C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)[O-])NC(=O)OCC2=CC=CC=C2.[Na+] D0AG8C HIGHSTAT Preclinical D0C2QF DRUG__ID D0C2QF D0C2QF DRUGCOMP Eli Lilly D0C2QF DRUGTYPE Small molecular drug D0C2QF DRUGINCH 1S/C22H35NO2/c1-17-16-23(13-11-21(25)18-7-4-3-5-8-18)14-12-22(17,2)19-9-6-10-20(24)15-19/h6,9-10,15,17-18,21,24-25H,3-5,7-8,11-14,16H2,1-2H3/t17-,21-,22+/m0/s1 D0C2QF DRUGINKE LVVHEFJXPXAUDD-BULFRSBZSA-N D0C2QF DRUGSMIL CC1CN(CCC1(C)C2=CC(=CC=C2)O)CCC(C3CCCCC3)O D0C2QF HIGHSTAT Preclinical D0E3SX DRUG__ID D0E3SX D0E3SX DRUGCOMP Schering-Plough Corp D0E3SX DRUGTYPE Small molecular drug D0E3SX DRUGINCH 1S/C18H18N4OS/c1-4-5-12-6-13(10-20-9-12)14-7-15(24-11-14)18(2)8-16(23)22(3)17(19)21-18/h6-7,9-11H,8H2,1-3H3,(H2,19,21)/t18-/m0/s1 D0E3SX DRUGINKE IKFZEHQGULJMKI-SFHVURJKSA-N D0E3SX DRUGSMIL CC#CC1=CC(=CN=C1)C2=CSC(=C2)C3(CC(=O)N(C(=N3)N)C)C D0E3SX HIGHSTAT Preclinical D0E8QK DRUG__ID D0E8QK D0E8QK DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0E8QK DRUGTYPE Small molecular drug D0E8QK DRUGINCH 1S/C23H17BrF2N4O3S/c1-13(16-8-6-15(25)12-18(16)26)29-23(31)17-7-5-14(24)11-20(17)30-34(32,33)21-4-2-3-19-22(21)28-10-9-27-19/h2-13,30H,1H3,(H,29,31)/t13-/m1/s1 D0E8QK DRUGINKE TZKCPFFVWLRNRZ-CYBMUJFWSA-N D0E8QK DRUGSMIL CC(C1=C(C=C(C=C1)F)F)NC(=O)C2=C(C=C(C=C2)Br)NS(=O)(=O)C3=CC=CC4=NC=CN=C43 D0E8QK HIGHSTAT Preclinical D0F6WV DRUG__ID D0F6WV D0F6WV DRUGCOMP Pfizer D0F6WV DRUGTYPE Small molecular drug D0F6WV DRUGINCH 1S/C13H10BrN3O4/c14-9-3-1-2-4-10(9)15-13(19)16-11-6-5-8(17(20)21)7-12(11)18/h1-7,18H,(H2,15,16,19) D0F6WV DRUGINKE MQBZVUNNWUIPMK-UHFFFAOYSA-N D0F6WV DRUGSMIL C1=CC=C(C(=C1)NC(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])O)Br D0F6WV HIGHSTAT Preclinical D0G5DK DRUG__ID D0G5DK D0G5DK DRUGCOMP Ono Pharmaceutical Co Ltd D0G5DK DRUGTYPE Small molecular drug D0G5DK DRUGINCH 1S/C26H24N2O4/c29-25(30)18-31-24-13-5-11-22-19(9-4-12-23(22)24)14-16-32-28-26(20-7-2-1-3-8-20)21-10-6-15-27-17-21/h1-3,5-11,13,15,17H,4,12,14,16,18H2,(H,29,30)/b28-26+ D0G5DK DRUGINKE WBBLIRPKRKYMTD-BYCLXTJYSA-N D0G5DK DRUGSMIL C1CC2=C(C=CC=C2OCC(=O)O)C(=C1)CCON=C(C3=CC=CC=C3)C4=CN=CC=C4 D0G5DK HIGHSTAT Preclinical D0G5ML DRUG__ID D0G5ML D0G5ML DRUGCOMP Pierre Fabre SA D0G5ML DRUGTYPE Small molecular drug D0G5ML DRUGINCH 1S/C23H25N5O2/c24-8-7-18-15-26-22-6-5-20(13-21(18)22)30-16-23(29)28-11-9-27(10-12-28)19-3-1-17(14-25)2-4-19/h1-6,13,15,26H,7-12,16,24H2 D0G5ML DRUGINKE SOHCKWZVTCTQBG-UHFFFAOYSA-N D0G5ML DRUGSMIL C1CN(CCN1C2=CC=C(C=C2)C#N)C(=O)COC3=CC4=C(C=C3)NC=C4CCN D0G5ML HIGHSTAT Preclinical D0H0AU DRUG__ID D0H0AU D0H0AU DRUGCOMP Vernalis plc D0H0AU DRUGTYPE Small molecular drug D0H0AU DRUGINCH 1S/C25H23Cl2N7O4/c26-16-6-5-15(7-17(16)27)9-30-25-33-19-22(29)31-12-32-23(19)34(25)24-21(36)20(35)18(38-24)11-37-10-14-3-1-13(8-28)2-4-14/h1-7,12,18,20-21,24,35-36H,9-11H2,(H,30,33)(H2,29,31,32)/t18-,20-,21-,24-/m1/s1 D0H0AU DRUGINKE ZXGGCBQORXDVTE-UMCMBGNQSA-N D0H0AU DRUGSMIL C1=CC(=CC=C1COCC2C(C(C(O2)N3C4=NC=NC(=C4N=C3NCC5=CC(=C(C=C5)Cl)Cl)N)O)O)C#N D0H0AU HIGHSTAT Preclinical D0H4GB DRUG__ID D0H4GB D0H4GB DRUGCOMP Bayer D0H4GB DRUGTYPE Small molecular drug D0H4GB DRUGINCH 1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)/p-1 D0H4GB DRUGINKE SBDNJUWAMKYJOX-UHFFFAOYSA-M D0H4GB DRUGSMIL CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl D0H4GB HIGHSTAT Preclinical D0HM5J DRUG__ID D0HM5J D0HM5J THERCLAS Antiviral Agents D0HM5J DRUGTYPE Small molecular drug D0HM5J DRUGINCH 1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1 D0HM5J DRUGINKE AEXFXNFMSAAELR-RXVVDRJESA-N D0HM5J DRUGSMIL CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)CC(C#N)NC(=O)C4CNCCCO4)OC1=O D0HM5J HIGHSTAT Preclinical D0I5HE DRUG__ID D0I5HE D0I5HE DRUGCOMP AstraZeneca D0I5HE DRUGTYPE Small molecular drug D0I5HE DRUGINCH 1S/C21H25N3O2/c1-14(2)24-18-7-5-4-6-16(18)20-15(3)17(8-9-19(20)24)22-21(25)23-10-12-26-13-11-23/h4-9,14H,10-13H2,1-3H3,(H,22,25) D0I5HE DRUGINKE ZNFMHLDBJPAFEQ-UHFFFAOYSA-N D0I5HE DRUGSMIL CC1=C(C=CC2=C1C3=CC=CC=C3N2C(C)C)NC(=O)N4CCOCC4 D0I5HE HIGHSTAT Preclinical D0I5VA DRUG__ID D0I5VA D0I5VA DRUGCOMP Can-Fite BioPharm D0I5VA DRUGTYPE Small molecular drug D0I5VA DRUGINCH 1S/C20H20Cl2N6O3/c1-23-18(31)20-6-11(20)13(14(29)15(20)30)28-8-25-12-16(26-19(22)27-17(12)28)24-7-9-3-2-4-10(21)5-9/h2-5,8,11,13-15,29-30H,6-7H2,1H3,(H,23,31)(H,24,26,27)/t11-,13-,14+,15+,20+/m1/s1 D0I5VA DRUGINKE GAYWHRPOIWFKIF-DDDALXFXSA-N D0I5VA DRUGSMIL CNC(=O)C12CC1C(C(C2O)O)N3C=NC4=C(N=C(N=C43)Cl)NCC5=CC(=CC=C5)Cl D0I5VA HIGHSTAT Preclinical D0I7OF DRUG__ID D0I7OF D0I7OF THERCLAS Antiviral Agents D0I7OF DRUGTYPE Small molecular drug D0I7OF DRUGINCH 1S/C12H18ClN7O/c13-8-10(20-5-3-1-2-4-6-20)18-9(14)7(17-8)11(21)19-12(15)16/h1-6H2,(H2,14,18)(H4,15,16,19,21) D0I7OF DRUGINKE RQQJJXVETXFINY-UHFFFAOYSA-N D0I7OF DRUGSMIL C1CCCN(CC1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N D0I7OF HIGHSTAT Preclinical D0I8FO DRUG__ID D0I8FO D0I8FO DRUGCOMP ActivBiotics Inc D0I8FO DRUGTYPE Small molecular drug D0I8FO DRUGINCH 1S/C46H56N4O12/c1-21-11-10-12-22(2)45(58)48-36-41(56)32-31(35-43(36)61-30-20-27(19-28(51)34(30)47-35)50-16-14-49(8)15-17-50)33-42(26(6)40(32)55)62-46(7,44(33)57)60-18-13-29(59-9)23(3)38(53)25(5)39(54)24(4)37(21)52/h10-13,18-21,23-25,29,37-39,52-55,57H,14-17H2,1-9H3,(H,48,58)/b11-10+,18-13+,22-12-/t21-,23+,24+,25-,29-,37-,38+,39+,46-/m0/s1 D0I8FO DRUGINKE XTWSBXHGYIWJJV-PMXQCPMZSA-N D0I8FO DRUGSMIL CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)O)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)C)O3)C D0I8FO HIGHSTAT Preclinical D0I9LO DRUG__ID D0I9LO D0I9LO DRUGCOMP RW Johnson Pharmaceutical Research Institute D0I9LO DRUGTYPE Small molecular drug D0I9LO DRUGINCH 1S/C18H20FN5O3/c1-11(25)20-6-14-9-24(18(26)27-14)13-3-4-17(15(19)5-13)23-8-12-7-22(2)21-16(12)10-23/h3-5,7,14H,6,8-10H2,1-2H3,(H,20,25)/t14-/m0/s1 D0I9LO DRUGINKE UCBHICFFJKDMMR-AWEZNQCLSA-N D0I9LO DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CC4=CN(N=C4C3)C)F D0I9LO HIGHSTAT Preclinical D0I9UP DRUG__ID D0I9UP D0I9UP DRUGCOMP Hybrigenics SA D0I9UP DRUGTYPE Small molecular drug D0I9UP DRUGINCH 1S/C13H3ClN4O/c14-6-1-2-7-8(3-6)13(19)12-11(7)17-9(4-15)10(5-16)18-12/h1-3H D0I9UP DRUGINKE BIGPXXAUSQLTQR-UHFFFAOYSA-N D0I9UP DRUGSMIL C1=CC2=C(C=C1Cl)C(=O)C3=NC(=C(N=C23)C#N)C#N D0I9UP HIGHSTAT Preclinical D0I9XH DRUG__ID D0I9XH D0I9XH DRUGCOMP Schering-Plough D0I9XH DRUGTYPE Small molecular drug D0I9XH DRUGINCH 1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1 D0I9XH DRUGINKE KQJSQWZMSAGSHN-JJWQIEBTSA-N D0I9XH DRUGSMIL CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O D0I9XH HIGHSTAT Preclinical D0IY0R DRUG__ID D0IY0R D0IY0R DRUGCOMP Aventis Pharma AG D0IY0R DRUGTYPE Small molecular drug D0IY0R DRUGINCH 1S/C25H29FN2O4S2/c1-32-17-5-6-21-18(13-17)24(20(26)14-27-21)22(29)7-4-16-8-9-28(15-19(16)25(30)31)10-12-34-23-3-2-11-33-23/h2-3,5-6,11,13-14,16,19,22,29H,4,7-10,12,15H2,1H3,(H,30,31)/t16-,19+,22+/m1/s1 D0IY0R DRUGINKE USGHRRVFKSLEJT-WVBUVRCRSA-N D0IY0R DRUGSMIL COC1=CC2=C(C(=CN=C2C=C1)F)C(CCC3CCN(CC3C(=O)O)CCSC4=CC=CS4)O D0IY0R HIGHSTAT Preclinical D0J6VN DRUG__ID D0J6VN D0J6VN THERCLAS Antifungal Agents D0J6VN DRUGTYPE Small molecular drug D0J6VN DRUGINCH 1S/C21H30O4/c1-14-6-9-17-20(2,11-5-12-21(17,3)19(23)24-4)16(14)8-7-15-10-13-25-18(15)22/h10,16-17H,1,5-9,11-13H2,2-4H3/t16-,17+,20+,21-/m0/s1 D0J6VN DRUGINKE WTKBZJAWPZXKJU-NLEAXPPASA-N D0J6VN DRUGSMIL CC12CCCC(C1CCC(=C)C2CCC3=CCOC3=O)(C)C(=O)OC D0J6VN HIGHSTAT Preclinical D0J8OC DRUG__ID D0J8OC D0J8OC DRUGCOMP Alexis Biochemicals D0J8OC DRUGTYPE Small molecular drug D0J8OC DRUGINCH 1S/C18H18N2O4/c21-15(19-24)10-2-1-3-11-20-17(22)13-8-4-6-12-7-5-9-14(16(12)13)18(20)23/h4-9,24H,1-3,10-11H2,(H,19,21) D0J8OC DRUGINKE JTDYUFSDZATMKU-UHFFFAOYSA-N D0J8OC DRUGSMIL C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CCCCCC(=O)NO D0J8OC HIGHSTAT Preclinical D0JC7A DRUG__ID D0JC7A D0JC7A DRUGCOMP National Cancer Institute D0JC7A DRUGTYPE Small molecular drug D0JC7A DRUGINCH 1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16) D0JC7A DRUGINKE UIYWFOZZIZEEKJ-UHFFFAOYSA-N D0JC7A DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F D0JC7A HIGHSTAT Preclinical D0K1UF DRUG__ID D0K1UF D0K1UF DRUGCOMP Reata Pharmaceuticals Inc D0K1UF DRUGTYPE Small molecular drug D0K1UF DRUGINCH 1S/C28H29NO5/c1-20-9-5-6-12-22-13-7-15-24(30)27(22)28(33)34-23(19-25(20)31)14-8-18-29-26(32)17-16-21-10-3-2-4-11-21/h2-8,10-11,13,15,18,20,23,25,30-31H,9,12,14,19H2,1H3,(H,29,32)/b6-5+,18-8+/t20-,23-,25+/m0/s1 D0K1UF DRUGINKE FTBLSENPBXIDKK-ZZHCZQHNSA-N D0K1UF DRUGSMIL CC1CC=CCC2=C(C(=CC=C2)O)C(=O)OC(CC1O)CC=CNC(=O)C#CC3=CC=CC=C3 D0K1UF HIGHSTAT Preclinical D0K2CR DRUG__ID D0K2CR D0K2CR DRUGCOMP Pharmacia & Upjohn AB D0K2CR DRUGTYPE Small molecular drug D0K2CR DRUGINCH 1S/C32H37NO13/c1-14-27(36)17(33-7-8-44-22(12-33)43-3)9-21(45-14)46-19-11-32(41,20(35)13-34)10-16-24(19)31(40)26-25(29(16)38)28(37)15-5-4-6-18(42-2)23(15)30(26)39/h4-6,14,17,19,21-22,27,34,36,38,40-41H,7-13H2,1-3H3/t14-,17-,19-,21-,22-,27+,32-/m0/s1 D0K2CR DRUGINKE CTMCWCONSULRHO-UHQPFXKFSA-N D0K2CR DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCOC(C6)OC)O D0K2CR HIGHSTAT Preclinical D0K5EE DRUG__ID D0K5EE D0K5EE DRUGCOMP Servier D0K5EE DRUGTYPE Small molecular drug D0K5EE DRUGINCH 1S/C29H29N3O2/c30-17-21-8-13-28-26(16-21)27-19-32(18-25(27)20-34-28)15-5-4-14-31-29(33)24-11-9-23(10-12-24)22-6-2-1-3-7-22/h1-3,6-13,16,25,27H,4-5,14-15,18-20H2,(H,31,33)/t25-,27+/m1/s1 D0K5EE DRUGINKE QQJHRQZZCNYDMX-VPUSJEBWSA-N D0K5EE DRUGSMIL C1C2COC3=C(C2CN1CCCCNC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)C=C(C=C3)C#N D0K5EE HIGHSTAT Preclinical D0K6NS DRUG__ID D0K6NS D0K6NS DRUGCOMP Schering Plough D0K6NS DRUGTYPE Small molecular drug D0K6NS DRUGINCH 1S/C27H32ClNO2/c1-4-29(5-2)18-19-31-26-16-12-24(13-17-26)27(30,23-10-6-21(3)7-11-23)20-22-8-14-25(28)15-9-22/h6-17,30H,4-5,18-20H2,1-3H3 D0K6NS DRUGINKE SYHDSBBKRLVLFF-UHFFFAOYSA-N D0K6NS DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)C(CC2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)C)O D0K6NS HIGHSTAT Preclinical D0KM7O DRUG__ID D0KM7O D0KM7O THERCLAS Antiviral Agents D0KM7O DRUGTYPE Small molecular drug D0KM7O DRUGINCH 1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1 D0KM7O DRUGINKE PFGVNLZDWRZPJW-OPAMFIHVSA-N D0KM7O DRUGSMIL CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-] D0KM7O HIGHSTAT Preclinical D0L5DZ DRUG__ID D0L5DZ D0L5DZ DRUGCOMP 4SC AG D0L5DZ DRUGTYPE Small molecular drug D0L5DZ DRUGINCH 1S/C23H21N5O3S.C7H8O3S/c1-27-16-19(14-25-27)18-7-9-20(10-8-18)32(30,31)28-13-12-17(15-28)6-11-23(29)26-22-5-3-2-4-21(22)24;1-6-2-4-7(5-3-6)11(8,9)10/h2-16H,24H2,1H3,(H,26,29);2-5H,1H3,(H,8,9,10)/b11-6+; D0L5DZ DRUGINKE IAVXAZDVNICKFJ-ICSBZGNSSA-N D0L5DZ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.CN1C=C(C=N1)C2=CC=C(C=C2)S(=O)(=O)N3C=CC(=C3)C=CC(=O)NC4=CC=CC=C4N D0L5DZ HIGHSTAT Preclinical D0M1YN DRUG__ID D0M1YN D0M1YN DRUGCOMP ARY x Therapeutics D0M1YN DRUGTYPE Small molecular drug D0M1YN DRUGINCH 1S/C24H37N3O2/c1-2-26-22-12-8-9-13-23(22)27(24(26)29)21-14-15-25(17-20(21)18-28)16-19-10-6-4-3-5-7-11-19/h8-9,12-13,19-21,28H,2-7,10-11,14-18H2,1H3/t20-,21+/m0/s1 D0M1YN DRUGINKE MBGVUMXBUGIIBQ-LEWJYISDSA-N D0M1YN DRUGSMIL CCN1C2=CC=CC=C2N(C1=O)C3CCN(CC3CO)CC4CCCCCCC4 D0M1YN HIGHSTAT Preclinical D0M9RE DRUG__ID D0M9RE D0M9RE DRUGCOMP Pfizer Inc D0M9RE DRUGTYPE Small molecular drug D0M9RE DRUGINCH 1S/C13H9ClN2O4S/c1-7-9-6-8(14)2-3-10(9)20-13(7)21(18,19)12-5-4-11(17)15-16-12/h2-6H,1H3,(H,15,17) D0M9RE DRUGINKE FXFPQPNUMWQRAO-UHFFFAOYSA-N D0M9RE DRUGSMIL CC1=C(OC2=C1C=C(C=C2)Cl)S(=O)(=O)C3=NNC(=O)C=C3 D0M9RE HIGHSTAT Preclinical D0MT5C DRUG__ID D0MT5C D0MT5C DRUGCOMP Merck D0MT5C DRUGTYPE Small molecular drug D0MT5C DRUGINCH 1S/C23H25IN2O5S/c24-18-3-11-23(12-4-18)32(29,30)26-19-5-1-17(2-6-19)13-14-25-15-21(28)16-31-22-9-7-20(27)8-10-22/h1-12,21,25-28H,13-16H2/t21-/m0/s1 D0MT5C DRUGINKE ZNTDIRUBXSTBGJ-NRFANRHFSA-N D0MT5C DRUGSMIL C1=CC(=CC=C1CCNCC(COC2=CC=C(C=C2)O)O)NS(=O)(=O)C3=CC=C(C=C3)I D0MT5C HIGHSTAT Preclinical D0N0IQ DRUG__ID D0N0IQ D0N0IQ DRUGCOMP Roche; Millenium D0N0IQ DRUGTYPE Small molecular drug D0N0IQ DRUGINCH 1S/C41H54N10O6/c1-3-12-36(53)47-32(21-27-15-7-8-16-27)38(55)49-33(22-26-13-5-4-6-14-26)39(56)48-31(19-11-20-45-41(43)44)37(54)50-34(40(57)51(2)25-35(42)52)23-28-24-46-30-18-10-9-17-29(28)30/h4-10,13-15,17-18,31-34H,3,11-12,16,19-25H2,1-2H3,(H2,42,52)(H,47,53)(H,48,56)(H,49,55)(H,50,54)(H4,43,44,45)/t31-,32-,33?,34?/m0/s1 D0N0IQ DRUGINKE IRCWGIYPMAYZQR-URRMOVRVSA-N D0N0IQ DRUGSMIL CCCC(=O)NC(CC1=CC=CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=C4C=CC=CC4=NC3)C(=O)N(C)CC(=O)N D0N0IQ HIGHSTAT Preclinical D0N1RG DRUG__ID D0N1RG D0N1RG DRUGCOMP Southern Research Institute D0N1RG DRUGTYPE Small molecular drug D0N1RG DRUGINCH 1S/C29H27ClN2O3/c30-21-6-3-17(4-7-21)20-11-19-13-29(34)23-12-18-5-8-22(33)26-24(18)28(29,27(35-26)25(19)31-14-20)9-10-32(23)15-16-1-2-16/h3-8,11,14,16,23,27,33-34H,1-2,9-10,12-13,15H2/t23-,27+,28+,29-/m1/s1 D0N1RG DRUGINKE WRVDUHKCIPYGNZ-FQYQUSJJSA-N D0N1RG DRUGSMIL C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C=C(C=N6)C8=CC=C(C=C8)Cl D0N1RG HIGHSTAT Preclinical D0N5NM DRUG__ID D0N5NM D0N5NM DRUGCOMP Akzo Nobel D0N5NM DRUGTYPE Small molecular drug D0N5NM DRUGINCH 1S/C26H30F2N2O/c27-23-9-5-20(6-10-23)26(21-7-11-24(28)12-8-21)22-13-18-29(19-14-22)15-3-4-25(31)30-16-1-2-17-30/h5-12H,1-4,13-19H2 D0N5NM DRUGINKE FZWURHPZIJCZOY-UHFFFAOYSA-N D0N5NM DRUGSMIL C1CCN(C1)C(=O)CCCN2CCC(=C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)CC2 D0N5NM HIGHSTAT Preclinical D0NY2E DRUG__ID D0NY2E D0NY2E THERCLAS Antiviral Agents D0NY2E DRUGTYPE Small molecular drug D0NY2E DRUGINCH 1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1 D0NY2E DRUGINKE SRVFFFJZQVENJC-IHRRRGAJSA-N D0NY2E DRUGSMIL CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C D0NY2E HIGHSTAT Preclinical D0P8YC DRUG__ID D0P8YC D0P8YC DRUGCOMP Pfizer D0P8YC DRUGTYPE Small molecular drug D0P8YC DRUGINCH 1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1 D0P8YC DRUGINKE XFILPEOLDIKJHX-QYZOEREBSA-N D0P8YC DRUGSMIL CC(C)CC(C(CSC1=CC=CS1)C(=O)NO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC D0P8YC HIGHSTAT Preclinical D0Q3GV DRUG__ID D0Q3GV D0Q3GV DRUGCOMP Shionogi D0Q3GV DRUGTYPE Small molecular drug D0Q3GV DRUGINCH 1S/C16H22N2O2/c1-2-7-18-8-9-20-15-13-10-12(16(17)19)4-3-11(13)5-6-14(15)18/h3-4,10,14-15H,2,5-9H2,1H3,(H2,17,19)/t14-,15-/m1/s1 D0Q3GV DRUGINKE XKTRZPQOQOCNJU-HUUCEWRRSA-N D0Q3GV DRUGSMIL CCCN1CCOC2C1CCC3=C2C=C(C=C3)C(=O)N D0Q3GV HIGHSTAT Preclinical D0Q3UL DRUG__ID D0Q3UL D0Q3UL DRUGCOMP Parke CDavis D0Q3UL DRUGTYPE Small molecular drug D0Q3UL DRUGINCH 1S/C18H17N3O4S/c1-11(2)12-6-3-4-8-15(12)26(24,25)16-10-14(19)17-13(7-5-9-20-17)18(16)21(22)23/h3-11H,19H2,1-2H3 D0Q3UL DRUGINKE YUVNGBZROXQYQH-UHFFFAOYSA-N D0Q3UL DRUGSMIL CC(C)C1=CC=CC=C1S(=O)(=O)C2=C(C3=C(C(=C2)N)N=CC=C3)[N+](=O)[O-] D0Q3UL HIGHSTAT Preclinical D0R1PZ DRUG__ID D0R1PZ D0R1PZ DRUGCOMP Centre de Recherche Pierre Fabre D0R1PZ DRUGTYPE Small molecular drug D0R1PZ DRUGINCH 1S/C24H29NO2/c1-24(2)16-21-11-6-12-22(23(21)27-24)26-14-13-25-17-18-7-5-10-20(15-18)19-8-3-4-9-19/h5-8,10-12,15,25H,3-4,9,13-14,16-17H2,1-2H3 D0R1PZ DRUGINKE RAIDOKRWKAIHOH-UHFFFAOYSA-N D0R1PZ DRUGSMIL CC1(CC2=C(O1)C(=CC=C2)OCCNCC3=CC(=CC=C3)C4=CCCC4)C D0R1PZ HIGHSTAT Preclinical D0R2CI DRUG__ID D0R2CI D0R2CI DRUGCOMP GSK D0R2CI DRUGTYPE Small molecular drug D0R2CI DRUGINCH 1S/C39H43N5O3.C2HF3O2/c1-47-26-30(24-27-12-3-2-4-13-27)43-38(46)36(22-11-23-42-39(40)41)44-37(45)25-35(33-20-9-16-28-14-5-7-18-31(28)33)34-21-10-17-29-15-6-8-19-32(29)34;3-2(4,5)1(6)7/h2-10,12-21,30,35-36H,11,22-26H2,1H3,(H,43,46)(H,44,45)(H4,40,41,42);(H,6,7)/t30-,36+;/m0./s1 D0R2CI DRUGINKE NZGALICACGXBQM-HOBHVFGFSA-N D0R2CI DRUGSMIL COCC(CC1=CC=CC=C1)NC(=O)C(CCCN=C(N)N)NC(=O)CC(C2=CC=CC3=CC=CC=C32)C4=CC=CC5=CC=CC=C54.C(=O)(C(F)(F)F)O D0R2CI HIGHSTAT Preclinical D0T3JW DRUG__ID D0T3JW D0T3JW DRUGCOMP Pfizer D0T3JW DRUGTYPE Small molecular drug D0T3JW DRUGINCH 1S/C17H27NO2.ClH/c1-5-7-18(8-6-2)15-9-13-11-16(19-3)17(20-4)12-14(13)10-15;/h11-12,15H,5-10H2,1-4H3;1H D0T3JW DRUGINKE NMBUOXDBNWBGIM-UHFFFAOYSA-N D0T3JW DRUGSMIL CCCN(CCC)C1CC2=CC(=C(C=C2C1)OC)OC.Cl D0T3JW HIGHSTAT Preclinical D0T8YK DRUG__ID D0T8YK D0T8YK DRUGCOMP Ardana D0T8YK DRUGTYPE Small molecular drug D0T8YK DRUGINCH 1S/C31H38N4O3/c1-31(2,32)19-11-16-27(36)34(4)26(21-22-17-18-23-12-9-10-15-25(23)20-22)30(38)35(5)28(29(37)33-3)24-13-7-6-8-14-24/h6-18,20,26,28H,19,21,32H2,1-5H3,(H,33,37)/b16-11+/t26-,28-/m1/s1 D0T8YK DRUGINKE DPTDDSCCZNKDBZ-JABCAPRSSA-N D0T8YK DRUGSMIL CC(C)(CC=CC(=O)N(C)C(CC1=CC2=CC=CC=C2C=C1)C(=O)N(C)C(C3=CC=CC=C3)C(=O)NC)N D0T8YK HIGHSTAT Preclinical D0TG4K DRUG__ID D0TG4K D0TG4K DRUGCOMP Oxygen biotherapeutics D0TG4K DRUGTYPE Small molecular drug D0TG4K DRUGINCH 1S/C10F20/c11-2(1(8(22,23)24,9(25,26)27)10(28,29)30)3(12,13)5(16,17)7(20,21)6(18,19)4(2,14)15 D0TG4K DRUGINKE VLTXBOGHSBHSAC-UHFFFAOYSA-N D0TG4K DRUGSMIL C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(C(F)(F)F)C(F)(F)F)F D0TG4K HIGHSTAT Preclinical D0TV4N DRUG__ID D0TV4N D0TV4N DRUGCOMP Takeda D0TV4N DRUGTYPE Small molecular drug D0TV4N DRUGINCH 1S/C26H27FN2O/c1-29(2)17-18-3-4-23-16-25(14-11-22(23)15-18)28-26(30)21-7-5-19(6-8-21)20-9-12-24(27)13-10-20/h5-14,16,18H,3-4,15,17H2,1-2H3,(H,28,30) D0TV4N DRUGINKE GXAQELJVODWLDD-UHFFFAOYSA-N D0TV4N DRUGSMIL CN(C)CC1CCC2=C(C1)C=CC(=C2)NC(=O)C3=CC=C(C=C3)C4=CC=C(C=C4)F D0TV4N HIGHSTAT Preclinical D0U0YR DRUG__ID D0U0YR D0U0YR DRUGCOMP Synaptic D0U0YR DRUGTYPE Small molecular drug D0U0YR DRUGINCH 1S/C31H37F2N5O6/c1-19(39)35-23-7-4-6-21(16-23)20-10-14-37(15-11-20)13-5-12-34-30(41)38-28(22-8-9-24(32)25(33)17-22)27(29(40)44-3)26(18-43-2)36-31(38)42/h4,6-9,16-17,20,28H,5,10-15,18H2,1-3H3,(H,34,41)(H,35,39)(H,36,42)/t28-/m0/s1 D0U0YR DRUGINKE FWMHZWMPUWAUPL-NDEPHWFRSA-N D0U0YR DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)COC)C(=O)OC)C4=CC(=C(C=C4)F)F D0U0YR HIGHSTAT Preclinical D0U1HP DRUG__ID D0U1HP D0U1HP DRUGCOMP Servier D0U1HP DRUGTYPE Small molecular drug D0U1HP DRUGINCH 1S/C19H20F3NO3.Li/c1-23(13-18(24)25)12-11-17(14-5-3-2-4-6-14)26-16-9-7-15(8-10-16)19(20,21)22;/h2-10,17H,11-13H2,1H3,(H,24,25);/q;+1/p-1 D0U1HP DRUGINKE VMQXVSNARQMSDL-UHFFFAOYSA-M D0U1HP DRUGSMIL [Li+].CN(CCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F)CC(=O)[O-] D0U1HP HIGHSTAT Preclinical D0U2FN DRUG__ID D0U2FN D0U2FN DRUGCOMP Roche Holding AG D0U2FN DRUGTYPE Small molecular drug D0U2FN DRUGINCH 1S/C15H16ClNO4/c1-9-12(8-20-15(2,3)14(18)19)21-13(17-9)10-4-6-11(16)7-5-10/h4-7H,8H2,1-3H3,(H,18,19) D0U2FN DRUGINKE LNXXSBRGLBOASF-UHFFFAOYSA-N D0U2FN DRUGSMIL CC1=C(OC(=N1)C2=CC=C(C=C2)Cl)COC(C)(C)C(=O)O D0U2FN HIGHSTAT Preclinical D0U9RR DRUG__ID D0U9RR D0U9RR DRUGCOMP Wyeth Research D0U9RR DRUGTYPE Small molecular drug D0U9RR DRUGINCH 1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H D0U9RR DRUGINKE XSCHRSMBECNVNS-UHFFFAOYSA-N D0U9RR DRUGSMIL C1=CC=C2C(=C1)N=CC=N2 D0U9RR HIGHSTAT Preclinical D0UC6H DRUG__ID D0UC6H D0UC6H THERCLAS Anticancer Agents D0UC6H DRUGTYPE Small molecular drug D0UC6H DRUGINCH 1S/C28H38N4O6/c1-28(2)27(37)30-20(16-18-10-5-3-6-11-18)26(36)32-15-9-13-21(32)25(35)29-19(24(34)31-28)12-7-4-8-14-22(33)23-17-38-23/h3,5-6,10-11,19-21,23H,4,7-9,12-17H2,1-2H3,(H,29,35)(H,30,37)(H,31,34)/t19-,20-,21+,23-/m0/s1 D0UC6H DRUGINKE SGYJGGKDGBXCNY-QXUYBEEESA-N D0UC6H DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCC(=O)C3CO3)CC4=CC=CC=C4)C D0UC6H HIGHSTAT Preclinical D0W0XM DRUG__ID D0W0XM D0W0XM DRUGCOMP NPS Pharmaceuticals Inc D0W0XM DRUGTYPE Small molecular drug D0W0XM DRUGINCH 1S/C19H21N3O/c23-18(17-11-20-15-3-1-2-4-16(15)21-17)22-19-8-12-5-13(9-19)7-14(6-12)10-19/h1-4,11-14H,5-10H2,(H,22,23) D0W0XM DRUGINKE ZKFVOZCCAXQXBU-UHFFFAOYSA-N D0W0XM DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)C4=NC5=CC=CC=C5N=C4 D0W0XM HIGHSTAT Preclinical D0WQ5S DRUG__ID D0WQ5S D0WQ5S DRUGCOMP Pfizer D0WQ5S DRUGTYPE Small molecular drug D0WQ5S DRUGINCH 1S/C20H27N3O/c1-3-24-19-10-7-13-21-20(19)22(2)18-11-14-23(15-12-18)16-17-8-5-4-6-9-17/h4-10,13,18H,3,11-12,14-16H2,1-2H3 D0WQ5S DRUGINKE VNSBZWKWQFCKGO-UHFFFAOYSA-N D0WQ5S DRUGSMIL CCOC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=CC=C3 D0WQ5S HIGHSTAT Preclinical D0WS1V DRUG__ID D0WS1V D0WS1V DRUGCOMP Merck D0WS1V DRUGTYPE Small molecular drug D0WS1V DRUGINCH 1S/C20H25ClN6O3/c1-10(2)15(8-28)24-20-25-17(16-18(26-20)27(9-22-16)11(3)4)23-12-5-6-13(19(29)30)14(21)7-12/h5-7,9-11,15,28H,8H2,1-4H3,(H,29,30)(H2,23,24,25,26)/t15-/m0/s1 D0WS1V DRUGINKE ZKDXRFMOHZVXSG-HNNXBMFYSA-N D0WS1V DRUGSMIL CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=C(C=C3)C(=O)O)Cl D0WS1V HIGHSTAT Preclinical D0X4SI DRUG__ID D0X4SI D0X4SI DRUGCOMP Roche D0X4SI DRUGTYPE Small molecular drug D0X4SI DRUGINCH 1S/C25H27N3O3/c1-17-8-9-22-20(16-17)25(31-24(29)27-22)11-14-28(15-12-25)13-10-21-18(2)30-23(26-21)19-6-4-3-5-7-19/h3-9,16H,10-15H2,1-2H3,(H,27,29) D0X4SI DRUGINKE ODNICNWASXKNNQ-UHFFFAOYSA-N D0X4SI DRUGSMIL CC1=CC2=C(C=C1)NC(=O)OC23CCN(CC3)CCC4=C(OC(=N4)C5=CC=CC=C5)C D0X4SI HIGHSTAT Preclinical D0X5GF DRUG__ID D0X5GF D0X5GF THERCLAS Antiviral Agents D0X5GF DRUGTYPE Small molecular drug D0X5GF DRUGINCH 1S/C7H2Br4N2S/c8-1-2(9)4(11)6-5(3(1)10)12-7(14)13-6/h(H2,12,13,14) D0X5GF DRUGINKE GYVCACUYQFXPLN-UHFFFAOYSA-N D0X5GF DRUGSMIL C12=C(C(=C(C(=C1Br)Br)Br)Br)NC(=S)N2 D0X5GF HIGHSTAT Preclinical D0X5OV DRUG__ID D0X5OV D0X5OV DRUGCOMP Merck & Co Inc D0X5OV DRUGTYPE Small molecular drug D0X5OV DRUGINCH 1S/C22H21F3N4O2/c1-14(19-8-7-18(12-28-19)31-13-22(23,24)25)29-20(30)11-16-3-5-17(6-4-16)21-15(2)26-9-10-27-21/h3-10,12,14H,11,13H2,1-2H3,(H,29,30)/t14-/m1/s1 D0X5OV DRUGINKE OURCOVUGQRXRTE-CQSZACIVSA-N D0X5OV DRUGSMIL CC1=NC=CN=C1C2=CC=C(C=C2)CC(=O)NC(C)C3=NC=C(C=C3)OCC(F)(F)F D0X5OV HIGHSTAT Preclinical D0X6SZ DRUG__ID D0X6SZ D0X6SZ DRUGCOMP University of Minneapolis D0X6SZ DRUGTYPE Small molecular drug D0X6SZ DRUGINCH 1S/C27H29N5O3/c28-25(29)30-15-4-5-18-16(10-15)17-11-27(34)20-9-14-3-6-19(33)23-21(14)26(27,24(35-23)22(17)31-18)7-8-32(20)12-13-1-2-13/h3-6,10,13,20,24,31,33-34H,1-2,7-9,11-12H2,(H4,28,29,30)/t20-,24+,26+,27-/m1/s1 D0X6SZ DRUGINKE VLNHDKDBGWXJEE-GYHUNEDQSA-N D0X6SZ DRUGSMIL C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C=CC(=C8)N=C(N)N D0X6SZ HIGHSTAT Preclinical D0Y6TI DRUG__ID D0Y6TI D0Y6TI DRUGCOMP Astellas D0Y6TI DRUGTYPE Small molecular drug D0Y6TI DRUGINCH 1S/C29H31FN4O3/c1-19-12-26(35)28(31-16-19)29(37)34-10-6-20(7-11-34)14-27(36)32-25-8-9-33(18-25)17-21-2-3-23-15-24(30)5-4-22(23)13-21/h2-5,12-16,25,35H,6-11,17-18H2,1H3,(H,32,36)/t25-/m1/s1 D0Y6TI DRUGINKE LHTPHICFHRATTG-RUZDIDTESA-N D0Y6TI DRUGSMIL CC1=CC(=C(N=C1)C(=O)N2CCC(=CC(=O)NC3CCN(C3)CC4=CC5=C(C=C4)C=C(C=C5)F)CC2)O D0Y6TI HIGHSTAT Preclinical D0YQ9P DRUG__ID D0YQ9P D0YQ9P THERCLAS Antiviral Agents D0YQ9P DRUGTYPE Small molecular drug D0YQ9P DRUGINCH 1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23) D0YQ9P DRUGINKE OVCDSSHSILBFBN-UHFFFAOYSA-N D0YQ9P DRUGSMIL CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O D0YQ9P HIGHSTAT Preclinical D1AD6L DRUG__ID D1AD6L D1AD6L DRUGCOMP NeoPharm D1AD6L DRUGTYPE Small molecular drug D1AD6L DRUGINCH 1S/C31H23F2N5O3/c1-18-27(31(40)38(37(18)2)22-11-8-20(32)9-12-22)30(39)36-21-10-13-25(24(33)16-21)41-26-14-15-34-29-28(26)23(17-35-29)19-6-4-3-5-7-19/h3-17H,1-2H3,(H,34,35)(H,36,39) D1AD6L DRUGINKE RGAZVGZUBCFHRJ-UHFFFAOYSA-N D1AD6L DRUGSMIL CC1=C(C(=O)N(N1C)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C5C(=CNC5=NC=C4)C6=CC=CC=C6)F D1AD6L HIGHSTAT Preclinical D2D9CN DRUG__ID D2D9CN D2D9CN DRUGCOMP InvivoGen D2D9CN DRUGTYPE Small molecular drug D2D9CN DRUGINCH 1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9,13-14,16,19H,10-12H2,1-4H3,(H,24,30)(H,25,29)(H,26,31)/t14-,16-,19-/m0/s1 D2D9CN DRUGINKE MIFGOLAMNLSLGH-QOKNQOGYSA-N D2D9CN DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)OCC1=CC=CC=C1 D2D9CN HIGHSTAT Preclinical D2K6DU DRUG__ID D2K6DU D2K6DU DRUGCOMP Progenra D2K6DU DRUGTYPE Small molecular drug D2K6DU DRUGINCH 1S/C12H7F2NO3S2/c1-6(16)11-5-9(15(17)18)12(20-11)19-10-3-2-7(13)4-8(10)14/h2-5H,1H3 D2K6DU DRUGINKE RMAMGGNACJHXHO-UHFFFAOYSA-N D2K6DU DRUGSMIL CC(=O)C1=CC(=C(S1)SC2=C(C=C(C=C2)F)F)[N+](=O)[O-] D2K6DU HIGHSTAT Preclinical D4X9MD DRUG__ID D4X9MD D4X9MD DRUGCOMP Hybrigenics D4X9MD DRUGTYPE Small molecular drug D4X9MD DRUGINCH 1S/C15H9N5O/c1-2-21-20-14-10-6-4-3-5-9(10)13-15(14)19-12(8-17)11(7-16)18-13/h3-6H,2H2,1H3 D4X9MD DRUGINKE VKVAJBRQGBRHIK-UHFFFAOYSA-N D4X9MD DRUGSMIL CCON=C1C2=CC=CC=C2C3=NC(=C(N=C31)C#N)C#N D4X9MD HIGHSTAT Preclinical D5Q4NY DRUG__ID D5Q4NY D5Q4NY DRUGCOMP TB D5Q4NY DRUGTYPE Small molecule D5Q4NY DRUGINCH InChI=1S/C29H29F3N4O3/c1-19-27(26-17-25(38-2)13-16-36(26)34-19)28(37)33-18-20-3-7-23(8-4-20)35-14-11-22(12-15-35)21-5-9-24(10-6-21)39-29(30,31)32/h3-10,13,16-17,22H,11-12,14-15,18H2,1-2H3,(H,33,37) D5Q4NY DRUGINKE HQECXZKIRDUGLC-UHFFFAOYSA-N D5Q4NY DRUGSMIL CC1=NN2C=CC(=CC2=C1C(=O)NCC3=CC=C(C=C3)N4CCC(CC4)C5=CC=C(C=C5)OC(F)(F)F)OC D5Q4NY HIGHSTAT Preclinical D70HIN DRUG__ID D70HIN D70HIN DRUGCOMP Merck D70HIN DRUGTYPE Small molecular drug D70HIN DRUGINCH 1S/C23H24ClN5O/c1-28-15-18(12-27-28)16-2-4-17(5-3-16)19-13-25-14-20(24)21(19)29-10-7-23(8-11-29)6-9-26-22(23)30/h2-5,12-15H,6-11H2,1H3,(H,26,30) D70HIN DRUGINKE LBFYQISQYCGDDW-UHFFFAOYSA-N D70HIN DRUGSMIL CN1C=C(C=N1)C2=CC=C(C=C2)C3=CN=CC(=C3N4CCC5(CCNC5=O)CC4)Cl D70HIN HIGHSTAT Preclinical D83YSR DRUG__ID D83YSR D83YSR DRUGCOMP Glaxo Wellcome D83YSR DRUGTYPE Small molecular drug D83YSR DRUGINCH 1S/C15H11FN2/c16-13-5-6-14-12(10-18-15(14)8-13)4-3-11-2-1-7-17-9-11/h1-10,18H/b4-3+ D83YSR DRUGINKE YBSDQTBCNYWBMX-ONEGZZNKSA-N D83YSR DRUGSMIL C1=CC(=CN=C1)C=CC2=CNC3=C2C=CC(=C3)F D83YSR HIGHSTAT Preclinical D86ILE DRUG__ID D86ILE D86ILE DRUGCOMP Exonate D86ILE DRUGTYPE Small molecular drug D86ILE DRUGINCH 1S/C27H24F3N5O2/c28-27(29,30)20-4-5-23(35-15-13-34(14-16-35)18-21-3-1-2-10-32-21)22(17-20)33-26(36)25-7-6-24(37-25)19-8-11-31-12-9-19/h1-12,17H,13-16,18H2,(H,33,36) D86ILE DRUGINKE VURLRACCOCGFDB-UHFFFAOYSA-N D86ILE DRUGSMIL C1CN(CCN1CC2=CC=CC=N2)C3=C(C=C(C=C3)C(F)(F)F)NC(=O)C4=CC=C(O4)C5=CC=NC=C5 D86ILE HIGHSTAT Preclinical D9PBQ8 DRUG__ID D9PBQ8 D9PBQ8 DRUGCOMP Pfizer D9PBQ8 DRUGTYPE Small molecular drug D9PBQ8 DRUGINCH 1S/C9H10N2O2/c10-7-5-6-3-1-2-4-8(6)11(13)9(7)12/h1-4,7,13H,5,10H2/t7-/m0/s1 D9PBQ8 DRUGINKE HYTRYTZFJVVZAF-ZETCQYMHSA-N D9PBQ8 DRUGSMIL C1C(C(=O)N(C2=CC=CC=C21)O)N D9PBQ8 HIGHSTAT Preclinical D9Y2KA DRUG__ID D9Y2KA D9Y2KA DRUGCOMP Genentech D9Y2KA DRUGTYPE Small molecular drug D9Y2KA DRUGINCH 1S/C6H5FN4O/c7-4-1-9-11(3-4)5-2-10-12-6(5)8/h1-3H,8H2 D9Y2KA DRUGINKE YCBKZPFCIBXKIG-UHFFFAOYSA-N D9Y2KA DRUGSMIL C1=C(C=NN1C2=C(ON=C2)N)F D9Y2KA HIGHSTAT Preclinical DA0OZ2 DRUG__ID DA0OZ2 DA0OZ2 DRUGCOMP Hybrigenics DA0OZ2 DRUGTYPE Small molecular drug DA0OZ2 DRUGINCH 1S/C25H28ClN3O/c1-29(17-18-8-3-2-4-9-18)15-7-14-27-25(30)19-12-13-23-21(16-19)24(26)20-10-5-6-11-22(20)28-23/h2-4,8-9,12-13,16H,5-7,10-11,14-15,17H2,1H3,(H,27,30) DA0OZ2 DRUGINKE ZCALMLVWZSQGGR-UHFFFAOYSA-N DA0OZ2 DRUGSMIL CN(CCCNC(=O)C1=CC2=C(C=C1)N=C3CCCCC3=C2Cl)CC4=CC=CC=C4 DA0OZ2 HIGHSTAT Preclinical DAD9V4 DRUG__ID DAD9V4 DAD9V4 DRUGCOMP GlaxoSmithKline DAD9V4 DRUGTYPE Small molecular drug DAD9V4 DRUGINCH 1S/C17H12FN3/c18-13-3-1-2-11(8-13)4-5-12-6-7-14-15(10-19)17(20)21-16(14)9-12/h1-9,21H,20H2/b5-4+ DAD9V4 DRUGINKE CGXBPMZRTMXEIA-SNAWJCMRSA-N DAD9V4 DRUGSMIL C1=CC(=CC(=C1)F)C=CC2=CC3=C(C=C2)C(=C(N3)N)C#N DAD9V4 HIGHSTAT Preclinical DAQ4G0 DRUG__ID DAQ4G0 DAQ4G0 DRUGCOMP Chinese Academy of Sciences DAQ4G0 DRUGTYPE Small molecular drug DAQ4G0 DRUGINCH 1S/C22H30O4/c1-13-14-4-7-22(19(13)25)16(10-14)21-6-3-5-20(2,15(21)11-17(22)23)8-9-26-12-18(21)24/h14-17,23H,1,3-12H2,2H3/t14-,15+,16-,17+,20-,21-,22+/m0/s1 DAQ4G0 DRUGINKE RCPPZYXWUAJXMA-KGYWYPJXSA-N DAQ4G0 DRUGSMIL CC12CCCC3(C1CC(C45C3CC(CC4)C(=C)C5=O)O)C(=O)COCC2 DAQ4G0 HIGHSTAT Preclinical DB0V3R DRUG__ID DB0V3R DB0V3R DRUGCOMP Shanghai Institute of Organic Chemistry; Harvard Medical School DB0V3R DRUGTYPE Small molecular drug DB0V3R DRUGINCH 1S/C15H11F2N3/c16-11-3-1-10(2-4-11)8-18-15-13-7-12(17)5-6-14(13)19-9-20-15/h1-7,9H,8H2,(H,18,19,20) DB0V3R DRUGINKE AWIVHRPYFSSVOG-UHFFFAOYSA-N DB0V3R DRUGSMIL C1=CC(=CC=C1CNC2=NC=NC3=C2C=C(C=C3)F)F DB0V3R HIGHSTAT Preclinical DCIP24 DRUG__ID DCIP24 DCIP24 DRUGCOMP Brigham and Women's Hospital DCIP24 DRUGTYPE Small molecular drug DCIP24 DRUGINCH 1S/C17H11Cl3N2O3/c1-9(23)25-21-16-13-7-12(19)3-5-15(13)22(17(16)24)8-10-6-11(18)2-4-14(10)20/h2-7H,8H2,1H3/b21-16- DCIP24 DRUGINKE OPQRFPHLZZPCCH-PGMHBOJBSA-N DCIP24 DRUGSMIL CC(=O)ON=C1C2=C(C=CC(=C2)Cl)N(C1=O)CC3=C(C=CC(=C3)Cl)Cl DCIP24 HIGHSTAT Preclinical DF1S3A DRUG__ID DF1S3A DF1S3A DRUGCOMP GlaxoSmithKline DF1S3A DRUGTYPE Small molecular drug DF1S3A DRUGINCH 1S/C10H7Cl2NO4/c11-5-3-7-8(4-6(5)12)17-10(16)13(7)2-1-9(14)15/h3-4H,1-2H2,(H,14,15) DF1S3A DRUGINKE MIGAKMWKMLYGJX-UHFFFAOYSA-N DF1S3A DRUGSMIL C1=C2C(=CC(=C1Cl)Cl)OC(=O)N2CCC(=O)O DF1S3A HIGHSTAT Preclinical DJ7Z5W DRUG__ID DJ7Z5W DJ7Z5W DRUGCOMP Roche DJ7Z5W DRUGTYPE Small molecular drug DJ7Z5W DRUGINCH 1S/C17H15N3O6S2/c1-25-15-7-6-13(9-16(15)26-2)28(23,24)19-17-18-14(10-27-17)11-4-3-5-12(8-11)20(21)22/h3-10H,1-2H3,(H,18,19) DJ7Z5W DRUGINKE NDPBMCKQJOZAQX-UHFFFAOYSA-N DJ7Z5W DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)NC2=NC(=CS2)C3=CC(=CC=C3)[N+](=O)[O-])OC DJ7Z5W HIGHSTAT Preclinical DNZ96J DRUG__ID DNZ96J DNZ96J DRUGCOMP Intercept DNZ96J DRUGTYPE Small molecular drug DNZ96J DRUGINCH 1S/C25H44O6S.Na/c1-5-17-21-14-16(26)8-11-25(21,4)20-9-12-24(3)18(6-7-19(24)22(20)23(17)27)15(2)10-13-31-32(28,29)30;/h15-23,26-27H,5-14H2,1-4H3,(H,28,29,30);/q;+1/p-1/t15-,16-,17-,18-,19+,20+,21+,22+,23-,24-,25-;/m1./s1 DNZ96J DRUGINKE TXIWHUPIUUZFFK-PMWRKVJASA-M DNZ96J DRUGSMIL CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCOS(=O)(=O)[O-])C)C)O.[Na+] DNZ96J HIGHSTAT Preclinical DV3KC5 DRUG__ID DV3KC5 DV3KC5 DRUGCOMP Progenra DV3KC5 DRUGTYPE Small molecular drug DV3KC5 DRUGINCH 1S/C12H7Cl2NO3S2/c1-6(16)10-5-8(15(17)18)12(20-10)19-9-4-2-3-7(13)11(9)14/h2-5H,1H3 DV3KC5 DRUGINKE LKZLGMAAKNEGCH-UHFFFAOYSA-N DV3KC5 DRUGSMIL CC(=O)C1=CC(=C(S1)SC2=C(C(=CC=C2)Cl)Cl)[N+](=O)[O-] DV3KC5 HIGHSTAT Preclinical DW0D7G DRUG__ID DW0D7G DW0D7G DRUGCOMP Genentech DW0D7G DRUGTYPE Small molecular drug DW0D7G DRUGINCH 1S/C23H24N6O3/c1-28-18-13-24-20(32-2)12-15(18)8-9-16(23(28)31)25-22(30)21-26-19-11-10-17(29(19)27-21)14-6-4-3-5-7-14/h3-7,12-13,16-17H,8-11H2,1-2H3,(H,25,30)/t16-,17-/m0/s1 DW0D7G DRUGINKE JXFYROJRZJPKTQ-IRXDYDNUSA-N DW0D7G DRUGSMIL CN1C2=CN=C(C=C2CCC(C1=O)NC(=O)C3=NN4C(CCC4=N3)C5=CC=CC=C5)OC DW0D7G HIGHSTAT Preclinical DW0Z1Y DRUG__ID DW0Z1Y DW0Z1Y DRUGCOMP Proteostasis Therapeutics DW0Z1Y DRUGTYPE Small molecular drug DW0Z1Y DRUGINCH 1S/C18H21FN2O/c1-13-11-17(18(22)12-20-9-3-4-10-20)14(2)21(13)16-7-5-15(19)6-8-16/h5-8,11H,3-4,9-10,12H2,1-2H3 DW0Z1Y DRUGINKE JUWDSDKJBMFLHE-UHFFFAOYSA-N DW0Z1Y DRUGSMIL CC1=CC(=C(N1C2=CC=C(C=C2)F)C)C(=O)CN3CCCC3 DW0Z1Y HIGHSTAT Preclinical DWR6A9 DRUG__ID DWR6A9 DWR6A9 DRUGCOMP National Institutes of Health DWR6A9 DRUGTYPE Small molecular drug DWR6A9 DRUGINCH 1S/C24H18F3N3O3S2/c1-15-7-10-18(11-8-15)35(32,33)30-20-13-17(24(25,26)27)9-12-19(20)22(31)29-23-28-21(14-34-23)16-5-3-2-4-6-16/h2-14,30H,1H3,(H,28,29,31) DWR6A9 DRUGINKE QZUGMNXETPARLI-UHFFFAOYSA-N DWR6A9 DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=C(C=CC(=C2)C(F)(F)F)C(=O)NC3=NC(=CS3)C4=CC=CC=C4 DWR6A9 HIGHSTAT Preclinical DY0HV9 DRUG__ID DY0HV9 DY0HV9 DRUGCOMP GlaxoSmithKline DY0HV9 DRUGTYPE Small molecular drug DY0HV9 DRUGINCH 1S/C17H16ClN3O4/c1-9-3-4-13(20-19-9)10(2)24-16-8-15-11(7-12(16)18)14(21-25-15)5-6-17(22)23/h3-4,7-8,10H,5-6H2,1-2H3,(H,22,23)/t10-/m1/s1 DY0HV9 DRUGINKE YWASLAPMFGBZQP-SNVBAGLBSA-N DY0HV9 DRUGSMIL CC1=NN=C(C=C1)C(C)OC2=C(C=C3C(=C2)ON=C3CCC(=O)O)Cl DY0HV9 HIGHSTAT Preclinical D00GES DRUG__ID D00GES D00GES DRUGCOMP Jenrin Discovery Inc. D00GES DRUGINCH 1S/C27H27Cl2N5O3S/c1-17(2)24(26(30)35)31-27(33-38(36,37)22-14-12-21(29)13-15-22)34-16-23(18-6-4-3-5-7-18)25(32-34)19-8-10-20(28)11-9-19/h3-15,17,23-24H,16H2,1-2H3,(H2,30,35)(H,31,33)/t23-,24+/m1/s1 D00GES DRUGINKE GTCSIQFTNPTSLO-RPWUZVMVSA-N D00GES DRUGSMIL CC(C)C(C(=O)N)N=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4 D00GES HIGHSTAT Preclinical D00JGL DRUG__ID D00JGL D00JGL DRUGTYPE Small molecular drug D00JGL DRUGINCH 1S/C23H18N4O3/c24-22(28)14-4-6-15(7-5-14)23-26-20(21(27-23)17-3-1-2-10-25-17)16-8-9-18-19(13-16)30-12-11-29-18/h1-10,13H,11-12H2,(H2,24,28)(H,26,27) D00JGL DRUGINKE DPDZHVCKYBCJHW-UHFFFAOYSA-N D00JGL DRUGSMIL C1COC2=C(O1)C=CC(=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 D00JGL HIGHSTAT Preclinical D00KJO DRUG__ID D00KJO D00KJO DRUGCOMP Mutabilis SA D00KJO DRUGINCH 1S/C15H13F2NO3/c1-2-8-6-12(19)14(7-10(8)16)21-13-4-3-9(15(18)20)5-11(13)17/h3-7,19H,2H2,1H3,(H2,18,20) D00KJO DRUGINKE QUHARGDBJJUOEB-UHFFFAOYSA-N D00KJO DRUGSMIL CCC1=CC(=C(C=C1F)OC2=C(C=C(C=C2)C(=O)N)F)O D00KJO HIGHSTAT Preclinical D00MIX DRUG__ID D00MIX D00MIX DRUGCOMP Pfizer D00MIX DRUGINCH 1S/C17H19F3N2O4S/c1-10(6-11-2-4-12(5-3-11)26-8-15(24)25)21-7-14(23)13-9-27-16(22-13)17(18,19)20/h2-5,9-10,14,21,23H,6-8H2,1H3,(H,24,25)/t10-,14+/m1/s1 D00MIX DRUGINKE YVIXXPCJZAUQHJ-YGRLFVJLSA-N D00MIX DRUGSMIL CC(CC1=CC=C(C=C1)OCC(=O)O)NCC(C2=CSC(=N2)C(F)(F)F)O D00MIX HIGHSTAT Preclinical D00QAX DRUG__ID D00QAX D00QAX DRUGCOMP Pfizer Inc D00QAX DRUGINCH 1S/C15H17N3O4/c1-8(2)18-11-4-3-10(5-9(11)6-13(18)19)17-7-12(14(16)20)22-15(17)21/h3-5,8,12H,6-7H2,1-2H3,(H2,16,20)/t12-/m1/s1 D00QAX DRUGINKE FKMDICPKYZOJFW-GFCCVEGCSA-N D00QAX DRUGSMIL CC(C)N1C(=O)CC2=C1C=CC(=C2)N3CC(OC3=O)C(=O)N D00QAX HIGHSTAT Preclinical D00UQF DRUG__ID D00UQF D00UQF DRUGTYPE Small molecular drug D00UQF DRUGINCH 1S/C28H22Cl3NO4/c1-16(2)27-21(26(32-36-27)25-22(29)7-4-8-23(25)30)15-35-20-12-11-18(24(31)14-20)10-9-17-5-3-6-19(13-17)28(33)34/h3-14,16H,15H2,1-2H3,(H,33,34)/b10-9+ D00UQF DRUGINKE BYTNEISLBIENSA-MDZDMXLPSA-N D00UQF DRUGSMIL CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC(=C(C=C3)C=CC4=CC(=CC=C4)C(=O)O)Cl D00UQF HIGHSTAT Preclinical D01GHV DRUG__ID D01GHV D01GHV DRUGTYPE Small molecular drug D01GHV DRUGINCH 1S/C21H24FN5O6.ClH/c1-14(28)23-11-17-13-26(21(29)33-17)15-2-4-19(18(22)10-15)25-8-6-24(7-9-25)12-16-3-5-20(32-16)27(30)31;/h2-5,10,17H,6-9,11-13H2,1H3,(H,23,28);1H/t17-;/m0./s1 D01GHV DRUGINKE XYGNKPXLGBABKJ-LMOVPXPDSA-N D01GHV DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)CC4=CC=C(O4)[N+](=O)[O-])F.Cl D01GHV HIGHSTAT Preclinical D02KGR DRUG__ID D02KGR D02KGR DRUGTYPE Small molecular drug D02KGR DRUGINCH 1S/C34H50O12/c1-9-12-13-14-15-17-24(37)43-28-26-25(20(5)27(28)44-30(38)19(4)11-3)29-34(41,33(8,40)31(39)45-29)22(42-23(36)16-10-2)18-32(26,7)46-21(6)35/h11,22,26-29,40-41H,9-10,12-18H2,1-8H3/b19-11-/t22-,26+,27-,28-,29-,32-,33+,34+/m0/s1 D02KGR DRUGINKE IXFPJGBNCFXKPI-FSIHEZPISA-N D02KGR DRUGSMIL CCCCCCCC(=O)OC1C2C(=C(C1OC(=O)C(=CC)C)C)C3C(C(CC2(C)OC(=O)C)OC(=O)CCC)(C(C(=O)O3)(C)O)O D02KGR HIGHSTAT Preclinical D02PSZ DRUG__ID D02PSZ D02PSZ DRUGCOMP Abbott D02PSZ DRUGINCH 1S/C44H56N8O9/c1-27-15-9-11-19-31(27)50-42(59)46-22-14-13-21-33(41(58)52(5)36(25-37(53)54)40(57)49-34(38(45)55)23-28-16-7-6-8-17-28)48-39(56)35(51-43(60)61-44(2,3)4)24-29-26-47-32-20-12-10-18-30(29)32/h6-12,15-20,26,33-36,47H,13-14,21-25H2,1-5H3,(H2,45,55)(H,48,56)(H,49,57)(H,51,60)(H,53,54)(H2,46,50,59)/t33-,34-,35-,36-/m0/s1 D02PSZ DRUGINKE KONMZUWCOVKBMG-ZYADHFCISA-N D02PSZ DRUGSMIL CC1=CC=CC=C1NC(=O)NCCCCC(C(=O)N(C)C(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)OC(C)(C)C D02PSZ HIGHSTAT Preclinical D02VBF DRUG__ID D02VBF D02VBF DRUGTYPE Small molecular drug D02VBF DRUGINCH 1S/C19H23F2N5O2/c1-10(2)5-6-26-11(3)18(28)25(4)15-9-22-19(24-17(15)26)23-12-7-13(20)16(27)14(21)8-12/h7-11,27H,5-6H2,1-4H3,(H,22,23,24) D02VBF DRUGINKE DTEKTGDVSARYDS-UHFFFAOYSA-N D02VBF DRUGSMIL CC1C(=O)N(C2=CN=C(N=C2N1CCC(C)C)NC3=CC(=C(C(=C3)F)O)F)C D02VBF HIGHSTAT Preclinical D02VOJ DRUG__ID D02VOJ D02VOJ DRUGTYPE Small molecular drug D02VOJ DRUGINCH 1S/C21H19F2N3O3/c1-2-29-12-26-17-11-13(22)7-8-16(17)25-10-9-18(27)19(21(25)26)20(28)24-15-6-4-3-5-14(15)23/h3-8,11H,2,9-10,12H2,1H3,(H,24,28) D02VOJ DRUGINKE VQOQDABVGWLROX-UHFFFAOYSA-N D02VOJ DRUGSMIL CCOCN1C2=C(C=CC(=C2)F)N3C1=C(C(=O)CC3)C(=O)NC4=CC=CC=C4F D02VOJ HIGHSTAT Preclinical D02YIW DRUG__ID D02YIW D02YIW DRUGTYPE Small molecular drug D02YIW DRUGINCH 1S/C12H18ClN7O/c13-8-10(20-5-3-1-2-4-6-20)18-9(14)7(17-8)11(21)19-12(15)16/h1-6H2,(H2,14,18)(H4,15,16,19,21) D02YIW DRUGINKE RQQJJXVETXFINY-UHFFFAOYSA-N D02YIW DRUGSMIL C1CCCN(CC1)C2=NC(=C(N=C2Cl)C(=O)N=C(N)N)N D02YIW HIGHSTAT Preclinical D03GWY DRUG__ID D03GWY D03GWY DRUGTYPE Small molecular drug D03GWY DRUGINCH 1S/C18H23NO3S/c1-18(9-3-2-4-10-18)12-22-14-7-5-13(6-8-14)11-15-16(20)19-17(21)23-15/h5-8,15H,2-4,9-12H2,1H3,(H,19,20,21) D03GWY DRUGINKE YZFWTZACSRHJQD-UHFFFAOYSA-N D03GWY DRUGSMIL CC1(CCCCC1)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D03GWY HIGHSTAT Preclinical D03SZR DRUG__ID D03SZR D03SZR DRUGTYPE Small molecular drug D03SZR DRUGINCH 1S/C10H10N2O4/c13-9(11-15)5-4-7-2-1-3-8(6-7)10(14)12-16/h1-6,15-16H,(H,11,13)(H,12,14)/b5-4+ D03SZR DRUGINKE OYKBQNOPCSXWBL-SNAWJCMRSA-N D03SZR DRUGSMIL C1=CC(=CC(=C1)C(=O)NO)C=CC(=O)NO D03SZR HIGHSTAT Preclinical D03TJN DRUG__ID D03TJN D03TJN DRUGCOMP Memorial Sloan-Kettering Cancer Center D03TJN DRUGINCH 1S/C27H36F3NO6/c1-15-8-7-9-19(27(28,29)30)10-11-21(16(2)12-20-13-17(3)37-31-20)36-23(33)14-22(32)26(5,6)25(35)18(4)24(15)34/h7-8,10,12-13,15,18,21-22,24,32,34H,9,11,14H2,1-6H3/b8-7+,16-12+,19-10+/t15-,18+,21-,22-,24-/m0/s1 D03TJN DRUGINKE DNCHSYUWCVTLJJ-PHNYORQKSA-N D03TJN DRUGSMIL CC1C=CCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=NOC(=C2)C)C)C(F)(F)F D03TJN HIGHSTAT Preclinical D04FAI DRUG__ID D04FAI D04FAI DRUGCOMP Scios Inc D04FAI DRUGINCH 1S/C27H30FN3O4/c1-29(2)27(34)25(32)22-16-30(3)23-15-24(35-4)21(14-20(22)23)26(33)31-11-9-18(10-12-31)13-17-5-7-19(28)8-6-17/h5-8,14-16,18H,9-13H2,1-4H3 D04FAI DRUGINKE JBNWDYGOTHQHOZ-UHFFFAOYSA-N D04FAI DRUGSMIL CN1C=C(C2=CC(=C(C=C21)OC)C(=O)N3CCC(CC3)CC4=CC=C(C=C4)F)C(=O)C(=O)N(C)C D04FAI HIGHSTAT Preclinical D04WDX DRUG__ID D04WDX D04WDX DRUGTYPE Small molecular drug D04WDX DRUGINCH 1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22) D04WDX DRUGINKE UYJZZVDLGDDTCL-UHFFFAOYSA-N D04WDX DRUGSMIL CN(C)CC(=O)NC1=CC2=C(C=C1)NC(=O)C3=CC=CC=C32 D04WDX HIGHSTAT Preclinical D05HCO DRUG__ID D05HCO D05HCO DRUGCOMP Glaxo Wellcome plc D05HCO DRUGINCH 1S/C16H21N5/c1-4-10(5-2)21-9(3)8-11-13(21)7-6-12-14(11)15(17)20-16(18)19-12/h6-8,10H,4-5H2,1-3H3,(H4,17,18,19,20) D05HCO DRUGINKE YBHNZQJIFKDDHM-UHFFFAOYSA-N D05HCO DRUGSMIL CCC(CC)N1C(=CC2=C1C=CC3=C2C(=NC(=N3)N)N)C D05HCO HIGHSTAT Preclinical D05XIA DRUG__ID D05XIA D05XIA DRUGTYPE Small molecular drug D05XIA DRUGINCH 1S/C15H17ClN2O2S2/c16-14-8-9-15(21-14)22(19,20)17-12-6-2-3-7-13(12)18-10-4-1-5-11-18/h2-3,6-9,17H,1,4-5,10-11H2 D05XIA DRUGINKE RXDWTDRPUXJDPY-UHFFFAOYSA-N D05XIA DRUGSMIL C1CCN(CC1)C2=CC=CC=C2NS(=O)(=O)C3=CC=C(S3)Cl D05XIA HIGHSTAT Preclinical D06IHW DRUG__ID D06IHW D06IHW DRUGTYPE Small molecular drug D06IHW DRUGINCH 1S/C22H14O4/c23-21(24)17-11-9-13-5-1-3-7-15(13)19(17)20-16-8-4-2-6-14(16)10-12-18(20)22(25)26/h1-12H,(H,23,24)(H,25,26) D06IHW DRUGINKE YDZNRNHKJQTGCG-UHFFFAOYSA-N D06IHW DRUGSMIL C1=CC=C2C(=C1)C=CC(=C2C3=C(C=CC4=CC=CC=C43)C(=O)O)C(=O)O D06IHW HIGHSTAT Preclinical D06ONB DRUG__ID D06ONB D06ONB DRUGTYPE Small molecular drug D06ONB DRUGINCH 1S/C29H38Cl2N4O4/c30-23-8-6-20(18-24(23)31)10-13-32-15-12-27(38)35(22-4-2-1-3-5-22)17-16-33-14-11-21-7-9-25(36)28-29(21)39-19-26(37)34-28/h6-9,18,22,32-33,36H,1-5,10-17,19H2,(H,34,37) D06ONB DRUGINKE LIBVHXXKHSODII-UHFFFAOYSA-N D06ONB DRUGSMIL C1CCC(CC1)N(CCNCCC2=C3C(=C(C=C2)O)NC(=O)CO3)C(=O)CCNCCC4=CC(=C(C=C4)Cl)Cl D06ONB HIGHSTAT Preclinical D06PPL DRUG__ID D06PPL D06PPL DRUGTYPE Small molecular drug D06PPL DRUGINCH 1S/C28H38N6O2/c1-32-12-7-13-34(17-16-32)28-30-24-19-26(36-3)25(35-2)18-23(24)27(31-28)29-22-10-14-33(15-11-22)20-21-8-5-4-6-9-21/h4-6,8-9,18-19,22H,7,10-17,20H2,1-3H3,(H,29,30,31) D06PPL DRUGINKE OSXFATOLZGZLSK-UHFFFAOYSA-N D06PPL DRUGSMIL CN1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)NC4CCN(CC4)CC5=CC=CC=C5)OC)OC D06PPL HIGHSTAT Preclinical D06QYR DRUG__ID D06QYR D06QYR DRUGTYPE Small molecular drug D06QYR DRUGINCH 1S/C17H18ClN5O2/c18-11-2-1-3-13(8-11)25-9-14-15-16(19)20-10-21-17(15)23(22-14)12-4-6-24-7-5-12/h1-3,8,10,12H,4-7,9H2,(H2,19,20,21) D06QYR DRUGINKE AUMDBEHGJRZSOO-UHFFFAOYSA-N D06QYR DRUGSMIL C1COCCC1N2C3=NC=NC(=C3C(=N2)COC4=CC(=CC=C4)Cl)N D06QYR HIGHSTAT Preclinical D06YFT DRUG__ID D06YFT D06YFT DRUGTYPE Small molecular drug D06YFT DRUGINCH 1S/C12H14N2O2/c1-14-7-8(6-10(13)12(15)16)9-4-2-3-5-11(9)14/h2-5,7,10H,6,13H2,1H3,(H,15,16)/t10-/m0/s1 D06YFT DRUGINKE ZADWXFSZEAPBJS-JTQLQIEISA-N D06YFT DRUGSMIL CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N D06YFT HIGHSTAT Preclinical D07IZG DRUG__ID D07IZG D07IZG DRUGTYPE Small molecular drug D07IZG DRUGINCH 1S/C18H21ClN2O4S/c1-18(2,3)25-17(22)12-20(10-13-4-6-14(19)7-5-13)11-15-8-9-16(26-15)21(23)24/h4-9H,10-12H2,1-3H3 D07IZG DRUGINKE WYSLOKHVFKLWOU-UHFFFAOYSA-N D07IZG DRUGSMIL CC(C)(C)OC(=O)CN(CC1=CC=C(C=C1)Cl)CC2=CC=C(S2)[N+](=O)[O-] D07IZG HIGHSTAT Preclinical D07JSI DRUG__ID D07JSI D07JSI DRUGTYPE Small molecular drug D07JSI DRUGINCH 1S/C26H33NO5/c1-3-4-5-6-16-24(30)27-17-10-14-21-18-23(29)19(2)11-7-8-12-20-13-9-15-22(28)25(20)26(31)32-21/h4-10,13,15-17,19,21,23,28-29H,3,11-12,14,18H2,1-2H3,(H,27,30)/b5-4-,8-7+,16-6-,17-10+/t19-,21-,23+/m0/s1 D07JSI DRUGINKE VFCUJHFLFHQCRD-PFIOQAQVSA-N D07JSI DRUGSMIL CCC=CC=CC(=O)NC=CCC1CC(C(CC=CCC2=C(C(=CC=C2)O)C(=O)O1)C)O D07JSI HIGHSTAT Preclinical D08MCT DRUG__ID D08MCT D08MCT DRUGCOMP BMS D08MCT DRUGINCH 1S/C21H18O9/c1-8(22)14-13(24)7-20(28)6-10-3-9-4-11(30-2)5-12(23)15(9)17(25)16(10)19(27)21(20,29)18(14)26/h3-5,23,25-26,28-29H,6-7H2,1-2H3 D08MCT DRUGINKE GEIAHRUFSQGALU-UHFFFAOYSA-N D08MCT DRUGSMIL CC(=O)C1=C(C2(C(=O)C3=C(C4=C(C=C(C=C4C=C3CC2(CC1=O)O)OC)O)O)O)O D08MCT HIGHSTAT Preclinical D09MJO DRUG__ID D09MJO D09MJO DRUGCOMP Taisho Pharmaceutical Co Ltd D09MJO DRUGINCH 1S/C28H49NOS/c1-6-7-8-9-10-11-12-13-14-15-16-17-21-31-22-27(30)29-28-25(23(2)3)19-18-20-26(28)24(4)5/h18-20,23-24H,6-17,21-22H2,1-5H3,(H,29,30) D09MJO DRUGINKE KRMKZDOWCOBWNU-UHFFFAOYSA-N D09MJO DRUGSMIL CCCCCCCCCCCCCCSCC(=O)NC1=C(C=CC=C1C(C)C)C(C)C D09MJO HIGHSTAT Preclinical D09TXO DRUG__ID D09TXO D09TXO DRUGTYPE Small molecular drug D09TXO DRUGINCH 1S/C119H204N34O32S2/c1-19-65(14)92(112(180)144-81(54-90(160)161)104(172)145-82(52-63(10)11)115(183)153-46-29-37-87(153)110(178)149-91(64(12)13)111(179)139-72(32-23-24-41-120)97(165)136-74(35-27-44-130-119(126)127)98(166)135-73(34-26-43-129-118(124)125)96(164)133-67(16)116(184)185)150-99(167)75(38-39-89(158)159)137-106(174)84(57-155)147-113(181)93(68(17)156)151-105(173)79(51-62(8)9)142-101(169)77(49-60(4)5)140-100(168)76(48-59(2)3)141-102(170)78(50-61(6)7)143-108(176)85(58-186)148-107(175)83(56-154)146-103(171)80(53-69-30-21-20-22-31-69)134-88(157)55-131-95(163)71(33-25-42-128-117(122)123)138-109(177)86-36-28-45-152(86)114(182)66(15)132-94(162)70(121)40-47-187-18/h20-22,30-31,59-68,70-87,91-93,154-156,186H,19,23-29,32-58,120-121H2,1-18H3,(H,131,163)(H,132,162)(H,133,164)(H,134,157)(H,135,166)(H,136,165)(H,137,174)(H,138,177)(H,139,179)(H,140,168)(H,141,170)(H,142,169)(H,143,176)(H,144,180)(H,145,172)(H,146,171)(H,147,181)(H,148,175)(H,149,178)(H,150,167)(H,151,173)(H,158,159)(H,160,161)(H,184,185)(H4,122,123,128)(H4,124,125,129)(H4,126,127,130)/t65-,66-,67-,68+,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,91-,92-,93-/m0/s1 D09TXO DRUGINKE DPEUWKZJZIPZKE-OFANTOPUSA-N D09TXO DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(CCSC)N D09TXO HIGHSTAT Preclinical D09XCX DRUG__ID D09XCX D09XCX DRUGTYPE Small molecular drug D09XCX DRUGINCH 1S/C14H14ClN3O2S/c1-8-4-3-5-10(9(8)2)16-12-6-11(15)17-14(18-12)21-7-13(19)20/h3-6H,7H2,1-2H3,(H,19,20)(H,16,17,18) D09XCX DRUGINKE SZRPDCCEHVWOJX-UHFFFAOYSA-N D09XCX DRUGSMIL CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C D09XCX HIGHSTAT Preclinical D0A5MD DRUG__ID D0A5MD D0A5MD DRUGCOMP Pfizer Inc D0A5MD DRUGINCH 1S/C16H20N2O3/c19-16(17-13-10-18-5-3-11(13)4-6-18)12-1-2-14-15(9-12)21-8-7-20-14/h1-2,9,11,13H,3-8,10H2,(H,17,19)/t13-/m0/s1 D0A5MD DRUGINKE LUVXHMJTVXZFPD-ZDUSSCGKSA-N D0A5MD DRUGSMIL C1CN2CCC1C(C2)NC(=O)C3=CC4=C(C=C3)OCCO4 D0A5MD HIGHSTAT Preclinical D0ALN1 DRUG__ID D0ALN1 D0ALN1 DRUGTYPE Small molecular drug D0ALN1 DRUGINCH 1S/C26H32BrN5O6/c1-26(2,3)16-4-14(5-17(27)8-16)21(10-23(36)37)32-22(35)13-28-24(38)15-6-18(9-19(33)7-15)31-25-29-11-20(34)12-30-25/h4-9,20-21,33-34H,10-13H2,1-3H3,(H,28,38)(H,32,35)(H,36,37)(H2,29,30,31)/t21-/m0/s1 D0ALN1 DRUGINKE YDHAGPCZRFQPOI-NRFANRHFSA-N D0ALN1 DRUGSMIL CC(C)(C)C1=CC(=CC(=C1)C(CC(=O)O)NC(=O)CNC(=O)C2=CC(=CC(=C2)O)NC3=NCC(CN3)O)Br D0ALN1 HIGHSTAT Preclinical D0BJ7W DRUG__ID D0BJ7W D0BJ7W DRUGCOMP ProSkelia Pharmaceuticals SAS D0BJ7W DRUGINCH 1S/C19H14F3N3O3/c1-24-17(28)25(14-8-7-12(10-23)15(9-14)19(20,21)22)16(27)18(24,11-26)13-5-3-2-4-6-13/h2-9,26H,11H2,1H3/t18-/m1/s1 D0BJ7W DRUGINKE VAJGULUVTFDTAS-GOSISDBHSA-N D0BJ7W DRUGSMIL CN1C(=O)N(C(=O)C1(CO)C2=CC=CC=C2)C3=CC(=C(C=C3)C#N)C(F)(F)F D0BJ7W HIGHSTAT Preclinical D0C5EG DRUG__ID D0C5EG D0C5EG DRUGTYPE Small molecular drug D0C5EG DRUGINCH 1S/C19H27N3O2/c1-23-16-12-14-15(21-18(20)19(14)6-4-7-19)13-17(16)24-11-5-10-22-8-2-3-9-22/h12-13H,2-11H2,1H3,(H2,20,21) D0C5EG DRUGINKE BKCDJTRMYWSXMC-UHFFFAOYSA-N D0C5EG DRUGSMIL COC1=C(C=C2C(=C1)C3(CCC3)C(=N2)N)OCCCN4CCCC4 D0C5EG HIGHSTAT Preclinical D0C7WP DRUG__ID D0C7WP D0C7WP DRUGTYPE Small molecular drug D0C7WP DRUGINCH 1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26) D0C7WP DRUGINKE FHYUGAJXYORMHI-UHFFFAOYSA-N D0C7WP DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 D0C7WP HIGHSTAT Preclinical D0CG9E DRUG__ID D0CG9E D0CG9E DRUGTYPE Small molecular drug D0CG9E DRUGINCH 1S/C17H38N4/c1-3-18-9-5-7-11-20-14-16-13-17(16)15-21-12-8-6-10-19-4-2/h16-21H,3-15H2,1-2H3/t16-,17-/m1/s1 D0CG9E DRUGINKE BAOFSMLABBUBJP-IAGOWNOFSA-N D0CG9E DRUGSMIL CCNCCCCNCC1CC1CNCCCCNCC D0CG9E HIGHSTAT Preclinical D0D5CQ DRUG__ID D0D5CQ D0D5CQ DRUGTYPE Small molecular drug D0D5CQ DRUGINCH 1S/C27H37ClN6O2/c1-19(16-35-2)32-20-6-8-21(9-7-20)33-26-14-22(23(28)15-30-26)24-4-3-5-25(34-24)31-18-27(17-29)10-12-36-13-11-27/h3-5,14-15,19-21,32H,6-13,16,18H2,1-2H3,(H,30,33)(H,31,34)/t19-,20?,21?/m1/s1 D0D5CQ DRUGINKE XWQVQSXLXAXOPJ-QNGMFEMESA-N D0D5CQ DRUGSMIL CC(COC)NC1CCC(CC1)NC2=NC=C(C(=C2)C3=NC(=CC=C3)NCC4(CCOCC4)C#N)Cl D0D5CQ HIGHSTAT Preclinical D0DO5U DRUG__ID D0DO5U D0DO5U DRUGTYPE Small molecular drug D0DO5U DRUGINCH 1S/C21H23N3O3/c25-20(23-27)12-7-16-3-5-17(6-4-16)15-22-21(26)18-8-10-19(11-9-18)24-13-1-2-14-24/h3-12,27H,1-2,13-15H2,(H,22,26)(H,23,25)/b12-7+ D0DO5U DRUGINKE JKVNVKOVLBVYHQ-KPKJPENVSA-N D0DO5U DRUGSMIL C1CCN(C1)C2=CC=C(C=C2)C(=O)NCC3=CC=C(C=C3)C=CC(=O)NO D0DO5U HIGHSTAT Preclinical D0E2FZ DRUG__ID D0E2FZ D0E2FZ DRUGCOMP Icagen Inc D0E2FZ DRUGINCH 1S/C11H6ClF2N3O/c12-11-15-4-7(5-16-11)17-10(18)6-1-2-8(13)9(14)3-6/h1-5H,(H,17,18) D0E2FZ DRUGINKE IIBSHMFXVWTQSJ-UHFFFAOYSA-N D0E2FZ DRUGSMIL C1=CC(=C(C=C1C(=O)NC2=CN=C(N=C2)Cl)F)F D0E2FZ HIGHSTAT Preclinical D0E2QN DRUG__ID D0E2QN D0E2QN DRUGCOMP AstraZeneca plc D0E2QN DRUGINCH 1S/C11H8Cl2FN3O3S/c1-20-11-10(15-5-8(14)16-11)17-21(18,19)7-4-2-3-6(12)9(7)13/h2-5H,1H3,(H,15,17) D0E2QN DRUGINKE NWSUDJQTTGDPIR-UHFFFAOYSA-N D0E2QN DRUGSMIL COC1=NC(=CN=C1NS(=O)(=O)C2=C(C(=CC=C2)Cl)Cl)F D0E2QN HIGHSTAT Preclinical D0F2AD DRUG__ID D0F2AD D0F2AD DRUGTYPE Small molecular drug D0F2AD DRUGINCH 1S/C45H72O16/c1-19-9-14-45(54-18-19)20(2)30-28(61-45)16-27-25-8-7-23-15-24(10-12-43(23,5)26(25)11-13-44(27,30)6)57-42-39(60-41-36(52)34(50)32(48)22(4)56-41)37(53)38(29(17-46)58-42)59-40-35(51)33(49)31(47)21(3)55-40/h7,19-22,24-42,46-53H,8-18H2,1-6H3/t19-,20+,21+,22+,24+,25-,26+,27+,28+,29-,30+,31+,32+,33-,34-,35-,36-,37+,38-,39-,40+,41+,42-,43+,44+,45-/m1/s1 D0F2AD DRUGINKE VNONINPVFQTJOC-ZGXDEBHDSA-N D0F2AD DRUGSMIL CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 D0F2AD HIGHSTAT Preclinical D0G1EH DRUG__ID D0G1EH D0G1EH DRUGCOMP Aeolus Pharmaceuticals; Aeolus Pharmaceuticals Inc D0G1EH DRUGINCH 1S/C48H56N12.5ClH.Mn/c1-9-53-25-26-54(10-2)45(53)41-33-17-19-35(49-33)42(46-55(11-3)27-28-56(46)12-4)37-21-23-39(51-37)44(48-59(15-7)31-32-60(48)16-8)40-24-22-38(52-40)43(36-20-18-34(41)50-36)47-57(13-5)29-30-58(47)14-6;;;;;;/h17-32H,9-16H2,1-8H3;5*1H;/q+2;;;;;;+3/p-5 D0G1EH DRUGINKE XMYHQLIAYLLEKT-UHFFFAOYSA-I D0G1EH DRUGSMIL CCN1C=C[N+](=C1C2=C3C=CC(=C(C4=NC(=C(C5=CC=C([N-]5)C(=C6C=CC2=N6)C7=[N+](C=CN7CC)CC)C8=[N+](C=CN8CC)CC)C=C4)C9=[N+](C=CN9CC)CC)[N-]3)CC.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3] D0G1EH HIGHSTAT Preclinical D0HE1P DRUG__ID D0HE1P D0HE1P DRUGTYPE Small molecular drug D0HE1P DRUGINCH 1S/C19H17N5O2S/c20-7-14-17(12-3-5-13(6-4-12)26-9-11-1-2-11)15(8-21)19(24-18(14)23)27-10-16(22)25/h3-6,11H,1-2,9-10H2,(H2,22,25)(H2,23,24) D0HE1P DRUGINKE ZTYHZMAZUWOXNC-UHFFFAOYSA-N D0HE1P DRUGSMIL C1CC1COC2=CC=C(C=C2)C3=C(C(=NC(=C3C#N)SCC(=O)N)N)C#N D0HE1P HIGHSTAT Preclinical D0J6OV DRUG__ID D0J6OV D0J6OV DRUGTYPE Small molecular drug D0J6OV DRUGINCH 1S/C23H25F4N3O3S/c24-20-13-18(12-16-6-7-28-14-19(16)20)34(32,33)29-21(22(31)30-8-1-2-9-30)11-15-4-3-5-17(10-15)23(25,26)27/h3-5,10,12-13,21,28-29H,1-2,6-9,11,14H2/t21-/m1/s1 D0J6OV DRUGINKE JCKGSPAAPQRPBW-OAQYLSRUSA-N D0J6OV DRUGSMIL C1CCN(C1)C(=O)C(CC2=CC(=CC=C2)C(F)(F)F)NS(=O)(=O)C3=CC4=C(CNCC4)C(=C3)F D0J6OV HIGHSTAT Preclinical D0K1VV DRUG__ID D0K1VV D0K1VV DRUGTYPE Small molecular drug D0K1VV DRUGINCH 1S/C18H19NO3S2/c1-3-22-18(21)14-10-12-6-4-5-7-13(12)11-19(14)17(20)15-8-9-16(23-2)24-15/h4-9,14H,3,10-11H2,1-2H3 D0K1VV DRUGINKE UIEBLUZPSFAFOC-UHFFFAOYSA-N D0K1VV DRUGSMIL CCOC(=O)C1CC2=CC=CC=C2CN1C(=O)C3=CC=C(S3)SC D0K1VV HIGHSTAT Preclinical D0LF0O DRUG__ID D0LF0O D0LF0O DRUGTYPE Small molecular drug D0LF0O DRUGINCH 1S/C26H31ClFN7O/c1-17-13-19(18-4-10-34(11-5-18)9-2-6-28)14-22-24(17)33-25(32-22)23-21(3-7-30-26(23)36)29-8-12-35-16-20(27)15-31-35/h3,7,13-16,18H,2,4-6,8-12H2,1H3,(H,32,33)(H2,29,30,36) D0LF0O DRUGINKE VWELCPLMPPEKOL-UHFFFAOYSA-N D0LF0O DRUGSMIL CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCCN4C=C(C=N4)Cl)C5CCN(CC5)CCCF D0LF0O HIGHSTAT Preclinical D0M5DH DRUG__ID D0M5DH D0M5DH DRUGTYPE Small molecular drug D0M5DH DRUGINCH 1S/C28H33FN4S/c1-6-33(25-11-10-22(19(2)3)18-26(25)34-5)28-30-20(4)16-27(31-28)32-14-12-21(13-15-32)23-8-7-9-24(29)17-23/h7-12,16-19H,6,13-15H2,1-5H3 D0M5DH DRUGINKE DDSMCPASYQDKFS-UHFFFAOYSA-N D0M5DH DRUGSMIL CCN(C1=C(C=C(C=C1)C(C)C)SC)C2=NC(=CC(=N2)N3CCC(=CC3)C4=CC(=CC=C4)F)C D0M5DH HIGHSTAT Preclinical D0M5FO DRUG__ID D0M5FO D0M5FO DRUGTYPE Small molecular drug D0M5FO DRUGINCH 1S/C23H24N6/c1-16(2)20-6-4-5-7-21(20)23-24-14-17(3)22(27-23)25-15-18-8-10-19(11-9-18)29-13-12-26-28-29/h4-14,16H,15H2,1-3H3,(H,24,25,27) D0M5FO DRUGINKE VUIRVWPJNKZOSS-UHFFFAOYSA-N D0M5FO DRUGSMIL CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C D0M5FO HIGHSTAT Preclinical D0O1WJ DRUG__ID D0O1WJ D0O1WJ DRUGCOMP Scripps Research Institute D0O1WJ DRUGINCH 1S/C15H13F6N3O4S2/c1-7-11(29-12(22-7)23-8(2)25)30(27,28)24-10-5-3-9(4-6-10)13(26,14(16,17)18)15(19,20)21/h3-6,24,26H,1-2H3,(H,22,23,25) D0O1WJ DRUGINKE OZBSSKGBKHOLGA-UHFFFAOYSA-N D0O1WJ DRUGSMIL CC1=C(SC(=N1)NC(=O)C)S(=O)(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O D0O1WJ HIGHSTAT Preclinical D0O8EK DRUG__ID D0O8EK D0O8EK DRUGCOMP Cubist Pharmaceuticals Inc D0O8EK DRUGINCH 1S/C73H111N17O27/c1-9-11-12-13-14-15-16-24-48(92)80-44(29-39-32-77-41-22-18-17-21-40(39)41)65(106)83-43(25-26-51(95)96)64(105)88-57(59(101)61(76)102)70(111)87-56-38(6)117-73(115)55(35(3)10-2)86-69(110)54(36(4)28-52(97)98)85-67(108)45(30-47(75)91)81-49(93)33-78-68(109)58(60(116-8)72(113)114)89-63(104)42(23-19-20-27-74)82-66(107)46(31-53(99)100)84-62(103)37(5)79-50(94)34-90(7)71(56)112/h17-18,21-22,32,35-38,42-46,54-60,77,101H,9-16,19-20,23-31,33-34,74H2,1-8H3,(H2,75,91)(H2,76,102)(H,78,109)(H,79,94)(H,80,92)(H,81,93)(H,82,107)(H,83,106)(H,84,103)(H,85,108)(H,86,110)(H,87,111)(H,88,105)(H,89,104)(H,95,96)(H,97,98)(H,99,100)(H,113,114)/t35-,36+,37-,38+,42+,43+,44-,45+,46-,54-,55-,56-,57-,58-,59+,60+/m0/s1 D0O8EK DRUGINKE IXYMYSZPMWIOEU-KRNKDTLPSA-N D0O8EK DRUGSMIL CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCC(=O)O)C(=O)NC(C(C(=O)N)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CN(C3=O)C)C)CC(=O)O)CCCCN)C(C(=O)O)OC)CC(=O)N)C(C)CC(=O)O)C(C)CC)C D0O8EK HIGHSTAT Preclinical D0P2EH DRUG__ID D0P2EH D0P2EH DRUGTYPE Small molecular drug D0P2EH DRUGINCH 1S/C18H16Cl2N4/c19-15-9-13-14(10-16(15)20)18(22-12-3-1-2-4-12)24-23-17(13)11-5-7-21-8-6-11/h5-10,12H,1-4H2,(H,22,24) D0P2EH DRUGINKE ABGOSOMRWSYAOB-UHFFFAOYSA-N D0P2EH DRUGSMIL C1CCC(C1)NC2=NN=C(C3=CC(=C(C=C32)Cl)Cl)C4=CC=NC=C4 D0P2EH HIGHSTAT Preclinical D0Q7JJ DRUG__ID D0Q7JJ D0Q7JJ DRUGCOMP Chugai Pharmaceutical Co Ltd D0Q7JJ DRUGINCH 1S/C34H48O9/c1-3-5-7-10-13-16-27(35)17-14-11-8-9-12-15-18-30(34(42,33(40)41)25-31(36)37)29(32(38)39)24-26-19-21-28(22-20-26)43-23-6-4-2/h15,18-22,29-30,42H,3,5,7-14,16-17,23-25H2,1-2H3,(H,36,37)(H,38,39)(H,40,41)/b18-15+/t29-,30-,34-/m0/s1 D0Q7JJ DRUGINKE XQPJMZTYCIBZTB-UIWDEBCHSA-N D0Q7JJ DRUGSMIL CCCCCCCC(=O)CCCCCCC=CC(C(CC1=CC=C(C=C1)OCC#CC)C(=O)O)C(CC(=O)O)(C(=O)O)O D0Q7JJ HIGHSTAT Preclinical D0R1JI DRUG__ID D0R1JI D0R1JI DRUGTYPE Small molecular drug D0R1JI DRUGINCH 1S/C30H28O8/c1-15-24(33)19(27(36)22(16(2)31)25(15)34)14-20-26(35)18-12-13-30(3,4)38-29(18)23(28(20)37)21(32)11-10-17-8-6-5-7-9-17/h5-13,33-37H,14H2,1-4H3/b11-10+ D0R1JI DRUGINKE DEZFNHCVIZBHBI-ZHACJKMWSA-N D0R1JI DRUGSMIL CC1=C(C(=C(C(=C1O)C(=O)C)O)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C=CC4=CC=CC=C4)O)O D0R1JI HIGHSTAT Preclinical D0SR4T DRUG__ID D0SR4T D0SR4T DRUGTYPE Small molecular drug D0SR4T DRUGINCH 1S/C20H23N3O2.C4H6O6/c1-20-11-12-22(2)18(20)23(3)17-10-9-15(13-16(17)20)25-19(24)21-14-7-5-4-6-8-14;5-1(3(7)8)2(6)4(9)10/h4-10,13,18H,11-12H2,1-3H3,(H,21,24);1-2,5-6H,(H,7,8)(H,9,10)/t18-,20+;1-,2-/m11/s1 D0SR4T DRUGINKE XKKPTCVQEJZDGT-PWUAAHBCSA-N D0SR4T DRUGSMIL CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C.C(C(C(=O)O)O)(C(=O)O)O D0SR4T HIGHSTAT Preclinical D0T0UC DRUG__ID D0T0UC D0T0UC DRUGCOMP Anavex D0T0UC DRUGINCH 1S/C19H23NO/c1-20(2)14-16-13-19(21-15-16,17-9-5-3-6-10-17)18-11-7-4-8-12-18/h3-12,16H,13-15H2,1-2H3 D0T0UC DRUGINKE AMVCMSPVJGQNFF-UHFFFAOYSA-N D0T0UC DRUGSMIL CN(C)CC1CC(OC1)(C2=CC=CC=C2)C3=CC=CC=C3 D0T0UC HIGHSTAT Preclinical D0TF1E DRUG__ID D0TF1E D0TF1E DRUGTYPE Small molecular drug D0TF1E DRUGINCH 1S/C11H12N4/c12-2-8-1-10(5-13-3-8)15-7-9-4-14-6-11(9)15/h1,3,5,9,11,14H,4,6-7H2/t9-,11-/m1/s1 D0TF1E DRUGINKE GPXAWLDGWSBLKM-MWLCHTKSSA-N D0TF1E DRUGSMIL C1C2CN(C2CN1)C3=CN=CC(=C3)C#N D0TF1E HIGHSTAT Preclinical D0UL5X DRUG__ID D0UL5X D0UL5X DRUGTYPE Small molecular drug D0UL5X DRUGINCH 1S/C19H21N3O3/c1-22(2)17-10-8-16(9-11-17)19(24)20-13-15-5-3-14(4-6-15)7-12-18(23)21-25/h3-12,25H,13H2,1-2H3,(H,20,24)(H,21,23)/b12-7+ D0UL5X DRUGINKE WWMASNYTEATYTC-KPKJPENVSA-N D0UL5X DRUGSMIL CN(C)C1=CC=C(C=C1)C(=O)NCC2=CC=C(C=C2)C=CC(=O)NO D0UL5X HIGHSTAT Preclinical D0UN8H DRUG__ID D0UN8H D0UN8H DRUGTYPE Small molecular drug D0UN8H DRUGINCH 1S/C18H17NO4/c1-21-11-8-16(22-2)14(17(9-11)23-3)10-13-12-6-4-5-7-15(12)19-18(13)20/h4-10H,1-3H3,(H,19,20)/b13-10+ D0UN8H DRUGINKE JBJYTZXCZDNOJW-JLHYYAGUSA-N D0UN8H DRUGSMIL COC1=CC(=C(C(=C1)OC)C=C2C3=CC=CC=C3NC2=O)OC D0UN8H HIGHSTAT Preclinical D0V2CO DRUG__ID D0V2CO D0V2CO DRUGTYPE Small molecular drug D0V2CO DRUGINCH 1S/C22H22N2O3/c1-14-12-22(2,3)24(18-11-7-6-8-15(14)18)19(25)13-23-20(26)16-9-4-5-10-17(16)21(23)27/h4-11,14H,12-13H2,1-3H3 D0V2CO DRUGINKE KDDHBJICVBONAX-UHFFFAOYSA-N D0V2CO DRUGSMIL CC1CC(N(C2=CC=CC=C12)C(=O)CN3C(=O)C4=CC=CC=C4C3=O)(C)C D0V2CO HIGHSTAT Preclinical D0V9YW DRUG__ID D0V9YW D0V9YW DRUGTYPE Small molecular drug D0V9YW DRUGINCH 1S/C18H15ClN4/c1-11-10-23-17(21-11)8-13-2-5-14(19)9-16(13)18(22-23)12-3-6-15(20)7-4-12/h2-7,9-10H,8,20H2,1H3 D0V9YW DRUGINKE FPXVCCSOTAQPIV-UHFFFAOYSA-N D0V9YW DRUGSMIL CC1=CN2C(=N1)CC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=C(C=C4)N D0V9YW HIGHSTAT Preclinical D0W8JE DRUG__ID D0W8JE D0W8JE DRUGTYPE Small molecular drug D0W8JE DRUGINCH 1S/C11H16O4/c1-3-7(13)11-9(15-11)5-4-8-10(14-8)6(2)12/h3-13H,1H2,2H3/b5-4+/t6-,7-,8+,9+,10+,11+/m1/s1 D0W8JE DRUGINKE DLVJMFOLJOOWFS-INMLLLKOSA-N D0W8JE DRUGSMIL CC(C1C(O1)C=CC2C(O2)C(C=C)O)O D0W8JE HIGHSTAT Preclinical D0X1ZV DRUG__ID D0X1ZV D0X1ZV DRUGTYPE Small molecular drug D0X1ZV DRUGINCH 1S/C7H8N2O4/c8-7(9-13)3-1-4(10)6(12)5(11)2-3/h1-2,10-13H,(H2,8,9) D0X1ZV DRUGINKE MSLJYSGFUMYUDX-UHFFFAOYSA-N D0X1ZV DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=NO)N D0X1ZV HIGHSTAT Preclinical D0X3RK DRUG__ID D0X3RK D0X3RK DRUGTYPE Small molecular drug D0X3RK DRUGINCH 1S/C36H42N6O/c1-28-27-42(34-11-4-2-9-32(28)34)22-19-40-17-20-41(21-18-40)35-12-5-3-10-33(35)30-23-29(26-37)24-31(25-30)36(43)38-13-8-16-39-14-6-7-15-39/h2-5,9-12,23-25,27H,6-8,13-22H2,1H3,(H,38,43) D0X3RK DRUGINKE PNYRDVBFYVDJJI-UHFFFAOYSA-N D0X3RK DRUGSMIL CC1=CN(C2=CC=CC=C12)CCN3CCN(CC3)C4=CC=CC=C4C5=CC(=CC(=C5)C#N)C(=O)NCCCN6CCCC6 D0X3RK HIGHSTAT Preclinical D0X6TZ DRUG__ID D0X6TZ D0X6TZ DRUGCOMP Celogos D0X6TZ DRUGINCH 1S/C13H12FN3O3/c1-7-16-10(11(18)13(20)17-7)12(19)15-6-8-2-4-9(14)5-3-8/h2-5,18H,6H2,1H3,(H,15,19)(H,16,17,20) D0X6TZ DRUGINKE QUOVSBFFBCDNHK-UHFFFAOYSA-N D0X6TZ DRUGSMIL CC1=NC(=C(C(=O)N1)O)C(=O)NCC2=CC=C(C=C2)F D0X6TZ HIGHSTAT Preclinical D0Y7OI DRUG__ID D0Y7OI D0Y7OI DRUGTYPE Small molecular drug D0Y7OI DRUGINCH 1S/C34H26O8/c35-25-15-11-23(12-16-25)29-31(39)32(40)30(24-13-17-26(36)18-14-24)34(42-28(38)20-22-9-5-2-6-10-22)33(29)41-27(37)19-21-7-3-1-4-8-21/h1-18,35-36,39-40H,19-20H2 D0Y7OI DRUGINKE NOJUKCRPSUMHQQ-UHFFFAOYSA-N D0Y7OI DRUGSMIL C1=CC=C(C=C1)CC(=O)OC2=C(C(=C(C(=C2C3=CC=C(C=C3)O)O)O)C4=CC=C(C=C4)O)OC(=O)CC5=CC=CC=C5 D0Y7OI HIGHSTAT Preclinical D0Z0PR DRUG__ID D0Z0PR D0Z0PR DRUGTYPE Small molecular drug D0Z0PR DRUGINCH 1S/C24H30N6O2S/c1-29-13-15-30(16-14-29)23-27-20(17-33-23)18-5-7-19(8-6-18)21(31)28-24(9-3-2-4-10-24)22(32)26-12-11-25/h5-8,17H,2-4,9-10,12-16H2,1H3,(H,26,32)(H,28,31) D0Z0PR DRUGINKE FIVYCSWOCXEWSE-UHFFFAOYSA-N D0Z0PR DRUGSMIL CN1CCN(CC1)C2=NC(=CS2)C3=CC=C(C=C3)C(=O)NC4(CCCCC4)C(=O)NCC#N D0Z0PR HIGHSTAT Preclinical D40DVS DRUG__ID D40DVS D40DVS DRUGTYPE Small molecular drug D40DVS DRUGINCH 1S/C20H24ClN3O4S/c1-2-28-20(25)23-10-9-16(13-23)12-22(11-15-3-5-17(21)6-4-15)14-18-7-8-19(29-18)24(26)27/h3-8,16H,2,9-14H2,1H3 D40DVS DRUGINKE MMJJNHOIVCGAAP-UHFFFAOYSA-N D40DVS DRUGSMIL CCOC(=O)N1CCC(C1)CN(CC2=CC=C(C=C2)Cl)CC3=CC=C(S3)[N+](=O)[O-] D40DVS HIGHSTAT Preclinical D4PG6A DRUG__ID D4PG6A D4PG6A DRUGTYPE Small molecular drug D4PG6A DRUGINCH 1S/C21H22O8/c1-23-13-8-7-11(9-15(13)24-2)14-10-12(22)16-17(25-3)19(26-4)21(28-6)20(27-5)18(16)29-14/h7-10H,1-6H3 D4PG6A DRUGINKE MRIAQLRQZPPODS-UHFFFAOYSA-N D4PG6A DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC)OC D4PG6A HIGHSTAT Preclinical D4RGV9 DRUG__ID D4RGV9 D4RGV9 DRUGTYPE Small molecular drug D4RGV9 DRUGINCH 1S/C5H10O3/c1-3-8-4(2)5(6)7/h4H,3H2,1-2H3,(H,6,7) D4RGV9 DRUGINKE XBHQOMRKOUANQQ-UHFFFAOYSA-N D4RGV9 DRUGSMIL CCOC(C)C(=O)O D4RGV9 HIGHSTAT Preclinical D4UFT5 DRUG__ID D4UFT5 D4UFT5 DRUGTYPE Small molecular drug D4UFT5 DRUGINCH 1S/C15H10O5/c16-10-6-5-9(14(18)15(10)19)13-7-11(17)8-3-1-2-4-12(8)20-13/h1-7,16,18-19H D4UFT5 DRUGINKE JJAXTFSPCLZPIW-UHFFFAOYSA-N D4UFT5 DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(O2)C3=C(C(=C(C=C3)O)O)O D4UFT5 HIGHSTAT Preclinical D5I3MF DRUG__ID D5I3MF D5I3MF DRUGTYPE Small molecular drug D5I3MF DRUGINCH 1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1 D5I3MF DRUGINKE UVERBUNNCOKGNZ-CQSZACIVSA-N D5I3MF DRUGSMIL CC1=C(C=C(C=C1)N)C(=O)NC(C)C2=CC=CC3=CC=CC=C32 D5I3MF HIGHSTAT Preclinical D5R7AE DRUG__ID D5R7AE D5R7AE DRUGTYPE Small molecular drug D5R7AE DRUGINCH 1S/C17H19NO5/c1-21-13-10-12(11-14(22-2)17(13)23-3)7-8-16(20)18-9-5-4-6-15(18)19/h4,6-8,10-11H,5,9H2,1-3H3/b8-7+ D5R7AE DRUGINKE VABYUUZNAVQNPG-BQYQJAHWSA-N D5R7AE DRUGSMIL COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O D5R7AE HIGHSTAT Preclinical D6QA4N DRUG__ID D6QA4N D6QA4N DRUGTYPE Small molecular drug D6QA4N DRUGINCH 1S/C9H12N2O4S/c10-6-3-1-2-4-8(6)16(14,15)5-7(11)9(12)13/h1-4,7H,5,10-11H2,(H,12,13)/t7-/m0/s1 D6QA4N DRUGINKE JJUXYMMPJKOKBD-ZETCQYMHSA-N D6QA4N DRUGSMIL C1=CC=C(C(=C1)N)S(=O)(=O)CC(C(=O)O)N D6QA4N HIGHSTAT Preclinical D7ZXE5 DRUG__ID D7ZXE5 D7ZXE5 DRUGTYPE Small molecular drug D7ZXE5 DRUGINCH 1S/C3H6N2/c4-2-1-3-5/h1-2,4H2 D7ZXE5 DRUGINKE AGSPXMVUFBBBMO-UHFFFAOYSA-N D7ZXE5 DRUGSMIL C(CN)C#N D7ZXE5 HIGHSTAT Preclinical D8VH5Q DRUG__ID D8VH5Q D8VH5Q DRUGTYPE Small molecular drug D8VH5Q DRUGINCH 1S/C25H31NO6/c1-15-7-16(2)13-26(12-15)24(28)11-19(17-5-6-21-22(8-17)32-14-31-21)25-20(27)9-18(29-3)10-23(25)30-4/h5-6,8-10,15-16,19,27H,7,11-14H2,1-4H3/t15-,16+,19? D8VH5Q DRUGINKE YEKVAIMYYCZDLI-MCPYQZEQSA-N D8VH5Q DRUGSMIL CC1CC(CN(C1)C(=O)CC(C2=CC3=C(C=C2)OCO3)C4=C(C=C(C=C4OC)OC)O)C D8VH5Q HIGHSTAT Preclinical D95KWS DRUG__ID D95KWS D95KWS DRUGTYPE Small molecular drug D95KWS DRUGINCH 1S/C21H22N2O4S/c1-28(25,26)22(15-17-7-6-12-27-17)13-16(24)14-23-20-10-4-2-8-18(20)19-9-3-5-11-21(19)23/h2-12,16,24H,13-15H2,1H3 D95KWS DRUGINKE OQAFDLPAPSSOHY-UHFFFAOYSA-N D95KWS DRUGSMIL CS(=O)(=O)N(CC1=CC=CO1)CC(CN2C3=CC=CC=C3C4=CC=CC=C42)O D95KWS HIGHSTAT Preclinical D9D6QN DRUG__ID D9D6QN D9D6QN DRUGTYPE Small molecular drug D9D6QN DRUGINCH 1S/C17H10F9NO2/c18-15(19,20)11-3-1-9(2-4-11)13(28)27-12-7-5-10(6-8-12)14(29,16(21,22)23)17(24,25)26/h1-8,29H,(H,27,28) D9D6QN DRUGINKE DUXWIYXHHGNUJU-UHFFFAOYSA-N D9D6QN DRUGSMIL C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O)C(F)(F)F D9D6QN HIGHSTAT Preclinical D9MT4S DRUG__ID D9MT4S D9MT4S DRUGTYPE Small molecular drug D9MT4S DRUGINCH 1S/C19H31N3O6/c1-5-9-20-16(23)14-15(28-14)17(24)21-13(11(3)6-2)18(25)22-10-7-8-12(22)19(26)27-4/h11-15H,5-10H2,1-4H3,(H,20,23)(H,21,24)/t11-,12-,13-,14-,15-/m0/s1 D9MT4S DRUGINKE XGWSRLSPWIEMLQ-YTFOTSKYSA-N D9MT4S DRUGSMIL CCCNC(=O)C1C(O1)C(=O)NC(C(C)CC)C(=O)N2CCCC2C(=O)OC D9MT4S HIGHSTAT Preclinical D9SMC5 DRUG__ID D9SMC5 D9SMC5 DRUGTYPE Small molecular drug D9SMC5 DRUGINCH 1S/C38H71NO12P2/c1-27(2)14-9-15-28(3)16-10-17-29(4)18-11-19-30(5)20-12-21-31(6)22-13-23-32(7)24-25-48-52(44,45)51-53(46,47)50-38-35(39-33(8)41)37(43)36(42)34(26-40)49-38/h14,16,18,20,22,24,27-32,34-38,40,42-43H,9-13,15,17,19,21,23,25-26H2,1-8H3,(H,39,41)(H,44,45)(H,46,47)/q-6/t28?,29?,30?,31?,32?,34-,35-,36-,37-,38-/m1/s1 D9SMC5 DRUGINKE CREFDRPJYMJUQD-PVHPPTMHSA-N D9SMC5 DRUGSMIL CC(C)[CH-]CCC(C)[CH-]CCC(C)[CH-]CCC(C)[CH-]CCC(C)[CH-]CCC(C)[CH-]COP(=O)(O)OP(=O)(O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C D9SMC5 HIGHSTAT Preclinical DA5RC6 DRUG__ID DA5RC6 DA5RC6 DRUGTYPE Small molecular drug DA5RC6 DRUGINCH 1S/C26H26N4/c1-3-15-29-25(5-1)23-11-7-21(8-12-23)19-27-17-18-28-20-22-9-13-24(14-10-22)26-6-2-4-16-30-26/h1-16,27-28H,17-20H2 DA5RC6 DRUGINKE IXEPQJQQSLMESJ-UHFFFAOYSA-N DA5RC6 DRUGSMIL C1=CC=NC(=C1)C2=CC=C(C=C2)CNCCNCC3=CC=C(C=C3)C4=CC=CC=N4 DA5RC6 HIGHSTAT Preclinical DB1U9N DRUG__ID DB1U9N DB1U9N DRUGTYPE Small molecular drug DB1U9N DRUGINCH 1S/C9H11NO3S/c10-8(9(11)12)6-14(13)7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-,14?/m0/s1 DB1U9N DRUGINKE YIYUCMJLQCHZLS-BVVIDWAXSA-N DB1U9N DRUGSMIL C1=CC=C(C=C1)S(=O)CC(C(=O)O)N DB1U9N HIGHSTAT Preclinical DB4D2N DRUG__ID DB4D2N DB4D2N DRUGTYPE Small molecular drug DB4D2N DRUGINCH 1S/C23H35N5O2/c1-29-20-16-18-19(17-21(20)30-2)25-23(28-14-8-9-15-28)26-22(18)24-10-4-3-5-11-27-12-6-7-13-27/h16-17H,3-15H2,1-2H3,(H,24,25,26) DB4D2N DRUGINKE WEXCGGWTIDNVNT-UHFFFAOYSA-N DB4D2N DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCCC3)NCCCCCN4CCCC4)OC DB4D2N HIGHSTAT Preclinical DBA5M7 DRUG__ID DBA5M7 DBA5M7 DRUGTYPE Small molecular drug DBA5M7 DRUGINCH 1S/C45H62N10O6/c46-45(47)49-24-9-18-34-40(57)48-23-10-19-35(51-39(56)22-21-29-12-3-1-4-13-29)44(61)55-25-11-20-38(55)43(60)54-36(26-30-14-5-2-6-15-30)41(58)53-37(42(59)52-34)27-31-28-50-33-17-8-7-16-32(31)33/h1,3-4,7-8,12-13,16-17,28,30,34-38,50H,2,5-6,9-11,14-15,18-27H2,(H,48,57)(H,51,56)(H,52,59)(H,53,58)(H,54,60)(H4,46,47,49)/t34-,35-,36+,37-,38-/m0/s1 DBA5M7 DRUGINKE VATFHFJULBPYLM-ILOBPARPSA-N DBA5M7 DRUGSMIL C1CCC(CC1)CC2C(=O)NC(C(=O)NC(C(=O)NCCCC(C(=O)N3CCCC3C(=O)N2)NC(=O)CCC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65 DBA5M7 HIGHSTAT Preclinical DBJ5Z0 DRUG__ID DBJ5Z0 DBJ5Z0 DRUGTYPE Small molecular drug DBJ5Z0 DRUGINCH 1S/C15H29NO4/c1-2-3-4-5-6-7-8-16-12-9-11(10-17)13(18)15(20)14(12)19/h9,12-20H,2-8,10H2,1H3/t12-,13+,14+,15+/m1/s1 DBJ5Z0 DRUGINKE UPZUHYMBTUUPML-QPSCCSFWSA-N DBJ5Z0 DRUGSMIL CCCCCCCCNC1C=C(C(C(C1O)O)O)CO DBJ5Z0 HIGHSTAT Preclinical DCL8J5 DRUG__ID DCL8J5 DCL8J5 DRUGTYPE Small molecular drug DCL8J5 DRUGINCH 1S/C20H13FO6/c21-16-8-3-9-17(26-19(24)12-4-1-6-14(22)10-12)18(16)27-20(25)13-5-2-7-15(23)11-13/h1-11,22-23H DCL8J5 DRUGINKE FRSWCCBXIHFKKY-UHFFFAOYSA-N DCL8J5 DRUGSMIL C1=CC(=CC(=C1)O)C(=O)OC2=C(C(=CC=C2)F)OC(=O)C3=CC(=CC=C3)O DCL8J5 HIGHSTAT Preclinical DD3XO8 DRUG__ID DD3XO8 DD3XO8 DRUGTYPE Small molecular drug DD3XO8 DRUGINCH 1S/C12H12N4O2S2/c1-2-7-15-11(13-14-12(15)19)8-20-10-6-4-3-5-9(10)16(17)18/h2-6H,1,7-8H2,(H,14,19) DD3XO8 DRUGINKE VWFIHGWHMXSTAO-UHFFFAOYSA-N DD3XO8 DRUGSMIL C=CCN1C(=NNC1=S)CSC2=CC=CC=C2[N+](=O)[O-] DD3XO8 HIGHSTAT Preclinical DD9NG5 DRUG__ID DD9NG5 DD9NG5 DRUGTYPE Small molecular drug DD9NG5 DRUGINCH 1S/C20H17NO5/c1-3-12-26-17-10-8-14(13-18(17)25-2)9-11-19(22)21-16-7-5-4-6-15(16)20(23)24/h1,4-11,13H,12H2,2H3,(H,21,22)(H,23,24)/b11-9+ DD9NG5 DRUGINKE UIWZIDIJCUEOMT-PKNBQFBNSA-N DD9NG5 DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OCC#C DD9NG5 HIGHSTAT Preclinical DDV09U DRUG__ID DDV09U DDV09U DRUGTYPE Small molecular drug DDV09U DRUGINCH 1S/C21H21F3O4/c1-2-27-19(12-20(25)26)13-6-8-14(9-7-13)28-18-11-10-15-16(18)4-3-5-17(15)21(22,23)24/h3-9,18-19H,2,10-12H2,1H3,(H,25,26)/t18-,19+/m1/s1 DDV09U DRUGINKE YHLQVQKZDZYMIP-MOPGFXCFSA-N DDV09U DRUGSMIL CCOC(CC(=O)O)C1=CC=C(C=C1)OC2CCC3=C2C=CC=C3C(F)(F)F DDV09U HIGHSTAT Preclinical DE7BZ4 DRUG__ID DE7BZ4 DE7BZ4 DRUGTYPE Small molecular drug DE7BZ4 DRUGINCH 1S/C26H24F7N3O/c27-23-15-21(24(37,25(28,29)30)26(31,32)33)5-6-22(23)20-3-1-18(2-4-20)16-35-11-13-36(14-12-35)17-19-7-9-34-10-8-19/h1-10,15,37H,11-14,16-17H2 DE7BZ4 DRUGINKE KVHKWAZUPPBMLL-UHFFFAOYSA-N DE7BZ4 DRUGSMIL C1CN(CCN1CC2=CC=C(C=C2)C3=C(C=C(C=C3)C(C(F)(F)F)(C(F)(F)F)O)F)CC4=CC=NC=C4 DE7BZ4 HIGHSTAT Preclinical DELC48 DRUG__ID DELC48 DELC48 DRUGTYPE Small molecular drug DELC48 DRUGINCH 1S/C29H38Cl2N4O4/c30-23-10-9-20(17-24(23)31)11-13-32-14-12-28(38)35(21-5-2-1-3-6-21)16-15-33-18-26(36)22-7-4-8-25-29(22)39-19-27(37)34-25/h4,7-10,17,21,26,32-33,36H,1-3,5-6,11-16,18-19H2,(H,34,37)/t26-/m0/s1 DELC48 DRUGINKE WVRBXBROEPXZHF-SANMLTNESA-N DELC48 DRUGSMIL C1CCC(CC1)N(CCNCC(C2=C3C(=CC=C2)NC(=O)CO3)O)C(=O)CCNCCC4=CC(=C(C=C4)Cl)Cl DELC48 HIGHSTAT Preclinical DF90DS DRUG__ID DF90DS DF90DS DRUGTYPE Small molecular drug DF90DS DRUGINCH 1S/C28H27N3O3/c1-30-27(19-8-5-4-6-9-19)22(23-10-7-14-29-28(23)30)11-12-26(32)31-15-13-20-16-24(33-2)25(34-3)17-21(20)18-31/h4-12,14,16-17H,13,15,18H2,1-3H3/b12-11+ DF90DS DRUGINKE IJYPHMXWKKKHGT-VAWYXSNFSA-N DF90DS DRUGSMIL CN1C(=C(C2=C1N=CC=C2)C=CC(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5 DF90DS HIGHSTAT Preclinical DH67XF DRUG__ID DH67XF DH67XF DRUGTYPE Small molecular drug DH67XF DRUGINCH 1S/C17H15NO2S2/c1-2-10-18-16(19)15(22-17(18)21)11-13-8-9-14(20-13)12-6-4-3-5-7-12/h2-9,11,16,19H,1,10H2/b15-11- DH67XF DRUGINKE OAISXFLGAPLDSA-PTNGSMBKSA-N DH67XF DRUGSMIL C=CCN1C(C(=CC2=CC=C(O2)C3=CC=CC=C3)SC1=S)O DH67XF HIGHSTAT Preclinical DHD79B DRUG__ID DHD79B DHD79B DRUGTYPE Small molecular drug DHD79B DRUGINCH 1S/C11H4N4O2/c16-9-6-4-2-1-3-5(6)7-8(9)13-11-10(12-7)14-17-15-11/h1-4H DHD79B DRUGINKE SFSSAKVWCKFRHE-UHFFFAOYSA-N DHD79B DRUGSMIL C1=CC=C2C(=C1)C3=NC4=NON=C4N=C3C2=O DHD79B HIGHSTAT Preclinical DJ1Q9B DRUG__ID DJ1Q9B DJ1Q9B DRUGTYPE Small molecular drug DJ1Q9B DRUGINCH 1S/C22H35N5O2/c1-5-6-7-8-11-23-22-25-18-15-20(29-4)19(28-3)14-17(18)21(26-22)24-16-9-12-27(2)13-10-16/h14-16H,5-13H2,1-4H3,(H2,23,24,25,26) DJ1Q9B DRUGINKE ZYNUWSFRZCRKSN-UHFFFAOYSA-N DJ1Q9B DRUGSMIL CCCCCCNC1=NC2=CC(=C(C=C2C(=N1)NC3CCN(CC3)C)OC)OC DJ1Q9B HIGHSTAT Preclinical DJK0W9 DRUG__ID DJK0W9 DJK0W9 DRUGTYPE Small molecular drug DJK0W9 DRUGINCH 1S/C24H22IN3O4/c1-28(19-7-3-2-4-8-19)23(30)15-26-24(31)20-9-5-6-10-21(20)32-16-22(29)27-18-13-11-17(25)12-14-18/h2-14H,15-16H2,1H3,(H,26,31)(H,27,29) DJK0W9 DRUGINKE HFVDMJQQAKLUSN-UHFFFAOYSA-N DJK0W9 DRUGSMIL CN(C1=CC=CC=C1)C(=O)CNC(=O)C2=CC=CC=C2OCC(=O)NC3=CC=C(C=C3)I DJK0W9 HIGHSTAT Preclinical DL74RO DRUG__ID DL74RO DL74RO DRUGTYPE Small molecular drug DL74RO DRUGINCH 1S/C16H13NO4/c18-13(19)8-3-9-17-15(20)11-6-1-4-10-5-2-7-12(14(10)11)16(17)21/h1-2,4-7H,3,8-9H2,(H,18,19) DL74RO DRUGINKE ZHXRDXTYPCPBTI-UHFFFAOYSA-N DL74RO DRUGSMIL C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CCCC(=O)O DL74RO HIGHSTAT Preclinical DLKQ59 DRUG__ID DLKQ59 DLKQ59 DRUGTYPE Small molecular drug DLKQ59 DRUGINCH 1S/C16H13ClN2OS/c1-10-7-14-13(9-12(10)17)18-16(21-14)19-15(20)8-11-5-3-2-4-6-11/h2-7,9H,8H2,1H3,(H,18,19,20) DLKQ59 DRUGINKE DYHAMRNAHTWYKY-UHFFFAOYSA-N DLKQ59 DRUGSMIL CC1=CC2=C(C=C1Cl)N=C(S2)NC(=O)CC3=CC=CC=C3 DLKQ59 HIGHSTAT Preclinical DM16YT DRUG__ID DM16YT DM16YT DRUGTYPE Small molecular drug DM16YT DRUGINCH 1S/C22H21F4N3O8/c1-3-14(29-6-4-5-12(21(29)34)28-22(35)36-2)20(33)27-13(8-16(31)32)15(30)9-37-19-17(25)10(23)7-11(24)18(19)26/h4-7,13-14H,3,8-9H2,1-2H3,(H,27,33)(H,28,35)(H,31,32)/t13-,14-/m0/s1 DM16YT DRUGINKE WQNDPVUOABHOHK-KBPBESRZSA-N DM16YT DRUGSMIL CCC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)N2C=CC=C(C2=O)NC(=O)OC DM16YT HIGHSTAT Preclinical DM69TL DRUG__ID DM69TL DM69TL DRUGTYPE Small molecular drug DM69TL DRUGINCH 1S/C21H22N4O4/c1-15(19(26)13-23-22)24-20(27)18(12-16-8-4-2-5-9-16)25-21(28)29-14-17-10-6-3-7-11-17/h2-11,13,15,18H,12,14H2,1H3,(H,24,27)(H,25,28)/t15-,18-/m0/s1 DM69TL DRUGINKE QMPATRQNERZOMF-YJBOKZPZSA-N DM69TL DRUGSMIL CC(C(=O)C=[N+]=[N-])NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2 DM69TL HIGHSTAT Preclinical DNL2F1 DRUG__ID DNL2F1 DNL2F1 DRUGTYPE Small molecular drug DNL2F1 DRUGINCH 1S/C16H20N2O2S2/c1-13-9-10-16(21-13)22(19,20)17-14-7-3-4-8-15(14)18-11-5-2-6-12-18/h3-4,7-10,17H,2,5-6,11-12H2,1H3 DNL2F1 DRUGINKE IRGYSXZCDAWOOC-UHFFFAOYSA-N DNL2F1 DRUGSMIL CC1=CC=C(S1)S(=O)(=O)NC2=CC=CC=C2N3CCCCC3 DNL2F1 HIGHSTAT Preclinical DONA19 DRUG__ID DONA19 DONA19 DRUGTYPE Small molecular drug DONA19 DRUGINCH 1S/C11H12ClN3O2S/c12-10-1-2-11(18(16,17)15-6-4-13)9-7-14-5-3-8(9)10/h1-3,5,7,15H,4,6,13H2 DONA19 DRUGINKE OGKYMFFYOWUTKV-UHFFFAOYSA-N DONA19 DRUGSMIL C1=CC(=C2C=CN=CC2=C1S(=O)(=O)NCCN)Cl DONA19 HIGHSTAT Preclinical DP3J2W DRUG__ID DP3J2W DP3J2W DRUGTYPE Small molecular drug DP3J2W DRUGINCH 1S/C11H8Cl2O3/c12-8-2-1-5(3-9(8)13)10(14)6-4-7(6)11(15)16/h1-3,6-7H,4H2,(H,15,16)/t6-,7-/m0/s1 DP3J2W DRUGINKE ZBRKMOHDGFGXLN-BQBZGAKWSA-N DP3J2W DRUGSMIL C1C(C1C(=O)O)C(=O)C2=CC(=C(C=C2)Cl)Cl DP3J2W HIGHSTAT Preclinical DPBE75 DRUG__ID DPBE75 DPBE75 DRUGTYPE Small molecular drug DPBE75 DRUGINCH 1S/C11H13N5O4/c1-13-4-6-14(7-5-13)9-3-2-8(15(17)18)10-11(9)16(19)20-12-10/h2-3H,4-7H2,1H3 DPBE75 DRUGINKE MWFZDJLPWDCQIL-UHFFFAOYSA-N DPBE75 DRUGSMIL CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-] DPBE75 HIGHSTAT Preclinical DPN2R7 DRUG__ID DPN2R7 DPN2R7 DRUGTYPE Small molecular drug DPN2R7 DRUGINCH 1S/C25H21N7O3/c26-19-7-6-16(14-28-19)24(33)29-17-4-1-3-15(13-17)22-30-20-18-5-2-8-27-25(18)35-21(20)23(31-22)32-9-11-34-12-10-32/h1-8,13-14H,9-12H2,(H2,26,28)(H,29,33) DPN2R7 DRUGINKE YBPIBGNBHHGLEB-UHFFFAOYSA-N DPN2R7 DRUGSMIL C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N DPN2R7 HIGHSTAT Preclinical DPQ4U3 DRUG__ID DPQ4U3 DPQ4U3 DRUGTYPE Small molecular drug DPQ4U3 DRUGINCH 1S/C17H21FN4O4/c1-9-8-26-16-13-10(15(23)11(17(24)25)7-22(9)13)6-12(18)14(16)20-2-4-21(19)5-3-20/h6,9,11H,2-5,7-8,19H2,1H3,(H,24,25)/t9-,11?/m0/s1 DPQ4U3 DRUGINKE SBYIJFJAUBGBOA-FTNKSUMCSA-N DPQ4U3 DRUGSMIL CC1COC2=C3N1CC(C(=O)C3=CC(=C2N4CCN(CC4)N)F)C(=O)O DPQ4U3 HIGHSTAT Preclinical DPUF69 DRUG__ID DPUF69 DPUF69 DRUGTYPE Small molecular drug DPUF69 DRUGINCH 1S/C15H29NO4/c1-2-3-4-5-6-7-8-16-12-9-11(10-17)13(18)15(20)14(12)19/h9,12-20H,2-8,10H2,1H3/t12-,13-,14+,15+/m1/s1 DPUF69 DRUGINKE UPZUHYMBTUUPML-KBXIAJHMSA-N DPUF69 DRUGSMIL CCCCCCCCNC1C=C(C(C(C1O)O)O)CO DPUF69 HIGHSTAT Preclinical DRN30U DRUG__ID DRN30U DRN30U DRUGTYPE Small molecular drug DRN30U DRUGINCH 1S/C25H28ClF3N4O4/c1-14-13-32(20-10-22(36-3)30-12-18(20)26)9-8-21(14)37-17-6-4-16(5-7-17)33-19(11-23(34)35)15(2)24(31-33)25(27,28)29/h4-7,10,12,14-15,19,21H,8-9,11,13H2,1-3H3,(H,34,35)/t14-,15+,19+,21-/m1/s1 DRN30U DRUGINKE GKIUHMMLGAMMOO-OITFXXTJSA-N DRN30U DRUGSMIL CC1CN(CCC1OC2=CC=C(C=C2)N3C(C(C(=N3)C(F)(F)F)C)CC(=O)O)C4=CC(=NC=C4Cl)OC DRN30U HIGHSTAT Preclinical DRT90B DRUG__ID DRT90B DRT90B DRUGTYPE Small molecular drug DRT90B DRUGINCH 1S/C21H21NO.ClH/c1-15-3-7-17(8-4-15)11-19-13-22-14-20(21(19)23)12-18-9-5-16(2)6-10-18;/h3-12,22H,13-14H2,1-2H3;1H/b19-11+,20-12+; DRT90B DRUGINKE ZOKZLTXPTLIWOJ-BYCVLTJGSA-N DRT90B DRUGSMIL CC1=CC=C(C=C1)C=C2CNCC(=CC3=CC=C(C=C3)C)C2=O.Cl DRT90B HIGHSTAT Preclinical DS19UZ DRUG__ID DS19UZ DS19UZ DRUGTYPE Small molecular drug DS19UZ DRUGINCH 1S/C18H16N4O3S/c1-11(2)12-7-9-13(10-8-12)26(24,25)18-16-19-17(23)14-5-3-4-6-15(14)22(16)21-20-18/h3-11,21H,1-2H3 DS19UZ DRUGINKE GIFXGSITUBUVGH-UHFFFAOYSA-N DS19UZ DRUGSMIL CC(C)C1=CC=C(C=C1)S(=O)(=O)C2=NNN3C2=NC(=O)C4=CC=CC=C43 DS19UZ HIGHSTAT Preclinical DSHE52 DRUG__ID DSHE52 DSHE52 DRUGTYPE Small molecular drug DSHE52 DRUGINCH 1S/C26H34ClF3N4O4S/c27-22-14-23-17(11-24(35)32-23)10-21(22)25(36)31-18-12-19-2-3-20(13-18)34(19)39(37,38)15-16-4-8-33(9-5-16)7-1-6-26(28,29)30/h10,14,16,18-20H,1-9,11-13,15H2,(H,31,36)(H,32,35)/t18?,19-,20+ DSHE52 DRUGINKE OTEIUEJPHNOGBG-IHWFROFDSA-N DSHE52 DRUGSMIL C1CC2CC(CC1N2S(=O)(=O)CC3CCN(CC3)CCCC(F)(F)F)NC(=O)C4=C(C=C5C(=C4)CC(=O)N5)Cl DSHE52 HIGHSTAT Preclinical DSU7K2 DRUG__ID DSU7K2 DSU7K2 DRUGTYPE Small molecular drug DSU7K2 DRUGINCH 1S/C14H22N4O4S/c1-10-5-7-11(8-6-10)23(20,21)18-12(13(19)22-2)4-3-9-17-14(15)16/h5-8,12,18H,3-4,9H2,1-2H3,(H4,15,16,17)/t12-/m0/s1 DSU7K2 DRUGINKE FKMJXALNHKIDOD-LBPRGKRZSA-N DSU7K2 DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(CCCN=C(N)N)C(=O)OC DSU7K2 HIGHSTAT Preclinical DT6P8M DRUG__ID DT6P8M DT6P8M DRUGTYPE Small molecular drug DT6P8M DRUGINCH 1S/C22H20Cl2F2N6O3/c1-2-31(19(34)11-33)18-10-32(30-20(18)13-6-7-16(23)17(24)8-13)22(28-12-27)29-14-4-3-5-15(9-14)35-21(25)26/h3-9,18,21,33H,2,10-11H2,1H3,(H,28,29)/t18-/m0/s1 DT6P8M DRUGINKE OTTJIRVZJJGFTK-SFHVURJKSA-N DT6P8M DRUGSMIL CCN(C1CN(N=C1C2=CC(=C(C=C2)Cl)Cl)C(=NC3=CC(=CC=C3)OC(F)F)NC#N)C(=O)CO DT6P8M HIGHSTAT Preclinical DV59ZT DRUG__ID DV59ZT DV59ZT DRUGTYPE Small molecular drug DV59ZT DRUGINCH 1S/C7H5N5S2/c8-2-13-4-1-5(14-3-9)7(11)12-6(4)10/h1H,(H4,10,11,12) DV59ZT DRUGINKE ZXOBLNBVNROVLC-UHFFFAOYSA-N DV59ZT DRUGSMIL C1=C(C(=NC(=C1SC#N)N)N)SC#N DV59ZT HIGHSTAT Preclinical DW18LK DRUG__ID DW18LK DW18LK DRUGTYPE Small molecular drug DW18LK DRUGINCH 1S/C23H31ClN4O3S/c1-2-3-4-12-25-23(29)27-13-11-19(16-27)15-26(14-18-5-7-20(24)8-6-18)17-21-9-10-22(32-21)28(30)31/h5-10,19H,2-4,11-17H2,1H3,(H,25,29) DW18LK DRUGINKE PPUYOYQTTWJTIU-UHFFFAOYSA-N DW18LK DRUGSMIL CCCCCNC(=O)N1CCC(C1)CN(CC2=CC=C(C=C2)Cl)CC3=CC=C(S3)[N+](=O)[O-] DW18LK HIGHSTAT Preclinical DW24LQ DRUG__ID DW24LQ DW24LQ DRUGTYPE Small molecular drug DW24LQ DRUGINCH 1S/C22H26N4O4/c1-26(2)22(29)17(14-15-8-4-3-5-9-15)25-21(28)19-18(30-19)20(27)24-13-11-16-10-6-7-12-23-16/h3-10,12,17-19H,11,13-14H2,1-2H3,(H,24,27)(H,25,28)/t17-,18-,19-/m0/s1 DW24LQ DRUGINKE SXMRSAGDCJGMTG-FHWLQOOXSA-N DW24LQ DRUGSMIL CN(C)C(=O)C(CC1=CC=CC=C1)NC(=O)C2C(O2)C(=O)NCCC3=CC=CC=N3 DW24LQ HIGHSTAT Preclinical DW5R6Y DRUG__ID DW5R6Y DW5R6Y DRUGTYPE Small molecular drug DW5R6Y DRUGINCH 1S/C22H22F6N2O2/c1-15(31)30-12-10-29(11-13-30)14-16-2-4-17(5-3-16)18-6-8-19(9-7-18)20(32,21(23,24)25)22(26,27)28/h2-9,32H,10-14H2,1H3 DW5R6Y DRUGINKE LTFVNEZXOPUABB-UHFFFAOYSA-N DW5R6Y DRUGSMIL CC(=O)N1CCN(CC1)CC2=CC=C(C=C2)C3=CC=C(C=C3)C(C(F)(F)F)(C(F)(F)F)O DW5R6Y HIGHSTAT Preclinical DWF98V DRUG__ID DWF98V DWF98V DRUGTYPE Small molecular drug DWF98V DRUGINCH 1S/C19H32N8O5/c1-25(2)5-3-6-26(7-4-11(20)19(30)31)8-12-14(28)15(29)18(32-12)27-10-24-13-16(21)22-9-23-17(13)27/h9-12,14-15,18,28-29H,3-8,20H2,1-2H3,(H,30,31)(H2,21,22,23)/t11-,12+,14+,15+,18+/m0/s1 DWF98V DRUGINKE FYXRZDCUJHGULY-URQYDQELSA-N DWF98V DRUGSMIL CN(C)CCCN(CCC(C(=O)O)N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O DWF98V HIGHSTAT Preclinical DYU3I8 DRUG__ID DYU3I8 DYU3I8 DRUGTYPE Small molecular drug DYU3I8 DRUGINCH 1S/C25H30N4O5/c1-16(30)27-19-11-9-17(10-12-19)13-14-26-23(31)21-22(34-21)24(32)28-20(25(33)29(2)3)15-18-7-5-4-6-8-18/h4-12,20-22H,13-15H2,1-3H3,(H,26,31)(H,27,30)(H,28,32)/t20-,21-,22+/m0/s1 DYU3I8 DRUGINKE BULLLJQHDGSHOZ-FDFHNCONSA-N DYU3I8 DRUGSMIL CC(=O)NC1=CC=C(C=C1)CCNC(=O)C2C(O2)C(=O)NC(CC3=CC=CC=C3)C(=O)N(C)C DYU3I8 HIGHSTAT Preclinical DZ28EB DRUG__ID DZ28EB DZ28EB DRUGTYPE Small molecular drug DZ28EB DRUGINCH 1S/C13H9F6NO3S2/c14-12(15,16)11(21,13(17,18)19)8-3-5-9(6-4-8)20-25(22,23)10-2-1-7-24-10/h1-7,20-21H DZ28EB DRUGINKE LZWUNZRMANFRAO-UHFFFAOYSA-N DZ28EB DRUGSMIL C1=CSC(=C1)S(=O)(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O DZ28EB HIGHSTAT Preclinical DZ8UP4 DRUG__ID DZ8UP4 DZ8UP4 DRUGTYPE Small molecular drug DZ8UP4 DRUGINCH 1S/C11H8FN5/c12-8-2-3-9-7(6-13-10(9)5-8)1-4-11-14-16-17-15-11/h1-6,13H,(H,14,15,16,17)/b4-1+ DZ8UP4 DRUGINKE JDBSZVDIUIRSDG-DAFODLJHSA-N DZ8UP4 DRUGSMIL C1=CC2=C(C=C1F)NC=C2C=CC3=NNN=N3 DZ8UP4 HIGHSTAT Preclinical DZK7E0 DRUG__ID DZK7E0 DZK7E0 DRUGTYPE Small molecular drug DZK7E0 DRUGINCH 1S/C19H20FN5.2ClH/c20-14-8-6-13(7-9-14)17-18(16-10-11-22-19(21)24-16)25(12-23-17)15-4-2-1-3-5-15;;/h6-12,15H,1-5H2,(H2,21,22,24);2*1H DZK7E0 DRUGINKE PSNKGVAXBSAHCH-UHFFFAOYSA-N DZK7E0 DRUGSMIL C1CCC(CC1)N2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F.Cl.Cl DZK7E0 HIGHSTAT Preclinical D00QIJ DRUG__ID D00QIJ D00QIJ DRUGCOMP Alnylam Pharmaceuticals & Medtronic, Inc. D00QIJ THERCLAS Antisense D00QIJ DRUGTYPE Antisense drug D00QIJ HIGHSTAT Preclinical D04QQG DRUG__ID D04QQG D04QQG DRUGCOMP Aurigene/Curis D04QQG DRUGTYPE Peptide D04QQG DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)NC(C)C(=O)C(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCCNNC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C=O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CO)N)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NN D04QQG HIGHSTAT Preclinical D0F3II DRUG__ID D0F3II D0F3II DRUGCOMP Cortical D0F3II DRUGTYPE Small molecular drug D0F3II DRUGSMIL CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F.CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3 D0F3II HIGHSTAT Preclinical D0FC2D DRUG__ID D0FC2D D0FC2D THERCLAS Antiviral Agents D0FC2D DRUGTYPE Protein/peptide drug D0FC2D DRUGSMIL CCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)CCl D0FC2D HIGHSTAT Preclinical D0KB2E DRUG__ID D0KB2E D0KB2E DRUGINCH 1S/C19H17Cl2NO3/c1-10-16(19(2,3)24)11-6-4-9-14(17(11)25-10)22-18(23)15-12(20)7-5-8-13(15)21/h4-9,24H,1-3H3,(H,22,23) D0KB2E DRUGINKE GCAOVMKRBUCSET-UHFFFAOYSA-N D0KB2E DRUGSMIL CC1=C(C2=C(O1)C(=CC=C2)NC(=O)C3=C(C=CC=C3Cl)Cl)C(C)(C)O D0KB2E HIGHSTAT Preclinical D01QKD DRUG__ID D01QKD D01QKD DRUGCOMP Antisense Therapeutics D01QKD DRUGTYPE Antisense drug D01QKD HIGHSTAT Preclinical D01SNU DRUG__ID D01SNU D01SNU DRUGCOMP Poseida Therapeutics D01SNU DRUGTYPE CAR T Cell Therapy D01SNU HIGHSTAT Preclinical D02AUY DRUG__ID D02AUY D02AUY THERCLAS Antiviral Agents D02AUY DRUGTYPE Protein/peptide drug D02AUY HIGHSTAT Preclinical D02JOA DRUG__ID D02JOA D02JOA THERCLAS Antiviral Agents D02JOA DRUGTYPE Small molecular drug D02JOA HIGHSTAT Preclinical D03IQP DRUG__ID D03IQP D03IQP THERCLAS Antiviral Agents D03IQP DRUGTYPE Protein/peptide drug D03IQP HIGHSTAT Preclinical D03OPS DRUG__ID D03OPS D03OPS THERCLAS Antiviral Agents D03OPS DRUGTYPE Protein/peptide drug D03OPS HIGHSTAT Preclinical D03RYN DRUG__ID D03RYN D03RYN DRUGCOMP CytoDyn D03RYN DRUGTYPE Antibody D03RYN HIGHSTAT Preclinical D03TXY DRUG__ID D03TXY D03TXY THERCLAS Antiviral Agents D03TXY DRUGTYPE Small molecular drug D03TXY HIGHSTAT Preclinical D04CFL DRUG__ID D04CFL D04CFL DRUGCOMP SmithKline Beecham Biologicals D04CFL DRUGTYPE Small molecular drug D04CFL HIGHSTAT Preclinical D04CLH DRUG__ID D04CLH D04CLH THERCLAS Antiviral Agents D04CLH DRUGTYPE Small molecular drug D04CLH HIGHSTAT Preclinical D04DNL DRUG__ID D04DNL D04DNL DRUGCOMP Alnylam Pharmaceuticals Inc D04DNL DRUGTYPE siRNA drug D04DNL HIGHSTAT Preclinical D04ITR DRUG__ID D04ITR D04ITR THERCLAS Antiviral Agents D04ITR DRUGTYPE Small molecular drug D04ITR HIGHSTAT Preclinical D04JSI DRUG__ID D04JSI D04JSI DRUGCOMP Zhujiang Hospital D04JSI DRUGTYPE CAR T Cell Therapy D04JSI HIGHSTAT Preclinical D05HFU DRUG__ID D05HFU D05HFU DRUGCOMP ThromboGenics NV D05HFU DRUGTYPE Antibody D05HFU HIGHSTAT Preclinical D05VEP DRUG__ID D05VEP D05VEP DRUGCOMP Dyax Corp D05VEP DRUGTYPE Antibody D05VEP HIGHSTAT Preclinical D06SDP DRUG__ID D06SDP D06SDP DRUGCOMP Clinuvel Pharmaceuticals D06SDP DRUGTYPE Small molecular drug D06SDP HIGHSTAT Preclinical D06UAD DRUG__ID D06UAD D06UAD THERCLAS Antiviral Agents D06UAD DRUGTYPE Protein/peptide drug D06UAD HIGHSTAT Preclinical D07TJM DRUG__ID D07TJM D07TJM THERCLAS Antiviral Agents D07TJM DRUGTYPE Small molecular drug D07TJM HIGHSTAT Preclinical D07WEV DRUG__ID D07WEV D07WEV THERCLAS Antiviral Agents D07WEV DRUGTYPE Small molecular drug D07WEV HIGHSTAT Preclinical D08ABX DRUG__ID D08ABX D08ABX DRUGCOMP Zhujiang Hospital D08ABX DRUGTYPE CAR T Cell Therapy D08ABX HIGHSTAT Preclinical D08DSC DRUG__ID D08DSC D08DSC DRUGCOMP BioStratum Inc D08DSC DRUGTYPE Antibody D08DSC HIGHSTAT Preclinical D08KQK DRUG__ID D08KQK D08KQK THERCLAS Antiviral Agents D08KQK DRUGTYPE Small molecular drug D08KQK HIGHSTAT Preclinical D09NHD DRUG__ID D09NHD D09NHD THERCLAS Antiviral Agents D09NHD DRUGTYPE Protein/peptide drug D09NHD HIGHSTAT Preclinical D0AJ3O DRUG__ID D0AJ3O D0AJ3O THERCLAS Antiviral Agents D0AJ3O DRUGTYPE Small molecular drug D0AJ3O HIGHSTAT Preclinical D0AN9V DRUG__ID D0AN9V D0AN9V DRUGCOMP Almac Discovery D0AN9V DRUGTYPE Small molecular drug D0AN9V HIGHSTAT Preclinical D0AS1Y DRUG__ID D0AS1Y D0AS1Y THERCLAS Antiviral Agents D0AS1Y DRUGTYPE Vaccine D0AS1Y HIGHSTAT Preclinical D0B2JZ DRUG__ID D0B2JZ D0B2JZ THERCLAS Antiviral Agents D0B2JZ DRUGTYPE Small molecular drug D0B2JZ HIGHSTAT Preclinical D0B8UD DRUG__ID D0B8UD D0B8UD THERCLAS Antiviral Agents D0B8UD DRUGTYPE Vaccine D0B8UD HIGHSTAT Preclinical D0BR5W DRUG__ID D0BR5W D0BR5W THERCLAS Antiviral Agents D0BR5W DRUGTYPE Protein/peptide drug D0BR5W HIGHSTAT Preclinical D0CR6E DRUG__ID D0CR6E D0CR6E THERCLAS Antiviral Agents D0CR6E DRUGTYPE Small molecular drug D0CR6E HIGHSTAT Preclinical D0E5GO DRUG__ID D0E5GO D0E5GO THERCLAS Antiviral Agents D0E5GO DRUGTYPE Small molecular drug D0E5GO HIGHSTAT Preclinical D0E9UT DRUG__ID D0E9UT D0E9UT THERCLAS Antiviral Agents D0E9UT DRUGTYPE Combination drug D0E9UT HIGHSTAT Preclinical D0EV0H DRUG__ID D0EV0H D0EV0H THERCLAS Antiviral Agents D0EV0H DRUGTYPE Protein/peptide drug D0EV0H HIGHSTAT Preclinical D0FP6V DRUG__ID D0FP6V D0FP6V THERCLAS Antiviral Agents D0FP6V DRUGTYPE Protein/peptide drug D0FP6V HIGHSTAT Preclinical D0G3AT DRUG__ID D0G3AT D0G3AT THERCLAS Antiviral Agents D0G3AT DRUGTYPE Small molecular drug D0G3AT HIGHSTAT Preclinical D0G9OC DRUG__ID D0G9OC D0G9OC DRUGCOMP ISIS Pharm; Bristol-Myers Squibb D0G9OC DRUGTYPE Antisense drug D0G9OC HIGHSTAT Preclinical D0H5HJ DRUG__ID D0H5HJ D0H5HJ DRUGCOMP Alnylam Pharmaceuticals D0H5HJ DRUGTYPE RNAi therapeutics D0H5HJ HIGHSTAT Preclinical D0I6RV DRUG__ID D0I6RV D0I6RV THERCLAS Antiviral Agents D0I6RV DRUGTYPE Protein/peptide drug D0I6RV HIGHSTAT Preclinical D0JT0U DRUG__ID D0JT0U D0JT0U DRUGCOMP Zhujiang Hospital D0JT0U DRUGTYPE CAR T Cell Therapy D0JT0U HIGHSTAT Preclinical D0JW9E DRUG__ID D0JW9E D0JW9E DRUGCOMP Zhujiang Hospital D0JW9E DRUGTYPE CAR T Cell Therapy D0JW9E HIGHSTAT Preclinical D0K6XI DRUG__ID D0K6XI D0K6XI THERCLAS Antiviral Agents D0K6XI DRUGTYPE Protein/peptide drug D0K6XI HIGHSTAT Preclinical D0KQ8H DRUG__ID D0KQ8H D0KQ8H THERCLAS Antiviral Agents D0KQ8H DRUGTYPE Small molecular drug D0KQ8H HIGHSTAT Preclinical D0L4WO DRUG__ID D0L4WO D0L4WO DRUGCOMP Seattle Genetics D0L4WO DRUGTYPE Antibody D0L4WO HIGHSTAT Preclinical D0N3US DRUG__ID D0N3US D0N3US THERCLAS Antiviral Agents D0N3US DRUGTYPE Small molecular drug D0N3US HIGHSTAT Preclinical D0N4VG DRUG__ID D0N4VG D0N4VG DRUGCOMP Zhujiang Hospital D0N4VG DRUGTYPE CAR T Cell Therapy D0N4VG HIGHSTAT Preclinical D0Q2HM DRUG__ID D0Q2HM D0Q2HM DRUGCOMP Expression Drug Designs D0Q2HM DRUGTYPE Antibody D0Q2HM HIGHSTAT Preclinical D0RV9C DRUG__ID D0RV9C D0RV9C THERCLAS Antiviral Agents D0RV9C DRUGTYPE Small molecular drug D0RV9C HIGHSTAT Preclinical D0SU5N DRUG__ID D0SU5N D0SU5N THERCLAS Antiviral Agents D0SU5N DRUGTYPE Small molecular drug D0SU5N HIGHSTAT Preclinical D0T9TR DRUG__ID D0T9TR D0T9TR THERCLAS Antiviral Agents D0T9TR DRUGTYPE Protein/peptide drug D0T9TR HIGHSTAT Preclinical D0TS2B DRUG__ID D0TS2B D0TS2B DRUGCOMP Zhujiang Hospital D0TS2B DRUGTYPE CAR T Cell Therapy D0TS2B HIGHSTAT Preclinical D0V0SE DRUG__ID D0V0SE D0V0SE THERCLAS Antiviral Agents D0V0SE DRUGTYPE Protein/peptide drug D0V0SE HIGHSTAT Preclinical D0V2RK DRUG__ID D0V2RK D0V2RK DRUGCOMP University of Vienna D0V2RK DRUGTYPE Antibody D0V2RK HIGHSTAT Preclinical D0V7VX DRUG__ID D0V7VX D0V7VX DRUGCOMP Alnylam Pharmaceuticals D0V7VX DRUGTYPE RNAi therapeutics D0V7VX HIGHSTAT Preclinical D0W8HP DRUG__ID D0W8HP D0W8HP DRUGCOMP Cerus Corp D0W8HP DRUGTYPE Vaccine D0W8HP HIGHSTAT Preclinical D0WD6K DRUG__ID D0WD6K D0WD6K DRUGCOMP Memorial Sloan-Kettering Cancer Center D0WD6K DRUGTYPE Vaccine D0WD6K HIGHSTAT Preclinical D0WL2E DRUG__ID D0WL2E D0WL2E THERCLAS Antiviral Agents D0WL2E DRUGTYPE Small molecular drug D0WL2E HIGHSTAT Preclinical D0Y4BO DRUG__ID D0Y4BO D0Y4BO DRUGCOMP Abraxis BioScience Inc D0Y4BO DRUGTYPE Antibody D0Y4BO HIGHSTAT Preclinical D0ZS1I DRUG__ID D0ZS1I D0ZS1I DRUGCOMP Guangzhou Maxinovel Pharmaceuticals D0ZS1I DRUGTYPE Small molecule immunotherapy D0ZS1I HIGHSTAT Preclinical D24EPJ DRUG__ID D24EPJ D24EPJ DRUGCOMP Catabasis D24EPJ DRUGTYPE Small molecular drug D24EPJ HIGHSTAT Preclinical D28JEC DRUG__ID D28JEC D28JEC DRUGCOMP Atara Biotherapeutics D28JEC DRUGTYPE CAR T Cell Therapy D28JEC HIGHSTAT Preclinical D2J4YT DRUG__ID D2J4YT D2J4YT DRUGCOMP Telix Pharma D2J4YT DRUGTYPE Radiopharmaceutical therapy agent D2J4YT HIGHSTAT Preclinical D2ZI3H DRUG__ID D2ZI3H D2ZI3H DRUGCOMP Bionomics D2ZI3H DRUGTYPE Antibody D2ZI3H HIGHSTAT Preclinical D3JP1T DRUG__ID D3JP1T D3JP1T DRUGCOMP Moderna D3JP1T DRUGTYPE Vaccine D3JP1T HIGHSTAT Preclinical D3Q1OL DRUG__ID D3Q1OL D3Q1OL DRUGCOMP Debiopharm D3Q1OL DRUGTYPE Small molecular drug D3Q1OL HIGHSTAT Preclinical D3UDE8 DRUG__ID D3UDE8 D3UDE8 DRUGCOMP Moderna D3UDE8 DRUGTYPE Vaccine D3UDE8 HIGHSTAT Preclinical D43ADF DRUG__ID D43ADF D43ADF DRUGCOMP NB Health Laboratory D43ADF DRUGTYPE Antibody D43ADF HIGHSTAT Preclinical D46EBX DRUG__ID D46EBX D46EBX DRUGCOMP V ClinBio D46EBX DRUGTYPE Small molecular drug D46EBX HIGHSTAT Preclinical D4K2CQ DRUG__ID D4K2CQ D4K2CQ DRUGCOMP Deciphera Pharmaceuticals D4K2CQ DRUGTYPE Small molecular drug D4K2CQ HIGHSTAT Preclinical D5E1QZ DRUG__ID D5E1QZ D5E1QZ DRUGCOMP BIONTECH D5E1QZ DRUGTYPE Cell therapy D5E1QZ HIGHSTAT Preclinical D5OEL4 DRUG__ID D5OEL4 D5OEL4 DRUGCOMP OranoMed/Morphotek D5OEL4 DRUGTYPE Radiopharmaceutical therapy agent D5OEL4 HIGHSTAT Preclinical D6MEX0 DRUG__ID D6MEX0 D6MEX0 DRUGCOMP Alnylam Pharmaceuticals D6MEX0 DRUGTYPE Small interfering RNA D6MEX0 HIGHSTAT Preclinical D6TL2N DRUG__ID D6TL2N D6TL2N DRUGCOMP Moderna D6TL2N DRUGTYPE Vaccine D6TL2N HIGHSTAT Preclinical D6VLX2 DRUG__ID D6VLX2 D6VLX2 DRUGCOMP Janssen D6VLX2 DRUGTYPE Small molecular drug D6VLX2 HIGHSTAT Preclinical D78LHD DRUG__ID D78LHD D78LHD DRUGCOMP Teva Pharmaceutical D78LHD DRUGTYPE Small molecule D78LHD HIGHSTAT Preclinical D82DGN DRUG__ID D82DGN D82DGN DRUGCOMP Jyant Technologies D82DGN DRUGTYPE Antibody D82DGN HIGHSTAT Preclinical D8AI0N DRUG__ID D8AI0N D8AI0N DRUGCOMP Atara Biotherapeutics D8AI0N DRUGTYPE CAR T Cell Therapy D8AI0N HIGHSTAT Preclinical D9P8LE DRUG__ID D9P8LE D9P8LE DRUGCOMP Roche D9P8LE DRUGTYPE Small molecular drug D9P8LE HIGHSTAT Preclinical DB8J1O DRUG__ID DB8J1O DB8J1O DRUGCOMP Moderna DB8J1O DRUGTYPE Vaccine DB8J1O HIGHSTAT Preclinical DBJ36R DRUG__ID DBJ36R DBJ36R DRUGCOMP Jyant Technologies DBJ36R DRUGTYPE Antibody DBJ36R HIGHSTAT Preclinical DDY1P5 DRUG__ID DDY1P5 DDY1P5 DRUGCOMP Moderna DDY1P5 DRUGTYPE Vaccine DDY1P5 HIGHSTAT Preclinical DEN52G DRUG__ID DEN52G DEN52G DRUGCOMP TB DEN52G DRUGTYPE Small molecule DEN52G HIGHSTAT Preclinical DG07UD DRUG__ID DG07UD DG07UD DRUGCOMP V ClinBio DG07UD DRUGTYPE Small molecular drug DG07UD HIGHSTAT Preclinical DI2X8V DRUG__ID DI2X8V DI2X8V DRUGCOMP Atara Biotherapeutics DI2X8V DRUGTYPE CAR T Cell Therapy DI2X8V HIGHSTAT Preclinical DI8ZG7 DRUG__ID DI8ZG7 DI8ZG7 DRUGCOMP Visterra DI8ZG7 DRUGTYPE Antibody DI8ZG7 HIGHSTAT Preclinical DI9ZQ6 DRUG__ID DI9ZQ6 DI9ZQ6 DRUGCOMP OranoMed/NordicNanovector DI9ZQ6 DRUGTYPE Radiopharmaceutical therapy agent DI9ZQ6 HIGHSTAT Preclinical DIW58H DRUG__ID DIW58H DIW58H DRUGCOMP Cellectis DIW58H DRUGTYPE CAR T Cell Therapy DIW58H HIGHSTAT Preclinical DL1E6F DRUG__ID DL1E6F DL1E6F DRUGCOMP OranoMed/Cellectar DL1E6F DRUGTYPE Radiopharmaceutical therapy agent DL1E6F HIGHSTAT Preclinical DNUS02 DRUG__ID DNUS02 DNUS02 DRUGCOMP Purple DNUS02 DRUGTYPE Antibody DNUS02 HIGHSTAT Preclinical DO6UE8 DRUG__ID DO6UE8 DO6UE8 DRUGCOMP Bayer DO6UE8 DRUGTYPE Radiopharmaceutical therapy agent DO6UE8 HIGHSTAT Preclinical DPJ05C DRUG__ID DPJ05C DPJ05C DRUGCOMP Mochida DPJ05C DRUGTYPE Small molecular drug DPJ05C HIGHSTAT Preclinical DRJU35 DRUG__ID DRJU35 DRJU35 DRUGCOMP Almac Discovery DRJU35 DRUGTYPE Small molecular drug DRJU35 HIGHSTAT Preclinical DXT2W8 DRUG__ID DXT2W8 DXT2W8 DRUGCOMP Moderna DXT2W8 DRUGTYPE Vaccine DXT2W8 HIGHSTAT Preclinical DY2EJ1 DRUG__ID DY2EJ1 DY2EJ1 DRUGCOMP Atara Biotherapeutics DY2EJ1 DRUGTYPE CAR T Cell Therapy DY2EJ1 HIGHSTAT Preclinical DY7IP9 DRUG__ID DY7IP9 DY7IP9 DRUGCOMP Amgen DY7IP9 DRUGTYPE Antibody DY7IP9 HIGHSTAT Preclinical DYL40R DRUG__ID DYL40R DYL40R DRUGCOMP Moderna DYL40R DRUGTYPE Vaccine DYL40R HIGHSTAT Preclinical DZK24C DRUG__ID DZK24C DZK24C DRUGCOMP Emcure Pharmaceuticals DZK24C DRUGTYPE Small molecular drug DZK24C HIGHSTAT Preclinical D00AQY DRUG__ID D00AQY D00AQY DRUGCOMP Amgen D00AQY HIGHSTAT Preclinical D00CEI DRUG__ID D00CEI D00CEI DRUGCOMP Georgia Institute of Technology D00CEI HIGHSTAT Preclinical D00HDK DRUG__ID D00HDK D00HDK DRUGCOMP Psychiatric Genomics Inc D00HDK HIGHSTAT Preclinical D00INM DRUG__ID D00INM D00INM DRUGCOMP ViRexx Medical Corp D00INM HIGHSTAT Preclinical D00KWF DRUG__ID D00KWF D00KWF DRUGCOMP Botanic Century (Beijing) Co Ltd D00KWF HIGHSTAT Preclinical D00LWR DRUG__ID D00LWR D00LWR DRUGCOMP BioVitrum D00LWR HIGHSTAT Preclinical D00NOP DRUG__ID D00NOP D00NOP DRUGCOMP Oncolys BioPharma Inc D00NOP HIGHSTAT Preclinical D00TEN DRUG__ID D00TEN D00TEN DRUGCOMP Aventis Behring LLC D00TEN HIGHSTAT Preclinical D00XBH DRUG__ID D00XBH D00XBH DRUGCOMP MNLpharma Ltd D00XBH HIGHSTAT Preclinical D01ECN DRUG__ID D01ECN D01ECN DRUGCOMP Bavarian Nordic A/S D01ECN HIGHSTAT Preclinical D01EXY DRUG__ID D01EXY D01EXY DRUGCOMP Bionovo Inc D01EXY HIGHSTAT Preclinical D01GDO DRUG__ID D01GDO D01GDO DRUGCOMP Helix BioMedix Inc D01GDO HIGHSTAT Preclinical D01UNF DRUG__ID D01UNF D01UNF DRUGCOMP NAEJA Pharmaceuticals Inc D01UNF HIGHSTAT Preclinical D01XEC DRUG__ID D01XEC D01XEC DRUGCOMP DynPort Vaccine Company D01XEC HIGHSTAT Preclinical D01ZCL DRUG__ID D01ZCL D01ZCL DRUGCOMP University of Illinois D01ZCL HIGHSTAT Preclinical D02CJA DRUG__ID D02CJA D02CJA DRUGCOMP Cenomed BioSciences LLC D02CJA HIGHSTAT Preclinical D02FHP DRUG__ID D02FHP D02FHP DRUGCOMP Rib-X Pharmaceuticals Inc D02FHP HIGHSTAT Preclinical D02LYH DRUG__ID D02LYH D02LYH DRUGCOMP Phytomedics D02LYH HIGHSTAT Preclinical D02MNY DRUG__ID D02MNY D02MNY DRUGCOMP Onconova Therapeutics Inc D02MNY HIGHSTAT Preclinical D02NEZ DRUG__ID D02NEZ D02NEZ DRUGCOMP Inimex Pharmaceuticals Inc D02NEZ HIGHSTAT Preclinical D02PNH DRUG__ID D02PNH D02PNH DRUGCOMP Collegium Pharmaceuticals D02PNH HIGHSTAT Preclinical D02PTD DRUG__ID D02PTD D02PTD DRUGCOMP Il Dong Pharmaceutical Co Ltd D02PTD HIGHSTAT Preclinical D02SMV DRUG__ID D02SMV D02SMV DRUGCOMP Quigley Pharma Inc D02SMV HIGHSTAT Preclinical D02ZWR DRUG__ID D02ZWR D02ZWR DRUGCOMP Idera Pharmaceuticals D02ZWR HIGHSTAT Preclinical D03JZD DRUG__ID D03JZD D03JZD DRUGCOMP VitreoRetinal Technologies Inc D03JZD HIGHSTAT Preclinical D03LNN DRUG__ID D03LNN D03LNN DRUGCOMP Idenix D03LNN HIGHSTAT Preclinical D03MFV DRUG__ID D03MFV D03MFV DRUGCOMP MNLpharma Ltd D03MFV HIGHSTAT Preclinical D03VGW DRUG__ID D03VGW D03VGW DRUGCOMP Glenmark D03VGW HIGHSTAT Preclinical D03WUU DRUG__ID D03WUU D03WUU DRUGCOMP Karolinska Institute D03WUU HIGHSTAT Preclinical D03WVP DRUG__ID D03WVP D03WVP DRUGCOMP PLx Pharma D03WVP HIGHSTAT Preclinical D04ABS DRUG__ID D04ABS D04ABS DRUGCOMP Octamer Inc D04ABS HIGHSTAT Preclinical D04BXJ DRUG__ID D04BXJ D04BXJ DRUGCOMP Sosei R&D Ltd D04BXJ HIGHSTAT Preclinical D04CEY DRUG__ID D04CEY D04CEY DRUGCOMP Phytopharm plc D04CEY HIGHSTAT Preclinical D04EIX DRUG__ID D04EIX D04EIX DRUGCOMP Bionovo Inc D04EIX HIGHSTAT Preclinical D04GFO DRUG__ID D04GFO D04GFO DRUGCOMP MaxoCore Pharmaceuticals Inc D04GFO HIGHSTAT Preclinical D04HMM DRUG__ID D04HMM D04HMM DRUGCOMP XenoPort Inc D04HMM HIGHSTAT Preclinical D04LDK DRUG__ID D04LDK D04LDK DRUGCOMP Tranzyme Pharma Inc D04LDK HIGHSTAT Preclinical D04MGI DRUG__ID D04MGI D04MGI DRUGCOMP Pfizer Inc D04MGI HIGHSTAT Preclinical D04PBS DRUG__ID D04PBS D04PBS DRUGCOMP MaxoCore Pharmaceuticals Inc D04PBS HIGHSTAT Preclinical D04RAT DRUG__ID D04RAT D04RAT DRUGCOMP Boehringer Ingelheim Corp D04RAT HIGHSTAT Preclinical D04RSI DRUG__ID D04RSI D04RSI THERCLAS Antifungal Agents D04RSI HIGHSTAT Preclinical D04UOJ DRUG__ID D04UOJ D04UOJ DRUGCOMP Hong Kong Jockey Club Institute of Chinese Medicine Limited D04UOJ HIGHSTAT Preclinical D04USK DRUG__ID D04USK D04USK DRUGCOMP BioDiem Ltd D04USK HIGHSTAT Preclinical D04VLR DRUG__ID D04VLR D04VLR DRUGCOMP Panacos Pharmaceuticals Inc D04VLR HIGHSTAT Preclinical D04XLU DRUG__ID D04XLU D04XLU DRUGCOMP ODC Therapy Inc D04XLU HIGHSTAT Preclinical D05LVL DRUG__ID D05LVL D05LVL DRUGCOMP Cetek Corp D05LVL HIGHSTAT Preclinical D05PQW DRUG__ID D05PQW D05PQW DRUGCOMP AstraZeneca plc D05PQW HIGHSTAT Preclinical D05UJU DRUG__ID D05UJU D05UJU DRUGCOMP Miravant Medical Technologies D05UJU HIGHSTAT Preclinical D05VOP DRUG__ID D05VOP D05VOP DRUGCOMP RAPID Pharmaceuticals AG D05VOP HIGHSTAT Preclinical D05YRV DRUG__ID D05YRV D05YRV DRUGCOMP E-Therapeutics Ltd D05YRV HIGHSTAT Preclinical D06DFU DRUG__ID D06DFU D06DFU THERCLAS Psychiatric D06DFU HIGHSTAT Preclinical D06GFG DRUG__ID D06GFG D06GFG DRUGCOMP Kalypsys D06GFG HIGHSTAT Preclinical D06GSA DRUG__ID D06GSA D06GSA DRUGCOMP Vical D06GSA HIGHSTAT Preclinical D06KYU DRUG__ID D06KYU D06KYU DRUGCOMP Columbia University D06KYU HIGHSTAT Preclinical D06LBZ DRUG__ID D06LBZ D06LBZ DRUGCOMP Bavarian Nordic A/S D06LBZ HIGHSTAT Preclinical D06RVY DRUG__ID D06RVY D06RVY DRUGCOMP Sirion Therapeutics Inc D06RVY HIGHSTAT Preclinical D06TGS DRUG__ID D06TGS D06TGS DRUGCOMP Mesoblast; stemedica cell technologies D06TGS HIGHSTAT Preclinical D06YGP DRUG__ID D06YGP D06YGP DRUGCOMP Bionovo Inc D06YGP HIGHSTAT Preclinical D07IND DRUG__ID D07IND D07IND DRUGCOMP Serentis Ltd D07IND HIGHSTAT Preclinical D07JPK DRUG__ID D07JPK D07JPK DRUGCOMP E-Therapeutics Ltd D07JPK HIGHSTAT Preclinical D07SYN DRUG__ID D07SYN D07SYN DRUGCOMP Flexion Therapeutics D07SYN HIGHSTAT Preclinical D07YVM DRUG__ID D07YVM D07YVM DRUGCOMP Calyx Therapeutics Inc D07YVM HIGHSTAT Preclinical D07ZJC DRUG__ID D07ZJC D07ZJC DRUGCOMP Prostagenics LLC D07ZJC HIGHSTAT Preclinical D08MGU DRUG__ID D08MGU D08MGU DRUGCOMP Transave Inc D08MGU HIGHSTAT Preclinical D08SIR DRUG__ID D08SIR D08SIR DRUGCOMP Cyanamid D08SIR HIGHSTAT Preclinical D08TAB DRUG__ID D08TAB D08TAB DRUGCOMP Exelixis Inc D08TAB HIGHSTAT Preclinical D08UZD DRUG__ID D08UZD D08UZD DRUGCOMP Deli Solar (USA) Inc D08UZD HIGHSTAT Preclinical D08VWF DRUG__ID D08VWF D08VWF DRUGCOMP GlaxoSmithKline plc D08VWF HIGHSTAT Preclinical D08WOE DRUG__ID D08WOE D08WOE DRUGCOMP MaxoCore Pharmaceuticals Inc D08WOE HIGHSTAT Preclinical D09DER DRUG__ID D09DER D09DER DRUGCOMP Quigley Pharma Inc D09DER HIGHSTAT Preclinical D09DKY DRUG__ID D09DKY D09DKY DRUGCOMP Aeterna Zentaris Inc. D09DKY HIGHSTAT Preclinical D09FQS DRUG__ID D09FQS D09FQS DRUGCOMP F2G Ltd D09FQS HIGHSTAT Preclinical D09HDV DRUG__ID D09HDV D09HDV DRUGCOMP Sosei R&D Ltd D09HDV HIGHSTAT Preclinical D09IFW DRUG__ID D09IFW D09IFW THERCLAS Antifungal Agents D09IFW HIGHSTAT Preclinical D09JDX DRUG__ID D09JDX D09JDX DRUGCOMP Celogos D09JDX HIGHSTAT Preclinical D09KRX DRUG__ID D09KRX D09KRX DRUGCOMP Cetek Corp D09KRX HIGHSTAT Preclinical D09MQQ DRUG__ID D09MQQ D09MQQ DRUGCOMP University of Toledo D09MQQ HIGHSTAT Preclinical D09ODU DRUG__ID D09ODU D09ODU DRUGCOMP Exelixis D09ODU HIGHSTAT Preclinical D09OUT DRUG__ID D09OUT D09OUT DRUGCOMP University of Illinois D09OUT HIGHSTAT Preclinical D09UCO DRUG__ID D09UCO D09UCO DRUGCOMP Ambrx; bristol-myers squibb D09UCO HIGHSTAT Preclinical D09WVR DRUG__ID D09WVR D09WVR DRUGCOMP Fibrex Medical R&D GmbH D09WVR HIGHSTAT Preclinical D0A1VL DRUG__ID D0A1VL D0A1VL DRUGCOMP Fisons; AstraZeneca D0A1VL HIGHSTAT Preclinical D0A5BJ DRUG__ID D0A5BJ D0A5BJ DRUGCOMP Oxford BioMedica plc D0A5BJ HIGHSTAT Preclinical D0A6UQ DRUG__ID D0A6UQ D0A6UQ DRUGCOMP E-Therapeutics Ltd D0A6UQ HIGHSTAT Preclinical D0AM6F DRUG__ID D0AM6F D0AM6F DRUGCOMP E-Therapeutics Ltd D0AM6F HIGHSTAT Preclinical D0B1DA DRUG__ID D0B1DA D0B1DA DRUGCOMP ADIENNE Pharma & Biotech D0B1DA HIGHSTAT Preclinical D0B2RZ DRUG__ID D0B2RZ D0B2RZ DRUGCOMP Addex Pharmaceuticals SA D0B2RZ HIGHSTAT Preclinical D0B6YY DRUG__ID D0B6YY D0B6YY DRUGCOMP Gentium SpA D0B6YY HIGHSTAT Preclinical D0B7OM DRUG__ID D0B7OM D0B7OM DRUGCOMP Pierre Fabre SA D0B7OM HIGHSTAT Preclinical D0BA0O DRUG__ID D0BA0O D0BA0O DRUGCOMP INSERM D0BA0O HIGHSTAT Preclinical D0C0ME DRUG__ID D0C0ME D0C0ME DRUGCOMP Roche D0C0ME HIGHSTAT Preclinical D0C3RF DRUG__ID D0C3RF D0C3RF DRUGCOMP REPLICor Inc D0C3RF HIGHSTAT Preclinical D0D1RF DRUG__ID D0D1RF D0D1RF DRUGCOMP Ablynx NV D0D1RF HIGHSTAT Preclinical D0D4AQ DRUG__ID D0D4AQ D0D4AQ DRUGCOMP Pharmacyclics Inc D0D4AQ HIGHSTAT Preclinical D0D8CE DRUG__ID D0D8CE D0D8CE DRUGCOMP Envivo pharmaceuticals D0D8CE HIGHSTAT Preclinical D0E2YV DRUG__ID D0E2YV D0E2YV DRUGCOMP MedGenesis Therapeutix Inc D0E2YV HIGHSTAT Preclinical D0E4VT DRUG__ID D0E4VT D0E4VT DRUGCOMP Advanced Plant Pharmaceuticals D0E4VT HIGHSTAT Preclinical D0E6MW DRUG__ID D0E6MW D0E6MW DRUGCOMP Bionovo Inc D0E6MW HIGHSTAT Preclinical D0FJ3P DRUG__ID D0FJ3P D0FJ3P DRUGCOMP SmithKline Beecham Pharmaceuticals D0FJ3P HIGHSTAT Preclinical D0FX5D DRUG__ID D0FX5D D0FX5D DRUGCOMP Mesoblast; stemedica cell technologies D0FX5D HIGHSTAT Preclinical D0G1SM DRUG__ID D0G1SM D0G1SM DRUGCOMP AstraZeneca plc D0G1SM HIGHSTAT Preclinical D0G3CO DRUG__ID D0G3CO D0G3CO DRUGCOMP Yale University D0G3CO HIGHSTAT Preclinical D0G7LP DRUG__ID D0G7LP D0G7LP DRUGCOMP Proteotech D0G7LP HIGHSTAT Preclinical D0G8NP DRUG__ID D0G8NP D0G8NP DRUGCOMP Shenzhen Chipscreen Biosciences Ltd D0G8NP HIGHSTAT Preclinical D0H3YC DRUG__ID D0H3YC D0H3YC DRUGCOMP Maxim Pharmaceuticals Inc D0H3YC HIGHSTAT Preclinical D0I2LX DRUG__ID D0I2LX D0I2LX DRUGCOMP Remergent D0I2LX HIGHSTAT Preclinical D0I3TS DRUG__ID D0I3TS D0I3TS DRUGCOMP GSK D0I3TS HIGHSTAT Preclinical D0I4EI DRUG__ID D0I4EI D0I4EI DRUGCOMP NeuroSolutions Ltd D0I4EI HIGHSTAT Preclinical D0I6JG DRUG__ID D0I6JG D0I6JG DRUGCOMP Akzo Nobel D0I6JG HIGHSTAT Preclinical D0I8TV DRUG__ID D0I8TV D0I8TV DRUGCOMP Delex Therapeutics Inc D0I8TV HIGHSTAT Preclinical D0IZ1I DRUG__ID D0IZ1I D0IZ1I DRUGCOMP Sosei Group Corp D0IZ1I HIGHSTAT Preclinical D0J7WO DRUG__ID D0J7WO D0J7WO DRUGCOMP Abbott D0J7WO HIGHSTAT Preclinical D0J9CF DRUG__ID D0J9CF D0J9CF DRUGCOMP Amgen D0J9CF HIGHSTAT Preclinical D0K5WM DRUG__ID D0K5WM D0K5WM DRUGCOMP Daiichi-Sankyo D0K5WM HIGHSTAT Preclinical D0KE7K DRUG__ID D0KE7K D0KE7K DRUGCOMP Urigen Pharmaceuticals Inc D0KE7K HIGHSTAT Preclinical D0KJ0U DRUG__ID D0KJ0U D0KJ0U DRUGCOMP AstraZeneca plc D0KJ0U HIGHSTAT Preclinical D0M6OW DRUG__ID D0M6OW D0M6OW DRUGCOMP Anavex D0M6OW HIGHSTAT Preclinical D0M8PM DRUG__ID D0M8PM D0M8PM DRUGCOMP IRX Therapeutics Inc D0M8PM HIGHSTAT Preclinical D0MC2E DRUG__ID D0MC2E D0MC2E DRUGCOMP MorphoSys AG D0MC2E HIGHSTAT Preclinical D0N3RC DRUG__ID D0N3RC D0N3RC DRUGCOMP Tranzyme Pharma Inc D0N3RC HIGHSTAT Preclinical D0N4AB DRUG__ID D0N4AB D0N4AB DRUGCOMP Rib-X Pharmaceuticals D0N4AB HIGHSTAT Preclinical D0N6YN DRUG__ID D0N6YN D0N6YN DRUGCOMP Bionovo Inc D0N6YN HIGHSTAT Preclinical D0NO6E DRUG__ID D0NO6E D0NO6E DRUGCOMP Dompe D0NO6E HIGHSTAT Preclinical D0O5ZT DRUG__ID D0O5ZT D0O5ZT DRUGCOMP Akzo Nobel D0O5ZT HIGHSTAT Preclinical D0O6DC DRUG__ID D0O6DC D0O6DC DRUGCOMP Eli Lilly D0O6DC HIGHSTAT Preclinical D0OMC3 DRUG__ID D0OMC3 D0OMC3 DRUGTYPE Antibody D0OMC3 HIGHSTAT Preclinical D0P4FT DRUG__ID D0P4FT D0P4FT DRUGCOMP Artisan Pharma D0P4FT HIGHSTAT Preclinical D0P5NU DRUG__ID D0P5NU D0P5NU DRUGCOMP Bionovo Inc D0P5NU HIGHSTAT Preclinical D0P6LP DRUG__ID D0P6LP D0P6LP DRUGCOMP Cosmo Pharmaceuticals SpA D0P6LP HIGHSTAT Preclinical D0Q2VL DRUG__ID D0Q2VL D0Q2VL DRUGCOMP Pfizer D0Q2VL HIGHSTAT Preclinical D0Q6ED DRUG__ID D0Q6ED D0Q6ED DRUGCOMP Astellas Pharma D0Q6ED HIGHSTAT Preclinical D0Q7CR DRUG__ID D0Q7CR D0Q7CR DRUGCOMP Maxim Pharmaceuticals Inc D0Q7CR HIGHSTAT Preclinical D0QB8Q DRUG__ID D0QB8Q D0QB8Q DRUGCOMP Maxim Pharmaceuticals Inc D0QB8Q HIGHSTAT Preclinical D0QI9N DRUG__ID D0QI9N D0QI9N DRUGCOMP Bionovo Inc D0QI9N HIGHSTAT Preclinical D0QS6G DRUG__ID D0QS6G D0QS6G DRUGCOMP Biosyn Inc D0QS6G HIGHSTAT Preclinical D0QX9U DRUG__ID D0QX9U D0QX9U DRUGCOMP Bionovo Inc D0QX9U HIGHSTAT Preclinical D0R2SW DRUG__ID D0R2SW D0R2SW THERCLAS Antifungal Agents D0R2SW HIGHSTAT Preclinical D0R9WI DRUG__ID D0R9WI D0R9WI DRUGCOMP Pierre Fabre SA D0R9WI HIGHSTAT Preclinical D0S0MR DRUG__ID D0S0MR D0S0MR DRUGCOMP Novacta Biosystems Ltd D0S0MR HIGHSTAT Preclinical D0SS2E DRUG__ID D0SS2E D0SS2E DRUGCOMP AstraZeneca plc D0SS2E HIGHSTAT Preclinical D0T4YZ DRUG__ID D0T4YZ D0T4YZ DRUGCOMP Relevare Pharmaceuticals Ltd D0T4YZ HIGHSTAT Preclinical D0TI4U DRUG__ID D0TI4U D0TI4U DRUGCOMP Bristol-Myers Squibb D0TI4U HIGHSTAT Preclinical D0TK2J DRUG__ID D0TK2J D0TK2J DRUGCOMP Bionovo Inc D0TK2J HIGHSTAT Preclinical D0TP7T DRUG__ID D0TP7T D0TP7T DRUGCOMP SCYNEXIS D0TP7T HIGHSTAT Preclinical D0U1BU DRUG__ID D0U1BU D0U1BU DRUGCOMP Novo Nordisk A/S D0U1BU HIGHSTAT Preclinical D0U1CL DRUG__ID D0U1CL D0U1CL DRUGCOMP Psychiatric Genomics Inc D0U1CL HIGHSTAT Preclinical D0U1FR DRUG__ID D0U1FR D0U1FR DRUGCOMP BioChem Therapeutic Inc D0U1FR HIGHSTAT Preclinical D0U7ZY DRUG__ID D0U7ZY D0U7ZY DRUGCOMP Supratek Pharma Inc D0U7ZY HIGHSTAT Preclinical D0U9GZ DRUG__ID D0U9GZ D0U9GZ DRUGCOMP BioPort Corporation D0U9GZ HIGHSTAT Preclinical D0U9OJ DRUG__ID D0U9OJ D0U9OJ DRUGCOMP GlaxoSmithKline D0U9OJ HIGHSTAT Preclinical D0US1X DRUG__ID D0US1X D0US1X DRUGCOMP Oscotec Inc D0US1X HIGHSTAT Preclinical D0V2FZ DRUG__ID D0V2FZ D0V2FZ DRUGCOMP University of Toronto D0V2FZ HIGHSTAT Preclinical D0V7FG DRUG__ID D0V7FG D0V7FG DRUGCOMP Sanochemia Pharmazeutika AG D0V7FG HIGHSTAT Preclinical D0V9ME DRUG__ID D0V9ME D0V9ME DRUGCOMP Viron Therapeutics D0V9ME HIGHSTAT Preclinical D0V9ND DRUG__ID D0V9ND D0V9ND DRUGCOMP Pfizer D0V9ND HIGHSTAT Preclinical D0VF8Z DRUG__ID D0VF8Z D0VF8Z DRUGCOMP Serentis Ltd D0VF8Z HIGHSTAT Preclinical D0W4OZ DRUG__ID D0W4OZ D0W4OZ DRUGCOMP GSK D0W4OZ HIGHSTAT Preclinical D0WM3E DRUG__ID D0WM3E D0WM3E DRUGCOMP Creative Antibiotics Sweden AB D0WM3E HIGHSTAT Preclinical D0X4UH DRUG__ID D0X4UH D0X4UH DRUGCOMP Sonus Pharmaceuticals D0X4UH HIGHSTAT Preclinical D0X5YU DRUG__ID D0X5YU D0X5YU DRUGCOMP Kosan Biosciences Inc D0X5YU HIGHSTAT Preclinical D0X6LG DRUG__ID D0X6LG D0X6LG DRUGCOMP MaxoCore Pharmaceuticals Inc D0X6LG HIGHSTAT Preclinical D0X7OH DRUG__ID D0X7OH D0X7OH DRUGTYPE Small molecular drug D0X7OH HIGHSTAT Preclinical D0XB4D DRUG__ID D0XB4D D0XB4D DRUGCOMP Neurotech Pharmaceuticals Inc D0XB4D HIGHSTAT Preclinical D0XL4I DRUG__ID D0XL4I D0XL4I DRUGCOMP Eisai Co Ltd D0XL4I HIGHSTAT Preclinical D0XM3S DRUG__ID D0XM3S D0XM3S DRUGCOMP Cortex Pharmaceuticals Inc D0XM3S HIGHSTAT Preclinical D0Y9KR DRUG__ID D0Y9KR D0Y9KR DRUGCOMP Sanofi-Aventis D0Y9KR HIGHSTAT Preclinical D0YC1Z DRUG__ID D0YC1Z D0YC1Z DRUGCOMP Ontario Inc D0YC1Z HIGHSTAT Preclinical D0YH9A DRUG__ID D0YH9A D0YH9A THERCLAS Neurodegenerative D0YH9A HIGHSTAT Preclinical D0Z2NA DRUG__ID D0Z2NA D0Z2NA DRUGCOMP Androclus Therapeutics D0Z2NA HIGHSTAT Preclinical D0Z4NA DRUG__ID D0Z4NA D0Z4NA DRUGCOMP Neos therapeutics D0Z4NA HIGHSTAT Preclinical D0Z8EJ DRUG__ID D0Z8EJ D0Z8EJ DRUGCOMP Kosan Biosciences Inc D0Z8EJ HIGHSTAT Preclinical D16JNF DRUG__ID D16JNF D16JNF DRUGTYPE Small molecular drug D16JNF HIGHSTAT Preclinical D17TRG DRUG__ID D17TRG D17TRG DRUGTYPE Small molecular drug D17TRG HIGHSTAT Preclinical D1Y6RQ DRUG__ID D1Y6RQ D1Y6RQ DRUGTYPE Small molecular drug D1Y6RQ HIGHSTAT Preclinical D23FRK DRUG__ID D23FRK D23FRK DRUGTYPE Antibody D23FRK HIGHSTAT Preclinical D2DLN9 DRUG__ID D2DLN9 D2DLN9 DRUGTYPE Small molecular drug D2DLN9 HIGHSTAT Preclinical D2NK6M DRUG__ID D2NK6M D2NK6M DRUGCOMP Teva Pharmaceutical D2NK6M HIGHSTAT Preclinical D2NU0H DRUG__ID D2NU0H D2NU0H DRUGTYPE Antibody D2NU0H HIGHSTAT Preclinical D35SKV DRUG__ID D35SKV D35SKV DRUGTYPE Small molecular drug D35SKV HIGHSTAT Preclinical D49AGF DRUG__ID D49AGF D49AGF DRUGTYPE Small molecular drug D49AGF HIGHSTAT Preclinical D4JS3A DRUG__ID D4JS3A D4JS3A DRUGTYPE Antibody D4JS3A HIGHSTAT Preclinical D4M0GR DRUG__ID D4M0GR D4M0GR DRUGTYPE Small molecular drug D4M0GR HIGHSTAT Preclinical D4V0SI DRUG__ID D4V0SI D4V0SI DRUGTYPE Small molecular drug D4V0SI HIGHSTAT Preclinical D50NHR DRUG__ID D50NHR D50NHR DRUGTYPE Antibody D50NHR HIGHSTAT Preclinical D58KTN DRUG__ID D58KTN D58KTN DRUGCOMP TB D58KTN HIGHSTAT Preclinical D6PRE7 DRUG__ID D6PRE7 D6PRE7 DRUGTYPE Small molecular drug D6PRE7 HIGHSTAT Preclinical D7FL3H DRUG__ID D7FL3H D7FL3H DRUGCOMP CinFina Pharma D7FL3H HIGHSTAT Preclinical D7K0GP DRUG__ID D7K0GP D7K0GP DRUGTYPE Peptide D7K0GP HIGHSTAT Preclinical D7TIB0 DRUG__ID D7TIB0 D7TIB0 DRUGTYPE Antibody D7TIB0 HIGHSTAT Preclinical D86ALC DRUG__ID D86ALC D86ALC DRUGCOMP Symberix D86ALC HIGHSTAT Preclinical D8WBZ2 DRUG__ID D8WBZ2 D8WBZ2 DRUGTYPE Small molecular drug D8WBZ2 HIGHSTAT Preclinical D9FZN0 DRUG__ID D9FZN0 D9FZN0 DRUGCOMP Second Genome D9FZN0 HIGHSTAT Preclinical D9L1NP DRUG__ID D9L1NP D9L1NP DRUGCOMP Teva Pharmaceutical D9L1NP HIGHSTAT Preclinical DA6F1D DRUG__ID DA6F1D DA6F1D DRUGTYPE Antibody DA6F1D HIGHSTAT Preclinical DA85KQ DRUG__ID DA85KQ DA85KQ DRUGCOMP Aclipse Therapeutics DA85KQ HIGHSTAT Preclinical DB1P9T DRUG__ID DB1P9T DB1P9T DRUGTYPE Small molecular drug DB1P9T HIGHSTAT Preclinical DC4AT7 DRUG__ID DC4AT7 DC4AT7 DRUGTYPE Antibody DC4AT7 HIGHSTAT Preclinical DC9J1Y DRUG__ID DC9J1Y DC9J1Y DRUGCOMP Roche DC9J1Y HIGHSTAT Preclinical DCZ16N DRUG__ID DCZ16N DCZ16N DRUGTYPE Small molecular drug DCZ16N HIGHSTAT Preclinical DDC63W DRUG__ID DDC63W DDC63W DRUGTYPE Small molecular drug DDC63W HIGHSTAT Preclinical DE02TN DRUG__ID DE02TN DE02TN DRUGCOMP Teva Pharmaceutical DE02TN HIGHSTAT Preclinical DE9GB2 DRUG__ID DE9GB2 DE9GB2 DRUGCOMP Teva Pharmaceutical DE9GB2 HIGHSTAT Preclinical DFI5N1 DRUG__ID DFI5N1 DFI5N1 DRUGCOMP TB DFI5N1 HIGHSTAT Preclinical DG90VQ DRUG__ID DG90VQ DG90VQ DRUGTYPE Small molecular drug DG90VQ HIGHSTAT Preclinical DGP6V3 DRUG__ID DGP6V3 DGP6V3 DRUGTYPE Small molecular drug DGP6V3 HIGHSTAT Preclinical DI53SE DRUG__ID DI53SE DI53SE DRUGCOMP TB DI53SE HIGHSTAT Preclinical DL3K7I DRUG__ID DL3K7I DL3K7I DRUGCOMP Teva Pharmaceutical DL3K7I HIGHSTAT Preclinical DMHS37 DRUG__ID DMHS37 DMHS37 DRUGCOMP Teva Pharmaceutical DMHS37 HIGHSTAT Preclinical DNE4B9 DRUG__ID DNE4B9 DNE4B9 DRUGTYPE Peptide DNE4B9 HIGHSTAT Preclinical DNE73Q DRUG__ID DNE73Q DNE73Q DRUGTYPE Antibody DNE73Q HIGHSTAT Preclinical DNSK92 DRUG__ID DNSK92 DNSK92 DRUGCOMP Teva Pharmaceutical DNSK92 HIGHSTAT Preclinical DO7HS1 DRUG__ID DO7HS1 DO7HS1 DRUGTYPE Antibody DO7HS1 HIGHSTAT Preclinical DOJ6D9 DRUG__ID DOJ6D9 DOJ6D9 DRUGTYPE Small molecular drug DOJ6D9 HIGHSTAT Preclinical DOMC56 DRUG__ID DOMC56 DOMC56 DRUGCOMP Symbiotix Biotherapies DOMC56 HIGHSTAT Preclinical DOZQ70 DRUG__ID DOZQ70 DOZQ70 DRUGTYPE Small molecular drug DOZQ70 HIGHSTAT Preclinical DP8T7K DRUG__ID DP8T7K DP8T7K DRUGTYPE Antibody DP8T7K HIGHSTAT Preclinical DPW1K9 DRUG__ID DPW1K9 DPW1K9 DRUGCOMP Dyve Biosciences DPW1K9 HIGHSTAT Preclinical DQ3NC4 DRUG__ID DQ3NC4 DQ3NC4 DRUGTYPE Small molecular drug DQ3NC4 HIGHSTAT Preclinical DR6EK5 DRUG__ID DR6EK5 DR6EK5 DRUGCOMP Dyve Biosciences DR6EK5 HIGHSTAT Preclinical DRD0M5 DRUG__ID DRD0M5 DRD0M5 DRUGCOMP Symbiotix Biotherapies DRD0M5 HIGHSTAT Preclinical DRO7H6 DRUG__ID DRO7H6 DRO7H6 DRUGTYPE Peptide DRO7H6 HIGHSTAT Preclinical DS58AE DRUG__ID DS58AE DS58AE DRUGTYPE Small molecular drug DS58AE HIGHSTAT Preclinical DSM03D DRUG__ID DSM03D DSM03D DRUGTYPE Small molecular drug DSM03D HIGHSTAT Preclinical DT29OQ DRUG__ID DT29OQ DT29OQ DRUGTYPE Antibody DT29OQ HIGHSTAT Preclinical DU9RB1 DRUG__ID DU9RB1 DU9RB1 DRUGTYPE Oligonucleotide DU9RB1 HIGHSTAT Preclinical DV19IS DRUG__ID DV19IS DV19IS DRUGTYPE Antibody DV19IS HIGHSTAT Preclinical DV74TF DRUG__ID DV74TF DV74TF DRUGTYPE Small molecular drug DV74TF HIGHSTAT Preclinical DV7JX1 DRUG__ID DV7JX1 DV7JX1 DRUGCOMP CinFina Pharma DV7JX1 HIGHSTAT Preclinical DV8A1L DRUG__ID DV8A1L DV8A1L DRUGTYPE Small molecular drug DV8A1L HIGHSTAT Preclinical DVQ37G DRUG__ID DVQ37G DVQ37G DRUGTYPE Small molecular drug DVQ37G HIGHSTAT Preclinical DW68KF DRUG__ID DW68KF DW68KF DRUGTYPE Small molecular drug DW68KF HIGHSTAT Preclinical DWX20P DRUG__ID DWX20P DWX20P DRUGCOMP Teva Pharmaceutical DWX20P HIGHSTAT Preclinical DX1U8I DRUG__ID DX1U8I DX1U8I DRUGTYPE Antibody DX1U8I HIGHSTAT Preclinical DXNT71 DRUG__ID DXNT71 DXNT71 DRUGTYPE Small molecular drug DXNT71 HIGHSTAT Preclinical DY5KS2 DRUG__ID DY5KS2 DY5KS2 DRUGTYPE Antibody DY5KS2 HIGHSTAT Preclinical DYN07P DRUG__ID DYN07P DYN07P DRUGCOMP Teva Pharmaceutical DYN07P HIGHSTAT Preclinical DZ38PI DRUG__ID DZ38PI DZ38PI DRUGTYPE Small molecular drug DZ38PI HIGHSTAT Preclinical D01MZT DRUG__ID D01MZT D01MZT HIGHSTAT Preclinical D09KAK DRUG__ID D09KAK D09KAK HIGHSTAT Preclinical D00XEU DRUG__ID D00XEU D00XEU DRUGCOMP GlaxoSmithKline D00XEU THERCLAS Anticancer Agents D00XEU DRUGTYPE Small molecular drug D00XEU DRUGINCH 1S/C32H38ClN5O4/c1-20(2)42-29-13-12-24(16-27(29)33)32(41)35-25(17-34-30(40)19-37(4)5)15-22-8-10-23(11-9-22)28-18-38-14-6-7-26(21(3)39)31(38)36-28/h6-14,16,18,20-21,25,39H,15,17,19H2,1-5H3,(H,34,40)(H,35,41)/t21-,25-/m0/s1 D00XEU DRUGINKE WHMXDBPHBVLYRC-OFVILXPXSA-N D00XEU DRUGSMIL CC(C)OC1=C(C=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)C3=CN4C=CC=C(C4=N3)C(C)O)CNC(=O)CN(C)C)Cl D00XEU HIGHSTAT Terminated D04XMJ DRUG__ID D04XMJ D04XMJ DRUGCOMP Eli Lilly D04XMJ THERCLAS Analgesics D04XMJ DRUGTYPE Small molecular drug D04XMJ DRUGINCH 1S/C23H34N6O2/c1-3-15(4-2)14-31-23(30)21-12-17-11-18(10-9-16(17)13-24-21)25-20-8-6-5-7-19(20)22-26-28-29-27-22/h5-8,15-18,21,24-25H,3-4,9-14H2,1-2H3,(H,26,27,28,29)/t16-,17+,18-,21-/m0/s1 D04XMJ DRUGINKE KQDBQKHPLFHNIW-NYUBLWNDSA-N D04XMJ DRUGSMIL CCC(CC)COC(=O)C1CC2CC(CCC2CN1)NC3=CC=CC=C3C4=NNN=N4 D04XMJ HIGHSTAT Terminated D06TEO DRUG__ID D06TEO D06TEO DRUGCOMP University College London D06TEO THERCLAS Analgesics D06TEO DRUGTYPE Small molecular drug D06TEO DRUGINCH 1S/C13H13N3O/c14-8-11-3-5-13(6-4-11)17-7-1-2-12-9-15-10-16-12/h3-6,9-10H,1-2,7H2,(H,15,16) D06TEO DRUGINKE XQNBJFUWFIHAMW-UHFFFAOYSA-N D06TEO DRUGSMIL C1=CC(=CC=C1C#N)OCCCC2=CN=CN2 D06TEO HIGHSTAT Terminated D07IEM DRUG__ID D07IEM D07IEM DRUGCOMP Amgen D07IEM THERCLAS Analgesics D07IEM DRUGTYPE Small molecular drug D07IEM DRUGINCH 1S/C24H25F3N2O2/c25-24(26,27)18-9-7-16(22(14-18)29-11-2-1-3-12-29)8-10-23(31)28-21-6-4-5-17-13-19(30)15-20(17)21/h4-10,14,19,30H,1-3,11-13,15H2,(H,28,31)/b10-8+/t19-/m1/s1 D07IEM DRUGINKE HAZYXDWNLMGLIS-LHUXKHBRSA-N D07IEM DRUGSMIL C1CCN(CC1)C2=C(C=CC(=C2)C(F)(F)F)C=CC(=O)NC3=CC=CC4=C3CC(C4)O D07IEM HIGHSTAT Terminated D08WBF DRUG__ID D08WBF D08WBF DRUGCOMP Vernalis D08WBF THERCLAS Anticancer Agents D08WBF DRUGTYPE Small molecular drug D08WBF DRUGINCH 1S/C20H32N4O5/c1-12(2)11-13(15(29-6)18(26)24-28)17(25)23-16(20(3,4)5)19(27)22-14-9-7-8-10-21-14/h7-10,12-13,15-16,28H,11H2,1-6H3,(H,23,25)(H,24,26)(H,21,22,27)/t13-,15+,16-/m1/s1 D08WBF DRUGINKE WORSVFBVUCBRIP-VNQPRFMTSA-N D08WBF DRUGSMIL CC(C)CC(C(C(=O)NO)OC)C(=O)NC(C(=O)NC1=CC=CC=N1)C(C)(C)C D08WBF HIGHSTAT Terminated D08XOT DRUG__ID D08XOT D08XOT DRUGCOMP Eli Lilly D08XOT THERCLAS Analgesics D08XOT DRUGTYPE Small molecular drug D08XOT DRUGINCH 1S/C21H29N5O3.ClH/c1-13(2)12-28-21(27)18-10-15-9-16(8-7-14(15)11-22-18)29-19-6-4-3-5-17(19)20-23-25-26-24-20;/h3-6,13-16,18,22H,7-12H2,1-2H3,(H,23,24,25,26);1H/t14-,15+,16+,18+;/m0./s1 D08XOT DRUGINKE STJGUHHJXMUHAN-DYZVKEBGSA-N D08XOT DRUGSMIL CC(C)COC(=O)C1CC2CC(CCC2CN1)OC3=CC=CC=C3C4=NNN=N4.Cl D08XOT HIGHSTAT Terminated D08ZIH DRUG__ID D08ZIH D08ZIH DRUGCOMP Cognetix D08ZIH THERCLAS Analgesics D08ZIH DRUGTYPE Small molecular drug D08ZIH DRUGINCH 1S/C89H144N20O34/c1-41(2)29-57(89(140)141)106-86(137)69(42(3)4)94-34-49(30-46-16-18-50(115)19-17-46)98-85(136)60-15-12-28-109(60)88(139)55(14-9-11-27-91)104-79(130)51(13-8-10-26-90)103-87(138)70(44(6)142-61-31-48(38-111)73(125)76(71(61)97-45(7)114)143-62-32-47(37-110)72(124)75(127)74(62)126)108-77(128)43(5)96-82(133)56(33-63(92)116)105-83(134)58(39-112)100-66(119)36-93-65(118)35-95-78(129)52(21-24-67(120)121)101-81(132)54(22-25-68(122)123)102-84(135)59(40-113)107-80(131)53-20-23-64(117)99-53/h16-19,41-44,47-49,51-62,69-76,94,110-113,115,124-127H,8-15,20-40,90-91H2,1-7H3,(H2,92,116)(H,93,118)(H,95,129)(H,96,133)(H,97,114)(H,98,136)(H,99,117)(H,100,119)(H,101,132)(H,102,135)(H,103,138)(H,104,130)(H,105,134)(H,106,137)(H,107,131)(H,108,128)(H,120,121)(H,122,123)(H,140,141)/t43-,44-,47-,48?,49-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61?,62+,69-,70+,71?,72+,73?,74+,75+,76?/m0/s1 D08ZIH DRUGINKE BDYYRSHYAJPHLA-CDMGOGEFSA-N D08ZIH DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(C(C)C)NCC(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C(C)OC3CC(C(C(C3NC(=O)C)OC4CC(C(C(C4O)O)O)CO)O)CO)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)CNC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C5CCC(=O)N5 D08ZIH HIGHSTAT Terminated D0NE3C DRUG__ID D0NE3C D0NE3C DRUGCOMP AstraZeneca D0NE3C THERCLAS Anticancer Agents D0NE3C DRUGTYPE Small molecular drug D0NE3C DRUGINCH 1S/C29H39FN4O3S2/c1-19(2)37-28(35)26(12-15-38-4)33-20(3)25-16-23(8-7-21(25)11-13-30)32-18-24-9-10-27(34-24)39-29(36)22-6-5-14-31-17-22/h5-8,14,16-17,19,24,26-27,32-34H,3,9-13,15,18H2,1-2,4H3/t24-,26-,27-/m0/s1 D0NE3C DRUGINKE GIJNHMGFNKZBIR-URORMMCBSA-N D0NE3C DRUGSMIL CC(C)OC(=O)C(CCSC)NC(=C)C1=C(C=CC(=C1)NCC2CCC(N2)SC(=O)C3=CN=CC=C3)CCF D0NE3C HIGHSTAT Terminated D0T7XN DRUG__ID D0T7XN D0T7XN DRUGCOMP Eisai Inc. D0T7XN THERCLAS Analgesics D0T7XN DRUGTYPE Small molecular drug D0T7XN DRUGINCH 1S/C14H18BNO5/c1-13(2)14(3,4)21-15(20-13)8-7-9-11(17)6-5-10(16-9)12(18)19/h5-8,17H,1-4H3,(H,18,19)/b8-7+ D0T7XN DRUGINKE WTOZVQHWGKJNCT-BQYQJAHWSA-N D0T7XN DRUGSMIL B1(OC(C(O1)(C)C)(C)C)C=CC2=C(C=CC(=N2)C(=O)O)O D0T7XN HIGHSTAT Terminated D00ARN DRUG__ID D00ARN D00ARN DRUGCOMP Discovery Laboratories D00ARN DRUGTYPE Small molecular drug D00ARN DRUGINCH 1S/C14H22O.C2H4O.CH2O/c1-13(2,3)10-14(4,5)11-6-8-12(15)9-7-11;1-2-3-1;1-2/h6-9,15H,10H2,1-5H3;1-2H2;1H2 D00ARN DRUGINKE MDYZKJNTKZIUSK-UHFFFAOYSA-N D00ARN DRUGSMIL CC(C)(C)CC(C)(C)C1=CC=C(C=C1)O.C=O.C1CO1 D00ARN HIGHSTAT Terminated D00AWA DRUG__ID D00AWA D00AWA DRUGCOMP Sterling Winthrop Group Ltd D00AWA DRUGTYPE Small molecular drug D00AWA DRUGINCH 1S/C25H28Cl2N2O8S/c1-15(2)17-12-16(34-3)13-20-21(17)24(30)29(38(20,32)33)14-37-25(31)22-18(26)4-5-19(23(22)27)36-11-8-28-6-9-35-10-7-28/h4-5,12-13,15H,6-11,14H2,1-3H3 D00AWA DRUGINKE AGROLWZEYXFDEB-UHFFFAOYSA-N D00AWA DRUGSMIL CC(C)C1=C2C(=CC(=C1)OC)S(=O)(=O)N(C2=O)COC(=O)C3=C(C=CC(=C3Cl)OCCN4CCOCC4)Cl D00AWA HIGHSTAT Terminated D00FRY DRUG__ID D00FRY D00FRY DRUGCOMP Bio-Mega Research Division D00FRY DRUGTYPE Small molecular drug D00FRY DRUGINCH 1S/C39H68N4O7/c1-13-27(36(4,5)6)40-33(47)31(39(34(48)49)19-14-15-20-39)42-32(46)25(22-28(45)37(7,8)9)21-26(44)30(38(10,11)12)43-35(50)41-29-23(2)17-16-18-24(29)3/h23-25,27,29-31H,13-22H2,1-12H3,(H,40,47)(H,42,46)(H,48,49)(H2,41,43,50)/t23-,24+,25-,27+,29?,30+,31+/m0/s1 D00FRY DRUGINKE BICMJCLCIQRONK-CVXWQFLKSA-N D00FRY DRUGSMIL CCC(C(C)(C)C)NC(=O)C(C1(CCCC1)C(=O)O)NC(=O)C(CC(=O)C(C(C)(C)C)NC(=O)NC2C(CCCC2C)C)CC(=O)C(C)(C)C D00FRY HIGHSTAT Terminated D00FWB DRUG__ID D00FWB D00FWB DRUGCOMP Merck & Co Inc D00FWB DRUGTYPE Small molecular drug D00FWB DRUGINCH 1S/C36H39N5O5S/c1-5-11-32-39-33-25(4)30(38-35(42)28-12-7-6-8-13-28)22-37-34(33)41(32)23-26-16-18-27(19-17-26)29-14-9-10-15-31(29)47(44,45)40-36(43)46-21-20-24(2)3/h6-10,12-19,22,24H,5,11,20-21,23H2,1-4H3,(H,38,42)(H,40,43) D00FWB DRUGINKE WGFOETKPMPCUOG-UHFFFAOYSA-N D00FWB DRUGSMIL CCCC1=NC2=C(C(=CN=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC(=O)OCCC(C)C)NC(=O)C5=CC=CC=C5)C D00FWB HIGHSTAT Terminated D00IRU DRUG__ID D00IRU D00IRU DRUGCOMP Esteve D00IRU DRUGTYPE Small molecular drug D00IRU DRUGINCH 1S/C17H21FN4.C6H8O7/c18-17-5-3-15(4-6-17)16-7-11-21(12-8-16)9-1-2-10-22-14-19-13-20-22;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-7,13-14H,1-2,8-12H2;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D00IRU DRUGINKE LTBKOSQVBVYJKW-UHFFFAOYSA-N D00IRU DRUGSMIL C1CN(CC=C1C2=CC=C(C=C2)F)CCCCN3C=NC=N3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O D00IRU HIGHSTAT Terminated D00ITG DRUG__ID D00ITG D00ITG DRUGCOMP Parke-Davis & Co D00ITG DRUGTYPE Small molecular drug D00ITG DRUGINCH 1S/C17H17ClFN3O3/c18-13-14-10(5-12(19)15(13)21-4-3-8(20)6-21)16(23)11(17(24)25)7-22(14)9-1-2-9/h5,7-9H,1-4,6,20H2,(H,24,25) D00ITG DRUGINKE QGPKADBNRMWEQR-UHFFFAOYSA-N D00ITG DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)Cl)N4CCC(C4)N)F)C(=O)O D00ITG HIGHSTAT Terminated D00JNL DRUG__ID D00JNL D00JNL DRUGCOMP Hoechst Marion Roussel Inc D00JNL DRUGTYPE Small molecular drug D00JNL DRUGINCH 1S/C8H10N2OS/c11-8-7(9-3-4-10-8)6-2-1-5-12-6/h1-2,5,7,9H,3-4H2,(H,10,11) D00JNL DRUGINKE BBACKDMGYMXYLE-UHFFFAOYSA-N D00JNL DRUGSMIL C1CNC(=O)C(N1)C2=CC=CS2 D00JNL HIGHSTAT Terminated D00KWA DRUG__ID D00KWA D00KWA DRUGCOMP Wyeth D00KWA DRUGTYPE Small molecular drug D00KWA DRUGINCH 1S/C15H25N3O/c1-11(2)16-9-6-10-17-15(19)18-14-12(3)7-5-8-13(14)4/h5,7-8,11,16H,6,9-10H2,1-4H3,(H2,17,18,19) D00KWA DRUGINKE WHJSFPCTWYLZRC-UHFFFAOYSA-N D00KWA DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)NCCCNC(C)C D00KWA HIGHSTAT Terminated D00LYW DRUG__ID D00LYW D00LYW DRUGCOMP Burroughs Wellcome Inc D00LYW DRUGTYPE Small molecular drug D00LYW DRUGINCH 1S/C10H7Cl3N4.C2H6O3S/c11-4-1-5(8(13)7(12)2-4)6-3-16-10(15)17-9(6)14;1-2-6(3,4)5/h1-3H,(H4,14,15,16,17);2H2,1H3,(H,3,4,5) D00LYW DRUGINKE NVKJAOGJEDODFZ-UHFFFAOYSA-N D00LYW DRUGSMIL CCS(=O)(=O)O.C1=C(C=C(C(=C1C2=CN=C(N=C2N)N)Cl)Cl)Cl D00LYW HIGHSTAT Terminated D00MEV DRUG__ID D00MEV D00MEV DRUGCOMP Schering-Plough Corp D00MEV DRUGTYPE Small molecular drug D00MEV DRUGINCH 1S/C28H22O10/c1-9-3-13(29)25-19(37-9)5-11-21(15(31)7-17(33)23(11)27(25)35)22-12-6-20-26(14(30)4-10(2)38-20)28(36)24(12)18(34)8-16(22)32/h5-10,31-36H,3-4H2,1-2H3 D00MEV DRUGINKE JGQBYBXYRUCBQY-UHFFFAOYSA-N D00MEV DRUGSMIL CC1CC(=O)C2=C(O1)C=C3C(=C2O)C(=CC(=C3C4=C(C=C(C5=C(C6=C(C=C54)OC(CC6=O)C)O)O)O)O)O D00MEV HIGHSTAT Terminated D00MFY DRUG__ID D00MFY D00MFY DRUGCOMP Scios Inc D00MFY DRUGTYPE Small molecular drug D00MFY DRUGINCH 1S/C11H22NO5P/c12-10(11(13)14)7-9-4-2-1-3-8(9)5-6-18(15,16)17/h8-10H,1-7,12H2,(H,13,14)(H2,15,16,17) D00MFY DRUGINKE DHJQWBSZKBDBFP-UHFFFAOYSA-N D00MFY DRUGSMIL C1CCC(C(C1)CCP(=O)(O)O)CC(C(=O)O)N D00MFY HIGHSTAT Terminated D00PXQ DRUG__ID D00PXQ D00PXQ DRUGCOMP Sanofi-Aventis D00PXQ DRUGTYPE Small molecular drug D00PXQ DRUGINCH 1S/C23H24FN3O2S/c24-19-8-10-20(11-9-19)26-16-14-25(15-17-26)12-3-13-27-21-6-1-4-18-5-2-7-22(23(18)21)30(27,28)29/h1-2,4-11H,3,12-17H2 D00PXQ DRUGINKE VGIGHGMPMUCLIQ-UHFFFAOYSA-N D00PXQ DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC4=C3C(=CC=C4)S2(=O)=O)C5=CC=C(C=C5)F D00PXQ HIGHSTAT Terminated D00PYP DRUG__ID D00PYP D00PYP DRUGCOMP Neurocrine Biosci D00PYP DRUGTYPE Small molecular drug D00PYP DRUGINCH 1S/C31H31F3N8O8S2.2ClH/c1-39-5-7-40(8-6-39)24-17(33)9-15-23(19(24)34)41(4-3-32)10-16(25(15)43)30(48)50-11-14-12-51-28-21(27(45)42(28)22(14)29(46)47)37-26(44)20(38-49-2)18-13-52-31(35)36-18;;/h9-10,13,21,28H,3-8,11-12H2,1-2H3,(H2,35,36)(H,37,44)(H,46,47);2*1H/b38-20-;;/t21-,28-;;/m1../s1 D00PYP DRUGINKE DSGXXSRGPIYUHF-ZVOUVGCISA-N D00PYP DRUGSMIL CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)OCC4=C(N5C(C(C5=O)NC(=O)C(=NOC)C6=CSC(=N6)N)SC4)C(=O)O)CCF)F.Cl.Cl D00PYP HIGHSTAT Terminated D00PZH DRUG__ID D00PZH D00PZH DRUGCOMP Amylin Pharmaceuticals Inc D00PZH DRUGTYPE Small molecular drug D00PZH DRUGINCH 1S/C127H205N37O40/c1-59(2)44-81(156-122(200)99(63(9)10)142-68(15)171)105(183)139-54-96(178)143-74(22-16-18-40-128)106(184)151-84(47-62(7)8)114(192)159-90(57-166)119(197)148-77(34-37-92(130)174)108(186)146-79(36-39-98(180)181)109(187)153-83(46-61(5)6)113(191)154-85(50-71-53-137-58-141-71)115(193)145-75(23-17-19-41-129)107(185)152-82(45-60(3)4)112(190)147-78(35-38-93(131)175)111(189)162-103(67(14)170)125(203)158-88(49-70-28-32-73(173)33-29-70)126(204)164-43-21-25-91(164)120(198)149-76(24-20-42-138-127(135)136)110(188)161-102(66(13)169)124(202)157-87(52-95(133)177)117(195)160-100(64(11)167)121(199)140-55-97(179)144-89(56-165)118(196)155-86(51-94(132)176)116(194)163-101(65(12)168)123(201)150-80(104(134)182)48-69-26-30-72(172)31-27-69/h26-33,53,58-67,74-91,99-103,165-170,172-173H,16-25,34-52,54-57,128-129H2,1-15H3,(H2,130,174)(H2,131,175)(H2,132,176)(H2,133,177)(H2,134,182)(H,137,141)(H,139,183)(H,140,199)(H,142,171)(H,143,178)(H,144,179)(H,145,193)(H,146,186)(H,147,190)(H,148,197)(H,149,198)(H,150,201)(H,151,184)(H,152,185)(H,153,187)(H,154,191)(H,155,196)(H,156,200)(H,157,202)(H,158,203)(H,159,192)(H,160,195)(H,161,188)(H,162,189)(H,163,194)(H,180,181)(H4,135,136,138)/t64-,65-,66-,67-,74+,75+,76+,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,99+,100+,101+,102+,103+/m1/s1 D00PZH DRUGINKE ZLFXHYNEZYAYPG-AABHONRUSA-N D00PZH DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C D00PZH HIGHSTAT Terminated D00QHT DRUG__ID D00QHT D00QHT DRUGCOMP Alkermes Inc D00QHT DRUGTYPE Small molecular drug D00QHT DRUGINCH 1S/C26H40N4O6/c1-4-21(23(31)25(33)27-11-8-12-30-13-15-35-16-14-30)28-24(32)22(17-19(2)3)29-26(34)36-18-20-9-6-5-7-10-20/h5-7,9-10,19,21-22H,4,8,11-18H2,1-3H3,(H,27,33)(H,28,32)(H,29,34)/t21?,22-/m0/s1 D00QHT DRUGINKE TZVQRMYLYQNBOA-KEKNWZKVSA-N D00QHT DRUGSMIL CCC(C(=O)C(=O)NCCCN1CCOCC1)NC(=O)C(CC(C)C)NC(=O)OCC2=CC=CC=C2 D00QHT HIGHSTAT Terminated D00QOG DRUG__ID D00QOG D00QOG DRUGCOMP Pierre Fabre SA D00QOG DRUGTYPE Small molecular drug D00QOG DRUGINCH 1S/C15H15ClO/c1-15(2,17)12-9-7-11(8-10-12)13-5-3-4-6-14(13)16/h3-10,17H,1-2H3 D00QOG DRUGINKE VILCOLBQTAITPH-UHFFFAOYSA-N D00QOG DRUGSMIL CC(C)(C1=CC=C(C=C1)C2=CC=CC=C2Cl)O D00QOG HIGHSTAT Terminated D00RFZ DRUG__ID D00RFZ D00RFZ DRUGCOMP Pharmasset Inc D00RFZ DRUGTYPE Small molecular drug D00RFZ DRUGINCH 1S/C10H14FN3O4/c1-10(11)7(16)5(4-15)18-8(10)14-3-2-6(12)13-9(14)17/h2-3,5,7-8,15-16H,4H2,1H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1 D00RFZ DRUGINKE NYPIRLYMDJMKGW-VPCXQMTMSA-N D00RFZ DRUGSMIL CC1(C(C(OC1N2C=CC(=NC2=O)N)CO)O)F D00RFZ HIGHSTAT Terminated D00SIR DRUG__ID D00SIR D00SIR DRUGCOMP Sankyo Co Ltd D00SIR DRUGTYPE Small molecular drug D00SIR DRUGINCH 1S/C20H22N6O6S3.H2O4S/c1-9-12(3-4-27)35-8-25(9)5-10-6-33-18-14(17(29)26(18)15(10)19(30)31)23-16(28)13(24-32-2)11-7-34-20(21)22-11;1-5(2,3)4/h7-8,14,18,27H,3-6H2,1-2H3,(H3-,21,22,23,28,30,31);(H2,1,2,3,4)/b24-13+;/t14-,18-;/m1./s1 D00SIR DRUGINKE WNNXOUAREUXOEN-CZFAVYDOSA-N D00SIR DRUGSMIL CC1=C(SC=[N+]1CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O)CCO.OS(=O)(=O)[O-] D00SIR HIGHSTAT Terminated D00XRI DRUG__ID D00XRI D00XRI DRUGCOMP Tsumura & Co D00XRI DRUGTYPE Small molecular drug D00XRI DRUGINCH 1S/C39H44N2O6/c1-7-45-38-36(44-6)22-27-15-17-41(3)31-19-25-10-13-32(42-4)34(20-25)46-28-11-8-24(9-12-28)18-30-29-23-35(47-39(38)37(27)31)33(43-5)21-26(29)14-16-40(30)2/h8-13,20-23,30-31H,7,14-19H2,1-6H3/t30-,31-/m0/s1 D00XRI DRUGINKE VNBSKOLSTYLJBG-CONSDPRKSA-N D00XRI DRUGSMIL CCOC1=C(C=C2CCN(C3C2=C1OC4=C(C=C5CCN(C(C5=C4)CC6=CC=C(C=C6)OC7=C(C=CC(=C7)C3)OC)C)OC)C)OC D00XRI HIGHSTAT Terminated D00YGA DRUG__ID D00YGA D00YGA DRUGCOMP SmithKline Beecham plc D00YGA DRUGTYPE Small molecular drug D00YGA DRUGINCH 1S/C21H21F3N2O5/c1-26(20-25-16-4-2-3-5-17(16)31-20)10-11-29-15-8-6-14(7-9-15)12-18(19(27)28)30-13-21(22,23)24/h2-9,18H,10-13H2,1H3,(H,27,28)/t18-/m0/s1 D00YGA DRUGINKE IRAAJHYKQDFNFO-SFHVURJKSA-N D00YGA DRUGSMIL CN(CCOC1=CC=C(C=C1)CC(C(=O)O)OCC(F)(F)F)C2=NC3=CC=CC=C3O2 D00YGA HIGHSTAT Terminated D00YQZ DRUG__ID D00YQZ D00YQZ DRUGCOMP Merck & Co Inc D00YQZ DRUGTYPE Small molecular drug D00YQZ DRUGINCH 1S/C25H27N3O4S.ClH/c1-33(30,31)27-20-5-7-24-22(14-20)23(29)15-25(32-24)8-10-28(11-9-25)21-6-4-18-12-17(16-26)2-3-19(18)13-21;/h2-3,5,7,12,14,21,27H,4,6,8-11,13,15H2,1H3;1H/t21-;/m1./s1 D00YQZ DRUGINKE BASAUWFNEPUJDQ-ZMBIFBSDSA-N D00YQZ DRUGSMIL CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)C4CCC5=C(C4)C=CC(=C5)C#N)CC2=O.Cl D00YQZ HIGHSTAT Terminated D00ZWG DRUG__ID D00ZWG D00ZWG DRUGCOMP NeuroSearch A/S D00ZWG DRUGTYPE Small molecular drug D00ZWG DRUGINCH 1S/C15H11ClF3N3/c16-11-4-1-9(2-5-11)8-22-13-6-3-10(15(17,18)19)7-12(13)21-14(22)20/h1-7H,8H2,(H2,20,21) D00ZWG DRUGINKE GXQCVUZORDAARJ-UHFFFAOYSA-N D00ZWG DRUGSMIL C1=CC(=CC=C1CN2C3=C(C=C(C=C3)C(F)(F)F)N=C2N)Cl D00ZWG HIGHSTAT Terminated D01DVX DRUG__ID D01DVX D01DVX DRUGCOMP Bristol-Myers Squibb Pharma D01DVX DRUGTYPE Small molecular drug D01DVX DRUGINCH 1S/C27H32N4O4/c1-17(2)14-24(25(32)30-34)31-13-12-27(28,26(31)33)20-8-10-21(11-9-20)35-16-19-15-18(3)29-23-7-5-4-6-22(19)23/h4-11,15,17,24,34H,12-14,16,28H2,1-3H3,(H,30,32)/t24-,27-/m1/s1 D01DVX DRUGINKE QVNZBDLTUKCPGJ-SHQCIBLASA-N D01DVX DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)COC3=CC=C(C=C3)C4(CCN(C4=O)C(CC(C)C)C(=O)NO)N D01DVX HIGHSTAT Terminated D01ESJ DRUG__ID D01ESJ D01ESJ DRUGCOMP Endo Pharmaceuticals Solutions Inc D01ESJ DRUGTYPE Small molecular drug D01ESJ DRUGINCH 1S/C19H20N2O/c1-14(22)20-12-11-17-16-9-5-6-10-18(16)21-19(17)13-15-7-3-2-4-8-15/h2-10,21H,11-13H2,1H3,(H,20,22) D01ESJ DRUGINKE WVVXBPKOIZGVNS-UHFFFAOYSA-N D01ESJ DRUGSMIL CC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 D01ESJ HIGHSTAT Terminated D01FLN DRUG__ID D01FLN D01FLN DRUGCOMP Lexicon Pharmaceuticals Inc D01FLN DRUGTYPE Small molecular drug D01FLN DRUGINCH 1S/C10H13N3O5/c14-4-7(15)9(17)8(16)6-3-11-10(12-6)5-1-2-18-13-5/h1-3,7-9,14-17H,4H2,(H,11,12)/t7-,8-,9-/m1/s1 D01FLN DRUGINKE WGDPRIZUIYIENM-IWSPIJDZSA-N D01FLN DRUGSMIL C1=CON=C1C2=NC=C(N2)C(C(C(CO)O)O)O D01FLN HIGHSTAT Terminated D01IJL DRUG__ID D01IJL D01IJL DRUGCOMP Fujisawa Pharmaceutical Co Ltd D01IJL DRUGTYPE Small molecular drug D01IJL DRUGINCH 1S/C24H32O5/c1-9-7-13-17(21(26)11(3)20(13)25)16-12(9)8-14-18(16)19-22-10(2)15(28-23(19)27)5-6-24(14,4)29-22/h7,10-18,20-21,25-26H,5-6,8H2,1-4H3/t10-,11+,12+,13-,14-,15+,16+,17+,18-,20+,21-,24+/m0/s1 D01IJL DRUGINKE WMRQHSFWMFGIFW-OUNSMTAHSA-N D01IJL DRUGSMIL CC1C(C2C=C(C3CC4C(C3C2C1O)C5=C6C(C(CCC4(O6)C)OC5=O)C)C)O D01IJL HIGHSTAT Terminated D01JHN DRUG__ID D01JHN D01JHN DRUGCOMP RottaPharma D01JHN DRUGTYPE Small molecular drug D01JHN DRUGINCH 1S/C20H22N2O/c1-21-15-8-9-16(21)11-17(10-15)22-12-14-7-6-13-4-2-3-5-18(13)19(14)20(22)23/h2-7,15-17H,8-12H2,1H3/t15-,16+,17? D01JHN DRUGINKE RCJGTDKFZCRBAH-SJPCQFCGSA-N D01JHN DRUGSMIL CN1C2CCC1CC(C2)N3CC4=C(C3=O)C5=CC=CC=C5C=C4 D01JHN HIGHSTAT Terminated D01KIU DRUG__ID D01KIU D01KIU DRUGCOMP INSERM D01KIU DRUGTYPE Small molecular drug D01KIU DRUGINCH 1S/C19H27NO3/c21-18(23-16-13-20-11-14-22-15-12-20)19(9-5-2-6-10-19)17-7-3-1-4-8-17/h1,3-4,7-8H,2,5-6,9-16H2 D01KIU DRUGINKE RQHKZUBCUZVZEF-UHFFFAOYSA-N D01KIU DRUGSMIL C1CCC(CC1)(C2=CC=CC=C2)C(=O)OCCN3CCOCC3 D01KIU HIGHSTAT Terminated D01LRH DRUG__ID D01LRH D01LRH DRUGCOMP Bristol-Myers Squibb Pharma Co D01LRH DRUGTYPE Small molecular drug D01LRH DRUGINCH 1S/C23H18N4/c1-3-19-21(26-9-1)22-20(4-2-10-27-22)23(19,15-17-5-11-24-12-6-17)16-18-7-13-25-14-8-18/h1-14H,15-16H2 D01LRH DRUGINKE FJYRSJDIZKTXKB-UHFFFAOYSA-N D01LRH DRUGSMIL C1=CC2=C(C3=C(C2(CC4=CC=NC=C4)CC5=CC=NC=C5)C=CC=N3)N=C1 D01LRH HIGHSTAT Terminated D01MIP DRUG__ID D01MIP D01MIP DRUGCOMP Sugen Pharmaceuticals D01MIP DRUGTYPE Small molecular drug D01MIP DRUGINCH 1S/C15H13ClN2O/c1-8-5-9(2)17-14(8)7-12-11-6-10(16)3-4-13(11)18-15(12)19/h3-7,17H,1-2H3,(H,18,19)/b12-7- D01MIP DRUGINKE XLBQNZICMYZIQT-GHXNOFRVSA-N D01MIP DRUGSMIL CC1=CC(=C(N1)C=C2C3=C(C=CC(=C3)Cl)NC2=O)C D01MIP HIGHSTAT Terminated D01NBX DRUG__ID D01NBX D01NBX DRUGCOMP Sankyo Co Ltd D01NBX DRUGTYPE Small molecular drug D01NBX DRUGINCH 1S/C18H20N2O2.ClH/c19-12-8-11-17-13(5-2-6-14(17)21)20-15(22)7-9-3-1-4-10(12)16(9)18(11)20;/h2,5-6,9-10,12,16,21H,1,3-4,7-8,19H2;1H/t9-,10+,12-,16+;/m1./s1 D01NBX DRUGINKE MTSROZWZVOQAQW-PECACPRSSA-N D01NBX DRUGSMIL C1CC2CC(=O)N3C4=C(C5=C3C2C(C1)C(C5)N)C(=CC=C4)O.Cl D01NBX HIGHSTAT Terminated D01NNL DRUG__ID D01NNL D01NNL DRUGCOMP Inflazyme Pharmaceuticals D01NNL DRUGTYPE Small molecular drug D01NNL DRUGINCH 1S/HO3P/c1-4(2)3/h(H,1,2,3)/p-1 D01NNL DRUGINKE UEZVMMHDMIWARA-UHFFFAOYSA-M D01NNL DRUGSMIL [O-]P(=O)=O D01NNL HIGHSTAT Terminated D01OFY DRUG__ID D01OFY D01OFY DRUGCOMP Almirall Prodesfarma SA D01OFY DRUGTYPE Small molecular drug D01OFY DRUGINCH 1S/C11H12N2O3S/c1-13-7-9(12-17(2,15)16)11(14)8-5-3-4-6-10(8)13/h3-7,12H,1-2H3 D01OFY DRUGINKE LSIYNVMXGMDGMG-UHFFFAOYSA-N D01OFY DRUGSMIL CN1C=C(C(=O)C2=CC=CC=C21)NS(=O)(=O)C D01OFY HIGHSTAT Terminated D01QAR DRUG__ID D01QAR D01QAR DRUGCOMP Eli Lilly & Co D01QAR DRUGTYPE Small molecular drug D01QAR DRUGINCH 1S/C20H30N2O2S/c1-19(2,3)14-9-13(10-15(17(14)23)20(4,5)6)11-16-18(24)22(12-25-16)21(7)8/h9-11,23H,12H2,1-8H3/b16-11- D01QAR DRUGINKE DNXBQWAKVPAADQ-WJDWOHSUSA-N D01QAR DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)N(C)C D01QAR HIGHSTAT Terminated D01QRG DRUG__ID D01QRG D01QRG DRUGCOMP Aventis D01QRG DRUGTYPE Small molecular drug D01QRG DRUGINCH 1S/C24H25FN4O4/c1-24(23(30)29-10-12-31-13-11-29)14-32-22(33-15-24)21-27-19(16-2-4-18(25)5-3-16)20(28-21)17-6-8-26-9-7-17/h2-9,22H,10-15H2,1H3,(H,27,28) D01QRG DRUGINKE YEQUJOKCSZTBFS-UHFFFAOYSA-N D01QRG DRUGSMIL CC1(COC(OC1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)C(=O)N5CCOCC5 D01QRG HIGHSTAT Terminated D01RAE DRUG__ID D01RAE D01RAE DRUGCOMP Pfizer D01RAE DRUGTYPE Small molecular drug D01RAE DRUGINCH 1S/C21H27N3O3S/c22-28(25,26)19-7-5-18(6-8-19)24-14-12-23(13-15-24)11-9-21-20-4-2-1-3-17(20)10-16-27-21/h1-8,21H,9-16H2,(H2,22,25,26)/t21-/m0/s1 D01RAE DRUGINKE WNUQCGWXPNGORO-NRFANRHFSA-N D01RAE DRUGSMIL C1COC(C2=CC=CC=C21)CCN3CCN(CC3)C4=CC=C(C=C4)S(=O)(=O)N D01RAE HIGHSTAT Terminated D01RCC DRUG__ID D01RCC D01RCC DRUGCOMP Bristol-Myers Squibb Co D01RCC DRUGTYPE Small molecular drug D01RCC DRUGINCH 1S/C36H54N4O9/c1-35(2,3)48-33(44)38-28(20-25-10-8-7-9-11-25)30(41)22-37-23-31(42)29(39-34(45)49-36(4,5)6)21-26-12-14-27(15-13-26)47-24-32(43)40-16-18-46-19-17-40/h7-15,28-31,37,41-42H,16-24H2,1-6H3,(H,38,44)(H,39,45)/t28-,29-,30+,31+/m0/s1 D01RCC DRUGINKE OQHZMGOXOOOFEE-SYQUUIDJSA-N D01RCC DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(CNCC(C(CC2=CC=C(C=C2)OCC(=O)N3CCOCC3)NC(=O)OC(C)(C)C)O)O D01RCC HIGHSTAT Terminated D01SEO DRUG__ID D01SEO D01SEO DRUGCOMP Zeneca Group plc D01SEO DRUGTYPE Small molecular drug D01SEO DRUGINCH 1S/C24H34N2O4/c1-16(26(5)6)24(28,18-10-8-9-11-21(18)30-15-22(25)27)19-14-17(23(2,3)4)12-13-20(19)29-7/h8-14,16,28H,15H2,1-7H3,(H2,25,27)/t16-,24-/m1/s1 D01SEO DRUGINKE DLGGQRFVOGBFAX-VOIUYBSRSA-N D01SEO DRUGSMIL CC(C(C1=CC=CC=C1OCC(=O)N)(C2=C(C=CC(=C2)C(C)(C)C)OC)O)N(C)C D01SEO HIGHSTAT Terminated D01VCW DRUG__ID D01VCW D01VCW DRUGCOMP The Menarini Group D01VCW DRUGTYPE Small molecular drug D01VCW DRUGINCH 1S/C16H19N3O2S/c1-5-19-14-10-12(3)11(2)9-13(14)18(4)22(20,21)15-7-6-8-17-16(15)19/h6-10H,5H2,1-4H3 D01VCW DRUGINKE WLQKTBMFEMJDPC-UHFFFAOYSA-N D01VCW DRUGSMIL CCN1C2=C(C=C(C(=C2)C)C)N(S(=O)(=O)C3=C1N=CC=C3)C D01VCW HIGHSTAT Terminated D01YGF DRUG__ID D01YGF D01YGF DRUGCOMP Kyowa Hakko Kogyo Co Ltd D01YGF DRUGTYPE Small molecular drug D01YGF DRUGINCH 1S/C15H17N3O/c1-3-4-9-18-12-8-6-5-7-11(12)14-13(15(18)19)16-10-17(14)2/h5-8,10H,3-4,9H2,1-2H3 D01YGF DRUGINKE CVLGNWUGFVTZRC-UHFFFAOYSA-N D01YGF DRUGSMIL CCCCN1C2=CC=CC=C2C3=C(C1=O)N=CN3C D01YGF HIGHSTAT Terminated D01ZDR DRUG__ID D01ZDR D01ZDR DRUGCOMP Fujisawa Pharmaceutical Co Ltd D01ZDR DRUGTYPE Small molecular drug D01ZDR DRUGINCH 1S/C28H34N4O3/c1-4-23-22-15-9-11-19(3)25(22)32(17-24(33)20-12-6-5-7-13-20)27(34)26(30-23)31-28(35)29-21-14-8-10-18(2)16-21/h8-11,14-16,20,26H,4-7,12-13,17H2,1-3H3,(H2,29,31,35)/t26-/m0/s1 D01ZDR DRUGINKE HEJSSPHGFQDYCH-SANMLTNESA-N D01ZDR DRUGSMIL CCC1=NC(C(=O)N(C2=C(C=CC=C12)C)CC(=O)C3CCCCC3)NC(=O)NC4=CC=CC(=C4)C D01ZDR HIGHSTAT Terminated D01ZEY DRUG__ID D01ZEY D01ZEY DRUGCOMP Hoechst Marion Roussel Inc D01ZEY DRUGTYPE Small molecular drug D01ZEY DRUGINCH 1S/C10H13N5O/c11-9-8-10(13-4-12-9)15(5-14-8)6-1-2-7(16)3-6/h4-7,16H,1-3H2,(H2,11,12,13)/t6-,7+/m0/s1 D01ZEY DRUGINKE UZNXSBPBWFLVDK-NKWVEPMBSA-N D01ZEY DRUGSMIL C1CC(CC1N2C=NC3=C(N=CN=C32)N)O D01ZEY HIGHSTAT Terminated D01ZLI DRUG__ID D01ZLI D01ZLI DRUGCOMP Cumbre D01ZLI DRUGTYPE Small molecular drug D01ZLI DRUGINCH 1S/C65H81FN6O15/c1-31-13-12-14-32(2)61(80)68-50-44(56(77)47-48(57(50)78)55(76)37(7)59-49(47)60(79)64(9,87-59)85-26-20-46(84-11)33(3)58(86-38(8)73)36(6)54(75)35(5)53(31)74)28-67-71-24-18-41(19-25-71)69(10)65(21-22-65)40-17-23-70(29-40)52-34(4)51-42(39-15-16-39)27-43(63(82)83)62(81)72(51)30-45(52)66/h12-14,20,26-28,30-31,33,35-36,39-41,46,53-54,58,74-78H,15-19,21-25,29H2,1-11H3,(H,68,80)(H,82,83)/b13-12+,26-20+,32-14-,67-28-/t31-,33+,35+,36+,40+,46-,53-,54+,58+,64-/m0/s1 D01ZLI DRUGINKE OPZFMLLAJBIKAN-OSKJXBEZSA-N D01ZLI DRUGSMIL CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCC(CC5)N(C)C6(CC6)C7CCN(C7)C8=C(C9=C(C=C(C(=O)N9C=C8F)C(=O)O)C1CC1)C)C D01ZLI HIGHSTAT Terminated D02ABS DRUG__ID D02ABS D02ABS DRUGCOMP Bristol-Myers Squibb Co D02ABS DRUGTYPE Small molecular drug D02ABS DRUGINCH 1S/C24H22ClN7O2/c1-2-3-11-20-26-22(25)21(24(33)34)32(20)14-15-7-6-10-18-16(15)12-13-31(18)19-9-5-4-8-17(19)23-27-29-30-28-23/h4-10,12-13H,2-3,11,14H2,1H3,(H,33,34)(H,27,28,29,30) D02ABS DRUGINKE AIGVXGCHRIOQNR-UHFFFAOYSA-N D02ABS DRUGSMIL CCCCC1=NC(=C(N1CC2=C3C=CN(C3=CC=C2)C4=CC=CC=C4C5=NNN=N5)C(=O)O)Cl D02ABS HIGHSTAT Terminated D02CGC DRUG__ID D02CGC D02CGC DRUGCOMP Pfizer D02CGC DRUGTYPE Small molecular drug D02CGC DRUGINCH 1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1 D02CGC DRUGINKE LXANPKRCLVQAOG-NSHDSACASA-N D02CGC DRUGSMIL C1COC2=C(C13C(=O)NC(=O)N3)C=C(C=C2)F D02CGC HIGHSTAT Terminated D02CGY DRUG__ID D02CGY D02CGY DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D02CGY DRUGTYPE Small molecular drug D02CGY DRUGINCH 1S/C18H23NO/c1-19-13-7-8-14-20-18-12-6-5-11-17(18)15-16-9-3-2-4-10-16/h2-6,9-12,19H,7-8,13-15H2,1H3 D02CGY DRUGINKE QSQQPMHPCBLLGX-UHFFFAOYSA-N D02CGY DRUGSMIL CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2 D02CGY HIGHSTAT Terminated D02DHU DRUG__ID D02DHU D02DHU DRUGCOMP SmithKline Beecham Pharmaceuticals D02DHU DRUGTYPE Small molecular drug D02DHU DRUGINCH 1S/C16H16ClNO2/c17-15-11-6-7-18-9-13(10-4-2-1-3-5-10)12(11)8-14(19)16(15)20/h1-5,8,13,18-20H,6-7,9H2 D02DHU DRUGINKE GHWJEDJMOVUXEC-UHFFFAOYSA-N D02DHU DRUGSMIL C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=CC=C3 D02DHU HIGHSTAT Terminated D02HCU DRUG__ID D02HCU D02HCU DRUGCOMP Boehringer Ingelheim Corp D02HCU DRUGTYPE Small molecular drug D02HCU DRUGINCH 1S/C25H28ClN5OS/c1-4-10-30(11-5-2)24(32)16-12-18-20(13-16)33-25-22(18)23(17-8-6-7-9-19(17)26)27-14-21-29-28-15(3)31(21)25/h6-9,16H,4-5,10-14H2,1-3H3 D02HCU DRUGINKE SCSIRWUYQVAIRL-UHFFFAOYSA-N D02HCU DRUGSMIL CCCN(CCC)C(=O)C1CC2=C(C1)SC3=C2C(=NCC4=NN=C(N43)C)C5=CC=CC=C5Cl D02HCU HIGHSTAT Terminated D02JNY DRUG__ID D02JNY D02JNY DRUGCOMP Boehringer Ingelheim Corp D02JNY DRUGTYPE Small molecular drug D02JNY DRUGINCH 1S/C32H44N4O3/c1-5-19-32(3,4)31(39)35(6-2)20-11-12-24-17-21-34(22-18-24)23-29(37)36-27-15-9-7-13-25(27)30(38)33-26-14-8-10-16-28(26)36/h7-10,13-16,24H,5-6,11-12,17-23H2,1-4H3,(H,33,38) D02JNY DRUGINKE LOAZWNRCWBWKAC-UHFFFAOYSA-N D02JNY DRUGSMIL CCCC(C)(C)C(=O)N(CC)CCCC1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=CC=CC=C42 D02JNY HIGHSTAT Terminated D02KAU DRUG__ID D02KAU D02KAU DRUGCOMP Pfizer D02KAU DRUGTYPE Small molecular drug D02KAU DRUGINCH 1S/C24H22ClN3O2/c25-21-12-18(8-5-17(21)13-26)28-23(14-3-1-2-4-14)20-10-6-15-11-16(24(29)30)7-9-19(15)22(20)27-28/h5,7-9,11-12,14,20,23H,1-4,6,10H2,(H,29,30)/t20-,23-/m0/s1 D02KAU DRUGINKE XNULRSOGWPFPBL-REWPJTCUSA-N D02KAU DRUGSMIL C1CCC(C1)C2C3CCC4=C(C3=NN2C5=CC(=C(C=C5)C#N)Cl)C=CC(=C4)C(=O)O D02KAU HIGHSTAT Terminated D02KBO DRUG__ID D02KBO D02KBO DRUGCOMP F Hoffmann-La Roche Ltd D02KBO DRUGTYPE Small molecular drug D02KBO DRUGINCH 1S/C37H55N5O8S/c1-37(2,36(47)42-15-17-50-18-16-42)51(48,49)23-28(19-25-9-5-3-6-10-25)34(45)41-31(21-29-22-38-24-39-29)35(46)40-30(20-26-11-7-4-8-12-26)33(44)32(43)27-13-14-27/h3,5-6,9-10,22,24,26-28,30-33,43-44H,4,7-8,11-21,23H2,1-2H3,(H,38,39)(H,40,46)(H,41,45)/t28-,30+,31+,32+,33-/m1/s1 D02KBO DRUGINKE PODHJNNUGIBMOP-HOQQKOLYSA-N D02KBO DRUGSMIL CC(C)(C(=O)N1CCOCC1)S(=O)(=O)CC(CC2=CC=CC=C2)C(=O)NC(CC3=CN=CN3)C(=O)NC(CC4CCCCC4)C(C(C5CC5)O)O D02KBO HIGHSTAT Terminated D02MHD DRUG__ID D02MHD D02MHD DRUGCOMP Scios Inc D02MHD DRUGTYPE Small molecular drug D02MHD DRUGINCH 1S/C23H19NO4/c25-22(26)15-9-11-16(12-10-15)24-23(27)28-14-13-21-19-7-3-1-5-17(19)18-6-2-4-8-20(18)21/h1-12,21H,13-14H2,(H,24,27)(H,25,26) D02MHD DRUGINKE QEOCEMPNYKUMCJ-UHFFFAOYSA-N D02MHD DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C32)CCOC(=O)NC4=CC=C(C=C4)C(=O)O D02MHD HIGHSTAT Terminated D02MVG DRUG__ID D02MVG D02MVG DRUGCOMP Amgen Inc D02MVG DRUGTYPE Small molecular drug D02MVG DRUGINCH 1S/C29H27N5O/c1-34-28(35)26(24-12-11-21-9-5-6-10-23(21)18-24)27(22-13-15-31-16-14-22)33-29(34)32-19-25(30)17-20-7-3-2-4-8-20/h2-16,18,25H,17,19,30H2,1H3,(H,32,33)/t25-/m0/s1 D02MVG DRUGINKE RQVKVJIRFKVPBF-VWLOTQADSA-N D02MVG DRUGSMIL CN1C(=O)C(=C(N=C1NCC(CC2=CC=CC=C2)N)C3=CC=NC=C3)C4=CC5=CC=CC=C5C=C4 D02MVG HIGHSTAT Terminated D02NYK DRUG__ID D02NYK D02NYK DRUGCOMP University of Illinois D02NYK DRUGTYPE Small molecular drug D02NYK DRUGINCH 1S/C16H18N2OS.BrH/c1-11-6-8-12(9-7-11)14(19)10-18-13-4-2-3-5-15(13)20-16(18)17;/h6-9,17H,2-5,10H2,1H3;1H D02NYK DRUGINKE HAGVCKULCLQGRF-UHFFFAOYSA-N D02NYK DRUGSMIL CC1=CC=C(C=C1)C(=O)CN2C3=C(CCCC3)SC2=N.Br D02NYK HIGHSTAT Terminated D02OTH DRUG__ID D02OTH D02OTH DRUGCOMP Fujisawa Pharmaceutical Co Ltd D02OTH DRUGTYPE Small molecular drug D02OTH DRUGINCH 1S/C16H17N.ClH/c1-16(14-8-3-2-4-9-14)15-10-6-5-7-13(15)11-12-17-16;/h2-10,17H,11-12H2,1H3;1H D02OTH DRUGINKE LUSUZDOXGNAITA-UHFFFAOYSA-N D02OTH DRUGSMIL CC1(C2=CC=CC=C2CCN1)C3=CC=CC=C3.Cl D02OTH HIGHSTAT Terminated D02PIN DRUG__ID D02PIN D02PIN DRUGCOMP Glaxo Group Research Ltd D02PIN DRUGTYPE Small molecular drug D02PIN DRUGINCH 1S/C19H25Cl2N3O3/c1-13(25)23-6-7-24(15(11-23)10-22-5-4-16(26)12-22)19(27)9-14-2-3-17(20)18(21)8-14/h2-3,8,15-16,26H,4-7,9-12H2,1H3 D02PIN DRUGINKE ZFWNCCCNZIYJAQ-UHFFFAOYSA-N D02PIN DRUGSMIL CC(=O)N1CCN(C(C1)CN2CCC(C2)O)C(=O)CC3=CC(=C(C=C3)Cl)Cl D02PIN HIGHSTAT Terminated D02RUO DRUG__ID D02RUO D02RUO DRUGCOMP Ono Pharmaceutical Co Ltd D02RUO DRUGTYPE Small molecular drug D02RUO DRUGINCH 1S/C22H35ClO4/c1-2-22(13-8-14-22)20(25)11-7-10-17-16(18(23)15-19(17)24)9-5-3-4-6-12-21(26)27/h3,5,7,10,16-20,24-25H,2,4,6,8-9,11-15H2,1H3,(H,26,27)/b5-3-,10-7+/t16-,17-,18-,19-,20+/m1/s1 D02RUO DRUGINKE LBIPUBVVGYRBNA-VGUVCEGPSA-N D02RUO DRUGSMIL CCC1(CCC1)C(CC=CC2C(CC(C2CC=CCCCC(=O)O)Cl)O)O D02RUO HIGHSTAT Terminated D02UIE DRUG__ID D02UIE D02UIE DRUGCOMP Bayer Schering Pharma AG D02UIE DRUGTYPE Small molecular drug D02UIE DRUGINCH 1S/C23H22N2O4/c1-3-28-23(26)22-16(14-27-2)20-18(12-24-22)25-17-10-7-11-19(21(17)20)29-13-15-8-5-4-6-9-15/h4-12,25H,3,13-14H2,1-2H3 D02UIE DRUGINKE WFPXOWCKXUEKCA-UHFFFAOYSA-N D02UIE DRUGSMIL CCOC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC=C3OCC4=CC=CC=C4 D02UIE HIGHSTAT Terminated D02UOE DRUG__ID D02UOE D02UOE DRUGCOMP Abbott Laboratories D02UOE DRUGTYPE Small molecular drug D02UOE DRUGINCH 1S/C19H22O2/c1-11(2)14-10-12-7-8-15-13(6-5-9-19(15,3)4)16(12)18(21)17(14)20/h7-8,10-11H,5-6,9H2,1-4H3 D02UOE DRUGINKE FEFAIBOZOKSLJR-UHFFFAOYSA-N D02UOE DRUGSMIL CC(C)C1=CC2=C(C3=C(C=C2)C(CCC3)(C)C)C(=O)C1=O D02UOE HIGHSTAT Terminated D02XMM DRUG__ID D02XMM D02XMM DRUGCOMP Daiichi Seiyaku Co Ltd D02XMM DRUGTYPE Small molecular drug D02XMM DRUGINCH 1S/C16H17N3/c1-2-6-13(7-3-1)14(12-16-18-10-11-19-16)15-8-4-5-9-17-15/h1-9,14H,10-12H2,(H,18,19) D02XMM DRUGINKE TYZQFNOLWJGHRZ-UHFFFAOYSA-N D02XMM DRUGSMIL C1CN=C(N1)CC(C2=CC=CC=C2)C3=CC=CC=N3 D02XMM HIGHSTAT Terminated D02YWV DRUG__ID D02YWV D02YWV DRUGCOMP Glaxo Group Research Ltd D02YWV DRUGTYPE Small molecular drug D02YWV DRUGINCH 1S/C23H27FN2O2S/c1-28-23(17-29(27)20-5-3-2-4-6-20)10-13-26(14-11-23)12-9-18-16-25-22-8-7-19(24)15-21(18)22/h2-8,15-16,25H,9-14,17H2,1H3/t29-/m1/s1 D02YWV DRUGINKE BANYJBHWTOJQDU-GDLZYMKVSA-N D02YWV DRUGSMIL COC1(CCN(CC1)CCC2=CNC3=C2C=C(C=C3)F)CS(=O)C4=CC=CC=C4 D02YWV HIGHSTAT Terminated D02ZPM DRUG__ID D02ZPM D02ZPM DRUGCOMP ASTA Medica AG D02ZPM DRUGTYPE Small molecular drug D02ZPM DRUGINCH 1S/C10H13ClN2S/c11-9-2-1-3-10(13-9)14-8-4-6-12-7-5-8/h1-3,8,12H,4-7H2 D02ZPM DRUGINKE GGALEXMXDMUMDM-UHFFFAOYSA-N D02ZPM DRUGSMIL C1CNCCC1SC2=NC(=CC=C2)Cl D02ZPM HIGHSTAT Terminated D03BTP DRUG__ID D03BTP D03BTP DRUGCOMP Heidelberg Pharma Holding GmbH D03BTP DRUGTYPE Small molecular drug D03BTP DRUGINCH 1S/C34H62FN2O10PS/c1-3-5-7-9-11-13-14-16-18-20-22-49-26-27(44-21-19-17-15-12-10-8-6-4-2)24-45-48(42,43)46-25-29-30(38)31(39)33(47-29)37-23-28(35)32(40)36-34(37)41/h23,27,29-31,33,38-39H,3-22,24-26H2,1-2H3,(H,42,43)(H,36,40,41)/t27?,29-,30-,31-,33-/m1/s1 D03BTP DRUGINKE LBBDGLOPGRGFDO-FKJRLRTPSA-N D03BTP DRUGSMIL CCCCCCCCCCCCSCC(COP(=O)(O)OCC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O)OCCCCCCCCCC D03BTP HIGHSTAT Terminated D03EHR DRUG__ID D03EHR D03EHR DRUGCOMP Bristol-Myers Squibb Pharma Co D03EHR DRUGTYPE Small molecular drug D03EHR DRUGINCH 1S/C34H40F2N4OS/c1-2-3-4-5-13-22-40(34(41)37-30-21-20-28(35)25-29(30)36)23-14-8-15-24-42-33-38-31(26-16-9-6-10-17-26)32(39-33)27-18-11-7-12-19-27/h6-7,9-12,16-21,25H,2-5,8,13-15,22-24H2,1H3,(H,37,41)(H,38,39) D03EHR DRUGINKE TVXOXGBTADZYCZ-UHFFFAOYSA-N D03EHR DRUGSMIL CCCCCCCN(CCCCCSC1=NC(=C(N1)C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC4=C(C=C(C=C4)F)F D03EHR HIGHSTAT Terminated D03EZQ DRUG__ID D03EZQ D03EZQ DRUGCOMP Meiji Seika Kaisha Ltd D03EZQ DRUGTYPE Small molecular drug D03EZQ DRUGINCH 1S/C41H47NO11/c1-10-12-28(44)51-36-22(26-18-40(6,42(8)9)38(21(5)48-26)52-29(45)13-11-2)14-15-23-31(36)34(47)32-24(33(23)46)16-19(3)30-25(43)17-27(50-37(30)32)41(7)39(53-41)35-20(4)49-35/h14-17,20-21,26,35,38-39H,10-13,18H2,1-9H3 D03EZQ DRUGINKE JBIOZJJHEWKRHG-UHFFFAOYSA-N D03EZQ DRUGSMIL CCCC(=O)OC1C(OC(CC1(C)N(C)C)C2=C(C3=C(C=C2)C(=O)C4=C(C3=O)C5=C(C(=C4)C)C(=O)C=C(O5)C6(C(O6)C7C(O7)C)C)OC(=O)CCC)C D03EZQ HIGHSTAT Terminated D03FUO DRUG__ID D03FUO D03FUO DRUGCOMP CGI Pharmaceuticals Inc D03FUO DRUGTYPE Small molecular drug D03FUO DRUGINCH 1S/C33H36N6O3S/c1-20-24(9-7-10-25(20)36-31(40)28-18-22-8-5-6-11-27(22)43-28)26-19-39(4)33(42)30(35-26)34-23-14-12-21(13-15-23)29-32(41)38(3)17-16-37(29)2/h7,9-10,12-15,18-19,29H,5-6,8,11,16-17H2,1-4H3,(H,34,35)(H,36,40)/t29-/m1/s1 D03FUO DRUGINKE CDOOFZZILLRUQH-GDLZYMKVSA-N D03FUO DRUGSMIL CC1=C(C=CC=C1NC(=O)C2=CC3=C(S2)CCCC3)C4=CN(C(=O)C(=N4)NC5=CC=C(C=C5)C6C(=O)N(CCN6C)C)C D03FUO HIGHSTAT Terminated D03GFC DRUG__ID D03GFC D03GFC DRUGCOMP AstraZeneca plc D03GFC DRUGTYPE Small molecular drug D03GFC DRUGINCH 1S/C19H18ClF3N2O5S/c1-18(28,19(21,22)23)17(27)24-15-9-8-13(10-14(15)20)31(29,30)12-6-4-11(5-7-12)16(26)25(2)3/h4-10,28H,1-3H3,(H,24,27)/t18-/m1/s1 D03GFC DRUGINKE DTDZLJHKVNTQGZ-GOSISDBHSA-N D03GFC DRUGSMIL CC(C(=O)NC1=C(C=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)N(C)C)Cl)(C(F)(F)F)O D03GFC HIGHSTAT Terminated D03GII DRUG__ID D03GII D03GII DRUGCOMP Sanofi D03GII DRUGTYPE Small molecular drug D03GII DRUGINCH 1S/C19H23ClNO3S/c1-19(2,3)18(22)24-17-10-14-12-21(23,9-8-16(14)25-17)11-13-6-4-5-7-15(13)20/h4-7,10,23H,8-9,11-12H2,1-3H3/q+1 D03GII DRUGINKE AZEZNHVYMHQRRH-UHFFFAOYSA-N D03GII DRUGSMIL CC(C)(C)C(=O)OC1=CC2=C(S1)CC[N+](C2)(CC3=CC=CC=C3Cl)O D03GII HIGHSTAT Terminated D03GKP DRUG__ID D03GKP D03GKP DRUGCOMP Taisho Pharmaceutical Co Ltd D03GKP DRUGTYPE Small molecular drug D03GKP DRUGINCH 1S/C33H54O8/c1-19-17-21(3)29(36)32-31(41-32)27(35)13-11-9-10-12-14-28(40-33(38)22(4)18-19)20(2)15-16-26(34)24(6)30(37)23(5)25(7)39-8/h9-12,17-18,20-21,23-32,34-37H,13-16H2,1-8H3/b11-9-,12-10-,19-17-,22-18-/t20?,21-,23-,24-,25+,26+,27?,28+,29+,30+,31?,32+/m1/s1 D03GKP DRUGINKE VOLRALTUADVHPT-QOKPVGNQSA-N D03GKP DRUGSMIL CC1C=C(C=C(C(=O)OC(CC=CC=CCC(C2C(C1O)O2)O)C(C)CCC(C(C)C(C(C)C(C)OC)O)O)C)C D03GKP HIGHSTAT Terminated D03GLM DRUG__ID D03GLM D03GLM DRUGCOMP Bristol-Myers Squibb Co D03GLM DRUGTYPE Small molecular drug D03GLM DRUGINCH 1S/C24H25ClF2N2O5S/c1-35(32,33)29-21-13-17(7-10-22(21)30)23(31)14-28-20(12-15-3-2-4-18(25)11-15)16-5-8-19(9-6-16)34-24(26)27/h2-11,13,20,23-24,28-31H,12,14H2,1H3/t20-,23+/m1/s1 D03GLM DRUGINKE DSEGFUSAJVUFLK-OFNKIYASSA-N D03GLM DRUGSMIL CS(=O)(=O)NC1=C(C=CC(=C1)C(CNC(CC2=CC(=CC=C2)Cl)C3=CC=C(C=C3)OC(F)F)O)O D03GLM HIGHSTAT Terminated D03GQC DRUG__ID D03GQC D03GQC DRUGCOMP Parke-Davis & Co D03GQC DRUGTYPE Small molecular drug D03GQC DRUGINCH 1S/C17H17F2N3O3/c18-12-5-10-14(13(19)15(12)21-4-3-8(20)6-21)22(9-1-2-9)7-11(16(10)23)17(24)25/h5,7-9H,1-4,6,20H2,(H,24,25) D03GQC DRUGINKE UHBXZNXCIZHGFF-UHFFFAOYSA-N D03GQC DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)F)N4CCC(C4)N)F)C(=O)O D03GQC HIGHSTAT Terminated D03GQH DRUG__ID D03GQH D03GQH DRUGCOMP Eisai Co Ltd D03GQH DRUGTYPE Small molecular drug D03GQH DRUGINCH 1S/C22H38N4O3S2/c1-15(2)20(24-12-17(23)14-30)13-25-19(11-16-7-5-4-6-8-16)21(27)26-18(22(28)29)9-10-31-3/h4-8,15,17-20,24-25,30H,9-14,23H2,1-3H3,(H,26,27)(H,28,29)/t17-,18+,19+,20-/m1/s1 D03GQH DRUGINKE QISLMXIYRQCLIR-FUMNGEBKSA-N D03GQH DRUGSMIL CC(C)C(CNC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)O)NCC(CS)N D03GQH HIGHSTAT Terminated D03ICO DRUG__ID D03ICO D03ICO DRUGCOMP Evolva Holding SA D03ICO DRUGTYPE Small molecular drug D03ICO DRUGINCH 1S/C27H27ClN6O4/c1-34(2)26(35)22-19(18-9-15(28)5-6-20(18)32-22)11-16-10-17-13(7-14-12-31-27(30)33-25(14)29)8-21(36-3)24(37-4)23(17)38-16/h5-6,8-10,12,32H,7,11H2,1-4H3,(H4,29,30,31,33) D03ICO DRUGINKE ASSNCSVJAZEMQG-UHFFFAOYSA-N D03ICO DRUGSMIL CN(C)C(=O)C1=C(C2=C(N1)C=CC(=C2)Cl)CC3=CC4=C(O3)C(=C(C=C4CC5=CN=C(N=C5N)N)OC)OC D03ICO HIGHSTAT Terminated D03NPZ DRUG__ID D03NPZ D03NPZ DRUGCOMP Novo Nordisk A/S D03NPZ DRUGTYPE Small molecular drug D03NPZ DRUGINCH 1S/C23H24FN3O5/c24-16-2-4-18-20(12-16)32-26-22(18)15-6-9-27(10-7-15)8-1-11-29-23(28)25-17-3-5-19-21(13-17)31-14-30-19/h2-5,12-13,15H,1,6-11,14H2,(H,25,28) D03NPZ DRUGINKE ZEMJDGPKDOUEEZ-UHFFFAOYSA-N D03NPZ DRUGSMIL C1CN(CCC1C2=NOC3=C2C=CC(=C3)F)CCCOC(=O)NC4=CC5=C(C=C4)OCO5 D03NPZ HIGHSTAT Terminated D03NZV DRUG__ID D03NZV D03NZV DRUGCOMP GD Searle & Co D03NZV DRUGTYPE Small molecular drug D03NZV DRUGINCH 1S/C16H11ClF3N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25) D03NZV DRUGINKE NSQNZEUFHPTJME-UHFFFAOYSA-N D03NZV DRUGSMIL C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)Cl D03NZV HIGHSTAT Terminated D03OFA DRUG__ID D03OFA D03OFA DRUGCOMP Roche Holding AG D03OFA DRUGTYPE Small molecular drug D03OFA DRUGINCH 1S/C31H31N11O10S3/c1-12-6-19(42-30(33-12)35-18(8-43)39-42)53-9-14-10-54-26-21(25(48)41(26)22(14)27(49)50)36-24(47)20(15-11-55-29(32)34-15)40-52-31(2,3)28(51)38-37-23(46)13-4-5-16(44)17(45)7-13/h4-7,11,21,26,43-45H,8-10H2,1-3H3,(H2,32,34)(H,36,47)(H,37,46)(H,38,51)(H,49,50)/b40-20+ D03OFA DRUGINKE CCOFMFVZORWSAE-KPRPFPDJSA-N D03OFA DRUGSMIL CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4C(C(C4=O)NC(=O)C(=NOC(C)(C)C(=O)NNC(=O)C5=CC(=C(C=C5)O)O)C6=CSC(=N6)N)SC3)C(=O)O)CO D03OFA HIGHSTAT Terminated D03QTP DRUG__ID D03QTP D03QTP DRUGCOMP Novartis AG D03QTP DRUGTYPE Small molecular drug D03QTP DRUGINCH 1S/C20H15N3O2/c24-19-15-11-17(21-13-7-3-1-4-8-13)18(12-16(15)20(25)23-19)22-14-9-5-2-6-10-14/h1-12,21-22H,(H,23,24,25) D03QTP DRUGINKE AAALVYBICLMAMA-UHFFFAOYSA-N D03QTP DRUGSMIL C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4 D03QTP HIGHSTAT Terminated D03RGO DRUG__ID D03RGO D03RGO DRUGCOMP Zeria Pharmaceutical Co Ltd D03RGO DRUGTYPE Small molecular drug D03RGO DRUGINCH 1S/C38H44ClN3O6S/c1-27-33(34-23-31(46-2)14-15-35(34)42(27)38(45)29-10-12-30(39)13-11-29)24-37(44)48-20-21-49-26-36(43)40-16-7-19-47-32-9-6-8-28(22-32)25-41-17-4-3-5-18-41/h6,8-15,22-23H,3-5,7,16-21,24-26H2,1-2H3,(H,40,43) D03RGO DRUGINKE SWFXMFDHMPMWMA-UHFFFAOYSA-N D03RGO DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCCSCC(=O)NCCCOC4=CC=CC(=C4)CN5CCCCC5 D03RGO HIGHSTAT Terminated D03RZU DRUG__ID D03RZU D03RZU DRUGCOMP CeNeS Pharmaceuticals Inc D03RZU DRUGTYPE Small molecular drug D03RZU DRUGINCH 1S/C16H18ClN3OS2/c1-20(11-5-4-6-13(9-11)23(3)21)16(18)19-15-10-12(22-2)7-8-14(15)17/h4-10H,1-3H3,(H2,18,19) D03RZU DRUGINKE RODJWDCTFWIGQR-UHFFFAOYSA-N D03RZU DRUGSMIL CN(C1=CC(=CC=C1)S(=O)C)C(=NC2=C(C=CC(=C2)SC)Cl)N D03RZU HIGHSTAT Terminated D03SDH DRUG__ID D03SDH D03SDH DRUGCOMP Istituto Lusofarmaco D`Italia SpA D03SDH DRUGTYPE Small molecular drug D03SDH DRUGINCH 1S/C24H30N2O4S/c1-16(2)25(4)14-15-26-20-8-6-7-9-21(20)31-23(22(24(26)28)30-17(3)27)18-10-12-19(29-5)13-11-18/h6-13,16,22-23H,14-15H2,1-5H3/t22-,23+/m1/s1 D03SDH DRUGINKE VVZILLNNYUUOIY-PKTZIBPZSA-N D03SDH DRUGSMIL CC(C)N(C)CCN1C2=CC=CC=C2SC(C(C1=O)OC(=O)C)C3=CC=C(C=C3)OC D03SDH HIGHSTAT Terminated D03UNN DRUG__ID D03UNN D03UNN DRUGCOMP Merck & Co Inc D03UNN DRUGTYPE Small molecular drug D03UNN DRUGINCH 1S/C17H15Cl2N3O3/c18-9-6-11(19)15-12(7-9)21-14(16(23)24)8-13(15)22-17(25)20-10-4-2-1-3-5-10/h1-7,13-14,21H,8H2,(H,23,24)(H2,20,22,25)/t13-,14+/m1/s1 D03UNN DRUGINKE UCKHICKHGAOGAP-KGLIPLIRSA-N D03UNN DRUGSMIL C1C(C2=C(C=C(C=C2Cl)Cl)NC1C(=O)O)NC(=O)NC3=CC=CC=C3 D03UNN HIGHSTAT Terminated D03WMY DRUG__ID D03WMY D03WMY DRUGCOMP Scios Inc D03WMY DRUGTYPE Small molecular drug D03WMY DRUGINCH 1S/C59H95N19O14/c1-2-23-92-35-27-42(71-29-35)53(88)78(54(89)43-25-33-13-6-7-15-38(33)73-43)59(55(90)91,48(83)44(31-79)76-51(86)41(24-32-11-4-3-5-12-32)74-46(81)30-72-50(85)40-26-34(80)28-70-40)36(18-21-69-58(65)66)47(82)45-17-10-22-77(45)52(87)39(16-9-20-68-57(63)64)75-49(84)37(60)14-8-19-67-56(61)62/h3-5,11-12,33-45,70-71,73,79-80H,2,6-10,13-31,60H2,1H3,(H,72,85)(H,74,81)(H,75,84)(H,76,86)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,34?,35-,36?,37+,38-,39-,40-,41-,42+,43?,44-,45-,59-/m0/s1 D03WMY DRUGINKE WYWZCALINPVKJW-KOCZGPIPSA-N D03WMY DRUGSMIL CCCOC1CC(NC1)C(=O)N(C(=O)C2CC3CCCCC3N2)C(C(CCN=C(N)N)C(=O)C4CCCN4C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)(C(=O)C(CO)NC(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C6CC(CN6)O)C(=O)O D03WMY HIGHSTAT Terminated D03YLN DRUG__ID D03YLN D03YLN DRUGCOMP Pfizer Inc D03YLN DRUGTYPE Small molecular drug D03YLN DRUGINCH 1S/C17H12F2N2O3/c1-2-21-8-11(17(23)24)16(22)10-7-12(18)13(14(19)15(10)21)9-3-5-20-6-4-9/h3-8H,2H2,1H3,(H,23,24) D03YLN DRUGINKE AVTJRMCCKOBMQP-UHFFFAOYSA-N D03YLN DRUGSMIL CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)C3=CC=NC=C3)F)C(=O)O D03YLN HIGHSTAT Terminated D03YVR DRUG__ID D03YVR D03YVR THERCLAS Anticancer Agents D03YVR DRUGTYPE Small molecular drug D03YVR DRUGINCH 1S/C17H14N2O4S/c20-17(18-21)12-5-4-7-14-8-6-9-15(13-14)19-24(22,23)16-10-2-1-3-11-16/h1-3,5-6,8-13,19,21H,(H,18,20)/b12-5+ D03YVR DRUGINKE QRPSQQUYPMFERG-LFYBBSHMSA-N D03YVR DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)C#CC=CC(=O)NO D03YVR HIGHSTAT Terminated D03ZVW DRUG__ID D03ZVW D03ZVW DRUGCOMP GlaxoSmithKline KK D03ZVW DRUGTYPE Small molecular drug D03ZVW DRUGINCH 1S/C30H39NO4/c32-27-21-28(35-22-23-15-17-25(18-16-23)24-11-5-3-6-12-24)26(13-7-1-2-8-14-29(33)34)30(27)31-19-9-4-10-20-31/h1-3,5-6,11-12,15-18,26-28,30,32H,4,7-10,13-14,19-22H2,(H,33,34)/b2-1-/t26-,27-,28-,30+/m0/s1 D03ZVW DRUGINKE GQGRDYWMOPRROR-XUSMOFMBSA-N D03ZVW DRUGSMIL C1CCN(CC1)C2C(CC(C2CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4)O D03ZVW HIGHSTAT Terminated D04AAR DRUG__ID D04AAR D04AAR DRUGCOMP Bristol-Myers Squibb Pharma Co D04AAR DRUGTYPE Small molecular drug D04AAR DRUGINCH 1S/C29H37N5O6S/c1-20-27(34(36)37)25(26(28(30)31-20)29(35)40-3)21-10-4-7-13-24(21)41(38)19-9-8-14-32-15-17-33(18-16-32)22-11-5-6-12-23(22)39-2/h4-7,10-13,25,31H,8-9,14-19,30H2,1-3H3 D04AAR DRUGINKE JQTJGLURUUNKCA-UHFFFAOYSA-N D04AAR DRUGSMIL CC1=C(C(C(=C(N1)N)C(=O)OC)C2=CC=CC=C2S(=O)CCCCN3CCN(CC3)C4=CC=CC=C4OC)[N+](=O)[O-] D04AAR HIGHSTAT Terminated D04AUA DRUG__ID D04AUA D04AUA DRUGCOMP Medivir AB D04AUA DRUGTYPE Small molecular drug D04AUA DRUGINCH 1S/C24H21F2N3O4S/c25-19-11-12-20(26)21-17(19)9-10-18-22(21)23(18)29-24(30)28-13-1-3-14(4-2-13)33-15-5-7-16(8-6-15)34(27,31)32/h1-8,11-12,18,22-23H,9-10H2,(H2,27,31,32)(H2,28,29,30)/t18-,22-,23-/m1/s1 D04AUA DRUGINKE FRIDRXJGZVLPIQ-SXSPYAJSSA-N D04AUA DRUGSMIL C1CC2=C(C=CC(=C2C3C1C3NC(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)S(=O)(=O)N)F)F D04AUA HIGHSTAT Terminated D04DMO DRUG__ID D04DMO D04DMO DRUGCOMP Fujisawa Pharmaceutical Co Ltd D04DMO DRUGTYPE Small molecular drug D04DMO DRUGINCH 1S/C27H37NO2S.ClH/c1-7-28(16-10-8-9-15-26(2,3)4)19-23-12-11-13-25(18-23)29-22-27(5,6)30-20-24-14-17-31-21-24;/h8,10-14,17-18,21H,7,16,19-20,22H2,1-6H3;1H/b10-8+; D04DMO DRUGINKE XZCWZZDUAVANHV-VRTOBVRTSA-N D04DMO DRUGSMIL CCN(CC=CC#CC(C)(C)C)CC1=CC(=CC=C1)OCC(C)(C)OCC2=CSC=C2.Cl D04DMO HIGHSTAT Terminated D04FXE DRUG__ID D04FXE D04FXE DRUGCOMP Kyowa Hakko Kogyo Co Ltd D04FXE DRUGTYPE Small molecular drug D04FXE DRUGINCH 1S/C26H25N7/c1-4-24-28-25-15(2)11-16(3)27-26(25)33(24)14-17-9-10-20-18-7-5-6-8-19(18)22(21(20)12-17)13-23-29-31-32-30-23/h5-12,22H,4,13-14H2,1-3H3,(H,29,30,31,32) D04FXE DRUGINKE DYYWUYUUDYPWON-UHFFFAOYSA-N D04FXE DRUGSMIL CCC1=NC2=C(N1CC3=CC4=C(C=C3)C5=CC=CC=C5C4CC6=NNN=N6)N=C(C=C2C)C D04FXE HIGHSTAT Terminated D04GSA DRUG__ID D04GSA D04GSA DRUGCOMP Boehringer Ingelheim Corp D04GSA DRUGTYPE Small molecular drug D04GSA DRUGINCH 1S/C17H21N3O4.ClH/c1-19-10-3-4-11(19)8-13(7-10)24-17(22)20-15-9-12(23-2)5-6-14(15)18-16(20)21;/h5-6,9-11,13H,3-4,7-8H2,1-2H3,(H,18,21);1H D04GSA DRUGINKE MXZAMPPIKDHMOJ-UHFFFAOYSA-N D04GSA DRUGSMIL CN1C2CCC1CC(C2)OC(=O)N3C4=C(C=CC(=C4)OC)NC3=O.Cl D04GSA HIGHSTAT Terminated D04JJE DRUG__ID D04JJE D04JJE DRUGCOMP Rhone-Poulenc SA D04JJE DRUGTYPE Small molecular drug D04JJE DRUGINCH 1S/C22H30O2S/c1-22(2,21(23)24)16-8-4-7-14-20-19(15-17-25-20)13-9-12-18-10-5-3-6-11-18/h3,5-6,10-11,15,17H,4,7-9,12-14,16H2,1-2H3,(H,23,24) D04JJE DRUGINKE QMXLXSYXJOJQSN-UHFFFAOYSA-N D04JJE DRUGSMIL CC(C)(CCCCCC1=C(C=CS1)CCCC2=CC=CC=C2)C(=O)O D04JJE HIGHSTAT Terminated D04JQR DRUG__ID D04JQR D04JQR DRUGCOMP Lilly Research Centre Ltd D04JQR DRUGTYPE Small molecular drug D04JQR DRUGINCH 1S/C10H11NO4/c1-5-4-6(9(12)13)2-3-7(5)8(11)10(14)15/h2-4,8H,11H2,1H3,(H,12,13)(H,14,15)/t8-/m0/s1 D04JQR DRUGINKE SGIKDIUCJAUSRD-QMMMGPOBSA-N D04JQR DRUGSMIL CC1=C(C=CC(=C1)C(=O)O)C(C(=O)O)N D04JQR HIGHSTAT Terminated D04LIR DRUG__ID D04LIR D04LIR DRUGCOMP Pfizer Inc D04LIR DRUGTYPE Small molecular drug D04LIR DRUGINCH 1S/C20H20NO5P/c21-19(20(22)23)10-13-7-14(12-27(24,25)26)9-18(8-13)17-6-5-15-3-1-2-4-16(15)11-17/h1-9,11,19H,10,12,21H2,(H,22,23)(H2,24,25,26)/t19-/m0/s1 D04LIR DRUGINKE GOPXMKDIVJBBQF-IBGZPJMESA-N D04LIR DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC(=CC(=C3)CP(=O)(O)O)CC(C(=O)O)N D04LIR HIGHSTAT Terminated D04MFY DRUG__ID D04MFY D04MFY DRUGCOMP Dainippon Pharmaceutical Co Ltd D04MFY DRUGTYPE Small molecular drug D04MFY DRUGINCH 1S/C27H27FN2O.2C4H4O4/c28-23-12-13-25-26(19-23)31-20-22-10-4-5-11-24(22)27(25)30-17-15-29(16-18-30)14-6-9-21-7-2-1-3-8-21;2*5-3(6)1-2-4(7)8/h1-13,19,27H,14-18,20H2;2*1-2H,(H,5,6)(H,7,8)/b9-6+;2*2-1+/t27-;;/m0../s1 D04MFY DRUGINKE BGBBGKWUEFWPAV-CDPVILSCSA-N D04MFY DRUGSMIL C1CN(CCN1CC=CC2=CC=CC=C2)C3C4=C(C=C(C=C4)F)OCC5=CC=CC=C35.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O D04MFY HIGHSTAT Terminated D04NSW DRUG__ID D04NSW D04NSW DRUGCOMP Servier D04NSW DRUGTYPE Small molecular drug D04NSW DRUGINCH 1S/C24H38N2O3S/c1-22(2,3)18-14-17(15-19(20(18)27)23(4,5)6)30-13-7-10-26-11-8-24(9-12-26)16-25-21(28)29-24/h14-15,27H,7-13,16H2,1-6H3,(H,25,28) D04NSW DRUGINKE AQYBPUABOQSUHO-UHFFFAOYSA-N D04NSW DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCCCN2CCC3(CC2)CNC(=O)O3 D04NSW HIGHSTAT Terminated D04OKJ DRUG__ID D04OKJ D04OKJ DRUGCOMP Toyama Chemical D04OKJ DRUGTYPE Small molecular drug D04OKJ DRUGINCH 1S/C23H20F2N2O4/c1-11-15-5-2-12(8-13(15)9-26-11)16-6-7-17-19(21(16)31-23(24)25)27(14-3-4-14)10-18(20(17)28)22(29)30/h2,5-8,10-11,14,23,26H,3-4,9H2,1H3,(H,29,30)/t11-/m1/s1 D04OKJ DRUGINKE NJDRXTDGYFKORP-LLVKDONJSA-N D04OKJ DRUGSMIL CC1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F D04OKJ HIGHSTAT Terminated D04OOC DRUG__ID D04OOC D04OOC DRUGCOMP Pharmacia & Upjohn AB D04OOC DRUGTYPE Small molecular drug D04OOC DRUGINCH 1S/C18H19NO3.ClH/c1-19(2)11-12-21-18(20)17-15-9-4-3-7-13(15)14-8-5-6-10-16(14)22-17;/h3-10,17H,11-12H2,1-2H3;1H D04OOC DRUGINKE OXJRPIUEFMWVOI-UHFFFAOYSA-N D04OOC DRUGSMIL CN(C)CCOC(=O)C1C2=CC=CC=C2C3=CC=CC=C3O1.Cl D04OOC HIGHSTAT Terminated D04PGO DRUG__ID D04PGO D04PGO DRUGCOMP Hoechst Marion Roussel Inc D04PGO DRUGTYPE Small molecular drug D04PGO DRUGINCH 1S/C21H23FN2O4S.ClH/c1-29(27,28)23-19-8-4-16(5-9-19)21(26)17-10-12-24(13-11-17)14-20(25)15-2-6-18(22)7-3-15;/h2-9,17,23H,10-14H2,1H3;1H D04PGO DRUGINKE YVIOSUWCZDHHEI-UHFFFAOYSA-N D04PGO DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C(=O)C2CCN(CC2)CC(=O)C3=CC=C(C=C3)F.Cl D04PGO HIGHSTAT Terminated D04QXK DRUG__ID D04QXK D04QXK DRUGCOMP University of Texas System D04QXK DRUGTYPE Small molecular drug D04QXK DRUGINCH 1S/C60H100N2O22/c1-40-18-16-14-12-10-8-6-7-9-11-13-15-17-19-47(83-59-57(72)54(61)56(71)43(4)82-59)37-51-53(58(73)62-22-23-76-26-27-78-30-31-80-33-32-79-29-28-77-25-24-75-5)50(68)39-60(74,84-51)38-46(65)34-44(63)20-21-48(66)49(67)35-45(64)36-52(69)81-42(3)41(2)55(40)70/h6-19,40-51,53-57,59,63-68,70-72,74H,20-39,61H2,1-5H3,(H,62,73)/b7-6+,10-8+,11-9+,14-12+,15-13+,18-16+,19-17+/t40-,41+,42-,43+,44-,45+,46-,47-,48-,49-,50-,51-,53+,54-,55+,56+,57-,59-,60+/m0/s1 D04QXK DRUGINKE GPWISCBGMSECOC-OGIFARMBSA-N D04QXK DRUGSMIL CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(CCC(C(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)NCCOCCOCCOCCOCCOCCOC)OC3C(C(C(C(O3)C)O)N)O D04QXK HIGHSTAT Terminated D04RCG DRUG__ID D04RCG D04RCG DRUGCOMP The Menarini Group D04RCG DRUGTYPE Small molecular drug D04RCG DRUGINCH 1S/C38H48N8O7S/c1-21(2)15-27-34(49)41-26(13-14-54-3)33(48)45-30-18-32(47)40-20-31(38(53)42-27)46-35(50)28(16-22-9-5-4-6-10-22)43-36(51)29(44-37(30)52)17-23-19-39-25-12-8-7-11-24(23)25/h4-12,19,21,26-31,39H,13-18,20H2,1-3H3,(H,40,47)(H,41,49)(H,42,53)(H,43,51)(H,44,52)(H,45,48)(H,46,50)/t26-,27-,28-,29-,30-,31-/m0/s1 D04RCG DRUGINKE CFDNUNSOUUFTQO-HPMAGDRPSA-N D04RCG DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC2CC(=O)NCC(C(=O)N1)NC(=O)C(NC(=O)C(NC2=O)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CCSC D04RCG HIGHSTAT Terminated D04SHO DRUG__ID D04SHO D04SHO DRUGCOMP NitroMed Inc D04SHO DRUGTYPE Small molecular drug D04SHO DRUGINCH 1S/C17H18N2O9/c1-11(12-3-4-14-8-15(25-2)6-5-13(14)7-12)17(20)26-9-16(28-19(23)24)10-27-18(21)22/h3-8,11,16H,9-10H2,1-2H3/t11-,16+/m0/s1 D04SHO DRUGINKE DHMLCNFGWGUOSW-MEDUHNTESA-N D04SHO DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)OCC(CO[N+](=O)[O-])O[N+](=O)[O-] D04SHO HIGHSTAT Terminated D04TKP DRUG__ID D04TKP D04TKP DRUGCOMP Merck & Co Inc D04TKP DRUGTYPE Small molecular drug D04TKP DRUGINCH 1S/C22H27N5O6S/c28-20(26-15-19(21(29)30)27-34(31,32)18-5-2-1-3-6-18)16-7-9-17(10-8-16)33-14-13-25-22-23-11-4-12-24-22/h1-3,5-10,19,27H,4,11-15H2,(H,26,28)(H,29,30)(H2,23,24,25)/t19-/m0/s1 D04TKP DRUGINKE XAHWDFRDQNVXQX-IBGZPJMESA-N D04TKP DRUGSMIL C1CNC(=NC1)NCCOC2=CC=C(C=C2)C(=O)NCC(C(=O)O)NS(=O)(=O)C3=CC=CC=C3 D04TKP HIGHSTAT Terminated D04WWG DRUG__ID D04WWG D04WWG DRUGCOMP Shionogi & Co Ltd D04WWG DRUGTYPE Small molecular drug D04WWG DRUGINCH 1S/C17H21Cl2N3O2.ClH/c1-11(2)21-8-13(23)9-24-17-15(19)5-4-14(18)16(17)12(3)22-7-6-20-10-22;/h4-7,10-11,13,21,23H,3,8-9H2,1-2H3;1H D04WWG DRUGINKE DGLQZJPSOFSWLE-UHFFFAOYSA-N D04WWG DRUGSMIL CC(C)NCC(COC1=C(C=CC(=C1C(=C)N2C=CN=C2)Cl)Cl)O.Cl D04WWG HIGHSTAT Terminated D04WZK DRUG__ID D04WZK D04WZK DRUGCOMP AstraZeneca plc D04WZK DRUGTYPE Small molecular drug D04WZK DRUGINCH 1S/C21H23N7O3S/c1-27-9-11-28(12-10-27)32(30,31)17-6-4-15(5-7-17)18-14-24-20(22)19(26-18)21(29)25-16-3-2-8-23-13-16/h2-8,13-14H,9-12H2,1H3,(H2,22,24)(H,25,29) D04WZK DRUGINKE FHCSBLWRGCOVPT-UHFFFAOYSA-N D04WZK DRUGSMIL CN1CCN(CC1)S(=O)(=O)C2=CC=C(C=C2)C3=CN=C(C(=N3)C(=O)NC4=CN=CC=C4)N D04WZK HIGHSTAT Terminated D04YNI DRUG__ID D04YNI D04YNI DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D04YNI DRUGTYPE Small molecular drug D04YNI DRUGINCH 1S/C25H18ClN5/c26-18-8-11-21-24(14-18)29-23(12-13-28-19-9-6-17(15-27)7-10-19)22-16-31(30-25(21)22)20-4-2-1-3-5-20/h1-11,14,16,28H,12-13H2 D04YNI DRUGINKE GYVYUQVVKBZPRY-UHFFFAOYSA-N D04YNI DRUGSMIL C1=CC=C(C=C1)N2C=C3C(=NC4=C(C3=N2)C=CC(=C4)Cl)CCNC5=CC=C(C=C5)C#N D04YNI HIGHSTAT Terminated D04ZCL DRUG__ID D04ZCL D04ZCL DRUGCOMP Grunenthal GmbH D04ZCL DRUGTYPE Small molecular drug D04ZCL DRUGINCH 1S/C13H16N2O3/c1-18-12-5-4-10-6-9(2-3-11(10)7-12)8-15(17)13(14)16/h4-7,17H,2-3,8H2,1H3,(H2,14,16) D04ZCL DRUGINKE CTGJXUUSOOOTRZ-UHFFFAOYSA-N D04ZCL DRUGSMIL COC1=CC2=C(C=C1)C=C(CC2)CN(C(=O)N)O D04ZCL HIGHSTAT Terminated D05ALG DRUG__ID D05ALG D05ALG THERCLAS Antifungal Agents D05ALG DRUGTYPE Small molecular drug D05ALG DRUGINCH 1S/C30H31N3O/c31-29(32)33-22-20-24-16-18-28(19-17-24)34-23-21-30(25-10-4-1-5-11-25,26-12-6-2-7-13-26)27-14-8-3-9-15-27/h1-19H,20-23H2,(H4,31,32,33) D05ALG DRUGINKE AJKCPFPHDCULCG-UHFFFAOYSA-N D05ALG DRUGSMIL C1=CC=C(C=C1)C(CCOC2=CC=C(C=C2)CCN=C(N)N)(C3=CC=CC=C3)C4=CC=CC=C4 D05ALG HIGHSTAT Terminated D05COG DRUG__ID D05COG D05COG DRUGCOMP Dainippon Pharmaceutical Co Ltd D05COG DRUGTYPE Small molecular drug D05COG DRUGINCH 1S/C26H37N5O7/c27-12-4-3-8-18(29-23(34)17-7-5-13-28-15-17)24(35)30-19(10-11-22(32)33)25(36)31-20-9-2-1-6-16(20)14-21(31)26(37)38/h5,7,13,15-16,18-21H,1-4,6,8-12,14,27H2,(H,29,34)(H,30,35)(H,32,33)(H,37,38)/t16-,18-,19+,20-,21-/m0/s1 D05COG DRUGINKE NDXIQTFRXMWLEQ-RQUKQETFSA-N D05COG DRUGSMIL C1CCC2C(C1)CC(N2C(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C3=CN=CC=C3)C(=O)O D05COG HIGHSTAT Terminated D05DNA DRUG__ID D05DNA D05DNA DRUGCOMP Fujisawa Pharmaceutical Co Ltd D05DNA DRUGTYPE Small molecular drug D05DNA DRUGINCH 1S/C17H19Cl2N5O2S.2ClH/c1-24(2)4-3-22-15(25)10-5-9(12-8-13(18)27-14(12)19)6-11(7-10)16(26)23-17(20)21;;/h5-8H,3-4H2,1-2H3,(H,22,25)(H4,20,21,23,26);2*1H D05DNA DRUGINKE NPUVTFLPUFCAOB-UHFFFAOYSA-N D05DNA DRUGSMIL CN(C)CCNC(=O)C1=CC(=CC(=C1)C2=C(SC(=C2)Cl)Cl)C(=O)N=C(N)N.Cl.Cl D05DNA HIGHSTAT Terminated D05EKM DRUG__ID D05EKM D05EKM DRUGCOMP Fujisawa Pharmaceutical Co Ltd D05EKM DRUGTYPE Small molecular drug D05EKM DRUGINCH 1S/C12H16FN3O3S/c1-10(17)15-6-8-16(9-7-15)14-20(18,19)12-4-2-11(13)3-5-12/h2-5,14H,6-9H2,1H3 D05EKM DRUGINKE PZQKOVUNWPDCCQ-UHFFFAOYSA-N D05EKM DRUGSMIL CC(=O)N1CCN(CC1)NS(=O)(=O)C2=CC=C(C=C2)F D05EKM HIGHSTAT Terminated D05FTY DRUG__ID D05FTY D05FTY DRUGCOMP Sankyo Co Ltd D05FTY DRUGTYPE Small molecular drug D05FTY DRUGINCH 1S/C50H67N7O6.2ClH/c1-32(2)23-43(46(59)28-47(60)55-44(24-33(3)4)49(62)53-22-10-9-19-39(51)30-58)56-50(63)45(27-40-29-52-31-54-40)57-48(61)38(25-36-17-11-15-34-13-5-7-20-41(34)36)26-37-18-12-16-35-14-6-8-21-42(35)37;;/h5-8,11-18,20-21,29,31-33,38-39,43-46,58-59H,9-10,19,22-28,30,51H2,1-4H3,(H,52,54)(H,53,62)(H,55,60)(H,56,63)(H,57,61);2*1H/t39-,43?,44-,45?,46-;;/m0../s1 D05FTY DRUGINKE IYZRFOAPEUBNQP-JPZLKUPGSA-N D05FTY DRUGSMIL CC(C)CC(C(CC(=O)NC(CC(C)C)C(=O)NCCCCC(CO)N)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC2=CC=CC3=CC=CC=C32)CC4=CC=CC5=CC=CC=C54.Cl.Cl D05FTY HIGHSTAT Terminated D05GOM DRUG__ID D05GOM D05GOM DRUGCOMP Servier D05GOM DRUGTYPE Small molecular drug D05GOM DRUGINCH 1S/C17H19NO/c19-17(15-8-4-9-15)18-12-11-14-7-3-6-13-5-1-2-10-16(13)14/h1-3,5-7,10,15H,4,8-9,11-12H2,(H,18,19) D05GOM DRUGINKE GLXSBZGTGMPDKH-UHFFFAOYSA-N D05GOM DRUGSMIL C1CC(C1)C(=O)NCCC2=CC=CC3=CC=CC=C32 D05GOM HIGHSTAT Terminated D05GQL DRUG__ID D05GQL D05GQL DRUGCOMP Japan Energy Corp D05GQL DRUGTYPE Small molecular drug D05GQL DRUGINCH 1S/C31H41N5O7/c1-31(2,3)35-28(40)24-15-10-16-36(24)29(41)26(38)22(17-20-11-6-4-7-12-20)33-27(39)23(18-25(32)37)34-30(42)43-19-21-13-8-5-9-14-21/h4-9,11-14,22-24,26,38H,10,15-19H2,1-3H3,(H2,32,37)(H,33,39)(H,34,42)(H,35,40)/t22-,23-,24-,26-/m0/s1 D05GQL DRUGINKE XCVUOCMQYKSJJR-IGRGDXOOSA-N D05GQL DRUGSMIL CC(C)(C)NC(=O)C1CCCN1C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CC(=O)N)NC(=O)OCC3=CC=CC=C3)O D05GQL HIGHSTAT Terminated D05HYL DRUG__ID D05HYL D05HYL DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D05HYL DRUGTYPE Small molecular drug D05HYL DRUGINCH 1S/C32H28N4O3/c1-21-11-10-15-24(19-21)33-32(39)35-30-31(38)36(20-28(37)25-16-7-6-12-22(25)2)27-18-9-8-17-26(27)29(34-30)23-13-4-3-5-14-23/h3-19,30H,20H2,1-2H3,(H2,33,35,39)/t30-/m0/s1 D05HYL DRUGINKE YCXFHPUBGMMWJQ-PMERELPUSA-N D05HYL DRUGSMIL CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)CC(=O)C5=CC=CC=C5C D05HYL HIGHSTAT Terminated D05IPO DRUG__ID D05IPO D05IPO DRUGCOMP Abbott D05IPO DRUGTYPE Small molecular drug D05IPO DRUGINCH 1S/C22H27ClN2O3/c1-26-20-5-3-2-4-19(20)25-10-8-16(9-11-25)13-24-14-18-15-27-21-7-6-17(23)12-22(21)28-18/h2-7,12,16,18,24H,8-11,13-15H2,1H3/t18-/m0/s1 D05IPO DRUGINKE QHLRKDSRGUZHSH-SFHVURJKSA-N D05IPO DRUGSMIL COC1=CC=CC=C1N2CCC(CC2)CNCC3COC4=C(O3)C=C(C=C4)Cl D05IPO HIGHSTAT Terminated D05IVZ DRUG__ID D05IVZ D05IVZ DRUGCOMP Aventis Pharma AG D05IVZ DRUGTYPE Small molecular drug D05IVZ DRUGINCH 1S/C16H15N3O2/c1-18-8-13-14(15(20)10-6-7-10)17-9-19(13)12-5-3-2-4-11(12)16(18)21/h2-5,9-10H,6-8H2,1H3 D05IVZ DRUGINKE KNOYNQIVNYWKJR-UHFFFAOYSA-N D05IVZ DRUGSMIL CN1CC2=C(N=CN2C3=CC=CC=C3C1=O)C(=O)C4CC4 D05IVZ HIGHSTAT Terminated D05JQF DRUG__ID D05JQF D05JQF DRUGCOMP Bristol-Myers Squibb Co D05JQF DRUGTYPE Small molecular drug D05JQF DRUGINCH 1S/C22H31FO2S2/c1-5-27-21(26-4)11-9-16-17-7-6-14-12-15(24)8-10-19(14,2)22(17,23)18(25)13-20(16,21)3/h8,10,12,16-18,25H,5-7,9,11,13H2,1-4H3/t16-,17-,18-,19-,20-,21+,22-/m0/s1 D05JQF DRUGINKE DXEXNWDGDYUITL-FXSSSKFRSA-N D05JQF DRUGSMIL CCSC1(CCC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)SC D05JQF HIGHSTAT Terminated D05KHN DRUG__ID D05KHN D05KHN DRUGCOMP Zeneca Group plc D05KHN DRUGTYPE Small molecular drug D05KHN DRUGINCH 1S/C19H20N2S/c1-21(2)12-13-22-19-17(15-8-4-3-5-9-15)14-16-10-6-7-11-18(16)20-19/h3-11,14H,12-13H2,1-2H3 D05KHN DRUGINKE HYOLQGVNMQNERE-UHFFFAOYSA-N D05KHN DRUGSMIL CN(C)CCSC1=NC2=CC=CC=C2C=C1C3=CC=CC=C3 D05KHN HIGHSTAT Terminated D05KRC DRUG__ID D05KRC D05KRC DRUGCOMP Knoll GmbH D05KRC DRUGTYPE Small molecular drug D05KRC DRUGINCH 1S/C23H30N2/c1-20(2)23(19-24,22-13-8-5-9-14-22)16-10-17-25(3)18-15-21-11-6-4-7-12-21/h4-9,11-14,20H,10,15-18H2,1-3H3 D05KRC DRUGINKE DWAWDSVKAUWFHC-UHFFFAOYSA-N D05KRC DRUGSMIL CC(C)C(CCCN(C)CCC1=CC=CC=C1)(C#N)C2=CC=CC=C2 D05KRC HIGHSTAT Terminated D05LXC DRUG__ID D05LXC D05LXC DRUGCOMP Mitsubishi-Tokyo Pharmaceuticals Inc D05LXC DRUGTYPE Small molecular drug D05LXC DRUGINCH 1S/C19H20FN3O4.ClH/c1-10-7-14(24)15-16-11(18(25)12(19(26)27)9-23(10)16)8-13(20)17(15)22-5-3-21(2)4-6-22;/h8-10H,3-7H2,1-2H3,(H,26,27);1H D05LXC DRUGINKE CDKHTKSBKPVKSD-UHFFFAOYSA-N D05LXC DRUGSMIL CC1CC(=O)C2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.Cl D05LXC HIGHSTAT Terminated D05MQO DRUG__ID D05MQO D05MQO DRUGCOMP Medivir AB D05MQO DRUGTYPE Small molecular drug D05MQO DRUGINCH 1S/C10H15N3O4/c11-8-1-2-13(10(16)12-8)9-3-6(4-14)7(5-15)17-9/h1-2,6-7,9,14-15H,3-5H2,(H2,11,12,16)/t6-,7-,9-/m1/s1 D05MQO DRUGINKE WZGBNAXNHRMYLG-ZXFLCMHBSA-N D05MQO DRUGSMIL C1C(C(OC1N2C=CC(=NC2=O)N)CO)CO D05MQO HIGHSTAT Terminated D05QFA DRUG__ID D05QFA D05QFA DRUGCOMP Sankyo Co Ltd D05QFA DRUGTYPE Small molecular drug D05QFA DRUGINCH 1S/C22H20F2N4O4/c23-10-13-12-32-21-18-14(20(29)15(22(30)31)11-28(13)18)9-16(24)19(21)27-7-5-26(6-8-27)17-3-1-2-4-25-17/h1-4,9,11,13H,5-8,10,12H2,(H,30,31) D05QFA DRUGINKE FASWMSDWHLSHQI-UHFFFAOYSA-N D05QFA DRUGSMIL C1CN(CCN1C2=CC=CC=N2)C3=C(C=C4C5=C3OCC(N5C=C(C4=O)C(=O)O)CF)F D05QFA HIGHSTAT Terminated D05RDE DRUG__ID D05RDE D05RDE DRUGCOMP Tsumura & Co D05RDE DRUGTYPE Small molecular drug D05RDE DRUGINCH 1S/C30H41NO7.ClH/c1-5-31-15-17-8-11-22(36-3)30-19(17)12-20(25(30)31)28(33)14-23(37-4)29(34)13-21(30)24(28)26(29)38-27(32)16-6-9-18(35-2)10-7-16;/h6-7,9-10,17,19-26,33-34H,5,8,11-15H2,1-4H3;1H D05RDE DRUGINKE OTWHFNPJXVKZPR-UHFFFAOYSA-N D05RDE DRUGSMIL CCN1CC2CCC(C34C2CC(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=C(C=C7)OC)O)OC)O)OC.Cl D05RDE HIGHSTAT Terminated D05REH DRUG__ID D05REH D05REH DRUGCOMP Novartis AG D05REH DRUGTYPE Small molecular drug D05REH DRUGINCH 1S/C16H13F2NO4S/c1-24(21,22)19-13-6-9-2-4-14(20)11(9)8-16(13)23-15-5-3-10(17)7-12(15)18/h3,5-8,19H,2,4H2,1H3 D05REH DRUGINKE CXJONBHNIJFARE-UHFFFAOYSA-N D05REH DRUGSMIL CS(=O)(=O)NC1=C(C=C2C(=C1)CCC2=O)OC3=C(C=C(C=C3)F)F D05REH HIGHSTAT Terminated D05RMW DRUG__ID D05RMW D05RMW DRUGCOMP AstraZeneca D05RMW DRUGTYPE Small molecular drug D05RMW DRUGINCH 1S/C28H30N2O2S/c1-2-33(32)26-25(12-7-15-29-26)28(31)13-16-30(17-14-28)19-27-18-22(20-8-3-5-10-23(20)27)21-9-4-6-11-24(21)27/h3-12,15,22,31H,2,13-14,16-19H2,1H3 D05RMW DRUGINKE LVMVFEHQMHETDS-UHFFFAOYSA-N D05RMW DRUGSMIL CCS(=O)C1=C(C=CC=N1)C2(CCN(CC2)CC34CC(C5=CC=CC=C53)C6=CC=CC=C46)O D05RMW HIGHSTAT Terminated D05SOF DRUG__ID D05SOF D05SOF DRUGCOMP Schwarz Pharma AG D05SOF DRUGTYPE Small molecular drug D05SOF DRUGINCH 1S/C10H18N2O6S/c1-4-17-8(13)7(5-19)11-9(14)10(2,3)6-18-12(15)16/h7,19H,4-6H2,1-3H3,(H,11,14)/t7-/m0/s1 D05SOF DRUGINKE KCKXBNDUEKMBFJ-ZETCQYMHSA-N D05SOF DRUGSMIL CCOC(=O)C(CS)NC(=O)C(C)(C)CO[N+](=O)[O-] D05SOF HIGHSTAT Terminated D05SSJ DRUG__ID D05SSJ D05SSJ DRUGCOMP Ferrer Internacional SA D05SSJ DRUGTYPE Small molecular drug D05SSJ DRUGINCH 1S/C29H34N2O2/c1-4-11-25(12-5-1)28(26-13-6-2-7-14-26)31-21-19-30(20-22-31)18-10-17-29(32-23-24-33-29)27-15-8-3-9-16-27/h1-9,11-16,28H,10,17-24H2 D05SSJ DRUGINKE LRMJAFKKJLRDLE-UHFFFAOYSA-N D05SSJ DRUGSMIL C1CN(CCN1CCCC2(OCCO2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=CC=CC=C5 D05SSJ HIGHSTAT Terminated D05UQD DRUG__ID D05UQD D05UQD DRUGCOMP Bristol-Myers Squibb D05UQD DRUGTYPE Small molecular drug D05UQD DRUGINCH 1S/C19H24N2O4S2/c22-17(15(26)11-12-5-2-1-3-6-12)20-13-9-10-27-16-8-4-7-14(19(24)25)21(16)18(13)23/h1-3,5-6,13-16,26H,4,7-11H2,(H,20,22)(H,24,25)/t13-,14-,15-,16-/m0/s1 D05UQD DRUGINKE LVRLSYPNFFBYCZ-VGWMRTNUSA-N D05UQD DRUGSMIL C1CC(N2C(C1)SCCC(C2=O)NC(=O)C(CC3=CC=CC=C3)S)C(=O)O D05UQD HIGHSTAT Terminated D05VLN DRUG__ID D05VLN D05VLN DRUGCOMP Merck KGaA D05VLN DRUGTYPE Small molecular drug D05VLN DRUGINCH 1S/C14H13N3O2S/c1-19-13-7-9(20(2)18)3-4-10(13)14-16-11-5-6-15-8-12(11)17-14/h3-8H,1-2H3,(H,16,17) D05VLN DRUGINKE JQUKCPUPFALELS-UHFFFAOYSA-N D05VLN DRUGSMIL COC1=C(C=CC(=C1)S(=O)C)C2=NC3=C(N2)C=NC=C3 D05VLN HIGHSTAT Terminated D05XMY DRUG__ID D05XMY D05XMY DRUGCOMP Tsumura & Co D05XMY DRUGTYPE Small molecular drug D05XMY DRUGINCH 1S/C29H36O15/c1-13-22(36)23(37)24(38)29(41-13)44-27-25(39)28(40-9-8-15-3-6-17(32)19(34)11-15)42-20(12-30)26(27)43-21(35)7-4-14-2-5-16(31)18(33)10-14/h2-7,10-11,13,20,22-34,36-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29-/m0/s1 D05XMY DRUGINKE FBSKJMQYURKNSU-ZLSOWSIRSA-N D05XMY DRUGSMIL CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)O)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O D05XMY HIGHSTAT Terminated D05XTO DRUG__ID D05XTO D05XTO DRUGCOMP Abbott Laboratories D05XTO DRUGTYPE Small molecular drug D05XTO DRUGINCH 1S/C27H19F3N4O3/c1-34-17-33-15-25(34)26(35,21-7-2-18(13-31)3-8-21)16-36-24-11-4-19(14-32)12-23(24)20-5-9-22(10-6-20)37-27(28,29)30/h2-12,15,17,35H,16H2,1H3/t26-/m0/s1 D05XTO DRUGINKE HEUVRFNVTLGKMZ-SANMLTNESA-N D05XTO DRUGSMIL CN1C=NC=C1C(COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O D05XTO HIGHSTAT Terminated D05ZGW DRUG__ID D05ZGW D05ZGW DRUGCOMP Novartis AG D05ZGW DRUGTYPE Small molecular drug D05ZGW DRUGINCH 1S/C29H30N4O2/c30-19-24-18-26-27(31-24)12-7-13-28(26)35-21-25(34)20-32-14-16-33(17-15-32)29(22-8-3-1-4-9-22)23-10-5-2-6-11-23/h1-13,18,25,29,31,34H,14-17,20-21H2 D05ZGW DRUGINKE BYBYHCOEAFHGJL-UHFFFAOYSA-N D05ZGW DRUGSMIL C1CN(CCN1CC(COC2=CC=CC3=C2C=C(N3)C#N)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D05ZGW HIGHSTAT Terminated D06AHQ DRUG__ID D06AHQ D06AHQ DRUGCOMP Roche Holding AG D06AHQ DRUGTYPE Small molecular drug D06AHQ DRUGINCH 1S/C28H28N4O2/c1-30(2)15-17-12-13-32-22-11-7-5-9-19(22)24(23(32)14-17)26-25(27(33)29-28(26)34)20-16-31(3)21-10-6-4-8-18(20)21/h4-11,16-17H,12-15H2,1-3H3,(H,29,33,34) D06AHQ DRUGINKE FXGHOAZJQNLNFD-UHFFFAOYSA-N D06AHQ DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C5CC(CCN5C6=CC=CC=C64)CN(C)C D06AHQ HIGHSTAT Terminated D06AKJ DRUG__ID D06AKJ D06AKJ DRUGCOMP Fujisawa Pharmaceutical Co Ltd D06AKJ DRUGTYPE Small molecular drug D06AKJ DRUGINCH 1S/C22H34O7/c1-13(2)6-8-17-21(4,29-17)20-19(26-5)16(10-11-22(20)12-27-22)28-18(25)9-7-15(24)14(3)23/h6-7,9,14-17,19-20,23-24H,8,10-12H2,1-5H3/b9-7+/t14?,15?,16-,17-,19-,20-,21+,22+/m1/s1 D06AKJ DRUGINKE PBVLBMJXKARLBU-VWNABXHMSA-N D06AKJ DRUGSMIL CC(C(C=CC(=O)OC1CCC2(CO2)C(C1OC)C3(C(O3)CC=C(C)C)C)O)O D06AKJ HIGHSTAT Terminated D06AZH DRUG__ID D06AZH D06AZH DRUGCOMP OxyPharma AB D06AZH DRUGTYPE Small molecular drug D06AZH DRUGINCH 1S/C20H22N4/c1-13-11-16-17(12-14(13)2)22-20-19(21-16)15-7-5-6-8-18(15)24(20)10-9-23(3)4/h5-8,11-12H,9-10H2,1-4H3 D06AZH DRUGINKE FPLSGFJELWCFTH-UHFFFAOYSA-N D06AZH DRUGSMIL CC1=CC2=C(C=C1C)N=C3C(=N2)C4=CC=CC=C4N3CCN(C)C D06AZH HIGHSTAT Terminated D06BPF DRUG__ID D06BPF D06BPF DRUGCOMP Sankyo Co Ltd D06BPF DRUGTYPE Small molecular drug D06BPF DRUGINCH 1S/C29H30F6N3O4P/c1-19(28(39,15-38-18-36-17-37-38)24-11-8-21(30)12-25(24)31)43-23-13-40-26(41-14-23)5-3-2-4-20-6-9-22(10-7-20)42-16-29(34,35)27(32)33/h2-12,17-19,23,26-27,39,43H,13-16H2,1H3/b4-2+,5-3+/t19-,23?,26?,28-,43?/m1/s1 D06BPF DRUGINKE GEPIYSMJYAOIAG-CPHRTWTNSA-N D06BPF DRUGSMIL CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)PC3COC(OC3)C=CC=CC4=CC=C(C=C4)OCC(C(F)F)(F)F D06BPF HIGHSTAT Terminated D06BTF DRUG__ID D06BTF D06BTF DRUGCOMP Actelion Pharma. D06BTF DRUGTYPE Small molecular drug D06BTF DRUGINCH 1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1 D06BTF DRUGINKE DKMACHNQISHMDN-RPLLCQBOSA-N D06BTF DRUGSMIL CNC(=O)C(C1=CC=CC=C1)N2CCC3=CC(=C(C=C3C2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC D06BTF HIGHSTAT Terminated D06EQN DRUG__ID D06EQN D06EQN DRUGCOMP Xenova Ltd D06EQN DRUGTYPE Small molecular drug D06EQN DRUGINCH 1S/C39H48FN5O6S/c1-6-12-36-42-33(8-3)38(34(46)19-22-44(37(47)13-7-2)30-14-11-21-41-25-30)45(36)26-29-18-17-28(24-32(29)40)31-15-9-10-16-35(31)52(49,50)43-39(48)51-23-20-27(4)5/h9-11,14-18,21,24-25,27H,6-8,12-13,19-20,22-23,26H2,1-5H3,(H,43,48) D06EQN DRUGINKE QBFKQSDMKSSMRE-UHFFFAOYSA-N D06EQN DRUGSMIL CCCC1=NC(=C(N1CC2=C(C=C(C=C2)C3=CC=CC=C3S(=O)(=O)NC(=O)OCCC(C)C)F)C(=O)CCN(C4=CN=CC=C4)C(=O)CCC)CC D06EQN HIGHSTAT Terminated D06HQG DRUG__ID D06HQG D06HQG DRUGCOMP Schwarz Pharma AG D06HQG DRUGTYPE Small molecular drug D06HQG DRUGINCH 1S/C10H16N2O5S.C5H9NO3/c1-4-16-5-8(6-18)11-9(13)10(2,3)7-17-12(14)15;1-3(5(8)9)6-4(2)7/h4,6,8H,1,5,7H2,2-3H3,(H,11,13);3H,1-2H3,(H,6,7)(H,8,9)/t8-;3-/m10/s1 D06HQG DRUGINKE ZONOMVGGONAQQA-QTBHSTJXSA-N D06HQG DRUGSMIL CC(C(=O)O)NC(=O)C.CC(C)(CO[N+](=O)[O-])C(=O)NC(COC=C)C=S D06HQG HIGHSTAT Terminated D06HYG DRUG__ID D06HYG D06HYG DRUGCOMP BASF AG D06HYG DRUGTYPE Small molecular drug D06HYG DRUGINCH 1S/C22H30N2O2/c1-16(2)23-11-7-8-12-26-22-17(3)24-21(19-14-25-15-20(19)22)13-18-9-5-4-6-10-18/h4-6,9-10,16,23H,7-8,11-15H2,1-3H3 D06HYG DRUGINKE KXSKBNFNSAMNEZ-UHFFFAOYSA-N D06HYG DRUGSMIL CC1=C(C2=C(COC2)C(=N1)CC3=CC=CC=C3)OCCCCNC(C)C D06HYG HIGHSTAT Terminated D06JVU DRUG__ID D06JVU D06JVU DRUGCOMP Abbott Laboratories D06JVU DRUGTYPE Small molecular drug D06JVU DRUGINCH 1S/C48H62N8O13S/c1-4-6-16-36(52-41(57)24-21-30-19-22-33(23-20-30)69-70(66,67)68)44(61)51-29-42(58)53-39(26-32-28-50-35-18-12-11-15-34(32)35)47(64)54-37(17-7-5-2)45(62)55-40(27-43(59)60)48(65)56-46(63)38(49-3)25-31-13-9-8-10-14-31/h8-15,18-20,22-23,28,36-40,49-50H,4-7,16-17,21,24-27,29H2,1-3H3,(H,51,61)(H,52,57)(H,53,58)(H,54,64)(H,55,62)(H,59,60)(H,56,63,65)(H,66,67,68)/t36-,37-,38-,39-,40-/m0/s1 D06JVU DRUGINKE HTISDDBHNNOAGK-HECCNADXSA-N D06JVU DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(=O)C(CC3=CC=CC=C3)NC)NC(=O)CCC4=CC=C(C=C4)OS(=O)(=O)O D06JVU HIGHSTAT Terminated D06KFR DRUG__ID D06KFR D06KFR DRUGCOMP Rhone-Poulenc SA D06KFR DRUGTYPE Small molecular drug D06KFR DRUGINCH 1S/C26H30N4OS/c1-20-19-21(2)30(29-20)17-11-3-4-12-18-32(31)26-27-24(22-13-7-5-8-14-22)25(28-26)23-15-9-6-10-16-23/h5-10,13-16,19H,3-4,11-12,17-18H2,1-2H3,(H,27,28) D06KFR DRUGINKE TVSPJKIQOPZAPE-UHFFFAOYSA-N D06KFR DRUGSMIL CC1=CC(=NN1CCCCCCS(=O)C2=NC(=C(N2)C3=CC=CC=C3)C4=CC=CC=C4)C D06KFR HIGHSTAT Terminated D06LKM DRUG__ID D06LKM D06LKM DRUGCOMP Pfizer D06LKM DRUGTYPE Small molecular drug D06LKM DRUGINCH 1S/C14H17ClN2O.ClH/c15-12-3-1-11(2-4-12)14(18)16-13-9-17-7-5-10(13)6-8-17;/h1-4,10,13H,5-9H2,(H,16,18);1H/t13-;/m0./s1 D06LKM DRUGINKE HSEQUIRZHDYOIX-ZOWNYOTGSA-N D06LKM DRUGSMIL C1CN2CCC1C(C2)NC(=O)C3=CC=C(C=C3)Cl.Cl D06LKM HIGHSTAT Terminated D06MLZ DRUG__ID D06MLZ D06MLZ DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D06MLZ DRUGTYPE Small molecular drug D06MLZ DRUGINCH 1S/C21H25N3O4S/c1-24(13-18-8-7-16-5-3-4-6-21(16)22-18)14-19(25)15-28-20-11-9-17(10-12-20)23-29(2,26)27/h3-12,19,23,25H,13-15H2,1-2H3 D06MLZ DRUGINKE DOUINBOCIFSYBA-UHFFFAOYSA-N D06MLZ DRUGSMIL CN(CC1=NC2=CC=CC=C2C=C1)CC(COC3=CC=C(C=C3)NS(=O)(=O)C)O D06MLZ HIGHSTAT Terminated D06MPF DRUG__ID D06MPF D06MPF DRUGCOMP Schering-Plough Corp D06MPF DRUGTYPE Small molecular drug D06MPF DRUGINCH 1S/C18H15ClN2O/c19-12-5-3-6-13(11-12)21-16-9-2-1-7-14(16)17(22)15-8-4-10-20-18(15)21/h3-6,8,10-11H,1-2,7,9H2 D06MPF DRUGINKE SLPWZBSWUHLVRY-UHFFFAOYSA-N D06MPF DRUGSMIL C1CCC2=C(C1)C(=O)C3=C(N2C4=CC(=CC=C4)Cl)N=CC=C3 D06MPF HIGHSTAT Terminated D06MUI DRUG__ID D06MUI D06MUI DRUGCOMP Abbott Laboratories D06MUI DRUGTYPE Small molecular drug D06MUI DRUGINCH 1S/C23H22N6O2/c1-2-14-29(22-20(23(30)31)8-5-13-24-22)15-16-9-11-17(12-10-16)18-6-3-4-7-19(18)21-25-27-28-26-21/h3-13H,2,14-15H2,1H3,(H,30,31)(H,25,26,27,28) D06MUI DRUGINKE DLMNZGAILMQDHA-UHFFFAOYSA-N D06MUI DRUGSMIL CCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=C(C=CC=N4)C(=O)O D06MUI HIGHSTAT Terminated D06MUZ DRUG__ID D06MUZ D06MUZ DRUGCOMP Novartis AG D06MUZ DRUGTYPE Small molecular drug D06MUZ DRUGINCH 1S/C19H22ClNS.ClH/c1-19(2,3)11-6-5-7-12-21(4)13-15-9-8-10-16-17(20)14-22-18(15)16;/h5,7-10,14H,12-13H2,1-4H3;1H/b7-5+; D06MUZ DRUGINKE INNKFGGCJAUIMK-GZOLSCHFSA-N D06MUZ DRUGSMIL CC(C)(C)C#CC=CCN(C)CC1=C2C(=CC=C1)C(=CS2)Cl.Cl D06MUZ HIGHSTAT Terminated D06PAW DRUG__ID D06PAW D06PAW DRUGCOMP Zambon Co SpA D06PAW DRUGTYPE Small molecular drug D06PAW DRUGINCH 1S/C9H12N2O4/c1-6-5-7(15-11-6)9(14)10-4-2-3-8(12)13/h5H,2-4H2,1H3,(H,10,14)(H,12,13) D06PAW DRUGINKE QVLJRVUEXTYYQK-UHFFFAOYSA-N D06PAW DRUGSMIL CC1=NOC(=C1)C(=O)NCCCC(=O)O D06PAW HIGHSTAT Terminated D06QOK DRUG__ID D06QOK D06QOK DRUGCOMP Dong Wha Pharmaceutical Co Ltd D06QOK DRUGTYPE Small molecular drug D06QOK DRUGINCH 1S/C24H22N4O4S.ClH/c25-19-8-6-17(7-9-19)23(29)27-13-12-18-14-20(10-11-22(18)27)33(31,32)28-15-21(26-24(28)30)16-4-2-1-3-5-16;/h1-11,14,21H,12-13,15,25H2,(H,26,30);1H/t21-;/m1./s1 D06QOK DRUGINKE BNYPEIJMDFCULT-ZMBIFBSDSA-N D06QOK DRUGSMIL C1CN(C2=C1C=C(C=C2)S(=O)(=O)N3CC(NC3=O)C4=CC=CC=C4)C(=O)C5=CC=C(C=C5)N.Cl D06QOK HIGHSTAT Terminated D06QYJ DRUG__ID D06QYJ D06QYJ DRUGCOMP Matrix Therapeutics Ltd D06QYJ DRUGTYPE Small molecular drug D06QYJ DRUGINCH 1S/C204H339N61O55/c1-33-105(24)161(198(317)244-122(48-39-41-73-206)174(293)240-128(59-67-150(210)272)179(298)247-134(78-96(6)7)186(305)242-126(57-65-148(208)270)172(291)229-108(27)166(285)235-125(51-44-76-225-204(220)221)182(301)264-163(107(26)35-3)200(319)258-133(77-95(4)5)183(302)232-110(29)168(287)261-159(103(20)21)196(315)245-132(63-71-157(280)281)178(297)237-124(50-43-75-224-203(218)219)176(295)254-141(85-114-52-54-117(268)55-53-114)190(309)251-136(80-98(10)11)184(303)238-121(47-38-40-72-205)175(294)257-146(90-158(282)283)194(313)234-120(165(215)284)56-64-147(207)269)260-155(277)93-227-170(289)142(86-115-91-226-119-46-37-36-45-118(115)119)259-197(316)160(104(22)23)262-201(320)164(112(31)266)265-195(314)140(84-102(18)19)248-180(299)130(61-69-152(212)274)243-187(306)137(81-99(12)13)250-188(307)138(82-100(14)15)252-191(310)143(87-116-92-222-94-228-116)255-181(300)129(60-68-151(211)273)241-177(296)127(58-66-149(209)271)236-167(286)109(28)230-173(292)131(62-70-156(278)279)246-199(318)162(106(25)34-2)263-169(288)111(30)231-171(290)123(49-42-74-223-202(216)217)239-185(304)135(79-97(8)9)249-189(308)139(83-101(16)17)253-193(312)145(89-154(214)276)256-192(311)144(88-153(213)275)233-113(32)267/h36-37,45-46,52-55,91-92,94-112,120-146,159-164,226,266,268H,33-35,38-44,47-51,56-90,93,205-206H2,1-32H3,(H2,207,269)(H2,208,270)(H2,209,271)(H2,210,272)(H2,211,273)(H2,212,274)(H2,213,275)(H2,214,276)(H2,215,284)(H,222,228)(H,227,289)(H,229,291)(H,230,292)(H,231,290)(H,232,302)(H,233,267)(H,234,313)(H,235,285)(H,236,286)(H,237,297)(H,238,303)(H,239,304)(H,240,293)(H,241,296)(H,242,305)(H,243,306)(H,244,317)(H,245,315)(H,246,318)(H,247,298)(H,248,299)(H,249,308)(H,250,307)(H,251,309)(H,252,310)(H,253,312)(H,254,295)(H,255,300)(H,256,311)(H,257,294)(H,258,319)(H,259,316)(H,260,277)(H,261,287)(H,262,320)(H,263,288)(H,264,301)(H,265,314)(H,278,279)(H,280,281)(H,282,283)(H4,216,217,223)(H4,218,219,224)(H4,220,221,225)/t105-,106-,107-,108-,109-,110-,111-,112+,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,139-,140-,141-,142-,143-,144-,145-,146-,159-,160-,161-,162-,163-,164-/m0/s1 D06QYJ DRUGINKE GNJOBORNQQWCJY-LXRBGHIZSA-N D06QYJ DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(C(C)C)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CN=CN4)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C D06QYJ HIGHSTAT Terminated D06VXY DRUG__ID D06VXY D06VXY DRUGCOMP SmithKline Beecham plc D06VXY DRUGTYPE Small molecular drug D06VXY DRUGINCH 1S/C20H25N3O5/c1-27-18-9-4-15(14-19(18)28-2)10-13-21-11-3-12-22-20(24)16-5-7-17(8-6-16)23(25)26/h4-9,14,21H,3,10-13H2,1-2H3,(H,22,24) D06VXY DRUGINKE XEAKAKKNLOUHDV-UHFFFAOYSA-N D06VXY DRUGSMIL COC1=C(C=C(C=C1)CCNCCCNC(=O)C2=CC=C(C=C2)[N+](=O)[O-])OC D06VXY HIGHSTAT Terminated D06WBA DRUG__ID D06WBA D06WBA DRUGCOMP Squibb Corp D06WBA DRUGTYPE Small molecular drug D06WBA DRUGINCH 1S/C13H17NO3S/c15-12(16)6-7-14-13(17)11(9-18)8-10-4-2-1-3-5-10/h1-5,11,18H,6-9H2,(H,14,17)(H,15,16) D06WBA DRUGINKE ZCTDTVUDURCGFX-UHFFFAOYSA-N D06WBA DRUGSMIL C1=CC=C(C=C1)CC(CS)C(=O)NCCC(=O)O D06WBA HIGHSTAT Terminated D06XAK DRUG__ID D06XAK D06XAK DRUGCOMP Astra AB D06XAK DRUGTYPE Small molecular drug D06XAK DRUGINCH 1S/C25H41N3O6/c29-22-7-12-28(13-8-22)25(31)27-11-10-26-17-23(30)19-34-24-5-3-20(4-6-24)9-14-32-15-16-33-18-21-1-2-21/h3-6,21-23,26,29-30H,1-2,7-19H2,(H,27,31) D06XAK DRUGINKE IWACLEHDBMHXHC-UHFFFAOYSA-N D06XAK DRUGSMIL C1CC1COCCOCCC2=CC=C(C=C2)OCC(CNCCNC(=O)N3CCC(CC3)O)O D06XAK HIGHSTAT Terminated D07DGM DRUG__ID D07DGM D07DGM DRUGCOMP MSD Japan D07DGM DRUGTYPE Small molecular drug D07DGM DRUGINCH 1S/C32H38N6O7S/c1-17(2)13-21-28(41)34-22(14-18-16-33-20-8-4-3-7-19(18)20)29(42)36-23(15-26(39)40)32(45)38-11-5-9-24(38)30(43)37-27(31(44)35-21)25-10-6-12-46-25/h3-4,6-8,10,12,16-17,21-24,27,33H,5,9,11,13-15H2,1-2H3,(H,34,41)(H,35,44)(H,36,42)(H,37,43)(H,39,40)/t21-,22+,23+,24-,27+/m0/s1 D07DGM DRUGINKE KXUDUVUGZWJNHV-QEXRHJMMSA-N D07DGM DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C3=CC=CS3)CC(=O)O)CC4=CNC5=CC=CC=C54 D07DGM HIGHSTAT Terminated D07EGS DRUG__ID D07EGS D07EGS DRUGCOMP Novartis AG D07EGS DRUGTYPE Small molecular drug D07EGS DRUGINCH 1S/C19H21NO5/c1-10(2)15-9-14(5-6-16(15)21)25-17-11(3)7-13(8-12(17)4)20-18(22)19(23)24/h5-10,21H,1-4H3,(H,20,22)(H,23,24) D07EGS DRUGINKE UOJMJBUYXYEPFX-UHFFFAOYSA-N D07EGS DRUGSMIL CC1=CC(=CC(=C1OC2=CC(=C(C=C2)O)C(C)C)C)NC(=O)C(=O)O D07EGS HIGHSTAT Terminated D07GIB DRUG__ID D07GIB D07GIB DRUGCOMP AstraZeneca D07GIB DRUGTYPE Small molecular drug D07GIB DRUGINCH 1S/C31H43F2N3O5S2/c1-4-36(31(37)19-23-5-7-29(8-6-23)42(2,38)39)28-11-14-34(15-12-28)16-13-30(25-20-26(32)22-27(33)21-25)24-9-17-35(18-10-24)43(3,40)41/h5-8,20-22,24,28,30H,4,9-19H2,1-3H3/t30-/m1/s1 D07GIB DRUGINKE QOSMEMHKXNNIGG-SSEXGKCCSA-N D07GIB DRUGSMIL CCN(C1CCN(CC1)CCC(C2CCN(CC2)S(=O)(=O)C)C3=CC(=CC(=C3)F)F)C(=O)CC4=CC=C(C=C4)S(=O)(=O)C D07GIB HIGHSTAT Terminated D07GQA DRUG__ID D07GQA D07GQA DRUGCOMP Zeneca Group plc D07GQA DRUGTYPE Small molecular drug D07GQA DRUGINCH 1S/C26H26N6O/c1-3-19-15-24-22(23(4-2)27-19)13-14-25(33)32(24)16-17-9-11-18(12-10-17)20-7-5-6-8-21(20)26-28-30-31-29-26/h5-12,15H,3-4,13-14,16H2,1-2H3,(H,28,29,30,31) D07GQA DRUGINKE BFVNEYDCFJNLGN-UHFFFAOYSA-N D07GQA DRUGSMIL CCC1=CC2=C(CCC(=O)N2CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=N1)CC D07GQA HIGHSTAT Terminated D07IGE DRUG__ID D07IGE D07IGE DRUGCOMP National Taiwan University D07IGE DRUGTYPE Small molecular drug D07IGE DRUGINCH 1S/C18H19NO7/c1-19-11-8(6-7-9(20)15(11)23-2)13(21)10-12(19)16(24-3)18(26-5)17(25-4)14(10)22/h6-7,20,22H,1-5H3 D07IGE DRUGINKE IHSANOPPEBGTGL-UHFFFAOYSA-N D07IGE DRUGSMIL CN1C2=C(C=CC(=C2OC)O)C(=O)C3=C1C(=C(C(=C3O)OC)OC)OC D07IGE HIGHSTAT Terminated D07IZF DRUG__ID D07IZF D07IZF DRUGCOMP Schering-Plough Corp D07IZF DRUGTYPE Small molecular drug D07IZF DRUGINCH 1S/C25H31N3O2S/c1-30-22-9-13-24(14-10-22)31(29)23-11-7-20(8-12-23)25(19-26)28-17-15-27(16-18-28)21-5-3-2-4-6-21/h7-14,21,25H,2-6,15-18H2,1H3 D07IZF DRUGINKE BFELQLHLUNQIHL-UHFFFAOYSA-N D07IZF DRUGSMIL COC1=CC=C(C=C1)S(=O)C2=CC=C(C=C2)C(C#N)N3CCN(CC3)C4CCCCC4 D07IZF HIGHSTAT Terminated D07JOS DRUG__ID D07JOS D07JOS DRUGCOMP NeuroSearch A/S D07JOS DRUGTYPE Small molecular drug D07JOS DRUGINCH 1S/C14H8ClF3N2O2/c15-8-2-4-12(21)11(6-8)20-10-3-1-7(14(16,17)18)5-9(10)19-13(20)22/h1-6,21H,(H,19,22) D07JOS DRUGINKE WYLYBVMNGZOYOH-UHFFFAOYSA-N D07JOS DRUGSMIL C1=CC2=C(C=C1C(F)(F)F)NC(=O)N2C3=C(C=CC(=C3)Cl)O D07JOS HIGHSTAT Terminated D07JSK DRUG__ID D07JSK D07JSK DRUGCOMP Boehringer Mannheim GmbH D07JSK DRUGTYPE Small molecular drug D07JSK DRUGINCH 1S/C16H17NO5S/c18-16(19)12-22-14-8-6-13(7-9-14)10-11-17-23(20,21)15-4-2-1-3-5-15/h1-9,17H,10-12H2,(H,18,19) D07JSK DRUGINKE XTNWJMVJVSGKLR-UHFFFAOYSA-N D07JSK DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NCCC2=CC=C(C=C2)OCC(=O)O D07JSK HIGHSTAT Terminated D07KIJ DRUG__ID D07KIJ D07KIJ DRUGCOMP Incyte Corp D07KIJ DRUGTYPE Small molecular drug D07KIJ DRUGINCH 1S/C29H34F3N3O6/c1-2-39-25-16-35(21-8-10-28(38,11-9-21)19-6-7-23-24(13-19)41-17-40-23)15-22(25)34-26(36)14-33-27(37)18-4-3-5-20(12-18)29(30,31)32/h3-7,12-13,21-22,25,38H,2,8-11,14-17H2,1H3,(H,33,37)(H,34,36)/t21?,22-,25-,28?/m0/s1 D07KIJ DRUGINKE MZEOSVPWMSEFPW-XYCDVDSTSA-N D07KIJ DRUGSMIL CCOC1CN(CC1NC(=O)CNC(=O)C2=CC(=CC=C2)C(F)(F)F)C3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O D07KIJ HIGHSTAT Terminated D07LEW DRUG__ID D07LEW D07LEW DRUGCOMP Boehringer Ingelheim Corp D07LEW DRUGTYPE Small molecular drug D07LEW DRUGINCH 1S/C32H36N4O3/c1-2-3-13-30-35-28-19-18-25(34-32(39)33-24-9-5-4-6-10-24)20-29(28)36(30)21-22-14-16-23(17-15-22)26-11-7-8-12-27(26)31(37)38/h7-8,11-12,14-20,24H,2-6,9-10,13,21H2,1H3,(H,37,38)(H2,33,34,39) D07LEW DRUGINKE OLQFKFSAJNUOPT-UHFFFAOYSA-N D07LEW DRUGSMIL CCCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2)NC(=O)NC5CCCCC5 D07LEW HIGHSTAT Terminated D07MWY DRUG__ID D07MWY D07MWY DRUGCOMP Xenova Ltd D07MWY DRUGTYPE Small molecular drug D07MWY DRUGINCH 1S/C22H23N3O3/c1-25(2)12-13-28-18-10-8-17(9-11-18)15-20-22(27)23-19(21(26)24-20)14-16-6-4-3-5-7-16/h3-11,14-15H,12-13H2,1-2H3,(H,23,27)(H,24,26)/b19-14+,20-15- D07MWY DRUGINKE SKAOOZAHHYQXKN-WOBBTWAASA-N D07MWY DRUGSMIL CN(C)CCOC1=CC=C(C=C1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2 D07MWY HIGHSTAT Terminated D07OCC DRUG__ID D07OCC D07OCC DRUGCOMP Jerini AG D07OCC DRUGTYPE Small molecular drug D07OCC DRUGINCH 1S/C28H24F3N5O2/c1-16-9-10-32-23(14-36-11-5-7-22(27(36)37)28(29,30)31)21(16)15-38-24-8-4-6-19-20(12-18(3)34-26(19)24)25-17(2)13-33-35-25/h4-13H,14-15H2,1-3H3,(H,33,35) D07OCC DRUGINKE KFVOKCIYVVCZGF-UHFFFAOYSA-N D07OCC DRUGSMIL CC1=C(C(=NC=C1)CN2C=CC=C(C2=O)C(F)(F)F)COC3=CC=CC4=C(C=C(N=C43)C)C5=C(C=NN5)C D07OCC HIGHSTAT Terminated D07OEY DRUG__ID D07OEY D07OEY DRUGCOMP Bayer Schering Pharma AG D07OEY DRUGTYPE Small molecular drug D07OEY DRUGINCH 1S/C21H33ClO5/c1-14-6-2-3-7-15(14)19(23)10-9-17-16(18(22)12-20(17)24)8-4-5-11-27-13-21(25)26/h4-5,9-10,14-20,23-24H,2-3,6-8,11-13H2,1H3,(H,25,26)/b5-4-,10-9+/t14?,15?,16-,17-,18-,19-,20-/m1/s1 D07OEY DRUGINKE JPMWVHYATGJOOX-OSIODEBVSA-N D07OEY DRUGSMIL CC1CCCCC1C(C=CC2C(CC(C2CC=CCOCC(=O)O)Cl)O)O D07OEY HIGHSTAT Terminated D07OLO DRUG__ID D07OLO D07OLO DRUGCOMP GD Searle & Co D07OLO DRUGTYPE Small molecular drug D07OLO DRUGINCH 1S/C7H16N2O/c1-2-3-4-5-9-6-7(8)10/h9H,2-6H2,1H3,(H2,8,10) D07OLO DRUGINKE GJNNXIYZWIZFRH-UHFFFAOYSA-N D07OLO DRUGSMIL CCCCCNCC(=O)N D07OLO HIGHSTAT Terminated D07PLK DRUG__ID D07PLK D07PLK DRUGCOMP Sterling Winthrop Products Inc D07PLK DRUGTYPE Small molecular drug D07PLK DRUGINCH 1S/C40H36N6O4/c47-33-31-21-39(25-15-7-9-17-27(25)43-37(39)45(31)35(49)29(41-33)19-23-11-3-1-4-12-23)40-22-32-34(48)42-30(20-24-13-5-2-6-14-24)36(50)46(32)38(40)44-28-18-10-8-16-26(28)40/h1-18,29-32,37-38,43-44H,19-22H2,(H,41,47)(H,42,48)/t29-,30-,31-,32-,37+,38+,39-,40-/m0/s1 D07PLK DRUGINKE ZEANERNKMXBETI-BJHDJDSNSA-N D07PLK DRUGSMIL C1C2C(=O)NC(C(=O)N2C3C1(C4=CC=CC=C4N3)C56CC7C(=O)NC(C(=O)N7C5NC8=CC=CC=C68)CC9=CC=CC=C9)CC1=CC=CC=C1 D07PLK HIGHSTAT Terminated D07PSP DRUG__ID D07PSP D07PSP DRUGCOMP Pharmacia & Upjohn Co D07PSP DRUGTYPE Small molecular drug D07PSP DRUGINCH 1S/C45H61N7O7/c1-5-29(4)40(45(58)48-25-32-18-11-12-21-47-32)52-44(57)39(28(2)3)42(55)41(54)35(22-30-14-7-6-8-15-30)51-43(56)36(23-33-24-46-27-49-33)50-38(53)26-59-37-20-13-17-31-16-9-10-19-34(31)37/h9-13,16-21,24,27-30,35-36,39-42,54-55H,5-8,14-15,22-23,25-26H2,1-4H3,(H,46,49)(H,48,58)(H,50,53)(H,51,56)(H,52,57)/t29-,35-,36-,39+,40-,41+,42+/m0/s1 D07PSP DRUGINKE ZTKCGLWIXHAITR-JIFWBGJESA-N D07PSP DRUGSMIL CCC(C)C(C(=O)NCC1=CC=CC=N1)NC(=O)C(C(C)C)C(C(C(CC2CCCCC2)NC(=O)C(CC3=CN=CN3)NC(=O)COC4=CC=CC5=CC=CC=C54)O)O D07PSP HIGHSTAT Terminated D07QSA DRUG__ID D07QSA D07QSA DRUGCOMP Pfizer Inc D07QSA DRUGTYPE Small molecular drug D07QSA DRUGINCH 1S/C22H24O4/c1-26-22(25)16-20(24)15-19(23)13-8-14-21(17-9-4-2-5-10-17)18-11-6-3-7-12-18/h2-14,19-20,23-24H,15-16H2,1H3/b13-8+/t19-,20-/m1/s1 D07QSA DRUGINKE NSZBOSJMBQKKKB-ZCBOBATRSA-N D07QSA DRUGSMIL COC(=O)CC(CC(C=CC=C(C1=CC=CC=C1)C2=CC=CC=C2)O)O D07QSA HIGHSTAT Terminated D07SDE DRUG__ID D07SDE D07SDE DRUGCOMP Otsuka Pharmaceutical Co Ltd D07SDE DRUGTYPE Small molecular drug D07SDE DRUGINCH 1S/C25H24N2O6/c1-16-21(24(28)32-3)23(19-12-7-13-20(15-19)27(30)31)22(17(2)26-16)25(29)33-14-8-11-18-9-5-4-6-10-18/h4-13,15,23,26H,14H2,1-3H3/b11-8+ D07SDE DRUGINKE XTFPDGZNWTZCMF-DHZHZOJOSA-N D07SDE DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC D07SDE HIGHSTAT Terminated D07SXO DRUG__ID D07SXO D07SXO DRUGCOMP Chugai Pharmaceutical Co Ltd D07SXO DRUGTYPE Small molecular drug D07SXO DRUGINCH 1S/C31H36N4O5/c1-5-39-28(40-6-2)20-35-26-10-8-7-9-25(26)31(29(35)37,19-27(36)32-23-15-11-21(3)12-16-23)34-30(38)33-24-17-13-22(4)14-18-24/h7-18,28H,5-6,19-20H2,1-4H3,(H,32,36)(H2,33,34,38)/t31-/m1/s1 D07SXO DRUGINKE KOLPMNSDISYEBU-WJOKGBTCSA-N D07SXO DRUGSMIL CCOC(CN1C2=CC=CC=C2C(C1=O)(CC(=O)NC3=CC=C(C=C3)C)NC(=O)NC4=CC=C(C=C4)C)OCC D07SXO HIGHSTAT Terminated D07XHJ DRUG__ID D07XHJ D07XHJ DRUGCOMP Takeda Pharmaceutical Co Ltd D07XHJ DRUGTYPE Small molecular drug D07XHJ DRUGINCH 1S/C6H8N2O4/c7-4(5(9)10)1-3-2-8-12-6(3)11/h2,4,8H,1,7H2,(H,9,10)/t4-/m0/s1 D07XHJ DRUGINKE LVNJBTYSYFSYFG-BYPYZUCNSA-N D07XHJ DRUGSMIL C1=C(C(=O)ON1)CC(C(=O)O)N D07XHJ HIGHSTAT Terminated D07YUY DRUG__ID D07YUY D07YUY DRUGCOMP Hoechst Marion Roussel Inc D07YUY DRUGTYPE Small molecular drug D07YUY DRUGINCH 1S/C29H44O2S2/c1-26(2,3)20-13-18(14-21(24(20)30)27(4,5)6)32-17-33-19-15-22(28(7,8)9)25(31)23(16-19)29(10,11)12/h13-16,30-31H,17H2,1-12H3 D07YUY DRUGINKE GAABJUNZYPATIQ-UHFFFAOYSA-N D07YUY DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCSC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C D07YUY HIGHSTAT Terminated D08BCU DRUG__ID D08BCU D08BCU DRUGCOMP Pharmacia & Upjohn Co D08BCU DRUGTYPE Small molecular drug D08BCU DRUGINCH 1S/C17H13ClN6O/c18-10-3-4-12-11(7-10)15-19-5-6-23(15)17-13(20-8-24(12)17)14-21-16(25-22-14)9-1-2-9/h3-4,7-9H,1-2,5-6H2 D08BCU DRUGINKE CLPSAAPUJUVQPP-UHFFFAOYSA-N D08BCU DRUGSMIL C1CC1C2=NC(=NO2)C3=C4N5CCN=C5C6=C(N4C=N3)C=CC(=C6)Cl D08BCU HIGHSTAT Terminated D08EIX DRUG__ID D08EIX D08EIX DRUGCOMP Tanabe Seiyaku Co Ltd D08EIX DRUGTYPE Small molecular drug D08EIX DRUGINCH 1S/C21H19NO5/c1-25-17-11-14(12-18(26-2)19(17)27-3)10-16-15(20(23)22-21(16)24)9-13-7-5-4-6-8-13/h4-12H,1-3H3,(H,22,23,24)/b15-9+,16-10+ D08EIX DRUGINKE YQALUFAJAWGTQV-KAVGSWPWSA-N D08EIX DRUGSMIL COC1=CC(=CC(=C1OC)OC)C=C2C(=CC3=CC=CC=C3)C(=O)NC2=O D08EIX HIGHSTAT Terminated D08ELM DRUG__ID D08ELM D08ELM DRUGCOMP RW Johnson Pharmaceutical Research Institute D08ELM DRUGTYPE Small molecular drug D08ELM DRUGINCH 1S/C40H42Cl2F2N8O3/c41-30-9-6-10-31(42)29(30)23-52-37-21-27(12-13-28(37)36(50-52)24-51-17-4-5-18-51)47-40(55)49-35(20-26-11-14-32(43)33(44)19-26)39(54)48-34(15-16-45)38(53)46-22-25-7-2-1-3-8-25/h1-3,6-14,19,21,34-35H,4-5,15-18,20,22-24,45H2,(H,46,53)(H,48,54)(H2,47,49,55)/t34-,35-/m0/s1 D08ELM DRUGINKE KEDDGIDZMJSBEW-PXLJZGITSA-N D08ELM DRUGSMIL C1CCN(C1)CC2=NN(C3=C2C=CC(=C3)NC(=O)NC(CC4=CC(=C(C=C4)F)F)C(=O)NC(CCN)C(=O)NCC5=CC=CC=C5)CC6=C(C=CC=C6Cl)Cl D08ELM HIGHSTAT Terminated D08FAT DRUG__ID D08FAT D08FAT DRUGCOMP Kayaku Co Ltd D08FAT DRUGTYPE Small molecular drug D08FAT DRUGINCH 1S/C7H11N3O5/c11-3-6(4-12)15-5-9-2-1-8-7(9)10(13)14/h1-2,6,11-12H,3-5H2 D08FAT DRUGINKE DWSFCAKOSWFTCK-UHFFFAOYSA-N D08FAT DRUGSMIL C1=CN(C(=N1)[N+](=O)[O-])COC(CO)CO D08FAT HIGHSTAT Terminated D08GNA DRUG__ID D08GNA D08GNA DRUGCOMP SmithKline Beecham plc D08GNA DRUGTYPE Small molecular drug D08GNA DRUGINCH 1S/C23H44N2/c1-3-9-22(10-4-2)11-13-23(14-12-22)15-20-25(21-23)19-8-18-24-16-6-5-7-17-24/h3-21H2,1-2H3 D08GNA DRUGINKE FPYDSYNEQOHKET-UHFFFAOYSA-N D08GNA DRUGSMIL CCCC1(CCC2(CC1)CCN(C2)CCCN3CCCCC3)CCC D08GNA HIGHSTAT Terminated D08GQK DRUG__ID D08GQK D08GQK DRUGCOMP Fujisawa Pharmaceutical Co Ltd D08GQK DRUGTYPE Small molecular drug D08GQK DRUGINCH 1S/C18H24N2O5S/c1-11(21)7-5-4-6-8-15-19-13(10-26-15)16-17(25-3)14(24-2)9-12(20-16)18(22)23/h9-11,21H,4-8H2,1-3H3,(H,22,23) D08GQK DRUGINKE RGHLFUKUTGFTCO-UHFFFAOYSA-N D08GQK DRUGSMIL CC(CCCCCC1=NC(=CS1)C2=C(C(=CC(=N2)C(=O)O)OC)OC)O D08GQK HIGHSTAT Terminated D08HDD DRUG__ID D08HDD D08HDD DRUGCOMP Rhone-Poulenc SA D08HDD DRUGTYPE Small molecular drug D08HDD DRUGINCH 1S/C20H25N3O3/c1-14(9-10-23-13-22-16-5-3-4-6-17(16)23)21-12-19(25)15-7-8-18(24)20(11-15)26-2/h3-8,11,13-14,19,21,24-25H,9-10,12H2,1-2H3 D08HDD DRUGINKE NKKPVWPMPWLEMY-UHFFFAOYSA-N D08HDD DRUGSMIL CC(CCN1C=NC2=CC=CC=C21)NCC(C3=CC(=C(C=C3)O)OC)O D08HDD HIGHSTAT Terminated D08IHF DRUG__ID D08IHF D08IHF DRUGCOMP Abbott Laboratories D08IHF DRUGTYPE Small molecular drug D08IHF DRUGINCH 1S/C25H25FN4O5.ClH/c1-2-6-16(27)24(32)28-19-9-5-10-29(19)21-15(26)11-13-20-23(21)35-18-8-4-3-7-17(18)30(20)12-14(22(13)31)25(33)34;/h3-4,7-8,11-12,16,19H,2,5-6,9-10,27H2,1H3,(H,28,32)(H,33,34);1H D08IHF DRUGINKE UFBYBJURMXBKFU-UHFFFAOYSA-N D08IHF DRUGSMIL CCCC(C(=O)NC1CCCN1C2=C(C=C3C4=C2OC5=CC=CC=C5N4C=C(C3=O)C(=O)O)F)N.Cl D08IHF HIGHSTAT Terminated D08KXE DRUG__ID D08KXE D08KXE DRUGCOMP Rhone-Poulenc SA D08KXE DRUGTYPE Small molecular drug D08KXE DRUGINCH 1S/C29H30N2O2/c1-33-27-15-9-8-10-21(27)18-28(30)31-19-24-25(20-31)29(17-16-26(24)32,22-11-4-2-5-12-22)23-13-6-3-7-14-23/h2-15,24-25,30H,16-20H2,1H3/t24-,25+/m0/s1 D08KXE DRUGINKE VWBOQFANCXZMAU-LOSJGSFVSA-N D08KXE DRUGSMIL COC1=CC=CC=C1CC(=N)N2CC3C(C2)C(CCC3=O)(C4=CC=CC=C4)C5=CC=CC=C5 D08KXE HIGHSTAT Terminated D08LDG DRUG__ID D08LDG D08LDG DRUGCOMP Organon BioSciences D08LDG DRUGTYPE Small molecular drug D08LDG DRUGINCH 1S/C50H75N9O10S/c1-5-8-12-24-36(23-9-6-2)69-50(67)43(70(4)68)30-41(56-44(60)37(52)7-3)48(64)58-40(29-35-31-53-32-54-35)47(63)57-39(27-33-19-13-10-14-20-33)46(62)55-38(25-17-18-26-51)45(61)59-42(49(65)66)28-34-21-15-11-16-22-34/h10-11,13-16,19-22,31-32,35-43H,5-9,12,17-18,23-30,51-52H2,1-4H3,(H,55,62)(H,56,60)(H,57,63)(H,58,64)(H,59,61)(H,65,66)/t35?,36?,37?,38-,39+,40+,41+,42+,43?,70?/m1/s1 D08LDG DRUGINKE WRSKQNYFHKIVPM-LDOUIJQZSA-N D08LDG DRUGSMIL CCCCCC(CCCC)OC(=O)C(CC(C(=O)NC(CC1C=NC=N1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC)N)S(=O)C D08LDG HIGHSTAT Terminated D08LHE DRUG__ID D08LHE D08LHE DRUGCOMP Rhone-Poulenc SA D08LHE DRUGTYPE Small molecular drug D08LHE DRUGINCH 1S/C13H14N4O2/c1-17-7-9-6-8(2-3-10(9)14-13(17)19)11-4-5-12(18)16-15-11/h2-3,6H,4-5,7H2,1H3,(H,14,19)(H,16,18) D08LHE DRUGINKE SUCNEHPNQBBVHQ-UHFFFAOYSA-N D08LHE DRUGSMIL CN1CC2=C(C=CC(=C2)C3=NNC(=O)CC3)NC1=O D08LHE HIGHSTAT Terminated D08LUT DRUG__ID D08LUT D08LUT DRUGCOMP Abbott Laboratories D08LUT DRUGTYPE Small molecular drug D08LUT DRUGINCH 1S/C22H19BrN6O/c23-16-3-1-2-14(10-16)17-11-18(28-22-20(17)21(24)26-13-27-22)15-4-5-19(25-12-15)29-6-8-30-9-7-29/h1-5,10-13H,6-9H2,(H2,24,26,27,28) D08LUT DRUGINKE RQCXKDWOCUJWQZ-UHFFFAOYSA-N D08LUT DRUGSMIL C1COCCN1C2=NC=C(C=C2)C3=NC4=NC=NC(=C4C(=C3)C5=CC(=CC=C5)Br)N D08LUT HIGHSTAT Terminated D08MLG DRUG__ID D08MLG D08MLG DRUGCOMP Picower Institute for Medical Research D08MLG DRUGTYPE Small molecular drug D08MLG DRUGINCH 1S/C16H18N4O2.ClH/c1-9-5-15(19-16(17)20(9)4)18-14-7-12(10(2)21)6-13(8-14)11(3)22;/h5-8H,1-4H3,(H2,17,18,19);1H D08MLG DRUGINKE MPCCEBBDYNZILE-UHFFFAOYSA-N D08MLG DRUGSMIL CC1=CC(=NC2=CC(=CC(=C2)C(=O)C)C(=O)C)N=C(N1C)N.Cl D08MLG HIGHSTAT Terminated D08MVK DRUG__ID D08MVK D08MVK DRUGCOMP The Green Cross Corp D08MVK DRUGTYPE Small molecular drug D08MVK DRUGINCH 1S/C10H10ClN5S/c1-13-10(17)16-9(12)14-8(15-16)6-2-4-7(11)5-3-6/h2-5H,1H3,(H,13,17)(H2,12,14,15) D08MVK DRUGINKE PWDDJOGPFSDPEK-UHFFFAOYSA-N D08MVK DRUGSMIL CNC(=S)N1C(=NC(=N1)C2=CC=C(C=C2)Cl)N D08MVK HIGHSTAT Terminated D08QTP DRUG__ID D08QTP D08QTP DRUGCOMP Bristol-Myers Squibb D08QTP DRUGTYPE Small molecular drug D08QTP DRUGINCH 1S/C21H23N5O2/c27-12-4-3-11-24-17-6-2-1-5-16(17)23-20(24)14-25-19-13-22-10-9-18(19)26(21(25)28)15-7-8-15/h1-2,5-6,9-10,13,15,27H,3-4,7-8,11-12,14H2 D08QTP DRUGINKE KSHJXDWYTZJUEI-UHFFFAOYSA-N D08QTP DRUGSMIL C1CC1N2C3=C(C=NC=C3)N(C2=O)CC4=NC5=CC=CC=C5N4CCCCO D08QTP HIGHSTAT Terminated D08ULI DRUG__ID D08ULI D08ULI DRUGCOMP Organon BioSciences D08ULI DRUGTYPE Small molecular drug D08ULI DRUGINCH 1S/C21H30O2/c1-4-21(23)10-8-18-19-13(2)11-14-12-15(22)5-6-16(14)17(19)7-9-20(18,21)3/h1,13,15,17-19,22-23H,5-12H2,2-3H3/t13-,15-,17-,18+,19-,20+,21+/m1/s1 D08ULI DRUGINKE YLEUWNOTNJZCBN-CZTKNSHGSA-N D08ULI DRUGSMIL CC1CC2=C(CCC(C2)O)C3C1C4CCC(C4(CC3)C)(C#C)O D08ULI HIGHSTAT Terminated D08VTA DRUG__ID D08VTA D08VTA DRUGCOMP Bristol-Myers Squibb Pharma Co D08VTA DRUGTYPE Small molecular drug D08VTA DRUGINCH 1S/C25H26ClN3O5.Na/c1-3-4-9-20-28-22(26)21(15(2)24(31)32)29(20)14-16-10-12-17(13-11-16)27-23(30)18-7-5-6-8-19(18)25(33)34;/h5-8,10-13,15H,3-4,9,14H2,1-2H3,(H,27,30)(H,31,32)(H,33,34);/q;+1/p-1 D08VTA DRUGINKE OSDQJFVHDVAJSD-UHFFFAOYSA-M D08VTA DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)NC(=O)C3=CC=CC=C3C(=O)O)C(C)C(=O)[O-])Cl.[Na+] D08VTA HIGHSTAT Terminated D08VWL DRUG__ID D08VWL D08VWL DRUGCOMP SmithKline Beecham plc D08VWL DRUGTYPE Small molecular drug D08VWL DRUGINCH 1S/C10H8N4O3S.Na/c1-13-3-5(11-12-13)2-6-8(15)14-7(10(16)17)4-18-9(6)14;/h2-4,9H,1H3,(H,16,17);/q;+1/p-1/b6-2-;/t9-;/m1./s1 D08VWL DRUGINKE OMJBLZMKGVWHQP-VKVLVNHFSA-M D08VWL DRUGSMIL CN1C=C(N=N1)C=C2C3N(C2=O)C(=CS3)C(=O)[O-].[Na+] D08VWL HIGHSTAT Terminated D09BHF DRUG__ID D09BHF D09BHF DRUGCOMP Fujisawa Pharmaceutical Co Ltd D09BHF DRUGTYPE Small molecular drug D09BHF DRUGINCH 1S/C19H20N2O8/c22-8-20-7-16(26)10-1-3-14(24)12(5-10)13-6-11(2-4-15(13)25)18(27)17(19(28)29)21-9-23/h1-6,8-9,16-18,24-27H,7H2,(H,20,22)(H,21,23)(H,28,29) D09BHF DRUGINKE WQVWUCSBLUJLNT-UHFFFAOYSA-N D09BHF DRUGSMIL C1=CC(=C(C=C1C(CNC=O)O)C2=C(C=CC(=C2)C(C(C(=O)O)NC=O)O)O)O D09BHF HIGHSTAT Terminated D09BKE DRUG__ID D09BKE D09BKE THERCLAS Analgesics D09BKE DRUGTYPE Small molecular drug D09BKE DRUGINCH 1S/C13H18N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h7-9,11,14H,2-6H2,1H3 D09BKE DRUGINKE KTDZCOWXCWUPEO-UHFFFAOYSA-N D09BKE DRUGSMIL CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2CCCCC2 D09BKE HIGHSTAT Terminated D09BRE DRUG__ID D09BRE D09BRE DRUGCOMP Pharmacia & Upjohn Co D09BRE DRUGTYPE Small molecular drug D09BRE DRUGINCH 1S/C30H44N6O2.2ClH/c1-21-22(2)28-24(23(3)27(21)37)9-10-30(4,38-28)20-33-15-17-35(18-16-33)26-19-25(34-11-5-6-12-34)31-29(32-26)36-13-7-8-14-36;;/h19,37H,5-18,20H2,1-4H3;2*1H D09BRE DRUGINKE KJGXSMZHYBXPIS-UHFFFAOYSA-N D09BRE DRUGSMIL CC1=C(C2=C(CCC(O2)(C)CN3CCN(CC3)C4=NC(=NC(=C4)N5CCCC5)N6CCCC6)C(=C1O)C)C.Cl.Cl D09BRE HIGHSTAT Terminated D09BVL DRUG__ID D09BVL D09BVL DRUGCOMP NeuroSearch A/S D09BVL DRUGTYPE Small molecular drug D09BVL DRUGINCH 1S/C15H8F6N2O2/c16-14(17,18)7-1-3-10-9(5-7)22-13(25)23(10)11-6-8(15(19,20)21)2-4-12(11)24/h1-6,24H,(H,22,25) D09BVL DRUGINKE YLFMCMWKHSDUCT-UHFFFAOYSA-N D09BVL DRUGSMIL C1=CC2=C(C=C1C(F)(F)F)NC(=O)N2C3=C(C=CC(=C3)C(F)(F)F)O D09BVL HIGHSTAT Terminated D09BWC DRUG__ID D09BWC D09BWC DRUGCOMP Eisai Co Ltd D09BWC DRUGTYPE Small molecular drug D09BWC DRUGINCH 1S/C27H34N4O3.2ClH/c1-30(16-12-23-18-25(33-2)20-26(19-23)34-3)15-5-13-29-27(32)7-4-6-22-8-10-24(11-9-22)31-17-14-28-21-31;;/h4,6,8-11,14,17-21H,5,7,12-13,15-16H2,1-3H3,(H,29,32);2*1H/b6-4+;; D09BWC DRUGINKE KKUNFGOKUGASRQ-SLNOCBGISA-N D09BWC DRUGSMIL CN(CCCNC(=O)CC=CC1=CC=C(C=C1)N2C=CN=C2)CCC3=CC(=CC(=C3)OC)OC.Cl.Cl D09BWC HIGHSTAT Terminated D09DRG DRUG__ID D09DRG D09DRG DRUGCOMP Taisho D09DRG DRUGTYPE Small molecular drug D09DRG DRUGINCH 1S/C23H33NO2.ClH/c1-4-15-24(16-5-2)17-13-21-11-12-22(25-3)23(19-21)26-18-14-20-9-7-6-8-10-20;/h6-12,19H,4-5,13-18H2,1-3H3;1H D09DRG DRUGINKE ZHGMDXSHODHWHV-UHFFFAOYSA-N D09DRG DRUGSMIL CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl D09DRG HIGHSTAT Terminated D09HIC DRUG__ID D09HIC D09HIC DRUGCOMP Biofor Inc D09HIC DRUGTYPE Small molecular drug D09HIC DRUGINCH 1S/C18H27NO2/c1-17(2,3)13-10-12(19-9-7-8-15(19)20)11-14(16(13)21)18(4,5)6/h10-11,21H,7-9H2,1-6H3 D09HIC DRUGINKE OWJSEESROFTAQV-UHFFFAOYSA-N D09HIC DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)N2CCCC2=O D09HIC HIGHSTAT Terminated D09JYF DRUG__ID D09JYF D09JYF DRUGCOMP Bristol-Myers Squibb Co D09JYF DRUGTYPE Small molecular drug D09JYF DRUGINCH 1S/C22H27NO4/c1-11(2)7-8-22(4)21(27-22)17-12(3)16(26)9-14-18-13(10-24)5-6-15(25)20(18)23-19(14)17/h5-6,9,11,21,23-26H,7-8,10H2,1-4H3 D09JYF DRUGINKE JFHJFCCMTNIENN-UHFFFAOYSA-N D09JYF DRUGSMIL CC1=C(C=C2C3=C(C=CC(=C3NC2=C1C4C(O4)(C)CCC(C)C)O)CO)O D09JYF HIGHSTAT Terminated D09LQP DRUG__ID D09LQP D09LQP DRUGCOMP Rhone-Poulenc SA D09LQP DRUGTYPE Small molecular drug D09LQP DRUGINCH 1S/C29H27NO4/c1-30(16-15-21-9-4-2-5-10-21)28(31)19-23-17-24(29(32)33)18-26-25(23)13-8-14-27(26)34-20-22-11-6-3-7-12-22/h2-14,17-18H,15-16,19-20H2,1H3,(H,32,33) D09LQP DRUGINKE VPJQGXIZXVPFOC-UHFFFAOYSA-N D09LQP DRUGSMIL CN(CCC1=CC=CC=C1)C(=O)CC2=C3C=CC=C(C3=CC(=C2)C(=O)O)OCC4=CC=CC=C4 D09LQP HIGHSTAT Terminated D09OTG DRUG__ID D09OTG D09OTG DRUGCOMP Schering AG D09OTG DRUGTYPE Small molecular drug D09OTG DRUGINCH 1S/C18H26ClN3O2/c1-24-13-12-20-8-10-21(11-9-20)14-15-6-7-22(18(15)23)17-4-2-16(19)3-5-17/h2-5,15H,6-14H2,1H3/t15-/m1/s1 D09OTG DRUGINKE DKVVPXLIRYCKCS-OAHLLOKOSA-N D09OTG DRUGSMIL COCCN1CCN(CC1)CC2CCN(C2=O)C3=CC=C(C=C3)Cl D09OTG HIGHSTAT Terminated D09PEV DRUG__ID D09PEV D09PEV DRUGCOMP Pharmacia & Upjohn Co D09PEV DRUGTYPE Small molecular drug D09PEV DRUGINCH 1S/C18H14F3NO2S/c1-23-13-7-3-11(4-8-13)15-16(25-17(22-15)18(19,20)21)12-5-9-14(24-2)10-6-12/h3-10H,1-2H3 D09PEV DRUGINKE CIPBQTCSXVEDSG-UHFFFAOYSA-N D09PEV DRUGSMIL COC1=CC=C(C=C1)C2=C(SC(=N2)C(F)(F)F)C3=CC=C(C=C3)OC D09PEV HIGHSTAT Terminated D09PRY DRUG__ID D09PRY D09PRY DRUGCOMP KS Biomedix Holdings plc D09PRY DRUGTYPE Small molecular drug D09PRY DRUGINCH 1S/C9H9Cl2NO2/c10-5-6-14-9(13)12-8-3-1-7(11)2-4-8/h1-4H,5-6H2,(H,12,13) D09PRY DRUGINKE ZJFHLTWUBUCUGP-UHFFFAOYSA-N D09PRY DRUGSMIL C1=CC(=CC=C1NC(=O)OCCCl)Cl D09PRY HIGHSTAT Terminated D09PTL DRUG__ID D09PTL D09PTL DRUGCOMP Southern Research Institute D09PTL DRUGTYPE Small molecular drug D09PTL DRUGINCH 1S/C32H40N6O2/c1-6-38(7-2)21-22(4)19-23(5)33-26-20-27(35-32(39)40-8-3)34-31-30(26)36-28(24-15-11-9-12-16-24)29(37-31)25-17-13-10-14-18-25/h9-18,20,22-23H,6-8,19,21H2,1-5H3,(H2,33,34,35,37,39) D09PTL DRUGINKE MKJUVACMILVNTO-UHFFFAOYSA-N D09PTL DRUGSMIL CCN(CC)CC(C)CC(C)NC1=CC(=NC2=C1N=C(C(=N2)C3=CC=CC=C3)C4=CC=CC=C4)NC(=O)OCC D09PTL HIGHSTAT Terminated D09QOF DRUG__ID D09QOF D09QOF DRUGCOMP Eisai Co Ltd D09QOF DRUGTYPE Small molecular drug D09QOF DRUGINCH 1S/C32H57N5O16P2/c1-20(2)13-11-9-7-5-4-6-8-10-12-15-35(3)53-55(48,49)37(17-23(33)39)54(46,47)52-30-27(43)25(41)21(18-38)29(30)50-19-22-26(42)28(44)31(51-22)36-16-14-24(40)34-32(36)45/h14,16,20,22,25-28,30-31,38,41-44H,4-13,15,17-19H2,1-3H3,(H2,33,39)(H,46,47)(H,48,49)(H,34,40,45) D09QOF DRUGINKE MTKDUTOCKQTOED-UHFFFAOYSA-N D09QOF DRUGSMIL CC(C)CCCCCCCCCCCN(C)OP(=O)(N(CC(=O)N)P(=O)(O)OC1C(C(C(=C1OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)CO)O)O)O D09QOF HIGHSTAT Terminated D09RTF DRUG__ID D09RTF D09RTF DRUGCOMP University of Toronto D09RTF DRUGTYPE Small molecular drug D09RTF DRUGINCH 1S/C14H16O4/c1-9(2)7-12(15)11-8-10(14(16)18-4)5-6-13(11)17-3/h5-8H,1-4H3 D09RTF DRUGINKE OBVVORXDELICKT-UHFFFAOYSA-N D09RTF DRUGSMIL CC(=CC(=O)C1=C(C=CC(=C1)C(=O)OC)OC)C D09RTF HIGHSTAT Terminated D09SCI DRUG__ID D09SCI D09SCI DRUGCOMP SmithKline Beecham plc D09SCI DRUGTYPE Small molecular drug D09SCI DRUGINCH 1S/C17H14FN3/c18-14-5-3-12(4-6-14)16-17(13-7-9-19-10-8-13)21-11-1-2-15(21)20-16/h3-10H,1-2,11H2 D09SCI DRUGINKE GJFVAEMLAFFGDZ-UHFFFAOYSA-N D09SCI DRUGSMIL C1CC2=NC(=C(N2C1)C3=CC=NC=C3)C4=CC=C(C=C4)F D09SCI HIGHSTAT Terminated D09VHA DRUG__ID D09VHA D09VHA DRUGCOMP Beiersdorf AG D09VHA DRUGTYPE Small molecular drug D09VHA DRUGINCH 1S/C28H27N3O3/c29-15-22-14-25-26(30-22)12-7-13-27(25)34-19-23(32)18-33-24-16-31(17-24)28(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-14,23-24,28,30,32H,16-19H2 D09VHA DRUGINKE KQQFGABYYXEKDM-UHFFFAOYSA-N D09VHA DRUGSMIL C1C(CN1C(C2=CC=CC=C2)C3=CC=CC=C3)OCC(COC4=CC=CC5=C4C=C(N5)C#N)O D09VHA HIGHSTAT Terminated D09XPJ DRUG__ID D09XPJ D09XPJ DRUGCOMP Shionogi & Co Ltd D09XPJ DRUGTYPE Small molecular drug D09XPJ DRUGINCH 1S/C27H39N3O4S3.Zn/c1-6-7-8-10-16-11-9-12-19(31)20(16)22-28-17(13-35-22)23-30(5)18(14-36-23)21(32)26(2,3)24-29-27(4,15-37-24)25(33)34;/h9,11-12,17-18,21,23,31-32H,6-8,10,13-15H2,1-5H3,(H,33,34);/q;+2/p-2/t17-,18+,21+,23-,27-;/m1./s1 D09XPJ DRUGINKE KZAWXYROUMCPEQ-LRLOAOIRSA-L D09XPJ DRUGSMIL CCCCCC1=C(C(=CC=C1)[O-])C2=NC(CS2)C3N(C(CS3)C(C(C)(C)C4=NC(CS4)(C)C(=O)[O-])O)C.[Zn+2] D09XPJ HIGHSTAT Terminated D09YUQ DRUG__ID D09YUQ D09YUQ DRUGCOMP Sanofi D09YUQ DRUGTYPE Small molecular drug D09YUQ DRUGINCH 1S/C24H28O4/c1-22(2)11-12-23(3,4)20-15-18(9-10-19(20)22)24(27-13-14-28-24)17-7-5-16(6-8-17)21(25)26/h5-10,15H,11-14H2,1-4H3,(H,25,26) D09YUQ DRUGINKE ZZUKALQMHNSWTK-UHFFFAOYSA-N D09YUQ DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C3(OCCO3)C4=CC=C(C=C4)C(=O)O)(C)C)C D09YUQ HIGHSTAT Terminated D09ZVR DRUG__ID D09ZVR D09ZVR DRUGCOMP Hoechst Marion Roussel Inc D09ZVR DRUGTYPE Small molecular drug D09ZVR DRUGINCH 1S/C25H42O4S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-21-16-15-20-17-18-23(28)29-24(20)25(21)30-19-22(26)27/h14,20,24-25H,2-13,15-19H2,1H3,(H,26,27)/b21-14+/t20-,24-,25-/m1/s1 D09ZVR DRUGINKE GKTHCWOVKAXGOW-HTJMSZESSA-N D09ZVR DRUGSMIL CCCCCCCCCCCCCC=C1CCC2CCC(=O)OC2C1SCC(=O)O D09ZVR HIGHSTAT Terminated D0A3OF DRUG__ID D0A3OF D0A3OF DRUGCOMP Merck KGaA D0A3OF DRUGTYPE Small molecular drug D0A3OF DRUGINCH 1S/C19H18F3N3O4S/c1-24-8-10-25(11-9-24)18-14-12-13(29-30(26,27)19(20,21)22)6-7-16(14)28-17-5-3-2-4-15(17)23-18/h2-7,12H,8-11H2,1H3 D0A3OF DRUGINKE DQNCRNVCBHYBQP-UHFFFAOYSA-N D0A3OF DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)OS(=O)(=O)C(F)(F)F D0A3OF HIGHSTAT Terminated D0A5ZJ DRUG__ID D0A5ZJ D0A5ZJ DRUGCOMP Dong Wha Pharmaceutical Co Ltd D0A5ZJ DRUGTYPE Small molecular drug D0A5ZJ DRUGINCH 1S/C25H31N3O3S/c1-17(2)24-23(27-18(3)32-24)19-7-11-21(12-8-19)30-15-5-4-6-16-31-22-13-9-20(10-14-22)25(26)28-29/h7-14,17,29H,4-6,15-16H2,1-3H3,(H2,26,28) D0A5ZJ DRUGINKE JDXVNCOKDAGOAM-UHFFFAOYSA-N D0A5ZJ DRUGSMIL CC1=NC(=C(S1)C(C)C)C2=CC=C(C=C2)OCCCCCOC3=CC=C(C=C3)C(=NO)N D0A5ZJ HIGHSTAT Terminated D0A6PL DRUG__ID D0A6PL D0A6PL DRUGCOMP Servier D0A6PL DRUGTYPE Small molecular drug D0A6PL DRUGINCH 1S/C24H26FN3O2/c1-30-21-10-7-18-3-2-4-23(22(18)17-21)28-15-13-27(14-16-28)12-11-26-24(29)19-5-8-20(25)9-6-19/h2-10,17H,11-16H2,1H3,(H,26,29) D0A6PL DRUGINKE IFMQODYDAUKKEN-UHFFFAOYSA-N D0A6PL DRUGSMIL COC1=CC2=C(C=CC=C2N3CCN(CC3)CCNC(=O)C4=CC=C(C=C4)F)C=C1 D0A6PL HIGHSTAT Terminated D0A8BK DRUG__ID D0A8BK D0A8BK DRUGCOMP The Menarini Group D0A8BK DRUGTYPE Small molecular drug D0A8BK DRUGINCH 1S/C16H14N4S2/c1-3-20-13-12-11(7-5-8-17-12)22-14(13)16(21)19(2)10-6-4-9-18-15(10)20/h4-9H,3H2,1-2H3 D0A8BK DRUGINKE YRSMQXBXGMENSN-UHFFFAOYSA-N D0A8BK DRUGSMIL CCN1C2=C(C(=S)N(C3=C1N=CC=C3)C)SC4=C2N=CC=C4 D0A8BK HIGHSTAT Terminated D0A8HL DRUG__ID D0A8HL D0A8HL DRUGCOMP Bristol-Myers Squibb Pharma Co D0A8HL DRUGTYPE Small molecular drug D0A8HL DRUGINCH 1S/C23H24N6O2/c1-3-7-20-24-19(4-2)21(23(30)31)29(20)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-25-27-28-26-22/h5-6,8-13H,3-4,7,14H2,1-2H3,(H,30,31)(H,25,26,27,28) D0A8HL DRUGINKE OFYWYKMCRWMPPQ-UHFFFAOYSA-N D0A8HL DRUGSMIL CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)CC D0A8HL HIGHSTAT Terminated D0AD9Y DRUG__ID D0AD9Y D0AD9Y DRUGCOMP Genethon D0AD9Y DRUGTYPE Small molecular drug D0AD9Y DRUGINCH 1S/C8H12N2O6/c11-1-2-3(12)4(13)5(14)6-9-7(15)8(16)10(2)6/h2-6,11-14H,1H2,(H,9,15)/t2-,3-,4+,5+,6+/m1/s1 D0AD9Y DRUGINKE OIURYJWYVIAOCW-PQMKYFCFSA-N D0AD9Y DRUGSMIL C(C1C(C(C(C2N1C(=O)C(=O)N2)O)O)O)O D0AD9Y HIGHSTAT Terminated D0AN1Y DRUG__ID D0AN1Y D0AN1Y DRUGCOMP Merck & Co Inc D0AN1Y DRUGTYPE Small molecular drug D0AN1Y DRUGINCH 1S/C22H21F2NO4S/c1-30(28,29)16-7-5-13(6-8-16)12-25-21-14(9-20(26)27)3-2-4-17(21)18-10-15(23)11-19(24)22(18)25/h5-8,10-11,14H,2-4,9,12H2,1H3,(H,26,27) D0AN1Y DRUGINKE GMJWAIMJHBTYPD-UHFFFAOYSA-N D0AN1Y DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)CN2C3=C(CCCC3CC(=O)O)C4=C2C(=CC(=C4)F)F D0AN1Y HIGHSTAT Terminated D0AX4E DRUG__ID D0AX4E D0AX4E DRUGCOMP Solvay Pharmaceuticals GmbH D0AX4E DRUGTYPE Small molecular drug D0AX4E DRUGINCH 1S/C19H36N2/c1-15(2)10-20-11-17-13-21(16(3)4)14-18(12-20)19(17)8-6-5-7-9-19/h15-18H,5-14H2,1-4H3/t17-,18-/m0/s1 D0AX4E DRUGINKE AOIVZQPSIHOHMP-ROUUACIJSA-N D0AX4E DRUGSMIL CC(C)CN1CC2CN(CC(C1)C23CCCCC3)C(C)C D0AX4E HIGHSTAT Terminated D0AZ5V DRUG__ID D0AZ5V D0AZ5V DRUGCOMP Merck & Co Inc D0AZ5V DRUGTYPE Small molecular drug D0AZ5V DRUGINCH 1S/C9H7ClN2O3/c10-6-2-1-5-3-8(12(14)15)9(13)11-7(5)4-6/h1-2,4,8H,3H2,(H,11,13) D0AZ5V DRUGINKE JXGOSNKBNBJAGV-UHFFFAOYSA-N D0AZ5V DRUGSMIL C1C(C(=O)NC2=C1C=CC(=C2)Cl)[N+](=O)[O-] D0AZ5V HIGHSTAT Terminated D0B0GC DRUG__ID D0B0GC D0B0GC DRUGCOMP Eisai Co Ltd D0B0GC DRUGTYPE Small molecular drug D0B0GC DRUGINCH 1S/C12H11FN2O3/c1-6-5-12(10(16)14-11(17)15-12)8-4-7(13)2-3-9(8)18-6/h2-4,6H,5H2,1H3,(H2,14,15,16,17)/t6-,12+/m1/s1 D0B0GC DRUGINKE SEAQTHCVAGBRFY-INWYIAFRSA-N D0B0GC DRUGSMIL CC1CC2(C3=C(O1)C=CC(=C3)F)C(=O)NC(=O)N2 D0B0GC HIGHSTAT Terminated D0B0QX DRUG__ID D0B0QX D0B0QX DRUGCOMP Medivir AB D0B0QX DRUGTYPE Small molecular drug D0B0QX DRUGINCH 1S/C18H17BrFN3O3/c1-2-14(24)10-4-5-12(20)16(17(10)25)11-7-13(11)22-18(26)23-15-6-3-9(19)8-21-15/h3-6,8,11,13,25H,2,7H2,1H3,(H2,21,22,23,26)/t11-,13+/m0/s1 D0B0QX DRUGINKE VRAJWAGCJIXJHQ-WCQYABFASA-N D0B0QX DRUGSMIL CCC(=O)C1=C(C(=C(C=C1)F)C2CC2NC(=O)NC3=NC=C(C=C3)Br)O D0B0QX HIGHSTAT Terminated D0B1PD DRUG__ID D0B1PD D0B1PD DRUGCOMP Scios Inc D0B1PD DRUGTYPE Small molecular drug D0B1PD DRUGINCH 1S/C27H33NO4.ClH/c1-20-26(30)24-19-23(11-12-25(24)32-27(20)21-9-5-4-6-10-21)31-18-8-3-2-7-15-28-16-13-22(29)14-17-28;/h4-6,9-12,19,22,29H,2-3,7-8,13-18H2,1H3;1H D0B1PD DRUGINKE GWSBQIZSTCDSLE-UHFFFAOYSA-N D0B1PD DRUGSMIL CC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4=CC=CC=C4.Cl D0B1PD HIGHSTAT Terminated D0B2LF DRUG__ID D0B2LF D0B2LF DRUGCOMP Rigel Pharmaceuticals Inc D0B2LF DRUGTYPE Small molecular drug D0B2LF DRUGINCH 1S/C21H29N/c1-17(2)22(18(3)4)16-15-21(19-11-7-5-8-12-19)20-13-9-6-10-14-20/h5-14,17-18,21H,15-16H2,1-4H3 D0B2LF DRUGINKE YBJKOPHEJOMRMN-UHFFFAOYSA-N D0B2LF DRUGSMIL CC(C)N(CCC(C1=CC=CC=C1)C2=CC=CC=C2)C(C)C D0B2LF HIGHSTAT Terminated D0B3CT DRUG__ID D0B3CT D0B3CT DRUGCOMP MSD Japan D0B3CT DRUGTYPE Small molecular drug D0B3CT DRUGINCH 1S/C20H11N3O4/c24-9-5-1-3-7-11-13-14(20(27)23-19(13)26)12-8-4-2-6-10(25)16(8)22-18(12)17(11)21-15(7)9/h1-6,21-22,24-25H,(H,23,26,27) D0B3CT DRUGINKE FETFZHLVPOJEBR-UHFFFAOYSA-N D0B3CT DRUGSMIL C1=CC2=C(C(=C1)O)NC3=C4C(=C5C(=C23)C(=O)NC5=O)C6=C(N4)C(=CC=C6)O D0B3CT HIGHSTAT Terminated D0B3MV DRUG__ID D0B3MV D0B3MV DRUGCOMP Sanofi-Synthelabo D0B3MV DRUGTYPE Small molecular drug D0B3MV DRUGINCH 1S/C27H32N4O7S/c1-18(2)20-14-19(36-3)15-22-25(20)27(33)31(39(22,34)35)17-38-23-16-24(32)30-11-7-8-21(26(30)28-23)37-13-12-29-9-5-4-6-10-29/h7-8,11,14-16,18H,4-6,9-10,12-13,17H2,1-3H3 D0B3MV DRUGINKE DRZXDZYWZSKFDL-UHFFFAOYSA-N D0B3MV DRUGSMIL CC(C)C1=C2C(=CC(=C1)OC)S(=O)(=O)N(C2=O)COC3=CC(=O)N4C=CC=C(C4=N3)OCCN5CCCCC5 D0B3MV HIGHSTAT Terminated D0B7BX DRUG__ID D0B7BX D0B7BX DRUGCOMP Esteve D0B7BX DRUGTYPE Small molecular drug D0B7BX DRUGINCH 1S/C21H22N2O3/c24-21(25)19-12-7-13-23(16-19)14-15-26-22-20(17-8-3-1-4-9-17)18-10-5-2-6-11-18/h1-6,8-12H,7,13-16H2,(H,24,25) D0B7BX DRUGINKE NGNALWDRPKNJGR-UHFFFAOYSA-N D0B7BX DRUGSMIL C1CN(CC(=C1)C(=O)O)CCON=C(C2=CC=CC=C2)C3=CC=CC=C3 D0B7BX HIGHSTAT Terminated D0B7HJ DRUG__ID D0B7HJ D0B7HJ DRUGCOMP Pharmacia & Upjohn Co D0B7HJ DRUGTYPE Small molecular drug D0B7HJ DRUGINCH 1S/C18H24Cl2N2O/c1-21(18(23)13-8-9-14(19)15(20)12-13)16-6-2-3-7-17(16)22-10-4-5-11-22/h8-9,12,16-17H,2-7,10-11H2,1H3/t16-,17-/m1/s1 D0B7HJ DRUGINKE JUBNVWGVNWIXMB-IAGOWNOFSA-N D0B7HJ DRUGSMIL CN(C1CCCCC1N2CCCC2)C(=O)C3=CC(=C(C=C3)Cl)Cl D0B7HJ HIGHSTAT Terminated D0B7ND DRUG__ID D0B7ND D0B7ND DRUGCOMP Grupo Uriach D0B7ND DRUGTYPE Small molecular drug D0B7ND DRUGINCH 1S/C18H14N2O2/c1-18(2)10-15(20-8-4-3-5-16(20)21)14-9-12(11-19)6-7-13(14)17(18)22/h3-10H,1-2H3 D0B7ND DRUGINKE PJCGOKFHROWGBX-UHFFFAOYSA-N D0B7ND DRUGSMIL CC1(C=C(C2=C(C1=O)C=CC(=C2)C#N)N3C=CC=CC3=O)C D0B7ND HIGHSTAT Terminated D0B8QA DRUG__ID D0B8QA D0B8QA DRUGCOMP Rhone-Poulenc SA D0B8QA DRUGTYPE Small molecular drug D0B8QA DRUGINCH 1S/C20H22FN3S/c21-17-7-5-15(6-8-17)16-9-11-23(12-10-16)13-14-24-18-3-1-2-4-19(18)25-20(24)22/h1-8,16,22H,9-14H2 D0B8QA DRUGINKE YIJMYOZUUPAERG-UHFFFAOYSA-N D0B8QA DRUGSMIL C1CN(CCC1C2=CC=C(C=C2)F)CCN3C4=CC=CC=C4SC3=N D0B8QA HIGHSTAT Terminated D0B9TX DRUG__ID D0B9TX D0B9TX DRUGCOMP Novartis AG D0B9TX DRUGTYPE Small molecular drug D0B9TX DRUGINCH 1S/C19H21N3O5/c1-5-25-18(23)14-10(3)20-11(4)15(19(24)26-6-2)16(14)12-8-7-9-13-17(12)22-27-21-13/h7-9,16,20H,5-6H2,1-4H3 D0B9TX DRUGINKE QERUYFVNIOLCHV-UHFFFAOYSA-N D0B9TX DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC3=NON=C32)C(=O)OCC)C)C D0B9TX HIGHSTAT Terminated D0BW9R DRUG__ID D0BW9R D0BW9R DRUGCOMP Bristol-Myers Squibb Co D0BW9R DRUGTYPE Small molecular drug D0BW9R DRUGINCH 1S/C39H41NO20/c1-10-4-16-23(30(49)20(10)36(53)40-17(8-41)37(54)55)22-14(7-15-24(31(22)50)27(46)13-5-12(56-3)6-18(42)21(13)26(15)45)28(47)34(16)59-39-33(52)35(25(44)11(2)58-39)60-38-32(51)29(48)19(43)9-57-38/h4-7,11,17,19,25,28-29,32-35,38-39,41-44,47-52H,8-9H2,1-3H3,(H,40,53)(H,54,55)/t11?,17?,19?,25?,28?,29?,32?,33?,34-,35?,38?,39?/m0/s1 D0BW9R DRUGINKE AXPBRQZJFXIYTD-PWEAUJHISA-N D0BW9R DRUGSMIL CC1C(C(C(C(O1)OC2C(C3=CC4=C(C(=C3C5=C2C=C(C(=C5O)C(=O)NC(CO)C(=O)O)C)O)C(=O)C6=C(C4=O)C(=CC(=C6)OC)O)O)O)OC7C(C(C(CO7)O)O)O)O D0BW9R HIGHSTAT Terminated D0C1MB DRUG__ID D0C1MB D0C1MB DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0C1MB DRUGTYPE Small molecular drug D0C1MB DRUGINCH 1S/C18H14Cl2N2O2/c1-11(23)22-16-6-5-15(19)14(18(16)20)10-24-17-4-2-3-12-9-21-8-7-13(12)17/h2-9H,10H2,1H3,(H,22,23) D0C1MB DRUGINKE YXVRCTRMIKAODR-UHFFFAOYSA-N D0C1MB DRUGSMIL CC(=O)NC1=C(C(=C(C=C1)Cl)COC2=CC=CC3=C2C=CN=C3)Cl D0C1MB HIGHSTAT Terminated D0C4JX DRUG__ID D0C4JX D0C4JX THERCLAS Analgesics D0C4JX DRUGTYPE Small molecular drug D0C4JX DRUGINCH 1S/C16H26N2O.BrH/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5;/h9-11H,6-8,12H2,1-5H3;1H D0C4JX DRUGINKE DLHMKHREUTXMCH-UHFFFAOYSA-N D0C4JX DRUGSMIL CC[N+](CC)(CC)CC(=O)NC1=C(C=CC=C1C)C.[Br-] D0C4JX HIGHSTAT Terminated D0C7KK DRUG__ID D0C7KK D0C7KK DRUGCOMP Ono Pharmaceutical; Fujisawa Pharmaceutical D0C7KK DRUGTYPE Small molecular drug D0C7KK DRUGINCH 1S/C17H11BrClFN2O4/c18-10-2-1-9(13(20)5-10)7-22-16(25)12-4-3-11(19)6-14(12)21(17(22)26)8-15(23)24/h1-6H,7-8H2,(H,23,24) D0C7KK DRUGINKE SXONDGSPUVNZLO-UHFFFAOYSA-N D0C7KK DRUGSMIL C1=CC2=C(C=C1Cl)N(C(=O)N(C2=O)CC3=C(C=C(C=C3)Br)F)CC(=O)O D0C7KK HIGHSTAT Terminated D0C8DC DRUG__ID D0C8DC D0C8DC DRUGCOMP Kirin Brewery Co Ltd D0C8DC DRUGTYPE Small molecular drug D0C8DC DRUGINCH 1S/C15H14N4/c16-12-19-15(14-7-4-9-17-11-14)18-10-8-13-5-2-1-3-6-13/h1-7,9,11H,8,10H2,(H,18,19) D0C8DC DRUGINKE SUPZSNPDPSPMTK-UHFFFAOYSA-N D0C8DC DRUGSMIL C1=CC=C(C=C1)CCN=C(C2=CN=CC=C2)NC#N D0C8DC HIGHSTAT Terminated D0C8ZD DRUG__ID D0C8ZD D0C8ZD DRUGCOMP Abbott Laboratories D0C8ZD DRUGTYPE Small molecular drug D0C8ZD DRUGINCH 1S/C44H56N8O9/c1-27-15-9-11-19-31(27)50-42(59)46-22-14-13-21-33(39(56)49-35(25-37(53)54)41(58)52(5)36(38(45)55)23-28-16-7-6-8-17-28)48-40(57)34(51-43(60)61-44(2,3)4)24-29-26-47-32-20-12-10-18-30(29)32/h6-12,15-20,26,33-36,47H,13-14,21-25H2,1-5H3,(H2,45,55)(H,48,57)(H,49,56)(H,51,60)(H,53,54)(H2,46,50,59)/t33-,34-,35-,36-/m0/s1 D0C8ZD DRUGINKE KNHCBYMGWWTGSO-ZYADHFCISA-N D0C8ZD DRUGSMIL CC1=CC=CC=C1NC(=O)NCCCCC(C(=O)NC(CC(=O)O)C(=O)N(C)C(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)OC(C)(C)C D0C8ZD HIGHSTAT Terminated D0C9RZ DRUG__ID D0C9RZ D0C9RZ DRUGCOMP Bristol-Myers Squibb Co D0C9RZ DRUGTYPE Small molecular drug D0C9RZ DRUGINCH 1S/C17H27NO3/c1-13(2)8-6-4-3-5-7-11-21-17(20)15-12-14(19)9-10-16(15)18/h9-10,12-13,19H,3-8,11,18H2,1-2H3 D0C9RZ DRUGINKE WQDDSULPVSBTBO-UHFFFAOYSA-N D0C9RZ DRUGSMIL CC(C)CCCCCCCOC(=O)C1=C(C=CC(=C1)O)N D0C9RZ HIGHSTAT Terminated D0CH6Z DRUG__ID D0CH6Z D0CH6Z DRUGCOMP Cell Therapeutics D0CH6Z DRUGTYPE Small molecular drug D0CH6Z DRUGINCH 1S/C21H26N6O2/c1-26(2)10-8-24-16-3-4-17-19-18(16)21(29)14-5-6-23-13-15(14)20(19)25-27(17)11-7-22-9-12-28/h3-6,13,22,24,28H,7-12H2,1-2H3 D0CH6Z DRUGINKE ZHAKYGFJVGCOAE-UHFFFAOYSA-N D0CH6Z DRUGSMIL CN(C)CCNC1=C2C3=C(C=C1)N(N=C3C4=C(C2=O)C=CN=C4)CCNCCO D0CH6Z HIGHSTAT Terminated D0CS0D DRUG__ID D0CS0D D0CS0D DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D0CS0D DRUGTYPE Small molecular drug D0CS0D DRUGINCH 1S/C19H21NO3/c1-15-11-13-20(14-12-15)19(21)23-18-9-7-17(8-10-18)22-16-5-3-2-4-6-16/h2-10,15H,11-14H2,1H3 D0CS0D DRUGINKE QRGQONAZHIKMGC-UHFFFAOYSA-N D0CS0D DRUGSMIL CC1CCN(CC1)C(=O)OC2=CC=C(C=C2)OC3=CC=CC=C3 D0CS0D HIGHSTAT Terminated D0CV7T DRUG__ID D0CV7T D0CV7T DRUGCOMP Eisai Co Ltd D0CV7T DRUGTYPE Small molecular drug D0CV7T DRUGINCH 1S/C20H20N4O4S/c21-20(22)23-14-3-1-13(2-4-14)19(27)28-15-5-7-16(8-6-15)29-12-11-24-17(25)9-10-18(24)26/h1-8H,9-12H2,(H4,21,22,23) D0CV7T DRUGINKE ILRQPCQIFIURTG-UHFFFAOYSA-N D0CV7T DRUGSMIL C1CC(=O)N(C1=O)CCSC2=CC=C(C=C2)OC(=O)C3=CC=C(C=C3)N=C(N)N D0CV7T HIGHSTAT Terminated D0CY4V DRUG__ID D0CY4V D0CY4V DRUGCOMP Zeneca Group plc D0CY4V DRUGTYPE Small molecular drug D0CY4V DRUGINCH 1S/C16H26N2O4/c1-16(2,3)18-9-12(19)10-21-13-7-5-6-8-14(13)22-11-15(20)17-4/h5-8,12,18-19H,9-11H2,1-4H3,(H,17,20) D0CY4V DRUGINKE UWCBNAVPISMFJZ-UHFFFAOYSA-N D0CY4V DRUGSMIL CC(C)(C)NCC(COC1=CC=CC=C1OCC(=O)NC)O D0CY4V HIGHSTAT Terminated D0D0QA DRUG__ID D0D0QA D0D0QA DRUGCOMP AstraZeneca D0D0QA DRUGTYPE Small molecular drug D0D0QA DRUGINCH 1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1 D0D0QA DRUGINKE IRTDIKMSKMREGO-OAHLLOKOSA-N D0D0QA DRUGSMIL CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4 D0D0QA HIGHSTAT Terminated D0DI3E DRUG__ID D0DI3E D0DI3E DRUGCOMP Nippon Shinyaku Co Ltd D0DI3E DRUGTYPE Small molecular drug D0DI3E DRUGINCH 1S/C18H21N2O7P/c1-11-15(18(21)25-3)16(13-7-4-5-8-14(13)20(22)23)17(12(2)19-11)28(24)26-9-6-10-27-28/h4-5,7-8,16,19H,6,9-10H2,1-3H3 D0DI3E DRUGINKE GSWINTXYUFHJGW-UHFFFAOYSA-N D0DI3E DRUGSMIL CC1=C(C(C(=C(N1)C)P2(=O)OCCCO2)C3=CC=CC=C3[N+](=O)[O-])C(=O)OC D0DI3E HIGHSTAT Terminated D0DJ5T DRUG__ID D0DJ5T D0DJ5T DRUGCOMP Choay SA D0DJ5T DRUGTYPE Small molecular drug D0DJ5T DRUGINCH 1S/C10H18ClN3O6/c1-19-8-4-6(9(16)7(5-15)20-8)12-10(17)14(13-18)3-2-11/h6-9,15-16H,2-5H2,1H3,(H,12,17)/t6-,7-,8+,9+/m1/s1 D0DJ5T DRUGINKE YQYBWJPESSJLTK-HXFLIBJXSA-N D0DJ5T DRUGSMIL COC1CC(C(C(O1)CO)O)NC(=O)N(CCCl)N=O D0DJ5T HIGHSTAT Terminated D0DS4P DRUG__ID D0DS4P D0DS4P DRUGCOMP Novartis AG D0DS4P DRUGTYPE Small molecular drug D0DS4P DRUGINCH 1S/C28H26N5O3P/c34-37(35-25-12-6-2-7-13-25,36-26-14-8-3-9-15-26)21-29-27(28-30-32-33-31-28)20-22-16-18-24(19-17-22)23-10-4-1-5-11-23/h1-19,27,29H,20-21H2,(H,30,31,32,33)/t27-/m0/s1 D0DS4P DRUGINKE AHIFMZUYRNPRJK-MHZLTWQESA-N D0DS4P DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC(C3=NNN=N3)NCP(=O)(OC4=CC=CC=C4)OC5=CC=CC=C5 D0DS4P HIGHSTAT Terminated D0E1SQ DRUG__ID D0E1SQ D0E1SQ DRUGCOMP Boehringer Ingelheim Corp D0E1SQ DRUGTYPE Small molecular drug D0E1SQ DRUGINCH 1S/C30H43N7O4/c1-19-14-36(15-20(2)40-19)27-24(23-10-8-7-9-11-23)31-25-26(32-27)33-29(37-16-21(3)41-22(4)17-37)34-28(25)35(12-13-38)18-30(5,6)39/h7-11,19-22,38-39H,12-18H2,1-6H3/t19-,20+,21-,22+ D0E1SQ DRUGINKE JNHIGDFEPXMPAO-COPRSSIGSA-N D0E1SQ DRUGSMIL CC1CN(CC(O1)C)C2=NC3=C(C(=NC(=N3)N4CC(OC(C4)C)C)N(CCO)CC(C)(C)O)N=C2C5=CC=CC=C5 D0E1SQ HIGHSTAT Terminated D0E6VL DRUG__ID D0E6VL D0E6VL DRUGCOMP RW Johnson Pharmaceutical Research Institute D0E6VL DRUGTYPE Small molecular drug D0E6VL DRUGINCH 1S/C27H30ClFN2O4S/c1-18-23(27(32)35-15-14-31(2)17-19-9-4-3-5-10-19)25(24-20(28)11-8-12-21(24)29)26-22(30-18)13-6-7-16-36(26,33)34/h3-5,8-12,25,30H,6-7,13-17H2,1-2H3 D0E6VL DRUGINKE AHYGPFWAZFOLSI-UHFFFAOYSA-N D0E6VL DRUGSMIL CC1=C(C(C2=C(N1)CCCCS2(=O)=O)C3=C(C=CC=C3Cl)F)C(=O)OCCN(C)CC4=CC=CC=C4 D0E6VL HIGHSTAT Terminated D0E9PT DRUG__ID D0E9PT D0E9PT DRUGCOMP Berlex Laboratories Inc D0E9PT DRUGTYPE Small molecular drug D0E9PT DRUGINCH 1S/C15H14N4O2/c1-2-12-13(18-15(21)17-12)14(20)10-3-5-11(6-4-10)19-8-7-16-9-19/h3-9H,2H2,1H3,(H2,17,18,21) D0E9PT DRUGINKE FIYSLYBKJKWZMC-UHFFFAOYSA-N D0E9PT DRUGSMIL CCC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)N3C=CN=C3 D0E9PT HIGHSTAT Terminated D0EG1F DRUG__ID D0EG1F D0EG1F DRUGCOMP Glaxo Wellcome plc D0EG1F DRUGTYPE Small molecular drug D0EG1F DRUGINCH 1S/C28H32FN5O4/c29-19-12-14-20(15-13-19)30-28(38)31-25-26(36)33(18-24(35)32-16-6-7-17-32)22-10-4-5-11-23(22)34(27(25)37)21-8-2-1-3-9-21/h4-5,10-15,21,25H,1-3,6-9,16-18H2,(H2,30,31,38)/t25-/m0/s1 D0EG1F DRUGINKE URMOKEJAUAGZGV-VWLOTQADSA-N D0EG1F DRUGSMIL C1CCC(CC1)N2C3=CC=CC=C3N(C(=O)C(C2=O)NC(=O)NC4=CC=C(C=C4)F)CC(=O)N5CCCC5 D0EG1F HIGHSTAT Terminated D0F4GJ DRUG__ID D0F4GJ D0F4GJ DRUGCOMP Glaxo Wellcome plc D0F4GJ DRUGTYPE Small molecular drug D0F4GJ DRUGINCH 1S/C25H25N3O/c1-28(2)17-18-29-22-16-10-9-15-21(22)25-26-23(19-11-5-3-6-12-19)24(27-25)20-13-7-4-8-14-20/h3-16H,17-18H2,1-2H3,(H,26,27) D0F4GJ DRUGINKE KGVYOGLFOPNPDJ-UHFFFAOYSA-N D0F4GJ DRUGSMIL CN(C)CCOC1=CC=CC=C1C2=NC(=C(N2)C3=CC=CC=C3)C4=CC=CC=C4 D0F4GJ HIGHSTAT Terminated D0F5CO DRUG__ID D0F5CO D0F5CO DRUGCOMP American Cyanamid Co D0F5CO DRUGTYPE Small molecular drug D0F5CO DRUGINCH 1S/C7H16N2O.C6H8O4.Pt/c8-5-7(6-9)1-3-10-4-2-7;7-4(8)6(5(9)10)2-1-3-6;/h1-6,8-9H2;1-3H2,(H,7,8)(H,9,10); D0F5CO DRUGINKE MTYYEDWZHRMBOL-UHFFFAOYSA-N D0F5CO DRUGSMIL C1CC(C1)(C(=O)O)C(=O)O.C1COCCC1(CN)CN.[Pt] D0F5CO HIGHSTAT Terminated D0F6ZS DRUG__ID D0F6ZS D0F6ZS DRUGCOMP F Hoffmann-La Roche Ltd D0F6ZS DRUGTYPE Small molecular drug D0F6ZS DRUGINCH 1S/C19H17F3N6O6S2/c20-19(21,22)6-27-2-1-7(14(27)30)3-8-4-35-16-11(15(31)28(16)12(8)17(32)33)25-13(29)10(26-34)9-5-36-18(23)24-9/h3,5,11,16,34H,1-2,4,6H2,(H2,23,24)(H,25,29)(H,32,33)/b7-3+,26-10-/t11-,16-/m1/s1 D0F6ZS DRUGINKE NOAJGZYUGGBORE-SUVYSZLLSA-N D0F6ZS DRUGSMIL C1CN(C(=O)C1=CC2=C(N3C(C(C3=O)NC(=O)C(=NO)C4=CSC(=N4)N)SC2)C(=O)O)CC(F)(F)F D0F6ZS HIGHSTAT Terminated D0F7TV DRUG__ID D0F7TV D0F7TV DRUGCOMP Hoechst Marion Roussel Inc D0F7TV DRUGTYPE Small molecular drug D0F7TV DRUGINCH 1S/C16H26N4O4/c1-5-24-11-19-10-17-13-12(19)14(21)20(15(22)18(13)4)9-7-6-8-16(2,3)23/h10,23H,5-9,11H2,1-4H3 D0F7TV DRUGINKE QSXXLDDWVCEBFP-UHFFFAOYSA-N D0F7TV DRUGSMIL CCOCN1C=NC2=C1C(=O)N(C(=O)N2C)CCCCC(C)(C)O D0F7TV HIGHSTAT Terminated D0F9IS DRUG__ID D0F9IS D0F9IS DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0F9IS DRUGTYPE Small molecular drug D0F9IS DRUGINCH 1S/C14H15N3O6/c15-13(20)22-5-7-11-9(1-6(4-18)2-10(11)19)17-3-8-12(16-8)14(7,21)23-17/h1-2,4,7-8,12,16,19,21H,3,5H2,(H2,15,20)/t7-,8-,12-,14+/m0/s1 D0F9IS DRUGINKE XVPSPMLUMQEEIU-QHGAOHLJSA-N D0F9IS DRUGSMIL C1C2C(N2)C3(C(C4=C(N1O3)C=C(C=C4O)C=O)COC(=O)N)O D0F9IS HIGHSTAT Terminated D0F9KI DRUG__ID D0F9KI D0F9KI DRUGCOMP Almirall Prodesfarma SA D0F9KI DRUGTYPE Small molecular drug D0F9KI DRUGINCH 1S/C28H31F2NO2/c1-20-4-3-5-21(2)27(20)33-19-18-31-16-14-24(15-17-31)28(32,22-6-10-25(29)11-7-22)23-8-12-26(30)13-9-23/h3-13,24,32H,14-19H2,1-2H3 D0F9KI DRUGINKE BIZCZAJFIUSFDU-UHFFFAOYSA-N D0F9KI DRUGSMIL CC1=C(C(=CC=C1)C)OCCN2CCC(CC2)C(C3=CC=C(C=C3)F)(C4=CC=C(C=C4)F)O D0F9KI HIGHSTAT Terminated D0FN1P DRUG__ID D0FN1P D0FN1P DRUGCOMP Hoechst AG D0FN1P DRUGTYPE Small molecular drug D0FN1P DRUGINCH 1S/C15H10F7N3O2S2/c16-13(17,14(18,19)15(20,21)22)7-27-9-1-2-23-8(3-9)6-29(26)12-24-10-4-28-5-11(10)25-12/h1-5H,6-7H2,(H,24,25) D0FN1P DRUGINKE ARFGGIRJBPTBPP-UHFFFAOYSA-N D0FN1P DRUGSMIL C1=CN=C(C=C1OCC(C(C(F)(F)F)(F)F)(F)F)CS(=O)C2=NC3=CSC=C3N2 D0FN1P HIGHSTAT Terminated D0G1RT DRUG__ID D0G1RT D0G1RT DRUGCOMP Merck & Co Inc D0G1RT DRUGTYPE Small molecular drug D0G1RT DRUGINCH 1S/C20H21N5O3S/c1-29(26,27)25-16-5-2-13(3-6-16)10-19-23-20(28-24-19)14-4-7-18-17(11-14)15(8-9-21)12-22-18/h2-7,11-12,22,25H,8-10,21H2,1H3 D0G1RT DRUGINKE HKXMQLISPYELRD-UHFFFAOYSA-N D0G1RT DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)CC2=NOC(=N2)C3=CC4=C(C=C3)NC=C4CCN D0G1RT HIGHSTAT Terminated D0G2LT DRUG__ID D0G2LT D0G2LT DRUGCOMP Gedeon Richter D0G2LT DRUGTYPE Small molecular drug D0G2LT DRUGINCH 1S/C26H30N4O2S/c1-31-25-7-3-2-6-24(25)29-15-13-28(14-16-29)12-4-5-18-32-22-10-8-21(9-11-22)23-20-30-17-19-33-26(30)27-23/h2-3,6-11,17,19-20H,4-5,12-16,18H2,1H3 D0G2LT DRUGINKE XFCPMLXQURUUPM-UHFFFAOYSA-N D0G2LT DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCCCOC3=CC=C(C=C3)C4=CN5C=CSC5=N4 D0G2LT HIGHSTAT Terminated D0G2VT DRUG__ID D0G2VT D0G2VT DRUGCOMP Daiichi Suntory Pharma D0G2VT DRUGTYPE Small molecular drug D0G2VT DRUGINCH 1S/C5H8F3NO2S/c6-5(7,8)12-2-1-3(9)4(10)11/h3H,1-2,9H2,(H,10,11) D0G2VT DRUGINKE YLJLTSVBCXYTQK-UHFFFAOYSA-N D0G2VT DRUGSMIL C(CSC(F)(F)F)C(C(=O)O)N D0G2VT HIGHSTAT Terminated D0G3MH DRUG__ID D0G3MH D0G3MH DRUGCOMP University of Gothenburg D0G3MH DRUGTYPE Small molecular drug D0G3MH DRUGINCH 1S/C15H23NO2S.ClH/c1-3-9-16-10-5-7-14(12-16)13-6-4-8-15(11-13)19(2,17)18;/h4,6,8,11,14H,3,5,7,9-10,12H2,1-2H3;1H/t14-;/m1./s1 D0G3MH DRUGINKE LEMGVHZVBREXAD-PFEQFJNWSA-N D0G3MH DRUGSMIL CCCN1CCCC(C1)C2=CC(=CC=C2)S(=O)(=O)C.Cl D0G3MH HIGHSTAT Terminated D0G7SP DRUG__ID D0G7SP D0G7SP DRUGCOMP SmithKline Beecham plc D0G7SP DRUGTYPE Small molecular drug D0G7SP DRUGINCH 1S/C23H19Cl2NO3S/c24-18-7-4-8-19(25)23(18)30-15-17-9-11-21(20(26-17)10-12-22(27)28)29-14-13-16-5-2-1-3-6-16/h1-12H,13-15H2,(H,27,28)/b12-10+ D0G7SP DRUGINKE ZJLFOOWTDISDIO-ZRDIBKRKSA-N D0G7SP DRUGSMIL C1=CC=C(C=C1)CCOC2=C(N=C(C=C2)CSC3=C(C=CC=C3Cl)Cl)C=CC(=O)O D0G7SP HIGHSTAT Terminated D0GA3M DRUG__ID D0GA3M D0GA3M DRUGCOMP MSD Japan D0GA3M DRUGTYPE Small molecular drug D0GA3M DRUGINCH 1S/C16H29N3O7/c1-8(2)5-10(6-12(21)19-26)14(22)17-11(7-20)15(23)18-13(9(3)4)16(24)25/h8-11,13,20,26H,5-7H2,1-4H3,(H,17,22)(H,18,23)(H,19,21)(H,24,25)/t10?,11-,13-/m0/s1 D0GA3M DRUGINKE ZTDAMCPLHAKWAY-KUNJKIHDSA-N D0GA3M DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)O D0GA3M HIGHSTAT Terminated D0GM4S DRUG__ID D0GM4S D0GM4S DRUGCOMP Agouron Pharmaceuticals Inc D0GM4S DRUGTYPE Small molecular drug D0GM4S DRUGINCH 1S/C39H52N2O5/c1-5-39(21-11-12-22-39)41(24-26-43)36(45)34-16-10-9-13-30(34)19-20-33(44)28-31-18-17-29(2)27-35(31)37(46)40(23-25-42)38(3,4)32-14-7-6-8-15-32/h6-10,13-18,27,33,42-44H,5,11-12,19-26,28H2,1-4H3 D0GM4S DRUGINKE MBNPLZRTGOAFGX-UHFFFAOYSA-N D0GM4S DRUGSMIL CCC1(CCCC1)N(CCO)C(=O)C2=CC=CC=C2CCC(CC3=C(C=C(C=C3)C)C(=O)N(CCO)C(C)(C)C4=CC=CC=C4)O D0GM4S HIGHSTAT Terminated D0H1TA DRUG__ID D0H1TA D0H1TA DRUGCOMP Takeda Pharmaceutical Co Ltd D0H1TA DRUGTYPE Small molecular drug D0H1TA DRUGINCH 1S/C29H40N6O7S.C2H4O2/c1-4-35(25(29(41)34-33-19(2)36)17-20-8-6-5-7-9-20)26(38)18-31-28(40)24(14-15-43(3)42)32-27(39)23(30)16-21-10-12-22(37)13-11-21;1-2(3)4/h5-13,23-25,37H,4,14-18,30H2,1-3H3,(H,31,40)(H,32,39)(H,33,36)(H,34,41);1H3,(H,3,4)/t23-,24+,25-,43?;/m0./s1 D0H1TA DRUGINKE NOOIAQHTLKMMAW-VQCKKKRLSA-N D0H1TA DRUGSMIL CCN(C(CC1=CC=CC=C1)C(=O)NNC(=O)C)C(=O)CNC(=O)C(CCS(=O)C)NC(=O)C(CC2=CC=C(C=C2)O)N.CC(=O)O D0H1TA HIGHSTAT Terminated D0H4JN DRUG__ID D0H4JN D0H4JN DRUGCOMP Research Triangle Institute D0H4JN DRUGTYPE Small molecular drug D0H4JN DRUGINCH 1S/C21H22ClNO2/c1-23-16-11-12-19(23)20(21(24)25-17-5-3-2-4-6-17)18(13-16)14-7-9-15(22)10-8-14/h2-10,16,18-20H,11-13H2,1H3/t16?,18-,19?,20+/m1/s1 D0H4JN DRUGINKE AAEKULYONKUBOZ-MLFFRYNPSA-N D0H4JN DRUGSMIL CN1C2CCC1C(C(C2)C3=CC=C(C=C3)Cl)C(=O)OC4=CC=CC=C4 D0H4JN HIGHSTAT Terminated D0H5CD DRUG__ID D0H5CD D0H5CD DRUGCOMP Glaxo Inc D0H5CD DRUGTYPE Small molecular drug D0H5CD DRUGINCH 1S/C25H33N3O4S/c1-17(2)14-20(21(24(30)28-32)16-33-19-12-8-5-9-13-19)23(29)27-22(25(31)26-3)15-18-10-6-4-7-11-18/h4-13,17,20-22,32H,14-16H2,1-3H3,(H,26,31)(H,27,29)(H,28,30)/t20-,21+,22+/m1/s1 D0H5CD DRUGINKE UBFGIEDUTRCMEQ-FSSWDIPSSA-N D0H5CD DRUGSMIL CC(C)CC(C(CSC1=CC=CC=C1)C(=O)NO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC D0H5CD HIGHSTAT Terminated D0HP3M DRUG__ID D0HP3M D0HP3M DRUGCOMP Bio-Mega Research Division D0HP3M DRUGTYPE Small molecular drug D0HP3M DRUGINCH 1S/C51H76N6O9/c1-33(2)40(56(9)47(64)36(28-34-20-12-10-13-21-34)29-35-22-14-11-15-23-35)44(61)54-41(50(6,7)8)45(62)53-38(30-39(59)57-26-18-19-27-57)43(60)55-42(51(48(65)66)24-16-17-25-51)46(63)52-37(32-58)31-49(3,4)5/h10-15,20-23,33,36-38,40-42,58H,16-19,24-32H2,1-9H3,(H,52,63)(H,53,62)(H,54,61)(H,55,60)(H,65,66)/t37-,38-,40-,41+,42+/m0/s1 D0HP3M DRUGINKE ZEZGINAYPYMJJU-HOMVEOSBSA-N D0HP3M DRUGSMIL CC(C)C(C(=O)NC(C(=O)NC(CC(=O)N1CCCC1)C(=O)NC(C(=O)NC(CC(C)(C)C)CO)C2(CCCC2)C(=O)O)C(C)(C)C)N(C)C(=O)C(CC3=CC=CC=C3)CC4=CC=CC=C4 D0HP3M HIGHSTAT Terminated D0HQ1W DRUG__ID D0HQ1W D0HQ1W DRUGCOMP SmithKline Beecham plc D0HQ1W DRUGTYPE Small molecular drug D0HQ1W DRUGINCH 1S/C22H26N2O3.ClH/c1-25-20-9-5-18(6-10-20)4-3-15-27-22(16-24-14-13-23-17-24)19-7-11-21(26-2)12-8-19;/h5-14,17,22H,3-4,15-16H2,1-2H3;1H D0HQ1W DRUGINKE FWLPKVQUECFKSW-UHFFFAOYSA-N D0HQ1W DRUGSMIL COC1=CC=C(C=C1)CCCOC(CN2C=CN=C2)C3=CC=C(C=C3)OC.Cl D0HQ1W HIGHSTAT Terminated D0I2OP DRUG__ID D0I2OP D0I2OP DRUGCOMP Abbott D0I2OP DRUGTYPE Small molecular drug D0I2OP DRUGINCH 1S/C22H22FN3O2/c23-16-7-5-14(6-8-16)18-11-15-12-25(13-19(15)18)9-10-26-21(27)17-3-1-2-4-20(17)24-22(26)28/h1-8,15,18-19H,9-13H2,(H,24,28)/t15-,18-,19+/m1/s1 D0I2OP DRUGINKE XLJWJFKYRFPJSD-LZQZEXGQSA-N D0I2OP DRUGSMIL C1C2CN(CC2C1C3=CC=C(C=C3)F)CCN4C(=O)C5=CC=CC=C5NC4=O D0I2OP HIGHSTAT Terminated D0I2YV DRUG__ID D0I2YV D0I2YV DRUGCOMP Dr Karl Thomae GmbH D0I2YV DRUGTYPE Small molecular drug D0I2YV DRUGINCH 1S/C22H21ClN2O2/c23-20-7-5-19(6-8-20)22(26)25-12-9-17(10-13-25)15-16-1-3-18(4-2-16)21-24-11-14-27-21/h1-8,15H,9-14H2 D0I2YV DRUGINKE JQNWPWUJMRAASQ-UHFFFAOYSA-N D0I2YV DRUGSMIL C1CN(CCC1=CC2=CC=C(C=C2)C3=NCCO3)C(=O)C4=CC=C(C=C4)Cl D0I2YV HIGHSTAT Terminated D0I3CV DRUG__ID D0I3CV D0I3CV DRUGCOMP Merck & Co Inc D0I3CV DRUGTYPE Small molecular drug D0I3CV DRUGINCH 1S/C27H23N3O5/c1-14(31)23-22-11-19(24(27(34)35)30(22)26(23)33)16-4-6-18-20(10-16)17-5-3-15(9-21(17)25(18)32)12-29-8-7-28(2)13-29/h3-10,13-14,22-23,31H,11-12H2,1-2H3/t14-,22-,23-/m1/s1 D0I3CV DRUGINKE ZPXTVRPOCJUEHR-BQKRCXSJSA-N D0I3CV DRUGSMIL CC(C1C2CC(=C(N2C1=O)C(=O)[O-])C3=CC4=C(C=C3)C(=O)C5=C4C=CC(=C5)CN6C=C[N+](=C6)C)O D0I3CV HIGHSTAT Terminated D0I8RY DRUG__ID D0I8RY D0I8RY DRUGCOMP Novartis AG D0I8RY DRUGTYPE Small molecular drug D0I8RY DRUGINCH 1S/C18H22N2O3/c1-20-11-6-7-12(20)9-13(8-11)23-18(21)15-10-19-17-14(15)4-3-5-16(17)22-2/h3-5,10-13,19H,6-9H2,1-2H3/t11-,12+,13? D0I8RY DRUGINKE GMKZFWHCKJSRHX-FUNVUKJBSA-N D0I8RY DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4OC D0I8RY HIGHSTAT Terminated D0II9K DRUG__ID D0II9K D0II9K DRUGCOMP EGIS Gyogyszergyar RT D0II9K DRUGTYPE Small molecular drug D0II9K DRUGINCH 1S/C18H17ClN2O2/c1-11-7-13-9-16(22-2)17(23-3)10-15(13)18(21-20-11)12-5-4-6-14(19)8-12/h4-6,8-10H,7H2,1-3H3 D0II9K DRUGINKE VQYLGVVODFDFNK-UHFFFAOYSA-N D0II9K DRUGSMIL CC1=NN=C(C2=CC(=C(C=C2C1)OC)OC)C3=CC(=CC=C3)Cl D0II9K HIGHSTAT Terminated D0IX7G DRUG__ID D0IX7G D0IX7G DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0IX7G DRUGTYPE Small molecular drug D0IX7G DRUGINCH 1S/C25H26N4O4/c1-18-24(25(30)26-10-11-28-12-14-33-15-13-28)22(20-8-5-9-21(16-20)29(31)32)17-23(27-18)19-6-3-2-4-7-19/h2-9,16-17H,10-15H2,1H3,(H,26,30) D0IX7G DRUGINKE HNBRMVZTOLAZRW-UHFFFAOYSA-N D0IX7G DRUGSMIL CC1=C(C(=CC(=N1)C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)NCCN4CCOCC4 D0IX7G HIGHSTAT Terminated D0J0JC DRUG__ID D0J0JC D0J0JC DRUGCOMP Fujirebio KK D0J0JC DRUGTYPE Small molecular drug D0J0JC DRUGINCH 1S/C22H30N2O4S/c25-22(18-29(26)17-21-9-5-13-28-21)23-10-6-14-27-20-8-4-7-19(15-20)16-24-11-2-1-3-12-24/h4-5,7-9,13,15H,1-3,6,10-12,14,16-18H2,(H,23,25) D0J0JC DRUGINKE IWLUMUDDKHJJPB-UHFFFAOYSA-N D0J0JC DRUGSMIL C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CS(=O)CC3=CC=CO3 D0J0JC HIGHSTAT Terminated D0J3NJ DRUG__ID D0J3NJ D0J3NJ DRUGCOMP Rhone-Poulenc SA D0J3NJ DRUGTYPE Small molecular drug D0J3NJ DRUGINCH 1S/C23H23N5O/c1-4-10-18(11-5-1)20-16-21(19-12-6-2-7-13-19)24-23(17-20)29-15-9-3-8-14-22-25-27-28-26-22/h1-2,4-7,10-13,16-17H,3,8-9,14-15H2,(H,25,26,27,28) D0J3NJ DRUGINKE MIZPMMYJEGMAHP-UHFFFAOYSA-N D0J3NJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)OCCCCCC3=NNN=N3)C4=CC=CC=C4 D0J3NJ HIGHSTAT Terminated D0J3OV DRUG__ID D0J3OV D0J3OV DRUGCOMP H Lee Moffitt Cancer Center and Research Institute D0J3OV DRUGTYPE Small molecular drug D0J3OV DRUGINCH 1S/C43H50O16/c1-18-25(44)8-10-32(53-18)57-27-9-11-33(54-20(27)3)59-41(5)16-31(46)43(51)35-24(12-13-42(43,50)17-41)37(48)34-23(38(35)49)7-6-22(36(34)47)28-15-29-39(21(4)52-28)58-40-30(56-29)14-26(45)19(2)55-40/h6-8,10,12-13,18-21,26-30,32-33,39-40,45,47,50-51H,9,11,14-17H2,1-5H3 D0J3OV DRUGINKE RILCLFZXOSENQY-UHFFFAOYSA-N D0J3OV DRUGSMIL CC1C(CCC(O1)OC2(CC(=O)C3(C4=C(C=CC3(C2)O)C(=O)C5=C(C4=O)C=CC(=C5O)C6CC7C(C(O6)C)OC8C(O7)CC(C(O8)C)O)O)C)OC9C=CC(=O)C(O9)C D0J3OV HIGHSTAT Terminated D0J3QU DRUG__ID D0J3QU D0J3QU DRUGCOMP Zeneca Group plc D0J3QU DRUGTYPE Small molecular drug D0J3QU DRUGINCH 1S/C31H34Cl2N2O2S/c1-3-35-30(25-9-4-5-10-26(25)31(35)36)24(22-12-13-27(32)28(33)20-22)16-19-34-17-14-21(15-18-34)23-8-6-7-11-29(23)38(2)37/h4-13,20-21,24,30H,3,14-19H2,1-2H3/t24-,30+,38-/m0/s1 D0J3QU DRUGINKE JYCLPXSCZKCIMO-YEFUCVGBSA-N D0J3QU DRUGSMIL CCN1C(C2=CC=CC=C2C1=O)C(CCN3CCC(CC3)C4=CC=CC=C4S(=O)C)C5=CC(=C(C=C5)Cl)Cl D0J3QU HIGHSTAT Terminated D0J4EG DRUG__ID D0J4EG D0J4EG DRUGCOMP Merck & Co Inc D0J4EG DRUGTYPE Small molecular drug D0J4EG DRUGINCH 1S/C24H28O8S/c1-3-5-20-22(12-10-19(16(2)25)24(20)29)32-14-4-15-33(30,31)18-8-6-17(7-9-18)21(26)11-13-23(27)28/h6-10,12,29H,3-5,11,13-15H2,1-2H3,(H,27,28) D0J4EG DRUGINKE ZAKKEARLDPTRLX-UHFFFAOYSA-N D0J4EG DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCCCS(=O)(=O)C2=CC=C(C=C2)C(=O)CCC(=O)O D0J4EG HIGHSTAT Terminated D0J5HU DRUG__ID D0J5HU D0J5HU DRUGCOMP Roche Holding AG D0J5HU DRUGTYPE Small molecular drug D0J5HU DRUGINCH 1S/C23H27N3O6S/c1-23(2,3)16-8-10-19(11-9-16)33(28,29)26-21-20(22(25-15-24-21)31-13-12-27)32-18-7-5-6-17(14-18)30-4/h5-11,14-15,27H,12-13H2,1-4H3,(H,24,25,26) D0J5HU DRUGINKE ZNXOKLWCOWOECF-UHFFFAOYSA-N D0J5HU DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC=N2)OCCO)OC3=CC=CC(=C3)OC D0J5HU HIGHSTAT Terminated D0J5QW DRUG__ID D0J5QW D0J5QW DRUGCOMP Taisho Pharmaceutical Co Ltd D0J5QW DRUGTYPE Small molecular drug D0J5QW DRUGINCH 1S/C16H14ClF2NO5S2/c17-10-1-3-12(4-2-10)27(23,24)20-5-6-26-11-7-13(18)16(14(19)8-11)25-9-15(21)22/h1-4,7-8,20H,5-6,9H2,(H,21,22) D0J5QW DRUGINKE FEYKNJZBWNIWJD-UHFFFAOYSA-N D0J5QW DRUGSMIL C1=CC(=CC=C1S(=O)(=O)NCCSC2=CC(=C(C(=C2)F)OCC(=O)O)F)Cl D0J5QW HIGHSTAT Terminated D0J5UC DRUG__ID D0J5UC D0J5UC DRUGCOMP Novartis AG D0J5UC DRUGTYPE Small molecular drug D0J5UC DRUGINCH 1S/C20H23NO5/c1-23-15-6-13(7-16(9-15)24-2)20-17-10-19(26-4)18(25-3)8-12(17)5-14(11-22)21-20/h6-10,14,22H,5,11H2,1-4H3/t14-/m0/s1 D0J5UC DRUGINKE GHBUMWHHZFGRDI-AWEZNQCLSA-N D0J5UC DRUGSMIL COC1=CC(=CC(=C1)C2=NC(CC3=CC(=C(C=C32)OC)OC)CO)OC D0J5UC HIGHSTAT Terminated D0J7AI DRUG__ID D0J7AI D0J7AI DRUGCOMP Institut Henri Beaufour D0J7AI DRUGTYPE Small molecular drug D0J7AI DRUGINCH 1S/C21H18N2O4/c1-2-21(26)9-18(24)27-11-14-15(21)8-17-19-13(10-23(17)20(14)25)7-12-5-3-4-6-16(12)22-19/h3-8,26H,2,9-11H2,1H3 D0J7AI DRUGINKE PAEZRCINULFAGO-UHFFFAOYSA-N D0J7AI DRUGSMIL CCC1(CC(=O)OCC2=C1C=C3C4=NC5=CC=CC=C5C=C4CN3C2=O)O D0J7AI HIGHSTAT Terminated D0J7UI DRUG__ID D0J7UI D0J7UI DRUGCOMP Zeneca Group plc D0J7UI DRUGTYPE Small molecular drug D0J7UI DRUGINCH 1S/C28H28N4O6S/c1-37-26-15-19(27(33)31-39(35,36)24-9-3-2-4-10-24)11-12-21(26)18-32-25-16-22(14-13-20(25)17-29-32)30-28(34)38-23-7-5-6-8-23/h2-4,9-17,23H,5-8,18H2,1H3,(H,30,34)(H,31,33) D0J7UI DRUGINKE YRCPIXCRSAKRGM-UHFFFAOYSA-N D0J7UI DRUGSMIL COC1=C(C=CC(=C1)C(=O)NS(=O)(=O)C2=CC=CC=C2)CN3C4=C(C=CC(=C4)NC(=O)OC5CCCC5)C=N3 D0J7UI HIGHSTAT Terminated D0J9JQ DRUG__ID D0J9JQ D0J9JQ DRUGCOMP Xenova Ltd D0J9JQ DRUGTYPE Small molecular drug D0J9JQ DRUGINCH 1S/C22H23N3O2S/c1-25(2)12-13-28-18-10-8-17(9-11-18)15-20-22(27)23-19(21(26)24-20)14-16-6-4-3-5-7-16/h3-11,14-15H,12-13H2,1-2H3,(H,23,27)(H,24,26)/b19-14+,20-15- D0J9JQ DRUGINKE RYRKPESQGOEIQY-WOBBTWAASA-N D0J9JQ DRUGSMIL CN(C)CCSC1=CC=C(C=C1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2 D0J9JQ HIGHSTAT Terminated D0JB4W DRUG__ID D0JB4W D0JB4W DRUGCOMP Chiron Corp D0JB4W DRUGTYPE Small molecular drug D0JB4W DRUGINCH 1S/C38H55N5O3/c1-26(2)28-13-15-31-29(21-28)14-16-33-37(3,17-8-18-38(31,33)4)25-41-22-35(45)42(20-19-39)24-36(46)43(23-34(40)44)32-12-7-10-27-9-5-6-11-30(27)32/h5-6,9,11,13,15,21,26,32-33,41H,7-8,10,12,14,16-20,22-25,39H2,1-4H3,(H2,40,44)/t32?,33-,37-,38+/m0/s1 D0JB4W DRUGINKE UCQJCJGDMWOONX-XEWALUAGSA-N D0JB4W DRUGSMIL CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)CNCC(=O)N(CCN)CC(=O)N(CC(=O)N)C4CCCC5=CC=CC=C45)C D0JB4W HIGHSTAT Terminated D0JI1J DRUG__ID D0JI1J D0JI1J DRUGCOMP Metabasis Therapeutics Inc D0JI1J DRUGTYPE Small molecular drug D0JI1J DRUGINCH 1S/C23H22N4O3/c1-14-19(28)20(29)23(30-14)27-12-17(15-8-4-2-5-9-15)18-21(24-13-25-22(18)27)26-16-10-6-3-7-11-16/h2-14,19-20,23,28-29H,1H3,(H,24,25,26)/t14-,19-,20-,23-/m1/s1 D0JI1J DRUGINKE YPWISWJHVQIXIL-DVHMWJAFSA-N D0JI1J DRUGSMIL CC1C(C(C(O1)N2C=C(C3=C(N=CN=C32)NC4=CC=CC=C4)C5=CC=CC=C5)O)O D0JI1J HIGHSTAT Terminated D0JI5G DRUG__ID D0JI5G D0JI5G DRUGCOMP National Institutes of Health D0JI5G DRUGTYPE Small molecular drug D0JI5G DRUGINCH 1S/C8H11ClN4O4/c9-3-4-13(12-17)8(16)10-5-1-2-6(14)11-7(5)15/h5H,1-4H2,(H,10,16)(H,11,14,15) D0JI5G DRUGINKE KHWIRCOLWPNBJP-UHFFFAOYSA-N D0JI5G DRUGSMIL C1CC(=O)NC(=O)C1NC(=O)N(CCCl)N=O D0JI5G HIGHSTAT Terminated D0K0DB DRUG__ID D0K0DB D0K0DB THERCLAS Analgesics D0K0DB DRUGTYPE Small molecular drug D0K0DB DRUGINCH 1S/C22H29NO2/c1-17(22(25)20-7-9-21(24)10-8-20)16-23-13-11-19(12-14-23)15-18-5-3-2-4-6-18/h2-10,17,19,22,24-25H,11-16H2,1H3/t17-,22+/m0/s1 D0K0DB DRUGINKE WVZSEUPGUDIELE-HTAPYJJXSA-N D0K0DB DRUGSMIL CC(CN1CCC(CC1)CC2=CC=CC=C2)C(C3=CC=C(C=C3)O)O D0K0DB HIGHSTAT Terminated D0K0KP DRUG__ID D0K0KP D0K0KP DRUGCOMP University of Vienna D0K0KP DRUGTYPE Small molecular drug D0K0KP DRUGINCH 1S/C21H25NO2/c1-2-14-22-15-19(23)21-18(13-12-16-8-4-3-5-9-16)17-10-6-7-11-20(17)24-21/h3-11,19,22-23H,2,12-15H2,1H3 D0K0KP DRUGINKE XPEXCFSBFPOSQR-UHFFFAOYSA-N D0K0KP DRUGSMIL CCCNCC(C1=C(C2=CC=CC=C2O1)CCC3=CC=CC=C3)O D0K0KP HIGHSTAT Terminated D0K1AF DRUG__ID D0K1AF D0K1AF DRUGCOMP Abbott Laboratories D0K1AF DRUGTYPE Small molecular drug D0K1AF DRUGINCH 1S/C44H74N4O8/c1-5-6-18-40(56-41(30-35-16-11-8-12-17-35)44(52)48-23-19-36(20-24-48)55-32-53-4)43(51)46-38(29-34-14-9-7-10-15-34)39(49)31-37(33(2)3)42(50)45-21-13-22-47-25-27-54-28-26-47/h8,11-12,16-17,33-34,36-41,49H,5-7,9-10,13-15,18-32H2,1-4H3,(H,45,50)(H,46,51)/t37?,38?,39?,40-,41-/m0/s1 D0K1AF DRUGINKE NVMVSIUABPBQIL-UOKFUGOKSA-N D0K1AF DRUGSMIL CCCCC(C(=O)NC(CC1CCCCC1)C(CC(C(C)C)C(=O)NCCCN2CCOCC2)O)OC(CC3=CC=CC=C3)C(=O)N4CCC(CC4)OCOC D0K1AF HIGHSTAT Terminated D0K4PN DRUG__ID D0K4PN D0K4PN DRUGCOMP AstraZeneca plc D0K4PN DRUGTYPE Small molecular drug D0K4PN DRUGINCH 1S/C28H32FN5O4/c1-3-26(36)34-14-12-32(13-15-34)21-6-4-20(5-7-21)30-28(37)25-18-24(35)22-16-19(29)17-23(27(22)38-25)33-10-8-31(2)9-11-33/h4-7,16-18H,3,8-15H2,1-2H3,(H,30,37) D0K4PN DRUGINKE CKBARMWSFIJZTL-UHFFFAOYSA-N D0K4PN DRUGSMIL CCC(=O)N1CCN(CC1)C2=CC=C(C=C2)NC(=O)C3=CC(=O)C4=C(O3)C(=CC(=C4)F)N5CCN(CC5)C D0K4PN HIGHSTAT Terminated D0K5IQ DRUG__ID D0K5IQ D0K5IQ DRUGCOMP Taisho Pharmaceutical Co Ltd D0K5IQ DRUGTYPE Small molecular drug D0K5IQ DRUGINCH 1S/C24H24ClNO3/c1-17(2)28-23-12-8-7-9-19(23)16-26(18(3)27)22-14-13-20(25)15-24(22)29-21-10-5-4-6-11-21/h4-15,17H,16H2,1-3H3 D0K5IQ DRUGINKE CGUBOFYHGYNUDL-UHFFFAOYSA-N D0K5IQ DRUGSMIL CC(C)OC1=CC=CC=C1CN(C2=C(C=C(C=C2)Cl)OC3=CC=CC=C3)C(=O)C D0K5IQ HIGHSTAT Terminated D0K7PQ DRUG__ID D0K7PQ D0K7PQ DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D0K7PQ DRUGTYPE Small molecular drug D0K7PQ DRUGINCH 1S/C22H29NO3.ClH/c1-4-23(15-20(24)16-8-6-5-7-9-16)19-11-10-17-13-21(25-2)22(26-3)14-18(17)12-19;/h5-9,13-14,19-20,24H,4,10-12,15H2,1-3H3;1H D0K7PQ DRUGINKE WJUIBTVLKPPFBR-UHFFFAOYSA-N D0K7PQ DRUGSMIL CCN(CC(C1=CC=CC=C1)O)C2CCC3=CC(=C(C=C3C2)OC)OC.Cl D0K7PQ HIGHSTAT Terminated D0K9TC DRUG__ID D0K9TC D0K9TC DRUGCOMP Astra AB D0K9TC DRUGTYPE Small molecular drug D0K9TC DRUGINCH 1S/C21H34N2O/c1-4-6-7-11-16-23-17-14-21(15-18-23,20(24)22(3)5-2)19-12-9-8-10-13-19/h8-10,12-13H,4-7,11,14-18H2,1-3H3 D0K9TC DRUGINKE TYWUGCGYWNSRPS-UHFFFAOYSA-N D0K9TC DRUGSMIL CCCCCCN1CCC(CC1)(C2=CC=CC=C2)C(=O)N(C)CC D0K9TC HIGHSTAT Terminated D0KJ4U DRUG__ID D0KJ4U D0KJ4U DRUGCOMP Acea Pharmaceuticals Inc D0KJ4U DRUGTYPE Small molecular drug D0KJ4U DRUGINCH 1S/C9H4ClF3N2O2/c10-4-1-3(9(11,12)13)2-5-6(4)15-8(17)7(16)14-5/h1-2H,(H,14,16)(H,15,17) D0KJ4U DRUGINKE JDCKMCIQUXTYQI-UHFFFAOYSA-N D0KJ4U DRUGSMIL C1=C(C=C(C2=C1NC(=O)C(=O)N2)Cl)C(F)(F)F D0KJ4U HIGHSTAT Terminated D0KN7H DRUG__ID D0KN7H D0KN7H DRUGCOMP Merck KGaA D0KN7H DRUGTYPE Small molecular drug D0KN7H DRUGINCH 1S/C17H12O4/c18-14-10-15(11-5-2-1-3-6-11)21-17-12(9-16(19)20)7-4-8-13(14)17/h1-8,10H,9H2,(H,19,20) D0KN7H DRUGINKE TZZNWMJZDWYJAZ-UHFFFAOYSA-N D0KN7H DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=CC=CC(=C3O2)CC(=O)O D0KN7H HIGHSTAT Terminated D0L1VR DRUG__ID D0L1VR D0L1VR DRUGCOMP Synvista Therapeutics Inc D0L1VR DRUGTYPE Small molecular drug D0L1VR DRUGINCH 1S/C5H13N5O.ClH/c1-5(11)8-3-2-7-4-9-10-6;/h4,10H,2-3,6H2,1H3,(H,7,9)(H,8,11);1H D0L1VR DRUGINKE CMCWIHQJEQYHPX-UHFFFAOYSA-N D0L1VR DRUGSMIL CC(=O)NCCN=CNNN.Cl D0L1VR HIGHSTAT Terminated D0L2QJ DRUG__ID D0L2QJ D0L2QJ DRUGCOMP Uniroyal Chemical Co Inc D0L2QJ DRUGTYPE Small molecular drug D0L2QJ DRUGINCH 1S/C16H18ClNO4S/c1-9(2)22-16(20)12-8-11(4-5-13(12)17)18-15(19)14-10(3)21-6-7-23-14/h4-5,8-9H,6-7H2,1-3H3,(H,18,19) D0L2QJ DRUGINKE FMQGUMRNTBJHEA-UHFFFAOYSA-N D0L2QJ DRUGSMIL CC1=C(SCCO1)C(=O)NC2=CC(=C(C=C2)Cl)C(=O)OC(C)C D0L2QJ HIGHSTAT Terminated D0L3GG DRUG__ID D0L3GG D0L3GG DRUGCOMP Idera Pharmaceuticals Inc D0L3GG DRUGTYPE Small molecular drug D0L3GG DRUGINCH 1S/C201H259N75O122P20/c1-81-42-262(197(294)252-175(81)278)137-27-91(385-405(311,312)348-55-113-94(30-140(369-113)265-45-84(4)178(281)255-200(265)297)387-407(315,316)350-57-115-99(35-148(372-115)274-78-232-158-172(274)243-189(214)249-183(158)286)392-413(327,328)354-61-120-101(37-136(364-120)261-21-16-130(206)239-196(261)293)394-416(331,337-9)359-66-125-105(41-150(379-125)276-80-234-160-174(276)245-191(216)251-185(160)288)398-418(333,339-11)358-65-124-104(40-144(378-124)270-74-228-154-164(210)220-70-224-168(154)270)397-417(332,338-10)357-64-123-103(39-143(377-123)269-73-227-153-163(209)219-69-223-167(153)269)396-415(330,336-8)355-62-121-90(26-135(365-121)260-20-15-129(205)238-195(260)292)383-400(301,302)341-47-106-86(277)22-131(360-106)267-71-225-151-161(207)217-67-221-165(151)267)110(366-137)52-345-402(305,306)381-88-24-133(258-18-13-127(203)236-193(258)290)361-107(88)49-342-401(303,304)380-87-23-132(257-17-12-126(202)235-192(257)289)362-108(87)50-343-408(317,318)388-95-31-142(268-72-226-152-162(208)218-68-222-166(152)268)371-114(95)56-349-406(313,314)386-93-29-139(264-44-83(3)177(280)254-199(264)296)368-112(93)54-347-404(309,310)384-92-28-138(263-43-82(2)176(279)253-198(263)295)367-111(92)53-346-403(307,308)382-89-25-134(259-19-14-128(204)237-194(259)291)363-109(89)51-344-409(319,320)389-96-32-145(271-75-229-155-169(271)240-186(211)246-180(155)283)373-116(96)58-351-410(321,322)390-97-33-146(272-76-230-156-170(272)241-187(212)247-181(156)284)374-117(97)59-352-411(323,324)391-98-34-147(273-77-231-157-171(273)242-188(213)248-182(157)285)375-118(98)60-353-412(325,326)393-100-36-149(275-79-233-159-173(275)244-190(215)250-184(159)287)376-122(100)63-356-414(329,335-7)395-102-38-141(266-46-85(5)179(282)256-201(266)298)370-119(102)48-340-399(299,300)334-6/h12-21,42-46,67-80,86-125,131-150,277H,22-41,47-66H2,1-11H3,(H,299,300)(H,301,302)(H,303,304)(H,305,306)(H,307,308)(H,309,310)(H,311,312)(H,313,314)(H,315,316)(H,317,318)(H,319,320)(H,321,322)(H,323,324)(H,325,326)(H,327,328)(H2,202,235,289)(H2,203,236,290)(H2,204,237,291)(H2,205,238,292)(H2,206,239,293)(H2,207,217,221)(H2,208,218,222)(H2,209,219,223)(H2,210,220,224)(H,252,278,294)(H,253,279,295)(H,254,280,296)(H,255,281,297)(H,256,282,298)(H3,211,240,246,283)(H3,212,241,247,284)(H3,213,242,248,285)(H3,214,243,249,286)(H3,215,244,250,287)(H3,216,245,251,288) D0L3GG DRUGINKE OUGPQMKVHOPOBY-UHFFFAOYSA-N D0L3GG DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(OC)OC1CC(OC1COP(=O)(O)OC)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(OC)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(OC)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(OC)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(OC)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O D0L3GG HIGHSTAT Terminated D0L5YF DRUG__ID D0L5YF D0L5YF DRUGCOMP AstraZeneca plc D0L5YF DRUGTYPE Small molecular drug D0L5YF DRUGINCH 1S/C19H16BrFN6O2/c1-28-17-9-13-16(10-18(17)29-7-6-27-5-4-24-26-27)22-11-23-19(13)25-15-3-2-12(20)8-14(15)21/h2-5,8-11H,6-7H2,1H3,(H,22,23,25) D0L5YF DRUGINKE YBTGTVGEKMZEQX-UHFFFAOYSA-N D0L5YF DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C=C(C=C3)Br)F)OCCN4C=CN=N4 D0L5YF HIGHSTAT Terminated D0L8RG DRUG__ID D0L8RG D0L8RG DRUGCOMP Parke-Davis & Co D0L8RG DRUGTYPE Small molecular drug D0L8RG DRUGINCH 1S/C16H22N2OS2.C5H14NO/c1-15(2,3)10-7-9(13-17-18-14(20)21-13)8-11(12(10)19)16(4,5)6;1-6(2,3)4-5-7/h7-8,19H,1-6H3,(H,18,20);7H,4-5H2,1-3H3/q;+1/p-1 D0L8RG DRUGINKE BIZSVVIRPJXFOI-UHFFFAOYSA-M D0L8RG DRUGSMIL CC(C)(C)C1=CC(=CC(=C1[O-])C(C)(C)C)C2=NNC(=S)S2.C[N+](C)(C)CCO D0L8RG HIGHSTAT Terminated D0L8TN DRUG__ID D0L8TN D0L8TN DRUGCOMP Bristol-Myers Squibb Co D0L8TN DRUGTYPE Small molecular drug D0L8TN DRUGINCH 1S/C27H42N2O5/c1-14-6-7-19-18(10-14)11-15(2)20(12-16(3)33-23-9-8-21(28)17(4)34-23)27(19,5)25(31)24-22(30)13-29-26(24)32/h11,14,16-21,23,31H,6-10,12-13,28H2,1-5H3,(H,29,32)/b25-24- D0L8TN DRUGINKE NKWRHFUPAYVQCE-IZHYLOQSSA-N D0L8TN DRUGSMIL CC1CCC2C(C1)C=C(C(C2(C)C(=C3C(=O)CNC3=O)O)CC(C)OC4CCC(C(O4)C)N)C D0L8TN HIGHSTAT Terminated D0L9PL DRUG__ID D0L9PL D0L9PL DRUGCOMP Uniroyal Chemical Co Inc D0L9PL DRUGTYPE Small molecular drug D0L9PL DRUGINCH 1S/C14H18ClNO3S/c1-8(2)18-13(17)11-7-10(5-6-12(11)15)16-14(20)19-9(3)4/h5-9H,1-4H3,(H,16,20) D0L9PL DRUGINKE AXTNFJKQZPETJA-UHFFFAOYSA-N D0L9PL DRUGSMIL CC(C)OC(=O)C1=C(C=CC(=C1)NC(=S)OC(C)C)Cl D0L9PL HIGHSTAT Terminated D0LB4T DRUG__ID D0LB4T D0LB4T DRUGCOMP Dainippon Pharmaceutical Co Ltd D0LB4T DRUGTYPE Small molecular drug D0LB4T DRUGINCH 1S/C22H20N2O5S/c1-13-19(23-21(29-13)15-5-3-2-4-6-15)17(25)12-28-16-9-7-14(8-10-16)11-18-20(26)24-22(27)30-18/h2-10,17-18,25H,11-12H2,1H3,(H,24,26,27) D0LB4T DRUGINKE YVQKIDLSVHRBGZ-UHFFFAOYSA-N D0LB4T DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)C(COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)O D0LB4T HIGHSTAT Terminated D0LK9N DRUG__ID D0LK9N D0LK9N DRUGCOMP Boehringer Ingelheim Corp D0LK9N DRUGTYPE Small molecular drug D0LK9N DRUGINCH 1S/C20H21N3O4/c21-19(22)14-3-1-12(2-4-14)13-5-7-17(8-6-13)27-11-16-9-15(10-18(24)25)20(26)23-16/h1-8,15-16H,9-11H2,(H3,21,22)(H,23,26)(H,24,25)/t15-,16-/m0/s1 D0LK9N DRUGINKE IKZACQMAVUIGPY-HOTGVXAUSA-N D0LK9N DRUGSMIL C1C(C(=O)NC1COC2=CC=C(C=C2)C3=CC=C(C=C3)C(=N)N)CC(=O)O D0LK9N HIGHSTAT Terminated D0LS4U DRUG__ID D0LS4U D0LS4U DRUGCOMP Chiesi SA D0LS4U DRUGTYPE Small molecular drug D0LS4U DRUGINCH 1S/C8H12N2S/c1-9-6-2-3-7-8(4-6)11-5-10-7/h5-6,9H,2-4H2,1H3 D0LS4U DRUGINKE YDSVAKPJAOSZJA-UHFFFAOYSA-N D0LS4U DRUGSMIL CNC1CCC2=C(C1)SC=N2 D0LS4U HIGHSTAT Terminated D0LV0R DRUG__ID D0LV0R D0LV0R DRUGCOMP Aventis Pharma AG D0LV0R DRUGTYPE Small molecular drug D0LV0R DRUGINCH 1S/C42H55N5O8/c48-28-33(49)39(52)40(53)41(54)42(55)45-27-15-6-4-2-1-3-5-10-24-35(50)46-31-21-12-11-20-30(31)37(47-34-23-14-17-26-44-34)36(32-22-13-16-25-43-32)38(51)29-18-8-7-9-19-29/h7-9,11-14,16-23,25-26,33,36-41,48-49,51-54H,1-6,10,15,24,27-28H2,(H,44,47)(H,45,55)(H,46,50)/t33-,36+,37-,38-,39-,40+,41-/m1/s1 D0LV0R DRUGINKE LNLNLJFTSXTELN-TVKRVUGASA-N D0LV0R DRUGSMIL C1=CC=C(C=C1)C(C(C2=CC=CC=N2)C(C3=CC=CC=C3NC(=O)CCCCCCCCCCNC(=O)C(C(C(C(CO)O)O)O)O)NC4=CC=CC=N4)O D0LV0R HIGHSTAT Terminated D0M0NT DRUG__ID D0M0NT D0M0NT DRUGCOMP Pfizer D0M0NT DRUGTYPE Small molecular drug D0M0NT DRUGINCH 1S/C21H24N4O4/c22-19-18-20(24-12-23-19)29-10-9-25(21(18)28)16-7-5-15(6-8-16)14-3-1-13(2-4-14)11-17(26)27/h5-8,12-14H,1-4,9-11H2,(H,26,27)(H2,22,23,24) D0M0NT DRUGINKE GEVVQZHMFVFGLN-UHFFFAOYSA-N D0M0NT DRUGSMIL C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)N3CCOC4=NC=NC(=C4C3=O)N D0M0NT HIGHSTAT Terminated D0M0UJ DRUG__ID D0M0UJ D0M0UJ DRUGCOMP Gilead Sciences Inc D0M0UJ DRUGTYPE Small molecular drug D0M0UJ DRUGINCH 1S/C10H11FN5O5P/c11-5-1-6(20-4-22(17,18)19)21-10(5)16-3-15-7-8(12)13-2-14-9(7)16/h1-3,6,10H,4H2,(H2,12,13,14)(H2,17,18,19)/t6-,10+/m0/s1 D0M0UJ DRUGINKE MPSGQQOHTJUJKB-QUBYGPBYSA-N D0M0UJ DRUGSMIL C1=C(C(OC1OCP(=O)(O)O)N2C=NC3=C(N=CN=C32)N)F D0M0UJ HIGHSTAT Terminated D0M3JI DRUG__ID D0M3JI D0M3JI DRUGCOMP Sumitomo Pharmaceuticals Co Ltd D0M3JI DRUGTYPE Small molecular drug D0M3JI DRUGINCH 1S/C18H14ClN5O3S.Na/c1-12-16(11-20)17(24(22-12)14-5-3-2-4-6-14)21-18(25)23-28(26,27)15-9-7-13(19)8-10-15;/h2-10H,1H3,(H2,21,22,23,25);/q;+1/p-1 D0M3JI DRUGINKE FBSZSOXTWRKLKD-UHFFFAOYSA-M D0M3JI DRUGSMIL CC1=NN(C(=C1C#N)NC(=O)[N-]S(=O)(=O)C2=CC=C(C=C2)Cl)C3=CC=CC=C3.[Na+] D0M3JI HIGHSTAT Terminated D0M4HM DRUG__ID D0M4HM D0M4HM DRUGCOMP The Menarini Group D0M4HM DRUGTYPE Small molecular drug D0M4HM DRUGINCH 1S/C16H14N4OS/c1-3-20-13-12-11(7-5-8-17-12)21-14(13)16(22)19(2)10-6-4-9-18-15(10)20/h4-9H,3H2,1-2H3 D0M4HM DRUGINKE SSUWZXRTDXAIQO-UHFFFAOYSA-N D0M4HM DRUGSMIL CCN1C2=C(C(=S)N(C3=C1N=CC=C3)C)OC4=C2N=CC=C4 D0M4HM HIGHSTAT Terminated D0M4LF DRUG__ID D0M4LF D0M4LF DRUGCOMP AstraZeneca plc D0M4LF DRUGTYPE Small molecular drug D0M4LF DRUGINCH 1S/C23H26N4O5S/c1-3-32-23(29)20-13-19(14-24)21(25-16(20)2)27-11-9-18(10-12-27)22(28)26-33(30,31)15-17-7-5-4-6-8-17/h4-8,13,18H,3,9-12,15H2,1-2H3,(H,26,28) D0M4LF DRUGINKE NEMHKCNXXRQYRF-UHFFFAOYSA-N D0M4LF DRUGSMIL CCOC(=O)C1=C(N=C(C(=C1)C#N)N2CCC(CC2)C(=O)NS(=O)(=O)CC3=CC=CC=C3)C D0M4LF HIGHSTAT Terminated D0M7BW DRUG__ID D0M7BW D0M7BW DRUGCOMP Glaxo Group Research Ltd D0M7BW DRUGTYPE Small molecular drug D0M7BW DRUGINCH 1S/C19H25Cl2N3O3/c1-27-19(26)23-8-9-24(15(13-23)12-22-6-2-3-7-22)18(25)11-14-4-5-16(20)17(21)10-14/h4-5,10,15H,2-3,6-9,11-13H2,1H3 D0M7BW DRUGINKE HJUAKZYKCANOOZ-UHFFFAOYSA-N D0M7BW DRUGSMIL COC(=O)N1CCN(C(C1)CN2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl D0M7BW HIGHSTAT Terminated D0M7VW DRUG__ID D0M7VW D0M7VW DRUGCOMP Glaxo Group Research Ltd D0M7VW DRUGTYPE Small molecular drug D0M7VW DRUGINCH 1S/C16H17N3O/c1-11-13(18-10-17-11)7-8-16(20)15-9-12-5-3-4-6-14(12)19(15)2/h3-6,9-10H,7-8H2,1-2H3,(H,17,18) D0M7VW DRUGINKE AQCBJPZFJDPIGL-UHFFFAOYSA-N D0M7VW DRUGSMIL CC1=C(N=CN1)CCC(=O)C2=CC3=CC=CC=C3N2C D0M7VW HIGHSTAT Terminated D0M9CV DRUG__ID D0M9CV D0M9CV DRUGCOMP Tanabe Seiyaku Co Ltd D0M9CV DRUGTYPE Small molecular drug D0M9CV DRUGINCH 1S/C23H28N2O3S/c1-15-6-9-18(10-7-15)22-21(28-17(3)26)23(27)25(13-12-24(4)5)19-11-8-16(2)14-20(19)29-22/h6-11,14,21-22H,12-13H2,1-5H3 D0M9CV DRUGINKE FVGKAJGOHWOXLU-UHFFFAOYSA-N D0M9CV DRUGSMIL CC1=CC=C(C=C1)C2C(C(=O)N(C3=C(S2)C=C(C=C3)C)CCN(C)C)OC(=O)C D0M9CV HIGHSTAT Terminated D0M9ER DRUG__ID D0M9ER D0M9ER DRUGCOMP Exonhit D0M9ER DRUGTYPE Small molecular drug D0M9ER DRUGINCH 1S/C25H27F3N2O4S.2ClH/c26-25(27,28)18-4-5-20-21(14-18)29-7-6-24(20)35-13-3-1-2-10-33-23-17-34-19(15-22(23)31)16-30-8-11-32-12-9-30;;/h4-7,14-15,17H,1-3,8-13,16H2;2*1H D0M9ER DRUGINKE LSECOAJFCKFQJG-UHFFFAOYSA-N D0M9ER DRUGSMIL C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl D0M9ER HIGHSTAT Terminated D0M9GE DRUG__ID D0M9GE D0M9GE DRUGCOMP GlaxoSmithKline D0M9GE DRUGTYPE Small molecular drug D0M9GE DRUGINCH 1S/C21H27N3/c1-16-14-23(15-17(2)22-16)12-7-13-24-20-10-5-3-8-18(20)19-9-4-6-11-21(19)24/h3-6,8-11,16-17,22H,7,12-15H2,1-2H3/t16-,17+ D0M9GE DRUGINKE GUDVQJXODNJRIJ-CALCHBBNSA-N D0M9GE DRUGSMIL CC1CN(CC(N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42 D0M9GE HIGHSTAT Terminated D0M9VZ DRUG__ID D0M9VZ D0M9VZ DRUGCOMP Bayer Schering Pharma AG D0M9VZ DRUGTYPE Small molecular drug D0M9VZ DRUGINCH 1S/C9H11N5O4/c10-13-12-5-3-8(18-6(5)4-15)14-2-1-7(16)11-9(14)17/h1-2,5-6,8,15H,3-4H2,(H,11,16,17)/t5-,6+,8+/m0/s1 D0M9VZ DRUGINKE ZSNNBSPEFVIUDS-SHYZEUOFSA-N D0M9VZ DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)CO)N=[N+]=[N-] D0M9VZ HIGHSTAT Terminated D0MK2C DRUG__ID D0MK2C D0MK2C DRUGCOMP Sanofi-Aventis D0MK2C DRUGTYPE Small molecular drug D0MK2C DRUGINCH 1S/C22H31Cl.ClH/c23-22-17-19(12-8-11-18-9-4-1-2-5-10-18)15-16-21(22)20-13-6-3-7-14-20;/h8,12,15-18,20H,1-7,9-11,13-14H2;1H/b12-8-; D0MK2C DRUGINKE YAPBCZRQTMBLEF-JCTPKUEWSA-N D0MK2C DRUGSMIL C1CCCC(CC1)CC=CC2=CC(=C(C=C2)C3CCCCC3)Cl.Cl D0MK2C HIGHSTAT Terminated D0ML0R DRUG__ID D0ML0R D0ML0R DRUGCOMP SmithKline Beecham plc D0ML0R DRUGTYPE Small molecular drug D0ML0R DRUGINCH 1S/C20H40N2.2ClH/c1-5-8-19(9-6-2)10-12-20(13-11-19)14-17-22(18-20)16-7-15-21(3)4;;/h5-18H2,1-4H3;2*1H D0ML0R DRUGINKE DEMCXQLRORUZNV-UHFFFAOYSA-N D0ML0R DRUGSMIL CCCC1(CCC2(CC1)CCN(C2)CCCN(C)C)CCC.Cl.Cl D0ML0R HIGHSTAT Terminated D0MP1C DRUG__ID D0MP1C D0MP1C DRUGCOMP Knoll Pharmaceuticals Co D0MP1C DRUGTYPE Small molecular drug D0MP1C DRUGINCH 1S/C11H10FNO2S/c1-13-6-10(16(2)15)11(14)8-4-3-7(12)5-9(8)13/h3-6H,1-2H3 D0MP1C DRUGINKE UYGONJYYUKVHDD-UHFFFAOYSA-N D0MP1C DRUGSMIL CN1C=C(C(=O)C2=C1C=C(C=C2)F)S(=O)C D0MP1C HIGHSTAT Terminated D0N1WM DRUG__ID D0N1WM D0N1WM DRUGCOMP Abbott Laboratories D0N1WM DRUGTYPE Small molecular drug D0N1WM DRUGINCH 1S/C16H17NO3/c17-9-15-11-6-7-13(18)16(19)12(11)8-14(20-15)10-4-2-1-3-5-10/h1-7,14-15,18-19H,8-9,17H2/t14-,15-/m0/s1 D0N1WM DRUGINKE SUHGRZPINGKYNV-GJZGRUSLSA-N D0N1WM DRUGSMIL C1C(OC(C2=C1C(=C(C=C2)O)O)CN)C3=CC=CC=C3 D0N1WM HIGHSTAT Terminated D0N4SU DRUG__ID D0N4SU D0N4SU DRUGCOMP OXIS International Inc D0N4SU DRUGTYPE Small molecular drug D0N4SU DRUGINCH 1S/C7H13NO4/c1-11-4-5-12-7(10)3-2-6(8)9/h2-5H2,1H3,(H2,8,9) D0N4SU DRUGINKE VJDVWBDSMDTODO-UHFFFAOYSA-N D0N4SU DRUGSMIL COCCOC(=O)CCC(=O)N D0N4SU HIGHSTAT Terminated D0N5CT DRUG__ID D0N5CT D0N5CT DRUGCOMP Boehringer Ingelheim Corp D0N5CT DRUGTYPE Small molecular drug D0N5CT DRUGINCH 1S/C33H37Cl2N5O4/c1-4-6-8-18-39(33(44)36-3)23-14-17-26-27(19-23)40(28(38-26)9-7-5-2)20-21-10-12-22(13-11-21)37-31(41)29-24(34)15-16-25(35)30(29)32(42)43/h10-17,19H,4-9,18,20H2,1-3H3,(H,36,44)(H,37,41)(H,42,43) D0N5CT DRUGINKE ZHWGRXBJGUEATA-UHFFFAOYSA-N D0N5CT DRUGSMIL CCCCCN(C1=CC2=C(C=C1)N=C(N2CC3=CC=C(C=C3)NC(=O)C4=C(C=CC(=C4C(=O)O)Cl)Cl)CCCC)C(=O)NC D0N5CT HIGHSTAT Terminated D0N5YX DRUG__ID D0N5YX D0N5YX DRUGCOMP Pfizer Inc D0N5YX DRUGTYPE Small molecular drug D0N5YX DRUGINCH 1S/C20H20NO5P/c21-19(20(22)23)11-13-8-14(12-27(24,25)26)10-16(9-13)18-7-3-5-15-4-1-2-6-17(15)18/h1-10,19H,11-12,21H2,(H,22,23)(H2,24,25,26)/t19-/m0/s1 D0N5YX DRUGINKE YFASPHLUVUCGGI-IBGZPJMESA-N D0N5YX DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C3=CC(=CC(=C3)CP(=O)(O)O)CC(C(=O)O)N D0N5YX HIGHSTAT Terminated D0N8NK DRUG__ID D0N8NK D0N8NK DRUGCOMP AstraZeneca plc D0N8NK DRUGTYPE Small molecular drug D0N8NK DRUGINCH 1S/C18H21F4N3O6S/c1-17(15(26)23-16(27)24-17)10-32(28,29)25-8-6-12(7-9-25)30-11-2-4-13(5-3-11)31-18(21,22)14(19)20/h2-5,12,14H,6-10H2,1H3,(H2,23,24,26,27)/t17-/m1/s1 D0N8NK DRUGINKE SBVAXUGOISPYPX-QGZVFWFLSA-N D0N8NK DRUGSMIL CC1(C(=O)NC(=O)N1)CS(=O)(=O)N2CCC(CC2)OC3=CC=C(C=C3)OC(C(F)F)(F)F D0N8NK HIGHSTAT Terminated D0N9DZ DRUG__ID D0N9DZ D0N9DZ DRUGCOMP Faustus Forschungs Cie Translational Cancer Research GmbH D0N9DZ DRUGTYPE Small molecular drug D0N9DZ DRUGINCH 1S/C5H10ClN3O3/c6-1-3-9(8-12)5(11)7-2-4-10/h10H,1-4H2,(H,7,11) D0N9DZ DRUGINKE YJZJEQBSODVMTH-UHFFFAOYSA-N D0N9DZ DRUGSMIL C(CO)NC(=O)N(CCCl)N=O D0N9DZ HIGHSTAT Terminated D0NF7S DRUG__ID D0NF7S D0NF7S DRUGCOMP Janssen Pharmaceutica NV D0NF7S DRUGTYPE Small molecular drug D0NF7S DRUGINCH 1S/C22H23N3OS/c1-24(22-23-20-11-5-6-12-21(20)27-22)18-13-15-25(17-18)14-7-8-16-26-19-9-3-2-4-10-19/h2-6,9-13,15,17H,7-8,14,16H2,1H3 D0NF7S DRUGINKE PFBZXLGUUGDBNI-UHFFFAOYSA-N D0NF7S DRUGSMIL CN(C1=CN(C=C1)CCCCOC2=CC=CC=C2)C3=NC4=CC=CC=C4S3 D0NF7S HIGHSTAT Terminated D0NH6F DRUG__ID D0NH6F D0NH6F DRUGCOMP Organon BioSciences D0NH6F DRUGTYPE Small molecular drug D0NH6F DRUGINCH 1S/C23H23F2NO.C4H4O4/c1-2-26(15-14-18-6-4-3-5-7-18)27-17-20-10-13-22(25)16-23(20)19-8-11-21(24)12-9-19;5-3(6)1-2-4(7)8/h3-13,16H,2,14-15,17H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D0NH6F DRUGINKE GMPALWBPFJCWPO-BTJKTKAUSA-N D0NH6F DRUGSMIL CCN(CCC1=CC=CC=C1)OCC2=C(C=C(C=C2)F)C3=CC=C(C=C3)F.C(=CC(=O)O)C(=O)O D0NH6F HIGHSTAT Terminated D0NR3V DRUG__ID D0NR3V D0NR3V DRUGCOMP Boehringer Ingelheim Corp D0NR3V DRUGTYPE Small molecular drug D0NR3V DRUGINCH 1S/C26H36N2O5/c1-27(13-9-19-7-8-22(30-2)23(15-19)31-3)11-6-12-28-14-10-20-16-24(32-4)25(33-5)17-21(20)18-26(28)29/h7-8,15-17H,6,9-14,18H2,1-5H3 D0NR3V DRUGINKE KEDQCFRVSHYKLR-UHFFFAOYSA-N D0NR3V DRUGSMIL CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CCC3=CC(=C(C=C3)OC)OC D0NR3V HIGHSTAT Terminated D0O0QG DRUG__ID D0O0QG D0O0QG DRUGCOMP GD Searle & Co D0O0QG DRUGTYPE Small molecular drug D0O0QG DRUGINCH 1S/C24H29N7O/c1-3-5-11-22-27-31(16-6-4-2)24(32)30(22)17-18-12-14-19(15-13-18)20-9-7-8-10-21(20)23-25-28-29-26-23/h7-10,12-15H,3-6,11,16-17H2,1-2H3,(H,25,26,28,29) D0O0QG DRUGINKE STODEQQYGGTXOS-UHFFFAOYSA-N D0O0QG DRUGSMIL CCCCC1=NN(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CCCC D0O0QG HIGHSTAT Terminated D0O0RK DRUG__ID D0O0RK D0O0RK DRUGCOMP Abbott Laboratories D0O0RK DRUGTYPE Small molecular drug D0O0RK DRUGINCH 1S/C23H23N7O2/c1-2-3-12-30(22-20(23(31)32)13-24-15-25-22)14-16-8-10-17(11-9-16)18-6-4-5-7-19(18)21-26-28-29-27-21/h4-11,13,15H,2-3,12,14H2,1H3,(H,31,32)(H,26,27,28,29) D0O0RK DRUGINKE AHZXSVWCNDLJER-UHFFFAOYSA-N D0O0RK DRUGSMIL CCCCN(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C4=NC=NC=C4C(=O)O D0O0RK HIGHSTAT Terminated D0O1AV DRUG__ID D0O1AV D0O1AV DRUGCOMP Glaxo Wellcome plc D0O1AV DRUGTYPE Small molecular drug D0O1AV DRUGINCH 1S/C35H46O14/c1-7-19(2)17-20(3)13-14-25(37)47-28-27(38)33(48-29(30(39)40)34(45,31(41)42)35(28,49-33)32(43)44)16-15-21(4)26(46-23(6)36)22(5)18-24-11-9-8-10-12-24/h8-14,19-20,22,26-29,38,45H,4,7,15-18H2,1-3,5-6H3,(H,39,40)(H,41,42)(H,43,44)/b14-13+/t19-,20+,22+,26+,27+,28+,29+,33-,34+,35-/m0/s1 D0O1AV DRUGINKE DFKDOZMCHOGOBR-NCSQYGPNSA-N D0O1AV DRUGSMIL CCC(C)CC(C)C=CC(=O)OC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCC(=C)C(C(C)CC3=CC=CC=C3)OC(=O)C)O D0O1AV HIGHSTAT Terminated D0O1OX DRUG__ID D0O1OX D0O1OX DRUGCOMP Shire Human Genetic Therapies Inc D0O1OX DRUGTYPE Small molecular drug D0O1OX DRUGINCH 1S/C9H21O2PS/c1-4-6-8-11-12(3,10)13-9-7-5-2/h4-9H2,1-3H3 D0O1OX DRUGINKE OLNWHPYZGKSVEV-UHFFFAOYSA-N D0O1OX DRUGSMIL CCCCOP(=O)(C)SCCCC D0O1OX HIGHSTAT Terminated D0O1RH DRUG__ID D0O1RH D0O1RH DRUGCOMP Kuraray Co Ltd D0O1RH DRUGTYPE Small molecular drug D0O1RH DRUGINCH 1S/C12H10O3/c13-11-8-10(12(14)15-11)7-6-9-4-2-1-3-5-9/h1-8,12,14H/b7-6+ D0O1RH DRUGINKE BRSGPHVHVGTCQM-VOTSOKGWSA-N D0O1RH DRUGSMIL C1=CC=C(C=C1)C=CC2=CC(=O)OC2O D0O1RH HIGHSTAT Terminated D0O5LL DRUG__ID D0O5LL D0O5LL DRUGCOMP Gliatech Inc D0O5LL DRUGTYPE Small molecular drug D0O5LL DRUGINCH 1S/C14H20N2/c1-14(2,3)7-5-4-6-11-8-12(11)13-9-15-10-16-13/h9-12H,5,7-8H2,1-3H3,(H,15,16)/t11-,12-/m0/s1 D0O5LL DRUGINKE CVKJAXCQPFOAIN-RYUDHWBXSA-N D0O5LL DRUGSMIL CC(C)(C)CCC#CC1CC1C2=CN=CN2 D0O5LL HIGHSTAT Terminated D0O6WJ DRUG__ID D0O6WJ D0O6WJ DRUGCOMP Research Institute for Medicine & Chemistry Inc D0O6WJ DRUGTYPE Small molecular drug D0O6WJ DRUGINCH 1S/C29H45NO3/c1-20(9-14-28(33)30-16-5-4-6-17-30)25-12-13-26-22(8-7-15-29(25,26)3)10-11-23-18-24(31)19-27(32)21(23)2/h10-11,20,24-27,31-32H,2,4-9,12-19H2,1,3H3/b22-10+,23-11-/t20-,24+,25+,26-,27-,29+/m0/s1 D0O6WJ DRUGINKE DXWZPQRKPXFQGC-QCUPEZPBSA-N D0O6WJ DRUGSMIL CC(CCC(=O)N1CCCCC1)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D0O6WJ HIGHSTAT Terminated D0O7BW DRUG__ID D0O7BW D0O7BW DRUGCOMP Scotia Holdings plc D0O7BW DRUGTYPE Small molecular drug D0O7BW DRUGINCH 1S/C14H10FN3/c15-12-3-1-11(2-4-12)14-13(9-17-18-14)10-5-7-16-8-6-10/h1-9H,(H,17,18) D0O7BW DRUGINKE BILJSHVAAVZERY-UHFFFAOYSA-N D0O7BW DRUGSMIL C1=CC(=CC=C1C2=C(C=NN2)C3=CC=NC=C3)F D0O7BW HIGHSTAT Terminated D0O9IB DRUG__ID D0O9IB D0O9IB DRUGCOMP Parke-Davis & Co D0O9IB DRUGTYPE Small molecular drug D0O9IB DRUGINCH 1S/C15H17NO5/c1-21-12-6-2-10(3-7-12)15(20)16-11(4-8-13(16)17)5-9-14(18)19/h2-3,6-7,11H,4-5,8-9H2,1H3,(H,18,19) D0O9IB DRUGINKE RETXVYVFAUXRHY-UHFFFAOYSA-N D0O9IB DRUGSMIL COC1=CC=C(C=C1)C(=O)N2C(CCC2=O)CCC(=O)O D0O9IB HIGHSTAT Terminated D0OL9V DRUG__ID D0OL9V D0OL9V DRUGCOMP Novartis AG D0OL9V DRUGTYPE Small molecular drug D0OL9V DRUGINCH 1S/C57H77N3O12/c1-29-26-32(4)39(33(5)27-29)28-59-21-23-60(24-22-59)45-44-51-42-41(52(45)67-16)43-50(37(9)49(42)71-55(65)56(11,12)13)72-57(14,53(43)64)68-25-20-40(66-15)34(6)48(69-38(10)61)36(8)47(63)35(7)46(62)30(2)18-17-19-31(3)54(58-44)70-51/h17-20,25-27,30,34-36,40,46-48,53,62-64H,21-24,28H2,1-16H3/b18-17+,25-20+,31-19- D0OL9V DRUGINKE CGBMSJVNJLFYAU-DEQLRLSPSA-N D0OL9V DRUGSMIL CC1C=CC=C(C2=NC3=C(O2)C4=C(C(=C5C(=C4C(=C3N6CCN(CC6)CC7=C(C=C(C=C7C)C)C)OC)C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C)OC(=O)C(C)(C)C)C D0OL9V HIGHSTAT Terminated D0OM5M DRUG__ID D0OM5M D0OM5M DRUGCOMP Roche Holding AG D0OM5M DRUGTYPE Small molecular drug D0OM5M DRUGINCH 1S/C10H10N2O5S/c1-10(3-2-4-11)8(9(14)15)12-6(13)5-7(12)18(10,16)17/h2-3,7-8H,5H2,1H3,(H,14,15)/b3-2+/t7-,8+,10+/m1/s1 D0OM5M DRUGINKE JYGFUXUBGZBBAC-RCRIAUEHSA-N D0OM5M DRUGSMIL CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C=CC#N D0OM5M HIGHSTAT Terminated D0OP7B DRUG__ID D0OP7B D0OP7B DRUGCOMP Eli Lilly & Co D0OP7B DRUGTYPE Small molecular drug D0OP7B DRUGINCH 1S/C30H28O8/c1-36-21-10-7-19(8-11-21)6-4-2-3-5-17-37-25-15-12-23-28(33)24-18-20(30(34)35)9-14-26(24)38-29(23)22(25)13-16-27(31)32/h4,6-12,14-15,18H,2-3,5,13,16-17H2,1H3,(H,31,32)(H,34,35)/b6-4+ D0OP7B DRUGINKE MTTBGOLFCYOWSV-GQCTYLIASA-N D0OP7B DRUGSMIL COC1=CC=C(C=C1)C=CCCCCOC2=C(C3=C(C=C2)C(=O)C4=C(O3)C=CC(=C4)C(=O)O)CCC(=O)O D0OP7B HIGHSTAT Terminated D0OQ4H DRUG__ID D0OQ4H D0OQ4H DRUGCOMP Abbott Laboratories D0OQ4H DRUGTYPE Small molecular drug D0OQ4H DRUGINCH 1S/C20H24BrNO4/c1-22-6-5-12-8-18(24-2)17(23)10-14(12)16(22)7-13-9-19(25-3)20(26-4)11-15(13)21/h8-11,16,23H,5-7H2,1-4H3 D0OQ4H DRUGINKE YVBUTIYRCMQJHW-UHFFFAOYSA-N D0OQ4H DRUGSMIL CN1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3Br)OC)OC)O)OC D0OQ4H HIGHSTAT Terminated D0OX9Q DRUG__ID D0OX9Q D0OX9Q DRUGCOMP Medinox Inc D0OX9Q DRUGTYPE Small molecular drug D0OX9Q DRUGINCH 1S/C12H14N2O2/c1-12(13,11(15)16)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,14H,6,13H2,1H3,(H,15,16) D0OX9Q DRUGINKE ZTTWHZHBPDYSQB-UHFFFAOYSA-N D0OX9Q DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)O)N D0OX9Q HIGHSTAT Terminated D0OY1V DRUG__ID D0OY1V D0OY1V DRUGCOMP NeuroSearch A/S D0OY1V DRUGTYPE Small molecular drug D0OY1V DRUGINCH 1S/C14H10ClF3N2O2/c15-9-4-5-12(21)11(7-9)20-13(22)19-10-3-1-2-8(6-10)14(16,17)18/h1-7,21H,(H2,19,20,22) D0OY1V DRUGINKE KRHJDJMOIKRPNN-UHFFFAOYSA-N D0OY1V DRUGSMIL C1=CC(=CC(=C1)NC(=O)NC2=C(C=CC(=C2)Cl)O)C(F)(F)F D0OY1V HIGHSTAT Terminated D0P3IE DRUG__ID D0P3IE D0P3IE DRUGCOMP Bayer Schering Pharma AG D0P3IE DRUGTYPE Small molecular drug D0P3IE DRUGINCH 1S/C18H20N2O3/c1-5-22-18(21)17-11(4)15-13(9-19-17)20-12-7-6-8-14(16(12)15)23-10(2)3/h6-10,20H,5H2,1-4H3 D0P3IE DRUGINKE VMDUABMKBUKKPG-UHFFFAOYSA-N D0P3IE DRUGSMIL CCOC(=O)C1=NC=C2C(=C1C)C3=C(N2)C=CC=C3OC(C)C D0P3IE HIGHSTAT Terminated D0P5NW DRUG__ID D0P5NW D0P5NW DRUGCOMP SmithKline Beecham Pharmaceuticals D0P5NW DRUGTYPE Small molecular drug D0P5NW DRUGINCH 1S/C14H9NO6/c1-5-2-8-6(4-15-5)12(17)10-9(21-8)3-7(16)13(18)11(10)14(19)20/h2-4,16,18H,1H3,(H,19,20) D0P5NW DRUGINKE JQSDDXAUCUZICT-UHFFFAOYSA-N D0P5NW DRUGSMIL CC1=CC2=C(C=N1)C(=O)C3=C(O2)C=C(C(=C3C(=O)O)O)O D0P5NW HIGHSTAT Terminated D0P9JW DRUG__ID D0P9JW D0P9JW DRUGCOMP Takeda Pharmaceutical Co Ltd D0P9JW DRUGTYPE Small molecular drug D0P9JW DRUGINCH 1S/C7H16N2O2/c1-9(2,3)5-6(8)4-7(10)11/h6H,4-5,8H2,1-3H3/t6-/m1/s1 D0P9JW DRUGINKE DAWBGYHPBBDHMQ-ZCFIWIBFSA-N D0P9JW DRUGSMIL C[N+](C)(C)CC(CC(=O)[O-])N D0P9JW HIGHSTAT Terminated D0PB6P DRUG__ID D0PB6P D0PB6P DRUGCOMP Organon BioSciences D0PB6P DRUGTYPE Small molecular drug D0PB6P DRUGINCH 1S/C15H16N2O3S/c1-8-4-14(18)16-17-15(8)13-6-9-5-10(19-2)11(20-3)7-12(9)21-13/h5-8H,4H2,1-3H3,(H,16,18) D0PB6P DRUGINKE KIYDKXDCNSPKQQ-UHFFFAOYSA-N D0PB6P DRUGSMIL CC1CC(=O)NN=C1C2=CC3=CC(=C(C=C3S2)OC)OC D0PB6P HIGHSTAT Terminated D0PC7I DRUG__ID D0PC7I D0PC7I DRUGCOMP Merck & Co Inc D0PC7I DRUGTYPE Small molecular drug D0PC7I DRUGINCH 1S/C32H34N4O6.ClH/c1-17-26(29(32(41)42)34-28(17)27(18(2)37)31(34)40)20-4-6-22-23(14-20)21-5-3-19(13-24(21)30(22)39)15-35-7-10-36(11-8-35,12-9-35)16-25(33)38;/h3-6,13-14,17-18,27-28,37H,7-12,15-16H2,1-2H3,(H-2,33,38,41,42);1H/t17-,18+,27+,28+,35?,36?;/m0./s1 D0PC7I DRUGINKE LKKUUWNEQCXTNI-BLNZHTMDSA-N D0PC7I DRUGSMIL CC1C2C(C(=O)N2C(=C1C3=CC4=C(C=C3)C(=O)C5=C4C=CC(=C5)C[N+]67CC[N+](CC6)(CC7)CC(=O)N)C(=O)[O-])C(C)O.[Cl-] D0PC7I HIGHSTAT Terminated D0PE1A DRUG__ID D0PE1A D0PE1A THERCLAS Analgesics D0PE1A DRUGTYPE Small molecular drug D0PE1A DRUGINCH 1S/C18H24N4O3/c1-3-5-21-16-12(17(23)22(6-4-2)18(21)24)19-15(20-16)11-8-9-7-10(11)14-13(9)25-14/h9-11,13-14H,3-8H2,1-2H3,(H,19,20)/t9-,10-,11-,13+,14-/m0/s1 D0PE1A DRUGINKE OQCJPFYWFGUHIN-JZKMBYMZSA-N D0PE1A DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CC4CC3C5C4O5 D0PE1A HIGHSTAT Terminated D0PN9E DRUG__ID D0PN9E D0PN9E DRUGCOMP Sanwa Kagaku Kenkyusho Co Ltd D0PN9E DRUGTYPE Small molecular drug D0PN9E DRUGINCH 1S/C19H26ClN3O2.C4H4O4/c1-12-10-13-16(21)15(20)11-14(17(13)25-12)18(24)22-7-6-19-4-2-8-23(19)9-3-5-19;5-3(6)1-2-4(7)8/h11-12H,2-10,21H2,1H3,(H,22,24);1-2H,(H,5,6)(H,7,8)/b;2-1+/t12-;/m0./s1 D0PN9E DRUGINKE ILIMVHLSANAUTN-GYDOPSIJSA-N D0PN9E DRUGSMIL CC1CC2=C(O1)C(=CC(=C2N)Cl)C(=O)NCCC34CCCN3CCC4.C(=CC(=O)O)C(=O)O D0PN9E HIGHSTAT Terminated D0PV3Y DRUG__ID D0PV3Y D0PV3Y DRUGCOMP Meiji Seika Kaisha Ltd D0PV3Y DRUGTYPE Small molecular drug D0PV3Y DRUGINCH 1S/C23H21N5O6S/c1-10-15(19(23(33)34)28-18(10)16(11(2)29)21(28)32)13-7-27-9-25-17(22(27)35-13)20(31)12-4-3-5-26(6-12)8-14(24)30/h3-7,9-11,16,18,29H,8H2,1-2H3,(H2-,24,30,33,34)/t10-,11+,16+,18+/m0/s1 D0PV3Y DRUGINKE LZKPUSJSJVEXAW-WDXSGGTDSA-N D0PV3Y DRUGSMIL CC1C2C(C(=O)N2C(=C1C3=CN4C=NC(=C4S3)C(=O)C5=C[N+](=CC=C5)CC(=O)N)C(=O)[O-])C(C)O D0PV3Y HIGHSTAT Terminated D0Q0HR DRUG__ID D0Q0HR D0Q0HR DRUGCOMP Mitsubishi Pharma D0Q0HR DRUGTYPE Small molecular drug D0Q0HR DRUGINCH 1S/C20H19FN4S/c1-24-8-10-25(11-9-24)19-18-14-4-2-3-5-17(14)26-20(18)23-16-12-13(21)6-7-15(16)22-19/h2-7,12,23H,8-11H2,1H3 D0Q0HR DRUGINKE ILMHNKKMKWQVCE-UHFFFAOYSA-N D0Q0HR DRUGSMIL CN1CCN(CC1)C2=NC3=C(C=C(C=C3)F)NC4=C2C5=CC=CC=C5S4 D0Q0HR HIGHSTAT Terminated D0Q2JS DRUG__ID D0Q2JS D0Q2JS DRUGCOMP SmithKline Beecham Pharmaceuticals D0Q2JS DRUGTYPE Small molecular drug D0Q2JS DRUGINCH 1S/C27H31Cl2N3O2/c28-24-7-4-19(16-25(24)29)5-9-27(34)30-12-2-1-3-13-32-14-10-20(11-15-32)23-18-31-26-8-6-21(33)17-22(23)26/h4-9,16-18,20,31,33H,1-3,10-15H2,(H,30,34)/b9-5+ D0Q2JS DRUGINKE QBRLVMQBZIFWTB-WEVVVXLNSA-N D0Q2JS DRUGSMIL C1CN(CCC1C2=CNC3=C2C=C(C=C3)O)CCCCCNC(=O)C=CC4=CC(=C(C=C4)Cl)Cl D0Q2JS HIGHSTAT Terminated D0Q2PF DRUG__ID D0Q2PF D0Q2PF DRUGCOMP Eli Lilly & Co D0Q2PF DRUGTYPE Small molecular drug D0Q2PF DRUGINCH 1S/C19H26N2O/c1-4-8-21(9-5-2)15-10-14-12-20-18-7-6-16(13(3)22)17(11-15)19(14)18/h6-7,12,15,20H,4-5,8-11H2,1-3H3/t15-/m0/s1 D0Q2PF DRUGINKE CKYZLYQSDNLGPT-HNNXBMFYSA-N D0Q2PF DRUGSMIL CCCN(CCC)C1CC2=CNC3=C2C(=C(C=C3)C(=O)C)C1 D0Q2PF HIGHSTAT Terminated D0Q4US DRUG__ID D0Q4US D0Q4US DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0Q4US DRUGTYPE Small molecular drug D0Q4US DRUGINCH 1S/C14H18N4O4/c1-3-11(10(2)18(21)22)7-13(17-20)9-16-14(19)12-5-4-6-15-8-12/h4-8,10,20H,3,9H2,1-2H3,(H,16,19)/b11-7+,17-13+ D0Q4US DRUGINKE KIWSYRHAAPLJFJ-QHMSGILQSA-N D0Q4US DRUGSMIL CCC(=CC(=NO)CNC(=O)C1=CN=CC=C1)C(C)[N+](=O)[O-] D0Q4US HIGHSTAT Terminated D0Q5QE DRUG__ID D0Q5QE D0Q5QE DRUGCOMP Discovery Laboratories Inc D0Q5QE DRUGTYPE Small molecular drug D0Q5QE DRUGINCH 1S/C13H18N2O2/c1-3-17-13(16)12-8-9(2)14-10-6-4-5-7-11(10)15-12/h4-7,9,12,14-15H,3,8H2,1-2H3 D0Q5QE DRUGINKE MGQPKIPVCPMXQF-UHFFFAOYSA-N D0Q5QE DRUGSMIL CCOC(=O)C1CC(NC2=CC=CC=C2N1)C D0Q5QE HIGHSTAT Terminated D0Q5QF DRUG__ID D0Q5QF D0Q5QF DRUGCOMP Novartis AG D0Q5QF DRUGTYPE Small molecular drug D0Q5QF DRUGINCH 1S/C10H10N2O3S.Na/c1-10(9(14)15)5-16-8(12-10)7-6(13)3-2-4-11-7;/h2-4,13H,5H2,1H3,(H,14,15);/q;+1/p-1/t10-;/m1./s1 D0Q5QF DRUGINKE UGJSEILLHZKUBG-HNCPQSOCSA-M D0Q5QF DRUGSMIL CC1(CSC(=N1)C2=C(C=CC=N2)O)C(=O)[O-].[Na+] D0Q5QF HIGHSTAT Terminated D0Q5ZN DRUG__ID D0Q5ZN D0Q5ZN DRUGCOMP Greenwich Pharmaceuticals Inc D0Q5ZN DRUGTYPE Small molecular drug D0Q5ZN DRUGINCH 1S/C16H30O6/c1-4-5-6-7-8-9-19-13-12(11(18)10-17)20-15-14(13)21-16(2,3)22-15/h11-15,17-18H,4-10H2,1-3H3/t11-,12-,13+,14-,15-/m1/s1 D0Q5ZN DRUGINKE GWSUUEYOBZZHIJ-UXXRCYHCSA-N D0Q5ZN DRUGSMIL CCCCCCCOC1C2C(OC1C(CO)O)OC(O2)(C)C D0Q5ZN HIGHSTAT Terminated D0Q6EN DRUG__ID D0Q6EN D0Q6EN DRUGCOMP A H Robins Co Inc D0Q6EN DRUGTYPE Small molecular drug D0Q6EN DRUGINCH 1S/C31H35F2NO3.C2H2O4/c1-22(2)30(35)23-4-14-29(15-5-23)37-21-3-18-34-19-16-26(17-20-34)31(36,24-6-10-27(32)11-7-24)25-8-12-28(33)13-9-25;3-1(4)2(5)6/h4-15,22,26,36H,3,16-21H2,1-2H3;(H,3,4)(H,5,6) D0Q6EN DRUGINKE IJLRCTPQUZWJSL-UHFFFAOYSA-N D0Q6EN DRUGSMIL CC(C)C(=O)C1=CC=C(C=C1)OCCCN2CCC(CC2)C(C3=CC=C(C=C3)F)(C4=CC=C(C=C4)F)O.C(=O)(C(=O)O)O D0Q6EN HIGHSTAT Terminated D0Q7VI DRUG__ID D0Q7VI D0Q7VI DRUGCOMP SmithKline Beecham plc D0Q7VI DRUGTYPE Small molecular drug D0Q7VI DRUGINCH 1S/C14H16N6O/c1-9-7-12(21)19-20-13(9)10-3-5-11(6-4-10)18-14(16-2)17-8-15/h3-6,9H,7H2,1-2H3,(H,19,21)(H2,16,17,18) D0Q7VI DRUGINKE NUHPODZZKHQQET-UHFFFAOYSA-N D0Q7VI DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)NC(=NC)NC#N D0Q7VI HIGHSTAT Terminated D0Q8YN DRUG__ID D0Q8YN D0Q8YN DRUGCOMP Schering-Plough Corp D0Q8YN DRUGTYPE Small molecular drug D0Q8YN DRUGINCH 1S/C20H22ClN3O/c1-14(25)23-9-11-24(12-10-23)20-18-7-6-17(21)13-16(18)5-4-15-3-2-8-22-19(15)20/h2-3,6-8,13,20H,4-5,9-12H2,1H3 D0Q8YN DRUGINKE AIESXMXVDNOKQF-UHFFFAOYSA-N D0Q8YN DRUGSMIL CC(=O)N1CCN(CC1)C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl D0Q8YN HIGHSTAT Terminated D0QH0R DRUG__ID D0QH0R D0QH0R DRUGCOMP SmithKline Beecham plc D0QH0R DRUGTYPE Small molecular drug D0QH0R DRUGINCH 1S/C38H46N4O5/c1-25(2)34(42-38(46)47-24-29-18-12-7-13-19-29)37(45)41-31(21-28-16-10-6-11-17-28)33(43)22-30(20-27-14-8-5-9-15-27)36-39-23-32(40-36)35(44)26(3)4/h5-19,23,25-26,30-31,33-34,43H,20-22,24H2,1-4H3,(H,39,40)(H,41,45)(H,42,46)/t30-,31+,33+,34+/m1/s1 D0QH0R DRUGINKE RQAVEWKEUKIFLD-LVPKLHHISA-N D0QH0R DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(CC(CC2=CC=CC=C2)C3=NC=C(N3)C(=O)C(C)C)O)NC(=O)OCC4=CC=CC=C4 D0QH0R HIGHSTAT Terminated D0QL3T DRUG__ID D0QL3T D0QL3T DRUGCOMP Kagoshima University D0QL3T DRUGTYPE Small molecular drug D0QL3T DRUGINCH 1S/C25H29FN4O4/c1-27(2)14-17-22-16(24(31)18(25(32)33)15-28(22)3)13-19(26)23(17)30-11-9-29(10-12-30)20-7-5-6-8-21(20)34-4/h5-8,13,15H,9-12,14H2,1-4H3,(H,32,33) D0QL3T DRUGINKE KOVGKNZMHASFHP-UHFFFAOYSA-N D0QL3T DRUGSMIL CN1C=C(C(=O)C2=CC(=C(C(=C21)CN(C)C)N3CCN(CC3)C4=CC=CC=C4OC)F)C(=O)O D0QL3T HIGHSTAT Terminated D0QM0N DRUG__ID D0QM0N D0QM0N DRUGCOMP Boehringer Ingelheim Corp D0QM0N DRUGTYPE Small molecular drug D0QM0N DRUGINCH 1S/C44H70N6O9/c1-28(2)34(49(9)32(52)20-19-29-17-11-10-12-18-29)38(55)47-35(43(6,7)8)39(56)46-31(25-33(53)50-23-15-16-24-50)37(54)48-36(44(41(58)59)21-13-14-22-44)40(57)45-30(27-51)26-42(3,4)5/h10-12,17-18,28,30-31,34-36,51H,13-16,19-27H2,1-9H3,(H,45,57)(H,46,56)(H,47,55)(H,48,54)(H,58,59)/t30?,31-,34-,35+,36+/m0/s1 D0QM0N DRUGINKE KEQHTXSUCBEFIM-GSKLOGINSA-N D0QM0N DRUGSMIL CC(C)C(C(=O)NC(C(=O)NC(CC(=O)N1CCCC1)C(=O)NC(C(=O)NC(CC(C)(C)C)CO)C2(CCCC2)C(=O)O)C(C)(C)C)N(C)C(=O)CCC3=CC=CC=C3 D0QM0N HIGHSTAT Terminated D0QR4H DRUG__ID D0QR4H D0QR4H DRUGCOMP ASTA Medica AG D0QR4H DRUGTYPE Small molecular drug D0QR4H DRUGINCH 1S/C14H10N2O/c1-2-7-12(8-3-1)17-14-13-9-5-4-6-11(13)10-15-16-14/h1-10H D0QR4H DRUGINKE CSHSXUZQMJVDJY-UHFFFAOYSA-N D0QR4H DRUGSMIL C1=CC=C(C=C1)OC2=NN=CC3=CC=CC=C32 D0QR4H HIGHSTAT Terminated D0R1QJ DRUG__ID D0R1QJ D0R1QJ DRUGCOMP ASTA Medica AG D0R1QJ DRUGTYPE Small molecular drug D0R1QJ DRUGINCH 1S/C16H20N4O2/c1-5-9-19-11-7-8-13(22-4)18-15(11)20-12(6-2)17-10(3)14(20)16(19)21/h7-8H,5-6,9H2,1-4H3 D0R1QJ DRUGINKE PJRYVTGCPZXGEY-UHFFFAOYSA-N D0R1QJ DRUGSMIL CCCN1C2=C(N=C(C=C2)OC)N3C(=NC(=C3C1=O)C)CC D0R1QJ HIGHSTAT Terminated D0R1VL DRUG__ID D0R1VL D0R1VL DRUGCOMP Boehringer Ingelheim Corp D0R1VL DRUGTYPE Small molecular drug D0R1VL DRUGINCH 1S/C31H42ClN5O3/c1-5-15-31(3,4)30(40)36(6-2)17-8-9-22-13-18-35(19-14-22)21-27(38)37-26-12-11-23(32)20-24(26)29(39)34-25-10-7-16-33-28(25)37/h7,10-12,16,20,22H,5-6,8-9,13-15,17-19,21H2,1-4H3,(H,34,39) D0R1VL DRUGINKE LUPAFPUKESJDMZ-UHFFFAOYSA-N D0R1VL DRUGSMIL CCCC(C)(C)C(=O)N(CC)CCCC1CCN(CC1)CC(=O)N2C3=C(C=C(C=C3)Cl)C(=O)NC4=C2N=CC=C4 D0R1VL HIGHSTAT Terminated D0R3SI DRUG__ID D0R3SI D0R3SI DRUGCOMP Novo Nordisk A/S D0R3SI DRUGTYPE Small molecular drug D0R3SI DRUGINCH 1S/C25H33F3N2O.2ClH/c1-4-5-15-30-16-14-24(19-6-10-22(11-7-19)29(2)3)20(17-30)18-31-23-12-8-21(9-13-23)25(26,27)28;;/h6-13,20,24H,4-5,14-18H2,1-3H3;2*1H/t20-,24-;;/m1../s1 D0R3SI DRUGINKE VAJHWBBBDAHYRE-OYNPXDHBSA-N D0R3SI DRUGSMIL CCCCN1CCC(C(C1)COC2=CC=C(C=C2)C(F)(F)F)C3=CC=C(C=C3)N(C)C.Cl.Cl D0R3SI HIGHSTAT Terminated D0R8RK DRUG__ID D0R8RK D0R8RK DRUGCOMP Roche Holding AG D0R8RK DRUGTYPE Small molecular drug D0R8RK DRUGINCH 1S/C41H41FN10O12S2/c1-41(2,39(63)47-46-33(56)18-3-6-27(53)28(54)11-18)64-48-29(24-17-66-40(43)44-24)34(57)45-30-35(58)52-31(38(61)62)19(16-65-36(30)52)14-49-7-9-50(10-8-49)26-13-25-21(12-23(26)42)32(55)22(37(59)60)15-51(25)20-4-5-20/h3,6,11-13,15,17,20,30,36,53-54H,4-5,7-10,14,16H2,1-2H3,(H2,43,44)(H,45,57)(H,46,56)(H,47,63)(H,59,60)(H,61,62)/b48-29-/t30-,36-/m1/s1 D0R8RK DRUGINKE IXDFVVUXTFRFQQ-MOSWNVLFSA-N D0R8RK DRUGSMIL CC(C)(C(=O)NNC(=O)C1=CC(=C(C=C1)O)O)ON=C(C2=CSC(=N2)N)C(=O)NC3C4N(C3=O)C(=C(CS4)CN5CCN(CC5)C6=C(C=C7C(=C6)N(C=C(C7=O)C(=O)O)C8CC8)F)C(=O)O D0R8RK HIGHSTAT Terminated D0RM5W DRUG__ID D0RM5W D0RM5W DRUGCOMP Malesci Ist Farmacobiologico SpA D0RM5W DRUGTYPE Small molecular drug D0RM5W DRUGINCH 1S/C11H16N4O2/c1-11(2,3)5-15-6-12-8-7(15)9(16)14(4)10(17)13-8/h6H,5H2,1-4H3,(H,13,17) D0RM5W DRUGINKE ATDPBUXMNPNXPM-UHFFFAOYSA-N D0RM5W DRUGSMIL CC(C)(C)CN1C=NC2=C1C(=O)N(C(=O)N2)C D0RM5W HIGHSTAT Terminated D0RZ0N DRUG__ID D0RZ0N D0RZ0N DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0RZ0N DRUGTYPE Small molecular drug D0RZ0N DRUGINCH 1S/C16H18O5/c1-3-20-13(17)10-9-12-14(11-7-5-4-6-8-11)15(19-2)16(18)21-12/h4-8,12H,3,9-10H2,1-2H3 D0RZ0N DRUGINKE ODHJHYPKZNTPCS-UHFFFAOYSA-N D0RZ0N DRUGSMIL CCOC(=O)CCC1C(=C(C(=O)O1)OC)C2=CC=CC=C2 D0RZ0N HIGHSTAT Terminated D0S0VZ DRUG__ID D0S0VZ D0S0VZ DRUGCOMP Fidia-Georgetown Institute for the Neurosciences D0S0VZ DRUGTYPE Small molecular drug D0S0VZ DRUGINCH 1S/C8H9ClN2O2S/c1-5-10-7-3-2-6(9)4-8(7)14(12,13)11-5/h2-5,10-11H,1H3 D0S0VZ DRUGINKE VZRNTCHTJRLTMU-UHFFFAOYSA-N D0S0VZ DRUGSMIL CC1NC2=C(C=C(C=C2)Cl)S(=O)(=O)N1 D0S0VZ HIGHSTAT Terminated D0S1XO DRUG__ID D0S1XO D0S1XO DRUGCOMP Boehringer Ingelheim Corp D0S1XO DRUGTYPE Small molecular drug D0S1XO DRUGINCH 1S/C23H29ClN2O/c1-25(2)16-17-4-6-18(7-5-17)19-10-14-22(15-11-19)26(3)23(27)20-8-12-21(24)13-9-20/h4-9,12-13,19,22H,10-11,14-16H2,1-3H3 D0S1XO DRUGINKE WBNUHWUTAHSPER-UHFFFAOYSA-N D0S1XO DRUGSMIL CN(C)CC1=CC=C(C=C1)C2CCC(CC2)N(C)C(=O)C3=CC=C(C=C3)Cl D0S1XO HIGHSTAT Terminated D0S6VX DRUG__ID D0S6VX D0S6VX DRUGCOMP Novartis AG D0S6VX DRUGTYPE Small molecular drug D0S6VX DRUGINCH 1S/C17H19N9.3ClH/c18-15(19)13-5-1-3-11(7-13)9-23-25-17(22)26-24-10-12-4-2-6-14(8-12)16(20)21;;;/h1-10H,(H3,18,19)(H3,20,21)(H3,22,25,26);3*1H/b23-9+,24-10+;;; D0S6VX DRUGINKE OTMBXWAKBWGKPN-VOTJPXFPSA-N D0S6VX DRUGSMIL C1=CC(=CC(=C1)C(=N)N)C=NNC(=NN=CC2=CC(=CC=C2)C(=N)N)N.Cl.Cl.Cl D0S6VX HIGHSTAT Terminated D0S7DS DRUG__ID D0S7DS D0S7DS DRUGCOMP Shire plc D0S7DS DRUGTYPE Small molecular drug D0S7DS DRUGINCH 1S/C12H16N6O3/c13-12-16-10(15-6-1-2-6)9-11(17-12)18(5-14-9)7-4-20-8(3-19)21-7/h5-8,19H,1-4H2,(H3,13,15,16,17)/t7-,8-/m1/s1 D0S7DS DRUGINKE ATSMZGDYBPOXMZ-HTQZYQBOSA-N D0S7DS DRUGSMIL C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4COC(O4)CO D0S7DS HIGHSTAT Terminated D0S8YL DRUG__ID D0S8YL D0S8YL DRUGCOMP Eli Lilly & Co D0S8YL DRUGTYPE Small molecular drug D0S8YL DRUGINCH 1S/C16H22N4O3/c1-3-6-13-14(9-8-12(11(2)21)16(13)22)23-10-5-4-7-15-17-19-20-18-15/h8-9,22H,3-7,10H2,1-2H3,(H,17,18,19,20) D0S8YL DRUGINKE MWYHLEQJTQJHSS-UHFFFAOYSA-N D0S8YL DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCC2=NNN=N2 D0S8YL HIGHSTAT Terminated D0S9XV DRUG__ID D0S9XV D0S9XV DRUGCOMP Abbott Laboratories D0S9XV DRUGTYPE Small molecular drug D0S9XV DRUGINCH 1S/C11H14IN5O2/c12-4-2-17(6-1-5(13)8(18)9(6)19)11-7(4)10(14)15-3-16-11/h2-3,5-6,8-9,18-19H,1,13H2,(H2,14,15,16)/t5-,6+,8+,9-/m0/s1 D0S9XV DRUGINKE NSXJHIFQIZKLGF-LWIVVEGESA-N D0S9XV DRUGSMIL C1C(C(C(C1N2C=C(C3=C(N=CN=C32)N)I)O)O)N D0S9XV HIGHSTAT Terminated D0SE4D DRUG__ID D0SE4D D0SE4D DRUGCOMP Organon BioSciences D0SE4D DRUGTYPE Small molecular drug D0SE4D DRUGINCH 1S/C25H40ClNO3/c1-24-8-7-19-17(18(24)5-6-20(24)23(29)15-26)4-3-16-13-22(28)21(14-25(16,19)2)27-9-11-30-12-10-27/h16-22,28H,3-15H2,1-2H3/t16-,17-,18-,19-,20+,21-,22-,24-,25-/m0/s1 D0SE4D DRUGINKE NZFNABGZEQPYBX-PMBZPZLSSA-N D0SE4D DRUGSMIL CC12CCC3C(C1CCC2C(=O)CCl)CCC4C3(CC(C(C4)O)N5CCOCC5)C D0SE4D HIGHSTAT Terminated D0SI4C DRUG__ID D0SI4C D0SI4C DRUGCOMP Kyowa Hakko Kogyo Co Ltd D0SI4C DRUGTYPE Small molecular drug D0SI4C DRUGINCH 1S/C15H10N4O/c20-15-13-12(17-9-18-13)11-7-4-8-16-14(11)19(15)10-5-2-1-3-6-10/h1-9H,(H,17,18) D0SI4C DRUGINKE NDDBRRFHXNPOLY-UHFFFAOYSA-N D0SI4C DRUGSMIL C1=CC=C(C=C1)N2C3=C(C=CC=N3)C4=C(C2=O)NC=N4 D0SI4C HIGHSTAT Terminated D0SZ3B DRUG__ID D0SZ3B D0SZ3B DRUGCOMP Eisai Co Ltd D0SZ3B DRUGTYPE Small molecular drug D0SZ3B DRUGINCH 1S/C27H26ClN3O5/c1-33-20-10-5-17(6-11-20)24-16-25(30-31(24)19-8-12-21(34-2)13-9-19)27(35-3,36-4)18-7-14-23(28)22(15-18)26(29)32/h5-16H,1-4H3,(H2,29,32) D0SZ3B DRUGINKE USJVSASRKOHVHQ-UHFFFAOYSA-N D0SZ3B DRUGSMIL COC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)OC)C(C4=CC(=C(C=C4)Cl)C(=O)N)(OC)OC D0SZ3B HIGHSTAT Terminated D0T0BS DRUG__ID D0T0BS D0T0BS DRUGCOMP Novartis AG D0T0BS DRUGTYPE Small molecular drug D0T0BS DRUGINCH 1S/C16H23NO2.ClH/c1-3-9-17-10-5-6-12-13(17)11-19-15-8-4-7-14(18-2)16(12)15;/h4,7-8,12-13H,3,5-6,9-11H2,1-2H3;1H/t12-,13+;/m1./s1 D0T0BS DRUGINKE IIARBXRSECAIPI-KZCZEQIWSA-N D0T0BS DRUGSMIL CCCN1CCCC2C1COC3=C2C(=CC=C3)OC.Cl D0T0BS HIGHSTAT Terminated D0T0LO DRUG__ID D0T0LO D0T0LO DRUGCOMP Rhone-Poulenc SA D0T0LO DRUGTYPE Small molecular drug D0T0LO DRUGINCH 1S/C13H12ClNOS2/c1-8-10-5-3-2-4-9(10)6-7-15(8)12-11(14)13(16)18-17-12/h2-5,8H,6-7H2,1H3 D0T0LO DRUGINKE BEJJGVDFQORITE-UHFFFAOYSA-N D0T0LO DRUGSMIL CC1C2=CC=CC=C2CCN1C3=C(C(=O)SS3)Cl D0T0LO HIGHSTAT Terminated D0T1SF DRUG__ID D0T1SF D0T1SF DRUGCOMP Pharmacia & Upjohn Inc D0T1SF DRUGTYPE Small molecular drug D0T1SF DRUGINCH 1S/C24H31N3O3/c1-25-24(28)19-3-8-22-18(17-19)10-16-30-23(22)9-11-26-12-14-27(15-13-26)20-4-6-21(29-2)7-5-20/h3-8,17,23H,9-16H2,1-2H3,(H,25,28)/t23-/m0/s1 D0T1SF DRUGINKE UDLSEQDYARNKTL-QHCPKHFHSA-N D0T1SF DRUGSMIL CNC(=O)C1=CC2=C(C=C1)C(OCC2)CCN3CCN(CC3)C4=CC=C(C=C4)OC D0T1SF HIGHSTAT Terminated D0T4OE DRUG__ID D0T4OE D0T4OE DRUGCOMP Bio-Mega Research Division D0T4OE DRUGTYPE Small molecular drug D0T4OE DRUGINCH 1S/C41H52N6O5/c1-27(2)37(45-38(49)33-16-15-30-13-9-10-14-32(30)43-33)40(51)44-34(23-28-11-7-6-8-12-28)36(48)25-47-22-19-31(52-26-29-17-20-42-21-18-29)24-35(47)39(50)46-41(3,4)5/h6-18,20-21,27,31,34-37,48H,19,22-26H2,1-5H3,(H,44,51)(H,45,49)(H,46,50)/t31-,34+,35+,36-,37+/m1/s1 D0T4OE DRUGINKE RXBWRFDZXRAEJT-SZNOJMITSA-N D0T4OE DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN2CCC(CC2C(=O)NC(C)(C)C)OCC3=CC=NC=C3)O)NC(=O)C4=NC5=CC=CC=C5C=C4 D0T4OE HIGHSTAT Terminated D0T5IN DRUG__ID D0T5IN D0T5IN DRUGCOMP Oncothyreon Inc D0T5IN DRUGTYPE Small molecular drug D0T5IN DRUGINCH 1S/C27H33NO8/c1-14(29)35-17-11-26(2)16(7-8-18(26)30)20-22(17)27(3)19(13-34-4)36-25(33)15(12-28-9-5-6-10-28)21(27)24(32)23(20)31/h12,16-17,19,32H,5-11,13H2,1-4H3/b15-12-/t16-,17+,19+,26-,27-/m0/s1 D0T5IN DRUGINKE JUSZLIOETSSZJM-WQVKNQJISA-N D0T5IN DRUGSMIL CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C(=CN5CCCC5)C4=C(C3=O)O)COC)C)C D0T5IN HIGHSTAT Terminated D0T5SG DRUG__ID D0T5SG D0T5SG DRUGCOMP Meiji Seika Kaisha Ltd D0T5SG DRUGTYPE Small molecular drug D0T5SG DRUGINCH 1S/C22H21N5O2/c1-14-12-20(21(28-3)15(2)23-14)29-13-16-8-10-17(11-9-16)18-6-4-5-7-19(18)22-24-26-27-25-22/h4-12H,13H2,1-3H3,(H,24,25,26,27) D0T5SG DRUGINKE FTDRSCZZEUAAIP-UHFFFAOYSA-N D0T5SG DRUGSMIL CC1=CC(=C(C(=N1)C)OC)OCC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4 D0T5SG HIGHSTAT Terminated D0T6MU DRUG__ID D0T6MU D0T6MU DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0T6MU DRUGTYPE Small molecular drug D0T6MU DRUGINCH 1S/C35H39N5O6/c1-23(42)32(37-24(2)43)35(46)40(33(44)29(36)19-27-21-39(22-41)30-17-11-10-16-28(27)30)34(45)31(18-25-12-6-4-7-13-25)38(3)20-26-14-8-5-9-15-26/h4-17,21-23,29,31-32,42H,18-20,36H2,1-3H3,(H,37,43)/t23-,29-,31+,32+/m1/s1 D0T6MU DRUGINKE GUMFSDXELXANKA-KGLGFYCJSA-N D0T6MU DRUGSMIL CC(C(C(=O)N(C(=O)C(CC1=CN(C2=CC=CC=C21)C=O)N)C(=O)C(CC3=CC=CC=C3)N(C)CC4=CC=CC=C4)NC(=O)C)O D0T6MU HIGHSTAT Terminated D0T6VU DRUG__ID D0T6VU D0T6VU DRUGCOMP MSD Japan D0T6VU DRUGTYPE Small molecular drug D0T6VU DRUGINCH 1S/C26H21N3O9/c30-6-15-22(34)23(35)24(36)25(38-15)9-3-8-12(4-13(9)32)28-21-17(8)18-11(5-27-26(18)37)16-10-1-7(31)2-14(33)19(10)29-20(16)21/h1,4-5,9,15,22-25,30-32,34-36H,2-3,6H2/t9?,15-,22-,23+,24-,25+/m1/s1 D0T6VU DRUGINKE GEFUXTHVYBRRRD-FKKAOLSPSA-N D0T6VU DRUGSMIL C1C(C(=CC2=C1C3=C4C(=C5C6=C(C(=O)CC(=C6)O)N=C5C3=N2)C=NC4=O)O)C7C(C(C(C(O7)CO)O)O)O D0T6VU HIGHSTAT Terminated D0T7WQ DRUG__ID D0T7WQ D0T7WQ DRUGCOMP Sanofi D0T7WQ DRUGTYPE Small molecular drug D0T7WQ DRUGINCH 1S/C23H27N3O.ClH/c1-5-25(6-2)11-12-26-10-9-18-16(4)23-22(15(3)20(18)14-26)19-13-17(27)7-8-21(19)24-23;/h7-10,13-14,27H,5-6,11-12H2,1-4H3;1H D0T7WQ DRUGINKE UCICRVXYPSKKJK-UHFFFAOYSA-N D0T7WQ DRUGSMIL CCN(CC)CC[N+]1=CC2=C(C3=C(C(=C2C=C1)C)NC4=C3C=C(C=C4)O)C.[Cl-] D0T7WQ HIGHSTAT Terminated D0T8BP DRUG__ID D0T8BP D0T8BP DRUGCOMP Dainippon Pharmaceutical Co Ltd D0T8BP DRUGTYPE Small molecular drug D0T8BP DRUGINCH 1S/C18H25N.C4H4O4/c1-14-11-17-6-5-16(13-18(17)12-15(14)2)7-10-19-8-3-4-9-19;5-3(6)1-2-4(7)8/h11-13H,3-10H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D0T8BP DRUGINKE AYOYFVLAAQPHJT-WLHGVMLRSA-N D0T8BP DRUGSMIL CC1=CC2=C(C=C1C)C=C(CC2)CCN3CCCC3.C(=CC(=O)O)C(=O)O D0T8BP HIGHSTAT Terminated D0TP9A DRUG__ID D0TP9A D0TP9A DRUGCOMP Zeneca Group plc D0TP9A DRUGTYPE Small molecular drug D0TP9A DRUGINCH 1S/C26H22BrN5O2/c1-3-11-32(16-20-12-22-24(13-23(20)27)30-17(2)31-26(22)34)21-8-6-19(7-9-21)25(33)29-15-18-5-4-10-28-14-18/h1,4-10,12-14H,11,15-16H2,2H3,(H,29,33)(H,30,31,34) D0TP9A DRUGINKE SHNBLWMBWXIKMR-UHFFFAOYSA-N D0TP9A DRUGSMIL CC1=NC2=C(C=C(C(=C2)Br)CN(CC#C)C3=CC=C(C=C3)C(=O)NCC4=CN=CC=C4)C(=O)N1 D0TP9A HIGHSTAT Terminated D0TR4Z DRUG__ID D0TR4Z D0TR4Z DRUGCOMP Evonik Degussa GmbH D0TR4Z DRUGTYPE Small molecular drug D0TR4Z DRUGINCH 1S/C21H21NO4/c1-5-22-20-11-10-18(26-15(4)24)12-19(20)13(2)21(22)16-6-8-17(9-7-16)25-14(3)23/h6-12H,5H2,1-4H3 D0TR4Z DRUGINKE KSZGVNZSUJHOJA-UHFFFAOYSA-N D0TR4Z DRUGSMIL CCN1C2=C(C=C(C=C2)OC(=O)C)C(=C1C3=CC=C(C=C3)OC(=O)C)C D0TR4Z HIGHSTAT Terminated D0U0FH DRUG__ID D0U0FH D0U0FH DRUGCOMP Eli Lilly & Co D0U0FH DRUGTYPE Small molecular drug D0U0FH DRUGINCH 1S/C3H2N4S/c4-1-5-3-7-6-2-8-3/h2H,(H,5,7) D0U0FH DRUGINKE YUCHAYRHHXJNQK-UHFFFAOYSA-N D0U0FH DRUGSMIL C1=NN=C(S1)NC#N D0U0FH HIGHSTAT Terminated D0U1FZ DRUG__ID D0U1FZ D0U1FZ DRUGCOMP Eukarion Inc D0U1FZ DRUGTYPE Small molecular drug D0U1FZ DRUGINCH 1S/C22H26N2O6/c25-21-17-3-1-5-19(21)29-13-11-27-9-10-28-12-14-30-20-6-2-4-18(22(20)26)16-24-8-7-23-15-17/h1-6,15-16,25-26H,7-14H2 D0U1FZ DRUGINKE IJRRNMCPHVFFMW-UHFFFAOYSA-N D0U1FZ DRUGSMIL C1CN=CC2=C(C(=CC=C2)OCCOCCOCCOC3=CC=CC(=C3O)C=N1)O D0U1FZ HIGHSTAT Terminated D0U4WY DRUG__ID D0U4WY D0U4WY DRUGCOMP Bio-Mega Research Division D0U4WY DRUGTYPE Small molecular drug D0U4WY DRUGINCH 1S/C51H76N6O8/c1-11-38(49(4,5)6)53-46(62)42(51(48(64)65)26-18-19-27-51)55-43(59)37(32-39(58)57-28-20-21-29-57)52-45(61)41(50(7,8)9)54-44(60)40(33(2)3)56(10)47(63)36(30-34-22-14-12-15-23-34)31-35-24-16-13-17-25-35/h12-17,22-25,33,36-38,40-42H,11,18-21,26-32H2,1-10H3,(H,52,61)(H,53,62)(H,54,60)(H,55,59)(H,64,65)/t37-,38+,40-,41+,42+/m0/s1 D0U4WY DRUGINKE QRACUPFHILQVKO-ZEIRWQBWSA-N D0U4WY DRUGSMIL CCC(C(C)(C)C)NC(=O)C(C1(CCCC1)C(=O)O)NC(=O)C(CC(=O)N2CCCC2)NC(=O)C(C(C)(C)C)NC(=O)C(C(C)C)N(C)C(=O)C(CC3=CC=CC=C3)CC4=CC=CC=C4 D0U4WY HIGHSTAT Terminated D0U5EY DRUG__ID D0U5EY D0U5EY DRUGCOMP Organon BioSciences D0U5EY DRUGTYPE Small molecular drug D0U5EY DRUGINCH 1S/C14H19NO2/c1-16-13-6-5-10-3-2-4-12(10)14(13)17-11-7-8-15-9-11/h5-6,11,15H,2-4,7-9H2,1H3/t11-/m0/s1 D0U5EY DRUGINKE QDJAYXYEXHVXJV-NSHDSACASA-N D0U5EY DRUGSMIL COC1=C(C2=C(CCC2)C=C1)OC3CCNC3 D0U5EY HIGHSTAT Terminated D0U5GI DRUG__ID D0U5GI D0U5GI DRUGCOMP Rhone-Poulenc SA D0U5GI DRUGTYPE Small molecular drug D0U5GI DRUGINCH 1S/C21H27N3O2S2/c1-22-20(27)21(18-9-7-14-23-16-18)13-6-5-8-17(21)12-15-24-28(25,26)19-10-3-2-4-11-19/h2-4,7,9-11,14,16-17,24H,5-6,8,12-13,15H2,1H3,(H,22,27)/t17-,21+/m1/s1 D0U5GI DRUGINKE GLFXCUUHWBFHSB-UTKZUKDTSA-N D0U5GI DRUGSMIL CNC(=S)C1(CCCCC1CCNS(=O)(=O)C2=CC=CC=C2)C3=CN=CC=C3 D0U5GI HIGHSTAT Terminated D0U5PR DRUG__ID D0U5PR D0U5PR DRUGCOMP A Carlsson Research AB D0U5PR DRUGTYPE Small molecular drug D0U5PR DRUGINCH 1S/C14H20FNO2S/c1-3-16-6-4-11(5-7-16)12-8-13(15)10-14(9-12)19(2,17)18/h8-11H,3-7H2,1-2H3 D0U5PR DRUGINKE PHRDGRSMZPOCAB-UHFFFAOYSA-N D0U5PR DRUGSMIL CCN1CCC(CC1)C2=CC(=CC(=C2)S(=O)(=O)C)F D0U5PR HIGHSTAT Terminated D0U6AL DRUG__ID D0U6AL D0U6AL DRUGCOMP Boehringer Ingelheim Corp D0U6AL DRUGTYPE Small molecular drug D0U6AL DRUGINCH 1S/C18H18O4S/c1-12-10-14(5-6-15-4-3-9-23-15)11-13(2)18(12)22-17(21)8-7-16(19)20/h3-6,9-11H,7-8H2,1-2H3,(H,19,20)/b6-5+ D0U6AL DRUGINKE OIDYLVFJAIPWBI-AATRIKPKSA-N D0U6AL DRUGSMIL CC1=CC(=CC(=C1OC(=O)CCC(=O)O)C)C=CC2=CC=CS2 D0U6AL HIGHSTAT Terminated D0U7HD DRUG__ID D0U7HD D0U7HD DRUGCOMP Squibb Corp D0U7HD DRUGTYPE Small molecular drug D0U7HD DRUGINCH 1S/C30H40N2O5/c33-27(34)16-13-21-11-4-5-12-22(21)18-23-25-14-15-26(37-25)28(23)30-32-24(19-36-30)29(35)31-17-7-6-10-20-8-2-1-3-9-20/h4-5,11-12,19-20,23,25-26,28H,1-3,6-10,13-18H2,(H,31,35)(H,33,34)/t23-,25-,26+,28-/m0/s1 D0U7HD DRUGINKE MWTFNTGEEFCRGV-ZEIIVYBKSA-N D0U7HD DRUGSMIL C1CCC(CC1)CCCCNC(=O)C2=COC(=N2)C3C4CCC(C3CC5=CC=CC=C5CCC(=O)O)O4 D0U7HD HIGHSTAT Terminated D0U7KR DRUG__ID D0U7KR D0U7KR DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0U7KR DRUGTYPE Small molecular drug D0U7KR DRUGINCH 1S/C18H29NO5/c1-11(2)6-7-13-17(3,24-13)15-14(21-5)12(23-16(20)19-4)8-9-18(15)10-22-18/h6,12-15H,7-10H2,1-5H3,(H,19,20)/t12-,13-,14-,15-,17+,18+/m1/s1 D0U7KR DRUGINKE AMAXEUYAJTYMDS-CNGUFQHNSA-N D0U7KR DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)NC)OC)C D0U7KR HIGHSTAT Terminated D0U8KA DRUG__ID D0U8KA D0U8KA DRUGCOMP Novartis AG D0U8KA DRUGTYPE Small molecular drug D0U8KA DRUGINCH 1S/C56H73N3O12/c1-28-25-31(4)38(32(5)26-28)27-58-20-22-59(23-21-58)44-43-51-41-40(47(44)63)42-50(36(9)49(41)70-54(65)55(11,12)13)71-56(14,52(42)64)67-24-19-39(66-15)33(6)48(68-37(10)60)35(8)46(62)34(7)45(61)29(2)17-16-18-30(3)53(57-43)69-51/h16-19,24-26,29,33-35,39,45-46,48,61-63H,20-23,27H2,1-15H3/b17-16+,24-19+,30-18-/t29-,33+,34?,35+,39-,45?,46+,48-,56-/m0/s1 D0U8KA DRUGINKE QFULYWYYYANMNL-IYQMJTCPSA-N D0U8KA DRUGSMIL CC1C=CC=C(C2=NC3=C(O2)C4=C(C(=C5C(=C4C(=C3N6CCN(CC6)CC7=C(C=C(C=C7C)C)C)O)C(=O)C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)OC(=O)C(C)(C)C)C D0U8KA HIGHSTAT Terminated D0U8XD DRUG__ID D0U8XD D0U8XD DRUGCOMP Taiho Pharmaceutical Co Ltd D0U8XD DRUGTYPE Small molecular drug D0U8XD DRUGINCH 1S/C7H10N4O3/c1-9(2)6(12)5-10-4-3-8-7(10)11(13)14/h3-4H,5H2,1-2H3 D0U8XD DRUGINKE NXUUXBZRCPNIBU-UHFFFAOYSA-N D0U8XD DRUGSMIL CN(C)C(=O)CN1C=CN=C1[N+](=O)[O-] D0U8XD HIGHSTAT Terminated D0UB1J DRUG__ID D0UB1J D0UB1J DRUGCOMP SmithKline Beecham plc D0UB1J DRUGTYPE Small molecular drug D0UB1J DRUGINCH 1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-4-13(6)16-3-1-2-14/h4,14H,1-3H2,(H3,9,11,12,15) D0UB1J DRUGINKE UWCACOXRVYDNEE-UHFFFAOYSA-N D0UB1J DRUGSMIL C1=NC2=C(N1OCCCO)N=C(NC2=O)N D0UB1J HIGHSTAT Terminated D0UJ8E DRUG__ID D0UJ8E D0UJ8E DRUGCOMP Schering-Plough Corp D0UJ8E DRUGTYPE Small molecular drug D0UJ8E DRUGINCH 1S/C20H12O7/c21-12-7-8-13(22)19-18(12,27-19)16(23)15-17(24-15)20(19)25-10-5-1-3-9-4-2-6-11(26-20)14(9)10/h1-8,12,15,17,21H/t12-,15+,17+,18-,19-/m0/s1 D0UJ8E DRUGINKE HYDQYYPALJMCCU-MUKCLNALSA-N D0UJ8E DRUGSMIL C1=CC2=C3C(=C1)OC4(C5C(O5)C(=O)C67C4(O6)C(=O)C=CC7O)OC3=CC=C2 D0UJ8E HIGHSTAT Terminated D0UU3J DRUG__ID D0UU3J D0UU3J DRUGCOMP RW Johnson Pharmaceutical Research Institute D0UU3J DRUGTYPE Small molecular drug D0UU3J DRUGINCH 1S/C21H25ClN2O2/c1-14-19(18(25)13-24-11-5-4-6-12-24)15(2)23(3)20(14)21(26)16-7-9-17(22)10-8-16/h7-10H,4-6,11-13H2,1-3H3 D0UU3J DRUGINKE BCRATZJXVPSAOZ-UHFFFAOYSA-N D0UU3J DRUGSMIL CC1=C(N(C(=C1C(=O)CN2CCCCC2)C)C)C(=O)C3=CC=C(C=C3)Cl D0UU3J HIGHSTAT Terminated D0V1HK DRUG__ID D0V1HK D0V1HK DRUGCOMP Helopharm D0V1HK DRUGTYPE Small molecular drug D0V1HK DRUGINCH 1S/C19H25NO2/c1-19(2,3)20-13-16(21)14-22-18-12-8-7-11-17(18)15-9-5-4-6-10-15/h4-12,16,20-21H,13-14H2,1-3H3 D0V1HK DRUGINKE DBHPVKNFKBKJCE-UHFFFAOYSA-N D0V1HK DRUGSMIL CC(C)(C)NCC(COC1=CC=CC=C1C2=CC=CC=C2)O D0V1HK HIGHSTAT Terminated D0V1SD DRUG__ID D0V1SD D0V1SD DRUGCOMP Bioprojet D0V1SD DRUGTYPE Small molecular drug D0V1SD DRUGINCH 1S/C17H22N4O/c1-20-12-7-8-13(20)10-11(9-12)18-17(22)16-14-5-3-4-6-15(14)21(2)19-16/h3-6,11-13H,7-10H2,1-2H3,(H,18,22)/t11?,12-,13+ D0V1SD DRUGINKE DDHAJFBBJWHSBR-YHWZYXNKSA-N D0V1SD DRUGSMIL CN1C2CCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C D0V1SD HIGHSTAT Terminated D0V2WK DRUG__ID D0V2WK D0V2WK DRUGCOMP Abbott Laboratories D0V2WK DRUGTYPE Small molecular drug D0V2WK DRUGINCH 1S/C29H33F3N6O5.ClH/c1-3-5-21(33)27(40)35-22(6-4-2)28(41)34-16-9-10-37(13-16)26-20(32)12-17-24(39)18(29(42)43)14-38(25(17)36-26)23-8-7-15(30)11-19(23)31;/h7-8,11-12,14,16,21-22H,3-6,9-10,13,33H2,1-2H3,(H,34,41)(H,35,40)(H,42,43);1H/t16?,21-,22-;/m0./s1 D0V2WK DRUGINKE FTKPWZYQYLDWSN-KSNQKOBFSA-N D0V2WK DRUGSMIL CCCC(C(=O)NC(CCC)C(=O)NC1CCN(C1)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C(=O)O)F)N.Cl D0V2WK HIGHSTAT Terminated D0V3PN DRUG__ID D0V3PN D0V3PN DRUGCOMP University of Kansas D0V3PN DRUGTYPE Small molecular drug D0V3PN DRUGINCH 1S/C28H38O6/c1-14-11-21(33-25(32)17(14)13-29)15(2)18-5-6-19-16-12-24-28(34-24)23(31)8-7-22(30)27(28,4)20(16)9-10-26(18,19)3/h7-8,15-16,18-21,23-24,29,31H,5-6,9-13H2,1-4H3/t15-,16-,18+,19-,20-,21+,23-,24+,26+,27-,28+/m0/s1 D0V3PN DRUGINKE DBRXOUCRJQVYJQ-CKNDUULBSA-N D0V3PN DRUGSMIL CC1=C(C(=O)OC(C1)C(C)C2CCC3C2(CCC4C3CC5C6(C4(C(=O)C=CC6O)C)O5)C)CO D0V3PN HIGHSTAT Terminated D0V4QE DRUG__ID D0V4QE D0V4QE DRUGCOMP Ipsen D0V4QE DRUGTYPE Small molecular drug D0V4QE DRUGINCH 1S/C25H26O9/c1-4-5-20(26)34-24-14-9-17-16(32-11-33-17)8-13(14)21(22-15(24)10-31-25(22)28)12-6-18(29-2)23(27)19(7-12)30-3/h6-9,15,21-22,24,27H,4-5,10-11H2,1-3H3/t15-,21+,22-,24-/m0/s1 D0V4QE DRUGINKE IZICVMOVTLJVDP-ANCALKEFSA-N D0V4QE DRUGSMIL CCCC(=O)OC1C2COC(=O)C2C(C3=CC4=C(C=C13)OCO4)C5=CC(=C(C(=C5)OC)O)OC D0V4QE HIGHSTAT Terminated D0V5XL DRUG__ID D0V5XL D0V5XL DRUGCOMP Kissei Pharmaceutical Co Ltd D0V5XL DRUGTYPE Small molecular drug D0V5XL DRUGINCH 1S/C38H51N5O7/c1-25(2)50-38(48)35(45)32(19-26-9-4-3-5-10-26)41-37(47)33(22-30-23-39-24-40-30)42-36(46)29(21-34(44)43-15-17-49-18-16-43)20-28-13-8-12-27-11-6-7-14-31(27)28/h6-8,11-14,23-26,29,32-33,35,45H,3-5,9-10,15-22H2,1-2H3,(H,39,40)(H,41,47)(H,42,46)/t29-,32?,33+,35?/m1/s1 D0V5XL DRUGINKE NQXSBCTYTMQGGJ-GBDGZKRDSA-N D0V5XL DRUGSMIL CC(C)OC(=O)C(C(CC1CCCCC1)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=CC4=CC=CC=C43)CC(=O)N5CCOCC5)O D0V5XL HIGHSTAT Terminated D0V6JP DRUG__ID D0V6JP D0V6JP DRUGCOMP Sanofi D0V6JP DRUGTYPE Small molecular drug D0V6JP DRUGINCH 1S/C15H15Cl2N3O/c16-10-1-2-12(13(17)9-10)14-3-4-15(19-18-14)20-7-5-11(21)6-8-20/h1-4,9,11,21H,5-8H2 D0V6JP DRUGINKE COWWILCLLRVLSC-UHFFFAOYSA-N D0V6JP DRUGSMIL C1CN(CCC1O)C2=NN=C(C=C2)C3=C(C=C(C=C3)Cl)Cl D0V6JP HIGHSTAT Terminated D0V6RE DRUG__ID D0V6RE D0V6RE DRUGCOMP Shire BioChem Inc D0V6RE DRUGTYPE Small molecular drug D0V6RE DRUGINCH 1S/C9H11N5O2S/c10-8-7-9(12-3-11-8)14(4-13-7)5-2-16-6(1-15)17-5/h3-6,15H,1-2H2,(H2,10,11,12)/t5-,6-/m1/s1 D0V6RE DRUGINKE UXBLEIWMFILNFD-PHDIDXHHSA-N D0V6RE DRUGSMIL C1C(SC(O1)CO)N2C=NC3=C(N=CN=C32)N D0V6RE HIGHSTAT Terminated D0V6VL DRUG__ID D0V6VL D0V6VL DRUGCOMP Eli Lilly D0V6VL DRUGTYPE Small molecular drug D0V6VL DRUGINCH 1S/C49H71N7O17/c1-5-6-7-8-9-10-19-73-31-17-13-28(14-18-31)42(65)50-32-21-34(61)45(68)54-47(70)38-39(62)24(2)22-56(38)49(72)36(26(4)58)52-46(69)37(41(64)40(63)27-11-15-29(59)16-12-27)53-44(67)33-20-30(60)23-55(33)48(71)35(25(3)57)51-43(32)66/h11-18,24-26,30,32-41,45,57-64,68H,5-10,19-23H2,1-4H3,(H,50,65)(H,51,66)(H,52,69)(H,53,67)(H,54,70)/t24-,25+,26+,30+,32-,33-,34+,35-,36-,37-,38-,39-,40-,41-,45+/m0/s1 D0V6VL DRUGINKE ZKZKCEAHVFVZDJ-MTUMARHDSA-N D0V6VL DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)C(=O)NC2CC(C(NC(=O)C3C(C(CN3C(=O)C(NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)C(C)O)O)C(C(C5=CC=C(C=C5)O)O)O)C(C)O)C)O)O)O D0V6VL HIGHSTAT Terminated D0V7HD DRUG__ID D0V7HD D0V7HD DRUGCOMP Ipsen D0V7HD DRUGTYPE Small molecular drug D0V7HD DRUGINCH 1S/C34H48ClN5O2S2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18-23-44(41,42)39-22-21-28-30(25-39)43-34-32(28)33(27-19-16-17-20-29(27)35)36-24-31-38-37-26(2)40(31)34/h16-17,19-20H,3-15,18,21-25H2,1-2H3 D0V7HD DRUGINKE XYNVFDKKFDLTPP-UHFFFAOYSA-N D0V7HD DRUGSMIL CCCCCCCCCCCCCCCCS(=O)(=O)N1CCC2=C(C1)SC3=C2C(=NCC4=NN=C(N43)C)C5=CC=CC=C5Cl D0V7HD HIGHSTAT Terminated D0V8HF DRUG__ID D0V8HF D0V8HF DRUGCOMP Gilead Sciences Inc D0V8HF DRUGTYPE Small molecular drug D0V8HF DRUGINCH 1S/C20H18FN3O4S/c1-23(29(2,27)28)18-14-4-3-9-22-17(14)19(25)16-15(18)11-24(20(16)26)10-12-5-7-13(21)8-6-12/h3-9,25H,10-11H2,1-2H3 D0V8HF DRUGINKE RJWBOLLTMJMYNV-UHFFFAOYSA-N D0V8HF DRUGSMIL CN(C1=C2CN(C(=O)C2=C(C3=C1C=CC=N3)O)CC4=CC=C(C=C4)F)S(=O)(=O)C D0V8HF HIGHSTAT Terminated D0V8KI DRUG__ID D0V8KI D0V8KI DRUGCOMP Kissei Pharmaceutical Co Ltd D0V8KI DRUGTYPE Small molecular drug D0V8KI DRUGINCH 1S/C15H20N2O2.ClH/c18-14-16-12-15(19-14)7-10-17(11-8-15)9-6-13-4-2-1-3-5-13;/h1-5H,6-12H2,(H,16,18);1H D0V8KI DRUGINKE FIKFLLIUPUVONI-UHFFFAOYSA-N D0V8KI DRUGSMIL C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.Cl D0V8KI HIGHSTAT Terminated D0VZ3D DRUG__ID D0VZ3D D0VZ3D DRUGCOMP Dr Karl Thomae GmbH D0VZ3D DRUGTYPE Small molecular drug D0VZ3D DRUGINCH 1S/C27H37N5O2/c1-3-30(4-2)17-8-7-10-21-14-18-31(19-15-21)20-25(33)32-24-13-6-5-11-22(24)27(34)29-23-12-9-16-28-26(23)32/h5-6,9,11-13,16,21H,3-4,7-8,10,14-15,17-20H2,1-2H3,(H,29,34) D0VZ3D DRUGINKE BCUGCHZRMKTPMU-UHFFFAOYSA-N D0VZ3D DRUGSMIL CCN(CC)CCCCC1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 D0VZ3D HIGHSTAT Terminated D0W0LS DRUG__ID D0W0LS D0W0LS DRUGCOMP Takeda D0W0LS DRUGTYPE Small molecular drug D0W0LS DRUGINCH 1S/C33H38N2O2.ClH/c1-24-7-11-27(12-8-24)28-14-13-26-5-4-6-29(22-30(26)21-28)33(36)34-31-15-9-25(10-16-31)23-35(2,3)32-17-19-37-20-18-32;/h7-16,21-22,32H,4-6,17-20,23H2,1-3H3;1H D0W0LS DRUGINKE VDALIBWXVQVFGZ-UHFFFAOYSA-N D0W0LS DRUGSMIL CC1=CC=C(C=C1)C2=CC3=C(CCCC(=C3)C(=O)NC4=CC=C(C=C4)C[N+](C)(C)C5CCOCC5)C=C2.[Cl-] D0W0LS HIGHSTAT Terminated D0W2DV DRUG__ID D0W2DV D0W2DV DRUGCOMP Boehringer Mannheim GmbH D0W2DV DRUGTYPE Small molecular drug D0W2DV DRUGINCH 1S/C13H17NO3/c1-2-12(13(15)16)14-17-10-6-9-11-7-4-3-5-8-11/h3-5,7-8H,2,6,9-10H2,1H3,(H,15,16)/b14-12- D0W2DV DRUGINKE TVHDNHNLJMQXMI-OWBHPGMISA-N D0W2DV DRUGSMIL CCC(=NOCCCC1=CC=CC=C1)C(=O)O D0W2DV HIGHSTAT Terminated D0W8OH DRUG__ID D0W8OH D0W8OH DRUGCOMP SmithKline Beecham plc D0W8OH DRUGTYPE Small molecular drug D0W8OH DRUGINCH 1S/C14H14N4O2/c1-2-7-20-10-6-4-3-5-9(10)12-17-13-11(14(19)18-12)15-8-16-13/h3-6,8H,2,7H2,1H3,(H2,15,16,17,18,19) D0W8OH DRUGINKE PQTJTRTXCNZDFT-UHFFFAOYSA-N D0W8OH DRUGSMIL CCCOC1=CC=CC=C1C2=NC3=C(C(=O)N2)NC=N3 D0W8OH HIGHSTAT Terminated D0W8QG DRUG__ID D0W8QG D0W8QG DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0W8QG DRUGTYPE Small molecular drug D0W8QG DRUGINCH 1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)16-7-9-19-20(12-16)26(14(2)24-19)13-15-6-8-17(22)18(23)11-15/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27) D0W8QG DRUGINKE QLXVZAXTUBLQJW-UHFFFAOYSA-N D0W8QG DRUGSMIL CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=CC(=C(C=C3)Cl)Cl)C D0W8QG HIGHSTAT Terminated D0W8VI DRUG__ID D0W8VI D0W8VI DRUGCOMP Purdue Neuroscience Corp D0W8VI DRUGTYPE Small molecular drug D0W8VI DRUGINCH 1S/C22H36O5S2.Na/c1-20(24)10-11-21(2)14(12-20)4-5-15-16-6-7-18(19(23)13-28-29(25,26)27)22(16,3)9-8-17(15)21;/h14-18,24H,4-13H2,1-3H3,(H,25,26,27);/q;+1/p-1/t14-,15-,16-,17-,18+,20+,21-,22-;/m0./s1 D0W8VI DRUGINKE GEUAPBGNNDAYOF-XCSLDGFESA-M D0W8VI DRUGSMIL CC1(CCC2(C(C1)CCC3C2CCC4(C3CCC4C(=O)CSS(=O)(=O)[O-])C)C)O.[Na+] D0W8VI HIGHSTAT Terminated D0WP7P DRUG__ID D0WP7P D0WP7P DRUGCOMP Novo Nordisk A/S D0WP7P DRUGTYPE Small molecular drug D0WP7P DRUGINCH 1S/C8H10ClN3O2S2/c1-4(2)10-8-11-5-3-6(9)15-7(5)16(13,14)12-8/h3-4H,1-2H3,(H2,10,11,12) D0WP7P DRUGINKE NDBOSDQLHXHDSC-UHFFFAOYSA-N D0WP7P DRUGSMIL CC(C)N=C1NC2=C(SC(=C2)Cl)S(=O)(=O)N1 D0WP7P HIGHSTAT Terminated D0X6MO DRUG__ID D0X6MO D0X6MO DRUGCOMP Parke-Davis & Co D0X6MO DRUGTYPE Small molecular drug D0X6MO DRUGINCH 1S/C13H13ClN2O2S/c1-8-4-3-5-9(14)13(8)15-10(17)6-12-16(2)11(18)7-19-12/h3-6H,7H2,1-2H3,(H,15,17)/b12-6- D0X6MO DRUGINKE YJXQTIXFPYPQFT-SDQBBNPISA-N D0X6MO DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=O)C=C2N(C(=O)CS2)C D0X6MO HIGHSTAT Terminated D0X6PG DRUG__ID D0X6PG D0X6PG DRUGCOMP Eli Lilly & Co D0X6PG DRUGTYPE Small molecular drug D0X6PG DRUGINCH 1S/C11H20NO5P/c13-11(14)10-4-9-3-7(6-18(15,16)17)1-2-8(9)5-12-10/h7-10,12H,1-6H2,(H,13,14)(H2,15,16,17)/t7-,8-,9+,10-/m0/s1 D0X6PG DRUGINKE STIRHCNEGQQBOY-QEYWKRMJSA-N D0X6PG DRUGSMIL C1CC2CNC(CC2CC1CP(=O)(O)O)C(=O)O D0X6PG HIGHSTAT Terminated D0X8MZ DRUG__ID D0X8MZ D0X8MZ DRUGCOMP H Lundbeck A/S D0X8MZ DRUGTYPE Small molecular drug D0X8MZ DRUGINCH 1S/C9H15N5/c1-3-14-11-9(10-12-14)8-5-4-6-13(2)7-8/h5H,3-4,6-7H2,1-2H3 D0X8MZ DRUGINKE RNMOMKCRCIRYCZ-UHFFFAOYSA-N D0X8MZ DRUGSMIL CCN1N=C(N=N1)C2=CCCN(C2)C D0X8MZ HIGHSTAT Terminated D0X8QI DRUG__ID D0X8QI D0X8QI DRUGCOMP Laboratories UPSA D0X8QI DRUGTYPE Small molecular drug D0X8QI DRUGINCH 1S/C19H19Cl2N3O2/c1-19(2,9-17(25)26)8-16-23-15-7-14(21)10-22-18(15)24(16)11-12-3-5-13(20)6-4-12/h3-7,10H,8-9,11H2,1-2H3,(H,25,26) D0X8QI DRUGINKE NJDYXRUUHUXUDU-UHFFFAOYSA-N D0X8QI DRUGSMIL CC(C)(CC1=NC2=C(N1CC3=CC=C(C=C3)Cl)N=CC(=C2)Cl)CC(=O)O D0X8QI HIGHSTAT Terminated D0X9FO DRUG__ID D0X9FO D0X9FO DRUGCOMP Chugai Pharmaceutical Co Ltd D0X9FO DRUGTYPE Small molecular drug D0X9FO DRUGINCH 1S/C15H13F2N3O3S/c16-8-15(9-17)7-12(14(24)19-5-1-4-18)11-6-10(20(21)22)2-3-13(11)23-15/h2-3,6-7H,1,5,8-9H2,(H,19,24) D0X9FO DRUGINKE LKUDLWNQCZSCQW-UHFFFAOYSA-N D0X9FO DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C(=CC(O2)(CF)CF)C(=S)NCCC#N D0X9FO HIGHSTAT Terminated D0XI9O DRUG__ID D0XI9O D0XI9O DRUGCOMP RW Johnson Pharmaceutical Research Institute D0XI9O DRUGTYPE Small molecular drug D0XI9O DRUGINCH 1S/C26H29N5O3/c1-4-26(3)15-20(14-24(33)34-5-2)31(23(32)16-26)17-18-10-12-19(13-11-18)21-8-6-7-9-22(21)25-27-29-30-28-25/h6-14H,4-5,15-17H2,1-3H3,(H,27,28,29,30)/b20-14+ D0XI9O DRUGINKE JBEUFWOCGLXNCS-XSFVSMFZSA-N D0XI9O DRUGSMIL CCC1(CC(=CC(=O)OCC)N(C(=O)C1)CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C D0XI9O HIGHSTAT Terminated D0XJ0P DRUG__ID D0XJ0P D0XJ0P DRUGCOMP BioCryst Pharmaceuticals Inc D0XJ0P DRUGTYPE Small molecular drug D0XJ0P DRUGINCH 1S/C10H12N4O3/c1-5(15)13-7-3-2-6(9(16)17)4-8(7)14-10(11)12/h2-4H,1H3,(H,13,15)(H,16,17)(H4,11,12,14) D0XJ0P DRUGINKE UDQJOWCVSMIZJP-UHFFFAOYSA-N D0XJ0P DRUGSMIL CC(=O)NC1=C(C=C(C=C1)C(=O)O)N=C(N)N D0XJ0P HIGHSTAT Terminated D0XP0Q DRUG__ID D0XP0Q D0XP0Q DRUGCOMP Pharmacia & Upjohn SpA D0XP0Q DRUGTYPE Small molecular drug D0XP0Q DRUGINCH 1S/C22H25N3O4/c1-5-28-21(26)18-14(3)24-15(4)19(22(27)29-6-2)20(18)16-7-9-17(10-8-16)25-12-11-23-13-25/h7-13,20,24H,5-6H2,1-4H3 D0XP0Q DRUGINKE YQKJDJKRFKYJSQ-UHFFFAOYSA-N D0XP0Q DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=C(C=C2)N3C=CN=C3)C(=O)OCC)C)C D0XP0Q HIGHSTAT Terminated D0Y0AP DRUG__ID D0Y0AP D0Y0AP DRUGCOMP Glaxo Wellcome plc D0Y0AP DRUGTYPE Small molecular drug D0Y0AP DRUGINCH 1S/C18H27N5O2/c19-18(20)14-1-3-15(4-2-14)22-9-11-23(12-10-22)16-5-7-21(8-6-16)13-17(24)25/h1-4,16H,5-13H2,(H3,19,20)(H,24,25) D0Y0AP DRUGINKE QGEGSJUSWLLZLH-UHFFFAOYSA-N D0Y0AP DRUGSMIL C1CN(CCC1N2CCN(CC2)C3=CC=C(C=C3)C(=N)N)CC(=O)O D0Y0AP HIGHSTAT Terminated D0Y1OF DRUG__ID D0Y1OF D0Y1OF DRUGCOMP Taisho Pharmaceutical Co Ltd D0Y1OF DRUGTYPE Small molecular drug D0Y1OF DRUGINCH 1S/C22H25N3O5/c1-2-22-9-5-10-23-11-8-16-15-6-3-4-7-17(15)24(19(16)20(22)23)18(14-22)21(26)29-12-13-30-25(27)28/h3-4,6-7,14,20H,2,5,8-13H2,1H3/t20-,22+/m1/s1 D0Y1OF DRUGINKE VDHLDQHKSSLLJV-IRLDBZIGSA-N D0Y1OF DRUGSMIL CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCCO[N+](=O)[O-] D0Y1OF HIGHSTAT Terminated D0Y2ES DRUG__ID D0Y2ES D0Y2ES DRUGCOMP Boehringer Ingelheim Corp D0Y2ES DRUGTYPE Small molecular drug D0Y2ES DRUGINCH 1S/C23H22ClN5O2S/c1-13-26-27-19-12-25-21(15-4-2-3-5-17(15)24)20-16-10-14(11-18(16)32-23(20)29(13)19)22(30)28-6-8-31-9-7-28/h2-5,14H,6-12H2,1H3 D0Y2ES DRUGINKE FWYVRZOREBYLCY-UHFFFAOYSA-N D0Y2ES DRUGSMIL CC1=NN=C2N1C3=C(C4=C(S3)CC(C4)C(=O)N5CCOCC5)C(=NC2)C6=CC=CC=C6Cl D0Y2ES HIGHSTAT Terminated D0Y2MP DRUG__ID D0Y2MP D0Y2MP DRUGCOMP Eisai Co Ltd D0Y2MP DRUGTYPE Small molecular drug D0Y2MP DRUGINCH 1S/C20H29NO3/c1-19(2,3)15-11-13(12-16(17(15)22)20(4,5)6)10-14-8-9-21(24-7)18(14)23/h10-12,22H,8-9H2,1-7H3/b14-10+ D0Y2MP DRUGINKE NJTQENWDJVHUOX-GXDHUFHOSA-N D0Y2MP DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2CCN(C2=O)OC D0Y2MP HIGHSTAT Terminated D0Y3OR DRUG__ID D0Y3OR D0Y3OR DRUGCOMP Bristol-Myers Squibb Co D0Y3OR DRUGTYPE Small molecular drug D0Y3OR DRUGINCH 1S/C23H23FNO5P.2Na/c1-15(2)23-19-5-3-4-6-20(19)25(17-9-7-16(24)8-10-17)21(23)11-12-31(29,30)14-18(26)13-22(27)28;;/h3-10,15,18,26H,13-14H2,1-2H3,(H,27,28)(H,29,30);;/q;2*+1/p-2/t18-;;/m0../s1 D0Y3OR DRUGINKE FXHKSTYWSZZOBF-NTEVMMBTSA-L D0Y3OR DRUGSMIL CC(C)C1=C(N(C2=CC=CC=C21)C3=CC=C(C=C3)F)C#CP(=O)(CC(CC(=O)[O-])O)[O-].[Na+].[Na+] D0Y3OR HIGHSTAT Terminated D0Y4ZS DRUG__ID D0Y4ZS D0Y4ZS DRUGCOMP NeuroSearch A/S D0Y4ZS DRUGTYPE Small molecular drug D0Y4ZS DRUGINCH 1S/C16H9BrF6N6O/c17-9-1-2-12(11(6-9)13-26-28-29-27-13)25-14(30)24-10-4-7(15(18,19)20)3-8(5-10)16(21,22)23/h1-6H,(H2,24,25,30)(H,26,27,28,29) D0Y4ZS DRUGINKE AEFYFGMSRKDXHZ-UHFFFAOYSA-N D0Y4ZS DRUGSMIL C1=CC(=C(C=C1Br)C2=NNN=N2)NC(=O)NC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0Y4ZS HIGHSTAT Terminated D0Y6SN DRUG__ID D0Y6SN D0Y6SN DRUGCOMP GlaxoSmithKline D0Y6SN DRUGTYPE Small molecular drug D0Y6SN DRUGINCH 1S/C28H30N4O/c29-18-21-5-8-23-19-32(16-13-22(23)17-21)15-12-20-6-9-24(10-7-20)31-28(33)26-11-14-30-27-4-2-1-3-25(26)27/h1-5,8,11,14,17,20,24H,6-7,9-10,12-13,15-16,19H2,(H,31,33) D0Y6SN DRUGINKE OLWRVVHPJFLNPW-UHFFFAOYSA-N D0Y6SN DRUGSMIL C1CC(CCC1CCN2CCC3=C(C2)C=CC(=C3)C#N)NC(=O)C4=CC=NC5=CC=CC=C45 D0Y6SN HIGHSTAT Terminated D0Y7BV DRUG__ID D0Y7BV D0Y7BV DRUGCOMP Ferrer Internacional SA D0Y7BV DRUGTYPE Small molecular drug D0Y7BV DRUGINCH 1S/C23H22F3N3O2/c24-23(25,26)16-7-8-17-20(9-10-27-21(17)15-16)28-19-6-2-1-5-18(19)22(30)31-14-13-29-11-3-4-12-29/h1-2,5-10,15H,3-4,11-14H2,(H,27,28) D0Y7BV DRUGINKE DQOYUDHAZMAVLD-UHFFFAOYSA-N D0Y7BV DRUGSMIL C1CCN(C1)CCOC(=O)C2=CC=CC=C2NC3=C4C=CC(=CC4=NC=C3)C(F)(F)F D0Y7BV HIGHSTAT Terminated D0Y8LT DRUG__ID D0Y8LT D0Y8LT DRUGCOMP Mera Pharmaceuticals D0Y8LT DRUGTYPE Small molecular drug D0Y8LT DRUGINCH 1S/C40H52O4/c1-27(17-13-19-29(3)21-23-33-31(5)37(43)35(41)25-39(33,7)8)15-11-12-16-28(2)18-14-20-30(4)22-24-34-32(6)38(44)36(42)26-40(34,9)10/h11-24,35-36,41-42H,25-26H2,1-10H3 D0Y8LT DRUGINKE MQZIGYBFDRPAKN-UHFFFAOYSA-N D0Y8LT DRUGSMIL CC1=C(C(CC(C1=O)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)C(CC2(C)C)O)C)C)C D0Y8LT HIGHSTAT Terminated D0YS8C DRUG__ID D0YS8C D0YS8C DRUGCOMP Biota Holdings Ltd D0YS8C DRUGTYPE Small molecular drug D0YS8C DRUGINCH 1S/C21H28N4O2/c1-3-27-22-16-19-5-7-20(8-6-19)26-15-12-18-10-13-25(14-11-18)21-9-4-17(2)23-24-21/h4-9,16,18H,3,10-15H2,1-2H3/b22-16+ D0YS8C DRUGINKE LNKHWGSSSPTTHB-CJLVFECKSA-N D0YS8C DRUGSMIL CCON=CC1=CC=C(C=C1)OCCC2CCN(CC2)C3=NN=C(C=C3)C D0YS8C HIGHSTAT Terminated D0Z0RU DRUG__ID D0Z0RU D0Z0RU DRUGCOMP Bristol-Myers Squibb Co D0Z0RU DRUGTYPE Small molecular drug D0Z0RU DRUGINCH 1S/C21H21N6O7P/c1-27-16-7-11(20(29)26-15(21(30)31)9-35(32,33)34)3-5-13(16)25-18(27)8-17-23-12-4-2-10(19(22)28)6-14(12)24-17/h2-7,15H,8-9H2,1H3,(H2,22,28)(H,23,24)(H,26,29)(H,30,31)(H2,32,33,34)/t15-/m0/s1 D0Z0RU DRUGINKE PEXFKSJDXSBOLP-HNNXBMFYSA-N D0Z0RU DRUGSMIL CN1C2=C(C=CC(=C2)C(=O)NC(CP(=O)(O)O)C(=O)O)N=C1CC3=NC4=C(N3)C=C(C=C4)C(=O)N D0Z0RU HIGHSTAT Terminated D0Z1TF DRUG__ID D0Z1TF D0Z1TF DRUGCOMP Roche Holding AG D0Z1TF DRUGTYPE Small molecular drug D0Z1TF DRUGINCH 1S/C33H44O8/c1-2-11-27-30(18-16-26-28(34)20-23-41-33(26)27)40-21-8-4-3-6-12-24-13-10-14-29(25(24)17-19-32(37)38)39-22-9-5-7-15-31(35)36/h10,13-14,16,18H,2-9,11-12,15,17,19-23H2,1H3,(H,35,36)(H,37,38) D0Z1TF DRUGINKE KLENIMLYAFNVOB-UHFFFAOYSA-N D0Z1TF DRUGSMIL CCCC1=C(C=CC2=C1OCCC2=O)OCCCCCCC3=C(C(=CC=C3)OCCCCCC(=O)O)CCC(=O)O D0Z1TF HIGHSTAT Terminated D0Z3AK DRUG__ID D0Z3AK D0Z3AK DRUGCOMP Scios Inc D0Z3AK DRUGTYPE Small molecular drug D0Z3AK DRUGINCH 1S/C23H17Cl2NO4/c24-14-3-7-17-18-8-4-15(25)12-20(18)22(19(17)11-14)30-10-9-21(27)26-16-5-1-13(2-6-16)23(28)29/h1-8,11-12,22H,9-10H2,(H,26,27)(H,28,29) D0Z3AK DRUGINKE JTYWUQLFBWFIEV-UHFFFAOYSA-N D0Z3AK DRUGSMIL C1=CC(=CC=C1C(=O)O)NC(=O)CCOC2C3=C(C=CC(=C3)Cl)C4=C2C=C(C=C4)Cl D0Z3AK HIGHSTAT Terminated D0Z4NX DRUG__ID D0Z4NX D0Z4NX DRUGCOMP Fujisawa Pharmaceutical Corp D0Z4NX DRUGTYPE Small molecular drug D0Z4NX DRUGINCH 1S/C19H11Cl3N2O4S/c1-28-16(25)9-15-18(27)24(12-5-2-10(20)3-6-12)19(29-15)23-17(26)13-7-4-11(21)8-14(13)22/h2-9H,1H3/b15-9+,23-19? D0Z4NX DRUGINKE SDGLYCKTPKZBGI-DALCUZTNSA-N D0Z4NX DRUGSMIL COC(=O)C=C1C(=O)N(C(=NC(=O)C2=C(C=C(C=C2)Cl)Cl)S1)C3=CC=C(C=C3)Cl D0Z4NX HIGHSTAT Terminated D0Z4QC DRUG__ID D0Z4QC D0Z4QC DRUGCOMP Novartis AG D0Z4QC DRUGTYPE Small molecular drug D0Z4QC DRUGINCH 1S/C15H20N2/c1-16-7-5-12-9-17-8-6-11-3-2-4-13(15(11)17)14(12)10-16/h2-4,12,14H,5-10H2,1H3/t12-,14-/m1/s1 D0Z4QC DRUGINKE YASBOGFWAMXINH-TZMCWYRMSA-N D0Z4QC DRUGSMIL CN1CCC2CN3CCC4=C3C(=CC=C4)C2C1 D0Z4QC HIGHSTAT Terminated D0Z5HB DRUG__ID D0Z5HB D0Z5HB DRUGCOMP Taisho Pharmaceutical Co Ltd D0Z5HB DRUGTYPE Small molecular drug D0Z5HB DRUGINCH 1S/C22H30N2.ClH/c1-5-13-24(14-6-2)15-12-18-8-7-9-19-21(18)20-16(3)10-11-17(4)22(20)23-19;/h7-11,23H,5-6,12-15H2,1-4H3;1H D0Z5HB DRUGINKE NSLYKDHGJLVNIJ-UHFFFAOYSA-N D0Z5HB DRUGSMIL CCCN(CCC)CCC1=C2C(=CC=C1)NC3=C(C=CC(=C23)C)C.Cl D0Z5HB HIGHSTAT Terminated D0Z7AN DRUG__ID D0Z7AN D0Z7AN DRUGCOMP Roche Holding AG D0Z7AN DRUGTYPE Small molecular drug D0Z7AN DRUGINCH 1S/C25H21ClN2O3/c26-18-9-8-17-10-12-28-23(20(17)13-18)22(25(31)27-11-4-7-19(27)15-29)14-21(24(28)30)16-5-2-1-3-6-16/h1-3,5-6,8-10,12-14,19,29H,4,7,11,15H2/t19-/m1/s1 D0Z7AN DRUGINKE MAHSERINKSLHDX-LJQANCHMSA-N D0Z7AN DRUGSMIL C1CC(N(C1)C(=O)C2=C3C4=C(C=CC(=C4)Cl)C=CN3C(=O)C(=C2)C5=CC=CC=C5)CO D0Z7AN HIGHSTAT Terminated D0ZE5V DRUG__ID D0ZE5V D0ZE5V DRUGCOMP Fisons plc D0ZE5V DRUGTYPE Small molecular drug D0ZE5V DRUGINCH 1S/C27H30O9.Na/c1-4-6-19-22(10-8-17(15(3)28)25(19)31)34-13-16(29)14-35-23-11-9-18-21(30)12-24(27(32)33)36-26(18)20(23)7-5-2;/h8-12,16,29,31H,4-7,13-14H2,1-3H3,(H,32,33);/q;+1/p-1 D0ZE5V DRUGINKE ZDEVPOBNLIVGFA-UHFFFAOYSA-M D0ZE5V DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCC(COC2=C(C3=C(C=C2)C(=O)C=C(O3)C(=O)[O-])CCC)O.[Na+] D0ZE5V HIGHSTAT Terminated D0ZQ7P DRUG__ID D0ZQ7P D0ZQ7P DRUGCOMP Schering-Plough Corp D0ZQ7P DRUGTYPE Small molecular drug D0ZQ7P DRUGINCH 1S/C20H26O7/c21-12-7-8-13(22)19-18(12,27-19)16(23)15-17(24-15)20(19)25-10-5-1-3-9-4-2-6-11(26-20)14(9)10/h9-15,17,21-22H,1-8H2 D0ZQ7P DRUGINKE MVEULHYPNLBION-UHFFFAOYSA-N D0ZQ7P DRUGSMIL C1CC2CCCC3C2C(C1)OC4(O3)C5C(O5)C(=O)C67C4(O6)C(CCC7O)O D0ZQ7P HIGHSTAT Terminated D0ZV0R DRUG__ID D0ZV0R D0ZV0R DRUGCOMP Eos Biotechnology Inc D0ZV0R DRUGTYPE Small molecular drug D0ZV0R DRUGINCH 1S/C18H18FN5OS/c1-11(2)22-16-8-14(20-10-21-16)15-9-26-18(23-15)24(3)17(25)12-4-6-13(19)7-5-12/h4-11H,1-3H3,(H,20,21,22) D0ZV0R DRUGINKE WIVGIKIKQHUFOD-UHFFFAOYSA-N D0ZV0R DRUGSMIL CC(C)NC1=NC=NC(=C1)C2=CSC(=N2)N(C)C(=O)C3=CC=C(C=C3)F D0ZV0R HIGHSTAT Terminated D0ZV1F DRUG__ID D0ZV1F D0ZV1F DRUGCOMP Roche Holding AG D0ZV1F DRUGTYPE Small molecular drug D0ZV1F DRUGINCH 1S/C31H29N11O11S3/c1-11-6-17(42-30(33-11)36-21(39-42)27(50)51)54-8-13-9-55-25-19(24(47)41(25)20(13)26(48)49)35-23(46)18(14-10-56-29(32)34-14)40-53-31(2,3)28(52)38-37-22(45)12-4-5-15(43)16(44)7-12/h4-7,10,19,25,43-44H,8-9H2,1-3H3,(H2,32,34)(H,35,46)(H,37,45)(H,38,52)(H,48,49)(H,50,51)/b40-18+/t19-,25-/m1/s1 D0ZV1F DRUGINKE KLYNTNRELYHTCT-MRANZGMHSA-N D0ZV1F DRUGSMIL CC1=NC2=NC(=NN2C(=C1)SCC3=C(N4C(C(C4=O)NC(=O)C(=NOC(C)(C)C(=O)NNC(=O)C5=CC(=C(C=C5)O)O)C6=CSC(=N6)N)SC3)C(=O)O)C(=O)O D0ZV1F HIGHSTAT Terminated D00BPA DRUG__ID D00BPA D00BPA DRUGTYPE Small molecular drug D00BPA DRUGINCH 1S/C15H18N6O/c1-21-10-18-12-13(17-9-11-5-3-2-4-6-11)19-15(16-7-8-22)20-14(12)21/h2-6,10,22H,7-9H2,1H3,(H2,16,17,19,20) D00BPA DRUGINKE GTVPOLSIJWJJNY-UHFFFAOYSA-N D00BPA DRUGSMIL CN1C=NC2=C(N=C(N=C21)NCCO)NCC3=CC=CC=C3 D00BPA HIGHSTAT Terminated D00CEG DRUG__ID D00CEG D00CEG DRUGTYPE Small molecular drug D00CEG DRUGINCH 1S/C38H44N4O8/c1-38(2,3)50-37(47)42-30-20-11-9-17-27(30)23-32(42)34(44)41-29-19-10-8-16-26(29)22-31(41)33(43)40-28(35(45)48-4)18-12-13-21-39-36(46)49-24-25-14-6-5-7-15-25/h5-11,14-17,19-20,28,31-32H,12-13,18,21-24H2,1-4H3,(H,39,46)(H,40,43)/t28-,31-,32-/m0/s1 D00CEG DRUGINKE GKYGBJABPHBINI-MHDHXZMLSA-N D00CEG DRUGSMIL CC(C)(C)OC(=O)N1C(CC2=CC=CC=C21)C(=O)N3C(CC4=CC=CC=C43)C(=O)NC(CCCCNC(=O)OCC5=CC=CC=C5)C(=O)OC D00CEG HIGHSTAT Terminated D00COB DRUG__ID D00COB D00COB DRUGTYPE Small molecular drug D00COB DRUGINCH 1S/C35H40N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-12,19,21-22,24-25,29,32,36H,13-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/b12-11+/t21?,22?,24?,25?,29-,32?,35+/m0/s1 D00COB DRUGINKE REMAMJQTIPBFTH-MYJPUEAFSA-N D00COB DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC(C3=CC=CC=C3)NC(=O)C=CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D00COB HIGHSTAT Terminated D00CQB DRUG__ID D00CQB D00CQB DRUGTYPE Small molecular drug D00CQB DRUGINCH 1S/C30H29N3O4/c1-20(21-10-4-3-5-11-21)32-28(34)30(2,17-23-18-31-26-14-8-7-13-25(23)26)33-29(35)36-19-24-16-22-12-6-9-15-27(22)37-24/h3-16,18,20,31H,17,19H2,1-2H3,(H,32,34)(H,33,35)/t20-,30+/m0/s1 D00CQB DRUGINKE IVIQHHCTWSXXCT-WENCNXQZSA-N D00CQB DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C(C)(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC5=CC=CC=C5O4 D00CQB HIGHSTAT Terminated D00FOE DRUG__ID D00FOE D00FOE DRUGTYPE Small molecular drug D00FOE DRUGINCH 1S/C45H60Cl2O6/c1-25(2)8-6-9-26(3)35-14-15-36-32-13-12-30-20-27(16-18-44(30,4)37(32)17-19-45(35,36)5)10-7-11-31(28-21-33(42(50)51)40(48)38(46)23-28)29-22-34(43(52)53)41(49)39(47)24-29/h11,21-27,30,32,35-37,48-49H,6-10,12-20H2,1-5H3,(H,50,51)(H,52,53)/t26-,27+,30+,32+,35-,36+,37+,44+,45-/m1/s1 D00FOE DRUGINKE VOJOOGPALCATLT-ZFQBPCNVSA-N D00FOE DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)CCC=C(C5=CC(=C(C(=C5)Cl)O)C(=O)O)C6=CC(=C(C(=C6)Cl)O)C(=O)O)C)C D00FOE HIGHSTAT Terminated D00HHP DRUG__ID D00HHP D00HHP DRUGCOMP Pfizer Inc D00HHP DRUGINCH 1S/C20H25NO8/c1-3-6-27-13-5-4-11(8-12(13)22)7-10(2)20(26)21-14-15(23)17(25)19-18(16(14)24)28-9-29-19/h3-5,7-8,14-19,22-25H,1,6,9H2,2H3,(H,21,26)/b10-7+/t14-,15+,16-,17-,18+,19-/m1/s1 D00HHP DRUGINKE NGSRLTSVOTUMKD-ZKVKIDQDSA-N D00HHP DRUGSMIL CC(=CC1=CC(=C(C=C1)OCC=C)O)C(=O)NC2C(C(C3C(C2O)OCO3)O)O D00HHP HIGHSTAT Terminated D00ICM DRUG__ID D00ICM D00ICM DRUGTYPE Small molecular drug D00ICM DRUGINCH 1S/C26H28N2O4S.ClH/c1-17(29)32-23-24(19-9-12-20(31-4)13-10-19)33-25-21-8-6-5-7-18(21)11-14-22(25)28(26(23)30)16-15-27(2)3;/h5-14,23-24H,15-16H2,1-4H3;1H/t23-,24+;/m1./s1 D00ICM DRUGINKE SFTBZKFGODNAKF-ITNPDYSASA-N D00ICM DRUGSMIL CC(=O)OC1C(SC2=C(C=CC3=CC=CC=C32)N(C1=O)CCN(C)C)C4=CC=C(C=C4)OC.Cl D00ICM HIGHSTAT Terminated D00JMZ DRUG__ID D00JMZ D00JMZ DRUGTYPE Small molecular drug D00JMZ DRUGINCH 1S/C32H30N4O11/c1-15-23(29(37)45-5)27(19-9-7-11-21(13-19)35(41)42)25(17(3)33-15)31(39)47-32(40)26-18(4)34-16(2)24(30(38)46-6)28(26)20-10-8-12-22(14-20)36(43)44/h7-14,27-28,33-34H,1-6H3/t27-,28+ D00JMZ DRUGINKE PZNZOWSLQRURNA-HNRBIFIRSA-N D00JMZ DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(=O)C2=C(NC(=C(C2C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC)C)C)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC D00JMZ HIGHSTAT Terminated D00JQQ DRUG__ID D00JQQ D00JQQ DRUGCOMP Chugai Pharmaceutical Co Ltd D00JQQ DRUGINCH 1S/C22H19NO2/c1-16-6-2-3-7-18(16)13-10-17-11-14-19(15-12-17)23-21-9-5-4-8-20(21)22(24)25/h2-15,23H,1H3,(H,24,25)/b13-10+ D00JQQ DRUGINKE FUJSSIRYCZLXQW-JLHYYAGUSA-N D00JQQ DRUGSMIL CC1=CC=CC=C1C=CC2=CC=C(C=C2)NC3=CC=CC=C3C(=O)O D00JQQ HIGHSTAT Terminated D00KQT DRUG__ID D00KQT D00KQT DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00KQT DRUGINCH 1S/C30H37NO2/c1-2-3-4-5-6-15-22-33-29-21-14-13-20-27(29)24-30(32)31-28(26-18-11-8-12-19-26)23-25-16-9-7-10-17-25/h7-14,16-21,28H,2-6,15,22-24H2,1H3,(H,31,32) D00KQT DRUGINKE XUCJTVYTRXSOJC-UHFFFAOYSA-N D00KQT DRUGSMIL CCCCCCCCOC1=CC=CC=C1CC(=O)NC(CC2=CC=CC=C2)C3=CC=CC=C3 D00KQT HIGHSTAT Terminated D00KZF DRUG__ID D00KZF D00KZF DRUGTYPE Small molecular drug D00KZF DRUGINCH 1S/C22H31N3O3/c1-28-19-7-3-2-6-18(19)24-13-10-23(11-14-24)12-15-25-20(26)16-22(17-21(25)27)8-4-5-9-22/h2-3,6-7H,4-5,8-17H2,1H3 D00KZF DRUGINKE AYYCFGDXLUPJAQ-UHFFFAOYSA-N D00KZF DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O D00KZF HIGHSTAT Terminated D00NLD DRUG__ID D00NLD D00NLD DRUGTYPE Small molecular drug D00NLD DRUGINCH 1S/C14H17N5/c1-18(2)6-5-11-8-15-14-4-3-12(7-13(11)14)19-9-16-17-10-19/h3-4,7-10,15H,5-6H2,1-2H3 D00NLD DRUGINKE IGNXHSPBUUSUHB-UHFFFAOYSA-N D00NLD DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)N3C=NN=C3 D00NLD HIGHSTAT Terminated D00UBK DRUG__ID D00UBK D00UBK DRUGTYPE Small molecular drug D00UBK DRUGINCH 1S/C37H37N7O2/c1-3-5-11-23-43(36(45)28-13-7-6-8-14-28)29-21-22-33-32(24-29)37(46)44(34(38-33)12-4-2)25-26-17-19-27(20-18-26)30-15-9-10-16-31(30)35-39-41-42-40-35/h6-10,13-22,24H,3-5,11-12,23,25H2,1-2H3,(H,39,40,41,42) D00UBK DRUGINKE JQXJNTQZCWEHKS-UHFFFAOYSA-N D00UBK DRUGSMIL CCCCCN(C1=CC2=C(C=C1)N=C(N(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)CCC)C(=O)C6=CC=CC=C6 D00UBK HIGHSTAT Terminated D00UEG DRUG__ID D00UEG D00UEG DRUGTYPE Small molecular drug D00UEG DRUGINCH 1S/C22H18BrN3O2/c23-17-11-13-18(14-12-17)24-22(28)26-20(16-9-5-2-6-10-16)19(21(27)25-26)15-7-3-1-4-8-15/h1-14,19-20H,(H,24,28)(H,25,27) D00UEG DRUGINKE LMUQHXHWJWQXSD-UHFFFAOYSA-N D00UEG DRUGSMIL C1=CC=C(C=C1)C2C(N(NC2=O)C(=O)NC3=CC=C(C=C3)Br)C4=CC=CC=C4 D00UEG HIGHSTAT Terminated D00UEQ DRUG__ID D00UEQ D00UEQ DRUGTYPE Small molecular drug D00UEQ DRUGINCH 1S/C17H23ClO4/c1-2-20-16(19)17(13-22-17)11-5-3-4-6-12-21-15-9-7-14(18)8-10-15/h7-10H,2-6,11-13H2,1H3/t17-/m1/s1 D00UEQ DRUGINKE DZLOHEOHWICNIL-QGZVFWFLSA-N D00UEQ DRUGSMIL CCOC(=O)C1(CO1)CCCCCCOC2=CC=C(C=C2)Cl D00UEQ HIGHSTAT Terminated D00XRK DRUG__ID D00XRK D00XRK DRUGCOMP Bristol-Myers Squibb Co D00XRK DRUGINCH 1S/C30H45N3O6/c1-29(2,3)38-27(36)32-23(17-21-13-9-7-10-14-21)25(34)19-31-20-26(35)24(18-22-15-11-8-12-16-22)33-28(37)39-30(4,5)6/h7-16,23-26,31,34-35H,17-20H2,1-6H3,(H,32,36)(H,33,37)/t23-,24-,25+,26+/m0/s1 D00XRK DRUGINKE KKRYDPVDJYCEER-QEGGNFSNSA-N D00XRK DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(CNCC(C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C)O)O D00XRK HIGHSTAT Terminated D00YOW DRUG__ID D00YOW D00YOW DRUGCOMP Laboratorios Menarini SA D00YOW DRUGINCH 1S/C30H24N2O4/c33-29(31-16-15-20-5-7-23(8-6-20)30(34)35)24-10-9-21-12-14-27(18-25(21)17-24)36-19-26-13-11-22-3-1-2-4-28(22)32-26/h1-14,17-18H,15-16,19H2,(H,31,33)(H,34,35) D00YOW DRUGINKE IXSRNSVQRMOPTQ-UHFFFAOYSA-N D00YOW DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC4=C(C=CC(=C4)C(=O)NCCC5=CC=C(C=C5)C(=O)O)C=C3 D00YOW HIGHSTAT Terminated D00YPW DRUG__ID D00YPW D00YPW DRUGTYPE Small molecular drug D00YPW DRUGINCH 1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19) D00YPW DRUGINKE REZGGXNDEMKIQB-UHFFFAOYSA-N D00YPW DRUGSMIL CCCOC1=CC=CC=C1C2=NC3=NNN=C3C(=O)N2 D00YPW HIGHSTAT Terminated D00ZZH DRUG__ID D00ZZH D00ZZH DRUGTYPE Small molecular drug D00ZZH DRUGINCH 1S/C15H14ClN7O5S2.Na/c1-22-15(18-20-21-22)30-5-6-4-29-13-10(12(25)23(13)11(6)14(26)27)17-9(24)3-7-2-8(16)19-28-7;/h2,10,13H,3-5H2,1H3,(H,17,24)(H,26,27);/q;+1/p-1/t10-,13-;/m1./s1 D00ZZH DRUGINKE XQPMNRFOIDADDS-HTMVYDOJSA-M D00ZZH DRUGSMIL CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CC(=NO4)Cl)SC2)C(=O)[O-].[Na+] D00ZZH HIGHSTAT Terminated D01BCQ DRUG__ID D01BCQ D01BCQ DRUGTYPE Small molecular drug D01BCQ DRUGINCH 1S/C17H17N3O2/c1-4-13-11(2)20-10-14(18-17(20)19-16(13)22-3)15(21)12-8-6-5-7-9-12/h5-10H,4H2,1-3H3 D01BCQ DRUGINKE NRJVHCSYLGLURI-UHFFFAOYSA-N D01BCQ DRUGSMIL CCC1=C(N2C=C(N=C2N=C1OC)C(=O)C3=CC=CC=C3)C D01BCQ HIGHSTAT Terminated D01CNV DRUG__ID D01CNV D01CNV DRUGCOMP PLIVA dd D01CNV DRUGINCH 1S/C13H16N2O5S/c1-9(16)14-10-2-4-11(5-3-10)21(17,18)15-12-6-19-8-20-7-13(12)15/h2-5,12-13H,6-8H2,1H3,(H,14,16) D01CNV DRUGINKE AEDPBBOGLHONFN-UHFFFAOYSA-N D01CNV DRUGSMIL CC(=O)NC1=CC=C(C=C1)S(=O)(=O)N2C3C2COCOC3 D01CNV HIGHSTAT Terminated D01EDE DRUG__ID D01EDE D01EDE DRUGTYPE Small molecular drug D01EDE DRUGINCH 1S/C36H35N3O4/c1-23-17-24(2)19-28(18-23)35(41)39(3)33(20-25-13-15-27(16-14-25)26-9-5-4-6-10-26)34(40)38-32(36(42)43)21-29-22-37-31-12-8-7-11-30(29)31/h4-19,22,32-33,37H,20-21H2,1-3H3,(H,38,40)(H,42,43)/t32-,33+/m0/s1 D01EDE DRUGINKE UZDORQWMYRRLQV-JHOUSYSJSA-N D01EDE DRUGSMIL CC1=CC(=CC(=C1)C(=O)N(C)C(CC2=CC=C(C=C2)C3=CC=CC=C3)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)O)C D01EDE HIGHSTAT Terminated D01EFO DRUG__ID D01EFO D01EFO DRUGCOMP Novartis AG D01EFO DRUGINCH 1S/C23H19N5O/c1-16-9-10-19(26-22(29)17-6-3-2-4-7-17)14-21(16)28-23-25-13-11-20(27-23)18-8-5-12-24-15-18/h2-15H,1H3,(H,26,29)(H,25,27,28) D01EFO DRUGINKE UOEJSOXEHKCNAE-UHFFFAOYSA-N D01EFO DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC=CC=C2)NC3=NC=CC(=N3)C4=CN=CC=C4 D01EFO HIGHSTAT Terminated D01FRF DRUG__ID D01FRF D01FRF DRUGTYPE Small molecular drug D01FRF DRUGINCH 1S/C24H27N3O3/c1-14-9-15(2)23(16(3)10-14)25-22-13-19-18-12-21(30-6)20(29-5)11-17(18)7-8-27(19)24(28)26(22)4/h9-13H,7-8H2,1-6H3 D01FRF DRUGINKE MCMSJVMUSBZUCN-UHFFFAOYSA-N D01FRF DRUGSMIL CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2C)OC)OC)C D01FRF HIGHSTAT Terminated D01PWK DRUG__ID D01PWK D01PWK DRUGTYPE Small molecular drug D01PWK DRUGINCH 1S/C15H11BrCl2N2O4S/c16-9-3-1-2-8(4-9)7-20-14(15(21)22)19-12-6-10(17)5-11(18)13(12)25(20,23)24/h1-6,14,19H,7H2,(H,21,22) D01PWK DRUGINKE HNXXFIJGNAGRFN-UHFFFAOYSA-N D01PWK DRUGSMIL C1=CC(=CC(=C1)Br)CN2C(NC3=C(S2(=O)=O)C(=CC(=C3)Cl)Cl)C(=O)O D01PWK HIGHSTAT Terminated D01QUF DRUG__ID D01QUF D01QUF DRUGCOMP GlaxoSmithKline Inc D01QUF DRUGINCH 1S/C21H29NO5/c1-14(23)21(2)13-22(20(24)26-4)12-17(21)15-9-10-18(25-3)19(11-15)27-16-7-5-6-8-16/h9-11,16-17H,5-8,12-13H2,1-4H3/t17-,21-/m0/s1 D01QUF DRUGINKE YTFBNFMILWHYAP-UWJYYQICSA-N D01QUF DRUGSMIL CC(=O)C1(CN(CC1C2=CC(=C(C=C2)OC)OC3CCCC3)C(=O)OC)C D01QUF HIGHSTAT Terminated D01RBK DRUG__ID D01RBK D01RBK DRUGCOMP AFG Biosolutions Inc D01RBK DRUGINCH 1S/C143H230N42O37S7/c1-24-69(11)105(148)135(213)162-82(27-4)118(196)174-94-58-225-59-95(175-123(201)89(48-67(7)8)169-115(193)74(16)158-138(216)107(70(12)25-2)180-132(94)210)133(211)184-112-79(21)229-61-96(160-104(190)56-152-134(212)100-38-34-44-185(100)142(112)220)128(206)164-84(36-29-32-42-145)120(198)182-109-76(18)226-60-97(161-103(189)55-151-117(195)85(39-45-223-22)165-122(200)88(47-66(5)6)168-113(191)72(14)156-102(188)54-153-136(109)214)129(207)171-92(51-101(147)187)125(203)166-86(40-46-224-23)119(197)163-83(35-28-31-41-144)121(199)183-110-77(19)228-63-99-130(208)170-90(49-80-52-149-64-154-80)124(202)176-98(62-227-78(20)111(141(219)177-99)181-116(194)75(17)159-140(110)218)131(209)173-93(57-186)127(205)179-108(71(13)26-3)139(217)172-91(50-81-53-150-65-155-81)126(204)178-106(68(9)10)137(215)157-73(15)114(192)167-87(143(221)222)37-30-33-43-146/h27,52-53,64-72,75-79,83-100,105-112,186H,15-16,24-26,28-51,54-63,144-146,148H2,1-14,17-23H3,(H2,147,187)(H,149,154)(H,150,155)(H,151,195)(H,152,212)(H,153,214)(H,156,188)(H,157,215)(H,158,216)(H,159,218)(H,160,190)(H,161,189)(H,162,213)(H,163,197)(H,164,206)(H,165,200)(H,166,203)(H,167,192)(H,168,191)(H,169,193)(H,170,208)(H,171,207)(H,172,217)(H,173,209)(H,174,196)(H,175,201)(H,176,202)(H,177,219)(H,178,204)(H,179,205)(H,180,210)(H,181,194)(H,182,198)(H,183,199)(H,184,211)(H,221,222)/b82-27- D01RBK DRUGINKE NVNLLIYOARQCIX-GSJOZIGCSA-N D01RBK DRUGSMIL CCC(C)C1C(=O)NC(=C)C(=O)NC(C(=O)NC(CSCC(C(=O)N1)NC(=O)C(=CC)NC(=O)C(C(C)CC)N)C(=O)NC2C(SCC(NC(=O)CNC(=O)C3CCCN3C2=O)C(=O)NC(CCCCN)C(=O)NC4C(SCC(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC4=O)C)CC(C)C)CCSC)C(=O)NC(CC(=O)N)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC5C(SCC6C(=O)NC(C(=O)NC(CSC(C(C(=O)N6)NC(=O)C(NC5=O)C)C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC7=CN=CN7)C(=O)NC(C(C)C)C(=O)NC(=C)C(=O)NC(CCCCN)C(=O)O)CC8=CN=CN8)C)C)C)CC(C)C D01RBK HIGHSTAT Terminated D01RFI DRUG__ID D01RFI D01RFI DRUGTYPE Small molecular drug D01RFI DRUGINCH 1S/C27H36N2O2/c1-4-5-6-13-24(25-16-18-26(31-3)19-17-25)14-8-15-27(30)29-22(2)10-7-11-23-12-9-20-28-21-23/h8-9,12,14-22H,4-7,10-11,13H2,1-3H3,(H,29,30)/b15-8+,24-14+/t22-/m1/s1 D01RFI DRUGINKE HLCHRSFXEXAMLU-YDQNRGGDSA-N D01RFI DRUGSMIL CCCCCC(=CC=CC(=O)NC(C)CCCC1=CN=CC=C1)C2=CC=C(C=C2)OC D01RFI HIGHSTAT Terminated D01RKQ DRUG__ID D01RKQ D01RKQ DRUGCOMP Novartis AG D01RKQ DRUGINCH 1S/C61H99N9O14/c1-21-37(9)50-52(73)62-33-45(71)66(16)48(35(5)6)53(74)63-42(31-40-26-28-41(82-20)29-27-40)60(81)83-39(11)55(76)70-30-24-23-25-43(70)56(77)67(17)49(36(7)8)54(75)64-47(34(3)4)58(79)65(15)44(32-46(72)84-61(12,13)14)57(78)69(19)51(38(10)22-2)59(80)68(50)18/h26-29,34-39,42-44,47-51H,21-25,30-33H2,1-20H3,(H,62,73)(H,63,74)(H,64,75)/t37-,38-,39+,42-,43-,44-,47-,48-,49-,50-,51-/m0/s1 D01RKQ DRUGINKE UGWMRFXIOXUDPM-OUABENRGSA-N D01RKQ DRUGSMIL CCC(C)C1C(=O)NCC(=O)N(C(C(=O)NC(C(=O)OC(C(=O)N2CCCCC2C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)CC)C)CC(=O)OC(C)(C)C)C)C(C)C)C(C)C)C)C)CC3=CC=C(C=C3)OC)C(C)C)C D01RKQ HIGHSTAT Terminated D01SBP DRUG__ID D01SBP D01SBP DRUGCOMP Purdue Neuroscience Corp D01SBP DRUGINCH 1S/C31H40O3/c1-20(32)23-7-5-22(6-8-23)13-16-31(34)18-17-29(3)24(19-31)9-10-25-27-12-11-26(21(2)33)30(27,4)15-14-28(25)29/h5-8,24-28,34H,9-12,14-15,17-19H2,1-4H3/t24-,25-,26+,27-,28-,29-,30+,31+/m0/s1 D01SBP DRUGINKE ZPPSBQVNGSDAFI-KWJNIICQSA-N D01SBP DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C#CC5=CC=C(C=C5)C(=O)C)O)C)C D01SBP HIGHSTAT Terminated D01TSN DRUG__ID D01TSN D01TSN DRUGTYPE Small molecular drug D01TSN DRUGINCH 1S/C11H15N3S/c1-14-6-2-3-7-8(14)4-5-9-10(7)13-11(12)15-9/h3,8H,2,4-6H2,1H3,(H2,12,13) D01TSN DRUGINKE XFJSSDHKIXXJLM-UHFFFAOYSA-N D01TSN DRUGSMIL CN1CCC=C2C1CCC3=C2N=C(S3)N D01TSN HIGHSTAT Terminated D01VUE DRUG__ID D01VUE D01VUE DRUGTYPE Small molecular drug D01VUE DRUGINCH 1S/C17H19N3O3S/c1-11-12(2)18-23-17(11)19-24(21,22)16-10-6-7-13-14(16)8-5-9-15(13)20(3)4/h5-10,19H,1-4H3 D01VUE DRUGINKE MJRGSRRZKSJHOE-UHFFFAOYSA-N D01VUE DRUGSMIL CC1=C(ON=C1C)NS(=O)(=O)C2=CC=CC3=C2C=CC=C3N(C)C D01VUE HIGHSTAT Terminated D01WGJ DRUG__ID D01WGJ D01WGJ DRUGTYPE Small molecular drug D01WGJ DRUGINCH 1S/C21H20O9/c22-8-16-18(25)19(26)20(27)21(30-16)29-12-5-6-13-15(7-12)28-9-14(17(13)24)10-1-3-11(23)4-2-10/h1-7,9,16,18-23,25-27H,8H2/t16-,18-,19+,20-,21-/m1/s1 D01WGJ DRUGINKE KYQZWONCHDNPDP-QNDFHXLGSA-N D01WGJ DRUGSMIL C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)O)O D01WGJ HIGHSTAT Terminated D01WJV DRUG__ID D01WJV D01WJV DRUGTYPE Small molecular drug D01WJV DRUGINCH 1S/C29H28N4O6/c1-19-25(28(34)38-3)27(23-7-4-8-24(16-23)33(36)37)26(20(2)31-19)29(35)39-15-5-6-21-9-11-22(12-10-21)17-32-14-13-30-18-32/h4-14,16,18,27,31H,15,17H2,1-3H3/b6-5+ D01WJV DRUGINKE CSBQPRGTYHAYKS-AATRIKPKSA-N D01WJV DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=C(C=C2)CN3C=CN=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC D01WJV HIGHSTAT Terminated D01XEQ DRUG__ID D01XEQ D01XEQ DRUGCOMP Rigel Pharmaceuticals D01XEQ DRUGINCH 1S/C8H11N/c1-3-8-6-9-5-4-7(8)2/h4-6H,3H2,1-2H3 D01XEQ DRUGINKE JDQNYWYMNFRKNQ-UHFFFAOYSA-N D01XEQ DRUGSMIL CCC1=C(C=CN=C1)C D01XEQ HIGHSTAT Terminated D01XMO DRUG__ID D01XMO D01XMO DRUGTYPE Small molecular drug D01XMO DRUGINCH 1S/C34H29FO9/c1-2-19-16-25(20-4-7-22(35)8-5-20)27(36)18-30(19)43-15-3-14-42-28-12-9-24-32(39)26-17-21(34(40)41)6-11-29(26)44-33(24)23(28)10-13-31(37)38/h4-9,11-12,16-18,36H,2-3,10,13-15H2,1H3,(H,37,38)(H,40,41) D01XMO DRUGINKE DCTKEJXAVFAMFK-UHFFFAOYSA-N D01XMO DRUGSMIL CCC1=CC(=C(C=C1OCCCOC2=C(C3=C(C=C2)C(=O)C4=C(O3)C=CC(=C4)C(=O)O)CCC(=O)O)O)C5=CC=C(C=C5)F D01XMO HIGHSTAT Terminated D01ZSF DRUG__ID D01ZSF D01ZSF DRUGTYPE Small molecular drug D01ZSF DRUGINCH 1S/C24H33NO3S/c1-4-14-25(15-5-2)22-9-8-20-16-19(6-7-21(20)17-22)18-29(26,27)24-12-10-23(28-3)11-13-24/h6-7,10-13,16,22H,4-5,8-9,14-15,17-18H2,1-3H3 D01ZSF DRUGINKE HUXFXXWYIRBVJR-UHFFFAOYSA-N D01ZSF DRUGSMIL CCCN(CCC)C1CCC2=C(C1)C=CC(=C2)CS(=O)(=O)C3=CC=C(C=C3)OC D01ZSF HIGHSTAT Terminated D02DLE DRUG__ID D02DLE D02DLE DRUGTYPE Small molecular drug D02DLE DRUGINCH 1S/C16H18N5O3P/c22-25(23,24)11-17-15(16-18-20-21-19-16)10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,15,17H,10-11H2,(H2,22,23,24)(H,18,19,20,21)/t15-/m0/s1 D02DLE DRUGINKE UUMKQZVEZSXWBY-HNNXBMFYSA-N D02DLE DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC(C3=NNN=N3)NCP(=O)(O)O D02DLE HIGHSTAT Terminated D02FNU DRUG__ID D02FNU D02FNU DRUGTYPE Small molecular drug D02FNU DRUGINCH 1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2 D02FNU DRUGINKE TZJUVVIWVWFLCD-UHFFFAOYSA-N D02FNU DRUGSMIL C1CN(CCN1CCCCN2C(=O)C3=CC=CC=C3S2(=O)=O)C4=NC=CC=N4 D02FNU HIGHSTAT Terminated D02INZ DRUG__ID D02INZ D02INZ DRUGTYPE Small molecular drug D02INZ DRUGINCH 1S/C17H16N8/c18-16(19)8-1-3-10-12(5-8)24-14(22-10)7-15-23-11-4-2-9(17(20)21)6-13(11)25-15/h1-6H,7H2,(H3,18,19)(H3,20,21)(H,22,24)(H,23,25) D02INZ DRUGINKE QZKOOEFIMWKZPK-UHFFFAOYSA-N D02INZ DRUGSMIL C1=CC2=C(C=C1C(=N)N)NC(=N2)CC3=NC4=C(N3)C=C(C=C4)C(=N)N D02INZ HIGHSTAT Terminated D02JIB DRUG__ID D02JIB D02JIB DRUGCOMP Roche Holding AG D02JIB DRUGINCH 1S/C32H29F2N5O9S2/c33-20-11-18-25(38(16-3-4-16)12-19(27(18)41)30(43)44)22(34)26(20)36-5-7-37(8-6-36)32(47)48-13-15-14-50-29-23(28(42)39(29)24(15)31(45)46)35-21(40)10-17-2-1-9-49-17/h1-2,9,11-12,16,23,29H,3-8,10,13-14H2,(H,35,40)(H,43,44)(H,45,46)/t23-,29-/m1/s1 D02JIB DRUGINKE XEKHRWZGVAICLA-RNWIMVQKSA-N D02JIB DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)F)N4CCN(CC4)C(=O)OCC5=C(N6C(C(C6=O)NC(=O)CC7=CC=CS7)SC5)C(=O)O)F)C(=O)O D02JIB HIGHSTAT Terminated D02KAF DRUG__ID D02KAF D02KAF DRUGCOMP Gliatech Inc D02KAF DRUGINCH 1S/C6H9N3/c7-5-1-4(5)6-2-8-3-9-6/h2-5H,1,7H2,(H,8,9)/t4-,5-/m1/s1 D02KAF DRUGINKE OWWNABDDYQLERE-RFZPGFLSSA-N D02KAF DRUGSMIL C1C(C1N)C2=CN=CN2 D02KAF HIGHSTAT Terminated D02KLW DRUG__ID D02KLW D02KLW DRUGTYPE Small molecular drug D02KLW DRUGINCH 1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3/t15-,16+/m1/s1 D02KLW DRUGINKE LBOJYSIDWZQNJS-CVEARBPZSA-N D02KLW DRUGSMIL CC12C3=CC=CC=C3CC(N1)C4=CC=CC=C24 D02KLW HIGHSTAT Terminated D02KZI DRUG__ID D02KZI D02KZI DRUGCOMP Merck Research Laboratories D02KZI DRUGINCH 1S/C31H37N5O7S.ClH/c1-18-22(29(31(40)41)34-28(18)26(19(2)37)30(34)39)16-33-23-5-3-4-21-20(6-7-24(27(21)23)44(33,42)43)8-9-35-10-13-36(14-11-35,15-12-35)17-25(32)38;/h3-7,18-19,26,28,37H,8-17H2,1-2H3,(H-2,32,38,40,41);1H/t18-,19+,26+,28+,35?,36?;/m0./s1 D02KZI DRUGINKE BRFWKOFAMCKDLC-OZBXVNDPSA-N D02KZI DRUGSMIL CC1C2C(C(=O)N2C(=C1CN3C4=CC=CC5=C(C=CC(=C54)S3(=O)=O)CC[N+]67CC[N+](CC6)(CC7)CC(=O)N)C(=O)[O-])C(C)O.[Cl-] D02KZI HIGHSTAT Terminated D02NFA DRUG__ID D02NFA D02NFA DRUGCOMP Abbott Laboratories D02NFA DRUGINCH 1S/C68H116N26O15S2/c1-5-36(3)52(63(108)88-45(30-39-19-11-8-12-20-39)59(104)86-43(23-15-27-81-67(75)76)56(101)91-48(35-111)62(107)94-61(106)47(34-110)90-55(100)40(69)21-13-25-79-65(71)72)93-58(103)44(24-16-28-82-68(77)78)87-60(105)46(31-51(97)98)89-64(109)53(37(4)6-2)92-57(102)42(22-14-26-80-66(73)74)85-50(96)33-83-49(95)32-84-54(99)41(70)29-38-17-9-7-10-18-38/h8,11-12,19-20,32,36-38,40-48,52-53,110-111H,5-7,9-10,13-18,21-31,33-35,69-70H2,1-4H3,(H,83,95)(H,85,96)(H,86,104)(H,87,105)(H,88,108)(H,89,109)(H,90,100)(H,91,101)(H,92,102)(H,93,103)(H,97,98)(H4,71,72,79)(H4,73,74,80)(H4,75,76,81)(H4,77,78,82)(H,94,106,107)/t36-,37-,40-,41-,42-,43-,44-,45-,46-,47-,48-,52-,53-/m0/s1 D02NFA DRUGINKE HCJNLCHEKMAIHX-WXWPIKAFSA-N D02NFA DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCN=C(N)N)C(=O)NC(CS)C(=O)NC(=O)C(CS)NC(=O)C(CCCN=C(N)N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C=NC(=O)C(CC2CCCCC2)N D02NFA HIGHSTAT Terminated D02NLI DRUG__ID D02NLI D02NLI DRUGTYPE Small molecular drug D02NLI DRUGINCH 1S/C24H32N2O/c1-19-11-9-12-20(2)26(19)18-10-17-25-24(27)23(21-13-5-3-6-14-21)22-15-7-4-8-16-22/h3-8,13-16,19-20,23H,9-12,17-18H2,1-2H3,(H,25,27) D02NLI DRUGINKE BPZBEIHSHWNWTE-UHFFFAOYSA-N D02NLI DRUGSMIL CC1CCCC(N1CCCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)C D02NLI HIGHSTAT Terminated D02OKK DRUG__ID D02OKK D02OKK DRUGTYPE Small molecular drug D02OKK DRUGINCH 1S/C25H28N4O5S/c1-34-25(31)21-17-19-20(26-21)8-6-9-22(19)28-15-13-27(14-16-28)11-4-5-12-29-24(30)18-7-2-3-10-23(18)35(29,32)33/h2-3,6-10,17,26H,4-5,11-16H2,1H3 D02OKK DRUGINKE LPPRLWFUMJHAKF-UHFFFAOYSA-N D02OKK DRUGSMIL COC(=O)C1=CC2=C(N1)C=CC=C2N3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O D02OKK HIGHSTAT Terminated D02ONK DRUG__ID D02ONK D02ONK DRUGTYPE Small molecular drug D02ONK DRUGINCH 1S/C19H29N3O4S.ClH/c1-3-4-7-22-8-5-6-15(22)12-21-19(23)17-11-16(27(20,24)25)10-14-9-13(2)26-18(14)17;/h10-11,13,15H,3-9,12H2,1-2H3,(H,21,23)(H2,20,24,25);1H D02ONK DRUGINKE GZXVXVNELOPJSZ-UHFFFAOYSA-N D02ONK DRUGSMIL CCCCN1CCCC1CNC(=O)C2=CC(=CC3=C2OC(C3)C)S(=O)(=O)N.Cl D02ONK HIGHSTAT Terminated D02QGM DRUG__ID D02QGM D02QGM DRUGCOMP Novartis AG D02QGM DRUGINCH 1S/C25H24FN3O4/c26-21-7-5-19(6-8-21)18-3-1-17(2-4-18)16-28-12-11-20-15-22(9-10-23(20)24(28)30)33-14-13-29(32)25(27)31/h1-10,15,32H,11-14,16H2,(H2,27,31) D02QGM DRUGINKE QFDRKYCYRMSXMS-UHFFFAOYSA-N D02QGM DRUGSMIL C1CN(C(=O)C2=C1C=C(C=C2)OCCN(C(=O)N)O)CC3=CC=C(C=C3)C4=CC=C(C=C4)F D02QGM HIGHSTAT Terminated D02QTV DRUG__ID D02QTV D02QTV DRUGTYPE Small molecular drug D02QTV DRUGINCH 1S/C21H32N6O3/c1-24-17(13-15-7-3-2-4-8-15)20(30)27-12-6-10-18(27)19(29)26-16(14-28)9-5-11-25-21(22)23/h2-4,7-8,14,16-18,24H,5-6,9-13H2,1H3,(H,26,29)(H4,22,23,25)/t16-,17+,18-/m0/s1 D02QTV DRUGINKE KAGLWQUWUNBAOO-KSZLIROESA-N D02QTV DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C=O D02QTV HIGHSTAT Terminated D02QZL DRUG__ID D02QZL D02QZL DRUGCOMP NeuroSearch A/S D02QZL DRUGINCH 1S/C12H12N4O4/c1-15-3-2-6-7(5-15)10-8(4-9(6)16(19)20)13-11(17)12(18)14-10/h4H,2-3,5H2,1H3,(H,13,17)(H,14,18) D02QZL DRUGINKE GDSGJOIKTYTOQG-UHFFFAOYSA-N D02QZL DRUGSMIL CN1CCC2=C(C=C3C(=C2C1)NC(=O)C(=O)N3)[N+](=O)[O-] D02QZL HIGHSTAT Terminated D02RDE DRUG__ID D02RDE D02RDE DRUGTYPE Small molecular drug D02RDE DRUGINCH 1S/C39H44N4O4S/c1-41(2)30-19-23-42(24-20-30)37(44)16-10-25-47-35-27-29(39(46)43-22-9-8-15-36-34(43)21-26-48-36)17-18-33(35)40-38(45)32-14-7-6-13-31(32)28-11-4-3-5-12-28/h3-7,11-14,17-18,21,26-27,30H,8-10,15-16,19-20,22-25H2,1-2H3,(H,40,45) D02RDE DRUGINKE LKUCMBNAHQWPJK-UHFFFAOYSA-N D02RDE DRUGSMIL CN(C)C1CCN(CC1)C(=O)CCCOC2=C(C=CC(=C2)C(=O)N3CCCCC4=C3C=CS4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6 D02RDE HIGHSTAT Terminated D02TGW DRUG__ID D02TGW D02TGW DRUGCOMP Biosearch Italia SpA D02TGW DRUGINCH 1S/C30H41N7O7/c1-18(2)25(27(41)34-21(17-38)15-19-7-4-3-5-8-19)37-26(40)23(9-6-14-33-29(31)32)35-30(44)36-24(28(42)43)16-20-10-12-22(39)13-11-20/h3-5,7-8,10-13,17-18,21,23-25,39H,6,9,14-16H2,1-2H3,(H,34,41)(H,37,40)(H,42,43)(H4,31,32,33)(H2,35,36,44)/t21-,23-,24-,25-/m0/s1 D02TGW DRUGINKE DYNPEHYVIZVLIF-LFBFJMOVSA-N D02TGW DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)C(CCCN=C(N)N)NC(=O)NC(CC2=CC=C(C=C2)O)C(=O)O D02TGW HIGHSTAT Terminated D02TKI DRUG__ID D02TKI D02TKI DRUGTYPE Small molecular drug D02TKI DRUGINCH 1S/C20H19F6NO/c21-19(22,23)15-9-13(10-16(11-15)20(24,25)26)12-28-17-7-4-8-27-18(17)14-5-2-1-3-6-14/h1-3,5-6,9-11,17-18,27H,4,7-8,12H2/t17-,18-/m0/s1 D02TKI DRUGINKE FCDRFVCGMLUYPG-ROUUACIJSA-N D02TKI DRUGSMIL C1CC(C(NC1)C2=CC=CC=C2)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D02TKI HIGHSTAT Terminated D02YAQ DRUG__ID D02YAQ D02YAQ DRUGCOMP Glaxo Wellcome plc D02YAQ DRUGINCH 1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28) D02YAQ DRUGINKE DYYZXRCFCVDSKD-UHFFFAOYSA-N D02YAQ DRUGSMIL CN(C)C1=NC=C2C(=C1)C(=NC=N2)NC3=CC4=C(C=C3)N(N=C4)CC5=CC=CC=C5 D02YAQ HIGHSTAT Terminated D02YSI DRUG__ID D02YSI D02YSI DRUGTYPE Small molecular drug D02YSI DRUGINCH 1S/C47H63N9O13/c1-8-28-40(61)51-30-16-17-36(59)56(44(30)65)33(19-26-13-10-9-11-14-26)45(66)55(7)32-20-27-21-34(57)35(58)22-31(27)52-47(68)48-18-12-15-29(50-39(60)24(4)5)41(62)54-38(43(64)49-28)25(6)69-46(67)37(23(2)3)53-42(32)63/h8-11,13-14,21-25,29-30,32-33,36-38,57-59H,12,15-20H2,1-7H3,(H,49,64)(H,50,60)(H,51,61)(H,53,63)(H,54,62)(H2,48,52,68)/b28-8-/t25-,29-,30-,32-,33-,36+,37-,38-/m0/s1 D02YSI DRUGINKE MHMMGTGXNPFNAJ-MVPXUFHVSA-N D02YSI DRUGSMIL CC=C1C(=O)NC2CCC(N(C2=O)C(C(=O)N(C3CC4=CC(=C(C=C4NC(=O)NCCCC(C(=O)NC(C(OC(=O)C(NC3=O)C(C)C)C)C(=O)N1)NC(=O)C(C)C)O)O)C)CC5=CC=CC=C5)O D02YSI HIGHSTAT Terminated D02YXQ DRUG__ID D02YXQ D02YXQ DRUGTYPE Small molecular drug D02YXQ DRUGINCH 1S/C19H31N3O/c23-19(9-5-4-8-16-6-2-1-3-7-16)22-12-10-17(11-13-22)18-14-20-15-21-18/h14-17H,1-13H2,(H,20,21) D02YXQ DRUGINKE YTCGNPGLMAECND-UHFFFAOYSA-N D02YXQ DRUGSMIL C1CCC(CC1)CCCCC(=O)N2CCC(CC2)C3=CN=CN3 D02YXQ HIGHSTAT Terminated D02ZSO DRUG__ID D02ZSO D02ZSO DRUGTYPE Small molecular drug D02ZSO DRUGINCH 1S/C25H29FN6/c26-22-5-1-3-20(15-22)8-10-31-13-11-30(12-14-31)9-2-4-21-17-27-25-7-6-23(16-24(21)25)32-18-28-29-19-32/h1,3,5-7,15-19,27H,2,4,8-14H2 D02ZSO DRUGINKE ZUTQCPBDRJBADG-UHFFFAOYSA-N D02ZSO DRUGSMIL C1CN(CCN1CCCC2=CNC3=C2C=C(C=C3)N4C=NN=C4)CCC5=CC(=CC=C5)F D02ZSO HIGHSTAT Terminated D03AKL DRUG__ID D03AKL D03AKL DRUGTYPE Small molecular drug D03AKL DRUGINCH 1S/C14H14O2S/c1-10(14(15)16-2)11-3-5-12(6-4-11)13-7-8-17-9-13/h3-10H,1-2H3 D03AKL DRUGINKE WINXAKJYORVNHU-UHFFFAOYSA-N D03AKL DRUGSMIL CC(C1=CC=C(C=C1)C2=CSC=C2)C(=O)OC D03AKL HIGHSTAT Terminated D03AZY DRUG__ID D03AZY D03AZY DRUGCOMP Pfizer D03AZY DRUGINCH 1S/C18H21F3N2O3S.ClH/c1-2-12-22-13-11-14-3-5-15(6-4-14)23-27(24,25)17-9-7-16(8-10-17)26-18(19,20)21;/h3-10,22-23H,2,11-13H2,1H3;1H D03AZY DRUGINKE UOMDLHQTLPWCCE-UHFFFAOYSA-N D03AZY DRUGSMIL CCCNCCC1=CC=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)OC(F)(F)F.Cl D03AZY HIGHSTAT Terminated D03CNT DRUG__ID D03CNT D03CNT DRUGTYPE Small molecular drug D03CNT DRUGINCH 1S/C15H10ClNO2/c16-10-6-7-11-12(8-10)17-15(19)13(14(11)18)9-4-2-1-3-5-9/h1-8H,(H2,17,18,19) D03CNT DRUGINKE RDXQSWLUXKUQSI-UHFFFAOYSA-N D03CNT DRUGSMIL C1=CC=C(C=C1)C2=C(C3=C(C=C(C=C3)Cl)NC2=O)O D03CNT HIGHSTAT Terminated D03DMI DRUG__ID D03DMI D03DMI DRUGTYPE Small molecular drug D03DMI DRUGINCH 1S/C13H18N2O/c1-15-6-5-9-3-4-10-7-12(16-2)14-8-11(10)13(9)15/h7-9,13H,3-6H2,1-2H3 D03DMI DRUGINKE MMHQNOZJLLYHKX-UHFFFAOYSA-N D03DMI DRUGSMIL CN1CCC2C1C3=CN=C(C=C3CC2)OC D03DMI HIGHSTAT Terminated D03EFD DRUG__ID D03EFD D03EFD DRUGCOMP Toho Chemical Industry Co D03EFD DRUGINCH 1S/C24H25NO5S/c1-12(26)29-17-7-5-15-19-22(17)30-23-18(31-13(2)27)8-6-16-20(21(15)28)25(11-14-3-4-14)10-9-24(16,19)23/h5-8,14,16,18,20,23H,3-4,9-11H2,1-2H3/t16-,18+,20-,23-,24-/m0/s1 D03EFD DRUGINKE JALSXEHOWOEHCB-SDAQKBEVSA-N D03EFD DRUGSMIL CC(=O)OC1=C2C3=C(C=C1)C(=O)C4C5C3(CCN4CC6CC6)C(O2)C(C=C5)SC(=O)C D03EFD HIGHSTAT Terminated D03FZA DRUG__ID D03FZA D03FZA DRUGTYPE Small molecular drug D03FZA DRUGINCH 1S/C16H12O7/c1-21-15(20)9-5-8(6-17)7-22-16-12(9)14(19)13-10(18)3-2-4-11(13)23-16/h2-5,7,17-18H,6H2,1H3 D03FZA DRUGINKE LJNGMSGIOXTZLN-UHFFFAOYSA-N D03FZA DRUGSMIL COC(=O)C1=CC(=COC2=C1C(=O)C3=C(C=CC=C3O2)O)CO D03FZA HIGHSTAT Terminated D03GCN DRUG__ID D03GCN D03GCN DRUGTYPE Small molecular drug D03GCN DRUGINCH 1S/C19H25N3O4/c23-17(24)5-9-21-18(25)14-1-2-15-12-22(19(26)16(15)11-14)10-6-13-3-7-20-8-4-13/h1-2,11,13,20H,3-10,12H2,(H,21,25)(H,23,24) D03GCN DRUGINKE YAAYYZAARZCUQN-UHFFFAOYSA-N D03GCN DRUGSMIL C1CNCCC1CCN2CC3=C(C2=O)C=C(C=C3)C(=O)NCCC(=O)O D03GCN HIGHSTAT Terminated D03HDP DRUG__ID D03HDP D03HDP DRUGCOMP Purdue Neuroscience Corp D03HDP DRUGINCH 1S/C9H6ClN3O4/c1-3-4(10)2-5-6(7(3)13(16)17)12-9(15)8(14)11-5/h2H,1H3,(H,11,14)(H,12,15) D03HDP DRUGINKE CODLITRXBIRDTG-UHFFFAOYSA-N D03HDP DRUGSMIL CC1=C(C=C2C(=C1[N+](=O)[O-])NC(=O)C(=O)N2)Cl D03HDP HIGHSTAT Terminated D03HTI DRUG__ID D03HTI D03HTI DRUGTYPE Small molecular drug D03HTI DRUGINCH 1S/C41H62FN5O10/c1-12-29-41(8)32(47(38(52)57-41)19-14-13-18-46-22-44-27-16-15-17-43-35(27)46)25(4)30(48)23(2)21-39(6,53-11)34(26(5)33(50)40(7,42)37(51)55-29)56-36-31(49)28(45(9)10)20-24(3)54-36/h15-17,22-26,28-29,31-32,34,36,49H,12-14,18-21H2,1-11H3/t23-,24-,25+,26+,28+,29-,31-,32-,34-,36+,39-,40+,41-/m1/s1 D03HTI DRUGINKE NRYQCCZBHGMXIN-SAWHFZNOSA-N D03HTI DRUGSMIL CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)(C)F)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=NC5=C4N=CC=C5)C D03HTI HIGHSTAT Terminated D03JRJ DRUG__ID D03JRJ D03JRJ DRUGCOMP Nissin Foods Holdings Co Ltd D03JRJ DRUGINCH 1S/C38H58N6O2/c1-41(2)33-23-19-31(20-24-33)39-37(45)43(35-11-7-5-8-12-35)27-29-15-17-30(18-16-29)28-44(36-13-9-6-10-14-36)38(46)40-32-21-25-34(26-22-32)42(3)4/h19-26,29-30,35-36H,5-18,27-28H2,1-4H3,(H,39,45)(H,40,46) D03JRJ DRUGINKE SIHFCVXQGXGQQO-UHFFFAOYSA-N D03JRJ DRUGSMIL CN(C)C1=CC=C(C=C1)NC(=O)N(CC2CCC(CC2)CN(C3CCCCC3)C(=O)NC4=CC=C(C=C4)N(C)C)C5CCCCC5 D03JRJ HIGHSTAT Terminated D03KGJ DRUG__ID D03KGJ D03KGJ DRUGTYPE Small molecular drug D03KGJ DRUGINCH 1S/C19H24Cl2N2O4S.C7H6O2/c1-23(10-9-14-3-8-18(20)19(21)11-14)12-16(24)13-27-17-6-4-15(5-7-17)22-28(2,25)26;8-7(9)6-4-2-1-3-5-6/h3-8,11,16,22,24H,9-10,12-13H2,1-2H3;1-5H,(H,8,9) D03KGJ DRUGINKE KLXOTINBPRNEFS-UHFFFAOYSA-N D03KGJ DRUGSMIL CN(CCC1=CC(=C(C=C1)Cl)Cl)CC(COC2=CC=C(C=C2)NS(=O)(=O)C)O.C1=CC=C(C=C1)C(=O)O D03KGJ HIGHSTAT Terminated D03KJS DRUG__ID D03KJS D03KJS DRUGTYPE Small molecular drug D03KJS DRUGINCH 1S/C24H34N4/c1-9-11-12-27(10-2)23-21-18(6)19(7)28(24(21)26-20(8)25-23)22-16(4)13-15(3)14-17(22)5/h13-14H,9-12H2,1-8H3 D03KJS DRUGINKE IXPROWGEHNVJOY-UHFFFAOYSA-N D03KJS DRUGSMIL CCCCN(CC)C1=NC(=NC2=C1C(=C(N2C3=C(C=C(C=C3C)C)C)C)C)C D03KJS HIGHSTAT Terminated D03OFO DRUG__ID D03OFO D03OFO DRUGTYPE Small molecular drug D03OFO DRUGINCH 1S/C27H18F9N3O2/c28-25(29,30)14-39-20-9-5-4-8-18(20)22(15-6-2-1-3-7-15)38-23(24(39)41)37-21(40)12-16-10-11-17(26(31,32)33)13-19(16)27(34,35)36/h1-11,13,23H,12,14H2,(H,37,40)/t23-/m1/s1 D03OFO DRUGINKE VVCYJFVTVHMTBV-HSZRJFAPSA-N D03OFO DRUGSMIL C1=CC=C(C=C1)C2=NC(C(=O)N(C3=CC=CC=C32)CC(F)(F)F)NC(=O)CC4=C(C=C(C=C4)C(F)(F)F)C(F)(F)F D03OFO HIGHSTAT Terminated D03OLA DRUG__ID D03OLA D03OLA DRUGTYPE Small molecular drug D03OLA DRUGINCH 1S/C21H29N3O2S/c1-26-12-9-18-14-24(11-10-23(18)13-17(22)15-27)21(25)20-8-4-6-16-5-2-3-7-19(16)20/h2-8,17-18,27H,9-15,22H2,1H3/t17-,18+/m0/s1 D03OLA DRUGINKE GKTZPBPAMFCBNI-ZWKOTPCHSA-N D03OLA DRUGSMIL COCCC1CN(CCN1CC(CS)N)C(=O)C2=CC=CC3=CC=CC=C32 D03OLA HIGHSTAT Terminated D03PJW DRUG__ID D03PJW D03PJW DRUGTYPE Small molecular drug D03PJW DRUGINCH 1S/C14H16N2O/c1-17-11-2-3-14-12(8-11)13(9-16-14)10-4-6-15-7-5-10/h2-4,8-9,15-16H,5-7H2,1H3 D03PJW DRUGINKE KRVMLPUDAOWOGN-UHFFFAOYSA-N D03PJW DRUGSMIL COC1=CC2=C(C=C1)NC=C2C3=CCNCC3 D03PJW HIGHSTAT Terminated D03QHI DRUG__ID D03QHI D03QHI DRUGTYPE Small molecular drug D03QHI DRUGINCH 1S/C21H21N3O8/c1-24(21(30)13-4-2-12(3-5-13)20(22)23)9-15(25)14-6-7-16(31-10-18(26)27)17(8-14)32-11-19(28)29/h2-8H,9-11H2,1H3,(H3,22,23)(H,26,27)(H,28,29) D03QHI DRUGINKE ZCCMELPMDDSRHL-UHFFFAOYSA-N D03QHI DRUGSMIL CN(CC(=O)C1=CC(=C(C=C1)OCC(=O)O)OCC(=O)O)C(=O)C2=CC=C(C=C2)C(=N)N D03QHI HIGHSTAT Terminated D03QMR DRUG__ID D03QMR D03QMR DRUGTYPE Small molecular drug D03QMR DRUGINCH 1S/C19H23NO5/c1-21-17-8-5-9-18(22-2)19(17)23-11-10-20-12-14-13-24-15-6-3-4-7-16(15)25-14/h3-9,14,20H,10-13H2,1-2H3 D03QMR DRUGINKE GYSZUJHYXCZAKI-UHFFFAOYSA-N D03QMR DRUGSMIL COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2 D03QMR HIGHSTAT Terminated D03QMS DRUG__ID D03QMS D03QMS DRUGTYPE Small molecular drug D03QMS DRUGINCH 1S/C32H40N2O/c35-32-29(25-33-20-9-1-2-10-21-33)18-17-28-24-34(23-19-31(28)32)22-11-16-30(26-12-5-3-6-13-26)27-14-7-4-8-15-27/h3-8,12-15,17-18,30,35H,1-2,9-11,16,19-25H2 D03QMS DRUGINKE SBYWDPHGZJEZBN-UHFFFAOYSA-N D03QMS DRUGSMIL C1CCCN(CC1)CC2=C(C3=C(CN(CC3)CCCC(C4=CC=CC=C4)C5=CC=CC=C5)C=C2)O D03QMS HIGHSTAT Terminated D03RQI DRUG__ID D03RQI D03RQI DRUGTYPE Small molecular drug D03RQI DRUGINCH 1S/C22H21N3O3.ClH/c1-24(2)9-8-14-21(27)15-10-23-11-25-16-7-6-12-13(4-3-5-17(12)26)18(16)19(20(15)25)22(14)28;/h3,5,10-11,14H,4,6-9H2,1-2H3;1H D03RQI DRUGINKE WTKWSQVGFMBOGJ-UHFFFAOYSA-N D03RQI DRUGSMIL CN(C)CCC1C(=O)C2=CN=CN3C2=C(C1=O)C4=C3CCC5=C4CC=CC5=O.Cl D03RQI HIGHSTAT Terminated D03SXN DRUG__ID D03SXN D03SXN DRUGTYPE Small molecular drug D03SXN DRUGINCH 1S/C28H32N2O/c1-31-25-15-9-8-14-24(25)20-29-27-23-16-18-30(19-17-23)28(27)26(21-10-4-2-5-11-21)22-12-6-3-7-13-22/h2-15,23,26-29H,16-20H2,1H3/t27-,28-/m0/s1 D03SXN DRUGINKE FLNYLINBEZROPL-NSOVKSMOSA-N D03SXN DRUGSMIL COC1=CC=CC=C1CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3 D03SXN HIGHSTAT Terminated D03WTT DRUG__ID D03WTT D03WTT DRUGTYPE Small molecular drug D03WTT DRUGINCH 1S/C16H14N2O2/c1-19-15-6-5-12(9-16(15)20-2)8-14(10-17)13-4-3-7-18-11-13/h3-9,11H,1-2H3/b14-8+ D03WTT DRUGINKE DBGZNJVTHYFQJI-RIYZIHGNSA-N D03WTT DRUGSMIL COC1=C(C=C(C=C1)C=C(C#N)C2=CN=CC=C2)OC D03WTT HIGHSTAT Terminated D03WYF DRUG__ID D03WYF D03WYF DRUGTYPE Small molecular drug D03WYF DRUGINCH 1S/C11H8ClNO4/c1-17-11(16)8-9(14)6-3-2-5(12)4-7(6)13-10(8)15/h2-4H,1H3,(H2,13,14,15) D03WYF DRUGINKE GEUWRNTWGHPTPU-UHFFFAOYSA-N D03WYF DRUGSMIL COC(=O)C1=C(C2=C(C=C(C=C2)Cl)NC1=O)O D03WYF HIGHSTAT Terminated D03XPV DRUG__ID D03XPV D03XPV DRUGTYPE Small molecular drug D03XPV DRUGINCH 1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9-,10+,11+,15+,17?,18?,19-,20-/m1/s1 D03XPV DRUGINKE SQOJOAFXDQDRGF-RLAVLKHASA-N D03XPV DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5)C(C)(C)C)C(C(=O)OC6O4)O)O D03XPV HIGHSTAT Terminated D03YPJ DRUG__ID D03YPJ D03YPJ DRUGTYPE Small molecular drug D03YPJ DRUGINCH 1S/C17H16N4O/c1-20-7-4-12-10-16-13(9-15(12)20)5-8-21(16)17(22)19-14-3-2-6-18-11-14/h2-4,6-7,9-11H,5,8H2,1H3,(H,19,22) D03YPJ DRUGINKE QJQORSLQNXDVGE-UHFFFAOYSA-N D03YPJ DRUGSMIL CN1C=CC2=CC3=C(CCN3C(=O)NC4=CN=CC=C4)C=C21 D03YPJ HIGHSTAT Terminated D04AOA DRUG__ID D04AOA D04AOA DRUGTYPE Small molecular drug D04AOA DRUGINCH 1S/C25H30N6O/c1-3-5-9-21-18-30(16-6-4-2)25(32)31(21)17-19-12-14-20(15-13-19)22-10-7-8-11-23(22)24-26-28-29-27-24/h7-8,10-15,18H,3-6,9,16-17H2,1-2H3,(H,26,27,28,29) D04AOA DRUGINKE JYOGXGMOSXSRMV-UHFFFAOYSA-N D04AOA DRUGSMIL CCCCC1=CN(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CCCC D04AOA HIGHSTAT Terminated D04AWZ DRUG__ID D04AWZ D04AWZ DRUGTYPE Small molecular drug D04AWZ DRUGINCH 1S/C30H36N2O5S.Li/c1-36-26-15-12-23(13-16-26)9-6-4-2-3-5-7-20-37-29-18-14-25(32-28(29)17-19-30(33)34)22-38(35)27-11-8-10-24(31)21-27;/h8,10-19,21H,2-7,9,20,22,31H2,1H3,(H,33,34);/q;+1/p-1/b19-17+; D04AWZ DRUGINKE RVRATNAADXHAQO-ZJSKVYKZSA-M D04AWZ DRUGSMIL [Li+].COC1=CC=C(C=C1)CCCCCCCCOC2=C(N=C(C=C2)CS(=O)C3=CC=CC(=C3)N)C=CC(=O)[O-] D04AWZ HIGHSTAT Terminated D04DYZ DRUG__ID D04DYZ D04DYZ DRUGTYPE Small molecular drug D04DYZ DRUGINCH 1S/C32H46N2O3S/c1-4-5-19-34(20-17-25-12-7-6-8-13-25)23-26-15-16-28(29(22-26)27-14-10-9-11-24(27)2)31(35)33-30(32(36)37)18-21-38-3/h9-11,14-16,22,25,30H,4-8,12-13,17-21,23H2,1-3H3,(H,33,35)(H,36,37)/t30-/m0/s1 D04DYZ DRUGINKE GAQHYZNOMLXSEA-PMERELPUSA-N D04DYZ DRUGSMIL CCCCN(CCC1CCCCC1)CC2=CC(=C(C=C2)C(=O)NC(CCSC)C(=O)O)C3=CC=CC=C3C D04DYZ HIGHSTAT Terminated D04DZE DRUG__ID D04DZE D04DZE DRUGTYPE Small molecular drug D04DZE DRUGINCH 1S/C19H23NO3.C5H6O3/c1-14(20-13-18(21)16-6-4-3-5-7-16)12-15-8-10-17(11-9-15)19(22)23-2;1-4(6)2-3-5(7)8/h3-11,14,18,20-21H,12-13H2,1-2H3;2-3H,1H3,(H,7,8)/b;3-2+/t14-,18+;/m0./s1 D04DZE DRUGINKE OIZISCUUSLPUEN-LMORPYAASA-N D04DZE DRUGSMIL CC(CC1=CC=C(C=C1)C(=O)OC)NCC(C2=CC=CC=C2)O.CC(=O)C=CC(=O)O D04DZE HIGHSTAT Terminated D04EEU DRUG__ID D04EEU D04EEU DRUGTYPE Small molecular drug D04EEU DRUGINCH 1S/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16) D04EEU DRUGINKE XQGZSYKGWHUSDH-UHFFFAOYSA-N D04EEU DRUGSMIL C1=CC(=CC=C1C(=O)O)OCCN2C=CN=C2 D04EEU HIGHSTAT Terminated D04JNR DRUG__ID D04JNR D04JNR DRUGTYPE Small molecular drug D04JNR DRUGINCH 1S/C12H14N2.C4H4O4/c1-3-10-7-11(9-13-8-10)12-5-4-6-14(12)2;5-3(6)1-2-4(7)8/h1,7-9,12H,4-6H2,2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+ D04JNR DRUGINKE BCPPKHPWLRPWBJ-WLHGVMLRSA-N D04JNR DRUGSMIL CN1CCCC1C2=CN=CC(=C2)C#C.C(=CC(=O)O)C(=O)O D04JNR HIGHSTAT Terminated D04KDA DRUG__ID D04KDA D04KDA DRUGTYPE Small molecular drug D04KDA DRUGINCH 1S/C40H42N2O8/c1-3-23-41(25-27-15-19-31(20-16-27)49-29-11-7-5-8-12-29)37(43)33-34(36(40(47)48)35(33)39(45)46)38(44)42(24-4-2)26-28-17-21-32(22-18-28)50-30-13-9-6-10-14-30/h5-22,33-36H,3-4,23-26H2,1-2H3,(H,45,46)(H,47,48)/t33-,34-,35-,36-/m0/s1 D04KDA DRUGINKE PNOGMVDDWILAMR-ZYADHFCISA-N D04KDA DRUGSMIL CCCN(CC1=CC=C(C=C1)OC2=CC=CC=C2)C(=O)C3C(C(C3C(=O)O)C(=O)O)C(=O)N(CCC)CC4=CC=C(C=C4)OC5=CC=CC=C5 D04KDA HIGHSTAT Terminated D04KMO DRUG__ID D04KMO D04KMO DRUGTYPE Small molecular drug D04KMO DRUGINCH 1S/C8H20NO4P/c1-3-12-8(13-4-2)14(10,11)7-5-6-9/h8H,3-7,9H2,1-2H3,(H,10,11) D04KMO DRUGINKE QIIVUOWTHWIXFO-UHFFFAOYSA-N D04KMO DRUGSMIL CCOC(OCC)P(=O)(CCCN)O D04KMO HIGHSTAT Terminated D04LFG DRUG__ID D04LFG D04LFG DRUGCOMP Novartis AG D04LFG DRUGINCH 1S/C15H20ClN3O2.ClH/c1-4-19(5-2)7-6-18-15(20)12-8-11(10-17)13(16)9-14(12)21-3;/h8-9H,4-7H2,1-3H3,(H,18,20);1H D04LFG DRUGINKE ZETCQNUMZFZSLJ-UHFFFAOYSA-N D04LFG DRUGSMIL CCN(CC)CCNC(=O)C1=C(C=C(C(=C1)C#N)Cl)OC.Cl D04LFG HIGHSTAT Terminated D04MBS DRUG__ID D04MBS D04MBS DRUGCOMP Bristol-Myers Squibb Co D04MBS DRUGINCH 1S/C21H22N2O4S/c24-19(25)13-23-17-9-5-4-8-15(17)10-11-16(21(23)27)22-20(26)18(28)12-14-6-2-1-3-7-14/h1-9,16,18,28H,10-13H2,(H,22,26)(H,24,25)/t16-,18-/m0/s1 D04MBS DRUGINKE TYXFDFMUHPWCDX-WMZOPIPTSA-N D04MBS DRUGSMIL C1CC2=CC=CC=C2N(C(=O)C1NC(=O)C(CC3=CC=CC=C3)S)CC(=O)O D04MBS HIGHSTAT Terminated D04NFB DRUG__ID D04NFB D04NFB DRUGTYPE Small molecular drug D04NFB DRUGINCH 1S/C14H9F5N2O/c15-8-3-4-9-10(11(8)16)13(14(17,18)19,21-12(22)20-9)6-5-7-1-2-7/h3-4,7H,1-2H2,(H2,20,21,22)/t13-/m0/s1 D04NFB DRUGINKE QCNJQJJFXFJVCX-ZDUSSCGKSA-N D04NFB DRUGSMIL C1CC1C#CC2(C3=C(C=CC(=C3F)F)NC(=O)N2)C(F)(F)F D04NFB HIGHSTAT Terminated D04PGB DRUG__ID D04PGB D04PGB DRUGTYPE Small molecular drug D04PGB DRUGINCH 1S/C20H28N2O4/c1-4-20(2,3)17(23)18(24)22-12-6-10-16(22)19(25)26-13-7-9-15-8-5-11-21-14-15/h5,8,11,14,16H,4,6-7,9-10,12-13H2,1-3H3/t16-/m0/s1 D04PGB DRUGINKE OQAHHWOPVDDWHD-INIZCTEOSA-N D04PGB DRUGSMIL CCC(C)(C)C(=O)C(=O)N1CCCC1C(=O)OCCCC2=CN=CC=C2 D04PGB HIGHSTAT Terminated D04QXG DRUG__ID D04QXG D04QXG DRUGTYPE Small molecular drug D04QXG DRUGINCH 1S/C43H54N6O4S/c1-48(2)30-34-16-14-33(15-17-34)29-45-41(44)36-20-18-32(19-21-36)27-40(43(51)49-24-8-9-25-49)46-42(50)39(26-31-10-4-3-5-11-31)47-54(52,53)38-23-22-35-12-6-7-13-37(35)28-38/h3-7,10-13,18-23,28,33-34,39-40,47H,8-9,14-17,24-27,29-30H2,1-2H3,(H2,44,45)(H,46,50)/t33?,34?,39-,40-/m1/s1 D04QXG DRUGINKE GKKPXBHNFVDHAQ-USNYZCROSA-N D04QXG DRUGSMIL CN(C)CC1CCC(CC1)CN=C(C2=CC=C(C=C2)CC(C(=O)N3CCCC3)NC(=O)C(CC4=CC=CC=C4)NS(=O)(=O)C5=CC6=CC=CC=C6C=C5)N D04QXG HIGHSTAT Terminated D04TSV DRUG__ID D04TSV D04TSV DRUGTYPE Small molecular drug D04TSV DRUGINCH 1S/C33H52N6O7S2/c1-22(2)17-29(40)30(41)26(18-23-9-5-3-6-10-23)36-31(42)27(20-25-21-47-33(34)35-25)37-32(43)28(19-24-11-7-4-8-12-24)38-48(44,45)39-13-15-46-16-14-39/h4,7-8,11-12,21-23,26-30,38,40-41H,3,5-6,9-10,13-20H2,1-2H3,(H2,34,35)(H,36,42)(H,37,43)/t26-,27-,28-,29-,30+/m0/s1 D04TSV DRUGINKE QGJKHQRFJGLJLV-VFFRCKCKSA-N D04TSV DRUGSMIL CC(C)CC(C(C(CC1CCCCC1)NC(=O)C(CC2=CSC(=N2)N)NC(=O)C(CC3=CC=CC=C3)NS(=O)(=O)N4CCOCC4)O)O D04TSV HIGHSTAT Terminated D04VDY DRUG__ID D04VDY D04VDY DRUGTYPE Small molecular drug D04VDY DRUGINCH 1S/C23H22F6N4O2/c24-22(25,26)16-9-14(10-17(11-16)23(27,28)29)13-35-18-7-4-8-33(12-19-30-21(34)32-31-19)20(18)15-5-2-1-3-6-15/h1-3,5-6,9-11,18,20H,4,7-8,12-13H2,(H2,30,31,32,34)/t18-,20-/m0/s1 D04VDY DRUGINKE ZUWHBRRBKKTMQO-ICSRJNTNSA-N D04VDY DRUGSMIL C1CC(C(N(C1)CC2=NNC(=O)N2)C3=CC=CC=C3)OCC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D04VDY HIGHSTAT Terminated D04VPV DRUG__ID D04VPV D04VPV DRUGTYPE Small molecular drug D04VPV DRUGINCH 1S/C39H43NO12/c1-4-5-14-28(41)49-19-29(42)51-22-15-24-32(39(47)34-33(37(24)45)36(44)23-12-9-13-26(48-3)31(23)38(34)46)27(16-22)52-30-17-25(35(43)20(2)50-30)40-18-21-10-7-6-8-11-21/h6-13,20,22,25,27,30,35,40,43,45,47H,4-5,14-19H2,1-3H3/t20-,22-,25-,27-,30-,35-/m0/s1 D04VPV DRUGINKE DFEZNIBKLJWMIQ-VEUGUUDJSA-N D04VPV DRUGSMIL CCCCC(=O)OCC(=O)OC1CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NCC6=CC=CC=C6 D04VPV HIGHSTAT Terminated D04XCQ DRUG__ID D04XCQ D04XCQ DRUGTYPE Small molecular drug D04XCQ DRUGINCH 1S/C30H35F2N5O5/c1-3-23-24(26(33)38)25(19-10-11-21(31)22(32)18-19)37(29(41)35-23)28(40)34-14-7-15-36-16-12-30(13-17-36,27(39)42-2)20-8-5-4-6-9-20/h4-6,8-11,18,25H,3,7,12-17H2,1-2H3,(H2,33,38)(H,34,40)(H,35,41) D04XCQ DRUGINKE YCUQRVLXIFFFNB-UHFFFAOYSA-N D04XCQ DRUGSMIL CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)N D04XCQ HIGHSTAT Terminated D04YJU DRUG__ID D04YJU D04YJU DRUGTYPE Small molecular drug D04YJU DRUGINCH 1S/C30H40N4O6S/c1-2-3-4-5-19-32-30(37)33-24-10-16-29(17-11-24)41(38,39)34-25-8-6-23(7-9-25)18-20-31-21-27(36)22-40-28-14-12-26(35)13-15-28/h6-17,27,31,34-36H,2-5,18-22H2,1H3,(H2,32,33,37)/t27-/m0/s1 D04YJU DRUGINKE NYYJKMXNVNFOFQ-MHZLTWQESA-N D04YJU DRUGSMIL CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCNCC(COC3=CC=C(C=C3)O)O D04YJU HIGHSTAT Terminated D04ZCZ DRUG__ID D04ZCZ D04ZCZ DRUGTYPE Small molecular drug D04ZCZ DRUGINCH 1S/C20H24O10/c1-6-12(23)28-11-9(21)18-8-5-7(16(2,3)4)17(18)10(22)13(24)29-15(17)30-20(18,14(25)27-8)19(6,11)26/h6-11,15,21-22,26H,5H2,1-4H3 D04ZCZ DRUGINKE SQOJOAFXDQDRGF-UHFFFAOYSA-N D04ZCZ DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5)C(C)(C)C)C(C(=O)OC6O4)O)O D04ZCZ HIGHSTAT Terminated D04ZIJ DRUG__ID D04ZIJ D04ZIJ DRUGTYPE Small molecular drug D04ZIJ DRUGINCH 1S/C34H63N5O9/c1-17(2)12-23(37-33(47)31(21(9)10)39-34(48)30(20(7)8)38-27(42)14-19(5)6)25(40)15-28(43)35-22(11)32(46)36-24(13-18(3)4)26(41)16-29(44)45/h17-26,30-31,40-41H,12-16H2,1-11H3,(H,35,43)(H,36,46)(H,37,47)(H,38,42)(H,39,48)(H,44,45)/t22-,23-,24-,25-,26-,30-,31-/m0/s1 D04ZIJ DRUGINKE FAXGPCHRFPCXOO-LXTPJMTPSA-N D04ZIJ DRUGSMIL CC(C)CC(C(CC(=O)O)O)NC(=O)C(C)NC(=O)CC(C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)CC(C)C)O D04ZIJ HIGHSTAT Terminated D04ZWL DRUG__ID D04ZWL D04ZWL DRUGTYPE Small molecular drug D04ZWL DRUGINCH 1S/C8H10N2O4/c9-5(8(13)14)3-10-2-1-6(11)7(12)4-10/h1-2,4-5,12H,3,9H2,(H,13,14) D04ZWL DRUGINKE WZNJWVWKTVETCG-UHFFFAOYSA-N D04ZWL DRUGSMIL C1=CN(C=C(C1=O)O)CC(C(=O)O)N D04ZWL HIGHSTAT Terminated D05AHQ DRUG__ID D05AHQ D05AHQ DRUGTYPE Small molecular drug D05AHQ DRUGINCH 1S/C19H23N5O2/c1-3-25-15-10-13(9-14-12-22-19(21)23-18(14)20)11-16(26-4-2)17(15)24-7-5-6-8-24/h5-8,10-12H,3-4,9H2,1-2H3,(H4,20,21,22,23) D05AHQ DRUGINKE NMARPFMJVCXSAV-UHFFFAOYSA-N D05AHQ DRUGSMIL CCOC1=CC(=CC(=C1N2C=CC=C2)OCC)CC3=CN=C(N=C3N)N D05AHQ HIGHSTAT Terminated D05CEK DRUG__ID D05CEK D05CEK DRUGTYPE Small molecular drug D05CEK DRUGINCH 1S/C34H59N3O6.ClH/c1-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-25-35-33(39)42-28-32(41-4)29-43-34(40)37(30(3)38)27-31-24-21-23-26-36(31)6-2;/h21,23-24,26,32H,5-20,22,25,27-29H2,1-4H3;1H D05CEK DRUGINKE APUCCVGQZPNXIO-UHFFFAOYSA-N D05CEK DRUGSMIL CCCCCCCCCCCCCCCCCCNC(=O)OCC(COC(=O)N(CC1=CC=CC=[N+]1CC)C(=O)C)OC.[Cl-] D05CEK HIGHSTAT Terminated D05EYG DRUG__ID D05EYG D05EYG DRUGTYPE Small molecular drug D05EYG DRUGINCH 1S/C16H13F2NO3S2/c1-24(21,22)19-13-6-9-2-4-14(20)11(9)8-16(13)23-15-5-3-10(17)7-12(15)18/h3,5-8,19H,2,4H2,1H3 D05EYG DRUGINKE HDUWKQUHMUSICC-UHFFFAOYSA-N D05EYG DRUGSMIL CS(=O)(=O)NC1=C(C=C2C(=C1)CCC2=O)SC3=C(C=C(C=C3)F)F D05EYG HIGHSTAT Terminated D05FFR DRUG__ID D05FFR D05FFR DRUGTYPE Small molecular drug D05FFR DRUGINCH 1S/C5H12N8/c1-3(11-13-5(8)9)2-10-12-4(6)7/h2H,1H3,(H4,6,7,12)(H4,8,9,13)/b10-2+,11-3+ D05FFR DRUGINKE MXWHMTNPTTVWDM-NXOFHUPFSA-N D05FFR DRUGSMIL CC(=NN=C(N)N)C=NN=C(N)N D05FFR HIGHSTAT Terminated D05FYA DRUG__ID D05FYA D05FYA DRUGTYPE Small molecular drug D05FYA DRUGINCH 1S/C15H24N4S/c20-15(18-13-4-2-1-3-5-13)19-8-6-12(7-9-19)14-10-16-11-17-14/h10-13H,1-9H2,(H,16,17)(H,18,20) D05FYA DRUGINKE QKDDJDBFONZGBW-UHFFFAOYSA-N D05FYA DRUGSMIL C1CCC(CC1)NC(=S)N2CCC(CC2)C3=CN=CN3 D05FYA HIGHSTAT Terminated D05HGU DRUG__ID D05HGU D05HGU DRUGTYPE Small molecular drug D05HGU DRUGINCH 1S/C31H37N5O5/c1-31(2,3)41-29(39)34-25(16-21-18-32-23-13-8-7-12-22(21)23)28(38)33-24-14-9-15-35-26(24)17-27(37)36(30(35)40)19-20-10-5-4-6-11-20/h4-8,10-13,18,24-26,32H,9,14-17,19H2,1-3H3,(H,33,38)(H,34,39)/t24-,25+,26+/m1/s1 D05HGU DRUGINKE JRSRZYFBWXHHNX-ZNZIZOMTSA-N D05HGU DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC3CCCN4C3CC(=O)N(C4=O)CC5=CC=CC=C5 D05HGU HIGHSTAT Terminated D05HKB DRUG__ID D05HKB D05HKB DRUGTYPE Small molecular drug D05HKB DRUGINCH 1S/C11H18N2O2/c1-3-13-9(14)8-11(10(13)15)4-6-12(2)7-5-11/h3-8H2,1-2H3 D05HKB DRUGINKE UIHKDOBBVHGTAQ-UHFFFAOYSA-N D05HKB DRUGSMIL CCN1C(=O)CC2(C1=O)CCN(CC2)C D05HKB HIGHSTAT Terminated D05HSW DRUG__ID D05HSW D05HSW DRUGTYPE Small molecular drug D05HSW DRUGINCH 1S/C17H26O4/c1-2-3-4-5-6-7-8-9-10-11-13-16(20)14(18)12-15(19)17(13)21/h12,18,21H,2-11H2,1H3 D05HSW DRUGINKE IRSFLDGTOHBADP-UHFFFAOYSA-N D05HSW DRUGSMIL CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O D05HSW HIGHSTAT Terminated D05IML DRUG__ID D05IML D05IML DRUGTYPE Small molecular drug D05IML DRUGINCH 1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3 D05IML DRUGINKE SVJMLYUFVDMUHP-UHFFFAOYSA-N D05IML DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC D05IML HIGHSTAT Terminated D05JHJ DRUG__ID D05JHJ D05JHJ DRUGCOMP LG Chem Ltd D05JHJ DRUGINCH 1S/C27H24N8O9S2/c28-17-5-7-34(11-30-17)6-1-2-13-9-45-24-19(23(39)35(24)20(13)25(40)41)32-22(38)18(14-10-46-27(29)31-14)33-44-21(26(42)43)12-3-4-15(36)16(37)8-12/h1-5,7-8,10-11,19,21,24,28,36-37H,6,9H2,(H2,29,31)(H,32,38)(H,40,41)(H,42,43)/b2-1+,28-17?,33-18-/t19-,21+,24-/m1/s1 D05JHJ DRUGINKE RCSASTDJDIXEOI-JBVQHFTOSA-N D05JHJ DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NOC(C3=CC(=C(C=C3)O)O)C(=O)O)C4=CSC(=N4)N)C(=O)O)C=CCN5C=CC(=N)N=C5 D05JHJ HIGHSTAT Terminated D05LYL DRUG__ID D05LYL D05LYL DRUGTYPE Small molecular drug D05LYL DRUGINCH 1S/C31H41NO7/c1-4-6-23-26(14-10-21-9-11-22(39-29(21)23)12-16-28(33)34)37-17-5-18-38-27-15-13-24(31(35)32-2)30(36-3)25(27)19-20-7-8-20/h10,13-15,20,22H,4-9,11-12,16-19H2,1-3H3,(H,32,35)(H,33,34) D05LYL DRUGINKE YWYUQSGYKDEAMJ-UHFFFAOYSA-N D05LYL DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)CCC(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)NC)OC)CC4CC4 D05LYL HIGHSTAT Terminated D05RBL DRUG__ID D05RBL D05RBL DRUGTYPE Small molecular drug D05RBL DRUGINCH 1S/C33H46NO7PS/c1-4-5-6-7-8-9-10-11-12-13-14-15-22-39-30-20-17-21-31(32(30)33(35)38-3)41-42(36,37)40-29-19-16-18-28(23-29)25-34-24-27(2)43-26-34/h16-21,23-24,26H,4-15,22,25H2,1-3H3 D05RBL DRUGINKE VGVUQNMRGKNUJA-UHFFFAOYSA-N D05RBL DRUGSMIL CCCCCCCCCCCCCCOC1=C(C(=CC=C1)OP(=O)([O-])OC2=CC=CC(=C2)C[N+]3=CSC(=C3)C)C(=O)OC D05RBL HIGHSTAT Terminated D05REL DRUG__ID D05REL D05REL DRUGCOMP Glaxo Group Research Ltd D05REL DRUGINCH 1S/C69H91N15O16/c1-38(2)31-54(65(97)77-48(58(72)90)34-42-37-73-45-16-8-7-15-44(42)45)83-30-26-69(68(83)100)25-12-29-84(69)67(99)51(33-41-19-21-43(85)22-20-41)81-62(94)49(32-40-13-5-4-6-14-40)78-61(93)46(17-9-10-27-70)76-63(95)50(35-55(71)86)79-64(96)53-18-11-28-82(53)66(98)52(36-57(88)89)80-59(91)39(3)74-60(92)47-23-24-56(87)75-47/h4-8,13-16,19-22,37-39,46-54,73,85H,9-12,17-18,23-36,70H2,1-3H3,(H2,71,86)(H2,72,90)(H,74,92)(H,75,87)(H,76,95)(H,77,97)(H,78,93)(H,79,96)(H,80,91)(H,81,94)(H,88,89)/t39-,46-,47-,48-,49-,50-,51-,52-,53-,54-,69-/m0/s1 D05REL DRUGINKE KWECNVXXONDEKG-JTCMYMKESA-N D05REL DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N)N3CCC4(C3=O)CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C7CCCN7C(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C8CCC(=O)N8 D05REL HIGHSTAT Terminated D05VGS DRUG__ID D05VGS D05VGS DRUGCOMP Albany Molecular Research Inc. D05VGS DRUGINCH 1S/C23H21FN4O2/c1-27-21-6-8-25-13-20(21)19-5-4-17(10-22(19)27)28-9-7-18(11-23(28)29)30-14-16-3-2-15(24)12-26-16/h2-5,7,9-12,25H,6,8,13-14H2,1H3 D05VGS DRUGINKE VUUUHLIHQHVLLE-UHFFFAOYSA-N D05VGS DRUGSMIL CN1C2=C(CNCC2)C3=C1C=C(C=C3)N4C=CC(=CC4=O)OCC5=NC=C(C=C5)F D05VGS HIGHSTAT Terminated D05VNG DRUG__ID D05VNG D05VNG DRUGTYPE Small molecular drug D05VNG DRUGINCH 1S/C21H31N3O4/c1-5-9-16(20(26)24-28)17(12-14(2)3)19(25)23-18(21(27)22-4)13-15-10-7-6-8-11-15/h5-8,10-11,14,16-18,28H,1,9,12-13H2,2-4H3,(H,22,27)(H,23,25)(H,24,26)/t16-,17+,18-/m0/s1 D05VNG DRUGINKE GKHRDWHFKKUYAX-KSZLIROESA-N D05VNG DRUGSMIL CC(C)CC(C(CC=C)C(=O)NO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC D05VNG HIGHSTAT Terminated D05WPQ DRUG__ID D05WPQ D05WPQ DRUGTYPE Small molecular drug D05WPQ DRUGINCH 1S/C17H17NO3/c1-14(19)18(20)12-6-8-15-7-5-11-17(13-15)21-16-9-3-2-4-10-16/h2-11,13,20H,12H2,1H3/b8-6+ D05WPQ DRUGINKE CEUDWZXMLMKPNN-SOFGYWHQSA-N D05WPQ DRUGSMIL CC(=O)N(CC=CC1=CC(=CC=C1)OC2=CC=CC=C2)O D05WPQ HIGHSTAT Terminated D06ACX DRUG__ID D06ACX D06ACX DRUGTYPE Small molecular drug D06ACX DRUGINCH 1S/C22H35NO2/c1-14-7-6-9-17(23(14)3)11-12-19-18-10-5-4-8-16(18)13-20-21(19)15(2)25-22(20)24/h11-12,14-21H,4-10,13H2,1-3H3/b12-11+/t14-,15-,16+,17+,18-,19+,20-,21+/m0/s1 D06ACX DRUGINKE FMPNFDSPHNUFOS-LPJDIUFZSA-N D06ACX DRUGSMIL CC1CCCC(N1C)C=CC2C3CCCCC3CC4C2C(OC4=O)C D06ACX HIGHSTAT Terminated D06ALB DRUG__ID D06ALB D06ALB DRUGTYPE Small molecular drug D06ALB DRUGINCH 1S/C64H93N11O16/c1-5-40(4)55(71-59(85)48-24-17-33-73(48)61(87)44(28-29-53(78)79)69-56(82)45(37-42-21-10-7-11-22-42)70-57(83)46(38-54(80)81)68-51(76)26-12-14-30-65)63(89)74-34-18-25-49(74)62(88)75(50(64(90)91)35-39(2)3)52(77)27-13-15-31-67-58(84)47-23-16-32-72(47)60(86)43(66)36-41-19-8-6-9-20-41/h6-11,19-22,39-40,43-50,55H,5,12-18,23-38,65-66H2,1-4H3,(H,67,84)(H,68,76)(H,69,82)(H,70,83)(H,71,85)(H,78,79)(H,80,81)(H,90,91)/t40-,43+,44-,45-,46-,47-,48-,49-,50-,55-/m0/s1 D06ALB DRUGINKE VKIPOMGKUAJAEY-GEPLSBMPSA-N D06ALB DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)N(C(CC(C)C)C(=O)O)C(=O)CCCCNC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)N)NC(=O)C4CCCN4C(=O)C(CCC(=O)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)O)NC(=O)CCCCN D06ALB HIGHSTAT Terminated D06BFP DRUG__ID D06BFP D06BFP DRUGTYPE Small molecular drug D06BFP DRUGINCH 1S/C16H14ClN3O/c17-10-5-7-11(8-6-10)20-16(21)13-9-18-14-4-2-1-3-12(14)15(13)19-20/h5-9,19H,1-4H2 D06BFP DRUGINKE NZEIZTTWQRQFFV-UHFFFAOYSA-N D06BFP DRUGSMIL C1CCC2=NC=C3C(=C2C1)NN(C3=O)C4=CC=C(C=C4)Cl D06BFP HIGHSTAT Terminated D06DZI DRUG__ID D06DZI D06DZI DRUGTYPE Small molecular drug D06DZI DRUGINCH 1S/C29H31N5O3/c1-19-17-23(28-30-20(2)37-32-28)9-11-25(19)21-5-7-22(8-6-21)29(35)31-24-10-12-27(36-4)26(18-24)34-15-13-33(3)14-16-34/h5-12,17-18H,13-16H2,1-4H3,(H,31,35) D06DZI DRUGINKE YDBCEBYHYKAFRX-UHFFFAOYSA-N D06DZI DRUGSMIL CC1=C(C=CC(=C1)C2=NOC(=N2)C)C3=CC=C(C=C3)C(=O)NC4=CC(=C(C=C4)OC)N5CCN(CC5)C D06DZI HIGHSTAT Terminated D06FEF DRUG__ID D06FEF D06FEF DRUGTYPE Small molecular drug D06FEF DRUGINCH 1S/C22H31NO4/c1-7-22(23(2)3,18-11-9-8-10-12-18)16-27-15-17-13-19(24-4)21(26-6)20(14-17)25-5/h8-14H,7,15-16H2,1-6H3/t22-/m0/s1 D06FEF DRUGINKE MVKIWCDXKCUDEH-QFIPXVFZSA-N D06FEF DRUGSMIL CCC(COCC1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C D06FEF HIGHSTAT Terminated D06FMY DRUG__ID D06FMY D06FMY DRUGCOMP Novartis AG D06FMY DRUGINCH 1S/C38H51N5O7/c1-25(2)32(40-36(47)49-6)34(45)39-30(22-26-14-10-8-11-15-26)31(44)24-43(42-35(46)33(38(3,4)5)41-37(48)50-7)23-27-18-20-29(21-19-27)28-16-12-9-13-17-28/h8-21,25,30-33,44H,22-24H2,1-7H3,(H,39,45)(H,40,47)(H,41,48)(H,42,46)/t30-,31-,32-,33+/m0/s1 D06FMY DRUGINKE BYEWWQZDUPJZHX-ZWDYZTTJSA-N D06FMY DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=C3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC D06FMY HIGHSTAT Terminated D06GBK DRUG__ID D06GBK D06GBK DRUGTYPE Small molecular drug D06GBK DRUGINCH 1S/C16H14N2/c1-11-8-14-15(9-12(11)2)18-16(10-17-14)13-6-4-3-5-7-13/h3-10H,1-2H3 D06GBK DRUGINKE FQNCLVJEQCJWSU-UHFFFAOYSA-N D06GBK DRUGSMIL CC1=CC2=NC=C(N=C2C=C1C)C3=CC=CC=C3 D06GBK HIGHSTAT Terminated D06GSE DRUG__ID D06GSE D06GSE DRUGCOMP MGI GP Inc D06GSE DRUGINCH 1S/C21H30N2O3/c1-4-21(2,3)18(24)20(26)23-15-9-13-17(23)19(25)22-14-8-12-16-10-6-5-7-11-16/h5-7,10-11,17H,4,8-9,12-15H2,1-3H3,(H,22,25)/t17-/m0/s1 D06GSE DRUGINKE CHPKUAHVBYHZKC-KRWDZBQOSA-N D06GSE DRUGSMIL CCC(C)(C)C(=O)C(=O)N1CCCC1C(=O)NCCCC2=CC=CC=C2 D06GSE HIGHSTAT Terminated D06HRY DRUG__ID D06HRY D06HRY DRUGTYPE Small molecular drug D06HRY DRUGINCH 1S/C36H40N4O5.ClH/c1-25-31(33(32(26(2)38-25)35(42)45-3)27-15-17-30(18-16-27)40(43)44)34(41)37-21-10-22-39-23-19-36(20-24-39,28-11-6-4-7-12-28)29-13-8-5-9-14-29;/h4-9,11-18,33,38H,10,19-24H2,1-3H3,(H,37,41);1H D06HRY DRUGINKE MXELDPKESKXREN-UHFFFAOYSA-N D06HRY DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5.Cl D06HRY HIGHSTAT Terminated D06IVH DRUG__ID D06IVH D06IVH DRUGCOMP Organon BioSciences D06IVH DRUGINCH 1S/C19H27NO3/c1-19-6-5-11-12(14(19)9-17(23)18(19)20-2)4-3-10-7-15(21)16(22)8-13(10)11/h7-8,11-12,14,17-18,20-23H,3-6,9H2,1-2H3/t11-,12+,14-,17+,18-,19-/m0/s1 D06IVH DRUGINKE YVBSZXJRJYYVQR-AFKMTKAPSA-N D06IVH DRUGSMIL CC12CCC3C(C1CC(C2NC)O)CCC4=CC(=C(C=C34)O)O D06IVH HIGHSTAT Terminated D06JUR DRUG__ID D06JUR D06JUR DRUGTYPE Small molecular drug D06JUR DRUGINCH 1S/C12H14N2O2/c1-2-12(9-4-7-13-8-5-9)6-3-10(15)14-11(12)16/h4-5,7-8H,2-3,6H2,1H3,(H,14,15,16) D06JUR DRUGINKE QXKJWHWUDVQATH-UHFFFAOYSA-N D06JUR DRUGSMIL CCC1(CCC(=O)NC1=O)C2=CC=NC=C2 D06JUR HIGHSTAT Terminated D06PWA DRUG__ID D06PWA D06PWA DRUGTYPE Small molecular drug D06PWA DRUGINCH 1S/C7H8N2O3/c8-7(9-12)4-1-2-5(10)6(11)3-4/h1-3,10-12H,(H2,8,9) D06PWA DRUGINKE JOAASNKBYBFGDN-UHFFFAOYSA-N D06PWA DRUGSMIL C1=CC(=C(C=C1C(=NO)N)O)O D06PWA HIGHSTAT Terminated D06SIG DRUG__ID D06SIG D06SIG DRUGTYPE Small molecular drug D06SIG DRUGINCH 1S/C170H210N70O103P16S2/c1-57-23-224(166(260)219-137(57)243)96-6-62(242)80(312-96)29-309-358(293,360)343-78-22-112(240-56-194-124-136(240)206-165(182)218-153(124)259)327-94(78)43-308-357(291,292)341-77-21-111(239-55-193-123-135(239)205-164(181)217-152(123)258)326-93(77)42-307-356(289,290)337-73-17-107(235-51-189-119-131(235)201-160(177)213-148(119)254)319-86(73)35-300-346(269,270)330-66-10-99(227-26-60(4)140(246)222-169(227)263)315-83(66)32-297-350(277,278)334-70-14-104(232-48-186-116-128(232)198-157(174)210-145(116)251)323-90(70)39-304-355(287,288)340-76-20-110(238-54-192-122-134(238)204-163(180)216-151(122)257)325-92(76)41-306-352(281,282)336-72-16-106(234-50-188-118-130(234)200-159(176)212-147(118)253)318-85(72)34-299-345(267,268)329-65-9-98(226-25-59(3)139(245)221-168(226)262)314-82(65)31-296-349(275,276)333-69-13-103(231-47-185-115-127(231)197-156(173)209-144(115)250)322-89(69)38-303-354(285,286)339-75-19-109(237-53-191-121-133(237)203-162(179)215-150(121)256)324-91(75)40-305-351(279,280)335-71-15-105(233-49-187-117-129(233)199-158(175)211-146(117)252)317-84(71)33-298-344(265,266)328-64-8-97(225-24-58(2)138(244)220-167(225)261)313-81(64)30-295-348(273,274)332-68-12-102(230-46-184-114-126(230)196-155(172)208-143(114)249)321-88(68)37-302-353(283,284)338-74-18-108(236-52-190-120-132(236)202-161(178)214-149(120)255)320-87(74)36-301-347(271,272)331-67-11-100(228-27-61(5)141(247)223-170(228)264)316-95(67)44-310-359(294,361)342-63-7-101(311-79(63)28-241)229-45-183-113-125(229)195-154(171)207-142(113)248/h23-27,45-56,62-112,241-242H,6-22,28-44H2,1-5H3,(H,265,266)(H,267,268)(H,269,270)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H,289,290)(H,291,292)(H,293,360)(H,294,361)(H,219,243,260)(H,220,244,261)(H,221,245,262)(H,222,246,263)(H,223,247,264)(H3,171,195,207,248)(H3,172,196,208,249)(H3,173,197,209,250)(H3,174,198,210,251)(H3,175,199,211,252)(H3,176,200,212,253)(H3,177,201,213,254)(H3,178,202,214,255)(H3,179,203,215,256)(H3,180,204,216,257)(H3,181,205,217,258)(H3,182,206,218,259) D06SIG DRUGINKE FTRWNHBXCNPGCA-UHFFFAOYSA-N D06SIG DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)OC8CC(OC8COP(=O)(O)OC9CC(OC9COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(O)OC1CC(OC1COP(=O)(OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)S)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)O D06SIG HIGHSTAT Terminated D06VTU DRUG__ID D06VTU D06VTU DRUGTYPE Small molecular drug D06VTU DRUGINCH 1S/C17H25FN2O4S/c1-11(2)9-14(10-21)19-17(22)16(12(3)4)20-25(23,24)15-7-5-13(18)6-8-15/h5-8,10-12,14,16,20H,9H2,1-4H3,(H,19,22)/t14-,16-/m0/s1 D06VTU DRUGINKE WSJWUIDLGZAXID-HOCLYGCPSA-N D06VTU DRUGSMIL CC(C)CC(C=O)NC(=O)C(C(C)C)NS(=O)(=O)C1=CC=C(C=C1)F D06VTU HIGHSTAT Terminated D06VWA DRUG__ID D06VWA D06VWA DRUGCOMP Fujisawa Pharmaceutical Co Ltd D06VWA DRUGINCH 1S/C71H116N14O23/c1-9-10-11-12-13-14-15-16-17-18-19-21-45-32-52(95)78-55(38(5)86)65(101)75-37(4)61(97)77-47(30-42-23-25-43(90)26-24-42)62(98)80-54(36(2)3)69(105)85-35-44(91)31-48(85)63(99)81-57(40(7)88)67(103)82-58(41(8)89)70(106)84-29-27-49(92)60(84)68(104)83-59(50(93)33-51(73)94)64(100)74-34-53(96)79-56(39(6)87)66(102)76-46(22-20-28-72)71(107)108-45/h23-26,36-41,44-50,54-60,86-93H,9-22,27-35,72H2,1-8H3,(H2,73,94)(H,74,100)(H,75,101)(H,76,102)(H,77,97)(H,78,95)(H,79,96)(H,80,98)(H,81,99)(H,82,103)(H,83,104)/t37-,38-,39-,40-,41-,44-,45-,46+,47+,48+,49+,50-,54+,55-,56-,57-,58+,59+,60+/m1/s1 D06VWA DRUGINKE LTLDDYQPSWDOBJ-UNEDFBIISA-N D06VWA DRUGSMIL CCCCCCCCCCCCCC1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CC(CC2C(=O)NC(C(=O)NC(C(=O)N3CCC(C3C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O1)CCCN)C(C)O)C(CC(=O)N)O)O)C(C)O)C(C)O)O)C(C)C)CC4=CC=C(C=C4)O)C)C(C)O D06VWA HIGHSTAT Terminated D06WBE DRUG__ID D06WBE D06WBE DRUGTYPE Small molecular drug D06WBE DRUGINCH 1S/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1 D06WBE DRUGINKE FONCZICQWCUXEB-RUZDIDTESA-N D06WBE DRUGSMIL CC1=CC(=CC(=C1OC(CC2=CC=CC=C2)C(=O)O)C)C3=C4C(=C(SC4=C(C5=CC=CC=C53)Br)C)C D06WBE HIGHSTAT Terminated D06WHL DRUG__ID D06WHL D06WHL DRUGCOMP NeuroSearch A/S D06WHL DRUGINCH 1S/C13H16N4O4S/c1-16(2)22(20,21)10-4-7-11(14-13(18)12(7)15-19)9-6-17(3)5-8(9)10/h4,14,18H,5-6H2,1-3H3 D06WHL DRUGINKE ZPJJGAUEQIVPRW-UHFFFAOYSA-N D06WHL DRUGSMIL CN1CC2=C(C=C3C(=C2C1)NC(=C3N=O)O)S(=O)(=O)N(C)C D06WHL HIGHSTAT Terminated D06XRQ DRUG__ID D06XRQ D06XRQ DRUGTYPE Small molecular drug D06XRQ DRUGINCH 1S/C21H26O3/c1-16-17(2)21(24)19(18(3)20(16)23)14-12-10-8-6-4-5-7-9-11-13-15-22/h22H,5,7-10,12,14-15H2,1-3H3 D06XRQ DRUGINKE WDEABJKSGGRCQA-UHFFFAOYSA-N D06XRQ DRUGSMIL CC1=C(C(=O)C(=C(C1=O)C)CCCCC#CCCCC#CCO)C D06XRQ HIGHSTAT Terminated D06ZAM DRUG__ID D06ZAM D06ZAM DRUGTYPE Small molecular drug D06ZAM DRUGINCH 1S/C15H30N2O2/c1-14-11-17(12-15(2)19-14)10-8-6-4-3-5-7-9-16-13-18/h13-15H,3-12H2,1-2H3,(H,16,18)/t14-,15+ D06ZAM DRUGINKE UXVBAZRPAJEAHR-GASCZTMLSA-N D06ZAM DRUGSMIL CC1CN(CC(O1)C)CCCCCCCCNC=O D06ZAM HIGHSTAT Terminated D06ZKG DRUG__ID D06ZKG D06ZKG DRUGCOMP GD Searle & Co D06ZKG DRUGINCH 1S/C14H14BrNO3S/c1-10-6-5-8-12(19-2)14(10)16-20(17,18)13-9-4-3-7-11(13)15/h3-9,16H,1-2H3 D06ZKG DRUGINKE ZENBMAKLSOHDBZ-UHFFFAOYSA-N D06ZKG DRUGSMIL CC1=C(C(=CC=C1)OC)NS(=O)(=O)C2=CC=CC=C2Br D06ZKG HIGHSTAT Terminated D07BCO DRUG__ID D07BCO D07BCO DRUGTYPE Small molecular drug D07BCO DRUGINCH 1S/C25H34N4O2/c1-31-23-12-6-5-11-22(23)28-18-15-27(16-19-28)17-20-29(24-13-7-8-14-26-24)25(30)21-9-3-2-4-10-21/h5-8,11-14,21H,2-4,9-10,15-20H2,1H3 D07BCO DRUGINKE SBPRIAGPYFYCRT-UHFFFAOYSA-N D07BCO DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4 D07BCO HIGHSTAT Terminated D07FDM DRUG__ID D07FDM D07FDM DRUGCOMP Fujisawa Pharmaceutical Co Ltd D07FDM DRUGINCH 1S/C51H82N8O21S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-37(66)53-30-22-34(64)47(72)57-49(74)41-42(67)26(2)24-59(41)51(76)39(33(63)23-36(52)65)55-48(73)40(44(69)43(68)28-18-19-32(62)35(20-28)80-81(77,78)79)56-46(71)31-21-29(61)25-58(31)50(75)38(27(3)60)54-45(30)70/h18-20,26-27,29-31,33-34,38-44,47,60-64,67-69,72H,4-17,21-25H2,1-3H3,(H2,52,65)(H,53,66)(H,54,70)(H,55,73)(H,56,71)(H,57,74)(H,77,78,79)/t26-,27+,29+,30-,31-,33+,34+,38-,39-,40-,41-,42-,43-,44-,47-/m0/s1 D07FDM DRUGINKE KAPLTEIQCKDUAT-WAULFNKYSA-N D07FDM DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(C(CN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC(=C(C=C4)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O D07FDM HIGHSTAT Terminated D07FHZ DRUG__ID D07FHZ D07FHZ DRUGTYPE Small molecular drug D07FHZ DRUGINCH 1S/C15H22N2O3/c1-3-4-7-20-14-9-11(5-6-13(14)19-2)8-12-10-16-15(18)17-12/h5-6,9,12H,3-4,7-8,10H2,1-2H3,(H2,16,17,18) D07FHZ DRUGINKE PDMUULPVBYQBBK-UHFFFAOYSA-N D07FHZ DRUGSMIL CCCCOC1=C(C=CC(=C1)CC2CNC(=O)N2)OC D07FHZ HIGHSTAT Terminated D07MWD DRUG__ID D07MWD D07MWD DRUGTYPE Small molecular drug D07MWD DRUGINCH 1S/C20H24FNO/c21-19-8-6-16(7-9-19)10-13-22-14-11-18(12-15-22)20(23)17-4-2-1-3-5-17/h1-9,18,20,23H,10-15H2 D07MWD DRUGINKE HRSUYEGDQAVTRC-UHFFFAOYSA-N D07MWD DRUGSMIL C1CN(CCC1C(C2=CC=CC=C2)O)CCC3=CC=C(C=C3)F D07MWD HIGHSTAT Terminated D07NWC DRUG__ID D07NWC D07NWC DRUGCOMP Bristol-Myers Squibb Pharma Co D07NWC DRUGINCH 1S/C20H27BrN6O2/c1-13(2)15-6-7-17(16(21)12-15)27-20-18(24-25-27)19(22-14(3)23-20)26(8-10-28-4)9-11-29-5/h6-7,12-13H,8-11H2,1-5H3 D07NWC DRUGINKE DMJNPPHUVMMIEQ-UHFFFAOYSA-N D07NWC DRUGSMIL CC1=NC2=C(C(=N1)N(CCOC)CCOC)N=NN2C3=C(C=C(C=C3)C(C)C)Br D07NWC HIGHSTAT Terminated D07ODD DRUG__ID D07ODD D07ODD DRUGTYPE Small molecular drug D07ODD DRUGINCH 1S/C22H25N5O2/c1-29-20-9-5-4-8-19(20)26-12-10-25(11-13-26)15-16-14-23-21-17-6-2-3-7-18(17)24-22(28)27(16)21/h2-9,16,23H,10-15H2,1H3 D07ODD DRUGINKE COCJIISORPXDPN-UHFFFAOYSA-N D07ODD DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CC3CNC4=C5C=CC=CC5=NC(=O)N34 D07ODD HIGHSTAT Terminated D07OGR DRUG__ID D07OGR D07OGR DRUGTYPE Small molecular drug D07OGR DRUGINCH 1S/C45H62O8/c1-3-5-7-9-11-13-15-17-19-21-36(48)41-43(50)40(44(51)42(45(41)52)37(49)22-20-18-16-14-12-10-8-6-4-2)35-30-38(31-23-25-32(46)26-24-31)53-39-29-33(47)27-28-34(35)39/h23-29,35,38,46-47,50-52H,3-22,30H2,1-2H3 D07OGR DRUGINKE CEJAYJCUSZHYDS-UHFFFAOYSA-N D07OGR DRUGSMIL CCCCCCCCCCCC(=O)C1=C(C(=C(C(=C1O)C2CC(OC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O)O)C(=O)CCCCCCCCCCC)O D07OGR HIGHSTAT Terminated D07PAY DRUG__ID D07PAY D07PAY DRUGCOMP Eisai Co Ltd D07PAY DRUGINCH 1S/C24H36N2O3S2/c1-17(2)19(11-12-21(25)16-30)9-10-20(15-18-7-5-4-6-8-18)23(27)26-22(24(28)29)13-14-31-3/h4-12,17,19-22,30H,13-16,25H2,1-3H3,(H,26,27)(H,28,29)/b10-9+,12-11+/t19-,20+,21+,22-/m0/s1 D07PAY DRUGINKE IPRQDTJTDYDPBX-KPVQYLNHSA-N D07PAY DRUGSMIL CC(C)C(C=CC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)O)C=CC(CS)N D07PAY HIGHSTAT Terminated D07PIA DRUG__ID D07PIA D07PIA DRUGTYPE Small molecular drug D07PIA DRUGINCH 1S/C30H41N3O4S2.CH4O3S/c1-19-22(11-8-12-25(19)34)28(36)31-23(18-39-21-9-6-5-7-10-21)26(35)17-33-16-20-13-14-38-27(20)15-24(33)29(37)32-30(2,3)4;1-5(2,3)4/h5-12,20,23-24,26-27,34-35H,13-18H2,1-4H3,(H,31,36)(H,32,37);1H3,(H,2,3,4)/t20-,23+,24+,26-,27+;/m1./s1 D07PIA DRUGINKE WYCLUAUPFCMDTI-KZMNDDLNSA-N D07PIA DRUGSMIL CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCSC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O D07PIA HIGHSTAT Terminated D07RPB DRUG__ID D07RPB D07RPB DRUGCOMP Chugai Pharmaceutical Co Ltd D07RPB DRUGINCH 1S/C23H32N2O3/c1-15-3-2-4-20-21(15)28-19(14-27-20)13-24-5-6-25-22(26)23-10-16-7-17(11-23)9-18(8-16)12-23/h2-4,16-19,24H,5-14H2,1H3,(H,25,26) D07RPB DRUGINKE QKQSDPQVNKEJPX-UHFFFAOYSA-N D07RPB DRUGSMIL CC1=C2C(=CC=C1)OCC(O2)CNCCNC(=O)C34CC5CC(C3)CC(C5)C4 D07RPB HIGHSTAT Terminated D07SZJ DRUG__ID D07SZJ D07SZJ DRUGCOMP Abbott Laboratories D07SZJ DRUGINCH 1S/C20H25NO.ClH/c1-21(13-12-16-6-3-2-4-7-16)15-18-9-5-8-17-14-19(22)10-11-20(17)18;/h2-4,6-7,10-11,14,18,22H,5,8-9,12-13,15H2,1H3;1H D07SZJ DRUGINKE APKIWAWHUXJRIV-UHFFFAOYSA-N D07SZJ DRUGSMIL CN(CCC1=CC=CC=C1)CC2CCCC3=C2C=CC(=C3)O.Cl D07SZJ HIGHSTAT Terminated D07TDT DRUG__ID D07TDT D07TDT DRUGCOMP Merck & Co Inc D07TDT DRUGINCH 1S/C52H85N9O16/c1-5-28(2)24-29(3)12-10-8-6-7-9-11-13-39(68)55-34-26-38(67)50(77-23-21-54)59-49(74)43-37(66)19-22-60(43)52(76)41(36(65)18-20-53)57-48(73)42(45(70)44(69)31-14-16-32(63)17-15-31)58-47(72)35-25-33(64)27-61(35)51(75)40(30(4)62)56-46(34)71/h14-17,28-30,33-38,40-43,45,50,62-67,70H,5-13,18-27,53-54H2,1-4H3,(H,55,68)(H,56,71)(H,57,73)(H,58,72)(H,59,74)/t28?,29?,30-,33-,34+,35+,36-,37+,38-,40?,41+,42?,43+,45+,50+/m1/s1 D07TDT DRUGINKE UWUVRFXWJQIKTQ-NQPUGUJXSA-N D07TDT DRUGSMIL CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(=O)C4=CC=C(C=C4)O)O)C(CCN)O)O)OCCN)O D07TDT HIGHSTAT Terminated D07TNU DRUG__ID D07TNU D07TNU DRUGTYPE Small molecular drug D07TNU DRUGINCH 1S/C18H36N6O6/c1-8(20)10-5-4-9(21)18(29-10)30-16-12(22)14(26)17(28-3)13(15(16)27)24(2)11(25)6-23-7-19/h7-10,12-18,26-27H,4-6,20-22H2,1-3H3,(H2,19,23) D07TNU DRUGINKE VFBPKQSATYZKRX-UHFFFAOYSA-N D07TNU DRUGSMIL CC(C1CCC(C(O1)OC2C(C(C(C(C2O)N(C)C(=O)CN=CN)OC)O)N)N)N D07TNU HIGHSTAT Terminated D07TZM DRUG__ID D07TZM D07TZM DRUGTYPE Small molecular drug D07TZM DRUGINCH 1S/C17H12F4N2O2S/c1-26(24,25)14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3 D07TZM DRUGINKE JHBIMJKLBUMNAU-UHFFFAOYSA-N D07TZM DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)N2C(=CC(=N2)C(F)(F)F)C3=CC=C(C=C3)F D07TZM HIGHSTAT Terminated D07ULS DRUG__ID D07ULS D07ULS DRUGTYPE Small molecular drug D07ULS DRUGINCH 1S/C9H12FN3O3/c10-6-3-5(4-14)16-8(6)13-2-1-7(11)12-9(13)15/h1-2,5-6,8,14H,3-4H2,(H2,11,12,15)/t5-,6-,8+/m0/s1 D07ULS DRUGINKE LTDCCBLBAQXNKP-VMHSAVOQSA-N D07ULS DRUGSMIL C1C(OC(C1F)N2C=CC(=NC2=O)N)CO D07ULS HIGHSTAT Terminated D07WDS DRUG__ID D07WDS D07WDS DRUGCOMP Novo Nordisk A/S D07WDS DRUGINCH 1S/C20H20FN7O/c1-26-6-8-27(9-7-26)18-14-10-13(21)4-5-15(14)28-11-22-16(19(28)24-18)17-23-20(29-25-17)12-2-3-12/h4-5,10-12H,2-3,6-9H2,1H3 D07WDS DRUGINKE HIBQQLJKYMSZOZ-UHFFFAOYSA-N D07WDS DRUGSMIL CN1CCN(CC1)C2=NC3=C(N=CN3C4=C2C=C(C=C4)F)C5=NOC(=N5)C6CC6 D07WDS HIGHSTAT Terminated D08CEE DRUG__ID D08CEE D08CEE DRUGTYPE Small molecular drug D08CEE DRUGINCH 1S/C25H33N3O4/c1-17(2)16-22(24(30)27-20-12-8-5-9-13-20)28-23(29)21(26-18(3)25(31)32)15-14-19-10-6-4-7-11-19/h4-13,17-18,21-22,26H,14-16H2,1-3H3,(H,27,30)(H,28,29)(H,31,32)/t18-,21+,22+/m1/s1 D08CEE DRUGINKE DLCYKLDSIUJNLE-COPCDDAFSA-N D08CEE DRUGSMIL CC(C)CC(C(=O)NC1=CC=CC=C1)NC(=O)C(CCC2=CC=CC=C2)NC(C)C(=O)O D08CEE HIGHSTAT Terminated D08CQL DRUG__ID D08CQL D08CQL DRUGTYPE Small molecular drug D08CQL DRUGINCH 1S/C26H31N7O6S2/c1-33-18(9-6-12-29-26(27)28)24(38)30-14-21(34)31-17(13-22(35)36)23(37)32-16-8-3-5-11-20(16)41-40-19-10-4-2-7-15(19)25(33)39/h2-5,7-8,10-11,17-18H,6,9,12-14H2,1H3,(H,30,38)(H,31,34)(H,32,37)(H,35,36)(H4,27,28,29)/t17-,18-/m0/s1 D08CQL DRUGINKE YITSCMGHJOGUNC-ROUUACIJSA-N D08CQL DRUGSMIL CN1C(C(=O)NCC(=O)NC(C(=O)NC2=CC=CC=C2SSC3=CC=CC=C3C1=O)CC(=O)O)CCCN=C(N)N D08CQL HIGHSTAT Terminated D08FHV DRUG__ID D08FHV D08FHV DRUGTYPE Small molecular drug D08FHV DRUGINCH 1S/C16H22O2/c1-2-3-4-5-6-7-12-15-13-10-8-9-11-14(13)16(17)18-15/h8-11,15H,2-7,12H2,1H3 D08FHV DRUGINKE MYGRPRSFUHJZPY-UHFFFAOYSA-N D08FHV DRUGSMIL CCCCCCCCC1C2=CC=CC=C2C(=O)O1 D08FHV HIGHSTAT Terminated D08HES DRUG__ID D08HES D08HES DRUGCOMP Microcide Pharmaceuticals Inc D08HES DRUGINCH 1S/C22H23N9O5S5/c23-20(24)38-4-8-1-2-11(9(3-8)5-39-21(25)26)41-12-7-37-18-14(17(33)31(18)15(12)19(34)35)29-16(32)13(30-36)10-6-40-22(27)28-10/h1-3,6,14,18,36H,4-5,7H2,(H3,23,24)(H3,25,26)(H2,27,28)(H,29,32)(H,34,35)/b30-13+/t14-,18-/m1/s1 D08HES DRUGINKE ZFCGALFUDLENDT-GAWQCMHKSA-N D08HES DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)C(=O)O)SC4=C(C=C(C=C4)CSC(=N)N)CSC(=N)N D08HES HIGHSTAT Terminated D08IDQ DRUG__ID D08IDQ D08IDQ DRUGCOMP Boehringer Ingelheim Corp D08IDQ DRUGINCH 1S/C39H62N6O5S/c1-27(2)20-34(46)37(49)33(21-28-12-6-4-7-13-28)43-38(50)30(22-32-26-51-39(40)42-32)23-35(47)45(24-29-14-8-5-9-15-29)25-36(48)44(3)19-17-31-16-10-11-18-41-31/h10-11,16,18,26-30,33-34,37,46,49H,4-9,12-15,17,19-25H2,1-3H3,(H2,40,42)(H,43,50)/t30-,33-,34-,37+/m0/s1 D08IDQ DRUGINKE RTFZIRGGIOYLOO-KGVCAXOZSA-N D08IDQ DRUGSMIL CC(C)CC(C(C(CC1CCCCC1)NC(=O)C(CC2=CSC(=N2)N)CC(=O)N(CC3CCCCC3)CC(=O)N(C)CCC4=CC=CC=N4)O)O D08IDQ HIGHSTAT Terminated D08IRR DRUG__ID D08IRR D08IRR DRUGCOMP Organon BioSciences D08IRR DRUGINCH 1S/C17H19NO/c1-18-12-10-14-6-2-4-8-16(14)19-17-9-5-3-7-15(17)11-13-18/h2-9H,10-13H2,1H3 D08IRR DRUGINKE NREYMNFZCFNECP-UHFFFAOYSA-N D08IRR DRUGSMIL CN1CCC2=CC=CC=C2OC3=CC=CC=C3CC1 D08IRR HIGHSTAT Terminated D08JKK DRUG__ID D08JKK D08JKK DRUGCOMP RW Johnson Pharmaceutical Research Institute D08JKK DRUGINCH 1S/C11H10FNO3S2/c1-18(14,15)13-10-6-7-11(17-10)16-9-4-2-8(12)3-5-9/h2-7,13H,1H3 D08JKK DRUGINKE BEIZIEZPGSIQGR-UHFFFAOYSA-N D08JKK DRUGSMIL CS(=O)(=O)NC1=CC=C(S1)OC2=CC=C(C=C2)F D08JKK HIGHSTAT Terminated D08LIG DRUG__ID D08LIG D08LIG DRUGTYPE Small molecular drug D08LIG DRUGINCH 1S/C25H34N6O6S/c1-17-3-5-19(6-4-17)38(36,37)29-21(25(34)35)16-27-23(32)20-15-22-24(33)30(12-2-13-31(22)28-20)14-9-18-7-10-26-11-8-18/h3-6,15,18,21,26,29H,2,7-14,16H2,1H3,(H,27,32)(H,34,35)/t21-/m0/s1 D08LIG DRUGINKE YLFFZEQHDMFOEC-NRFANRHFSA-N D08LIG DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(CNC(=O)C2=NN3CCCN(C(=O)C3=C2)CCC4CCNCC4)C(=O)O D08LIG HIGHSTAT Terminated D08LLR DRUG__ID D08LLR D08LLR DRUGCOMP Pfizer Ltd D08LLR DRUGINCH 1S/C22H28ClN3O6/c1-4-32-22(29)20-16(12-31-10-9-25-11-17(24)27)26-13(2)18(21(28)30-3)19(20)14-7-5-6-8-15(14)23/h5-8,19,25-26H,4,9-12H2,1-3H3,(H2,24,27) D08LLR DRUGINKE FAKQIHAUXYAVJI-UHFFFAOYSA-N D08LLR DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCNCC(=O)N D08LLR HIGHSTAT Terminated D08MJX DRUG__ID D08MJX D08MJX DRUGTYPE Small molecular drug D08MJX DRUGINCH 1S/C23H28FN3OS/c1-26(23-25-21-6-2-3-7-22(21)29-23)19-12-15-27(16-13-19)14-4-5-17-28-20-10-8-18(24)9-11-20/h2-3,6-11,19H,4-5,12-17H2,1H3 D08MJX DRUGINKE PZPXREFPAFDHNG-UHFFFAOYSA-N D08MJX DRUGSMIL CN(C1CCN(CC1)CCCCOC2=CC=C(C=C2)F)C3=NC4=CC=CC=C4S3 D08MJX HIGHSTAT Terminated D08NHF DRUG__ID D08NHF D08NHF DRUGCOMP SRI International D08NHF DRUGINCH 1S/C28H29F3O3/c1-26(2)10-11-27(3,4)23-15-20-19(14-22(23)26)12-18(13-21(20)24(34-5)28(29,30)31)16-6-8-17(9-7-16)25(32)33/h6-9,12-15,24H,10-11H2,1-5H3,(H,32,33) D08NHF DRUGINKE GGBXAGJOPKQCJV-UHFFFAOYSA-N D08NHF DRUGSMIL CC1(CCC(C2=CC3=C(C=C(C=C3C=C21)C4=CC=C(C=C4)C(=O)O)C(C(F)(F)F)OC)(C)C)C D08NHF HIGHSTAT Terminated D08NXX DRUG__ID D08NXX D08NXX DRUGTYPE Small molecular drug D08NXX DRUGINCH 1S/C12H11N3O/c1-6-3-4-9-8(7(6)2)5-10-11(13-9)15-12(16)14-10/h3-5H,1-2H3,(H2,13,14,15,16) D08NXX DRUGINKE ODCKPUDNMNCWMR-UHFFFAOYSA-N D08NXX DRUGSMIL CC1=C(C2=CC3=C(NC(=O)N3)N=C2C=C1)C D08NXX HIGHSTAT Terminated D08OWQ DRUG__ID D08OWQ D08OWQ DRUGTYPE Small molecular drug D08OWQ DRUGINCH 1S/C16H22ClNO/c1-12(2)8-11-19-16-5-4-15(17)13-6-9-18(3)10-7-14(13)16/h4-5,8H,6-7,9-11H2,1-3H3 D08OWQ DRUGINKE MBYSTKNEMJZSIK-UHFFFAOYSA-N D08OWQ DRUGSMIL CC(=CCOC1=C2CCN(CCC2=C(C=C1)Cl)C)C D08OWQ HIGHSTAT Terminated D08PAC DRUG__ID D08PAC D08PAC DRUGTYPE Small molecular drug D08PAC DRUGINCH 1S/C28H33N3O6/c1-19(32)29-15-11-22(12-16-29)37-23-7-8-24(26(17-23)35-2)27(33)30-13-9-21(10-14-30)31-25-6-4-3-5-20(25)18-36-28(31)34/h3-8,17,21-22H,9-16,18H2,1-2H3 D08PAC DRUGINKE WDERJSQJYIJOPD-UHFFFAOYSA-N D08PAC DRUGSMIL CC(=O)N1CCC(CC1)OC2=CC(=C(C=C2)C(=O)N3CCC(CC3)N4C5=CC=CC=C5COC4=O)OC D08PAC HIGHSTAT Terminated D08PUW DRUG__ID D08PUW D08PUW DRUGTYPE Small molecular drug D08PUW DRUGINCH 1S/C21H18O11/c22-9-6-10(8-4-2-1-3-5-8)30-11-7-12(14(23)15(24)13(9)11)31-21-18(27)16(25)17(26)19(32-21)20(28)29/h1-7,16-19,21,23-27H,(H,28,29)/t16-,17-,18+,19-,21+/m0/s1 D08PUW DRUGINKE IKIIZLYTISPENI-ZFORQUDYSA-N D08PUW DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O D08PUW HIGHSTAT Terminated D08QYJ DRUG__ID D08QYJ D08QYJ DRUGTYPE Small molecular drug D08QYJ DRUGINCH 1S/C13H14N2O2/c1-8-5-4-6-9(2)12(8)13(16)14-11-7-10(3)17-15-11/h4-7H,1-3H3,(H,14,15,16) D08QYJ DRUGINKE GBTKANSDFYFQBK-UHFFFAOYSA-N D08QYJ DRUGSMIL CC1=C(C(=CC=C1)C)C(=O)NC2=NOC(=C2)C D08QYJ HIGHSTAT Terminated D08VKZ DRUG__ID D08VKZ D08VKZ DRUGCOMP Roche Holding AG D08VKZ DRUGINCH 1S/C24H20N2O4S2/c1-14-18(25-23(30-14)15-5-3-2-4-6-15)9-11-29-19-8-7-16(21-17(19)10-12-31-21)13-20-22(27)26-24(28)32-20/h2-8,10,12,20H,9,11,13H2,1H3,(H,26,27,28) D08VKZ DRUGINKE HAAXAFNSRADSMK-UHFFFAOYSA-N D08VKZ DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=C4C=CSC4=C(C=C3)CC5C(=O)NC(=O)S5 D08VKZ HIGHSTAT Terminated D08ZAX DRUG__ID D08ZAX D08ZAX DRUGTYPE Small molecular drug D08ZAX DRUGINCH 1S/C27H30N2O9/c1-16-23(26(32)36-3)25(19-5-4-6-20(13-19)29(34)35)24(17(2)28-16)27(33)37-12-11-18-7-9-22(10-8-18)38-15-21(31)14-30/h4-10,13,21,25,28,30-31H,11-12,14-15H2,1-3H3 D08ZAX DRUGINKE QLNAYPDWIWUVHP-UHFFFAOYSA-N D08ZAX DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCC2=CC=C(C=C2)OCC(CO)O)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC D08ZAX HIGHSTAT Terminated D08ZBV DRUG__ID D08ZBV D08ZBV DRUGTYPE Small molecular drug D08ZBV DRUGINCH 1S/C22H18F6N2O3/c1-12(31)30-19(8-14-10-29-18-5-3-2-4-17(14)18)20(32)33-11-13-6-15(21(23,24)25)9-16(7-13)22(26,27)28/h2-7,9-10,19,29H,8,11H2,1H3,(H,30,31)/t19-/m0/s1 D08ZBV DRUGINKE BYYQYXVAWXAYQC-IBGZPJMESA-N D08ZBV DRUGSMIL CC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D08ZBV HIGHSTAT Terminated D09AAM DRUG__ID D09AAM D09AAM DRUGTYPE Small molecular drug D09AAM DRUGINCH 1S/C34H55NO3/c1-4-5-22-35(3)32(38)15-13-11-9-7-6-8-10-12-14-25-23-26-24-27(36)16-17-28(26)29-20-21-34(2)30(33(25)29)18-19-31(34)37/h16-17,24-25,29-31,33,36-37H,4-15,18-23H2,1-3H3/t25-,29-,30+,31+,33-,34+/m1/s1 D09AAM DRUGINKE BVVFOLSZMQVDKV-KXQIQQEYSA-N D09AAM DRUGSMIL CCCCN(C)C(=O)CCCCCCCCCCC1CC2=C(C=CC(=C2)O)C3C1C4CCC(C4(CC3)C)O D09AAM HIGHSTAT Terminated D09BHA DRUG__ID D09BHA D09BHA DRUGCOMP Eli Lilly & Co Ltd D09BHA DRUGINCH 1S/C29H41N5O2/c1-19(2)34-25-6-4-3-5-24(25)26(32-34)27(35)30-9-12-33-10-7-23(8-11-33)31-28(36)29-16-20-13-21(17-29)15-22(14-20)18-29/h3-6,19-23H,7-18H2,1-2H3,(H,30,35)(H,31,36) D09BHA DRUGINKE QEZYDSSGVBTNBH-UHFFFAOYSA-N D09BHA DRUGSMIL CC(C)N1C2=CC=CC=C2C(=N1)C(=O)NCCN3CCC(CC3)NC(=O)C45CC6CC(C4)CC(C6)C5 D09BHA HIGHSTAT Terminated D09DLN DRUG__ID D09DLN D09DLN DRUGTYPE Small molecular drug D09DLN DRUGINCH 1S/C24H41N3O6S2/c1-5-17(2)21(26-14-19(25)16-34)15-33-22(13-18-9-7-6-8-10-18)23(28)27-20(24(29)32-3)11-12-35(4,30)31/h6-10,17,19-22,26,34H,5,11-16,25H2,1-4H3,(H,27,28)/t17-,19+,20-,21+,22-/m0/s1 D09DLN DRUGINKE XDPAYLCHZOZGMW-NDYOWHOSSA-N D09DLN DRUGSMIL CCC(C)C(COC(CC1=CC=CC=C1)C(=O)NC(CCS(=O)(=O)C)C(=O)OC)NCC(CS)N D09DLN HIGHSTAT Terminated D09EBJ DRUG__ID D09EBJ D09EBJ DRUGCOMP Microcide Pharmaceuticals Inc D09EBJ DRUGINCH 1S/C20H25N7O4S4/c21-19(22)25-5-6-32-9-13(28)26-14-16(29)27-15(18(30)31)12(8-33-17(14)27)35-11-4-2-1-3-10(11)7-34-20(23)24/h1-4,14,17H,5-9H2,(H3,23,24)(H,26,28)(H,30,31)(H4,21,22,25)/t14-,17-/m1/s1 D09EBJ DRUGINKE AMKVWBHXJRHCAZ-RHSMWYFYSA-N D09EBJ DRUGSMIL C1C(=C(N2C(S1)C(C2=O)NC(=O)CSCCN=C(N)N)C(=O)O)SC3=CC=CC=C3CSC(=N)N D09EBJ HIGHSTAT Terminated D09FQB DRUG__ID D09FQB D09FQB DRUGCOMP Grupo Uriach D09FQB DRUGINCH 1S/C27H29N5O/c1-21-24(13-8-14-29-21)25(19-28)31-15-17-32(18-16-31)26(33)20-30-27(22-9-4-2-5-10-22)23-11-6-3-7-12-23/h2-14,25,27,30H,15-18,20H2,1H3 D09FQB DRUGINKE RJKFZZBPTCGMAY-UHFFFAOYSA-N D09FQB DRUGSMIL CC1=C(C=CC=N1)C(C#N)N2CCN(CC2)C(=O)CNC(C3=CC=CC=C3)C4=CC=CC=C4 D09FQB HIGHSTAT Terminated D09ICC DRUG__ID D09ICC D09ICC DRUGTYPE Small molecular drug D09ICC DRUGINCH 1S/C18H19FN6/c19-13-3-1-12(2-4-13)16-17(15-7-10-22-18(20)24-15)25(11-23-16)14-5-8-21-9-6-14/h1-4,7,10-11,14,21H,5-6,8-9H2,(H2,20,22,24) D09ICC DRUGINKE VSPFURGQAYMVAN-UHFFFAOYSA-N D09ICC DRUGSMIL C1CNCCC1N2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F D09ICC HIGHSTAT Terminated D09OTF DRUG__ID D09OTF D09OTF DRUGCOMP Acea Pharmaceuticals Inc D09OTF DRUGINCH 1S/C8H3Br2N3O4/c9-2-1-3-5(6(4(2)10)13(16)17)12-8(15)7(14)11-3/h1H,(H,11,14)(H,12,15) D09OTF DRUGINKE HPDZNXVZXICVSF-UHFFFAOYSA-N D09OTF DRUGSMIL C1=C2C(=C(C(=C1Br)Br)[N+](=O)[O-])NC(=O)C(=O)N2 D09OTF HIGHSTAT Terminated D09QRO DRUG__ID D09QRO D09QRO DRUGTYPE Small molecular drug D09QRO DRUGINCH 1S/C13H16N2O2/c16-13(17)8-3-1-2-5-11-6-4-7-12-9-14-10-15(11)12/h4,6-7,9-10H,1-3,5,8H2,(H,16,17) D09QRO DRUGINKE LIFOFTJHFFTNRV-UHFFFAOYSA-N D09QRO DRUGSMIL C1=CC2=CN=CN2C(=C1)CCCCCC(=O)O D09QRO HIGHSTAT Terminated D09TED DRUG__ID D09TED D09TED DRUGTYPE Small molecular drug D09TED DRUGINCH 1S/C31H33F3N4O5S/c1-5-6-15-27-35-38(25-13-9-8-12-24(25)31(32,33)34)29(40)37(27)20-21-16-18-22(19-17-21)23-11-7-10-14-26(23)44(41,42)36-28(39)43-30(2,3)4/h7-14,16-19H,5-6,15,20H2,1-4H3,(H,36,39) D09TED DRUGINKE IVFMKMCSJZZCKV-UHFFFAOYSA-N D09TED DRUGSMIL CCCCC1=NN(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3S(=O)(=O)NC(=O)OC(C)(C)C)C4=CC=CC=C4C(F)(F)F D09TED HIGHSTAT Terminated D09UMA DRUG__ID D09UMA D09UMA DRUGTYPE Small molecular drug D09UMA DRUGINCH 1S/C13H12N4O/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17/h1-4,7-9H,5-6H2,(H,16,18) D09UMA DRUGINKE VXMYWVMXSWJFCV-UHFFFAOYSA-N D09UMA DRUGSMIL C1CC(=O)NN=C1C2=CC=C(C=C2)N3C=CN=C3 D09UMA HIGHSTAT Terminated D09WPN DRUG__ID D09WPN D09WPN DRUGTYPE Small molecular drug D09WPN DRUGINCH 1S/C30H41N3O10P2/c1-18(34)32-25(13-20-11-12-27(44(37,38)39)28(14-20)45(40,41)42)30(36)33-24-10-6-5-9-21-15-26(23(29(31)35)16-22(21)24)43-17-19-7-3-2-4-8-19/h11-12,14-16,19,24-25H,2-10,13,17H2,1H3,(H2,31,35)(H,32,34)(H,33,36)(H2,37,38,39)(H2,40,41,42)/t24-,25-/m0/s1 D09WPN DRUGINKE SPSGYTWOIGAABK-DQEYMECFSA-N D09WPN DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)P(=O)(O)O)P(=O)(O)O)C(=O)NC2CCCCC3=CC(=C(C=C23)C(=O)N)OCC4CCCCC4 D09WPN HIGHSTAT Terminated D09XXW DRUG__ID D09XXW D09XXW DRUGCOMP Purdue Neuroscience Corp D09XXW DRUGINCH 1S/C35H44O7.Na/c1-22(36)24-6-4-23(5-7-24)14-17-35(41)19-18-33(2)25(20-35)8-9-26-27-10-11-29(34(27,3)16-15-28(26)33)30(37)21-42-32(40)13-12-31(38)39;/h4-7,25-29,41H,8-13,15-16,18-21H2,1-3H3,(H,38,39);/q;+1/p-1/t25-,26+,27+,28+,29-,33+,34+,35-;/m1./s1 D09XXW DRUGINKE CVQVSNULXHBAIN-HGNHJUIHSA-M D09XXW DRUGSMIL CC(=O)C1=CC=C(C=C1)C#CC2(CCC3(C(C2)CCC4C3CCC5(C4CCC5C(=O)COC(=O)CCC(=O)[O-])C)C)O.[Na+] D09XXW HIGHSTAT Terminated D0A3HF DRUG__ID D0A3HF D0A3HF DRUGCOMP Sterling Winthrop Products Inc D0A3HF DRUGINCH 1S/C28H31Cl2N3O9/c1-15(2)24(33-28(40)42-13-17-8-5-4-6-9-17)26(38)31-16(3)25(37)32-20(12-22(35)36)21(34)14-41-27(39)23-18(29)10-7-11-19(23)30/h4-11,15-16,20,24H,12-14H2,1-3H3,(H,31,38)(H,32,37)(H,33,40)(H,35,36)/t16-,20+,24-/m0/s1 D0A3HF DRUGINKE DFQKZFFVISYVDA-GANZUKCXSA-N D0A3HF DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)COC(=O)C1=C(C=CC=C1Cl)Cl)NC(=O)OCC2=CC=CC=C2 D0A3HF HIGHSTAT Terminated D0A4RM DRUG__ID D0A4RM D0A4RM DRUGTYPE Small molecular drug D0A4RM DRUGINCH 1S/C10H13ClN4.2ClH/c11-9-3-4-10(14-13-9)15-5-7-1-2-8(6-15)12-7;;/h3-4,7-8,12H,1-2,5-6H2;2*1H D0A4RM DRUGINKE FMBGHZXNKMHVDT-UHFFFAOYSA-N D0A4RM DRUGSMIL C1CC2CN(CC1N2)C3=NN=C(C=C3)Cl.Cl.Cl D0A4RM HIGHSTAT Terminated D0A9VO DRUG__ID D0A9VO D0A9VO DRUGTYPE Small molecular drug D0A9VO DRUGINCH 1S/C17H15N3O2/c1-10-6-12-7-15-16(22-9-21-15)8-14(12)17(20-19-10)11-2-4-13(18)5-3-11/h2-5,7-8H,6,9,18H2,1H3 D0A9VO DRUGINKE LFBZZHVSGAHQPP-UHFFFAOYSA-N D0A9VO DRUGSMIL CC1=NN=C(C2=CC3=C(C=C2C1)OCO3)C4=CC=C(C=C4)N D0A9VO HIGHSTAT Terminated D0AB7G DRUG__ID D0AB7G D0AB7G DRUGTYPE Small molecular drug D0AB7G DRUGINCH 1S/C22H28N2O3S/c1-5-22(6-2,21(26)27)13-19(25)23-17-9-7-8-16(12-17)10-11-20-24-18(14-28-20)15(3)4/h7-12,14-15H,5-6,13H2,1-4H3,(H,23,25)(H,26,27)/b11-10+ D0AB7G DRUGINKE PGLNVMJTDKEOBE-ZHACJKMWSA-N D0AB7G DRUGSMIL CCC(CC)(CC(=O)NC1=CC=CC(=C1)C=CC2=NC(=CS2)C(C)C)C(=O)O D0AB7G HIGHSTAT Terminated D0B4BN DRUG__ID D0B4BN D0B4BN DRUGTYPE Small molecular drug D0B4BN DRUGINCH 1S/C11H12ClFN2/c1-7(14)6-15-3-2-8-4-10(13)9(12)5-11(8)15/h2-5,7H,6,14H2,1H3/t7-/m0/s1 D0B4BN DRUGINKE XJJZQXUGLLXTHO-ZETCQYMHSA-N D0B4BN DRUGSMIL CC(CN1C=CC2=CC(=C(C=C21)Cl)F)N D0B4BN HIGHSTAT Terminated D0B4CO DRUG__ID D0B4CO D0B4CO DRUGCOMP Novo Nordisk A/S D0B4CO DRUGINCH 1S/C20H18FN5O2/c21-13-2-1-3-15-17(13)19(25-6-8-27-9-7-25)23-20-18(22-11-26(15)20)16-10-14(24-28-16)12-4-5-12/h1-3,10-12H,4-9H2 D0B4CO DRUGINKE LTGJBZSFPNAUIP-UHFFFAOYSA-N D0B4CO DRUGSMIL C1CC1C2=NOC(=C2)C3=C4N=C(C5=C(N4C=N3)C=CC=C5F)N6CCOCC6 D0B4CO HIGHSTAT Terminated D0B5HA DRUG__ID D0B5HA D0B5HA DRUGCOMP Isis Pharmaceuticals Inc D0B5HA DRUGINCH 1S/C80H101N28O43P7S7/c1-29-13-101(77(119)97-65(29)111)49-5-33(110)42(138-49)18-130-152(123,159)146-35-7-51(103-15-31(3)67(113)99-79(103)121)140-44(35)20-132-155(126,162)148-37-9-53(105-25-85-57-61(105)89-73(81)93-69(57)115)142-46(37)22-134-157(128,164)150-39-11-55(107-27-87-59-63(107)91-75(83)95-71(59)117)144-48(39)24-136-158(129,165)151-40-12-56(108-28-88-60-64(108)92-76(84)96-72(60)118)143-47(40)23-135-156(127,163)149-38-10-54(106-26-86-58-62(106)90-74(82)94-70(58)116)141-45(38)21-133-154(125,161)147-36-8-52(104-16-32(4)68(114)100-80(104)122)139-43(36)19-131-153(124,160)145-34-6-50(137-41(34)17-109)102-14-30(2)66(112)98-78(102)120/h13-16,25-28,33-56,109-110H,5-12,17-24H2,1-4H3,(H,123,159)(H,124,160)(H,125,161)(H,126,162)(H,127,163)(H,128,164)(H,129,165)(H,97,111,119)(H,98,112,120)(H,99,113,121)(H,100,114,122)(H3,81,89,93,115)(H3,82,90,94,116)(H3,83,91,95,117)(H3,84,92,96,118) D0B5HA DRUGINKE VMYSGODVFYYRAW-UHFFFAOYSA-N D0B5HA DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=O)(OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9CO)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O D0B5HA HIGHSTAT Terminated D0B8NW DRUG__ID D0B8NW D0B8NW DRUGCOMP AlumiFuel Power Corp D0B8NW DRUGINCH 1S/C10H17N4O7P/c11-9-6(10(12)17)13-3-14(9)5-1-4(7(15)8(5)16)2-21-22(18,19)20/h3-5,7-8,15-16H,1-2,11H2,(H2,12,17)(H2,18,19,20)/t4-,5-,7-,8+/m0/s1 D0B8NW DRUGINKE VFGPDCAAUMRRSL-BKMCOVHNSA-N D0B8NW DRUGSMIL C1C(C(C(C1N2C=NC(=C2N)C(=O)N)O)O)COP(=O)(O)O D0B8NW HIGHSTAT Terminated D0BC6Q DRUG__ID D0BC6Q D0BC6Q DRUGTYPE Small molecular drug D0BC6Q DRUGINCH 1S/C12H16N4O/c1-8-9(16-12-14-4-5-15-12)2-3-10-11(8)13-6-7-17-10/h2-3,13H,4-7H2,1H3,(H2,14,15,16) D0BC6Q DRUGINKE OSJZLDGTMVBIRV-UHFFFAOYSA-N D0BC6Q DRUGSMIL CC1=C(C=CC2=C1NCCO2)NC3=NCCN3 D0BC6Q HIGHSTAT Terminated D0BD3U DRUG__ID D0BD3U D0BD3U DRUGTYPE Small molecular drug D0BD3U DRUGINCH 1S/C28H28N2O3/c1-31-25-16-20(17-26(32-2)27(25)33-3)9-8-19-10-12-21(13-11-19)24-18-22-6-4-5-7-23(22)28-29-14-15-30(24)28/h4-7,10-13,16-18H,8-9,14-15H2,1-3H3 D0BD3U DRUGINKE FKRBSORUVOGNEK-UHFFFAOYSA-N D0BD3U DRUGSMIL COC1=CC(=CC(=C1OC)OC)CCC2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35 D0BD3U HIGHSTAT Terminated D0BM3R DRUG__ID D0BM3R D0BM3R DRUGCOMP Eli Lilly & Co D0BM3R DRUGINCH 1S/C58H74N7O19P.Na/c1-5-6-7-24-84-39-20-16-35(17-21-39)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(73)59-41-26-43(69)54(76)63-56(78)47-48(70)29(2)27-65(47)58(80)45(31(4)67)61-55(77)46(50(72)49(71)36-18-22-40(23-19-36)85(81,82)83)62-53(75)42-25-38(68)28-64(42)57(79)44(30(3)66)60-52(41)74;/h8-23,29-31,38,41-50,54,66-72,76H,5-7,24-28H2,1-4H3,(H,59,73)(H,60,74)(H,61,77)(H,62,75)(H,63,78)(H2,81,82,83);/q;+1/p-1/t29-,30+,31+,38+,41+,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+;/m0./s1 D0BM3R DRUGINKE AMJZIRXAMIVVNS-PWPJTPCMSA-M D0BM3R DRUGSMIL CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(N=C4[O-])C(C)O)O)C(C(C7=CC=C(C=C7)[P+](O)(O)[O-])O)O)C(C)O)C)O)O)O.[Na+] D0BM3R HIGHSTAT Terminated D0BU5Z DRUG__ID D0BU5Z D0BU5Z DRUGCOMP Biosearch Italia SpA D0BU5Z DRUGINCH 1S/C41H46N10O8S/c1-6-26-37(55)46-22(3)41(58)51(4)19-34(53)45-21(2)40-50-31(20-60-40)39(57)49-30(14-23-16-42-27-11-8-7-10-25(23)27)38(56)48-29(36(54)44-18-33(52)47-26)15-24-17-43-28-12-9-13-32(59-5)35(24)28/h7-13,16-17,20-21,26,29-30,42-43H,3,6,14-15,18-19H2,1-2,4-5H3,(H,44,54)(H,45,53)(H,46,55)(H,47,52)(H,48,56)(H,49,57)/t21-,26-,29+,30+/m1/s1 D0BU5Z DRUGINKE OVJDNZFLEREPKG-VPMCBBNJSA-N D0BU5Z DRUGSMIL CCC1C(=O)NC(=C)C(=O)N(CC(=O)NC(C2=NC(=CS2)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CC3=CNC4=C3C(=CC=C4)OC)CC5=CNC6=CC=CC=C65)C)C D0BU5Z HIGHSTAT Terminated D0C0JT DRUG__ID D0C0JT D0C0JT DRUGTYPE Small molecular drug D0C0JT DRUGINCH 1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3 D0C0JT DRUGINKE HYWYRSMBCFDLJT-UHFFFAOYSA-N D0C0JT DRUGSMIL CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2 D0C0JT HIGHSTAT Terminated D0C2UY DRUG__ID D0C2UY D0C2UY DRUGTYPE Small molecular drug D0C2UY DRUGINCH 1S/C31H38N2O7/c1-5-6-11-19(2)16-20(3)17-21(4)30(38)32-22-18-31(39,29-28(40-29)27(22)37)15-10-8-7-9-12-25(36)33-26-23(34)13-14-24(26)35/h7-10,12,15-19,28-29,34,39H,5-6,11,13-14H2,1-4H3,(H,32,38)(H,33,36)/b8-7+,12-9+,15-10+,20-16+,21-17+/t19-,28-,29-,31+/m1/s1 D0C2UY DRUGINKE TWWQHCKLTXDWBD-MVTGTTCWSA-N D0C2UY DRUGSMIL CCCCC(C)C=C(C)C=C(C)C(=O)NC1=CC(C2C(C1=O)O2)(C=CC=CC=CC(=O)NC3=C(CCC3=O)O)O D0C2UY HIGHSTAT Terminated D0C3TE DRUG__ID D0C3TE D0C3TE DRUGCOMP Teijin Institute for Biomedical Research D0C3TE DRUGINCH 1S/C31H29NO5/c33-30(32-29-9-5-4-8-28(29)31(34)35)18-21-10-14-25(15-11-21)37-27-17-13-22-19-26(16-12-23(22)20-27)36-24-6-2-1-3-7-24/h4-5,8-17,19-20,24H,1-3,6-7,18H2,(H,32,33)(H,34,35) D0C3TE DRUGINKE XNTHZBOCPVDIQB-UHFFFAOYSA-N D0C3TE DRUGSMIL C1CCC(CC1)OC2=CC3=C(C=C2)C=C(C=C3)OC4=CC=C(C=C4)CC(=O)NC5=CC=CC=C5C(=O)O D0C3TE HIGHSTAT Terminated D0C4YF DRUG__ID D0C4YF D0C4YF DRUGCOMP Takeda Pharmaceutical Co Ltd D0C4YF DRUGINCH 1S/C39H41NO15/c1-6-15(2)36(49)54-31-16(3)53-24(14-23(31)42)18-11-12-19-25(28(18)43)29(44)26-20(38(19,4)52-5)13-21-32(55-37(50)17-9-7-8-10-22(17)41)30(45)27(35(40)48)34(47)39(21,51)33(26)46/h6-12,16,20-21,23-24,31-32,41-44,47,51H,13-14H2,1-5H3,(H2,40,48)/b15-6+ D0C4YF DRUGINKE SNWJINGOFNDVIF-GIDUJCDVSA-N D0C4YF DRUGSMIL CC=C(C)C(=O)OC1C(OC(CC1O)C2=C(C3=C(C=C2)C(C4CC5C(C(=O)C(=C(C5(C(=O)C4=C3O)O)O)C(=O)N)OC(=O)C6=CC=CC=C6O)(C)OC)O)C D0C4YF HIGHSTAT Terminated D0C5DM DRUG__ID D0C5DM D0C5DM DRUGCOMP GD Searle & Co D0C5DM DRUGINCH 1S/C6H8BNO2.ClH/c8-6-3-1-5(2-4-6)7(9)10;/h1-4,9-10H,8H2;1H D0C5DM DRUGINKE QBYGJJSFMOVYOA-UHFFFAOYSA-N D0C5DM DRUGSMIL B(C1=CC=C(C=C1)N)(O)O.Cl D0C5DM HIGHSTAT Terminated D0C5YQ DRUG__ID D0C5YQ D0C5YQ DRUGCOMP Novartis AG D0C5YQ DRUGINCH 1S/C27H58NO6P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-23-32-25-27(31-5)26-34-35(29,30)33-24-22-28(2,3)4/h27H,6-26H2,1-5H3/p+1 D0C5YQ DRUGINKE MHFRGQHAERHWKZ-UHFFFAOYSA-O D0C5YQ DRUGSMIL CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC D0C5YQ HIGHSTAT Terminated D0C7FN DRUG__ID D0C7FN D0C7FN DRUGTYPE Small molecular drug D0C7FN DRUGINCH 1S/C18H21FN4O3/c1-18(2,3)23-8-12(17(25)26)14(24)11-5-13(19)16(21-15(11)23)22-7-9-4-10(22)6-20-9/h5,8-10,20H,4,6-7H2,1-3H3,(H,25,26)/t9-,10-/m1/s1 D0C7FN DRUGINKE KNHLHFDFFDCJJR-NXEZZACHSA-N D0C7FN DRUGSMIL CC(C)(C)N1C=C(C(=O)C2=CC(=C(N=C21)N3CC4CC3CN4)F)C(=O)O D0C7FN HIGHSTAT Terminated D0C7RV DRUG__ID D0C7RV D0C7RV DRUGTYPE Small molecular drug D0C7RV DRUGINCH 1S/C24H42O7P2/c1-11-28-32(26,29-12-2)21(33(27,30-13-3)31-14-4)17-18-15-19(23(5,6)7)22(25)20(16-18)24(8,9)10/h15-17,25H,11-14H2,1-10H3 D0C7RV DRUGINKE YQLJDECYQDRSBI-UHFFFAOYSA-N D0C7RV DRUGSMIL CCOP(=O)(C(=CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)P(=O)(OCC)OCC)OCC D0C7RV HIGHSTAT Terminated D0C9KD DRUG__ID D0C9KD D0C9KD DRUGTYPE Small molecular drug D0C9KD DRUGINCH 1S/C12H15ClN2/c13-12-5-4-8(7-14-12)10-6-9-2-1-3-11(10)15-9/h4-5,7,9-11,15H,1-3,6H2 D0C9KD DRUGINKE GDSORCYTZJIZHU-UHFFFAOYSA-N D0C9KD DRUGSMIL C1CC2CC(C(C1)N2)C3=CN=C(C=C3)Cl D0C9KD HIGHSTAT Terminated D0D0WF DRUG__ID D0D0WF D0D0WF DRUGTYPE Small molecular drug D0D0WF DRUGINCH 1S/C27H33N3O3S/c1-17(2)13-25(27(32)33-3)30-26(31)23-12-11-20(29-15-19(28)16-34)14-24(23)22-10-6-8-18-7-4-5-9-21(18)22/h4-12,14,17,19,25,29,34H,13,15-16,28H2,1-3H3,(H,30,31)/t19-,25+/m1/s1 D0D0WF DRUGINKE XVWPFYDMUFBHBF-CLOONOSVSA-N D0D0WF DRUGSMIL CC(C)CC(C(=O)OC)NC(=O)C1=C(C=C(C=C1)NCC(CS)N)C2=CC=CC3=CC=CC=C32 D0D0WF HIGHSTAT Terminated D0D1GV DRUG__ID D0D1GV D0D1GV DRUGCOMP CeNeS Pharmaceuticals Inc D0D1GV DRUGINCH 1S/C24H21N3O/c1-28-22-14-13-20(17-6-2-3-7-18(17)22)26-24(25)27-21-12-11-16-10-9-15-5-4-8-19(21)23(15)16/h2-8,11-14H,9-10H2,1H3,(H3,25,26,27) D0D1GV DRUGINKE AZZRFSWIWLKNLQ-UHFFFAOYSA-N D0D1GV DRUGSMIL COC1=CC=C(C2=CC=CC=C21)NC(=NC3=CC=C4CCC5=C4C3=CC=C5)N D0D1GV HIGHSTAT Terminated D0D2PQ DRUG__ID D0D2PQ D0D2PQ DRUGCOMP Cell Therapeutics Inc D0D2PQ DRUGINCH 1S/C25H26ClNO2/c1-28-24-11-8-20(17-25(24)29-22-4-2-3-5-22)23(16-18-12-14-27-15-13-18)19-6-9-21(26)10-7-19/h6-15,17,22-23H,2-5,16H2,1H3/t23-/m1/s1 D0D2PQ DRUGINKE PUMZWWFKADZJCP-HSZRJFAPSA-N D0D2PQ DRUGSMIL COC1=C(C=C(C=C1)C(CC2=CC=NC=C2)C3=CC=C(C=C3)Cl)OC4CCCC4 D0D2PQ HIGHSTAT Terminated D0D8MD DRUG__ID D0D8MD D0D8MD DRUGTYPE Small molecular drug D0D8MD DRUGINCH 1S/C24H26FNO4/c1-3-26-22-6-4-17(12-18(22)5-7-23(26)27)16-30-21-14-19(13-20(25)15-21)24(28-2)8-10-29-11-9-24/h4-7,12-15H,3,8-11,16H2,1-2H3 D0D8MD DRUGINKE ZROVOGSXAWNIQB-UHFFFAOYSA-N D0D8MD DRUGSMIL CCN1C2=C(C=CC1=O)C=C(C=C2)COC3=CC(=CC(=C3)C4(CCOCC4)OC)F D0D8MD HIGHSTAT Terminated D0DM5A DRUG__ID D0DM5A D0DM5A DRUGTYPE Small molecular drug D0DM5A DRUGINCH 1S/C29H36F2N2O3/c1-32(16-17-33(2)20-21-18-27(34-3)29(36-5)28(19-21)35-4)15-14-26(22-6-10-24(30)11-7-22)23-8-12-25(31)13-9-23/h6-13,18-19,26H,14-17,20H2,1-5H3 D0DM5A DRUGINKE NOMSFNRBXCWAIE-UHFFFAOYSA-N D0DM5A DRUGSMIL CN(CCC(C1=CC=C(C=C1)F)C2=CC=C(C=C2)F)CCN(C)CC3=CC(=C(C(=C3)OC)OC)OC D0DM5A HIGHSTAT Terminated D0DN1I DRUG__ID D0DN1I D0DN1I DRUGCOMP Japan Tobacco Inc D0DN1I DRUGINCH 1S/C34H43N3O3S2/c1-6-8-25(9-7-2)26-14-16-28(17-15-26)40-22-24-10-12-27(13-11-24)29-23-41-32(36-29)20-37(21-33(38)39)19-31-35-18-30(42-31)34(3,4)5/h10-18,23,25H,6-9,19-22H2,1-5H3,(H,38,39) D0DN1I DRUGINKE FKGBFRNVTCFMGU-UHFFFAOYSA-N D0DN1I DRUGSMIL CCCC(CCC)C1=CC=C(C=C1)OCC2=CC=C(C=C2)C3=CSC(=N3)CN(CC4=NC=C(S4)C(C)(C)C)CC(=O)O D0DN1I HIGHSTAT Terminated D0DP8P DRUG__ID D0DP8P D0DP8P DRUGTYPE Small molecular drug D0DP8P DRUGINCH 1S/C10H10F3N3/c11-10(12,13)7-2-1-3-8(6-7)16-5-4-9(14)15-16/h1-3,6H,4-5H2,(H2,14,15) D0DP8P DRUGINKE CPXGGWXJNQSFEP-UHFFFAOYSA-N D0DP8P DRUGSMIL C1CN(N=C1N)C2=CC=CC(=C2)C(F)(F)F D0DP8P HIGHSTAT Terminated D0DX6L DRUG__ID D0DX6L D0DX6L DRUGCOMP Sandoz Pharma Ltd D0DX6L DRUGINCH 1S/C20H23ClN2O/c1-13-10-15(21)6-7-17(13)23-9-8-22(2)18-11-14-4-3-5-20(24)16(14)12-19(18)23/h3-7,10,18-19,24H,8-9,11-12H2,1-2H3/t18-,19-/m1/s1 D0DX6L DRUGINKE VCFAZLUWIBQVRD-RTBURBONSA-N D0DX6L DRUGSMIL CC1=C(C=CC(=C1)Cl)N2CCN(C3C2CC4=C(C3)C=CC=C4O)C D0DX6L HIGHSTAT Terminated D0E0GW DRUG__ID D0E0GW D0E0GW DRUGCOMP Swedish Orphan Biovitrum AB D0E0GW DRUGINCH 1S/C16H18ClN3O4S2/c1-11-13(17)3-2-4-14(11)26(22,23)19-16-18-12(10-25-16)5-6-20-7-8-24-9-15(20)21/h2-4,10H,5-9H2,1H3,(H,18,19) D0E0GW DRUGINKE WZFZJEPHYDDFCT-UHFFFAOYSA-N D0E0GW DRUGSMIL CC1=C(C=CC=C1Cl)S(=O)(=O)NC2=NC(=CS2)CCN3CCOCC3=O D0E0GW HIGHSTAT Terminated D0E1WY DRUG__ID D0E1WY D0E1WY DRUGTYPE Small molecular drug D0E1WY DRUGINCH 1S/C40H35Cl3N2O4S/c41-32-19-21-37-34(25-32)33(13-7-8-27-14-17-31(18-15-27)40(46)47)38(22-23-44-50(48,49)26-28-16-20-35(42)36(43)24-28)45(37)39(29-9-3-1-4-10-29)30-11-5-2-6-12-30/h1-6,9-12,14-21,24-25,39,44H,7-8,13,22-23,26H2,(H,46,47) D0E1WY DRUGINKE HIZOPJQOPKRKFM-UHFFFAOYSA-N D0E1WY DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)N3C4=C(C=C(C=C4)Cl)C(=C3CCNS(=O)(=O)CC5=CC(=C(C=C5)Cl)Cl)CCCC6=CC=C(C=C6)C(=O)O D0E1WY HIGHSTAT Terminated D0E2CO DRUG__ID D0E2CO D0E2CO DRUGTYPE Small molecular drug D0E2CO DRUGINCH 1S/C23H20F2N4O3/c1-29-23(26-27-28-29)20(11-10-19-12-18(30)13-21(31)32-19)22(14-2-6-16(24)7-3-14)15-4-8-17(25)9-5-15/h2-11,18-19,30H,12-13H2,1H3/b11-10+/t18-,19-/m1/s1 D0E2CO DRUGINKE VIMMECPCYZXUCI-MMKWGKFASA-N D0E2CO DRUGSMIL CN1C(=NN=N1)C(=C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C=CC4CC(CC(=O)O4)O D0E2CO HIGHSTAT Terminated D0E3UM DRUG__ID D0E3UM D0E3UM DRUGTYPE Small molecular drug D0E3UM DRUGINCH 1S/C21H21ClFNO2/c22-15-6-4-13(5-7-15)12-24-19-9-8-16(23)11-18(19)17-3-1-2-14(21(17)24)10-20(25)26/h4-9,11,14,17,21H,1-3,10,12H2,(H,25,26) D0E3UM DRUGINKE USFMJLOJQLMDAA-UHFFFAOYSA-N D0E3UM DRUGSMIL C1CC(C2C(C1)C3=C(N2CC4=CC=C(C=C4)Cl)C=CC(=C3)F)CC(=O)O D0E3UM HIGHSTAT Terminated D0E4RG DRUG__ID D0E4RG D0E4RG DRUGCOMP NicOx SA D0E4RG DRUGINCH 1S/C14H17NO7/c1-11(16)22-13-8-4-3-7-12(13)14(17)20-9-5-2-6-10-21-15(18)19/h3-4,7-8H,2,5-6,9-10H2,1H3 D0E4RG DRUGINKE XURBPQKAHCNAOM-UHFFFAOYSA-N D0E4RG DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)OCCCCCO[N+](=O)[O-] D0E4RG HIGHSTAT Terminated D0E4WF DRUG__ID D0E4WF D0E4WF DRUGTYPE Small molecular drug D0E4WF DRUGINCH 1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1 D0E4WF DRUGINKE WUUGFSXJNOTRMR-IOSLPCCCSA-N D0E4WF DRUGSMIL CSCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0E4WF HIGHSTAT Terminated D0E5GY DRUG__ID D0E5GY D0E5GY DRUGTYPE Small molecular drug D0E5GY DRUGINCH 1S/C15H29N3O4/c1-9(2)7-10(8-11(19)18-22)13(20)17-12(14(21)16-6)15(3,4)5/h9-10,12,22H,7-8H2,1-6H3,(H,16,21)(H,17,20)(H,18,19)/t10-,12-/m1/s1 D0E5GY DRUGINKE QRXOZHSEEGNRFC-ZYHUDNBSSA-N D0E5GY DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)NC)C(C)(C)C D0E5GY HIGHSTAT Terminated D0E6LC DRUG__ID D0E6LC D0E6LC DRUGTYPE Small molecular drug D0E6LC DRUGINCH 1S/C18H11F3N2O3S2/c1-7-3-2-4-10-15(7)23(17(26)11(27-10)6-12(24)25)18-22-14-13(21)8(19)5-9(20)16(14)28-18/h2-5,11H,6H2,1H3,(H,24,25) D0E6LC DRUGINKE ZVSDXQXCVBUOHA-UHFFFAOYSA-N D0E6LC DRUGSMIL CC1=C2C(=CC=C1)SC(C(=O)N2C3=NC4=C(C(=CC(=C4S3)F)F)F)CC(=O)O D0E6LC HIGHSTAT Terminated D0E6OA DRUG__ID D0E6OA D0E6OA DRUGTYPE Small molecular drug D0E6OA DRUGINCH 1S/C24H31NO3/c1-26-23-8-7-20(17-24(23)27-2)18-9-13-25(14-10-18)15-11-19-12-16-28-22-6-4-3-5-21(19)22/h3-8,17-19H,9-16H2,1-2H3/t19-/m0/s1 D0E6OA DRUGINKE UIZPEXQHMIZQPQ-IBGZPJMESA-N D0E6OA DRUGSMIL COC1=C(C=C(C=C1)C2CCN(CC2)CCC3CCOC4=CC=CC=C34)OC D0E6OA HIGHSTAT Terminated D0E8KS DRUG__ID D0E8KS D0E8KS DRUGTYPE Small molecular drug D0E8KS DRUGINCH 1S/C16H20N2O2/c19-16(20-11-10-18-8-4-1-5-9-18)14-12-17-15-7-3-2-6-13(14)15/h2-3,6-7,12,17H,1,4-5,8-11H2 D0E8KS DRUGINKE YGKPIROTKVQCCU-UHFFFAOYSA-N D0E8KS DRUGSMIL C1CCN(CC1)CCOC(=O)C2=CNC3=CC=CC=C32 D0E8KS HIGHSTAT Terminated D0E8SE DRUG__ID D0E8SE D0E8SE DRUGCOMP Burroughs Wellcome Inc D0E8SE DRUGINCH 1S/C31H42N10O8/c32-22(15-18-7-11-21(42)12-8-18)28(45)39-23(3-1-13-36-31(34)35)29(46)37-17-26(43)38-24(16-19-5-9-20(10-6-19)41(48)49)30(47)40-14-2-4-25(40)27(33)44/h5-12,22-25H,1-4,13-17,32H2,(H10,33,34,35,36,37,38,39,42,43,44,45,46)/t22-,23+,24+,25+/m1/s1 D0E8SE DRUGINKE CQEKFKUITZRTPQ-ROHNOIKCSA-N D0E8SE DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CNC(=O)C(CCCN=C(N)[NH-])NC(=O)C(CC3=CC=C(C=C3)O)[NH3+])C(=O)N D0E8SE HIGHSTAT Terminated D0EF7V DRUG__ID D0EF7V D0EF7V DRUGTYPE Small molecular drug D0EF7V DRUGINCH 1S/C19H35N3O6/c1-7-28-19(26)13(6)20-18(25)15(9-12(4)5)21-17(24)14(8-11(2)3)10-16(23)22-27/h11-15,27H,7-10H2,1-6H3,(H,20,25)(H,21,24)(H,22,23)/t13-,14+,15-/m0/s1 D0EF7V DRUGINKE XKRONJXEXGFBRZ-ZNMIVQPWSA-N D0EF7V DRUGSMIL CCOC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)CC(=O)NO D0EF7V HIGHSTAT Terminated D0EH2O DRUG__ID D0EH2O D0EH2O DRUGCOMP Boehringer Ingelheim Corp D0EH2O DRUGINCH 1S/C25H27FN2O2/c1-30-22-10-11-24-23(15-22)20(16-27-24)14-18-4-2-12-28(17-18)13-3-5-25(29)19-6-8-21(26)9-7-19/h4,6-11,15-16,27H,2-3,5,12-14,17H2,1H3 D0EH2O DRUGINKE CIPFPNCFILKTBF-UHFFFAOYSA-N D0EH2O DRUGSMIL COC1=CC2=C(C=C1)NC=C2CC3=CCCN(C3)CCCC(=O)C4=CC=C(C=C4)F D0EH2O HIGHSTAT Terminated D0EN4G DRUG__ID D0EN4G D0EN4G DRUGCOMP Sankyo Co Ltd D0EN4G DRUGINCH 1S/C34H51NO4/c1-4-5-6-7-8-9-10-11-12-20-34(36)39-32-26-30(35(2)27-32)23-24-38-33-19-14-13-17-29(33)22-21-28-16-15-18-31(25-28)37-3/h13-19,25,30,32H,4-12,20-24,26-27H2,1-3H3/t30-,32-/m1/s1 D0EN4G DRUGINKE ZVCROHONSVCKKH-XLJNKUFUSA-N D0EN4G DRUGSMIL CCCCCCCCCCCC(=O)OC1CC(N(C1)C)CCOC2=CC=CC=C2CCC3=CC(=CC=C3)OC D0EN4G HIGHSTAT Terminated D0EP5O DRUG__ID D0EP5O D0EP5O DRUGCOMP NeuroSearch A/S D0EP5O DRUGINCH 1S/C18H16N2O2/c1-2-20-9-14-12(11-6-4-3-5-7-11)8-13-16(15(14)10-20)19-18(22)17(13)21/h3-8H,2,9-10H2,1H3,(H,19,21,22) D0EP5O DRUGINKE IWRZGAAKMZJBHL-UHFFFAOYSA-N D0EP5O DRUGSMIL CCN1CC2=C(C1)C3=C(C=C2C4=CC=CC=C4)C(=O)C(=O)N3 D0EP5O HIGHSTAT Terminated D0ES4S DRUG__ID D0ES4S D0ES4S DRUGTYPE Small molecular drug D0ES4S DRUGINCH 1S/C25H29FN4O2S/c26-21-6-7-23-22(16-21)20(17-27-23)15-18-8-11-28(12-9-18)13-14-29-24-5-1-3-19-4-2-10-30(25(19)24)33(29,31)32/h1,3,5-7,16-18,27H,2,4,8-15H2 D0ES4S DRUGINKE NZUSTSFFNOEAHE-UHFFFAOYSA-N D0ES4S DRUGSMIL C1CC2=C3C(=CC=C2)N(S(=O)(=O)N3C1)CCN4CCC(CC4)CC5=CNC6=C5C=C(C=C6)F D0ES4S HIGHSTAT Terminated D0EY9P DRUG__ID D0EY9P D0EY9P DRUGTYPE Small molecular drug D0EY9P DRUGINCH 1S/C26H24ClN3O/c27-22-5-6-23-21(17-22)4-3-20-2-1-11-29-26(20)25(23)19-9-14-30(15-10-19)24(31)16-18-7-12-28-13-8-18/h1-2,5-8,11-13,17H,3-4,9-10,14-16H2 D0EY9P DRUGINKE KIFXOXSGYMUANJ-UHFFFAOYSA-N D0EY9P DRUGSMIL C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)C(=O)CC4=CC=NC=C4)C5=C1C=CC=N5 D0EY9P HIGHSTAT Terminated D0F0CS DRUG__ID D0F0CS D0F0CS DRUGTYPE Small molecular drug D0F0CS DRUGINCH 1S/C12H10F2N2O3/c1-18-10-6-7(2-4-9(10)19-12(13)14)8-3-5-11(17)16-15-8/h2-6,12H,1H3,(H,16,17) D0F0CS DRUGINKE HJMQDJPMQIHLPB-UHFFFAOYSA-N D0F0CS DRUGSMIL COC1=C(C=CC(=C1)C2=NNC(=O)C=C2)OC(F)F D0F0CS HIGHSTAT Terminated D0F3TI DRUG__ID D0F3TI D0F3TI DRUGCOMP DARA BioSciences Inc D0F3TI DRUGINCH 1S/C9H17BN2O5/c11-6(3-4-8(13)14)9(15)12-5-1-2-7(12)10(16)17/h6-7,16-17H,1-5,11H2,(H,13,14)/t6-,7-/m0/s1 D0F3TI DRUGINKE DMTPQYQQHYOTQM-BQBZGAKWSA-N D0F3TI DRUGSMIL B(C1CCCN1C(=O)C(CCC(=O)O)N)(O)O D0F3TI HIGHSTAT Terminated D0F4JL DRUG__ID D0F4JL D0F4JL DRUGTYPE Small molecular drug D0F4JL DRUGINCH 1S/C46H48N2O8.C2H4O2/c1-19-9-25-27(41-31-13-21(3)47-23(5)39(31)33(49)17-35(41)51)15-29(45(53)43(25)37(11-19)55-7)30-16-28(26-10-20(2)12-38(56-8)44(26)46(30)54)42-32-14-22(4)48-24(6)40(32)34(50)18-36(42)52;1-2(3)4/h9-12,15-18,21-24,47-54H,13-14H2,1-8H3;1H3,(H,3,4)/t21-,22-,23+,24+;/m0./s1 D0F4JL DRUGINKE IHCBLDDSPLYUGN-ZODOTUICSA-N D0F4JL DRUGSMIL CC1CC2=C(C(=CC(=C2C(N1)C)O)O)C3=CC(=C(C4=C3C=C(C=C4OC)C)O)C5=C(C6=C(C=C(C=C6OC)C)C(=C5)C7=C8CC(NC(C8=C(C=C7O)O)C)C)O.CC(=O)O D0F4JL HIGHSTAT Terminated D0F5VB DRUG__ID D0F5VB D0F5VB DRUGTYPE Small molecular drug D0F5VB DRUGINCH 1S/C31H32N4O3/c1-21-16-22(14-15-26(21)33(2)3)18-34-20-32-25-19-35(28(31(37)38)17-27(25)34)30(36)29(23-10-6-4-7-11-23)24-12-8-5-9-13-24/h4-16,20,28-29H,17-19H2,1-3H3,(H,37,38)/t28-/m0/s1 D0F5VB DRUGINKE YSTVFDAKLDMYCR-NDEPHWFRSA-N D0F5VB DRUGSMIL CC1=C(C=CC(=C1)CN2C=NC3=C2CC(N(C3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)O)N(C)C D0F5VB HIGHSTAT Terminated D0F6AB DRUG__ID D0F6AB D0F6AB DRUGCOMP AstraZeneca plc D0F6AB DRUGINCH 1S/C23H31N3O5S2/c1-17-3-5-18(6-4-17)10-14-31-15-13-25-33(29,30)16-2-11-24-12-9-19-7-8-20(27)21-22(19)32-23(28)26-21/h3-8,24-25,27H,2,9-16H2,1H3,(H,26,28) D0F6AB DRUGINKE FIDWUJWRKJJJLL-UHFFFAOYSA-N D0F6AB DRUGSMIL CC1=CC=C(C=C1)CCOCCNS(=O)(=O)CCCNCCC2=C3C(=C(C=C2)O)NC(=O)S3 D0F6AB HIGHSTAT Terminated D0F6GR DRUG__ID D0F6GR D0F6GR DRUGTYPE Small molecular drug D0F6GR DRUGINCH 1S/C22H25ClN2O4S/c1-14(26)29-20-21(15-5-8-17(28-4)9-6-15)30-19-13-16(23)7-10-18(19)25(22(20)27)12-11-24(2)3/h5-10,13,20-21H,11-12H2,1-4H3/t20-,21+/m1/s1 D0F6GR DRUGINKE GYKFWCDBQAFCLJ-RTWAWAEBSA-N D0F6GR DRUGSMIL CC(=O)OC1C(SC2=C(C=CC(=C2)Cl)N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC D0F6GR HIGHSTAT Terminated D0F6XR DRUG__ID D0F6XR D0F6XR DRUGTYPE Small molecular drug D0F6XR DRUGINCH 1S/C21H25FN4O3.C4H4O4/c22-17-6-4-15(5-7-17)19(27)16-8-11-24(12-9-16)13-14-26-20(28)23-18-3-1-2-10-25(18)21(26)29;5-3(6)1-2-4(7)8/h4-7,16H,1-3,8-14H2;1-2H,(H,5,6)(H,7,8)/b;2-1- D0F6XR DRUGINKE GVSYIVYQDRVBAL-BTJKTKAUSA-N D0F6XR DRUGSMIL C1CCN2C(=NC(=O)N(C2=O)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F)C1.C(=CC(=O)O)C(=O)O D0F6XR HIGHSTAT Terminated D0F8DL DRUG__ID D0F8DL D0F8DL DRUGTYPE Small molecular drug D0F8DL DRUGINCH 1S/C21H16FN3OS/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15/h2-13H,1H3,(H,24,25) D0F8DL DRUGINKE CDMGBJANTYXAIV-UHFFFAOYSA-N D0F8DL DRUGSMIL CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F D0F8DL HIGHSTAT Terminated D0F9FA DRUG__ID D0F9FA D0F9FA DRUGTYPE Small molecular drug D0F9FA DRUGINCH 1S/C23H32N4O8/c1-12(2)20(23(35)24-13(3)21(33)26-16(11-28)10-19(31)32)27-22(34)18(25-14(4)29)9-15-5-7-17(30)8-6-15/h5-8,11-13,16,18,20,30H,9-10H2,1-4H3,(H,24,35)(H,25,29)(H,26,33)(H,27,34)(H,31,32)/t13-,16-,18-,20-/m0/s1 D0F9FA DRUGINKE LPIARALSGDVZEP-SJVNDZIOSA-N D0F9FA DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C=O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C D0F9FA HIGHSTAT Terminated D0FB6T DRUG__ID D0FB6T D0FB6T DRUGCOMP NAEJA Pharmaceuticals Inc D0FB6T DRUGINCH 1S/C19H18F2N6O3/c20-13-15(22)12-16(26(9-1-2-9)8-11(18(12)28)19(29)30)14(21)17(13)25-5-3-10(7-25)27-6-4-23-24-27/h4,6,8-10H,1-3,5,7,22H2,(H,29,30) D0FB6T DRUGINKE VTNJFSSLVQOXCY-UHFFFAOYSA-N D0FB6T DRUGSMIL C1CC1N2C=C(C(=O)C3=C(C(=C(C(=C32)F)N4CCC(C4)N5C=CN=N5)F)N)C(=O)O D0FB6T HIGHSTAT Terminated D0FC5T DRUG__ID D0FC5T D0FC5T DRUGTYPE Small molecular drug D0FC5T DRUGINCH 1S/C13H16N4O2/c1-18-10-4-3-8(6-11(10)19-2)5-9-7-16-13(15)17-12(9)14/h3-4,6-7H,5H2,1-2H3,(H4,14,15,16,17) D0FC5T DRUGINKE LDBTVAXGKYIFHO-UHFFFAOYSA-N D0FC5T DRUGSMIL COC1=C(C=C(C=C1)CC2=CN=C(N=C2N)N)OC D0FC5T HIGHSTAT Terminated D0FF7A DRUG__ID D0FF7A D0FF7A DRUGCOMP Zambon Co SpA D0FF7A DRUGINCH 1S/C13H15NO6/c1-3-19-12(15)8-9-5-6-10(13(16)20-4-2)7-11(9)14(17)18/h5-7H,3-4,8H2,1-2H3 D0FF7A DRUGINKE SKZKACZIGOSXQL-UHFFFAOYSA-N D0FF7A DRUGSMIL CCOC(=O)CC1=C(C=C(C=C1)C(=O)OCC)[N+](=O)[O-] D0FF7A HIGHSTAT Terminated D0FS9K DRUG__ID D0FS9K D0FS9K DRUGTYPE Small molecular drug D0FS9K DRUGINCH 1S/C19H23NO2/c1-18-10-8-15(21)17(20)14(18)4-3-11-12-5-6-16(22)19(12,2)9-7-13(11)18/h3-4,8,10-13H,5-7,9,20H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1 D0FS9K DRUGINKE DAKHYLIFCYPHQW-KZQROQTASA-N D0FS9K DRUGSMIL CC12CCC3C(C1CCC2=O)C=CC4=C(C(=O)C=CC34C)N D0FS9K HIGHSTAT Terminated D0FT9P DRUG__ID D0FT9P D0FT9P DRUGTYPE Small molecular drug D0FT9P DRUGINCH 1S/C68H110N22O27S2/c1-25-42(87-57(89-55(25)74)31(16-38(72)95)81-18-30(71)56(75)105)59(107)88-44(52(32-19-78-24-82-32)114-67-54(48(101)45(98)36(20-91)113-67)115-66-50(103)53(116-68(76)110)46(99)37(21-92)112-66)61(109)83-26(2)35(94)17-40(97)86-43(27(3)93)60(108)90-62(117-65-49(102)47(100)41(73)28(4)111-65)51(104)64-85-34(23-119-64)63-84-33(22-118-63)58(106)80-13-7-9-29(70)15-39(96)79-14-8-12-77-11-6-5-10-69/h19,22-24,26-31,35-37,41,43-54,62,65-67,77,81,91-94,98-104H,5-18,20-21,69-71,73H2,1-4H3,(H2,72,95)(H2,75,105)(H2,76,110)(H,78,82)(H,79,96)(H,80,106)(H,83,109)(H,86,97)(H,88,107)(H,90,108)(H2,74,87,89)/t26?,27?,28-,29?,30?,31?,35?,36-,37+,41+,43?,44?,45+,46+,47+,48-,49+,50-,51?,52?,53-,54-,62?,65-,66+,67+/m0/s1 D0FT9P DRUGINKE VUPBDWQPEOWRQP-SDSCCWNESA-N D0FT9P DRUGSMIL CC1C(C(C(C(O1)OC(C(C2=NC(=CS2)C3=NC(=CS3)C(=O)NCCCC(CC(=O)NCCCNCCCCN)N)O)NC(=O)C(C(C)O)NC(=O)CC(C(C)NC(=O)C(C(C4=CN=CN4)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)OC(=O)N)O)NC(=O)C7=C(C(=NC(=N7)C(CC(=O)N)NCC(C(=O)N)N)N)C)O)O)O)N D0FT9P HIGHSTAT Terminated D0G0GI DRUG__ID D0G0GI D0G0GI DRUGTYPE Small molecular drug D0G0GI DRUGINCH 1S/C18H21Cl2N5O2/c1-10-16(14-6-5-12(19)7-15(14)20)17-21-11(2)22-18(25(17)24-10)23-13(8-26-3)9-27-4/h5-7,13H,8-9H2,1-4H3,(H,21,22,23) D0G0GI DRUGINKE MDWRPTOUDPFXKK-UHFFFAOYSA-N D0G0GI DRUGSMIL CC1=NN2C(=C1C3=C(C=C(C=C3)Cl)Cl)N=C(N=C2NC(COC)COC)C D0G0GI HIGHSTAT Terminated D0G1VS DRUG__ID D0G1VS D0G1VS DRUGTYPE Small molecular drug D0G1VS DRUGINCH 1S/C29H35NO2/c1-31-28-16-14-24(15-17-28)9-8-20-30-21-18-25(19-22-30)23-32-29(26-10-4-2-5-11-26)27-12-6-3-7-13-27/h2-7,10-17,25,29H,8-9,18-23H2,1H3 D0G1VS DRUGINKE WRTXEGOLODUQIE-UHFFFAOYSA-N D0G1VS DRUGSMIL COC1=CC=C(C=C1)CCCN2CCC(CC2)COC(C3=CC=CC=C3)C4=CC=CC=C4 D0G1VS HIGHSTAT Terminated D0G2JZ DRUG__ID D0G2JZ D0G2JZ DRUGTYPE Small molecular drug D0G2JZ DRUGINCH 1S/C27H28N6O/c1-3-34-21-8-4-18(5-9-21)26-28-22-10-6-19(16-24(22)30-26)27-29-23-11-7-20(17-25(23)31-27)33-14-12-32(2)13-15-33/h4-11,16-17H,3,12-15H2,1-2H3,(H,28,30)(H,29,31) D0G2JZ DRUGINKE PRDFBSVERLRRMY-UHFFFAOYSA-N D0G2JZ DRUGSMIL CCOC1=CC=C(C=C1)C2=NC3=C(N2)C=C(C=C3)C4=NC5=C(N4)C=C(C=C5)N6CCN(CC6)C D0G2JZ HIGHSTAT Terminated D0G2XM DRUG__ID D0G2XM D0G2XM DRUGTYPE Small molecular drug D0G2XM DRUGINCH 1S/C30H33NO4/c1-2-10-26(31-35-30(23-11-5-3-6-12-23)24-13-7-4-8-14-24)20-22-17-18-27-25(19-22)15-9-16-28(27)34-21-29(32)33/h3-9,11-16,22,30H,2,10,17-21H2,1H3,(H,32,33)/b31-26+ D0G2XM DRUGINKE XNRBBSJYERPMMB-GKPLWNPISA-N D0G2XM DRUGSMIL CCCC(=NOC(C1=CC=CC=C1)C2=CC=CC=C2)CC3CCC4=C(C3)C=CC=C4OCC(=O)O D0G2XM HIGHSTAT Terminated D0G5ZE DRUG__ID D0G5ZE D0G5ZE DRUGTYPE Small molecular drug D0G5ZE DRUGINCH 1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1 D0G5ZE DRUGINKE NGBKFLTYGSREKK-PMACEKPBSA-N D0G5ZE DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2 D0G5ZE HIGHSTAT Terminated D0G6HZ DRUG__ID D0G6HZ D0G6HZ DRUGTYPE Small molecular drug D0G6HZ DRUGINCH 1S/C31H36N4O2/c36-30-24(20-34-12-3-1-4-13-34)17-22(26-9-11-32-19-28(26)30)16-23-18-25(21-35-14-5-2-6-15-35)31(37)29-27(23)8-7-10-33-29/h7-11,17-19,36-37H,1-6,12-16,20-21H2 D0G6HZ DRUGINKE WJEZXIYONPULSN-UHFFFAOYSA-N D0G6HZ DRUGSMIL C1CCN(CC1)CC2=C(C3=C(C=CC=N3)C(=C2)CC4=CC(=C(C5=C4C=CN=C5)O)CN6CCCCC6)O D0G6HZ HIGHSTAT Terminated D0G7HO DRUG__ID D0G7HO D0G7HO DRUGCOMP NeuroSearch A/S D0G7HO DRUGINCH 1S/C16H14F3N3O2/c1-23-10-4-6-14(24-2)13(8-10)22-12-5-3-9(16(17,18)19)7-11(12)21-15(22)20/h3-8H,1-2H3,(H2,20,21) D0G7HO DRUGINKE RUTNWAGOFFGBCZ-UHFFFAOYSA-N D0G7HO DRUGSMIL COC1=CC(=C(C=C1)OC)N2C3=C(C=C(C=C3)C(F)(F)F)N=C2N D0G7HO HIGHSTAT Terminated D0G7YZ DRUG__ID D0G7YZ D0G7YZ DRUGTYPE Small molecular drug D0G7YZ DRUGINCH 1S/C22H34N6O4S/c1-33(31,32)26-18(14-16-6-3-2-4-7-16)21(30)28-11-5-8-19(28)20(29)25-15-17-9-12-27(13-10-17)22(23)24/h2-4,6-7,17-19,26H,5,8-15H2,1H3,(H3,23,24)(H,25,29)/t18-,19+/m1/s1 D0G7YZ DRUGINKE UCVAQBJLJIKTFJ-MOPGFXCFSA-N D0G7YZ DRUGSMIL CS(=O)(=O)NC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NCC3CCN(CC3)C(=N)N D0G7YZ HIGHSTAT Terminated D0G9BX DRUG__ID D0G9BX D0G9BX DRUGTYPE Small molecular drug D0G9BX DRUGINCH 1S/C22H35N5O5/c1-32-17-10-8-16(9-11-17)12-14-25-21(31)18(15-20(29)30)27-19(28)7-5-3-2-4-6-13-26-22(23)24/h8-11,18H,2-7,12-15H2,1H3,(H,25,31)(H,27,28)(H,29,30)(H4,23,24,26)/t18-/m0/s1 D0G9BX DRUGINKE LVVRYABDHQGPGK-SFHVURJKSA-N D0G9BX DRUGSMIL COC1=CC=C(C=C1)CCNC(=O)C(CC(=O)O)NC(=O)CCCCCCCN=C(N)N D0G9BX HIGHSTAT Terminated D0GE2F DRUG__ID D0GE2F D0GE2F DRUGCOMP Genelabs Technologies Inc D0GE2F DRUGINCH 1S/C27H25BF2N2O6S/c1-31-27(33)25-20-12-19(16-4-5-16)23(13-24(20)38-26(25)17-6-8-18(29)9-7-17)32(39(2,36)37)14-15-3-10-21(28(34)35)22(30)11-15/h3,6-13,16,34-35H,4-5,14H2,1-2H3,(H,31,33) D0GE2F DRUGINKE GDSKPIAEYNJODX-UHFFFAOYSA-N D0GE2F DRUGSMIL B(C1=C(C=C(C=C1)CN(C2=C(C=C3C(=C2)OC(=C3C(=O)NC)C4=CC=C(C=C4)F)C5CC5)S(=O)(=O)C)F)(O)O D0GE2F HIGHSTAT Terminated D0GO7W DRUG__ID D0GO7W D0GO7W DRUGTYPE Small molecular drug D0GO7W DRUGINCH 1S/C27H42N2O6S/c1-15-8-7-9-27(6)21(35-27)11-19(16(2)10-18-14-36-22(13-28)29-18)34-23(31)12-20(30)26(4,5)25(33)17(3)24(15)32/h10,14-15,17,19-21,24,30,32H,7-9,11-13,28H2,1-6H3/b16-10+/t15-,17+,19-,20-,21-,24-,27+/m0/s1 D0GO7W DRUGINKE PFJFPBDHCFMQPN-RGJAOAFDSA-N D0GO7W DRUGSMIL CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)CN)C)C D0GO7W HIGHSTAT Terminated D0GR2H DRUG__ID D0GR2H D0GR2H DRUGTYPE Small molecular drug D0GR2H DRUGINCH 1S/C19H27N5O3/c20-19(21)22-10-4-8-15(13-25)23-18(27)16-9-5-11-24(16)17(26)12-14-6-2-1-3-7-14/h1-3,6-7,13,15-16H,4-5,8-12H2,(H,23,27)(H4,20,21,22)/t15-,16-/m0/s1 D0GR2H DRUGINKE FWMLVCYBCSOEBZ-HOTGVXAUSA-N D0GR2H DRUGSMIL C1CC(N(C1)C(=O)CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C=O D0GR2H HIGHSTAT Terminated D0GS7N DRUG__ID D0GS7N D0GS7N DRUGTYPE Small molecular drug D0GS7N DRUGINCH 1S/C24H23N7/c1-4-21-26-22-15(2)13-16(3)25-24(22)31(21)14-17-9-11-18(12-10-17)19-7-5-6-8-20(19)23-27-29-30-28-23/h5-13H,4,14H2,1-3H3,(H,27,28,29,30) D0GS7N DRUGINKE YFWXFHNZGKNDBC-UHFFFAOYSA-N D0GS7N DRUGSMIL CCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)N=C(C=C2C)C D0GS7N HIGHSTAT Terminated D0GZ7B DRUG__ID D0GZ7B D0GZ7B DRUGTYPE Small molecular drug D0GZ7B DRUGINCH 1S/C17H14N2O3/c18-10-14(8-13-6-7-15(20)16(21)9-13)17(22)19-11-12-4-2-1-3-5-12/h1-9,20-21H,11H2,(H,19,22)/b14-8+ D0GZ7B DRUGINKE TUCIOBMMDDOEMM-RIYZIHGNSA-N D0GZ7B DRUGSMIL C1=CC=C(C=C1)CNC(=O)C(=CC2=CC(=C(C=C2)O)O)C#N D0GZ7B HIGHSTAT Terminated D0H0IA DRUG__ID D0H0IA D0H0IA DRUGCOMP Wyeth-Ayerst International Inc D0H0IA DRUGINCH 1S/C19H23NO/c1-13-8-10-15(11-9-13)19(21)18-14(2)12-16-6-4-3-5-7-17(16)20-18/h8-12,19,21H,3-7H2,1-2H3 D0H0IA DRUGINKE KLGYQZZTJRHYIN-UHFFFAOYSA-N D0H0IA DRUGSMIL CC1=CC=C(C=C1)C(C2=NC3=C(CCCCC3)C=C2C)O D0H0IA HIGHSTAT Terminated D0H0KK DRUG__ID D0H0KK D0H0KK DRUGTYPE Small molecular drug D0H0KK DRUGINCH 1S/C25H20O6/c1-28-19-10-8-18(9-11-19)25(27)20(13-16-5-3-2-4-6-16)23(24(26)31-25)17-7-12-21-22(14-17)30-15-29-21/h2-12,14,27H,13,15H2,1H3 D0H0KK DRUGINKE JZHLIUOZBXWYGJ-UHFFFAOYSA-N D0H0KK DRUGSMIL COC1=CC=C(C=C1)C2(C(=C(C(=O)O2)C3=CC4=C(C=C3)OCO4)CC5=CC=CC=C5)O D0H0KK HIGHSTAT Terminated D0H1YE DRUG__ID D0H1YE D0H1YE DRUGCOMP MSD Japan D0H1YE DRUGINCH 1S/C46H48N10O12S4/c1-23-45(67)69-19-29(51-41(63)37-33(57)15-25-11-7-9-13-27(25)49-37)39(61)47-18-36(60)56(6)32-22-72-71-21-31(43(65)53(23)3)55(5)35(59)17-48-40(62)30(20-70-46(68)24(2)54(4)44(32)66)52-42(64)38-34(58)16-26-12-8-10-14-28(26)50-38/h7-16,29-32,57-58H,1-2,17-22H2,3-6H3,(H,47,61)(H,48,62)(H,51,63)(H,52,64) D0H1YE DRUGINKE QLOZXPNJEDVFIH-UHFFFAOYSA-N D0H1YE DRUGSMIL CN1C2CSSCC(C(=O)N(C(=C)C(=O)SCC(C(=O)NCC1=O)NC(=O)C3=NC4=CC=CC=C4C=C3O)C)N(C(=O)CNC(=O)C(CSC(=O)C(=C)N(C2=O)C)NC(=O)C5=NC6=CC=CC=C6C=C5O)C D0H1YE HIGHSTAT Terminated D0H2RB DRUG__ID D0H2RB D0H2RB DRUGTYPE Small molecular drug D0H2RB DRUGINCH 1S/C16H16N2O2/c1-12-10-16(19)18(17-12)8-9-20-15-7-6-13-4-2-3-5-14(13)11-15/h2-7,11H,8-10H2,1H3 D0H2RB DRUGINKE ISBUYSPRIJRBKX-UHFFFAOYSA-N D0H2RB DRUGSMIL CC1=NN(C(=O)C1)CCOC2=CC3=CC=CC=C3C=C2 D0H2RB HIGHSTAT Terminated D0H3XB DRUG__ID D0H3XB D0H3XB DRUGTYPE Small molecular drug D0H3XB DRUGINCH 1S/C25H19N3O2S/c29-23(17-6-2-1-3-7-17)18-8-4-10-20(14-18)27-24(30)21-11-13-28-22(21)16-31-25(28)19-9-5-12-26-15-19/h1-15,25H,16H2,(H,27,30) D0H3XB DRUGINKE PQQFNXGONTVQLM-UHFFFAOYSA-N D0H3XB DRUGSMIL C1C2=C(C=CN2C(S1)C3=CN=CC=C3)C(=O)NC4=CC=CC(=C4)C(=O)C5=CC=CC=C5 D0H3XB HIGHSTAT Terminated D0H4GI DRUG__ID D0H4GI D0H4GI DRUGTYPE Small molecular drug D0H4GI DRUGINCH 1S/C28H28N2O3/c1-16(2)33-15-17-8-9-23-20(12-17)25-22-14-29-28(32)26(22)24-19-7-4-3-6-18(19)13-21(24)27(25)30(23)10-5-11-31/h3-4,6-9,12,16,31H,5,10-11,13-15H2,1-2H3,(H,29,32) D0H4GI DRUGINKE MLIFNJABMANKEU-UHFFFAOYSA-N D0H4GI DRUGSMIL CC(C)OCC1=CC2=C(C=C1)N(C3=C2C4=C(C5=C3CC6=CC=CC=C65)C(=O)NC4)CCCO D0H4GI HIGHSTAT Terminated D0H5CV DRUG__ID D0H5CV D0H5CV DRUGTYPE Small molecular drug D0H5CV DRUGINCH 1S/C25H32N2O2/c1-19-23-18-22(29)12-13-24(23)27(25(19)20-8-10-21(28)11-9-20)17-5-3-2-4-14-26-15-6-7-16-26/h8-13,18,28-29H,2-7,14-17H2,1H3 D0H5CV DRUGINKE SACIXOLGIWUXTG-UHFFFAOYSA-N D0H5CV DRUGSMIL CC1=C(N(C2=C1C=C(C=C2)O)CCCCCCN3CCCC3)C4=CC=C(C=C4)O D0H5CV HIGHSTAT Terminated D0H5PD DRUG__ID D0H5PD D0H5PD DRUGCOMP Cortech Inc D0H5PD DRUGINCH 1S/C58H89N19O13S/c59-38(16-6-20-66-56(60)61)48(82)72-39(17-7-21-67-57(62)63)51(85)74-23-9-19-43(74)53(87)77-30-36(79)26-44(77)50(84)69-28-46(80)71-41(27-37-15-10-24-91-37)49(83)73-42(32-78)52(86)76-29-34-12-5-4-11-33(34)25-45(76)54(88)75(35-13-2-1-3-14-35)31-47(81)70-40(55(89)90)18-8-22-68-58(64)65/h4-5,10-12,15,24,35-36,38-45,78-79H,1-3,6-9,13-14,16-23,25-32,59H2,(H,69,84)(H,70,81)(H,71,80)(H,72,82)(H,73,83)(H,89,90)(H4,60,61,66)(H4,62,63,67)(H4,64,65,68)/t36-,38-,39+,40+,41+,42+,43+,44+,45-/m1/s1 D0H5PD DRUGINKE UZTHIUKOCVEJNZ-GWJNKJQQSA-N D0H5PD DRUGSMIL C1CCC(CC1)N(CC(=O)NC(CCCN=C(N)N)C(=O)O)C(=O)C2CC3=CC=CC=C3CN2C(=O)C(CO)NC(=O)C(CC4=CC=CS4)NC(=O)CNC(=O)C5CC(CN5C(=O)C6CCCN6C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O D0H5PD HIGHSTAT Terminated D0H5VF DRUG__ID D0H5VF D0H5VF DRUGTYPE Small molecular drug D0H5VF DRUGINCH 1S/C19H25N3O3S2/c1-27-8-7-17(19(24)25)22-18(23)16-4-2-3-12-9-14(5-6-15(12)16)21-10-13(20)11-26/h2-6,9,13,17,21,26H,7-8,10-11,20H2,1H3,(H,22,23)(H,24,25)/t13-,17+/m1/s1 D0H5VF DRUGINKE YUXOGMIOPNYIQR-DYVFJYSZSA-N D0H5VF DRUGSMIL CSCCC(C(=O)O)NC(=O)C1=CC=CC2=C1C=CC(=C2)NCC(CS)N D0H5VF HIGHSTAT Terminated D0H8KG DRUG__ID D0H8KG D0H8KG DRUGTYPE Small molecular drug D0H8KG DRUGINCH 1S/C26H27Cl2N5O2/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31) D0H8KG DRUGINKE IFPPYSWJNWHOLQ-UHFFFAOYSA-N D0H8KG DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl D0H8KG HIGHSTAT Terminated D0HJ1Y DRUG__ID D0HJ1Y D0HJ1Y DRUGTYPE Small molecular drug D0HJ1Y DRUGINCH 1S/C17H17FN2O3/c1-12(20(22)17(19)21)5-6-13-3-2-4-16(11-13)23-15-9-7-14(18)8-10-15/h2-12,22H,1H3,(H2,19,21)/b6-5+ D0HJ1Y DRUGINKE UAIYNMRLUHHRMF-AATRIKPKSA-N D0HJ1Y DRUGSMIL CC(C=CC1=CC(=CC=C1)OC2=CC=C(C=C2)F)N(C(=O)N)O D0HJ1Y HIGHSTAT Terminated D0HO1S DRUG__ID D0HO1S D0HO1S DRUGTYPE Small molecular drug D0HO1S DRUGINCH 1S/C20H13F2N3O2/c21-11-1-5-13(6-2-11)23-17-9-15-16(20(27)25-19(15)26)10-18(17)24-14-7-3-12(22)4-8-14/h1-10,23-24H,(H,25,26,27) D0HO1S DRUGINKE RONQPWQYDRPRGG-UHFFFAOYSA-N D0HO1S DRUGSMIL C1=CC(=CC=C1NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)F)F D0HO1S HIGHSTAT Terminated D0HS3X DRUG__ID D0HS3X D0HS3X DRUGCOMP BioChem Therapeutic Inc D0HS3X DRUGINCH 1S/C20H22N2O5/c1-22(2)10-6-9-21-19(25)15-11-14-16(20(26-3)27-15)18(24)13-8-5-4-7-12(13)17(14)23/h4-5,7-8,11,20H,6,9-10H2,1-3H3,(H,21,25) D0HS3X DRUGINKE PFPVQJAKWPMYDX-UHFFFAOYSA-N D0HS3X DRUGSMIL CN(C)CCCNC(=O)C1=CC2=C(C(O1)OC)C(=O)C3=CC=CC=C3C2=O D0HS3X HIGHSTAT Terminated D0I3BT DRUG__ID D0I3BT D0I3BT DRUGTYPE Small molecular drug D0I3BT DRUGINCH 1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33+/m0/s1 D0I3BT DRUGINKE PGOLWKTUHWHYJS-SFMDGOMNSA-N D0I3BT DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0I3BT HIGHSTAT Terminated D0I3XW DRUG__ID D0I3XW D0I3XW DRUGTYPE Small molecular drug D0I3XW DRUGINCH 1S/C27H31NOS2/c1-5-28(14-8-6-7-13-27(2,3)4)18-22-10-9-11-25(16-22)29-19-26-17-24(21-31-26)23-12-15-30-20-23/h6,8-12,15-17,20-21H,5,14,18-19H2,1-4H3/b8-6+ D0I3XW DRUGINKE KIRGLCXNEVICOG-SOFGYWHQSA-N D0I3XW DRUGSMIL CCN(CC=CC#CC(C)(C)C)CC1=CC(=CC=C1)OCC2=CC(=CS2)C3=CSC=C3 D0I3XW HIGHSTAT Terminated D0I5QZ DRUG__ID D0I5QZ D0I5QZ DRUGTYPE Small molecular drug D0I5QZ DRUGINCH 1S/C17H22N2O4S/c1-11(16(21)19-9-5-8-13(19)17(22)23)18-15(20)14(24)10-12-6-3-2-4-7-12/h2-4,6-7,11,13-14,24H,5,8-10H2,1H3,(H,18,20)(H,22,23)/t11-,13-,14-/m0/s1 D0I5QZ DRUGINKE YSFYVNRABGRTNY-UBHSHLNASA-N D0I5QZ DRUGSMIL CC(C(=O)N1CCCC1C(=O)O)NC(=O)C(CC2=CC=CC=C2)S D0I5QZ HIGHSTAT Terminated D0I7BL DRUG__ID D0I7BL D0I7BL DRUGTYPE Small molecular drug D0I7BL DRUGINCH 1S/C11H15N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h3-6,8-9,17-19H,1-2H2,(H2,12,13,14)/t5-,6-,8-,9+/m1/s1 D0I7BL DRUGINKE UGRNVLGKAGREKS-GCXDCGAKSA-N D0I7BL DRUGSMIL C1C(C(C(C1N2C=NC3=C(N=CN=C32)N)O)O)CO D0I7BL HIGHSTAT Terminated D0I7EU DRUG__ID D0I7EU D0I7EU DRUGTYPE Small molecular drug D0I7EU DRUGINCH 1S/C28H29N5O4/c1-32(22-11-9-19(10-12-22)26(29)30)27(36)20-7-8-21-17-33(14-13-18-5-3-2-4-6-18)28(37)24(16-25(34)35)31-23(21)15-20/h2-12,15,24,31H,13-14,16-17H2,1H3,(H3,29,30)(H,34,35) D0I7EU DRUGINKE WCZAIWWFRSMLCO-UHFFFAOYSA-N D0I7EU DRUGSMIL CN(C1=CC=C(C=C1)C(=N)N)C(=O)C2=CC3=C(CN(C(=O)C(N3)CC(=O)O)CCC4=CC=CC=C4)C=C2 D0I7EU HIGHSTAT Terminated D0I7TN DRUG__ID D0I7TN D0I7TN DRUGTYPE Small molecular drug D0I7TN DRUGINCH 1S/C11H14N4O4/c12-10-7-5(1-2-13-10)15(4-14-7)11-9(18)8(17)6(3-16)19-11/h1-2,4,6,8-9,11,16-18H,3H2,(H2,12,13)/t6-,8-,9-,11-/m1/s1 D0I7TN DRUGINKE DBZQFUNLCALWDY-PNHWDRBUSA-N D0I7TN DRUGSMIL C1=CN=C(C2=C1N(C=N2)C3C(C(C(O3)CO)O)O)N D0I7TN HIGHSTAT Terminated D0I9JH DRUG__ID D0I9JH D0I9JH DRUGTYPE Small molecular drug D0I9JH DRUGINCH 1S/C21H21ClFNO2/c1-13-17-10-16(23)8-9-18(17)24(12-14-4-6-15(22)7-5-14)19(13)11-21(2,3)20(25)26/h4-10H,11-12H2,1-3H3,(H,25,26) D0I9JH DRUGINKE JLPYLHLUHJOPNL-UHFFFAOYSA-N D0I9JH DRUGSMIL CC1=C(N(C2=C1C=C(C=C2)F)CC3=CC=C(C=C3)Cl)CC(C)(C)C(=O)O D0I9JH HIGHSTAT Terminated D0I9QH DRUG__ID D0I9QH D0I9QH DRUGCOMP Sanofi-Synthelabo D0I9QH DRUGINCH 1S/C20H22ClNO4/c21-16-3-1-2-14(8-16)19(23)11-22-17-6-4-13-5-7-18(10-15(13)9-17)26-12-20(24)25/h1-3,5,7-8,10,17,19,22-23H,4,6,9,11-12H2,(H,24,25)/t17-,19?/m0/s1 D0I9QH DRUGINKE PLYWAKPAFSZPAL-KKFHFHRHSA-N D0I9QH DRUGSMIL C1CC2=C(CC1NCC(C3=CC(=CC=C3)Cl)O)C=C(C=C2)OCC(=O)O D0I9QH HIGHSTAT Terminated D0I9UH DRUG__ID D0I9UH D0I9UH DRUGTYPE Small molecular drug D0I9UH DRUGINCH 1S/C15H17NOS.C4H4O4/c1-16(2)11-12-6-3-4-9-15(12)18-14-8-5-7-13(17)10-14;5-3(6)1-2-4(7)8/h3-10,17H,11H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D0I9UH DRUGINKE YLZUWDVZEDYTBB-BTJKTKAUSA-N D0I9UH DRUGSMIL C[NH+](C)CC1=CC=CC=C1SC2=CC=CC(=C2)O.C(=CC(=O)[O-])C(=O)O D0I9UH HIGHSTAT Terminated D0IA7K DRUG__ID D0IA7K D0IA7K DRUGCOMP Mediolanum Farmaceutici SpA D0IA7K DRUGINCH 1S/C23H23N3O3/c1-13-20-17(22(27)18(23(28)29)12-26(20)16-6-7-16)10-19(24)21(13)25-9-8-14-4-2-3-5-15(14)11-25/h2-5,10,12,16H,6-9,11,24H2,1H3,(H,28,29) D0IA7K DRUGINKE LLVLMYRWABCVEU-UHFFFAOYSA-N D0IA7K DRUGSMIL CC1=C2C(=CC(=C1N3CCC4=CC=CC=C4C3)N)C(=O)C(=CN2C5CC5)C(=O)O D0IA7K HIGHSTAT Terminated D0IJ3R DRUG__ID D0IJ3R D0IJ3R DRUGTYPE Small molecular drug D0IJ3R DRUGINCH 1S/2C7H8O4.C6H14N2.Pt/c2*1-3(8)5-6(9)4(2)11-7(5)10;7-5-3-1-2-4-6(5)8;/h2*4,9H,1-2H3;5-6H,1-4,7-8H2;/q;;;+2/p-2/t4-;;;/m0.../s1 D0IJ3R DRUGINKE JSEUNYAKBKVVLC-WJXVXWFNSA-L D0IJ3R DRUGSMIL CC1C(=C(C(=O)O1)C(=O)C)[O-].CC1C(=C(C(=O)O1)C(=O)C)[O-].C1CCC(C(C1)N)N.[Pt+2] D0IJ3R HIGHSTAT Terminated D0IJ5I DRUG__ID D0IJ5I D0IJ5I DRUGCOMP Solvay Pharmaceuticals BV D0IJ5I DRUGINCH 1S/C25H31N3O2/c1-19(2)20-7-9-22(10-8-20)25(29)26(3)12-13-27-14-16-28(17-15-27)23-6-4-5-21-11-18-30-24(21)23/h4-11,18-19H,12-17H2,1-3H3 D0IJ5I DRUGINKE XZHMFCUWVDUYBV-UHFFFAOYSA-N D0IJ5I DRUGSMIL CC(C)C1=CC=C(C=C1)C(=O)N(C)CCN2CCN(CC2)C3=CC=CC4=C3OC=C4 D0IJ5I HIGHSTAT Terminated D0IL8R DRUG__ID D0IL8R D0IL8R DRUGCOMP Abbott Laboratories D0IL8R DRUGINCH 1S/C26H28N2O4/c1-18(26(29)30)28-32-25(20-8-3-2-4-9-20)21-12-15-23(16-13-21)31-17-22-14-11-19-7-5-6-10-24(19)27-22/h5-7,10-16,20,25H,2-4,8-9,17H2,1H3,(H,29,30)/b28-18- D0IL8R DRUGINKE USBHSZPRMPADOE-VEILYXNESA-N D0IL8R DRUGSMIL CC(=NOC(C1CCCCC1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O D0IL8R HIGHSTAT Terminated D0IQ6O DRUG__ID D0IQ6O D0IQ6O DRUGCOMP Sankyo Co Ltd D0IQ6O DRUGINCH 1S/C10H18N2O4/c1-10(2,3)16-9(15)12-6-4-7(8(13)14)11-5-6/h6-7,11H,4-5H2,1-3H3,(H,12,15)(H,13,14)/t6-,7+/m1/s1 D0IQ6O DRUGINKE ZLTYSXLMVYGBJO-RQJHMYQMSA-N D0IQ6O DRUGSMIL CC(C)(C)OC(=O)NC1CC(NC1)C(=O)O D0IQ6O HIGHSTAT Terminated D0IW0Y DRUG__ID D0IW0Y D0IW0Y DRUGCOMP The Menarini Group D0IW0Y DRUGINCH 1S/C57H68N14O10/c1-30(2)49(71-55(80)47(25-34-29-65-42-15-8-5-12-38(34)42)69-52(77)44(22-31-17-19-35(72)20-18-31)67-51(76)39(58)26-48(73)74)56(81)70-46(24-33-28-64-41-14-7-4-11-37(33)41)54(79)68-45(23-32-27-63-40-13-6-3-10-36(32)40)53(78)66-43(50(59)75)16-9-21-62-57(60)61/h3-8,10-15,17-20,27-30,39,43-47,49,63-65,72H,9,16,21-26,58H2,1-2H3,(H2,59,75)(H,66,78)(H,67,76)(H,68,79)(H,69,77)(H,70,81)(H,71,80)(H,73,74)(H4,60,61,62)/t39-,43-,44-,45+,46+,47+,49-/m0/s1 D0IW0Y DRUGINKE RLHLZLAKTUPWES-PEURKWGASA-N D0IW0Y DRUGSMIL CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(CC(=O)O)N D0IW0Y HIGHSTAT Terminated D0J0MK DRUG__ID D0J0MK D0J0MK DRUGTYPE Small molecular drug D0J0MK DRUGINCH 1S/C11H18O3/c1-8-2-4-9(5-3-8)10(12)6-7-11(13)14/h8-9H,2-7H2,1H3,(H,13,14) D0J0MK DRUGINKE JOWMTYWOBJALGB-UHFFFAOYSA-N D0J0MK DRUGSMIL CC1CCC(CC1)C(=O)CCC(=O)O D0J0MK HIGHSTAT Terminated D0J1FL DRUG__ID D0J1FL D0J1FL DRUGCOMP AstraZeneca plc D0J1FL DRUGINCH 1S/C11H9Cl2N3O3S/c1-19-11-10(14-5-6-15-11)16-20(17,18)8-4-2-3-7(12)9(8)13/h2-6H,1H3,(H,14,16) D0J1FL DRUGINKE FLSMVCMSUNISFK-UHFFFAOYSA-N D0J1FL DRUGSMIL COC1=NC=CN=C1NS(=O)(=O)C2=C(C(=CC=C2)Cl)Cl D0J1FL HIGHSTAT Terminated D0J4ZH DRUG__ID D0J4ZH D0J4ZH DRUGTYPE Small molecular drug D0J4ZH DRUGINCH 1S/C27H32NO.HI/c1-5-26(22-12-8-6-9-13-22)27(23-14-10-7-11-15-23)24-16-18-25(19-17-24)29-21-20-28(2,3)4;/h6-19H,5,20-21H2,1-4H3;1H/q+1;/p-1/b27-26-; D0J4ZH DRUGINKE PXJJOGITBQXZEQ-JTHROIFXSA-M D0J4ZH DRUGSMIL CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCC[N+](C)(C)C)C3=CC=CC=C3.[I-] D0J4ZH HIGHSTAT Terminated D0J5TN DRUG__ID D0J5TN D0J5TN DRUGTYPE Small molecular drug D0J5TN DRUGINCH 1S/C27H23N3O4/c1-26-27(13-31,33-2)11-19(34-26)29-17-9-5-3-7-14(17)21-22-16(12-28-25(22)32)20-15-8-4-6-10-18(15)30(26)24(20)23(21)29/h3-10,19,31H,11-13H2,1-2H3,(H,28,32)/t19?,26-,27-/m0/s1 D0J5TN DRUGINKE NMMGUHANGUWNBN-OGLOGDKOSA-N D0J5TN DRUGSMIL CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)OC D0J5TN HIGHSTAT Terminated D0J7RW DRUG__ID D0J7RW D0J7RW DRUGTYPE Small molecular drug D0J7RW DRUGINCH 1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3/t20-/m1/s1 D0J7RW DRUGINKE HQVHOQAKMCMIIM-HXUWFJFHSA-N D0J7RW DRUGSMIL CC1=C(C2=C3N1C(COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65 D0J7RW HIGHSTAT Terminated D0J8RS DRUG__ID D0J8RS D0J8RS DRUGTYPE Small molecular drug D0J8RS DRUGINCH 1S/C15H11NS/c1-3-7-13-10(5-1)12-9-17-14-8-4-2-6-11(14)15(12)16-13/h1-8,16H,9H2 D0J8RS DRUGINKE ZGOOPZVQMLHPFM-UHFFFAOYSA-N D0J8RS DRUGSMIL C1C2=C(C3=CC=CC=C3S1)NC4=CC=CC=C24 D0J8RS HIGHSTAT Terminated D0J8UV DRUG__ID D0J8UV D0J8UV DRUGTYPE Small molecular drug D0J8UV DRUGINCH 1S/C20H29FN2O2/c1-2-3-5-16-8-12-22(13-9-16)10-4-11-23-18-7-6-17(21)14-19(18)25-15-20(23)24/h6-7,14,16H,2-5,8-13,15H2,1H3 D0J8UV DRUGINKE BWAKMLKESHKOHK-UHFFFAOYSA-N D0J8UV DRUGSMIL CCCCC1CCN(CC1)CCCN2C(=O)COC3=C2C=CC(=C3)F D0J8UV HIGHSTAT Terminated D0J9GD DRUG__ID D0J9GD D0J9GD DRUGTYPE Small molecular drug D0J9GD DRUGINCH 1S/C23H34O5/c1-4-14(2)23(26)28-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-18-12-17(24)13-21(25)27-18/h6,8-9,14-15,17-20,22,24H,4-5,7,10-13H2,1-3H3/t14-,15-,17+,18+,19-,20-,22-/m0/s1 D0J9GD DRUGINKE AJLFOPYRIVGYMJ-INTXDZFKSA-N D0J9GD DRUGSMIL CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O D0J9GD HIGHSTAT Terminated D0J9UI DRUG__ID D0J9UI D0J9UI DRUGTYPE Small molecular drug D0J9UI DRUGINCH 1S/C27H31N5O5S/c1-18(28)31-12-10-25(11-13-31)37-24-8-6-23(7-9-24)32(38(35,36)17-26(33)34)16-19-2-3-20-4-5-21(27(29)30)15-22(20)14-19/h2-9,14-15,25,28H,10-13,16-17H2,1H3,(H3,29,30)(H,33,34) D0J9UI DRUGINKE NPBKHEMDWREFJJ-UHFFFAOYSA-N D0J9UI DRUGSMIL CC(=N)N1CCC(CC1)OC2=CC=C(C=C2)N(CC3=CC4=C(C=C3)C=CC(=C4)C(=N)N)S(=O)(=O)CC(=O)O D0J9UI HIGHSTAT Terminated D0K1CL DRUG__ID D0K1CL D0K1CL DRUGCOMP Sandoz Research Institute D0K1CL DRUGINCH 1S/C28H31Cl2N3O9/c1-16(2)23(32-28(39)42-14-18-8-5-4-6-9-18)25(37)31-17(3)24(36)33-26(40-13-12-34)21(35)15-41-27(38)22-19(29)10-7-11-20(22)30/h4-12,16-17,23,26H,13-15H2,1-3H3,(H,31,37)(H,32,39)(H,33,36)/t17-,23-,26-/m0/s1 D0K1CL DRUGINKE ABGURXXQCVTOBD-RUJAXMSRSA-N D0K1CL DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(C(=O)COC(=O)C1=C(C=CC=C1Cl)Cl)OCC=O)NC(=O)OCC2=CC=CC=C2 D0K1CL HIGHSTAT Terminated D0K1PR DRUG__ID D0K1PR D0K1PR DRUGCOMP Eisai Co Ltd D0K1PR DRUGINCH 1S/C9H7IN2S/c10-6-2-1-3-7-5(6)4-8(13-7)9(11)12/h1-4H,(H3,11,12) D0K1PR DRUGINKE YERQOXAYAFWFEJ-UHFFFAOYSA-N D0K1PR DRUGSMIL C1=CC2=C(C=C(S2)C(=N)N)C(=C1)I D0K1PR HIGHSTAT Terminated D0K2CV DRUG__ID D0K2CV D0K2CV DRUGTYPE Small molecular drug D0K2CV DRUGINCH 1S/C14H20N4O3S/c1-22(20,21)12-9-10(13(19)17-14(15)16)5-6-11(12)18-7-3-2-4-8-18/h5-6,9H,2-4,7-8H2,1H3,(H4,15,16,17,19) D0K2CV DRUGINKE WITSYJHGEIZBQU-UHFFFAOYSA-N D0K2CV DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)C(=O)N=C(N)N)N2CCCCC2 D0K2CV HIGHSTAT Terminated D0K3YG DRUG__ID D0K3YG D0K3YG DRUGTYPE Small molecular drug D0K3YG DRUGINCH 1S/CH3O4PS/c2-1(3)6(4,5)7/h(H,2,3)(H2,4,5,7) D0K3YG DRUGINKE OSIAURSWRZARKZ-UHFFFAOYSA-N D0K3YG DRUGSMIL C(=O)(O)P(=S)(O)O D0K3YG HIGHSTAT Terminated D0K5KL DRUG__ID D0K5KL D0K5KL DRUGTYPE Small molecular drug D0K5KL DRUGINCH 1S/C27H37N3O2/c1-6-16-29-18-21(5)30(19-20(29)4)26(24-10-9-11-25(31)17-24)22-12-14-23(15-13-22)27(32)28(7-2)8-3/h6,9-15,17,20-21,26,31H,1,7-8,16,18-19H2,2-5H3/t20-,21+,26-/m1/s1 D0K5KL DRUGINKE LBLDMHBSVIVJPM-YZIHRLCOSA-N D0K5KL DRUGSMIL CCN(CC)C(=O)C1=CC=C(C=C1)C(C2=CC(=CC=C2)O)N3CC(N(CC3C)CC=C)C D0K5KL HIGHSTAT Terminated D0K5UH DRUG__ID D0K5UH D0K5UH DRUGTYPE Small molecular drug D0K5UH DRUGINCH 1S/C27H38N2O4/c1-3-5-9-18-29(19-10-6-4-2)27(33)24(14-11-15-25(30)31)28-26(32)23-17-16-21-12-7-8-13-22(21)20-23/h7-8,12-13,16-17,20,24H,3-6,9-11,14-15,18-19H2,1-2H3,(H,28,32)(H,30,31)/t24-/m1/s1 D0K5UH DRUGINKE VHCOMPFCZPOZFX-XMMPIXPASA-N D0K5UH DRUGSMIL CCCCCN(CCCCC)C(=O)C(CCCC(=O)O)NC(=O)C1=CC2=CC=CC=C2C=C1 D0K5UH HIGHSTAT Terminated D0K6DG DRUG__ID D0K6DG D0K6DG DRUGCOMP Ono Pharmaceutical Co Ltd D0K6DG DRUGINCH 1S/C25H28N2O5S2/c1-16(2)13-27(34(30,31)25-26-17(3)15-33-25)22-11-20-5-4-6-21(20)12-23(22)32-14-18-7-9-19(10-8-18)24(28)29/h7-12,15-16H,4-6,13-14H2,1-3H3,(H,28,29) D0K6DG DRUGINKE IOXMDBQCUCDLAF-UHFFFAOYSA-N D0K6DG DRUGSMIL CC1=CSC(=N1)S(=O)(=O)N(CC(C)C)C2=C(C=C3CCCC3=C2)OCC4=CC=C(C=C4)C(=O)O D0K6DG HIGHSTAT Terminated D0K9JP DRUG__ID D0K9JP D0K9JP DRUGTYPE Small molecular drug D0K9JP DRUGINCH 1S/C23H27NO2/c1-24(13-11-17-9-10-18-12-14-26-23(18)15-17)16-19-5-3-7-21-20(19)6-4-8-22(21)25-2/h4,6,8-10,12,14-15,19H,3,5,7,11,13,16H2,1-2H3/t19-/m0/s1 D0K9JP DRUGINKE MHPMXTGKTXJIDI-IBGZPJMESA-N D0K9JP DRUGSMIL CN(CCC1=CC2=C(C=C1)C=CO2)CC3CCCC4=C3C=CC=C4OC D0K9JP HIGHSTAT Terminated D0K9OL DRUG__ID D0K9OL D0K9OL DRUGTYPE Small molecular drug D0K9OL DRUGINCH 1S/C8H15NO3/c1-8(2)5-12-6(4-9-8)3-7(10)11/h6,9H,3-5H2,1-2H3,(H,10,11)/t6-/m0/s1 D0K9OL DRUGINKE SEYCKMQSPUVYEF-LURJTMIESA-N D0K9OL DRUGSMIL CC1(COC(CN1)CC(=O)O)C D0K9OL HIGHSTAT Terminated D0K9YR DRUG__ID D0K9YR D0K9YR DRUGTYPE Small molecular drug D0K9YR DRUGINCH 1S/C33H46N5O8PS/c1-48(45,46)38-27(15-7-10-18-34)30(39)37-29(19-23-11-3-2-4-12-23)47(43,44)22-33(16-8-9-17-33)32(42)36-28(31(40)41)20-24-21-35-26-14-6-5-13-25(24)26/h2-6,11-14,21,27-29,35,38H,7-10,15-20,22,34H2,1H3,(H,36,42)(H,37,39)(H,40,41)(H,43,44)/t27-,28-,29+/m0/s1 D0K9YR DRUGINKE UBQFBYMIHFXWBF-YTCPBCGMSA-N D0K9YR DRUGSMIL CS(=O)(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)P(=O)(CC2(CCCC2)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)O D0K9YR HIGHSTAT Terminated D0KC5X DRUG__ID D0KC5X D0KC5X DRUGCOMP Servier D0KC5X DRUGINCH 1S/C12H13ClN2O/c13-10-3-1-2-8-4-5-12(6-9(8)10)7-16-11(14)15-12/h1-3H,4-7H2,(H2,14,15)/t12-/m0/s1 D0KC5X DRUGINKE OAXNLMLMEYQSSS-LBPRGKRZSA-N D0KC5X DRUGSMIL C1CC2(CC3=C1C=CC=C3Cl)COC(=N2)N D0KC5X HIGHSTAT Terminated D0KK4U DRUG__ID D0KK4U D0KK4U DRUGCOMP LEO Pharma A/S D0KK4U DRUGINCH 1S/C16H23NO4/c1-16(2,3)21-15(20)17-13(11-14(18)19)10-9-12-7-5-4-6-8-12/h4-8,13H,9-11H2,1-3H3,(H,17,20)(H,18,19)/t13-/m1/s1 D0KK4U DRUGINKE MYWZFJXOLAXENE-CYBMUJFWSA-N D0KK4U DRUGSMIL CC(C)(C)OC(=O)NC(CCC1=CC=CC=C1)CC(=O)O D0KK4U HIGHSTAT Terminated D0KR3X DRUG__ID D0KR3X D0KR3X DRUGCOMP Ciba-Geigy Corp D0KR3X DRUGINCH 1S/C23H32N2O6S/c1-14(2)19(32-15(3)26)20(27)25-23(11-5-6-12-23)22(30)24-18(21(28)29)13-16-7-9-17(31-4)10-8-16/h7-10,14,18-19H,5-6,11-13H2,1-4H3,(H,24,30)(H,25,27)(H,28,29)/t18-,19-/m0/s1 D0KR3X DRUGINKE POVJRTWSWOOUQR-OALUTQOASA-N D0KR3X DRUGSMIL CC(C)C(C(=O)NC1(CCCC1)C(=O)NC(CC2=CC=C(C=C2)OC)C(=O)O)SC(=O)C D0KR3X HIGHSTAT Terminated D0KW2A DRUG__ID D0KW2A D0KW2A DRUGTYPE Small molecular drug D0KW2A DRUGINCH 1S/C28H26ClN5O2S3/c1-16-31-32-24-13-30-27(18-6-4-5-7-20(18)29)26-19-10-11-33(14-23(19)39-28(26)34(16)24)25(37)15-38-17-8-9-21(35-2)22(12-17)36-3/h4-9,12H,10-11,13-15H2,1-3H3 D0KW2A DRUGINKE MRVWRDZEYURFSW-UHFFFAOYSA-N D0KW2A DRUGSMIL CC1=NN=C2N1C3=C(C4=C(S3)CN(CC4)C(=S)CSC5=CC(=C(C=C5)OC)OC)C(=NC2)C6=CC=CC=C6Cl D0KW2A HIGHSTAT Terminated D0L0CL DRUG__ID D0L0CL D0L0CL DRUGCOMP Pfizer Inc D0L0CL DRUGINCH 1S/C21H23FN2O7S/c22-15-3-5-16(6-4-15)31-17-7-9-18(10-8-17)32(29,30)24(14-11-19(25)26)21(20(27)23-28)12-1-2-13-21/h3-10,28H,1-2,11-14H2,(H,23,27)(H,25,26) D0L0CL DRUGINKE VHHGUBHZBLPTKL-UHFFFAOYSA-N D0L0CL DRUGSMIL C1CCC(C1)(C(=O)NO)N(CCC(=O)O)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)F D0L0CL HIGHSTAT Terminated D0L0UF DRUG__ID D0L0UF D0L0UF DRUGCOMP The Menarini Group D0L0UF DRUGINCH 1S/C38H40N4O3/c1-25-15-17-26(18-16-25)23-36(43)42(2)35(22-27-19-20-28-9-3-4-10-29(28)21-27)38(45)41-34-14-8-7-13-33(34)40-37(44)31-24-39-32-12-6-5-11-30(31)32/h3-6,9-12,15-21,24,33-35,39H,7-8,13-14,22-23H2,1-2H3,(H,40,44)(H,41,45)/t33-,34+,35+/m0/s1 D0L0UF DRUGINKE JXDKAWGCUBTYFX-BMPTZRATSA-N D0L0UF DRUGSMIL CC1=CC=C(C=C1)CC(=O)N(C)C(CC2=CC3=CC=CC=C3C=C2)C(=O)NC4CCCCC4NC(=O)C5=CNC6=CC=CC=C65 D0L0UF HIGHSTAT Terminated D0L1IH DRUG__ID D0L1IH D0L1IH DRUGTYPE Small molecular drug D0L1IH DRUGINCH 1S/C15H13FN2O4/c1-10(18(20)15(17)19)2-5-12-8-9-14(21-12)22-13-6-3-11(16)4-7-13/h3-4,6-10,20H,1H3,(H2,17,19)/t10-/m1/s1 D0L1IH DRUGINKE OLZHFFKRBCZHHT-SNVBAGLBSA-N D0L1IH DRUGSMIL CC(C#CC1=CC=C(O1)OC2=CC=C(C=C2)F)N(C(=O)N)O D0L1IH HIGHSTAT Terminated D0L3AR DRUG__ID D0L3AR D0L3AR DRUGTYPE Small molecular drug D0L3AR DRUGINCH 1S/C28H26O9.Na/c1-32-19-8-5-17(6-9-19)26(29)20(11-16-12-23(33-2)27(35-4)24(13-16)34-3)25(28(30)31)18-7-10-21-22(14-18)37-15-36-21;/h5-10,12-14H,11,15H2,1-4H3,(H,30,31);/q;+1/p-1/b25-20-; D0L3AR DRUGINKE ZLHQEGFYBMZQGM-RKVLWQGQSA-M D0L3AR DRUGSMIL COC1=CC=C(C=C1)C(=O)C(=C(C2=CC3=C(C=C2)OCO3)C(=O)[O-])CC4=CC(=C(C(=C4)OC)OC)OC.[Na+] D0L3AR HIGHSTAT Terminated D0L5AS DRUG__ID D0L5AS D0L5AS DRUGTYPE Small molecular drug D0L5AS DRUGINCH 1S/C20H27N3O3S2/c1-26-20(25)18(8-9-28-2)23-19(24)17-5-3-4-13-10-15(6-7-16(13)17)22-11-14(21)12-27/h3-7,10,14,18,22,27H,8-9,11-12,21H2,1-2H3,(H,23,24)/t14-,18+/m1/s1 D0L5AS DRUGINKE PXCDDWIKPOASGU-KDOFPFPSSA-N D0L5AS DRUGSMIL COC(=O)C(CCSC)NC(=O)C1=CC=CC2=C1C=CC(=C2)NCC(CS)N D0L5AS HIGHSTAT Terminated D0L5TJ DRUG__ID D0L5TJ D0L5TJ DRUGTYPE Small molecular drug D0L5TJ DRUGINCH 1S/C24H24N4O3S/c1-31-18-5-2-4-15-16(18)8-7-14-12-27(13-17(14)15)10-11-28-23(29)22-21(26-24(28)30)20-19(32-22)6-3-9-25-20/h2-6,9,14,17H,7-8,10-13H2,1H3,(H,26,30)/t14-,17+/m0/s1 D0L5TJ DRUGINKE OLPQNRLJYOGSGV-WMLDXEAASA-N D0L5TJ DRUGSMIL COC1=CC=CC2=C1CCC3C2CN(C3)CCN4C(=O)C5=C(C6=C(S5)C=CC=N6)NC4=O D0L5TJ HIGHSTAT Terminated D0L8WH DRUG__ID D0L8WH D0L8WH DRUGTYPE Small molecular drug D0L8WH DRUGINCH 1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1 D0L8WH DRUGINKE HPLNQCPCUACXLM-PGUFJCEWSA-N D0L8WH DRUGSMIL CN(C)CCC(CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-] D0L8WH HIGHSTAT Terminated D0L9SN DRUG__ID D0L9SN D0L9SN DRUGTYPE Small molecular drug D0L9SN DRUGINCH 1S/C23H27N3O3/c1-29-21-11-5-4-10-20(21)25-16-14-24(15-17-25)12-6-7-13-26-22(27)18-8-2-3-9-19(18)23(26)28/h2-5,8-11H,6-7,12-17H2,1H3 D0L9SN DRUGINKE SJDOMIRMMUGQQK-UHFFFAOYSA-N D0L9SN DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)C4=CC=CC=C4C3=O D0L9SN HIGHSTAT Terminated D0LD9S DRUG__ID D0LD9S D0LD9S DRUGTYPE Small molecular drug D0LD9S DRUGINCH 1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2 D0LD9S DRUGINKE PFNFFQXMRSDOHW-UHFFFAOYSA-N D0LD9S DRUGSMIL C(CCNCCCN)CNCCCN D0LD9S HIGHSTAT Terminated D0LT1S DRUG__ID D0LT1S D0LT1S DRUGTYPE Small molecular drug D0LT1S DRUGINCH 1S/C22H23N5O4/c1-26-11-14-9-13(7-8-15(14)23-18(22(26)31)10-20(28)29)21(30)27(2)12-19-24-16-5-3-4-6-17(16)25-19/h3-9,18,23H,10-12H2,1-2H3,(H,24,25)(H,28,29)/t18-/m0/s1 D0LT1S DRUGINKE PVNQAXDNDZYXIW-SFHVURJKSA-N D0LT1S DRUGSMIL CN1CC2=C(C=CC(=C2)C(=O)N(C)CC3=NC4=CC=CC=C4N3)NC(C1=O)CC(=O)O D0LT1S HIGHSTAT Terminated D0LX5D DRUG__ID D0LX5D D0LX5D DRUGTYPE Small molecular drug D0LX5D DRUGINCH 1S/C46H56N10O10/c1-27(51-43(63)35(47)21-31-13-17-33(57)18-14-31)41(61)49-25-39(59)53-37(23-29-9-5-3-6-10-29)45(65)55-56-46(66)38(24-30-11-7-4-8-12-30)54-40(60)26-50-42(62)28(2)52-44(64)36(48)22-32-15-19-34(58)20-16-32/h3-20,27-28,35-38,57-58H,21-26,47-48H2,1-2H3,(H,49,61)(H,50,62)(H,51,63)(H,52,64)(H,53,59)(H,54,60)(H,55,65)(H,56,66)/t27-,28-,35+,36+,37+,38+/m1/s1 D0LX5D DRUGINKE DESSEGDLRYOPTJ-VRANXALZSA-N D0LX5D DRUGSMIL CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NNC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D0LX5D HIGHSTAT Terminated D0M1WN DRUG__ID D0M1WN D0M1WN DRUGTYPE Small molecular drug D0M1WN DRUGINCH 1S/C21H14ClNO3/c22-14-9-10-17-18(12-14)23-21(25)19(20(17)24)13-5-4-8-16(11-13)26-15-6-2-1-3-7-15/h1-12H,(H2,23,24,25) D0M1WN DRUGINKE FLVRDMUHUXVRET-UHFFFAOYSA-N D0M1WN DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)C3=C(C4=C(C=C(C=C4)Cl)NC3=O)O D0M1WN HIGHSTAT Terminated D0M2GI DRUG__ID D0M2GI D0M2GI DRUGCOMP Parke-Davis & Co D0M2GI DRUGINCH 1S/C13H14Cl2N2/c14-9-6-11(15)10-8-17-5-3-1-2-4-13(17)16-12(10)7-9/h6-7H,1-5,8H2 D0M2GI DRUGINKE WTPSHLVHJOJDIF-UHFFFAOYSA-N D0M2GI DRUGSMIL C1CCC2=NC3=C(CN2CC1)C(=CC(=C3)Cl)Cl D0M2GI HIGHSTAT Terminated D0M4LC DRUG__ID D0M4LC D0M4LC DRUGTYPE Small molecular drug D0M4LC DRUGINCH 1S/C24H34O5/c1-3-4-5-7-17(2)22(25)10-9-20-21-15-18(14-19(21)16-23(20)26)11-13-29-12-6-8-24(27)28/h11,17,19-23,25-26H,3,6-8,12-16H2,1-2H3,(H,27,28)/b18-11+/t17-,19-,20+,21-,22+,23+/m0/s1 D0M4LC DRUGINKE MAUUNYHAXGTMMQ-AMXXQSRZSA-N D0M4LC DRUGSMIL CCC#CCC(C)C(C#CC1C(CC2C1CC(=CCOCCCC(=O)O)C2)O)O D0M4LC HIGHSTAT Terminated D0M5NK DRUG__ID D0M5NK D0M5NK DRUGCOMP Novartis AG D0M5NK DRUGINCH 1S/C19H16Cl3NO3/c20-13-2-4-14(5-3-13)25-11-15-10-23-18(24)7-8-19(23,26-15)12-1-6-16(21)17(22)9-12/h1-6,9,15H,7-8,10-11H2/t15-,19+/m0/s1 D0M5NK DRUGINKE AUDZPOJILZPYBI-HNAYVOBHSA-N D0M5NK DRUGSMIL C1CC2(N(C1=O)CC(O2)COC3=CC=C(C=C3)Cl)C4=CC(=C(C=C4)Cl)Cl D0M5NK HIGHSTAT Terminated D0M6JP DRUG__ID D0M6JP D0M6JP DRUGCOMP Servier D0M6JP DRUGINCH 1S/C14H11NOS/c16-14(10-4-2-1-3-5-10)11-6-7-12-13(8-11)17-9-15-12/h1-8,15H,9H2 D0M6JP DRUGINKE BSJCMEIUFYPGNL-UHFFFAOYSA-N D0M6JP DRUGSMIL C1NC2=C(S1)C=C(C=C2)C(=O)C3=CC=CC=C3 D0M6JP HIGHSTAT Terminated D0M6YE DRUG__ID D0M6YE D0M6YE DRUGTYPE Small molecular drug D0M6YE DRUGINCH 1S/C21H35N9O8S2/c1-10(31)27-13-9-40-39-8-12(17(22)35)29-18(36)11(6-16(33)34)28-15(32)7-26-19(37)14(30(2)20(13)38)4-3-5-25-21(23)24/h11-14H,3-9H2,1-2H3,(H2,22,35)(H,26,37)(H,27,31)(H,28,32)(H,29,36)(H,33,34)(H4,23,24,25)/t11-,12-,13-,14-/m0/s1 D0M6YE DRUGINKE WZFJXIKSGKCGRW-XUXIUFHCSA-N D0M6YE DRUGSMIL CC(=O)NC1CSSCC(NC(=O)C(NC(=O)CNC(=O)C(N(C1=O)C)CCCN=C(N)N)CC(=O)O)C(=O)N D0M6YE HIGHSTAT Terminated D0M7MW DRUG__ID D0M7MW D0M7MW DRUGTYPE Small molecular drug D0M7MW DRUGINCH 1S/C19H20N4O3/c1-11-7-13-8-16-17(26-10-25-16)9-15(13)18(22-23(11)19(24)21-2)12-3-5-14(20)6-4-12/h3-6,8-9,11H,7,10,20H2,1-2H3,(H,21,24) D0M7MW DRUGINKE SMGACXZFVXKEAX-UHFFFAOYSA-N D0M7MW DRUGSMIL CC1CC2=CC3=C(C=C2C(=NN1C(=O)NC)C4=CC=C(C=C4)N)OCO3 D0M7MW HIGHSTAT Terminated D0M8AS DRUG__ID D0M8AS D0M8AS DRUGTYPE Small molecular drug D0M8AS DRUGINCH 1S/C23H34N2OS2/c1-18(2)20-14-13-19(22(26)21-12-11-17-27-21)23(24-20)28-16-10-8-6-5-7-9-15-25(3)4/h11-14,17-18H,5-10,15-16H2,1-4H3 D0M8AS DRUGINKE HAGHKJDWBDSFKC-UHFFFAOYSA-N D0M8AS DRUGSMIL CC(C)C1=NC(=C(C=C1)C(=O)C2=CC=CS2)SCCCCCCCCN(C)C D0M8AS HIGHSTAT Terminated D0MA3D DRUG__ID D0MA3D D0MA3D DRUGTYPE Small molecular drug D0MA3D DRUGINCH 1S/C24H32O8S/c1-7-10-31-24-21(29-4)13-16(14-22(24)33(6,25)26)18-9-8-17(32-18)15-11-19(27-2)23(30-5)20(12-15)28-3/h11-14,17-18H,7-10H2,1-6H3/t17-,18-/m0/s1 D0MA3D DRUGINKE NZWPFJNQOZFEDT-ROUUACIJSA-N D0MA3D DRUGSMIL CCCOC1=C(C=C(C=C1S(=O)(=O)C)C2CCC(O2)C3=CC(=C(C(=C3)OC)OC)OC)OC D0MA3D HIGHSTAT Terminated D0N0LB DRUG__ID D0N0LB D0N0LB DRUGTYPE Small molecular drug D0N0LB DRUGINCH 1S/C7H5ClN2O/c8-4-1-2-6-5(3-4)10-7(9)11-6/h1-3H,(H2,9,10) D0N0LB DRUGINKE YGCODSQDUUUKIV-UHFFFAOYSA-N D0N0LB DRUGSMIL C1=CC2=C(C=C1Cl)N=C(O2)N D0N0LB HIGHSTAT Terminated D0N0SB DRUG__ID D0N0SB D0N0SB DRUGCOMP Otsuka Pharmaceutical Co Ltd D0N0SB DRUGINCH 1S/C25H23N7O10S4/c1-9-15(3-17(35)36)46-25(27-9)45-8-16-20(23(39)40)32-12(7-43-16)19(22(32)38)29-21(37)18(11-6-44-24(26)28-11)30-42-5-10-2-13(33)14(34)4-31(10)41/h2,4,6,12,19,34,41H,3,5,7-8H2,1H3,(H2,26,28)(H,29,37)(H,35,36)(H,39,40)/b30-18+/t12-,19+/m1/s1 D0N0SB DRUGINKE CDVRFBGCECZUCK-NXQVOKNZSA-N D0N0SB DRUGSMIL CC1=C(SC(=N1)SCC2=C(N3C(CS2)C(C3=O)NC(=O)C(=NOCC4=CC(=O)C(=CN4O)O)C5=CSC(=N5)N)C(=O)O)CC(=O)O D0N0SB HIGHSTAT Terminated D0N1BC DRUG__ID D0N1BC D0N1BC DRUGTYPE Small molecular drug D0N1BC DRUGINCH 1S/C36H52O11/c1-6-7-19-35(47-34(44)17-16-32(40)41)21-22-36(46-30(35)14-10-25(3)23-33(42)43)20-18-27(5)29(45-36)13-9-24(2)8-12-28(37)26(4)11-15-31(38)39/h8-12,14-15,23,26-30,37H,6-7,13,16-22H2,1-5H3,(H,38,39)(H,40,41)(H,42,43)/b12-8+,14-10+,15-11+,24-9+,25-23+/t26-,27-,28-,29+,30-,35+,36-/m0/s1 D0N1BC DRUGINKE ZESGNAJSBDILTB-OXVOKJAASA-N D0N1BC DRUGSMIL CCCCC1(CCC2(CCC(C(O2)CC=C(C)C=CC(C(C)C=CC(=O)O)O)C)OC1C=CC(=CC(=O)O)C)OC(=O)CCC(=O)O D0N1BC HIGHSTAT Terminated D0N1EF DRUG__ID D0N1EF D0N1EF DRUGTYPE Small molecular drug D0N1EF DRUGINCH 1S/C23H20N2O4S/c1-14-18(24-22(29-14)17-5-3-2-4-6-17)11-12-19(26)16-9-7-15(8-10-16)13-20-21(27)25-23(28)30-20/h2-10,20H,11-13H2,1H3,(H,25,27,28) D0N1EF DRUGINKE QQKNSPHAFATFNQ-UHFFFAOYSA-N D0N1EF DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCC(=O)C3=CC=C(C=C3)CC4C(=O)NC(=O)S4 D0N1EF HIGHSTAT Terminated D0N1XD DRUG__ID D0N1XD D0N1XD DRUGTYPE Small molecular drug D0N1XD DRUGINCH 1S/C13H14N2O4S2/c1-14-10(18)12-5-7-3-2-4-8(17)9(7)15(12)11(19)13(14,6-16)21-20-12/h2-4,8-9,16-17H,5-6H2,1H3/t8-,9-,12+,13+/m0/s1 D0N1XD DRUGINKE FIVPIPIDMRVLAY-RBJBARPLSA-N D0N1XD DRUGSMIL CN1C(=O)C23CC4=CC=CC(C4N2C(=O)C1(SS3)CO)O D0N1XD HIGHSTAT Terminated D0N2CN DRUG__ID D0N2CN D0N2CN DRUGTYPE Small molecular drug D0N2CN DRUGINCH 1S/C14H13ClN4O/c15-11-3-1-10(2-4-11)7-13-18-14(20-19-13)6-5-12-8-16-9-17-12/h1-4,8-9H,5-7H2,(H,16,17) D0N2CN DRUGINKE CPOUJACQGWJJQB-UHFFFAOYSA-N D0N2CN DRUGSMIL C1=CC(=CC=C1CC2=NOC(=N2)CCC3=CN=CN3)Cl D0N2CN HIGHSTAT Terminated D0N6OE DRUG__ID D0N6OE D0N6OE DRUGTYPE Small molecular drug D0N6OE DRUGINCH 1S/C23H27N3O3.2C4H4O4/c1-14(27)24-16-7-5-15(6-8-16)23-18-12-22(29-4)21(28-3)11-17(18)19-13-26(2)10-9-20(19)25-23;2*5-3(6)1-2-4(7)8/h5-8,11-12,19-20H,9-10,13H2,1-4H3,(H,24,27);2*1-2H,(H,5,6)(H,7,8)/b;2*2-1+/t19-,20-;;/m1../s1 D0N6OE DRUGINKE BWJFLHODOYZAML-GODXOYSCSA-N D0N6OE DRUGSMIL CC(=O)NC1=CC=C(C=C1)C2=NC3CCN(CC3C4=CC(=C(C=C42)OC)OC)C.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O D0N6OE HIGHSTAT Terminated D0N7LZ DRUG__ID D0N7LZ D0N7LZ DRUGTYPE Small molecular drug D0N7LZ DRUGINCH 1S/C14H14ClNS/c1-3-12-10-8-16(2)7-6-9-11(15)4-5-13(17-12)14(9)10/h3-5H,1,6-8H2,2H3 D0N7LZ DRUGINKE WKXSXFYQPCWZOS-UHFFFAOYSA-N D0N7LZ DRUGSMIL CN1CCC2=C(C=CC3=C2C(=C(S3)C=C)C1)Cl D0N7LZ HIGHSTAT Terminated D0N8XL DRUG__ID D0N8XL D0N8XL DRUGCOMP Bristol-Myers Squibb Co D0N8XL DRUGINCH 1S/C35H47N5O9S/c1-9-21-18-35(21,31(43)39-50(45,46)24-11-12-24)38-28(41)26-17-23(48-29-25-13-10-22(47-8)16-20(25)14-15-36-29)19-40(26)30(42)27(33(2,3)4)37-32(44)49-34(5,6)7/h9-10,13-16,21,23-24,26-27H,1,11-12,17-19H2,2-8H3,(H,37,44)(H,38,41)(H,39,43)/t21-,23-,26+,27-,35-/m1/s1 D0N8XL DRUGINKE IYWRCNFZPNEADN-CXODAYGWSA-N D0N8XL DRUGSMIL CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=CC5=C4C=CC(=C5)OC)NC(=O)OC(C)(C)C D0N8XL HIGHSTAT Terminated D0NK8D DRUG__ID D0NK8D D0NK8D DRUGTYPE Small molecular drug D0NK8D DRUGINCH 1S/C31H41NO7/c1-4-6-23-26(14-10-21-9-11-22(39-29(21)23)12-16-28(33)34)37-17-5-18-38-27-15-13-24(31(35)32-2)30(36-3)25(27)19-20-7-8-20/h10,13-15,20,22H,4-9,11-12,16-19H2,1-3H3,(H,32,35)(H,33,34)/t22-/m0/s1 D0NK8D DRUGINKE YWYUQSGYKDEAMJ-QFIPXVFZSA-N D0NK8D DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)CCC(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)NC)OC)CC4CC4 D0NK8D HIGHSTAT Terminated D0NQ5I DRUG__ID D0NQ5I D0NQ5I DRUGTYPE Small molecular drug D0NQ5I DRUGINCH 1S/C18H21N5O4/c1-10-4-2-3-5-11(10)6-19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)12(7-24)27-18/h2-5,8-9,12,14-15,18,24-26H,6-7H2,1H3,(H,19,20,21)/t12-,14-,15-,18-/m1/s1 D0NQ5I DRUGINKE OOEMZCZWZXHBKW-SCFUHWHPSA-N D0NQ5I DRUGSMIL CC1=CC=CC=C1CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D0NQ5I HIGHSTAT Terminated D0O0JH DRUG__ID D0O0JH D0O0JH DRUGCOMP Sankyo Co Ltd D0O0JH DRUGINCH 1S/C21H28O4/c1-12-6-7-17-20(2,3)8-5-9-21(17,4)14(12)10-13-18(24)15(22)11-16(23)19(13)25/h11,14,17,22,25H,1,5-10H2,2-4H3/t14-,17-,21+/m0/s1 D0O0JH DRUGINKE KFAYECQGXSDHKU-XXHMAFKTSA-N D0O0JH DRUGSMIL CC1(CCCC2(C1CCC(=C)C2CC3=C(C(=O)C=C(C3=O)O)O)C)C D0O0JH HIGHSTAT Terminated D0O2AC DRUG__ID D0O2AC D0O2AC DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0O2AC DRUGINCH 1S/C30H22ClF3N2O2/c1-18-7-12-26-23(13-18)28(20-8-10-21(31)11-9-20)27(38-26)17-36(16-19-5-3-2-4-6-19)30(37)35-29-24(33)14-22(32)15-25(29)34/h2-15H,16-17H2,1H3,(H,35,37) D0O2AC DRUGINKE GJRPAGNTTAPJCC-UHFFFAOYSA-N D0O2AC DRUGSMIL CC1=CC2=C(C=C1)OC(=C2C3=CC=C(C=C3)Cl)CN(CC4=CC=CC=C4)C(=O)NC5=C(C=C(C=C5F)F)F D0O2AC HIGHSTAT Terminated D0O3FX DRUG__ID D0O3FX D0O3FX DRUGTYPE Small molecular drug D0O3FX DRUGINCH 1S/C9H8N2O2/c1-5-10-8-6(9(13)11-5)3-2-4-7(8)12/h2-4,12H,1H3,(H,10,11,13) D0O3FX DRUGINKE YJDAOHJWLUNFLX-UHFFFAOYSA-N D0O3FX DRUGSMIL CC1=NC2=C(C=CC=C2O)C(=O)N1 D0O3FX HIGHSTAT Terminated D0O4JH DRUG__ID D0O4JH D0O4JH THERCLAS Analgesics D0O4JH DRUGINCH 1S/C10H9N3O4/c1-4-3-6-7(8(5(4)2)13(16)17)12-10(15)9(14)11-6/h3H,1-2H3,(H,11,14)(H,12,15) D0O4JH DRUGINKE CYJRVSOLVYLORV-UHFFFAOYSA-N D0O4JH DRUGSMIL CC1=CC2=C(C(=C1C)[N+](=O)[O-])NC(=O)C(=O)N2 D0O4JH HIGHSTAT Terminated D0O6GN DRUG__ID D0O6GN D0O6GN DRUGTYPE Small molecular drug D0O6GN DRUGINCH 1S/C29H37F5N4O6/c1-16(2)21(23(39)28(30,31)29(32,33)34)35-25(41)20-6-5-11-38(20)27(43)22(17(3)4)36-24(40)18-7-9-19(10-8-18)26(42)37-12-14-44-15-13-37/h7-10,16-17,20-22H,5-6,11-15H2,1-4H3,(H,35,41)(H,36,40)/t20-,21-,22-/m1/s1 D0O6GN DRUGINKE XQAMVCHQGHAELT-YPAWHYETSA-N D0O6GN DRUGSMIL CC(C)C(C(=O)C(C(F)(F)F)(F)F)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C2=CC=C(C=C2)C(=O)N3CCOCC3 D0O6GN HIGHSTAT Terminated D0O6RU DRUG__ID D0O6RU D0O6RU DRUGCOMP CJ Corp D0O6RU DRUGINCH 1S/C52H85N11O22/c1-2-3-4-5-6-7-8-9-26(53)16-29(67)19-30(85-52-44(76)42(74)35(68)24-84-52)17-27-18-36(69)59-34(23-65)49(81)63-39(41(73)25-10-12-28(66)13-11-25)51(83)60-32(20-38(71)72)48(80)61-33(22-64)47(79)57-21-37(70)56-15-14-31(54)46(78)62-40(50(82)58-27)43(75)45(55)77/h10-13,26-27,29-35,39-44,52,64-68,73-76H,2-9,14-24,53-54H2,1H3,(H2,55,77)(H,56,70)(H,57,79)(H,58,82)(H,59,69)(H,60,83)(H,61,80)(H,62,78)(H,63,81)(H,71,72) D0O6RU DRUGINKE AHNDNUVPXFPPIH-UHFFFAOYSA-N D0O6RU DRUGSMIL CCCCCCCCCC(CC(CC(CC1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NCCC(C(=O)NC(C(=O)N1)C(C(=O)N)O)N)CO)CC(=O)O)C(C2=CC=C(C=C2)O)O)CO)OC3C(C(C(CO3)O)O)O)O)N D0O6RU HIGHSTAT Terminated D0O6SQ DRUG__ID D0O6SQ D0O6SQ DRUGCOMP Roche Holding AG D0O6SQ DRUGINCH 1S/C29H26F2N6O9S/c30-17-7-15-22(36(14-1-2-14)9-16(24(15)39)27(41)42)19(31)23(17)35-6-4-13(8-35)33-29(45)46-10-12-11-47-26-20(34-18(38)3-5-32)25(40)37(26)21(12)28(43)44/h7,9,13-14,20,26H,1-4,6,8,10-11H2,(H,33,45)(H,34,38)(H,41,42)(H,43,44)/t13-,20+,26+/m0/s1 D0O6SQ DRUGINKE UTMBXIHIDJLCKA-JCKKSSKCSA-N D0O6SQ DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)F)N4CCC(C4)NC(=O)OCC5=C(N6C(C(C6=O)NC(=O)CC#N)SC5)C(=O)O)F)C(=O)O D0O6SQ HIGHSTAT Terminated D0O6UF DRUG__ID D0O6UF D0O6UF DRUGCOMP Glaxo Wellcome plc D0O6UF DRUGINCH 1S/C16H18ClNOS.ClH/c1-18(2)10-12-5-3-4-6-15(12)20-16-8-7-14(17)9-13(16)11-19;/h3-9,19H,10-11H2,1-2H3;1H D0O6UF DRUGINKE UTHAGXYCVSCSKS-UHFFFAOYSA-N D0O6UF DRUGSMIL CN(C)CC1=CC=CC=C1SC2=C(C=C(C=C2)Cl)CO.Cl D0O6UF HIGHSTAT Terminated D0O7DB DRUG__ID D0O7DB D0O7DB DRUGCOMP Abbott Laboratories D0O7DB DRUGINCH 1S/C14H17N3O2S/c1-20(18,19)17-13-7-3-4-10-11(13)5-2-6-12(10)14-8-15-9-16-14/h3-4,7-9,12,17H,2,5-6H2,1H3,(H,15,16) D0O7DB DRUGINKE FTWWLMPVXHMPNP-UHFFFAOYSA-N D0O7DB DRUGSMIL CS(=O)(=O)NC1=CC=CC2=C1CCCC2C3=CN=CN3 D0O7DB HIGHSTAT Terminated D0O7DU DRUG__ID D0O7DU D0O7DU DRUGCOMP Celltech Therapeutics Ltd D0O7DU DRUGINCH 1S/C19H28ClN3O4/c1-19(2,3)16(17(21)25)22-18(26)13(11-15(24)23-27)6-4-5-12-7-9-14(20)10-8-12/h7-10,13,16,27H,4-6,11H2,1-3H3,(H2,21,25)(H,22,26)(H,23,24)/t13-,16-/m1/s1 D0O7DU DRUGINKE CZCIELLKWLGEFJ-CZUORRHYSA-N D0O7DU DRUGSMIL CC(C)(C)C(C(=O)N)NC(=O)C(CCCC1=CC=C(C=C1)Cl)CC(=O)NO D0O7DU HIGHSTAT Terminated D0O8ZE DRUG__ID D0O8ZE D0O8ZE DRUGTYPE Small molecular drug D0O8ZE DRUGINCH 1S/C22H25NO2/c1-2-3-4-12-22(24)18-9-7-10-20(15-18)25-16-19-14-13-17-8-5-6-11-21(17)23-19/h5-11,13-15,22,24H,2-4,12,16H2,1H3 D0O8ZE DRUGINKE JRLOEMCOOZSCQP-UHFFFAOYSA-N D0O8ZE DRUGSMIL CCCCCC(C1=CC(=CC=C1)OCC2=NC3=CC=CC=C3C=C2)O D0O8ZE HIGHSTAT Terminated D0O9JX DRUG__ID D0O9JX D0O9JX DRUGTYPE Small molecular drug D0O9JX DRUGINCH 1S/C20H19FO2S/c1-24(22,23)17-8-4-15(5-9-17)19-13-20(10-11-20)12-18(19)14-2-6-16(21)7-3-14/h2-9H,10-13H2,1H3 D0O9JX DRUGINKE VZCIAZMKVAJRCL-UHFFFAOYSA-N D0O9JX DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=C(CC3(C2)CC3)C4=CC=C(C=C4)F D0O9JX HIGHSTAT Terminated D0OH5V DRUG__ID D0OH5V D0OH5V DRUGTYPE Small molecular drug D0OH5V DRUGINCH 1S/C21H25N5O4/c22-6-1-7-24-12-2-3-13-17-16(12)21(30)19-15(29)5-4-14(28)18(19)20(17)25-26(13)10-8-23-9-11-27/h2-5,23,25,27,29-30H,1,6-11,22H2 D0OH5V DRUGINKE UKNVCOILWOLTLJ-UHFFFAOYSA-N D0OH5V DRUGSMIL C1=CC(=NCCCN)C2=C(C3=C(C=CC(=O)C3=C4C2=C1N(N4)CCNCCO)O)O D0OH5V HIGHSTAT Terminated D0OK8M DRUG__ID D0OK8M D0OK8M DRUGCOMP Teijin Ltd D0OK8M DRUGINCH 1S/C24H37NO4/c1-5-6-7-8-9-10-11-12-16-24(2,3)23(27)25-21-20(28-4)14-13-18-19(26)15-17-29-22(18)21/h13-14H,5-12,15-17H2,1-4H3,(H,25,27) D0OK8M DRUGINKE DJBINNZKEHJIFK-UHFFFAOYSA-N D0OK8M DRUGSMIL CCCCCCCCCCC(C)(C)C(=O)NC1=C(C=CC2=C1OCCC2=O)OC D0OK8M HIGHSTAT Terminated D0ON2X DRUG__ID D0ON2X D0ON2X DRUGTYPE Small molecular drug D0ON2X DRUGINCH 1S/C30H27Cl2N5O4/c1-18-7-10-21-5-4-6-25(30(21)35-18)41-17-22-23(31)11-12-24(29(22)32)37(3)28(40)16-34-27(39)14-9-20-8-13-26(33-15-20)36-19(2)38/h4-15H,16-17H2,1-3H3,(H,34,39)(H,33,36,38)/b14-9+ D0ON2X DRUGINKE XCKWRUGRUFVXGC-NTEUORMPSA-N D0ON2X DRUGSMIL CC1=NC2=C(C=CC=C2OCC3=C(C=CC(=C3Cl)N(C)C(=O)CNC(=O)C=CC4=CN=C(C=C4)NC(=O)C)Cl)C=C1 D0ON2X HIGHSTAT Terminated D0OU7P DRUG__ID D0OU7P D0OU7P DRUGTYPE Small molecular drug D0OU7P DRUGINCH 1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2 D0OU7P DRUGINKE JUDKOGFHZYMDMF-UHFFFAOYSA-N D0OU7P DRUGSMIL C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3 D0OU7P HIGHSTAT Terminated D0OW1R DRUG__ID D0OW1R D0OW1R DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D0OW1R DRUGINCH 1S/C23H26ClN3O3/c1-30-21-12-20(26-22(28)16-7-8-16)19(24)11-18(21)23(29)25-17-9-10-27(14-17)13-15-5-3-2-4-6-15/h2-6,11-12,16-17H,7-10,13-14H2,1H3,(H,25,29)(H,26,28)/t17-/m0/s1 D0OW1R DRUGINKE CPVZPPFHQBIJNB-KRWDZBQOSA-N D0OW1R DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CCN(C2)CC3=CC=CC=C3)Cl)NC(=O)C4CC4 D0OW1R HIGHSTAT Terminated D0OW2O DRUG__ID D0OW2O D0OW2O DRUGTYPE Small molecular drug D0OW2O DRUGINCH 1S/C30H35F2N3O2/c1-21(2)24-3-4-25(30(37)28(19-24)33-13-18-36)20-34-14-16-35(17-15-34)29(22-5-9-26(31)10-6-22)23-7-11-27(32)12-8-23/h3-12,19,21,29,36H,13-18,20H2,1-2H3,(H,33,37) D0OW2O DRUGINKE UVPCKMJVJLKETQ-UHFFFAOYSA-N D0OW2O DRUGSMIL CC(C)C1=CC=C(C(=O)C(=C1)NCCO)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0OW2O HIGHSTAT Terminated D0OW6Z DRUG__ID D0OW6Z D0OW6Z DRUGCOMP Takeda Pharmaceutical Co Ltd D0OW6Z DRUGINCH 1S/C25H25N3O4S/c1-2-31-24-20(10-13-23(29)30)15-28(27-24)14-18-8-11-22(12-9-18)32-16-21-17-33-25(26-21)19-6-4-3-5-7-19/h3-9,11-12,15,17H,2,10,13-14,16H2,1H3,(H,29,30) D0OW6Z DRUGINKE SRFCAWATPLCLMG-UHFFFAOYSA-N D0OW6Z DRUGSMIL CCOC1=NN(C=C1CCC(=O)O)CC2=CC=C(C=C2)OCC3=CSC(=N3)C4=CC=CC=C4 D0OW6Z HIGHSTAT Terminated D0P1JI DRUG__ID D0P1JI D0P1JI DRUGTYPE Small molecular drug D0P1JI DRUGINCH 1S/C23H24O8/c1-10(24)30-13-7-22(2)12(5-6-14(22)25)16-18(13)23(3)15(9-28-4)31-21(27)11-8-29-20(17(11)23)19(16)26/h8,12-13,15H,5-7,9H2,1-4H3/t12-,13+,15+,22-,23-/m0/s1 D0P1JI DRUGINKE QDLHCMPXEPAAMD-QAIWCSMKSA-N D0P1JI DRUGSMIL CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C5=COC(=C54)C3=O)COC)C)C D0P1JI HIGHSTAT Terminated D0P2YS DRUG__ID D0P2YS D0P2YS DRUGTYPE Small molecular drug D0P2YS DRUGINCH 1S/C20H27NO3/c21-10-17-14-1-2-16(22)19(23)15(14)6-18(24-17)20-7-11-3-12(8-20)5-13(4-11)9-20/h1-2,11-13,17-18,22-23H,3-10,21H2/t11?,12?,13?,17-,18-,20?/m0/s1 D0P2YS DRUGINKE QLJOSZATCBCBDR-DFKUFRTHSA-N D0P2YS DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4CC5=C(C=CC(=C5O)O)C(O4)CN D0P2YS HIGHSTAT Terminated D0P3IZ DRUG__ID D0P3IZ D0P3IZ DRUGCOMP Eisai Co Ltd D0P3IZ DRUGINCH 1S/C15H23BN2O3/c1-6-19-12-9-13(17)18-10-11(12)7-8-16-20-14(2,3)15(4,5)21-16/h7-10H,6H2,1-5H3,(H2,17,18)/b8-7+ D0P3IZ DRUGINKE LHNZICNYYCFWCS-BQYQJAHWSA-N D0P3IZ DRUGSMIL B1(OC(C(O1)(C)C)(C)C)C=CC2=CN=C(C=C2OCC)N D0P3IZ HIGHSTAT Terminated D0P6CN DRUG__ID D0P6CN D0P6CN DRUGCOMP Xenova Ltd D0P6CN DRUGINCH 1S/C22H30O4/c1-13-6-7-15-19-16-14(12-25-19)17(23)18(24)20(16)26-22(15,4)10-5-9-21(2,3)11-8-13/h5,8-9,14-16,19,24H,6-7,10-12H2,1-4H3/b9-5+,13-8+/t14-,15-,16-,19-,22+/m0/s1 D0P6CN DRUGINKE WDFUVZRTUNQXHC-KVPIFFDFSA-N D0P6CN DRUGSMIL CC1=CCC(C=CCC2(C(CC1)C3C4C(CO3)C(=O)C(=C4O2)O)C)(C)C D0P6CN HIGHSTAT Terminated D0P6EL DRUG__ID D0P6EL D0P6EL DRUGCOMP The Procter & Gamble Co D0P6EL DRUGINCH 1S/C27H45NO7/c1-14-20(29)21(30)22(31)24(34-14)35-16-7-10-25(2)15(13-16)5-6-18-17(25)8-11-26(3)19(23(32)33-4)9-12-27(18,26)28/h14-22,24,29-31H,5-13,28H2,1-4H3/t14-,15+,16-,17-,18+,19+,20-,21+,22+,24-,25-,26+,27-/m0/s1 D0P6EL DRUGINKE HKWLCBGLVAWZRK-CBYCSKBWSA-N D0P6EL DRUGSMIL CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C(=O)OC)N)C)C)O)O)O D0P6EL HIGHSTAT Terminated D0PA6K DRUG__ID D0PA6K D0PA6K DRUGTYPE Small molecular drug D0PA6K DRUGINCH 1S/C23H32N2O3/c1-13(2)25-12-16-10-21-19(18-7-6-8-20(25)22(16)18)9-17(11-24(21)5)23(27)28-15(4)14(3)26/h6-8,12-15,17,19,21,26H,9-11H2,1-5H3/t14?,15?,17-,19-,21-/m1/s1 D0PA6K DRUGINKE JQYLIGHHVGCTPR-LYRPIDSHSA-N D0PA6K DRUGSMIL CC(C)N1C=C2CC3C(CC(CN3C)C(=O)OC(C)C(C)O)C4=C2C1=CC=C4 D0PA6K HIGHSTAT Terminated D0PG0S DRUG__ID D0PG0S D0PG0S DRUGCOMP Warner-Lambert Co D0PG0S DRUGINCH 1S/C25H35NO5S.Na/c1-15(2)19-11-9-12-20(16(3)4)23(19)30-25(27)26-32(28,29)31-24-21(17(5)6)13-10-14-22(24)18(7)8;/h9-18H,1-8H3,(H,26,27);/q;+1/p-1 D0PG0S DRUGINKE XVUJDEGOJDKQDX-UHFFFAOYSA-M D0PG0S DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)OC(=NS(=O)(=O)OC2=C(C=CC=C2C(C)C)C(C)C)[O-].[Na+] D0PG0S HIGHSTAT Terminated D0PM9P DRUG__ID D0PM9P D0PM9P DRUGTYPE Small molecular drug D0PM9P DRUGINCH 1S/C18H16FN3O4S.ClH/c1-20-2-4-21(5-3-20)14-11(19)6-10-13-16(14)26-7-9-8-27-17(22(9)13)12(15(10)23)18(24)25;/h6,8H,2-5,7H2,1H3,(H,24,25);1H D0PM9P DRUGINKE YNPLQSCXSPGFPU-UHFFFAOYSA-N D0PM9P DRUGSMIL CN1CCN(CC1)C2=C(C=C3C4=C2OCC5=CSC(=C(C3=O)C(=O)O)N54)F.Cl D0PM9P HIGHSTAT Terminated D0PZ9R DRUG__ID D0PZ9R D0PZ9R DRUGTYPE Small molecular drug D0PZ9R DRUGINCH 1S/C16H25N3OS.ClH/c1-2-3-4-5-10-21-16-15(17-7-8-18-16)20-14-12-19-9-6-13(14)11-19;/h7-8,13-14H,2-6,9-12H2,1H3;1H/t13?,14-;/m0./s1 D0PZ9R DRUGINKE QAXRREHLPKHWBI-IJDFPQMLSA-N D0PZ9R DRUGSMIL CCCCCCSC1=NC=CN=C1OC2CN3CCC2C3.Cl D0PZ9R HIGHSTAT Terminated D0Q1ER DRUG__ID D0Q1ER D0Q1ER DRUGTYPE Small molecular drug D0Q1ER DRUGINCH 1S/C17H17F3N4.2C4H4O4/c1-22-7-9-23(10-8-22)16-15-3-2-6-24(15)14-5-4-12(17(18,19)20)11-13(14)21-16;2*5-3(6)1-2-4(7)8/h2-6,11H,7-10H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1- D0Q1ER DRUGINKE HTEVMLYDEWVIQE-SPIKMXEPSA-N D0Q1ER DRUGSMIL CN1CCN(CC1)C2=NC3=C(C=CC(=C3)C(F)(F)F)N4C2=CC=C4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O D0Q1ER HIGHSTAT Terminated D0Q1RC DRUG__ID D0Q1RC D0Q1RC DRUGTYPE Small molecular drug D0Q1RC DRUGINCH 1S/C20H16FN3O4/c21-13-7-11-16-19(17(13)23-6-5-10(22)8-23)28-15-4-2-1-3-14(15)24(16)9-12(18(11)25)20(26)27/h1-4,7,9-10H,5-6,8,22H2,(H,26,27)/t10-/m0/s1 D0Q1RC DRUGINKE OLNJLTFSGFZCKE-JTQLQIEISA-N D0Q1RC DRUGSMIL C1CN(CC1N)C2=C(C=C3C4=C2OC5=CC=CC=C5N4C=C(C3=O)C(=O)O)F D0Q1RC HIGHSTAT Terminated D0Q1UR DRUG__ID D0Q1UR D0Q1UR DRUGTYPE Small molecular drug D0Q1UR DRUGINCH 1S/C19H23NO4S/c1-12-16(18(21)23-4)13(2)20-14(3)17(12)19(22)24-10-11-25-15-8-6-5-7-9-15/h5-9,12,20H,10-11H2,1-4H3 D0Q1UR DRUGINKE DHCNAWNKZMNTIS-UHFFFAOYSA-N D0Q1UR DRUGSMIL CC1C(=C(NC(=C1C(=O)OCCSC2=CC=CC=C2)C)C)C(=O)OC D0Q1UR HIGHSTAT Terminated D0Q3SP DRUG__ID D0Q3SP D0Q3SP DRUGCOMP NPS Pharmaceuticals Inc D0Q3SP DRUGINCH 1S/C16H17F2N/c1-11(10-19)16(12-4-2-6-14(17)8-12)13-5-3-7-15(18)9-13/h2-9,11,16H,10,19H2,1H3/t11-/m0/s1 D0Q3SP DRUGINKE WEEQOTXCUZRCLD-NSHDSACASA-N D0Q3SP DRUGSMIL CC(CN)C(C1=CC(=CC=C1)F)C2=CC(=CC=C2)F D0Q3SP HIGHSTAT Terminated D0Q3ZN DRUG__ID D0Q3ZN D0Q3ZN DRUGCOMP Gilead Sciences Inc D0Q3ZN DRUGINCH 1S/C13H19ClN4O2/c1-13(2,3)20-12(19)18-8-6-17(7-9-18)11-10(14)15-4-5-16-11/h4-5H,6-9H2,1-3H3 D0Q3ZN DRUGINKE IJINSJSWDSHUBL-UHFFFAOYSA-N D0Q3ZN DRUGSMIL CC(C)(C)OC(=O)N1CCN(CC1)C2=NC=CN=C2Cl D0Q3ZN HIGHSTAT Terminated D0Q6YP DRUG__ID D0Q6YP D0Q6YP DRUGTYPE Small molecular drug D0Q6YP DRUGINCH 1S/C15H18O4/c1-7-6-10-12(8(2)14(18)19-10)13(17)15(3)9(7)4-5-11(15)16/h4-5,7,9-10,12-13,17H,2,6H2,1,3H3/t7-,9+,10-,12-,13+,15+/m1/s1 D0Q6YP DRUGINKE ZVLOPMNVFLSSAA-XEPQRQSNSA-N D0Q6YP DRUGSMIL CC1CC2C(C(C3(C1C=CC3=O)C)O)C(=C)C(=O)O2 D0Q6YP HIGHSTAT Terminated D0Q7SO DRUG__ID D0Q7SO D0Q7SO DRUGCOMP Roche Bioscience D0Q7SO DRUGINCH 1S/C27H25N5O2/c1-2-3-16-32-23-11-7-6-10-22(23)25(27(33)34)24(32)17-18-12-14-19(15-13-18)20-8-4-5-9-21(20)26-28-30-31-29-26/h4-15H,2-3,16-17H2,1H3,(H,33,34)(H,28,29,30,31) D0Q7SO DRUGINKE LGRDYINVULLPLL-UHFFFAOYSA-N D0Q7SO DRUGSMIL CCCCN1C2=CC=CC=C2C(=C1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O D0Q7SO HIGHSTAT Terminated D0Q8YA DRUG__ID D0Q8YA D0Q8YA DRUGTYPE Small molecular drug D0Q8YA DRUGINCH 1S/C28H30N4O/c1-21-30-26-19-29-15-12-27(26)32(21)20-22-13-16-31(17-14-22)28(33)18-25(23-8-4-2-5-9-23)24-10-6-3-7-11-24/h2-12,15,19,22,25H,13-14,16-18,20H2,1H3 D0Q8YA DRUGINKE HXCOKIFMWJDWPX-UHFFFAOYSA-N D0Q8YA DRUGSMIL CC1=NC2=C(N1CC3CCN(CC3)C(=O)CC(C4=CC=CC=C4)C5=CC=CC=C5)C=CN=C2 D0Q8YA HIGHSTAT Terminated D0Q9XI DRUG__ID D0Q9XI D0Q9XI DRUGTYPE Small molecular drug D0Q9XI DRUGINCH 1S/C36H44N6O6/c1-23(2)17-29(40-36(48)41-15-9-3-4-10-16-41)33(44)38-30(19-25-21-42(22-43)32-14-8-6-12-27(25)32)34(45)39-31(35(46)47)18-24-20-37-28-13-7-5-11-26(24)28/h5-8,11-14,20-23,29-31,37H,3-4,9-10,15-19H2,1-2H3,(H,38,44)(H,39,45)(H,40,48)(H,46,47)/t29-,30+,31+/m0/s1 D0Q9XI DRUGINKE QHSRPPJQBFQWSC-OJDZSJEKSA-N D0Q9XI DRUGSMIL CC(C)CC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C=O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)NC(=O)N5CCCCCC5 D0Q9XI HIGHSTAT Terminated D0QI8I DRUG__ID D0QI8I D0QI8I DRUGTYPE Small molecular drug D0QI8I DRUGINCH 1S/C18H13NO4/c1-23-18(22)13-8-4-5-9-14(13)19-15-10-16(20)17(21)12-7-3-2-6-11(12)15/h2-10,19H,1H3 D0QI8I DRUGINKE PEJZAKFAABRDEN-UHFFFAOYSA-N D0QI8I DRUGSMIL COC(=O)C1=CC=CC=C1NC2=CC(=O)C(=O)C3=CC=CC=C32 D0QI8I HIGHSTAT Terminated D0R1DP DRUG__ID D0R1DP D0R1DP DRUGCOMP Abbott Laboratories D0R1DP DRUGINCH 1S/C29H34N2O3/c1-34-24-6-4-5-17-7-8-18-15-30(16-23(18)25(17)24)13-2-3-14-31-28(32)26-21-11-12-22(27(26)29(31)33)20-10-9-19(20)21/h4-6,9-12,18-23,26-27H,2-3,7-8,13-16H2,1H3/t18-,19?,20?,21-,22+,23-,26?,27?/m1/s1 D0R1DP DRUGINKE FIVMUTRIOVYDHZ-TZNWWNPGSA-N D0R1DP DRUGSMIL COC1=CC=CC2=C1C3CN(CC3CC2)CCCCN4C(=O)C5C6C=CC(C5C4=O)C7C6C=C7 D0R1DP HIGHSTAT Terminated D0R2TM DRUG__ID D0R2TM D0R2TM DRUGTYPE Small molecular drug D0R2TM DRUGINCH 1S/C28H26N2O10/c31-16-8-6-14(7-9-16)26(36)30-18-13-29-10-2-5-22(18)40-28(39)15-11-20(33)24(21(34)12-15)25(35)23-17(27(37)38)3-1-4-19(23)32/h1,3-4,6-9,11-12,18,22,29,31-34H,2,5,10,13H2,(H,30,36)(H,37,38)/t18-,22-/m1/s1 D0R2TM DRUGINKE XYUFCXJZFZPEJD-XMSQKQJNSA-N D0R2TM DRUGSMIL C1CC(C(CNC1)NC(=O)C2=CC=C(C=C2)O)OC(=O)C3=CC(=C(C(=C3)O)C(=O)C4=C(C=CC=C4O)C(=O)O)O D0R2TM HIGHSTAT Terminated D0R5TT DRUG__ID D0R5TT D0R5TT DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0R5TT DRUGINCH 1S/C17H12FN3O2S/c1-24(22,23)16-8-2-12(3-9-16)17-10-14(11-19)20-21(17)15-6-4-13(18)5-7-15/h2-10H,1H3 D0R5TT DRUGINKE NKBRWXWNSUIHNI-UHFFFAOYSA-N D0R5TT DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)F)C#N D0R5TT HIGHSTAT Terminated D0R5ZJ DRUG__ID D0R5ZJ D0R5ZJ DRUGCOMP Taisho Pharmaceutical Co Ltd D0R5ZJ DRUGINCH 1S/C26H30O5/c1-18(2)14-15-30-21-11-12-22(24(16-21)31-17-25(28)29)23(27)13-8-19-6-9-20(10-7-19)26(3,4)5/h6-14,16H,15,17H2,1-5H3,(H,28,29)/b13-8+ D0R5ZJ DRUGINKE ANQKJBMYDIXLBL-MDWZMJQESA-N D0R5ZJ DRUGSMIL CC(=CCOC1=CC(=C(C=C1)C(=O)C=CC2=CC=C(C=C2)C(C)(C)C)OCC(=O)O)C D0R5ZJ HIGHSTAT Terminated D0R5ZR DRUG__ID D0R5ZR D0R5ZR DRUGTYPE Small molecular drug D0R5ZR DRUGINCH 1S/C28H28N4O2/c1-30(2)15-17-12-13-32-22-11-7-5-9-19(22)24(23(32)14-17)26-25(27(33)29-28(26)34)20-16-31(3)21-10-6-4-8-18(20)21/h4-11,16-17H,12-15H2,1-3H3,(H,29,33,34)/t17-/m0/s1 D0R5ZR DRUGINKE FXGHOAZJQNLNFD-KRWDZBQOSA-N D0R5ZR DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C5CC(CCN5C6=CC=CC=C64)CN(C)C D0R5ZR HIGHSTAT Terminated D0R7GL DRUG__ID D0R7GL D0R7GL DRUGTYPE Small molecular drug D0R7GL DRUGINCH 1S/C21H25NO4/c1-21(13-24,14-25)22-12-19-15-6-2-4-8-17(15)20(26-11-10-23)18-9-5-3-7-16(18)19/h2-9,22-25H,10-14H2,1H3 D0R7GL DRUGINKE JPCHHZXQVHSGGC-UHFFFAOYSA-N D0R7GL DRUGSMIL CC(CO)(CO)NCC1=C2C=CC=CC2=C(C3=CC=CC=C31)OCCO D0R7GL HIGHSTAT Terminated D0R7MJ DRUG__ID D0R7MJ D0R7MJ DRUGTYPE Small molecular drug D0R7MJ DRUGINCH 1S/C11H8O5/c12-6-3-1-2-5-4-7(13)10(15)11(16)8(5)9(6)14/h1-4,13,15-16H,(H,12,14) D0R7MJ DRUGINKE WDGFFVCWBZVLCE-UHFFFAOYSA-N D0R7MJ DRUGSMIL C1=CC2=CC(=C(C(=C2C(=O)C(=C1)O)O)O)O D0R7MJ HIGHSTAT Terminated D0R7MN DRUG__ID D0R7MN D0R7MN DRUGTYPE Small molecular drug D0R7MN DRUGINCH 1S/C36H59N2O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-26-37-36(39)42-30-33-24-25-34(45-33)31-44-46(40,41)43-29-28-38-27-20-22-32-21-17-18-23-35(32)38/h17-18,20-23,27,33-34H,2-16,19,24-26,28-31H2,1H3,(H-,37,39,40,41)/t33-,34+/m0/s1 D0R7MN DRUGINKE OLDMQSKCCHULOB-SZAHLOSFSA-N D0R7MN DRUGSMIL CCCCCCCCCCCCCCCCCCNC(=O)OCC1CCC(O1)COP(=O)([O-])OCC[N+]2=CC=CC3=CC=CC=C32 D0R7MN HIGHSTAT Terminated D0R9PL DRUG__ID D0R9PL D0R9PL DRUGTYPE Small molecular drug D0R9PL DRUGINCH 1S/C25H36N4O2/c1-20(2)31-24-9-5-4-8-23(24)28-16-14-27(15-17-28)18-21-11-12-22(26(21)3)19-29-13-7-6-10-25(29)30/h4-5,8-9,11-12,20H,6-7,10,13-19H2,1-3H3 D0R9PL DRUGINKE BLFPEKXTSDYQOQ-UHFFFAOYSA-N D0R9PL DRUGSMIL CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(N3C)CN4CCCCC4=O D0R9PL HIGHSTAT Terminated D0RG2P DRUG__ID D0RG2P D0RG2P DRUGTYPE Small molecular drug D0RG2P DRUGINCH 1S/C24H29N7/c1-3-5-11-22-25-23(12-6-4-2)31(28-22)17-18-13-15-19(16-14-18)20-9-7-8-10-21(20)24-26-29-30-27-24/h7-10,13-16H,3-6,11-12,17H2,1-2H3,(H,26,27,29,30) D0RG2P DRUGINKE LRZYXWIVLLNUPK-UHFFFAOYSA-N D0RG2P DRUGSMIL CCCCC1=NN(C(=N1)CCCC)CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4 D0RG2P HIGHSTAT Terminated D0RP8F DRUG__ID D0RP8F D0RP8F DRUGTYPE Small molecular drug D0RP8F DRUGINCH 1S/C21H31ClN6O3/c22-13-18(29)16(8-4-10-26-21(24)25)27-19(30)17-9-5-11-28(17)20(31)15(23)12-14-6-2-1-3-7-14/h1-3,6-7,15-17H,4-5,8-13,23H2,(H,27,30)(H4,24,25,26)/t15-,16+,17+/m1/s1 D0RP8F DRUGINKE KWPACVJPAFGBEQ-IKGGRYGDSA-N D0RP8F DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)NC(CCCN=C(N)N)C(=O)CCl D0RP8F HIGHSTAT Terminated D0RU3M DRUG__ID D0RU3M D0RU3M DRUGTYPE Small molecular drug D0RU3M DRUGINCH 1S/C13H26O6P2/c1-11(2)7-6-9-12(3)8-4-5-10-13(20(14,15)16)21(17,18)19/h7-8,13H,4-6,9-10H2,1-3H3,(H2,14,15,16)(H2,17,18,19)/b12-8+ D0RU3M DRUGINKE ISMDHWZGHKZNRH-XYOKQWHBSA-N D0RU3M DRUGSMIL CC(=CCCC(=CCCCC(P(=O)(O)O)P(=O)(O)O)C)C D0RU3M HIGHSTAT Terminated D0S1VV DRUG__ID D0S1VV D0S1VV DRUGTYPE Small molecular drug D0S1VV DRUGINCH 1S/C14H16N2O/c1-17-9-6-7-13-11(8-9)14(15)10-4-2-3-5-12(10)16-13/h6-8H,2-5H2,1H3,(H2,15,16) D0S1VV DRUGINKE APQPVVOYBLOJDY-UHFFFAOYSA-N D0S1VV DRUGSMIL COC1=CC2=C(C=C1)N=C3CCCCC3=C2N D0S1VV HIGHSTAT Terminated D0S2JG DRUG__ID D0S2JG D0S2JG DRUGTYPE Small molecular drug D0S2JG DRUGINCH 1S/C26H31N5O3S/c1-31(22-8-4-5-9-22)26(32)24(16-18-10-12-20(13-11-18)25(27)29-28)30-35(33,34)23-15-14-19-6-2-3-7-21(19)17-23/h2-3,6-7,10-15,17,22,24,30H,4-5,8-9,16,28H2,1H3,(H2,27,29)/t24-/m0/s1 D0S2JG DRUGINKE ZPDICRPCOSQEDS-DEOSSOPVSA-N D0S2JG DRUGSMIL CN(C1CCCC1)C(=O)C(CC2=CC=C(C=C2)C(=NN)N)NS(=O)(=O)C3=CC4=CC=CC=C4C=C3 D0S2JG HIGHSTAT Terminated D0S5DY DRUG__ID D0S5DY D0S5DY DRUGTYPE Small molecular drug D0S5DY DRUGINCH 1S/C21H22ClN5O3/c1-15-23-26(14-20(29)16-2-4-17(22)5-3-16)21(30)27(15)25-12-10-24(11-13-25)18-6-8-19(28)9-7-18/h2-9,28H,10-14H2,1H3 D0S5DY DRUGINKE VZSLWTZQSOCFIA-UHFFFAOYSA-N D0S5DY DRUGSMIL CC1=NN(C(=O)N1N2CCN(CC2)C3=CC=C(C=C3)O)CC(=O)C4=CC=C(C=C4)Cl D0S5DY HIGHSTAT Terminated D0S6PJ DRUG__ID D0S6PJ D0S6PJ DRUGTYPE Small molecular drug D0S6PJ DRUGINCH 1S/C13H14N4O2/c18-17(19)11-2-3-12-10(9-11)1-4-13(15-12)16-7-5-14-6-8-16/h1-4,9,14H,5-8H2 D0S6PJ DRUGINKE GGDBEAVVGFNWIA-UHFFFAOYSA-N D0S6PJ DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)[N+](=O)[O-] D0S6PJ HIGHSTAT Terminated D0S6XD DRUG__ID D0S6XD D0S6XD DRUGTYPE Small molecular drug D0S6XD DRUGINCH 1S/C44H38O14/c1-20(56-43(50)22-10-8-7-9-11-22)16-25-31-32-26(17-21(2)57-44(51)58-24-14-12-23(45)13-15-24)42(55-6)40(49)34-28(47)19-30(53-4)36(38(32)34)35-29(52-3)18-27(46)33(37(31)35)39(48)41(25)54-5/h7-15,18-21,45,48-49H,16-17H2,1-6H3 D0S6XD DRUGINKE LSUTUUOITDQYNO-UHFFFAOYSA-N D0S6XD DRUGSMIL CC(CC1=C2C3=C(C(=C(C4=C3C(=C5C2=C(C(=O)C=C5OC)C(=C1OC)O)C(=CC4=O)OC)O)OC)CC(C)OC(=O)OC6=CC=C(C=C6)O)OC(=O)C7=CC=CC=C7 D0S6XD HIGHSTAT Terminated D0S6XJ DRUG__ID D0S6XJ D0S6XJ DRUGCOMP Gilead Sciences Inc D0S6XJ DRUGINCH 1S/C42H71N15O22/c1-16(58)31(37(74)48-8-23(65)46-13-28(70)55-36(21(6)63)42(79)57-34(19(4)61)40(77)50-10-25(67)47-15-30(72)73)53-29(71)14-51-38(75)32(17(2)59)52-27(69)12-45-24(66)9-49-39(76)33(18(3)60)56-41(78)35(20(5)62)54-26(68)11-44-22(64)7-43/h16-21,31-36,58-63H,7-15,43H2,1-6H3,(H,44,64)(H,45,66)(H,46,65)(H,47,67)(H,48,74)(H,49,76)(H,50,77)(H,51,75)(H,52,69)(H,53,71)(H,54,68)(H,55,70)(H,56,78)(H,57,79)(H,72,73)/t16-,17-,18-,19-,20-,21-,31+,32+,33+,34+,35+,36+/m1/s1 D0S6XJ DRUGINKE QHRKUKVLFJBEQL-CPVSMZBNSA-N D0S6XJ DRUGSMIL CC(C(C(=O)NCC(=O)NC(C(C)O)C(=O)NCC(=O)NCC(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NCC(=O)NCC(=O)O)NC(=O)CNC(=O)CNC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)CN)O D0S6XJ HIGHSTAT Terminated D0S9JH DRUG__ID D0S9JH D0S9JH DRUGTYPE Small molecular drug D0S9JH DRUGINCH 1S/C50H65N7O10/c1-8-29(5)43(48(64)55-41(50(66)67)25-35-27-51-37-18-14-13-17-36(35)37)57-49(65)44(30(6)9-2)56-47(63)40(26-42(59)60)54-45(61)38(23-28(3)4)53-46(62)39(52-31(7)58)24-32-19-21-34(22-20-32)33-15-11-10-12-16-33/h10-22,27-30,38-41,43-44,51H,8-9,23-26H2,1-7H3,(H,52,58)(H,53,62)(H,54,61)(H,55,64)(H,56,63)(H,57,65)(H,59,60)(H,66,67)/t29-,30-,38-,39+,40-,41-,43-,44-/m0/s1 D0S9JH DRUGINKE IFDNLSRYZKUGIR-KXXXQFFTSA-N D0S9JH DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=C(C=C3)C4=CC=CC=C4)NC(=O)C D0S9JH HIGHSTAT Terminated D0SM0J DRUG__ID D0SM0J D0SM0J DRUGTYPE Small molecular drug D0SM0J DRUGINCH 1S/C27H25NO4S/c29-20-7-3-19(4-8-20)27-25(23-12-9-21(30)17-24(23)33-27)26(31)18-5-10-22(11-6-18)32-16-15-28-13-1-2-14-28/h3-12,17,29-30H,1-2,13-16H2 D0SM0J DRUGINKE JLERVPBPJHKRBJ-UHFFFAOYSA-N D0SM0J DRUGSMIL C1CCN(C1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O D0SM0J HIGHSTAT Terminated D0T2IQ DRUG__ID D0T2IQ D0T2IQ DRUGTYPE Small molecular drug D0T2IQ DRUGINCH 1S/C19H35N3O5/c1-4-5-6-8-14(11-16(24)21-27)18(25)20-17(13(2)3)19(26)22-10-7-9-15(22)12-23/h13-15,17,23,27H,4-12H2,1-3H3,(H,20,25)(H,21,24)/t14-,15+,17+/m1/s1 D0T2IQ DRUGINKE XJLATMLVMSFZBN-VYDXJSESSA-N D0T2IQ DRUGSMIL CCCCCC(CC(=O)NO)C(=O)NC(C(C)C)C(=O)N1CCCC1CO D0T2IQ HIGHSTAT Terminated D0T4IQ DRUG__ID D0T4IQ D0T4IQ DRUGCOMP The Menarini Group D0T4IQ DRUGINCH 1S/C38H40N4O3/c1-25-15-17-26(18-16-25)23-36(43)42(2)35(22-27-19-20-28-9-3-4-10-29(28)21-27)41-37(44)31-12-6-8-14-34(31)40-38(45)32-24-39-33-13-7-5-11-30(32)33/h3-5,7,9-11,13,15-21,24,31,34-35,39H,6,8,12,14,22-23H2,1-2H3,(H,40,45)(H,41,44)/t31-,34+,35?/m1/s1 D0T4IQ DRUGINKE DTPDRMYRFVVGJZ-SKZJHLMYSA-N D0T4IQ DRUGSMIL CC1=CC=C(C=C1)CC(=O)N(C)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C4CCCCC4NC(=O)C5=CNC6=CC=CC=C65 D0T4IQ HIGHSTAT Terminated D0TB1X DRUG__ID D0TB1X D0TB1X DRUGCOMP The Green Cross Corp D0TB1X DRUGINCH 1S/C14H18N6.ClH/c15-8-18-14(19-11-3-4-13(16)17-7-11)20-12-6-9-1-2-10(12)5-9;/h3-4,7,9-10,12H,1-2,5-6H2,(H2,16,17)(H2,18,19,20);1H/t9-,10+,12-;/m1./s1 D0TB1X DRUGINKE ZIVGNHQBUJFAOF-QQQUOLKDSA-N D0TB1X DRUGSMIL C1CC2CC1CC2N=C(NC#N)NC3=CN=C(C=C3)N.Cl D0TB1X HIGHSTAT Terminated D0U2TQ DRUG__ID D0U2TQ D0U2TQ DRUGTYPE Small molecular drug D0U2TQ DRUGINCH 1S/C18H18ClN5O/c19-14-3-1-4-15(12-14)23-18-22-9-6-16(24-18)13-5-8-21-17(11-13)20-7-2-10-25/h1,3-6,8-9,11-12,25H,2,7,10H2,(H,20,21)(H,22,23,24) D0U2TQ DRUGINKE IYNDTACKOAXKBJ-UHFFFAOYSA-N D0U2TQ DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO D0U2TQ HIGHSTAT Terminated D0U3HP DRUG__ID D0U3HP D0U3HP DRUGTYPE Small molecular drug D0U3HP DRUGINCH 1S/C22H25N3O4/c1-26-18-7-13-5-6-25(12-14(13)8-19(18)27-2)22-10-16(23)15-9-20(28-3)21(29-4)11-17(15)24-22/h7-11H,5-6,12H2,1-4H3,(H2,23,24) D0U3HP DRUGINKE ANZIISNSHPKVRV-UHFFFAOYSA-N D0U3HP DRUGSMIL COC1=C(C=C2CN(CCC2=C1)C3=NC4=CC(=C(C=C4C(=C3)N)OC)OC)OC D0U3HP HIGHSTAT Terminated D0U4ZY DRUG__ID D0U4ZY D0U4ZY DRUGTYPE Small molecular drug D0U4ZY DRUGINCH 1S/C26H38N8O7/c1-14(2)21-25(41)34(3)18(8-5-9-29-26(27)28)24(40)31-13-19(35)32-17(11-20(36)37)23(39)30-12-15-6-4-7-16(10-15)22(38)33-21/h4,6-7,10,14,17-18,21H,5,8-9,11-13H2,1-3H3,(H,30,39)(H,31,40)(H,32,35)(H,33,38)(H,36,37)(H4,27,28,29)/t17-,18-,21-/m0/s1 D0U4ZY DRUGINKE TZZMWRLTTWMKCL-WFXMLNOXSA-N D0U4ZY DRUGSMIL CC(C)C1C(=O)N(C(C(=O)NCC(=O)NC(C(=O)NCC2=CC(=CC=C2)C(=O)N1)CC(=O)O)CCCN=C(N)N)C D0U4ZY HIGHSTAT Terminated D0U6BB DRUG__ID D0U6BB D0U6BB DRUGTYPE Small molecular drug D0U6BB DRUGINCH 1S/C23H32N4O4/c28-21(7-3-4-16-10-12-24-13-11-16)26-15-22(29)27-20(23(30)31)9-8-17-14-25-19-6-2-1-5-18(17)19/h1-2,5-6,14,16,20,24-25H,3-4,7-13,15H2,(H,26,28)(H,27,29)(H,30,31)/t20-/m1/s1 D0U6BB DRUGINKE WDRKDCBKBCRZSK-HXUWFJFHSA-N D0U6BB DRUGSMIL C1CNCCC1CCCC(=O)NCC(=O)NC(CCC2=CNC3=CC=CC=C32)C(=O)O D0U6BB HIGHSTAT Terminated D0U6RP DRUG__ID D0U6RP D0U6RP DRUGCOMP CJ Corp D0U6RP DRUGINCH 1S/C41H76O5/c1-5-7-8-9-10-11-12-13-14-15-16-20-23-26-29-32-40(43)45-35-39(42)36-46-41(44)33-30-27-24-21-18-17-19-22-25-28-31-38(4)34-37(3)6-2/h10-11,13-14,37-39,42H,5-9,12,15-36H2,1-4H3/b11-10+,14-13+ D0U6RP DRUGINKE WFTOOGFFSZCCNW-IWCZYTNJSA-N D0U6RP DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC(C)CC(C)CC)O D0U6RP HIGHSTAT Terminated D0U7OU DRUG__ID D0U7OU D0U7OU DRUGTYPE Small molecular drug D0U7OU DRUGINCH 1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3 D0U7OU DRUGINKE RHMXXJGYXNZAPX-UHFFFAOYSA-N D0U7OU DRUGSMIL CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O D0U7OU HIGHSTAT Terminated D0UB6U DRUG__ID D0UB6U D0UB6U DRUGTYPE Small molecular drug D0UB6U DRUGINCH 1S/C5H10N2O2/c1-3-2-7(9)5(8)4(3)6/h3-4,9H,2,6H2,1H3/t3-,4-/m1/s1 D0UB6U DRUGINKE SKYSFPFYQBZGDC-QWWZWVQMSA-N D0UB6U DRUGSMIL CC1CN(C(=O)C1N)O D0UB6U HIGHSTAT Terminated D0V0RW DRUG__ID D0V0RW D0V0RW DRUGCOMP Vernalis plc D0V0RW DRUGINCH 1S/C17H31N3O5/c1-10(2)13(14(21)17(24)20-25)16(23)19-12(15(22)18-3)9-11-7-5-4-6-8-11/h10-14,21,25H,4-9H2,1-3H3,(H,18,22)(H,19,23)(H,20,24)/t12-,13+,14-/m0/s1 D0V0RW DRUGINKE OOYLWSYMDSXZMO-MJBXVCDLSA-N D0V0RW DRUGSMIL CC(C)C(C(C(=O)NO)O)C(=O)NC(CC1CCCCC1)C(=O)NC D0V0RW HIGHSTAT Terminated D0V2GT DRUG__ID D0V2GT D0V2GT DRUGTYPE Small molecular drug D0V2GT DRUGINCH 1S/C27H31N5O3/c28-27(29)30-17-7-12-23(25(34)31-18-19-13-15-22(33)16-14-19)32-26(35)24(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-6,8-11,13-16,23-24,33H,7,12,17-18H2,(H,31,34)(H,32,35)(H4,28,29,30)/t23-/m1/s1 D0V2GT DRUGINKE KUWBXRGRMQZCSS-HSZRJFAPSA-N D0V2GT DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NCC3=CC=C(C=C3)O D0V2GT HIGHSTAT Terminated D0V4FK DRUG__ID D0V4FK D0V4FK DRUGTYPE Small molecular drug D0V4FK DRUGINCH 1S/C22H27FN2O4.BrH/c23-17-8-5-15(6-9-17)4-3-11-24-20(22(29)25-12-1-2-13-25)21(28)16-7-10-18(26)19(27)14-16;/h5-10,14,20-21,24,26-28H,1-4,11-13H2;1H/t20-,21+;/m0./s1 D0V4FK DRUGINKE VGHBGPUSJITFJL-JUDYQFGCSA-N D0V4FK DRUGSMIL C1CCN(C1)C(=O)C(C(C2=CC(=C(C=C2)O)O)O)NCCCC3=CC=C(C=C3)F.Br D0V4FK HIGHSTAT Terminated D0V4GI DRUG__ID D0V4GI D0V4GI DRUGTYPE Small molecular drug D0V4GI DRUGINCH 1S/C16H10ClN3O/c17-10-5-7-11(8-6-10)20-16(21)13-9-18-14-4-2-1-3-12(14)15(13)19-20/h1-9,19H D0V4GI DRUGINKE QCBUAKLOWCOUCR-UHFFFAOYSA-N D0V4GI DRUGSMIL C1=CC=C2C(=C1)C3=C(C=N2)C(=O)N(N3)C4=CC=C(C=C4)Cl D0V4GI HIGHSTAT Terminated D0V4JO DRUG__ID D0V4JO D0V4JO DRUGTYPE Small molecular drug D0V4JO DRUGINCH 1S/C23H29F2N3O/c1-2-26-23(29)28-16-14-27(15-17-28)13-3-4-22(18-5-9-20(24)10-6-18)19-7-11-21(25)12-8-19/h5-12,22H,2-4,13-17H2,1H3,(H,26,29) D0V4JO DRUGINKE NNAIYOXJNVGUOM-UHFFFAOYSA-N D0V4JO DRUGSMIL CCNC(=O)N1CCN(CC1)CCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D0V4JO HIGHSTAT Terminated D0V8NS DRUG__ID D0V8NS D0V8NS DRUGTYPE Small molecular drug D0V8NS DRUGINCH 1S/C24H29N3O3/c1-24(2)19-9-5-4-8-18(19)22(28)27(23(24)29)17-14-25-12-15-26(16-13-25)20-10-6-7-11-21(20)30-3/h4-11H,12-17H2,1-3H3 D0V8NS DRUGINKE JFNKXGOEOQCXDM-UHFFFAOYSA-N D0V8NS DRUGSMIL CC1(C2=CC=CC=C2C(=O)N(C1=O)CCN3CCN(CC3)C4=CC=CC=C4OC)C D0V8NS HIGHSTAT Terminated D0V8PN DRUG__ID D0V8PN D0V8PN DRUGCOMP GD Searle & Co D0V8PN DRUGINCH 1S/C29H51N5O4.ClH/c1-20(2)15-16-34(27(38)33-29(6,7)8)19-23(35)22(17-21-13-11-10-12-14-21)31-26(37)25(28(3,4)5)32-24(36)18-30-9;/h10-14,20,22-23,25,30,35H,15-19H2,1-9H3,(H,31,37)(H,32,36)(H,33,38);1H/t22-,23+,25+;/m0./s1 D0V8PN DRUGINKE IYKXRORSPVZSHP-ZELIPEIJSA-N D0V8PN DRUGSMIL CC(C)CCN(CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)(C)C)NC(=O)CNC)O)C(=O)NC(C)(C)C.Cl D0V8PN HIGHSTAT Terminated D0V9HI DRUG__ID D0V9HI D0V9HI DRUGTYPE Small molecular drug D0V9HI DRUGINCH 1S/C24H29FN4O/c25-19-7-5-18(6-8-19)22-17-23(21-4-2-1-3-20(21)22)28-14-11-27(12-15-28)13-16-29-10-9-26-24(29)30/h1-8,22-23H,9-17H2,(H,26,30)/t22-,23+/m0/s1 D0V9HI DRUGINKE GHAMYXPEZSUOCU-XZOQPEGZSA-N D0V9HI DRUGSMIL C1CN(C(=O)N1)CCN2CCN(CC2)C3CC(C4=CC=CC=C34)C5=CC=C(C=C5)F D0V9HI HIGHSTAT Terminated D0W2ED DRUG__ID D0W2ED D0W2ED DRUGTYPE Small molecular drug D0W2ED DRUGINCH 1S/C19H40N4O4S/c1-5-12(3)16(21-9-14(20)11-28)10-22-17(13(4)6-2)18(25)23-15(7-8-24)19(26)27/h12-17,21-22,24,28H,5-11,20H2,1-4H3,(H,23,25)(H,26,27)/t12-,13-,14+,15-,16+,17-/m0/s1 D0W2ED DRUGINKE LMTIEVNRUFAFPM-NYXISSTPSA-N D0W2ED DRUGSMIL CCC(C)C(CNC(C(C)CC)C(=O)NC(CCO)C(=O)O)NCC(CS)N D0W2ED HIGHSTAT Terminated D0WU8Z DRUG__ID D0WU8Z D0WU8Z DRUGCOMP Vernalis plc D0WU8Z DRUGINCH 1S/C27H42O5/c1-6-8-18-13-19-10-9-17(3)22(12-11-21-15-20(28)16-24(29)31-21)25(19)23(14-18)32-26(30)27(4,5)7-2/h6,8-10,17-23,25,28H,7,11-16H2,1-5H3/b8-6+/t17-,18-,19-,20+,21+,22-,23-,25-/m0/s1 D0WU8Z DRUGINKE FPFKPDQXLUTVQE-XNFUBWTISA-N D0WU8Z DRUGSMIL CCC(C)(C)C(=O)OC1CC(CC2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C=CC D0WU8Z HIGHSTAT Terminated D0X0HN DRUG__ID D0X0HN D0X0HN DRUGTYPE Small molecular drug D0X0HN DRUGINCH 1S/C27H25N3O4/c31-16-17-10-12-30-15-21(19-7-2-4-9-23(19)30)25-24(26(32)28-27(25)33)20-14-29(11-5-13-34-17)22-8-3-1-6-18(20)22/h1-4,6-9,14-15,17,31H,5,10-13,16H2,(H,28,32,33) D0X0HN DRUGINKE XIFXMAQLEGCDQV-UHFFFAOYSA-N D0X0HN DRUGSMIL C1CN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCC(OC1)CO)C6=CC=CC=C65)C(=O)NC4=O D0X0HN HIGHSTAT Terminated D0X2OV DRUG__ID D0X2OV D0X2OV DRUGTYPE Small molecular drug D0X2OV DRUGINCH 1S/C22H30ClNO4S/c1-15-13-18(23)11-12-21(15)29(27,28)24-14-20-17-9-7-16(8-10-17)19(20)5-3-2-4-6-22(25)26/h3,5,11-13,16-17,19-20,24H,2,4,6-10,14H2,1H3,(H,25,26)/b5-3-/t16?,17?,19-,20-/m0/s1 D0X2OV DRUGINKE VVEXPDRCGCQELD-CFDZEDGGSA-N D0X2OV DRUGSMIL CC1=C(C=CC(=C1)Cl)S(=O)(=O)NCC2C3CCC(C2C=CCCCC(=O)O)CC3 D0X2OV HIGHSTAT Terminated D0X3KX DRUG__ID D0X3KX D0X3KX DRUGCOMP Pharmacia & Upjohn Co D0X3KX DRUGINCH 1S/C13H16N2O/c1-12-6-4-10-14(12)8-2-3-9-15-11-5-7-13(15)16/h4,6,10H,5,7-9,11H2,1H3 D0X3KX DRUGINKE RBCXUJODVKKGBN-UHFFFAOYSA-N D0X3KX DRUGSMIL CC1=CC=CN1CC#CCN2CCCC2=O D0X3KX HIGHSTAT Terminated D0X5PX DRUG__ID D0X5PX D0X5PX DRUGTYPE Small molecular drug D0X5PX DRUGINCH 1S/C18H11Cl2NO4/c19-10-6-13(20)15-12(16(18(24)25)21-14(15)7-10)8-11(17(22)23)9-4-2-1-3-5-9/h1-8,21H,(H,22,23)(H,24,25)/b11-8+ D0X5PX DRUGINKE LPWVUDLZUVBQGP-DHZHZOJOSA-N D0X5PX DRUGSMIL C1=CC=C(C=C1)C(=CC2=C(NC3=C2C(=CC(=C3)Cl)Cl)C(=O)O)C(=O)O D0X5PX HIGHSTAT Terminated D0X9KE DRUG__ID D0X9KE D0X9KE DRUGTYPE Small molecular drug D0X9KE DRUGINCH 1S/C15H13FN2O4/c1-10(18(20)15(17)19)2-5-12-8-9-14(21-12)22-13-6-3-11(16)4-7-13/h3-4,6-10,20H,1H3,(H2,17,19) D0X9KE DRUGINKE OLZHFFKRBCZHHT-UHFFFAOYSA-N D0X9KE DRUGSMIL CC(C#CC1=CC=C(O1)OC2=CC=C(C=C2)F)N(C(=O)N)O D0X9KE HIGHSTAT Terminated D0XH1H DRUG__ID D0XH1H D0XH1H THERCLAS Analgesics D0XH1H DRUGINCH 1S/C18H23N3O3/c1-2-18(22)19-12-16-9-10-17(13-19)20(16)11-3-4-14-5-7-15(8-6-14)21(23)24/h3-8,16-17H,2,9-13H2,1H3/b4-3+ D0XH1H DRUGINKE VWJDGZDXFSHUPA-ONEGZZNKSA-N D0XH1H DRUGSMIL CCC(=O)N1CC2CCC(C1)N2CC=CC3=CC=C(C=C3)[N+](=O)[O-] D0XH1H HIGHSTAT Terminated D0XK2K DRUG__ID D0XK2K D0XK2K DRUGTYPE Small molecular drug D0XK2K DRUGINCH 1S/C30H31FN2O/c31-25-12-14-26(15-13-25)33-21-23(27-9-2-4-11-29(27)33)7-5-6-18-32-19-16-30(17-20-32)28-10-3-1-8-24(28)22-34-30/h1-4,8-15,21H,5-7,16-20,22H2 D0XK2K DRUGINKE XWAONOGAGZNUSF-UHFFFAOYSA-N D0XK2K DRUGSMIL C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F D0XK2K HIGHSTAT Terminated D0Y0ZB DRUG__ID D0Y0ZB D0Y0ZB DRUGCOMP SmithKline Beecham Corp D0Y0ZB DRUGINCH 1S/C25H35N3O2/c1-5-27-12-11-25(18-9-8-10-20(29)13-18)15-22-21(14-19(25)16-27)17(4)23(26-22)24(30)28(6-2)7-3/h8-10,13,19,26,29H,5-7,11-12,14-16H2,1-4H3/t19-,25-/m1/s1 D0Y0ZB DRUGINKE LCXJNOQXEGZLDX-KBMIEXCESA-N D0Y0ZB DRUGSMIL CCN1CCC2(CC3=C(CC2C1)C(=C(N3)C(=O)N(CC)CC)C)C4=CC(=CC=C4)O D0Y0ZB HIGHSTAT Terminated D0Y1PG DRUG__ID D0Y1PG D0Y1PG DRUGTYPE Small molecular drug D0Y1PG DRUGINCH 1S/C19H22ClNO4/c1-13(21-11-18(22)15-3-2-4-16(20)10-15)9-14-5-7-17(8-6-14)25-12-19(23)24/h2-8,10,13,18,21-22H,9,11-12H2,1H3,(H,23,24)/t13-,18+/m1/s1 D0Y1PG DRUGINKE ZGGNJJJYUVRADP-ACJLOTCBSA-N D0Y1PG DRUGSMIL CC(CC1=CC=C(C=C1)OCC(=O)O)NCC(C2=CC(=CC=C2)Cl)O D0Y1PG HIGHSTAT Terminated D0Y1XT DRUG__ID D0Y1XT D0Y1XT DRUGTYPE Small molecular drug D0Y1XT DRUGINCH 1S/C19H29N3O5/c1-12(2)9-14(11-17(23)22-26)18(24)21-16(19(25)20-3)10-13-5-7-15(27-4)8-6-13/h5-8,12,14,16,26H,9-11H2,1-4H3,(H,20,25)(H,21,24)(H,22,23)/t14-,16+/m1/s1 D0Y1XT DRUGINKE QYZPDCGWIJYZMN-ZBFHGGJFSA-N D0Y1XT DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CC=C(C=C1)OC)C(=O)NC D0Y1XT HIGHSTAT Terminated D0Y2IH DRUG__ID D0Y2IH D0Y2IH DRUGTYPE Small molecular drug D0Y2IH DRUGINCH 1S/C19H28N4O3/c1-5-14-11-15(13(2)24)16(25)12-17(14)26-10-8-6-7-9-19(3,4)18-20-22-23-21-18/h11-12,25H,5-10H2,1-4H3,(H,20,21,22,23) D0Y2IH DRUGINKE WCGXJPFHTHQNJL-UHFFFAOYSA-N D0Y2IH DRUGSMIL CCC1=CC(=C(C=C1OCCCCCC(C)(C)C2=NNN=N2)O)C(=O)C D0Y2IH HIGHSTAT Terminated D0Y5EX DRUG__ID D0Y5EX D0Y5EX DRUGTYPE Small molecular drug D0Y5EX DRUGINCH 1S/C21H33BN6O5/c1-14(29)26-16(13-15-7-3-2-4-8-15)20(31)28-12-6-9-17(28)19(30)27-18(22(32)33)10-5-11-25-21(23)24/h2-4,7-8,16-18,32-33H,5-6,9-13H2,1H3,(H,26,29)(H,27,30)(H4,23,24,25)/t16-,17+,18+/m1/s1 D0Y5EX DRUGINKE FXFYPTZERULUBS-SQNIBIBYSA-N D0Y5EX DRUGSMIL B(C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)C)(O)O D0Y5EX HIGHSTAT Terminated D0Y5QO DRUG__ID D0Y5QO D0Y5QO DRUGCOMP Taisho Pharmaceutical Co Ltd D0Y5QO DRUGINCH 1S/C18H14N2OS.ClH/c1-12-19-8-9-20(12)10-14-11-22-16-7-6-13-4-2-3-5-15(13)17(16)18(14)21;/h2-9,11H,10H2,1H3;1H D0Y5QO DRUGINKE DBXKJORICFHAQA-UHFFFAOYSA-N D0Y5QO DRUGSMIL CC1=NC=CN1CC2=CSC3=C(C2=O)C4=CC=CC=C4C=C3.Cl D0Y5QO HIGHSTAT Terminated D0Y6GJ DRUG__ID D0Y6GJ D0Y6GJ DRUGTYPE Small molecular drug D0Y6GJ DRUGINCH 1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22) D0Y6GJ DRUGINKE PWTBZOIUWZOPFT-UHFFFAOYSA-N D0Y6GJ DRUGSMIL C1=COC(=C1)C2=NN3C(=NC(=NC3=N2)NCCC4=CC=C(C=C4)O)N D0Y6GJ HIGHSTAT Terminated D0Y7VJ DRUG__ID D0Y7VJ D0Y7VJ DRUGTYPE Small molecular drug D0Y7VJ DRUGINCH 1S/C8H17N3O2/c1-6(9)11-5-3-2-4-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1 D0Y7VJ DRUGINKE ONYFNWIHJBLQKE-ZETCQYMHSA-N D0Y7VJ DRUGSMIL CC(=NCCCCC(C(=O)O)N)N D0Y7VJ HIGHSTAT Terminated D0Y7WL DRUG__ID D0Y7WL D0Y7WL DRUGTYPE Small molecular drug D0Y7WL DRUGINCH 1S/C22H32Cl2N2O4/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16/h9-10,15,19H,3-8,11-14H2,1-2H3,(H,25,29)(H,27,28) D0Y7WL DRUGINKE IEKOTSCYBBDIJC-UHFFFAOYSA-N D0Y7WL DRUGSMIL CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl D0Y7WL HIGHSTAT Terminated D0Y8PH DRUG__ID D0Y8PH D0Y8PH DRUGCOMP Parke-Davis & Co D0Y8PH DRUGINCH 1S/C27H22F3N7O3/c1-2-6-21-31-25(36-14-5-9-20(36)23(38)27(28,29)30)22(26(39)40)37(21)15-16-10-12-17(13-11-16)18-7-3-4-8-19(18)24-32-34-35-33-24/h3-5,7-14H,2,6,15H2,1H3,(H,39,40)(H,32,33,34,35) D0Y8PH DRUGINKE MGSBGAVGFLLRDU-UHFFFAOYSA-N D0Y8PH DRUGSMIL CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)N5C=CC=C5C(=O)C(F)(F)F D0Y8PH HIGHSTAT Terminated D0Y9HH DRUG__ID D0Y9HH D0Y9HH DRUGTYPE Small molecular drug D0Y9HH DRUGINCH 1S/C12H14N2/c1-3-10-7-11(9-13-8-10)12-5-4-6-14(12)2/h1,7-9,12H,4-6H2,2H3/t12-/m0/s1 D0Y9HH DRUGINKE NUPUDYKEEJNZRG-LBPRGKRZSA-N D0Y9HH DRUGSMIL CN1CCCC1C2=CN=CC(=C2)C#C D0Y9HH HIGHSTAT Terminated D0YK7C DRUG__ID D0YK7C D0YK7C DRUGTYPE Small molecular drug D0YK7C DRUGINCH 1S/C20H21N3O2S2/c1-23(2)10-11-26-18-9-8-15(27-18)13-17-20(25)21-16(19(24)22-17)12-14-6-4-3-5-7-14/h3-9,12-13H,10-11H2,1-2H3,(H,21,25)(H,22,24)/b16-12-,17-13- D0YK7C DRUGINKE ODQGWMYUSNRXFW-MCOFMCJXSA-N D0YK7C DRUGSMIL CN(C)CCSC1=CC=C(S1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2 D0YK7C HIGHSTAT Terminated D0YP7L DRUG__ID D0YP7L D0YP7L DRUGTYPE Small molecular drug D0YP7L DRUGINCH 1S/C18H28N2O3S/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18/h2,5-6,14-16,21H,3-4,7-13H2,1H3/t16-/m1/s1 D0YP7L DRUGINKE HWKROQUZSKPIKQ-MRXNPFEDSA-N D0YP7L DRUGSMIL CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O D0YP7L HIGHSTAT Terminated D0Z0KD DRUG__ID D0Z0KD D0Z0KD DRUGTYPE Small molecular drug D0Z0KD DRUGINCH 1S/C28H35N5O2/c34-15-1-2-19-11-13-32(14-12-19)24-8-6-23(7-9-24)30-28-29-18-22-5-10-26(35)33(27(22)31-28)25-17-20-3-4-21(25)16-20/h5-10,18-21,25,34H,1-4,11-17H2,(H,29,30,31) D0Z0KD DRUGINKE PETCVZZPKYJZAU-UHFFFAOYSA-N D0Z0KD DRUGSMIL C1CC2CC1CC2N3C(=O)C=CC4=CN=C(N=C43)NC5=CC=C(C=C5)N6CCC(CC6)CCCO D0Z0KD HIGHSTAT Terminated D0Z0XQ DRUG__ID D0Z0XQ D0Z0XQ DRUGTYPE Small molecular drug D0Z0XQ DRUGINCH 1S/C20H27N5O7/c1-10(2)16(20(31)32)25-19(30)13(9-15(27)28)24-14(26)7-8-23-18(29)12-5-3-11(4-6-12)17(21)22/h3-6,10,13,16H,7-9H2,1-2H3,(H3,21,22)(H,23,29)(H,24,26)(H,25,30)(H,27,28)(H,31,32)/t13-,16-/m0/s1 D0Z0XQ DRUGINKE RRUJJOMANFUDEN-BBRMVZONSA-N D0Z0XQ DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)CCNC(=O)C1=CC=C(C=C1)C(=N)N D0Z0XQ HIGHSTAT Terminated D0Z1HQ DRUG__ID D0Z1HQ D0Z1HQ DRUGTYPE Small molecular drug D0Z1HQ DRUGINCH 1S/C31H39N3O.ClH/c1-2-3-4-5-6-7-8-9-13-17-26-19-20-27(33-26)22-30-31(35-24-25-15-11-10-12-16-25)23-29(34-30)28-18-14-21-32-28;/h10-12,14-16,18-23,32-33H,2-9,13,17,24H2,1H3;1H/b30-22-; D0Z1HQ DRUGINKE ODJQLZRYBXCIPR-VDFJEELKSA-N D0Z1HQ DRUGSMIL CCCCCCCCCCCC1=CC=C(N1)C=C2C(=CC(=N2)C3=CC=CN3)OCC4=CC=CC=C4.Cl D0Z1HQ HIGHSTAT Terminated D0Z4VA DRUG__ID D0Z4VA D0Z4VA DRUGCOMP Boehringer Ingelheim Corp D0Z4VA DRUGINCH 1S/C18H16N4O2/c1-10-8-16(24)21-22-17(10)12-4-7-14-15(9-12)20-18(19-14)11-2-5-13(23)6-3-11/h2-7,9-10,23H,8H2,1H3,(H,19,20)(H,21,24) D0Z4VA DRUGINKE QOAXSEARPHDXFC-UHFFFAOYSA-N D0Z4VA DRUGSMIL CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)O D0Z4VA HIGHSTAT Terminated D0Z7AW DRUG__ID D0Z7AW D0Z7AW DRUGTYPE Small molecular drug D0Z7AW DRUGINCH 1S/C19H22F2N4O/c20-15-2-5-18(6-3-15)26-13-14-1-4-17-12-25(8-7-24(17)11-14)19-22-9-16(21)10-23-19/h2-3,5-6,9-10,14,17H,1,4,7-8,11-13H2/t14-,17+/m1/s1 D0Z7AW DRUGINKE QXWNESOGWFJDFR-PBHICJAKSA-N D0Z7AW DRUGSMIL C1CC2CN(CCN2CC1COC3=CC=C(C=C3)F)C4=NC=C(C=N4)F D0Z7AW HIGHSTAT Terminated D0Z9CC DRUG__ID D0Z9CC D0Z9CC DRUGTYPE Small molecular drug D0Z9CC DRUGINCH 1S/C13H9N5O6/c19-11(20)5-17-8-4-9(16-2-1-14-6-16)10(18(23)24)3-7(8)15-12(21)13(17)22/h1-4,6H,5H2,(H,15,21)(H,19,20) D0Z9CC DRUGINKE SPXYHZRWPRQLNS-UHFFFAOYSA-N D0Z9CC DRUGSMIL C1=CN(C=N1)C2=C(C=C3C(=C2)N(C(=O)C(=O)N3)CC(=O)O)[N+](=O)[O-] D0Z9CC HIGHSTAT Terminated D0Z9UB DRUG__ID D0Z9UB D0Z9UB DRUGTYPE Small molecular drug D0Z9UB DRUGINCH 1S/C14H16ClNO/c1-16-13-6-2-9-8-10(15)3-4-11(9)12(13)5-7-14(16)17/h3-4,8,12-13H,2,5-7H2,1H3/t12-,13-/m1/s1 D0Z9UB DRUGINKE WQBIOEFDDDEARX-CHWSQXEVSA-N D0Z9UB DRUGSMIL CN1C2CCC3=C(C2CCC1=O)C=CC(=C3)Cl D0Z9UB HIGHSTAT Terminated D0ZG9N DRUG__ID D0ZG9N D0ZG9N DRUGTYPE Small molecular drug D0ZG9N DRUGINCH 1S/C16H22ClN3O2/c1-22-15-8-13(18)12(17)7-11(15)16(21)19-9-10-4-6-20-5-2-3-14(10)20/h7-8,10,14H,2-6,9,18H2,1H3,(H,19,21)/t10-,14-/m0/s1 D0ZG9N DRUGINKE GAYSOZKZPOVDSB-HZMBPMFUSA-N D0ZG9N DRUGSMIL COC1=CC(=C(C=C1C(=O)NCC2CCN3C2CCC3)Cl)N D0ZG9N HIGHSTAT Terminated D0ZJ0A DRUG__ID D0ZJ0A D0ZJ0A DRUGCOMP GlaxoSmithKline Inc D0ZJ0A DRUGINCH 1S/C21H27NO2S/c1-3-5-15-21(4-2)16-25(23,24)19-14-10-9-13-18(19)20(22-21)17-11-7-6-8-12-17/h6-14,20,22H,3-5,15-16H2,1-2H3/t20-,21-/m1/s1 D0ZJ0A DRUGINKE RUWCWTXHTOBJIA-NHCUHLMSSA-N D0ZJ0A DRUGSMIL CCCCC1(CS(=O)(=O)C2=CC=CC=C2C(N1)C3=CC=CC=C3)CC D0ZJ0A HIGHSTAT Terminated D00QIK DRUG__ID D00QIK D00QIK DRUGINCH 1S/C12H19NO4/c1-4-5-7-9-12(11(16)17-9,13-10(7)15)8(14)6(2)3/h6-9,14H,4-5H2,1-3H3,(H,13,15)/t7-,8+,9+,12-/m1/s1 D00QIK DRUGINKE KMXHEXRPYSXLRN-JDVQERKKSA-N D00QIK DRUGSMIL CCCC1C2C(C(=O)O2)(NC1=O)C(C(C)C)O D00QIK HIGHSTAT Terminated D01BQJ DRUG__ID D01BQJ D01BQJ DRUGINCH 1S/C15H12BrClN2O2/c1-15(2)18-14(12-5-3-4-6-19(12)20)9-7-10(16)11(17)8-13(9)21-15/h3-8H,1-2H3 D01BQJ DRUGINKE YUEQBWZPZJXBHY-UHFFFAOYSA-N D01BQJ DRUGSMIL CC1(N=C(C2=CC(=C(C=C2O1)Cl)Br)C3=CC=CC=[N+]3[O-])C D01BQJ HIGHSTAT Terminated D03ATH DRUG__ID D03ATH D03ATH DRUGINCH 1S/C103H115N23O23/c1-54-102(147)126-35-15-26-83(126)100(145)123-81(46-85(131)110-51-87(133)114-72(90(105)135)45-86(132)115-77(40-60-47-107-69-23-12-9-20-66(60)69)96(141)121-79(43-63-50-106-53-112-63)91(136)111-52-88(134)125-89(55(2)127)101(146)113-54)99(144)120-78(41-61-48-108-70-24-13-10-21-67(61)70)97(142)118-73(36-56-16-5-3-6-17-56)92(137)116-74(37-57-18-7-4-8-19-57)94(139)122-80(44-84(104)130)98(143)119-75(38-58-27-31-64(128)32-28-58)93(138)117-76(39-59-29-33-65(129)34-30-59)95(140)124-82(103(148)149)42-62-49-109-71-25-14-11-22-68(62)71/h3-14,16-25,27-34,47-50,53-55,72-83,89,107-109,127-129H,15,26,35-46,51-52H2,1-2H3,(H2,104,130)(H2,105,135)(H,106,112)(H,110,131)(H,111,136)(H,113,146)(H,114,133)(H,115,132)(H,116,137)(H,117,138)(H,118,142)(H,119,143)(H,120,144)(H,121,141)(H,122,139)(H,123,145)(H,124,140)(H,125,134)(H,148,149)/t54-,55+,72?,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,89-/m0/s1 D03ATH DRUGINKE GKJHBAGJUMHZCI-WOMVBXCFSA-N D03ATH DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(CC(=O)NCC(=O)NC(CC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)C(C)O)CC3=CN=CN3)CC4=CNC5=CC=CC=C54)C(=O)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CC9=CC=CC=C9)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O D03ATH HIGHSTAT Terminated D03CCH DRUG__ID D03CCH D03CCH DRUGINCH 1S/C18H19ClN4O3S/c1-25-12-2-3-13-14(10-12)22-18(21-13)27(24)11-15-17(19)16(4-5-20-15)23-6-8-26-9-7-23/h2-5,10H,6-9,11H2,1H3,(H,21,22) D03CCH DRUGINKE OGHHMBMLUJWHGH-UHFFFAOYSA-N D03CCH DRUGSMIL COC1=CC2=C(C=C1)N=C(N2)S(=O)CC3=NC=CC(=C3Cl)N4CCOCC4 D03CCH HIGHSTAT Terminated D03WYV DRUG__ID D03WYV D03WYV DRUGINCH 1S/C11H17N5O3S/c1-8-4-9-13-7-14-16(9)15-10(8)19-5-11(2,3)6-20(12,17)18/h4,7H,5-6H2,1-3H3,(H2,12,17,18) D03WYV DRUGINKE CAFKKIIVXSPURY-UHFFFAOYSA-N D03WYV DRUGSMIL CC1=CC2=NC=NN2N=C1OCC(C)(C)CS(=O)(=O)N D03WYV HIGHSTAT Terminated D05MSL DRUG__ID D05MSL D05MSL DRUGINCH 1S/C19H21F2N3O4/c1-28-18-15-11(17(25)12(19(26)27)7-24(15)10-2-3-10)4-13(21)16(18)23-6-9(5-20)14(22)8-23/h4,7,9-10,14H,2-3,5-6,8,22H2,1H3,(H,26,27)/t9-,14+/m0/s1 D05MSL DRUGINKE XGZPDXTUAWRGLD-LKFCYVNXSA-N D05MSL DRUGSMIL COC1=C2C(=CC(=C1N3CC(C(C3)N)CF)F)C(=O)C(=CN2C4CC4)C(=O)O D05MSL HIGHSTAT Terminated D08YUP DRUG__ID D08YUP D08YUP DRUGINCH 1S/C23H24N2O/c1-25-10-9-23(18-6-4-7-20(26)13-18)14-22-17(12-19(23)15-25)11-16-5-2-3-8-21(16)24-22/h2-8,11,13,19,26H,9-10,12,14-15H2,1H3/t19-,23+/m0/s1 D08YUP DRUGINKE LEPBHAAYNPPRRA-WMZHIEFXSA-N D08YUP DRUGSMIL CN1CCC2(CC3=NC4=CC=CC=C4C=C3CC2C1)C5=CC(=CC=C5)O D08YUP HIGHSTAT Terminated D0I0FM DRUG__ID D0I0FM D0I0FM DRUGINCH 1S/C61H81N13O18/c1-30(2)23-39-53(81)65-37-17-10-11-21-63-46(76)27-43(61(89)90)71-55(83)41-28-48(78)91-29-44(72-57(85)45-18-12-22-74(45)60(88)42(70-51(37)79)24-33-13-6-5-7-14-33)56(84)66-38(19-20-47(77)92-32(4)50(59(87)69-39)73-58(86)49(62)31(3)75)52(80)67-40(54(82)68-41)26-35-25-34-15-8-9-16-36(34)64-35/h5-9,13-16,25,30-32,37-45,49-50,64,75H,10-12,17-24,26-29,62H2,1-4H3,(H,63,76)(H,65,81)(H,66,84)(H,67,80)(H,68,82)(H,69,87)(H,70,79)(H,71,83)(H,72,85)(H,73,86)(H,89,90)/t31-,32+,37+,38+,39+,40+,41+,42+,43+,44+,45+,49+,50+/m1/s1 D0I0FM DRUGINKE OBJRDBYSSAEARM-WSFPPIIISA-N D0I0FM DRUGSMIL CC1C(C(=O)NC(C(=O)NC2CCCCNC(=O)CC(NC(=O)C3CC(=O)OCC(C(=O)NC(CCC(=O)O1)C(=O)NC(C(=O)N3)CC4=CC5=CC=CC=C5N4)NC(=O)C6CCCN6C(=O)C(NC2=O)CC7=CC=CC=C7)C(=O)O)CC(C)C)NC(=O)C(C(C)O)N D0I0FM HIGHSTAT Terminated D0Q7TH DRUG__ID D0Q7TH D0Q7TH DRUGINCH 1S/C25H28N6O3/c1-16-22(24(33)23(16)32)29-18-5-6-20-19(12-18)17(13-27-20)4-3-7-30-8-10-31(11-9-30)25-21(34-2)14-26-15-28-25/h5-6,12-15,27,29H,3-4,7-11H2,1-2H3 D0Q7TH DRUGINKE HCXROGVQIBVJTA-UHFFFAOYSA-N D0Q7TH DRUGSMIL CC1=C(C(=O)C1=O)NC2=CC3=C(C=C2)NC=C3CCCN4CCN(CC4)C5=NC=NC=C5OC D0Q7TH HIGHSTAT Terminated D0T7EZ DRUG__ID D0T7EZ D0T7EZ DRUGINCH 1S/C66H78N24O22S6.2Na/c67-53(91)17-25-87(26-18-54(68)92)113(99,100)45-9-1-5-39(33-45)75-61-81-62(76-40-6-2-10-46(34-40)114(101,102)88(27-19-55(69)93)28-20-56(70)94)84-65(83-61)79-43-13-15-49(51(37-43)117(107,108)109)50-16-14-44(38-52(50)118(110,111)112)80-66-85-63(77-41-7-3-11-47(35-41)115(103,104)89(29-21-57(71)95)30-22-58(72)96)82-64(86-66)78-42-8-4-12-48(36-42)116(105,106)90(31-23-59(73)97)32-24-60(74)98;;/h1-16,33-38H,17-32H2,(H2,67,91)(H2,68,92)(H2,69,93)(H2,70,94)(H2,71,95)(H2,72,96)(H2,73,97)(H2,74,98)(H,107,108,109)(H,110,111,112)(H3,75,76,79,81,83,84)(H3,77,78,80,82,85,86);;/q;2*+1/p-2 D0T7EZ DRUGINKE RHYDQBKNSGARFE-UHFFFAOYSA-L D0T7EZ DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N(CCC(=O)N)CCC(=O)N)NC2=NC(=NC(=N2)NC3=CC(=C(C=C3)C4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)N(CCC(=O)N)CCC(=O)N)NC7=CC(=CC=C7)S(=O)(=O)N(CCC(=O)N)CCC(=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])NC8=CC(=CC=C8)S(=O)(=O)N(CCC(=O)N)CCC(=O)N.[Na+].[Na+] D0T7EZ HIGHSTAT Terminated D0W8TS DRUG__ID D0W8TS D0W8TS DRUGINCH 1S/C55H66N10O13/c1-3-4-19-45(54(77)64-43(29-48(70)71)53(76)61-40(49(57)72)24-32-13-7-5-8-14-32)65(2)55(78)44(27-35-30-58-39-18-12-11-17-37(35)39)60-46(67)31-59-51(74)41(25-33-15-9-6-10-16-33)63-52(75)42(26-34-20-22-36(66)23-21-34)62-50(73)38(56)28-47(68)69/h5-18,20-23,30,38,40-45,58,66H,3-4,19,24-29,31,56H2,1-2H3,(H2,57,72)(H,59,74)(H,60,67)(H,61,76)(H,62,73)(H,63,75)(H,64,77)(H,68,69)(H,70,71)/t38-,40-,41+,42-,43-,44-,45-/m0/s1 D0W8TS DRUGINKE IJHCWGDIGBABKC-GDHOWUIUSA-N D0W8TS DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)N D0W8TS HIGHSTAT Terminated D0Z9LD DRUG__ID D0Z9LD D0Z9LD DRUGINCH 1S/C22H33N5O6/c23-22(24)25-12-8-3-1-2-7-11-18(28)26-16(14-19(29)30)20(31)27-17(21(32)33)13-15-9-5-4-6-10-15/h4-6,9-10,16-17H,1-3,7-8,11-14H2,(H,26,28)(H,27,31)(H,29,30)(H,32,33)(H4,23,24,25)/t16-,17-/m0/s1 D0Z9LD DRUGINKE PLSJXKVBQIPFJY-IRXDYDNUSA-N D0Z9LD DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C(CC(=O)O)NC(=O)CCCCCCCN=C(N)N D0Z9LD HIGHSTAT Terminated D02BHP DRUG__ID D02BHP D02BHP DRUGCOMP Pharmacia & Upjohn AB D02BHP DRUGTYPE Monoclonal antibody D02BHP HIGHSTAT Terminated D02RAI DRUG__ID D02RAI D02RAI DRUGCOMP Amgen D02RAI DRUGTYPE Antibody D02RAI HIGHSTAT Terminated D03VFV DRUG__ID D03VFV D03VFV DRUGCOMP Cytos Biotechnology AG D03VFV DRUGTYPE Vaccine D03VFV HIGHSTAT Terminated D05ITS DRUG__ID D05ITS D05ITS DRUGCOMP Alnylam Pharmaceuticals Inc D05ITS DRUGTYPE siRNA drug D05ITS HIGHSTAT Terminated D05YHW DRUG__ID D05YHW D05YHW DRUGCOMP BioTie Therapies Corp D05YHW DRUGTYPE Antibody D05YHW HIGHSTAT Terminated D06MJP DRUG__ID D06MJP D06MJP DRUGCOMP Cytos Biotechnology AG D06MJP DRUGTYPE Vaccine D06MJP HIGHSTAT Terminated D07ULK DRUG__ID D07ULK D07ULK DRUGCOMP Orexo AB D07ULK DRUGTYPE Antibody D07ULK HIGHSTAT Terminated D07ZKK DRUG__ID D07ZKK D07ZKK DRUGCOMP Duke University D07ZKK DRUGTYPE Antibody D07ZKK HIGHSTAT Terminated D08QJD DRUG__ID D08QJD D08QJD DRUGCOMP PDL BioPharma Inc D08QJD DRUGTYPE Antibody D08QJD HIGHSTAT Terminated D0B9CA DRUG__ID D0B9CA D0B9CA DRUGCOMP Novartis AG D0B9CA DRUGTYPE Monoclonal antibody D0B9CA HIGHSTAT Terminated D0CY2Z DRUG__ID D0CY2Z D0CY2Z DRUGCOMP Genmab A/S D0CY2Z DRUGTYPE Antibody D0CY2Z HIGHSTAT Terminated D0F6HW DRUG__ID D0F6HW D0F6HW DRUGCOMP Universite de la Mediterranee D0F6HW DRUGTYPE Antibody D0F6HW HIGHSTAT Terminated D0I0SY DRUG__ID D0I0SY D0I0SY DRUGCOMP Medlmmune LLC D0I0SY DRUGTYPE Antibody D0I0SY HIGHSTAT Terminated D0JS4E DRUG__ID D0JS4E D0JS4E DRUGCOMP ICOS Corp D0JS4E DRUGTYPE Antibody D0JS4E HIGHSTAT Terminated D0LG1K DRUG__ID D0LG1K D0LG1K DRUGCOMP Ramot at Tel Aviv University Ltd D0LG1K DRUGTYPE Antibody D0LG1K HIGHSTAT Terminated D0M0UV DRUG__ID D0M0UV D0M0UV DRUGCOMP Inex Pharmaceuticals Corp D0M0UV DRUGTYPE Antisense drug D0M0UV HIGHSTAT Terminated D0M8JF DRUG__ID D0M8JF D0M8JF DRUGCOMP MorphoSys AG D0M8JF DRUGTYPE Antibody D0M8JF HIGHSTAT Terminated D0N5UA DRUG__ID D0N5UA D0N5UA DRUGCOMP Sanofi-Aventis D0N5UA DRUGTYPE Combination drug (Antibody) D0N5UA HIGHSTAT Terminated D0O9AZ DRUG__ID D0O9AZ D0O9AZ DRUGCOMP Cytos Biotechnology AG D0O9AZ DRUGTYPE Vaccine D0O9AZ HIGHSTAT Terminated D0PU8Z DRUG__ID D0PU8Z D0PU8Z DRUGCOMP Roche; Genentech D0PU8Z DRUGTYPE Monoclonal antibody D0PU8Z HIGHSTAT Terminated D0Q4DT DRUG__ID D0Q4DT D0Q4DT DRUGCOMP Genmab A/S D0Q4DT DRUGTYPE Antibody D0Q4DT HIGHSTAT Terminated D0R4OD DRUG__ID D0R4OD D0R4OD DRUGCOMP Advanced Biotherapy Inc D0R4OD DRUGTYPE Antibody D0R4OD HIGHSTAT Terminated D0R6EQ DRUG__ID D0R6EQ D0R6EQ DRUGCOMP Boehringer Ingelheim International GmbH D0R6EQ DRUGTYPE Antibody D0R6EQ HIGHSTAT Terminated D0U3OY DRUG__ID D0U3OY D0U3OY DRUGCOMP ICOS Corp D0U3OY DRUGTYPE Antibody D0U3OY HIGHSTAT Terminated D0V4FP DRUG__ID D0V4FP D0V4FP DRUGCOMP Orexo AB D0V4FP DRUGTYPE Antibody D0V4FP HIGHSTAT Terminated D0V4PH DRUG__ID D0V4PH D0V4PH DRUGCOMP Innogenetics NV D0V4PH DRUGTYPE Antibody D0V4PH HIGHSTAT Terminated D0VV3O DRUG__ID D0VV3O D0VV3O DRUGCOMP GENimmune NV D0VV3O DRUGTYPE Antibody D0VV3O HIGHSTAT Terminated D0W5NP DRUG__ID D0W5NP D0W5NP DRUGCOMP Pharmacia & Upjohn Inc D0W5NP DRUGTYPE Antibody D0W5NP HIGHSTAT Terminated D0W6MA DRUG__ID D0W6MA D0W6MA DRUGCOMP Eisai D0W6MA THERCLAS Analgesics D0W6MA HIGHSTAT Terminated D0Z0HS DRUG__ID D0Z0HS D0Z0HS DRUGCOMP PDL BioPharma D0Z0HS DRUGTYPE Antibody D0Z0HS HIGHSTAT Terminated D00ACH DRUG__ID D00ACH D00ACH DRUGCOMP Aventis Pharma AG D00ACH HIGHSTAT Terminated D00ADV DRUG__ID D00ADV D00ADV DRUGCOMP Wyeth Research D00ADV HIGHSTAT Terminated D00DAU DRUG__ID D00DAU D00DAU DRUGCOMP Veloxis Pharmaceuticals A/S D00DAU HIGHSTAT Terminated D00DSD DRUG__ID D00DSD D00DSD DRUGCOMP Galileo Pharmaceuticals Inc D00DSD HIGHSTAT Terminated D00EML DRUG__ID D00EML D00EML DRUGCOMP CSL Ltd D00EML HIGHSTAT Terminated D00FJS DRUG__ID D00FJS D00FJS DRUGCOMP Kureha D00FJS HIGHSTAT Terminated D00FSS DRUG__ID D00FSS D00FSS DRUGCOMP Shire plc D00FSS HIGHSTAT Terminated D00FYP DRUG__ID D00FYP D00FYP DRUGCOMP Pharmagenesis Inc D00FYP HIGHSTAT Terminated D00GAV DRUG__ID D00GAV D00GAV DRUGCOMP Evolva Holding SA D00GAV HIGHSTAT Terminated D00GDN DRUG__ID D00GDN D00GDN DRUGCOMP Milkhaus Laboratory Inc D00GDN HIGHSTAT Terminated D00HNK DRUG__ID D00HNK D00HNK DRUGCOMP Somatogen Inc D00HNK HIGHSTAT Terminated D00HTT DRUG__ID D00HTT D00HTT DRUGCOMP XenoStat Inc D00HTT HIGHSTAT Terminated D00IOS DRUG__ID D00IOS D00IOS DRUGCOMP Cytos Biotechnology AG D00IOS HIGHSTAT Terminated D00IPW DRUG__ID D00IPW D00IPW DRUGCOMP Novartis AG D00IPW HIGHSTAT Terminated D00IZW DRUG__ID D00IZW D00IZW DRUGCOMP Boehringer Mannheim GmbH D00IZW HIGHSTAT Terminated D00JSG DRUG__ID D00JSG D00JSG DRUGCOMP Harvard University D00JSG HIGHSTAT Terminated D00JWL DRUG__ID D00JWL D00JWL DRUGCOMP Lexin Pharmaceutical D00JWL HIGHSTAT Terminated D00JZX DRUG__ID D00JZX D00JZX DRUGCOMP Enanta Pharmaceuticals Inc D00JZX HIGHSTAT Terminated D00KLH DRUG__ID D00KLH D00KLH DRUGCOMP Gedeon Richter Ltd D00KLH HIGHSTAT Terminated D00KXQ DRUG__ID D00KXQ D00KXQ DRUGCOMP Fournier Pharma D00KXQ HIGHSTAT Terminated D00LWX DRUG__ID D00LWX D00LWX DRUGCOMP GD Searle & Co D00LWX HIGHSTAT Terminated D00MIF DRUG__ID D00MIF D00MIF DRUGCOMP Japan Tobacco Inc D00MIF HIGHSTAT Terminated D00MLQ DRUG__ID D00MLQ D00MLQ DRUGCOMP Abbott Laboratories D00MLQ HIGHSTAT Terminated D00MSP DRUG__ID D00MSP D00MSP DRUGCOMP Fujisawa Pharmaceutical Co Ltd D00MSP HIGHSTAT Terminated D00MVK DRUG__ID D00MVK D00MVK DRUGCOMP F Hoffmann-La Roche Ltd D00MVK HIGHSTAT Terminated D00PPV DRUG__ID D00PPV D00PPV DRUGCOMP Pharmacia & Upjohn Co D00PPV HIGHSTAT Terminated D00TKC DRUG__ID D00TKC D00TKC DRUGCOMP Nobex Corp D00TKC HIGHSTAT Terminated D00TRL DRUG__ID D00TRL D00TRL DRUGCOMP Evolutec Group plc D00TRL HIGHSTAT Terminated D00TTS DRUG__ID D00TTS D00TTS DRUGCOMP Stem Cell Therapeutics Corp D00TTS HIGHSTAT Terminated D00TVI DRUG__ID D00TVI D00TVI DRUGCOMP Sanofi-Synthelabo D00TVI HIGHSTAT Terminated D00WEL DRUG__ID D00WEL D00WEL DRUGCOMP American Biogenetic Sciences Inc D00WEL HIGHSTAT Terminated D00WYV DRUG__ID D00WYV D00WYV DRUGCOMP US Army Medical Research Institute of Infectious Diseases D00WYV HIGHSTAT Terminated D00XQK DRUG__ID D00XQK D00XQK DRUGCOMP Ontario Inc D00XQK HIGHSTAT Terminated D00XTS DRUG__ID D00XTS D00XTS DRUGCOMP Rottapharm Madaus D00XTS HIGHSTAT Terminated D00YEO DRUG__ID D00YEO D00YEO DRUGCOMP Novazyme Pharmaceuticals Inc D00YEO HIGHSTAT Terminated D00YWH DRUG__ID D00YWH D00YWH DRUGCOMP Shikoku Chemicals Corp D00YWH HIGHSTAT Terminated D00ZNS DRUG__ID D00ZNS D00ZNS DRUGCOMP Devgen NV D00ZNS HIGHSTAT Terminated D01AJM DRUG__ID D01AJM D01AJM DRUGCOMP Rosanto Pharmaceuticals Ltd D01AJM HIGHSTAT Terminated D01CJB DRUG__ID D01CJB D01CJB DRUGCOMP Viventia Biotech D01CJB HIGHSTAT Terminated D01DJA DRUG__ID D01DJA D01DJA DRUGCOMP Kyowa Hakko Kogyo Co Ltd D01DJA HIGHSTAT Terminated D01DRL DRUG__ID D01DRL D01DRL DRUGCOMP Gedeon Richter Ltd D01DRL HIGHSTAT Terminated D01DTQ DRUG__ID D01DTQ D01DTQ DRUGCOMP Pharmaxis Ltd D01DTQ HIGHSTAT Terminated D01EPP DRUG__ID D01EPP D01EPP DRUGCOMP Elan Corp plc D01EPP HIGHSTAT Terminated D01EWC DRUG__ID D01EWC D01EWC DRUGCOMP Rottapharm Madaus D01EWC HIGHSTAT Terminated D01EYM DRUG__ID D01EYM D01EYM DRUGCOMP Vernalis plc D01EYM HIGHSTAT Terminated D01EZY DRUG__ID D01EZY D01EZY DRUGCOMP Japan Tobacco Inc D01EZY HIGHSTAT Terminated D01FME DRUG__ID D01FME D01FME DRUGCOMP Acambis Inc D01FME HIGHSTAT Terminated D01GCT DRUG__ID D01GCT D01GCT DRUGCOMP Alizyme plc D01GCT HIGHSTAT Terminated D01GCY DRUG__ID D01GCY D01GCY DRUGCOMP Novo Nordisk A/S D01GCY HIGHSTAT Terminated D01HPI DRUG__ID D01HPI D01HPI DRUGCOMP Delex Therapeutics Inc D01HPI HIGHSTAT Terminated D01HVE DRUG__ID D01HVE D01HVE DRUGCOMP Zeneca Group plc D01HVE HIGHSTAT Terminated D01JEI DRUG__ID D01JEI D01JEI DRUGCOMP Pierre Fabre SA D01JEI HIGHSTAT Terminated D01JRF DRUG__ID D01JRF D01JRF DRUGCOMP Shire plc D01JRF HIGHSTAT Terminated D01KKM DRUG__ID D01KKM D01KKM DRUGCOMP Allergenics Inc D01KKM HIGHSTAT Terminated D01KWB DRUG__ID D01KWB D01KWB DRUGCOMP Sosei R&D Ltd D01KWB HIGHSTAT Terminated D01LXG DRUG__ID D01LXG D01LXG DRUGCOMP Solvay Pharmaceuticals Inc D01LXG HIGHSTAT Terminated D01LZC DRUG__ID D01LZC D01LZC DRUGCOMP Genetic Therapy Inc D01LZC HIGHSTAT Terminated D01OUA DRUG__ID D01OUA D01OUA DRUGCOMP Tsumura & Co D01OUA HIGHSTAT Terminated D01QIA DRUG__ID D01QIA D01QIA DRUGCOMP Bioglan Pharmaceuticals Co D01QIA HIGHSTAT Terminated D01TCM DRUG__ID D01TCM D01TCM DRUGCOMP Novo Nordisk A/S D01TCM HIGHSTAT Terminated D01TGH DRUG__ID D01TGH D01TGH DRUGCOMP Pfizer Inc D01TGH HIGHSTAT Terminated D01TIN DRUG__ID D01TIN D01TIN DRUGCOMP Roche Holding AG D01TIN HIGHSTAT Terminated D01TPU DRUG__ID D01TPU D01TPU DRUGCOMP ASTA Medica AG D01TPU HIGHSTAT Terminated D01UDR DRUG__ID D01UDR D01UDR DRUGCOMP Roche Holding AG D01UDR HIGHSTAT Terminated D01WJM DRUG__ID D01WJM D01WJM DRUGCOMP ASTA Medica AG D01WJM HIGHSTAT Terminated D01XMS DRUG__ID D01XMS D01XMS DRUGCOMP Entropin Inc D01XMS HIGHSTAT Terminated D01XPG DRUG__ID D01XPG D01XPG DRUGCOMP GlycoGenesys Inc D01XPG HIGHSTAT Terminated D01YSH DRUG__ID D01YSH D01YSH DRUGCOMP Daiichi Seiyaku Co Ltd D01YSH HIGHSTAT Terminated D02ADJ DRUG__ID D02ADJ D02ADJ DRUGCOMP Savient Pharmaceuticals Inc D02ADJ HIGHSTAT Terminated D02AEI DRUG__ID D02AEI D02AEI DRUGCOMP Boehringer Mannheim GmbH D02AEI HIGHSTAT Terminated D02AXS DRUG__ID D02AXS D02AXS DRUGCOMP GlaxoSmithKline D02AXS HIGHSTAT Terminated D02ERH DRUG__ID D02ERH D02ERH DRUGCOMP Celera South San Francisco D02ERH HIGHSTAT Terminated D02GFZ DRUG__ID D02GFZ D02GFZ DRUGCOMP Scios Inc D02GFZ HIGHSTAT Terminated D02GJE DRUG__ID D02GJE D02GJE DRUGCOMP Calydon Inc D02GJE HIGHSTAT Terminated D02GYD DRUG__ID D02GYD D02GYD DRUGCOMP UCB Celltech D02GYD HIGHSTAT Terminated D02IJP DRUG__ID D02IJP D02IJP DRUGCOMP Calyx Therapeutics Inc D02IJP HIGHSTAT Terminated D02IPI DRUG__ID D02IPI D02IPI DRUGCOMP Johns Hopkins University D02IPI HIGHSTAT Terminated D02ISP DRUG__ID D02ISP D02ISP DRUGCOMP SK Pharmaceutical Co Ltd D02ISP HIGHSTAT Terminated D02KQE DRUG__ID D02KQE D02KQE DRUGCOMP Onconova Therapeutics Inc D02KQE HIGHSTAT Terminated D02LUP DRUG__ID D02LUP D02LUP DRUGCOMP Renovo Group plc D02LUP HIGHSTAT Terminated D02MBO DRUG__ID D02MBO D02MBO DRUGCOMP Axis Genetics plc D02MBO HIGHSTAT Terminated D02NVF DRUG__ID D02NVF D02NVF DRUGCOMP Zeneca Group plc D02NVF HIGHSTAT Terminated D02OCF DRUG__ID D02OCF D02OCF DRUGCOMP AstraZeneca plc D02OCF HIGHSTAT Terminated D02PAJ DRUG__ID D02PAJ D02PAJ DRUGCOMP Grupo Uriach D02PAJ HIGHSTAT Terminated D02RCV DRUG__ID D02RCV D02RCV DRUGCOMP Actelion Pharmaceuticals D02RCV HIGHSTAT Terminated D02RLS DRUG__ID D02RLS D02RLS DRUGCOMP Roche Holding AG D02RLS HIGHSTAT Terminated D02TLD DRUG__ID D02TLD D02TLD DRUGCOMP Amsterdam Molecular Therapeutics BV D02TLD HIGHSTAT Terminated D02UCW DRUG__ID D02UCW D02UCW DRUGCOMP Chiron Corp D02UCW HIGHSTAT Terminated D02UQU DRUG__ID D02UQU D02UQU DRUGCOMP American Biogenetic Sciences Inc D02UQU HIGHSTAT Terminated D02VFK DRUG__ID D02VFK D02VFK DRUGCOMP PharmaPrint Inc D02VFK HIGHSTAT Terminated D02VHE DRUG__ID D02VHE D02VHE DRUGCOMP Abbott Laboratories D02VHE HIGHSTAT Terminated D02WEL DRUG__ID D02WEL D02WEL DRUGCOMP Viragen Inc D02WEL HIGHSTAT Terminated D02WUW DRUG__ID D02WUW D02WUW DRUGCOMP PLIVA dd D02WUW HIGHSTAT Terminated D02YQJ DRUG__ID D02YQJ D02YQJ DRUGCOMP Sankyo Co Ltd D02YQJ HIGHSTAT Terminated D02ZKB DRUG__ID D02ZKB D02ZKB DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D02ZKB HIGHSTAT Terminated D02ZWG DRUG__ID D02ZWG D02ZWG DRUGCOMP Sanofi D02ZWG HIGHSTAT Terminated D03AFX DRUG__ID D03AFX D03AFX DRUGCOMP Cenomed BioSciences LLC D03AFX HIGHSTAT Terminated D03BVH DRUG__ID D03BVH D03BVH DRUGCOMP Elbion AG D03BVH HIGHSTAT Terminated D03CIN DRUG__ID D03CIN D03CIN DRUGCOMP PanTherix Ltd D03CIN HIGHSTAT Terminated D03CMR DRUG__ID D03CMR D03CMR DRUGCOMP Telik Inc D03CMR HIGHSTAT Terminated D03CUS DRUG__ID D03CUS D03CUS DRUGCOMP Shenzhen Chipscreen Biosciences Ltd D03CUS HIGHSTAT Terminated D03DFY DRUG__ID D03DFY D03DFY DRUGCOMP Marina Biotech Inc D03DFY HIGHSTAT Terminated D03DNI DRUG__ID D03DNI D03DNI DRUGCOMP XTL Biopharmaceuticals Ltd D03DNI HIGHSTAT Terminated D03DVV DRUG__ID D03DVV D03DVV DRUGCOMP Nippon Shoji Co Ltd D03DVV HIGHSTAT Terminated D03DYB DRUG__ID D03DYB D03DYB DRUGCOMP AstraZeneca plc D03DYB HIGHSTAT Terminated D03FAP DRUG__ID D03FAP D03FAP DRUGCOMP Abbott Laboratories D03FAP HIGHSTAT Terminated D03HSF DRUG__ID D03HSF D03HSF DRUGCOMP Roche Holding AG D03HSF HIGHSTAT Terminated D03IIP DRUG__ID D03IIP D03IIP DRUGCOMP EPIX Pharmaceuticals Inc D03IIP HIGHSTAT Terminated D03JMN DRUG__ID D03JMN D03JMN DRUGCOMP Sosei R&D Ltd D03JMN HIGHSTAT Terminated D03KJP DRUG__ID D03KJP D03KJP DRUGCOMP Baxter International Inc D03KJP HIGHSTAT Terminated D03OBV DRUG__ID D03OBV D03OBV DRUGCOMP Antisoma plc D03OBV HIGHSTAT Terminated D03PBT DRUG__ID D03PBT D03PBT DRUGCOMP Bristol-Myers Squibb Pharma Co D03PBT HIGHSTAT Terminated D03PCJ DRUG__ID D03PCJ D03PCJ DRUGCOMP Myriad Genetics Inc D03PCJ HIGHSTAT Terminated D03QSR DRUG__ID D03QSR D03QSR DRUGCOMP Celldex Therapeutics Inc D03QSR HIGHSTAT Terminated D03QTB DRUG__ID D03QTB D03QTB DRUGCOMP NeuroSearch A/S D03QTB HIGHSTAT Terminated D03RZM DRUG__ID D03RZM D03RZM DRUGCOMP AMUR Pharmaceuticals Inc D03RZM HIGHSTAT Terminated D03SVZ DRUG__ID D03SVZ D03SVZ DRUGCOMP Mucosis BV D03SVZ HIGHSTAT Terminated D03UXT DRUG__ID D03UXT D03UXT DRUGCOMP Maxygen Inc D03UXT HIGHSTAT Terminated D03VEZ DRUG__ID D03VEZ D03VEZ DRUGCOMP Tanox Inc D03VEZ HIGHSTAT Terminated D03WUH DRUG__ID D03WUH D03WUH DRUGCOMP Yamanouchi Pharmaceutical Co Ltd D03WUH HIGHSTAT Terminated D03XHD DRUG__ID D03XHD D03XHD DRUGCOMP Arrow Therapeutics Ltd D03XHD HIGHSTAT Terminated D03XIH DRUG__ID D03XIH D03XIH DRUGCOMP American Biogenetic Sciences Inc D03XIH HIGHSTAT Terminated D03XST DRUG__ID D03XST D03XST DRUGCOMP Microcide Pharmaceuticals Inc D03XST HIGHSTAT Terminated D03XUQ DRUG__ID D03XUQ D03XUQ DRUGCOMP Argolyn Bioscience Inc D03XUQ HIGHSTAT Terminated D03YIT DRUG__ID D03YIT D03YIT DRUGCOMP Lederle Laboratories D03YIT HIGHSTAT Terminated D03YJZ DRUG__ID D03YJZ D03YJZ DRUGCOMP Novartis AG D03YJZ HIGHSTAT Terminated D03YPL DRUG__ID D03YPL D03YPL DRUGCOMP Rhone-Poulenc SA D03YPL HIGHSTAT Terminated D03ZBL DRUG__ID D03ZBL D03ZBL DRUGCOMP Wyeth D03ZBL HIGHSTAT Terminated D03ZGV DRUG__ID D03ZGV D03ZGV DRUGCOMP Purdue Neuroscience Corp D03ZGV HIGHSTAT Terminated D03ZPY DRUG__ID D03ZPY D03ZPY DRUGCOMP Squibb Corp D03ZPY HIGHSTAT Terminated D04APY DRUG__ID D04APY D04APY DRUGCOMP Solvay Deutschland GmbH D04APY HIGHSTAT Terminated D04BFX DRUG__ID D04BFX D04BFX DRUGCOMP Inflazyme Pharmaceuticals D04BFX HIGHSTAT Terminated D04BSZ DRUG__ID D04BSZ D04BSZ DRUGCOMP Parke-Davis & Co D04BSZ HIGHSTAT Terminated D04CNX DRUG__ID D04CNX D04CNX DRUGCOMP Roche Holding AG D04CNX HIGHSTAT Terminated D04DUG DRUG__ID D04DUG D04DUG DRUGCOMP Avigen Inc D04DUG HIGHSTAT Terminated D04DVF DRUG__ID D04DVF D04DVF DRUGCOMP Chiesi Farmaceutici SpA D04DVF HIGHSTAT Terminated D04EET DRUG__ID D04EET D04EET DRUGCOMP Crucell NV D04EET HIGHSTAT Terminated D04FYI DRUG__ID D04FYI D04FYI DRUGCOMP Apovia AG D04FYI HIGHSTAT Terminated D04GJX DRUG__ID D04GJX D04GJX DRUGCOMP AstraZeneca plc D04GJX HIGHSTAT Terminated D04GXS DRUG__ID D04GXS D04GXS DRUGCOMP Bioglan Pharmaceuticals Co D04GXS HIGHSTAT Terminated D04ICN DRUG__ID D04ICN D04ICN DRUGCOMP Bristol-Myers Squibb Pharma Co D04ICN HIGHSTAT Terminated D04IDT DRUG__ID D04IDT D04IDT DRUGCOMP AstraZeneca plc D04IDT HIGHSTAT Terminated D04JLW DRUG__ID D04JLW D04JLW DRUGCOMP Elbion AG D04JLW HIGHSTAT Terminated D04JVX DRUG__ID D04JVX D04JVX DRUGCOMP Akesis Pharmaceuticals Inc D04JVX HIGHSTAT Terminated D04LRU DRUG__ID D04LRU D04LRU DRUGCOMP A H Robins Co Inc D04LRU HIGHSTAT Terminated D04QFV DRUG__ID D04QFV D04QFV DRUGCOMP Elan Pharmaceuticals Inc D04QFV HIGHSTAT Terminated D04RDT DRUG__ID D04RDT D04RDT DRUGCOMP Cephalon Inc D04RDT HIGHSTAT Terminated D04RFE DRUG__ID D04RFE D04RFE DRUGCOMP Corixa Corp D04RFE HIGHSTAT Terminated D04RMP DRUG__ID D04RMP D04RMP DRUGCOMP Purdue Neuroscience Corp D04RMP HIGHSTAT Terminated D04SIO DRUG__ID D04SIO D04SIO DRUGCOMP Neurogen Corp D04SIO HIGHSTAT Terminated D04STQ DRUG__ID D04STQ D04STQ DRUGCOMP XTL Biopharmaceuticals Ltd D04STQ HIGHSTAT Terminated D04SVB DRUG__ID D04SVB D04SVB DRUGCOMP Fujisawa Pharmaceutical Co Ltd D04SVB HIGHSTAT Terminated D04TZT DRUG__ID D04TZT D04TZT DRUGCOMP Novartis AG D04TZT HIGHSTAT Terminated D04VXS DRUG__ID D04VXS D04VXS DRUGCOMP Entropin Inc D04VXS HIGHSTAT Terminated D04WIG DRUG__ID D04WIG D04WIG DRUGCOMP Epimmune Inc D04WIG HIGHSTAT Terminated D04XIA DRUG__ID D04XIA D04XIA DRUGCOMP Chiron SpA D04XIA HIGHSTAT Terminated D04YEY DRUG__ID D04YEY D04YEY DRUGCOMP Pharmacopeia Inc D04YEY HIGHSTAT Terminated D05AON DRUG__ID D05AON D05AON DRUGCOMP Lipid Sciences Inc D05AON HIGHSTAT Terminated D05AXS DRUG__ID D05AXS D05AXS DRUGCOMP Zalicus Inc D05AXS HIGHSTAT Terminated D05BBQ DRUG__ID D05BBQ D05BBQ DRUGCOMP Rhone-Poulenc SA D05BBQ HIGHSTAT Terminated D05BIT DRUG__ID D05BIT D05BIT DRUGCOMP Maxygen Inc D05BIT HIGHSTAT Terminated D05CTS DRUG__ID D05CTS D05CTS DRUGCOMP CepTor Corp D05CTS HIGHSTAT Terminated D05DNH DRUG__ID D05DNH D05DNH DRUGCOMP Abbott Laboratories D05DNH HIGHSTAT Terminated D05GBZ DRUG__ID D05GBZ D05GBZ DRUGCOMP American Biogenetic Sciences Inc D05GBZ HIGHSTAT Terminated D05HHP DRUG__ID D05HHP D05HHP DRUGCOMP Glycomed Inc D05HHP HIGHSTAT Terminated D05IZG DRUG__ID D05IZG D05IZG DRUGCOMP Bayer AG D05IZG HIGHSTAT Terminated D05KOA DRUG__ID D05KOA D05KOA DRUGCOMP PowderJect Pharmaceuticals plc D05KOA HIGHSTAT Terminated D05KTV DRUG__ID D05KTV D05KTV DRUGCOMP Neurogen Corp D05KTV HIGHSTAT Terminated D05KWY DRUG__ID D05KWY D05KWY DRUGCOMP Zeneca Group plc D05KWY HIGHSTAT Terminated D05LCX DRUG__ID D05LCX D05LCX DRUGCOMP Abbott Laboratories D05LCX HIGHSTAT Terminated D05MLX DRUG__ID D05MLX D05MLX DRUGCOMP Onyx Pharmaceuticals Inc D05MLX HIGHSTAT Terminated D05NQR DRUG__ID D05NQR D05NQR DRUGCOMP Innogenetics NV D05NQR HIGHSTAT Terminated D05NTY DRUG__ID D05NTY D05NTY DRUGCOMP Scios Inc D05NTY HIGHSTAT Terminated D05OVR DRUG__ID D05OVR D05OVR DRUGCOMP Grunenthal GmbH D05OVR HIGHSTAT Terminated D05PTG DRUG__ID D05PTG D05PTG DRUGCOMP Heidelberg Pharma Holding GmbH D05PTG HIGHSTAT Terminated D05QLQ DRUG__ID D05QLQ D05QLQ DRUGCOMP Merck & Co Inc D05QLQ HIGHSTAT Terminated D05QTO DRUG__ID D05QTO D05QTO DRUGCOMP Fournier Pharma D05QTO HIGHSTAT Terminated D05SBI DRUG__ID D05SBI D05SBI DRUGCOMP Encysive Pharmaceuticals Inc D05SBI HIGHSTAT Terminated D05SUA DRUG__ID D05SUA D05SUA DRUGCOMP Abbott Laboratories D05SUA HIGHSTAT Terminated D05SVQ DRUG__ID D05SVQ D05SVQ DRUGCOMP Glaxo Wellcome plc D05SVQ HIGHSTAT Terminated D05SXC DRUG__ID D05SXC D05SXC DRUGCOMP BioImage A/S D05SXC HIGHSTAT Terminated D05SXL DRUG__ID D05SXL D05SXL DRUGCOMP PLIVA dd D05SXL HIGHSTAT Terminated D05UMO DRUG__ID D05UMO D05UMO DRUGCOMP Bayer AG D05UMO HIGHSTAT Terminated D05URT DRUG__ID D05URT D05URT DRUGCOMP Maxia Pharmaceuticals Inc D05URT HIGHSTAT Terminated D05VQD DRUG__ID D05VQD D05VQD DRUGCOMP Bristol-Myers Squibb Co D05VQD HIGHSTAT Terminated D05VXQ DRUG__ID D05VXQ D05VXQ DRUGCOMP Sirus Pharmaceuticals Ltd D05VXQ HIGHSTAT Terminated D05WDD DRUG__ID D05WDD D05WDD DRUGCOMP Provalis plc D05WDD HIGHSTAT Terminated D05WYW DRUG__ID D05WYW D05WYW DRUGCOMP Merck & Co Inc D05WYW HIGHSTAT Terminated D05YOT DRUG__ID D05YOT D05YOT DRUGCOMP University of Southern California D05YOT HIGHSTAT Terminated D06BBZ DRUG__ID D06BBZ D06BBZ DRUGCOMP Zeneca Group plc D06BBZ HIGHSTAT Terminated D06BDP DRUG__ID D06BDP D06BDP DRUGCOMP Apovia AG D06BDP HIGHSTAT Terminated D06DLO DRUG__ID D06DLO D06DLO DRUGCOMP Roche Holding AG D06DLO HIGHSTAT Terminated D06FTW DRUG__ID D06FTW D06FTW DRUGCOMP Repligen Corp D06FTW HIGHSTAT Terminated D06FWG DRUG__ID D06FWG D06FWG DRUGCOMP Coremed Inc D06FWG HIGHSTAT Terminated D06IAA DRUG__ID D06IAA D06IAA DRUGCOMP Lek Pharmaceutical and Chemical Co DD D06IAA HIGHSTAT Terminated D06KJG DRUG__ID D06KJG D06KJG DRUGCOMP Calyx Therapeutics Inc D06KJG HIGHSTAT Terminated D06LAN DRUG__ID D06LAN D06LAN DRUGCOMP ADVENTRX Pharmaceuticals Inc D06LAN HIGHSTAT Terminated D06LCS DRUG__ID D06LCS D06LCS DRUGCOMP University of California Los Angeles D06LCS HIGHSTAT Terminated D06MIU DRUG__ID D06MIU D06MIU DRUGCOMP XOMA Ltd D06MIU HIGHSTAT Terminated D06MTM DRUG__ID D06MTM D06MTM DRUGCOMP Servier D06MTM HIGHSTAT Terminated D06NOU DRUG__ID D06NOU D06NOU DRUGCOMP UCB Celltech D06NOU HIGHSTAT Terminated D06NSL DRUG__ID D06NSL D06NSL DRUGCOMP Paligent Inc D06NSL HIGHSTAT Terminated D06QJE DRUG__ID D06QJE D06QJE DRUGCOMP Fornix BioSciences NV D06QJE HIGHSTAT Terminated D06REJ DRUG__ID D06REJ D06REJ DRUGCOMP Maxia Pharmaceuticals Inc D06REJ HIGHSTAT Terminated D06THT DRUG__ID D06THT D06THT DRUGCOMP Introgen Therapeutics Inc D06THT HIGHSTAT Terminated D06TTS DRUG__ID D06TTS D06TTS DRUGCOMP Meiji Institute of Health Science D06TTS HIGHSTAT Terminated D06UFH DRUG__ID D06UFH D06UFH DRUGCOMP Stehlin Foundation For Cancer Research D06UFH HIGHSTAT Terminated D06UXL DRUG__ID D06UXL D06UXL DRUGCOMP Glaxo Wellcome plc D06UXL HIGHSTAT Terminated D06XJP DRUG__ID D06XJP D06XJP DRUGCOMP SmithKline Beecham plc D06XJP HIGHSTAT Terminated D06YOD DRUG__ID D06YOD D06YOD DRUGCOMP Zeneca Group plc D06YOD HIGHSTAT Terminated D06ZZL DRUG__ID D06ZZL D06ZZL DRUGCOMP University of Kentucky D06ZZL HIGHSTAT Terminated D07AGR DRUG__ID D07AGR D07AGR DRUGCOMP SmithKline Beecham plc D07AGR HIGHSTAT Terminated D07BBD DRUG__ID D07BBD D07BBD DRUGCOMP Repros Therapeutics Inc D07BBD HIGHSTAT Terminated D07CGH DRUG__ID D07CGH D07CGH DRUGCOMP GPC Biotech AG D07CGH HIGHSTAT Terminated D07DCX DRUG__ID D07DCX D07DCX DRUGCOMP UCB Celltech D07DCX HIGHSTAT Terminated D07FHI DRUG__ID D07FHI D07FHI DRUGCOMP Maxim Pharmaceuticals Inc D07FHI HIGHSTAT Terminated D07FWH DRUG__ID D07FWH D07FWH DRUGCOMP Hoechst Marion Roussel SA D07FWH HIGHSTAT Terminated D07GLX DRUG__ID D07GLX D07GLX DRUGCOMP CeNeS Pharmaceuticals Inc D07GLX HIGHSTAT Terminated D07GZZ DRUG__ID D07GZZ D07GZZ DRUGCOMP Allergenics Inc D07GZZ HIGHSTAT Terminated D07MTL DRUG__ID D07MTL D07MTL DRUGCOMP Sirus Pharmaceuticals Ltd D07MTL HIGHSTAT Terminated D07OUE DRUG__ID D07OUE D07OUE DRUGCOMP Auxeris Therapeutics Inc D07OUE HIGHSTAT Terminated D07PAG DRUG__ID D07PAG D07PAG DRUGCOMP Pharmacia & Upjohn Co D07PAG HIGHSTAT Terminated D07PMU DRUG__ID D07PMU D07PMU DRUGCOMP CIS Bio international D07PMU HIGHSTAT Terminated D07QXG DRUG__ID D07QXG D07QXG DRUGCOMP Scotia Holdings plc D07QXG HIGHSTAT Terminated D07SEB DRUG__ID D07SEB D07SEB DRUGCOMP Boehringer Mannheim GmbH D07SEB HIGHSTAT Terminated D07THJ DRUG__ID D07THJ D07THJ DRUGCOMP Innate Pharma SA D07THJ HIGHSTAT Terminated D07UAJ DRUG__ID D07UAJ D07UAJ DRUGCOMP UCB Celltech D07UAJ HIGHSTAT Terminated D07UHY DRUG__ID D07UHY D07UHY DRUGCOMP Kowa Pharmaceutical Co Ltd D07UHY HIGHSTAT Terminated D07VMC DRUG__ID D07VMC D07VMC DRUGCOMP Eli Lilly & Co D07VMC HIGHSTAT Terminated D07VUD DRUG__ID D07VUD D07VUD DRUGCOMP AstraZeneca plc D07VUD HIGHSTAT Terminated D07XAX DRUG__ID D07XAX D07XAX DRUGCOMP Novartis AG D07XAX HIGHSTAT Terminated D07XGT DRUG__ID D07XGT D07XGT DRUGCOMP Zenyth Therapeutics Ltd D07XGT HIGHSTAT Terminated D07YNH DRUG__ID D07YNH D07YNH DRUGCOMP Sanomune Inc D07YNH HIGHSTAT Terminated D08ALQ DRUG__ID D08ALQ D08ALQ DRUGCOMP Rhone-Poulenc Rorer Inc D08ALQ HIGHSTAT Terminated D08BIN DRUG__ID D08BIN D08BIN DRUGCOMP Montana State University D08BIN HIGHSTAT Terminated D08EVM DRUG__ID D08EVM D08EVM DRUGCOMP Fujisawa Pharmaceutical Co Ltd D08EVM HIGHSTAT Terminated D08KDL DRUG__ID D08KDL D08KDL DRUGCOMP Chugai Pharmaceutical Co Ltd D08KDL HIGHSTAT Terminated D08KDP DRUG__ID D08KDP D08KDP DRUGCOMP Dainippon D08KDP HIGHSTAT Terminated D08LFX DRUG__ID D08LFX D08LFX DRUGCOMP Megabios Corp D08LFX HIGHSTAT Terminated D08MAR DRUG__ID D08MAR D08MAR DRUGCOMP Pfizer Inc D08MAR HIGHSTAT Terminated D08MCO DRUG__ID D08MCO D08MCO DRUGCOMP Shire BioChem Inc D08MCO HIGHSTAT Terminated D08MDV DRUG__ID D08MDV D08MDV DRUGCOMP Cell Therapeutics Inc D08MDV HIGHSTAT Terminated D08MDX DRUG__ID D08MDX D08MDX DRUGCOMP Innogenetics NV D08MDX HIGHSTAT Terminated D08MYO DRUG__ID D08MYO D08MYO DRUGCOMP Novartis AG D08MYO HIGHSTAT Terminated D08NQG DRUG__ID D08NQG D08NQG DRUGCOMP Viventia Biotech D08NQG HIGHSTAT Terminated D08OUU DRUG__ID D08OUU D08OUU DRUGCOMP Collateral Therapeutics Inc D08OUU HIGHSTAT Terminated D08RDC DRUG__ID D08RDC D08RDC DRUGCOMP Roche Holding AG D08RDC HIGHSTAT Terminated D08TCU DRUG__ID D08TCU D08TCU DRUGCOMP Gliatech Inc D08TCU HIGHSTAT Terminated D08VGS DRUG__ID D08VGS D08VGS DRUGCOMP Hawaii Biotechnology Group Inc D08VGS HIGHSTAT Terminated D08VJI DRUG__ID D08VJI D08VJI DRUGCOMP Pierre Fabre SA D08VJI HIGHSTAT Terminated D08VKQ DRUG__ID D08VKQ D08VKQ DRUGCOMP VirRx Inc D08VKQ HIGHSTAT Terminated D08YRD DRUG__ID D08YRD D08YRD DRUGCOMP Glycadia Inc D08YRD HIGHSTAT Terminated D08ZFC DRUG__ID D08ZFC D08ZFC DRUGCOMP Igeneon GmbH D08ZFC HIGHSTAT Terminated D08ZXH DRUG__ID D08ZXH D08ZXH DRUGCOMP SYGNIS Bioscience GmbH & Co KG D08ZXH HIGHSTAT Terminated D08ZZO DRUG__ID D08ZZO D08ZZO DRUGCOMP NeuroSearch A/S D08ZZO HIGHSTAT Terminated D09AGZ DRUG__ID D09AGZ D09AGZ DRUGCOMP BTG plc D09AGZ HIGHSTAT Terminated D09BCC DRUG__ID D09BCC D09BCC DRUGCOMP Able Laboratories Inc D09BCC HIGHSTAT Terminated D09BID DRUG__ID D09BID D09BID DRUGCOMP Progenics Pharmaceuticals Inc D09BID HIGHSTAT Terminated D09CRQ DRUG__ID D09CRQ D09CRQ DRUGCOMP Replikun Biotech Pty Ltd D09CRQ HIGHSTAT Terminated D09CTY DRUG__ID D09CTY D09CTY DRUGCOMP Ophidian Pharmaceuticals Inc D09CTY HIGHSTAT Terminated D09DAQ DRUG__ID D09DAQ D09DAQ DRUGCOMP Isis Pharmaceuticals D09DAQ HIGHSTAT Terminated D09ENA DRUG__ID D09ENA D09ENA DRUGCOMP Organon BioSciences D09ENA HIGHSTAT Terminated D09FJH DRUG__ID D09FJH D09FJH DRUGCOMP CJ Corp D09FJH HIGHSTAT Terminated D09GGO DRUG__ID D09GGO D09GGO DRUGCOMP Abbott Laboratories D09GGO HIGHSTAT Terminated D09GIP DRUG__ID D09GIP D09GIP DRUGCOMP Fournier Pharma D09GIP HIGHSTAT Terminated D09GRB DRUG__ID D09GRB D09GRB DRUGCOMP Novo Nordisk A/S D09GRB HIGHSTAT Terminated D09IUG DRUG__ID D09IUG D09IUG DRUGCOMP Pierre Fabre SA D09IUG HIGHSTAT Terminated D09KGZ DRUG__ID D09KGZ D09KGZ DRUGCOMP Quark Pharmaceuticals Inc D09KGZ HIGHSTAT Terminated D09KKD DRUG__ID D09KKD D09KKD DRUGCOMP AstraZeneca plc D09KKD HIGHSTAT Terminated D09KLO DRUG__ID D09KLO D09KLO DRUGCOMP AstraZeneca plc D09KLO HIGHSTAT Terminated D09LIE DRUG__ID D09LIE D09LIE DRUGCOMP Intracel Corp D09LIE HIGHSTAT Terminated D09MOD DRUG__ID D09MOD D09MOD DRUGCOMP Agouron Pharmaceuticals Inc D09MOD HIGHSTAT Terminated D09NKX DRUG__ID D09NKX D09NKX DRUGCOMP Valeant Pharmaceuticals International Inc D09NKX HIGHSTAT Terminated D09PPF DRUG__ID D09PPF D09PPF DRUGCOMP CeNeS Pharmaceuticals Inc D09PPF HIGHSTAT Terminated D09QVT DRUG__ID D09QVT D09QVT DRUGCOMP Actinova Ltd D09QVT HIGHSTAT Terminated D09RMS DRUG__ID D09RMS D09RMS DRUGCOMP Digna Biotech SL D09RMS HIGHSTAT Terminated D09TRM DRUG__ID D09TRM D09TRM DRUGCOMP UCB Celltech D09TRM HIGHSTAT Terminated D09VQO DRUG__ID D09VQO D09VQO DRUGCOMP Clera Inc D09VQO HIGHSTAT Terminated D09VRZ DRUG__ID D09VRZ D09VRZ DRUGCOMP Alizyme plc D09VRZ HIGHSTAT Terminated D09XMP DRUG__ID D09XMP D09XMP DRUGCOMP Scotia Holdings plc D09XMP HIGHSTAT Terminated D09XNZ DRUG__ID D09XNZ D09XNZ DRUGCOMP Cell Therapeutics Inc D09XNZ HIGHSTAT Terminated D09XYU DRUG__ID D09XYU D09XYU DRUGCOMP Xenova Group plc D09XYU HIGHSTAT Terminated D09ZAV DRUG__ID D09ZAV D09ZAV DRUGCOMP Repligen Corp D09ZAV HIGHSTAT Terminated D09ZCH DRUG__ID D09ZCH D09ZCH DRUGCOMP Ontario Inc D09ZCH HIGHSTAT Terminated D09ZFF DRUG__ID D09ZFF D09ZFF DRUGCOMP Ontario Inc D09ZFF HIGHSTAT Terminated D0A0CC DRUG__ID D0A0CC D0A0CC DRUGCOMP INSERM D0A0CC HIGHSTAT Terminated D0A0MJ DRUG__ID D0A0MJ D0A0MJ DRUGCOMP Genentech Inc D0A0MJ HIGHSTAT Terminated D0A1GJ DRUG__ID D0A1GJ D0A1GJ DRUGCOMP Epimmune Inc D0A1GJ HIGHSTAT Terminated D0A2IK DRUG__ID D0A2IK D0A2IK DRUGCOMP NPS Pharmaceuticals Inc D0A2IK HIGHSTAT Terminated D0A3AB DRUG__ID D0A3AB D0A3AB DRUGCOMP Incyte Corp D0A3AB HIGHSTAT Terminated D0A4VI DRUG__ID D0A4VI D0A4VI DRUGCOMP AstraZeneca plc D0A4VI HIGHSTAT Terminated D0A4XN DRUG__ID D0A4XN D0A4XN DRUGCOMP Pharmos Corp D0A4XN HIGHSTAT Terminated D0A5CU DRUG__ID D0A5CU D0A5CU DRUGCOMP Roche Holding AG D0A5CU HIGHSTAT Terminated D0A5PM DRUG__ID D0A5PM D0A5PM DRUGCOMP PharmaPrint Inc D0A5PM HIGHSTAT Terminated D0A7PW DRUG__ID D0A7PW D0A7PW DRUGCOMP Pfizer Inc D0A7PW HIGHSTAT Terminated D0A7VF DRUG__ID D0A7VF D0A7VF DRUGCOMP Pfizer Inc D0A7VF HIGHSTAT Terminated D0A9QL DRUG__ID D0A9QL D0A9QL DRUGTYPE Antibody D0A9QL HIGHSTAT Terminated D0B0TO DRUG__ID D0B0TO D0B0TO DRUGCOMP Merck Sharp & Dohme Research Laboratories D0B0TO HIGHSTAT Terminated D0B0WW DRUG__ID D0B0WW D0B0WW DRUGCOMP Neurobiological Technologies Inc D0B0WW HIGHSTAT Terminated D0B1VQ DRUG__ID D0B1VQ D0B1VQ DRUGCOMP Glaxo Group Research Ltd D0B1VQ HIGHSTAT Terminated D0B2CQ DRUG__ID D0B2CQ D0B2CQ DRUGCOMP Glaxo Group Research Ltd D0B2CQ HIGHSTAT Terminated D0B4AB DRUG__ID D0B4AB D0B4AB DRUGCOMP Purdue Neuroscience Corp D0B4AB HIGHSTAT Terminated D0B6BQ DRUG__ID D0B6BQ D0B6BQ DRUGCOMP Zeneca Group plc D0B6BQ HIGHSTAT Terminated D0B6QO DRUG__ID D0B6QO D0B6QO DRUGCOMP NovoScience Pharma Inc D0B6QO HIGHSTAT Terminated D0B6VQ DRUG__ID D0B6VQ D0B6VQ DRUGCOMP ASTA Medica AG D0B6VQ HIGHSTAT Terminated D0B6WN DRUG__ID D0B6WN D0B6WN DRUGCOMP Sanofi-Aventis D0B6WN HIGHSTAT Terminated D0BB1X DRUG__ID D0BB1X D0BB1X DRUGCOMP Kyorin Pharmaceutical Co Ltd D0BB1X HIGHSTAT Terminated D0BX1S DRUG__ID D0BX1S D0BX1S DRUGCOMP Taisho Pharmaceutical Co Ltd D0BX1S HIGHSTAT Terminated D0C0EX DRUG__ID D0C0EX D0C0EX DRUGCOMP Novartis AG D0C0EX HIGHSTAT Terminated D0C3DH DRUG__ID D0C3DH D0C3DH DRUGCOMP MediGene AG D0C3DH HIGHSTAT Terminated D0C3LM DRUG__ID D0C3LM D0C3LM DRUGCOMP Wyeth D0C3LM HIGHSTAT Terminated D0C4HZ DRUG__ID D0C4HZ D0C4HZ DRUGCOMP PLIVA dd D0C4HZ HIGHSTAT Terminated D0C5HV DRUG__ID D0C5HV D0C5HV DRUGCOMP Cornerstone Therapeutics D0C5HV HIGHSTAT Terminated D0C5LI DRUG__ID D0C5LI D0C5LI DRUGCOMP Synthelabo D0C5LI HIGHSTAT Terminated D0C5OF DRUG__ID D0C5OF D0C5OF DRUGCOMP F Hoffmann-La Roche Ltd D0C5OF HIGHSTAT Terminated D0C5YK DRUG__ID D0C5YK D0C5YK DRUGCOMP NitroMed Inc D0C5YK HIGHSTAT Terminated D0C6FL DRUG__ID D0C6FL D0C6FL DRUGCOMP Shire plc D0C6FL HIGHSTAT Terminated D0C8PQ DRUG__ID D0C8PQ D0C8PQ DRUGCOMP Dendreon San Diego LLC D0C8PQ HIGHSTAT Terminated D0C9KQ DRUG__ID D0C9KQ D0C9KQ DRUGCOMP MD Anderson Cancer Center; Novopharm Biotech D0C9KQ HIGHSTAT Terminated D0C9RV DRUG__ID D0C9RV D0C9RV DRUGCOMP Sirus Pharmaceuticals Ltd D0C9RV HIGHSTAT Terminated D0CI5O DRUG__ID D0CI5O D0CI5O DRUGCOMP Shire plc D0CI5O HIGHSTAT Terminated D0CQ8D DRUG__ID D0CQ8D D0CQ8D DRUGCOMP Amarin Corp plc D0CQ8D HIGHSTAT Terminated D0CX2J DRUG__ID D0CX2J D0CX2J DRUGCOMP Roche Holding AG D0CX2J HIGHSTAT Terminated D0D0XX DRUG__ID D0D0XX D0D0XX DRUGCOMP Eli Lilly & Co D0D0XX HIGHSTAT Terminated D0D2JD DRUG__ID D0D2JD D0D2JD DRUGCOMP Theratechnologies D0D2JD HIGHSTAT Terminated D0D2RZ DRUG__ID D0D2RZ D0D2RZ DRUGCOMP Novartis Pharmaceuticals Corp USA D0D2RZ HIGHSTAT Terminated D0D3HV DRUG__ID D0D3HV D0D3HV DRUGCOMP PLIVA dd D0D3HV HIGHSTAT Terminated D0D5IJ DRUG__ID D0D5IJ D0D5IJ DRUGCOMP LipoNova AG D0D5IJ HIGHSTAT Terminated D0D8KI DRUG__ID D0D8KI D0D8KI DRUGCOMP University of California San Diego D0D8KI HIGHSTAT Terminated D0D8ZU DRUG__ID D0D8ZU D0D8ZU DRUGCOMP SYGNIS Bioscience GmbH & Co KG D0D8ZU HIGHSTAT Terminated D0DD0O DRUG__ID D0DD0O D0DD0O DRUGCOMP ASTA Medica AG D0DD0O HIGHSTAT Terminated D0DG0W DRUG__ID D0DG0W D0DG0W DRUGCOMP NPS Allelix Corp D0DG0W HIGHSTAT Terminated D0DG9M DRUG__ID D0DG9M D0DG9M DRUGCOMP AstraZeneca plc D0DG9M HIGHSTAT Terminated D0DJ8D DRUG__ID D0DJ8D D0DJ8D DRUGCOMP MGI GP Inc D0DJ8D HIGHSTAT Terminated D0DR3I DRUG__ID D0DR3I D0DR3I DRUGCOMP Servier D0DR3I HIGHSTAT Terminated D0E1ZE DRUG__ID D0E1ZE D0E1ZE DRUGCOMP Eisai Co Ltd D0E1ZE HIGHSTAT Terminated D0E3LW DRUG__ID D0E3LW D0E3LW DRUGCOMP Novogen Ltd D0E3LW HIGHSTAT Terminated D0E3QU DRUG__ID D0E3QU D0E3QU DRUGCOMP Shire plc D0E3QU HIGHSTAT Terminated D0E4HZ DRUG__ID D0E4HZ D0E4HZ DRUGCOMP Pierre Fabre SA D0E4HZ HIGHSTAT Terminated D0E4MX DRUG__ID D0E4MX D0E4MX DRUGCOMP Andaris Group Ltd D0E4MX HIGHSTAT Terminated D0E4UB DRUG__ID D0E4UB D0E4UB DRUGCOMP SYGNIS Bioscience GmbH & Co KG D0E4UB HIGHSTAT Terminated D0E6JF DRUG__ID D0E6JF D0E6JF DRUGCOMP Wyeth-Ayerst Pharmaceuticals Inc D0E6JF HIGHSTAT Terminated D0E7BC DRUG__ID D0E7BC D0E7BC DRUGCOMP Genetic Therapy Inc D0E7BC HIGHSTAT Terminated D0E7BP DRUG__ID D0E7BP D0E7BP DRUGCOMP Pfizer Inc D0E7BP HIGHSTAT Terminated D0E8JL DRUG__ID D0E8JL D0E8JL DRUGCOMP Taisho Pharmaceutical Co Ltd D0E8JL HIGHSTAT Terminated D0EA7H DRUG__ID D0EA7H D0EA7H DRUGCOMP Fournier Pharma D0EA7H HIGHSTAT Terminated D0EF9I DRUG__ID D0EF9I D0EF9I DRUGCOMP Abbott Laboratories D0EF9I HIGHSTAT Terminated D0F0TW DRUG__ID D0F0TW D0F0TW DRUGCOMP Synthelabo D0F0TW HIGHSTAT Terminated D0F1AX DRUG__ID D0F1AX D0F1AX DRUGCOMP Cubist Pharmaceuticals Inc D0F1AX HIGHSTAT Terminated D0F1EI DRUG__ID D0F1EI D0F1EI DRUGCOMP AstraZeneca plc D0F1EI HIGHSTAT Terminated D0F1KP DRUG__ID D0F1KP D0F1KP DRUGCOMP Astellas Pharma Inc D0F1KP HIGHSTAT Terminated D0F2PQ DRUG__ID D0F2PQ D0F2PQ DRUGCOMP Hebrew University of Jerusalem D0F2PQ HIGHSTAT Terminated D0F2PZ DRUG__ID D0F2PZ D0F2PZ DRUGCOMP Suntory Ltd D0F2PZ HIGHSTAT Terminated D0F2TY DRUG__ID D0F2TY D0F2TY DRUGCOMP Queensland Institute of Medical Research D0F2TY HIGHSTAT Terminated D0F4WS DRUG__ID D0F4WS D0F4WS DRUGCOMP Boehringer Mannheim GmbH D0F4WS HIGHSTAT Terminated D0F6CI DRUG__ID D0F6CI D0F6CI DRUGCOMP Roche Holding AG D0F6CI HIGHSTAT Terminated D0F7EK DRUG__ID D0F7EK D0F7EK DRUGCOMP Maxia Pharmaceuticals Inc D0F7EK HIGHSTAT Terminated D0F7LE DRUG__ID D0F7LE D0F7LE DRUGCOMP AstraZeneca plc D0F7LE HIGHSTAT Terminated D0F7SW DRUG__ID D0F7SW D0F7SW DRUGCOMP Molecumetics Ltd D0F7SW HIGHSTAT Terminated D0F7XN DRUG__ID D0F7XN D0F7XN DRUGCOMP Zeneca Group plc D0F7XN HIGHSTAT Terminated D0F9BX DRUG__ID D0F9BX D0F9BX DRUGCOMP Zambon Co SpA D0F9BX HIGHSTAT Terminated D0FG6T DRUG__ID D0FG6T D0FG6T DRUGCOMP University of California San Francisco D0FG6T HIGHSTAT Terminated D0FQ4M DRUG__ID D0FQ4M D0FQ4M DRUGCOMP Ipsen D0FQ4M HIGHSTAT Terminated D0FZ1Z DRUG__ID D0FZ1Z D0FZ1Z DRUGCOMP Immunomedics Inc D0FZ1Z HIGHSTAT Terminated D0G0UZ DRUG__ID D0G0UZ D0G0UZ DRUGCOMP Curacel International Pty Ltd; Freedom Eye Ltd D0G0UZ HIGHSTAT Terminated D0G2CL DRUG__ID D0G2CL D0G2CL DRUGCOMP Agouron Pharmaceuticals Inc D0G2CL HIGHSTAT Terminated D0G6PL DRUG__ID D0G6PL D0G6PL DRUGCOMP Ligand Pharmaceuticals Inc D0G6PL HIGHSTAT Terminated D0G6US DRUG__ID D0G6US D0G6US DRUGCOMP Solvay SA D0G6US HIGHSTAT Terminated D0G7DP DRUG__ID D0G7DP D0G7DP DRUGCOMP Repligen Corp D0G7DP HIGHSTAT Terminated D0G9AP DRUG__ID D0G9AP D0G9AP DRUGCOMP Eisai Co Ltd D0G9AP HIGHSTAT Terminated D0G9RW DRUG__ID D0G9RW D0G9RW DRUGCOMP Takeda Pharmaceutical Co Ltd D0G9RW HIGHSTAT Terminated D0GH1C DRUG__ID D0GH1C D0GH1C DRUGCOMP Gilead Palo Alto Inc D0GH1C HIGHSTAT Terminated D0GH9Z DRUG__ID D0GH9Z D0GH9Z DRUGCOMP Glaxo Wellcome plc D0GH9Z HIGHSTAT Terminated D0GN9J DRUG__ID D0GN9J D0GN9J DRUGCOMP Organon BioSciences D0GN9J HIGHSTAT Terminated D0H0HB DRUG__ID D0H0HB D0H0HB DRUGCOMP Favrille Inc D0H0HB HIGHSTAT Terminated D0H2AM DRUG__ID D0H2AM D0H2AM DRUGCOMP Xenova Group plc D0H2AM HIGHSTAT Terminated D0H2KE DRUG__ID D0H2KE D0H2KE DRUGCOMP LipoNova AG D0H2KE HIGHSTAT Terminated D0H2UN DRUG__ID D0H2UN D0H2UN DRUGCOMP Scotia Holdings plc D0H2UN HIGHSTAT Terminated D0H3CV DRUG__ID D0H3CV D0H3CV DRUGCOMP F Hoffmann-La Roche Ltd D0H3CV HIGHSTAT Terminated D0H4GE DRUG__ID D0H4GE D0H4GE DRUGCOMP Genaera Corp D0H4GE HIGHSTAT Terminated D0H6VG DRUG__ID D0H6VG D0H6VG DRUGCOMP Kyowa Hakko Kogyo Co Ltd D0H6VG HIGHSTAT Terminated D0H9QX DRUG__ID D0H9QX D0H9QX DRUGCOMP TheraPei Pharmaceuticals Inc D0H9QX HIGHSTAT Terminated D0H9SF DRUG__ID D0H9SF D0H9SF DRUGCOMP Sankyo Co Ltd D0H9SF HIGHSTAT Terminated D0HV6O DRUG__ID D0HV6O D0HV6O DRUGCOMP ARIAD Pharmaceuticals Inc D0HV6O HIGHSTAT Terminated D0I0RF DRUG__ID D0I0RF D0I0RF DRUGCOMP Swedish Orphan Biovitrum AB D0I0RF HIGHSTAT Terminated D0I0TD DRUG__ID D0I0TD D0I0TD DRUGCOMP Alizyme plc D0I0TD HIGHSTAT Terminated D0I1BX DRUG__ID D0I1BX D0I1BX DRUGCOMP Novartis AG D0I1BX HIGHSTAT Terminated D0I2HL DRUG__ID D0I2HL D0I2HL DRUGCOMP Duke University Medical Center D0I2HL HIGHSTAT Terminated D0I4LB DRUG__ID D0I4LB D0I4LB DRUGCOMP Biogen Inc D0I4LB HIGHSTAT Terminated D0I4RX DRUG__ID D0I4RX D0I4RX DRUGCOMP Phytera Inc D0I4RX HIGHSTAT Terminated D0I7EX DRUG__ID D0I7EX D0I7EX DRUGCOMP Organon BioSciences D0I7EX HIGHSTAT Terminated D0I8NM DRUG__ID D0I8NM D0I8NM DRUGCOMP Valentis Inc D0I8NM HIGHSTAT Terminated D0I8ZB DRUG__ID D0I8ZB D0I8ZB DRUGCOMP Paligent Inc D0I8ZB HIGHSTAT Terminated D0I9AR DRUG__ID D0I9AR D0I9AR DRUGCOMP Bristol-Myers Squibb AG D0I9AR HIGHSTAT Terminated D0I9NC DRUG__ID D0I9NC D0I9NC DRUGCOMP Hoechst Marion Roussel Inc D0I9NC HIGHSTAT Terminated D0I9YI DRUG__ID D0I9YI D0I9YI DRUGCOMP AstraZeneca plc D0I9YI HIGHSTAT Terminated D0ID0R DRUG__ID D0ID0R D0ID0R DRUGCOMP Fournier Pharma D0ID0R HIGHSTAT Terminated D0J0ZM DRUG__ID D0J0ZM D0J0ZM DRUGCOMP Repligen Corp D0J0ZM HIGHSTAT Terminated D0J1RH DRUG__ID D0J1RH D0J1RH DRUGCOMP Epimmune Inc D0J1RH HIGHSTAT Terminated D0J1WJ DRUG__ID D0J1WJ D0J1WJ DRUGCOMP Advanced Life Sciences Holdings Inc D0J1WJ HIGHSTAT Terminated D0J3PS DRUG__ID D0J3PS D0J3PS DRUGCOMP Astellas Pharma Inc D0J3PS HIGHSTAT Terminated D0J3VV DRUG__ID D0J3VV D0J3VV DRUGCOMP Cancer Research Technology Ltd D0J3VV HIGHSTAT Terminated D0J4GQ DRUG__ID D0J4GQ D0J4GQ DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0J4GQ HIGHSTAT Terminated D0J6MS DRUG__ID D0J6MS D0J6MS DRUGCOMP Boehringer Ingelheim Corp D0J6MS HIGHSTAT Terminated D0J6VU DRUG__ID D0J6VU D0J6VU DRUGCOMP Dendreon San Diego LLC D0J6VU HIGHSTAT Terminated D0J7CE DRUG__ID D0J7CE D0J7CE DRUGCOMP Devgen NV D0J7CE HIGHSTAT Terminated D0J8TH DRUG__ID D0J8TH D0J8TH DRUGCOMP Wyeth D0J8TH HIGHSTAT Terminated D0J8XO DRUG__ID D0J8XO D0J8XO DRUGCOMP Shire BioChem Inc D0J8XO HIGHSTAT Terminated D0JC8G DRUG__ID D0JC8G D0JC8G DRUGCOMP PLx Pharma D0JC8G HIGHSTAT Terminated D0JI1S DRUG__ID D0JI1S D0JI1S DRUGCOMP Valeant Pharmaceuticals International Inc D0JI1S HIGHSTAT Terminated D0K0IW DRUG__ID D0K0IW D0K0IW DRUGCOMP Celera Genomics D0K0IW HIGHSTAT Terminated D0K0KJ DRUG__ID D0K0KJ D0K0KJ DRUGCOMP Fournier Pharma D0K0KJ HIGHSTAT Terminated D0K0XG DRUG__ID D0K0XG D0K0XG DRUGCOMP Mediolanum Farmaceutici SpA D0K0XG HIGHSTAT Terminated D0K1UD DRUG__ID D0K1UD D0K1UD DRUGCOMP Jacobus Pharmaceutical Co Inc D0K1UD HIGHSTAT Terminated D0K3WN DRUG__ID D0K3WN D0K3WN DRUGCOMP De Novo Pharmaceuticals Ltd D0K3WN HIGHSTAT Terminated D0K6ZH DRUG__ID D0K6ZH D0K6ZH DRUGCOMP Pharmasset Inc D0K6ZH HIGHSTAT Terminated D0K7XR DRUG__ID D0K7XR D0K7XR DRUGCOMP KS Biomedix Holdings plc D0K7XR HIGHSTAT Terminated D0K8KJ DRUG__ID D0K8KJ D0K8KJ DRUGCOMP Bristol-Myers Squibb Pharma Co D0K8KJ HIGHSTAT Terminated D0K9KS DRUG__ID D0K9KS D0K9KS DRUGCOMP Instituto Venezolano de Investigaciones Cientificas D0K9KS HIGHSTAT Terminated D0K9RR DRUG__ID D0K9RR D0K9RR DRUGCOMP Fournier Pharma D0K9RR HIGHSTAT Terminated D0KC7K DRUG__ID D0KC7K D0KC7K DRUGCOMP Biogen Idec Inc D0KC7K HIGHSTAT Terminated D0KD1A DRUG__ID D0KD1A D0KD1A DRUGCOMP Southampton University D0KD1A HIGHSTAT Terminated D0KD4U DRUG__ID D0KD4U D0KD4U DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0KD4U HIGHSTAT Terminated D0KE1V DRUG__ID D0KE1V D0KE1V DRUGCOMP Novartis AG D0KE1V HIGHSTAT Terminated D0KX3A DRUG__ID D0KX3A D0KX3A DRUGCOMP Pfizer Inc D0KX3A HIGHSTAT Terminated D0L0AU DRUG__ID D0L0AU D0L0AU DRUGCOMP Glaxo Wellcome plc D0L0AU HIGHSTAT Terminated D0L0NE DRUG__ID D0L0NE D0L0NE DRUGCOMP Bristol-Myers Squibb Pharma Co D0L0NE HIGHSTAT Terminated D0L1YS DRUG__ID D0L1YS D0L1YS DRUGCOMP Taisho Pharmaceutical Co Ltd D0L1YS HIGHSTAT Terminated D0L2BH DRUG__ID D0L2BH D0L2BH DRUGCOMP Kaken Pharmaceutical Co Ltd D0L2BH HIGHSTAT Terminated D0L2QC DRUG__ID D0L2QC D0L2QC DRUGCOMP Optimer Pharmaceuticals Inc D0L2QC HIGHSTAT Terminated D0L3OE DRUG__ID D0L3OE D0L3OE DRUGCOMP Sirus Pharmaceuticals Ltd D0L3OE HIGHSTAT Terminated D0L4BR DRUG__ID D0L4BR D0L4BR DRUGCOMP Amgen D0L4BR HIGHSTAT Terminated D0L4GF DRUG__ID D0L4GF D0L4GF DRUGCOMP Agouron Pharmaceuticals Inc D0L4GF HIGHSTAT Terminated D0L7JE DRUG__ID D0L7JE D0L7JE DRUGCOMP Ontogen Corp D0L7JE HIGHSTAT Terminated D0L7ZX DRUG__ID D0L7ZX D0L7ZX DRUGCOMP Arris Pharmaceutical Corp D0L7ZX HIGHSTAT Terminated D0L8TL DRUG__ID D0L8TL D0L8TL DRUGCOMP Rosanto Pharmaceuticals Ltd D0L8TL HIGHSTAT Terminated D0LR2Q DRUG__ID D0LR2Q D0LR2Q DRUGCOMP LXR Biotechnology Inc D0LR2Q HIGHSTAT Terminated D0M0GJ DRUG__ID D0M0GJ D0M0GJ DRUGCOMP Arkopharma SA D0M0GJ HIGHSTAT Terminated D0M0WY DRUG__ID D0M0WY D0M0WY DRUGCOMP KS Biomedix Holdings plc D0M0WY HIGHSTAT Terminated D0M1UE DRUG__ID D0M1UE D0M1UE DRUGCOMP IDM Pharma D0M1UE HIGHSTAT Terminated D0M2OW DRUG__ID D0M2OW D0M2OW DRUGCOMP Walter Reed Army Institute of Research D0M2OW HIGHSTAT Terminated D0M4FO DRUG__ID D0M4FO D0M4FO DRUGCOMP Chiron PathoGenesis D0M4FO HIGHSTAT Terminated D0M4HC DRUG__ID D0M4HC D0M4HC DRUGCOMP Merck & Co Inc D0M4HC HIGHSTAT Terminated D0M4UE DRUG__ID D0M4UE D0M4UE DRUGCOMP Sirna Therapeutics Inc D0M4UE HIGHSTAT Terminated D0M7HO DRUG__ID D0M7HO D0M7HO DRUGCOMP Bristol-Myers Squibb Co D0M7HO HIGHSTAT Terminated D0M8QG DRUG__ID D0M8QG D0M8QG DRUGCOMP University of Manitoba D0M8QG HIGHSTAT Terminated D0M9FF DRUG__ID D0M9FF D0M9FF DRUGCOMP University of Bristol D0M9FF HIGHSTAT Terminated D0M9FT DRUG__ID D0M9FT D0M9FT DRUGCOMP Viragen Inc D0M9FT HIGHSTAT Terminated D0M9SL DRUG__ID D0M9SL D0M9SL DRUGCOMP Dianippen D0M9SL HIGHSTAT Terminated D0M9WX DRUG__ID D0M9WX D0M9WX DRUGCOMP Amsterdam Molecular Therapeutics BV D0M9WX HIGHSTAT Terminated D0MA2J DRUG__ID D0MA2J D0MA2J DRUGCOMP Polifarma SpA D0MA2J HIGHSTAT Terminated D0MS1D DRUG__ID D0MS1D D0MS1D DRUGCOMP Pharmacia & Upjohn SpA D0MS1D HIGHSTAT Terminated D0N0JE DRUG__ID D0N0JE D0N0JE DRUGCOMP Laboratories UPSA D0N0JE HIGHSTAT Terminated D0N1QX DRUG__ID D0N1QX D0N1QX DRUGCOMP Oxford BioMedica plc D0N1QX HIGHSTAT Terminated D0N3FJ DRUG__ID D0N3FJ D0N3FJ DRUGCOMP Bioglan Pharmaceuticals Co D0N3FJ HIGHSTAT Terminated D0N4DO DRUG__ID D0N4DO D0N4DO DRUGCOMP Children's Hospital Boston D0N4DO HIGHSTAT Terminated D0N4MR DRUG__ID D0N4MR D0N4MR DRUGCOMP Devgen NV D0N4MR HIGHSTAT Terminated D0N4PC DRUG__ID D0N4PC D0N4PC DRUGCOMP Aventis Pharma AG D0N4PC HIGHSTAT Terminated D0N4YU DRUG__ID D0N4YU D0N4YU DRUGCOMP Nabi Biopharmaceuticals D0N4YU HIGHSTAT Terminated D0N8UU DRUG__ID D0N8UU D0N8UU DRUGCOMP Shionogi D0N8UU HIGHSTAT Terminated D0NC1D DRUG__ID D0NC1D D0NC1D DRUGCOMP Maxia Pharmaceuticals Inc D0NC1D HIGHSTAT Terminated D0NN5B DRUG__ID D0NN5B D0NN5B DRUGCOMP Fujisawa Pharmaceutical Co Ltd D0NN5B HIGHSTAT Terminated D0NP8B DRUG__ID D0NP8B D0NP8B DRUGCOMP Imperial Cancer Research Technology Ltd D0NP8B HIGHSTAT Terminated D0O0HK DRUG__ID D0O0HK D0O0HK DRUGCOMP CytRx Corp D0O0HK HIGHSTAT Terminated D0O1PU DRUG__ID D0O1PU D0O1PU DRUGCOMP Bayer AG D0O1PU HIGHSTAT Terminated D0O1XU DRUG__ID D0O1XU D0O1XU DRUGCOMP Xenova Group plc D0O1XU HIGHSTAT Terminated D0O2PK DRUG__ID D0O2PK D0O2PK DRUGCOMP Novozymes GroPep Limited D0O2PK HIGHSTAT Terminated D0O2XI DRUG__ID D0O2XI D0O2XI DRUGCOMP Allergenics Inc D0O2XI HIGHSTAT Terminated D0O3LC DRUG__ID D0O3LC D0O3LC DRUGCOMP Tanox Inc D0O3LC HIGHSTAT Terminated D0O3PP DRUG__ID D0O3PP D0O3PP DRUGCOMP ARIAD Pharmaceuticals Inc D0O3PP HIGHSTAT Terminated D0O7DN DRUG__ID D0O7DN D0O7DN DRUGCOMP Cephalon Inc D0O7DN HIGHSTAT Terminated D0O7EC DRUG__ID D0O7EC D0O7EC DRUGCOMP Gliatech Inc D0O7EC HIGHSTAT Terminated D0O8SY DRUG__ID D0O8SY D0O8SY DRUGCOMP Glaxo Wellcome plc D0O8SY HIGHSTAT Terminated D0O8UF DRUG__ID D0O8UF D0O8UF DRUGCOMP Sirus Pharmaceuticals Ltd D0O8UF HIGHSTAT Terminated D0OF9D DRUG__ID D0OF9D D0OF9D DRUGCOMP Chiron SpA D0OF9D HIGHSTAT Terminated D0OI7B DRUG__ID D0OI7B D0OI7B DRUGCOMP AstraZeneca plc D0OI7B HIGHSTAT Terminated D0OL4S DRUG__ID D0OL4S D0OL4S DRUGCOMP GlycoForm Ltd D0OL4S HIGHSTAT Terminated D0OT3Y DRUG__ID D0OT3Y D0OT3Y DRUGCOMP Nippon Kayaku Co Ltd D0OT3Y HIGHSTAT Terminated D0OU1V DRUG__ID D0OU1V D0OU1V DRUGCOMP Parke-Davis & Co D0OU1V HIGHSTAT Terminated D0P1JV DRUG__ID D0P1JV D0P1JV DRUGCOMP Savient Pharmaceuticals Inc D0P1JV HIGHSTAT Terminated D0P1YO DRUG__ID D0P1YO D0P1YO DRUGCOMP Molecumetics Ltd D0P1YO HIGHSTAT Terminated D0P3SH DRUG__ID D0P3SH D0P3SH DRUGCOMP University of Bristol D0P3SH HIGHSTAT Terminated D0P5UE DRUG__ID D0P5UE D0P5UE DRUGCOMP Shionogi & Co Ltd D0P5UE HIGHSTAT Terminated D0P5VX DRUG__ID D0P5VX D0P5VX DRUGCOMP Repros Therapeutics Inc D0P5VX HIGHSTAT Terminated D0P5VZ DRUG__ID D0P5VZ D0P5VZ DRUGCOMP Chiron Corp D0P5VZ HIGHSTAT Terminated D0P6DF DRUG__ID D0P6DF D0P6DF DRUGCOMP Parke-Davis & Co D0P6DF HIGHSTAT Terminated D0P6YO DRUG__ID D0P6YO D0P6YO DRUGCOMP NeuroSearch A/S D0P6YO HIGHSTAT Terminated D0P7KS DRUG__ID D0P7KS D0P7KS DRUGCOMP Nisshin Flour Milling Co Ltd D0P7KS HIGHSTAT Terminated D0P7MF DRUG__ID D0P7MF D0P7MF DRUGCOMP Breakthrough Therapeutics D0P7MF HIGHSTAT Terminated D0P9DL DRUG__ID D0P9DL D0P9DL DRUGCOMP Mucosis BV D0P9DL HIGHSTAT Terminated D0P9TS DRUG__ID D0P9TS D0P9TS DRUGCOMP MacroNex Inc D0P9TS HIGHSTAT Terminated D0PA0S DRUG__ID D0PA0S D0PA0S DRUGCOMP La Jolla Pharmaceutical Co D0PA0S HIGHSTAT Terminated D0PE9T DRUG__ID D0PE9T D0PE9T DRUGCOMP Gilead Sciences Inc D0PE9T HIGHSTAT Terminated D0PL5F DRUG__ID D0PL5F D0PL5F DRUGCOMP LEO Pharma A/S D0PL5F HIGHSTAT Terminated D0PM1R DRUG__ID D0PM1R D0PM1R DRUGCOMP Tsumura & Co D0PM1R HIGHSTAT Terminated D0PQ3V DRUG__ID D0PQ3V D0PQ3V DRUGCOMP NAEJA Pharmaceuticals Inc D0PQ3V HIGHSTAT Terminated D0Q0MH DRUG__ID D0Q0MH D0Q0MH DRUGCOMP AstraZeneca D0Q0MH HIGHSTAT Terminated D0Q1JW DRUG__ID D0Q1JW D0Q1JW DRUGCOMP Savient Pharmaceuticals Inc D0Q1JW HIGHSTAT Terminated D0Q5MU DRUG__ID D0Q5MU D0Q5MU DRUGCOMP Maxygen Inc D0Q5MU HIGHSTAT Terminated D0Q5RA DRUG__ID D0Q5RA D0Q5RA DRUGCOMP Axis Genetics plc D0Q5RA HIGHSTAT Terminated D0Q7OA DRUG__ID D0Q7OA D0Q7OA DRUGCOMP Endo Pharmaceuticals D0Q7OA HIGHSTAT Terminated D0Q7WW DRUG__ID D0Q7WW D0Q7WW DRUGCOMP Grupo Uriach D0Q7WW HIGHSTAT Terminated D0Q8FE DRUG__ID D0Q8FE D0Q8FE DRUGCOMP Grupo Uriach D0Q8FE HIGHSTAT Terminated D0QF6E DRUG__ID D0QF6E D0QF6E DRUGCOMP Biopharm D0QF6E HIGHSTAT Terminated D0QQ7N DRUG__ID D0QQ7N D0QQ7N DRUGCOMP Theratechnologies Inc D0QQ7N HIGHSTAT Terminated D0R1QX DRUG__ID D0R1QX D0R1QX DRUGCOMP Biovation Ltd D0R1QX HIGHSTAT Terminated D0R2KR DRUG__ID D0R2KR D0R2KR DRUGCOMP Vaccine Solutions Pty Ltd D0R2KR HIGHSTAT Terminated D0R3JE DRUG__ID D0R3JE D0R3JE DRUGCOMP Gilead Sciences Inc D0R3JE HIGHSTAT Terminated D0R3OR DRUG__ID D0R3OR D0R3OR DRUGCOMP Sanofi D0R3OR HIGHSTAT Terminated D0R6OD DRUG__ID D0R6OD D0R6OD DRUGCOMP Corixa Corp D0R6OD HIGHSTAT Terminated D0R7DW DRUG__ID D0R7DW D0R7DW DRUGCOMP Sankyo Co Ltd D0R7DW HIGHSTAT Terminated D0R7QW DRUG__ID D0R7QW D0R7QW DRUGCOMP LEO Pharma A/S D0R7QW HIGHSTAT Terminated D0R7UK DRUG__ID D0R7UK D0R7UK DRUGCOMP Grupo Uriach D0R7UK HIGHSTAT Terminated D0R8YO DRUG__ID D0R8YO D0R8YO DRUGCOMP Cedona Pharmaceuticals BV D0R8YO HIGHSTAT Terminated D0R9NQ DRUG__ID D0R9NQ D0R9NQ DRUGCOMP Hoechst AG D0R9NQ HIGHSTAT Terminated D0RE9H DRUG__ID D0RE9H D0RE9H DRUGCOMP Poniard Pharmaceuticals Inc D0RE9H HIGHSTAT Terminated D0RJ6R DRUG__ID D0RJ6R D0RJ6R DRUGCOMP Solvay SA D0RJ6R HIGHSTAT Terminated D0RO0T DRUG__ID D0RO0T D0RO0T DRUGCOMP Miikana Therapeutics Inc D0RO0T HIGHSTAT Terminated D0RO7R DRUG__ID D0RO7R D0RO7R DRUGCOMP University College London D0RO7R HIGHSTAT Terminated D0RR4T DRUG__ID D0RR4T D0RR4T DRUGCOMP GlaxoSmithKline Inc D0RR4T HIGHSTAT Terminated D0RT2E DRUG__ID D0RT2E D0RT2E DRUGCOMP Rhone-Poulenc SA D0RT2E HIGHSTAT Terminated D0S0IW DRUG__ID D0S0IW D0S0IW DRUGCOMP PowderJect Pharmaceuticals plc D0S0IW HIGHSTAT Terminated D0S1RT DRUG__ID D0S1RT D0S1RT DRUGCOMP Pfizer Inc D0S1RT HIGHSTAT Terminated D0S2KX DRUG__ID D0S2KX D0S2KX DRUGCOMP PLIVA dd D0S2KX HIGHSTAT Terminated D0S7AR DRUG__ID D0S7AR D0S7AR DRUGCOMP Large Scale Biology Corp D0S7AR HIGHSTAT Terminated D0S7VN DRUG__ID D0S7VN D0S7VN DRUGCOMP Novartis AG D0S7VN HIGHSTAT Terminated D0S8KE DRUG__ID D0S8KE D0S8KE DRUGCOMP NeuroSearch A/S D0S8KE HIGHSTAT Terminated D0S8RG DRUG__ID D0S8RG D0S8RG DRUGCOMP Berna Biotech AG D0S8RG HIGHSTAT Terminated D0S9MO DRUG__ID D0S9MO D0S9MO DRUGCOMP Medlmmune LLC D0S9MO HIGHSTAT Terminated D0SF2R DRUG__ID D0SF2R D0SF2R DRUGCOMP Genvax Ltd D0SF2R HIGHSTAT Terminated D0SF5F DRUG__ID D0SF5F D0SF5F DRUGCOMP Organon BioSciences D0SF5F HIGHSTAT Terminated D0SG0N DRUG__ID D0SG0N D0SG0N DRUGCOMP DARA BioSciences D0SG0N HIGHSTAT Terminated D0SG4W DRUG__ID D0SG4W D0SG4W DRUGCOMP Oshadi Drug Administration Ltd D0SG4W HIGHSTAT Terminated D0SK1W DRUG__ID D0SK1W D0SK1W DRUGCOMP Merck Serono SA D0SK1W HIGHSTAT Terminated D0T2DL DRUG__ID D0T2DL D0T2DL DRUGCOMP Glycomed Inc D0T2DL HIGHSTAT Terminated D0T2OT DRUG__ID D0T2OT D0T2OT DRUGCOMP Glaxo Wellcome plc D0T2OT HIGHSTAT Terminated D0T2QI DRUG__ID D0T2QI D0T2QI DRUGCOMP Orion Corp D0T2QI HIGHSTAT Terminated D0T4EL DRUG__ID D0T4EL D0T4EL DRUGCOMP Abbott Laboratories D0T4EL HIGHSTAT Terminated D0T4HS DRUG__ID D0T4HS D0T4HS DRUGCOMP Glaxo Group Research Ltd D0T4HS HIGHSTAT Terminated D0T4XV DRUG__ID D0T4XV D0T4XV DRUGCOMP Sanofi-Synthelabo D0T4XV HIGHSTAT Terminated D0T5ZC DRUG__ID D0T5ZC D0T5ZC DRUGCOMP Bayer AG D0T5ZC HIGHSTAT Terminated D0T8HU DRUG__ID D0T8HU D0T8HU DRUGCOMP H Lundbeck A/S D0T8HU HIGHSTAT Terminated D0T9KF DRUG__ID D0T9KF D0T9KF DRUGCOMP Ardea Biosciences Inc D0T9KF HIGHSTAT Terminated D0T9SJ DRUG__ID D0T9SJ D0T9SJ DRUGCOMP LEO Pharma A/S D0T9SJ HIGHSTAT Terminated D0T9ZG DRUG__ID D0T9ZG D0T9ZG DRUGCOMP PLIVA dd D0T9ZG HIGHSTAT Terminated D0TC1T DRUG__ID D0TC1T D0TC1T DRUGCOMP Roche Holding AG D0TC1T HIGHSTAT Terminated D0TH6O DRUG__ID D0TH6O D0TH6O DRUGCOMP Aronex Pharmaceuticals Inc D0TH6O HIGHSTAT Terminated D0TK0W DRUG__ID D0TK0W D0TK0W DRUGCOMP F Hoffmann-La Roche Ltd D0TK0W HIGHSTAT Terminated D0U0OF DRUG__ID D0U0OF D0U0OF DRUGCOMP Tapestry Pharmaceuticals Inc D0U0OF HIGHSTAT Terminated D0U0PV DRUG__ID D0U0PV D0U0PV DRUGCOMP Metaphore Pharmaceuticals Inc D0U0PV HIGHSTAT Terminated D0U4WB DRUG__ID D0U4WB D0U4WB DRUGCOMP The Liposome Company Inc D0U4WB HIGHSTAT Terminated D0U4WF DRUG__ID D0U4WF D0U4WF DRUGCOMP Repros Therapeutics Inc D0U4WF HIGHSTAT Terminated D0U4WG DRUG__ID D0U4WG D0U4WG DRUGCOMP Solvay SA D0U4WG HIGHSTAT Terminated D0U5NW DRUG__ID D0U5NW D0U5NW DRUGCOMP Swedish Orphan Biovitrum AB D0U5NW HIGHSTAT Terminated D0U6NV DRUG__ID D0U6NV D0U6NV DRUGCOMP Isis Pharmaceuticals Inc D0U6NV HIGHSTAT Terminated D0U7VO DRUG__ID D0U7VO D0U7VO DRUGCOMP CeNeS Pharmaceuticals Inc D0U7VO HIGHSTAT Terminated D0U9SM DRUG__ID D0U9SM D0U9SM DRUGCOMP Orexo AB D0U9SM HIGHSTAT Terminated D0UO9T DRUG__ID D0UO9T D0UO9T DRUGCOMP Vectura Group plc D0UO9T HIGHSTAT Terminated D0US3C DRUG__ID D0US3C D0US3C DRUGCOMP Bayer Schering Pharma AG D0US3C HIGHSTAT Terminated D0V0TT DRUG__ID D0V0TT D0V0TT DRUGCOMP Shenzhen Chipscreen Biosciences Ltd D0V0TT HIGHSTAT Terminated D0V1CG DRUG__ID D0V1CG D0V1CG DRUGCOMP Milkhaus Laboratory Inc D0V1CG HIGHSTAT Terminated D0V1GK DRUG__ID D0V1GK D0V1GK DRUGCOMP Karo Bio AB D0V1GK HIGHSTAT Terminated D0V1NI DRUG__ID D0V1NI D0V1NI DRUGCOMP Zenyth Therapeutics Ltd D0V1NI HIGHSTAT Terminated D0V2YC DRUG__ID D0V2YC D0V2YC DRUGCOMP Ontogen Corp D0V2YC HIGHSTAT Terminated D0V2ZJ DRUG__ID D0V2ZJ D0V2ZJ DRUGCOMP BioCryst Pharmaceuticals Inc D0V2ZJ HIGHSTAT Terminated D0V3LD DRUG__ID D0V3LD D0V3LD DRUGCOMP DiObex D0V3LD HIGHSTAT Terminated D0V3QE DRUG__ID D0V3QE D0V3QE DRUGCOMP Sosei Group Corp D0V3QE HIGHSTAT Terminated D0V3WQ DRUG__ID D0V3WQ D0V3WQ DRUGCOMP Schering-Plough Corp D0V3WQ HIGHSTAT Terminated D0V3XK DRUG__ID D0V3XK D0V3XK DRUGCOMP SWITCH Biotech AG D0V3XK HIGHSTAT Terminated D0V4GT DRUG__ID D0V4GT D0V4GT DRUGCOMP CytoMed Inc D0V4GT HIGHSTAT Terminated D0V4UR DRUG__ID D0V4UR D0V4UR DRUGCOMP NeuroSearch A/S D0V4UR HIGHSTAT Terminated D0V6LH DRUG__ID D0V6LH D0V6LH DRUGCOMP ProMetic Life Sciences Inc D0V6LH HIGHSTAT Terminated D0V9NB DRUG__ID D0V9NB D0V9NB DRUGCOMP Large Scale Biology Corp D0V9NB HIGHSTAT Terminated D0V9TE DRUG__ID D0V9TE D0V9TE DRUGCOMP MGI GP Inc D0V9TE HIGHSTAT Terminated D0V9ZR DRUG__ID D0V9ZR D0V9ZR DRUGCOMP Epimmune Inc D0V9ZR HIGHSTAT Terminated D0VN2Y DRUG__ID D0VN2Y D0VN2Y DRUGCOMP Bioglan Pharmaceuticals Co D0VN2Y HIGHSTAT Terminated D0VS2M DRUG__ID D0VS2M D0VS2M DRUGCOMP Baxter International Inc D0VS2M HIGHSTAT Terminated D0VZ8S DRUG__ID D0VZ8S D0VZ8S DRUGCOMP Dr Willmar Schwabe GmbH & Co D0VZ8S HIGHSTAT Terminated D0W0KW DRUG__ID D0W0KW D0W0KW DRUGCOMP Roche Holding AG D0W0KW HIGHSTAT Terminated D0W0RT DRUG__ID D0W0RT D0W0RT DRUGCOMP PanTherix Ltd D0W0RT HIGHSTAT Terminated D0W1YM DRUG__ID D0W1YM D0W1YM DRUGCOMP Antisoma plc D0W1YM HIGHSTAT Terminated D0W2JT DRUG__ID D0W2JT D0W2JT DRUGCOMP LXR Biotechnology Inc D0W2JT HIGHSTAT Terminated D0W2LW DRUG__ID D0W2LW D0W2LW DRUGCOMP Medinox Inc D0W2LW HIGHSTAT Terminated D0W3OQ DRUG__ID D0W3OQ D0W3OQ DRUGCOMP Bristol-Myers Squibb AG D0W3OQ HIGHSTAT Terminated D0W5GP DRUG__ID D0W5GP D0W5GP DRUGCOMP LipoNova AG D0W5GP HIGHSTAT Terminated D0W5ZU DRUG__ID D0W5ZU D0W5ZU DRUGCOMP Biogen Idec D0W5ZU HIGHSTAT Terminated D0W7DD DRUG__ID D0W7DD D0W7DD DRUGCOMP Celera South San Francisco D0W7DD HIGHSTAT Terminated D0W7WG DRUG__ID D0W7WG D0W7WG DRUGCOMP Repros Therapeutics Inc D0W7WG HIGHSTAT Terminated D0W8NZ DRUG__ID D0W8NZ D0W8NZ DRUGCOMP Scotia Holdings plc D0W8NZ HIGHSTAT Terminated D0W8ZW DRUG__ID D0W8ZW D0W8ZW DRUGCOMP Chiron PathoGenesis D0W8ZW HIGHSTAT Terminated D0W9LP DRUG__ID D0W9LP D0W9LP DRUGCOMP Yakult Honsha KK D0W9LP HIGHSTAT Terminated D0WL1C DRUG__ID D0WL1C D0WL1C DRUGCOMP Biopharm (UK) Ltd D0WL1C HIGHSTAT Terminated D0WR7U DRUG__ID D0WR7U D0WR7U DRUGCOMP Boehringer Ingelheim Corp D0WR7U HIGHSTAT Terminated D0WU0K DRUG__ID D0WU0K D0WU0K DRUGCOMP Toyo Jozo Co Ltd D0WU0K HIGHSTAT Terminated D0WV4N DRUG__ID D0WV4N D0WV4N DRUGCOMP Wyeth Research (UK) Ltd D0WV4N HIGHSTAT Terminated D0X0QC DRUG__ID D0X0QC D0X0QC DRUGCOMP AusAm Biotechnologies Inc D0X0QC HIGHSTAT Terminated D0X1TD DRUG__ID D0X1TD D0X1TD DRUGCOMP Remedyne Corp D0X1TD HIGHSTAT Terminated D0X4UA DRUG__ID D0X4UA D0X4UA DRUGCOMP Xenova D0X4UA HIGHSTAT Terminated D0X5CU DRUG__ID D0X5CU D0X5CU DRUGCOMP Zenyth Therapeutics Ltd D0X5CU HIGHSTAT Terminated D0X5JF DRUG__ID D0X5JF D0X5JF DRUGCOMP AstraZeneca plc D0X5JF HIGHSTAT Terminated D0X6FF DRUG__ID D0X6FF D0X6FF DRUGCOMP Spectrum Pharmaceuticals Inc D0X6FF HIGHSTAT Terminated D0X7YC DRUG__ID D0X7YC D0X7YC DRUGCOMP Novartis AG D0X7YC HIGHSTAT Terminated D0X7YR DRUG__ID D0X7YR D0X7YR DRUGCOMP GlaxoSmithKline D0X7YR HIGHSTAT Terminated D0XW4W DRUG__ID D0XW4W D0XW4W DRUGCOMP Sunovion Pharmaceuticals Inc D0XW4W HIGHSTAT Terminated D0XY4Q DRUG__ID D0XY4Q D0XY4Q DRUGCOMP Alpha-Beta Technology Inc D0XY4Q HIGHSTAT Terminated D0Y0BC DRUG__ID D0Y0BC D0Y0BC DRUGCOMP Exelixis Inc D0Y0BC HIGHSTAT Terminated D0Y1YX DRUG__ID D0Y1YX D0Y1YX DRUGCOMP AstraZeneca plc D0Y1YX HIGHSTAT Terminated D0Y2IF DRUG__ID D0Y2IF D0Y2IF DRUGCOMP AstraZeneca plc D0Y2IF HIGHSTAT Terminated D0Y3OQ DRUG__ID D0Y3OQ D0Y3OQ DRUGCOMP Alizyme plc D0Y3OQ HIGHSTAT Terminated D0Y3ZX DRUG__ID D0Y3ZX D0Y3ZX DRUGCOMP ASTA Medica AG D0Y3ZX HIGHSTAT Terminated D0Y4PL DRUG__ID D0Y4PL D0Y4PL DRUGCOMP Novartis AG D0Y4PL HIGHSTAT Terminated D0Y5ZG DRUG__ID D0Y5ZG D0Y5ZG DRUGCOMP Epimmune Inc D0Y5ZG HIGHSTAT Terminated D0Y6HA DRUG__ID D0Y6HA D0Y6HA DRUGCOMP Cyclacel Pharmaceuticals Inc D0Y6HA HIGHSTAT Terminated D0Y6HY DRUG__ID D0Y6HY D0Y6HY DRUGCOMP Arrow Therapeutics Ltd D0Y6HY HIGHSTAT Terminated D0Y6IJ DRUG__ID D0Y6IJ D0Y6IJ DRUGCOMP F Hoffmann-La Roche Ltd D0Y6IJ HIGHSTAT Terminated D0Y6LO DRUG__ID D0Y6LO D0Y6LO DRUGCOMP Novo Nordisk A/S D0Y6LO HIGHSTAT Terminated D0Y8GL DRUG__ID D0Y8GL D0Y8GL DRUGCOMP A P Pharma Inc D0Y8GL HIGHSTAT Terminated D0Y8IF DRUG__ID D0Y8IF D0Y8IF DRUGCOMP Maxia Pharmaceuticals Inc D0Y8IF HIGHSTAT Terminated D0Y9CC DRUG__ID D0Y9CC D0Y9CC DRUGCOMP T Cell Sciences Inc D0Y9CC HIGHSTAT Terminated D0Y9CV DRUG__ID D0Y9CV D0Y9CV DRUGCOMP RW Johnson Pharmaceutical Research Institute D0Y9CV HIGHSTAT Terminated D0YB6P DRUG__ID D0YB6P D0YB6P DRUGCOMP Molecular SkinCare Ltd D0YB6P HIGHSTAT Terminated D0YG7H DRUG__ID D0YG7H D0YG7H DRUGCOMP Cenomed BioSciences LLC D0YG7H HIGHSTAT Terminated D0YK7J DRUG__ID D0YK7J D0YK7J DRUGCOMP UCB Celltech D0YK7J HIGHSTAT Terminated D0YP5Z DRUG__ID D0YP5Z D0YP5Z DRUGCOMP Cytovax Biotechnologies Inc D0YP5Z HIGHSTAT Terminated D0YQ9G DRUG__ID D0YQ9G D0YQ9G DRUGCOMP GelTex Pharmaceuticals Inc D0YQ9G HIGHSTAT Terminated D0Z0KE DRUG__ID D0Z0KE D0Z0KE DRUGCOMP Berlex Biosciences D0Z0KE HIGHSTAT Terminated D0Z5OJ DRUG__ID D0Z5OJ D0Z5OJ DRUGCOMP NitroMed Inc D0Z5OJ HIGHSTAT Terminated D0Z7GJ DRUG__ID D0Z7GJ D0Z7GJ DRUGCOMP Tyrian Diagnostics Ltd D0Z7GJ HIGHSTAT Terminated D0Z7PI DRUG__ID D0Z7PI D0Z7PI DRUGCOMP Glaxo Wellcome plc D0Z7PI HIGHSTAT Terminated D0ZL9B DRUG__ID D0ZL9B D0ZL9B DRUGCOMP Baxter Healthcare Ltd D0ZL9B HIGHSTAT Terminated D0ZV6W DRUG__ID D0ZV6W D0ZV6W DRUGCOMP Aventis Behring LLC D0ZV6W HIGHSTAT Terminated D0ZX0C DRUG__ID D0ZX0C D0ZX0C DRUGCOMP UCB Celltech D0ZX0C HIGHSTAT Terminated DC9FD4 DRUG__ID DC9FD4 DC9FD4 DRUGCOMP Recida Therapeutics DC9FD4 HIGHSTAT Terminated D02RNJ DRUG__ID D02RNJ D02RNJ HIGHSTAT Terminated D04XMN DRUG__ID D04XMN D04XMN HIGHSTAT Terminated D08NPB DRUG__ID D08NPB D08NPB HIGHSTAT Terminated D09YUS DRUG__ID D09YUS D09YUS HIGHSTAT Terminated D0D4XF DRUG__ID D0D4XF D0D4XF HIGHSTAT Terminated D0H5YE DRUG__ID D0H5YE D0H5YE HIGHSTAT Terminated D0L6UZ DRUG__ID D0L6UZ D0L6UZ HIGHSTAT Terminated D0Y3XB DRUG__ID D0Y3XB D0Y3XB HIGHSTAT Terminated D00QDJ DRUG__ID D00QDJ D00QDJ DRUGCOMP GlaxoSmithKline D00QDJ THERCLAS Antiviral Agents D00QDJ DRUGTYPE Small molecular drug D00QDJ DRUGINCH 1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34) D00QDJ DRUGINKE LIRYPHYGHXZJBZ-UHFFFAOYSA-N D00QDJ DRUGSMIL CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5 D00QDJ HIGHSTAT Investigative D04FFY DRUG__ID D04FFY D04FFY DRUGCOMP Amgen D04FFY THERCLAS Analgesics D04FFY DRUGTYPE Small molecular drug D04FFY DRUGINCH 1S/C24H25F3N2O2/c25-24(26,27)18-9-7-16(22(14-18)29-11-2-1-3-12-29)8-10-23(31)28-21-6-4-5-17-13-19(30)15-20(17)21/h4-10,14,19,30H,1-3,11-13,15H2,(H,28,31)/b10-8+/t19-/m0/s1 D04FFY DRUGINKE HAZYXDWNLMGLIS-RQMBKDMJSA-N D04FFY DRUGSMIL C1CCN(CC1)C2=C(C=CC(=C2)C(F)(F)F)C=CC(=O)NC3=CC=CC4=C3CC(C4)O D04FFY HIGHSTAT Investigative D05VYY DRUG__ID D05VYY D05VYY DRUGCOMP Genentech D05VYY THERCLAS Antiviral Agents D05VYY DRUGTYPE Small molecular drug D05VYY DRUGINCH 1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1 D05VYY DRUGINKE QFJCIRLUMZQUOT-HPLJOQBZSA-N D05VYY DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC D05VYY HIGHSTAT Investigative D05YTN DRUG__ID D05YTN D05YTN DRUGCOMP AstraZeneca D05YTN THERCLAS Antiviral Agents D05YTN DRUGTYPE Small molecular drug D05YTN DRUGINCH 1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31) D05YTN DRUGINKE OUKYUETWWIPKQR-UHFFFAOYSA-N D05YTN DRUGSMIL CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl D05YTN HIGHSTAT Investigative D06CAC DRUG__ID D06CAC D06CAC DRUGCOMP Pfizer Pharmaceuticals D06CAC THERCLAS Antiviral Agents D06CAC DRUGTYPE Small molecular drug D06CAC DRUGINCH 1S/C58H73N7O17/c1-5-6-7-24-82-40-22-18-35(19-23-40)33-10-8-32(9-11-33)34-12-14-37(15-13-34)51(74)59-41-26-43(70)54(77)63-56(79)47-48(71)29(2)27-65(47)58(81)45(31(4)67)61-55(78)46(50(73)49(72)36-16-20-38(68)21-17-36)62-53(76)42-25-39(69)28-64(42)57(80)44(30(3)66)60-52(41)75/h8-23,29-31,39,41-50,54,66-73,77H,5-7,24-28H2,1-4H3,(H,59,74)(H,60,75)(H,61,78)(H,62,76)(H,63,79)/t29-,30+,31+,39+,41-,42-,43+,44-,45-,46-,47-,48-,49-,50-,54+/m0/s1 D06CAC DRUGINKE JHVAMHSQVVQIOT-MFAJLEFUSA-N D06CAC DRUGSMIL CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O D06CAC HIGHSTAT Investigative D08MUX DRUG__ID D08MUX D08MUX DRUGCOMP Servier D08MUX THERCLAS Psychiatric D08MUX DRUGTYPE Small molecular drug D08MUX DRUGINCH 1S/C18H27NO2/c1-19(2)13-17(18(20)9-5-4-6-10-18)12-14-7-8-15(21-3)11-16(14)17/h7-8,11,20H,4-6,9-10,12-13H2,1-3H3 D08MUX DRUGINKE UBIQMAFTTDZGEX-UHFFFAOYSA-N D08MUX DRUGSMIL CN(C)CC1(CC2=C1C=C(C=C2)OC)C3(CCCCC3)O D08MUX HIGHSTAT Investigative D08QLM DRUG__ID D08QLM D08QLM DRUGCOMP GSK D08QLM THERCLAS Antiviral Agents D08QLM DRUGTYPE Small molecular drug D08QLM DRUGINCH 1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)/t18-/m0/s1 D08QLM DRUGINKE JBPUGFODGPKTDW-SFHVURJKSA-N D08QLM DRUGSMIL COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4 D08QLM HIGHSTAT Investigative D09ZSC DRUG__ID D09ZSC D09ZSC DRUGCOMP Novartis D09ZSC THERCLAS Antiviral Agents D09ZSC DRUGTYPE Small molecular drug D09ZSC DRUGINCH 1S/C53H83NO14/c1-32-16-12-11-13-17-33(2)44(63-8)30-40-21-19-38(7)53(62,68-40)50(59)51(60)54-23-15-14-18-41(54)52(61)67-45(35(4)28-39-20-22-43(66-25-24-55)46(29-39)64-9)31-42(56)34(3)27-37(6)48(58)49(65-10)47(57)36(5)26-32/h11-13,16-17,27,32,34-36,38-41,43-46,48-49,55,58,62H,14-15,18-26,28-31H2,1-10H3/b13-11+,16-12+,33-17+,37-27+/t32-,34-,35-,36-,38-,39+,40+,41+,43-,44+,45+,46-,48-,49+,53-/m1/s1 D09ZSC DRUGINKE HKVAMNSJSFKALM-GKUWKFKPSA-N D09ZSC DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC D09ZSC HIGHSTAT Investigative D0AJ1V DRUG__ID D0AJ1V D0AJ1V DRUGCOMP Bristol-Myers Squibb Co D0AJ1V THERCLAS Antiviral Agents D0AJ1V DRUGTYPE Small molecular drug D0AJ1V DRUGINCH 1S/C34H38O13/c1-40-20-12-10-19(11-13-20)34-27(18-8-6-5-7-9-18)26(30(38)42-3)29(37)33(34,39)28-23(41-2)14-21(15-24(28)47-34)45-32-31(43-4)44-17-25(46-32)22(36)16-35/h5-15,22,25-27,29,31-32,35-37,39H,16-17H2,1-4H3/t22-,25-,26-,27-,29-,31-,32-,33+,34+/m1/s1 D0AJ1V DRUGINKE GVKXFVCXBFGBCD-QKDMMWSPSA-N D0AJ1V DRUGSMIL COC1C(OC(CO1)C(CO)O)OC2=CC3=C(C(=C2)OC)C4(C(C(C(C4(O3)C5=CC=C(C=C5)OC)C6=CC=CC=C6)C(=O)OC)O)O D0AJ1V HIGHSTAT Investigative D0DG0P DRUG__ID D0DG0P D0DG0P DRUGCOMP Bristol-Myers Squibb D0DG0P THERCLAS Antiviral Agents D0DG0P DRUGTYPE Small molecular drug D0DG0P DRUGINCH 1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3 D0DG0P DRUGINKE XSCGXQMFQXDFCW-UHFFFAOYSA-N D0DG0P DRUGSMIL CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F D0DG0P HIGHSTAT Investigative D0FT8G DRUG__ID D0FT8G D0FT8G DRUGCOMP Biomira D0FT8G THERCLAS Antiviral Agents D0FT8G DRUGTYPE Small molecular drug D0FT8G DRUGINCH 1S/C7H12N2S2/c1-3-6(2)10-11-7-8-4-5-9-7/h4-6H,3H2,1-2H3,(H,8,9) D0FT8G DRUGINKE BPBPYQWMFCTCNG-UHFFFAOYSA-N D0FT8G DRUGSMIL CCC(C)SSC1=NC=CN1 D0FT8G HIGHSTAT Investigative D0I1PS DRUG__ID D0I1PS D0I1PS DRUGCOMP Bristol Myers Squibb D0I1PS THERCLAS Antiviral Agents D0I1PS DRUGTYPE Small molecular drug D0I1PS DRUGINCH 1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27) D0I1PS DRUGINKE ZBNZXTGUTAYRHI-UHFFFAOYSA-N D0I1PS DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO D0I1PS HIGHSTAT Investigative D0JL1M DRUG__ID D0JL1M D0JL1M DRUGCOMP Norvatis Phamaceuticals Corporation D0JL1M THERCLAS Antiviral Agents D0JL1M DRUGTYPE Small molecular drug D0JL1M DRUGINCH 1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3 D0JL1M DRUGINKE XCTYLCDETUVOIP-UHFFFAOYSA-N D0JL1M DRUGSMIL CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C D0JL1M HIGHSTAT Investigative D0P7VQ DRUG__ID D0P7VQ D0P7VQ DRUGCOMP Purdue Pharma D0P7VQ THERCLAS Analgesics D0P7VQ DRUGTYPE Small molecular drug D0P7VQ DRUGINCH 1S/C20H25ClN4O/c1-20(2,3)15-6-8-16(9-7-15)23-19(26)25-13-11-24(12-14-25)18-17(21)5-4-10-22-18/h4-10H,11-14H2,1-3H3,(H,23,26) D0P7VQ DRUGINKE ROGUAPYLUCHQGK-UHFFFAOYSA-N D0P7VQ DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl D0P7VQ HIGHSTAT Investigative D0R1VR DRUG__ID D0R1VR D0R1VR DRUGCOMP Bristol-Myers Squibb D0R1VR THERCLAS Antiviral Agents D0R1VR DRUGTYPE Small molecular drug D0R1VR DRUGINCH 1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2 D0R1VR DRUGINKE PLDUPXSUYLZYBN-UHFFFAOYSA-N D0R1VR DRUGSMIL C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO D0R1VR HIGHSTAT Investigative D0UB0T DRUG__ID D0UB0T D0UB0T DRUGCOMP Pfizer D0UB0T THERCLAS Analgesics D0UB0T DRUGTYPE Small molecular drug D0UB0T DRUGINCH 1S/C23H30F2N2O/c1-16(2)15-22(26-3)23(28)27-14-4-5-21(17-6-10-19(24)11-7-17)18-8-12-20(25)13-9-18/h6-13,16,21-22,26H,4-5,14-15H2,1-3H3,(H,27,28)/t22-/m0/s1 D0UB0T DRUGINKE QGJKMAIASNMXFI-QFIPXVFZSA-N D0UB0T DRUGSMIL CC(C)CC(C(=O)NCCCC(C1=CC=C(C=C1)F)C2=CC=C(C=C2)F)NC D0UB0T HIGHSTAT Investigative D0UJ9N DRUG__ID D0UJ9N D0UJ9N DRUGCOMP Wyeth Pharmaceuticals D0UJ9N THERCLAS Antiviral Agents D0UJ9N DRUGTYPE Small molecular drug D0UJ9N DRUGINCH 1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3 D0UJ9N DRUGINKE PWWVAXIEGOYWEE-UHFFFAOYSA-N D0UJ9N DRUGSMIL CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C D0UJ9N HIGHSTAT Investigative D0VD1R DRUG__ID D0VD1R D0VD1R DRUGCOMP Bayer Pharmaceuticals Corporation D0VD1R THERCLAS Antiviral Agents D0VD1R DRUGTYPE Small molecular drug D0VD1R DRUGINCH 1S/C51H40N6O23S6/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80) D0VD1R DRUGINKE FIAFUQMPZJWCLV-UHFFFAOYSA-N D0VD1R DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C D0VD1R HIGHSTAT Investigative D0XS1W DRUG__ID D0XS1W D0XS1W DRUGCOMP Merck & Co D0XS1W THERCLAS Antiviral Agents D0XS1W DRUGTYPE Small molecular drug D0XS1W DRUGINCH 1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1 D0XS1W DRUGINKE RLAWWYSOJDYHDC-BZSNNMDCSA-N D0XS1W DRUGSMIL C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O D0XS1W HIGHSTAT Investigative D0YN5T DRUG__ID D0YN5T D0YN5T DRUGCOMP AstraZeneca D0YN5T THERCLAS Antiviral Agents D0YN5T DRUGTYPE Small molecular drug D0YN5T DRUGINCH 1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26) D0YN5T DRUGINKE CYOHGALHFOKKQC-UHFFFAOYSA-N D0YN5T DRUGSMIL CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO D0YN5T HIGHSTAT Investigative D00EIL DRUG__ID D00EIL D00EIL DRUGCOMP CG Pharmaceuticals Inc D00EIL DRUGTYPE Small molecular drug D00EIL DRUGINCH 1S/C18H15N3O3S/c1-21-10-11(13-4-2-3-5-17(13)21)8-15-14-9-12(25(19,23)24)6-7-16(14)20-18(15)22/h2-10H,1H3,(H,20,22)(H2,19,23,24)/b15-8- D00EIL DRUGINKE MLKHXLFEYOOYEY-NVNXTCNLSA-N D00EIL DRUGSMIL CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC(=C4)S(=O)(=O)N)NC3=O D00EIL HIGHSTAT Investigative D00FAW DRUG__ID D00FAW D00FAW DRUGCOMP Charleston Laboratories Inc D00FAW DRUGTYPE Small molecular drug D00FAW DRUGINCH 1S/C12H8F3N3O4S2/c13-12(14,15)22-7-3-1-2-6(4-7)9(21)16-10-17-18-11(24-10)23-5-8(19)20/h1-4H,5H2,(H,19,20)(H,16,17,21) D00FAW DRUGINKE RAIBXQFEDDRDPH-UHFFFAOYSA-N D00FAW DRUGSMIL C1=CC(=CC(=C1)OC(F)(F)F)C(=O)NC2=NN=C(S2)SCC(=O)O D00FAW HIGHSTAT Investigative D00FEA DRUG__ID D00FEA D00FEA DRUGCOMP Purdue University D00FEA DRUGTYPE Small molecular drug D00FEA DRUGINCH 1S/C29H40N2O7S2/c1-20(2)16-31(40(35,36)25-10-8-21(18-32)9-11-25)17-27(33)26(19-39-24-6-4-3-5-7-24)30-29(34)38-23-14-22-12-13-37-28(22)15-23/h3-11,20,22-23,26-28,32-33H,12-19H2,1-2H3,(H,30,34)/t22-,23+,26-,27+,28+/m0/s1 D00FEA DRUGINKE MNXUZAOQXFTGTG-GOIXWRCSSA-N D00FEA DRUGSMIL CC(C)CN(CC(C(CSC1=CC=CC=C1)NC(=O)OC2CC3CCOC3C2)O)S(=O)(=O)C4=CC=C(C=C4)CO D00FEA HIGHSTAT Investigative D00FIV DRUG__ID D00FIV D00FIV DRUGCOMP Actinobac Biomed Inc D00FIV DRUGTYPE Small molecular drug D00FIV DRUGINCH 1S/C18H34O4/c1-2-3-4-5-7-10-13-16(19)17(20)14-11-8-6-9-12-15-18(21)22/h7,10,16-17,19-20H,2-6,8-9,11-15H2,1H3,(H,21,22)/b10-7- D00FIV DRUGINKE XEBKSQSGNGRGDW-YFHOEESVSA-N D00FIV DRUGSMIL CCCCCC=CCC(C(CCCCCCCC(=O)O)O)O D00FIV HIGHSTAT Investigative D00JKJ DRUG__ID D00JKJ D00JKJ DRUGCOMP Heat Biologics D00JKJ DRUGTYPE Small molecular drug D00JKJ DRUGINCH 1S/C26H46N2.2HI/c1-25-14-12-21(28(5)17-6-7-18-28)19-20(25)10-11-22-23(25)13-15-26(2)24(22)9-8-16-27(26,3)4;;/h10,21-24H,6-9,11-19H2,1-5H3;2*1H/q+2;;/p-2/t21-,22+,23-,24-,25-,26-;;/m0../s1 D00JKJ DRUGINKE GGAGIPMNQXAXNH-XDMKMBKMSA-L D00JKJ DRUGSMIL CC12CCC(CC1=CCC3C2CCC4(C3CCC[N+]4(C)C)C)[N+]5(CCCC5)C.[I-].[I-] D00JKJ HIGHSTAT Investigative D00JVC DRUG__ID D00JVC D00JVC DRUGCOMP Antibe Therapeutics Inc D00JVC DRUGTYPE Small molecular drug D00JVC DRUGINCH 1S/C16H11NO3S3/c17-10-3-6-14(18)12(7-10)15(19)20-11-4-1-9(2-5-11)13-8-22-23-16(13)21/h1-8,18H,17H2 D00JVC DRUGINKE IFYIEDLRMQRZEP-UHFFFAOYSA-N D00JVC DRUGSMIL C1=CC(=CC=C1C2=CSSC2=S)OC(=O)C3=C(C=CC(=C3)N)O D00JVC HIGHSTAT Investigative D00MCY DRUG__ID D00MCY D00MCY DRUGCOMP Recordati D00MCY DRUGTYPE Small molecular drug D00MCY DRUGINCH 1S/C26H33N5O5.ClH/c1-16(2)17-7-6-8-20(33-3)24(17)36-15-23(32)30-9-11-31(12-10-30)26-28-19-14-22(35-5)21(34-4)13-18(19)25(27)29-26;/h6-8,13-14,16H,9-12,15H2,1-5H3,(H2,27,28,29);1H D00MCY DRUGINKE YLPWNPUPMQZIKN-UHFFFAOYSA-N D00MCY DRUGSMIL CC(C)C1=C(C(=CC=C1)OC)OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC.Cl D00MCY HIGHSTAT Investigative D00NJE DRUG__ID D00NJE D00NJE DRUGCOMP Rockefeller University D00NJE DRUGTYPE Small molecular drug D00NJE DRUGINCH 1S/C34H52N7O17P3S/c1-19(2)14-21-6-8-22(9-7-21)20(3)33(46)62-13-12-36-24(42)10-11-37-31(45)28(44)34(4,5)16-55-61(52,53)58-60(50,51)54-15-23-27(57-59(47,48)49)26(43)32(56-23)41-18-40-25-29(35)38-17-39-30(25)41/h6-9,17-20,23,26-28,32,43-44H,10-16H2,1-5H3,(H,36,42)(H,37,45)(H,50,51)(H,52,53)(H2,35,38,39)(H2,47,48,49)/t20-,23+,26+,27+,28-,32+/m0/s1 D00NJE DRUGINKE ZWOQHSZKILPKKA-MIXAKNBRSA-N D00NJE DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O D00NJE HIGHSTAT Investigative D00OTH DRUG__ID D00OTH D00OTH DRUGCOMP Piramal Healthcare Ltd D00OTH DRUGTYPE Small molecular drug D00OTH DRUGINCH 1S/C18H20N2/c1-19-12-6-7-14(13-19)20-17-10-4-2-8-15(17)16-9-3-5-11-18(16)20/h2-5,8-11,14H,6-7,12-13H2,1H3 D00OTH DRUGINKE QTWMKHMFYDJEBU-UHFFFAOYSA-N D00OTH DRUGSMIL CN1CCCC(C1)N2C3=CC=CC=C3C4=CC=CC=C42 D00OTH HIGHSTAT Investigative D00TBD DRUG__ID D00TBD D00TBD DRUGCOMP Pfizer Inc D00TBD DRUGTYPE Small molecular drug D00TBD DRUGINCH 1S/C32H34Cl2N4O4S/c1-19-29(35-20(2)30(19)32(40)38-14-6-7-21(38)17-37-12-3-4-13-37)16-24-23-15-22(10-11-28(23)36-31(24)39)43(41,42)18-25-26(33)8-5-9-27(25)34/h5,8-11,15-16,21,35H,3-4,6-7,12-14,17-18H2,1-2H3,(H,36,39)/b24-16-/t21-/m1/s1 D00TBD DRUGINKE OYONTEXKYJZFHA-SSHUPFPWSA-N D00TBD DRUGSMIL CC1=C(NC(=C1C(=O)N2CCCC2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O D00TBD HIGHSTAT Investigative D00WPU DRUG__ID D00WPU D00WPU DRUGCOMP University of Illinois D00WPU DRUGTYPE Small molecular drug D00WPU DRUGINCH 1S/C15H20N2O2/c18-8-4-2-1-3-5-13-9-15(11-16-10-13)19-12-14-6-7-17-14/h9-11,14,17-18H,1-2,4,6-8,12H2/t14-/m0/s1 D00WPU DRUGINKE WONBUILDJNKYCB-AWEZNQCLSA-N D00WPU DRUGSMIL C1CNC1COC2=CN=CC(=C2)C#CCCCCO D00WPU HIGHSTAT Investigative D00WVI DRUG__ID D00WVI D00WVI DRUGCOMP Astellas Pharma Inc D00WVI DRUGTYPE Small molecular drug D00WVI DRUGINCH 1S/C19H27N3O4S/c23-17(24)6-1-3-13-7-9-22(10-8-13)19-15-11-27(25,26)12-16(15)20-18(21-19)14-4-2-5-14/h13-14H,1-12H2,(H,23,24) D00WVI DRUGINKE NFFANIJTECFGGM-UHFFFAOYSA-N D00WVI DRUGSMIL C1CC(C1)C2=NC3=C(CS(=O)(=O)C3)C(=N2)N4CCC(CC4)CCCC(=O)O D00WVI HIGHSTAT Investigative D00YAS DRUG__ID D00YAS D00YAS DRUGCOMP Quro Science Inc D00YAS DRUGTYPE Small molecular drug D00YAS DRUGINCH 1S/C13H21N3.ClH/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12;/h9-10,13H,2-8H2,1H3,(H,14,15);1H/t10-,13-;/m1./s1 D00YAS DRUGINKE HJHVRVJTYPKTHX-HTMVYDOJSA-N D00YAS DRUGSMIL CCCN1CCCC2C1CC3=C(C2)NN=C3.Cl D00YAS HIGHSTAT Investigative D00YNY DRUG__ID D00YNY D00YNY DRUGCOMP University of Virginia D00YNY DRUGTYPE Small molecular drug D00YNY DRUGINCH 1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18) D00YNY DRUGINKE ZFGXZJKLOFCECI-UHFFFAOYSA-N D00YNY DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)NC3=CC=C(C=C3)O)Cl D00YNY HIGHSTAT Investigative D00ZMN DRUG__ID D00ZMN D00ZMN DRUGCOMP Central South University D00ZMN DRUGTYPE Small molecular drug D00ZMN DRUGINCH 1S/C12H10FNO/c1-9-5-6-12(15)14(8-9)11-4-2-3-10(13)7-11/h2-8H,1H3 D00ZMN DRUGINKE JDZYVVUJIQYGRX-UHFFFAOYSA-N D00ZMN DRUGSMIL CC1=CN(C(=O)C=C1)C2=CC(=CC=C2)F D00ZMN HIGHSTAT Investigative D01CBU DRUG__ID D01CBU D01CBU DRUGCOMP Sun Yat-Sen University D01CBU DRUGTYPE Small molecular drug D01CBU DRUGINCH 1S/C36H39N5/c1-5-40(6-2)32-22-17-28(18-23-32)34-35(29-19-24-33(25-20-29)41(7-3)8-4)39-36(38-34)30-15-12-27(13-16-30)14-21-31-11-9-10-26-37-31/h9-26H,5-8H2,1-4H3,(H,38,39)/b21-14+ D01CBU DRUGINKE VXANOYUPSVZIAA-KGENOOAVSA-N D01CBU DRUGSMIL CCN(CC)C1=CC=C(C=C1)C2=C(N=C(N2)C3=CC=C(C=C3)C=CC4=CC=CC=N4)C5=CC=C(C=C5)N(CC)CC D01CBU HIGHSTAT Investigative D01CIN DRUG__ID D01CIN D01CIN DRUGCOMP Stanford University D01CIN DRUGTYPE Small molecular drug D01CIN DRUGINCH 1S/C15H13N3S/c1-11-3-2-4-13(9-11)17-15-18-14(10-19-15)12-5-7-16-8-6-12/h2-10H,1H3,(H,17,18) D01CIN DRUGINKE KATNUHQNJGNLPW-UHFFFAOYSA-N D01CIN DRUGSMIL CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3 D01CIN HIGHSTAT Investigative D01DMT DRUG__ID D01DMT D01DMT DRUGCOMP INSERM D01DMT DRUGTYPE Small molecular drug D01DMT DRUGINCH 1S/C32H55N3O2/c1-21(2)7-6-8-22(3)26-9-10-27-25-17-29(34-16-13-23-19-33-20-35-23)32(37)18-24(36)11-15-31(32,5)28(25)12-14-30(26,27)4/h19-22,24-29,34,36-37H,6-18H2,1-5H3,(H,33,35)/t22-,24+,25+,26-,27+,28+,29-,30-,31-,32+/m1/s1 D01DMT DRUGINKE AVFNYTPENXWWCA-BULFVYHESA-N D01DMT DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CC(C4(C3(CCC(C4)O)C)O)NCCC5=CN=CN5)C D01DMT HIGHSTAT Investigative D01GAZ DRUG__ID D01GAZ D01GAZ DRUGCOMP FUJIFILM Corp D01GAZ DRUGTYPE Small molecular drug D01GAZ DRUGINCH 1S/C16H11IN4/c17-13-5-6-16-19-15(10-21(16)9-13)12-3-1-11(2-4-12)14-7-8-18-20-14/h1-10H,(H,18,20)/i17-4 D01GAZ DRUGINKE OLFQWTDIJLVADS-HHRLKWFBSA-N D01GAZ DRUGSMIL C1=CC(=CC=C1C2=CC=NN2)C3=CN4C=C(C=CC4=N3)I D01GAZ HIGHSTAT Investigative D01GEO DRUG__ID D01GEO D01GEO DRUGCOMP Geron Corp D01GEO DRUGTYPE Small molecular drug D01GEO DRUGINCH 1S/C26H14N8O7S/c1-9-17-24-30-14(6-39-24)21-28-12(4-37-21)19-27-11(3-35-19)20-29-13(5-36-20)22-31-15(7-38-22)26-32-16(8-42-26)23-33-18(10(2)40-23)25(34-17)41-9/h3-7,16H,8H2,1-2H3 D01GEO DRUGINKE YVSQVYZBDXIXCC-UHFFFAOYSA-N D01GEO DRUGSMIL CC1=C2C3=NC(=C(O3)C)C4=NC(=CO4)C5=NC(=CO5)C6=NC(=CO6)C7=NC(=CO7)C8=NC(=CO8)C9=NC(CS9)C(=N2)O1 D01GEO HIGHSTAT Investigative D01GIW DRUG__ID D01GIW D01GIW DRUGCOMP EntoPharm Co Ltd D01GIW DRUGTYPE Small molecular drug D01GIW DRUGINCH 1S/S3/c1-3-2 D01GIW DRUGINKE NVSDADJBGGUCLP-UHFFFAOYSA-N D01GIW DRUGSMIL S=S=S D01GIW HIGHSTAT Investigative D01JEO DRUG__ID D01JEO D01JEO DRUGCOMP University of North Carolina D01JEO DRUGTYPE Small molecular drug D01JEO DRUGINCH 1S/C39H60O8/c1-8-9-10-11-15-33-37(5,42)19-16-30-31(43-33)17-20-38(6)35(44-30)23-32-36(47-38)28(41)24-39(7)34(45-32)22-27(4)29(46-39)14-12-13-25(2)26(3)18-21-40/h8-10,13,18,21,27-36,41-42H,1,11-12,14-17,19-20,22-24H2,2-7H3/b10-9-,25-13+,26-18+/t27-,28-,29-,30+,31-,32+,33+,34+,35-,36-,37+,38+,39+/m0/s1 D01JEO DRUGINKE JPBOABGEVHVPNM-GFIBHCGLSA-N D01JEO DRUGSMIL CC1CC2C(CC(C3C(O2)CC4C(O3)(CCC5C(O4)CCC(C(O5)CCC=CC=C)(C)O)C)O)(OC1CCC=C(C)C(=CC=O)C)C D01JEO HIGHSTAT Investigative D01MFK DRUG__ID D01MFK D01MFK THERCLAS Analgesics D01MFK DRUGTYPE Small molecular drug D01MFK DRUGINCH 1S/C19H17FO4S/c1-19(2)17(12-7-9-15(10-8-12)25(3,22)23)16(18(21)24-19)13-5-4-6-14(20)11-13/h4-11H,1-3H3 D01MFK DRUGINKE NXERGIJHYVUXHM-UHFFFAOYSA-N D01MFK DRUGSMIL CC1(C(=C(C(=O)O1)C2=CC(=CC=C2)F)C3=CC=C(C=C3)S(=O)(=O)C)C D01MFK HIGHSTAT Investigative D01MNK DRUG__ID D01MNK D01MNK DRUGCOMP Imperial College London D01MNK DRUGTYPE Small molecular drug D01MNK DRUGINCH 1S/C20H27N5O3/c1-13(2)15-10-22-25-19(21-9-14-6-4-3-5-7-14)8-18(24-20(15)25)23-16(11-26)17(28)12-27/h3-8,10,13,16-17,21,26-28H,9,11-12H2,1-2H3,(H,23,24)/t16-,17+/m0/s1 D01MNK DRUGINKE KRIWIRSMQRQYJG-DLBZAZTESA-N D01MNK DRUGSMIL CC(C)C1=C2N=C(C=C(N2N=C1)NCC3=CC=CC=C3)NC(CO)C(CO)O D01MNK HIGHSTAT Investigative D01MPX DRUG__ID D01MPX D01MPX DRUGCOMP Prolysis Ltd D01MPX DRUGTYPE Small molecular drug D01MPX DRUGINCH 1S/C14H8ClF2N3O2S/c15-6-3-8-14(19-4-6)23-10(20-8)5-22-9-2-1-7(16)11(12(9)17)13(18)21/h1-4H,5H2,(H2,18,21) D01MPX DRUGINKE INYJNSBDHOVLAH-UHFFFAOYSA-N D01MPX DRUGSMIL C1=CC(=C(C(=C1OCC2=NC3=C(S2)N=CC(=C3)Cl)F)C(=O)N)F D01MPX HIGHSTAT Investigative D01QYQ DRUG__ID D01QYQ D01QYQ DRUGCOMP University of Virginia D01QYQ DRUGTYPE Small molecular drug D01QYQ DRUGINCH 1S/C26H26N6O4/c1-3-13-31-24-22(25(34)32(14-4-2)26(31)35)29-23(30-24)18-7-11-20(12-8-18)36-16-21(33)28-19-9-5-17(15-27)6-10-19/h5-12H,3-4,13-14,16H2,1-2H3,(H,28,33)(H,29,30) D01QYQ DRUGINKE AJBBEYXFRYFVNM-UHFFFAOYSA-N D01QYQ DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N D01QYQ HIGHSTAT Investigative D01SUL DRUG__ID D01SUL D01SUL DRUGCOMP Johnson & Johnson D01SUL DRUGTYPE Small molecular drug D01SUL DRUGINCH 1S/C19H20Br2N2O3/c1-19(2)25-11-16(17(26-19)12-6-4-3-5-7-12)23-18(24)22-15-9-8-13(20)10-14(15)21/h3-10,16-17H,11H2,1-2H3,(H2,22,23,24)/t16-,17-/m0/s1 D01SUL DRUGINKE RBKIJGLHFFQHBE-IRXDYDNUSA-N D01SUL DRUGSMIL CC1(OCC(C(O1)C2=CC=CC=C2)NC(=O)NC3=C(C=C(C=C3)Br)Br)C D01SUL HIGHSTAT Investigative D01SUO DRUG__ID D01SUO D01SUO DRUGCOMP EcoBiotics Ltd D01SUO DRUGTYPE Small molecular drug D01SUO DRUGINCH 1S/C30H42O10/c1-9-13(3)23(33)38-21-16(6)28(36)17-11-15(5)20(32)29(17,37)25(35)27(12-31)22(39-27)18(28)19-26(7,8)30(19,21)40-24(34)14(4)10-2/h9,11,14,16-19,21-22,25,31,35-37H,10,12H2,1-8H3/b13-9+/t14-,16+,17-,18+,19+,21+,22-,25+,27-,28-,29+,30+/m0/s1 D01SUO DRUGINKE YLQZMOUMDYVSQR-FOWZUWBHSA-N D01SUO DRUGSMIL CCC(C)C(=O)OC12C(C1(C)C)C3C4C(O4)(C(C5(C(C3(C(C2OC(=O)C(=CC)C)C)O)C=C(C5=O)C)O)O)CO D01SUO HIGHSTAT Investigative D01SVO DRUG__ID D01SVO D01SVO THERCLAS Antiviral Agents D01SVO DRUGTYPE Small molecular drug D01SVO DRUGINCH 1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1 D01SVO DRUGINKE XCUAIINAJCDIPM-XVFCMESISA-N D01SVO DRUGSMIL C1=CN(C(=O)N=C1NO)C2C(C(C(O2)CO)O)O D01SVO HIGHSTAT Investigative D01TBL DRUG__ID D01TBL D01TBL DRUGCOMP Innoventus Project AB D01TBL DRUGTYPE Small molecular drug D01TBL DRUGINCH 1S/C12H9N3O/c16-12-10(5-8-6-13-7-14-8)9-3-1-2-4-11(9)15-12/h1-7H,(H,13,14)(H,15,16)/b10-5+ D01TBL DRUGINKE VEEGZPWAAPPXRB-BJMVGYQFSA-N D01TBL DRUGSMIL C1=CC=C2C(=C1)C(=CC3=CN=CN3)C(=O)N2 D01TBL HIGHSTAT Investigative D01UHU DRUG__ID D01UHU D01UHU DRUGCOMP Massachusetts Institute of Technology D01UHU DRUGTYPE Small molecular drug D01UHU DRUGINCH 1S/C5H5N.2ClH.2H3N.Pt/c1-2-4-6-5-3-1;;;;;/h1-5H;2*1H;2*1H3;/q;;;;;+2/p-2 D01UHU DRUGINKE JDWBOMGRVMIMAU-UHFFFAOYSA-L D01UHU DRUGSMIL C1=CC=NC=C1.N.N.[Cl-].Cl[Pt+] D01UHU HIGHSTAT Investigative D01UXP DRUG__ID D01UXP D01UXP DRUGCOMP Universidade Federal do Rio de Janeiro D01UXP DRUGTYPE Small molecular drug D01UXP DRUGINCH 1S/C13H10N2O3S/c16-13(15-14-7-10-2-1-5-19-10)9-3-4-11-12(6-9)18-8-17-11/h1-7H,8H2,(H,15,16)/b14-7+ D01UXP DRUGINKE YMOJHAPRGAZUPL-VGOFMYFVSA-N D01UXP DRUGSMIL C1OC2=C(O1)C=C(C=C2)C(=O)NN=CC3=CC=CS3 D01UXP HIGHSTAT Investigative D02AQM DRUG__ID D02AQM D02AQM DRUGCOMP Weizmann Institute of Science D02AQM DRUGTYPE Small molecular drug D02AQM DRUGINCH 1S/C14H14N2O/c1-3-9-16(2)10-11-6-7-13(17)14-12(11)5-4-8-15-14/h1,4-8,17H,9-10H2,2H3 D02AQM DRUGINKE FQFLPZZATVCNLA-UHFFFAOYSA-N D02AQM DRUGSMIL CN(CC#C)CC1=C2C=CC=NC2=C(C=C1)O D02AQM HIGHSTAT Investigative D02BDL DRUG__ID D02BDL D02BDL DRUGCOMP Johns Hopkins University D02BDL DRUGTYPE Small molecular drug D02BDL DRUGINCH 1S/C15H12O2/c16-14(12-7-3-1-4-8-12)11-15(17)13-9-5-2-6-10-13/h1-10H,11H2 D02BDL DRUGINKE NZZIMKJIVMHWJC-UHFFFAOYSA-N D02BDL DRUGSMIL C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=CC=C2 D02BDL HIGHSTAT Investigative D02CBD DRUG__ID D02CBD D02CBD DRUGCOMP National Health Research Institutes D02CBD DRUGTYPE Small molecular drug D02CBD DRUGINCH 1S/C21H19N3O4S/c1-28-17-5-7-18(8-6-17)29(26,27)24-14-11-15-3-2-4-19(20(15)24)23-21(25)16-9-12-22-13-10-16/h2-10,12-13H,11,14H2,1H3,(H,23,25) D02CBD DRUGINKE QGWOKAXBIMWTNE-UHFFFAOYSA-N D02CBD DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)N2CCC3=C2C(=CC=C3)NC(=O)C4=CC=NC=C4 D02CBD HIGHSTAT Investigative D02CCA DRUG__ID D02CCA D02CCA DRUGCOMP SmithKline Beecham SpA D02CCA DRUGTYPE Small molecular drug D02CCA DRUGINCH 1S/C26H22FN3O/c27-19-10-6-9-18(15-19)25-23(28)22(20-11-4-5-12-21(20)29-25)26(31)30-24(17-13-14-17)16-7-2-1-3-8-16/h1-12,15,17,24H,13-14,28H2,(H,30,31)/t24-/m1/s1 D02CCA DRUGINKE ZKGNLARKIMWKFE-XMMPIXPASA-N D02CCA DRUGSMIL C1CC1C(C2=CC=CC=C2)NC(=O)C3=C(C(=NC4=CC=CC=C43)C5=CC(=CC=C5)F)N D02CCA HIGHSTAT Investigative D02KYP DRUG__ID D02KYP D02KYP DRUGCOMP TWi Biotechnology Inc D02KYP DRUGTYPE Small molecular drug D02KYP DRUGINCH 1S/C8H6O/c9-8-5-6-3-1-2-4-7(6)8/h1-4H,5H2 D02KYP DRUGINKE XOGFXHMYHKGOGP-UHFFFAOYSA-N D02KYP DRUGSMIL C1C2=CC=CC=C2C1=O D02KYP HIGHSTAT Investigative D02MXT DRUG__ID D02MXT D02MXT DRUGCOMP Merck Frosst Canada & Co D02MXT DRUGTYPE Small molecular drug D02MXT DRUGINCH 1S/C25H22F3NO3S/c1-14-20(13-16-3-7-19(8-4-16)25(26,27)28)21(15(2)33-14)22(30)29-24(11-12-24)18-9-5-17(6-10-18)23(31)32/h3-10H,11-13H2,1-2H3,(H,29,30)(H,31,32) D02MXT DRUGINKE QJZQFVRFJCGDKF-UHFFFAOYSA-N D02MXT DRUGSMIL CC1=C(C(=C(S1)C)C(=O)NC2(CC2)C3=CC=C(C=C3)C(=O)O)CC4=CC=C(C=C4)C(F)(F)F D02MXT HIGHSTAT Investigative D02OCD DRUG__ID D02OCD D02OCD DRUGCOMP Novartis Institutes for BioMedical Research Inc D02OCD DRUGTYPE Small molecular drug D02OCD DRUGINCH 1S/C22H24N2O5/c1-5-28-19-17(27-4)11-6-13-12-16(21(26)29-18(13)19)20(25)24-15-9-7-14(8-10-15)22(2,3)23/h6-12H,5,23H2,1-4H3,(H,24,25) D02OCD DRUGINKE NFOLAKWLEGGBTA-UHFFFAOYSA-N D02OCD DRUGSMIL CCOC1=C(C=CC2=C1OC(=O)C(=C2)C(=O)NC3=CC=C(C=C3)C(C)(C)N)OC D02OCD HIGHSTAT Investigative D02RBQ DRUG__ID D02RBQ D02RBQ DRUGCOMP Diamyd Inc D02RBQ DRUGTYPE Small molecular drug D02RBQ DRUGINCH 1S/C13H18N2O3/c1-17-12-4-2-3-11(9-12)14-13(16)10-15-5-7-18-8-6-15/h2-4,9H,5-8,10H2,1H3,(H,14,16) D02RBQ DRUGINKE JTUXMPVNCNABTI-UHFFFAOYSA-N D02RBQ DRUGSMIL COC1=CC=CC(=C1)NC(=O)CN2CCOCC2 D02RBQ HIGHSTAT Investigative D02RUZ DRUG__ID D02RUZ D02RUZ DRUGCOMP Abbott Laboratories D02RUZ DRUGTYPE Small molecular drug D02RUZ DRUGINCH 1S/C26H24N2O4/c29-24(22-7-4-8-23(22)25(30)31)19-11-9-17(10-12-19)18-13-15-21(16-14-18)28-26(32)27-20-5-2-1-3-6-20/h1-3,5-6,9-16,22-23H,4,7-8H2,(H,30,31)(H2,27,28,32)/t22-,23-/m1/s1 D02RUZ DRUGINKE BOZRFEQDOFSZBV-DHIUTWEWSA-N D02RUZ DRUGSMIL C1CC(C(C1)C(=O)O)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)NC(=O)NC4=CC=CC=C4 D02RUZ HIGHSTAT Investigative D02SAK DRUG__ID D02SAK D02SAK DRUGCOMP University of Milan D02SAK DRUGTYPE Small molecular drug D02SAK DRUGINCH 1S/C21H24N4O6/c1-30-19-9-4-15(11-18(19)21(27)23-13-14-3-2-10-22-12-14)20(26)24-16-5-7-17(8-6-16)31-25(28)29/h2-4,9-12,16-17H,5-8,13H2,1H3,(H,23,27)(H,24,26) D02SAK DRUGINKE CIBUKDIHIGMBEF-UHFFFAOYSA-N D02SAK DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2CCC(CC2)O[N+](=O)[O-])C(=O)NCC3=CN=CC=C3 D02SAK HIGHSTAT Investigative D02SJN DRUG__ID D02SJN D02SJN DRUGCOMP Validus Biopharma Inc D02SJN DRUGTYPE Small molecular drug D02SJN DRUGINCH 1S/C15H15N3O6/c16-11(14(22)23)8-17-6-5-12(19)18(15(17)24)7-9-1-3-10(4-2-9)13(20)21/h1-6,11H,7-8,16H2,(H,20,21)(H,22,23)/t11-/m0/s1 D02SJN DRUGINKE XLRLZPOBHPIDFX-NSHDSACASA-N D02SJN DRUGSMIL C1=CC(=CC=C1CN2C(=O)C=CN(C2=O)CC(C(=O)O)N)C(=O)O D02SJN HIGHSTAT Investigative D02VRN DRUG__ID D02VRN D02VRN DRUGCOMP Tsumura & Co D02VRN DRUGTYPE Small molecular drug D02VRN DRUGINCH 1S/C16H22N4O6.C4H4O4/c1-23-12-9-11-13(15(25-3)14(12)24-2)18-10-19-16(11)17-7-5-4-6-8-26-20(21)22;5-3(6)1-2-4(7)8/h9-10H,4-8H2,1-3H3,(H,17,18,19);1-2H,(H,5,6)(H,7,8)/b;2-1- D02VRN DRUGINKE HYJLIYABULAXFC-BTJKTKAUSA-N D02VRN DRUGSMIL COC1=C(C(=C2C(=C1)C(=NC=N2)NCCCCCO[N+](=O)[O-])OC)OC.C(=CC(=O)O)C(=O)O D02VRN HIGHSTAT Investigative D02WGD DRUG__ID D02WGD D02WGD DRUGCOMP Lorus Therapeutics Inc D02WGD DRUGTYPE Small molecular drug D02WGD DRUGINCH 1S/C23H14BrN3/c24-13-9-10-20-18(11-13)19(12-25-20)23-26-21-16-7-3-1-5-14(16)15-6-2-4-8-17(15)22(21)27-23/h1-12,25H,(H,26,27) D02WGD DRUGINKE XFVVNPCUAYGFFE-UHFFFAOYSA-N D02WGD DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3C4=C2NC(=N4)C5=CNC6=C5C=C(C=C6)Br D02WGD HIGHSTAT Investigative D02XNT DRUG__ID D02XNT D02XNT DRUGCOMP Bristol-Myers Squibb Co D02XNT DRUGTYPE Small molecular drug D02XNT DRUGINCH 1S/C16H10ClF3N2O3/c17-12-5-6-13(23)10(7-12)8-22-15(24)25-14(21-22)9-1-3-11(4-2-9)16(18,19)20/h1-7,23H,8H2 D02XNT DRUGINKE QKOWACXSXTXRKA-UHFFFAOYSA-N D02XNT DRUGSMIL C1=CC(=CC=C1C2=NN(C(=O)O2)CC3=C(C=CC(=C3)Cl)O)C(F)(F)F D02XNT HIGHSTAT Investigative D02YNH DRUG__ID D02YNH D02YNH DRUGCOMP Pharmacia Corp D02YNH DRUGTYPE Small molecular drug D02YNH DRUGINCH 1S/C15H17ClN4O/c16-13-3-1-2-12(8-13)11-21-15-10-18-9-14(19-15)20-6-4-17-5-7-20/h1-3,8-10,17H,4-7,11H2 D02YNH DRUGINKE PCWGGOVOEWHPMG-UHFFFAOYSA-N D02YNH DRUGSMIL C1CN(CCN1)C2=CN=CC(=N2)OCC3=CC(=CC=C3)Cl D02YNH HIGHSTAT Investigative D03BPU DRUG__ID D03BPU D03BPU DRUGCOMP Tartis Inc D03BPU DRUGTYPE Small molecular drug D03BPU DRUGINCH 1S/C30H56N4O2/c1-21(4-9-28(36)34-19-18-33-17-16-32-15-14-31)25-7-8-26-24-6-5-22-20-23(35)10-12-29(22,2)27(24)11-13-30(25,26)3/h21-27,32-33,35H,4-20,31H2,1-3H3,(H,34,36)/t21?,22-,23-,24?,25-,26?,27?,29+,30-/m1/s1 D03BPU DRUGINKE PGUNLBUELRAXEJ-IALXPZHFSA-N D03BPU DRUGSMIL CC(CCC(=O)NCCNCCNCCN)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D03BPU HIGHSTAT Investigative D03HMM DRUG__ID D03HMM D03HMM DRUGCOMP Argolyn Bioscience Inc D03HMM DRUGTYPE Small molecular drug D03HMM DRUGINCH 1S/C40H67N9O8/c1-24(2)22-30(38(56)57)47-36(54)32(40(4,5)6)48-34(52)29(23-26-15-17-27(50)18-16-26)46-35(53)31-14-11-21-49(31)37(55)28(13-10-20-44-39(42)43)45-33(51)25(3)12-8-7-9-19-41/h15-18,24-25,28-32,50H,7-14,19-23,41H2,1-6H3,(H,45,51)(H,46,53)(H,47,54)(H,48,52)(H,56,57)(H4,42,43,44)/t25-,28-,29-,30-,31-,32+/m0/s1 D03HMM DRUGINKE BLKOJISPADSFAG-JPDBKSEFSA-N D03HMM DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(C)CCCCCN D03HMM HIGHSTAT Investigative D03KYI DRUG__ID D03KYI D03KYI DRUGCOMP Institute of Medicinal Molecular Design Inc D03KYI DRUGTYPE Small molecular drug D03KYI DRUGINCH 1S/C17H11Cl2NO5S/c18-10-2-1-8(3-11(10)19)7-20-16(24)14(26-17(20)25)6-9-4-12(21)15(23)13(22)5-9/h1-6,21-23H,7H2/b14-6- D03KYI DRUGINKE LOGYYEXKVXHOIW-NSIKDUERSA-N D03KYI DRUGSMIL C1=CC(=C(C=C1CN2C(=O)C(=CC3=CC(=C(C(=C3)O)O)O)SC2=O)Cl)Cl D03KYI HIGHSTAT Investigative D03NMM DRUG__ID D03NMM D03NMM DRUGCOMP Amira Pharmaceuticals Inc D03NMM DRUGTYPE Small molecular drug D03NMM DRUGINCH 1S/C36H40N4O4S.Na/c1-23-8-13-26(37-18-23)22-44-27-14-15-30-29(16-27)32(45-35(2,3)4)31(17-36(5,6)34(41)42)40(30)21-24-9-11-25(12-10-24)33-38-19-28(43-7)20-39-33;/h8-16,18-20H,17,21-22H2,1-7H3,(H,41,42);/q;+1/p-1 D03NMM DRUGINKE UFKVTMVFNCOIKU-UHFFFAOYSA-M D03NMM DRUGSMIL CC1=CN=C(C=C1)COC2=CC3=C(C=C2)N(C(=C3SC(C)(C)C)CC(C)(C)C(=O)[O-])CC4=CC=C(C=C4)C5=NC=C(C=N5)OC.[Na+] D03NMM HIGHSTAT Investigative D03QGB DRUG__ID D03QGB D03QGB DRUGCOMP Johnson & Johnson D03QGB DRUGTYPE Small molecular drug D03QGB DRUGINCH 1S/C20H32N2O/c1-3-12-21(13-4-1)16-7-17-23-20-10-8-19(9-11-20)18-22-14-5-2-6-15-22/h8-11H,1-7,12-18H2 D03QGB DRUGINKE PTKHFRNHJULJKT-UHFFFAOYSA-N D03QGB DRUGSMIL C1CCN(CC1)CCCOC2=CC=C(C=C2)CN3CCCCC3 D03QGB HIGHSTAT Investigative D03QJA DRUG__ID D03QJA D03QJA DRUGCOMP GlaxoSmithKline plc D03QJA DRUGTYPE Small molecular drug D03QJA DRUGINCH 1S/C24H32N6O/c1-27-12-14-29(15-13-27)23-10-4-9-22-26-19(21(17-31)30(22)23)16-28(2)20-8-3-6-18-7-5-11-25-24(18)20/h4-5,7,9-11,20,31H,3,6,8,12-17H2,1-2H3/t20-/m0/s1 D03QJA DRUGINKE QUDMHFVRKBVGBY-FQEVSTJZSA-N D03QJA DRUGSMIL CN1CCN(CC1)C2=CC=CC3=NC(=C(N32)CO)CN(C)C4CCCC5=C4N=CC=C5 D03QJA HIGHSTAT Investigative D03ROA DRUG__ID D03ROA D03ROA DRUGCOMP Trojantec Ltd D03ROA DRUGTYPE Small molecular drug D03ROA DRUGINCH 1S/C22H27N3O6/c1-21(2,29)10-15-17-16(12-7-6-11(31-3)9-13(12)23-17)18(26)22(30)20(28)24-8-4-5-14(24)19(27)25(15)22/h6-7,9,14-15,18,23,26,29-30H,4-5,8,10H2,1-3H3/t14-,15-,18-,22+/m0/s1 D03ROA DRUGINKE PIWNJAZCHHBADQ-MECALSEWSA-N D03ROA DRUGSMIL CC(C)(CC1C2=C(C(C3(N1C(=O)C4CCCN4C3=O)O)O)C5=C(N2)C=C(C=C5)OC)O D03ROA HIGHSTAT Investigative D03TDE DRUG__ID D03TDE D03TDE DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D03TDE DRUGTYPE Small molecular drug D03TDE DRUGINCH 1S/C6H6Cl2N2.ClH/c7-4-1-2-5(8)6(3-4)10-9;/h1-3,10H,9H2;1H D03TDE DRUGINKE RQZTURFFWSJCMT-UHFFFAOYSA-N D03TDE DRUGSMIL C1=CC(=C(C=C1Cl)NN)Cl.Cl D03TDE HIGHSTAT Investigative D03TRO DRUG__ID D03TRO D03TRO DRUGCOMP Pfizer Inc D03TRO DRUGTYPE Small molecular drug D03TRO DRUGINCH 1S/C22H15F2N3O2/c23-22(24)29-20-9-7-16(12-15(20)6-8-18-5-1-2-10-25-18)21(28)27-13-17-4-3-11-26-19(17)14-27/h1-5,7,9-12,22H,13-14H2 D03TRO DRUGINKE JITMSIRHBAVREW-UHFFFAOYSA-N D03TRO DRUGSMIL C1C2=C(CN1C(=O)C3=CC(=C(C=C3)OC(F)F)C#CC4=CC=CC=N4)N=CC=C2 D03TRO HIGHSTAT Investigative D03TTT DRUG__ID D03TTT D03TTT DRUGCOMP Array BioPharma Inc D03TTT DRUGTYPE Small molecular drug D03TTT DRUGINCH 1S/C19H18N4O2/c24-10-9-23-12-17(19(21-23)13-5-7-20-8-6-13)15-1-3-16-14(11-15)2-4-18(16)22-25/h1,3,5-8,11-12,24-25H,2,4,9-10H2/b22-18- D03TTT DRUGINKE DEZZLWQELQORIU-PYCFMQQDSA-N D03TTT DRUGSMIL C1CC(=NO)C2=C1C=C(C=C2)C3=CN(N=C3C4=CC=NC=C4)CCO D03TTT HIGHSTAT Investigative D03ZEH DRUG__ID D03ZEH D03ZEH DRUGCOMP Pacira Pharmaceuticals Inc D03ZEH DRUGTYPE Small molecular drug D03ZEH DRUGINCH 1S/C4H6O3/c5-2-1-4(7)3-6/h2-4,7H,1H2/t4-/m1/s1 D03ZEH DRUGINKE VTERBIYJBWDXDT-SCSAIBSYSA-N D03ZEH DRUGSMIL C(C=O)C(C=O)O D03ZEH HIGHSTAT Investigative D04ATY DRUG__ID D04ATY D04ATY DRUGCOMP Xel Pharmaceuticals Inc D04ATY DRUGTYPE Small molecular drug D04ATY DRUGINCH 1S/C35H49NO9/c1-8-36-17-32(18-40-3)14-13-23(42-5)35-22-15-33(39)24(43-6)16-34(45-19(2)37,27(31(35)36)29(44-7)30(32)35)25(22)26(33)28(38)20-9-11-21(41-4)12-10-20/h9-12,22-27,29-31,39H,8,13-18H2,1-7H3/t22-,23+,24+,25-,26+,27-,29+,30-,31?,32+,33+,34-,35+/m1/s1 D04ATY DRUGINKE YRECILNLFWZVRM-JNQVLWDESA-N D04ATY DRUGSMIL CCN1CC2(CCC(C34C2C(C(C31)C5(CC(C6(CC4C5C6C(=O)C7=CC=C(C=C7)OC)O)OC)OC(=O)C)OC)OC)COC D04ATY HIGHSTAT Investigative D04CUZ DRUG__ID D04CUZ D04CUZ DRUGCOMP LTT Bio-Pharma Co Ltd D04CUZ DRUGTYPE Small molecular drug D04CUZ DRUGINCH 1S/C24H41N5O7/c1-12(2)18-16(30)11-17(31)25-10-8-7-9-15(21(32)27-18)26-22(33)19(13(3)4)28-24(36)29-20(14(5)6)23(34)35/h7,9,12-16,18-20,30H,8,10-11H2,1-6H3,(H,25,31)(H,26,33)(H,27,32)(H,34,35)(H2,28,29,36)/b9-7+/t15-,16+,18-,19-,20-/m0/s1 D04CUZ DRUGINKE OSJZOUADGQCZOA-WJLJZQKYSA-N D04CUZ DRUGSMIL CC(C)C1C(CC(=O)NCCC=CC(C(=O)N1)NC(=O)C(C(C)C)NC(=O)NC(C(C)C)C(=O)O)O D04CUZ HIGHSTAT Investigative D04DBA DRUG__ID D04DBA D04DBA THERCLAS Anticancer Agents D04DBA DRUGTYPE Small molecular drug D04DBA DRUGINCH 1S/C28H21N5/c1-19-32-26-17-31-25-13-8-20(6-7-21-5-4-14-30-16-21)15-24(25)27(26)33(19)23-11-9-22(10-12-23)28(2,3)18-29/h4-5,8-17H,1-3H3 D04DBA DRUGINKE GVPAGJWVBUZHNQ-UHFFFAOYSA-N D04DBA DRUGSMIL CC1=NC2=CN=C3C=CC(=CC3=C2N1C4=CC=C(C=C4)C(C)(C)C#N)C#CC5=CN=CC=C5 D04DBA HIGHSTAT Investigative D04EQF DRUG__ID D04EQF D04EQF DRUGCOMP Cardiff ProTides Ltd D04EQF DRUGTYPE Small molecular drug D04EQF DRUGINCH 1S/C19H17NO2/c1-14(19(21)20-17-9-3-2-4-10-17)22-18-12-11-15-7-5-6-8-16(15)13-18/h2-14H,1H3,(H,20,21) D04EQF DRUGINKE LVKTWOXHRYGDMM-UHFFFAOYSA-N D04EQF DRUGSMIL CC(C(=O)NC1=CC=CC=C1)OC2=CC3=CC=CC=C3C=C2 D04EQF HIGHSTAT Investigative D04EXX DRUG__ID D04EXX D04EXX DRUGCOMP Shaheed Beheshti Medical University D04EXX DRUGTYPE Small molecular drug D04EXX DRUGINCH 1S/C10H11FN4OS/c1-6(16)14-9-3-2-7(4-8(9)11)5-13-15-10(12)17/h2-5H,1H3,(H,14,16)(H3,12,15,17)/b13-5+ D04EXX DRUGINKE LPOOMGIKZQEQHR-WLRTZDKTSA-N D04EXX DRUGSMIL CC(=O)NC1=C(C=C(C=C1)C=NNC(=S)N)F D04EXX HIGHSTAT Investigative D04JFB DRUG__ID D04JFB D04JFB DRUGCOMP Resolvyx Pharmaceuticals Inc D04JFB DRUGTYPE Small molecular drug D04JFB DRUGINCH 1S/C22H32O4/c1-2-3-10-15-20(23)17-12-8-9-13-18-21(24)16-11-6-4-5-7-14-19-22(25)26/h3,5-13,17-18,20-21,23-24H,2,4,14-16,19H2,1H3,(H,25,26)/b7-5-,9-8+,10-3-,11-6-,17-12-,18-13+/t20-,21+/m0/s1 D04JFB DRUGINKE CRDZYJSQHCXHEG-SFVBTVKNSA-N D04JFB DRUGSMIL CCC=CCC(C=CC=CC=CC(CC=CCC=CCCC(=O)O)O)O D04JFB HIGHSTAT Investigative D04JPQ DRUG__ID D04JPQ D04JPQ DRUGCOMP OSI Pharma D04JPQ DRUGTYPE Small molecular drug D04JPQ DRUGINCH 1S/C30H53N3O6.C18H15ClN2O6S2/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);3-5,7,21H,6,8H2,1-2H3/t22-,23-,24-,25-;/m0./s1 D04JPQ DRUGINKE FVDZRAUCUALTCQ-NATPOTRJSA-N D04JPQ DRUGSMIL CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N D04JPQ HIGHSTAT Investigative D04JSE DRUG__ID D04JSE D04JSE DRUGCOMP Merck & Co Inc D04JSE DRUGTYPE Small molecular drug D04JSE DRUGINCH 1S/C25H19F6N5O5S/c1-23(2,37)22-34-21(35-41-22)16-4-3-5-17-19(16)36(12-13-6-11-18(24(26,27)28)33-20(13)32-17)42(38,39)15-9-7-14(8-10-15)40-25(29,30)31/h3-11,37H,12H2,1-2H3,(H,32,33) D04JSE DRUGINKE WQQNCCUPGPFWOI-UHFFFAOYSA-N D04JSE DRUGSMIL CC(C)(C1=NC(=NO1)C2=C3C(=CC=C2)NC4=C(CN3S(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F)C=CC(=N4)C(F)(F)F)O D04JSE HIGHSTAT Investigative D04KFR DRUG__ID D04KFR D04KFR DRUGCOMP Novartis AG D04KFR DRUGTYPE Small molecular drug D04KFR DRUGINCH 1S/C36H45N5O5S/c1-38-18-20-39(21-19-38)35(42)30-14-16-41(17-15-30)47(44,45)31-12-13-34(32(26-31)36(43)40-22-24-46-25-23-40)37-27-33(28-8-4-2-5-9-28)29-10-6-3-7-11-29/h2-13,26,30,33,37H,14-25,27H2,1H3 D04KFR DRUGINKE VODUCDWVPSEMSZ-UHFFFAOYSA-N D04KFR DRUGSMIL CN1CCN(CC1)C(=O)C2CCN(CC2)S(=O)(=O)C3=CC(=C(C=C3)NCC(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)N6CCOCC6 D04KFR HIGHSTAT Investigative D04KQF DRUG__ID D04KQF D04KQF DRUGCOMP Broad Institute D04KQF DRUGTYPE Small molecular drug D04KQF DRUGINCH 1S/C41H43N3O7S/c45-26-28-17-19-29(20-18-28)35-25-34(27-52-41-43-38(30-11-5-3-6-12-30)39(51-41)31-13-7-4-8-14-31)49-40(50-35)32-21-23-33(24-22-32)42-36(46)15-9-1-2-10-16-37(47)44-48/h3-8,11-14,17-24,34-35,40,45,48H,1-2,9-10,15-16,25-27H2,(H,42,46)(H,44,47)/t34-,35+,40+/m1/s1 D04KQF DRUGINKE BHUZLJOUHMBZQY-YXQOSMAKSA-N D04KQF DRUGSMIL C1C(OC(OC1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6 D04KQF HIGHSTAT Investigative D04LMJ DRUG__ID D04LMJ D04LMJ DRUGCOMP Southwest Research Institute D04LMJ DRUGTYPE Small molecular drug D04LMJ DRUGINCH 1S/C13H12N4O2.2BrH/c18-14-9-12-1-5-16(6-2-12)11-17-7-3-13(4-8-17)10-15-19;;/h1-10H,11H2;2*1H D04LMJ DRUGINKE ZKQNRRLCBJUEBC-UHFFFAOYSA-N D04LMJ DRUGSMIL C1=C[N+](=CC=C1C=NO)C[N+]2=CC=C(C=C2)C=NO.[Br-].[Br-] D04LMJ HIGHSTAT Investigative D04PEI DRUG__ID D04PEI D04PEI DRUGCOMP Bristol-Myers Squibb D04PEI DRUGTYPE Small molecular drug D04PEI DRUGINCH 1S/C32H41N5O4S2/c1-20-16-26(41-7)25(30(40)37-14-12-36(13-15-37)22(3)38)17-27(20)42-28-19-34-31(43-28)35-29(39)24-10-8-23(9-11-24)18-33-21(2)32(4,5)6/h8-11,16-17,19,21,33H,12-15,18H2,1-7H3,(H,34,35,39) D04PEI DRUGINKE ZHXNIYGJAOPMSO-UHFFFAOYSA-N D04PEI DRUGSMIL CC1=CC(=C(C=C1SC2=CN=C(S2)NC(=O)C3=CC=C(C=C3)CNC(C)C(C)(C)C)C(=O)N4CCN(CC4)C(=O)C)OC D04PEI HIGHSTAT Investigative D04QGH DRUG__ID D04QGH D04QGH THERCLAS Endocrine, nutritional and metabolic diseases D04QGH DRUGTYPE Small molecular drug D04QGH DRUGINCH 1S/C19H20ClN3O4S/c1-28(26,27)17-5-3-13(10-16(17)20)15(9-12-2-4-14(24)8-12)19(25)23-18-11-21-6-7-22-18/h3,5-7,10-12,15H,2,4,8-9H2,1H3,(H,22,23,25)/t12-,15+/m0/s1 D04QGH DRUGINKE XEANIURBPHCHMG-SWLSCSKDSA-N D04QGH DRUGSMIL CS(=O)(=O)C1=C(C=C(C=C1)C(CC2CCC(=O)C2)C(=O)NC3=NC=CN=C3)Cl D04QGH HIGHSTAT Investigative D04SDN DRUG__ID D04SDN D04SDN DRUGCOMP DuPont, Vicuron RW Johnson D04SDN DRUGTYPE Small molecular drug D04SDN DRUGINCH 1S/C9H5ClOS2/c10-8-7(9(11)13-12-8)6-4-2-1-3-5-6/h1-5H D04SDN DRUGINKE BWTGFYQZOUAOQW-UHFFFAOYSA-N D04SDN DRUGSMIL C1=CC=C(C=C1)C2=C(SSC2=O)Cl D04SDN HIGHSTAT Investigative D04ZBA DRUG__ID D04ZBA D04ZBA DRUGCOMP NuView Life Sciences D04ZBA DRUGTYPE Small molecular drug D04ZBA DRUGINCH 1S/C10H12FN5O3/c11-5-4(1-17)19-10(7(5)18)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5+,7-,10?/m1/s1/i11-1 D04ZBA DRUGINKE QCDAWXDDXYQEJJ-OLKTUBJCSA-N D04ZBA DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)F)O)N D04ZBA HIGHSTAT Investigative D05BCF DRUG__ID D05BCF D05BCF DRUGCOMP GlaxoSmithKline D05BCF DRUGTYPE Small molecular drug D05BCF DRUGINCH 1S/C8H9NO5.K/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/q;+1/p-1/b4-1-;/t6-,7-;/m1./s1 D05BCF DRUGINKE ABVRVIZBZKUTMK-JSYANWSFSA-M D05BCF DRUGSMIL C1C2N(C1=O)C(C(=CCO)O2)C(=O)[O-].[K+] D05BCF HIGHSTAT Investigative D05BIJ DRUG__ID D05BIJ D05BIJ DRUGCOMP DuPont, Vicuron RW Johnson D05BIJ DRUGTYPE Small molecular drug D05BIJ DRUGINCH 1S/C11H14N4O2S/c1-14-8-7(9(16)13-10(14)17)15-5-3-2-4-6-18-11(15)12-8/h2-6H2,1H3,(H,13,16,17) D05BIJ DRUGINKE IGKRUASVZKVVLL-UHFFFAOYSA-N D05BIJ DRUGSMIL CN1C2=C(C(=O)NC1=O)N3CCCCCSC3=N2 D05BIJ HIGHSTAT Investigative D05CRG DRUG__ID D05CRG D05CRG DRUGCOMP Merck D05CRG DRUGTYPE Small molecular drug D05CRG DRUGINCH 1S/C32H43N5O2S/c1-21(2)30(40-19-16-33)36-29(38)28(22(3)25-20-34-27-11-7-5-9-24(25)27)35-31(39)37-17-14-32(15-18-37)13-12-23-8-4-6-10-26(23)32/h4-11,20-22,28,30,34H,12-19,33H2,1-3H3,(H,35,39)(H,36,38) D05CRG DRUGINKE UDRSIUYQZOTMRD-UHFFFAOYSA-N D05CRG DRUGSMIL CC(C)C(NC(=O)C(C(C)C1=CNC2=CC=CC=C21)NC(=O)N3CCC4(CCC5=CC=CC=C54)CC3)SCCN D05CRG HIGHSTAT Investigative D05GLT DRUG__ID D05GLT D05GLT DRUGCOMP China Pharmaceutical University D05GLT DRUGTYPE Small molecular drug D05GLT DRUGINCH 1S/C18H19NO4/c1-22-14-8-11-10(6-13(14)20)5-12-16-9(3-4-19-12)7-15(23-2)18(21)17(11)16/h6-8,12,19-21H,3-5H2,1-2H3/t12-/m0/s1 D05GLT DRUGINKE HORZNQYQXBFWNZ-LBPRGKRZSA-N D05GLT DRUGSMIL COC1=C(C2=C3C(CC4=CC(=C(C=C42)OC)O)NCCC3=C1)O D05GLT HIGHSTAT Investigative D05GQH DRUG__ID D05GQH D05GQH DRUGCOMP Addex Pharmaceuticals SA D05GQH DRUGTYPE Small molecular drug D05GQH DRUGINCH 1S/C12H12N6S/c1-7-3-4-13-11(16-7)18-12-17-10(8(2)19-12)9-5-14-15-6-9/h3-6H,1-2H3,(H,14,15)(H,13,16,17,18) D05GQH DRUGINKE MIQNXKWDQRNHAU-UHFFFAOYSA-N D05GQH DRUGSMIL CC1=NC(=NC=C1)NC2=NC(=C(S2)C)C3=CNN=C3 D05GQH HIGHSTAT Investigative D05JBC DRUG__ID D05JBC D05JBC THERCLAS Antiviral Agents D05JBC DRUGTYPE Small molecular drug D05JBC DRUGINCH 1S/C6H15N3/c7-1-2-8-3-4-9-5-6-9/h8H,1-7H2 D05JBC DRUGINKE XJNAQZHMIAKQOK-UHFFFAOYSA-N D05JBC DRUGSMIL C1CN1CCNCCN D05JBC HIGHSTAT Investigative D05LLH DRUG__ID D05LLH D05LLH THERCLAS Antiviral Agents D05LLH DRUGTYPE Small molecular drug D05LLH DRUGINCH 1S/C10H15N5O3/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17/h5-6,16-17H,1-4H2,(H3,11,13,14,18) D05LLH DRUGINKE JNTOCHDNEULJHD-UHFFFAOYSA-N D05LLH DRUGSMIL C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N D05LLH HIGHSTAT Investigative D05MEY DRUG__ID D05MEY D05MEY DRUGCOMP Hutchison Medipharma Enterprises Ltd D05MEY DRUGTYPE Small molecular drug D05MEY DRUGINCH 1S/C24H26N6O2/c1-4-17-7-6-8-18(13-17)27-23-19-14-21(22(32-3)15-20(19)25-16-26-23)28-24(31)30-11-9-29(5-2)10-12-30/h1,6-8,13-16H,5,9-12H2,2-3H3,(H,28,31)(H,25,26,27) D05MEY DRUGINKE DQAZPZIYEOGZAF-UHFFFAOYSA-N D05MEY DRUGSMIL CCN1CCN(CC1)C(=O)NC2=C(C=C3C(=C2)C(=NC=N3)NC4=CC=CC(=C4)C#C)OC D05MEY HIGHSTAT Investigative D05OBK DRUG__ID D05OBK D05OBK DRUGCOMP ISIS D05OBK DRUGTYPE Small molecular drug D05OBK DRUGINCH 1S/C18H20N4O2.2ClH/c1-21(2)12-6-11-19-18-13-7-3-4-8-14(13)20-15-9-5-10-16(17(15)18)22(23)24;;/h3-5,7-10H,6,11-12H2,1-2H3,(H,19,20);2*1H D05OBK DRUGINKE XBHIADYHFGJGSK-UHFFFAOYSA-N D05OBK DRUGSMIL C[NH+](C)CCC[NH2+]C1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-].[Cl-].[Cl-] D05OBK HIGHSTAT Investigative D05QCE DRUG__ID D05QCE D05QCE DRUGCOMP Toa Eiyo KK D05QCE DRUGTYPE Small molecular drug D05QCE DRUGINCH 1S/C17H13Cl2N3O3S2/c1-26-17-14(27(24,25)13-8-6-12(19)7-9-13)15(21-22-17)20-16(23)10-2-4-11(18)5-3-10/h2-9H,1H3,(H2,20,21,22,23) D05QCE DRUGINKE OOEJKNSQVFIOEF-UHFFFAOYSA-N D05QCE DRUGSMIL CSC1=NNC(=C1S(=O)(=O)C2=CC=C(C=C2)Cl)NC(=O)C3=CC=C(C=C3)Cl D05QCE HIGHSTAT Investigative D05QMQ DRUG__ID D05QMQ D05QMQ DRUGCOMP Millennium Pharmaceuticals Inc D05QMQ DRUGTYPE Small molecular drug D05QMQ DRUGINCH 1S/C24H25F3N6S/c1-14-19(9-15(12-28-14)5-4-8-33(2)3)31-23-29-13-16-10-21(34)30-20-11-17(24(25,26)27)6-7-18(20)22(16)32-23/h6-7,9,11-13H,4-5,8,10H2,1-3H3,(H,30,34)(H,29,31,32) D05QMQ DRUGINKE CODBZFJPKJDNDT-UHFFFAOYSA-N D05QMQ DRUGSMIL CC1=C(C=C(C=N1)CCCN(C)C)NC2=NC=C3CC(=S)NC4=C(C3=N2)C=CC(=C4)C(F)(F)F D05QMQ HIGHSTAT Investigative D05TDS DRUG__ID D05TDS D05TDS DRUGCOMP Lakewood-Amedex Inc D05TDS DRUGTYPE Small molecular drug D05TDS DRUGINCH 1S/C12H22ClN4O3/c1-11(2)7-9(8-12(3,4)17(11)20)14-10(18)16(15-19)6-5-13/h9H,5-8H2,1-4H3,(H,14,18) D05TDS DRUGINKE UAXKBFHONACCHL-UHFFFAOYSA-N D05TDS DRUGSMIL CC1(CC(CC(N1[O])(C)C)NC(=O)N(CCCl)N=O)C D05TDS HIGHSTAT Investigative D05YFE DRUG__ID D05YFE D05YFE DRUGCOMP Nordic Bioscience A/S D05YFE DRUGTYPE Small molecular drug D05YFE DRUGINCH 1S/C21H16O7/c1-24-15-6-11-12(7-16(15)25-2)20(22)13-8-26-21(23)19(13)18(11)10-3-4-14-17(5-10)28-9-27-14/h3-7,22H,8-9H2,1-2H3 D05YFE DRUGINKE VMEJANRODATDOF-UHFFFAOYSA-N D05YFE DRUGSMIL COC1=C(C=C2C(=C1)C(=C3C(=C2O)COC3=O)C4=CC5=C(C=C4)OCO5)OC D05YFE HIGHSTAT Investigative D06EHW DRUG__ID D06EHW D06EHW DRUGCOMP Incyte Corp D06EHW DRUGTYPE Small molecular drug D06EHW DRUGINCH 1S/C22H27N3O5/c1-30-21(28)25-14-22(9-10-22)13-17(19(26)23-29)18(25)20(27)24-11-7-16(8-12-24)15-5-3-2-4-6-15/h2-7,17-18,29H,8-14H2,1H3,(H,23,26)/t17-,18-/m0/s1 D06EHW DRUGINKE CKZHFOKQZRZCPF-ROUUACIJSA-N D06EHW DRUGSMIL COC(=O)N1CC2(CC2)CC(C1C(=O)N3CCC(=CC3)C4=CC=CC=C4)C(=O)NO D06EHW HIGHSTAT Investigative D06EMQ DRUG__ID D06EMQ D06EMQ DRUGCOMP Amura Therapeutics Ltd D06EMQ DRUGTYPE Small molecular drug D06EMQ DRUGINCH 1S/C14H22N2O5/c1-7(17)8-11(18)16-9(13(19)20)10(21-12(8)16)14(2,3)5-4-6-15/h7-8,12,17H,4-6,15H2,1-3H3,(H,19,20)/t7-,8+,12-/m1/s1 D06EMQ DRUGINKE MJNFEDQKHJZAEX-RGNHYFCHSA-N D06EMQ DRUGSMIL CC(C1C2N(C1=O)C(=C(O2)C(C)(C)CCCN)C(=O)O)O D06EMQ HIGHSTAT Investigative D06EPP DRUG__ID D06EPP D06EPP DRUGCOMP The Salk Institute for Biological Studies D06EPP DRUGTYPE Small molecular drug D06EPP DRUGINCH 1S/C27H24N2O4/c1-32-26-16-19(10-14-24(26)30)8-12-21-18-23(29(28-21)22-6-4-3-5-7-22)13-9-20-11-15-25(31)27(17-20)33-2/h3-18,30-31H,1-2H3/b12-8+,13-9+ D06EPP DRUGINKE QUOCIDQIFWYHLB-QHKWOANTSA-N D06EPP DRUGSMIL COC1=C(C=CC(=C1)C=CC2=CC(=NN2C3=CC=CC=C3)C=CC4=CC(=C(C=C4)O)OC)O D06EPP HIGHSTAT Investigative D06HXC DRUG__ID D06HXC D06HXC DRUGCOMP Pfizer D06HXC DRUGTYPE Small molecular drug D06HXC DRUGINCH 1S/C30H35N5O3/c31-29(35-30(37)34-21-26-15-8-16-38-26)33-20-24-12-7-11-23(17-24)19-32-28(36)27(25-13-5-2-6-14-25)18-22-9-3-1-4-10-22/h1-7,9-14,17,26-27H,8,15-16,18-21H2,(H,32,36)(H4,31,33,34,35,37) D06HXC DRUGINKE BSGMHDGHMYUSDC-UHFFFAOYSA-N D06HXC DRUGSMIL C1CC(OC1)CNC(=O)NC(=NCC2=CC=CC(=C2)CNC(=O)C(CC3=CC=CC=C3)C4=CC=CC=C4)N D06HXC HIGHSTAT Investigative D06LUH DRUG__ID D06LUH D06LUH DRUGCOMP Abxign Inc D06LUH DRUGTYPE Small molecular drug D06LUH DRUGINCH 1S/C18H19N3O4S/c1-23-17(26)19-8-15-9-21(18(22)25-15)13-5-4-12-10-24-11-14-3-2-6-20(14)16(12)7-13/h2-7,15H,8-11H2,1H3,(H,19,26)/t15-/m0/s1 D06LUH DRUGINKE FSQKREKRQLHTJL-HNNXBMFYSA-N D06LUH DRUGSMIL COC(=S)NCC1CN(C(=O)O1)C2=CC3=C(COCC4=CC=CN43)C=C2 D06LUH HIGHSTAT Investigative D06NIT DRUG__ID D06NIT D06NIT DRUGCOMP Pfizer Inc D06NIT DRUGTYPE Small molecular drug D06NIT DRUGINCH 1S/C24H27N7O/c1-15-12-30(13-16-6-7-20-21(10-16)26-9-8-25-20)14-19(15)22-28-23-18(24(32)29-22)11-27-31(23)17-4-2-3-5-17/h6-11,15,17,19H,2-5,12-14H2,1H3,(H,28,29,32)/t15-,19-/m1/s1 D06NIT DRUGINKE SNCRCEGCQVMUBS-DNVCBOLYSA-N D06NIT DRUGSMIL CC1CN(CC1C2=NC3=C(C=NN3C4CCCC4)C(=O)N2)CC5=CC6=NC=CN=C6C=C5 D06NIT HIGHSTAT Investigative D06NKA DRUG__ID D06NKA D06NKA DRUGCOMP Ipsen D06NKA DRUGTYPE Small molecular drug D06NKA DRUGINCH 1S/C22H19FN4O4S.ClH/c23-19-12-18(10-11-20(19)27-32(24,28)29)31-17-8-6-15(7-9-17)21-13-25-22(26-21)14-30-16-4-2-1-3-5-16;/h1-13,27H,14H2,(H,25,26)(H2,24,28,29);1H D06NKA DRUGINKE WDKXZCKBBNZPLY-UHFFFAOYSA-N D06NKA DRUGSMIL C1=CC=C(C=C1)OCC2=NC=C(N2)C3=CC=C(C=C3)OC4=CC(=C(C=C4)NS(=O)(=O)N)F.Cl D06NKA HIGHSTAT Investigative D06NMZ DRUG__ID D06NMZ D06NMZ DRUGCOMP Novartis D06NMZ DRUGTYPE Small molecular drug D06NMZ DRUGINCH 1S/C28H31N5O/c29-27-26-25(22-9-6-10-24(15-22)34-18-20-7-2-1-3-8-20)17-33(28(26)31-19-30-27)23-13-21(14-23)16-32-11-4-5-12-32/h1-3,6-10,15,17,19,21,23H,4-5,11-14,16,18H2,(H2,29,30,31) D06NMZ DRUGINKE LSFLAQVDISHMNB-UHFFFAOYSA-N D06NMZ DRUGSMIL C1CCN(C1)CC2CC(C2)N3C=C(C4=C(N=CN=C43)N)C5=CC(=CC=C5)OCC6=CC=CC=C6 D06NMZ HIGHSTAT Investigative D06QOM DRUG__ID D06QOM D06QOM DRUGCOMP Technophage SA D06QOM DRUGTYPE Small molecular drug D06QOM DRUGINCH 1S/C31H41N3O6/c1-20(2)29(31(40)32-24(19-35)16-22-8-12-25(36)13-9-22)34-30(39)27(17-23-10-14-26(37)15-11-23)33-28(38)18-21-6-4-3-5-7-21/h8-15,19-21,24,27,29,36-37H,3-7,16-18H2,1-2H3,(H,32,40)(H,33,38)(H,34,39)/t24?,27-,29-/m0/s1 D06QOM DRUGINKE PBHZSZHBJWAKIL-TXJYOHDVSA-N D06QOM DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C=O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CC3CCCCC3 D06QOM HIGHSTAT Investigative D06QRY DRUG__ID D06QRY D06QRY DRUGCOMP Indena SpA D06QRY DRUGTYPE Small molecular drug D06QRY DRUGINCH 1S/C41H57NO14/c1-21(2)18-26(42-37(50)56-38(6,7)8)32(46)36(49)53-27-19-41(51)34(54-35(48)25-14-12-11-13-15-25)30(40(55-24(5)44)20-52-28(40)16-17-43)23(4)31(45)33(47)29(22(27)3)39(41,9)10/h11-15,21,26-28,30,32,34,43,45-46,51H,16-20H2,1-10H3,(H,42,50)/b31-23+/t26-,27-,28+,30+,32+,34-,40-,41+/m0/s1 D06QRY DRUGINKE UKFDBDGJFYRBHE-QWSJSTABSA-N D06QRY DRUGSMIL CC1=C2C(=O)C(=C(C(C(C(C2(C)C)(CC1OC(=O)C(C(CC(C)C)NC(=O)OC(C)(C)C)O)O)OC(=O)C3=CC=CC=C3)C4(COC4CCO)OC(=O)C)C)O D06QRY HIGHSTAT Investigative D06SRX DRUG__ID D06SRX D06SRX DRUGCOMP MD Anderson Cancer Center D06SRX DRUGTYPE Small molecular drug D06SRX DRUGINCH 1S/C21H23N3O2/c1-2-3-4-10-15-24-18-14-9-8-13-17(18)19(21(24)26)22-23-20(25)16-11-6-5-7-12-16/h5-9,11-14,26H,2-4,10,15H2,1H3 D06SRX DRUGINKE ICNRTDOKKSWDRL-UHFFFAOYSA-N D06SRX DRUGSMIL CCCCCCN1C2=CC=CC=C2C(=C1O)N=NC(=O)C3=CC=CC=C3 D06SRX HIGHSTAT Investigative D06TQD DRUG__ID D06TQD D06TQD DRUGCOMP Merck & Co Inc D06TQD DRUGTYPE Small molecular drug D06TQD DRUGINCH 1S/C35H47FN4O2/c1-5-40-33(21-30(37-40)18-25-10-7-6-8-11-25)26-14-16-39(17-15-26)23-28-20-31(38(4)34(24(2)3)35(41)42)22-32(28)27-12-9-13-29(36)19-27/h6-13,19,21,24,26,28,31-32,34H,5,14-18,20,22-23H2,1-4H3,(H,41,42)/t28-,31+,32-,34-/m1/s1 D06TQD DRUGINKE ZTENZJJCFACIAK-ADWVOTLJSA-N D06TQD DRUGSMIL CCN1C(=CC(=N1)CC2=CC=CC=C2)C3CCN(CC3)CC4CC(CC4C5=CC(=CC=C5)F)N(C)C(C(C)C)C(=O)O D06TQD HIGHSTAT Investigative D06VMV DRUG__ID D06VMV D06VMV DRUGCOMP Novartis AG D06VMV DRUGTYPE Small molecular drug D06VMV DRUGINCH 1S/C19H20F3N3/c1-11-23-10-16(13-4-6-15(7-5-13)19(20,21)22)18(24-11)25-17-9-12-2-3-14(17)8-12/h4-7,10,12,14,17H,2-3,8-9H2,1H3,(H,23,24,25)/t12-,14+,17+/m0/s1 D06VMV DRUGINKE ADHZHPOKTRHZGT-DXCKQFNASA-N D06VMV DRUGSMIL CC1=NC=C(C(=N1)NC2CC3CCC2C3)C4=CC=C(C=C4)C(F)(F)F D06VMV HIGHSTAT Investigative D06WHN DRUG__ID D06WHN D06WHN DRUGCOMP KinDEx Therapeutics D06WHN DRUGTYPE Small molecular drug D06WHN DRUGINCH 1S/C21H34O5/c1-12(2)7-9-15-19(24)18(16(22)11-14(5)6)20(25)21(15,26)17(23)10-8-13(3)4/h12-15,25-26H,7-11H2,1-6H3/t15-,21+/m1/s1 D06WHN DRUGINKE JIZQRWKUYFNSDM-VFNWGFHPSA-N D06WHN DRUGSMIL CC(C)CCC1C(=O)C(=C(C1(C(=O)CCC(C)C)O)O)C(=O)CC(C)C D06WHN HIGHSTAT Investigative D06YAG DRUG__ID D06YAG D06YAG DRUGCOMP Abxign Inc D06YAG DRUGTYPE Small molecular drug D06YAG DRUGINCH 1S/C18H18ClN3O4/c19-7-17(23)20-8-15-9-22(18(24)26-15)13-4-3-12-10-25-11-14-2-1-5-21(14)16(12)6-13/h1-6,15H,7-11H2,(H,20,23)/t15-/m0/s1 D06YAG DRUGINKE MHHOUFZYQHOCDM-HNNXBMFYSA-N D06YAG DRUGSMIL C1C(OC(=O)N1C2=CC3=C(COCC4=CC=CN43)C=C2)CNC(=O)CCl D06YAG HIGHSTAT Investigative D06YEE DRUG__ID D06YEE D06YEE DRUGCOMP Aida Pharmaceuticals Inc D06YEE DRUGTYPE Small molecular drug D06YEE DRUGINCH 1S/C20H25N3O/c1-4-5-6-8-15-11-16(22-14(15)2)12-19-20(24-3)13-18(23-19)17-9-7-10-21-17/h7,9-13,21-22H,4-6,8H2,1-3H3/b19-12- D06YEE DRUGINKE SHUNBVWMKSXXOM-UNOMPAQXSA-N D06YEE DRUGSMIL CCCCCC1=C(NC(=C1)C=C2C(=CC(=N2)C3=CC=CN3)OC)C D06YEE HIGHSTAT Investigative D07DNV DRUG__ID D07DNV D07DNV DRUGCOMP New York University D07DNV DRUGTYPE Small molecular drug D07DNV DRUGINCH 1S/C12H12N2O/c15-12-7-2-1-6-11(12)14-9-10-5-3-4-8-13-10/h1-8,14-15H,9H2 D07DNV DRUGINKE GXJRVWZNMZGWAQ-UHFFFAOYSA-N D07DNV DRUGSMIL C1=CC=C(C(=C1)NCC2=CC=CC=N2)O D07DNV HIGHSTAT Investigative D07DTC DRUG__ID D07DTC D07DTC DRUGCOMP Endacea Inc D07DTC DRUGTYPE Small molecular drug D07DTC DRUGINCH 1S/C29H38N6O3/c1-3-15-35-28(37)26-27(34(29(35)38)16-14-22-10-12-24(30)13-11-22)31-25(21-23-8-6-5-7-9-23)33(26)18-17-32(4-2)19-20-36/h5-13,36H,3-4,14-21,30H2,1-2H3 D07DTC DRUGINKE QVEHDKFBFDUCEZ-UHFFFAOYSA-N D07DTC DRUGSMIL CCCN1C(=O)C2=C(N=C(N2CCN(CC)CCO)CC3=CC=CC=C3)N(C1=O)CCC4=CC=C(C=C4)N D07DTC HIGHSTAT Investigative D07IYO DRUG__ID D07IYO D07IYO THERCLAS Antiviral Agents D07IYO DRUGTYPE Small molecular drug D07IYO DRUGINCH 1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9) D07IYO DRUGINKE IDVQGNMSSHPZSJ-UHFFFAOYSA-N D07IYO DRUGSMIL CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-] D07IYO HIGHSTAT Investigative D07IZS DRUG__ID D07IZS D07IZS DRUGCOMP AhR Pharmaceuticals Inc D07IZS DRUGTYPE Small molecular drug D07IZS DRUGINCH 1S/C14H10N2O3S/c1-19-14(18)11-7-20-13(16-11)12(17)9-6-15-10-5-3-2-4-8(9)10/h2-7,15H,1H3 D07IZS DRUGINKE KDDXOGDIPZSCTM-UHFFFAOYSA-N D07IZS DRUGSMIL COC(=O)C1=CSC(=N1)C(=O)C2=CNC3=CC=CC=C32 D07IZS HIGHSTAT Investigative D07MQC DRUG__ID D07MQC D07MQC DRUGCOMP Takeda D07MQC DRUGTYPE Small molecular drug D07MQC DRUGINCH 1S/C17H11ClN4O/c18-11-6-13-12-3-5-20-9-15(12)21-16(13)14(7-11)22-17(23)10-2-1-4-19-8-10/h1-9,21H,(H,22,23) D07MQC DRUGINKE JZRMBDHPALEPDM-UHFFFAOYSA-N D07MQC DRUGSMIL C1=CC(=CN=C1)C(=O)NC2=CC(=CC3=C2NC4=C3C=CN=C4)Cl D07MQC HIGHSTAT Investigative D07QTB DRUG__ID D07QTB D07QTB DRUGCOMP AFFICHEM D07QTB DRUGTYPE Small molecular drug D07QTB DRUGINCH 1S/C34H63N3O2/c1-24(2)10-8-11-25(3)28-12-13-29-27-22-31(37-21-9-20-36-19-7-6-18-35)34(39)23-26(38)14-17-33(34,5)30(27)15-16-32(28,29)4/h22,24-26,28-31,36-39H,6-21,23,35H2,1-5H3/t25-,26+,28-,29+,30+,31-,32-,33-,34+/m1/s1 D07QTB DRUGINKE BLYVUYZBUKXNDE-GDAXLBPBSA-N D07QTB DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2=CC(C4(C3(CCC(C4)O)C)O)NCCCNCCCCN)C D07QTB HIGHSTAT Investigative D07VQW DRUG__ID D07VQW D07VQW DRUGCOMP Sigma-Tau D07VQW DRUGTYPE Small molecular drug D07VQW DRUGINCH 1S/C20H27N7O13P2S/c21-16-10-18(24-4-23-16)27(5-25-10)20-14(31)12(29)9(40-20)2-38-42(35,36)6-41(33,34)37-1-8-11(28)13(30)15(39-8)19-26-7(3-43-19)17(22)32/h3-5,8-9,11-15,20,28-31H,1-2,6H2,(H2,22,32)(H,33,34)(H,35,36)(H2,21,23,24)/t8-,9-,11-,12-,13-,14-,15-,20-/m1/s1 D07VQW DRUGINKE CRWWKLKZKYLFQV-HVIRUEHBSA-N D07VQW DRUGSMIL C1=C(N=C(S1)C2C(C(C(O2)COP(=O)(CP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)O)C(=O)N D07VQW HIGHSTAT Investigative D07VWP DRUG__ID D07VWP D07VWP DRUGCOMP Aventis D07VWP DRUGTYPE Small molecular drug D07VWP DRUGINCH 1S/C29H27N3O3/c33-28(31-19-17-24-13-8-9-18-30-24)27-16-7-6-15-26(27)25-14-5-4-12-23(25)20-32-29(34)35-21-22-10-2-1-3-11-22/h1-16,18H,17,19-21H2,(H,31,33)(H,32,34) D07VWP DRUGINKE FLOLVFLAXFXKBU-UHFFFAOYSA-N D07VWP DRUGSMIL C1=CC=C(C=C1)COC(=O)NCC2=CC=CC=C2C3=CC=CC=C3C(=O)NCCC4=CC=CC=N4 D07VWP HIGHSTAT Investigative D07ZHM DRUG__ID D07ZHM D07ZHM DRUGCOMP Hamamatsu Photonics D07ZHM DRUGTYPE Small molecular drug D07ZHM DRUGINCH 1S/C42H45N7O12.4Na/c1-6-22-19(2)27-14-32-25(11-12-43-61)42(5,60)35(47-32)16-28-21(4)24(8-10-37(51)49-34(41(58)59)18-39(54)55)31(46-28)15-30-23(20(3)26(45-30)13-29(22)44-27)7-9-36(50)48-33(40(56)57)17-38(52)53;;;;/h6,11-16,33-34,43,47,60-61H,1,7-10,17-18H2,2-5H3,(H,48,50)(H,49,51)(H,52,53)(H,54,55)(H,56,57)(H,58,59);;;;/q;4*+1/p-4/b12-11+,26-13?,27-14?,31-15?,35-16?;;;;/t33-,34-,42?;;;;/m0..../s1 D07ZHM DRUGINKE CFDYXPRZJQKYQB-FALBFATCSA-J D07ZHM DRUGSMIL CC1=C(C2=NC1=CC3=NC(=CC4=C(C(C(=CC5=NC(=C2)C(=C5C)CCC(=O)NC(CC(=O)[O-])C(=O)[O-])N4)(C)O)C=CNO)C(=C3C=C)C)CCC(=O)NC(CC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+] D07ZHM HIGHSTAT Investigative D08GBT DRUG__ID D08GBT D08GBT DRUGCOMP Sanofi D08GBT DRUGTYPE Small molecular drug D08GBT DRUGINCH 1S/C18H22N4O4/c1-5-22-15(19)13(17(24)20-3)14(23)12-7-6-11(21-16(12)22)8-9-18(2,25)10-26-4/h6-7,25H,5,10,19H2,1-4H3,(H,20,24)/t18-/m1/s1 D08GBT DRUGINKE PFMPOBVAYMTUOX-GOSISDBHSA-N D08GBT DRUGSMIL CCN1C(=C(C(=O)C2=C1N=C(C=C2)C#CC(C)(COC)O)C(=O)NC)N D08GBT HIGHSTAT Investigative D08HTF DRUG__ID D08HTF D08HTF DRUGCOMP Johnson & Johnson D08HTF DRUGTYPE Small molecular drug D08HTF DRUGINCH 1S/C16H11F4N3OS/c17-12-2-1-10(7-11(12)16(18,19)20)22-15-23-14(13(8-24)25-15)9-3-5-21-6-4-9/h1-7,24H,8H2,(H,22,23) D08HTF DRUGINKE JBSVHWCIKVSTTH-UHFFFAOYSA-N D08HTF DRUGSMIL C1=CC(=C(C=C1NC2=NC(=C(S2)CO)C3=CC=NC=C3)C(F)(F)F)F D08HTF HIGHSTAT Investigative D08JML DRUG__ID D08JML D08JML THERCLAS Analgesics D08JML DRUGTYPE Small molecular drug D08JML DRUGINCH 1S/C8H11N5O4S/c1-13-5-6(9-2-3-18(15,16)17)10-4-11-7(5)12-8(13)14/h4H,2-3H2,1H3,(H,15,16,17)(H2,9,10,11,12,14) D08JML DRUGINKE OTYWCUOKKIHICD-UHFFFAOYSA-N D08JML DRUGSMIL CN1C2=C(NC1=O)N=CN=C2NCCS(=O)(=O)O D08JML HIGHSTAT Investigative D08JSE DRUG__ID D08JSE D08JSE DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D08JSE DRUGTYPE Small molecular drug D08JSE DRUGINCH 1S/C12H6ClF3N4O3/c13-6-1-7-8(2-9(6)23-12(14,15)16)19-11(18-7)20-4-5(3-17-20)10(21)22/h1-4H,(H,18,19)(H,21,22) D08JSE DRUGINKE FXHHASJVTYRJHH-UHFFFAOYSA-N D08JSE DRUGSMIL C1=C2C(=CC(=C1Cl)OC(F)(F)F)N=C(N2)N3C=C(C=N3)C(=O)O D08JSE HIGHSTAT Investigative D08KHD DRUG__ID D08KHD D08KHD DRUGCOMP Fudan University D08KHD DRUGTYPE Small molecular drug D08KHD DRUGINCH 1S/C14H21N3O5/c1-20-10-7-9(8-11(21-2)12(10)18)13(19)22-6-4-3-5-17-14(15)16/h7-8,18H,3-6H2,1-2H3,(H4,15,16,17) D08KHD DRUGINKE WNGSUWLDMZFYNZ-UHFFFAOYSA-N D08KHD DRUGSMIL COC1=CC(=CC(=C1O)OC)C(=O)OCCCCN=C(N)N D08KHD HIGHSTAT Investigative D08KZJ DRUG__ID D08KZJ D08KZJ DRUGCOMP 7TM Pharma A/S D08KZJ DRUGTYPE Small molecular drug D08KZJ DRUGINCH 1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-15)17-4-2-3-5-19(17)24(20)13-21(25)26/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26) D08KZJ DRUGINKE CANCTKXGRVNXFP-UHFFFAOYSA-N D08KZJ DRUGSMIL CN(C1CCC2=C(C1)C3=CC=CC=C3N2CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F D08KZJ HIGHSTAT Investigative D08LYB DRUG__ID D08LYB D08LYB THERCLAS Analgesics D08LYB DRUGTYPE Small molecular drug D08LYB DRUGINCH 1S/C20H21FN4O2/c1-27-20-22-11-10-17(24-20)19-18(13-2-4-14(21)5-3-13)23-12-25(19)15-6-8-16(26)9-7-15/h2-5,10-12,15-16,26H,6-9H2,1H3 D08LYB DRUGINKE ZQUSFAUAYSEREK-UHFFFAOYSA-N D08LYB DRUGSMIL COC1=NC=CC(=N1)C2=C(N=CN2C3CCC(CC3)O)C4=CC=C(C=C4)F D08LYB HIGHSTAT Investigative D08LZZ DRUG__ID D08LZZ D08LZZ DRUGCOMP Merck & Co Inc D08LZZ DRUGTYPE Small molecular drug D08LZZ DRUGINCH 1S/C22H29OP/c1-17(2)21-15-14-18(3)16-22(21)24(23,19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,17-18,21-22H,14-16H2,1-3H3/t18-,21+,22+/m1/s1 D08LZZ DRUGINKE BPCNGVCAHAIZEE-COPCDDAFSA-N D08LZZ DRUGSMIL CC1CCC(C(C1)P(=O)(C2=CC=CC=C2)C3=CC=CC=C3)C(C)C D08LZZ HIGHSTAT Investigative D08NTD DRUG__ID D08NTD D08NTD DRUGCOMP CTD Holdings Inc D08NTD DRUGTYPE Small molecular drug D08NTD DRUGINCH 1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3/t22?,23?,24?,25?,26?,27?,28?,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-/m1/s1 D08NTD DRUGINKE ODLHGICHYURWBS-LKONHMLTSA-N D08NTD DRUGSMIL CC(COCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)O)O)O D08NTD HIGHSTAT Investigative D08NYO DRUG__ID D08NYO D08NYO DRUGCOMP Selective Genetics D08NYO DRUGTYPE Small molecular drug D08NYO DRUGINCH 1S/C28H37BrN4O3.C6H6O3S/c1-5-36-30-26(22-6-8-24(29)9-7-22)23-11-15-32(16-12-23)28(4)13-18-31(19-14-28)27(34)25-20(2)10-17-33(35)21(25)3;7-10(8,9)6-4-2-1-3-5-6/h6-10,17,23H,5,11-16,18-19H2,1-4H3;1-5H,(H,7,8,9)/b30-26+; D08NYO DRUGINKE RVIRPEALZXBUMV-REAKUJNMSA-N D08NYO DRUGSMIL CCON=C(C1CCN(CC1)C2(CCN(CC2)C(=O)C3=C(C=C[N+](=C3C)[O-])C)C)C4=CC=C(C=C4)Br.C1=CC=C(C=C1)S(=O)(=O)O D08NYO HIGHSTAT Investigative D08OLB DRUG__ID D08OLB D08OLB DRUGCOMP Chugai Pharmaceutical Co Ltd D08OLB DRUGTYPE Small molecular drug D08OLB DRUGINCH 1S/C16H13ClN4OS/c1-23-16-20-14(19-15(18)21-16)13-10-4-2-3-8-6-22-7-9(12(8)10)5-11(13)17/h2-5H,6-7H2,1H3,(H2,18,19,20,21) D08OLB DRUGINKE FPTCGMGLTQPTGE-UHFFFAOYSA-N D08OLB DRUGSMIL CSC1=NC(=NC(=N1)N)C2=C(C=C3COCC4=C3C2=CC=C4)Cl D08OLB HIGHSTAT Investigative D08QPJ DRUG__ID D08QPJ D08QPJ DRUGCOMP Ardea Biosciences Inc D08QPJ DRUGTYPE Small molecular drug D08QPJ DRUGINCH 1S/C14H17NO5/c1-14(2,3)19-13(18)20-15-11(16)9-7-4-5-8(6-7)10(9)12(15)17/h4-5,7-10H,6H2,1-3H3/t7-,8+,9?,10? D08QPJ DRUGINKE SMTQMXCDEUEZRS-BQKDNTBBSA-N D08QPJ DRUGSMIL CC(C)(C)OC(=O)ON1C(=O)C2C3CC(C2C1=O)C=C3 D08QPJ HIGHSTAT Investigative D08ROQ DRUG__ID D08ROQ D08ROQ DRUGCOMP Servier D08ROQ DRUGTYPE Small molecular drug D08ROQ DRUGINCH 1S/C22H29F3N4O6S/c23-22(24,25)17-10-11-19(18(12-17)29(32)33)36(34,35)26-13-14-6-8-16(9-7-14)21(31)28-27-20(30)15-4-2-1-3-5-15/h1-5,14,16-19,26H,6-13H2,(H,27,30)(H,28,31) D08ROQ DRUGINKE MODMVZPKMVZXFO-UHFFFAOYSA-N D08ROQ DRUGSMIL C1CC(CCC1CNS(=O)(=O)C2CCC(CC2[N+](=O)[O-])C(F)(F)F)C(=O)NNC(=O)C3=CC=CC=C3 D08ROQ HIGHSTAT Investigative D08RUN DRUG__ID D08RUN D08RUN DRUGCOMP Memorial Sloan-Kettering Cancer Center D08RUN DRUGTYPE Small molecular drug D08RUN DRUGINCH 1S/C16H31BrO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(17)16(18)19/h15H,2-14H2,1H3,(H,18,19) D08RUN DRUGINKE DPRAYRYQQAXQPE-UHFFFAOYSA-N D08RUN DRUGSMIL CCCCCCCCCCCCCCC(C(=O)O)Br D08RUN HIGHSTAT Investigative D08SZP DRUG__ID D08SZP D08SZP DRUGCOMP Technophage SA D08SZP DRUGTYPE Small molecular drug D08SZP DRUGINCH 1S/C22H33NO3/c1-2-25-21(24)22(19-9-4-3-5-10-19)13-16-23(17-14-22)15-7-6-11-20-12-8-18-26-20/h3-5,9-10,20H,2,6-8,11-18H2,1H3 D08SZP DRUGINKE KYEXKNZXSZSPFG-UHFFFAOYSA-N D08SZP DRUGSMIL CCOC(=O)C1(CCN(CC1)CCCCC2CCCO2)C3=CC=CC=C3 D08SZP HIGHSTAT Investigative D08TZZ DRUG__ID D08TZZ D08TZZ DRUGCOMP Biopharm Technology Corp D08TZZ DRUGTYPE Small molecular drug D08TZZ DRUGINCH 1S/C25H32O13/c1-3-13-14(9-19(29)35-7-6-12-4-5-16(27)17(28)8-12)15(23(33)34-2)11-36-24(13)38-25-22(32)21(31)20(30)18(10-26)37-25/h3-5,8,11,14,18,20-22,24-28,30-32H,6-7,9-10H2,1-2H3/b13-3+/t14-,18+,20+,21-,22+,24-,25-/m0/s1 D08TZZ DRUGINKE RFWGABANNQMHMZ-ZCHJGGQASA-N D08TZZ DRUGSMIL CC=C1C(C(=COC1OC2C(C(C(C(O2)CO)O)O)O)C(=O)OC)CC(=O)OCCC3=CC(=C(C=C3)O)O D08TZZ HIGHSTAT Investigative D08UZL DRUG__ID D08UZL D08UZL DRUGCOMP Geron Corp D08UZL DRUGTYPE Small molecular drug D08UZL DRUGINCH 1S/C44H37N8/c1-49-21-13-29(14-22-49)41-33-5-7-35(45-33)42(30-15-23-50(2)24-16-30)37-9-11-39(47-37)44(32-19-27-52(4)28-20-32)40-12-10-38(48-40)43(36-8-6-34(41)46-36)31-17-25-51(3)26-18-31/h5-28H,1-4H3,(H,45,46,47,48)/q+3/p+1 D08UZL DRUGINKE ABCGFHPGHXSVKI-UHFFFAOYSA-O D08UZL DRUGSMIL C[N+]1=CC=C(C=C1)C2=C3C=CC(=C(C4=NC(=C(C5=CC=C(N5)C(=C6C=CC2=N6)C7=CC=[N+](C=C7)C)C8=CC=[N+](C=C8)C)C=C4)C9=CC=[N+](C=C9)C)N3 D08UZL HIGHSTAT Investigative D08WGI DRUG__ID D08WGI D08WGI DRUGCOMP ActoKine Therapeutics D08WGI DRUGTYPE Small molecular drug D08WGI DRUGINCH 1S/C8H14N4OS/c1-4-7-10-11-8(14-7)9-6(13)5-12(2)3/h4-5H2,1-3H3,(H,9,11,13) D08WGI DRUGINKE ZJVYZVJAFBJZJK-UHFFFAOYSA-N D08WGI DRUGSMIL CCC1=NN=C(S1)NC(=O)CN(C)C D08WGI HIGHSTAT Investigative D08XOF DRUG__ID D08XOF D08XOF DRUGCOMP 13 Therapeutics Inc D08XOF DRUGTYPE Small molecular drug D08XOF DRUGINCH 1S/C12H17NO3.ClH/c1-13(2)6-7-14-10-4-3-5-11-12(10)16-9-8-15-11;/h3-5H,6-9H2,1-2H3;1H D08XOF DRUGINKE AUJCEAYZLRBQJV-UHFFFAOYSA-N D08XOF DRUGSMIL C[NH+](C)CCOC1=CC=CC2=C1OCCO2.[Cl-] D08XOF HIGHSTAT Investigative D08ZRW DRUG__ID D08ZRW D08ZRW THERCLAS Antisense D08ZRW DRUGTYPE Combination drug (Antisense drug) D08ZRW DRUGINCH 1S/2ClH.2H2N.Pt/h2*1H;2*1H2;/q;;2*-1;+4/p-2 D08ZRW DRUGINKE DQLATGHUWYMOKM-UHFFFAOYSA-L D08ZRW DRUGSMIL [NH2-].[NH2-].Cl[Pt+2]Cl D08ZRW HIGHSTAT Investigative D09DDQ DRUG__ID D09DDQ D09DDQ DRUGCOMP BioProjet; Societe Civile de Recherche D09DDQ DRUGTYPE Small molecular drug D09DDQ DRUGINCH 1S/C8H14N2O/c1-2-11-5-3-4-8-6-9-7-10-8/h6-7H,2-5H2,1H3,(H,9,10) D09DDQ DRUGINKE RSHKAUMLIJVWFJ-UHFFFAOYSA-N D09DDQ DRUGSMIL CCOCCCC1=CN=CN1 D09DDQ HIGHSTAT Investigative D09ENZ DRUG__ID D09ENZ D09ENZ DRUGCOMP Epizyme Inc D09ENZ DRUGTYPE Small molecular drug D09ENZ DRUGINCH 1S/C28H41N7O4/c1-17(2)34(13-6-12-30-27(38)33-19-9-7-18(8-10-19)28(3,4)5)15-21-22(36)23(37)26(39-21)35-14-11-20-24(29)31-16-32-25(20)35/h7-11,14,16-17,21-23,26,36-37H,6,12-13,15H2,1-5H3,(H2,29,31,32)(H2,30,33,38)/t21-,22-,23-,26-/m1/s1 D09ENZ DRUGINKE WXRGFPHDRFQODR-ICLZECGLSA-N D09ENZ DRUGSMIL CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C(N=CN=C43)N)O)O D09ENZ HIGHSTAT Investigative D09EOZ DRUG__ID D09EOZ D09EOZ DRUGCOMP Taipei-Veterans General Hospital D09EOZ DRUGTYPE Small molecular drug D09EOZ DRUGINCH 1S/C10H12BrCl2O3PS/c1-3-14-17(18,15-4-2)16-10-6-8(12)7(11)5-9(10)13/h5-6H,3-4H2,1-2H3 D09EOZ DRUGINKE KWGUFOITWDSNQY-UHFFFAOYSA-N D09EOZ DRUGSMIL CCOP(=S)(OCC)OC1=CC(=C(C=C1Cl)Br)Cl D09EOZ HIGHSTAT Investigative D09EQZ DRUG__ID D09EQZ D09EQZ DRUGCOMP Zhejiang University D09EQZ DRUGTYPE Small molecular drug D09EQZ DRUGINCH 1S/C19H21N3O4/c1-23-13-7-5-11(6-8-13)16-17(21-22-19(16)20)12-9-14(24-2)18(26-4)15(10-12)25-3/h5-10H,1-4H3,(H3,20,21,22) D09EQZ DRUGINKE SITNEARYBVAYKV-UHFFFAOYSA-N D09EQZ DRUGSMIL COC1=CC=C(C=C1)C2=C(NN=C2N)C3=CC(=C(C(=C3)OC)OC)OC D09EQZ HIGHSTAT Investigative D09EZU DRUG__ID D09EZU D09EZU DRUGCOMP Toyama Medical; Pharmaceutical University D09EZU DRUGTYPE Small molecular drug D09EZU DRUGINCH 1S/C30H52O3/c1-22(13-9-15-24(3)21-31)11-8-12-23(2)14-10-16-26-29(6)19-18-27(32)28(4,5)25(29)17-20-30(26,7)33/h11,14-15,25-27,31-33H,8-10,12-13,16-21H2,1-7H3/b22-11+,23-14+,24-15+/t25-,26?,27-,29-,30+/m0/s1 D09EZU DRUGINKE KKOJENOIJUTRDK-FHILKHTASA-N D09EZU DRUGSMIL CC(=CCCC1C2(CCC(C(C2CCC1(C)O)(C)C)O)C)CCC=C(C)CCC=C(C)CO D09EZU HIGHSTAT Investigative D09HVH DRUG__ID D09HVH D09HVH DRUGCOMP Nerviano Medical Sciences Srl D09HVH DRUGTYPE Small molecular drug D09HVH DRUGINCH 1S/C22H22N4O7/c1-25-8-6-13(7-9-25)23-22(29)17-12-20(33-24-17)21-18(28)10-15(27)11-19(21)32-16-4-2-14(3-5-16)26(30)31/h2-5,10-13,27-28H,6-9H2,1H3,(H,23,29) D09HVH DRUGINKE YLQODGGPIHWTHR-UHFFFAOYSA-N D09HVH DRUGSMIL CN1CCC(CC1)NC(=O)C2=NOC(=C2)C3=C(C=C(C=C3OC4=CC=C(C=C4)[N+](=O)[O-])O)O D09HVH HIGHSTAT Investigative D09HYI DRUG__ID D09HYI D09HYI DRUGCOMP SyndromeX Ltd D09HYI DRUGTYPE Small molecular drug D09HYI DRUGINCH 1S/C11H14O3.Na/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9;/h4-7,12H,2-3,8H2,1H3;/q;+1/p-1 D09HYI DRUGINKE OGBHACNFHJJTQT-UHFFFAOYSA-M D09HYI DRUGSMIL CCCCOC(=O)C1=CC=C(C=C1)[O-].[Na+] D09HYI HIGHSTAT Investigative D09IKZ DRUG__ID D09IKZ D09IKZ DRUGCOMP Astellas Pharma Inc D09IKZ DRUGTYPE Small molecular drug D09IKZ DRUGINCH 1S/C20H18ClNO2S/c1-14(16-5-3-2-4-6-16)22-20(23)19-18(11-12-25-19)24-13-15-7-9-17(21)10-8-15/h2-12,14H,13H2,1H3,(H,22,23)/t14-/m0/s1 D09IKZ DRUGINKE RFZPGNRLOKVZJY-AWEZNQCLSA-N D09IKZ DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=C(C=CS2)OCC3=CC=C(C=C3)Cl D09IKZ HIGHSTAT Investigative D09JYY DRUG__ID D09JYY D09JYY DRUGCOMP Cytovia Inc D09JYY DRUGTYPE Small molecular drug D09JYY DRUGINCH 1S/C7H5NO/c1-2-6-3-4-8-7(9)5-6/h1,3-5H,(H,8,9) D09JYY DRUGINKE PWWRIYINHRKVFL-UHFFFAOYSA-N D09JYY DRUGSMIL C#CC1=CC(=O)NC=C1 D09JYY HIGHSTAT Investigative D09LPK DRUG__ID D09LPK D09LPK THERCLAS Antiviral Agents D09LPK DRUGTYPE Small molecular drug D09LPK DRUGINCH 1S/C22H14ClNO4S2/c23-17-8-6-14(10-16(17)21(26)27)18-9-7-15(28-18)11-19-20(25)24(22(29)30-19)12-13-4-2-1-3-5-13/h1-11H,12H2,(H,26,27)/b19-11- D09LPK DRUGINKE WOBPZFKXPCYOLU-ODLFYWEKSA-N D09LPK DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C(=CC3=CC=C(O3)C4=CC(=C(C=C4)Cl)C(=O)O)SC2=S D09LPK HIGHSTAT Investigative D09MCG DRUG__ID D09MCG D09MCG THERCLAS Antiviral Agents D09MCG DRUGTYPE Small molecular drug D09MCG DRUGINCH 1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2 D09MCG DRUGINKE DKNWSYNQZKUICI-UHFFFAOYSA-N D09MCG DRUGSMIL C1C2CC3CC1CC(C2)(C3)N D09MCG HIGHSTAT Investigative D09OKV DRUG__ID D09OKV D09OKV THERCLAS Antiviral Agents D09OKV DRUGTYPE Small molecular drug D09OKV DRUGINCH 1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1 D09OKV DRUGINKE YMARZQAQMVYCKC-OEMFJLHTSA-N D09OKV DRUGSMIL CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N D09OKV HIGHSTAT Investigative D09OPS DRUG__ID D09OPS D09OPS DRUGCOMP University of Auckland D09OPS DRUGTYPE Small molecular drug D09OPS DRUGINCH 1S/C19H22N4O2/c1-12-6-5-7-13-10-14-17(21-16(12)13)15(11-23(4)19(14)25)18(24)20-8-9-22(2)3/h5-7,10-11H,8-9H2,1-4H3,(H,20,24) D09OPS DRUGINKE CSMRPIFORJZYCJ-UHFFFAOYSA-N D09OPS DRUGSMIL CC1=C2C(=CC=C1)C=C3C(=N2)C(=CN(C3=O)C)C(=O)NCCN(C)C D09OPS HIGHSTAT Investigative D09PTP DRUG__ID D09PTP D09PTP DRUGCOMP Cephalon Inc D09PTP DRUGTYPE Small molecular drug D09PTP DRUGINCH 1S/C28H35ClN6O3/c1-37-25-20-8-7-19(35-10-12-38-13-11-35)6-4-16(20)5-9-22(25)32-28-31-15-21(29)27(34-28)33-24-18-3-2-17(14-18)23(24)26(30)36/h2-3,5,9,15,17-19,23-24H,4,6-8,10-14H2,1H3,(H2,30,36)(H2,31,32,33,34)/t17-,18+,19+,23+,24-/m1/s1 D09PTP DRUGINKE LAJAFFLJAJMYLK-CVOKMOJFSA-N D09PTP DRUGSMIL COC1=C(C=CC2=C1CCC(CC2)N3CCOCC3)NC4=NC=C(C(=N4)NC5C6CC(C5C(=O)N)C=C6)Cl D09PTP HIGHSTAT Investigative D09QVI DRUG__ID D09QVI D09QVI DRUGCOMP Universidade Federal do Rio de Janeiro D09QVI DRUGTYPE Small molecular drug D09QVI DRUGINCH 1S/C19H12O4/c20-16-11-6-1-2-7-12(11)17(21)19-15(16)18-13(9-22-19)10-5-3-4-8-14(10)23-18/h1-8,13,18H,9H2/t13-,18+/m1/s1 D09QVI DRUGINKE BUEHOQICFGQBNY-ACJLOTCBSA-N D09QVI DRUGSMIL C1C2C(C3=C(O1)C(=O)C4=CC=CC=C4C3=O)OC5=CC=CC=C25 D09QVI HIGHSTAT Investigative D09RKU DRUG__ID D09RKU D09RKU DRUGCOMP Schering-Plough Corp D09RKU DRUGTYPE Small molecular drug D09RKU DRUGINCH 1S/C19H24N4O2/c1-12-9-14(24-3)10-15-16(11-23-5-4-7-25-8-6-23)17-13(2)21-22-19(17)20-18(12)15/h9-10H,4-8,11H2,1-3H3,(H,20,21,22) D09RKU DRUGINKE IPHACPSYWWYGQN-UHFFFAOYSA-N D09RKU DRUGSMIL CC1=CC(=CC2=C(C3=C(NN=C3N=C12)C)CN4CCCOCC4)OC D09RKU HIGHSTAT Investigative D09VHS DRUG__ID D09VHS D09VHS DRUGCOMP National Institutes of Health D09VHS DRUGTYPE Small molecular drug D09VHS DRUGINCH 1S/C19H18N2O2/c22-17-13-18(21-11-9-20-10-12-21)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13,20H,9-12H2 D09VHS DRUGINKE NGAGMBNBKCDCDJ-UHFFFAOYSA-N D09VHS DRUGSMIL C1CN(CCN1)C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4 D09VHS HIGHSTAT Investigative D09WUY DRUG__ID D09WUY D09WUY DRUGCOMP Technophage SA D09WUY DRUGTYPE Small molecular drug D09WUY DRUGINCH 1S/C35H37N3O6/c1-22(2)33(35(44)36-27(21-39)18-23-10-14-28(40)15-11-23)38-34(43)31(19-24-12-16-29(41)17-13-24)37-32(42)20-26-8-5-7-25-6-3-4-9-30(25)26/h3-17,21-22,27,31,33,40-41H,18-20H2,1-2H3,(H,36,44)(H,37,42)(H,38,43)/t27?,31-,33-/m0/s1 D09WUY DRUGINKE BOKINRZKCHWTCT-ODYHTTIYSA-N D09WUY DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C=O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CC3=CC=CC4=CC=CC=C43 D09WUY HIGHSTAT Investigative D09YBF DRUG__ID D09YBF D09YBF DRUGCOMP Davos Life Science Pte Ltd D09YBF DRUGTYPE Small molecular drug D09YBF DRUGINCH 1S/C28H42O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-19-26(29)23(5)24(6)27(25)30-28/h11,13,15,19,29H,8-10,12,14,16-18H2,1-7H3/b21-13+,22-15+/t28-/m1/s1 D09YBF DRUGINKE OTXNTMVVOOBZCV-WAZJVIJMSA-N D09YBF DRUGSMIL CC1=C(C=C2CCC(OC2=C1C)(C)CCC=C(C)CCC=C(C)CCC=C(C)C)O D09YBF HIGHSTAT Investigative D09YHI DRUG__ID D09YHI D09YHI DRUGCOMP Strox Biopharmaceuticals LLC D09YHI DRUGTYPE Small molecular drug D09YHI DRUGINCH 1S/C18H23BrN2O4/c1-11-7-12(2)10-21(9-11)18(25)14-8-13(19)3-4-15(14)20-16(22)5-6-17(23)24/h3-4,8,11-12H,5-7,9-10H2,1-2H3,(H,20,22)(H,23,24)/t11-,12+ D09YHI DRUGINKE JSVSGWHGYIDZFX-TXEJJXNPSA-N D09YHI DRUGSMIL CC1CC(CN(C1)C(=O)C2=C(C=CC(=C2)Br)NC(=O)CCC(=O)O)C D09YHI HIGHSTAT Investigative D09YTH DRUG__ID D09YTH D09YTH DRUGCOMP China Pharmaceutical University D09YTH DRUGTYPE Small molecular drug D09YTH DRUGINCH 1S/C23H26N2O4S/c1-18(26)25(15-14-19-10-12-21(13-11-19)24-30(2,27)28)16-17-29-23-9-5-7-20-6-3-4-8-22(20)23/h3-13,24H,14-17H2,1-2H3 D09YTH DRUGINKE NSXHCQYUSBIMAJ-UHFFFAOYSA-N D09YTH DRUGSMIL CC(=O)N(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=CC3=CC=CC=C32 D09YTH HIGHSTAT Investigative D09ZPN DRUG__ID D09ZPN D09ZPN DRUGCOMP Merck Frosst Canada & Co D09ZPN DRUGTYPE Small molecular drug D09ZPN DRUGINCH 1S/C19H22N4O5/c1-19(2,18(27)21-13-6-4-3-5-12(13)17(25)26)9-15-22-16(23-28-15)14-8-7-11(24)10-20-14/h7-8,10,24H,3-6,9H2,1-2H3,(H,21,27)(H,25,26) D09ZPN DRUGINKE CJHXBFSJXDUJHP-UHFFFAOYSA-N D09ZPN DRUGSMIL CC(C)(CC1=NC(=NO1)C2=NC=C(C=C2)O)C(=O)NC3=C(CCCC3)C(=O)O D09ZPN HIGHSTAT Investigative D0A0GU DRUG__ID D0A0GU D0A0GU THERCLAS Antiviral Agents D0A0GU DRUGTYPE Small molecular drug D0A0GU DRUGINCH 1S/C20H23N3O2/c1-16-14-20(25-13-10-22-8-11-24-12-9-22)21-23(16)19-7-6-17-4-2-3-5-18(17)15-19/h2-7,14-15H,8-13H2,1H3 D0A0GU DRUGINKE DGPGXHRHNRYVDH-UHFFFAOYSA-N D0A0GU DRUGSMIL CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4 D0A0GU HIGHSTAT Investigative D0A0JM DRUG__ID D0A0JM D0A0JM DRUGCOMP Ajinomoto Co Inc D0A0JM DRUGTYPE Small molecular drug D0A0JM DRUGINCH 1S/C27H24Cl2N4O5/c1-31(2)17-11-12-22-18(14-17)25(35)33(27(38)32(22)3)16-9-7-15(8-10-16)13-21(26(36)37)30-24(34)23-19(28)5-4-6-20(23)29/h4-12,14,21H,13H2,1-3H3,(H,30,34)(H,36,37)/t21-/m0/s1 D0A0JM DRUGINKE YQKBOUPIOWUMTE-NRFANRHFSA-N D0A0JM DRUGSMIL CN1C2=C(C=C(C=C2)N(C)C)C(=O)N(C1=O)C3=CC=C(C=C3)CC(C(=O)O)NC(=O)C4=C(C=CC=C4Cl)Cl D0A0JM HIGHSTAT Investigative D0A1QC DRUG__ID D0A1QC D0A1QC DRUGCOMP IntelliHep D0A1QC DRUGTYPE Small molecular drug D0A1QC DRUGINCH 1S/C14H25NO21S3/c1-29-9-7(17)10(35-38(23,24)25)14(34-11(9)12(18)19)33-8-4(3-31-37(20,21)22)32-13(30-2)5(6(8)16)15-36-39(26,27)28/h4-11,13-17H,3H2,1-2H3,(H,18,19)(H,20,21,22)(H,23,24,25)(H,26,27,28)/t4-,5-,6-,7+,8-,9+,10-,11-,13+,14+/m0/s1 D0A1QC DRUGINKE AUQASCCBXZRMEG-RHKLHVFKSA-N D0A1QC DRUGSMIL COC1C(C(C(OC1C(=O)O)OC2C(OC(C(C2O)NOS(=O)(=O)O)OC)COS(=O)(=O)O)OS(=O)(=O)O)O D0A1QC HIGHSTAT Investigative D0A3CW DRUG__ID D0A3CW D0A3CW DRUGCOMP Max-Planck-Gesellschaft zur Forderung der Wissenschaften eV D0A3CW DRUGTYPE Small molecular drug D0A3CW DRUGINCH 1S/C23H48NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-27-29(25,26)28-23-21-24(2,3)4/h12-13H,5-11,14-23H2,1-4H3/b13-12- D0A3CW DRUGINKE SLVOKEOPLJCHCQ-SEYXRHQNSA-N D0A3CW DRUGSMIL CCCCCCCCC=CCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C D0A3CW HIGHSTAT Investigative D0A3RP DRUG__ID D0A3RP D0A3RP THERCLAS Antiviral Agents D0A3RP DRUGTYPE Small molecular drug D0A3RP DRUGINCH 1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31) D0A3RP DRUGINKE JOOXLOJCABQBSG-UHFFFAOYSA-N D0A3RP DRUGSMIL CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4 D0A3RP HIGHSTAT Investigative D0A4VW DRUG__ID D0A4VW D0A4VW DRUGCOMP Microbial Chemistry Research Foundation D0A4VW DRUGTYPE Small molecular drug D0A4VW DRUGINCH 1S/C37H41N3O6/c1-24(2)35(37(44)38-29(23-41)20-25-12-16-30(45-3)17-13-25)40-36(43)33(21-26-14-18-31(46-4)19-15-26)39-34(42)22-28-10-7-9-27-8-5-6-11-32(27)28/h5-19,23-24,29,33,35H,20-22H2,1-4H3,(H,38,44)(H,39,42)(H,40,43)/t29?,33-,35-/m0/s1 D0A4VW DRUGINKE IJDYUMDIJFFMQQ-ROSKKCPQSA-N D0A4VW DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)OC)C=O)NC(=O)C(CC2=CC=C(C=C2)OC)NC(=O)CC3=CC=CC4=CC=CC=C43 D0A4VW HIGHSTAT Investigative D0A4XJ DRUG__ID D0A4XJ D0A4XJ DRUGCOMP Sugen Inc D0A4XJ DRUGTYPE Small molecular drug D0A4XJ DRUGINCH 1S/C17H16N2O3/c1-10-9-18-15(11(10)6-7-16(20)21)8-13-12-4-2-3-5-14(12)19-17(13)22/h2-5,8-9,18H,6-7H2,1H3,(H,19,22)(H,20,21)/b13-8- D0A4XJ DRUGINKE JNDVEAXZWJIOKB-JYRVWZFOSA-N D0A4XJ DRUGSMIL CC1=CNC(=C1CCC(=O)O)C=C2C3=CC=CC=C3NC2=O D0A4XJ HIGHSTAT Investigative D0A6NU DRUG__ID D0A6NU D0A6NU THERCLAS Antiviral Agents D0A6NU DRUGTYPE Small molecular drug D0A6NU DRUGINCH 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 D0A6NU DRUGINKE LNEPOXFFQSENCJ-UHFFFAOYSA-N D0A6NU DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F D0A6NU HIGHSTAT Investigative D0A6OJ DRUG__ID D0A6OJ D0A6OJ DRUGCOMP Technophage SA D0A6OJ DRUGTYPE Small molecular drug D0A6OJ DRUGINCH 1S/C31H35N3O6/c1-20(2)29(31(40)32-24(19-35)16-22-8-12-25(36)13-9-22)34-30(39)27(17-23-10-14-26(37)15-11-23)33-28(38)18-21-6-4-3-5-7-21/h3-15,19-20,24,27,29,36-37H,16-18H2,1-2H3,(H,32,40)(H,33,38)(H,34,39)/t24?,27-,29-/m0/s1 D0A6OJ DRUGINKE XTGWWZCPEOEIIX-TXJYOHDVSA-N D0A6OJ DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C=O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CC3=CC=CC=C3 D0A6OJ HIGHSTAT Investigative D0A6QR DRUG__ID D0A6QR D0A6QR THERCLAS Antiviral Agents D0A6QR DRUGTYPE Small molecular drug D0A6QR DRUGINCH 1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20) D0A6QR DRUGINKE PHAOTASRLQMKBE-UHFFFAOYSA-N D0A6QR DRUGSMIL CN(C)C1=NC2=C(N1CC(=O)O)C(=C(C(=C2Br)Br)Br)Br D0A6QR HIGHSTAT Investigative D0A8RP DRUG__ID D0A8RP D0A8RP DRUGCOMP Tibotec BVBA D0A8RP DRUGTYPE Small molecular drug D0A8RP DRUGINCH 1S/C19H12N4O3/c1-21-16-5-3-2-4-15(16)18-17(21)10-12(11-20)19(24)22(18)13-6-8-14(9-7-13)23(25)26/h2-10H,1H3 D0A8RP DRUGINKE TZEXGCXFOXXFKH-UHFFFAOYSA-N D0A8RP DRUGSMIL CN1C2=CC=CC=C2C3=C1C=C(C(=O)N3C4=CC=C(C=C4)[N+](=O)[O-])C#N D0A8RP HIGHSTAT Investigative D0A9NN DRUG__ID D0A9NN D0A9NN THERCLAS Antiviral Agents D0A9NN DRUGTYPE Small molecular drug D0A9NN DRUGINCH 1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1 D0A9NN DRUGINKE CBVCZFGXHXORBI-PXQQMZJSSA-N D0A9NN DRUGSMIL CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5 D0A9NN HIGHSTAT Investigative D0AC0A DRUG__ID D0AC0A D0AC0A DRUGCOMP SRI International D0AC0A DRUGTYPE Small molecular drug D0AC0A DRUGINCH 1S/C24H29Cl2NO/c1-16-4-2-5-20-19(16)9-8-17(14-23(20)28)15-27-12-10-18(11-13-27)24-21(25)6-3-7-22(24)26/h2-7,17-18,23,28H,8-15H2,1H3/t17-,23-/m0/s1 D0AC0A DRUGINKE OHRDCQFCAWLDBP-SBUREZEXSA-N D0AC0A DRUGSMIL CC1=C2CCC(CC(C2=CC=C1)O)CN3CCC(CC3)C4=C(C=CC=C4Cl)Cl D0AC0A HIGHSTAT Investigative D0AI3G DRUG__ID D0AI3G D0AI3G DRUGCOMP Human Genome Sciences Inc D0AI3G DRUGTYPE Small molecular drug D0AI3G DRUGINCH 1S/C15H21NO2/c1-12-6-5-7-13(2)14(12)15(17)18-11-10-16-8-3-4-9-16/h5-7H,3-4,8-11H2,1-2H3 D0AI3G DRUGINKE PPNRGAWIOVQCBT-UHFFFAOYSA-N D0AI3G DRUGSMIL CC1=C(C(=CC=C1)C)C(=O)OCCN2CCCC2 D0AI3G HIGHSTAT Investigative D0AK8E DRUG__ID D0AK8E D0AK8E DRUGCOMP Moberg Derma AB D0AK8E DRUGTYPE Small molecular drug D0AK8E DRUGINCH 1S/C12H8Cl2O3S/c13-9-1-5-11(6-2-9)17-18(15,16)12-7-3-10(14)4-8-12/h1-8H D0AK8E DRUGINKE RZXLPPRPEOUENN-UHFFFAOYSA-N D0AK8E DRUGSMIL C1=CC(=CC=C1OS(=O)(=O)C2=CC=C(C=C2)Cl)Cl D0AK8E HIGHSTAT Investigative D0AL2K DRUG__ID D0AL2K D0AL2K THERCLAS Antiviral Agents D0AL2K DRUGTYPE Small molecular drug D0AL2K DRUGINCH 1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30) D0AL2K DRUGINKE YOSHYTLCDANDAN-UHFFFAOYSA-N D0AL2K DRUGSMIL CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D0AL2K HIGHSTAT Investigative D0AX3M DRUG__ID D0AX3M D0AX3M DRUGCOMP Kyowa Hakko Kogyo Co Ltd D0AX3M DRUGTYPE Small molecular drug D0AX3M DRUGINCH 1S/C25H36N2O4S/c1-15(2)27(16(3)4)24(28)23-11-10-22-21-8-6-17-14-18(31-32(26,29)30)7-9-19(17)20(21)12-13-25(22,23)5/h7,9,11,14-16,20-22H,6,8,10,12-13H2,1-5H3,(H2,26,29,30)/t20-,21-,22+,25+/m1/s1 D0AX3M DRUGINKE OCJKMKKDAMUFAY-APDHKMKFSA-N D0AX3M DRUGSMIL CC(C)N(C(C)C)C(=O)C1=CCC2C1(CCC3C2CCC4=C3C=CC(=C4)OS(=O)(=O)N)C D0AX3M HIGHSTAT Investigative D0AY7O DRUG__ID D0AY7O D0AY7O THERCLAS Antiviral Agents D0AY7O DRUGTYPE Small molecular drug D0AY7O DRUGINCH 1S/C10H13N4O8P.C9H14N3O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17;10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20);1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,10-;4-,6-,7-,8-/m11/s1 D0AY7O DRUGINKE ACEVNMQDUCOKHT-ZLOOHWKQSA-N D0AY7O DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O D0AY7O HIGHSTAT Investigative D0AZ6M DRUG__ID D0AZ6M D0AZ6M THERCLAS Antiviral Agents D0AZ6M DRUGTYPE Small molecular drug D0AZ6M DRUGINCH 1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 D0AZ6M DRUGINKE TYZROVQLWOKYKF-ZDUSSCGKSA-N D0AZ6M DRUGSMIL CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F D0AZ6M HIGHSTAT Investigative D0B0RZ DRUG__ID D0B0RZ D0B0RZ THERCLAS Antiviral Agents D0B0RZ DRUGTYPE Small molecular drug D0B0RZ DRUGINCH 1S/C26H28N2O3/c1-18(22-8-4-6-20-5-2-3-7-23(20)22)28-13-11-21(12-14-28)26(29)27-16-19-9-10-24-25(15-19)31-17-30-24/h2-10,15,18,21H,11-14,16-17H2,1H3,(H,27,29)/t18-/m1/s1 D0B0RZ DRUGINKE IVXBCFLWMPMSAP-GOSISDBHSA-N D0B0RZ DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)N3CCC(CC3)C(=O)NCC4=CC5=C(C=C4)OCO5 D0B0RZ HIGHSTAT Investigative D0B0TW DRUG__ID D0B0TW D0B0TW DRUGCOMP Synstar Japan Co Ltd D0B0TW DRUGTYPE Small molecular drug D0B0TW DRUGINCH 1S/C25H22N4O/c1-3-29(4-2)18-9-10-21-23(15-18)30-24-16-22(27-17-11-13-26-14-12-17)19-7-5-6-8-20(19)25(24)28-21/h5-16H,3-4H2,1-2H3 D0B0TW DRUGINKE HBSWMATYASLRBW-UHFFFAOYSA-N D0B0TW DRUGSMIL CCN(CC)C1=CC2=C(C=C1)N=C3C4=CC=CC=C4C(=NC5=CC=NC=C5)C=C3O2 D0B0TW HIGHSTAT Investigative D0B1PH DRUG__ID D0B1PH D0B1PH THERCLAS Antiviral Agents D0B1PH DRUGTYPE Small molecular drug D0B1PH DRUGINCH 1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-/t14-,15+,16-,17-,19-,20-,21-/m0/s1 D0B1PH DRUGINKE ICMWWNHDUZJFDW-DHODBPELSA-N D0B1PH DRUGSMIL CC12CCC3C(C1CCC2(C)O)CCC4C3(CC(=CO)C(=O)C4)C D0B1PH HIGHSTAT Investigative D0B5SC DRUG__ID D0B5SC D0B5SC DRUGCOMP Bristol-Myers Squibb Co D0B5SC DRUGTYPE Small molecular drug D0B5SC DRUGINCH 1S/C34H38O13/c1-40-20-12-10-19(11-13-20)34-27(18-8-6-5-7-9-18)26(30(38)42-3)29(37)33(34,39)28-23(41-2)14-21(15-24(28)47-34)45-32-31(43-4)44-17-25(46-32)22(36)16-35/h5-15,22,25-27,29,31-32,35-37,39H,16-17H2,1-4H3/t22-,25-,26-,27-,29-,31-,32-,33+,34+/m1/s1 D0B5SC DRUGINKE GVKXFVCXBFGBCD-QKDMMWSPSA-N D0B5SC DRUGSMIL COC1C(OC(CO1)C(CO)O)OC2=CC3=C(C(=C2)OC)C4(C(C(C(C4(O3)C5=CC=C(C=C5)OC)C6=CC=CC=C6)C(=O)OC)O)O D0B5SC HIGHSTAT Investigative D0B7AH DRUG__ID D0B7AH D0B7AH DRUGCOMP Intercept Pharmaceuticals Inc D0B7AH DRUGTYPE Small molecular drug D0B7AH DRUGINCH 1S/C27H46O5/c1-6-17-20-12-16(28)9-10-26(20,4)21-13-22(29)27(5)18(14(2)11-15(3)25(31)32)7-8-19(27)23(21)24(17)30/h14-24,28-30H,6-13H2,1-5H3,(H,31,32)/t14-,15+,16-,17-,18-,19+,20+,21+,22+,23+,24-,26+,27-/m1/s1 D0B7AH DRUGINKE NPBCMXATLRCCLF-IRRLEISYSA-N D0B7AH DRUGSMIL CCC1C2CC(CCC2(C3CC(C4(C(C3C1O)CCC4C(C)CC(C)C(=O)O)C)O)C)O D0B7AH HIGHSTAT Investigative D0B7LU DRUG__ID D0B7LU D0B7LU DRUGCOMP Cylene Pharmaceuticals Inc D0B7LU DRUGTYPE Small molecular drug D0B7LU DRUGINCH 1S/C27H27N7O2S/c1-17-14-29-18(15-28-17)16-30-26(36)23-24(35)19-8-9-22(33-11-5-10-32(2)12-13-33)31-25(19)34-20-6-3-4-7-21(20)37-27(23)34/h3-4,6-9,14-15H,5,10-13,16H2,1-2H3,(H,30,36) D0B7LU DRUGINKE XGPBJCHFROADCK-UHFFFAOYSA-N D0B7LU DRUGSMIL CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C D0B7LU HIGHSTAT Investigative D0B7UD DRUG__ID D0B7UD D0B7UD DRUGCOMP Technophage SA D0B7UD DRUGTYPE Small molecular drug D0B7UD DRUGINCH 1S/C35H37N3O6/c1-22(2)33(35(44)36-28(21-39)18-23-8-13-29(40)14-9-23)38-34(43)31(19-24-10-15-30(41)16-11-24)37-32(42)20-25-7-12-26-5-3-4-6-27(26)17-25/h3-17,21-22,28,31,33,40-41H,18-20H2,1-2H3,(H,36,44)(H,37,42)(H,38,43)/t28?,31-,33-/m0/s1 D0B7UD DRUGINKE DZFIWZFBLUWJSU-GMILHWHJSA-N D0B7UD DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C=O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CC3=CC4=CC=CC=C4C=C3 D0B7UD HIGHSTAT Investigative D0B8AT DRUG__ID D0B8AT D0B8AT THERCLAS Antiviral Agents D0B8AT DRUGTYPE Small molecular drug D0B8AT DRUGINCH 1S/C24H38N2O/c1-27-24-14-6-12-22-20(8-5-13-23(22)24)9-7-15-25-16-18-26(19-17-25)21-10-3-2-4-11-21/h6,12,14,20-21H,2-5,7-11,13,15-19H2,1H3 D0B8AT DRUGINKE PHRCDWVPTULQMT-UHFFFAOYSA-N D0B8AT DRUGSMIL COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4 D0B8AT HIGHSTAT Investigative D0B8ZP DRUG__ID D0B8ZP D0B8ZP THERCLAS Antiviral Agents D0B8ZP DRUGTYPE Small molecular drug D0B8ZP DRUGINCH 1S/C18H22N2O/c1-3-10-20-11-4-5-16(13-20)18-12-17(19-21-18)15-8-6-14(2)7-9-15/h5-9,12H,3-4,10-11,13H2,1-2H3 D0B8ZP DRUGINKE FOQRKFCLRMMKAT-UHFFFAOYSA-N D0B8ZP DRUGSMIL CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C D0B8ZP HIGHSTAT Investigative D0BP7C DRUG__ID D0BP7C D0BP7C DRUGCOMP MSD Japan D0BP7C DRUGTYPE Small molecular drug D0BP7C DRUGINCH 1S/C38H32N2O12/c1-21(26(25-15-16-29-30(18-25)49-20-48-29)9-6-12-31-39-27-10-4-5-11-28(27)50-31)40(19-22-13-14-23-7-2-3-8-24(23)17-22)34(41)32-33(35(42)43)52-38(51-32,36(44)45)37(46)47/h2-8,10-18,21,26,32-33H,9,19-20H2,1H3,(H,42,43)(H,44,45)(H,46,47)/b12-6+/t21-,26+,32+,33-/m1/s1 D0BP7C DRUGINKE CXDSZFRIMJUZKT-MRGWGSTCSA-N D0BP7C DRUGSMIL CC(C(CC=CC1=NC2=CC=CC=C2O1)C3=CC4=C(C=C3)OCO4)N(CC5=CC6=CC=CC=C6C=C5)C(=O)C7C(OC(O7)(C(=O)O)C(=O)O)C(=O)O D0BP7C HIGHSTAT Investigative D0BV3B DRUG__ID D0BV3B D0BV3B DRUGCOMP Schering-Plough Corp D0BV3B DRUGTYPE Small molecular drug D0BV3B DRUGINCH 1S/C28H33N3O4/c1-3-34-28(33)31-21-10-11-22-19(14-21)15-24-26(17(2)35-27(24)32)23(22)12-9-20-8-7-18(16-30-20)25-6-4-5-13-29-25/h4-9,12-13,16-17,19,21-24,26H,3,10-11,14-15H2,1-2H3,(H,31,33)/b12-9+/t17-,19+,21-,22-,23+,24-,26+/m1/s1 D0BV3B DRUGINKE IHWKYASJAJITBL-MSGZWQTISA-N D0BV3B DRUGSMIL CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC=CC=N5)C(OC3=O)C D0BV3B HIGHSTAT Investigative D0BW1O DRUG__ID D0BW1O D0BW1O THERCLAS Antiviral Agents D0BW1O DRUGTYPE Small molecular drug D0BW1O DRUGINCH 1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1 D0BW1O DRUGINKE ARAIBEBZBOPLMB-UFGQHTETSA-N D0BW1O DRUGSMIL CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N D0BW1O HIGHSTAT Investigative D0C0BE DRUG__ID D0C0BE D0C0BE DRUGCOMP ViroPharma Inc D0C0BE DRUGTYPE Small molecular drug D0C0BE DRUGINCH 1S/C21H19N5OS2/c22-16-14-11-13-9-5-2-6-10-15(13)23-20(14)28-17(16)18(27)24-21-26-25-19(29-21)12-7-3-1-4-8-12/h1,3-4,7-8,11H,2,5-6,9-10,22H2,(H,24,26,27) D0C0BE DRUGINKE FGRXYHXHXBKKAK-UHFFFAOYSA-N D0C0BE DRUGSMIL C1CCC2=CC3=C(N=C2CC1)SC(=C3N)C(=O)NC4=NN=C(S4)C5=CC=CC=C5 D0C0BE HIGHSTAT Investigative D0C0ZC DRUG__ID D0C0ZC D0C0ZC DRUGCOMP AstraZeneca plc D0C0ZC DRUGTYPE Small molecular drug D0C0ZC DRUGINCH 1S/C27H25N5O2/c1-17-8-9-21(31-25(33)18-6-5-7-19(12-18)27(2,3)15-28)14-24(17)30-20-10-11-23-22(13-20)26(34)32(4)16-29-23/h5-14,16,30H,1-4H3,(H,31,33) D0C0ZC DRUGINKE ZGBGPEDJXCYQPH-UHFFFAOYSA-N D0C0ZC DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(C)(C)C#N)NC3=CC4=C(C=C3)N=CN(C4=O)C D0C0ZC HIGHSTAT Investigative D0C3ET DRUG__ID D0C3ET D0C3ET DRUGCOMP Asubio Pharma Co Ltd D0C3ET DRUGTYPE Small molecular drug D0C3ET DRUGINCH 1S/C23H29N5O2S/c1-15-19-13-20(31-23(19)28(26-15)17-5-3-2-4-6-17)22(30)25-16-7-8-21(24-14-16)27-11-9-18(29)10-12-27/h7-8,13-14,17-18,29H,2-6,9-12H2,1H3,(H,25,30) D0C3ET DRUGINKE NFWMSIMJLJHZPQ-UHFFFAOYSA-N D0C3ET DRUGSMIL CC1=NN(C2=C1C=C(S2)C(=O)NC3=CN=C(C=C3)N4CCC(CC4)O)C5CCCCC5 D0C3ET HIGHSTAT Investigative D0C4BI DRUG__ID D0C4BI D0C4BI DRUGCOMP Bristol-Myers Squibb Co D0C4BI DRUGTYPE Small molecular drug D0C4BI DRUGINCH 1S/C24H31N7O5.ClH/c1-24(2,26)22(33)27-18(15-35-13-16-8-5-4-6-9-16)21-29-28-20-11-7-10-17(31(20)21)14-36-23(34)30(3)12-19(25)32;/h4-11,18H,12-15,26H2,1-3H3,(H2,25,32)(H,27,33);1H/t18-;/m1./s1 D0C4BI DRUGINKE DFDPBEQMMOYQHK-GMUIIQOCSA-N D0C4BI DRUGSMIL CC(C)(C(=O)NC(COCC1=CC=CC=C1)C2=NN=C3N2C(=CC=C3)COC(=O)N(C)CC(=O)N)N.Cl D0C4BI HIGHSTAT Investigative D0C5JH DRUG__ID D0C5JH D0C5JH THERCLAS Antiviral Agents D0C5JH DRUGTYPE Small molecular drug D0C5JH DRUGINCH 1S/C12H21N/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12/h8-11H,2-7,13H2,1H3 D0C5JH DRUGINKE UBCHPRBFMUDMNC-UHFFFAOYSA-N D0C5JH DRUGSMIL CC(C12CC3CC(C1)CC(C3)C2)N D0C5JH HIGHSTAT Investigative D0C5WK DRUG__ID D0C5WK D0C5WK DRUGCOMP Eli Lilly & Co D0C5WK DRUGTYPE Small molecular drug D0C5WK DRUGINCH 1S/C16H21NO2S2/c1-12(2)21(18,19)17-10-13(3)14-4-6-15(7-5-14)16-8-9-20-11-16/h4-9,11-13,17H,10H2,1-3H3 D0C5WK DRUGINKE QFAUPDBCVKBKSH-UHFFFAOYSA-N D0C5WK DRUGSMIL CC(C)S(=O)(=O)NCC(C)C1=CC=C(C=C1)C2=CSC=C2 D0C5WK HIGHSTAT Investigative D0C7LA DRUG__ID D0C7LA D0C7LA DRUGCOMP Roussel Morishita Pharmaceutical Co Ltd D0C7LA DRUGTYPE Small molecular drug D0C7LA DRUGINCH 1S/C15H17N3O4/c1-3-9(2)22-12-7-5-4-6-11(12)17-15-16-8-10(14(20)21)13(19)18-15/h4-9H,3H2,1-2H3,(H,20,21)(H2,16,17,18,19) D0C7LA DRUGINKE GPASXNHOXQCREW-UHFFFAOYSA-N D0C7LA DRUGSMIL CCC(C)OC1=CC=CC=C1NC2=NC=C(C(=O)N2)C(=O)O D0C7LA HIGHSTAT Investigative D0C9KY DRUG__ID D0C9KY D0C9KY THERCLAS Antifungal Agents D0C9KY DRUGTYPE Small molecular drug D0C9KY DRUGINCH 1S/C10H7N3/c1-2-7-8(11-5-1)3-4-9-10(7)13-6-12-9/h1-6,11H D0C9KY DRUGINKE FOLSLCYDXFQZJP-UHFFFAOYSA-N D0C9KY DRUGSMIL C1=CNC2=CC=C3C(=NC=N3)C2=C1 D0C9KY HIGHSTAT Investigative D0CP8N DRUG__ID D0CP8N D0CP8N THERCLAS Antiviral Agents D0CP8N DRUGTYPE Small molecular drug D0CP8N DRUGINCH 1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25) D0CP8N DRUGINKE MUOKSQABCJCOPU-UHFFFAOYSA-N D0CP8N DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4 D0CP8N HIGHSTAT Investigative D0CR9I DRUG__ID D0CR9I D0CR9I DRUGCOMP Cylene Pharmaceuticals Inc D0CR9I DRUGTYPE Small molecular drug D0CR9I DRUGINCH 1S/C20H12N4O2.Na/c1-2-12-4-3-5-14(8-12)23-19-18-16(10-21-11-22-18)15-7-6-13(20(25)26)9-17(15)24-19;/h1,3-11H,(H,23,24)(H,25,26);/q;+1/p-1 D0CR9I DRUGINKE FSIFELDKZUCPMJ-UHFFFAOYSA-M D0CR9I DRUGSMIL C#CC1=CC(=CC=C1)NC2=NC3=C(C=CC(=C3)C(=O)[O-])C4=CN=CN=C42.[Na+] D0CR9I HIGHSTAT Investigative D0CS6N DRUG__ID D0CS6N D0CS6N DRUGCOMP Acura Pharmaceuticals Inc D0CS6N DRUGTYPE Small molecular drug D0CS6N DRUGINCH 1S/C9H8N2/c1-2-6-9-8(4-1)5-3-7-10-11-9/h1-7,11H D0CS6N DRUGINKE SVUOLADPCWQTTE-UHFFFAOYSA-N D0CS6N DRUGSMIL C1=CC=C2C(=C1)C=CC=NN2 D0CS6N HIGHSTAT Investigative D0CW3B DRUG__ID D0CW3B D0CW3B DRUGCOMP Hemarina D0CW3B DRUGTYPE Small molecular drug D0CW3B DRUGINCH 1S/C16H25NO3.ClH/c1-11(2)14-10-15(20-13(4)18)12(3)9-16(14)19-8-7-17(5)6;/h9-11H,7-8H2,1-6H3;1H D0CW3B DRUGINKE IPWGSXZCDPTDEH-UHFFFAOYSA-N D0CW3B DRUGSMIL CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCC[NH+](C)C.[Cl-] D0CW3B HIGHSTAT Investigative D0D0TQ DRUG__ID D0D0TQ D0D0TQ DRUGCOMP Swedish Orphan Biovitrum AB D0D0TQ DRUGTYPE Small molecular drug D0D0TQ DRUGINCH 1S/C17H14N6/c18-16-17(22-13-1-2-14-12(9-13)5-8-20-14)23-15(10-21-16)11-3-6-19-7-4-11/h1-10,20H,(H2,18,21)(H,22,23) D0D0TQ DRUGINKE JLRIJKVMMZEKDF-UHFFFAOYSA-N D0D0TQ DRUGSMIL C1=CC2=C(C=CN2)C=C1NC3=NC(=CN=C3N)C4=CC=NC=C4 D0D0TQ HIGHSTAT Investigative D0D1BC DRUG__ID D0D1BC D0D1BC DRUGCOMP Santhera D0D1BC DRUGTYPE Small molecular drug D0D1BC DRUGINCH 1S/C17H34O3/c1-20-17(19)15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-18/h18H,2-16H2,1H3 D0D1BC DRUGINKE AOTMRIXFFOGWDT-UHFFFAOYSA-N D0D1BC DRUGSMIL COC(=O)CCCCCCCCCCCCCCCO D0D1BC HIGHSTAT Investigative D0D1CS DRUG__ID D0D1CS D0D1CS THERCLAS Antiviral Agents D0D1CS DRUGTYPE Small molecular drug D0D1CS DRUGINCH 1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1 D0D1CS DRUGINKE LHHCSNFAOIFYRV-DOVBMPENSA-N D0D1CS DRUGSMIL CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C D0D1CS HIGHSTAT Investigative D0D1HH DRUG__ID D0D1HH D0D1HH THERCLAS Antiviral Agents D0D1HH DRUGTYPE Small molecular drug D0D1HH DRUGINCH 1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3 D0D1HH DRUGINKE OGHNVEJMJSYVRP-UHFFFAOYSA-N D0D1HH DRUGSMIL COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O D0D1HH HIGHSTAT Investigative D0D1OG DRUG__ID D0D1OG D0D1OG THERCLAS Antiviral Agents D0D1OG DRUGTYPE Small molecular drug D0D1OG DRUGINCH 1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19) D0D1OG DRUGINKE GYLDXIAOMVERTK-UHFFFAOYSA-N D0D1OG DRUGSMIL CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N D0D1OG HIGHSTAT Investigative D0D2KU DRUG__ID D0D2KU D0D2KU THERCLAS Antiviral Agents D0D2KU DRUGTYPE Small molecular drug D0D2KU DRUGINCH 1S/C23H25ClN4O2S/c1-12-13(2)31-22-19(12)20(15-7-9-16(24)10-8-15)25-17(11-18(29)30-23(4,5)6)21-27-26-14(3)28(21)22/h7-10,17H,11H2,1-6H3/t17-/m0/s1 D0D2KU DRUGINKE DNVXATUJJDPFDM-KRWDZBQOSA-N D0D2KU DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C D0D2KU HIGHSTAT Investigative D0D2PD DRUG__ID D0D2PD D0D2PD THERCLAS Antiviral Agents D0D2PD DRUGTYPE Small molecular drug D0D2PD DRUGINCH 1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28(4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3,(H,30,33) D0D2PD DRUGINKE OEDSFMUSNZDJFD-UHFFFAOYSA-N D0D2PD DRUGSMIL CCNC(=O)C1=CC2=C(N1)C(=O)N(C=C2C3=C(C=CC(=C3)C(C)(C)O)OC4=C(C=C(C=C4C)F)C)C D0D2PD HIGHSTAT Investigative D0D3CJ DRUG__ID D0D3CJ D0D3CJ DRUGCOMP Nycomed D0D3CJ DRUGTYPE Small molecular drug D0D3CJ DRUGINCH 1S/C14H14N4O/c1-19-11-6-8-15-10(9-11)4-5-13-17-12-3-2-7-16-14(12)18-13/h2-3,6-9H,4-5H2,1H3,(H,16,17,18) D0D3CJ DRUGINKE YBOCDKFRGBOOFO-UHFFFAOYSA-N D0D3CJ DRUGSMIL COC1=CC(=NC=C1)CCC2=NC3=C(N2)C=CC=N3 D0D3CJ HIGHSTAT Investigative D0D3SW DRUG__ID D0D3SW D0D3SW DRUGCOMP Abxign Inc D0D3SW DRUGTYPE Small molecular drug D0D3SW DRUGINCH 1S/C18H18BrN3O4/c19-7-17(23)20-8-15-9-22(18(24)26-15)13-4-3-12-10-25-11-14-2-1-5-21(14)16(12)6-13/h1-6,15H,7-11H2,(H,20,23)/t15-/m0/s1 D0D3SW DRUGINKE JSSIINUBMRUCIW-HNNXBMFYSA-N D0D3SW DRUGSMIL C1C(OC(=O)N1C2=CC3=C(COCC4=CC=CN43)C=C2)CNC(=O)CBr D0D3SW HIGHSTAT Investigative D0D5EW DRUG__ID D0D5EW D0D5EW DRUGCOMP Grunenthal D0D5EW DRUGTYPE Small molecular drug D0D5EW DRUGINCH 1S/C21H15Cl2FN4O/c1-11-8-13(6-7-17(11)24)26-21-25-10-12-9-14(20(29)28(2)19(12)27-21)18-15(22)4-3-5-16(18)23/h3-10H,1-2H3,(H,25,26,27) D0D5EW DRUGINKE SLCFEJAMCRLYRG-UHFFFAOYSA-N D0D5EW DRUGSMIL CC1=C(C=CC(=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl)F D0D5EW HIGHSTAT Investigative D0D6MC DRUG__ID D0D6MC D0D6MC DRUGCOMP Hydra Biosciences Inc D0D6MC DRUGTYPE Small molecular drug D0D6MC DRUGINCH 1S/C18H21N5O3/c1-11(2)12-5-7-13(8-6-12)20-14(24)9-23-10-19-16-15(23)17(25)22(4)18(26)21(16)3/h5-8,10-11H,9H2,1-4H3,(H,20,24) D0D6MC DRUGINKE HEQDZPHDVAOBLN-UHFFFAOYSA-N D0D6MC DRUGSMIL CC(C)C1=CC=C(C=C1)NC(=O)CN2C=NC3=C2C(=O)N(C(=O)N3C)C D0D6MC HIGHSTAT Investigative D0D6ZB DRUG__ID D0D6ZB D0D6ZB DRUGCOMP Kyorin Pharmaceutical Co Ltd D0D6ZB DRUGTYPE Small molecular drug D0D6ZB DRUGINCH 1S/C22H26N4O3/c1-5-14-11-16(28-4)12-18-19(14)22(27)29-21(24-18)17-7-6-9-23-20(17)26-10-8-15(13-26)25(2)3/h6-7,9,11-12,15H,5,8,10,13H2,1-4H3/t15-/m0/s1 D0D6ZB DRUGINKE RCPIMTCZGQJSGZ-HNNXBMFYSA-N D0D6ZB DRUGSMIL CCC1=C2C(=CC(=C1)OC)N=C(OC2=O)C3=C(N=CC=C3)N4CCC(C4)N(C)C D0D6ZB HIGHSTAT Investigative D0D7EK DRUG__ID D0D7EK D0D7EK DRUGCOMP Mixture Sciences Inc D0D7EK DRUGTYPE Small molecular drug D0D7EK DRUGINCH 1S/C25H35FN6S/c1-19(16-29-17-21-7-3-2-4-8-21)32-18-23(11-6-13-30-24(27)28)31(25(32)33)14-12-20-9-5-10-22(26)15-20/h2-5,7-10,15,19,23,29H,6,11-14,16-18H2,1H3,(H4,27,28,30)/t19-,23-/m0/s1 D0D7EK DRUGINKE DSJVYEAOYVHUJW-CVDCTZTESA-N D0D7EK DRUGSMIL CC(CNCC1=CC=CC=C1)N2CC(N(C2=S)CCC3=CC(=CC=C3)F)CCCN=C(N)N D0D7EK HIGHSTAT Investigative D0D8RC DRUG__ID D0D8RC D0D8RC THERCLAS Antiviral Agents D0D8RC DRUGTYPE Small molecular drug D0D8RC DRUGINCH 1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8) D0D8RC DRUGINKE XZWYZXLIPXDOLR-UHFFFAOYSA-N D0D8RC DRUGSMIL CN(C)C(=N)N=C(N)N D0D8RC HIGHSTAT Investigative D0D8SU DRUG__ID D0D8SU D0D8SU THERCLAS Antiviral Agents D0D8SU DRUGTYPE Small molecular drug D0D8SU DRUGINCH 1S/C27H28N4O3S2/c1-19-16-22(11-14-25(19)20-9-12-24(13-10-20)36(2,32)33)34-18-26-29-30-27(35-23-7-3-4-8-23)31(26)21-6-5-15-28-17-21/h5-6,9-17,23H,3-4,7-8,18H2,1-2H3 D0D8SU DRUGINKE UJGTUKMAJVCBIS-UHFFFAOYSA-N D0D8SU DRUGSMIL CC1=C(C=CC(=C1)OCC2=NN=C(N2C3=CN=CC=C3)SC4CCCC4)C5=CC=C(C=C5)S(=O)(=O)C D0D8SU HIGHSTAT Investigative D0D9CO DRUG__ID D0D9CO D0D9CO THERCLAS Analgesics D0D9CO DRUGTYPE Small molecular drug D0D9CO DRUGINCH 1S/C25H27NO.ClH/c1-25(2,19-10-5-4-6-11-19)20-13-15-21(16-14-20)27-24-22-12-8-7-9-18(22)17-23(24)26-3;/h4-16,23-24,26H,17H2,1-3H3;1H/t23-,24+;/m1./s1 D0D9CO DRUGINKE GWFDWCZMDDKZDV-ITNPDYSASA-N D0D9CO DRUGSMIL CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)OC3C(CC4=CC=CC=C34)NC.Cl D0D9CO HIGHSTAT Investigative D0DH1H DRUG__ID D0DH1H D0DH1H DRUGCOMP Cancer Research Technology Ltd D0DH1H DRUGTYPE Small molecular drug D0DH1H DRUGINCH 1S/C23H27FN4O4/c1-23(2,30)15-10-25-11-17(15)27-21-13-8-19(31-3)20(32-4)9-16(13)26-22(28-21)14-7-12(24)5-6-18(14)29/h5-9,15,17,25,29-30H,10-11H2,1-4H3,(H,26,27,28)/t15-,17-/m1/s1 D0DH1H DRUGINKE HZASIAXCPXTISQ-NVXWUHKLSA-N D0DH1H DRUGSMIL CC(C)(C1CNCC1NC2=NC(=NC3=CC(=C(C=C32)OC)OC)C4=C(C=CC(=C4)F)O)O D0DH1H HIGHSTAT Investigative D0DO0B DRUG__ID D0DO0B D0DO0B DRUGCOMP Thrombotargets Corp D0DO0B DRUGTYPE Small molecular drug D0DO0B DRUGINCH 1S/C13H19N5.ClH/c1-4-17(5-2)11(3)13-14-15-16-18(13)12-9-7-6-8-10-12;/h6-11H,4-5H2,1-3H3;1H D0DO0B DRUGINKE JSNKEZSHZQDXNE-UHFFFAOYSA-N D0DO0B DRUGSMIL CCN(CC)C(C)C1=NN=NN1C2=CC=CC=C2.Cl D0DO0B HIGHSTAT Investigative D0E5FF DRUG__ID D0E5FF D0E5FF DRUGCOMP NaniRx Inc D0E5FF DRUGTYPE Small molecular drug D0E5FF DRUGINCH 1S/Pt D0E5FF DRUGINKE BASFCYQUMIYNBI-UHFFFAOYSA-N D0E5FF DRUGSMIL [Pt] D0E5FF HIGHSTAT Investigative D0E5VP DRUG__ID D0E5VP D0E5VP DRUGCOMP Kyowa Hakko Kirin Co Ltd D0E5VP DRUGTYPE Small molecular drug D0E5VP DRUGINCH 1S/C18H22N4O5/c1-8-12(19)15(24)11-9(7-27-17(25)21-4-5-21)18(26-3)16-10(20(16)2)6-22(18)13(11)14(8)23/h9-10,16H,4-7,19H2,1-3H3 D0E5VP DRUGINKE FZLZUGFFXNJCRD-UHFFFAOYSA-N D0E5VP DRUGSMIL CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N5CC5)OC)N4C)N D0E5VP HIGHSTAT Investigative D0E6AP DRUG__ID D0E6AP D0E6AP DRUGCOMP Oregon Health Sciences University D0E6AP DRUGTYPE Small molecular drug D0E6AP DRUGINCH 1S/C9H15N3O2/c1-9(2,3)8-12-11-7(14-8)6(13)5-10-4/h10H,5H2,1-4H3 D0E6AP DRUGINKE CLBJJWUUSJAAPJ-UHFFFAOYSA-N D0E6AP DRUGSMIL CC(C)(C)C1=NN=C(O1)C(=O)CNC D0E6AP HIGHSTAT Investigative D0E7FG DRUG__ID D0E7FG D0E7FG DRUGCOMP Yantai University D0E7FG DRUGTYPE Small molecular drug D0E7FG DRUGINCH 1S/C18H14O8/c19-12-4-1-9(8-14(12)21)7-11(18(25)26)16-10(3-6-15(22)23)2-5-13(20)17(16)24/h1-8,19-21,24H,(H,22,23)(H,25,26)/b6-3+,11-7+ D0E7FG DRUGINKE OAHRXWZJURTMHG-ACIWFXKJSA-N D0E7FG DRUGSMIL C1=CC(=C(C=C1C=C(C2=C(C=CC(=C2O)O)C=CC(=O)O)C(=O)O)O)O D0E7FG HIGHSTAT Investigative D0EU1R DRUG__ID D0EU1R D0EU1R DRUGCOMP GlaxoSmithKline plc D0EU1R DRUGTYPE Small molecular drug D0EU1R DRUGINCH 1S/C25H34N8O/c1-15-8-9-17(24(34)28-18-6-4-3-5-7-18)14-33(15)22-13-20(29-25(27-2)30-22)16-10-11-19-21(12-16)31-32-23(19)26/h10-13,15,17-18H,3-9,14H2,1-2H3,(H,28,34)(H3,26,31,32)(H,27,29,30)/t15-,17+/m1/s1 D0EU1R DRUGINKE QLPHOXTXAKOFMU-WBVHZDCISA-N D0EU1R DRUGSMIL CC1CCC(CN1C2=NC(=NC(=C2)C3=CC4=C(C=C3)C(=NN4)N)NC)C(=O)NC5CCCCC5 D0EU1R HIGHSTAT Investigative D0EV6U DRUG__ID D0EV6U D0EV6U DRUGCOMP DesignMedix Inc D0EV6U DRUGTYPE Small molecular drug D0EV6U DRUGINCH 1S/C24H27BrN6O2/c1-17-4-9-22(21(25)12-17)31(11-10-26)24-13-23(27-16-28-24)29-18-5-7-20(8-6-18)33-15-19(32)14-30(2)3/h4-9,12-13,16,19,32H,11,14-15H2,1-3H3,(H,27,28,29)/t19-/m0/s1 D0EV6U DRUGINKE UUISESFNPSRBFN-IBGZPJMESA-N D0EV6U DRUGSMIL CC1=CC(=C(C=C1)N(CC#N)C2=NC=NC(=C2)NC3=CC=C(C=C3)OCC(CN(C)C)O)Br D0EV6U HIGHSTAT Investigative D0EW9U DRUG__ID D0EW9U D0EW9U DRUGCOMP Johns Hopkins University D0EW9U DRUGTYPE Small molecular drug D0EW9U DRUGINCH 1S/C18H23FN4O8/c19-13-6-4-10(9-21-13)15(26)20-8-2-1-3-11(16(27)28)22-18(31)23-12(17(29)30)5-7-14(24)25/h4,6,9,11-12H,1-3,5,7-8H2,(H,20,26)(H,24,25)(H,27,28)(H,29,30)(H2,22,23,31)/t11-,12-/m0/s1/i19-1 D0EW9U DRUGINKE OLWVRJUNLXQDSP-MVBOSPHXSA-N D0EW9U DRUGSMIL C1=CC(=NC=C1C(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)F D0EW9U HIGHSTAT Investigative D0F1PH DRUG__ID D0F1PH D0F1PH DRUGCOMP Merck KGaA D0F1PH DRUGTYPE Small molecular drug D0F1PH DRUGINCH 1S/C11H15N3O5S2/c1-6-4-8(20(2,16)17)9(21(3,18)19)5-7(6)10(15)14-11(12)13/h4-5H,1-3H3,(H4,12,13,14,15) D0F1PH DRUGINKE GROMEQPXDKRRIE-UHFFFAOYSA-N D0F1PH DRUGSMIL CC1=CC(=C(C=C1C(=O)N=C(N)N)S(=O)(=O)C)S(=O)(=O)C D0F1PH HIGHSTAT Investigative D0F3FC DRUG__ID D0F3FC D0F3FC DRUGCOMP GlaxoSmithKline plc D0F3FC DRUGTYPE Small molecular drug D0F3FC DRUGINCH 1S/C25H22N2O2/c28-25(29)20-11-10-18(12-21(20)17-8-4-5-9-17)23-15-27-24-22(23)13-19(14-26-24)16-6-2-1-3-7-16/h1-3,6-7,10-15,17H,4-5,8-9H2,(H,26,27)(H,28,29) D0F3FC DRUGINKE WVSBGSNVCDAMCF-UHFFFAOYSA-N D0F3FC DRUGSMIL C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=C3C=C(C=N4)C5=CC=CC=C5)C(=O)O D0F3FC HIGHSTAT Investigative D0F4LI DRUG__ID D0F4LI D0F4LI DRUGCOMP Universidade Federal do Rio de Janeiro D0F4LI DRUGTYPE Small molecular drug D0F4LI DRUGINCH 1S/C23H27N3O6/c1-22(2,3)15-7-13(8-16(20(15)27)23(4,5)6)11-24-25-21(28)14-9-18-19(32-12-31-18)10-17(14)26(29)30/h7-11,27H,12H2,1-6H3,(H,25,28)/b24-11+ D0F4LI DRUGINKE XEYZVZBNMMRXSN-BHGWPJFGSA-N D0F4LI DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=NNC(=O)C2=CC3=C(C=C2[N+](=O)[O-])OCO3 D0F4LI HIGHSTAT Investigative D0F4MI DRUG__ID D0F4MI D0F4MI DRUGCOMP Takeda Pharmaceutical Co Ltd D0F4MI DRUGTYPE Small molecular drug D0F4MI DRUGINCH 1S/C29H38N4O.C7H8O3S/c1-7-21-15-17-23(18-16-21)29(8-2,9-3)31-27(34)25-20(4)32-33-26(25)30-24(19-28(33,5)6)22-13-11-10-12-14-22;1-6-2-4-7(5-3-6)11(8,9)10/h10-18,24,30H,7-9,19H2,1-6H3,(H,31,34);2-5H,1H3,(H,8,9,10)/t24-;/m1./s1 D0F4MI DRUGINKE NDWLAPXXXCPRNP-GJFSDDNBSA-N D0F4MI DRUGSMIL CCC1=CC=C(C=C1)C(CC)(CC)NC(=O)C2=C3NC(CC(N3N=C2C)(C)C)C4=CC=CC=C4.CC1=CC=C(C=C1)S(=O)(=O)O D0F4MI HIGHSTAT Investigative D0F5JG DRUG__ID D0F5JG D0F5JG DRUGCOMP ActoKine Therapeutics D0F5JG DRUGTYPE Small molecular drug D0F5JG DRUGINCH 1S/C19H21N3O5S/c23-19(20-16-8-6-9-17(14-16)22(24)25)15-7-5-10-18(13-15)28(26,27)21-11-3-1-2-4-12-21/h5-10,13-14H,1-4,11-12H2,(H,20,23) D0F5JG DRUGINKE HAYBKCHPEBZNGW-UHFFFAOYSA-N D0F5JG DRUGSMIL C1CCCN(CC1)S(=O)(=O)C2=CC=CC(=C2)C(=O)NC3=CC(=CC=C3)[N+](=O)[O-] D0F5JG HIGHSTAT Investigative D0F8HX DRUG__ID D0F8HX D0F8HX THERCLAS Anticancer Agents D0F8HX DRUGTYPE Small molecular drug D0F8HX DRUGINCH 1S/C24H27NO8/c1-9-17-19(24-15(31-9)8-16(26)33-24)22(29)12-6-5-11(21(28)18(12)23(17)30)14-7-13(25(3)4)20(27)10(2)32-14/h5-6,9-10,13-15,20,24,27-28H,7-8H2,1-4H3/t9-,10-,13-,14-,15-,20-,24+/m1/s1 D0F8HX DRUGINKE NYJGMJFBEVSQNN-CNRHASOASA-N D0F8HX DRUGSMIL CC1C(C(CC(O1)C2=C(C3=C(C=C2)C(=O)C4=C(C3=O)C(OC5C4OC(=O)C5)C)O)N(C)C)O D0F8HX HIGHSTAT Investigative D0F9VF DRUG__ID D0F9VF D0F9VF THERCLAS Antiviral Agents D0F9VF DRUGTYPE Small molecular drug D0F9VF DRUGINCH 1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3 D0F9VF DRUGINKE OLBCVFGFOZPWHH-UHFFFAOYSA-N D0F9VF DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)O D0F9VF HIGHSTAT Investigative D0FF6S DRUG__ID D0FF6S D0FF6S THERCLAS Analgesics D0FF6S DRUGTYPE Small molecular drug D0FF6S DRUGINCH 1S/C19H16ClNO4/c1-23-15-9-14(10-16(11-15)24-2)21-19(22)18-8-7-17(25-18)12-3-5-13(20)6-4-12/h3-11H,1-2H3,(H,21,22) D0FF6S DRUGINKE VHKBTPQDHDSBSP-UHFFFAOYSA-N D0FF6S DRUGSMIL COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl)OC D0FF6S HIGHSTAT Investigative D0FZ4X DRUG__ID D0FZ4X D0FZ4X DRUGCOMP Antipodean Pharmaceuticals Inc D0FZ4X DRUGTYPE Small molecular drug D0FZ4X DRUGINCH 1S/C33H37NO2P.BrH/c1-33(2,3)34(35)27-28-21-23-29(24-22-28)36-25-13-14-26-37(30-15-7-4-8-16-30,31-17-9-5-10-18-31)32-19-11-6-12-20-32;/h4-12,15-24,27H,13-14,25-26H2,1-3H3;1H/q+1;/p-1/b34-27-; D0FZ4X DRUGINKE JZMWLDMVLIVXEF-KWYZZNRTSA-M D0FZ4X DRUGSMIL CC(C)(C)[N+](=CC1=CC=C(C=C1)OCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)[O-].[Br-] D0FZ4X HIGHSTAT Investigative D0G0BJ DRUG__ID D0G0BJ D0G0BJ DRUGCOMP University of Oxford D0G0BJ DRUGTYPE Small molecular drug D0G0BJ DRUGINCH 1S/C18H16N4O3S/c1-26(24,25)14-9-7-12(8-10-14)15-11-20-17(19)16(22-15)18(23)21-13-5-3-2-4-6-13/h2-11H,1H3,(H2,19,20)(H,21,23) D0G0BJ DRUGINKE DUIHHZKTCSNTGM-UHFFFAOYSA-N D0G0BJ DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N D0G0BJ HIGHSTAT Investigative D0G9FF DRUG__ID D0G9FF D0G9FF DRUGCOMP The University of Hong Kong D0G9FF DRUGTYPE Small molecular drug D0G9FF DRUGINCH 1S/C21H19ClN4O4/c1-14-19(20(23-30-14)15-5-3-2-4-6-15)21(27)25-11-9-24(10-12-25)18-8-7-16(26(28)29)13-17(18)22/h2-8,13H,9-12H2,1H3 D0G9FF DRUGINKE OWXBJAPOSQSWAO-UHFFFAOYSA-N D0G9FF DRUGSMIL CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N3CCN(CC3)C4=C(C=C(C=C4)[N+](=O)[O-])Cl D0G9FF HIGHSTAT Investigative D0GH8X DRUG__ID D0GH8X D0GH8X THERCLAS Antiviral Agents D0GH8X DRUGTYPE Small molecular drug D0GH8X DRUGINCH 1S/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/t2*2-,3-,4+,5-;/m11./s1 D0GH8X DRUGINKE ZSKINHGFQOKUDM-IYEMJOQQSA-N D0GH8X DRUGSMIL C(C(C(C(C(C(=O)O)O)O)O)O)O.C(C(C(C(C(C(=O)O)O)O)O)O)O.[Zn] D0GH8X HIGHSTAT Investigative D0GT5W DRUG__ID D0GT5W D0GT5W THERCLAS Antiviral Agents D0GT5W DRUGTYPE Small molecular drug D0GT5W DRUGINCH 1S/C49H55N9O7/c1-27(2)41(54-48(61)63-5)45(59)56-20-10-14-37(56)43-50-25-34(52-43)30-17-19-36-32(22-30)23-39-33-18-16-31(24-40(33)65-47(58(36)39)29-12-8-7-9-13-29)35-26-51-44(53-35)38-15-11-21-57(38)46(60)42(28(3)4)55-49(62)64-6/h7-9,12-13,16-19,22-28,37-38,41-42,47H,10-11,14-15,20-21H2,1-6H3,(H,50,52)(H,51,53)(H,54,61)(H,55,62)/t37-,38-,41-,42-,47-/m0/s1 D0GT5W DRUGINKE BVAZQCUMNICBAQ-PZHYSIFUSA-N D0GT5W DRUGSMIL CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC D0GT5W HIGHSTAT Investigative D0GZ8Q DRUG__ID D0GZ8Q D0GZ8Q THERCLAS Antiviral Agents D0GZ8Q DRUGTYPE Small molecular drug D0GZ8Q DRUGINCH 1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25- D0GZ8Q DRUGINKE XFCLJVABOIYOMF-QPLCGJKRSA-N D0GZ8Q DRUGSMIL CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3 D0GZ8Q HIGHSTAT Investigative D0H0BF DRUG__ID D0H0BF D0H0BF THERCLAS Antiviral Agents D0H0BF DRUGTYPE Small molecular drug D0H0BF DRUGINCH 1S/C18H12F6N6O/c19-17(20,21)12-7-11(8-13(9-12)18(22,23)24)16-26-10-30(29-16)6-4-15(31)28-27-14-3-1-2-5-25-14/h1-10H,(H,25,27)(H,28,31)/b6-4- D0H0BF DRUGINKE OPAKEJZFFCECPN-XQRVVYSFSA-N D0H0BF DRUGSMIL C1=CC=NC(=C1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0H0BF HIGHSTAT Investigative D0H0KA DRUG__ID D0H0KA D0H0KA THERCLAS Anticancer Agents D0H0KA DRUGTYPE Small molecular drug D0H0KA DRUGINCH 1S/C30H42N2O8/c1-16-10-9-11-17(2)29(35)32-23-15-21(33)14-22(25(23)34)27(38-7)20(5)13-24(37-6)28(39-8)19(4)12-18(3)26(16)40-30(31)36/h9-12,14-16,19-20,24,26-28H,13H2,1-8H3,(H2,31,36)(H,32,35) D0H0KA DRUGINKE PLTGBUPHJAKFMA-UHFFFAOYSA-N D0H0KA DRUGSMIL CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C=C(C1OC)C2=O)C)C)OC(=O)N)C)C)OC)OC D0H0KA HIGHSTAT Investigative D0H1VG DRUG__ID D0H1VG D0H1VG THERCLAS Antiviral Agents D0H1VG DRUGTYPE Small molecular drug D0H1VG DRUGINCH 1S/C42H45ClN8O7S/c1-23-24(2)59-42-35(23)37(26-13-15-27(43)16-14-26)46-29(38-49-48-25(3)50(38)42)21-33(53)44-19-8-6-4-5-7-9-20-45-34(54)22-58-31-12-10-11-28-36(31)41(57)51(40(28)56)30-17-18-32(52)47-39(30)55/h10-16,29-30H,4-9,17-22H2,1-3H3,(H,44,53)(H,45,54)(H,47,52,55)/t29-,30?/m0/s1 D0H1VG DRUGINKE JGQPZPLJOBHHBK-UFXYQILXSA-N D0H1VG DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NCCCCCCCCNC(=O)COC4=CC=CC5=C4C(=O)N(C5=O)C6CCC(=O)NC6=O)C7=CC=C(C=C7)Cl)C D0H1VG HIGHSTAT Investigative D0H3JH DRUG__ID D0H3JH D0H3JH DRUGCOMP CGI Pharmaceuticals Inc D0H3JH DRUGTYPE Small molecular drug D0H3JH DRUGINCH 1S/C34H37N5O4/c1-22-27(7-6-8-28(22)37-31(40)23-9-13-25(14-10-23)34(2,3)4)29-21-38(5)33(42)30(36-29)35-26-15-11-24(12-16-26)32(41)39-17-19-43-20-18-39/h6-16,21H,17-20H2,1-5H3,(H,35,36)(H,37,40) D0H3JH DRUGINKE JIFCFQDXHMUPGP-UHFFFAOYSA-N D0H3JH DRUGSMIL CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C(C)(C)C)C3=CN(C(=O)C(=N3)NC4=CC=C(C=C4)C(=O)N5CCOCC5)C D0H3JH HIGHSTAT Investigative D0H4BF DRUG__ID D0H4BF D0H4BF DRUGCOMP NeuroSearch A/S D0H4BF DRUGTYPE Small molecular drug D0H4BF DRUGINCH 1S/C17H15Cl2N3/c18-12-8-10-4-3-7-14(11(10)9-13(12)19)20-17-21-15-5-1-2-6-16(15)22-17/h1-2,5-6,8-9,14H,3-4,7H2,(H2,20,21,22) D0H4BF DRUGINKE JHLGZRSIUIFADK-UHFFFAOYSA-N D0H4BF DRUGSMIL C1CC(C2=CC(=C(C=C2C1)Cl)Cl)NC3=NC4=CC=CC=C4N3 D0H4BF HIGHSTAT Investigative D0H4TP DRUG__ID D0H4TP D0H4TP DRUGCOMP GlaxoSmithKline D0H4TP DRUGTYPE Small molecular drug D0H4TP DRUGINCH 1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25) D0H4TP DRUGINKE WROHEWWOCPRMIA-UHFFFAOYSA-N D0H4TP DRUGSMIL CNC(=O)C1=CN=C(C=C1)OC2=CC3=C(CCN(CC3)C4CCC4)C=C2 D0H4TP HIGHSTAT Investigative D0H4TT DRUG__ID D0H4TT D0H4TT THERCLAS Antiviral Agents D0H4TT DRUGTYPE Small molecular drug D0H4TT DRUGINCH 1S/C60H91N5O13/c1-11-43-30-37(6)60(63-55(43)72)41(10)53(70)40(9)51(78-60)33-49(69)35(4)20-14-12-15-21-36(5)50-26-17-13-16-25-48(68)39(8)54(71)45(28-27-38(7)66)56(73)62-52(34(2)3)57(74)61-47(32-42-22-18-23-44(67)31-42)58(75)65-29-19-24-46(64-65)59(76)77-50/h12-13,15-18,21-23,25,31,34-35,37,39-41,43,45-54,64,67-71H,11,14,19-20,24,26-30,32-33H2,1-10H3,(H,61,74)(H,62,73)(H,63,72)/b15-12+,17-13+,25-16+,36-21+/t35-,37-,39-,40-,41-,43-,45+,46-,47-,48-,49-,50-,51-,52-,53-,54+,60+/m0/s1 D0H4TT DRUGINKE ONJZYZYZIKTIEG-CFBQITSMSA-N D0H4TT DRUGSMIL CCC1CC(C2(C(C(C(C(O2)CC(C(C)CCC=CC=C(C)C3CC=CC=CC(C(C(C(C(=O)NC(C(=O)NC(C(=O)N4CCCC(N4)C(=O)O3)CC5=CC(=CC=C5)O)C(C)C)CCC(=O)C)O)C)O)O)C)O)C)NC1=O)C D0H4TT HIGHSTAT Investigative D0H5TU DRUG__ID D0H5TU D0H5TU DRUGCOMP Pfizer Inc D0H5TU DRUGTYPE Small molecular drug D0H5TU DRUGINCH 1S/C22H17ClFNO4/c1-13(14-2-4-15(5-3-14)22(27)28)25-21(26)19-12-16(23)6-11-20(19)29-18-9-7-17(24)8-10-18/h2-13H,1H3,(H,25,26)(H,27,28)/t13-/m0/s1 D0H5TU DRUGINKE MWBNCZHVEXULBD-ZDUSSCGKSA-N D0H5TU DRUGSMIL CC(C1=CC=C(C=C1)C(=O)O)NC(=O)C2=C(C=CC(=C2)Cl)OC3=CC=C(C=C3)F D0H5TU HIGHSTAT Investigative D0H7JC DRUG__ID D0H7JC D0H7JC DRUGCOMP Gliknik Inc D0H7JC DRUGTYPE Small molecular drug D0H7JC DRUGINCH 1S/C9H6O/c1-2-8-4-3-5-9(6-8)7-10/h1,3-7H D0H7JC DRUGINKE IGIUWNVGCVCNPV-UHFFFAOYSA-N D0H7JC DRUGSMIL C#CC1=CC=CC(=C1)C=O D0H7JC HIGHSTAT Investigative D0H7JE DRUG__ID D0H7JE D0H7JE DRUGCOMP Roche D0H7JE DRUGTYPE Small molecular drug D0H7JE DRUGINCH 1S/C19H28ClN3O5S/c1-29(25,26)22-6-9-23-7-4-13(5-8-23)2-3-16(24)14-12-15(20)17(21)19-18(14)27-10-11-28-19/h12-13,22H,2-11,21H2,1H3 D0H7JE DRUGINKE NBUGBCTWXCXBQD-UHFFFAOYSA-N D0H7JE DRUGSMIL CS(=O)(=O)NCCN1CCC(CC1)CCC(=O)C2=CC(=C(C3=C2OCCO3)N)Cl D0H7JE HIGHSTAT Investigative D0H9AJ DRUG__ID D0H9AJ D0H9AJ THERCLAS Antiviral Agents D0H9AJ DRUGTYPE Small molecular drug D0H9AJ DRUGINCH 1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1 D0H9AJ DRUGINKE NGBKFLTYGSREKK-PMACEKPBSA-N D0H9AJ DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)OCC2=CC=CC=C2 D0H9AJ HIGHSTAT Investigative D0H9HO DRUG__ID D0H9HO D0H9HO THERCLAS Antiviral Agents D0H9HO DRUGTYPE Small molecular drug D0H9HO DRUGINCH 1S/C21H34N4O4S/c1-14-13-30-21(25(14)2)24-23-20(28)18(26)17(15-9-11-29-12-10-15)22-19(27)16-7-5-3-4-6-8-16/h14-17H,3-13H2,1-2H3,(H,22,27)(H,23,28)/b24-21-/t14-,17+/m1/s1 D0H9HO DRUGINKE BTZCSXIUAFVRTE-CHGLIHOBSA-N D0H9HO DRUGSMIL CC1CSC(=NNC(=O)C(=O)C(C2CCOCC2)NC(=O)C3CCCCCC3)N1C D0H9HO HIGHSTAT Investigative D0H9XR DRUG__ID D0H9XR D0H9XR DRUGCOMP Pharmacia Corp D0H9XR DRUGTYPE Small molecular drug D0H9XR DRUGINCH 1S/C36H55N2O6S/c1-5-7-15-36(16-8-6-2)27-45(40,41)33-26-32(43-4)31(42-3)25-30(33)34(35(36)39)28-11-13-29(14-12-28)44-24-10-9-20-38-21-17-37(18-22-38)19-23-38/h11-14,25-26,34-35,39H,5-10,15-24,27H2,1-4H3/q+1/t34-,35-/m1/s1 D0H9XR DRUGINKE PHAUFFBQHZENJE-VSJLXWSYSA-N D0H9XR DRUGSMIL CCCCC1(CS(=O)(=O)C2=CC(=C(C=C2C(C1O)C3=CC=C(C=C3)OCCCC[N+]45CCN(CC4)CC5)OC)OC)CCCC D0H9XR HIGHSTAT Investigative D0HH3W DRUG__ID D0HH3W D0HH3W THERCLAS Antiviral Agents D0HH3W DRUGTYPE Small molecular drug D0HH3W DRUGINCH 1S/C23H29F4N3O5S/c1-2-17(19(31)22(33)28-16-9-10-16)30-21(32)18(12-36(34,35)11-13-3-4-13)29-20(23(25,26)27)14-5-7-15(24)8-6-14/h5-8,13,16-18,20,29H,2-4,9-12H2,1H3,(H,28,33)(H,30,32)/t17-,18-,20-/m0/s1 D0HH3W DRUGINKE PPUXXDKQNAHHON-BJLQDIEVSA-N D0HH3W DRUGSMIL CCC(C(=O)C(=O)NC1CC1)NC(=O)C(CS(=O)(=O)CC2CC2)NC(C3=CC=C(C=C3)F)C(F)(F)F D0HH3W HIGHSTAT Investigative D0HK3U DRUG__ID D0HK3U D0HK3U DRUGCOMP Amira Pharmaceuticals Inc D0HK3U DRUGTYPE Small molecular drug D0HK3U DRUGINCH 1S/C23H24F3NO4.Na/c1-3-27(22(30)15-5-6-15)13-16-12-17(23(24,25)26)7-8-18(16)19-10-14(11-21(28)29)4-9-20(19)31-2;/h4,7-10,12,15H,3,5-6,11,13H2,1-2H3,(H,28,29);/q;+1/p-1 D0HK3U DRUGINKE WFUYBZRTYBYLFG-UHFFFAOYSA-M D0HK3U DRUGSMIL CCN(CC1=C(C=CC(=C1)C(F)(F)F)C2=C(C=CC(=C2)CC(=O)[O-])OC)C(=O)C3CC3.[Na+] D0HK3U HIGHSTAT Investigative D0HR5B DRUG__ID D0HR5B D0HR5B THERCLAS Antiviral Agents D0HR5B DRUGTYPE Small molecular drug D0HR5B DRUGINCH 1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24) D0HR5B DRUGINKE NETXMUIMUZJUTB-UHFFFAOYSA-N D0HR5B DRUGSMIL CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2 D0HR5B HIGHSTAT Investigative D0HR5H DRUG__ID D0HR5H D0HR5H THERCLAS Antiviral Agents D0HR5H DRUGTYPE Small molecular drug D0HR5H DRUGINCH 1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2 D0HR5H DRUGINKE JBDGDEWWOUBZPM-UHFFFAOYSA-N D0HR5H DRUGSMIL C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O D0HR5H HIGHSTAT Investigative D0HV6R DRUG__ID D0HV6R D0HV6R THERCLAS Antiviral Agents D0HV6R DRUGTYPE Small molecular drug D0HV6R DRUGINCH 1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+ D0HV6R DRUGINKE RTGDFNSFWBGLEC-SYZQJQIISA-N D0HV6R DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)OCCN3CCOCC3)O D0HV6R HIGHSTAT Investigative D0HZ8B DRUG__ID D0HZ8B D0HZ8B THERCLAS Antiviral Agents D0HZ8B DRUGTYPE Small molecular drug D0HZ8B DRUGINCH 1S/C40H50F6N14O6/c41-39(42,43)21-13-25(57-31(61)5-1-3-9-53-37(47)48)33(65-23-7-11-51-18-23)27(15-21)59-35(63)29-17-30(56-20-55-29)36(64)60-28-16-22(40(44,45)46)14-26(34(28)66-24-8-12-52-19-24)58-32(62)6-2-4-10-54-38(49)50/h13-17,20,23-24,51-52H,1-12,18-19H2,(H,57,61)(H,58,62)(H,59,63)(H,60,64)(H4,47,48,53)(H4,49,50,54)/t23-,24-/m1/s1 D0HZ8B DRUGINKE QPDYBCZNGUJZDK-DNQXCXABSA-N D0HZ8B DRUGSMIL C1CNCC1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4OC5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N D0HZ8B HIGHSTAT Investigative D0I0TB DRUG__ID D0I0TB D0I0TB THERCLAS Antiviral Agents D0I0TB DRUGTYPE Small molecular drug D0I0TB DRUGINCH 1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3 D0I0TB DRUGINKE RHMXXJGYXNZAPX-UHFFFAOYSA-N D0I0TB DRUGSMIL CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)O D0I0TB HIGHSTAT Investigative D0I4GT DRUG__ID D0I4GT D0I4GT THERCLAS Antiviral Agents D0I4GT DRUGTYPE Small molecular drug D0I4GT DRUGINCH 1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18) D0I4GT DRUGINKE AOCCBINRVIKJHY-UHFFFAOYSA-N D0I4GT DRUGSMIL CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F D0I4GT HIGHSTAT Investigative D0I6UK DRUG__ID D0I6UK D0I6UK DRUGCOMP Memorial Sloan-Kettering Cancer Center D0I6UK DRUGTYPE Small molecular drug D0I6UK DRUGINCH 1S/C26H27Cl2N3O2/c27-9-11-31(12-10-28)13-14-33-21-16-19(18-32)15-20(17-21)29-26-22-5-1-3-7-24(22)30-25-8-4-2-6-23(25)26/h1-8,15-17,32H,9-14,18H2,(H,29,30) D0I6UK DRUGINKE SRZKWNZALGFBCW-UHFFFAOYSA-N D0I6UK DRUGSMIL C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC(=CC(=C4)CO)OCCN(CCCl)CCCl D0I6UK HIGHSTAT Investigative D0I8OE DRUG__ID D0I8OE D0I8OE THERCLAS Analgesics D0I8OE DRUGTYPE Small molecular drug D0I8OE DRUGINCH 1S/C200H312N62O57S6/c1-13-102(10)157-194(316)261-74-36-54-142(261)189(311)239-116(46-23-28-66-203)167(289)244-128(78-106-84-221-112-42-19-17-40-109(106)112)176(298)230-114(44-21-26-64-201)161(283)223-89-147(269)229-135-91-320-321-93-137-183(305)245-129(79-107-85-222-113-43-20-18-41-110(107)113)177(299)234-115(45-22-27-65-202)164(286)231-119(49-31-69-217-197(208)209)165(287)232-120(50-32-70-218-198(210)211)166(288)233-122(52-34-72-220-200(214)215)169(291)248-134(90-263)181(303)243-127(77-105-38-15-14-16-39-105)175(297)238-125(59-63-151(276)277)173(295)254-155(100(6)7)192(314)253-140(186(308)256-156(101(8)9)193(315)260-73-35-53-141(260)188(310)240-117(47-24-29-67-204)171(293)258-158(103(11)264)195(317)262-75-37-55-143(262)190(312)241-118(48-25-30-68-205)172(294)259-159(104(12)265)196(318)319)96-325-323-94-138(250-179(301)132(82-152(278)279)228-146(268)88-225-163(285)130(80-108-86-216-97-226-108)246-168(290)121(51-33-71-219-199(212)213)235-178(300)131(81-144(207)266)247-191(313)154(99(4)5)255-185(135)307)184(306)252-136(92-322-324-95-139(187(309)257-157)251-180(302)133(83-153(280)281)242-160(282)111(206)56-60-148(270)271)182(304)236-123(57-61-149(272)273)162(284)224-87-145(267)227-126(76-98(2)3)174(296)237-124(170(292)249-137)58-62-150(274)275/h14-20,38-43,84-86,97-104,111,114-143,154-159,221-222,263-265H,13,21-37,44-83,87-96,201-206H2,1-12H3,(H2,207,266)(H,216,226)(H,223,283)(H,224,284)(H,225,285)(H,227,267)(H,228,268)(H,229,269)(H,230,298)(H,231,286)(H,232,287)(H,233,288)(H,234,299)(H,235,300)(H,236,304)(H,237,296)(H,238,297)(H,239,311)(H,240,310)(H,241,312)(H,242,282)(H,243,303)(H,244,289)(H,245,305)(H,246,290)(H,247,313)(H,248,291)(H,249,292)(H,250,301)(H,251,302)(H,252,306)(H,253,314)(H,254,295)(H,255,307)(H,256,308)(H,257,309)(H,258,293)(H,259,294)(H,270,271)(H,272,273)(H,274,275)(H,276,277)(H,278,279)(H,280,281)(H,318,319)(H4,208,209,217)(H4,210,211,218)(H4,212,213,219)(H4,214,215,220) D0I8OE DRUGINKE LICLJUGDURFZIM-UHFFFAOYSA-N D0I8OE DRUGSMIL CCC(C)C1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC3CSSCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N4)CCC(=O)O)CC(C)C)CCC(=O)O)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC3=O)C(C)C)CC(=O)N)CCCNC(=N)N)CC5=CNC=N5)CC(=O)O)C(=O)NC(C(C)C)C(=O)N6CCCC6C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)N7CCCC7C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CCC(=O)O)CC8=CC=CC=C8)CO)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCCN)CC9=CNC1=CC=CC=C19)CCCCN)CC1=CNC2=CC=CC=C21)CCCCN D0I8OE HIGHSTAT Investigative D0IC6D DRUG__ID D0IC6D D0IC6D DRUGCOMP Cellceutix Corp D0IC6D DRUGTYPE Small molecular drug D0IC6D DRUGINCH 1S/C16H20N6O3/c17-16-20-14(19-10-2-3-10)13-15(21-16)22(8-18-13)11-4-1-9(5-11)7-25-12(24)6-23/h1,4,8-11,23H,2-3,5-7H2,(H3,17,19,20,21)/t9-,11+/m1/s1 D0IC6D DRUGINKE ZBBZROWQLKCFQK-KOLCDFICSA-N D0IC6D DRUGSMIL C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)COC(=O)CO D0IC6D HIGHSTAT Investigative D0IK1U DRUG__ID D0IK1U D0IK1U DRUGCOMP Taisho Pharmaceutical Co Ltd D0IK1U DRUGTYPE Small molecular drug D0IK1U DRUGINCH 1S/C21H19F2NO3/c1-2-25-18-8-10-21(20(24)12-18)27-17-6-4-16(5-7-17)26-13-14-11-15(22)3-9-19(14)23/h3-12H,2,13,24H2,1H3 D0IK1U DRUGINKE YSUBLPUJDOWYDP-UHFFFAOYSA-N D0IK1U DRUGSMIL CCOC1=CC(=C(C=C1)OC2=CC=C(C=C2)OCC3=C(C=CC(=C3)F)F)N D0IK1U HIGHSTAT Investigative D0IL1B DRUG__ID D0IL1B D0IL1B DRUGCOMP Mithridion Madison, WI D0IL1B DRUGTYPE Small molecular drug D0IL1B DRUGINCH 1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1 D0IL1B DRUGINKE ANGKOCUUWGHLCE-UHFFFAOYSA-N D0IL1B DRUGSMIL C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C D0IL1B HIGHSTAT Investigative D0IS5V DRUG__ID D0IS5V D0IS5V DRUGCOMP Targacept Inc D0IS5V DRUGTYPE Small molecular drug D0IS5V DRUGINCH 1S/C20H23N3O2/c1-13(2)21-18-15-12-14(9-10-20(3,4)24)7-8-16(15)22-19(23-18)17-6-5-11-25-17/h5-13,24H,1-4H3,(H,21,22,23) D0IS5V DRUGINKE INWQHHRLNZWEFG-UHFFFAOYSA-N D0IS5V DRUGSMIL CC(C)NC1=NC(=NC2=C1C=C(C=C2)C=CC(C)(C)O)C3=CC=CO3 D0IS5V HIGHSTAT Investigative D0J5SD DRUG__ID D0J5SD D0J5SD DRUGCOMP F Hoffmann-La Roche Ltd D0J5SD DRUGTYPE Small molecular drug D0J5SD DRUGINCH 1S/C26H24F3N3O3/c1-15-11-31(14-30-15)22-6-3-16(8-24(22)34-2)7-17-4-5-19-12-35-13-23(32(19)26(17)33)18-9-20(27)25(29)21(28)10-18/h3,6-11,14,19,23H,4-5,12-13H2,1-2H3/b17-7+/t19-,23-/m0/s1 D0J5SD DRUGINKE VHNYOQKVZQVBLC-RTCGXNAVSA-N D0J5SD DRUGSMIL CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3CCC4COCC(N4C3=O)C5=CC(=C(C(=C5)F)F)F)OC D0J5SD HIGHSTAT Investigative D0J6XO DRUG__ID D0J6XO D0J6XO DRUGCOMP Abbott D0J6XO DRUGTYPE Small molecular drug D0J6XO DRUGINCH 1S/C22H27N3O/c1-24(2)21-12-14-25(17-21)13-3-15-26-22-10-8-20(9-11-22)19-6-4-18(16-23)5-7-19/h4-11,21H,3,12-15,17H2,1-2H3/t21-/m1/s1 D0J6XO DRUGINKE FXIPXWLVYIHFEP-OAQYLSRUSA-N D0J6XO DRUGSMIL CN(C)C1CCN(C1)CCCOC2=CC=C(C=C2)C3=CC=C(C=C3)C#N D0J6XO HIGHSTAT Investigative D0JN5H DRUG__ID D0JN5H D0JN5H DRUGCOMP Symbion Discovery Inc D0JN5H DRUGTYPE Small molecular drug D0JN5H DRUGINCH 1S/C43H63N7O8S/c1-11-25(4)33-38(54)44-26(5)41(56)50-21-17-20-32(50)37(53)45-29(22-28-18-15-14-16-19-28)40-47-31(24-59-40)36(52)49-34(27(6)58-43(9,10)13-3)39(55)46-30(35(51)48-33)23-57-42(7,8)12-2/h12-16,18-19,25-27,29-34H,2-3,11,17,20-24H2,1,4-10H3,(H,44,54)(H,45,53)(H,46,55)(H,48,51)(H,49,52)/t25-,26-,27+,29-,30-,31-,32-,33-,34-/m0/s1 D0JN5H DRUGINKE UTERRJKSLJLXTA-LVPVHDLMSA-N D0JN5H DRUGSMIL CCC(C)C1C(=O)NC(C(=O)N2CCCC2C(=O)NC(C3=NC(CS3)C(=O)NC(C(=O)NC(C(=O)N1)COC(C)(C)C=C)C(C)OC(C)(C)C=C)CC4=CC=CC=C4)C D0JN5H HIGHSTAT Investigative D0JY2K DRUG__ID D0JY2K D0JY2K DRUGCOMP NeuroSearch A/S D0JY2K DRUGTYPE Small molecular drug D0JY2K DRUGINCH 1S/C15H10F6N2O3/c16-14(17,18)7-1-3-11(24)9(5-7)22-13(26)23-10-6-8(15(19,20)21)2-4-12(10)25/h1-6,24-25H,(H2,22,23,26) D0JY2K DRUGINKE NJFVQMRYJZHGME-UHFFFAOYSA-N D0JY2K DRUGSMIL C1=CC(=C(C=C1C(F)(F)F)NC(=O)NC2=C(C=CC(=C2)C(F)(F)F)O)O D0JY2K HIGHSTAT Investigative D0K0ZK DRUG__ID D0K0ZK D0K0ZK DRUGCOMP Addex Pharmaceuticals SA D0K0ZK DRUGTYPE Small molecular drug D0K0ZK DRUGINCH 1S/C20H17F2N3O2/c21-16-7-3-13(4-8-16)18-23-19(27-24-18)15-2-1-11-25(12-15)20(26)14-5-9-17(22)10-6-14/h3-10,15H,1-2,11-12H2/t15-/m0/s1 D0K0ZK DRUGINKE VXQCCZHCFBHTTD-HNNXBMFYSA-N D0K0ZK DRUGSMIL C1CC(CN(C1)C(=O)C2=CC=C(C=C2)F)C3=NC(=NO3)C4=CC=C(C=C4)F D0K0ZK HIGHSTAT Investigative D0K1YQ DRUG__ID D0K1YQ D0K1YQ DRUGCOMP Samaritan Pharmaceuticals Inc D0K1YQ DRUGTYPE Small molecular drug D0K1YQ DRUGINCH 1S/C31H37N5O5/c1-19-18-34(14-15-35(19)29(38)21-8-9-21)30(39)26(33-28(37)20-10-12-23(13-11-20)36(40)41)16-22-17-32-27-24(22)6-5-7-25(27)31(2,3)4/h5-7,10-13,17,19,21,26,32H,8-9,14-16,18H2,1-4H3,(H,33,37) D0K1YQ DRUGINKE DNDVBYOVESXLDM-UHFFFAOYSA-N D0K1YQ DRUGSMIL CC1CN(CCN1C(=O)C2CC2)C(=O)C(CC3=CNC4=C3C=CC=C4C(C)(C)C)NC(=O)C5=CC=C(C=C5)[N+](=O)[O-] D0K1YQ HIGHSTAT Investigative D0K2KR DRUG__ID D0K2KR D0K2KR THERCLAS Antiviral Agents D0K2KR DRUGTYPE Small molecular drug D0K2KR DRUGINCH 1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1 D0K2KR DRUGINKE JUKPWJGBANNWMW-VWBFHTRKSA-N D0K2KR DRUGSMIL CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC D0K2KR HIGHSTAT Investigative D0K9QQ DRUG__ID D0K9QQ D0K9QQ THERCLAS Antiviral Agents D0K9QQ DRUGTYPE Small molecular drug D0K9QQ DRUGINCH 1S/2C26H28N3.C23H16O6/c2*1-19-17-21(20(2)29(19)24-9-7-6-8-10-24)11-13-23-14-12-22-18-25(27(3)4)15-16-26(22)28(23)5;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h2*6-18H,1-5H3;1-10,24-25H,11H2,(H,26,27)(H,28,29)/q2*+1;/p-2 D0K9QQ DRUGINKE OOPDAHSJBRZRPH-UHFFFAOYSA-L D0K9QQ DRUGSMIL CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C.CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)[O-])[O-])C(=O)O D0K9QQ HIGHSTAT Investigative D0KD9F DRUG__ID D0KD9F D0KD9F THERCLAS Antiviral Agents D0KD9F DRUGTYPE Small molecular drug D0KD9F DRUGINCH 1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1 D0KD9F DRUGINKE WKRLQDKEXYKHJB-HFTRVMKXSA-N D0KD9F DRUGSMIL CC12CCC3C(=CCC4=C3C=CC(=C4)O)C1CCC2=O D0KD9F HIGHSTAT Investigative D0KP0W DRUG__ID D0KP0W D0KP0W THERCLAS Antiviral Agents D0KP0W DRUGTYPE Small molecular drug D0KP0W DRUGINCH 1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10) D0KP0W DRUGINKE NIJJYAXOARWZEE-UHFFFAOYSA-N D0KP0W DRUGSMIL CCCC(CCC)C(=O)O D0KP0W HIGHSTAT Investigative D0KW2M DRUG__ID D0KW2M D0KW2M THERCLAS Antiviral Agents D0KW2M DRUGTYPE Small molecular drug D0KW2M DRUGINCH 1S/C27H32N4O6S/c1-17(2)14-21(30-27(34)24-15-19-8-4-5-9-23(19)37-24)26(33)29-20-12-11-18(3)31(16-22(20)32)38(35,36)25-10-6-7-13-28-25/h4-10,13,15,17-18,20-21H,11-12,14,16H2,1-3H3,(H,29,33)(H,30,34)/t18-,20+,21+/m1/s1 D0KW2M DRUGINKE BWYBBMQLUKXECQ-GIVPXCGWSA-N D0KW2M DRUGSMIL CC1CCC(C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)C(CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3 D0KW2M HIGHSTAT Investigative D0L0RX DRUG__ID D0L0RX D0L0RX DRUGCOMP Abxign Inc D0L0RX DRUGTYPE Small molecular drug D0L0RX DRUGINCH 1S/C23H27N3O4/c1-2-3-4-5-8-22(27)24-13-20-14-26(23(28)30-20)18-10-9-17-15-29-16-19-7-6-11-25(19)21(17)12-18/h5-12,20H,2-4,13-16H2,1H3,(H,24,27)/b8-5+/t20-/m0/s1 D0L0RX DRUGINKE UTDQLUHWNVCYMK-FKIZTMCRSA-N D0L0RX DRUGSMIL CCCCC=CC(=O)NCC1CN(C(=O)O1)C2=CC3=C(COCC4=CC=CN43)C=C2 D0L0RX HIGHSTAT Investigative D0L1BS DRUG__ID D0L1BS D0L1BS DRUGCOMP Pfizer Inc D0L1BS DRUGTYPE Small molecular drug D0L1BS DRUGINCH 1S/C21H26ClFN4O2/c1-25(2)20(28)16(12-27-13-17(22)10-24-27)11-26-7-5-21(6-8-26)19-9-18(23)4-3-15(19)14-29-21/h3-4,9-10,13,16H,5-8,11-12,14H2,1-2H3 D0L1BS DRUGINKE BVXVLXUGXQOMEP-UHFFFAOYSA-N D0L1BS DRUGSMIL CN(C)C(=O)C(CN1CCC2(CC1)C3=C(CO2)C=CC(=C3)F)CN4C=C(C=N4)Cl D0L1BS HIGHSTAT Investigative D0L2XO DRUG__ID D0L2XO D0L2XO DRUGCOMP Biomol D0L2XO DRUGTYPE Small molecular drug D0L2XO DRUGINCH 1S/C10H9NO2S/c1-9-3-5-10(6-4-9)14(12,13)8-2-7-11/h2-6,8H,1H3/b8-2+ D0L2XO DRUGINKE DOEWDSDBFRHVAP-KRXBUXKQSA-N D0L2XO DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C=CC#N D0L2XO HIGHSTAT Investigative D0L8YY DRUG__ID D0L8YY D0L8YY DRUGCOMP SRI International D0L8YY DRUGTYPE Small molecular drug D0L8YY DRUGINCH 1S/C22H25N3O/c26-22-23-19-10-4-5-11-21(19)25(22)18-13-14-24-17(15-18)9-6-12-20(24)16-7-2-1-3-8-16/h1-5,7-8,10-11,17-18,20H,6,9,12-15H2,(H,23,26)/t17-,18-,20+/m1/s1 D0L8YY DRUGINKE KMUYAJQKQQUKSQ-GGPKGHCWSA-N D0L8YY DRUGSMIL C1CC2CC(CCN2C(C1)C3=CC=CC=C3)N4C5=CC=CC=C5NC4=O D0L8YY HIGHSTAT Investigative D0L9TQ DRUG__ID D0L9TQ D0L9TQ THERCLAS Antiviral Agents D0L9TQ DRUGTYPE Small molecular drug D0L9TQ DRUGINCH 1S/C35H48N6O8/c1-20(2)16-27(39-35(47)30(21(3)4)40-31(43)23(6)37-34(46)28-17-22(5)49-41-28)33(45)38-26(18-25-14-15-36-32(25)44)12-13-29(42)48-19-24-10-8-7-9-11-24/h7-13,17,20-21,23,25-27,30H,14-16,18-19H2,1-6H3,(H,36,44)(H,37,46)(H,38,45)(H,39,47)(H,40,43)/b13-12-/t23-,25-,26+,27-,30-/m0/s1 D0L9TQ DRUGINKE IDBWWEGDLCFCTD-NQJFWITJSA-N D0L9TQ DRUGSMIL CC1=CC(=NO1)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC2CCNC2=O)C=CC(=O)OCC3=CC=CC=C3 D0L9TQ HIGHSTAT Investigative D0LC0Q DRUG__ID D0LC0Q D0LC0Q THERCLAS Antiviral Agents D0LC0Q DRUGTYPE Small molecular drug D0LC0Q DRUGINCH 1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1 D0LC0Q DRUGINKE WXJFKKQWPMNTIM-VWLOTQADSA-N D0LC0Q DRUGSMIL CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O D0LC0Q HIGHSTAT Investigative D0LI3A DRUG__ID D0LI3A D0LI3A DRUGCOMP Gene Signal SAS D0LI3A DRUGTYPE Small molecular drug D0LI3A DRUGINCH 1S/C15H14FN3O3S/c16-13-8-12(23(17,21)22)6-7-14(13)19-10-18(9-15(19)20)11-4-2-1-3-5-11/h1-8H,9-10H2,(H2,17,21,22) D0LI3A DRUGINKE KNRSNEGKENASLR-UHFFFAOYSA-N D0LI3A DRUGSMIL C1C(=O)N(CN1C2=CC=CC=C2)C3=C(C=C(C=C3)S(=O)(=O)N)F D0LI3A HIGHSTAT Investigative D0LJ7R DRUG__ID D0LJ7R D0LJ7R DRUGCOMP Vascular Laboratory Inc D0LJ7R DRUGTYPE Small molecular drug D0LJ7R DRUGINCH 1S/C17H12F3N3O2S2/c18-17(19,20)16-13-9-26-14-4-2-1-3-12(14)15(13)23(22-16)10-5-7-11(8-6-10)27(21,24)25/h1-8H,9H2,(H2,21,24,25) D0LJ7R DRUGINKE ACFQQDXFCVFBIX-UHFFFAOYSA-N D0LJ7R DRUGSMIL C1C2=C(C3=CC=CC=C3S1)N(N=C2C(F)(F)F)C4=CC=C(C=C4)S(=O)(=O)N D0LJ7R HIGHSTAT Investigative D0LP7W DRUG__ID D0LP7W D0LP7W DRUGCOMP GlaxoSmithKline plc D0LP7W DRUGTYPE Small molecular drug D0LP7W DRUGINCH 1S/C14H14N4O2S/c1-9-12(21-13-15-8-16-18(9)13)10(2)20-14(19)17-11-6-4-3-5-7-11/h3-8,10H,1-2H3,(H,17,19)/t10-/m1/s1 D0LP7W DRUGINKE AOUUMBPBMVOBSP-SNVBAGLBSA-N D0LP7W DRUGSMIL CC1=C(SC2=NC=NN12)C(C)OC(=O)NC3=CC=CC=C3 D0LP7W HIGHSTAT Investigative D0M1OU DRUG__ID D0M1OU D0M1OU DRUGCOMP Xenon Pharmaceuticals Inc D0M1OU DRUGTYPE Small molecular drug D0M1OU DRUGINCH 1S/C21H21NO4/c1-2-3-6-9-22-16-8-5-4-7-14(16)21(20(22)23)12-24-17-11-19-18(10-15(17)21)25-13-26-19/h4-5,7-8,10-11H,2-3,6,9,12-13H2,1H3 D0M1OU DRUGINKE PHMRUZIIERITEP-UHFFFAOYSA-N D0M1OU DRUGSMIL CCCCCN1C2=CC=CC=C2C3(C1=O)COC4=CC5=C(C=C34)OCO5 D0M1OU HIGHSTAT Investigative D0M2LD DRUG__ID D0M2LD D0M2LD DRUGCOMP Merck & Co Inc D0M2LD DRUGTYPE Small molecular drug D0M2LD DRUGINCH 1S/C18H15NO4/c1-23-13-8-6-12(7-9-13)10-19-11-15(18(21)22)17(20)14-4-2-3-5-16(14)19/h2-9,11H,10H2,1H3,(H,21,22) D0M2LD DRUGINKE BZBBTGCKPRSPGF-UHFFFAOYSA-N D0M2LD DRUGSMIL COC1=CC=C(C=C1)CN2C=C(C(=O)C3=CC=CC=C32)C(=O)O D0M2LD HIGHSTAT Investigative D0M3AR DRUG__ID D0M3AR D0M3AR DRUGCOMP Merck Research Laboratories D0M3AR DRUGTYPE Small molecular drug D0M3AR DRUGINCH 1S/C24H20BrClN2O/c1-2-13-29-23-8-5-18(25)14-20(23)21-15-22(16-3-6-19(26)7-4-16)28-24(21)17-9-11-27-12-10-17/h3-12,14-15,28H,2,13H2,1H3 D0M3AR DRUGINKE HHBOWXZOLYQFNY-UHFFFAOYSA-N D0M3AR DRUGSMIL CCCOC1=C(C=C(C=C1)Br)C2=C(NC(=C2)C3=CC=C(C=C3)Cl)C4=CC=NC=C4 D0M3AR HIGHSTAT Investigative D0M6TA DRUG__ID D0M6TA D0M6TA DRUGCOMP Lek Pharmaceutical and Chemical Co DD D0M6TA DRUGTYPE Small molecular drug D0M6TA DRUGINCH 1S/C14H17NO4/c1-3-7-11-8-5-4-6-9(19-2)10(8)12(14(17)18)15(11)13(7)16/h3,8-9,11H,4-6H2,1-2H3,(H,17,18)/b7-3+/t8-,9-,11-/m0/s1 D0M6TA DRUGINKE ACQFJWSLWQLLIA-PLWQYUFKSA-N D0M6TA DRUGSMIL CC=C1C2C3CCCC(C3=C(N2C1=O)C(=O)O)OC D0M6TA HIGHSTAT Investigative D0M7NA DRUG__ID D0M7NA D0M7NA DRUGCOMP Abbott D0M7NA THERCLAS Analgesics D0M7NA DRUGINCH 1S/C19H17ClF3N3O/c1-12-11-26(17-16(20)3-2-9-24-17)10-8-15(12)18(27)25-14-6-4-13(5-7-14)19(21,22)23/h2-9,12H,10-11H2,1H3,(H,25,27)/t12-/m1/s1 D0M7NA DRUGINKE IYXRQYVHUISAIP-GFCCVEGCSA-N D0M7NA DRUGSMIL CC1CN(CC=C1C(=O)NC2=CC=C(C=C2)C(F)(F)F)C3=C(C=CC=N3)Cl D0M7NA HIGHSTAT Investigative D0M8FF DRUG__ID D0M8FF D0M8FF DRUGCOMP Drexel University D0M8FF DRUGTYPE Small molecular drug D0M8FF DRUGINCH 1S/C17H33NO5/c19-12-13-15(21)16(22)14(20)11-18(13)10-6-2-5-9-17(23)7-3-1-4-8-17/h13-16,19-23H,1-12H2/t13-,14+,15-,16-/m1/s1 D0M8FF DRUGINKE FQNCRPHSICYZQC-QKPAOTATSA-N D0M8FF DRUGSMIL C1CCC(CC1)(CCCCCN2CC(C(C(C2CO)O)O)O)O D0M8FF HIGHSTAT Investigative D0MI0Q DRUG__ID D0MI0Q D0MI0Q THERCLAS Antiviral Agents D0MI0Q DRUGTYPE Small molecular drug D0MI0Q DRUGINCH 1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1 D0MI0Q DRUGINKE XGVJWXAYKUHDOO-DANNLKNASA-N D0MI0Q DRUGSMIL C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 D0MI0Q HIGHSTAT Investigative D0MP2S DRUG__ID D0MP2S D0MP2S DRUGCOMP Taiho Pharmaceutical Co Ltd D0MP2S DRUGTYPE Small molecular drug D0MP2S DRUGINCH 1S/C24H24ClN3O4/c1-30-20-11-13-10-19(27-21(13)23(32-3)22(20)31-2)24(29)28-18-12-17(26)15-7-5-4-6-14(15)16(18)8-9-25/h4-7,10-12,27H,8-9,26H2,1-3H3,(H,28,29) D0MP2S DRUGINKE MNFPZBOQEWMBOK-UHFFFAOYSA-N D0MP2S DRUGSMIL COC1=C(C(=C2C(=C1)C=C(N2)C(=O)NC3=C(C4=CC=CC=C4C(=C3)N)CCCl)OC)OC D0MP2S HIGHSTAT Investigative D0N3NI DRUG__ID D0N3NI D0N3NI DRUGCOMP Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd D0N3NI DRUGTYPE Small molecular drug D0N3NI DRUGINCH 1S/C30H30N4O4/c1-15-9-20-12-25-17(3)21(5-7-29(35)36)27(33-25)14-28-22(6-8-30(37)38)18(4)26(34-28)13-24-16(2)10-19(32-24)11-23(15)31-20/h9-14,31-32H,5-8H2,1-4H3,(H,35,36)(H,37,38) D0N3NI DRUGINKE VAJVGAQAYOAJQI-UHFFFAOYSA-N D0N3NI DRUGSMIL CC1=CC2=CC3=C(C=C(N3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)O)CCC(=O)O)C)C D0N3NI HIGHSTAT Investigative D0N3OH DRUG__ID D0N3OH D0N3OH DRUGCOMP Abbott D0N3OH DRUGTYPE Small molecular drug D0N3OH DRUGINCH 1S/C25H31N3O5/c1-18(26-24(30)22-4-2-16-33-22)25(31)28-14-12-27(13-15-28)11-3-17-32-21-9-7-20(8-10-21)23(29)19-5-6-19/h2,4,7-10,16,18-19H,3,5-6,11-15,17H2,1H3,(H,26,30)/t18-/m1/s1 D0N3OH DRUGINKE RTRADBQSZJIRMT-GOSISDBHSA-N D0N3OH DRUGSMIL CC(C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)NC(=O)C4=CC=CO4 D0N3OH HIGHSTAT Investigative D0N5SW DRUG__ID D0N5SW D0N5SW DRUGCOMP Kirin Brewery Co Ltd D0N5SW DRUGTYPE Small molecular drug D0N5SW DRUGINCH 1S/C17H16O7/c1-8-4-11(19)15(12(20)5-8)16(21)14-10(17(22)24-3)6-9(18)7-13(14)23-2/h4-7,18-20H,1-3H3 D0N5SW DRUGINKE YJRLSCDUYLRBIZ-UHFFFAOYSA-N D0N5SW DRUGSMIL CC1=CC(=C(C(=C1)O)C(=O)C2=C(C=C(C=C2OC)O)C(=O)OC)O D0N5SW HIGHSTAT Investigative D0N6FZ DRUG__ID D0N6FZ D0N6FZ DRUGCOMP Wyeth D0N6FZ DRUGTYPE Small molecular drug D0N6FZ DRUGINCH 1S/C23H25N3O2/c27-23-24-20-8-3-9-21(22(20)28-23)26-15-13-25(14-16-26)12-4-6-18-11-10-17-5-1-2-7-19(17)18/h1-3,5,7-9,11H,4,6,10,12-16H2,(H,24,27) D0N6FZ DRUGINKE NBEGULJEDOLHOO-UHFFFAOYSA-N D0N6FZ DRUGSMIL C1CN(CCN1CCCC2=CCC3=CC=CC=C32)C4=CC=CC5=C4OC(=O)N5 D0N6FZ HIGHSTAT Investigative D0N6KO DRUG__ID D0N6KO D0N6KO DRUGCOMP Merck & Co Inc D0N6KO DRUGTYPE Small molecular drug D0N6KO DRUGINCH 1S/C33H41ClN6O2/c34-28-12-10-24(11-13-28)18-30(38-31(41)29-19-25-6-4-5-7-26(25)20-36-29)32(42)39-16-14-33(15-17-39,21-40-23-35-22-37-40)27-8-2-1-3-9-27/h4-7,10-13,22-23,27,29-30,36H,1-3,8-9,14-21H2,(H,38,41)/t29-,30-/m1/s1 D0N6KO DRUGINKE HLCHESOMJVGDSJ-LOYHVIPDSA-N D0N6KO DRUGSMIL C1CCC(CC1)C2(CCN(CC2)C(=O)C(CC3=CC=C(C=C3)Cl)NC(=O)C4CC5=CC=CC=C5CN4)CN6C=NC=N6 D0N6KO HIGHSTAT Investigative D0N8NN DRUG__ID D0N8NN D0N8NN DRUGCOMP University of Virginia D0N8NN DRUGTYPE Small molecular drug D0N8NN DRUGINCH 1S/C14H23N5O3/c1-9(20)6-4-5-7-19-13(21)11-12(18(3)14(19)22)17-10(16-11)8-15-2/h9,15,20H,4-8H2,1-3H3,(H,16,17)/t9-/m1/s1 D0N8NN DRUGINKE BVMJUQHSWLWOAD-SECBINFHSA-N D0N8NN DRUGSMIL CC(CCCCN1C(=O)C2=C(N=C(N2)CNC)N(C1=O)C)O D0N8NN HIGHSTAT Investigative D0NH1E DRUG__ID D0NH1E D0NH1E DRUGCOMP University of California D0NH1E DRUGTYPE Small molecular drug D0NH1E DRUGINCH 1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24) D0NH1E DRUGINKE ROFVXGGUISEHAM-UHFFFAOYSA-N D0NH1E DRUGSMIL C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N D0NH1E HIGHSTAT Investigative D0NJ3Q DRUG__ID D0NJ3Q D0NJ3Q DRUGCOMP Gatekeeper Pharmaceuticals Inc D0NJ3Q DRUGTYPE Small molecular drug D0NJ3Q DRUGINCH 1S/C24H25ClN6O2/c1-3-22(32)27-18-5-4-6-20(15-18)33-23-21(25)16-26-24(29-23)28-17-7-9-19(10-8-17)31-13-11-30(2)12-14-31/h3-10,15-16H,1,11-14H2,2H3,(H,27,32)(H,26,28,29) D0NJ3Q DRUGINKE APHGZZPEOCCYNO-UHFFFAOYSA-N D0NJ3Q DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl D0NJ3Q HIGHSTAT Investigative D0NS9C DRUG__ID D0NS9C D0NS9C DRUGCOMP Boehringer Ingelheim Corp D0NS9C DRUGTYPE Small molecular drug D0NS9C DRUGINCH 1S/C18H21N5O5S.CH4O3S/c1-29(26,27)15-11-12(16(24)21-18(19)20)4-5-13(15)22-6-8-23(9-7-22)17(25)14-3-2-10-28-14;1-5(2,3)4/h2-5,10-11H,6-9H2,1H3,(H4,19,20,21,24);1H3,(H,2,3,4) D0NS9C DRUGINKE CIZHNWRBNREPCL-UHFFFAOYSA-N D0NS9C DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)C(=O)N=C(N)N)N2CCN(CC2)C(=O)C3=CC=CO3.CS(=O)(=O)O D0NS9C HIGHSTAT Investigative D0NY1R DRUG__ID D0NY1R D0NY1R DRUGCOMP Amylin Pharmaceuticals Inc D0NY1R DRUGTYPE Small molecular drug D0NY1R DRUGINCH 1S/C5H3BrClN/c6-5-2-1-4(7)3-8-5/h1-3H D0NY1R DRUGINKE BZUUVQCSPHPUQA-UHFFFAOYSA-N D0NY1R DRUGSMIL C1=CC(=NC=C1Cl)Br D0NY1R HIGHSTAT Investigative D0O0RY DRUG__ID D0O0RY D0O0RY DRUGCOMP Chiron D0O0RY DRUGTYPE Small molecular drug D0O0RY DRUGINCH 1S/C28H50O3/c1-5-6-8-21(14-16-29)19(2)25-12-13-26-22(9-7-15-28(25,26)4)10-11-23-17-24(30)18-27(31)20(23)3/h19,21-22,24-27,29-31H,5-18H2,1-4H3/t19-,21+,22?,24-,25-,26+,27+,28-/m1/s1 D0O0RY DRUGINKE DHZOGFADXFKXSH-PMMQCNKASA-N D0O0RY DRUGSMIL CCCCC(CCO)C(C)C1CCC2C1(CCCC2CCC3=C(C(CC(C3)O)O)C)C D0O0RY HIGHSTAT Investigative D0O3SA DRUG__ID D0O3SA D0O3SA DRUGCOMP Pennsylvania State University D0O3SA DRUGTYPE Small molecular drug D0O3SA DRUGINCH 1S/C24H25N7O3/c1-3-12-30-21-19(23(33)31(24(30)34)17-8-9-17)27-20(28-21)15-7-10-18(26-14-15)29(4-2)22(32)16-6-5-11-25-13-16/h5-7,10-11,13-14,17H,3-4,8-9,12H2,1-2H3,(H,27,28) D0O3SA DRUGINKE WULKGVCEOREGQF-UHFFFAOYSA-N D0O3SA DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)C3CC3)NC(=N2)C4=CN=C(C=C4)N(CC)C(=O)C5=CN=CC=C5 D0O3SA HIGHSTAT Investigative D0O3YA DRUG__ID D0O3YA D0O3YA DRUGCOMP Morria Biopharmaceuticals plc D0O3YA DRUGTYPE Small molecular drug D0O3YA DRUGINCH 1S/C13H20N5O7P/c1-2-3-23-26(21,22)24-4-7-9(19)10(20)13(25-7)18-6-17-8-11(14)15-5-16-12(8)18/h5-7,9-10,13,19-20H,2-4H2,1H3,(H,21,22)(H2,14,15,16)/t7-,9-,10-,13-/m1/s1 D0O3YA DRUGINKE XAMXMSZRQHPMRX-QYVSTXNMSA-N D0O3YA DRUGSMIL CCCOP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0O3YA HIGHSTAT Investigative D0O8AR DRUG__ID D0O8AR D0O8AR DRUGCOMP AstraZeneca plc D0O8AR DRUGTYPE Small molecular drug D0O8AR DRUGINCH 1S/C17H19ClFN7O/c1-9(2)27-15-6-14(25-26-15)23-16-12(18)8-21-17(24-16)22-10(3)13-5-4-11(19)7-20-13/h4-10H,1-3H3,(H3,21,22,23,24,25,26)/t10-/m0/s1 D0O8AR DRUGINKE LBVKEEFIPBQIMD-JTQLQIEISA-N D0O8AR DRUGSMIL CC(C)OC1=NNC(=C1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=C3)F D0O8AR HIGHSTAT Investigative D0O8SS DRUG__ID D0O8SS D0O8SS DRUGCOMP Strox Biopharmaceuticals LLC D0O8SS DRUGTYPE Small molecular drug D0O8SS DRUGINCH 1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3/p+1 D0O8SS DRUGINKE BCZUAADEACICHN-UHFFFAOYSA-O D0O8SS DRUGSMIL C[N+]1=CC(=CN1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2 D0O8SS HIGHSTAT Investigative D0O8TE DRUG__ID D0O8TE D0O8TE DRUGCOMP Universidade Federal do Rio de Janeiro D0O8TE DRUGTYPE Small molecular drug D0O8TE DRUGINCH 1S/C18H13N3O3/c22-18(16-8-7-14-3-1-2-4-15(14)11-16)20-19-12-13-5-9-17(10-6-13)21(23)24/h1-12H,(H,20,22)/b19-12+ D0O8TE DRUGINKE RUQCGNRXDVIDAJ-XDHOZWIPSA-N D0O8TE DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)NN=CC3=CC=C(C=C3)[N+](=O)[O-] D0O8TE HIGHSTAT Investigative D0P0DA DRUG__ID D0P0DA D0P0DA DRUGCOMP Boehringer Mannheim GmbH D0P0DA DRUGTYPE Small molecular drug D0P0DA DRUGINCH 1S/C11H10O4/c12-8-1-4-10(5-2-8)7-11(15-10)6-3-9(13)14-11/h1-2,4-5H,3,6-7H2 D0P0DA DRUGINKE CAZSBBDSSNQJGI-UHFFFAOYSA-N D0P0DA DRUGSMIL C1CC2(CC3(O2)C=CC(=O)C=C3)OC1=O D0P0DA HIGHSTAT Investigative D0P3QR DRUG__ID D0P3QR D0P3QR DRUGCOMP Kukje Pharmaceuticals D0P3QR DRUGTYPE Small molecular drug D0P3QR DRUGINCH 1S/C6H7NO/c8-6-4-5-2-1-3-7(5)6/h1,3,5H,2,4H2/t5-/m1/s1 D0P3QR DRUGINKE YZBQHRLRFGPBSL-RXMQYKEDSA-N D0P3QR DRUGSMIL C1C=CN2C1CC2=O D0P3QR HIGHSTAT Investigative D0P7BQ DRUG__ID D0P7BQ D0P7BQ DRUGCOMP Meiji Seika Kaisha Ltd D0P7BQ DRUGTYPE Small molecular drug D0P7BQ DRUGINCH 1S/C15H23NO5/c1-6-8(2)7-9(3)11(17)10-12(18)13(20-4)15(21-5)16-14(10)19/h8-9H,6-7H2,1-5H3,(H2,16,18,19)/t8-,9+/m1/s1 D0P7BQ DRUGINKE UQWHXKHYKUVKKD-BDAKNGLRSA-N D0P7BQ DRUGSMIL CCC(C)CC(C)C(=O)C1=C(C(=C(NC1=O)OC)OC)O D0P7BQ HIGHSTAT Investigative D0P7HI DRUG__ID D0P7HI D0P7HI DRUGCOMP Accera Inc D0P7HI DRUGTYPE Small molecular drug D0P7HI DRUGINCH 1S/C19H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22-18-15-14-17(23-18)19(20)21/h14-15H,2-13,16H2,1H3,(H,20,21) D0P7HI DRUGINKE CZRCFAOMWRAFIC-UHFFFAOYSA-N D0P7HI DRUGSMIL CCCCCCCCCCCCCCOC1=CC=C(O1)C(=O)O D0P7HI HIGHSTAT Investigative D0P9XE DRUG__ID D0P9XE D0P9XE DRUGCOMP Trius Therapeutics Inc D0P9XE DRUGTYPE Small molecular drug D0P9XE DRUGINCH 1S/C20H17N7S/c1-10-7-15-16(8-11(10)2)27(18(24-15)19-23-5-6-28-19)12-3-4-13-14(9-12)25-20(22)26-17(13)21/h3-9H,1-2H3,(H4,21,22,25,26) D0P9XE DRUGINKE RLRIWYVVMLSWOC-UHFFFAOYSA-N D0P9XE DRUGSMIL CC1=CC2=C(C=C1C)N(C(=N2)C3=NC=CS3)C4=CC5=C(C=C4)C(=NC(=N5)N)N D0P9XE HIGHSTAT Investigative D0PC8Q DRUG__ID D0PC8Q D0PC8Q DRUGCOMP Morria Biopharmaceuticals plc D0PC8Q DRUGTYPE Small molecular drug D0PC8Q DRUGINCH 1S/C2H3ClO2/c1-5-2(3)4/h1H3 D0PC8Q DRUGINKE XMJHPCRAQCTCFT-UHFFFAOYSA-N D0PC8Q DRUGSMIL COC(=O)Cl D0PC8Q HIGHSTAT Investigative D0PD0F DRUG__ID D0PD0F D0PD0F DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D0PD0F DRUGTYPE Small molecular drug D0PD0F DRUGINCH 1S/C23H28O11/c1-20-9-22(29)13-7-23(20,32-18-16(27)15(26)14(25)12(8-24)31-18)21(13,19(33-20)34-22)10-30-17(28)11-5-3-2-4-6-11/h2-6,12-16,18-19,24-27,29H,7-10H2,1H3/t12-,13-,14-,15+,16-,18+,19-,20+,21+,22-,23+/m1/s1 D0PD0F DRUGINKE YKRGDOXKVOZESV-WRJNSLSBSA-N D0PD0F DRUGSMIL CC12CC3(C4CC1(C4(C(O2)O3)COC(=O)C5=CC=CC=C5)OC6C(C(C(C(O6)CO)O)O)O)O D0PD0F HIGHSTAT Investigative D0PE8P DRUG__ID D0PE8P D0PE8P THERCLAS Analgesics D0PE8P DRUGTYPE Small molecular drug D0PE8P DRUGINCH 1S/C38H53N3O3/c1-27(2)23-34(41(9)25-29-15-19-31(20-16-29)37(3,4)5)36(43)39-33(35(42)40-38(6,7)8)24-28-17-21-32(22-18-28)44-26-30-13-11-10-12-14-30/h10-22,27,33-34H,23-26H2,1-9H3,(H,39,43)(H,40,42)/t33-,34-/m0/s1 D0PE8P DRUGINKE GCDHMGROXQUFNR-HEVIKAOCSA-N D0PE8P DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)C(=O)NC(C)(C)C)N(C)CC3=CC=C(C=C3)C(C)(C)C D0PE8P HIGHSTAT Investigative D0PG7V DRUG__ID D0PG7V D0PG7V THERCLAS Antiviral Agents D0PG7V DRUGTYPE Small molecular drug D0PG7V DRUGINCH 1S/C29H44O12/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-/m0/s1 D0PG7V DRUGINKE LPMXVESGRSUGHW-HBYQJFLCSA-N D0PG7V DRUGSMIL CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O D0PG7V HIGHSTAT Investigative D0PL2Q DRUG__ID D0PL2Q D0PL2Q DRUGCOMP Health Research Inc D0PL2Q DRUGTYPE Small molecular drug D0PL2Q DRUGINCH 1S/C46H87N3O13P2S.2Na/c1-3-5-7-9-11-13-15-17-18-19-21-23-25-27-29-31-35-65-38-39(60-42(50)32-30-28-26-24-22-20-16-14-12-10-8-6-4-2)36-58-63(54,55)62-64(56,57)59-37-40-43(51)44(52)45(61-40)49-34-33-41(47)48-46(49)53;;/h33-34,39-40,43-45,51-52H,3-32,35-38H2,1-2H3,(H,54,55)(H,56,57)(H2,47,48,53);;/q;2*+1/t39?,40-,43-,44+,45-;;/m1../s1 D0PL2Q DRUGINKE IOJAKVFOYVOQAC-YOCDIIJISA-N D0PL2Q DRUGSMIL CCCCCCCCCCCCCCCCCCSCC(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O)OC(=O)CCCCCCCCCCCCCCC.[Na+].[Na+] D0PL2Q HIGHSTAT Investigative D0PP5M DRUG__ID D0PP5M D0PP5M DRUGCOMP AuricX Pharmaceuticals Inc D0PP5M DRUGTYPE Small molecular drug D0PP5M DRUGINCH 1S/C16H19O7PS.3K/c17-24(18,19)16(25(20,21)22)11-5-7-13-6-4-10-15(12-13)23-14-8-2-1-3-9-14;;;/h1-4,6,8-10,12,16H,5,7,11H2,(H2,17,18,19)(H,20,21,22);;;/q;3*+1/p-3 D0PP5M DRUGINKE DRADVLDMPYYQDB-UHFFFAOYSA-K D0PP5M DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-].[K+].[K+].[K+] D0PP5M HIGHSTAT Investigative D0Q4BI DRUG__ID D0Q4BI D0Q4BI DRUGCOMP DesignMedix Inc D0Q4BI DRUGTYPE Small molecular drug D0Q4BI DRUGINCH 1S/C7H3Cl3O2/c8-3-1-2-4(9)6(10)5(3)7(11)12/h1-2H,(H,11,12) D0Q4BI DRUGINKE XZIDTOHMJBOSOX-UHFFFAOYSA-N D0Q4BI DRUGSMIL C1=CC(=C(C(=C1Cl)C(=O)O)Cl)Cl D0Q4BI HIGHSTAT Investigative D0Q4EQ DRUG__ID D0Q4EQ D0Q4EQ DRUGCOMP Johnson & Johnson D0Q4EQ DRUGTYPE Small molecular drug D0Q4EQ DRUGINCH 1S/C15H17ClN6O3/c1-3-18-15(23)22-12-5-4-9(6-11(12)16)25-14-10(7-21-24-2)13(17)19-8-20-14/h4-8H,3H2,1-2H3,(H2,17,19,20)(H2,18,22,23)/b21-7+ D0Q4EQ DRUGINKE BJHCYTJNPVGSBZ-QPSGOUHRSA-N D0Q4EQ DRUGSMIL CCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC(=C2C=NOC)N)Cl D0Q4EQ HIGHSTAT Investigative D0Q4MO DRUG__ID D0Q4MO D0Q4MO DRUGCOMP Proteolix Inc D0Q4MO DRUGTYPE Small molecular drug D0Q4MO DRUGINCH 1S/C31H40N4O7/c1-21(32-27(36)19-35-13-15-41-16-14-35)29(38)34-26(18-23-9-11-24(40-3)12-10-23)30(39)33-25(28(37)31(2)20-42-31)17-22-7-5-4-6-8-22/h4-12,21,25-26H,13-20H2,1-3H3,(H,32,36)(H,33,39)(H,34,38)/t21-,25-,26-,31+/m0/s1 D0Q4MO DRUGINKE WQAVPPWWLLVGFK-VTNASVEKSA-N D0Q4MO DRUGSMIL CC(C(=O)NC(CC1=CC=C(C=C1)OC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C)NC(=O)CN4CCOCC4 D0Q4MO HIGHSTAT Investigative D0Q5MC DRUG__ID D0Q5MC D0Q5MC DRUGCOMP Pharmacyclics Inc D0Q5MC DRUGTYPE Small molecular drug D0Q5MC DRUGINCH 1S/C17H16N2O3/c1-22-15-6-2-12(3-7-15)11-19-9-8-13-4-5-14(10-16(13)19)17(20)18-21/h2-10,21H,11H2,1H3,(H,18,20) D0Q5MC DRUGINKE AJRGHIGYPXNABY-UHFFFAOYSA-N D0Q5MC DRUGSMIL COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO D0Q5MC HIGHSTAT Investigative D0Q6ZQ DRUG__ID D0Q6ZQ D0Q6ZQ DRUGCOMP Elan Pharmaceuticals Inc D0Q6ZQ DRUGTYPE Small molecular drug D0Q6ZQ DRUGINCH 1S/C20H14F5N3O2S/c21-15-7-13-17(8-16(15)22)28(19(10-1-2-10)14-9-26-27-18(13)14)31(29,30)12-5-3-11(4-6-12)20(23,24)25/h3-10,19H,1-2H2,(H,26,27)/t19-/m1/s1 D0Q6ZQ DRUGINKE XODSHWXKSMPDRP-LJQANCHMSA-N D0Q6ZQ DRUGSMIL C1CC1C2C3=C(C4=CC(=C(C=C4N2S(=O)(=O)C5=CC=C(C=C5)C(F)(F)F)F)F)NN=C3 D0Q6ZQ HIGHSTAT Investigative D0Q7MQ DRUG__ID D0Q7MQ D0Q7MQ DRUGCOMP Pfizer D0Q7MQ DRUGTYPE Small molecular drug D0Q7MQ DRUGINCH 1S/C19H24N2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3/t17-,19-/m1/s1 D0Q7MQ DRUGINKE DTQNEFOKTXXQKV-IEBWSBKVSA-N D0Q7MQ DRUGSMIL COC1=CC=CC=C1CNC2CCCNC2C3=CC=CC=C3 D0Q7MQ HIGHSTAT Investigative D0Q8RD DRUG__ID D0Q8RD D0Q8RD DRUGCOMP FluGen Inc D0Q8RD DRUGTYPE Small molecular drug D0Q8RD DRUGINCH 1S/C38H62O8/c1-21(2)23-11-16-38(20-44-22(3)40)18-17-36(7)24(29(23)38)9-10-27-35(6)14-13-28(34(4,5)26(35)12-15-37(27,36)8)46-33-32(43)31(42)30(41)25(19-39)45-33/h23-33,39,41-43H,1,9-20H2,2-8H3/t23-,24+,25+,26-,27+,28-,29+,30+,31-,32+,33-,35-,36+,37+,38+/m0/s1 D0Q8RD DRUGINKE WENSCPLYCPJIKC-SOILWKPBSA-N D0Q8RD DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC6C(C(C(C(O6)CO)O)O)O)C)COC(=O)C D0Q8RD HIGHSTAT Investigative D0Q8YZ DRUG__ID D0Q8YZ D0Q8YZ DRUGCOMP Dong Wha Pharmaceutical Co Ltd D0Q8YZ DRUGTYPE Small molecular drug D0Q8YZ DRUGINCH 1S/C20H23FN4O4.ClH/c1-20(9-22)10-24(8-17(20)23-29-2)16-6-15-12(5-14(16)21)18(26)13(19(27)28)7-25(15)11-3-4-11;/h5-7,11H,3-4,8-10,22H2,1-2H3,(H,27,28);1H/b23-17+; D0Q8YZ DRUGINKE CYZKABVRITVCDA-YFZNFVDXSA-N D0Q8YZ DRUGSMIL CC1(CN(CC1=NOC)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F)CN.Cl D0Q8YZ HIGHSTAT Investigative D0Q9IE DRUG__ID D0Q9IE D0Q9IE DRUGCOMP Bristol-Myers Squibb Co D0Q9IE DRUGTYPE Small molecular drug D0Q9IE DRUGINCH 1S/C17H19FN4O5S/c1-21-16(25)14(23)13(15(24)19-10-11-4-6-12(18)7-5-11)20-17(21)22-8-2-3-9-28(22,26)27/h4-7,23H,2-3,8-10H2,1H3,(H,19,24) D0Q9IE DRUGINKE VNIWZCGZPBJWBI-UHFFFAOYSA-N D0Q9IE DRUGSMIL CN1C(=O)C(=C(N=C1N2CCCCS2(=O)=O)C(=O)NCC3=CC=C(C=C3)F)O D0Q9IE HIGHSTAT Investigative D0QG6A DRUG__ID D0QG6A D0QG6A DRUGCOMP Aventis D0QG6A DRUGTYPE Small molecular drug D0QG6A DRUGINCH 1S/C23H27N3O6/c1-23(2)22(28)21(24-14-6-7-14)16-11-17(18(26(29)30)12-19(16)32-23)25-20(27)10-13-4-8-15(31-3)9-5-13/h4-5,8-9,11-12,14,21-22,24,28H,6-7,10H2,1-3H3,(H,25,27)/t21-,22+/m0/s1 D0QG6A DRUGINKE HWADWMAQVCHLHJ-FCHUYYIVSA-N D0QG6A DRUGSMIL CC1(C(C(C2=CC(=C(C=C2O1)[N+](=O)[O-])NC(=O)CC3=CC=C(C=C3)OC)NC4CC4)O)C D0QG6A HIGHSTAT Investigative D0QM4U DRUG__ID D0QM4U D0QM4U THERCLAS Antiviral Agents D0QM4U DRUGTYPE Small molecular drug D0QM4U DRUGINCH 1S/C16H16O5/c1-8(2)3-4-10(17)9-7-13(20)14-11(18)5-6-12(19)15(14)16(9)21/h3,5-7,10,17-19H,4H2,1-2H3/t10-/m1/s1 D0QM4U DRUGINKE NEZONWMXZKDMKF-SNVBAGLBSA-N D0QM4U DRUGSMIL CC(=CCC(C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C D0QM4U HIGHSTAT Investigative D0QY4L DRUG__ID D0QY4L D0QY4L DRUGCOMP The Global Alliance for TB Drug Development D0QY4L DRUGTYPE Small molecular drug D0QY4L DRUGINCH 1S/C3H3N3O2/c7-6(8)3-4-1-2-5-3/h1-2H,(H,4,5) D0QY4L DRUGINKE YZEUHQHUFTYLPH-UHFFFAOYSA-N D0QY4L DRUGSMIL C1=CN=C(N1)[N+](=O)[O-] D0QY4L HIGHSTAT Investigative D0R4WT DRUG__ID D0R4WT D0R4WT DRUGCOMP Novaflux Biosciences Inc D0R4WT DRUGTYPE Small molecular drug D0R4WT DRUGINCH 1S/C16H34N14.2ClH/c17-5-8-27-15(22)29-13(20)25-6-3-1-2-4-7-26-14(21)30-16(23)28-10-9-24-12(19)11-18;;/h1-10,17H2,(H2,19,24)(H5,20,22,25,27,29)(H5,21,23,26,28,30);2*1H D0R4WT DRUGINKE CNGBVJCBMLEXDO-UHFFFAOYSA-N D0R4WT DRUGSMIL C(CCC[NH+]=C(N)NC(=NCCN=C(C#N)N)N)CC[NH+]=C(N)NC(=NCCN)N.[Cl-].[Cl-] D0R4WT HIGHSTAT Investigative D0RE8R DRUG__ID D0RE8R D0RE8R DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0RE8R DRUGTYPE Small molecular drug D0RE8R DRUGINCH 1S/C12H14NO4PS/c1-3-16-18(19,17-4-2)13-11(14)9-7-5-6-8-10(9)12(13)15/h5-8H,3-4H2,1-2H3 D0RE8R DRUGINKE MTBZIGHNGSTDJV-UHFFFAOYSA-N D0RE8R DRUGSMIL CCOP(=S)(N1C(=O)C2=CC=CC=C2C1=O)OCC D0RE8R HIGHSTAT Investigative D0RG9A DRUG__ID D0RG9A D0RG9A THERCLAS Antiviral Agents D0RG9A DRUGTYPE Small molecular drug D0RG9A DRUGINCH 1S/C36H62O11.Na/c1-10-34(31-20(3)16-26(43-31)28-19(2)15-21(4)36(41,18-37)46-28)12-11-27(44-34)33(8)13-14-35(47-33)17-25(38)22(5)30(45-35)23(6)29(42-9)24(7)32(39)40;/h19-31,37-38,41H,10-18H2,1-9H3,(H,39,40);/q;+1/p-1/t19-,20-,21+,22+,23-,24-,25-,26+,27+,28-,29+,30-,31+,33-,34-,35+,36-;/m0./s1 D0RG9A DRUGINKE XOIQMTLWECTKJL-FBZUZRIGSA-M D0RG9A DRUGSMIL CCC1(CCC(O1)C2(CCC3(O2)CC(C(C(O3)C(C)C(C(C)C(=O)[O-])OC)C)O)C)C4C(CC(O4)C5C(CC(C(O5)(CO)O)C)C)C.[Na+] D0RG9A HIGHSTAT Investigative D0RI6L DRUG__ID D0RI6L D0RI6L DRUGCOMP SyndromeX Ltd D0RI6L DRUGTYPE Small molecular drug D0RI6L DRUGINCH 1S/C6H5Cl2N/c1-4-2-5(7)3-6(8)9-4/h2-3H,1H3 D0RI6L DRUGINKE WUGTXQVNSRFDNV-UHFFFAOYSA-N D0RI6L DRUGSMIL CC1=CC(=CC(=N1)Cl)Cl D0RI6L HIGHSTAT Investigative D0S8MG DRUG__ID D0S8MG D0S8MG DRUGCOMP Genzyme Corp D0S8MG DRUGTYPE Small molecular drug D0S8MG DRUGINCH 1S/C16H14ClFN2O2/c1-2-22-14-6-4-10(18)8-12(14)16(21)11-7-9(17)3-5-13(11)20-15(16)19/h3-8,21H,2H2,1H3,(H2,19,20) D0S8MG DRUGINKE AUZAOHTZCMKRJQ-UHFFFAOYSA-N D0S8MG DRUGSMIL CCOC1=C(C=C(C=C1)F)C2(C3=C(C=CC(=C3)Cl)N=C2N)O D0S8MG HIGHSTAT Investigative D0SE9S DRUG__ID D0SE9S D0SE9S DRUGCOMP Schering-Plough Corp D0SE9S DRUGTYPE Small molecular drug D0SE9S DRUGINCH 1S/C28H31NO/c1-20-10-6-8-14-25(20)27(26-15-9-7-11-21(26)2)29-23-16-17-24(29)19-28(30,18-23)22-12-4-3-5-13-22/h3-15,23-24,27,30H,16-19H2,1-2H3 D0SE9S DRUGINKE LOSJNRBXNQTUNT-UHFFFAOYSA-N D0SE9S DRUGSMIL CC1=CC=CC=C1C(C2=CC=CC=C2C)N3C4CCC3CC(C4)(C5=CC=CC=C5)O D0SE9S HIGHSTAT Investigative D0T0VA DRUG__ID D0T0VA D0T0VA DRUGCOMP ConjuGon Inc D0T0VA DRUGTYPE Small molecular drug D0T0VA DRUGINCH 1S/C10H9BrN2O/c1-2-9-12-13-10(14-9)7-4-3-5-8(11)6-7/h3-6H,2H2,1H3 D0T0VA DRUGINKE SWAUFAYIAMQUMJ-UHFFFAOYSA-N D0T0VA DRUGSMIL CCC1=NN=C(O1)C2=CC(=CC=C2)Br D0T0VA HIGHSTAT Investigative D0T1DZ DRUG__ID D0T1DZ D0T1DZ DRUGCOMP British Columbia Cancer Agency D0T1DZ DRUGTYPE Small molecular drug D0T1DZ DRUGINCH 1S/C21H27ClO5/c1-21(2,15-3-7-19(8-4-15)26-13-17(24)11-22)16-5-9-20(10-6-16)27-14-18(25)12-23/h3-10,17-18,23-25H,11-14H2,1-2H3 D0T1DZ DRUGINKE HDTYUHNZRYZEEB-UHFFFAOYSA-N D0T1DZ DRUGSMIL CC(C)(C1=CC=C(C=C1)OCC(CO)O)C2=CC=C(C=C2)OCC(CCl)O D0T1DZ HIGHSTAT Investigative D0T1TC DRUG__ID D0T1TC D0T1TC DRUGCOMP Protein Sciences Corp D0T1TC DRUGTYPE Small molecular drug D0T1TC DRUGINCH 1S/C8H6FNO4/c9-7-4-6(10(13)14)2-1-5(7)3-8(11)12/h1-2,4H,3H2,(H,11,12) D0T1TC DRUGINKE HKGNZXXYXCKJHO-UHFFFAOYSA-N D0T1TC DRUGSMIL C1=CC(=C(C=C1[N+](=O)[O-])F)CC(=O)O D0T1TC HIGHSTAT Investigative D0T2MV DRUG__ID D0T2MV D0T2MV DRUGCOMP Dainippon Pharmaceuticals D0T2MV DRUGTYPE Small molecular drug D0T2MV DRUGINCH 1S/C14H19NO3/c1-5-18-14(17)13-9(3)15(11-6-7-11)8(2)12(13)10(4)16/h11H,5-7H2,1-4H3 D0T2MV DRUGINKE KUMRNXGGFLRUIV-UHFFFAOYSA-N D0T2MV DRUGSMIL CCOC(=O)C1=C(N(C(=C1C(=O)C)C)C2CC2)C D0T2MV HIGHSTAT Investigative D0T4QX DRUG__ID D0T4QX D0T4QX DRUGCOMP F Hoffmann-La Roche Ltd D0T4QX DRUGTYPE Small molecular drug D0T4QX DRUGINCH 1S/C19H13ClF3N3O/c1-12-17(8-3-14-9-10-24-18(20)11-14)25-13(2)26(12)15-4-6-16(7-5-15)27-19(21,22)23/h4-7,9-11H,1-2H3 D0T4QX DRUGINKE GOHCTCOGYKAJLZ-UHFFFAOYSA-N D0T4QX DRUGSMIL CC1=C(N=C(N1C2=CC=C(C=C2)OC(F)(F)F)C)C#CC3=CC(=NC=C3)Cl D0T4QX HIGHSTAT Investigative D0T4SJ DRUG__ID D0T4SJ D0T4SJ DRUGCOMP Schering-Plough Corp D0T4SJ DRUGTYPE Small molecular drug D0T4SJ DRUGINCH 1S/C16H11NO4/c1-21-15-12(19)6-10-13-11(17-16(10)20)4-7-2-3-8(18)5-9(7)14(13)15/h2-6,18-19H,1H3,(H,17,20) D0T4SJ DRUGINKE PFXGXKFPTAJYHV-UHFFFAOYSA-N D0T4SJ DRUGSMIL COC1=C(C=C2C3=C(C=C4C=CC(=CC4=C31)O)NC2=O)O D0T4SJ HIGHSTAT Investigative D0T5AH DRUG__ID D0T5AH D0T5AH DRUGCOMP Pharmacia Inc D0T5AH DRUGTYPE Small molecular drug D0T5AH DRUGINCH 1S/C17H21N3O2S/c1-10(2)15-9-18-17(23-15)20-16(22)11(3)13-5-7-14(8-6-13)19-12(4)21/h5-11H,1-4H3,(H,19,21)(H,18,20,22)/t11-/m0/s1 D0T5AH DRUGINKE NFSKEXQRNDSSAN-NSHDSACASA-N D0T5AH DRUGSMIL CC(C)C1=CN=C(S1)NC(=O)C(C)C2=CC=C(C=C2)NC(=O)C D0T5AH HIGHSTAT Investigative D0TY0P DRUG__ID D0TY0P D0TY0P DRUGCOMP Genentech Inc D0TY0P DRUGTYPE Small molecular drug D0TY0P DRUGINCH 1S/C17H14F2IN3O4/c1-8(24)7-26-23-17(25)16-14(10-5-21-6-12(19)15(10)27-16)22-13-3-2-9(20)4-11(13)18/h2-6,8,22,24H,7H2,1H3,(H,23,25)/t8-/m0/s1 D0TY0P DRUGINKE ZEZHPEIEEFTILY-QMMMGPOBSA-N D0TY0P DRUGSMIL CC(CONC(=O)C1=C(C2=CN=CC(=C2O1)F)NC3=C(C=C(C=C3)I)F)O D0TY0P HIGHSTAT Investigative D0TZ6M DRUG__ID D0TZ6M D0TZ6M THERCLAS Antiviral Agents D0TZ6M DRUGTYPE Small molecular drug D0TZ6M DRUGINCH 1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14) D0TZ6M DRUGINKE QPFYXYFORQJZEC-UHFFFAOYSA-N D0TZ6M DRUGSMIL C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N D0TZ6M HIGHSTAT Investigative D0U3RU DRUG__ID D0U3RU D0U3RU DRUGCOMP Merck & Co Inc D0U3RU DRUGTYPE Small molecular drug D0U3RU DRUGINCH 1S/C20H12Cl2N4O2/c21-13-6-12(10-23)7-15(8-13)28-19-9-14(3-4-17(19)22)27-11-18-16-2-1-5-24-20(16)26-25-18/h1-9H,11H2,(H,24,25,26) D0U3RU DRUGINKE SVMHTBVIPYVDIL-UHFFFAOYSA-N D0U3RU DRUGSMIL C1=CC2=C(NN=C2N=C1)COC3=CC(=C(C=C3)Cl)OC4=CC(=CC(=C4)C#N)Cl D0U3RU HIGHSTAT Investigative D0U3SK DRUG__ID D0U3SK D0U3SK DRUGCOMP Roche Holding AG D0U3SK DRUGTYPE Small molecular drug D0U3SK DRUGINCH 1S/C26H37NO8S2/c1-27(15-12-20-8-10-22(32-2)24(18-20)34-4)14-6-13-26(36(28,29)16-7-17-37(26,30)31)21-9-11-23(33-3)25(19-21)35-5/h8-11,18-19H,6-7,12-17H2,1-5H3 D0U3SK DRUGINKE ZROUQTNYPCANTN-UHFFFAOYSA-N D0U3SK DRUGSMIL CN(CCCC1(S(=O)(=O)CCCS1(=O)=O)C2=CC(=C(C=C2)OC)OC)CCC3=CC(=C(C=C3)OC)OC D0U3SK HIGHSTAT Investigative D0U4PG DRUG__ID D0U4PG D0U4PG DRUGCOMP Aeolus Pharmaceuticals Inc D0U4PG DRUGTYPE Small molecular drug D0U4PG DRUGINCH 1S/C26H15F6N4O4.ClH.Mn/c1-39-23(37)19-11-3-7-15(33-11)21(25(27,28)29)17-9-5-13(35-17)20(24(38)40-2)14-6-10-18(36-14)22(26(30,31)32)16-8-4-12(19)34-16;;/h3-10H,1-2H3,(H-,33,34,35,36,37,38);1H;/q-1;;+3/p-2 D0U4PG DRUGINKE IDBVCYVKZWVRKL-UHFFFAOYSA-L D0U4PG DRUGSMIL COC(=O)C1=C2C=CC(=C(C3=NC(=C(C4=CC=C([N-]4)C(=C5C=CC1=N5)C(F)(F)F)C(=O)OC)C=C3)C(F)(F)F)[N-]2.[Cl-].[Mn+3] D0U4PG HIGHSTAT Investigative D0U6AI DRUG__ID D0U6AI D0U6AI DRUGCOMP Aarden Pharmaceuticals Inc D0U6AI DRUGTYPE Small molecular drug D0U6AI DRUGINCH 1S/C29H25N5O6/c35-24-15-25-22(14-21(24)29(37)38)27(28(40-25)18-4-2-1-3-5-18)23-16-34(32-31-23)17-26(36)30-19-6-8-20(9-7-19)33-10-12-39-13-11-33/h1-9,14-16,35H,10-13,17H2,(H,30,36)(H,37,38) D0U6AI DRUGINKE XDUPIYKMBPUQSZ-UHFFFAOYSA-N D0U6AI DRUGSMIL C1COCCN1C2=CC=C(C=C2)NC(=O)CN3C=C(N=N3)C4=C(OC5=CC(=C(C=C54)C(=O)O)O)C6=CC=CC=C6 D0U6AI HIGHSTAT Investigative D0U9UF DRUG__ID D0U9UF D0U9UF DRUGCOMP Abbott Laboratories D0U9UF DRUGTYPE Small molecular drug D0U9UF DRUGINCH 1S/C12H14FNO/c1-3-12(14-15)9(2)8-10-4-6-11(13)7-5-10/h4-8,15H,3H2,1-2H3/b9-8+,14-12- D0U9UF DRUGINKE HKROEBDHHKMNBZ-BYKJOZEVSA-N D0U9UF DRUGSMIL CCC(=NO)C(=CC1=CC=C(C=C1)F)C D0U9UF HIGHSTAT Investigative D0UK7Z DRUG__ID D0UK7Z D0UK7Z THERCLAS Antiviral Agents D0UK7Z DRUGTYPE Small molecular drug D0UK7Z DRUGINCH 1S/C29H40N2O4.ClH/c1-6-18-17-31-10-8-20-14-27(33-3)29(35-5)16-23(20)25(31)12-21(18)11-24-22-15-28(34-4)26(32-2)13-19(22)7-9-30-24;/h13-16,18,21,24-25,30H,6-12,17H2,1-5H3;1H/t18-,21-,24+,25-;/m0./s1 D0UK7Z DRUGINKE HUEYSSLYFJVUIS-MRFSYGAJSA-N D0UK7Z DRUGSMIL CCC1CN2CCC3=CC(=C(C=C3C2CC1CC4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC.Cl D0UK7Z HIGHSTAT Investigative D0UV9F DRUG__ID D0UV9F D0UV9F DRUGCOMP GlaxoSmithKline plc D0UV9F DRUGTYPE Small molecular drug D0UV9F DRUGINCH 1S/C24H28FN3O4S/c1-15-13-28(14-16(2)26-15)18-6-10-24(31-4)22(11-18)27-33(29,30)19-7-8-20(21(25)12-19)23-9-5-17(3)32-23/h5-12,15-16,26-27H,13-14H2,1-4H3/t15-,16+ D0UV9F DRUGINKE OIWVNMRPHUCLHN-IYBDPMFKSA-N D0UV9F DRUGSMIL CC1CN(CC(N1)C)C2=CC(=C(C=C2)OC)NS(=O)(=O)C3=CC(=C(C=C3)C4=CC=C(O4)C)F D0UV9F HIGHSTAT Investigative D0V0YM DRUG__ID D0V0YM D0V0YM DRUGCOMP Merck Research Laboratories D0V0YM DRUGTYPE Small molecular drug D0V0YM DRUGINCH 1S/C27H23Cl3N4O2/c1-14-10-22(34-33-14)25(35)31-23-13-27(2,3)36-26-20(23)12-19(15-4-6-16(28)7-5-15)24(32-26)18-9-8-17(29)11-21(18)30/h4-12,23H,13H2,1-3H3,(H,31,35)(H,33,34)/t23-/m1/s1 D0V0YM DRUGINKE IDUFEEHNNASCMH-HSZRJFAPSA-N D0V0YM DRUGSMIL CC1=CC(=NN1)C(=O)NC2CC(OC3=C2C=C(C(=N3)C4=C(C=C(C=C4)Cl)Cl)C5=CC=C(C=C5)Cl)(C)C D0V0YM HIGHSTAT Investigative D0V4EX DRUG__ID D0V4EX D0V4EX DRUGCOMP Ambit Biosciences Corp D0V4EX DRUGTYPE Small molecular drug D0V4EX DRUGINCH 1S/C31H42N6O4/c1-9-37-30(5,6)17-23(18-31(37,7)8)40-22-14-15-24(32-19-22)27(38)33-20-10-12-21(13-11-20)34-28(39)35-26-16-25(41-36-26)29(2,3)4/h10-16,19,23H,9,17-18H2,1-8H3,(H,33,38)(H2,34,35,36,39) D0V4EX DRUGINKE JVCWPUFNLFSKFS-UHFFFAOYSA-N D0V4EX DRUGSMIL CCN1C(CC(CC1(C)C)OC2=CN=C(C=C2)C(=O)NC3=CC=C(C=C3)NC(=O)NC4=NOC(=C4)C(C)(C)C)(C)C D0V4EX HIGHSTAT Investigative D0V4JW DRUG__ID D0V4JW D0V4JW DRUGCOMP University of Bristol D0V4JW DRUGTYPE Small molecular drug D0V4JW DRUGINCH 1S/C18H18F3N3O/c19-18(20,21)14-4-5-16(24-10-2-1-3-11-24)15(12-14)23-17(25)13-6-8-22-9-7-13/h4-9,12H,1-3,10-11H2,(H,23,25) D0V4JW DRUGINKE DWFGGOFPIISJIT-UHFFFAOYSA-N D0V4JW DRUGSMIL C1CCN(CC1)C2=C(C=C(C=C2)C(F)(F)F)NC(=O)C3=CC=NC=C3 D0V4JW HIGHSTAT Investigative D0V4KL DRUG__ID D0V4KL D0V4KL DRUGCOMP Varinel Inc D0V4KL DRUGTYPE Small molecular drug D0V4KL DRUGINCH 1S/C17H19N3O/c1-2-8-19-9-11-20(12-10-19)13-14-5-6-16(21)17-15(14)4-3-7-18-17/h1,3-7,21H,8-13H2 D0V4KL DRUGINKE JWUOZHTYFQHGAB-UHFFFAOYSA-N D0V4KL DRUGSMIL C#CCN1CCN(CC1)CC2=C3C=CC=NC3=C(C=C2)O D0V4KL HIGHSTAT Investigative D0V5LJ DRUG__ID D0V5LJ D0V5LJ DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0V5LJ DRUGTYPE Small molecular drug D0V5LJ DRUGINCH 1S/C30H34ClF3N6O3S/c1-36-26-9-8-22(31)18-27(26)40(29(36)41)23-10-15-37(16-11-23)13-3-14-39-25-12-17-38(44(2,42)43)19-24(25)28(35-39)20-4-6-21(7-5-20)30(32,33)34/h4-9,18,23H,3,10-17,19H2,1-2H3 D0V5LJ DRUGINKE NVAHQQYCEWEDKM-UHFFFAOYSA-N D0V5LJ DRUGSMIL CN1C2=C(C=C(C=C2)Cl)N(C1=O)C3CCN(CC3)CCCN4C5=C(CN(CC5)S(=O)(=O)C)C(=N4)C6=CC=C(C=C6)C(F)(F)F D0V5LJ HIGHSTAT Investigative D0V5OG DRUG__ID D0V5OG D0V5OG DRUGCOMP Norges Teknisk Naturvitenskapelige Universitet D0V5OG DRUGTYPE Small molecular drug D0V5OG DRUGINCH 1S/C27H37NO3/c1-4-5-6-7-17-24-18-11-8-14-22(2)15-9-12-19-25(29)26(30)21-23(3)16-10-13-20-27(31)28-24/h6-16,19-21,24-26,29-30H,4-5,17-18H2,1-3H3,(H,28,31)/b7-6+,11-8-,15-9-,16-10-,19-12-,20-13-,22-14-,23-21- D0V5OG DRUGINKE ALYLZDHKQZUVDF-SFDMNNJASA-N D0V5OG DRUGSMIL CCCC=CCC1CC=CC=C(C=CC=CC(C(C=C(C=CC=CC(=O)N1)C)O)O)C D0V5OG HIGHSTAT Investigative D0V6EY DRUG__ID D0V6EY D0V6EY DRUGCOMP Microbiotix D0V6EY DRUGTYPE Small molecular drug D0V6EY DRUGINCH 1S/C16H29NO/c1-4-5-7-13(2)10-14-11-16(3,18)15-8-6-9-17(15)12-14/h10,13,15,18H,4-9,11-12H2,1-3H3/b14-10-/t13-,15+,16+/m1/s1 D0V6EY DRUGINKE OKTQTXDNHCOLHT-AJKPHIATSA-N D0V6EY DRUGSMIL CCCCC(C)C=C1CC(C2CCCN2C1)(C)O D0V6EY HIGHSTAT Investigative D0V6IN DRUG__ID D0V6IN D0V6IN DRUGCOMP Provid Pharmaceuticals Inc D0V6IN DRUGTYPE Small molecular drug D0V6IN DRUGINCH 1S/C40H57N9O6/c1-25(2)35(45-26(3)50)39(55)48(30-17-8-5-9-18-30)24-34(51)46-31(19-12-20-44-40(42)43)38(54)49-23-29-16-11-10-15-28(29)22-33(49)37(53)47-32(36(41)52)21-27-13-6-4-7-14-27/h4,6-7,10-11,13-16,25,30-33,35H,5,8-9,12,17-24H2,1-3H3,(H2,41,52)(H,45,50)(H,46,51)(H,47,53)(H4,42,43,44)/t31-,32-,33-,35-/m0/s1 D0V6IN DRUGINKE NRHMIZFGJDOCJV-TUCRWICHSA-N D0V6IN DRUGSMIL CC(C)C(C(=O)N(CC(=O)NC(CCCN=C(N)N)C(=O)N1CC2=CC=CC=C2CC1C(=O)NC(CC3=CC=CC=C3)C(=O)N)C4CCCCC4)NC(=O)C D0V6IN HIGHSTAT Investigative D0V6VQ DRUG__ID D0V6VQ D0V6VQ DRUGCOMP Pfizer Inc D0V6VQ DRUGTYPE Small molecular drug D0V6VQ DRUGINCH 1S/C18H26N6O/c1-13-6-10-24(18(25)23-8-3-4-9-23)11-15(13)22(2)17-14-5-7-19-16(14)20-12-21-17/h5,7,12-13,15H,3-4,6,8-11H2,1-2H3,(H,19,20,21)/t13-,15+/m1/s1 D0V6VQ DRUGINKE RONMOMUOZGIDET-HIFRSBDPSA-N D0V6VQ DRUGSMIL CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)N4CCCC4 D0V6VQ HIGHSTAT Investigative D0V7PX DRUG__ID D0V7PX D0V7PX DRUGCOMP Sanford-Burnham Medical Research Institute D0V7PX DRUGTYPE Small molecular drug D0V7PX DRUGINCH 1S/C28H30O6/c1-11(2)21-15-7-13(5)23(25(31)17(15)9-19(29)27(21)33)24-14(6)8-16-18(26(24)32)10-20(30)28(34)22(16)12(3)4/h7-12,29-34H,1-6H3 D0V7PX DRUGINKE PBJKWGWHZVXBGU-UHFFFAOYSA-N D0V7PX DRUGSMIL CC1=CC2=C(C(=C(C=C2C(=C1C3=C(C4=CC(=C(C(=C4C=C3C)C(C)C)O)O)O)O)O)O)C(C)C D0V7PX HIGHSTAT Investigative D0VD7H DRUG__ID D0VD7H D0VD7H DRUGCOMP Universita degli Studi di Firenze D0VD7H DRUGTYPE Small molecular drug D0VD7H DRUGINCH 1S/C2H4N4O2S2/c3-1-5-6-2(9-1)10(4,7)8/h(H2,3,5)(H2,4,7,8) D0VD7H DRUGINKE VGMVBPQOACUDRU-UHFFFAOYSA-N D0VD7H DRUGSMIL C1(=NN=C(S1)S(=O)(=O)N)N D0VD7H HIGHSTAT Investigative D0VY5O DRUG__ID D0VY5O D0VY5O DRUGCOMP Abbott Laboratories D0VY5O DRUGTYPE Small molecular drug D0VY5O DRUGINCH 1S/C16H22N4O/c1-2-8-20-9-6-11(7-10-20)16-18-13-5-3-4-12(15(17)21)14(13)19-16/h3-5,11H,2,6-10H2,1H3,(H2,17,21)(H,18,19) D0VY5O DRUGINKE KXSIHXHEHABEJX-UHFFFAOYSA-N D0VY5O DRUGSMIL CCCN1CCC(CC1)C2=NC3=C(C=CC=C3N2)C(=O)N D0VY5O HIGHSTAT Investigative D0VZ2A DRUG__ID D0VZ2A D0VZ2A DRUGCOMP Sequella Inc D0VZ2A DRUGTYPE Small molecular drug D0VZ2A DRUGINCH 1S/C22H38N2O/c25-21-3-7-23(8-4-21)15-17-1-5-24(6-2-17)16-22-12-18-9-19(13-22)11-20(10-18)14-22/h17-21,25H,1-16H2 D0VZ2A DRUGINKE YUBKDPOCUHUSLW-UHFFFAOYSA-N D0VZ2A DRUGSMIL C1CN(CCC1CN2CCC(CC2)O)CC34CC5CC(C3)CC(C5)C4 D0VZ2A HIGHSTAT Investigative D0W2KR DRUG__ID D0W2KR D0W2KR DRUGCOMP Shenzhen Chipscreen Biosciences Ltd D0W2KR DRUGTYPE Small molecular drug D0W2KR DRUGINCH 1S/C23H27FN4O4/c1-13-20(10-18-17-9-15(24)3-4-19(17)27-22(18)30)26-14(2)21(13)23(31)25-11-16(29)12-28-5-7-32-8-6-28/h3-4,9-10,16,26,29H,5-8,11-12H2,1-2H3,(H,25,31)(H,27,30)/b18-10+/t16-/m0/s1 D0W2KR DRUGINKE CTNPALGJUAXMMC-HKJBKDEOSA-N D0W2KR DRUGSMIL CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O D0W2KR HIGHSTAT Investigative D0W4HJ DRUG__ID D0W4HJ D0W4HJ DRUGCOMP Universitat Wurzburg D0W4HJ DRUGTYPE Small molecular drug D0W4HJ DRUGINCH 1S/C21H23N4O7P.2Na/c1-4-11-25-20(26)18-19(24(21(25)27)12-6-13-32-33(28,29)30)22-17(23(18)2)10-9-15-7-5-8-16(14-15)31-3;;/h1,5,7-10,14H,6,11-13H2,2-3H3,(H2,28,29,30);;/q;2*+1/p-2/b10-9+;; D0W4HJ DRUGINKE ZYVZWCILYQDHNU-TTWKNDKESA-L D0W4HJ DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2CCCOP(=O)([O-])[O-])CC#C)C=CC3=CC(=CC=C3)OC.[Na+].[Na+] D0W4HJ HIGHSTAT Investigative D0W4JY DRUG__ID D0W4JY D0W4JY DRUGCOMP Microbial Chemistry Research Foundation D0W4JY DRUGTYPE Small molecular drug D0W4JY DRUGINCH 1S/C32H44N6O11/c1-4-5-6-16-7-9-17(10-8-16)34-28(44)18-11-13-36(2)21(29(45)37(18)3)26(49-31-25(43)22(40)19(15-33)47-31)27-23(41)24(42)30(48-27)38-14-12-20(39)35-32(38)46/h7-12,14,19,21-27,30-31,40-43H,4-6,13,15,33H2,1-3H3,(H,34,44)(H,35,39,46)/t19-,21+,22-,23+,24-,25-,26+,27+,30-,31+/m1/s1 D0W4JY DRUGINKE RQVDLVWYEOCAJE-KDHSHZOVSA-N D0W4JY DRUGSMIL CCCCC1=CC=C(C=C1)NC(=O)C2=CCN(C(C(=O)N2C)C(C3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)OC5C(C(C(O5)CN)O)O)C D0W4JY HIGHSTAT Investigative D0W4WP DRUG__ID D0W4WP D0W4WP DRUGCOMP Gilead Palo Alto Inc D0W4WP DRUGTYPE Small molecular drug D0W4WP DRUGINCH 1S/C24H19NO7S/c1-33(29,30)25-18-7-5-16(6-8-18)21-14-32-22-12-19(9-10-20(22)23(21)26)31-13-15-3-2-4-17(11-15)24(27)28/h2-12,14,25H,13H2,1H3,(H,27,28) D0W4WP DRUGINKE YYOOFJZTRCPVFD-UHFFFAOYSA-N D0W4WP DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)OCC4=CC(=CC=C4)C(=O)O D0W4WP HIGHSTAT Investigative D0W5IF DRUG__ID D0W5IF D0W5IF DRUGCOMP Chugai Pharmaceutical Co Ltd D0W5IF DRUGTYPE Small molecular drug D0W5IF DRUGINCH 1S/C15H17ClN4O3S2/c1-15(2)13(21)20(11-5-4-10(9-17)12(16)8-11)14(24)19(15)6-3-7-25(18,22)23/h4-5,8H,3,6-7H2,1-2H3,(H2,18,22,23) D0W5IF DRUGINKE DSIHXMZSDDJEHM-UHFFFAOYSA-N D0W5IF DRUGSMIL CC1(C(=O)N(C(=S)N1CCCS(=O)(=O)N)C2=CC(=C(C=C2)C#N)Cl)C D0W5IF HIGHSTAT Investigative D0W5WZ DRUG__ID D0W5WZ D0W5WZ THERCLAS Antiviral Agents D0W5WZ DRUGTYPE Small molecular drug D0W5WZ DRUGINCH 1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2 D0W5WZ DRUGINKE PMJIHLSCWIDGMD-UHFFFAOYSA-N D0W5WZ DRUGSMIL C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43 D0W5WZ HIGHSTAT Investigative D0W7TU DRUG__ID D0W7TU D0W7TU DRUGCOMP National Cancer Institute D0W7TU DRUGTYPE Small molecular drug D0W7TU DRUGINCH 1S/C16H14N4O2S/c1-22-11-8-6-10(7-9-11)17-16(23)20-19-14-12-4-2-3-5-13(12)18-15(14)21/h2-9,18,21H,1H3,(H,17,23) D0W7TU DRUGINKE RRCQAXBOKBNIDS-UHFFFAOYSA-N D0W7TU DRUGSMIL COC1=CC=C(C=C1)NC(=S)N=NC2=C(NC3=CC=CC=C32)O D0W7TU HIGHSTAT Investigative D0W7VX DRUG__ID D0W7VX D0W7VX DRUGCOMP MedinCell SA D0W7VX DRUGTYPE Small molecular drug D0W7VX DRUGINCH 1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3 D0W7VX DRUGINKE RYMZZMVNJRMUDD-UHFFFAOYSA-N D0W7VX DRUGSMIL CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C D0W7VX HIGHSTAT Investigative D0W8XH DRUG__ID D0W8XH D0W8XH THERCLAS Anticancer Agents D0W8XH DRUGTYPE Small molecular drug D0W8XH DRUGINCH 1S/C19H16N4O3/c24-13-4-1-3-12(11-13)17-21-15-14-5-2-6-20-19(14)26-16(15)18(22-17)23-7-9-25-10-8-23/h1-6,11,24H,7-10H2 D0W8XH DRUGINKE TUVCWJQQGGETHL-UHFFFAOYSA-N D0W8XH DRUGSMIL C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O D0W8XH HIGHSTAT Investigative D0X4FY DRUG__ID D0X4FY D0X4FY DRUGCOMP Torrey Pines Institute for Molecular Studies D0X4FY DRUGTYPE Small molecular drug D0X4FY DRUGINCH 1S/C48H91NO11S/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)40-58-48-46(54)47(60-61(55,56)57)45(53)43(39-50)59-48/h17-18,35,37,41-43,45-48,50-51,53-54H,3-16,19-34,36,38-40H2,1-2H3,(H,49,52)(H,55,56,57)/b18-17-,37-35+/t41-,42+,43+,45-,46+,47-,48+/m0/s1 D0X4FY DRUGINKE ZZQWQNAZXFNSEP-JCOQVFCVSA-N D0X4FY DRUGSMIL CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)OS(=O)(=O)O)O)NC(=O)CCCCCCCCCCCCCC=CCCCCCCCC)O D0X4FY HIGHSTAT Investigative D0X7LY DRUG__ID D0X7LY D0X7LY DRUGCOMP CisThera Inc D0X7LY DRUGTYPE Small molecular drug D0X7LY DRUGINCH 1S/C26H34O7/c1-18(2)13-14-20-25(3,33-20)24-23(30-4)19(15-16-26(24)17-31-26)32-22(29)12-10-8-6-5-7-9-11-21(27)28/h5-13,19-20,23-24H,14-17H2,1-4H3,(H,27,28)/b7-5+,8-6+,11-9+,12-10+/t19-,20-,23-,24+,25+,26+/m1/s1 D0X7LY DRUGINKE NGGMYCMLYOUNGM-FKSJYSFPSA-N D0X7LY DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C D0X7LY HIGHSTAT Investigative D0X7ZH DRUG__ID D0X7ZH D0X7ZH DRUGCOMP OncoMab GmbH D0X7ZH DRUGTYPE Small molecular drug D0X7ZH DRUGINCH 1S/C30H46O4/c1-24(2)11-13-28(23(31)32)14-12-26(5)19(20(28)17-24)7-8-22-27(26,6)10-9-21-25(3,4)30(33)16-15-29(21,22)18-34-30/h7,20-22,33H,8-18H2,1-6H3,(H,31,32)/t20?,21?,22?,26-,27-,28+,29-,30-/m1/s1 D0X7ZH DRUGINKE UFVGYQQCHANGSN-ZTDSIJLQSA-N D0X7ZH DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C46CCC(C5(C)C)(OC6)O)C)C2C1)C)C(=O)O)C D0X7ZH HIGHSTAT Investigative D0XA1B DRUG__ID D0XA1B D0XA1B DRUGCOMP University of Texas Southwestern Medical Center D0XA1B DRUGTYPE Small molecular drug D0XA1B DRUGINCH 1S/C27H48O11/c1-8-16(14-28)9-15(2)19-10-17(34-5)13-22(29)26(3,4)27(33)24(31)21(36-7)12-18(38-27)11-20(35-6)23(30)25(32)37-19/h9,16-24,28-31,33H,8,10-14H2,1-7H3/b15-9-/t16-,17-,18+,19+,20-,21-,22+,23+,24-,27+/m0/s1 D0XA1B DRUGINKE NETARJWZTMGMRM-JRTPPQMASA-N D0XA1B DRUGSMIL CCC(CO)C=C(C)C1CC(CC(C(C2(C(C(CC(O2)CC(C(C(=O)O1)O)OC)OC)O)O)(C)C)O)OC D0XA1B HIGHSTAT Investigative D0Y0ID DRUG__ID D0Y0ID D0Y0ID DRUGCOMP National Academy of Sciences of Ukraine D0Y0ID DRUGTYPE Small molecular drug D0Y0ID DRUGINCH 1S/C8H12N4O5/c9-4-1-10-12(8(16)11-4)7-6(15)5(14)3(2-13)17-7/h1,3,5-7,13-15H,2H2,(H2,9,11,16)/t3-,5-,6-,7-/m1/s1 D0Y0ID DRUGINKE OZQDLJNDRVBCST-SHUUEZRQSA-N D0Y0ID DRUGSMIL C1=NN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O D0Y0ID HIGHSTAT Investigative D0Y0KV DRUG__ID D0Y0KV D0Y0KV DRUGCOMP Sankyo Co Ltd D0Y0KV DRUGTYPE Small molecular drug D0Y0KV DRUGINCH 1S/C34H51N5O13/c1-4-5-6-7-8-9-10-14-23(42)50-28-25(48-3)26(51-32(28)39-16-15-22(41)38-34(39)47)27(29(35)44)52-33-24(43)20(40)17-21(49-33)31(46)37-19-13-11-12-18(2)36-30(19)45/h15-20,24-28,32-33,40,43H,4-14H2,1-3H3,(H2,35,44)(H,36,45)(H,37,46)(H,38,41,47)/t18-,19+,20+,24+,25-,26+,27-,28-,32-,33-/m1/s1 D0Y0KV DRUGINKE MTVCVDHANKHRCR-MNJNIPBHSA-N D0Y0KV DRUGSMIL CCCCCCCCCC(=O)OC1C(C(OC1N2C=CC(=O)NC2=O)C(C(=O)N)OC3C(C(C=C(O3)C(=O)NC4CCCC(NC4=O)C)O)O)OC D0Y0KV HIGHSTAT Investigative D0Y2TI DRUG__ID D0Y2TI D0Y2TI DRUGCOMP Korea Institute of Science and Technology D0Y2TI DRUGTYPE Small molecular drug D0Y2TI DRUGINCH 1S/C13H11N3O5S2/c1-14-10(18)12-5-7-2-3-8(16(20)21)4-9(7)15(12)11(19)13(14,6-17)23-22-12/h2-4,17H,5-6H2,1H3/t12-,13-/m0/s1 D0Y2TI DRUGINKE VRFJINVAZRAFHH-STQMWFEESA-N D0Y2TI DRUGSMIL CN1C(=O)C23CC4=C(N2C(=O)C1(SS3)CO)C=C(C=C4)[N+](=O)[O-] D0Y2TI HIGHSTAT Investigative D0Y4WR DRUG__ID D0Y4WR D0Y4WR DRUGCOMP Pharmagene plc D0Y4WR DRUGTYPE Small molecular drug D0Y4WR DRUGINCH 1S/C32H58O13/c1-5-7-9-11-13-15-21(17-23(33)34)43-24(35)18-22(16-14-12-10-8-6-2)44-32-30(28(39)26(37)20(4)42-32)45-31-29(40)27(38)25(36)19(3)41-31/h19-22,25-32,36-40H,5-18H2,1-4H3,(H,33,34)/t19-,20-,21?,22?,25-,26-,27+,28+,29+,30+,31-,32-/m0/s1 D0Y4WR DRUGINKE FCBUKWWQSZQDDI-SESCQDRSSA-N D0Y4WR DRUGSMIL CCCCCCCC(CC(=O)O)OC(=O)CC(CCCCCCC)OC1C(C(C(C(O1)C)O)O)OC2C(C(C(C(O2)C)O)O)O D0Y4WR HIGHSTAT Investigative D0Y5BR DRUG__ID D0Y5BR D0Y5BR DRUGCOMP Phylogica Ltd D0Y5BR DRUGTYPE Small molecular drug D0Y5BR DRUGINCH 1S/C23H28N2O3/c1-16(2)24-21(26)23(3)14-19(23)20(18-12-8-5-9-13-18)25-22(27)28-15-17-10-6-4-7-11-17/h4-13,16,19-20H,14-15H2,1-3H3,(H,24,26)(H,25,27) D0Y5BR DRUGINKE ONJDWAYKGBYQHM-UHFFFAOYSA-N D0Y5BR DRUGSMIL CC(C)NC(=O)C1(CC1C(C2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)C D0Y5BR HIGHSTAT Investigative D0Y8BJ DRUG__ID D0Y8BJ D0Y8BJ DRUGCOMP Curative Health Services D0Y8BJ DRUGTYPE Small molecular drug D0Y8BJ DRUGINCH 1S/C16H21NO4S/c1-3-5-6-9-21-12-8-7-11(10-13(12)20-4-2)14-15(18)17-16(19)22-14/h7-8,10,14H,3-6,9H2,1-2H3,(H,17,18,19) D0Y8BJ DRUGINKE CRPGRUONUFDYBG-UHFFFAOYSA-N D0Y8BJ DRUGSMIL CCCCCOC1=C(C=C(C=C1)C2C(=O)NC(=O)S2)OCC D0Y8BJ HIGHSTAT Investigative D0Y8VC DRUG__ID D0Y8VC D0Y8VC DRUGCOMP Maruho Co Ltd D0Y8VC DRUGTYPE Small molecular drug D0Y8VC DRUGINCH 1S/C10H13NO3/c1-14-8-4-2-7(3-5-8)6-9(11)10(12)13/h2-5,9H,6,11H2,1H3,(H,12,13)/t9-/m0/s1 D0Y8VC DRUGINKE GEYBMYRBIABFTA-VIFPVBQESA-N D0Y8VC DRUGSMIL COC1=CC=C(C=C1)CC(C(=O)O)N D0Y8VC HIGHSTAT Investigative D0Y9GA DRUG__ID D0Y9GA D0Y9GA DRUGCOMP Keio University D0Y9GA DRUGTYPE Small molecular drug D0Y9GA DRUGINCH 1S/C13H11NO5/c15-8-4-2-1-3-6(8)13(18)14-7-5-9(16)11-12(19-11)10(7)17/h1-5,10-12,15,17H,(H,14,18)/t10-,11+,12-/m0/s1 D0Y9GA DRUGINKE IUOMATKBBPCLFR-TUAOUCFPSA-N D0Y9GA DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC(=O)C3C(C2O)O3)O D0Y9GA HIGHSTAT Investigative D0Y9RN DRUG__ID D0Y9RN D0Y9RN DRUGCOMP Nereus Pharmaceuticals Inc D0Y9RN DRUGTYPE Small molecular drug D0Y9RN DRUGINCH 1S/C15H21NO4/c1-3-10-12(18)16-15(13(19)20-14(10,15)2)11(17)9-7-5-4-6-8-9/h5,7,9-11,17H,3-4,6,8H2,1-2H3,(H,16,18)/t9-,10+,11+,14+,15+/m1/s1 D0Y9RN DRUGINKE SCJZQKFFYIGMCI-SHTIJGAHSA-N D0Y9RN DRUGSMIL CCC1C(=O)NC2(C1(OC2=O)C)C(C3CCCC=C3)O D0Y9RN HIGHSTAT Investigative D0YD9E DRUG__ID D0YD9E D0YD9E DRUGCOMP Pfizer Inc D0YD9E DRUGTYPE Small molecular drug D0YD9E DRUGINCH 1S/C27H24N2O5/c1-33-23-10-8-22(9-11-23)25(30)29-15-14-27(17-29,26(31)32)18-34-24-12-6-21(7-13-24)20-4-2-19(16-28)3-5-20/h2-13H,14-15,17-18H2,1H3,(H,31,32) D0YD9E DRUGINKE MDVYCLAYSVNYDS-UHFFFAOYSA-N D0YD9E DRUGSMIL COC1=CC=C(C=C1)C(=O)N2CCC(C2)(COC3=CC=C(C=C3)C4=CC=C(C=C4)C#N)C(=O)O D0YD9E HIGHSTAT Investigative D0YN3T DRUG__ID D0YN3T D0YN3T DRUGCOMP Academia Sinica D0YN3T DRUGTYPE Small molecular drug D0YN3T DRUGINCH 1S/C13H25N2O5P/c1-4-9(5-2)20-12-7-10(21(17,18)19)6-11(14)13(12)15-8(3)16/h7,9,11-13H,4-6,14H2,1-3H3,(H,15,16)(H2,17,18,19)/t11-,12+,13+/m0/s1 D0YN3T DRUGINKE MSIIIHISTLWEPM-YNEHKIRRSA-N D0YN3T DRUGSMIL CCC(CC)OC1C=C(CC(C1NC(=O)C)N)P(=O)(O)O D0YN3T HIGHSTAT Investigative D0YW6B DRUG__ID D0YW6B D0YW6B DRUGCOMP Amira Pharmaceuticals Inc D0YW6B DRUGTYPE Small molecular drug D0YW6B DRUGINCH 1S/C40H44N4O5S/c1-25(45)44-29(18-28-10-8-9-11-33(28)44)24-49-30-16-17-34-32(19-30)36(50-39(2,3)4)35(20-40(5,6)38(46)47)43(34)23-26-12-14-27(15-13-26)37-41-21-31(48-7)22-42-37/h8-17,19,21-22,29H,18,20,23-24H2,1-7H3,(H,46,47)/t29-/m0/s1 D0YW6B DRUGINKE VYXWHVDEWWHDLH-LJAQVGFWSA-N D0YW6B DRUGSMIL CC(=O)N1C(CC2=CC=CC=C21)COC3=CC4=C(C=C3)N(C(=C4SC(C)(C)C)CC(C)(C)C(=O)O)CC5=CC=C(C=C5)C6=NC=C(C=N6)OC D0YW6B HIGHSTAT Investigative D0Z8EV DRUG__ID D0Z8EV D0Z8EV THERCLAS Antiviral Agents D0Z8EV DRUGTYPE Small molecular drug D0Z8EV DRUGINCH 1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+ D0Z8EV DRUGINKE HPNSFSBZBAHARI-RUDMXATFSA-N D0Z8EV DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O D0Z8EV HIGHSTAT Investigative D0ZU9T DRUG__ID D0ZU9T D0ZU9T DRUGCOMP National Cancer Institute D0ZU9T DRUGTYPE Small molecular drug D0ZU9T DRUGINCH 1S/C27H34N2O2/c1-4-18-17-29-12-10-20-15-26(30-2)27(31-3)16-23(20)25(29)14-21(18)13-24-22-8-6-5-7-19(22)9-11-28-24/h5-8,15-16,24-25,28H,4,9-14,17H2,1-3H3/t24-,25-/m1/s1 D0ZU9T DRUGINKE HDIJLRXRAJUXQB-JWQCQUIFSA-N D0ZU9T DRUGSMIL CCC1=C(CC2C3=CC(=C(C=C3CCN2C1)OC)OC)CC4C5=CC=CC=C5CCN4 D0ZU9T HIGHSTAT Investigative DCJX65 DRUG__ID DCJX65 DCJX65 DRUGCOMP University of North Carolina DCJX65 DRUGTYPE Small molecular drug DCJX65 DRUGINCH 1S/C28H40N6O/c1-3-4-13-29-28-30-18-25-26(20-34(27(25)31-28)23-9-11-24(35)12-10-23)22-7-5-21(6-8-22)19-33-16-14-32(2)15-17-33/h5-8,18,20,23-24,35H,3-4,9-17,19H2,1-2H3,(H,29,30,31) DCJX65 DRUGINKE MJSHVHLADKXCML-UHFFFAOYSA-N DCJX65 DRUGSMIL CCCCNC1=NC=C2C(=CN(C2=N1)C3CCC(CC3)O)C4=CC=C(C=C4)CN5CCN(CC5)C DCJX65 HIGHSTAT Investigative DEV97R DRUG__ID DEV97R DEV97R DRUGCOMP Soochow University DEV97R DRUGTYPE Small molecular drug DEV97R DRUGINCH 1S/C22H24N4O3S/c1-13-19(26-22(28)29-17-6-4-3-5-7-17)10-16(12-23-13)15-8-9-18-20(11-15)30-21(25-18)24-14(2)27/h8-12,17H,3-7H2,1-2H3,(H,26,28)(H,24,25,27) DEV97R DRUGINKE DRCNWQYEKZTTEW-UHFFFAOYSA-N DEV97R DRUGSMIL CC1=C(C=C(C=N1)C2=CC3=C(C=C2)N=C(S3)NC(=O)C)NC(=O)OC4CCCCC4 DEV97R HIGHSTAT Investigative DF5C2I DRUG__ID DF5C2I DF5C2I DRUGCOMP National Institute of Biological Sciences DF5C2I DRUGTYPE Small molecular drug DF5C2I DRUGINCH 1S/C13H19NO2/c1-4-13(2,3)12(15)14(16)10-11-8-6-5-7-9-11/h5-9,16H,4,10H2,1-3H3 DF5C2I DRUGINKE AVYVHIKSFXVDBG-UHFFFAOYSA-N DF5C2I DRUGSMIL CCC(C)(C)C(=O)N(CC1=CC=CC=C1)O DF5C2I HIGHSTAT Investigative DY9CM8 DRUG__ID DY9CM8 DY9CM8 DRUGCOMP Harvard University DY9CM8 DRUGTYPE Small molecular drug DY9CM8 DRUGINCH 1S/C30H32N4O7S/c1-20-16-34(21(2)18-35)42(37,38)29-9-6-23(5-4-22-10-12-31-13-11-22)14-27(29)41-28(20)17-33(3)30(36)32-24-7-8-25-26(15-24)40-19-39-25/h6-15,20-21,28,35H,16-19H2,1-3H3,(H,32,36)/t20-,21-,28+/m0/s1 DY9CM8 DRUGINKE OYKBHWDUAQJSNT-YHGPEZAFSA-N DY9CM8 DRUGSMIL CC1CN(S(=O)(=O)C2=C(C=C(C=C2)C#CC3=CC=NC=C3)OC1CN(C)C(=O)NC4=CC5=C(C=C4)OCO5)C(C)CO DY9CM8 HIGHSTAT Investigative D00AAN DRUG__ID D00AAN D00AAN DRUGTYPE Small molecular drug D00AAN DRUGINCH 1S/C42H47ClN4O5S/c43-28-12-16-31(17-13-28)53(50,51)52-36-11-7-10-32-33-18-21-44-38(39(33)45-37(32)36)34-26-42(49)20-5-3-1-2-4-6-22-46-24-19-35(34)41(27-46)25-29-14-15-30(48)9-8-23-47(29)40(41)42/h1,3,7,10-13,16-18,21,26,29,35,40,45,49H,2,4-6,8-9,14-15,19-20,22-25,27H2/b3-1-/t29-,35?,40+,41-,42-/m0/s1 D00AAN DRUGINKE MSUMHGMGRZWLMN-WXPZYUJUSA-N D00AAN DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCC(=O)CC5)O)C6=NC=CC7=C6NC8=C7C=CC=C8OS(=O)(=O)C9=CC=C(C=C9)Cl D00AAN HIGHSTAT Investigative D00AAU DRUG__ID D00AAU D00AAU DRUGTYPE Small molecular drug D00AAU DRUGINCH 1S/C18H22O2/c1-3-17(13-7-5-9-15(19)11-13)18(4-2)14-8-6-10-16(20)12-14/h5-12,17-20H,3-4H2,1-2H3 D00AAU DRUGINKE KUJAWCSIKNKXLL-UHFFFAOYSA-N D00AAU DRUGSMIL CCC(C1=CC(=CC=C1)O)C(CC)C2=CC(=CC=C2)O D00AAU HIGHSTAT Investigative D00ACX DRUG__ID D00ACX D00ACX DRUGTYPE Small molecular drug D00ACX DRUGINCH 1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17) D00ACX DRUGINKE DNTSIBUQMRRYIU-UHFFFAOYSA-N D00ACX DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=C(C=CC(=C2)[N+](=O)[O-])Cl D00ACX HIGHSTAT Investigative D00AEX DRUG__ID D00AEX D00AEX DRUGTYPE Small molecular drug D00AEX DRUGINCH 1S/C14H19N3O/c1-2-3-4-5-10-18-14-7-6-13(11-16-14)17-9-8-15-12-17/h6-9,11-12H,2-5,10H2,1H3 D00AEX DRUGINKE DCDHWTNKKCKJLQ-UHFFFAOYSA-N D00AEX DRUGSMIL CCCCCCOC1=NC=C(C=C1)N2C=CN=C2 D00AEX HIGHSTAT Investigative D00AHD DRUG__ID D00AHD D00AHD DRUGTYPE Small molecular drug D00AHD DRUGINCH 1S/C27H17NOS/c29-27(26-20-11-3-1-9-18(20)17-19-10-2-4-12-21(19)26)28-22-13-5-7-15-24(22)30-25-16-8-6-14-23(25)28/h1-17H D00AHD DRUGINKE GEDDVJWUHICGPI-UHFFFAOYSA-N D00AHD DRUGSMIL C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)N4C5=CC=CC=C5SC6=CC=CC=C64 D00AHD HIGHSTAT Investigative D00AII DRUG__ID D00AII D00AII DRUGTYPE Small molecular drug D00AII DRUGINCH 1S/C16H16O3/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11,17H,1-2H3/b4-3+ D00AII DRUGINKE VLEUZFDZJKSGMX-ONEGZZNKSA-N D00AII DRUGSMIL COC1=CC(=CC(=C1)C=CC2=CC=C(C=C2)O)OC D00AII HIGHSTAT Investigative D00AJB DRUG__ID D00AJB D00AJB DRUGTYPE Small molecular drug D00AJB DRUGINCH 1S/C22H28N2O3/c1-4-14-9-13-11-22(21(25)27-3)19-16(7-8-24(12-13)20(14)22)17-10-15(26-2)5-6-18(17)23-19/h5-6,10,13-14,20,23H,4,7-9,11-12H2,1-3H3/t13-,14-,20-,22+/m0/s1 D00AJB DRUGINKE MMAYTCMMKJYIAM-RUGRQLENSA-N D00AJB DRUGSMIL CCC1CC2CC3(C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC)C(=O)OC D00AJB HIGHSTAT Investigative D00ANJ DRUG__ID D00ANJ D00ANJ DRUGTYPE Small molecular drug D00ANJ DRUGINCH 1S/C20H29NO2/c1-2-3-4-5-6-7-8-9-10-13-16-21-18-15-12-11-14-17(18)19(22)20(21)23/h11-12,14-15H,2-10,13,16H2,1H3 D00ANJ DRUGINKE GQEQKTGRIPEAKW-UHFFFAOYSA-N D00ANJ DRUGSMIL CCCCCCCCCCCCN1C2=CC=CC=C2C(=O)C1=O D00ANJ HIGHSTAT Investigative D00AON DRUG__ID D00AON D00AON DRUGTYPE Small molecular drug D00AON DRUGINCH 1S/C18H25NO5S/c1-2-3-4-5-6-7-8-9-14-13-17(20)16-12-15(24-25(19,21)22)10-11-18(16)23-14/h10-13H,2-9H2,1H3,(H2,19,21,22) D00AON DRUGINKE ATSLCAISNROVSQ-UHFFFAOYSA-N D00AON DRUGSMIL CCCCCCCCCC1=CC(=O)C2=C(O1)C=CC(=C2)OS(=O)(=O)N D00AON HIGHSTAT Investigative D00APD DRUG__ID D00APD D00APD DRUGTYPE Small molecular drug D00APD DRUGINCH 1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-7-10(15)3-4-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3 D00APD DRUGINKE WUQMRWPLIMXBDX-UHFFFAOYSA-N D00APD DRUGSMIL CN(C)CCC1=CNC2=C1C=CC(=C2)O D00APD HIGHSTAT Investigative D00AQR DRUG__ID D00AQR D00AQR DRUGTYPE Small molecular drug D00AQR DRUGINCH 1S/C17H12ClN5OS/c1-24-15(19)17-23-12-7-6-11-13(14(12)25-17)16(21-8-20-11)22-10-4-2-9(18)3-5-10/h2-8,19H,1H3,(H,20,21,22) D00AQR DRUGINKE BGXZIBSLBRKDTP-UHFFFAOYSA-N D00AQR DRUGSMIL COC(=N)C1=NC2=C(S1)C3=C(C=C2)N=CN=C3NC4=CC=C(C=C4)Cl D00AQR HIGHSTAT Investigative D00ARM DRUG__ID D00ARM D00ARM DRUGTYPE Small molecular drug D00ARM DRUGINCH 1S/C11H10BrN5.C4H6O6/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8;5-1(3(7)8)2(6)4(9)10/h1-4H,5-6H2,(H2,15,16,17);1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1 D00ARM DRUGINKE QZHBYNSSDLTCRG-LREBCSMRSA-N D00ARM DRUGSMIL C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O D00ARM HIGHSTAT Investigative D00ASA DRUG__ID D00ASA D00ASA DRUGTYPE Small molecular drug D00ASA DRUGINCH 1S/C15H9ClO2/c16-11-5-3-4-10(8-11)15-9-13(17)12-6-1-2-7-14(12)18-15/h1-9H D00ASA DRUGINKE JWTQJUQJIRWZLA-UHFFFAOYSA-N D00ASA DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC(=CC=C3)Cl D00ASA HIGHSTAT Investigative D00ASH DRUG__ID D00ASH D00ASH DRUGTYPE Small molecular drug D00ASH DRUGINCH 1S/C12H15NO4/c1-12(13,11(15)16)7-10(14)8-4-3-5-9(6-8)17-2/h3-6H,7,13H2,1-2H3,(H,15,16) D00ASH DRUGINKE WRBHWPHQKJOLHX-UHFFFAOYSA-N D00ASH DRUGSMIL CC(CC(=O)C1=CC(=CC=C1)OC)(C(=O)O)N D00ASH HIGHSTAT Investigative D00ASL DRUG__ID D00ASL D00ASL DRUGTYPE Small molecular drug D00ASL DRUGINCH 1S/C34H56O3/c1-9-10-19-37-28(36)34-17-15-29(2,3)22-25(34)24-11-12-27-31(6)21-23(35)20-30(4,5)26(31)13-14-33(27,8)32(24,7)16-18-34/h11,23,25-27,35H,9-10,12-22H2,1-8H3/t23-,25+,26+,27-,31+,32-,33-,34+/m1/s1 D00ASL DRUGINKE UZTYAEIRVQJQQC-XXJJMGNBSA-N D00ASL DRUGSMIL CCCCOC(=O)C12CCC(CC1C3=CCC4C(C3(CC2)C)(CCC5C4(CC(CC5(C)C)O)C)C)(C)C D00ASL HIGHSTAT Investigative D00ASZ DRUG__ID D00ASZ D00ASZ DRUGTYPE Small molecular drug D00ASZ DRUGINCH 1S/C16H20N6O5/c17-13-10-14(21-16(20-13)26-4-2-8-1-3-18-5-8)22(7-19-10)15-12(25)11(24)9(6-23)27-15/h1,3,5,7,9,11-12,15,18,23-25H,2,4,6H2,(H2,17,20,21)/t9-,11-,12-,15-/m1/s1 D00ASZ DRUGINKE OBDCLFIHFXHMSJ-SDBHATRESA-N D00ASZ DRUGSMIL C1=CNC=C1CCOC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D00ASZ HIGHSTAT Investigative D00ATA DRUG__ID D00ATA D00ATA DRUGTYPE Small molecular drug D00ATA DRUGINCH 1S/C13H10N2O/c16-13-11(8-9-4-3-7-14-9)10-5-1-2-6-12(10)15-13/h1-8,14H,(H,15,16)/b11-8- D00ATA DRUGINKE SEZFNTZQMWJIAI-FLIBITNWSA-N D00ATA DRUGSMIL C1=CC=C2C(=C1)C(=CC3=CC=CN3)C(=O)N2 D00ATA HIGHSTAT Investigative D00AVR DRUG__ID D00AVR D00AVR DRUGTYPE Small molecular drug D00AVR DRUGINCH 1S/C14H14N4O/c1-17-12(13(19)18(2)14(17)15)7-9-8-16-11-6-4-3-5-10(9)11/h3-8,15,19H,1-2H3/b9-7+,15-14? D00AVR DRUGINKE CYKDGQFRORUDQP-YHUDWFPJSA-N D00AVR DRUGSMIL CN1C(=C(N(C1=N)C)O)C=C2C=NC3=CC=CC=C32 D00AVR HIGHSTAT Investigative D00AVT DRUG__ID D00AVT D00AVT DRUGTYPE Small molecular drug D00AVT DRUGINCH 1S/C10H14O/c1-8(2)10-5-3-9(7-11)4-6-10/h3,7,10H,1,4-6H2,2H3 D00AVT DRUGINKE RUMOYJJNUMEFDD-UHFFFAOYSA-N D00AVT DRUGSMIL CC(=C)C1CCC(=CC1)C=O D00AVT HIGHSTAT Investigative D00AWM DRUG__ID D00AWM D00AWM DRUGTYPE Small molecular drug D00AWM DRUGINCH 1S/C25H24ClN3O3S/c1-31-22-14-19(8-9-21(22)32-13-12-28-10-2-3-11-28)29-16-27-20-15-23(33-24(20)25(29)30)17-4-6-18(26)7-5-17/h4-9,14-16H,2-3,10-13H2,1H3 D00AWM DRUGINKE MWULMTACIBZPGN-UHFFFAOYSA-N D00AWM DRUGSMIL COC1=C(C=CC(=C1)N2C=NC3=C(C2=O)SC(=C3)C4=CC=C(C=C4)Cl)OCCN5CCCC5 D00AWM HIGHSTAT Investigative D00BAJ DRUG__ID D00BAJ D00BAJ DRUGTYPE Small molecular drug D00BAJ DRUGINCH 1S/C15H13Cl2N3O2/c1-3-22-15(21)14-11(8(6-18)7-19)9-4-5-10(16)12(17)13(9)20(14)2/h4-6H,3,18H2,1-2H3/b8-6- D00BAJ DRUGINKE CXJCGSPAPOTTSF-VURMDHGXSA-N D00BAJ DRUGSMIL CCOC(=O)C1=C(C2=C(N1C)C(=C(C=C2)Cl)Cl)C(=CN)C#N D00BAJ HIGHSTAT Investigative D00BEA DRUG__ID D00BEA D00BEA DRUGTYPE Small molecular drug D00BEA DRUGINCH 1S/C22H34O5/c1-8-20(5)12-14(24)16-21(6)11-9-10-19(3,4)17(21)15(25)18(26-13(2)23)22(16,7)27-20/h8,15-18,25H,1,9-12H2,2-7H3/t15-,16+,17-,18-,20-,21+,22-/m0/s1 D00BEA DRUGINKE ZKZMDXUDDJYAIB-SUCLLAFCSA-N D00BEA DRUGSMIL CC(=O)OC1C(C2C(CCCC2(C3C1(OC(CC3=O)(C)C=C)C)C)(C)C)O D00BEA HIGHSTAT Investigative D00BEM DRUG__ID D00BEM D00BEM DRUGTYPE Small molecular drug D00BEM DRUGINCH 1S/C15H12N2O/c1-10-4-2-5-11(8-10)13-9-14(18)12-6-3-7-16-15(12)17-13/h2-9H,1H3,(H,16,17,18) D00BEM DRUGINKE IZFIIAGLKAXALT-UHFFFAOYSA-N D00BEM DRUGSMIL CC1=CC(=CC=C1)C2=CC(=O)C3=C(N2)N=CC=C3 D00BEM HIGHSTAT Investigative D00BFT DRUG__ID D00BFT D00BFT DRUGTYPE Small molecular drug D00BFT DRUGINCH 1S/C4H7NO2/c6-4(7)3-1-2-5-3/h3,5H,1-2H2,(H,6,7)/t3-/m0/s1 D00BFT DRUGINKE IADUEWIQBXOCDZ-VKHMYHEASA-N D00BFT DRUGSMIL C1CNC1C(=O)O D00BFT HIGHSTAT Investigative D00BGN DRUG__ID D00BGN D00BGN DRUGTYPE Small molecular drug D00BGN DRUGINCH 1S/C9H8N2O2/c12-7-2-1-3-8(13)9(7)6-4-10-5-11-6/h1-5,12-13H,(H,10,11) D00BGN DRUGINKE VMNQZTQDHXFNPD-UHFFFAOYSA-N D00BGN DRUGSMIL C1=CC(=C(C(=C1)O)C2=CN=CN2)O D00BGN HIGHSTAT Investigative D00BLD DRUG__ID D00BLD D00BLD DRUGTYPE Small molecular drug D00BLD DRUGINCH 1S/C41H32O26/c42-17-1-12(2-18(43)28(17)52)36(57)62-11-27-33(64-37(58)13-3-19(44)29(53)20(45)4-13)34(65-38(59)14-5-21(46)30(54)22(47)6-14)35(66-39(60)15-7-23(48)31(55)24(49)8-15)41(63-27)67-40(61)16-9-25(50)32(56)26(51)10-16/h1-10,27,33-35,41-56H,11H2/t27-,33-,34+,35-,41?/m1/s1/i1D,3D,5D,7D,9D D00BLD DRUGINKE QJYNZEYHSMRWBK-GYNONJAESA-N D00BLD DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O D00BLD HIGHSTAT Investigative D00BLY DRUG__ID D00BLY D00BLY DRUGTYPE Small molecular drug D00BLY DRUGINCH 1S/C11H13NOS/c1-8(2)14-10-5-4-9(7-12)11(6-10)13-3/h4-6,8H,1-3H3 D00BLY DRUGINKE MIAOMCWVGGHYSA-UHFFFAOYSA-N D00BLY DRUGSMIL CC(C)SC1=CC(=C(C=C1)C#N)OC D00BLY HIGHSTAT Investigative D00BMI DRUG__ID D00BMI D00BMI DRUGTYPE Small molecular drug D00BMI DRUGINCH 1S/C2H4N4O2S2/c3-10(7,8)6-2-5-4-1-9-2/h1H,(H,5,6)(H2,3,7,8) D00BMI DRUGINKE TXIIDPYBTNXTDC-UHFFFAOYSA-N D00BMI DRUGSMIL C1=NN=C(S1)NS(=O)(=O)N D00BMI HIGHSTAT Investigative D00BNE DRUG__ID D00BNE D00BNE DRUGTYPE Small molecular drug D00BNE DRUGINCH 1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11-,12-/m0/s1 D00BNE DRUGINKE MSTNYGQPCMXVAQ-RYUDHWBXSA-N D00BNE DRUGSMIL C1C(NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D00BNE HIGHSTAT Investigative D00BSX DRUG__ID D00BSX D00BSX DRUGTYPE Small molecular drug D00BSX DRUGINCH 1S/C15H12O4/c1-7-2-8-4-9-5-10(16)6-12(18)14(9)15(19)13(8)11(17)3-7/h2-3,5-6,16-18H,4H2,1H3 D00BSX DRUGINKE LAJSXCAVRQXZIO-UHFFFAOYSA-N D00BSX DRUGSMIL CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2)C=C(C=C3O)O D00BSX HIGHSTAT Investigative D00BVP DRUG__ID D00BVP D00BVP DRUGTYPE Small molecular drug D00BVP DRUGINCH 1S/C20H16N2O3/c1-24-15-8-6-14(7-9-15)20-17(12-22-11-10-21-13-22)19(23)16-4-2-3-5-18(16)25-20/h2-11,13H,12H2,1H3 D00BVP DRUGINKE GMZSVBKZQWIFKJ-UHFFFAOYSA-N D00BVP DRUGSMIL COC1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)CN4C=CN=C4 D00BVP HIGHSTAT Investigative D00BWZ DRUG__ID D00BWZ D00BWZ DRUGTYPE Small molecular drug D00BWZ DRUGINCH 1S/C14H13N3O/c18-14(16-12-5-3-8-15-10-12)17-9-7-11-4-1-2-6-13(11)17/h1-6,8,10H,7,9H2,(H,16,18) D00BWZ DRUGINKE ODXHNGJYIWHPAG-UHFFFAOYSA-N D00BWZ DRUGSMIL C1CN(C2=CC=CC=C21)C(=O)NC3=CN=CC=C3 D00BWZ HIGHSTAT Investigative D00BXG DRUG__ID D00BXG D00BXG DRUGTYPE Small molecular drug D00BXG DRUGINCH 1S/C37H40N4O5/c38-32(19-27-15-17-31(42)18-16-27)36(44)41-24-29-14-8-7-13-28(29)22-30(41)23-39-33(20-25-9-3-1-4-10-25)35(43)40-34(37(45)46)21-26-11-5-2-6-12-26/h1-18,30,32-34,39,42H,19-24,38H2,(H,40,43)(H,45,46)/t30-,32-,33-,34-/m0/s1 D00BXG DRUGINKE RPKMHCAOERKVEC-DYTOPAQESA-N D00BXG DRUGSMIL C1C(N(CC2=CC=CC=C21)C(=O)C(CC3=CC=C(C=C3)O)N)CNC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)O D00BXG HIGHSTAT Investigative D00CAF DRUG__ID D00CAF D00CAF DRUGTYPE Small molecular drug D00CAF DRUGINCH 1S/C12H14N2/c1-13-7-3-11(4-8-13)12-5-9-14(2)10-6-12/h3-10H,1-2H3/q+2 D00CAF DRUGINKE INFDPOAKFNIJBF-UHFFFAOYSA-N D00CAF DRUGSMIL C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C D00CAF HIGHSTAT Investigative D00CAU DRUG__ID D00CAU D00CAU DRUGTYPE Small molecular drug D00CAU DRUGINCH 1S/C20H31NO2/c1-4-5-6-7-14-23-18-10-8-16(9-11-18)19(22)21-17-12-13-20(2,3)15-17/h8-11,17H,4-7,12-15H2,1-3H3,(H,21,22) D00CAU DRUGINKE SPDGMSMRHOXECU-UHFFFAOYSA-N D00CAU DRUGSMIL CCCCCCOC1=CC=C(C=C1)C(=O)NC2CCC(C2)(C)C D00CAU HIGHSTAT Investigative D00CCV DRUG__ID D00CCV D00CCV DRUGTYPE Small molecular drug D00CCV DRUGINCH 1S/C28H42N4/c1-25-9-7-11-27(23-25)31-19-15-29(16-20-31)13-5-3-4-6-14-30-17-21-32(22-18-30)28-12-8-10-26(2)24-28/h7-12,23-24H,3-6,13-22H2,1-2H3 D00CCV DRUGINKE CQEUVRXXXLSTIL-UHFFFAOYSA-N D00CCV DRUGSMIL CC1=CC(=CC=C1)N2CCN(CC2)CCCCCCN3CCN(CC3)C4=CC=CC(=C4)C D00CCV HIGHSTAT Investigative D00CDF DRUG__ID D00CDF D00CDF DRUGTYPE Small molecular drug D00CDF DRUGINCH 1S/C19H18F3N3O6/c1-11(26)23-12-3-6-14(7-4-12)31-10-18(2,28)17(27)24-13-5-8-16(25(29)30)15(9-13)19(20,21)22/h3-9,28H,10H2,1-2H3,(H,23,26)(H,24,27)/t18-/m0/s1 D00CDF DRUGINKE YVXVTLGIDOACBJ-SFHVURJKSA-N D00CDF DRUGSMIL CC(=O)NC1=CC=C(C=C1)OCC(C)(C(=O)NC2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)O D00CDF HIGHSTAT Investigative D00CDM DRUG__ID D00CDM D00CDM DRUGTYPE Small molecular drug D00CDM DRUGINCH 1S/C14H19NO3/c1-2-5-15-6-7-17-14-11-8-10(16)3-4-13(11)18-9-12(14)15/h3-4,8,12,14,16H,2,5-7,9H2,1H3/t12-,14-/m0/s1 D00CDM DRUGINKE YOILXOMTHPUMRG-JSGCOSHPSA-N D00CDM DRUGSMIL CCCN1CCOC2C1COC3=C2C=C(C=C3)O D00CDM HIGHSTAT Investigative D00CEN DRUG__ID D00CEN D00CEN DRUGTYPE Small molecular drug D00CEN DRUGINCH 1S/C38H48O12/c1-25(16-13-21-27-17-5-3-6-18-27)14-9-10-22-29(39)48-31-30(40)36(23-12-11-15-26(2)24-28-19-7-4-8-20-28)49-32(33(41)42)37(47,34(43)44)38(31,50-36)35(45)46/h3-9,14,17-20,25-26,30-32,40,47H,10-13,15-16,21-24H2,1-2H3,(H,41,42)(H,43,44)(H,45,46)/b14-9+/t25?,26?,30-,31-,32?,36?,37?,38?/m1/s1 D00CEN DRUGINKE ZOTNYZYRJOAANS-OIAIRNFISA-N D00CEN DRUGSMIL CC(CCCCC12C(C(C(O1)(C(C(O2)C(=O)O)(C(=O)O)O)C(=O)O)OC(=O)CCC=CC(C)CCCC3=CC=CC=C3)O)CC4=CC=CC=C4 D00CEN HIGHSTAT Investigative D00CEO DRUG__ID D00CEO D00CEO DRUGTYPE Small molecular drug D00CEO DRUGINCH 1S/C8H12N2O3/c1-5-6(3-2-4-11)9-8(13)10-7(5)12/h11H,2-4H2,1H3,(H2,9,10,12,13) D00CEO DRUGINKE OIEJBPVNLZZLGQ-UHFFFAOYSA-N D00CEO DRUGSMIL CC1=C(NC(=O)NC1=O)CCCO D00CEO HIGHSTAT Investigative D00CGJ DRUG__ID D00CGJ D00CGJ DRUGTYPE Small molecular drug D00CGJ DRUGINCH 1S/C10H14BrNO/c1-7(12)5-8-3-4-9(11)6-10(8)13-2/h3-4,6-7H,5,12H2,1-2H3 D00CGJ DRUGINKE YWONMRKCBJPFCM-UHFFFAOYSA-N D00CGJ DRUGSMIL CC(CC1=C(C=C(C=C1)Br)OC)N D00CGJ HIGHSTAT Investigative D00CHD DRUG__ID D00CHD D00CHD DRUGTYPE Small molecular drug D00CHD DRUGINCH 1S/C20H37NO3/c1-2-3-4-13-16-19(22)21-18-15-12-10-8-6-5-7-9-11-14-17-20(23)24/h6,8H,2-5,7,9-18H2,1H3,(H,21,22)(H,23,24)/b8-6- D00CHD DRUGINKE QCBRCTHDMJHJJU-VURMDHGXSA-N D00CHD DRUGSMIL CCCCCCC(=O)NCCCCC=CCCCCCCC(=O)O D00CHD HIGHSTAT Investigative D00CIW DRUG__ID D00CIW D00CIW DRUGTYPE Small molecular drug D00CIW DRUGINCH 1S/C6H7O3P/c7-10(8,9)6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) D00CIW DRUGINKE QLZHNIAADXEJJP-UHFFFAOYSA-N D00CIW DRUGSMIL C1=CC=C(C=C1)P(=O)(O)O D00CIW HIGHSTAT Investigative D00CJJ DRUG__ID D00CJJ D00CJJ DRUGTYPE Small molecular drug D00CJJ DRUGINCH 1S/C13H12BrN5/c14-13-18-10-11(15)16-8-17-12(10)19(13)7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,15,16,17) D00CJJ DRUGINKE LQIMXMMBTNEKMZ-UHFFFAOYSA-N D00CJJ DRUGSMIL C1=CC=C(C=C1)CCN2C3=NC=NC(=C3N=C2Br)N D00CJJ HIGHSTAT Investigative D00CKY DRUG__ID D00CKY D00CKY DRUGTYPE Small molecular drug D00CKY DRUGINCH 1S/C15H18N2OS/c18-14(15-17-16-12-19-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D00CKY DRUGINKE QUVXRHLPGVMXRU-UHFFFAOYSA-N D00CKY DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CS2 D00CKY HIGHSTAT Investigative D00CLB DRUG__ID D00CLB D00CLB DRUGTYPE Small molecular drug D00CLB DRUGINCH 1S/C31H42N4O3S/c1-22(2)18-27(33-31(37)29-19-24-8-5-6-9-28(24)39-29)30(36)32-25-14-16-35(21-25)20-23-10-12-26(13-11-23)38-17-7-15-34(3)4/h5-6,8-13,19,22,25,27H,7,14-18,20-21H2,1-4H3,(H,32,36)(H,33,37)/t25-,27-/m0/s1 D00CLB DRUGINKE HLMWNBIZKQIDFC-BDYUSTAISA-N D00CLB DRUGSMIL CC(C)CC(C(=O)NC1CCN(C1)CC2=CC=C(C=C2)OCCCN(C)C)NC(=O)C3=CC4=CC=CC=C4S3 D00CLB HIGHSTAT Investigative D00CPI DRUG__ID D00CPI D00CPI DRUGTYPE Small molecular drug D00CPI DRUGINCH 1S/C13H20N2O/c1-2-6-14-7-9-15(10-8-14)12-4-3-5-13(16)11-12/h3-5,11,16H,2,6-10H2,1H3 D00CPI DRUGINKE AWROKCIGUWAVRF-UHFFFAOYSA-N D00CPI DRUGSMIL CCCN1CCN(CC1)C2=CC(=CC=C2)O D00CPI HIGHSTAT Investigative D00CPM DRUG__ID D00CPM D00CPM DRUGTYPE Small molecular drug D00CPM DRUGINCH 1S/C16H13NO2/c1-19-12-8-6-11(7-9-12)16-14(10-18)13-4-2-3-5-15(13)17-16/h2-10,17H,1H3 D00CPM DRUGINKE QIMWZVMNUAWWSJ-UHFFFAOYSA-N D00CPM DRUGSMIL COC1=CC=C(C=C1)C2=C(C3=CC=CC=C3N2)C=O D00CPM HIGHSTAT Investigative D00CQR DRUG__ID D00CQR D00CQR DRUGTYPE Small molecular drug D00CQR DRUGINCH 1S/C9H14O2/c1-7-3-2-4-9(7)5-6-11-8(9)10/h7H,2-6H2,1H3 D00CQR DRUGINKE IDYXKZWAEUMDEE-UHFFFAOYSA-N D00CQR DRUGSMIL CC1CCCC12CCOC2=O D00CQR HIGHSTAT Investigative D00CQT DRUG__ID D00CQT D00CQT DRUGTYPE Small molecular drug D00CQT DRUGINCH 1S/C13H8Cl2O3/c14-10(15)6-5-9-11(16)7-3-1-2-4-8(7)12(17)13(9)18/h1-4,6,16H,5H2 D00CQT DRUGINKE LWQZLQISFLBSGW-UHFFFAOYSA-N D00CQT DRUGSMIL C1=CC=C2C(=C1)C(=C(C(=O)C2=O)CC=C(Cl)Cl)O D00CQT HIGHSTAT Investigative D00CRA DRUG__ID D00CRA D00CRA DRUGTYPE Small molecular drug D00CRA DRUGINCH 1S/C11H14N2O/c1-7-9(4-5-12)10-6-8(14)2-3-11(10)13-7/h2-3,6,13-14H,4-5,12H2,1H3 D00CRA DRUGINKE WYWNEDARFVJQSG-UHFFFAOYSA-N D00CRA DRUGSMIL CC1=C(C2=C(N1)C=CC(=C2)O)CCN D00CRA HIGHSTAT Investigative D00CUZ DRUG__ID D00CUZ D00CUZ DRUGTYPE Small molecular drug D00CUZ DRUGINCH 1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)/i1T3 D00CUZ DRUGINKE RMHMFHUVIITRHF-RLXJOQACSA-N D00CUZ DRUGSMIL CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 D00CUZ HIGHSTAT Investigative D00CVB DRUG__ID D00CVB D00CVB DRUGTYPE Small molecular drug D00CVB DRUGINCH 1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1 D00CVB DRUGINKE MXHRCPNRJAMMIM-SHYZEUOFSA-N D00CVB DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)CO)O D00CVB HIGHSTAT Investigative D00CVD DRUG__ID D00CVD D00CVD DRUGTYPE Small molecular drug D00CVD DRUGINCH 1S/C19H16Cl2O3/c1-10(2)23-16-8-11(3)4-6-13(16)19-17(21)18(22)14-9-12(20)5-7-15(14)24-19/h4-10H,1-3H3 D00CVD DRUGINKE PWGZOUCWGRTPSM-UHFFFAOYSA-N D00CVD DRUGSMIL CC1=CC(=C(C=C1)C2=C(C(=O)C3=C(O2)C=CC(=C3)Cl)Cl)OC(C)C D00CVD HIGHSTAT Investigative D00CWH DRUG__ID D00CWH D00CWH DRUGTYPE Small molecular drug D00CWH DRUGINCH 1S/C7H16N2O/c1-7(2,3)5(8)6(10)9-4/h5H,8H2,1-4H3,(H,9,10) D00CWH DRUGINKE BPKJNEIOHOEWLO-UHFFFAOYSA-N D00CWH DRUGSMIL CC(C)(C)C(C(=O)NC)N D00CWH HIGHSTAT Investigative D00CWN DRUG__ID D00CWN D00CWN DRUGTYPE Small molecular drug D00CWN DRUGINCH 1S/C15H11NO2/c17-12-4-1-10(2-5-12)14-7-3-11-9-13(18)6-8-15(11)16-14/h1-9,17-18H D00CWN DRUGINKE SEKOFPJLRLFURL-UHFFFAOYSA-N D00CWN DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C2)C=C(C=C3)O)O D00CWN HIGHSTAT Investigative D00CYX DRUG__ID D00CYX D00CYX DRUGTYPE Small molecular drug D00CYX DRUGINCH 1S/C45H70N8O16/c1-22(2)17-29(49-43(66)31(20-36(59)60)51-42(65)30(18-23(3)4)50-40(63)27(46)13-15-34(55)56)38(61)33(54)21-47-25(7)39(62)53-37(24(5)6)44(67)48-28(14-16-35(57)58)41(64)52-32(45(68)69)19-26-11-9-8-10-12-26/h8-12,22-25,27-33,37,47,54H,13-21,46H2,1-7H3,(H,48,67)(H,49,66)(H,50,63)(H,51,65)(H,52,64)(H,53,62)(H,55,56)(H,57,58)(H,59,60)(H,68,69)/t25-,27-,28-,29-,30-,31-,32-,33?,37-/m0/s1 D00CYX DRUGINKE WAHCXYBUKGOGCQ-SHELQGHFSA-N D00CYX DRUGSMIL CC(C)CC(C(=O)C(CNC(C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)N D00CYX HIGHSTAT Investigative D00DBR DRUG__ID D00DBR D00DBR DRUGTYPE Small molecular drug D00DBR DRUGINCH 1S/C5H7N5O3/c1-7-3-2(10(12)13)4(11)9-5(6)8-3/h1H3,(H4,6,7,8,9,11) D00DBR DRUGINKE NMCMUSAXKISTKW-UHFFFAOYSA-N D00DBR DRUGSMIL CNC1=C(C(=O)NC(=N1)N)[N+](=O)[O-] D00DBR HIGHSTAT Investigative D00DBV DRUG__ID D00DBV D00DBV DRUGTYPE Small molecular drug D00DBV DRUGINCH 1S/C2H6N2O/c1-4-2(3)5/h1H3,(H3,3,4,5) D00DBV DRUGINKE XGEGHDBEHXKFPX-UHFFFAOYSA-N D00DBV DRUGSMIL CNC(=O)N D00DBV HIGHSTAT Investigative D00DDH DRUG__ID D00DDH D00DDH DRUGTYPE Small molecular drug D00DDH DRUGINCH 1S/C14H27N3O2/c1-4-10(3)9-16-13(18)12-7-6-8-17(12)14(19)11(15)5-2/h10-12H,4-9,15H2,1-3H3,(H,16,18)/t10-,11-,12-/m0/s1 D00DDH DRUGINKE KKFKEHDSJNUMHG-SRVKXCTJSA-N D00DDH DRUGSMIL CCC(C)CNC(=O)C1CCCN1C(=O)C(CC)N D00DDH HIGHSTAT Investigative D00DDJ DRUG__ID D00DDJ D00DDJ DRUGTYPE Small molecular drug D00DDJ DRUGINCH 1S/C15H24N2O/c18-14(17-3-1-16-2-4-17)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13,16H,1-10H2 D00DDJ DRUGINKE XAFSAELWLMDLKL-UHFFFAOYSA-N D00DDJ DRUGSMIL C1CN(CCN1)C(=O)C23CC4CC(C2)CC(C4)C3 D00DDJ HIGHSTAT Investigative D00DDO DRUG__ID D00DDO D00DDO DRUGTYPE Small molecular drug D00DDO DRUGINCH 1S/C13H9BrO3/c14-11-7-9(8-4-2-1-3-5-8)6-10(12(11)15)13(16)17/h1-7,15H,(H,16,17) D00DDO DRUGINKE XVZSXNULHSIRCQ-UHFFFAOYSA-N D00DDO DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C(=C2)Br)O)C(=O)O D00DDO HIGHSTAT Investigative D00DDT DRUG__ID D00DDT D00DDT DRUGTYPE Small molecular drug D00DDT DRUGINCH 1S/C12H19NS/c1-10(13(2)3)9-11-5-7-12(14-4)8-6-11/h5-8,10H,9H2,1-4H3 D00DDT DRUGINKE NFRBJBFYUNQIQP-UHFFFAOYSA-N D00DDT DRUGSMIL CC(CC1=CC=C(C=C1)SC)N(C)C D00DDT HIGHSTAT Investigative D00DEH DRUG__ID D00DEH D00DEH DRUGTYPE Small molecular drug D00DEH DRUGINCH 1S/C17H18ClNO/c18-14-4-3-5-15(12-14)20-17-7-2-1-6-16(17)13-8-10-19-11-9-13/h1-7,12-13,19H,8-11H2 D00DEH DRUGINKE QHHWSRAVBLCPAI-UHFFFAOYSA-N D00DEH DRUGSMIL C1CNCCC1C2=CC=CC=C2OC3=CC(=CC=C3)Cl D00DEH HIGHSTAT Investigative D00DFR DRUG__ID D00DFR D00DFR DRUGTYPE Small molecular drug D00DFR DRUGINCH 1S/C20H20O3/c21-18-12-7-13-19(22-14-16-8-3-1-4-9-16)20(18)23-15-17-10-5-2-6-11-17/h1-12,19-20H,13-15H2/t19-,20-/m1/s1 D00DFR DRUGINKE PHZAKVRYDXRMRQ-WOJBJXKFSA-N D00DFR DRUGSMIL C1C=CC(=O)C(C1OCC2=CC=CC=C2)OCC3=CC=CC=C3 D00DFR HIGHSTAT Investigative D00DHM DRUG__ID D00DHM D00DHM DRUGTYPE Small molecular drug D00DHM DRUGINCH 1S/C21H29N3O/c1-12-15-10-18-16(14-7-6-8-17(22-12)19(14)15)9-13(11-24(18)5)23-20(25)21(2,3)4/h6-8,13,16,18,22H,9-11H2,1-5H3,(H,23,25) D00DHM DRUGINKE ZNMWUMGOSWLWOH-UHFFFAOYSA-N D00DHM DRUGSMIL CC1=C2CC3C(CC(CN3C)NC(=O)C(C)(C)C)C4=C2C(=CC=C4)N1 D00DHM HIGHSTAT Investigative D00DHV DRUG__ID D00DHV D00DHV DRUGTYPE Small molecular drug D00DHV DRUGINCH 1S/C10H12N4S/c1-6-15-9-8(1)12-7-13-10(9)14-4-2-11-3-5-14/h1,6-7,11H,2-5H2 D00DHV DRUGINKE GVNSLBIXJYZCCB-UHFFFAOYSA-N D00DHV DRUGSMIL C1CN(CCN1)C2=NC=NC3=C2SC=C3 D00DHV HIGHSTAT Investigative D00DIF DRUG__ID D00DIF D00DIF DRUGTYPE Small molecular drug D00DIF DRUGINCH 1S/C16H23N5/c1-11-10-15(18-14-7-5-4-6-8-14)19-16(17-11)21-13(3)9-12(2)20-21/h9-10,14H,4-8H2,1-3H3,(H,17,18,19) D00DIF DRUGINKE USEMRPYUFJNFQN-UHFFFAOYSA-N D00DIF DRUGSMIL CC1=CC(=NC(=N1)N2C(=CC(=N2)C)C)NC3CCCCC3 D00DIF HIGHSTAT Investigative D00DJC DRUG__ID D00DJC D00DJC DRUGCOMP China Pharmaceutical University D00DJC DRUGINCH 1S/C23H31ClN4O5/c1-4-33-22(30)20-17(13-32-12-11-27-23-25-9-10-26-23)28-14(2)18(21(29)31-3)19(20)15-7-5-6-8-16(15)24/h5-8,17,19-20,28H,4,9-13H2,1-3H3,(H2,25,26,27) D00DJC DRUGINKE LXRRBJNJPCPMOH-UHFFFAOYSA-N D00DJC DRUGSMIL CCOC(=O)C1C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCNC3=NCCN3 D00DJC HIGHSTAT Investigative D00DJE DRUG__ID D00DJE D00DJE DRUGTYPE Small molecular drug D00DJE DRUGINCH 1S/C17H15N3/c1-2-6-13-10-14(9-12(13)5-1)20-17-15-7-3-4-8-16(15)18-11-19-17/h1-8,11,14H,9-10H2,(H,18,19,20) D00DJE DRUGINKE CLVFUKGYGOFREN-UHFFFAOYSA-N D00DJE DRUGSMIL C1C(CC2=CC=CC=C21)NC3=NC=NC4=CC=CC=C43 D00DJE HIGHSTAT Investigative D00DJX DRUG__ID D00DJX D00DJX DRUGTYPE Small molecular drug D00DJX DRUGINCH 1S/C30H31NO5/c32-21-7-11-26-27(18-21)35-16-12-25-24-10-6-22(33)19-28(24)36-30(29(25)26)20-4-8-23(9-5-20)34-17-15-31-13-2-1-3-14-31/h4-11,18-19,30,32-33H,1-3,12-17H2/t30-/m1/s1 D00DJX DRUGINKE OFYZVZJXVRFMIW-SSEXGKCCSA-N D00DJX DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)C3C4=C(CCOC5=C4C=CC(=C5)O)C6=C(O3)C=C(C=C6)O D00DJX HIGHSTAT Investigative D00DLU DRUG__ID D00DLU D00DLU DRUGTYPE Small molecular drug D00DLU DRUGINCH 1S/C20H19Cl2F6NO2/c1-2-3-8-29(11-12-9-15(21)17(30)16(22)10-12)14-6-4-13(5-7-14)18(31,19(23,24)25)20(26,27)28/h4-7,9-10,30-31H,2-3,8,11H2,1H3 D00DLU DRUGINKE TYYLMKBOWXDDCT-UHFFFAOYSA-N D00DLU DRUGSMIL CCCCN(CC1=CC(=C(C(=C1)Cl)O)Cl)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O D00DLU HIGHSTAT Investigative D00DNT DRUG__ID D00DNT D00DNT DRUGTYPE Small molecular drug D00DNT DRUGINCH 1S/C20H32O/c1-4-5-6-14-20(2,3)18-12-10-16(11-13-18)17-8-7-9-19(21)15-17/h10-13,17,19,21H,4-9,14-15H2,1-3H3/t17-,19-/m1/s1 D00DNT DRUGINKE RGRMJFXCHLLHAS-IEBWSBKVSA-N D00DNT DRUGSMIL CCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D00DNT HIGHSTAT Investigative D00DNY DRUG__ID D00DNY D00DNY DRUGTYPE Small molecular drug D00DNY DRUGINCH 1S/C17H14N2/c1-10-14-9-18-8-7-12(14)11(2)17-16(10)13-5-3-4-6-15(13)19-17/h3-9,19H,1-2H3 D00DNY DRUGINKE CTSPAMFJBXKSOY-UHFFFAOYSA-N D00DNY DRUGSMIL CC1=C2C=CN=CC2=C(C3=C1NC4=CC=CC=C43)C D00DNY HIGHSTAT Investigative D00DPX DRUG__ID D00DPX D00DPX DRUGTYPE Small molecular drug D00DPX DRUGINCH 1S/C30H32N6O3/c1-38-18-17-36-29(32-33-34-36)28(26-20-24-19-25(39-2)13-14-27(24)31-30(26)37)35(21-23-11-7-4-8-12-23)16-15-22-9-5-3-6-10-22/h3-14,19-20,28H,15-18,21H2,1-2H3,(H,31,37) D00DPX DRUGINKE JKKKHIBCTKIWFJ-UHFFFAOYSA-N D00DPX DRUGSMIL COCCN1C(=NN=N1)C(C2=CC3=C(C=CC(=C3)OC)NC2=O)N(CCC4=CC=CC=C4)CC5=CC=CC=C5 D00DPX HIGHSTAT Investigative D00DQZ DRUG__ID D00DQZ D00DQZ DRUGTYPE Small molecular drug D00DQZ DRUGINCH 1S/C17H23NO3S/c1-14(19)22-13-16(20)11-7-2-3-8-12-17(21)18-15-9-5-4-6-10-15/h4-6,9-10H,2-3,7-8,11-13H2,1H3,(H,18,21) D00DQZ DRUGINKE OCDCFMXSXAYLLI-UHFFFAOYSA-N D00DQZ DRUGSMIL CC(=O)SCC(=O)CCCCCCC(=O)NC1=CC=CC=C1 D00DQZ HIGHSTAT Investigative D00DSE DRUG__ID D00DSE D00DSE DRUGTYPE Small molecular drug D00DSE DRUGINCH 1S/C18H14FN/c19-18-3-1-2-17(13-18)16-6-4-14(5-7-16)12-15-8-10-20-11-9-15/h1-11,13H,12H2 D00DSE DRUGINKE NDUUGOAGHNLAIZ-UHFFFAOYSA-N D00DSE DRUGSMIL C1=CC(=CC(=C1)F)C2=CC=C(C=C2)CC3=CC=NC=C3 D00DSE HIGHSTAT Investigative D00DSQ DRUG__ID D00DSQ D00DSQ DRUGTYPE Small molecular drug D00DSQ DRUGINCH 1S/C14H14BrN3OS/c15-11-3-6-13(17-9-11)18-14(20)16-8-7-10-1-4-12(19)5-2-10/h1-6,9,19H,7-8H2,(H2,16,17,18,20) D00DSQ DRUGINKE UAUYJJLEWDLTLK-UHFFFAOYSA-N D00DSQ DRUGSMIL C1=CC(=CC=C1CCNC(=S)NC2=NC=C(C=C2)Br)O D00DSQ HIGHSTAT Investigative D00DSW DRUG__ID D00DSW D00DSW DRUGTYPE Small molecular drug D00DSW DRUGINCH 1S/C28H20N4O3S/c1-19-27(26(33)16-15-20-9-8-14-23(17-20)32(34)35)36-28(29-19)31-25(22-12-6-3-7-13-22)18-24(30-31)21-10-4-2-5-11-21/h2-18H,1H3/b16-15+ D00DSW DRUGINKE CJUKTJXWIFOPJJ-FOCLMDBBSA-N D00DSW DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC(=CC=C5)[N+](=O)[O-] D00DSW HIGHSTAT Investigative D00DUJ DRUG__ID D00DUJ D00DUJ DRUGTYPE Small molecular drug D00DUJ DRUGINCH 1S/C19H13N/c1-2-8-16-14(6-1)12-19(15-7-5-11-20-13-15)18-10-4-3-9-17(16)18/h1-13H D00DUJ DRUGINKE PNVGXPZDAYDCKZ-UHFFFAOYSA-N D00DUJ DRUGSMIL C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)C4=CN=CC=C4 D00DUJ HIGHSTAT Investigative D00DXB DRUG__ID D00DXB D00DXB DRUGTYPE Small molecular drug D00DXB DRUGINCH 1S/C8H15NO2S/c10-8(11)7(5-12)6-2-1-3-9-4-6/h6-7,9,12H,1-5H2,(H,10,11) D00DXB DRUGINKE ZEKJYPSRDZCIDP-UHFFFAOYSA-N D00DXB DRUGSMIL C1CC(CNC1)C(CS)C(=O)O D00DXB HIGHSTAT Investigative D00DXI DRUG__ID D00DXI D00DXI DRUGTYPE Small molecular drug D00DXI DRUGINCH 1S/C15H17N3O4S/c1-8-4-10(3)15(23(20,21)22)7-12(8)17-18-13-5-9(2)14(19)6-11(13)16/h4-7,19H,16H2,1-3H3,(H,20,21,22) D00DXI DRUGINKE UUECJWRVDTUDCB-UHFFFAOYSA-N D00DXI DRUGSMIL CC1=CC(=C(C=C1N=NC2=C(C=C(C(=C2)C)O)N)S(=O)(=O)O)C D00DXI HIGHSTAT Investigative D00DXV DRUG__ID D00DXV D00DXV DRUGTYPE Small molecular drug D00DXV DRUGINCH 1S/C24H23BrN4O8S2/c1-34-19-9-18(30)15(20(21(19)25)23(31)35-2)10-38-11-17(22-28-37-8-7-36-22)27-24-26-16(12-39-24)13-3-5-14(6-4-13)29(32)33/h3-6,9,12,17,30H,7-8,10-11H2,1-2H3,(H,26,27)/t17-/m0/s1 D00DXV DRUGINKE MRGBDARDZKENAD-KRWDZBQOSA-N D00DXV DRUGSMIL COC1=C(C(=C(C(=C1)O)CSCC(C2=NOCCO2)NC3=NC(=CS3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)OC)Br D00DXV HIGHSTAT Investigative D00DZY DRUG__ID D00DZY D00DZY DRUGTYPE Small molecular drug D00DZY DRUGINCH 1S/C16H18N2O2S/c19-21(20,14-6-2-1-3-7-14)16-9-5-4-8-15(16)18-12-10-17-11-13-18/h1-9,17H,10-13H2 D00DZY DRUGINKE QHMSQHVDMJCBCI-UHFFFAOYSA-N D00DZY DRUGSMIL C1CN(CCN1)C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C3 D00DZY HIGHSTAT Investigative D00ECV DRUG__ID D00ECV D00ECV DRUGTYPE Small molecular drug D00ECV DRUGINCH 1S/C23H25NO8S3/c1-16(24-33(4,25)26)17-5-10-20(11-6-17)34(27,28)22-14-9-19(32-3)15-23(22)35(29,30)21-12-7-18(31-2)8-13-21/h5-16,24H,1-4H3/i2-1 D00ECV DRUGINKE NXODIUKWAVUFGF-JVVVGQRLSA-N D00ECV DRUGSMIL CC(C1=CC=C(C=C1)S(=O)(=O)C2=C(C=C(C=C2)OC)S(=O)(=O)C3=CC=C(C=C3)OC)NS(=O)(=O)C D00ECV HIGHSTAT Investigative D00EFA DRUG__ID D00EFA D00EFA DRUGTYPE Small molecular drug D00EFA DRUGINCH 1S/C20H22N4O2/c25-19(22-16-4-2-1-3-5-16)23-17-10-14-11-20(26-18(14)21-12-17)13-24-8-6-15(20)7-9-24/h1-5,10,12,15H,6-9,11,13H2,(H2,22,23,25)/t20-/m0/s1 D00EFA DRUGINKE BUOWEYLLAFLKCW-FQEVSTJZSA-N D00EFA DRUGSMIL C1CN2CCC1C3(C2)CC4=C(O3)N=CC(=C4)NC(=O)NC5=CC=CC=C5 D00EFA HIGHSTAT Investigative D00EHP DRUG__ID D00EHP D00EHP DRUGTYPE Small molecular drug D00EHP DRUGINCH 1S/C15H19NO2S/c1-10-6-12(3)15(13(4)7-10)19(17,18)16-9-11(2)8-14(16)5/h6-9H,1-5H3 D00EHP DRUGINKE AFZWZVLPIMHLSE-UHFFFAOYSA-N D00EHP DRUGSMIL CC1=CC(=C(C(=C1)C)S(=O)(=O)N2C=C(C=C2C)C)C D00EHP HIGHSTAT Investigative D00EJS DRUG__ID D00EJS D00EJS DRUGTYPE Small molecular drug D00EJS DRUGINCH 1S/C8H7NO/c10-7-1-2-8-6(5-7)3-4-9-8/h1-5,9-10H D00EJS DRUGINKE LMIQERWZRIFWNZ-UHFFFAOYSA-N D00EJS DRUGSMIL C1=CC2=C(C=CN2)C=C1O D00EJS HIGHSTAT Investigative D00EMF DRUG__ID D00EMF D00EMF DRUGTYPE Small molecular drug D00EMF DRUGINCH 1S/C21H19ClN4O2/c1-13-10-15-7-9-26(18(15)11-17(13)22)21(27)25-16-5-6-20(24-12-16)28-19-4-3-8-23-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,25,27) D00EMF DRUGINKE GIUZEIJUFOPTMR-UHFFFAOYSA-N D00EMF DRUGSMIL CC1=CC2=C(C=C1Cl)N(CC2)C(=O)NC3=CN=C(C=C3)OC4=C(N=CC=C4)C D00EMF HIGHSTAT Investigative D00EMH DRUG__ID D00EMH D00EMH DRUGTYPE Small molecular drug D00EMH DRUGINCH 1S/C29H32ClFN8O3/c1-29(2)14-22(36-28(42)39-11-4-5-12-39)26(41)35-21-13-16(9-10-18(21)29)34-27-33-15-19(30)24(38-27)37-23-17(25(40)32-3)7-6-8-20(23)31/h6-10,13,15,22H,4-5,11-12,14H2,1-3H3,(H,32,40)(H,35,41)(H,36,42)(H2,33,34,37,38)/t22-/m1/s1 D00EMH DRUGINKE HGSNUBHWAMMKIR-JOCHJYFZSA-N D00EMH DRUGSMIL CC1(CC(C(=O)NC2=C1C=CC(=C2)NC3=NC=C(C(=N3)NC4=C(C=CC=C4F)C(=O)NC)Cl)NC(=O)N5CCCC5)C D00EMH HIGHSTAT Investigative D00ENC DRUG__ID D00ENC D00ENC DRUGTYPE Small molecular drug D00ENC DRUGINCH 1S/C5H8O3/c1-4(6)2-3-5(7)8/h2-4,6H,1H3,(H,7,8)/b3-2+ D00ENC DRUGINKE YANJKPZKTWMMOF-NSCUHMNNSA-N D00ENC DRUGSMIL CC(C=CC(=O)O)O D00ENC HIGHSTAT Investigative D00ENR DRUG__ID D00ENR D00ENR DRUGTYPE Small molecular drug D00ENR DRUGINCH 1S/C17H14O4/c1-2-12(18)11-7-6-10-8-9-4-3-5-13(19)14(9)17(21)15(10)16(11)20/h3-7,19-20H,2,8H2,1H3 D00ENR DRUGINKE KGAHUIIBPUKUER-UHFFFAOYSA-N D00ENR DRUGSMIL CCC(=O)C1=C(C2=C(CC3=C(C2=O)C(=CC=C3)O)C=C1)O D00ENR HIGHSTAT Investigative D00EOD DRUG__ID D00EOD D00EOD DRUGTYPE Small molecular drug D00EOD DRUGINCH 1S/C20H22O7/c1-5-10(2)18(23)26-15-8-20(4)16(22)7-13(27-20)12(9-21)6-14-17(15)11(3)19(24)25-14/h5-7,14-15,17,21H,3,8-9H2,1-2,4H3/b10-5-,12-6-/t14-,15+,17+,20-/m1/s1 D00EOD DRUGINKE BMVJFNLJSZHNNS-YUDFMKBLSA-N D00EOD DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=CC3C1C(=C)C(=O)O3)CO)C D00EOD HIGHSTAT Investigative D00EOP DRUG__ID D00EOP D00EOP DRUGTYPE Small molecular drug D00EOP DRUGINCH 1S/C22H20N2O4S/c1-14-18(23-21(28-14)16-5-3-2-4-6-16)11-12-27-17-9-7-15(8-10-17)13-19-20(25)24-22(26)29-19/h2-10,19H,11-13H2,1H3,(H,24,25,26) D00EOP DRUGINKE GUTCYOKMCPFRGH-UHFFFAOYSA-N D00EOP DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC4C(=O)NC(=O)S4 D00EOP HIGHSTAT Investigative D00EPD DRUG__ID D00EPD D00EPD DRUGTYPE Small molecular drug D00EPD DRUGINCH 1S/C10H7ClN2O3S/c11-7-3-1-2-4-8(7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D00EPD DRUGINKE FTLDTGWMVVXYAM-UHFFFAOYSA-N D00EPD DRUGSMIL C1=CC=C(C(=C1)S(=O)(=O)C2=NNC(=O)C=C2)Cl D00EPD HIGHSTAT Investigative D00EPL DRUG__ID D00EPL D00EPL DRUGTYPE Small molecular drug D00EPL DRUGINCH 1S/C19H19N5/c1-3-7-16-14(5-1)13-15-6-2-4-8-17(15)24-18(16)21-22-19(24)23-11-9-20-10-12-23/h1-8,20H,9-13H2 D00EPL DRUGINKE GXFWOMYQHNODFA-UHFFFAOYSA-N D00EPL DRUGSMIL C1CN(CCN1)C2=NN=C3N2C4=CC=CC=C4CC5=CC=CC=C53 D00EPL HIGHSTAT Investigative D00EPM DRUG__ID D00EPM D00EPM DRUGTYPE Small molecular drug D00EPM DRUGINCH 1S/C13H8ClFN4O/c14-9-1-2-12(17-7-9)19-13(20)18-11-4-8(6-16)3-10(15)5-11/h1-5,7H,(H2,17,18,19,20) D00EPM DRUGINKE KDANLHLWAYNCMV-UHFFFAOYSA-N D00EPM DRUGSMIL C1=CC(=NC=C1Cl)NC(=O)NC2=CC(=CC(=C2)C#N)F D00EPM HIGHSTAT Investigative D00ERW DRUG__ID D00ERW D00ERW DRUGTYPE Small molecular drug D00ERW DRUGINCH 1S/C20H18ClN7O3S/c21-13-5-15-17(6-14(13)24-9-12-8-23-11-32-12)30-3-1-2-4-31-19-16(7-22)25-10-18(27-19)28-20(29)26-15/h5-6,8,10-11,24H,1-4,9H2,(H2,26,27,28,29) D00ERW DRUGINKE AZTMYWWWILJAKW-UHFFFAOYSA-N D00ERW DRUGSMIL C1CCOC2=NC(=CN=C2C#N)NC(=O)NC3=CC(=C(C=C3OC1)NCC4=CN=CS4)Cl D00ERW HIGHSTAT Investigative D00ESG DRUG__ID D00ESG D00ESG DRUGTYPE Small molecular drug D00ESG DRUGINCH 1S/C10H14N4O/c11-10(15)14-7-5-13(6-8-14)9-3-1-2-4-12-9/h1-4H,5-8H2,(H2,11,15) D00ESG DRUGINKE XYIDWLYTWKIZQC-UHFFFAOYSA-N D00ESG DRUGSMIL C1CN(CCN1C2=CC=CC=N2)C(=O)N D00ESG HIGHSTAT Investigative D00EUD DRUG__ID D00EUD D00EUD DRUGTYPE Small molecular drug D00EUD DRUGINCH 1S/C11H17NS/c1-3-10(12)8-9-4-6-11(13-2)7-5-9/h4-7,10H,3,8,12H2,1-2H3 D00EUD DRUGINKE DTEDVKORISMLCH-UHFFFAOYSA-N D00EUD DRUGSMIL CCC(CC1=CC=C(C=C1)SC)N D00EUD HIGHSTAT Investigative D00EUE DRUG__ID D00EUE D00EUE DRUGTYPE Small molecular drug D00EUE DRUGINCH 1S/C3H7NO5S2/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1 D00EUE DRUGINKE NOKPBJYHPHHWAN-REOHCLBHSA-N D00EUE DRUGSMIL C(C(C(=O)O)N)SS(=O)(=O)O D00EUE HIGHSTAT Investigative D00EVC DRUG__ID D00EVC D00EVC DRUGTYPE Small molecular drug D00EVC DRUGINCH 1S/C10H16N2/c1-7(2)4-9-5-8(3)6-10(11)12-9/h5-7H,4H2,1-3H3,(H2,11,12) D00EVC DRUGINKE VMTPVCVORKDABN-UHFFFAOYSA-N D00EVC DRUGSMIL CC1=CC(=NC(=C1)N)CC(C)C D00EVC HIGHSTAT Investigative D00EWP DRUG__ID D00EWP D00EWP DRUGTYPE Small molecular drug D00EWP DRUGINCH 1S/C18H14N2O4/c1-9(21)19-11-3-5-13-15(7-11)18(24)16-8-12(20-10(2)22)4-6-14(16)17(13)23/h3-8H,1-2H3,(H,19,21)(H,20,22) D00EWP DRUGINKE SNSGXIQBZKNIJT-UHFFFAOYSA-N D00EWP DRUGSMIL CC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)C D00EWP HIGHSTAT Investigative D00EYY DRUG__ID D00EYY D00EYY DRUGTYPE Small molecular drug D00EYY DRUGINCH 1S/C33H41N5O3.ClH/c1-7-8-15-38-31-25(13-10-14-35-31)28(23-11-9-12-24(18-23)41-6)30(32(38)39)37-33(40)36-29-26(20(2)3)16-22(19-34)17-27(29)21(4)5;/h9-14,16-18,20-21H,7-8,15,19,34H2,1-6H3,(H2,36,37,40);1H D00EYY DRUGINKE SZCBDIVMCGFVPW-UHFFFAOYSA-N D00EYY DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)CN)C(C)C)C4=CC(=CC=C4)OC.Cl D00EYY HIGHSTAT Investigative D00FAY DRUG__ID D00FAY D00FAY DRUGTYPE Small molecular drug D00FAY DRUGINCH 1S/C10H10N2S/c11-9-2-1-7(5-10(9)12)8-3-4-13-6-8/h1-6H,11-12H2 D00FAY DRUGINKE OZEWMDJTNVDPJN-UHFFFAOYSA-N D00FAY DRUGSMIL C1=CC(=C(C=C1C2=CSC=C2)N)N D00FAY HIGHSTAT Investigative D00FCF DRUG__ID D00FCF D00FCF DRUGTYPE Small molecular drug D00FCF DRUGINCH 1S/C28H30N2O4/c31-25-21-13-11-19(29-27(33)17-7-3-1-4-8-17)15-23(21)26(32)24-16-20(12-14-22(24)25)30-28(34)18-9-5-2-6-10-18/h11-18H,1-10H2,(H,29,33)(H,30,34) D00FCF DRUGINKE ISUCEGSINPVOBA-UHFFFAOYSA-N D00FCF DRUGSMIL C1CCC(CC1)C(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)C5CCCCC5 D00FCF HIGHSTAT Investigative D00FCJ DRUG__ID D00FCJ D00FCJ DRUGTYPE Small molecular drug D00FCJ DRUGINCH 1S/C18H21N3O3/c1-12-3-2-4-15(11-12)24-14-7-5-13(6-8-14)21-17(22)10-9-16(19)18(20)23/h2-8,11,16H,9-10,19H2,1H3,(H2,20,23)(H,21,22)/t16-/m0/s1 D00FCJ DRUGINKE JZBKUKPJKVOVGL-INIZCTEOSA-N D00FCJ DRUGSMIL CC1=CC(=CC=C1)OC2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D00FCJ HIGHSTAT Investigative D00FDS DRUG__ID D00FDS D00FDS DRUGTYPE Small molecular drug D00FDS DRUGINCH 1S/C18H21NO2/c1-2-7-17(8-3-1)21-18-11-9-16(10-12-18)20-14-15-6-4-5-13-19-15/h1-3,7-12,15,19H,4-6,13-14H2/t15-/m1/s1 D00FDS DRUGINKE CSJNBXMUZIPBKQ-OAHLLOKOSA-N D00FDS DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)OC3=CC=CC=C3 D00FDS HIGHSTAT Investigative D00FEH DRUG__ID D00FEH D00FEH DRUGTYPE Small molecular drug D00FEH DRUGINCH 1S/C30H36O6/c1-17(2)12-13-29(5,34)30(6)16-21-26(33)25(22(31)14-18(3)4)28-24(27(21)36-30)20(15-23(32)35-28)19-10-8-7-9-11-19/h7-11,15,17-18,33-34H,12-14,16H2,1-6H3 D00FEH DRUGINKE PABMLJMVAOFHKY-UHFFFAOYSA-N D00FEH DRUGSMIL CC(C)CCC(C)(C1(CC2=C(C(=C3C(=C2O1)C(=CC(=O)O3)C4=CC=CC=C4)C(=O)CC(C)C)O)C)O D00FEH HIGHSTAT Investigative D00FGA DRUG__ID D00FGA D00FGA DRUGTYPE Small molecular drug D00FGA DRUGINCH 1S/C5H8N2/c6-5-7-3-1-2-4-7/h1-4H2 D00FGA DRUGINKE QJRYYOWARFCJQZ-UHFFFAOYSA-N D00FGA DRUGSMIL C1CCN(C1)C#N D00FGA HIGHSTAT Investigative D00FGB DRUG__ID D00FGB D00FGB DRUGTYPE Small molecular drug D00FGB DRUGINCH 1S/C11H14N2O3S/c1-7(14)13-10-4-8-2-3-11(17(12,15)16)6-9(8)5-10/h2-3,6,10H,4-5H2,1H3,(H,13,14)(H2,12,15,16) D00FGB DRUGINKE RVPDXKXWYPPTAL-UHFFFAOYSA-N D00FGB DRUGSMIL CC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D00FGB HIGHSTAT Investigative D00FHZ DRUG__ID D00FHZ D00FHZ DRUGTYPE Small molecular drug D00FHZ DRUGINCH 1S/C12H13N3O/c16-11-2-1-10-12(15-11)9(7-14-10)8-3-5-13-6-4-8/h1-3,7,13-14H,4-6H2,(H,15,16) D00FHZ DRUGINKE PJYVGMRFPFNZCT-UHFFFAOYSA-N D00FHZ DRUGSMIL C1CNCC=C1C2=CNC3=C2NC(=O)C=C3 D00FHZ HIGHSTAT Investigative D00FIE DRUG__ID D00FIE D00FIE DRUGTYPE Small molecular drug D00FIE DRUGINCH 1S/C16H12N2O2/c19-9-8-18-13-7-3-6-12-14(13)15(17-18)10-4-1-2-5-11(10)16(12)20/h1-7,19H,8-9H2 D00FIE DRUGINKE IWTWHJYONHLOQB-UHFFFAOYSA-N D00FIE DRUGSMIL C1=CC=C2C(=C1)C3=NN(C4=CC=CC(=C43)C2=O)CCO D00FIE HIGHSTAT Investigative D00FIT DRUG__ID D00FIT D00FIT DRUGTYPE Small molecular drug D00FIT DRUGINCH 1S/C17H21N5O/c1-12(23)14(9-5-8-13-6-3-2-4-7-13)22-11-21-15-16(18)19-10-20-17(15)22/h2-4,6-7,10-12,14,23H,5,8-9H2,1H3,(H2,18,19,20)/t12-,14+/m0/s1 D00FIT DRUGINKE KTRFRUCNFHFSAF-GXTWGEPZSA-N D00FIT DRUGSMIL CC(C(CCCC1=CC=CC=C1)N2C=NC3=C(N=CN=C32)N)O D00FIT HIGHSTAT Investigative D00FJT DRUG__ID D00FJT D00FJT DRUGTYPE Small molecular drug D00FJT DRUGINCH 1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1/i1-1 D00FJT DRUGINKE HXTGXYRHXAGCFP-AVUPQLEMSA-N D00FJT DRUGSMIL COC1=CC=CC(=C1OC)C(C2CCN(CC2)CCC3=CC=C(C=C3)F)O D00FJT HIGHSTAT Investigative D00FLQ DRUG__ID D00FLQ D00FLQ DRUGTYPE Small molecular drug D00FLQ DRUGINCH 1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33-/m0/s1 D00FLQ DRUGINKE PGOLWKTUHWHYJS-VRJYPAKCSA-N D00FLQ DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D00FLQ HIGHSTAT Investigative D00FLT DRUG__ID D00FLT D00FLT DRUGTYPE Small molecular drug D00FLT DRUGINCH 1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1 D00FLT DRUGINKE LMXOHSDXUQEUSF-YECHIGJVSA-N D00FLT DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CC(CCC(C(=O)O)N)N)O)O)N D00FLT HIGHSTAT Investigative D00FMX DRUG__ID D00FMX D00FMX DRUGTYPE Small molecular drug D00FMX DRUGINCH 1S/C17H20N2O/c1-13-5-2-3-7-16(13)20-17-15(6-4-10-19-17)14-8-11-18-12-9-14/h2-7,10,14,18H,8-9,11-12H2,1H3 D00FMX DRUGINKE BLKKGRNFYMEBJN-UHFFFAOYSA-N D00FMX DRUGSMIL CC1=CC=CC=C1OC2=C(C=CC=N2)C3CCNCC3 D00FMX HIGHSTAT Investigative D00FOZ DRUG__ID D00FOZ D00FOZ DRUGTYPE Small molecular drug D00FOZ DRUGINCH 1S/C14H20N2O3/c1-4-5-9-18-13-8-6-7-12(10-13)15-14(17)19-16-11(2)3/h6-8,10H,4-5,9H2,1-3H3,(H,15,17) D00FOZ DRUGINKE GNTLUXBWYDMBFL-UHFFFAOYSA-N D00FOZ DRUGSMIL CCCCOC1=CC=CC(=C1)NC(=O)ON=C(C)C D00FOZ HIGHSTAT Investigative D00FPB DRUG__ID D00FPB D00FPB DRUGTYPE Small molecular drug D00FPB DRUGINCH 1S/C5H10O3/c1-4(3-6)2-5(7)8/h4,6H,2-3H2,1H3,(H,7,8) D00FPB DRUGINKE ZGYGEPZZMAXSKH-UHFFFAOYSA-N D00FPB DRUGSMIL CC(CC(=O)O)CO D00FPB HIGHSTAT Investigative D00FPG DRUG__ID D00FPG D00FPG DRUGTYPE Small molecular drug D00FPG DRUGINCH 1S/C10H10N2O/c1-12-6-8(10(11)13)7-4-2-3-5-9(7)12/h2-6H,1H3,(H2,11,13) D00FPG DRUGINKE UHQHFXKJFJHBAE-UHFFFAOYSA-N D00FPG DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)N D00FPG HIGHSTAT Investigative D00FPI DRUG__ID D00FPI D00FPI DRUGTYPE Small molecular drug D00FPI DRUGINCH 1S/C42H38N2O8/c1-45-35-7-5-25-15-33-29-19-39-37(49-23-51-39)17-27(29)9-11-43(33)21-31(25)41(35)47-13-3-4-14-48-42-32-22-44-12-10-28-18-38-40(52-24-50-38)20-30(28)34(44)16-26(32)6-8-36(42)46-2/h5-8,15-22H,3-4,9-14,23-24H2,1-2H3/q+2 D00FPI DRUGINKE SJALLAIALHPUMH-UHFFFAOYSA-N D00FPI DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=C(C=CC7=CC8=[N+](CCC9=CC1=C(C=C98)OCO1)C=C76)OC D00FPI HIGHSTAT Investigative D00FPJ DRUG__ID D00FPJ D00FPJ DRUGTYPE Small molecular drug D00FPJ DRUGINCH 1S/C15H10O5/c16-8-3-1-7(2-4-8)12-14(19)10-5-9(17)6-11(18)13(10)15(12)20/h1-6,12,16-18H D00FPJ DRUGINKE GXKXWCKNQMYETG-UHFFFAOYSA-N D00FPJ DRUGSMIL C1=CC(=CC=C1C2C(=O)C3=C(C2=O)C(=CC(=C3)O)O)O D00FPJ HIGHSTAT Investigative D00FPT DRUG__ID D00FPT D00FPT DRUGTYPE Small molecular drug D00FPT DRUGINCH 1S/C11H18N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H6-,12,13,14,19,20,21,22,23,24,25,26)/p+1/t4-,6-,7-,10-/m1/s1 D00FPT DRUGINKE DKVRNHPCAOHRSI-KQYNXXCUSA-O D00FPT DRUGSMIL CN1C=[N+](C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D00FPT HIGHSTAT Investigative D00FTQ DRUG__ID D00FTQ D00FTQ DRUGTYPE Small molecular drug D00FTQ DRUGINCH 1S/C8H16O3/c1-2-3-4-5-7(9)6-8(10)11/h7,9H,2-6H2,1H3,(H,10,11) D00FTQ DRUGINKE NDPLAKGOSZHTPH-UHFFFAOYSA-N D00FTQ DRUGSMIL CCCCCC(CC(=O)O)O D00FTQ HIGHSTAT Investigative D00FUO DRUG__ID D00FUO D00FUO DRUGTYPE Small molecular drug D00FUO DRUGINCH 1S/C29H31NO2/c1-31-26-14-16-28-24(21-26)11-15-27(22-7-3-2-4-8-22)29(28)23-9-12-25(13-10-23)32-20-19-30-17-5-6-18-30/h2-4,7-10,12-14,16,21H,5-6,11,15,17-20H2,1H3 D00FUO DRUGINKE JEYWNNAZDLFBFF-UHFFFAOYSA-N D00FUO DRUGSMIL COC1=CC2=C(C=C1)C(=C(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5 D00FUO HIGHSTAT Investigative D00FUS DRUG__ID D00FUS D00FUS DRUGTYPE Small molecular drug D00FUS DRUGINCH 1S/C10H15NO/c1-8(11)7-9-5-3-4-6-10(9)12-2/h3-6,8H,7,11H2,1-2H3 D00FUS DRUGINKE VBAHFEPKESUPDE-UHFFFAOYSA-N D00FUS DRUGSMIL CC(CC1=CC=CC=C1OC)N D00FUS HIGHSTAT Investigative D00FUT DRUG__ID D00FUT D00FUT DRUGTYPE Small molecular drug D00FUT DRUGINCH 1S/C41H63N11O10/c1-24(2)20-28(40(61)62)48-36(57)31-14-8-17-50(31)38(59)29(23-53)49-34(55)27(21-25-10-4-3-5-11-25)47-33(54)22-46-35(56)30-13-7-18-51(30)39(60)32-15-9-19-52(32)37(58)26(42)12-6-16-45-41(43)44/h3-5,10-11,24,26-32,53H,6-9,12-23,42H2,1-2H3,(H,46,56)(H,47,54)(H,48,57)(H,49,55)(H,61,62)(H4,43,44,45)/t26-,27-,28-,29-,30-,31-,32-/m0/s1 D00FUT DRUGINKE BGAPYBBQGHUQNM-YYGRSCHNSA-N D00FUT DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D00FUT HIGHSTAT Investigative D00FXL DRUG__ID D00FXL D00FXL DRUGTYPE Small molecular drug D00FXL DRUGINCH 1S/C34H46N8O9S/c1-17(2)11-23(32(49)42-28(18(3)44)33(50)51)39-31(48)24(13-19-7-5-4-6-8-19)38-27(45)15-37-30(47)25(16-43)40-29(46)21(35)12-20-9-10-22-26(14-20)52-34(36)41-22/h4-10,14,17-18,21,23-25,28,43-44H,11-13,15-16,35H2,1-3H3,(H2,36,41)(H,37,47)(H,38,45)(H,39,48)(H,40,46)(H,42,49)(H,50,51)/t18-,21+,23+,24+,25+,28+/m1/s1 D00FXL DRUGINKE XSYMBKQKMSKFJU-LEKCGIOJSA-N D00FXL DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(CO)NC(=O)C(CC2=CC3=C(C=C2)N=C(S3)N)N D00FXL HIGHSTAT Investigative D00FZN DRUG__ID D00FZN D00FZN DRUGTYPE Small molecular drug D00FZN DRUGINCH 1S/C30H33N5O5/c31-24(14-20-10-12-23(36)13-11-20)29(39)34-26-16-21-8-4-5-9-22(21)17-35(30(26)40)18-27(37)33-25(28(32)38)15-19-6-2-1-3-7-19/h1-13,24-26,36H,14-18,31H2,(H2,32,38)(H,33,37)(H,34,39)/t24-,25-,26+/m0/s1 D00FZN DRUGINKE XIRBKSHTAOQLGM-KKUQBAQOSA-N D00FZN DRUGSMIL C1C(C(=O)N(CC2=CC=CC=C21)CC(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D00FZN HIGHSTAT Investigative D00GBB DRUG__ID D00GBB D00GBB DRUGTYPE Small molecular drug D00GBB DRUGINCH 1S/C14H19N3O4/c18-12(17-21)9-5-2-6-10-15-14(20)16-13(19)11-7-3-1-4-8-11/h1,3-4,7-8,21H,2,5-6,9-10H2,(H,17,18)(H2,15,16,19,20) D00GBB DRUGINKE VQLQZMGNGMOMPU-UHFFFAOYSA-N D00GBB DRUGSMIL C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCC(=O)NO D00GBB HIGHSTAT Investigative D00GBX DRUG__ID D00GBX D00GBX DRUGTYPE Small molecular drug D00GBX DRUGINCH 1S/C19H24O2S/c1-18(2,3)13-10-12(16(20)15-8-7-9-22-15)11-14(17(13)21)19(4,5)6/h7-11,21H,1-6H3 D00GBX DRUGINKE WAAVMZLJRXYRMA-UHFFFAOYSA-N D00GBX DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)C2=CC=CS2 D00GBX HIGHSTAT Investigative D00GCC DRUG__ID D00GCC D00GCC DRUGTYPE Small molecular drug D00GCC DRUGINCH 1S/C34H47FN4O/c1-27(2)38-22-24-39(25-23-38)33(29-11-14-30(35)15-12-29)26-37-20-18-36(19-21-37)17-7-6-10-32-31-9-5-4-8-28(31)13-16-34(32)40-3/h4-5,8-9,11-16,27,33H,6-7,10,17-26H2,1-3H3/t33-/m1/s1 D00GCC DRUGINKE SLGLZEJKMBCODK-MGBGTMOVSA-N D00GCC DRUGSMIL CC(C)N1CCN(CC1)C(CN2CCN(CC2)CCCCC3=C(C=CC4=CC=CC=C43)OC)C5=CC=C(C=C5)F D00GCC HIGHSTAT Investigative D00GCK DRUG__ID D00GCK D00GCK DRUGTYPE Small molecular drug D00GCK DRUGINCH 1S/2C19H13N/c2*1-3-9-17-15(7-1)16-8-2-4-10-18(16)19(17)12-14-6-5-11-20-13-14/h2*1-13H D00GCK DRUGINKE QQJHSQKNTSNWIQ-UHFFFAOYSA-N D00GCK DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC4=CN=CC=C4.C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC4=CN=CC=C4 D00GCK HIGHSTAT Investigative D00GCN DRUG__ID D00GCN D00GCN DRUGTYPE Small molecular drug D00GCN DRUGINCH 1S/C18H12N2O/c21-17-11-16(20-18-15(17)6-3-9-19-18)14-8-7-12-4-1-2-5-13(12)10-14/h1-11H,(H,19,20,21) D00GCN DRUGINKE SIAZQYUZGIPPRX-UHFFFAOYSA-N D00GCN DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC(=O)C4=C(N3)N=CC=C4 D00GCN HIGHSTAT Investigative D00GDI DRUG__ID D00GDI D00GDI DRUGTYPE Small molecular drug D00GDI DRUGINCH 1S/C13H17Cl2NO/c1-8(16-13(2,3)4)12(17)9-5-6-10(14)11(15)7-9/h5-8,16H,1-4H3 D00GDI DRUGINKE MXUDEADPGZWZCH-UHFFFAOYSA-N D00GDI DRUGSMIL CC(C(=O)C1=CC(=C(C=C1)Cl)Cl)NC(C)(C)C D00GDI HIGHSTAT Investigative D00GEE DRUG__ID D00GEE D00GEE DRUGTYPE Small molecular drug D00GEE DRUGINCH 1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19-/m0/s1 D00GEE DRUGINKE BLGXFZZNTVWLAY-DKJBZYCGSA-N D00GEE DRUGSMIL COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O D00GEE HIGHSTAT Investigative D00GHB DRUG__ID D00GHB D00GHB DRUGTYPE Small molecular drug D00GHB DRUGINCH 1S/C6H15O13P3/c7-5-3(2-17-20(9,10)11)1-4(6(5)8)18-22(15,16)19-21(12,13)14/h3-8H,1-2H2,(H,15,16)(H2,9,10,11)(H2,12,13,14)/t3-,4+,5-,6+/m1/s1 D00GHB DRUGINKE OICBXEWBKALHHB-MOJAZDJTSA-N D00GHB DRUGSMIL C1C(C(C(C1OP(=O)(O)OP(=O)(O)O)O)O)COP(=O)(O)O D00GHB HIGHSTAT Investigative D00GHK DRUG__ID D00GHK D00GHK DRUGTYPE Small molecular drug D00GHK DRUGINCH 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-18,22H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17-,18+/m1/s1 D00GHK DRUGINKE VSRXYLYXIXYEST-KZTWKYQFSA-N D00GHK DRUGSMIL CCCCCC(=O)CCC1C(C(CC1=O)O)CC=CCCCC(=O)O D00GHK HIGHSTAT Investigative D00GIB DRUG__ID D00GIB D00GIB DRUGTYPE Small molecular drug D00GIB DRUGINCH 1S/C20H14BrNO4/c21-16-11-10-13(12-18(16)26-14-6-2-1-3-7-14)19(23)22-17-9-5-4-8-15(17)20(24)25/h1-12H,(H,22,23)(H,24,25) D00GIB DRUGINKE XOENRMSDPFHAEO-UHFFFAOYSA-N D00GIB DRUGSMIL C1=CC=C(C=C1)OC2=C(C=CC(=C2)C(=O)NC3=CC=CC=C3C(=O)O)Br D00GIB HIGHSTAT Investigative D00GII DRUG__ID D00GII D00GII DRUGTYPE Small molecular drug D00GII DRUGINCH 1S/C37H49N11O6/c1-48-30(9-5-17-43-37(40)41)34(53)46-27(8-4-16-42-36(38)39)33(52)47-28(19-22-11-14-26(49)15-12-22)32(51)44-21-31(50)45-29(35(48)54)20-23-10-13-24-6-2-3-7-25(24)18-23/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,50)(H,46,53)(H,47,52)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30-/m0/s1 D00GII DRUGINKE UYLRGPNGYHIOPK-XJYHXZFBSA-N D00GII DRUGSMIL CN1C(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C1=O)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O)CCCN=C(N)N)CCCN=C(N)N D00GII HIGHSTAT Investigative D00GIK DRUG__ID D00GIK D00GIK DRUGTYPE Small molecular drug D00GIK DRUGINCH 1S/C12H13ClN2/c13-12-5-3-11(4-6-12)2-1-8-15-9-7-14-10-15/h3-7,9-10H,1-2,8H2 D00GIK DRUGINKE CLJJKXWBLJQDDT-UHFFFAOYSA-N D00GIK DRUGSMIL C1=CC(=CC=C1CCCN2C=CN=C2)Cl D00GIK HIGHSTAT Investigative D00GIU DRUG__ID D00GIU D00GIU DRUGTYPE Small molecular drug D00GIU DRUGINCH 1S/C26H32N6.C2H4O2/c1-17-13-25(21-15-19(27)7-9-23(21)31-17)29-11-5-3-4-6-12-30-26-14-18(2)32-24-10-8-20(28)16-22(24)26;1-2(3)4/h7-10,13-16H,3-6,11-12,27-28H2,1-2H3,(H,29,31)(H,30,32);1H3,(H,3,4) D00GIU DRUGINKE LSRAVPLRIOILDT-UHFFFAOYSA-N D00GIU DRUGSMIL CC1=CC(=C2C=C(C=CC2=N1)N)NCCCCCCNC3=C4C=C(C=CC4=NC(=C3)C)N.CC(=O)O D00GIU HIGHSTAT Investigative D00GIW DRUG__ID D00GIW D00GIW DRUGTYPE Small molecular drug D00GIW DRUGINCH 1S/C10H8Br2N2/c11-9-3-8(4-10(12)5-9)6-14-2-1-13-7-14/h1-5,7H,6H2 D00GIW DRUGINKE QXITVPZFTOHIGY-UHFFFAOYSA-N D00GIW DRUGSMIL C1=CN(C=N1)CC2=CC(=CC(=C2)Br)Br D00GIW HIGHSTAT Investigative D00GJZ DRUG__ID D00GJZ D00GJZ DRUGTYPE Small molecular drug D00GJZ DRUGINCH 1S/C35H40N4O4.Cu/c1-8-22-18(3)28-17-33-23(9-2)21(6)32(39(33)7)16-27-20(5)25(11-13-35(42)43)31(38-27)15-30-24(10-12-34(40)41)19(4)26(36-30)14-29(22)37-28;/h14-17H,8-13H2,1-7H3,(H3,36,37,38,40,41,42,43);/q;+2/p-1 D00GJZ DRUGINKE WLMGFVUEDVZKTK-UHFFFAOYSA-M D00GJZ DRUGSMIL CCC1=C(C2=CC3=C(C(=C(N3C)C=C4C(=C(C(=N4)C=C5C(=C(C(=CC1=N2)[N-]5)C)CCC(=O)O)CCC(=O)O)C)C)CC)C.[Cu+2] D00GJZ HIGHSTAT Investigative D00GNW DRUG__ID D00GNW D00GNW DRUGTYPE Small molecular drug D00GNW DRUGINCH 1S/C23H23N3/c1-3-16(4-2)22-25-21-19(17-11-7-5-8-12-17)15-20(24-23(21)26-22)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3,(H,24,25,26) D00GNW DRUGINKE GPQRSDCKVYJMOH-UHFFFAOYSA-N D00GNW DRUGSMIL CCC(CC)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D00GNW HIGHSTAT Investigative D00GOC DRUG__ID D00GOC D00GOC DRUGTYPE Small molecular drug D00GOC DRUGINCH 1S/C9H13N3O6/c10-9(17)4-6(15)3(11-12-4)8-7(16)5(14)2(1-13)18-8/h2,5,7-8,13-16H,1H2,(H2,10,17)(H,11,12)/t2-,5-,7-,8+/m1/s1 D00GOC DRUGINKE XESARGFCSKSFID-FLLFQEBCSA-N D00GOC DRUGSMIL C(C1C(C(C(O1)C2=NNC(=C2O)C(=O)N)O)O)O D00GOC HIGHSTAT Investigative D00GOD DRUG__ID D00GOD D00GOD DRUGTYPE Small molecular drug D00GOD DRUGINCH 1S/C9H15N3O2/c10-4-2-1-3-7(9(13)14)8-5-11-6-12-8/h5-7H,1-4,10H2,(H,11,12)(H,13,14) D00GOD DRUGINKE ATNHCKIPIWIEGH-UHFFFAOYSA-N D00GOD DRUGSMIL C1=C(NC=N1)C(CCCCN)C(=O)O D00GOD HIGHSTAT Investigative D00GOQ DRUG__ID D00GOQ D00GOQ DRUGTYPE Small molecular drug D00GOQ DRUGINCH 1S/C21H22O6/c1-22-21-16(7-14-3-5-18-20(9-14)27-12-25-18)15(10-23-21)6-13-2-4-17-19(8-13)26-11-24-17/h2-5,8-9,15-16,21H,6-7,10-12H2,1H3/t15-,16+,21+/m0/s1 D00GOQ DRUGINKE UUUXPUGZNDRYSV-GCKMJXCFSA-N D00GOQ DRUGSMIL COC1C(C(CO1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 D00GOQ HIGHSTAT Investigative D00GOY DRUG__ID D00GOY D00GOY DRUGTYPE Small molecular drug D00GOY DRUGINCH 1S/C11H15BrN2/c1-8(13)7-14-5-4-9-2-3-10(12)6-11(9)14/h2-3,6,8H,4-5,7,13H2,1H3/t8-/m0/s1 D00GOY DRUGINKE QGRQJMXAQYGAKK-QMMMGPOBSA-N D00GOY DRUGSMIL CC(CN1CCC2=C1C=C(C=C2)Br)N D00GOY HIGHSTAT Investigative D00GQC DRUG__ID D00GQC D00GQC DRUGTYPE Small molecular drug D00GQC DRUGINCH 1S/C19H34O2/c1-2-3-4-5-7-10-13-17-16-18(17)14-11-8-6-9-12-15-19(20)21/h2-16H2,1H3,(H,20,21) D00GQC DRUGINKE PQRKPYLNZGDCFH-UHFFFAOYSA-N D00GQC DRUGSMIL CCCCCCCCC1=C(C1)CCCCCCCC(=O)O D00GQC HIGHSTAT Investigative D00GQI DRUG__ID D00GQI D00GQI DRUGTYPE Small molecular drug D00GQI DRUGINCH 1S/C20H19N3O/c1-14(2)20(24)23-18-13-17(15-9-5-3-6-10-15)21-19(22-18)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,21,22,23,24) D00GQI DRUGINKE ONJOWWUQGQUDTK-UHFFFAOYSA-N D00GQI DRUGSMIL CC(C)C(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D00GQI HIGHSTAT Investigative D00GQM DRUG__ID D00GQM D00GQM DRUGTYPE Small molecular drug D00GQM DRUGINCH 1S/C16H17N5O2/c22-9-11-1-3-12(4-2-11)14-19-15-13(17-10-18-15)16(20-14)21-5-7-23-8-6-21/h1-4,10,22H,5-9H2,(H,17,18,19,20) D00GQM DRUGINKE GSYUMLARWMDMOF-UHFFFAOYSA-N D00GQM DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=C(C=C4)CO D00GQM HIGHSTAT Investigative D00GQP DRUG__ID D00GQP D00GQP DRUGTYPE Small molecular drug D00GQP DRUGINCH 1S/C21H39NO4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-20(25)21(26)22-17-14-15-19(24)18-23/h23H,2-18H2,1H3,(H,22,26) D00GQP DRUGINKE JVJFDPHNZMYFII-UHFFFAOYSA-N D00GQP DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)CO D00GQP HIGHSTAT Investigative D00GRN DRUG__ID D00GRN D00GRN DRUGTYPE Small molecular drug D00GRN DRUGINCH 1S/C11H16O3S/c1-2-3-4-5-15-8-9-6-10(12)11(13)7-14-9/h6-7,13H,2-5,8H2,1H3 D00GRN DRUGINKE BSUYJCKSLPFPSA-UHFFFAOYSA-N D00GRN DRUGSMIL CCCCCSCC1=CC(=O)C(=CO1)O D00GRN HIGHSTAT Investigative D00GSD DRUG__ID D00GSD D00GSD DRUGTYPE Small molecular drug D00GSD DRUGINCH 1S/C30H34N4O/c31-23-25-14-16-26(17-15-25)24-32-30(35)13-5-2-8-18-33-19-21-34(22-20-33)29-12-7-6-11-28(29)27-9-3-1-4-10-27/h1,3-4,6-7,9-12,14-17H,2,5,8,13,18-22,24H2,(H,32,35) D00GSD DRUGINKE BQEDZLDNNBDKDS-UHFFFAOYSA-N D00GSD DRUGSMIL C1CN(CCN1CCCCCC(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3C4=CC=CC=C4 D00GSD HIGHSTAT Investigative D00GTC DRUG__ID D00GTC D00GTC DRUGTYPE Small molecular drug D00GTC DRUGINCH 1S/C13H14BrN3O/c1-9-8-12(15-6-7-18)17-13(16-9)10-2-4-11(14)5-3-10/h2-5,8,18H,6-7H2,1H3,(H,15,16,17) D00GTC DRUGINKE DUKPGOOUJNUIOI-UHFFFAOYSA-N D00GTC DRUGSMIL CC1=CC(=NC(=N1)C2=CC=C(C=C2)Br)NCCO D00GTC HIGHSTAT Investigative D00GTU DRUG__ID D00GTU D00GTU DRUGTYPE Small molecular drug D00GTU DRUGINCH 1S/C21H34O3S/c1-2-3-6-9-17(22)13-12-16-14-18-15-20(25-18)19(16)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17+,18-,19+,20-/m0/s1 D00GTU DRUGINKE OVGWMUWIRHGGJP-WVDJAODQSA-N D00GTU DRUGSMIL CCCCCC(C=CC1CC2CC(C1CC=CCCCC(=O)O)S2)O D00GTU HIGHSTAT Investigative D00GUE DRUG__ID D00GUE D00GUE DRUGTYPE Small molecular drug D00GUE DRUGINCH 1S/C24H19NO2S/c26-21(27)16-20-23(19-14-8-3-9-15-19)25-24(28-20)22(17-10-4-1-5-11-17)18-12-6-2-7-13-18/h1-15,22H,16H2,(H,26,27) D00GUE DRUGINKE GSFLUFCQJVKCFD-UHFFFAOYSA-N D00GUE DRUGSMIL C1=CC=C(C=C1)C2=C(SC(=N2)C(C3=CC=CC=C3)C4=CC=CC=C4)CC(=O)O D00GUE HIGHSTAT Investigative D00GUG DRUG__ID D00GUG D00GUG DRUGTYPE Small molecular drug D00GUG DRUGINCH 1S/C27H18N2O2/c30-29(31)23-15-11-19(12-16-23)10-13-22-18-26(21-7-2-1-3-8-21)28-25-17-14-20-6-4-5-9-24(20)27(22)25/h1-18H/b13-10+ D00GUG DRUGINKE TXOPJXIIAAMQKX-JLHYYAGUSA-N D00GUG DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C4=CC=CC=C4C=C3)C(=C2)C=CC5=CC=C(C=C5)[N+](=O)[O-] D00GUG HIGHSTAT Investigative D00GUM DRUG__ID D00GUM D00GUM DRUGTYPE Small molecular drug D00GUM DRUGINCH 1S/C31H44N2O10/c1-36-24-18-22(19-25(37-2)28(24)40-5)30(34)42-16-8-12-32-10-7-11-33(15-14-32)13-9-17-43-31(35)23-20-26(38-3)29(41-6)27(21-23)39-4/h18-21H,7-17H2,1-6H3 D00GUM DRUGINKE QVZCXCJXTMIDME-UHFFFAOYSA-N D00GUM DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)OCCCN2CCCN(CC2)CCCOC(=O)C3=CC(=C(C(=C3)OC)OC)OC D00GUM HIGHSTAT Investigative D00GVA DRUG__ID D00GVA D00GVA DRUGTYPE Small molecular drug D00GVA DRUGINCH 1S/C13H13N3O3S/c14-20(18,19)12-3-1-11(2-4-12)16-13(17)9-10-5-7-15-8-6-10/h1-8H,9H2,(H,16,17)(H2,14,18,19) D00GVA DRUGINKE CXBVXOMVANONBT-UHFFFAOYSA-N D00GVA DRUGSMIL C1=CC(=CC=C1NC(=O)CC2=CC=NC=C2)S(=O)(=O)N D00GVA HIGHSTAT Investigative D00GVV DRUG__ID D00GVV D00GVV DRUGTYPE Small molecular drug D00GVV DRUGINCH 1S/C17H15BrN2O/c18-11-5-6-16-13(8-11)14(17(21)20-16)9-12-7-10-3-1-2-4-15(10)19-12/h5-9,19H,1-4H2,(H,20,21)/b14-9- D00GVV DRUGINKE RFHPWPWVGFSLOP-ZROIWOOFSA-N D00GVV DRUGSMIL C1CCC2=C(C1)C=C(N2)C=C3C4=C(C=CC(=C4)Br)NC3=O D00GVV HIGHSTAT Investigative D00GYE DRUG__ID D00GYE D00GYE DRUGTYPE Small molecular drug D00GYE DRUGINCH 1S/C10H15FN2/c1-8-6-9(4-2-3-5-11)13-10(12)7-8/h6-7H,2-5H2,1H3,(H2,12,13) D00GYE DRUGINKE OTKWRERYYAYGSY-UHFFFAOYSA-N D00GYE DRUGSMIL CC1=CC(=NC(=C1)N)CCCCF D00GYE HIGHSTAT Investigative D00GYX DRUG__ID D00GYX D00GYX DRUGTYPE Small molecular drug D00GYX DRUGINCH 1S/C7H8S/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2 D00GYX DRUGINKE UENWRTRMUIOCKN-UHFFFAOYSA-N D00GYX DRUGSMIL C1=CC=C(C=C1)CS D00GYX HIGHSTAT Investigative D00HAJ DRUG__ID D00HAJ D00HAJ DRUGTYPE Small molecular drug D00HAJ DRUGINCH 1S/C49H63FN10O9/c1-29(2)17-22-34(43(63)56-38(27-32-18-20-33(50)21-19-32)45(65)55-36(42(52)62)25-30-11-5-3-6-12-30)53-47(67)40-16-10-24-60(40)48(68)35(15-9-23-51)54-44(64)37(26-31-13-7-4-8-14-31)57-46(66)39-28-41(61)59-49(69)58-39/h3-8,11-14,18-21,29,34-40H,9-10,15-17,22-28,51H2,1-2H3,(H2,52,62)(H,53,67)(H,54,64)(H,55,65)(H,56,63)(H,57,66)(H2,58,59,61,69)/t34-,35-,36+,37-,38-,39-,40-/m0/s1 D00HAJ DRUGINKE HXKFHHNEFCZKPG-VEKZNEBUSA-N D00HAJ DRUGSMIL CC(C)CCC(C(=O)NC(CC1=CC=C(C=C1)F)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CCCN)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CC(=O)NC(=O)N5 D00HAJ HIGHSTAT Investigative D00HAZ DRUG__ID D00HAZ D00HAZ DRUGTYPE Small molecular drug D00HAZ DRUGINCH 1S/C17H12N2O/c1-2-8-13-12(6-1)7-5-10-15(13)18-17-14-9-3-4-11-16(14)20-19-17/h1-11H,(H,18,19) D00HAZ DRUGINKE SOIDHQDYGYBXPJ-UHFFFAOYSA-N D00HAZ DRUGSMIL C1=CC=C2C(=C1)C=CC=C2NC3=NOC4=CC=CC=C43 D00HAZ HIGHSTAT Investigative D00HCC DRUG__ID D00HCC D00HCC DRUGTYPE Small molecular drug D00HCC DRUGINCH 1S/C16H18N2O/c1-2-6-14(7-3-1)19-16-9-5-4-8-15(16)18-12-10-17-11-13-18/h1-9,17H,10-13H2 D00HCC DRUGINKE VAXHGPCUAFNAQS-UHFFFAOYSA-N D00HCC DRUGSMIL C1CN(CCN1)C2=CC=CC=C2OC3=CC=CC=C3 D00HCC HIGHSTAT Investigative D00HCI DRUG__ID D00HCI D00HCI DRUGTYPE Small molecular drug D00HCI DRUGINCH 1S/C14H16BNO/c16-11-12-17-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10H,11-12,16H2 D00HCI DRUGINKE BLZVCIGGICSWIG-UHFFFAOYSA-N D00HCI DRUGSMIL B(C1=CC=CC=C1)(C2=CC=CC=C2)OCCN D00HCI HIGHSTAT Investigative D00HET DRUG__ID D00HET D00HET DRUGTYPE Small molecular drug D00HET DRUGINCH 1S/C21H18N2O2/c1-24-18-11-12-19-20(14-18)23-21(22-19)13-15-7-9-17(10-8-15)25-16-5-3-2-4-6-16/h2-12,14H,13H2,1H3,(H,22,23) D00HET DRUGINKE QXVTTYRBOJXPRC-UHFFFAOYSA-N D00HET DRUGSMIL COC1=CC2=C(C=C1)N=C(N2)CC3=CC=C(C=C3)OC4=CC=CC=C4 D00HET HIGHSTAT Investigative D00HFS DRUG__ID D00HFS D00HFS DRUGTYPE Small molecular drug D00HFS DRUGINCH 1S/C13H18N2O3/c1-10-6-8-11(9-7-10)14-12(16)4-2-3-5-13(17)15-18/h6-9,18H,2-5H2,1H3,(H,14,16)(H,15,17) D00HFS DRUGINKE VUUHXDZTBBCMIT-UHFFFAOYSA-N D00HFS DRUGSMIL CC1=CC=C(C=C1)NC(=O)CCCCC(=O)NO D00HFS HIGHSTAT Investigative D00HFT DRUG__ID D00HFT D00HFT DRUGTYPE Small molecular drug D00HFT DRUGINCH 1S/C32H36N2O8/c1-7-18-16-34-26-14-21(18)30(29(36)40-6,17-41-28(35)19-8-11-24(38-4)25(12-19)39-5)31-15-27(34)42-32(26,31)33(2)23-10-9-20(37-3)13-22(23)31/h7-13,21,26-27H,14-17H2,1-6H3/b18-7-/t21-,26-,27-,30-,31-,32-/m0/s1 D00HFT DRUGINKE DTINADCHYFZWSG-BUVDGYSPSA-N D00HFT DRUGSMIL CC=C1CN2C3CC1C(C45C3(N(C6=C4C=C(C=C6)OC)C)OC2C5)(COC(=O)C7=CC(=C(C=C7)OC)OC)C(=O)OC D00HFT HIGHSTAT Investigative D00HFV DRUG__ID D00HFV D00HFV DRUGTYPE Small molecular drug D00HFV DRUGINCH 1S/C14H11F3N2S/c15-14(16,17)11-5-1-9(2-6-11)10-3-7-12(8-4-10)19-13(18)20/h1-8H,(H3,18,19,20) D00HFV DRUGINKE VTGXCQVBAHHGLK-UHFFFAOYSA-N D00HFV DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)NC(=S)N)C(F)(F)F D00HFV HIGHSTAT Investigative D00HHK DRUG__ID D00HHK D00HHK DRUGTYPE Small molecular drug D00HHK DRUGINCH 1S/C21H25N3/c1-2-6-18(7-3-1)19-9-11-20(12-10-19)23-14-16-24(17-15-23)21-8-4-5-13-22-21/h1-9,13,20H,10-12,14-17H2 D00HHK DRUGINKE MBOHGQXYZVXXQF-UHFFFAOYSA-N D00HHK DRUGSMIL C1CC(=CCC1N2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=C4 D00HHK HIGHSTAT Investigative D00HIG DRUG__ID D00HIG D00HIG DRUGTYPE Small molecular drug D00HIG DRUGINCH 1S/C21H28N2OS/c1-3-21(24)23(18-8-5-4-6-9-18)20-12-14-22(16-17(20)2)13-11-19-10-7-15-25-19/h4-10,15,17,20H,3,11-14,16H2,1-2H3 D00HIG DRUGINKE SRARDYUHGVMEQI-UHFFFAOYSA-N D00HIG DRUGSMIL CCC(=O)N(C1CCN(CC1C)CCC2=CC=CS2)C3=CC=CC=C3 D00HIG HIGHSTAT Investigative D00HIH DRUG__ID D00HIH D00HIH DRUGTYPE Small molecular drug D00HIH DRUGINCH 1S/C18H20FN5O/c1-18(2,3)17-22-21-14-10-12(8-9-24(14)17)16-20-15(23-25-16)11-4-6-13(19)7-5-11/h4-7,12H,8-10H2,1-3H3/t12-/m0/s1 D00HIH DRUGINKE NPRJTKMKUYJGAL-LBPRGKRZSA-N D00HIH DRUGSMIL CC(C)(C)C1=NN=C2N1CCC(C2)C3=NC(=NO3)C4=CC=C(C=C4)F D00HIH HIGHSTAT Investigative D00HKQ DRUG__ID D00HKQ D00HKQ DRUGTYPE Small molecular drug D00HKQ DRUGINCH 1S/C22H20FN3O2/c1-3-4-10-26-11-8-18(19(14-24)22(26)27)16-5-6-21(20(23)13-16)28-17-7-9-25-15(2)12-17/h5-9,11-13H,3-4,10H2,1-2H3 D00HKQ DRUGINKE IPTWXMISVLTMAV-UHFFFAOYSA-N D00HKQ DRUGSMIL CCCCN1C=CC(=C(C1=O)C#N)C2=CC(=C(C=C2)OC3=CC(=NC=C3)C)F D00HKQ HIGHSTAT Investigative D00HLW DRUG__ID D00HLW D00HLW DRUGTYPE Small molecular drug D00HLW DRUGINCH 1S/C25H29ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h5-9,14-16H,4,10-13H2,1-3H3,(H,28,33)(H,27,29,30) D00HLW DRUGINKE SDGJBAUIGHSMRI-UHFFFAOYSA-N D00HLW DRUGSMIL CCC(=O)NC1=CC(=CC=C1)OC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC D00HLW HIGHSTAT Investigative D00HNG DRUG__ID D00HNG D00HNG DRUGTYPE Small molecular drug D00HNG DRUGINCH 1S/C30H37NO5/c1-18-13-22-23(30(4,5)12-11-29(22,2)3)15-19(18)14-20-9-10-24(36-20)28(32)31-27-25(34-7)16-21(33-6)17-26(27)35-8/h9-10,13,15-17H,11-12,14H2,1-8H3,(H,31,32) D00HNG DRUGINKE IPEMCIBPDYCJLO-UHFFFAOYSA-N D00HNG DRUGSMIL CC1=CC2=C(C=C1CC3=CC=C(O3)C(=O)NC4=C(C=C(C=C4OC)OC)OC)C(CCC2(C)C)(C)C D00HNG HIGHSTAT Investigative D00HSG DRUG__ID D00HSG D00HSG DRUGTYPE Small molecular drug D00HSG DRUGINCH 1S/C12H11ClN2/c13-11-6-2-1-5-10(11)12-9(8-14)4-3-7-15-12/h1-7H,8,14H2 D00HSG DRUGINKE FTTHUIFIPJIQEI-UHFFFAOYSA-N D00HSG DRUGSMIL C1=CC=C(C(=C1)C2=C(C=CC=N2)CN)Cl D00HSG HIGHSTAT Investigative D00HSJ DRUG__ID D00HSJ D00HSJ DRUGTYPE Small molecular drug D00HSJ DRUGINCH 1S/C16H14BrN5O4S/c1-11-3-5-13(22(23)24)7-15(11)27(25,26)20(2)19-9-14-8-18-16-6-4-12(17)10-21(14)16/h3-10H,1-2H3/b19-9+ D00HSJ DRUGINKE QTHCAAFKVUWAFI-DJKKODMXSA-N D00HSJ DRUGSMIL CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N(C)N=CC2=CN=C3N2C=C(C=C3)Br D00HSJ HIGHSTAT Investigative D00HUB DRUG__ID D00HUB D00HUB DRUGTYPE Small molecular drug D00HUB DRUGINCH 1S/C19H15NO/c21-20-14-15-11-12-18(16-7-3-1-4-8-16)19(13-15)17-9-5-2-6-10-17/h1-14,21H/b20-14+ D00HUB DRUGINKE XSIHFOOFJWBVHK-XSFVSMFZSA-N D00HUB DRUGSMIL C1=CC=C(C=C1)C2=C(C=C(C=C2)C=NO)C3=CC=CC=C3 D00HUB HIGHSTAT Investigative D00HUP DRUG__ID D00HUP D00HUP DRUGTYPE Small molecular drug D00HUP DRUGINCH 1S/C17H13N5/c1-3-7-12(8-4-1)15-21-14-16(18-11-19-17(14)22-15)20-13-9-5-2-6-10-13/h1-11H,(H2,18,19,20,21,22) D00HUP DRUGINKE OKZNIBWRMMFNQY-UHFFFAOYSA-N D00HUP DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N2)C(=NC=N3)NC4=CC=CC=C4 D00HUP HIGHSTAT Investigative D00HUV DRUG__ID D00HUV D00HUV DRUGTYPE Small molecular drug D00HUV DRUGINCH 1S/C16H17N3O/c1-2-5-13(6-3-1)11-17-9-10-20-15-8-4-7-14-16(15)19-12-18-14/h1-8,12,17H,9-11H2,(H,18,19) D00HUV DRUGINKE XQWCSGWUJUEAQM-UHFFFAOYSA-N D00HUV DRUGSMIL C1=CC=C(C=C1)CNCCOC2=CC=CC3=C2N=CN3 D00HUV HIGHSTAT Investigative D00HUY DRUG__ID D00HUY D00HUY DRUGTYPE Small molecular drug D00HUY DRUGINCH 1S/C22H24N2O3/c1-14-8-15(2)10-17(9-14)13-27-22(26)21(24-16(3)25)11-18-12-23-20-7-5-4-6-19(18)20/h4-10,12,21,23H,11,13H2,1-3H3,(H,24,25)/t21-/m0/s1 D00HUY DRUGINKE YIHWPQQGVKFHTC-NRFANRHFSA-N D00HUY DRUGSMIL CC1=CC(=CC(=C1)COC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C)C D00HUY HIGHSTAT Investigative D00HVA DRUG__ID D00HVA D00HVA DRUGTYPE Small molecular drug D00HVA DRUGINCH 1S/C18H20N4O4/c1-4-26-18-13(10-19)14(20)9-16(22-18)21-17(23)8-11-7-12(24-2)5-6-15(11)25-3/h5-7,9H,4,8H2,1-3H3,(H3,20,21,22,23) D00HVA DRUGINKE KQMPRSZTUSSXND-UHFFFAOYSA-N D00HVA DRUGSMIL CCOC1=C(C(=CC(=N1)NC(=O)CC2=C(C=CC(=C2)OC)OC)N)C#N D00HVA HIGHSTAT Investigative D00HVP DRUG__ID D00HVP D00HVP DRUGTYPE Small molecular drug D00HVP DRUGINCH 1S/C28H24O4/c29-22-9-13-24-21(17-22)8-3-18-4-10-23(11-5-18)32-28-16-20(7-14-26(28)30)2-1-19-6-12-25(24)27(31)15-19/h4-7,9-17,29-31H,1-3,8H2 D00HVP DRUGINKE JMKSVONWZFVEAI-UHFFFAOYSA-N D00HVP DRUGSMIL C1CC2=C(C=CC(=C2)O)C3=C(C=C(CCC4=CC(=C(C=C4)O)OC5=CC=C1C=C5)C=C3)O D00HVP HIGHSTAT Investigative D00HVX DRUG__ID D00HVX D00HVX DRUGTYPE Small molecular drug D00HVX DRUGINCH 1S/C9H6N4O/c14-9-8-10-5-11-13(8)7-4-2-1-3-6(7)12-9/h1-5H,(H,12,14) D00HVX DRUGINKE OEIMIUHARCZWJY-UHFFFAOYSA-N D00HVX DRUGSMIL C1=CC=C2C(=C1)NC(=O)C3=NC=NN23 D00HVX HIGHSTAT Investigative D00HWD DRUG__ID D00HWD D00HWD DRUGTYPE Small molecular drug D00HWD DRUGINCH 1S/C3H5NO5/c5-2(6)1-4(9)3(7)8/h9H,1H2,(H,5,6)(H,7,8) D00HWD DRUGINKE LJSQPIOQKDFEKE-UHFFFAOYSA-N D00HWD DRUGSMIL C(C(=O)O)N(C(=O)O)O D00HWD HIGHSTAT Investigative D00HWF DRUG__ID D00HWF D00HWF DRUGTYPE Small molecular drug D00HWF DRUGINCH 1S/C13H16N2O/c1-2-5-12(6-3-1)10-16-8-4-7-13-9-14-11-15-13/h1-3,5-6,9,11H,4,7-8,10H2,(H,14,15) D00HWF DRUGINKE WNWALBVQAAIULR-UHFFFAOYSA-N D00HWF DRUGSMIL C1=CC=C(C=C1)COCCCC2=CN=CN2 D00HWF HIGHSTAT Investigative D00HWJ DRUG__ID D00HWJ D00HWJ DRUGTYPE Small molecular drug D00HWJ DRUGINCH 1S/C28H28N4O4S2/c1-36-22-9-7-20-8-11-24(16-21(20)15-22)38(34,35)32(17-19-5-3-2-4-6-19)25-13-14-31(28(25)33)18-23-10-12-26(37-23)27(29)30/h2-12,15-16,25H,13-14,17-18H2,1H3,(H3,29,30)/t25-/m0/s1 D00HWJ DRUGINKE KKFJNRXJRRYNRJ-VWLOTQADSA-N D00HWJ DRUGSMIL COC1=CC2=C(C=C1)C=CC(=C2)S(=O)(=O)N(CC3=CC=CC=C3)C4CCN(C4=O)CC5=CC=C(S5)C(=N)N D00HWJ HIGHSTAT Investigative D00HXX DRUG__ID D00HXX D00HXX DRUGTYPE Small molecular drug D00HXX DRUGINCH 1S/C21H19FN4O/c22-18-9-10-20(19(23)13-18)25-21(27)11-8-17-14-24-26(15-17)12-4-7-16-5-2-1-3-6-16/h1-11,13-15H,12,23H2,(H,25,27)/b7-4+,11-8+ D00HXX DRUGINKE BLVQHYHDYFTPDV-VCABWLAWSA-N D00HXX DRUGSMIL C1=CC=C(C=C1)C=CCN2C=C(C=N2)C=CC(=O)NC3=C(C=C(C=C3)F)N D00HXX HIGHSTAT Investigative D00HXZ DRUG__ID D00HXZ D00HXZ DRUGTYPE Small molecular drug D00HXZ DRUGINCH 1S/C25H19NO3S2/c27-19-15-24(26-10-12-28-13-11-26)29-20-9-8-16(14-18(19)20)17-4-3-7-23-25(17)31-22-6-2-1-5-21(22)30-23/h1-9,14-15H,10-13H2 D00HXZ DRUGINKE NXGBJPCXFKHQKN-UHFFFAOYSA-N D00HXZ DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=C5C(=CC=C4)SC6=CC=CC=C6S5 D00HXZ HIGHSTAT Investigative D00HYO DRUG__ID D00HYO D00HYO DRUGTYPE Small molecular drug D00HYO DRUGINCH 1S/C25H24N6O5/c1-29-17(9-15-5-7-19-21(11-15)36-13-34-19)16(8-14-4-6-18-20(10-14)35-12-33-18)27-25(29)28-22-23(32)31(3)24(26)30(22)2/h4-7,10-11,26H,8-9,12-13H2,1-3H3/b26-24?,28-22+ D00HYO DRUGINKE RZKRATQHPLTYSI-GQZUJQTPSA-N D00HYO DRUGSMIL CN1C(=C(N=C1N=C2C(=O)N(C(=N)N2C)C)CC3=CC4=C(C=C3)OCO4)CC5=CC6=C(C=C5)OCO6 D00HYO HIGHSTAT Investigative D00HYS DRUG__ID D00HYS D00HYS DRUGTYPE Small molecular drug D00HYS DRUGINCH 1S/C17H12N4/c18-11-14-15(12-7-3-1-4-8-12)20-17(19)21-16(14)13-9-5-2-6-10-13/h1-10H,(H2,19,20,21) D00HYS DRUGINKE JMXZSEAMWCKILY-UHFFFAOYSA-N D00HYS DRUGSMIL C1=CC=C(C=C1)C2=C(C(=NC(=N2)N)C3=CC=CC=C3)C#N D00HYS HIGHSTAT Investigative D00HZT DRUG__ID D00HZT D00HZT DRUGTYPE Small molecular drug D00HZT DRUGINCH 1S/C17H11NO3/c19-13-4-3-10-7-12(2-1-11(10)8-13)17-18-15-6-5-14(20)9-16(15)21-17/h1-9,19-20H D00HZT DRUGINKE PZIKVWJRAOMJDU-UHFFFAOYSA-N D00HZT DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=NC4=C(O3)C=C(C=C4)O D00HZT HIGHSTAT Investigative D00IAE DRUG__ID D00IAE D00IAE DRUGTYPE Small molecular drug D00IAE DRUGINCH 1S/C10H9NO4S/c1-2-7-15-10(12)8-3-5-9(6-4-8)16(11,13)14/h1,3-6H,7H2,(H2,11,13,14) D00IAE DRUGINKE IORJVPBKDUGFOJ-UHFFFAOYSA-N D00IAE DRUGSMIL C#CCOC(=O)C1=CC=C(C=C1)S(=O)(=O)N D00IAE HIGHSTAT Investigative D00IAK DRUG__ID D00IAK D00IAK DRUGTYPE Small molecular drug D00IAK DRUGINCH 1S/C11H19F3O3S/c1-2-3-4-5-6-7-8-18(16,17)9-10(15)11(12,13)14/h2-9H2,1H3 D00IAK DRUGINKE LGBYSBJDEXOENJ-UHFFFAOYSA-N D00IAK DRUGSMIL CCCCCCCCS(=O)(=O)CC(=O)C(F)(F)F D00IAK HIGHSTAT Investigative D00IBG DRUG__ID D00IBG D00IBG DRUGTYPE Small molecular drug D00IBG DRUGINCH 1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,14-/m0/s1 D00IBG DRUGINKE FVTCRASFADXXNN-SCRDCRAPSA-N D00IBG DRUGSMIL CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)O)O)O)O D00IBG HIGHSTAT Investigative D00ICA DRUG__ID D00ICA D00ICA DRUGTYPE Small molecular drug D00ICA DRUGINCH 1S/C10H17N6O12P3/c11-8-5-9(13-2-12-8)16(3-14-5)10-7(18)6(17)4(27-10)1-26-31(24,25)28-30(22,23)15-29(19,20)21/h2-4,6-7,10,17-18H,1H2,(H,24,25)(H2,11,12,13)(H4,15,19,20,21,22,23)/t4-,6-,7-,10-/m1/s1 D00ICA DRUGINKE PVKSNHVPLWYQGJ-KQYNXXCUSA-N D00ICA DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N D00ICA HIGHSTAT Investigative D00IFJ DRUG__ID D00IFJ D00IFJ DRUGTYPE Small molecular drug D00IFJ DRUGINCH 1S/C13H13NO/c15-12-7-8-14-11(9-12)6-5-10-3-1-2-4-13(10)14/h1-4,9H,5-8H2 D00IFJ DRUGINKE OPJKPSOLCGGXEW-UHFFFAOYSA-N D00IFJ DRUGSMIL C1CC2=CC(=O)CCN2C3=CC=CC=C31 D00IFJ HIGHSTAT Investigative D00IGI DRUG__ID D00IGI D00IGI DRUGTYPE Small molecular drug D00IGI DRUGINCH 1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10) D00IGI DRUGINKE DDOQBQRIEWHWBT-UHFFFAOYSA-N D00IGI DRUGSMIL C(CP(=O)(O)O)C(C(=O)O)N D00IGI HIGHSTAT Investigative D00IIQ DRUG__ID D00IIQ D00IIQ DRUGTYPE Small molecular drug D00IIQ DRUGINCH 1S/C13H18N2O2/c1-11-3-2-9-14(11)10-8-12-4-6-13(7-5-12)15(16)17/h4-7,11H,2-3,8-10H2,1H3/t11-/m0/s1 D00IIQ DRUGINKE PFZYNGPCNCRLFU-NSHDSACASA-N D00IIQ DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)[N+](=O)[O-] D00IIQ HIGHSTAT Investigative D00IKQ DRUG__ID D00IKQ D00IKQ DRUGTYPE Small molecular drug D00IKQ DRUGINCH 1S/C6H8N2O3S/c1-11-5-2-3-8-4-6(5)12(7,9)10/h2-4H,1H3,(H2,7,9,10) D00IKQ DRUGINKE YLDUTJXETDRGDZ-UHFFFAOYSA-N D00IKQ DRUGSMIL COC1=C(C=NC=C1)S(=O)(=O)N D00IKQ HIGHSTAT Investigative D00IMW DRUG__ID D00IMW D00IMW DRUGTYPE Small molecular drug D00IMW DRUGINCH 1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1 D00IMW DRUGINKE VWWQXMAJTJZDQX-UYBVJOGSSA-N D00IMW DRUGSMIL CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O D00IMW HIGHSTAT Investigative D00IOF DRUG__ID D00IOF D00IOF DRUGTYPE Small molecular drug D00IOF DRUGINCH 1S/C21H30N4O3/c1-2-3-5-25-18(27)16-17(24(20(25)28)6-4-7-26)23-19(22-16)21-11-13-8-14(12-21)10-15(21)9-13/h13-15,26H,2-12H2,1H3,(H,22,23) D00IOF DRUGINKE CIBIXJYFYPFMTN-UHFFFAOYSA-N D00IOF DRUGSMIL CCCCN1C(=O)C2=C(N=C(N2)C34CC5CC(C3)CC4C5)N(C1=O)CCCO D00IOF HIGHSTAT Investigative D00IPO DRUG__ID D00IPO D00IPO DRUGTYPE Small molecular drug D00IPO DRUGINCH 1S/C12H16O2/c1-8(2)10-5-4-6-11(7-10)9(3)12(13)14/h4-9H,1-3H3,(H,13,14) D00IPO DRUGINKE DHFSUPPYOBITGY-UHFFFAOYSA-N D00IPO DRUGSMIL CC(C)C1=CC(=CC=C1)C(C)C(=O)O D00IPO HIGHSTAT Investigative D00IPP DRUG__ID D00IPP D00IPP DRUGTYPE Small molecular drug D00IPP DRUGINCH 1S/C10H19N3O2/c1-6(2)8(11)10(15)13-5-3-4-7(13)9(12)14/h6-8H,3-5,11H2,1-2H3,(H2,12,14)/t7-,8-/m0/s1 D00IPP DRUGINKE AGVCUVJROUBIKP-YUMQZZPRSA-N D00IPP DRUGSMIL CC(C)C(C(=O)N1CCCC1C(=O)N)N D00IPP HIGHSTAT Investigative D00IQV DRUG__ID D00IQV D00IQV DRUGCOMP ImmuneRegen BioSciences Inc D00IQV DRUGINCH 1S/C64H100N18O15S/c1-38(2)34-46(57(89)74-42(54(69)86)28-33-98(4,96)97)73-53(85)37-80(3)62(94)48(36-40-18-9-6-10-19-40)79-58(90)47(35-39-16-7-5-8-17-39)78-56(88)43(24-26-51(67)83)75-55(87)44(25-27-52(68)84)76-59(91)50-23-15-32-82(50)63(95)45(21-11-12-29-65)77-60(92)49-22-14-31-81(49)61(93)41(66)20-13-30-72-64(70)71/h5-10,16-19,38,41-50H,11-15,20-37,65-66H2,1-4H3,(H2,67,83)(H2,68,84)(H2,69,86)(H,73,85)(H,74,89)(H,75,87)(H,76,91)(H,77,92)(H,78,88)(H,79,90)(H4,70,71,72)/t41-,42-,43?,44-,45-,46-,47-,48-,49-,50-/m0/s1 D00IQV DRUGINKE OUPXSLGGCPUZJJ-HTTPISLZSA-N D00IQV DRUGSMIL CC(C)CC(C(=O)NC(CCS(=O)(=O)C)C(=O)N)NC(=O)CN(C)C(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D00IQV HIGHSTAT Investigative D00IRL DRUG__ID D00IRL D00IRL DRUGTYPE Small molecular drug D00IRL DRUGINCH 1S/C16H17NO4/c1-19-14-4-2-12(3-5-14)15-10-13(18)11-16(21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3 D00IRL DRUGINKE QJIHTEXMXZZXDS-UHFFFAOYSA-N D00IRL DRUGSMIL COC1=CC=C(C=C1)C2=CC(=O)C=C(O2)N3CCOCC3 D00IRL HIGHSTAT Investigative D00IUB DRUG__ID D00IUB D00IUB DRUGTYPE Small molecular drug D00IUB DRUGINCH 1S/C7H5NO/c8-5-6-1-3-7(9)4-2-6/h1-4,9H D00IUB DRUGINKE CVNOWLNNPYYEOH-UHFFFAOYSA-N D00IUB DRUGSMIL C1=CC(=CC=C1C#N)O D00IUB HIGHSTAT Investigative D00IUN DRUG__ID D00IUN D00IUN DRUGTYPE Small molecular drug D00IUN DRUGINCH 1S/C15H14N2S/c1-12(17-8-7-16-11-17)13-2-4-14(5-3-13)15-6-9-18-10-15/h2-12H,1H3 D00IUN DRUGINKE CPEUHVZSVWFLMC-UHFFFAOYSA-N D00IUN DRUGSMIL CC(C1=CC=C(C=C1)C2=CSC=C2)N3C=CN=C3 D00IUN HIGHSTAT Investigative D00IWH DRUG__ID D00IWH D00IWH DRUGTYPE Small molecular drug D00IWH DRUGINCH 1S/C11H13N3O5/c12-9(11(16)17)5-6-10(15)13-7-1-3-8(4-2-7)14(18)19/h1-4,9H,5-6,12H2,(H,13,15)(H,16,17)/t9-/m0/s1 D00IWH DRUGINKE WMZTYIRRBCGARG-VIFPVBQESA-N D00IWH DRUGSMIL C1=CC(=CC=C1NC(=O)CCC(C(=O)[O-])[NH3+])[N+](=O)[O-] D00IWH HIGHSTAT Investigative D00IXB DRUG__ID D00IXB D00IXB DRUGTYPE Small molecular drug D00IXB DRUGINCH 1S/C17H18O3/c1-4-15-16-9(2)13(18)7-5-11(16)12-6-8-14(19)10(3)17(12)20-15/h5-8,15,18-19H,4H2,1-3H3 D00IXB DRUGINKE IAFZPZLQCDKQGG-UHFFFAOYSA-N D00IXB DRUGSMIL CCC1C2=C(C=CC(=C2C)O)C3=C(O1)C(=C(C=C3)O)C D00IXB HIGHSTAT Investigative D00JAT DRUG__ID D00JAT D00JAT DRUGTYPE Small molecular drug D00JAT DRUGINCH 1S/C20H27NO/c22-16-7-6-15-11-19-17-3-1-2-8-20(17,18(15)12-16)9-10-21(19)13-14-4-5-14/h6-7,12,14,17,19,22H,1-5,8-11,13H2/t17?,19-,20-/m1/s1 D00JAT DRUGINKE NLBUEDSBXVNAPB-IPNZSQQUSA-N D00JAT DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)O)CC5CC5 D00JAT HIGHSTAT Investigative D00JBC DRUG__ID D00JBC D00JBC DRUGTYPE Small molecular drug D00JBC DRUGINCH 1S/C10H14N4O2/c1-3-4-5-14-9(15)7-8(12-6-11-7)13(2)10(14)16/h6H,3-5H2,1-2H3,(H,11,12) D00JBC DRUGINKE GDRIWEXJHHARCU-UHFFFAOYSA-N D00JBC DRUGSMIL CCCCN1C(=O)C2=C(N=CN2)N(C1=O)C D00JBC HIGHSTAT Investigative D00JHN DRUG__ID D00JHN D00JHN DRUGTYPE Small molecular drug D00JHN DRUGINCH 1S/C15H20N4O2S/c1-20-13-5-4-12(10-14(13)21-2)18-15(22)17-6-3-8-19-9-7-16-11-19/h4-5,7,9-11H,3,6,8H2,1-2H3,(H2,17,18,22) D00JHN DRUGINKE FZQXMGLQANXZRP-UHFFFAOYSA-N D00JHN DRUGSMIL COC1=C(C=C(C=C1)NC(=S)NCCCN2C=CN=C2)OC D00JHN HIGHSTAT Investigative D00JID DRUG__ID D00JID D00JID DRUGTYPE Small molecular drug D00JID DRUGINCH 1S/C44H58ClN7O10S/c1-4-25(2)38(52-42(59)37(24-63)47-26(3)53)43(60)50-35(22-28-10-16-31(54)17-11-28)40(57)48-33(7-5-6-20-46)39(56)49-34(21-27-8-14-30(45)15-9-27)41(58)51-36(44(61)62)23-29-12-18-32(55)19-13-29/h8-19,25,33-38,54-55,63H,4-7,20-24,46H2,1-3H3,(H,47,53)(H,48,57)(H,49,56)(H,50,60)(H,51,58)(H,52,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D00JID DRUGINKE MJPZCPCJFBXRAJ-LBNFHWTGSA-N D00JID DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)Cl)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D00JID HIGHSTAT Investigative D00JIV DRUG__ID D00JIV D00JIV DRUGCOMP Pfizer Inc D00JIV DRUGINCH 1S/C18H13FN6OS/c19-14-7-11(8-20)1-2-12(14)15-13(9-21)18(25-3-5-26-6-4-25)27-16(15)17-22-10-23-24-17/h1-2,7,10H,3-6H2,(H,22,23,24) D00JIV DRUGINKE MUENOTXSRZEFJV-UHFFFAOYSA-N D00JIV DRUGSMIL C1COCCN1C2=C(C(=C(S2)C3=NC=NN3)C4=C(C=C(C=C4)C#N)F)C#N D00JIV HIGHSTAT Investigative D00JJO DRUG__ID D00JJO D00JJO DRUGTYPE Small molecular drug D00JJO DRUGINCH 1S/C22H22O2/c1-23-21-12-7-10-19(16-21)17-24-22-13-6-5-11-20(22)15-14-18-8-3-2-4-9-18/h2-13,16H,14-15,17H2,1H3 D00JJO DRUGINKE GYSNUAVEYIUVBT-UHFFFAOYSA-N D00JJO DRUGSMIL COC1=CC=CC(=C1)COC2=CC=CC=C2CCC3=CC=CC=C3 D00JJO HIGHSTAT Investigative D00JJP DRUG__ID D00JJP D00JJP DRUGTYPE Small molecular drug D00JJP DRUGINCH 1S/C23H27N5O3/c1-17-19(9-6-10-25-17)21(16-24)27-11-13-28(14-12-27)22(29)15-20(26-23(30)31-2)18-7-4-3-5-8-18/h3-10,20-21H,11-15H2,1-2H3,(H,26,30) D00JJP DRUGINKE PMKMCABYJLILBB-UHFFFAOYSA-N D00JJP DRUGSMIL CC1=C(C=CC=N1)C(C#N)N2CCN(CC2)C(=O)CC(C3=CC=CC=C3)NC(=O)OC D00JJP HIGHSTAT Investigative D00JMT DRUG__ID D00JMT D00JMT DRUGTYPE Small molecular drug D00JMT DRUGINCH 1S/C21H27N7O/c1-2-4-15(5-3-1)24-20-18-19(23-14-22-18)26-21(27-20)25-16-6-8-17(9-7-16)28-10-12-29-13-11-28/h6-9,14-15H,1-5,10-13H2,(H3,22,23,24,25,26,27) D00JMT DRUGINKE ZFLJHSQHILSNCM-UHFFFAOYSA-N D00JMT DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NC4=CC=C(C=C4)N5CCOCC5 D00JMT HIGHSTAT Investigative D00JPB DRUG__ID D00JPB D00JPB DRUGTYPE Small molecular drug D00JPB DRUGINCH 1S/C21H21N3O2/c22-21(25)20-11-10-19(15-24-20)26-18-8-6-17(7-9-18)14-23-13-12-16-4-2-1-3-5-16/h1-11,15,23H,12-14H2,(H2,22,25) D00JPB DRUGINKE RDWUBDSRHFANBO-UHFFFAOYSA-N D00JPB DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC=C(C=C2)OC3=CN=C(C=C3)C(=O)N D00JPB HIGHSTAT Investigative D00JPH DRUG__ID D00JPH D00JPH DRUGTYPE Small molecular drug D00JPH DRUGINCH 1S/C16H15NO2/c18-12-15(11-13-7-3-1-4-8-13)17-16(19)14-9-5-2-6-10-14/h1-10,12,15H,11H2,(H,17,19)/t15-/m0/s1 D00JPH DRUGINKE HIVDFHSZNYCJQH-HNNXBMFYSA-N D00JPH DRUGSMIL C1=CC=C(C=C1)CC(C=O)NC(=O)C2=CC=CC=C2 D00JPH HIGHSTAT Investigative D00JPV DRUG__ID D00JPV D00JPV DRUGTYPE Small molecular drug D00JPV DRUGINCH 1S/C13H10N2O/c1-2-6-10(7-3-1)14-13-15-11-8-4-5-9-12(11)16-13/h1-9H,(H,14,15) D00JPV DRUGINKE BFLIOKCEGCUTNH-UHFFFAOYSA-N D00JPV DRUGSMIL C1=CC=C(C=C1)NC2=NC3=CC=CC=C3O2 D00JPV HIGHSTAT Investigative D00JTE DRUG__ID D00JTE D00JTE DRUGTYPE Small molecular drug D00JTE DRUGINCH 1S/C22H27NO/c1-23-20-12-13-21(23)15-17(14-20)16-22(24,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20-21,24H,12-16H2,1H3/t20-,21-/m1/s1 D00JTE DRUGINKE LAOBIJDCKIAALB-NHCUHLMSSA-N D00JTE DRUGSMIL CN1C2CCC1CC(C2)CC(C3=CC=CC=C3)(C4=CC=CC=C4)O D00JTE HIGHSTAT Investigative D00JUD DRUG__ID D00JUD D00JUD DRUGTYPE Small molecular drug D00JUD DRUGINCH 1S/C16H10O3/c1-9-6-16(17)19-14-8-15-12(7-11(9)14)10-4-2-3-5-13(10)18-15/h2-8H,1H3 D00JUD DRUGINKE MOTTUNALIBKKNF-UHFFFAOYSA-N D00JUD DRUGSMIL CC1=CC(=O)OC2=CC3=C(C=C12)C4=CC=CC=C4O3 D00JUD HIGHSTAT Investigative D00JUO DRUG__ID D00JUO D00JUO DRUGTYPE Small molecular drug D00JUO DRUGINCH 1S/C20H18ClN3OS/c1-13-10-17(14-4-2-5-15(21)11-14)23-12-16(13)18-6-3-8-24(18)20(25)19-22-7-9-26-19/h2,4-5,7,9-12,18H,3,6,8H2,1H3/t18-/m1/s1 D00JUO DRUGINKE GCSDBTCZHROCLZ-GOSISDBHSA-N D00JUO DRUGSMIL CC1=CC(=NC=C1C2CCCN2C(=O)C3=NC=CS3)C4=CC(=CC=C4)Cl D00JUO HIGHSTAT Investigative D00JWA DRUG__ID D00JWA D00JWA DRUGTYPE Small molecular drug D00JWA DRUGINCH 1S/C16H13N3O2/c1-11(20)18-15-5-4-13(12-6-8-17-9-7-12)16(19-15)14-3-2-10-21-14/h2-10H,1H3,(H,18,19,20) D00JWA DRUGINKE STFZQXRQDWXSGW-UHFFFAOYSA-N D00JWA DRUGSMIL CC(=O)NC1=NC(=C(C=C1)C2=CC=NC=C2)C3=CC=CO3 D00JWA HIGHSTAT Investigative D00JWB DRUG__ID D00JWB D00JWB DRUGTYPE Small molecular drug D00JWB DRUGINCH 1S/C16H18N4O2/c21-15(20-7-1-2-8-20)11-18-16(22)19-14-4-3-13-10-17-6-5-12(13)9-14/h3-6,9-10H,1-2,7-8,11H2,(H2,18,19,22) D00JWB DRUGINKE DMIDPTCQPIJYFE-UHFFFAOYSA-N D00JWB DRUGSMIL C1CCN(C1)C(=O)CNC(=O)NC2=CC3=C(C=C2)C=NC=C3 D00JWB HIGHSTAT Investigative D00JWR DRUG__ID D00JWR D00JWR DRUGTYPE Small molecular drug D00JWR DRUGINCH 1S/C12H12ClN3S2/c13-10-8-15-12(18-10)16-11(17)14-7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,14,15,16,17) D00JWR DRUGINKE FRTOQBKWAXWZAM-UHFFFAOYSA-N D00JWR DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC=C(S2)Cl D00JWR HIGHSTAT Investigative D00JXL DRUG__ID D00JXL D00JXL DRUGTYPE Small molecular drug D00JXL DRUGINCH 1S/C16H12N2OS/c19-15(13-9-5-2-6-10-13)18-16-17-14(11-20-16)12-7-3-1-4-8-12/h1-11H,(H,17,18,19) D00JXL DRUGINKE NIRMZOKDACPPER-UHFFFAOYSA-N D00JXL DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=CC=C3 D00JXL HIGHSTAT Investigative D00KCB DRUG__ID D00KCB D00KCB DRUGTYPE Small molecular drug D00KCB DRUGINCH 1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12+/m0/s1 D00KCB DRUGINKE WAAPEIZFCHNLKK-QPUJVOFHSA-N D00KCB DRUGSMIL C1C(OC2=C(C13C(=O)NC(=O)N3)C=C(C=C2)F)C(=O)N D00KCB HIGHSTAT Investigative D00KDF DRUG__ID D00KDF D00KDF DRUGTYPE Small molecular drug D00KDF DRUGINCH 1S/C24H15N3O3/c28-23-19-17-11-5-1-3-7-13(11)26-15-9-10-16(30-15)27-14-8-4-2-6-12(14)18(22(27)21(17)26)20(19)24(29)25-23/h1-8,15-16H,9-10H2,(H,25,28,29) D00KDF DRUGINKE OTPNDVKVEAIXTI-UHFFFAOYSA-N D00KDF DRUGSMIL C1CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C1O2)C7=C53)C(=O)NC6=O D00KDF HIGHSTAT Investigative D00KDZ DRUG__ID D00KDZ D00KDZ DRUGTYPE Small molecular drug D00KDZ DRUGINCH 1S/C16H16N2/c1-18(15-8-3-2-4-9-15)12-14-11-13-7-5-6-10-16(13)17-14/h2-11,17H,12H2,1H3 D00KDZ DRUGINKE KHSLYBCUWUKVBX-UHFFFAOYSA-N D00KDZ DRUGSMIL CN(CC1=CC2=CC=CC=C2N1)C3=CC=CC=C3 D00KDZ HIGHSTAT Investigative D00KEP DRUG__ID D00KEP D00KEP DRUGTYPE Small molecular drug D00KEP DRUGINCH 1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20) D00KEP DRUGINKE KCXVZYZYPLLWCC-UHFFFAOYSA-N D00KEP DRUGSMIL C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O D00KEP HIGHSTAT Investigative D00KFF DRUG__ID D00KFF D00KFF DRUGTYPE Small molecular drug D00KFF DRUGINCH 1S/C15H18F3NO2/c16-15(17,18)13(20)10-6-1-2-7-11-14(21)19-12-8-4-3-5-9-12/h3-5,8-9H,1-2,6-7,10-11H2,(H,19,21) D00KFF DRUGINKE KRCXZGYVOZSCSF-UHFFFAOYSA-N D00KFF DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)C(F)(F)F D00KFF HIGHSTAT Investigative D00KGK DRUG__ID D00KGK D00KGK DRUGTYPE Small molecular drug D00KGK DRUGINCH 1S/C9H6BrNO2/c10-7-5-3-1-2-4-6(5)11-9(13)8(7)12/h1-4,12H,(H,11,13) D00KGK DRUGINKE BSYFERFWIZPSKL-UHFFFAOYSA-N D00KGK DRUGSMIL C1=CC=C2C(=C1)C(=C(C(=O)N2)O)Br D00KGK HIGHSTAT Investigative D00KIK DRUG__ID D00KIK D00KIK DRUGTYPE Small molecular drug D00KIK DRUGINCH 1S/C20H27NS/c1-2-9-15-21(14-8-1)20(12-6-3-7-13-20)19-16-17-10-4-5-11-18(17)22-19/h4-5,10-11,16H,1-3,6-9,12-15H2 D00KIK DRUGINKE QDGRJLAJZNWVGV-UHFFFAOYSA-N D00KIK DRUGSMIL C1CCCN(CC1)C2(CCCCC2)C3=CC4=CC=CC=C4S3 D00KIK HIGHSTAT Investigative D00KIV DRUG__ID D00KIV D00KIV DRUGTYPE Small molecular drug D00KIV DRUGINCH 1S/C9H12NO2P/c10-9(13(11)12)7-6-8-4-2-1-3-5-8/h1-5,10-12H,6-7H2 D00KIV DRUGINKE YDYGVRIQAWAHCJ-UHFFFAOYSA-N D00KIV DRUGSMIL C1=CC=C(C=C1)CCC(=N)P(O)O D00KIV HIGHSTAT Investigative D00KJP DRUG__ID D00KJP D00KJP DRUGTYPE Small molecular drug D00KJP DRUGINCH 1S/C22H24N4O4S2/c1-25(19-7-8-26(22(19)27)12-14-9-20(21(23)24)31-13-14)32(28,29)18-6-4-15-3-5-17(30-2)10-16(15)11-18/h3-6,9-11,13,19H,7-8,12H2,1-2H3,(H3,23,24)/t19-/m0/s1 D00KJP DRUGINKE YQYYTNCSSDRJHZ-IBGZPJMESA-N D00KJP DRUGSMIL CN(C1CCN(C1=O)CC2=CSC(=C2)C(=N)N)S(=O)(=O)C3=CC4=C(C=CC(=C4)OC)C=C3 D00KJP HIGHSTAT Investigative D00KJV DRUG__ID D00KJV D00KJV DRUGTYPE Small molecular drug D00KJV DRUGINCH 1S/C10H21NO5/c1-2-3-4-11-6(5-12)7(13)8(14)9(15)10(11)16/h6-10,12-16H,2-5H2,1H3/t6-,7+,8+,9-,10+/m1/s1 D00KJV DRUGINKE JNYIOZRCMYRRED-KBDSZGMXSA-N D00KJV DRUGSMIL CCCCN1C(C(C(C(C1O)O)O)O)CO D00KJV HIGHSTAT Investigative D00KKN DRUG__ID D00KKN D00KKN DRUGTYPE Small molecular drug D00KKN DRUGINCH 1S/C19H22INO3/c1-2-22-16-5-3-4-6-17(16)24-19(18-13-21-11-12-23-18)14-7-9-15(20)10-8-14/h3-10,18-19,21H,2,11-13H2,1H3/t18-,19-/m0/s1 D00KKN DRUGINKE RVASAZVCHKJYMY-OALUTQOASA-N D00KKN DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=C(C=C3)I D00KKN HIGHSTAT Investigative D00KMC DRUG__ID D00KMC D00KMC DRUGTYPE Small molecular drug D00KMC DRUGINCH 1S/C18H19O8PS/c19-27(20,21)18(28(22,23)24)6-2-4-13-3-1-5-15(11-13)26-16-7-8-17-14(12-16)9-10-25-17/h1,3,5,7-12,18H,2,4,6H2,(H2,19,20,21)(H,22,23,24)/p-3 D00KMC DRUGINKE ILJWMHLLBUNHIQ-UHFFFAOYSA-K D00KMC DRUGSMIL C1=CC(=CC(=C1)OC2=CC3=C(C=C2)OC=C3)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-] D00KMC HIGHSTAT Investigative D00KMP DRUG__ID D00KMP D00KMP DRUGTYPE Small molecular drug D00KMP DRUGINCH 1S/C19H26N2/c1-2-3-7-16-14-21(13-12-18(16)20)19-11-6-9-15-8-4-5-10-17(15)19/h4-6,8-11,16,18H,2-3,7,12-14,20H2,1H3 D00KMP DRUGINKE CPKGFALQFTVZTA-UHFFFAOYSA-N D00KMP DRUGSMIL CCCCC1CN(CCC1N)C2=CC=CC3=CC=CC=C32 D00KMP HIGHSTAT Investigative D00KOE DRUG__ID D00KOE D00KOE DRUGTYPE Small molecular drug D00KOE DRUGINCH 1S/C7H14N2/c1-5(2)6-3-7(8)9-4-6/h5-6H,3-4H2,1-2H3,(H2,8,9) D00KOE DRUGINKE PUOKLNVZFQOPOS-UHFFFAOYSA-N D00KOE DRUGSMIL CC(C)C1CC(=NC1)N D00KOE HIGHSTAT Investigative D00KPR DRUG__ID D00KPR D00KPR DRUGTYPE Small molecular drug D00KPR DRUGINCH 1S/C6H14O2P2/c1-3-6(2,7)4-5-8-10-9/h7,9H,3-5H2,1-2H3 D00KPR DRUGINKE QGZAHEYJZLWZDX-UHFFFAOYSA-N D00KPR DRUGSMIL CCC(C)(CCOP=P)O D00KPR HIGHSTAT Investigative D00KQB DRUG__ID D00KQB D00KQB DRUGTYPE Small molecular drug D00KQB DRUGINCH 1S/C13H21NO/c1-3-4-9-15-13-7-5-12(6-8-13)10-11(2)14/h5-8,11H,3-4,9-10,14H2,1-2H3 D00KQB DRUGINKE XYGSKZYABPNAKO-UHFFFAOYSA-N D00KQB DRUGSMIL CCCCOC1=CC=C(C=C1)CC(C)N D00KQB HIGHSTAT Investigative D00KRL DRUG__ID D00KRL D00KRL DRUGTYPE Small molecular drug D00KRL DRUGINCH 1S/C23H20N2O2/c1-2-27-23(26)19-14-12-18(13-15-19)22-20-10-6-7-11-21(20)25(24-22)16-17-8-4-3-5-9-17/h3-15H,2,16H2,1H3 D00KRL DRUGINKE LPROLPQTWKDPNU-UHFFFAOYSA-N D00KRL DRUGSMIL CCOC(=O)C1=CC=C(C=C1)C2=NN(C3=CC=CC=C32)CC4=CC=CC=C4 D00KRL HIGHSTAT Investigative D00KRQ DRUG__ID D00KRQ D00KRQ DRUGTYPE Small molecular drug D00KRQ DRUGINCH 1S/C17H19NO/c1-2-6-15(7-3-1)19-17-9-5-4-8-16(17)14-10-12-18-13-11-14/h1-9,14,18H,10-13H2 D00KRQ DRUGINKE YWIYMDPWBAXEKQ-UHFFFAOYSA-N D00KRQ DRUGSMIL C1CNCCC1C2=CC=CC=C2OC3=CC=CC=C3 D00KRQ HIGHSTAT Investigative D00KSS DRUG__ID D00KSS D00KSS DRUGTYPE Small molecular drug D00KSS DRUGINCH 1S/C10H14O3S2/c1-13-9-3-5-10(6-4-9)15(11,12)8-2-7-14/h3-6,14H,2,7-8H2,1H3 D00KSS DRUGINKE JIFLEYNNNKKNOQ-UHFFFAOYSA-N D00KSS DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)CCCS D00KSS HIGHSTAT Investigative D00KTE DRUG__ID D00KTE D00KTE DRUGTYPE Small molecular drug D00KTE DRUGINCH 1S/C13H25N3O2/c1-3-5-8-15-12(17)11-7-6-9-16(11)13(18)10(14)4-2/h10-11H,3-9,14H2,1-2H3,(H,15,17)/t10-,11-/m0/s1 D00KTE DRUGINKE ZUFOHXXZTMOECH-QWRGUYRKSA-N D00KTE DRUGSMIL CCCCNC(=O)C1CCCN1C(=O)C(CC)N D00KTE HIGHSTAT Investigative D00KTT DRUG__ID D00KTT D00KTT DRUGTYPE Small molecular drug D00KTT DRUGINCH 1S/C16H15NO2S/c1-11(2)19-16(18)17-12-7-3-5-9-14(12)20-15-10-6-4-8-13(15)17/h3-11H,1-2H3 D00KTT DRUGINKE FFXIYTTZCCARMF-UHFFFAOYSA-N D00KTT DRUGSMIL CC(C)OC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D00KTT HIGHSTAT Investigative D00KWL DRUG__ID D00KWL D00KWL DRUGTYPE Small molecular drug D00KWL DRUGINCH 1S/C29H30N2O3/c1-23-22-31(28(33)30-27(23)32)20-12-5-13-21-34-29(24-14-6-2-7-15-24,25-16-8-3-9-17-25)26-18-10-4-11-19-26/h2-4,6-11,14-19,22H,5,12-13,20-21H2,1H3,(H,30,32,33) D00KWL DRUGINKE SLJLMYFAIDHROH-UHFFFAOYSA-N D00KWL DRUGSMIL CC1=CN(C(=O)NC1=O)CCCCCOC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D00KWL HIGHSTAT Investigative D00KXZ DRUG__ID D00KXZ D00KXZ DRUGTYPE Small molecular drug D00KXZ DRUGINCH 1S/C18H28Cl2NO3P/c1-13(15-7-8-17(19)18(20)9-15)21-10-16(22)12-25(23,24)11-14-5-3-2-4-6-14/h7-9,13-14,16,21-22H,2-6,10-12H2,1H3,(H,23,24)/t13-,16-/m0/s1 D00KXZ DRUGINKE JGGVBBYJRQOPPA-BBRMVZONSA-N D00KXZ DRUGSMIL CC(C1=CC(=C(C=C1)Cl)Cl)NCC(CP(=O)(CC2CCCCC2)O)O D00KXZ HIGHSTAT Investigative D00KZO DRUG__ID D00KZO D00KZO DRUGTYPE Small molecular drug D00KZO DRUGINCH 1S/C25H28O4/c1-14(2)5-7-16-11-19-20-13-28-24-17(8-6-15(3)4)21(26)10-9-18(24)25(20)29-23(19)12-22(16)27/h5-6,9-12,20,25-27H,7-8,13H2,1-4H3/t20-,25-/m0/s1 D00KZO DRUGINKE SAXBNTXROWQAKX-CPJSRVTESA-N D00KZO DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OC3C2COC4=C3C=CC(=C4CC=C(C)C)O)C D00KZO HIGHSTAT Investigative D00LAR DRUG__ID D00LAR D00LAR DRUGTYPE Small molecular drug D00LAR DRUGINCH 1S/C26H31N7O3S/c1-26(2,3)30-24(34)17-33(37(35,36)25-7-5-6-10-29-25)21-12-20-11-19(13-27)8-9-23(20)32(15-21)16-22-14-28-18-31(22)4/h5-11,14,18,21H,12,15-17H2,1-4H3,(H,30,34) D00LAR DRUGINKE BRCRPMJRHQPZEZ-UHFFFAOYSA-N D00LAR DRUGSMIL CC(C)(C)NC(=O)CN(C1CC2=C(C=CC(=C2)C#N)N(C1)CC3=CN=CN3C)S(=O)(=O)C4=CC=CC=N4 D00LAR HIGHSTAT Investigative D00LBX DRUG__ID D00LBX D00LBX DRUGTYPE Small molecular drug D00LBX DRUGINCH 1S/C20H17NO6/c1-21-5-4-10-6-14-15(25-8-24-14)7-12(10)17(21)18-11-2-3-13-19(26-9-23-13)16(11)20(22)27-18/h2-3,6-7,17-18H,4-5,8-9H2,1H3/t17-,18+/m0/s1 D00LBX DRUGINKE IYGYMKDQCDOMRE-ZWKOTPCHSA-N D00LBX DRUGSMIL CN1CCC2=CC3=C(C=C2C1C4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3 D00LBX HIGHSTAT Investigative D00LCE DRUG__ID D00LCE D00LCE DRUGTYPE Small molecular drug D00LCE DRUGINCH 1S/C12H11F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,7,10,18H,1H3,(H,17,19)/t7-,10-/m1/s1 D00LCE DRUGINKE YODXEQNROKSLLQ-GMSGAONNSA-N D00LCE DRUGSMIL CC(C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O D00LCE HIGHSTAT Investigative D00LEQ DRUG__ID D00LEQ D00LEQ DRUGTYPE Small molecular drug D00LEQ DRUGINCH 1S/C11H14F3NO8/c12-11(13,14)10(22)15-6-3(17)1-5(9(20)21)23-8(6)7(19)4(18)2-16/h1,3-4,6-8,16-19H,2H2,(H,15,22)(H,20,21)/t3-,4-,6+,7+,8?/m0/s1 D00LEQ DRUGINKE GEGPMWUYMRCINJ-DELVFIHMSA-N D00LEQ DRUGSMIL C1=C(OC(C(C1O)NC(=O)C(F)(F)F)C(C(CO)O)O)C(=O)O D00LEQ HIGHSTAT Investigative D00LFX DRUG__ID D00LFX D00LFX DRUGTYPE Small molecular drug D00LFX DRUGINCH 1S/C18H25NO4S/c1-18-9-8-14-13-5-3-12(20)10-11(13)2-4-15(14)16(18)6-7-17(18)23-24(19,21)22/h3,5,10,14-17,20H,2,4,6-9H2,1H3,(H2,19,21,22)/t14-,15-,16+,17+,18+/m1/s1 D00LFX DRUGINKE NALROBPVVYUESB-ZBRFXRBCSA-N D00LFX DRUGSMIL CC12CCC3C(C1CCC2OS(=O)(=O)N)CCC4=C3C=CC(=C4)O D00LFX HIGHSTAT Investigative D00LHS DRUG__ID D00LHS D00LHS DRUGTYPE Small molecular drug D00LHS DRUGINCH 1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38) D00LHS DRUGINKE PQAPVTKIEGUPRN-UHFFFAOYSA-N D00LHS DRUGSMIL CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C D00LHS HIGHSTAT Investigative D00LLO DRUG__ID D00LLO D00LLO DRUGTYPE Small molecular drug D00LLO DRUGINCH 1S/C33H41N5O4/c1-21-16-26(39)17-22(2)27(21)19-28(35)33(42)38-20-24-11-7-6-10-23(24)18-30(38)32(41)37-29(14-8-9-15-34)31(40)36-25-12-4-3-5-13-25/h3-7,10-13,16-17,28-30,39H,8-9,14-15,18-20,34-35H2,1-2H3,(H,36,40)(H,37,41) D00LLO DRUGINKE RTMKKGXDPBYWCA-UHFFFAOYSA-N D00LLO DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCN)C(=O)NC4=CC=CC=C4)N)C)O D00LLO HIGHSTAT Investigative D00LMG DRUG__ID D00LMG D00LMG DRUGTYPE Small molecular drug D00LMG DRUGINCH 1S/C15H10O6/c16-8-3-1-7(2-4-8)11-5-9(17)13-12(21-11)6-10(18)14(19)15(13)20/h1-6,16,18-20H D00LMG DRUGINKE JVXZRQGOGOXCEC-UHFFFAOYSA-N D00LMG DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O)O D00LMG HIGHSTAT Investigative D00LMT DRUG__ID D00LMT D00LMT DRUGTYPE Small molecular drug D00LMT DRUGINCH 1S/C18H28N2/c1-16-5-7-17(8-6-16)15-19-13-9-18(10-14-19)20-11-3-2-4-12-20/h5-8,18H,2-4,9-15H2,1H3 D00LMT DRUGINKE XJYLZLHTPACMIL-UHFFFAOYSA-N D00LMT DRUGSMIL CC1=CC=C(C=C1)CN2CCC(CC2)N3CCCCC3 D00LMT HIGHSTAT Investigative D00LNK DRUG__ID D00LNK D00LNK DRUGTYPE Small molecular drug D00LNK DRUGINCH 1S/C19H20F3NO3/c1-23(13-18(24)25)12-11-17(14-5-3-2-4-6-14)26-16-9-7-15(8-10-16)19(20,21)22/h2-10,17H,11-13H2,1H3,(H,24,25)/t17-/m1/s1 D00LNK DRUGINKE KZWQAWBTWNPFPW-QGZVFWFLSA-N D00LNK DRUGSMIL CN(CCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F)CC(=O)O D00LNK HIGHSTAT Investigative D00LOL DRUG__ID D00LOL D00LOL DRUGTYPE Small molecular drug D00LOL DRUGINCH 1S/C15H13N5O/c1-10-4-6-11(7-5-10)14(21)20-15(16)18-13(19-20)12-3-2-8-17-9-12/h2-9H,1H3,(H2,16,18,19) D00LOL DRUGINKE BIEYFOHSWAIQDF-UHFFFAOYSA-N D00LOL DRUGSMIL CC1=CC=C(C=C1)C(=O)N2C(=NC(=N2)C3=CN=CC=C3)N D00LOL HIGHSTAT Investigative D00LRC DRUG__ID D00LRC D00LRC DRUGTYPE Small molecular drug D00LRC DRUGINCH 1S/C16H19NO2/c1-18-15-8-12-7-13(11-5-3-4-6-11)10-17-14(12)9-16(15)19-2/h7-11H,3-6H2,1-2H3 D00LRC DRUGINKE BYQWDMZNUPGMNG-UHFFFAOYSA-N D00LRC DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3CCCC3 D00LRC HIGHSTAT Investigative D00LSZ DRUG__ID D00LSZ D00LSZ DRUGTYPE Small molecular drug D00LSZ DRUGINCH 1S/C18H23NO3/c20-17(9-3-1-2-4-10-18(21)19-22)16-12-11-14-7-5-6-8-15(14)13-16/h5-8,11-13,17,20,22H,1-4,9-10H2,(H,19,21) D00LSZ DRUGINKE JWCSCYWHCCHTEF-UHFFFAOYSA-N D00LSZ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(CCCCCCC(=O)NO)O D00LSZ HIGHSTAT Investigative D00LWQ DRUG__ID D00LWQ D00LWQ DRUGTYPE Small molecular drug D00LWQ DRUGINCH 1S/C16H13BrO3/c1-20-16-9-7-11(10-13(16)17)6-8-15(19)12-4-2-3-5-14(12)18/h2-10,18H,1H3/b8-6+ D00LWQ DRUGINKE KXSKRIQLDQIBNJ-SOFGYWHQSA-N D00LWQ DRUGSMIL COC1=C(C=C(C=C1)C=CC(=O)C2=CC=CC=C2O)Br D00LWQ HIGHSTAT Investigative D00LXH DRUG__ID D00LXH D00LXH DRUGTYPE Small molecular drug D00LXH DRUGINCH 1S/C11H13BrN2/c1-8(13)7-14-5-4-9-6-10(12)2-3-11(9)14/h2-6,8H,7,13H2,1H3 D00LXH DRUGINKE UOWVUNAMIYCETC-UHFFFAOYSA-N D00LXH DRUGSMIL CC(CN1C=CC2=C1C=CC(=C2)Br)N D00LXH HIGHSTAT Investigative D00LYI DRUG__ID D00LYI D00LYI DRUGTYPE Small molecular drug D00LYI DRUGINCH 1S/C26H22N2O2/c1-18(19-8-3-2-4-9-19)28-26(30)21-11-7-12-22(16-21)27-17-24-23-13-6-5-10-20(23)14-15-25(24)29/h2-18,29H,1H3,(H,28,30) D00LYI DRUGINKE USDKSBHPFQRCGR-UHFFFAOYSA-N D00LYI DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC(=CC=C2)N=CC3=C(C=CC4=CC=CC=C43)O D00LYI HIGHSTAT Investigative D00LZJ DRUG__ID D00LZJ D00LZJ DRUGTYPE Small molecular drug D00LZJ DRUGINCH 1S/C22H36O/c1-4-5-6-7-8-16-22(2,3)20-14-12-18(13-15-20)19-10-9-11-21(23)17-19/h12-15,19,21,23H,4-11,16-17H2,1-3H3/t19-,21-/m1/s1 D00LZJ DRUGINKE SHSCKELICBAALI-TZIWHRDSSA-N D00LZJ DRUGSMIL CCCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D00LZJ HIGHSTAT Investigative D00LZS DRUG__ID D00LZS D00LZS DRUGTYPE Small molecular drug D00LZS DRUGINCH 1S/C39H49N7O10S/c1-20(2)13-29(44-36(51)31(21(3)4)46-34(49)28(41)18-42-33(48)23-14-24(39(55)56)16-25(40)15-23)35(50)45-30(19-57-27-11-6-5-7-12-27)32(47)37(52)43-26-10-8-9-22(17-26)38(53)54/h5-12,14-17,20-21,28-32,47H,13,18-19,40-41H2,1-4H3,(H,42,48)(H,43,52)(H,44,51)(H,45,50)(H,46,49)(H,53,54)(H,55,56)/t28-,29-,30-,31-,32+/m0/s1 D00LZS DRUGINKE DFWUMZBCWONAOR-QEUNAIBPSA-N D00LZS DRUGSMIL CC(C)CC(C(=O)NC(CSC1=CC=CC=C1)C(C(=O)NC2=CC=CC(=C2)C(=O)O)O)NC(=O)C(C(C)C)NC(=O)C(CNC(=O)C3=CC(=CC(=C3)N)C(=O)O)N D00LZS HIGHSTAT Investigative D00MBG DRUG__ID D00MBG D00MBG DRUGTYPE Small molecular drug D00MBG DRUGINCH 1S/C9H12N2O4S/c1-7-4-5-8(11(12)13)6-9(7)16(14,15)10(2)3/h4-6H,1-3H3 D00MBG DRUGINKE IFIUFCJFLGCQPH-UHFFFAOYSA-N D00MBG DRUGSMIL CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N(C)C D00MBG HIGHSTAT Investigative D00MCG DRUG__ID D00MCG D00MCG DRUGTYPE Small molecular drug D00MCG DRUGINCH 1S/C17H16N2O3/c20-14-10-16(13-1-2-15-12(9-13)3-4-18-15)22-17(11-14)19-5-7-21-8-6-19/h1-4,9-11,18H,5-8H2 D00MCG DRUGINKE AWODDYAKSFDGCI-UHFFFAOYSA-N D00MCG DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC4=C(C=C3)NC=C4 D00MCG HIGHSTAT Investigative D00MCJ DRUG__ID D00MCJ D00MCJ DRUGTYPE Small molecular drug D00MCJ DRUGINCH 1S/C18H12N2O/c21-17-10-9-12-5-1-2-6-13(12)11-14(17)18-19-15-7-3-4-8-16(15)20-18/h1-11H,(H,19,20) D00MCJ DRUGINKE OZPIXWTVOIXFBH-UHFFFAOYSA-N D00MCJ DRUGSMIL C1=CC=C2C=C(C(=O)C=CC2=C1)C3=NC4=CC=CC=C4N3 D00MCJ HIGHSTAT Investigative D00MEM DRUG__ID D00MEM D00MEM DRUGTYPE Small molecular drug D00MEM DRUGINCH 1S/C31H34N6O4/c1-18-11-22(38)12-19(2)23(18)14-24(32)31(41)37-17-21-8-4-3-7-20(21)13-27(37)30(40)34-16-29(39)33-15-28-35-25-9-5-6-10-26(25)36-28/h3-12,24,27,38H,13-17,32H2,1-2H3,(H,33,39)(H,34,40)(H,35,36)/t24-,27?/m0/s1 D00MEM DRUGINKE LKKOHYJIXKBADA-BXXZMZEQSA-N D00MEM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NCC4=NC5=CC=CC=C5N4)N)C)O D00MEM HIGHSTAT Investigative D00MFA DRUG__ID D00MFA D00MFA DRUGTYPE Small molecular drug D00MFA DRUGINCH 1S/C14H18N2O5/c1-21-14(20)11(7-9-5-3-2-4-6-9)16-13(19)10(15)8-12(17)18/h2-6,10-11H,7-8,15H2,1H3,(H,16,19)(H,17,18)/t10-,11-/m0/s1 D00MFA DRUGINKE IAOZJIPTCAWIRG-QWRGUYRKSA-N D00MFA DRUGSMIL COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N D00MFA HIGHSTAT Investigative D00MFR DRUG__ID D00MFR D00MFR DRUGTYPE Small molecular drug D00MFR DRUGINCH 1S/C14H14N2O/c1-9-14-11(6-7-16(9)2)12-8-10(17-3)4-5-13(12)15-14/h4-8H,1-3H3/p+1 D00MFR DRUGINKE GKOBEAWUMYEQIP-UHFFFAOYSA-O D00MFR DRUGSMIL CC1=[N+](C=CC2=C1NC3=C2C=C(C=C3)OC)C D00MFR HIGHSTAT Investigative D00MFV DRUG__ID D00MFV D00MFV DRUGTYPE Small molecular drug D00MFV DRUGINCH 1S/C9H13N5/c1-3-6(2)14-5-13-7-8(10)11-4-12-9(7)14/h4-6H,3H2,1-2H3,(H2,10,11,12) D00MFV DRUGINKE WUUGZXPFGNZPJO-UHFFFAOYSA-N D00MFV DRUGSMIL CCC(C)N1C=NC2=C(N=CN=C21)N D00MFV HIGHSTAT Investigative D00MFZ DRUG__ID D00MFZ D00MFZ DRUGTYPE Small molecular drug D00MFZ DRUGINCH 1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m0/s1 D00MFZ DRUGINKE QPYJXFZUIJOGNX-ZLUOBGJFSA-N D00MFZ DRUGSMIL C1C(C(C(CN1)O)O)CO D00MFZ HIGHSTAT Investigative D00MGT DRUG__ID D00MGT D00MGT DRUGTYPE Small molecular drug D00MGT DRUGINCH 1S/C26H32N4O4/c1-27-17-20(14-19-15-23-18(16-24(19)27)4-3-5-25(23)34-2)26(31)29-12-10-28(11-13-29)21-6-8-22(9-7-21)30(32)33/h3-9,19-20,24H,10-17H2,1-2H3/t19-,20-,24-/m1/s1 D00MGT DRUGINKE INULNSAIIZKOQE-YOSAUDMPSA-N D00MGT DRUGSMIL CN1CC(CC2C1CC3=C(C2)C(=CC=C3)OC)C(=O)N4CCN(CC4)C5=CC=C(C=C5)[N+](=O)[O-] D00MGT HIGHSTAT Investigative D00MJG DRUG__ID D00MJG D00MJG DRUGTYPE Small molecular drug D00MJG DRUGINCH 1S/C31H39N5O3.ClH/c1-7-8-17-36-29-24(13-10-15-33-29)25(21-11-9-12-22(18-21)39-6)28(30(36)37)35-31(38)34-27-23(19(2)3)14-16-32-26(27)20(4)5;/h9-16,18-20,26,32H,7-8,17H2,1-6H3,(H2,34,35,38);1H D00MJG DRUGINKE UXCQVIIRKWYPHK-UHFFFAOYSA-N D00MJG DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=CNC3C(C)C)C(C)C)C4=CC(=CC=C4)OC.Cl D00MJG HIGHSTAT Investigative D00MLE DRUG__ID D00MLE D00MLE DRUGTYPE Small molecular drug D00MLE DRUGINCH 1S/C19H15N3O/c20-14-8-11-17-18(12-14)22-19(21-17)13-6-9-16(10-7-13)23-15-4-2-1-3-5-15/h1-12H,20H2,(H,21,22) D00MLE DRUGINKE YDXHPXOLZYGIGV-UHFFFAOYSA-N D00MLE DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=NC4=C(N3)C=C(C=C4)N D00MLE HIGHSTAT Investigative D00MLN DRUG__ID D00MLN D00MLN DRUGTYPE Small molecular drug D00MLN DRUGINCH 1S/C37H40N2O6/c1-38-14-12-24-19-31(42-4)33-21-27(24)28(38)17-23-8-11-30(41-3)32(18-23)44-26-9-6-22(7-10-26)16-29-35-25(13-15-39(29)2)20-34(43-5)36(40)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m0/s1 D00MLN DRUGINKE YJRWQNIRFXVBRB-URLMMPGGSA-N D00MLN DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=CC(=C(C=C7CCN6C)OC)O3)OC)O)OC D00MLN HIGHSTAT Investigative D00MNE DRUG__ID D00MNE D00MNE DRUGTYPE Small molecular drug D00MNE DRUGINCH 1S/C25H28O4/c1-15(2)5-7-17-11-19(12-18(25(17)28)8-6-16(3)4)23-14-22(27)21-10-9-20(26)13-24(21)29-23/h5-6,9-13,23,26,28H,7-8,14H2,1-4H3/t23-/m0/s1 D00MNE DRUGINKE JBQLRZGPTDOWQA-QHCPKHFHSA-N D00MNE DRUGSMIL CC(=CCC1=CC(=CC(=C1O)CC=C(C)C)C2CC(=O)C3=C(O2)C=C(C=C3)O)C D00MNE HIGHSTAT Investigative D00MPA DRUG__ID D00MPA D00MPA DRUGTYPE Small molecular drug D00MPA DRUGINCH 1S/C9H7N5O/c10-9-13-6(5-2-1-3-15-5)7-8(14-9)12-4-11-7/h1-4H,(H3,10,11,12,13,14) D00MPA DRUGINKE JZSMPSCWNAYWOI-UHFFFAOYSA-N D00MPA DRUGSMIL C1=COC(=C1)C2=C3C(=NC(=N2)N)N=CN3 D00MPA HIGHSTAT Investigative D00MPM DRUG__ID D00MPM D00MPM DRUGTYPE Small molecular drug D00MPM DRUGINCH 1S/C20H24O3/c1-14(2)6-8-17-12-15(7-11-19(17)22)4-3-5-16-9-10-18(21)13-20(16)23/h6-7,9-13,21-23H,3-5,8H2,1-2H3 D00MPM DRUGINKE CMOZGCJOTGLPKO-UHFFFAOYSA-N D00MPM DRUGSMIL CC(=CCC1=C(C=CC(=C1)CCCC2=C(C=C(C=C2)O)O)O)C D00MPM HIGHSTAT Investigative D00MSU DRUG__ID D00MSU D00MSU DRUGTYPE Small molecular drug D00MSU DRUGINCH 1S/C14H16N2O/c15-13-7-6-11-2-1-3-12(14(11)16-13)17-9-8-10-4-5-10/h1-3,6-7,10H,4-5,8-9H2,(H2,15,16) D00MSU DRUGINKE YLXQVSWEPLSGKN-UHFFFAOYSA-N D00MSU DRUGSMIL C1CC1CCOC2=CC=CC3=C2N=C(C=C3)N D00MSU HIGHSTAT Investigative D00MUJ DRUG__ID D00MUJ D00MUJ DRUGTYPE Small molecular drug D00MUJ DRUGINCH 1S/C16H17NO4S/c1-2-6-12-9-10-15(14(11-12)16(18)19)17-22(20,21)13-7-4-3-5-8-13/h3-5,7-11,17H,2,6H2,1H3,(H,18,19) D00MUJ DRUGINKE LZDCSXYOKAIIJO-UHFFFAOYSA-N D00MUJ DRUGSMIL CCCC1=CC(=C(C=C1)NS(=O)(=O)C2=CC=CC=C2)C(=O)O D00MUJ HIGHSTAT Investigative D00MXS DRUG__ID D00MXS D00MXS DRUGTYPE Small molecular drug D00MXS DRUGINCH 1S/C16H12O5/c1-20-15-12(19)7-10(17)14-11(18)8-13(21-16(14)15)9-5-3-2-4-6-9/h2-8,17,19H,1H3 D00MXS DRUGINKE XLTFNNCXVBYBSX-UHFFFAOYSA-N D00MXS DRUGSMIL COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3)O)O D00MXS HIGHSTAT Investigative D00MXW DRUG__ID D00MXW D00MXW DRUGTYPE Small molecular drug D00MXW DRUGINCH 1S/C21H19NO4/c1-14(23)15-5-2-3-6-16(15)17-7-4-8-18-19(24)13-20(26-21(17)18)22-9-11-25-12-10-22/h2-8,13H,9-12H2,1H3 D00MXW DRUGINKE GMTPLPJMRGXINX-UHFFFAOYSA-N D00MXW DRUGSMIL CC(=O)C1=CC=CC=C1C2=CC=CC3=C2OC(=CC3=O)N4CCOCC4 D00MXW HIGHSTAT Investigative D00MZD DRUG__ID D00MZD D00MZD DRUGTYPE Small molecular drug D00MZD DRUGINCH 1S/C11H19N5O11P2/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(26-10)2-25-29(23,24)27-28(20,21)22/h4,6-7,10,17-18H,2-3H2,1H3,(H,23,24)(H2,20,21,22)(H3,12,13,14,19)/t4-,6-,7-,10-/m1/s1 D00MZD DRUGINKE QQODJOAVWUWVHJ-KQYNXXCUSA-N D00MZD DRUGSMIL CN1CN(C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O D00MZD HIGHSTAT Investigative D00MZS DRUG__ID D00MZS D00MZS DRUGTYPE Small molecular drug D00MZS DRUGINCH 1S/C13H7Cl4NO2/c14-8-7(12(19)11(17)10(16)9(8)15)13(20)18-6-4-2-1-3-5-6/h1-5,19H,(H,18,20) D00MZS DRUGINKE BDOBMVIEWHZYDL-UHFFFAOYSA-N D00MZS DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)O D00MZS HIGHSTAT Investigative D00NCL DRUG__ID D00NCL D00NCL DRUGTYPE Small molecular drug D00NCL DRUGINCH 1S/C14H13N5S/c1-2-7-15-12(6-1)17-14-18-13-9-8-16-19-10(9)4-3-5-11(13)20-14/h1-2,6-8H,3-5H2,(H,16,19)(H,15,17,18) D00NCL DRUGINKE DBISXWCOHGUFSF-UHFFFAOYSA-N D00NCL DRUGSMIL C1CC2=C(C=NN2)C3=C(C1)SC(=N3)NC4=CC=CC=N4 D00NCL HIGHSTAT Investigative D00NEE DRUG__ID D00NEE D00NEE DRUGTYPE Small molecular drug D00NEE DRUGINCH 1S/C46H62N8O12/c1-25(55)38(44(62)54-21-5-7-37(54)43(61)50-35(6-3-4-20-47)41(59)53-39(26(2)56)46(65)66)52-42(60)36(24-29-12-18-32(57)19-13-29)51-40(58)33(48)22-27-8-14-30(15-9-27)31-16-10-28(11-17-31)23-34(49)45(63)64/h8-19,25-26,33-39,55-57H,3-7,20-24,47-49H2,1-2H3,(H,50,61)(H,51,58)(H,52,60)(H,53,59)(H,63,64)(H,65,66)/t25-,26-,33+,34+,35+,36+,37+,38+,39+/m1/s1 D00NEE DRUGINKE IBJQKBDBQJHDOQ-KOXSSGOCSA-N D00NEE DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=C(C=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N)O D00NEE HIGHSTAT Investigative D00NEK DRUG__ID D00NEK D00NEK DRUGTYPE Small molecular drug D00NEK DRUGINCH 1S/C20H15NO/c22-16-12-10-15(11-13-16)20-19(14-6-2-1-3-7-14)17-8-4-5-9-18(17)21-20/h1-13,21-22H D00NEK DRUGINKE HRWBDGGFCFVAHP-UHFFFAOYSA-N D00NEK DRUGSMIL C1=CC=C(C=C1)C2=C(NC3=CC=CC=C32)C4=CC=C(C=C4)O D00NEK HIGHSTAT Investigative D00NFW DRUG__ID D00NFW D00NFW DRUGTYPE Small molecular drug D00NFW DRUGINCH 1S/C20H17N3/c1-2-18-22-19-16(14-9-5-3-6-10-14)13-17(21-20(19)23-18)15-11-7-4-8-12-15/h3-13H,2H2,1H3,(H,21,22,23) D00NFW DRUGINKE PMDYRFYZMJGDQY-UHFFFAOYSA-N D00NFW DRUGSMIL CCC1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D00NFW HIGHSTAT Investigative D00NIT DRUG__ID D00NIT D00NIT DRUGTYPE Small molecular drug D00NIT DRUGINCH 1S/C39H38F2N4O3/c1-43(2)30-20-23-44(24-21-30)36(46)26-34-33-14-8-9-15-35(33)45(25-22-39(34,40)41)38(48)28-16-18-29(19-17-28)42-37(47)32-13-7-6-12-31(32)27-10-4-3-5-11-27/h3-19,26,30H,20-25H2,1-2H3,(H,42,47)/b34-26- D00NIT DRUGINKE ICRPTZMWRJGNQI-CLIDGEQKSA-N D00NIT DRUGSMIL CN(C)C1CCN(CC1)C(=O)C=C2C3=CC=CC=C3N(CCC2(F)F)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6 D00NIT HIGHSTAT Investigative D00NIX DRUG__ID D00NIX D00NIX DRUGTYPE Small molecular drug D00NIX DRUGINCH 1S/C28H27N2O4/c1-31-25-9-8-19-14-24-22-16-27-26(33-18-34-27)15-20(22)10-12-30(24)17-23(19)28(25)32-13-5-11-29-21-6-3-2-4-7-21/h2-4,6-9,14-17,29H,5,10-13,18H2,1H3/q+1 D00NIX DRUGINKE BRNHZXILANUSDI-UHFFFAOYSA-N D00NIX DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCNC6=CC=CC=C6 D00NIX HIGHSTAT Investigative D00NNP DRUG__ID D00NNP D00NNP DRUGTYPE Small molecular drug D00NNP DRUGINCH 1S/C12H17BrN4S/c13-10-4-5-11(14-8-10)16-12(18)15-9-17-6-2-1-3-7-17/h4-5,8H,1-3,6-7,9H2,(H2,14,15,16,18) D00NNP DRUGINKE QIWYYZPJZHMEPR-UHFFFAOYSA-N D00NNP DRUGSMIL C1CCN(CC1)CNC(=S)NC2=NC=C(C=C2)Br D00NNP HIGHSTAT Investigative D00NOG DRUG__ID D00NOG D00NOG DRUGTYPE Small molecular drug D00NOG DRUGINCH 1S/C66H96O2/c1-50(2)26-16-27-51(3)28-17-29-52(4)30-18-31-53(5)32-19-33-54(6)34-20-35-55(7)36-21-37-56(8)38-22-39-57(9)40-23-41-58(10)42-24-43-59(11)44-25-45-60(12)48-49-62-61(13)65(67)63-46-14-15-47-64(63)66(62)68/h14-15,26,28,30,32,34,36,38,40,42,44,46-48H,16-25,27,29,31,33,35,37,39,41,43,45,49H2,1-13H3/b51-28+,52-30+,53-32+,54-34+,55-36+,56-38+,57-40+,58-42+,59-44+,60-48+ D00NOG DRUGINKE YYDMANIEKFAEJC-RYZSZPJESA-N D00NOG DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C D00NOG HIGHSTAT Investigative D00NOH DRUG__ID D00NOH D00NOH DRUGTYPE Small molecular drug D00NOH DRUGINCH 1S/C24H32O3/c1-17-7-6-10-18(13-17)8-2-4-11-21-22-15-19(9-3-5-12-24(26)27)14-20(22)16-23(21)25/h4,6-7,10-11,13-14,20-23,25H,2-3,5,8-9,12,15-16H2,1H3,(H,26,27)/b11-4+/t20-,21+,22-,23+/m0/s1 D00NOH DRUGINKE UZEWMXSWYKBMJG-ROHPBGETSA-N D00NOH DRUGSMIL CC1=CC(=CC=C1)CCC=CC2C(CC3C2CC(=C3)CCCCC(=O)O)O D00NOH HIGHSTAT Investigative D00NOL DRUG__ID D00NOL D00NOL DRUGCOMP Merck & Co Inc D00NOL DRUGINCH 1S/C19H19ClFN3O4/c1-22(2)18(27)15-11-6-7-24(9-10-4-5-13(21)12(20)8-10)17(26)14(11)16(25)19(28)23(15)3/h4-5,8,25H,6-7,9H2,1-3H3 D00NOL DRUGINKE FFDVONMXYFIBBI-UHFFFAOYSA-N D00NOL DRUGSMIL CN1C(=C2CCN(C(=O)C2=C(C1=O)O)CC3=CC(=C(C=C3)F)Cl)C(=O)N(C)C D00NOL HIGHSTAT Investigative D00NQQ DRUG__ID D00NQQ D00NQQ DRUGTYPE Small molecular drug D00NQQ DRUGINCH 1S/C11H18N5O11P3/c12-10-9-11(14-3-13-10)16(4-15-9)8-1-6(17)7(26-8)2-25-28(18,19)5-29(20,21)27-30(22,23)24/h3-4,6-8,17H,1-2,5H2,(H,18,19)(H,20,21)(H2,12,13,14)(H2,22,23,24)/t6-,7+,8+/m0/s1 D00NQQ DRUGINKE XETARULVTCYJAN-XLPZGREQSA-N D00NQQ DRUGSMIL C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O D00NQQ HIGHSTAT Investigative D00NQV DRUG__ID D00NQV D00NQV DRUGTYPE Small molecular drug D00NQV DRUGINCH 1S/C21H28IN3O/c1-16(2)26-20-5-4-12-23-21(20)24(3)19-10-13-25(14-11-19)15-17-6-8-18(22)9-7-17/h4-9,12,16,19H,10-11,13-15H2,1-3H3 D00NQV DRUGINKE ZJAXDNQQFMPNAV-UHFFFAOYSA-N D00NQV DRUGSMIL CC(C)OC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=C(C=C3)I D00NQV HIGHSTAT Investigative D00NRB DRUG__ID D00NRB D00NRB DRUGTYPE Small molecular drug D00NRB DRUGINCH 1S/C19H23NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h1,6-7,13,16,18,21H,3-5,8-12H2/t16-,18+,19+/m0/s1 D00NRB DRUGINKE OKICQDFBWUMTDE-QXAKKESOSA-N D00NRB DRUGSMIL C#CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O D00NRB HIGHSTAT Investigative D00NRJ DRUG__ID D00NRJ D00NRJ DRUGTYPE Small molecular drug D00NRJ DRUGINCH 1S/C19H33N2OSi/c1-21(2)15-13-20(14-16-21)17-23(22,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3,5-6,9-10,19,22H,4,7-8,11-17H2,1-2H3/q+1 D00NRJ DRUGINKE GBISIIAKUATURW-UHFFFAOYSA-N D00NRJ DRUGSMIL C[N+]1(CCN(CC1)C[Si](C2CCCCC2)(C3=CC=CC=C3)O)C D00NRJ HIGHSTAT Investigative D00NSA DRUG__ID D00NSA D00NSA DRUGTYPE Small molecular drug D00NSA DRUGINCH 1S/C12H14N2O/c1-15-11-4-2-3-9-12(11)8-5-6-13-7-10(8)14-9/h2-4,13-14H,5-7H2,1H3 D00NSA DRUGINKE VPZWHBCLJCKHGZ-UHFFFAOYSA-N D00NSA DRUGSMIL COC1=CC=CC2=C1C3=C(N2)CNCC3 D00NSA HIGHSTAT Investigative D00NST DRUG__ID D00NST D00NST DRUGTYPE Small molecular drug D00NST DRUGINCH 1S/C12H13N3O/c1-8(13)7-15-12-9(6-14-15)2-3-11-10(12)4-5-16-11/h2-6,8H,7,13H2,1H3/t8-/m0/s1 D00NST DRUGINKE XAEAYQWCVVRSFL-QMMMGPOBSA-N D00NST DRUGSMIL CC(CN1C2=C(C=CC3=C2C=CO3)C=N1)N D00NST HIGHSTAT Investigative D00NUK DRUG__ID D00NUK D00NUK DRUGTYPE Small molecular drug D00NUK DRUGINCH 1S/C7H10N2O4S2/c1-14(10,11)9-6-2-4-7(5-3-6)15(8,12)13/h2-5,9H,1H3,(H2,8,12,13) D00NUK DRUGINKE KPLRLDFXFOARQY-UHFFFAOYSA-N D00NUK DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)S(=O)(=O)N D00NUK HIGHSTAT Investigative D00NVC DRUG__ID D00NVC D00NVC DRUGTYPE Small molecular drug D00NVC DRUGINCH 1S/C43H59N7O9/c1-9-27(6)36(40(54)47-35(26(4)5)41(55)58-8)48-42(56)50-49-39(53)34(23-31-20-15-19-30-18-13-14-21-32(30)31)46-38(52)33(22-25(2)3)45-37(51)28(7)44-43(57)59-24-29-16-11-10-12-17-29/h10-21,25-28,33-36H,9,22-24H2,1-8H3,(H,44,57)(H,45,51)(H,46,52)(H,47,54)(H,49,53)(H2,48,50,56) D00NVC DRUGINKE KMJURIDKPLGXEZ-UHFFFAOYSA-N D00NVC DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=CC2=CC=CC=C21)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC3=CC=CC=C3 D00NVC HIGHSTAT Investigative D00NWF DRUG__ID D00NWF D00NWF DRUGTYPE Small molecular drug D00NWF DRUGINCH 1S/C23H23N3O3/c1-15-7-10-18(24-23(29)17-5-4-6-19(13-17)26(2)3)14-21(15)25-22(28)16-8-11-20(27)12-9-16/h4-14,27H,1-3H3,(H,24,29)(H,25,28) D00NWF DRUGINKE PYEFPDQFAZNXLI-UHFFFAOYSA-N D00NWF DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)N(C)C)NC(=O)C3=CC=C(C=C3)O D00NWF HIGHSTAT Investigative D00NXA DRUG__ID D00NXA D00NXA DRUGTYPE Small molecular drug D00NXA DRUGINCH 1S/C8H7BO3/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5,10-11H D00NXA DRUGINKE PKRRNTJIHGOMRC-UHFFFAOYSA-N D00NXA DRUGSMIL B(C1=CC2=CC=CC=C2O1)(O)O D00NXA HIGHSTAT Investigative D00NYG DRUG__ID D00NYG D00NYG DRUGTYPE Small molecular drug D00NYG DRUGINCH 1S/C17H12N4/c18-11-14-15(12-7-3-1-4-8-12)20-17(21-16(14)19)13-9-5-2-6-10-13/h1-10H,(H2,19,20,21) D00NYG DRUGINKE RVAUJCJDJMOIOL-UHFFFAOYSA-N D00NYG DRUGSMIL C1=CC=C(C=C1)C2=C(C(=NC(=N2)C3=CC=CC=C3)N)C#N D00NYG HIGHSTAT Investigative D00NYT DRUG__ID D00NYT D00NYT DRUGTYPE Small molecular drug D00NYT DRUGINCH 1S/C18H15NO4/c1-22-13-7-3-11(4-8-13)15-16(18(21)19-17(15)20)12-5-9-14(23-2)10-6-12/h3-10H,1-2H3,(H,19,20,21) D00NYT DRUGINKE WRDXDCMVUJADCC-UHFFFAOYSA-N D00NYT DRUGSMIL COC1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=C(C=C3)OC D00NYT HIGHSTAT Investigative D00NZP DRUG__ID D00NZP D00NZP DRUGTYPE Small molecular drug D00NZP DRUGINCH 1S/C36H41N5O5/c1-22-15-28(42)16-23(2)29(22)20-30(37)36(46)41(3)21-33(43)39-32(18-24-9-5-4-6-10-24)35(45)40-31(34(38)44)19-25-13-14-26-11-7-8-12-27(26)17-25/h4-17,30-32,42H,18-21,37H2,1-3H3,(H2,38,44)(H,39,43)(H,40,45)/t30-,31+,32-/m0/s1 D00NZP DRUGINKE LCSGBFCHAFMKLD-QAXCHELISA-N D00NZP DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N(C)CC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)N)N)C)O D00NZP HIGHSTAT Investigative D00OAN DRUG__ID D00OAN D00OAN DRUGTYPE Small molecular drug D00OAN DRUGINCH 1S/C15H14N2O2/c1-2-7-19-15(18)13-8-11-10-5-3-4-6-12(10)17-14(11)9-16-13/h3-6,8-9,17H,2,7H2,1H3 D00OAN DRUGINKE WGRVAGIQTHEEQW-UHFFFAOYSA-N D00OAN DRUGSMIL CCCOC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D00OAN HIGHSTAT Investigative D00OBS DRUG__ID D00OBS D00OBS DRUGTYPE Small molecular drug D00OBS DRUGINCH 1S/C17H21BrN6O2/c18-10-3-4-11-9(8-22-13(11)7-10)6-14-16(26)23-12(15(25)24-14)2-1-5-21-17(19)20/h3-4,7-8,12,14,22H,1-2,5-6H2,(H,23,26)(H,24,25)(H4,19,20,21)/t12-,14-/m0/s1 D00OBS DRUGINKE HVWYYWIRLPBRTO-JSGCOSHPSA-N D00OBS DRUGSMIL C1=CC2=C(C=C1Br)NC=C2CC3C(=O)NC(C(=O)N3)CCCN=C(N)N D00OBS HIGHSTAT Investigative D00OCC DRUG__ID D00OCC D00OCC DRUGTYPE Small molecular drug D00OCC DRUGINCH 1S/C16H18N2O2S/c19-21(20,15-6-2-1-3-7-15)16-8-4-5-14(13-16)18-11-9-17-10-12-18/h1-8,13,17H,9-12H2 D00OCC DRUGINKE KDBOZUADFFNYSM-UHFFFAOYSA-N D00OCC DRUGSMIL C1CN(CCN1)C2=CC(=CC=C2)S(=O)(=O)C3=CC=CC=C3 D00OCC HIGHSTAT Investigative D00OCV DRUG__ID D00OCV D00OCV DRUGTYPE Small molecular drug D00OCV DRUGINCH 1S/C13H18N2O/c1-9-10(7-8-15(2)3)13-11(14-9)5-4-6-12(13)16/h4-6,14,16H,7-8H2,1-3H3 D00OCV DRUGINKE HXNGZUVNHQYMKL-UHFFFAOYSA-N D00OCV DRUGSMIL CC1=C(C2=C(N1)C=CC=C2O)CCN(C)C D00OCV HIGHSTAT Investigative D00ODL DRUG__ID D00ODL D00ODL DRUGTYPE Small molecular drug D00ODL DRUGINCH 1S/C31H38N6O4/c1-31(2,3)35-29(40)34-25(16-21-18-32-23-13-8-7-12-22(21)23)28(39)33-24-14-9-15-36-26(24)17-27(38)37(30(36)41)19-20-10-5-4-6-11-20/h4-8,10-13,18,24-26,32H,9,14-17,19H2,1-3H3,(H,33,39)(H2,34,35,40)/t24-,25+,26+/m1/s1 D00ODL DRUGINKE JQMXXJDAKTTXOB-ZNZIZOMTSA-N D00ODL DRUGSMIL CC(C)(C)NC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC3CCCN4C3CC(=O)N(C4=O)CC5=CC=CC=C5 D00ODL HIGHSTAT Investigative D00ODN DRUG__ID D00ODN D00ODN DRUGTYPE Small molecular drug D00ODN DRUGINCH 1S/C18H14N4S/c1-3-7-14(8-4-1)11-22-13-21-16-17(22)19-12-20-18(16)23-15-9-5-2-6-10-15/h1-10,12-13H,11H2 D00ODN DRUGINKE ADCGNZUTMCMTDC-UHFFFAOYSA-N D00ODN DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C2N=CN=C3SC4=CC=CC=C4 D00ODN HIGHSTAT Investigative D00OFN DRUG__ID D00OFN D00OFN DRUGTYPE Small molecular drug D00OFN DRUGINCH 1S/C11H12N4S/c1-2-16-11-14-9(13-10(12)15-11)8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,12,13,14,15) D00OFN DRUGINKE UMHVGNHYSDRNNN-UHFFFAOYSA-N D00OFN DRUGSMIL CCSC1=NC(=NC(=N1)N)C2=CC=CC=C2 D00OFN HIGHSTAT Investigative D00OFV DRUG__ID D00OFV D00OFV DRUGTYPE Small molecular drug D00OFV DRUGINCH 1S/C31H29N5O4/c1-17(2)15-22-29(39)36-25-14-8-5-11-20(25)31(40,30(36)34-22)16-23-26-32-21-12-6-3-9-18(21)28(38)35(26)24-13-7-4-10-19(24)27(37)33-23/h3-14,17,22-23,30,34,40H,15-16H2,1-2H3,(H,33,37)/t22-,23-,30-,31-/m0/s1 D00OFV DRUGINKE MGMRIOLWEROPJY-FPACPZPDSA-N D00OFV DRUGSMIL CC(C)CC1C(=O)N2C(N1)C(C3=CC=CC=C32)(CC4C5=NC6=CC=CC=C6C(=O)N5C7=CC=CC=C7C(=O)N4)O D00OFV HIGHSTAT Investigative D00OLH DRUG__ID D00OLH D00OLH DRUGTYPE Small molecular drug D00OLH DRUGINCH 1S/C20H16O3/c21-17-7-1-14(2-8-17)13-20(15-3-9-18(22)10-4-15)16-5-11-19(23)12-6-16/h1-13,21-23H D00OLH DRUGINKE LZHPXIZTZSFAAE-UHFFFAOYSA-N D00OLH DRUGSMIL C1=CC(=CC=C1C=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)O D00OLH HIGHSTAT Investigative D00OLX DRUG__ID D00OLX D00OLX DRUGTYPE Small molecular drug D00OLX DRUGINCH 1S/C16H18N4O3/c1-10-6-5-7-11(8-10)9-23-15-17-13-12(18(15)2)14(21)20(4)16(22)19(13)3/h5-8H,9H2,1-4H3 D00OLX DRUGINKE AFSVTGXZVYXITM-UHFFFAOYSA-N D00OLX DRUGSMIL CC1=CC(=CC=C1)COC2=NC3=C(N2C)C(=O)N(C(=O)N3C)C D00OLX HIGHSTAT Investigative D00OMV DRUG__ID D00OMV D00OMV DRUGTYPE Small molecular drug D00OMV DRUGINCH 1S/C35H42O8/c1-16(2)12-23(37)41-22-14-18(4)24-21(36)13-17(3)25(24)28-26(22)35(31(39)43-28)15-34-11-10-32(35,6)29(34)27-20(8-9-33(34,7)40)19(5)30(38)42-27/h10-11,13,16,20,22,25-29,40H,5,8-9,12,14-15H2,1-4,6-7H3/t20-,22-,25-,26+,27-,28+,29-,32+,33+,34-,35+/m0/s1 D00OMV DRUGINKE RAKYLPJLLBOHHN-CFTUDFFSSA-N D00OMV DRUGSMIL CC1=C2C(C3C(C(C1)OC(=O)CC(C)C)C4(CC56C=CC4(C5C7C(CCC6(C)O)C(=C)C(=O)O7)C)C(=O)O3)C(=CC2=O)C D00OMV HIGHSTAT Investigative D00OMW DRUG__ID D00OMW D00OMW DRUGTYPE Small molecular drug D00OMW DRUGINCH 1S/C17H16N2O4S2/c1-8(2)12(16(22)23)19-15(21)13(25-17(19)24)11-9-6-4-5-7-10(9)18(3)14(11)20/h4-8,12H,1-3H3,(H,22,23)/b13-11- D00OMW DRUGINKE ICRQMQBVDGOOFY-QBFSEMIESA-N D00OMW DRUGSMIL CC(C)C(C(=O)O)N1C(=O)C(=C2C3=CC=CC=C3N(C2=O)C)SC1=S D00OMW HIGHSTAT Investigative D00OPO DRUG__ID D00OPO D00OPO DRUGTYPE Small molecular drug D00OPO DRUGINCH 1S/C43H46N2O10/c1-3-23-44(27-29-15-19-33(20-16-29)54-31-11-7-5-8-12-31)39(48)35-25-36(43(42(52)53,26-37(46)47)38(35)41(50)51)40(49)45(24-4-2)28-30-17-21-34(22-18-30)55-32-13-9-6-10-14-32/h5-22,35-36,38H,3-4,23-28H2,1-2H3,(H,46,47)(H,50,51)(H,52,53)/t35-,36-,38+,43-/m0/s1 D00OPO DRUGINKE SZUVGFMDDVSKSI-WIFOCOSTSA-N D00OPO DRUGSMIL CCCN(CC1=CC=C(C=C1)OC2=CC=CC=C2)C(=O)C3CC(C(C3C(=O)O)(CC(=O)O)C(=O)O)C(=O)N(CCC)CC4=CC=C(C=C4)OC5=CC=CC=C5 D00OPO HIGHSTAT Investigative D00OQL DRUG__ID D00OQL D00OQL DRUGTYPE Small molecular drug D00OQL DRUGINCH 1S/C16H16O4/c1-9(17)8-19-14-7-6-12-11-4-3-5-13(11)16(18)20-15(12)10(14)2/h6-7H,3-5,8H2,1-2H3 D00OQL DRUGINKE JLYIBZRYQJEBHZ-UHFFFAOYSA-N D00OQL DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=C2CCC3)OCC(=O)C D00OQL HIGHSTAT Investigative D00ORM DRUG__ID D00ORM D00ORM DRUGTYPE Small molecular drug D00ORM DRUGINCH 1S/C17H17NO2/c19-17(20)11-5-6-12-18-15-9-3-1-7-13(15)14-8-2-4-10-16(14)18/h1-4,7-10H,5-6,11-12H2,(H,19,20) D00ORM DRUGINKE YEPJVQJMLQBLOE-UHFFFAOYSA-N D00ORM DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCC(=O)O D00ORM HIGHSTAT Investigative D00OTC DRUG__ID D00OTC D00OTC DRUGTYPE Small molecular drug D00OTC DRUGINCH 1S/C17H18O4/c1-19-14-8-13(9-15(11-14)20-2)5-4-12-6-7-17(21-3)16(18)10-12/h4-11,18H,1-3H3/b5-4+ D00OTC DRUGINKE UQIWTPQGJCCTPA-SNAWJCMRSA-N D00OTC DRUGSMIL COC1=C(C=C(C=C1)C=CC2=CC(=CC(=C2)OC)OC)O D00OTC HIGHSTAT Investigative D00OUF DRUG__ID D00OUF D00OUF DRUGTYPE Small molecular drug D00OUF DRUGINCH 1S/C19H30N2O/c1-3-8-19(9-4-1)22-17-7-12-20-15-10-18(11-16-20)21-13-5-2-6-14-21/h1,3-4,8-9,18H,2,5-7,10-17H2 D00OUF DRUGINKE GCJKCPQHXFIKIF-UHFFFAOYSA-N D00OUF DRUGSMIL C1CCN(CC1)C2CCN(CC2)CCCOC3=CC=CC=C3 D00OUF HIGHSTAT Investigative D00OWE DRUG__ID D00OWE D00OWE DRUGTYPE Small molecular drug D00OWE DRUGINCH 1S/C22H14F3NO2S2/c23-22(24,25)14-8-9-18-15(11-14)19(27)20(30-18)21(28)26-12-16(17-7-4-10-29-17)13-5-2-1-3-6-13/h1-12,27H,(H,26,28)/b16-12+ D00OWE DRUGINKE MWRHQMNEBAXDOF-FOWTUZBSSA-N D00OWE DRUGSMIL C1=CC=C(C=C1)C(=CNC(=O)C2=C(C3=C(S2)C=CC(=C3)C(F)(F)F)O)C4=CC=CS4 D00OWE HIGHSTAT Investigative D00OWZ DRUG__ID D00OWZ D00OWZ DRUGTYPE Small molecular drug D00OWZ DRUGINCH 1S/C11H10N2O2S/c1-15-9-4-2-8(3-5-9)10(14)13-11-12-6-7-16-11/h2-7H,1H3,(H,12,13,14) D00OWZ DRUGINKE PPERAEKJEHRHOY-UHFFFAOYSA-N D00OWZ DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NC=CS2 D00OWZ HIGHSTAT Investigative D00OXH DRUG__ID D00OXH D00OXH DRUGTYPE Small molecular drug D00OXH DRUGINCH 1S/C21H34O4/c1-2-3-6-9-17(22)12-13-18-16-14-20(25-15-16)19(18)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17-,18-,19+,20-/m0/s1 D00OXH DRUGINKE DJKDIKIDYDXHDD-IGUVKOCZSA-N D00OXH DRUGSMIL CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O D00OXH HIGHSTAT Investigative D00OZA DRUG__ID D00OZA D00OZA DRUGTYPE Small molecular drug D00OZA DRUGINCH 1S/C12H8N2O/c1-2-8-6-9-4-3-5-10(12(13)15)11(9)14-7-8/h1,3-7H,(H2,13,15) D00OZA DRUGINKE FVYCGVPNXRWDOH-UHFFFAOYSA-N D00OZA DRUGSMIL C#CC1=CN=C2C(=C1)C=CC=C2C(=O)N D00OZA HIGHSTAT Investigative D00OZN DRUG__ID D00OZN D00OZN DRUGTYPE Small molecular drug D00OZN DRUGINCH 1S/C14H11F3N2O/c15-14(16,17)11-3-1-2-10(8-11)9-4-6-12(7-5-9)19-13(18)20/h1-8H,(H3,18,19,20) D00OZN DRUGINKE MHFIGSQWRVHNRG-UHFFFAOYSA-N D00OZN DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C2=CC=C(C=C2)NC(=O)N D00OZN HIGHSTAT Investigative D00OZS DRUG__ID D00OZS D00OZS DRUGTYPE Small molecular drug D00OZS DRUGINCH 1S/C12H17NO5S/c1-2-3-4-9-17-12(14)10-5-7-11(8-6-10)18-19(13,15)16/h5-8H,2-4,9H2,1H3,(H2,13,15,16) D00OZS DRUGINKE ZFWKNIDIWKSQEP-UHFFFAOYSA-N D00OZS DRUGSMIL CCCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D00OZS HIGHSTAT Investigative D00PAG DRUG__ID D00PAG D00PAG DRUGTYPE Small molecular drug D00PAG DRUGINCH 1S/C10H15N5O9P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(23-10)1-22-25(18,19)24-26(20,21)27/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H2,20,21,27)/t4-,6-,7-,10-/m1/s1/i27+3 D00PAG DRUGINKE HCIKUKNAJRJFOW-JWNXZZODSA-N D00PAG DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=S)(O)O)O)O)N D00PAG HIGHSTAT Investigative D00PAS DRUG__ID D00PAS D00PAS DRUGTYPE Small molecular drug D00PAS DRUGINCH 1S/C21H22O5/c1-12(2)4-6-14-17(24-3)9-8-16-19(14)26-20-15-7-5-13(22)10-18(15)25-11-21(16,20)23/h4-5,7-10,20,22-23H,6,11H2,1-3H3/t20-,21+/m0/s1 D00PAS DRUGINKE ZHPYEBFYLDGZKF-LEWJYISDSA-N D00PAS DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3C2(COC4=C3C=CC(=C4)O)O)OC)C D00PAS HIGHSTAT Investigative D00PCE DRUG__ID D00PCE D00PCE DRUGTYPE Small molecular drug D00PCE DRUGINCH 1S/C16H22ClN3O2/c1-20-10-3-4-11(20)6-9(5-10)19-16(21)12-7-13(17)14(18)8-15(12)22-2/h7-11H,3-6,18H2,1-2H3,(H,19,21) D00PCE DRUGINKE HTMNINCXKXABOI-UHFFFAOYSA-N D00PCE DRUGSMIL CN1C2CCC1CC(C2)NC(=O)C3=CC(=C(C=C3OC)N)Cl D00PCE HIGHSTAT Investigative D00PEC DRUG__ID D00PEC D00PEC DRUGTYPE Small molecular drug D00PEC DRUGINCH 1S/C12H18N4S2/c13-11(14)17-6-4-9-2-1-3-10(8-9)5-7-18-12(15)16/h1-3,8H,4-7H2,(H3,13,14)(H3,15,16) D00PEC DRUGINKE YEUSLPIIQGZHQB-UHFFFAOYSA-N D00PEC DRUGSMIL C1=CC(=CC(=C1)CCSC(=N)N)CCSC(=N)N D00PEC HIGHSTAT Investigative D00PEJ DRUG__ID D00PEJ D00PEJ DRUGTYPE Small molecular drug D00PEJ DRUGINCH 1S/C16H15N5O2S/c17-16(18)20-15-14-10-13(7-6-11(14)8-9-19-15)24(22,23)21-12-4-2-1-3-5-12/h1-10,21H,(H4,17,18,19,20) D00PEJ DRUGINKE NNEJXIJKGKRBBF-UHFFFAOYSA-N D00PEJ DRUGSMIL C1=CC=C(C=C1)NS(=O)(=O)C2=CC3=C(C=C2)C=CN=C3N=C(N)N D00PEJ HIGHSTAT Investigative D00PEU DRUG__ID D00PEU D00PEU DRUGTYPE Small molecular drug D00PEU DRUGINCH 1S/C23H24FN3O2/c1-16-20(23(29)27-12-3-2-4-21(27)25-16)11-15-26-13-9-18(10-14-26)22(28)17-5-7-19(24)8-6-17/h2-8,12,18H,9-11,13-15H2,1H3 D00PEU DRUGINKE HXCNRYXBZNHDNE-UHFFFAOYSA-N D00PEU DRUGSMIL CC1=C(C(=O)N2C=CC=CC2=N1)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F D00PEU HIGHSTAT Investigative D00PJT DRUG__ID D00PJT D00PJT DRUGTYPE Small molecular drug D00PJT DRUGINCH 1S/C16H13FO2/c1-10-2-4-11(5-3-10)15-9-14(18)13-7-6-12(17)8-16(13)19-15/h2-8,15H,9H2,1H3/t15-/m0/s1 D00PJT DRUGINKE QNQXLNDULBVXEX-HNNXBMFYSA-N D00PJT DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)F D00PJT HIGHSTAT Investigative D00PLH DRUG__ID D00PLH D00PLH DRUGTYPE Small molecular drug D00PLH DRUGINCH 1S/C14H8F4O2/c15-7-1-3-11(17)9(5-7)13(19)14(20)10-6-8(16)2-4-12(10)18/h1-6,13,19H D00PLH DRUGINKE DMPZBXMNYCXAQZ-UHFFFAOYSA-N D00PLH DRUGSMIL C1=CC(=C(C=C1F)C(C(=O)C2=C(C=CC(=C2)F)F)O)F D00PLH HIGHSTAT Investigative D00PLM DRUG__ID D00PLM D00PLM DRUGTYPE Small molecular drug D00PLM DRUGINCH 1S/C10H8N2O2S/c13-10(12-14)9-4-3-8(15-9)7-2-1-5-11-6-7/h1-6,14H,(H,12,13) D00PLM DRUGINKE VJJJKVTXSSPWSW-UHFFFAOYSA-N D00PLM DRUGSMIL C1=CC(=CN=C1)C2=CC=C(S2)C(=O)NO D00PLM HIGHSTAT Investigative D00PMF DRUG__ID D00PMF D00PMF DRUGTYPE Small molecular drug D00PMF DRUGINCH 1S/C4H5BrN4O2.ClH/c5-1-2(9-6)7-4(11)8-3(1)10;/h6H2,(H3,7,8,9,10,11);1H D00PMF DRUGINKE FSNHPVKPJNIXAD-UHFFFAOYSA-N D00PMF DRUGSMIL C1(=C(NC(=O)NC1=O)NN)Br.Cl D00PMF HIGHSTAT Investigative D00PMS DRUG__ID D00PMS D00PMS DRUGTYPE Small molecular drug D00PMS DRUGINCH 1S/C17H19N5O2/c1-2-3-6-22-14(21-15-16(18)19-9-20-17(15)22)8-11-4-5-12-13(7-11)24-10-23-12/h4-5,7,9H,2-3,6,8,10H2,1H3,(H2,18,19,20) D00PMS DRUGINKE JCDXXNIRWRRGBX-UHFFFAOYSA-N D00PMS DRUGSMIL CCCCN1C(=NC2=C(N=CN=C21)N)CC3=CC4=C(C=C3)OCO4 D00PMS HIGHSTAT Investigative D00POF DRUG__ID D00POF D00POF DRUGTYPE Small molecular drug D00POF DRUGINCH 1S/C19H16N2/c20-19(21)18-11-10-16-12-15(8-9-17(16)13-18)7-6-14-4-2-1-3-5-14/h1-13H,(H3,20,21)/b7-6+ D00POF DRUGINKE YRAFBVUQILDIDH-VOTSOKGWSA-N D00POF DRUGSMIL C1=CC=C(C=C1)C=CC2=CC3=C(C=C2)C=C(C=C3)C(=N)N D00POF HIGHSTAT Investigative D00PPB DRUG__ID D00PPB D00PPB DRUGTYPE Small molecular drug D00PPB DRUGINCH 1S/C21H16F3NO2/c22-21(23,24)17-6-4-5-15(13-17)14-25-20(26)16-9-11-19(12-10-16)27-18-7-2-1-3-8-18/h1-13H,14H2,(H,25,26) D00PPB DRUGINKE FWPNYHMMZRISQJ-UHFFFAOYSA-N D00PPB DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC3=CC(=CC=C3)C(F)(F)F D00PPB HIGHSTAT Investigative D00PQC DRUG__ID D00PQC D00PQC DRUGTYPE Small molecular drug D00PQC DRUGINCH 1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D00PQC DRUGINKE PCDQPRRSZKQHHS-XVFCMESISA-N D00PQC DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D00PQC HIGHSTAT Investigative D00PRE DRUG__ID D00PRE D00PRE DRUGTYPE Small molecular drug D00PRE DRUGINCH 1S/C13H10F3NO2S/c14-13(15,16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)20(17,18)19/h1-8H,(H2,17,18,19) D00PRE DRUGINKE WWPFVDFIDSAULR-UHFFFAOYSA-N D00PRE DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)S(=O)(=O)N)C(F)(F)F D00PRE HIGHSTAT Investigative D00PRR DRUG__ID D00PRR D00PRR DRUGTYPE Small molecular drug D00PRR DRUGINCH 1S/C10H16ClN5O8P2/c1-12-8-7-9(15-10(11)14-8)16(5-13-7)2-6(3-23-25(17,18)19)4-24-26(20,21)22/h5-6H,2-4H2,1H3,(H,12,14,15)(H2,17,18,19)(H2,20,21,22) D00PRR DRUGINKE GMCUIIHBWNOHIM-UHFFFAOYSA-N D00PRR DRUGSMIL CNC1=C2C(=NC(=N1)Cl)N(C=N2)CC(COP(=O)(O)O)COP(=O)(O)O D00PRR HIGHSTAT Investigative D00PSJ DRUG__ID D00PSJ D00PSJ DRUGTYPE Small molecular drug D00PSJ DRUGINCH 1S/C6H11N3/c1-9-5-8-4-6(9)2-3-7/h4-5H,2-3,7H2,1H3 D00PSJ DRUGINKE CPAGZVLINCPJEH-UHFFFAOYSA-N D00PSJ DRUGSMIL CN1C=NC=C1CCN D00PSJ HIGHSTAT Investigative D00PSW DRUG__ID D00PSW D00PSW DRUGTYPE Small molecular drug D00PSW DRUGINCH 1S/C17H25N3/c1-2-4-15-18-19-16(20(15)5-3-1)17-9-12-6-13(10-17)8-14(7-12)11-17/h12-14H,1-11H2 D00PSW DRUGINKE VFTQRHWULYJKCI-UHFFFAOYSA-N D00PSW DRUGSMIL C1CCC2=NN=C(N2CC1)C34CC5CC(C3)CC(C5)C4 D00PSW HIGHSTAT Investigative D00PUF DRUG__ID D00PUF D00PUF DRUGTYPE Small molecular drug D00PUF DRUGINCH 1S/C4H9NO3/c5-2-3(6)1-4(7)8/h3,6H,1-2,5H2,(H,7,8) D00PUF DRUGINKE YQGDEPYYFWUPGO-UHFFFAOYSA-N D00PUF DRUGSMIL C(C(CN)O)C(=O)O D00PUF HIGHSTAT Investigative D00PUR DRUG__ID D00PUR D00PUR DRUGTYPE Small molecular drug D00PUR DRUGINCH 1S/C20H14OS/c21-18-9-4-7-15(12-18)14-6-3-8-16(11-14)20-13-17-5-1-2-10-19(17)22-20/h1-13,21H D00PUR DRUGINKE BQKUVAJYBNSSNI-UHFFFAOYSA-N D00PUR DRUGSMIL C1=CC=C2C(=C1)C=C(S2)C3=CC=CC(=C3)C4=CC(=CC=C4)O D00PUR HIGHSTAT Investigative D00PVO DRUG__ID D00PVO D00PVO DRUGTYPE Small molecular drug D00PVO DRUGINCH 1S/C19H16BrN3O2S/c1-12-2-7-17(25-12)15-8-18(24)23-10-22(11-26-19(23)16(15)9-21)14-5-3-13(20)4-6-14/h2-7,15H,8,10-11H2,1H3 D00PVO DRUGINKE DCNZODDMKOTPHQ-UHFFFAOYSA-N D00PVO DRUGSMIL CC1=CC=C(O1)C2CC(=O)N3CN(CSC3=C2C#N)C4=CC=C(C=C4)Br D00PVO HIGHSTAT Investigative D00PWV DRUG__ID D00PWV D00PWV DRUGTYPE Small molecular drug D00PWV DRUGINCH 1S/C17H18O2/c1-12(14-7-4-3-5-8-14)15-9-6-10-16(11-15)13(2)17(18)19/h3-13H,1-2H3,(H,18,19) D00PWV DRUGINKE WHCCIVDFHWZGFN-UHFFFAOYSA-N D00PWV DRUGSMIL CC(C1=CC=CC=C1)C2=CC(=CC=C2)C(C)C(=O)O D00PWV HIGHSTAT Investigative D00PXF DRUG__ID D00PXF D00PXF DRUGTYPE Small molecular drug D00PXF DRUGINCH 1S/C17H12FN3/c18-16-3-1-2-15(8-16)17-10-20-12-21(17)11-14-6-4-13(9-19)5-7-14/h1-8,10,12H,11H2 D00PXF DRUGINKE XBUPVQPMTRYFDV-UHFFFAOYSA-N D00PXF DRUGSMIL C1=CC(=CC(=C1)F)C2=CN=CN2CC3=CC=C(C=C3)C#N D00PXF HIGHSTAT Investigative D00PXO DRUG__ID D00PXO D00PXO DRUGTYPE Small molecular drug D00PXO DRUGINCH 1S/C23H18Cl3FN4O3S/c24-23(25,26)21(30-22(35)28-16-11-12-17(27)18(13-16)31(33)34)29-20(32)19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,19,21H,(H,29,32)(H2,28,30,35) D00PXO DRUGINKE HLCDNLNLQNYZTK-UHFFFAOYSA-N D00PXO DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC3=CC(=C(C=C3)F)[N+](=O)[O-] D00PXO HIGHSTAT Investigative D00PYB DRUG__ID D00PYB D00PYB DRUGTYPE Small molecular drug D00PYB DRUGINCH 1S/C18H19NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-12,17H,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1 D00PYB DRUGINKE XYYVYLMBEZUESM-CMKMFDCUSA-N D00PYB DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)C=C4 D00PYB HIGHSTAT Investigative D00PYW DRUG__ID D00PYW D00PYW DRUGTYPE Small molecular drug D00PYW DRUGINCH 1S/C15H19N3O2/c1-3-15(4-2-14(1)18-6-5-16-13-18)20-12-9-17-7-10-19-11-8-17/h1-6,13H,7-12H2 D00PYW DRUGINKE PXFGMZGVHWPLCC-UHFFFAOYSA-N D00PYW DRUGSMIL C1COCCN1CCOC2=CC=C(C=C2)N3C=CN=C3 D00PYW HIGHSTAT Investigative D00PZE DRUG__ID D00PZE D00PZE DRUGTYPE Small molecular drug D00PZE DRUGINCH 1S/C18H24O3/c1-18-7-6-11-12(14(18)4-5-17(18)21)3-2-10-8-15(19)16(20)9-13(10)11/h8-9,11-12,14,17,19-21H,2-7H2,1H3/t11-,12+,14-,17-,18-/m0/s1 D00PZE DRUGINKE DILDHNKDVHLEQB-XSSYPUMDSA-N D00PZE DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)O)O D00PZE HIGHSTAT Investigative D00PZM DRUG__ID D00PZM D00PZM DRUGTYPE Small molecular drug D00PZM DRUGINCH 1S/C20H20O5/c1-20(2)17(22)8-13-15(25-20)6-5-11-14-9-23-16-7-10(21)3-4-12(16)19(14)24-18(11)13/h3-7,14,17,19,21-22H,8-9H2,1-2H3/t14-,17?,19-/m0/s1 D00PZM DRUGINKE ZCLUCQDBFSBCJB-OZIHFDBSSA-N D00PZM DRUGSMIL CC1(C(CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)O)C D00PZM HIGHSTAT Investigative D00QCL DRUG__ID D00QCL D00QCL DRUGTYPE Small molecular drug D00QCL DRUGINCH 1S/C21H20O6/c1-11(2)4-9-14-15(23)10-16(26-3)17-18(24)19(25)20(27-21(14)17)12-5-7-13(22)8-6-12/h4-8,10,22-23,25H,9H2,1-3H3 D00QCL DRUGINKE VMLJAWUWVVHRNG-UHFFFAOYSA-N D00QCL DRUGSMIL CC(=CCC1=C2C(=C(C=C1O)OC)C(=O)C(=C(O2)C3=CC=C(C=C3)O)O)C D00QCL HIGHSTAT Investigative D00QCP DRUG__ID D00QCP D00QCP DRUGTYPE Small molecular drug D00QCP DRUGINCH 1S/C13H19NO2/c1-10-13(15,11-7-5-4-6-8-11)16-9-12(2,3)14-10/h4-8,10,14-15H,9H2,1-3H3/t10-,13+/m0/s1 D00QCP DRUGINKE NGHJSSNVKXEBAB-GXFFZTMASA-N D00QCP DRUGSMIL CC1C(OCC(N1)(C)C)(C2=CC=CC=C2)O D00QCP HIGHSTAT Investigative D00QDE DRUG__ID D00QDE D00QDE DRUGTYPE Small molecular drug D00QDE DRUGINCH 1S/C16H10BrNO3/c17-15-11-5-8(19)2-4-13(11)18-16-10-3-1-9(20)6-14(10)21-7-12(15)16/h1-6,19-20H,7H2 D00QDE DRUGINKE UHDQHUPIXKORDL-UHFFFAOYSA-N D00QDE DRUGSMIL C1C2=C(C3=C(C=CC(=C3)O)N=C2C4=C(O1)C=C(C=C4)O)Br D00QDE HIGHSTAT Investigative D00QDR DRUG__ID D00QDR D00QDR DRUGTYPE Small molecular drug D00QDR DRUGINCH 1S/C41H32O26/c42-17-1-12(2-18(43)28(17)52)36(57)62-11-27-33(64-37(58)13-3-19(44)29(53)20(45)4-13)34(65-38(59)14-5-21(46)30(54)22(47)6-14)35(66-39(60)15-7-23(48)31(55)24(49)8-15)41(63-27)67-40(61)16-9-25(50)32(56)26(51)10-16/h1-10,27,33-35,41-56H,11H2/t27-,33-,34+,35-,41+/m1/s1 D00QDR DRUGINKE QJYNZEYHSMRWBK-NIKIMHBISA-N D00QDR DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O D00QDR HIGHSTAT Investigative D00QFL DRUG__ID D00QFL D00QFL DRUGTYPE Small molecular drug D00QFL DRUGINCH 1S/C19H24NO5P/c1-19(2,26(22,23)24)18(21)20-13-7-9-15-8-6-12-17(14-15)25-16-10-4-3-5-11-16/h3-6,8,10-12,14H,7,9,13H2,1-2H3,(H,20,21)(H2,22,23,24) D00QFL DRUGINKE AGJZDRXKAQZWEP-UHFFFAOYSA-N D00QFL DRUGSMIL CC(C)(C(=O)NCCCC1=CC(=CC=C1)OC2=CC=CC=C2)P(=O)(O)O D00QFL HIGHSTAT Investigative D00QIA DRUG__ID D00QIA D00QIA DRUGTYPE Small molecular drug D00QIA DRUGINCH 1S/C11H21NO3/c1-8(2)6-9(7-13)12-10(14)15-11(3,4)5/h7-9H,6H2,1-5H3,(H,12,14)/t9-/m0/s1 D00QIA DRUGINKE RQSBRFZHUKLKNO-VIFPVBQESA-N D00QIA DRUGSMIL CC(C)CC(C=O)NC(=O)OC(C)(C)C D00QIA HIGHSTAT Investigative D00QIU DRUG__ID D00QIU D00QIU DRUGTYPE Small molecular drug D00QIU DRUGINCH 1S/C20H32O5/c1-2-3-8-14-18(22)19(23)15-10-7-5-4-6-9-12-17(21)13-11-16-20(24)25/h4-7,9-10,12,15,17-19,21-23H,2-3,8,11,13-14,16H2,1H3,(H,24,25)/b6-4-,7-5+,12-9+,15-10+/t17-,18+,19-/m1/s1 D00QIU DRUGINKE UXVRTOKOJOMENI-WLPVFMORSA-N D00QIU DRUGSMIL CCCCCC(C(C=CC=CC=CC=CC(CCCC(=O)O)O)O)O D00QIU HIGHSTAT Investigative D00QLH DRUG__ID D00QLH D00QLH DRUGTYPE Small molecular drug D00QLH DRUGINCH 1S/C32H36N4O6/c1-19-13-24(37)14-20(2)25(19)16-26(33)31(41)36-18-22-10-8-7-9-21(22)15-28(36)30(40)34-27(17-29(38)39)32(42)35(3)23-11-5-4-6-12-23/h4-14,26-28,37H,15-18,33H2,1-3H3,(H,34,40)(H,38,39)/t26-,27+,28-/m0/s1 D00QLH DRUGINKE HEKBLCZSNQVJKZ-IARZGTGTSA-N D00QLH DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)N(C)C4=CC=CC=C4)N)C)O D00QLH HIGHSTAT Investigative D00QLM DRUG__ID D00QLM D00QLM DRUGTYPE Small molecular drug D00QLM DRUGINCH 1S/C11H18N5O12P3/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(27-11)1-26-29(19,20)4-30(21,22)28-31(23,24)25/h2-3,5,7-8,11,17-18H,1,4H2,(H,19,20)(H,21,22)(H2,12,13,14)(H2,23,24,25)/t5-,7-,8-,11-/m1/s1 D00QLM DRUGINKE CAWZRIXWFRFUQB-IOSLPCCCSA-N D00QLM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O)O)N D00QLM HIGHSTAT Investigative D00QLR DRUG__ID D00QLR D00QLR DRUGTYPE Small molecular drug D00QLR DRUGINCH 1S/C21H30N2/c1-16(2)10-12-21-13-15-22(5)20(21)23(14-11-17(3)4)19-9-7-6-8-18(19)21/h6-11,20H,12-15H2,1-5H3/t20-,21+/m1/s1 D00QLR DRUGINKE NUWYFFDZPIGJJO-RTWAWAEBSA-N D00QLR DRUGSMIL CC(=CCC12CCN(C1N(C3=CC=CC=C23)CC=C(C)C)C)C D00QLR HIGHSTAT Investigative D00QMQ DRUG__ID D00QMQ D00QMQ DRUGTYPE Small molecular drug D00QMQ DRUGINCH 1S/C22H27Cl2N5S/c1-2-8-28(16-6-7-18-20(15-16)30-22(25)26-18)12-9-27-10-13-29(14-11-27)19-5-3-4-17(23)21(19)24/h1,3-5,16H,6-15H2,(H2,25,26) D00QMQ DRUGINKE AWFHSDHVMOYPMI-UHFFFAOYSA-N D00QMQ DRUGSMIL C#CCN(CCN1CCN(CC1)C2=C(C(=CC=C2)Cl)Cl)C3CCC4=C(C3)SC(=N4)N D00QMQ HIGHSTAT Investigative D00QMZ DRUG__ID D00QMZ D00QMZ DRUGTYPE Small molecular drug D00QMZ DRUGINCH 1S/C30H43N3O6/c1-6-8-16-31-27(35)19-25(34)24(17-21-12-10-9-11-13-21)32-30(37)28(20(3)7-2)33-29(36)23-15-14-22(38-4)18-26(23)39-5/h9-15,18,20,24-25,28,34H,6-8,16-17,19H2,1-5H3,(H,31,35)(H,32,37)(H,33,36)/t20-,24?,25?,28-/m0/s1 D00QMZ DRUGINKE BLKHGZANZRGYRY-WUCHSTEBSA-N D00QMZ DRUGSMIL CCCCNC(=O)CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)CC)NC(=O)C2=C(C=C(C=C2)OC)OC)O D00QMZ HIGHSTAT Investigative D00QOL DRUG__ID D00QOL D00QOL DRUGTYPE Small molecular drug D00QOL DRUGINCH 1S/C17H23NO/c19-17-15(13-14-7-3-1-4-8-14)11-12-18(17)16-9-5-2-6-10-16/h1,3-4,7-8,15-16H,2,5-6,9-13H2 D00QOL DRUGINKE DGGDICYTCJZLPW-UHFFFAOYSA-N D00QOL DRUGSMIL C1CCC(CC1)N2CCC(C2=O)CC3=CC=CC=C3 D00QOL HIGHSTAT Investigative D00QPG DRUG__ID D00QPG D00QPG DRUGTYPE Small molecular drug D00QPG DRUGINCH 1S/C17H16N2O/c1-19(2)13-9-7-12(8-10-13)11-15-14-5-3-4-6-16(14)18-17(15)20/h3-11H,1-2H3,(H,18,20) D00QPG DRUGINKE UAKWLVYMKBWHMX-UHFFFAOYSA-N D00QPG DRUGSMIL CN(C)C1=CC=C(C=C1)C=C2C3=CC=CC=C3NC2=O D00QPG HIGHSTAT Investigative D00QPU DRUG__ID D00QPU D00QPU DRUGTYPE Small molecular drug D00QPU DRUGINCH 1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/t13-,14-,15-,16-,18-,19-/m0/s1 D00QPU DRUGINKE CZWCKYRVOZZJNM-USOAJAOKSA-N D00QPU DRUGSMIL CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)OS(=O)(=O)O)C D00QPU HIGHSTAT Investigative D00QSV DRUG__ID D00QSV D00QSV DRUGTYPE Small molecular drug D00QSV DRUGINCH 1S/C10H15NO/c1-8(11)6-9-4-3-5-10(7-9)12-2/h3-5,7-8H,6,11H2,1-2H3 D00QSV DRUGINKE VEJWNIYARKAHFI-UHFFFAOYSA-N D00QSV DRUGSMIL CC(CC1=CC(=CC=C1)OC)N D00QSV HIGHSTAT Investigative D00QTX DRUG__ID D00QTX D00QTX DRUGTYPE Small molecular drug D00QTX DRUGINCH 1S/C21H33ClO4/c22-18-14-20(24)17(12-13-19(23)15-8-4-3-5-9-15)16(18)10-6-1-2-7-11-21(25)26/h1,6,12-13,15-20,23-24H,2-5,7-11,14H2,(H,25,26)/b6-1-,13-12+/t16?,17-,18-,19-,20-/m1/s1 D00QTX DRUGINKE ZOQXTNLUBHPZOZ-GZFHOOQWSA-N D00QTX DRUGSMIL C1CCC(CC1)C(C=CC2C(CC(C2CC=CCCCC(=O)O)Cl)O)O D00QTX HIGHSTAT Investigative D00QUN DRUG__ID D00QUN D00QUN DRUGTYPE Small molecular drug D00QUN DRUGINCH 1S/C21H36NO5P/c1-4-5-6-7-8-9-10-11-12-13-18-28(25,26-19(2)3)27-21-16-14-20(15-17-21)22(23)24/h14-17,19H,4-13,18H2,1-3H3 D00QUN DRUGINKE VZXZHBVWVCMVBS-UHFFFAOYSA-N D00QUN DRUGSMIL CCCCCCCCCCCCP(=O)(OC1=CC=C(C=C1)[N+](=O)[O-])OC(C)C D00QUN HIGHSTAT Investigative D00QVP DRUG__ID D00QVP D00QVP DRUGTYPE Small molecular drug D00QVP DRUGINCH 1S/C15H11NOS/c17-9-5-6-13-11(7-9)12-8-18-14-4-2-1-3-10(14)15(12)16-13/h1-7,16-17H,8H2 D00QVP DRUGINKE BVGUKMAMOJMOFD-UHFFFAOYSA-N D00QVP DRUGSMIL C1C2=C(C3=CC=CC=C3S1)NC4=C2C=C(C=C4)O D00QVP HIGHSTAT Investigative D00QYH DRUG__ID D00QYH D00QYH DRUGTYPE Small molecular drug D00QYH DRUGINCH 1S/C69H111N23O16S/c1-39(2)32-47(86-58(98)44(17-9-26-78-68(73)74)83-63(103)52-20-12-29-91(52)65(105)45(18-10-27-79-69(75)76)84-56(96)42(71)22-23-54(72)94)59(99)89-50(37-93)61(101)87-48(34-41-35-77-38-81-41)60(100)82-43(16-7-8-25-70)57(97)80-36-55(95)90-28-11-19-51(90)62(102)85-46(24-31-109-3)66(106)92-30-13-21-53(92)64(104)88-49(67(107)108)33-40-14-5-4-6-15-40/h4-6,14-15,35,38-39,42-53,93H,7-13,16-34,36-37,70-71H2,1-3H3,(H2,72,94)(H,77,81)(H,80,97)(H,82,100)(H,83,103)(H,84,96)(H,85,102)(H,86,98)(H,87,101)(H,88,104)(H,89,99)(H,107,108)(H4,73,74,78)(H4,75,76,79)/t42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-/m0/s1 D00QYH DRUGINKE XXCCRHIAIBQDPX-PEWBXTNBSA-N D00QYH DRUGSMIL CC(C)CC(C(=O)NC(CO)C(=O)NC(CC1=CN=CN1)C(=O)NC(CCCCN)C(=O)NCC(=O)N2CCCC2C(=O)NC(CCSC)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C5CCCN5C(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)N)N D00QYH HIGHSTAT Investigative D00QYO DRUG__ID D00QYO D00QYO DRUGTYPE Small molecular drug D00QYO DRUGINCH 1S/C10H16N5O11P3/c1-5-6(24-28(19,20)26-29(21,22)25-27(16,17)18)2-7(23-5)15-4-14-8-9(11)12-3-13-10(8)15/h3-7H,2H2,1H3,(H,19,20)(H,21,22)(H2,11,12,13)(H2,16,17,18)/t5-,6+,7-/m1/s1 D00QYO DRUGINKE ZJGUOEYCABTFNH-DSYKOEDSSA-N D00QYO DRUGSMIL CC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)OP(=O)(O)OP(=O)(O)OP(=O)(O)O D00QYO HIGHSTAT Investigative D00QZA DRUG__ID D00QZA D00QZA DRUGTYPE Small molecular drug D00QZA DRUGINCH 1S/C15H23N7O4S/c1-2-17-15(25)18-3-4-27-5-8-10(23)11(24)14(26-8)22-7-21-9-12(16)19-6-20-13(9)22/h6-8,10-11,14,23-24H,2-5H2,1H3,(H2,16,19,20)(H2,17,18,25)/t8-,10+,11-,14?/m1/s1 D00QZA DRUGINKE CACMCLIHCDTJHL-XLAISSFRSA-N D00QZA DRUGSMIL CCNC(=O)NCCSCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D00QZA HIGHSTAT Investigative D00RAK DRUG__ID D00RAK D00RAK DRUGTYPE Small molecular drug D00RAK DRUGINCH 1S/C9H13N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h4,6,15-17H,1-2H2,(H4,10,11,13,14,18)/t4-,6+/m1/s1 D00RAK DRUGINKE YQIFAMYNGGOTFB-XINAWCOVSA-N D00RAK DRUGSMIL C1C(=NC2=C(N1)N=C(NC2=O)N)C(C(CO)O)O D00RAK HIGHSTAT Investigative D00RAO DRUG__ID D00RAO D00RAO DRUGTYPE Small molecular drug D00RAO DRUGINCH 1S/C20H22O7/c1-6-9(2)18(23)25-13-8-20(5)14(21)7-12(27-20)10(3)16(22)17-15(13)11(4)19(24)26-17/h6-7,13,15-17,22H,3-4,8H2,1-2,5H3/b9-6-/t13-,15-,16+,17+,20-/m1/s1 D00RAO DRUGINKE LEMMNOMGQFFVKL-NPUWKFQTSA-N D00RAO DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=C)C(C3C1C(=C)C(=O)O3)O)C D00RAO HIGHSTAT Investigative D00RBV DRUG__ID D00RBV D00RBV DRUGTYPE Small molecular drug D00RBV DRUGINCH 1S/C16H14N2O2/c1-19-15-7-12-6-13(11-4-3-5-17-9-11)10-18-14(12)8-16(15)20-2/h3-10H,1-2H3 D00RBV DRUGINKE KYJQMVJJOORKLO-UHFFFAOYSA-N D00RBV DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CN=CC=C3 D00RBV HIGHSTAT Investigative D00RCV DRUG__ID D00RCV D00RCV DRUGTYPE Small molecular drug D00RCV DRUGINCH 1S/C14H16O2S/c1-3-4-5-8-11-17-14-10-7-6-9-13(14)16-12(2)15/h6-7,9-10H,3-4,11H2,1-2H3 D00RCV DRUGINKE MMWWBFVDWFUERO-UHFFFAOYSA-N D00RCV DRUGSMIL CCCC#CCSC1=CC=CC=C1OC(=O)C D00RCV HIGHSTAT Investigative D00RDE DRUG__ID D00RDE D00RDE DRUGTYPE Small molecular drug D00RDE DRUGINCH 1S/C13H14N4O2S/c1-15-10-2-4-11(5-3-10)16-17-12-6-8-13(9-7-12)20(14,18)19/h2-9,15H,1H3,(H2,14,18,19) D00RDE DRUGINKE RMLHDMTUTOMVIX-UHFFFAOYSA-N D00RDE DRUGSMIL CNC1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)N D00RDE HIGHSTAT Investigative D00RDS DRUG__ID D00RDS D00RDS DRUGTYPE Small molecular drug D00RDS DRUGINCH 1S/C20H20N2O/c1-20(2,3)16-10-8-14(9-11-16)19(23)22-17-12-15-6-4-5-7-18(15)21-13-17/h4-13H,1-3H3,(H,22,23) D00RDS DRUGINKE MUZWQZALZQTMBA-UHFFFAOYSA-N D00RDS DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D00RDS HIGHSTAT Investigative D00RDY DRUG__ID D00RDY D00RDY DRUGTYPE Small molecular drug D00RDY DRUGINCH 1S/C11H13IN4O3/c12-3-6-7(17)8(18)11(19-6)16-2-1-5-9(13)14-4-15-10(5)16/h1-2,4,6-8,11,17-18H,3H2,(H2,13,14,15)/t6-,7-,8-,11-/m1/s1 D00RDY DRUGINKE RUOLUSLZJXGWAU-KCGFPETGSA-N D00RDY DRUGSMIL C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CI)O)O D00RDY HIGHSTAT Investigative D00REB DRUG__ID D00REB D00REB DRUGTYPE Small molecular drug D00REB DRUGINCH 1S/C26H35N3O3/c1-16-2-3-20(25(31)29-14-21-12-27-13-22(15-29)32-21)7-23(16)28-24(30)11-26-8-17-4-18(9-26)6-19(5-17)10-26/h2-3,7,17-19,21-22,27H,4-6,8-15H2,1H3,(H,28,30) D00REB DRUGINKE XYNNEMHCLNODBL-UHFFFAOYSA-N D00REB DRUGSMIL CC1=C(C=C(C=C1)C(=O)N2CC3CNCC(C2)O3)NC(=O)CC45CC6CC(C4)CC(C6)C5 D00REB HIGHSTAT Investigative D00REK DRUG__ID D00REK D00REK DRUGTYPE Small molecular drug D00REK DRUGINCH 1S/C19H16N2O2/c22-13-15-10-11-18(23-15)19-16-8-4-5-9-17(16)21(20-19)12-14-6-2-1-3-7-14/h1-11,22H,12-13H2 D00REK DRUGINKE OQQVFCKUDYMWGV-UHFFFAOYSA-N D00REK DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)C4=CC=C(O4)CO D00REK HIGHSTAT Investigative D00REW DRUG__ID D00REW D00REW DRUGTYPE Small molecular drug D00REW DRUGINCH 1S/C18H16N4O2S/c1-21(2)13-8-9-19-17-14(13)15-16(25-17)18(23)22(10-20-15)11-4-6-12(24-3)7-5-11/h4-10H,1-3H3/i3-1 D00REW DRUGINKE COQPVKMATNFNLG-KTXUZGJCSA-N D00REW DRUGSMIL CN(C)C1=C2C3=C(C(=O)N(C=N3)C4=CC=C(C=C4)OC)SC2=NC=C1 D00REW HIGHSTAT Investigative D00RFY DRUG__ID D00RFY D00RFY DRUGTYPE Small molecular drug D00RFY DRUGINCH 1S/C16H12O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-7,17-19H,1H3 D00RFY DRUGINKE MBNGWHIJMBWFHU-UHFFFAOYSA-N D00RFY DRUGSMIL COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D00RFY HIGHSTAT Investigative D00RGD DRUG__ID D00RGD D00RGD DRUGTYPE Small molecular drug D00RGD DRUGINCH 1S/C13H18N2O3/c16-12(11-6-5-9-14-10-11)7-3-1-2-4-8-13(17)15-18/h5-6,9-10,18H,1-4,7-8H2,(H,15,17) D00RGD DRUGINKE AAHQDWBMLVLXAC-UHFFFAOYSA-N D00RGD DRUGSMIL C1=CC(=CN=C1)C(=O)CCCCCCC(=O)NO D00RGD HIGHSTAT Investigative D00RGO DRUG__ID D00RGO D00RGO DRUGTYPE Small molecular drug D00RGO DRUGINCH 1S/C10H4N6O/c17-9-6-4-2-1-3-5(6)7-8(9)13-16-10(11-7)12-14-15-16/h1-4H D00RGO DRUGINKE DPANHMGWPXVBQI-UHFFFAOYSA-N D00RGO DRUGSMIL C1=CC=C2C(=C1)C3=NC4=NN=NN4N=C3C2=O D00RGO HIGHSTAT Investigative D00RGP DRUG__ID D00RGP D00RGP DRUGTYPE Small molecular drug D00RGP DRUGINCH 1S/C21H24O7/c1-24-16-6-11(4-5-15(16)22)20-13-9-28-21(14(13)10-27-20)12-7-17(25-2)19(23)18(8-12)26-3/h4-8,13-14,20-23H,9-10H2,1-3H3/t13-,14-,20+,21+/m0/s1 D00RGP DRUGINKE VJOBNGRIBLNUKN-BMHXQBNDSA-N D00RGP DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC D00RGP HIGHSTAT Investigative D00RHH DRUG__ID D00RHH D00RHH DRUGTYPE Small molecular drug D00RHH DRUGINCH 1S/C30H35FN2O5/c1-19(2)33-26(15-14-23(34)17-24(35)18-27(36)37)28(20-10-12-21(31)13-11-20)25-9-6-16-32(30(38)29(25)33)22-7-4-3-5-8-22/h3-5,7-8,10-13,19,23-24,34-35H,6,9,14-18H2,1-2H3,(H,36,37)/p-1/t23-,24-/m1/s1 D00RHH DRUGINKE OMBVEVHRIQULKW-DNQXCXABSA-M D00RHH DRUGSMIL CC(C)N1C(=C(C2=C1C(=O)N(CCC2)C3=CC=CC=C3)C4=CC=C(C=C4)F)CCC(CC(CC(=O)[O-])O)O D00RHH HIGHSTAT Investigative D00RIX DRUG__ID D00RIX D00RIX DRUGTYPE Small molecular drug D00RIX DRUGINCH 1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H D00RIX DRUGINKE KZNIFHPLKGYRTM-UHFFFAOYSA-N D00RIX DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D00RIX HIGHSTAT Investigative D00RJT DRUG__ID D00RJT D00RJT DRUGTYPE Small molecular drug D00RJT DRUGINCH 1S/NO3/c2-1(3)4/q-1 D00RJT DRUGINKE NHNBFGGVMKEFGY-UHFFFAOYSA-N D00RJT DRUGSMIL [N+](=O)([O-])[O-] D00RJT HIGHSTAT Investigative D00RLE DRUG__ID D00RLE D00RLE DRUGTYPE Small molecular drug D00RLE DRUGINCH 1S/C16H13ClN2O/c1-19-16(20)14-5-3-2-4-13(14)15(18-19)10-11-6-8-12(17)9-7-11/h2-9H,10H2,1H3 D00RLE DRUGINKE QZOXWSKLFOUEKD-UHFFFAOYSA-N D00RLE DRUGSMIL CN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl D00RLE HIGHSTAT Investigative D00RLO DRUG__ID D00RLO D00RLO DRUGTYPE Small molecular drug D00RLO DRUGINCH 1S/C6H15BrN.BrH/c1-8(2,3)6-4-5-7;/h4-6H2,1-3H3;1H/q+1;/p-1 D00RLO DRUGINKE NNZGNZHUGJAKKT-UHFFFAOYSA-M D00RLO DRUGSMIL C[N+](C)(C)CCCBr.[Br-] D00RLO HIGHSTAT Investigative D00RNA DRUG__ID D00RNA D00RNA DRUGTYPE Small molecular drug D00RNA DRUGINCH 1S/C12H11NO4/c14-11(13-16)6-5-9-7-8-3-1-2-4-10(8)17-12(9)15/h1-4,7,16H,5-6H2,(H,13,14) D00RNA DRUGINKE HJRCGMHZQDXQAO-UHFFFAOYSA-N D00RNA DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)O2)CCC(=O)NO D00RNA HIGHSTAT Investigative D00RNZ DRUG__ID D00RNZ D00RNZ DRUGTYPE Small molecular drug D00RNZ DRUGINCH 1S/C16H12O3/c17-16-9-7-13-6-8-14(10-15(13)19-16)18-11-12-4-2-1-3-5-12/h1-10H,11H2 D00RNZ DRUGINKE QDLFCBKKECTJSK-UHFFFAOYSA-N D00RNZ DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)C=CC(=O)O3 D00RNZ HIGHSTAT Investigative D00RRV DRUG__ID D00RRV D00RRV DRUGTYPE Small molecular drug D00RRV DRUGINCH 1S/C12H11N3/c1-2-4-12-11(3-1)10(7-14-12)8-15-6-5-13-9-15/h1-7,9,14H,8H2 D00RRV DRUGINKE FRADTKAUXQUOIJ-UHFFFAOYSA-N D00RRV DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CN3C=CN=C3 D00RRV HIGHSTAT Investigative D00RST DRUG__ID D00RST D00RST DRUGTYPE Small molecular drug D00RST DRUGINCH 1S/C20H36N2O2/c1-2-8-24-9-6-4-3-5-7-21-19(23)22-20-13-16-10-17(14-20)12-18(11-16)15-20/h16-18H,2-15H2,1H3,(H2,21,22,23) D00RST DRUGINKE GXOBIXGHFWBEMM-UHFFFAOYSA-N D00RST DRUGSMIL CCCOCCCCCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D00RST HIGHSTAT Investigative D00RTM DRUG__ID D00RTM D00RTM DRUGTYPE Small molecular drug D00RTM DRUGINCH 1S/C13H18N2/c1-15(2)9-5-6-11-10-14-13-8-4-3-7-12(11)13/h3-4,7-8,10,14H,5-6,9H2,1-2H3 D00RTM DRUGINKE QHNWPRMHGXRBAO-UHFFFAOYSA-N D00RTM DRUGSMIL CN(C)CCCC1=CNC2=CC=CC=C21 D00RTM HIGHSTAT Investigative D00RUN DRUG__ID D00RUN D00RUN DRUGTYPE Small molecular drug D00RUN DRUGINCH 1S/C13H20N2/c1-13(2,3)9-7-5-4-6-8-12-10-14-11-15-12/h10-11H,6-9H2,1-3H3,(H,14,15) D00RUN DRUGINKE CNQBABLURIQXNU-UHFFFAOYSA-N D00RUN DRUGSMIL CC(C)(C)CCC#CCCC1=CN=CN1 D00RUN HIGHSTAT Investigative D00RZN DRUG__ID D00RZN D00RZN DRUGTYPE Small molecular drug D00RZN DRUGINCH 1S/C21H22O6/c1-11(2)4-5-12-6-13(7-19(26-3)21(12)25)17-10-16(24)20-15(23)8-14(22)9-18(20)27-17/h4,6-9,17,22-23,25H,5,10H2,1-3H3/t17-/m0/s1 D00RZN DRUGINKE UQFQODVSORPELA-KRWDZBQOSA-N D00RZN DRUGSMIL CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)OC)O)C D00RZN HIGHSTAT Investigative D00SAA DRUG__ID D00SAA D00SAA DRUGTYPE Small molecular drug D00SAA DRUGINCH 1S/C13H12O2/c1-8(2)11-7-9-5-3-4-6-10(9)12(14)13(11)15/h3-8H,1-2H3 D00SAA DRUGINKE KGCDZSGUSQQVKL-UHFFFAOYSA-N D00SAA DRUGSMIL CC(C)C1=CC2=CC=CC=C2C(=O)C1=O D00SAA HIGHSTAT Investigative D00SAB DRUG__ID D00SAB D00SAB DRUGTYPE Small molecular drug D00SAB DRUGINCH 1S/C15H12N2/c1-11-4-2-5-12(8-11)14-9-15-13(10-17-14)6-3-7-16-15/h2-10H,1H3 D00SAB DRUGINKE QFKQBMHTZFGQHK-UHFFFAOYSA-N D00SAB DRUGSMIL CC1=CC(=CC=C1)C2=NC=C3C=CC=NC3=C2 D00SAB HIGHSTAT Investigative D00SCI DRUG__ID D00SCI D00SCI DRUGTYPE Small molecular drug D00SCI DRUGINCH 1S/C18H25N5S2/c1-12(2)14-9-13-15(20-11-21-16(13)24-14)22-5-7-23(8-6-22)17-19-10-18(3,4)25-17/h9,11-12H,5-8,10H2,1-4H3 D00SCI DRUGINKE FUGQNAUKABUDQI-UHFFFAOYSA-N D00SCI DRUGSMIL CC(C)C1=CC2=C(N=CN=C2S1)N3CCN(CC3)C4=NCC(S4)(C)C D00SCI HIGHSTAT Investigative D00SDJ DRUG__ID D00SDJ D00SDJ DRUGTYPE Small molecular drug D00SDJ DRUGINCH 1S/C27H34F3N5O2/c1-26(2,3)25-31-22(27(28,29)30)18-23(32-25)34-16-14-33(15-17-34)12-6-7-13-35-20-9-5-4-8-19(20)21(36)10-11-24(35)37/h4-5,8-9,18H,6-7,10-17H2,1-3H3 D00SDJ DRUGINKE FKHBHNWGBJHKGW-UHFFFAOYSA-N D00SDJ DRUGSMIL CC(C)(C)C1=NC(=CC(=N1)N2CCN(CC2)CCCCN3C(=O)CCC(=O)C4=CC=CC=C43)C(F)(F)F D00SDJ HIGHSTAT Investigative D00SDP DRUG__ID D00SDP D00SDP DRUGTYPE Small molecular drug D00SDP DRUGINCH 1S/C26H32N2/c1-2-6-21(7-3-1)27-22-12-11-20-16-25-23-8-4-5-13-26(23,24(20)17-22)14-15-28(25)18-19-9-10-19/h1-3,6-7,11-12,17,19,23,25,27H,4-5,8-10,13-16,18H2/t23-,25+,26+/m0/s1 D00SDP DRUGINKE UVUFQEMGPJPSIS-SKBVVQJISA-N D00SDP DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NC5=CC=CC=C5)CC6CC6 D00SDP HIGHSTAT Investigative D00SDQ DRUG__ID D00SDQ D00SDQ DRUGTYPE Small molecular drug D00SDQ DRUGINCH 1S/C17H16ClFN4OS/c1-17(6-7-25-16(20)23-17)12-8-11(3-4-13(12)19)22-15(24)14-5-2-10(18)9-21-14/h2-5,8-9H,6-7H2,1H3,(H2,20,23)(H,22,24)/t17-/m0/s1 D00SDQ DRUGINKE VVZZZUNCWSTIOI-KRWDZBQOSA-N D00SDQ DRUGSMIL CC1(CCSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)Cl)F D00SDQ HIGHSTAT Investigative D00SEC DRUG__ID D00SEC D00SEC DRUGTYPE Small molecular drug D00SEC DRUGINCH 1S/C17H19N3O/c1-3-4-5-14-15(12-6-8-13(21-2)9-7-12)20-17-16(14)18-10-11-19-17/h6-11H,3-5H2,1-2H3,(H,19,20) D00SEC DRUGINKE WVMANZPBOBRWCB-UHFFFAOYSA-N D00SEC DRUGSMIL CCCCC1=C(NC2=NC=CN=C12)C3=CC=C(C=C3)OC D00SEC HIGHSTAT Investigative D00SEE DRUG__ID D00SEE D00SEE DRUGTYPE Small molecular drug D00SEE DRUGINCH 1S/C13H19NOS/c15-13(10-6-1-2-7-11-16)14-12-8-4-3-5-9-12/h3-5,8-9,16H,1-2,6-7,10-11H2,(H,14,15) D00SEE DRUGINKE CFKBMXXDXYFDET-UHFFFAOYSA-N D00SEE DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCS D00SEE HIGHSTAT Investigative D00SGZ DRUG__ID D00SGZ D00SGZ DRUGTYPE Small molecular drug D00SGZ DRUGINCH 1S/C35H38F2N4O4/c1-24-28(15-22-45-24)33(43)38-26-11-9-25(10-12-26)34(44)41-21-16-35(36,37)30(29-7-3-4-8-31(29)41)23-32(42)40-19-13-27(14-20-40)39-17-5-2-6-18-39/h3-4,7-12,15,22-23,27H,2,5-6,13-14,16-21H2,1H3,(H,38,43)/b30-23- D00SGZ DRUGINKE VDUUABBYYOPFAW-WMMMYUQOSA-N D00SGZ DRUGSMIL CC1=C(C=CO1)C(=O)NC2=CC=C(C=C2)C(=O)N3CCC(C(=CC(=O)N4CCC(CC4)N5CCCCC5)C6=CC=CC=C63)(F)F D00SGZ HIGHSTAT Investigative D00SHX DRUG__ID D00SHX D00SHX DRUGTYPE Small molecular drug D00SHX DRUGINCH 1S/C15H23N/c1-12-10-13(2)15(14(3)11-12)6-9-16-7-4-5-8-16/h10-11H,4-9H2,1-3H3 D00SHX DRUGINKE IYOUBSBBWJSRIG-UHFFFAOYSA-N D00SHX DRUGSMIL CC1=CC(=C(C(=C1)C)CCN2CCCC2)C D00SHX HIGHSTAT Investigative D00SJT DRUG__ID D00SJT D00SJT DRUGTYPE Small molecular drug D00SJT DRUGINCH 1S/C6H6FNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10) D00SJT DRUGINKE LFLSATHZMYYIAQ-UHFFFAOYSA-N D00SJT DRUGSMIL C1=CC(=CC=C1F)S(=O)(=O)N D00SJT HIGHSTAT Investigative D00SKS DRUG__ID D00SKS D00SKS DRUGCOMP Gilead Sciences Inc D00SKS DRUGINCH 1S/C33H49N2O12PS/c1-6-45-48(38,46-7-2)22-44-26-10-8-24(9-11-26)18-29(34-33(37)47-31-21-43-32-28(31)16-17-42-32)30(36)20-35(19-23(3)4)49(39,40)27-14-12-25(41-5)13-15-27/h8-15,23,28-32,36H,6-7,16-22H2,1-5H3,(H,34,37)/t28-,29-,30+,31-,32+/m0/s1 D00SKS DRUGINKE FCLYPCIMVVLLRN-FXSYQQGGSA-N D00SKS DRUGSMIL CCOP(=O)(COC1=CC=C(C=C1)CC(C(CN(CC(C)C)S(=O)(=O)C2=CC=C(C=C2)OC)O)NC(=O)OC3COC4C3CCO4)OCC D00SKS HIGHSTAT Investigative D00SLE DRUG__ID D00SLE D00SLE DRUGTYPE Small molecular drug D00SLE DRUGINCH 1S/C15H11NO2S/c17-12-6-4-10(5-7-12)14-9-16-15(19-14)11-2-1-3-13(18)8-11/h1-9,17-18H D00SLE DRUGINKE WBUPCNHALRFMCB-UHFFFAOYSA-N D00SLE DRUGSMIL C1=CC(=CC(=C1)O)C2=NC=C(S2)C3=CC=C(C=C3)O D00SLE HIGHSTAT Investigative D00SLJ DRUG__ID D00SLJ D00SLJ DRUGTYPE Small molecular drug D00SLJ DRUGINCH 1S/C18H20N2O3/c21-17(13-18(22)20-23)19-12-11-16(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-10,16,23H,11-13H2,(H,19,21)(H,20,22) D00SLJ DRUGINKE UYRUQIFSLBHLGY-UHFFFAOYSA-N D00SLJ DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)CC(=O)NO)C2=CC=CC=C2 D00SLJ HIGHSTAT Investigative D00SLR DRUG__ID D00SLR D00SLR DRUGTYPE Small molecular drug D00SLR DRUGINCH 1S/C24H28N4O4/c1-13(2)25-11-21(29)27-15-5-7-17-19(9-15)24(32)20-10-16(6-8-18(20)23(17)31)28-22(30)12-26-14(3)4/h5-10,13-14,25-26H,11-12H2,1-4H3,(H,27,29)(H,28,30) D00SLR DRUGINKE DKNQCGLIKICHPF-UHFFFAOYSA-N D00SLR DRUGSMIL CC(C)NCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CNC(C)C D00SLR HIGHSTAT Investigative D00SNJ DRUG__ID D00SNJ D00SNJ DRUGTYPE Small molecular drug D00SNJ DRUGINCH 1S/C24H26N2O/c1-18(19-8-3-2-4-9-19)26-16-14-21(15-17-26)25-24(27)23-13-7-11-20-10-5-6-12-22(20)23/h2-13,18,21H,14-17H2,1H3,(H,25,27) D00SNJ DRUGINKE ZNKBVXRAPNKVHW-UHFFFAOYSA-N D00SNJ DRUGSMIL CC(C1=CC=CC=C1)N2CCC(CC2)NC(=O)C3=CC=CC4=CC=CC=C43 D00SNJ HIGHSTAT Investigative D00SNO DRUG__ID D00SNO D00SNO DRUGTYPE Small molecular drug D00SNO DRUGINCH 1S/C18H18N4O/c1-21(2)10-9-19-13-7-8-14-17-16(13)18(23)12-5-3-4-6-15(12)22(17)11-20-14/h3-8,11,19H,9-10H2,1-2H3 D00SNO DRUGINKE ZRCXWSWJMWWTFD-UHFFFAOYSA-N D00SNO DRUGSMIL CN(C)CCNC1=C2C3=C(C=C1)N=CN3C4=CC=CC=C4C2=O D00SNO HIGHSTAT Investigative D00SOM DRUG__ID D00SOM D00SOM DRUGTYPE Small molecular drug D00SOM DRUGINCH 1S/C14H23N/c1-2-4-15-14(3-1)12-6-10-5-11(8-12)9-13(14)7-10/h10-13,15H,1-9H2 D00SOM DRUGINKE MAKUVZBPESPZLP-UHFFFAOYSA-N D00SOM DRUGSMIL C1CCNC2(C1)C3CC4CC(C3)CC2C4 D00SOM HIGHSTAT Investigative D00SRM DRUG__ID D00SRM D00SRM DRUGTYPE Small molecular drug D00SRM DRUGINCH 1S/C20H12N2O3/c23-15-9-14-18(22-13-8-4-3-7-12(13)21-14)17-16(15)19(24)10-5-1-2-6-11(10)20(17)25/h1-9,21-23H D00SRM DRUGINKE LCEVOWBTRGTTAG-UHFFFAOYSA-N D00SRM DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=C4C(=C3C2=O)NC5=CC=CC=C5N4)O D00SRM HIGHSTAT Investigative D00SRS DRUG__ID D00SRS D00SRS DRUGTYPE Small molecular drug D00SRS DRUGINCH 1S/C20H22O7/c1-5-10(2)18(23)26-15-8-20(4)16(22)7-13(27-20)12(9-21)6-14-17(15)11(3)19(24)25-14/h5-7,14-15,17,21H,3,8-9H2,1-2,4H3/b10-5-,12-6-/t14-,15-,17+,20-/m1/s1 D00SRS DRUGINKE BMVJFNLJSZHNNS-ZXRHVTAXSA-N D00SRS DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=CC3C1C(=C)C(=O)O3)CO)C D00SRS HIGHSTAT Investigative D00SSW DRUG__ID D00SSW D00SSW DRUGTYPE Small molecular drug D00SSW DRUGINCH 1S/C10H9NO4S/c11-7-1-2-9-6(3-7)4-8(5-10(9)12)16(13,14)15/h1-5,12H,11H2,(H,13,14,15) D00SSW DRUGINKE KYARBIJYVGJZLB-UHFFFAOYSA-N D00SSW DRUGSMIL C1=CC2=C(C=C(C=C2C=C1N)S(=O)(=O)O)O D00SSW HIGHSTAT Investigative D00SXO DRUG__ID D00SXO D00SXO DRUGTYPE Small molecular drug D00SXO DRUGINCH 1S/C17H12N2O2/c1-11-15-16(19(18-11)12-7-3-2-4-8-12)13-9-5-6-10-14(13)21-17(15)20/h2-10H,1H3 D00SXO DRUGINKE XQVHTRBZHCYIDD-UHFFFAOYSA-N D00SXO DRUGSMIL CC1=NN(C2=C1C(=O)OC3=CC=CC=C32)C4=CC=CC=C4 D00SXO HIGHSTAT Investigative D00TBG DRUG__ID D00TBG D00TBG DRUGTYPE Small molecular drug D00TBG DRUGINCH 1S/C25H26F2N2O4/c1-15(2)24-23(16-3-7-18(26)8-4-16)28-25(17-5-9-19(27)10-6-17)29(24)12-11-20(30)13-21(31)14-22(32)33/h3-12,15,20-21,30-31H,13-14H2,1-2H3,(H,32,33)/p-1/b12-11+/t20-,21-/m1/s1 D00TBG DRUGINKE TVIKMEWXHYDWEQ-LKWCPCFXSA-M D00TBG DRUGSMIL CC(C)C1=C(N=C(N1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D00TBG HIGHSTAT Investigative D00TDJ DRUG__ID D00TDJ D00TDJ DRUGTYPE Small molecular drug D00TDJ DRUGINCH 1S/C10H12N4S2/c1-2-15-9(11)13-6-3-4-8-7(5-6)14-10(12)16-8/h3-5H,2H2,1H3,(H2,11,13)(H2,12,14) D00TDJ DRUGINKE NXVMLACGHCLFBM-UHFFFAOYSA-N D00TDJ DRUGSMIL CCSC(=NC1=CC2=C(C=C1)SC(=N2)N)N D00TDJ HIGHSTAT Investigative D00TEI DRUG__ID D00TEI D00TEI DRUGTYPE Small molecular drug D00TEI DRUGINCH 1S/C15H20N2O7P2/c1-10(2)24-13-5-3-11(4-6-13)12-7-8-16-14(9-12)17-15(25(18,19)20)26(21,22)23/h3-10,15H,1-2H3,(H,16,17)(H2,18,19,20)(H2,21,22,23) D00TEI DRUGINKE DTXBFSJBRGLOHO-UHFFFAOYSA-N D00TEI DRUGSMIL CC(C)OC1=CC=C(C=C1)C2=CC(=NC=C2)NC(P(=O)(O)O)P(=O)(O)O D00TEI HIGHSTAT Investigative D00TFA DRUG__ID D00TFA D00TFA DRUGTYPE Small molecular drug D00TFA DRUGINCH 1S/C29H46N2O3S/c1-29(2,27(32)33)35-26-18-16-24(17-19-26)20-22-31(28(34)30-25-14-7-4-8-15-25)21-10-9-13-23-11-5-3-6-12-23/h16-19,23,25H,3-15,20-22H2,1-2H3,(H,30,34)(H,32,33) D00TFA DRUGINKE PKNYXWMTHFMHKD-UHFFFAOYSA-N D00TFA DRUGSMIL CC(C)(C(=O)O)SC1=CC=C(C=C1)CCN(CCCCC2CCCCC2)C(=O)NC3CCCCC3 D00TFA HIGHSTAT Investigative D00TGC DRUG__ID D00TGC D00TGC DRUGTYPE Small molecular drug D00TGC DRUGINCH 1S/C16H21N3OS/c1-16(2,3)12-7-5-11(6-8-12)10-21-15-18-13(17)9-14(20)19(15)4/h5-9H,10,17H2,1-4H3 D00TGC DRUGINKE AJMIFZLEDTUBTN-UHFFFAOYSA-N D00TGC DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CSC2=NC(=CC(=O)N2C)N D00TGC HIGHSTAT Investigative D00TIO DRUG__ID D00TIO D00TIO DRUGTYPE Small molecular drug D00TIO DRUGINCH 1S/C24H29FO4/c1-14(2)17-9-21(15(3)4)24(22(10-17)16-5-7-18(25)8-6-16)28-13-20-11-19(26)12-23(27)29-20/h5-10,14-15,19-20,26H,11-13H2,1-4H3/t19-,20?/m1/s1 D00TIO DRUGINKE JMEOINPEUMGNEF-FIWHBWSRSA-N D00TIO DRUGSMIL CC(C)C1=CC(=C(C(=C1)C(C)C)OCC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F D00TIO HIGHSTAT Investigative D00TJF DRUG__ID D00TJF D00TJF DRUGTYPE Small molecular drug D00TJF DRUGINCH 1S/C14H11ClN4/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,16H2,(H,17,18,19) D00TJF DRUGINKE AWAYNEMCHILZCF-UHFFFAOYSA-N D00TJF DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)N D00TJF HIGHSTAT Investigative D00TKO DRUG__ID D00TKO D00TKO DRUGTYPE Small molecular drug D00TKO DRUGINCH 1S/C11H11NO2S/c1-15(13,14)11-6-4-10(5-7-11)12-8-2-3-9-12/h2-9H,1H3 D00TKO DRUGINKE NIVLUABJSRHBFE-UHFFFAOYSA-N D00TKO DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)N2C=CC=C2 D00TKO HIGHSTAT Investigative D00TNN DRUG__ID D00TNN D00TNN DRUGTYPE Small molecular drug D00TNN DRUGINCH 1S/C18H21NO2/c1-2-7-17(8-3-1)21-18-11-9-16(10-12-18)20-14-15-6-4-5-13-19-15/h1-3,7-12,15,19H,4-6,13-14H2 D00TNN DRUGINKE CSJNBXMUZIPBKQ-UHFFFAOYSA-N D00TNN DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)OC3=CC=CC=C3 D00TNN HIGHSTAT Investigative D00TNR DRUG__ID D00TNR D00TNR DRUGTYPE Small molecular drug D00TNR DRUGINCH 1S/C32H37N5O5/c33-25(18-23-13-15-24(38)16-14-23)32(42)37-17-7-12-28(37)31(41)36-27(20-22-10-5-2-6-11-22)30(40)35-26(29(34)39)19-21-8-3-1-4-9-21/h1-6,8-11,13-16,25-28,38H,7,12,17-20,33H2,(H2,34,39)(H,35,40)(H,36,41)/t25-,26-,27-,28-/m0/s1 D00TNR DRUGINKE XIJHWXXXIMEHKW-LJWNLINESA-N D00TNR DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N D00TNR HIGHSTAT Investigative D00TOF DRUG__ID D00TOF D00TOF DRUGTYPE Small molecular drug D00TOF DRUGINCH 1S/C20H22O6/c21-9-15(5-13-1-3-17-19(7-13)25-11-23-17)16(10-22)6-14-2-4-18-20(8-14)26-12-24-18/h1-4,7-8,15-16,21-22H,5-6,9-12H2/t15-,16-/m0/s1 D00TOF DRUGINKE JKCVMTYNARDGET-HOTGVXAUSA-N D00TOF DRUGSMIL C1OC2=C(O1)C=C(C=C2)CC(CO)C(CC3=CC4=C(C=C3)OCO4)CO D00TOF HIGHSTAT Investigative D00TPG DRUG__ID D00TPG D00TPG DRUGTYPE Small molecular drug D00TPG DRUGINCH 1S/C11H10N2O2/c14-11(15)10-7-9(12-13-10)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H,12,13)(H,14,15) D00TPG DRUGINKE YYEOXPLPYNYVRY-UHFFFAOYSA-N D00TPG DRUGSMIL C1=CC=C(C=C1)CC2=CC(=NN2)C(=O)O D00TPG HIGHSTAT Investigative D00TPO DRUG__ID D00TPO D00TPO DRUGTYPE Small molecular drug D00TPO DRUGINCH 1S/C22H25NO2/c1-3-4-7-14-23-16-20(19-8-5-6-9-21(19)23)22(24)15-17-10-12-18(25-2)13-11-17/h5-6,8-13,16H,3-4,7,14-15H2,1-2H3 D00TPO DRUGINKE KQRKUKYSZPHOKC-UHFFFAOYSA-N D00TPO DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)OC D00TPO HIGHSTAT Investigative D00TQR DRUG__ID D00TQR D00TQR DRUGTYPE Small molecular drug D00TQR DRUGINCH 1S/C9H12N4O2/c1-3-4-13-7-6(10-5-11-7)8(14)12(2)9(13)15/h5H,3-4H2,1-2H3,(H,10,11) D00TQR DRUGINKE MCPROACZLSAAPY-UHFFFAOYSA-N D00TQR DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)C)NC=N2 D00TQR HIGHSTAT Investigative D00TRF DRUG__ID D00TRF D00TRF DRUGTYPE Small molecular drug D00TRF DRUGINCH 1S/C9H12N2O3/c12-9(11-13)6-10-14-7-8-4-2-1-3-5-8/h1-5,10,13H,6-7H2,(H,11,12) D00TRF DRUGINKE PMVJGZGFFBJYLQ-UHFFFAOYSA-N D00TRF DRUGSMIL C1=CC=C(C=C1)CONCC(=O)NO D00TRF HIGHSTAT Investigative D00TRY DRUG__ID D00TRY D00TRY DRUGTYPE Small molecular drug D00TRY DRUGINCH 1S/C13H23NO3/c1-13(2,3)17-12(16)14-11(9-15)10-7-5-4-6-8-10/h9-11H,4-8H2,1-3H3,(H,14,16)/t11-/m1/s1 D00TRY DRUGINKE BDSGOSWEKUGHOV-LLVKDONJSA-N D00TRY DRUGSMIL CC(C)(C)OC(=O)NC(C=O)C1CCCCC1 D00TRY HIGHSTAT Investigative D00TRZ DRUG__ID D00TRZ D00TRZ DRUGTYPE Small molecular drug D00TRZ DRUGINCH 1S/C19H30O/c1-4-5-13-19(2,3)17-11-9-15(10-12-17)16-7-6-8-18(20)14-16/h9-12,16,18,20H,4-8,13-14H2,1-3H3/t16-,18-/m1/s1 D00TRZ DRUGINKE WMICXNJEJDOUPN-SJLPKXTDSA-N D00TRZ DRUGSMIL CCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D00TRZ HIGHSTAT Investigative D00TSX DRUG__ID D00TSX D00TSX DRUGTYPE Small molecular drug D00TSX DRUGINCH 1S/C47H59N13O7/c1-2-3-12-35-42(63)60-39(23-31-25-51-26-54-31)46(67)58-37(21-27-15-16-28-9-4-5-10-29(28)20-27)44(65)57-36(14-8-19-52-47(49)50)43(64)59-38(22-30-24-53-33-13-7-6-11-32(30)33)45(66)56-34(41(48)62)17-18-40(61)55-35/h4-7,9-11,13,15-16,20,24-26,34-39,53H,2-3,8,12,14,17-19,21-23H2,1H3,(H2,48,62)(H,51,54)(H,55,61)(H,56,66)(H,57,65)(H,58,67)(H,59,64)(H,60,63)(H4,49,50,52)/t34-,35-,36-,37+,38-,39-/m0/s1 D00TSX DRUGINKE AYKQERUAGGPJLP-WYLITWLFSA-N D00TSX DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CC6=CN=CN6 D00TSX HIGHSTAT Investigative D00TUB DRUG__ID D00TUB D00TUB DRUGTYPE Small molecular drug D00TUB DRUGINCH 1S/C14H11N3O2/c15-9-6-4-8(5-7-9)13-16-12-10(14(19)17-13)2-1-3-11(12)18/h1-7,18H,15H2,(H,16,17,19) D00TUB DRUGINKE FNYTYXJFOSRUTI-UHFFFAOYSA-N D00TUB DRUGSMIL C1=CC2=C(C(=C1)O)N=C(NC2=O)C3=CC=C(C=C3)N D00TUB HIGHSTAT Investigative D00TUH DRUG__ID D00TUH D00TUH DRUGTYPE Small molecular drug D00TUH DRUGINCH 1S/C21H19NO4/c1-14(23)15-5-7-16(8-6-15)17-3-2-4-18-19(24)13-20(26-21(17)18)22-9-11-25-12-10-22/h2-8,13H,9-12H2,1H3 D00TUH DRUGINKE OEHLKVQEMZKDOJ-UHFFFAOYSA-N D00TUH DRUGSMIL CC(=O)C1=CC=C(C=C1)C2=CC=CC3=C2OC(=CC3=O)N4CCOCC4 D00TUH HIGHSTAT Investigative D00TWA DRUG__ID D00TWA D00TWA DRUGTYPE Small molecular drug D00TWA DRUGINCH 1S/C13H10OS3/c14-7-9-6-13(16-8-9)12-4-3-11(17-12)10-2-1-5-15-10/h1-6,8,14H,7H2 D00TWA DRUGINKE CTGDOERMEKYCRZ-UHFFFAOYSA-N D00TWA DRUGSMIL C1=CSC(=C1)C2=CC=C(S2)C3=CC(=CS3)CO D00TWA HIGHSTAT Investigative D00TWC DRUG__ID D00TWC D00TWC DRUGTYPE Small molecular drug D00TWC DRUGINCH 1S/C19H14Cl2O2/c1-12-4-2-3-5-15(12)13-6-8-19(17(22)10-13)23-18-9-7-14(20)11-16(18)21/h2-11,22H,1H3 D00TWC DRUGINKE VDWAWADVXJMBAA-UHFFFAOYSA-N D00TWC DRUGSMIL CC1=CC=CC=C1C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D00TWC HIGHSTAT Investigative D00TWK DRUG__ID D00TWK D00TWK DRUGTYPE Small molecular drug D00TWK DRUGINCH 1S/C14H14O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h3-9,15-17H,1-2H2 D00TWK DRUGINKE HITJFUSPLYBJPE-UHFFFAOYSA-N D00TWK DRUGSMIL C1=CC(=CC=C1CCC2=CC(=CC(=C2)O)O)O D00TWK HIGHSTAT Investigative D00TWV DRUG__ID D00TWV D00TWV DRUGTYPE Small molecular drug D00TWV DRUGINCH 1S/C29H27ClIN7O2/c1-2-5-25-33-27(30)26(29(40)32-15-14-18-10-13-24(39)23(31)16-18)38(25)17-19-8-11-20(12-9-19)21-6-3-4-7-22(21)28-34-36-37-35-28/h3-4,6-13,16,39H,2,5,14-15,17H2,1H3,(H,32,40)(H,34,35,36,37)/i31-2 D00TWV DRUGINKE WMCDNTWPKXBICS-DYSJZCPFSA-N D00TWV DRUGSMIL CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)NCCC5=CC(=C(C=C5)O)I)Cl D00TWV HIGHSTAT Investigative D00TYW DRUG__ID D00TYW D00TYW DRUGTYPE Small molecular drug D00TYW DRUGINCH 1S/C20H32O4/c1-3-5-7-9-11-13-16-15-18(22)19(20(23)24-16)17(21)14-12-10-8-6-4-2/h15,22H,3-14H2,1-2H3 D00TYW DRUGINKE UXMFHBGEDUHLJO-UHFFFAOYSA-N D00TYW DRUGSMIL CCCCCCCC1=CC(=C(C(=O)O1)C(=O)CCCCCCC)O D00TYW HIGHSTAT Investigative D00TYX DRUG__ID D00TYX D00TYX DRUGTYPE Small molecular drug D00TYX DRUGINCH 1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3/i2T3,3T3 D00TYX DRUGINKE KQKPFRSPSRPDEB-KERYDJPLSA-N D00TYX DRUGSMIL CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C D00TYX HIGHSTAT Investigative D00TZD DRUG__ID D00TZD D00TZD DRUGTYPE Small molecular drug D00TZD DRUGINCH 1S/C18H13BrN4O/c1-2-4-17(24)22-14-7-8-16-15(10-14)18(21-11-20-16)23-13-6-3-5-12(19)9-13/h3,5-11H,1H3,(H,22,24)(H,20,21,23) D00TZD DRUGINKE BTYYWOYVBXILOJ-UHFFFAOYSA-N D00TZD DRUGSMIL CC#CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br D00TZD HIGHSTAT Investigative D00UBR DRUG__ID D00UBR D00UBR DRUGTYPE Small molecular drug D00UBR DRUGINCH 1S/C20H23NO2/c22-20(21-15-16-8-3-1-4-9-16)23-19-13-7-12-18(14-19)17-10-5-2-6-11-17/h2,5-7,10-14,16H,1,3-4,8-9,15H2,(H,21,22) D00UBR DRUGINKE AARHPAICPBZNBZ-UHFFFAOYSA-N D00UBR DRUGSMIL C1CCC(CC1)CNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D00UBR HIGHSTAT Investigative D00UCP DRUG__ID D00UCP D00UCP DRUGTYPE Small molecular drug D00UCP DRUGINCH 1S/C22H22N2O3S/c1-17-11-13-19(14-12-17)28(26,27)24-21-10-6-5-9-20(21)22(25)23-16-15-18-7-3-2-4-8-18/h2-14,24H,15-16H2,1H3,(H,23,25) D00UCP DRUGINKE QLFGNZRFLMFTDF-UHFFFAOYSA-N D00UCP DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCCC3=CC=CC=C3 D00UCP HIGHSTAT Investigative D00UDX DRUG__ID D00UDX D00UDX DRUGTYPE Small molecular drug D00UDX DRUGINCH 1S/C8H22N4/c9-6-4-2-1-3-5-7-12-8(10)11/h8,12H,1-7,9-11H2 D00UDX DRUGINKE SKGAVCHIFDRDTK-UHFFFAOYSA-N D00UDX DRUGSMIL C(CCCN)CCCNC(N)N D00UDX HIGHSTAT Investigative D00UFJ DRUG__ID D00UFJ D00UFJ DRUGTYPE Small molecular drug D00UFJ DRUGINCH 1S/C16H11ClN2OS/c17-13-8-6-12(7-9-13)15(20)19-16-18-14(10-21-16)11-4-2-1-3-5-11/h1-10H,(H,18,19,20) D00UFJ DRUGINKE ZLQJUNKKCMQVHA-UHFFFAOYSA-N D00UFJ DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=C(C=C3)Cl D00UFJ HIGHSTAT Investigative D00UFR DRUG__ID D00UFR D00UFR DRUGTYPE Small molecular drug D00UFR DRUGINCH 1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/p-3/b3-1- D00UFR DRUGINKE GTZCVFVGUGFEME-IWQZZHSRSA-K D00UFR DRUGSMIL C(C(=CC(=O)[O-])C(=O)[O-])C(=O)[O-] D00UFR HIGHSTAT Investigative D00UIK DRUG__ID D00UIK D00UIK DRUGTYPE Small molecular drug D00UIK DRUGINCH 1S/C17H15NO/c19-17-11-10-16(14-8-4-5-9-15(14)17)18-12-13-6-2-1-3-7-13/h1-11,18-19H,12H2 D00UIK DRUGINKE GXGORQOUKCMHGK-UHFFFAOYSA-N D00UIK DRUGSMIL C1=CC=C(C=C1)CNC2=CC=C(C3=CC=CC=C32)O D00UIK HIGHSTAT Investigative D00UIN DRUG__ID D00UIN D00UIN DRUGTYPE Small molecular drug D00UIN DRUGINCH 1S/C20H22N2O3/c1-4-12-22(13-5-1)14-15-23-16-8-10-17(11-9-16)24-20-21-18-6-2-3-7-19(18)25-20/h2-3,6-11H,1,4-5,12-15H2 D00UIN DRUGINKE ZIQGASWXUSSORV-UHFFFAOYSA-N D00UIN DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)OC3=NC4=CC=CC=C4O3 D00UIN HIGHSTAT Investigative D00ULT DRUG__ID D00ULT D00ULT DRUGTYPE Small molecular drug D00ULT DRUGINCH 1S/C11H19F3O/c1-2-3-4-5-6-7-8-9-10(15)11(12,13)14/h2-9H2,1H3 D00ULT DRUGINKE ZKJPGCCWKBTIBE-UHFFFAOYSA-N D00ULT DRUGSMIL CCCCCCCCCC(=O)C(F)(F)F D00ULT HIGHSTAT Investigative D00UMG DRUG__ID D00UMG D00UMG DRUGTYPE Small molecular drug D00UMG DRUGINCH 1S/C23H23Cl2N3O3/c24-16-5-6-19-15(11-16)13-20(26-19)22(30)27-21(12-14-3-1-2-4-18(14)25)23(31)28-9-7-17(29)8-10-28/h1-6,11,13,17,21,26,29H,7-10,12H2,(H,27,30)/t21-/m0/s1 D00UMG DRUGINKE HJMXVPPJJMSWFO-NRFANRHFSA-N D00UMG DRUGSMIL C1CN(CCC1O)C(=O)C(CC2=CC=CC=C2Cl)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl D00UMG HIGHSTAT Investigative D00UOI DRUG__ID D00UOI D00UOI DRUGTYPE Small molecular drug D00UOI DRUGINCH 1S/C35H36FN3O5/c1-22(2)39-30(17-16-28(40)18-29(41)19-31(42)43)32(26-12-14-27(36)15-13-26)33(25-6-4-3-5-7-25)34(39)35(44)38-21-24-10-8-23(20-37)9-11-24/h3-15,22,28-29,40-41H,16-19,21H2,1-2H3,(H,38,44)(H,42,43)/p-1/t28-,29-/m1/s1 D00UOI DRUGINKE LRCUHVRZXKUPFJ-FQLXRVMXSA-M D00UOI DRUGSMIL CC(C)N1C(=C(C(=C1C(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3)C4=CC=C(C=C4)F)CCC(CC(CC(=O)[O-])O)O D00UOI HIGHSTAT Investigative D00URP DRUG__ID D00URP D00URP DRUGTYPE Small molecular drug D00URP DRUGINCH 1S/C15H14O3/c1-8-5-11(16)6-10-7-18-15-9(2)13(17)4-3-12(15)14(8)10/h3-6,16-17H,7H2,1-2H3 D00URP DRUGINKE UUVHCOKGCFXIER-UHFFFAOYSA-N D00URP DRUGSMIL CC1=CC(=CC2=C1C3=C(C(=C(C=C3)O)C)OC2)O D00URP HIGHSTAT Investigative D00UTF DRUG__ID D00UTF D00UTF DRUGTYPE Small molecular drug D00UTF DRUGINCH 1S/C23H19Cl2N7O2/c1-32(2)22(33)14-5-3-13(4-6-14)19-8-7-17(12-20(19)21-28-30-31-29-21)26-23(34)27-18-10-15(24)9-16(25)11-18/h3-12H,1-2H3,(H2,26,27,34)(H,28,29,30,31) D00UTF DRUGINKE FQIPXFVYNAMLDB-UHFFFAOYSA-N D00UTF DRUGSMIL CN(C)C(=O)C1=CC=C(C=C1)C2=C(C=C(C=C2)NC(=O)NC3=CC(=CC(=C3)Cl)Cl)C4=NNN=N4 D00UTF HIGHSTAT Investigative D00UTU DRUG__ID D00UTU D00UTU DRUGTYPE Small molecular drug D00UTU DRUGINCH 1S/C18H12BrN3O3/c1-9(23)25-22-16-10-5-2-3-8-13(10)20-17(16)14-11-6-4-7-12(19)15(11)21-18(14)24/h2-8,21,24H,1H3/b22-16- D00UTU DRUGINKE CHULSJBNZJIYCG-JWGURIENSA-N D00UTU DRUGSMIL CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC=C4Br)O D00UTU HIGHSTAT Investigative D00UUG DRUG__ID D00UUG D00UUG DRUGTYPE Small molecular drug D00UUG DRUGINCH 1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17-/m0/s1 D00UUG DRUGINKE DAOQLLQRJAXMGY-YOEHRIQHSA-N D00UUG DRUGSMIL C1=CC(=CC=C1C(CC2=CC3=C(C=C2)N=C(NC3=O)N)C(=O)O)C(=O)NC(CCC(=O)O)C(=O)O D00UUG HIGHSTAT Investigative D00UUM DRUG__ID D00UUM D00UUM DRUGTYPE Small molecular drug D00UUM DRUGINCH 1S/C8H12N5O4P/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-17-5-18(14,15)16/h3-4H,1-2,5H2,(H2,9,10,11)(H2,14,15,16) D00UUM DRUGINKE SUPKOOSCJHTBAH-UHFFFAOYSA-N D00UUM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N D00UUM HIGHSTAT Investigative D00UWL DRUG__ID D00UWL D00UWL DRUGTYPE Small molecular drug D00UWL DRUGINCH 1S/C46H73N13O10/c1-8-26(5)37(43(66)55-33(21-29-22-50-24-52-29)44(67)59-19-11-13-34(59)41(64)58-38(45(68)69)27(6)9-2)57-40(63)32(20-28-14-16-30(60)17-15-28)54-42(65)36(25(3)4)56-39(62)31(53-35(61)23-49-7)12-10-18-51-46(47)48/h14-17,22,24-27,31-34,36-38,49,60H,8-13,18-21,23H2,1-7H3,(H,50,52)(H,53,61)(H,54,65)(H,55,66)(H,56,62)(H,57,63)(H,58,64)(H,68,69)(H4,47,48,51) D00UWL DRUGINKE ZVUNAQTWOGAJRE-UHFFFAOYSA-N D00UWL DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(C(C)CC)C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D00UWL HIGHSTAT Investigative D00UZO DRUG__ID D00UZO D00UZO DRUGTYPE Small molecular drug D00UZO DRUGINCH 1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(24)25-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21,23H2,1H3/b7-6-,10-9-,13-12-,16-15- D00UZO DRUGINKE DLHLOYYQQGSXCC-DOFZRALJSA-N D00UZO DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)OCCN D00UZO HIGHSTAT Investigative D00VAN DRUG__ID D00VAN D00VAN DRUGTYPE Small molecular drug D00VAN DRUGINCH 1S/C15H14BrN3S/c1-10-4-2-5-11(8-10)14(18-19-15(17)20)12-6-3-7-13(16)9-12/h2-9H,1H3,(H3,17,19,20)/b18-14+ D00VAN DRUGINKE UUHYYCURIRMTND-NBVRZTHBSA-N D00VAN DRUGSMIL CC1=CC(=CC=C1)C(=NNC(=S)N)C2=CC(=CC=C2)Br D00VAN HIGHSTAT Investigative D00VBW DRUG__ID D00VBW D00VBW DRUGTYPE Small molecular drug D00VBW DRUGINCH 1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6-,12-11+,16-8+,17-13+ D00VBW DRUGINKE FPIPGXGPPPQFEQ-IOUUIBBYSA-N D00VBW DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C D00VBW HIGHSTAT Investigative D00VBX DRUG__ID D00VBX D00VBX DRUGTYPE Small molecular drug D00VBX DRUGINCH 1S/C12H10O4S/c1-17(14,15)10-6-4-9(5-7-10)12(13)11-3-2-8-16-11/h2-8H,1H3 D00VBX DRUGINKE CWRZECMEZICAFW-UHFFFAOYSA-N D00VBX DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C(=O)C2=CC=CO2 D00VBX HIGHSTAT Investigative D00VCW DRUG__ID D00VCW D00VCW DRUGTYPE Small molecular drug D00VCW DRUGINCH 1S/C22H36ClNO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15- D00VCW DRUGINKE SCJNCDSAIRBRIA-DOFZRALJSA-N D00VCW DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCCl D00VCW HIGHSTAT Investigative D00VEZ DRUG__ID D00VEZ D00VEZ DRUGTYPE Small molecular drug D00VEZ DRUGINCH 1S/C11H17NO8/c12-4(9(15)16)1-11(10(17)18)2-6-8(20-11)7(14)5(13)3-19-6/h4-8,13-14H,1-3,12H2,(H,15,16)(H,17,18)/p-1/t4-,5+,6?,7+,8?,11-/m1/s1 D00VEZ DRUGINKE NRTJEXLNSCGBJU-LUHIGIFZSA-M D00VEZ DRUGSMIL C1C2C(C(C(CO2)O)O)OC1(CC(C(=O)[O-])[NH3+])C(=O)[O-] D00VEZ HIGHSTAT Investigative D00VFM DRUG__ID D00VFM D00VFM THERCLAS Antifungal Agents D00VFM DRUGINCH 1S/C23H28ClN3O/c24-20-6-4-5-19(15-20)16-23(11-2-1-3-12-23)13-14-28-21-9-7-18(8-10-21)17-27-22(25)26/h2,4-11,15H,1,3,12-14,16-17H2,(H4,25,26,27) D00VFM DRUGINKE VJXVVAAVNHDMTH-UHFFFAOYSA-N D00VFM DRUGSMIL C1CC=CC(C1)(CCOC2=CC=C(C=C2)CN=C(N)N)CC3=CC(=CC=C3)Cl D00VFM HIGHSTAT Investigative D00VHG DRUG__ID D00VHG D00VHG DRUGTYPE Small molecular drug D00VHG DRUGINCH 1S/C19H22N2O5S/c1-12-6-4-5-7-15(12)10-17(22)21-16-8-13(2)19(14(3)9-16)27(25,26)20-11-18(23)24/h4-9,20H,10-11H2,1-3H3,(H,21,22)(H,23,24) D00VHG DRUGINKE CJKKMQCZOLCXAM-UHFFFAOYSA-N D00VHG DRUGSMIL CC1=CC=CC=C1CC(=O)NC2=CC(=C(C(=C2)C)S(=O)(=O)NCC(=O)O)C D00VHG HIGHSTAT Investigative D00VHN DRUG__ID D00VHN D00VHN DRUGTYPE Small molecular drug D00VHN DRUGINCH 1S/C19H35NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21-24H,2-8,13-16,20H2,1H3/q+1 D00VHN DRUGINKE CGCGFGUOJDITDE-UHFFFAOYSA-N D00VHN DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO[P+](O)(O)O)N D00VHN HIGHSTAT Investigative D00VHS DRUG__ID D00VHS D00VHS DRUGTYPE Small molecular drug D00VHS DRUGINCH 1S/C15H11NO2S/c17-12-5-1-10(2-6-12)14-9-16-19-15(14)11-3-7-13(18)8-4-11/h1-9,17-18H D00VHS DRUGINKE OCBISDMDUBGFSN-UHFFFAOYSA-N D00VHS DRUGSMIL C1=CC(=CC=C1C2=C(SN=C2)C3=CC=C(C=C3)O)O D00VHS HIGHSTAT Investigative D00VHW DRUG__ID D00VHW D00VHW DRUGTYPE Small molecular drug D00VHW DRUGINCH 1S/C22H27NO/c1-2-6-18(7-3-1)14-19-10-12-23(13-11-19)16-20-15-21-8-4-5-9-22(21)24-17-20/h1-9,19-20H,10-17H2 D00VHW DRUGINKE SLJXLWDNADHNLA-UHFFFAOYSA-N D00VHW DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4OC3 D00VHW HIGHSTAT Investigative D00VJY DRUG__ID D00VJY D00VJY DRUGTYPE Small molecular drug D00VJY DRUGINCH 1S/C8H18O/c1-2-3-4-5-6-7-8-9/h9H,2-8H2,1H3 D00VJY DRUGINKE KBPLFHHGFOOTCA-UHFFFAOYSA-N D00VJY DRUGSMIL CCCCCCCCO D00VJY HIGHSTAT Investigative D00VKB DRUG__ID D00VKB D00VKB DRUGTYPE Small molecular drug D00VKB DRUGINCH 1S/C13H23F3O2S/c1-2-3-4-5-6-7-8-9-10-19(18)11-12(17)13(14,15)16/h2-11H2,1H3 D00VKB DRUGINKE PWWCYKIIRMNUAY-UHFFFAOYSA-N D00VKB DRUGSMIL CCCCCCCCCCS(=O)CC(=O)C(F)(F)F D00VKB HIGHSTAT Investigative D00VKV DRUG__ID D00VKV D00VKV DRUGTYPE Small molecular drug D00VKV DRUGINCH 1S/C15H23NS/c1-3-9-15(10-4-1,14-8-7-13-17-14)16-11-5-2-6-12-16/h7-8,13H,1-6,9-12H2 D00VKV DRUGINKE JUZZEWSCNBCFRL-UHFFFAOYSA-N D00VKV DRUGSMIL C1CCC(CC1)(C2=CC=CS2)N3CCCCC3 D00VKV HIGHSTAT Investigative D00VMO DRUG__ID D00VMO D00VMO DRUGTYPE Small molecular drug D00VMO DRUGINCH 1S/C25H25ClFNO4/c1-14(2)25-20(9-8-18(29)12-19(30)13-23(31)32)24(15-3-6-17(27)7-4-15)21-11-16(26)5-10-22(21)28-25/h3-11,14,18-19,29-30H,12-13H2,1-2H3,(H,31,32)/p-1/b9-8+/t18?,19-/m1/s1 D00VMO DRUGINKE FMCKOMPEFSASBD-FLRXWSLESA-M D00VMO DRUGSMIL CC(C)C1=NC2=C(C=C(C=C2)Cl)C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F D00VMO HIGHSTAT Investigative D00VNC DRUG__ID D00VNC D00VNC DRUGTYPE Small molecular drug D00VNC DRUGINCH 1S/C30H48O3/c1-25(2)14-15-27(5)16-17-30(24(32)33)19(20(27)18-25)8-9-22-28(6)12-11-23(31)26(3,4)21(28)10-13-29(22,30)7/h8,20-23,31H,9-18H2,1-7H3,(H,32,33)/t20-,21?,22+,23-,27+,28-,29+,30+/m0/s1 D00VNC DRUGINKE QGOSJBZFTWGWDU-ROOBTRRZSA-N D00VNC DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C(=O)O)C)C D00VNC HIGHSTAT Investigative D00VQZ DRUG__ID D00VQZ D00VQZ DRUGTYPE Small molecular drug D00VQZ DRUGINCH 1S/C7H7N3O4/c11-7(9-12)8-5-1-3-6(4-2-5)10(13)14/h1-4,12H,(H2,8,9,11) D00VQZ DRUGINKE DXBVARSUKIUCDK-UHFFFAOYSA-N D00VQZ DRUGSMIL C1=CC(=CC=C1NC(=O)NO)[N+](=O)[O-] D00VQZ HIGHSTAT Investigative D00VRV DRUG__ID D00VRV D00VRV DRUGTYPE Small molecular drug D00VRV DRUGINCH 1S/C20H24BrN3O/c1-4-24(5-2)20(25)12-9-14-13-7-6-8-16-18(13)15(19(21)22-16)10-17(14)23(3)11-12/h6-9,12,17,22H,4-5,10-11H2,1-3H3/t12-,17-/m1/s1 D00VRV DRUGINKE VKRAXSZEDRWLAG-SJKOYZFVSA-N D00VRV DRUGSMIL CCN(CC)C(=O)C1CN(C2CC3=C(NC4=CC=CC(=C34)C2=C1)Br)C D00VRV HIGHSTAT Investigative D00VSQ DRUG__ID D00VSQ D00VSQ DRUGCOMP ProCor Pharmaceuticals D00VSQ DRUGINCH 1S/C14H20BNO2S/c1-13(2)14(3,4)18-15(17-13)9-8-11-6-7-12(19-5)16-10-11/h6-10H,1-5H3/b9-8+ D00VSQ DRUGINKE MTGNTJQBNWXEMY-CMDGGOBGSA-N D00VSQ DRUGSMIL B1(OC(C(O1)(C)C)(C)C)C=CC2=CN=C(C=C2)SC D00VSQ HIGHSTAT Investigative D00VUO DRUG__ID D00VUO D00VUO DRUGTYPE Small molecular drug D00VUO DRUGINCH 1S/C16H15NO/c1-18-15-7-6-13-4-5-14(16(13)10-15)9-12-3-2-8-17-11-12/h2-3,6-11H,4-5H2,1H3/b14-9+ D00VUO DRUGINKE NDEGTMIIOPDVPA-NTEUORMPSA-N D00VUO DRUGSMIL COC1=CC2=C(CCC2=CC3=CN=CC=C3)C=C1 D00VUO HIGHSTAT Investigative D00VUT DRUG__ID D00VUT D00VUT DRUGTYPE Small molecular drug D00VUT DRUGINCH 1S/C28H31FN2O/c29-24-13-11-21(12-14-24)27(32)20-30-17-18-31-19-25(30)15-16-26(31)28(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-14,25-28,32H,15-20H2/t25-,26-,27-/m0/s1 D00VUT DRUGINKE FESQDZTUIIZPPV-QKDODKLFSA-N D00VUT DRUGSMIL C1CC(N2CCN(C1C2)CC(C3=CC=C(C=C3)F)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D00VUT HIGHSTAT Investigative D00VVB DRUG__ID D00VVB D00VVB DRUGTYPE Small molecular drug D00VVB DRUGINCH 1S/C17H26N2O3/c1-4-5-6-7-8-13-21-16-11-9-15(10-12-16)18-17(20)22-19-14(2)3/h9-12H,4-8,13H2,1-3H3,(H,18,20) D00VVB DRUGINKE YXHJSUXZTSOPMI-UHFFFAOYSA-N D00VVB DRUGSMIL CCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D00VVB HIGHSTAT Investigative D00VWN DRUG__ID D00VWN D00VWN DRUGTYPE Small molecular drug D00VWN DRUGINCH 1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3/b10-7+ D00VWN DRUGINKE WTEVQBCEXWBHNA-JXMROGBWSA-N D00VWN DRUGSMIL CC(=CCCC(=CC=O)C)C D00VWN HIGHSTAT Investigative D00VWR DRUG__ID D00VWR D00VWR DRUGTYPE Small molecular drug D00VWR DRUGINCH 1S/C8H14O2/c1-3-8(4-2)5-6-10-7(8)9/h3-6H2,1-2H3 D00VWR DRUGINKE OKKTUDVXPHANCU-UHFFFAOYSA-N D00VWR DRUGSMIL CCC1(CCOC1=O)CC D00VWR HIGHSTAT Investigative D00VXE DRUG__ID D00VXE D00VXE DRUGTYPE Small molecular drug D00VXE DRUGINCH 1S/C23H24N2OS/c26-22(24-23-12-15-9-16(13-23)11-17(10-15)14-23)25-18-5-1-3-7-20(18)27-21-8-4-2-6-19(21)25/h1-8,15-17H,9-14H2,(H,24,26) D00VXE DRUGINKE YTNHIPMOCAHDRX-UHFFFAOYSA-N D00VXE DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64 D00VXE HIGHSTAT Investigative D00VXM DRUG__ID D00VXM D00VXM DRUGTYPE Small molecular drug D00VXM DRUGINCH 1S/C11H14ClNO3/c1-8-7-9(12)4-5-10(8)16-6-2-3-11(14)13-15/h4-5,7,15H,2-3,6H2,1H3,(H,13,14) D00VXM DRUGINKE JHSXDAWGLCZYSM-UHFFFAOYSA-N D00VXM DRUGSMIL CC1=C(C=CC(=C1)Cl)OCCCC(=O)NO D00VXM HIGHSTAT Investigative D00VYD DRUG__ID D00VYD D00VYD DRUGTYPE Small molecular drug D00VYD DRUGINCH 1S/C12H10ClNO2/c13-10-4-1-3-9(7-10)8-14-6-2-5-11(14)12(15)16/h1-7H,8H2,(H,15,16) D00VYD DRUGINKE VPTUTBZAHHDMAA-UHFFFAOYSA-N D00VYD DRUGSMIL C1=CC(=CC(=C1)Cl)CN2C=CC=C2C(=O)O D00VYD HIGHSTAT Investigative D00VZA DRUG__ID D00VZA D00VZA DRUGTYPE Small molecular drug D00VZA DRUGINCH 1S/C16H11NO3/c17-10-13(16(20)12-4-2-1-3-5-12)8-11-6-7-14(18)15(19)9-11/h1-9,18-19H/b13-8+ D00VZA DRUGINKE QBKFKKGORMOFFU-MDWZMJQESA-N D00VZA DRUGSMIL C1=CC=C(C=C1)C(=O)C(=CC2=CC(=C(C=C2)O)O)C#N D00VZA HIGHSTAT Investigative D00VZE DRUG__ID D00VZE D00VZE DRUGTYPE Small molecular drug D00VZE DRUGINCH 1S/C17H28N2O/c20-16(18-15-4-2-1-3-5-15)19-17-9-12-6-13(10-17)8-14(7-12)11-17/h12-15H,1-11H2,(H2,18,19,20) D00VZE DRUGINKE VESXWSWSGQONHC-UHFFFAOYSA-N D00VZE DRUGSMIL C1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D00VZE HIGHSTAT Investigative D00WBS DRUG__ID D00WBS D00WBS DRUGTYPE Small molecular drug D00WBS DRUGINCH 1S/C26H43NO5/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-/m1/s1 D00WBS DRUGINKE WVULKSPCQVQLCU-BUXLTGKBSA-N D00WBS DRUGSMIL CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C D00WBS HIGHSTAT Investigative D00WBU DRUG__ID D00WBU D00WBU DRUGTYPE Small molecular drug D00WBU DRUGINCH 1S/C31H33N5O5/c1-17-11-21(37)12-18(2)22(17)14-23(32)31(41)36-16-20-8-4-3-7-19(20)13-27(36)30(40)35-26(15-28(38)39)29-33-24-9-5-6-10-25(24)34-29/h3-12,23,26-27,37H,13-16,32H2,1-2H3,(H,33,34)(H,35,40)(H,38,39)/t23-,26+,27-/m0/s1 D00WBU DRUGINKE USVQTDLSVBRMCR-RNJDCESWSA-N D00WBU DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C4=NC5=CC=CC=C5N4)N)C)O D00WBU HIGHSTAT Investigative D00WEQ DRUG__ID D00WEQ D00WEQ DRUGTYPE Small molecular drug D00WEQ DRUGINCH 1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3 D00WEQ DRUGINKE FXMWUTGUCAKGQL-UHFFFAOYSA-N D00WEQ DRUGSMIL CC(CC1=CC(=C(C=C1OC)Br)OC)N D00WEQ HIGHSTAT Investigative D00WEV DRUG__ID D00WEV D00WEV DRUGTYPE Small molecular drug D00WEV DRUGINCH 1S/C43H47N7O9/c1-21-13-27(51)14-22(2)29(21)19-32(44)38(54)37-28-8-6-5-7-24(28)18-34(46-37)41(57)47-33(11-12-36(52)53)40(56)48-35(39(45)55)20-50-42(58)30-16-23-9-10-26(49(3)4)15-25(23)17-31(30)43(50)59/h5-10,13-17,32-35,37,46,51H,11-12,18-20,44H2,1-4H3,(H2,45,55)(H,47,57)(H,48,56)(H,52,53)/t32-,33-,34?,35?,37?/m0/s1 D00WEV DRUGINKE XJJAERVDDMSANL-TXQDRJNYSA-N D00WEV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)C2C3=CC=CC=C3CC(N2)C(=O)NC(CCC(=O)O)C(=O)NC(CN4C(=O)C5=C(C4=O)C=C6C=C(C=CC6=C5)N(C)C)C(=O)N)N)C)O D00WEV HIGHSTAT Investigative D00WFB DRUG__ID D00WFB D00WFB DRUGTYPE Small molecular drug D00WFB DRUGINCH 1S/C16H12O4/c17-11-3-1-10(2-4-11)7-13-9-15(19)14-6-5-12(18)8-16(14)20-13/h1-6,8-9,17-18H,7H2 D00WFB DRUGINKE ZUDKQDRWUFGUDQ-UHFFFAOYSA-N D00WFB DRUGSMIL C1=CC(=CC=C1CC2=CC(=O)C3=C(O2)C=C(C=C3)O)O D00WFB HIGHSTAT Investigative D00WFQ DRUG__ID D00WFQ D00WFQ DRUGTYPE Small molecular drug D00WFQ DRUGINCH 1S/C11H9N3O3/c1-8-4-2-3-5-10(8)11(15)13-7-9(6-12-13)14(16)17/h2-7H,1H3 D00WFQ DRUGINKE ORXYMBYYSLQOLK-UHFFFAOYSA-N D00WFQ DRUGSMIL CC1=CC=CC=C1C(=O)N2C=C(C=N2)[N+](=O)[O-] D00WFQ HIGHSTAT Investigative D00WFU DRUG__ID D00WFU D00WFU DRUGTYPE Small molecular drug D00WFU DRUGINCH 1S/C20H19N3O/c1-14(2)19(24)23-20-21-17(15-9-5-3-6-10-15)13-18(22-20)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,21,22,23,24) D00WFU DRUGINKE AGCKGTMTDBKSHH-UHFFFAOYSA-N D00WFU DRUGSMIL CC(C)C(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D00WFU HIGHSTAT Investigative D00WHO DRUG__ID D00WHO D00WHO DRUGTYPE Small molecular drug D00WHO DRUGINCH 1S/C15H14ClN3O3/c1-3-22-15(21)13-11-7-18(2)14(20)12-9(16)5-4-6-10(12)19(11)8-17-13/h4-6,8H,3,7H2,1-2H3 D00WHO DRUGINKE WSDBAFQWNWJTNG-UHFFFAOYSA-N D00WHO DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC=C3Cl)C D00WHO HIGHSTAT Investigative D00WKK DRUG__ID D00WKK D00WKK DRUGTYPE Small molecular drug D00WKK DRUGINCH 1S/C22H23N3O2/c26-22(19-8-4-10-23-16-19,20-9-5-11-24-17-20)21(18-6-2-1-3-7-18)25-12-14-27-15-13-25/h1-11,16-17,21,26H,12-15H2 D00WKK DRUGINKE WPLZJOHYEBBPRT-UHFFFAOYSA-N D00WKK DRUGSMIL C1COCCN1C(C2=CC=CC=C2)C(C3=CN=CC=C3)(C4=CN=CC=C4)O D00WKK HIGHSTAT Investigative D00WMC DRUG__ID D00WMC D00WMC DRUGTYPE Small molecular drug D00WMC DRUGINCH 1S/C15H11N3OS/c19-14(12-6-8-16-9-7-12)18-15-17-13(10-20-15)11-4-2-1-3-5-11/h1-10H,(H,17,18,19) D00WMC DRUGINKE PUUUVNHZQJNJSV-UHFFFAOYSA-N D00WMC DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=NC=C3 D00WMC HIGHSTAT Investigative D00WMS DRUG__ID D00WMS D00WMS DRUGTYPE Small molecular drug D00WMS DRUGINCH 1S/C13H19NO/c1-10(14-13(2,3)4)12(15)11-8-6-5-7-9-11/h5-10,14H,1-4H3 D00WMS DRUGINKE JQNSRSIGKZYQAA-UHFFFAOYSA-N D00WMS DRUGSMIL CC(C(=O)C1=CC=CC=C1)NC(C)(C)C D00WMS HIGHSTAT Investigative D00WMV DRUG__ID D00WMV D00WMV DRUGTYPE Small molecular drug D00WMV DRUGINCH 1S/C34H28N4/c1-3-10-33-29(8-1)31-16-18-37(33)23-27-6-5-7-28(20-27)24-38-19-17-32(30-9-2-4-11-34(30)38)36-22-26-14-12-25(13-15-26)21-35-31/h1-20H,21-24H2/p+2 D00WMV DRUGINKE HZWVJPDDZQOYGA-UHFFFAOYSA-P D00WMV DRUGSMIL C1C2=CC=C(CNC3=CC=[N+](CC4=CC=CC(=C4)C[N+]5=CC=C(N1)C6=CC=CC=C65)C7=CC=CC=C37)C=C2 D00WMV HIGHSTAT Investigative D00WNA DRUG__ID D00WNA D00WNA DRUGTYPE Small molecular drug D00WNA DRUGINCH 1S/C21H21N3O4/c1-14(19-9-4-5-10-22-19)24(3)21(26)20-12-18(28-23-20)13-27-17-8-6-7-16(11-17)15(2)25/h4-12,14H,13H2,1-3H3/t14-/m0/s1 D00WNA DRUGINKE JMYDHMCYZKRDPD-AWEZNQCLSA-N D00WNA DRUGSMIL CC(C1=CC=CC=N1)N(C)C(=O)C2=NOC(=C2)COC3=CC=CC(=C3)C(=O)C D00WNA HIGHSTAT Investigative D00WOE DRUG__ID D00WOE D00WOE DRUGTYPE Small molecular drug D00WOE DRUGINCH 1S/C13H12ClNO2S/c1-18(16,17)15-13-8-4-11(5-9-13)10-2-6-12(14)7-3-10/h2-9,15H,1H3 D00WOE DRUGINKE XUCHFNFYOSJPDH-UHFFFAOYSA-N D00WOE DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C2=CC=C(C=C2)Cl D00WOE HIGHSTAT Investigative D00WOK DRUG__ID D00WOK D00WOK DRUGTYPE Small molecular drug D00WOK DRUGINCH 1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D00WOK DRUGINKE HAEJPQIATWHALX-KQYNXXCUSA-N D00WOK DRUGSMIL C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D00WOK HIGHSTAT Investigative D00WON DRUG__ID D00WON D00WON DRUGTYPE Small molecular drug D00WON DRUGINCH 1S/C7H12O2/c1-3-7(2)4-5-9-6(7)8/h3-5H2,1-2H3 D00WON DRUGINKE DRTXQTMTWPIHLI-UHFFFAOYSA-N D00WON DRUGSMIL CCC1(CCOC1=O)C D00WON HIGHSTAT Investigative D00WSM DRUG__ID D00WSM D00WSM DRUGTYPE Small molecular drug D00WSM DRUGINCH 1S/C17H13NO3/c1-11-5-4-7-13(9-11)18-16(19)14-10-12-6-2-3-8-15(12)21-17(14)20/h2-10H,1H3,(H,18,19) D00WSM DRUGINKE XUNAVIWFCXQWCJ-UHFFFAOYSA-N D00WSM DRUGSMIL CC1=CC(=CC=C1)NC(=O)C2=CC3=CC=CC=C3OC2=O D00WSM HIGHSTAT Investigative D00WSN DRUG__ID D00WSN D00WSN DRUGTYPE Small molecular drug D00WSN DRUGINCH 1S/C15H15N3O5/c19-15(13-5-6-14(23-13)18(20)21)16-11-3-1-2-4-12(11)17-7-9-22-10-8-17/h1-6H,7-10H2,(H,16,19) D00WSN DRUGINKE BIQWNNXDPVEAPZ-UHFFFAOYSA-N D00WSN DRUGSMIL C1COCCN1C2=CC=CC=C2NC(=O)C3=CC=C(O3)[N+](=O)[O-] D00WSN HIGHSTAT Investigative D00WVG DRUG__ID D00WVG D00WVG DRUGTYPE Small molecular drug D00WVG DRUGINCH 1S/C14H15N3S/c1-2-6-11(7-3-1)13-10-18-14(15-13)17-16-12-8-4-5-9-12/h1-3,6-7,10H,4-5,8-9H2,(H,15,17) D00WVG DRUGINKE WUSIIHCESPBBHG-UHFFFAOYSA-N D00WVG DRUGSMIL C1CCC(=NNC2=NC(=CS2)C3=CC=CC=C3)C1 D00WVG HIGHSTAT Investigative D00WYS DRUG__ID D00WYS D00WYS DRUGTYPE Small molecular drug D00WYS DRUGINCH 1S/C21H15NOS/c23-18-9-4-8-16(12-18)19-13-17(15-6-2-1-3-7-15)14-20(22-19)21-10-5-11-24-21/h1-14,23H D00WYS DRUGINKE ARUHBJGNLAPWGO-UHFFFAOYSA-N D00WYS DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC=CS3)C4=CC(=CC=C4)O D00WYS HIGHSTAT Investigative D00WZG DRUG__ID D00WZG D00WZG DRUGTYPE Small molecular drug D00WZG DRUGINCH 1S/C19H16N2O3/c1-22-18-11-15-16(20-13-21-17(15)12-19(18)23-2)9-6-10-24-14-7-4-3-5-8-14/h3-5,7-8,11-13H,10H2,1-2H3 D00WZG DRUGINKE SKJFTWBCHDIBAC-UHFFFAOYSA-N D00WZG DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)C#CCOC3=CC=CC=C3)OC D00WZG HIGHSTAT Investigative D00WZI DRUG__ID D00WZI D00WZI DRUGTYPE Small molecular drug D00WZI DRUGINCH 1S/C9H9BO2S/c1-6-2-3-8-7(4-6)5-9(13-8)10(11)12/h2-5,11-12H,1H3 D00WZI DRUGINKE DHNHZPQPQAINDI-UHFFFAOYSA-N D00WZI DRUGSMIL B(C1=CC2=C(S1)C=CC(=C2)C)(O)O D00WZI HIGHSTAT Investigative D00XBM DRUG__ID D00XBM D00XBM DRUGTYPE Small molecular drug D00XBM DRUGINCH 1S/C37H49N11O6/c1-48-30(20-22-11-14-26(49)15-12-22)34(53)44-21-31(50)45-29(19-23-10-13-24-6-2-3-7-25(24)18-23)33(52)46-27(8-4-16-42-36(38)39)32(51)47-28(35(48)54)9-5-17-43-37(40)41/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,53)(H,45,50)(H,46,52)(H,47,51)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30+/m0/s1 D00XBM DRUGINKE KKHZUKILPGNUFR-RRGQHJHPSA-N D00XBM DRUGSMIL CN1C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C1=O)CCCN=C(N)N)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O D00XBM HIGHSTAT Investigative D00XCC DRUG__ID D00XCC D00XCC DRUGTYPE Small molecular drug D00XCC DRUGINCH 1S/C18H21N3O2/c19-15(11-13-7-3-1-4-8-13)18(23)21-16(17(20)22)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H2,20,22)(H,21,23)/t15-,16-/m1/s1 D00XCC DRUGINKE XXPXQEQOAZMUDD-HZPDHXFCSA-N D00XCC DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)N D00XCC HIGHSTAT Investigative D00XCL DRUG__ID D00XCL D00XCL DRUGTYPE Small molecular drug D00XCL DRUGINCH 1S/C9H13N3O3S2/c10-7-1-3-8(4-2-7)17(14,15)12-9(13)11-5-6-16/h1-4,16H,5-6,10H2,(H2,11,12,13) D00XCL DRUGINKE LHVDNDIAMJOEKH-UHFFFAOYSA-N D00XCL DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)NC(=O)NCCS D00XCL HIGHSTAT Investigative D00XDG DRUG__ID D00XDG D00XDG DRUGTYPE Small molecular drug D00XDG DRUGINCH 1S/C10H9N3O2/c11-8(14)7-9(12)15-10(13-7)6-4-2-1-3-5-6/h1-5H,12H2,(H2,11,14) D00XDG DRUGINKE UPWLRKVVLBSIPK-UHFFFAOYSA-N D00XDG DRUGSMIL C1=CC=C(C=C1)C2=NC(=C(O2)N)C(=O)N D00XDG HIGHSTAT Investigative D00XEN DRUG__ID D00XEN D00XEN DRUGTYPE Small molecular drug D00XEN DRUGINCH 1S/C28H29Cl2N3O.ClH/c29-25-8-5-9-26(27(25)30)33-16-14-32(15-17-33)13-4-3-12-31-28(34)21-10-11-24-22(19-21)18-20-6-1-2-7-23(20)24;/h1-2,5-11,19H,3-4,12-18H2,(H,31,34);1H D00XEN DRUGINKE PFIWYJNBKGCVFM-UHFFFAOYSA-N D00XEN DRUGSMIL C1CN(CCN1CCCCNC(=O)C2=CC3=C(C=C2)C4=CC=CC=C4C3)C5=C(C(=CC=C5)Cl)Cl.Cl D00XEN HIGHSTAT Investigative D00XGW DRUG__ID D00XGW D00XGW DRUGTYPE Small molecular drug D00XGW DRUGINCH 1S/C14H10Cl3NO2/c1-7-2-3-10(16)12(4-7)18-14(20)9-5-8(15)6-11(17)13(9)19/h2-6,19H,1H3,(H,18,20) D00XGW DRUGINKE UCOQCHLODZCXRH-UHFFFAOYSA-N D00XGW DRUGSMIL CC1=CC(=C(C=C1)Cl)NC(=O)C2=C(C(=CC(=C2)Cl)Cl)O D00XGW HIGHSTAT Investigative D00XHC DRUG__ID D00XHC D00XHC DRUGTYPE Small molecular drug D00XHC DRUGINCH 1S/C19H22N2OS/c1-13(2)20(14(3)4)19(22)21-15-9-5-7-11-17(15)23-18-12-8-6-10-16(18)21/h5-14H,1-4H3 D00XHC DRUGINKE RSDPPDLPSMZJPP-UHFFFAOYSA-N D00XHC DRUGSMIL CC(C)N(C(C)C)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D00XHC HIGHSTAT Investigative D00XIX DRUG__ID D00XIX D00XIX DRUGTYPE Small molecular drug D00XIX DRUGINCH 1S/C16H11ClOS2/c1-10-2-4-11(5-3-10)14-15(19-20-16(14)18)12-6-8-13(17)9-7-12/h2-9H,1H3 D00XIX DRUGINKE CUFDVUQUYHTZLD-UHFFFAOYSA-N D00XIX DRUGSMIL CC1=CC=C(C=C1)C2=C(SSC2=O)C3=CC=C(C=C3)Cl D00XIX HIGHSTAT Investigative D00XJA DRUG__ID D00XJA D00XJA DRUGTYPE Small molecular drug D00XJA DRUGINCH 1S/C11H8O5/c1-15-7-2-3-9-6(4-7)5-8(10(12)13)11(14)16-9/h2-5H,1H3,(H,12,13) D00XJA DRUGINKE XIQQAIQZABTSNZ-UHFFFAOYSA-N D00XJA DRUGSMIL COC1=CC2=C(C=C1)OC(=O)C(=C2)C(=O)O D00XJA HIGHSTAT Investigative D00XJR DRUG__ID D00XJR D00XJR DRUGTYPE Small molecular drug D00XJR DRUGINCH 1S/C13H15ClN4O/c1-17-4-6-18(7-5-17)13(19)12-15-10-3-2-9(14)8-11(10)16-12/h2-3,8H,4-7H2,1H3,(H,15,16) D00XJR DRUGINKE MOIWSUQWIOVGRH-UHFFFAOYSA-N D00XJR DRUGSMIL CN1CCN(CC1)C(=O)C2=NC3=C(N2)C=C(C=C3)Cl D00XJR HIGHSTAT Investigative D00XKA DRUG__ID D00XKA D00XKA DRUGTYPE Small molecular drug D00XKA DRUGINCH 1S/C25H36N2O2S.ClH/c1-24(2,3)20-16-19(17-21(23(20)29)25(4,5)6)30-15-12-22(28)27(7)14-11-18-10-8-9-13-26-18;/h8-10,13,16-17,29H,11-12,14-15H2,1-7H3;1H D00XKA DRUGINKE MCQQQXHGLCUPHW-UHFFFAOYSA-N D00XKA DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SCCC(=O)N(C)CCC2=CC=CC=N2.Cl D00XKA HIGHSTAT Investigative D00XKH DRUG__ID D00XKH D00XKH DRUGTYPE Small molecular drug D00XKH DRUGINCH 1S/C15H26N4O8S/c1-2-3-6-19(27)15(26)28-8-10(13(23)17-7-12(21)22)18-11(20)5-4-9(16)14(24)25/h9-10,27H,2-8,16H2,1H3,(H,17,23)(H,18,20)(H,21,22)(H,24,25)/t9-,10-/m0/s1 D00XKH DRUGINKE JHOFGABPPOTPEX-UWVGGRQHSA-N D00XKH DRUGSMIL CCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D00XKH HIGHSTAT Investigative D00XKM DRUG__ID D00XKM D00XKM DRUGTYPE Small molecular drug D00XKM DRUGINCH 1S/C10H12O3/c11-9(6-7-10(12)13)8-4-2-1-3-5-8/h1-5,9,11H,6-7H2,(H,12,13) D00XKM DRUGINKE OGQGIKZPOBBMNO-UHFFFAOYSA-N D00XKM DRUGSMIL C1=CC=C(C=C1)C(CCC(=O)O)O D00XKM HIGHSTAT Investigative D00XLU DRUG__ID D00XLU D00XLU DRUGTYPE Small molecular drug D00XLU DRUGINCH 1S/C19H17NO3S/c21-18-11-13-19(14-12-18)24(22,23)20(17-9-5-2-6-10-17)15-16-7-3-1-4-8-16/h1-14,21H,15H2 D00XLU DRUGINKE IXILNJSCQSTWEB-UHFFFAOYSA-N D00XLU DRUGSMIL C1=CC=C(C=C1)CN(C2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)O D00XLU HIGHSTAT Investigative D00XMO DRUG__ID D00XMO D00XMO DRUGTYPE Small molecular drug D00XMO DRUGINCH 1S/C14H17ClO/c1-2-16-14-5-3-4-12(14)10-11-6-8-13(15)9-7-11/h6-10,14H,2-5H2,1H3/b12-10+ D00XMO DRUGINKE VORGMCXCJIDOMV-ZRDIBKRKSA-N D00XMO DRUGSMIL CCOC1CCCC1=CC2=CC=C(C=C2)Cl D00XMO HIGHSTAT Investigative D00XMP DRUG__ID D00XMP D00XMP DRUGTYPE Small molecular drug D00XMP DRUGINCH 1S/C13H20N2/c1-12(13-6-4-3-5-7-13)15-10-8-14(2)9-11-15/h3-7,12H,8-11H2,1-2H3 D00XMP DRUGINKE CQTKDGNXBCFBTR-UHFFFAOYSA-N D00XMP DRUGSMIL CC(C1=CC=CC=C1)N2CCN(CC2)C D00XMP HIGHSTAT Investigative D00XNF DRUG__ID D00XNF D00XNF DRUGTYPE Small molecular drug D00XNF DRUGINCH 1S/C19H27NO2S/c1-18(2,3)13-8-12(9-14(16(13)21)19(4,5)6)10-15-17(22)20(7)11-23-15/h8-10,21H,11H2,1-7H3/b15-10- D00XNF DRUGINKE IXCMEASJCGKKQS-GDNBJRDFSA-N D00XNF DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)N(CS2)C D00XNF HIGHSTAT Investigative D00XNY DRUG__ID D00XNY D00XNY DRUGTYPE Small molecular drug D00XNY DRUGINCH 1S/C6H8N2O2.ClH/c9-6-4-1-2-7-3-5(4)10-8-6;/h7H,1-3H2,(H,8,9);1H D00XNY DRUGINKE ZDZDSZQYRBZPNN-UHFFFAOYSA-N D00XNY DRUGSMIL C1CNCC2=C1C(=O)NO2.Cl D00XNY HIGHSTAT Investigative D00XOQ DRUG__ID D00XOQ D00XOQ DRUGTYPE Small molecular drug D00XOQ DRUGINCH 1S/C21H23FN4O/c22-19-4-2-17(3-5-19)20-21(18-6-8-23-9-7-18)26(16-24-20)11-1-10-25-12-14-27-15-13-25/h2-9,16H,1,10-15H2 D00XOQ DRUGINKE ANWALZPQHPAZFO-UHFFFAOYSA-N D00XOQ DRUGSMIL C1COCCN1CCCN2C=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F D00XOQ HIGHSTAT Investigative D00XOT DRUG__ID D00XOT D00XOT DRUGTYPE Small molecular drug D00XOT DRUGINCH 1S/C12H12O3/c13-7-8-15-12-6-5-11(14)9-3-1-2-4-10(9)12/h1-6,13-14H,7-8H2 D00XOT DRUGINKE PABAILNRYWRUQG-UHFFFAOYSA-N D00XOT DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2OCCO)O D00XOT HIGHSTAT Investigative D00XOV DRUG__ID D00XOV D00XOV DRUGTYPE Small molecular drug D00XOV DRUGINCH 1S/C44H51N5O8/c1-30-19-21-33(22-20-30)28-55-34-26-37(40(50)48-39(18-10-11-25-45)44(53,54)42-46-35-16-8-9-17-38(35)57-42)49(27-34)41(51)36(24-23-31-12-4-2-5-13-31)47-43(52)56-29-32-14-6-3-7-15-32/h2-9,12-17,19-22,34,36-37,39,53-54H,10-11,18,23-29,45H2,1H3,(H,47,52)(H,48,50)/t34-,36-,37+,39+/m1/s1 D00XOV DRUGINKE KGNDCEVUMONOKF-UGPLYTSKSA-N D00XOV DRUGSMIL CC1=CC=C(C=C1)COC2CC(N(C2)C(=O)C(CCC3=CC=CC=C3)NC(=O)OCC4=CC=CC=C4)C(=O)NC(CCCCN)C(C5=NC6=CC=CC=C6O5)(O)O D00XOV HIGHSTAT Investigative D00XPB DRUG__ID D00XPB D00XPB DRUGTYPE Small molecular drug D00XPB DRUGINCH 1S/C24H22BrNO.ClH/c1-3-16-26(2)17-18-4-6-19(7-5-18)20-8-10-21(11-9-20)24(27)22-12-14-23(25)15-13-22;/h3-15H,1,16-17H2,2H3;1H D00XPB DRUGINKE MCMDJJBPNGLKKM-UHFFFAOYSA-N D00XPB DRUGSMIL CN(CC=C)CC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)Br.Cl D00XPB HIGHSTAT Investigative D00XQV DRUG__ID D00XQV D00XQV DRUGTYPE Small molecular drug D00XQV DRUGINCH 1S/C28H35N5O5/c29-21(16-19-10-12-20(34)13-11-19)27(37)33-15-5-9-24(33)26(36)31-22(17-18-6-2-1-3-7-18)28(38)32-14-4-8-23(32)25(30)35/h1-3,6-7,10-13,21-24,34H,4-5,8-9,14-17,29H2,(H2,30,35)(H,31,36)/t21?,22-,23?,24?/m1/s1 D00XQV DRUGINKE LSQXZIUREIDSHZ-NJEQKKOJSA-N D00XQV DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D00XQV HIGHSTAT Investigative D00XRH DRUG__ID D00XRH D00XRH DRUGTYPE Small molecular drug D00XRH DRUGINCH 1S/C20H23N5O2/c1-12-7-16-17(13-8-15(27-2)10-22-9-13)11-23-19(18(16)25-20(12)26)24-14-3-5-21-6-4-14/h7-11,14,21H,3-6H2,1-2H3,(H,23,24)(H,25,26) D00XRH DRUGINKE FPQQERRFPULCIK-UHFFFAOYSA-N D00XRH DRUGSMIL CC1=CC2=C(C(=NC=C2C3=CC(=CN=C3)OC)NC4CCNCC4)NC1=O D00XRH HIGHSTAT Investigative D00XTC DRUG__ID D00XTC D00XTC DRUGTYPE Small molecular drug D00XTC DRUGINCH 1S/C30H37N5O4S2/c1-20-28(38)35-18-9-13-24(35)27(37)33-23(12-3-2-8-19-40-41-25-14-6-7-17-31-25)26(36)34-30(29(39)32-20)16-15-21-10-4-5-11-22(21)30/h4-7,10-11,14,17,20,23-24H,2-3,8-9,12-13,15-16,18-19H2,1H3,(H,32,39)(H,33,37)(H,34,36)/t20-,23-,24+,30+/m0/s1 D00XTC DRUGINKE ZGCIQVPLYZBUHQ-AEPSZFNXSA-N D00XTC DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CCC4=CC=CC=C43)C(=O)N1)CCCCCSSC5=CC=CC=N5 D00XTC HIGHSTAT Investigative D00XUE DRUG__ID D00XUE D00XUE DRUGTYPE Small molecular drug D00XUE DRUGINCH 1S/C9H17NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h7-8H,1-6,10H2,(H,11,12)/t8-/m0/s1 D00XUE DRUGINKE ORQXBVXKBGUSBA-QMMMGPOBSA-N D00XUE DRUGSMIL C1CCC(CC1)CC(C(=O)O)N D00XUE HIGHSTAT Investigative D00XUF DRUG__ID D00XUF D00XUF DRUGTYPE Small molecular drug D00XUF DRUGINCH 1S/C17H16N6O/c1-2-3-7-13(24)21-16-14-17(20-10-19-16)23-15(22-14)12-6-4-5-11(8-12)9-18/h4-6,8,10H,2-3,7H2,1H3,(H2,19,20,21,22,23,24) D00XUF DRUGINKE FKLAKSOWIZORFH-UHFFFAOYSA-N D00XUF DRUGSMIL CCCCC(=O)NC1=NC=NC2=C1NC(=N2)C3=CC=CC(=C3)C#N D00XUF HIGHSTAT Investigative D00XVS DRUG__ID D00XVS D00XVS DRUGTYPE Small molecular drug D00XVS DRUGINCH 1S/C30H46O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h20-23,31H,1,8-17H2,2-7H3,(H,32,33)/t20-,21+,22-,23+,27+,28-,29-,30+/m1/s1 D00XVS DRUGINKE DZVARQVBYAEZFI-JZQYXDLISA-N D00XVS DRUGSMIL CC1=C2C3CCC4C5(CCC(C(C5CCC4(C3(CCC2(CCC1=C)C(=O)O)C)C)(C)C)O)C D00XVS HIGHSTAT Investigative D00XVV DRUG__ID D00XVV D00XVV DRUGTYPE Small molecular drug D00XVV DRUGINCH 1S/C25H34N4O2/c1-31-23-12-6-5-11-22(23)28-18-15-27(16-19-28)17-20-29(24-13-7-8-14-26-24)25(30)21-9-3-2-4-10-21/h5-8,11-14,21H,2-4,9-10,15-20H2,1H3/i25-1 D00XVV DRUGINKE SBPRIAGPYFYCRT-FNNGWQQSSA-N D00XVV DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4 D00XVV HIGHSTAT Investigative D00XZH DRUG__ID D00XZH D00XZH DRUGTYPE Small molecular drug D00XZH DRUGINCH 1S/C21H27NO/c1-17(2)21(23)13-15-22(16-14-21)20(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17,20,23H,13-16H2,1-2H3 D00XZH DRUGINKE BOIJUJOJZXIYHU-UHFFFAOYSA-N D00XZH DRUGSMIL CC(C)C1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O D00XZH HIGHSTAT Investigative D00XZZ DRUG__ID D00XZZ D00XZZ DRUGTYPE Small molecular drug D00XZZ DRUGINCH 1S/C16H18N2O/c1-2-3-5-13-7-9-14(10-8-13)16(19)18-15-6-4-11-17-12-15/h4,6-12H,2-3,5H2,1H3,(H,18,19) D00XZZ DRUGINKE KDHOWTVYQKITMO-UHFFFAOYSA-N D00XZZ DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 D00XZZ HIGHSTAT Investigative D00YAZ DRUG__ID D00YAZ D00YAZ DRUGTYPE Small molecular drug D00YAZ DRUGINCH 1S/C18H20FNO3S/c19-14-4-2-1-3-13(14)17(18(23)11-5-6-11)20-8-7-15(24)12(10-20)9-16(21)22/h1-4,9,11,15,17,24H,5-8,10H2,(H,21,22)/b12-9- D00YAZ DRUGINKE ZWUQVNSJSJHFPS-XFXZXTDPSA-N D00YAZ DRUGSMIL C1CC1C(=O)C(C2=CC=CC=C2F)N3CCC(C(=CC(=O)O)C3)S D00YAZ HIGHSTAT Investigative D00YBU DRUG__ID D00YBU D00YBU DRUGTYPE Small molecular drug D00YBU DRUGINCH 1S/C30H38N8O7/c31-30(32)33-13-7-12-20-26(42)34-17-24(39)35-23(16-25(40)41)29(45)38-22(15-19-10-5-2-6-11-19)28(44)37-21(27(43)36-20)14-18-8-3-1-4-9-18/h1-6,8-11,20-23H,7,12-17H2,(H,34,42)(H,35,39)(H,36,43)(H,37,44)(H,38,45)(H,40,41)(H4,31,32,33)/t20-,21-,22+,23-/m0/s1 D00YBU DRUGINKE VYLBOUQMYNRGBR-GPJHCHHRSA-N D00YBU DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CC=CC=C2)CC3=CC=CC=C3)CC(=O)O D00YBU HIGHSTAT Investigative D00YCG DRUG__ID D00YCG D00YCG DRUGTYPE Small molecular drug D00YCG DRUGINCH 1S/C14H14N2O/c1-2-8-16(7-1)9-10-17-13-3-4-14-12(11-13)5-6-15-14/h1-8,11,15H,9-10H2 D00YCG DRUGINKE NSZDJRLPCLOQAM-UHFFFAOYSA-N D00YCG DRUGSMIL C1=CN(C=C1)CCOC2=CC3=C(C=C2)NC=C3 D00YCG HIGHSTAT Investigative D00YCO DRUG__ID D00YCO D00YCO DRUGTYPE Small molecular drug D00YCO DRUGINCH 1S/C47H66O13/c1-29-20-19-21-31(3)42(53)38(50)24-17-11-10-12-18-25-40(60-41(52)27-26-30(2)39(51)28-29)33(5)43(54)32(4)36(48)22-15-13-14-16-23-37(49)34(6)58-47-46(57-9)44(55)45(56-8)35(7)59-47/h10-24,26,28,32-35,37-40,43-47,49-51,54-55H,25,27H2,1-9H3/b11-10+,14-13+,18-12+,20-19+,22-15+,23-16+,24-17+,29-28+,30-26-,31-21+/t32?,33?,34?,35-,37?,38?,39?,40?,43?,44+,45+,46-,47-/m1/s1 D00YCO DRUGINKE FXSFWUNCIOIMAC-YHQXOMPPSA-N D00YCO DRUGSMIL CC1C(C(C(C(O1)OC(C)C(C=CC=CC=CC(=O)C(C)C(C(C)C2CC=CC=CC=CC(C(=O)C(=CC=CC(=CC(C(=CCC(=O)O2)C)O)C)C)O)O)O)OC)O)OC D00YCO HIGHSTAT Investigative D00YCU DRUG__ID D00YCU D00YCU DRUGTYPE Small molecular drug D00YCU DRUGINCH 1S/C13H10N2O/c16-11-6-7-13-12(8-11)14-9-15(13)10-4-2-1-3-5-10/h1-9,16H D00YCU DRUGINKE OQAPWZCMAFFBBL-UHFFFAOYSA-N D00YCU DRUGSMIL C1=CC=C(C=C1)N2C=NC3=C2C=CC(=C3)O D00YCU HIGHSTAT Investigative D00YCW DRUG__ID D00YCW D00YCW DRUGTYPE Small molecular drug D00YCW DRUGINCH 1S/C21H27NO/c1-2-9-20(18-10-5-3-6-11-18)22-16-14-21(23,15-17-22)19-12-7-4-8-13-19/h3-8,10-13,20,23H,2,9,14-17H2,1H3 D00YCW DRUGINKE HVKSQGJIDXVAKX-UHFFFAOYSA-N D00YCW DRUGSMIL CCCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D00YCW HIGHSTAT Investigative D00YDR DRUG__ID D00YDR D00YDR DRUGTYPE Small molecular drug D00YDR DRUGINCH 1S/C22H29N3O2/c1-23-9-7-15-11-14-12-22(21(26)27-2)19-17(8-10-25(13-14)20(15)22)16-5-3-4-6-18(16)24-19/h3-6,14-15,20,23-24H,7-13H2,1-2H3/t14?,15-,20-,22+/m0/s1 D00YDR DRUGINKE YKMOJVPLIUXEIP-JNBMDGLNSA-N D00YDR DRUGSMIL CNCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC D00YDR HIGHSTAT Investigative D00YEB DRUG__ID D00YEB D00YEB DRUGTYPE Small molecular drug D00YEB DRUGINCH 1S/C23H27NO2/c1-3-7-21(25)26-20-11-6-9-17-15-19-22-16(12-14-24(19)13-4-2)8-5-10-18(22)23(17)20/h5-6,8-11,19H,3-4,7,12-15H2,1-2H3/t19-/m1/s1 D00YEB DRUGINKE PSFOXKHONDMYHK-LJQANCHMSA-N D00YEB DRUGSMIL CCCC(=O)OC1=CC=CC2=C1C3=CC=CC4=C3C(C2)N(CC4)CCC D00YEB HIGHSTAT Investigative D00YEF DRUG__ID D00YEF D00YEF DRUGTYPE Small molecular drug D00YEF DRUGINCH 1S/C10H24N2O6S2/c11-19(13,14)17-9-7-5-3-1-2-4-6-8-10-18-20(12,15)16/h1-10H2,(H2,11,13,14)(H2,12,15,16) D00YEF DRUGINKE XPDWKENHTJHZSC-UHFFFAOYSA-N D00YEF DRUGSMIL C(CCCCCOS(=O)(=O)N)CCCCOS(=O)(=O)N D00YEF HIGHSTAT Investigative D00YGP DRUG__ID D00YGP D00YGP DRUGTYPE Small molecular drug D00YGP DRUGINCH 1S/C15H10O5/c16-10-1-2-14-9(5-10)6-13(15(19)20-14)8-3-11(17)7-12(18)4-8/h1-7,16-18H D00YGP DRUGINKE DKFCOAXLNVHDTF-UHFFFAOYSA-N D00YGP DRUGSMIL C1=CC2=C(C=C1O)C=C(C(=O)O2)C3=CC(=CC(=C3)O)O D00YGP HIGHSTAT Investigative D00YHD DRUG__ID D00YHD D00YHD DRUGTYPE Small molecular drug D00YHD DRUGINCH 1S/C21H21NO/c1-15(2)21(18-10-12-22-13-11-18)17-8-6-16(7-9-17)19-4-3-5-20(23)14-19/h3-15,21,23H,1-2H3 D00YHD DRUGINKE YNPHCSJZYQIGGU-UHFFFAOYSA-N D00YHD DRUGSMIL CC(C)C(C1=CC=C(C=C1)C2=CC(=CC=C2)O)C3=CC=NC=C3 D00YHD HIGHSTAT Investigative D00YHI DRUG__ID D00YHI D00YHI DRUGTYPE Small molecular drug D00YHI DRUGINCH 1S/C20H25NO3/c1-13(2)11-21-9-8-20-7-6-15(22)10-17(20)24-19-16(23-3)5-4-14(12-21)18(19)20/h4-7,15,17,22H,1,8-12H2,2-3H3/t15-,17-,20-/m0/s1 D00YHI DRUGINKE FEKQBPRIVQKBRM-KNBMTAEXSA-N D00YHI DRUGSMIL CC(=C)CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O D00YHI HIGHSTAT Investigative D00YIS DRUG__ID D00YIS D00YIS DRUGTYPE Small molecular drug D00YIS DRUGINCH 1S/C14H15O7PS/c15-22(16,17)14(23(18,19)20)10-11-5-4-8-13(9-11)21-12-6-2-1-3-7-12/h1-9,14H,10H2,(H2,15,16,17)(H,18,19,20)/p-3 D00YIS DRUGINKE QZTDQEVQGQAOKB-UHFFFAOYSA-K D00YIS DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CC(P(=O)([O-])[O-])S(=O)(=O)[O-] D00YIS HIGHSTAT Investigative D00YNA DRUG__ID D00YNA D00YNA DRUGTYPE Small molecular drug D00YNA DRUGINCH 1S/C15H11NO2S/c17-12-5-1-3-10(7-12)14-9-16-15(19-14)11-4-2-6-13(18)8-11/h1-9,17-18H D00YNA DRUGINKE OYFRXCWZMBHNHW-UHFFFAOYSA-N D00YNA DRUGSMIL C1=CC(=CC(=C1)O)C2=CN=C(S2)C3=CC(=CC=C3)O D00YNA HIGHSTAT Investigative D00YNI DRUG__ID D00YNI D00YNI DRUGTYPE Small molecular drug D00YNI DRUGINCH 1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m0/s1 D00YNI DRUGINKE HSUGRBWQSSZJOP-LEWJYISDSA-N D00YNI DRUGSMIL CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC D00YNI HIGHSTAT Investigative D00YNW DRUG__ID D00YNW D00YNW DRUGTYPE Small molecular drug D00YNW DRUGINCH 1S/C28H45N7O6/c1-8-10-11-12-13-34(7)16-22(36)19(14-24(37)38)30-26(39)21(9-2)35-17-23(28(4,5)6)31-25(27(35)40)29-15-20-18(3)32-41-33-20/h17,19,21H,8-16H2,1-7H3,(H,29,31)(H,30,39)(H,37,38) D00YNW DRUGINKE XIMITGPWYYFUQF-UHFFFAOYSA-N D00YNW DRUGSMIL CCCCCCN(C)CC(=O)C(CC(=O)O)NC(=O)C(CC)N1C=C(N=C(C1=O)NCC2=NON=C2C)C(C)(C)C D00YNW HIGHSTAT Investigative D00YOM DRUG__ID D00YOM D00YOM DRUGTYPE Small molecular drug D00YOM DRUGINCH 1S/C16H14N2O/c1-11-7-8-14-15(19)13(10-17-16(14)18-11)9-12-5-3-2-4-6-12/h2-8,10H,9H2,1H3,(H,17,18,19) D00YOM DRUGINKE QRUPNIJLOWMQBO-UHFFFAOYSA-N D00YOM DRUGSMIL CC1=NC2=C(C=C1)C(=O)C(=CN2)CC3=CC=CC=C3 D00YOM HIGHSTAT Investigative D00YPH DRUG__ID D00YPH D00YPH DRUGTYPE Small molecular drug D00YPH DRUGINCH 1S/C16H11NO3/c18-15-13(16(19)20)11-8-4-5-9-12(11)17-14(15)10-6-2-1-3-7-10/h1-9,18H,(H,19,20) D00YPH DRUGINKE XAPRFLSJBSXESP-UHFFFAOYSA-N D00YPH DRUGSMIL C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2O)C(=O)O D00YPH HIGHSTAT Investigative D00YPO DRUG__ID D00YPO D00YPO DRUGTYPE Small molecular drug D00YPO DRUGINCH 1S/C18H20N4O/c1-12-10-17(23)20-21-18(12)13-6-8-14(9-7-13)22-11-19-15-4-2-3-5-16(15)22/h6-9,11-12H,2-5,10H2,1H3,(H,20,23) D00YPO DRUGINKE KDEKNYKHIZTSLE-UHFFFAOYSA-N D00YPO DRUGSMIL CC1CC(=O)NN=C1C2=CC=C(C=C2)N3C=NC4=C3CCCC4 D00YPO HIGHSTAT Investigative D00YTQ DRUG__ID D00YTQ D00YTQ DRUGTYPE Small molecular drug D00YTQ DRUGINCH 1S/C14H17N5.ClH/c1-9-3-4-11-12(7-9)19-10(2)8-17-14(19)13(18-11)16-6-5-15;/h3-4,7-8H,5-6,15H2,1-2H3,(H,16,18);1H D00YTQ DRUGINKE MIDKPVLYXNLFGZ-UHFFFAOYSA-N D00YTQ DRUGSMIL CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN.Cl D00YTQ HIGHSTAT Investigative D00YUO DRUG__ID D00YUO D00YUO DRUGTYPE Small molecular drug D00YUO DRUGINCH 1S/C8H9BINO3/c10-5-8(12)11-7-3-1-2-6(4-7)9(13)14/h1-4,13-14H,5H2,(H,11,12) D00YUO DRUGINKE LMHXPDZPXBIIEX-UHFFFAOYSA-N D00YUO DRUGSMIL B(C1=CC(=CC=C1)NC(=O)CI)(O)O D00YUO HIGHSTAT Investigative D00YUX DRUG__ID D00YUX D00YUX DRUGTYPE Small molecular drug D00YUX DRUGINCH 1S/C65H95N19O22S4/c1-29(2)18-37-63(104)84-17-7-10-46(84)65(106)83-16-6-9-45(83)62(103)81-42-27-110-108-26-41(72-49(89)23-66)59(100)80-43(60(101)78-39(24-85)57(98)76-37)28-109-107-25-40(51(69)92)79-54(95)34(19-32-11-13-33(86)14-12-32)74-56(97)36(22-50(90)91)75-61(102)44-8-5-15-82(44)64(105)38(21-48(68)88)77-55(96)35(20-47(67)87)73-53(94)31(4)70-52(93)30(3)71-58(42)99/h11-14,29-31,34-46,85-86H,5-10,15-28,66H2,1-4H3,(H2,67,87)(H2,68,88)(H2,69,92)(H,70,93)(H,71,99)(H,72,89)(H,73,94)(H,74,97)(H,75,102)(H,76,98)(H,77,96)(H,78,101)(H,79,95)(H,80,100)(H,81,103)(H,90,91)/t30-,31-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1 D00YUX DRUGINKE VUVGEYBNLLGGBG-MVPSLEAZSA-N D00YUX DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(CSSCC3C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CSSCC(C(=O)N3)NC(=O)CN)C(=O)NC(C(=O)N1)C)CC(C)C)CO)C(=O)N)CC6=CC=C(C=C6)O)CC(=O)O)CC(=O)N)CC(=O)N D00YUX HIGHSTAT Investigative D00YVE DRUG__ID D00YVE D00YVE DRUGTYPE Small molecular drug D00YVE DRUGINCH 1S/C13H15N/c1-10(14)8-11-6-7-12-4-2-3-5-13(12)9-11/h2-7,9-10H,8,14H2,1H3 D00YVE DRUGINKE UPQSZFKXKRKCGZ-UHFFFAOYSA-N D00YVE DRUGSMIL CC(CC1=CC2=CC=CC=C2C=C1)N D00YVE HIGHSTAT Investigative D00YVJ DRUG__ID D00YVJ D00YVJ DRUGTYPE Small molecular drug D00YVJ DRUGINCH 1S/C25H36F2N4O8/c1-12(2)20(25(38)39)30-22(35)13(3)29-24(37)21(14(4)32)31-23(36)18(7-8-19(33)34)28-10-9-15-5-6-16(26)17(27)11-15/h5-6,11-14,18,20-21,28,32H,7-10H2,1-4H3,(H,29,37)(H,30,35)(H,31,36)(H,33,34)(H,38,39)/t13-,14?,18-,20-,21-/m0/s1 D00YVJ DRUGINKE VPSVLXPCERTAAH-WHJBMRRRSA-N D00YVJ DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCC1=CC(=C(C=C1)F)F D00YVJ HIGHSTAT Investigative D00YWZ DRUG__ID D00YWZ D00YWZ DRUGTYPE Small molecular drug D00YWZ DRUGINCH 1S/C13H11N3S/c14-9-3-1-8(2-4-9)10-7-17-11-5-6-16-13(15)12(10)11/h1-7H,14H2,(H2,15,16) D00YWZ DRUGINKE RSUCBZJSTXEGSF-UHFFFAOYSA-N D00YWZ DRUGSMIL C1=CC(=CC=C1C2=CSC3=C2C(=NC=C3)N)N D00YWZ HIGHSTAT Investigative D00YXE DRUG__ID D00YXE D00YXE DRUGTYPE Small molecular drug D00YXE DRUGINCH 1S/C15H9ClN4/c16-9-5-6-12-13(7-9)20-15(19-12)14-8-17-10-3-1-2-4-11(10)18-14/h1-8H,(H,19,20) D00YXE DRUGINKE SOUPHJBGFDZRAD-UHFFFAOYSA-N D00YXE DRUGSMIL C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=C(C=C4)Cl D00YXE HIGHSTAT Investigative D00YXR DRUG__ID D00YXR D00YXR DRUGCOMP WntResearch AB D00YXR DRUGINCH 1S/C26H42N6O12S2/c1-13(2)8-17(26(43)44)32-24(41)15(4-5-20(35)36)30-25(42)18(11-45)29-19(34)10-27-22(39)16(9-21(37)38)31-23(40)14(28-12-33)6-7-46-3/h12-18,45H,4-11H2,1-3H3,(H,27,39)(H,28,33)(H,29,34)(H,30,42)(H,31,40)(H,32,41)(H,35,36)(H,37,38)(H,43,44)/t14-,15-,16-,17-,18-/m0/s1 D00YXR DRUGINKE WFZPJYYCTSHDJI-ATIWLJMLSA-N D00YXR DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CS)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC=O D00YXR HIGHSTAT Investigative D00ZAJ DRUG__ID D00ZAJ D00ZAJ DRUGTYPE Small molecular drug D00ZAJ DRUGINCH 1S/C13H12N4/c1-17-11-7-10(9-5-3-2-4-6-9)8-15-12(11)16-13(17)14/h2-8H,1H3,(H2,14,15,16) D00ZAJ DRUGINKE UQVKZNNCIHJZLS-UHFFFAOYSA-N D00ZAJ DRUGSMIL CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1N D00ZAJ HIGHSTAT Investigative D00ZBH DRUG__ID D00ZBH D00ZBH DRUGTYPE Small molecular drug D00ZBH DRUGINCH 1S/C7H8FO3PS/c8-6-3-1-5(2-4-6)7(13)12(9,10)11/h1-4,7,13H,(H2,9,10,11) D00ZBH DRUGINKE SWPCIELITKHGKY-UHFFFAOYSA-N D00ZBH DRUGSMIL C1=CC(=CC=C1C(P(=O)(O)O)S)F D00ZBH HIGHSTAT Investigative D00ZBL DRUG__ID D00ZBL D00ZBL DRUGTYPE Small molecular drug D00ZBL DRUGINCH 1S/C16H13NO3/c1-2-3-11-8-13(19)9-14-15(11)20-16(17-14)10-4-6-12(18)7-5-10/h2,4-9,18-19H,1,3H2 D00ZBL DRUGINKE XQORYXRHJJULMI-UHFFFAOYSA-N D00ZBL DRUGSMIL C=CCC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D00ZBL HIGHSTAT Investigative D00ZCU DRUG__ID D00ZCU D00ZCU DRUGTYPE Small molecular drug D00ZCU DRUGINCH 1S/C16H18N2OS.ClH/c1-11(17)7-12-9-18-16-5-4-13(8-15(12)16)19-10-14-3-2-6-20-14;/h2-6,8-9,11,18H,7,10,17H2,1H3;1H D00ZCU DRUGINKE PYJBJMIBANAOFJ-UHFFFAOYSA-N D00ZCU DRUGSMIL CC(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CS3)N.Cl D00ZCU HIGHSTAT Investigative D00ZDX DRUG__ID D00ZDX D00ZDX DRUGTYPE Small molecular drug D00ZDX DRUGINCH 1S/C22H28FNO4/c1-15-18(27-12-9-24-7-10-26-11-8-24)13-19-20(21(15)23)22(25)17(14-28-19)16-5-3-2-4-6-16/h13-14,16H,2-12H2,1H3 D00ZDX DRUGINKE PHQKNLJAPYWXQQ-UHFFFAOYSA-N D00ZDX DRUGSMIL CC1=C(C=C2C(=C1F)C(=O)C(=CO2)C3CCCCC3)OCCN4CCOCC4 D00ZDX HIGHSTAT Investigative D00ZEY DRUG__ID D00ZEY D00ZEY DRUGTYPE Small molecular drug D00ZEY DRUGINCH 1S/C21H23BrN2OS/c1-3-12-24(2)13-4-5-14-25-18-10-11-19-20(15-18)26-23-21(19)16-6-8-17(22)9-7-16/h3,6-11,15H,1,4-5,12-14H2,2H3 D00ZEY DRUGINKE PDHRIPJKNGUCJP-UHFFFAOYSA-N D00ZEY DRUGSMIL CN(CCCCOC1=CC2=C(C=C1)C(=NS2)C3=CC=C(C=C3)Br)CC=C D00ZEY HIGHSTAT Investigative D00ZGW DRUG__ID D00ZGW D00ZGW DRUGTYPE Small molecular drug D00ZGW DRUGINCH 1S/C18H19ClN4O/c1-4-23-17-14(10-22-23)16(19)15(9-20-17)18(24)21-8-13-6-5-11(2)7-12(13)3/h5-7,9-10H,4,8H2,1-3H3,(H,21,24) D00ZGW DRUGINKE XLMANSLWCIMZAE-UHFFFAOYSA-N D00ZGW DRUGSMIL CCN1C2=NC=C(C(=C2C=N1)Cl)C(=O)NCC3=C(C=C(C=C3)C)C D00ZGW HIGHSTAT Investigative D00ZIK DRUG__ID D00ZIK D00ZIK DRUGTYPE Small molecular drug D00ZIK DRUGINCH 1S/C22H19N7O/c1-13-6-3-4-9-16(13)29-17(27-15-8-5-7-14(2)18(15)22(29)30)10-28-12-26-19-20(23)24-11-25-21(19)28/h3-9,11-12H,10H2,1-2H3,(H2,23,24,25) D00ZIK DRUGINKE GNWHRHGTIBRNSM-UHFFFAOYSA-N D00ZIK DRUGSMIL CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C(N=CN=C54)N D00ZIK HIGHSTAT Investigative D00ZJG DRUG__ID D00ZJG D00ZJG DRUGTYPE Small molecular drug D00ZJG DRUGINCH 1S/C23H30FO5P/c1-14(2)20-9-15(3)10-21(17-5-6-22(24)16(4)11-17)19(20)7-8-30(28,29)13-18(25)12-23(26)27/h5-6,9-11,14,18,25H,7-8,12-13H2,1-4H3,(H,26,27)(H,28,29)/t18-/m0/s1 D00ZJG DRUGINKE IZGDXVLRMHXOJV-SFHVURJKSA-N D00ZJG DRUGSMIL CC1=CC(=C(C(=C1)C(C)C)CCP(=O)(CC(CC(=O)O)O)O)C2=CC(=C(C=C2)F)C D00ZJG HIGHSTAT Investigative D00ZKW DRUG__ID D00ZKW D00ZKW DRUGTYPE Small molecular drug D00ZKW DRUGINCH 1S/C8H17N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h7,9H,1-6H2,(H,11,12)(H2,13,14,15) D00ZKW DRUGINKE CUVGUPIVTLGRGI-UHFFFAOYSA-N D00ZKW DRUGSMIL C1CN(CC(N1)C(=O)O)CCCP(=O)(O)O D00ZKW HIGHSTAT Investigative D00ZME DRUG__ID D00ZME D00ZME DRUGTYPE Small molecular drug D00ZME DRUGINCH 1S/C18H16N2/c1-13(20-9-8-19-12-20)14-6-7-18-16(10-14)11-15-4-2-3-5-17(15)18/h2-10,12-13H,11H2,1H3 D00ZME DRUGINKE QOKBMECMKDLYIV-UHFFFAOYSA-N D00ZME DRUGSMIL CC(C1=CC2=C(C=C1)C3=CC=CC=C3C2)N4C=CN=C4 D00ZME HIGHSTAT Investigative D00ZMK DRUG__ID D00ZMK D00ZMK DRUGTYPE Small molecular drug D00ZMK DRUGINCH 1S/C39H51N5O6S/c1-24-18-28(43(6)17-16-40-5)19-25(2)35(24)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(3,4)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40,45,47H,16-17,20-23H2,1-6H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1 D00ZMK DRUGINKE LDLOTPBPEFKMMQ-SQKWSBCUSA-N D00ZMK DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)N(C)CCNC D00ZMK HIGHSTAT Investigative D00ZMS DRUG__ID D00ZMS D00ZMS DRUGTYPE Small molecular drug D00ZMS DRUGINCH 1S/C6H17NO6P2/c1-3-5(2)7-4-6(14(8,9)10)15(11,12)13/h5-7H,3-4H2,1-2H3,(H2,8,9,10)(H2,11,12,13) D00ZMS DRUGINKE BDBDLQIJTHDVGZ-UHFFFAOYSA-N D00ZMS DRUGSMIL CCC(C)NCC(P(=O)(O)O)P(=O)(O)O D00ZMS HIGHSTAT Investigative D00ZMY DRUG__ID D00ZMY D00ZMY DRUGTYPE Small molecular drug D00ZMY DRUGINCH 1S/C20H22O2/c21-20(14-16-8-3-1-4-9-16)22-19-13-7-12-18(15-19)17-10-5-2-6-11-17/h2,5-7,10-13,15-16H,1,3-4,8-9,14H2 D00ZMY DRUGINKE VBMZBWIWRKLCHP-UHFFFAOYSA-N D00ZMY DRUGSMIL C1CCC(CC1)CC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D00ZMY HIGHSTAT Investigative D00ZPJ DRUG__ID D00ZPJ D00ZPJ DRUGTYPE Small molecular drug D00ZPJ DRUGINCH 1S/C19H14ClN3O/c1-24-14-5-7-17-16(10-14)19(22-13-3-2-8-21-11-13)15-6-4-12(20)9-18(15)23-17/h2-11H,1H3,(H,22,23) D00ZPJ DRUGINKE LUUDYHCKONVRQY-UHFFFAOYSA-N D00ZPJ DRUGSMIL COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CN=CC=C4 D00ZPJ HIGHSTAT Investigative D00ZSD DRUG__ID D00ZSD D00ZSD DRUGTYPE Small molecular drug D00ZSD DRUGINCH 1S/C12H17NO3S/c14-12(13-15)9-5-2-6-10-17(16)11-7-3-1-4-8-11/h1,3-4,7-8,15H,2,5-6,9-10H2,(H,13,14) D00ZSD DRUGINKE LIZWRHXVIWNMIS-UHFFFAOYSA-N D00ZSD DRUGSMIL C1=CC=C(C=C1)S(=O)CCCCCC(=O)NO D00ZSD HIGHSTAT Investigative D00ZUQ DRUG__ID D00ZUQ D00ZUQ DRUGTYPE Small molecular drug D00ZUQ DRUGINCH 1S/C11H15NO4S/c1-2-16-11(13)8-5-9-3-6-10(7-4-9)17(12,14)15/h3-4,6-7H,2,5,8H2,1H3,(H2,12,14,15) D00ZUQ DRUGINKE OJBJALUJMRMNIR-UHFFFAOYSA-N D00ZUQ DRUGSMIL CCOC(=O)CCC1=CC=C(C=C1)S(=O)(=O)N D00ZUQ HIGHSTAT Investigative D00ZWA DRUG__ID D00ZWA D00ZWA DRUGTYPE Small molecular drug D00ZWA DRUGINCH 1S/C19H36O11P2/c1-15(2)7-5-8-16(3)10-12-29-32(26,27)30-31(24,25)28-11-6-9-17(20)13-19(4,23)14-18(21)22/h7,10,17,20,23H,5-6,8-9,11-14H2,1-4H3,(H,21,22)(H,24,25)(H,26,27)/b16-10+ D00ZWA DRUGINKE FPMYZHYONYFBNX-MHWRWJLKSA-N D00ZWA DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCCC(CC(C)(CC(=O)O)O)O)C)C D00ZWA HIGHSTAT Investigative D00ZWU DRUG__ID D00ZWU D00ZWU DRUGTYPE Small molecular drug D00ZWU DRUGINCH 1S/C20H20N2O/c1-2-3-6-15-9-11-16(12-10-15)20(23)22-18-13-17-7-4-5-8-19(17)21-14-18/h4-5,7-14H,2-3,6H2,1H3,(H,22,23) D00ZWU DRUGINKE LEGBMUNFZPMJOG-UHFFFAOYSA-N D00ZWU DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D00ZWU HIGHSTAT Investigative D00ZXX DRUG__ID D00ZXX D00ZXX DRUGTYPE Small molecular drug D00ZXX DRUGINCH 1S/C23H27N3O4/c1-3-28-20-11-8-15(14-21(20)29-4-2)23-25-22(26-30-23)18-7-5-6-17-16(18)9-10-19(17)24-12-13-27/h5-8,11,14,19,24,27H,3-4,9-10,12-13H2,1-2H3 D00ZXX DRUGINKE NUIKTBLZSPQGCP-UHFFFAOYSA-N D00ZXX DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)OCC D00ZXX HIGHSTAT Investigative D00ZYK DRUG__ID D00ZYK D00ZYK DRUGTYPE Small molecular drug D00ZYK DRUGINCH 1S/C11H11NO2/c13-11(14)6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6H2,(H,13,14) D00ZYK DRUGINKE GOLXRNDWAUTYKT-UHFFFAOYSA-N D00ZYK DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCC(=O)O D00ZYK HIGHSTAT Investigative D01AAD DRUG__ID D01AAD D01AAD DRUGTYPE Small molecular drug D01AAD DRUGINCH 1S/C22H12N2O4/c25-20-12-3-1-2-4-13(12)21(26)18-14(20)6-7-15-19(18)24-22(23-15)11-5-8-16-17(9-11)28-10-27-16/h1-9H,10H2,(H,23,24) D01AAD DRUGINKE FHLORIZAZVWSPG-UHFFFAOYSA-N D01AAD DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=NC4=C(N3)C=CC5=C4C(=O)C6=CC=CC=C6C5=O D01AAD HIGHSTAT Investigative D01AAI DRUG__ID D01AAI D01AAI DRUGTYPE Small molecular drug D01AAI DRUGINCH 1S/C21H17N5O2/c1-28-18-11-5-4-10-17(18)24-21(27)26-20-15-8-2-3-9-16(15)23-19(25-20)14-7-6-12-22-13-14/h2-13H,1H3,(H2,23,24,25,26,27) D01AAI DRUGINKE YRAFEJSZTVWUMD-UHFFFAOYSA-N D01AAI DRUGSMIL COC1=CC=CC=C1NC(=O)NC2=NC(=NC3=CC=CC=C32)C4=CN=CC=C4 D01AAI HIGHSTAT Investigative D01ABR DRUG__ID D01ABR D01ABR DRUGTYPE Small molecular drug D01ABR DRUGINCH 1S/C21H28N2O/c1-2-16-24-21-11-7-6-10-19(21)17-20(18-8-4-3-5-9-18)23-14-12-22-13-15-23/h3-11,20,22H,2,12-17H2,1H3 D01ABR DRUGINKE PSIGDYKJTYBHDY-UHFFFAOYSA-N D01ABR DRUGSMIL CCCOC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D01ABR HIGHSTAT Investigative D01ACT DRUG__ID D01ACT D01ACT DRUGTYPE Small molecular drug D01ACT DRUGINCH 1S/C10H13NO5S/c1-2-7-15-10(12)8-3-5-9(6-4-8)16-17(11,13)14/h3-6H,2,7H2,1H3,(H2,11,13,14) D01ACT DRUGINKE LUBKCXRNDIXVCG-UHFFFAOYSA-N D01ACT DRUGSMIL CCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D01ACT HIGHSTAT Investigative D01ADA DRUG__ID D01ADA D01ADA DRUGTYPE Small molecular drug D01ADA DRUGINCH 1S/C20H23NO2/c1-3-7-21-8-6-14-9-12(2)10-15-18(14)16(21)11-13-4-5-17(22)20(23)19(13)15/h4-5,9-10,16,22-23H,3,6-8,11H2,1-2H3/t16-/m1/s1 D01ADA DRUGINKE IQXHLUBOFQZZLM-MRXNPFEDSA-N D01ADA DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC(=C2)C)C(=C(C=C4)O)O D01ADA HIGHSTAT Investigative D01ADK DRUG__ID D01ADK D01ADK DRUGTYPE Small molecular drug D01ADK DRUGINCH 1S/C47H59N9O10/c1-3-4-15-38(45(64)54-36(25-41(59)60)43(62)53-35(42(49)61)23-28-11-6-5-7-12-28)55(2)47(66)37(24-30-26-50-34-14-9-8-13-32(30)34)52-40(58)27-51-44(63)39-16-10-21-56(39)46(65)33(48)22-29-17-19-31(57)20-18-29/h5-9,11-14,17-20,26,33,35-39,50,57H,3-4,10,15-16,21-25,27,48H2,1-2H3,(H2,49,61)(H,51,63)(H,52,58)(H,53,62)(H,54,64)(H,59,60)/t33-,35-,36-,37-,38-,39+/m0/s1 D01ADK DRUGINKE XMLJSDGQSNTHPG-TVUSJDTQSA-N D01ADK DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N D01ADK HIGHSTAT Investigative D01AFH DRUG__ID D01AFH D01AFH DRUGTYPE Small molecular drug D01AFH DRUGINCH 1S/C14H11NO6/c16-12-7-9(6-11(14(12)18)15(19)20)13(17)8-21-10-4-2-1-3-5-10/h1-7,16,18H,8H2 D01AFH DRUGINKE JFIYNCBDNTXFDN-UHFFFAOYSA-N D01AFH DRUGSMIL C1=CC=C(C=C1)OCC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-] D01AFH HIGHSTAT Investigative D01AFV DRUG__ID D01AFV D01AFV DRUGTYPE Small molecular drug D01AFV DRUGINCH 1S/C14H17BrO3/c15-11-6-7-13(18-9-14(16)17)12(8-11)10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17) D01AFV DRUGINKE ZWQTTYNQLIMKNE-UHFFFAOYSA-N D01AFV DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)Br)OCC(=O)O D01AFV HIGHSTAT Investigative D01AGR DRUG__ID D01AGR D01AGR DRUGTYPE Small molecular drug D01AGR DRUGINCH 1S/C15H15ClN2O2/c16-12-3-1-11(2-4-12)13-5-6-14(20-13)15(19)18-9-7-17-8-10-18/h1-6,17H,7-10H2 D01AGR DRUGINKE FSVUGYFGMKVKHY-UHFFFAOYSA-N D01AGR DRUGSMIL C1CN(CCN1)C(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl D01AGR HIGHSTAT Investigative D01AHL DRUG__ID D01AHL D01AHL DRUGTYPE Small molecular drug D01AHL DRUGINCH 1S/C13H12O2/c14-10-3-4-12-9(6-10)5-8-1-2-11(15)7-13(8)12/h3-4,6-8,14H,1-2,5H2 D01AHL DRUGINKE TVWXDDLDMKKZJT-UHFFFAOYSA-N D01AHL DRUGSMIL C1CC(=O)C=C2C1CC3=C2C=CC(=C3)O D01AHL HIGHSTAT Investigative D01AJQ DRUG__ID D01AJQ D01AJQ DRUGTYPE Small molecular drug D01AJQ DRUGINCH 1S/C22H24N2O6/c25-21(23-11-15-7-3-1-4-8-15)29-17-13-27-20-18(14-28-19(17)20)30-22(26)24-12-16-9-5-2-6-10-16/h1-10,17-20H,11-14H2,(H,23,25)(H,24,26)/t17-,18+,19-,20-/m1/s1 D01AJQ DRUGINKE PERBLOUPRPLYHU-IYWMVGAKSA-N D01AJQ DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NCC3=CC=CC=C3)OC(=O)NCC4=CC=CC=C4 D01AJQ HIGHSTAT Investigative D01AJZ DRUG__ID D01AJZ D01AJZ DRUGTYPE Small molecular drug D01AJZ DRUGINCH 1S/C15H10N4/c16-9-12-4-3-5-13(8-12)19-10-15(18-11-19)14-6-1-2-7-17-14/h1-8,10-11H D01AJZ DRUGINKE WFXSTBNPVNZJHP-UHFFFAOYSA-N D01AJZ DRUGSMIL C1=CC=NC(=C1)C2=CN(C=N2)C3=CC=CC(=C3)C#N D01AJZ HIGHSTAT Investigative D01ALS DRUG__ID D01ALS D01ALS DRUGTYPE Small molecular drug D01ALS DRUGINCH 1S/C10H7NS2/c1-8-11-9(7-13-8)4-5-10-3-2-6-12-10/h2-3,6-7H,1H3 D01ALS DRUGINKE SSSIEHWNKPXIHQ-UHFFFAOYSA-N D01ALS DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CS2 D01ALS HIGHSTAT Investigative D01AMS DRUG__ID D01AMS D01AMS DRUGTYPE Small molecular drug D01AMS DRUGINCH 1S/C16H24N2O3/c1-12-8-7-9-14(13(12)2)17-15(19)10-5-3-4-6-11-16(20)18-21/h7-9,21H,3-6,10-11H2,1-2H3,(H,17,19)(H,18,20) D01AMS DRUGINKE HBVNZQXOOFVNBV-UHFFFAOYSA-N D01AMS DRUGSMIL CC1=C(C(=CC=C1)NC(=O)CCCCCCC(=O)NO)C D01AMS HIGHSTAT Investigative D01AMV DRUG__ID D01AMV D01AMV DRUGTYPE Small molecular drug D01AMV DRUGINCH 1S/C15H9FN4/c16-11-4-5-14-13(7-11)15(19-9-18-14)20-12-3-1-2-10(6-12)8-17/h1-7,9H,(H,18,19,20) D01AMV DRUGINKE NWRSWZMZACUZPY-UHFFFAOYSA-N D01AMV DRUGSMIL C1=CC(=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)F)C#N D01AMV HIGHSTAT Investigative D01AOI DRUG__ID D01AOI D01AOI DRUGTYPE Small molecular drug D01AOI DRUGINCH 1S/C17H18N2O/c18-11-14-1-2-16-10-17(4-3-15(16)9-14)20-12-13-5-7-19-8-6-13/h1-4,9-10,13,19H,5-8,12H2 D01AOI DRUGINKE SHJHTXWKDLOBQS-UHFFFAOYSA-N D01AOI DRUGSMIL C1CNCCC1COC2=CC3=C(C=C2)C=C(C=C3)C#N D01AOI HIGHSTAT Investigative D01APA DRUG__ID D01APA D01APA DRUGTYPE Small molecular drug D01APA DRUGINCH 1S/C32H43N7O7/c1-2-3-19-45-32(44)37-17-15-36(16-18-37)27(40)21-33-30(42)25-20-29(39(35-25)24-11-5-4-6-12-24)46-22-28(41)38-14-8-13-26(38)31(43)34-23-9-7-10-23/h4-6,11-12,20,23,26H,2-3,7-10,13-19,21-22H2,1H3,(H,33,42)(H,34,43)/t26-/m0/s1 D01APA DRUGINKE QCKRRHRHLONWIP-SANMLTNESA-N D01APA DRUGSMIL CCCCOC(=O)N1CCN(CC1)C(=O)CNC(=O)C2=NN(C(=C2)OCC(=O)N3CCCC3C(=O)NC4CCC4)C5=CC=CC=C5 D01APA HIGHSTAT Investigative D01APL DRUG__ID D01APL D01APL DRUGTYPE Small molecular drug D01APL DRUGINCH 1S/C16H18N2O/c1-18-8-10(9-19)5-13-12-3-2-4-14-16(12)11(7-17-14)6-15(13)18/h2-5,7,10,15,17,19H,6,8-9H2,1H3/t10-,15-/m1/s1 D01APL DRUGINKE BIXJFIJYBLJTMK-MEBBXXQBSA-N D01APL DRUGSMIL CN1CC(C=C2C1CC3=CNC4=CC=CC2=C34)CO D01APL HIGHSTAT Investigative D01AQC DRUG__ID D01AQC D01AQC DRUGTYPE Small molecular drug D01AQC DRUGINCH 1S/C51H61N9O10/c1-3-4-19-43(50(69)59-41(28-45(63)64)49(68)57-39(46(53)65)25-31-13-7-5-8-14-31)60(2)51(70)42(27-34-29-54-38-18-12-11-17-36(34)38)56-44(62)30-55-48(67)40(26-32-15-9-6-10-16-32)58-47(66)37(52)24-33-20-22-35(61)23-21-33/h5-18,20-23,29,37,39-43,54,61H,3-4,19,24-28,30,52H2,1-2H3,(H2,53,65)(H,55,67)(H,56,62)(H,57,68)(H,58,66)(H,59,69)(H,63,64)/t37-,39-,40+,41-,42-,43-/m0/s1 D01AQC DRUGINKE KKPFQTRKARZYLE-NOGCUKNYSA-N D01AQC DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N D01AQC HIGHSTAT Investigative D01ARE DRUG__ID D01ARE D01ARE DRUGTYPE Small molecular drug D01ARE DRUGINCH 1S/C10H10N2S/c1-11-10-5-4-9(13-10)8-3-2-6-12-7-8/h2-7,11H,1H3 D01ARE DRUGINKE OUEHWWLIEPNPDR-UHFFFAOYSA-N D01ARE DRUGSMIL CNC1=CC=C(S1)C2=CN=CC=C2 D01ARE HIGHSTAT Investigative D01AUS DRUG__ID D01AUS D01AUS DRUGTYPE Small molecular drug D01AUS DRUGINCH 1S/C21H16O4/c22-20(16-6-8-18(9-7-16)21(23)24)17-10-12-19(13-11-17)25-14-15-4-2-1-3-5-15/h1-13H,14H2,(H,23,24) D01AUS DRUGINKE ZSVDQQIAIVOVRI-UHFFFAOYSA-N D01AUS DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C(=O)O D01AUS HIGHSTAT Investigative D01AUX DRUG__ID D01AUX D01AUX DRUGTYPE Small molecular drug D01AUX DRUGINCH 1S/C22H19NO3/c24-21(23-20-9-5-4-8-19(20)22(25)26)15-12-16-10-13-18(14-11-16)17-6-2-1-3-7-17/h1-11,13-14H,12,15H2,(H,23,24)(H,25,26) D01AUX DRUGINKE CAYOKBAXZPGNTO-UHFFFAOYSA-N D01AUX DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)NC3=CC=CC=C3C(=O)O D01AUX HIGHSTAT Investigative D01AVM DRUG__ID D01AVM D01AVM DRUGTYPE Small molecular drug D01AVM DRUGINCH 1S/C22H28O4/c1-3-26-20(24)12-14-11-19-18-6-4-13-10-15(23)5-7-16(13)17(18)8-9-22(19,2)21(14)25/h5,7,10,14,17-19,23H,3-4,6,8-9,11-12H2,1-2H3/t14?,17-,18-,19+,22+/m1/s1 D01AVM DRUGINKE SRWMNPAYNHYCEU-LRHWGCDKSA-N D01AVM DRUGSMIL CCOC(=O)CC1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D01AVM HIGHSTAT Investigative D01AVS DRUG__ID D01AVS D01AVS DRUGTYPE Small molecular drug D01AVS DRUGINCH 1S/C15H22N2O4/c1-21-13(10-6-3-7-11-14(18)17-20)15(19)16-12-8-4-2-5-9-12/h2,4-5,8-9,13,20H,3,6-7,10-11H2,1H3,(H,16,19)(H,17,18) D01AVS DRUGINKE JHNWNLJPMOWGAH-UHFFFAOYSA-N D01AVS DRUGSMIL COC(CCCCCC(=O)NO)C(=O)NC1=CC=CC=C1 D01AVS HIGHSTAT Investigative D01AWD DRUG__ID D01AWD D01AWD DRUGTYPE Small molecular drug D01AWD DRUGINCH 1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6+/m1/s1 D01AWD DRUGINKE NBSCHQHZLSJFNQ-DVKNGEFBSA-N D01AWD DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)OP(=O)(O)O D01AWD HIGHSTAT Investigative D01AWE DRUG__ID D01AWE D01AWE DRUGTYPE Small molecular drug D01AWE DRUGINCH 1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/t13-,16-,17-,18+,22-/m1/s1 D01AWE DRUGINKE ZSLZBFCDCINBPY-ZSJPKINUSA-N D01AWE DRUGSMIL CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D01AWE HIGHSTAT Investigative D01AXA DRUG__ID D01AXA D01AXA DRUGTYPE Small molecular drug D01AXA DRUGINCH 1S/C25H42N8O12/c1-11(2)7-14(21(41)32-16(9-19(38)39)23(43)33-17(10-34)24(44)45)31-20(40)13(5-4-6-28-25(26)27)30-22(42)15(8-18(36)37)29-12(3)35/h11,13-17,34H,4-10H2,1-3H3,(H,29,35)(H,30,42)(H,31,40)(H,32,41)(H,33,43)(H,36,37)(H,38,39)(H,44,45)(H4,26,27,28)/t13-,14-,15-,16-,17-/m0/s1 D01AXA DRUGINKE MBZXDXZGPJKBRJ-WOYTXXSLSA-N D01AXA DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C D01AXA HIGHSTAT Investigative D01AZJ DRUG__ID D01AZJ D01AZJ DRUGTYPE Small molecular drug D01AZJ DRUGINCH 1S/C19H18FN5O/c1-11(2)24-10-14-9-13(6-7-15(14)19(24)26)17-12(3)25(23-22-17)16-5-4-8-21-18(16)20/h4-9,11H,10H2,1-3H3/i20-1 D01AZJ DRUGINKE ZUWMBBZBDLJVHD-LRFGSCOBSA-N D01AZJ DRUGSMIL CC1=C(N=NN1C2=C(N=CC=C2)F)C3=CC4=C(C=C3)C(=O)N(C4)C(C)C D01AZJ HIGHSTAT Investigative D01BAG DRUG__ID D01BAG D01BAG DRUGTYPE Small molecular drug D01BAG DRUGINCH 1S/C20H19N3O6S/c1-11-8-22(10-14(21)18(25)26)20(29)23(17(11)24)9-13-7-15(30-16(13)19(27)28)12-5-3-2-4-6-12/h2-8,14H,9-10,21H2,1H3,(H,25,26)(H,27,28)/t14-/m0/s1 D01BAG DRUGINKE LCZDCKMQSBGXAH-AWEZNQCLSA-N D01BAG DRUGSMIL CC1=CN(C(=O)N(C1=O)CC2=C(SC(=C2)C3=CC=CC=C3)C(=O)O)CC(C(=O)O)N D01BAG HIGHSTAT Investigative D01BAK DRUG__ID D01BAK D01BAK DRUGTYPE Small molecular drug D01BAK DRUGINCH 1S/C30H36N4O4/c35-27(11-17-33-13-3-1-4-14-33)31-21-7-9-23-25(19-21)30(38)26-20-22(8-10-24(26)29(23)37)32-28(36)12-18-34-15-5-2-6-16-34/h7-10,19-20H,1-6,11-18H2,(H,31,35)(H,32,36) D01BAK DRUGINKE OFUHVIUIKBRCMP-UHFFFAOYSA-N D01BAK DRUGSMIL C1CCN(CC1)CCC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CCN5CCCCC5 D01BAK HIGHSTAT Investigative D01BCI DRUG__ID D01BCI D01BCI DRUGTYPE Small molecular drug D01BCI DRUGINCH 1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m1/s1 D01BCI DRUGINKE QNAYBMKLOCPYGJ-UWTATZPHSA-N D01BCI DRUGSMIL CC(C(=O)O)N D01BCI HIGHSTAT Investigative D01BCK DRUG__ID D01BCK D01BCK DRUGTYPE Small molecular drug D01BCK DRUGINCH 1S/C11H9NO2/c13-11(12-14)10-7-3-5-8-4-1-2-6-9(8)10/h1-7,14H,(H,12,13) D01BCK DRUGINKE JRZGPWOEHDOVMC-UHFFFAOYSA-N D01BCK DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C(=O)NO D01BCK HIGHSTAT Investigative D01BCL DRUG__ID D01BCL D01BCL DRUGTYPE Small molecular drug D01BCL DRUGINCH 1S/C11H13NO2/c12-11(10(13)14)6-5-8-3-1-2-4-9(8)7-11/h1-4H,5-7,12H2,(H,13,14) D01BCL DRUGINKE CDULPPOISZOUTK-UHFFFAOYSA-N D01BCL DRUGSMIL C1CC(CC2=CC=CC=C21)(C(=O)O)N D01BCL HIGHSTAT Investigative D01BDJ DRUG__ID D01BDJ D01BDJ DRUGTYPE Small molecular drug D01BDJ DRUGINCH 1S/C16H16O/c1-3-8-14(9-4-1)16(12-7-13-17-16)15-10-5-2-6-11-15/h1-6,8-11H,7,12-13H2 D01BDJ DRUGINKE ONRSPOWNRLCCGF-UHFFFAOYSA-N D01BDJ DRUGSMIL C1CC(OC1)(C2=CC=CC=C2)C3=CC=CC=C3 D01BDJ HIGHSTAT Investigative D01BGK DRUG__ID D01BGK D01BGK DRUGTYPE Small molecular drug D01BGK DRUGINCH 1S/C17H21NO3/c1-20-16-13-21-17(18-16)15(19)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D01BGK DRUGINKE PLTPISAOEFIJFK-UHFFFAOYSA-N D01BGK DRUGSMIL COC1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2 D01BGK HIGHSTAT Investigative D01BGY DRUG__ID D01BGY D01BGY DRUGTYPE Small molecular drug D01BGY DRUGINCH 1S/C30H35NO6/c1-34-26-12-6-22(7-13-26)30(23-8-14-27(35-2)15-9-23,24-10-16-28(36-3)17-11-24)37-20-19-31-18-4-5-25(31)21-29(32)33/h6-17,25H,4-5,18-21H2,1-3H3,(H,32,33)/t25-/m1/s1 D01BGY DRUGINKE LVXQSLPHTYSBIW-RUZDIDTESA-N D01BGY DRUGSMIL COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C3=CC=C(C=C3)OC)OCCN4CCCC4CC(=O)O D01BGY HIGHSTAT Investigative D01BIZ DRUG__ID D01BIZ D01BIZ DRUGTYPE Small molecular drug D01BIZ DRUGINCH 1S/C45H67N13O9/c1-24(2)20-33(52-38(60)32(18-13-19-49-43(47)48)54-45(66)67-23-28-14-9-8-10-15-28)39(61)56-36(26(5)6)42(64)57-58-44(65)53-34(21-29-22-50-31-17-12-11-16-30(29)31)40(62)55-35(25(3)4)41(63)51-27(7)37(46)59/h8-12,14-17,22,24-27,32-36,50H,13,18-21,23H2,1-7H3,(H2,46,59)(H,51,63)(H,52,60)(H,54,66)(H,55,62)(H,56,61)(H,57,64)(H4,47,48,49)(H2,53,58,65) D01BIZ DRUGINKE TXGCKASBHJKJOM-UHFFFAOYSA-N D01BIZ DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3 D01BIZ HIGHSTAT Investigative D01BJB DRUG__ID D01BJB D01BJB DRUGTYPE Small molecular drug D01BJB DRUGINCH 1S/C22H31NO2/c1-13(24)20-14(12-23)10-19-17-5-4-15-11-16(25)6-8-21(15,2)18(17)7-9-22(19,20)3/h4,14,16-20,25H,5-11H2,1-3H3/t14-,16-,17+,18-,19-,20-,21-,22-/m0/s1 D01BJB DRUGINKE VSBHRRMYCDQLJF-ZDNYCOCVSA-N D01BJB DRUGSMIL CC(=O)C1C(CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C#N D01BJB HIGHSTAT Investigative D01BJZ DRUG__ID D01BJZ D01BJZ DRUGTYPE Small molecular drug D01BJZ DRUGINCH 1S/C20H25NO/c1-22-20-10-7-16(8-11-20)12-13-21-15-17-6-9-18-4-2-3-5-19(18)14-17/h2-5,7-8,10-11,17,21H,6,9,12-15H2,1H3 D01BJZ DRUGINKE NJWKVUCAVMYELV-UHFFFAOYSA-N D01BJZ DRUGSMIL COC1=CC=C(C=C1)CCNCC2CCC3=CC=CC=C3C2 D01BJZ HIGHSTAT Investigative D01BKS DRUG__ID D01BKS D01BKS DRUGTYPE Small molecular drug D01BKS DRUGINCH 1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1 D01BKS DRUGINKE RWXIFXNRCLMQCD-JBVRGBGGSA-N D01BKS DRUGSMIL CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C D01BKS HIGHSTAT Investigative D01BMA DRUG__ID D01BMA D01BMA DRUGTYPE Small molecular drug D01BMA DRUGINCH 1S/C27H50O7P2/c1-5-9-19-31-35(28,32-20-10-6-2)24-26(18-23-30-27-16-14-13-15-17-27)25-36(29,33-21-11-7-3)34-22-12-8-4/h13-17,26H,5-12,18-25H2,1-4H3 D01BMA DRUGINKE QTBMDDQRDDABNC-UHFFFAOYSA-N D01BMA DRUGSMIL CCCCOP(=O)(CC(CCOC1=CC=CC=C1)CP(=O)(OCCCC)OCCCC)OCCCC D01BMA HIGHSTAT Investigative D01BPI DRUG__ID D01BPI D01BPI DRUGTYPE Small molecular drug D01BPI DRUGINCH 1S/C22H27FO7/c1-21-6-4-13-20(26)30-16(12-5-7-28-10-12)9-22(13,2)18(21)17(24)15(29-11-23)8-14(21)19(25)27-3/h5,7,10,13-16,18H,4,6,8-9,11H2,1-3H3/t13-,14-,15-,16-,18-,21-,22-/m0/s1 D01BPI DRUGINKE DDPYLPBMPHWVGO-VOVNARLJSA-N D01BPI DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCF)C)C4=COC=C4 D01BPI HIGHSTAT Investigative D01BPR DRUG__ID D01BPR D01BPR DRUGTYPE Small molecular drug D01BPR DRUGINCH 1S/C12H17N.ClH/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13;/h1,3-4,7-8H,2,5-6,9-11H2;1H D01BPR DRUGINKE MPPIBJJDFLONMO-UHFFFAOYSA-N D01BPR DRUGSMIL C1CCN(CC1)CC2=CC=CC=C2.Cl D01BPR HIGHSTAT Investigative D01BQD DRUG__ID D01BQD D01BQD DRUGTYPE Small molecular drug D01BQD DRUGINCH 1S/C20H17N3O/c21-15-8-11-18-19(13-15)23-20(22-18)12-14-6-9-17(10-7-14)24-16-4-2-1-3-5-16/h1-11,13H,12,21H2,(H,22,23) D01BQD DRUGINKE KVTYWLATLSZWKO-UHFFFAOYSA-N D01BQD DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=C(N3)C=C(C=C4)N D01BQD HIGHSTAT Investigative D01BQI DRUG__ID D01BQI D01BQI DRUGTYPE Small molecular drug D01BQI DRUGINCH 1S/C17H15NO3/c1-11-6-7-15-14(8-11)16(19)17(20)18(15)10-12-4-3-5-13(9-12)21-2/h3-9H,10H2,1-2H3 D01BQI DRUGINKE ZSPZSZMUOMBLFZ-UHFFFAOYSA-N D01BQI DRUGSMIL CC1=CC2=C(C=C1)N(C(=O)C2=O)CC3=CC(=CC=C3)OC D01BQI HIGHSTAT Investigative D01BTF DRUG__ID D01BTF D01BTF DRUGTYPE Small molecular drug D01BTF DRUGINCH 1S/C89H139N27O24S4/c1-43(2)67-82(135)101-40-64(119)102-53(18-12-30-97-87(91)92)74(127)113-68(44(3)4)83(136)109-59(36-47-22-24-49(118)25-23-47)77(130)107-58(20-14-32-99-89(95)96)85(138)116-33-15-21-63(116)81(134)111-62(80(133)108-60(37-48-39-100-52-17-11-10-16-50(48)52)78(131)104-55(26-27-65(120)121)75(128)114-69(45(5)6)86(139)140)42-144-143-41-61(79(132)105-57(29-35-142-9)76(129)112-67)110-72(125)54(19-13-31-98-88(93)94)103-73(126)56(28-34-141-8)106-84(137)70(46(7)117)115-71(124)51(90)38-66(122)123/h10-11,16-17,22-25,39,43-46,51,53-63,67-70,100,117-118H,12-15,18-21,26-38,40-42,90H2,1-9H3,(H,101,135)(H,102,119)(H,103,126)(H,104,131)(H,105,132)(H,106,137)(H,107,130)(H,108,133)(H,109,136)(H,110,125)(H,111,134)(H,112,129)(H,113,127)(H,114,128)(H,115,124)(H,120,121)(H,122,123)(H,139,140)(H4,91,92,97)(H4,93,94,98)(H4,95,96,99) D01BTF DRUGINKE ORRDHOMWDPJSNL-UHFFFAOYSA-N D01BTF DRUGSMIL CC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CCSC)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCSC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)O)CCCNC(=N)N)CC5=CC=C(C=C5)O)C(C)C)CCCNC(=N)N D01BTF HIGHSTAT Investigative D01BTV DRUG__ID D01BTV D01BTV DRUGTYPE Small molecular drug D01BTV DRUGINCH 1S/C2H5NO3/c3-6-1-2(4)5/h1,3H2,(H,4,5) D01BTV DRUGINKE NQRKYASMKDDGHT-UHFFFAOYSA-N D01BTV DRUGSMIL C(C(=O)O)ON D01BTV HIGHSTAT Investigative D01BUB DRUG__ID D01BUB D01BUB DRUGTYPE Small molecular drug D01BUB DRUGINCH 1S/C6H4F2O/c7-4-1-2-5(8)6(9)3-4/h1-3,9H D01BUB DRUGINKE INXKVYFOWNAVMU-UHFFFAOYSA-N D01BUB DRUGSMIL C1=CC(=C(C=C1F)O)F D01BUB HIGHSTAT Investigative D01BUT DRUG__ID D01BUT D01BUT DRUGCOMP Beijing Institute of Pharmacology and Toxicology D01BUT DRUGINCH 1S/C70H93ClN18O12/c1-40(2)32-52(61(94)83-51(20-12-30-79-70(75)76)68(101)89-31-13-21-58(89)67(100)80-41(3)59(72)92)84-64(97)56(37-46-16-10-28-77-38-46)85-60(93)50(19-11-29-78-69(73)74)82-66(99)57(39-90)88-65(98)54(34-43-14-6-5-7-15-43)87-63(96)55(35-44-23-26-49(71)27-24-44)86-62(95)53(81-42(4)91)36-45-22-25-47-17-8-9-18-48(47)33-45/h5-10,14-18,22-28,33,38,40-41,50-58,90H,11-13,19-21,29-32,34-37,39H2,1-4H3,(H2,72,92)(H,80,100)(H,81,91)(H,82,99)(H,83,94)(H,84,97)(H,85,93)(H,86,95)(H,87,96)(H,88,98)(H4,73,74,78)(H4,75,76,79)/t41-,50+,51+,52+,53-,54-,55-,56-,57+,58+/m1/s1 D01BUT DRUGINKE CRMRBNHNJMIODJ-OIIKBFRESA-N D01BUT DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CN=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D01BUT HIGHSTAT Investigative D01BVR DRUG__ID D01BVR D01BVR DRUGTYPE Small molecular drug D01BVR DRUGINCH 1S/C11H18N2OS/c1-2-3-9-10(15-13-11(9)14)8-4-6-12-7-5-8/h8,12H,2-7H2,1H3,(H,13,14) D01BVR DRUGINKE INIXNNKFVDXPBJ-UHFFFAOYSA-N D01BVR DRUGSMIL CCCC1=C(SNC1=O)C2CCNCC2 D01BVR HIGHSTAT Investigative D01BWV DRUG__ID D01BWV D01BWV DRUGTYPE Small molecular drug D01BWV DRUGINCH 1S/C28H34N4/c1-3-5-16-28(17-6-4-2)26-22(21-14-10-11-15-23(21)30-26)18-24(32-28)27-29-19-25(31-27)20-12-8-7-9-13-20/h7-15,19,24,30,32H,3-6,16-18H2,1-2H3,(H,29,31)/t24-/m1/s1 D01BWV DRUGINKE FOBFICSYUINKAA-XMMPIXPASA-N D01BWV DRUGSMIL CCCCC1(C2=C(CC(N1)C3=NC=C(N3)C4=CC=CC=C4)C5=CC=CC=C5N2)CCCC D01BWV HIGHSTAT Investigative D01BXE DRUG__ID D01BXE D01BXE DRUGTYPE Small molecular drug D01BXE DRUGINCH 1S/C19H12Cl3N3OS/c20-14-4-2-13(3-5-14)18-17(25-7-8-27-19(25)24-18)10-23-26-11-12-1-6-15(21)16(22)9-12/h1-10H,11H2/b23-10+ D01BXE DRUGINKE ZQWBOKJVVYNKTL-AUEPDCJTSA-N D01BXE DRUGSMIL C1=CC(=CC=C1C2=C(N3C=CSC3=N2)C=NOCC4=CC(=C(C=C4)Cl)Cl)Cl D01BXE HIGHSTAT Investigative D01BZE DRUG__ID D01BZE D01BZE DRUGTYPE Small molecular drug D01BZE DRUGINCH 1S/C30H48O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20+,21-,22+,23-,27-,28+,29+,30-/m0/s1 D01BZE DRUGINKE MDZKJHQSJHYOHJ-LLICELPBSA-N D01BZE DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C D01BZE HIGHSTAT Investigative D01BZH DRUG__ID D01BZH D01BZH DRUGTYPE Small molecular drug D01BZH DRUGINCH 1S/C18H29N7O8/c19-18(20)21-3-1-2-8-16(32)22-6-11(26)23-10(5-12(27)28)17(33)25-9-4-7(15(31)24-8)13(29)14(9)30/h7-10,13-14,29-30H,1-6H2,(H,22,32)(H,23,26)(H,24,31)(H,25,33)(H,27,28)(H4,19,20,21)/t7-,8+,9+,10+,13-,14-/m1/s1 D01BZH DRUGINKE VNLGSUKLIVHSOW-KOWOESDJSA-N D01BZH DRUGSMIL C1C2C(C(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O)O D01BZH HIGHSTAT Investigative D01CAC DRUG__ID D01CAC D01CAC DRUGTYPE Small molecular drug D01CAC DRUGINCH 1S/C20H23NO2/c1-23-19-11-9-18(10-12-19)20(22)21-14-5-8-17(13-15-21)16-6-3-2-4-7-16/h2-4,6-7,9-12,17H,5,8,13-15H2,1H3 D01CAC DRUGINKE SLZXHOMMTNEABC-UHFFFAOYSA-N D01CAC DRUGSMIL COC1=CC=C(C=C1)C(=O)N2CCCC(CC2)C3=CC=CC=C3 D01CAC HIGHSTAT Investigative D01CAY DRUG__ID D01CAY D01CAY DRUGTYPE Small molecular drug D01CAY DRUGINCH 1S/C20H20O5/c1-21-17-7-5-13(11-19(17)23-3)15-9-10-16(25-15)14-6-8-18(22-2)20(12-14)24-4/h5-12H,1-4H3 D01CAY DRUGINKE ZESHRVUYCRWWFA-UHFFFAOYSA-N D01CAY DRUGSMIL COC1=C(C=C(C=C1)C2=CC=C(O2)C3=CC(=C(C=C3)OC)OC)OC D01CAY HIGHSTAT Investigative D01CCG DRUG__ID D01CCG D01CCG DRUGTYPE Small molecular drug D01CCG DRUGINCH 1S/C18H16O2/c1-14-4-2-3-5-17(14)12-10-15-6-8-16(9-7-15)11-13-18(19)20/h2-9H,11,13H2,1H3,(H,19,20) D01CCG DRUGINKE FODHWOBAQBTTFS-UHFFFAOYSA-N D01CCG DRUGSMIL CC1=CC=CC=C1C#CC2=CC=C(C=C2)CCC(=O)O D01CCG HIGHSTAT Investigative D01CDL DRUG__ID D01CDL D01CDL DRUGTYPE Small molecular drug D01CDL DRUGINCH 1S/C22H28O7/c1-23-17-9-13(10-18(24-2)21(17)27-5)15-7-8-16(29-15)14-11-19(25-3)22(28-6)20(12-14)26-4/h9-12,15-16H,7-8H2,1-6H3/t15-,16-/m1/s1 D01CDL DRUGINKE YCCPYTPBHUIHGW-HZPDHXFCSA-N D01CDL DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2CCC(O2)C3=CC(=C(C(=C3)OC)OC)OC D01CDL HIGHSTAT Investigative D01CFO DRUG__ID D01CFO D01CFO DRUGTYPE Small molecular drug D01CFO DRUGINCH 1S/C47H76N14O8/c1-5-29(4)39(45(69)57-33(40(49)64)15-9-10-22-48)61-42(66)35(17-12-24-55-47(52)53)58-43(67)37(27-31-18-20-32(62)21-19-31)60-44(68)36(26-30-13-7-6-8-14-30)59-41(65)34(16-11-23-54-46(50)51)56-38(63)25-28(2)3/h6-8,13-14,18-21,28-29,33-37,39,62H,5,9-12,15-17,22-27,48H2,1-4H3,(H2,49,64)(H,56,63)(H,57,69)(H,58,67)(H,59,65)(H,60,68)(H,61,66)(H4,50,51,54)(H4,52,53,55)/t29-,33-,34-,35-,36-,37-,39-/m0/s1 D01CFO DRUGINKE WYGLGBXUEUHKTI-INYUMPDKSA-N D01CFO DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)CC(C)C D01CFO HIGHSTAT Investigative D01CGC DRUG__ID D01CGC D01CGC DRUGTYPE Small molecular drug D01CGC DRUGINCH 1S/C21H39NO3/c1-3-4-5-14-17-20(23)22(2)19-16-13-11-9-7-6-8-10-12-15-18-21(24)25/h7,9H,3-6,8,10-19H2,1-2H3,(H,24,25)/b9-7- D01CGC DRUGINKE CJHOGNAQWWHHBN-CLFYSBASSA-N D01CGC DRUGSMIL CCCCCCC(=O)N(C)CCCCC=CCCCCCCC(=O)O D01CGC HIGHSTAT Investigative D01CGM DRUG__ID D01CGM D01CGM DRUGTYPE Small molecular drug D01CGM DRUGINCH 1S/C22H22FN3O2S/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29) D01CGM DRUGINKE SMYALUSCZJXWHG-UHFFFAOYSA-N D01CGM DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=S D01CGM HIGHSTAT Investigative D01CGR DRUG__ID D01CGR D01CGR DRUGTYPE Small molecular drug D01CGR DRUGINCH 1S/C15H17N3/c1-11(2)15-13(9-18-8-7-16-10-18)12-5-3-4-6-14(12)17-15/h3-8,10-11,17H,9H2,1-2H3 D01CGR DRUGINKE NZXGMVRYQLENHC-UHFFFAOYSA-N D01CGR DRUGSMIL CC(C)C1=C(C2=CC=CC=C2N1)CN3C=CN=C3 D01CGR HIGHSTAT Investigative D01CJZ DRUG__ID D01CJZ D01CJZ DRUGTYPE Small molecular drug D01CJZ DRUGINCH 1S/C11H19N3/c1(3-11-8-13-9-14-11)2-10-4-6-12-7-5-10/h8-10,12H,1-7H2,(H,13,14) D01CJZ DRUGINKE YPGRNKJNOSUCLY-UHFFFAOYSA-N D01CJZ DRUGSMIL C1CNCCC1CCCC2=CN=CN2 D01CJZ HIGHSTAT Investigative D01CNF DRUG__ID D01CNF D01CNF DRUGTYPE Small molecular drug D01CNF DRUGINCH 1S/C17H25N5O15P2/c1-6(23)34-13-11(25)8(36-17(13)27)3-33-39(30,31)37-38(28,29)32-2-7-10(24)12(26)16(35-7)22-5-21-9-14(18)19-4-20-15(9)22/h4-5,7-8,10-13,16-17,24-27H,2-3H2,1H3,(H,28,29)(H,30,31)(H2,18,19,20)/t7-,8-,10-,11-,12-,13-,16-,17?/m1/s1 D01CNF DRUGINKE BFNOPXRXIQJDHO-YDKGJHSESA-N D01CNF DRUGSMIL CC(=O)OC1C(C(OC1O)COP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)O)O D01CNF HIGHSTAT Investigative D01CQU DRUG__ID D01CQU D01CQU DRUGTYPE Small molecular drug D01CQU DRUGINCH 1S/C27H29N5O5/c1-4-14-31-25-23(26(35)32(15-5-2)27(31)36)29-24(30-25)19-8-12-21(13-9-19)37-16-22(34)28-20-10-6-18(7-11-20)17(3)33/h6-13H,4-5,14-16H2,1-3H3,(H,28,34)(H,29,30) D01CQU DRUGINKE ZKUCFFYOQOJLGT-UHFFFAOYSA-N D01CQU DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C(=O)C D01CQU HIGHSTAT Investigative D01CRJ DRUG__ID D01CRJ D01CRJ DRUGTYPE Small molecular drug D01CRJ DRUGINCH 1S/C29H36O3/c30-27(29(22-11-23-29)21-10-14-24-12-2-1-3-13-24)19-8-6-17-25-15-4-5-16-26(25)18-7-9-20-28(31)32/h1-3,6,8,12-13,17-19,25,27,30H,4-5,7,9,11,15-16,20-23H2,(H,31,32)/b17-6+,19-8+,26-18+ D01CRJ DRUGINKE HILRZHRCCODTSA-AHQVELJISA-N D01CRJ DRUGSMIL C1CCC(=CCCCC(=O)O)C(C1)C=CC=CC(C2(CCC2)CC#CC3=CC=CC=C3)O D01CRJ HIGHSTAT Investigative D01CRK DRUG__ID D01CRK D01CRK DRUGTYPE Small molecular drug D01CRK DRUGINCH 1S/C15H14N2/c1-2-4-15-14(3-1)13(11-17-15)6-5-12-7-9-16-10-8-12/h1-4,7-11,17H,5-6H2 D01CRK DRUGINKE UUEYCHLWAOBOHG-UHFFFAOYSA-N D01CRK DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCC3=CC=NC=C3 D01CRK HIGHSTAT Investigative D01CSE DRUG__ID D01CSE D01CSE DRUGTYPE Small molecular drug D01CSE DRUGINCH 1S/C14H11Br2N3OS/c15-10-3-1-2-8(4-10)13(18-19-14(17)21)9-5-11(16)7-12(20)6-9/h1-7,20H,(H3,17,19,21)/b18-13- D01CSE DRUGINKE PWIIBRZZZZNLFE-AQTBWJFISA-N D01CSE DRUGSMIL C1=CC(=CC(=C1)Br)C(=NNC(=S)N)C2=CC(=CC(=C2)Br)O D01CSE HIGHSTAT Investigative D01CSM DRUG__ID D01CSM D01CSM DRUGTYPE Small molecular drug D01CSM DRUGINCH 1S/C30H32ClN3O8S/c1-32(2)28(36)24-15-19(35)17-33(24)30(21-8-6-7-9-25(21)41-4)22-14-18(31)10-12-23(22)34(29(30)37)43(38,39)27-13-11-20(40-3)16-26(27)42-5/h6-14,16,19,24,35H,15,17H2,1-5H3/t19-,24+,30+/m1/s1/i3T3,5T3 D01CSM DRUGINKE NJXZWIIMWNEOGJ-KGKCFUOPSA-N D01CSM DRUGSMIL CN(C)C(=O)C1CC(CN1C2(C3=C(C=CC(=C3)Cl)N(C2=O)S(=O)(=O)C4=C(C=C(C=C4)OC)OC)C5=CC=CC=C5OC)O D01CSM HIGHSTAT Investigative D01CSZ DRUG__ID D01CSZ D01CSZ DRUGTYPE Small molecular drug D01CSZ DRUGINCH 1S/C12H14N2O/c1-8(2)14-10-5-6-11(15)12-9(10)4-3-7-13-12/h3-8,14-15H,1-2H3 D01CSZ DRUGINKE BRXAKDWFCHQCDT-UHFFFAOYSA-N D01CSZ DRUGSMIL CC(C)NC1=C2C=CC=NC2=C(C=C1)O D01CSZ HIGHSTAT Investigative D01CTM DRUG__ID D01CTM D01CTM DRUGTYPE Small molecular drug D01CTM DRUGINCH 1S/C30H30F3N5O/c1-34-29(39)15-10-25-20-28(38(36-25)27-13-11-26(12-14-27)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-9,11-14,20,35H,10,15-19H2,1H3,(H,34,39) D01CTM DRUGINKE GHBUPSVATJKTRR-UHFFFAOYSA-N D01CTM DRUGSMIL CNC(=O)CCC1=NN(C(=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)N5CCNCC5 D01CTM HIGHSTAT Investigative D01CUJ DRUG__ID D01CUJ D01CUJ DRUGTYPE Small molecular drug D01CUJ DRUGINCH 1S/C13H16N2O5/c1-3-4-14-12(18)8(2)6-15(13(14)19)11-5-9(17)10(7-16)20-11/h1,6,9-11,16-17H,4-5,7H2,2H3/t9-,10+,11+/m0/s1 D01CUJ DRUGINKE LZHTUGCZNRVCGE-HBNTYKKESA-N D01CUJ DRUGSMIL CC1=CN(C(=O)N(C1=O)CC#C)C2CC(C(O2)CO)O D01CUJ HIGHSTAT Investigative D01CUR DRUG__ID D01CUR D01CUR DRUGTYPE Small molecular drug D01CUR DRUGINCH 1S/C13H12N2O/c1-2-16-13-7-10-9-5-3-4-6-11(9)15-12(10)8-14-13/h3-8,15H,2H2,1H3 D01CUR DRUGINKE FNNPSIGQQWCKKB-UHFFFAOYSA-N D01CUR DRUGSMIL CCOC1=NC=C2C(=C1)C3=CC=CC=C3N2 D01CUR HIGHSTAT Investigative D01CWN DRUG__ID D01CWN D01CWN DRUGTYPE Small molecular drug D01CWN DRUGINCH 1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m1/s1 D01CWN DRUGINKE CIWBSHSKHKDKBQ-MVHIGOERSA-N D01CWN DRUGSMIL C(C(C1C(=C(C(=O)O1)O)O)O)O D01CWN HIGHSTAT Investigative D01CXD DRUG__ID D01CXD D01CXD DRUGTYPE Small molecular drug D01CXD DRUGINCH 1S/C15H15N/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-8,15H,9-10,16H2 D01CXD DRUGINKE GEICAQNIOJFRQN-UHFFFAOYSA-N D01CXD DRUGSMIL C1C2=CC=CC=C2C(C3=CC=CC=C31)CN D01CXD HIGHSTAT Investigative D01CXM DRUG__ID D01CXM D01CXM DRUGTYPE Small molecular drug D01CXM DRUGINCH 1S/C13H12O4/c1-3-16-12-7-11-9(4-5-13(15)17-11)6-10(12)8(2)14/h4-7H,3H2,1-2H3 D01CXM DRUGINKE YPWNHEXIUIFWSP-UHFFFAOYSA-N D01CXM DRUGSMIL CCOC1=C(C=C2C=CC(=O)OC2=C1)C(=O)C D01CXM HIGHSTAT Investigative D01CYI DRUG__ID D01CYI D01CYI DRUGTYPE Small molecular drug D01CYI DRUGINCH 1S/C14H10N2O3/c17-10-3-1-9(2-4-10)16-8-15-13-7-11(18)5-6-12(13)14(16)19/h1-8,17-18H D01CYI DRUGINKE NECCEJFVHJYYDA-UHFFFAOYSA-N D01CYI DRUGSMIL C1=CC(=CC=C1N2C=NC3=C(C2=O)C=CC(=C3)O)O D01CYI HIGHSTAT Investigative D01DAQ DRUG__ID D01DAQ D01DAQ DRUGTYPE Small molecular drug D01DAQ DRUGINCH 1S/C8H8FN5O2/c9-5-4(12-8(16)13-6(5)15)3-14-2-1-11-7(14)10/h1-2H,3H2,(H2,10,11)(H2,12,13,15,16) D01DAQ DRUGINKE SFEMKOUUPCFITA-UHFFFAOYSA-N D01DAQ DRUGSMIL C1=CN(C(=N1)N)CC2=C(C(=O)NC(=O)N2)F D01DAQ HIGHSTAT Investigative D01DAU DRUG__ID D01DAU D01DAU DRUGTYPE Small molecular drug D01DAU DRUGINCH 1S/C15H16N2/c1-2-3-4-6-13-7-5-8-14(9-13)10-15-11-16-12-17-15/h5,7-9,11-12H,2-3,10H2,1H3,(H,16,17) D01DAU DRUGINKE JAPGJDHRYBFKBD-UHFFFAOYSA-N D01DAU DRUGSMIL CCCC#CC1=CC=CC(=C1)CC2=CN=CN2 D01DAU HIGHSTAT Investigative D01DCE DRUG__ID D01DCE D01DCE DRUGTYPE Small molecular drug D01DCE DRUGINCH 1S/C15H15NS/c16-12-6-8-13(9-7-12)17-15-10-5-11-3-1-2-4-14(11)15/h1-4,6-9,15H,5,10,16H2 D01DCE DRUGINKE WWGLOFVWIRHNNH-UHFFFAOYSA-N D01DCE DRUGSMIL C1CC2=CC=CC=C2C1SC3=CC=C(C=C3)N D01DCE HIGHSTAT Investigative D01DDB DRUG__ID D01DDB D01DDB DRUGTYPE Small molecular drug D01DDB DRUGINCH 1S/C18H16N4O/c1-13(23)20-16-9-5-6-14(10-16)17-11-19-12-18(22-17)21-15-7-3-2-4-8-15/h2-12H,1H3,(H,20,23)(H,21,22) D01DDB DRUGINKE MKRMZWIJCMWBDU-UHFFFAOYSA-N D01DDB DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2=CN=CC(=N2)NC3=CC=CC=C3 D01DDB HIGHSTAT Investigative D01DFX DRUG__ID D01DFX D01DFX DRUGTYPE Small molecular drug D01DFX DRUGINCH 1S/C10H11N3/c1-9-12-6-7-13(9)8-10-2-4-11-5-3-10/h2-7H,8H2,1H3 D01DFX DRUGINKE MNSNMTASPOHKEI-UHFFFAOYSA-N D01DFX DRUGSMIL CC1=NC=CN1CC2=CC=NC=C2 D01DFX HIGHSTAT Investigative D01DHW DRUG__ID D01DHW D01DHW DRUGTYPE Small molecular drug D01DHW DRUGINCH 1S/C27H24NO5/c1-29-24-8-7-18-13-23-21-15-26-25(32-17-33-26)14-19(21)9-10-28(23)16-22(18)27(24)31-12-11-30-20-5-3-2-4-6-20/h2-8,13-16H,9-12,17H2,1H3/q+1 D01DHW DRUGINKE BTWWJBNJLCMOGS-UHFFFAOYSA-N D01DHW DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCOC6=CC=CC=C6 D01DHW HIGHSTAT Investigative D01DIQ DRUG__ID D01DIQ D01DIQ DRUGTYPE Small molecular drug D01DIQ DRUGINCH 1S/C32H36N2O9/c1-7-17-15-34-25-13-20(17)30(29(36)41-6,16-42-28(35)18-10-23(38-3)27(40-5)24(11-18)39-4)31-14-26(34)43-32(25,31)33-22-9-8-19(37-2)12-21(22)31/h7-12,20,25-26,33H,13-16H2,1-6H3/b17-7-/t20-,25-,26-,30-,31-,32-/m0/s1 D01DIQ DRUGINKE JIBNKPQBEIZZCU-DYWXBFQLSA-N D01DIQ DRUGSMIL CC=C1CN2C3CC1C(C45C3(NC6=C4C=C(C=C6)OC)OC2C5)(COC(=O)C7=CC(=C(C(=C7)OC)OC)OC)C(=O)OC D01DIQ HIGHSTAT Investigative D01DIT DRUG__ID D01DIT D01DIT DRUGTYPE Small molecular drug D01DIT DRUGINCH 1S/C20H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h6-7,9-10,22H,2-5,8,11-19H2,1H3,(H,21,23)/b7-6-,10-9- D01DIT DRUGINKE KQXDGUVSAAQARU-HZJYTTRNSA-N D01DIT DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)NCCO D01DIT HIGHSTAT Investigative D01DMN DRUG__ID D01DMN D01DMN DRUGTYPE Small molecular drug D01DMN DRUGINCH 1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h6,8-10,15H,5,7H2,1-4H3,(H,22,23)(H,24,25)/t15-/m0/s1 D01DMN DRUGINKE PRGILOMAMBLWNG-HNNXBMFYSA-N D01DMN DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)O)OC)OC)OC D01DMN HIGHSTAT Investigative D01DMS DRUG__ID D01DMS D01DMS DRUGTYPE Small molecular drug D01DMS DRUGINCH 1S/C7H8IN3O4/c8-3-1-11(2-4(9)6(13)14)7(15)10-5(3)12/h1,4H,2,9H2,(H,13,14)(H,10,12,15)/t4-/m0/s1 D01DMS DRUGINKE AXXYLTBQIQBTES-BYPYZUCNSA-N D01DMS DRUGSMIL C1=C(C(=O)NC(=O)N1CC(C(=O)O)N)I D01DMS HIGHSTAT Investigative D01DOV DRUG__ID D01DOV D01DOV DRUGTYPE Small molecular drug D01DOV DRUGINCH 1S/C12H24N2OS/c13-11(8-2-1-5-9-16)12(15)14-10-6-3-4-7-10/h10-11,16H,1-9,13H2,(H,14,15)/t11-/m0/s1 D01DOV DRUGINKE BNEXTTBMNDFSSZ-NSHDSACASA-N D01DOV DRUGSMIL C1CCC(C1)NC(=O)C(CCCCCS)N D01DOV HIGHSTAT Investigative D01DOW DRUG__ID D01DOW D01DOW DRUGTYPE Small molecular drug D01DOW DRUGINCH 1S/3Na.H3O4P/c;;;1-5(2,3)4/h;;;(H3,1,2,3,4)/q3*+1;/p-3 D01DOW DRUGINKE RYFMWSXOAZQYPI-UHFFFAOYSA-K D01DOW DRUGSMIL [O-]P(=O)([O-])[O-].[Na+].[Na+].[Na+] D01DOW HIGHSTAT Investigative D01DPF DRUG__ID D01DPF D01DPF DRUGTYPE Small molecular drug D01DPF DRUGINCH 1S/C23H28ClNO3S/c1-5-12-28-22(26)20-17(7-3)19(23(27)29-13-6-2)18(8-4)25-21(20)15-10-9-11-16(24)14-15/h9-11,14H,5-8,12-13H2,1-4H3 D01DPF DRUGINKE RPTCJTNYKDJGHU-UHFFFAOYSA-N D01DPF DRUGSMIL CCCOC(=O)C1=C(N=C(C(=C1CC)C(=O)SCCC)CC)C2=CC(=CC=C2)Cl D01DPF HIGHSTAT Investigative D01DPN DRUG__ID D01DPN D01DPN DRUGTYPE Small molecular drug D01DPN DRUGINCH 1S/C13H12N2S/c1-3-13-12(15-10(2)16-13)7-6-11-5-4-8-14-9-11/h4-5,8-9H,3H2,1-2H3 D01DPN DRUGINKE SJJSHLRFCBWELS-UHFFFAOYSA-N D01DPN DRUGSMIL CCC1=C(N=C(S1)C)C#CC2=CN=CC=C2 D01DPN HIGHSTAT Investigative D01DTE DRUG__ID D01DTE D01DTE DRUGTYPE Small molecular drug D01DTE DRUGINCH 1S/C12H8Cl2O3/c13-7-1-3-12(10(16)5-7)17-11-4-2-8(15)6-9(11)14/h1-6,15-16H D01DTE DRUGINKE JVFMLMMBAJXPOQ-UHFFFAOYSA-N D01DTE DRUGSMIL C1=CC(=C(C=C1O)Cl)OC2=C(C=C(C=C2)Cl)O D01DTE HIGHSTAT Investigative D01DTW DRUG__ID D01DTW D01DTW DRUGTYPE Small molecular drug D01DTW DRUGINCH 1S/C15H26/c1-6-14(4)10-8-12-15(5)11-7-9-13(2)3/h6,9,12H,7-8,10-11H2,1-5H3/b14-6+,15-12+ D01DTW DRUGINKE JXBSHSBNOVLGHF-BUJBXKITSA-N D01DTW DRUGSMIL CC=C(C)CCC=C(C)CCC=C(C)C D01DTW HIGHSTAT Investigative D01DYZ DRUG__ID D01DYZ D01DYZ DRUGTYPE Small molecular drug D01DYZ DRUGINCH 1S/C23H25NO5/c1-25-19-7-13-6-15(14-8-21(27-3)23(29-5)22(9-14)28-4)17-11-24-12-18(17)16(13)10-20(19)26-2/h6-10,24H,11-12H2,1-5H3 D01DYZ DRUGINKE AECCJUJXNOJGBB-UHFFFAOYSA-N D01DYZ DRUGSMIL COC1=CC2=CC(=C3CNCC3=C2C=C1OC)C4=CC(=C(C(=C4)OC)OC)OC D01DYZ HIGHSTAT Investigative D01DZF DRUG__ID D01DZF D01DZF DRUGTYPE Small molecular drug D01DZF DRUGINCH 1S/C21H20N2O/c24-21(19-11-14-22-15-12-19)23-16-13-20(17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-12,14-15,20H,13,16H2,(H,23,24) D01DZF DRUGINKE FNZXNCPUNGHMCJ-UHFFFAOYSA-N D01DZF DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)C2=CC=NC=C2)C3=CC=CC=C3 D01DZF HIGHSTAT Investigative D01EAQ DRUG__ID D01EAQ D01EAQ DRUGTYPE Small molecular drug D01EAQ DRUGINCH 1S/C19H23F3N2O3S/c1-3-6-15(2)27-18-9-4-8-17(11-18)24(13-16-7-5-10-23-12-16)28(25,26)14-19(20,21)22/h4-5,7-12,15H,3,6,13-14H2,1-2H3 D01EAQ DRUGINKE ICFXZBZASBXILF-UHFFFAOYSA-N D01EAQ DRUGSMIL CCCC(C)OC1=CC=CC(=C1)N(CC2=CN=CC=C2)S(=O)(=O)CC(F)(F)F D01EAQ HIGHSTAT Investigative D01EBV DRUG__ID D01EBV D01EBV DRUGTYPE Small molecular drug D01EBV DRUGINCH 1S/C31H50O4/c1-18-11-14-31(26(34)35-8)16-15-29(6)20(24(31)19(18)2)9-10-23-28(5)17-21(32)25(33)27(3,4)22(28)12-13-30(23,29)7/h9,18-19,21-25,32-33H,10-17H2,1-8H3/t18-,19+,21-,22+,23-,24+,25-,28+,29-,30-,31+/m1/s1 D01EBV DRUGINKE BRZWXKGDPAZBLF-ZLSCOBDWSA-N D01EBV DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)OC D01EBV HIGHSTAT Investigative D01EBY DRUG__ID D01EBY D01EBY DRUGTYPE Small molecular drug D01EBY DRUGINCH 1S/C6H13N3O2S/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1 D01EBY DRUGINKE BKGWACHYAMTLAF-BYPYZUCNSA-N D01EBY DRUGSMIL C(CC(C(=O)O)N)CNC(=S)N D01EBY HIGHSTAT Investigative D01ECL DRUG__ID D01ECL D01ECL DRUGTYPE Small molecular drug D01ECL DRUGINCH 1S/C11H8N2S/c1-9-13-11(8-14-9)6-5-10-4-2-3-7-12-10/h2-4,7-8H,1H3 D01ECL DRUGINKE BQDSXKBRSCMFRW-UHFFFAOYSA-N D01ECL DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CC=N2 D01ECL HIGHSTAT Investigative D01EDB DRUG__ID D01EDB D01EDB DRUGTYPE Small molecular drug D01EDB DRUGINCH 1S/C14H14N4O2/c19-14(16-20)9-8-13-11-18(17-15-13)10-4-7-12-5-2-1-3-6-12/h1-9,11,20H,10H2,(H,16,19)/b7-4+,9-8+ D01EDB DRUGINKE IILXTLMEJJIBSG-NUXDXBQRSA-N D01EDB DRUGSMIL C1=CC=C(C=C1)C=CCN2C=C(N=N2)C=CC(=O)NO D01EDB HIGHSTAT Investigative D01EEM DRUG__ID D01EEM D01EEM DRUGTYPE Small molecular drug D01EEM DRUGINCH 1S/C13H12N2O3S2/c14-20(17,18)10-7-5-9(6-8-10)15-13(16)11-3-1-2-4-12(11)19/h1-8,19H,(H,15,16)(H2,14,17,18) D01EEM DRUGINKE MRLVIVXGUGNENL-UHFFFAOYSA-N D01EEM DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)N)S D01EEM HIGHSTAT Investigative D01EFQ DRUG__ID D01EFQ D01EFQ DRUGTYPE Small molecular drug D01EFQ DRUGINCH 1S/C18H24N2O4/c1-4-5-6-7-8-13-9-10-15(14(21)11-13)24-18-19-16(22-2)12-17(20-18)23-3/h9-12,21H,4-8H2,1-3H3 D01EFQ DRUGINKE YNAUOGCPBHCMDN-UHFFFAOYSA-N D01EFQ DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=NC(=CC(=N2)OC)OC)O D01EFQ HIGHSTAT Investigative D01EGN DRUG__ID D01EGN D01EGN DRUGTYPE Small molecular drug D01EGN DRUGINCH 1S/C23H17NO/c25-21-13-11-19(12-14-21)23-16-20(17-7-3-1-4-8-17)15-22(24-23)18-9-5-2-6-10-18/h1-16,25H D01EGN DRUGINKE LARDQALKCMOPHD-UHFFFAOYSA-N D01EGN DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC=C(C=C3)O)C4=CC=CC=C4 D01EGN HIGHSTAT Investigative D01EHP DRUG__ID D01EHP D01EHP DRUGTYPE Small molecular drug D01EHP DRUGINCH 1S/C11H15N5/c1-16-7-14-9-10(12-6-13-11(9)16)15-8-4-2-3-5-8/h6-8H,2-5H2,1H3,(H,12,13,15) D01EHP DRUGINKE LZMRVYPPUVMKOI-UHFFFAOYSA-N D01EHP DRUGSMIL CN1C=NC2=C(N=CN=C21)NC3CCCC3 D01EHP HIGHSTAT Investigative D01EHS DRUG__ID D01EHS D01EHS DRUGTYPE Small molecular drug D01EHS DRUGINCH 1S/C6H12N2S/c1-5-4-6(7)8-2-3-9-5/h5H,2-4H2,1H3,(H2,7,8) D01EHS DRUGINKE JXQWNOBSLLRHKM-UHFFFAOYSA-N D01EHS DRUGSMIL CC1CC(=NCCS1)N D01EHS HIGHSTAT Investigative D01EIS DRUG__ID D01EIS D01EIS DRUGTYPE Small molecular drug D01EIS DRUGINCH 1S/C18H22N2/c1-3-7-16(8-4-1)15-18(17-9-5-2-6-10-17)20-13-11-19-12-14-20/h1-10,18-19H,11-15H2 D01EIS DRUGINKE NIBIYLDNVMUKNB-UHFFFAOYSA-N D01EIS DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2)C3=CC=CC=C3 D01EIS HIGHSTAT Investigative D01EJH DRUG__ID D01EJH D01EJH DRUGTYPE Small molecular drug D01EJH DRUGINCH 1S/C20H18O4/c1-20(2)6-5-11-7-14-17(9-16(11)24-20)22-10-15-13-4-3-12(21)8-18(13)23-19(14)15/h3-9,15,19,21H,10H2,1-2H3/t15-,19-/m0/s1 D01EJH DRUGINKE OGFFMQWYZCTXCM-KXBFYZLASA-N D01EJH DRUGSMIL CC1(C=CC2=CC3=C(C=C2O1)OCC4C3OC5=C4C=CC(=C5)O)C D01EJH HIGHSTAT Investigative D01ENA DRUG__ID D01ENA D01ENA DRUGTYPE Small molecular drug D01ENA DRUGINCH 1S/6CN.Fe/c6*1-2;/q6*-1;+2 D01ENA DRUGINKE UETZVSHORCDDTH-UHFFFAOYSA-N D01ENA DRUGSMIL [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[Fe+2] D01ENA HIGHSTAT Investigative D01ENO DRUG__ID D01ENO D01ENO DRUGTYPE Small molecular drug D01ENO DRUGINCH 1S/C20H38O11P2/c1-16(2)8-7-9-17(3)11-13-30-33(27,28)31-32(25,26)29-12-6-5-10-18(21)14-20(4,24)15-19(22)23/h8,11,18,21,24H,5-7,9-10,12-15H2,1-4H3,(H,22,23)(H,25,26)(H,27,28)/b17-11+ D01ENO DRUGINKE PMUQIJKCGIYWGT-GZTJUZNOSA-N D01ENO DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCCCC(CC(C)(CC(=O)O)O)O)C)C D01ENO HIGHSTAT Investigative D01ENR DRUG__ID D01ENR D01ENR DRUGTYPE Small molecular drug D01ENR DRUGINCH 1S/C19H23NO2/c1-2-6-17(7-3-1)16-18-8-4-5-9-19(18)22-15-12-20-10-13-21-14-11-20/h1-9H,10-16H2 D01ENR DRUGINKE DQESEABEPUDVEZ-UHFFFAOYSA-N D01ENR DRUGSMIL C1COCCN1CCOC2=CC=CC=C2CC3=CC=CC=C3 D01ENR HIGHSTAT Investigative D01EOQ DRUG__ID D01EOQ D01EOQ DRUGTYPE Small molecular drug D01EOQ DRUGINCH 1S/C27H24BrN3O3/c1-18-15-21(16-19-7-6-10-24(17-19)34-2)27(33)31(30-18)25(20-8-4-3-5-9-20)26(32)29-23-13-11-22(28)12-14-23/h3-15,17,25H,16H2,1-2H3,(H,29,32)/t25-/m1/s1 D01EOQ DRUGINKE SPUZCVBKJUVZSD-RUZDIDTESA-N D01EOQ DRUGSMIL CC1=NN(C(=O)C(=C1)CC2=CC(=CC=C2)OC)C(C3=CC=CC=C3)C(=O)NC4=CC=C(C=C4)Br D01EOQ HIGHSTAT Investigative D01EOU DRUG__ID D01EOU D01EOU DRUGTYPE Small molecular drug D01EOU DRUGINCH 1S/C21H24ClNO2/c1-25-21(24)20(17-9-3-2-4-10-17)19-12-5-6-13-23(19)15-16-8-7-11-18(22)14-16/h2-4,7-11,14,19-20H,5-6,12-13,15H2,1H3/t19-,20-/m1/s1 D01EOU DRUGINKE MOEMZDNFRMSDIA-WOJBJXKFSA-N D01EOU DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC(=CC=C2)Cl)C3=CC=CC=C3 D01EOU HIGHSTAT Investigative D01EPU DRUG__ID D01EPU D01EPU DRUGTYPE Small molecular drug D01EPU DRUGINCH 1S/C21H29NO/c23-17-8-7-16-12-20-18-6-1-2-9-21(18,19(16)13-17)10-11-22(20)14-15-4-3-5-15/h7-8,13,15,18,20,23H,1-6,9-12,14H2/t18-,20+,21+/m0/s1 D01EPU DRUGINKE YSTAPDGDOHWKQR-CEWLAPEOSA-N D01EPU DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)O)CC5CCC5 D01EPU HIGHSTAT Investigative D01ERB DRUG__ID D01ERB D01ERB DRUGTYPE Small molecular drug D01ERB DRUGINCH 1S/C24H27NO2/c1-24-9-6-20-19-5-3-18(26)13-16(19)2-4-21(20)22(24)14-17(23(24)27)12-15-7-10-25-11-8-15/h3,5,7-8,10-13,20-23,26-27H,2,4,6,9,14H2,1H3/b17-12+/t20?,21?,22?,23-,24-/m0/s1 D01ERB DRUGINKE SOWVSBMETYFGLF-PHKWELIGSA-N D01ERB DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=NC=C4)C2O)CCC5=C3C=CC(=C5)O D01ERB HIGHSTAT Investigative D01ERW DRUG__ID D01ERW D01ERW DRUGTYPE Small molecular drug D01ERW DRUGINCH 1S/C19H16FN5O/c1-11-17(22-23-25(11)16-3-2-8-21-18(16)20)12-4-7-15-13(9-12)10-24(19(15)26)14-5-6-14/h2-4,7-9,14H,5-6,10H2,1H3 D01ERW DRUGINKE XZBFQWRAIYRPPZ-UHFFFAOYSA-N D01ERW DRUGSMIL CC1=C(N=NN1C2=C(N=CC=C2)F)C3=CC4=C(C=C3)C(=O)N(C4)C5CC5 D01ERW HIGHSTAT Investigative D01EST DRUG__ID D01EST D01EST DRUGTYPE Small molecular drug D01EST DRUGINCH 1S/C15H8Cl3NO2/c16-8-1-2-13-9(6-8)10(15(21)19-13)3-7-4-11(17)14(20)12(18)5-7/h1-6,20H,(H,19,21)/b10-3- D01EST DRUGINKE ZJFMARHFPUZEKI-KMKOMSMNSA-N D01EST DRUGSMIL C1=CC2=C(C=C1Cl)C(=CC3=CC(=C(C(=C3)Cl)O)Cl)C(=O)N2 D01EST HIGHSTAT Investigative D01ESV DRUG__ID D01ESV D01ESV DRUGTYPE Small molecular drug D01ESV DRUGINCH 1S/C14H10F3NO2/c15-14(16,17)11-5-1-9(2-6-11)10-3-7-12(8-4-10)20-13(18)19/h1-8H,(H2,18,19) D01ESV DRUGINKE ZIARVUIVYFGYIG-UHFFFAOYSA-N D01ESV DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)OC(=O)N)C(F)(F)F D01ESV HIGHSTAT Investigative D01ETL DRUG__ID D01ETL D01ETL DRUGTYPE Small molecular drug D01ETL DRUGINCH 1S/C21H19F3N2O4S/c1-29-19-9-2-3-10-20(19)30-18-8-4-7-17(12-18)26(14-16-6-5-11-25-13-16)31(27,28)15-21(22,23)24/h2-13H,14-15H2,1H3 D01ETL DRUGINKE GJWZEUKWBMFOAA-UHFFFAOYSA-N D01ETL DRUGSMIL COC1=CC=CC=C1OC2=CC=CC(=C2)N(CC3=CN=CC=C3)S(=O)(=O)CC(F)(F)F D01ETL HIGHSTAT Investigative D01ETZ DRUG__ID D01ETZ D01ETZ DRUGTYPE Small molecular drug D01ETZ DRUGINCH 1S/C19H24O2/c1-18-9-7-15-14-6-4-13(20)11-12(14)3-5-16(15)17(18)8-10-19(18,2)21/h7,9,11,16-17,21H,3-6,8,10H2,1-2H3/t16-,17+,18+,19+/m1/s1 D01ETZ DRUGINKE CCCIJQPRIXGQOE-XWSJACJDSA-N D01ETZ DRUGSMIL CC1(CCC2C1(C=CC3=C4CCC(=O)C=C4CCC23)C)O D01ETZ HIGHSTAT Investigative D01EVA DRUG__ID D01EVA D01EVA DRUGTYPE Small molecular drug D01EVA DRUGINCH 1S/C13H13NO4/c1-2-17-12(15)13-7-9(13)11(14-16)8-5-3-4-6-10(8)18-13/h3-6,9,16H,2,7H2,1H3/b14-11- D01EVA DRUGINKE FXCTZFMSAHZQTR-KAMYIIQDSA-N D01EVA DRUGSMIL CCOC(=O)C12CC1C(=NO)C3=CC=CC=C3O2 D01EVA HIGHSTAT Investigative D01EVE DRUG__ID D01EVE D01EVE DRUGTYPE Small molecular drug D01EVE DRUGINCH 1S/C12H10BrN5O/c1-19-8-3-2-6(13)4-7(8)9-10-11(16-5-15-10)18-12(14)17-9/h2-5H,1H3,(H3,14,15,16,17,18) D01EVE DRUGINKE KDNVOUMYSICLPF-UHFFFAOYSA-N D01EVE DRUGSMIL COC1=C(C=C(C=C1)Br)C2=C3C(=NC(=N2)N)N=CN3 D01EVE HIGHSTAT Investigative D01EVI DRUG__ID D01EVI D01EVI DRUGTYPE Small molecular drug D01EVI DRUGINCH 1S/C7H10O7/c1-7(14,6(12)13)3(5(10)11)2-4(8)9/h3,14H,2H2,1H3,(H,8,9)(H,10,11)(H,12,13)/t3-,7-/m1/s1 D01EVI DRUGINKE HHKPKXCSHMJWCF-WVBDSBKLSA-N D01EVI DRUGSMIL CC(C(CC(=O)O)C(=O)O)(C(=O)O)O D01EVI HIGHSTAT Investigative D01EVX DRUG__ID D01EVX D01EVX DRUGTYPE Small molecular drug D01EVX DRUGINCH 1S/C9H7ClN2O/c1-5-11-7-4-2-3-6(10)8(7)9(13)12-5/h2-4H,1H3,(H,11,12,13) D01EVX DRUGINKE GKDIFKSYPXLUJS-UHFFFAOYSA-N D01EVX DRUGSMIL CC1=NC2=C(C(=CC=C2)Cl)C(=O)N1 D01EVX HIGHSTAT Investigative D01EWD DRUG__ID D01EWD D01EWD DRUGTYPE Small molecular drug D01EWD DRUGINCH 1S/C15H22O2Se/c1-3-4-5-6-9-12-18-15-11-8-7-10-14(15)17-13(2)16/h7-8,10-11H,3-6,9,12H2,1-2H3 D01EWD DRUGINKE FDXGTFIBPBOUCY-UHFFFAOYSA-N D01EWD DRUGSMIL CCCCCCC[Se]C1=CC=CC=C1OC(=O)C D01EWD HIGHSTAT Investigative D01EZC DRUG__ID D01EZC D01EZC DRUGTYPE Small molecular drug D01EZC DRUGINCH 1S/C25H25NO3/c1-26(18-19-9-3-2-4-10-19)15-7-8-16-28-20-13-14-22-24(17-20)29-23-12-6-5-11-21(23)25(22)27/h2-6,9-14,17H,7-8,15-16,18H2,1H3 D01EZC DRUGINKE VUBALVZUDJIWHQ-UHFFFAOYSA-N D01EZC DRUGSMIL CN(CCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D01EZC HIGHSTAT Investigative D01FAA DRUG__ID D01FAA D01FAA DRUGTYPE Small molecular drug D01FAA DRUGINCH 1S/C11H10BrN5O2/c12-6-3-5-4(7-10(19)17-11(13)16-7)1-2-14-9(18)8(5)15-6/h3-5H,1-2H2,(H,14,18)(H2,13,17,19) D01FAA DRUGINKE QPCBNXNDVYOBIP-UHFFFAOYSA-N D01FAA DRUGSMIL C1CNC(=O)C2=NC(=CC2C1C3=NC(=NC3=O)N)Br D01FAA HIGHSTAT Investigative D01FAR DRUG__ID D01FAR D01FAR DRUGTYPE Small molecular drug D01FAR DRUGINCH 1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)/p-2 D01FAR DRUGINKE MUBZPKHOEPUJKR-UHFFFAOYSA-L D01FAR DRUGSMIL C(=O)(C(=O)[O-])[O-] D01FAR HIGHSTAT Investigative D01FBL DRUG__ID D01FBL D01FBL DRUGTYPE Small molecular drug D01FBL DRUGINCH 1S/C22H24O7/c1-24-19-9-14(10-20(25-2)21(19)26-3)7-16-15(11-27-22(16)23)6-13-4-5-17-18(8-13)29-12-28-17/h4-5,8-10,15-16H,6-7,11-12H2,1-3H3/t15-,16+/m0/s1 D01FBL DRUGINKE GMLDZDDTZKXJLU-JKSUJKDBSA-N D01FBL DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2C(COC2=O)CC3=CC4=C(C=C3)OCO4 D01FBL HIGHSTAT Investigative D01FCH DRUG__ID D01FCH D01FCH DRUGTYPE Small molecular drug D01FCH DRUGINCH 1S/C17H20N2O9S/c20-14(21)8-7-12(16(23)24)18-15(22)10-3-5-11(6-4-10)29(27,28)19-9-1-2-13(19)17(25)26/h3-6,12-13H,1-2,7-9H2,(H,18,22)(H,20,21)(H,23,24)(H,25,26)/t12-,13+/m0/s1 D01FCH DRUGINKE NDDOUBGQRWFVQM-QWHCGFSZSA-N D01FCH DRUGSMIL C1CC(N(C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)O D01FCH HIGHSTAT Investigative D01FEA DRUG__ID D01FEA D01FEA DRUGTYPE Small molecular drug D01FEA DRUGINCH 1S/C23H24O5/c1-12(2)8-10-14-19(25)16(11-9-13(3)4)23-18(20(14)26)21(27)15-6-5-7-17(24)22(15)28-23/h5-9,24-26H,10-11H2,1-4H3 D01FEA DRUGINKE GVQOVMKBYJKZSY-UHFFFAOYSA-N D01FEA DRUGSMIL CC(=CCC1=C(C(=C2C(=C1O)C(=O)C3=C(O2)C(=CC=C3)O)CC=C(C)C)O)C D01FEA HIGHSTAT Investigative D01FFX DRUG__ID D01FFX D01FFX DRUGTYPE Small molecular drug D01FFX DRUGINCH 1S/C16H19NO/c1-2-4-15-11-16(6-5-14(15)3-1)18-12-13-7-9-17-10-8-13/h1-6,11,13,17H,7-10,12H2 D01FFX DRUGINKE MUOXAGUZMVATIC-UHFFFAOYSA-N D01FFX DRUGSMIL C1CNCCC1COC2=CC3=CC=CC=C3C=C2 D01FFX HIGHSTAT Investigative D01FGM DRUG__ID D01FGM D01FGM DRUGTYPE Small molecular drug D01FGM DRUGINCH 1S/C16H12O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-7,17-19H,1H3 D01FGM DRUGINKE SCZVLDHREVKTSH-UHFFFAOYSA-N D01FGM DRUGSMIL COC1=C(C=CC(=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O D01FGM HIGHSTAT Investigative D01FGW DRUG__ID D01FGW D01FGW DRUGTYPE Small molecular drug D01FGW DRUGINCH 1S/C14H9Br2N3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19) D01FGW DRUGINKE GBBRIESLSQOJQX-UHFFFAOYSA-N D01FGW DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)Br D01FGW HIGHSTAT Investigative D01FJB DRUG__ID D01FJB D01FJB DRUGTYPE Small molecular drug D01FJB DRUGINCH 1S/C12H15N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-2,7-8H,3-6H2,(H3,13,14,15,16,17) D01FJB DRUGINKE RXNXVXFFAAPSTR-UHFFFAOYSA-N D01FJB DRUGSMIL C1CC(CC=C1)COC2=NC(=NC3=C2NC=N3)N D01FJB HIGHSTAT Investigative D01FJE DRUG__ID D01FJE D01FJE DRUGTYPE Small molecular drug D01FJE DRUGINCH 1S/C16H14O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-7,14,17-18H,8H2,1H3/t14-/m0/s1 D01FJE DRUGINKE HMUJXQRRKBLVOO-AWEZNQCLSA-N D01FJE DRUGSMIL COC1=CC=C(C=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O D01FJE HIGHSTAT Investigative D01FLQ DRUG__ID D01FLQ D01FLQ DRUGTYPE Small molecular drug D01FLQ DRUGINCH 1S/C7H9BO3/c1-11-7-5-3-2-4-6(7)8(9)10/h2-5,9-10H,1H3 D01FLQ DRUGINKE ROEQGIFOWRQYHD-UHFFFAOYSA-N D01FLQ DRUGSMIL B(C1=CC=CC=C1OC)(O)O D01FLQ HIGHSTAT Investigative D01FMS DRUG__ID D01FMS D01FMS DRUGTYPE Small molecular drug D01FMS DRUGINCH 1S/C20H30NO3.C13H21NO3.ClH/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15;1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-8,14,16-19,22H,9-13H2,1-3H3;4-6,12,14-17H,7-8H2,1-3H3;1H/q+1;;/p-1/t16-,17+,18?,19?,21?;12-;/m.0./s1 D01FMS DRUGINKE ABSQYTODNZGQMD-ORLLXICISA-M D01FMS DRUGSMIL CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.CC(C)(C)NCC(C1=CC(=C(C=C1)[O-])CO)O.Cl D01FMS HIGHSTAT Investigative D01FNC DRUG__ID D01FNC D01FNC DRUGTYPE Small molecular drug D01FNC DRUGINCH 1S/C14H9N3O2/c15-9-7-12(18)8-4-5-11(17-13(8)14(9)19)10-3-1-2-6-16-10/h1-7H,15H2 D01FNC DRUGINKE UMMNKCUSQIKSGP-UHFFFAOYSA-N D01FNC DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(C=C2)C(=O)C=C(C3=O)N D01FNC HIGHSTAT Investigative D01FNH DRUG__ID D01FNH D01FNH DRUGTYPE Small molecular drug D01FNH DRUGINCH 1S/C20H15NO3S/c1-23-14-10-12-15(13-11-14)24-20(22)21-16-6-2-4-8-18(16)25-19-9-5-3-7-17(19)21/h2-13H,1H3 D01FNH DRUGINKE OFQHJDQONOGHGC-UHFFFAOYSA-N D01FNH DRUGSMIL COC1=CC=C(C=C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D01FNH HIGHSTAT Investigative D01FOK DRUG__ID D01FOK D01FOK DRUGTYPE Small molecular drug D01FOK DRUGINCH 1S/C14H14O4/c1-3-10(15)13-11(17-4-2)7-5-9-6-8-12(16)18-14(9)13/h5-8H,3-4H2,1-2H3 D01FOK DRUGINKE LJTVZULEIDSNAK-UHFFFAOYSA-N D01FOK DRUGSMIL CCC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OCC D01FOK HIGHSTAT Investigative D01FOM DRUG__ID D01FOM D01FOM DRUGTYPE Small molecular drug D01FOM DRUGINCH 1S/C10H12N4S/c1-6-15-10-8(1)9(12-7-13-10)14-4-2-11-3-5-14/h1,6-7,11H,2-5H2 D01FOM DRUGINKE HFGUINASBGDWLY-UHFFFAOYSA-N D01FOM DRUGSMIL C1CN(CCN1)C2=C3C=CSC3=NC=N2 D01FOM HIGHSTAT Investigative D01FPD DRUG__ID D01FPD D01FPD DRUGTYPE Small molecular drug D01FPD DRUGINCH 1S/C24H31FO8/c1-23-6-4-15-22(28)33-18(14-5-8-30-12-14)11-24(15,2)20(23)19(26)17(32-13-31-9-7-25)10-16(23)21(27)29-3/h5,8,12,15-18,20H,4,6-7,9-11,13H2,1-3H3/t15-,16-,17-,18-,20-,23-,24-/m0/s1 D01FPD DRUGINKE BESVDGAGHUYOPY-WFOQEEKOSA-N D01FPD DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOCCF)C)C4=COC=C4 D01FPD HIGHSTAT Investigative D01FPX DRUG__ID D01FPX D01FPX DRUGTYPE Small molecular drug D01FPX DRUGINCH 1S/C11H11N3O2/c1-6-2-4-7(5-3-6)11-14-8(9(12)15)10(13)16-11/h2-5H,13H2,1H3,(H2,12,15) D01FPX DRUGINKE RSMHDVYJLCPVNY-UHFFFAOYSA-N D01FPX DRUGSMIL CC1=CC=C(C=C1)C2=NC(=C(O2)N)C(=O)N D01FPX HIGHSTAT Investigative D01FQZ DRUG__ID D01FQZ D01FQZ DRUGTYPE Small molecular drug D01FQZ DRUGINCH 1S/C21H18O5/c1-11(2)3-4-14-17(23)6-5-13-16-10-25-19-8-18(24)12(9-22)7-15(19)21(16)26-20(13)14/h3,5-9,23-24H,4,10H2,1-2H3 D01FQZ DRUGINKE AGFXXWXSPAYWMF-UHFFFAOYSA-N D01FQZ DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3=C2COC4=C3C=C(C(=C4)O)C=O)O)C D01FQZ HIGHSTAT Investigative D01FTB DRUG__ID D01FTB D01FTB DRUGTYPE Small molecular drug D01FTB DRUGINCH 1S/C9H9ClN2/c10-8-3-1-7(2-4-8)9-11-5-6-12-9/h1-4H,5-6H2,(H,11,12) D01FTB DRUGINKE XUMWMBLBTZAVLW-UHFFFAOYSA-N D01FTB DRUGSMIL C1CN=C(N1)C2=CC=C(C=C2)Cl D01FTB HIGHSTAT Investigative D01FTP DRUG__ID D01FTP D01FTP DRUGTYPE Small molecular drug D01FTP DRUGINCH 1S/C17H15N/c1-12-4-3-5-15(10-12)16-9-8-14-7-6-13(2)18-17(14)11-16/h3-11H,1-2H3 D01FTP DRUGINKE LRWHLTHMQZJGQD-UHFFFAOYSA-N D01FTP DRUGSMIL CC1=CC(=CC=C1)C2=CC3=C(C=CC(=N3)C)C=C2 D01FTP HIGHSTAT Investigative D01FVY DRUG__ID D01FVY D01FVY DRUGTYPE Small molecular drug D01FVY DRUGINCH 1S/C14H16N2O/c1-9(17)15-10-6-7-14-12(8-10)11-4-2-3-5-13(11)16-14/h2-5,10,16H,6-8H2,1H3,(H,15,17) D01FVY DRUGINKE DNJBLXBGYRYOBT-UHFFFAOYSA-N D01FVY DRUGSMIL CC(=O)NC1CCC2=C(C1)C3=CC=CC=C3N2 D01FVY HIGHSTAT Investigative D01FWD DRUG__ID D01FWD D01FWD DRUGTYPE Small molecular drug D01FWD DRUGINCH 1S/C13H10N2/c1-2-6-11(7-3-1)15-10-14-12-8-4-5-9-13(12)15/h1-10H D01FWD DRUGINKE XNCMQRWVMWLODV-UHFFFAOYSA-N D01FWD DRUGSMIL C1=CC=C(C=C1)N2C=NC3=CC=CC=C32 D01FWD HIGHSTAT Investigative D01FYB DRUG__ID D01FYB D01FYB DRUGTYPE Small molecular drug D01FYB DRUGINCH 1S/C15H12N4O/c16-11-3-1-2-4-12(11)19-15(20)10-5-6-13-14(9-10)18-8-7-17-13/h1-9H,16H2,(H,19,20) D01FYB DRUGINKE DINRLSVFUAZDMZ-UHFFFAOYSA-N D01FYB DRUGSMIL C1=CC=C(C(=C1)N)NC(=O)C2=CC3=NC=CN=C3C=C2 D01FYB HIGHSTAT Investigative D01GAR DRUG__ID D01GAR D01GAR DRUGTYPE Small molecular drug D01GAR DRUGINCH 1S/C8H21NO6P2/c1-2-3-4-5-6-9-7-8(16(10,11)12)17(13,14)15/h8-9H,2-7H2,1H3,(H2,10,11,12)(H2,13,14,15) D01GAR DRUGINKE QDLXIUDMSHZYCG-UHFFFAOYSA-N D01GAR DRUGSMIL CCCCCCNCC(P(=O)(O)O)P(=O)(O)O D01GAR HIGHSTAT Investigative D01GAX DRUG__ID D01GAX D01GAX DRUGTYPE Small molecular drug D01GAX DRUGINCH 1S/C12H15N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-7H,8-10H2,1H3 D01GAX DRUGINKE PLRACCBDVIHHLZ-UHFFFAOYSA-N D01GAX DRUGSMIL CN1CCC(=CC1)C2=CC=CC=C2 D01GAX HIGHSTAT Investigative D01GGU DRUG__ID D01GGU D01GGU DRUGTYPE Small molecular drug D01GGU DRUGINCH 1S/C17H21N5O/c1-3-4-8-22-14(10-12-6-5-7-13(9-12)23-2)21-15-16(18)19-11-20-17(15)22/h5-7,9,11H,3-4,8,10H2,1-2H3,(H2,18,19,20) D01GGU DRUGINKE BWLWUGBHOXIUBP-UHFFFAOYSA-N D01GGU DRUGSMIL CCCCN1C(=NC2=C(N=CN=C21)N)CC3=CC(=CC=C3)OC D01GGU HIGHSTAT Investigative D01GLG DRUG__ID D01GLG D01GLG DRUGTYPE Small molecular drug D01GLG DRUGINCH 1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1 D01GLG DRUGINKE IQFYYKKMVGJFEH-XLPZGREQSA-N D01GLG DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O D01GLG HIGHSTAT Investigative D01GMJ DRUG__ID D01GMJ D01GMJ DRUGTYPE Small molecular drug D01GMJ DRUGINCH 1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2 D01GMJ DRUGINKE VHJLVAABSRFDPM-UHFFFAOYSA-N D01GMJ DRUGSMIL C(C(C(CS)O)O)S D01GMJ HIGHSTAT Investigative D01GNF DRUG__ID D01GNF D01GNF DRUGTYPE Small molecular drug D01GNF DRUGINCH 1S/C16H10I2N2O2/c17-11-3-1-10(2-4-11)9-14-15(21)19-20(16(14)22)13-7-5-12(18)6-8-13/h1-9H,(H,19,21)/b14-9- D01GNF DRUGINKE HOZMXIPMJIGFMB-ZROIWOOFSA-N D01GNF DRUGSMIL C1=CC(=CC=C1C=C2C(=O)NN(C2=O)C3=CC=C(C=C3)I)I D01GNF HIGHSTAT Investigative D01GNQ DRUG__ID D01GNQ D01GNQ DRUGTYPE Small molecular drug D01GNQ DRUGINCH 1S/C6H7AsO3/c8-7(9)10-6-4-2-1-3-5-6/h1-5,8-9H D01GNQ DRUGINKE NOJGJOHOYAWLBB-UHFFFAOYSA-N D01GNQ DRUGSMIL C1=CC=C(C=C1)O[As](O)O D01GNQ HIGHSTAT Investigative D01GPC DRUG__ID D01GPC D01GPC DRUGTYPE Small molecular drug D01GPC DRUGINCH 1S/C20H25ClN4O3S/c1-29(26,27)17-2-3-19(22-13-17)28-9-6-15-10-18(15)14-4-7-25(8-5-14)20-23-11-16(21)12-24-20/h2-3,11-15,18H,4-10H2,1H3/t15-,18-/m1/s1 D01GPC DRUGINKE XFJBGINZIMNZBW-CRAIPNDOSA-N D01GPC DRUGSMIL CS(=O)(=O)C1=CN=C(C=C1)OCCC2CC2C3CCN(CC3)C4=NC=C(C=N4)Cl D01GPC HIGHSTAT Investigative D01GPY DRUG__ID D01GPY D01GPY DRUGTYPE Small molecular drug D01GPY DRUGINCH 1S/C17H14O2/c1-11-8-15(18)6-7-17(11)14-3-2-13-10-16(19)5-4-12(13)9-14/h2-10,18-19H,1H3 D01GPY DRUGINKE YIKDKHNOMWERET-UHFFFAOYSA-N D01GPY DRUGSMIL CC1=C(C=CC(=C1)O)C2=CC3=C(C=C2)C=C(C=C3)O D01GPY HIGHSTAT Investigative D01GRB DRUG__ID D01GRB D01GRB DRUGTYPE Small molecular drug D01GRB DRUGINCH 1S/C11H16N5O7PS/c1-25-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(23-10)2-22-24(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1 D01GRB DRUGINKE XVTFTCNRRAQHEQ-KQYNXXCUSA-N D01GRB DRUGSMIL CSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O)N D01GRB HIGHSTAT Investigative D01GSG DRUG__ID D01GSG D01GSG DRUGTYPE Small molecular drug D01GSG DRUGINCH 1S/C16H16N2O/c17-9-12-1-2-15-8-16(4-3-14(15)7-12)19-11-13-5-6-18-10-13/h1-4,7-8,13,18H,5-6,10-11H2/t13-/m1/s1 D01GSG DRUGINKE PYEILVKGQDUINV-CYBMUJFWSA-N D01GSG DRUGSMIL C1CNCC1COC2=CC3=C(C=C2)C=C(C=C3)C#N D01GSG HIGHSTAT Investigative D01GSO DRUG__ID D01GSO D01GSO DRUGTYPE Small molecular drug D01GSO DRUGINCH 1S/C12H16F3O4P/c1-3-17-20(16,18-4-2)19-11(12(13,14)15)10-8-6-5-7-9-10/h5-9,11H,3-4H2,1-2H3 D01GSO DRUGINKE LLGREQYHEQMYRW-UHFFFAOYSA-N D01GSO DRUGSMIL CCOP(=O)(OCC)OC(C1=CC=CC=C1)C(F)(F)F D01GSO HIGHSTAT Investigative D01GSW DRUG__ID D01GSW D01GSW DRUGTYPE Small molecular drug D01GSW DRUGINCH 1S/C20H18N2O4/c1-25-16-10-12(11-17(26-2)18(16)23)9-13-7-8-22-19(13)21-15-6-4-3-5-14(15)20(22)24/h3-6,9-11,23H,7-8H2,1-2H3/b13-9+ D01GSW DRUGINKE UBCUTNIGHUVICE-UKTHLTGXSA-N D01GSW DRUGSMIL COC1=CC(=CC(=C1O)OC)C=C2CCN3C2=NC4=CC=CC=C4C3=O D01GSW HIGHSTAT Investigative D01GUG DRUG__ID D01GUG D01GUG DRUGTYPE Small molecular drug D01GUG DRUGINCH 1S/C25H38O4/c1-22(14-26)9-5-10-23(2)17(22)8-11-24(3)18-7-6-15-16(13-29-21(15)28)25(18,4)20(27)12-19(23)24/h6,16-20,26-27H,5,7-14H2,1-4H3/t16-,17-,18-,19+,20+,22-,23-,24-,25+/m0/s1 D01GUG DRUGINKE LXWMXTKOJPFGPW-NFXGRNOLSA-N D01GUG DRUGSMIL CC1(CCCC2(C1CCC3(C2CC(C4(C3CC=C5C4COC5=O)C)O)C)C)CO D01GUG HIGHSTAT Investigative D01GUK DRUG__ID D01GUK D01GUK DRUGTYPE Small molecular drug D01GUK DRUGINCH 1S/C16H17N5/c1-2-8-13(9-3-1)21-11-19-14-15(17-10-18-16(14)21)20-12-6-4-5-7-12/h1-3,8-12H,4-7H2,(H,17,18,20) D01GUK DRUGINKE HMTXZOPPYXBLIU-UHFFFAOYSA-N D01GUK DRUGSMIL C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4=CC=CC=C4 D01GUK HIGHSTAT Investigative D01GWH DRUG__ID D01GWH D01GWH DRUGTYPE Small molecular drug D01GWH DRUGINCH 1S/C26H30N2O/c29-26(24-14-13-22-11-4-5-12-23(22)20-24)27-25-15-18-28(19-16-25)17-7-6-10-21-8-2-1-3-9-21/h1-5,8-9,11-14,20,25H,6-7,10,15-19H2,(H,27,29) D01GWH DRUGINKE XYKZGGUQORZZTO-UHFFFAOYSA-N D01GWH DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CCCCC4=CC=CC=C4 D01GWH HIGHSTAT Investigative D01GWN DRUG__ID D01GWN D01GWN DRUGTYPE Small molecular drug D01GWN DRUGINCH 1S/C29H46O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h8-11,15,19-26,30H,7,12-14,16-18H2,1-6H3/b9-8+/t20-,21-,22?,23+,24+,25-,26+,28+,29-/m1/s1 D01GWN DRUGINKE ZFRLPKWDPDXIMP-BLDYNFBXSA-N D01GWN DRUGSMIL CCC(C=CC(C)C1CCC2C1(CC=C3C2C=CC4C3(CCC(C4)O)C)C)C(C)C D01GWN HIGHSTAT Investigative D01GZV DRUG__ID D01GZV D01GZV DRUGTYPE Small molecular drug D01GZV DRUGINCH 1S/C22H43NO3/c1-3-5-6-7-8-9-10-11-12-13-14-15-18-21(24)22(25)23-19-16-17-20-26-4-2/h3-20H2,1-2H3,(H,23,25) D01GZV DRUGINKE ADDZROPIKDXVSC-UHFFFAOYSA-N D01GZV DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCCOCC D01GZV HIGHSTAT Investigative D01HAZ DRUG__ID D01HAZ D01HAZ DRUGTYPE Small molecular drug D01HAZ DRUGINCH 1S/C23H39NO/c1-4-7-10-11-12-21-13-15-22(16-14-21)23(25)17-20-24(18-8-5-2)19-9-6-3/h13-16H,4-12,17-20H2,1-3H3 D01HAZ DRUGINKE UMFRWWULZNWTFF-UHFFFAOYSA-N D01HAZ DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)CCN(CCCC)CCCC D01HAZ HIGHSTAT Investigative D01HBS DRUG__ID D01HBS D01HBS DRUGTYPE Small molecular drug D01HBS DRUGINCH 1S/C19H21NO2/c21-19(20-17-11-5-2-6-12-17)22-18-13-7-10-16(14-18)15-8-3-1-4-9-15/h1,3-4,7-10,13-14,17H,2,5-6,11-12H2,(H,20,21) D01HBS DRUGINKE KGKDDSYRBQOMLE-UHFFFAOYSA-N D01HBS DRUGSMIL C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D01HBS HIGHSTAT Investigative D01HCL DRUG__ID D01HCL D01HCL DRUGTYPE Small molecular drug D01HCL DRUGINCH 1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h15-17,19,21,23H,2-14H2,1H3,(H,24,25)/t15-,16+,17+,19+/m0/s1 D01HCL DRUGINKE DPOINJQWXDTOSF-DODZYUBVSA-N D01HCL DRUGSMIL CCCCCC(CCC1C(CC(=O)C1CCCCCCC(=O)O)O)O D01HCL HIGHSTAT Investigative D01HCO DRUG__ID D01HCO D01HCO DRUGTYPE Small molecular drug D01HCO DRUGINCH 1S/C14H15N3O3/c1-2-9-20-14-15-8-7-12(17-14)16-11-6-4-3-5-10(11)13(18)19/h3-8H,2,9H2,1H3,(H,18,19)(H,15,16,17) D01HCO DRUGINKE NZLCVQSIEXQTHO-UHFFFAOYSA-N D01HCO DRUGSMIL CCCOC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O D01HCO HIGHSTAT Investigative D01HCR DRUG__ID D01HCR D01HCR DRUGTYPE Small molecular drug D01HCR DRUGINCH 1S/C22H28N2O3/c1-2-3-4-5-6-10-17-26-21-15-13-20(14-16-21)24-22(25)27-23-18-19-11-8-7-9-12-19/h7-9,11-16,18H,2-6,10,17H2,1H3,(H,24,25)/b23-18+ D01HCR DRUGINKE BALHAPBNIAUXLM-PTGBLXJZSA-N D01HCR DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D01HCR HIGHSTAT Investigative D01HDD DRUG__ID D01HDD D01HDD DRUGTYPE Small molecular drug D01HDD DRUGINCH 1S/C15H7Cl4NO2/c16-10-8-9(11(17)13(19)12(10)18)15(22)20(14(8)21)6-7-4-2-1-3-5-7/h1-5H,6H2 D01HDD DRUGINKE MQFQHWBPMPPVNJ-UHFFFAOYSA-N D01HDD DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C3=C(C2=O)C(=C(C(=C3Cl)Cl)Cl)Cl D01HDD HIGHSTAT Investigative D01HFL DRUG__ID D01HFL D01HFL DRUGTYPE Small molecular drug D01HFL DRUGINCH 1S/C21H18N2/c1-4-10-17(11-5-1)20-22-16-21(23-20,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15H,16H2,(H,22,23) D01HFL DRUGINKE KXSXOHNHKQJMNF-UHFFFAOYSA-N D01HFL DRUGSMIL C1C(NC(=N1)C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D01HFL HIGHSTAT Investigative D01HGV DRUG__ID D01HGV D01HGV DRUGTYPE Small molecular drug D01HGV DRUGINCH 1S/C24H20O6/c25-22(14-23(26)24(27)28)19-11-20(29-15-17-7-3-1-4-8-17)13-21(12-19)30-16-18-9-5-2-6-10-18/h1-13H,14-16H2,(H,27,28) D01HGV DRUGINKE SLRLQBRWUMWEOZ-UHFFFAOYSA-N D01HGV DRUGSMIL C1=CC=C(C=C1)COC2=CC(=CC(=C2)C(=O)CC(=O)C(=O)O)OCC3=CC=CC=C3 D01HGV HIGHSTAT Investigative D01HJN DRUG__ID D01HJN D01HJN DRUGTYPE Small molecular drug D01HJN DRUGINCH 1S/C12H10O5/c1-2-16-11(14)9-5-7-3-4-8(13)6-10(7)17-12(9)15/h3-6,13H,2H2,1H3 D01HJN DRUGINKE IETDBZQIWIJQJG-UHFFFAOYSA-N D01HJN DRUGSMIL CCOC(=O)C1=CC2=C(C=C(C=C2)O)OC1=O D01HJN HIGHSTAT Investigative D01HJZ DRUG__ID D01HJZ D01HJZ DRUGTYPE Small molecular drug D01HJZ DRUGINCH 1S/C16H19N/c1-17(2)13-16(14-9-5-3-6-10-14)15-11-7-4-8-12-15/h3-12,16H,13H2,1-2H3 D01HJZ DRUGINKE UAUJDKBNVRSJBD-UHFFFAOYSA-N D01HJZ DRUGSMIL CN(C)CC(C1=CC=CC=C1)C2=CC=CC=C2 D01HJZ HIGHSTAT Investigative D01HKU DRUG__ID D01HKU D01HKU DRUGTYPE Small molecular drug D01HKU DRUGINCH 1S/C25H30N10O6/c1-34(12-14-11-28-21-19(29-14)20(26)31-25(27)32-21)15-6-4-13(5-7-15)22(37)30-16(24(39)40)8-9-18(36)35-10-2-3-17(35)23(38)33-41/h4-7,11,16-17,41H,2-3,8-10,12H2,1H3,(H,30,37)(H,33,38)(H,39,40)(H4,26,27,28,31,32)/t16-,17-/m0/s1 D01HKU DRUGINKE UYVVHTPVCDOQRA-IRXDYDNUSA-N D01HKU DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)N4CCCC4C(=O)NO)C(=O)O D01HKU HIGHSTAT Investigative D01HNP DRUG__ID D01HNP D01HNP DRUGTYPE Small molecular drug D01HNP DRUGINCH 1S/C2H4O3/c3-1-2(4)5/h3H,1H2,(H,4,5) D01HNP DRUGINKE AEMRFAOFKBGASW-UHFFFAOYSA-N D01HNP DRUGSMIL C(C(=O)O)O D01HNP HIGHSTAT Investigative D01HOO DRUG__ID D01HOO D01HOO DRUGTYPE Small molecular drug D01HOO DRUGINCH 1S/C11H17NO7/c12-6(9(14)15)2-11(10(16)17)3-8-7(19-11)1-5(13)4-18-8/h5-8,13H,1-4,12H2,(H,14,15)(H,16,17)/p-1/t5-,6-,7?,8?,11+/m0/s1 D01HOO DRUGINKE JVLNPAVKDNEYGY-SCTSMQQKSA-M D01HOO DRUGSMIL C1C(COC2C1OC(C2)(CC(C(=O)[O-])[NH3+])C(=O)[O-])O D01HOO HIGHSTAT Investigative D01HOP DRUG__ID D01HOP D01HOP DRUGTYPE Small molecular drug D01HOP DRUGINCH 1S/C30H40N6O7/c1-17(2)12-24(30(42)43)36-29(41)23(15-19-8-5-4-6-9-19)35-25(37)16-33-27(39)18(3)34-28(40)22(31)14-20-10-7-11-21(13-20)26(32)38/h4-11,13,17-18,22-24H,12,14-16,31H2,1-3H3,(H2,32,38)(H,33,39)(H,34,40)(H,35,37)(H,36,41)(H,42,43)/t18-,22-,23-,24-/m0/s1 D01HOP DRUGINKE CPTUJVNVSNEVEH-IMNFJDCFSA-N D01HOP DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(C)NC(=O)C(CC2=CC(=CC=C2)C(=O)N)N D01HOP HIGHSTAT Investigative D01HQV DRUG__ID D01HQV D01HQV DRUGTYPE Small molecular drug D01HQV DRUGINCH 1S/C16H12O3/c1-10-2-7-15-12(8-10)9-14(16(18)19-15)11-3-5-13(17)6-4-11/h2-9,17H,1H3 D01HQV DRUGINKE JSHUCMRTLUIFTM-UHFFFAOYSA-N D01HQV DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C(=C2)C3=CC=C(C=C3)O D01HQV HIGHSTAT Investigative D01HRG DRUG__ID D01HRG D01HRG DRUGTYPE Small molecular drug D01HRG DRUGINCH 1S/C14H9NO2/c16-13-11-8-4-5-9-12(11)15(14(13)17)10-6-2-1-3-7-10/h1-9H D01HRG DRUGINKE UWCPWBIMRYXUOU-UHFFFAOYSA-N D01HRG DRUGSMIL C1=CC=C(C=C1)N2C3=CC=CC=C3C(=O)C2=O D01HRG HIGHSTAT Investigative D01HRV DRUG__ID D01HRV D01HRV DRUGTYPE Small molecular drug D01HRV DRUGINCH 1S/C26H31FN6O/c27-21-5-3-19(4-6-21)26(16-34)31-22-9-12-32(13-10-22)11-1-2-20-15-28-25-8-7-23(14-24(20)25)33-17-29-30-18-33/h3-8,14-15,17-18,22,26,28,31,34H,1-2,9-13,16H2/t26-/m0/s1 D01HRV DRUGINKE HNKDAQNYMJNLCC-SANMLTNESA-N D01HRV DRUGSMIL C1CN(CCC1NC(CO)C2=CC=C(C=C2)F)CCCC3=CNC4=C3C=C(C=C4)N5C=NN=C5 D01HRV HIGHSTAT Investigative D01HST DRUG__ID D01HST D01HST DRUGTYPE Small molecular drug D01HST DRUGINCH 1S/C20H16N4O3S2/c1-12-2-4-13(5-3-12)15-9-28-19-22-23-20(24(15)19)29-10-18(25)21-14-6-7-16-17(8-14)27-11-26-16/h2-9H,10-11H2,1H3,(H,21,25) D01HST DRUGINKE XYXNYQAJSYUYNZ-UHFFFAOYSA-N D01HST DRUGSMIL CC1=CC=C(C=C1)C2=CSC3=NN=C(N23)SCC(=O)NC4=CC5=C(C=C4)OCO5 D01HST HIGHSTAT Investigative D01HTH DRUG__ID D01HTH D01HTH DRUGTYPE Small molecular drug D01HTH DRUGINCH 1S/C20H21N3.ClH/c1-3-15-8-6-11-17(14-15)23(2)20(21)22-19-13-7-10-16-9-4-5-12-18(16)19;/h4-14H,3H2,1-2H3,(H2,21,22);1H D01HTH DRUGINKE CKAKVKWRMCAYJD-UHFFFAOYSA-N D01HTH DRUGSMIL CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC3=CC=CC=C32)N.Cl D01HTH HIGHSTAT Investigative D01HTX DRUG__ID D01HTX D01HTX DRUGTYPE Small molecular drug D01HTX DRUGINCH 1S/C43H61N11O7/c1-3-5-16-31-38(57)51-32(17-6-4-2)39(58)53-34(23-26-13-8-7-9-14-26)41(60)52-33(19-12-22-47-43(45)46)40(59)54-35(24-27-25-48-29-18-11-10-15-28(27)29)42(61)50-30(37(44)56)20-21-36(55)49-31/h7-11,13-15,18,25,30-35,48H,3-6,12,16-17,19-24H2,1-2H3,(H2,44,56)(H,49,55)(H,50,61)(H,51,57)(H,52,60)(H,53,58)(H,54,59)(H4,45,46,47)/t30-,31-,32-,33-,34+,35-/m0/s1 D01HTX DRUGINKE WGLOHHGRWPHJBM-MAVCTHMOSA-N D01HTX DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CCCC D01HTX HIGHSTAT Investigative D01HUN DRUG__ID D01HUN D01HUN DRUGTYPE Small molecular drug D01HUN DRUGINCH 1S/C19H21F2N7O/c20-15-4-3-12(8-16(15)21)14(18-24-6-7-25-18)9-17(29)28-19(22)26-5-1-2-13-10-23-11-27-13/h3-4,6-8,10-11,14H,1-2,5,9H2,(H,23,27)(H,24,25)(H3,22,26,28,29) D01HUN DRUGINKE DGJMWXIXZSWRLP-UHFFFAOYSA-N D01HUN DRUGSMIL C1=CC(=C(C=C1C(CC(=O)NC(=NCCCC2=CN=CN2)N)C3=NC=CN3)F)F D01HUN HIGHSTAT Investigative D01HUO DRUG__ID D01HUO D01HUO DRUGTYPE Small molecular drug D01HUO DRUGINCH 1S/C16H7N3O4/c20-13-8-7-5-3-1-2-4-6(5)17-12(7)11-10(9(8)14(21)18-13)15(22)19-16(11)23/h1-4,17H,(H,18,20,21)(H,19,22,23) D01HUO DRUGINKE IZHSJTMCSHXFHX-UHFFFAOYSA-N D01HUO DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=C5C(=C3N2)C(=O)NC5=O)C(=O)NC4=O D01HUO HIGHSTAT Investigative D01HUQ DRUG__ID D01HUQ D01HUQ DRUGTYPE Small molecular drug D01HUQ DRUGINCH 1S/C7H10N2O/c8-7(10)2-1-6-3-4-9-5-6/h3-5,9H,1-2H2,(H2,8,10) D01HUQ DRUGINKE TWGRVIPCCGRSNM-UHFFFAOYSA-N D01HUQ DRUGSMIL C1=CNC=C1CCC(=O)N D01HUQ HIGHSTAT Investigative D01HZN DRUG__ID D01HZN D01HZN DRUGTYPE Small molecular drug D01HZN DRUGINCH 1S/C14H6F6O2/c15-7-1-5(2-8(16)11(7)19)13(21)14(22)6-3-9(17)12(20)10(18)4-6/h1-4,13,21H D01HZN DRUGINKE BBOPAMQNZSQMGE-UHFFFAOYSA-N D01HZN DRUGSMIL C1=C(C=C(C(=C1F)F)F)C(C(=O)C2=CC(=C(C(=C2)F)F)F)O D01HZN HIGHSTAT Investigative D01ICF DRUG__ID D01ICF D01ICF DRUGTYPE Small molecular drug D01ICF DRUGINCH 1S/C16H24N4O2/c1-5-8-9-17-14-12-10-18-20(6-2)15(12)19-11(4)13(14)16(21)22-7-3/h10H,5-9H2,1-4H3,(H,17,19) D01ICF DRUGINKE PCTRYMLLRKWXGF-UHFFFAOYSA-N D01ICF DRUGSMIL CCCCNC1=C2C=NN(C2=NC(=C1C(=O)OCC)C)CC D01ICF HIGHSTAT Investigative D01IDD DRUG__ID D01IDD D01IDD DRUGTYPE Small molecular drug D01IDD DRUGINCH 1S/C19H16N4O2S/c1-25-14-8-6-12(7-9-14)18(24)21-19-23-22-17(26-19)10-13-11-20-16-5-3-2-4-15(13)16/h2-9,11,20H,10H2,1H3,(H,21,23,24) D01IDD DRUGINKE AXHAJBIEOINPDH-UHFFFAOYSA-N D01IDD DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NN=C(S2)CC3=CNC4=CC=CC=C43 D01IDD HIGHSTAT Investigative D01IEX DRUG__ID D01IEX D01IEX DRUGTYPE Small molecular drug D01IEX DRUGINCH 1S/C26H19N3O8S2.2Na/c27-24-21(39(35,36)37)13-19(22-23(24)26(31)17-9-5-4-8-16(17)25(22)30)29-15-10-11-18(20(12-15)38(32,33)34)28-14-6-2-1-3-7-14;;/h1-13,28-29H,27H2,(H,32,33,34)(H,35,36,37);;/q;2*+1/p-2 D01IEX DRUGINKE QBLLYXXXOJUNCV-UHFFFAOYSA-L D01IEX DRUGSMIL C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+] D01IEX HIGHSTAT Investigative D01IFO DRUG__ID D01IFO D01IFO DRUGTYPE Small molecular drug D01IFO DRUGINCH 1S/C13H7F3N2/c14-13(15,16)10-4-1-3-9(7-10)12-6-2-5-11(8-17)18-12/h1-7H D01IFO DRUGINKE FYQRYAIHFASLNM-UHFFFAOYSA-N D01IFO DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C2=CC=CC(=N2)C#N D01IFO HIGHSTAT Investigative D01IFR DRUG__ID D01IFR D01IFR DRUGTYPE Small molecular drug D01IFR DRUGINCH 1S/C15H12N2OS/c19-15-17-16-14(18-15)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13H,(H,17,19) D01IFR DRUGINKE YCCKTVQLIQQBMK-UHFFFAOYSA-N D01IFR DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=NNC(=S)O3 D01IFR HIGHSTAT Investigative D01IGL DRUG__ID D01IGL D01IGL DRUGTYPE Small molecular drug D01IGL DRUGINCH 1S/C11H15NO2/c1-3-5-7-10(13)12-8-9(6-4-2)11(12)14/h3-4,9H,1-2,5-8H2 D01IGL DRUGINKE QVTWEMBUZOBMIJ-UHFFFAOYSA-N D01IGL DRUGSMIL C=CCCC(=O)N1CC(C1=O)CC=C D01IGL HIGHSTAT Investigative D01IGU DRUG__ID D01IGU D01IGU DRUGTYPE Small molecular drug D01IGU DRUGINCH 1S/C3H10N2O/c4-2-1-3-6-5/h1-5H2 D01IGU DRUGINKE VSZFWDPIWSPZON-UHFFFAOYSA-N D01IGU DRUGSMIL C(CN)CON D01IGU HIGHSTAT Investigative D01IGW DRUG__ID D01IGW D01IGW DRUGTYPE Small molecular drug D01IGW DRUGINCH 1S/C10H7ClN2O2/c11-8-7(6-4-2-1-3-5-6)9(14)13-10(15)12-8/h1-5H,(H2,12,13,14,15) D01IGW DRUGINKE ORRYLQRWCPCGJZ-UHFFFAOYSA-N D01IGW DRUGSMIL C1=CC=C(C=C1)C2=C(NC(=O)NC2=O)Cl D01IGW HIGHSTAT Investigative D01IHM DRUG__ID D01IHM D01IHM DRUGTYPE Small molecular drug D01IHM DRUGINCH 1S/C13H9F3N4/c1-8-17-18-12-6-5-11(19-20(8)12)9-3-2-4-10(7-9)13(14,15)16/h2-7H,1H3 D01IHM DRUGINKE GUOQUXNJZHGPQF-UHFFFAOYSA-N D01IHM DRUGSMIL CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)C(F)(F)F D01IHM HIGHSTAT Investigative D01IJD DRUG__ID D01IJD D01IJD DRUGTYPE Small molecular drug D01IJD DRUGINCH 1S/C24H36O4/c1-2-3-6-10-22(25)19-14-12-18(13-15-19)20-16-17-23(26)21(20)9-7-4-5-8-11-24(27)28/h12-15,20-22,25H,2-11,16-17H2,1H3,(H,27,28) D01IJD DRUGINKE XMQKDOCUWFCMEJ-UHFFFAOYSA-N D01IJD DRUGSMIL CCCCCC(C1=CC=C(C=C1)C2CCC(=O)C2CCCCCCC(=O)O)O D01IJD HIGHSTAT Investigative D01IJX DRUG__ID D01IJX D01IJX DRUGTYPE Small molecular drug D01IJX DRUGINCH 1S/C13H12N2S/c1-2-11(4-7-15-8-6-14-10-15)12-5-9-16-13(12)3-1/h1-3,5-6,8-10H,4,7H2 D01IJX DRUGINKE ZEWHOUCPWZPPGK-UHFFFAOYSA-N D01IJX DRUGSMIL C1=CC(=C2C=CSC2=C1)CCN3C=CN=C3 D01IJX HIGHSTAT Investigative D01ILH DRUG__ID D01ILH D01ILH DRUGTYPE Small molecular drug D01ILH DRUGINCH 1S/C14H28O6/c1-2-3-4-5-6-7-8-19-13-12(17)11(16)10(9-15)20-14(13)18/h10-18H,2-9H2,1H3/t10-,11-,12+,13-,14-/m1/s1 D01ILH DRUGINKE BVHPDIWLWHHJPD-RKQHYHRCSA-N D01ILH DRUGSMIL CCCCCCCCOC1C(C(C(OC1O)CO)O)O D01ILH HIGHSTAT Investigative D01ILN DRUG__ID D01ILN D01ILN DRUGTYPE Small molecular drug D01ILN DRUGINCH 1S/C18H14N6/c19-16-15-17(24-18(20)23-16)22-14(12-9-5-2-6-10-12)13(21-15)11-7-3-1-4-8-11/h1-10H,(H4,19,20,22,23,24) D01ILN DRUGINKE DDZJPETYMUJLIW-UHFFFAOYSA-N D01ILN DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2C4=CC=CC=C4)N)N D01ILN HIGHSTAT Investigative D01ILO DRUG__ID D01ILO D01ILO DRUGTYPE Small molecular drug D01ILO DRUGINCH 1S/C3H6N2S/c4-3-5-1-2-6-3/h1-2H2,(H2,4,5) D01ILO DRUGINKE REGFWZVTTFGQOJ-UHFFFAOYSA-N D01ILO DRUGSMIL C1CSC(=N1)N D01ILO HIGHSTAT Investigative D01ILT DRUG__ID D01ILT D01ILT DRUGTYPE Small molecular drug D01ILT DRUGINCH 1S/C23H23NO2.CH4O3S/c1-23(14-25,15-26)24-13-17-12-22-18-7-3-2-6-16(18)10-11-21(22)20-9-5-4-8-19(17)20;1-5(2,3)4/h2-12,24-26H,13-15H2,1H3;1H3,(H,2,3,4) D01ILT DRUGINKE NJWBUDCAWGTQAS-UHFFFAOYSA-N D01ILT DRUGSMIL CC(CO)(CO)NCC1=CC2=C(C=CC3=CC=CC=C32)C4=CC=CC=C41.CS(=O)(=O)O D01ILT HIGHSTAT Investigative D01IMJ DRUG__ID D01IMJ D01IMJ DRUGTYPE Small molecular drug D01IMJ DRUGINCH 1S/C11H10N2OS/c1-8-7-15-11(12-8)13-10(14)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14) D01IMJ DRUGINKE NEPIZAVYXKHUCD-UHFFFAOYSA-N D01IMJ DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC=CC=C2 D01IMJ HIGHSTAT Investigative D01IPF DRUG__ID D01IPF D01IPF DRUGTYPE Small molecular drug D01IPF DRUGINCH 1S/C17H17N3O2/c1-2-4-16(22)18-17-14-8-7-12(10-15(14)19-20-17)11-5-3-6-13(21)9-11/h3,5-10,21H,2,4H2,1H3,(H2,18,19,20,22) D01IPF DRUGINKE UKQRPDHIQLHFNS-UHFFFAOYSA-N D01IPF DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC(=CC=C3)O D01IPF HIGHSTAT Investigative D01IPS DRUG__ID D01IPS D01IPS DRUGTYPE Small molecular drug D01IPS DRUGINCH 1S/C10H13N4O9P/c15-5-3(1-22-24(19,20)21)23-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H4,12,13,17,18,19,20,21)/p+1/t3-,5-,6-,9-/m1/s1 D01IPS DRUGINKE XHDARDSMKMUDDI-UUOKFMHZSA-O D01IPS DRUGSMIL C1=[N+](C2=C(N1)C(=O)NC(=O)N2)C3C(C(C(O3)COP(=O)(O)O)O)O D01IPS HIGHSTAT Investigative D01IRO DRUG__ID D01IRO D01IRO DRUGTYPE Small molecular drug D01IRO DRUGINCH 1S/C17H13NO2/c19-14-8-5-12(6-9-14)16-10-7-13(11-18-20)15-3-1-2-4-17(15)16/h1-11,19-20H/b18-11+ D01IRO DRUGINKE VYQQTWUZKPWPRL-WOJGMQOQSA-N D01IRO DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2C3=CC=C(C=C3)O)C=NO D01IRO HIGHSTAT Investigative D01ISX DRUG__ID D01ISX D01ISX DRUGTYPE Small molecular drug D01ISX DRUGINCH 1S/C14H16N2O3S2/c15-21(18,19)13-5-3-11(4-6-13)7-8-16-14(17)10-12-2-1-9-20-12/h1-6,9H,7-8,10H2,(H,16,17)(H2,15,18,19) D01ISX DRUGINKE DWGJCBRJYFGGNR-UHFFFAOYSA-N D01ISX DRUGSMIL C1=CSC(=C1)CC(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N D01ISX HIGHSTAT Investigative D01IUB DRUG__ID D01IUB D01IUB DRUGTYPE Small molecular drug D01IUB DRUGINCH 1S/C20H30O5/c1-2-17(21)11-8-5-9-14-18(22)12-6-3-4-7-13-19(23)15-10-16-20(24)25/h3-9,11-13,17-19,21-23H,2,10,14-16H2,1H3,(H,24,25)/b4-3+,9-5-,11-8+,12-6+,13-7-/t17-,18-,19+/m0/s1 D01IUB DRUGINKE AOPOCGPBAIARAV-JJVMZPRHSA-N D01IUB DRUGSMIL CCC(C=CC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O)O D01IUB HIGHSTAT Investigative D01IUI DRUG__ID D01IUI D01IUI DRUGTYPE Small molecular drug D01IUI DRUGINCH 1S/C23H27NO2/c1-4-5-8-14-24-17(2)23(20-12-6-7-13-21(20)24)22(25)16-18-10-9-11-19(15-18)26-3/h6-7,9-13,15H,4-5,8,14,16H2,1-3H3 D01IUI DRUGINKE QZLRCHSRCYFMFK-UHFFFAOYSA-N D01IUI DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)OC)C D01IUI HIGHSTAT Investigative D01IWD DRUG__ID D01IWD D01IWD DRUGTYPE Small molecular drug D01IWD DRUGINCH 1S/C19H22N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,18,20,22H,5-8,10H2 D01IWD DRUGINKE MLWGAEVSWJXOQJ-UHFFFAOYSA-N D01IWD DRUGSMIL C1C2CC3CC(CC1N3CC2O)OC(=O)C4=CNC5=CC=CC=C54 D01IWD HIGHSTAT Investigative D01JCH DRUG__ID D01JCH D01JCH DRUGTYPE Small molecular drug D01JCH DRUGINCH 1S/C18H34O11P2/c1-14(2)6-5-7-15(3)8-10-27-30(23,24)29-31(25,26)28-11-9-16(19)12-18(4,22)13-17(20)21/h6,8,16,19,22H,5,7,9-13H2,1-4H3,(H,20,21)(H,23,24)(H,25,26)/b15-8+ D01JCH DRUGINKE WJXJJEWDRXZOEO-OVCLIPMQSA-N D01JCH DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCC(CC(C)(CC(=O)O)O)O)C)C D01JCH HIGHSTAT Investigative D01JCJ DRUG__ID D01JCJ D01JCJ DRUGTYPE Small molecular drug D01JCJ DRUGINCH 1S/C14H18N2O2/c1-2-3-4-5-6-8-11(17)14-16-13-12(18-14)9-7-10-15-13/h7,9-10H,2-6,8H2,1H3 D01JCJ DRUGINKE HTWHWGPGIJSJQP-UHFFFAOYSA-N D01JCJ DRUGSMIL CCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2 D01JCJ HIGHSTAT Investigative D01JEX DRUG__ID D01JEX D01JEX DRUGTYPE Small molecular drug D01JEX DRUGINCH 1S/C19H12N2O/c22-19-15-7-3-1-5-12(15)10-17-18-14(11-21(17)19)9-13-6-2-4-8-16(13)20-18/h1-10H,11H2 D01JEX DRUGINKE JORFMKUBMHCFKA-UHFFFAOYSA-N D01JEX DRUGSMIL C1C2=CC3=CC=CC=C3N=C2C4=CC5=CC=CC=C5C(=O)N41 D01JEX HIGHSTAT Investigative D01JFF DRUG__ID D01JFF D01JFF DRUGTYPE Small molecular drug D01JFF DRUGINCH 1S/C13H11ClN2O2/c1-18-12-8-9(5-6-10(12)14)16-13(17)11-4-2-3-7-15-11/h2-8H,1H3,(H,16,17) D01JFF DRUGINKE ARYUXFNGXHNNDM-UHFFFAOYSA-N D01JFF DRUGSMIL COC1=C(C=CC(=C1)NC(=O)C2=CC=CC=N2)Cl D01JFF HIGHSTAT Investigative D01JGB DRUG__ID D01JGB D01JGB DRUGTYPE Small molecular drug D01JGB DRUGINCH 1S/C16H23N3/c1-2-8-14-11-15(19-16(12-17)18-14)13-9-6-4-3-5-7-10-13/h11,13H,2-10H2,1H3 D01JGB DRUGINKE AWOXPJKLDJGFMS-UHFFFAOYSA-N D01JGB DRUGSMIL CCCC1=CC(=NC(=N1)C#N)C2CCCCCCC2 D01JGB HIGHSTAT Investigative D01JHA DRUG__ID D01JHA D01JHA DRUGTYPE Small molecular drug D01JHA DRUGINCH 1S/C21H29NO/c1-4-5-6-9-14-21(2,3)16-12-13-18(20(23)15-16)17-10-7-8-11-19(17)22/h7-8,10-13,15,23H,4-6,9,14,22H2,1-3H3 D01JHA DRUGINKE QCCUOHALIFFEGL-UHFFFAOYSA-N D01JHA DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CC=CC=C2N)O D01JHA HIGHSTAT Investigative D01JHR DRUG__ID D01JHR D01JHR DRUGTYPE Small molecular drug D01JHR DRUGINCH 1S/C14H23N3O6/c1-14(2)6-5-9(17(14)10(18)7-15)12(21)16-8(13(22)23)3-4-11(19)20/h8-9H,3-7,15H2,1-2H3,(H,16,21)(H,19,20)(H,22,23)/t8-,9-/m0/s1 D01JHR DRUGINKE KNUZCBVWBGSPRA-IUCAKERBSA-N D01JHR DRUGSMIL CC1(CCC(N1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O)C D01JHR HIGHSTAT Investigative D01JID DRUG__ID D01JID D01JID DRUGTYPE Small molecular drug D01JID DRUGINCH 1S/C22H26N4O4/c1-5-25(6-2)10-9-23-13-7-8-14-19-17(13)20(27)18-15(26(19)12-24-14)11-16(29-3)22(30-4)21(18)28/h7-8,11-12,23,27H,5-6,9-10H2,1-4H3 D01JID DRUGINKE GRQHDQZNSRJNRZ-UHFFFAOYSA-N D01JID DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=CC(=C(C(=O)C4=C2O)OC)OC D01JID HIGHSTAT Investigative D01JJH DRUG__ID D01JJH D01JJH DRUGTYPE Small molecular drug D01JJH DRUGINCH 1S/C15H20N2O4S/c1-5-22(19,20)17(4)13-11-8-10(9-16)6-7-12(11)21-15(2,3)14(13)18/h6-8,13-14,18H,5H2,1-4H3/t13-,14+/m0/s1 D01JJH DRUGINKE HVSJHHXUORMCGK-UONOGXRCSA-N D01JJH DRUGSMIL CCS(=O)(=O)N(C)C1C(C(OC2=C1C=C(C=C2)C#N)(C)C)O D01JJH HIGHSTAT Investigative D01JJR DRUG__ID D01JJR D01JJR DRUGTYPE Small molecular drug D01JJR DRUGINCH 1S/C35H36FN3O9/c1-21(40)37-29(19-23-13-16-27(26(18-23)32(43)48-2)35(36,33(44)45)34(46)47)30(41)38-28-10-6-7-17-39(31(28)42)20-22-11-14-25(15-12-22)24-8-4-3-5-9-24/h3-5,8-9,11-16,18,28-29H,6-7,10,17,19-20H2,1-2H3,(H,37,40)(H,38,41)(H,44,45)(H,46,47)/t28-,29-/m0/s1 D01JJR DRUGINKE RLLAUERCSKPFGD-VMPREFPWSA-N D01JJR DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)C(C(=O)O)(C(=O)O)F)C(=O)OC)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D01JJR HIGHSTAT Investigative D01JJV DRUG__ID D01JJV D01JJV DRUGTYPE Small molecular drug D01JJV DRUGINCH 1S/C17H22N2O2/c20-15-3-1-2-14(7-15)18-16(21)19-17-8-11-4-12(9-17)6-13(5-11)10-17/h1-3,7,11-13,20H,4-6,8-10H2,(H2,18,19,21) D01JJV DRUGINKE FBTNUWJYRWKVCD-UHFFFAOYSA-N D01JJV DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC(=CC=C4)O D01JJV HIGHSTAT Investigative D01JMW DRUG__ID D01JMW D01JMW DRUGTYPE Small molecular drug D01JMW DRUGINCH 1S/C13H18BrN3O2/c14-12-11(3-1-4-15-12)13(18)16-5-2-6-17-7-9-19-10-8-17/h1,3-4H,2,5-10H2,(H,16,18) D01JMW DRUGINKE ZMORGFKKKAMCBI-UHFFFAOYSA-N D01JMW DRUGSMIL C1COCCN1CCCNC(=O)C2=C(N=CC=C2)Br D01JMW HIGHSTAT Investigative D01JPJ DRUG__ID D01JPJ D01JPJ DRUGCOMP PTC Therapeutics Inc D01JPJ DRUGINCH 1S/C23H18F4N6O2S/c1-3-14-9-20-16(10-18(14)24)17(11-28)21(33(20)22-29-7-4-8-30-22)19-6-5-15(12-31-19)36(34,35)32-13(2)23(25,26)27/h4-10,12-13,32H,3H2,1-2H3/t13-/m0/s1 D01JPJ DRUGINKE OBULGMCFXOTNNK-ZDUSSCGKSA-N D01JPJ DRUGSMIL CCC1=CC2=C(C=C1F)C(=C(N2C3=NC=CC=N3)C4=NC=C(C=C4)S(=O)(=O)NC(C)C(F)(F)F)C#N D01JPJ HIGHSTAT Investigative D01JQX DRUG__ID D01JQX D01JQX DRUGTYPE Small molecular drug D01JQX DRUGINCH 1S/C21H34O/c1-4-5-6-7-15-21(2,3)19-13-11-17(12-14-19)18-9-8-10-20(22)16-18/h11-14,18,20,22H,4-10,15-16H2,1-3H3/t18-,20-/m0/s1 D01JQX DRUGINKE CICRJVLFNFCUOX-ICSRJNTNSA-N D01JQX DRUGSMIL CCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D01JQX HIGHSTAT Investigative D01JSA DRUG__ID D01JSA D01JSA DRUGTYPE Small molecular drug D01JSA DRUGINCH 1S/C40H54N10O9/c1-25-20-29(51)21-26(2)30(25)23-31(41)36(53)47-33(17-11-19-44-39(43)49-50(57)58)37(54)48-34(22-27-12-5-3-6-13-27)38(55)46-32(35(42)52)16-9-10-18-45-40(56)59-24-28-14-7-4-8-15-28/h3-8,12-15,20-21,31-34,51H,9-11,16-19,22-24,41H2,1-2H3,(H2,42,52)(H,45,56)(H,46,55)(H,47,53)(H,48,54)(H3,43,44,49)/t31?,32-,33+,34-/m0/s1 D01JSA DRUGINKE LMMJRHRZYGSRLK-OPTRWXFLSA-N D01JSA DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(CCCN=C(N)N[N+](=O)[O-])C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCNC(=O)OCC3=CC=CC=C3)C(=O)N)N)C)O D01JSA HIGHSTAT Investigative D01JTI DRUG__ID D01JTI D01JTI DRUGTYPE Small molecular drug D01JTI DRUGINCH 1S/C7H6BrF2NO2S/c8-6-3-1-2-5(4-6)7(9,10)14(11,12)13/h1-4H,(H2,11,12,13) D01JTI DRUGINKE RXNVOIIGCVXUGN-UHFFFAOYSA-N D01JTI DRUGSMIL C1=CC(=CC(=C1)Br)C(F)(F)S(=O)(=O)N D01JTI HIGHSTAT Investigative D01JTY DRUG__ID D01JTY D01JTY DRUGTYPE Small molecular drug D01JTY DRUGINCH 1S/C21H22FNO/c1-2-3-6-13-23-15-19(18-7-4-5-8-20(18)23)21(24)14-16-9-11-17(22)12-10-16/h4-5,7-12,15H,2-3,6,13-14H2,1H3 D01JTY DRUGINKE QGDPTDVGZNHCIR-UHFFFAOYSA-N D01JTY DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)F D01JTY HIGHSTAT Investigative D01JUI DRUG__ID D01JUI D01JUI DRUGTYPE Small molecular drug D01JUI DRUGINCH 1S/C17H15ClN4/c1-10-2-4-11(5-3-10)12-6-7-13-14(8-12)16(22-17(19)20)21-9-15(13)18/h2-9H,1H3,(H4,19,20,21,22) D01JUI DRUGINKE CHWRGRHMWONZIO-UHFFFAOYSA-N D01JUI DRUGSMIL CC1=CC=C(C=C1)C2=CC3=C(C=C2)C(=CN=C3N=C(N)N)Cl D01JUI HIGHSTAT Investigative D01JVG DRUG__ID D01JVG D01JVG DRUGTYPE Small molecular drug D01JVG DRUGINCH 1S/C16H11FO2S/c17-12-7-11(8-14(19)9-12)16-6-5-15(20-16)10-1-3-13(18)4-2-10/h1-9,18-19H D01JVG DRUGINKE OWTLTMXTNPNZPH-UHFFFAOYSA-N D01JVG DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC(=CC(=C3)F)O)O D01JVG HIGHSTAT Investigative D01JVP DRUG__ID D01JVP D01JVP DRUGTYPE Small molecular drug D01JVP DRUGINCH 1S/C19H22INO3/c1-2-22-16-5-3-4-6-17(16)24-19(18-13-21-11-12-23-18)14-7-9-15(20)10-8-14/h3-10,18-19,21H,2,11-13H2,1H3/t18-,19-/m1/s1 D01JVP DRUGINKE RVASAZVCHKJYMY-RTBURBONSA-N D01JVP DRUGSMIL CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=C(C=C3)I D01JVP HIGHSTAT Investigative D01JWT DRUG__ID D01JWT D01JWT DRUGTYPE Small molecular drug D01JWT DRUGINCH 1S/C21H27N3O2/c25-20-18-11-7-8-12-19(18)21(26)24(20)15-10-6-4-2-1-3-5-9-14-23-16-13-22-17-23/h7-8,11-13,16-17H,1-6,9-10,14-15H2 D01JWT DRUGINKE DOVKNTJKHQSOTE-UHFFFAOYSA-N D01JWT DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCCCCCCCN3C=CN=C3 D01JWT HIGHSTAT Investigative D01JYF DRUG__ID D01JYF D01JYF DRUGTYPE Small molecular drug D01JYF DRUGINCH 1S/C20H22O2/c1-5-7-15-9-11-20(22-4)18(13-15)16-10-12-19(21-3)17(14-16)8-6-2/h5-6,9-14H,1-2,7-8H2,3-4H3 D01JYF DRUGINKE GDCJELDNRAWYTE-UHFFFAOYSA-N D01JYF DRUGSMIL COC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)OC)CC=C D01JYF HIGHSTAT Investigative D01JYY DRUG__ID D01JYY D01JYY DRUGTYPE Small molecular drug D01JYY DRUGINCH 1S/C19H24N2O/c1-14(2)13-21(18-9-10-20-12-18)19(22)17-8-7-15-5-3-4-6-16(15)11-17/h3-8,11,14,18,20H,9-10,12-13H2,1-2H3/t18-/m1/s1 D01JYY DRUGINKE CEUJKSVEPJAVKD-GOSISDBHSA-N D01JYY DRUGSMIL CC(C)CN(C1CCNC1)C(=O)C2=CC3=CC=CC=C3C=C2 D01JYY HIGHSTAT Investigative D01JZO DRUG__ID D01JZO D01JZO DRUGTYPE Small molecular drug D01JZO DRUGINCH 1S/C10H9ClN2/c11-10-3-1-9(2-4-10)7-13-6-5-12-8-13/h1-6,8H,7H2 D01JZO DRUGINKE RPLWYOLCHGTNSX-UHFFFAOYSA-N D01JZO DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)Cl D01JZO HIGHSTAT Investigative D01JZV DRUG__ID D01JZV D01JZV DRUGTYPE Small molecular drug D01JZV DRUGINCH 1S/C21H22Cl2N4OS2/c22-16-3-1-13(9-17(16)23)11-27-7-5-15(6-8-27)25-20(28)12-29-21-26-18-4-2-14(24)10-19(18)30-21/h1-4,9-10,15H,5-8,11-12,24H2,(H,25,28) D01JZV DRUGINKE QOHFBKIKGAINLL-UHFFFAOYSA-N D01JZV DRUGSMIL C1CN(CCC1NC(=O)CSC2=NC3=C(S2)C=C(C=C3)N)CC4=CC(=C(C=C4)Cl)Cl D01JZV HIGHSTAT Investigative D01KAH DRUG__ID D01KAH D01KAH DRUGTYPE Small molecular drug D01KAH DRUGINCH 1S/C10H14N2O.ClH/c1-8(11)12-7-9-4-3-5-10(6-9)13-2;/h3-6H,7H2,1-2H3,(H2,11,12);1H D01KAH DRUGINKE KAHXLIVOQBJXSB-UHFFFAOYSA-N D01KAH DRUGSMIL CC(=NCC1=CC(=CC=C1)OC)N.Cl D01KAH HIGHSTAT Investigative D01KAM DRUG__ID D01KAM D01KAM DRUGTYPE Small molecular drug D01KAM DRUGINCH 1S/C17H13NO7/c19-13-8-12(23-6-7-24-18(21)22)9-16-17(13)14(20)10-15(25-16)11-4-2-1-3-5-11/h1-5,8-10,19H,6-7H2 D01KAM DRUGINKE NLJRSLKTBHDLMH-UHFFFAOYSA-N D01KAM DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OCCO[N+](=O)[O-])O D01KAM HIGHSTAT Investigative D01KAX DRUG__ID D01KAX D01KAX DRUGTYPE Small molecular drug D01KAX DRUGINCH 1S/C10H13N3O/c1-7(11)6-13-10-4-9(14)3-2-8(10)5-12-13/h2-5,7,14H,6,11H2,1H3/t7-/m0/s1 D01KAX DRUGINKE WBYHTZYHAFNBKW-ZETCQYMHSA-N D01KAX DRUGSMIL CC(CN1C2=C(C=CC(=C2)O)C=N1)N D01KAX HIGHSTAT Investigative D01KDQ DRUG__ID D01KDQ D01KDQ DRUGTYPE Small molecular drug D01KDQ DRUGINCH 1S/C8H20NO/c1-4-9(5-2,6-3)7-8-10/h10H,4-8H2,1-3H3/q+1 D01KDQ DRUGINKE GZBUMTPCIKCWFW-UHFFFAOYSA-N D01KDQ DRUGSMIL CC[N+](CC)(CC)CCO D01KDQ HIGHSTAT Investigative D01KEE DRUG__ID D01KEE D01KEE DRUGTYPE Small molecular drug D01KEE DRUGINCH 1S/CH2O/c1-2/h1H2 D01KEE DRUGINKE WSFSSNUMVMOOMR-UHFFFAOYSA-N D01KEE DRUGSMIL C=O D01KEE HIGHSTAT Investigative D01KEH DRUG__ID D01KEH D01KEH DRUGTYPE Small molecular drug D01KEH DRUGINCH 1S/C15H21NO6/c1-8(4-3-5-9(2)14(19)20)11-7-16-13(15(21)22)10(11)6-12(17)18/h3-5,9-11,13,16H,6-7H2,1-2H3,(H,17,18)(H,19,20)(H,21,22)/b5-3+,8-4+/t9-,10+,11-,13+/m1/s1 D01KEH DRUGINKE VZFRNCSOCOPNDB-JIUSADRUSA-N D01KEH DRUGSMIL CC(C=CC=C(C)C1CNC(C1CC(=O)O)C(=O)O)C(=O)O D01KEH HIGHSTAT Investigative D01KIH DRUG__ID D01KIH D01KIH DRUGTYPE Small molecular drug D01KIH DRUGINCH 1S/C18H20N4/c1-2-5-15(6-3-1)13-21-9-11-22(12-10-21)17-8-4-7-16-18(17)20-14-19-16/h1-8,14H,9-13H2,(H,19,20) D01KIH DRUGINKE ZNBOBGDGUIWKPE-UHFFFAOYSA-N D01KIH DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=CC=CC4=C3N=CN4 D01KIH HIGHSTAT Investigative D01KJU DRUG__ID D01KJU D01KJU DRUGTYPE Small molecular drug D01KJU DRUGINCH 1S/C16H11ClO2/c17-16-14-7-3-11(9-12(14)4-8-15(16)19)10-1-5-13(18)6-2-10/h1-9,18-19H D01KJU DRUGINKE YHEHVRSGKUYDON-UHFFFAOYSA-N D01KJU DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C=C2)C(=C(C=C3)O)Cl)O D01KJU HIGHSTAT Investigative D01KKU DRUG__ID D01KKU D01KKU DRUGTYPE Small molecular drug D01KKU DRUGINCH 1S/C15H10O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9,16H D01KKU DRUGINKE MQGPSCMMNJKMHQ-UHFFFAOYSA-N D01KKU DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)O D01KKU HIGHSTAT Investigative D01KMI DRUG__ID D01KMI D01KMI DRUGTYPE Small molecular drug D01KMI DRUGINCH 1S/C19H27NO4/c1-2-3-9-20-10-7-15(8-11-20)14-24-19(21)16-5-4-6-17-18(16)23-13-12-22-17/h4-6,15H,2-3,7-14H2,1H3 D01KMI DRUGINKE YGXXLNHVBNARBP-UHFFFAOYSA-N D01KMI DRUGSMIL CCCCN1CCC(CC1)COC(=O)C2=C3C(=CC=C2)OCCO3 D01KMI HIGHSTAT Investigative D01KNZ DRUG__ID D01KNZ D01KNZ DRUGTYPE Small molecular drug D01KNZ DRUGINCH 1S/C23H22IN5O5/c1-2-9-28-22(32)19-21(29(23(28)33)11-13-3-8-17(25)16(24)10-13)27-20(26-19)14-4-6-15(7-5-14)34-12-18(30)31/h3-8,10H,2,9,11-12,25H2,1H3,(H,26,27)(H,30,31)/i24-2 D01KNZ DRUGINKE DKJMGIXWGPEEFF-XXFZXMJFSA-N D01KNZ DRUGSMIL CCCN1C(=O)C2=C(N=C(N2)C3=CC=C(C=C3)OCC(=O)O)N(C1=O)CC4=CC(=C(C=C4)N)I D01KNZ HIGHSTAT Investigative D01KOI DRUG__ID D01KOI D01KOI DRUGTYPE Small molecular drug D01KOI DRUGINCH 1S/C9H8N2OS/c10-9-11-8(5-13-9)6-1-3-7(12)4-2-6/h1-5,12H,(H2,10,11) D01KOI DRUGINKE QGSJYYIRAFRPIT-UHFFFAOYSA-N D01KOI DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)N)O D01KOI HIGHSTAT Investigative D01KOO DRUG__ID D01KOO D01KOO DRUGTYPE Small molecular drug D01KOO DRUGINCH 1S/C6H13NO5S/c1-6(2)10-3-5(12-6)4-11-13(7,8)9/h5H,3-4H2,1-2H3,(H2,7,8,9) D01KOO DRUGINKE QFFBTRPNKKXQCZ-UHFFFAOYSA-N D01KOO DRUGSMIL CC1(OCC(O1)COS(=O)(=O)N)C D01KOO HIGHSTAT Investigative D01KPN DRUG__ID D01KPN D01KPN DRUGTYPE Small molecular drug D01KPN DRUGINCH 1S/C26H33NO4/c1-18(2)20-12-10-19(11-13-20)15-24(28)27-14-6-8-22(17-27)21-7-5-9-23(16-21)31-26(3,4)25(29)30/h5,7,9-13,16,18,22H,6,8,14-15,17H2,1-4H3,(H,29,30)/t22-/m1/s1 D01KPN DRUGINKE OISHBINQIFNIPV-JOCHJYFZSA-N D01KPN DRUGSMIL CC(C)C1=CC=C(C=C1)CC(=O)N2CCCC(C2)C3=CC(=CC=C3)OC(C)(C)C(=O)O D01KPN HIGHSTAT Investigative D01KPX DRUG__ID D01KPX D01KPX DRUGTYPE Small molecular drug D01KPX DRUGINCH 1S/C14H17N3S2/c1-2-12-10-19-14(16-12)17-13(18)15-9-8-11-6-4-3-5-7-11/h3-7,10H,2,8-9H2,1H3,(H2,15,16,17,18) D01KPX DRUGINKE SMLAKAQKPKAWNV-UHFFFAOYSA-N D01KPX DRUGSMIL CCC1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2 D01KPX HIGHSTAT Investigative D01KSR DRUG__ID D01KSR D01KSR DRUGTYPE Small molecular drug D01KSR DRUGINCH 1S/C13H8ClNO3/c14-9-5-10-12(6-11(9)17)18-13(15-10)7-1-3-8(16)4-2-7/h1-6,16-17H D01KSR DRUGINKE BXCKDNMAGMSBHF-UHFFFAOYSA-N D01KSR DRUGSMIL C1=CC(=CC=C1C2=NC3=CC(=C(C=C3O2)O)Cl)O D01KSR HIGHSTAT Investigative D01KTM DRUG__ID D01KTM D01KTM DRUGTYPE Small molecular drug D01KTM DRUGINCH 1S/C20H22O6/c1-23-17-7-11(3-5-15(17)21)19-13-9-26-20(14(13)10-25-19)12-4-6-16(22)18(8-12)24-2/h3-8,13-14,19-22H,9-10H2,1-2H3/t13-,14-,19+,20+/m1/s1 D01KTM DRUGINKE HGXBRUKMWQGOIE-NSMLZSOPSA-N D01KTM DRUGSMIL COC1=C(C=CC(=C1)C2C3COC(C3CO2)C4=CC(=C(C=C4)O)OC)O D01KTM HIGHSTAT Investigative D01KVG DRUG__ID D01KVG D01KVG DRUGTYPE Small molecular drug D01KVG DRUGINCH 1S/C26H30N2O/c29-25-26(16-7-11-22-10-6-12-23(27-25)24(22)26)15-4-5-17-28-18-13-21(14-19-28)20-8-2-1-3-9-20/h1-3,6,8-10,12-13H,4-5,7,11,14-19H2,(H,27,29) D01KVG DRUGINKE JBQOYPLKTTXLSQ-UHFFFAOYSA-N D01KVG DRUGSMIL C1CC2=C3C(=CC=C2)NC(=O)C3(C1)CCCCN4CCC(=CC4)C5=CC=CC=C5 D01KVG HIGHSTAT Investigative D01KVT DRUG__ID D01KVT D01KVT DRUGTYPE Small molecular drug D01KVT DRUGINCH 1S/C38H56N4O4/c1-5-41(29-31-19-11-13-21-37(31)45-3)25-17-9-7-15-23-39-33-27-36(44)34(28-35(33)43)40-24-16-8-10-18-26-42(6-2)30-32-20-12-14-22-38(32)46-4/h11-14,19-22,27-28,39-40H,5-10,15-18,23-26,29-30H2,1-4H3 D01KVT DRUGINKE VPXVPJQOPRBXPO-UHFFFAOYSA-N D01KVT DRUGSMIL CCN(CCCCCCNC1=CC(=O)C(=CC1=O)NCCCCCCN(CC)CC2=CC=CC=C2OC)CC3=CC=CC=C3OC D01KVT HIGHSTAT Investigative D01KWU DRUG__ID D01KWU D01KWU DRUGTYPE Small molecular drug D01KWU DRUGINCH 1S/C20H33N3O3S/c1-4-10-22-14-17(21-27(25,26)23(5-2)6-3)11-16-12-18-15(13-19(16)22)8-7-9-20(18)24/h7-9,16-17,19,21,24H,4-6,10-14H2,1-3H3 D01KWU DRUGINKE GDFGTRDCCWFXTG-UHFFFAOYSA-N D01KWU DRUGSMIL CCCN1CC(CC2C1CC3=C(C2)C(=CC=C3)O)NS(=O)(=O)N(CC)CC D01KWU HIGHSTAT Investigative D01KYM DRUG__ID D01KYM D01KYM DRUGTYPE Small molecular drug D01KYM DRUGINCH 1S/C11H20N2O2/c1-11(2,3)10(15)13-8-6-4-5-7-12-9(8)14/h8H,4-7H2,1-3H3,(H,12,14)(H,13,15)/t8-/m0/s1 D01KYM DRUGINKE FAFRIRJGUOTURZ-QMMMGPOBSA-N D01KYM DRUGSMIL CC(C)(C)C(=O)NC1CCCCNC1=O D01KYM HIGHSTAT Investigative D01KZF DRUG__ID D01KZF D01KZF DRUGTYPE Small molecular drug D01KZF DRUGINCH 1S/C16H13FO3/c1-19-12-6-7-13-14(18)9-15(20-16(13)8-12)10-2-4-11(17)5-3-10/h2-8,15H,9H2,1H3/t15-/m0/s1 D01KZF DRUGINKE LIINIWOYEGBFDA-HNNXBMFYSA-N D01KZF DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)F D01KZF HIGHSTAT Investigative D01LAU DRUG__ID D01LAU D01LAU DRUGTYPE Small molecular drug D01LAU DRUGINCH 1S/C14H17N3O3/c1-9(18)15-6-5-10-8-16-13-4-3-11(7-12(10)13)17-14(19)20-2/h3-4,7-8,16H,5-6H2,1-2H3,(H,15,18)(H,17,19) D01LAU DRUGINKE MPZVHKLZCUEJFO-UHFFFAOYSA-N D01LAU DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)NC(=O)OC D01LAU HIGHSTAT Investigative D01LCS DRUG__ID D01LCS D01LCS DRUGTYPE Small molecular drug D01LCS DRUGINCH 1S/C19H20N4O2/c20-18(21)11-8-9-14-15(10-11)23-19(22-14)13-6-3-7-16(17(13)24)25-12-4-1-2-5-12/h3,6-10,12,24H,1-2,4-5H2,(H3,20,21)(H,22,23) D01LCS DRUGINKE WCFWDBPDMBXMTQ-UHFFFAOYSA-N D01LCS DRUGSMIL C1CCC(C1)OC2=CC=CC(=C2O)C3=NC4=C(N3)C=C(C=C4)C(=N)N D01LCS HIGHSTAT Investigative D01LDO DRUG__ID D01LDO D01LDO DRUGTYPE Small molecular drug D01LDO DRUGINCH 1S/C7H16NO5P/c8-6(7(9)10)4-2-1-3-5-14(11,12)13/h6H,1-5,8H2,(H,9,10)(H2,11,12,13)/t6-/m1/s1 D01LDO DRUGINKE MYDMWESTDPJANS-ZCFIWIBFSA-N D01LDO DRUGSMIL C(CCC(C(=O)O)N)CCP(=O)(O)O D01LDO HIGHSTAT Investigative D01LDQ DRUG__ID D01LDQ D01LDQ DRUGTYPE Small molecular drug D01LDQ DRUGINCH 1S/C17H21NO6/c1-9(5-7-13(19)18-22)4-6-11-15(20)14-12(8-24-17(14)21)10(2)16(11)23-3/h4,20,22H,5-8H2,1-3H3,(H,18,19)/b9-4+ D01LDQ DRUGINKE XUEGRBSFQYYISJ-RUDMXATFSA-N D01LDQ DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)NO)O D01LDQ HIGHSTAT Investigative D01LEV DRUG__ID D01LEV D01LEV DRUGTYPE Small molecular drug D01LEV DRUGINCH 1S/C13H8BrNOS/c14-10-5-6-17-12(10)7-9-8-3-1-2-4-11(8)15-13(9)16/h1-7H,(H,15,16)/b9-7+ D01LEV DRUGINKE ZGCKMTQNGWQKEN-VQHVLOKHSA-N D01LEV DRUGSMIL C1=CC=C2C(=C1)C(=CC3=C(C=CS3)Br)C(=O)N2 D01LEV HIGHSTAT Investigative D01LFP DRUG__ID D01LFP D01LFP DRUGTYPE Small molecular drug D01LFP DRUGINCH 1S/C17H17ClN2O3/c18-14-8-6-13(7-9-14)11-19-16(21)15(17(22)20-23)10-12-4-2-1-3-5-12/h1-9,15,23H,10-11H2,(H,19,21)(H,20,22) D01LFP DRUGINKE MDFALTKCDXYVEX-UHFFFAOYSA-N D01LFP DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC2=CC=C(C=C2)Cl)C(=O)NO D01LFP HIGHSTAT Investigative D01LKO DRUG__ID D01LKO D01LKO DRUGTYPE Small molecular drug D01LKO DRUGINCH 1S/C35H38N8O5/c36-26(15-22-17-38-27-12-6-4-10-24(22)27)33(46)42-29(14-21-8-2-1-3-9-21)35(48)43-30(34(47)41-20-32(45)40-19-31(37)44)16-23-18-39-28-13-7-5-11-25(23)28/h1-13,17-18,26,29-30,38-39H,14-16,19-20,36H2,(H2,37,44)(H,40,45)(H,41,47)(H,42,46)(H,43,48)/t26-,29+,30-/m1/s1 D01LKO DRUGINKE WIJADCOBFJYNSF-JJZPZGAKSA-N D01LKO DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NCC(=O)NCC(=O)N)NC(=O)C(CC4=CNC5=CC=CC=C54)N D01LKO HIGHSTAT Investigative D01LOU DRUG__ID D01LOU D01LOU DRUGTYPE Small molecular drug D01LOU DRUGINCH 1S/C17H11N3O4/c21-16-12-3-1-2-4-14(12)24-17-11(9-19-8-7-18-10-19)5-6-13(15(16)17)20(22)23/h1-8,10H,9H2 D01LOU DRUGINKE JLTNBMDVMUSXHQ-UHFFFAOYSA-N D01LOU DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3O2)CN4C=CN=C4)[N+](=O)[O-] D01LOU HIGHSTAT Investigative D01LPG DRUG__ID D01LPG D01LPG DRUGTYPE Small molecular drug D01LPG DRUGINCH 1S/C10H9ClN4O2S/c11-9-5-13-6-10(15-9)14-7-1-3-8(4-2-7)18(12,16)17/h1-6H,(H,14,15)(H2,12,16,17) D01LPG DRUGINKE RSNSGNZRUMHXAY-UHFFFAOYSA-N D01LPG DRUGSMIL C1=CC(=CC=C1NC2=CN=CC(=N2)Cl)S(=O)(=O)N D01LPG HIGHSTAT Investigative D01LRC DRUG__ID D01LRC D01LRC DRUGTYPE Small molecular drug D01LRC DRUGINCH 1S/C30H50N/c1-5-7-9-11-13-15-17-19-22-28-26(3)29(30-24-21-25-31(30)27(28)4)23-20-18-16-14-12-10-8-6-2/h19-20,22-23H,5-18,21,24-25H2,1-4H3/q+1/b22-19-,23-20- D01LRC DRUGINKE LOTZSYKJMYSNJV-IKJQKJQYSA-N D01LRC DRUGSMIL CCCCCCCCC=CC1=C(C(=C2CCC[N+]2=C1C)C=CCCCCCCCC)C D01LRC HIGHSTAT Investigative D01LUB DRUG__ID D01LUB D01LUB DRUGTYPE Small molecular drug D01LUB DRUGINCH 1S/C17H18O4/c1-10-9-16(19)21-17-11(2)14(8-7-12(10)17)20-15-6-4-3-5-13(15)18/h7-9,15H,3-6H2,1-2H3 D01LUB DRUGINKE WRTZCCCOMNOONZ-UHFFFAOYSA-N D01LUB DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2C)OC3CCCCC3=O D01LUB HIGHSTAT Investigative D01LVY DRUG__ID D01LVY D01LVY DRUGTYPE Small molecular drug D01LVY DRUGINCH 1S/C20H15NOS/c1-14-10-12-15(13-11-14)20(22)21-16-6-2-4-8-18(16)23-19-9-5-3-7-17(19)21/h2-13H,1H3 D01LVY DRUGINKE BXCIQPXSBSOIQX-UHFFFAOYSA-N D01LVY DRUGSMIL CC1=CC=C(C=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D01LVY HIGHSTAT Investigative D01LWJ DRUG__ID D01LWJ D01LWJ DRUGTYPE Small molecular drug D01LWJ DRUGINCH 1S/C21H18O11/c22-9-3-1-8(2-4-9)13-7-12(24)15-11(23)5-10(6-14(15)31-13)30-21-18(27)16(25)17(26)19(32-21)20(28)29/h1-7,16-19,21-23,25-27H,(H,28,29)/t16-,17-,18+,19-,21+/m0/s1 D01LWJ DRUGINKE JBFOLLJCGUCDQP-ZFORQUDYSA-N D01LWJ DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O D01LWJ HIGHSTAT Investigative D01MAC DRUG__ID D01MAC D01MAC DRUGTYPE Small molecular drug D01MAC DRUGINCH 1S/C11H18N2O7/c1-2-3-4-12-11(14)19-7-5-17-10-8(20-13(15)16)6-18-9(7)10/h7-10H,2-6H2,1H3,(H,12,14)/t7-,8+,9+,10+/m0/s1 D01MAC DRUGINKE ZRPGNSMQMBUVBC-SGIHWFKDSA-N D01MAC DRUGSMIL CCCCNC(=O)OC1COC2C1OCC2O[N+](=O)[O-] D01MAC HIGHSTAT Investigative D01MAN DRUG__ID D01MAN D01MAN DRUGTYPE Small molecular drug D01MAN DRUGINCH 1S/C24H18N2O/c1-17-7-8-19-9-10-21(14-23(19)26-17)20-11-12-24(22(13-20)15-25)27-16-18-5-3-2-4-6-18/h2-14H,16H2,1H3 D01MAN DRUGINKE INOCIGKWKFGOCI-UHFFFAOYSA-N D01MAN DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=C(C=C3)OCC4=CC=CC=C4)C#N D01MAN HIGHSTAT Investigative D01MBF DRUG__ID D01MBF D01MBF DRUGTYPE Small molecular drug D01MBF DRUGINCH 1S/C17H17F2NO/c18-13-4-6-14(7-5-13)21-16-3-1-2-15(19)17(16)12-8-10-20-11-9-12/h1-7,12,20H,8-11H2 D01MBF DRUGINKE WPYMMOOTBZOFOZ-UHFFFAOYSA-N D01MBF DRUGSMIL C1CNCCC1C2=C(C=CC=C2F)OC3=CC=C(C=C3)F D01MBF HIGHSTAT Investigative D01MBG DRUG__ID D01MBG D01MBG DRUGTYPE Small molecular drug D01MBG DRUGINCH 1S/C21H30N4O5S2/c1-32-10-8-15(19(22)28)24-20(29)17-3-2-9-25(17)21(30)16(23-18(27)12-31)11-13-4-6-14(26)7-5-13/h4-7,15-17,26,31H,2-3,8-12H2,1H3,(H2,22,28)(H,23,27)(H,24,29)/t15-,16-,17-/m0/s1 D01MBG DRUGINKE LNLWXWOYQHAKTD-ULQDDVLXSA-N D01MBG DRUGSMIL CSCCC(C(=O)N)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)NC(=O)CS D01MBG HIGHSTAT Investigative D01MBR DRUG__ID D01MBR D01MBR DRUGTYPE Small molecular drug D01MBR DRUGINCH 1S/C33H41N7O5/c1-22-28(31(41)44-4)30(29(23(2)37-22)32(42)45-5)24-9-6-10-25(19-24)38-33(36-21-34)35-13-8-14-39-15-17-40(18-16-39)26-11-7-12-27(20-26)43-3/h6-7,9-12,19-20,30,37H,8,13-18H2,1-5H3,(H2,35,36,38) D01MBR DRUGINKE HDRYBCLMRKGHSG-UHFFFAOYSA-N D01MBR DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)NC(=NCCCN3CCN(CC3)C4=CC(=CC=C4)OC)NC#N)C(=O)OC D01MBR HIGHSTAT Investigative D01MCD DRUG__ID D01MCD D01MCD DRUGTYPE Small molecular drug D01MCD DRUGINCH 1S/C25H23Cl3N2O3/c1-13(31)23(32)29-21-12-25(2,3)33-24-19(21)11-18(14-4-6-15(26)7-5-14)22(30-24)17-9-8-16(27)10-20(17)28/h4-11,13,21,31H,12H2,1-3H3,(H,29,32)/t13-,21?/m1/s1 D01MCD DRUGINKE XCFWDLWOCXSJOK-ILRUXTBWSA-N D01MCD DRUGSMIL CC(C(=O)NC1CC(OC2=C1C=C(C(=N2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)(C)C)O D01MCD HIGHSTAT Investigative D01MDE DRUG__ID D01MDE D01MDE DRUGTYPE Small molecular drug D01MDE DRUGINCH 1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-2/b2-1+ D01MDE DRUGINKE VZCYOOQTPOCHFL-OWOJBTEDSA-L D01MDE DRUGSMIL C(=CC(=O)[O-])C(=O)[O-] D01MDE HIGHSTAT Investigative D01MEA DRUG__ID D01MEA D01MEA DRUGTYPE Small molecular drug D01MEA DRUGINCH 1S/C9H18N2S/c1-2-3-4-8-7-12-6-5-9(10)11-8/h8H,2-7H2,1H3,(H2,10,11) D01MEA DRUGINKE FGUKFZPUKNZRSR-UHFFFAOYSA-N D01MEA DRUGSMIL CCCCC1CSCCC(=N1)N D01MEA HIGHSTAT Investigative D01MEP DRUG__ID D01MEP D01MEP DRUGTYPE Small molecular drug D01MEP DRUGINCH 1S/C14H10IN3OS/c15-12-3-1-2-10(8-12)9-20-14-18-17-13(19-14)11-4-6-16-7-5-11/h1-8H,9H2 D01MEP DRUGINKE ZRHRPGSSSVYBRG-UHFFFAOYSA-N D01MEP DRUGSMIL C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3 D01MEP HIGHSTAT Investigative D01MFM DRUG__ID D01MFM D01MFM DRUGTYPE Small molecular drug D01MFM DRUGINCH 1S/C40H53N9O10/c1-25-20-29(50)21-26(2)30(25)23-31(41)35(51)45-32(17-11-19-43-39(42)48-49(57)58)36(52)47-34(22-27-12-5-3-6-13-27)37(53)46-33(38(54)55)16-9-10-18-44-40(56)59-24-28-14-7-4-8-15-28/h3-8,12-15,20-21,31-34,50H,9-11,16-19,22-24,41H2,1-2H3,(H,44,56)(H,45,51)(H,46,53)(H,47,52)(H,54,55)(H3,42,43,48)/t31?,32-,33+,34+/m1/s1 D01MFM DRUGINKE DTKHPEUFGZLWTF-OYKWTTPJSA-N D01MFM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(CCCN=C(N)N[N+](=O)[O-])C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCCNC(=O)OCC3=CC=CC=C3)C(=O)O)N)C)O D01MFM HIGHSTAT Investigative D01MFT DRUG__ID D01MFT D01MFT DRUGTYPE Small molecular drug D01MFT DRUGINCH 1S/C10H6Cl8/c11-3-1-2-4(5(3)12)9(16)7(14)6(13)8(2,15)10(9,17)18/h2-5H,1H2 D01MFT DRUGINKE BIWJNBZANLAXMG-UHFFFAOYSA-N D01MFT DRUGSMIL C1C2C(C(C1Cl)Cl)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl D01MFT HIGHSTAT Investigative D01MFV DRUG__ID D01MFV D01MFV DRUGTYPE Small molecular drug D01MFV DRUGINCH 1S/C12H16N2O2S/c15-11(13-8-9-17)6-7-12(16)14-10-4-2-1-3-5-10/h1-5,17H,6-9H2,(H,13,15)(H,14,16) D01MFV DRUGINKE DQJPTXLXOUGDMC-UHFFFAOYSA-N D01MFV DRUGSMIL C1=CC=C(C=C1)NC(=O)CCC(=O)NCCS D01MFV HIGHSTAT Investigative D01MGI DRUG__ID D01MGI D01MGI DRUGTYPE Small molecular drug D01MGI DRUGINCH 1S/C18H29N7O6/c19-18(20)21-5-1-2-11-16(30)22-8-13(26)24-12(7-14(27)28)17(31)23-10-4-3-9(6-10)15(29)25-11/h9-12H,1-8H2,(H,22,30)(H,23,31)(H,24,26)(H,25,29)(H,27,28)(H4,19,20,21)/t9-,10-,11+,12+/m1/s1 D01MGI DRUGINKE SLTMEZLQPRTTBL-WYUUTHIRSA-N D01MGI DRUGSMIL C1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D01MGI HIGHSTAT Investigative D01MHO DRUG__ID D01MHO D01MHO DRUGTYPE Small molecular drug D01MHO DRUGINCH 1S/C18H23NO6S/c1-19-8-7-18-11-4-6-14(25-26(20,21)22)17(18)24-16-13(23-2)5-3-10(15(16)18)9-12(11)19/h3,5,11-12,14,17H,4,6-9H2,1-2H3,(H,20,21,22)/t11-,12+,14-,17-,18-/m0/s1 D01MHO DRUGINKE UFGYWOICNCSHBB-XSSYPUMDSA-N D01MHO DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(CC4)OS(=O)(=O)O D01MHO HIGHSTAT Investigative D01MHP DRUG__ID D01MHP D01MHP DRUGTYPE Small molecular drug D01MHP DRUGINCH 1S/C35H44N2O12/c1-19(2)32(43)26(48-25(39)22-12-9-15-36-22)33(44)28(4)18-31(42)29(32,5)35(33,45)34(49-31)24(20(3)13-14-30(28,34)41)47-23(38)16-37-27(40)46-17-21-10-7-6-8-11-21/h6-12,15,19-20,24,26,36,41-45H,13-14,16-18H2,1-5H3,(H,37,40)/t20?,24-,26-,28+,29?,30?,31?,32?,33?,34?,35?/m1/s1 D01MHP DRUGINKE ZJAWJJNLZWLOIL-JIVHGXQSSA-N D01MHP DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CNC(=O)OCC6=CC=CC=C6)O4)O)O)OC(=O)C7=CC=CN7)(C(C)C)O)C)O)C)O D01MHP HIGHSTAT Investigative D01MJF DRUG__ID D01MJF D01MJF DRUGTYPE Small molecular drug D01MJF DRUGINCH 1S/C22H36O/c1-4-5-6-7-8-16-22(2,3)20-14-12-18(13-15-20)19-10-9-11-21(23)17-19/h12-15,19,21,23H,4-11,16-17H2,1-3H3/t19-,21+/m0/s1 D01MJF DRUGINKE SHSCKELICBAALI-PZJWPPBQSA-N D01MJF DRUGSMIL CCCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D01MJF HIGHSTAT Investigative D01MKM DRUG__ID D01MKM D01MKM DRUGTYPE Small molecular drug D01MKM DRUGINCH 1S/C33H39N5O5/c34-26(20-24-13-16-25(39)17-14-24)33(43)38-19-7-12-29(38)32(42)36-27(18-15-22-8-3-1-4-9-22)31(41)37-28(30(35)40)21-23-10-5-2-6-11-23/h1-6,8-11,13-14,16-17,26-29,39H,7,12,15,18-21,34H2,(H2,35,40)(H,36,42)(H,37,41)/t26-,27-,28-,29-/m0/s1 D01MKM DRUGINKE FNDQFOCGSSQYSF-DZUOILHNSA-N D01MKM DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CCC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N D01MKM HIGHSTAT Investigative D01MLQ DRUG__ID D01MLQ D01MLQ DRUGTYPE Small molecular drug D01MLQ DRUGINCH 1S/C19H20FNO/c20-18-9-5-4-8-17(18)19(22)21-12-10-16(11-13-21)14-15-6-2-1-3-7-15/h1-9,16H,10-14H2 D01MLQ DRUGINKE LEVTWCPGXIVKEH-UHFFFAOYSA-N D01MLQ DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3F D01MLQ HIGHSTAT Investigative D01MMM DRUG__ID D01MMM D01MMM DRUGTYPE Small molecular drug D01MMM DRUGINCH 1S/C25H30O7/c1-14(2)6-7-16-8-9-19(27)18(12-26)22(16)24(30)17-10-15(3)11-20(23(17)29)32-13-21(28)25(4,5)31/h6,8-12,21,27-29,31H,7,13H2,1-5H3 D01MMM DRUGINKE AXMCRMUBMNEKLN-UHFFFAOYSA-N D01MMM DRUGSMIL CC1=CC(=C(C(=C1)OCC(C(C)(C)O)O)O)C(=O)C2=C(C=CC(=C2C=O)O)CC=C(C)C D01MMM HIGHSTAT Investigative D01MMU DRUG__ID D01MMU D01MMU DRUGTYPE Small molecular drug D01MMU DRUGINCH 1S/C16H15NO2/c1-17-13-5-3-11(4-6-13)16-10-12-9-14(18-2)7-8-15(12)19-16/h3-10,17H,1-2H3 D01MMU DRUGINKE UPVZXZTUTQNNFR-UHFFFAOYSA-N D01MMU DRUGSMIL CNC1=CC=C(C=C1)C2=CC3=C(O2)C=CC(=C3)OC D01MMU HIGHSTAT Investigative D01MOQ DRUG__ID D01MOQ D01MOQ DRUGTYPE Small molecular drug D01MOQ DRUGINCH 1S/C12H14N2O/c1-3-4-9-7-11(15)10-6-5-8(2)13-12(10)14-9/h5-7H,3-4H2,1-2H3,(H,13,14,15) D01MOQ DRUGINKE JAFFZYFREVCDTP-UHFFFAOYSA-N D01MOQ DRUGSMIL CCCC1=CC(=O)C2=C(N1)N=C(C=C2)C D01MOQ HIGHSTAT Investigative D01MPK DRUG__ID D01MPK D01MPK DRUGTYPE Small molecular drug D01MPK DRUGINCH 1S/C11H12N2O2/c1-13-10(14)6-9(11(13)15)7-2-4-8(12)5-3-7/h2-5,9H,6,12H2,1H3 D01MPK DRUGINKE QMQMEAAIWVAXHW-UHFFFAOYSA-N D01MPK DRUGSMIL CN1C(=O)CC(C1=O)C2=CC=C(C=C2)N D01MPK HIGHSTAT Investigative D01MSM DRUG__ID D01MSM D01MSM DRUGTYPE Small molecular drug D01MSM DRUGINCH 1S/C10H6N2O5/c13-8-4-9(14)10(15)11-7-2-1-5(12(16)17)3-6(7)8/h1-4,13H,(H,11,14,15) D01MSM DRUGINKE QIUGYFFOPLNZSP-UHFFFAOYSA-N D01MSM DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C(=CC(=O)C(=O)N2)O D01MSM HIGHSTAT Investigative D01MSZ DRUG__ID D01MSZ D01MSZ DRUGCOMP Romark Laboratories LC D01MSZ DRUGINCH 1S/C13H11ClN2O3S/c1-7-3-4-8(12(18)19-2)9(5-7)11(17)16-13-15-10(14)6-20-13/h3-6H,1-2H3,(H,15,16,17) D01MSZ DRUGINKE YVTXSJMDCBNRHS-UHFFFAOYSA-N D01MSZ DRUGSMIL CC1=CC(=C(C=C1)C(=O)OC)C(=O)NC2=NC(=CS2)Cl D01MSZ HIGHSTAT Investigative D01MUN DRUG__ID D01MUN D01MUN DRUGTYPE Small molecular drug D01MUN DRUGINCH 1S/C13H11N3/c14-10-5-7-11(8-6-10)16-9-15-12-3-1-2-4-13(12)16/h1-9H,14H2 D01MUN DRUGINKE DWYMPMWWYZEKLQ-UHFFFAOYSA-N D01MUN DRUGSMIL C1=CC=C2C(=C1)N=CN2C3=CC=C(C=C3)N D01MUN HIGHSTAT Investigative D01MUV DRUG__ID D01MUV D01MUV DRUGTYPE Small molecular drug D01MUV DRUGINCH 1S/C22H29NO/c1-21(2,3)22(24)14-16-23(17-15-22)20(18-10-6-4-7-11-18)19-12-8-5-9-13-19/h4-13,20,24H,14-17H2,1-3H3 D01MUV DRUGINKE CSHMHUZYEYOBPL-UHFFFAOYSA-N D01MUV DRUGSMIL CC(C)(C)C1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O D01MUV HIGHSTAT Investigative D01MVX DRUG__ID D01MVX D01MVX DRUGTYPE Small molecular drug D01MVX DRUGINCH 1S/C30H36N4/c1(3-11-20-31-27-19-22-32-26-16-8-5-13-23(26)27)2-4-12-21-33-30-24-14-6-9-17-28(24)34-29-18-10-7-15-25(29)30/h5-6,8-9,13-14,16-17,19,22H,1-4,7,10-12,15,18,20-21H2,(H,31,32)(H,33,34) D01MVX DRUGINKE UNVOAAWEEGAXTN-UHFFFAOYSA-N D01MVX DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCCCNC4=CC=NC5=CC=CC=C54 D01MVX HIGHSTAT Investigative D01MWX DRUG__ID D01MWX D01MWX DRUGTYPE Small molecular drug D01MWX DRUGINCH 1S/C22H18N2O4/c25-19-15-7-5-13(23-21(27)11-1-2-11)9-17(15)20(26)18-10-14(6-8-16(18)19)24-22(28)12-3-4-12/h5-12H,1-4H2,(H,23,27)(H,24,28) D01MWX DRUGINKE SCYQIQINYUMLPD-UHFFFAOYSA-N D01MWX DRUGSMIL C1CC1C(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)C5CC5 D01MWX HIGHSTAT Investigative D01MXN DRUG__ID D01MXN D01MXN DRUGTYPE Small molecular drug D01MXN DRUGINCH 1S/C21H18N2O3/c24-19-13-20(23-8-10-25-11-9-23)26-21-16(2-1-3-17(19)21)14-4-5-18-15(12-14)6-7-22-18/h1-7,12-13,22H,8-11H2 D01MXN DRUGINKE LXMAOXUZAUDVCG-UHFFFAOYSA-N D01MXN DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC5=C(C=C4)NC=C5 D01MXN HIGHSTAT Investigative D01MYO DRUG__ID D01MYO D01MYO DRUGTYPE Small molecular drug D01MYO DRUGINCH 1S/C32H36N2O3/c1-33(2)29-19-17-27(18-20-29)26-15-12-25(13-16-26)23-34(32(36)28-9-5-4-6-10-28)30-11-7-8-24(22-30)14-21-31(35)37-3/h7-8,11-22,28H,4-6,9-10,23H2,1-3H3/b21-14+ D01MYO DRUGINKE VLQTUNDJHLEFEQ-KGENOOAVSA-N D01MYO DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC=C(C=C2)CN(C3=CC=CC(=C3)C=CC(=O)OC)C(=O)C4CCCCC4 D01MYO HIGHSTAT Investigative D01NBF DRUG__ID D01NBF D01NBF DRUGTYPE Small molecular drug D01NBF DRUGINCH 1S/C28H38O5/c1-18(17-26(30)31)5-12-22-19(2)6-14-24-23(22)13-15-25(28(24,3)4)33-27(32)16-9-20-7-10-21(29)11-8-20/h6-11,16,18,22-25,29H,5,12-15,17H2,1-4H3,(H,30,31)/b16-9+/t18-,22-,23+,24+,25-/m0/s1 D01NBF DRUGINKE ZSKLTPLHCIUPKA-LOWUFNJHSA-N D01NBF DRUGSMIL CC1=CCC2C(C1CCC(C)CC(=O)O)CCC(C2(C)C)OC(=O)C=CC3=CC=C(C=C3)O D01NBF HIGHSTAT Investigative D01NBK DRUG__ID D01NBK D01NBK DRUGTYPE Small molecular drug D01NBK DRUGINCH 1S/C8H13N2O5P/c1-5-8(11)7(2-9)6(3-10-5)4-15-16(12,13)14/h3,11H,2,4,9H2,1H3,(H2,12,13,14) D01NBK DRUGINKE ZMJGSOSNSPKHNH-UHFFFAOYSA-N D01NBK DRUGSMIL CC1=NC=C(C(=C1O)CN)COP(=O)(O)O D01NBK HIGHSTAT Investigative D01NCW DRUG__ID D01NCW D01NCW DRUGTYPE Small molecular drug D01NCW DRUGINCH 1S/C34H48N4O7S/c1-7-24(4)30(38-34(42)45-22-27-16-12-9-13-17-27)33(41)37-29(21-26-14-10-8-11-15-26)32(40)35-25(5)31(39)36-28(20-23(2)3)18-19-46(6,43)44/h8-19,23-25,28-30H,7,20-22H2,1-6H3,(H,35,40)(H,36,39)(H,37,41)(H,38,42)/b19-18+/t24-,25-,28+,29-,30-/m0/s1 D01NCW DRUGINKE NDQAQUAWHJQVGE-HZPWIFGKSA-N D01NCW DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC2=CC=CC=C2 D01NCW HIGHSTAT Investigative D01NDE DRUG__ID D01NDE D01NDE DRUGTYPE Small molecular drug D01NDE DRUGINCH 1S/C15H27F3OS/c1-2-3-4-5-6-7-8-9-10-11-12-20-13-14(19)15(16,17)18/h2-13H2,1H3 D01NDE DRUGINKE NACMLRDTSWENRZ-UHFFFAOYSA-N D01NDE DRUGSMIL CCCCCCCCCCCCSCC(=O)C(F)(F)F D01NDE HIGHSTAT Investigative D01NEZ DRUG__ID D01NEZ D01NEZ DRUGTYPE Small molecular drug D01NEZ DRUGINCH 1S/C26H43ClN6O10S/c1-13(2)21(27)22(31-24(37)20(42-3)12-43-44(39,40)41)25(38)33-16-10-19(35)18(34)9-15(16)8-17(33)23(36)30-6-4-14-5-7-32(11-14)26(28)29/h5,13,15-22,34-35H,4,6-12H2,1-3H3,(H6,28,29,30,31,36,37,39,40,41)/t15-,16+,17+,18+,19+,20-,21-,22-/m1/s1 D01NEZ DRUGINKE DLWZHBAKINZMIF-WNZJUFNWSA-N D01NEZ DRUGSMIL CC(C)C(C(C(=O)N1C2CC(C(CC2CC1C(=O)NCCC3=CC[N+](=C(N)N)C3)O)O)NC(=O)C(COS(=O)(=O)[O-])OC)Cl D01NEZ HIGHSTAT Investigative D01NFH DRUG__ID D01NFH D01NFH DRUGTYPE Small molecular drug D01NFH DRUGINCH 1S/C15H27N3O2/c1-2-14(19)18-10-8-13(9-11-18)17-15(20)16-12-6-4-3-5-7-12/h12-13H,2-11H2,1H3,(H2,16,17,20) D01NFH DRUGINKE VZLSZVQSSZTJPS-UHFFFAOYSA-N D01NFH DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2CCCCC2 D01NFH HIGHSTAT Investigative D01NHH DRUG__ID D01NHH D01NHH DRUGTYPE Small molecular drug D01NHH DRUGINCH 1S/C22H21N3/c1-22(2,3)21-24-19-17(15-10-6-4-7-11-15)14-18(23-20(19)25-21)16-12-8-5-9-13-16/h4-14H,1-3H3,(H,23,24,25) D01NHH DRUGINKE LYZUCUIUVUYBJL-UHFFFAOYSA-N D01NHH DRUGSMIL CC(C)(C)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D01NHH HIGHSTAT Investigative D01NOZ DRUG__ID D01NOZ D01NOZ DRUGTYPE Small molecular drug D01NOZ DRUGINCH 1S/C22H26F3N5O2/c1-28(2)11-12-29(3)21-27-18-10-7-16(13-19(18)30(21)4)26-20(31)14-32-17-8-5-15(6-9-17)22(23,24)25/h5-10,13H,11-12,14H2,1-4H3,(H,26,31) D01NOZ DRUGINKE KMPCTCXLXOJTGD-UHFFFAOYSA-N D01NOZ DRUGSMIL CN1C2=C(C=CC(=C2)NC(=O)COC3=CC=C(C=C3)C(F)(F)F)N=C1N(C)CCN(C)C D01NOZ HIGHSTAT Investigative D01NPA DRUG__ID D01NPA D01NPA DRUGTYPE Small molecular drug D01NPA DRUGINCH 1S/C50H80N14O14S/c1-26(2)18-34(45(73)58-32(42(53)70)15-17-79-6)57-38(67)23-55-49(77)40(27(3)4)63-47(75)35(19-29-12-8-7-9-13-29)60-48(76)37(24-65)62-46(74)36(21-39(68)69)61-50(78)41(28(5)66)64-44(72)33(14-10-11-16-51)59-43(71)31(52)20-30-22-54-25-56-30/h7-9,12-13,22,25-28,31-37,40-41,65-66H,10-11,14-21,23-24,51-52H2,1-6H3,(H2,53,70)(H,54,56)(H,55,77)(H,57,67)(H,58,73)(H,59,71)(H,60,76)(H,61,78)(H,62,74)(H,63,75)(H,64,72)(H,68,69)/t28-,31+,32+,33+,34+,35+,36+,37+,40+,41+/m1/s1 D01NPA DRUGINKE HEAUFJZALFKPBA-JPQUDPSNSA-N D01NPA DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC2=CN=CN2)N D01NPA HIGHSTAT Investigative D01NTI DRUG__ID D01NTI D01NTI DRUGTYPE Small molecular drug D01NTI DRUGINCH 1S/C18H22N6/c1-3-7-13(8-4-1)11-19-18-23-16-15(20-12-21-16)17(24-18)22-14-9-5-2-6-10-14/h1,3-4,7-8,12,14H,2,5-6,9-11H2,(H3,19,20,21,22,23,24) D01NTI DRUGINKE NPPHTZNKBUCRPG-UHFFFAOYSA-N D01NTI DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NCC4=CC=CC=C4 D01NTI HIGHSTAT Investigative D01NTM DRUG__ID D01NTM D01NTM DRUGTYPE Small molecular drug D01NTM DRUGINCH 1S/C12H17FN2S/c1-8(14)7-15-4-3-9-5-10(13)12(16-2)6-11(9)15/h5-6,8H,3-4,7,14H2,1-2H3/t8-/m0/s1 D01NTM DRUGINKE IGAAICGMRRWZJW-QMMMGPOBSA-N D01NTM DRUGSMIL CC(CN1CCC2=CC(=C(C=C21)SC)F)N D01NTM HIGHSTAT Investigative D01NTN DRUG__ID D01NTN D01NTN DRUGTYPE Small molecular drug D01NTN DRUGINCH 1S/C15H20Br2O3/c1-2-3-4-5-8-20-15-12(16)9-11(10-13(15)17)6-7-14(18)19/h9-10H,2-8H2,1H3,(H,18,19) D01NTN DRUGINKE FVDRTJXVCUAOCA-UHFFFAOYSA-N D01NTN DRUGSMIL CCCCCCOC1=C(C=C(C=C1Br)CCC(=O)O)Br D01NTN HIGHSTAT Investigative D01NTW DRUG__ID D01NTW D01NTW DRUGTYPE Small molecular drug D01NTW DRUGINCH 1S/C10H8N2O3/c11-5-7(10(12)15)3-6-1-2-8(13)9(14)4-6/h1-4,13-14H,(H2,12,15)/b7-3+ D01NTW DRUGINKE USOXQZNJFMKTKJ-XVNBXDOJSA-N D01NTW DRUGSMIL C1=CC(=C(C=C1C=C(C#N)C(=O)N)O)O D01NTW HIGHSTAT Investigative D01NTY DRUG__ID D01NTY D01NTY DRUGTYPE Small molecular drug D01NTY DRUGINCH 1S/C5H4IN5O/c6-4-8-1-2(9-4)10-5(7)11-3(1)12/h(H4,7,8,9,10,11,12) D01NTY DRUGINKE SXGFECRAKVVEJT-UHFFFAOYSA-N D01NTY DRUGSMIL C12=C(N=C(NC1=O)N)N=C(N2)I D01NTY HIGHSTAT Investigative D01NUT DRUG__ID D01NUT D01NUT DRUGTYPE Small molecular drug D01NUT DRUGINCH 1S/C29H34O4/c1-18(2)7-6-8-20(5)10-13-24-26(31)14-11-21-15-28(33-29(21)24)25-16-22(30)17-27(32)23(25)12-9-19(3)4/h7,9-11,14-17,30-32H,6,8,12-13H2,1-5H3/b20-10+ D01NUT DRUGINKE WCJPAQJEARHLGS-KEBDBYFISA-N D01NUT DRUGSMIL CC(=CCCC(=CCC1=C(C=CC2=C1OC(=C2)C3=C(C(=CC(=C3)O)O)CC=C(C)C)O)C)C D01NUT HIGHSTAT Investigative D01NVD DRUG__ID D01NVD D01NVD DRUGTYPE Small molecular drug D01NVD DRUGINCH 1S/C21H20ClN5O2/c1-11-18-19(22)16(10-23-20(18)27(4)25-11)21(28)24-9-14-5-7-15(8-6-14)17-12(2)26-29-13(17)3/h5-8,10H,9H2,1-4H3,(H,24,28) D01NVD DRUGINKE QWZQPWUWGYGVOC-UHFFFAOYSA-N D01NVD DRUGSMIL CC1=C(C(=NO1)C)C2=CC=C(C=C2)CNC(=O)C3=CN=C4C(=C3Cl)C(=NN4C)C D01NVD HIGHSTAT Investigative D01NVL DRUG__ID D01NVL D01NVL DRUGTYPE Small molecular drug D01NVL DRUGINCH 1S/C15H9ClN2O2S/c16-10-4-6-13-12(8-10)11-5-3-9-2-1-7-17-14(9)15(11)18-21(13,19)20/h1-8,18H D01NVL DRUGINKE JVPPTVNJBXFSPQ-UHFFFAOYSA-N D01NVL DRUGSMIL C1=CC2=C(C3=C(C=C2)C4=C(C=CC(=C4)Cl)S(=O)(=O)N3)N=C1 D01NVL HIGHSTAT Investigative D01NWQ DRUG__ID D01NWQ D01NWQ DRUGTYPE Small molecular drug D01NWQ DRUGINCH 1S/C18H14BrNO/c1-12-10-16(19)8-9-17(12)20-18(21)15-7-6-13-4-2-3-5-14(13)11-15/h2-11H,1H3,(H,20,21) D01NWQ DRUGINKE QDOYRUBXBHREAH-UHFFFAOYSA-N D01NWQ DRUGSMIL CC1=C(C=CC(=C1)Br)NC(=O)C2=CC3=CC=CC=C3C=C2 D01NWQ HIGHSTAT Investigative D01NWS DRUG__ID D01NWS D01NWS DRUGTYPE Small molecular drug D01NWS DRUGINCH 1S/C18H15NO2/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2 D01NWS DRUGINKE RKXYRLSZCAAEPX-UHFFFAOYSA-N D01NWS DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)C3=NC=CO3 D01NWS HIGHSTAT Investigative D01NZS DRUG__ID D01NZS D01NZS DRUGTYPE Small molecular drug D01NZS DRUGINCH 1S/C17H19N3O2/c21-16-14-7-3-4-8-15(14)17(22)20(16)11-6-2-1-5-10-19-12-9-18-13-19/h3-4,7-9,12-13H,1-2,5-6,10-11H2 D01NZS DRUGINKE CGDDIOSGLRENCV-UHFFFAOYSA-N D01NZS DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCCCN3C=CN=C3 D01NZS HIGHSTAT Investigative D01OAG DRUG__ID D01OAG D01OAG DRUGTYPE Small molecular drug D01OAG DRUGINCH 1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13- D01OAG DRUGINKE NCYCYZXNIZJOKI-HWCYFHEPSA-N D01OAG DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=O)C)C D01OAG HIGHSTAT Investigative D01OBJ DRUG__ID D01OBJ D01OBJ DRUGTYPE Small molecular drug D01OBJ DRUGINCH 1S/C12H9BrN2O/c1-16-10-3-2-8-11(12(10)13)7-4-5-14-6-9(7)15-8/h2-6,15H,1H3 D01OBJ DRUGINKE NXKWYFQQPHBFII-UHFFFAOYSA-N D01OBJ DRUGSMIL COC1=C(C2=C(C=C1)NC3=C2C=CN=C3)Br D01OBJ HIGHSTAT Investigative D01OCR DRUG__ID D01OCR D01OCR DRUGTYPE Small molecular drug D01OCR DRUGINCH 1S/C12H18O3S2/c1-3-11(8-9-16)17(13,14)12-6-4-10(15-2)5-7-12/h4-7,11,16H,3,8-9H2,1-2H3 D01OCR DRUGINKE PKYBEORBMGUOOP-UHFFFAOYSA-N D01OCR DRUGSMIL CCC(CCS)S(=O)(=O)C1=CC=C(C=C1)OC D01OCR HIGHSTAT Investigative D01OCZ DRUG__ID D01OCZ D01OCZ DRUGTYPE Small molecular drug D01OCZ DRUGINCH 1S/C22H28O2/c1-13(2)10-15-12-20-19-6-4-14-11-16(23)5-7-17(14)18(19)8-9-22(20,3)21(15)24/h5,7,10-11,13,18-20,23H,4,6,8-9,12H2,1-3H3/b15-10+/t18-,19-,20+,22+/m1/s1 D01OCZ DRUGINKE PTANBYHUNIXKEU-HDLVZFDGSA-N D01OCZ DRUGSMIL CC(C)C=C1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D01OCZ HIGHSTAT Investigative D01ODR DRUG__ID D01ODR D01ODR DRUGTYPE Small molecular drug D01ODR DRUGINCH 1S/C14H13BrN2O/c1-14(2,3)11-5-9(4-10(7-16)8-17)6-12(15)13(11)18/h4-6,18H,1-3H3 D01ODR DRUGINKE ABBADGFSRBWENF-UHFFFAOYSA-N D01ODR DRUGSMIL CC(C)(C)C1=C(C(=CC(=C1)C=C(C#N)C#N)Br)O D01ODR HIGHSTAT Investigative D01OFD DRUG__ID D01OFD D01OFD DRUGTYPE Small molecular drug D01OFD DRUGINCH 1S/C51H80O16/c1-9-39(25-36(7)49(59)60)43(52)21-19-38-24-33(4)22-32(3)23-35(6)48(58)34(5)17-20-42(67-47(57)29-41(51(63)64)27-45(55)65-30-38)15-13-11-10-12-14-31(2)16-18-37(8)66-46(56)28-40(50(61)62)26-44(53)54/h12,14,23-24,31,33-37,39-42,48,58H,9-11,13,15-22,25-30H2,1-8H3,(H,53,54)(H,59,60)(H,61,62)(H,63,64)/b14-12+,32-23+,38-24- D01OFD DRUGINKE ZJCPEIGQYKMZFE-PXQKRTIOSA-N D01OFD DRUGSMIL CCC(CC(C)C(=O)O)C(=O)CCC1=CC(CC(=CC(C(C(CCC(OC(=O)CC(CC(=O)OC1)C(=O)O)CCCCC=CC(C)CCC(C)OC(=O)CC(CC(=O)O)C(=O)O)C)O)C)C)C D01OFD HIGHSTAT Investigative D01OFH DRUG__ID D01OFH D01OFH DRUGTYPE Small molecular drug D01OFH DRUGINCH 1S/C19H20O2/c1-4-6-14-8-10-18(20)17(12-14)15-9-11-19(21-3)16(13-15)7-5-2/h4-5,8-13,20H,1-2,6-7H2,3H3 D01OFH DRUGINKE OQFHJKZVOALSPV-UHFFFAOYSA-N D01OFH DRUGSMIL COC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)O)CC=C D01OFH HIGHSTAT Investigative D01OGZ DRUG__ID D01OGZ D01OGZ DRUGTYPE Small molecular drug D01OGZ DRUGINCH 1S/C22H24F4N2O/c23-17-4-1-15(2-5-17)19-14-21(28-9-7-27(8-10-28)11-12-29)20-13-16(22(24,25)26)3-6-18(19)20/h1-6,13,19,21,29H,7-12,14H2/t19-,21+/m0/s1 D01OGZ DRUGINKE JSBWGXQXCRYYTG-PZJWPPBQSA-N D01OGZ DRUGSMIL C1CN(CCN1CCO)C2CC(C3=C2C=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)F D01OGZ HIGHSTAT Investigative D01OHV DRUG__ID D01OHV D01OHV DRUGTYPE Small molecular drug D01OHV DRUGINCH 1S/C4H4N6O/c5-4-6-2-1(3(11)7-4)8-10-9-2/h(H4,5,6,7,8,9,10,11) D01OHV DRUGINKE LPXQRXLUHJKZIE-UHFFFAOYSA-N D01OHV DRUGSMIL C12=NNN=C1N=C(NC2=O)N D01OHV HIGHSTAT Investigative D01OIJ DRUG__ID D01OIJ D01OIJ DRUGTYPE Small molecular drug D01OIJ DRUGINCH 1S/C24H28N6O3/c1-15-20(22(31)29-18(23(32)33)13-8-14-27-24(25)26)30-21(28-15)19(16-9-4-2-5-10-16)17-11-6-3-7-12-17/h2-7,9-12,18-19H,8,13-14H2,1H3,(H,28,30)(H,29,31)(H,32,33)(H4,25,26,27)/t18-/m0/s1 D01OIJ DRUGINKE RFBOIZXPIAOMAX-SFHVURJKSA-N D01OIJ DRUGSMIL CC1=C(N=C(N1)C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC(CCCN=C(N)N)C(=O)O D01OIJ HIGHSTAT Investigative D01OIK DRUG__ID D01OIK D01OIK DRUGTYPE Small molecular drug D01OIK DRUGINCH 1S/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22) D01OIK DRUGINKE DXPOSRCHIDYWHW-UHFFFAOYSA-N D01OIK DRUGSMIL C1COCCN1C(=O)NCCNCC(COC2=CC=C(C=C2)O)O D01OIK HIGHSTAT Investigative D01OIV DRUG__ID D01OIV D01OIV DRUGTYPE Small molecular drug D01OIV DRUGINCH 1S/C18H23NO5/c1-23-17-6-3-12(9-18(17)24-2)7-8-19-11-16(22)13-4-5-14(20)15(21)10-13/h3-6,9-10,16,19-22H,7-8,11H2,1-2H3 D01OIV DRUGINKE DIPGFXJERHNAQQ-UHFFFAOYSA-N D01OIV DRUGSMIL COC1=C(C=C(C=C1)CCNCC(C2=CC(=C(C=C2)O)O)O)OC D01OIV HIGHSTAT Investigative D01OJG DRUG__ID D01OJG D01OJG DRUGTYPE Small molecular drug D01OJG DRUGINCH 1S/C16H12N2O2/c19-15-13(11-7-3-1-4-8-11)14(16(20)18-15)17-12-9-5-2-6-10-12/h1-10H,(H2,17,18,19,20) D01OJG DRUGINKE ACQZMAJVOPRMQJ-UHFFFAOYSA-N D01OJG DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)NC2=O)NC3=CC=CC=C3 D01OJG HIGHSTAT Investigative D01OKF DRUG__ID D01OKF D01OKF DRUGTYPE Small molecular drug D01OKF DRUGINCH 1S/C18H20Cl2N2O/c1-14-2-6-16(7-3-14)21-18(23)15-4-8-17(9-5-15)22(12-10-19)13-11-20/h2-9H,10-13H2,1H3,(H,21,23) D01OKF DRUGINKE YUHSPIYJWBBMHU-UHFFFAOYSA-N D01OKF DRUGSMIL CC1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)N(CCCl)CCCl D01OKF HIGHSTAT Investigative D01OMG DRUG__ID D01OMG D01OMG DRUGTYPE Small molecular drug D01OMG DRUGINCH 1S/C14H8N4O/c15-8-10-3-1-4-11(7-10)14-17-13(18-19-14)12-5-2-6-16-9-12/h1-7,9H D01OMG DRUGINKE HGFXDSQLRSWUBO-UHFFFAOYSA-N D01OMG DRUGSMIL C1=CC(=CC(=C1)C2=NC(=NO2)C3=CN=CC=C3)C#N D01OMG HIGHSTAT Investigative D01OND DRUG__ID D01OND D01OND DRUGTYPE Small molecular drug D01OND DRUGINCH 1S/C15H16N2O2/c1-17(2)13-9-6-10-14(11-13)19-15(18)16-12-7-4-3-5-8-12/h3-11H,1-2H3,(H,16,18) D01OND DRUGINKE YNGSTYODGGYXSA-UHFFFAOYSA-N D01OND DRUGSMIL CN(C)C1=CC(=CC=C1)OC(=O)NC2=CC=CC=C2 D01OND HIGHSTAT Investigative D01OQW DRUG__ID D01OQW D01OQW DRUGTYPE Small molecular drug D01OQW DRUGINCH 1S/C34H26O8/c1-16-8-23-22-6-4-21(37)15-30(22)41-34(25-7-5-19(35)13-26(25)38)33(23)24(9-16)32-27(39)10-18(12-31(32)42-34)28-11-17-2-3-20(36)14-29(17)40-28/h2-7,9-15,23-24,33,35-39H,8H2,1H3/t23-,24-,33-,34+/m0/s1 D01OQW DRUGINKE MJJWBJFYYRAYKU-OPKNDJPNSA-N D01OQW DRUGSMIL CC1=CC2C3C(C1)C4=C(C=C(C=C4)O)OC3(OC5=CC(=CC(=C25)O)C6=CC7=C(O6)C=C(C=C7)O)C8=C(C=C(C=C8)O)O D01OQW HIGHSTAT Investigative D01ORL DRUG__ID D01ORL D01ORL DRUGTYPE Small molecular drug D01ORL DRUGINCH 1S/C21H24N2O/c24-20-7-6-18-13-19(22-21(18)14-20)15-23-10-8-17(9-11-23)12-16-4-2-1-3-5-16/h1-7,13-14,17,22,24H,8-12,15H2 D01ORL DRUGINKE XCBFDMFJYYJHAL-UHFFFAOYSA-N D01ORL DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3=CC4=C(N3)C=C(C=C4)O D01ORL HIGHSTAT Investigative D01OTW DRUG__ID D01OTW D01OTW DRUGTYPE Small molecular drug D01OTW DRUGINCH 1S/C7H7N3O2S2/c8-2-4-13-6-1-3-10-5-7(6)14(9,11)12/h1,3,5H,4H2,(H2,9,11,12) D01OTW DRUGINKE JOIYJNZMYUXKRS-UHFFFAOYSA-N D01OTW DRUGSMIL C1=CN=CC(=C1SCC#N)S(=O)(=O)N D01OTW HIGHSTAT Investigative D01OUJ DRUG__ID D01OUJ D01OUJ DRUGTYPE Small molecular drug D01OUJ DRUGINCH 1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/p+1/t7-,8+/m0/s1 D01OUJ DRUGINKE FKCMADOPPWWGNZ-JGVFFNPUSA-O D01OUJ DRUGSMIL B(C1CCCN1C(=O)C(C(C)C)[NH3+])(O)O D01OUJ HIGHSTAT Investigative D01OXV DRUG__ID D01OXV D01OXV DRUGTYPE Small molecular drug D01OXV DRUGINCH 1S/C17H20ClF4N7O/c1-23-15-10(17(20,21)22)4-24-16(27-15)26-12-5-25-29(14(12)18)13-2-3-28(6-11(13)19)9-7-30-8-9/h4-5,9,11,13H,2-3,6-8H2,1H3,(H2,23,24,26,27)/t11-,13-/m0/s1 D01OXV DRUGINKE PUXPEQJKNAWNQA-AAEUAGOBSA-N D01OXV DRUGSMIL CNC1=NC(=NC=C1C(F)(F)F)NC2=C(N(N=C2)C3CCN(CC3F)C4COC4)Cl D01OXV HIGHSTAT Investigative D01OYC DRUG__ID D01OYC D01OYC DRUGTYPE Small molecular drug D01OYC DRUGINCH 1S/C13H16N2O/c1-3-9(2)16-11-6-4-5-10-7-8-12(14)15-13(10)11/h4-9H,3H2,1-2H3,(H2,14,15) D01OYC DRUGINKE RDHSHZSWPBWALB-UHFFFAOYSA-N D01OYC DRUGSMIL CCC(C)OC1=CC=CC2=C1N=C(C=C2)N D01OYC HIGHSTAT Investigative D01OZF DRUG__ID D01OZF D01OZF DRUGTYPE Small molecular drug D01OZF DRUGINCH 1S/C20H25N3O3/c24-20(21-17-5-2-1-3-6-17)22-18-7-9-19(10-8-18)26-14-4-11-23-12-15-25-16-13-23/h1-3,5-10H,4,11-16H2,(H2,21,22,24) D01OZF DRUGINKE HTAZKQMMJVVVSK-UHFFFAOYSA-N D01OZF DRUGSMIL C1COCCN1CCCOC2=CC=C(C=C2)NC(=O)NC3=CC=CC=C3 D01OZF HIGHSTAT Investigative D01OZL DRUG__ID D01OZL D01OZL DRUGTYPE Small molecular drug D01OZL DRUGINCH 1S/C14H18N2O/c1-3-10(2)9-17-12-6-4-5-11-7-8-13(15)16-14(11)12/h4-8,10H,3,9H2,1-2H3,(H2,15,16) D01OZL DRUGINKE YLIRVLXATQGNTR-UHFFFAOYSA-N D01OZL DRUGSMIL CCC(C)COC1=CC=CC2=C1N=C(C=C2)N D01OZL HIGHSTAT Investigative D01OZS DRUG__ID D01OZS D01OZS DRUGTYPE Small molecular drug D01OZS DRUGINCH 1S/C10H18O2/c1-7(2)10(8(3)4)5-6-12-9(10)11/h7-8H,5-6H2,1-4H3 D01OZS DRUGINKE HBNIKFYZKDWFNE-UHFFFAOYSA-N D01OZS DRUGSMIL CC(C)C1(CCOC1=O)C(C)C D01OZS HIGHSTAT Investigative D01PAC DRUG__ID D01PAC D01PAC DRUGTYPE Small molecular drug D01PAC DRUGINCH 1S/C27H29IN2/c28-24-14-8-7-13-23(24)19-29-26-22-15-17-30(18-16-22)27(26)25(20-9-3-1-4-10-20)21-11-5-2-6-12-21/h1-14,22,25-27,29H,15-19H2/t26-,27-/m1/s1/i28-2 D01PAC DRUGINKE WSLTYZVXORBNLB-BRXFWFLGSA-N D01PAC DRUGSMIL C1CN2CCC1C(C2C(C3=CC=CC=C3)C4=CC=CC=C4)NCC5=CC=CC=C5I D01PAC HIGHSTAT Investigative D01PBO DRUG__ID D01PBO D01PBO DRUGTYPE Small molecular drug D01PBO DRUGINCH 1S/C18H20O7/c19-7-11-12(17(24)9-1-3-13(20)15(22)5-9)8-25-18(11)10-2-4-14(21)16(23)6-10/h1-6,11-12,17-24H,7-8H2/t11-,12+,17-,18-/m1/s1 D01PBO DRUGINKE XRDXBFUYROIFCX-FVEFGIFQSA-N D01PBO DRUGSMIL C1C(C(C(O1)C2=CC(=C(C=C2)O)O)CO)C(C3=CC(=C(C=C3)O)O)O D01PBO HIGHSTAT Investigative D01PEC DRUG__ID D01PEC D01PEC DRUGTYPE Small molecular drug D01PEC DRUGINCH 1S/C28H28Cl2N2O3/c1-17(33)26(34)31-24-16-28(13-5-2-6-14-28)35-27-22(24)15-21(18-9-11-19(29)12-10-18)25(32-27)20-7-3-4-8-23(20)30/h3-4,7-12,15,17,24,33H,2,5-6,13-14,16H2,1H3,(H,31,34)/t17-,24?/m1/s1 D01PEC DRUGINKE CBNQOXMUNJAOJO-BPNWFJGMSA-N D01PEC DRUGSMIL CC(C(=O)NC1CC2(CCCCC2)OC3=C1C=C(C(=N3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl)O D01PEC HIGHSTAT Investigative D01PEF DRUG__ID D01PEF D01PEF DRUGTYPE Small molecular drug D01PEF DRUGINCH 1S/C12H11N5O/c1-17-6-7(8-2-4-15-12(13)16-8)10-9(18)3-5-14-11(10)17/h2-6H,1H3,(H,14,18)(H2,13,15,16) D01PEF DRUGINKE PYDJIICXCHAWOI-UHFFFAOYSA-N D01PEF DRUGSMIL CN1C=C(C2=C1NC=CC2=O)C3=NC(=NC=C3)N D01PEF HIGHSTAT Investigative D01PES DRUG__ID D01PES D01PES DRUGTYPE Small molecular drug D01PES DRUGINCH 1S/C15H14N2/c1-2-7-13(8-3-1)16-11-14-10-12-6-4-5-9-15(12)17-14/h1-10,16-17H,11H2 D01PES DRUGINKE SSQTZURIXXHEKY-UHFFFAOYSA-N D01PES DRUGSMIL C1=CC=C(C=C1)NCC2=CC3=CC=CC=C3N2 D01PES HIGHSTAT Investigative D01PFN DRUG__ID D01PFN D01PFN DRUGTYPE Small molecular drug D01PFN DRUGINCH 1S/C14H16N2O/c15-13-8-7-11-5-2-6-12(14(11)16-13)17-9-10-3-1-4-10/h2,5-8,10H,1,3-4,9H2,(H2,15,16) D01PFN DRUGINKE LOSCSSHHWRUJGD-UHFFFAOYSA-N D01PFN DRUGSMIL C1CC(C1)COC2=CC=CC3=C2N=C(C=C3)N D01PFN HIGHSTAT Investigative D01PGO DRUG__ID D01PGO D01PGO DRUGTYPE Small molecular drug D01PGO DRUGINCH 1S/C17H27NO4/c1-8-9-21-16(20)14-10(2)13(11(3)18-14)15(19)22-12(4)17(5,6)7/h12,18H,8-9H2,1-7H3/t12-/m0/s1 D01PGO DRUGINKE DOYZAIRDDZPMQZ-LBPRGKRZSA-N D01PGO DRUGSMIL CCCOC(=O)C1=C(C(=C(N1)C)C(=O)OC(C)C(C)(C)C)C D01PGO HIGHSTAT Investigative D01PGU DRUG__ID D01PGU D01PGU DRUGTYPE Small molecular drug D01PGU DRUGINCH 1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6+,18-13+/t17-/m0/s1 D01PGU DRUGINKE VHRUMKCAEVRUBK-GODQJPCRSA-N D01PGU DRUGSMIL CCCCCC=CC=C1C(C=CC1=O)CC=CCCCC(=O)O D01PGU HIGHSTAT Investigative D01PGY DRUG__ID D01PGY D01PGY DRUGTYPE Small molecular drug D01PGY DRUGINCH 1S/C17H23N5O5/c1-3-4-5-6-7-11-19-15(21-26-2)12-16(20-11)22(9-18-12)17-14(25)13(24)10(8-23)27-17/h9-10,13-14,17,23-25H,3-5,8H2,1-2H3,(H,19,20,21)/t10-,13-,14-,17-/m1/s1 D01PGY DRUGINKE NIZLYCJGSQRCLN-IWCJZZDYSA-N D01PGY DRUGSMIL CCCCC#CC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NOC D01PGY HIGHSTAT Investigative D01PIU DRUG__ID D01PIU D01PIU DRUGTYPE Small molecular drug D01PIU DRUGINCH 1S/C16H13ClFN/c1-2-11-10-19(14-6-4-13(18)5-7-14)16-8-3-12(17)9-15(11)16/h3-10H,2H2,1H3 D01PIU DRUGINKE APVXBLPJSJGGAJ-UHFFFAOYSA-N D01PIU DRUGSMIL CCC1=CN(C2=C1C=C(C=C2)Cl)C3=CC=C(C=C3)F D01PIU HIGHSTAT Investigative D01PKC DRUG__ID D01PKC D01PKC DRUGTYPE Small molecular drug D01PKC DRUGINCH 1S/C22H27Cl2N5S2/c1-15-13-30-21-20(15)25-14-26-22(21)27-16(2)12-28-7-9-29(10-8-28)31(3,4)17-5-6-18(23)19(24)11-17/h5-6,11,13-14,16H,3-4,7-10,12H2,1-2H3,(H,25,26,27)/t16-/m0/s1 D01PKC DRUGINKE WBVRCGUUZYPAGR-INIZCTEOSA-N D01PKC DRUGSMIL CC1=CSC2=C1N=CN=C2NC(C)CN3CCN(CC3)S(=C)(=C)C4=CC(=C(C=C4)Cl)Cl D01PKC HIGHSTAT Investigative D01PLP DRUG__ID D01PLP D01PLP DRUGTYPE Small molecular drug D01PLP DRUGINCH 1S/C11H8O4/c12-8-2-1-6-5-10(13)9(11(14)15)4-7(6)3-8/h1-5,12-13H,(H,14,15) D01PLP DRUGINKE QMWOUSYSNFCKAZ-UHFFFAOYSA-N D01PLP DRUGSMIL C1=CC(=CC2=CC(=C(C=C21)O)C(=O)O)O D01PLP HIGHSTAT Investigative D01PNM DRUG__ID D01PNM D01PNM DRUGTYPE Small molecular drug D01PNM DRUGINCH 1S/C26H30O6/c1-14(2)6-7-16(15(3)4)10-19-21(29)12-24(31-5)25-22(30)13-23(32-26(19)25)18-9-8-17(27)11-20(18)28/h6,8-9,11-12,16,23,27-29H,3,7,10,13H2,1-2,4-5H3/t16-,23+/m1/s1 D01PNM DRUGINKE LTTQKYMNTNISSZ-MWTRTKDXSA-N D01PNM DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)OC)C(=O)CC(O2)C3=C(C=C(C=C3)O)O)C(=C)C)C D01PNM HIGHSTAT Investigative D01POG DRUG__ID D01POG D01POG DRUGTYPE Small molecular drug D01POG DRUGINCH 1S/C27H36F2N2O4/c1-4-6-7-8-9-17-31(26(34)30-24-15-12-21(28)19-23(24)29)18-16-20-10-13-22(14-11-20)35-27(3,5-2)25(32)33/h10-15,19H,4-9,16-18H2,1-3H3,(H,30,34)(H,32,33)/t27-/m0/s1 D01POG DRUGINKE VGSJXSLGVQINOL-MHZLTWQESA-N D01POG DRUGSMIL CCCCCCCN(CCC1=CC=C(C=C1)OC(C)(CC)C(=O)O)C(=O)NC2=C(C=C(C=C2)F)F D01POG HIGHSTAT Investigative D01PPZ DRUG__ID D01PPZ D01PPZ DRUGTYPE Small molecular drug D01PPZ DRUGINCH 1S/C16H24N4O2/c1-5-10(3)7-8-20-15-12(9-18-20)14(17)13(11(4)19-15)16(21)22-6-2/h9-10H,5-8H2,1-4H3,(H2,17,19) D01PPZ DRUGINKE YWSGZSUSPFMIIN-UHFFFAOYSA-N D01PPZ DRUGSMIL CCC(C)CCN1C2=NC(=C(C(=C2C=N1)N)C(=O)OCC)C D01PPZ HIGHSTAT Investigative D01PSS DRUG__ID D01PSS D01PSS DRUGTYPE Small molecular drug D01PSS DRUGINCH 1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 D01PSS DRUGINKE AHCYMLUZIRLXAA-SHYZEUOFSA-N D01PSS DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O D01PSS HIGHSTAT Investigative D01PTE DRUG__ID D01PTE D01PTE DRUGTYPE Small molecular drug D01PTE DRUGINCH 1S/C16H15NO2/c18-15-8-4-7-14-13(15)9-10-16(17-14)19-11-12-5-2-1-3-6-12/h1-3,5-6,9-10H,4,7-8,11H2 D01PTE DRUGINKE VGMBEUFDLPGOMH-UHFFFAOYSA-N D01PTE DRUGSMIL C1CC2=C(C=CC(=N2)OCC3=CC=CC=C3)C(=O)C1 D01PTE HIGHSTAT Investigative D01PWM DRUG__ID D01PWM D01PWM DRUGTYPE Small molecular drug D01PWM DRUGINCH 1S/C45H44O11/c1-21(2)6-10-27-33(48)15-14-29(41(27)53)42(54)38-31(26-12-8-24(46)18-34(26)49)16-23(5)17-32(38)39-36(51)20-37(52)40-43(55)30(11-7-22(3)4)44(56-45(39)40)28-13-9-25(47)19-35(28)50/h6-9,12-15,17-20,31-32,38,46-53H,10-11,16H2,1-5H3/t31-,32-,38-/m0/s1 D01PWM DRUGINKE DKBPTKFKCCNXNH-QXGWMLRCSA-N D01PWM DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C(=C(C=C3)O)CC=C(C)C)O)C4=C(C=C(C5=C4OC(=C(C5=O)CC=C(C)C)C6=C(C=C(C=C6)O)O)O)O D01PWM HIGHSTAT Investigative D01PWO DRUG__ID D01PWO D01PWO DRUGTYPE Small molecular drug D01PWO DRUGINCH 1S/C11H14N2O4S/c12-9(11(14)15)5-6-18-7-8-3-1-2-4-10(8)13(16)17/h1-4,9H,5-7,12H2,(H,14,15) D01PWO DRUGINKE QZOGSZKBBMQKMN-UHFFFAOYSA-N D01PWO DRUGSMIL C1=CC=C(C(=C1)CSCCC(C(=O)O)N)[N+](=O)[O-] D01PWO HIGHSTAT Investigative D01PYU DRUG__ID D01PYU D01PYU DRUGTYPE Small molecular drug D01PYU DRUGINCH 1S/C27H28N2/c1-3-10-21(11-4-1)17-19-29-18-9-14-23(20-29)26-24-15-7-8-16-25(24)28-27(26)22-12-5-2-6-13-22/h1-8,10-13,15-16,23,28H,9,14,17-20H2 D01PYU DRUGINKE HQXCPXHVSRWLFR-UHFFFAOYSA-N D01PYU DRUGSMIL C1CC(CN(C1)CCC2=CC=CC=C2)C3=C(NC4=CC=CC=C43)C5=CC=CC=C5 D01PYU HIGHSTAT Investigative D01PZP DRUG__ID D01PZP D01PZP DRUGTYPE Small molecular drug D01PZP DRUGINCH 1S/C10H20O2/c1-9(6-8-11)5-4-7-10(2,3)12/h8-9,12H,4-7H2,1-3H3 D01PZP DRUGINKE WPFVBOQKRVRMJB-UHFFFAOYSA-N D01PZP DRUGSMIL CC(CCCC(C)(C)O)CC=O D01PZP HIGHSTAT Investigative D01PZU DRUG__ID D01PZU D01PZU DRUGTYPE Small molecular drug D01PZU DRUGINCH 1S/C21H21N3O/c1-4-22-21(25)18-13-23-19(16-9-5-14(2)6-10-16)20(24-18)17-11-7-15(3)8-12-17/h5-13H,4H2,1-3H3,(H,22,25) D01PZU DRUGINKE BAXIFQMQEGUGGQ-UHFFFAOYSA-N D01PZU DRUGSMIL CCNC(=O)C1=CN=C(C(=N1)C2=CC=C(C=C2)C)C3=CC=C(C=C3)C D01PZU HIGHSTAT Investigative D01QBK DRUG__ID D01QBK D01QBK DRUGTYPE Small molecular drug D01QBK DRUGINCH 1S/C11H14BrN5/c12-11-16-8-9(13)14-6-15-10(8)17(11)7-4-2-1-3-5-7/h6-7H,1-5H2,(H2,13,14,15) D01QBK DRUGINKE IVKXIMVGTFMPDF-UHFFFAOYSA-N D01QBK DRUGSMIL C1CCC(CC1)N2C3=NC=NC(=C3N=C2Br)N D01QBK HIGHSTAT Investigative D01QDG DRUG__ID D01QDG D01QDG DRUGTYPE Small molecular drug D01QDG DRUGINCH 1S/C15H12O3/c1-18-14-7-3-5-10-12(14)8-11-9(15(10)17)4-2-6-13(11)16/h2-7,16H,8H2,1H3 D01QDG DRUGINKE ZLLAABQSJKWBDB-UHFFFAOYSA-N D01QDG DRUGSMIL COC1=CC=CC2=C1CC3=C(C2=O)C=CC=C3O D01QDG HIGHSTAT Investigative D01QJT DRUG__ID D01QJT D01QJT DRUGTYPE Small molecular drug D01QJT DRUGINCH 1S/C21H19ClN2O3S/c1-12-11-24-21(28-12)18(10-20(26)27)16-7-15(8-17(22)9-16)14-4-2-3-13(5-14)6-19(23)25/h2-5,7-9,11,18H,6,10H2,1H3,(H2,23,25)(H,26,27) D01QJT DRUGINKE SRVXSISGYBMIHR-UHFFFAOYSA-N D01QJT DRUGSMIL CC1=CN=C(S1)C(CC(=O)O)C2=CC(=CC(=C2)C3=CC=CC(=C3)CC(=O)N)Cl D01QJT HIGHSTAT Investigative D01QKK DRUG__ID D01QKK D01QKK DRUGTYPE Small molecular drug D01QKK DRUGINCH 1S/C30H30Cl2N4O4/c1-18(2)40-25-16-23(39-3)12-13-24(25)29-34-27(19-4-8-21(31)9-5-19)28(20-6-10-22(32)11-7-20)36(29)30(38)35-15-14-33-26(37)17-35/h4-13,16,18,27-28H,14-15,17H2,1-3H3,(H,33,37) D01QKK DRUGINKE BDUHCSBCVGXTJM-UHFFFAOYSA-N D01QKK DRUGSMIL CC(C)OC1=C(C=CC(=C1)OC)C2=NC(C(N2C(=O)N3CCNC(=O)C3)C4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl D01QKK HIGHSTAT Investigative D01QKX DRUG__ID D01QKX D01QKX DRUGTYPE Small molecular drug D01QKX DRUGINCH 1S/C27H50O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27(28)29/h18-19,22-23H,2-17,20-21,24-26H2,1H3,(H,28,29)/b19-18-,23-22- D01QKX DRUGINKE QHCUSXRHMXVISV-ZCIBKELESA-N D01QKX DRUGSMIL CCCCCCCCCCCCCCCCCC=CCCC=CCCCC(=O)O D01QKX HIGHSTAT Investigative D01QOB DRUG__ID D01QOB D01QOB DRUGTYPE Small molecular drug D01QOB DRUGINCH 1S/C13H18N2O4/c1-2-3-8-19-11-6-4-10(5-7-11)13(17)14-9-12(16)15-18/h4-7,18H,2-3,8-9H2,1H3,(H,14,17)(H,15,16) D01QOB DRUGINKE BFVCLRFRELSADQ-UHFFFAOYSA-N D01QOB DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)NCC(=O)NO D01QOB HIGHSTAT Investigative D01QOU DRUG__ID D01QOU D01QOU DRUGTYPE Small molecular drug D01QOU DRUGINCH 1S/C16H15NO2.Na/c1-12(16(18)19)9-13-4-6-14(7-5-13)10-15-3-2-8-17-11-15;/h2-9,11H,10H2,1H3,(H,18,19);/q;+1/p-1/b12-9+; D01QOU DRUGINKE ZAPOSLLMEZKFQS-NBYYMMLRSA-M D01QOU DRUGSMIL CC(=CC1=CC=C(C=C1)CC2=CN=CC=C2)C(=O)[O-].[Na+] D01QOU HIGHSTAT Investigative D01QQD DRUG__ID D01QQD D01QQD DRUGTYPE Small molecular drug D01QQD DRUGINCH 1S/C22H28N4O3S/c23-22(24)25-13-7-12-19(21(28)29)26-20(27)15-30-14-18(16-8-3-1-4-9-16)17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,26,27)(H,28,29)(H4,23,24,25)/t19-/m0/s1 D01QQD DRUGINKE OVJFQPIFXZBDKN-IBGZPJMESA-N D01QQD DRUGSMIL C1=CC=C(C=C1)C(CSCC(=O)NC(CCCN=C(N)N)C(=O)O)C2=CC=CC=C2 D01QQD HIGHSTAT Investigative D01QRR DRUG__ID D01QRR D01QRR DRUGTYPE Small molecular drug D01QRR DRUGINCH 1S/C20H25NO6/c22-19(14-8-4-5-9-14)26-15-11-24-18-16(12-25-17(15)18)27-20(23)21-10-13-6-2-1-3-7-13/h1-3,6-7,14-18H,4-5,8-12H2,(H,21,23)/t15-,16+,17-,18-/m1/s1 D01QRR DRUGINKE UPLFPBDRBGHRQW-XMTFNYHQSA-N D01QRR DRUGSMIL C1CCC(C1)C(=O)OC2COC3C2OCC3OC(=O)NCC4=CC=CC=C4 D01QRR HIGHSTAT Investigative D01QSU DRUG__ID D01QSU D01QSU DRUGTYPE Small molecular drug D01QSU DRUGINCH 1S/C31H47N3O7/c1-19(2)15-23(33)27(39)30(18-35,34(7)29(41)25(37)17-21(5)6)31(26(38)13-14-32,22-11-9-8-10-12-22)28(40)24(36)16-20(3)4/h8-12,18-20,23-25,36-37H,5,13-17,32-33H2,1-4,6-7H3/t23-,24?,25-,30-,31?/m0/s1 D01QSU DRUGINKE ZPYMSTAWPQJBRU-DJQJIUKYSA-N D01QSU DRUGSMIL CC(C)CC(C(=O)C(C=O)(C(C1=CC=CC=C1)(C(=O)CCN)C(=O)C(CC(C)C)O)N(C)C(=O)C(CC(=C)C)O)N D01QSU HIGHSTAT Investigative D01QWL DRUG__ID D01QWL D01QWL DRUGTYPE Small molecular drug D01QWL DRUGINCH 1S/C25H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-25(29)26-21-22-18-19-23(27)24(28)20-22/h9-10,18-20,27-28H,2-8,11-17,21H2,1H3,(H,26,29)/b10-9- D01QWL DRUGINKE DMFNZWDAFAVBIA-KTKRTIGZSA-N D01QWL DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC(=C(C=C1)O)O D01QWL HIGHSTAT Investigative D01QWO DRUG__ID D01QWO D01QWO DRUGTYPE Small molecular drug D01QWO DRUGINCH 1S/C16H18O3/c1-2-3-12-18-14-8-10-16(11-9-14)19-15-6-4-13(17)5-7-15/h4-11,17H,2-3,12H2,1H3 D01QWO DRUGINKE WZNRRCAQHKVCHJ-UHFFFAOYSA-N D01QWO DRUGSMIL CCCCOC1=CC=C(C=C1)OC2=CC=C(C=C2)O D01QWO HIGHSTAT Investigative D01QXL DRUG__ID D01QXL D01QXL DRUGTYPE Small molecular drug D01QXL DRUGINCH 1S/C17H11NO3/c19-11-4-6-13-10(8-11)2-1-3-14(13)17-18-15-9-12(20)5-7-16(15)21-17/h1-9,19-20H D01QXL DRUGINKE GLVGKXBQPYTMGJ-UHFFFAOYSA-N D01QXL DRUGSMIL C1=CC2=C(C=CC(=C2)O)C(=C1)C3=NC4=C(O3)C=CC(=C4)O D01QXL HIGHSTAT Investigative D01RAD DRUG__ID D01RAD D01RAD DRUGTYPE Small molecular drug D01RAD DRUGINCH 1S/C16H15F3N2O4/c1-8-12(15(22)25-3)13(14(21(23)24)9(2)20-8)10-6-4-5-7-11(10)16(17,18)19/h4-7,13,20H,1-3H3 D01RAD DRUGINKE ZFLWDHHVRRZMEI-UHFFFAOYSA-N D01RAD DRUGSMIL CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC D01RAD HIGHSTAT Investigative D01RDB DRUG__ID D01RDB D01RDB DRUGTYPE Small molecular drug D01RDB DRUGINCH 1S/C15H13N5O/c16-15(17)20-14(21)10-6-2-1-5-9(10)13-18-11-7-3-4-8-12(11)19-13/h1-8H,(H,18,19)(H4,16,17,20,21) D01RDB DRUGINKE FJRZRURKRDCIKZ-UHFFFAOYSA-N D01RDB DRUGSMIL C1=CC=C(C(=C1)C2=NC3=CC=CC=C3N2)C(=O)N=C(N)N D01RDB HIGHSTAT Investigative D01REI DRUG__ID D01REI D01REI DRUGTYPE Small molecular drug D01REI DRUGINCH 1S/C18H15NO2/c20-17-6-5-16(12-18(17)21)15-3-1-13(2-4-15)11-14-7-9-19-10-8-14/h1-10,12,20-21H,11H2 D01REI DRUGINKE KOYRCBKCALKGKO-UHFFFAOYSA-N D01REI DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)O)O D01REI HIGHSTAT Investigative D01RFF DRUG__ID D01RFF D01RFF DRUGTYPE Small molecular drug D01RFF DRUGINCH 1S/C21H23F2NO2/c1-5-25-18-11-13(21(2,3)4)9-10-14(18)17-12-26-20(24-17)19-15(22)7-6-8-16(19)23/h6-11,17H,5,12H2,1-4H3 D01RFF DRUGINKE IXSZQYVWNJNRAL-UHFFFAOYSA-N D01RFF DRUGSMIL CCOC1=C(C=CC(=C1)C(C)(C)C)C2COC(=N2)C3=C(C=CC=C3F)F D01RFF HIGHSTAT Investigative D01RFG DRUG__ID D01RFG D01RFG DRUGTYPE Small molecular drug D01RFG DRUGINCH 1S/C19H26N2O/c1-12-17-10-14-5-6-15(18(20)22)9-16(14)19(12,2)7-8-21(17)11-13-3-4-13/h5-6,9,12-13,17H,3-4,7-8,10-11H2,1-2H3,(H2,20,22)/t12-,17?,19-/m0/s1 D01RFG DRUGINKE FAVQVALXVLMHLE-BKBNBNODSA-N D01RFG DRUGSMIL CC1C2CC3=C(C1(CCN2CC4CC4)C)C=C(C=C3)C(=O)N D01RFG HIGHSTAT Investigative D01RGG DRUG__ID D01RGG D01RGG DRUGTYPE Small molecular drug D01RGG DRUGINCH 1S/C15H17N3S/c1-15(2,3)13-9-19-14(18-13)17-12-6-4-5-11-10(12)7-8-16-11/h4-9,16H,1-3H3,(H,17,18) D01RGG DRUGINKE ITGYBDHDFLFUCN-UHFFFAOYSA-N D01RGG DRUGSMIL CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=C2C=CN3 D01RGG HIGHSTAT Investigative D01RGM DRUG__ID D01RGM D01RGM DRUGTYPE Small molecular drug D01RGM DRUGINCH 1S/C10H11F3N2S/c1-2-16-9(14)15-8-5-3-7(4-6-8)10(11,12)13/h3-6H,2H2,1H3,(H2,14,15) D01RGM DRUGINKE LCMOXIFARISMOH-UHFFFAOYSA-N D01RGM DRUGSMIL CCSC(=NC1=CC=C(C=C1)C(F)(F)F)N D01RGM HIGHSTAT Investigative D01RHR DRUG__ID D01RHR D01RHR DRUGTYPE Small molecular drug D01RHR DRUGINCH 1S/C29H23F3N6O3/c1-3-25(39)35-20-8-5-9-21(13-20)38-28-33-15-23(16-34-28)37-27(41)24-14-22(11-10-17(24)2)36-26(40)18-6-4-7-19(12-18)29(30,31)32/h3-16H,1H2,2H3,(H,35,39)(H,36,40)(H,37,41)(H,33,34,38) D01RHR DRUGINKE BTWVWABAWDKQNJ-UHFFFAOYSA-N D01RHR DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)C(=O)NC3=CN=C(N=C3)NC4=CC(=CC=C4)NC(=O)C=C D01RHR HIGHSTAT Investigative D01RIP DRUG__ID D01RIP D01RIP DRUGTYPE Small molecular drug D01RIP DRUGINCH 1S/C33H35F2N3O6S/c1-33(2)30(31(42)37-27-21-12-7-6-11-20(21)16-25(27)39)38(18-45-33)32(43)28(41)24(15-19-9-4-3-5-10-19)36-26(40)17-44-29-22(34)13-8-14-23(29)35/h3-14,24-25,27-28,30,39,41H,15-18H2,1-2H3,(H,36,40)(H,37,42)/t24-,25+,27-,28-,30+/m0/s1 D01RIP DRUGINKE KCNWMHBIZSWXTB-UPZHSWQNSA-N D01RIP DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=C(C=CC=C3F)F)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D01RIP HIGHSTAT Investigative D01RJV DRUG__ID D01RJV D01RJV DRUGTYPE Small molecular drug D01RJV DRUGINCH 1S/C8H13N3/c1-6-7(2-3-10-6)8-4-9-5-11-8/h4-7,10H,2-3H2,1H3,(H,9,11)/t6-,7+/m0/s1 D01RJV DRUGINKE FLOJCNYYPGNYBP-NKWVEPMBSA-N D01RJV DRUGSMIL CC1C(CCN1)C2=CN=CN2 D01RJV HIGHSTAT Investigative D01RJY DRUG__ID D01RJY D01RJY DRUGTYPE Small molecular drug D01RJY DRUGINCH 1S/C19H23NO2/c21-19(20-22)11-7-2-1-4-8-16-12-14-18(15-13-16)17-9-5-3-6-10-17/h3,5-6,9-10,12-15,22H,1-2,4,7-8,11H2,(H,20,21) D01RJY DRUGINKE UDSUAIGMNDAMBQ-UHFFFAOYSA-N D01RJY DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCCCCCC(=O)NO D01RJY HIGHSTAT Investigative D01RKI DRUG__ID D01RKI D01RKI DRUGTYPE Small molecular drug D01RKI DRUGINCH 1S/C42H47BrN4O5S/c43-28-12-16-31(17-13-28)53(50,51)52-36-11-7-10-32-33-18-21-44-38(39(33)45-37(32)36)34-26-42(49)20-5-3-1-2-4-6-22-46-24-19-35(34)41(27-46)25-29-14-15-30(48)9-8-23-47(29)40(41)42/h1,3,7,10-13,16-18,21,26,29,35,40,45,49H,2,4-6,8-9,14-15,19-20,22-25,27H2/b3-1-/t29-,35?,40+,41-,42-/m0/s1 D01RKI DRUGINKE WYQZODVBTOVVOF-WXPZYUJUSA-N D01RKI DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCC(=O)CC5)O)C6=NC=CC7=C6NC8=C7C=CC=C8OS(=O)(=O)C9=CC=C(C=C9)Br D01RKI HIGHSTAT Investigative D01RLF DRUG__ID D01RLF D01RLF DRUGTYPE Small molecular drug D01RLF DRUGINCH 1S/C14H12N2O2/c1-2-18-14(17)12-7-10-9-5-3-4-6-11(9)16-13(10)8-15-12/h3-8,16H,2H2,1H3 D01RLF DRUGINKE KOVRZNUMIKACTB-UHFFFAOYSA-N D01RLF DRUGSMIL CCOC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D01RLF HIGHSTAT Investigative D01RNA DRUG__ID D01RNA D01RNA DRUGTYPE Small molecular drug D01RNA DRUGINCH 1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,9,19,21-25,28H,6,8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1 D01RNA DRUGINKE AVSXSVCZWQODGV-DPAQBDIFSA-N D01RNA DRUGSMIL CC(CCC=C(C)C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C D01RNA HIGHSTAT Investigative D01RPD DRUG__ID D01RPD D01RPD DRUGTYPE Small molecular drug D01RPD DRUGINCH 1S/C18H18N4O2/c1-20-14(12-8-7-11-13-9-5-4-6-10-13)19-16-15(20)17(23)22(3)18(24)21(16)2/h4-12H,1-3H3/b11-7+,12-8+ D01RPD DRUGINKE NDTZOLIJIQKCRC-MKICQXMISA-N D01RPD DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC=CC3=CC=CC=C3 D01RPD HIGHSTAT Investigative D01RPM DRUG__ID D01RPM D01RPM DRUGTYPE Small molecular drug D01RPM DRUGINCH 1S/C18H33NO4/c1-2-3-4-5-6-8-11-14-17(19(22)23)15-12-9-7-10-13-16-18(20)21/h14H,2-13,15-16H2,1H3,(H,20,21)/b17-14+ D01RPM DRUGINKE CQOAKBVRRVHWKV-SAPNQHFASA-N D01RPM DRUGSMIL CCCCCCCCC=C(CCCCCCCC(=O)O)[N+](=O)[O-] D01RPM HIGHSTAT Investigative D01RQK DRUG__ID D01RQK D01RQK DRUGTYPE Small molecular drug D01RQK DRUGINCH 1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6-,18-13+/t17-/m0/s1 D01RQK DRUGINKE VHRUMKCAEVRUBK-WKELIDJCSA-N D01RQK DRUGSMIL CCCCCC=CC=C1C(C=CC1=O)CC=CCCCC(=O)O D01RQK HIGHSTAT Investigative D01RSH DRUG__ID D01RSH D01RSH DRUGTYPE Small molecular drug D01RSH DRUGINCH 1S/C14H9BrClNO3/c15-9-3-1-2-8(6-9)13(18)17-12-7-10(16)4-5-11(12)14(19)20/h1-7H,(H,17,18)(H,19,20) D01RSH DRUGINKE NKUSVNRZDILGSG-UHFFFAOYSA-N D01RSH DRUGSMIL C1=CC(=CC(=C1)Br)C(=O)NC2=C(C=CC(=C2)Cl)C(=O)O D01RSH HIGHSTAT Investigative D01RTR DRUG__ID D01RTR D01RTR DRUGTYPE Small molecular drug D01RTR DRUGINCH 1S/C12H18N2/c1-11-4-3-8-14(11)9-6-12-5-2-7-13-10-12/h2,5,7,10-11H,3-4,6,8-9H2,1H3/t11-/m1/s1 D01RTR DRUGINKE WJLLZUXQRCOTAJ-LLVKDONJSA-N D01RTR DRUGSMIL CC1CCCN1CCC2=CN=CC=C2 D01RTR HIGHSTAT Investigative D01RTU DRUG__ID D01RTU D01RTU DRUGTYPE Small molecular drug D01RTU DRUGINCH 1S/C22H34N4O2/c1-24-19(14-16-6-3-2-4-7-16)22(28)26-13-5-8-20(26)21(27)25-15-17-9-11-18(23)12-10-17/h2-4,6-7,17-20,24H,5,8-15,23H2,1H3,(H,25,27)/t17?,18?,19-,20+/m1/s1 D01RTU DRUGINKE MDSVGJAUFNXYRR-TUNPWDSISA-N D01RTU DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NCC3CCC(CC3)N D01RTU HIGHSTAT Investigative D01RUH DRUG__ID D01RUH D01RUH DRUGTYPE Small molecular drug D01RUH DRUGINCH 1S/C18H13NO3/c1-21-13-9-10-7-8-19-16-14(10)15(18(13)22-2)11-5-3-4-6-12(11)17(16)20/h3-9H,1-2H3 D01RUH DRUGINKE DPBMWJXWUINLQT-UHFFFAOYSA-N D01RUH DRUGSMIL COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC=CC=C42)OC D01RUH HIGHSTAT Investigative D01RUN DRUG__ID D01RUN D01RUN DRUGTYPE Small molecular drug D01RUN DRUGINCH 1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m0/s1 D01RUN DRUGINKE HJORMJIFDVBMOB-LBPRGKRZSA-N D01RUN DRUGSMIL COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 D01RUN HIGHSTAT Investigative D01RUO DRUG__ID D01RUO D01RUO DRUGTYPE Small molecular drug D01RUO DRUGINCH 1S/C14H11N/c1-2-7-13-10-15-14-8-4-3-6-12(14)9-11(13)5-1/h1-8,10H,9H2 D01RUO DRUGINKE IDWNSAXOQLJYOF-UHFFFAOYSA-N D01RUO DRUGSMIL C1C2=CC=CC=C2C=NC3=CC=CC=C31 D01RUO HIGHSTAT Investigative D01RVF DRUG__ID D01RVF D01RVF DRUGTYPE Small molecular drug D01RVF DRUGINCH 1S/C18H22N2O/c1-2-5-15(6-3-1)13-20-16-8-10-18(11-9-16)21-14-17-7-4-12-19-17/h1-3,5-6,8-11,17,19-20H,4,7,12-14H2/t17-/m1/s1 D01RVF DRUGINKE HITMFLNAOQIZSN-QGZVFWFLSA-N D01RVF DRUGSMIL C1CC(NC1)COC2=CC=C(C=C2)NCC3=CC=CC=C3 D01RVF HIGHSTAT Investigative D01RWS DRUG__ID D01RWS D01RWS DRUGTYPE Small molecular drug D01RWS DRUGINCH 1S/C20H20O2/c1-13(2)17-10-9-14(3)19-18(17)12-16(20(21)22-19)11-15-7-5-4-6-8-15/h4-10,12-13H,11H2,1-3H3 D01RWS DRUGINKE PFSLDHWSUPFZPK-UHFFFAOYSA-N D01RWS DRUGSMIL CC1=C2C(=C(C=C1)C(C)C)C=C(C(=O)O2)CC3=CC=CC=C3 D01RWS HIGHSTAT Investigative D01RWY DRUG__ID D01RWY D01RWY DRUGTYPE Small molecular drug D01RWY DRUGINCH 1S/C17H26ClNO/c1-5-6-7-11-15(19-17(2,3)4)16(20)13-9-8-10-14(18)12-13/h8-10,12,15,19H,5-7,11H2,1-4H3 D01RWY DRUGINKE OROOSQVGDDDAFY-UHFFFAOYSA-N D01RWY DRUGSMIL CCCCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D01RWY HIGHSTAT Investigative D01RXM DRUG__ID D01RXM D01RXM DRUGTYPE Small molecular drug D01RXM DRUGINCH 1S/C9H9NO/c1-11-8-2-3-9-7(6-8)4-5-10-9/h2-6,10H,1H3 D01RXM DRUGINKE DWAQDRSOVMLGRQ-UHFFFAOYSA-N D01RXM DRUGSMIL COC1=CC2=C(C=C1)NC=C2 D01RXM HIGHSTAT Investigative D01RZP DRUG__ID D01RZP D01RZP DRUGTYPE Small molecular drug D01RZP DRUGINCH 1S/C17H14O2S/c1-11-7-12(5-6-16(11)19)14-9-17(20-10-14)13-3-2-4-15(18)8-13/h2-10,18-19H,1H3 D01RZP DRUGINKE STFVOGWUKNAWOF-UHFFFAOYSA-N D01RZP DRUGSMIL CC1=C(C=CC(=C1)C2=CSC(=C2)C3=CC(=CC=C3)O)O D01RZP HIGHSTAT Investigative D01SAX DRUG__ID D01SAX D01SAX DRUGTYPE Small molecular drug D01SAX DRUGINCH 1S/C22H27N3O3S/c1-25(14-12-17-10-11-19(26-2)20(16-17)27-3)13-7-15-28-22-23-21(29-24-22)18-8-5-4-6-9-18/h4-6,8-11,16H,7,12-15H2,1-3H3 D01SAX DRUGINKE RHJGWXNLFGHPHA-UHFFFAOYSA-N D01SAX DRUGSMIL CN(CCCOC1=NSC(=N1)C2=CC=CC=C2)CCC3=CC(=C(C=C3)OC)OC D01SAX HIGHSTAT Investigative D01SBC DRUG__ID D01SBC D01SBC DRUGCOMP Scripps Research Institute D01SBC DRUGINCH 1S/C42H46F6N6O12/c43-41(44,45)29-14-10-25(11-15-29)23-65-39(63)53-31(37(59)60)8-1-3-18-49-33(55)21-51-35(57)27-6-5-7-28(20-27)36(58)52-22-34(56)50-19-4-2-9-32(38(61)62)54-40(64)66-24-26-12-16-30(17-13-26)42(46,47)48/h5-7,10-17,20,31-32H,1-4,8-9,18-19,21-24H2,(H,49,55)(H,50,56)(H,51,57)(H,52,58)(H,53,63)(H,54,64)(H,59,60)(H,61,62)/t31-,32-/m0/s1 D01SBC DRUGINKE QRURLAHCTNYZLV-ACHIHNKUSA-N D01SBC DRUGSMIL C1=CC(=CC(=C1)C(=O)NCC(=O)NCCCCC(C(=O)O)NC(=O)OCC2=CC=C(C=C2)C(F)(F)F)C(=O)NCC(=O)NCCCCC(C(=O)O)NC(=O)OCC3=CC=C(C=C3)C(F)(F)F D01SBC HIGHSTAT Investigative D01SBZ DRUG__ID D01SBZ D01SBZ DRUGTYPE Small molecular drug D01SBZ DRUGINCH 1S/C16H19NO/c1-13(17)11-14-7-9-16(10-8-14)18-12-15-5-3-2-4-6-15/h2-10,13H,11-12,17H2,1H3 D01SBZ DRUGINKE ZDZASCUBDMUTSR-UHFFFAOYSA-N D01SBZ DRUGSMIL CC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)N D01SBZ HIGHSTAT Investigative D01SDX DRUG__ID D01SDX D01SDX DRUGTYPE Small molecular drug D01SDX DRUGINCH 1S/C29H37N7O6S2/c1-16(33-26(39)19(30)12-18-8-9-20-23(14-18)44-29(31)36-20)25(38)32-15-24(37)34-22(13-17-6-4-3-5-7-17)27(40)35-21(28(41)42)10-11-43-2/h3-9,14,16,19,21-22H,10-13,15,30H2,1-2H3,(H2,31,36)(H,32,38)(H,33,39)(H,34,37)(H,35,40)(H,41,42)/t16-,19-,21-,22-/m0/s1 D01SDX DRUGINKE NQZMBRNFTRPOCP-PWZKMPOXSA-N D01SDX DRUGSMIL CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)O)NC(=O)C(CC2=CC3=C(C=C2)N=C(S3)N)N D01SDX HIGHSTAT Investigative D01SGC DRUG__ID D01SGC D01SGC DRUGTYPE Small molecular drug D01SGC DRUGINCH 1S/C33H35FN2O6/c1-20(2)31-30(33(42)35-24-12-14-25(37)15-13-24)29(21-6-4-3-5-7-21)32(22-8-10-23(34)11-9-22)36(31)17-16-26(38)18-27(39)19-28(40)41/h3-15,20,26-27,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41)/t26-,27-/m1/s1 D01SGC DRUGINKE SOZOATLLFFVAPM-KAYWLYCHSA-N D01SGC DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=C(C=C4)O D01SGC HIGHSTAT Investigative D01SGP DRUG__ID D01SGP D01SGP DRUGTYPE Small molecular drug D01SGP DRUGINCH 1S/C21H27NO3/c1-21-8-7-16-15-6-4-14(23)9-12(15)3-5-17(16)18(21)10-13(20(21)25)11-19(24)22-2/h4,6,9,13,16-18,23H,3,5,7-8,10-11H2,1-2H3,(H,22,24)/t13?,16?,17?,18?,21-/m0/s1 D01SGP DRUGINKE VGAXMSUTCOBBFZ-XMTGCZIPSA-N D01SGP DRUGSMIL CC12CCC3C(C1CC(C2=O)CC(=O)NC)CCC4=C3C=CC(=C4)O D01SGP HIGHSTAT Investigative D01SHB DRUG__ID D01SHB D01SHB DRUGTYPE Small molecular drug D01SHB DRUGINCH 1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14) D01SHB DRUGINKE HCZHHEIFKROPDY-UHFFFAOYSA-N D01SHB DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(N2)C(=O)O D01SHB HIGHSTAT Investigative D01SHR DRUG__ID D01SHR D01SHR DRUGTYPE Small molecular drug D01SHR DRUGINCH 1S/C17H19NO2/c1-12-6-2-4-8-15(12)20-17-13(10-18)11-19-16-9-5-3-7-14(16)17/h2-9,13,17H,10-11,18H2,1H3/t13-,17-/m1/s1 D01SHR DRUGINKE RQRGTZIPGLRQOJ-CXAGYDPISA-N D01SHR DRUGSMIL CC1=CC=CC=C1OC2C(COC3=CC=CC=C23)CN D01SHR HIGHSTAT Investigative D01SJL DRUG__ID D01SJL D01SJL DRUGTYPE Small molecular drug D01SJL DRUGINCH 1S/C10H12ClN3O/c1-6(12)5-14-10-7(4-13-14)2-3-8(15)9(10)11/h2-4,6,15H,5,12H2,1H3/t6-/m0/s1 D01SJL DRUGINKE VCXUEWRCJZWCJB-LURJTMIESA-N D01SJL DRUGSMIL CC(CN1C2=C(C=CC(=C2Cl)O)C=N1)N D01SJL HIGHSTAT Investigative D01SLA DRUG__ID D01SLA D01SLA DRUGTYPE Small molecular drug D01SLA DRUGINCH 1S/C21H28O2/c1-4-21(23)12-9-18-16-6-5-14-13-15(22)7-10-19(14,2)17(16)8-11-20(18,21)3/h1,13,16-18,23H,5-12H2,2-3H3/t16-,17+,18+,19+,20+,21+/m1/s1 D01SLA DRUGINKE CHNXZKVNWQUJIB-CEGNMAFCSA-N D01SLA DRUGSMIL CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C#C)O)C D01SLA HIGHSTAT Investigative D01SLG DRUG__ID D01SLG D01SLG DRUGTYPE Small molecular drug D01SLG DRUGINCH 1S/C44H68O13/c1-25-21-34(55-44(23-25)35(46)12-11-31(54-44)24-41(6,50)40(48)49)26(2)9-10-30-14-18-43(53-30)19-15-33-39(57-43)36(47)29(5)38(52-33)32(45)22-28(4)37-27(3)13-17-42(56-37)16-7-8-20-51-42/h9-10,23,26-28,30-39,45-47,50H,5,7-8,11-22,24H2,1-4,6H3,(H,48,49)/b10-9+/t26-,27-,28+,30+,31+,32+,33-,34+,35-,36-,37+,38+,39-,41-,42+,43-,44-/m1/s1 D01SLG DRUGINKE QNDVLZJODHBUFM-WFXQOWMNSA-N D01SLG DRUGSMIL CC1CCC2(CCCCO2)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)O)O)O)C)O)O D01SLG HIGHSTAT Investigative D01SLS DRUG__ID D01SLS D01SLS DRUGTYPE Small molecular drug D01SLS DRUGINCH 1S/C15H17ClN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18/h1-2,4-7,17H,3,8-11H2 D01SLS DRUGINKE OZSMSRIUUDGTEP-UHFFFAOYSA-N D01SLS DRUGSMIL C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl D01SLS HIGHSTAT Investigative D01SLZ DRUG__ID D01SLZ D01SLZ DRUGTYPE Small molecular drug D01SLZ DRUGINCH 1S/C27H24N2O3/c30-25-18-20-29(26(31)28-25)19-10-11-21-32-27(22-12-4-1-5-13-22,23-14-6-2-7-15-23)24-16-8-3-9-17-24/h1-18,20H,19,21H2,(H,28,30,31)/b11-10- D01SLZ DRUGINKE ISRBLVQOVMVNRK-KHPPLWFESA-N D01SLZ DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCC=CCN4C=CC(=O)NC4=O D01SLZ HIGHSTAT Investigative D01SNR DRUG__ID D01SNR D01SNR DRUGTYPE Small molecular drug D01SNR DRUGINCH 1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3 D01SNR DRUGINKE FULAPETWGIGNMT-UHFFFAOYSA-N D01SNR DRUGSMIL CC1(C(=C(C(=O)O1)OCC2CC2)C3=CC=C(C=C3)S(=O)(=O)C)C D01SNR HIGHSTAT Investigative D01SNS DRUG__ID D01SNS D01SNS DRUGTYPE Small molecular drug D01SNS DRUGINCH 1S/C22H24N2O2/c1-3-6-21(25)23-12-11-18-19-13-16(26-2)9-10-20(19)24-14-15-7-4-5-8-17(15)22(18)24/h4-5,7-10,13H,3,6,11-12,14H2,1-2H3,(H,23,25) D01SNS DRUGINKE RQYIUGOJQFWLAZ-UHFFFAOYSA-N D01SNS DRUGSMIL CCCC(=O)NCCC1=C2C3=CC=CC=C3CN2C4=C1C=C(C=C4)OC D01SNS HIGHSTAT Investigative D01SPH DRUG__ID D01SPH D01SPH DRUGTYPE Small molecular drug D01SPH DRUGINCH 1S/C7H15NO10P2/c9-5(10)4-2-1-3-8(4)6(11)7(12,19(13,14)15)20(16,17)18/h4,6,11-12H,1-3H2,(H,9,10)(H2,13,14,15)(H2,16,17,18) D01SPH DRUGINKE CDFDGXYBANXCPC-UHFFFAOYSA-N D01SPH DRUGSMIL C1CC(N(C1)C(C(O)(P(=O)(O)O)P(=O)(O)O)O)C(=O)O D01SPH HIGHSTAT Investigative D01SQY DRUG__ID D01SQY D01SQY DRUGTYPE Small molecular drug D01SQY DRUGINCH 1S/C18H19NO2/c1-10-7-13(8-11(2)18(10)20)17-12(3)15-9-14(21-4)5-6-16(15)19-17/h5-9,19-20H,1-4H3 D01SQY DRUGINKE OZFHUMGEWVYBRM-UHFFFAOYSA-N D01SQY DRUGSMIL CC1=CC(=CC(=C1O)C)C2=C(C3=C(N2)C=CC(=C3)OC)C D01SQY HIGHSTAT Investigative D01SRL DRUG__ID D01SRL D01SRL DRUGTYPE Small molecular drug D01SRL DRUGINCH 1S/C9H10N2O2/c12-11(13)9-2-1-7-3-4-10-6-8(7)5-9/h1-2,5,10H,3-4,6H2 D01SRL DRUGINKE YPRWYZSUBZXORL-UHFFFAOYSA-N D01SRL DRUGSMIL C1CNCC2=C1C=CC(=C2)[N+](=O)[O-] D01SRL HIGHSTAT Investigative D01SRS DRUG__ID D01SRS D01SRS DRUGTYPE Small molecular drug D01SRS DRUGINCH 1S/C10H12N2O2/c1-7-4-8-2-3-10(12(13)14)5-9(8)6-11-7/h2-3,5,7,11H,4,6H2,1H3 D01SRS DRUGINKE OTVSEAHLIUCIKT-UHFFFAOYSA-N D01SRS DRUGSMIL CC1CC2=C(CN1)C=C(C=C2)[N+](=O)[O-] D01SRS HIGHSTAT Investigative D01SSI DRUG__ID D01SSI D01SSI DRUGTYPE Small molecular drug D01SSI DRUGINCH 1S/C27H31FN6OS/c28-21-3-4-22-20(5-6-29-22)24(21)26-30-23-15-19(17-33-9-7-32(8-10-33)16-18-1-2-18)36-25(23)27(31-26)34-11-13-35-14-12-34/h3-6,15,18,29H,1-2,7-14,16-17H2 D01SSI DRUGINKE YDNOHCOYQVZOMC-UHFFFAOYSA-N D01SSI DRUGSMIL C1CC1CN2CCN(CC2)CC3=CC4=C(S3)C(=NC(=N4)C5=C(C=CC6=C5C=CN6)F)N7CCOCC7 D01SSI HIGHSTAT Investigative D01STE DRUG__ID D01STE D01STE DRUGTYPE Small molecular drug D01STE DRUGINCH 1S/C21H45O6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-26-19-21(22)20-27-28(23,24)25/h21-22H,2-20H2,1H3,(H2,23,24,25)/t21-/m0/s1 D01STE DRUGINKE HUUYDUFSUADEJQ-NRFANRHFSA-N D01STE DRUGSMIL CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)O)O D01STE HIGHSTAT Investigative D01SUE DRUG__ID D01SUE D01SUE DRUGTYPE Small molecular drug D01SUE DRUGINCH 1S/C15H13N/c1-2-6-15-13(5-1)7-8-14(15)10-12-4-3-9-16-11-12/h1-6,9-11H,7-8H2/b14-10+ D01SUE DRUGINKE WDSJJUYCBHIJRT-GXDHUFHOSA-N D01SUE DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=CC=CC=C31 D01SUE HIGHSTAT Investigative D01SWO DRUG__ID D01SWO D01SWO DRUGTYPE Small molecular drug D01SWO DRUGINCH 1S/C23H18O2/c24-19-7-3-6-15(10-19)22-12-18-11-20(25)8-9-21(18)23(22)13-16-4-1-2-5-17(16)14-23/h1-12,24-25H,13-14H2 D01SWO DRUGINKE NBNSBPOETAKHET-UHFFFAOYSA-N D01SWO DRUGSMIL C1C2=CC=CC=C2CC13C4=C(C=C(C=C4)O)C=C3C5=CC(=CC=C5)O D01SWO HIGHSTAT Investigative D01SXB DRUG__ID D01SXB D01SXB DRUGTYPE Small molecular drug D01SXB DRUGINCH 1S/C16H15NO4/c18-11-12-2-1-3-13(8-12)15-9-14(19)10-16(21-15)17-4-6-20-7-5-17/h1-3,8-11H,4-7H2 D01SXB DRUGINKE JXTKUJIDCHLXDV-UHFFFAOYSA-N D01SXB DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC(=C3)C=O D01SXB HIGHSTAT Investigative D01SYO DRUG__ID D01SYO D01SYO DRUGTYPE Small molecular drug D01SYO DRUGINCH 1S/C11H8N2S/c1-9-13-11(8-14-9)3-2-10-4-6-12-7-5-10/h4-8H,1H3 D01SYO DRUGINKE WWKCHJLBBNNNCI-UHFFFAOYSA-N D01SYO DRUGSMIL CC1=NC(=CS1)C#CC2=CC=NC=C2 D01SYO HIGHSTAT Investigative D01SZX DRUG__ID D01SZX D01SZX DRUGTYPE Small molecular drug D01SZX DRUGINCH 1S/C17H12N2O2/c20-17-13-5-1-2-6-14(13)21-15-7-3-4-12(16(15)17)10-19-9-8-18-11-19/h1-9,11H,10H2 D01SZX DRUGINKE FJYGKMHQKKRCON-UHFFFAOYSA-N D01SZX DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC=C3O2)CN4C=CN=C4 D01SZX HIGHSTAT Investigative D01TDC DRUG__ID D01TDC D01TDC DRUGTYPE Small molecular drug D01TDC DRUGINCH 1S/C5H10N2S/c1-4-2-3-7-5(6)8-4/h4H,2-3H2,1H3,(H2,6,7) D01TDC DRUGINKE BATVOUKHGLKDGQ-UHFFFAOYSA-N D01TDC DRUGSMIL CC1CCN=C(S1)N D01TDC HIGHSTAT Investigative D01TDG DRUG__ID D01TDG D01TDG DRUGTYPE Small molecular drug D01TDG DRUGINCH 1S/C9H12N2S/c1-2-12-9(10)11-8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,10,11) D01TDG DRUGINKE LAXNJIWNBHHMDO-UHFFFAOYSA-N D01TDG DRUGSMIL CCSC(=NC1=CC=CC=C1)N D01TDG HIGHSTAT Investigative D01TDV DRUG__ID D01TDV D01TDV DRUGTYPE Small molecular drug D01TDV DRUGINCH 1S/C25H28N6O2/c1-29-12-14-30(15-13-29)22-10-5-19(16-23(22)33-3)27-24-11-4-18-17-26-31(25(18)28-24)20-6-8-21(32-2)9-7-20/h4-11,16-17H,12-15H2,1-3H3,(H,27,28) D01TDV DRUGINKE LZQFMCFJCXQTTG-UHFFFAOYSA-N D01TDV DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=C3)C=NN4C5=CC=C(C=C5)OC)OC D01TDV HIGHSTAT Investigative D01TFO DRUG__ID D01TFO D01TFO DRUGTYPE Small molecular drug D01TFO DRUGINCH 1S/C36H59N7O9/c1-11-22(7)28(32(46)39-27(21(5)6)34(48)51-10)41-35(49)43-42-33(47)29(23(8)12-2)40-31(45)26(18-20(3)4)38-30(44)24(9)37-36(50)52-19-25-16-14-13-15-17-25/h13-17,20-24,26-29H,11-12,18-19H2,1-10H3,(H,37,50)(H,38,44)(H,39,46)(H,40,45)(H,42,47)(H2,41,43,49) D01TFO DRUGINKE HGMOIJOFHZHWKH-UHFFFAOYSA-N D01TFO DRUGSMIL CCC(C)C(C(=O)NNC(=O)NC(C(C)CC)C(=O)NC(C(C)C)C(=O)OC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC1=CC=CC=C1 D01TFO HIGHSTAT Investigative D01TFQ DRUG__ID D01TFQ D01TFQ DRUGTYPE Small molecular drug D01TFQ DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(42)36-29-25-14-7-6-12-23(25)17-27(29)39)37(20-45-34)33(43)30(41)26(16-21-9-4-3-5-10-21)35-28(40)19-44-24-13-8-11-22(15-24)18-38/h3-15,26-27,29-31,38-39,41H,16-20H2,1-2H3,(H,35,40)(H,36,42)/t26-,27+,29-,30-,31+/m0/s1 D01TFQ DRUGINKE NRLFBLHYKZDHHW-VFCPCCRCSA-N D01TFQ DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC(=C3)CO)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D01TFQ HIGHSTAT Investigative D01TGI DRUG__ID D01TGI D01TGI DRUGTYPE Small molecular drug D01TGI DRUGINCH 1S/C18H12Cl2O2/c19-14-7-9-17(15(20)11-14)22-18-8-6-13(10-16(18)21)12-4-2-1-3-5-12/h1-11,21H D01TGI DRUGINKE NOKHJANPMHROFU-UHFFFAOYSA-N D01TGI DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D01TGI HIGHSTAT Investigative D01THF DRUG__ID D01THF D01THF DRUGTYPE Small molecular drug D01THF DRUGINCH 1S/C17H17NOS/c1-11-7-12(2)17(13(3)8-11)20-15-6-5-14(10-18)16(9-15)19-4/h5-9H,1-4H3 D01THF DRUGINKE YPJRESPHGOONFU-UHFFFAOYSA-N D01THF DRUGSMIL CC1=CC(=C(C(=C1)C)SC2=CC(=C(C=C2)C#N)OC)C D01THF HIGHSTAT Investigative D01THG DRUG__ID D01THG D01THG DRUGTYPE Small molecular drug D01THG DRUGINCH 1S/C5H8O2/c1-3-4(2)5(6)7/h3H,1-2H3,(H,6,7)/b4-3+ D01THG DRUGINKE UIERETOOQGIECD-ONEGZZNKSA-N D01THG DRUGSMIL CC=C(C)C(=O)O D01THG HIGHSTAT Investigative D01TKS DRUG__ID D01TKS D01TKS DRUGTYPE Small molecular drug D01TKS DRUGINCH 1S/C28H38N6O6S/c1-17(32-27(39)21(29)14-19-8-10-20(35)11-9-19)26(38)31-16-24(36)33-23(15-18-6-4-3-5-7-18)28(40)34-22(25(30)37)12-13-41-2/h3-11,17,21-23,35H,12-16,29H2,1-2H3,(H2,30,37)(H,31,38)(H,32,39)(H,33,36)(H,34,40)/t17-,21+,22+,23+/m1/s1 D01TKS DRUGINKE ANZXICRKKYOVMY-SZOBAZRNSA-N D01TKS DRUGSMIL CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N D01TKS HIGHSTAT Investigative D01TLN DRUG__ID D01TLN D01TLN DRUGTYPE Small molecular drug D01TLN DRUGINCH 1S/C29H28NO5/c1-31-26-10-9-20-15-25-23-17-28-27(34-19-35-28)16-21(23)11-12-30(25)18-24(20)29(26)33-14-6-5-13-32-22-7-3-2-4-8-22/h2-4,7-10,15-18H,5-6,11-14,19H2,1H3/q+1 D01TLN DRUGINKE BKMOSBYJXKOCTP-UHFFFAOYSA-N D01TLN DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=CC=CC=C6 D01TLN HIGHSTAT Investigative D01TMC DRUG__ID D01TMC D01TMC DRUGTYPE Small molecular drug D01TMC DRUGINCH 1S/C17H15N5O2/c1-2-22-20-17(19-21-22)18-16(23)15-11-7-3-5-9-13(11)24-14-10-6-4-8-12(14)15/h3-10,15H,2H2,1H3,(H,18,20,23) D01TMC DRUGINKE HVTLYEBQNBWUIT-UHFFFAOYSA-N D01TMC DRUGSMIL CCN1N=C(N=N1)NC(=O)C2C3=CC=CC=C3OC4=CC=CC=C24 D01TMC HIGHSTAT Investigative D01TNT DRUG__ID D01TNT D01TNT DRUGTYPE Small molecular drug D01TNT DRUGINCH 1S/C40H38O11/c1-19(2)4-3-5-20-12-27(24-9-6-21(41)14-29(24)44)36(39(49)26-11-8-23(43)16-31(26)46)28(13-20)37-32(47)18-35-38(40(37)50)33(48)17-34(51-35)25-10-7-22(42)15-30(25)45/h4,6-11,13-16,18,27-28,34,36,41-47,50H,3,5,12,17H2,1-2H3/t27-,28?,34?,36-/m1/s1 D01TNT DRUGINKE VYCKCQBOVSSJSK-CFQOWUBYSA-N D01TNT DRUGSMIL CC(=CCCC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C5=C(C=C4O)OC(CC5=O)C6=C(C=C(C=C6)O)O)O)C D01TNT HIGHSTAT Investigative D01TOR DRUG__ID D01TOR D01TOR DRUGTYPE Small molecular drug D01TOR DRUGINCH 1S/C20H16N4/c1-2-7-15(8-3-1)13-22-20-17-10-4-5-11-18(17)23-19(24-20)16-9-6-12-21-14-16/h1-12,14H,13H2,(H,22,23,24) D01TOR DRUGINKE AELMNLIYFALJIR-UHFFFAOYSA-N D01TOR DRUGSMIL C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)C4=CN=CC=C4 D01TOR HIGHSTAT Investigative D01TOU DRUG__ID D01TOU D01TOU DRUGTYPE Small molecular drug D01TOU DRUGINCH 1S/C21H25FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11H,4,6,12-16H2,1H3 D01TOU DRUGINKE IRYFCWPNDIUQOW-UHFFFAOYSA-N D01TOU DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F D01TOU HIGHSTAT Investigative D01TPW DRUG__ID D01TPW D01TPW DRUGTYPE Small molecular drug D01TPW DRUGINCH 1S/C4H6O3.Na/c5-3-1-2-4(6)7;/h1-2,5H,3H2,(H,6,7);/q;+1/p-1/b2-1+; D01TPW DRUGINKE PUAFPEZXZZJTBR-TYYBGVCCSA-M D01TPW DRUGSMIL C(C=CC(=O)[O-])O.[Na+] D01TPW HIGHSTAT Investigative D01TQD DRUG__ID D01TQD D01TQD DRUGTYPE Small molecular drug D01TQD DRUGINCH 1S/C19H19FN2O2/c1-13(19(2,3)24)22-18(23)17-10-9-15(12-21-17)8-7-14-5-4-6-16(20)11-14/h4-6,9-13,24H,1-3H3,(H,22,23)/t13-/m1/s1 D01TQD DRUGINKE ZPKZAFDYFVJULO-CYBMUJFWSA-N D01TQD DRUGSMIL CC(C(C)(C)O)NC(=O)C1=NC=C(C=C1)C#CC2=CC(=CC=C2)F D01TQD HIGHSTAT Investigative D01TRI DRUG__ID D01TRI D01TRI DRUGTYPE Small molecular drug D01TRI DRUGINCH 1S/C30H22N2O4/c33-27(15-19-7-3-1-4-8-19)31-21-11-13-23-25(17-21)30(36)26-18-22(12-14-24(26)29(23)35)32-28(34)16-20-9-5-2-6-10-20/h1-14,17-18H,15-16H2,(H,31,33)(H,32,34) D01TRI DRUGINKE YFLLPGICLQVMIU-UHFFFAOYSA-N D01TRI DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CC5=CC=CC=C5 D01TRI HIGHSTAT Investigative D01TRN DRUG__ID D01TRN D01TRN DRUGTYPE Small molecular drug D01TRN DRUGINCH 1S/C29H28N2O5/c1-18-7-12-27-26(13-18)30(3)16-23(36-27)17-35-22-10-8-20(9-11-22)29(34)31-19(2)14-24-21(15-28(32)33)5-4-6-25(24)31/h4-14,23H,15-17H2,1-3H3,(H,32,33)/t23-/m0/s1 D01TRN DRUGINKE PDLHJVXUGHZZQP-QHCPKHFHSA-N D01TRN DRUGSMIL CC1=CC2=C(C=C1)OC(CN2C)COC3=CC=C(C=C3)C(=O)N4C(=CC5=C(C=CC=C54)CC(=O)O)C D01TRN HIGHSTAT Investigative D01TSM DRUG__ID D01TSM D01TSM DRUGTYPE Small molecular drug D01TSM DRUGINCH 1S/C21H18N2O2/c1-14(24)15-7-9-16(10-8-15)18-11-12-19(22)20(13-18)23-21(25)17-5-3-2-4-6-17/h2-13H,22H2,1H3,(H,23,25) D01TSM DRUGINKE NWHQDZJUELCUHQ-UHFFFAOYSA-N D01TSM DRUGSMIL CC(=O)C1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D01TSM HIGHSTAT Investigative D01TSX DRUG__ID D01TSX D01TSX DRUGTYPE Small molecular drug D01TSX DRUGINCH 1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3/t7-/m1/s1 D01TSX DRUGINKE BGMZUEKZENQUJY-SSDOTTSWSA-N D01TSX DRUGSMIL CC(CC1=CC(=C(C=C1OC)I)OC)N D01TSX HIGHSTAT Investigative D01TWD DRUG__ID D01TWD D01TWD DRUGTYPE Small molecular drug D01TWD DRUGINCH 1S/C22H28N4O3S/c1-16-8-10-19(11-9-16)30(28,29)25-20(22(27)26-12-3-2-4-13-26)15-17-6-5-7-18(14-17)21(23)24/h5-11,14,20,25H,2-4,12-13,15H2,1H3,(H3,23,24) D01TWD DRUGINKE RNNMXTSTLVYYQG-UHFFFAOYSA-N D01TWD DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(CC2=CC(=CC=C2)C(=N)N)C(=O)N3CCCCC3 D01TWD HIGHSTAT Investigative D01TYJ DRUG__ID D01TYJ D01TYJ DRUGTYPE Small molecular drug D01TYJ DRUGINCH 1S/C14H10N4O6S/c15-9-1-3-11(4-2-9)25(23,24)16-6-5-12-13(16)7-10(17(19)20)8-14(12)18(21)22/h1-8H,15H2 D01TYJ DRUGINKE NMGNRDGVTLTPFO-UHFFFAOYSA-N D01TYJ DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)N2C=CC3=C2C=C(C=C3[N+](=O)[O-])[N+](=O)[O-] D01TYJ HIGHSTAT Investigative D01TZT DRUG__ID D01TZT D01TZT DRUGTYPE Small molecular drug D01TZT DRUGINCH 1S/C13H11NO5/c15-10-6-3-7-11(16)12(10)13(17)8-4-1-2-5-9(8)14(18)19/h1-2,4-5,12H,3,6-7H2 D01TZT DRUGINKE ZZJZBPYZTKGWTD-UHFFFAOYSA-N D01TZT DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2=CC=CC=C2[N+](=O)[O-] D01TZT HIGHSTAT Investigative D01UAO DRUG__ID D01UAO D01UAO DRUGTYPE Small molecular drug D01UAO DRUGINCH 1S/C13H10ClNO3/c14-12-11(8-1-4-10(16)5-2-8)6-3-9(7-15-18)13(12)17/h1-6,16-17H,7H2 D01UAO DRUGINKE CIYDFCOZUPKHFA-UHFFFAOYSA-N D01UAO DRUGSMIL C1=CC(=CC=C1C2=C(C(=C(C=C2)CN=O)O)Cl)O D01UAO HIGHSTAT Investigative D01UAS DRUG__ID D01UAS D01UAS DRUGTYPE Small molecular drug D01UAS DRUGINCH 1S/C12H10BrNO3/c1-2-17-12(16)9-6-14-10-4-3-7(13)5-8(10)11(9)15/h3-6H,2H2,1H3,(H,14,15) D01UAS DRUGINKE IVZIOBTVAJBBAS-UHFFFAOYSA-N D01UAS DRUGSMIL CCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)Br D01UAS HIGHSTAT Investigative D01UDC DRUG__ID D01UDC D01UDC DRUGTYPE Small molecular drug D01UDC DRUGINCH 1S/C9H15NO2/c1-6(11)12-9-5-7-3-2-4-8(9)10-7/h7-10H,2-5H2,1H3 D01UDC DRUGINKE HHXDJDWQQPSWHW-UHFFFAOYSA-N D01UDC DRUGSMIL CC(=O)OC1CC2CCCC1N2 D01UDC HIGHSTAT Investigative D01UDU DRUG__ID D01UDU D01UDU DRUGTYPE Small molecular drug D01UDU DRUGINCH 1S/C6H8ClN3O2S/c7-5-3-4(13(9,11)12)1-2-6(5)10-8/h1-3,10H,8H2,(H2,9,11,12) D01UDU DRUGINKE MIIRMBFCBFPOKU-UHFFFAOYSA-N D01UDU DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)Cl)NN D01UDU HIGHSTAT Investigative D01UFF DRUG__ID D01UFF D01UFF DRUGTYPE Small molecular drug D01UFF DRUGINCH 1S/C22H32O3/c1-3-13-11-19-18-6-4-14-10-15(24)5-7-16(14)17(18)8-9-22(19,2)21(13)20(25)12-23/h10,13,16-19,21,23H,3-9,11-12H2,1-2H3/t13-,16+,17-,18-,19+,21-,22+/m1/s1 D01UFF DRUGINKE IJLXLZGJDSJGIQ-BILPMHSYSA-N D01UFF DRUGSMIL CCC1CC2C3CCC4=CC(=O)CCC4C3CCC2(C1C(=O)CO)C D01UFF HIGHSTAT Investigative D01UFM DRUG__ID D01UFM D01UFM DRUGTYPE Small molecular drug D01UFM DRUGINCH 1S/C16H17NO3/c18-15(17-12-7-2-1-3-8-12)13-10-11-6-4-5-9-14(11)20-16(13)19/h4-6,9-10,12H,1-3,7-8H2,(H,17,18) D01UFM DRUGINKE KUWSPPXPGQEHSQ-UHFFFAOYSA-N D01UFM DRUGSMIL C1CCC(CC1)NC(=O)C2=CC3=CC=CC=C3OC2=O D01UFM HIGHSTAT Investigative D01UIY DRUG__ID D01UIY D01UIY DRUGTYPE Small molecular drug D01UIY DRUGINCH 1S/C14H21NO3/c1-4-18-14-8-7-13(17-3)10-12(14)6-5-9-15-11(2)16/h7-8,10H,4-6,9H2,1-3H3,(H,15,16) D01UIY DRUGINKE GTXCCVOUHCBPES-UHFFFAOYSA-N D01UIY DRUGSMIL CCOC1=C(C=C(C=C1)OC)CCCNC(=O)C D01UIY HIGHSTAT Investigative D01UJL DRUG__ID D01UJL D01UJL DRUGTYPE Small molecular drug D01UJL DRUGINCH 1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/p+1/t8-/m0/s1 D01UJL DRUGINKE MXNRLFUSFKVQSK-QMMMGPOBSA-O D01UJL DRUGSMIL C[N+](C)(C)CCCCC(C(=O)O)N D01UJL HIGHSTAT Investigative D01UKL DRUG__ID D01UKL D01UKL DRUGTYPE Small molecular drug D01UKL DRUGINCH 1S/C18H32N4O8S/c1-2-3-4-5-6-9-22(30)18(29)31-11-13(16(26)20-10-15(24)25)21-14(23)8-7-12(19)17(27)28/h12-13,30H,2-11,19H2,1H3,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t12-,13-/m0/s1 D01UKL DRUGINKE BRCVFVPDJZMQPO-STQMWFEESA-N D01UKL DRUGSMIL CCCCCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D01UKL HIGHSTAT Investigative D01UKV DRUG__ID D01UKV D01UKV DRUGTYPE Small molecular drug D01UKV DRUGINCH 1S/C20H21NO/c1-2-4-16(5-3-1)15-22-19-8-6-17(7-9-19)20-14-21-12-10-18(20)11-13-21/h1-9,14,18H,10-13,15H2 D01UKV DRUGINKE OKNMXSHKBLYYKN-UHFFFAOYSA-N D01UKV DRUGSMIL C1CN2CCC1C(=C2)C3=CC=C(C=C3)OCC4=CC=CC=C4 D01UKV HIGHSTAT Investigative D01ULE DRUG__ID D01ULE D01ULE DRUGTYPE Small molecular drug D01ULE DRUGINCH 1S/C7H9O3PS/c8-11(9,10)7(12)6-4-2-1-3-5-6/h1-5,7,12H,(H2,8,9,10) D01ULE DRUGINKE FSPBPXVXCWHRHO-UHFFFAOYSA-N D01ULE DRUGSMIL C1=CC=C(C=C1)C(P(=O)(O)O)S D01ULE HIGHSTAT Investigative D01ULX DRUG__ID D01ULX D01ULX DRUGCOMP Celgene Corp D01ULX DRUGINCH 1S/C20H21Cl2NO6/c1-29-10-17(24)23-16(18(25)19(26)20(27)28)6-11-2-4-12(5-3-11)13-7-14(21)9-15(22)8-13/h2-5,7-9,16,18-19,25-26H,6,10H2,1H3,(H,23,24)(H,27,28)/t16-,18-,19+/m0/s1 D01ULX DRUGINKE NTCBTNCWNRCBGX-YTQUADARSA-N D01ULX DRUGSMIL COCC(=O)NC(CC1=CC=C(C=C1)C2=CC(=CC(=C2)Cl)Cl)C(C(C(=O)O)O)O D01ULX HIGHSTAT Investigative D01UNC DRUG__ID D01UNC D01UNC DRUGTYPE Small molecular drug D01UNC DRUGINCH 1S/C8H10N2O4S/c9-6-1-3-7(4-2-6)15(13,14)10-5-8(11)12/h1-4,10H,5,9H2,(H,11,12) D01UNC DRUGINKE BPJUMYMTQYMSFZ-UHFFFAOYSA-N D01UNC DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)NCC(=O)O D01UNC HIGHSTAT Investigative D01UNE DRUG__ID D01UNE D01UNE DRUGTYPE Small molecular drug D01UNE DRUGINCH 1S/C38H41N4O7PS/c1-48-33-18-10-11-19-34(33)51-25-29(37(44)41-32(36(39)43)21-28-22-40-31-17-9-8-16-30(28)31)24-50(46,47)35(20-26-12-4-2-5-13-26)42-38(45)49-23-27-14-6-3-7-15-27/h2-19,22,29,32,35,40H,20-21,23-25H2,1H3,(H2,39,43)(H,41,44)(H,42,45)(H,46,47)/t29-,32-,35+/m0/s1 D01UNE DRUGINKE YDDMVPLLJTZTQL-LAABSITASA-N D01UNE DRUGSMIL COC1=CC=CC=C1SCC(CP(=O)(C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)O)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)N D01UNE HIGHSTAT Investigative D01UNT DRUG__ID D01UNT D01UNT DRUGTYPE Small molecular drug D01UNT DRUGINCH 1S/C30H34ClF3N4O7S/c1-16(2)23(29(43)36-28(42)22-6-5-15-38(22)24(17(3)4)25(39)30(32,33)34)35-26(40)18-7-9-19(10-8-18)27(41)37-46(44,45)21-13-11-20(31)12-14-21/h7-14,16-17,22-24H,5-6,15H2,1-4H3,(H,35,40)(H,37,41)(H,36,42,43)/t22-,23-,24?/m0/s1 D01UNT DRUGINKE SMCMGLCPSSSOQE-NTZARQNWSA-N D01UNT DRUGSMIL CC(C)C(C(=O)NC(=O)C1CCCN1C(C(C)C)C(=O)C(F)(F)F)NC(=O)C2=CC=C(C=C2)C(=O)NS(=O)(=O)C3=CC=C(C=C3)Cl D01UNT HIGHSTAT Investigative D01UOO DRUG__ID D01UOO D01UOO DRUGTYPE Small molecular drug D01UOO DRUGINCH 1S/C17H15N3O3S/c1-2-24-17-18-15-9-8-13(20(22)23)10-14(15)16(21)19(17)11-12-6-4-3-5-7-12/h3-10H,2,11H2,1H3 D01UOO DRUGINKE XLPYZVKSRJZTGS-UHFFFAOYSA-N D01UOO DRUGSMIL CCSC1=NC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)N1CC3=CC=CC=C3 D01UOO HIGHSTAT Investigative D01UPT DRUG__ID D01UPT D01UPT DRUGCOMP Universitat Autonoma de Barcelona D01UPT DRUGINCH 1S/C15H18N2O/c1-4-5-8-16(2)11-13-9-12-10-14(18)6-7-15(12)17(13)3/h6-7,9-10,18H,8,11H2,1-3H3 D01UPT DRUGINKE VJSXYTMXFSBYDX-UHFFFAOYSA-N D01UPT DRUGSMIL CC#CCN(C)CC1=CC2=C(N1C)C=CC(=C2)O D01UPT HIGHSTAT Investigative D01URR DRUG__ID D01URR D01URR DRUGTYPE Small molecular drug D01URR DRUGINCH 1S/C24H24N6O/c1-15(2)22-28-24(31-29-22)17-6-8-30(9-7-17)23-20(13-26)11-21(14-27-23)18-4-5-19(12-25)16(3)10-18/h4-5,10-11,14-15,17H,6-9H2,1-3H3 D01URR DRUGINKE TXALYVIWRLTFFP-UHFFFAOYSA-N D01URR DRUGSMIL CC1=C(C=CC(=C1)C2=CC(=C(N=C2)N3CCC(CC3)C4=NC(=NO4)C(C)C)C#N)C#N D01URR HIGHSTAT Investigative D01URS DRUG__ID D01URS D01URS DRUGTYPE Small molecular drug D01URS DRUGINCH 1S/C13H21N3O/c1-3-6-16-8-12(17-9-10(16)2)11-4-5-13(14)15-7-11/h4-5,7,10,12H,3,6,8-9H2,1-2H3,(H2,14,15)/t10-,12-/m0/s1 D01URS DRUGINKE DFTCYTDJDXZFSK-JQWIXIFHSA-N D01URS DRUGSMIL CCCN1CC(OCC1C)C2=CN=C(C=C2)N D01URS HIGHSTAT Investigative D01USH DRUG__ID D01USH D01USH DRUGTYPE Small molecular drug D01USH DRUGINCH 1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-25,28-29H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,24?,25+,26+,27-/m1/s1 D01USH DRUGINKE OYXZMSRRJOYLLO-UOQFGJKXSA-N D01USH DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C D01USH HIGHSTAT Investigative D01UUH DRUG__ID D01UUH D01UUH DRUGTYPE Small molecular drug D01UUH DRUGINCH 1S/C10H7N3S/c11-10-13-9(7-14-10)4-3-8-2-1-5-12-6-8/h1-2,5-7H,(H2,11,13) D01UUH DRUGINKE BQUGCIBMYSKXRH-UHFFFAOYSA-N D01UUH DRUGSMIL C1=CC(=CN=C1)C#CC2=CSC(=N2)N D01UUH HIGHSTAT Investigative D01UUW DRUG__ID D01UUW D01UUW DRUGTYPE Small molecular drug D01UUW DRUGINCH 1S/2C21H37FN2O3S.C4H4O4/c2*1-5-24(16-8-6-7-15-21(2,3)22)17-9-10-20(25)18-11-13-19(14-12-18)23-28(4,26)27;5-3(6)1-2-4(7)8/h2*11-14,20,23,25H,5-10,15-17H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*20-;/m00./s1 D01UUW DRUGINKE ODFOUAATRQAOLG-MMSVOLSESA-N D01UUW DRUGSMIL CCN(CCCCCC(C)(C)F)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCN(CCCCCC(C)(C)F)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O D01UUW HIGHSTAT Investigative D01UUZ DRUG__ID D01UUZ D01UUZ DRUGTYPE Small molecular drug D01UUZ DRUGINCH 1S/C18H30N2O2/c1-2-3-4-5-6-7-8-15-9-11-16(12-10-15)20-18(22)17(19)13-14-21/h9-12,17,21H,2-8,13-14,19H2,1H3,(H,20,22)/t17-/m1/s1 D01UUZ DRUGINKE QJTVTVAQRCRXSM-QGZVFWFLSA-N D01UUZ DRUGSMIL CCCCCCCCC1=CC=C(C=C1)NC(=O)C(CCO)N D01UUZ HIGHSTAT Investigative D01UVA DRUG__ID D01UVA D01UVA DRUGTYPE Small molecular drug D01UVA DRUGINCH 1S/C19H28O7/c1-9(2)16(21)25-13-7-18(5)14(20)8-19(23,26-18)10(3)6-12-15(13)11(4)17(22)24-12/h9-10,12-15,20,23H,4,6-8H2,1-3,5H3/t10-,12+,13+,14-,15-,18+,19+/m0/s1 D01UVA DRUGINKE HREHFPZHVCNOMQ-XNNFIIJVSA-N D01UVA DRUGSMIL CC1CC2C(C(CC3(C(CC1(O3)O)O)C)OC(=O)C(C)C)C(=C)C(=O)O2 D01UVA HIGHSTAT Investigative D01UVD DRUG__ID D01UVD D01UVD DRUGTYPE Small molecular drug D01UVD DRUGINCH 1S/C20H36INO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)22-19-18-21/h6-7,9-10H,2-5,8,11-19H2,1H3,(H,22,23)/b7-6-,10-9- D01UVD DRUGINKE WVKIJZMEKURTIW-HZJYTTRNSA-N D01UVD DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)NCCI D01UVD HIGHSTAT Investigative D01UVU DRUG__ID D01UVU D01UVU DRUGTYPE Small molecular drug D01UVU DRUGINCH 1S/C12H8BrN3O/c13-11-6-15-16-7-9(5-14-12(11)16)8-1-3-10(17)4-2-8/h1-7,17H D01UVU DRUGINKE XBHIAJWNXVJSAA-UHFFFAOYSA-N D01UVU DRUGSMIL C1=CC(=CC=C1C2=CN3C(=C(C=N3)Br)N=C2)O D01UVU HIGHSTAT Investigative D01UWZ DRUG__ID D01UWZ D01UWZ DRUGTYPE Small molecular drug D01UWZ DRUGINCH 1S/C35H45N5O4.ClH/c1-6-7-15-40-33-27(13-9-14-37-33)30(25-11-8-12-26(20-25)44-17-10-16-41)32(34(40)42)39-35(43)38-31-28(22(2)3)18-24(21-36)19-29(31)23(4)5;/h8-9,11-14,18-20,22-23,41H,6-7,10,15-17,21,36H2,1-5H3,(H2,38,39,43);1H D01UWZ DRUGINKE OXTVBHDILDPYAS-UHFFFAOYSA-N D01UWZ DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)CN)C(C)C)C4=CC(=CC=C4)OCCCO.Cl D01UWZ HIGHSTAT Investigative D01UYI DRUG__ID D01UYI D01UYI DRUGTYPE Small molecular drug D01UYI DRUGINCH 1S/C15H10O4/c16-10-6-11(17)15-12(18)8-13(19-14(15)7-10)9-4-2-1-3-5-9/h1-8,16-17H D01UYI DRUGINKE RTIXKCRFFJGDFG-UHFFFAOYSA-N D01UYI DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O D01UYI HIGHSTAT Investigative D01UYS DRUG__ID D01UYS D01UYS DRUGTYPE Small molecular drug D01UYS DRUGINCH 1S/C16H14N2O3/c1-20-14-6-11-5-12(10-3-4-16(19)18-8-10)9-17-13(11)7-15(14)21-2/h3-9H,1-2H3,(H,18,19) D01UYS DRUGINKE RWZAFECYIQQVPG-UHFFFAOYSA-N D01UYS DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CNC(=O)C=C3 D01UYS HIGHSTAT Investigative D01UZH DRUG__ID D01UZH D01UZH DRUGCOMP Samjin Pharmaceutical Co Ltd D01UZH DRUGINCH 1S/C20H24N2O3/c1-11(2)16-17(18(23)15-8-12(3)7-13(4)9-15)22(10-14-5-6-14)20(25)21-19(16)24/h7-9,11,14H,5-6,10H2,1-4H3,(H,21,24,25) D01UZH DRUGINKE UCOAKFIVSAVHLC-UHFFFAOYSA-N D01UZH DRUGSMIL CC1=CC(=CC(=C1)C(=O)C2=C(C(=O)NC(=O)N2CC3CC3)C(C)C)C D01UZH HIGHSTAT Investigative D01UZT DRUG__ID D01UZT D01UZT DRUGTYPE Small molecular drug D01UZT DRUGINCH 1S/C14H10ClN3/c15-13-6-4-11(5-7-13)12-9-17-18(10-12)14-3-1-2-8-16-14/h1-10H D01UZT DRUGINKE NJMIDEUMQUSYDE-UHFFFAOYSA-N D01UZT DRUGSMIL C1=CC=NC(=C1)N2C=C(C=N2)C3=CC=C(C=C3)Cl D01UZT HIGHSTAT Investigative D01VAU DRUG__ID D01VAU D01VAU DRUGTYPE Small molecular drug D01VAU DRUGINCH 1S/C16H14O4/c1-19-13-7-3-5-11(9-13)15(17)16(18)12-6-4-8-14(10-12)20-2/h3-10H,1-2H3 D01VAU DRUGINKE PJGXOGKIVAJFTE-UHFFFAOYSA-N D01VAU DRUGSMIL COC1=CC=CC(=C1)C(=O)C(=O)C2=CC(=CC=C2)OC D01VAU HIGHSTAT Investigative D01VCE DRUG__ID D01VCE D01VCE DRUGCOMP Guerbet D01VCE DRUGINCH 1S/C228H316Br12N32O116.Gd/c229-161-153(217(373)265(57-109(289)177(333)193(349)125(305)73-273)58-110(290)178(334)194(350)126(306)74-274)165(233)173(166(234)154(161)218(374)266(59-111(291)179(335)195(351)127(307)75-275)60-112(292)180(336)196(352)128(308)76-276)257-149(329)53-245-209(365)89-1-25-101(26-2-89)253-213(369)93-9-17-97(18-10-93)249-145(325)49-241-141(321)37-33-105(225(381)382)261-41-43-262(106(226(383)384)34-38-142(322)242-50-146(326)250-98-19-11-94(12-20-98)214(370)254-102-27-3-90(4-28-102)210(366)246-54-150(330)258-174-167(235)155(219(375)267(61-113(293)181(337)197(353)129(309)77-277)62-114(294)182(338)198(354)130(310)78-278)162(230)156(168(174)236)220(376)268(63-115(295)183(339)199(355)131(311)79-279)64-116(296)184(340)200(356)132(312)80-280)45-47-264(108(228(387)388)36-40-144(324)244-52-148(328)252-100-23-15-96(16-24-100)216(372)256-104-31-7-92(8-32-104)212(368)248-56-152(332)260-176-171(239)159(223(379)271(69-121(301)189(345)205(361)137(317)85-285)70-122(302)190(346)206(362)138(318)86-286)164(232)160(172(176)240)224(380)272(71-123(303)191(347)207(363)139(319)87-287)72-124(304)192(348)208(364)140(320)88-288)48-46-263(44-42-261)107(227(385)386)35-39-143(323)243-51-147(327)251-99-21-13-95(14-22-99)215(371)255-103-29-5-91(6-30-103)211(367)247-55-151(331)259-175-169(237)157(221(377)269(65-117(297)185(341)201(357)133(313)81-281)66-118(298)186(342)202(358)134(314)82-282)163(231)158(170(175)238)222(378)270(67-119(299)187(343)203(359)135(315)83-283)68-120(300)188(344)204(360)136(316)84-284;/h1-32,105-140,177-208,273-320,333-364H,33-88H2,(H,241,321)(H,242,322)(H,243,323)(H,244,324)(H,245,365)(H,246,366)(H,247,367)(H,248,368)(H,249,325)(H,250,326)(H,251,327)(H,252,328)(H,253,369)(H,254,370)(H,255,371)(H,256,372)(H,257,329)(H,258,330)(H,259,331)(H,260,332)(H,381,382)(H,383,384)(H,385,386)(H,387,388);/q;+3/p-3/t105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,135+,136+,137+,138+,139+,140-,177+,178+,179+,180+,181+,182+,183+,184+,185+,186+,187+,188+,189+,190+,191+,192+,193+,194+,195+,196+,197+,198+,199+,200+,201+,202+,203+,204+,205+,206+,207+,208+;/m0./s1 D01VCE DRUGINKE IJXRBDZLPVFPLJ-BBAPOLETSA-K D01VCE DRUGSMIL C1CN(CCN(CCN(CCN1C(CCC(=O)NCC(=O)NC2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)C(=O)NCC(=O)NC4=C(C(=C(C(=C4Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)O)C(CCC(=O)NCC(=O)NC5=CC=C(C=C5)C(=O)NC6=CC=C(C=C6)C(=O)NCC(=O)NC7=C(C(=C(C(=C7Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)[O-])C(CCC(=O)NCC(=O)NC8=CC=C(C=C8)C(=O)NC9=CC=C(C=C9)C(=O)NCC(=O)NC1=C(C(=C(C(=C1Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)[O-])C(CCC(=O)NCC(=O)NC1=CC=C(C=C1)C(=O)NC1=CC=C(C=C1)C(=O)NCC(=O)NC1=C(C(=C(C(=C1Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)N(CC(C(C(C(CO)O)O)O)O)CC(C(C(C(CO)O)O)O)O)Br)C(=O)[O-].[Gd+3] D01VCE HIGHSTAT Investigative D01VCS DRUG__ID D01VCS D01VCS DRUGTYPE Small molecular drug D01VCS DRUGINCH 1S/C14H6F4O2/c15-7-3-1-4-8(16)11(7)13(19)14(20)12-9(17)5-2-6-10(12)18/h1-6H D01VCS DRUGINKE ZQTHCEAXUHQYSG-UHFFFAOYSA-N D01VCS DRUGSMIL C1=CC(=C(C(=C1)F)C(=O)C(=O)C2=C(C=CC=C2F)F)F D01VCS HIGHSTAT Investigative D01VDB DRUG__ID D01VDB D01VDB DRUGTYPE Small molecular drug D01VDB DRUGINCH 1S/C22H20O6/c23-17-12-14-19(25)28-22(17)20(26)21(16-9-5-2-6-10-16)27-18(24)13-11-15-7-3-1-4-8-15/h1-14,17,20-23,26H/b13-11+/t17-,20+,21+,22+/m0/s1 D01VDB DRUGINKE HCJURVKKVSCZRL-VTWBULIDSA-N D01VDB DRUGSMIL C1=CC=C(C=C1)C=CC(=O)OC(C2=CC=CC=C2)C(C3C(C=CC(=O)O3)O)O D01VDB HIGHSTAT Investigative D01VEP DRUG__ID D01VEP D01VEP DRUGTYPE Small molecular drug D01VEP DRUGINCH 1S/C23H38O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-28-23(27)19-17-20(24)22(26)21(25)18-19/h17-18,24-26H,2-16H2,1H3 D01VEP DRUGINKE TYCUSKFOGZNIBO-UHFFFAOYSA-N D01VEP DRUGSMIL CCCCCCCCCCCCCCCCOC(=O)C1=CC(=C(C(=C1)O)O)O D01VEP HIGHSTAT Investigative D01VEU DRUG__ID D01VEU D01VEU DRUGTYPE Small molecular drug D01VEU DRUGINCH 1S/C15H13N5/c1-2-20-12(9-8-11-6-4-3-5-7-11)19-13-14(16)17-10-18-15(13)20/h3-7,10H,2H2,1H3,(H2,16,17,18) D01VEU DRUGINKE AXENMZHFYBPHQF-UHFFFAOYSA-N D01VEU DRUGSMIL CCN1C(=NC2=C(N=CN=C21)N)C#CC3=CC=CC=C3 D01VEU HIGHSTAT Investigative D01VEV DRUG__ID D01VEV D01VEV DRUGCOMP GW Pharmaceuticals plc D01VEV DRUGINCH 1S/2C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15;1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,16-17,22H,5-10H2,1-4H3;11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t16-,17-;17-,18+/m10/s1 D01VEV DRUGINKE SSNHGLKFJISNTR-DYSNNVSPSA-N D01VEV DRUGSMIL CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O.CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O D01VEV HIGHSTAT Investigative D01VFR DRUG__ID D01VFR D01VFR DRUGTYPE Small molecular drug D01VFR DRUGINCH 1S/C17H13BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h2-10H,1H2,(H,21,23)(H,19,20,22) D01VFR DRUGINKE HTUBKQUPEREOGA-UHFFFAOYSA-N D01VFR DRUGSMIL C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br D01VFR HIGHSTAT Investigative D01VIA DRUG__ID D01VIA D01VIA DRUGTYPE Small molecular drug D01VIA DRUGINCH 1S/C24H30N2O/c27-24(22-14-8-3-9-15-22)26-18-16-25(17-19-26)23(20-10-4-1-5-11-20)21-12-6-2-7-13-21/h1-2,4-7,10-13,22-23H,3,8-9,14-19H2 D01VIA DRUGINKE OZIJATBNGVKZLU-UHFFFAOYSA-N D01VIA DRUGSMIL C1CCC(CC1)C(=O)N2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4 D01VIA HIGHSTAT Investigative D01VIX DRUG__ID D01VIX D01VIX DRUGTYPE Small molecular drug D01VIX DRUGINCH 1S/C19H23ClF3NO3/c20-15-2-1-14(27-19(21,22)23)12-16(15)24-9-7-18(8-10-24)5-3-13(4-6-18)11-17(25)26/h1-2,12-13H,3-11H2,(H,25,26) D01VIX DRUGINKE WUJVPELCYCESAP-UHFFFAOYSA-N D01VIX DRUGSMIL C1CC2(CCC1CC(=O)O)CCN(CC2)C3=C(C=CC(=C3)OC(F)(F)F)Cl D01VIX HIGHSTAT Investigative D01VJT DRUG__ID D01VJT D01VJT DRUGTYPE Small molecular drug D01VJT DRUGINCH 1S/C26H17NO2S2/c27-24-21(31-17-11-5-2-6-12-17)15-20(30-16-9-3-1-4-10-16)22-23(24)26(29)19-14-8-7-13-18(19)25(22)28/h1-15H,27H2 D01VJT DRUGINKE XAJKSCYRAOFPAT-UHFFFAOYSA-N D01VJT DRUGSMIL C1=CC=C(C=C1)SC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)SC5=CC=CC=C5 D01VJT HIGHSTAT Investigative D01VKE DRUG__ID D01VKE D01VKE DRUGTYPE Small molecular drug D01VKE DRUGINCH 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3 D01VKE DRUGINKE FMGSKLZLMKYGDP-UHFFFAOYSA-N D01VKE DRUGSMIL CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C D01VKE HIGHSTAT Investigative D01VKI DRUG__ID D01VKI D01VKI DRUGTYPE Small molecular drug D01VKI DRUGINCH 1S/C58H84N14O16S/c1-31(2)25-39(54(84)66-36(49(61)79)21-24-89-4)65-47(76)30-62-51(81)40(27-34-15-17-35(73)18-16-34)68-55(85)41(26-33-11-6-5-7-12-33)69-53(83)37(13-8-9-22-59)67-56(86)42(28-45(60)74)70-57(87)44-14-10-23-72(44)58(88)43(29-48(77)78)71-50(80)32(3)63-52(82)38-19-20-46(75)64-38/h5-7,11-12,15-18,31-32,36-44,73H,8-10,13-14,19-30,59H2,1-4H3,(H2,60,74)(H2,61,79)(H,62,81)(H,63,82)(H,64,75)(H,65,76)(H,66,84)(H,67,86)(H,68,85)(H,69,83)(H,70,87)(H,71,80)(H,77,78) D01VKI DRUGINKE SHSUJLMLURFKID-UHFFFAOYSA-N D01VKI DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C3CCCN3C(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C4CCC(=O)N4 D01VKI HIGHSTAT Investigative D01VLQ DRUG__ID D01VLQ D01VLQ DRUGTYPE Small molecular drug D01VLQ DRUGINCH 1S/C20H32O3/c1-2-3-13-16-19(21)17-14-11-9-7-5-4-6-8-10-12-15-18-20(22)23/h4-6,8,10,12,15,18-19,21H,2-3,7,9,11,13-14,16-17H2,1H3,(H,22,23)/b5-4+,8-6+,12-10+,18-15+ D01VLQ DRUGINKE GQHZVWMHPQXBIA-QYANQBPOSA-N D01VLQ DRUGSMIL CCCCCC(CCCCCC=CC=CC=CC=CC(=O)O)O D01VLQ HIGHSTAT Investigative D01VLV DRUG__ID D01VLV D01VLV DRUGTYPE Small molecular drug D01VLV DRUGINCH 1S/C17H17N3O2S2/c1-22-12-5-8-14-15(9-12)20-17(19-14)24-10-16(21)18-11-3-6-13(23-2)7-4-11/h3-9H,10H2,1-2H3,(H,18,21)(H,19,20) D01VLV DRUGINKE FKTAXVGJKVSANI-UHFFFAOYSA-N D01VLV DRUGSMIL COC1=CC2=C(C=C1)N=C(N2)SCC(=O)NC3=CC=C(C=C3)SC D01VLV HIGHSTAT Investigative D01VMU DRUG__ID D01VMU D01VMU DRUGTYPE Small molecular drug D01VMU DRUGINCH 1S/C41H57N11O6/c42-36(54)30-15-6-7-19-45-20-9-18-35(53)52-22-10-17-34(52)40(58)51-32(23-26-11-2-1-3-12-26)38(56)49-31(16-8-21-46-41(43)44)37(55)50-33(39(57)48-30)24-27-25-47-29-14-5-4-13-28(27)29/h1-5,11-14,25,30-34,45,47H,6-10,15-24H2,(H2,42,54)(H,48,57)(H,49,56)(H,50,55)(H,51,58)(H4,43,44,46)/t30-,31-,32+,33-,34-/m0/s1 D01VMU DRUGINKE VFHJQMPJMWPJBF-UBLLTGQXSA-N D01VMU DRUGSMIL C1CCNCCCC(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC=CC=C5 D01VMU HIGHSTAT Investigative D01VNL DRUG__ID D01VNL D01VNL DRUGCOMP Maruishi Pharmaceutical Co Ltd D01VNL DRUGINCH 1S/C24H27N3O2/c1-25-10-12-26(13-11-25)23(28)16-22-20-14-17-6-5-7-18(17)15-21(20)24(29)27(22)19-8-3-2-4-9-19/h2-4,8-9,14-15,22H,5-7,10-13,16H2,1H3/t22-/m1/s1 D01VNL DRUGINKE MBGOHVUPIPFVMM-JOCHJYFZSA-N D01VNL DRUGSMIL CN1CCN(CC1)C(=O)CC2C3=C(C=C4CCCC4=C3)C(=O)N2C5=CC=CC=C5 D01VNL HIGHSTAT Investigative D01VNN DRUG__ID D01VNN D01VNN DRUGTYPE Small molecular drug D01VNN DRUGINCH 1S/C15H10Cl2O6/c16-10-4-6(2-8(12(10)18)14(20)21)1-7-3-9(15(22)23)13(19)11(17)5-7/h2-5,18-19H,1H2,(H,20,21)(H,22,23) D01VNN DRUGINKE BFCJNYJGIGUQJA-UHFFFAOYSA-N D01VNN DRUGSMIL C1=C(C=C(C(=C1C(=O)O)O)Cl)CC2=CC(=C(C(=C2)Cl)O)C(=O)O D01VNN HIGHSTAT Investigative D01VOU DRUG__ID D01VOU D01VOU DRUGTYPE Small molecular drug D01VOU DRUGINCH 1S/C15H12O6/c16-9-3-1-8(12(19)5-9)2-4-11(18)15-13(20)6-10(17)7-14(15)21/h1-7,16-17,19-21H/b4-2+ D01VOU DRUGINKE MDRJIGPMMMALHB-DUXPYHPUSA-N D01VOU DRUGSMIL C1=CC(=C(C=C1O)O)C=CC(=O)C2=C(C=C(C=C2O)O)O D01VOU HIGHSTAT Investigative D01VPZ DRUG__ID D01VPZ D01VPZ DRUGTYPE Small molecular drug D01VPZ DRUGINCH 1S/C16H12OS/c1-11-6-8-12(9-7-11)15-10-16(18)13-4-2-3-5-14(13)17-15/h2-10H,1H3 D01VPZ DRUGINKE PUUXSOGZGHKVIT-UHFFFAOYSA-N D01VPZ DRUGSMIL CC1=CC=C(C=C1)C2=CC(=S)C3=CC=CC=C3O2 D01VPZ HIGHSTAT Investigative D01VRB DRUG__ID D01VRB D01VRB DRUGTYPE Small molecular drug D01VRB DRUGINCH 1S/C15H9Cl2NS/c16-12-5-1-10(2-6-12)14-9-18-19-15(14)11-3-7-13(17)8-4-11/h1-9H D01VRB DRUGINKE FCOMTKBRAKMDNZ-UHFFFAOYSA-N D01VRB DRUGSMIL C1=CC(=CC=C1C2=C(SN=C2)C3=CC=C(C=C3)Cl)Cl D01VRB HIGHSTAT Investigative D01VSI DRUG__ID D01VSI D01VSI DRUGTYPE Small molecular drug D01VSI DRUGINCH 1S/C63H83N17O14/c1-34(2)24-45(58(90)74-43(18-11-23-70-63(68)69)57(89)75-44(54(67)86)26-35-12-5-3-6-13-35)73-53(85)32-72-56(88)46(27-36-14-7-4-8-15-36)77-62(94)50(33-81)80-61(93)49(30-52(66)84)79-59(91)47(28-38-31-71-42-17-10-9-16-40(38)42)78-60(92)48(29-51(65)83)76-55(87)41(64)25-37-19-21-39(82)22-20-37/h3-10,12-17,19-22,31,34,41,43-50,71,81-82H,11,18,23-30,32-33,64H2,1-2H3,(H2,65,83)(H2,66,84)(H2,67,86)(H,72,88)(H,73,85)(H,74,90)(H,75,89)(H,76,87)(H,77,94)(H,78,92)(H,79,91)(H,80,93)(H4,68,69,70)/t41-,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D01VSI DRUGINKE RITKWYDZSSQNJI-INXYWQKQSA-N D01VSI DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)CNC(=O)C(CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC(=O)N)NC(=O)C(CC5=CC=C(C=C5)O)N D01VSI HIGHSTAT Investigative D01VVM DRUG__ID D01VVM D01VVM DRUGTYPE Small molecular drug D01VVM DRUGINCH 1S/C16H13N8O19P3/c17-13-10-14(19-4-18-13)21(5-20-10)15-12-11(7(39-15)3-38-45(34,35)43-46(36,37)42-44(31,32)33)40-16(41-12)8(23(27)28)1-6(22(25)26)2-9(16)24(29)30/h1-2,4-5,8,10,17H,3H2,(H4,31,32,33,34,35,36,37)/p-1 D01VVM DRUGINKE NHXFSKZBEIIARS-UHFFFAOYSA-M D01VVM DRUGSMIL C1=C(C=C(C2(C1[N+](=O)[O-])OC3=C(OC(=C3O2)[N+]4=C5C(C(=NC=N5)N)N=C4)COP(=O)(O)OP(=O)(O)OP(=O)([O-])[O-])[N+](=O)[O-])[N+](=O)[O-] D01VVM HIGHSTAT Investigative D01VXC DRUG__ID D01VXC D01VXC DRUGTYPE Small molecular drug D01VXC DRUGINCH 1S/C19H17N3O/c1-2-18(23)22-19-20-16(14-9-5-3-6-10-14)13-17(21-19)15-11-7-4-8-12-15/h3-13H,2H2,1H3,(H,20,21,22,23) D01VXC DRUGINKE AZXIPRTZIQWIHR-UHFFFAOYSA-N D01VXC DRUGSMIL CCC(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D01VXC HIGHSTAT Investigative D01VXP DRUG__ID D01VXP D01VXP DRUGTYPE Small molecular drug D01VXP DRUGINCH 1S/C13H15N5O5/c1-3-7-15-11(17-22-2)8-12(16-7)18(5-14-8)13-10(21)9(20)6(4-19)23-13/h1,5-6,9-10,13,19-21H,4H2,2H3,(H,15,16,17)/t6-,9-,10-,13-/m1/s1 D01VXP DRUGINKE DPDYWTZJFUXIEE-ZRFIDHNTSA-N D01VXP DRUGSMIL CONC1=C2C(=NC(=N1)C#C)N(C=N2)C3C(C(C(O3)CO)O)O D01VXP HIGHSTAT Investigative D01VZL DRUG__ID D01VZL D01VZL DRUGTYPE Small molecular drug D01VZL DRUGINCH 1S/C18H24N4O4/c1-18(2,3)25-17(23)22-10-6-14(7-11-22)24-12-15-20-16(21-26-15)13-4-8-19-9-5-13/h4-5,8-9,14H,6-7,10-12H2,1-3H3 D01VZL DRUGINKE LHZWKWCEAXQUMX-UHFFFAOYSA-N D01VZL DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)OCC2=NC(=NO2)C3=CC=NC=C3 D01VZL HIGHSTAT Investigative D01WAI DRUG__ID D01WAI D01WAI DRUGTYPE Small molecular drug D01WAI DRUGINCH 1S/C11H11N5O2/c12-11-15-8(10(18)16-11)6-2-4-14-9(17)7-5(6)1-3-13-7/h1,3,13H,2,4H2,(H,14,17)(H3,12,15,16,18)/b8-6- D01WAI DRUGINKE JYRJOQGKGMHTOO-VURMDHGXSA-N D01WAI DRUGSMIL C1CNC(=O)C2=C(C1=C3C(=O)NC(=N3)N)C=CN2 D01WAI HIGHSTAT Investigative D01WCA DRUG__ID D01WCA D01WCA DRUGTYPE Small molecular drug D01WCA DRUGINCH 1S/C14H10O3/c15-11-3-1-9(2-4-11)14-8-10-7-12(16)5-6-13(10)17-14/h1-8,15-16H D01WCA DRUGINKE SNNNDCMXZYWCCI-UHFFFAOYSA-N D01WCA DRUGSMIL C1=CC(=CC=C1C2=CC3=C(O2)C=CC(=C3)O)O D01WCA HIGHSTAT Investigative D01WDB DRUG__ID D01WDB D01WDB DRUGTYPE Small molecular drug D01WDB DRUGINCH 1S/C27H36N8O5/c28-21(17-18-7-2-1-3-8-18)26(38)34-16-5-4-10-23(34)25(37)33-22(9-6-15-31-27(29)30)24(36)32-19-11-13-20(14-12-19)35(39)40/h1-3,7-8,11-14,21-23H,4-6,9-10,15-17,28H2,(H,32,36)(H,33,37)(H4,29,30,31)/t21-,22+,23+/m1/s1 D01WDB DRUGINKE YDMBNDUHUNWWRP-VJBWXMMDSA-N D01WDB DRUGSMIL C1CCN(C(C1)C(=O)NC(CCCN=C(N)N)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-])C(=O)C(CC3=CC=CC=C3)N D01WDB HIGHSTAT Investigative D01WDI DRUG__ID D01WDI D01WDI DRUGTYPE Small molecular drug D01WDI DRUGINCH 1S/C15H13N3.ClH/c1-2-6-12(7-3-1)10-16-15-13-8-4-5-9-14(13)17-11-18-15;/h1-9,11H,10H2,(H,16,17,18);1H D01WDI DRUGINKE DIKWZEPKULLMFX-UHFFFAOYSA-N D01WDI DRUGSMIL C1=CC=C(C=C1)CNC2=NC=NC3=CC=CC=C32.Cl D01WDI HIGHSTAT Investigative D01WDS DRUG__ID D01WDS D01WDS DRUGTYPE Small molecular drug D01WDS DRUGINCH 1S/C22H23N3O/c26-22(25-20-14-17-6-4-5-9-21(17)23-15-20)16-10-12-19(13-11-16)24-18-7-2-1-3-8-18/h4-6,9-15,18,24H,1-3,7-8H2,(H,25,26) D01WDS DRUGINKE SWEAAERORIFOIX-UHFFFAOYSA-N D01WDS DRUGSMIL C1CCC(CC1)NC2=CC=C(C=C2)C(=O)NC3=CC4=CC=CC=C4N=C3 D01WDS HIGHSTAT Investigative D01WHI DRUG__ID D01WHI D01WHI DRUGTYPE Small molecular drug D01WHI DRUGINCH 1S/C30H33ClN6O5S/c1-36(2)19-5-18-32-27(38)17-10-21-8-15-24(16-9-21)43(41,42)37(23-13-11-22(31)12-14-23)20-28(39)34-35-29-25-6-3-4-7-26(25)33-30(29)40/h3-4,6-9,11-16,33,40H,5,10,17-20H2,1-2H3,(H,32,38) D01WHI DRUGINKE BOPHFCQTNVDEDL-UHFFFAOYSA-N D01WHI DRUGSMIL CN(C)CCCNC(=O)CCC1=CC=C(C=C1)S(=O)(=O)N(CC(=O)N=NC2=C(NC3=CC=CC=C32)O)C4=CC=C(C=C4)Cl D01WHI HIGHSTAT Investigative D01WIH DRUG__ID D01WIH D01WIH DRUGTYPE Small molecular drug D01WIH DRUGINCH 1S/C11H8FN5/c12-7-1-3-8(4-2-7)17-11-9-10(14-5-13-9)15-6-16-11/h1-6H,(H2,13,14,15,16,17) D01WIH DRUGINKE SCRHVVOELSYCSO-UHFFFAOYSA-N D01WIH DRUGSMIL C1=CC(=CC=C1NC2=NC=NC3=C2NC=N3)F D01WIH HIGHSTAT Investigative D01WKR DRUG__ID D01WKR D01WKR DRUGTYPE Small molecular drug D01WKR DRUGINCH 1S/C7H13NO4/c1-2-7(8,6(11)12)4-3-5(9)10/h2-4,8H2,1H3,(H,9,10)(H,11,12)/t7-/m0/s1 D01WKR DRUGINKE QFYBYZLHPIALCZ-ZETCQYMHSA-N D01WKR DRUGSMIL CCC(CCC(=O)O)(C(=O)O)N D01WKR HIGHSTAT Investigative D01WLL DRUG__ID D01WLL D01WLL DRUGTYPE Small molecular drug D01WLL DRUGINCH 1S/C12H12N2O2S2/c1-18(15,16)14-11-7-8-13-9-12(11)17-10-5-3-2-4-6-10/h2-9H,1H3,(H,13,14) D01WLL DRUGINKE SQQJATJQZCRBEZ-UHFFFAOYSA-N D01WLL DRUGSMIL CS(=O)(=O)NC1=C(C=NC=C1)SC2=CC=CC=C2 D01WLL HIGHSTAT Investigative D01WMU DRUG__ID D01WMU D01WMU DRUGTYPE Small molecular drug D01WMU DRUGINCH 1S/C26H29NO/c1-20-10-6-8-14-23(20)25(24-15-9-7-11-21(24)2)27-18-16-26(28,17-19-27)22-12-4-3-5-13-22/h3-15,25,28H,16-19H2,1-2H3 D01WMU DRUGINKE MHYKPRJMOSXVFG-UHFFFAOYSA-N D01WMU DRUGSMIL CC1=CC=CC=C1C(C2=CC=CC=C2C)N3CCC(CC3)(C4=CC=CC=C4)O D01WMU HIGHSTAT Investigative D01WNA DRUG__ID D01WNA D01WNA DRUGTYPE Small molecular drug D01WNA DRUGINCH 1S/C7H8BrN5/c1-2-13-6-4(12-7(13)8)5(9)10-3-11-6/h3H,2H2,1H3,(H2,9,10,11) D01WNA DRUGINKE GACDSQLJMZANKT-UHFFFAOYSA-N D01WNA DRUGSMIL CCN1C2=NC=NC(=C2N=C1Br)N D01WNA HIGHSTAT Investigative D01WNO DRUG__ID D01WNO D01WNO DRUGTYPE Small molecular drug D01WNO DRUGINCH 1S/C11H11ClN2/c12-9-2-1-8-5-10-7-13-3-4-14(10)11(8)6-9/h1-2,5-6,13H,3-4,7H2 D01WNO DRUGINKE PSLRQWHMXFDQNK-UHFFFAOYSA-N D01WNO DRUGSMIL C1CN2C(=CC3=C2C=C(C=C3)Cl)CN1 D01WNO HIGHSTAT Investigative D01WPJ DRUG__ID D01WPJ D01WPJ DRUGTYPE Small molecular drug D01WPJ DRUGINCH 1S/C10H12O2/c1-5-6(2)10(12)8(4)7(3)9(5)11/h1-4H3 D01WPJ DRUGINKE WAMKWBHYPYBEJY-UHFFFAOYSA-N D01WPJ DRUGSMIL CC1=C(C(=O)C(=C(C1=O)C)C)C D01WPJ HIGHSTAT Investigative D01WQF DRUG__ID D01WQF D01WQF DRUGTYPE Small molecular drug D01WQF DRUGINCH 1S/C36H48N6O10/c1-20(2)30(34(49)38-21(3)31(46)39-26(36(51)52)15-16-29(44)45)41-32(47)27(19-23-11-13-24(43)14-12-23)40-33(48)28-10-7-17-42(28)35(50)25(37)18-22-8-5-4-6-9-22/h4-6,8-9,11-14,20-21,25-28,30,43H,7,10,15-19,37H2,1-3H3,(H,38,49)(H,39,46)(H,40,48)(H,41,47)(H,44,45)(H,51,52)/t21-,25-,26-,27-,28-,30-/m0/s1 D01WQF DRUGINKE QKSOHTFYHNYHRK-YFVDCHTDSA-N D01WQF DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)N D01WQF HIGHSTAT Investigative D01WQL DRUG__ID D01WQL D01WQL DRUGCOMP Myrexis Inc D01WQL DRUGINCH 1S/C23H20N6O/c24-14-17-11-15(3-6-21(17)29-9-1-2-10-29)20-7-8-25-23(28-20)26-18-4-5-19-16(12-18)13-22(30)27-19/h3-8,11-12H,1-2,9-10,13H2,(H,27,30)(H,25,26,28) D01WQL DRUGINKE DHPSFJYFPJRCTN-UHFFFAOYSA-N D01WQL DRUGSMIL C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC5=C(C=C4)NC(=O)C5)C#N D01WQL HIGHSTAT Investigative D01WRT DRUG__ID D01WRT D01WRT DRUGTYPE Small molecular drug D01WRT DRUGINCH 1S/C20H17N5O2/c1-2-24-19-6-4-3-5-15(19)16-11-17(21)18(12-20(16)24)23-22-13-7-9-14(10-8-13)25(26)27/h3-12H,2,21H2,1H3 D01WRT DRUGINKE WTQFEDKUNFYXPZ-UHFFFAOYSA-N D01WRT DRUGSMIL CCN1C2=CC=CC=C2C3=CC(=C(C=C31)N=NC4=CC=C(C=C4)[N+](=O)[O-])N D01WRT HIGHSTAT Investigative D01WTQ DRUG__ID D01WTQ D01WTQ DRUGTYPE Small molecular drug D01WTQ DRUGINCH 1S/C24H24O6/c1-12(2)6-7-14-19-17(10-15(25)23(14)28-5)29-18-11-16-13(8-9-24(3,4)30-16)21(26)20(18)22(19)27/h6,8-11,25-26H,7H2,1-5H3 D01WTQ DRUGINKE HQWHKELJHUFLGD-UHFFFAOYSA-N D01WTQ DRUGSMIL CC(=CCC1=C(C(=CC2=C1C(=O)C3=C(C4=C(C=C3O2)OC(C=C4)(C)C)O)O)OC)C D01WTQ HIGHSTAT Investigative D01WVE DRUG__ID D01WVE D01WVE DRUGTYPE Small molecular drug D01WVE DRUGINCH 1S/C18H14I2O4/c1-10-13(12-4-2-3-5-16(12)24-10)6-11-7-14(19)18(15(20)8-11)23-9-17(21)22/h2-5,7-8H,6,9H2,1H3,(H,21,22) D01WVE DRUGINKE OLIKCJUMYWSDIV-UHFFFAOYSA-N D01WVE DRUGSMIL CC1=C(C2=CC=CC=C2O1)CC3=CC(=C(C(=C3)I)OCC(=O)O)I D01WVE HIGHSTAT Investigative D01WVV DRUG__ID D01WVV D01WVV DRUGTYPE Small molecular drug D01WVV DRUGINCH 1S/C27H36N4O5S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27/h4-12,22H,13-19,28H2,1-3H3,(H,29,33)/t22-/m1/s1/i37+3 D01WVV DRUGINKE UMUPQWIGCOZEOY-KRTHATKOSA-N D01WVV DRUGSMIL CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=CC=CC=C34)S(=O)(=O)C)N D01WVV HIGHSTAT Investigative D01WWC DRUG__ID D01WWC D01WWC DRUGTYPE Small molecular drug D01WWC DRUGINCH 1S/C20H23NO4/c1-21-6-5-11-9-17(24-3)20(25-4)19-13-10-16(23-2)15(22)8-12(13)7-14(21)18(11)19/h8-10,14,22H,5-7H2,1-4H3/t14-/m0/s1 D01WWC DRUGINKE ZFLRVRLYWHNAEC-AWEZNQCLSA-N D01WWC DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)OC)OC D01WWC HIGHSTAT Investigative D01WWK DRUG__ID D01WWK D01WWK DRUGTYPE Small molecular drug D01WWK DRUGINCH 1S/C16H30O6P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16(23(17,18)19)24(20,21)22/h7,9,11,16H,5-6,8,10,12H2,1-4H3,(H2,17,18,19)(H2,20,21,22)/b14-9+,15-11+ D01WWK DRUGINKE QBAOBDKNTDWTHR-YFVJMOTDSA-N D01WWK DRUGSMIL CC(=CCCC(=CCCC(=CCC(P(=O)(O)O)P(=O)(O)O)C)C)C D01WWK HIGHSTAT Investigative D01WWO DRUG__ID D01WWO D01WWO DRUGTYPE Small molecular drug D01WWO DRUGINCH 1S/C24H21F3N2O5S/c1-15(2)34-21-13-6-4-11-19(21)23(31)29-20-12-5-3-10-18(20)22(30)28-16-8-7-9-17(14-16)35(32,33)24(25,26)27/h3-15H,1-2H3,(H,28,30)(H,29,31) D01WWO DRUGINKE RSYHJSDOGMSLDH-UHFFFAOYSA-N D01WWO DRUGSMIL CC(C)OC1=CC=CC=C1C(=O)NC2=CC=CC=C2C(=O)NC3=CC(=CC=C3)S(=O)(=O)C(F)(F)F D01WWO HIGHSTAT Investigative D01WXA DRUG__ID D01WXA D01WXA DRUGTYPE Small molecular drug D01WXA DRUGINCH 1S/C22H37NO5/c1-6-23(7-2)14-12-10-8-9-11-13-15-28-22(24)18-16-19(25-3)21(27-5)20(17-18)26-4/h16-17H,6-15H2,1-5H3 D01WXA DRUGINKE IBQMHBGFMLHHLE-UHFFFAOYSA-N D01WXA DRUGSMIL CCN(CC)CCCCCCCCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC D01WXA HIGHSTAT Investigative D01WXB DRUG__ID D01WXB D01WXB DRUGTYPE Small molecular drug D01WXB DRUGINCH 1S/C3H8O2S/c4-1-3(5)2-6/h3-6H,1-2H2 D01WXB DRUGINKE PJUIMOJAAPLTRJ-UHFFFAOYSA-N D01WXB DRUGSMIL C(C(CS)O)O D01WXB HIGHSTAT Investigative D01WXR DRUG__ID D01WXR D01WXR DRUGTYPE Small molecular drug D01WXR DRUGINCH 1S/C18H15N3O/c1-13(22)19-18-20-16(14-8-4-2-5-9-14)12-17(21-18)15-10-6-3-7-11-15/h2-12H,1H3,(H,19,20,21,22) D01WXR DRUGINKE ZDCIIHIXQUEUCV-UHFFFAOYSA-N D01WXR DRUGSMIL CC(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D01WXR HIGHSTAT Investigative D01WXV DRUG__ID D01WXV D01WXV DRUGTYPE Small molecular drug D01WXV DRUGINCH 1S/C20H20N2O2/c1-3-23-19-12-16-17(11-10-15-8-6-5-7-9-15)21-14-22-18(16)13-20(19)24-4-2/h5-14H,3-4H2,1-2H3/b11-10+ D01WXV DRUGINKE MVIQZBWZLCMZGF-ZHACJKMWSA-N D01WXV DRUGSMIL CCOC1=C(C=C2C(=C1)C(=NC=N2)C=CC3=CC=CC=C3)OCC D01WXV HIGHSTAT Investigative D01WXZ DRUG__ID D01WXZ D01WXZ DRUGTYPE Small molecular drug D01WXZ DRUGINCH 1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12,14,16-18,21H,2-3,5-6,8-11,13,15H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1 D01WXZ DRUGINKE CTHZICXYLKQMKI-FOSBLDSVSA-N D01WXZ DRUGSMIL CCCCCC(C=CC1CCC(=O)C1CC=CCCCC(=O)O)O D01WXZ HIGHSTAT Investigative D01WYI DRUG__ID D01WYI D01WYI DRUGTYPE Small molecular drug D01WYI DRUGINCH 1S/C18H16N4O/c1-3-17(23)21-14-7-8-16-15(10-14)18(20-11-19-16)22-13-6-4-5-12(2)9-13/h3-11H,1H2,2H3,(H,21,23)(H,19,20,22) D01WYI DRUGINKE AWQLTDUXGVCRBV-UHFFFAOYSA-N D01WYI DRUGSMIL CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C(C=C3)NC(=O)C=C D01WYI HIGHSTAT Investigative D01XBZ DRUG__ID D01XBZ D01XBZ DRUGTYPE Small molecular drug D01XBZ DRUGINCH 1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h3H,4H2,1-2H3,(H,9,10)(H2,6,7,8) D01XBZ DRUGINKE CBIDRCWHNCKSTO-UHFFFAOYSA-N D01XBZ DRUGSMIL CC(=CCOP(=O)(O)OP(=O)(O)O)C D01XBZ HIGHSTAT Investigative D01XCA DRUG__ID D01XCA D01XCA DRUGTYPE Small molecular drug D01XCA DRUGINCH 1S/C18H21NO3S/c20-17-11-13-18(14-12-17)23(21,22)19(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1,3-4,7-8,11-14,16,20H,2,5-6,9-10H2 D01XCA DRUGINKE INJVHCJLNBTEGC-UHFFFAOYSA-N D01XCA DRUGSMIL C1CCC(CC1)N(C2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)O D01XCA HIGHSTAT Investigative D01XDV DRUG__ID D01XDV D01XDV DRUGTYPE Small molecular drug D01XDV DRUGINCH 1S/C18H17NO4/c1-20-15-6-4-5-7-16(15)23-14-8-9-19-13-11-18(22-3)17(21-2)10-12(13)14/h4-11H,1-3H3 D01XDV DRUGINKE ZTLZYKICAWTOKI-UHFFFAOYSA-N D01XDV DRUGSMIL COC1=CC=CC=C1OC2=C3C=C(C(=CC3=NC=C2)OC)OC D01XDV HIGHSTAT Investigative D01XEY DRUG__ID D01XEY D01XEY DRUGTYPE Small molecular drug D01XEY DRUGINCH 1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6+/m1/s1 D01XEY DRUGINKE SHZGCJCMOBCMKK-PHYPRBDBSA-N D01XEY DRUGSMIL CC1C(C(C(C(O1)O)O)O)O D01XEY HIGHSTAT Investigative D01XFH DRUG__ID D01XFH D01XFH DRUGTYPE Small molecular drug D01XFH DRUGINCH 1S/C10H10N2O3S/c1-2-7-12-10(13)8-3-5-9(6-4-8)16(11,14)15/h1,3-6H,7H2,(H,12,13)(H2,11,14,15) D01XFH DRUGINKE KRDXLVUMSYUYOP-UHFFFAOYSA-N D01XFH DRUGSMIL C#CCNC(=O)C1=CC=C(C=C1)S(=O)(=O)N D01XFH HIGHSTAT Investigative D01XFR DRUG__ID D01XFR D01XFR DRUGTYPE Small molecular drug D01XFR DRUGINCH 1S/C14H20N4O2/c1-4-7-16-10-15-12-11(16)13(19)18(9-6-3)14(20)17(12)8-5-2/h4,10H,1,5-9H2,2-3H3 D01XFR DRUGINKE NRUARHUVQRNQPB-UHFFFAOYSA-N D01XFR DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)N(C=N2)CC=C D01XFR HIGHSTAT Investigative D01XFT DRUG__ID D01XFT D01XFT DRUGTYPE Small molecular drug D01XFT DRUGINCH 1S/C19H25N5O/c1-14(25)16(11-7-3-6-10-15-8-4-2-5-9-15)24-13-23-17-18(20)21-12-22-19(17)24/h2,4-5,8-9,12-14,16,25H,3,6-7,10-11H2,1H3,(H2,20,21,22)/t14-,16+/m0/s1 D01XFT DRUGINKE JVHQYTUGDFGNES-GOEBONIOSA-N D01XFT DRUGSMIL CC(C(CCCCCC1=CC=CC=C1)N2C=NC3=C(N=CN=C32)N)O D01XFT HIGHSTAT Investigative D01XGG DRUG__ID D01XGG D01XGG DRUGTYPE Small molecular drug D01XGG DRUGINCH 1S/C17H15NO3/c1-11(19)18-16-10-14-13(12-6-4-3-5-7-12)8-9-15(20-2)17(14)21-16/h3-10H,1-2H3,(H,18,19) D01XGG DRUGINKE QFMYZXFFZWTGIP-UHFFFAOYSA-N D01XGG DRUGSMIL CC(=O)NC1=CC2=C(C=CC(=C2O1)OC)C3=CC=CC=C3 D01XGG HIGHSTAT Investigative D01XGP DRUG__ID D01XGP D01XGP DRUGTYPE Small molecular drug D01XGP DRUGINCH 1S/C9H6O2/c10-8-5-6-3-1-2-4-7(6)9(8)11/h1-4H,5H2 D01XGP DRUGINKE WFFZGYRTVIPBFN-UHFFFAOYSA-N D01XGP DRUGSMIL C1C2=CC=CC=C2C(=O)C1=O D01XGP HIGHSTAT Investigative D01XHU DRUG__ID D01XHU D01XHU DRUGCOMP Tulane University D01XHU DRUGINCH 1S/C95H121N19O26/c1-48(2)35-61(87(129)107-60(19-13-31-101-94(97)98)93(135)114-34-14-20-66(114)92(134)103-44-71(96)118)108-85(127)58(106-88(130)62(36-50-24-26-53(116)27-25-50)109-91(133)65(45-115)112-89(131)63(37-51-42-102-57-17-6-5-15-54(51)57)110-90(132)64(38-52-43-99-47-104-52)111-86(128)59-28-29-73(120)105-59)18-7-8-30-100-72(119)22-12-23-74(121)138-46-70(117)95(136)40-56-77(69(41-95)140-75-39-67(80(122)49(3)139-75)113-32-9-10-33-113)84(126)79-78(82(56)124)81(123)55-16-11-21-68(137-4)76(55)83(79)125/h5-6,9,11,15-17,21,24-27,32,42-43,47-49,58-67,69,75,80,102,115-116,122,124,126,136H,7-8,10,12-14,18-20,22-23,28-31,33-41,44-46H2,1-4H3,(H2,96,118)(H,99,104)(H,100,119)(H,103,134)(H,105,120)(H,106,130)(H,107,129)(H,108,127)(H,109,133)(H,110,132)(H,111,128)(H,112,131)(H4,97,98,101)/t49-,58+,59-,60-,61-,62-,63-,64-,65-,66-,67-,69-,75-,80+,95-/m0/s1 D01XHU DRUGINKE OIUSKDFJNIKIQX-OACKXKLTSA-N D01XHU DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CCCC(=O)NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)N6CCCC6C(=O)NCC(=O)N)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(CO)NC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CC1=CN=CN1)NC(=O)C1CCC(=O)N1)O)N1CCC=C1)O D01XHU HIGHSTAT Investigative D01XHX DRUG__ID D01XHX D01XHX DRUGTYPE Small molecular drug D01XHX DRUGINCH 1S/C22H27NO2/c1-25-22(24)21(19-12-6-3-7-13-19)20-14-8-9-16-23(20)17-15-18-10-4-2-5-11-18/h2-7,10-13,20-21H,8-9,14-17H2,1H3/t20-,21-/m1/s1 D01XHX DRUGINKE XALKSMFHDRJAKZ-NHCUHLMSSA-N D01XHX DRUGSMIL COC(=O)C(C1CCCCN1CCC2=CC=CC=C2)C3=CC=CC=C3 D01XHX HIGHSTAT Investigative D01XKY DRUG__ID D01XKY D01XKY DRUGTYPE Small molecular drug D01XKY DRUGINCH 1S/C19H12BrNOS/c20-14-11-9-13(10-12-14)19(22)21-15-5-1-3-7-17(15)23-18-8-4-2-6-16(18)21/h1-12H D01XKY DRUGINKE HIHPKBOMPNDAIA-UHFFFAOYSA-N D01XKY DRUGSMIL C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)C4=CC=C(C=C4)Br D01XKY HIGHSTAT Investigative D01XLZ DRUG__ID D01XLZ D01XLZ DRUGTYPE Small molecular drug D01XLZ DRUGINCH 1S/C20H20N4O3/c1-22-9-11-23(12-10-22)20(25)19-18(14-5-3-2-4-6-14)16-13-15(24(26)27)7-8-17(16)21-19/h2-8,13,21H,9-12H2,1H3 D01XLZ DRUGINKE BLSWPPPBUQFKHH-UHFFFAOYSA-N D01XLZ DRUGSMIL CN1CCN(CC1)C(=O)C2=C(C3=C(N2)C=CC(=C3)[N+](=O)[O-])C4=CC=CC=C4 D01XLZ HIGHSTAT Investigative D01XMK DRUG__ID D01XMK D01XMK DRUGTYPE Small molecular drug D01XMK DRUGINCH 1S/C18H14N2/c1-13-5-6-15-7-8-17(12-18(15)20-13)16-4-2-3-14(11-16)9-10-19/h2-8,11-12H,9H2,1H3 D01XMK DRUGINKE XNAOGJHXZYYKMV-UHFFFAOYSA-N D01XMK DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC(=C3)CC#N D01XMK HIGHSTAT Investigative D01XMM DRUG__ID D01XMM D01XMM DRUGTYPE Small molecular drug D01XMM DRUGINCH 1S/C13H14N2O4S/c16-12-10-8-9(4-5-11(10)14-13(12)17)20(18,19)15-6-2-1-3-7-15/h4-5,8H,1-3,6-7H2,(H,14,16,17) D01XMM DRUGINKE YATIWPMEKYVTAO-UHFFFAOYSA-N D01XMM DRUGSMIL C1CCN(CC1)S(=O)(=O)C2=CC3=C(C=C2)NC(=O)C3=O D01XMM HIGHSTAT Investigative D01XMY DRUG__ID D01XMY D01XMY DRUGTYPE Small molecular drug D01XMY DRUGINCH 1S/C24H38O6/c1-5-15(3)24(29)30-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-18(25)12-19(26)13-22(27)28/h6-7,10,14-16,18-21,23,25-26H,5,8-9,11-13H2,1-4H3,(H,27,28)/p-1/t14-,15-,16-,18+,19-,20-,21+,23?/m0/s1 D01XMY DRUGINKE QLJODMDSTUBWDW-VPUMEXOFSA-M D01XMY DRUGSMIL CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)C D01XMY HIGHSTAT Investigative D01XOR DRUG__ID D01XOR D01XOR DRUGTYPE Small molecular drug D01XOR DRUGINCH 1S/C6H12N2OS/c7-6-1-2-10-4-5(3-9)8-6/h5,9H,1-4H2,(H2,7,8) D01XOR DRUGINKE LARUWSZSMYBJIP-UHFFFAOYSA-N D01XOR DRUGSMIL C1CSCC(N=C1N)CO D01XOR HIGHSTAT Investigative D01XRG DRUG__ID D01XRG D01XRG DRUGTYPE Small molecular drug D01XRG DRUGINCH 1S/C30H49N3O/c1-20-14-23(27-10-6-12-32(4)29(27)16-20)18-25-8-5-9-26(31-25)19-24-15-21(2)17-30-28(24)11-7-13-33(30)22(3)34/h20-21,25-26,29-31H,5-19H2,1-4H3/t20-,21+,25-,26-,29+,30+/m1/s1 D01XRG DRUGINKE GNBIIUGCLQZEQB-QERBKSRWSA-N D01XRG DRUGSMIL CC1CC2C(=C(C1)CC3CCCC(N3)CC4=C5CCCN(C5CC(C4)C)C(=O)C)CCCN2C D01XRG HIGHSTAT Investigative D01XSX DRUG__ID D01XSX D01XSX DRUGTYPE Small molecular drug D01XSX DRUGINCH 1S/C20H34N2O2/c1-2-3-4-5-6-7-10-17-12-14-18(15-13-17)22-20(24)19(21)11-8-9-16-23/h12-15,19,23H,2-11,16,21H2,1H3,(H,22,24)/t19-/m0/s1 D01XSX DRUGINKE UKLIXHBQCDTKPU-IBGZPJMESA-N D01XSX DRUGSMIL CCCCCCCCC1=CC=C(C=C1)NC(=O)C(CCCCO)N D01XSX HIGHSTAT Investigative D01XUU DRUG__ID D01XUU D01XUU DRUGTYPE Small molecular drug D01XUU DRUGINCH 1S/C22H26N4O5S3/c27-20(25-13-18(21(28)29)26-34(30,31)17-2-1-7-24-12-17)19-11-15-10-16(32-22(15)33-19)4-3-14-5-8-23-9-6-14/h1-2,7,10-12,14,18,23,26H,3-6,8-9,13H2,(H,25,27)(H,28,29)/t18-/m0/s1 D01XUU DRUGINKE QDIFCBMBPLLNGR-SFHVURJKSA-N D01XUU DRUGSMIL C1CNCCC1CCC2=CC3=C(S2)SC(=C3)C(=O)NCC(C(=O)O)NS(=O)(=O)C4=CN=CC=C4 D01XUU HIGHSTAT Investigative D01XWL DRUG__ID D01XWL D01XWL DRUGTYPE Small molecular drug D01XWL DRUGINCH 1S/C11H9NO3/c1-6-2-3-7-8(4-6)12-11(15)10(14)5-9(7)13/h2-5,13H,1H3,(H,12,14,15) D01XWL DRUGINKE HJKATLKAMYKFOH-UHFFFAOYSA-N D01XWL DRUGSMIL CC1=CC2=C(C=C1)C(=CC(=O)C(=O)N2)O D01XWL HIGHSTAT Investigative D01XWZ DRUG__ID D01XWZ D01XWZ DRUGTYPE Small molecular drug D01XWZ DRUGINCH 1S/C19H23NOS/c21-19(10-6-1-2-7-15-22)20-18-13-11-17(12-14-18)16-8-4-3-5-9-16/h3-5,8-9,11-14,22H,1-2,6-7,10,15H2,(H,20,21) D01XWZ DRUGINKE QTXIBRBGYJCFEU-UHFFFAOYSA-N D01XWZ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)CCCCCCS D01XWZ HIGHSTAT Investigative D01XXN DRUG__ID D01XXN D01XXN DRUGTYPE Small molecular drug D01XXN DRUGINCH 1S/C15H14N2O3/c18-14(10-11-4-2-1-3-5-11)16-13-8-6-12(7-9-13)15(19)17-20/h1-9,20H,10H2,(H,16,18)(H,17,19) D01XXN DRUGINKE VQGKLYBEQDAOSV-UHFFFAOYSA-N D01XXN DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=CC=C(C=C2)C(=O)NO D01XXN HIGHSTAT Investigative D01XXZ DRUG__ID D01XXZ D01XXZ DRUGTYPE Small molecular drug D01XXZ DRUGINCH 1S/C17H14O2/c1-2-12-8-9-16-14(10-12)15(18)11-17(19-16)13-6-4-3-5-7-13/h3-11H,2H2,1H3 D01XXZ DRUGINKE ILUYTTQELSQWNA-UHFFFAOYSA-N D01XXZ DRUGSMIL CCC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3 D01XXZ HIGHSTAT Investigative D01XYD DRUG__ID D01XYD D01XYD DRUGTYPE Small molecular drug D01XYD DRUGINCH 1S/C18H13N3O.CH4O3S/c22-18-16(10-14-4-2-8-20-14)15-9-12(5-6-17(15)21-18)13-3-1-7-19-11-13;1-5(2,3)4/h1-11,20H,(H,21,22);1H3,(H,2,3,4)/b16-10-; D01XYD DRUGINKE ZUDPNBZMAJGYTE-HYMQDMCPSA-N D01XYD DRUGSMIL CS(=O)(=O)O.C1=CC(=CN=C1)C2=CC3=C(C=C2)NC(=O)C3=CC4=CC=CN4 D01XYD HIGHSTAT Investigative D01XZI DRUG__ID D01XZI D01XZI DRUGTYPE Small molecular drug D01XZI DRUGINCH 1S/C18H21N/c1-19(2)16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,12-13H2,1-2H3/t16-,18-/m0/s1 D01XZI DRUGINKE DXJUCAUQIHNOAF-WMZOPIPTSA-N D01XZI DRUGSMIL CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3 D01XZI HIGHSTAT Investigative D01YBD DRUG__ID D01YBD D01YBD DRUGTYPE Small molecular drug D01YBD DRUGINCH 1S/C15H18N4/c1-18-9-11-19(12-10-18)15-16-8-7-14(17-15)13-5-3-2-4-6-13/h2-8H,9-12H2,1H3 D01YBD DRUGINKE QHOBPFOGFURKFZ-UHFFFAOYSA-N D01YBD DRUGSMIL CN1CCN(CC1)C2=NC=CC(=N2)C3=CC=CC=C3 D01YBD HIGHSTAT Investigative D01YBR DRUG__ID D01YBR D01YBR DRUGTYPE Small molecular drug D01YBR DRUGINCH 1S/C16H21N3O4/c20-16(18-21)6-5-14-1-3-15(4-2-14)13-17-23-12-9-19-7-10-22-11-8-19/h1-6,13,21H,7-12H2,(H,18,20)/b6-5+,17-13+ D01YBR DRUGINKE KKMCPDKFGBXVNL-WDGODYKHSA-N D01YBR DRUGSMIL C1COCCN1CCON=CC2=CC=C(C=C2)C=CC(=O)NO D01YBR HIGHSTAT Investigative D01YDO DRUG__ID D01YDO D01YDO DRUGTYPE Small molecular drug D01YDO DRUGINCH 1S/C15H25NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h5-6,8-9,12,14,16-17H,4,7,10-11H2,1-3H3 D01YDO DRUGINKE JVHCMYZFGCOCTD-UHFFFAOYSA-N D01YDO DRUGSMIL CCCC1=CC=CC=C1OCC(CNC(C)C)O D01YDO HIGHSTAT Investigative D01YDR DRUG__ID D01YDR D01YDR DRUGTYPE Small molecular drug D01YDR DRUGINCH 1S/C13H15IN2O2/c1-18-10-2-3-12-11(6-10)9(8-16-12)4-5-15-13(17)7-14/h2-3,6,8,16H,4-5,7H2,1H3,(H,15,17)/i14-2 D01YDR DRUGINKE BCFPPJOYYKSYLA-XSBOKVBDSA-N D01YDR DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCNC(=O)CI D01YDR HIGHSTAT Investigative D01YED DRUG__ID D01YED D01YED DRUGTYPE Small molecular drug D01YED DRUGINCH 1S/C15H21NO2/c1-12(16-9-4-3-5-10-16)15(17)13-7-6-8-14(11-13)18-2/h6-8,11-12H,3-5,9-10H2,1-2H3 D01YED DRUGINKE VIWKHXNVEIOPSC-UHFFFAOYSA-N D01YED DRUGSMIL CC(C(=O)C1=CC(=CC=C1)OC)N2CCCCC2 D01YED HIGHSTAT Investigative D01YEN DRUG__ID D01YEN D01YEN DRUGTYPE Small molecular drug D01YEN DRUGINCH 1S/C5H6N2O4/c6-4(5(9)10)2-1-3(8)7-11-2/h1,4H,6H2,(H,7,8)(H,9,10) D01YEN DRUGINKE IRJCBFDCFXCWGO-UHFFFAOYSA-N D01YEN DRUGSMIL C1=C(ONC1=O)C(C(=O)O)N D01YEN HIGHSTAT Investigative D01YHK DRUG__ID D01YHK D01YHK DRUGTYPE Small molecular drug D01YHK DRUGINCH 1S/C6H8FN3O2S/c7-5-3-4(13(9,11)12)1-2-6(5)10-8/h1-3,10H,8H2,(H2,9,11,12) D01YHK DRUGINKE IDSRHQBHQWPDNY-UHFFFAOYSA-N D01YHK DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)F)NN D01YHK HIGHSTAT Investigative D01YIR DRUG__ID D01YIR D01YIR DRUGTYPE Small molecular drug D01YIR DRUGINCH 1S/C15H13N3O2/c1-20-10-5-2-4-9(8-10)15-17-12-7-3-6-11(14(16)19)13(12)18-15/h2-8H,1H3,(H2,16,19)(H,17,18) D01YIR DRUGINKE NVVWVYYHTKCIAE-UHFFFAOYSA-N D01YIR DRUGSMIL COC1=CC=CC(=C1)C2=NC3=C(C=CC=C3N2)C(=O)N D01YIR HIGHSTAT Investigative D01YJJ DRUG__ID D01YJJ D01YJJ DRUGTYPE Small molecular drug D01YJJ DRUGINCH 1S/C20H24N2O4/c21-18(20(24)25)12-13-19(23)22-16-8-10-17(11-9-16)26-14-4-7-15-5-2-1-3-6-15/h1-3,5-6,8-11,18H,4,7,12-14,21H2,(H,22,23)(H,24,25)/t18-/m0/s1 D01YJJ DRUGINKE NFTAKLODMXBWJT-SFHVURJKSA-N D01YJJ DRUGSMIL C1=CC=C(C=C1)CCCOC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D01YJJ HIGHSTAT Investigative D01YNC DRUG__ID D01YNC D01YNC DRUGTYPE Small molecular drug D01YNC DRUGINCH 1S/C13H23N3O3/c1-6-9(2)10(11(17)15-8-7-14)16-12(18)19-13(3,4)5/h9-10H,6,8H2,1-5H3,(H,15,17)(H,16,18)/t9-,10+/m1/s1 D01YNC DRUGINKE HNTBSHVGXMFKKB-ZJUUUORDSA-N D01YNC DRUGSMIL CCC(C)C(C(=O)NCC#N)NC(=O)OC(C)(C)C D01YNC HIGHSTAT Investigative D01YNL DRUG__ID D01YNL D01YNL DRUGTYPE Small molecular drug D01YNL DRUGINCH 1S/C23H29N3/c1-2-6-21(7-3-1)22-11-9-20(10-12-22)13-15-25-16-18-26(19-17-25)23-8-4-5-14-24-23/h1-8,11,14,20H,9-10,12-13,15-19H2/t20-/m1/s1 D01YNL DRUGINKE MQHGACGPMGUHSJ-HXUWFJFHSA-N D01YNL DRUGSMIL C1CC(=CCC1CCN2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=C4 D01YNL HIGHSTAT Investigative D01YNT DRUG__ID D01YNT D01YNT DRUGTYPE Small molecular drug D01YNT DRUGINCH 1S/C10H18N2/c1-2-3-6-9-7-4-5-8-10(11)12-9/h2-3,9H,4-8H2,1H3,(H2,11,12)/b3-2+ D01YNT DRUGINKE JYALIDLLQJSBKD-NSCUHMNNSA-N D01YNT DRUGSMIL CC=CCC1CCCCC(=N1)N D01YNT HIGHSTAT Investigative D01YNZ DRUG__ID D01YNZ D01YNZ DRUGTYPE Small molecular drug D01YNZ DRUGINCH 1S/C18H21NO/c1-2-6-15(7-3-1)14-20-18-9-5-4-8-17(18)16-10-12-19-13-11-16/h1-9,16,19H,10-14H2 D01YNZ DRUGINKE XJJHPGZYVOFINN-UHFFFAOYSA-N D01YNZ DRUGSMIL C1CNCCC1C2=CC=CC=C2OCC3=CC=CC=C3 D01YNZ HIGHSTAT Investigative D01YPD DRUG__ID D01YPD D01YPD DRUGTYPE Small molecular drug D01YPD DRUGINCH 1S/C18H12N2O/c1-11-6-8-12(9-7-11)16-10-15-17(20-19-16)13-4-2-3-5-14(13)18(15)21/h2-10H,1H3 D01YPD DRUGINKE ITHVHASAWMAMQC-UHFFFAOYSA-N D01YPD DRUGSMIL CC1=CC=C(C=C1)C2=NN=C3C4=CC=CC=C4C(=O)C3=C2 D01YPD HIGHSTAT Investigative D01YQX DRUG__ID D01YQX D01YQX DRUGTYPE Small molecular drug D01YQX DRUGINCH 1S/C18H28O3/c1-2-3-4-5-6-7-8-9-10-11-14-17(19)15-12-13-16-18(20)21/h17,19H,2-8,12-13,15-16H2,1H3,(H,20,21) D01YQX DRUGINKE APWVQFPFWVNZPF-UHFFFAOYSA-N D01YQX DRUGSMIL CCCCCCCCC#CC#CC(CCCCC(=O)O)O D01YQX HIGHSTAT Investigative D01YRT DRUG__ID D01YRT D01YRT DRUGTYPE Small molecular drug D01YRT DRUGINCH 1S/C14H19N9O3/c1-22-5-9(18-7-24)19-12(22)14(26)21-10-6-23(2)11(20-10)13(25)17-4-3-8(15)16/h5-7H,3-4H2,1-2H3,(H3,15,16)(H,17,25)(H,18,24)(H,21,26) D01YRT DRUGINKE WISSDOJERIUENW-UHFFFAOYSA-N D01YRT DRUGSMIL CN1C=C(N=C1C(=O)NC2=CN(C(=N2)C(=O)NCCC(=N)N)C)NC=O D01YRT HIGHSTAT Investigative D01YSN DRUG__ID D01YSN D01YSN DRUGTYPE Small molecular drug D01YSN DRUGINCH 1S/C20H18ClN3O2S/c1-9-11(3)27-20-16(9)18(12-4-6-13(21)7-5-12)23-14(8-15(22)25)19-17(20)10(2)24-26-19/h4-7,14H,8H2,1-3H3,(H2,22,25)/t14-/m0/s1 D01YSN DRUGINKE DRSQZZRFHBWKKZ-AWEZNQCLSA-N D01YSN DRUGSMIL CC1=C(SC2=C1C(=NC(C3=C2C(=NO3)C)CC(=O)N)C4=CC=C(C=C4)Cl)C D01YSN HIGHSTAT Investigative D01YTS DRUG__ID D01YTS D01YTS DRUGTYPE Small molecular drug D01YTS DRUGINCH 1S/C28H29N3O5/c32-22-13-11-19(12-14-22)15-16-29-27(34)24-25(36-24)28(35)31-23(17-20-7-3-1-4-8-20)26(33)30-18-21-9-5-2-6-10-21/h1-14,23-25,32H,15-18H2,(H,29,34)(H,30,33)(H,31,35)/t23-,24-,25-/m0/s1 D01YTS DRUGINKE ZMZQYVMNDRBKLO-SDHOMARFSA-N D01YTS DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC2=CC=CC=C2)NC(=O)C3C(O3)C(=O)NCCC4=CC=C(C=C4)O D01YTS HIGHSTAT Investigative D01YWD DRUG__ID D01YWD D01YWD DRUGTYPE Small molecular drug D01YWD DRUGINCH 1S/C20H24FNO3/c1-3-5-14-24-17-10-6-15(7-11-17)19(4-2)22-20(23)25-18-12-8-16(21)9-13-18/h6-13,19H,3-5,14H2,1-2H3,(H,22,23) D01YWD DRUGINKE IEKBPHHXDXKATO-UHFFFAOYSA-N D01YWD DRUGSMIL CCCCOC1=CC=C(C=C1)C(CC)NC(=O)OC2=CC=C(C=C2)F D01YWD HIGHSTAT Investigative D01YWE DRUG__ID D01YWE D01YWE DRUGTYPE Small molecular drug D01YWE DRUGINCH 1S/C17H14N4O4/c18-17(25)12(9-2-1-3-11(22)8-9)21-14-13(15(23)16(14)24)20-10-4-6-19-7-5-10/h1-8,12,21-22H,(H2,18,25)(H,19,20) D01YWE DRUGINKE GPXKVULNYYNGDP-UHFFFAOYSA-N D01YWE DRUGSMIL C1=CC(=CC(=C1)O)C(C(=O)N)NC2=C(C(=O)C2=O)NC3=CC=NC=C3 D01YWE HIGHSTAT Investigative D01ZAL DRUG__ID D01ZAL D01ZAL DRUGTYPE Small molecular drug D01ZAL DRUGINCH 1S/C27H28FNO3/c1-17(2)27-23(13-12-22-14-21(30)15-26(31)32-22)24(18-8-10-20(28)11-9-18)16-25(29-27)19-6-4-3-5-7-19/h3-11,16-17,21-22,30H,12-15H2,1-2H3/t21-,22?/m1/s1 D01ZAL DRUGINKE QVBVQHTXLPNXEY-ZMFCMNQTSA-N D01ZAL DRUGSMIL CC(C)C1=C(C(=CC(=N1)C2=CC=CC=C2)C3=CC=C(C=C3)F)CCC4CC(CC(=O)O4)O D01ZAL HIGHSTAT Investigative D01ZCG DRUG__ID D01ZCG D01ZCG DRUGTYPE Small molecular drug D01ZCG DRUGINCH 1S/C16H12O2S/c17-13-6-4-11(5-7-13)15-8-9-16(19-15)12-2-1-3-14(18)10-12/h1-10,17-18H D01ZCG DRUGINKE PKHBRBMFZXTMIS-UHFFFAOYSA-N D01ZCG DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC=C(C=C3)O D01ZCG HIGHSTAT Investigative D01ZCI DRUG__ID D01ZCI D01ZCI DRUGTYPE Small molecular drug D01ZCI DRUGINCH 1S/C41H81O19P3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(42)55-31-33(57-35(43)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)32-56-63(53,54)60-41-37(45)39(58-61(47,48)49)36(44)40(38(41)46)59-62(50,51)52/h33,36-41,44-46H,3-32H2,1-2H3,(H,53,54)(H2,47,48,49)(H2,50,51,52)/t33-,36?,37-,38-,39-,40+,41?/m1/s1 D01ZCI DRUGINKE UZMPYXSDDZXMAI-OHKKONBVSA-N D01ZCI DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)O)OP(=O)(O)O)O)OC(=O)CCCCCCCCCCCCCCC D01ZCI HIGHSTAT Investigative D01ZHK DRUG__ID D01ZHK D01ZHK DRUGTYPE Small molecular drug D01ZHK DRUGINCH 1S/C22H25NO4/c1-12(2)23-8-7-14-15-6-5-13-9-18(24)19(26-3)10-16(13)20(15)22(27-4)21(25)17(14)11-23/h5-6,9-10,12,24-25H,7-8,11H2,1-4H3 D01ZHK DRUGINKE AWJWBWOWUNPLTO-UHFFFAOYSA-N D01ZHK DRUGSMIL CC(C)N1CCC2=C3C=CC4=CC(=C(C=C4C3=C(C(=C2C1)O)OC)OC)O D01ZHK HIGHSTAT Investigative D01ZHW DRUG__ID D01ZHW D01ZHW DRUGTYPE Small molecular drug D01ZHW DRUGINCH 1S/C22H35NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21(24)23-20-22(25)26/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-20H2,1H3,(H,23,24)(H,25,26)/b7-6-,10-9-,13-12-,16-15- D01ZHW DRUGINKE YLEARPUNMCCKMP-DOFZRALJSA-N D01ZHW DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCC(=O)O D01ZHW HIGHSTAT Investigative D01ZIP DRUG__ID D01ZIP D01ZIP DRUGTYPE Small molecular drug D01ZIP DRUGINCH 1S/C14H15N3O2/c1-2-9-5-3-4-6-10(9)11-7-8-12(19-11)13(18)17-14(15)16/h3-8H,2H2,1H3,(H4,15,16,17,18) D01ZIP DRUGINKE CCKFOHBQWASBLB-UHFFFAOYSA-N D01ZIP DRUGSMIL CCC1=CC=CC=C1C2=CC=C(O2)C(=O)N=C(N)N D01ZIP HIGHSTAT Investigative D01ZJF DRUG__ID D01ZJF D01ZJF DRUGTYPE Small molecular drug D01ZJF DRUGINCH 1S/C20H21N3O4/c24-18(25)7-9-22-19(26)14-2-1-3-15(10-14)20(27)23-17-5-4-13-6-8-21-12-16(13)11-17/h1-5,10-11,21H,6-9,12H2,(H,22,26)(H,23,27)(H,24,25) D01ZJF DRUGINKE MPYXISYAFIYYRD-UHFFFAOYSA-N D01ZJF DRUGSMIL C1CNCC2=C1C=CC(=C2)NC(=O)C3=CC=CC(=C3)C(=O)NCCC(=O)O D01ZJF HIGHSTAT Investigative D01ZKN DRUG__ID D01ZKN D01ZKN DRUGTYPE Small molecular drug D01ZKN DRUGINCH 1S/C19H20N4O/c1-22(2)11-5-10-20-14-8-9-15-18-17(14)19(24)13-6-3-4-7-16(13)23(18)12-21-15/h3-4,6-9,12,20H,5,10-11H2,1-2H3 D01ZKN DRUGINKE KWLWSGBEPRFXEU-UHFFFAOYSA-N D01ZKN DRUGSMIL CN(C)CCCNC1=C2C3=C(C=C1)N=CN3C4=CC=CC=C4C2=O D01ZKN HIGHSTAT Investigative D01ZMJ DRUG__ID D01ZMJ D01ZMJ DRUGTYPE Small molecular drug D01ZMJ DRUGINCH 1S/C16H24N2O3/c1-2-13-9-7-8-10-14(13)17-15(19)11-5-3-4-6-12-16(20)18-21/h7-10,21H,2-6,11-12H2,1H3,(H,17,19)(H,18,20) D01ZMJ DRUGINKE COKQAZFZACGKGP-UHFFFAOYSA-N D01ZMJ DRUGSMIL CCC1=CC=CC=C1NC(=O)CCCCCCC(=O)NO D01ZMJ HIGHSTAT Investigative D01ZMO DRUG__ID D01ZMO D01ZMO DRUGTYPE Small molecular drug D01ZMO DRUGINCH 1S/C16H15N/c17-15-9-5-12(6-10-15)11-14-8-7-13-3-1-2-4-16(13)14/h1-6,8-10H,7,11,17H2 D01ZMO DRUGINKE IJBWRSORBVHQFX-UHFFFAOYSA-N D01ZMO DRUGSMIL C1C=C(C2=CC=CC=C21)CC3=CC=C(C=C3)N D01ZMO HIGHSTAT Investigative D01ZMP DRUG__ID D01ZMP D01ZMP DRUGTYPE Small molecular drug D01ZMP DRUGINCH 1S/C13H13NO3S/c15-10-8-11(12-2-1-7-18-12)17-13(9-10)14-3-5-16-6-4-14/h1-2,7-9H,3-6H2 D01ZMP DRUGINKE MEBJAUWWCSKYMY-UHFFFAOYSA-N D01ZMP DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CS3 D01ZMP HIGHSTAT Investigative D01ZRX DRUG__ID D01ZRX D01ZRX DRUGTYPE Small molecular drug D01ZRX DRUGINCH 1S/C13H9ClN2O2/c14-13-11-7-10(18)5-6-12(11)15-16(13)8-1-3-9(17)4-2-8/h1-7,17-18H D01ZRX DRUGINKE ZNHQDSBJVFFIAK-UHFFFAOYSA-N D01ZRX DRUGSMIL C1=CC(=CC=C1N2C(=C3C=C(C=CC3=N2)O)Cl)O D01ZRX HIGHSTAT Investigative D01ZUN DRUG__ID D01ZUN D01ZUN DRUGTYPE Small molecular drug D01ZUN DRUGINCH 1S/C13H21NO/c1-3-5-7-9-13(10-8-6-4-2)11-14-12(13)15/h3-4H,1-2,5-11H2,(H,14,15) D01ZUN DRUGINKE RZYCKKZEBQDDLK-UHFFFAOYSA-N D01ZUN DRUGSMIL C=CCCCC1(CNC1=O)CCCC=C D01ZUN HIGHSTAT Investigative D01ZZJ DRUG__ID D01ZZJ D01ZZJ DRUGTYPE Small molecular drug D01ZZJ DRUGINCH 1S/C9H14N3O8P/c10-9-11-5(13)1-2-12(9)8-7(15)6(14)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,14-15H,3H2,(H2,10,11,13)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D01ZZJ DRUGINKE ONSQLDCEJIIUJS-XVFCMESISA-N D01ZZJ DRUGSMIL C1=CN(C(=NC1=O)N)C2C(C(C(O2)COP(=O)(O)O)O)O D01ZZJ HIGHSTAT Investigative D02AAH DRUG__ID D02AAH D02AAH DRUGTYPE Small molecular drug D02AAH DRUGINCH 1S/C10H7ClN2O3S/c11-7-1-3-8(4-2-7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D02AAH DRUGINKE MLRLSUWJTAHEKD-UHFFFAOYSA-N D02AAH DRUGSMIL C1=CC(=CC=C1S(=O)(=O)C2=NNC(=O)C=C2)Cl D02AAH HIGHSTAT Investigative D02ACL DRUG__ID D02ACL D02ACL DRUGTYPE Small molecular drug D02ACL DRUGINCH 1S/C13H14ClN7O/c14-9-11(16)20-10(15)8(19-9)12(22)21-13(17)18-6-7-4-2-1-3-5-7/h1-5H,6H2,(H4,15,16,20)(H3,17,18,21,22) D02ACL DRUGINKE KXDROGADUISDGY-UHFFFAOYSA-N D02ACL DRUGSMIL C1=CC=C(C=C1)CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N D02ACL HIGHSTAT Investigative D02ADV DRUG__ID D02ADV D02ADV DRUGTYPE Small molecular drug D02ADV DRUGINCH 1S/C9H9N3/c1-7-2-4-8(5-3-7)9-6-10-12-11-9/h2-6H,1H3,(H,10,11,12) D02ADV DRUGINKE ZPCIKQLLQORQCV-UHFFFAOYSA-N D02ADV DRUGSMIL CC1=CC=C(C=C1)C2=NNN=C2 D02ADV HIGHSTAT Investigative D02AFI DRUG__ID D02AFI D02AFI DRUGTYPE Small molecular drug D02AFI DRUGINCH 1S/C10H15N3O6/c11-5-1-2-13(10(18)12-5)9-8(17)7(16)6(15)4(3-14)19-9/h1-2,4,6-9,14-17H,3H2,(H2,11,12,18)/t4-,6-,7+,8-,9-/m1/s1 D02AFI DRUGINKE YYUQXKHCNLFJNF-DDIGBBAMSA-N D02AFI DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(C(O2)CO)O)O)O D02AFI HIGHSTAT Investigative D02AFZ DRUG__ID D02AFZ D02AFZ DRUGTYPE Small molecular drug D02AFZ DRUGINCH 1S/C14H14N2/c1-2-8-16-9-7-12-11-5-3-4-6-13(11)15-14(12)10-16/h3-7,9-10H,2,8H2,1H3/p+1 D02AFZ DRUGINKE SFUAYJFEBSOZSQ-UHFFFAOYSA-O D02AFZ DRUGSMIL CCC[N+]1=CC2=C(C=C1)C3=CC=CC=C3N2 D02AFZ HIGHSTAT Investigative D02AIH DRUG__ID D02AIH D02AIH DRUGTYPE Small molecular drug D02AIH DRUGINCH 1S/C13H14N2O2/c1-2-3-7-11(16)13-15-9-12(17-13)10-6-4-5-8-14-10/h4-6,8-9H,2-3,7H2,1H3 D02AIH DRUGINKE ZGJFSRIJAXSNIH-UHFFFAOYSA-N D02AIH DRUGSMIL CCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2 D02AIH HIGHSTAT Investigative D02AKP DRUG__ID D02AKP D02AKP DRUGTYPE Small molecular drug D02AKP DRUGINCH 1S/C16H16N2O3/c1-21-14-9-7-13(8-10-14)16(20)18-17-15(19)11-12-5-3-2-4-6-12/h2-10H,11H2,1H3,(H,17,19)(H,18,20) D02AKP DRUGINKE BJVRKPCYZSFHDT-UHFFFAOYSA-N D02AKP DRUGSMIL COC1=CC=C(C=C1)C(=O)NNC(=O)CC2=CC=CC=C2 D02AKP HIGHSTAT Investigative D02ALI DRUG__ID D02ALI D02ALI DRUGTYPE Small molecular drug D02ALI DRUGINCH 1S/C30H39N5O7S2/c1-29(2)23(34-25(38)20(31)14-18-10-12-19(36)13-11-18)27(40)32-16-22(37)33-21(15-17-8-6-5-7-9-17)26(39)35-24(28(41)42)30(3,4)44-43-29/h5-13,20-21,23-24,36H,14-16,31H2,1-4H3,(H,32,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t20-,21?,23-,24?/m1/s1 D02ALI DRUGINKE MCMMCRYPQBNCPH-ZNNNFZKMSA-N D02ALI DRUGSMIL CC1(C(C(=O)NCC(=O)NC(C(=O)NC(C(SS1)(C)C)C(=O)O)CC2=CC=CC=C2)NC(=O)C(CC3=CC=C(C=C3)O)N)C D02ALI HIGHSTAT Investigative D02ALK DRUG__ID D02ALK D02ALK DRUGTYPE Small molecular drug D02ALK DRUGINCH 1S/C15H11NO/c17-15-6-5-11-8-12(3-4-13(11)9-15)14-2-1-7-16-10-14/h1-10,17H D02ALK DRUGINKE MDXMZUQFVFTPDO-UHFFFAOYSA-N D02ALK DRUGSMIL C1=CC(=CN=C1)C2=CC3=C(C=C2)C=C(C=C3)O D02ALK HIGHSTAT Investigative D02ALQ DRUG__ID D02ALQ D02ALQ DRUGTYPE Small molecular drug D02ALQ DRUGINCH 1S/C18H24O4/c1-17(2,3)12-9-11(7-8-14(19)16(21)22)10-13(15(12)20)18(4,5)6/h7-10,20H,1-6H3,(H,21,22)/b8-7+ D02ALQ DRUGINKE XIQDGAUDNMVMCD-BQYQJAHWSA-N D02ALQ DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=CC(=O)C(=O)O D02ALQ HIGHSTAT Investigative D02ANE DRUG__ID D02ANE D02ANE DRUGTYPE Small molecular drug D02ANE DRUGINCH 1S/C15H15N/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15/h1-7,14,16H,8-10H2 D02ANE DRUGINKE HKHCSWPSUSWGLI-UHFFFAOYSA-N D02ANE DRUGSMIL C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3 D02ANE HIGHSTAT Investigative D02ANG DRUG__ID D02ANG D02ANG DRUGTYPE Small molecular drug D02ANG DRUGINCH 1S/C5H8N2O2S/c6-5-7-3(2-10-5)1-4(8)9/h3H,1-2H2,(H2,6,7)(H,8,9) D02ANG DRUGINKE ANCWBXJZUCHVHL-UHFFFAOYSA-N D02ANG DRUGSMIL C1C(N=C(S1)N)CC(=O)O D02ANG HIGHSTAT Investigative D02ANL DRUG__ID D02ANL D02ANL DRUGTYPE Small molecular drug D02ANL DRUGINCH 1S/C11H14FNO2S/c12-9-3-1-2-8(6-9)7-16-5-4-10(13)11(14)15/h1-3,6,10H,4-5,7,13H2,(H,14,15) D02ANL DRUGINKE BWUFBZIPJLPDQV-UHFFFAOYSA-N D02ANL DRUGSMIL C1=CC(=CC(=C1)F)CSCCC(C(=O)O)N D02ANL HIGHSTAT Investigative D02ANZ DRUG__ID D02ANZ D02ANZ DRUGTYPE Small molecular drug D02ANZ DRUGINCH 1S/C34H49NO4/c1-3-4-5-15-20-30(32(37)25-28-18-13-12-14-19-28)21-16-10-8-6-7-9-11-17-22-34(38)35-27-29-23-24-31(36)33(26-29)39-2/h10,12-14,16,18-19,23-24,26,30,36H,3-9,11,15,17,20-22,25,27H2,1-2H3,(H,35,38)/b16-10-/t30-/m1/s1 D02ANZ DRUGINKE STBVSPCCKFGBHG-DJVRBGHSSA-N D02ANZ DRUGSMIL CCCCCCC(CC=CCCCCCCCC(=O)NCC1=CC(=C(C=C1)O)OC)C(=O)CC2=CC=CC=C2 D02ANZ HIGHSTAT Investigative D02AOT DRUG__ID D02AOT D02AOT DRUGTYPE Small molecular drug D02AOT DRUGINCH 1S/C32H35N3O3/c1-19(2)38-18-20-12-13-26-23(15-20)29-25-17-33-32(37)30(25)28-22-10-6-5-9-21(22)16-24(28)31(29)35(26)14-8-7-11-27(36)34(3)4/h5-6,9-10,12-13,15,19H,7-8,11,14,16-18H2,1-4H3,(H,33,37) D02AOT DRUGINKE FBRQJIGPZJLFIQ-UHFFFAOYSA-N D02AOT DRUGSMIL CC(C)OCC1=CC2=C(C=C1)N(C3=C2C4=C(C5=C3CC6=CC=CC=C65)C(=O)NC4)CCCCC(=O)N(C)C D02AOT HIGHSTAT Investigative D02APY DRUG__ID D02APY D02APY DRUGTYPE Small molecular drug D02APY DRUGINCH 1S/C15H22ClN3O3S/c1-9(2)23-7-6-12(17)13(20)15(22)19-18-14(21)10-4-3-5-11(16)8-10/h3-5,8-9,12-13,20H,6-7,17H2,1-2H3,(H,18,21)(H,19,22)/t12-,13+/m1/s1 D02APY DRUGINKE BYBVYIPUGPZRSX-OLZOCXBDSA-N D02APY DRUGSMIL CC(C)SCCC(C(C(=O)NNC(=O)C1=CC(=CC=C1)Cl)O)N D02APY HIGHSTAT Investigative D02AQG DRUG__ID D02AQG D02AQG DRUGTYPE Small molecular drug D02AQG DRUGINCH 1S/C24H29NO/c1-3-4-14-26-24-13-12-22-16-21(10-11-23(22)17-24)15-19(2)25-18-20-8-6-5-7-9-20/h5-13,16-17,19,25H,3-4,14-15,18H2,1-2H3 D02AQG DRUGINKE YIPJGAAYIMEAQI-UHFFFAOYSA-N D02AQG DRUGSMIL CCCCOC1=CC2=C(C=C1)C=C(C=C2)CC(C)NCC3=CC=CC=C3 D02AQG HIGHSTAT Investigative D02ARA DRUG__ID D02ARA D02ARA DRUGTYPE Small molecular drug D02ARA DRUGINCH 1S/C23H18N4/c1-2-6-17(7-3-1)15-27-13-12-18-14-19(10-11-22(18)27)26-23-20-8-4-5-9-21(20)24-16-25-23/h1-14,16H,15H2,(H,24,25,26) D02ARA DRUGINKE HSEFNFDMTWKPLM-UHFFFAOYSA-N D02ARA DRUGSMIL C1=CC=C(C=C1)CN2C=CC3=C2C=CC(=C3)NC4=NC=NC5=CC=CC=C54 D02ARA HIGHSTAT Investigative D02ATA DRUG__ID D02ATA D02ATA DRUGTYPE Small molecular drug D02ATA DRUGINCH 1S/C15H26N2O3/c1-2-3-9-12-16-15(20)17-13-10-7-5-4-6-8-11-14(18)19/h2-3,5,7-13H2,1H3,(H,18,19)(H2,16,17,20) D02ATA DRUGINKE RYPHFFFUDQDRHY-UHFFFAOYSA-N D02ATA DRUGSMIL CCCCCNC(=O)NCCCCC#CCCC(=O)O D02ATA HIGHSTAT Investigative D02AVL DRUG__ID D02AVL D02AVL DRUGTYPE Small molecular drug D02AVL DRUGINCH 1S/C23H19Cl3N6O3S/c1-27-23-28-5-6-32(23)10-12-11-36-20(18(12)26)22(34)31-19-15(7-14(25)8-16(19)35-2)21(33)30-17-4-3-13(24)9-29-17/h3-9,11H,10H2,1-2H3,(H,27,28)(H,31,34)(H,29,30,33) D02AVL DRUGINKE LLHSZBPXQIOQJJ-UHFFFAOYSA-N D02AVL DRUGSMIL CNC1=NC=CN1CC2=CSC(=C2Cl)C(=O)NC3=C(C=C(C=C3OC)Cl)C(=O)NC4=NC=C(C=C4)Cl D02AVL HIGHSTAT Investigative D02AVN DRUG__ID D02AVN D02AVN DRUGTYPE Small molecular drug D02AVN DRUGINCH 1S/C11H13ClN2O/c12-10-3-1-2-9(8-10)11(15)14-6-4-13-5-7-14/h1-3,8,13H,4-7H2 D02AVN DRUGINKE FBTDRVSCKFZIQH-UHFFFAOYSA-N D02AVN DRUGSMIL C1CN(CCN1)C(=O)C2=CC(=CC=C2)Cl D02AVN HIGHSTAT Investigative D02AVZ DRUG__ID D02AVZ D02AVZ DRUGTYPE Small molecular drug D02AVZ DRUGINCH 1S/C40H38N4O4.Fe/c1-7-26-21(3)30-18-32-23(5)28(14-16-36(45)46)39(43-32)38(25-12-10-9-11-13-25)40-29(15-17-37(47)48)24(6)33(44-40)20-35-27(8-2)22(4)31(42-35)19-34(26)41-30;/h7-13,18-20H,1-2,14-17H2,3-6H3,(H4,41,42,43,44,45,46,47,48);/q;+2/p-2 D02AVZ DRUGINKE FQZJPOQXUNESIK-UHFFFAOYSA-L D02AVZ DRUGSMIL CC1=C(C2=C(C3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C=C)C)C=C)C)C(=C3CCC(=O)O)C)C6=CC=CC=C6)CCC(=O)O.[Fe+2] D02AVZ HIGHSTAT Investigative D02AYD DRUG__ID D02AYD D02AYD DRUGTYPE Small molecular drug D02AYD DRUGINCH 1S/C20H29N5O2/c1-2-4-6-16(5-3-1)24-20-17-13-19(21-14-18(17)22-15-23-20)27-12-9-25-7-10-26-11-8-25/h13-16H,1-12H2,(H,22,23,24) D02AYD DRUGINKE OGIVDFLCEHDQBN-UHFFFAOYSA-N D02AYD DRUGSMIL C1CCCC(CC1)NC2=NC=NC3=CN=C(C=C32)OCCN4CCOCC4 D02AYD HIGHSTAT Investigative D02AYI DRUG__ID D02AYI D02AYI DRUGTYPE Small molecular drug D02AYI DRUGINCH 1S/C14H15NO2/c15-10-11-16-12-6-8-14(9-7-12)17-13-4-2-1-3-5-13/h1-9H,10-11,15H2 D02AYI DRUGINKE FBLANPWAVFBRNS-UHFFFAOYSA-N D02AYI DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)OCCN D02AYI HIGHSTAT Investigative D02AYX DRUG__ID D02AYX D02AYX DRUGTYPE Small molecular drug D02AYX DRUGINCH 1S/C11H6N2O3/c14-9-7-5-6-3-1-2-4-8(6)16-10(7)13-11(15)12-9/h1-5H,(H,12,14,15) D02AYX DRUGINKE BFMCRAXOACCPEL-UHFFFAOYSA-N D02AYX DRUGSMIL C1=CC=C2C(=C1)C=C3C(=O)NC(=O)N=C3O2 D02AYX HIGHSTAT Investigative D02BBA DRUG__ID D02BBA D02BBA DRUGTYPE Small molecular drug D02BBA DRUGINCH 1S/C32H37N5O3/c1-21-15-22(2)35-32(39)28(21)18-33-31(38)27-16-25(17-30-29(27)19-34-37(30)26-5-3-4-6-26)24-9-7-23(8-10-24)20-36-11-13-40-14-12-36/h7-10,15-17,19,26H,3-6,11-14,18,20H2,1-2H3,(H,33,38)(H,35,39) D02BBA DRUGINKE ZOIBZSZLMJDVDQ-UHFFFAOYSA-N D02BBA DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CC=C(C=C4)CN5CCOCC5)C6CCCC6)C D02BBA HIGHSTAT Investigative D02BBJ DRUG__ID D02BBJ D02BBJ DRUGTYPE Small molecular drug D02BBJ DRUGINCH 1S/C15H13NO2/c1-16-12-4-2-10(3-5-12)15-9-11-8-13(17)6-7-14(11)18-15/h2-9,16-17H,1H3 D02BBJ DRUGINKE ZNESXKIPTICLME-UHFFFAOYSA-N D02BBJ DRUGSMIL CNC1=CC=C(C=C1)C2=CC3=C(O2)C=CC(=C3)O D02BBJ HIGHSTAT Investigative D02BBN DRUG__ID D02BBN D02BBN DRUGTYPE Small molecular drug D02BBN DRUGINCH 1S/C12H13NO3/c13-7-9(6-12(14)15)11-5-8-3-1-2-4-10(8)16-11/h1-5,9H,6-7,13H2,(H,14,15) D02BBN DRUGINKE SRLRWPSSQWUHQC-UHFFFAOYSA-N D02BBN DRUGSMIL C1=CC=C2C(=C1)C=C(O2)C(CC(=O)O)CN D02BBN HIGHSTAT Investigative D02BBT DRUG__ID D02BBT D02BBT DRUGTYPE Small molecular drug D02BBT DRUGINCH 1S/C12H16BrN3O2/c13-11-10(2-1-3-14-11)12(17)15-4-5-16-6-8-18-9-7-16/h1-3H,4-9H2,(H,15,17) D02BBT DRUGINKE FKGFLJZEVNCAEZ-UHFFFAOYSA-N D02BBT DRUGSMIL C1COCCN1CCNC(=O)C2=C(N=CC=C2)Br D02BBT HIGHSTAT Investigative D02BCM DRUG__ID D02BCM D02BCM DRUGTYPE Small molecular drug D02BCM DRUGINCH 1S/C20H16N2O2/c23-20-16-9-4-5-10-17(16)21-19(18-11-6-14-24-18)22(20)13-12-15-7-2-1-3-8-15/h1-11,14H,12-13H2 D02BCM DRUGINKE ZFIMKOHGGKYLGR-UHFFFAOYSA-N D02BCM DRUGSMIL C1=CC=C(C=C1)CCN2C(=NC3=CC=CC=C3C2=O)C4=CC=CO4 D02BCM HIGHSTAT Investigative D02BEJ DRUG__ID D02BEJ D02BEJ DRUGTYPE Small molecular drug D02BEJ DRUGINCH 1S/C16H10F2OS/c17-13-5-4-11(9-14(13)18)16-7-6-15(20-16)10-2-1-3-12(19)8-10/h1-9,19H D02BEJ DRUGINKE PKUPEZBIFLWEBN-UHFFFAOYSA-N D02BEJ DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC(=C(C=C3)F)F D02BEJ HIGHSTAT Investigative D02BER DRUG__ID D02BER D02BER DRUGTYPE Small molecular drug D02BER DRUGINCH 1S/C25H37NO2/c1-24-14-15-26(3)23(16-19-9-11-21(28)17-22(19)24)25(24,2)13-12-20(27)10-8-18-6-4-5-7-18/h9,11,17-18,23,28H,4-8,10,12-16H2,1-3H3/t23-,24+,25?/m1/s1 D02BER DRUGINKE LOYWOYCPSWPKFH-CSIQULDISA-N D02BER DRUGSMIL CC12CCN(C(C1(C)CCC(=O)CCC3CCCC3)CC4=C2C=C(C=C4)O)C D02BER HIGHSTAT Investigative D02BFK DRUG__ID D02BFK D02BFK DRUGTYPE Small molecular drug D02BFK DRUGINCH 1S/C12H8ClNS/c1-9-14-12(8-15-9)6-5-10-3-2-4-11(13)7-10/h2-4,7-8H,1H3 D02BFK DRUGINKE ORFSHDWOPQJKQL-UHFFFAOYSA-N D02BFK DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)Cl D02BFK HIGHSTAT Investigative D02BGA DRUG__ID D02BGA D02BGA DRUGTYPE Small molecular drug D02BGA DRUGINCH 1S/C8H8N8/c1-15-7-5(6(9)10-4-11-7)14-8(15)16-12-2-3-13-16/h2-4H,1H3,(H2,9,10,11) D02BGA DRUGINKE ZTJZVOMEMRNYKF-UHFFFAOYSA-N D02BGA DRUGSMIL CN1C2=NC=NC(=C2N=C1N3N=CC=N3)N D02BGA HIGHSTAT Investigative D02BGR DRUG__ID D02BGR D02BGR DRUGTYPE Small molecular drug D02BGR DRUGINCH 1S/C21H24N2O2/c1-17(22-21(24)11-10-18-6-3-2-4-7-18)19-8-5-9-20(16-19)23-12-14-25-15-13-23/h2-11,16-17H,12-15H2,1H3,(H,22,24)/b11-10+/t17-/m0/s1 D02BGR DRUGINKE QMIMHUDEVKGOTQ-DVQDXYAYSA-N D02BGR DRUGSMIL CC(C1=CC(=CC=C1)N2CCOCC2)NC(=O)C=CC3=CC=CC=C3 D02BGR HIGHSTAT Investigative D02BIK DRUG__ID D02BIK D02BIK DRUGTYPE Small molecular drug D02BIK DRUGINCH 1S/C19H20N6O4S/c1-29-10-9-23-30(27,28)15-6-4-13(5-7-15)16-12-22-18(20)17(25-16)19(26)24-14-3-2-8-21-11-14/h2-8,11-12,23H,9-10H2,1H3,(H2,20,22)(H,24,26) D02BIK DRUGINKE OMGQIHJJEYTELG-UHFFFAOYSA-N D02BIK DRUGSMIL COCCNS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CN=CC=C3)N D02BIK HIGHSTAT Investigative D02BJB DRUG__ID D02BJB D02BJB DRUGTYPE Small molecular drug D02BJB DRUGINCH 1S/C28H39Cl2N3O4/c1-18(2)24(32-28(34)31-21-15-25(35-4)27(37-6)26(16-21)36-5)17-33(3)11-9-19(10-12-33)13-20-7-8-22(29)23(30)14-20/h7-8,14-16,18-19,24H,9-13,17H2,1-6H3,(H-,31,32,34)/p+1/t19?,24-,33?/m0/s1 D02BJB DRUGINKE INQAQQXKVUWERW-WXJUUJJFSA-O D02BJB DRUGSMIL CC(C)C(C[N+]1(CCC(CC1)CC2=CC(=C(C=C2)Cl)Cl)C)NC(=O)NC3=CC(=C(C(=C3)OC)OC)OC D02BJB HIGHSTAT Investigative D02BLC DRUG__ID D02BLC D02BLC DRUGTYPE Small molecular drug D02BLC DRUGINCH 1S/C6H13NO2S/c7-4-2-1-3-5(10)6(8)9/h5,10H,1-4,7H2,(H,8,9) D02BLC DRUGINKE JNQDJHCXDRGZJD-UHFFFAOYSA-N D02BLC DRUGSMIL C(CCN)CC(C(=O)O)S D02BLC HIGHSTAT Investigative D02BMV DRUG__ID D02BMV D02BMV DRUGTYPE Small molecular drug D02BMV DRUGINCH 1S/C8H8N2O2S2/c1-2-5-13-7-3-4-10-6-8(7)14(9,11)12/h1,3-4,6H,5H2,(H2,9,11,12) D02BMV DRUGINKE DGLKDMDQEUWHSZ-UHFFFAOYSA-N D02BMV DRUGSMIL C#CCSC1=C(C=NC=C1)S(=O)(=O)N D02BMV HIGHSTAT Investigative D02BNC DRUG__ID D02BNC D02BNC DRUGTYPE Small molecular drug D02BNC DRUGINCH 1S/C15H9N3/c16-10-11-3-1-4-13(9-11)14-7-6-12-5-2-8-17-15(12)18-14/h1-9H D02BNC DRUGINKE ANJYTIPEHJCPPM-UHFFFAOYSA-N D02BNC DRUGSMIL C1=CC(=CC(=C1)C2=NC3=C(C=CC=N3)C=C2)C#N D02BNC HIGHSTAT Investigative D02BOG DRUG__ID D02BOG D02BOG DRUGTYPE Small molecular drug D02BOG DRUGINCH 1S/C20H25N3O3/c1-13-5-3-4-6-15(13)12-18(19(22)24)23-20(25)17(21)11-14-7-9-16(26-2)10-8-14/h3-10,17-18H,11-12,21H2,1-2H3,(H2,22,24)(H,23,25)/t17-,18-/m0/s1 D02BOG DRUGINKE DZDNCKHJPMLWQZ-ROUUACIJSA-N D02BOG DRUGSMIL CC1=CC=CC=C1CC(C(=O)N)NC(=O)C(CC2=CC=C(C=C2)OC)N D02BOG HIGHSTAT Investigative D02BOW DRUG__ID D02BOW D02BOW DRUGTYPE Small molecular drug D02BOW DRUGINCH 1S/C14H17ClN2O2.ClH/c1-17(2,3)9-4-5-10-19-14(18)16-13-8-6-7-12(15)11-13;/h6-8,11H,9-10H2,1-3H3;1H D02BOW DRUGINKE CXFZFEJJLNLOTA-UHFFFAOYSA-N D02BOW DRUGSMIL C[N+](C)(C)CC#CCOC(=O)NC1=CC(=CC=C1)Cl.[Cl-] D02BOW HIGHSTAT Investigative D02BPI DRUG__ID D02BPI D02BPI DRUGTYPE Small molecular drug D02BPI DRUGINCH 1S/C16H8Cl4N2O2/c17-9-5-13(19)15(21-7-9)23-11-1-2-12(4-3-11)24-16-14(20)6-10(18)8-22-16/h1-8H D02BPI DRUGINKE BAFKRPOFIYPKBQ-UHFFFAOYSA-N D02BPI DRUGSMIL C1=CC(=CC=C1OC2=C(C=C(C=N2)Cl)Cl)OC3=C(C=C(C=N3)Cl)Cl D02BPI HIGHSTAT Investigative D02BPT DRUG__ID D02BPT D02BPT DRUGTYPE Small molecular drug D02BPT DRUGINCH 1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3 D02BPT DRUGINKE SNICXCGAKADSCV-UHFFFAOYSA-N D02BPT DRUGSMIL CN1CCCC1C2=CN=CC=C2 D02BPT HIGHSTAT Investigative D02BTV DRUG__ID D02BTV D02BTV DRUGTYPE Small molecular drug D02BTV DRUGINCH 1S/C13H19NO3S/c1-2-3-7-12(10-13(15)14-16)18(17)11-8-5-4-6-9-11/h4-6,8-9,12,16H,2-3,7,10H2,1H3,(H,14,15) D02BTV DRUGINKE SQIUCETXNXHTSW-UHFFFAOYSA-N D02BTV DRUGSMIL CCCCC(CC(=O)NO)S(=O)C1=CC=CC=C1 D02BTV HIGHSTAT Investigative D02BUW DRUG__ID D02BUW D02BUW DRUGTYPE Small molecular drug D02BUW DRUGINCH 1S/C10H6N2O3/c11-4-7(5-12)1-6-2-8(13)10(15)9(14)3-6/h1-3,13-15H D02BUW DRUGINKE YZOFLYUAQDJWKV-UHFFFAOYSA-N D02BUW DRUGSMIL C1=C(C=C(C(=C1O)O)O)C=C(C#N)C#N D02BUW HIGHSTAT Investigative D02BVS DRUG__ID D02BVS D02BVS DRUGTYPE Small molecular drug D02BVS DRUGINCH 1S/C39H51N5O6S/c1-24-18-28(40-16-17-43(5)6)19-25(2)35(24)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(3,4)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40,45,47H,16-17,20-23H2,1-6H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1 D02BVS DRUGINKE MXFYEUZYULOCTL-SQKWSBCUSA-N D02BVS DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NCCN(C)C D02BVS HIGHSTAT Investigative D02BWQ DRUG__ID D02BWQ D02BWQ DRUGTYPE Small molecular drug D02BWQ DRUGINCH 1S/C16H15N/c1-12-9-14(10-13-5-4-8-17-11-13)16-7-3-2-6-15(12)16/h2-8,10-12H,9H2,1H3/b14-10- D02BWQ DRUGINKE KMRIBBKLCIMDTB-UVTDQMKNSA-N D02BWQ DRUGSMIL CC1CC(=CC2=CN=CC=C2)C3=CC=CC=C13 D02BWQ HIGHSTAT Investigative D02BXA DRUG__ID D02BXA D02BXA DRUGTYPE Small molecular drug D02BXA DRUGINCH 1S/C11H16N2/c1-2-7-12-11(5-1)6-10-13-8-3-4-9-13/h1-2,5,7H,3-4,6,8-10H2 D02BXA DRUGINKE OXEFHEYEQUISKC-UHFFFAOYSA-N D02BXA DRUGSMIL C1CCN(C1)CCC2=CC=CC=N2 D02BXA HIGHSTAT Investigative D02BXC DRUG__ID D02BXC D02BXC DRUGTYPE Small molecular drug D02BXC DRUGINCH 1S/C16H13NO2/c1-19-12-7-8-14-13(9-12)16(18)10-15(17-14)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18) D02BXC DRUGINKE CKFBIYVXNYYXAI-UHFFFAOYSA-N D02BXC DRUGSMIL COC1=CC2=C(C=C1)NC(=CC2=O)C3=CC=CC=C3 D02BXC HIGHSTAT Investigative D02BXG DRUG__ID D02BXG D02BXG DRUGTYPE Small molecular drug D02BXG DRUGINCH 1S/C14H17NS/c15-14(8-4-1-5-9-14)13-10-11-6-2-3-7-12(11)16-13/h2-3,6-7,10H,1,4-5,8-9,15H2 D02BXG DRUGINKE HYVMNAZTYJDWIZ-UHFFFAOYSA-N D02BXG DRUGSMIL C1CCC(CC1)(C2=CC3=CC=CC=C3S2)N D02BXG HIGHSTAT Investigative D02BXJ DRUG__ID D02BXJ D02BXJ DRUGTYPE Small molecular drug D02BXJ DRUGINCH 1S/C30H33F3N6O3/c1-20-4-5-22(16-21(20)7-9-25-18-35-27(37(25)3)29(42)34-2)28(41)36-24-8-6-23(26(17-24)30(31,32)33)19-39-12-10-38(11-13-39)14-15-40/h4-6,8,16-18,40H,10-15,19H2,1-3H3,(H,34,42)(H,36,41) D02BXJ DRUGINKE SUXYGJZMCWKJJI-UHFFFAOYSA-N D02BXJ DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)CCO)C(F)(F)F)C#CC4=CN=C(N4C)C(=O)NC D02BXJ HIGHSTAT Investigative D02BXS DRUG__ID D02BXS D02BXS DRUGTYPE Small molecular drug D02BXS DRUGINCH 1S/C18H17N3/c19-17-6-5-16(12-18(17)20)15-3-1-13(2-4-15)11-14-7-9-21-10-8-14/h1-10,12H,11,19-20H2 D02BXS DRUGINKE SRXFPSNWVWAMBL-UHFFFAOYSA-N D02BXS DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)N)N D02BXS HIGHSTAT Investigative D02BYS DRUG__ID D02BYS D02BYS DRUGTYPE Small molecular drug D02BYS DRUGINCH 1S/C22H24N2O2S/c1-14-6-9-19(10-7-14)27(25,26)20-11-8-18(5)23-22(20)24-21-16(3)12-15(2)13-17(21)4/h6-13H,1-5H3,(H,23,24) D02BYS DRUGINKE VEYJKVDTZSJZQR-UHFFFAOYSA-N D02BYS DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C(N=C(C=C2)C)NC3=C(C=C(C=C3C)C)C D02BYS HIGHSTAT Investigative D02BZV DRUG__ID D02BZV D02BZV DRUGTYPE Small molecular drug D02BZV DRUGINCH 1S/C29H33NO5/c1-20-22(12-9-13-24(20)21-10-5-4-6-11-21)19-35-23-16-27(33-2)25(28(17-23)34-3)18-30-15-8-7-14-26(30)29(31)32/h4-6,9-13,16-17,26H,7-8,14-15,18-19H2,1-3H3,(H,31,32)/t26-/m0/s1 D02BZV DRUGINKE ZBOYJODMIAUJHH-SANMLTNESA-N D02BZV DRUGSMIL CC1=C(C=CC=C1C2=CC=CC=C2)COC3=CC(=C(C(=C3)OC)CN4CCCCC4C(=O)O)OC D02BZV HIGHSTAT Investigative D02CAT DRUG__ID D02CAT D02CAT DRUGTYPE Small molecular drug D02CAT DRUGINCH 1S/C13H11IO3/c14-9-5-2-1-4-8(9)13(17)12-10(15)6-3-7-11(12)16/h1-2,4-5,12H,3,6-7H2 D02CAT DRUGINKE OGHGLYVCKWVCJJ-UHFFFAOYSA-N D02CAT DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2=CC=CC=C2I D02CAT HIGHSTAT Investigative D02CBR DRUG__ID D02CBR D02CBR DRUGTYPE Small molecular drug D02CBR DRUGINCH 1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1 D02CBR DRUGINKE QCHPKSFMDHPSNR-VKHMYHEASA-N D02CBR DRUGSMIL CC(CN)C(=O)O D02CBR HIGHSTAT Investigative D02CCB DRUG__ID D02CCB D02CCB DRUGTYPE Small molecular drug D02CCB DRUGINCH 1S/C18H18O3/c1-19-16-9-8-15(17(20-2)18(16)21-3)14-10-12-6-4-5-7-13(12)11-14/h4-10H,11H2,1-3H3 D02CCB DRUGINKE ULQHBVJHLIJHLL-UHFFFAOYSA-N D02CCB DRUGSMIL COC1=C(C(=C(C=C1)C2=CC3=CC=CC=C3C2)OC)OC D02CCB HIGHSTAT Investigative D02CCD DRUG__ID D02CCD D02CCD DRUGTYPE Small molecular drug D02CCD DRUGINCH 1S/C30H32N2O3/c1-24-23-32(29(34)31-28(24)33)21-13-2-3-14-22-35-30(25-15-7-4-8-16-25,26-17-9-5-10-18-26)27-19-11-6-12-20-27/h4-12,15-20,23H,2-3,13-14,21-22H2,1H3,(H,31,33,34) D02CCD DRUGINKE POQKPOUSJVGFHD-UHFFFAOYSA-N D02CCD DRUGSMIL CC1=CN(C(=O)NC1=O)CCCCCCOC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D02CCD HIGHSTAT Investigative D02CFE DRUG__ID D02CFE D02CFE DRUGTYPE Small molecular drug D02CFE DRUGINCH 1S/C20H16N2O3S/c23-19-18(26-20(24)22-19)9-14-8-15-6-7-16(10-17(15)21-11-14)25-12-13-4-2-1-3-5-13/h1-8,10-11,18H,9,12H2,(H,22,23,24) D02CFE DRUGINKE AZKFGOQRYCSQPK-UHFFFAOYSA-N D02CFE DRUGSMIL C1=CC=C(C=C1)COC2=CC3=NC=C(C=C3C=C2)CC4C(=O)NC(=O)S4 D02CFE HIGHSTAT Investigative D02CFH DRUG__ID D02CFH D02CFH DRUGTYPE Small molecular drug D02CFH DRUGINCH 1S/C7H8N2S/c8-7(10)9-6-4-2-1-3-5-6/h1-5H,(H3,8,9,10) D02CFH DRUGINKE FULZLIGZKMKICU-UHFFFAOYSA-N D02CFH DRUGSMIL C1=CC=C(C=C1)NC(=S)N D02CFH HIGHSTAT Investigative D02CGG DRUG__ID D02CGG D02CGG DRUGTYPE Small molecular drug D02CGG DRUGINCH 1S/C15H20O2/c1-3-5-6-7-10-13-11-8-9-12-14(13)17-15(16)4-2/h4,8-9,11-12H,2-3,5-7,10H2,1H3 D02CGG DRUGINKE MADYBBZSBQFZRP-UHFFFAOYSA-N D02CGG DRUGSMIL CCCCCCC1=CC=CC=C1OC(=O)C=C D02CGG HIGHSTAT Investigative D02CHG DRUG__ID D02CHG D02CHG DRUGTYPE Small molecular drug D02CHG DRUGINCH 1S/C15H9ClO2/c16-11-6-7-14-12(8-11)13(17)9-15(18-14)10-4-2-1-3-5-10/h1-9H D02CHG DRUGINKE IFNDLWHUYFSXBK-UHFFFAOYSA-N D02CHG DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)Cl D02CHG HIGHSTAT Investigative D02CIT DRUG__ID D02CIT D02CIT DRUGTYPE Small molecular drug D02CIT DRUGINCH 1S/C23H26N4O2/c1-5-17(6-2)27-8-7-18-19(10-16(12-24)11-21(18)27)22(28)25-13-20-14(3)9-15(4)26-23(20)29/h7-11,17H,5-6,13H2,1-4H3,(H,25,28)(H,26,29) D02CIT DRUGINKE PFHDWRIVDDIFRP-UHFFFAOYSA-N D02CIT DRUGSMIL CCC(CC)N1C=CC2=C(C=C(C=C21)C#N)C(=O)NCC3=C(C=C(NC3=O)C)C D02CIT HIGHSTAT Investigative D02CKF DRUG__ID D02CKF D02CKF DRUGTYPE Small molecular drug D02CKF DRUGINCH 1S/C19H34N2O3/c1-2-3-13-16-20-19(24)21-17-14-11-9-7-5-4-6-8-10-12-15-18(22)23/h2-4,6,8-17H2,1H3,(H,22,23)(H2,20,21,24) D02CKF DRUGINKE CFQZBGUYWSZYQK-UHFFFAOYSA-N D02CKF DRUGSMIL CCCCCNC(=O)NCCCCC#CCCCCCCC(=O)O D02CKF HIGHSTAT Investigative D02CKL DRUG__ID D02CKL D02CKL DRUGTYPE Small molecular drug D02CKL DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(42)36-29-24-14-8-6-12-22(24)17-26(29)39)37(20-45-34)33(43)30(41)25(16-21-10-4-3-5-11-21)35-28(40)19-44-27-15-9-7-13-23(27)18-38/h3-15,25-26,29-31,38-39,41H,16-20H2,1-2H3,(H,35,40)(H,36,42)/t25-,26+,29-,30-,31+/m0/s1 D02CKL DRUGINKE XBWSFLDHKBAMBA-XPLSERNMSA-N D02CKL DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC=C3CO)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D02CKL HIGHSTAT Investigative D02CKM DRUG__ID D02CKM D02CKM DRUGTYPE Small molecular drug D02CKM DRUGINCH 1S/C14H8ClFN2O/c15-11-2-1-3-13(7-11)18-14(19)10-4-9(8-17)5-12(16)6-10/h1-7H,(H,18,19) D02CKM DRUGINKE FNDUFJARTKDXEF-UHFFFAOYSA-N D02CKM DRUGSMIL C1=CC(=CC(=C1)Cl)NC(=O)C2=CC(=CC(=C2)C#N)F D02CKM HIGHSTAT Investigative D02COM DRUG__ID D02COM D02COM DRUGTYPE Small molecular drug D02COM DRUGINCH 1S/C24H34N2O4/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24/h5-12,27-28H,13-18H2,1-4H3/q+2 D02COM DRUGINKE JIWUESGGKYLPPG-UHFFFAOYSA-N D02COM DRUGSMIL C[N+]1(CCOC(C1)(C2=CC=C(C=C2)C3=CC=C(C=C3)C4(C[N+](CCO4)(C)C)O)O)C D02COM HIGHSTAT Investigative D02COQ DRUG__ID D02COQ D02COQ DRUGTYPE Small molecular drug D02COQ DRUGINCH 1S/C25H38O5/c1-23(2)9-5-10-25(4)18(23)8-11-24(3)16-13-17(15-12-20(26)30-22(15)28)29-21(27)14(16)6-7-19(24)25/h12,14,16-19,21-22,27-28H,5-11,13H2,1-4H3/t14-,16+,17+,18-,19-,21+,22?,24-,25-/m0/s1 D02COQ DRUGINKE KBXIJAUSPXZGMP-IDONBMJRSA-N D02COQ DRUGSMIL CC1(CCCC2(C1CCC3(C2CCC4C3CC(OC4O)C5=CC(=O)OC5O)C)C)C D02COQ HIGHSTAT Investigative D02CQN DRUG__ID D02CQN D02CQN DRUGTYPE Small molecular drug D02CQN DRUGINCH 1S/C20H17ClN2O/c1-14-4-2-3-5-16(14)13-23-20(24)18-10-17(11-22-12-18)15-6-8-19(21)9-7-15/h2-12H,13H2,1H3,(H,23,24) D02CQN DRUGINKE MLDMXXWILKZITA-UHFFFAOYSA-N D02CQN DRUGSMIL CC1=CC=CC=C1CNC(=O)C2=CN=CC(=C2)C3=CC=C(C=C3)Cl D02CQN HIGHSTAT Investigative D02CQW DRUG__ID D02CQW D02CQW DRUGTYPE Small molecular drug D02CQW DRUGINCH 1S/C43H61N11O10S2/c1-22-37(58)50-31(18-26-19-47-29-14-8-7-13-27(26)29)40(61)49-30(15-9-10-16-44)39(60)54-35(24(3)56)43(64)52-33(42(63)53-34(23(2)55)36(46)57)21-66-65-20-32(41(62)48-22)51-38(59)28(45)17-25-11-5-4-6-12-25/h4-8,11-14,19,22-24,28,30-35,47,55-56H,9-10,15-18,20-21,44-45H2,1-3H3,(H2,46,57)(H,48,62)(H,49,61)(H,50,58)(H,51,59)(H,52,64)(H,53,63)(H,54,60)/t22-,23+,24+,28+,30-,31+,32-,33-,34-,35-/m0/s1 D02CQW DRUGINKE DNIBTKHTGSPUNA-RHSAGAAYSA-N D02CQW DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(C)O)C(=O)N)C(C)O)CCCCN)CC3=CNC4=CC=CC=C43 D02CQW HIGHSTAT Investigative D02CSC DRUG__ID D02CSC D02CSC DRUGTYPE Small molecular drug D02CSC DRUGINCH 1S/C16H8N2O2/c19-15-9-3-1-2-4-10(9)16(20)13-11(15)5-6-12-14(13)18-8-7-17-12/h1-8H D02CSC DRUGINKE DGLSEJAACVWJNU-UHFFFAOYSA-N D02CSC DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=NC=CN=C4C=C3 D02CSC HIGHSTAT Investigative D02CSU DRUG__ID D02CSU D02CSU DRUGTYPE Small molecular drug D02CSU DRUGINCH 1S/C15H13N/c1-2-4-15-13(3-1)5-6-14(15)11-12-7-9-16-10-8-12/h1-4,7-11H,5-6H2/b14-11- D02CSU DRUGINKE ZHGWOEHABOMOSV-KAMYIIQDSA-N D02CSU DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=CC=CC=C31 D02CSU HIGHSTAT Investigative D02CUF DRUG__ID D02CUF D02CUF DRUGTYPE Small molecular drug D02CUF DRUGINCH 1S/C18H18N2O2/c1-21-17-9-14-8-15(12-20-16(14)10-18(17)22-2)19-11-13-6-4-3-5-7-13/h3-10,12,19H,11H2,1-2H3 D02CUF DRUGINKE JDKRDQWKIJSKHE-UHFFFAOYSA-N D02CUF DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)NCC3=CC=CC=C3 D02CUF HIGHSTAT Investigative D02CWE DRUG__ID D02CWE D02CWE DRUGTYPE Small molecular drug D02CWE DRUGINCH 1S/Mo.2O.H2S/h;;;1H2/p-1 D02CWE DRUGINKE LMGKUBJWYNQHBP-UHFFFAOYSA-M D02CWE DRUGSMIL O=[Mo]=O.[SH-] D02CWE HIGHSTAT Investigative D02CWP DRUG__ID D02CWP D02CWP DRUGTYPE Small molecular drug D02CWP DRUGINCH 1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1 D02CWP DRUGINKE QBYUNVOYXHFVKC-GBURMNQMSA-N D02CWP DRUGSMIL CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D02CWP HIGHSTAT Investigative D02CWR DRUG__ID D02CWR D02CWR DRUGTYPE Small molecular drug D02CWR DRUGINCH 1S/C14H12O3/c1-17-11-7-8-12(13(15)9-11)14(16)10-5-3-2-4-6-10/h2-9,15H,1H3 D02CWR DRUGINKE DXGLGDHPHMLXJC-UHFFFAOYSA-N D02CWR DRUGSMIL COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O D02CWR HIGHSTAT Investigative D02CWZ DRUG__ID D02CWZ D02CWZ DRUGTYPE Small molecular drug D02CWZ DRUGINCH 1S/C8H11N7S/c9-7(10)14-12-5-1-3-6(4-2-5)13-15-8(11)16/h1-4,12H,(H2,11,16)(H4,9,10,14) D02CWZ DRUGINKE ANZIOUQAFBXNHU-UHFFFAOYSA-N D02CWZ DRUGSMIL C1=CC(=CC=C1NN=C(N)N)N=NC(=S)N D02CWZ HIGHSTAT Investigative D02CXU DRUG__ID D02CXU D02CXU DRUGTYPE Small molecular drug D02CXU DRUGINCH 1S/C15H13NO2/c1-11-4-3-5-13(8-11)18-14-7-6-12(10-16)9-15(14)17-2/h3-9H,1-2H3 D02CXU DRUGINKE XMFGJPOABFQKTB-UHFFFAOYSA-N D02CXU DRUGSMIL CC1=CC(=CC=C1)OC2=C(C=C(C=C2)C#N)OC D02CXU HIGHSTAT Investigative D02CYQ DRUG__ID D02CYQ D02CYQ DRUGTYPE Small molecular drug D02CYQ DRUGINCH 1S/C6H9NO6/c8-4(9)2-1-3(6(11)12)5(10)7-13/h3,13H,1-2H2,(H,7,10)(H,8,9)(H,11,12) D02CYQ DRUGINKE FSDICXJFWIWOEV-UHFFFAOYSA-N D02CYQ DRUGSMIL C(CC(=O)O)C(C(=O)NO)C(=O)O D02CYQ HIGHSTAT Investigative D02CYZ DRUG__ID D02CYZ D02CYZ DRUGTYPE Small molecular drug D02CYZ DRUGINCH 1S/C5H10N2O6P2/c8-14(9,10)5(15(11,12)13)4-7-3-1-2-6-7/h1-3,5H,4H2,(H2,8,9,10)(H2,11,12,13) D02CYZ DRUGINKE UUGUSMHQBIUYKQ-UHFFFAOYSA-N D02CYZ DRUGSMIL C1=CN(N=C1)CC(P(=O)(O)O)P(=O)(O)O D02CYZ HIGHSTAT Investigative D02CZC DRUG__ID D02CZC D02CZC DRUGTYPE Small molecular drug D02CZC DRUGINCH 1S/C20H16FNO/c21-18-13-11-17(12-14-18)20(19(22)23,15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1-14H,(H2,22,23) D02CZC DRUGINKE JHPLFDBQYVMFCT-UHFFFAOYSA-N D02CZC DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)F)C(=O)N D02CZC HIGHSTAT Investigative D02CZO DRUG__ID D02CZO D02CZO DRUGTYPE Small molecular drug D02CZO DRUGINCH 1S/C17H21NO3/c1-4-12-5-6-15-13(9-12)16(19)14(10-18-15)17(20)21-8-7-11(2)3/h5-6,9-11H,4,7-8H2,1-3H3,(H,18,19) D02CZO DRUGINKE YQYRRRVQWIMSFP-UHFFFAOYSA-N D02CZO DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OCCC(C)C D02CZO HIGHSTAT Investigative D02DAJ DRUG__ID D02DAJ D02DAJ DRUGTYPE Small molecular drug D02DAJ DRUGINCH 1S/C13H9Cl2NO2/c14-8-2-1-3-10(6-8)16-12-7-9(15)4-5-11(12)13(17)18/h1-7,16H,(H,17,18) D02DAJ DRUGINKE GSDQYSSLIKJJOG-UHFFFAOYSA-N D02DAJ DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=C(C=CC(=C2)Cl)C(=O)O D02DAJ HIGHSTAT Investigative D02DBP DRUG__ID D02DBP D02DBP DRUGTYPE Small molecular drug D02DBP DRUGINCH 1S/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8H D02DBP DRUGINKE GHMLBKRAJCXXBS-UHFFFAOYSA-N D02DBP DRUGSMIL C1=CC(=CC(=C1)O)O D02DBP HIGHSTAT Investigative D02DCD DRUG__ID D02DCD D02DCD DRUGTYPE Small molecular drug D02DCD DRUGINCH 1S/C18H19NO2/c1-18(2,3)15-8-4-13(5-9-15)12-19-16-10-6-14(7-11-16)17(20)21/h4-12H,1-3H3,(H,20,21) D02DCD DRUGINKE CZLMLVYXQCJOGH-UHFFFAOYSA-N D02DCD DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C=NC2=CC=C(C=C2)C(=O)O D02DCD HIGHSTAT Investigative D02DCM DRUG__ID D02DCM D02DCM DRUGTYPE Small molecular drug D02DCM DRUGINCH 1S/C19H19FN2/c20-17-4-1-14(2-5-17)12-19(8-10-21-13-19)16-3-6-18-15(11-16)7-9-22-18/h1-7,9,11,21-22H,8,10,12-13H2 D02DCM DRUGINKE RBNFIIOAQFISLC-UHFFFAOYSA-N D02DCM DRUGSMIL C1CNCC1(CC2=CC=C(C=C2)F)C3=CC4=C(C=C3)NC=C4 D02DCM HIGHSTAT Investigative D02DDI DRUG__ID D02DDI D02DDI DRUGTYPE Small molecular drug D02DDI DRUGINCH 1S/C31H37N5O3S/c1-3-36-29(27-9-5-6-10-28(27)33-31(36)35-19-7-4-8-20-35)21-30(37)32-22-24-13-15-25(16-14-24)34-40(38,39)26-17-11-23(2)12-18-26/h5-6,9-18,29,34H,3-4,7-8,19-22H2,1-2H3,(H,32,37) D02DDI DRUGINKE AAULUGZZFCAQJP-UHFFFAOYSA-N D02DDI DRUGSMIL CCN1C(C2=CC=CC=C2N=C1N3CCCCC3)CC(=O)NCC4=CC=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)C D02DDI HIGHSTAT Investigative D02DDM DRUG__ID D02DDM D02DDM DRUGTYPE Small molecular drug D02DDM DRUGINCH 1S/C16H17NO4/c1-19-14-5-3-2-4-13(14)15-10-12(18)11-16(21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3 D02DDM DRUGINKE ZDNMYLJFYAXNHH-UHFFFAOYSA-N D02DDM DRUGSMIL COC1=CC=CC=C1C2=CC(=O)C=C(O2)N3CCOCC3 D02DDM HIGHSTAT Investigative D02DEF DRUG__ID D02DEF D02DEF DRUGTYPE Small molecular drug D02DEF DRUGINCH 1S/C22H23F3N4/c23-22(24,25)20-18(10-13-29-19(14-15-6-7-15)26-27-21(20)29)28-11-8-17(9-12-28)16-4-2-1-3-5-16/h1-5,10,13,15,17H,6-9,11-12,14H2 D02DEF DRUGINKE BQAVZGJJQFJSMW-UHFFFAOYSA-N D02DEF DRUGSMIL C1CC1CC2=NN=C3N2C=CC(=C3C(F)(F)F)N4CCC(CC4)C5=CC=CC=C5 D02DEF HIGHSTAT Investigative D02DFT DRUG__ID D02DFT D02DFT DRUGTYPE Small molecular drug D02DFT DRUGINCH 1S/C17H15NOS/c1-18-14-6-2-12(3-7-14)16-10-11-17(20-16)13-4-8-15(19)9-5-13/h2-11,18-19H,1H3 D02DFT DRUGINKE CXLILFMFVYDZLM-UHFFFAOYSA-N D02DFT DRUGSMIL CNC1=CC=C(C=C1)C2=CC=C(S2)C3=CC=C(C=C3)O D02DFT HIGHSTAT Investigative D02DKM DRUG__ID D02DKM D02DKM DRUGTYPE Small molecular drug D02DKM DRUGINCH 1S/C16H24N2O3/c1-4-5-6-7-12-20-15-10-8-14(9-11-15)17-16(19)21-18-13(2)3/h8-11H,4-7,12H2,1-3H3,(H,17,19) D02DKM DRUGINKE OTUAPVMKCJEVBD-UHFFFAOYSA-N D02DKM DRUGSMIL CCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D02DKM HIGHSTAT Investigative D02DKX DRUG__ID D02DKX D02DKX DRUGTYPE Small molecular drug D02DKX DRUGINCH 1S/C25H32N4O6/c26-14-19-13-23(34-12-11-33-16-18-1-2-18)7-8-24(19)35-17-22(31)15-27-9-10-28-25(32)29-20-3-5-21(30)6-4-20/h3-8,13,18,22,27,30-31H,1-2,9-12,15-17H2,(H2,28,29,32) D02DKX DRUGINKE VAWYRUMIUGPAEX-UHFFFAOYSA-N D02DKX DRUGSMIL C1CC1COCCOC2=CC(=C(C=C2)OCC(CNCCNC(=O)NC3=CC=C(C=C3)O)O)C#N D02DKX HIGHSTAT Investigative D02DLC DRUG__ID D02DLC D02DLC DRUGTYPE Small molecular drug D02DLC DRUGINCH 1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22) D02DLC DRUGINKE GBNWWXHUOVAUHT-UHFFFAOYSA-N D02DLC DRUGSMIL COC1=CC=CC(=C1)NC2=NC=CC(=N2)C3=C4C=CC=NN4N=C3 D02DLC HIGHSTAT Investigative D02DLW DRUG__ID D02DLW D02DLW DRUGTYPE Small molecular drug D02DLW DRUGINCH 1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1 D02DLW DRUGINKE HVYWMOMLDIMFJA-DPAQBDIFSA-N D02DLW DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C D02DLW HIGHSTAT Investigative D02DML DRUG__ID D02DML D02DML DRUGTYPE Small molecular drug D02DML DRUGINCH 1S/C15H8O5/c16-7-1-3-9-11(5-7)19-14-10-4-2-8(17)6-12(10)20-15(18)13(9)14/h1-6,16-17H D02DML DRUGINKE ZZIALNLLNHEQPJ-UHFFFAOYSA-N D02DML DRUGSMIL C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=C3C=CC(=C4)O D02DML HIGHSTAT Investigative D02DOP DRUG__ID D02DOP D02DOP DRUGTYPE Small molecular drug D02DOP DRUGINCH 1S/C15H10N4/c16-11-12-4-3-5-13(10-12)14-7-9-19(18-14)15-6-1-2-8-17-15/h1-10H D02DOP DRUGINKE LQROCYQCXGUXNA-UHFFFAOYSA-N D02DOP DRUGSMIL C1=CC=NC(=C1)N2C=CC(=N2)C3=CC=CC(=C3)C#N D02DOP HIGHSTAT Investigative D02DOQ DRUG__ID D02DOQ D02DOQ DRUGTYPE Small molecular drug D02DOQ DRUGINCH 1S/C13H21O3PS/c1-10(2)15-17(14,16-11(3)4)13-8-6-5-7-12(13)9-18/h5-8,10-11,18H,9H2,1-4H3 D02DOQ DRUGINKE JFZVPWMZPZJUTE-UHFFFAOYSA-N D02DOQ DRUGSMIL CC(C)OP(=O)(C1=CC=CC=C1CS)OC(C)C D02DOQ HIGHSTAT Investigative D02DOX DRUG__ID D02DOX D02DOX DRUGTYPE Small molecular drug D02DOX DRUGINCH 1S/C21H13N3/c1-3-7-17-13(5-1)15-9-11-24-12-10-16-14-6-2-4-8-18(14)23-20(16)21(24)19(15)22-17/h1-12,22H D02DOX DRUGINKE MNJDUMFRXPRNJB-UHFFFAOYSA-N D02DOX DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C4=C5C(=C6C=CC=CC6=N5)C=CN4C=C3 D02DOX HIGHSTAT Investigative D02DPK DRUG__ID D02DPK D02DPK DRUGTYPE Small molecular drug D02DPK DRUGINCH 1S/C18H26O5/c1-3-5-7-9-12(19)16-14(21)11-15(22)17(18(16)23)13(20)10-8-6-4-2/h11,21-23H,3-10H2,1-2H3 D02DPK DRUGINKE JRHOSBCIYWDGHN-UHFFFAOYSA-N D02DPK DRUGSMIL CCCCCC(=O)C1=C(C(=C(C=C1O)O)C(=O)CCCCC)O D02DPK HIGHSTAT Investigative D02DPM DRUG__ID D02DPM D02DPM DRUGTYPE Small molecular drug D02DPM DRUGINCH 1S/C34H48N4O4/c1-25-15-11-17-27-29(25)33(41)35(31(27)39)19-13-23-37(3,4)21-9-7-8-10-22-38(5,6)24-14-20-36-32(40)28-18-12-16-26(2)30(28)34(36)42/h11-12,15-18H,7-10,13-14,19-24H2,1-6H3/q+2 D02DPM DRUGINKE HMXRJKOINNJHNS-UHFFFAOYSA-N D02DPM DRUGSMIL CC1=C2C(=CC=C1)C(=O)N(C2=O)CCC[N+](C)(C)CCCCCC[N+](C)(C)CCCN3C(=O)C4=CC=CC(=C4C3=O)C D02DPM HIGHSTAT Investigative D02DQQ DRUG__ID D02DQQ D02DQQ DRUGTYPE Small molecular drug D02DQQ DRUGINCH 1S/C8H18N4O2/c1-12(2)8(10)11-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H2,10,11)(H,13,14)/t6-/m0/s1 D02DQQ DRUGINKE YDGMGEXADBMOMJ-LURJTMIESA-N D02DQQ DRUGSMIL CN(C)C(=NCCCC(C(=O)O)N)N D02DQQ HIGHSTAT Investigative D02DQT DRUG__ID D02DQT D02DQT DRUGTYPE Small molecular drug D02DQT DRUGINCH 1S/C22H22N2O7S2/c1-29-16-5-7-18(8-6-16)33(27,28)24(13-15-4-9-20-21(11-15)31-14-30-20)19(22(25)23-26)12-17-3-2-10-32-17/h2-11,19,26H,12-14H2,1H3,(H,23,25)/t19-/m1/s1 D02DQT DRUGINKE PGEHBYYTLWHQOM-LJQANCHMSA-N D02DQT DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)N(CC2=CC3=C(C=C2)OCO3)C(CC4=CC=CS4)C(=O)NO D02DQT HIGHSTAT Investigative D02DRL DRUG__ID D02DRL D02DRL DRUGTYPE Small molecular drug D02DRL DRUGINCH 1S/C8H9ClN2S.ClH/c9-7-4-2-1-3-6(7)5-12-8(10)11;/h1-4H,5H2,(H3,10,11);1H D02DRL DRUGINKE CEICVYXCGHTEIT-UHFFFAOYSA-N D02DRL DRUGSMIL C1=CC=C(C(=C1)CSC(=N)N)Cl.Cl D02DRL HIGHSTAT Investigative D02DTR DRUG__ID D02DTR D02DTR DRUGTYPE Small molecular drug D02DTR DRUGINCH 1S/C17H17N3O/c1-3-15(13-18-9-1)4-2-12-21-17-7-5-16(6-8-17)20-11-10-19-14-20/h1,3,5-11,13-14H,2,4,12H2 D02DTR DRUGINKE GCRYIIOKZWQWIH-UHFFFAOYSA-N D02DTR DRUGSMIL C1=CC(=CN=C1)CCCOC2=CC=C(C=C2)N3C=CN=C3 D02DTR HIGHSTAT Investigative D02DUJ DRUG__ID D02DUJ D02DUJ DRUGTYPE Small molecular drug D02DUJ DRUGINCH 1S/C15H21N3O3/c1-15-7-8-17(3)21-13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15-/m0/s1 D02DUJ DRUGINKE CNBHDDBNEKKMJH-ZFWWWQNUSA-N D02DUJ DRUGSMIL CC12CCN(OC1N(C3=C2C=C(C=C3)OC(=O)NC)C)C D02DUJ HIGHSTAT Investigative D02DUO DRUG__ID D02DUO D02DUO DRUGTYPE Small molecular drug D02DUO DRUGINCH 1S/C28H30N4O/c33-27(29-21-22-12-4-1-5-13-22)20-26-24-16-8-9-17-25(24)30-28(31-18-10-3-11-19-31)32(26)23-14-6-2-7-15-23/h1-2,4-9,12-17,26H,3,10-11,18-21H2,(H,29,33) D02DUO DRUGINKE IROXHJVGJHVBSD-UHFFFAOYSA-N D02DUO DRUGSMIL C1CCN(CC1)C2=NC3=CC=CC=C3C(N2C4=CC=CC=C4)CC(=O)NCC5=CC=CC=C5 D02DUO HIGHSTAT Investigative D02DVT DRUG__ID D02DVT D02DVT DRUGTYPE Small molecular drug D02DVT DRUGINCH 1S/C23H22O3/c1-2-3-22(16-4-10-19(24)11-5-16)23(17-6-12-20(25)13-7-17)18-8-14-21(26)15-9-18/h4-15,24-26H,2-3H2,1H3 D02DVT DRUGINKE OCRBCWNNWUOJIP-UHFFFAOYSA-N D02DVT DRUGSMIL CCCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O D02DVT HIGHSTAT Investigative D02DWE DRUG__ID D02DWE D02DWE DRUGTYPE Small molecular drug D02DWE DRUGINCH 1S/C12H26O5/c1-3-13-5-7-15-9-11-17-12-10-16-8-6-14-4-2/h3-12H2,1-2H3 D02DWE DRUGINKE HYDWALOBQJFOMS-UHFFFAOYSA-N D02DWE DRUGSMIL CCOCCOCCOCCOCCOCC D02DWE HIGHSTAT Investigative D02DXP DRUG__ID D02DXP D02DXP DRUGTYPE Small molecular drug D02DXP DRUGINCH 1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7) D02DXP DRUGINKE QWCKQJZIFLGMSD-UHFFFAOYSA-N D02DXP DRUGSMIL CCC(C(=O)O)N D02DXP HIGHSTAT Investigative D02DYB DRUG__ID D02DYB D02DYB DRUGTYPE Small molecular drug D02DYB DRUGINCH 1S/C28H42O4/c1-15-13-21-26(4,24(32)22(15)30)10-12-27(5)20-8-7-17-16(2)23(31)19(29)14-18(17)25(20,3)9-11-28(21,27)6/h15,18-21,24,29,32H,7-14H2,1-6H3/t15-,18-,19+,20+,21-,24-,25+,26-,27-,28+/m1/s1 D02DYB DRUGINKE UUGCGHAFZPEHIC-OIOGIDCRSA-N D02DYB DRUGSMIL CC1CC2C(CCC3(C2(CCC4(C3CCC5=C(C(=O)C(CC54)O)C)C)C)C)(C(C1=O)O)C D02DYB HIGHSTAT Investigative D02DYG DRUG__ID D02DYG D02DYG DRUGTYPE Small molecular drug D02DYG DRUGINCH 1S/C12H11ClN2O2S/c13-9-1-5-11(6-2-9)15-18(16,17)12-7-3-10(14)4-8-12/h1-8,15H,14H2 D02DYG DRUGINKE RBJGYDGKXTYSSL-UHFFFAOYSA-N D02DYG DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)NC2=CC=C(C=C2)Cl D02DYG HIGHSTAT Investigative D02DYZ DRUG__ID D02DYZ D02DYZ DRUGTYPE Small molecular drug D02DYZ DRUGINCH 1S/C25H30N2O3/c1-25-9-6-19-18-5-3-17(28)12-16(18)2-4-20(19)22(25)13-21(23(25)29)24(30)27-14-15-7-10-26-11-8-15/h3,5,7-8,10-12,19-23,28-29H,2,4,6,9,13-14H2,1H3,(H,27,30)/t19?,20?,21?,22?,23-,25-/m0/s1 D02DYZ DRUGINKE PHCMYYPTUPNLMJ-GYDLEPMTSA-N D02DYZ DRUGSMIL CC12CCC3C(C1CC(C2O)C(=O)NCC4=CC=NC=C4)CCC5=C3C=CC(=C5)O D02DYZ HIGHSTAT Investigative D02DZN DRUG__ID D02DZN D02DZN DRUGTYPE Small molecular drug D02DZN DRUGINCH 1S/6ClH.14H3N.2O.3Ru/h6*1H;14*1H3;;;;;/q;;;;;;;;;;;;;;;;;;;;2*-2;;2*+5/p-6 D02DZN DRUGINKE HURLCDYOFIWHCF-UHFFFAOYSA-H D02DZN DRUGSMIL N.N.N.N.N.N.N.N.N.N.N.N.N.N.[O-2].[O-2].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ru].[Ru+5].[Ru+5] D02DZN HIGHSTAT Investigative D02EAO DRUG__ID D02EAO D02EAO DRUGTYPE Small molecular drug D02EAO DRUGINCH 1S/C17H20N6/c1-3-7-12(8-4-1)20-16-14-15(19-11-18-14)22-17(23-16)21-13-9-5-2-6-10-13/h2,5-6,9-12H,1,3-4,7-8H2,(H3,18,19,20,21,22,23) D02EAO DRUGINKE FDFMDLSSHFEJOS-UHFFFAOYSA-N D02EAO DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)NC4=CC=CC=C4 D02EAO HIGHSTAT Investigative D02EAP DRUG__ID D02EAP D02EAP DRUGTYPE Small molecular drug D02EAP DRUGINCH 1S/C12H11NOS2/c1-2-9(8-13-5-1)10-3-4-11(14-10)12-15-6-7-16-12/h1-5,8,12H,6-7H2 D02EAP DRUGINKE UITMTMQMFFBLFB-UHFFFAOYSA-N D02EAP DRUGSMIL C1CSC(S1)C2=CC=C(O2)C3=CN=CC=C3 D02EAP HIGHSTAT Investigative D02EBQ DRUG__ID D02EBQ D02EBQ DRUGTYPE Small molecular drug D02EBQ DRUGINCH 1S/C7H7NO2/c9-7(10)4-6-2-1-3-8-5-6/h1-3,5H,4H2,(H,9,10) D02EBQ DRUGINKE WGNUNYPERJMVRM-UHFFFAOYSA-N D02EBQ DRUGSMIL C1=CC(=CN=C1)CC(=O)O D02EBQ HIGHSTAT Investigative D02ECA DRUG__ID D02ECA D02ECA DRUGTYPE Small molecular drug D02ECA DRUGINCH 1S/C25H20N2O3S/c28-24(29)15-22(20-4-2-1-3-5-20)27-25(30)23-14-21(16-31-23)18-8-6-17(7-9-18)19-10-12-26-13-11-19/h1-14,16,22H,15H2,(H,27,30)(H,28,29)/t22-/m1/s1 D02ECA DRUGINKE VMTJQZUZINLEKC-JOCHJYFZSA-N D02ECA DRUGSMIL C1=CC=C(C=C1)C(CC(=O)O)NC(=O)C2=CC(=CS2)C3=CC=C(C=C3)C4=CC=NC=C4 D02ECA HIGHSTAT Investigative D02EFK DRUG__ID D02EFK D02EFK DRUGTYPE Small molecular drug D02EFK DRUGINCH 1S/C25H26N2O3/c28-24(26-30)23(18-21-12-6-2-7-13-21)25(29)27(19-22-14-8-3-9-15-22)17-16-20-10-4-1-5-11-20/h1-15,23,30H,16-19H2,(H,26,28) D02EFK DRUGINKE PQZSZTWFWIQBGX-UHFFFAOYSA-N D02EFK DRUGSMIL C1=CC=C(C=C1)CCN(CC2=CC=CC=C2)C(=O)C(CC3=CC=CC=C3)C(=O)NO D02EFK HIGHSTAT Investigative D02EFQ DRUG__ID D02EFQ D02EFQ DRUGTYPE Small molecular drug D02EFQ DRUGINCH 1S/C17H18BrNO4S/c1-11(2)16(17(20)21)19-24(22,23)15-9-5-13(6-10-15)12-3-7-14(18)8-4-12/h3-11,16,19H,1-2H3,(H,20,21)/t16-/m1/s1 D02EFQ DRUGINKE GJOCABIDMCKCEG-MRXNPFEDSA-N D02EFQ DRUGSMIL CC(C)C(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)Br D02EFQ HIGHSTAT Investigative D02EFX DRUG__ID D02EFX D02EFX DRUGTYPE Small molecular drug D02EFX DRUGINCH 1S/C24H21N3O5S/c28-23-16-33-24(29)26(23)21(7-4-17-10-12-25-13-11-17)15-32-22-8-5-18(6-9-22)19-2-1-3-20(14-19)27(30)31/h1-3,5-6,8-14,21H,4,7,15-16H2 D02EFX DRUGINKE VQEHBLGYANQWEA-UHFFFAOYSA-N D02EFX DRUGSMIL C1C(=O)N(C(=O)S1)C(CCC2=CC=NC=C2)COC3=CC=C(C=C3)C4=CC(=CC=C4)[N+](=O)[O-] D02EFX HIGHSTAT Investigative D02EHL DRUG__ID D02EHL D02EHL DRUGTYPE Small molecular drug D02EHL DRUGINCH 1S/C13H15NS/c14-13(7-3-4-8-13)12-9-10-5-1-2-6-11(10)15-12/h1-2,5-6,9H,3-4,7-8,14H2 D02EHL DRUGINKE CHUXWBUYFQVPQD-UHFFFAOYSA-N D02EHL DRUGSMIL C1CCC(C1)(C2=CC3=CC=CC=C3S2)N D02EHL HIGHSTAT Investigative D02EHQ DRUG__ID D02EHQ D02EHQ DRUGTYPE Small molecular drug D02EHQ DRUGINCH 1S/C21H28O4/c1-12(22)21(25)9-7-16-15-5-4-13-10-14(23)6-8-19(13,2)18(15)17(24)11-20(16,21)3/h10,15-16,18,25H,4-9,11H2,1-3H3/t15-,16-,18+,19-,20-,21-/m0/s1 D02EHQ DRUGINKE PUKLDDOGISCFCP-JSQCKWNTSA-N D02EHQ DRUGSMIL CC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O D02EHQ HIGHSTAT Investigative D02EHY DRUG__ID D02EHY D02EHY DRUGTYPE Small molecular drug D02EHY DRUGINCH 1S/C27H44O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b21-11+/t18-,22+,23-,24+,25+,27+/m0/s1 D02EHY DRUGINKE UHMPCVGLSKFXHR-NAQZCRMNSA-N D02EHY DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(=C)C(C3)O)O)C D02EHY HIGHSTAT Investigative D02EHZ DRUG__ID D02EHZ D02EHZ DRUGTYPE Small molecular drug D02EHZ DRUGINCH 1S/C13H9ClN2O2S2/c14-11-6-7-12(19-11)20(17,18)16-10-5-1-3-9-4-2-8-15-13(9)10/h1-8,16H D02EHZ DRUGINKE SNSCETRSXPPXIM-UHFFFAOYSA-N D02EHZ DRUGSMIL C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(S3)Cl)N=CC=C2 D02EHZ HIGHSTAT Investigative D02EIB DRUG__ID D02EIB D02EIB DRUGTYPE Small molecular drug D02EIB DRUGINCH 1S/C19H19NO2/c21-15-7-5-14(6-8-15)17-13-19(9-11-20-12-10-19)22-18-4-2-1-3-16(17)18/h1-8,13,20-21H,9-12H2 D02EIB DRUGINKE OZOVJRMTVPPLSS-UHFFFAOYSA-N D02EIB DRUGSMIL C1CNCCC12C=C(C3=CC=CC=C3O2)C4=CC=C(C=C4)O D02EIB HIGHSTAT Investigative D02EIK DRUG__ID D02EIK D02EIK DRUGTYPE Small molecular drug D02EIK DRUGINCH 1S/C6H5O3S.Hg/c7-10(8,9)6-4-2-1-3-5-6;/h2-5H,(H,7,8,9); D02EIK DRUGINKE KQAOIKIZSJJTII-UHFFFAOYSA-N D02EIK DRUGSMIL C1=CC(=CC=C1S(=O)(=O)O)[Hg] D02EIK HIGHSTAT Investigative D02EJM DRUG__ID D02EJM D02EJM DRUGTYPE Small molecular drug D02EJM DRUGINCH 1S/C16H13NO3/c1-2-3-11-8-13(19)9-14-15(11)20-16(17-14)10-4-6-12(18)7-5-10/h2-9,18-19H,1H3/b3-2- D02EJM DRUGINKE GBNLUWROABYNBX-IHWYPQMZSA-N D02EJM DRUGSMIL CC=CC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D02EJM HIGHSTAT Investigative D02EKR DRUG__ID D02EKR D02EKR DRUGTYPE Small molecular drug D02EKR DRUGINCH 1S/C12H16ClNO/c1-8(2)14-9(3)12(15)10-5-4-6-11(13)7-10/h4-9,14H,1-3H3 D02EKR DRUGINKE WHPARCHZPIKXEX-UHFFFAOYSA-N D02EKR DRUGSMIL CC(C)NC(C)C(=O)C1=CC(=CC=C1)Cl D02EKR HIGHSTAT Investigative D02ELA DRUG__ID D02ELA D02ELA DRUGTYPE Small molecular drug D02ELA DRUGINCH 1S/C7H15N3O2/c1-5(8)10-4-2-3-6(9)7(11)12/h6H,2-4,9H2,1H3,(H2,8,10)(H,11,12)/t6-/m0/s1 D02ELA DRUGINKE UYZFAUAYFLEHRC-LURJTMIESA-N D02ELA DRUGSMIL CC(=NCCCC(C(=O)O)N)N D02ELA HIGHSTAT Investigative D02ELG DRUG__ID D02ELG D02ELG DRUGTYPE Small molecular drug D02ELG DRUGINCH 1S/C13H16O7/c14-5-7-1-3-8(4-2-7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-5,9-13,15-18H,6H2/t9-,10-,11+,12-,13-/m1/s1 D02ELG DRUGINKE OLZAGZCCJJBKNZ-UJPOAAIJSA-N D02ELG DRUGSMIL C1=CC(=CC=C1C=O)OC2C(C(C(C(O2)CO)O)O)O D02ELG HIGHSTAT Investigative D02EMH DRUG__ID D02EMH D02EMH DRUGTYPE Small molecular drug D02EMH DRUGINCH 1S/C20H26O3/c1-14(7-6-8-15(2)13-19(22)23)9-10-17-16(3)18(21)11-12-20(17,4)5/h6-10,13H,11-12H2,1-5H3,(H,22,23)/b8-6+,10-9+,14-7+,15-13+ D02EMH DRUGINKE GGCUJPCCTQNTJF-FRCNGJHJSA-N D02EMH DRUGSMIL CC1=C(C(CCC1=O)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D02EMH HIGHSTAT Investigative D02ENH DRUG__ID D02ENH D02ENH DRUGTYPE Small molecular drug D02ENH DRUGINCH 1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2/t15-/m1/s1 D02ENH DRUGINKE WIQRCHMSJFFONW-OAHLLOKOSA-N D02ENH DRUGSMIL C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F D02ENH HIGHSTAT Investigative D02ENI DRUG__ID D02ENI D02ENI DRUGTYPE Small molecular drug D02ENI DRUGINCH 1S/C25H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23(27)25-26-22-19-17-18-21-24(22)28-25/h9-10,17-19,21H,2-8,11-16,20H2,1H3/b10-9- D02ENI DRUGINKE APIPEDDJLOMNRC-KTKRTIGZSA-N D02ENI DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NC2=CC=CC=C2O1 D02ENI HIGHSTAT Investigative D02EOF DRUG__ID D02EOF D02EOF DRUGTYPE Small molecular drug D02EOF DRUGINCH 1S/C6H12N2/c1-2-5-3-6(7)8-4-5/h5H,2-4H2,1H3,(H2,7,8) D02EOF DRUGINKE YDJLYZDTIUKJQI-UHFFFAOYSA-N D02EOF DRUGSMIL CCC1CC(=NC1)N D02EOF HIGHSTAT Investigative D02EPD DRUG__ID D02EPD D02EPD DRUGTYPE Small molecular drug D02EPD DRUGINCH 1S/C29H42N4O6/c1-5-9-18-30-24(34)22(25(35)31(28(30)38)19-10-6-2)16-14-13-15-17-23-26(36)32(20-11-7-3)29(39)33(27(23)37)21-12-8-4/h13-17,34H,5-12,18-21H2,1-4H3 D02EPD DRUGINKE CQAPPGVBCMJDML-UHFFFAOYSA-N D02EPD DRUGSMIL CCCCN1C(=C(C(=O)N(C1=O)CCCC)C=CC=CC=C2C(=O)N(C(=O)N(C2=O)CCCC)CCCC)O D02EPD HIGHSTAT Investigative D02EPZ DRUG__ID D02EPZ D02EPZ DRUGTYPE Small molecular drug D02EPZ DRUGINCH 1S/C12H16N2/c1-9-4-3-5-10(2)11(9)8-12-13-6-7-14-12/h3-5H,6-8H2,1-2H3,(H,13,14) D02EPZ DRUGINKE GPUVYOKQAJEFBO-UHFFFAOYSA-N D02EPZ DRUGSMIL CC1=C(C(=CC=C1)C)CC2=NCCN2 D02EPZ HIGHSTAT Investigative D02EQL DRUG__ID D02EQL D02EQL DRUGTYPE Small molecular drug D02EQL DRUGINCH 1S/C25H26FO5P/c26-18-9-7-17(8-10-18)24-20-5-1-2-6-21(20)25(12-3-4-13-25)22(24)11-14-32(30,31)16-19(27)15-23(28)29/h1-2,5-11,14,19,27H,3-4,12-13,15-16H2,(H,28,29)(H,30,31)/b14-11+/t19-/m0/s1 D02EQL DRUGINKE AOSODOHQJJPEAM-VUVZNRFTSA-N D02EQL DRUGSMIL C1CCC2(C1)C3=CC=CC=C3C(=C2C=CP(=O)(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F D02EQL HIGHSTAT Investigative D02ESW DRUG__ID D02ESW D02ESW DRUGTYPE Small molecular drug D02ESW DRUGINCH 1S/C8H11ClN4/c9-7-5-11-6-8(12-7)13-3-1-10-2-4-13/h5-6,10H,1-4H2 D02ESW DRUGINKE CJAWPFJGFFNXQI-UHFFFAOYSA-N D02ESW DRUGSMIL C1CN(CCN1)C2=CN=CC(=N2)Cl D02ESW HIGHSTAT Investigative D02ETA DRUG__ID D02ETA D02ETA DRUGTYPE Small molecular drug D02ETA DRUGINCH 1S/C28H28N2.2ClH/c1-5-13-23(14-6-1)27(24-15-7-2-8-16-24)29-21-22-30-28(25-17-9-3-10-18-25)26-19-11-4-12-20-26;;/h1-20,27-30H,21-22H2;2*1H D02ETA DRUGINKE YRQCDCNQANSUPB-UHFFFAOYSA-N D02ETA DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)NCCNC(C3=CC=CC=C3)C4=CC=CC=C4.Cl.Cl D02ETA HIGHSTAT Investigative D02EWM DRUG__ID D02EWM D02EWM DRUGTYPE Small molecular drug D02EWM DRUGINCH 1S/C26H22N2O2/c1-18(19-9-3-2-4-10-19)28-26(30)22-13-7-8-14-24(22)27-17-23-21-12-6-5-11-20(21)15-16-25(23)29/h2-18,29H,1H3,(H,28,30)/t18-/m1/s1 D02EWM DRUGINKE UXJFDYIHRJGPFS-GOSISDBHSA-N D02EWM DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC=CC=C2N=CC3=C(C=CC4=CC=CC=C43)O D02EWM HIGHSTAT Investigative D02EWR DRUG__ID D02EWR D02EWR DRUGTYPE Small molecular drug D02EWR DRUGINCH 1S/C33H43N7O3/c1-21(26-20-35-27-10-3-2-9-25(26)27)30(31(41)36-19-23-8-6-7-22(17-23)18-34)38-32(42)39-15-13-24(14-16-39)40-29-12-5-4-11-28(29)37-33(40)43/h2-5,9-12,20-24,30,35H,6-8,13-19,34H2,1H3,(H,36,41)(H,37,43)(H,38,42)/t21-,22+,23+,30+/m0/s1 D02EWR DRUGINKE DDVPVAOEMZRZQU-JONNCTARSA-N D02EWR DRUGSMIL CC(C1=CNC2=CC=CC=C21)C(C(=O)NCC3CCCC(C3)CN)NC(=O)N4CCC(CC4)N5C6=CC=CC=C6NC5=O D02EWR HIGHSTAT Investigative D02EXX DRUG__ID D02EXX D02EXX DRUGTYPE Small molecular drug D02EXX DRUGINCH 1S/C39H59N5O10/c1-4-5-6-7-8-9-10-11-12-23-34(27(2)35(47)40-30-20-15-18-25-44(52)38(30)49)54-39(50)31(21-16-17-24-43(51)28(3)45)41-36(48)32-26-53-37(42-32)29-19-13-14-22-33(29)46/h13-14,19,22,26-27,30-31,34,46,51-52H,4-12,15-18,20-21,23-25H2,1-3H3,(H,40,47)(H,41,48) D02EXX DRUGINKE QFWVGKDFYOXTQO-UHFFFAOYSA-N D02EXX DRUGSMIL CCCCCCCCCCCC(C(C)C(=O)NC1CCCCN(C1=O)O)OC(=O)C(CCCCN(C(=O)C)O)NC(=O)C2=COC(=N2)C3=CC=CC=C3O D02EXX HIGHSTAT Investigative D02EZF DRUG__ID D02EZF D02EZF DRUGTYPE Small molecular drug D02EZF DRUGINCH 1S/C34H43N5O4/c1-6-7-15-39-32-26(13-9-14-36-32)29(23-11-8-12-25(18-23)43-17-10-16-40)31(33(39)41)38-34(42)37-30-27(21(2)3)19-24(35)20-28(30)22(4)5/h8-9,11-14,18-22,40H,6-7,10,15-17,35H2,1-5H3,(H2,37,38,42) D02EZF DRUGINKE HNRUUMLUBDTZHX-UHFFFAOYSA-N D02EZF DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OCCCO D02EZF HIGHSTAT Investigative D02FCR DRUG__ID D02FCR D02FCR DRUGTYPE Small molecular drug D02FCR DRUGINCH 1S/C4H5NO3S/c6-3(7)2-1-9-4(8)5-2/h2H,1H2,(H,5,8)(H,6,7)/p-1 D02FCR DRUGINKE BMLMGCPTLHPWPY-UHFFFAOYSA-M D02FCR DRUGSMIL C1C(NC(=O)S1)C(=O)[O-] D02FCR HIGHSTAT Investigative D02FCS DRUG__ID D02FCS D02FCS DRUGTYPE Small molecular drug D02FCS DRUGINCH 1S/C21H26N2O3/c1-25-10-8-14-13-11-21(20(24)26-2)18-16(7-9-23(12-13)19(14)21)15-5-3-4-6-17(15)22-18/h3-6,13-14,19,22H,7-12H2,1-2H3/t13?,14?,19-,21+/m0/s1 D02FCS DRUGINKE VNPGFSWKZRZJCI-XZKBRSTLSA-N D02FCS DRUGSMIL COCCC1C2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC D02FCS HIGHSTAT Investigative D02FCY DRUG__ID D02FCY D02FCY DRUGTYPE Small molecular drug D02FCY DRUGINCH 1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7-/m0/s1 D02FCY DRUGINKE OPVPGKGADVGKTG-BQBZGAKWSA-N D02FCY DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O D02FCY HIGHSTAT Investigative D02FEF DRUG__ID D02FEF D02FEF DRUGTYPE Small molecular drug D02FEF DRUGINCH 1S/C14H14N2O3S/c1-19-13-4-2-3-11(9-13)10-16-12-5-7-14(8-6-12)20(15,17)18/h2-10H,1H3,(H2,15,17,18) D02FEF DRUGINKE PMXSUWQVMRZMRV-UHFFFAOYSA-N D02FEF DRUGSMIL COC1=CC=CC(=C1)C=NC2=CC=C(C=C2)S(=O)(=O)N D02FEF HIGHSTAT Investigative D02FGF DRUG__ID D02FGF D02FGF DRUGTYPE Small molecular drug D02FGF DRUGINCH 1S/C17H24N3O6P/c1-2-3-7-14(20-27(24,25)26)16(21)19-15(17(22)23)9-11-10-18-13-8-5-4-6-12(11)13/h4-6,8,10,14-15,18H,2-3,7,9H2,1H3,(H,19,21)(H,22,23)(H3,20,24,25,26)/p-3/t14-,15-/m0/s1 D02FGF DRUGINKE MFLINLZAVZVZNC-GJZGRUSLSA-K D02FGF DRUGSMIL CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-])[O-] D02FGF HIGHSTAT Investigative D02FGK DRUG__ID D02FGK D02FGK DRUGTYPE Small molecular drug D02FGK DRUGINCH 1S/C23H18F4N4O2/c24-19-9-7-15(11-18(19)23(25,26)27)20-12-17(33-31-20)13-29-21(32)5-1-4-16-8-6-14-3-2-10-28-22(14)30-16/h2-3,6-12H,1,4-5,13H2,(H,29,32) D02FGK DRUGINKE SWKGPCNQBPGWNX-UHFFFAOYSA-N D02FGK DRUGSMIL C1=CC2=C(N=C1)N=C(C=C2)CCCC(=O)NCC3=CC(=NO3)C4=CC(=C(C=C4)F)C(F)(F)F D02FGK HIGHSTAT Investigative D02FGY DRUG__ID D02FGY D02FGY DRUGTYPE Small molecular drug D02FGY DRUGINCH 1S/C12H10FNO2/c13-10-3-1-2-4-11(10)14-6-5-9(8-14)7-12(15)16/h1-6,8H,7H2,(H,15,16) D02FGY DRUGINKE FBDSYHLMZKXXBC-UHFFFAOYSA-N D02FGY DRUGSMIL C1=CC=C(C(=C1)N2C=CC(=C2)CC(=O)O)F D02FGY HIGHSTAT Investigative D02FHX DRUG__ID D02FHX D02FHX DRUGTYPE Small molecular drug D02FHX DRUGINCH 1S/C5H10N2O/c1-2-4-3-8-5(6)7-4/h4H,2-3H2,1H3,(H2,6,7) D02FHX DRUGINKE JTEWXLMHFCOPAX-UHFFFAOYSA-N D02FHX DRUGSMIL CCC1COC(=N1)N D02FHX HIGHSTAT Investigative D02FJX DRUG__ID D02FJX D02FJX DRUGTYPE Small molecular drug D02FJX DRUGINCH 1S/C16H15F3N4O3/c1-21-11-12(22(2)15(25)23(3)13(11)24)20-14(21)26-8-9-5-4-6-10(7-9)16(17,18)19/h4-7H,8H2,1-3H3 D02FJX DRUGINKE MJKQEGLZEOPZNY-UHFFFAOYSA-N D02FJX DRUGSMIL CN1C2=C(N=C1OCC3=CC(=CC=C3)C(F)(F)F)N(C(=O)N(C2=O)C)C D02FJX HIGHSTAT Investigative D02FLH DRUG__ID D02FLH D02FLH DRUGTYPE Small molecular drug D02FLH DRUGINCH 1S/C21H19N3/c1-2-9-19-23-20-17(15-10-5-3-6-11-15)14-18(22-21(20)24-19)16-12-7-4-8-13-16/h3-8,10-14H,2,9H2,1H3,(H,22,23,24) D02FLH DRUGINKE DBBRCPJIWFJBPI-UHFFFAOYSA-N D02FLH DRUGSMIL CCCC1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D02FLH HIGHSTAT Investigative D02FMN DRUG__ID D02FMN D02FMN DRUGTYPE Small molecular drug D02FMN DRUGINCH 1S/C21H31N4O8P/c1-12(20(30)23-13(2)19(22)29)11-34(32,33)17(9-15-7-5-4-6-8-15)25-21(31)16(10-18(27)28)24-14(3)26/h4-8,12-13,16-17H,9-11H2,1-3H3,(H2,22,29)(H,23,30)(H,24,26)(H,25,31)(H,27,28)(H,32,33)/t12-,13+,16+,17-/m1/s1 D02FMN DRUGINKE OCAZUTUOYLAIOA-OSRSDYAFSA-N D02FMN DRUGSMIL CC(CP(=O)(C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C)O)C(=O)NC(C)C(=O)N D02FMN HIGHSTAT Investigative D02FMR DRUG__ID D02FMR D02FMR DRUGTYPE Small molecular drug D02FMR DRUGINCH 1S/C14H9BrClN3/c15-9-4-5-13-12(6-9)14(18-8-17-13)19-11-3-1-2-10(16)7-11/h1-8H,(H,17,18,19) D02FMR DRUGINKE LYKXFKUSOXETGV-UHFFFAOYSA-N D02FMR DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)Br D02FMR HIGHSTAT Investigative D02FPU DRUG__ID D02FPU D02FPU DRUGTYPE Small molecular drug D02FPU DRUGINCH 1S/C12H12F3NO2/c1-2-10(7-17)16-11(18)8-4-3-5-9(6-8)12(13,14)15/h3-7,10H,2H2,1H3,(H,16,18) D02FPU DRUGINKE BXZCQIXITWILKZ-UHFFFAOYSA-N D02FPU DRUGSMIL CCC(C=O)NC(=O)C1=CC(=CC=C1)C(F)(F)F D02FPU HIGHSTAT Investigative D02FQG DRUG__ID D02FQG D02FQG DRUGTYPE Small molecular drug D02FQG DRUGINCH 1S/C26H33ClN2O4/c1-32-23-7-5-19(6-8-23)24-18-29(12-9-26(31)10-13-33-14-11-26)17-20(24)15-25(30)28-22-4-2-3-21(27)16-22/h2-8,16,20,24,31H,9-15,17-18H2,1H3,(H,28,30)/t20-,24+/m0/s1 D02FQG DRUGINKE OLINDOIRFAZHRH-GBXCKJPGSA-N D02FQG DRUGSMIL COC1=CC=C(C=C1)C2CN(CC2CC(=O)NC3=CC(=CC=C3)Cl)CCC4(CCOCC4)O D02FQG HIGHSTAT Investigative D02FRA DRUG__ID D02FRA D02FRA DRUGTYPE Small molecular drug D02FRA DRUGINCH 1S/C15H16ClN/c1-15(2,13-9-6-10-17-11-13)14(16)12-7-4-3-5-8-12/h3-11,14H,1-2H3 D02FRA DRUGINKE DEEQECRKPXLAOA-UHFFFAOYSA-N D02FRA DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CC=CC=C2)Cl D02FRA HIGHSTAT Investigative D02FTR DRUG__ID D02FTR D02FTR DRUGTYPE Small molecular drug D02FTR DRUGINCH 1S/C17H27NO4/c1-8-9-21-16(20)14-10(2)13(11(3)18-14)15(19)22-12(4)17(5,6)7/h12,18H,8-9H2,1-7H3 D02FTR DRUGINKE DOYZAIRDDZPMQZ-UHFFFAOYSA-N D02FTR DRUGSMIL CCCOC(=O)C1=C(C(=C(N1)C)C(=O)OC(C)C(C)(C)C)C D02FTR HIGHSTAT Investigative D02FUG DRUG__ID D02FUG D02FUG DRUGTYPE Small molecular drug D02FUG DRUGINCH 1S/C9H9ClO3/c1-6(9(11)12)13-8-4-2-7(10)3-5-8/h2-6H,1H3,(H,11,12) D02FUG DRUGINKE DKHJWWRYTONYHB-UHFFFAOYSA-N D02FUG DRUGSMIL CC(C(=O)O)OC1=CC=C(C=C1)Cl D02FUG HIGHSTAT Investigative D02FVV DRUG__ID D02FVV D02FVV DRUGTYPE Small molecular drug D02FVV DRUGINCH 1S/C20H12O5/c1-20-5-4-16(23)12-8-25-19(17(12)20)18(24)11-6-9-10(7-13(11)20)15(22)3-2-14(9)21/h2-3,6-8H,4-5H2,1H3/t20-/m0/s1 D02FVV DRUGINKE SMGBXXZKAPMTBB-FQEVSTJZSA-N D02FVV DRUGSMIL CC12CCC(=O)C3=COC(=C31)C(=O)C4=C2C=C5C(=O)C=CC(=O)C5=C4 D02FVV HIGHSTAT Investigative D02FXS DRUG__ID D02FXS D02FXS DRUGTYPE Small molecular drug D02FXS DRUGINCH 1S/C12H11NO3/c1-2-7-3-4-10-8(5-7)11(14)9(6-13-10)12(15)16/h3-6H,2H2,1H3,(H,13,14)(H,15,16) D02FXS DRUGINKE RESVKOSPFKHQBK-UHFFFAOYSA-N D02FXS DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)O D02FXS HIGHSTAT Investigative D02FYN DRUG__ID D02FYN D02FYN DRUGTYPE Small molecular drug D02FYN DRUGINCH 1S/C12H11NO3S/c13-17(14,15)12-7-4-10(5-8-12)3-6-11-2-1-9-16-11/h1-9H,(H2,13,14,15)/b6-3+ D02FYN DRUGINKE LUXIPMZZPXZHSJ-ZZXKWVIFSA-N D02FYN DRUGSMIL C1=COC(=C1)C=CC2=CC=C(C=C2)S(=O)(=O)N D02FYN HIGHSTAT Investigative D02FZD DRUG__ID D02FZD D02FZD DRUGTYPE Small molecular drug D02FZD DRUGINCH 1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)/t12-/m1/s1 D02FZD DRUGINKE HJORMJIFDVBMOB-GFCCVEGCSA-N D02FZD DRUGSMIL COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 D02FZD HIGHSTAT Investigative D02FZM DRUG__ID D02FZM D02FZM DRUGTYPE Small molecular drug D02FZM DRUGINCH 1S/C18H24N4O7/c19-14(16(23)21-11-3-5-15(21)17(24)25)4-1-2-10-20-18(26)29-13-8-6-12(7-9-13)22(27)28/h6-9,14-15H,1-5,10-11,19H2,(H,20,26)(H,24,25)/t14?,15-/m0/s1 D02FZM DRUGINKE XECWFUGQRJPWRP-LOACHALJSA-N D02FZM DRUGSMIL C1CC(N(C1)C(=O)C(CCCCNC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])N)C(=O)O D02FZM HIGHSTAT Investigative D02FZQ DRUG__ID D02FZQ D02FZQ DRUGTYPE Small molecular drug D02FZQ DRUGINCH 1S/C18H16O2S/c1-19-15-7-3-13(4-8-15)17-11-12-18(21-17)14-5-9-16(20-2)10-6-14/h3-12H,1-2H3 D02FZQ DRUGINKE SNVBIBDQUGLRIV-UHFFFAOYSA-N D02FZQ DRUGSMIL COC1=CC=C(C=C1)C2=CC=C(S2)C3=CC=C(C=C3)OC D02FZQ HIGHSTAT Investigative D02FZW DRUG__ID D02FZW D02FZW DRUGTYPE Small molecular drug D02FZW DRUGINCH 1S/C27H28N2O4/c1-16-3-5-17(6-4-16)7-10-22(32)28-27-12-11-20(31)25-26(27)13-14-29(2)21(27)15-18-8-9-19(30)24(33-25)23(18)26/h3-10,21,25,30H,11-15H2,1-2H3,(H,28,32)/b10-7+/t21?,25-,26-,27+/m0/s1 D02FZW DRUGINKE JRFZMFGBYRTYRZ-KPAXYDNFSA-N D02FZW DRUGSMIL CC1=CC=C(C=C1)C=CC(=O)NC23CCC(=O)C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)C D02FZW HIGHSTAT Investigative D02GDG DRUG__ID D02GDG D02GDG DRUGTYPE Small molecular drug D02GDG DRUGINCH 1S/C31H25N3OS/c1-22(20-24-12-6-3-7-13-24)18-19-29(35)30-23(2)32-31(36-30)34-28(26-16-10-5-11-17-26)21-27(33-34)25-14-8-4-9-15-25/h3-21H,1-2H3/b19-18+,22-20+ D02GDG DRUGINKE FGKMUICUBCAKMJ-RFBAJPLNSA-N D02GDG DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC(=CC5=CC=CC=C5)C D02GDG HIGHSTAT Investigative D02GEQ DRUG__ID D02GEQ D02GEQ DRUGTYPE Small molecular drug D02GEQ DRUGINCH 1S/C7H16NO7P/c1-6(9)13-4-7(10)5-15-16(11,12)14-3-2-8/h7,10H,2-5,8H2,1H3,(H,11,12)/p-1/t7-/m1/s1 D02GEQ DRUGINKE CWRILEGKIAOYKP-SSDOTTSWSA-M D02GEQ DRUGSMIL CC(=O)OCC(COP(=O)([O-])OCCN)O D02GEQ HIGHSTAT Investigative D02GFK DRUG__ID D02GFK D02GFK DRUGTYPE Small molecular drug D02GFK DRUGINCH 1S/C16H14N2O/c1-19-14-5-4-11-8-13(3-2-12(11)9-14)15-10-18-7-6-16(15)17/h2-10H,1H3,(H2,17,18) D02GFK DRUGINKE WAIWXNYKRBBVSH-UHFFFAOYSA-N D02GFK DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=C(C=CN=C3)N D02GFK HIGHSTAT Investigative D02GJG DRUG__ID D02GJG D02GJG DRUGTYPE Small molecular drug D02GJG DRUGINCH 1S/C14H8F2O2/c15-11-7-3-1-5-9(11)13(17)14(18)10-6-2-4-8-12(10)16/h1-8H D02GJG DRUGINKE UWQCHLREAXYCBW-UHFFFAOYSA-N D02GJG DRUGSMIL C1=CC=C(C(=C1)C(=O)C(=O)C2=CC=CC=C2F)F D02GJG HIGHSTAT Investigative D02GJI DRUG__ID D02GJI D02GJI DRUGTYPE Small molecular drug D02GJI DRUGINCH 1S/C10H9N3O2S/c1-15-8-4-2-3-7(5-8)9(14)12-10-13-11-6-16-10/h2-6H,1H3,(H,12,13,14) D02GJI DRUGINKE UMVWXZHHIZNLAO-UHFFFAOYSA-N D02GJI DRUGSMIL COC1=CC=CC(=C1)C(=O)NC2=NN=CS2 D02GJI HIGHSTAT Investigative D02GLM DRUG__ID D02GLM D02GLM DRUGTYPE Small molecular drug D02GLM DRUGINCH 1S/C17H32N4/c1-12(2)7-8-15-9-16(18-10-13(3)4)21-17(20-15)19-11-14(5)6/h9,12-14H,7-8,10-11H2,1-6H3,(H2,18,19,20,21) D02GLM DRUGINKE FELVKNQXOFEZOY-UHFFFAOYSA-N D02GLM DRUGSMIL CC(C)CCC1=CC(=NC(=N1)NCC(C)C)NCC(C)C D02GLM HIGHSTAT Investigative D02GLY DRUG__ID D02GLY D02GLY DRUGTYPE Small molecular drug D02GLY DRUGINCH 1S/C13H9BrN2/c1-10-2-4-13(16-7-10)5-3-11-6-12(14)9-15-8-11/h2,4,6-9H,1H3 D02GLY DRUGINKE IHHBVGZPZBDKRA-UHFFFAOYSA-N D02GLY DRUGSMIL CC1=CN=C(C=C1)C#CC2=CC(=CN=C2)Br D02GLY HIGHSTAT Investigative D02GMU DRUG__ID D02GMU D02GMU DRUGTYPE Small molecular drug D02GMU DRUGINCH 1S/C34H41N5O5/c1-21-15-22(2)17-25(16-21)20-29(32(42)37-28(31(36)41)19-23-7-4-3-5-8-23)38-33(43)30-9-6-14-39(30)34(44)27(35)18-24-10-12-26(40)13-11-24/h3-5,7-8,10-13,15-17,27-30,40H,6,9,14,18-20,35H2,1-2H3,(H2,36,41)(H,37,42)(H,38,43)/t27-,28-,29-,30-/m0/s1 D02GMU DRUGINKE WGUOAUNVYIRMQJ-KRCBVYEFSA-N D02GMU DRUGSMIL CC1=CC(=CC(=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N)C D02GMU HIGHSTAT Investigative D02GNN DRUG__ID D02GNN D02GNN DRUGTYPE Small molecular drug D02GNN DRUGINCH 1S/C16H19N/c1-17-13-12-16(14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-11,16-17H,12-13H2,1H3 D02GNN DRUGINKE AKEGHAUFMKCWGX-UHFFFAOYSA-N D02GNN DRUGSMIL CNCCC(C1=CC=CC=C1)C2=CC=CC=C2 D02GNN HIGHSTAT Investigative D02GNX DRUG__ID D02GNX D02GNX DRUGTYPE Small molecular drug D02GNX DRUGINCH 1S/C11H11ClN4/c12-9-6-10(16-11(13)15-9)14-7-8-4-2-1-3-5-8/h1-6H,7H2,(H3,13,14,15,16) D02GNX DRUGINKE GXNJAZPAQIPYMJ-UHFFFAOYSA-N D02GNX DRUGSMIL C1=CC=C(C=C1)CNC2=CC(=NC(=N2)N)Cl D02GNX HIGHSTAT Investigative D02GOH DRUG__ID D02GOH D02GOH DRUGTYPE Small molecular drug D02GOH DRUGINCH 1S/C26H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-26(29)27-24-20-22-25(28)23-21-24/h6-7,9-10,12-13,15-16,20-23,28H,2-5,8,11,14,17-19H2,1H3,(H,27,29)/b7-6-,10-9-,13-12-,16-15- D02GOH DRUGINKE IJBZOOZRAXHERC-DOFZRALJSA-N D02GOH DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=CC=C(C=C1)O D02GOH HIGHSTAT Investigative D02GPJ DRUG__ID D02GPJ D02GPJ DRUGTYPE Small molecular drug D02GPJ DRUGINCH 1S/C18H15N3O2/c19-7-8-4-5-12-11(6-8)13-15-14(17(22)21-18(15)23)9-2-1-3-10(9)16(13)20-12/h4-6,20H,1-3,7,19H2,(H,21,22,23) D02GPJ DRUGINKE SDXBGOVSVBZDFL-UHFFFAOYSA-N D02GPJ DRUGSMIL C1CC2=C(C1)C3=C(C4=C(N3)C=CC(=C4)CN)C5=C2C(=O)NC5=O D02GPJ HIGHSTAT Investigative D02GRY DRUG__ID D02GRY D02GRY DRUGTYPE Small molecular drug D02GRY DRUGINCH 1S/C13H12O4/c1-2-13(9-6-4-3-5-7-9)11(14)8-10(17-13)12(15)16/h3-8H,2H2,1H3,(H,15,16) D02GRY DRUGINKE SUHZZFNDVLWPTL-UHFFFAOYSA-N D02GRY DRUGSMIL CCC1(C(=O)C=C(O1)C(=O)O)C2=CC=CC=C2 D02GRY HIGHSTAT Investigative D02GSL DRUG__ID D02GSL D02GSL DRUGTYPE Small molecular drug D02GSL DRUGINCH 1S/C13H13IN4O2/c14-11-8-13(17-5-3-15-4-6-17)16-12-2-1-9(18(19)20)7-10(11)12/h1-2,7-8,15H,3-6H2 D02GSL DRUGINKE ABNBXDNNSDJWKN-UHFFFAOYSA-N D02GSL DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)I D02GSL HIGHSTAT Investigative D02GSX DRUG__ID D02GSX D02GSX DRUGTYPE Small molecular drug D02GSX DRUGINCH 1S/C16H13N3O/c17-8-9-19-13-7-3-6-12-14(13)15(18-19)10-4-1-2-5-11(10)16(12)20/h1-7H,8-9,17H2 D02GSX DRUGINKE BELLEOUYTCSNAZ-UHFFFAOYSA-N D02GSX DRUGSMIL C1=CC=C2C(=C1)C3=NN(C4=CC=CC(=C43)C2=O)CCN D02GSX HIGHSTAT Investigative D02GTZ DRUG__ID D02GTZ D02GTZ DRUGTYPE Small molecular drug D02GTZ DRUGINCH 1S/C30H18O4/c31-24-18-27(33-25-12-6-4-10-22(24)25)19-14-16-20(17-15-19)28-29(32)23-11-5-7-13-26(23)34-30(28)21-8-2-1-3-9-21/h1-18H D02GTZ DRUGINKE DKAAIRCEBVCHAT-UHFFFAOYSA-N D02GTZ DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)C4=CC=C(C=C4)C5=CC(=O)C6=CC=CC=C6O5 D02GTZ HIGHSTAT Investigative D02GZX DRUG__ID D02GZX D02GZX DRUGTYPE Small molecular drug D02GZX DRUGINCH 1S/C17H18O2S/c1-3-20-16-6-4-5-15(11-16)14-9-7-13(8-10-14)12(2)17(18)19/h4-12H,3H2,1-2H3,(H,18,19) D02GZX DRUGINKE QGKUCOODYMVNGO-UHFFFAOYSA-N D02GZX DRUGSMIL CCSC1=CC=CC(=C1)C2=CC=C(C=C2)C(C)C(=O)O D02GZX HIGHSTAT Investigative D02HAL DRUG__ID D02HAL D02HAL DRUGTYPE Small molecular drug D02HAL DRUGINCH 1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D02HAL DRUGINKE XCCTYIAWTASOJW-XVFCMESISA-N D02HAL DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)O)O)O D02HAL HIGHSTAT Investigative D02HCQ DRUG__ID D02HCQ D02HCQ DRUGTYPE Small molecular drug D02HCQ DRUGINCH 1S/C16H18O9/c17-9-3-1-8(5-10(9)18)2-4-13(20)25-12-7-16(24,15(22)23)6-11(19)14(12)21/h1-5,11-12,14,17-19,21,24H,6-7H2,(H,22,23)/b4-2+/t11-,12-,14-,16+/m1/s1 D02HCQ DRUGINKE CWVRJTMFETXNAD-JUHZACGLSA-N D02HCQ DRUGSMIL C1C(C(C(CC1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O D02HCQ HIGHSTAT Investigative D02HDI DRUG__ID D02HDI D02HDI DRUGTYPE Small molecular drug D02HDI DRUGINCH 1S/C23H37NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(25)24-22-20-21-22/h6-7,9-10,12-13,15-16,22H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15- D02HDI DRUGINKE GLGAUBPACOBAMV-DOFZRALJSA-N D02HDI DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1CC1 D02HDI HIGHSTAT Investigative D02HEK DRUG__ID D02HEK D02HEK DRUGTYPE Small molecular drug D02HEK DRUGINCH 1S/C13H10N2O/c1-8(16)12-6-10-9-4-2-3-5-11(9)15-13(10)7-14-12/h2-7,15H,1H3 D02HEK DRUGINKE MPLXFBXMWYMAFN-UHFFFAOYSA-N D02HEK DRUGSMIL CC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D02HEK HIGHSTAT Investigative D02HGS DRUG__ID D02HGS D02HGS DRUGTYPE Small molecular drug D02HGS DRUGINCH 1S/C15H10ClNO2/c16-15-11-5-6-12(9-1-3-10(18)4-2-9)17-13(11)7-8-14(15)19/h1-8,18-19H D02HGS DRUGINKE FGSBNIBNUVNBIW-UHFFFAOYSA-N D02HGS DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C2)C(=C(C=C3)O)Cl)O D02HGS HIGHSTAT Investigative D02HHW DRUG__ID D02HHW D02HHW DRUGTYPE Small molecular drug D02HHW DRUGINCH 1S/C23H25ClN8O5/c1-11-5-15(37-31-11)35-8-12-3-4-14(24)6-13(12)7-27-20-17-21(29-9-28-20)32(10-30-17)23-18(33)16(25)19(36-23)22(34)26-2/h3-6,9-10,16,18-19,23,33H,7-8,25H2,1-2H3,(H,26,34)(H,27,28,29)/t16-,18+,19-,23+/m0/s1 D02HHW DRUGINKE KXDJDMIUJGBFAV-QYUDBREXSA-N D02HHW DRUGSMIL CC1=NOC(=C1)OCC2=C(C=C(C=C2)Cl)CNC3=C4C(=NC=N3)N(C=N4)C5C(C(C(O5)C(=O)NC)N)O D02HHW HIGHSTAT Investigative D02HMN DRUG__ID D02HMN D02HMN DRUGTYPE Small molecular drug D02HMN DRUGINCH 1S/C13H9F2N/c14-13(15)8-5-6-10-9-3-1-2-4-11(9)16-12(10)7-8/h1-7,13,16H D02HMN DRUGINKE JHTSEXLNQMISRI-UHFFFAOYSA-N D02HMN DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)C(F)F D02HMN HIGHSTAT Investigative D02HMZ DRUG__ID D02HMZ D02HMZ DRUGTYPE Small molecular drug D02HMZ DRUGINCH 1S/C16H10F3NOS/c17-16(18,19)21-15-7-2-1-6-13(15)11-4-3-5-12(8-11)14-9-22-10-20-14/h1-10H D02HMZ DRUGINKE AJYWSJBYBSJCBJ-UHFFFAOYSA-N D02HMZ DRUGSMIL C1=CC=C(C(=C1)C2=CC(=CC=C2)C3=CSC=N3)OC(F)(F)F D02HMZ HIGHSTAT Investigative D02HNE DRUG__ID D02HNE D02HNE DRUGTYPE Small molecular drug D02HNE DRUGINCH 1S/C9H14N2S/c1-2-7-11(6-1)8-4-9-3-5-10-12-9/h3,5H,1-2,4,6-8H2 D02HNE DRUGINKE GRXWPIZSBSTAQX-UHFFFAOYSA-N D02HNE DRUGSMIL C1CCN(C1)CCC2=CC=NS2 D02HNE HIGHSTAT Investigative D02HNM DRUG__ID D02HNM D02HNM DRUGTYPE Small molecular drug D02HNM DRUGINCH 1S/C9H13ClNO3P/c10-9-3-1-7(2-4-9)8(5-11)6-15(12,13)14/h1-4,8H,5-6,11H2,(H2,12,13,14) D02HNM DRUGINKE VSGNGLJPOGUDON-UHFFFAOYSA-N D02HNM DRUGSMIL C1=CC(=CC=C1C(CN)CP(=O)(O)O)Cl D02HNM HIGHSTAT Investigative D02HNQ DRUG__ID D02HNQ D02HNQ DRUGTYPE Small molecular drug D02HNQ DRUGINCH 1S/C26H22ClNO4S/c27-23-11-8-18(13-22(23)26(30)31)17-5-3-4-16(12-17)15-32-20-9-10-21-24(14-20)33-28(25(21)29)19-6-1-2-7-19/h3-5,8-14,19H,1-2,6-7,15H2,(H,30,31) D02HNQ DRUGINKE ZQBPXBADOJMCRU-UHFFFAOYSA-N D02HNQ DRUGSMIL C1CCC(C1)N2C(=O)C3=C(S2)C=C(C=C3)OCC4=CC(=CC=C4)C5=CC(=C(C=C5)Cl)C(=O)O D02HNQ HIGHSTAT Investigative D02HOG DRUG__ID D02HOG D02HOG DRUGTYPE Small molecular drug D02HOG DRUGINCH 1S/C8H9O6P/c1-13-7-4-2-3-6(5-9)8(7)14-15(10,11)12/h2-5H,1H3,(H2,10,11,12) D02HOG DRUGINKE CGEZBCISRKFHLZ-UHFFFAOYSA-N D02HOG DRUGSMIL COC1=CC=CC(=C1OP(=O)(O)O)C=O D02HOG HIGHSTAT Investigative D02HOL DRUG__ID D02HOL D02HOL DRUGTYPE Small molecular drug D02HOL DRUGINCH 1S/C8H10BrN5/c1-2-3-14-7-5(13-8(14)9)6(10)11-4-12-7/h4H,2-3H2,1H3,(H2,10,11,12) D02HOL DRUGINKE ATNWURROUOXVHM-UHFFFAOYSA-N D02HOL DRUGSMIL CCCN1C2=NC=NC(=C2N=C1Br)N D02HOL HIGHSTAT Investigative D02HOP DRUG__ID D02HOP D02HOP DRUGTYPE Small molecular drug D02HOP DRUGINCH 1S/C13H14IN3/c14-11-2-3-12-10(9-11)1-4-13(16-12)17-7-5-15-6-8-17/h1-4,9,15H,5-8H2 D02HOP DRUGINKE BZVOKNDAJHHFPT-UHFFFAOYSA-N D02HOP DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)I D02HOP HIGHSTAT Investigative D02HQK DRUG__ID D02HQK D02HQK DRUGTYPE Small molecular drug D02HQK DRUGINCH 1S/C15H15NO2/c1-16(18)15(17)11-12-7-9-14(10-8-12)13-5-3-2-4-6-13/h2-10,18H,11H2,1H3 D02HQK DRUGINKE OKCNSKAFTYDWAP-UHFFFAOYSA-N D02HQK DRUGSMIL CN(C(=O)CC1=CC=C(C=C1)C2=CC=CC=C2)O D02HQK HIGHSTAT Investigative D02HQS DRUG__ID D02HQS D02HQS DRUGTYPE Small molecular drug D02HQS DRUGINCH 1S/C14H6F4O2/c15-7-1-3-9(11(17)5-7)13(19)14(20)10-4-2-8(16)6-12(10)18/h1-6H D02HQS DRUGINKE GMRRDQVLRFWXPQ-UHFFFAOYSA-N D02HQS DRUGSMIL C1=CC(=C(C=C1F)F)C(=O)C(=O)C2=C(C=C(C=C2)F)F D02HQS HIGHSTAT Investigative D02HSP DRUG__ID D02HSP D02HSP DRUGTYPE Small molecular drug D02HSP DRUGINCH 1S/C24H32O8/c1-26-18-9-14(10-19(27-2)22(18)30-5)7-16-13-32-24(25)17(16)8-15-11-20(28-3)23(31-6)21(12-15)29-4/h9-12,16-17,24-25H,7-8,13H2,1-6H3/t16-,17+,24?/m0/s1 D02HSP DRUGINKE PIYHDSUVUSVLGU-HSQXHLSASA-N D02HSP DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2COC(C2CC3=CC(=C(C(=C3)OC)OC)OC)O D02HSP HIGHSTAT Investigative D02HSZ DRUG__ID D02HSZ D02HSZ DRUGTYPE Small molecular drug D02HSZ DRUGINCH 1S/C19H16INO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) D02HSZ DRUGINKE CXBFZYKAVCAPSV-UHFFFAOYSA-N D02HSZ DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)I)C=CC(=C2)OC)CC(=O)O D02HSZ HIGHSTAT Investigative D02HTG DRUG__ID D02HTG D02HTG DRUGTYPE Small molecular drug D02HTG DRUGINCH 1S/C10H8F2N2/c11-9-3-8(4-10(12)5-9)6-14-2-1-13-7-14/h1-5,7H,6H2 D02HTG DRUGINKE HGEAQRQBZSYPGD-UHFFFAOYSA-N D02HTG DRUGSMIL C1=CN(C=N1)CC2=CC(=CC(=C2)F)F D02HTG HIGHSTAT Investigative D02HVH DRUG__ID D02HVH D02HVH DRUGTYPE Small molecular drug D02HVH DRUGINCH 1S/C16H20N2OS2/c19-15(10-6-1-2-7-11-20)18-16-17-14(12-21-16)13-8-4-3-5-9-13/h3-5,8-9,12,20H,1-2,6-7,10-11H2,(H,17,18,19) D02HVH DRUGINKE LUXAHBUKMVESIS-UHFFFAOYSA-N D02HVH DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)CCCCCCS D02HVH HIGHSTAT Investigative D02HVL DRUG__ID D02HVL D02HVL DRUGTYPE Small molecular drug D02HVL DRUGINCH 1S/C11H13ClO3/c1-2-5-15-10-4-3-8(6-9(10)12)7-11(13)14/h3-4,6H,2,5,7H2,1H3,(H,13,14) D02HVL DRUGINKE QEJHPAGTOOIBFT-UHFFFAOYSA-N D02HVL DRUGSMIL CCCOC1=C(C=C(C=C1)CC(=O)O)Cl D02HVL HIGHSTAT Investigative D02HVT DRUG__ID D02HVT D02HVT DRUGTYPE Small molecular drug D02HVT DRUGINCH 1S/C35H58N6O12S/c1-6-19(4)29(34(51)39-24(15-21-10-8-7-9-11-21)31(48)40-26(17-54)35(52)53)41-33(50)23(14-18(2)3)38-30(47)22(12-13-27(43)44)37-32(49)25(16-28(45)46)36-20(5)42/h18-19,21-26,29,54H,6-17H2,1-5H3,(H,36,42)(H,37,49)(H,38,47)(H,39,51)(H,40,48)(H,41,50)(H,43,44)(H,45,46)(H,52,53)/t19-,22+,23+,24+,25+,26+,29+/m1/s1 D02HVT DRUGINKE CSWPZICAVWHBCE-ZZOXDLJQSA-N D02HVT DRUGSMIL CCC(C)C(C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D02HVT HIGHSTAT Investigative D02HWL DRUG__ID D02HWL D02HWL DRUGTYPE Small molecular drug D02HWL DRUGINCH 1S/C26H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h12-13,25,28H,5-11,14-24H2,1-4H3/b13-12-/t25-/m1/s1 D02HWL DRUGINKE YAMUFBLWGFFICM-PTGWMXDISA-N D02HWL DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O D02HWL HIGHSTAT Investigative D02HXC DRUG__ID D02HXC D02HXC DRUGTYPE Small molecular drug D02HXC DRUGINCH 1S/C20H15N3O5S2/c21-29(24,25)19-8-1-4-13-12-14(10-11-15(13)19)22-23-18-7-2-6-17-16(18)5-3-9-20(17)30(26,27)28/h1-12H,(H2,21,24,25)(H,26,27,28) D02HXC DRUGINKE PJYDTRSKIYLDEE-UHFFFAOYSA-N D02HXC DRUGSMIL C1=CC2=C(C=CC(=C2)N=NC3=CC=CC4=C3C=CC=C4S(=O)(=O)O)C(=C1)S(=O)(=O)N D02HXC HIGHSTAT Investigative D02HYG DRUG__ID D02HYG D02HYG DRUGTYPE Small molecular drug D02HYG DRUGINCH 1S/C4H9NO/c5-3-1-2-4-6/h4H,1-3,5H2 D02HYG DRUGINKE DZQLQEYLEYWJIB-UHFFFAOYSA-N D02HYG DRUGSMIL C(CC=O)CN D02HYG HIGHSTAT Investigative D02HYT DRUG__ID D02HYT D02HYT DRUGTYPE Small molecular drug D02HYT DRUGINCH 1S/C19H17N3O/c1-2-18(23)21-17-13-16(14-9-5-3-6-10-14)20-19(22-17)15-11-7-4-8-12-15/h3-13H,2H2,1H3,(H,20,21,22,23) D02HYT DRUGINKE GFLZXPLJINFGKI-UHFFFAOYSA-N D02HYT DRUGSMIL CCC(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D02HYT HIGHSTAT Investigative D02HYW DRUG__ID D02HYW D02HYW DRUGTYPE Small molecular drug D02HYW DRUGINCH 1S/C23H26O6/c1-6-23(4,5)19-14(25)9-13(24)18-21(28)17-12(8-7-11(2)3)20(27)15(26)10-16(17)29-22(18)19/h6-7,9-10,18,22,24-27H,1,8H2,2-5H3 D02HYW DRUGINKE RAIAMYMZPGRUDU-UHFFFAOYSA-N D02HYW DRUGSMIL CC(=CCC1=C(C(=CC2=C1C(=O)C3C(O2)C(=C(C=C3O)O)C(C)(C)C=C)O)O)C D02HYW HIGHSTAT Investigative D02HZG DRUG__ID D02HZG D02HZG DRUGTYPE Small molecular drug D02HZG DRUGINCH 1S/C10H14BrNO/c1-12(2)7-8-13-10-6-4-3-5-9(10)11/h3-6H,7-8H2,1-2H3 D02HZG DRUGINKE OUWAXRLVNYTZJK-UHFFFAOYSA-N D02HZG DRUGSMIL CN(C)CCOC1=CC=CC=C1Br D02HZG HIGHSTAT Investigative D02HZJ DRUG__ID D02HZJ D02HZJ DRUGTYPE Small molecular drug D02HZJ DRUGINCH 1S/C23H17N3O/c27-23(19-14-8-3-9-15-19)26-21-16-20(17-10-4-1-5-11-17)24-22(25-21)18-12-6-2-7-13-18/h1-16H,(H,24,25,26,27) D02HZJ DRUGINKE GQFWFPVBIHHTGX-UHFFFAOYSA-N D02HZJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=N2)C3=CC=CC=C3)NC(=O)C4=CC=CC=C4 D02HZJ HIGHSTAT Investigative D02IBM DRUG__ID D02IBM D02IBM DRUGTYPE Small molecular drug D02IBM DRUGINCH 1S/C21H29N3O4/c25-20(26)11-7-2-1-6-10-16-17(19-13-12-18(16)28-19)14-22-24-21(27)23-15-8-4-3-5-9-15/h1,3-6,8-9,16-19,22H,2,7,10-14H2,(H,25,26)(H2,23,24,27)/b6-1-/t16-,17+,18-,19+/m1/s1 D02IBM DRUGINKE RJNDVCNWVBWHLY-OQMICVBCSA-N D02IBM DRUGSMIL C1CC2C(C(C1O2)CC=CCCCC(=O)O)CNNC(=O)NC3=CC=CC=C3 D02IBM HIGHSTAT Investigative D02ICX DRUG__ID D02ICX D02ICX DRUGTYPE Small molecular drug D02ICX DRUGINCH 1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3 D02ICX DRUGINKE SWUVZKWCOBGPTH-UHFFFAOYSA-N D02ICX DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2 D02ICX HIGHSTAT Investigative D02IDM DRUG__ID D02IDM D02IDM DRUGTYPE Small molecular drug D02IDM DRUGINCH 1S/C14H17NO/c1-10(15)7-11-3-4-13-9-14(16-2)6-5-12(13)8-11/h3-6,8-10H,7,15H2,1-2H3 D02IDM DRUGINKE YYZOZFYDYBTLPQ-UHFFFAOYSA-N D02IDM DRUGSMIL CC(CC1=CC2=C(C=C1)C=C(C=C2)OC)N D02IDM HIGHSTAT Investigative D02IDN DRUG__ID D02IDN D02IDN DRUGTYPE Small molecular drug D02IDN DRUGINCH 1S/C19H13NO2/c20-14-8-5-13(6-9-14)18-11-17(21)16-10-7-12-3-1-2-4-15(12)19(16)22-18/h1-11H,20H2 D02IDN DRUGINKE JXHKSKYNJHBJDZ-UHFFFAOYSA-N D02IDN DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2OC(=CC3=O)C4=CC=C(C=C4)N D02IDN HIGHSTAT Investigative D02IEO DRUG__ID D02IEO D02IEO DRUGTYPE Small molecular drug D02IEO DRUGINCH 1S/C21H28N2O3/c1-12(24)13(2)26-21(25)15-8-17-16-6-5-7-18-20(16)14(10-22(18)3)9-19(17)23(4)11-15/h5-7,10,12-13,15,17,19,24H,8-9,11H2,1-4H3 D02IEO DRUGINKE YLCYDARNSJPGCV-UHFFFAOYSA-N D02IEO DRUGSMIL CC(C(C)OC(=O)C1CC2C(CC3=CN(C4=CC=CC2=C34)C)N(C1)C)O D02IEO HIGHSTAT Investigative D02IIN DRUG__ID D02IIN D02IIN DRUGTYPE Small molecular drug D02IIN DRUGINCH 1S/C29H31N3O/c1-4-29(33)14-12-22-20-10-9-19-15-24-18(16-27(19,2)21(20)11-13-28(22,29)3)17-32-25-8-6-5-7-23(25)30-26(32)31-24/h1,5-8,15,17,20-22,33H,9-14,16H2,2-3H3/t20-,21+,22+,27+,28+,29+/m1/s1 D02IIN DRUGINKE YBCYJDNOPAFFOW-XOAARHKISA-N D02IIN DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=NC6=NC7=CC=CC=C7N6C=C5CC34C D02IIN HIGHSTAT Investigative D02IJB DRUG__ID D02IJB D02IJB DRUGTYPE Small molecular drug D02IJB DRUGINCH 1S/C80H106Cl2N11O27P.ClH/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39;/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114);1H/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-;/m0./s1 D02IJB DRUGINKE GSSIWSIRBWAZHG-ACOPVEIWSA-N D02IJB DRUGSMIL CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C.Cl D02IJB HIGHSTAT Investigative D02IJM DRUG__ID D02IJM D02IJM DRUGTYPE Small molecular drug D02IJM DRUGINCH 1S/C11H12O3/c1-11(7-12)5-4-8-6-9(13)2-3-10(8)14-11/h2-6,12-13H,7H2,1H3/t11-/m1/s1 D02IJM DRUGINKE LTKJWSBGTNWRNP-LLVKDONJSA-N D02IJM DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2)O)CO D02IJM HIGHSTAT Investigative D02IJW DRUG__ID D02IJW D02IJW DRUGTYPE Small molecular drug D02IJW DRUGINCH 1S/C12H18N2/c1-11-3-2-9-14(11)10-6-12-4-7-13-8-5-12/h4-5,7-8,11H,2-3,6,9-10H2,1H3/t11-/m0/s1 D02IJW DRUGINKE HTPLEJUDOQHUSX-NSHDSACASA-N D02IJW DRUGSMIL CC1CCCN1CCC2=CC=NC=C2 D02IJW HIGHSTAT Investigative D02IMZ DRUG__ID D02IMZ D02IMZ DRUGTYPE Small molecular drug D02IMZ DRUGINCH 1S/C29H36N2O2/c32-28(30-19-21-7-2-1-3-8-21)33-24-13-12-23-17-27-25-11-4-5-14-29(25,26(23)18-24)15-16-31(27)20-22-9-6-10-22/h1-3,7-8,12-13,18,22,25,27H,4-6,9-11,14-17,19-20H2,(H,30,32) D02IMZ DRUGINKE VTNMTWBEHGIRGV-UHFFFAOYSA-N D02IMZ DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)NCC5=CC=CC=C5)CC6CCC6 D02IMZ HIGHSTAT Investigative D02INF DRUG__ID D02INF D02INF DRUGTYPE Small molecular drug D02INF DRUGINCH 1S/C26H40O2/c1-8-9-10-11-14-25(3,4)19-16-22(27-7)24-20-15-18(2)12-13-21(20)26(5,6)28-23(24)17-19/h16-17,20-21H,2,8-15H2,1,3-7H3/t20-,21-/m1/s1 D02INF DRUGINKE BJIIKHXAZBTGLF-NHCUHLMSSA-N D02INF DRUGSMIL CCCCCCC(C)(C)C1=CC2=C(C3CC(=C)CCC3C(O2)(C)C)C(=C1)OC D02INF HIGHSTAT Investigative D02INJ DRUG__ID D02INJ D02INJ DRUGTYPE Small molecular drug D02INJ DRUGINCH 1S/C11H13N3/c1-2-4-10(5-3-1)13-7-6-11-8-12-9-14-11/h1-5,8-9,13H,6-7H2,(H,12,14) D02INJ DRUGINKE JNHQUQHJWWFGKK-UHFFFAOYSA-N D02INJ DRUGSMIL C1=CC=C(C=C1)NCCC2=CN=CN2 D02INJ HIGHSTAT Investigative D02IOC DRUG__ID D02IOC D02IOC DRUGTYPE Small molecular drug D02IOC DRUGINCH 1S/C23H32N4/c1-8-10-11-26(9-2)22-20-18(6)14-27(23(20)25-19(7)24-22)21-16(4)12-15(3)13-17(21)5/h12-14H,8-11H2,1-7H3 D02IOC DRUGINKE FHQYJZCJRZHINA-UHFFFAOYSA-N D02IOC DRUGSMIL CCCCN(CC)C1=NC(=NC2=C1C(=CN2C3=C(C=C(C=C3C)C)C)C)C D02IOC HIGHSTAT Investigative D02IPX DRUG__ID D02IPX D02IPX DRUGTYPE Small molecular drug D02IPX DRUGINCH 1S/C20H32O6/c1-2-3-6-9-15(24-23)12-13-17-16(18-14-19(17)26-25-18)10-7-4-5-8-11-20(21)22/h4,7,12-13,15-19,23H,2-3,5-6,8-11,14H2,1H3,(H,21,22)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 D02IPX DRUGINKE SGUKUZOVHSFKPH-YNNPMVKQSA-N D02IPX DRUGSMIL CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OO2)OO D02IPX HIGHSTAT Investigative D02IQG DRUG__ID D02IQG D02IQG DRUGTYPE Small molecular drug D02IQG DRUGINCH 1S/C23H30N4O3/c1-14-9-18(28)10-15(2)19(14)12-20(25)23(30)27-13-17-6-4-3-5-16(17)11-21(27)22(29)26-8-7-24/h3-6,9-10,20-21,28H,7-8,11-13,24-25H2,1-2H3,(H,26,29)/t20-,21?/m0/s1 D02IQG DRUGINKE VIPTXSCSZKOVSA-BGERDNNASA-N D02IQG DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCN)N)C)O D02IQG HIGHSTAT Investigative D02IQH DRUG__ID D02IQH D02IQH DRUGTYPE Small molecular drug D02IQH DRUGINCH 1S/C10H6N2O3S/c11-12-8-5-4-7-2-1-3-10(9(7)6-8)16(13,14)15/h1-6H D02IQH DRUGINKE ABQHTWPSSABLIQ-UHFFFAOYSA-N D02IQH DRUGSMIL C1=CC2=C(C=C(C=C2)[N+]#N)C(=C1)S(=O)(=O)[O-] D02IQH HIGHSTAT Investigative D02IQP DRUG__ID D02IQP D02IQP DRUGTYPE Small molecular drug D02IQP DRUGINCH 1S/C11H12N2O2/c1-2-3-5-8(14)11-13-10-9(15-11)6-4-7-12-10/h4,6-7H,2-3,5H2,1H3 D02IQP DRUGINKE FBFLUTUPSIYUIG-UHFFFAOYSA-N D02IQP DRUGSMIL CCCCC(=O)C1=NC2=C(O1)C=CC=N2 D02IQP HIGHSTAT Investigative D02IRC DRUG__ID D02IRC D02IRC DRUGTYPE Small molecular drug D02IRC DRUGINCH 1S/C12H14N2O2S/c13-7-9-3-1-2-4-10(9)8-17-6-5-11(14)12(15)16/h1-4,11H,5-6,8,14H2,(H,15,16) D02IRC DRUGINKE JVNHJGWGKVBEAG-UHFFFAOYSA-N D02IRC DRUGSMIL C1=CC=C(C(=C1)CSCCC(C(=O)O)N)C#N D02IRC HIGHSTAT Investigative D02ITS DRUG__ID D02ITS D02ITS DRUGTYPE Small molecular drug D02ITS DRUGINCH 1S/C23H25FN4O4/c1-14(2)22-19(8-7-17(29)11-18(30)12-21(31)32)23(15-3-5-16(24)6-4-15)28(27-22)20-13-25-9-10-26-20/h3-10,13-14,17-18,29-30H,11-12H2,1-2H3,(H,31,32)/b8-7+/t17-,18-/m1/s1 D02ITS DRUGINKE DPRJPRMZJGWLHY-HNGSOEQISA-N D02ITS DRUGSMIL CC(C)C1=NN(C(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=NC=CN=C3 D02ITS HIGHSTAT Investigative D02IUX DRUG__ID D02IUX D02IUX DRUGTYPE Small molecular drug D02IUX DRUGINCH 1S/C31H45FN4O4.ClH/c1-9-34-28(38)24(18-21-12-15-26(37)23(16-21)31(4,5)6)35-29(39)27(19(2)3)36(8)30(40)25(33-7)17-20-10-13-22(32)14-11-20;/h10-16,19,24-25,27,33,37H,9,17-18H2,1-8H3,(H,34,38)(H,35,39);1H/t24-,25-,27-;/m0./s1 D02IUX DRUGINKE AMSDRHOIAWZBTJ-PBQYMGKRSA-N D02IUX DRUGSMIL CCNC(=O)C(CC1=CC(=C(C=C1)O)C(C)(C)C)NC(=O)C(C(C)C)N(C)C(=O)C(CC2=CC=C(C=C2)F)NC.Cl D02IUX HIGHSTAT Investigative D02IVJ DRUG__ID D02IVJ D02IVJ DRUGTYPE Small molecular drug D02IVJ DRUGINCH 1S/C8H9FN2S.ClH/c9-7-3-1-6(2-4-7)5-12-8(10)11;/h1-4H,5H2,(H3,10,11);1H D02IVJ DRUGINKE STUFCQTWEPJJSZ-UHFFFAOYSA-N D02IVJ DRUGSMIL C1=CC(=CC=C1CSC(=N)N)F.Cl D02IVJ HIGHSTAT Investigative D02IVR DRUG__ID D02IVR D02IVR DRUGTYPE Small molecular drug D02IVR DRUGINCH 1S/C24H38O6/c1-3-4-5-15(2)12-18(25)10-11-19-20(23(28)14-22(19)27)13-21(26)16-6-8-17(9-7-16)24(29)30/h10-11,15-20,22,25,27H,3-9,12-14H2,1-2H3,(H,29,30)/b11-10+/t15-,16?,17?,18+,19+,20+,22+/m0/s1 D02IVR DRUGINKE KWRRIFVHVJWXPU-HVCOQRSISA-N D02IVR DRUGSMIL CCCCC(C)CC(C=CC1C(CC(=O)C1CC(=O)C2CCC(CC2)C(=O)O)O)O D02IVR HIGHSTAT Investigative D02IVU DRUG__ID D02IVU D02IVU DRUGTYPE Small molecular drug D02IVU DRUGINCH 1S/C25H36O4/c1-16-8-12-25-15-23(25,2)10-4-5-20(25)24(16,3)11-9-17-6-7-19(28-14-17)18-13-21(26)29-22(18)27/h6,13,16,19-20,22,27H,4-5,7-12,14-15H2,1-3H3/t16-,19+,20+,22+,23-,24-,25-/m0/s1 D02IVU DRUGINKE FPUWYDSKOKLTDH-FRMRWZTPSA-N D02IVU DRUGSMIL CC1CCC23CC2(CCCC3C1(C)CCC4=CCC(OC4)C5=CC(=O)OC5O)C D02IVU HIGHSTAT Investigative D02IYE DRUG__ID D02IYE D02IYE DRUGTYPE Small molecular drug D02IYE DRUGINCH 1S/C25H35F2N3O7/c1-5-15(4)20(30-25(36)37-13-16-9-7-6-8-10-16)23(33)29-18(11-14(2)3)22(32)28-17(12-19(26)27)21(31)24(34)35/h6-10,14-15,17-20H,5,11-13H2,1-4H3,(H,28,32)(H,29,33)(H,30,36)(H,34,35)/t15?,17?,18-,20-/m0/s1 D02IYE DRUGINKE IXLOEMUNKMDCDV-IVJQXSGXSA-N D02IYE DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC(F)F)C(=O)C(=O)O)NC(=O)OCC1=CC=CC=C1 D02IYE HIGHSTAT Investigative D02IYN DRUG__ID D02IYN D02IYN DRUGTYPE Small molecular drug D02IYN DRUGINCH 1S/C33H33N3O6/c1-22(38)34-30(18-24-12-15-27(19-31(39)40)28(17-24)21-37)32(41)35-29-9-5-6-16-36(33(29)42)20-23-10-13-26(14-11-23)25-7-3-2-4-8-25/h2-4,7-8,10-15,17-18,21,29H,5-6,9,16,19-20H2,1H3,(H,34,38)(H,35,41)(H,39,40)/b30-18-/t29-/m0/s1 D02IYN DRUGINKE NKMPOVPTYDXGEC-MNRBYUMSSA-N D02IYN DRUGSMIL CC(=O)NC(=CC1=CC(=C(C=C1)CC(=O)O)C=O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D02IYN HIGHSTAT Investigative D02JCM DRUG__ID D02JCM D02JCM DRUGTYPE Small molecular drug D02JCM DRUGINCH 1S/C16H23N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h7-10,12-13,16,22-24H,1-6H2,(H,17,18,20)/t10-,12-,13-,16-/m1/s1 D02JCM DRUGINKE SZBULDQSDUXAPJ-XNIJJKJLSA-N D02JCM DRUGSMIL C1CCC(CC1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D02JCM HIGHSTAT Investigative D02JEZ DRUG__ID D02JEZ D02JEZ DRUGTYPE Small molecular drug D02JEZ DRUGINCH 1S/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H D02JEZ DRUGINKE ORHBXUUXSCNDEV-UHFFFAOYSA-N D02JEZ DRUGSMIL C1=CC(=CC2=C1C=CC(=O)O2)O D02JEZ HIGHSTAT Investigative D02JFD DRUG__ID D02JFD D02JFD DRUGTYPE Small molecular drug D02JFD DRUGINCH 1S/C18H21Cl2N3O4S/c1-26-17-4-3-13(11-16(17)23-7-5-21-6-8-23)28(24,25)22-15-10-12(19)9-14(20)18(15)27-2/h3-4,9-11,21-22H,5-8H2,1-2H3 D02JFD DRUGINKE ATKZKAYWARYLBW-UHFFFAOYSA-N D02JFD DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)NC2=C(C(=CC(=C2)Cl)Cl)OC)N3CCNCC3 D02JFD HIGHSTAT Investigative D02JGZ DRUG__ID D02JGZ D02JGZ DRUGTYPE Small molecular drug D02JGZ DRUGINCH 1S/C36H60O55S9/c1-68-13-10(7-74-92(41,42)43)78-34(26(16(13)69-2)88-97(56,57)58)82-19-17(70-3)25(72-5)33(84-23(19)30(37)38)80-15-12(9-76-94(47,48)49)79-35(29(91-100(65,66)67)22(15)87-96(53,54)55)83-20-18(71-4)27(89-98(59,60)61)36(85-24(20)31(39)40)81-14-11(8-75-93(44,45)46)77-32(73-6)28(90-99(62,63)64)21(14)86-95(50,51)52/h10-29,32-36H,7-9H2,1-6H3,(H,37,38)(H,39,40)(H,41,42,43)(H,44,45,46)(H,47,48,49)(H,50,51,52)(H,53,54,55)(H,56,57,58)(H,59,60,61)(H,62,63,64)(H,65,66,67)/t10-,11-,12-,13-,14-,15-,16+,17+,18+,19+,20+,21+,22+,23+,24-,25-,26-,27-,28-,29-,32+,33-,34-,35-,36-/m1/s1 D02JGZ DRUGINKE MQLWHPBUPXUQHM-XAYBSJBFSA-N D02JGZ DRUGSMIL COC1C(OC(C(C1OC)OS(=O)(=O)O)OC2C(C(C(OC2C(=O)O)OC3C(OC(C(C3OS(=O)(=O)O)OS(=O)(=O)O)OC4C(C(C(OC4C(=O)O)OC5C(OC(C(C5OS(=O)(=O)O)OS(=O)(=O)O)OC)COS(=O)(=O)O)OS(=O)(=O)O)OC)COS(=O)(=O)O)OC)OC)COS(=O)(=O)O D02JGZ HIGHSTAT Investigative D02JIL DRUG__ID D02JIL D02JIL DRUGTYPE Small molecular drug D02JIL DRUGINCH 1S/C14H10N4O3/c19-13(9-4-3-5-10(8-9)18(20)21)17-14-15-11-6-1-2-7-12(11)16-14/h1-8H,(H2,15,16,17,19) D02JIL DRUGINKE QPKROMNIEAEFQA-UHFFFAOYSA-N D02JIL DRUGSMIL C1=CC=C2C(=C1)NC(=N2)NC(=O)C3=CC(=CC=C3)[N+](=O)[O-] D02JIL HIGHSTAT Investigative D02JJU DRUG__ID D02JJU D02JJU DRUGTYPE Small molecular drug D02JJU DRUGINCH 1S/C17H11NO3/c19-13-4-3-10-7-12(2-1-11(10)8-13)17-18-15-9-14(20)5-6-16(15)21-17/h1-9,19-20H D02JJU DRUGINKE PRBSKPRGLMJEEA-UHFFFAOYSA-N D02JJU DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=NC4=C(O3)C=CC(=C4)O D02JJU HIGHSTAT Investigative D02JJX DRUG__ID D02JJX D02JJX DRUGTYPE Small molecular drug D02JJX DRUGINCH 1S/C16H13BrF2N2O4/c17-10-5-11(18)12(19)6-14(10)25-9-3-1-8(2-4-9)21-15(22)7-13(20)16(23)24/h1-6,13H,7,20H2,(H,21,22)(H,23,24)/t13-/m0/s1 D02JJX DRUGINKE BNYDDAAZMBUFRG-ZDUSSCGKSA-N D02JJX DRUGSMIL C1=CC(=CC=C1NC(=O)CC(C(=O)O)N)OC2=CC(=C(C=C2Br)F)F D02JJX HIGHSTAT Investigative D02JMR DRUG__ID D02JMR D02JMR DRUGTYPE Small molecular drug D02JMR DRUGINCH 1S/C20H21ClN6O5/c21-10-1-2-11-9(6-23-12(11)5-10)3-4-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)13(7-28)32-19/h1-2,5-6,8,13,15-16,19,23,28-30H,3-4,7H2,(H2,22,25,26)/t13-,15-,16-,19-/m1/s1 D02JMR DRUGINKE QEBJMUICJFPGLR-NVQRDWNXSA-N D02JMR DRUGSMIL C1=CC2=C(C=C1Cl)NC=C2CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D02JMR HIGHSTAT Investigative D02JOZ DRUG__ID D02JOZ D02JOZ DRUGTYPE Small molecular drug D02JOZ DRUGINCH 1S/C13H13BrN4O2/c14-11-8-13(17-5-3-15-4-6-17)16-12-2-1-9(18(19)20)7-10(11)12/h1-2,7-8,15H,3-6H2 D02JOZ DRUGINKE NRCNLRMWSMFETI-UHFFFAOYSA-N D02JOZ DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)Br D02JOZ HIGHSTAT Investigative D02JPD DRUG__ID D02JPD D02JPD DRUGTYPE Small molecular drug D02JPD DRUGINCH 1S/C26H26N2/c1-3-9-20(10-4-1)19-28-17-15-21(16-18-28)25-23-13-7-8-14-24(23)27-26(25)22-11-5-2-6-12-22/h1-14,21,27H,15-19H2 D02JPD DRUGINKE DGLKVJXUWHYMSL-UHFFFAOYSA-N D02JPD DRUGSMIL C1CN(CCC1C2=C(NC3=CC=CC=C32)C4=CC=CC=C4)CC5=CC=CC=C5 D02JPD HIGHSTAT Investigative D02JRB DRUG__ID D02JRB D02JRB DRUGTYPE Small molecular drug D02JRB DRUGINCH 1S/C19H20O4/c1-19-5-4-13-12-3-2-11(21)7-15(12)17(22)8-14(13)16(19)6-10(9-20)18(19)23/h2-3,7,9,13-14,16,20-21H,4-6,8H2,1H3/b10-9-/t13?,14?,16?,19-/m0/s1 D02JRB DRUGINKE ZRLTUTFRAVMGPJ-SSNSBQRSSA-N D02JRB DRUGSMIL CC12CCC3C(C1CC(=CO)C2=O)CC(=O)C4=C3C=CC(=C4)O D02JRB HIGHSTAT Investigative D02JRK DRUG__ID D02JRK D02JRK DRUGTYPE Small molecular drug D02JRK DRUGINCH 1S/C20H25NO3/c1-3-5-15-23-17-13-11-16(12-14-17)19(4-2)21-20(22)24-18-9-7-6-8-10-18/h6-14,19H,3-5,15H2,1-2H3,(H,21,22) D02JRK DRUGINKE FSKKTZPFXFTOGX-UHFFFAOYSA-N D02JRK DRUGSMIL CCCCOC1=CC=C(C=C1)C(CC)NC(=O)OC2=CC=CC=C2 D02JRK HIGHSTAT Investigative D02JUJ DRUG__ID D02JUJ D02JUJ DRUGTYPE Small molecular drug D02JUJ DRUGINCH 1S/C16H13NO2/c1-19-16-5-4-11-6-12(2-3-13(11)8-16)14-7-15(18)10-17-9-14/h2-10,18H,1H3 D02JUJ DRUGINKE YXTBYYAJCILARD-UHFFFAOYSA-N D02JUJ DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CC(=CN=C3)O D02JUJ HIGHSTAT Investigative D02JUP DRUG__ID D02JUP D02JUP DRUGTYPE Small molecular drug D02JUP DRUGINCH 1S/C12H16N4O3S/c1-20-4-7-8(17)9(18)12(19-7)16-3-2-6-10(13)14-5-15-11(6)16/h2-3,5,7-9,12,17-18H,4H2,1H3,(H2,13,14,15)/t7-,8-,9-,12-/m1/s1 D02JUP DRUGINKE WBPLMFVTQMIPLW-MFYTUXHUSA-N D02JUP DRUGSMIL CSCC1C(C(C(O1)N2C=CC3=C(N=CN=C32)N)O)O D02JUP HIGHSTAT Investigative D02JVA DRUG__ID D02JVA D02JVA DRUGTYPE Small molecular drug D02JVA DRUGINCH 1S/C47H64N14O7/c1-2-3-13-34-41(64)58-35(15-8-21-53-46(49)50)42(65)60-37(24-27-17-18-28-10-4-5-11-29(28)23-27)44(67)59-36(16-9-22-54-47(51)52)43(66)61-38(25-30-26-55-32-14-7-6-12-31(30)32)45(68)57-33(40(48)63)19-20-39(62)56-34/h4-7,10-12,14,17-18,23,26,33-38,55H,2-3,8-9,13,15-16,19-22,24-25H2,1H3,(H2,48,63)(H,56,62)(H,57,68)(H,58,64)(H,59,67)(H,60,65)(H,61,66)(H4,49,50,53)(H4,51,52,54)/t33-,34-,35+,36-,37+,38-/m0/s1 D02JVA DRUGINKE UHCXNXMBPAFWDS-VRHOQGROSA-N D02JVA DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CCCN=C(N)N D02JVA HIGHSTAT Investigative D02JVG DRUG__ID D02JVG D02JVG DRUGTYPE Small molecular drug D02JVG DRUGINCH 1S/C11H17NS/c1-3-13-11-6-4-10(5-7-11)8-9(2)12/h4-7,9H,3,8,12H2,1-2H3 D02JVG DRUGINKE WOBAXWXQKSIHCH-UHFFFAOYSA-N D02JVG DRUGSMIL CCSC1=CC=C(C=C1)CC(C)N D02JVG HIGHSTAT Investigative D02JVI DRUG__ID D02JVI D02JVI DRUGTYPE Small molecular drug D02JVI DRUGINCH 1S/C19H19NO2/c21-17(19-20-16-12-7-8-14-18(16)22-19)13-6-2-5-11-15-9-3-1-4-10-15/h1,3-4,7-10,12,14H,2,5-6,11,13H2 D02JVI DRUGINKE PCLBCMUYLOBYMW-UHFFFAOYSA-N D02JVI DRUGSMIL C1=CC=C(C=C1)CCCCCC(=O)C2=NC3=CC=CC=C3O2 D02JVI HIGHSTAT Investigative D02JWD DRUG__ID D02JWD D02JWD DRUGTYPE Small molecular drug D02JWD DRUGINCH 1S/C18H32O3/c1-2-3-11-14-17(19)15-12-9-7-5-4-6-8-10-13-16-18(20)21/h7,9,12,15,17,19H,2-6,8,10-11,13-14,16H2,1H3,(H,20,21)/b9-7-,15-12+ D02JWD DRUGINKE HNICUWMFWZBIFP-BSZOFBHHSA-N D02JWD DRUGSMIL CCCCCC(C=CC=CCCCCCCCC(=O)O)O D02JWD HIGHSTAT Investigative D02JWY DRUG__ID D02JWY D02JWY DRUGTYPE Small molecular drug D02JWY DRUGINCH 1S/C10H13N3OS/c1-7(12-13-10(11)15)8-3-5-9(14-2)6-4-8/h3-6H,1-2H3,(H3,11,13,15)/b12-7+ D02JWY DRUGINKE JPXKIPVPEBSPLT-KPKJPENVSA-N D02JWY DRUGSMIL CC(=NNC(=S)N)C1=CC=C(C=C1)OC D02JWY HIGHSTAT Investigative D02JXK DRUG__ID D02JXK D02JXK DRUGTYPE Small molecular drug D02JXK DRUGINCH 1S/C39H62N2O2/c1-3-38(34-20-18-22-36(42)30-34)24-12-16-28-40(32-38)26-14-10-8-6-5-7-9-11-15-27-41-29-17-13-25-39(4-2,33-41)35-21-19-23-37(43)31-35/h18-23,30-31,42-43H,3-17,24-29,32-33H2,1-2H3/t38-,39-/m1/s1 D02JXK DRUGINKE IMWJSGSESWBQFI-LJEWAXOPSA-N D02JXK DRUGSMIL CCC1(CCCCN(C1)CCCCCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D02JXK HIGHSTAT Investigative D02JXQ DRUG__ID D02JXQ D02JXQ DRUGTYPE Small molecular drug D02JXQ DRUGINCH 1S/C27H46O3/c1-17(7-6-12-25(2,3)30)20-8-9-21-24-22(11-14-27(20,21)5)26(4)13-10-19(28)15-18(26)16-23(24)29/h16-17,19-24,28-30H,6-15H2,1-5H3/t17-,19+,20-,21+,22+,23-,24+,26+,27-/m1/s1 D02JXQ DRUGINKE BQMSKLCEWBSPPY-IKVTXIKFSA-N D02JXQ DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C D02JXQ HIGHSTAT Investigative D02KDH DRUG__ID D02KDH D02KDH DRUGTYPE Small molecular drug D02KDH DRUGINCH 1S/C8H11N3O3S/c1-6(12)10-11-7-4-2-3-5-8(7)15(9,13)14/h2-5,11H,1H3,(H,10,12)(H2,9,13,14) D02KDH DRUGINKE NGNPYNHOTNXXJP-UHFFFAOYSA-N D02KDH DRUGSMIL CC(=O)NNC1=CC=CC=C1S(=O)(=O)N D02KDH HIGHSTAT Investigative D02KGZ DRUG__ID D02KGZ D02KGZ DRUGTYPE Small molecular drug D02KGZ DRUGINCH 1S/C12H12N2O3/c13-5-6-14-11(15)9-7-8-3-1-2-4-10(8)17-12(9)16/h1-4,7H,5-6,13H2,(H,14,15) D02KGZ DRUGINKE ZZZHRZHNTZJEMF-UHFFFAOYSA-N D02KGZ DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)O2)C(=O)NCCN D02KGZ HIGHSTAT Investigative D02KHF DRUG__ID D02KHF D02KHF DRUGTYPE Small molecular drug D02KHF DRUGINCH 1S/C13H15N/c1-2-6-12(7-3-1)9-10-13-8-4-5-11-14-13/h4-5,8,11-12H,1-3,6-7H2 D02KHF DRUGINKE WDQDPHLOSGNFKP-UHFFFAOYSA-N D02KHF DRUGSMIL C1CCC(CC1)C#CC2=CC=CC=N2 D02KHF HIGHSTAT Investigative D02KIM DRUG__ID D02KIM D02KIM DRUGTYPE Small molecular drug D02KIM DRUGINCH 1S/C22H24ClN5O3S/c1-13-21(27-20-7-2-14(11-24)8-19(20)23)25-12-26-22(13)31-17-9-15-3-4-16(10-17)28(15)32(29,30)18-5-6-18/h2,7-8,12,15-18H,3-6,9-10H2,1H3,(H,25,26,27)/t15-,16-/m0/s1 D02KIM DRUGINKE JONDVPWMQDOELC-HOTGVXAUSA-N D02KIM DRUGSMIL CC1=C(N=CN=C1OC2CC3CCC(C2)N3S(=O)(=O)C4CC4)NC5=C(C=C(C=C5)C#N)Cl D02KIM HIGHSTAT Investigative D02KIS DRUG__ID D02KIS D02KIS DRUGTYPE Small molecular drug D02KIS DRUGINCH 1S/C10H13N/c1-8-6-9-4-2-3-5-10(9)7-11-8/h2-5,8,11H,6-7H2,1H3/t8-/m0/s1 D02KIS DRUGINKE UEKQPSAKUNXFHL-QMMMGPOBSA-N D02KIS DRUGSMIL CC1CC2=CC=CC=C2CN1 D02KIS HIGHSTAT Investigative D02KJI DRUG__ID D02KJI D02KJI DRUGTYPE Small molecular drug D02KJI DRUGINCH 1S/C7H7BO4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4,11-12H,(H,9,10) D02KJI DRUGINKE DBVFWZMQJQMJCB-UHFFFAOYSA-N D02KJI DRUGSMIL B(C1=CC(=CC=C1)C(=O)O)(O)O D02KJI HIGHSTAT Investigative D02KKL DRUG__ID D02KKL D02KKL DRUGTYPE Small molecular drug D02KKL DRUGINCH 1S/C16H14N6/c17-16(18)9-5-6-12-13(7-9)22-15(21-12)8-14-19-10-3-1-2-4-11(10)20-14/h1-7H,8H2,(H3,17,18)(H,19,20)(H,21,22) D02KKL DRUGINKE KKJYVDXDZURHMA-UHFFFAOYSA-N D02KKL DRUGSMIL C1=CC=C2C(=C1)NC(=N2)CC3=NC4=C(N3)C=C(C=C4)C(=N)N D02KKL HIGHSTAT Investigative D02KKU DRUG__ID D02KKU D02KKU DRUGTYPE Small molecular drug D02KKU DRUGINCH 1S/C30H46O3/c1-25(2)14-16-30(24(32)33)17-15-28(6)19(20(30)18-25)8-9-22-27(5)12-11-23(31)26(3,4)21(27)10-13-29(22,28)7/h8,20-22H,9-18H2,1-7H3,(H,32,33)/t20-,21-,22+,27-,28+,29+,30-/m0/s1 D02KKU DRUGINKE FMIMFCRXYXVFTA-FUAOEXFOSA-N D02KKU DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1)C)C(=O)O)C D02KKU HIGHSTAT Investigative D02KLE DRUG__ID D02KLE D02KLE DRUGTYPE Small molecular drug D02KLE DRUGINCH 1S/C44H39N3O19S/c48-31-21-22-47(43(55)45-31)37-33(50)32(49)29(61-37)24-60-67(57,58)46-44(56)66-42-36(65-41(54)28-19-11-4-12-20-28)35(64-40(53)27-17-9-3-10-18-27)34(63-39(52)26-15-7-2-8-16-26)30(62-42)23-59-38(51)25-13-5-1-6-14-25/h1-22,29-30,32-37,42,49-50H,23-24H2,(H,46,56)(H,45,48,55)/t29-,30-,32-,33-,34-,35+,36-,37-,42-/m1/s1 D02KLE DRUGINKE SUAOMMKFCCTVDC-NSIBRLCRSA-N D02KLE DRUGSMIL C1=CC=C(C=C1)C(=O)OCC2C(C(C(C(O2)OC(=O)NS(=O)(=O)OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)OC(=O)C5=CC=CC=C5)OC(=O)C6=CC=CC=C6)OC(=O)C7=CC=CC=C7 D02KLE HIGHSTAT Investigative D02KLU DRUG__ID D02KLU D02KLU DRUGTYPE Small molecular drug D02KLU DRUGINCH 1S/C5H11O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h1,3-5,7-9H,2H2,(H2,10,11,12)/t3-,4+,5-/m0/s1 D02KLU DRUGINKE PPQRONHOSHZGFQ-LMVFSUKVSA-N D02KLU DRUGSMIL C(C(C(C(C=O)O)O)O)OP(=O)(O)O D02KLU HIGHSTAT Investigative D02KNP DRUG__ID D02KNP D02KNP DRUGTYPE Small molecular drug D02KNP DRUGINCH 1S/C26H34N6O2S/c1-17-9-11-18(12-10-17)23(33)28-25-27-22-21(35-25)20(29-32(22)26(2,3)4)24(34)31-15-7-8-19(31)16-30-13-5-6-14-30/h9-12,19H,5-8,13-16H2,1-4H3,(H,27,28,33)/t19-/m0/s1 D02KNP DRUGINKE GJBQMIZKUFMWPV-IBGZPJMESA-N D02KNP DRUGSMIL CC1=CC=C(C=C1)C(=O)NC2=NC3=C(S2)C(=NN3C(C)(C)C)C(=O)N4CCCC4CN5CCCC5 D02KNP HIGHSTAT Investigative D02KPV DRUG__ID D02KPV D02KPV DRUGTYPE Small molecular drug D02KPV DRUGINCH 1S/C28H40O8/c1-7-9-20(30)35-24-16(4)27(34)18(22-25(5,6)28(22,24)36-21(31)10-8-2)12-17(14-29)13-26(33)19(27)11-15(3)23(26)32/h11-12,16,18-19,22,24,29,33-34H,7-10,13-14H2,1-6H3/t16-,18+,19-,22-,24-,26-,27-,28-/m1/s1 D02KPV DRUGINKE BQJRUJTZSGYBEZ-YVQNUNKESA-N D02KPV DRUGSMIL CCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)CCC)O)C D02KPV HIGHSTAT Investigative D02KSN DRUG__ID D02KSN D02KSN DRUGTYPE Small molecular drug D02KSN DRUGINCH 1S/C19H18N8/c1-14-11-27(24-23-14)8-7-26-13-21-18(17-10-22-25(2)12-17)19(26)16-5-3-15(9-20)4-6-16/h3-6,10-13H,7-8H2,1-2H3 D02KSN DRUGINKE YPRKVQKJNRKXFN-UHFFFAOYSA-N D02KSN DRUGSMIL CC1=CN(N=N1)CCN2C=NC(=C2C3=CC=C(C=C3)C#N)C4=CN(N=C4)C D02KSN HIGHSTAT Investigative D02KVB DRUG__ID D02KVB D02KVB DRUGTYPE Small molecular drug D02KVB DRUGINCH 1S/C13H8N4O/c14-6-10(13(17)11(7-15)8-16)5-9-1-3-12(18)4-2-9/h1-5,18H,17H2/b10-5+ D02KVB DRUGINKE DXVJRTIPBNBLLB-BJMVGYQFSA-N D02KVB DRUGSMIL C1=CC(=CC=C1C=C(C#N)C(=C(C#N)C#N)N)O D02KVB HIGHSTAT Investigative D02KVR DRUG__ID D02KVR D02KVR DRUGTYPE Small molecular drug D02KVR DRUGINCH 1S/C30H27BrN4O2/c31-24-10-8-22(9-11-24)17-35-21-32-16-25(35)18-33-19-28(27-7-3-5-23-4-1-2-6-26(23)27)29(20-33)30(36)34-12-14-37-15-13-34/h1-11,16,19-21H,12-15,17-18H2 D02KVR DRUGINKE GUUIRIMAQGOLHT-UHFFFAOYSA-N D02KVR DRUGSMIL C1COCCN1C(=O)C2=CN(C=C2C3=CC=CC4=CC=CC=C43)CC5=CN=CN5CC6=CC=C(C=C6)Br D02KVR HIGHSTAT Investigative D02KXU DRUG__ID D02KXU D02KXU DRUGTYPE Small molecular drug D02KXU DRUGINCH 1S/C17H16O3/c1-11-3-5-12(6-4-11)16-10-15(18)14-8-7-13(19-2)9-17(14)20-16/h3-9,16H,10H2,1-2H3 D02KXU DRUGINKE JVZDRFASOQJJTF-UHFFFAOYSA-N D02KXU DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)OC D02KXU HIGHSTAT Investigative D02KXX DRUG__ID D02KXX D02KXX DRUGTYPE Small molecular drug D02KXX DRUGINCH 1S/C14H11ClO3S/c15-12-8-6-11(7-9-12)14(16)10-19(17,18)13-4-2-1-3-5-13/h1-9H,10H2 D02KXX DRUGINKE KZACHGLUJYSTGQ-UHFFFAOYSA-N D02KXX DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CC(=O)C2=CC=C(C=C2)Cl D02KXX HIGHSTAT Investigative D02KZD DRUG__ID D02KZD D02KZD DRUGTYPE Small molecular drug D02KZD DRUGINCH 1S/C23H15ClF2N2O2/c24-16-8-6-15(7-9-16)23-18-4-2-1-3-17(18)22(30)28(23)12-11-27(23)21(29)14-5-10-19(25)20(26)13-14/h1-10,13H,11-12H2/t23-/m0/s1 D02KZD DRUGINKE GXBAKXRLQAPKEE-QHCPKHFHSA-N D02KZD DRUGSMIL C1CN(C2(N1C(=O)C3=CC=CC=C32)C4=CC=C(C=C4)Cl)C(=O)C5=CC(=C(C=C5)F)F D02KZD HIGHSTAT Investigative D02LCC DRUG__ID D02LCC D02LCC DRUGTYPE Small molecular drug D02LCC DRUGINCH 1S/C16H15NO3/c1-9(2)13-7-12(19)8-14-15(13)20-16(17-14)10-3-5-11(18)6-4-10/h3-9,18-19H,1-2H3 D02LCC DRUGINKE XMPVRZGJAQOXGV-UHFFFAOYSA-N D02LCC DRUGSMIL CC(C)C1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D02LCC HIGHSTAT Investigative D02LCH DRUG__ID D02LCH D02LCH DRUGTYPE Small molecular drug D02LCH DRUGINCH 1S/C36H55N5O7S/c1-21(2)16-30(31(42)17-24(7)33(43)40-32(22(3)4)36(46)37-23(5)6)39-35(45)28-18-27(19-29(20-28)41(9)49(10,47)48)34(44)38-25(8)26-14-12-11-13-15-26/h11-15,18-25,30-32,42H,16-17H2,1-10H3,(H,37,46)(H,38,44)(H,39,45)(H,40,43)/t24-,25-,30+,31+,32+/m1/s1 D02LCH DRUGINKE BJOCXJJVELLFKM-LLWRDSBASA-N D02LCH DRUGSMIL CC(C)CC(C(CC(C)C(=O)NC(C(C)C)C(=O)NC(C)C)O)NC(=O)C1=CC(=CC(=C1)C(=O)NC(C)C2=CC=CC=C2)N(C)S(=O)(=O)C D02LCH HIGHSTAT Investigative D02LCT DRUG__ID D02LCT D02LCT DRUGTYPE Small molecular drug D02LCT DRUGINCH 1S/C23H30O7/c1-13-4-9-18-14(2)20(26-12-15-5-7-16(8-6-15)19(24)25)27-21-23(18)17(13)10-11-22(3,28-21)29-30-23/h5-8,13-14,17-18,20-21H,4,9-12H2,1-3H3,(H,24,25)/t13-,14-,17+,18+,20+,21-,22-,23-/m1/s1 D02LCT DRUGINKE UVNHKOOJXSALHN-ILQPJIFQSA-N D02LCT DRUGSMIL CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OCC5=CC=C(C=C5)C(=O)O)C D02LCT HIGHSTAT Investigative D02LDY DRUG__ID D02LDY D02LDY DRUGTYPE Small molecular drug D02LDY DRUGINCH 1S/C13H12N2O4S/c14-20(16,17)15-11-4-1-9(2-5-11)10-3-6-12-13(7-10)19-8-18-12/h1-7,15H,8H2,(H2,14,16,17) D02LDY DRUGINKE ZFMUZDFMEJBCPQ-UHFFFAOYSA-N D02LDY DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=CC=C(C=C3)NS(=O)(=O)N D02LDY HIGHSTAT Investigative D02LFU DRUG__ID D02LFU D02LFU DRUGTYPE Small molecular drug D02LFU DRUGINCH 1S/C19H20N2O2S/c22-24(23,16-8-2-1-3-9-16)21-14-18(15-7-6-12-20-13-15)17-10-4-5-11-19(17)21/h1-5,8-11,14-15,20H,6-7,12-13H2 D02LFU DRUGINKE QUUSSZWUXRDTJG-UHFFFAOYSA-N D02LFU DRUGSMIL C1CC(CNC1)C2=CN(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4 D02LFU HIGHSTAT Investigative D02LHQ DRUG__ID D02LHQ D02LHQ DRUGTYPE Small molecular drug D02LHQ DRUGINCH 1S/C9H10O4/c10-7-3-1-6(8(11)5-7)2-4-9(12)13/h1,3,5,10-11H,2,4H2,(H,12,13) D02LHQ DRUGINKE HMCMTJPPXSGYJY-UHFFFAOYSA-N D02LHQ DRUGSMIL C1=CC(=C(C=C1O)O)CCC(=O)O D02LHQ HIGHSTAT Investigative D02LIR DRUG__ID D02LIR D02LIR DRUGTYPE Small molecular drug D02LIR DRUGINCH 1S/C19H15Cl2N3O3/c1-26-14-6-9-10(7-15(14)27-2)18(25)16-17(9)23-24-19(16)22-8-11-12(20)4-3-5-13(11)21/h3-7H,8H2,1-2H3,(H2,22,23,24) D02LIR DRUGINKE UUDNGLPFGYJJQX-UHFFFAOYSA-N D02LIR DRUGSMIL COC1=C(C=C2C(=C1)C3=C(C2=O)C(=NN3)NCC4=C(C=CC=C4Cl)Cl)OC D02LIR HIGHSTAT Investigative D02LQG DRUG__ID D02LQG D02LQG DRUGTYPE Small molecular drug D02LQG DRUGINCH 1S/C16H21NO2/c1-17-12-8-9-14(17)15(16(18)19-2)13(10-12)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14+,15-/m0/s1 D02LQG DRUGINKE OMBOXYLBBHNWHL-YJNKXOJESA-N D02LQG DRUGSMIL CN1C2CCC1C(C(C2)C3=CC=CC=C3)C(=O)OC D02LQG HIGHSTAT Investigative D02LTS DRUG__ID D02LTS D02LTS DRUGTYPE Small molecular drug D02LTS DRUGINCH 1S/C27H29ClN2O3/c1-15-11-20(9-10-24(15)28)18(4)29-23-8-6-7-21(14-23)22-12-16(2)25(17(3)13-22)26(31)30-19(5)27(32)33/h6-14,18-19,29H,1-5H3,(H,30,31)(H,32,33)/t18-,19+/m1/s1 D02LTS DRUGINKE KYHUARFFBDLROH-MOPGFXCFSA-N D02LTS DRUGSMIL CC1=CC(=CC(=C1C(=O)NC(C)C(=O)O)C)C2=CC(=CC=C2)NC(C)C3=CC(=C(C=C3)Cl)C D02LTS HIGHSTAT Investigative D02LTV DRUG__ID D02LTV D02LTV DRUGTYPE Small molecular drug D02LTV DRUGINCH 1S/C20H15ClN2O/c21-16-7-5-15(6-8-16)18-13-23-10-2-4-19(23)20(24)17(18)11-14-3-1-9-22-12-14/h1-12,18H,13H2/b17-11- D02LTV DRUGINKE UQXVMFWGYFYXDC-BOPFTXTBSA-N D02LTV DRUGSMIL C1C(C(=CC2=CN=CC=C2)C(=O)C3=CC=CN31)C4=CC=C(C=C4)Cl D02LTV HIGHSTAT Investigative D02LUF DRUG__ID D02LUF D02LUF DRUGTYPE Small molecular drug D02LUF DRUGINCH 1S/C21H28O3/c1-20(2)8-5-9-21(3)14-10-13-11-18(23-4)15(22)12-17(13)24-16(14)6-7-19(20)21/h10-12,16,19,22H,5-9H2,1-4H3/t16-,19-,21+/m0/s1 D02LUF DRUGINKE VKVKDSPLZVAEMG-NBHGPNQESA-N D02LUF DRUGSMIL CC1(CCCC2(C1CCC3C2=CC4=CC(=C(C=C4O3)O)OC)C)C D02LUF HIGHSTAT Investigative D02LWB DRUG__ID D02LWB D02LWB DRUGTYPE Small molecular drug D02LWB DRUGINCH 1S/C14H11N/c1-2-5-12-9-14(8-11(12)4-1)13-6-3-7-15-10-13/h1-8,10H,9H2 D02LWB DRUGINKE NNEAKBWZBQOQDH-UHFFFAOYSA-N D02LWB DRUGSMIL C1C2=CC=CC=C2C=C1C3=CN=CC=C3 D02LWB HIGHSTAT Investigative D02LWX DRUG__ID D02LWX D02LWX DRUGTYPE Small molecular drug D02LWX DRUGINCH 1S/C12H10N2O/c1-14-5-4-9-10-6-8(15)2-3-11(10)13-12(9)7-14/h2-7,15H,1H3/p+1 D02LWX DRUGINKE FTXCPBMJKVPYRT-UHFFFAOYSA-O D02LWX DRUGSMIL C[N+]1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)O D02LWX HIGHSTAT Investigative D02LXI DRUG__ID D02LXI D02LXI DRUGTYPE Small molecular drug D02LXI DRUGINCH 1S/C23H23ClN2O5S/c1-14-21(25-23(29)30-15(2)18-5-3-4-6-19(18)24)22(31-26-14)17-9-7-16(8-10-17)13-32-12-11-20(27)28/h3-10,15H,11-13H2,1-2H3,(H,25,29)(H,27,28) D02LXI DRUGINKE LLIFMNUXGDHTRO-UHFFFAOYSA-N D02LXI DRUGSMIL CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)CSCCC(=O)O D02LXI HIGHSTAT Investigative D02LXJ DRUG__ID D02LXJ D02LXJ DRUGTYPE Small molecular drug D02LXJ DRUGINCH 1S/C18H16O2/c19-18(20)14-13-17-11-5-4-10-16(17)12-6-9-15-7-2-1-3-8-15/h1-11,13-14H,12H2,(H,19,20)/b9-6+,14-13+ D02LXJ DRUGINKE LDBYEQVSQBZSEH-BDXQXIFWSA-N D02LXJ DRUGSMIL C1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O D02LXJ HIGHSTAT Investigative D02LZL DRUG__ID D02LZL D02LZL DRUGTYPE Small molecular drug D02LZL DRUGINCH 1S/C15H22N2/c1(2-7-11-15-12-16-13-17-15)4-8-14-9-5-3-6-10-14/h12-14H,3-11H2,(H,16,17) D02LZL DRUGINKE LATXTZVCBBIDBM-UHFFFAOYSA-N D02LZL DRUGSMIL C1CCC(CC1)CCC#CCCC2=CN=CN2 D02LZL HIGHSTAT Investigative D02MAK DRUG__ID D02MAK D02MAK DRUGTYPE Small molecular drug D02MAK DRUGINCH 1S/C11H8O4/c1-6(12)8-4-7-2-3-11(14)15-10(7)5-9(8)13/h2-5,13H,1H3 D02MAK DRUGINKE MYJIZBGGFRMXEM-UHFFFAOYSA-N D02MAK DRUGSMIL CC(=O)C1=C(C=C2C(=C1)C=CC(=O)O2)O D02MAK HIGHSTAT Investigative D02MBV DRUG__ID D02MBV D02MBV DRUGTYPE Small molecular drug D02MBV DRUGINCH 1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)/i25-4 D02MBV DRUGINKE BUZAJRPLUGXRAB-VEFBWTBNSA-N D02MBV DRUGSMIL CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I D02MBV HIGHSTAT Investigative D02MBW DRUG__ID D02MBW D02MBW DRUGTYPE Small molecular drug D02MBW DRUGINCH 1S/C7H10N2OS/c1-5(3-10)2-6-4-11-7(8)9-6/h3-5H,2H2,1H3,(H2,8,9)/t5-/m0/s1 D02MBW DRUGINKE KFMAJVLZSDMFBV-YFKPBYRVSA-N D02MBW DRUGSMIL CC(CC1=CSC(=N1)N)C=O D02MBW HIGHSTAT Investigative D02MDC DRUG__ID D02MDC D02MDC DRUGTYPE Small molecular drug D02MDC DRUGINCH 1S/C23H26N4O4S/c1-4-26(16-19-9-7-13-24-14-19)23(28)17-27(20-11-12-22(31-3)25-15-20)32(29,30)21-10-6-5-8-18(21)2/h5-15H,4,16-17H2,1-3H3 D02MDC DRUGINKE KJPHTXTWFHVJIG-UHFFFAOYSA-N D02MDC DRUGSMIL CCN(CC1=CN=CC=C1)C(=O)CN(C2=CN=C(C=C2)OC)S(=O)(=O)C3=CC=CC=C3C D02MDC HIGHSTAT Investigative D02MEX DRUG__ID D02MEX D02MEX DRUGTYPE Small molecular drug D02MEX DRUGINCH 1S/C25H28FNO4/c1-16-23(13-12-21(28)14-22(29)15-24(30)31)25(18-8-10-19(26)11-9-18)17(2)27(16)20-6-4-3-5-7-20/h3-11,21-22,28-29H,12-15H2,1-2H3,(H,30,31)/p-1/t21-,22-/m1/s1 D02MEX DRUGINKE QKLXBIHSGMPUQS-FGZHOGPDSA-M D02MEX DRUGSMIL CC1=C(C(=C(N1C2=CC=CC=C2)C)C3=CC=C(C=C3)F)CCC(CC(CC(=O)[O-])O)O D02MEX HIGHSTAT Investigative D02MFQ DRUG__ID D02MFQ D02MFQ DRUGTYPE Small molecular drug D02MFQ DRUGINCH 1S/C8H16N2/c9-8-6-4-2-1-3-5-7-10-8/h1-7H2,(H2,9,10) D02MFQ DRUGINKE NHHGJWDDKUEZBV-UHFFFAOYSA-N D02MFQ DRUGSMIL C1CCCC(=NCCC1)N D02MFQ HIGHSTAT Investigative D02MFX DRUG__ID D02MFX D02MFX DRUGTYPE Small molecular drug D02MFX DRUGINCH 1S/C46H58N8O15/c1-24(2)18-33-45(67)53-32(14-17-40(61)62)43(65)49-27(21-36(47)56)9-15-37(57)50-31(12-8-25-6-4-3-5-7-25)44(66)54-34(19-26-20-41(63)69-35-22-28(55)10-11-29(26)35)46(68)52-30(13-16-39(59)60)42(64)48-23-38(58)51-33/h3-7,10-11,20,22,24,27,30-34,55H,8-9,12-19,21,23H2,1-2H3,(H2,47,56)(H,48,64)(H,49,65)(H,50,57)(H,51,58)(H,52,68)(H,53,67)(H,54,66)(H,59,60)(H,61,62)/t27-,30-,31-,32-,33-,34-/m0/s1 D02MFX DRUGINKE TZBPOQODYKOULE-HDARCNCQSA-N D02MFX DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CCC(=O)O)CC2=CC(=O)OC3=C2C=CC(=C3)O)CCC4=CC=CC=C4)CC(=O)N)CCC(=O)O D02MFX HIGHSTAT Investigative D02MIH DRUG__ID D02MIH D02MIH DRUGTYPE Small molecular drug D02MIH DRUGINCH 1S/C14H12BrF2N3S/c15-9-4-5-13(19-8-9)20-14(21)18-7-6-10-11(16)2-1-3-12(10)17/h1-5,8H,6-7H2,(H2,18,19,20,21) D02MIH DRUGINKE TWONRKIIQCCNQJ-UHFFFAOYSA-N D02MIH DRUGSMIL C1=CC(=C(C(=C1)F)CCNC(=S)NC2=NC=C(C=C2)Br)F D02MIH HIGHSTAT Investigative D02MIN DRUG__ID D02MIN D02MIN DRUGTYPE Small molecular drug D02MIN DRUGINCH 1S/C36H44N4O6/c1-36(19-27-20-37-30-10-6-5-9-29(27)30,40-35(45)46-33-25-14-23-13-24(16-25)17-26(33)15-23)34(44)39-28(18-22-7-3-2-4-8-22)21-38-31(41)11-12-32(42)43/h2-10,20,23-26,28,33,37H,11-19,21H2,1H3,(H,38,41)(H,39,44)(H,40,45)(H,42,43)/t23?,24?,25?,26?,28-,33?,36+/m1/s1 D02MIN DRUGINKE HAQJDPAHYIINDW-KMDPWDFKSA-N D02MIN DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CNC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D02MIN HIGHSTAT Investigative D02MJE DRUG__ID D02MJE D02MJE DRUGTYPE Small molecular drug D02MJE DRUGINCH 1S/C18H19N3OS/c1-2-5-14(6-3-1)7-4-12-22-18-17(19-23-20-18)16-13-21-10-8-15(16)9-11-21/h1-3,5-6,15-16H,8-13H2 D02MJE DRUGINKE SNSMIIQEKVYNOH-UHFFFAOYSA-N D02MJE DRUGSMIL C1CN2CCC1C(C2)C3=NSN=C3OCC#CC4=CC=CC=C4 D02MJE HIGHSTAT Investigative D02MJN DRUG__ID D02MJN D02MJN DRUGTYPE Small molecular drug D02MJN DRUGINCH 1S/C14H9N3O2S/c15-8-10-3-1-4-11(7-10)20(18,19)14-6-2-5-13(17)12(14)9-16/h1-7H,17H2 D02MJN DRUGINKE PZWWWGPTXCTXOT-UHFFFAOYSA-N D02MJN DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)C2=CC=CC(=C2C#N)N)C#N D02MJN HIGHSTAT Investigative D02MKW DRUG__ID D02MKW D02MKW DRUGTYPE Small molecular drug D02MKW DRUGINCH 1S/C10H15N2O7PS/c1-5-3-12(10(14)11-9(5)13)8-2-7(21)6(19-8)4-18-20(15,16)17/h3,6-8,21H,2,4H2,1H3,(H,11,13,14)(H2,15,16,17)/t6-,7+,8-/m1/s1 D02MKW DRUGINKE BORVFKJZAOEGOO-GJMOJQLCSA-N D02MKW DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)S D02MKW HIGHSTAT Investigative D02MLI DRUG__ID D02MLI D02MLI DRUGTYPE Small molecular drug D02MLI DRUGINCH 1S/C30H40F2N4O2/c1-21(15-22-7-10-29(38-2)33-17-22)18-34-19-23-5-3-4-6-25(23)26(20-34)30(37)36-13-11-35(12-14-36)24-8-9-27(31)28(32)16-24/h7-10,16-17,21,23,25-26H,3-6,11-15,18-20H2,1-2H3/t21?,23-,25-,26+/m0/s1 D02MLI DRUGINKE RDSAUPRYZCQORM-RIVQXRJNSA-N D02MLI DRUGSMIL CC(CC1=CN=C(C=C1)OC)CN2CC3CCCCC3C(C2)C(=O)N4CCN(CC4)C5=CC(=C(C=C5)F)F D02MLI HIGHSTAT Investigative D02MME DRUG__ID D02MME D02MME DRUGTYPE Small molecular drug D02MME DRUGINCH 1S/C10H13NO/c1-9(11(2)8-12)10-6-4-3-5-7-10/h3-9H,1-2H3/t9-/m0/s1 D02MME DRUGINKE YYPINKULTUCCJA-VIFPVBQESA-N D02MME DRUGSMIL CC(C1=CC=CC=C1)N(C)C=O D02MME HIGHSTAT Investigative D02MMS DRUG__ID D02MMS D02MMS DRUGTYPE Small molecular drug D02MMS DRUGINCH 1S/C14H23NS/c1-4-10-15-13(5-2)11-12-6-8-14(16-3)9-7-12/h6-9,13,15H,4-5,10-11H2,1-3H3 D02MMS DRUGINKE BVNCGPDTVNALJQ-UHFFFAOYSA-N D02MMS DRUGSMIL CCCNC(CC)CC1=CC=C(C=C1)SC D02MMS HIGHSTAT Investigative D02MNM DRUG__ID D02MNM D02MNM DRUGTYPE Small molecular drug D02MNM DRUGINCH 1S/C23H31N5O4/c24-13-5-4-8-19(23(31)32)27-21(29)16-10-12-17(25)20(14-16)28-22(30)18(26)11-9-15-6-2-1-3-7-15/h1-3,6-7,10,12,14,18-19H,4-5,8-9,11,13,24-26H2,(H,27,29)(H,28,30)(H,31,32)/t18-,19-/m0/s1 D02MNM DRUGINKE XPUCDWKMNQBXIH-OALUTQOASA-N D02MNM DRUGSMIL C1=CC=C(C=C1)CCC(C(=O)NC2=C(C=CC(=C2)C(=O)NC(CCCCN)C(=O)O)N)N D02MNM HIGHSTAT Investigative D02MOV DRUG__ID D02MOV D02MOV DRUGTYPE Small molecular drug D02MOV DRUGINCH 1S/C14H9BrFN3/c15-9-4-5-13-12(6-9)14(18-8-17-13)19-11-3-1-2-10(16)7-11/h1-8H,(H,17,18,19) D02MOV DRUGINKE ALKMBIXEONKULX-UHFFFAOYSA-N D02MOV DRUGSMIL C1=CC(=CC(=C1)F)NC2=NC=NC3=C2C=C(C=C3)Br D02MOV HIGHSTAT Investigative D02MPG DRUG__ID D02MPG D02MPG DRUGTYPE Small molecular drug D02MPG DRUGINCH 1S/C15H14ClNO3/c16-12-3-1-11(2-4-12)14-9-13(18)10-15(20-14)17-5-7-19-8-6-17/h1-4,9-10H,5-8H2 D02MPG DRUGINKE VYDDKZSYMMZLQU-UHFFFAOYSA-N D02MPG DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=C(C=C3)Cl D02MPG HIGHSTAT Investigative D02MPP DRUG__ID D02MPP D02MPP DRUGTYPE Small molecular drug D02MPP DRUGINCH 1S/C8H9NO2/c1-11-7-4-2-3-6(5-7)8(9)10/h2-5H,1H3,(H2,9,10) D02MPP DRUGINKE VKPLPDIMEREJJF-UHFFFAOYSA-N D02MPP DRUGSMIL COC1=CC=CC(=C1)C(=O)N D02MPP HIGHSTAT Investigative D02MPZ DRUG__ID D02MPZ D02MPZ DRUGTYPE Small molecular drug D02MPZ DRUGINCH 1S/C43H57N13O7/c1-2-3-13-31-38(59)56-35(21-27-23-47-24-50-27)42(63)54-33(19-25-10-5-4-6-11-25)40(61)53-32(15-9-18-48-43(45)46)39(60)55-34(20-26-22-49-29-14-8-7-12-28(26)29)41(62)52-30(37(44)58)16-17-36(57)51-31/h4-8,10-12,14,22-24,30-35,49H,2-3,9,13,15-21H2,1H3,(H2,44,58)(H,47,50)(H,51,57)(H,52,62)(H,53,61)(H,54,63)(H,55,60)(H,56,59)(H4,45,46,48)/t30-,31-,32-,33+,34-,35-/m0/s1 D02MPZ DRUGINKE JWVUTJWCWBNVDW-CXJNCMCBSA-N D02MPZ DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5 D02MPZ HIGHSTAT Investigative D02MQL DRUG__ID D02MQL D02MQL THERCLAS Antifungal Agents D02MQL DRUGINCH 1S/C22H19N5O/c23-21(24)14-5-9-18(10-6-14)28-17-7-3-13(4-8-17)19-11-15-1-2-16(22(25)26)12-20(15)27-19/h1-12,27H,(H3,23,24)(H3,25,26) D02MQL DRUGINKE OSSYTOVYXCAWPG-UHFFFAOYSA-N D02MQL DRUGSMIL C1=CC(=CC=C1C2=CC3=C(N2)C=C(C=C3)C(=N)N)OC4=CC=C(C=C4)C(=N)N D02MQL HIGHSTAT Investigative D02MQM DRUG__ID D02MQM D02MQM DRUGTYPE Small molecular drug D02MQM DRUGINCH 1S/C14H19BrN2O2/c15-11-14(19)16-10-6-2-5-9-13(18)17-12-7-3-1-4-8-12/h1,3-4,7-8H,2,5-6,9-11H2,(H,16,19)(H,17,18) D02MQM DRUGINKE HWYLREOMBVUGJQ-UHFFFAOYSA-N D02MQM DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCNC(=O)CBr D02MQM HIGHSTAT Investigative D02MQT DRUG__ID D02MQT D02MQT DRUGTYPE Small molecular drug D02MQT DRUGINCH 1S/C27H31NO2/c1-27-13-12-23-22-11-9-21(29)15-18(22)6-10-24(23)25(27)16-19(26(27)30)14-17-4-7-20(8-5-17)28(2)3/h4-5,7-9,11,14-15,23-25,29H,6,10,12-13,16H2,1-3H3/b19-14+/t23?,24?,25?,27-/m0/s1 D02MQT DRUGINKE ZDWWQQXXGWLFMH-IMNIJDOTSA-N D02MQT DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=C(C=C4)N(C)C)C2=O)CCC5=C3C=CC(=C5)O D02MQT HIGHSTAT Investigative D02MUO DRUG__ID D02MUO D02MUO DRUGTYPE Small molecular drug D02MUO DRUGINCH 1S/C24H13Br2ClO4/c25-17-10-12(4-8-20(17)28)24(13-5-9-21(29)18(26)11-13)16-3-1-2-14-19(27)7-6-15(22(14)16)23(30)31-24/h1-11,28-29H D02MUO DRUGINKE GFGZCXHXQCQRFP-UHFFFAOYSA-N D02MUO DRUGSMIL C1=CC2=C(C=CC3=C2C(=C1)C(OC3=O)(C4=CC(=C(C=C4)O)Br)C5=CC(=C(C=C5)O)Br)Cl D02MUO HIGHSTAT Investigative D02MVR DRUG__ID D02MVR D02MVR DRUGTYPE Small molecular drug D02MVR DRUGINCH 1S/C13H14N2/c1-2-4-13-11(3-1)12(9-15-13)10-5-7-14-8-6-10/h1-5,9,14-15H,6-8H2 D02MVR DRUGINKE CIRSPTXGPFAXRE-UHFFFAOYSA-N D02MVR DRUGSMIL C1CNCC=C1C2=CNC3=CC=CC=C32 D02MVR HIGHSTAT Investigative D02MYV DRUG__ID D02MYV D02MYV DRUGTYPE Small molecular drug D02MYV DRUGINCH 1S/C17H18Cl2O4/c1-17(10-4-2-3-5-10)7-9-6-11(23-8-12(20)21)14(18)15(19)13(9)16(17)22/h6,10H,2-5,7-8H2,1H3,(H,20,21) D02MYV DRUGINKE RNOJGTHBMJBOSP-UHFFFAOYSA-N D02MYV DRUGSMIL CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3CCCC3 D02MYV HIGHSTAT Investigative D02MZN DRUG__ID D02MZN D02MZN DRUGTYPE Small molecular drug D02MZN DRUGINCH 1S/C24H35NO3/c1-4-25(5-2)22(27)14-16-13-21-20-8-6-15-12-17(26)7-9-18(15)19(20)10-11-24(21,3)23(16)28/h7,9,12,16,19-21,23,26,28H,4-6,8,10-11,13-14H2,1-3H3/t16?,19?,20?,21?,23-,24-/m0/s1 D02MZN DRUGINKE VGGFHJKLCAAIOU-CGCZFLRESA-N D02MZN DRUGSMIL CCN(CC)C(=O)CC1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O D02MZN HIGHSTAT Investigative D02MZZ DRUG__ID D02MZZ D02MZZ DRUGTYPE Small molecular drug D02MZZ DRUGINCH 1S/C14H12N2O2S/c1-10-5-2-3-7-13(10)19(17,18)14-8-4-6-12(16)11(14)9-15/h2-8H,16H2,1H3 D02MZZ DRUGINKE YJZJHTMOZPILRK-UHFFFAOYSA-N D02MZZ DRUGSMIL CC1=CC=CC=C1S(=O)(=O)C2=CC=CC(=C2C#N)N D02MZZ HIGHSTAT Investigative D02NAF DRUG__ID D02NAF D02NAF DRUGTYPE Small molecular drug D02NAF DRUGINCH 1S/C30H37N5O4S2/c1-20-28(38)35-18-9-13-24(35)27(37)33-23(12-3-2-8-19-40-41-25-14-6-7-17-31-25)26(36)34-30(29(39)32-20)16-15-21-10-4-5-11-22(21)30/h4-7,10-11,14,17,20,23-24H,2-3,8-9,12-13,15-16,18-19H2,1H3,(H,32,39)(H,33,37)(H,34,36)/t20-,23-,24+,30-/m0/s1 D02NAF DRUGINKE ZGCIQVPLYZBUHQ-KGPFVPCYSA-N D02NAF DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CCC4=CC=CC=C43)C(=O)N1)CCCCCSSC5=CC=CC=N5 D02NAF HIGHSTAT Investigative D02NAG DRUG__ID D02NAG D02NAG DRUGTYPE Small molecular drug D02NAG DRUGINCH 1S/C15H12ClN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8+ D02NAG DRUGINKE GQENGHZHJWXFLG-XYOKQWHBSA-N D02NAG DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)Cl D02NAG HIGHSTAT Investigative D02NAW DRUG__ID D02NAW D02NAW DRUGTYPE Small molecular drug D02NAW DRUGINCH 1S/C29H30Cl2N2O3/c1-28(2,35)27(34)32-24-17-29(14-6-3-7-15-29)36-26-22(24)16-21(18-10-12-19(30)13-11-18)25(33-26)20-8-4-5-9-23(20)31/h4-5,8-13,16,24,35H,3,6-7,14-15,17H2,1-2H3,(H,32,34) D02NAW DRUGINKE UTPSWDIIQDVVTK-UHFFFAOYSA-N D02NAW DRUGSMIL CC(C)(C(=O)NC1CC2(CCCCC2)OC3=C1C=C(C(=N3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl)O D02NAW HIGHSTAT Investigative D02NBB DRUG__ID D02NBB D02NBB DRUGTYPE Small molecular drug D02NBB DRUGINCH 1S/C16H12N6O3/c17-16-19-13(12-5-2-6-25-12)14-15(20-16)21(9-18-14)8-10-3-1-4-11(7-10)22(23)24/h1-7,9H,8H2,(H2,17,19,20) D02NBB DRUGINKE LYSMIARHRJVSBZ-UHFFFAOYSA-N D02NBB DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])CN2C=NC3=C(N=C(N=C32)N)C4=CC=CO4 D02NBB HIGHSTAT Investigative D02NCO DRUG__ID D02NCO D02NCO DRUGTYPE Small molecular drug D02NCO DRUGINCH 1S/C37H37F2N3O4S/c1-22(2)35(44)40-26-16-14-25(15-17-26)34-28(19-41(5)18-24-10-7-6-8-11-24)32-33(43)29(37(45)46-23(3)4)21-42(36(32)47-34)20-27-30(38)12-9-13-31(27)39/h6-17,21-23H,18-20H2,1-5H3,(H,40,44) D02NCO DRUGINKE RANJJVIMTOIWIN-UHFFFAOYSA-N D02NCO DRUGSMIL CC(C)C(=O)NC1=CC=C(C=C1)C2=C(C3=C(S2)N(C=C(C3=O)C(=O)OC(C)C)CC4=C(C=CC=C4F)F)CN(C)CC5=CC=CC=C5 D02NCO HIGHSTAT Investigative D02NCW DRUG__ID D02NCW D02NCW DRUGTYPE Small molecular drug D02NCW DRUGINCH 1S/C30H50O2/c1-25(2)15-16-27(5)18-24(32)30(8)19(20(27)17-25)9-10-22-28(6)13-12-23(31)26(3,4)21(28)11-14-29(22,30)7/h9,20-24,31-32H,10-18H2,1-8H3/t20-,21-,22+,23-,24-,27+,28-,29+,30-/m0/s1 D02NCW DRUGINKE XVKHGUQJCRRKSC-WXIGGWTCSA-N D02NCW DRUGSMIL CC1(CCC2(CC(C3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)O)C)C D02NCW HIGHSTAT Investigative D02NCY DRUG__ID D02NCY D02NCY DRUGTYPE Small molecular drug D02NCY DRUGINCH 1S/C10H8ClN3O2/c11-6-1-3-7(4-2-6)12-8-5-9(15)14-10(16)13-8/h1-5H,(H3,12,13,14,15,16) D02NCY DRUGINKE POKMZWROIKHVLE-UHFFFAOYSA-N D02NCY DRUGSMIL C1=CC(=CC=C1NC2=CC(=O)NC(=O)N2)Cl D02NCY HIGHSTAT Investigative D02NED DRUG__ID D02NED D02NED DRUGTYPE Small molecular drug D02NED DRUGINCH 1S/C19H20N4O2/c1-11-21-15-6-5-14(20-8-9-22(2)3)17-18(15)23(11)16-7-4-12(24)10-13(16)19(17)25/h4-7,10,20,24H,8-9H2,1-3H3 D02NED DRUGINKE RWGHRNQPAMSGPF-UHFFFAOYSA-N D02NED DRUGSMIL CC1=NC2=C3N1C4=C(C=C(C=C4)O)C(=O)C3=C(C=C2)NCCN(C)C D02NED HIGHSTAT Investigative D02NGU DRUG__ID D02NGU D02NGU DRUGTYPE Small molecular drug D02NGU DRUGINCH 1S/C12H15N3O2S/c1-13-7-8-15-18(16,17)12-4-2-3-10-9-14-6-5-11(10)12/h2-6,9,13,15H,7-8H2,1H3 D02NGU DRUGINKE PJWUXKNZVMEPPH-UHFFFAOYSA-N D02NGU DRUGSMIL CNCCNS(=O)(=O)C1=CC=CC2=C1C=CN=C2 D02NGU HIGHSTAT Investigative D02NHS DRUG__ID D02NHS D02NHS DRUGTYPE Small molecular drug D02NHS DRUGINCH 1S/C22H26N6O2/c1-15-12-26-21(24-11-10-17-6-4-3-5-7-17)22(30)28(15)14-20(29)25-13-18-8-9-19(23)27-16(18)2/h3-9,12H,10-11,13-14H2,1-2H3,(H2,23,27)(H,24,26)(H,25,29) D02NHS DRUGINKE PVDHYBJORRALSQ-UHFFFAOYSA-N D02NHS DRUGSMIL CC1=CN=C(C(=O)N1CC(=O)NCC2=C(N=C(C=C2)N)C)NCCC3=CC=CC=C3 D02NHS HIGHSTAT Investigative D02NHZ DRUG__ID D02NHZ D02NHZ DRUGTYPE Small molecular drug D02NHZ DRUGINCH 1S/C17H15NO/c1-12-3-4-14-5-6-15(11-17(14)18-12)13-7-9-16(19-2)10-8-13/h3-11H,1-2H3 D02NHZ DRUGINKE NCNHXSMXZZAGHM-UHFFFAOYSA-N D02NHZ DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=C(C=C3)OC D02NHZ HIGHSTAT Investigative D02NKD DRUG__ID D02NKD D02NKD DRUGTYPE Small molecular drug D02NKD DRUGINCH 1S/C20H13N3O2/c24-23(25)17-10-4-8-15(12-17)20-19-16(9-5-11-21-19)13-18(22-20)14-6-2-1-3-7-14/h1-13H D02NKD DRUGINKE SRVUGPYWYLBZNI-UHFFFAOYSA-N D02NKD DRUGSMIL C1=CC=C(C=C1)C2=NC(=C3C(=C2)C=CC=N3)C4=CC(=CC=C4)[N+](=O)[O-] D02NKD HIGHSTAT Investigative D02NKV DRUG__ID D02NKV D02NKV DRUGTYPE Small molecular drug D02NKV DRUGINCH 1S/C17H16FN5/c18-13-5-3-12(4-6-13)15-16(14-7-8-20-17(19)22-14)23(10-21-15)9-11-1-2-11/h3-8,10-11H,1-2,9H2,(H2,19,20,22) D02NKV DRUGINKE DFEYXQGDDCDXJK-UHFFFAOYSA-N D02NKV DRUGSMIL C1CC1CN2C=NC(=C2C3=NC(=NC=C3)N)C4=CC=C(C=C4)F D02NKV HIGHSTAT Investigative D02NMN DRUG__ID D02NMN D02NMN DRUGTYPE Small molecular drug D02NMN DRUGINCH 1S/C19H14N4O2S/c1-3-9-20-14-8-10-21-18-15(14)16-17(26-18)19(24)23(11-22-16)12-4-6-13(25-2)7-5-12/h1,4-8,10-11H,9H2,2H3,(H,20,21) D02NMN DRUGINKE WIAAIYJUCDAKFY-UHFFFAOYSA-N D02NMN DRUGSMIL COC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=NC=CC(=C34)NCC#C D02NMN HIGHSTAT Investigative D02NMY DRUG__ID D02NMY D02NMY DRUGTYPE Small molecular drug D02NMY DRUGINCH 1S/C13H14BrN3/c14-11-2-3-12-10(9-11)1-4-13(16-12)17-7-5-15-6-8-17/h1-4,9,15H,5-8H2 D02NMY DRUGINKE MKIHFWMBAKJYJL-UHFFFAOYSA-N D02NMY DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)Br D02NMY HIGHSTAT Investigative D02NNS DRUG__ID D02NNS D02NNS DRUGTYPE Small molecular drug D02NNS DRUGINCH 1S/C22H28F3N3O2/c1-15(28-20(29)12-22(13-21(28)30)4-2-3-5-22)14-26-6-8-27(9-7-26)19-11-17(24)16(23)10-18(19)25/h10-11,15H,2-9,12-14H2,1H3/t15-/m1/s1 D02NNS DRUGINKE WCWNYVYNQAPOOX-OAHLLOKOSA-N D02NNS DRUGSMIL CC(CN1CCN(CC1)C2=CC(=C(C=C2F)F)F)N3C(=O)CC4(CCCC4)CC3=O D02NNS HIGHSTAT Investigative D02NNT DRUG__ID D02NNT D02NNT DRUGTYPE Small molecular drug D02NNT DRUGINCH 1S/C17H15F2N7/c1-9-5-15(26-25-9)23-17-13(19)6-11(7-20)16(24-17)22-10(2)14-4-3-12(18)8-21-14/h3-6,8,10H,1-2H3,(H3,22,23,24,25,26)/t10-/m0/s1 D02NNT DRUGINKE HIHOEGPXVVKJPP-JTQLQIEISA-N D02NNT DRUGSMIL CC1=CC(=NN1)NC2=C(C=C(C(=N2)NC(C)C3=NC=C(C=C3)F)C#N)F D02NNT HIGHSTAT Investigative D02NNU DRUG__ID D02NNU D02NNU DRUGTYPE Small molecular drug D02NNU DRUGINCH 1S/C18H13ClN4O2S/c1-9-6-20-14-12(25-9)7-21-17-13(14)15-16(26-17)18(24)23(8-22-15)11-4-2-10(19)3-5-11/h2-5,7-9,20H,6H2,1H3/t9-/m0/s1 D02NNU DRUGINKE LFUPTQIEOBBAJE-VIFPVBQESA-N D02NNU DRUGSMIL CC1CNC2=C3C4=C(C(=O)N(C=N4)C5=CC=C(C=C5)Cl)SC3=NC=C2O1 D02NNU HIGHSTAT Investigative D02NQB DRUG__ID D02NQB D02NQB DRUGTYPE Small molecular drug D02NQB DRUGINCH 1S/C22H25NO5/c1-15(22(27)28)13-19(23-20(24)11-12-21(25)26)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,15,19H,11-14H2,1H3,(H,23,24)(H,25,26)(H,27,28)/t15-,19+/m1/s1 D02NQB DRUGINKE DOBNVUFHFMVMDB-BEFAXECRSA-N D02NQB DRUGSMIL CC(CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O)C(=O)O D02NQB HIGHSTAT Investigative D02NQK DRUG__ID D02NQK D02NQK DRUGTYPE Small molecular drug D02NQK DRUGINCH 1S/C10H9N3O3S2/c11-18(15,16)9-7-12-5-4-8(9)17-10-3-1-2-6-13(10)14/h1-7H,(H2,11,15,16) D02NQK DRUGINKE DQAURQJZVIJAAO-UHFFFAOYSA-N D02NQK DRUGSMIL C1=CC=[N+](C(=C1)SC2=C(C=NC=C2)S(=O)(=O)N)[O-] D02NQK HIGHSTAT Investigative D02NRI DRUG__ID D02NRI D02NRI DRUGTYPE Small molecular drug D02NRI DRUGINCH 1S/C21H20O4/c1-12(2)4-6-15-18(23-3)9-8-14-17-11-24-19-10-13(22)5-7-16(19)21(17)25-20(14)15/h4-5,7-10,22H,6,11H2,1-3H3 D02NRI DRUGINKE BYZVMAQRPFEPSV-UHFFFAOYSA-N D02NRI DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3=C2COC4=C3C=CC(=C4)O)OC)C D02NRI HIGHSTAT Investigative D02NRP DRUG__ID D02NRP D02NRP DRUGTYPE Small molecular drug D02NRP DRUGINCH 1S/C16H26FNO22P4/c17-9-10(21)6(3-19)36-16(12(9)23)37-42(28,29)39-44(32,33)40-43(30,31)38-41(26,27)34-4-7-11(22)13(24)14(35-7)5-1-2-8(20)18-15(5)25/h1-2,5-7,9-14,16,19,21-24H,3-4H2,(H,26,27)(H,28,29)(H,30,31)(H,32,33)(H,18,20,25)/t5?,6-,7-,9+,10-,11-,12-,13-,14+,16-/m1/s1 D02NRP DRUGINKE SMNRFWMNPDABKZ-WVALLCKVSA-N D02NRP DRUGSMIL C1=CC(=O)NC(=O)C1C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)F)O)O)O D02NRP HIGHSTAT Investigative D02NRY DRUG__ID D02NRY D02NRY DRUGTYPE Small molecular drug D02NRY DRUGINCH 1S/C11H9BrN2O/c1-8-4-2-3-5-10(8)11(15)14-7-9(12)6-13-14/h2-7H,1H3 D02NRY DRUGINKE PNYXHXJNRYYIKD-UHFFFAOYSA-N D02NRY DRUGSMIL CC1=CC=CC=C1C(=O)N2C=C(C=N2)Br D02NRY HIGHSTAT Investigative D02NSY DRUG__ID D02NSY D02NSY DRUGTYPE Small molecular drug D02NSY DRUGINCH 1S/C27H35N3O2/c31-26(25-12-6-17-30(25)20-22-8-2-1-3-9-22)28-15-7-16-29-18-13-27(14-19-29)24-11-5-4-10-23(24)21-32-27/h1-5,8-11,25H,6-7,12-21H2,(H,28,31)/t25-/m1/s1 D02NSY DRUGINKE MAKMQGKJURAJEN-RUZDIDTESA-N D02NSY DRUGSMIL C1CC(N(C1)CC2=CC=CC=C2)C(=O)NCCCN3CCC4(CC3)C5=CC=CC=C5CO4 D02NSY HIGHSTAT Investigative D02NUR DRUG__ID D02NUR D02NUR DRUGTYPE Small molecular drug D02NUR DRUGINCH 1S/C13H17F2NO/c1-8(16-13(2,3)4)12(17)9-5-10(14)7-11(15)6-9/h5-8,16H,1-4H3 D02NUR DRUGINKE CXFKXPAAWKFBPJ-UHFFFAOYSA-N D02NUR DRUGSMIL CC(C(=O)C1=CC(=CC(=C1)F)F)NC(C)(C)C D02NUR HIGHSTAT Investigative D02NVY DRUG__ID D02NVY D02NVY DRUGTYPE Small molecular drug D02NVY DRUGINCH 1S/C30H37N5O4S2/c1-20-28(38)35-16-9-13-24(35)27(37)33-23(12-3-2-8-17-40-41-25-14-6-7-15-31-25)26(36)34-30(29(39)32-20)18-21-10-4-5-11-22(21)19-30/h4-7,10-11,14-15,20,23-24H,2-3,8-9,12-13,16-19H2,1H3,(H,32,39)(H,33,37)(H,34,36)/t20-,23-,24+/m0/s1 D02NVY DRUGINKE RKZORBYVFSJNHI-NKKJXINNSA-N D02NVY DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CC4=CC=CC=C4C3)C(=O)N1)CCCCCSSC5=CC=CC=N5 D02NVY HIGHSTAT Investigative D02NWF DRUG__ID D02NWF D02NWF DRUGTYPE Small molecular drug D02NWF DRUGINCH 1S/C19H15N3S/c1-2-7-14(8-3-1)13-20-18-15-9-4-5-10-16(15)21-19(22-18)17-11-6-12-23-17/h1-12H,13H2,(H,20,21,22) D02NWF DRUGINKE XITKIGBKTNSGCP-UHFFFAOYSA-N D02NWF DRUGSMIL C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)C4=CC=CS4 D02NWF HIGHSTAT Investigative D02NWL DRUG__ID D02NWL D02NWL DRUGTYPE Small molecular drug D02NWL DRUGINCH 1S/C26H34IN7O2/c27-23-17-21(8-9-24(23)29)25(35)30-11-12-32-26(33-19-28)31-10-5-15-36-22-7-4-6-20(16-22)18-34-13-2-1-3-14-34/h4,6-9,16-17H,1-3,5,10-15,18,29H2,(H,30,35)(H2,31,32,33)/i27-2 D02NWL DRUGINKE VJTYCMQYDRXNNY-ALRLDUCRSA-N D02NWL DRUGSMIL C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=CC(=C(C=C3)N)I)NC#N D02NWL HIGHSTAT Investigative D02NWS DRUG__ID D02NWS D02NWS DRUGTYPE Small molecular drug D02NWS DRUGINCH 1S/C10H13NO2/c12-10(11-13)8-4-7-9-5-2-1-3-6-9/h1-3,5-6,13H,4,7-8H2,(H,11,12) D02NWS DRUGINKE UPHXPXYRKPCXHK-UHFFFAOYSA-N D02NWS DRUGSMIL C1=CC=C(C=C1)CCCC(=O)NO D02NWS HIGHSTAT Investigative D02NZE DRUG__ID D02NZE D02NZE DRUGTYPE Small molecular drug D02NZE DRUGINCH 1S/C31H33ClF3N5O/c32-25-7-8-27(31(33,34)35)24(17-25)20-40-16-11-36-29-28(40)18-23(19-37-29)21-3-5-22(6-4-21)30(41)39-14-9-26(10-15-39)38-12-1-2-13-38/h3-8,17-19,26H,1-2,9-16,20H2,(H,36,37) D02NZE DRUGINKE JVVGHVJDZJSKRA-UHFFFAOYSA-N D02NZE DRUGSMIL C1CCN(C1)C2CCN(CC2)C(=O)C3=CC=C(C=C3)C4=CC5=C(NCCN5CC6=C(C=CC(=C6)Cl)C(F)(F)F)N=C4 D02NZE HIGHSTAT Investigative D02NZI DRUG__ID D02NZI D02NZI DRUGTYPE Small molecular drug D02NZI DRUGINCH 1S/C22H23ClF3N3O3/c1-3-28(4-2)9-10-29-17-12-13(19(27)30)11-15(22(24,25)26)18(17)21(32,20(29)31)14-7-5-6-8-16(14)23/h5-8,11-12,32H,3-4,9-10H2,1-2H3,(H2,27,30) D02NZI DRUGINKE YSSPGXCFFITNCE-UHFFFAOYSA-N D02NZI DRUGSMIL CCN(CC)CCN1C2=CC(=CC(=C2C(C1=O)(C3=CC=CC=C3Cl)O)C(F)(F)F)C(=O)N D02NZI HIGHSTAT Investigative D02OAB DRUG__ID D02OAB D02OAB DRUGTYPE Small molecular drug D02OAB DRUGINCH 1S/C7H5BrN2/c8-6-1-2-7-5(3-6)4-9-10-7/h1-4H,(H,9,10) D02OAB DRUGINKE STVHMYNPQCLUNJ-UHFFFAOYSA-N D02OAB DRUGSMIL C1=CC2=C(C=C1Br)C=NN2 D02OAB HIGHSTAT Investigative D02OAI DRUG__ID D02OAI D02OAI DRUGTYPE Small molecular drug D02OAI DRUGINCH 1S/C22H22BrF2NO4/c1-21(2)5-6-22(3,4)16-11(21)9-14(18(27)17(16)23)26-19(28)10-7-12(24)15(20(29)30)13(25)8-10/h7-9,27H,5-6H2,1-4H3,(H,26,28)(H,29,30) D02OAI DRUGINKE FADQHUSDAKOWFT-UHFFFAOYSA-N D02OAI DRUGSMIL CC1(CCC(C2=C(C(=C(C=C21)NC(=O)C3=CC(=C(C(=C3)F)C(=O)O)F)O)Br)(C)C)C D02OAI HIGHSTAT Investigative D02OAJ DRUG__ID D02OAJ D02OAJ DRUGTYPE Small molecular drug D02OAJ DRUGINCH 1S/C9H15N2O14P3S/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(23-8)3-22-26(16,17)24-27(18,19)25-28(20,21)29/h1-2,4,6-8,13-14H,3H2,(H,16,17)(H,18,19)(H,10,12,15)(H2,20,21,29)/t4-,6-,7-,8-/m1/s1 D02OAJ DRUGINKE DUDALCZPYHIGIR-XVFCMESISA-N D02OAJ DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O D02OAJ HIGHSTAT Investigative D02OBA DRUG__ID D02OBA D02OBA DRUGTYPE Small molecular drug D02OBA DRUGINCH 1S/C17H10O5/c18-11-1-3-13-9(5-11)7-15(21-13)17(20)16-8-10-6-12(19)2-4-14(10)22-16/h1-8,18-19H D02OBA DRUGINKE TYHFGEDRLCAJMH-UHFFFAOYSA-N D02OBA DRUGSMIL C1=CC2=C(C=C1O)C=C(O2)C(=O)C3=CC4=C(O3)C=CC(=C4)O D02OBA HIGHSTAT Investigative D02ODJ DRUG__ID D02ODJ D02ODJ DRUGTYPE Small molecular drug D02ODJ DRUGINCH 1S/C17H22N2O2/c1-11(20)18-10-12-5-4-6-16-17(12)14-9-13(21-3)7-8-15(14)19(16)2/h7-9,12H,4-6,10H2,1-3H3,(H,18,20) D02ODJ DRUGINKE CYOQJCSHEFAKNY-UHFFFAOYSA-N D02ODJ DRUGSMIL CC(=O)NCC1CCCC2=C1C3=C(N2C)C=CC(=C3)OC D02ODJ HIGHSTAT Investigative D02OEI DRUG__ID D02OEI D02OEI DRUGTYPE Small molecular drug D02OEI DRUGINCH 1S/C13H19N/c1-10-5-3-7-13(11(10)2)12-6-4-8-14-9-12/h3,5,7,12,14H,4,6,8-9H2,1-2H3 D02OEI DRUGINKE TXQGNZXKUWJMKW-UHFFFAOYSA-N D02OEI DRUGSMIL CC1=C(C(=CC=C1)C2CCCNC2)C D02OEI HIGHSTAT Investigative D02OET DRUG__ID D02OET D02OET DRUGTYPE Small molecular drug D02OET DRUGINCH 1S/C28H31FNO5P/c1-4-23-26(19-10-12-21(29)13-11-19)24(14-15-36(34,35)17-22(31)16-25(32)33)27(18(2)3)30-28(23)20-8-6-5-7-9-20/h5-15,18,22,31H,4,16-17H2,1-3H3,(H,32,33)(H,34,35)/p-2/b15-14+/t22-/m1/s1 D02OET DRUGINKE LPNRUMVKXCLEBE-JXVRESAISA-L D02OET DRUGSMIL CCC1=C(C(=C(N=C1C2=CC=CC=C2)C(C)C)C=CP(=O)(CC(CC(=O)[O-])O)[O-])C3=CC=C(C=C3)F D02OET HIGHSTAT Investigative D02OHW DRUG__ID D02OHW D02OHW DRUGTYPE Small molecular drug D02OHW DRUGINCH 1S/C15H11ClN2/c1-10-5-6-11-7-8-14(18-15(11)17-10)12-3-2-4-13(16)9-12/h2-9H,1H3 D02OHW DRUGINKE LLSDDUWUZVPZOE-UHFFFAOYSA-N D02OHW DRUGSMIL CC1=NC2=C(C=C1)C=CC(=N2)C3=CC(=CC=C3)Cl D02OHW HIGHSTAT Investigative D02OKF DRUG__ID D02OKF D02OKF DRUGTYPE Small molecular drug D02OKF DRUGINCH 1S/C16H11ClO2/c17-16-9-14(19)5-6-15(16)12-2-1-11-8-13(18)4-3-10(11)7-12/h1-9,18-19H D02OKF DRUGINKE FNSIACDWDZGUHN-UHFFFAOYSA-N D02OKF DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=C(C=C(C=C3)O)Cl D02OKF HIGHSTAT Investigative D02OMP DRUG__ID D02OMP D02OMP DRUGTYPE Small molecular drug D02OMP DRUGINCH 1S/C17H19IN6O4/c18-9-3-8(1-2-10(9)19)4-20-15-12-16(22-6-21-15)24(7-23-12)17-14(27)13(26)11(5-25)28-17/h1-3,6-7,11,13-14,17,25-27H,4-5,19H2,(H,20,21,22)/t11-,13-,14-,17-/m1/s1 D02OMP DRUGINKE REGZQZHKIFOMRK-LSCFUAHRSA-N D02OMP DRUGSMIL C1=CC(=C(C=C1CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)I)N D02OMP HIGHSTAT Investigative D02ONP DRUG__ID D02ONP D02ONP DRUGTYPE Small molecular drug D02ONP DRUGINCH 1S/C21H14O8/c1-27-19(24)14(15-17(22)10-6-2-4-8-12(10)28-20(15)25)16-18(23)11-7-3-5-9-13(11)29-21(16)26/h2-9,14,22-23H,1H3 D02ONP DRUGINKE XCIPOAZOZKLEOW-UHFFFAOYSA-N D02ONP DRUGSMIL COC(=O)C(C1=C(C2=CC=CC=C2OC1=O)O)C3=C(C4=CC=CC=C4OC3=O)O D02ONP HIGHSTAT Investigative D02ONZ DRUG__ID D02ONZ D02ONZ DRUGTYPE Small molecular drug D02ONZ DRUGINCH 1S/C15H8BrNO4/c16-10-3-6-14-12(7-10)13(18)8-15(21-14)9-1-4-11(5-2-9)17(19)20/h1-8H D02ONZ DRUGINKE GMVMGIYPRPPNMB-UHFFFAOYSA-N D02ONZ DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=CC(=C3)Br)[N+](=O)[O-] D02ONZ HIGHSTAT Investigative D02OPG DRUG__ID D02OPG D02OPG DRUGTYPE Small molecular drug D02OPG DRUGINCH 1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23-,24-,26+/m0/s1/i14T/t14?,21-,22+,23-,24-,26+ D02OPG DRUGINKE VYCMAAOURFJIHD-HCGDBENESA-N D02OPG DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43 D02OPG HIGHSTAT Investigative D02OPH DRUG__ID D02OPH D02OPH DRUGTYPE Small molecular drug D02OPH DRUGINCH 1S/C17H10Cl2N2O4/c18-9-3-1-2-8(6-9)13-14(16(23)21-15(13)22)20-10-4-5-12(19)11(7-10)17(24)25/h1-7H,(H,24,25)(H2,20,21,22,23) D02OPH DRUGINKE ONVZFCHLOZUXRP-UHFFFAOYSA-N D02OPH DRUGSMIL C1=CC(=CC(=C1)Cl)C2=C(C(=O)NC2=O)NC3=CC(=C(C=C3)Cl)C(=O)O D02OPH HIGHSTAT Investigative D02OVN DRUG__ID D02OVN D02OVN DRUGTYPE Small molecular drug D02OVN DRUGINCH 1S/C17H19N5O7S2/c1-7-5-30-13(21-10(7)14(25)26)8(4-23)19-12(24)11(9-6-31-16(18)20-9)22-29-17(2,3)15(27)28/h4,6,8,13H,1,5H2,2-3H3,(H2,18,20)(H,19,24)(H,25,26)(H,27,28)/b22-11-/t8-,13-/m1/s1 D02OVN DRUGINKE VEHPZKIFULQYFS-BZXVCXBKSA-N D02OVN DRUGSMIL CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC(C=O)C2N=C(C(=C)CS2)C(=O)O D02OVN HIGHSTAT Investigative D02OYL DRUG__ID D02OYL D02OYL DRUGTYPE Small molecular drug D02OYL DRUGINCH 1S/C22H29N3O/c26-22(23-15-5-8-18-25-16-6-2-7-17-25)24-21-13-11-20(12-14-21)19-9-3-1-4-10-19/h1,3-4,9-14H,2,5-8,15-18H2,(H2,23,24,26) D02OYL DRUGINKE MUIUUGJVKFYPIF-UHFFFAOYSA-N D02OYL DRUGSMIL C1CCN(CC1)CCCCNC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3 D02OYL HIGHSTAT Investigative D02OZB DRUG__ID D02OZB D02OZB DRUGTYPE Small molecular drug D02OZB DRUGINCH 1S/C10H14N2O/c13-10-4-2-1-3-9(10)12-7-5-11-6-8-12/h1-4,11,13H,5-8H2 D02OZB DRUGINKE UORNTHBBLYBAJJ-UHFFFAOYSA-N D02OZB DRUGSMIL C1CN(CCN1)C2=CC=CC=C2O D02OZB HIGHSTAT Investigative D02PAU DRUG__ID D02PAU D02PAU DRUGTYPE Small molecular drug D02PAU DRUGINCH 1S/C20H17Cl3N4O3S/c1-24-7-10-9-31-18(16(10)23)20(29)27-17-13(5-12(22)6-14(17)30-2)19(28)26-15-4-3-11(21)8-25-15/h3-6,8-9,24H,7H2,1-2H3,(H,27,29)(H,25,26,28) D02PAU DRUGINKE CYFNXPSIQONWKY-UHFFFAOYSA-N D02PAU DRUGSMIL CNCC1=CSC(=C1Cl)C(=O)NC2=C(C=C(C=C2OC)Cl)C(=O)NC3=NC=C(C=C3)Cl D02PAU HIGHSTAT Investigative D02PBS DRUG__ID D02PBS D02PBS DRUGTYPE Small molecular drug D02PBS DRUGINCH 1S/C20H17NO5/c22-17-13-19(21-8-10-24-11-9-21)26-18-12-15(6-7-16(17)18)25-20(23)14-4-2-1-3-5-14/h1-7,12-13H,8-11H2 D02PBS DRUGINKE GIEJDWWZPMOULL-UHFFFAOYSA-N D02PBS DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)OC(=O)C4=CC=CC=C4 D02PBS HIGHSTAT Investigative D02PBY DRUG__ID D02PBY D02PBY DRUGTYPE Small molecular drug D02PBY DRUGINCH 1S/C20H28N4O2/c1-3-5-22-18-17(19(25)23(6-4-2)20(22)26)24(11-21-18)16-14-8-12-7-13(10-14)15(16)9-12/h11-16H,3-10H2,1-2H3 D02PBY DRUGINKE CTRHINADNBPODV-UHFFFAOYSA-N D02PBY DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)N(C=N2)C3C4CC5CC(C4)C3C5 D02PBY HIGHSTAT Investigative D02PDP DRUG__ID D02PDP D02PDP DRUGTYPE Small molecular drug D02PDP DRUGINCH 1S/C23H17NO/c25-21-13-7-12-19(14-21)20-15-22(17-8-3-1-4-9-17)24-23(16-20)18-10-5-2-6-11-18/h1-16,25H D02PDP DRUGINKE JTTGRNWIRRFPKZ-UHFFFAOYSA-N D02PDP DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC(=N2)C3=CC=CC=C3)C4=CC(=CC=C4)O D02PDP HIGHSTAT Investigative D02PFJ DRUG__ID D02PFJ D02PFJ DRUGTYPE Small molecular drug D02PFJ DRUGINCH 1S/C10H17N3O/c1-12(10(11)14)6-2-3-7-13-8-4-5-9-13/h4-9H2,1H3,(H2,11,14) D02PFJ DRUGINKE NSYYEAWIQXWYBA-UHFFFAOYSA-N D02PFJ DRUGSMIL CN(CC#CCN1CCCC1)C(=O)N D02PFJ HIGHSTAT Investigative D02PIG DRUG__ID D02PIG D02PIG DRUGTYPE Small molecular drug D02PIG DRUGINCH 1S/C28H36N6O7S/c1-42-12-11-21(28(40)41)34-27(39)22(14-17-5-3-2-4-6-17)33-24(36)16-31-23(35)15-32-26(38)20(29)13-18-7-9-19(10-8-18)25(30)37/h2-10,20-22H,11-16,29H2,1H3,(H2,30,37)(H,31,35)(H,32,38)(H,33,36)(H,34,39)(H,40,41)/t20-,21-,22-/m0/s1 D02PIG DRUGINKE OOJZMMQHNUJUPF-FKBYEOEOSA-N D02PIG DRUGSMIL CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)C(=O)N)N D02PIG HIGHSTAT Investigative D02PKO DRUG__ID D02PKO D02PKO DRUGTYPE Small molecular drug D02PKO DRUGINCH 1S/C12H16O3S2/c1-15-9-2-5-11(6-3-9)17(13,14)12-7-4-10(16)8-12/h2-3,5-6,10,12,16H,4,7-8H2,1H3 D02PKO DRUGINKE JDPMCWHMTGTQGU-UHFFFAOYSA-N D02PKO DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)C2CCC(C2)S D02PKO HIGHSTAT Investigative D02PKR DRUG__ID D02PKR D02PKR DRUGTYPE Small molecular drug D02PKR DRUGINCH 1S/C13H13BrN4O2/c14-11-8-9-7-10(18(19)20)1-2-12(9)16-13(11)17-5-3-15-4-6-17/h1-2,7-8,15H,3-6H2 D02PKR DRUGINKE MPHPQAKQQDLIGK-UHFFFAOYSA-N D02PKR DRUGSMIL C1CN(CCN1)C2=C(C=C3C=C(C=CC3=N2)[N+](=O)[O-])Br D02PKR HIGHSTAT Investigative D02PLD DRUG__ID D02PLD D02PLD DRUGTYPE Small molecular drug D02PLD DRUGINCH 1S/C14H22N2O/c1-2-3-12-17-14-7-5-4-6-13(14)16-10-8-15-9-11-16/h4-7,15H,2-3,8-12H2,1H3 D02PLD DRUGINKE YNPHKRWUIFAKLL-UHFFFAOYSA-N D02PLD DRUGSMIL CCCCOC1=CC=CC=C1N2CCNCC2 D02PLD HIGHSTAT Investigative D02PLG DRUG__ID D02PLG D02PLG DRUGTYPE Small molecular drug D02PLG DRUGINCH 1S/C17H14O2S3/c1-18-13-7-3-11(4-8-13)15-16(21-22-17(15)20)12-5-9-14(19-2)10-6-12/h3-10H,1-2H3 D02PLG DRUGINKE CLEJIKNYKPUJCS-UHFFFAOYSA-N D02PLG DRUGSMIL COC1=CC=C(C=C1)C2=C(SSC2=S)C3=CC=C(C=C3)OC D02PLG HIGHSTAT Investigative D02POA DRUG__ID D02POA D02POA DRUGTYPE Small molecular drug D02POA DRUGINCH 1S/C20H27NO/c1-4-5-6-7-12-20(2,3)17-10-11-18(19(22)14-17)16-9-8-13-21-15-16/h8-11,13-15,22H,4-7,12H2,1-3H3 D02POA DRUGINKE OYBDWAVFBKZYIO-UHFFFAOYSA-N D02POA DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CN=CC=C2)O D02POA HIGHSTAT Investigative D02POV DRUG__ID D02POV D02POV DRUGTYPE Small molecular drug D02POV DRUGINCH 1S/C13H15N3S2/c1-10(11-5-3-2-4-6-11)9-15-12(17)16-13-14-7-8-18-13/h2-8,10H,9H2,1H3,(H2,14,15,16,17) D02POV DRUGINKE NQIQJPRBRMXGMW-UHFFFAOYSA-N D02POV DRUGSMIL CC(CNC(=S)NC1=NC=CS1)C2=CC=CC=C2 D02POV HIGHSTAT Investigative D02PPQ DRUG__ID D02PPQ D02PPQ DRUGTYPE Small molecular drug D02PPQ DRUGINCH 1S/C14H13N3O4S/c1-2-21-14(18)13-4-3-7-17(13)22(19,20)10-5-6-11-12(8-10)16-9-15-11/h3-9H,2H2,1H3,(H,15,16) D02PPQ DRUGINKE UVYMCWVOZHENRB-UHFFFAOYSA-N D02PPQ DRUGSMIL CCOC(=O)C1=CC=CN1S(=O)(=O)C2=CC3=C(C=C2)N=CN3 D02PPQ HIGHSTAT Investigative D02PSL DRUG__ID D02PSL D02PSL DRUGTYPE Small molecular drug D02PSL DRUGINCH 1S/C18H15N3/c1-14-3-2-4-17(9-14)18-11-20-13-21(18)12-16-7-5-15(10-19)6-8-16/h2-9,11,13H,12H2,1H3 D02PSL DRUGINKE PLRIEAPRLTXNAI-UHFFFAOYSA-N D02PSL DRUGSMIL CC1=CC(=CC=C1)C2=CN=CN2CC3=CC=C(C=C3)C#N D02PSL HIGHSTAT Investigative D02PSR DRUG__ID D02PSR D02PSR DRUGTYPE Small molecular drug D02PSR DRUGINCH 1S/C9H12N2.ClH/c1-8(7-11-10)9-5-3-2-4-6-9;/h2-6,11H,1,7,10H2;1H D02PSR DRUGINKE SSRWZZHWIPKMCQ-UHFFFAOYSA-N D02PSR DRUGSMIL C=C(CNN)C1=CC=CC=C1.Cl D02PSR HIGHSTAT Investigative D02PUV DRUG__ID D02PUV D02PUV DRUGTYPE Small molecular drug D02PUV DRUGINCH 1S/C17H18O2/c1-12(2)11-17(13-3-7-15(18)8-4-13)14-5-9-16(19)10-6-14/h3-12,18-19H,1-2H3 D02PUV DRUGINKE DDEWRRMILVWZOZ-UHFFFAOYSA-N D02PUV DRUGSMIL CC(C)C=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O D02PUV HIGHSTAT Investigative D02PVB DRUG__ID D02PVB D02PVB DRUGTYPE Small molecular drug D02PVB DRUGINCH 1S/C14H8N2O/c17-14-9-5-2-1-4-8(9)13-12-10(14)6-3-7-11(12)15-16-13/h1-7H,(H,15,16) D02PVB DRUGINKE ACPOUJIDANTYHO-UHFFFAOYSA-N D02PVB DRUGSMIL C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O D02PVB HIGHSTAT Investigative D02PVD DRUG__ID D02PVD D02PVD DRUGTYPE Small molecular drug D02PVD DRUGINCH 1S/C15H31NO7P2/c1-14(2)8-5-9-15(3)10-6-11-16(4)12-7-13-22-25(20,21)23-24(17,18)19/h8,10H,5-7,9,11-13H2,1-4H3,(H,20,21)(H2,17,18,19)/b15-10+ D02PVD DRUGINKE PNEIVJAQBZSMGD-XNTDXEJSSA-N D02PVD DRUGSMIL CC(=CCCC(=CCCN(C)CCCOP(=O)(O)OP(=O)(O)O)C)C D02PVD HIGHSTAT Investigative D02PWZ DRUG__ID D02PWZ D02PWZ DRUGTYPE Small molecular drug D02PWZ DRUGINCH 1S/C14H13NO5/c16-10-2-1-8(13(19)6-10)7-15-14(20)9-3-11(17)5-12(18)4-9/h1-6,16-19H,7H2,(H,15,20) D02PWZ DRUGINKE OFDRVQUXDYIMFW-UHFFFAOYSA-N D02PWZ DRUGSMIL C1=CC(=C(C=C1O)O)CNC(=O)C2=CC(=CC(=C2)O)O D02PWZ HIGHSTAT Investigative D02PXN DRUG__ID D02PXN D02PXN DRUGTYPE Small molecular drug D02PXN DRUGINCH 1S/C22H37N5O2S/c1-27(2)21-11-5-10-20-19(21)9-6-12-22(20)30(28,29)26-18-8-17-25-15-4-3-14-24-16-7-13-23/h5-6,9-12,24-26H,3-4,7-8,13-18,23H2,1-2H3 D02PXN DRUGINKE NSUSGNAFCIMCDH-UHFFFAOYSA-N D02PXN DRUGSMIL CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCNCCCCNCCCN D02PXN HIGHSTAT Investigative D02PZJ DRUG__ID D02PZJ D02PZJ DRUGTYPE Small molecular drug D02PZJ DRUGINCH 1S/C16H10F3NO2/c17-16(18,19)22-15-7-2-1-6-13(15)11-4-3-5-12(8-11)14-9-21-10-20-14/h1-10H D02PZJ DRUGINKE QUFLMZRMQIORDK-UHFFFAOYSA-N D02PZJ DRUGSMIL C1=CC=C(C(=C1)C2=CC(=CC=C2)C3=COC=N3)OC(F)(F)F D02PZJ HIGHSTAT Investigative D02PZZ DRUG__ID D02PZZ D02PZZ DRUGTYPE Small molecular drug D02PZZ DRUGINCH 1S/C15H12N2O/c1-18-14-3-2-12-8-13(10-17-15(12)9-14)11-4-6-16-7-5-11/h2-10H,1H3 D02PZZ DRUGINKE NGPCGERQDPJHQQ-UHFFFAOYSA-N D02PZZ DRUGSMIL COC1=CC2=NC=C(C=C2C=C1)C3=CC=NC=C3 D02PZZ HIGHSTAT Investigative D02QAZ DRUG__ID D02QAZ D02QAZ DRUGTYPE Small molecular drug D02QAZ DRUGINCH 1S/C22H20F3N5O3S/c1-34(32,33)16-4-2-3-13(9-16)11-26-20-17(22(23,24)25)12-27-21(30-20)28-15-6-7-18-14(10-15)5-8-19(31)29-18/h2-4,6-7,9-10,12H,5,8,11H2,1H3,(H,29,31)(H2,26,27,28,30) D02QAZ DRUGINKE HESLKTSGTIBHJU-UHFFFAOYSA-N D02QAZ DRUGSMIL CS(=O)(=O)C1=CC=CC(=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)CC4 D02QAZ HIGHSTAT Investigative D02QBH DRUG__ID D02QBH D02QBH DRUGTYPE Small molecular drug D02QBH DRUGINCH 1S/C17H16N2O3/c1-20-16-9-13-14(10-17(16)21-2)19-7-6-15(13)22-12-5-3-4-11(18)8-12/h3-10H,18H2,1-2H3 D02QBH DRUGINKE KOTHQRYMXOUUHZ-UHFFFAOYSA-N D02QBH DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=CC(=C3)N D02QBH HIGHSTAT Investigative D02QBV DRUG__ID D02QBV D02QBV DRUGTYPE Small molecular drug D02QBV DRUGINCH 1S/C16H17FN2O2/c17-14-3-1-2-13(8-14)11-21-15-6-4-12(5-7-15)9-19-10-16(18)20/h1-8,19H,9-11H2,(H2,18,20) D02QBV DRUGINKE UZDHMFDYNZICFG-UHFFFAOYSA-N D02QBV DRUGSMIL C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CNCC(=O)N D02QBV HIGHSTAT Investigative D02QCC DRUG__ID D02QCC D02QCC DRUGTYPE Small molecular drug D02QCC DRUGINCH 1S/C20H20O5/c1-20(2)17(22)8-13-15(25-20)6-5-11-14-9-23-16-7-10(21)3-4-12(16)19(14)24-18(11)13/h3-7,14,17,19,21-22H,8-9H2,1-2H3/t14-,17?,19-/m1/s1 D02QCC DRUGINKE ZCLUCQDBFSBCJB-LJMFKLJISA-N D02QCC DRUGSMIL CC1(C(CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)O)C D02QCC HIGHSTAT Investigative D02QDW DRUG__ID D02QDW D02QDW DRUGTYPE Small molecular drug D02QDW DRUGINCH 1S/C10H19N3O2/c1-2-4-7(11)10(15)13-6-3-5-8(13)9(12)14/h7-8H,2-6,11H2,1H3,(H2,12,14)/t7-,8-/m0/s1 D02QDW DRUGINKE NOBVHVGPMMOHAE-YUMQZZPRSA-N D02QDW DRUGSMIL CCCC(C(=O)N1CCCC1C(=O)N)N D02QDW HIGHSTAT Investigative D02QEP DRUG__ID D02QEP D02QEP DRUGTYPE Small molecular drug D02QEP DRUGINCH 1S/C19H17FN2O2/c20-16-3-1-2-14(12-16)4-6-17-7-5-15(13-21-17)19(24)22-10-8-18(23)9-11-22/h1-3,5,7,12-13,18,23H,8-11H2 D02QEP DRUGINKE ZKKOJUZGUBLAJQ-UHFFFAOYSA-N D02QEP DRUGSMIL C1CN(CCC1O)C(=O)C2=CN=C(C=C2)C#CC3=CC(=CC=C3)F D02QEP HIGHSTAT Investigative D02QGI DRUG__ID D02QGI D02QGI DRUGTYPE Small molecular drug D02QGI DRUGINCH 1S/C5H14N2/c6-4-2-1-3-5-7/h1-7H2 D02QGI DRUGINKE VHRGRCVQAFMJIZ-UHFFFAOYSA-N D02QGI DRUGSMIL C(CCN)CCN D02QGI HIGHSTAT Investigative D02QJW DRUG__ID D02QJW D02QJW DRUGTYPE Small molecular drug D02QJW DRUGINCH 1S/C21H37ClN/c1-4-7-8-9-11-18-23(5-2,6-3)19-12-10-13-20-14-16-21(22)17-15-20/h14-17H,4-13,18-19H2,1-3H3/q+1 D02QJW DRUGINKE WPSYTTKBGAZSCX-UHFFFAOYSA-N D02QJW DRUGSMIL CCCCCCC[N+](CC)(CC)CCCCC1=CC=C(C=C1)Cl D02QJW HIGHSTAT Investigative D02QLY DRUG__ID D02QLY D02QLY DRUGTYPE Small molecular drug D02QLY DRUGINCH 1S/C23H17NO4/c25-18-5-1-3-14(12-18)15-7-9-20-16(11-15)8-10-21(27)22(20)23(28)24-17-4-2-6-19(26)13-17/h1-13,25-27H,(H,24,28) D02QLY DRUGINKE JFOMBBOIWCMHKV-UHFFFAOYSA-N D02QLY DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)C(=C(C=C3)O)C(=O)NC4=CC(=CC=C4)O D02QLY HIGHSTAT Investigative D02QME DRUG__ID D02QME D02QME DRUGTYPE Small molecular drug D02QME DRUGINCH 1S/C21H15NO/c22-15-20(16-11-13-19(23)14-12-16)21(17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-14,23H D02QME DRUGINKE IMMSDZNZGPJVRN-UHFFFAOYSA-N D02QME DRUGSMIL C1=CC=C(C=C1)C(=C(C#N)C2=CC=C(C=C2)O)C3=CC=CC=C3 D02QME HIGHSTAT Investigative D02QML DRUG__ID D02QML D02QML DRUGTYPE Small molecular drug D02QML DRUGINCH 1S/C18H15NO/c1-12-6-7-14-8-9-17(11-18(14)19-12)16-5-3-4-15(10-16)13(2)20/h3-11H,1-2H3 D02QML DRUGINKE RDDPBRGDKLSJLB-UHFFFAOYSA-N D02QML DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC=C3)C(=O)C D02QML HIGHSTAT Investigative D02QMU DRUG__ID D02QMU D02QMU DRUGTYPE Small molecular drug D02QMU DRUGINCH 1S/C28H27N2O5/c1-31-24-8-7-19-14-23-21-16-26-25(34-18-35-26)15-20(21)9-11-30(23)17-22(19)28(24)33-13-5-4-12-32-27-6-2-3-10-29-27/h2-3,6-8,10,14-17H,4-5,9,11-13,18H2,1H3/q+1 D02QMU DRUGINKE MZPIENUCQFUDBE-UHFFFAOYSA-N D02QMU DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=CC=CC=N6 D02QMU HIGHSTAT Investigative D02QOD DRUG__ID D02QOD D02QOD DRUGTYPE Small molecular drug D02QOD DRUGINCH 1S/C71H110N24O18S/c1-34(2)24-47(92-62(105)43(14-11-22-79-71(76)77)89-64(107)45(15-18-52(72)96)90-63(106)44-17-20-55(99)85-44)61(104)81-31-56(100)87-51(28-54(74)98)69(112)91-46(16-19-53(73)97)65(108)94-49(26-38-29-80-41-13-10-9-12-40(38)41)66(109)84-37(7)60(103)95-58(36(5)6)70(113)82-32-57(101)86-50(27-39-30-78-33-83-39)68(111)93-48(25-35(3)4)67(110)88-42(59(75)102)21-23-114-8/h9-10,12-13,29-30,33-37,42-51,58,80H,11,14-28,31-32H2,1-8H3,(H2,72,96)(H2,73,97)(H2,74,98)(H2,75,102)(H,78,83)(H,81,104)(H,82,113)(H,84,109)(H,85,99)(H,86,101)(H,87,100)(H,88,110)(H,89,107)(H,90,106)(H,91,112)(H,92,105)(H,93,111)(H,94,108)(H,95,103)(H4,76,77,79)/t37-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,58-/m0/s1 D02QOD DRUGINKE QXZBMSIDSOZZHK-DOPDSADYSA-N D02QOD DRUGSMIL CC(C)CC(C(=O)NCC(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC3=CNC=N3)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C4CCC(=O)N4 D02QOD HIGHSTAT Investigative D02QOT DRUG__ID D02QOT D02QOT DRUGTYPE Small molecular drug D02QOT DRUGINCH 1S/C17H21NO2S/c18-16(12-11-15-7-3-1-4-8-15)13-14-21(19,20)17-9-5-2-6-10-17/h1-10,16H,11-14,18H2/t16-/m0/s1 D02QOT DRUGINKE WQRZZKAHRWPIFX-INIZCTEOSA-N D02QOT DRUGSMIL C1=CC=C(C=C1)CCC(CCS(=O)(=O)C2=CC=CC=C2)N D02QOT HIGHSTAT Investigative D02QPP DRUG__ID D02QPP D02QPP DRUGTYPE Small molecular drug D02QPP DRUGINCH 1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3/t11-,17-/m0/s1 D02QPP DRUGINKE LSLYOANBFKQKPT-GTNSWQLSSA-N D02QPP DRUGSMIL CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O D02QPP HIGHSTAT Investigative D02QQD DRUG__ID D02QQD D02QQD DRUGTYPE Small molecular drug D02QQD DRUGINCH 1S/C17H18ClN3OS/c1-9-7-13-14(19)15(23-17(13)21-10(9)2)16(22)20-8-11-3-5-12(18)6-4-11/h3-7,14-15H,8,19H2,1-2H3,(H,20,22) D02QQD DRUGINKE VUEHIWNVURDJMB-UHFFFAOYSA-N D02QQD DRUGSMIL CC1=CC2=C(N=C1C)SC(C2N)C(=O)NCC3=CC=C(C=C3)Cl D02QQD HIGHSTAT Investigative D02QSH DRUG__ID D02QSH D02QSH DRUGTYPE Small molecular drug D02QSH DRUGINCH 1S/C17H13FN2O3/c18-12-3-1-11(2-4-12)17(20-6-5-19-9-20)13-7-15-16(8-14(13)21)23-10-22-15/h1-9,17,21H,10H2 D02QSH DRUGINKE WOTHQAYNAPHLDM-UHFFFAOYSA-N D02QSH DRUGSMIL C1OC2=C(O1)C=C(C(=C2)C(C3=CC=C(C=C3)F)N4C=CN=C4)O D02QSH HIGHSTAT Investigative D02QTB DRUG__ID D02QTB D02QTB DRUGTYPE Small molecular drug D02QTB DRUGINCH 1S/C26H24FNO/c1-2-3-8-16-28-18-20(17-25(28)23-13-6-7-15-24(23)27)26(29)22-14-9-11-19-10-4-5-12-21(19)22/h4-7,9-15,17-18H,2-3,8,16H2,1H3 D02QTB DRUGINKE WYNZPDDTQGVCLZ-UHFFFAOYSA-N D02QTB DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2F)C(=O)C3=CC=CC4=CC=CC=C43 D02QTB HIGHSTAT Investigative D02QTE DRUG__ID D02QTE D02QTE DRUGTYPE Small molecular drug D02QTE DRUGINCH 1S/C12H13ClN6O/c1-19(2)11-9(13)17-8(10(14)18-11)12(20)16-7-4-3-5-15-6-7/h3-6H,1-2H3,(H2,14,18)(H,16,20) D02QTE DRUGINKE RNGRUHWJJPTYNR-UHFFFAOYSA-N D02QTE DRUGSMIL CN(C)C1=NC(=C(N=C1Cl)C(=O)NC2=CN=CC=C2)N D02QTE HIGHSTAT Investigative D02QUS DRUG__ID D02QUS D02QUS DRUGTYPE Small molecular drug D02QUS DRUGINCH 1S/C18H14ClN3OS/c19-13-4-1-5-14(9-13)21-17(23)15-6-8-22-16(15)11-24-18(22)12-3-2-7-20-10-12/h1-10,18H,11H2,(H,21,23) D02QUS DRUGINKE MJGVBIXLFIUPQU-UHFFFAOYSA-N D02QUS DRUGSMIL C1C2=C(C=CN2C(S1)C3=CN=CC=C3)C(=O)NC4=CC(=CC=C4)Cl D02QUS HIGHSTAT Investigative D02QWB DRUG__ID D02QWB D02QWB DRUGTYPE Small molecular drug D02QWB DRUGINCH 1S/C5H10N2O6P2/c8-14(9,10)5(15(11,12)13)3-7-2-1-6-4-7/h1-2,4-5H,3H2,(H2,8,9,10)(H2,11,12,13) D02QWB DRUGINKE FBSQLNMIJFINOJ-UHFFFAOYSA-N D02QWB DRUGSMIL C1=CN(C=N1)CC(P(=O)(O)O)P(=O)(O)O D02QWB HIGHSTAT Investigative D02QWO DRUG__ID D02QWO D02QWO DRUGTYPE Small molecular drug D02QWO DRUGINCH 1S/C37H40N2O6/c1-38-14-12-24-19-31(42-4)33-21-27(24)28(38)17-23-8-11-30(41-3)32(18-23)44-26-9-6-22(7-10-26)16-29-35-25(13-15-39(29)2)20-34(43-5)36(40)37(35)45-33/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29+/m1/s1 D02QWO DRUGINKE YJRWQNIRFXVBRB-WDYNHAJCSA-N D02QWO DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=CC(=C(C=C7CCN6C)OC)O3)OC)O)OC D02QWO HIGHSTAT Investigative D02QXF DRUG__ID D02QXF D02QXF DRUGTYPE Small molecular drug D02QXF DRUGINCH 1S/C14H18N2O/c1-3-5-10(2)17-12-7-4-6-11-8-9-13(15)16-14(11)12/h4,6-10H,3,5H2,1-2H3,(H2,15,16) D02QXF DRUGINKE KMEFXXMANWGJCR-UHFFFAOYSA-N D02QXF DRUGSMIL CCCC(C)OC1=CC=CC2=C1N=C(C=C2)N D02QXF HIGHSTAT Investigative D02QXT DRUG__ID D02QXT D02QXT DRUGTYPE Small molecular drug D02QXT DRUGINCH 1S/C14H15NO/c1-16-12-4-5-13-11(8-12)3-2-10-6-7-15-9-14(10)13/h2-5,8,15H,6-7,9H2,1H3 D02QXT DRUGINKE LTVUTAZPBISUIF-UHFFFAOYSA-N D02QXT DRUGSMIL COC1=CC2=C(C=C1)C3=C(CCNC3)C=C2 D02QXT HIGHSTAT Investigative D02QZF DRUG__ID D02QZF D02QZF DRUGTYPE Small molecular drug D02QZF DRUGINCH 1S/C15H13N3O/c16-15(19)13-8-4-7-12-10-18(17-14(12)13)9-11-5-2-1-3-6-11/h1-8,10H,9H2,(H2,16,19) D02QZF DRUGINKE FCHCPSCDAOGWGQ-UHFFFAOYSA-N D02QZF DRUGSMIL C1=CC=C(C=C1)CN2C=C3C=CC=C(C3=N2)C(=O)N D02QZF HIGHSTAT Investigative D02RAN DRUG__ID D02RAN D02RAN DRUGTYPE Small molecular drug D02RAN DRUGINCH 1S/C6H10N4S/c7-6(8)11-2-1-5-3-9-4-10-5/h3-4H,1-2H2,(H3,7,8)(H,9,10) D02RAN DRUGINKE PEHSVUKQDJULKE-UHFFFAOYSA-N D02RAN DRUGSMIL C1=C(NC=N1)CCSC(=N)N D02RAN HIGHSTAT Investigative D02RAY DRUG__ID D02RAY D02RAY DRUGTYPE Small molecular drug D02RAY DRUGINCH 1S/C21H25NO4/c1-22-7-6-12-9-18(25-4)21(26-5)20-14-11-17(24-3)16(23-2)10-13(14)8-15(22)19(12)20/h9-11,15H,6-8H2,1-5H3/t15-/m0/s1 D02RAY DRUGINKE RUZIUYOSRDWYQF-HNNXBMFYSA-N D02RAY DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)OC)OC D02RAY HIGHSTAT Investigative D02RBK DRUG__ID D02RBK D02RBK DRUGTYPE Small molecular drug D02RBK DRUGINCH 1S/C12H10BrN5/c13-12-17-9-10(14)15-7-16-11(9)18(12)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H2,14,15,16) D02RBK DRUGINKE OUPAEJUFVKPEHM-UHFFFAOYSA-N D02RBK DRUGSMIL C1=CC=C(C=C1)CN2C3=NC=NC(=C3N=C2Br)N D02RBK HIGHSTAT Investigative D02RBU DRUG__ID D02RBU D02RBU DRUGTYPE Small molecular drug D02RBU DRUGINCH 1S/C12H17NO3/c1-3-4-9-16-11-7-5-10(6-8-11)12(14)13(2)15/h5-8,15H,3-4,9H2,1-2H3 D02RBU DRUGINKE OFVDFLZBUJEGOQ-UHFFFAOYSA-N D02RBU DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)N(C)O D02RBU HIGHSTAT Investigative D02RDY DRUG__ID D02RDY D02RDY DRUGTYPE Small molecular drug D02RDY DRUGINCH 1S/C29H30F2N4O2/c30-24-9-5-20(6-10-24)28(21-7-11-25(31)12-8-21)34-15-13-33(14-16-34)27(36)17-26(32)29(37)35-18-22-3-1-2-4-23(22)19-35/h1-12,26,28H,13-19,32H2 D02RDY DRUGINKE ZKIQFLSGMMYCGS-UHFFFAOYSA-N D02RDY DRUGSMIL C1CN(CCN1C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C(=O)CC(C(=O)N4CC5=CC=CC=C5C4)N D02RDY HIGHSTAT Investigative D02RGB DRUG__ID D02RGB D02RGB DRUGTYPE Small molecular drug D02RGB DRUGINCH 1S/C18H19NO4/c19-16(18(22)23)11-15(17(20)21)7-3-4-12-8-9-13-5-1-2-6-14(13)10-12/h1-6,8-10,15-16H,7,11,19H2,(H,20,21)(H,22,23)/b4-3+ D02RGB DRUGINKE KNAYYBRIBNEIAL-ONEGZZNKSA-N D02RGB DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C=CCC(CC(C(=O)O)N)C(=O)O D02RGB HIGHSTAT Investigative D02RIE DRUG__ID D02RIE D02RIE DRUGTYPE Small molecular drug D02RIE DRUGINCH 1S/C17H18Cl2N2O2S/c1-11-2-5-13(6-3-11)24(22,23)21-9-15(17(20)10-21)14-7-4-12(18)8-16(14)19/h2-8,15,17H,9-10,20H2,1H3 D02RIE DRUGINKE XFWVFJXNYYSICX-UHFFFAOYSA-N D02RIE DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CC(C(C2)N)C3=C(C=C(C=C3)Cl)Cl D02RIE HIGHSTAT Investigative D02RIG DRUG__ID D02RIG D02RIG DRUGTYPE Small molecular drug D02RIG DRUGINCH 1S/C12H8N2O2/c13-5-7(6-14)8-1-2-10-9(8)3-4-11(15)12(10)16/h3-4,15-16H,1-2H2 D02RIG DRUGINKE QNMCUDUCYPYEQM-UHFFFAOYSA-N D02RIG DRUGSMIL C1CC(=C(C#N)C#N)C2=C1C(=C(C=C2)O)O D02RIG HIGHSTAT Investigative D02RIH DRUG__ID D02RIH D02RIH DRUGTYPE Small molecular drug D02RIH DRUGINCH 1S/C16H15F3N2O4/c1-8-12(15(22)25-3)13(14(21(23)24)9(2)20-8)10-6-4-5-7-11(10)16(17,18)19/h4-7,13,20H,1-3H3/t13-/m0/s1 D02RIH DRUGINKE ZFLWDHHVRRZMEI-ZDUSSCGKSA-N D02RIH DRUGSMIL CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)OC D02RIH HIGHSTAT Investigative D02RJA DRUG__ID D02RJA D02RJA DRUGTYPE Small molecular drug D02RJA DRUGINCH 1S/C14H13NO5S/c1-19-12-6-2-4-10(8-12)14(16)11-5-3-7-13(9-11)20-21(15,17)18/h2-9H,1H3,(H2,15,17,18) D02RJA DRUGINKE WHDKAZSQSIKUGW-UHFFFAOYSA-N D02RJA DRUGSMIL COC1=CC=CC(=C1)C(=O)C2=CC(=CC=C2)OS(=O)(=O)N D02RJA HIGHSTAT Investigative D02RMR DRUG__ID D02RMR D02RMR DRUGTYPE Small molecular drug D02RMR DRUGINCH 1S/C9H12N4O2/c1-3-12-7-6(10-5-11-7)8(14)13(4-2)9(12)15/h5H,3-4H2,1-2H3,(H,10,11) D02RMR DRUGINKE GIMNFISWKTZFKJ-UHFFFAOYSA-N D02RMR DRUGSMIL CCN1C2=C(C(=O)N(C1=O)CC)NC=N2 D02RMR HIGHSTAT Investigative D02RMS DRUG__ID D02RMS D02RMS DRUGTYPE Small molecular drug D02RMS DRUGINCH 1S/C9H15N3/c1-2-10-8-3-4-9-7(5-8)6-11-12-9/h6,8,10H,2-5H2,1H3,(H,11,12) D02RMS DRUGINKE DDFOVLJCDZCIIF-UHFFFAOYSA-N D02RMS DRUGSMIL CCNC1CCC2=C(C1)C=NN2 D02RMS HIGHSTAT Investigative D02RNH DRUG__ID D02RNH D02RNH DRUGTYPE Small molecular drug D02RNH DRUGINCH 1S/C3H8N2Se/c1-2-6-3(4)5/h2H2,1H3,(H3,4,5) D02RNH DRUGINKE FFKYNFXDBBLWGF-UHFFFAOYSA-N D02RNH DRUGSMIL CC[Se]C(=N)N D02RNH HIGHSTAT Investigative D02RQP DRUG__ID D02RQP D02RQP DRUGTYPE Small molecular drug D02RQP DRUGINCH 1S/C15H16O2/c1-15(2,11-3-7-13(16)8-4-11)12-5-9-14(17)10-6-12/h3-10,16-17H,1-2H3 D02RQP DRUGINKE IISBACLAFKSPIT-UHFFFAOYSA-N D02RQP DRUGSMIL CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O D02RQP HIGHSTAT Investigative D02RRY DRUG__ID D02RRY D02RRY DRUGTYPE Small molecular drug D02RRY DRUGINCH 1S/C15H13N3O4S/c1-10-7-8-12(18(19)20)9-15(10)23(21,22)17-11(2)16-13-5-3-4-6-14(13)17/h3-9H,1-2H3 D02RRY DRUGINKE ILVCPQPMRPHZSG-UHFFFAOYSA-N D02RRY DRUGSMIL CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)N2C(=NC3=CC=CC=C32)C D02RRY HIGHSTAT Investigative D02RTS DRUG__ID D02RTS D02RTS DRUGTYPE Small molecular drug D02RTS DRUGINCH 1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D02RTS DRUGINKE KRKNYBCHXYNGOX-UHFFFAOYSA-N D02RTS DRUGSMIL C(C(=O)O)C(CC(=O)O)(C(=O)O)O D02RTS HIGHSTAT Investigative D02RUV DRUG__ID D02RUV D02RUV DRUGTYPE Small molecular drug D02RUV DRUGINCH 1S/C8H14O2/c1-6(2)8(3)4-5-10-7(8)9/h6H,4-5H2,1-3H3 D02RUV DRUGINKE NUQBWYMPMSPNQT-UHFFFAOYSA-N D02RUV DRUGSMIL CC(C)C1(CCOC1=O)C D02RUV HIGHSTAT Investigative D02RWC DRUG__ID D02RWC D02RWC DRUGTYPE Small molecular drug D02RWC DRUGINCH 1S/C28H21F4N5O2/c1-15-4-6-19(35-27(39)37-25-11-16(28(30,31)32)5-9-22(25)29)13-23(15)34-18-7-8-20-21(12-17-3-2-10-33-17)26(38)36-24(20)14-18/h2-14,33-34H,1H3,(H,36,38)(H2,35,37,39)/b21-12- D02RWC DRUGINKE YYDUWLSETXNJJT-MTJSOVHGSA-N D02RWC DRUGSMIL CC1=C(C=C(C=C1)NC(=O)NC2=C(C=CC(=C2)C(F)(F)F)F)NC3=CC4=C(C=C3)C(=CC5=CC=CN5)C(=O)N4 D02RWC HIGHSTAT Investigative D02RWK DRUG__ID D02RWK D02RWK DRUGTYPE Small molecular drug D02RWK DRUGINCH 1S/C27H25N3O4/c1-26(2)27(33,13-31)11-19(34-26)30-18-10-6-4-8-15(18)21-22-16(12-28-25(22)32)20-14-7-3-5-9-17(14)29-23(20)24(21)30/h3-10,19,29,31,33H,11-13H2,1-2H3,(H,28,32)/t19-,27-/m1/s1 D02RWK DRUGINKE ONSKSKMJNHEONW-XHCCPWGMSA-N D02RWK DRUGSMIL CC1(C(CC(O1)N2C3=CC=CC=C3C4=C5C(=C6C7=CC=CC=C7NC6=C42)CNC5=O)(CO)O)C D02RWK HIGHSTAT Investigative D02RWL DRUG__ID D02RWL D02RWL DRUGTYPE Small molecular drug D02RWL DRUGINCH 1S/C14H12O/c15-11-10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-9,11H,10H2 D02RWL DRUGINKE OIDMZCMVYZLDLI-UHFFFAOYSA-N D02RWL DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC=O D02RWL HIGHSTAT Investigative D02RXA DRUG__ID D02RXA D02RXA DRUGTYPE Small molecular drug D02RXA DRUGINCH 1S/C43H60N8O10/c1-22(2)18-30(44)38(55)49-35(23(3)4)41(58)46-24(5)37(54)48-33(19-26-13-15-28(53)16-14-26)42(59)51-17-9-12-34(51)40(57)47-32(39(56)50-36(25(6)52)43(60)61)20-27-21-45-31-11-8-7-10-29(27)31/h7-8,10-11,13-16,21-25,30,32-36,45,52-53H,9,12,17-20,44H2,1-6H3,(H,46,58)(H,47,57)(H,48,54)(H,49,55)(H,50,56)(H,60,61)/t24-,25+,30-,32-,33-,34-,35-,36-/m0/s1 D02RXA DRUGINKE KBSQBKDKTBPPIE-DTSDQQARSA-N D02RXA DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(C(C)O)C(=O)O)N D02RXA HIGHSTAT Investigative D02RYR DRUG__ID D02RYR D02RYR DRUGTYPE Small molecular drug D02RYR DRUGINCH 1S/C10H21O4P/c1-2-3-4-5-6-7-8-9-10-14-15(11,12)13/h2H,1,3-10H2,(H2,11,12,13) D02RYR DRUGINKE LVTDUQMIHPQSMK-UHFFFAOYSA-N D02RYR DRUGSMIL C=CCCCCCCCCOP(=O)(O)O D02RYR HIGHSTAT Investigative D02RYZ DRUG__ID D02RYZ D02RYZ DRUGTYPE Small molecular drug D02RYZ DRUGINCH 1S/C45H56N4O5/c1-28-20-34(50)21-29(2)36(28)25-39(46)44(53)49-27-33-11-4-3-10-31(33)22-41(49)43(52)47-18-15-42(51)54-35-14-13-32-23-40-37-12-5-6-16-45(37,38(32)24-35)17-19-48(40)26-30-8-7-9-30/h3-4,10-11,13-14,20-21,24,30,37,39-41,50H,5-9,12,15-19,22-23,25-27,46H2,1-2H3,(H,47,52)/t37-,39-,40+,41-,45+/m0/s1 D02RYZ DRUGINKE FYEXOHKTNZXZQH-KKEISOQISA-N D02RYZ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCC(=O)OC4=CC5=C(CC6C7C5(CCCC7)CCN6CC8CCC8)C=C4)N)C)O D02RYZ HIGHSTAT Investigative D02RZH DRUG__ID D02RZH D02RZH DRUGTYPE Small molecular drug D02RZH DRUGINCH 1S/C14H8F2N2O/c15-11-2-1-3-13(7-11)18-14(19)10-4-9(8-17)5-12(16)6-10/h1-7H,(H,18,19) D02RZH DRUGINKE PXKKWNKVXLXAEB-UHFFFAOYSA-N D02RZH DRUGSMIL C1=CC(=CC(=C1)F)NC(=O)C2=CC(=CC(=C2)C#N)F D02RZH HIGHSTAT Investigative D02SAD DRUG__ID D02SAD D02SAD DRUGTYPE Small molecular drug D02SAD DRUGINCH 1S/C19H18O3/c1-22-18-12-9-15(10-13-18)5-4-8-16-6-2-3-7-17(16)11-14-19(20)21/h2-7,9-14H,8H2,1H3,(H,20,21)/b5-4+,14-11+ D02SAD DRUGINKE UIMOCAMZLBHNCQ-CTLAPNPFSA-N D02SAD DRUGSMIL COC1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O D02SAD HIGHSTAT Investigative D02SAE DRUG__ID D02SAE D02SAE DRUGTYPE Small molecular drug D02SAE DRUGINCH 1S/C23H33NO8/c1-12(25)17-19-15-10-7-11-16(29-3)18(15)20(24(19)21(17)26)22(27)30-13(2)31-23(28)32-14-8-5-4-6-9-14/h12-17,19,25H,4-11H2,1-3H3/t12-,13?,15+,16+,17-,19-/m1/s1 D02SAE DRUGINKE QFEICXCLIGZEJB-IRVPUMQPSA-N D02SAE DRUGSMIL CC(C1C2C3CCCC(C3=C(N2C1=O)C(=O)OC(C)OC(=O)OC4CCCCC4)OC)O D02SAE HIGHSTAT Investigative D02SAF DRUG__ID D02SAF D02SAF DRUGTYPE Small molecular drug D02SAF DRUGINCH 1S/C12H18N2O2/c1-15-10-3-4-12(16-2)11(9-10)14-7-5-13-6-8-14/h3-4,9,13H,5-8H2,1-2H3 D02SAF DRUGINKE IZFHRJZAZNTUOI-UHFFFAOYSA-N D02SAF DRUGSMIL COC1=CC(=C(C=C1)OC)N2CCNCC2 D02SAF HIGHSTAT Investigative D02SBM DRUG__ID D02SBM D02SBM DRUGTYPE Small molecular drug D02SBM DRUGINCH 1S/C18H20N4O2S/c1-13-2-5-15(6-3-13)25(23,24)18-16-7-4-14(12-17(16)20-21-18)22-10-8-19-9-11-22/h2-7,12,19H,8-11H2,1H3,(H,20,21) D02SBM DRUGINKE HACUZCXCVMCHQD-UHFFFAOYSA-N D02SBM DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C3C=CC(=CC3=NN2)N4CCNCC4 D02SBM HIGHSTAT Investigative D02SDM DRUG__ID D02SDM D02SDM DRUGTYPE Small molecular drug D02SDM DRUGINCH 1S/C23H24F2N2O2/c24-17-10-6-15(7-11-17)19(16-8-12-18(25)13-9-16)3-2-14-26-20-4-1-5-21-22(20)23(28)27-29-21/h6-13,19-20,26H,1-5,14H2,(H,27,28) D02SDM DRUGINKE QOSIKKDOOCQXMT-UHFFFAOYSA-N D02SDM DRUGSMIL C1CC(C2=C(C1)ONC2=O)NCCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D02SDM HIGHSTAT Investigative D02SDT DRUG__ID D02SDT D02SDT DRUGTYPE Small molecular drug D02SDT DRUGINCH 1S/C15H27F3O3S/c1-2-3-4-5-6-7-8-9-10-11-12-22(20,21)13-14(19)15(16,17)18/h2-13H2,1H3 D02SDT DRUGINKE JUVLUOYDHJEJIQ-UHFFFAOYSA-N D02SDT DRUGSMIL CCCCCCCCCCCCS(=O)(=O)CC(=O)C(F)(F)F D02SDT HIGHSTAT Investigative D02SDX DRUG__ID D02SDX D02SDX DRUGTYPE Small molecular drug D02SDX DRUGINCH 1S/C17H21N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3 D02SDX DRUGINKE YHDCGYWZEFIUHE-UHFFFAOYSA-N D02SDX DRUGSMIL CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=C2 D02SDX HIGHSTAT Investigative D02SFJ DRUG__ID D02SFJ D02SFJ DRUGTYPE Small molecular drug D02SFJ DRUGINCH 1S/C20H21N/c1-21-12-10-15(11-13-21)20-18-8-4-2-6-16(18)14-17-7-3-5-9-19(17)20/h2-9H,10-14H2,1H3 D02SFJ DRUGINKE ZOARGTMABFXNDY-UHFFFAOYSA-N D02SFJ DRUGSMIL CN1CCC(=C2C3=CC=CC=C3CC4=CC=CC=C42)CC1 D02SFJ HIGHSTAT Investigative D02SGH DRUG__ID D02SGH D02SGH DRUGTYPE Small molecular drug D02SGH DRUGINCH 1S/C18H19NO2/c1-18(2,3)12-6-7-13-14-9-11(17(20)21-4)5-8-15(14)19-16(13)10-12/h5-10,19H,1-4H3 D02SGH DRUGINKE UIUMIPOASYICHI-UHFFFAOYSA-N D02SGH DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)C(=O)OC D02SGH HIGHSTAT Investigative D02SGJ DRUG__ID D02SGJ D02SGJ DRUGTYPE Small molecular drug D02SGJ DRUGINCH 1S/C21H22NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,9-12H,7-8H2,1-4H3/q+1 D02SGJ DRUGINKE QUCQEUCGKKTEBI-UHFFFAOYSA-N D02SGJ DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC D02SGJ HIGHSTAT Investigative D02SIT DRUG__ID D02SIT D02SIT DRUGTYPE Small molecular drug D02SIT DRUGINCH 1S/C22H16N2/c1-2-8-17(9-3-1)22(24-15-14-23-16-24)20-12-6-4-10-18(20)19-11-5-7-13-21(19)22/h1-16H D02SIT DRUGINKE DNCKVRPGVMTVNH-UHFFFAOYSA-N D02SIT DRUGSMIL C1=CC=C(C=C1)C2(C3=CC=CC=C3C4=CC=CC=C42)N5C=CN=C5 D02SIT HIGHSTAT Investigative D02SKN DRUG__ID D02SKN D02SKN DRUGTYPE Small molecular drug D02SKN DRUGINCH 1S/C21H22O5/c1-4-23-15-12-16(24-5-2)18-17(13-15)26-20(14-10-8-7-9-11-14)21(19(18)22)25-6-3/h7-13H,4-6H2,1-3H3 D02SKN DRUGINKE YMQQPRDUZIXHBJ-UHFFFAOYSA-N D02SKN DRUGSMIL CCOC1=CC2=C(C(=C1)OCC)C(=O)C(=C(O2)C3=CC=CC=C3)OCC D02SKN HIGHSTAT Investigative D02SMG DRUG__ID D02SMG D02SMG DRUGTYPE Small molecular drug D02SMG DRUGINCH 1S/C13H13NO4/c15-10-8-12(11-2-1-5-17-11)18-13(9-10)14-3-6-16-7-4-14/h1-2,5,8-9H,3-4,6-7H2 D02SMG DRUGINKE AHAIOLWQJGMAQA-UHFFFAOYSA-N D02SMG DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CO3 D02SMG HIGHSTAT Investigative D02SMK DRUG__ID D02SMK D02SMK DRUGTYPE Small molecular drug D02SMK DRUGINCH 1S/C23H18FN5O2S2/c1-13-9-15-5-8-17(31-2)10-19(15)29-21(13)27-28-23(29)33-12-20(30)26-22-25-18(11-32-22)14-3-6-16(24)7-4-14/h3-11H,12H2,1-2H3,(H,25,26,30) D02SMK DRUGINKE NQAXYXKWUOWLNN-UHFFFAOYSA-N D02SMK DRUGSMIL CC1=CC2=C(C=C(C=C2)OC)N3C1=NN=C3SCC(=O)NC4=NC(=CS4)C5=CC=C(C=C5)F D02SMK HIGHSTAT Investigative D02SNO DRUG__ID D02SNO D02SNO DRUGTYPE Small molecular drug D02SNO DRUGINCH 1S/C19H23NO/c1-15(16-9-4-2-5-10-16)21-18-13-8-14-20-19(18)17-11-6-3-7-12-17/h2-7,9-12,15,18-20H,8,13-14H2,1H3/t15-,18+,19+/m1/s1 D02SNO DRUGINKE FFKDZHIKRMLWQT-MNEFBYGVSA-N D02SNO DRUGSMIL CC(C1=CC=CC=C1)OC2CCCNC2C3=CC=CC=C3 D02SNO HIGHSTAT Investigative D02SNU DRUG__ID D02SNU D02SNU DRUGTYPE Small molecular drug D02SNU DRUGINCH 1S/C7H12N2O6P2/c1-5-3-2-4-8-6(5)9-7(16(10,11)12)17(13,14)15/h2-4,7H,1H3,(H,8,9)(H2,10,11,12)(H2,13,14,15) D02SNU DRUGINKE NAIJOBGUXRHQJW-UHFFFAOYSA-N D02SNU DRUGSMIL CC1=C(N=CC=C1)NC(P(=O)(O)O)P(=O)(O)O D02SNU HIGHSTAT Investigative D02SQF DRUG__ID D02SQF D02SQF DRUGTYPE Small molecular drug D02SQF DRUGINCH 1S/C6H11N3/c1-5-6(2-3-7)9-4-8-5/h4H,2-3,7H2,1H3,(H,8,9) D02SQF DRUGINKE UGYXPZQILZRKJJ-UHFFFAOYSA-N D02SQF DRUGSMIL CC1=C(N=CN1)CCN D02SQF HIGHSTAT Investigative D02SRL DRUG__ID D02SRL D02SRL DRUGTYPE Small molecular drug D02SRL DRUGINCH 1S/C9H7NS2/c11-9-10-8(6-12-9)7-4-2-1-3-5-7/h1-6H,(H,10,11) D02SRL DRUGINKE CYCKHTAVNBPQDB-UHFFFAOYSA-N D02SRL DRUGSMIL C1=CC=C(C=C1)C2=CSC(=S)N2 D02SRL HIGHSTAT Investigative D02SSD DRUG__ID D02SSD D02SSD DRUGTYPE Small molecular drug D02SSD DRUGINCH 1S/C17H15NO/c1-12-7-8-13-9-10-14(11-16(13)18-12)15-5-3-4-6-17(15)19-2/h3-11H,1-2H3 D02SSD DRUGINKE JLXDREZJLZGNTK-UHFFFAOYSA-N D02SSD DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC=C3OC D02SSD HIGHSTAT Investigative D02SSG DRUG__ID D02SSG D02SSG DRUGTYPE Small molecular drug D02SSG DRUGINCH 1S/C33H41N5O/c1-36(21-11-4-12-22-37-23-13-14-24-37)33-35-30-20-10-9-19-29(30)31(38(33)28-17-7-3-8-18-28)25-32(39)34-26-27-15-5-2-6-16-27/h2-3,5-10,15-20,31H,4,11-14,21-26H2,1H3,(H,34,39) D02SSG DRUGINKE DKHAGFIMNLTLHC-UHFFFAOYSA-N D02SSG DRUGSMIL CN(CCCCCN1CCCC1)C2=NC3=CC=CC=C3C(N2C4=CC=CC=C4)CC(=O)NCC5=CC=CC=C5 D02SSG HIGHSTAT Investigative D02SWF DRUG__ID D02SWF D02SWF DRUGTYPE Small molecular drug D02SWF DRUGINCH 1S/C7H13N3/c1-5(6(2)8)7-3-9-4-10-7/h3-6H,8H2,1-2H3,(H,9,10)/t5-,6-/m1/s1 D02SWF DRUGINKE QQTWSOMOTYJIQP-PHDIDXHHSA-N D02SWF DRUGSMIL CC(C1=CN=CN1)C(C)N D02SWF HIGHSTAT Investigative D02TCZ DRUG__ID D02TCZ D02TCZ DRUGTYPE Small molecular drug D02TCZ DRUGINCH 1S/C16H15N3OS/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2 D02TCZ DRUGINKE LGFZVFQIQUWUBJ-UHFFFAOYSA-N D02TCZ DRUGSMIL C1CSCCN1C2=CC(=O)N3C=CC4=CC=CC=C4C3=N2 D02TCZ HIGHSTAT Investigative D02TEW DRUG__ID D02TEW D02TEW DRUGTYPE Small molecular drug D02TEW DRUGINCH 1S/C17H14N4/c1-11-6-8-12(9-7-11)21-10-14-13-4-2-3-5-15(13)19-17(18)16(14)20-21/h2-10H,1H3,(H2,18,19) D02TEW DRUGINKE XVEJYBYRDZTECS-UHFFFAOYSA-N D02TEW DRUGSMIL CC1=CC=C(C=C1)N2C=C3C4=CC=CC=C4N=C(C3=N2)N D02TEW HIGHSTAT Investigative D02TFD DRUG__ID D02TFD D02TFD DRUGTYPE Small molecular drug D02TFD DRUGINCH 1S/C18H13NO3/c19-9-8-14-10-18(20)22-17-11-15(6-7-16(14)17)21-12-13-4-2-1-3-5-13/h1-7,10-11H,8,12H2 D02TFD DRUGINKE QXYWJHCXXQZBTQ-UHFFFAOYSA-N D02TFD DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)C(=CC(=O)O3)CC#N D02TFD HIGHSTAT Investigative D02TIO DRUG__ID D02TIO D02TIO DRUGTYPE Small molecular drug D02TIO DRUGINCH 1S/C33H35N3O7/c1-21(37)34-29(18-23-12-15-26(19-30(38)39)27(17-23)33(42)43)31(40)35-28-9-5-6-16-36(32(28)41)20-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,17,28-29H,5-6,9,16,18-20H2,1H3,(H,34,37)(H,35,40)(H,38,39)(H,42,43)/t28-,29-/m0/s1 D02TIO DRUGINKE CEKLBQMULVLLTD-VMPREFPWSA-N D02TIO DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)CC(=O)O)C(=O)O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D02TIO HIGHSTAT Investigative D02TIT DRUG__ID D02TIT D02TIT DRUGTYPE Small molecular drug D02TIT DRUGINCH 1S/C23H28FN7O4/c1-13(2)20-18(10-9-16(32)11-17(33)12-19(34)35)21(14-5-7-15(24)8-6-14)26-22(25-20)30(3)23-27-28-29-31(23)4/h5-10,13,16-17,32-33H,11-12H2,1-4H3,(H,34,35)/p-1/b10-9+/t16-,17-/m1/s1 D02TIT DRUGINKE KOTLFRFIWUOROR-VEUZHWNKSA-M D02TIT DRUGSMIL CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)C3=NN=NN3C D02TIT HIGHSTAT Investigative D02TJY DRUG__ID D02TJY D02TJY DRUGTYPE Small molecular drug D02TJY DRUGINCH 1S/C3H3N3/c1-2-4-6-5-3-1/h1-3H D02TJY DRUGINKE JYEUMXHLPRZUAT-UHFFFAOYSA-N D02TJY DRUGSMIL C1=CN=NN=C1 D02TJY HIGHSTAT Investigative D02TKC DRUG__ID D02TKC D02TKC DRUGTYPE Small molecular drug D02TKC DRUGINCH 1S/C20H21NO6/c1-10(22)26-17-5-12-3-4-21-8-13-6-15-16(25-9-24-15)7-14(13)18(19(12)21)20(17)27-11(2)23/h5-7,17-20H,3-4,8-9H2,1-2H3/t17-,18-,19+,20+/m0/s1 D02TKC DRUGINKE LMZHAKUXAHOCST-VNTMZGSJSA-N D02TKC DRUGSMIL CC(=O)OC1C=C2CCN3C2C(C1OC(=O)C)C4=CC5=C(C=C4C3)OCO5 D02TKC HIGHSTAT Investigative D02TLP DRUG__ID D02TLP D02TLP DRUGTYPE Small molecular drug D02TLP DRUGINCH 1S/C9H8O2/c1-7(10)9(11)8-5-3-2-4-6-8/h2-6H,1H3 D02TLP DRUGINKE BVQVLAIMHVDZEL-UHFFFAOYSA-N D02TLP DRUGSMIL CC(=O)C(=O)C1=CC=CC=C1 D02TLP HIGHSTAT Investigative D02TLZ DRUG__ID D02TLZ D02TLZ DRUGTYPE Small molecular drug D02TLZ DRUGINCH 1S/C16H15NO2/c1-17(19)16(18)12-9-13-7-10-15(11-8-13)14-5-3-2-4-6-14/h2-12,19H,1H3/b12-9+ D02TLZ DRUGINKE TUEHLNCQVBWQNV-FMIVXFBMSA-N D02TLZ DRUGSMIL CN(C(=O)C=CC1=CC=C(C=C1)C2=CC=CC=C2)O D02TLZ HIGHSTAT Investigative D02TMK DRUG__ID D02TMK D02TMK DRUGTYPE Small molecular drug D02TMK DRUGINCH 1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3 D02TMK DRUGINKE NGBBVGZWCFBOGO-UHFFFAOYSA-N D02TMK DRUGSMIL CC(CC1=CC2=C(C=C1)OCO2)N D02TMK HIGHSTAT Investigative D02TMR DRUG__ID D02TMR D02TMR DRUGTYPE Small molecular drug D02TMR DRUGINCH 1S/C16H18N4O3/c17-13(16(18)22)7-8-14(21)20-11-6-9-15(19-10-11)23-12-4-2-1-3-5-12/h1-6,9-10,13H,7-8,17H2,(H2,18,22)(H,20,21)/t13-/m0/s1 D02TMR DRUGINKE LJOISTVTSQVPGY-ZDUSSCGKSA-N D02TMR DRUGSMIL C1=CC=C(C=C1)OC2=NC=C(C=C2)NC(=O)CCC(C(=O)N)N D02TMR HIGHSTAT Investigative D02TMX DRUG__ID D02TMX D02TMX DRUGTYPE Small molecular drug D02TMX DRUGINCH 1S/C9H14N2/c1-3-4-8-5-7(2)6-9(10)11-8/h5-6H,3-4H2,1-2H3,(H2,10,11) D02TMX DRUGINKE QGCCHDIBMYPTPX-UHFFFAOYSA-N D02TMX DRUGSMIL CCCC1=NC(=CC(=C1)C)N D02TMX HIGHSTAT Investigative D02TNR DRUG__ID D02TNR D02TNR DRUGTYPE Small molecular drug D02TNR DRUGINCH 1S/C16H19N3O2/c17-11-12-18-15(21)16(9-5-2-6-10-16)19-14(20)13-7-3-1-4-8-13/h1,3-4,7-8H,2,5-6,9-10,12H2,(H,18,21)(H,19,20) D02TNR DRUGINKE CSOZFSBRJJRGIA-UHFFFAOYSA-N D02TNR DRUGSMIL C1CCC(CC1)(C(=O)NCC#N)NC(=O)C2=CC=CC=C2 D02TNR HIGHSTAT Investigative D02TOP DRUG__ID D02TOP D02TOP DRUGTYPE Small molecular drug D02TOP DRUGINCH 1S/C17H17N5O6S/c23-5-11-13(24)14(25)17(28-11)21-8-20-12-15(21)18-7-19-16(12)29-6-9-1-3-10(4-2-9)22(26)27/h1-4,7-8,11,13-14,17,23-25H,5-6H2/t11-,13-,14-,17-/m1/s1 D02TOP DRUGINKE DYCJFJRCWPVDHY-LSCFUAHRSA-N D02TOP DRUGSMIL C1=CC(=CC=C1CSC2=NC=NC3=C2N=CN3C4C(C(C(O4)CO)O)O)[N+](=O)[O-] D02TOP HIGHSTAT Investigative D02TPO DRUG__ID D02TPO D02TPO DRUGTYPE Small molecular drug D02TPO DRUGINCH 1S/C31H33NO5/c1-34-24-10-12-25-26-13-17-36-28-19-22(33)7-11-27(28)30(26)31(37-29(25)20-24)21-5-8-23(9-6-21)35-18-16-32-14-3-2-4-15-32/h5-12,19-20,31,33H,2-4,13-18H2,1H3/t31-/m1/s1 D02TPO DRUGINKE MEGWHNJGIHFDSO-WJOKGBTCSA-N D02TPO DRUGSMIL COC1=CC2=C(C=C1)C3=C(C(O2)C4=CC=C(C=C4)OCCN5CCCCC5)C6=C(C=C(C=C6)O)OCC3 D02TPO HIGHSTAT Investigative D02TPY DRUG__ID D02TPY D02TPY DRUGTYPE Small molecular drug D02TPY DRUGINCH 1S/C22H27N3/c1-4-22(2,3)15-19-16-24-21(25-19)13-10-17-8-11-18(12-9-17)20-7-5-6-14-23-20/h5-9,11-12,14,16H,4,10,13,15H2,1-3H3,(H,24,25) D02TPY DRUGINKE WVAKRQOMAINQPU-UHFFFAOYSA-N D02TPY DRUGSMIL CCC(C)(C)CC1=CN=C(N1)CCC2=CC=C(C=C2)C3=CC=CC=N3 D02TPY HIGHSTAT Investigative D02TQA DRUG__ID D02TQA D02TQA DRUGTYPE Small molecular drug D02TQA DRUGINCH 1S/C15H12ClNO2/c16-14-8-6-13(7-9-14)12-4-1-11(2-5-12)3-10-15(18)17-19/h1-10,19H,(H,17,18)/b10-3+ D02TQA DRUGINKE GBZPSEMNRBQROD-XCVCLJGOSA-N D02TQA DRUGSMIL C1=CC(=CC=C1C=CC(=O)NO)C2=CC=C(C=C2)Cl D02TQA HIGHSTAT Investigative D02TQC DRUG__ID D02TQC D02TQC DRUGTYPE Small molecular drug D02TQC DRUGINCH 1S/C9H8BrN5/c10-7-5(15-9(11)12)1-2-6-8(7)14-4-3-13-6/h1-4H,(H4,11,12,15) D02TQC DRUGINKE WBGSURPVIDDDHF-UHFFFAOYSA-N D02TQC DRUGSMIL C1=CC2=NC=CN=C2C(=C1N=C(N)N)Br D02TQC HIGHSTAT Investigative D02TRN DRUG__ID D02TRN D02TRN DRUGTYPE Small molecular drug D02TRN DRUGINCH 1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7- D02TRN DRUGINKE SECPZKHBENQXJG-FPLPWBNLSA-N D02TRN DRUGSMIL CCCCCCC=CCCCCCCCC(=O)O D02TRN HIGHSTAT Investigative D02TSN DRUG__ID D02TSN D02TSN DRUGTYPE Small molecular drug D02TSN DRUGINCH 1S/C21H24N4O3S/c1-14-13-28-11-10-25(14)19-12-18(21(7-8-21)29(2,26)27)23-20(24-19)16-4-3-5-17-15(16)6-9-22-17/h3-6,9,12,14,22H,7-8,10-11,13H2,1-2H3/t14-/m1/s1 D02TSN DRUGINKE SCGCBAAYLFTIJU-CQSZACIVSA-N D02TSN DRUGSMIL CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=O)(=O)C)C4=C5C=CNC5=CC=C4 D02TSN HIGHSTAT Investigative D02TVQ DRUG__ID D02TVQ D02TVQ DRUGTYPE Small molecular drug D02TVQ DRUGINCH 1S/C31H39N7O2/c1-6-7-23-14-21(4)35-31(40)26(23)18-33-30(39)25-15-24(16-28-27(25)19-34-38(28)20(2)3)22-8-9-32-29(17-22)37-12-10-36(5)11-13-37/h8-9,14-17,19-20H,6-7,10-13,18H2,1-5H3,(H,33,39)(H,35,40) D02TVQ DRUGINKE ULNXAWLQFZMIHX-UHFFFAOYSA-N D02TVQ DRUGSMIL CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CC(=NC=C4)N5CCN(CC5)C)C(C)C D02TVQ HIGHSTAT Investigative D02TVS DRUG__ID D02TVS D02TVS DRUGTYPE Small molecular drug D02TVS DRUGINCH 1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18) D02TVS DRUGINKE IPCSVZSSVZVIGE-UHFFFAOYSA-N D02TVS DRUGSMIL CCCCCCCCCCCCCCCC(=O)O D02TVS HIGHSTAT Investigative D02TXW DRUG__ID D02TXW D02TXW DRUGTYPE Small molecular drug D02TXW DRUGINCH 1S/C29H38N4O9/c1-6-40-27(38)29(4,5)42-23-17-22(30-21-16-18(3)8-9-19(21)23)25(36)31-20(10-11-24(34)35)26(37)32-12-14-33(15-13-32)28(39)41-7-2/h8-9,16-17,20H,6-7,10-15H2,1-5H3,(H,31,36)(H,34,35)/t20-/m0/s1 D02TXW DRUGINKE PHDMSNZRDFPYNQ-FQEVSTJZSA-N D02TXW DRUGSMIL CCOC(=O)C(C)(C)OC1=CC(=NC2=C1C=CC(=C2)C)C(=O)NC(CCC(=O)O)C(=O)N3CCN(CC3)C(=O)OCC D02TXW HIGHSTAT Investigative D02TYK DRUG__ID D02TYK D02TYK DRUGTYPE Small molecular drug D02TYK DRUGINCH 1S/C13H9FN4/c14-10-4-1-9(2-5-10)3-6-11-12-13(17-7-15-11)18-8-16-12/h1-8H,(H,15,16,17,18)/b6-3+ D02TYK DRUGINKE QUTNZZOCHSVJRB-ZZXKWVIFSA-N D02TYK DRUGSMIL C1=CC(=CC=C1C=CC2=C3C(=NC=N2)N=CN3)F D02TYK HIGHSTAT Investigative D02TYS DRUG__ID D02TYS D02TYS DRUGTYPE Small molecular drug D02TYS DRUGINCH 1S/C5H10N2S/c6-5-4-8-3-1-2-7-5/h1-4H2,(H2,6,7) D02TYS DRUGINKE GMUCRJMNMMHHFX-UHFFFAOYSA-N D02TYS DRUGSMIL C1CN=C(CSC1)N D02TYS HIGHSTAT Investigative D02UEJ DRUG__ID D02UEJ D02UEJ DRUGTYPE Small molecular drug D02UEJ DRUGINCH 1S/C21H22FNO/c1-2-3-8-13-23-15-18(17-10-5-7-12-20(17)23)21(24)14-16-9-4-6-11-19(16)22/h4-7,9-12,15H,2-3,8,13-14H2,1H3 D02UEJ DRUGINKE RLINGXSUWCVHIQ-UHFFFAOYSA-N D02UEJ DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3F D02UEJ HIGHSTAT Investigative D02UES DRUG__ID D02UES D02UES DRUGTYPE Small molecular drug D02UES DRUGINCH 1S/C37H49N11O6/c1-48-30(9-5-17-43-37(40)41)34(53)47-28(19-22-11-14-26(49)15-12-22)32(51)44-21-31(50)45-29(20-23-10-13-24-6-2-3-7-25(24)18-23)33(52)46-27(35(48)54)8-4-16-42-36(38)39/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,50)(H,46,52)(H,47,53)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30+/m0/s1 D02UES DRUGINKE ACYXHFQQOQRMGX-RRGQHJHPSA-N D02UES DRUGSMIL CN1C(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C1=O)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O)CCCN=C(N)N D02UES HIGHSTAT Investigative D02UHP DRUG__ID D02UHP D02UHP DRUGTYPE Small molecular drug D02UHP DRUGINCH 1S/C9H3Br2NO2/c10-5-6(11)9(14)7-4(8(5)13)2-1-3-12-7/h1-3H D02UHP DRUGINKE CPZKOUMVYNIHQE-UHFFFAOYSA-N D02UHP DRUGSMIL C1=CC2=C(C(=O)C(=C(C2=O)Br)Br)N=C1 D02UHP HIGHSTAT Investigative D02UHS DRUG__ID D02UHS D02UHS DRUGTYPE Small molecular drug D02UHS DRUGINCH 1S/C27H31N5O6/c1-15-6-4-5-7-19(15)20(16-8-17(36-2)10-18(9-16)37-3)11-28-25-22-26(30-13-29-25)32(14-31-22)27-24(35)23(34)21(12-33)38-27/h4-10,13-14,20-21,23-24,27,33-35H,11-12H2,1-3H3,(H,28,29,30)/t20?,21-,23-,24-,27-/m1/s1 D02UHS DRUGINKE BUHVIAUBTBOHAG-FOYDDCNASA-N D02UHS DRUGSMIL CC1=CC=CC=C1C(CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)C5=CC(=CC(=C5)OC)OC D02UHS HIGHSTAT Investigative D02UII DRUG__ID D02UII D02UII DRUGTYPE Small molecular drug D02UII DRUGINCH 1S/C6H6O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h1,4,9H,(H,7,8)(H,10,11)(H,12,13)/p-3/b2-1+/t4-/m1/s1 D02UII DRUGINKE WUUVSJBKHXDKBS-ROFOPDMZSA-K D02UII DRUGSMIL C(=C(C(C(=O)[O-])O)C(=O)[O-])C(=O)[O-] D02UII HIGHSTAT Investigative D02UJO DRUG__ID D02UJO D02UJO DRUGTYPE Small molecular drug D02UJO DRUGINCH 1S/C75H92N12O15S/c1-47(2)33-63(73(98)79-55(44-101-42-51-25-15-7-16-26-51)45-102-43-52-27-17-8-18-28-52)87-41-53-29-31-86(66(53)75(87)100)74(99)62(36-50-23-13-6-14-24-50)85-70(95)59(35-49-21-11-5-12-22-49)81-69(94)58(34-48-19-9-4-10-20-48)82-72(97)61(39-65(90)91)84-71(96)60(37-54-40-77-46-78-54)83-68(93)57(30-32-103-3)80-67(92)56(76)38-64(88)89/h4-28,40,46-47,53,55-63,66H,29-39,41-45,76H2,1-3H3,(H,77,78)(H,79,98)(H,80,92)(H,81,94)(H,82,97)(H,83,93)(H,84,96)(H,85,95)(H,88,89)(H,90,91)/t53-,56+,57+,58+,59+,60+,61+,62+,63-,66-/m1/s1 D02UJO DRUGINKE SHZVIDXXKGEHEF-QEPUNBJPSA-N D02UJO DRUGSMIL CC(C)CC(C(=O)NC(COCC1=CC=CC=C1)COCC2=CC=CC=C2)N3CC4CCN(C4C3=O)C(=O)C(CC5=CC=CC=C5)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)O)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(CC(=O)O)N D02UJO HIGHSTAT Investigative D02UJV DRUG__ID D02UJV D02UJV DRUGTYPE Small molecular drug D02UJV DRUGINCH 1S/C20H25N3O3/c24-20(21-17-6-2-1-3-7-17)22-18-8-4-9-19(16-18)26-13-5-10-23-11-14-25-15-12-23/h1-4,6-9,16H,5,10-15H2,(H2,21,22,24) D02UJV DRUGINKE ANYYSWDTIHWUQV-UHFFFAOYSA-N D02UJV DRUGSMIL C1COCCN1CCCOC2=CC=CC(=C2)NC(=O)NC3=CC=CC=C3 D02UJV HIGHSTAT Investigative D02UKE DRUG__ID D02UKE D02UKE DRUGTYPE Small molecular drug D02UKE DRUGINCH 1S/C7H5N3S2/c11-7-10-9-6(12-7)5-1-3-8-4-2-5/h1-4H,(H,10,11) D02UKE DRUGINKE BSPHQWQMWIUIPM-UHFFFAOYSA-N D02UKE DRUGSMIL C1=CN=CC=C1C2=NNC(=S)S2 D02UKE HIGHSTAT Investigative D02UKY DRUG__ID D02UKY D02UKY DRUGTYPE Small molecular drug D02UKY DRUGINCH 1S/C7H7N5O2/c8-7-11-5-4(6(14)12-7)10-3(2-13)1-9-5/h1,13H,2H2,(H3,8,9,11,12,14) D02UKY DRUGINKE XGWIBNWDLMIPNF-UHFFFAOYSA-N D02UKY DRUGSMIL C1=C(N=C2C(=O)NC(=NC2=N1)N)CO D02UKY HIGHSTAT Investigative D02UNX DRUG__ID D02UNX D02UNX DRUGTYPE Small molecular drug D02UNX DRUGINCH 1S/C18H20N6O3S2/c25-17(24-12-10-23(11-13-24)14-4-7-19-8-5-14)6-9-20-29(26,27)16-3-1-2-15-18(16)22-28-21-15/h1-5,7-8,20H,6,9-13H2 D02UNX DRUGINKE WXDHQWPQLKGANZ-UHFFFAOYSA-N D02UNX DRUGSMIL C1CN(CCN1C2=CC=NC=C2)C(=O)CCNS(=O)(=O)C3=CC=CC4=NSN=C43 D02UNX HIGHSTAT Investigative D02UTC DRUG__ID D02UTC D02UTC DRUGTYPE Small molecular drug D02UTC DRUGINCH 1S/C16H16N2O3/c19-15(10-12-4-2-1-3-5-12)17-11-13-6-8-14(9-7-13)16(20)18-21/h1-9,21H,10-11H2,(H,17,19)(H,18,20) D02UTC DRUGINKE YHZMFLZXDBVBJK-UHFFFAOYSA-N D02UTC DRUGSMIL C1=CC=C(C=C1)CC(=O)NCC2=CC=C(C=C2)C(=O)NO D02UTC HIGHSTAT Investigative D02UUC DRUG__ID D02UUC D02UUC DRUGTYPE Small molecular drug D02UUC DRUGINCH 1S/C16H21NO2/c1-10-3-5-11(6-4-10)13-9-12-7-8-14(17-12)15(13)16(18)19-2/h3-6,12-15,17H,7-9H2,1-2H3 D02UUC DRUGINKE YUMUSCBAOZYAIX-UHFFFAOYSA-N D02UUC DRUGSMIL CC1=CC=C(C=C1)C2CC3CCC(C2C(=O)OC)N3 D02UUC HIGHSTAT Investigative D02UUK DRUG__ID D02UUK D02UUK DRUGTYPE Small molecular drug D02UUK DRUGINCH 1S/C30H40O5/c1-8-29(4,5)23-14-20(24(31)17-25(23)32)11-9-10-19-15-26(33)28(34)22(16-27-30(6,7)35-27)21(19)13-12-18(2)3/h8,12,14-15,17,27,31-34H,1,9-11,13,16H2,2-7H3 D02UUK DRUGINKE YTBAFGRFSDPCBF-UHFFFAOYSA-N D02UUK DRUGSMIL CC(=CCC1=C(C(=C(C=C1CCCC2=CC(=C(C=C2O)O)C(C)(C)C=C)O)O)CC3C(O3)(C)C)C D02UUK HIGHSTAT Investigative D02UUO DRUG__ID D02UUO D02UUO DRUGTYPE Small molecular drug D02UUO DRUGINCH 1S/C18H40NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h17-18,20H,2-16,19H2,1H3,(H2,21,22,23)/t17-,18+/m0/s1 D02UUO DRUGINKE YHEDRJPUIRMZMP-ZWKOTPCHSA-N D02UUO DRUGSMIL CCCCCCCCCCCCCCCC(C(COP(=O)(O)O)N)O D02UUO HIGHSTAT Investigative D02UUR DRUG__ID D02UUR D02UUR DRUGTYPE Small molecular drug D02UUR DRUGINCH 1S/C15H11NO3/c17-12-6-4-10(5-7-12)14-9-15(19-16-14)11-2-1-3-13(18)8-11/h1-9,17-18H D02UUR DRUGINKE ZYSCCHLCNRGGTO-UHFFFAOYSA-N D02UUR DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=NO2)C3=CC=C(C=C3)O D02UUR HIGHSTAT Investigative D02UVG DRUG__ID D02UVG D02UVG DRUGTYPE Small molecular drug D02UVG DRUGINCH 1S/C11H11BrN2/c12-7-1-2-8-9-3-4-13-6-11(9)14-10(8)5-7/h1-2,5,13-14H,3-4,6H2 D02UVG DRUGINKE XAHAQVIJZAMMLO-UHFFFAOYSA-N D02UVG DRUGSMIL C1CNCC2=C1C3=C(N2)C=C(C=C3)Br D02UVG HIGHSTAT Investigative D02UVH DRUG__ID D02UVH D02UVH DRUGTYPE Small molecular drug D02UVH DRUGINCH 1S/C14H28O6/c1-2-3-4-5-6-7-8-19-14-13(18)12(17)11(16)10(9-15)20-14/h10-18H,2-9H2,1H3/t10-,11-,12+,13-,14-/m1/s1 D02UVH DRUGINKE HEGSGKPQLMEBJL-RKQHYHRCSA-N D02UVH DRUGSMIL CCCCCCCCOC1C(C(C(C(O1)CO)O)O)O D02UVH HIGHSTAT Investigative D02UVR DRUG__ID D02UVR D02UVR DRUGTYPE Small molecular drug D02UVR DRUGINCH 1S/C40H56O8/c1-23-7-11-31-37(3,16-13-33(43)39(31,5)21-41)28(23)10-9-25-19-30(48-35(25)45)27(26-15-18-47-36(26)46)20-29-24(2)8-12-32-38(29,4)17-14-34(44)40(32,6)22-42/h9-10,15,19,27-34,41-44H,1-2,7-8,11-14,16-18,20-22H2,3-6H3/b10-9+/t27?,28-,29-,30?,31+,32+,33-,34-,37+,38+,39+,40+/m1/s1 D02UVR DRUGINKE WQHWOZANSOUSAY-LZBAHHAZSA-N D02UVR DRUGSMIL CC12CCC(C(C1CCC(=C)C2CC(C3C=C(C(=O)O3)C=CC4C(=C)CCC5C4(CCC(C5(C)CO)O)C)C6=CCOC6=O)(C)CO)O D02UVR HIGHSTAT Investigative D02UVS DRUG__ID D02UVS D02UVS DRUGTYPE Small molecular drug D02UVS DRUGINCH 1S/C6H12N2S4/c1-7(2)5(9)11-12-6(10)8(3)4/h1-4H3 D02UVS DRUGINKE KUAZQDVKQLNFPE-UHFFFAOYSA-N D02UVS DRUGSMIL CN(C)C(=S)SSC(=S)N(C)C D02UVS HIGHSTAT Investigative D02UWB DRUG__ID D02UWB D02UWB DRUGTYPE Small molecular drug D02UWB DRUGINCH 1S/C11H13N3O/c12-4-3-8-6-14-10-2-1-7(11(13)15)5-9(8)10/h1-2,5-6,14H,3-4,12H2,(H2,13,15) D02UWB DRUGINKE WKZLNEWVIAGNAW-UHFFFAOYSA-N D02UWB DRUGSMIL C1=CC2=C(C=C1C(=O)N)C(=CN2)CCN D02UWB HIGHSTAT Investigative D02UYR DRUG__ID D02UYR D02UYR DRUGTYPE Small molecular drug D02UYR DRUGINCH 1S/C19H29N3O5/c1-11-6-8-12(9-7-11)14(13(10-23)16(24)22-27)17(25)21-15(18(26)20-5)19(2,3)4/h6-9,13-15,23,27H,10H2,1-5H3,(H,20,26)(H,21,25)(H,22,24)/t13-,14+,15+/m0/s1 D02UYR DRUGINKE KNCYWVRUUBOHGE-RRFJBIMHSA-N D02UYR DRUGSMIL CC1=CC=C(C=C1)C(C(CO)C(=O)NO)C(=O)NC(C(=O)NC)C(C)(C)C D02UYR HIGHSTAT Investigative D02UZI DRUG__ID D02UZI D02UZI DRUGTYPE Small molecular drug D02UZI DRUGINCH 1S/C13H11N/c1-2-5-12(6-3-1)8-9-13-7-4-10-14-11-13/h1-11H/b9-8- D02UZI DRUGINKE RMSGACVDMOLUPL-HJWRWDBZSA-N D02UZI DRUGSMIL C1=CC=C(C=C1)C=CC2=CN=CC=C2 D02UZI HIGHSTAT Investigative D02VFF DRUG__ID D02VFF D02VFF DRUGTYPE Small molecular drug D02VFF DRUGINCH 1S/C17H17F2NO2/c1-2-3-10-22-14-7-4-12(5-8-14)17(21)20-16-9-6-13(18)11-15(16)19/h4-9,11H,2-3,10H2,1H3,(H,20,21) D02VFF DRUGINKE AHCYOTLTLQTPSU-UHFFFAOYSA-N D02VFF DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)F)F D02VFF HIGHSTAT Investigative D02VFM DRUG__ID D02VFM D02VFM DRUGTYPE Small molecular drug D02VFM DRUGINCH 1S/C33H44N3.2HI/c1-36(2,3)22-14-9-7-5-4-6-8-13-17-28-30(25-15-11-10-12-16-25)24-32(35)29-21-19-26-18-20-27(34)23-31(26)33(28)29;;/h10-12,15-16,18-21,23-24H,4-9,13-14,17,22,34-35H2,1-3H3;2*1H/q+1;;/p-1 D02VFM DRUGINKE RJEYFBQMUHTEAX-UHFFFAOYSA-M D02VFM DRUGSMIL C[N+](C)(C)CCCCCCCCCCC1=C2C(=C(C=C1C3=CC=CC=C3)N)C=CC4=C2C=C(C=C4)N.I.[I-] D02VFM HIGHSTAT Investigative D02VFQ DRUG__ID D02VFQ D02VFQ DRUGTYPE Small molecular drug D02VFQ DRUGINCH 1S/C14H13BrFN3S/c15-11-4-5-13(18-9-11)19-14(20)17-7-6-10-2-1-3-12(16)8-10/h1-5,8-9H,6-7H2,(H2,17,18,19,20) D02VFQ DRUGINKE OEBGVSGGLQGGNH-UHFFFAOYSA-N D02VFQ DRUGSMIL C1=CC(=CC(=C1)F)CCNC(=S)NC2=NC=C(C=C2)Br D02VFQ HIGHSTAT Investigative D02VGM DRUG__ID D02VGM D02VGM DRUGTYPE Small molecular drug D02VGM DRUGINCH 1S/C21H23NO3/c23-20(25-19-15-22-13-11-16(19)12-14-22)21(24,17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-10,16,19,24H,11-15H2 D02VGM DRUGINKE HGMITUYOCPPQLE-UHFFFAOYSA-N D02VGM DRUGSMIL C1CN2CCC1C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O D02VGM HIGHSTAT Investigative D02VGS DRUG__ID D02VGS D02VGS DRUGTYPE Small molecular drug D02VGS DRUGINCH 1S/C49H62N10O13S2/c1-73-18-16-34(46(69)56-36(20-28-12-14-30(60)15-13-28)44(67)43(66)32(50)23-41(62)63)54-40(61)26-53-45(68)37(22-29-25-52-33-11-7-6-10-31(29)33)57-47(70)35(17-19-74-2)55-48(71)38(24-42(64)65)58-49(72)39(59-51)21-27-8-4-3-5-9-27/h3-15,25,32,34-39,52,59-60H,16-24,26,50-51H2,1-2H3,(H,53,68)(H,54,61)(H,55,71)(H,56,69)(H,57,70)(H,58,72)(H,62,63)(H,64,65)/t32-,34-,35-,36-,37-,38-,39-/m0/s1 D02VGS DRUGINKE ZBTPHEHKAHBSMT-YRVFCXMDSA-N D02VGS DRUGSMIL CSCCC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)C(=O)C(CC(=O)O)N)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCSC)NC(=O)C(CC(=O)O)NC(=O)C(CC4=CC=CC=C4)NN D02VGS HIGHSTAT Investigative D02VHD DRUG__ID D02VHD D02VHD DRUGTYPE Small molecular drug D02VHD DRUGINCH 1S/C19H18F3N5O/c1-26-17(28)15-16(27-13-4-2-3-12(13)23-18(26)27)25-14(24-15)9-10-5-7-11(8-6-10)19(20,21)22/h5-8,12-13H,2-4,9H2,1H3,(H,24,25)/t12-,13+/m0/s1 D02VHD DRUGINKE JOSMPBVYYKRYLG-QWHCGFSZSA-N D02VHD DRUGSMIL CN1C(=O)C2=C(N=C(N2)CC3=CC=C(C=C3)C(F)(F)F)N4C1=NC5C4CCC5 D02VHD HIGHSTAT Investigative D02VHJ DRUG__ID D02VHJ D02VHJ DRUGTYPE Small molecular drug D02VHJ DRUGINCH 1S/C16H16N2O2S/c17-11-10-13-12-18(16-9-5-4-8-15(13)16)21(19,20)14-6-2-1-3-7-14/h1-9,12H,10-11,17H2 D02VHJ DRUGINKE GSOZASAZEKGFMK-UHFFFAOYSA-N D02VHJ DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)N2C=C(C3=CC=CC=C32)CCN D02VHJ HIGHSTAT Investigative D02VHZ DRUG__ID D02VHZ D02VHZ DRUGTYPE Small molecular drug D02VHZ DRUGINCH 1S/C12H19NS/c1-3-11(13)9-10-5-7-12(8-6-10)14-4-2/h5-8,11H,3-4,9,13H2,1-2H3 D02VHZ DRUGINKE PCPVEGXNPCSDGS-UHFFFAOYSA-N D02VHZ DRUGSMIL CCC(CC1=CC=C(C=C1)SCC)N D02VHZ HIGHSTAT Investigative D02VIV DRUG__ID D02VIV D02VIV DRUGTYPE Small molecular drug D02VIV DRUGINCH 1S/C9H10N4O/c1-13-8(14)6-4-2-3-5-7(6)11-9(13)12-10/h2-5H,10H2,1H3,(H,11,12) D02VIV DRUGINKE BQDOAXFBKRUNTF-UHFFFAOYSA-N D02VIV DRUGSMIL CN1C(=O)C2=CC=CC=C2N=C1NN D02VIV HIGHSTAT Investigative D02VIW DRUG__ID D02VIW D02VIW DRUGTYPE Small molecular drug D02VIW DRUGINCH 1S/C28H29NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,26,28,30-31H,1-3,14-17H2/t26-,28-/m1/s1 D02VIW DRUGINKE IKZMTNSYXDOFJH-IXCJQBJRSA-N D02VIW DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O D02VIW HIGHSTAT Investigative D02VIZ DRUG__ID D02VIZ D02VIZ DRUGTYPE Small molecular drug D02VIZ DRUGINCH 1S/C14H18N2O2/c1-10(17)15-6-8-16-7-4-11-2-3-13-12(14(11)16)5-9-18-13/h2-3H,4-9H2,1H3,(H,15,17) D02VIZ DRUGINKE LTYWTNUOUBBVNZ-UHFFFAOYSA-N D02VIZ DRUGSMIL CC(=O)NCCN1CCC2=C1C3=C(C=C2)OCC3 D02VIZ HIGHSTAT Investigative D02VJX DRUG__ID D02VJX D02VJX DRUGTYPE Small molecular drug D02VJX DRUGINCH 1S/C29H32N4O5S2/c1-5-30-29(35)32-40(36,37)28-24(16-23(39-28)15-19(2)3)21-13-11-20(12-14-21)17-33-25(18-34)27(38-4)31-26(33)22-9-7-6-8-10-22/h6-14,16,18-19H,5,15,17H2,1-4H3,(H2,30,32,35) D02VJX DRUGINKE QTOZBSNPDCWHPV-UHFFFAOYSA-N D02VJX DRUGSMIL CCNC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C(=C(N=C3C4=CC=CC=C4)OC)C=O D02VJX HIGHSTAT Investigative D02VKU DRUG__ID D02VKU D02VKU DRUGTYPE Small molecular drug D02VKU DRUGINCH 1S/C110H192N40O24S4/c1-11-58(7)83(118)103(169)136-66(30-17-22-38-113)94(160)142-77-53-176-175-51-75(89(155)128-50-82(153)131-64(28-15-20-36-111)90(156)138-71(88(119)154)46-80(116)151)144-106(172)85(59(8)12-2)147-95(161)67(31-18-23-39-114)132-92(158)68(33-25-41-126-109(120)121)135-100(166)78-54-178-177-52-76(143-96(162)74(47-81(117)152)140-101(77)167)99(165)134-65(29-16-21-37-112)91(157)133-69(34-26-42-127-110(122)123)93(159)139-72(44-62-48-124-55-129-62)97(163)146-84(57(5)6)104(170)149-87(61(10)14-4)105(171)137-70(32-19-24-40-115)108(174)150-43-27-35-79(150)102(168)141-73(45-63-49-125-56-130-63)98(164)148-86(60(9)13-3)107(173)145-78/h48-49,55-79,83-87H,11-47,50-54,111-115,118H2,1-10H3,(H2,116,151)(H2,117,152)(H2,119,154)(H,128,155)(H,131,153)(H,132,158)(H,133,157)(H,134,165)(H,135,166)(H,136,169)(H,137,171)(H,138,156)(H,139,159)(H,140,167)(H,141,168)(H,142,160)(H,143,162)(H,144,172)(H,145,173)(H,146,163)(H,147,161)(H,148,164)(H,149,170)(H4,120,121,126)(H4,122,123,127) D02VKU DRUGINKE QMBRLNFAEHGOLY-UHFFFAOYSA-N D02VKU DRUGSMIL CCC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C3CCCN3C(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCCCN)CCCNC(=N)N)CC4C=NC=N4)C(C)C)C(C)CC)CCCCN)CC5C=NC=N5)C(C)CC)CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)N)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)N D02VKU HIGHSTAT Investigative D02VKX DRUG__ID D02VKX D02VKX DRUGTYPE Small molecular drug D02VKX DRUGINCH 1S/C16H20O2/c17-13-1-2-14(15(18)6-13)16-7-10-3-11(8-16)5-12(4-10)9-16/h1-2,6,10-12,17-18H,3-5,7-9H2 D02VKX DRUGINKE NAJPJOQCMCYGLX-UHFFFAOYSA-N D02VKX DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=C(C=C4)O)O D02VKX HIGHSTAT Investigative D02VLR DRUG__ID D02VLR D02VLR DRUGTYPE Small molecular drug D02VLR DRUGINCH 1S/C15H18O2S/c1-3-4-5-6-9-12-18-15-11-8-7-10-14(15)17-13(2)16/h7-8,10-11H,3-5,12H2,1-2H3 D02VLR DRUGINKE GXMBHQRROXQUJS-UHFFFAOYSA-N D02VLR DRUGSMIL CCCCC#CCSC1=CC=CC=C1OC(=O)C D02VLR HIGHSTAT Investigative D02VPC DRUG__ID D02VPC D02VPC DRUGTYPE Small molecular drug D02VPC DRUGINCH 1S/C10H9NO3/c12-7-1-2-9-8(4-7)6(5-11-9)3-10(13)14/h1-2,4-5,11-12H,3H2,(H,13,14) D02VPC DRUGINKE DUUGKQCEGZLZNO-UHFFFAOYSA-N D02VPC DRUGSMIL C1=CC2=C(C=C1O)C(=CN2)CC(=O)O D02VPC HIGHSTAT Investigative D02VPW DRUG__ID D02VPW D02VPW DRUGTYPE Small molecular drug D02VPW DRUGINCH 1S/C14H21N3O3/c1-14(2,3)15-7-9(18)8-20-11-6-4-5-10-12(11)17-13(19)16-10/h4-6,9,15,18H,7-8H2,1-3H3,(H2,16,17,19)/t9-/m0/s1 D02VPW DRUGINKE UMQUQWCJKFOUGV-VIFPVBQESA-N D02VPW DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1NC(=O)N2)O D02VPW HIGHSTAT Investigative D02VQK DRUG__ID D02VQK D02VQK DRUGTYPE Small molecular drug D02VQK DRUGINCH 1S/C17H14N2O2S/c1-21-14-9-7-13(8-10-14)16(20)19-17-18-15(11-22-17)12-5-3-2-4-6-12/h2-11H,1H3,(H,18,19,20) D02VQK DRUGINKE FVWGKRAXWKLEHX-UHFFFAOYSA-N D02VQK DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NC(=CS2)C3=CC=CC=C3 D02VQK HIGHSTAT Investigative D02VQO DRUG__ID D02VQO D02VQO DRUGTYPE Small molecular drug D02VQO DRUGINCH 1S/C28H27F2N7O4/c1-41-23-12-4-19(5-13-23)16-36-26(35-27(39)37(28(36)40)17-18-2-8-21(29)9-3-18)33-15-14-32-25(31)34-24(38)20-6-10-22(30)11-7-20/h2-13H,14-17H2,1H3,(H,33,35,39)(H3,31,32,34,38) D02VQO DRUGINKE XZNHZFUKGYYVMQ-UHFFFAOYSA-N D02VQO DRUGSMIL COC1=CC=C(C=C1)CN2C(=NC(=O)N(C2=O)CC3=CC=C(C=C3)F)NCCN=C(N)NC(=O)C4=CC=C(C=C4)F D02VQO HIGHSTAT Investigative D02VQU DRUG__ID D02VQU D02VQU DRUGCOMP University of Auckland D02VQU DRUGINCH 1S/C23H25N3O3S/c1-23(2,3)19-10-12-21(13-11-19)30(28,29)25-15-17-6-8-18(9-7-17)22(27)26-20-5-4-14-24-16-20/h4-14,16,25H,15H2,1-3H3,(H,26,27) D02VQU DRUGINKE NGQPRVWTFNBUHA-UHFFFAOYSA-N D02VQU DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NCC2=CC=C(C=C2)C(=O)NC3=CN=CC=C3 D02VQU HIGHSTAT Investigative D02VSL DRUG__ID D02VSL D02VSL DRUGTYPE Small molecular drug D02VSL DRUGINCH 1S/C22H32O/c1-7-12-21(3,4)16-9-10-17-18-13-15(2)8-11-19(18)22(5,6)23-20(17)14-16/h8-10,14,18-19H,7,11-13H2,1-6H3/t18-,19+/m0/s1 D02VSL DRUGINKE YSBFLLZNALVODA-RBUKOAKNSA-N D02VSL DRUGSMIL CCCC(C)(C)C1=CC2=C(C=C1)C3CC(=CCC3C(O2)(C)C)C D02VSL HIGHSTAT Investigative D02VUM DRUG__ID D02VUM D02VUM DRUGTYPE Small molecular drug D02VUM DRUGINCH 1S/C23H32O7/c1-16(13-17(2)14-18-10-6-4-7-11-18)9-5-3-8-12-19(21(26)27)23(30,22(28)29)15-20(24)25/h4,6-7,10-11,13,17,19,30H,3,5,8-9,12,14-15H2,1-2H3,(H,24,25)(H,26,27)(H,28,29)/b16-13+ D02VUM DRUGINKE NLNJIEVMUWDLAZ-DTQAZKPQSA-N D02VUM DRUGSMIL CC(CC1=CC=CC=C1)C=C(C)CCCCCC(C(=O)O)C(CC(=O)O)(C(=O)O)O D02VUM HIGHSTAT Investigative D02VVU DRUG__ID D02VVU D02VVU DRUGTYPE Small molecular drug D02VVU DRUGINCH 1S/C13H12N2O4S/c16-13(14-17)10-6-8-11(9-7-10)15-20(18,19)12-4-2-1-3-5-12/h1-9,15,17H,(H,14,16) D02VVU DRUGINKE ZSIKBIFOAPITGF-UHFFFAOYSA-N D02VVU DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C(=O)NO D02VVU HIGHSTAT Investigative D02VXW DRUG__ID D02VXW D02VXW DRUGTYPE Small molecular drug D02VXW DRUGINCH 1S/C12H11NO2S2/c13-17(14,15)12-7-4-10(5-8-12)3-6-11-2-1-9-16-11/h1-9H,(H2,13,14,15)/b6-3+ D02VXW DRUGINKE OZEBJQJPQRQDDH-ZZXKWVIFSA-N D02VXW DRUGSMIL C1=CSC(=C1)C=CC2=CC=C(C=C2)S(=O)(=O)N D02VXW HIGHSTAT Investigative D02VYI DRUG__ID D02VYI D02VYI DRUGTYPE Small molecular drug D02VYI DRUGINCH 1S/C16H24F3O4P/c1-3-5-12-21-24(20,22-13-6-4-2)23-15(16(17,18)19)14-10-8-7-9-11-14/h7-11,15H,3-6,12-13H2,1-2H3 D02VYI DRUGINKE BREZEIOVGIZIOU-UHFFFAOYSA-N D02VYI DRUGSMIL CCCCOP(=O)(OCCCC)OC(C1=CC=CC=C1)C(F)(F)F D02VYI HIGHSTAT Investigative D02VZI DRUG__ID D02VZI D02VZI DRUGTYPE Small molecular drug D02VZI DRUGINCH 1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6-/m0/s1 D02VZI DRUGINKE KDZOASGQNOPSCU-WDSKDSINSA-N D02VZI DRUGSMIL C(CC(C(=O)O)N)CN=C(N)NC(CC(=O)O)C(=O)O D02VZI HIGHSTAT Investigative D02WBC DRUG__ID D02WBC D02WBC DRUGTYPE Small molecular drug D02WBC DRUGINCH 1S/C12H17ClN2O/c13-11-4-2-1-3-10(11)12(9-14)15-5-7-16-8-6-15/h1-4,12H,5-9,14H2 D02WBC DRUGINKE OJHPTRVTZGOWAO-UHFFFAOYSA-N D02WBC DRUGSMIL C1COCCN1C(CN)C2=CC=CC=C2Cl D02WBC HIGHSTAT Investigative D02WBU DRUG__ID D02WBU D02WBU DRUGTYPE Small molecular drug D02WBU DRUGINCH 1S/C48H78N14O8/c1-6-29(3)38(44(69)57-33(39(50)64)17-11-12-24-49)62-41(66)34(18-13-25-55-46(51)52)58-42(67)37(28-31-20-22-32(63)23-21-31)60-43(68)36(27-30-15-9-8-10-16-30)59-40(65)35(19-14-26-56-47(53)54)61-45(70)48(4,5)7-2/h8-10,15-16,20-23,29,33-38,63H,6-7,11-14,17-19,24-28,49H2,1-5H3,(H2,50,64)(H,57,69)(H,58,67)(H,59,65)(H,60,68)(H,61,70)(H,62,66)(H4,51,52,55)(H4,53,54,56)/t29-,33-,34-,35-,36-,37-,38-/m0/s1 D02WBU DRUGINKE JOZALXQUIMQHHA-AVTNSMPVSA-N D02WBU DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)(C)CC D02WBU HIGHSTAT Investigative D02WBY DRUG__ID D02WBY D02WBY DRUGTYPE Small molecular drug D02WBY DRUGINCH 1S/C32H38N4O2/c1-24(37)35-20-14-28-10-11-30(22-31(28)35)36(32(38)12-9-26-7-4-8-27(21-26)23-33)29-15-18-34(19-16-29)17-13-25-5-2-3-6-25/h4,7-12,21-22,25,29H,2-3,5-6,13-20H2,1H3/b12-9+ D02WBY DRUGINKE DSEJCLDJIFTPPH-FMIVXFBMSA-N D02WBY DRUGSMIL CC(=O)N1CCC2=C1C=C(C=C2)N(C3CCN(CC3)CCC4CCCC4)C(=O)C=CC5=CC(=CC=C5)C#N D02WBY HIGHSTAT Investigative D02WCJ DRUG__ID D02WCJ D02WCJ DRUGTYPE Small molecular drug D02WCJ DRUGINCH 1S/C38H64N12O8/c1-5-22(4)30(34(55)48-28(36(57)58)19-21(2)3)49-32(53)27(20-23-12-14-24(51)15-13-23)47-33(54)29-11-8-18-50(29)35(56)26(10-7-17-45-38(42)43)46-31(52)25(39)9-6-16-44-37(40)41/h12-15,21-22,25-30,51H,5-11,16-20,39H2,1-4H3,(H,46,52)(H,47,54)(H,48,55)(H,49,53)(H,57,58)(H4,40,41,44)(H4,42,43,45)/t22-,25-,26-,27-,28-,29-,30-/m0/s1 D02WCJ DRUGINKE DQDBCHHEIKQPJD-ODKJCKIQSA-N D02WCJ DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N D02WCJ HIGHSTAT Investigative D02WFA DRUG__ID D02WFA D02WFA DRUGTYPE Small molecular drug D02WFA DRUGINCH 1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20) D02WFA DRUGINKE QIQXTHQIDYTFRH-UHFFFAOYSA-N D02WFA DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)O D02WFA HIGHSTAT Investigative D02WIL DRUG__ID D02WIL D02WIL DRUGTYPE Small molecular drug D02WIL DRUGINCH 1S/C19H16BrNO2/c20-15-9-18-17(22-10-23-18)8-14(15)19-13-6-3-5-11(13)12-4-1-2-7-16(12)21-19/h1-5,7-9,11,13,19,21H,6,10H2/t11-,13-,19+/m0/s1 D02WIL DRUGINKE YOLTZIVRJAPVPH-MJLGCCKJSA-N D02WIL DRUGSMIL C1C=CC2C1C(NC3=CC=CC=C23)C4=CC5=C(C=C4Br)OCO5 D02WIL HIGHSTAT Investigative D02WJT DRUG__ID D02WJT D02WJT DRUGTYPE Small molecular drug D02WJT DRUGINCH 1S/C15H17N3/c1-11-7-3-5-9-13(11)17-15(16)18-14-10-6-4-8-12(14)2/h3-10H,1-2H3,(H3,16,17,18) D02WJT DRUGINKE OPNUROKCUBTKLF-UHFFFAOYSA-N D02WJT DRUGSMIL CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N D02WJT HIGHSTAT Investigative D02WKB DRUG__ID D02WKB D02WKB DRUGTYPE Small molecular drug D02WKB DRUGINCH 1S/C31H32NO5/c1-33-28-12-11-22-17-27-25-19-30-29(36-21-37-30)18-23(25)13-14-32(27)20-26(22)31(28)35-16-8-3-2-7-15-34-24-9-5-4-6-10-24/h4-6,9-12,17-20H,2-3,7-8,13-16,21H2,1H3/q+1 D02WKB DRUGINKE LXNXNTQFJHYTEN-UHFFFAOYSA-N D02WKB DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCCCOC6=CC=CC=C6 D02WKB HIGHSTAT Investigative D02WOQ DRUG__ID D02WOQ D02WOQ DRUGTYPE Small molecular drug D02WOQ DRUGINCH 1S/C16H13FO2/c1-10-2-4-11(5-3-10)15-9-14(18)13-7-6-12(17)8-16(13)19-15/h2-8,15H,9H2,1H3/t15-/m1/s1 D02WOQ DRUGINKE QNQXLNDULBVXEX-OAHLLOKOSA-N D02WOQ DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)F D02WOQ HIGHSTAT Investigative D02WRU DRUG__ID D02WRU D02WRU DRUGTYPE Small molecular drug D02WRU DRUGINCH 1S/C20H11F6N3O/c21-19(22,23)14-10-15(20(24,25)26)29-18(27-14)16(11-6-8-13(30)9-7-11)17(28-29)12-4-2-1-3-5-12/h1-10,30H D02WRU DRUGINKE AEZPAUSGTAHLOQ-UHFFFAOYSA-N D02WRU DRUGSMIL C1=CC=C(C=C1)C2=NN3C(=CC(=NC3=C2C4=CC=C(C=C4)O)C(F)(F)F)C(F)(F)F D02WRU HIGHSTAT Investigative D02WSA DRUG__ID D02WSA D02WSA DRUGTYPE Small molecular drug D02WSA DRUGINCH 1S/C14H10N2O3/c17-10-6-11-13(12(18)7-10)14(19)16(8-15-11)9-4-2-1-3-5-9/h1-8,17-18H D02WSA DRUGINKE LUBZIRZXRMLBKH-UHFFFAOYSA-N D02WSA DRUGSMIL C1=CC=C(C=C1)N2C=NC3=C(C2=O)C(=CC(=C3)O)O D02WSA HIGHSTAT Investigative D02WTN DRUG__ID D02WTN D02WTN DRUGTYPE Small molecular drug D02WTN DRUGINCH 1S/C21H21N3O/c1-2-3-14-20(25)23-19-15-18(16-10-6-4-7-11-16)22-21(24-19)17-12-8-5-9-13-17/h4-13,15H,2-3,14H2,1H3,(H,22,23,24,25) D02WTN DRUGINKE AJUVVGPOXGXRAI-UHFFFAOYSA-N D02WTN DRUGSMIL CCCCC(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D02WTN HIGHSTAT Investigative D02WUU DRUG__ID D02WUU D02WUU DRUGTYPE Small molecular drug D02WUU DRUGINCH 1S/C15H14O3S/c1-12-7-9-13(10-8-12)15(16)11-19(17,18)14-5-3-2-4-6-14/h2-10H,11H2,1H3 D02WUU DRUGINKE DITVWQPTRBYVRP-UHFFFAOYSA-N D02WUU DRUGSMIL CC1=CC=C(C=C1)C(=O)CS(=O)(=O)C2=CC=CC=C2 D02WUU HIGHSTAT Investigative D02WUY DRUG__ID D02WUY D02WUY DRUGTYPE Small molecular drug D02WUY DRUGINCH 1S/C26H36IN2O7P/c1-18(20-6-5-7-21(15-20)26(33)34)29-16-22(30)17-37(35,36)13-4-2-3-12-28-25(32)11-9-19-8-10-24(31)23(27)14-19/h5-8,10,14-15,18,22,29-31H,2-4,9,11-13,16-17H2,1H3,(H,28,32)(H,33,34)(H,35,36)/t18-,22+/m1/s1/i27-2 D02WUY DRUGINKE RLYLJDJFHZHCTR-ZNAYHWKRSA-N D02WUY DRUGSMIL CC(C1=CC(=CC=C1)C(=O)O)NCC(CP(=O)(CCCCCNC(=O)CCC2=CC(=C(C=C2)O)I)O)O D02WUY HIGHSTAT Investigative D02WUZ DRUG__ID D02WUZ D02WUZ DRUGTYPE Small molecular drug D02WUZ DRUGINCH 1S/C34H40N4O6/c1-2-44-34(43)29(22-24-12-7-4-8-13-24)37-31(40)28(21-23-10-5-3-6-11-23)36-32(41)30-14-9-19-38(30)33(42)27(35)20-25-15-17-26(39)18-16-25/h3-8,10-13,15-18,27-30,39H,2,9,14,19-22,35H2,1H3,(H,36,41)(H,37,40)/t27-,28-,29-,30-/m0/s1 D02WUZ DRUGINKE JKMFJIMTIXQDHF-KRCBVYEFSA-N D02WUZ DRUGSMIL CCOC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D02WUZ HIGHSTAT Investigative D02WWM DRUG__ID D02WWM D02WWM DRUGTYPE Small molecular drug D02WWM DRUGINCH 1S/C19H32N2O2/c1-3-5-6-7-9-16-20(4-2)17-10-8-11-18-12-14-19(15-13-18)21(22)23/h12-15H,3-11,16-17H2,1-2H3 D02WWM DRUGINKE YTYATOMQOOFRNA-UHFFFAOYSA-N D02WWM DRUGSMIL CCCCCCCN(CC)CCCCC1=CC=C(C=C1)[N+](=O)[O-] D02WWM HIGHSTAT Investigative D02WYE DRUG__ID D02WYE D02WYE DRUGTYPE Small molecular drug D02WYE DRUGINCH 1S/C14H21NO/c15-9-8-11-6-7-14(16)13(10-11)12-4-2-1-3-5-12/h6-7,10,12,16H,1-5,8-9,15H2 D02WYE DRUGINKE DOCCSEDGBYCYLS-UHFFFAOYSA-N D02WYE DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)CCN)O D02WYE HIGHSTAT Investigative D02WZA DRUG__ID D02WZA D02WZA DRUGTYPE Small molecular drug D02WZA DRUGINCH 1S/C11H7N3O3S2/c15-9-5-6-10(14-13-9)19(16,17)11-12-7-3-1-2-4-8(7)18-11/h1-6H,(H,13,15) D02WZA DRUGINKE AWYKKLWCTAPMDK-UHFFFAOYSA-N D02WZA DRUGSMIL C1=CC=C2C(=C1)N=C(S2)S(=O)(=O)C3=NNC(=O)C=C3 D02WZA HIGHSTAT Investigative D02WZK DRUG__ID D02WZK D02WZK DRUGTYPE Small molecular drug D02WZK DRUGINCH 1S/C22H23NO3/c24-21(22-23-15-17-26-22)10-6-1-2-7-16-25-20-13-11-19(12-14-20)18-8-4-3-5-9-18/h3-5,8-9,11-15,17H,1-2,6-7,10,16H2 D02WZK DRUGINKE ASDDHZUEOBVPNO-UHFFFAOYSA-N D02WZK DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)C3=NC=CO3 D02WZK HIGHSTAT Investigative D02XAX DRUG__ID D02XAX D02XAX DRUGTYPE Small molecular drug D02XAX DRUGINCH 1S/C20H26N2O3/c1-11(23)12(2)25-20(24)14-7-16-15-5-4-6-17-19(15)13(9-21-17)8-18(16)22(3)10-14/h4-6,9,11-12,14,16,18,21,23H,7-8,10H2,1-3H3 D02XAX DRUGINKE GOHDSZGHAHFEHG-UHFFFAOYSA-N D02XAX DRUGSMIL CC(C(C)OC(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C)O D02XAX HIGHSTAT Investigative D02XEX DRUG__ID D02XEX D02XEX DRUGTYPE Small molecular drug D02XEX DRUGINCH 1S/C32H48O5/c1-18-9-12-28(4)15-16-30(6)21(25(28)19(18)2)17-22(34)26-29(5)13-11-24(37-20(3)33)32(8,27(35)36)23(29)10-14-31(26,30)7/h17-19,23-26H,9-16H2,1-8H3,(H,35,36)/t18-,19+,23-,24-,25+,26-,28-,29+,30-,31-,32-/m1/s1 D02XEX DRUGINKE HMMGKOVEOFBCAU-BCDBGHSCSA-N D02XEX DRUGSMIL CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C(=O)O)OC(=O)C)C)C)C2C1C)C)C D02XEX HIGHSTAT Investigative D02XFR DRUG__ID D02XFR D02XFR DRUGTYPE Small molecular drug D02XFR DRUGINCH 1S/C11H9ClN2OS/c1-7-6-16-11(13-7)14-10(15)8-3-2-4-9(12)5-8/h2-6H,1H3,(H,13,14,15) D02XFR DRUGINKE MXGUAAMFCPDOEZ-UHFFFAOYSA-N D02XFR DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC(=CC=C2)Cl D02XFR HIGHSTAT Investigative D02XGS DRUG__ID D02XGS D02XGS DRUGTYPE Small molecular drug D02XGS DRUGINCH 1S/C19H22FNO3/c1-2-3-4-7-14-23-16-12-10-15(11-13-16)21-19(22)24-18-9-6-5-8-17(18)20/h5-6,8-13H,2-4,7,14H2,1H3,(H,21,22) D02XGS DRUGINKE ASBZIVYPMZQHBL-UHFFFAOYSA-N D02XGS DRUGSMIL CCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D02XGS HIGHSTAT Investigative D02XHC DRUG__ID D02XHC D02XHC DRUGTYPE Small molecular drug D02XHC DRUGINCH 1S/C16H17N3O/c1-2-3-4-13-14(11-5-7-12(20)8-6-11)19-16-15(13)17-9-10-18-16/h5-10,20H,2-4H2,1H3,(H,18,19) D02XHC DRUGINKE PRIGRJPRGZCFAS-UHFFFAOYSA-N D02XHC DRUGSMIL CCCCC1=C(NC2=NC=CN=C12)C3=CC=C(C=C3)O D02XHC HIGHSTAT Investigative D02XHH DRUG__ID D02XHH D02XHH DRUGTYPE Small molecular drug D02XHH DRUGINCH 1S/C13H11BrN2/c14-11-3-4-13-9(5-11)1-2-10(13)6-12-7-15-8-16-12/h3-8H,1-2H2,(H,15,16)/b10-6- D02XHH DRUGINKE SNWLVVNOSVKKRA-POHAHGRESA-N D02XHH DRUGSMIL C1CC(=CC2=CN=CN2)C3=C1C=C(C=C3)Br D02XHH HIGHSTAT Investigative D02XHM DRUG__ID D02XHM D02XHM DRUGTYPE Small molecular drug D02XHM DRUGINCH 1S/C31H37NO3/c1-32(24-25-15-9-8-10-16-25)21-13-6-4-2-3-5-7-14-22-34-26-19-20-28-30(23-26)35-29-18-12-11-17-27(29)31(28)33/h8-12,15-20,23H,2-7,13-14,21-22,24H2,1H3 D02XHM DRUGINKE YOTLTNQICYMZSI-UHFFFAOYSA-N D02XHM DRUGSMIL CN(CCCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D02XHM HIGHSTAT Investigative D02XIF DRUG__ID D02XIF D02XIF DRUGTYPE Small molecular drug D02XIF DRUGINCH 1S/C10H14N2O2/c1-9-4-2-5-10(11-9)6-3-7-12(14)8-13/h2,4-5,8,14H,3,6-7H2,1H3 D02XIF DRUGINKE FJYUGRZKJXCRFF-UHFFFAOYSA-N D02XIF DRUGSMIL CC1=NC(=CC=C1)CCCN(C=O)O D02XIF HIGHSTAT Investigative D02XJW DRUG__ID D02XJW D02XJW DRUGTYPE Small molecular drug D02XJW DRUGINCH 1S/C6H8N2S2/c1-9-5-3-2-4(10-5)6(7)8/h2-3H,1H3,(H3,7,8) D02XJW DRUGINKE AXSQTCBARFBKPH-UHFFFAOYSA-N D02XJW DRUGSMIL CSC1=CC=C(S1)C(=N)N D02XJW HIGHSTAT Investigative D02XKD DRUG__ID D02XKD D02XKD DRUGTYPE Small molecular drug D02XKD DRUGINCH 1S/C17H17BrO3/c1-19-14-8-6-12(7-9-14)4-5-13-10-15(18)17(21-3)16(11-13)20-2/h4-11H,1-3H3/b5-4- D02XKD DRUGINKE HORVHXITWDPZBG-PLNGDYQASA-N D02XKD DRUGSMIL COC1=CC=C(C=C1)C=CC2=CC(=C(C(=C2)Br)OC)OC D02XKD HIGHSTAT Investigative D02XKE DRUG__ID D02XKE D02XKE DRUGTYPE Small molecular drug D02XKE DRUGINCH 1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9- D02XKE DRUGINKE RZRNAYUHWVFMIP-KTKRTIGZSA-N D02XKE DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)O D02XKE HIGHSTAT Investigative D02XKJ DRUG__ID D02XKJ D02XKJ DRUGTYPE Small molecular drug D02XKJ DRUGINCH 1S/C14H12N2O/c1-17-12-7-8-14-13(9-12)15-10-16(14)11-5-3-2-4-6-11/h2-10H,1H3 D02XKJ DRUGINKE BMNCXCJXZKZJII-UHFFFAOYSA-N D02XKJ DRUGSMIL COC1=CC2=C(C=C1)N(C=N2)C3=CC=CC=C3 D02XKJ HIGHSTAT Investigative D02XLC DRUG__ID D02XLC D02XLC DRUGTYPE Small molecular drug D02XLC DRUGINCH 1S/C15H10N2O2/c1-7-6-9-12(15(19)17-14(9)18)11-8-4-2-3-5-10(8)16-13(7)11/h2-6,16H,1H3,(H,17,18,19) D02XLC DRUGINKE IMEDEXINTFAKNV-UHFFFAOYSA-N D02XLC DRUGSMIL CC1=CC2=C(C3=C1NC4=CC=CC=C43)C(=O)NC2=O D02XLC HIGHSTAT Investigative D02XMQ DRUG__ID D02XMQ D02XMQ DRUGTYPE Small molecular drug D02XMQ DRUGINCH 1S/C15H11NO3/c1-19-11-7-6-10(16)12-13(11)15(18)9-5-3-2-4-8(9)14(12)17/h2-7H,16H2,1H3 D02XMQ DRUGINKE KXOGXZAXERYOTC-UHFFFAOYSA-N D02XMQ DRUGSMIL COC1=C2C(=C(C=C1)N)C(=O)C3=CC=CC=C3C2=O D02XMQ HIGHSTAT Investigative D02XNU DRUG__ID D02XNU D02XNU DRUGTYPE Small molecular drug D02XNU DRUGINCH 1S/C8H15O8P/c9-5-2-8(13,7(11)12)1-4(6(5)10)3-17(14,15)16/h4-6,9-10,13H,1-3H2,(H,11,12)(H2,14,15,16)/t4-,5-,6-,8+/m1/s1 D02XNU DRUGINKE BKLICLLAHMTUPK-UNGCPHIMSA-N D02XNU DRUGSMIL C1C(C(C(CC1(C(=O)O)O)O)O)CP(=O)(O)O D02XNU HIGHSTAT Investigative D02XOP DRUG__ID D02XOP D02XOP DRUGTYPE Small molecular drug D02XOP DRUGINCH 1S/C10H13NOS/c1-3-10(11-12)8(2)7-9-5-4-6-13-9/h4-7,10H,3H2,1-2H3/b8-7+ D02XOP DRUGINKE KWDFITPUCBENQZ-BQYQJAHWSA-N D02XOP DRUGSMIL CCC(C(=CC1=CC=CS1)C)N=O D02XOP HIGHSTAT Investigative D02XPB DRUG__ID D02XPB D02XPB DRUGTYPE Small molecular drug D02XPB DRUGINCH 1S/C22H23N3O2/c1-26-21-13-17(14-25-19-10-8-18(9-11-19)22(23)24)7-12-20(21)27-15-16-5-3-2-4-6-16/h2-13,25H,14-15H2,1H3,(H3,23,24) D02XPB DRUGINKE YPLDWUAEABIXKN-UHFFFAOYSA-N D02XPB DRUGSMIL COC1=C(C=CC(=C1)CNC2=CC=C(C=C2)C(=N)N)OCC3=CC=CC=C3 D02XPB HIGHSTAT Investigative D02XPR DRUG__ID D02XPR D02XPR DRUGTYPE Small molecular drug D02XPR DRUGINCH 1S/C8H11N5O2/c9-7-6-8(11-3-10-7)13(4-12-6)1-5(15)2-14/h3-5,14-15H,1-2H2,(H2,9,10,11)/t5-/m0/s1 D02XPR DRUGINKE GSLQFBVNOFBPRJ-YFKPBYRVSA-N D02XPR DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CC(CO)O)N D02XPR HIGHSTAT Investigative D02XQX DRUG__ID D02XQX D02XQX DRUGTYPE Small molecular drug D02XQX DRUGINCH 1S/C11H15NO2S/c1-3-15-8-9-6-4-5-7-10(9)14-11(13)12-2/h4-7H,3,8H2,1-2H3,(H,12,13) D02XQX DRUGINKE HEZNVIYQEUHLNI-UHFFFAOYSA-N D02XQX DRUGSMIL CCSCC1=CC=CC=C1OC(=O)NC D02XQX HIGHSTAT Investigative D02XRG DRUG__ID D02XRG D02XRG DRUGTYPE Small molecular drug D02XRG DRUGINCH 1S/C12H13NO/c1-2-13-11-7-8-12(14)10-6-4-3-5-9(10)11/h3-8,13-14H,2H2,1H3 D02XRG DRUGINKE SKQYPGROWSDIBN-UHFFFAOYSA-N D02XRG DRUGSMIL CCNC1=CC=C(C2=CC=CC=C21)O D02XRG HIGHSTAT Investigative D02XSH DRUG__ID D02XSH D02XSH DRUGTYPE Small molecular drug D02XSH DRUGINCH 1S/C39H46N2O6/c1-40-16-14-27-21-35(43-4)37(45-6)23-30(27)32(40)18-25-8-11-29(12-9-25)47-39-20-26(10-13-34(39)42-3)19-33-31-24-38(46-7)36(44-5)22-28(31)15-17-41(33)2/h8-13,20-24,32-33H,14-19H2,1-7H3/t32-,33+/m1/s1 D02XSH DRUGINKE UHYCXSGUNAWVBW-SAIUNTKASA-N D02XSH DRUGSMIL CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)OC)OC)OC D02XSH HIGHSTAT Investigative D02XTS DRUG__ID D02XTS D02XTS DRUGTYPE Small molecular drug D02XTS DRUGINCH 1S/C19H15N/c1-3-9-17(10-4-1)19(18-11-5-2-6-12-18)14-16-8-7-13-20-15-16/h1-15H D02XTS DRUGINKE GOQNCJGTIMHWGO-UHFFFAOYSA-N D02XTS DRUGSMIL C1=CC=C(C=C1)C(=CC2=CN=CC=C2)C3=CC=CC=C3 D02XTS HIGHSTAT Investigative D02XUD DRUG__ID D02XUD D02XUD DRUGTYPE Small molecular drug D02XUD DRUGINCH 1S/C20H20N2O2/c23-20-18(19(24-22-20)15-9-11-21-12-10-15)17-8-4-7-16(13-17)14-5-2-1-3-6-14/h1-8,13,15,21H,9-12H2,(H,22,23) D02XUD DRUGINKE KLKHVLINJXRNBG-UHFFFAOYSA-N D02XUD DRUGSMIL C1CNCCC1C2=C(C(=O)NO2)C3=CC=CC(=C3)C4=CC=CC=C4 D02XUD HIGHSTAT Investigative D02XVV DRUG__ID D02XVV D02XVV DRUGTYPE Small molecular drug D02XVV DRUGINCH 1S/C15H12O3/c1-8-4-3-5-10-11-6-7-12(16)9(2)14(11)18-15(17)13(8)10/h3-7,16H,1-2H3 D02XVV DRUGINKE BSCZPVUHFUQDQP-UHFFFAOYSA-N D02XVV DRUGSMIL CC1=C2C(=CC=C1)C3=C(C(=C(C=C3)O)C)OC2=O D02XVV HIGHSTAT Investigative D02XWJ DRUG__ID D02XWJ D02XWJ DRUGTYPE Small molecular drug D02XWJ DRUGINCH 1S/C16H14N2O2/c1-19-15-8-12-13(9-16(15)20-2)18-14(10-17-12)11-6-4-3-5-7-11/h3-10H,1-2H3 D02XWJ DRUGINKE QNOXYUNHIGOWNY-UHFFFAOYSA-N D02XWJ DRUGSMIL COC1=C(C=C2C(=C1)N=CC(=N2)C3=CC=CC=C3)OC D02XWJ HIGHSTAT Investigative D02XXA DRUG__ID D02XXA D02XXA DRUGTYPE Small molecular drug D02XXA DRUGINCH 1S/C13H19N/c1-2-9-14-10-8-13(11-14)12-6-4-3-5-7-12/h3-7,13H,2,8-11H2,1H3 D02XXA DRUGINKE SUMWVMTWESCBLU-UHFFFAOYSA-N D02XXA DRUGSMIL CCCN1CCC(C1)C2=CC=CC=C2 D02XXA HIGHSTAT Investigative D02XXK DRUG__ID D02XXK D02XXK DRUGTYPE Small molecular drug D02XXK DRUGINCH 1S/C15H15N5/c1-2-4-11(5-3-1)8-20-10-18-13-14(19-12-6-7-12)16-9-17-15(13)20/h1-5,9-10,12H,6-8H2,(H,16,17,19) D02XXK DRUGINKE AVSPKBDDPGPKRA-UHFFFAOYSA-N D02XXK DRUGSMIL C1CC1NC2=C3C(=NC=N2)N(C=N3)CC4=CC=CC=C4 D02XXK HIGHSTAT Investigative D02XYV DRUG__ID D02XYV D02XYV DRUGTYPE Small molecular drug D02XYV DRUGINCH 1S/C7H14N2/c1-3-7(9)5-4-6(2)8/h1,6-7H,4-5,8-9H2,2H3 D02XYV DRUGINKE QIADQCOYEFCREQ-UHFFFAOYSA-N D02XYV DRUGSMIL CC(CCC(C#C)N)N D02XYV HIGHSTAT Investigative D02XZI DRUG__ID D02XZI D02XZI DRUGTYPE Small molecular drug D02XZI DRUGINCH 1S/C11H16N3O7P/c1-6-10(15)8(3-13-9-5-20-14-11(9)16)7(2-12-6)4-21-22(17,18)19/h2,9,13,15H,3-5H2,1H3,(H,14,16)(H2,17,18,19) D02XZI DRUGINKE NNRZSZJOQKAGTO-UHFFFAOYSA-N D02XZI DRUGSMIL CC1=NC=C(C(=C1O)CNC2CONC2=O)COP(=O)(O)O D02XZI HIGHSTAT Investigative D02XZO DRUG__ID D02XZO D02XZO DRUGTYPE Small molecular drug D02XZO DRUGINCH 1S/C24H27NO2/c1-24-10-9-20-19-8-6-18(26)13-15(19)5-7-21(20)22(24)14-16(23(24)27)12-17-4-2-3-11-25-17/h2-4,6,8,11-13,20-23,26-27H,5,7,9-10,14H2,1H3/b16-12+/t20?,21?,22?,23-,24-/m0/s1 D02XZO DRUGINKE NEJZGGCMSBCPLE-NSLXHHGFSA-N D02XZO DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=CC=N4)C2O)CCC5=C3C=CC(=C5)O D02XZO HIGHSTAT Investigative D02YBV DRUG__ID D02YBV D02YBV DRUGTYPE Small molecular drug D02YBV DRUGINCH 1S/C46H66N14O11S2/c1-24(2)37-44(70)57-32(20-35(48)62)41(67)58-33(45(71)60-17-7-11-34(60)43(69)54-29(10-6-16-52-46(50)51)39(65)53-21-36(49)63)23-73-72-22-28(47)38(64)55-30(19-26-12-14-27(61)15-13-26)40(66)56-31(42(68)59-37)18-25-8-4-3-5-9-25/h3-5,8-9,12-15,24,28-34,37,61H,6-7,10-11,16-23,47H2,1-2H3,(H2,48,62)(H2,49,63)(H,53,65)(H,54,69)(H,55,64)(H,56,66)(H,57,70)(H,58,67)(H,59,68)(H4,50,51,52)/t28-,29+,30-,31-,32-,33-,34-,37-/m0/s1 D02YBV DRUGINKE JITASQOSGITBPR-FMCGBTBPSA-N D02YBV DRUGSMIL CC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)N)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N D02YBV HIGHSTAT Investigative D02YCY DRUG__ID D02YCY D02YCY DRUGTYPE Small molecular drug D02YCY DRUGINCH 1S/C18H20N2O/c1-20-7-6-12-8-13(21-2)10-14-17-11(4-3-5-15(17)19)9-16(20)18(12)14/h3-5,8,10,16H,6-7,9,19H2,1-2H3/t16-/m1/s1 D02YCY DRUGINKE RHZAGARGKYFZJB-MRXNPFEDSA-N D02YCY DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=CC=C4)N D02YCY HIGHSTAT Investigative D02YDU DRUG__ID D02YDU D02YDU DRUGTYPE Small molecular drug D02YDU DRUGINCH 1S/C13H22N2/c1-3-9-15(10-4-2)13-7-5-12(11-14)6-8-13/h5,13H,3-4,6-10H2,1-2H3 D02YDU DRUGINKE WKFNOWSGTCBYBL-UHFFFAOYSA-N D02YDU DRUGSMIL CCCN(CCC)C1CCC(=CC1)C#N D02YDU HIGHSTAT Investigative D02YEE DRUG__ID D02YEE D02YEE DRUGTYPE Small molecular drug D02YEE DRUGINCH 1S/C16H15F3N2O2/c17-16(18,19)8-9-23-14-7-6-13(11-20-14)15(22)21-10-12-4-2-1-3-5-12/h1-7,11H,8-10H2,(H,21,22) D02YEE DRUGINKE KOPBISOWPWQPSS-UHFFFAOYSA-N D02YEE DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CN=C(C=C2)OCCC(F)(F)F D02YEE HIGHSTAT Investigative D02YFZ DRUG__ID D02YFZ D02YFZ DRUGTYPE Small molecular drug D02YFZ DRUGINCH 1S/C11H13N3/c12-9-10-3-1-2-4-11(10)14-7-5-13-6-8-14/h1-4,13H,5-8H2 D02YFZ DRUGINKE FRICBZWJFIRJOB-UHFFFAOYSA-N D02YFZ DRUGSMIL C1CN(CCN1)C2=CC=CC=C2C#N D02YFZ HIGHSTAT Investigative D02YGR DRUG__ID D02YGR D02YGR DRUGTYPE Small molecular drug D02YGR DRUGINCH 1S/C16H25NO4/c1-7-8-20-15(19)13-10(2)12(11(3)17-13)14(18)21-9-16(4,5)6/h17H,7-9H2,1-6H3 D02YGR DRUGINKE JFOGEVBSXYRAFN-UHFFFAOYSA-N D02YGR DRUGSMIL CCCOC(=O)C1=C(C(=C(N1)C)C(=O)OCC(C)(C)C)C D02YGR HIGHSTAT Investigative D02YGZ DRUG__ID D02YGZ D02YGZ DRUGTYPE Small molecular drug D02YGZ DRUGINCH 1S/C14H19FS2/c1-14(2,3)11-8-16-13(17-9-11)10-4-6-12(15)7-5-10/h4-7,11,13H,8-9H2,1-3H3 D02YGZ DRUGINKE MFJQBAHBCVIQEE-UHFFFAOYSA-N D02YGZ DRUGSMIL CC(C)(C)C1CSC(SC1)C2=CC=C(C=C2)F D02YGZ HIGHSTAT Investigative D02YHA DRUG__ID D02YHA D02YHA DRUGTYPE Small molecular drug D02YHA DRUGINCH 1S/C10H20O7P2/c1-9(2)5-4-6-10(3)7-8-16-19(14,15)17-18(11,12)13/h5,7H,4,6,8H2,1-3H3,(H,14,15)(H2,11,12,13)/b10-7+ D02YHA DRUGINKE GVVPGTZRZFNKDS-JXMROGBWSA-N D02YHA DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)O)C)C D02YHA HIGHSTAT Investigative D02YHD DRUG__ID D02YHD D02YHD DRUGTYPE Small molecular drug D02YHD DRUGINCH 1S/C29H29N3O4/c1-28(2)12-13-29(3,4)22-16-25-20(15-21(22)28)26(17-6-8-18(9-7-17)27(33)34)30-23-14-19(32(35)36)10-11-24(23)31(25)5/h6-11,14-16H,12-13H2,1-5H3,(H,33,34) D02YHD DRUGINKE SXKPGYKPQPYJER-UHFFFAOYSA-N D02YHD DRUGSMIL CC1(CCC(C2=C1C=C3C(=C2)N(C4=C(C=C(C=C4)[N+](=O)[O-])N=C3C5=CC=C(C=C5)C(=O)O)C)(C)C)C D02YHD HIGHSTAT Investigative D02YIJ DRUG__ID D02YIJ D02YIJ DRUGTYPE Small molecular drug D02YIJ DRUGINCH 1S/C21H34O4/c1-2-3-4-8-17(22)10-11-18-19-13-15(7-5-6-9-21(24)25)12-16(19)14-20(18)23/h10-12,16-20,22-23H,2-9,13-14H2,1H3,(H,24,25)/b11-10+/t16-,17-,18+,19-,20+/m0/s1 D02YIJ DRUGINKE JANVYOZZTKSZGN-WCAFQOMDSA-N D02YIJ DRUGSMIL CCCCCC(C=CC1C(CC2C1CC(=C2)CCCCC(=O)O)O)O D02YIJ HIGHSTAT Investigative D02YJL DRUG__ID D02YJL D02YJL DRUGTYPE Small molecular drug D02YJL DRUGINCH 1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1 D02YJL DRUGINKE BHTRKEVKTKCXOH-BJLOMENOSA-N D02YJL DRUGSMIL CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C D02YJL HIGHSTAT Investigative D02YKK DRUG__ID D02YKK D02YKK DRUGTYPE Small molecular drug D02YKK DRUGINCH 1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 D02YKK DRUGINKE XJLXINKUBYWONI-NNYOXOHSSA-O D02YKK DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=O)N D02YKK HIGHSTAT Investigative D02YMI DRUG__ID D02YMI D02YMI DRUGTYPE Small molecular drug D02YMI DRUGINCH 1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1 D02YMI DRUGINKE PMMYEEVYMWASQN-DMTCNVIQSA-N D02YMI DRUGSMIL C1C(CNC1C(=O)O)O D02YMI HIGHSTAT Investigative D02YMQ DRUG__ID D02YMQ D02YMQ DRUGTYPE Small molecular drug D02YMQ DRUGINCH 1S/C19H14N2/c1-2-4-14(5-3-1)16-6-7-17-18(13-21-19(17)12-16)15-8-10-20-11-9-15/h1-13,21H D02YMQ DRUGINKE QPUYBWAAFGEKSG-UHFFFAOYSA-N D02YMQ DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(C=C2)C(=CN3)C4=CC=NC=C4 D02YMQ HIGHSTAT Investigative D02YOO DRUG__ID D02YOO D02YOO DRUGTYPE Small molecular drug D02YOO DRUGINCH 1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3 D02YOO DRUGINKE ITJNARMNRKSWTA-UHFFFAOYSA-N D02YOO DRUGSMIL CNCCC(C1=CC=CC=C1)OC2=CC=CC=C2OC D02YOO HIGHSTAT Investigative D02YPE DRUG__ID D02YPE D02YPE DRUGTYPE Small molecular drug D02YPE DRUGINCH 1S/C14H10O3/c15-11-6-5-9-7-8-3-1-2-4-10(8)13(16)12(9)14(11)17/h1-6,15,17H,7H2 D02YPE DRUGINKE VQTRJTVHFJIZMI-UHFFFAOYSA-N D02YPE DRUGSMIL C1C2=C(C(=C(C=C2)O)O)C(=O)C3=CC=CC=C31 D02YPE HIGHSTAT Investigative D02YSN DRUG__ID D02YSN D02YSN DRUGTYPE Small molecular drug D02YSN DRUGINCH 1S/C15H23NO/c1-15(2,3)12-6-4-11(5-7-12)14-9-8-13(10-16)17-14/h4-7,13-14H,8-10,16H2,1-3H3 D02YSN DRUGINKE OOZOQFAQHUVOAM-UHFFFAOYSA-N D02YSN DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C2CCC(O2)CN D02YSN HIGHSTAT Investigative D02YSX DRUG__ID D02YSX D02YSX DRUGTYPE Small molecular drug D02YSX DRUGINCH 1S/C21H25N3/c1-15-4-7-20-18(12-15)19-14-23(3)10-9-21(19)24(20)11-8-17-6-5-16(2)22-13-17/h4-7,12-13H,8-11,14H2,1-3H3 D02YSX DRUGINKE JNODQFNWMXFMEV-UHFFFAOYSA-N D02YSX DRUGSMIL CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C D02YSX HIGHSTAT Investigative D02YVZ DRUG__ID D02YVZ D02YVZ DRUGTYPE Small molecular drug D02YVZ DRUGINCH 1S/C19H21N3O/c23-19-16-12-8-14-20-18(16)21-17(22-19)13-7-2-1-4-9-15-10-5-3-6-11-15/h3,5-6,8,10-12,14H,1-2,4,7,9,13H2,(H,20,21,22,23) D02YVZ DRUGINKE WWIOUCLIAKKTPW-UHFFFAOYSA-N D02YVZ DRUGSMIL C1=CC=C(C=C1)CCCCCCC2=NC3=C(C=CC=N3)C(=O)N2 D02YVZ HIGHSTAT Investigative D02YXP DRUG__ID D02YXP D02YXP DRUGTYPE Small molecular drug D02YXP DRUGINCH 1S/C33H43N7O2/c1-7-8-24-15-23(6)37-33(42)28(24)19-35-32(41)27-16-26(17-30-29(27)20-36-40(30)22(4)5)25-9-10-31(34-18-25)39-13-11-38(12-14-39)21(2)3/h9-10,15-18,20-22H,7-8,11-14,19H2,1-6H3,(H,35,41)(H,37,42) D02YXP DRUGINKE DPJNKUOXBZSZAI-UHFFFAOYSA-N D02YXP DRUGSMIL CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CN=C(C=C4)N5CCN(CC5)C(C)C)C(C)C D02YXP HIGHSTAT Investigative D02YXR DRUG__ID D02YXR D02YXR DRUGTYPE Small molecular drug D02YXR DRUGINCH 1S/C20H23NO7S/c1-11(22)26-15-6-4-12-10-14-13-5-7-16(28-29(23,24)25)19-20(13,8-9-21(14,2)3)17(12)18(15)27-19/h4-7,13-14,16,19H,8-10H2,1-3H3/t13-,14+,16-,19-,20-/m0/s1 D02YXR DRUGINKE QNHZSCHPVZZALI-BKRJIHRRSA-N D02YXR DRUGSMIL CC(=O)OC1=C2C3=C(CC4C5C3(CC[N+]4(C)C)C(O2)C(C=C5)OS(=O)(=O)[O-])C=C1 D02YXR HIGHSTAT Investigative D02YYQ DRUG__ID D02YYQ D02YYQ DRUGTYPE Small molecular drug D02YYQ DRUGINCH 1S/C11H15N7O4/c12-8-5-9(16-2-15-8)18(3-17-5)10-7(20)6(19)4(22-10)1-14-11(13)21/h2-4,6-7,10,19-20H,1H2,(H2,12,15,16)(H3,13,14,21)/t4-,6-,7-,10-/m1/s1 D02YYQ DRUGINKE MRVWQDQRJFAPMW-KQYNXXCUSA-N D02YYQ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CNC(=O)N)O)O)N D02YYQ HIGHSTAT Investigative D02ZCP DRUG__ID D02ZCP D02ZCP DRUGTYPE Small molecular drug D02ZCP DRUGINCH 1S/C14H12N4S/c15-13-12-10(17-14(16)18-13)7-4-8-11(12)19-9-5-2-1-3-6-9/h1-8H,(H4,15,16,17,18) D02ZCP DRUGINKE BUFDQCGCADQQQY-UHFFFAOYSA-N D02ZCP DRUGSMIL C1=CC=C(C=C1)SC2=CC=CC3=C2C(=NC(=N3)N)N D02ZCP HIGHSTAT Investigative D02ZEE DRUG__ID D02ZEE D02ZEE DRUGTYPE Small molecular drug D02ZEE DRUGINCH 1S/C14H11NO2/c1-17-14-8-10(6-7-11(14)9-15)12-4-2-3-5-13(12)16/h2-8,16H,1H3 D02ZEE DRUGINKE LZGNSWNEFCSNST-UHFFFAOYSA-N D02ZEE DRUGSMIL COC1=C(C=CC(=C1)C2=CC=CC=C2O)C#N D02ZEE HIGHSTAT Investigative D02ZFN DRUG__ID D02ZFN D02ZFN DRUGTYPE Small molecular drug D02ZFN DRUGINCH 1S/C14H19Cl2NO/c1-18-9-11(14-4-2-3-7-17-14)10-5-6-12(15)13(16)8-10/h5-6,8,11,14,17H,2-4,7,9H2,1H3/t11-,14-/m1/s1 D02ZFN DRUGINKE JJZIIHYRMWUFJU-BXUZGUMPSA-N D02ZFN DRUGSMIL COCC(C1CCCCN1)C2=CC(=C(C=C2)Cl)Cl D02ZFN HIGHSTAT Investigative D02ZGN DRUG__ID D02ZGN D02ZGN DRUGTYPE Small molecular drug D02ZGN DRUGINCH 1S/C9H14N2O/c1-6-3-8(5-7(2)12)11-9(10)4-6/h3-4,7,12H,5H2,1-2H3,(H2,10,11) D02ZGN DRUGINKE KSEWELLLEMDLDQ-UHFFFAOYSA-N D02ZGN DRUGSMIL CC1=CC(=NC(=C1)N)CC(C)O D02ZGN HIGHSTAT Investigative D02ZIO DRUG__ID D02ZIO D02ZIO DRUGTYPE Small molecular drug D02ZIO DRUGINCH 1S/C26H32N4O4/c1-3-5-11-27-15-23(31)29-17-7-9-19-21(13-17)26(34)22-14-18(8-10-20(22)25(19)33)30-24(32)16-28-12-6-4-2/h7-10,13-14,27-28H,3-6,11-12,15-16H2,1-2H3,(H,29,31)(H,30,32) D02ZIO DRUGINKE FYPZVYMKSUFNRS-UHFFFAOYSA-N D02ZIO DRUGSMIL CCCCNCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CNCCCC D02ZIO HIGHSTAT Investigative D02ZIY DRUG__ID D02ZIY D02ZIY DRUGTYPE Small molecular drug D02ZIY DRUGINCH 1S/C18H15N5O3/c24-8-2-7-23-10-12(11-3-1-4-21-16(11)23)14-15(18(26)22-17(14)25)13-9-19-5-6-20-13/h1,3-6,9-10,24H,2,7-8H2,(H,22,25,26) D02ZIY DRUGINKE ZDEJZKULWCZIHL-UHFFFAOYSA-N D02ZIY DRUGSMIL C1=CC2=C(N=C1)N(C=C2C3=C(C(=O)NC3=O)C4=NC=CN=C4)CCCO D02ZIY HIGHSTAT Investigative D02ZLE DRUG__ID D02ZLE D02ZLE DRUGTYPE Small molecular drug D02ZLE DRUGINCH 1S/C16H15NO4/c18-12-17(20)9-10-21-15-8-4-7-14(11-15)16(19)13-5-2-1-3-6-13/h1-8,11-12,20H,9-10H2 D02ZLE DRUGINKE ZHFKBNAHHTUQBH-UHFFFAOYSA-N D02ZLE DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC(=CC=C2)OCCN(C=O)O D02ZLE HIGHSTAT Investigative D02ZML DRUG__ID D02ZML D02ZML DRUGTYPE Small molecular drug D02ZML DRUGINCH 1S/C35H33N5O4/c1-23(2)39(25-17-19-26(44-3)20-18-25)33(41)22-38-31-15-9-10-16-32(31)40(24-11-5-4-6-12-24)35(43)28(34(38)42)21-30-27-13-7-8-14-29(27)36-37-30/h4-20,23,28H,21-22H2,1-3H3,(H,36,37) D02ZML DRUGINKE LGYKPDHARJMLQN-UHFFFAOYSA-N D02ZML DRUGSMIL CC(C)N(C1=CC=C(C=C1)OC)C(=O)CN2C3=CC=CC=C3N(C(=O)C(C2=O)CC4=C5C=CC=CC5=NN4)C6=CC=CC=C6 D02ZML HIGHSTAT Investigative D02ZNQ DRUG__ID D02ZNQ D02ZNQ DRUGTYPE Small molecular drug D02ZNQ DRUGINCH 1S/C25H22N4O8/c1-9-14(10-6-8-13(35-2)23(36-3)20(10)30)15(26)19(29-17(9)25(33)34)12-7-5-11-18(28-12)22(32)16(27)24(37-4)21(11)31/h5-8,30H,26-27H2,1-4H3,(H,33,34) D02ZNQ DRUGINKE PVYJZLYGTZKPJE-UHFFFAOYSA-N D02ZNQ DRUGSMIL CC1=C(C(=C(N=C1C(=O)O)C2=NC3=C(C=C2)C(=O)C(=C(C3=O)N)OC)N)C4=C(C(=C(C=C4)OC)OC)O D02ZNQ HIGHSTAT Investigative D02ZPV DRUG__ID D02ZPV D02ZPV DRUGTYPE Small molecular drug D02ZPV DRUGINCH 1S/C17H26N4/c1-12-15(18-14-8-9-14)19-16(13-6-7-13)20-17(12)21-10-4-2-3-5-11-21/h13-14H,2-11H2,1H3,(H,18,19,20) D02ZPV DRUGINKE XMDRTFUFPOAGDR-UHFFFAOYSA-N D02ZPV DRUGSMIL CC1=C(N=C(N=C1N2CCCCCC2)C3CC3)NC4CC4 D02ZPV HIGHSTAT Investigative D02ZPZ DRUG__ID D02ZPZ D02ZPZ DRUGTYPE Small molecular drug D02ZPZ DRUGINCH 1S/C16H14N4/c17-15-14-12(10-9-11-5-2-1-3-6-11)7-4-8-13(14)19-16(18)20-15/h1-10H,(H4,17,18,19,20)/b10-9+ D02ZPZ DRUGINKE YPIDSPOROIRHIL-MDZDMXLPSA-N D02ZPZ DRUGSMIL C1=CC=C(C=C1)C=CC2=C3C(=CC=C2)N=C(N=C3N)N D02ZPZ HIGHSTAT Investigative D02ZQH DRUG__ID D02ZQH D02ZQH DRUGTYPE Small molecular drug D02ZQH DRUGINCH 1S/C6H7NO2/c1-2-7-5(8)3-4-6(7)9/h3-4H,2H2,1H3 D02ZQH DRUGINKE HDFGOPSGAURCEO-UHFFFAOYSA-N D02ZQH DRUGSMIL CCN1C(=O)C=CC1=O D02ZQH HIGHSTAT Investigative D02ZQK DRUG__ID D02ZQK D02ZQK DRUGTYPE Small molecular drug D02ZQK DRUGINCH 1S/C12H13BrN2/c13-12-5-3-11(4-6-12)2-1-8-15-9-7-14-10-15/h3-7,9-10H,1-2,8H2 D02ZQK DRUGINKE QCQTVUDLIJGAGO-UHFFFAOYSA-N D02ZQK DRUGSMIL C1=CC(=CC=C1CCCN2C=CN=C2)Br D02ZQK HIGHSTAT Investigative D02ZQM DRUG__ID D02ZQM D02ZQM DRUGTYPE Small molecular drug D02ZQM DRUGINCH 1S/C15H15NO/c17-15-6-5-11-8-12(3-4-13(11)9-15)14-2-1-7-16-10-14/h1-4,7-8,10,15,17H,5-6,9H2 D02ZQM DRUGINKE ROYVUWJYYRTBSK-UHFFFAOYSA-N D02ZQM DRUGSMIL C1CC2=C(CC1O)C=CC(=C2)C3=CN=CC=C3 D02ZQM HIGHSTAT Investigative D02ZRO DRUG__ID D02ZRO D02ZRO DRUGTYPE Small molecular drug D02ZRO DRUGINCH 1S/C14H10BrN3/c15-10-4-3-5-11(8-10)18-14-12-6-1-2-7-13(12)16-9-17-14/h1-9H,(H,16,17,18) D02ZRO DRUGINKE SUTRLYZWRGPLSJ-UHFFFAOYSA-N D02ZRO DRUGSMIL C1=CC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br D02ZRO HIGHSTAT Investigative D02ZRX DRUG__ID D02ZRX D02ZRX DRUGTYPE Small molecular drug D02ZRX DRUGINCH 1S/C12H15NO/c1-13-9-11(7-8-12(13)14)10-5-3-2-4-6-10/h2-6,11H,7-9H2,1H3 D02ZRX DRUGINKE ASTTXNJRFSDNDJ-UHFFFAOYSA-N D02ZRX DRUGSMIL CN1CC(CCC1=O)C2=CC=CC=C2 D02ZRX HIGHSTAT Investigative D02ZSX DRUG__ID D02ZSX D02ZSX DRUGTYPE Small molecular drug D02ZSX DRUGINCH 1S/C15H22O5/c1-2-3-4-5-6-7-8-20-15(19)11-9-12(16)14(18)13(17)10-11/h9-10,16-18H,2-8H2,1H3 D02ZSX DRUGINKE NRPKURNSADTHLJ-UHFFFAOYSA-N D02ZSX DRUGSMIL CCCCCCCCOC(=O)C1=CC(=C(C(=C1)O)O)O D02ZSX HIGHSTAT Investigative D02ZWC DRUG__ID D02ZWC D02ZWC DRUGTYPE Small molecular drug D02ZWC DRUGINCH 1S/C33H39IN4O5/c1-33(16-23-17-36-28-5-3-2-4-25(23)28,38-32(42)43-30-21-9-19-8-20(11-21)12-22(30)10-19)31(41)37-24(15-29(39)40)13-18-6-7-27(35)26(34)14-18/h2-7,14,17,19-22,24,30,36H,8-13,15-16,35H2,1H3,(H,37,41)(H,38,42)(H,39,40)/t19?,20?,21?,22?,24-,30?,33+/m0/s1/i34-2 D02ZWC DRUGINKE YMNQSYWYYQDKJU-PDZULBFKSA-N D02ZWC DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC(=C(C=C3)N)I)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D02ZWC HIGHSTAT Investigative D02ZYA DRUG__ID D02ZYA D02ZYA DRUGTYPE Small molecular drug D02ZYA DRUGINCH 1S/C11H19N5O/c12-8-9(13)15-11(14)16-10(8)17-6-7-4-2-1-3-5-7/h7H,1-6,12H2,(H4,13,14,15,16) D02ZYA DRUGINKE IMNSQZHRHASLAR-UHFFFAOYSA-N D02ZYA DRUGSMIL C1CCC(CC1)COC2=NC(=NC(=C2N)N)N D02ZYA HIGHSTAT Investigative D02ZZA DRUG__ID D02ZZA D02ZZA DRUGTYPE Small molecular drug D02ZZA DRUGINCH 1S/C11H17NS/c1-3-13-11-6-4-10(5-7-11)8-9(2)12/h4-7,9H,3,8,12H2,1-2H3/t9-/m0/s1 D02ZZA DRUGINKE WOBAXWXQKSIHCH-VIFPVBQESA-N D02ZZA DRUGSMIL CCSC1=CC=C(C=C1)CC(C)N D02ZZA HIGHSTAT Investigative D02ZZQ DRUG__ID D02ZZQ D02ZZQ DRUGTYPE Small molecular drug D02ZZQ DRUGINCH 1S/C14H14N2O/c1-8-7-11-12(9(2)14(8)17)13-10(16(11)3)5-4-6-15-13/h4-7,17H,1-3H3 D02ZZQ DRUGINKE HGIQNBUVVTWBSJ-UHFFFAOYSA-N D02ZZQ DRUGSMIL CC1=CC2=C(C(=C1O)C)C3=C(N2C)C=CC=N3 D02ZZQ HIGHSTAT Investigative D03AAC DRUG__ID D03AAC D03AAC DRUGTYPE Small molecular drug D03AAC DRUGINCH 1S/C16H27N2O4P/c1-2-3-4-5-7-13-8-6-9-14(12-13)18-16(19)15(17)10-11-23(20,21)22/h6,8-9,12,15H,2-5,7,10-11,17H2,1H3,(H,18,19)(H2,20,21,22)/t15-/m1/s1 D03AAC DRUGINKE FWJRVGZWNDOOFH-OAHLLOKOSA-N D03AAC DRUGSMIL CCCCCCC1=CC(=CC=C1)NC(=O)C(CCP(=O)(O)O)N D03AAC HIGHSTAT Investigative D03AER DRUG__ID D03AER D03AER DRUGTYPE Small molecular drug D03AER DRUGINCH 1S/C32H36N8O3/c1-38-25-6-4-3-5-20(25)17-26(38)32(41)36-24-8-7-21(18-27(24)42-2)29-28-30(33)34-19-35-31(28)40(37-29)23-9-13-39(14-10-23)22-11-15-43-16-12-22/h3-8,17-19,22-23H,9-16H2,1-2H3,(H,36,41)(H2,33,34,35) D03AER DRUGINKE CMFPSTWYLODPNE-UHFFFAOYSA-N D03AER DRUGSMIL CN1C2=CC=CC=C2C=C1C(=O)NC3=C(C=C(C=C3)C4=NN(C5=NC=NC(=C45)N)C6CCN(CC6)C7CCOCC7)OC D03AER HIGHSTAT Investigative D03AGD DRUG__ID D03AGD D03AGD DRUGTYPE Small molecular drug D03AGD DRUGINCH 1S/C25H37N3O5/c29-22(20-13-7-4-8-14-20)17-26-28-21(15-9-1-2-10-16-23(30)31)24(32)27(25(28)33)18-19-11-5-3-6-12-19/h3,5-6,11-12,20-22,26,29H,1-2,4,7-10,13-18H2,(H,30,31) D03AGD DRUGINKE YZJVWSKJHGEIBL-UHFFFAOYSA-N D03AGD DRUGSMIL C1CCC(CC1)C(CNN2C(C(=O)N(C2=O)CC3=CC=CC=C3)CCCCCCC(=O)O)O D03AGD HIGHSTAT Investigative D03AGV DRUG__ID D03AGV D03AGV DRUGTYPE Small molecular drug D03AGV DRUGINCH 1S/C10H13N3O3S/c1-6-3-4-7(9(14)13-10(11)12)5-8(6)17(2,15)16/h3-5H,1-2H3,(H4,11,12,13,14) D03AGV DRUGINKE LHXXNXYVTIIVIY-UHFFFAOYSA-N D03AGV DRUGSMIL CC1=C(C=C(C=C1)C(=O)N=C(N)N)S(=O)(=O)C D03AGV HIGHSTAT Investigative D03AHJ DRUG__ID D03AHJ D03AHJ DRUGTYPE Small molecular drug D03AHJ DRUGINCH 1S/C18H35NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H2,19,20)/b10-9- D03AHJ DRUGINKE FATBGEAMYMYZAF-KTKRTIGZSA-N D03AHJ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)N D03AHJ HIGHSTAT Investigative D03AHQ DRUG__ID D03AHQ D03AHQ DRUGTYPE Small molecular drug D03AHQ DRUGINCH 1S/C43H53N9O7S2/c1-26(53)47-37-25-61-60-24-36(38(45)54)52-41(57)34(21-28-14-6-3-7-15-28)49-39(55)32(18-10-11-19-44)48-42(58)35(22-29-23-46-31-17-9-8-16-30(29)31)51-40(56)33(50-43(37)59)20-27-12-4-2-5-13-27/h2-9,12-17,23,32-37,46H,10-11,18-22,24-25,44H2,1H3,(H2,45,54)(H,47,53)(H,48,58)(H,49,55)(H,50,59)(H,51,56)(H,52,57)/t32-,33-,34-,35-,36-,37-/m0/s1 D03AHQ DRUGINKE PRZDRTMXFMEFAP-DUGSHLAESA-N D03AHQ DRUGSMIL CC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCCCN)CC5=CC=CC=C5)C(=O)N D03AHQ HIGHSTAT Investigative D03AHW DRUG__ID D03AHW D03AHW DRUGTYPE Small molecular drug D03AHW DRUGINCH 1S/C37H63NO28/c1-8-15(19(46)26(53)35(59-8)65-31-12(5-41)62-34(28(55)23(31)50)58-7-14-18(45)20(47)25(52)33(57)60-14)38-10-2-9(3-39)30(22(49)16(10)43)64-37-29(56)24(51)32(13(6-42)63-37)66-36-27(54)21(48)17(44)11(4-40)61-36/h2,8,10-57H,3-7H2,1H3/t8-,10+,11+,12+,13-,14+,15-,16-,17+,18+,19+,20-,21-,22+,23-,24-,25+,26-,27+,28-,29-,30-,31-,32-,33+,34-,35+,36-,37+/m1/s1 D03AHW DRUGINKE MBNITLCAVXHYER-AGOKNQOUSA-N D03AHW DRUGSMIL CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)O)O)O)O)CO)O)O)NC4C=C(C(C(C4O)O)OC5C(C(C(C(O5)CO)OC6C(C(C(C(O6)CO)O)O)O)O)O)CO D03AHW HIGHSTAT Investigative D03AJS DRUG__ID D03AJS D03AJS DRUGTYPE Small molecular drug D03AJS DRUGINCH 1S/C20H24O7/c1-25-14-8-6-12(7-9-14)10-13-4-2-3-5-15(13)26-20-19(24)18(23)17(22)16(11-21)27-20/h2-9,16-24H,10-11H2,1H3/t16-,17-,18+,19-,20-/m1/s1 D03AJS DRUGINKE HFLCZNNDZKKXCS-OUUBHVDSSA-N D03AJS DRUGSMIL COC1=CC=C(C=C1)CC2=CC=CC=C2OC3C(C(C(C(O3)CO)O)O)O D03AJS HIGHSTAT Investigative D03AJW DRUG__ID D03AJW D03AJW DRUGTYPE Small molecular drug D03AJW DRUGINCH 1S/C14H18N2O2/c1-2-5-13(17)15-9-4-7-11-6-3-8-12-14(11)18-10-16-12/h3,6,8,10H,2,4-5,7,9H2,1H3,(H,15,17) D03AJW DRUGINKE ADFZAUSXPZLXMN-UHFFFAOYSA-N D03AJW DRUGSMIL CCCC(=O)NCCCC1=C2C(=CC=C1)N=CO2 D03AJW HIGHSTAT Investigative D03AMR DRUG__ID D03AMR D03AMR DRUGTYPE Small molecular drug D03AMR DRUGINCH 1S/C30H41N3O5/c1-4-11-25(29(35)32-37)26(18-21(2)3)28(34)31-27-16-8-9-17-33(30(27)36)20-22-12-10-15-24(19-22)38-23-13-6-5-7-14-23/h5-7,10,12-15,19,21,25-27,37H,4,8-9,11,16-18,20H2,1-3H3,(H,31,34)(H,32,35)/t25-,26+,27-/m0/s1 D03AMR DRUGINKE WICQDDCNCVTFDX-VJGNERBWSA-N D03AMR DRUGSMIL CCCC(C(CC(C)C)C(=O)NC1CCCCN(C1=O)CC2=CC(=CC=C2)OC3=CC=CC=C3)C(=O)NO D03AMR HIGHSTAT Investigative D03ANS DRUG__ID D03ANS D03ANS DRUGTYPE Small molecular drug D03ANS DRUGINCH 1S/C21H21N5/c1-13-6-5-7-16(24-13)19-18(25-20(26-19)21(2,3)4)14-8-9-15-17(12-14)23-11-10-22-15/h5-12H,1-4H3,(H,25,26) D03ANS DRUGINKE DKPQHFZUICCZHF-UHFFFAOYSA-N D03ANS DRUGSMIL CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3 D03ANS HIGHSTAT Investigative D03APP DRUG__ID D03APP D03APP DRUGTYPE Small molecular drug D03APP DRUGINCH 1S/C13H11NO2/c15-13(16)11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h1-9,14H,(H,15,16) D03APP DRUGINKE ZWJINEZUASEZBH-UHFFFAOYSA-N D03APP DRUGSMIL C1=CC=C(C=C1)NC2=CC=CC=C2C(=O)O D03APP HIGHSTAT Investigative D03ATU DRUG__ID D03ATU D03ATU DRUGTYPE Small molecular drug D03ATU DRUGINCH 1S/C14H12BrN5/c1-16-13-6-11-12(7-17-13)18-8-19-14(11)20-10-4-2-3-9(15)5-10/h2-8H,1H3,(H,16,17)(H,18,19,20) D03ATU DRUGINKE KFHMLBXBRCITHF-UHFFFAOYSA-N D03ATU DRUGSMIL CNC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br D03ATU HIGHSTAT Investigative D03AWH DRUG__ID D03AWH D03AWH DRUGTYPE Small molecular drug D03AWH DRUGINCH 1S/C24H32O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h10-11,13-15,25-26H,6-9,12H2,1-5H3 D03AWH DRUGINKE UNSSGNVPLKLAPB-UHFFFAOYSA-N D03AWH DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)O)(C)C)O D03AWH HIGHSTAT Investigative D03AYF DRUG__ID D03AYF D03AYF DRUGTYPE Small molecular drug D03AYF DRUGINCH 1S/C18H20ClNO3/c1-2-3-11-22-16-9-7-14(8-10-16)13-20-18(21)23-17-6-4-5-15(19)12-17/h4-10,12H,2-3,11,13H2,1H3,(H,20,21) D03AYF DRUGINKE RFAALCRYXIMHGO-UHFFFAOYSA-N D03AYF DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CC(=CC=C2)Cl D03AYF HIGHSTAT Investigative D03AZI DRUG__ID D03AZI D03AZI DRUGTYPE Small molecular drug D03AZI DRUGINCH 1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5+,6?/m1/s1 D03AZI DRUGINKE HXXFSFRBOHSIMQ-QTVWNMPRSA-N D03AZI DRUGSMIL C(C1C(C(C(C(O1)OP(=O)(O)O)O)O)O)O D03AZI HIGHSTAT Investigative D03BAB DRUG__ID D03BAB D03BAB DRUGTYPE Small molecular drug D03BAB DRUGINCH 1S/C25H36O4/c1-16-6-5-7-21-24(16,3)12-10-17(2)25(21,4)13-11-18-8-9-20(28-15-18)19-14-22(26)29-23(19)27/h6,8,14,17,20-21,23,27H,5,7,9-13,15H2,1-4H3/t17-,20+,21-,23+,24-,25-/m0/s1 D03BAB DRUGINKE WBDQPITVPUAHAN-DRCQBYJMSA-N D03BAB DRUGSMIL CC1CCC2(C(C1(C)CCC3=CCC(OC3)C4=CC(=O)OC4O)CCC=C2C)C D03BAB HIGHSTAT Investigative D03BDK DRUG__ID D03BDK D03BDK DRUGTYPE Small molecular drug D03BDK DRUGINCH 1S/C42H56N8O6/c1-3-28(2)35(46-37(53)33(43)24-29-15-16-30-13-6-7-14-31(30)23-29)36(52)41(27-51)17-12-22-50(41)38(54)34(44)25-32-26-45-42(47-32,39(55)48-18-8-4-9-19-48)40(56)49-20-10-5-11-21-49/h6-7,13-16,23,26-28,33-35H,3-5,8-12,17-22,24-25,43-44H2,1-2H3,(H,46,53)/t28-,33-,34+,35-,41-/m0/s1 D03BDK DRUGINKE OCVKQRQVXSMCCJ-HWFQYKCLSA-N D03BDK DRUGSMIL CCC(C)C(C(=O)C1(CCCN1C(=O)C(CC2=NC(N=C2)(C(=O)N3CCCCC3)C(=O)N4CCCCC4)N)C=O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N D03BDK HIGHSTAT Investigative D03BFH DRUG__ID D03BFH D03BFH DRUGTYPE Small molecular drug D03BFH DRUGINCH 1S/C36H41ClN8O5/c1-50-25-14-10-22(11-15-25)18-30(44-36(39)40)35(49)45-16-4-7-31(45)34(48)43-29(19-23-20-41-27-6-3-2-5-26(23)27)33(47)42-28(32(38)46)17-21-8-12-24(37)13-9-21/h2-3,5-6,8-15,20,28-31,41H,4,7,16-19H2,1H3,(H2,38,46)(H,42,47)(H,43,48)(H4,39,40,44)/t28-,29-,30-,31-/m0/s1 D03BFH DRUGINKE IEBSBPORJZXBGY-ORYMTKCHSA-N D03BFH DRUGSMIL COC1=CC=C(C=C1)CC(C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=C(C=C5)Cl)C(=O)N)N=C(N)N D03BFH HIGHSTAT Investigative D03BHQ DRUG__ID D03BHQ D03BHQ DRUGTYPE Small molecular drug D03BHQ DRUGINCH 1S/C22H14O3/c23-13-19-14-25-21-12-18(10-11-20(21)22(19)24)17-8-6-16(7-9-17)15-4-2-1-3-5-15/h1-14H D03BHQ DRUGINKE LWZMEMOPULJQIN-UHFFFAOYSA-N D03BHQ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC4=C(C=C3)C(=O)C(=CO4)C=O D03BHQ HIGHSTAT Investigative D03BIQ DRUG__ID D03BIQ D03BIQ DRUGTYPE Small molecular drug D03BIQ DRUGINCH 1S/C22H21F3N4O2/c1-14-18-12-16(6-9-19(18)28-21(26-14)29-10-2-3-11-29)27-20(30)13-31-17-7-4-15(5-8-17)22(23,24)25/h4-9,12H,2-3,10-11,13H2,1H3,(H,27,30) D03BIQ DRUGINKE UPUPELYLRJEQHO-UHFFFAOYSA-N D03BIQ DRUGSMIL CC1=C2C=C(C=CC2=NC(=N1)N3CCCC3)NC(=O)COC4=CC=C(C=C4)C(F)(F)F D03BIQ HIGHSTAT Investigative D03BIT DRUG__ID D03BIT D03BIT DRUGTYPE Small molecular drug D03BIT DRUGINCH 1S/C7H9N5O8P2/c8-7-11-5-4(6(13)12-7)10-3(1-9-5)2-19-22(17,18)20-21(14,15)16/h1H,2H2,(H,17,18)(H2,14,15,16)(H3,8,9,11,12,13) D03BIT DRUGINKE AMDUVUKDRBIVAH-UHFFFAOYSA-N D03BIT DRUGSMIL C1=C(N=C2C(=O)NC(=NC2=N1)N)COP(=O)(O)OP(=O)(O)O D03BIT HIGHSTAT Investigative D03BJB DRUG__ID D03BJB D03BJB DRUGTYPE Small molecular drug D03BJB DRUGINCH 1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(9-14)27-18-11-19(26-12-25-18)28-16-5-2-6-17(10-16)29-20(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,29,30)(H2,25,26,27,28) D03BJB DRUGINKE YOHYSYJDKVYCJI-UHFFFAOYSA-N D03BJB DRUGSMIL C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=NC(=C3)NC4=CC=CC(=C4)C(F)(F)F D03BJB HIGHSTAT Investigative D03BJF DRUG__ID D03BJF D03BJF DRUGTYPE Small molecular drug D03BJF DRUGINCH 1S/C25H34N6O2/c32-24(19-3-1-4-19)27-12-2-11-26-23-22(18-5-6-18)17-28-25(30-23)29-20-7-9-21(10-8-20)31-13-15-33-16-14-31/h7-10,17-19H,1-6,11-16H2,(H,27,32)(H2,26,28,29,30) D03BJF DRUGINKE CJPMSUUANYLPET-UHFFFAOYSA-N D03BJF DRUGSMIL C1CC(C1)C(=O)NCCCNC2=NC(=NC=C2C3CC3)NC4=CC=C(C=C4)N5CCOCC5 D03BJF HIGHSTAT Investigative D03BNC DRUG__ID D03BNC D03BNC DRUGTYPE Small molecular drug D03BNC DRUGINCH 1S/C14H13BrFN3S/c15-11-5-6-13(18-9-11)19-14(20)17-8-7-10-3-1-2-4-12(10)16/h1-6,9H,7-8H2,(H2,17,18,19,20) D03BNC DRUGINKE MIJLSRZJDIBHJU-UHFFFAOYSA-N D03BNC DRUGSMIL C1=CC=C(C(=C1)CCNC(=S)NC2=NC=C(C=C2)Br)F D03BNC HIGHSTAT Investigative D03BNM DRUG__ID D03BNM D03BNM DRUGTYPE Small molecular drug D03BNM DRUGINCH 1S/C30H36N4O6/c1-18(2)24(26(35)28-31-21-13-8-9-15-23(21)40-28)32-27(36)22-14-10-16-34(22)29(37)25(19(3)4)33-30(38)39-17-20-11-6-5-7-12-20/h5-9,11-13,15,18-19,22,24-25H,10,14,16-17H2,1-4H3,(H,32,36)(H,33,38)/t22-,24-,25-/m0/s1 D03BNM DRUGINKE MRIBOSDZTNAJSS-HVCNVCAESA-N D03BNM DRUGSMIL CC(C)C(C(=O)C1=NC2=CC=CC=C2O1)NC(=O)C3CCCN3C(=O)C(C(C)C)NC(=O)OCC4=CC=CC=C4 D03BNM HIGHSTAT Investigative D03BNO DRUG__ID D03BNO D03BNO DRUGTYPE Small molecular drug D03BNO DRUGINCH 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-19(17)25-24-18)10-7-4-5-8-11-20(22)23/h4,7,12-13,15-19,21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1 D03BNO DRUGINKE YIBNHAJFJUQSRA-YNNPMVKQSA-N D03BNO DRUGSMIL CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OO2)O D03BNO HIGHSTAT Investigative D03BOO DRUG__ID D03BOO D03BOO DRUGTYPE Small molecular drug D03BOO DRUGINCH 1S/C23H28N4/c1-18(2)13-14-21-15-22(24-16-19-9-5-3-6-10-19)27-23(26-21)25-17-20-11-7-4-8-12-20/h3-12,15,18H,13-14,16-17H2,1-2H3,(H2,24,25,26,27) D03BOO DRUGINKE HEIDJEFGBUXABK-UHFFFAOYSA-N D03BOO DRUGSMIL CC(C)CCC1=CC(=NC(=N1)NCC2=CC=CC=C2)NCC3=CC=CC=C3 D03BOO HIGHSTAT Investigative D03BPG DRUG__ID D03BPG D03BPG DRUGTYPE Small molecular drug D03BPG DRUGINCH 1S/C12H8ClN3O3/c13-11-2-1-9(16(18)19)7-10(11)12(17)15-8-3-5-14-6-4-8/h1-7H,(H,14,15,17) D03BPG DRUGINKE FRPJSHKMZHWJBE-UHFFFAOYSA-N D03BPG DRUGSMIL C1=CC(=C(C=C1[N+](=O)[O-])C(=O)NC2=CC=NC=C2)Cl D03BPG HIGHSTAT Investigative D03BQI DRUG__ID D03BQI D03BQI DRUGTYPE Small molecular drug D03BQI DRUGINCH 1S/C16H15N3O3/c1-21-14-7-12-13(8-15(14)22-2)17-9-18-16(12)19-10-3-5-11(20)6-4-10/h3-9,20H,1-2H3,(H,17,18,19) D03BQI DRUGINKE HOZUXBLMYUPGPZ-UHFFFAOYSA-N D03BQI DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)O)OC D03BQI HIGHSTAT Investigative D03BQJ DRUG__ID D03BQJ D03BQJ DRUGTYPE Small molecular drug D03BQJ DRUGINCH 1S/C16H12O2/c1-11-6-8-12(9-7-11)16-10-14(17)13-4-2-3-5-15(13)18-16/h2-10H,1H3 D03BQJ DRUGINKE OPHKKQQCOYMLPW-UHFFFAOYSA-N D03BQJ DRUGSMIL CC1=CC=C(C=C1)C2=CC(=O)C3=CC=CC=C3O2 D03BQJ HIGHSTAT Investigative D03BQS DRUG__ID D03BQS D03BQS DRUGTYPE Small molecular drug D03BQS DRUGINCH 1S/C15H13NO2/c17-15(16-18)14-12-7-3-1-5-10(12)9-11-6-2-4-8-13(11)14/h1-8,14,18H,9H2,(H,16,17) D03BQS DRUGINKE SIYRPEHGIQLXJG-UHFFFAOYSA-N D03BQS DRUGSMIL C1C2=CC=CC=C2C(C3=CC=CC=C31)C(=O)NO D03BQS HIGHSTAT Investigative D03BQV DRUG__ID D03BQV D03BQV DRUGTYPE Small molecular drug D03BQV DRUGINCH 1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15-/m0/s1 D03BQV DRUGINKE GJJFMKBJSRMPLA-ZFWWWQNUSA-N D03BQV DRUGSMIL CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2 D03BQV HIGHSTAT Investigative D03BRB DRUG__ID D03BRB D03BRB DRUGTYPE Small molecular drug D03BRB DRUGINCH 1S/C49H58N8O10/c1-27-18-34(58)19-28(2)35(27)24-38(50)49(67)56-25-31-11-8-7-10-29(31)23-41(56)46(64)54-39(15-16-43(60)61)45(63)52-17-9-5-6-12-42(59)53-40(44(51)62)26-57-47(65)36-21-30-13-14-33(55(3)4)20-32(30)22-37(36)48(57)66/h7-8,10-11,13-14,18-22,38-41,58H,5-6,9,12,15-17,23-26,50H2,1-4H3,(H2,51,62)(H,52,63)(H,53,59)(H,54,64)(H,60,61)/t38-,39-,40?,41?/m0/s1 D03BRB DRUGINKE DURKEIXAKJIEGD-JHIBKCPMSA-N D03BRB DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCC(=O)O)C(=O)NCCCCCC(=O)NC(CN4C(=O)C5=C(C4=O)C=C6C=C(C=CC6=C5)N(C)C)C(=O)N)N)C)O D03BRB HIGHSTAT Investigative D03BRM DRUG__ID D03BRM D03BRM DRUGTYPE Small molecular drug D03BRM DRUGINCH 1S/C25H20F3NO2S/c26-25(27,28)21-13-18(7-8-20(21)17-4-2-1-3-5-17)23-14-19-12-16(6-9-22(19)32-23)15-29-11-10-24(30)31/h1-9,12-14,29H,10-11,15H2,(H,30,31) D03BRM DRUGINKE SKYYWSWIUKISCX-UHFFFAOYSA-N D03BRM DRUGSMIL C1=CC=C(C=C1)C2=C(C=C(C=C2)C3=CC4=C(S3)C=CC(=C4)CNCCC(=O)O)C(F)(F)F D03BRM HIGHSTAT Investigative D03BSR DRUG__ID D03BSR D03BSR DRUGTYPE Small molecular drug D03BSR DRUGINCH 1S/C30H38FN3O2/c1-20(2)28-24-13-12-23(31)19-22(24)14-15-30(28,36-29(35)21-10-11-21)16-18-34(3)17-6-9-27-32-25-7-4-5-8-26(25)33-27/h4-5,7-8,12-13,19-21,28H,6,9-11,14-18H2,1-3H3,(H,32,33)/t28-,30-/m0/s1 D03BSR DRUGINKE VHHVPDKNKPNKHY-JDXGNMNLSA-N D03BSR DRUGSMIL CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)C5CC5)C=C(C=C2)F D03BSR HIGHSTAT Investigative D03BTJ DRUG__ID D03BTJ D03BTJ DRUGTYPE Small molecular drug D03BTJ DRUGINCH 1S/C22H26N4O3/c1-24-18-13-16(23-21(27)15-9-5-6-10-20(15)29-3)17(26-11-7-4-8-12-26)14-19(18)25(2)22(24)28/h5-6,9-10,13-14H,4,7-8,11-12H2,1-3H3,(H,23,27) D03BTJ DRUGINKE LTUGYAOMCKNTGG-UHFFFAOYSA-N D03BTJ DRUGSMIL CN1C2=C(C=C(C(=C2)NC(=O)C3=CC=CC=C3OC)N4CCCCC4)N(C1=O)C D03BTJ HIGHSTAT Investigative D03BUD DRUG__ID D03BUD D03BUD DRUGTYPE Small molecular drug D03BUD DRUGINCH 1S/C20H29NO2/c1-4-20-9-10-21(13-19(23)7-8-19)17(18(20,2)3)11-14-5-6-15(22)12-16(14)20/h5-6,12,17,22-23H,4,7-11,13H2,1-3H3/t17-,20+/m1/s1 D03BUD DRUGINKE ZDXGFIXMPOUDFF-XLIONFOSSA-N D03BUD DRUGSMIL CCC12CCN(C(C1(C)C)CC3=C2C=C(C=C3)O)CC4(CC4)O D03BUD HIGHSTAT Investigative D03BUG DRUG__ID D03BUG D03BUG DRUGTYPE Small molecular drug D03BUG DRUGINCH 1S/C13H13NO/c1-2-4-11-9(3-1)5-12(15-11)13-6-10(13)7-14-8-13/h1-5,10,14H,6-8H2 D03BUG DRUGINKE FRXUZFQLSGFGPV-UHFFFAOYSA-N D03BUG DRUGSMIL C1C2C1(CNC2)C3=CC4=CC=CC=C4O3 D03BUG HIGHSTAT Investigative D03BVN DRUG__ID D03BVN D03BVN DRUGTYPE Small molecular drug D03BVN DRUGINCH 1S/C48H78N14O8/c1-5-14-30(4)41(65)58-35(18-12-25-55-47(51)52)42(66)60-37(27-31-15-8-7-9-16-31)45(69)61-38(28-32-20-22-33(63)23-21-32)44(68)59-36(19-13-26-56-48(53)54)43(67)62-39(29(3)6-2)46(70)57-34(40(50)64)17-10-11-24-49/h7-9,15-16,20-23,29-30,34-39,63H,5-6,10-14,17-19,24-28,49H2,1-4H3,(H2,50,64)(H,57,70)(H,58,65)(H,59,68)(H,60,66)(H,61,69)(H,62,67)(H4,51,52,55)(H4,53,54,56)/t29-,30?,34-,35-,36-,37-,38-,39-/m0/s1 D03BVN DRUGINKE TYNKFZNKNQQZMB-GUICQBDJSA-N D03BVN DRUGSMIL CCCC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)N D03BVN HIGHSTAT Investigative D03BWH DRUG__ID D03BWH D03BWH DRUGTYPE Small molecular drug D03BWH DRUGINCH 1S/C29H34O11/c1-14(2)5-10-18-20(37-12-11-30)13-19(31)21-23(33)28(40-29-25(35)24(34)22(32)15(3)38-29)26(39-27(18)21)16-6-8-17(36-4)9-7-16/h5-9,13,15,22,24-25,29-32,34-35H,10-12H2,1-4H3/t15-,22-,24+,25+,29+/m1/s1 D03BWH DRUGINKE MMEHTVTVEQHORK-NXPCAARESA-N D03BWH DRUGSMIL CC1C(C(C(C(O1)OC2=C(OC3=C(C2=O)C(=CC(=C3CC=C(C)C)OCCO)O)C4=CC=C(C=C4)OC)O)O)O D03BWH HIGHSTAT Investigative D03BXA DRUG__ID D03BXA D03BXA DRUGTYPE Small molecular drug D03BXA DRUGINCH 1S/C22H20N4O/c23-17-8-11-21-20(14-17)22(26-15-25-21)24-13-12-16-6-9-19(10-7-16)27-18-4-2-1-3-5-18/h1-11,14-15H,12-13,23H2,(H,24,25,26) D03BXA DRUGINKE IBAKVEUZKHOWNG-UHFFFAOYSA-N D03BXA DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CCNC3=NC=NC4=C3C=C(C=C4)N D03BXA HIGHSTAT Investigative D03BZT DRUG__ID D03BZT D03BZT DRUGTYPE Small molecular drug D03BZT DRUGINCH 1S/C18H20O3/c1-18-7-6-12-11-3-2-10(19)8-14(11)16(20)9-13(12)15(18)4-5-17(18)21/h2-3,8,12-13,15,19H,4-7,9H2,1H3/t12-,13-,15+,18+/m1/s1 D03BZT DRUGINKE JOVYPIGRPWIXHQ-ONUSSAAZSA-N D03BZT DRUGSMIL CC12CCC3C(C1CCC2=O)CC(=O)C4=C3C=CC(=C4)O D03BZT HIGHSTAT Investigative D03BZV DRUG__ID D03BZV D03BZV DRUGTYPE Small molecular drug D03BZV DRUGINCH 1S/C20H14Cl2N4O3S/c21-15-2-1-3-16(22)19(15)20(27)12-4-9-18-25-17(11-26(18)10-12)24-13-5-7-14(8-6-13)30(23,28)29/h1-11,24H,(H2,23,28,29) D03BZV DRUGINKE UQAWGIKJINAKIZ-UHFFFAOYSA-N D03BZV DRUGSMIL C1=CC(=C(C(=C1)Cl)C(=O)C2=CN3C=C(N=C3C=C2)NC4=CC=C(C=C4)S(=O)(=O)N)Cl D03BZV HIGHSTAT Investigative D03BZW DRUG__ID D03BZW D03BZW DRUGTYPE Small molecular drug D03BZW DRUGINCH 1S/C14H21N3O3/c1-14(2,3)15-7-9(18)8-20-11-6-4-5-10-12(11)17-13(19)16-10/h4-6,9,15,18H,7-8H2,1-3H3,(H2,16,17,19) D03BZW DRUGINKE UMQUQWCJKFOUGV-UHFFFAOYSA-N D03BZW DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1NC(=O)N2)O D03BZW HIGHSTAT Investigative D03BZY DRUG__ID D03BZY D03BZY DRUGTYPE Small molecular drug D03BZY DRUGINCH 1S/C38H46N4O6S2/c1-23-14-16-25(17-15-23)19-31(44)39-29(21-49-4)35(46)40-28(18-24-10-6-5-7-11-24)33(45)37(48)42-22-50-38(2,3)34(42)36(47)41-32-27-13-9-8-12-26(27)20-30(32)43/h5-17,28-30,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t28-,29-,30+,32-,33-,34+/m0/s1 D03BZY DRUGINKE OMAVDDWHFQLABL-DYCNJNKSSA-N D03BZY DRUGSMIL CC1=CC=C(C=C1)CC(=O)NC(CSC)C(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D03BZY HIGHSTAT Investigative D03CAE DRUG__ID D03CAE D03CAE DRUGTYPE Small molecular drug D03CAE DRUGINCH 1S/C19H25NO/c21-19-12-10-18(11-13-19)14-16-20-15-6-2-5-9-17-7-3-1-4-8-17/h1,3-4,7-8,10-13,20-21H,2,5-6,9,14-16H2 D03CAE DRUGINKE GMQWOUOTGDXTNP-UHFFFAOYSA-N D03CAE DRUGSMIL C1=CC=C(C=C1)CCCCCNCCC2=CC=C(C=C2)O D03CAE HIGHSTAT Investigative D03CAJ DRUG__ID D03CAJ D03CAJ DRUGTYPE Small molecular drug D03CAJ DRUGINCH 1S/C8H15N3O2/c9-8-4-2-1-3-7(10-8)5-6-11(12)13/h7H,1-6H2,(H2,9,10) D03CAJ DRUGINKE ILALABPIKINZAM-UHFFFAOYSA-N D03CAJ DRUGSMIL C1CCC(=NC(C1)CC[N+](=O)[O-])N D03CAJ HIGHSTAT Investigative D03CBD DRUG__ID D03CBD D03CBD DRUGTYPE Small molecular drug D03CBD DRUGINCH 1S/C4H3NO3/c6-4(7)3-1-2-8-5-3/h1-2H,(H,6,7) D03CBD DRUGINKE UXYRXGFUANQKTA-UHFFFAOYSA-N D03CBD DRUGSMIL C1=CON=C1C(=O)O D03CBD HIGHSTAT Investigative D03CCP DRUG__ID D03CCP D03CCP DRUGTYPE Small molecular drug D03CCP DRUGINCH 1S/C13H6FNS/c1-2-13-15-12(9-16-13)7-6-10-4-3-5-11(14)8-10/h1,3-5,8-9H D03CCP DRUGINKE SECGPKGEFXVRQQ-UHFFFAOYSA-N D03CCP DRUGSMIL C#CC1=NC(=CS1)C#CC2=CC(=CC=C2)F D03CCP HIGHSTAT Investigative D03CDB DRUG__ID D03CDB D03CDB DRUGTYPE Small molecular drug D03CDB DRUGINCH 1S/C50H54N6O7/c57-45(39-27-16-28-51-39)52-40(29-34-17-6-1-7-18-34)46(58)53-41(30-35-19-8-2-9-20-35)47(59)54-42(31-36-21-10-3-11-22-36)48(60)55-43(32-37-23-12-4-13-24-37)49(61)56-44(50(62)63)33-38-25-14-5-15-26-38/h1-15,17-26,39-44,51H,16,27-33H2,(H,52,57)(H,53,58)(H,54,59)(H,55,60)(H,56,61)(H,62,63)/t39-,40-,41-,42-,43-,44-/m0/s1 D03CDB DRUGINKE GFXHQPYZLJKWEI-WGXSSYHUSA-N D03CDB DRUGSMIL C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)O D03CDB HIGHSTAT Investigative D03CDH DRUG__ID D03CDH D03CDH DRUGTYPE Small molecular drug D03CDH DRUGINCH 1S/C20H18O3/c21-18-16-11-10-14-8-4-5-9-15(14)19(16)23-20(22)17(18)12-13-6-2-1-3-7-13/h1-3,6-7,10-11,21H,4-5,8-9,12H2 D03CDH DRUGINKE AGXYLUCTDKGDGR-UHFFFAOYSA-N D03CDH DRUGSMIL C1CCC2=C(C1)C=CC3=C2OC(=O)C(=C3O)CC4=CC=CC=C4 D03CDH HIGHSTAT Investigative D03CDM DRUG__ID D03CDM D03CDM DRUGTYPE Small molecular drug D03CDM DRUGINCH 1S/C14H18N2O2/c1-3-17-9-10(2)18-12-6-4-5-11-7-8-13(15)16-14(11)12/h4-8,10H,3,9H2,1-2H3,(H2,15,16) D03CDM DRUGINKE NPQHPGOWIVAOJW-UHFFFAOYSA-N D03CDM DRUGSMIL CCOCC(C)OC1=CC=CC2=C1N=C(C=C2)N D03CDM HIGHSTAT Investigative D03CEZ DRUG__ID D03CEZ D03CEZ DRUGTYPE Small molecular drug D03CEZ DRUGINCH 1S/C16H18N2/c1-10-6-13-12-4-3-5-14-16(12)11(8-17-14)7-15(13)18(2)9-10/h3-6,8,13,15,17H,7,9H2,1-2H3/t13-,15-/m1/s1 D03CEZ DRUGINKE XJOOMMHNYOJWCZ-UKRRQHHQSA-N D03CEZ DRUGSMIL CC1=CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C D03CEZ HIGHSTAT Investigative D03CKF DRUG__ID D03CKF D03CKF DRUGTYPE Small molecular drug D03CKF DRUGINCH 1S/C29H36N6O6/c30-21(14-17-7-9-20(36)10-8-17)26(39)33-23-6-3-13-32-24(37)12-11-22(25(31)38)34-28(41)29(35-27(23)40)15-18-4-1-2-5-19(18)16-29/h1-2,4-5,7-10,21-23,36H,3,6,11-16,30H2,(H2,31,38)(H,32,37)(H,33,39)(H,34,41)(H,35,40)/t21-,22+,23-/m0/s1 D03CKF DRUGINKE YFKXNEKIMXIPLT-ZRBLBEILSA-N D03CKF DRUGSMIL C1CC(C(=O)NC2(CC3=CC=CC=C3C2)C(=O)NC(CCC(=O)NC1)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D03CKF HIGHSTAT Investigative D03CKG DRUG__ID D03CKG D03CKG DRUGTYPE Small molecular drug D03CKG DRUGINCH 1S/C12H13NO3S/c1-13(2)12-5-3-4-9-8-10(17(14,15)16)6-7-11(9)12/h3-8H,1-2H3,(H,14,15,16) D03CKG DRUGINKE VENHBDIMAAXWKI-UHFFFAOYSA-N D03CKG DRUGSMIL CN(C)C1=CC=CC2=C1C=CC(=C2)S(=O)(=O)O D03CKG HIGHSTAT Investigative D03CKN DRUG__ID D03CKN D03CKN DRUGTYPE Small molecular drug D03CKN DRUGINCH 1S/C15H17NO3/c1-4-10-6-7-12-11(8-10)14(17)13(9(3)16-12)15(18)19-5-2/h6-8H,4-5H2,1-3H3,(H,16,17) D03CKN DRUGINKE RYTCQLITPWABMH-UHFFFAOYSA-N D03CKN DRUGSMIL CCC1=CC2=C(C=C1)NC(=C(C2=O)C(=O)OCC)C D03CKN HIGHSTAT Investigative D03CPB DRUG__ID D03CPB D03CPB DRUGTYPE Small molecular drug D03CPB DRUGINCH 1S/C16H14N4O2S/c21-13-3-1-2-11(8-13)9-18-15(22)20-16-19-14(10-23-16)12-4-6-17-7-5-12/h1-8,10,21H,9H2,(H2,18,19,20,22) D03CPB DRUGINKE GDVRVPIXWXOKQO-UHFFFAOYSA-N D03CPB DRUGSMIL C1=CC(=CC(=C1)O)CNC(=O)NC2=NC(=CS2)C3=CC=NC=C3 D03CPB HIGHSTAT Investigative D03CSL DRUG__ID D03CSL D03CSL DRUGTYPE Small molecular drug D03CSL DRUGINCH 1S/C19H35NO4/c1-2-3-13-16-20-19(23)24-17-14-11-9-7-5-4-6-8-10-12-15-18(21)22/h5,7H,2-4,6,8-17H2,1H3,(H,20,23)(H,21,22)/b7-5- D03CSL DRUGINKE MSASWGXYEFVTGT-ALCCZGGFSA-N D03CSL DRUGSMIL CCCCCNC(=O)OCCCCC=CCCCCCCC(=O)O D03CSL HIGHSTAT Investigative D03CUH DRUG__ID D03CUH D03CUH DRUGTYPE Small molecular drug D03CUH DRUGINCH 1S/C37H54O13/c1-5-6-7-8-9-10-11-12-13-17-22-47-30-29(39)35(49-31(32(40)41)36(46,33(42)43)37(30,50-35)34(44)45)21-20-24(2)28(48-26(4)38)25(3)23-27-18-15-14-16-19-27/h14-16,18-19,25,28-31,39,46H,2,5-13,17,20-23H2,1,3-4H3,(H,40,41)(H,42,43)(H,44,45)/t25-,28-,29-,30-,31?,35?,36?,37?/m1/s1 D03CUH DRUGINKE VGNCBRNRHXEODV-XXVHXNRLSA-N D03CUH DRUGSMIL CCCCCCCCCCCCOC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCC(=C)C(C(C)CC3=CC=CC=C3)OC(=O)C)O D03CUH HIGHSTAT Investigative D03CVQ DRUG__ID D03CVQ D03CVQ DRUGTYPE Small molecular drug D03CVQ DRUGINCH 1S/C22H24N2O2/c1-3-25-21-14-18-19(13-9-8-12-17-10-6-5-7-11-17)23-16-24-20(18)15-22(21)26-4-2/h5-7,9-11,13-16H,3-4,8,12H2,1-2H3/b13-9+ D03CVQ DRUGINKE TYVCCOFEERYUGD-UKTHLTGXSA-N D03CVQ DRUGSMIL CCOC1=C(C=C2C(=C1)C(=NC=N2)C=CCCC3=CC=CC=C3)OCC D03CVQ HIGHSTAT Investigative D03CVY DRUG__ID D03CVY D03CVY DRUGTYPE Small molecular drug D03CVY DRUGINCH 1S/C17H11NOS2/c1-3-16(20-7-1)14-9-13(12-5-6-19-11-12)10-15(18-14)17-4-2-8-21-17/h1-11H D03CVY DRUGINKE HCNMYINNCZEXQR-UHFFFAOYSA-N D03CVY DRUGSMIL C1=CSC(=C1)C2=CC(=CC(=N2)C3=CC=CS3)C4=COC=C4 D03CVY HIGHSTAT Investigative D03CWL DRUG__ID D03CWL D03CWL DRUGTYPE Small molecular drug D03CWL DRUGINCH 1S/C14H16N2O2/c1-18-14(17)8-7-13-9-15-11-16(13)10-12-5-3-2-4-6-12/h2-6,9,11H,7-8,10H2,1H3 D03CWL DRUGINKE FEWHBUJYQHXFMV-UHFFFAOYSA-N D03CWL DRUGSMIL COC(=O)CCC1=CN=CN1CC2=CC=CC=C2 D03CWL HIGHSTAT Investigative D03CYV DRUG__ID D03CYV D03CYV DRUGTYPE Small molecular drug D03CYV DRUGINCH 1S/C24H36N4O8/c1-6-12(3)17-21(33)28-20(23(35)26-11-16(30)31)24(4,7-2)36-15-10-13(8-9-14(15)29)19(32)18(25-5)22(34)27-17/h8-10,12,17-20,25,29,32H,6-7,11H2,1-5H3,(H,26,35)(H,27,34)(H,28,33)(H,30,31)/t12-,17+,18+,19-,20-,24-/m1/s1 D03CYV DRUGINKE HXTMSBIVCTYGAS-NBNOUWLYSA-N D03CYV DRUGSMIL CCC(C)C1C(=O)NC(C(OC2=C(C=CC(=C2)C(C(C(=O)N1)NC)O)O)(C)CC)C(=O)NCC(=O)O D03CYV HIGHSTAT Investigative D03CYY DRUG__ID D03CYY D03CYY DRUGTYPE Small molecular drug D03CYY DRUGINCH 1S/C24H32N6O9/c25-11-18(31)28-16(9-14-5-2-1-3-6-14)24(39)30-8-4-7-17(30)23(38)29-15(10-20(33)34)22(37)27-12-19(32)26-13-21(35)36/h1-3,5-6,15-17H,4,7-13,25H2,(H,26,32)(H,27,37)(H,28,31)(H,29,38)(H,33,34)(H,35,36)/t15-,16-,17-/m0/s1 D03CYY DRUGINKE NLYXJKKWVSCTSP-ULQDDVLXSA-N D03CYY DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)NC(=O)CN)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NCC(=O)O D03CYY HIGHSTAT Investigative D03DAM DRUG__ID D03DAM D03DAM DRUGTYPE Small molecular drug D03DAM DRUGINCH 1S/C11H16N2O3S/c1-11(2,3)10(14)13-8-4-6-9(7-5-8)17(12,15)16/h4-7H,1-3H3,(H,13,14)(H2,12,15,16) D03DAM DRUGINKE KGBTVIQRHXYTRQ-UHFFFAOYSA-N D03DAM DRUGSMIL CC(C)(C)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N D03DAM HIGHSTAT Investigative D03DBW DRUG__ID D03DBW D03DBW DRUGCOMP Duquesne University D03DBW DRUGINCH 1S/C36H55N5O5S/c1-8-24(4)32(39-34(43)30-16-12-13-19-40(30)6)35(44)41(7)29(23(2)3)17-18-31-38-28(22-47-31)33(42)37-27(20-25(5)36(45)46)21-26-14-10-9-11-15-26/h9-11,14-15,22-25,27,29-30,32H,8,12-13,16-21H2,1-7H3,(H,37,42)(H,39,43)(H,45,46)/t24-,25-,27+,29+,30+,32-/m0/s1 D03DBW DRUGINKE IUQKJKPHUBJDJV-UMNBWOBWSA-N D03DBW DRUGSMIL CCC(C)C(C(=O)N(C)C(CCC1=NC(=CS1)C(=O)NC(CC2=CC=CC=C2)CC(C)C(=O)O)C(C)C)NC(=O)C3CCCCN3C D03DBW HIGHSTAT Investigative D03DCE DRUG__ID D03DCE D03DCE DRUGTYPE Small molecular drug D03DCE DRUGINCH 1S/C17H20NO5P/c19-17(13-24(20,21)22)18-11-5-7-14-6-4-10-16(12-14)23-15-8-2-1-3-9-15/h1-4,6,8-10,12H,5,7,11,13H2,(H,18,19)(H2,20,21,22) D03DCE DRUGINKE GNETVUVZFYJATO-UHFFFAOYSA-N D03DCE DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CCCNC(=O)CP(=O)(O)O D03DCE HIGHSTAT Investigative D03DDL DRUG__ID D03DDL D03DDL DRUGTYPE Small molecular drug D03DDL DRUGINCH 1S/C22H24ClNO/c1-3-4-7-13-24-16(2)22(19-11-5-6-12-20(19)24)21(25)15-17-9-8-10-18(23)14-17/h5-6,8-12,14H,3-4,7,13,15H2,1-2H3 D03DDL DRUGINKE IVDPZBGEPKPWGK-UHFFFAOYSA-N D03DDL DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)Cl)C D03DDL HIGHSTAT Investigative D03DEJ DRUG__ID D03DEJ D03DEJ DRUGTYPE Small molecular drug D03DEJ DRUGINCH 1S/C29H24N2O3/c1-29(2)14-13-23(21-15-19-5-3-4-6-26(19)30-17-21)24-16-20(9-12-25(24)29)27(32)31-22-10-7-18(8-11-22)28(33)34/h3-13,15-17H,14H2,1-2H3,(H,31,32)(H,33,34) D03DEJ DRUGINKE WGLMBRZXZDAQHP-UHFFFAOYSA-N D03DEJ DRUGSMIL CC1(CC=C(C2=C1C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)C4=CC5=CC=CC=C5N=C4)C D03DEJ HIGHSTAT Investigative D03DEO DRUG__ID D03DEO D03DEO DRUGTYPE Small molecular drug D03DEO DRUGINCH 1S/C22H30O4/c1-19(2)13-8-11-21(4)14(20(13,3)10-9-15(19)23)7-6-12-16(24)17(25)18(26)22(12,21)5/h6-7,13-15,23-24H,8-11H2,1-5H3/t13-,14+,15-,20-,21+,22-/m0/s1 D03DEO DRUGINKE KIAKLFLISZCITK-PPAUHQMUSA-N D03DEO DRUGSMIL CC1(C2CCC3(C(C2(CCC1O)C)C=CC4=C(C(=O)C(=O)C43C)O)C)C D03DEO HIGHSTAT Investigative D03DET DRUG__ID D03DET D03DET DRUGTYPE Small molecular drug D03DET DRUGINCH 1S/C26H28N4O/c1-20-10-11-23-24(28-20)8-3-9-25(23)31-18-17-29-13-15-30(16-14-29)19-22-6-2-5-21-7-4-12-27-26(21)22/h2-12H,13-19H2,1H3 D03DET DRUGINKE RMCSKUADBRROSI-UHFFFAOYSA-N D03DET DRUGSMIL CC1=NC2=C(C=C1)C(=CC=C2)OCCN3CCN(CC3)CC4=CC=CC5=C4N=CC=C5 D03DET HIGHSTAT Investigative D03DEX DRUG__ID D03DEX D03DEX DRUGTYPE Small molecular drug D03DEX DRUGINCH 1S/C17H21N5O10P2/c23-13-11(7-30-34(28,29)32-33(25,26)27)31-17(14(13)24)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23-24H,6-7H2,(H,28,29)(H,18,19,20)(H2,25,26,27)/t11-,13-,14-,17-/m1/s1 D03DEX DRUGINKE MRHGMAGSDAQUFH-LSCFUAHRSA-N D03DEX DRUGSMIL C1=CC=C(C=C1)CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)COP(=O)(O)OP(=O)(O)O)O)O D03DEX HIGHSTAT Investigative D03DFG DRUG__ID D03DFG D03DFG DRUGTYPE Small molecular drug D03DFG DRUGINCH 1S/C20H34N2OS/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(23)20-22-21-18-24-20/h9-10,18H,2-8,11-17H2,1H3/b10-9- D03DFG DRUGINKE OGPJTMSGDUTXCW-KTKRTIGZSA-N D03DFG DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NN=CS1 D03DFG HIGHSTAT Investigative D03DGP DRUG__ID D03DGP D03DGP DRUGTYPE Small molecular drug D03DGP DRUGINCH 1S/C21H19NO4/c1-14(23)16-4-2-3-5-17(16)15-6-7-20-18(12-15)19(24)13-21(26-20)22-8-10-25-11-9-22/h2-7,12-13H,8-11H2,1H3 D03DGP DRUGINKE IMYDVWVTZRVBCX-UHFFFAOYSA-N D03DGP DRUGSMIL CC(=O)C1=CC=CC=C1C2=CC3=C(C=C2)OC(=CC3=O)N4CCOCC4 D03DGP HIGHSTAT Investigative D03DIP DRUG__ID D03DIP D03DIP DRUGTYPE Small molecular drug D03DIP DRUGINCH 1S/C25H27N5O2/c1-3-29(4-2)13-12-22(31)26-16-9-10-21-19(15-16)25(32)30-14-11-18-17-7-5-6-8-20(17)27-23(18)24(30)28-21/h5-10,15,27H,3-4,11-14H2,1-2H3,(H,26,31) D03DIP DRUGINKE XTKDYIOBJOQMHV-UHFFFAOYSA-N D03DIP DRUGSMIL CCN(CC)CCC(=O)NC1=CC2=C(C=C1)N=C3C4=C(CCN3C2=O)C5=CC=CC=C5N4 D03DIP HIGHSTAT Investigative D03DIV DRUG__ID D03DIV D03DIV DRUGTYPE Small molecular drug D03DIV DRUGINCH 1S/C16H15F3O/c17-16(18,19)15(20)8-4-1-5-12-9-10-13-6-2-3-7-14(13)11-12/h2-3,6-7,9-11H,1,4-5,8H2 D03DIV DRUGINKE VCWWTQMRNJSJGC-UHFFFAOYSA-N D03DIV DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CCCCC(=O)C(F)(F)F D03DIV HIGHSTAT Investigative D03DJC DRUG__ID D03DJC D03DJC DRUGTYPE Small molecular drug D03DJC DRUGINCH 1S/C15H16N2O3/c16-13-4-2-1-3-12(13)14-9-11(18)10-15(20-14)17-5-7-19-8-6-17/h1-4,9-10H,5-8,16H2 D03DJC DRUGINKE SGCZGVONFZVNLU-UHFFFAOYSA-N D03DJC DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC=C3N D03DJC HIGHSTAT Investigative D03DJR DRUG__ID D03DJR D03DJR DRUGTYPE Small molecular drug D03DJR DRUGINCH 1S/C21H18N2O3/c1-2-5-20(24)26-15-8-9-17-14(10-15)12-19(23-17)21(25)18-11-13-6-3-4-7-16(13)22-18/h3-4,6-12,22-23H,2,5H2,1H3 D03DJR DRUGINKE CZDUJGOCEPWCNA-UHFFFAOYSA-N D03DJR DRUGSMIL CCCC(=O)OC1=CC2=C(C=C1)NC(=C2)C(=O)C3=CC4=CC=CC=C4N3 D03DJR HIGHSTAT Investigative D03DKN DRUG__ID D03DKN D03DKN DRUGTYPE Small molecular drug D03DKN DRUGINCH 1S/C20H29N10O22P5/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(47-19)1-45-57(44,52-56(42,43)51-55(40,41)50-54(38,39)49-53(35,36)37)46-2-8-12(32)14(34)20(48-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,38,39)(H,40,41)(H,42,43)(H2,21,23,25)(H2,22,24,26)(H2,35,36,37)/p-5/t7-,8-,11?,12?,13?,14?,19-,20-,57?/m1/s1 D03DKN DRUGINKE DZDFIEYYTZFGFQ-ICIWVTHHSA-I D03DKN DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)N D03DKN HIGHSTAT Investigative D03DKZ DRUG__ID D03DKZ D03DKZ DRUGTYPE Small molecular drug D03DKZ DRUGINCH 1S/C17H12F3NO4/c1-24-11-4-2-10(3-5-11)9-21-14-7-6-12(25-17(18,19)20)8-13(14)15(22)16(21)23/h2-8H,9H2,1H3 D03DKZ DRUGINKE CKLGZXFOLMHCMC-UHFFFAOYSA-N D03DKZ DRUGSMIL COC1=CC=C(C=C1)CN2C3=C(C=C(C=C3)OC(F)(F)F)C(=O)C2=O D03DKZ HIGHSTAT Investigative D03DLD DRUG__ID D03DLD D03DLD DRUGTYPE Small molecular drug D03DLD DRUGINCH 1S/C30H35N5O5/c1-19(33-29(39)24(31)16-22-12-14-23(36)15-13-22)28(38)35-26(18-21-10-6-3-7-11-21)30(40)34-25(27(32)37)17-20-8-4-2-5-9-20/h2-15,19,24-26,36H,16-18,31H2,1H3,(H2,32,37)(H,33,39)(H,34,40)(H,35,38)/t19-,24-,25-,26-/m0/s1 D03DLD DRUGINKE MVUYXNQARFGHMJ-UBLBMGLWSA-N D03DLD DRUGSMIL CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CC3=CC=C(C=C3)O)N D03DLD HIGHSTAT Investigative D03DLZ DRUG__ID D03DLZ D03DLZ DRUGTYPE Small molecular drug D03DLZ DRUGINCH 1S/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H3 D03DLZ DRUGINKE DMULVCHRPCFFGV-UHFFFAOYSA-N D03DLZ DRUGSMIL CN(C)CCC1=CNC2=CC=CC=C21 D03DLZ HIGHSTAT Investigative D03DMA DRUG__ID D03DMA D03DMA DRUGTYPE Small molecular drug D03DMA DRUGINCH 1S/C19H22O3/c1-14(2)5-4-6-15(3)11-12-21-17-9-7-16-8-10-19(20)22-18(16)13-17/h4-5,7-11,13-14H,6,12H2,1-3H3/b5-4+,15-11+ D03DMA DRUGINKE KAYCKFWCZGZEHA-WEPZFIBGSA-N D03DMA DRUGSMIL CC(C)C=CCC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C D03DMA HIGHSTAT Investigative D03DMN DRUG__ID D03DMN D03DMN DRUGTYPE Small molecular drug D03DMN DRUGINCH 1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16-,19+/m0/s1 D03DMN DRUGINKE GRTOGORTSDXSFK-BMYCAMMWSA-N D03DMN DRUGSMIL CC1C2CN3CCC4=C(C3CC2C(=CO1)C(=O)OC)NC5=CC=CC=C45 D03DMN HIGHSTAT Investigative D03DMR DRUG__ID D03DMR D03DMR DRUGTYPE Small molecular drug D03DMR DRUGINCH 1S/C29H54NO2/c1-20(8-7-9-23(32)19-30(4,5)6)25-12-13-26-24-11-10-21-18-22(31)14-16-28(21,2)27(24)15-17-29(25,26)3/h20-27,31-32H,7-19H2,1-6H3/q+1 D03DMR DRUGINKE KWEWGNPMETZMTR-UHFFFAOYSA-N D03DMR DRUGSMIL CC(CCCC(C[N+](C)(C)C)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C D03DMR HIGHSTAT Investigative D03DND DRUG__ID D03DND D03DND DRUGTYPE Small molecular drug D03DND DRUGINCH 1S/C15H14Cl2O2/c1-2-3-10-4-6-15(13(18)8-10)19-14-7-5-11(16)9-12(14)17/h4-9,18H,2-3H2,1H3 D03DND DRUGINKE ILBQDZVPNAVUMD-UHFFFAOYSA-N D03DND DRUGSMIL CCCC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D03DND HIGHSTAT Investigative D03DNV DRUG__ID D03DNV D03DNV DRUGTYPE Small molecular drug D03DNV DRUGINCH 1S/C13H18BN3O4/c1-9(16-12(18)10-4-6-15-7-5-10)13(19)17-8-2-3-11(17)14(20)21/h4-7,9,11,20-21H,2-3,8H2,1H3,(H,16,18)/t9-,11+/m1/s1 D03DNV DRUGINKE DRBWRJPFNOBNIO-KOLCDFICSA-N D03DNV DRUGSMIL B(C1CCCN1C(=O)C(C)NC(=O)C2=CC=NC=C2)(O)O D03DNV HIGHSTAT Investigative D03DQQ DRUG__ID D03DQQ D03DQQ DRUGTYPE Small molecular drug D03DQQ DRUGINCH 1S/C17H17F2NO/c18-13-3-1-4-14(11-13)21-16-6-2-5-15(19)17(16)12-7-9-20-10-8-12/h1-6,11-12,20H,7-10H2 D03DQQ DRUGINKE IMXJQWVQVSZOKO-UHFFFAOYSA-N D03DQQ DRUGSMIL C1CNCCC1C2=C(C=CC=C2F)OC3=CC(=CC=C3)F D03DQQ HIGHSTAT Investigative D03DRF DRUG__ID D03DRF D03DRF DRUGTYPE Small molecular drug D03DRF DRUGINCH 1S/C18H15N3O3S/c1-2-10-25-18-19-16-9-8-14(21(23)24)11-15(16)17(22)20(18)12-13-6-4-3-5-7-13/h2-9,11H,1,10,12H2 D03DRF DRUGINKE BDDASWRESYMCMC-UHFFFAOYSA-N D03DRF DRUGSMIL C=CCSC1=NC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)N1CC3=CC=CC=C3 D03DRF HIGHSTAT Investigative D03DRM DRUG__ID D03DRM D03DRM DRUGTYPE Small molecular drug D03DRM DRUGINCH 1S/C11H5F2NO4S/c12-11(13)17-6-2-1-5(3-7(6)18-11)4-8-9(15)14-10(16)19-8/h1-4H,(H,14,15,16)/b8-4- D03DRM DRUGINKE SRLVNYDXMUGOFI-YWEYNIOJSA-N D03DRM DRUGSMIL C1=CC2=C(C=C1C=C3C(=O)NC(=O)S3)OC(O2)(F)F D03DRM HIGHSTAT Investigative D03DTZ DRUG__ID D03DTZ D03DTZ DRUGTYPE Small molecular drug D03DTZ DRUGINCH 1S/C21H28N2O3.2ClH/c24-14-16-25-15-13-22-9-11-23(12-10-22)18-19-5-4-8-21(17-19)26-20-6-2-1-3-7-20;;/h1-8,17,24H,9-16,18H2;2*1H D03DTZ DRUGINKE MPACCEKWFGWZHS-UHFFFAOYSA-N D03DTZ DRUGSMIL C1CN(CCN1CCOCCO)CC2=CC(=CC=C2)OC3=CC=CC=C3.Cl.Cl D03DTZ HIGHSTAT Investigative D03DUN DRUG__ID D03DUN D03DUN DRUGTYPE Small molecular drug D03DUN DRUGINCH 1S/C7H13NO7/c8-6(13)7(14)5(12)4(11)3(10)2(1-9)15-7/h2-5,9-12,14H,1H2,(H2,8,13)/t2-,3-,4+,5-,7-/m1/s1 D03DUN DRUGINKE DTZYCNDAJQDPQC-UHKLXPPTSA-N D03DUN DRUGSMIL C(C1C(C(C(C(O1)(C(=O)N)O)O)O)O)O D03DUN HIGHSTAT Investigative D03DUX DRUG__ID D03DUX D03DUX DRUGTYPE Small molecular drug D03DUX DRUGINCH 1S/C16H13NO4S/c1-11-5-4-7-14-12(11)9-10-17(14)22(20,21)15-8-3-2-6-13(15)16(18)19/h2-10H,1H3,(H,18,19) D03DUX DRUGINKE FSVUAMOXCTUQEP-UHFFFAOYSA-N D03DUX DRUGSMIL CC1=C2C=CN(C2=CC=C1)S(=O)(=O)C3=CC=CC=C3C(=O)O D03DUX HIGHSTAT Investigative D03DVF DRUG__ID D03DVF D03DVF DRUGTYPE Small molecular drug D03DVF DRUGINCH 1S/C7H9NO2/c8-6-3-1-2-5(4-6)7(9)10/h1-3,6H,4,8H2,(H,9,10) D03DVF DRUGINKE KFNRJXCQEJIBER-UHFFFAOYSA-N D03DVF DRUGSMIL C1C(C=CC=C1C(=O)O)N D03DVF HIGHSTAT Investigative D03DVM DRUG__ID D03DVM D03DVM DRUGTYPE Small molecular drug D03DVM DRUGINCH 1S/C23H18O2/c24-19-7-3-6-15(10-19)21-11-16-8-9-20(25)12-22(16)23(21)13-17-4-1-2-5-18(17)14-23/h1-12,24-25H,13-14H2 D03DVM DRUGINKE GWRXSPPQGAVBCP-UHFFFAOYSA-N D03DVM DRUGSMIL C1C2=CC=CC=C2CC13C(=CC4=C3C=C(C=C4)O)C5=CC(=CC=C5)O D03DVM HIGHSTAT Investigative D03DWG DRUG__ID D03DWG D03DWG DRUGTYPE Small molecular drug D03DWG DRUGINCH 1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 D03DWG DRUGINKE ACFIXJIJDZMPPO-NNYOXOHSSA-N D03DWG DRUGSMIL C1C=CN(C=C1C(=O)N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O D03DWG HIGHSTAT Investigative D03DXV DRUG__ID D03DXV D03DXV DRUGTYPE Small molecular drug D03DXV DRUGINCH 1S/C13H15N3O2S/c1-2-3-8-14-13(17)18-11-6-4-10(5-7-11)12-9-19-16-15-12/h4-7,9H,2-3,8H2,1H3,(H,14,17) D03DXV DRUGINKE XVFSPFDRDOHQIV-UHFFFAOYSA-N D03DXV DRUGSMIL CCCCNC(=O)OC1=CC=C(C=C1)C2=CSN=N2 D03DXV HIGHSTAT Investigative D03DYT DRUG__ID D03DYT D03DYT DRUGTYPE Small molecular drug D03DYT DRUGINCH 1S/C27H21N3O5/c1-26-27(33,25(32)34-2)11-18(35-26)29-16-9-5-3-7-13(16)20-21-15(12-28-24(21)31)19-14-8-4-6-10-17(14)30(26)23(19)22(20)29/h3-10,18,33H,11-12H2,1-2H3,(H,28,31)/t18-,26+,27+/m1/s1 D03DYT DRUGINKE KOZFSFOOLUUIGY-SOLYNIJKSA-N D03DYT DRUGSMIL CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(C(=O)OC)O D03DYT HIGHSTAT Investigative D03DZO DRUG__ID D03DZO D03DZO DRUGTYPE Small molecular drug D03DZO DRUGINCH 1S/C12H11N3O/c16-12-9-7-11(8-1-4-13-5-2-8)15-10(9)3-6-14-12/h1-2,4-5,7,15H,3,6H2,(H,14,16) D03DZO DRUGINKE DKXHSOUZPMHNIZ-UHFFFAOYSA-N D03DZO DRUGSMIL C1CNC(=O)C2=C1NC(=C2)C3=CC=NC=C3 D03DZO HIGHSTAT Investigative D03DZP DRUG__ID D03DZP D03DZP DRUGTYPE Small molecular drug D03DZP DRUGINCH 1S/C14H13BrFN3S/c15-11-3-6-13(18-9-11)19-14(20)17-8-7-10-1-4-12(16)5-2-10/h1-6,9H,7-8H2,(H2,17,18,19,20) D03DZP DRUGINKE SDMLMNPOMWSLBF-UHFFFAOYSA-N D03DZP DRUGSMIL C1=CC(=CC=C1CCNC(=S)NC2=NC=C(C=C2)Br)F D03DZP HIGHSTAT Investigative D03EAN DRUG__ID D03EAN D03EAN DRUGTYPE Small molecular drug D03EAN DRUGINCH 1S/C23H30FNO4/c1-14(2)23-20(10-9-18(26)11-19(27)12-22(28)29)21(13-25(23)15(3)4)16-5-7-17(24)8-6-16/h5-10,13-15,18-19,26-27H,11-12H2,1-4H3,(H,28,29)/p-1/b10-9+/t18-,19-/m1/s1 D03EAN DRUGINKE JNPGUXGVLNJQSQ-BGGMYYEUSA-M D03EAN DRUGSMIL CC(C)C1=C(C(=CN1C(C)C)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)[O-])O)O D03EAN HIGHSTAT Investigative D03EBE DRUG__ID D03EBE D03EBE DRUGTYPE Small molecular drug D03EBE DRUGINCH 1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4-,6-/m1/s1 D03EBE DRUGINKE FNKQXYHWGSIFBK-ZMIZWQJLSA-N D03EBE DRUGSMIL CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O D03EBE HIGHSTAT Investigative D03EBZ DRUG__ID D03EBZ D03EBZ DRUGTYPE Small molecular drug D03EBZ DRUGINCH 1S/C19H22ClN3O5S2/c1-21-19(29)23-30(25,26)17-10-12(4-6-16(17)28-3)8-9-22-18(24)14-11-13(20)5-7-15(14)27-2/h4-7,10-11H,8-9H2,1-3H3,(H,22,24)(H2,21,23,29) D03EBZ DRUGINKE VXTKXGKPBOLHRY-UHFFFAOYSA-N D03EBZ DRUGSMIL CNC(=S)NS(=O)(=O)C1=C(C=CC(=C1)CCNC(=O)C2=C(C=CC(=C2)Cl)OC)OC D03EBZ HIGHSTAT Investigative D03ECU DRUG__ID D03ECU D03ECU DRUGTYPE Small molecular drug D03ECU DRUGINCH 1S/C15H21IN4S/c16-13-5-3-12(4-6-13)7-8-19-15(17)21-9-1-2-14-10-18-11-20-14/h3-6,10-11,15,19H,1-2,7-9,17H2,(H,18,20)/t15-/m0/s1 D03ECU DRUGINKE UWFACTDPNOOPFV-HNNXBMFYSA-N D03ECU DRUGSMIL C1=CC(=CC=C1CCNC(N)SCCCC2=CN=CN2)I D03ECU HIGHSTAT Investigative D03EDD DRUG__ID D03EDD D03EDD DRUGCOMP University of Maryland D03EDD DRUGINCH 1S/C21H27N3O/c1-20-9-7-15(25)11-14(20)3-4-16-17-5-6-19(24-13-22-12-23-24)21(17,2)10-8-18(16)20/h6,11-13,16-18H,3-5,7-10H2,1-2H3/t16-,17-,18-,20-,21-/m0/s1 D03EDD DRUGINKE OPPZNEHAUJDDQH-OEUJLIAZSA-N D03EDD DRUGSMIL CC12CCC(=O)C=C1CCC3C2CCC4(C3CC=C4N5C=NC=N5)C D03EDD HIGHSTAT Investigative D03EDF DRUG__ID D03EDF D03EDF DRUGTYPE Small molecular drug D03EDF DRUGINCH 1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+ D03EDF DRUGINKE HJTVQHVGMGKONQ-LUZURFALSA-N D03EDF DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O D03EDF HIGHSTAT Investigative D03EDR DRUG__ID D03EDR D03EDR DRUGTYPE Small molecular drug D03EDR DRUGINCH 1S/C9H16N2O7/c1-3(13)10-9(17)11-8-7(16)6(15)5(14)4(2-12)18-8/h4-8,12,14-16H,2H2,1H3,(H2,10,11,13,17)/t4-,5-,6+,7-,8-/m1/s1 D03EDR DRUGINKE UQKBNLXZEGBQAF-JAJWTYFOSA-N D03EDR DRUGSMIL CC(=O)NC(=O)NC1C(C(C(C(O1)CO)O)O)O D03EDR HIGHSTAT Investigative D03EDW DRUG__ID D03EDW D03EDW DRUGTYPE Small molecular drug D03EDW DRUGINCH 1S/C22H32N4O/c1-2-10-25(21-8-9-22-19(17-21)18-23-27-22)14-11-24-12-15-26(16-13-24)20-6-4-3-5-7-20/h3-7,18,21H,2,8-17H2,1H3 D03EDW DRUGINKE SYVXHALPVYBOLF-UHFFFAOYSA-N D03EDW DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)C=NO4 D03EDW HIGHSTAT Investigative D03EEO DRUG__ID D03EEO D03EEO DRUGTYPE Small molecular drug D03EEO DRUGINCH 1S/C8H10NO5P/c1-5-8(10)7-4-14-15(11,12)13-3-6(7)2-9-5/h2,10H,3-4H2,1H3,(H,11,12) D03EEO DRUGINKE KCAJHODRYGNBSX-UHFFFAOYSA-N D03EEO DRUGSMIL CC1=NC=C2COP(=O)(OCC2=C1O)O D03EEO HIGHSTAT Investigative D03EGA DRUG__ID D03EGA D03EGA DRUGTYPE Small molecular drug D03EGA DRUGINCH 1S/C25H23N7OS.ClH/c33-24(22-13-27-20-7-3-4-8-21(20)28-22)29-19-6-2-1-5-18(19)23-15-32-17(16-34-25(32)30-23)14-31-11-9-26-10-12-31;/h1-8,13,15-16,26H,9-12,14H2,(H,29,33);1H D03EGA DRUGINKE DTGRRMPPXCRRIM-UHFFFAOYSA-N D03EGA DRUGSMIL C1CN(CCN1)CC2=CSC3=NC(=CN23)C4=CC=CC=C4NC(=O)C5=NC6=CC=CC=C6N=C5.Cl D03EGA HIGHSTAT Investigative D03EGZ DRUG__ID D03EGZ D03EGZ DRUGTYPE Small molecular drug D03EGZ DRUGINCH 1S/C23H16O5/c24-10-5-6-12-14(7-10)23-20-13(11-3-1-2-4-18(11)28-23)8-15(25)21-17(27)9-16(26)19(12)22(20)21/h1-7,9,13,20,23-24,26-27H,8H2/t13-,20+,23+/m1/s1 D03EGZ DRUGINKE DBGJQYIYUBGFLT-GQIHDASDSA-N D03EGZ DRUGSMIL C1C2C3C(C4=C(C=CC(=C4)O)C5=C3C(=C(C=C5O)O)C1=O)OC6=CC=CC=C26 D03EGZ HIGHSTAT Investigative D03EHB DRUG__ID D03EHB D03EHB DRUGTYPE Small molecular drug D03EHB DRUGINCH 1S/C8H4BrN3/c9-8-6-3-1-2-5(4-10)7(6)11-12-8/h1-3H,(H,11,12) D03EHB DRUGINKE MRGZUAUMTMLMTE-UHFFFAOYSA-N D03EHB DRUGSMIL C1=CC2=C(NN=C2C(=C1)C#N)Br D03EHB HIGHSTAT Investigative D03EHM DRUG__ID D03EHM D03EHM DRUGTYPE Small molecular drug D03EHM DRUGINCH 1S/C17H17N7/c18-15-13-14(11-7-10-5-6-19-16(10)20-8-11)23-24(12-3-1-2-4-12)17(13)22-9-21-15/h5-9,12H,1-4H2,(H,19,20)(H2,18,21,22) D03EHM DRUGINKE NVRXTLZYXZNATH-UHFFFAOYSA-N D03EHM DRUGSMIL C1CCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CN=C5C(=C4)C=CN5)N D03EHM HIGHSTAT Investigative D03EIM DRUG__ID D03EIM D03EIM DRUGTYPE Small molecular drug D03EIM DRUGINCH 1S/C28H43NO6/c1-17-12-18(2)14-20(4)27(32)21(16-29)8-5-6-11-25(22-9-7-10-23(22)28(33)34)35-26(31)15-24(30)19(3)13-17/h5-6,8,17-20,22-25,27,30,32H,7,9-15H2,1-4H3,(H,33,34)/b6-5+,21-8-/t17-,18+,19-,20-,22+,23+,24-,25-,27+/m0/s1 D03EIM DRUGINKE OJCKRNPLOZHAOU-UGKRXNSESA-N D03EIM DRUGSMIL CC1CC(CC(C(C(=CC=CCC(OC(=O)CC(C(C1)C)O)C2CCCC2C(=O)O)C#N)O)C)C D03EIM HIGHSTAT Investigative D03EJP DRUG__ID D03EJP D03EJP DRUGTYPE Small molecular drug D03EJP DRUGINCH 1S/C26H24FN3O3/c27-22-13-11-19(12-14-22)17-28-24(31)29-15-16-30-23(18-29)26(33-25(30)32,20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-14,23H,15-18H2,(H,28,31) D03EJP DRUGINKE SFRQIPRTNYHJHP-UHFFFAOYSA-N D03EJP DRUGSMIL C1CN2C(CN1C(=O)NCC3=CC=C(C=C3)F)C(OC2=O)(C4=CC=CC=C4)C5=CC=CC=C5 D03EJP HIGHSTAT Investigative D03EMO DRUG__ID D03EMO D03EMO DRUGTYPE Small molecular drug D03EMO DRUGINCH 1S/C17H26ClN/c1-2-3-4-7-16(17-8-5-6-13-19-17)14-9-11-15(18)12-10-14/h9-12,16-17,19H,2-8,13H2,1H3 D03EMO DRUGINKE PAZWPXLTYQROKI-UHFFFAOYSA-N D03EMO DRUGSMIL CCCCCC(C1CCCCN1)C2=CC=C(C=C2)Cl D03EMO HIGHSTAT Investigative D03EOD DRUG__ID D03EOD D03EOD DRUGTYPE Small molecular drug D03EOD DRUGINCH 1S/C21H18O3/c1-14(15-2-8-18(22)9-3-15)21(16-4-10-19(23)11-5-16)17-6-12-20(24)13-7-17/h2-13,22-24H,1H3 D03EOD DRUGINKE FFGNPMKMQDXQJJ-UHFFFAOYSA-N D03EOD DRUGSMIL CC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O D03EOD HIGHSTAT Investigative D03EOK DRUG__ID D03EOK D03EOK DRUGTYPE Small molecular drug D03EOK DRUGINCH 1S/C19H16N2O2/c22-18(15-11-20-16-8-4-3-7-14(15)16)19(23)21-17-10-9-12-5-1-2-6-13(12)17/h1-8,11,17,20H,9-10H2,(H,21,23) D03EOK DRUGINKE HPOOEGNMALNZJV-UHFFFAOYSA-N D03EOK DRUGSMIL C1CC2=CC=CC=C2C1NC(=O)C(=O)C3=CNC4=CC=CC=C43 D03EOK HIGHSTAT Investigative D03EPA DRUG__ID D03EPA D03EPA DRUGTYPE Small molecular drug D03EPA DRUGINCH 1S/C50H59N9O10/c1-2-3-17-38(48(67)59-42(27-44(62)63)50(69)57-39(45(52)64)24-30-12-6-4-7-13-30)56-49(68)41(26-33-28-53-37-18-11-10-16-35(33)37)55-43(61)29-54-47(66)40(25-31-14-8-5-9-15-31)58-46(65)36(51)23-32-19-21-34(60)22-20-32/h4-16,18-22,28,36,38-42,53,60H,2-3,17,23-27,29,51H2,1H3,(H2,52,64)(H,54,66)(H,55,61)(H,56,68)(H,57,69)(H,58,65)(H,59,67)(H,62,63)/t36-,38-,39-,40+,41-,42-/m0/s1 D03EPA DRUGINKE DWHRPZRXNRDAQF-GEQJWKGNSA-N D03EPA DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N D03EPA HIGHSTAT Investigative D03EPB DRUG__ID D03EPB D03EPB DRUGTYPE Small molecular drug D03EPB DRUGINCH 1S/C50H72N6O4/c1-35-29-37-31-43-41(17-19-45(57)51-43)49(33-35)39(37)15-13-25-55(49)47(59)21-27-53(3)23-11-9-7-5-6-8-10-12-24-54(4)28-22-48(60)56-26-14-16-40-38-30-36(2)34-50(40,56)42-18-20-46(58)52-44(42)32-38/h17-20,29-30,37-40H,5-16,21-28,31-34H2,1-4H3,(H,51,57)(H,52,58)/t37?,38?,39-,40-,49-,50-/m1/s1 D03EPB DRUGINKE AATUHPZQANSFHE-NKUZXIPXSA-N D03EPB DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4C(=O)CCN(C)CCCCCCCCCCN(C)CCC(=O)N5CCCC6C57CC(=CC6CC8=C7C=CC(=O)N8)C D03EPB HIGHSTAT Investigative D03EPY DRUG__ID D03EPY D03EPY DRUGTYPE Small molecular drug D03EPY DRUGINCH 1S/C9H11N/c1-2-4-9-7-10-6-5-8(9)3-1/h1-4,10H,5-7H2 D03EPY DRUGINKE UWYZHKAOTLEWKK-UHFFFAOYSA-N D03EPY DRUGSMIL C1CNCC2=CC=CC=C21 D03EPY HIGHSTAT Investigative D03EQH DRUG__ID D03EQH D03EQH DRUGTYPE Small molecular drug D03EQH DRUGINCH 1S/C15H16N4O/c1-3-19-15-13(10(2)18-19)17-12(20)9-16-14(15)11-7-5-4-6-8-11/h4-8H,3,9H2,1-2H3,(H,17,20) D03EQH DRUGINKE YFHYNLHGFKXAIQ-UHFFFAOYSA-N D03EQH DRUGSMIL CCN1C2=C(C(=N1)C)NC(=O)CN=C2C3=CC=CC=C3 D03EQH HIGHSTAT Investigative D03EQN DRUG__ID D03EQN D03EQN DRUGTYPE Small molecular drug D03EQN DRUGINCH 1S/C9H15N3O10P2/c13-5-3-8(12-2-1-7(14)10-9(12)15)22-6(5)4-21-24(19,20)11-23(16,17)18/h1-2,5-6,8,13H,3-4H2,(H,10,14,15)(H4,11,16,17,18,19,20)/t5-,6+,8+/m0/s1 D03EQN DRUGINKE COFNIXBQVWFHTR-SHYZEUOFSA-N D03EQN DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(NP(=O)(O)O)O)O D03EQN HIGHSTAT Investigative D03ERS DRUG__ID D03ERS D03ERS DRUGTYPE Small molecular drug D03ERS DRUGINCH 1S/C13H18IN5O8P2/c1-15-10-9-11(18-12(14)17-10)19(5-16-9)7-2-8(27-29(23,24)25)13(3-6(7)13)4-26-28(20,21)22/h5-8H,2-4H2,1H3,(H,15,17,18)(H2,20,21,22)(H2,23,24,25)/t6-,7+,8+,13+/m1/s1 D03ERS DRUGINKE NMVWLEUONAKGCD-SMWKGLLFSA-N D03ERS DRUGSMIL CNC1=C2C(=NC(=N1)I)N(C=N2)C3CC(C4(C3C4)COP(=O)(O)O)OP(=O)(O)O D03ERS HIGHSTAT Investigative D03ESA DRUG__ID D03ESA D03ESA DRUGTYPE Small molecular drug D03ESA DRUGINCH 1S/C25H27IN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3 D03ESA DRUGINKE DHMLNZRDVQLQBB-UHFFFAOYSA-N D03ESA DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4=CC=C(C=C4)I D03ESA HIGHSTAT Investigative D03ESC DRUG__ID D03ESC D03ESC DRUGTYPE Small molecular drug D03ESC DRUGINCH 1S/C21H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-16-20(22)18-21(23)17-19/h2,4-5,7-8,16-18,22-23H,1,3,6,9-15H2/b5-4-,8-7- D03ESC DRUGINKE OOXBEOHCOCMKAC-UTOQUPLUSA-N D03ESC DRUGSMIL C=CCC=CCC=CCCCCCCCC1=CC(=CC(=C1)O)O D03ESC HIGHSTAT Investigative D03ETD DRUG__ID D03ETD D03ETD DRUGTYPE Small molecular drug D03ETD DRUGINCH 1S/C23H32O7/c1-8-9-14-12-22(29-6)13(2)18(23(30-7,20(14)24)21(22)25)15-10-16(26-3)19(28-5)17(11-15)27-4/h8,10-13,18,20-21,24-25H,1,9H2,2-7H3/t13-,18+,20-,21-,22+,23-/m0/s1 D03ETD DRUGINKE OHVTXDBRSOSKKO-BHIPVSGSSA-N D03ETD DRUGSMIL CC1C(C2(C(C(=CC1(C2O)OC)CC=C)O)OC)C3=CC(=C(C(=C3)OC)OC)OC D03ETD HIGHSTAT Investigative D03ETK DRUG__ID D03ETK D03ETK DRUGTYPE Small molecular drug D03ETK DRUGINCH 1S/C10H15NOS/c1-8(11-12)7-9-3-5-10(13-2)6-4-9/h3-6,8,11-12H,7H2,1-2H3 D03ETK DRUGINKE WSDWYDJPBFHVDU-UHFFFAOYSA-N D03ETK DRUGSMIL CC(CC1=CC=C(C=C1)SC)NO D03ETK HIGHSTAT Investigative D03ETT DRUG__ID D03ETT D03ETT DRUGTYPE Small molecular drug D03ETT DRUGINCH 1S/C36H55N9O9/c1-9-22(6)29(33(49)42-28(21(4)5)34(50)53-8)43-35(51)45-44-32(48)27(16-25-17-37-19-38-25)41-31(47)26(15-20(2)3)40-30(46)23(7)39-36(52)54-18-24-13-11-10-12-14-24/h10-14,17,19-23,26-29H,9,15-16,18H2,1-8H3,(H,37,38)(H,39,52)(H,40,46)(H,41,47)(H,42,49)(H,44,48)(H2,43,45,51) D03ETT DRUGINKE IVHANADPEKMLMO-UHFFFAOYSA-N D03ETT DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CN=CN1)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2 D03ETT HIGHSTAT Investigative D03ETX DRUG__ID D03ETX D03ETX DRUGTYPE Small molecular drug D03ETX DRUGINCH 1S/C17H16N2S2/c20-17(21-12-13-6-2-1-3-7-13)18-11-15-10-14-8-4-5-9-16(14)19-15/h1-10,19H,11-12H2,(H,18,20) D03ETX DRUGINKE PHBHIYCWGKONRK-UHFFFAOYSA-N D03ETX DRUGSMIL C1=CC=C(C=C1)CSC(=S)NCC2=CC3=CC=CC=C3N2 D03ETX HIGHSTAT Investigative D03EXD DRUG__ID D03EXD D03EXD DRUGTYPE Small molecular drug D03EXD DRUGINCH 1S/C18H15NO2/c20-17-7-5-14(6-8-17)13-1-3-15(4-2-13)18(21)16-9-11-19-12-10-16/h1-12,18,20-21H D03EXD DRUGINKE ABUNZHUAYBOXCN-UHFFFAOYSA-N D03EXD DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)O)C(C3=CC=NC=C3)O D03EXD HIGHSTAT Investigative D03EYA DRUG__ID D03EYA D03EYA DRUGTYPE Small molecular drug D03EYA DRUGINCH 1S/C10H16O/c1-7(2)9-5-4-8(3)10(11)6-9/h4,9-11H,1,5-6H2,2-3H3 D03EYA DRUGINKE BAVONGHXFVOKBV-UHFFFAOYSA-N D03EYA DRUGSMIL CC1=CCC(CC1O)C(=C)C D03EYA HIGHSTAT Investigative D03EYI DRUG__ID D03EYI D03EYI DRUGTYPE Small molecular drug D03EYI DRUGINCH 1S/C19H15NO2/c21-19(20-17-11-5-2-6-12-17)22-18-13-7-10-16(14-18)15-8-3-1-4-9-15/h1-14H,(H,20,21) D03EYI DRUGINKE DKEGWVCCNFYZEE-UHFFFAOYSA-N D03EYI DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)OC(=O)NC3=CC=CC=C3 D03EYI HIGHSTAT Investigative D03FAG DRUG__ID D03FAG D03FAG DRUGTYPE Small molecular drug D03FAG DRUGINCH 1S/C19H17N/c20-19(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H,20H2 D03FAG DRUGINKE BZVJOYBTLHNRDW-UHFFFAOYSA-N D03FAG DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)N D03FAG HIGHSTAT Investigative D03FAI DRUG__ID D03FAI D03FAI DRUGTYPE Small molecular drug D03FAI DRUGINCH 1S/C18H38N2O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-23(19,21)22/h9-10,20H,2-8,11-18H2,1H3,(H2,19,21,22)/b10-9- D03FAI DRUGINKE VIGWMDIVSRLQST-KTKRTIGZSA-N D03FAI DRUGSMIL CCCCCCCCC=CCCCCCCCCNS(=O)(=O)N D03FAI HIGHSTAT Investigative D03FAX DRUG__ID D03FAX D03FAX DRUGTYPE Small molecular drug D03FAX DRUGINCH 1S/C15H25N/c1-2-4-16-14(3-1)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-14,16H,1-10H2 D03FAX DRUGINKE CGRWFWOAXCFBRF-UHFFFAOYSA-N D03FAX DRUGSMIL C1CCNC(C1)C23CC4CC(C2)CC(C4)C3 D03FAX HIGHSTAT Investigative D03FBI DRUG__ID D03FBI D03FBI DRUGTYPE Small molecular drug D03FBI DRUGINCH 1S/C14H15N3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9H,15-17H2/b2-1+ D03FBI DRUGINKE QRFAISVLMWANDO-OWOJBTEDSA-N D03FBI DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)N)N)N D03FBI HIGHSTAT Investigative D03FBS DRUG__ID D03FBS D03FBS DRUGTYPE Small molecular drug D03FBS DRUGINCH 1S/C15H17NO3/c1-3-7-19-15(18)12-9-16-13-6-5-10(4-2)8-11(13)14(12)17/h5-6,8-9H,3-4,7H2,1-2H3,(H,16,17) D03FBS DRUGINKE RSBPUSKIUBSGGR-UHFFFAOYSA-N D03FBS DRUGSMIL CCCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC D03FBS HIGHSTAT Investigative D03FCU DRUG__ID D03FCU D03FCU DRUGTYPE Small molecular drug D03FCU DRUGINCH 1S/C19H19NO3/c1-4-13-6-5-7-14(10-13)23-17-8-9-20-16-12-19(22-3)18(21-2)11-15(16)17/h5-12H,4H2,1-3H3 D03FCU DRUGINKE BXXFKNUQXUJVKP-UHFFFAOYSA-N D03FCU DRUGSMIL CCC1=CC(=CC=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC D03FCU HIGHSTAT Investigative D03FDC DRUG__ID D03FDC D03FDC DRUGTYPE Small molecular drug D03FDC DRUGINCH 1S/C6H14O3P/c1-5(2)8-10(7)9-6(3)4/h5-6H,1-4H3/q+1 D03FDC DRUGINKE BJLZAAWLLPMZQR-UHFFFAOYSA-N D03FDC DRUGSMIL CC(C)O[P+](=O)OC(C)C D03FDC HIGHSTAT Investigative D03FEI DRUG__ID D03FEI D03FEI DRUGTYPE Small molecular drug D03FEI DRUGINCH 1S/C14H22O3S2/c1-3-4-5-13(18)10-11-19(15,16)14-8-6-12(17-2)7-9-14/h6-9,13,18H,3-5,10-11H2,1-2H3 D03FEI DRUGINKE XJUQEFFNMKAWSV-UHFFFAOYSA-N D03FEI DRUGSMIL CCCCC(CCS(=O)(=O)C1=CC=C(C=C1)OC)S D03FEI HIGHSTAT Investigative D03FEV DRUG__ID D03FEV D03FEV DRUGTYPE Small molecular drug D03FEV DRUGINCH 1S/C8H12N2O/c1-9-5-6-11-8-3-2-4-10-7-8/h2-4,7,9H,5-6H2,1H3 D03FEV DRUGINKE HKLZABNBARUZMN-UHFFFAOYSA-N D03FEV DRUGSMIL CNCCOC1=CN=CC=C1 D03FEV HIGHSTAT Investigative D03FFI DRUG__ID D03FFI D03FFI DRUGTYPE Small molecular drug D03FFI DRUGINCH 1S/C17H19NO3/c19-16(8-2-1-3-9-17(20)18-21)15-11-10-13-6-4-5-7-14(13)12-15/h4-7,10-12,21H,1-3,8-9H2,(H,18,20) D03FFI DRUGINKE AQLMJRZLPWGPGD-UHFFFAOYSA-N D03FFI DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)CCCCCC(=O)NO D03FFI HIGHSTAT Investigative D03FGM DRUG__ID D03FGM D03FGM DRUGTYPE Small molecular drug D03FGM DRUGINCH 1S/C19H23N3O/c20-19(23)17-8-4-5-15(13-17)14-18(16-6-2-1-3-7-16)22-11-9-21-10-12-22/h1-8,13,18,21H,9-12,14H2,(H2,20,23) D03FGM DRUGINKE AGCDRDCNYZHHKS-UHFFFAOYSA-N D03FGM DRUGSMIL C1CN(CCN1)C(CC2=CC(=CC=C2)C(=O)N)C3=CC=CC=C3 D03FGM HIGHSTAT Investigative D03FHV DRUG__ID D03FHV D03FHV DRUGTYPE Small molecular drug D03FHV DRUGINCH 1S/C30H32O5/c1-18(2)10-9-14-30(5)15-13-21-27(33)26(23(31)16-19(3)4)29-25(28(21)35-30)22(17-24(32)34-29)20-11-7-6-8-12-20/h6-8,10-13,15,17,19,33H,9,14,16H2,1-5H3 D03FHV DRUGINKE STYQYOHXCPHKKX-UHFFFAOYSA-N D03FHV DRUGSMIL CC(C)CC(=O)C1=C2C(=C3C(=C1O)C=CC(O3)(C)CCC=C(C)C)C(=CC(=O)O2)C4=CC=CC=C4 D03FHV HIGHSTAT Investigative D03FIE DRUG__ID D03FIE D03FIE DRUGCOMP AEterna Zentaris Inc D03FIE DRUGINCH 1S/C19H22N6O3S/c1-5-20-19(29)25-15-7-6-12-18(23-15)24-16(10-21-12)22-11-8-13(26-2)17(28-4)14(9-11)27-3/h6-10H,5H2,1-4H3,(H3,20,22,23,24,25,29) D03FIE DRUGINKE YJGOOHUUMIONLF-UHFFFAOYSA-N D03FIE DRUGSMIL CCNC(=S)NC1=NC2=NC(=CN=C2C=C1)NC3=CC(=C(C(=C3)OC)OC)OC D03FIE HIGHSTAT Investigative D03FJH DRUG__ID D03FJH D03FJH DRUGTYPE Small molecular drug D03FJH DRUGINCH 1S/C49H74N12O10/c1-10-30(8)40(44(65)58-38(28(4)5)43(64)55-37(46(67)70-9)24-32-25-53-34-20-15-14-19-33(32)34)59-48(68)61-60-45(66)39(29(6)7)57-42(63)36(23-27(2)3)54-41(62)35(21-16-22-52-47(50)51)56-49(69)71-26-31-17-12-11-13-18-31/h11-15,17-20,25,27-30,35-40,53H,10,16,21-24,26H2,1-9H3,(H,54,62)(H,55,64)(H,56,69)(H,57,63)(H,58,65)(H,60,66)(H4,50,51,52)(H2,59,61,68) D03FJH DRUGINKE LIQDTPYQUQZTGR-UHFFFAOYSA-N D03FJH DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OC)NC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3 D03FJH HIGHSTAT Investigative D03FJK DRUG__ID D03FJK D03FJK DRUGTYPE Small molecular drug D03FJK DRUGINCH 1S/C16H22N2O/c1-11(10-16(2,3)4)19-13-7-5-6-12-8-9-14(17)18-15(12)13/h5-9,11H,10H2,1-4H3,(H2,17,18) D03FJK DRUGINKE ZDVPLVAZUCNXKZ-UHFFFAOYSA-N D03FJK DRUGSMIL CC(CC(C)(C)C)OC1=CC=CC2=C1N=C(C=C2)N D03FJK HIGHSTAT Investigative D03FJM DRUG__ID D03FJM D03FJM DRUGTYPE Small molecular drug D03FJM DRUGINCH 1S/C6H13N5O4/c7-4(5(12)13)2-1-3-10(6(8)9)11(14)15/h4H,1-3,7H2,(H3,8,9)(H,12,13)/t4-/m0/s1 D03FJM DRUGINKE ZXGQUZOHXHNDPE-BYPYZUCNSA-N D03FJM DRUGSMIL C(CC(C(=O)O)N)CN(C(=N)N)[N+](=O)[O-] D03FJM HIGHSTAT Investigative D03FJS DRUG__ID D03FJS D03FJS DRUGTYPE Small molecular drug D03FJS DRUGINCH 1S/C33H56OS/c1-6-8-9-10-11-12-13-25-15-17-29-28-16-14-26-23-27(35-31(34)22-24(3)7-2)18-20-33(26,5)30(28)19-21-32(25,29)4/h14,24-25,27-30H,6-13,15-23H2,1-5H3 D03FJS DRUGINKE LQEPAKNLJUMKSY-UHFFFAOYSA-N D03FJS DRUGSMIL CCCCCCCCC1CCC2C1(CCC3C2CC=C4C3(CCC(C4)SC(=O)CC(C)CC)C)C D03FJS HIGHSTAT Investigative D03FKF DRUG__ID D03FKF D03FKF DRUGTYPE Small molecular drug D03FKF DRUGINCH 1S/C21H24N2O4S/c24-21-18-8-2-4-10-20(18)28(25,26)23(21)14-6-5-13-22-15-17-12-11-16-7-1-3-9-19(16)27-17/h1-4,7-10,17,22H,5-6,11-15H2/t17-/m1/s1 D03FKF DRUGINKE YGYBFMRFXNDIPO-QGZVFWFLSA-N D03FKF DRUGSMIL C1CC2=CC=CC=C2OC1CNCCCCN3C(=O)C4=CC=CC=C4S3(=O)=O D03FKF HIGHSTAT Investigative D03FNQ DRUG__ID D03FNQ D03FNQ DRUGTYPE Small molecular drug D03FNQ DRUGINCH 1S/C21H21F3N4O2/c1-27-18-12-15(6-9-17(18)26-20(27)28-10-2-3-11-28)25-19(29)13-30-16-7-4-14(5-8-16)21(22,23)24/h4-9,12H,2-3,10-11,13H2,1H3,(H,25,29) D03FNQ DRUGINKE BHTNQFXUFJJYNG-UHFFFAOYSA-N D03FNQ DRUGSMIL CN1C2=C(C=CC(=C2)NC(=O)COC3=CC=C(C=C3)C(F)(F)F)N=C1N4CCCC4 D03FNQ HIGHSTAT Investigative D03FOD DRUG__ID D03FOD D03FOD DRUGTYPE Small molecular drug D03FOD DRUGINCH 1S/C11H15NO2/c1-11(2,3)9-6-4-8(5-7-9)10(13)12-14/h4-7,14H,1-3H3,(H,12,13) D03FOD DRUGINKE HVTKRCPHQXJOFW-UHFFFAOYSA-N D03FOD DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NO D03FOD HIGHSTAT Investigative D03FOM DRUG__ID D03FOM D03FOM DRUGTYPE Small molecular drug D03FOM DRUGINCH 1S/C17H12N2/c1-12-6-7-13-8-9-14(10-17(13)19-12)16-5-3-2-4-15(16)11-18/h2-10H,1H3 D03FOM DRUGINKE MUNVAMLSVBEAIR-UHFFFAOYSA-N D03FOM DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC=C3C#N D03FOM HIGHSTAT Investigative D03FPH DRUG__ID D03FPH D03FPH DRUGTYPE Small molecular drug D03FPH DRUGINCH 1S/C13H11BrO3/c14-9-5-2-1-4-8(9)13(17)12-10(15)6-3-7-11(12)16/h1-2,4-5,12H,3,6-7H2 D03FPH DRUGINKE XECQPEVQAQFNOX-UHFFFAOYSA-N D03FPH DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2=CC=CC=C2Br D03FPH HIGHSTAT Investigative D03FPQ DRUG__ID D03FPQ D03FPQ DRUGTYPE Small molecular drug D03FPQ DRUGINCH 1S/C13H14ClN3O4/c1-7-4-12(17-21-7)16-13(18)15-9-5-8(14)10(19-2)6-11(9)20-3/h4-6H,1-3H3,(H2,15,16,17,18) D03FPQ DRUGINKE CEIIEALEIHQDBX-UHFFFAOYSA-N D03FPQ DRUGSMIL CC1=CC(=NO1)NC(=O)NC2=CC(=C(C=C2OC)OC)Cl D03FPQ HIGHSTAT Investigative D03FQJ DRUG__ID D03FQJ D03FQJ DRUGTYPE Small molecular drug D03FQJ DRUGINCH 1S/C13H14F4O/c14-11(12(18)13(15,16)17)9-5-4-8-10-6-2-1-3-7-10/h1-3,6-7,11H,4-5,8-9H2 D03FQJ DRUGINKE NWIVHHJMCFVMET-UHFFFAOYSA-N D03FQJ DRUGSMIL C1=CC=C(C=C1)CCCCC(C(=O)C(F)(F)F)F D03FQJ HIGHSTAT Investigative D03FQP DRUG__ID D03FQP D03FQP DRUGTYPE Small molecular drug D03FQP DRUGINCH 1S/C37H65NO12/c1-14-25-37(10,43)30(40)20(4)28-18(2)16-36(9,50-28)32(49-34-27(39)24(38(11)12)15-19(3)45-34)21(5)29(22(6)33(42)47-25)48-26-17-35(8,44-13)31(41)23(7)46-26/h19-27,29-32,34,39-41,43H,14-17H2,1-13H3/t19-,20+,21+,22-,23+,24+,25-,26+,27-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1 D03FQP DRUGINKE JFVYXJKGJMUGRG-KJPZRSJGSA-N D03FQP DRUGSMIL CCC1C(C(C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)C)C)C)O)(C)O D03FQP HIGHSTAT Investigative D03FQU DRUG__ID D03FQU D03FQU DRUGTYPE Small molecular drug D03FQU DRUGINCH 1S/C26H33N5O5/c1-16(23(28)33)29-24(34)21(15-17-6-3-2-4-7-17)30-25(35)22-8-5-13-31(22)26(36)20(27)14-18-9-11-19(32)12-10-18/h2-4,6-7,9-12,16,20-22,32H,5,8,13-15,27H2,1H3,(H2,28,33)(H,29,34)(H,30,35)/t16-,20-,21-,22-/m0/s1 D03FQU DRUGINKE WNYNLZIGNIJEJM-KPQYALRZSA-N D03FQU DRUGSMIL CC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)N D03FQU HIGHSTAT Investigative D03FTE DRUG__ID D03FTE D03FTE DRUGTYPE Small molecular drug D03FTE DRUGINCH 1S/C21H17NO4/c23-14-12-19(25-20(13-14)22-8-10-24-11-9-22)17-6-3-5-16-15-4-1-2-7-18(15)26-21(16)17/h1-7,12-13H,8-11H2 D03FTE DRUGINKE YREPYLIFIQVESI-UHFFFAOYSA-N D03FTE DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC4=C3OC5=CC=CC=C45 D03FTE HIGHSTAT Investigative D03FVK DRUG__ID D03FVK D03FVK DRUGTYPE Small molecular drug D03FVK DRUGINCH 1S/C18H18N6O5/c1-28-23-16-13-17(22-12(21-16)3-2-10-4-6-19-7-5-10)24(9-20-13)18-15(27)14(26)11(8-25)29-18/h4-7,9,11,14-15,18,25-27H,8H2,1H3,(H,21,22,23)/t11-,14-,15-,18-/m1/s1 D03FVK DRUGINKE NZIZYIGAKAUPPW-XKLVTHTNSA-N D03FVK DRUGSMIL CONC1=C2C(=NC(=N1)C#CC3=CC=NC=C3)N(C=N2)C4C(C(C(O4)CO)O)O D03FVK HIGHSTAT Investigative D03FXI DRUG__ID D03FXI D03FXI DRUGTYPE Small molecular drug D03FXI DRUGINCH 1S/C13H11N3O4S/c14-21(19,20)13-7-3-11(4-8-13)15-9-10-1-5-12(6-2-10)16(17)18/h1-9H,(H2,14,19,20) D03FXI DRUGINKE IJEQJCKQAKELNC-UHFFFAOYSA-N D03FXI DRUGSMIL C1=CC(=CC=C1C=NC2=CC=C(C=C2)S(=O)(=O)N)[N+](=O)[O-] D03FXI HIGHSTAT Investigative D03FZK DRUG__ID D03FZK D03FZK DRUGTYPE Small molecular drug D03FZK DRUGINCH 1S/C7H17BrN.BrH/c1-9(2,3)7-5-4-6-8;/h4-7H2,1-3H3;1H/q+1;/p-1 D03FZK DRUGINKE ZQKJDSWJSPZYNR-UHFFFAOYSA-M D03FZK DRUGSMIL C[N+](C)(C)CCCCBr.[Br-] D03FZK HIGHSTAT Investigative D03GAQ DRUG__ID D03GAQ D03GAQ DRUGTYPE Small molecular drug D03GAQ DRUGINCH 1S/C11H9N3O/c1-6-3-2-4-8-7(6)5-9-10(12-8)14-11(15)13-9/h2-5H,1H3,(H2,12,13,14,15) D03GAQ DRUGINKE NFWDGDAZJTYAHA-UHFFFAOYSA-N D03GAQ DRUGSMIL CC1=C2C=C3C(=NC2=CC=C1)NC(=O)N3 D03GAQ HIGHSTAT Investigative D03GBO DRUG__ID D03GBO D03GBO DRUGTYPE Small molecular drug D03GBO DRUGINCH 1S/C9H5Cl2NO2/c10-4-1-6(11)5-3-8(9(13)14)12-7(5)2-4/h1-3,12H,(H,13,14) D03GBO DRUGINKE DHXISZKSSIWRLH-UHFFFAOYSA-N D03GBO DRUGSMIL C1=C(C=C(C2=C1NC(=C2)C(=O)O)Cl)Cl D03GBO HIGHSTAT Investigative D03GDP DRUG__ID D03GDP D03GDP DRUGTYPE Small molecular drug D03GDP DRUGINCH 1S/C25H34O3/c1-7-8-9-10-13-24(2,3)17-14-21(26)23-19-16-18(27-6)11-12-20(19)25(4,5)28-22(23)15-17/h11-12,14-16,26H,7-10,13H2,1-6H3 D03GDP DRUGINKE ZNHVPFVYQXICIO-UHFFFAOYSA-N D03GDP DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)OC)(C)C)O D03GDP HIGHSTAT Investigative D03GES DRUG__ID D03GES D03GES DRUGTYPE Small molecular drug D03GES DRUGINCH 1S/C19H21N3O/c1-2-4-16(5-3-1)13-21-9-7-18(8-10-21)22-11-6-17(14-22)19-12-20-15-23-19/h1-6,11-12,14-15,18H,7-10,13H2 D03GES DRUGINKE ASGPPKHUWWRTLM-UHFFFAOYSA-N D03GES DRUGSMIL C1CN(CCC1N2C=CC(=C2)C3=CN=CO3)CC4=CC=CC=C4 D03GES HIGHSTAT Investigative D03GHN DRUG__ID D03GHN D03GHN DRUGTYPE Small molecular drug D03GHN DRUGINCH 1S/C10H20O3/c1-2-3-4-5-6-7-9(11)8-10(12)13/h9,11H,2-8H2,1H3,(H,12,13) D03GHN DRUGINKE FYSSBMZUBSBFJL-UHFFFAOYSA-N D03GHN DRUGSMIL CCCCCCCC(CC(=O)O)O D03GHN HIGHSTAT Investigative D03GJB DRUG__ID D03GJB D03GJB DRUGTYPE Small molecular drug D03GJB DRUGINCH 1S/C14H12N6O3/c15-14-19-11-10(12(21)20-14)18-9(6-17-11)5-16-8-3-1-7(2-4-8)13(22)23/h1-4,6,16H,5H2,(H,22,23)(H3,15,17,19,20,21) D03GJB DRUGINKE JOAQINSXLLMRCV-UHFFFAOYSA-N D03GJB DRUGSMIL C1=CC(=CC=C1C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N D03GJB HIGHSTAT Investigative D03GON DRUG__ID D03GON D03GON DRUGTYPE Small molecular drug D03GON DRUGINCH 1S/C21H24N2O3/c1-2-6-14-23(13-5-1)15-16-24-17-9-11-18(12-10-17)25-21-22-19-7-3-4-8-20(19)26-21/h3-4,7-12H,1-2,5-6,13-16H2 D03GON DRUGINKE RUOSQGLZVMYCMI-UHFFFAOYSA-N D03GON DRUGSMIL C1CCCN(CC1)CCOC2=CC=C(C=C2)OC3=NC4=CC=CC=C4O3 D03GON HIGHSTAT Investigative D03GPH DRUG__ID D03GPH D03GPH DRUGTYPE Small molecular drug D03GPH DRUGINCH 1S/C20H31ClN2O/c1-3-5-7-9-17(10-8-6-4-2)15-16-22-20(24)23-19-13-11-18(21)12-14-19/h11-15H,3-10,16H2,1-2H3,(H2,22,23,24) D03GPH DRUGINKE CIWRUSYLNXXOOQ-UHFFFAOYSA-N D03GPH DRUGSMIL CCCCCC(=CCNC(=O)NC1=CC=C(C=C1)Cl)CCCCC D03GPH HIGHSTAT Investigative D03GQF DRUG__ID D03GQF D03GQF DRUGTYPE Small molecular drug D03GQF DRUGINCH 1S/C36H44N4O2/c41-26-10-9-20-40-25(13-14-26)22-35-24-39-19-8-4-2-1-3-7-17-36(42,34(35)40)23-29(30(35)16-21-39)32-33-28(15-18-37-32)27-11-5-6-12-31(27)38-33/h1,3,5-6,11-12,15,18,23,25,30,34,38,42H,2,4,7-10,13-14,16-17,19-22,24H2/b3-1-/t25?,30-,34?,35-,36-/m0/s1 D03GQF DRUGINKE LTHULOBARTYAMF-JUOMLHCBSA-N D03GQF DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCC(=O)CC5)O)C6=NC=CC7=C6NC8=CC=CC=C78 D03GQF HIGHSTAT Investigative D03GQI DRUG__ID D03GQI D03GQI DRUGTYPE Small molecular drug D03GQI DRUGINCH 1S/C16H11IN2O2/c17-12-6-8-13(9-7-12)19-16(21)14(15(20)18-19)10-11-4-2-1-3-5-11/h1-10H,(H,18,20)/b14-10- D03GQI DRUGINKE KAGAMCCGZCDKMX-UVTDQMKNSA-N D03GQI DRUGSMIL C1=CC=C(C=C1)C=C2C(=O)NN(C2=O)C3=CC=C(C=C3)I D03GQI HIGHSTAT Investigative D03GRA DRUG__ID D03GRA D03GRA DRUGTYPE Small molecular drug D03GRA DRUGINCH 1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9)/p-1/t6-/m1/s1 D03GRA DRUGINKE KJTLQQUUPVSXIM-ZCFIWIBFSA-M D03GRA DRUGSMIL CC(CCO)(CC(=O)[O-])O D03GRA HIGHSTAT Investigative D03GVL DRUG__ID D03GVL D03GVL DRUGTYPE Small molecular drug D03GVL DRUGINCH 1S/C8H12N3O9P/c12-4-1-9-11(8(15)10-4)7-6(14)5(13)3(20-7)2-19-21(16,17)18/h1,3,5-7,13-14H,2H2,(H,10,12,15)(H2,16,17,18)/t3-,5-,6-,7-/m1/s1 D03GVL DRUGINKE LRVZOSYMNMNQFR-SHUUEZRQSA-N D03GVL DRUGSMIL C1=NN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O D03GVL HIGHSTAT Investigative D03GWA DRUG__ID D03GWA D03GWA DRUGTYPE Small molecular drug D03GWA DRUGINCH 1S/C16H16N4/c1-20-10-12(11-5-3-2-4-6-11)9-13-15(20)8-7-14(17)16(13)19-18/h2-9,18H,10,17H2,1H3 D03GWA DRUGINKE VZQKWRKRDCBNCA-UHFFFAOYSA-N D03GWA DRUGSMIL CN1CC(=CC2=C1C=CC(=C2N=N)N)C3=CC=CC=C3 D03GWA HIGHSTAT Investigative D03GXQ DRUG__ID D03GXQ D03GXQ DRUGTYPE Small molecular drug D03GXQ DRUGINCH 1S/C2H4INO/c3-1-2(4)5/h1H2,(H2,4,5) D03GXQ DRUGINKE PGLTVOMIXTUURA-UHFFFAOYSA-N D03GXQ DRUGSMIL C(C(=O)N)I D03GXQ HIGHSTAT Investigative D03GYS DRUG__ID D03GYS D03GYS DRUGTYPE Small molecular drug D03GYS DRUGINCH 1S/C17H17NO3/c1-2-3-4-12-9-14(20)10-15-16(12)21-17(18-15)11-5-7-13(19)8-6-11/h5-10,19-20H,2-4H2,1H3 D03GYS DRUGINKE MEBUPUARJUIPAP-UHFFFAOYSA-N D03GYS DRUGSMIL CCCCC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D03GYS HIGHSTAT Investigative D03HBG DRUG__ID D03HBG D03HBG DRUGTYPE Small molecular drug D03HBG DRUGINCH 1S/C20H21BrN6O5/c21-10-2-1-3-11-13(10)9(6-23-11)4-5-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)12(7-28)32-19/h1-3,6,8,12,15-16,19,23,28-30H,4-5,7H2,(H2,22,25,26)/t12-,15-,16-,19-/m1/s1 D03HBG DRUGINKE GBCVNJCVWVIDED-BGIGGGFGSA-N D03HBG DRUGSMIL C1=CC2=C(C(=C1)Br)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D03HBG HIGHSTAT Investigative D03HBZ DRUG__ID D03HBZ D03HBZ DRUGTYPE Small molecular drug D03HBZ DRUGINCH 1S/C18H21N3/c1-3-13-20(16-9-11-19-12-10-16)21-14-15(4-2)17-7-5-6-8-18(17)21/h5-12,14H,3-4,13H2,1-2H3 D03HBZ DRUGINKE KHGNFQVPPCBUSI-UHFFFAOYSA-N D03HBZ DRUGSMIL CCCN(C1=CC=NC=C1)N2C=C(C3=CC=CC=C32)CC D03HBZ HIGHSTAT Investigative D03HCR DRUG__ID D03HCR D03HCR DRUGTYPE Small molecular drug D03HCR DRUGINCH 1S/C9H18N2O/c1-3-5-7-8(6-4-2)12-9(10)11-7/h7-8H,3-6H2,1-2H3,(H2,10,11)/t7-,8-/m0/s1 D03HCR DRUGINKE LRHNWJTUXJXJRP-YUMQZZPRSA-N D03HCR DRUGSMIL CCCC1C(OC(=N1)N)CCC D03HCR HIGHSTAT Investigative D03HCT DRUG__ID D03HCT D03HCT DRUGTYPE Small molecular drug D03HCT DRUGINCH 1S/C23H25FN4O3/c24-18-6-4-5-16(13-18)15-28-22(30)19-8-7-17(14-20(19)26-23(28)31)21(29)25-9-12-27-10-2-1-3-11-27/h4-8,13-14H,1-3,9-12,15H2,(H,25,29)(H,26,31) D03HCT DRUGINKE YKQRXGQZAGVEJY-UHFFFAOYSA-N D03HCT DRUGSMIL C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC(=CC=C4)F D03HCT HIGHSTAT Investigative D03HDS DRUG__ID D03HDS D03HDS DRUGTYPE Small molecular drug D03HDS DRUGINCH 1S/C26H33N5O13P2/c1-12(4-5-14-19(32)17-15(7-41-26(17)35)13(2)22(14)40-3)6-42-45(36,37)11-46(38,39)43-8-16-20(33)21(34)25(44-16)31-10-30-18-23(27)28-9-29-24(18)31/h4,9-10,16,20-21,25,32-34H,5-8,11H2,1-3H3,(H,36,37)(H,38,39)(H2,27,28,29)/b12-4+/t16-,20-,21-,25-/m1/s1 D03HDS DRUGINKE MCYWJNDIVYMDSF-AWOYCZEKSA-N D03HDS DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)COP(=O)(CP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O D03HDS HIGHSTAT Investigative D03HFH DRUG__ID D03HFH D03HFH DRUGTYPE Small molecular drug D03HFH DRUGINCH 1S/C16H19NS/c1-13(17)11-14-7-9-16(10-8-14)18-12-15-5-3-2-4-6-15/h2-10,13H,11-12,17H2,1H3 D03HFH DRUGINKE TXLRFCSLKMDOTM-UHFFFAOYSA-N D03HFH DRUGSMIL CC(CC1=CC=C(C=C1)SCC2=CC=CC=C2)N D03HFH HIGHSTAT Investigative D03HFM DRUG__ID D03HFM D03HFM DRUGTYPE Small molecular drug D03HFM DRUGINCH 1S/C23H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)24-21-20-22(21)25/h6-7,9-10,12-13,15-16,21-22,25H,2-5,8,11,14,17-20H2,1H3,(H,24,26)/b7-6-,10-9-,13-12-,16-15-/t21-,22-/m1/s1 D03HFM DRUGINKE LZHCSJBKBARIFQ-OXAAUTCPSA-N D03HFM DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1CC1O D03HFM HIGHSTAT Investigative D03HHP DRUG__ID D03HHP D03HHP DRUGTYPE Small molecular drug D03HHP DRUGINCH 1S/C3H5NO2/c1-2(4)3(5)6/h1,4H2,(H,5,6) D03HHP DRUGINKE UQBOJOOOTLPNST-UHFFFAOYSA-N D03HHP DRUGSMIL C=C(C(=O)O)N D03HHP HIGHSTAT Investigative D03HJW DRUG__ID D03HJW D03HJW DRUGTYPE Small molecular drug D03HJW DRUGINCH 1S/C28H32Cl2N4O6S2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35H,9-13,16H2,1-2H3,(H,31,36)/t21-,22-/m0/s1 D03HJW DRUGINKE IVYQPSHHYIAUFO-VXKWHMMOSA-N D03HJW DRUGSMIL CC(C)CC(C(=O)N1CCN(CC1)C(=O)C(CO)NS(=O)(=O)C2=C(C=C(C=C2)Cl)Cl)NC(=O)C3=CC4=CC=CC=C4S3 D03HJW HIGHSTAT Investigative D03HKV DRUG__ID D03HKV D03HKV DRUGTYPE Small molecular drug D03HKV DRUGINCH 1S/C10H15NO3/c1-11-6-9(13)7-3-4-8(12)10(5-7)14-2/h3-5,9,11-13H,6H2,1-2H3 D03HKV DRUGINKE JWJCTZKFYGDABJ-UHFFFAOYSA-N D03HKV DRUGSMIL CNCC(C1=CC(=C(C=C1)O)OC)O D03HKV HIGHSTAT Investigative D03HLH DRUG__ID D03HLH D03HLH DRUGTYPE Small molecular drug D03HLH DRUGINCH 1S/C16H13BrN2O3/c1-20-14-7-12-13(8-15(14)21-2)18-9-19-16(12)22-11-5-3-4-10(17)6-11/h3-9H,1-2H3 D03HLH DRUGINKE BRHOGFZRGDIAMT-UHFFFAOYSA-N D03HLH DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)OC3=CC(=CC=C3)Br)OC D03HLH HIGHSTAT Investigative D03HLU DRUG__ID D03HLU D03HLU DRUGTYPE Small molecular drug D03HLU DRUGINCH 1S/C10H21O4P/c1-2-3-4-5-6-7-8-9-10-14-15(11,12)13/h6-7H,2-5,8-10H2,1H3,(H2,11,12,13)/b7-6+ D03HLU DRUGINKE KAHLDJCENUPBQU-VOTSOKGWSA-N D03HLU DRUGSMIL CCCCCC=CCCCOP(=O)(O)O D03HLU HIGHSTAT Investigative D03HNC DRUG__ID D03HNC D03HNC DRUGTYPE Small molecular drug D03HNC DRUGINCH 1S/C17H13NO2/c19-17(18-20)14-10-8-13(9-11-14)16-7-3-5-12-4-1-2-6-15(12)16/h1-11,20H,(H,18,19) D03HNC DRUGINKE PKQVYJOPUCLLCD-UHFFFAOYSA-N D03HNC DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C3=CC=C(C=C3)C(=O)NO D03HNC HIGHSTAT Investigative D03HQE DRUG__ID D03HQE D03HQE DRUGTYPE Small molecular drug D03HQE DRUGINCH 1S/C18H22N6O.2ClH/c1-3-14(19)10-21-17-6-7-20-18(23-17)15-8-12(4-5-16(15)25)13-9-22-24(2)11-13;;/h4-9,11,14,25H,3,10,19H2,1-2H3,(H,20,21,23);2*1H/t14-;;/m1../s1 D03HQE DRUGINKE CXYCRYGNFKDPRH-FMOMHUKBSA-N D03HQE DRUGSMIL CCC(CNC1=NC(=NC=C1)C2=C(C=CC(=C2)C3=CN(N=C3)C)O)N.Cl.Cl D03HQE HIGHSTAT Investigative D03HQF DRUG__ID D03HQF D03HQF DRUGTYPE Small molecular drug D03HQF DRUGINCH 1S/C11H14BrNO/c12-9-3-1-8(2-4-9)11-6-5-10(7-13)14-11/h1-4,10-11H,5-7,13H2 D03HQF DRUGINKE NZCDMSTWUUULEH-UHFFFAOYSA-N D03HQF DRUGSMIL C1CC(OC1CN)C2=CC=C(C=C2)Br D03HQF HIGHSTAT Investigative D03HQK DRUG__ID D03HQK D03HQK DRUGTYPE Small molecular drug D03HQK DRUGINCH 1S/C16H11N3O/c17-10-13-8-4-5-9-14(13)19-16-18-11-15(20-16)12-6-2-1-3-7-12/h1-9,11H,(H,18,19) D03HQK DRUGINKE FPMCYJLZCOBPEC-UHFFFAOYSA-N D03HQK DRUGSMIL C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC=C3C#N D03HQK HIGHSTAT Investigative D03HTT DRUG__ID D03HTT D03HTT DRUGTYPE Small molecular drug D03HTT DRUGINCH 1S/C24H18N4/c1-16-7-2-5-12-22(16)26-24-21-10-4-3-9-20(21)23(27-28-24)19-11-6-8-17-15-25-14-13-18(17)19/h2-15H,1H3,(H,26,28) D03HTT DRUGINKE AQWOEJFWZLDYCH-UHFFFAOYSA-N D03HTT DRUGSMIL CC1=CC=CC=C1NC2=NN=C(C3=CC=CC=C32)C4=CC=CC5=C4C=CN=C5 D03HTT HIGHSTAT Investigative D03HVE DRUG__ID D03HVE D03HVE DRUGTYPE Small molecular drug D03HVE DRUGINCH 1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) D03HVE DRUGINKE FDGQSTZJBFJUBT-UHFFFAOYSA-N D03HVE DRUGSMIL C1=NC2=C(N1)C(=O)NC=N2 D03HVE HIGHSTAT Investigative D03HXD DRUG__ID D03HXD D03HXD DRUGTYPE Small molecular drug D03HXD DRUGINCH 1S/C20H21NO/c1-15(21)11-17-7-8-19-13-20(10-9-18(19)12-17)22-14-16-5-3-2-4-6-16/h2-10,12-13,15H,11,14,21H2,1H3 D03HXD DRUGINKE KDDLNYYBHKHYRE-UHFFFAOYSA-N D03HXD DRUGSMIL CC(CC1=CC2=C(C=C1)C=C(C=C2)OCC3=CC=CC=C3)N D03HXD HIGHSTAT Investigative D03HXN DRUG__ID D03HXN D03HXN DRUGTYPE Small molecular drug D03HXN DRUGINCH 1S/C49H56N8O7/c1-26-14-35(58)15-27(2)37(26)20-39(50)48(63)56-24-33-12-8-6-10-31(33)18-43(56)46(61)52-22-41-30(5)54-42(45(60)55-41)23-53-47(62)44-19-32-11-7-9-13-34(32)25-57(44)49(64)40(51)21-38-28(3)16-36(59)17-29(38)4/h6-17,39-40,43-44,58-59H,18-25,50-51H2,1-5H3,(H,52,61)(H,53,62)(H,55,60)/t39-,40-,43?,44?/m0/s1 D03HXN DRUGINKE BOYVBTQTUISOKQ-XQIDWOBFSA-N D03HXN DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=C(N=C(C(=O)N4)CNC(=O)C5CC6=CC=CC=C6CN5C(=O)C(CC7=C(C=C(C=C7C)O)C)N)C)N)C)O D03HXN HIGHSTAT Investigative D03HYZ DRUG__ID D03HYZ D03HYZ DRUGTYPE Small molecular drug D03HYZ DRUGINCH 1S/C20H36N4O8/c1-6-9-21-13(7-8-14(26)27)18(29)24-16(12(5)25)19(30)22-11(4)17(28)23-15(10(2)3)20(31)32/h10-13,15-16,21,25H,6-9H2,1-5H3,(H,22,30)(H,23,28)(H,24,29)(H,26,27)(H,31,32)/t11-,12?,13-,15-,16-/m0/s1 D03HYZ DRUGINKE NHQFROHPNIZUKF-VSZKUSEYSA-N D03HYZ DRUGSMIL CCCNC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)O D03HYZ HIGHSTAT Investigative D03HZT DRUG__ID D03HZT D03HZT DRUGTYPE Small molecular drug D03HZT DRUGINCH 1S/C14H8Cl2O2/c15-11-7-3-1-5-9(11)13(17)14(18)10-6-2-4-8-12(10)16/h1-8H D03HZT DRUGINKE VOSNNSVWVJFJCR-UHFFFAOYSA-N D03HZT DRUGSMIL C1=CC=C(C(=C1)C(=O)C(=O)C2=CC=CC=C2Cl)Cl D03HZT HIGHSTAT Investigative D03IES DRUG__ID D03IES D03IES DRUGTYPE Small molecular drug D03IES DRUGINCH 1S/C19H21F3N2O3S/c20-19(21,22)14-28(25,26)24(13-15-5-4-10-23-12-15)16-6-3-9-18(11-16)27-17-7-1-2-8-17/h3-6,9-12,17H,1-2,7-8,13-14H2 D03IES DRUGINKE WCYYNLFGFUQJMF-UHFFFAOYSA-N D03IES DRUGSMIL C1CCC(C1)OC2=CC=CC(=C2)N(CC3=CN=CC=C3)S(=O)(=O)CC(F)(F)F D03IES HIGHSTAT Investigative D03IHA DRUG__ID D03IHA D03IHA DRUGCOMP Vernalis D03IHA DRUGINCH 1S/C6H8N2O3S.ClH/c1-5-6(12-4-7-5)2-3-11-8(9)10;/h4H,2-3H2,1H3;1H D03IHA DRUGINKE AFJHNVYIRRYUJM-UHFFFAOYSA-N D03IHA DRUGSMIL CC1=C(SC=N1)CCO[N+](=O)[O-].Cl D03IHA HIGHSTAT Investigative D03IMY DRUG__ID D03IMY D03IMY DRUGTYPE Small molecular drug D03IMY DRUGINCH 1S/C11H17ClN2O2/c1-2-3-4-5-6-7-8-9(12)13-11(16)14-10(8)15/h2-7H2,1H3,(H2,13,14,15,16) D03IMY DRUGINKE CIAJCIKDDKGJBP-UHFFFAOYSA-N D03IMY DRUGSMIL CCCCCCCC1=C(NC(=O)NC1=O)Cl D03IMY HIGHSTAT Investigative D03IMZ DRUG__ID D03IMZ D03IMZ DRUGTYPE Small molecular drug D03IMZ DRUGINCH 1S/C3H2N2O4/c6-2-1(3(7)8)4-9-5-2/h(H,5,6)(H,7,8) D03IMZ DRUGINKE IBRWUZLLHSXPKL-UHFFFAOYSA-N D03IMZ DRUGSMIL C1(=NONC1=O)C(=O)O D03IMZ HIGHSTAT Investigative D03IPZ DRUG__ID D03IPZ D03IPZ DRUGTYPE Small molecular drug D03IPZ DRUGINCH 1S/C17H14FNO3/c1-20-16-9-13-14(10-17(16)21-2)19-7-6-15(13)22-12-5-3-4-11(18)8-12/h3-10H,1-2H3 D03IPZ DRUGINKE LQOBRLFNSGKIFO-UHFFFAOYSA-N D03IPZ DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC(=CC=C3)F D03IPZ HIGHSTAT Investigative D03IQX DRUG__ID D03IQX D03IQX DRUGTYPE Small molecular drug D03IQX DRUGINCH 1S/C19H11FO2/c20-16-8-4-3-7-14(16)18-11-17(21)15-10-9-12-5-1-2-6-13(12)19(15)22-18/h1-11H D03IQX DRUGINKE PBCBXDLSTLVGDE-UHFFFAOYSA-N D03IQX DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2OC(=CC3=O)C4=CC=CC=C4F D03IQX HIGHSTAT Investigative D03IRR DRUG__ID D03IRR D03IRR DRUGTYPE Small molecular drug D03IRR DRUGINCH 1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3 D03IRR DRUGINKE VEQOALNAAJBPNY-UHFFFAOYSA-N D03IRR DRUGSMIL CC1=CC(=O)N(N1C)C2=CC=CC=C2 D03IRR HIGHSTAT Investigative D03ITH DRUG__ID D03ITH D03ITH DRUGTYPE Small molecular drug D03ITH DRUGINCH 1S/C36H38N4O5/c41-31-29(22-44-36(26-15-7-2-8-16-26,27-17-9-3-10-18-27)28-19-11-4-12-20-28)45-35(32(31)42)40-24-37-30-33(40)38-23-39(34(30)43)21-25-13-5-1-6-14-25/h2-4,7-12,15-20,23-25,29,31-32,35,41-42H,1,5-6,13-14,21-22H2/t29-,31-,32-,35-/m1/s1 D03ITH DRUGINKE CFSSQQKSMHGUJB-QSYCCZFCSA-N D03ITH DRUGSMIL C1CCC(CC1)CN2C=NC3=C(C2=O)N=CN3C4C(C(C(O4)COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)O)O D03ITH HIGHSTAT Investigative D03IVC DRUG__ID D03IVC D03IVC DRUGTYPE Small molecular drug D03IVC DRUGINCH 1S/C17H18N4O5/c1-8(2)25-17(22)13-9(3)18-10(4)16(21(23)24)14(13)11-6-5-7-12-15(11)20-26-19-12/h5-8,14,18H,1-4H3/t14-/m1/s1 D03IVC DRUGINKE LYFZEFDZKPJBJK-CQSZACIVSA-N D03IVC DRUGSMIL CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC3=NON=C32)C(=O)OC(C)C D03IVC HIGHSTAT Investigative D03IVG DRUG__ID D03IVG D03IVG DRUGTYPE Small molecular drug D03IVG DRUGINCH 1S/C14H16N2O2/c1-2-16-8-7-15-14(16)9-11-10-17-12-5-3-4-6-13(12)18-11/h3-8,11H,2,9-10H2,1H3 D03IVG DRUGINKE UXABARREKCJULM-UHFFFAOYSA-N D03IVG DRUGSMIL CCN1C=CN=C1CC2COC3=CC=CC=C3O2 D03IVG HIGHSTAT Investigative D03IVU DRUG__ID D03IVU D03IVU DRUGTYPE Small molecular drug D03IVU DRUGINCH 1S/C20H38N2O3/c1-3-4-17-21-20(24)22-18-15-13-11-9-7-5-6-8-10-12-14-16-19(23)25-2/h5,7H,3-4,6,8-18H2,1-2H3,(H2,21,22,24)/b7-5- D03IVU DRUGINKE CGNYGIBRDHWVDW-ALCCZGGFSA-N D03IVU DRUGSMIL CCCCNC(=O)NCCCCCC=CCCCCCCC(=O)OC D03IVU HIGHSTAT Investigative D03IVW DRUG__ID D03IVW D03IVW DRUGTYPE Small molecular drug D03IVW DRUGINCH 1S/C22H23Cl2N7O/c1-13-3-6-16(14(2)9-13)11-28-29-12-27-22(32)18-20(25)31-21(19(24)30-18)26-10-15-4-7-17(23)8-5-15/h3-9,12,28H,10-11H2,1-2H3,(H3,25,26,31)(H,27,29,32) D03IVW DRUGINKE OTVLDNYCQTWHCT-UHFFFAOYSA-N D03IVW DRUGSMIL CC1=CC(=C(C=C1)CNN=CNC(=O)C2=C(N=C(C(=N2)Cl)NCC3=CC=C(C=C3)Cl)N)C D03IVW HIGHSTAT Investigative D03IWC DRUG__ID D03IWC D03IWC DRUGTYPE Small molecular drug D03IWC DRUGINCH 1S/C15H13NO2/c1-11-7-8-13-14(9-11)18-15(17)16(13)10-12-5-3-2-4-6-12/h2-9H,10H2,1H3 D03IWC DRUGINKE HYWGUCHKPHXSGZ-UHFFFAOYSA-N D03IWC DRUGSMIL CC1=CC2=C(C=C1)N(C(=O)O2)CC3=CC=CC=C3 D03IWC HIGHSTAT Investigative D03IWW DRUG__ID D03IWW D03IWW DRUGTYPE Small molecular drug D03IWW DRUGINCH 1S/C6H11NO2/c8-6(9)5-2-1-3-7-4-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1 D03IWW DRUGINKE XJLSEXAGTJCILF-YFKPBYRVSA-N D03IWW DRUGSMIL C1CC(CNC1)C(=O)O D03IWW HIGHSTAT Investigative D03IWX DRUG__ID D03IWX D03IWX DRUGTYPE Small molecular drug D03IWX DRUGINCH 1S/C16H17NO/c1-18-13-7-6-12-8-11-4-2-3-5-14(11)16(10-17)15(12)9-13/h2-7,9,16H,8,10,17H2,1H3 D03IWX DRUGINKE UKAGNBPAZOMJAO-UHFFFAOYSA-N D03IWX DRUGSMIL COC1=CC2=C(CC3=CC=CC=C3C2CN)C=C1 D03IWX HIGHSTAT Investigative D03IZV DRUG__ID D03IZV D03IZV DRUGTYPE Small molecular drug D03IZV DRUGINCH 1S/C18H10Br2ClN3OS/c19-11-8-13(20)16-22-15(14-2-1-7-26-14)17(24(16)9-11)23-18(25)10-3-5-12(21)6-4-10/h1-9H,(H,23,25) D03IZV DRUGINKE MEWSBNIVOLYKGU-UHFFFAOYSA-N D03IZV DRUGSMIL C1=CSC(=C1)C2=C(N3C=C(C=C(C3=N2)Br)Br)NC(=O)C4=CC=C(C=C4)Cl D03IZV HIGHSTAT Investigative D03JAE DRUG__ID D03JAE D03JAE DRUGTYPE Small molecular drug D03JAE DRUGINCH 1S/C8H9BrN2S.BrH/c9-7-3-1-6(2-4-7)5-12-8(10)11;/h1-4H,5H2,(H3,10,11);1H D03JAE DRUGINKE PHMCIGUUXGYEBU-UHFFFAOYSA-N D03JAE DRUGSMIL C1=CC(=CC=C1CSC(=N)N)Br.Br D03JAE HIGHSTAT Investigative D03JAL DRUG__ID D03JAL D03JAL DRUGTYPE Small molecular drug D03JAL DRUGINCH 1S/C6H16NO3P/c1-2-3-4-5-6(7)11(8,9)10/h6H,2-5,7H2,1H3,(H2,8,9,10) D03JAL DRUGINKE ODMTWOKJHVPSLP-UHFFFAOYSA-N D03JAL DRUGSMIL CCCCCC(N)P(=O)(O)O D03JAL HIGHSTAT Investigative D03JDL DRUG__ID D03JDL D03JDL DRUGTYPE Small molecular drug D03JDL DRUGINCH 1S/C18H13Cl2N5O4/c1-2-5-21-16(26)11-7-10(25(28)29)8-12-15(11)23-18(24-17(12)27)22-9-3-4-13(19)14(20)6-9/h2-4,6-8H,1,5H2,(H,21,26)(H2,22,23,24,27) D03JDL DRUGINKE VUBILPOZTRGZJK-UHFFFAOYSA-N D03JDL DRUGSMIL C=CCNC(=O)C1=CC(=CC2=C1N=C(NC2=O)NC3=CC(=C(C=C3)Cl)Cl)[N+](=O)[O-] D03JDL HIGHSTAT Investigative D03JEU DRUG__ID D03JEU D03JEU DRUGTYPE Small molecular drug D03JEU DRUGINCH 1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2-,3+,4-,6?/m0/s1 D03JEU DRUGINKE AEMOLEFTQBMNLQ-AQKNRBDQSA-N D03JEU DRUGSMIL C1(C(C(OC(C1O)O)C(=O)O)O)O D03JEU HIGHSTAT Investigative D03JEW DRUG__ID D03JEW D03JEW DRUGTYPE Small molecular drug D03JEW DRUGINCH 1S/C23H23N3O3/c27-23(20-8-7-18-3-1-2-4-19(18)15-20)24-21-11-13-25(14-12-21)16-17-5-9-22(10-6-17)26(28)29/h1-10,15,21H,11-14,16H2,(H,24,27) D03JEW DRUGINKE BAYSOSKDAJWQFJ-UHFFFAOYSA-N D03JEW DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)[N+](=O)[O-] D03JEW HIGHSTAT Investigative D03JFB DRUG__ID D03JFB D03JFB DRUGTYPE Small molecular drug D03JFB DRUGINCH 1S/C26H26ClN5O2/c27-20-10-12-21(13-11-20)31-32-26(34)30-24(16-19-17-29-23-9-5-4-8-22(19)23)25(33)28-15-14-18-6-2-1-3-7-18/h1-13,17,24,29,31H,14-16H2,(H,28,33)(H2,30,32,34)/t24-/m1/s1 D03JFB DRUGINKE SLTBMTIRYMGWLX-XMMPIXPASA-N D03JFB DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)NNC4=CC=C(C=C4)Cl D03JFB HIGHSTAT Investigative D03JFC DRUG__ID D03JFC D03JFC DRUGTYPE Small molecular drug D03JFC DRUGINCH 1S/C17H16N2O3/c1-2-10-18-17(20)21-13-7-5-6-12(11-13)16-19-14-8-3-4-9-15(14)22-16/h3-9,11H,2,10H2,1H3,(H,18,20) D03JFC DRUGINKE VWTFAQPOTOAJGW-UHFFFAOYSA-N D03JFC DRUGSMIL CCCNC(=O)OC1=CC=CC(=C1)C2=NC3=CC=CC=C3O2 D03JFC HIGHSTAT Investigative D03JFL DRUG__ID D03JFL D03JFL DRUGTYPE Small molecular drug D03JFL DRUGINCH 1S/C15H20O4S/c16-14(17)12(7-2-1-5-9-20)10-11-6-3-4-8-13(11)15(18)19/h3-4,6,8,12,20H,1-2,5,7,9-10H2,(H,16,17)(H,18,19) D03JFL DRUGINKE MLFBNUWBZSWDEZ-UHFFFAOYSA-N D03JFL DRUGSMIL C1=CC=C(C(=C1)CC(CCCCCS)C(=O)O)C(=O)O D03JFL HIGHSTAT Investigative D03JFU DRUG__ID D03JFU D03JFU DRUGTYPE Small molecular drug D03JFU DRUGINCH 1S/C3H9O3PS/c1-2-3(8)7(4,5)6/h3,8H,2H2,1H3,(H2,4,5,6) D03JFU DRUGINKE PMCCSSODVYHTNA-UHFFFAOYSA-N D03JFU DRUGSMIL CCC(P(=O)(O)O)S D03JFU HIGHSTAT Investigative D03JFX DRUG__ID D03JFX D03JFX DRUGTYPE Small molecular drug D03JFX DRUGINCH 1S/C7H9N5/c1-2-12-4-11-5-6(8)9-3-10-7(5)12/h3-4H,2H2,1H3,(H2,8,9,10) D03JFX DRUGINKE MUIPLRMGAXZWSQ-UHFFFAOYSA-N D03JFX DRUGSMIL CCN1C=NC2=C(N=CN=C21)N D03JFX HIGHSTAT Investigative D03JLK DRUG__ID D03JLK D03JLK DRUGTYPE Small molecular drug D03JLK DRUGINCH 1S/C37H45N7O6/c1-23(45)41-32(20-24-9-3-2-4-10-24)36(49)44-33(21-26-22-40-29-12-6-5-11-28(26)29)37(50)42-30(13-7-8-18-38)35(48)43-31(34(39)47)19-25-14-16-27(46)17-15-25/h2-6,9-12,14-17,22,30-33,40,46H,7-8,13,18-21,38H2,1H3,(H2,39,47)(H,41,45)(H,42,50)(H,43,48)(H,44,49)/t30-,31-,32-,33-/m0/s1 D03JLK DRUGINKE YBFQDCKGFBIRPS-YRCZKMHPSA-N D03JLK DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N D03JLK HIGHSTAT Investigative D03JMD DRUG__ID D03JMD D03JMD DRUGTYPE Small molecular drug D03JMD DRUGINCH 1S/C9H9N3S.BrH/c10-5-7-1-3-8(4-2-7)6-13-9(11)12;/h1-4H,6H2,(H3,11,12);1H D03JMD DRUGINKE ONSRFABKCKXUCK-UHFFFAOYSA-N D03JMD DRUGSMIL C1=CC(=CC=C1CSC(=N)N)C#N.Br D03JMD HIGHSTAT Investigative D03JNC DRUG__ID D03JNC D03JNC DRUGTYPE Small molecular drug D03JNC DRUGINCH 1S/C38H50O6/c1-22(2)11-13-27(25(7)8)20-37-21-28(15-12-23(3)4)36(9,10)38(35(37)44,18-17-24(5)6)34(43)31(33(37)42)32(41)26-14-16-29(39)30(40)19-26/h11-12,14,16-17,19,27-28,39-41H,7,13,15,18,20-21H2,1-6,8-10H3/b32-31-/t27-,28+,37+,38-/m0/s1 D03JNC DRUGINKE DTTONLKLWRTCAB-BZSUNBQASA-N D03JNC DRUGSMIL CC(=CCC1CC2(C(=O)C(=C(C3=CC(=C(C=C3)O)O)O)C(=O)C(C2=O)(C1(C)C)CC=C(C)C)CC(CC=C(C)C)C(=C)C)C D03JNC HIGHSTAT Investigative D03JOS DRUG__ID D03JOS D03JOS DRUGTYPE Small molecular drug D03JOS DRUGINCH 1S/C19H21N3/c1-2-6-17(7-3-1)22-12-10-21(11-13-22)15-16-14-20-19-9-5-4-8-18(16)19/h1-9,14,20H,10-13,15H2 D03JOS DRUGINKE FDOZNCJWYJMHAG-UHFFFAOYSA-N D03JOS DRUGSMIL C1CN(CCN1CC2=CNC3=CC=CC=C32)C4=CC=CC=C4 D03JOS HIGHSTAT Investigative D03JOX DRUG__ID D03JOX D03JOX DRUGTYPE Small molecular drug D03JOX DRUGINCH 1S/C16H23NO/c1-3-8-15(17-11-6-7-12-17)16(18)14-10-5-4-9-13(14)2/h4-5,9-10,15H,3,6-8,11-12H2,1-2H3 D03JOX DRUGINKE VVIVTDYOMWHKAE-UHFFFAOYSA-N D03JOX DRUGSMIL CCCC(C(=O)C1=CC=CC=C1C)N2CCCC2 D03JOX HIGHSTAT Investigative D03JPL DRUG__ID D03JPL D03JPL DRUGTYPE Small molecular drug D03JPL DRUGINCH 1S/C12H24O3/c13-11-9-7-5-3-1-2-4-6-8-10-12(14)15/h13H,1-11H2,(H,14,15) D03JPL DRUGINKE ZDHCZVWCTKTBRY-UHFFFAOYSA-N D03JPL DRUGSMIL C(CCCCCC(=O)O)CCCCCO D03JPL HIGHSTAT Investigative D03JPN DRUG__ID D03JPN D03JPN DRUGTYPE Small molecular drug D03JPN DRUGINCH 1S/C17H20N4/c1-20-9-14-11-21(12-15(14)10-20)17-8-7-16(18-19-17)13-5-3-2-4-6-13/h2-8,14-15H,9-12H2,1H3 D03JPN DRUGINKE GTMRUYCIJSNXGB-UHFFFAOYSA-N D03JPN DRUGSMIL CN1CC2CN(CC2C1)C3=NN=C(C=C3)C4=CC=CC=C4 D03JPN HIGHSTAT Investigative D03JQD DRUG__ID D03JQD D03JQD DRUGTYPE Small molecular drug D03JQD DRUGINCH 1S/C20H17F3N2O2S/c1-2-28(26)19-24-17(12-18(25-19)20(21,22)23)15-9-6-10-16(11-15)27-13-14-7-4-3-5-8-14/h3-12H,2,13H2,1H3 D03JQD DRUGINKE NTDFYGSSDDMNHI-UHFFFAOYSA-N D03JQD DRUGSMIL CCS(=O)C1=NC(=CC(=N1)C(F)(F)F)C2=CC(=CC=C2)OCC3=CC=CC=C3 D03JQD HIGHSTAT Investigative D03JRX DRUG__ID D03JRX D03JRX DRUGTYPE Small molecular drug D03JRX DRUGINCH 1S/C26H40N2O/c1-3-4-5-6-7-8-9-10-11-14-19-27-26-22-15-12-13-16-24(22)28-25-18-17-21(29-2)20-23(25)26/h17-18,20H,3-16,19H2,1-2H3,(H,27,28) D03JRX DRUGINKE YFVGMWQTMYFWMS-UHFFFAOYSA-N D03JRX DRUGSMIL CCCCCCCCCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D03JRX HIGHSTAT Investigative D03JTS DRUG__ID D03JTS D03JTS DRUGTYPE Small molecular drug D03JTS DRUGINCH 1S/C12H8N2O2/c13-9-5-4-8-10-6(9)2-1-3-7(10)11(15)14-12(8)16/h1-5H,13H2,(H,14,15,16) D03JTS DRUGINKE SSMIFVHARFVINF-UHFFFAOYSA-N D03JTS DRUGSMIL C1=CC2=C(C=CC3=C2C(=C1)C(=O)NC3=O)N D03JTS HIGHSTAT Investigative D03JWH DRUG__ID D03JWH D03JWH DRUGTYPE Small molecular drug D03JWH DRUGINCH 1S/C12H14N2OS/c1-3-10-11(15)14-12(16-10)13-9-7-5-4-6-8(9)2/h4-7,10H,3H2,1-2H3,(H,13,14,15) D03JWH DRUGINKE CWOSTWNWVJUZID-UHFFFAOYSA-N D03JWH DRUGSMIL CCC1C(=O)NC(=NC2=CC=CC=C2C)S1 D03JWH HIGHSTAT Investigative D03JXX DRUG__ID D03JXX D03JXX DRUGTYPE Small molecular drug D03JXX DRUGINCH 1S/C6H12N2/c1-4-3-6(7)8-5(4)2/h4-5H,3H2,1-2H3,(H2,7,8) D03JXX DRUGINKE HLFGYTAETWRDBS-UHFFFAOYSA-N D03JXX DRUGSMIL CC1CC(=NC1C)N D03JXX HIGHSTAT Investigative D03JYN DRUG__ID D03JYN D03JYN DRUGTYPE Small molecular drug D03JYN DRUGINCH 1S/C15H15N3S/c1-11-7-9-13(10-8-11)14(17-18-15(16)19)12-5-3-2-4-6-12/h2-10H,1H3,(H3,16,18,19)/b17-14+ D03JYN DRUGINKE DZOZYORQEZEOCT-SAPNQHFASA-N D03JYN DRUGSMIL CC1=CC=C(C=C1)C(=NNC(=S)N)C2=CC=CC=C2 D03JYN HIGHSTAT Investigative D03JZQ DRUG__ID D03JZQ D03JZQ DRUGTYPE Small molecular drug D03JZQ DRUGINCH 1S/C21H15NOS/c23-19-8-4-7-16(11-19)20-12-18(15-5-2-1-3-6-15)13-21(22-20)17-9-10-24-14-17/h1-14,23H D03JZQ DRUGINKE GZCPVCLLSOKGCF-UHFFFAOYSA-N D03JZQ DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CSC=C3)C4=CC(=CC=C4)O D03JZQ HIGHSTAT Investigative D03KAQ DRUG__ID D03KAQ D03KAQ DRUGTYPE Small molecular drug D03KAQ DRUGINCH 1S/C25H32N2O/c1-27-12-11-25-10-6-5-9-21(25)23(27)14-19-13-20(24(28)15-22(19)25)17-26-16-18-7-3-2-4-8-18/h2-4,7-8,13,15,21,23,26,28H,5-6,9-12,14,16-17H2,1H3/t21-,23+,25+/m0/s1 D03KAQ DRUGINKE BGGKLNVUQJUZIE-QQKQFIJSSA-N D03KAQ DRUGSMIL CN1CCC23CCCCC2C1CC4=CC(=C(C=C34)O)CNCC5=CC=CC=C5 D03KAQ HIGHSTAT Investigative D03KBV DRUG__ID D03KBV D03KBV DRUGTYPE Small molecular drug D03KBV DRUGINCH 1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9) D03KBV DRUGINKE GXIURPTVHJPJLF-UHFFFAOYSA-N D03KBV DRUGSMIL C(C(C(=O)O)OP(=O)(O)O)O D03KBV HIGHSTAT Investigative D03KDD DRUG__ID D03KDD D03KDD DRUGTYPE Small molecular drug D03KDD DRUGINCH 1S/C9H12N2/c1-3-7-11(2)8-9-5-4-6-10-9/h1,4-6,10H,7-8H2,2H3 D03KDD DRUGINKE PFQFUSNKIZWHOA-UHFFFAOYSA-N D03KDD DRUGSMIL CN(CC#C)CC1=CC=CN1 D03KDD HIGHSTAT Investigative D03KGX DRUG__ID D03KGX D03KGX DRUGTYPE Small molecular drug D03KGX DRUGINCH 1S/C30H48O5/c1-18-9-14-30(24(33)34)16-15-27(4)19(23(30)29(18,6)35)7-8-21-25(2)12-11-22(32)26(3,17-31)20(25)10-13-28(21,27)5/h7,18,20-23,31-32,35H,8-17H2,1-6H3,(H,33,34)/t18-,20-,21-,22+,23-,25+,26-,27-,28-,29-,30+/m1/s1 D03KGX DRUGINKE YLHQFGOOMKJFLP-VNUPIYKRSA-N D03KGX DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)O D03KGX HIGHSTAT Investigative D03KJL DRUG__ID D03KJL D03KJL DRUGTYPE Small molecular drug D03KJL DRUGINCH 1S/C6H4INO4/c9-7(10)5-1-3-6(4-2-5)8(11)12/h1-4H D03KJL DRUGINKE BMXXYWBYOJKMLW-UHFFFAOYSA-N D03KJL DRUGSMIL C1=CC(=CC=C1[N+](=O)[O-])I(=O)=O D03KJL HIGHSTAT Investigative D03KKH DRUG__ID D03KKH D03KKH DRUGTYPE Small molecular drug D03KKH DRUGINCH 1S/C8H9NO2/c9-7(8(10)11)6-4-2-1-3-5-6/h1-5,7H,9H2,(H,10,11)/t7-/m0/s1 D03KKH DRUGINKE ZGUNAGUHMKGQNY-ZETCQYMHSA-N D03KKH DRUGSMIL C1=CC=C(C=C1)C(C(=O)O)N D03KKH HIGHSTAT Investigative D03KKK DRUG__ID D03KKK D03KKK DRUGTYPE Small molecular drug D03KKK DRUGINCH 1S/C11H16N4O2/c1-3-5-14-9-8(12-7-13-9)10(16)15(6-4-2)11(14)17/h7H,3-6H2,1-2H3,(H,12,13) D03KKK DRUGINKE MJVIGUCNSRXAFO-UHFFFAOYSA-N D03KKK DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC=N2 D03KKK HIGHSTAT Investigative D03KKR DRUG__ID D03KKR D03KKR DRUGTYPE Small molecular drug D03KKR DRUGINCH 1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2 D03KKR DRUGINKE NGOGFTYYXHNFQH-UHFFFAOYSA-N D03KKR DRUGSMIL C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3 D03KKR HIGHSTAT Investigative D03KLN DRUG__ID D03KLN D03KLN DRUGTYPE Small molecular drug D03KLN DRUGINCH 1S/C14H12N2O/c1-17-14-9-12-5-3-2-4-11(12)8-13(14)16-7-6-15-10-16/h2-10H,1H3 D03KLN DRUGINKE HDJQGQGNKJFUSV-UHFFFAOYSA-N D03KLN DRUGSMIL COC1=CC2=CC=CC=C2C=C1N3C=CN=C3 D03KLN HIGHSTAT Investigative D03KLO DRUG__ID D03KLO D03KLO DRUGTYPE Small molecular drug D03KLO DRUGINCH 1S/C10H13N3/c1-4-8-12-9-6(2)5-7(3)11-10(9)13-8/h5H,4H2,1-3H3,(H,11,12,13) D03KLO DRUGINKE XWWJWZJOSWSJQV-UHFFFAOYSA-N D03KLO DRUGSMIL CCC1=NC2=C(N1)C(=CC(=N2)C)C D03KLO HIGHSTAT Investigative D03KLT DRUG__ID D03KLT D03KLT DRUGTYPE Small molecular drug D03KLT DRUGINCH 1S/C24H32N8O7/c25-24(26)27-8-4-7-15-20(36)28-11-18(33)30-16(10-19(34)35)21(37)29-14-9-17(22(38)31-15)32(12-14)23(39)13-5-2-1-3-6-13/h1-3,5-6,14-17H,4,7-12H2,(H,28,36)(H,29,37)(H,30,33)(H,31,38)(H,34,35)(H4,25,26,27)/t14-,15-,16-,17-/m0/s1 D03KLT DRUGINKE UIBGFNHGJUQMPO-QAETUUGQSA-N D03KLT DRUGSMIL C1C2CN(C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N)C(=O)C3=CC=CC=C3 D03KLT HIGHSTAT Investigative D03KLU DRUG__ID D03KLU D03KLU DRUGCOMP Creabilis Therapeutics SpA D03KLU DRUGINCH 1S/C10H12F3N3O4/c11-10(12,13)4-2-16(9(19)15-8(4)14)7-1-5(18)6(3-17)20-7/h2,5-7,17-18H,1,3H2,(H2,14,15,19)/t5-,6+,7+/m0/s1 D03KLU DRUGINKE XNSPCSMIPDACTB-RRKCRQDMSA-N D03KLU DRUGSMIL C1C(C(OC1N2C=C(C(=NC2=O)N)C(F)(F)F)CO)O D03KLU HIGHSTAT Investigative D03KLW DRUG__ID D03KLW D03KLW DRUGTYPE Small molecular drug D03KLW DRUGINCH 1S/C14H11ClF3N3S/c15-8-1-2-13(20-7-8)21-14(22)19-4-3-10-11(17)5-9(16)6-12(10)18/h1-2,5-7H,3-4H2,(H2,19,20,21,22) D03KLW DRUGINKE FSXKIIYITCFGGK-UHFFFAOYSA-N D03KLW DRUGSMIL C1=CC(=NC=C1Cl)NC(=S)NCCC2=C(C=C(C=C2F)F)F D03KLW HIGHSTAT Investigative D03KMG DRUG__ID D03KMG D03KMG DRUGTYPE Small molecular drug D03KMG DRUGINCH 1S/C13H19NO2S/c1-11-7-6-8-12(2)14(11)17(15,16)13-9-4-3-5-10-13/h3-5,9-12H,6-8H2,1-2H3/t11-,12+ D03KMG DRUGINKE JINDARNDFYFWDT-TXEJJXNPSA-N D03KMG DRUGSMIL CC1CCCC(N1S(=O)(=O)C2=CC=CC=C2)C D03KMG HIGHSTAT Investigative D03KNI DRUG__ID D03KNI D03KNI DRUGTYPE Small molecular drug D03KNI DRUGINCH 1S/C19H26FN3O5S/c1-27-18-17(15-11-14(20)3-4-16(15)22-18)19(24)28-12-13-5-8-23(9-6-13)10-7-21-29(2,25)26/h3-4,11,13,21-22H,5-10,12H2,1-2H3 D03KNI DRUGINKE SSPCCAYAIDNNJX-UHFFFAOYSA-N D03KNI DRUGSMIL COC1=C(C2=C(N1)C=CC(=C2)F)C(=O)OCC3CCN(CC3)CCNS(=O)(=O)C D03KNI HIGHSTAT Investigative D03KPA DRUG__ID D03KPA D03KPA DRUGTYPE Small molecular drug D03KPA DRUGINCH 1S/C16H22N2/c1-2-13-5-6-16-15(11-13)14(12-17-16)7-10-18-8-3-4-9-18/h5-6,11-12,17H,2-4,7-10H2,1H3 D03KPA DRUGINKE PWLIYMBPGFVKOO-UHFFFAOYSA-N D03KPA DRUGSMIL CCC1=CC2=C(C=C1)NC=C2CCN3CCCC3 D03KPA HIGHSTAT Investigative D03KQG DRUG__ID D03KQG D03KQG DRUGTYPE Small molecular drug D03KQG DRUGINCH 1S/C5H11N3S/c6-5(9)7-8-3-1-2-4-8/h1-4H2,(H3,6,7,9) D03KQG DRUGINKE LUZJFNYVKQEEGM-UHFFFAOYSA-N D03KQG DRUGSMIL C1CCN(C1)NC(=S)N D03KQG HIGHSTAT Investigative D03KRB DRUG__ID D03KRB D03KRB DRUGTYPE Small molecular drug D03KRB DRUGINCH 1S/C10H10N4O4S3/c11-20(15,16)9-5-13-3-1-7(9)19-8-2-4-14-6-10(8)21(12,17)18/h1-6H,(H2,11,15,16)(H2,12,17,18) D03KRB DRUGINKE JYMNSJBFCKCLMB-UHFFFAOYSA-N D03KRB DRUGSMIL C1=CN=CC(=C1SC2=C(C=NC=C2)S(=O)(=O)N)S(=O)(=O)N D03KRB HIGHSTAT Investigative D03KRW DRUG__ID D03KRW D03KRW DRUGTYPE Small molecular drug D03KRW DRUGINCH 1S/C19H23NO4S/c1-24-17-8-10-18(11-9-17)25(22,23)20-14-5-12-19(21,13-15-20)16-6-3-2-4-7-16/h2-4,6-11,21H,5,12-15H2,1H3 D03KRW DRUGINKE CTMRNVLOBOSBEA-UHFFFAOYSA-N D03KRW DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)N2CCCC(CC2)(C3=CC=CC=C3)O D03KRW HIGHSTAT Investigative D03KSL DRUG__ID D03KSL D03KSL DRUGTYPE Small molecular drug D03KSL DRUGINCH 1S/C22H24BrNO3/c1-14(11-22(25)26)10-19-15(2)24(13-16-4-6-17(23)7-5-16)21-9-8-18(27-3)12-20(19)21/h4-9,12,14H,10-11,13H2,1-3H3,(H,25,26) D03KSL DRUGINKE AXFSURYONUFFTK-UHFFFAOYSA-N D03KSL DRUGSMIL CC1=C(C2=C(N1CC3=CC=C(C=C3)Br)C=CC(=C2)OC)CC(C)CC(=O)O D03KSL HIGHSTAT Investigative D03KTU DRUG__ID D03KTU D03KTU DRUGTYPE Small molecular drug D03KTU DRUGINCH 1S/C21H29N5O3.C6H6O3S/c1-14-13-17(29-6)7-8-18(14)19-15(2)24-26-20(19)22-16(3)23-21(26)25(9-11-27-4)10-12-28-5;7-10(8,9)6-4-2-1-3-5-6/h7-8,13H,9-12H2,1-6H3;1-5H,(H,7,8,9) D03KTU DRUGINKE ZQUBMILBXQLTDU-UHFFFAOYSA-N D03KTU DRUGSMIL CC1=C(C=CC(=C1)OC)C2=C3N=C(N=C(N3N=C2C)N(CCOC)CCOC)C.C1=CC=C(C=C1)S(=O)(=O)O D03KTU HIGHSTAT Investigative D03KUH DRUG__ID D03KUH D03KUH DRUGTYPE Small molecular drug D03KUH DRUGINCH 1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1 D03KUH DRUGINKE AADCDMQTJNYOSS-LBPRGKRZSA-N D03KUH DRUGSMIL CCC1=CC(=C(C(=C1O)C(=O)NCC2CCCN2CC)OC)Cl D03KUH HIGHSTAT Investigative D03KXQ DRUG__ID D03KXQ D03KXQ DRUGTYPE Small molecular drug D03KXQ DRUGINCH 1S/C17H25N3O2/c1-12(2)15(18)17(22)20-10-6-9-14(20)16(21)19-11-13-7-4-3-5-8-13/h3-5,7-8,12,14-15H,6,9-11,18H2,1-2H3,(H,19,21)/t14-,15-/m0/s1 D03KXQ DRUGINKE LCASDNOITBVYIV-GJZGRUSLSA-N D03KXQ DRUGSMIL CC(C)C(C(=O)N1CCCC1C(=O)NCC2=CC=CC=C2)N D03KXQ HIGHSTAT Investigative D03KXT DRUG__ID D03KXT D03KXT DRUGTYPE Small molecular drug D03KXT DRUGINCH 1S/C17H17N3O/c1(2-15-7-9-18-10-8-15)13-21-17-5-3-16(4-6-17)20-12-11-19-14-20/h3-12,14H,1-2,13H2 D03KXT DRUGINKE PFAUOLMRDJNYLJ-UHFFFAOYSA-N D03KXT DRUGSMIL C1=CC(=CC=C1N2C=CN=C2)OCCCC3=CC=NC=C3 D03KXT HIGHSTAT Investigative D03KYW DRUG__ID D03KYW D03KYW DRUGTYPE Small molecular drug D03KYW DRUGINCH 1S/C21H32O2/c1-13-11-14-12-15(22)5-8-19(14,2)16-6-9-20(3)17(18(13)16)7-10-21(20,4)23/h12-13,16-18,23H,5-11H2,1-4H3/t13-,16-,17-,18+,19-,20-,21-/m0/s1 D03KYW DRUGINKE IVFYLRMMHVYGJH-PVPPCFLZSA-N D03KYW DRUGSMIL CC1CC2=CC(=O)CCC2(C3C1C4CCC(C4(CC3)C)(C)O)C D03KYW HIGHSTAT Investigative D03KYZ DRUG__ID D03KYZ D03KYZ DRUGTYPE Small molecular drug D03KYZ DRUGINCH 1S/C17H19ClN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 D03KYZ DRUGINKE JFADNUHMEURSIM-LBPRGKRZSA-N D03KYZ DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)Cl D03KYZ HIGHSTAT Investigative D03KZH DRUG__ID D03KZH D03KZH DRUGTYPE Small molecular drug D03KZH DRUGINCH 1S/C35H41N5O4/c1-24(36-2)33(42)37-29-23-39(31(41)22-25-12-6-3-7-13-25)21-20-28-18-19-30(40(28)35(29)44)34(43)38-32(26-14-8-4-9-15-26)27-16-10-5-11-17-27/h3-17,24,28-30,32,36H,18-23H2,1-2H3,(H,37,42)(H,38,43)/t24-,28+,29-,30-/m0/s1 D03KZH DRUGINKE YBYZHVZWINISJO-XPSCAIQQSA-N D03KZH DRUGSMIL CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)CC5=CC=CC=C5)NC D03KZH HIGHSTAT Investigative D03KZK DRUG__ID D03KZK D03KZK DRUGTYPE Small molecular drug D03KZK DRUGINCH 1S/C4H12NO3P/c1-9(7,8)3-4(6)2-5/h4,6H,2-3,5H2,1H3,(H,7,8) D03KZK DRUGINKE FUUPFUIGNBPCAY-UHFFFAOYSA-N D03KZK DRUGSMIL CP(=O)(CC(CN)O)O D03KZK HIGHSTAT Investigative D03LBD DRUG__ID D03LBD D03LBD DRUGCOMP GenSpera Inc D03LBD DRUGINCH 1S/C20H24F2N4O.3ClH/c1-14-2-3-15(13-26-8-6-23-7-9-26)10-19(14)25-20(27)12-24-16-4-5-17(21)18(22)11-16;;;/h2-5,10-11,23-24H,6-9,12-13H2,1H3,(H,25,27);3*1H D03LBD DRUGINKE WSBRAHWNJBXXJM-UHFFFAOYSA-N D03LBD DRUGSMIL CC1=C(C=C(C=C1)CN2CCNCC2)NC(=O)CNC3=CC(=C(C=C3)F)F.Cl.Cl.Cl D03LBD HIGHSTAT Investigative D03LCM DRUG__ID D03LCM D03LCM DRUGTYPE Small molecular drug D03LCM DRUGINCH 1S/C12H8Cl2N2O/c13-9-4-1-3-8(7-9)12(17)16-11-6-2-5-10(14)15-11/h1-7H,(H,15,16,17) D03LCM DRUGINKE FCJWDXAXERKUEZ-UHFFFAOYSA-N D03LCM DRUGSMIL C1=CC(=CC(=C1)Cl)C(=O)NC2=NC(=CC=C2)Cl D03LCM HIGHSTAT Investigative D03LDH DRUG__ID D03LDH D03LDH DRUGTYPE Small molecular drug D03LDH DRUGINCH 1S/C21H26N2O/c1-2-6-18(7-3-1)16-22-12-14-23(15-13-22)17-20-11-10-19-8-4-5-9-21(19)24-20/h1-9,20H,10-17H2 D03LDH DRUGINKE AJZBPCAHQHCXMX-UHFFFAOYSA-N D03LDH DRUGSMIL C1CC2=CC=CC=C2OC1CN3CCN(CC3)CC4=CC=CC=C4 D03LDH HIGHSTAT Investigative D03LGM DRUG__ID D03LGM D03LGM DRUGTYPE Small molecular drug D03LGM DRUGINCH 1S/C23H29N3O2/c1-2-15-25-22(27)19-14-9-16-26(19)23(28)21(24)20(17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19-21H,2,9,14-16,24H2,1H3,(H,25,27)/t19-,21+/m0/s1 D03LGM DRUGINKE HZKKJPDVZGOOPU-PZJWPPBQSA-N D03LGM DRUGSMIL CCCNC(=O)C1CCCN1C(=O)C(C(C2=CC=CC=C2)C3=CC=CC=C3)N D03LGM HIGHSTAT Investigative D03LGV DRUG__ID D03LGV D03LGV DRUGTYPE Small molecular drug D03LGV DRUGINCH 1S/C9H9ClFN/c10-7-3-1-6(2-4-7)9(11)5-8(9)12/h1-4,8H,5,12H2/t8-,9-/m0/s1 D03LGV DRUGINKE UTADHPUNQUNGFZ-IUCAKERBSA-N D03LGV DRUGSMIL C1C(C1(C2=CC=C(C=C2)Cl)F)N D03LGV HIGHSTAT Investigative D03LGX DRUG__ID D03LGX D03LGX DRUGCOMP Neurimmune Therapeutics AG D03LGX DRUGINCH 1S/C16H15F3N2O3/c1-8-13(10(3)22)14(15(21(23)24)9(2)20-8)11-6-4-5-7-12(11)16(17,18)19/h4-7,14,20H,1-3H3 D03LGX DRUGINKE YYIGWZQIEFYARO-UHFFFAOYSA-N D03LGX DRUGSMIL CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC=C2C(F)(F)F)C(=O)C D03LGX HIGHSTAT Investigative D03LHJ DRUG__ID D03LHJ D03LHJ DRUGTYPE Small molecular drug D03LHJ DRUGINCH 1S/C14H14O4/c1-3-8-17-11-6-4-10-5-7-12(16)18-14(10)13(11)9(2)15/h4-7H,3,8H2,1-2H3 D03LHJ DRUGINKE XDGJEUMPGBUXDY-UHFFFAOYSA-N D03LHJ DRUGSMIL CCCOC1=C(C2=C(C=C1)C=CC(=O)O2)C(=O)C D03LHJ HIGHSTAT Investigative D03LIP DRUG__ID D03LIP D03LIP DRUGTYPE Small molecular drug D03LIP DRUGINCH 1S/C25H21N5O2/c1-17-28-29-24-23(27-25(31)32-16-18-10-4-2-5-11-18)26-22(19-12-6-3-7-13-19)20-14-8-9-15-21(20)30(17)24/h2-15,23H,16H2,1H3,(H,27,31) D03LIP DRUGINKE TUWDLUFFAHHNEF-UHFFFAOYSA-N D03LIP DRUGSMIL CC1=NN=C2N1C3=CC=CC=C3C(=NC2NC(=O)OCC4=CC=CC=C4)C5=CC=CC=C5 D03LIP HIGHSTAT Investigative D03LIS DRUG__ID D03LIS D03LIS DRUGTYPE Small molecular drug D03LIS DRUGINCH 1S/C9H12N2O5Se/c10-8(15)3-2-17-9(11-3)7-6(14)5(13)4(1-12)16-7/h2,4-7,12-14H,1H2,(H2,10,15)/t4-,5-,6-,7-/m1/s1 D03LIS DRUGINKE CKMBACZHCFMPLQ-DBRKOABJSA-N D03LIS DRUGSMIL C1=C(N=C([Se]1)C2C(C(C(O2)CO)O)O)C(=O)N D03LIS HIGHSTAT Investigative D03LJX DRUG__ID D03LJX D03LJX DRUGTYPE Small molecular drug D03LJX DRUGINCH 1S/C15H10BrNO2/c16-10-6-7-12-11(8-10)13(17)15(19-12)14(18)9-4-2-1-3-5-9/h1-8H,17H2 D03LJX DRUGINKE SBFAYONAJFSEPC-UHFFFAOYSA-N D03LJX DRUGSMIL C1=CC=C(C=C1)C(=O)C2=C(C3=C(O2)C=CC(=C3)Br)N D03LJX HIGHSTAT Investigative D03LLM DRUG__ID D03LLM D03LLM DRUGTYPE Small molecular drug D03LLM DRUGINCH 1S/C39H72O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(41)43-36-37(35-40)44-39(42)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h12,14,18,20,37,40H,3-11,13,15-17,19,21-36H2,1-2H3/b14-12-,20-18-/t37-/m0/s1 D03LLM DRUGINKE AJMZUFBKADIAKC-SKTOPKGQSA-N D03LLM DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCCCCC D03LLM HIGHSTAT Investigative D03LMH DRUG__ID D03LMH D03LMH DRUGTYPE Small molecular drug D03LMH DRUGINCH 1S/C25H38N4O8/c1-14(2)20(25(36)37)28-22(33)15(3)27-24(35)21(16(4)30)29-23(34)18(10-11-19(31)32)26-13-12-17-8-6-5-7-9-17/h5-9,14-16,18,20-21,26,30H,10-13H2,1-4H3,(H,27,35)(H,28,33)(H,29,34)(H,31,32)(H,36,37)/t15-,16?,18-,20-,21-/m0/s1 D03LMH DRUGINKE DJKUAJMLBSOLFF-GDEPEFMTSA-N D03LMH DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCC1=CC=CC=C1 D03LMH HIGHSTAT Investigative D03LMM DRUG__ID D03LMM D03LMM DRUGTYPE Small molecular drug D03LMM DRUGINCH 1S/C20H40N4O10/c1-6(25)14-11(27)10(26)9(23)18(32-14)33-15-7(21)4-8(22)16(12(15)28)34-19-13(29)17(24-3)20(2,30)5-31-19/h6-19,24-30H,4-5,21-23H2,1-3H3/t6-,7+,8-,9-,10-,11+,12+,13-,14-,15-,16+,17-,18-,19-,20+/m1/s1 D03LMM DRUGINKE BRZYSWJRSDMWLG-DJWUNRQOSA-N D03LMM DRUGSMIL CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O D03LMM HIGHSTAT Investigative D03LMR DRUG__ID D03LMR D03LMR DRUGTYPE Small molecular drug D03LMR DRUGINCH 1S/C19H17NO3/c1-2-23-19(22)16-12-20-17-9-8-14(11-15(17)18(16)21)10-13-6-4-3-5-7-13/h3-9,11-12H,2,10H2,1H3,(H,20,21) D03LMR DRUGINKE WQYYZNGOTUCWQX-UHFFFAOYSA-N D03LMR DRUGSMIL CCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC3=CC=CC=C3 D03LMR HIGHSTAT Investigative D03LNF DRUG__ID D03LNF D03LNF DRUGTYPE Small molecular drug D03LNF DRUGINCH 1S/C16H17N3O4S/c1-19-10-11-9-12(7-8-13(11)17-16(19)20)18-24(21,22)15-6-4-3-5-14(15)23-2/h3-9,18H,10H2,1-2H3,(H,17,20) D03LNF DRUGINKE TXZPMHLMPKIUGK-UHFFFAOYSA-N D03LNF DRUGSMIL CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O D03LNF HIGHSTAT Investigative D03LOG DRUG__ID D03LOG D03LOG DRUGTYPE Small molecular drug D03LOG DRUGINCH 1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9- D03LOG DRUGINKE OYHQOLUKZRVURQ-HZJYTTRNSA-N D03LOG DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)O D03LOG HIGHSTAT Investigative D03LPH DRUG__ID D03LPH D03LPH DRUGTYPE Small molecular drug D03LPH DRUGINCH 1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2 D03LPH DRUGINKE CFTOTSJVQRFXOF-UHFFFAOYSA-N D03LPH DRUGSMIL C1CNCC2=C1C3=CC=CC=C3N2 D03LPH HIGHSTAT Investigative D03LRN DRUG__ID D03LRN D03LRN DRUGTYPE Small molecular drug D03LRN DRUGINCH 1S/C7H16O2P2/c1-6(2)7(3,8)4-5-9-11-10/h6,8,10H,4-5H2,1-3H3 D03LRN DRUGINKE VODAHBTZSLKFBN-UHFFFAOYSA-N D03LRN DRUGSMIL CC(C)C(C)(CCOP=P)O D03LRN HIGHSTAT Investigative D03LRQ DRUG__ID D03LRQ D03LRQ DRUGTYPE Small molecular drug D03LRQ DRUGINCH 1S/C13H11NO3/c15-12(16)9-14-7-6-11(8-14)13(17)10-4-2-1-3-5-10/h1-8H,9H2,(H,15,16) D03LRQ DRUGINKE NFEXRSVGIRNYEZ-UHFFFAOYSA-N D03LRQ DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CN(C=C2)CC(=O)O D03LRQ HIGHSTAT Investigative D03LRY DRUG__ID D03LRY D03LRY DRUGTYPE Small molecular drug D03LRY DRUGINCH 1S/C12H13NO/c1-14-11-5-6-12-9(7-11)3-2-4-10(12)8-13/h2-7H,8,13H2,1H3 D03LRY DRUGINKE HOVVWANIDLIBGI-UHFFFAOYSA-N D03LRY DRUGSMIL COC1=CC2=C(C=C1)C(=CC=C2)CN D03LRY HIGHSTAT Investigative D03LSH DRUG__ID D03LSH D03LSH DRUGTYPE Small molecular drug D03LSH DRUGINCH 1S/C21H22ClN3O2/c1-24-11-9-14(10-12-24)13-19(26)25-18-8-3-2-5-15(18)21(27)23-17-7-4-6-16(22)20(17)25/h2-8,14H,9-13H2,1H3,(H,23,27) D03LSH DRUGINKE UFJWXHOFKIGIAF-UHFFFAOYSA-N D03LSH DRUGSMIL CN1CCC(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2C(=CC=C4)Cl D03LSH HIGHSTAT Investigative D03LVI DRUG__ID D03LVI D03LVI DRUGTYPE Small molecular drug D03LVI DRUGINCH 1S/C15H10Cl4N2O3S/c16-10-3-7-12(8-4-10)25-14(15(17,18)19)20-13(22)9-1-5-11(6-2-9)21(23)24/h1-8,14H,(H,20,22) D03LVI DRUGINKE DNTIPHKVCXUYRM-UHFFFAOYSA-N D03LVI DRUGSMIL C1=CC(=CC=C1C(=O)NC(C(Cl)(Cl)Cl)SC2=CC=C(C=C2)Cl)[N+](=O)[O-] D03LVI HIGHSTAT Investigative D03LVL DRUG__ID D03LVL D03LVL DRUGTYPE Small molecular drug D03LVL DRUGINCH 1S/C37H38BrF3N4O/c38-28-12-13-30-32(23-28)42-34(25-8-7-11-27(22-25)37(39,40)41)31(24-44-20-14-29(15-21-44)45-18-5-2-6-19-45)33(30)35(46)43-36(16-17-36)26-9-3-1-4-10-26/h1,3-4,7-13,22-23,29H,2,5-6,14-21,24H2,(H,43,46) D03LVL DRUGINKE UIVOZBSCHXCGPS-UHFFFAOYSA-N D03LVL DRUGSMIL C1CCN(CC1)C2CCN(CC2)CC3=C(C4=C(C=C(C=C4)Br)N=C3C5=CC(=CC=C5)C(F)(F)F)C(=O)NC6(CC6)C7=CC=CC=C7 D03LVL HIGHSTAT Investigative D03LVT DRUG__ID D03LVT D03LVT DRUGTYPE Small molecular drug D03LVT DRUGINCH 1S/C25H45NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-23(2)25(28)26-21-22-29-24(3)27/h16-17,20H,4-15,18-19,21-22H2,1-3H3,(H,26,28)/b17-16+,23-20+ D03LVT DRUGINKE QXKJTHBWYQHGEY-UEAIFQQQSA-N D03LVT DRUGSMIL CCCCCCCCCCCCCC=CCCC=C(C)C(=O)NCCOC(=O)C D03LVT HIGHSTAT Investigative D03LWV DRUG__ID D03LWV D03LWV DRUGTYPE Small molecular drug D03LWV DRUGINCH 1S/C16H27N3O6/c1-2-3-5-10(17)15(23)19-9-4-6-12(19)14(22)18-11(16(24)25)7-8-13(20)21/h10-12H,2-9,17H2,1H3,(H,18,22)(H,20,21)(H,24,25)/t10-,11-,12-/m0/s1 D03LWV DRUGINKE SGASVGGGJFNOSL-SRVKXCTJSA-N D03LWV DRUGSMIL CCCCC(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)O)N D03LWV HIGHSTAT Investigative D03LWY DRUG__ID D03LWY D03LWY DRUGTYPE Small molecular drug D03LWY DRUGINCH 1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2 D03LWY DRUGINKE QAOWNCQODCNURD-UHFFFAOYSA-L D03LWY DRUGSMIL [O-]S(=O)(=O)[O-] D03LWY HIGHSTAT Investigative D03MDA DRUG__ID D03MDA D03MDA DRUGTYPE Small molecular drug D03MDA DRUGINCH 1S/C15H15NO2S/c17-13-10-14(12-4-2-1-3-5-12)19-15(11-13)16-6-8-18-9-7-16/h1-5,10-11H,6-9H2 D03MDA DRUGINKE ZRGAPZKMQHRLTD-UHFFFAOYSA-N D03MDA DRUGSMIL C1COCCN1C2=CC(=O)C=C(S2)C3=CC=CC=C3 D03MDA HIGHSTAT Investigative D03MEI DRUG__ID D03MEI D03MEI DRUGTYPE Small molecular drug D03MEI DRUGINCH 1S/C19H23N5/c1-13-6-7-17(15(3)9-13)24-19-16(10-22-24)18(20-12-21-19)23-8-4-5-14(2)11-23/h6-7,9-10,12,14H,4-5,8,11H2,1-3H3 D03MEI DRUGINKE CLQVVBPDAXJGBV-UHFFFAOYSA-N D03MEI DRUGSMIL CC1CCCN(C1)C2=NC=NC3=C2C=NN3C4=C(C=C(C=C4)C)C D03MEI HIGHSTAT Investigative D03MHA DRUG__ID D03MHA D03MHA DRUGTYPE Small molecular drug D03MHA DRUGINCH 1S/C22H19N5/c1-15-12-27(14-25-15)18-7-4-6-17(11-18)26-22-20-10-9-16-5-2-3-8-19(16)21(20)23-13-24-22/h2-8,11-14H,9-10H2,1H3,(H,23,24,26) D03MHA DRUGINKE LFKNMCJSJZOQJF-UHFFFAOYSA-N D03MHA DRUGSMIL CC1=CN(C=N1)C2=CC=CC(=C2)NC3=NC=NC4=C3CCC5=CC=CC=C54 D03MHA HIGHSTAT Investigative D03MJJ DRUG__ID D03MJJ D03MJJ DRUGTYPE Small molecular drug D03MJJ DRUGINCH 1S/C14H17NO2S/c1-15(2)8-5-9-17-12-10-14(16)18-13-7-4-3-6-11(12)13/h3-4,6-7,10H,5,8-9H2,1-2H3 D03MJJ DRUGINKE DIOZFKOOIBATNZ-UHFFFAOYSA-N D03MJJ DRUGSMIL CN(C)CCCOC1=CC(=O)SC2=CC=CC=C21 D03MJJ HIGHSTAT Investigative D03MJM DRUG__ID D03MJM D03MJM DRUGTYPE Small molecular drug D03MJM DRUGINCH 1S/C8H9NO4/c10-6-8(13-9(11)12)7-4-2-1-3-5-7/h1-5,8,10H,6H2/t8-/m0/s1 D03MJM DRUGINKE HJZAIMHRCPGGNJ-QMMMGPOBSA-N D03MJM DRUGSMIL C1=CC=C(C=C1)C(CO)O[N+](=O)[O-] D03MJM HIGHSTAT Investigative D03MJQ DRUG__ID D03MJQ D03MJQ DRUGTYPE Small molecular drug D03MJQ DRUGINCH 1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/t1?,2-,3+,4-,5-,6?/m1/s1 D03MJQ DRUGINKE INAPMGSXUVUWAF-GCVPSNMTSA-N D03MJQ DRUGSMIL C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O D03MJQ HIGHSTAT Investigative D03MKT DRUG__ID D03MKT D03MKT DRUGTYPE Small molecular drug D03MKT DRUGINCH 1S/C15H12FN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9+ D03MKT DRUGINKE KVRYTKBSTLSXKC-FMIVXFBMSA-N D03MKT DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)F D03MKT HIGHSTAT Investigative D03MLC DRUG__ID D03MLC D03MLC DRUGTYPE Small molecular drug D03MLC DRUGINCH 1S/C16H12O7/c1-22-16-11(20)6-13-14(15(16)21)10(19)5-12(23-13)7-2-3-8(17)9(18)4-7/h2-6,17-18,20-21H,1H3 D03MLC DRUGINKE FHHSEFRSDKWJKJ-UHFFFAOYSA-N D03MLC DRUGSMIL COC1=C(C2=C(C=C1O)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O D03MLC HIGHSTAT Investigative D03MNO DRUG__ID D03MNO D03MNO DRUGTYPE Small molecular drug D03MNO DRUGINCH 1S/C16H20N2O9S/c1-8(19)27-6-9-7-28(24,25)15-12(26-2)14(21)18(15)11(9)13(20)17-5-3-4-10(17)16(22)23/h10,12,15H,3-7H2,1-2H3,(H,22,23)/t10-,12-,15+/m0/s1 D03MNO DRUGINKE SMZXYXKZTNLAKY-ITDIGPHOSA-N D03MNO DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)OC)S(=O)(=O)C1)C(=O)N3CCCC3C(=O)O D03MNO HIGHSTAT Investigative D03MOQ DRUG__ID D03MOQ D03MOQ DRUGTYPE Small molecular drug D03MOQ DRUGINCH 1S/C22H19ClN2O/c23-19-11-13-20(14-12-19)25-22(26)24-16-15-21(17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-15H,16H2,(H2,24,25,26) D03MOQ DRUGINKE BVFBYUIDPPDGCS-UHFFFAOYSA-N D03MOQ DRUGSMIL C1=CC=C(C=C1)C(=CCNC(=O)NC2=CC=C(C=C2)Cl)C3=CC=CC=C3 D03MOQ HIGHSTAT Investigative D03MQA DRUG__ID D03MQA D03MQA DRUGTYPE Small molecular drug D03MQA DRUGINCH 1S/C12H13NOS/c1-14-12-6-11(5-4-10(12)7-13)15-8-9-2-3-9/h4-6,9H,2-3,8H2,1H3 D03MQA DRUGINKE KLTYCOFPIFASIE-UHFFFAOYSA-N D03MQA DRUGSMIL COC1=C(C=CC(=C1)SCC2CC2)C#N D03MQA HIGHSTAT Investigative D03MQI DRUG__ID D03MQI D03MQI DRUGTYPE Small molecular drug D03MQI DRUGINCH 1S/C18H15NO4/c1-22-16-8-13-7-14(10-19-15(13)9-17(16)23-2)11-3-5-12(6-4-11)18(20)21/h3-10H,1-2H3,(H,20,21) D03MQI DRUGINKE YEEIRSIWKQULLK-UHFFFAOYSA-N D03MQI DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=C(C=C3)C(=O)O D03MQI HIGHSTAT Investigative D03MUW DRUG__ID D03MUW D03MUW DRUGTYPE Small molecular drug D03MUW DRUGINCH 1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/t3-/m0/s1 D03MUW DRUGINKE AWUCVROLDVIAJX-VKHMYHEASA-N D03MUW DRUGSMIL C(C(COP(=O)(O)O)O)O D03MUW HIGHSTAT Investigative D03MUZ DRUG__ID D03MUZ D03MUZ DRUGTYPE Small molecular drug D03MUZ DRUGINCH 1S/C20H13Cl2FN6/c21-16-4-12(1-2-18(16)23)29-19-11(6-24)7-27-20-15(19)3-13(5-17(20)22)26-9-14-8-25-10-28-14/h1-5,7-8,10,26H,9H2,(H,25,28)(H,27,29) D03MUZ DRUGINKE ONXROKMQGCSOMG-UHFFFAOYSA-N D03MUZ DRUGSMIL C1=CC(=C(C=C1NC2=C3C=C(C=C(C3=NC=C2C#N)Cl)NCC4=CN=CN4)Cl)F D03MUZ HIGHSTAT Investigative D03MVY DRUG__ID D03MVY D03MVY DRUGTYPE Small molecular drug D03MVY DRUGINCH 1S/C14H14N2S/c15-6-5-11-9-16-13-4-3-10(8-12(11)13)14-2-1-7-17-14/h1-4,7-9,16H,5-6,15H2 D03MVY DRUGINKE KULFBKTWESBCBG-UHFFFAOYSA-N D03MVY DRUGSMIL C1=CSC(=C1)C2=CC3=C(C=C2)NC=C3CCN D03MVY HIGHSTAT Investigative D03MYL DRUG__ID D03MYL D03MYL DRUGTYPE Small molecular drug D03MYL DRUGINCH 1S/C21H44NO9P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-20(24)29-15-18(23)16-30-32(27,28)31-17-19(22)21(25)26/h18-20,23-24H,2-17,22H2,1H3,(H,25,26)(H,27,28)/t18-,19+,20?/m1/s1 D03MYL DRUGINKE RPZLJDFLPRHXGM-LFPSWIHMSA-N D03MYL DRUGSMIL CCCCCCCCCCCCCCC(O)OCC(COP(=O)(O)OCC(C(=O)O)N)O D03MYL HIGHSTAT Investigative D03MYV DRUG__ID D03MYV D03MYV DRUGTYPE Small molecular drug D03MYV DRUGINCH 1S/C19H21N3/c20-15-18-9-5-4-8-17(18)14-19(16-6-2-1-3-7-16)22-12-10-21-11-13-22/h1-9,19,21H,10-14H2 D03MYV DRUGINKE FCHUPCOGZXEFDS-UHFFFAOYSA-N D03MYV DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2C#N)C3=CC=CC=C3 D03MYV HIGHSTAT Investigative D03MYY DRUG__ID D03MYY D03MYY DRUGTYPE Small molecular drug D03MYY DRUGINCH 1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1 D03MYY DRUGINKE DCXYFEDJOCDNAF-REOHCLBHSA-N D03MYY DRUGSMIL C(C(C(=O)O)N)C(=O)N D03MYY HIGHSTAT Investigative D03NBX DRUG__ID D03NBX D03NBX DRUGTYPE Small molecular drug D03NBX DRUGINCH 1S/C18H18O5/c1-22-17-12-14(4-8-16(17)20)5-9-18(21)23-11-10-13-2-6-15(19)7-3-13/h2-9,12,19-20H,10-11H2,1H3/b9-5+ D03NBX DRUGINKE JMSFLLZUCIXALN-WEVVVXLNSA-N D03NBX DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)OCCC2=CC=C(C=C2)O)O D03NBX HIGHSTAT Investigative D03NCB DRUG__ID D03NCB D03NCB DRUGTYPE Small molecular drug D03NCB DRUGINCH 1S/C43H53N9O8S2/c1-25(53)47-37-24-62-61-23-36(38(45)55)52-41(58)34(20-27-14-16-29(54)17-15-27)49-39(56)32(13-7-8-18-44)48-42(59)35(21-28-22-46-31-12-6-5-11-30(28)31)51-40(57)33(50-43(37)60)19-26-9-3-2-4-10-26/h2-6,9-12,14-17,22,32-37,46,54H,7-8,13,18-21,23-24,44H2,1H3,(H2,45,55)(H,47,53)(H,48,59)(H,49,56)(H,50,60)(H,51,57)(H,52,58)/t32-,33-,34+,35-,36-,37-/m0/s1 D03NCB DRUGINKE UHSPHALTSYXFRP-PCRAMSICSA-N D03NCB DRUGSMIL CC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)CCCCN)CC5=CC=C(C=C5)O)C(=O)N D03NCB HIGHSTAT Investigative D03NCF DRUG__ID D03NCF D03NCF DRUGTYPE Small molecular drug D03NCF DRUGINCH 1S/C29H37N5O5/c30-22(18-20-10-13-21(35)14-11-20)28(38)34-17-5-9-25(34)27(37)32-23(15-12-19-6-2-1-3-7-19)29(39)33-16-4-8-24(33)26(31)36/h1-3,6-7,10-11,13-14,22-25,35H,4-5,8-9,12,15-18,30H2,(H2,31,36)(H,32,37)/t22-,23-,24-,25-/m0/s1 D03NCF DRUGINKE SJJQQBJUOIMODQ-QORCZRPOSA-N D03NCF DRUGSMIL C1CC(N(C1)C(=O)C(CCC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N)C(=O)N D03NCF HIGHSTAT Investigative D03NCK DRUG__ID D03NCK D03NCK DRUGTYPE Small molecular drug D03NCK DRUGINCH 1S/C32H33N3O6/c1-21(37)33-29(18-23-12-15-27(32(40)41)26(17-23)20-36)30(38)34-28-9-5-6-16-35(31(28)39)19-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,17,20,28-29H,5-6,9,16,18-19H2,1H3,(H,33,37)(H,34,38)(H,40,41)/t28-,29-/m0/s1 D03NCK DRUGINKE WKTQBTSOHBKBRW-VMPREFPWSA-N D03NCK DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)C(=O)O)C=O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D03NCK HIGHSTAT Investigative D03NDD DRUG__ID D03NDD D03NDD DRUGTYPE Small molecular drug D03NDD DRUGINCH 1S/C16H24F2N2O4/c17-16(18)5-13(15(23)24)20(8-16)7-9-1-2-10-6-19-12(14(21)22)4-11(10)3-9/h9-13,19H,1-8H2,(H,21,22)(H,23,24)/t9-,10-,11+,12-,13-/m0/s1 D03NDD DRUGINKE OXQXJYQSWZFDBB-WJTVCTBASA-N D03NDD DRUGSMIL C1CC2CNC(CC2CC1CN3CC(CC3C(=O)O)(F)F)C(=O)O D03NDD HIGHSTAT Investigative D03NEF DRUG__ID D03NEF D03NEF DRUGTYPE Small molecular drug D03NEF DRUGINCH 1S/C28H32O16/c1-9-16(31)20(35)22(37)27(41-9)40-8-14-17(32)21(36)23(38)28(43-14)44-26-19(34)15-13(7-12(30)25(39-2)18(15)33)42-24(26)10-3-5-11(29)6-4-10/h3-7,9,14,16-17,20-23,27-33,35-38H,8H2,1-2H3/t9-,14+,16-,17-,20+,21-,22+,23+,27+,28-/m0/s1 D03NEF DRUGINKE FPVLVSUOCXHCMR-GBNKVCQDSA-N D03NEF DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=C(C3=O)C(=C(C(=C4)O)OC)O)C5=CC=C(C=C5)O)O)O)O)O)O)O D03NEF HIGHSTAT Investigative D03NFW DRUG__ID D03NFW D03NFW DRUGTYPE Small molecular drug D03NFW DRUGINCH 1S/C20H23N5O2/c26-6-8-27-7-5-21-19-11-17-18(12-22-19)23-13-24-20(17)25-16-9-14-3-1-2-4-15(14)10-16/h1-4,11-13,16,26H,5-10H2,(H,21,22)(H,23,24,25) D03NFW DRUGINKE QFBGUCZGHVJUGC-UHFFFAOYSA-N D03NFW DRUGSMIL C1C(CC2=CC=CC=C21)NC3=NC=NC4=CN=C(C=C43)NCCOCCO D03NFW HIGHSTAT Investigative D03NIO DRUG__ID D03NIO D03NIO DRUGTYPE Small molecular drug D03NIO DRUGINCH 1S/C10H7N3S/c1-8-13-10(6-14-8)3-2-9-4-11-7-12-5-9/h4-7H,1H3 D03NIO DRUGINKE ILVDLPMGOZQXLY-UHFFFAOYSA-N D03NIO DRUGSMIL CC1=NC(=CS1)C#CC2=CN=CN=C2 D03NIO HIGHSTAT Investigative D03NLE DRUG__ID D03NLE D03NLE DRUGTYPE Small molecular drug D03NLE DRUGINCH 1S/C25H40O2/c1-20(13-14-24-21(2)9-7-16-25(24,3)4)8-5-10-22(18-26)11-6-12-23-15-17-27-19-23/h8-9,15,17,19,22,24,26H,5-7,10-14,16,18H2,1-4H3/b20-8+ D03NLE DRUGINKE UJVZMYQCMKGVLL-DNTJNYDQSA-N D03NLE DRUGSMIL CC1=CCCC(C1CCC(=CCCC(CCCC2=COC=C2)CO)C)(C)C D03NLE HIGHSTAT Investigative D03NLJ DRUG__ID D03NLJ D03NLJ DRUGCOMP Functional Genetics Inc D03NLJ DRUGINCH 1S/C28H38N6.4ClH/c1-19-17-25(29-13-7-15-33(3)4)23-11-10-22-21(27(23)31-19)9-12-24-26(18-20(2)32-28(22)24)30-14-8-16-34(5)6;;;;/h9-12,17-18H,7-8,13-16H2,1-6H3,(H,29,31)(H,30,32);4*1H D03NLJ DRUGINKE YUQCVPFHAFZFPV-UHFFFAOYSA-N D03NLJ DRUGSMIL CC1=CC(=C2C=CC3=C(C2=N1)C=CC4=C(C=C(N=C34)C)NCCCN(C)C)NCCCN(C)C.Cl.Cl.Cl.Cl D03NLJ HIGHSTAT Investigative D03NLL DRUG__ID D03NLL D03NLL DRUGTYPE Small molecular drug D03NLL DRUGINCH 1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3/t10-/m1/s1 D03NLL DRUGINKE VLPIATFUUWWMKC-SNVBAGLBSA-N D03NLL DRUGSMIL CC1=C(C(=CC=C1)C)OCC(C)N D03NLL HIGHSTAT Investigative D03NMB DRUG__ID D03NMB D03NMB DRUGTYPE Small molecular drug D03NMB DRUGINCH 1S/C10H12BrN2Se/c1-13(2)10(14)12-7-8-3-5-9(11)6-4-8/h3-6H,7H2,1-2H3 D03NMB DRUGINKE FFMCEZVYXHAZHZ-UHFFFAOYSA-N D03NMB DRUGSMIL CN(C)C(=NCC1=CC=C(C=C1)Br)[Se] D03NMB HIGHSTAT Investigative D03NND DRUG__ID D03NND D03NND DRUGTYPE Small molecular drug D03NND DRUGINCH 1S/C13H16N2O2/c1-2-12(16)14-8-4-6-10-5-3-7-11-13(10)17-9-15-11/h3,5,7,9H,2,4,6,8H2,1H3,(H,14,16) D03NND DRUGINKE KCCKMLVZBSMOBW-UHFFFAOYSA-N D03NND DRUGSMIL CCC(=O)NCCCC1=C2C(=CC=C1)N=CO2 D03NND HIGHSTAT Investigative D03NOU DRUG__ID D03NOU D03NOU DRUGTYPE Small molecular drug D03NOU DRUGINCH 1S/C5H8O3/c1-3(2)4(6)5(7)8/h3H,1-2H3,(H,7,8) D03NOU DRUGINKE QHKABHOOEWYVLI-UHFFFAOYSA-N D03NOU DRUGSMIL CC(C)C(=O)C(=O)O D03NOU HIGHSTAT Investigative D03NPA DRUG__ID D03NPA D03NPA DRUGTYPE Small molecular drug D03NPA DRUGINCH 1S/C30H44O7/c1-15(10-17(31)11-16(2)26(36)37)18-12-23(35)30(7)25-19(32)13-21-27(3,4)22(34)8-9-28(21,5)24(25)20(33)14-29(18,30)6/h15-16,18-19,21,23,32,35H,8-14H2,1-7H3,(H,36,37)/t15-,16-,18-,19+,21+,23+,28+,29-,30+/m1/s1 D03NPA DRUGINKE DYOKDAQBNHPJFD-JNTBEZBXSA-N D03NPA DRUGSMIL CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O D03NPA HIGHSTAT Investigative D03NPX DRUG__ID D03NPX D03NPX DRUGTYPE Small molecular drug D03NPX DRUGINCH 1S/C21H16Cl2N4OS/c1-27-19-12(9-15(20(27)28)18-16(22)7-4-8-17(18)23)11-24-21(26-19)25-13-5-3-6-14(10-13)29-2/h3-11H,1-2H3,(H,24,25,26) D03NPX DRUGINKE VAARYSWULJUGST-UHFFFAOYSA-N D03NPX DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC(=CC=C4)SC D03NPX HIGHSTAT Investigative D03NRJ DRUG__ID D03NRJ D03NRJ DRUGTYPE Small molecular drug D03NRJ DRUGINCH 1S/C20H25NO2S/c22-24(23,19-11-5-2-6-12-19)20-13-16-21(17-14-20)15-7-10-18-8-3-1-4-9-18/h1-6,8-9,11-12,20H,7,10,13-17H2 D03NRJ DRUGINKE PZLOABUPAFZHAF-UHFFFAOYSA-N D03NRJ DRUGSMIL C1CN(CCC1S(=O)(=O)C2=CC=CC=C2)CCCC3=CC=CC=C3 D03NRJ HIGHSTAT Investigative D03NSJ DRUG__ID D03NSJ D03NSJ DRUGTYPE Small molecular drug D03NSJ DRUGINCH 1S/C22H16N4O7S2/c27-20-13-12-19(22-18(20)2-1-3-21(22)35(31,32)33)26-25-15-6-4-14(5-7-15)23-24-16-8-10-17(11-9-16)34(28,29)30/h1-13,27H,(H,28,29,30)(H,31,32,33) D03NSJ DRUGINKE KRSNYIGWUHIMKB-UHFFFAOYSA-N D03NSJ DRUGSMIL C1=CC2=C(C=CC(=C2C(=C1)S(=O)(=O)O)N=NC3=CC=C(C=C3)N=NC4=CC=C(C=C4)S(=O)(=O)O)O D03NSJ HIGHSTAT Investigative D03NTD DRUG__ID D03NTD D03NTD DRUGTYPE Small molecular drug D03NTD DRUGINCH 1S/C17H18O3/c1-18-15-8-6-13(7-9-15)4-5-14-10-16(19-2)12-17(11-14)20-3/h4-12H,1-3H3/b5-4- D03NTD DRUGINKE GDHNBPHYVRHYCC-PLNGDYQASA-N D03NTD DRUGSMIL COC1=CC=C(C=C1)C=CC2=CC(=CC(=C2)OC)OC D03NTD HIGHSTAT Investigative D03NTG DRUG__ID D03NTG D03NTG DRUGTYPE Small molecular drug D03NTG DRUGINCH 1S/C19H27N5O5S2/c1-12(25)20-8-10-30-31-11-9-23-17(26)13-2-4-14(5-3-13)24-18(27)15-16(19(28)29)22-7-6-21-15/h6-7,13-14H,2-5,8-11H2,1H3,(H,20,25)(H,23,26)(H,24,27)(H,28,29) D03NTG DRUGINKE OMSKFAYIWROESZ-UHFFFAOYSA-N D03NTG DRUGSMIL CC(=O)NCCSSCCNC(=O)C1CCC(CC1)NC(=O)C2=NC=CN=C2C(=O)O D03NTG HIGHSTAT Investigative D03NTO DRUG__ID D03NTO D03NTO DRUGTYPE Small molecular drug D03NTO DRUGINCH 1S/C20H20N2O6/c23-19(14-7-4-8-21-10-14)27-15-11-25-18-16(12-26-17(15)18)28-20(24)22-9-13-5-2-1-3-6-13/h1-8,10,15-18H,9,11-12H2,(H,22,24)/t15-,16+,17-,18-/m1/s1 D03NTO DRUGINKE FYZLBYYWOFEUSZ-XMTFNYHQSA-N D03NTO DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NCC3=CC=CC=C3)OC(=O)C4=CN=CC=C4 D03NTO HIGHSTAT Investigative D03NTQ DRUG__ID D03NTQ D03NTQ DRUGTYPE Small molecular drug D03NTQ DRUGINCH 1S/C17H20N2O/c20-17(16-12-8-14-18-19-16)13-7-2-1-4-9-15-10-5-3-6-11-15/h3,5-6,8,10-12,14H,1-2,4,7,9,13H2 D03NTQ DRUGINKE DXGZKZUTNHLJNE-UHFFFAOYSA-N D03NTQ DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CC=C2 D03NTQ HIGHSTAT Investigative D03NUC DRUG__ID D03NUC D03NUC DRUGTYPE Small molecular drug D03NUC DRUGINCH 1S/C18H19NO2/c20-18(19-16-10-4-5-11-16)21-17-12-6-9-15(13-17)14-7-2-1-3-8-14/h1-3,6-9,12-13,16H,4-5,10-11H2,(H,19,20) D03NUC DRUGINKE ASBRBCNHGJSXLE-UHFFFAOYSA-N D03NUC DRUGSMIL C1CCC(C1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D03NUC HIGHSTAT Investigative D03NUN DRUG__ID D03NUN D03NUN DRUGTYPE Small molecular drug D03NUN DRUGINCH 1S/C13H18N2O/c14-13(16)12(10-6-2-1-3-7-10)11-8-4-5-9-15-11/h1-3,6-7,11-12,15H,4-5,8-9H2,(H2,14,16)/t11-,12-/m1/s1 D03NUN DRUGINKE LJLMNWPXAYKPGV-VXGBXAGGSA-N D03NUN DRUGSMIL C1CCNC(C1)C(C2=CC=CC=C2)C(=O)N D03NUN HIGHSTAT Investigative D03NUT DRUG__ID D03NUT D03NUT DRUGTYPE Small molecular drug D03NUT DRUGINCH 1S/C15H23NO5S/c1-2-3-4-5-6-7-12-20-15(17)13-8-10-14(11-9-13)21-22(16,18)19/h8-11H,2-7,12H2,1H3,(H2,16,18,19) D03NUT DRUGINKE YDCCVRPKBUQXHB-UHFFFAOYSA-N D03NUT DRUGSMIL CCCCCCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D03NUT HIGHSTAT Investigative D03NVE DRUG__ID D03NVE D03NVE DRUGTYPE Small molecular drug D03NVE DRUGINCH 1S/C20H17ClN8O3/c1-2-7-29-19(30)15-17(26-20(29)31)25-16(24-15)12-8-22-28(9-12)10-14-23-18(32-27-14)11-3-5-13(21)6-4-11/h3-6,8-9H,2,7,10H2,1H3,(H,24,25)(H,26,31) D03NVE DRUGINKE HWHLLTUJISZFDN-UHFFFAOYSA-N D03NVE DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CN(N=C3)CC4=NOC(=N4)C5=CC=C(C=C5)Cl D03NVE HIGHSTAT Investigative D03NWH DRUG__ID D03NWH D03NWH DRUGTYPE Small molecular drug D03NWH DRUGINCH 1S/C15H9BrO2/c16-11-5-3-4-10(8-11)15-9-13(17)12-6-1-2-7-14(12)18-15/h1-9H D03NWH DRUGINKE YFEZLTPSCJWVHI-UHFFFAOYSA-N D03NWH DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC(=CC=C3)Br D03NWH HIGHSTAT Investigative D03NWI DRUG__ID D03NWI D03NWI DRUGTYPE Small molecular drug D03NWI DRUGINCH 1S/C13H21N3O6/c1-7(14)12(20)16-6-2-3-9(16)11(19)15-8(13(21)22)4-5-10(17)18/h7-9H,2-6,14H2,1H3,(H,15,19)(H,17,18)(H,21,22)/t7-,8-,9-/m0/s1 D03NWI DRUGINKE IORKCNUBHNIMKY-CIUDSAMLSA-N D03NWI DRUGSMIL CC(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)O)N D03NWI HIGHSTAT Investigative D03NWV DRUG__ID D03NWV D03NWV DRUGTYPE Small molecular drug D03NWV DRUGINCH 1S/C12H18N2O/c1-2-15-12-6-4-3-5-11(12)14-9-7-13-8-10-14/h3-6,13H,2,7-10H2,1H3 D03NWV DRUGINKE FBQIUSDQWOLCNY-UHFFFAOYSA-N D03NWV DRUGSMIL CCOC1=CC=CC=C1N2CCNCC2 D03NWV HIGHSTAT Investigative D03NXV DRUG__ID D03NXV D03NXV DRUGTYPE Small molecular drug D03NXV DRUGINCH 1S/C22H28N4O4/c27-13-11-23-7-9-25-17-5-6-18(26-10-8-24-12-14-28)20-19(17)21(29)15-3-1-2-4-16(15)22(20)30/h1-6,23-28H,7-14H2 D03NXV DRUGINKE FFGSXKJJVBXWCY-UHFFFAOYSA-N D03NXV DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCNCCO)NCCNCCO D03NXV HIGHSTAT Investigative D03NXZ DRUG__ID D03NXZ D03NXZ DRUGTYPE Small molecular drug D03NXZ DRUGINCH 1S/C17H19N5O5/c1-26-9-4-2-8(3-5-9)15-20-14(18)11-16(21-15)22(7-19-11)17-13(25)12(24)10(6-23)27-17/h2-5,7,10,12-13,17,23-25H,6H2,1H3,(H2,18,20,21)/t10-,12-,13-,17-/m1/s1 D03NXZ DRUGINKE VKSRAKNPXOTFAX-CNEMSGBDSA-N D03NXZ DRUGSMIL COC1=CC=C(C=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D03NXZ HIGHSTAT Investigative D03NYE DRUG__ID D03NYE D03NYE DRUGTYPE Small molecular drug D03NYE DRUGINCH 1S/C20H37NO4/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18(22)20(25)21-17-14-16-19(23)24/h2-17H2,1H3,(H,21,25)(H,23,24) D03NYE DRUGINKE GCTDVJHSYNCJRN-UHFFFAOYSA-N D03NYE DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)O D03NYE HIGHSTAT Investigative D03NYF DRUG__ID D03NYF D03NYF DRUGTYPE Small molecular drug D03NYF DRUGINCH 1S/C18H13NS/c1-14-19-18(13-20-14)12-9-15-7-10-17(11-8-15)16-5-3-2-4-6-16/h2-8,10-11,13H,1H3 D03NYF DRUGINKE DGRLZFWNJWSHOX-UHFFFAOYSA-N D03NYF DRUGSMIL CC1=NC(=CS1)C#CC2=CC=C(C=C2)C3=CC=CC=C3 D03NYF HIGHSTAT Investigative D03NZW DRUG__ID D03NZW D03NZW DRUGTYPE Small molecular drug D03NZW DRUGINCH 1S/C10H20O2/c1-7-4-5-8(9(11)6-7)10(2,3)12/h7-9,11-12H,4-6H2,1-3H3/t7-,8-,9-/m1/s1 D03NZW DRUGINKE LMXFTMYMHGYJEI-IWSPIJDZSA-N D03NZW DRUGSMIL CC1CCC(C(C1)O)C(C)(C)O D03NZW HIGHSTAT Investigative D03OCS DRUG__ID D03OCS D03OCS DRUGTYPE Small molecular drug D03OCS DRUGINCH 1S/C38H69NO13/c1-14-26-38(11,46)31(42)21(5)28(40)19(3)17-36(9,45)33(52-35-29(41)25(39(12)15-2)16-20(4)48-35)22(6)30(23(7)34(44)50-26)51-27-18-37(10,47-13)32(43)24(8)49-27/h19-27,29-33,35,41-43,45-46H,14-18H2,1-13H3 D03OCS DRUGINKE DYYAPFZVDGCKCL-UHFFFAOYSA-N D03OCS DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC)O)(C)O)C)C)O)(C)O D03OCS HIGHSTAT Investigative D03ODQ DRUG__ID D03ODQ D03ODQ DRUGTYPE Small molecular drug D03ODQ DRUGINCH 1S/C5H10N2O/c6-5-1-3-8-4-2-7-5/h1-4H2,(H2,6,7) D03ODQ DRUGINKE IJBIVIJNRYYPRZ-UHFFFAOYSA-N D03ODQ DRUGSMIL C1COCCN=C1N D03ODQ HIGHSTAT Investigative D03OED DRUG__ID D03OED D03OED DRUGTYPE Small molecular drug D03OED DRUGINCH 1S/C17H16FN3O/c1-2-3-16(22)19-17-14-9-6-12(10-15(14)20-21-17)11-4-7-13(18)8-5-11/h4-10H,2-3H2,1H3,(H2,19,20,21,22) D03OED DRUGINKE ORRUGYIZWSJRJU-UHFFFAOYSA-N D03OED DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=C(C=C3)F D03OED HIGHSTAT Investigative D03OEN DRUG__ID D03OEN D03OEN DRUGTYPE Small molecular drug D03OEN DRUGINCH 1S/C14H15N3O4/c1-2-3-6-15-14(19)13(18)11-8-16-12-5-4-9(17(20)21)7-10(11)12/h4-5,7-8,16H,2-3,6H2,1H3,(H,15,19) D03OEN DRUGINKE FFNPFJOEAUFBBY-UHFFFAOYSA-N D03OEN DRUGSMIL CCCCNC(=O)C(=O)C1=CNC2=C1C=C(C=C2)[N+](=O)[O-] D03OEN HIGHSTAT Investigative D03OGA DRUG__ID D03OGA D03OGA DRUGTYPE Small molecular drug D03OGA DRUGINCH 1S/C16H17NO3/c1-11(18)17-9-8-14-15-10-13(19-2)6-4-12(15)5-7-16(14)20-3/h4-10H,1-3H3,(H,17,18)/b9-8+ D03OGA DRUGINKE HMYFXYOFPXZULT-CMDGGOBGSA-N D03OGA DRUGSMIL CC(=O)NC=CC1=C(C=CC2=C1C=C(C=C2)OC)OC D03OGA HIGHSTAT Investigative D03OGD DRUG__ID D03OGD D03OGD DRUGTYPE Small molecular drug D03OGD DRUGINCH 1S/C18H21NO4/c1-22-18(21)15-13-23-17(19-15)16(20)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D03OGD DRUGINKE CRHSFDPXTRFSMK-UHFFFAOYSA-N D03OGD DRUGSMIL COC(=O)C1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2 D03OGD HIGHSTAT Investigative D03OGO DRUG__ID D03OGO D03OGO DRUGTYPE Small molecular drug D03OGO DRUGINCH 1S/C17H17N2O7P/c1-11-8-19(17(21)18-16(11)20)15-7-6-13(25-15)10-24-27(22)23-9-12-4-2-3-5-14(12)26-27/h2-8,13,15H,9-10H2,1H3,(H,18,20,21)/t13-,15+,27?/m0/s1 D03OGO DRUGINKE NEUXRWCLDPVEMR-OHDXJBIGSA-N D03OGO DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)COP3(=O)OCC4=CC=CC=C4O3 D03OGO HIGHSTAT Investigative D03OKV DRUG__ID D03OKV D03OKV DRUGTYPE Small molecular drug D03OKV DRUGINCH 1S/C21H22ClN7/c1-13-4-3-5-15(22)19(13)27-20-17-10-23-12-29(17)21-16(25-20)6-7-18(26-21)28-9-8-24-14(2)11-28/h3-7,10,12,14,24H,8-9,11H2,1-2H3,(H,25,27)/t14-/m0/s1 D03OKV DRUGINKE PUNYTBZWCMNSRO-AWEZNQCLSA-N D03OKV DRUGSMIL CC1CN(CCN1)C2=NC3=C(C=C2)N=C(C4=CN=CN43)NC5=C(C=CC=C5Cl)C D03OKV HIGHSTAT Investigative D03OLR DRUG__ID D03OLR D03OLR DRUGTYPE Small molecular drug D03OLR DRUGINCH 1S/C24H25N5OS/c1-4-6-17-7-5-8-20(25-17)21-22(15-9-10-19-16(12-15)13-29(3)27-19)28-31-24(21)26-23(30)18-11-14(18)2/h5,7-10,12-14,18H,4,6,11H2,1-3H3,(H,26,30)/t14-,18-/m1/s1 D03OLR DRUGINKE DMJNZMXZSQWBRT-RDTXWAMCSA-N D03OLR DRUGSMIL CCCC1=NC(=CC=C1)C2=C(SN=C2C3=CC4=CN(N=C4C=C3)C)NC(=O)C5CC5C D03OLR HIGHSTAT Investigative D03OLU DRUG__ID D03OLU D03OLU DRUGTYPE Small molecular drug D03OLU DRUGINCH 1S/C14H22Cl2N2O2S/c1-10(2)17-7-8-18(11(3)4)21(19,20)14-6-5-12(15)9-13(14)16/h5-6,9-11,17H,7-8H2,1-4H3 D03OLU DRUGINKE IHYZMEAZAIFMTN-UHFFFAOYSA-N D03OLU DRUGSMIL CC(C)NCCN(C(C)C)S(=O)(=O)C1=C(C=C(C=C1)Cl)Cl D03OLU HIGHSTAT Investigative D03OLX DRUG__ID D03OLX D03OLX DRUGTYPE Small molecular drug D03OLX DRUGINCH 1S/C12H18N6O3/c1-17(2)3-6-8(19)9(20)12(21-6)18-5-16-7-10(13)14-4-15-11(7)18/h4-6,8-9,12,19-20H,3H2,1-2H3,(H2,13,14,15)/t6-,8-,9-,12-/m1/s1 D03OLX DRUGINKE SLNWRDWGFHZRAQ-WOUKDFQISA-N D03OLX DRUGSMIL CN(C)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D03OLX HIGHSTAT Investigative D03OQG DRUG__ID D03OQG D03OQG DRUGTYPE Small molecular drug D03OQG DRUGINCH 1S/C7H10O2/c1-5-4-7(5)2-3-9-6(7)8/h5H,2-4H2,1H3 D03OQG DRUGINKE FQIBVSQKGHYUKI-UHFFFAOYSA-N D03OQG DRUGSMIL CC1CC12CCOC2=O D03OQG HIGHSTAT Investigative D03OQK DRUG__ID D03OQK D03OQK DRUGTYPE Small molecular drug D03OQK DRUGINCH 1S/C18H19NO4S/c1-22-16(20)14-15(19-9-5-6-10-19)13-11-7-3-4-8-12(11)24-18(13,14)17(21)23-2/h3-4,7-8,13H,5-6,9-10H2,1-2H3 D03OQK DRUGINKE WEPFRJIQIIGTEM-UHFFFAOYSA-N D03OQK DRUGSMIL COC(=O)C1=C(C2C1(SC3=CC=CC=C23)C(=O)OC)N4CCCC4 D03OQK HIGHSTAT Investigative D03OSO DRUG__ID D03OSO D03OSO DRUGCOMP Helperby Therapeutics Limited D03OSO DRUGINCH 1S/C26H24N2O/c1-19-23-15-17-28(16-14-20-8-4-2-5-9-20)26(23)24-18-22(12-13-25(24)27-19)29-21-10-6-3-7-11-21/h2-13,18H,14-17H2,1H3 D03OSO DRUGINKE XCZMUTGHJBFKPM-UHFFFAOYSA-N D03OSO DRUGSMIL CC1=C2CCN(C2=C3C=C(C=CC3=N1)OC4=CC=CC=C4)CCC5=CC=CC=C5 D03OSO HIGHSTAT Investigative D03OUU DRUG__ID D03OUU D03OUU DRUGTYPE Small molecular drug D03OUU DRUGINCH 1S/C14H15NO3/c15-8-7-10-3-6-12(17)14(18)13(10)9-1-4-11(16)5-2-9/h1-6,16-18H,7-8,15H2 D03OUU DRUGINKE AHHHSPLFRASFOU-UHFFFAOYSA-N D03OUU DRUGSMIL C1=CC(=CC=C1C2=C(C=CC(=C2O)O)CCN)O D03OUU HIGHSTAT Investigative D03OXL DRUG__ID D03OXL D03OXL DRUGTYPE Small molecular drug D03OXL DRUGINCH 1S/C14H24N4O8S/c1-2-5-18(26)14(25)27-7-9(12(22)16-6-11(20)21)17-10(19)4-3-8(15)13(23)24/h8-9,26H,2-7,15H2,1H3,(H,16,22)(H,17,19)(H,20,21)(H,23,24)/t8-,9-/m0/s1 D03OXL DRUGINKE MWNYPJZEPXNOON-IUCAKERBSA-N D03OXL DRUGSMIL CCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D03OXL HIGHSTAT Investigative D03OYD DRUG__ID D03OYD D03OYD DRUGTYPE Small molecular drug D03OYD DRUGINCH 1S/C22H33ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h5-7,12,16,18-21,24-26H,1-4,8-11,13-14H2,(H,27,28)/t16-,18-,19-,20+,21-/m1/s1 D03OYD DRUGINKE XECZBZWECQIBDA-LELZANKISA-N D03OYD DRUGSMIL C1C(C(C(C1O)CCC(COC2=CC(=CC=C2)Cl)O)CCCCCCC(=O)O)O D03OYD HIGHSTAT Investigative D03OYL DRUG__ID D03OYL D03OYL DRUGTYPE Small molecular drug D03OYL DRUGINCH 1S/C17H21NO3/c19-17(18-20)9-3-1-2-6-12-21-16-11-10-14-7-4-5-8-15(14)13-16/h4-5,7-8,10-11,13,20H,1-3,6,9,12H2,(H,18,19) D03OYL DRUGINKE KSNWLAUWIDTBGS-UHFFFAOYSA-N D03OYL DRUGSMIL C1=CC=C2C=C(C=CC2=C1)OCCCCCCC(=O)NO D03OYL HIGHSTAT Investigative D03OZD DRUG__ID D03OZD D03OZD DRUGTYPE Small molecular drug D03OZD DRUGINCH 1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m0/s1 D03OZD DRUGINKE KTEIFNKAUNYNJU-LBPRGKRZSA-N D03OZD DRUGSMIL CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N D03OZD HIGHSTAT Investigative D03PAH DRUG__ID D03PAH D03PAH DRUGTYPE Small molecular drug D03PAH DRUGINCH 1S/C14H22N2O/c1-3-8-15-9-11-16(12-10-15)13-6-4-5-7-14(13)17-2/h4-7H,3,8-12H2,1-2H3 D03PAH DRUGINKE CXGGCNYHKKNQGW-UHFFFAOYSA-N D03PAH DRUGSMIL CCCN1CCN(CC1)C2=CC=CC=C2OC D03PAH HIGHSTAT Investigative D03PBN DRUG__ID D03PBN D03PBN DRUGTYPE Small molecular drug D03PBN DRUGINCH 1S/C21H34O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h13-18,22-23H,3-12H2,1-2H3/t13-,14+,15-,16-,17-,18+,20-,21-/m0/s1 D03PBN DRUGINKE CYKYBWRSLLXBOW-GDYGHMJCSA-N D03PBN DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3CCC4C(=O)CO)C)O D03PBN HIGHSTAT Investigative D03PEA DRUG__ID D03PEA D03PEA DRUGTYPE Small molecular drug D03PEA DRUGINCH 1S/C47H48N6O17P4.4Na/c1-27-9-13-33(45(56)50-39-15-11-29(23-71(59,60)61)17-35(39)25-73(65,66)67)21-41(27)52-43(54)31-5-3-7-37(19-31)48-47(58)49-38-8-4-6-32(20-38)44(55)53-42-22-34(14-10-28(42)2)46(57)51-40-16-12-30(24-72(62,63)64)18-36(40)26-74(68,69)70;;;;/h3-22H,23-26H2,1-2H3,(H,50,56)(H,51,57)(H,52,54)(H,53,55)(H2,48,49,58)(H2,59,60,61)(H2,62,63,64)(H2,65,66,67)(H2,68,69,70);;;;/q;4*+1/p-4 D03PEA DRUGINKE GSMUPMANKNAMAS-UHFFFAOYSA-J D03PEA DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=C(C=C(C=C2)CP(=O)(O)[O-])CP(=O)(O)[O-])NC(=O)C3=CC(=CC=C3)NC(=O)NC4=CC=CC(=C4)C(=O)NC5=C(C=CC(=C5)C(=O)NC6=C(C=C(C=C6)CP(=O)(O)[O-])CP(=O)(O)[O-])C.[Na+].[Na+].[Na+].[Na+] D03PEA HIGHSTAT Investigative D03PGF DRUG__ID D03PGF D03PGF DRUGTYPE Small molecular drug D03PGF DRUGINCH 1S/C14H11ClN2O4/c1-14(5-9(18)19)8-3-2-6(15)4-7(8)10-11(14)17-13(21)12(20)16-10/h2-4H,5H2,1H3,(H,16,20)(H,17,21)(H,18,19) D03PGF DRUGINKE XNLOOYJBLRHTMX-UHFFFAOYSA-N D03PGF DRUGSMIL CC1(C2=C(C=C(C=C2)Cl)C3=C1NC(=O)C(=O)N3)CC(=O)O D03PGF HIGHSTAT Investigative D03PGL DRUG__ID D03PGL D03PGL DRUGTYPE Small molecular drug D03PGL DRUGINCH 1S/C12H11N3/c13-12-14-9-8-11(15-12)7-6-10-4-2-1-3-5-10/h1-9H,(H2,13,14,15)/b7-6+ D03PGL DRUGINKE LNUXNUNUGIHCPA-VOTSOKGWSA-N D03PGL DRUGSMIL C1=CC=C(C=C1)C=CC2=NC(=NC=C2)N D03PGL HIGHSTAT Investigative D03PGV DRUG__ID D03PGV D03PGV DRUGTYPE Small molecular drug D03PGV DRUGINCH 1S/C28H29N3O2/c1-19(2)20-13-15-23(16-14-20)30-28(33)27(21-9-5-4-6-10-21)31(3)26(32)17-22-18-29-25-12-8-7-11-24(22)25/h4-16,18-19,27,29H,17H2,1-3H3,(H,30,33) D03PGV DRUGINKE PQAYCXMQTUEDRD-UHFFFAOYSA-N D03PGV DRUGSMIL CC(C)C1=CC=C(C=C1)NC(=O)C(C2=CC=CC=C2)N(C)C(=O)CC3=CNC4=CC=CC=C43 D03PGV HIGHSTAT Investigative D03PIF DRUG__ID D03PIF D03PIF DRUGTYPE Small molecular drug D03PIF DRUGINCH 1S/C26H34O8/c1-25-9-7-16-24(29)34-19(15-8-11-31-14-15)13-26(16,2)22(25)21(27)18(12-17(25)23(28)30-3)33-20-6-4-5-10-32-20/h8,11,14,16-20,22H,4-7,9-10,12-13H2,1-3H3/t16-,17-,18-,19-,20?,22-,25-,26-/m0/s1 D03PIF DRUGINKE QFGJOBZLFYQWNI-UBPYUYODSA-N D03PIF DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OC4CCCCO4)C)C5=COC=C5 D03PIF HIGHSTAT Investigative D03PIP DRUG__ID D03PIP D03PIP DRUGTYPE Small molecular drug D03PIP DRUGINCH 1S/C28H42N4O2/c1-33-27-11-7-9-25(23-27)31-19-15-29(16-20-31)13-5-3-4-6-14-30-17-21-32(22-18-30)26-10-8-12-28(24-26)34-2/h7-12,23-24H,3-6,13-22H2,1-2H3 D03PIP DRUGINKE IMWNCWRNMUKPGO-UHFFFAOYSA-N D03PIP DRUGSMIL COC1=CC=CC(=C1)N2CCN(CC2)CCCCCCN3CCN(CC3)C4=CC(=CC=C4)OC D03PIP HIGHSTAT Investigative D03PJO DRUG__ID D03PJO D03PJO DRUGTYPE Small molecular drug D03PJO DRUGINCH 1S/C12H8Cl2O2/c13-8-1-4-10(5-2-8)16-12-6-3-9(14)7-11(12)15/h1-7,15H D03PJO DRUGINKE BYNQFCJOHGOKSS-UHFFFAOYSA-N D03PJO DRUGSMIL C1=CC(=CC=C1OC2=C(C=C(C=C2)Cl)O)Cl D03PJO HIGHSTAT Investigative D03PLH DRUG__ID D03PLH D03PLH DRUGTYPE Small molecular drug D03PLH DRUGINCH 1S/C21H34O4/c1-2-3-6-9-17(22)12-13-19-18(16-14-20(19)25-15-16)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17+,18+,19-,20-/m1/s1 D03PLH DRUGINKE LQANGKSBLPMBTJ-BRSNVKEHSA-N D03PLH DRUGSMIL CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)CO2)O D03PLH HIGHSTAT Investigative D03PLP DRUG__ID D03PLP D03PLP DRUGTYPE Small molecular drug D03PLP DRUGINCH 1S/C18H14O3/c19-14-7-5-12(6-8-14)17-3-1-2-4-18(17)13-9-15(20)11-16(21)10-13/h1-11,19-21H D03PLP DRUGINKE UGGGRFWZAHTXBI-UHFFFAOYSA-N D03PLP DRUGSMIL C1=CC=C(C(=C1)C2=CC=C(C=C2)O)C3=CC(=CC(=C3)O)O D03PLP HIGHSTAT Investigative D03PLV DRUG__ID D03PLV D03PLV DRUGTYPE Small molecular drug D03PLV DRUGINCH 1S/C11H14N4O4/c12-5-1-2-13-10-7(5)14-4-15(10)11-9(18)8(17)6(3-16)19-11/h1-2,4,6,8-9,11,16-18H,3H2,(H2,12,13)/t6-,8-,9-,11-/m1/s1 D03PLV DRUGINKE NVUDDRWKCUAERS-PNHWDRBUSA-N D03PLV DRUGSMIL C1=CN=C2C(=C1N)N=CN2C3C(C(C(O3)CO)O)O D03PLV HIGHSTAT Investigative D03POE DRUG__ID D03POE D03POE DRUGTYPE Small molecular drug D03POE DRUGINCH 1S/C21H17NO3/c23-20(22-18-14-8-7-13-17(18)21(24)25)19(15-9-3-1-4-10-15)16-11-5-2-6-12-16/h1-14,19H,(H,22,23)(H,24,25) D03POE DRUGINKE NDZQPXFPOCTXEF-UHFFFAOYSA-N D03POE DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC3=CC=CC=C3C(=O)O D03POE HIGHSTAT Investigative D03POP DRUG__ID D03POP D03POP DRUGTYPE Small molecular drug D03POP DRUGINCH 1S/C19H19N5O5/c1-28-23-17-14-18(22-13(21-17)8-7-11-5-3-2-4-6-11)24(10-20-14)19-16(27)15(26)12(9-25)29-19/h2-6,10,12,15-16,19,25-27H,9H2,1H3,(H,21,22,23)/t12-,15+,16+,19+/m0/s1 D03POP DRUGINKE GWYJBOYUQUUQGN-GCUGWZBJSA-N D03POP DRUGSMIL CONC1=C2C(=NC(=N1)C#CC3=CC=CC=C3)N(C=N2)C4C(C(C(O4)CO)O)O D03POP HIGHSTAT Investigative D03POU DRUG__ID D03POU D03POU DRUGTYPE Small molecular drug D03POU DRUGINCH 1S/C13H14N6O2/c1-20-7-4-3-6(5-8(7)21-2)11-16-9-10(14)17-13(15)19-12(9)18-11/h3-5H,1-2H3,(H5,14,15,16,17,18,19) D03POU DRUGINKE LXQDFGKWPJDZOK-UHFFFAOYSA-N D03POU DRUGSMIL COC1=C(C=C(C=C1)C2=NC3=NC(=NC(=C3N2)N)N)OC D03POU HIGHSTAT Investigative D03PPZ DRUG__ID D03PPZ D03PPZ DRUGTYPE Small molecular drug D03PPZ DRUGINCH 1S/C16H16N2O2/c1-16(2,3)20-15(19)13-8-11-10-6-4-5-7-12(10)18-14(11)9-17-13/h4-9,18H,1-3H3 D03PPZ DRUGINKE FVFFDKKTXYVCCW-UHFFFAOYSA-N D03PPZ DRUGSMIL CC(C)(C)OC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D03PPZ HIGHSTAT Investigative D03PQH DRUG__ID D03PQH D03PQH DRUGTYPE Small molecular drug D03PQH DRUGINCH 1S/C9H13NO.HI/c1-10(2,3)8-5-4-6-9(11)7-8;/h4-7H,1-3H3;1H D03PQH DRUGINKE KNPHMCQIKGHPRU-UHFFFAOYSA-N D03PQH DRUGSMIL C[N+](C)(C)C1=CC(=CC=C1)O.[I-] D03PQH HIGHSTAT Investigative D03PRG DRUG__ID D03PRG D03PRG DRUGTYPE Small molecular drug D03PRG DRUGINCH 1S/C32H43N5O4S2/c1-32(2)31(41)35-25(17-11-15-23-13-5-3-6-14-23)30(40)37-21-12-18-26(37)29(39)34-24(28(38)36-32)16-7-4-10-22-42-43-27-19-8-9-20-33-27/h3,5-6,8-9,13-14,19-20,24-26H,4,7,10-12,15-18,21-22H2,1-2H3,(H,34,39)(H,35,41)(H,36,38)/t24-,25-,26+/m0/s1 D03PRG DRUGINKE DIIWIWBDXZTFQP-KKUQBAQOSA-N D03PRG DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CCCC4=CC=CC=C4)C D03PRG HIGHSTAT Investigative D03PSY DRUG__ID D03PSY D03PSY DRUGTYPE Small molecular drug D03PSY DRUGINCH 1S/C39H73NO13/c1-15-27-39(12,47)32(43)22(6)29(41)20(4)17-37(10,46)34(53-36-30(42)26(16-21(5)49-36)40(13)19(2)3)23(7)31(24(8)35(45)51-27)52-28-18-38(11,48-14)33(44)25(9)50-28/h19-34,36,41-44,46-47H,15-18H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1 D03PSY DRUGINKE RXJCJWPPKSQMAS-IRNFSOKPSA-N D03PSY DRUGSMIL CCC1C(C(C(C(C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C(C)C)O)(C)O)C)O)C)O)(C)O D03PSY HIGHSTAT Investigative D03PTV DRUG__ID D03PTV D03PTV DRUGTYPE Small molecular drug D03PTV DRUGINCH 1S/C26H29NO/c1-2-28-26(24-16-10-5-11-17-24)18-20-27(21-19-26)25(22-12-6-3-7-13-22)23-14-8-4-9-15-23/h3-17,25H,2,18-21H2,1H3 D03PTV DRUGINKE HFALMYBPBZADRA-UHFFFAOYSA-N D03PTV DRUGSMIL CCOC1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4 D03PTV HIGHSTAT Investigative D03PVF DRUG__ID D03PVF D03PVF DRUGTYPE Small molecular drug D03PVF DRUGINCH 1S/C17H18N4O2S/c1-14-4-6-16(7-5-14)24(22,23)21-11-9-20(10-12-21)17-15(13-18)3-2-8-19-17/h2-8H,9-12H2,1H3 D03PVF DRUGINKE NYLACAAEFWBUQQ-UHFFFAOYSA-N D03PVF DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=C(C=CC=N3)C#N D03PVF HIGHSTAT Investigative D03PVM DRUG__ID D03PVM D03PVM DRUGTYPE Small molecular drug D03PVM DRUGINCH 1S/C12H24N2Se/c1-10(2)14(12(15)13(3)4)11-8-6-5-7-9-11/h10-11H,5-9H2,1-4H3 D03PVM DRUGINKE WEFWDSQOLMAXHJ-UHFFFAOYSA-N D03PVM DRUGSMIL CC(C)N(C1CCCCC1)C(=[Se])N(C)C D03PVM HIGHSTAT Investigative D03PVS DRUG__ID D03PVS D03PVS DRUGTYPE Small molecular drug D03PVS DRUGINCH 1S/C9H8N2OS/c10-7-5-3-1-2-4-6(5)13-8(7)9(11)12/h1-4H,10H2,(H2,11,12) D03PVS DRUGINKE LTNWICBPQWPXDK-UHFFFAOYSA-N D03PVS DRUGSMIL C1=CC=C2C(=C1)C(=C(S2)C(=O)N)N D03PVS HIGHSTAT Investigative D03PVV DRUG__ID D03PVV D03PVV DRUGTYPE Small molecular drug D03PVV DRUGINCH 1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m0/s1 D03PVV DRUGINKE ASWBNKHCZGQVJV-QHCPKHFHSA-N D03PVV DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O D03PVV HIGHSTAT Investigative D03PWU DRUG__ID D03PWU D03PWU DRUGTYPE Small molecular drug D03PWU DRUGINCH 1S/C13H16N2O5/c1-14-9-4-2-8(3-5-9)12(18)15-10(13(19)20)6-7-11(16)17/h2-5,10,14H,6-7H2,1H3,(H,15,18)(H,16,17)(H,19,20) D03PWU DRUGINKE UFBUCKLNZUNJHS-UHFFFAOYSA-N D03PWU DRUGSMIL CNC1=CC=C(C=C1)C(=O)NC(CCC(=O)O)C(=O)O D03PWU HIGHSTAT Investigative D03PXS DRUG__ID D03PXS D03PXS DRUGTYPE Small molecular drug D03PXS DRUGINCH 1S/C16H11NO3/c18-15(17-12-7-2-1-3-8-12)13-10-11-6-4-5-9-14(11)20-16(13)19/h1-10H,(H,17,18) D03PXS DRUGINKE IMFBGZCBLOPVCJ-UHFFFAOYSA-N D03PXS DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3OC2=O D03PXS HIGHSTAT Investigative D03PYX DRUG__ID D03PYX D03PYX DRUGTYPE Small molecular drug D03PYX DRUGINCH 1S/C16H25NO/c1-3-9-17(10-4-2)15-7-5-13-6-8-16(18)12-14(13)11-15/h6,8,12,15,18H,3-5,7,9-11H2,1-2H3 D03PYX DRUGINKE BLYMJBIZMIGWFK-UHFFFAOYSA-N D03PYX DRUGSMIL CCCN(CCC)C1CCC2=C(C1)C=C(C=C2)O D03PYX HIGHSTAT Investigative D03QAN DRUG__ID D03QAN D03QAN DRUGTYPE Small molecular drug D03QAN DRUGINCH 1S/C21H20N6O/c1-11-7-17(22)15-9-13(3-5-19(15)24-11)26-21(28)27-14-4-6-20-16(10-14)18(23)8-12(2)25-20/h3-10H,1-2H3,(H2,22,24)(H2,23,25)(H2,26,27,28) D03QAN DRUGINKE HOUSDILKOJMENG-UHFFFAOYSA-N D03QAN DRUGSMIL CC1=CC(=C2C=C(C=CC2=N1)NC(=O)NC3=CC4=C(C=C(N=C4C=C3)C)N)N D03QAN HIGHSTAT Investigative D03QAQ DRUG__ID D03QAQ D03QAQ DRUGTYPE Small molecular drug D03QAQ DRUGINCH 1S/C24H22N6O3S/c1-15-13-21(30(29-15)19-6-4-5-17(14-19)23(25)26)24(31)28-18-11-9-16(10-12-18)20-7-2-3-8-22(20)34(27,32)33/h2-14H,1H3,(H3,25,26)(H,28,31)(H2,27,32,33) D03QAQ DRUGINKE APFKCRTWNKCURW-UHFFFAOYSA-N D03QAQ DRUGSMIL CC1=NN(C(=C1)C(=O)NC2=CC=C(C=C2)C3=CC=CC=C3S(=O)(=O)N)C4=CC=CC(=C4)C(=N)N D03QAQ HIGHSTAT Investigative D03QDS DRUG__ID D03QDS D03QDS DRUGTYPE Small molecular drug D03QDS DRUGINCH 1S/C17H13NO2/c19-15-10-5-12(6-11-15)4-8-14-9-7-13-2-1-3-16(20)17(13)18-14/h1-11,19-20H/b8-4+ D03QDS DRUGINKE YMSHSKJZBZKCOR-XBXARRHUSA-N D03QDS DRUGSMIL C1=CC2=C(C(=C1)O)N=C(C=C2)C=CC3=CC=C(C=C3)O D03QDS HIGHSTAT Investigative D03QFD DRUG__ID D03QFD D03QFD DRUGTYPE Small molecular drug D03QFD DRUGINCH 1S/C27H30FN5O5S/c1-38-25-16-23(33(34)35)8-9-26(25)39(36,37)32-18-21(24(19-32)20-5-4-6-22(28)15-20)17-30-11-13-31(14-12-30)27-7-2-3-10-29-27/h2-10,15-16,21,24H,11-14,17-19H2,1H3 D03QFD DRUGINKE TUSCHIFEASZBBF-UHFFFAOYSA-N D03QFD DRUGSMIL COC1=C(C=CC(=C1)[N+](=O)[O-])S(=O)(=O)N2CC(C(C2)C3=CC(=CC=C3)F)CN4CCN(CC4)C5=CC=CC=N5 D03QFD HIGHSTAT Investigative D03QHG DRUG__ID D03QHG D03QHG DRUGTYPE Small molecular drug D03QHG DRUGINCH 1S/C20H22O5/c1-20(2,3)10-13-14(22)8-15(23)18-16(24)9-17(25-19(13)18)11-4-6-12(21)7-5-11/h4-8,17,21-23H,9-10H2,1-3H3/t17-/m0/s1 D03QHG DRUGINKE SBFJMGDUIWYKMQ-KRWDZBQOSA-N D03QHG DRUGSMIL CC(C)(C)CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D03QHG HIGHSTAT Investigative D03QKF DRUG__ID D03QKF D03QKF DRUGTYPE Small molecular drug D03QKF DRUGINCH 1S/C14H10Cl2N2O3/c15-8-5-9(16)7-10(6-8)17-14(21)18-12-4-2-1-3-11(12)13(19)20/h1-7H,(H,19,20)(H2,17,18,21) D03QKF DRUGINKE PIWYMPXOKMFVER-UHFFFAOYSA-N D03QKF DRUGSMIL C1=CC=C(C(=C1)C(=O)O)NC(=O)NC2=CC(=CC(=C2)Cl)Cl D03QKF HIGHSTAT Investigative D03QMU DRUG__ID D03QMU D03QMU DRUGTYPE Small molecular drug D03QMU DRUGINCH 1S/C10H20N2/c1-2-3-6-9-7-4-5-8-10(11)12-9/h9H,2-8H2,1H3,(H2,11,12) D03QMU DRUGINKE LXZWIIJORJEBKG-UHFFFAOYSA-N D03QMU DRUGSMIL CCCCC1CCCCC(=N1)N D03QMU HIGHSTAT Investigative D03QNE DRUG__ID D03QNE D03QNE DRUGTYPE Small molecular drug D03QNE DRUGINCH 1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3 D03QNE DRUGINKE HXTGXYRHXAGCFP-UHFFFAOYSA-N D03QNE DRUGSMIL COC1=CC=CC(=C1OC)C(C2CCN(CC2)CCC3=CC=C(C=C3)F)O D03QNE HIGHSTAT Investigative D03QNS DRUG__ID D03QNS D03QNS DRUGTYPE Small molecular drug D03QNS DRUGINCH 1S/C15H10O3/c16-12-7-6-11-8-13(10-4-2-1-3-5-10)15(17)18-14(11)9-12/h1-9,16H D03QNS DRUGINKE RIPZCQZTVDNJHQ-UHFFFAOYSA-N D03QNS DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(C=C(C=C3)O)OC2=O D03QNS HIGHSTAT Investigative D03QOD DRUG__ID D03QOD D03QOD DRUGTYPE Small molecular drug D03QOD DRUGINCH 1S/C14H13NO2/c16-14(15-17)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13,17H,(H,15,16) D03QOD DRUGINKE OFSBBVCLWMCGNY-UHFFFAOYSA-N D03QOD DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NO D03QOD HIGHSTAT Investigative D03QQH DRUG__ID D03QQH D03QQH DRUGTYPE Small molecular drug D03QQH DRUGINCH 1S/C17H17NO3/c19-16-12-14(18-8-10-21-11-9-18)6-7-15(16)17(20)13-4-2-1-3-5-13/h1-7,12,19H,8-11H2 D03QQH DRUGINKE FALILNHGILFDLC-UHFFFAOYSA-N D03QQH DRUGSMIL C1COCCN1C2=CC(=C(C=C2)C(=O)C3=CC=CC=C3)O D03QQH HIGHSTAT Investigative D03QRG DRUG__ID D03QRG D03QRG DRUGTYPE Small molecular drug D03QRG DRUGINCH 1S/C13H11N3/c1-10-4-3-5-12(8-10)6-7-13-15-11(2)9-14-16-13/h3-5,8-9H,1-2H3 D03QRG DRUGINKE SGAMWPHZFACGBU-UHFFFAOYSA-N D03QRG DRUGSMIL CC1=CC(=CC=C1)C#CC2=NC(=CN=N2)C D03QRG HIGHSTAT Investigative D03QRT DRUG__ID D03QRT D03QRT DRUGTYPE Small molecular drug D03QRT DRUGINCH 1S/C21H24N4O2/c1-4-24(5-2)11-10-22-16-7-8-17-20-19(16)21(26)15-12-14(27-3)6-9-18(15)25(20)13-23-17/h6-9,12-13,22H,4-5,10-11H2,1-3H3 D03QRT DRUGINKE WEZYUEYLARXRME-UHFFFAOYSA-N D03QRT DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=C(C=C4)OC D03QRT HIGHSTAT Investigative D03QSQ DRUG__ID D03QSQ D03QSQ DRUGTYPE Small molecular drug D03QSQ DRUGINCH 1S/C9H18N2/c1-3-5-7-6-9(10)11-8(7)4-2/h7-8H,3-6H2,1-2H3,(H2,10,11) D03QSQ DRUGINKE ZRHQCTSUMZLGON-UHFFFAOYSA-N D03QSQ DRUGSMIL CCCC1CC(=NC1CC)N D03QSQ HIGHSTAT Investigative D03QTH DRUG__ID D03QTH D03QTH DRUGTYPE Small molecular drug D03QTH DRUGINCH 1S/C15H16N2OS2/c1-2-9-20-15-16-12-8-10-19-13(12)14(18)17(15)11-6-4-3-5-7-11/h3-7H,2,8-10H2,1H3 D03QTH DRUGINKE YHNDCCKFNWDQGW-UHFFFAOYSA-N D03QTH DRUGSMIL CCCSC1=NC2=C(C(=O)N1C3=CC=CC=C3)SCC2 D03QTH HIGHSTAT Investigative D03QUQ DRUG__ID D03QUQ D03QUQ DRUGTYPE Small molecular drug D03QUQ DRUGINCH 1S/C28H29N3O4/c1-19-8-6-7-11-24(19)20-12-14-22(15-13-20)28(34)31-18-23(30-35-2)16-25(31)27(33)29-17-26(32)21-9-4-3-5-10-21/h3-15,25-26,32H,16-18H2,1-2H3,(H,29,33)/b30-23+/t25-,26+/m0/s1 D03QUQ DRUGINKE IBXGJPAYWMFXSF-OLFRMSBUSA-N D03QUQ DRUGSMIL CC1=CC=CC=C1C2=CC=C(C=C2)C(=O)N3CC(=NOC)CC3C(=O)NCC(C4=CC=CC=C4)O D03QUQ HIGHSTAT Investigative D03QWP DRUG__ID D03QWP D03QWP DRUGTYPE Small molecular drug D03QWP DRUGINCH 1S/C29H35N7O8S2/c1-15-9-18(26(30)39)10-16(2)20(15)7-8-24(37)34-23-14-46-45-13-22(27(31)40)35-29(42)21(33-25(38)12-32-28(23)41)11-17-3-5-19(6-4-17)36(43)44/h3-6,9-10,21-23H,7-8,11-14H2,1-2H3,(H2,30,39)(H2,31,40)(H,32,41)(H,33,38)(H,34,37)(H,35,42)/t21-,22-,23-/m0/s1 D03QWP DRUGINKE IPRXWMYVCKZIQS-VABKMULXSA-N D03QWP DRUGSMIL CC1=CC(=CC(=C1CCC(=O)NC2CSSCC(NC(=O)C(NC(=O)CNC2=O)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N)C)C(=O)N D03QWP HIGHSTAT Investigative D03QXD DRUG__ID D03QXD D03QXD DRUGCOMP Commissariat a l`Energie Atomique D03QXD DRUGINCH 1S/C35H35BrClN4O10P/c36-24-8-10-27(11-9-24)52(49,50)19-23(33(45)39-28(13-15-32(43)44)34(46)40-29(35(47)48)12-14-31(38)42)17-26-18-30(41-51-26)21-6-4-20(5-7-21)22-2-1-3-25(37)16-22/h1-11,16,18,23,28-29H,12-15,17,19H2,(H2,38,42)(H,39,45)(H,40,46)(H,43,44)(H,47,48)(H,49,50)/t23-,28+,29+/m1/s1 D03QXD DRUGINKE SCLRICMZGZSWFY-MGONOCMRSA-N D03QXD DRUGSMIL C1=CC(=CC(=C1)Cl)C2=CC=C(C=C2)C3=NOC(=C3)CC(CP(=O)(C4=CC=C(C=C4)Br)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)O D03QXD HIGHSTAT Investigative D03QYZ DRUG__ID D03QYZ D03QYZ DRUGTYPE Small molecular drug D03QYZ DRUGINCH 1S/C17H28N2O/c1-2-19-5-3-4-15(19)17(20)18-16-13-7-11-6-12(9-13)10-14(16)8-11/h11-16H,2-10H2,1H3,(H,18,20)/t11?,12?,13?,14?,15-,16?/m1/s1 D03QYZ DRUGINKE UJRJQNDIYCDCNX-BAPHQMLMSA-N D03QYZ DRUGSMIL CCN1CCCC1C(=O)NC2C3CC4CC(C3)CC2C4 D03QYZ HIGHSTAT Investigative D03RBD DRUG__ID D03RBD D03RBD DRUGTYPE Small molecular drug D03RBD DRUGINCH 1S/C20H24N2O2S/c1-13-5-8-19(25-13)12-22-15-6-7-16(22)11-18(10-15)24-17-4-2-3-14(9-17)20(21)23/h2-5,8-9,15-16,18H,6-7,10-12H2,1H3,(H2,21,23)/t15-,16+,18? D03RBD DRUGINKE RLHOWHVHHMGIKE-BYICEURKSA-N D03RBD DRUGSMIL CC1=CC=C(S1)CN2C3CCC2CC(C3)OC4=CC=CC(=C4)C(=O)N D03RBD HIGHSTAT Investigative D03REA DRUG__ID D03REA D03REA DRUGTYPE Small molecular drug D03REA DRUGINCH 1S/C18H16O4/c1-20-15-7-4-3-6-12(15)10-13-11-14-16(21-2)8-5-9-17(14)22-18(13)19/h3-9,11H,10H2,1-2H3 D03REA DRUGINKE PUMXCXWQMAPHFQ-UHFFFAOYSA-N D03REA DRUGSMIL COC1=CC=CC=C1CC2=CC3=C(C=CC=C3OC)OC2=O D03REA HIGHSTAT Investigative D03RFA DRUG__ID D03RFA D03RFA DRUGTYPE Small molecular drug D03RFA DRUGINCH 1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1 D03RFA DRUGINKE SQMWSBKSHWARHU-SDBHATRESA-N D03RFA DRUGSMIL C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D03RFA HIGHSTAT Investigative D03RFS DRUG__ID D03RFS D03RFS DRUGTYPE Small molecular drug D03RFS DRUGINCH 1S/C23H23NO/c25-23(18-19-10-4-1-5-11-19)24-17-16-22(20-12-6-2-7-13-20)21-14-8-3-9-15-21/h1-15,22H,16-18H2,(H,24,25) D03RFS DRUGINKE JFOKDVSVRVUJTI-UHFFFAOYSA-N D03RFS DRUGSMIL C1=CC=C(C=C1)CC(=O)NCCC(C2=CC=CC=C2)C3=CC=CC=C3 D03RFS HIGHSTAT Investigative D03RGI DRUG__ID D03RGI D03RGI DRUGTYPE Small molecular drug D03RGI DRUGINCH 1S/C3H5N5/c4-3(5)8-2-6-1-7-8/h1-2H,(H3,4,5)/p+1 D03RGI DRUGINKE CDIOIIJXUJXYPB-UHFFFAOYSA-O D03RGI DRUGSMIL C1=NN(C=N1)C(=[NH2+])N D03RGI HIGHSTAT Investigative D03RGV DRUG__ID D03RGV D03RGV DRUGTYPE Small molecular drug D03RGV DRUGINCH 1S/C24H21NO/c1-2-15-25-17-20(16-23(25)19-10-4-3-5-11-19)24(26)22-14-8-12-18-9-6-7-13-21(18)22/h3-14,16-17H,2,15H2,1H3 D03RGV DRUGINKE CVADUNUZYYADMA-UHFFFAOYSA-N D03RGV DRUGSMIL CCCN1C=C(C=C1C2=CC=CC=C2)C(=O)C3=CC=CC4=CC=CC=C43 D03RGV HIGHSTAT Investigative D03RHW DRUG__ID D03RHW D03RHW DRUGTYPE Small molecular drug D03RHW DRUGINCH 1S/C17H24N2O/c1-4-5-15(20)10-13-6-7-17-16(11-13)14(12-18-17)8-9-19(2)3/h6-7,11-12,18H,4-5,8-10H2,1-3H3 D03RHW DRUGINKE OQDBJMBOPCUBGS-UHFFFAOYSA-N D03RHW DRUGSMIL CCCC(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C D03RHW HIGHSTAT Investigative D03RJH DRUG__ID D03RJH D03RJH DRUGTYPE Small molecular drug D03RJH DRUGINCH 1S/C18H16O2S/c1-19-15-9-5-3-7-13(15)17-11-12-18(21-17)14-8-4-6-10-16(14)20-2/h3-12H,1-2H3 D03RJH DRUGINKE VXQDFBRKMXPIGY-UHFFFAOYSA-N D03RJH DRUGSMIL COC1=CC=CC=C1C2=CC=C(S2)C3=CC=CC=C3OC D03RJH HIGHSTAT Investigative D03RKP DRUG__ID D03RKP D03RKP DRUGTYPE Small molecular drug D03RKP DRUGINCH 1S/C28H44F2/c1-23(2)13-9-16-26(5)19-10-17-24(3)14-7-8-15-25(4)18-11-20-27(6)21-12-22-28(29)30/h13-15,19-20,22H,7-12,16-18,21H2,1-6H3/b24-14+,25-15+,26-19+,27-20+ D03RKP DRUGINKE VSXSIZULFIRURF-OGDZRKEVSA-N D03RKP DRUGSMIL CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(F)F)C)C)C D03RKP HIGHSTAT Investigative D03RKW DRUG__ID D03RKW D03RKW DRUGTYPE Small molecular drug D03RKW DRUGINCH 1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16-,17+,18-,19-,20+,21+,22+,24+,25+,26-/m1/s1 D03RKW DRUGINKE BHTRKEVKTKCXOH-LBSADWJPSA-N D03RKW DRUGSMIL CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C D03RKW HIGHSTAT Investigative D03RLA DRUG__ID D03RLA D03RLA DRUGTYPE Small molecular drug D03RLA DRUGINCH 1S/C39H49NO16/c1-14-32(49-7)39(4,52-10)33(50-8)36(53-14)54-19-13-37(2,48)24(34(47)51-9)15-11-16-21(27(43)20(15)19)28(44)22-18(41)12-17-30(23(22)26(16)42)55-35-29(45)25(40(5)6)31(46)38(17,3)56-35/h11-12,14,19,24-25,29,31-33,35-36,41,43,45-46,48H,13H2,1-10H3/t14-,19-,24-,25-,29-,31+,32-,33-,35+,36-,37-,38+,39+/m0/s1 D03RLA DRUGINKE KGTDRFCXGRULNK-JYOBTZKQSA-N D03RLA DRUGSMIL CC1C(C(C(C(O1)OC2CC(C(C3=CC4=C(C(=C23)O)C(=O)C5=C(C=C6C(=C5C4=O)OC7C(C(C(C6(O7)C)O)N(C)C)O)O)C(=O)OC)(C)O)OC)(C)OC)OC D03RLA HIGHSTAT Investigative D03RLJ DRUG__ID D03RLJ D03RLJ DRUGTYPE Small molecular drug D03RLJ DRUGINCH 1S/C13H22N3O13P/c17-5-16(24)6(10(20)21)2-1-3-15-11(22)13(14-12(15)23)9(19)8(18)7(29-13)4-28-30(25,26)27/h6-9,17-19,24H,1-5H2,(H,14,23)(H,20,21)(H2,25,26,27)/t6-,7-,8-,9-,13+/m1/s1 D03RLJ DRUGINKE MAXSFYCTFIBEAR-OJMIUMIFSA-N D03RLJ DRUGSMIL C(CC(C(=O)O)N(CO)O)CN1C(=O)C2(C(C(C(O2)COP(=O)(O)O)O)O)NC1=O D03RLJ HIGHSTAT Investigative D03RMB DRUG__ID D03RMB D03RMB DRUGTYPE Small molecular drug D03RMB DRUGINCH 1S/C21H25NO5/c1-22-5-4-14-10-15(27-9-8-26-7-6-23)12-16-19(14)17(22)11-13-2-3-18(24)21(25)20(13)16/h2-3,10,12,17,23-25H,4-9,11H2,1H3/t17-/m1/s1 D03RMB DRUGINKE LUIRUBNQVJTQKP-QGZVFWFLSA-N D03RMB DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OCCOCCO)C(=C(C=C4)O)O D03RMB HIGHSTAT Investigative D03RMI DRUG__ID D03RMI D03RMI DRUGTYPE Small molecular drug D03RMI DRUGINCH 1S/C13H14ClN3O2S/c1-5-7-9(15)10(11(18)16-6-3-4-6)20-13(7)17-12(19-2)8(5)14/h6H,3-4,15H2,1-2H3,(H,16,18) D03RMI DRUGINKE CTEGQKDJTBWFHW-UHFFFAOYSA-N D03RMI DRUGSMIL CC1=C2C(=C(SC2=NC(=C1Cl)OC)C(=O)NC3CC3)N D03RMI HIGHSTAT Investigative D03RMT DRUG__ID D03RMT D03RMT DRUGTYPE Small molecular drug D03RMT DRUGINCH 1S/C14H18O4S/c15-13(16)11(5-1-2-7-19)8-10-4-3-6-12(9-10)14(17)18/h3-4,6,9,11,19H,1-2,5,7-8H2,(H,15,16)(H,17,18) D03RMT DRUGINKE NHGYNJPSUMLAJY-UHFFFAOYSA-N D03RMT DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CCCCS)C(=O)O D03RMT HIGHSTAT Investigative D03RYU DRUG__ID D03RYU D03RYU DRUGTYPE Small molecular drug D03RYU DRUGINCH 1S/C13H9NO4/c15-7-1-3-9(11(17)5-7)13-14-10-4-2-8(16)6-12(10)18-13/h1-6,15-17H D03RYU DRUGINKE FLDXQSCXJKEXJF-UHFFFAOYSA-N D03RYU DRUGSMIL C1=CC(=C(C=C1O)O)C2=NC3=C(O2)C=C(C=C3)O D03RYU HIGHSTAT Investigative D03RYY DRUG__ID D03RYY D03RYY DRUGTYPE Small molecular drug D03RYY DRUGINCH 1S/C56H83N19O13S2/c57-35(13-4-17-66-53(60)61)45(80)71-38(14-5-18-67-54(62)63)50(85)74-20-6-15-42(74)44(79)34(16-19-68-55(64)65)56(52(87)88,43(78)28-70-47(82)39-24-31(77)27-69-39)75(49(84)37(59)26-33-12-8-22-90-33)51(86)40(23-30-9-2-1-3-10-30)72-48(83)41(29-76)73-46(81)36(58)25-32-11-7-21-89-32/h1-3,7-12,21-22,31,34-42,69,76-77H,4-6,13-20,23-29,57-59H2,(H,70,82)(H,71,80)(H,72,83)(H,73,81)(H,87,88)(H4,60,61,66)(H4,62,63,67)(H4,64,65,68)/t31-,34?,35-,36+,37+,38+,39+,40-,41+,42+,56-/m1/s1 D03RYY DRUGINKE MHBUKMPYIGAURU-WIDHDRDXSA-N D03RYY DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)C(CCN=C(N)N)C(C(=O)CNC(=O)C2CC(CN2)O)(C(=O)O)N(C(=O)C(CC3=CC=CS3)N)C(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)C(CC5=CC=CS5)N D03RYY HIGHSTAT Investigative D03SAM DRUG__ID D03SAM D03SAM DRUGTYPE Small molecular drug D03SAM DRUGINCH 1S/C6H11N3/c1-5(7)2-6-3-8-4-9-6/h3-5H,2,7H2,1H3,(H,8,9)/t5-/m1/s1 D03SAM DRUGINKE XNQIOISZPFVUFG-RXMQYKEDSA-N D03SAM DRUGSMIL CC(CC1=CN=CN1)N D03SAM HIGHSTAT Investigative D03SAV DRUG__ID D03SAV D03SAV DRUGTYPE Small molecular drug D03SAV DRUGINCH 1S/C21H24Cl2N2O/c1-24(21(26)14-16-9-10-18(22)19(23)13-16)20(15-25-11-5-6-12-25)17-7-3-2-4-8-17/h2-4,7-10,13,20H,5-6,11-12,14-15H2,1H3/t20-/m1/s1 D03SAV DRUGINKE AEJOEPSMZCEYJN-HXUWFJFHSA-N D03SAV DRUGSMIL CN(C(CN1CCCC1)C2=CC=CC=C2)C(=O)CC3=CC(=C(C=C3)Cl)Cl D03SAV HIGHSTAT Investigative D03SAZ DRUG__ID D03SAZ D03SAZ DRUGTYPE Small molecular drug D03SAZ DRUGINCH 1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7+,8-/m1/s1 D03SAZ DRUGINKE IERHLVCPSMICTF-CCXZUQQUSA-N D03SAZ DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O D03SAZ HIGHSTAT Investigative D03SBI DRUG__ID D03SBI D03SBI DRUGTYPE Small molecular drug D03SBI DRUGINCH 1S/C21H24N4O2/c1-4-24(5-2)12-11-22-15-9-10-16-20-18(15)21(26)14-7-6-8-17(27-3)19(14)25(20)13-23-16/h6-10,13,22H,4-5,11-12H2,1-3H3 D03SBI DRUGINKE UOASRCCYMFZXGC-UHFFFAOYSA-N D03SBI DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=CC=C4OC D03SBI HIGHSTAT Investigative D03SCD DRUG__ID D03SCD D03SCD DRUGTYPE Small molecular drug D03SCD DRUGINCH 1S/C18H20N4/c1-14(2)13-22-18(19-20-21-22)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14H,12-13H2,1-2H3 D03SCD DRUGINKE GASXPOWMPRTYRR-UHFFFAOYSA-N D03SCD DRUGSMIL CC(C)CN1C(=NN=N1)CC2=CC=C(C=C2)C3=CC=CC=C3 D03SCD HIGHSTAT Investigative D03SEC DRUG__ID D03SEC D03SEC DRUGTYPE Small molecular drug D03SEC DRUGINCH 1S/C13H16N2O/c1-2-3-9-16-11-6-4-5-10-7-8-12(14)15-13(10)11/h4-8H,2-3,9H2,1H3,(H2,14,15) D03SEC DRUGINKE RANHBKGFWNIVKN-UHFFFAOYSA-N D03SEC DRUGSMIL CCCCOC1=CC=CC2=C1N=C(C=C2)N D03SEC HIGHSTAT Investigative D03SFB DRUG__ID D03SFB D03SFB DRUGTYPE Small molecular drug D03SFB DRUGINCH 1S/C16H10N2O2/c1-8-17-12-7-6-11-13(14(12)18-8)16(20)10-5-3-2-4-9(10)15(11)19/h2-7H,1H3,(H,17,18) D03SFB DRUGINKE IXPPRTBZHPTQCM-UHFFFAOYSA-N D03SFB DRUGSMIL CC1=NC2=C(N1)C=CC3=C2C(=O)C4=CC=CC=C4C3=O D03SFB HIGHSTAT Investigative D03SHX DRUG__ID D03SHX D03SHX DRUGTYPE Small molecular drug D03SHX DRUGINCH 1S/C11H13IN4O3/c1-4-7(17)8(18)11(19-4)16-2-5(12)6-9(13)14-3-15-10(6)16/h2-4,7-8,11,17-18H,1H3,(H2,13,14,15)/t4-,7-,8-,11-/m1/s1 D03SHX DRUGINKE NTXUAWGNGBSCRS-TZQXKBMNSA-N D03SHX DRUGSMIL CC1C(C(C(O1)N2C=C(C3=C(N=CN=C32)N)I)O)O D03SHX HIGHSTAT Investigative D03SJY DRUG__ID D03SJY D03SJY DRUGTYPE Small molecular drug D03SJY DRUGINCH 1S/C21H32N2O2/c1-2-3-4-5-6-7-8-9-10-21(25)22-14-13-17-16-23-20-12-11-18(24)15-19(17)20/h11-12,15-16,23-24H,2-10,13-14H2,1H3,(H,22,25) D03SJY DRUGINKE RNYSECALLZNZML-UHFFFAOYSA-N D03SJY DRUGSMIL CCCCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O D03SJY HIGHSTAT Investigative D03SKE DRUG__ID D03SKE D03SKE DRUGTYPE Small molecular drug D03SKE DRUGINCH 1S/C14H11Br3O4/c15-8-5-10(19)9(18)3-6(8)1-2-7-4-11(20)14(21)13(17)12(7)16/h3-5,18-21H,1-2H2 D03SKE DRUGINKE NFQMJMJFBMIAAK-UHFFFAOYSA-N D03SKE DRUGSMIL C1=C(C(=CC(=C1O)O)Br)CCC2=CC(=C(C(=C2Br)Br)O)O D03SKE HIGHSTAT Investigative D03SNI DRUG__ID D03SNI D03SNI DRUGTYPE Small molecular drug D03SNI DRUGINCH 1S/C20H22N4/c1-23-11-13-24(14-12-23)20-19(15-16-7-3-2-4-8-16)21-17-9-5-6-10-18(17)22-20/h2-10H,11-15H2,1H3 D03SNI DRUGINKE PQQUQVYOCGJWAX-UHFFFAOYSA-N D03SNI DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3N=C2CC4=CC=CC=C4 D03SNI HIGHSTAT Investigative D03SNK DRUG__ID D03SNK D03SNK DRUGTYPE Small molecular drug D03SNK DRUGINCH 1S/C17H17NO6S/c19-16(20)11-10-15(17(21)22)18-25(23,24)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9,15,18H,10-11H2,(H,19,20)(H,21,22) D03SNK DRUGINKE IQGHPUPMOUUHPP-UHFFFAOYSA-N D03SNK DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)NC(CCC(=O)O)C(=O)O D03SNK HIGHSTAT Investigative D03SNN DRUG__ID D03SNN D03SNN DRUGTYPE Small molecular drug D03SNN DRUGINCH 1S/C17H18FNO3/c1-2-3-12-21-14-10-8-13(9-11-14)19-17(20)22-16-7-5-4-6-15(16)18/h4-11H,2-3,12H2,1H3,(H,19,20) D03SNN DRUGINKE IDOBASBUNMSFTC-UHFFFAOYSA-N D03SNN DRUGSMIL CCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D03SNN HIGHSTAT Investigative D03SPJ DRUG__ID D03SPJ D03SPJ DRUGTYPE Small molecular drug D03SPJ DRUGINCH 1S/C27H22O18/c28-9-1-6(2-10(29)16(9)32)24(39)45-27-22(38)23-19(35)13(43-27)5-42-25(40)7-3-11(30)17(33)20(36)14(7)15-8(26(41)44-23)4-12(31)18(34)21(15)37/h1-4,13,19,22-23,27-38H,5H2/t13-,19-,22-,23+,27+/m1/s1 D03SPJ DRUGINKE TUSDEZXZIZRFGC-XIGLUPEJSA-N D03SPJ DRUGSMIL C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)O)O D03SPJ HIGHSTAT Investigative D03SRV DRUG__ID D03SRV D03SRV DRUGTYPE Small molecular drug D03SRV DRUGINCH 1S/C27H27NO2/c1-3-4-9-17-28-19-21(18-25(28)24-14-7-8-16-26(24)30-2)27(29)23-15-10-12-20-11-5-6-13-22(20)23/h5-8,10-16,18-19H,3-4,9,17H2,1-2H3 D03SRV DRUGINKE RWYPPHVLXFTKAG-UHFFFAOYSA-N D03SRV DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2OC)C(=O)C3=CC=CC4=CC=CC=C43 D03SRV HIGHSTAT Investigative D03STO DRUG__ID D03STO D03STO DRUGTYPE Small molecular drug D03STO DRUGINCH 1S/C14H17NO2/c1-3-14(4-2)12(16)15(13(14)17)10-11-8-6-5-7-9-11/h5-9H,3-4,10H2,1-2H3 D03STO DRUGINKE FWKVKYCYDHDEBH-UHFFFAOYSA-N D03STO DRUGSMIL CCC1(C(=O)N(C1=O)CC2=CC=CC=C2)CC D03STO HIGHSTAT Investigative D03SUI DRUG__ID D03SUI D03SUI DRUGTYPE Small molecular drug D03SUI DRUGINCH 1S/C17H20N2O3/c1-2-3-11-21-15-8-6-14(7-9-15)12-19-17(20)22-16-5-4-10-18-13-16/h4-10,13H,2-3,11-12H2,1H3,(H,19,20) D03SUI DRUGINKE CZFYUEMAFQHRFG-UHFFFAOYSA-N D03SUI DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CN=CC=C2 D03SUI HIGHSTAT Investigative D03SYO DRUG__ID D03SYO D03SYO DRUGTYPE Small molecular drug D03SYO DRUGINCH 1S/C10H12N2/c1-11-7-3-2-5-10-6-4-8-12-9-10/h4,6,8-9,11H,3,7H2,1H3 D03SYO DRUGINKE WBAIXNUCEGCLDC-UHFFFAOYSA-N D03SYO DRUGSMIL CNCCC#CC1=CN=CC=C1 D03SYO HIGHSTAT Investigative D03TBA DRUG__ID D03TBA D03TBA DRUGTYPE Small molecular drug D03TBA DRUGINCH 1S/C22H23N3O/c1-24-22(23)25-19-12-13-21(20(16-19)18-10-6-3-7-11-18)26-15-14-17-8-4-2-5-9-17/h2-13,16H,14-15H2,1H3,(H3,23,24,25) D03TBA DRUGINKE QXDMVRPQHNFBSZ-UHFFFAOYSA-N D03TBA DRUGSMIL CN=C(N)NC1=CC(=C(C=C1)OCCC2=CC=CC=C2)C3=CC=CC=C3 D03TBA HIGHSTAT Investigative D03TDN DRUG__ID D03TDN D03TDN DRUGTYPE Small molecular drug D03TDN DRUGINCH 1S/C14H16N2/c1-2-6-13-12(4-1)5-3-7-14(13)16-10-8-15-9-11-16/h1-7,15H,8-11H2 D03TDN DRUGINKE VNICFCQJUVFULD-UHFFFAOYSA-N D03TDN DRUGSMIL C1CN(CCN1)C2=CC=CC3=CC=CC=C32 D03TDN HIGHSTAT Investigative D03TEJ DRUG__ID D03TEJ D03TEJ DRUGTYPE Small molecular drug D03TEJ DRUGINCH 1S/C37H47N5O2/c1-25(2)28-15-13-16-29(26(3)4)33(28)41-35(44)42-36(5,22-27-23-39-31-17-8-7-14-30(27)31)34(43)40-24-37(19-10-6-11-20-37)32-18-9-12-21-38-32/h7-9,12-18,21,23,25-26,39H,6,10-11,19-20,22,24H2,1-5H3,(H,40,43)(H2,41,42,44)/t36-/m0/s1 D03TEJ DRUGINKE RVCSRPVACXMJEL-BHVANESWSA-N D03TEJ DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NC(C)(CC2=CNC3=CC=CC=C32)C(=O)NCC4(CCCCC4)C5=CC=CC=N5 D03TEJ HIGHSTAT Investigative D03TFP DRUG__ID D03TFP D03TFP DRUGTYPE Small molecular drug D03TFP DRUGINCH 1S/C41H55N5O6S/c1-7-42-18-19-45(8-2)30-20-26(3)37(27(4)21-30)52-24-34(48)43-32(22-28-14-10-9-11-15-28)36(49)40(51)46-25-53-41(5,6)38(46)39(50)44-35-31-17-13-12-16-29(31)23-33(35)47/h9-17,20-21,32-33,35-36,38,42,47,49H,7-8,18-19,22-25H2,1-6H3,(H,43,48)(H,44,50)/t32-,33+,35-,36-,38+/m0/s1 D03TFP DRUGINKE TYAUZZDMTCDBHN-CTRNRRKFSA-N D03TFP DRUGSMIL CCNCCN(CC)C1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D03TFP HIGHSTAT Investigative D03THP DRUG__ID D03THP D03THP DRUGTYPE Small molecular drug D03THP DRUGINCH 1S/C17H15NOS/c1-19-15-8-4-13(5-9-15)17-11-10-16(20-17)12-2-6-14(18)7-3-12/h2-11H,18H2,1H3 D03THP DRUGINKE JJUWIYUCBOADAD-UHFFFAOYSA-N D03THP DRUGSMIL COC1=CC=C(C=C1)C2=CC=C(S2)C3=CC=C(C=C3)N D03THP HIGHSTAT Investigative D03TIA DRUG__ID D03TIA D03TIA DRUGTYPE Small molecular drug D03TIA DRUGINCH 1S/C26H34N2O4/c1-20(2)16-28(18-22-9-10-23-24(15-22)31-13-6-12-30-23)26(29)25-19-27(11-14-32-25)17-21-7-4-3-5-8-21/h3-5,7-10,15,20,25H,6,11-14,16-19H2,1-2H3 D03TIA DRUGINKE KQQGCZSZDMHKOX-UHFFFAOYSA-N D03TIA DRUGSMIL CC(C)CN(CC1=CC2=C(C=C1)OCCCO2)C(=O)C3CN(CCO3)CC4=CC=CC=C4 D03TIA HIGHSTAT Investigative D03TJJ DRUG__ID D03TJJ D03TJJ DRUGTYPE Small molecular drug D03TJJ DRUGINCH 1S/C22H20FIN6O3/c23-15-3-1-13(2-4-15)20(31)14-7-9-29(10-8-14)11-12-30-21(32)16-5-6-17(27-28-25)18(24)19(16)26-22(30)33/h1-6,14H,7-12H2,(H,26,33)/i24-2 D03TJJ DRUGINKE OALSEJAYBSRMHM-XXFZXMJFSA-N D03TJJ DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=C(C(=C(C=C4)N=[N+]=[N-])I)NC3=O D03TJJ HIGHSTAT Investigative D03TKT DRUG__ID D03TKT D03TKT DRUGTYPE Small molecular drug D03TKT DRUGINCH 1S/C33H35FN2O6/c1-20(2)31-30(33(42)35-26-10-6-7-11-27(26)39)29(21-8-4-3-5-9-21)32(22-12-14-23(34)15-13-22)36(31)17-16-24(37)18-25(38)19-28(40)41/h3-15,20,24-25,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41)/t24-,25-/m1/s1 D03TKT DRUGINKE CZBPKFICAYVHHM-JWQCQUIFSA-N D03TKT DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4O D03TKT HIGHSTAT Investigative D03TLR DRUG__ID D03TLR D03TLR DRUGTYPE Small molecular drug D03TLR DRUGINCH 1S/C16H12ClNS/c1-11-2-4-12(5-3-11)15-10-18-19-16(15)13-6-8-14(17)9-7-13/h2-10H,1H3 D03TLR DRUGINKE LELNOQBBNOVPJP-UHFFFAOYSA-N D03TLR DRUGSMIL CC1=CC=C(C=C1)C2=C(SN=C2)C3=CC=C(C=C3)Cl D03TLR HIGHSTAT Investigative D03TMD DRUG__ID D03TMD D03TMD DRUGTYPE Small molecular drug D03TMD DRUGINCH 1S/C16H11F3N2O3S/c17-16(18,19)11-4-2-1-3-9(11)12-6-5-8(24-12)7-10-13(22)20-15(25)21-14(10)23/h1-6,10H,7H2,(H2,20,21,22,23,25) D03TMD DRUGINKE DNZPLHRZXUJATK-UHFFFAOYSA-N D03TMD DRUGSMIL C1=CC=C(C(=C1)C2=CC=C(O2)CC3C(=O)NC(=S)NC3=O)C(F)(F)F D03TMD HIGHSTAT Investigative D03TNE DRUG__ID D03TNE D03TNE DRUGTYPE Small molecular drug D03TNE DRUGINCH 1S/C14H20N2O4/c1-20-12(9-5-6-10-13(17)16-19)14(18)15-11-7-3-2-4-8-11/h2-4,7-8,12,19H,5-6,9-10H2,1H3,(H,15,18)(H,16,17) D03TNE DRUGINKE GTYJNCDOILRMGX-UHFFFAOYSA-N D03TNE DRUGSMIL COC(CCCCC(=O)NO)C(=O)NC1=CC=CC=C1 D03TNE HIGHSTAT Investigative D03TNT DRUG__ID D03TNT D03TNT DRUGTYPE Small molecular drug D03TNT DRUGINCH 1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1 D03TNT DRUGINKE OMFXVFTZEKFJBZ-HJTSIMOOSA-N D03TNT DRUGSMIL CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O D03TNT HIGHSTAT Investigative D03TOK DRUG__ID D03TOK D03TOK DRUGTYPE Small molecular drug D03TOK DRUGINCH 1S/C18H16O2/c19-17-11-7-15(8-12-17)5-3-1-2-4-6-16-9-13-18(20)14-10-16/h1-14,19-20H/b2-1+,5-3+,6-4+ D03TOK DRUGINKE FXGYAFMJWIVHGO-CRQXNEITSA-N D03TOK DRUGSMIL C1=CC(=CC=C1C=CC=CC=CC2=CC=C(C=C2)O)O D03TOK HIGHSTAT Investigative D03TPB DRUG__ID D03TPB D03TPB DRUGTYPE Small molecular drug D03TPB DRUGINCH 1S/C20H15BrI2N2O/c21-15-5-11-18(12-6-15)24-20(26)25-19(13-1-7-16(22)8-2-13)14-3-9-17(23)10-4-14/h1-12,19H,(H2,24,25,26) D03TPB DRUGINKE ALTGZVPJBKOZHG-UHFFFAOYSA-N D03TPB DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)I)NC(=O)NC3=CC=C(C=C3)Br)I D03TPB HIGHSTAT Investigative D03TPH DRUG__ID D03TPH D03TPH DRUGTYPE Small molecular drug D03TPH DRUGINCH 1S/C8H4ClNO2/c9-4-1-2-6-5(3-4)7(11)8(12)10-6/h1-3H,(H,10,11,12) D03TPH DRUGINKE XHDJYQWGFIBCEP-UHFFFAOYSA-N D03TPH DRUGSMIL C1=CC2=C(C=C1Cl)C(=O)C(=O)N2 D03TPH HIGHSTAT Investigative D03TPY DRUG__ID D03TPY D03TPY DRUGTYPE Small molecular drug D03TPY DRUGINCH 1S/C16H20ClN3O2/c1-22-14-4-13(18)12(17)3-10(14)16(21)19-15-9-2-8-5-20(6-9)7-11(8)15/h3-4,8-9,11,15H,2,5-7,18H2,1H3,(H,19,21) D03TPY DRUGINKE MRKYTIJPEALHEE-UHFFFAOYSA-N D03TPY DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2C3CC4C2CN(C4)C3)Cl)N D03TPY HIGHSTAT Investigative D03TQD DRUG__ID D03TQD D03TQD DRUGTYPE Small molecular drug D03TQD DRUGINCH 1S/C16H24N2O4/c1-2-12-22-14(10-6-7-11-15(19)18-21)16(20)17-13-8-4-3-5-9-13/h3-5,8-9,14,21H,2,6-7,10-12H2,1H3,(H,17,20)(H,18,19) D03TQD DRUGINKE HYIYBZGKHUILKH-UHFFFAOYSA-N D03TQD DRUGSMIL CCCOC(CCCCC(=O)NO)C(=O)NC1=CC=CC=C1 D03TQD HIGHSTAT Investigative D03TQO DRUG__ID D03TQO D03TQO DRUGTYPE Small molecular drug D03TQO DRUGINCH 1S/C19H17NO4/c21-15-3-1-2-13(10-15)14-4-5-18-16(11-14)17(22)12-19(24-18)20-6-8-23-9-7-20/h1-5,10-12,21H,6-9H2 D03TQO DRUGINKE PLPMLPUPRLWRRG-UHFFFAOYSA-N D03TQO DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC(=CC=C4)O D03TQO HIGHSTAT Investigative D03TRM DRUG__ID D03TRM D03TRM DRUGTYPE Small molecular drug D03TRM DRUGINCH 1S/C13H12N2/c1-2-4-13-10(3-1)5-6-11(13)7-12-8-14-9-15-12/h1-4,7-9H,5-6H2,(H,14,15)/b11-7+ D03TRM DRUGINKE FXLOWXDBTSZJFZ-YRNVUSSQSA-N D03TRM DRUGSMIL C1CC(=CC2=CN=CN2)C3=CC=CC=C31 D03TRM HIGHSTAT Investigative D03TSY DRUG__ID D03TSY D03TSY DRUGTYPE Small molecular drug D03TSY DRUGINCH 1S/C16H23N3/c1-12-16(13(2)19(5)17-12)15-8-6-7-14(11-15)9-10-18(3)4/h6-8,11H,9-10H2,1-5H3 D03TSY DRUGINKE MFUWRMRKXKCSPL-UHFFFAOYSA-N D03TSY DRUGSMIL CC1=C(C(=NN1C)C)C2=CC=CC(=C2)CCN(C)C D03TSY HIGHSTAT Investigative D03TUM DRUG__ID D03TUM D03TUM DRUGTYPE Small molecular drug D03TUM DRUGINCH 1S/C24H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-23(26)25-22-19-21-24(27)28/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-22H2,1H3,(H,25,26)(H,27,28)/b7-6-,10-9-,13-12-,16-15- D03TUM DRUGINKE JKUDIEXTAYKJNX-DOFZRALJSA-N D03TUM DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCCC(=O)O D03TUM HIGHSTAT Investigative D03TUX DRUG__ID D03TUX D03TUX DRUGTYPE Small molecular drug D03TUX DRUGINCH 1S/C9H13NO/c10-9(7-11)6-8-4-2-1-3-5-8/h1-5,9,11H,6-7,10H2/t9-/m0/s1 D03TUX DRUGINKE STVVMTBJNDTZBF-VIFPVBQESA-N D03TUX DRUGSMIL C1=CC=C(C=C1)CC(CO)N D03TUX HIGHSTAT Investigative D03TWR DRUG__ID D03TWR D03TWR DRUGTYPE Small molecular drug D03TWR DRUGINCH 1S/C24H20B2O/c1-5-13-21(14-6-1)25(22-15-7-2-8-16-22)27-26(23-17-9-3-10-18-23)24-19-11-4-12-20-24/h1-20H D03TWR DRUGINKE SNQFEECGHGUHBK-UHFFFAOYSA-N D03TWR DRUGSMIL B(C1=CC=CC=C1)(C2=CC=CC=C2)OB(C3=CC=CC=C3)C4=CC=CC=C4 D03TWR HIGHSTAT Investigative D03TYC DRUG__ID D03TYC D03TYC DRUGTYPE Small molecular drug D03TYC DRUGINCH 1S/C7H15NO5/c9-1-3-5(11)7(13)6(12)4(2-10)8-3/h3-13H,1-2H2/t3-,4-,5-,6+,7?/m1/s1 D03TYC DRUGINKE CLVUFWXGNIFGNC-QTSLKERKSA-N D03TYC DRUGSMIL C(C1C(C(C(C(N1)CO)O)O)O)O D03TYC HIGHSTAT Investigative D03TYE DRUG__ID D03TYE D03TYE DRUGTYPE Small molecular drug D03TYE DRUGINCH 1S/C15H15F2N3S/c1-10-5-6-14(19-9-10)20-15(21)18-8-7-11-12(16)3-2-4-13(11)17/h2-6,9H,7-8H2,1H3,(H2,18,19,20,21) D03TYE DRUGINKE FIASQQMTLFRFPZ-UHFFFAOYSA-N D03TYE DRUGSMIL CC1=CN=C(C=C1)NC(=S)NCCC2=C(C=CC=C2F)F D03TYE HIGHSTAT Investigative D03TYV DRUG__ID D03TYV D03TYV DRUGTYPE Small molecular drug D03TYV DRUGINCH 1S/C5H4N4S4/c10-4-8-6-2(12-4)1-3-7-9-5(11)13-3/h1H2,(H,8,10)(H,9,11) D03TYV DRUGINKE XUFJHTRVFXOZOI-UHFFFAOYSA-N D03TYV DRUGSMIL C(C1=NNC(=S)S1)C2=NNC(=S)S2 D03TYV HIGHSTAT Investigative D03UCC DRUG__ID D03UCC D03UCC DRUGTYPE Small molecular drug D03UCC DRUGINCH 1S/C6H16NO3P/c1-4-7(5-2)11(8,9)10-6-3/h4-6H2,1-3H3,(H,8,9) D03UCC DRUGINKE DUNFIZRDIMDMIH-UHFFFAOYSA-N D03UCC DRUGSMIL CCN(CC)P(=O)(O)OCC D03UCC HIGHSTAT Investigative D03UFD DRUG__ID D03UFD D03UFD DRUGTYPE Small molecular drug D03UFD DRUGINCH 1S/C23H22N2O3/c1-25-9-8-22-18-12-6-7-16(26)20(18)28-21(22)19-14(11-23(22,27)17(25)10-12)13-4-2-3-5-15(13)24-19/h2-7,17,21,24,26-27H,8-11H2,1H3/t17-,21+,22+,23-/m1/s1 D03UFD DRUGINKE YQNZUKAKYJMEFE-LMDOGRNLSA-N D03UFD DRUGSMIL CN1CCC23C4C5=C(CC2(C1CC6=C3C(=C(C=C6)O)O4)O)C7=CC=CC=C7N5 D03UFD HIGHSTAT Investigative D03UHT DRUG__ID D03UHT D03UHT DRUGTYPE Small molecular drug D03UHT DRUGINCH 1S/C22H28N2O2/c25-21-23-18-10-15-11-19-16-6-1-2-7-22(16,17(15)12-20(18)26-21)8-9-24(19)13-14-4-3-5-14/h10,12,14,16,19H,1-9,11,13H2,(H,23,25)/t16-,19+,22+/m0/s1 D03UHT DRUGINKE PSLNEDDFOIXXGT-DKZVUGQWSA-N D03UHT DRUGSMIL C1CCC23CCN(C(C2C1)CC4=CC5=C(C=C34)OC(=O)N5)CC6CCC6 D03UHT HIGHSTAT Investigative D03UIF DRUG__ID D03UIF D03UIF DRUGTYPE Small molecular drug D03UIF DRUGINCH 1S/C16H24N2O3S2/c1-11(8-22)15(19)17-14(16(20)21)10-23-9-12-4-6-13(7-5-12)18(2)3/h4-7,11,14,22H,8-10H2,1-3H3,(H,17,19)(H,20,21)/t11-,14+/m1/s1 D03UIF DRUGINKE HLSVAMGQMKPXOP-RISCZKNCSA-N D03UIF DRUGSMIL CC(CS)C(=O)NC(CSCC1=CC=C(C=C1)N(C)C)C(=O)O D03UIF HIGHSTAT Investigative D03UIR DRUG__ID D03UIR D03UIR DRUGTYPE Small molecular drug D03UIR DRUGINCH 1S/C9H15NO6/c1-16-7(11)3-2-5(8(12)13)4-6(10)9(14)15/h5-6H,2-4,10H2,1H3,(H,12,13)(H,14,15)/t5-,6+/m1/s1 D03UIR DRUGINKE IPTIKQIFOOZKAT-RITPCOANSA-N D03UIR DRUGSMIL COC(=O)CCC(CC(C(=O)O)N)C(=O)O D03UIR HIGHSTAT Investigative D03UJT DRUG__ID D03UJT D03UJT DRUGTYPE Small molecular drug D03UJT DRUGINCH 1S/C26H36N2O3/c1-20(2)26(19-27,22-11-12-24(30-5)25(18-22)31-6)14-8-15-28(3)16-13-21-9-7-10-23(17-21)29-4/h7,9-12,17-18,20H,8,13-16H2,1-6H3/t26-/m0/s1 D03UJT DRUGINKE VMVKIDPOEOLUFS-SANMLTNESA-N D03UJT DRUGSMIL CC(C)C(CCCN(C)CCC1=CC(=CC=C1)OC)(C#N)C2=CC(=C(C=C2)OC)OC D03UJT HIGHSTAT Investigative D03UJW DRUG__ID D03UJW D03UJW DRUGTYPE Small molecular drug D03UJW DRUGINCH 1S/C22H29NO/c1-2-3-14-22(24)15-17-23(18-16-22)21(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21,24H,2-3,14-18H2,1H3 D03UJW DRUGINKE REUKRNAMFNVGPA-UHFFFAOYSA-N D03UJW DRUGSMIL CCCCC1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O D03UJW HIGHSTAT Investigative D03URI DRUG__ID D03URI D03URI DRUGTYPE Small molecular drug D03URI DRUGINCH 1S/C30H28N2O6S/c1-3-37-28-23-12-8-9-13-24(23)29(38-4-2)27-25(28)19-32(30(27)34)21-16-14-20(15-17-21)18-26(33)31-39(35,36)22-10-6-5-7-11-22/h5-17H,3-4,18-19H2,1-2H3,(H,31,33) D03URI DRUGINKE XREWXJVMYAXCJV-UHFFFAOYSA-N D03URI DRUGSMIL CCOC1=C2CN(C(=O)C2=C(C3=CC=CC=C31)OCC)C4=CC=C(C=C4)CC(=O)NS(=O)(=O)C5=CC=CC=C5 D03URI HIGHSTAT Investigative D03UTI DRUG__ID D03UTI D03UTI DRUGTYPE Small molecular drug D03UTI DRUGINCH 1S/C7H5IN2/c8-6-2-1-3-7-5(6)4-9-10-7/h1-4H,(H,9,10) D03UTI DRUGINKE CJQXSPSUIGJNJX-UHFFFAOYSA-N D03UTI DRUGSMIL C1=CC2=C(C=NN2)C(=C1)I D03UTI HIGHSTAT Investigative D03UUO DRUG__ID D03UUO D03UUO DRUGTYPE Small molecular drug D03UUO DRUGINCH 1S/C15H18N4O2/c1-2-3-9-16-15-17-10-8-13(19-15)18-12-7-5-4-6-11(12)14(20)21/h4-8,10H,2-3,9H2,1H3,(H,20,21)(H2,16,17,18,19) D03UUO DRUGINKE FSZJHCURVIQYSG-UHFFFAOYSA-N D03UUO DRUGSMIL CCCCNC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O D03UUO HIGHSTAT Investigative D03UVR DRUG__ID D03UVR D03UVR DRUGTYPE Small molecular drug D03UVR DRUGINCH 1S/C21H22F4N6O/c22-13-32-18-9-8-16(31-20(21(23,24)25)28-29-30-31)11-15(18)12-27-17-7-4-10-26-19(17)14-5-2-1-3-6-14/h1-3,5-6,8-9,11,17,19,26-27H,4,7,10,12-13H2/t17-,19-/m0/s1/i22-1 D03UVR DRUGINKE KSKJMSAKVZSMMV-LBXDGNDASA-N D03UVR DRUGSMIL C1CC(C(NC1)C2=CC=CC=C2)NCC3=C(C=CC(=C3)N4C(=NN=N4)C(F)(F)F)OCF D03UVR HIGHSTAT Investigative D03UXO DRUG__ID D03UXO D03UXO DRUGTYPE Small molecular drug D03UXO DRUGINCH 1S/C12H11N3O2/c13-12-14-6-8-9(15-12)4-7(5-10(8)16)11-2-1-3-17-11/h1-3,6-7H,4-5H2,(H2,13,14,15) D03UXO DRUGINKE SOJUSNIBPPMLCC-UHFFFAOYSA-N D03UXO DRUGSMIL C1C(CC(=O)C2=CN=C(N=C21)N)C3=CC=CO3 D03UXO HIGHSTAT Investigative D03UYO DRUG__ID D03UYO D03UYO DRUGTYPE Small molecular drug D03UYO DRUGINCH 1S/C27H35N3O6/c1-4-21(24(32)26(34)28-16-23(31)20-13-9-6-10-14-20)29-25(33)22(15-18(2)3)30-27(35)36-17-19-11-7-5-8-12-19/h5-14,18,21-23,31H,4,15-17H2,1-3H3,(H,28,34)(H,29,33)(H,30,35) D03UYO DRUGINKE CZZWUFZBGQIPTE-UHFFFAOYSA-N D03UYO DRUGSMIL CCC(C(=O)C(=O)NCC(C1=CC=CC=C1)O)NC(=O)C(CC(C)C)NC(=O)OCC2=CC=CC=C2 D03UYO HIGHSTAT Investigative D03UZZ DRUG__ID D03UZZ D03UZZ DRUGTYPE Small molecular drug D03UZZ DRUGINCH 1S/C16H9FN2O/c1-2-11-4-3-5-15(8-11)19-16(20)13-6-12(10-18)7-14(17)9-13/h1,3-9H,(H,19,20) D03UZZ DRUGINKE WPLAMCXDNWYUEU-UHFFFAOYSA-N D03UZZ DRUGSMIL C#CC1=CC(=CC=C1)NC(=O)C2=CC(=CC(=C2)C#N)F D03UZZ HIGHSTAT Investigative D03VAA DRUG__ID D03VAA D03VAA DRUGTYPE Small molecular drug D03VAA DRUGINCH 1S/C17H10O5/c18-11-3-1-9-5-15(21-13(9)7-11)17(20)16-6-10-2-4-12(19)8-14(10)22-16/h1-8,18-19H D03VAA DRUGINKE RMZPEAFTFQMIEY-UHFFFAOYSA-N D03VAA DRUGSMIL C1=CC2=C(C=C1O)OC(=C2)C(=O)C3=CC4=C(O3)C=C(C=C4)O D03VAA HIGHSTAT Investigative D03VAO DRUG__ID D03VAO D03VAO DRUGTYPE Small molecular drug D03VAO DRUGINCH 1S/C14H9BrFN3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19) D03VAO DRUGINKE FQRFQQLJZXACCG-UHFFFAOYSA-N D03VAO DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)F D03VAO HIGHSTAT Investigative D03VBJ DRUG__ID D03VBJ D03VBJ DRUGTYPE Small molecular drug D03VBJ DRUGINCH 1S/C11H19N2O7P/c1-11(2,3)8-6(4-7(12)10(14)15)9(13-20-8)19-5-21(16,17)18/h7H,4-5,12H2,1-3H3,(H,14,15)(H2,16,17,18) D03VBJ DRUGINKE AGSOOCUNMTYPSE-UHFFFAOYSA-N D03VBJ DRUGSMIL CC(C)(C)C1=C(C(=NO1)OCP(=O)(O)O)CC(C(=O)O)N D03VBJ HIGHSTAT Investigative D03VDM DRUG__ID D03VDM D03VDM DRUGTYPE Small molecular drug D03VDM DRUGINCH 1S/C23H20N2O/c26-23(19-12-10-18(11-13-19)17-6-2-1-3-7-17)24-15-14-20-16-25-22-9-5-4-8-21(20)22/h1-13,16,25H,14-15H2,(H,24,26) D03VDM DRUGINKE GYEGDDXJVFNDOP-UHFFFAOYSA-N D03VDM DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NCCC3=CNC4=CC=CC=C43 D03VDM HIGHSTAT Investigative D03VGO DRUG__ID D03VGO D03VGO DRUGTYPE Small molecular drug D03VGO DRUGINCH 1S/C25H24N4O3/c30-24(18-1-2-18)28-11-9-16(15-28)13-23-26-27-25(31)29(23)21-6-3-17(4-7-21)19-5-8-22-20(14-19)10-12-32-22/h3-8,10,12,14,16,18H,1-2,9,11,13,15H2,(H,27,31)/t16-/m0/s1 D03VGO DRUGINKE AQTPWCUIYUOEMG-INIZCTEOSA-N D03VGO DRUGSMIL C1CC1C(=O)N2CCC(C2)CC3=NNC(=O)N3C4=CC=C(C=C4)C5=CC6=C(C=C5)OC=C6 D03VGO HIGHSTAT Investigative D03VGR DRUG__ID D03VGR D03VGR DRUGTYPE Small molecular drug D03VGR DRUGINCH 1S/C31H49N3O9S/c1-3-4-5-6-7-8-9-10-11-12-13-14-17-26(25(35)16-15-18-28(37)38)44-22-24(30(41)33-21-29(39)40)34-27(36)20-19-23(32-2)31(42)43/h7-8,10-14,17,23-26,32,35H,3-6,9,15-16,18-22H2,1-2H3,(H,33,41)(H,34,36)(H,37,38)(H,39,40)(H,42,43)/b8-7-,11-10-,13-12+,17-14+/t23?,24?,25-,26+/m0/s1 D03VGR DRUGINKE FPLBRCJNODNRQZ-LZHUJPGBSA-N D03VGR DRUGSMIL CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)NC D03VGR HIGHSTAT Investigative D03VHK DRUG__ID D03VHK D03VHK DRUGTYPE Small molecular drug D03VHK DRUGINCH 1S/C26H31N3O5S/c1-20(30)28-17-22-6-5-7-25(16-22)34-19-24(31)18-27-15-14-21-10-12-23(13-11-21)29-35(32,33)26-8-3-2-4-9-26/h2-13,16,24,27,29,31H,14-15,17-19H2,1H3,(H,28,30)/t24-/m0/s1 D03VHK DRUGINKE AWIONHVPTYTSHZ-DEOSSOPVSA-N D03VHK DRUGSMIL CC(=O)NCC1=CC(=CC=C1)OCC(CNCCC2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3)O D03VHK HIGHSTAT Investigative D03VHO DRUG__ID D03VHO D03VHO DRUGTYPE Small molecular drug D03VHO DRUGINCH 1S/C40H59N7O10/c1-10-25(6)33(37(51)44-32(24(4)5)38(52)56-9)45-39(53)47-46-36(50)31(21-27-16-18-29(55-8)19-17-27)43-35(49)30(20-23(2)3)42-34(48)26(7)41-40(54)57-22-28-14-12-11-13-15-28/h11-19,23-26,30-33H,10,20-22H2,1-9H3,(H,41,54)(H,42,48)(H,43,49)(H,44,51)(H,46,50)(H2,45,47,53) D03VHO DRUGINKE QZSSZOWDSLCTPA-UHFFFAOYSA-N D03VHO DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=C(C=C1)OC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2 D03VHO HIGHSTAT Investigative D03VIS DRUG__ID D03VIS D03VIS DRUGTYPE Small molecular drug D03VIS DRUGINCH 1S/C13H16N2S/c1-13(2,3)11-9-16-12(15-11)14-10-7-5-4-6-8-10/h4-9H,1-3H3,(H,14,15) D03VIS DRUGINKE OZPRKERRJSPXIW-UHFFFAOYSA-N D03VIS DRUGSMIL CC(C)(C)C1=CSC(=N1)NC2=CC=CC=C2 D03VIS HIGHSTAT Investigative D03VMX DRUG__ID D03VMX D03VMX DRUGTYPE Small molecular drug D03VMX DRUGINCH 1S/C27H25FN4O4S/c1-3-35-25(34)20-7-11-23(12-8-20)32-16-21(13-19-14-29-26(30-15-19)36-4-2)24(33)31-27(32)37-17-18-5-9-22(28)10-6-18/h5-12,14-16H,3-4,13,17H2,1-2H3 D03VMX DRUGINKE PTPNCCWOTBBVJR-UHFFFAOYSA-N D03VMX DRUGSMIL CCOC1=NC=C(C=N1)CC2=CN(C(=NC2=O)SCC3=CC=C(C=C3)F)C4=CC=C(C=C4)C(=O)OCC D03VMX HIGHSTAT Investigative D03VNZ DRUG__ID D03VNZ D03VNZ DRUGTYPE Small molecular drug D03VNZ DRUGINCH 1S/C10H6N2O2/c13-9-6-1-2-7-5(3-4-11-7)8(6)10(14)12-9/h1-4,11H,(H,12,13,14) D03VNZ DRUGINKE KVIRPIKEFDXNQF-UHFFFAOYSA-N D03VNZ DRUGSMIL C1=CC2=C(C=CN2)C3=C1C(=O)NC3=O D03VNZ HIGHSTAT Investigative D03VOB DRUG__ID D03VOB D03VOB DRUGTYPE Small molecular drug D03VOB DRUGINCH 1S/C10H16N5O5P/c1-6(4-21(17,18)19)20-3-2-15-5-12-7-8(15)13-10(11)14-9(7)16/h5-6H,2-4H2,1H3,(H2,17,18,19)(H3,11,13,14,16) D03VOB DRUGINKE XUOAETDFEFTPTL-UHFFFAOYSA-N D03VOB DRUGSMIL CC(CP(=O)(O)O)OCCN1C=NC2=C1N=C(NC2=O)N D03VOB HIGHSTAT Investigative D03VOM DRUG__ID D03VOM D03VOM DRUGTYPE Small molecular drug D03VOM DRUGINCH 1S/C17H27NO/c1-4-5-6-7-8-15-9-11-16(12-10-15)17(19)13-14-18(2)3/h9-12H,4-8,13-14H2,1-3H3 D03VOM DRUGINKE KDBREDBLOZXWHK-UHFFFAOYSA-N D03VOM DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)CCN(C)C D03VOM HIGHSTAT Investigative D03VPS DRUG__ID D03VPS D03VPS DRUGTYPE Small molecular drug D03VPS DRUGINCH 1S/C19H23N3O2/c1-15-5-4-6-17(13-15)19(23)20-14-21-11-8-16(9-12-21)18-7-2-3-10-22(18)24/h2-7,10,13,16H,8-9,11-12,14H2,1H3,(H,20,23) D03VPS DRUGINKE PUMMPCXNEPHBNN-UHFFFAOYSA-N D03VPS DRUGSMIL CC1=CC(=CC=C1)C(=O)NCN2CCC(CC2)C3=CC=CC=[N+]3[O-] D03VPS HIGHSTAT Investigative D03VQC DRUG__ID D03VQC D03VQC DRUGTYPE Small molecular drug D03VQC DRUGINCH 1S/C13H17NOS/c1-10(2)6-7-16-12-5-4-11(9-14)13(8-12)15-3/h4-5,8,10H,6-7H2,1-3H3 D03VQC DRUGINKE XWPLSLIGOKRGBS-UHFFFAOYSA-N D03VQC DRUGSMIL CC(C)CCSC1=CC(=C(C=C1)C#N)OC D03VQC HIGHSTAT Investigative D03VQF DRUG__ID D03VQF D03VQF DRUGTYPE Small molecular drug D03VQF DRUGINCH 1S/C27H32O6/c1-15(2)7-8-17(16(3)4)11-20-21(29)13-25(32-6)26-22(30)14-24(33-27(20)26)19-10-9-18(28)12-23(19)31-5/h7,9-10,12-13,17,24,28-29H,3,8,11,14H2,1-2,4-6H3/t17-,24+/m1/s1 D03VQF DRUGINKE KTAQQSUPNZAWEY-OSPHWJPCSA-N D03VQF DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)OC)C(=O)CC(O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C D03VQF HIGHSTAT Investigative D03VRC DRUG__ID D03VRC D03VRC DRUGTYPE Small molecular drug D03VRC DRUGINCH 1S/C10H9BrN2/c11-10-3-1-9(2-4-10)7-13-6-5-12-8-13/h1-6,8H,7H2 D03VRC DRUGINKE MZJSYLIOMLCYIS-UHFFFAOYSA-N D03VRC DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)Br D03VRC HIGHSTAT Investigative D03VSJ DRUG__ID D03VSJ D03VSJ DRUGTYPE Small molecular drug D03VSJ DRUGINCH 1S/C40H44N6O5/c1-23-16-29(47)17-24(2)31(23)21-32(41)40(51)46-15-7-12-36(46)39(50)45-35(20-28-22-43-33-11-6-5-10-30(28)33)38(49)44-34(37(42)48)19-25-13-14-26-8-3-4-9-27(26)18-25/h3-6,8-11,13-14,16-18,22,32,34-36,43,47H,7,12,15,19-21,41H2,1-2H3,(H2,42,48)(H,44,49)(H,45,50)/t32-,34+,35-,36+/m0/s1 D03VSJ DRUGINKE RVBUBWGVXJZPJO-GIFUDOJISA-N D03VSJ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC6=CC=CC=C6C=C5)C(=O)N)N)C)O D03VSJ HIGHSTAT Investigative D03VSQ DRUG__ID D03VSQ D03VSQ DRUGTYPE Small molecular drug D03VSQ DRUGINCH 1S/C26H30O7/c1-13(2)6-7-15(14(3)4)10-18-20(29)12-21(32-5)22-23(30)24(31)26(33-25(18)22)17-9-8-16(27)11-19(17)28/h6,8-9,11-12,15,24,26-29,31H,3,7,10H2,1-2,4-5H3 D03VSQ DRUGINKE QKEDJCCCNZWOBS-UHFFFAOYSA-N D03VSQ DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)OC)C(=O)C(C(O2)C3=C(C=C(C=C3)O)O)O)C(=C)C)C D03VSQ HIGHSTAT Investigative D03VUU DRUG__ID D03VUU D03VUU DRUGTYPE Small molecular drug D03VUU DRUGINCH 1S/C17H19N/c1-18-11-10-17-15-8-4-2-6-13(15)12-14-7-3-5-9-16(14)17/h2-9,17-18H,10-12H2,1H3 D03VUU DRUGINKE PVWQFOKNAQZORV-UHFFFAOYSA-N D03VUU DRUGSMIL CNCCC1C2=CC=CC=C2CC3=CC=CC=C13 D03VUU HIGHSTAT Investigative D03VYO DRUG__ID D03VYO D03VYO DRUGTYPE Small molecular drug D03VYO DRUGINCH 1S/C15H13NO2/c1-2-16-12-8-4-6-10-14(12)18-13-9-5-3-7-11(13)15(16)17/h3-10H,2H2,1H3 D03VYO DRUGINKE MRBRHCRUXKHKKI-UHFFFAOYSA-N D03VYO DRUGSMIL CCN1C2=CC=CC=C2OC3=CC=CC=C3C1=O D03VYO HIGHSTAT Investigative D03VYU DRUG__ID D03VYU D03VYU DRUGTYPE Small molecular drug D03VYU DRUGINCH 1S/C15H20O2/c1-9-5-4-6-15(3)8-13-11(7-12(9)15)10(2)14(16)17-13/h11-13H,1-2,4-8H2,3H3 D03VYU DRUGINKE CVUANYCQTOGILD-UHFFFAOYSA-N D03VYU DRUGSMIL CC12CCCC(=C)C1CC3C(C2)OC(=O)C3=C D03VYU HIGHSTAT Investigative D03VZF DRUG__ID D03VZF D03VZF DRUGTYPE Small molecular drug D03VZF DRUGINCH 1S/C7H5NO4/c9-4-5-1-2-7(10)6(3-5)8(11)12/h1-4,10H D03VZF DRUGINKE YTHJCZRFJGXPTL-UHFFFAOYSA-N D03VZF DRUGSMIL C1=CC(=C(C=C1C=O)[N+](=O)[O-])O D03VZF HIGHSTAT Investigative D03WAE DRUG__ID D03WAE D03WAE DRUGTYPE Small molecular drug D03WAE DRUGINCH 1S/C17H13BrN2O2/c18-17-14-6-2-1-4-12(14)7-8-15(17)22-11-16(21)20-13-5-3-9-19-10-13/h1-10H,11H2,(H,20,21) D03WAE DRUGINKE WLLRAGBPCSOJNH-UHFFFAOYSA-N D03WAE DRUGSMIL C1=CC=C2C(=C1)C=CC(=C2Br)OCC(=O)NC3=CN=CC=C3 D03WAE HIGHSTAT Investigative D03WBX DRUG__ID D03WBX D03WBX DRUGTYPE Small molecular drug D03WBX DRUGINCH 1S/C10H16N2O11P2/c13-6-1-2-12(10(16)11-6)9-8(15)7(14)5(23-9)3-22-25(20,21)4-24(17,18)19/h1-2,5,7-9,14-15H,3-4H2,(H,20,21)(H,11,13,16)(H2,17,18,19)/t5-,7-,8-,9-/m1/s1 D03WBX DRUGINKE PDEGDTTUBZXACY-ZOQUXTDFSA-N D03WBX DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(CP(=O)(O)O)O)O)O D03WBX HIGHSTAT Investigative D03WDY DRUG__ID D03WDY D03WDY DRUGTYPE Small molecular drug D03WDY DRUGINCH 1S/C9H7N3OS/c13-8(7-4-2-1-3-5-7)11-9-12-10-6-14-9/h1-6H,(H,11,12,13) D03WDY DRUGINKE RWOUBULBQYRRNL-UHFFFAOYSA-N D03WDY DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NN=CS2 D03WDY HIGHSTAT Investigative D03WEN DRUG__ID D03WEN D03WEN DRUGTYPE Small molecular drug D03WEN DRUGINCH 1S/C16H13BrN2O3/c1-2-15(21)18-12-6-7-14(20)13(9-12)16(22)19-11-5-3-4-10(17)8-11/h2-9,20H,1H2,(H,18,21)(H,19,22) D03WEN DRUGINKE BVFCILADOWKWJB-UHFFFAOYSA-N D03WEN DRUGSMIL C=CC(=O)NC1=CC(=C(C=C1)O)C(=O)NC2=CC(=CC=C2)Br D03WEN HIGHSTAT Investigative D03WGD DRUG__ID D03WGD D03WGD DRUGTYPE Small molecular drug D03WGD DRUGINCH 1S/C21H26N2O/c1-23-16-11-12-17(23)14-18(13-16)24-21(15-7-3-2-4-8-15)19-9-5-6-10-20(19)22/h2-10,16-18,21H,11-14,22H2,1H3 D03WGD DRUGINKE KZFDKINRISJFCO-UHFFFAOYSA-N D03WGD DRUGSMIL CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4N D03WGD HIGHSTAT Investigative D03WHD DRUG__ID D03WHD D03WHD DRUGTYPE Small molecular drug D03WHD DRUGINCH 1S/C10H7F3N2O/c11-10(12,13)7-4-9(16)15-8-2-1-5(14)3-6(7)8/h1-4H,14H2,(H,15,16) D03WHD DRUGINKE LMXZMEMPGRLDIG-UHFFFAOYSA-N D03WHD DRUGSMIL C1=CC2=C(C=C1N)C(=CC(=O)N2)C(F)(F)F D03WHD HIGHSTAT Investigative D03WIK DRUG__ID D03WIK D03WIK DRUGTYPE Small molecular drug D03WIK DRUGINCH 1S/C26H56NO6P/c1-6-8-9-10-11-12-13-14-15-16-17-18-19-20-22-30-24-26(31-7-2)25-33-34(28,29)32-23-21-27(3,4)5/h26H,6-25H2,1-5H3/p+1 D03WIK DRUGINKE LPHUUVMLQFHHQG-UHFFFAOYSA-O D03WIK DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OCC D03WIK HIGHSTAT Investigative D03WJD DRUG__ID D03WJD D03WJD DRUGTYPE Small molecular drug D03WJD DRUGINCH 1S/C18H18N2O5S/c1-25-15-4-6-16(7-5-15)26(23,24)20-11-10-14-12-13(2-8-17(14)20)3-9-18(21)19-22/h2-9,12,22H,10-11H2,1H3,(H,19,21)/b9-3+ D03WJD DRUGINKE LMFNVOGHSBJWLX-YCRREMRBSA-N D03WJD DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)N2CCC3=C2C=CC(=C3)C=CC(=O)NO D03WJD HIGHSTAT Investigative D03WJG DRUG__ID D03WJG D03WJG DRUGTYPE Small molecular drug D03WJG DRUGINCH 1S/C18H20N2O8S/c21-14-10-20(15(18(24)19-25)17(23)16(14)22)29(26,27)13-8-6-12(7-9-13)28-11-4-2-1-3-5-11/h1-9,14-17,21-23,25H,10H2,(H,19,24)/t14-,15+,16+,17+/m0/s1 D03WJG DRUGINKE WLWNRAWQDZRXMB-YLFCFFPRSA-N D03WJG DRUGSMIL C1C(C(C(C(N1S(=O)(=O)C2=CC=C(C=C2)OC3=CC=CC=C3)C(=O)NO)O)O)O D03WJG HIGHSTAT Investigative D03WNI DRUG__ID D03WNI D03WNI DRUGTYPE Small molecular drug D03WNI DRUGINCH 1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9) D03WNI DRUGINKE BJEPYKJPYRNKOW-UHFFFAOYSA-N D03WNI DRUGSMIL C(C(C(=O)O)O)C(=O)O D03WNI HIGHSTAT Investigative D03WOS DRUG__ID D03WOS D03WOS DRUGTYPE Small molecular drug D03WOS DRUGINCH 1S/C13H13ClN2/c14-10-6-3-5-9-12(15)8-4-1-2-7-11(8)16-13(9)10/h3,5-6H,1-2,4,7H2,(H2,15,16) D03WOS DRUGINKE DREAHDLCWZKIJL-UHFFFAOYSA-N D03WOS DRUGSMIL C1CCC2=C(C1)C(=C3C=CC=C(C3=N2)Cl)N D03WOS HIGHSTAT Investigative D03WOU DRUG__ID D03WOU D03WOU DRUGTYPE Small molecular drug D03WOU DRUGINCH 1S/C22H14O2/c23-21(19-11-9-15-5-1-3-7-17(15)13-19)22(24)20-12-10-16-6-2-4-8-18(16)14-20/h1-14H D03WOU DRUGINKE CUUMQBIJNWGQLU-UHFFFAOYSA-N D03WOU DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)C(=O)C3=CC4=CC=CC=C4C=C3 D03WOU HIGHSTAT Investigative D03WOZ DRUG__ID D03WOZ D03WOZ DRUGTYPE Small molecular drug D03WOZ DRUGINCH 1S/C7H5N3O2/c11-10(12)6-3-1-2-5-4-8-9-7(5)6/h1-4H,(H,8,9) D03WOZ DRUGINKE PQCAUHUKTBHUSA-UHFFFAOYSA-N D03WOZ DRUGSMIL C1=CC2=C(C(=C1)[N+](=O)[O-])NN=C2 D03WOZ HIGHSTAT Investigative D03WPE DRUG__ID D03WPE D03WPE DRUGTYPE Small molecular drug D03WPE DRUGINCH 1S/C20H23N7O6/c1-2-21-17(31)18(32)26-20-24-15(23-10-6-4-3-5-7-10)12-16(25-20)27(9-22-12)19-14(30)13(29)11(8-28)33-19/h3-7,9,11,13-14,19,28-30H,2,8H2,1H3,(H,21,31)(H2,23,24,25,26,32)/t11-,13-,14-,19-/m1/s1 D03WPE DRUGINKE ZLZSAUQLHYWSOL-HLFSEMCJSA-N D03WPE DRUGSMIL CCNC(=O)C(=O)NC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC4=CC=CC=C4 D03WPE HIGHSTAT Investigative D03WQK DRUG__ID D03WQK D03WQK DRUGTYPE Small molecular drug D03WQK DRUGINCH 1S/C7H13NO6/c8-7(13)6-5(12)4(11)3(10)2(1-9)14-6/h2-6,9-12H,1H2,(H2,8,13)/t2-,3-,4+,5-,6+/m1/s1 D03WQK DRUGINKE UKWLGCFJAVEFPE-DVKNGEFBSA-N D03WQK DRUGSMIL C(C1C(C(C(C(O1)C(=O)N)O)O)O)O D03WQK HIGHSTAT Investigative D03WTU DRUG__ID D03WTU D03WTU DRUGTYPE Small molecular drug D03WTU DRUGINCH 1S/C23H26N2O4/c1-16-13-18-7-5-6-8-19(18)25(16)12-11-24-22(26)10-9-17-14-20(27-2)23(29-4)21(15-17)28-3/h5-10,13-15H,11-12H2,1-4H3,(H,24,26)/b10-9+ D03WTU DRUGINKE YBHUXHFZLMFETJ-MDZDMXLPSA-N D03WTU DRUGSMIL CC1=CC2=CC=CC=C2N1CCNC(=O)C=CC3=CC(=C(C(=C3)OC)OC)OC D03WTU HIGHSTAT Investigative D03WYO DRUG__ID D03WYO D03WYO DRUGTYPE Small molecular drug D03WYO DRUGINCH 1S/C18H23NO2/c1-11-16-17(21)14-6-5-13(20)9-15(14)18(11,2)7-8-19(16)10-12-3-4-12/h5-6,9,11-12,16,20H,3-4,7-8,10H2,1-2H3/t11-,16-,18-/m0/s1 D03WYO DRUGINKE HQBZLVPZOGIAIQ-PBQZTSCYSA-N D03WYO DRUGSMIL CC1C2C(=O)C3=C(C1(CCN2CC4CC4)C)C=C(C=C3)O D03WYO HIGHSTAT Investigative D03XAE DRUG__ID D03XAE D03XAE DRUGTYPE Small molecular drug D03XAE DRUGINCH 1S/C14H20N2/c1-4-11-5-6-14-13(9-11)12(10-15-14)7-8-16(2)3/h5-6,9-10,15H,4,7-8H2,1-3H3 D03XAE DRUGINKE ZEHXYLDGQMEYAX-UHFFFAOYSA-N D03XAE DRUGSMIL CCC1=CC2=C(C=C1)NC=C2CCN(C)C D03XAE HIGHSTAT Investigative D03XBA DRUG__ID D03XBA D03XBA DRUGTYPE Small molecular drug D03XBA DRUGINCH 1S/C14H14BrN3S/c15-12-6-7-13(17-10-12)18-14(19)16-9-8-11-4-2-1-3-5-11/h1-7,10H,8-9H2,(H2,16,17,18,19) D03XBA DRUGINKE FKDHVFZSRUETTG-UHFFFAOYSA-N D03XBA DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC=C(C=C2)Br D03XBA HIGHSTAT Investigative D03XCG DRUG__ID D03XCG D03XCG DRUGTYPE Small molecular drug D03XCG DRUGINCH 1S/C18H29NO/c1-3-5-6-7-8-16-9-11-17(12-10-16)18(20)13-15-19-14-4-2/h9-12,19H,3-8,13-15H2,1-2H3 D03XCG DRUGINKE IHAKHGFZWJHPER-UHFFFAOYSA-N D03XCG DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)CCNCCC D03XCG HIGHSTAT Investigative D03XDN DRUG__ID D03XDN D03XDN DRUGTYPE Small molecular drug D03XDN DRUGINCH 1S/C17H15BrN4O/c1-2-16(23)21-13-6-7-15-14(9-13)17(20-10-19-15)22-12-5-3-4-11(18)8-12/h3-10H,2H2,1H3,(H,21,23)(H,19,20,22) D03XDN DRUGINKE WUPUZEMRHDROEO-UHFFFAOYSA-N D03XDN DRUGSMIL CCC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br D03XDN HIGHSTAT Investigative D03XEU DRUG__ID D03XEU D03XEU DRUGTYPE Small molecular drug D03XEU DRUGINCH 1S/C15H12O4/c1-18-14-8-12(17)6-10-7-13(19-15(10)14)9-2-4-11(16)5-3-9/h2-8,16-17H,1H3 D03XEU DRUGINKE KEWMBPCQWDVBAS-UHFFFAOYSA-N D03XEU DRUGSMIL COC1=C2C(=CC(=C1)O)C=C(O2)C3=CC=C(C=C3)O D03XEU HIGHSTAT Investigative D03XGJ DRUG__ID D03XGJ D03XGJ DRUGTYPE Small molecular drug D03XGJ DRUGINCH 1S/C12H11N3O/c13-10-7-6-9(12(14)15-10)11(16)8-4-2-1-3-5-8/h1-7H,(H4,13,14,15) D03XGJ DRUGINKE CUQWNLDNYKQYLY-UHFFFAOYSA-N D03XGJ DRUGSMIL C1=CC=C(C=C1)C(=O)C2=C(N=C(C=C2)N)N D03XGJ HIGHSTAT Investigative D03XHE DRUG__ID D03XHE D03XHE DRUGTYPE Small molecular drug D03XHE DRUGINCH 1S/C19H15ClN4O2/c1-26-17-12-13(23-24-18-8-4-5-11-21-18)9-10-16(17)22-19(25)14-6-2-3-7-15(14)20/h2-12H,1H3,(H,22,25) D03XHE DRUGINKE JJRNGNCTPCWXGM-UHFFFAOYSA-N D03XHE DRUGSMIL COC1=C(C=CC(=C1)N=NC2=CC=CC=N2)NC(=O)C3=CC=CC=C3Cl D03XHE HIGHSTAT Investigative D03XHF DRUG__ID D03XHF D03XHF DRUGTYPE Small molecular drug D03XHF DRUGINCH 1S/C16H11FO2S/c17-13-6-3-11(9-14(13)19)16-8-7-15(20-16)10-1-4-12(18)5-2-10/h1-9,18-19H D03XHF DRUGINKE QFKIHVDWWIPQTB-UHFFFAOYSA-N D03XHF DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC(=C(C=C3)F)O)O D03XHF HIGHSTAT Investigative D03XIY DRUG__ID D03XIY D03XIY DRUGTYPE Small molecular drug D03XIY DRUGINCH 1S/C16H19NOS/c18-15(16-17-12-13-19-16)11-7-2-1-4-8-14-9-5-3-6-10-14/h3,5-6,9-10,12-13H,1-2,4,7-8,11H2 D03XIY DRUGINKE BBVVJTRLCDWSMU-UHFFFAOYSA-N D03XIY DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=CS2 D03XIY HIGHSTAT Investigative D03XJE DRUG__ID D03XJE D03XJE DRUGTYPE Small molecular drug D03XJE DRUGINCH 1S/C18H19NO2/c20-14-1-2-16-17(8-14)21-18(19-16)9-15-12-4-10-3-11(6-12)7-13(15)5-10/h1-2,8-13,20H,3-7H2 D03XJE DRUGINKE CEAARYLECHJRSD-UHFFFAOYSA-N D03XJE DRUGSMIL C1C2CC3CC1CC(C2)C3=CC4=NC5=C(O4)C=C(C=C5)O D03XJE HIGHSTAT Investigative D03XKJ DRUG__ID D03XKJ D03XKJ DRUGTYPE Small molecular drug D03XKJ DRUGINCH 1S/C16H17ClN2O2/c17-14-5-1-13(2-6-14)11-21-15-7-3-12(4-8-15)9-19-10-16(18)20/h1-8,19H,9-11H2,(H2,18,20) D03XKJ DRUGINKE OIWXOGDFIRHEKD-UHFFFAOYSA-N D03XKJ DRUGSMIL C1=CC(=CC=C1CNCC(=O)N)OCC2=CC=C(C=C2)Cl D03XKJ HIGHSTAT Investigative D03XKK DRUG__ID D03XKK D03XKK DRUGTYPE Small molecular drug D03XKK DRUGINCH 1S/C13H13N5O/c1-8-3-2-4-9(5-8)6-19-12-10-11(16-7-15-10)17-13(14)18-12/h2-5,7H,6H2,1H3,(H3,14,15,16,17,18) D03XKK DRUGINKE WSSNDTDMMVLPHS-UHFFFAOYSA-N D03XKK DRUGSMIL CC1=CC(=CC=C1)COC2=NC(=NC3=C2NC=N3)N D03XKK HIGHSTAT Investigative D03XKL DRUG__ID D03XKL D03XKL DRUGTYPE Small molecular drug D03XKL DRUGINCH 1S/C26H36Cl2N4/c27-23-7-5-9-25(21-23)31-17-13-29(14-18-31)11-3-1-2-4-12-30-15-19-32(20-16-30)26-10-6-8-24(28)22-26/h5-10,21-22H,1-4,11-20H2 D03XKL DRUGINKE YWGRWBCJUGEEBA-UHFFFAOYSA-N D03XKL DRUGSMIL C1CN(CCN1CCCCCCN2CCN(CC2)C3=CC(=CC=C3)Cl)C4=CC(=CC=C4)Cl D03XKL HIGHSTAT Investigative D03XKU DRUG__ID D03XKU D03XKU DRUGTYPE Small molecular drug D03XKU DRUGINCH 1S/C10H13N3/c1-2-8-7-5-3-4-6-9(7)13-10(11)12-8/h3-6,8H,2H2,1H3,(H3,11,12,13) D03XKU DRUGINKE FUFWGLRRMNVLPD-UHFFFAOYSA-N D03XKU DRUGSMIL CCC1C2=CC=CC=C2NC(=N1)N D03XKU HIGHSTAT Investigative D03XLS DRUG__ID D03XLS D03XLS DRUGTYPE Small molecular drug D03XLS DRUGINCH 1S/C8H15N2O5P/c11-8(12)7-6-10(4-2-9-7)3-1-5-16(13,14)15/h1,5,7,9H,2-4,6H2,(H,11,12)(H2,13,14,15)/b5-1+ D03XLS DRUGINKE VZXMZMJSGLFKQI-ORCRQEGFSA-N D03XLS DRUGSMIL C1CN(CC(N1)C(=O)O)CC=CP(=O)(O)O D03XLS HIGHSTAT Investigative D03XMD DRUG__ID D03XMD D03XMD DRUGTYPE Small molecular drug D03XMD DRUGINCH 1S/C34H45N3O.2ClH/c1-36(2)24-25-37(34(38)21-16-28-10-6-7-11-28)27-31-14-19-33(20-15-31)32-17-12-30(13-18-32)26-35-23-22-29-8-4-3-5-9-29;;/h3-5,8-9,12-15,17-20,28,35H,6-7,10-11,16,21-27H2,1-2H3;2*1H D03XMD DRUGINKE QJMKBIHLMPTYTI-UHFFFAOYSA-N D03XMD DRUGSMIL CN(C)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)CNCCC3=CC=CC=C3)C(=O)CCC4CCCC4.Cl.Cl D03XMD HIGHSTAT Investigative D03XOB DRUG__ID D03XOB D03XOB DRUGTYPE Small molecular drug D03XOB DRUGINCH 1S/C8H7BO3S/c10-6-1-2-7-5(3-6)4-8(13-7)9(11)12/h1-4,10-12H D03XOB DRUGINKE VDCIKADVYWVDGT-UHFFFAOYSA-N D03XOB DRUGSMIL B(C1=CC2=C(S1)C=CC(=C2)O)(O)O D03XOB HIGHSTAT Investigative D03XQB DRUG__ID D03XQB D03XQB DRUGTYPE Small molecular drug D03XQB DRUGINCH 1S/C16H13FO3/c1-19-12-5-2-10(3-6-12)15-9-14(18)13-7-4-11(17)8-16(13)20-15/h2-8,15H,9H2,1H3 D03XQB DRUGINKE MQUZZZVJAVDIPR-UHFFFAOYSA-N D03XQB DRUGSMIL COC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)F D03XQB HIGHSTAT Investigative D03XVJ DRUG__ID D03XVJ D03XVJ DRUGTYPE Small molecular drug D03XVJ DRUGINCH 1S/C33H46N4O4/c1-36(2,24-14-20-34-30(38)26-16-8-9-17-27(26)31(34)39)22-12-6-5-7-13-23-37(3,4)25-15-21-35-32(40)28-18-10-11-19-29(28)33(35)41/h8-11,16-19H,5-7,12-15,20-25H2,1-4H3/q+2 D03XVJ DRUGINKE OSALRKZRWVYPFR-UHFFFAOYSA-N D03XVJ DRUGSMIL C[N+](C)(CCCCCCC[N+](C)(C)CCCN1C(=O)C2=CC=CC=C2C1=O)CCCN3C(=O)C4=CC=CC=C4C3=O D03XVJ HIGHSTAT Investigative D03XVT DRUG__ID D03XVT D03XVT DRUGTYPE Small molecular drug D03XVT DRUGINCH 1S/C19H22O/c20-19(16-15-18-11-5-2-6-12-18)14-8-7-13-17-9-3-1-4-10-17/h1-7,9-13,19-20H,8,14-16H2/b13-7+/t19-/m0/s1 D03XVT DRUGINKE DPRCKWANIKZGTF-KRSRXSRCSA-N D03XVT DRUGSMIL C1=CC=C(C=C1)CCC(CCC=CC2=CC=CC=C2)O D03XVT HIGHSTAT Investigative D03XXI DRUG__ID D03XXI D03XXI DRUGTYPE Small molecular drug D03XXI DRUGINCH 1S/C20H22O4/c21-19(20(22)23)10-6-1-2-7-15-24-18-13-11-17(12-14-18)16-8-4-3-5-9-16/h3-5,8-9,11-14H,1-2,6-7,10,15H2,(H,22,23) D03XXI DRUGINKE VREZMJDAPPMITK-UHFFFAOYSA-N D03XXI DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)C(=O)O D03XXI HIGHSTAT Investigative D03XXT DRUG__ID D03XXT D03XXT DRUGTYPE Small molecular drug D03XXT DRUGINCH 1S/C28H33ClN4O3/c1-18(32-11-13-35-14-12-32)17-33-25-8-7-22(28-19(2)31-36-20(28)3)16-24(25)30-27(33)10-6-21-5-9-26(34-4)23(29)15-21/h5,7-9,15-16,18H,6,10-14,17H2,1-4H3/t18-/m0/s1 D03XXT DRUGINKE GEPYBHCJBORHCE-SFHVURJKSA-N D03XXT DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)CCC4=CC(=C(C=C4)OC)Cl)CC(C)N5CCOCC5 D03XXT HIGHSTAT Investigative D03XXV DRUG__ID D03XXV D03XXV DRUGTYPE Small molecular drug D03XXV DRUGINCH 1S/C20H20N2O2/c1-15-7-8-19-17(13-15)18(14-20(23)24-19)22-11-9-21(10-12-22)16-5-3-2-4-6-16/h2-8,13-14H,9-12H2,1H3 D03XXV DRUGINKE FYWXEEJKGHDKBJ-UHFFFAOYSA-N D03XXV DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C=C2N3CCN(CC3)C4=CC=CC=C4 D03XXV HIGHSTAT Investigative D03XYK DRUG__ID D03XYK D03XYK DRUGTYPE Small molecular drug D03XYK DRUGINCH 1S/C18H13FN4S/c19-14-6-8-15(9-7-14)24-18-16-17(20-11-21-18)23(12-22-16)10-13-4-2-1-3-5-13/h1-9,11-12H,10H2 D03XYK DRUGINKE MYVLGUBXADPZJM-UHFFFAOYSA-N D03XYK DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C2N=CN=C3SC4=CC=C(C=C4)F D03XYK HIGHSTAT Investigative D03XZJ DRUG__ID D03XZJ D03XZJ DRUGTYPE Small molecular drug D03XZJ DRUGINCH 1S/C13H12O2S2/c1-17(14,15)13-6-4-11(5-7-13)2-3-12-8-9-16-10-12/h2-10H,1H3/b3-2+ D03XZJ DRUGINKE HPDGNEAMPZEKTB-NSCUHMNNSA-N D03XZJ DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C=CC2=CSC=C2 D03XZJ HIGHSTAT Investigative D03YAG DRUG__ID D03YAG D03YAG DRUGTYPE Small molecular drug D03YAG DRUGINCH 1S/C21H29NO3/c23-21(22-14-8-5-9-15-22)11-7-4-2-1-3-6-10-18-12-13-19-20(16-18)25-17-24-19/h6,10,12-13,16H,1-5,7-9,11,14-15,17H2/b10-6+ D03YAG DRUGINKE FAXXHNWVMKTOFF-UXBLZVDNSA-N D03YAG DRUGSMIL C1CCN(CC1)C(=O)CCCCCCC=CC2=CC3=C(C=C2)OCO3 D03YAG HIGHSTAT Investigative D03YBH DRUG__ID D03YBH D03YBH DRUGTYPE Small molecular drug D03YBH DRUGINCH 1S/C25H40N2O6S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22(21(28)15-14-17-23(29)30)34-19-20(26)25(33)27-18-24(31)32/h6-7,9-13,16,20-22,28H,2-5,8,14-15,17-19,26H2,1H3,(H,27,33)(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t20-,21-,22+/m0/s1 D03YBH DRUGINKE YEESKJGWJFYOOK-IJHYULJSSA-N D03YBH DRUGSMIL CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)N D03YBH HIGHSTAT Investigative D03YBR DRUG__ID D03YBR D03YBR DRUGTYPE Small molecular drug D03YBR DRUGINCH 1S/C11H10N2O3S/c14-10-6-7-11(13-12-10)17(15,16)8-9-4-2-1-3-5-9/h1-7H,8H2,(H,12,14) D03YBR DRUGINKE QUZYPEPCSQAPEU-UHFFFAOYSA-N D03YBR DRUGSMIL C1=CC=C(C=C1)CS(=O)(=O)C2=NNC(=O)C=C2 D03YBR HIGHSTAT Investigative D03YCW DRUG__ID D03YCW D03YCW DRUGTYPE Small molecular drug D03YCW DRUGINCH 1S/C21H20O8/c1-25-15-3-9(4-16(26-2)20(15)23)17-10-5-13-14(29-8-28-13)6-11(10)19(22)12-7-27-21(24)18(12)17/h3-6,12,17-19,22-23H,7-8H2,1-2H3/t12-,17+,18-,19+/m0/s1 D03YCW DRUGINKE YVCVYCSAAZQOJI-JHQYFNNDSA-N D03YCW DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O D03YCW HIGHSTAT Investigative D03YDG DRUG__ID D03YDG D03YDG DRUGTYPE Small molecular drug D03YDG DRUGINCH 1S/C29H31N5O3/c1-17-11-21(35)12-18(2)22(17)14-23(30)29(37)34-16-20-8-4-3-7-19(20)13-26(34)28(36)31-15-27-32-24-9-5-6-10-25(24)33-27/h3-12,23,26,35H,13-16,30H2,1-2H3,(H,31,36)(H,32,33)/t23-,26-/m0/s1 D03YDG DRUGINKE XRZTZWCPHAJWJQ-OZXSUGGESA-N D03YDG DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=NC5=CC=CC=C5N4)N)C)O D03YDG HIGHSTAT Investigative D03YHE DRUG__ID D03YHE D03YHE DRUGTYPE Small molecular drug D03YHE DRUGINCH 1S/C7H13NO3S/c1-5(9)8-6(7(10)11)3-4-12-2/h6H,3-4H2,1-2H3,(H,8,9)(H,10,11)/t6-/m0/s1 D03YHE DRUGINKE XUYPXLNMDZIRQH-LURJTMIESA-N D03YHE DRUGSMIL CC(=O)NC(CCSC)C(=O)O D03YHE HIGHSTAT Investigative D03YHF DRUG__ID D03YHF D03YHF DRUGTYPE Small molecular drug D03YHF DRUGINCH 1S/C15H22N2O3/c1-4-5-10-19-14-8-6-13(7-9-14)11-16-15(18)20-17-12(2)3/h6-9H,4-5,10-11H2,1-3H3,(H,16,18) D03YHF DRUGINKE VRTSWQPAWLHCJK-UHFFFAOYSA-N D03YHF DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)ON=C(C)C D03YHF HIGHSTAT Investigative D03YHZ DRUG__ID D03YHZ D03YHZ DRUGTYPE Small molecular drug D03YHZ DRUGINCH 1S/C18H14N2O/c21-18-8-6-13-9-12(5-7-17(13)20-18)16-11-19-10-14-3-1-2-4-15(14)16/h1-5,7,9-11H,6,8H2,(H,20,21) D03YHZ DRUGINKE TVVPAZUMRVMIFM-UHFFFAOYSA-N D03YHZ DRUGSMIL C1CC(=O)NC2=C1C=C(C=C2)C3=CN=CC4=CC=CC=C43 D03YHZ HIGHSTAT Investigative D03YJD DRUG__ID D03YJD D03YJD DRUGTYPE Small molecular drug D03YJD DRUGINCH 1S/C22H16N4O3/c27-22(17-11-13-19(14-12-17)26(28)29)24-21-20(16-7-3-1-4-8-16)15-23-25(21)18-9-5-2-6-10-18/h1-15H,(H,24,27) D03YJD DRUGINKE UCQCMSNDKYLLFD-UHFFFAOYSA-N D03YJD DRUGSMIL C1=CC=C(C=C1)C2=C(N(N=C2)C3=CC=CC=C3)NC(=O)C4=CC=C(C=C4)[N+](=O)[O-] D03YJD HIGHSTAT Investigative D03YLQ DRUG__ID D03YLQ D03YLQ DRUGTYPE Small molecular drug D03YLQ DRUGINCH 1S/C19H20INO2/c20-17-11-13(5-8-18(17)22)9-10-21-12-15-7-6-14-3-1-2-4-16(14)19(15)23/h1-5,8,11,15,21-22H,6-7,9-10,12H2/i20-2 D03YLQ DRUGINKE DUOOAUBZMQZYLO-STTHPYEQSA-N D03YLQ DRUGSMIL C1CC2=CC=CC=C2C(=O)C1CNCCC3=CC(=C(C=C3)O)I D03YLQ HIGHSTAT Investigative D03YLX DRUG__ID D03YLX D03YLX DRUGTYPE Small molecular drug D03YLX DRUGINCH 1S/C12H10N2/c1-8-6-10-9-4-2-3-5-11(9)14-12(10)7-13-8/h2-7,14H,1H3 D03YLX DRUGINKE XOHBPUCYRSORIZ-UHFFFAOYSA-N D03YLX DRUGSMIL CC1=CC2=C(C=N1)NC3=CC=CC=C32 D03YLX HIGHSTAT Investigative D03YLY DRUG__ID D03YLY D03YLY DRUGTYPE Small molecular drug D03YLY DRUGINCH 1S/C17H28N8O6/c18-17(19)20-3-1-2-9-14(29)22-7-12(26)24-11(5-13(27)28)16(31)23-8-4-10(21-6-8)15(30)25-9/h8-11,21H,1-7H2,(H,22,29)(H,23,31)(H,24,26)(H,25,30)(H,27,28)(H4,18,19,20)/t8-,9-,10-,11-/m0/s1 D03YLY DRUGINKE RLABYQGJZRFBJA-NAKRPEOUSA-N D03YLY DRUGSMIL C1C2CNC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D03YLY HIGHSTAT Investigative D03YMX DRUG__ID D03YMX D03YMX DRUGTYPE Small molecular drug D03YMX DRUGINCH 1S/C12H5Br5O2/c13-5-1-2-9(6(14)3-5)19-12-10(17)7(15)4-8(16)11(12)18/h1-4,18H D03YMX DRUGINKE FAGFPLJEMPQMRV-UHFFFAOYSA-N D03YMX DRUGSMIL C1=CC(=C(C=C1Br)Br)OC2=C(C(=CC(=C2Br)Br)Br)O D03YMX HIGHSTAT Investigative D03YQY DRUG__ID D03YQY D03YQY DRUGTYPE Small molecular drug D03YQY DRUGINCH 1S/C14H21NO2/c1-10-6-5-7-12(8-10)14(16)11(2)15-13(3,4)9-17-14/h5-8,11,15-16H,9H2,1-4H3/t11-,14+/m0/s1 D03YQY DRUGINKE RLZACOPBIXSOEX-SMDDNHRTSA-N D03YQY DRUGSMIL CC1C(OCC(N1)(C)C)(C2=CC=CC(=C2)C)O D03YQY HIGHSTAT Investigative D03YRN DRUG__ID D03YRN D03YRN DRUGTYPE Small molecular drug D03YRN DRUGINCH 1S/C20H20N6S4/c27-13-23-15-5-3-7-17(11-15)25-19(29)21-9-1-2-10-22-20(30)26-18-8-4-6-16(12-18)24-14-28/h3-8,11-12H,1-2,9-10H2,(H2,21,25,29)(H2,22,26,30) D03YRN DRUGINKE QOHNRGHTJPFMSL-UHFFFAOYSA-N D03YRN DRUGSMIL C1=CC(=CC(=C1)N=C=S)NC(=S)NCCCCNC(=S)NC2=CC(=CC=C2)N=C=S D03YRN HIGHSTAT Investigative D03YRO DRUG__ID D03YRO D03YRO DRUGTYPE Small molecular drug D03YRO DRUGINCH 1S/C9H18N2O/c1-3-5-7-8(6-4-2)12-9(10)11-7/h7-8H,3-6H2,1-2H3,(H2,10,11)/t7-,8+/m0/s1 D03YRO DRUGINKE LRHNWJTUXJXJRP-JGVFFNPUSA-N D03YRO DRUGSMIL CCCC1C(OC(=N1)N)CCC D03YRO HIGHSTAT Investigative D03YUL DRUG__ID D03YUL D03YUL DRUGTYPE Small molecular drug D03YUL DRUGINCH 1S/C24H29N3O3S/c1-24(2,3)27-23(28)21(22(31(27,29)30)18-10-6-4-7-11-18)25-19-12-14-20(15-13-19)26-16-8-5-9-17-26/h4,6-7,10-15,25H,5,8-9,16-17H2,1-3H3 D03YUL DRUGINKE IVANYIPLGFVBGR-UHFFFAOYSA-N D03YUL DRUGSMIL CC(C)(C)N1C(=O)C(=C(S1(=O)=O)C2=CC=CC=C2)NC3=CC=C(C=C3)N4CCCCC4 D03YUL HIGHSTAT Investigative D03YUT DRUG__ID D03YUT D03YUT DRUGTYPE Small molecular drug D03YUT DRUGINCH 1S/C10H7ClN2O2/c11-5-8(14)10-13-6-9(15-10)7-3-1-2-4-12-7/h1-4,6H,5H2 D03YUT DRUGINKE MKVLXIACPLGLLP-UHFFFAOYSA-N D03YUT DRUGSMIL C1=CC=NC(=C1)C2=CN=C(O2)C(=O)CCl D03YUT HIGHSTAT Investigative D03YUW DRUG__ID D03YUW D03YUW DRUGTYPE Small molecular drug D03YUW DRUGINCH 1S/C9H7NO4/c11-10(12)4-3-7-1-2-8-9(5-7)14-6-13-8/h1-5H,6H2/b4-3+ D03YUW DRUGINKE KFLWBZPSJQPRDD-ONEGZZNKSA-N D03YUW DRUGSMIL C1OC2=C(O1)C=C(C=C2)C=C[N+](=O)[O-] D03YUW HIGHSTAT Investigative D03YVB DRUG__ID D03YVB D03YVB DRUGTYPE Small molecular drug D03YVB DRUGINCH 1S/C32H37N7O3/c1-22-7-6-8-23(2)31(22)36-32(40)39(27-14-13-26(41-4)19-28(27)42-5)30-20-29(33-21-34-30)35-24-9-11-25(12-10-24)38-17-15-37(3)16-18-38/h6-14,19-21H,15-18H2,1-5H3,(H,36,40)(H,33,34,35) D03YVB DRUGINKE UYUHRKLITDJEHB-UHFFFAOYSA-N D03YVB DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)N(C2=C(C=C(C=C2)OC)OC)C3=NC=NC(=C3)NC4=CC=C(C=C4)N5CCN(CC5)C D03YVB HIGHSTAT Investigative D03YVL DRUG__ID D03YVL D03YVL DRUGTYPE Small molecular drug D03YVL DRUGINCH 1S/C17H11ClN2O/c18-16-12(10-5-1-3-7-14(10)19-16)9-13-11-6-2-4-8-15(11)20-17(13)21/h1-9,19H,(H,20,21)/b13-9+ D03YVL DRUGINKE QJKBRWSJWQVKLY-UKTHLTGXSA-N D03YVL DRUGSMIL C1=CC=C2C(=C1)C(=CC3=C(NC4=CC=CC=C43)Cl)C(=O)N2 D03YVL HIGHSTAT Investigative D03YXB DRUG__ID D03YXB D03YXB DRUGTYPE Small molecular drug D03YXB DRUGINCH 1S/C36H40N2O6.ClH/c1-37-13-11-24-18-34(42-3)32(40)20-27(24)29(37)15-22-5-8-26(9-6-22)44-36-17-23(7-10-31(36)39)16-30-28-21-33(41)35(43-4)19-25(28)12-14-38(30)2;/h5-10,17-21,29-30,39-41H,11-16H2,1-4H3;1H/t29-,30+;/m0./s1 D03YXB DRUGINKE JOARPLDATXXJHM-XCCPJCIBSA-N D03YXB DRUGSMIL CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)O)O)O)OC.Cl D03YXB HIGHSTAT Investigative D03YZT DRUG__ID D03YZT D03YZT DRUGTYPE Small molecular drug D03YZT DRUGINCH 1S/C5H10N2O/c1-2-4-3-7-5(6)8-4/h4H,2-3H2,1H3,(H2,6,7) D03YZT DRUGINKE MFMHWQFUMUNREN-UHFFFAOYSA-N D03YZT DRUGSMIL CCC1CN=C(O1)N D03YZT HIGHSTAT Investigative D03ZBS DRUG__ID D03ZBS D03ZBS DRUGTYPE Small molecular drug D03ZBS DRUGINCH 1S/C21H34NO3P/c1-3-5-6-7-8-9-10-11-12-13-18-26(23,24-4-2)25-21-16-14-20(19-22)15-17-21/h14-17H,3-13,18H2,1-2H3 D03ZBS DRUGINKE FHIBETIKXBGJPS-UHFFFAOYSA-N D03ZBS DRUGSMIL CCCCCCCCCCCCP(=O)(OCC)OC1=CC=C(C=C1)C#N D03ZBS HIGHSTAT Investigative D03ZDC DRUG__ID D03ZDC D03ZDC DRUGTYPE Small molecular drug D03ZDC DRUGINCH 1S/C8H13NO7P2/c9-7-4-2-1-3-6(7)5-8(10,17(11,12)13)18(14,15)16/h1-4,10H,5,9H2,(H2,11,12,13)(H2,14,15,16) D03ZDC DRUGINKE VJXYJONFUZXZJZ-UHFFFAOYSA-N D03ZDC DRUGSMIL C1=CC=C(C(=C1)CC(O)(P(=O)(O)O)P(=O)(O)O)N D03ZDC HIGHSTAT Investigative D03ZDY DRUG__ID D03ZDY D03ZDY DRUGTYPE Small molecular drug D03ZDY DRUGINCH 1S/C18H21BrN2/c19-17-9-5-4-8-16(17)14-18(15-6-2-1-3-7-15)21-12-10-20-11-13-21/h1-9,18,20H,10-14H2 D03ZDY DRUGINKE KVNXQYJMNFSXRE-UHFFFAOYSA-N D03ZDY DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2Br)C3=CC=CC=C3 D03ZDY HIGHSTAT Investigative D03ZDZ DRUG__ID D03ZDZ D03ZDZ DRUGTYPE Small molecular drug D03ZDZ DRUGINCH 1S/C13H23NO7/c1-2-7-8(5-15)21-9(6-16)12(13(7)20)14-10(17)3-4-11(18)19/h7-9,12-13,15-16,20H,2-6H2,1H3,(H,14,17)(H,18,19)/t7-,8-,9+,12+,13+/m1/s1 D03ZDZ DRUGINKE PTKIBGLZJSEXPT-KOOJSXSQSA-N D03ZDZ DRUGSMIL CCC1C(OC(C(C1O)NC(=O)CCC(=O)O)CO)CO D03ZDZ HIGHSTAT Investigative D03ZEL DRUG__ID D03ZEL D03ZEL DRUGTYPE Small molecular drug D03ZEL DRUGINCH 1S/C24H28O3/c1-15-12-19-20(24(4,5)11-10-23(19,2)3)14-17(15)18-13-16(6-8-21(18)25)7-9-22(26)27/h6-9,12-14,25H,10-11H2,1-5H3,(H,26,27)/b9-7+ D03ZEL DRUGINKE DYLLZSVPAUUSSB-VQHVLOKHSA-N D03ZEL DRUGSMIL CC1=CC2=C(C=C1C3=C(C=CC(=C3)C=CC(=O)O)O)C(CCC2(C)C)(C)C D03ZEL HIGHSTAT Investigative D03ZFX DRUG__ID D03ZFX D03ZFX DRUGTYPE Small molecular drug D03ZFX DRUGINCH 1S/C27H32N2O/c30-25(18-21-10-4-1-5-11-21)20-28-24-16-17-26(29-19-24)27(22-12-6-2-7-13-22)23-14-8-3-9-15-23/h1-15,24-30H,16-20H2/t24-,25+,26-/m0/s1 D03ZFX DRUGINKE YKFRXVGLZNKBAS-NXCFDTQHSA-N D03ZFX DRUGSMIL C1CC(NCC1NCC(CC2=CC=CC=C2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D03ZFX HIGHSTAT Investigative D03ZHB DRUG__ID D03ZHB D03ZHB DRUGTYPE Small molecular drug D03ZHB DRUGINCH 1S/C10H12ClN3/c1-2-7-9-6(11)4-3-5-8(9)14-10(12)13-7/h3-5,7H,2H2,1H3,(H3,12,13,14) D03ZHB DRUGINKE MICIQKQOEFSTDP-UHFFFAOYSA-N D03ZHB DRUGSMIL CCC1C2=C(C=CC=C2Cl)NC(=N1)N D03ZHB HIGHSTAT Investigative D03ZHK DRUG__ID D03ZHK D03ZHK DRUGTYPE Small molecular drug D03ZHK DRUGINCH 1S/C24H19N3O5/c1-31-23(29)21-19(15-10-25-17-6-4-3-5-13(15)17)20(22(27-21)24(30)32-2)16-11-26-18-8-7-12(28)9-14(16)18/h3-11,25-28H,1-2H3 D03ZHK DRUGINKE SZBJDRXMLSSPCV-UHFFFAOYSA-N D03ZHK DRUGSMIL COC(=O)C1=C(C(=C(N1)C(=O)OC)C2=CNC3=CC=CC=C32)C4=CNC5=C4C=C(C=C5)O D03ZHK HIGHSTAT Investigative D03ZIH DRUG__ID D03ZIH D03ZIH DRUGTYPE Small molecular drug D03ZIH DRUGINCH 1S/C34H35N3O11/c1-3-21-17-20(13-14-24(21)37(31(41)33(44)45)25-10-5-4-9-22(25)32(42)43)18-23-30(40)36(19-28(39)35-23)15-6-7-16-48-27-12-8-11-26(38)29(27)34(46)47-2/h4-5,8-14,17,23,38H,3,6-7,15-16,18-19H2,1-2H3,(H,35,39)(H,42,43)(H,44,45)/t23-/m1/s1 D03ZIH DRUGINKE BKPFVUCQPXAMRL-HSZRJFAPSA-N D03ZIH DRUGSMIL CCC1=C(C=CC(=C1)CC2C(=O)N(CC(=O)N2)CCCCOC3=CC=CC(=C3C(=O)OC)O)N(C4=CC=CC=C4C(=O)O)C(=O)C(=O)O D03ZIH HIGHSTAT Investigative D03ZKN DRUG__ID D03ZKN D03ZKN DRUGTYPE Small molecular drug D03ZKN DRUGINCH 1S/C4H9N3O2/c5-4(6)7-2-1-3(8)9/h1-2H2,(H,8,9)(H4,5,6,7) D03ZKN DRUGINKE KMXXSJLYVJEBHI-UHFFFAOYSA-N D03ZKN DRUGSMIL C(CN=C(N)N)C(=O)O D03ZKN HIGHSTAT Investigative D03ZMQ DRUG__ID D03ZMQ D03ZMQ DRUGTYPE Small molecular drug D03ZMQ DRUGINCH 1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H D03ZMQ DRUGINKE ZYGHJZDHTFUPRJ-UHFFFAOYSA-N D03ZMQ DRUGSMIL C1=CC=C2C(=C1)C=CC(=O)O2 D03ZMQ HIGHSTAT Investigative D03ZNB DRUG__ID D03ZNB D03ZNB DRUGTYPE Small molecular drug D03ZNB DRUGINCH 1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m0/s1 D03ZNB DRUGINKE AHLPHDHHMVZTML-BYPYZUCNSA-N D03ZNB DRUGSMIL C(CC(C(=O)O)N)CN D03ZNB HIGHSTAT Investigative D03ZOJ DRUG__ID D03ZOJ D03ZOJ DRUGTYPE Small molecular drug D03ZOJ DRUGINCH 1S/C22H33N5/c1-2-10-26(21-8-9-22-19(17-21)18-23-24-22)14-11-25-12-15-27(16-13-25)20-6-4-3-5-7-20/h3-7,18,21H,2,8-17H2,1H3,(H,23,24) D03ZOJ DRUGINKE LHOJVHKKDRWEEV-UHFFFAOYSA-N D03ZOJ DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)C=NN4 D03ZOJ HIGHSTAT Investigative D03ZPH DRUG__ID D03ZPH D03ZPH DRUGTYPE Small molecular drug D03ZPH DRUGINCH 1S/C20H30O4/c1-2-3-4-5-6-9-12-16-17(19(22)15-18(16)21)13-10-7-8-11-14-20(23)24/h6-7,9-10,12,17,19,22H,2-5,8,11,13-15H2,1H3,(H,23,24)/b9-6+,10-7-,16-12+/t17-,19+/m1/s1 D03ZPH DRUGINKE QUGBPWLPAUHDTI-PLGLXCLHSA-N D03ZPH DRUGSMIL CCCCCC=CC=C1C(C(CC1=O)O)CC=CCCCC(=O)O D03ZPH HIGHSTAT Investigative D03ZSY DRUG__ID D03ZSY D03ZSY DRUGTYPE Small molecular drug D03ZSY DRUGINCH 1S/C6H9NO6/c8-4(9)1-7(2-5(10)11)3-6(12)13/h1-3H2,(H,8,9)(H,10,11)(H,12,13) D03ZSY DRUGINKE MGFYIUFZLHCRTH-UHFFFAOYSA-N D03ZSY DRUGSMIL C(C(=O)O)N(CC(=O)O)CC(=O)O D03ZSY HIGHSTAT Investigative D03ZUB DRUG__ID D03ZUB D03ZUB DRUGTYPE Small molecular drug D03ZUB DRUGINCH 1S/C17H18FNO2S/c1-13-4-10-16(11-5-13)22(20,21)19-12-2-3-17(19)14-6-8-15(18)9-7-14/h4-11,17H,2-3,12H2,1H3 D03ZUB DRUGINKE DAEHFYNGSSBGSS-UHFFFAOYSA-N D03ZUB DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCCC2C3=CC=C(C=C3)F D03ZUB HIGHSTAT Investigative D03ZUJ DRUG__ID D03ZUJ D03ZUJ DRUGTYPE Small molecular drug D03ZUJ DRUGINCH 1S/C23H31N5O3S/c1-3-28(4-2)21-14-10-19(11-15-21)25-26-20-12-16-22(17-13-20)32(30,31)27-23(29)24-18-8-6-5-7-9-18/h10-18H,3-9H2,1-2H3,(H2,24,27,29) D03ZUJ DRUGINKE FCHDFDWESRUUDK-UHFFFAOYSA-N D03ZUJ DRUGSMIL CCN(CC)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 D03ZUJ HIGHSTAT Investigative D03ZUM DRUG__ID D03ZUM D03ZUM DRUGTYPE Small molecular drug D03ZUM DRUGINCH 1S/C25H38N6O5/c1-25(2,3)36-24(35)30-19(15-17-9-5-4-6-10-17)22(34)31-14-8-12-20(31)21(33)29-18(16-32)11-7-13-28-23(26)27/h4-6,9-10,16,18-20H,7-8,11-15H2,1-3H3,(H,29,33)(H,30,35)(H4,26,27,28)/t18-,19+,20-/m0/s1 D03ZUM DRUGINKE JDXUSWQJCGTBLN-ZCNNSNEGSA-N D03ZUM DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C=O D03ZUM HIGHSTAT Investigative D03ZUZ DRUG__ID D03ZUZ D03ZUZ DRUGTYPE Small molecular drug D03ZUZ DRUGINCH 1S/C16H23N3O4/c20-14(19-23)11-7-2-1-3-8-12-17-16(22)18-15(21)13-9-5-4-6-10-13/h4-6,9-10,23H,1-3,7-8,11-12H2,(H,19,20)(H2,17,18,21,22) D03ZUZ DRUGINKE WUKFQTZVXXYEAB-UHFFFAOYSA-N D03ZUZ DRUGSMIL C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCCCC(=O)NO D03ZUZ HIGHSTAT Investigative D03ZVM DRUG__ID D03ZVM D03ZVM DRUGTYPE Small molecular drug D03ZVM DRUGINCH 1S/C18H22N2/c1-20-13-5-8-18(20)16-10-12-17(19-14-16)11-9-15-6-3-2-4-7-15/h2-4,6-7,10,12,14,18H,5,8-9,11,13H2,1H3 D03ZVM DRUGINKE YJFYNYHEHYBROJ-UHFFFAOYSA-N D03ZVM DRUGSMIL CN1CCCC1C2=CN=C(C=C2)CCC3=CC=CC=C3 D03ZVM HIGHSTAT Investigative D03ZWB DRUG__ID D03ZWB D03ZWB DRUGTYPE Small molecular drug D03ZWB DRUGINCH 1S/C20H18N2O4/c1-22-18(14-8-10-21-11-9-14)16(12-17(19(22)23)20(24)26-3)13-4-6-15(25-2)7-5-13/h4-12H,1-3H3 D03ZWB DRUGINKE LENMNEQXCQXJHV-UHFFFAOYSA-N D03ZWB DRUGSMIL CN1C(=C(C=C(C1=O)C(=O)OC)C2=CC=C(C=C2)OC)C3=CC=NC=C3 D03ZWB HIGHSTAT Investigative D03ZWK DRUG__ID D03ZWK D03ZWK DRUGTYPE Small molecular drug D03ZWK DRUGINCH 1S/C13H20O2/c1-2-3-4-5-6-11-15-13-9-7-12(14)8-10-13/h7-10,14H,2-6,11H2,1H3 D03ZWK DRUGINKE HZBABTUFXQLADL-UHFFFAOYSA-N D03ZWK DRUGSMIL CCCCCCCOC1=CC=C(C=C1)O D03ZWK HIGHSTAT Investigative D03ZWL DRUG__ID D03ZWL D03ZWL DRUGTYPE Small molecular drug D03ZWL DRUGINCH 1S/C26H31N5O2/c1-17-6-5-7-20(14-17)27-26(33)29-23-25(32)30(2)22-9-4-3-8-21(22)24(28-23)31-15-18-10-11-19(16-31)13-12-18/h3-9,14,18-19,23H,10-13,15-16H2,1-2H3,(H2,27,29,33)/t18?,19?,23-/m0/s1 D03ZWL DRUGINKE QYERABWMFRRINX-XWEVFREBSA-N D03ZWL DRUGSMIL CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)N4CC5CCC(C4)CC5)C D03ZWL HIGHSTAT Investigative D04AAI DRUG__ID D04AAI D04AAI DRUGTYPE Small molecular drug D04AAI DRUGINCH 1S/C18H22N2O2S/c1-23(21,22)18-9-5-8-17(14-18)20-12-10-19(11-13-20)15-16-6-3-2-4-7-16/h2-9,14H,10-13,15H2,1H3 D04AAI DRUGINKE DABGEKAEKHHGFN-UHFFFAOYSA-N D04AAI DRUGSMIL CS(=O)(=O)C1=CC=CC(=C1)N2CCN(CC2)CC3=CC=CC=C3 D04AAI HIGHSTAT Investigative D04AAT DRUG__ID D04AAT D04AAT DRUGTYPE Small molecular drug D04AAT DRUGINCH 1S/C18H20BrNO2S/c19-17-9-8-16(23-17)13-4-6-14(7-5-13)18(21)12-20-10-2-1-3-15(20)11-22-18/h4-9,15,21H,1-3,10-12H2 D04AAT DRUGINKE NQOYZHHHGSRJGT-UHFFFAOYSA-N D04AAT DRUGSMIL C1CCN2CC(OCC2C1)(C3=CC=C(C=C3)C4=CC=C(S4)Br)O D04AAT HIGHSTAT Investigative D04AAV DRUG__ID D04AAV D04AAV DRUGTYPE Small molecular drug D04AAV DRUGINCH 1S/C16H18N2O2/c1-3-17(4-2)11-7-8-12-18-15(19)13-9-5-6-10-14(13)16(18)20/h5-6,9-10H,3-4,11-12H2,1-2H3 D04AAV DRUGINKE DEWGBLHKQDVWLX-UHFFFAOYSA-N D04AAV DRUGSMIL CCN(CC)CC#CCN1C(=O)C2=CC=CC=C2C1=O D04AAV HIGHSTAT Investigative D04ACJ DRUG__ID D04ACJ D04ACJ DRUGTYPE Small molecular drug D04ACJ DRUGINCH 1S/C17H16ClN3O/c1-2-5-16(22)19-17-13-9-8-11(10-15(13)20-21-17)12-6-3-4-7-14(12)18/h3-4,6-10H,2,5H2,1H3,(H2,19,20,21,22) D04ACJ DRUGINKE WPJGFQOEGTUKTE-UHFFFAOYSA-N D04ACJ DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=CC=C3Cl D04ACJ HIGHSTAT Investigative D04AED DRUG__ID D04AED D04AED DRUGTYPE Small molecular drug D04AED DRUGINCH 1S/C27H20O4/c28-25(19-11-13-23(14-12-19)27(29)30)20-15-17-24(18-16-20)31-26(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-18,26H,(H,29,30) D04AED DRUGINKE RSHGTUVDNJDFHP-UHFFFAOYSA-N D04AED DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)OC3=CC=C(C=C3)C(=O)C4=CC=C(C=C4)C(=O)O D04AED HIGHSTAT Investigative D04AEG DRUG__ID D04AEG D04AEG DRUGTYPE Small molecular drug D04AEG DRUGINCH 1S/C18H12N2OS/c21-17-14(10-13-8-4-5-9-15(13)19-17)16-11-22-18(20-16)12-6-2-1-3-7-12/h1-11H,(H,19,21) D04AEG DRUGINKE OANBFUCSFFQVAU-UHFFFAOYSA-N D04AEG DRUGSMIL C1=CC=C(C=C1)C2=NC(=CS2)C3=CC4=CC=CC=C4NC3=O D04AEG HIGHSTAT Investigative D04AGC DRUG__ID D04AGC D04AGC DRUGTYPE Small molecular drug D04AGC DRUGINCH 1S/C17H12F3NO/c18-17(19,20)15-10-13(12-8-4-5-9-14(12)21-15)16(22)11-6-2-1-3-7-11/h1-10,16,22H D04AGC DRUGINKE CCEVSDBDTAPCRQ-UHFFFAOYSA-N D04AGC DRUGSMIL C1=CC=C(C=C1)C(C2=CC(=NC3=CC=CC=C32)C(F)(F)F)O D04AGC HIGHSTAT Investigative D04ALU DRUG__ID D04ALU D04ALU DRUGTYPE Small molecular drug D04ALU DRUGINCH 1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3 D04ALU DRUGINKE HSUGRBWQSSZJOP-UHFFFAOYSA-N D04ALU DRUGSMIL CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC D04ALU HIGHSTAT Investigative D04AMC DRUG__ID D04AMC D04AMC DRUGTYPE Small molecular drug D04AMC DRUGINCH 1S/C22H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23(26)20-21-24/h6-7,9-10,12-13,15-16,24,26H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15- D04AMC DRUGINKE GSKSTUBDYCGHNA-DOFZRALJSA-N D04AMC DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)N(CCO)O D04AMC HIGHSTAT Investigative D04AQE DRUG__ID D04AQE D04AQE DRUGTYPE Small molecular drug D04AQE DRUGINCH 1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 D04AQE DRUGINKE JTEJPPKMYBDEMY-UHFFFAOYSA-N D04AQE DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCN D04AQE HIGHSTAT Investigative D04AQW DRUG__ID D04AQW D04AQW DRUGTYPE Small molecular drug D04AQW DRUGINCH 1S/C16H15NO2/c1-11(2)17-13-8-4-6-10-15(13)19-14-9-5-3-7-12(14)16(17)18/h3-11H,1-2H3 D04AQW DRUGINKE ACJZSMFIMMQNTP-UHFFFAOYSA-N D04AQW DRUGSMIL CC(C)N1C2=CC=CC=C2OC3=CC=CC=C3C1=O D04AQW HIGHSTAT Investigative D04ARH DRUG__ID D04ARH D04ARH DRUGTYPE Small molecular drug D04ARH DRUGINCH 1S/C17H33N3O2/c1-3-5-6-7-8-9-12-18-17(22)19-15-10-13-20(14-11-15)16(21)4-2/h15H,3-14H2,1-2H3,(H2,18,19,22) D04ARH DRUGINKE QCBCCMKAGKJZIU-UHFFFAOYSA-N D04ARH DRUGSMIL CCCCCCCCNC(=O)NC1CCN(CC1)C(=O)CC D04ARH HIGHSTAT Investigative D04ATN DRUG__ID D04ATN D04ATN DRUGTYPE Small molecular drug D04ATN DRUGINCH 1S/C14H14N2O/c1-2-12-5-7-14(8-6-12)17-9-3-4-13-10-15-11-16-13/h1,5-8,10-11H,3-4,9H2,(H,15,16) D04ATN DRUGINKE LMKPPWNWUJXSAQ-UHFFFAOYSA-N D04ATN DRUGSMIL C#CC1=CC=C(C=C1)OCCCC2=CN=CN2 D04ATN HIGHSTAT Investigative D04ATU DRUG__ID D04ATU D04ATU DRUGTYPE Small molecular drug D04ATU DRUGINCH 1S/C16H12N2O/c17-10-6-5-9-7-14-11-3-1-2-4-12(11)16(19)18-15(14)13(9)8-10/h1-6,8H,7,17H2,(H,18,19) D04ATU DRUGINKE LQEYAIKMIJUZNT-UHFFFAOYSA-N D04ATU DRUGSMIL C1C2=C(C=C(C=C2)N)C3=C1C4=CC=CC=C4C(=O)N3 D04ATU HIGHSTAT Investigative D04AUL DRUG__ID D04AUL D04AUL DRUGTYPE Small molecular drug D04AUL DRUGINCH 1S/C20H32N2O3/c1-4-5-6-7-8-9-10-11-16-24-19-14-12-18(13-15-19)21-20(23)25-22-17(2)3/h12-15H,4-11,16H2,1-3H3,(H,21,23) D04AUL DRUGINKE VUIWYGFHHJXEAE-UHFFFAOYSA-N D04AUL DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D04AUL HIGHSTAT Investigative D04AUM DRUG__ID D04AUM D04AUM DRUGTYPE Small molecular drug D04AUM DRUGINCH 1S/C23H28O4/c1-5-6-7-8-11-23(2,3)15-12-19(24)21-18-14-16(26-4)9-10-17(18)22(25)27-20(21)13-15/h9-10,12-14,24H,5-8,11H2,1-4H3 D04AUM DRUGINKE ZAIKPEWFCSQNQB-UHFFFAOYSA-N D04AUM DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C(=C1)OC(=O)C3=C2C=C(C=C3)OC)O D04AUM HIGHSTAT Investigative D04AWP DRUG__ID D04AWP D04AWP DRUGTYPE Small molecular drug D04AWP DRUGINCH 1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1 D04AWP DRUGINKE RQFCJASXJCIDSX-UUOKFMHZSA-N D04AWP DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(NC2=O)N D04AWP HIGHSTAT Investigative D04AWS DRUG__ID D04AWS D04AWS DRUGTYPE Small molecular drug D04AWS DRUGINCH 1S/C18H18N2OS/c21-18(19-13-7-1-2-8-13)20-14-9-3-5-11-16(14)22-17-12-6-4-10-15(17)20/h3-6,9-13H,1-2,7-8H2,(H,19,21) D04AWS DRUGINKE WVGVWICAQSPEPE-UHFFFAOYSA-N D04AWS DRUGSMIL C1CCC(C1)NC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D04AWS HIGHSTAT Investigative D04AXH DRUG__ID D04AXH D04AXH DRUGTYPE Small molecular drug D04AXH DRUGINCH 1S/C24H40N2O2/c1-5-6-7-8-9-10-12-19-13-11-14-22-21(19)16-15-20(17-27)25-24(28)23(18(2)3)26(22)4/h11,13-14,18,20,23,27H,5-10,12,15-17H2,1-4H3,(H,25,28)/t20-,23-/m0/s1 D04AXH DRUGINKE IDVIOLNZWSXZGL-REWPJTCUSA-N D04AXH DRUGSMIL CCCCCCCCC1=C2CCC(NC(=O)C(N(C2=CC=C1)C)C(C)C)CO D04AXH HIGHSTAT Investigative D04AXP DRUG__ID D04AXP D04AXP DRUGTYPE Small molecular drug D04AXP DRUGINCH 1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1 D04AXP DRUGINKE JKKFKPJIXZFSSB-CBZIJGRNSA-N D04AXP DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O D04AXP HIGHSTAT Investigative D04AXR DRUG__ID D04AXR D04AXR DRUGTYPE Small molecular drug D04AXR DRUGINCH 1S/C8H4ClNO2/c9-4-2-1-3-5-6(4)7(11)8(12)10-5/h1-3H,(H,10,11,12) D04AXR DRUGINKE HSYFISNDMZKGRS-UHFFFAOYSA-N D04AXR DRUGSMIL C1=CC2=C(C(=C1)Cl)C(=O)C(=O)N2 D04AXR HIGHSTAT Investigative D04AXY DRUG__ID D04AXY D04AXY DRUGTYPE Small molecular drug D04AXY DRUGINCH 1S/C18H19N3/c1-20-10-12-21(13-11-20)18-16-8-3-2-6-14(16)15-7-4-5-9-17(15)19-18/h2-9H,10-13H2,1H3 D04AXY DRUGINKE ZVJIBTNUNUXAIO-UHFFFAOYSA-N D04AXY DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3C4=CC=CC=C42 D04AXY HIGHSTAT Investigative D04AYN DRUG__ID D04AYN D04AYN DRUGTYPE Small molecular drug D04AYN DRUGINCH 1S/C24H27N9O6/c25-20-16-21(28-10-27-20)33(11-29-16)24-18(36)17(35)19(39-24)23(38)32-6-4-31(5-7-32)9-15(34)30-14-3-1-2-12-13(14)8-26-22(12)37/h1-3,10-11,17-19,24,35-36H,4-9H2,(H,26,37)(H,30,34)(H2,25,27,28)/t17-,18+,19-,24+/m0/s1 D04AYN DRUGINKE DDFLFKTXUWPNMV-UAKAABGRSA-N D04AYN DRUGSMIL C1CN(CCN1CC(=O)NC2=CC=CC3=C2CNC3=O)C(=O)C4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O D04AYN HIGHSTAT Investigative D04AZE DRUG__ID D04AZE D04AZE DRUGTYPE Small molecular drug D04AZE DRUGINCH 1S/C14H14N4OS/c1-9-7-13(20-17-9)16-14(19)15-11-3-4-12-10(8-11)5-6-18(12)2/h3-8H,1-2H3,(H2,15,16,19) D04AZE DRUGINKE USFUFHFQWXDVMH-UHFFFAOYSA-N D04AZE DRUGSMIL CC1=NSC(=C1)NC(=O)NC2=CC3=C(C=C2)N(C=C3)C D04AZE HIGHSTAT Investigative D04BBF DRUG__ID D04BBF D04BBF DRUGTYPE Small molecular drug D04BBF DRUGINCH 1S/C20H30N7O23P5/c1-8-3-26(20(32)25-18(8)31)12-2-9(28)10(45-12)4-43-51(33,34)47-53(37,38)49-55(41,42)50-54(39,40)48-52(35,36)44-5-11-14(29)15(30)19(46-11)27-7-24-13-16(21)22-6-23-17(13)27/h3,6-7,9-12,14-15,19,28-30H,2,4-5H2,1H3,(H,33,34)(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H2,21,22,23)(H,25,31,32)/t9-,10+,11+,12+,14+,15+,19+/m0/s1 D04BBF DRUGINKE JCFDSPQTEMXXLO-SLFMBYJQSA-N D04BBF DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O D04BBF HIGHSTAT Investigative D04BBK DRUG__ID D04BBK D04BBK DRUGTYPE Small molecular drug D04BBK DRUGINCH 1S/C18H19N3OS/c1-10-9-11(2)20-18-14(10)15(19)16(23-18)17(22)21-12(3)13-7-5-4-6-8-13/h4-9,12H,19H2,1-3H3,(H,21,22)/t12-/m0/s1 D04BBK DRUGINKE MCAYWJFTDPUQKE-LBPRGKRZSA-N D04BBK DRUGSMIL CC1=CC(=NC2=C1C(=C(S2)C(=O)NC(C)C3=CC=CC=C3)N)C D04BBK HIGHSTAT Investigative D04BDL DRUG__ID D04BDL D04BDL DRUGTYPE Small molecular drug D04BDL DRUGINCH 1S/C30H34N4O/c1-2-15-32-26-19-30(25-9-5-3-8-23(25)26)13-16-33(17-14-30)20-21-11-12-28-24(18-21)22-7-4-6-10-27(22)34(28)29(31)35/h3-12,18,26,32H,2,13-17,19-20H2,1H3,(H2,31,35)/t26-/m1/s1 D04BDL DRUGINKE LMNFAMWQPPUUNJ-AREMUKBSSA-N D04BDL DRUGSMIL CCCNC1CC2(CCN(CC2)CC3=CC4=C(C=C3)N(C5=CC=CC=C54)C(=O)N)C6=CC=CC=C16 D04BDL HIGHSTAT Investigative D04BES DRUG__ID D04BES D04BES DRUGTYPE Small molecular drug D04BES DRUGINCH 1S/C16H14ClN/c1-13-6-4-11-16(18-13)10-3-2-7-14-8-5-9-15(17)12-14/h4-6,8-9,11-12H,2,7H2,1H3 D04BES DRUGINKE PLDMRMLBISIHNX-UHFFFAOYSA-N D04BES DRUGSMIL CC1=NC(=CC=C1)C#CCCC2=CC(=CC=C2)Cl D04BES HIGHSTAT Investigative D04BGT DRUG__ID D04BGT D04BGT DRUGTYPE Small molecular drug D04BGT DRUGINCH 1S/C15H15N3/c1-3-5-13-9-14(18-15(10-16)17-13)12-7-4-6-11(2)8-12/h4,6-9H,3,5H2,1-2H3 D04BGT DRUGINKE LWTLVKKUNGVFHE-UHFFFAOYSA-N D04BGT DRUGSMIL CCCC1=CC(=NC(=N1)C#N)C2=CC=CC(=C2)C D04BGT HIGHSTAT Investigative D04BHL DRUG__ID D04BHL D04BHL DRUGTYPE Small molecular drug D04BHL DRUGINCH 1S/C21H29N5O6/c1-3-4-9-31-21(29)25-17(20(28)30-2)12-24-18(27)11-15-10-16(26-32-15)13-5-7-14(8-6-13)19(22)23/h5-8,15,17H,3-4,9-12H2,1-2H3,(H3,22,23)(H,24,27)(H,25,29)/t15-,17+/m1/s1 D04BHL DRUGINKE IRAXRQFCCSHQDX-WBVHZDCISA-N D04BHL DRUGSMIL CCCCOC(=O)NC(CNC(=O)CC1CC(=NO1)C2=CC=C(C=C2)C(=N)N)C(=O)OC D04BHL HIGHSTAT Investigative D04BHQ DRUG__ID D04BHQ D04BHQ DRUGTYPE Small molecular drug D04BHQ DRUGINCH 1S/C15H14N2O3/c1-10-7-8-13(11(2)9-10)16-15(18)12-5-3-4-6-14(12)17(19)20/h3-9H,1-2H3,(H,16,18) D04BHQ DRUGINKE WGMMCHJMOXWGPL-UHFFFAOYSA-N D04BHQ DRUGSMIL CC1=CC(=C(C=C1)NC(=O)C2=CC=CC=C2[N+](=O)[O-])C D04BHQ HIGHSTAT Investigative D04BHR DRUG__ID D04BHR D04BHR DRUGTYPE Small molecular drug D04BHR DRUGINCH 1S/C13H15N3S2/c1-10-9-18-13(15-10)16-12(17)14-8-7-11-5-3-2-4-6-11/h2-6,9H,7-8H2,1H3,(H2,14,15,16,17) D04BHR DRUGINKE ZIPXZWMTOPUETF-UHFFFAOYSA-N D04BHR DRUGSMIL CC1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2 D04BHR HIGHSTAT Investigative D04BIH DRUG__ID D04BIH D04BIH DRUGTYPE Small molecular drug D04BIH DRUGINCH 1S/C23H23NO2/c25-23(24-17-8-7-12-19-10-3-1-4-11-19)26-22-16-9-15-21(18-22)20-13-5-2-6-14-20/h1-6,9-11,13-16,18H,7-8,12,17H2,(H,24,25) D04BIH DRUGINKE WZSGWNPOHRAUQO-UHFFFAOYSA-N D04BIH DRUGSMIL C1=CC=C(C=C1)CCCCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D04BIH HIGHSTAT Investigative D04BII DRUG__ID D04BII D04BII DRUGTYPE Small molecular drug D04BII DRUGINCH 1S/C31H34N4O6/c1-18-12-23(36)13-19(2)24(18)15-25(32)31(41)35-17-21-9-7-6-8-20(21)14-27(35)30(40)34-26(16-28(37)38)29(39)33-22-10-4-3-5-11-22/h3-13,25-27,36H,14-17,32H2,1-2H3,(H,33,39)(H,34,40)(H,37,38)/t25-,26+,27-/m0/s1 D04BII DRUGINKE ISUHYDNNFIRLMN-VJGNERBWSA-N D04BII DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)NC4=CC=CC=C4)N)C)O D04BII HIGHSTAT Investigative D04BKU DRUG__ID D04BKU D04BKU DRUGTYPE Small molecular drug D04BKU DRUGINCH 1S/C4H12N2O6S2/c5-13(7,8)11-3-1-2-4-12-14(6,9)10/h1-4H2,(H2,5,7,8)(H2,6,9,10) D04BKU DRUGINKE XHCZRWMTVBHWQT-UHFFFAOYSA-N D04BKU DRUGSMIL C(CCOS(=O)(=O)N)COS(=O)(=O)N D04BKU HIGHSTAT Investigative D04BLL DRUG__ID D04BLL D04BLL DRUGTYPE Small molecular drug D04BLL DRUGINCH 1S/C14H29O4P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17/h3-4H,2,5-14H2,1H3,(H2,15,16,17)/b4-3+ D04BLL DRUGINKE VKPRWVOYFUXFAT-ONEGZZNKSA-N D04BLL DRUGSMIL CCC=CCCCCCCCCCCOP(=O)(O)O D04BLL HIGHSTAT Investigative D04BLO DRUG__ID D04BLO D04BLO DRUGTYPE Small molecular drug D04BLO DRUGINCH 1S/C15H15F2NO2/c1-20-12-6-5-10-3-2-4-11(13(10)9-12)7-8-18-15(19)14(16)17/h2-6,9,14H,7-8H2,1H3,(H,18,19) D04BLO DRUGINKE UTLRQLQDJLNKNY-UHFFFAOYSA-N D04BLO DRUGSMIL COC1=CC2=C(C=CC=C2CCNC(=O)C(F)F)C=C1 D04BLO HIGHSTAT Investigative D04BNM DRUG__ID D04BNM D04BNM DRUGTYPE Small molecular drug D04BNM DRUGINCH 1S/C12H12Cl2N2O4/c13-5-1-7-8(2-6(5)14)16(4-15-7)12-11(19)10(18)9(3-17)20-12/h1-2,4,9-12,17-19H,3H2/t9-,10-,11-,12-/m1/s1 D04BNM DRUGINKE XHSQDZXAVJRBMX-DDHJBXDOSA-N D04BNM DRUGSMIL C1=C2C(=CC(=C1Cl)Cl)N(C=N2)C3C(C(C(O3)CO)O)O D04BNM HIGHSTAT Investigative D04BOG DRUG__ID D04BOG D04BOG DRUGTYPE Small molecular drug D04BOG DRUGINCH 1S/C41H55N11O9/c1-2-3-13-28-36(57)52-32(21-34(54)55)40(61)50-30(19-23-10-5-4-6-11-23)38(59)49-29(15-9-18-45-41(43)44)37(58)51-31(20-24-22-46-26-14-8-7-12-25(24)26)39(60)48-27(35(42)56)16-17-33(53)47-28/h4-8,10-12,14,22,27-32,46H,2-3,9,13,15-21H2,1H3,(H2,42,56)(H,47,53)(H,48,60)(H,49,59)(H,50,61)(H,51,58)(H,52,57)(H,54,55)(H4,43,44,45)/t27-,28-,29-,30+,31-,32-/m0/s1 D04BOG DRUGINKE HUAMIBCEKZFYST-BCLKUREPSA-N D04BOG DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC(=O)O D04BOG HIGHSTAT Investigative D04BOQ DRUG__ID D04BOQ D04BOQ DRUGTYPE Small molecular drug D04BOQ DRUGINCH 1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h15,17-18,20-25,28-30H,5-14,16H2,1-4H3/t17?,18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1 D04BOQ DRUGINKE RXMHNAKZMGJANZ-DTTSCKGMSA-N D04BOQ DRUGSMIL CC(CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C)CO D04BOQ HIGHSTAT Investigative D04BPQ DRUG__ID D04BPQ D04BPQ DRUGTYPE Small molecular drug D04BPQ DRUGINCH 1S/C33H55BBrN7O9/c1-2-3-13-23(31(47)42-27(34(50)51)14-10-18-35)39-30(46)24(16-17-28(37)44)40-33(49)26(21-43)41-32(48)25(20-22-11-6-4-7-12-22)38-29(45)15-8-5-9-19-36/h4,6-7,11-12,23-27,43,50-51H,2-3,5,8-10,13-21,36H2,1H3,(H2,37,44)(H,38,45)(H,39,46)(H,40,49)(H,41,48)(H,42,47)/t23-,24-,25-,26-,27+/m0/s1 D04BPQ DRUGINKE AKGOAAVLALZKCN-JSLVBRCRSA-N D04BPQ DRUGSMIL B(C(CCCBr)NC(=O)C(CCCC)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)CCCCCN)(O)O D04BPQ HIGHSTAT Investigative D04BSJ DRUG__ID D04BSJ D04BSJ DRUGTYPE Small molecular drug D04BSJ DRUGINCH 1S/C65H126N10O12S/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-41-58(77)86-48-51(87-59(78)42-28-26-24-22-20-18-16-14-12-10-8-6-4-2)49-88-50-52(70)60(79)75-57(47-76)64(83)73-54(38-30-34-44-67)62(81)71-53(37-29-33-43-66)61(80)72-55(39-31-35-45-68)63(82)74-56(65(84)85)40-32-36-46-69/h51-57,76H,3-50,66-70H2,1-2H3,(H,71,81)(H,72,80)(H,73,83)(H,74,82)(H,75,79)(H,84,85)/t51?,52-,53-,54-,55-,56-,57-/m0/s1 D04BSJ DRUGINKE LJUIOEFZFQRWJG-KKIBDXJDSA-N D04BSJ DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(CSCC(C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)O)N)OC(=O)CCCCCCCCCCCCCCC D04BSJ HIGHSTAT Investigative D04BVW DRUG__ID D04BVW D04BVW DRUGTYPE Small molecular drug D04BVW DRUGINCH 1S/C37H49N11O6/c1-48-30(20-23-10-13-24-6-2-3-7-25(24)18-23)35(54)46-28(9-5-17-43-37(40)41)33(52)45-27(8-4-16-42-36(38)39)34(53)47-29(32(51)44-21-31(48)50)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,52)(H,46,54)(H,47,53)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30+/m1/s1 D04BVW DRUGINKE XUKFERKCRCTLBJ-ATIZSFMBSA-N D04BVW DRUGSMIL CN1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC1=O)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D04BVW HIGHSTAT Investigative D04BWH DRUG__ID D04BWH D04BWH DRUGTYPE Small molecular drug D04BWH DRUGINCH 1S/C8H7BO2S/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5,10-11H D04BWH DRUGINKE YNCYPMUJDDXIRH-UHFFFAOYSA-N D04BWH DRUGSMIL B(C1=CC2=CC=CC=C2S1)(O)O D04BWH HIGHSTAT Investigative D04BXL DRUG__ID D04BXL D04BXL DRUGTYPE Small molecular drug D04BXL DRUGINCH 1S/C21H17NO3/c23-19-15-21(22-10-12-24-13-11-22)25-20-14-17(8-9-18(19)20)7-6-16-4-2-1-3-5-16/h1-5,8-9,14-15H,10-13H2 D04BXL DRUGINKE INSPUQMNGZSNFZ-UHFFFAOYSA-N D04BXL DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)C#CC4=CC=CC=C4 D04BXL HIGHSTAT Investigative D04BYL DRUG__ID D04BYL D04BYL DRUGTYPE Small molecular drug D04BYL DRUGINCH 1S/C8H10FNO3/c9-7-4(6(12)3-10)1-2-5(11)8(7)13/h1-2,6,11-13H,3,10H2/t6-/m0/s1 D04BYL DRUGINKE FOTRTWXNJQSQJS-LURJTMIESA-N D04BYL DRUGSMIL C1=CC(=C(C(=C1C(CN)O)F)O)O D04BYL HIGHSTAT Investigative D04BYU DRUG__ID D04BYU D04BYU DRUGTYPE Small molecular drug D04BYU DRUGINCH 1S/C23H16O6/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-10,24-25H,11H2,(H,26,27)(H,28,29) D04BYU DRUGINKE WLJNZVDCPSBLRP-UHFFFAOYSA-N D04BYU DRUGSMIL C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O D04BYU HIGHSTAT Investigative D04CAR DRUG__ID D04CAR D04CAR DRUGTYPE Small molecular drug D04CAR DRUGINCH 1S/C6H13BN2O3/c8-4-6(10)9-3-1-2-5(9)7(11)12/h5,11-12H,1-4,8H2/t5-/m0/s1 D04CAR DRUGINKE BZTBBVKEKPNNBE-YFKPBYRVSA-N D04CAR DRUGSMIL B(C1CCCN1C(=O)CN)(O)O D04CAR HIGHSTAT Investigative D04CDV DRUG__ID D04CDV D04CDV DRUGTYPE Small molecular drug D04CDV DRUGINCH 1S/C14H8F4O2/c15-7-3-1-4-8(16)11(7)13(19)14(20)12-9(17)5-2-6-10(12)18/h1-6,13,19H D04CDV DRUGINKE JVCMBBUYARXRIK-UHFFFAOYSA-N D04CDV DRUGSMIL C1=CC(=C(C(=C1)F)C(C(=O)C2=C(C=CC=C2F)F)O)F D04CDV HIGHSTAT Investigative D04CDZ DRUG__ID D04CDZ D04CDZ DRUGTYPE Small molecular drug D04CDZ DRUGINCH 1S/C30H39N5O4S2/c1-21-28(38)35-18-11-15-24(35)27(37)33-23(14-7-4-10-19-40-41-25-16-8-9-17-31-25)26(36)34-30(2,29(39)32-21)20-22-12-5-3-6-13-22/h3,5-6,8-9,12-13,16-17,21,23-24H,4,7,10-11,14-15,18-20H2,1-2H3,(H,32,39)(H,33,37)(H,34,36)/t21-,23-,24+,30+/m0/s1 D04CDZ DRUGINKE ITTWBEZYTYPCGB-HVGAQBFTSA-N D04CDZ DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)(C)CC3=CC=CC=C3)CCCCCSSC4=CC=CC=N4 D04CDZ HIGHSTAT Investigative D04CFM DRUG__ID D04CFM D04CFM DRUGTYPE Small molecular drug D04CFM DRUGINCH 1S/C22H30N4O4S/c23-20(28)16(27)11-13-1-6-17-18(13)19-21(24-12-25-22(19)31-17)30-15-4-2-14(3-5-15)26-7-9-29-10-8-26/h12-16,27H,1-11H2,(H2,23,28)/t13-,14?,15?,16+/m1/s1 D04CFM DRUGINKE ZSMULWAVKYFPSS-LMPOIIKSSA-N D04CFM DRUGSMIL C1CC(CCC1N2CCOCC2)OC3=C4C5=C(CCC5CC(C(=O)N)O)SC4=NC=N3 D04CFM HIGHSTAT Investigative D04CFP DRUG__ID D04CFP D04CFP DRUGTYPE Small molecular drug D04CFP DRUGINCH 1S/C20H16N2/c1-3-17(18-5-6-20-19(14-18)9-12-22-20)4-2-15(1)13-16-7-10-21-11-8-16/h1-12,14,22H,13H2 D04CFP DRUGINKE VVBPUVXDCLUNKF-UHFFFAOYSA-N D04CFP DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC4=C(C=C3)NC=C4 D04CFP HIGHSTAT Investigative D04CJG DRUG__ID D04CJG D04CJG DRUGTYPE Small molecular drug D04CJG DRUGINCH 1S/C14H31O4P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17/h2-14H2,1H3,(H2,15,16,17) D04CJG DRUGINKE KRIXEEBVZRZHOS-UHFFFAOYSA-N D04CJG DRUGSMIL CCCCCCCCCCCCCCOP(=O)(O)O D04CJG HIGHSTAT Investigative D04CLL DRUG__ID D04CLL D04CLL DRUGTYPE Small molecular drug D04CLL DRUGINCH 1S/C16H15N/c1-12-4-2-6-16-14(7-8-15(12)16)10-13-5-3-9-17-11-13/h2-6,9-11H,7-8H2,1H3/b14-10+ D04CLL DRUGINKE ORCOWTSQEFCEFC-GXDHUFHOSA-N D04CLL DRUGSMIL CC1=C2CCC(=CC3=CN=CC=C3)C2=CC=C1 D04CLL HIGHSTAT Investigative D04CPW DRUG__ID D04CPW D04CPW DRUGTYPE Small molecular drug D04CPW DRUGINCH 1S/C20H26N2O/c1-2-14-21-15-6-7-16-22-20(23)19-12-10-18(11-13-19)17-8-4-3-5-9-17/h3-5,8-13,21H,2,6-7,14-16H2,1H3,(H,22,23) D04CPW DRUGINKE QAAKBUYWNXINKR-UHFFFAOYSA-N D04CPW DRUGSMIL CCCNCCCCNC(=O)C1=CC=C(C=C1)C2=CC=CC=C2 D04CPW HIGHSTAT Investigative D04CQG DRUG__ID D04CQG D04CQG DRUGTYPE Small molecular drug D04CQG DRUGINCH 1S/C26H27Cl2N5O2.2ClH/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28;;/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31);2*1H D04CQG DRUGINKE NADLBPWBFGTESN-UHFFFAOYSA-N D04CQG DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl.Cl.Cl D04CQG HIGHSTAT Investigative D04CQM DRUG__ID D04CQM D04CQM DRUGTYPE Small molecular drug D04CQM DRUGINCH 1S/C27H33NO3/c1-16(17-6-4-3-5-7-17)28-26(31)23-15-24-22-10-8-18-14-19(29)9-11-20(18)21(22)12-13-27(24,2)25(23)30/h3-7,9,11,14,16,21-25,29-30H,8,10,12-13,15H2,1-2H3,(H,28,31)/t16?,21?,22?,23?,24?,25-,27-/m0/s1 D04CQM DRUGINKE NLFQZGZNWSXJNG-CDPVEVCASA-N D04CQM DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2CC3C4CCC5=C(C4CCC3(C2O)C)C=CC(=C5)O D04CQM HIGHSTAT Investigative D04CRB DRUG__ID D04CRB D04CRB DRUGTYPE Small molecular drug D04CRB DRUGINCH 1S/C11H8N4S/c1-2-4-8(5-3-1)16-11-9-10(13-6-12-9)14-7-15-11/h1-7H,(H,12,13,14,15) D04CRB DRUGINKE CTDPZFBZKUUAED-UHFFFAOYSA-N D04CRB DRUGSMIL C1=CC=C(C=C1)SC2=NC=NC3=C2NC=N3 D04CRB HIGHSTAT Investigative D04CTN DRUG__ID D04CTN D04CTN DRUGTYPE Small molecular drug D04CTN DRUGINCH 1S/C13H19NO/c1-2-7-14-8-6-12(10-14)11-4-3-5-13(15)9-11/h3-5,9,12,15H,2,6-8,10H2,1H3 D04CTN DRUGINKE WPYVGSUSOOZONM-UHFFFAOYSA-N D04CTN DRUGSMIL CCCN1CCC(C1)C2=CC(=CC=C2)O D04CTN HIGHSTAT Investigative D04CTO DRUG__ID D04CTO D04CTO DRUGTYPE Small molecular drug D04CTO DRUGINCH 1S/C26H19NOS/c28-26(18-19-14-16-21(17-15-19)20-8-2-1-3-9-20)27-22-10-4-6-12-24(22)29-25-13-7-5-11-23(25)27/h1-17H,18H2 D04CTO DRUGINKE HQYQYXMOSDNQPG-UHFFFAOYSA-N D04CTO DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)N3C4=CC=CC=C4SC5=CC=CC=C53 D04CTO HIGHSTAT Investigative D04CUA DRUG__ID D04CUA D04CUA DRUGTYPE Small molecular drug D04CUA DRUGINCH 1S/C24H27N7O/c25-23-20(24-29-21-4-3-19(12-22(21)32-24)30-9-1-2-10-30)11-16(13-27-23)17-14-28-31(15-17)18-5-7-26-8-6-18/h3-4,11-15,18,26H,1-2,5-10H2,(H2,25,27) D04CUA DRUGINKE MWVKLRSIDOXBSE-UHFFFAOYSA-N D04CUA DRUGSMIL C1CCN(C1)C2=CC3=C(C=C2)N=C(O3)C4=C(N=CC(=C4)C5=CN(N=C5)C6CCNCC6)N D04CUA HIGHSTAT Investigative D04CUL DRUG__ID D04CUL D04CUL DRUGTYPE Small molecular drug D04CUL DRUGINCH 1S/C22H30N4O3/c27-20(23-11-14-25-12-5-2-6-13-25)16-9-10-18-19(15-16)24-22(29)26(21(18)28)17-7-3-1-4-8-17/h9-10,15,17H,1-8,11-14H2,(H,23,27)(H,24,29) D04CUL DRUGINKE NNJAFUNKEIDAAF-UHFFFAOYSA-N D04CUL DRUGSMIL C1CCC(CC1)N2C(=O)C3=C(C=C(C=C3)C(=O)NCCN4CCCCC4)NC2=O D04CUL HIGHSTAT Investigative D04CZF DRUG__ID D04CZF D04CZF DRUGTYPE Small molecular drug D04CZF DRUGINCH 1S/C18H21N3O3/c19-16(18(20)23)10-11-17(22)21-14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16H,10-12,19H2,(H2,20,23)(H,21,22)/t16-/m0/s1 D04CZF DRUGINKE PKTMQSKBGCPRGD-INIZCTEOSA-N D04CZF DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D04CZF HIGHSTAT Investigative D04CZQ DRUG__ID D04CZQ D04CZQ DRUGTYPE Small molecular drug D04CZQ DRUGINCH 1S/C24H25FN2O4/c1-3-24(4-2,23(29)30)14-22(28)27-18-6-5-7-20(13-18)31-15-19-11-9-16-8-10-17(25)12-21(16)26-19/h5-13H,3-4,14-15H2,1-2H3,(H,27,28)(H,29,30) D04CZQ DRUGINKE BFNAFTJCDGWFMQ-UHFFFAOYSA-N D04CZQ DRUGSMIL CCC(CC)(CC(=O)NC1=CC(=CC=C1)OCC2=NC3=C(C=CC(=C3)F)C=C2)C(=O)O D04CZQ HIGHSTAT Investigative D04DBR DRUG__ID D04DBR D04DBR DRUGTYPE Small molecular drug D04DBR DRUGINCH 1S/C13H8N2O2.C7H8O3S/c16-13-9-5-1-2-7-11(9)15(17)12(13)10-6-3-4-8-14-10;1-6-2-4-7(5-3-6)11(8,9)10/h1-8H;2-5H,1H3,(H,8,9,10) D04DBR DRUGINKE MMPTYEXNPWSTOR-UHFFFAOYSA-N D04DBR DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)O.C1=CC=C2C(=C1)C(=O)C(=[N+]2[O-])C3=CC=CC=N3 D04DBR HIGHSTAT Investigative D04DCW DRUG__ID D04DCW D04DCW DRUGTYPE Small molecular drug D04DCW DRUGINCH 1S/C16H13FO2/c1-10-2-7-13-14(18)9-15(19-16(13)8-10)11-3-5-12(17)6-4-11/h2-8,15H,9H2,1H3 D04DCW DRUGINKE ZWJDAELXCJQOJQ-UHFFFAOYSA-N D04DCW DRUGSMIL CC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)F D04DCW HIGHSTAT Investigative D04DFX DRUG__ID D04DFX D04DFX DRUGTYPE Small molecular drug D04DFX DRUGINCH 1S/C14H11Br2N3OS/c15-10-3-1-2-8(6-10)13(18-19-14(17)21)9-4-5-12(20)11(16)7-9/h1-7,20H,(H3,17,19,21)/b18-13- D04DFX DRUGINKE UIMSYLGHIQKPJZ-AQTBWJFISA-N D04DFX DRUGSMIL C1=CC(=CC(=C1)Br)C(=NNC(=S)N)C2=CC(=C(C=C2)O)Br D04DFX HIGHSTAT Investigative D04DHB DRUG__ID D04DHB D04DHB DRUGTYPE Small molecular drug D04DHB DRUGINCH 1S/C10H5Cl2NO3/c11-4-1-5(12)9-6(2-4)13-7(10(15)16)3-8(9)14/h1-3H,(H,13,14)(H,15,16) D04DHB DRUGINKE BGKFPRIGXAVYNX-UHFFFAOYSA-N D04DHB DRUGSMIL C1=C(C=C(C2=C1NC(=CC2=O)C(=O)O)Cl)Cl D04DHB HIGHSTAT Investigative D04DHD DRUG__ID D04DHD D04DHD DRUGTYPE Small molecular drug D04DHD DRUGINCH 1S/C14H17NO5S/c1-8(14(17)18)15-13(16)10(6-21)4-9-2-3-11-12(5-9)20-7-19-11/h2-3,5,8,10,21H,4,6-7H2,1H3,(H,15,16)(H,17,18)/t8-,10+/m0/s1 D04DHD DRUGINKE TXSINLUUGRGAJO-WCBMZHEXSA-N D04DHD DRUGSMIL CC(C(=O)O)NC(=O)C(CC1=CC2=C(C=C1)OCO2)CS D04DHD HIGHSTAT Investigative D04DJM DRUG__ID D04DJM D04DJM DRUGTYPE Small molecular drug D04DJM DRUGINCH 1S/C20H26O3/c1-12(2)16-11-14-9-8-13(3)15(7-6-10-20(4,5)23)17(14)19(22)18(16)21/h8-9,11-12,23H,6-7,10H2,1-5H3 D04DJM DRUGINKE QJYXXTULLNTAEX-UHFFFAOYSA-N D04DJM DRUGSMIL CC1=C(C2=C(C=C1)C=C(C(=O)C2=O)C(C)C)CCCC(C)(C)O D04DJM HIGHSTAT Investigative D04DKM DRUG__ID D04DKM D04DKM DRUGTYPE Small molecular drug D04DKM DRUGINCH 1S/C7H11NO4/c8-7(6(11)12)2-1-4(3-7)5(9)10/h4H,1-3,8H2,(H,9,10)(H,11,12)/t4-,7+/m1/s1 D04DKM DRUGINKE YFYNOWXBIBKGHB-FBCQKBJTSA-N D04DKM DRUGSMIL C1CC(CC1C(=O)O)(C(=O)O)N D04DKM HIGHSTAT Investigative D04DKX DRUG__ID D04DKX D04DKX DRUGTYPE Small molecular drug D04DKX DRUGINCH 1S/C12H20N2S4/c15-11(13-7-3-1-4-8-13)17-18-12(16)14-9-5-2-6-10-14/h1-10H2 D04DKX DRUGINKE KNBRWWCHBRQLNY-UHFFFAOYSA-N D04DKX DRUGSMIL C1CCN(CC1)C(=S)SSC(=S)N2CCCCC2 D04DKX HIGHSTAT Investigative D04DLM DRUG__ID D04DLM D04DLM DRUGTYPE Small molecular drug D04DLM DRUGINCH 1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13) D04DLM DRUGINKE HSMNQINEKMPTIC-UHFFFAOYSA-N D04DLM DRUGSMIL C1=CC(=CC=C1C(=O)NCC(=O)O)N D04DLM HIGHSTAT Investigative D04DLR DRUG__ID D04DLR D04DLR DRUGTYPE Small molecular drug D04DLR DRUGINCH 1S/C23H25N3O2/c1-26(2)15-3-4-19-16-20(7-10-22(19)27)23(28)25-21-8-5-17(6-9-21)18-11-13-24-14-12-18/h5-14,16,27H,3-4,15H2,1-2H3,(H,25,28) D04DLR DRUGINKE ZAGAUUVCYGSPBP-UHFFFAOYSA-N D04DLR DRUGSMIL CN(C)CCCC1=C(C=CC(=C1)C(=O)NC2=CC=C(C=C2)C3=CC=NC=C3)O D04DLR HIGHSTAT Investigative D04DOL DRUG__ID D04DOL D04DOL DRUGTYPE Small molecular drug D04DOL DRUGINCH 1S/C20H24N2O3/c23-19(10-6-1-2-7-11-20(24)22-25)21-18-14-12-17(13-15-18)16-8-4-3-5-9-16/h3-5,8-9,12-15,25H,1-2,6-7,10-11H2,(H,21,23)(H,22,24) D04DOL DRUGINKE MIYLHRAVWYBTPV-UHFFFAOYSA-N D04DOL DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)CCCCCCC(=O)NO D04DOL HIGHSTAT Investigative D04DOV DRUG__ID D04DOV D04DOV DRUGTYPE Small molecular drug D04DOV DRUGINCH 1S/C3H9N/c1-4(2)3/h1-3H3 D04DOV DRUGINKE GETQZCLCWQTVFV-UHFFFAOYSA-N D04DOV DRUGSMIL CN(C)C D04DOV HIGHSTAT Investigative D04DQF DRUG__ID D04DQF D04DQF DRUGTYPE Small molecular drug D04DQF DRUGINCH 1S/C17H17NO4/c1-12(19)13-3-2-4-14(9-13)16-10-15(20)11-17(22-16)18-5-7-21-8-6-18/h2-4,9-11H,5-8H2,1H3 D04DQF DRUGINKE MUGFHNCVHGYLEQ-UHFFFAOYSA-N D04DQF DRUGSMIL CC(=O)C1=CC=CC(=C1)C2=CC(=O)C=C(O2)N3CCOCC3 D04DQF HIGHSTAT Investigative D04DQJ DRUG__ID D04DQJ D04DQJ DRUGTYPE Small molecular drug D04DQJ DRUGINCH 1S/C18H18O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h3-4,7-12,19-20H,1-2,5-6H2 D04DQJ DRUGINKE FVYXIJYOAGAUQK-UHFFFAOYSA-N D04DQJ DRUGSMIL C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C D04DQJ HIGHSTAT Investigative D04DRM DRUG__ID D04DRM D04DRM DRUGTYPE Small molecular drug D04DRM DRUGINCH 1S/C18H20N2O4/c19-16(10-11-17(21)22)18(23)20-14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16H,10-12,19H2,(H,20,23)(H,21,22)/t16-/m1/s1 D04DRM DRUGINKE IYYBWKOXCQKLHX-MRXNPFEDSA-N D04DRM DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)C(CCC(=O)O)N D04DRM HIGHSTAT Investigative D04DTE DRUG__ID D04DTE D04DTE DRUGTYPE Small molecular drug D04DTE DRUGINCH 1S/C29H36N4O6/c30-24-9-3-1-2-4-10-25(29(39)31-18-21-8-6-5-7-20(21)16-27(36)37)33-26(35)17-22(32-28(24)38)15-19-11-13-23(34)14-12-19/h1-2,5-8,11-14,22,24-25,34H,3-4,9-10,15-18,30H2,(H,31,39)(H,32,38)(H,33,35)(H,36,37)/b2-1+/t22-,24-,25-/m0/s1 D04DTE DRUGINKE QUJXIMWUJGTUEG-CLKUPZDLSA-N D04DTE DRUGSMIL C1CC(C(=O)NC(CC(=O)NC(CCC=C1)C(=O)NCC2=CC=CC=C2CC(=O)O)CC3=CC=C(C=C3)O)N D04DTE HIGHSTAT Investigative D04DVT DRUG__ID D04DVT D04DVT DRUGTYPE Small molecular drug D04DVT DRUGINCH 1S/C19H22N4O5/c1-3-9-22-17-15(18(26)23(10-4-2)19(22)27)20-16(21-17)12-5-7-13(8-6-12)28-11-14(24)25/h5-8H,3-4,9-11H2,1-2H3,(H,20,21)(H,24,25) D04DVT DRUGINKE QTMMGCYGCFXBFI-UHFFFAOYSA-N D04DVT DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)O D04DVT HIGHSTAT Investigative D04DWJ DRUG__ID D04DWJ D04DWJ DRUGTYPE Small molecular drug D04DWJ DRUGINCH 1S/Zn/q+2 D04DWJ DRUGINKE PTFCDOFLOPIGGS-UHFFFAOYSA-N D04DWJ DRUGSMIL [Zn+2] D04DWJ HIGHSTAT Investigative D04DXC DRUG__ID D04DXC D04DXC DRUGTYPE Small molecular drug D04DXC DRUGINCH 1S/C40H55N5O9S/c1-4-24(2)34(38(51)42-30(22-26-14-8-5-9-15-26)37(50)43-31(23-55)40(53)54)44-39(52)35(45-36(49)29(41-25(3)46)20-21-32(47)48)33(27-16-10-6-11-17-27)28-18-12-7-13-19-28/h6-7,10-13,16-19,24,26,29-31,33-35,55H,4-5,8-9,14-15,20-23H2,1-3H3,(H,41,46)(H,42,51)(H,43,50)(H,44,52)(H,45,49)(H,47,48)(H,53,54)/t24-,29+,30+,31-,34-,35+/m1/s1 D04DXC DRUGINKE WLXMMKXNDCWWHB-KGIQSIOISA-N D04DXC DRUGSMIL CCC(C)C(C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(C(C2=CC=CC=C2)C3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C D04DXC HIGHSTAT Investigative D04DYA DRUG__ID D04DYA D04DYA DRUGCOMP Tokyo University Of Agriculture & Technology Co Ltd D04DYA DRUGINCH 1S/C24H33NO4/c1-15(2)8-6-9-16(3)10-7-11-24(4)21(27)13-18-20(26)12-17-19(22(18)29-24)14-25(5)23(17)28/h8,10,12,21,26-27H,6-7,9,11,13-14H2,1-5H3/b16-10+/t21-,24-/m0/s1 D04DYA DRUGINKE QIEGDUWARWIZQX-IRTPIHDWSA-N D04DYA DRUGSMIL CC(=CCCC(=CCCC1(C(CC2=C(C=C3C(=C2O1)CN(C3=O)C)O)O)C)C)C D04DYA HIGHSTAT Investigative D04DYM DRUG__ID D04DYM D04DYM DRUGTYPE Small molecular drug D04DYM DRUGINCH 1S/C30H29N3O4/c1-33(28-13-7-8-18-31-28)19-20-37-24-16-14-22(15-17-24)21-27(30(35)36)32-26-12-6-5-11-25(26)29(34)23-9-3-2-4-10-23/h2-18,27,32H,19-21H2,1H3,(H,35,36)/t27-/m0/s1 D04DYM DRUGINKE QTQMRBZOBKYXCG-MHZLTWQESA-N D04DYM DRUGSMIL CN(CCOC1=CC=C(C=C1)CC(C(=O)O)NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C4=CC=CC=N4 D04DYM HIGHSTAT Investigative D04DYO DRUG__ID D04DYO D04DYO DRUGTYPE Small molecular drug D04DYO DRUGINCH 1S/C16H12O6/c1-21-10-4-2-8(3-5-10)16-15(20)14(19)13-11(18)6-9(17)7-12(13)22-16/h2-7,17-18,20H,1H3 D04DYO DRUGINKE SQFSKOYWJBQGKQ-UHFFFAOYSA-N D04DYO DRUGSMIL COC1=CC=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O D04DYO HIGHSTAT Investigative D04DZS DRUG__ID D04DZS D04DZS DRUGTYPE Small molecular drug D04DZS DRUGINCH 1S/C18H33O6PS/c1-15(2)9-7-11-17(4)13-8-12-16(3)10-5-6-14-18(25(19,20)21)26(22,23)24/h9-10,13,18H,5-8,11-12,14H2,1-4H3,(H2,19,20,21)(H,22,23,24)/p-3/b16-10+,17-13+ D04DZS DRUGINKE GAGCDEGBGYUQJJ-QKXOVSGLSA-K D04DZS DRUGSMIL CC(=CCCC(=CCCC(=CCCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])C)C)C D04DZS HIGHSTAT Investigative D04DZZ DRUG__ID D04DZZ D04DZZ DRUGTYPE Small molecular drug D04DZZ DRUGINCH 1S/C16H26N2O5S/c1-3-4-5-6-7-8-9-12-23-16-13-14(18(19)20)10-11-15(16)17-24(2,21)22/h10-11,13,17H,3-9,12H2,1-2H3 D04DZZ DRUGINKE QXUZIGSBVCSGCD-UHFFFAOYSA-N D04DZZ DRUGSMIL CCCCCCCCCOC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C D04DZZ HIGHSTAT Investigative D04EAY DRUG__ID D04EAY D04EAY DRUGTYPE Small molecular drug D04EAY DRUGINCH 1S/C13H9NO3/c15-8-5-6-10-12(7-8)17-14-13(10)9-3-1-2-4-11(9)16/h1-7,15-16H D04EAY DRUGINKE PKKSNVBSDIEUEZ-UHFFFAOYSA-N D04EAY DRUGSMIL C1=CC=C(C(=C1)C2=NOC3=C2C=CC(=C3)O)O D04EAY HIGHSTAT Investigative D04ECT DRUG__ID D04ECT D04ECT DRUGTYPE Small molecular drug D04ECT DRUGINCH 1S/C17H15NO2S/c19-17-11-15(18-5-7-21-8-6-18)14-9-12-3-1-2-4-13(12)10-16(14)20-17/h1-4,9-11H,5-8H2 D04ECT DRUGINKE UYBNTAODFKOXIU-UHFFFAOYSA-N D04ECT DRUGSMIL C1CSCCN1C2=CC(=O)OC3=CC4=CC=CC=C4C=C23 D04ECT HIGHSTAT Investigative D04ECZ DRUG__ID D04ECZ D04ECZ DRUGTYPE Small molecular drug D04ECZ DRUGINCH 1S/C21H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)22-19-18-20(19)23/h9-10,19-20,23H,2-8,11-18H2,1H3,(H,22,24)/b10-9-/t19-,20-/m1/s1 D04ECZ DRUGINKE VCMSNKIQHBVCSW-BHGRFLGOSA-N D04ECZ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC1CC1O D04ECZ HIGHSTAT Investigative D04EDK DRUG__ID D04EDK D04EDK DRUGTYPE Small molecular drug D04EDK DRUGINCH 1S/C12H16FN3O2/c13-11-2-1-10(9-15-11)12(17)14-3-4-16-5-7-18-8-6-16/h1-2,9H,3-8H2,(H,14,17) D04EDK DRUGINKE GHLPFUPTLVEUTA-UHFFFAOYSA-N D04EDK DRUGSMIL C1COCCN1CCNC(=O)C2=CN=C(C=C2)F D04EDK HIGHSTAT Investigative D04EDO DRUG__ID D04EDO D04EDO DRUGTYPE Small molecular drug D04EDO DRUGINCH 1S/C9H14N6/c1-11-9(14-6-10)13-4-2-3-8-5-12-7-15-8/h5,7H,2-4H2,1H3,(H,12,15)(H2,11,13,14) D04EDO DRUGINKE CXTGREPICTYOGB-UHFFFAOYSA-N D04EDO DRUGSMIL CN=C(NCCCC1=CN=CN1)NC#N D04EDO HIGHSTAT Investigative D04EIE DRUG__ID D04EIE D04EIE DRUGTYPE Small molecular drug D04EIE DRUGINCH 1S/C10H19N3O2/c1-2-3-6-9(12)13-7-4-5-8(11)10(14)15/h3,6,8H,2,4-5,7,11H2,1H3,(H2,12,13)(H,14,15)/b6-3+/t8-/m0/s1 D04EIE DRUGINKE CIYWWIHMEYBDFA-HFSLJOEWSA-N D04EIE DRUGSMIL CCC=CC(=NCCCC(C(=O)O)N)N D04EIE HIGHSTAT Investigative D04EKZ DRUG__ID D04EKZ D04EKZ DRUGTYPE Small molecular drug D04EKZ DRUGINCH 1S/C21H23FN2O3/c22-18-5-1-15(2-6-18)16-9-11-24(12-10-16)13-19(25)14-27-20-7-3-17(4-8-20)21(23)26/h1-9,19,25H,10-14H2,(H2,23,26) D04EKZ DRUGINKE HFHFPCVDUCBNLG-UHFFFAOYSA-N D04EKZ DRUGSMIL C1CN(CC=C1C2=CC=C(C=C2)F)CC(COC3=CC=C(C=C3)C(=O)N)O D04EKZ HIGHSTAT Investigative D04ELJ DRUG__ID D04ELJ D04ELJ DRUGTYPE Small molecular drug D04ELJ DRUGINCH 1S/C15H12ClN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8- D04ELJ DRUGINKE GQENGHZHJWXFLG-WQLSENKSSA-N D04ELJ DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)Cl D04ELJ HIGHSTAT Investigative D04EOH DRUG__ID D04EOH D04EOH DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D04EOH DRUGINCH 1S/C36H71NO5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-34(39)41-32-36(37,31-38)33-42-35(40)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h38H,3-33,37H2,1-2H3 D04EOH DRUGINKE GVKXQWJWYPCNOW-UHFFFAOYSA-N D04EOH DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(CO)(COC(=O)CCCCCCCCCCCCCCC)N D04EOH HIGHSTAT Investigative D04EOV DRUG__ID D04EOV D04EOV DRUGTYPE Small molecular drug D04EOV DRUGINCH 1S/C15H17NO3/c1-3-5-10-6-7-13-11(8-10)14(17)12(9-16-13)15(18)19-4-2/h6-9H,3-5H2,1-2H3,(H,16,17) D04EOV DRUGINKE GLVXKESFOXDNRX-UHFFFAOYSA-N D04EOV DRUGSMIL CCCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OCC D04EOV HIGHSTAT Investigative D04EOZ DRUG__ID D04EOZ D04EOZ DRUGTYPE Small molecular drug D04EOZ DRUGINCH 1S/C17H26O/c1-4-17(2,3)15-10-8-13(9-11-15)14-6-5-7-16(18)12-14/h8-11,14,16,18H,4-7,12H2,1-3H3/t14-,16+/m0/s1 D04EOZ DRUGINKE NGNJEMWGXAUJKO-GOEBONIOSA-N D04EOZ DRUGSMIL CCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D04EOZ HIGHSTAT Investigative D04EPO DRUG__ID D04EPO D04EPO DRUGTYPE Small molecular drug D04EPO DRUGINCH 1S/C17H11NO2/c18-10-14-7-13(11-2-1-3-15(19)8-11)6-12-4-5-16(20)9-17(12)14/h1-9,19-20H D04EPO DRUGINKE UXJULIKCAFGFJL-UHFFFAOYSA-N D04EPO DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=C3C=C(C=CC3=C2)O)C#N D04EPO HIGHSTAT Investigative D04EPS DRUG__ID D04EPS D04EPS DRUGCOMP Onconova Therapeutics Inc D04EPS DRUGINCH 1S/C18H22N2O6S/c1-23-13-10-17(25-3)14(18(11-13)26-4)7-8-27(21,22)20-12-5-6-16(24-2)15(19)9-12/h5-11,20H,19H2,1-4H3/b8-7+ D04EPS DRUGINKE OLRRWEXEHIWZJV-BQYQJAHWSA-N D04EPS DRUGSMIL COC1=C(C=C(C=C1)NS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)N D04EPS HIGHSTAT Investigative D04EQE DRUG__ID D04EQE D04EQE DRUGTYPE Small molecular drug D04EQE DRUGINCH 1S/C28H31NO7/c1-29-14-13-26-15-21(35-22(30)12-9-17-7-5-4-6-8-17)25(32)28(34-3)27(26,29)16-20(36-28)18-10-11-19(33-2)24(31)23(18)26/h4-12,20-21,25,31-32H,13-16H2,1-3H3/b12-9+/t20-,21-,25-,26-,27-,28+/m0/s1 D04EQE DRUGINKE ZPAQRVPCPJNTSC-YZVVQLETSA-N D04EQE DRUGSMIL CN1CCC23C14CC(C5=C2C(=C(C=C5)OC)O)OC4(C(C(C3)OC(=O)C=CC6=CC=CC=C6)O)OC D04EQE HIGHSTAT Investigative D04ETB DRUG__ID D04ETB D04ETB DRUGTYPE Small molecular drug D04ETB DRUGINCH 1S/C26H36O6/c1-7-24(30)32-23(13-26(6)17(4)9-11-21(28)18(26)5)15(2)8-10-19-22(29)12-16(3)20(14-27)25(19)31/h8,12,14,17-18,23,29,31H,7,9-11,13H2,1-6H3/b15-8+/t17-,18+,23-,26+/m1/s1 D04ETB DRUGINKE VLFRJRBSRCFKPU-AXNCTASFSA-N D04ETB DRUGSMIL CCC(=O)OC(CC1(C(CCC(=O)C1C)C)C)C(=CCC2=C(C=C(C(=C2O)C=O)C)O)C D04ETB HIGHSTAT Investigative D04ETX DRUG__ID D04ETX D04ETX DRUGTYPE Small molecular drug D04ETX DRUGINCH 1S/C14H17F3O2/c15-14(16,17)13(18)10-6-1-2-7-11-19-12-8-4-3-5-9-12/h3-5,8-9H,1-2,6-7,10-11H2 D04ETX DRUGINKE MSSNESMCPBOBIG-UHFFFAOYSA-N D04ETX DRUGSMIL C1=CC=C(C=C1)OCCCCCCC(=O)C(F)(F)F D04ETX HIGHSTAT Investigative D04EWW DRUG__ID D04EWW D04EWW DRUGTYPE Small molecular drug D04EWW DRUGINCH 1S/C10H10O4/c1-14-9-4-2-7(6-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+ D04EWW DRUGINKE QURCVMIEKCOAJU-HWKANZROSA-N D04EWW DRUGSMIL COC1=C(C=C(C=C1)C=CC(=O)O)O D04EWW HIGHSTAT Investigative D04EXA DRUG__ID D04EXA D04EXA DRUGTYPE Small molecular drug D04EXA DRUGINCH 1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-7-17-12)9-5-6-10(15)11(16)8-9/h5-6,8,12-13,17H,2-4,7H2,1H3/t12-,13+/m1/s1 D04EXA DRUGINKE JUKMAYKVHWKRKY-OLZOCXBDSA-N D04EXA DRUGSMIL COC(=O)C(C1CCCCN1)C2=CC(=C(C=C2)Cl)Cl D04EXA HIGHSTAT Investigative D04EXR DRUG__ID D04EXR D04EXR DRUGTYPE Small molecular drug D04EXR DRUGINCH 1S/C8H3Cl2NO2/c9-3-1-4(10)6-5(2-3)11-8(13)7(6)12/h1-2H,(H,11,12,13) D04EXR DRUGINKE CGCVHJCZBIYRQC-UHFFFAOYSA-N D04EXR DRUGSMIL C1=C(C=C(C2=C1NC(=O)C2=O)Cl)Cl D04EXR HIGHSTAT Investigative D04EYR DRUG__ID D04EYR D04EYR DRUGTYPE Small molecular drug D04EYR DRUGINCH 1S/C24H26FN3O2/c1-16-3-8-22-26-17(2)21(24(30)28(22)15-16)11-14-27-12-9-19(10-13-27)23(29)18-4-6-20(25)7-5-18/h3-8,15,19H,9-14H2,1-2H3 D04EYR DRUGINKE AXQRPYKSPHUOGZ-UHFFFAOYSA-N D04EYR DRUGSMIL CC1=CN2C(=NC(=C(C2=O)CCN3CCC(CC3)C(=O)C4=CC=C(C=C4)F)C)C=C1 D04EYR HIGHSTAT Investigative D04EZN DRUG__ID D04EZN D04EZN DRUGTYPE Small molecular drug D04EZN DRUGINCH 1S/C14H17NS2/c1-11(15(2)3)10-12(13-6-4-8-16-13)14-7-5-9-17-14/h4-11H,1-3H3 D04EZN DRUGINKE CANBGVXYBPOLRR-UHFFFAOYSA-N D04EZN DRUGSMIL CC(C=C(C1=CC=CS1)C2=CC=CS2)N(C)C D04EZN HIGHSTAT Investigative D04FBZ DRUG__ID D04FBZ D04FBZ DRUGTYPE Small molecular drug D04FBZ DRUGINCH 1S/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2/t12-,13+,15-,18-,19-/m0/s1 D04FBZ DRUGINKE UIQMVEYFGZJHCZ-SSTWWWIQSA-N D04FBZ DRUGSMIL C=CCN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O D04FBZ HIGHSTAT Investigative D04FFS DRUG__ID D04FFS D04FFS DRUGTYPE Small molecular drug D04FFS DRUGINCH 1S/C19H22N2O3/c1-2-3-7-14-23-18-12-10-17(11-13-18)21-19(22)24-20-15-16-8-5-4-6-9-16/h4-6,8-13,15H,2-3,7,14H2,1H3,(H,21,22)/b20-15+ D04FFS DRUGINKE RMGKIVHTNJBERM-HMMYKYKNSA-N D04FFS DRUGSMIL CCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D04FFS HIGHSTAT Investigative D04FHG DRUG__ID D04FHG D04FHG DRUGTYPE Small molecular drug D04FHG DRUGINCH 1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3/t26-/m1/s1 D04FHG DRUGINKE HVAUUPRFYPCOCA-AREMUKBSSA-N D04FHG DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C D04FHG HIGHSTAT Investigative D04FHZ DRUG__ID D04FHZ D04FHZ DRUGTYPE Small molecular drug D04FHZ DRUGINCH 1S/C21H25N3O2/c1-14-7-5-6-8-17(14)22-20(25)26-15-9-10-18-16(13-15)21(2)11-12-23(3)19(21)24(18)4/h5-10,13,19H,11-12H2,1-4H3,(H,22,25)/t19?,21-/m0/s1 D04FHZ DRUGINKE JGAGHIIOCADQOV-QWAKEFERSA-N D04FHZ DRUGSMIL CC1=CC=CC=C1NC(=O)OC2=CC3=C(C=C2)N(C4C3(CCN4C)C)C D04FHZ HIGHSTAT Investigative D04FIN DRUG__ID D04FIN D04FIN DRUGTYPE Small molecular drug D04FIN DRUGINCH 1S/C19H18O6/c1-21-12-6-5-7-13(22-2)18(12)16-10-11(20)17-14(25-16)8-9-15(23-3)19(17)24-4/h5-10H,1-4H3 D04FIN DRUGINKE PBQMALAAFQMDSP-UHFFFAOYSA-N D04FIN DRUGSMIL COC1=C(C(=CC=C1)OC)C2=CC(=O)C3=C(O2)C=CC(=C3OC)OC D04FIN HIGHSTAT Investigative D04FLL DRUG__ID D04FLL D04FLL DRUGTYPE Small molecular drug D04FLL DRUGINCH 1S/C10H11NOS/c12-10-7-13-9(6-11-10)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12) D04FLL DRUGINKE RTCSYBNOEYGSSX-UHFFFAOYSA-N D04FLL DRUGSMIL C1C(SCC(=O)N1)C2=CC=CC=C2 D04FLL HIGHSTAT Investigative D04FMU DRUG__ID D04FMU D04FMU DRUGTYPE Small molecular drug D04FMU DRUGINCH 1S/C18H11N3O/c19-10-15-13(12-5-2-1-3-6-12)9-14(16(11-20)18(15)21)17-7-4-8-22-17/h1-9H,21H2 D04FMU DRUGINKE SLQVQKSDEBBOSA-UHFFFAOYSA-N D04FMU DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C(=C2C#N)N)C#N)C3=CC=CO3 D04FMU HIGHSTAT Investigative D04FNI DRUG__ID D04FNI D04FNI DRUGTYPE Small molecular drug D04FNI DRUGINCH 1S/C30H28N6O6S4/c1-33-21(39)27-11-25(15-7-3-5-9-17(15)31-19(25)35(27)23(41)29(33,13-37)45-43-27)26-12-28-22(40)34(2)30(14-38,46-44-28)24(42)36(28)20(26)32-18-10-6-4-8-16(18)26/h3-10,19-20,31-32,37-38H,11-14H2,1-2H3/t19-,20-,25+,26+,27+,28+,29+,30+/m1/s1 D04FNI DRUGINKE PZPPOCZWRGNKIR-PNVYSBBASA-N D04FNI DRUGSMIL CN1C(=O)C23CC4(C(N2C(=O)C1(SS3)CO)NC5=CC=CC=C54)C67CC89C(=O)N(C(C(=O)N8C6NC1=CC=CC=C71)(SS9)CO)C D04FNI HIGHSTAT Investigative D04FNY DRUG__ID D04FNY D04FNY DRUGTYPE Small molecular drug D04FNY DRUGINCH 1S/C25H24N4O4/c1-14-18(9-11-23(30)31)15(2)26-22(14)13-20-19-12-16(8-10-21(19)27-25(20)33)24(32)29-28-17-6-4-3-5-7-17/h3-8,10,12-13,26,28H,9,11H2,1-2H3,(H,27,33)(H,29,32)(H,30,31)/b20-13- D04FNY DRUGINKE GCZQBFMPHLFNIO-MOSHPQCFSA-N D04FNY DRUGSMIL CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=C(C=CC(=C3)C(=O)NNC4=CC=CC=C4)NC2=O D04FNY HIGHSTAT Investigative D04FQV DRUG__ID D04FQV D04FQV DRUGTYPE Small molecular drug D04FQV DRUGINCH 1S/C52H68N8O15S/c1-31(2)27-40(49(69)57-39(23-25-45(64)65)48(68)56-38(22-24-44(62)63)47(67)54-33(5)46(53)66)55-43(61)29-60(76(73,74)37-20-18-36(19-21-37)35-15-10-7-11-16-35)51(71)41(28-32(3)4)58-50(70)42-17-12-26-59(42)52(72)75-30-34-13-8-6-9-14-34/h6-11,13-16,18-21,31-33,38-42H,12,17,22-30H2,1-5H3,(H2,53,66)(H,54,67)(H,55,61)(H,56,68)(H,57,69)(H,58,70)(H,62,63)(H,64,65)/t33-,38-,39-,40-,41-,42-/m0/s1 D04FQV DRUGINKE XGNIOZCAZTWXMZ-WCHFFXHOSA-N D04FQV DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)N)NC(=O)CN(C(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)OCC2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)C4=CC=CC=C4 D04FQV HIGHSTAT Investigative D04FQZ DRUG__ID D04FQZ D04FQZ DRUGTYPE Small molecular drug D04FQZ DRUGINCH 1S/C16H20O3/c1-2-3-4-5-6-13-7-9-14(10-8-13)15(17)11-12-16(18)19/h7-12H,2-6H2,1H3,(H,18,19) D04FQZ DRUGINKE HKEVTQICMJNUNY-UHFFFAOYSA-N D04FQZ DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)C=CC(=O)O D04FQZ HIGHSTAT Investigative D04FUZ DRUG__ID D04FUZ D04FUZ DRUGTYPE Small molecular drug D04FUZ DRUGINCH 1S/C18H29NO3/c1-20-17-8-6-9-18(16-17)22-15-14-21-13-7-12-19-10-4-2-3-5-11-19/h6,8-9,16H,2-5,7,10-15H2,1H3 D04FUZ DRUGINKE CRNTZNDTRWBBPM-UHFFFAOYSA-N D04FUZ DRUGSMIL COC1=CC(=CC=C1)OCCOCCCN2CCCCCC2 D04FUZ HIGHSTAT Investigative D04FVX DRUG__ID D04FVX D04FVX DRUGTYPE Small molecular drug D04FVX DRUGINCH 1S/C16H29NO4/c1-2-3-4-6-9-12-15(17(20)21)13-10-7-5-8-11-14-16(18)19/h12H,2-11,13-14H2,1H3,(H,18,19)/b15-12+ D04FVX DRUGINKE YZNSJIAWRWPQGX-NTCAYCPXSA-N D04FVX DRUGSMIL CCCCCCC=C(CCCCCCCC(=O)O)[N+](=O)[O-] D04FVX HIGHSTAT Investigative D04FWH DRUG__ID D04FWH D04FWH DRUGTYPE Small molecular drug D04FWH DRUGINCH 1S/C8H8O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,6,10H,5H2 D04FWH DRUGINKE IPRPPFIAVHPVJH-UHFFFAOYSA-N D04FWH DRUGSMIL C1=CC(=CC=C1CC=O)O D04FWH HIGHSTAT Investigative D04FXD DRUG__ID D04FXD D04FXD DRUGTYPE Small molecular drug D04FXD DRUGINCH 1S/CNO/c2-1-3/q-1 D04FXD DRUGINKE IQPQWNKOIGAROB-UHFFFAOYSA-N D04FXD DRUGSMIL C(=[N-])=O D04FXD HIGHSTAT Investigative D04FYN DRUG__ID D04FYN D04FYN DRUGTYPE Small molecular drug D04FYN DRUGINCH 1S/C20H21NO4/c1-3-24-19(22)18(20(23)25-4-2)14-21-17-12-8-11-16(13-17)15-9-6-5-7-10-15/h5-14,18H,3-4H2,1-2H3 D04FYN DRUGINKE WHQSBENLMFJXRC-UHFFFAOYSA-N D04FYN DRUGSMIL CCOC(=O)C(C=NC1=CC=CC(=C1)C2=CC=CC=C2)C(=O)OCC D04FYN HIGHSTAT Investigative D04GAX DRUG__ID D04GAX D04GAX DRUGTYPE Small molecular drug D04GAX DRUGINCH 1S/C13H16N2O3/c1-2-6-15-13(16)18-11-5-3-4-10(9-11)12-14-7-8-17-12/h3-5,9H,2,6-8H2,1H3,(H,15,16) D04GAX DRUGINKE JLCYRBIRENXOKD-UHFFFAOYSA-N D04GAX DRUGSMIL CCCNC(=O)OC1=CC=CC(=C1)C2=NCCO2 D04GAX HIGHSTAT Investigative D04GBL DRUG__ID D04GBL D04GBL DRUGTYPE Small molecular drug D04GBL DRUGINCH 1S/C13H16N2/c1-11-4-2-3-5-13(11)15-9-7-12(10-15)6-8-14/h2-5,7,9-10H,6,8,14H2,1H3 D04GBL DRUGINKE MQJFADBSJHNKPK-UHFFFAOYSA-N D04GBL DRUGSMIL CC1=CC=CC=C1N2C=CC(=C2)CCN D04GBL HIGHSTAT Investigative D04GDW DRUG__ID D04GDW D04GDW DRUGTYPE Small molecular drug D04GDW DRUGINCH 1S/C19H27NO5S/c1-19-8-7-12-13(15(19)5-6-18(19)25-26(20,22)23)4-3-11-9-16(21)17(24-2)10-14(11)12/h9-10,12-13,15,18,21H,3-8H2,1-2H3,(H2,20,22,23)/t12-,13+,15-,18-,19-/m0/s1 D04GDW DRUGINKE AOEHUXLJSHGXHN-SSTWWWIQSA-N D04GDW DRUGSMIL CC12CCC3C(C1CCC2OS(=O)(=O)N)CCC4=CC(=C(C=C34)OC)O D04GDW HIGHSTAT Investigative D04GDY DRUG__ID D04GDY D04GDY DRUGTYPE Small molecular drug D04GDY DRUGINCH 1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h9,12-13,16-17,22H,5-8,10-11H2,1-4H3/t16-,17-/m1/s1 D04GDY DRUGINKE HCAWPGARWVBULJ-IAGOWNOFSA-N D04GDY DRUGSMIL CCCCCC1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)C)O D04GDY HIGHSTAT Investigative D04GFX DRUG__ID D04GFX D04GFX DRUGTYPE Small molecular drug D04GFX DRUGINCH 1S/C15H9ClO2/c16-13-14(17)11-8-4-5-9-12(11)18-15(13)10-6-2-1-3-7-10/h1-9H D04GFX DRUGINKE FHXDSQYFCFWKAW-UHFFFAOYSA-N D04GFX DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)Cl D04GFX HIGHSTAT Investigative D04GGK DRUG__ID D04GGK D04GGK DRUGTYPE Small molecular drug D04GGK DRUGINCH 1S/C32H61N2O6P/c1-5-7-8-9-10-11-12-13-14-15-16-17-18-20-27-37-29-32(38-6-2)30-40-41(35,36)39-28-21-19-24-34-25-22-31(23-26-34)33(3)4/h22-23,25-26,32H,5-21,24,27-30H2,1-4H3 D04GGK DRUGINKE ZVLFCHBGXDQHSD-UHFFFAOYSA-N D04GGK DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCCCC[N+]1=CC=C(C=C1)N(C)C)OCC D04GGK HIGHSTAT Investigative D04GGW DRUG__ID D04GGW D04GGW DRUGTYPE Small molecular drug D04GGW DRUGINCH 1S/C13H19N3O3/c17-12(15-11-7-9-14-10-8-11)5-3-1-2-4-6-13(18)16-19/h7-10,19H,1-6H2,(H,16,18)(H,14,15,17) D04GGW DRUGINKE RJMOPRKLNDSPIG-UHFFFAOYSA-N D04GGW DRUGSMIL C1=CN=CC=C1NC(=O)CCCCCCC(=O)NO D04GGW HIGHSTAT Investigative D04GHK DRUG__ID D04GHK D04GHK DRUGTYPE Small molecular drug D04GHK DRUGINCH 1S/C11H17NOS/c1-3-10(12-13)8-9-4-6-11(14-2)7-5-9/h4-7,10,12-13H,3,8H2,1-2H3 D04GHK DRUGINKE HJFQUPKLSAEIPC-UHFFFAOYSA-N D04GHK DRUGSMIL CCC(CC1=CC=C(C=C1)SC)NO D04GHK HIGHSTAT Investigative D04GOO DRUG__ID D04GOO D04GOO DRUGTYPE Small molecular drug D04GOO DRUGINCH 1S/C24H24N2O4/c1-29-21-10-3-6-17(12-21)15-25-23(27)19-8-5-9-20(14-19)24(28)26-16-18-7-4-11-22(13-18)30-2/h3-14H,15-16H2,1-2H3,(H,25,27)(H,26,28) D04GOO DRUGINKE XDBOLPFDJWTESQ-UHFFFAOYSA-N D04GOO DRUGSMIL COC1=CC=CC(=C1)CNC(=O)C2=CC(=CC=C2)C(=O)NCC3=CC(=CC=C3)OC D04GOO HIGHSTAT Investigative D04GPT DRUG__ID D04GPT D04GPT DRUGTYPE Small molecular drug D04GPT DRUGINCH 1S/C15H13ClN2O2/c1-10(19)17-13-6-3-7-14(9-13)18-15(20)11-4-2-5-12(16)8-11/h2-9H,1H3,(H,17,19)(H,18,20) D04GPT DRUGINKE XZMOBKLRYXTSSS-UHFFFAOYSA-N D04GPT DRUGSMIL CC(=O)NC1=CC(=CC=C1)NC(=O)C2=CC(=CC=C2)Cl D04GPT HIGHSTAT Investigative D04GRS DRUG__ID D04GRS D04GRS DRUGTYPE Small molecular drug D04GRS DRUGINCH 1S/C19H19NO4/c1-20-6-5-11-8-14-19(24-9-23-14)17-15(11)12(20)7-10-3-4-13(22-2)18(21)16(10)17/h3-4,8,12,21H,5-7,9H2,1-2H3/t12-/m0/s1 D04GRS DRUGINKE LODGIKWNLDQZBM-LBPRGKRZSA-N D04GRS DRUGSMIL CN1CCC2=CC3=C(C4=C2C1CC5=C4C(=C(C=C5)OC)O)OCO3 D04GRS HIGHSTAT Investigative D04GSN DRUG__ID D04GSN D04GSN DRUGTYPE Small molecular drug D04GSN DRUGINCH 1S/C40H50O14/c1-25(15-12-20-28-16-6-4-7-17-28)14-10-11-22-31(42)52-33-32(43)38(53-34(35(44)45)39(50,36(46)47)40(33,54-38)37(48)49)23-13-21-30(51-27(3)41)26(2)24-29-18-8-5-9-19-29/h4-10,14,16-19,25-26,30,32-34,43,50H,11-13,15,20-24H2,1-3H3,(H,44,45)(H,46,47)(H,48,49)/b14-10+/t25-,26+,30+,32+,33+,34+,38-,39+,40-/m0/s1 D04GSN DRUGINKE KQMNJFMTGHRJHM-ZFSXNWTMSA-N D04GSN DRUGSMIL CC(CCCC1=CC=CC=C1)C=CCCC(=O)OC2C(C3(OC(C(C2(O3)C(=O)O)(C(=O)O)O)C(=O)O)CCCC(C(C)CC4=CC=CC=C4)OC(=O)C)O D04GSN HIGHSTAT Investigative D04GTP DRUG__ID D04GTP D04GTP DRUGTYPE Small molecular drug D04GTP DRUGINCH 1S/C22H27N3O3.ClH/c1-5-15-8-6-7-9-18(15)23-21(26)28-16-10-11-19-17(14-16)22(2)12-13-25(4,27)20(22)24(19)3;/h6-11,14,20H,5,12-13H2,1-4H3,(H,23,26);1H/t20-,22-,25?;/m0./s1 D04GTP DRUGINKE GPQRGFUTRVNTHA-QFPJJMDASA-N D04GTP DRUGSMIL CCC1=CC=CC=C1NC(=O)OC2=CC3=C(C=C2)N(C4C3(CC[N+]4(C)[O-])C)C.Cl D04GTP HIGHSTAT Investigative D04GVX DRUG__ID D04GVX D04GVX DRUGTYPE Small molecular drug D04GVX DRUGINCH 1S/C11H9BrN2/c12-7-1-2-10-9(5-7)8-3-4-13-6-11(8)14-10/h1-2,5-6,14H,3-4H2 D04GVX DRUGINKE PAHAIWFYCZHWKN-UHFFFAOYSA-N D04GVX DRUGSMIL C1CN=CC2=C1C3=C(N2)C=CC(=C3)Br D04GVX HIGHSTAT Investigative D04GWD DRUG__ID D04GWD D04GWD DRUGTYPE Small molecular drug D04GWD DRUGINCH 1S/C21H23N3O/c22-14-19-20(10-13-24(21(19)25)15-16-6-7-16)23-11-8-18(9-12-23)17-4-2-1-3-5-17/h1-5,10,13,16,18H,6-9,11-12,15H2 D04GWD DRUGINKE RVRHQHDKALSKLY-UHFFFAOYSA-N D04GWD DRUGSMIL C1CC1CN2C=CC(=C(C2=O)C#N)N3CCC(CC3)C4=CC=CC=C4 D04GWD HIGHSTAT Investigative D04GWR DRUG__ID D04GWR D04GWR DRUGTYPE Small molecular drug D04GWR DRUGINCH 1S/C16H15N7S2/c17-14(18)23-16-22-12(8-24-16)13-6-5-9(25-13)7-19-15-20-10-3-1-2-4-11(10)21-15/h1-6,8H,7H2,(H2,19,20,21)(H4,17,18,22,23) D04GWR DRUGINKE CKJGKHXCUDWFDC-UHFFFAOYSA-N D04GWR DRUGSMIL C1=CC=C2C(=C1)NC(=N2)NCC3=CC=C(S3)C4=CSC(=N4)N=C(N)N D04GWR HIGHSTAT Investigative D04GXW DRUG__ID D04GXW D04GXW DRUGTYPE Small molecular drug D04GXW DRUGINCH 1S/C9H12IN2O8P/c10-4-2-12(9(15)11-8(4)14)7-1-5(13)6(20-7)3-19-21(16,17)18/h2,5-7,13H,1,3H2,(H,11,14,15)(H2,16,17,18)/t5-,6+,7+/m0/s1 D04GXW DRUGINKE WXFYBFRZROJDLL-RRKCRQDMSA-N D04GXW DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)I)COP(=O)(O)O)O D04GXW HIGHSTAT Investigative D04GYD DRUG__ID D04GYD D04GYD DRUGTYPE Small molecular drug D04GYD DRUGINCH 1S/C22H16O3/c23-17-11-12-18-19(24)14-21(25-20(18)13-17)22(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1-14,22-23H D04GYD DRUGINKE VVMXRAGTHNZYRJ-UHFFFAOYSA-N D04GYD DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=CC(=O)C4=C(O3)C=C(C=C4)O D04GYD HIGHSTAT Investigative D04GYT DRUG__ID D04GYT D04GYT DRUGTYPE Small molecular drug D04GYT DRUGINCH 1S/C33H33N3O4/c1-39-30-20-25-17-19-36(22-26(25)21-31(30)40-2)18-16-23-12-14-27(15-13-23)34-33(38)28-10-6-7-11-29(28)35-32(37)24-8-4-3-5-9-24/h3-15,20-21H,16-19,22H2,1-2H3,(H,34,38)(H,35,37) D04GYT DRUGINKE AEXVPZYELNSRFS-UHFFFAOYSA-N D04GYT DRUGSMIL COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4NC(=O)C5=CC=CC=C5)OC D04GYT HIGHSTAT Investigative D04GZD DRUG__ID D04GZD D04GZD DRUGTYPE Small molecular drug D04GZD DRUGINCH 1S/C21H16O4/c22-20(23)14-15-6-8-16(9-7-15)21(24)17-10-12-19(13-11-17)25-18-4-2-1-3-5-18/h1-13H,14H2,(H,22,23) D04GZD DRUGINKE VRBHQDUOTOPSLA-UHFFFAOYSA-N D04GZD DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)CC(=O)O D04GZD HIGHSTAT Investigative D04HDO DRUG__ID D04HDO D04HDO DRUGTYPE Small molecular drug D04HDO DRUGINCH 1S/C22H18N2O/c25-22-19-13-7-8-14-20(19)23-21(18-11-5-2-6-12-18)24(22)16-15-17-9-3-1-4-10-17/h1-14H,15-16H2 D04HDO DRUGINKE KANHEDFPOIQKTH-UHFFFAOYSA-N D04HDO DRUGSMIL C1=CC=C(C=C1)CCN2C(=NC3=CC=CC=C3C2=O)C4=CC=CC=C4 D04HDO HIGHSTAT Investigative D04HFC DRUG__ID D04HFC D04HFC DRUGTYPE Small molecular drug D04HFC DRUGINCH 1S/C22H23NO3/c1-25-14-5-6-15-16-8-13-4-3-7-23(13)12-20(16)19-11-22(26-2)21(24)10-18(19)17(15)9-14/h5-6,9-11,13,24H,3-4,7-8,12H2,1-2H3/t13-/m1/s1 D04HFC DRUGINKE DACRWRGHESRUQW-CYBMUJFWSA-N D04HFC DRUGSMIL COC1=CC2=C(C=C1)C3=C(CN4CCCC4C3)C5=CC(=C(C=C52)O)OC D04HFC HIGHSTAT Investigative D04HGN DRUG__ID D04HGN D04HGN DRUGTYPE Small molecular drug D04HGN DRUGINCH 1S/C19H12Cl2F3N5O2S/c20-13-2-1-3-14(21)17(13)30-8-15-26-16(31-28-15)9-32-18-27-25-10-29(18)12-6-4-11(5-7-12)19(22,23)24/h1-7,10H,8-9H2 D04HGN DRUGINKE UUZRVUXGULNUHU-UHFFFAOYSA-N D04HGN DRUGSMIL C1=CC(=C(C(=C1)Cl)OCC2=NOC(=N2)CSC3=NN=CN3C4=CC=C(C=C4)C(F)(F)F)Cl D04HGN HIGHSTAT Investigative D04HHR DRUG__ID D04HHR D04HHR DRUGTYPE Small molecular drug D04HHR DRUGINCH 1S/C17H24ClN3O2/c1-10-3-2-4-12-7-11(5-6-21(10)12)20-17(23)13-8-14(18)15(19)9-16(13)22/h8-12,22H,2-7,19H2,1H3,(H,20,23)/t10-,11+,12-/m1/s1 D04HHR DRUGINKE SQQXDSFKORQHET-GRYCIOLGSA-N D04HHR DRUGSMIL CC1CCCC2N1CCC(C2)NC(=O)C3=CC(=C(C=C3O)N)Cl D04HHR HIGHSTAT Investigative D04HMD DRUG__ID D04HMD D04HMD DRUGTYPE Small molecular drug D04HMD DRUGINCH 1S/C3H8NO5P/c5-3(6)1-4-2-10(7,8)9/h4H,1-2H2,(H,5,6)(H2,7,8,9) D04HMD DRUGINKE XDDAORKBJWWYJS-UHFFFAOYSA-N D04HMD DRUGSMIL C(C(=O)O)NCP(=O)(O)O D04HMD HIGHSTAT Investigative D04HNO DRUG__ID D04HNO D04HNO DRUGTYPE Small molecular drug D04HNO DRUGINCH 1S/C13H12N2O7S2/c14-23(17,18)21-11-5-1-3-9(7-11)13(16)10-4-2-6-12(8-10)22-24(15,19)20/h1-8H,(H2,14,17,18)(H2,15,19,20) D04HNO DRUGINKE YKEGOWCJKMPGLE-UHFFFAOYSA-N D04HNO DRUGSMIL C1=CC(=CC(=C1)OS(=O)(=O)N)C(=O)C2=CC(=CC=C2)OS(=O)(=O)N D04HNO HIGHSTAT Investigative D04HPX DRUG__ID D04HPX D04HPX DRUGTYPE Small molecular drug D04HPX DRUGINCH 1S/C22H25NO3/c1-4-9-23-10-8-16-11-17(25-3)13-18-21(16)19(23)12-15-6-5-7-20(22(15)18)26-14(2)24/h5-7,11,13,19H,4,8-10,12H2,1-3H3/t19-/m1/s1 D04HPX DRUGINKE ICIICPHBNXIOKJ-LJQANCHMSA-N D04HPX DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=CC=C4)OC(=O)C D04HPX HIGHSTAT Investigative D04HQK DRUG__ID D04HQK D04HQK DRUGTYPE Small molecular drug D04HQK DRUGINCH 1S/C9H8N4O3S2/c10-18(15,16)9-13-12-8(17-9)11-7(14)6-4-2-1-3-5-6/h1-5H,(H2,10,15,16)(H,11,12,14) D04HQK DRUGINKE PMNNJWNEWDGYIV-UHFFFAOYSA-N D04HQK DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NN=C(S2)S(=O)(=O)N D04HQK HIGHSTAT Investigative D04HQL DRUG__ID D04HQL D04HQL DRUGTYPE Small molecular drug D04HQL DRUGINCH 1S/C24H42N4O8/c1-13(2)19(24(35)36)27-21(32)14(3)26-23(34)20(15(4)29)28-22(33)17(10-11-18(30)31)25-12-16-8-6-5-7-9-16/h13-17,19-20,25,29H,5-12H2,1-4H3,(H,26,34)(H,27,32)(H,28,33)(H,30,31)(H,35,36)/t14-,15?,17-,19-,20-/m0/s1 D04HQL DRUGINKE NRBYXUOJAWZKTA-VFWSWVEUSA-N D04HQL DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCC1CCCCC1 D04HQL HIGHSTAT Investigative D04HQP DRUG__ID D04HQP D04HQP DRUGTYPE Small molecular drug D04HQP DRUGINCH 1S/C11H14N2/c1-13(2)9-4-3-6-11-7-5-8-12-10-11/h5,7-8,10H,4,9H2,1-2H3 D04HQP DRUGINKE SGURIVLPISZAAK-UHFFFAOYSA-N D04HQP DRUGSMIL CN(C)CCC#CC1=CN=CC=C1 D04HQP HIGHSTAT Investigative D04HRS DRUG__ID D04HRS D04HRS DRUGTYPE Small molecular drug D04HRS DRUGINCH 1S/C12H11N3O3S/c13-19(17,18)12-7-3-10(4-8-12)15-14-9-1-5-11(16)6-2-9/h1-8,16H,(H2,13,17,18) D04HRS DRUGINKE IPPFWRRJWLCWGK-UHFFFAOYSA-N D04HRS DRUGSMIL C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)N)O D04HRS HIGHSTAT Investigative D04HSS DRUG__ID D04HSS D04HSS DRUGTYPE Small molecular drug D04HSS DRUGINCH 1S/C13H19NOS/c15-13(12-8-4-3-5-9-12)14-10-6-1-2-7-11-16/h3-5,8-9,16H,1-2,6-7,10-11H2,(H,14,15) D04HSS DRUGINKE HCPPYAZFTICCOW-UHFFFAOYSA-N D04HSS DRUGSMIL C1=CC=C(C=C1)C(=O)NCCCCCCS D04HSS HIGHSTAT Investigative D04HVL DRUG__ID D04HVL D04HVL DRUGTYPE Small molecular drug D04HVL DRUGINCH 1S/C17H21NO3/c1-19-15-10-13(11-16(20-2)17(15)21-3)5-4-12-6-8-14(18)9-7-12/h6-11H,4-5,18H2,1-3H3 D04HVL DRUGINKE BPIQFCQFIYIISU-UHFFFAOYSA-N D04HVL DRUGSMIL COC1=CC(=CC(=C1OC)OC)CCC2=CC=C(C=C2)N D04HVL HIGHSTAT Investigative D04HWF DRUG__ID D04HWF D04HWF DRUGTYPE Small molecular drug D04HWF DRUGINCH 1S/C27H30ClFN4O3/c1-16-13-33(17(2)12-32(16)14-18-6-8-19(29)9-7-18)26(35)21-10-20-22(25(34)27(36)30(3)4)15-31(5)24(20)11-23(21)28/h6-11,15-17H,12-14H2,1-5H3/t16-,17+/m0/s1 D04HWF DRUGINKE ZMELOYOKMZBMRB-DLBZAZTESA-N D04HWF DRUGSMIL CC1CN(C(CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F D04HWF HIGHSTAT Investigative D04HWJ DRUG__ID D04HWJ D04HWJ DRUGTYPE Small molecular drug D04HWJ DRUGINCH 1S/C12H27O3P/c1-3-4-5-6-7-8-9-10-11-12-16(13,14)15-2/h3-12H2,1-2H3,(H,13,14) D04HWJ DRUGINKE JBVUSHKPEBKWQP-UHFFFAOYSA-N D04HWJ DRUGSMIL CCCCCCCCCCCP(=O)(O)OC D04HWJ HIGHSTAT Investigative D04HXF DRUG__ID D04HXF D04HXF DRUGTYPE Small molecular drug D04HXF DRUGINCH 1S/C16H25NO3/c1-13(2)15-5-3-4-6-16(15)20-12-14(18)11-17-7-9-19-10-8-17/h3-6,13-14,18H,7-12H2,1-2H3 D04HXF DRUGINKE OFEYQVJHAZFCJS-UHFFFAOYSA-N D04HXF DRUGSMIL CC(C)C1=CC=CC=C1OCC(CN2CCOCC2)O D04HXF HIGHSTAT Investigative D04HXU DRUG__ID D04HXU D04HXU DRUGTYPE Small molecular drug D04HXU DRUGINCH 1S/C11H15N3O7/c12-8-13-6-2-4-9(17,1-15)5-3(16)10(2,14-8)7(19-6)11(18,20-4)21-5/h2-7,15-18H,1H2,(H3,12,13,14)/p+1 D04HXU DRUGINKE STNXQECXKDMLJK-UHFFFAOYSA-O D04HXU DRUGSMIL C(C1(C2C3C4[NH+]=C(NC35C(C1OC(C5O4)(O2)O)O)N)O)O D04HXU HIGHSTAT Investigative D04HZA DRUG__ID D04HZA D04HZA DRUGTYPE Small molecular drug D04HZA DRUGINCH 1S/C18H12BrNO3/c19-14-8-7-11-9-13(6-5-12(11)10-14)17(21)20-16-4-2-1-3-15(16)18(22)23/h1-10H,(H,20,21)(H,22,23) D04HZA DRUGINKE KNVPXLPBRSRJCV-UHFFFAOYSA-N D04HZA DRUGSMIL C1=CC=C(C(=C1)C(=O)O)NC(=O)C2=CC3=C(C=C2)C=C(C=C3)Br D04HZA HIGHSTAT Investigative D04HZW DRUG__ID D04HZW D04HZW DRUGTYPE Small molecular drug D04HZW DRUGINCH 1S/C10H6N2O3S/c11-12-8-5-1-3-7-4-2-6-9(10(7)8)16(13,14)15/h1-6H D04HZW DRUGINKE FBINSYHNLCGKLZ-UHFFFAOYSA-N D04HZW DRUGSMIL C1=CC2=C(C(=C1)[N+]#N)C(=CC=C2)S(=O)(=O)[O-] D04HZW HIGHSTAT Investigative D04IBH DRUG__ID D04IBH D04IBH DRUGTYPE Small molecular drug D04IBH DRUGINCH 1S/C16H12BrNO/c1-19-15-7-5-12-9-11(4-6-14(12)16(15)17)13-3-2-8-18-10-13/h2-10H,1H3 D04IBH DRUGINKE ZVOWEWSHEFYCIY-UHFFFAOYSA-N D04IBH DRUGSMIL COC1=C(C2=C(C=C1)C=C(C=C2)C3=CN=CC=C3)Br D04IBH HIGHSTAT Investigative D04ICJ DRUG__ID D04ICJ D04ICJ DRUGTYPE Small molecular drug D04ICJ DRUGINCH 1S/C24H31N3O/c28-24(25-22-14-8-3-9-15-22)27-18-16-26(17-19-27)23(20-10-4-1-5-11-20)21-12-6-2-7-13-21/h1-2,4-7,10-13,22-23H,3,8-9,14-19H2,(H,25,28) D04ICJ DRUGINKE IRRGBCHOFRYUCB-UHFFFAOYSA-N D04ICJ DRUGSMIL C1CCC(CC1)NC(=O)N2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4 D04ICJ HIGHSTAT Investigative D04ICS DRUG__ID D04ICS D04ICS DRUGTYPE Small molecular drug D04ICS DRUGINCH 1S/C24H47NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(27)18(25)17-31-24-23(30)22(29)21(28)20(16-26)32-24/h14-15,18-24,26-30H,2-13,16-17,25H2,1H3/b15-14+/t18-,19+,20+,21-,22-,23+,24+/m0/s1 D04ICS DRUGINKE HHJTWTPUPVQKNA-PIIMIWFASA-N D04ICS DRUGSMIL CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)N)O D04ICS HIGHSTAT Investigative D04IEW DRUG__ID D04IEW D04IEW DRUGTYPE Small molecular drug D04IEW DRUGINCH 1S/C20H24O9/c1-7-12(22)26-10-6-17-9-5-8(16(2,3)4)18(17)11(21)13(23)28-15(18)29-20(17,14(24)27-9)19(7,10)25/h7-11,15,21,25H,5-6H2,1-4H3/t7-,8+,9-,10+,11+,15+,17-,18+,19-,20-/m1/s1 D04IEW DRUGINKE FPUXKXIZEIDQKW-VKMVSBOZSA-N D04IEW DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2)C6(C(C5)C(C)(C)C)C(C(=O)OC6O4)O)O D04IEW HIGHSTAT Investigative D04IFV DRUG__ID D04IFV D04IFV DRUGTYPE Small molecular drug D04IFV DRUGINCH 1S/C11H11NOS/c1-7-3-5-9(6-4-7)11-12-10(13)8(2)14-11/h3-6,13H,1-2H3 D04IFV DRUGINKE CKXYNXQZWQQOOO-UHFFFAOYSA-N D04IFV DRUGSMIL CC1=CC=C(C=C1)C2=NC(=C(S2)C)O D04IFV HIGHSTAT Investigative D04IHL DRUG__ID D04IHL D04IHL DRUGTYPE Small molecular drug D04IHL DRUGINCH 1S/C29H37N5O5/c1-32(25(18-19-7-3-2-4-8-19)29(39)33-15-5-9-23(33)26(31)36)28(38)24-10-6-16-34(24)27(37)22(30)17-20-11-13-21(35)14-12-20/h2-4,7-8,11-14,22-25,35H,5-6,9-10,15-18,30H2,1H3,(H2,31,36)/t22?,23-,24?,25-/m1/s1 D04IHL DRUGINKE JAKBYSTWCHUQOK-RULIFZQXSA-N D04IHL DRUGSMIL CN(C(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)N)C(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D04IHL HIGHSTAT Investigative D04IIB DRUG__ID D04IIB D04IIB DRUGTYPE Small molecular drug D04IIB DRUGINCH 1S/C32H36N4O6/c1-19-12-24(37)13-20(2)25(19)15-26(33)32(42)36-18-23-11-7-6-10-22(23)14-28(36)31(41)35-27(16-29(38)39)30(40)34-17-21-8-4-3-5-9-21/h3-13,26-28,37H,14-18,33H2,1-2H3,(H,34,40)(H,35,41)(H,38,39)/t26-,27-,28-/m0/s1 D04IIB DRUGINKE RBFLTKCFTXQSNZ-KCHLEUMXSA-N D04IIB DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)NCC4=CC=CC=C4)N)C)O D04IIB HIGHSTAT Investigative D04IIK DRUG__ID D04IIK D04IIK DRUGTYPE Small molecular drug D04IIK DRUGINCH 1S/C19H21NO2/c1-3-20-8-7-13-9-14(22-2)11-15-18(13)16(20)10-12-5-4-6-17(21)19(12)15/h4-6,9,11,16,21H,3,7-8,10H2,1-2H3 D04IIK DRUGINKE OQCBYARNXRSEMX-UHFFFAOYSA-N D04IIK DRUGSMIL CCN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=CC=C4)O D04IIK HIGHSTAT Investigative D04IJB DRUG__ID D04IJB D04IJB DRUGTYPE Small molecular drug D04IJB DRUGINCH 1S/C37H39IO9/c1-20(2)35-16-22(4)37-26(33(35)45-36(46-35,47-37)18-23-9-7-6-8-10-23)12-25(17-34(42)29(37)11-21(3)32(34)41)19-44-30(39)15-24-13-27(38)31(40)28(14-24)43-5/h6-14,22,26,29,33,40,42H,1,15-19H2,2-5H3/t22-,26+,29-,33-,34-,35-,36-,37-/m1/s1/i38-2 D04IJB DRUGINKE TZUJORCXGLGWDV-FOFZJNPASA-N D04IJB DRUGSMIL CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C(=C6)I)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C D04IJB HIGHSTAT Investigative D04IJE DRUG__ID D04IJE D04IJE DRUGTYPE Small molecular drug D04IJE DRUGINCH 1S/C19H13N/c1-3-7-17-15(5-1)16-6-2-4-8-18(16)19(17)13-14-9-11-20-12-10-14/h1-13H D04IJE DRUGINKE YVNXZDHQCSSQMR-UHFFFAOYSA-N D04IJE DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3C2=CC4=CC=NC=C4 D04IJE HIGHSTAT Investigative D04IKS DRUG__ID D04IKS D04IKS DRUGTYPE Small molecular drug D04IKS DRUGINCH 1S/C16H14N2O/c1-11-6-7-13-10-17-15(9-16(13)18-11)12-4-3-5-14(8-12)19-2/h3-10H,1-2H3 D04IKS DRUGINKE FNFGNQRSMXJCIJ-UHFFFAOYSA-N D04IKS DRUGSMIL CC1=NC2=CC(=NC=C2C=C1)C3=CC(=CC=C3)OC D04IKS HIGHSTAT Investigative D04ILS DRUG__ID D04ILS D04ILS DRUGTYPE Small molecular drug D04ILS DRUGINCH 1S/C13H8Cl2N2O/c14-11-3-1-2-9(4-11)8-18-13-6-10(7-16)5-12(15)17-13/h1-6H,8H2 D04ILS DRUGINKE MGYAMTJNJZZLMV-UHFFFAOYSA-N D04ILS DRUGSMIL C1=CC(=CC(=C1)Cl)COC2=NC(=CC(=C2)C#N)Cl D04ILS HIGHSTAT Investigative D04IMY DRUG__ID D04IMY D04IMY DRUGTYPE Small molecular drug D04IMY DRUGINCH 1S/C17H13N3O3/c21-16-13(8-11-6-7-14-15(9-11)23-10-22-14)19-17(20-16)18-12-4-2-1-3-5-12/h1-9H,10H2,(H2,18,19,20,21)/b13-8- D04IMY DRUGINKE PGPHHJBZEGSUNE-JYRVWZFOSA-N D04IMY DRUGSMIL C1OC2=C(O1)C=C(C=C2)C=C3C(=O)NC(=N3)NC4=CC=CC=C4 D04IMY HIGHSTAT Investigative D04IRR DRUG__ID D04IRR D04IRR DRUGTYPE Small molecular drug D04IRR DRUGINCH 1S/C35H42N8O15/c36-35-42-28-27(30(50)43-35)18(15-37-28)6-3-16-1-4-17(5-2-16)29(49)41-22(34(57)58)9-13-25(46)39-20(32(53)54)7-11-23(44)38-19(31(51)52)8-12-24(45)40-21(33(55)56)10-14-26(47)48/h1-2,4-5,15,19-22H,3,6-14H2,(H,38,44)(H,39,46)(H,40,45)(H,41,49)(H,47,48)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H4,36,37,42,43,50)/t19-,20-,21?,22-/m0/s1 D04IRR DRUGINKE DICHBVJYDUDAIQ-QEGIFBSNSA-N D04IRR DRUGSMIL C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O D04IRR HIGHSTAT Investigative D04ISG DRUG__ID D04ISG D04ISG DRUGTYPE Small molecular drug D04ISG DRUGINCH 1S/C16H12ClNO/c1-19-13-6-4-11-5-7-14(16(17)15(11)9-13)12-3-2-8-18-10-12/h2-10H,1H3 D04ISG DRUGINKE KRLGQBXIHBDUPS-UHFFFAOYSA-N D04ISG DRUGSMIL COC1=CC2=C(C=C1)C=CC(=C2Cl)C3=CN=CC=C3 D04ISG HIGHSTAT Investigative D04IWB DRUG__ID D04IWB D04IWB DRUGTYPE Small molecular drug D04IWB DRUGINCH 1S/C9H15N2O14P3S/c12-5-1-2-11(9(29)10-5)8-7(14)6(13)4(23-8)3-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,4,6-8,13-14H,3H2,(H,18,19)(H,20,21)(H,10,12,29)(H2,15,16,17)/t4-,6-,7-,8-/m1/s1 D04IWB DRUGINKE KHYOUGAATNYCAZ-XVFCMESISA-N D04IWB DRUGSMIL C1=CN(C(=S)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D04IWB HIGHSTAT Investigative D04IXN DRUG__ID D04IXN D04IXN DRUGTYPE Small molecular drug D04IXN DRUGINCH 1S/C19H12ClNO2S/c20-13-9-11-14(12-10-13)23-19(22)21-15-5-1-3-7-17(15)24-18-8-4-2-6-16(18)21/h1-12H D04IXN DRUGINKE OTLLKYSWTVZPOJ-UHFFFAOYSA-N D04IXN DRUGSMIL C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)OC4=CC=C(C=C4)Cl D04IXN HIGHSTAT Investigative D04IZU DRUG__ID D04IZU D04IZU DRUGTYPE Small molecular drug D04IZU DRUGINCH 1S/C16H16N2O/c1-18(2)12-14-5-3-4-6-16(14)19-15-9-7-13(11-17)8-10-15/h3-10H,12H2,1-2H3 D04IZU DRUGINKE RQDOQYXVLGVVBA-UHFFFAOYSA-N D04IZU DRUGSMIL CN(C)CC1=CC=CC=C1OC2=CC=C(C=C2)C#N D04IZU HIGHSTAT Investigative D04JAX DRUG__ID D04JAX D04JAX DRUGTYPE Small molecular drug D04JAX DRUGINCH 1S/C21H22N2O2/c1-15-7-8-20-17(13-15)19(14-21(24)25-20)23-11-9-22(10-12-23)18-6-4-3-5-16(18)2/h3-8,13-14H,9-12H2,1-2H3 D04JAX DRUGINKE WISLSRMHRCKWLA-UHFFFAOYSA-N D04JAX DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C=C2N3CCN(CC3)C4=CC=CC=C4C D04JAX HIGHSTAT Investigative D04JCJ DRUG__ID D04JCJ D04JCJ DRUGTYPE Small molecular drug D04JCJ DRUGINCH 1S/C21H21N3O2/c22-21(25)19-7-4-8-20(24-19)26-18-11-9-16(10-12-18)13-14-23-15-17-5-2-1-3-6-17/h1-12,23H,13-15H2,(H2,22,25) D04JCJ DRUGINKE JKDWSAGAQLISRL-UHFFFAOYSA-N D04JCJ DRUGSMIL C1=CC=C(C=C1)CNCCC2=CC=C(C=C2)OC3=CC=CC(=N3)C(=O)N D04JCJ HIGHSTAT Investigative D04JCK DRUG__ID D04JCK D04JCK DRUGTYPE Small molecular drug D04JCK DRUGINCH 1S/C25H33NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,9-10,17-18,21,27-28H,5,8,11-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1 D04JCK DRUGINKE CAHCBJPUTCKATP-FAWZKKEFSA-N D04JCK DRUGSMIL CCCC(C)(C1CC23C=CC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)C)OC)O D04JCK HIGHSTAT Investigative D04JCW DRUG__ID D04JCW D04JCW DRUGTYPE Small molecular drug D04JCW DRUGINCH 1S/C19H25NO6/c1-2-3-9-16(21)25-14-11-23-18-15(12-24-17(14)18)26-19(22)20-10-13-7-5-4-6-8-13/h4-8,14-15,17-18H,2-3,9-12H2,1H3,(H,20,22)/t14-,15+,17-,18-/m1/s1 D04JCW DRUGINKE CFMVNQSTYPRCII-CYGHRXIMSA-N D04JCW DRUGSMIL CCCCC(=O)OC1COC2C1OCC2OC(=O)NCC3=CC=CC=C3 D04JCW HIGHSTAT Investigative D04JDQ DRUG__ID D04JDQ D04JDQ DRUGTYPE Small molecular drug D04JDQ DRUGINCH 1S/C17H15N5O/c18-17-20-14(13-7-4-10-23-13)15-16(21-17)22(11-19-15)9-8-12-5-2-1-3-6-12/h1-7,10-11H,8-9H2,(H2,18,20,21) D04JDQ DRUGINKE LOCNLYLIABVQFH-UHFFFAOYSA-N D04JDQ DRUGSMIL C1=CC=C(C=C1)CCN2C=NC3=C(N=C(N=C32)N)C4=CC=CO4 D04JDQ HIGHSTAT Investigative D04JFL DRUG__ID D04JFL D04JFL DRUGTYPE Small molecular drug D04JFL DRUGINCH 1S/C20H25NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,14-15,18,22-24H,1-2,5-10H2/t14-,15+,18-,19-,20+/m0/s1 D04JFL DRUGINKE JLVNEHKORQFVQJ-SBCNTATESA-N D04JFL DRUGSMIL C1CC1CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O D04JFL HIGHSTAT Investigative D04JGC DRUG__ID D04JGC D04JGC DRUGTYPE Small molecular drug D04JGC DRUGINCH 1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3/t11-,17+/m1/s1 D04JGC DRUGINKE LSLYOANBFKQKPT-DIFFPNOSSA-N D04JGC DRUGSMIL CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O D04JGC HIGHSTAT Investigative D04JGZ DRUG__ID D04JGZ D04JGZ DRUGTYPE Small molecular drug D04JGZ DRUGINCH 1S/C21H19NO3/c23-19-15-20(22-11-13-24-14-12-22)25-21-17(7-4-8-18(19)21)10-9-16-5-2-1-3-6-16/h1-10,15H,11-14H2/b10-9+ D04JGZ DRUGINKE OLQGOHPEAUHNBE-MDZDMXLPSA-N D04JGZ DRUGSMIL C1COCCN1C2=CC(=O)C3=CC=CC(=C3O2)C=CC4=CC=CC=C4 D04JGZ HIGHSTAT Investigative D04JIN DRUG__ID D04JIN D04JIN DRUGTYPE Small molecular drug D04JIN DRUGINCH 1S/C7H6BrF2NO2S/c8-6-4-2-1-3-5(6)7(9,10)14(11,12)13/h1-4H,(H2,11,12,13) D04JIN DRUGINKE QUUHLCHEVDHKEL-UHFFFAOYSA-N D04JIN DRUGSMIL C1=CC=C(C(=C1)C(F)(F)S(=O)(=O)N)Br D04JIN HIGHSTAT Investigative D04JIR DRUG__ID D04JIR D04JIR DRUGTYPE Small molecular drug D04JIR DRUGINCH 1S/C6H7N5/c1-11-3-10-4-5(7)8-2-9-6(4)11/h2-3H,1H3,(H2,7,8,9) D04JIR DRUGINKE WRXCXOUDSPTXNX-UHFFFAOYSA-N D04JIR DRUGSMIL CN1C=NC2=C(N=CN=C21)N D04JIR HIGHSTAT Investigative D04JJL DRUG__ID D04JJL D04JJL DRUGTYPE Small molecular drug D04JJL DRUGINCH 1S/C17H21N3/c1-3-13-5-9-15(10-6-13)19-17(18)20-16-11-7-14(4-2)8-12-16/h5-12H,3-4H2,1-2H3,(H3,18,19,20) D04JJL DRUGINKE DXGARAMIKHFTJV-UHFFFAOYSA-N D04JJL DRUGSMIL CCC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)CC)N D04JJL HIGHSTAT Investigative D04JKL DRUG__ID D04JKL D04JKL DRUGTYPE Small molecular drug D04JKL DRUGINCH 1S/C11H11NO4/c12-11(10(15)16)4-3-6-5-7(9(13)14)1-2-8(6)11/h1-2,5H,3-4,12H2,(H,13,14)(H,15,16) D04JKL DRUGINKE LSTPKMWNRWCNLS-UHFFFAOYSA-N D04JKL DRUGSMIL C1CC(C2=C1C=C(C=C2)C(=O)O)(C(=O)O)N D04JKL HIGHSTAT Investigative D04JNZ DRUG__ID D04JNZ D04JNZ DRUGTYPE Small molecular drug D04JNZ DRUGINCH 1S/C22H30O6/c1-11-6-16-20(26,18(11)25)9-14(10-23)7-15-17-19(4,5)21(17,28-13(3)24)8-12(2)22(15,16)27/h6-7,12,15-17,23,26-27H,8-10H2,1-5H3/t12-,15+,16-,17-,20-,21+,22-/m1/s1 D04JNZ DRUGINKE BOJKFRKNLSCGHY-HXGSDTCMSA-N D04JNZ DRUGSMIL CC1CC2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)OC(=O)C D04JNZ HIGHSTAT Investigative D04JOG DRUG__ID D04JOG D04JOG DRUGTYPE Small molecular drug D04JOG DRUGINCH 1S/C27H27NO5S/c1-2-8-19-17-23(33-21-10-4-3-5-11-21)13-14-24(19)32-16-7-15-31-22-12-6-9-20(18-22)25-26(29)28-27(30)34-25/h3-6,9-14,17-18,25H,2,7-8,15-16H2,1H3,(H,28,29,30) D04JOG DRUGINKE ZNLPWBJCSSSCCR-UHFFFAOYSA-N D04JOG DRUGSMIL CCCC1=C(C=CC(=C1)OC2=CC=CC=C2)OCCCOC3=CC=CC(=C3)C4C(=O)NC(=O)S4 D04JOG HIGHSTAT Investigative D04JOV DRUG__ID D04JOV D04JOV DRUGTYPE Small molecular drug D04JOV DRUGINCH 1S/C12H16N4O3S/c1-20-3-6-10(17)11(18)8(16-6)5-2-13-9-7(5)14-4-15-12(9)19/h2,4,6-8,10-11,16-18H,3H2,1H3,(H,14,15,19)/p+1/t6-,7?,8-,10-,11-/m0/s1 D04JOV DRUGINKE BRUVQLYKVACVPE-KTEKBNEVSA-O D04JOV DRUGSMIL CSCC1C(C(C([NH2+]1)C2=CN=C3C2N=CNC3=O)O)O D04JOV HIGHSTAT Investigative D04JSS DRUG__ID D04JSS D04JSS DRUGTYPE Small molecular drug D04JSS DRUGINCH 1S/C16H22N6O4S/c17-14(24)12-6-27-8-22(12)16(26)11(4-9-5-18-7-19-9)21-15(25)10-2-1-3-13(23)20-10/h5,7,10-12H,1-4,6,8H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12+/m0/s1 D04JSS DRUGINKE OGUDACTYCTVDNZ-SDDRHHMPSA-N D04JSS DRUGSMIL C1CC(NC(=O)C1)C(=O)NC(CC2=CN=CN2)C(=O)N3CSCC3C(=O)N D04JSS HIGHSTAT Investigative D04JTK DRUG__ID D04JTK D04JTK DRUGTYPE Small molecular drug D04JTK DRUGINCH 1S/C19H17N3O/c23-12-15-9-17-16-8-14(20-10-13-4-2-1-3-5-13)6-7-18(16)22-19(17)11-21-15/h1-9,11,20,22-23H,10,12H2 D04JTK DRUGINKE PCESGKMKSBKSOT-UHFFFAOYSA-N D04JTK DRUGSMIL C1=CC=C(C=C1)CNC2=CC3=C(C=C2)NC4=C3C=C(N=C4)CO D04JTK HIGHSTAT Investigative D04JTY DRUG__ID D04JTY D04JTY DRUGTYPE Small molecular drug D04JTY DRUGINCH 1S/C11H14O2S/c1-5-7(2)6-11(4)9(12)8(3)10(13)14-11/h5-6,12H,1H2,2-4H3/b7-6+/t11-/m1/s1 D04JTY DRUGINKE SYQNUQSGEWNWKV-XUIVZRPNSA-N D04JTY DRUGSMIL CC1=C(C(SC1=O)(C)C=C(C)C=C)O D04JTY HIGHSTAT Investigative D04JUH DRUG__ID D04JUH D04JUH DRUGTYPE Small molecular drug D04JUH DRUGINCH 1S/C15H9NO4/c17-13-9-15(20-14-7-2-1-6-12(13)14)10-4-3-5-11(8-10)16(18)19/h1-9H D04JUH DRUGINKE NFMFVPFUTZLMGI-UHFFFAOYSA-N D04JUH DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC(=CC=C3)[N+](=O)[O-] D04JUH HIGHSTAT Investigative D04JUJ DRUG__ID D04JUJ D04JUJ DRUGTYPE Small molecular drug D04JUJ DRUGINCH 1S/C10H13NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-6,11-13H,2-3H2,1H3 D04JUJ DRUGINKE IBRKLUSXDYATLG-UHFFFAOYSA-N D04JUJ DRUGSMIL CC1C2=CC(=C(C=C2CCN1)O)O D04JUJ HIGHSTAT Investigative D04JVA DRUG__ID D04JVA D04JVA DRUGTYPE Small molecular drug D04JVA DRUGINCH 1S/C9H15F3O3S/c1-2-3-4-5-6-16(14,15)7-8(13)9(10,11)12/h2-7H2,1H3 D04JVA DRUGINKE MAGOHNFKWBKUKQ-UHFFFAOYSA-N D04JVA DRUGSMIL CCCCCCS(=O)(=O)CC(=O)C(F)(F)F D04JVA HIGHSTAT Investigative D04JWS DRUG__ID D04JWS D04JWS DRUGTYPE Small molecular drug D04JWS DRUGINCH 1S/C24H14O8/c25-19-13-7-3-1-5-11(13)15(9-17(19)23(29)30)21(27)22(28)16-10-18(24(31)32)20(26)14-8-4-2-6-12(14)16/h1-10,25-26H,(H,29,30)(H,31,32) D04JWS DRUGINKE BRCWHTNRFUVIQT-UHFFFAOYSA-N D04JWS DRUGSMIL C1=CC=C2C(=C1)C(=CC(=C2O)C(=O)O)C(=O)C(=O)C3=CC(=C(C4=CC=CC=C43)O)C(=O)O D04JWS HIGHSTAT Investigative D04JWW DRUG__ID D04JWW D04JWW DRUGTYPE Small molecular drug D04JWW DRUGINCH 1S/C16H18INO2/c17-15-12-20-16(18-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D04JWW DRUGINKE JCDUQBRWCLLJHF-UHFFFAOYSA-N D04JWW DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)I D04JWW HIGHSTAT Investigative D04JXA DRUG__ID D04JXA D04JXA DRUGTYPE Small molecular drug D04JXA DRUGINCH 1S/C30H36N2O2/c1-21(2)23-11-16-26(17-12-23)32(20-22-9-14-25(15-10-22)31(3)4)30(33)28-8-6-7-24-13-18-27(34-5)19-29(24)28/h9-19,21,28H,6-8,20H2,1-5H3 D04JXA DRUGINKE DVYASSBBADJRAS-UHFFFAOYSA-N D04JXA DRUGSMIL CC(C)C1=CC=C(C=C1)N(CC2=CC=C(C=C2)N(C)C)C(=O)C3CCCC4=C3C=C(C=C4)OC D04JXA HIGHSTAT Investigative D04JXX DRUG__ID D04JXX D04JXX DRUGTYPE Small molecular drug D04JXX DRUGINCH 1S/C49H70N14O12S2/c1-49(2)24-40(67)57-32(22-28-13-15-29(75-3)16-14-28)43(70)60-33(21-27-9-5-4-6-10-27)44(71)58-31(17-18-37(50)64)42(69)61-34(23-38(51)65)45(72)62-35(26-76-77-49)47(74)63-20-8-12-36(63)46(73)59-30(11-7-19-55-48(53)54)41(68)56-25-39(52)66/h4-6,9-10,13-16,30-36H,7-8,11-12,17-26H2,1-3H3,(H2,50,64)(H2,51,65)(H2,52,66)(H,56,68)(H,57,67)(H,58,71)(H,59,73)(H,60,70)(H,61,69)(H,62,72)(H4,53,54,55) D04JXX DRUGINKE HNOGCDKPALYUIG-UHFFFAOYSA-N D04JXX DRUGSMIL CC1(CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)OC)C D04JXX HIGHSTAT Investigative D04JYI DRUG__ID D04JYI D04JYI DRUGTYPE Small molecular drug D04JYI DRUGINCH 1S/C16H15N3S2/c20-15(17-11-10-12-6-2-1-3-7-12)19-16-18-13-8-4-5-9-14(13)21-16/h1-9H,10-11H2,(H2,17,18,19,20) D04JYI DRUGINKE PKNPAMNXDLTPNX-UHFFFAOYSA-N D04JYI DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC3=CC=CC=C3S2 D04JYI HIGHSTAT Investigative D04JYW DRUG__ID D04JYW D04JYW DRUGTYPE Small molecular drug D04JYW DRUGINCH 1S/C19H34O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(20)22-17-18-16-21-18/h7-8,18H,2-6,9-17H2,1H3/b8-7- D04JYW DRUGINKE FWEHVPCBXKCYHE-FPLPWBNLSA-N D04JYW DRUGSMIL CCCCCCC=CCCCCCCCC(=O)OCC1CO1 D04JYW HIGHSTAT Investigative D04JZJ DRUG__ID D04JZJ D04JZJ DRUGTYPE Small molecular drug D04JZJ DRUGINCH 1S/C22H23NO2/c24-22-19(16-25-21-9-5-4-8-20(21)22)15-23-12-10-18(11-13-23)14-17-6-2-1-3-7-17/h1-9,16,18H,10-15H2 D04JZJ DRUGINKE WZWRAAKVOATXPL-UHFFFAOYSA-N D04JZJ DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O D04JZJ HIGHSTAT Investigative D04JZV DRUG__ID D04JZV D04JZV DRUGTYPE Small molecular drug D04JZV DRUGINCH 1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4-,6+/m1/s1 D04JZV DRUGINKE FNKQXYHWGSIFBK-KODRXGBYSA-N D04JZV DRUGSMIL CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O D04JZV HIGHSTAT Investigative D04JZY DRUG__ID D04JZY D04JZY DRUGTYPE Small molecular drug D04JZY DRUGINCH 1S/C14H12O6S.K/c15-12-7-11(8-13(16)9-12)2-1-10-3-5-14(6-4-10)20-21(17,18)19;/h1-9,15-16H,(H,17,18,19);/q;+1/p-1/b2-1+; D04JZY DRUGINKE DBEZAQWZIMHBRG-TYYBGVCCSA-M D04JZY DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)OS(=O)(=O)[O-].[K+] D04JZY HIGHSTAT Investigative D04KAM DRUG__ID D04KAM D04KAM DRUGTYPE Small molecular drug D04KAM DRUGINCH 1S/C14H20O2S/c1-3-4-5-8-11-17-14-10-7-6-9-13(14)16-12(2)15/h6-7,9-10H,3-5,8,11H2,1-2H3 D04KAM DRUGINKE IIONGZARVQOSAZ-UHFFFAOYSA-N D04KAM DRUGSMIL CCCCCCSC1=CC=CC=C1OC(=O)C D04KAM HIGHSTAT Investigative D04KAS DRUG__ID D04KAS D04KAS DRUGTYPE Small molecular drug D04KAS DRUGINCH 1S/C22H28N4O5/c1-12(2)18(19(28)21-24-15-8-5-6-10-17(15)31-21)25-20(29)16-9-7-11-26(16)22(30)13(3)23-14(4)27/h5-6,8,10,12-13,16,18H,7,9,11H2,1-4H3,(H,23,27)(H,25,29)/t13-,16-,18-/m0/s1 D04KAS DRUGINKE BITOROACNLSRME-OWQGQXMQSA-N D04KAS DRUGSMIL CC(C)C(C(=O)C1=NC2=CC=CC=C2O1)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C D04KAS HIGHSTAT Investigative D04KAZ DRUG__ID D04KAZ D04KAZ DRUGTYPE Small molecular drug D04KAZ DRUGINCH 1S/C15H14O3S/c16-15(13-7-3-1-4-8-13)11-12-19(17,18)14-9-5-2-6-10-14/h1-10H,11-12H2 D04KAZ DRUGINKE IOTOILGYCOMTGK-UHFFFAOYSA-N D04KAZ DRUGSMIL C1=CC=C(C=C1)C(=O)CCS(=O)(=O)C2=CC=CC=C2 D04KAZ HIGHSTAT Investigative D04KCX DRUG__ID D04KCX D04KCX DRUGTYPE Small molecular drug D04KCX DRUGINCH 1S/C8H6N2O2S/c11-6-3-1-5(2-4-6)7-9-10-8(13)12-7/h1-4,11H,(H,10,13) D04KCX DRUGINKE NGBOFOYNPCHKQQ-UHFFFAOYSA-N D04KCX DRUGSMIL C1=CC(=CC=C1C2=NNC(=S)O2)O D04KCX HIGHSTAT Investigative D04KDB DRUG__ID D04KDB D04KDB DRUGTYPE Small molecular drug D04KDB DRUGINCH 1S/C12H11N3O/c16-12-4-1-9-7-10(2-3-11(9)14-12)15-6-5-13-8-15/h2-3,5-8H,1,4H2,(H,14,16) D04KDB DRUGINKE BDMKPUAZENLRDY-UHFFFAOYSA-N D04KDB DRUGSMIL C1CC(=O)NC2=C1C=C(C=C2)N3C=CN=C3 D04KDB HIGHSTAT Investigative D04KDW DRUG__ID D04KDW D04KDW DRUGTYPE Small molecular drug D04KDW DRUGINCH 1S/C28H32N4O4/c33-25(9-15-31-11-1-2-12-31)29-19-5-7-21-23(17-19)28(36)24-18-20(6-8-22(24)27(21)35)30-26(34)10-16-32-13-3-4-14-32/h5-8,17-18H,1-4,9-16H2,(H,29,33)(H,30,34) D04KDW DRUGINKE CUZAYOMYKDAXQR-UHFFFAOYSA-N D04KDW DRUGSMIL C1CCN(C1)CCC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CCN5CCCC5 D04KDW HIGHSTAT Investigative D04KGK DRUG__ID D04KGK D04KGK DRUGTYPE Small molecular drug D04KGK DRUGINCH 1S/C14H13N/c1-3-7-13-11(5-1)9-10-12-6-2-4-8-14(12)15-13/h1-8,15H,9-10H2 D04KGK DRUGINKE ZSMRRZONCYIFNB-UHFFFAOYSA-N D04KGK DRUGSMIL C1CC2=CC=CC=C2NC3=CC=CC=C31 D04KGK HIGHSTAT Investigative D04KHE DRUG__ID D04KHE D04KHE DRUGTYPE Small molecular drug D04KHE DRUGINCH 1S/C55H64N8O8/c1-34-26-42(65)27-35(2)43(34)32-45(57)55(71)63-33-40-17-10-9-16-39(40)31-49(63)52(68)59-24-23-58-50(66)46(29-36-12-5-3-6-13-36)60-51(67)47(30-37-14-7-4-8-15-37)61-53(69)48-18-11-25-62(48)54(70)44(56)28-38-19-21-41(64)22-20-38/h3-10,12-17,19-22,26-27,44-49,64-65H,11,18,23-25,28-33,56-57H2,1-2H3,(H,58,66)(H,59,68)(H,60,67)(H,61,69)/t44-,45-,46-,47-,48-,49?/m0/s1 D04KHE DRUGINKE CJBITXMCHBQEBZ-PGXNEIGQSA-N D04KHE DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCCN6C(=O)C(CC7=CC=C(C=C7)O)N)N)C)O D04KHE HIGHSTAT Investigative D04KOZ DRUG__ID D04KOZ D04KOZ DRUGTYPE Small molecular drug D04KOZ DRUGINCH 1S/C9H13NS/c10-9(7-11)6-8-4-2-1-3-5-8/h1-5,9,11H,6-7,10H2/t9-/m0/s1 D04KOZ DRUGINKE BUAPSNKVPWEGPA-VIFPVBQESA-N D04KOZ DRUGSMIL C1=CC=C(C=C1)CC(CS)N D04KOZ HIGHSTAT Investigative D04KPW DRUG__ID D04KPW D04KPW DRUGTYPE Small molecular drug D04KPW DRUGINCH 1S/C15H13NO2/c1-11-4-3-5-13(8-11)18-14-7-6-12(10-16)15(9-14)17-2/h3-9H,1-2H3 D04KPW DRUGINKE NXORRFHUCGSBOI-UHFFFAOYSA-N D04KPW DRUGSMIL CC1=CC(=CC=C1)OC2=CC(=C(C=C2)C#N)OC D04KPW HIGHSTAT Investigative D04KQT DRUG__ID D04KQT D04KQT DRUGTYPE Small molecular drug D04KQT DRUGINCH 1S/C12H27O3PS/c1-2-3-4-5-6-7-8-9-10-11-12-15-16(13,14)17/h2-12H2,1H3,(H2,13,14,17) D04KQT DRUGINKE ISWBBUXCFWZBKC-UHFFFAOYSA-N D04KQT DRUGSMIL CCCCCCCCCCCCOP(=S)(O)O D04KQT HIGHSTAT Investigative D04KSU DRUG__ID D04KSU D04KSU DRUGTYPE Small molecular drug D04KSU DRUGINCH 1S/C25H28O6/c1-14(2)6-7-16-8-9-19(27)18(12-26)22(16)23(28)17-10-15(3)11-20-24(17)31-21(13-30-20)25(4,5)29/h6,8-12,21,27,29H,7,13H2,1-5H3 D04KSU DRUGINKE DYNXQZCWMXLZCW-UHFFFAOYSA-N D04KSU DRUGSMIL CC1=CC(=C2C(=C1)OCC(O2)C(C)(C)O)C(=O)C3=C(C=CC(=C3C=O)O)CC=C(C)C D04KSU HIGHSTAT Investigative D04KTJ DRUG__ID D04KTJ D04KTJ DRUGTYPE Small molecular drug D04KTJ DRUGINCH 1S/C19H20N4O/c1-12-21-15-9-8-14(20-10-11-22(2)3)17-18(15)23(12)16-7-5-4-6-13(16)19(17)24/h4-9,20H,10-11H2,1-3H3 D04KTJ DRUGINKE WTFFYWWTDRXKDI-UHFFFAOYSA-N D04KTJ DRUGSMIL CC1=NC2=C3N1C4=CC=CC=C4C(=O)C3=C(C=C2)NCCN(C)C D04KTJ HIGHSTAT Investigative D04KUP DRUG__ID D04KUP D04KUP DRUGTYPE Small molecular drug D04KUP DRUGINCH 1S/C7H5BrN2/c8-6-2-1-5-4-9-10-7(5)3-6/h1-4H,(H,9,10) D04KUP DRUGINKE WMKDUJVLNZANRN-UHFFFAOYSA-N D04KUP DRUGSMIL C1=CC2=C(C=C1Br)NN=C2 D04KUP HIGHSTAT Investigative D04KWH DRUG__ID D04KWH D04KWH DRUGTYPE Small molecular drug D04KWH DRUGINCH 1S/C18H20Cl4N4/c1-3-6-26(9-11-4-5-11)18-15(22)17(23-10(2)24-18)25-16-13(20)7-12(19)8-14(16)21/h7-8,11H,3-6,9H2,1-2H3,(H,23,24,25) D04KWH DRUGINKE KNADXBVKFAUMCR-UHFFFAOYSA-N D04KWH DRUGSMIL CCCN(CC1CC1)C2=NC(=NC(=C2Cl)NC3=C(C=C(C=C3Cl)Cl)Cl)C D04KWH HIGHSTAT Investigative D04KZX DRUG__ID D04KZX D04KZX DRUGTYPE Small molecular drug D04KZX DRUGINCH 1S/C14H19Cl2NO/c1-5-12(17-14(2,3)4)13(18)9-6-7-10(15)11(16)8-9/h6-8,12,17H,5H2,1-4H3 D04KZX DRUGINKE JYBXLCIZWPNCMU-UHFFFAOYSA-N D04KZX DRUGSMIL CCC(C(=O)C1=CC(=C(C=C1)Cl)Cl)NC(C)(C)C D04KZX HIGHSTAT Investigative D04LBJ DRUG__ID D04LBJ D04LBJ DRUGTYPE Small molecular drug D04LBJ DRUGINCH 1S/C13H15N3O5S/c1-3-19-4-5-20-12(18)11(17)15-13-14-9(7-22-13)10-6-8(2)16-21-10/h6-7H,3-5H2,1-2H3,(H,14,15,17) D04LBJ DRUGINKE IKYTUOHXXXPNOG-UHFFFAOYSA-N D04LBJ DRUGSMIL CCOCCOC(=O)C(=O)NC1=NC(=CS1)C2=CC(=NO2)C D04LBJ HIGHSTAT Investigative D04LBT DRUG__ID D04LBT D04LBT DRUGTYPE Small molecular drug D04LBT DRUGINCH 1S/C28H40N2O9/c1-6-7-8-9-11-20-25(39-22(32)14-16(2)3)18(5)38-28(36)23(17(4)37-27(20)35)30-26(34)19-12-10-13-21(24(19)33)29-15-31/h10,12-13,15-18,20,23,25,33H,6-9,11,14H2,1-5H3,(H,29,31)(H,30,34)/t17-,18+,20-,23+,25+/m1/s1 D04LBT DRUGINKE UIFFUZWRFRDZJC-SBOOETFBSA-N D04LBT DRUGSMIL CCCCCCC1C(C(OC(=O)C(C(OC1=O)C)NC(=O)C2=C(C(=CC=C2)NC=O)O)C)OC(=O)CC(C)C D04LBT HIGHSTAT Investigative D04LBV DRUG__ID D04LBV D04LBV DRUGTYPE Small molecular drug D04LBV DRUGINCH 1S/C24H29N5O3/c1-16-12-29(15-25-16)22-8-7-17(11-23(22)30-2)26-24-27-20-9-10-31-13-19(20)21(28-24)14-32-18-5-3-4-6-18/h7-8,11-12,15,18H,3-6,9-10,13-14H2,1-2H3,(H,26,27,28) D04LBV DRUGINKE RMRFSIAFQBYBSN-UHFFFAOYSA-N D04LBV DRUGSMIL CC1=CN(C=N1)C2=C(C=C(C=C2)NC3=NC4=C(COCC4)C(=N3)COC5CCCC5)OC D04LBV HIGHSTAT Investigative D04LDH DRUG__ID D04LDH D04LDH DRUGTYPE Small molecular drug D04LDH DRUGINCH 1S/C20H18N4O/c1-25-19-9-7-16(8-10-19)20-17(13-23-12-11-21-15-23)14-24(22-20)18-5-3-2-4-6-18/h2-12,14-15H,13H2,1H3 D04LDH DRUGINKE CZOCKHTYPCJURT-UHFFFAOYSA-N D04LDH DRUGSMIL COC1=CC=C(C=C1)C2=NN(C=C2CN3C=CN=C3)C4=CC=CC=C4 D04LDH HIGHSTAT Investigative D04LDP DRUG__ID D04LDP D04LDP DRUGTYPE Small molecular drug D04LDP DRUGINCH 1S/C5H11O8P/c6-2(1-14(11,12)13)3(7)4(8)5(9)10/h2-4,6-8H,1H2,(H,9,10)(H2,11,12,13)/p-3 D04LDP DRUGINKE XCBNBIPHASXSKG-UHFFFAOYSA-K D04LDP DRUGSMIL C(C(C(C(C(=O)[O-])O)O)O)P(=O)([O-])[O-] D04LDP HIGHSTAT Investigative D04LEF DRUG__ID D04LEF D04LEF DRUGTYPE Small molecular drug D04LEF DRUGINCH 1S/C38H66N8O7/c1-5-25(4)33(36(50)44-31(38(52)53)21-24(2)3)45-34(48)30(22-26-14-16-28(47)17-15-26)43-35(49)32-13-10-20-46(32)37(51)29(12-7-9-19-40)42-23-27(41)11-6-8-18-39/h14-17,24-25,27,29-33,42,47H,5-13,18-23,39-41H2,1-4H3,(H,43,49)(H,44,50)(H,45,48)(H,52,53)/t25-,27-,29-,30-,31-,32-,33-/m0/s1 D04LEF DRUGINKE TZCYVPLNMOJUIL-GULBXNHPSA-N D04LEF DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCCN)NCC(CCCCN)N D04LEF HIGHSTAT Investigative D04LFK DRUG__ID D04LFK D04LFK DRUGTYPE Small molecular drug D04LFK DRUGINCH 1S/C14H18N2/c1-2-6-14-12(5-1)11-13(15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2 D04LFK DRUGINKE IVJNJVNKYYOCPC-UHFFFAOYSA-N D04LFK DRUGSMIL C1CCN(C1)CCC2=CC3=CC=CC=C3N2 D04LFK HIGHSTAT Investigative D04LGV DRUG__ID D04LGV D04LGV DRUGTYPE Small molecular drug D04LGV DRUGINCH 1S/C20H25NO3S/c1-2-17-9-11-19(12-10-17)25(23,24)21-15-6-13-20(22,14-16-21)18-7-4-3-5-8-18/h3-5,7-12,22H,2,6,13-16H2,1H3 D04LGV DRUGINKE BUVJJRPTSWXSAA-UHFFFAOYSA-N D04LGV DRUGSMIL CCC1=CC=C(C=C1)S(=O)(=O)N2CCCC(CC2)(C3=CC=CC=C3)O D04LGV HIGHSTAT Investigative D04LJH DRUG__ID D04LJH D04LJH DRUGTYPE Small molecular drug D04LJH DRUGINCH 1S/C17H21N4/c1-21(2)12-14-10-15(21)11-20(14)17-9-8-16(18-19-17)13-6-4-3-5-7-13/h3-9,14-15H,10-12H2,1-2H3/q+1 D04LJH DRUGINKE AKMKIDQMKPFYDJ-UHFFFAOYSA-N D04LJH DRUGSMIL C[N+]1(CC2CC1CN2C3=NN=C(C=C3)C4=CC=CC=C4)C D04LJH HIGHSTAT Investigative D04LLD DRUG__ID D04LLD D04LLD DRUGTYPE Small molecular drug D04LLD DRUGINCH 1S/C19H23NO3/c21-19(20-22)10-6-1-2-7-15-23-18-13-11-17(12-14-18)16-8-4-3-5-9-16/h3-5,8-9,11-14,22H,1-2,6-7,10,15H2,(H,20,21) D04LLD DRUGINKE KASXKFPWIZYBSG-UHFFFAOYSA-N D04LLD DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)NO D04LLD HIGHSTAT Investigative D04LMF DRUG__ID D04LMF D04LMF DRUGTYPE Small molecular drug D04LMF DRUGINCH 1S/C70H92IN17O14/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+/m1/s1/i71-2 D04LMF DRUGINKE MVDPNTCYCFVFOX-SZENRQNHSA-N D04LMF DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)I)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D04LMF HIGHSTAT Investigative D04LNI DRUG__ID D04LNI D04LNI DRUGTYPE Small molecular drug D04LNI DRUGINCH 1S/C16H18O2/c1-9-5-13(6-10(2)15(9)17)14-7-11(3)16(18)12(4)8-14/h5-8,17-18H,1-4H3 D04LNI DRUGINKE YGYPMFPGZQPETF-UHFFFAOYSA-N D04LNI DRUGSMIL CC1=CC(=CC(=C1O)C)C2=CC(=C(C(=C2)C)O)C D04LNI HIGHSTAT Investigative D04LPX DRUG__ID D04LPX D04LPX DRUGTYPE Small molecular drug D04LPX DRUGINCH 1S/C16H11BrN2OS/c17-13-8-6-12(7-9-13)15(20)19-16-18-14(10-21-16)11-4-2-1-3-5-11/h1-10H,(H,18,19,20) D04LPX DRUGINKE PJMUFKFWQNWHCY-UHFFFAOYSA-N D04LPX DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=C(C=C3)Br D04LPX HIGHSTAT Investigative D04LPY DRUG__ID D04LPY D04LPY DRUGTYPE Small molecular drug D04LPY DRUGINCH 1S/C15H15FN4O3/c1-18-11-12(19(2)15(22)20(3)13(11)21)17-14(18)23-8-9-5-4-6-10(16)7-9/h4-7H,8H2,1-3H3 D04LPY DRUGINKE YAQZRUHNOYDFHZ-UHFFFAOYSA-N D04LPY DRUGSMIL CN1C2=C(N=C1OCC3=CC(=CC=C3)F)N(C(=O)N(C2=O)C)C D04LPY HIGHSTAT Investigative D04LRN DRUG__ID D04LRN D04LRN DRUGTYPE Small molecular drug D04LRN DRUGINCH 1S/C19H16N2O2/c1-22-18-10-17-14(9-16(18)19-11-20-12-23-19)8-15(21-17)7-13-5-3-2-4-6-13/h2-6,8-12,21H,7H2,1H3 D04LRN DRUGINKE HWRLJNBXLQMWKB-UHFFFAOYSA-N D04LRN DRUGSMIL COC1=C(C=C2C=C(NC2=C1)CC3=CC=CC=C3)C4=CN=CO4 D04LRN HIGHSTAT Investigative D04LSR DRUG__ID D04LSR D04LSR DRUGTYPE Small molecular drug D04LSR DRUGINCH 1S/C20H25ClN4S/c1-20(2,3)15-6-8-16(9-7-15)23-19(26)25-13-11-24(12-14-25)18-17(21)5-4-10-22-18/h4-10H,11-14H2,1-3H3,(H,23,26) D04LSR DRUGINKE ODPJGEXSZMHIBU-UHFFFAOYSA-N D04LSR DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=S)N2CCN(CC2)C3=C(C=CC=N3)Cl D04LSR HIGHSTAT Investigative D04LTV DRUG__ID D04LTV D04LTV DRUGTYPE Small molecular drug D04LTV DRUGINCH 1S/C18H12N2O2/c1-9-10(2)20-16-14(19-9)8-7-13-15(16)18(22)12-6-4-3-5-11(12)17(13)21/h3-8H,1-2H3 D04LTV DRUGINKE WDHCRURNPCZZII-UHFFFAOYSA-N D04LTV DRUGSMIL CC1=C(N=C2C(=N1)C=CC3=C2C(=O)C4=CC=CC=C4C3=O)C D04LTV HIGHSTAT Investigative D04LUF DRUG__ID D04LUF D04LUF DRUGTYPE Small molecular drug D04LUF DRUGINCH 1S/C39H51N5O11S/c1-23(45)40-27(17-19-31(46)47)36(51)44-34(33(25-13-7-3-8-14-25)26-15-9-4-10-16-26)38(53)41-28(18-20-32(48)49)35(50)42-29(21-24-11-5-2-6-12-24)37(52)43-30(22-56)39(54)55/h3-4,7-10,13-16,24,27-30,33-34,56H,2,5-6,11-12,17-22H2,1H3,(H,40,45)(H,41,53)(H,42,50)(H,43,52)(H,44,51)(H,46,47)(H,48,49)(H,54,55)/t27-,28-,29-,30-,34-/m0/s1 D04LUF DRUGINKE JVFCWJBRHCCRTF-ULYIESCMSA-N D04LUF DRUGSMIL CC(=O)NC(CCC(=O)O)C(=O)NC(C(C1=CC=CC=C1)C2=CC=CC=C2)C(=O)NC(CCC(=O)O)C(=O)NC(CC3CCCCC3)C(=O)NC(CS)C(=O)O D04LUF HIGHSTAT Investigative D04LUI DRUG__ID D04LUI D04LUI DRUGTYPE Small molecular drug D04LUI DRUGINCH 1S/C5H11O8P/c6-1-2-3(7)4(8)5(12-2)13-14(9,10)11/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5-/m1/s1 D04LUI DRUGINKE YXJDFQJKERBOBM-TXICZTDVSA-N D04LUI DRUGSMIL C(C1C(C(C(O1)OP(=O)(O)O)O)O)O D04LUI HIGHSTAT Investigative D04LWD DRUG__ID D04LWD D04LWD DRUGTYPE Small molecular drug D04LWD DRUGINCH 1S/C22H27N/c1-2-6-18(7-3-1)14-19-10-12-23(13-11-19)17-20-15-21-8-4-5-9-22(21)16-20/h1-9,19-20H,10-17H2 D04LWD DRUGINKE YMEBJHPCSQTYQZ-UHFFFAOYSA-N D04LWD DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C3 D04LWD HIGHSTAT Investigative D04LWL DRUG__ID D04LWL D04LWL DRUGTYPE Small molecular drug D04LWL DRUGINCH 1S/C11H11NO/c1-8-7-11(13)12(2)10-6-4-3-5-9(8)10/h3-7H,1-2H3 D04LWL DRUGINKE CEONKCOBRZOYJS-UHFFFAOYSA-N D04LWL DRUGSMIL CC1=CC(=O)N(C2=CC=CC=C12)C D04LWL HIGHSTAT Investigative D04LXG DRUG__ID D04LXG D04LXG DRUGTYPE Small molecular drug D04LXG DRUGINCH 1S/C23H26N2O2/c1-3-26-22-15-19-20(24-17-25-21(19)16-23(22)27-4-2)14-10-6-9-13-18-11-7-5-8-12-18/h5,7-8,10-12,14-17H,3-4,6,9,13H2,1-2H3/b14-10+ D04LXG DRUGINKE QLOYTAAAUVDJCT-GXDHUFHOSA-N D04LXG DRUGSMIL CCOC1=C(C=C2C(=C1)C(=NC=N2)C=CCCCC3=CC=CC=C3)OCC D04LXG HIGHSTAT Investigative D04LXR DRUG__ID D04LXR D04LXR DRUGTYPE Small molecular drug D04LXR DRUGINCH 1S/C22H18O4/c23-21(24)15-8-16-6-9-17(10-7-16)22(25)18-11-13-20(14-12-18)26-19-4-2-1-3-5-19/h1-7,9-14H,8,15H2,(H,23,24) D04LXR DRUGINKE FYPQECPTVJQSOG-UHFFFAOYSA-N D04LXR DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)CCC(=O)O D04LXR HIGHSTAT Investigative D04LZA DRUG__ID D04LZA D04LZA DRUGTYPE Small molecular drug D04LZA DRUGINCH 1S/C27H27NO/c1-3-4-9-17-28-19-22(18-26(28)23-14-7-5-11-20(23)2)27(29)25-16-10-13-21-12-6-8-15-24(21)25/h5-8,10-16,18-19H,3-4,9,17H2,1-2H3 D04LZA DRUGINKE HZMLAMXVETUEJZ-UHFFFAOYSA-N D04LZA DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2C)C(=O)C3=CC=CC4=CC=CC=C43 D04LZA HIGHSTAT Investigative D04LZJ DRUG__ID D04LZJ D04LZJ DRUGTYPE Small molecular drug D04LZJ DRUGINCH 1S/C3H10NO3P/c4-2-1-3-8(5,6)7/h1-4H2,(H2,5,6,7) D04LZJ DRUGINKE GSZQTIFGANBTNF-UHFFFAOYSA-N D04LZJ DRUGSMIL C(CN)CP(=O)(O)O D04LZJ HIGHSTAT Investigative D04LZN DRUG__ID D04LZN D04LZN DRUGTYPE Small molecular drug D04LZN DRUGINCH 1S/C9H10BrN5/c10-9-14-6-7(11)12-4-13-8(6)15(9)5-2-1-3-5/h4-5H,1-3H2,(H2,11,12,13) D04LZN DRUGINKE ODVHXPRTEZXIFW-UHFFFAOYSA-N D04LZN DRUGSMIL C1CC(C1)N2C3=NC=NC(=C3N=C2Br)N D04LZN HIGHSTAT Investigative D04MAM DRUG__ID D04MAM D04MAM DRUGTYPE Small molecular drug D04MAM DRUGINCH 1S/C10H13NO4S/c11-16(12,13)14-7-9-6-5-8-3-1-2-4-10(8)15-9/h1-4,9H,5-7H2,(H2,11,12,13) D04MAM DRUGINKE OXNGFJDSVRPPCH-UHFFFAOYSA-N D04MAM DRUGSMIL C1CC2=CC=CC=C2OC1COS(=O)(=O)N D04MAM HIGHSTAT Investigative D04MAP DRUG__ID D04MAP D04MAP DRUGTYPE Small molecular drug D04MAP DRUGINCH 1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32) D04MAP DRUGINKE VGUQVYZXABOXCX-UHFFFAOYSA-N D04MAP DRUGSMIL CC1=CC=C(C=C1)C2=NNC3=C2C(N(C3=O)C4=CC=C(C=C4)C(=O)O)C5=CC(=CC=C5)O D04MAP HIGHSTAT Investigative D04MBD DRUG__ID D04MBD D04MBD DRUGTYPE Small molecular drug D04MBD DRUGINCH 1S/C14H8Cl2O/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6H,7H2 D04MBD DRUGINKE AYDNUUZHQKPRKA-UHFFFAOYSA-N D04MBD DRUGSMIL C1C2=C(C(=CC=C2)Cl)C(=O)C3=C1C=CC=C3Cl D04MBD HIGHSTAT Investigative D04MEE DRUG__ID D04MEE D04MEE DRUGTYPE Small molecular drug D04MEE DRUGINCH 1S/C14H15IN2/c1-14(2,12-6-4-8-17-10-12)13(15)11-5-3-7-16-9-11/h3-10,13H,1-2H3 D04MEE DRUGINKE BPACVLBDZBTCAO-UHFFFAOYSA-N D04MEE DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CN=CC=C2)I D04MEE HIGHSTAT Investigative D04MHP DRUG__ID D04MHP D04MHP DRUGCOMP INSERM D04MHP DRUGINCH 1S/C25H44N6.2H2O4S/c1-21(2)19-31(20-22(3)4)14-8-13-30-17-15-29(16-18-30)12-7-11-26-25-27-23-9-5-6-10-24(23)28-25;2*1-5(2,3)4/h5-6,9-10,21-22H,7-8,11-20H2,1-4H3,(H2,26,27,28);2*(H2,1,2,3,4) D04MHP DRUGINKE GIYBNVHXNIZNBZ-UHFFFAOYSA-N D04MHP DRUGSMIL CC(C)CN(CCCN1CCN(CC1)CCCNC2=NC3=CC=CC=C3N2)CC(C)C.OS(=O)(=O)O.OS(=O)(=O)O D04MHP HIGHSTAT Investigative D04MIG DRUG__ID D04MIG D04MIG DRUGTYPE Small molecular drug D04MIG DRUGINCH 1S/C15H11FN2OS2/c1-9-14(13(19)10-6-7-20-8-10)21-15(17-9)18-12-4-2-11(16)3-5-12/h2-8H,1H3,(H,17,18) D04MIG DRUGINKE PEAMDZVDNYENPN-UHFFFAOYSA-N D04MIG DRUGSMIL CC1=C(SC(=N1)NC2=CC=C(C=C2)F)C(=O)C3=CSC=C3 D04MIG HIGHSTAT Investigative D04MIN DRUG__ID D04MIN D04MIN DRUGTYPE Small molecular drug D04MIN DRUGINCH 1S/C25H22ClFN6O4/c26-17-3-1-2-13(22(17)27)11-30-23(34)21-9-14-8-20(14)33(21)25(36)31-18-12-32(24(29)35)19-5-4-15(10-16(18)19)37-7-6-28/h1-5,10,12,14,20-21H,7-9,11H2,(H2,29,35)(H,30,34)(H,31,36)/t14-,20-,21+/m1/s1 D04MIN DRUGINKE SOCAXRLFGRNEPK-IFZYUDKTSA-N D04MIN DRUGSMIL C1C2C1N(C(C2)C(=O)NCC3=C(C(=CC=C3)Cl)F)C(=O)NC4=CN(C5=C4C=C(C=C5)OCC#N)C(=O)N D04MIN HIGHSTAT Investigative D04MIY DRUG__ID D04MIY D04MIY DRUGTYPE Small molecular drug D04MIY DRUGINCH 1S/C12H8ClN3/c13-8-4-5-9-11(7-8)16-12(15-9)10-3-1-2-6-14-10/h1-7H,(H,15,16) D04MIY DRUGINKE AIASBFLKLNIZOK-UHFFFAOYSA-N D04MIY DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(N2)C=C(C=C3)Cl D04MIY HIGHSTAT Investigative D04MKB DRUG__ID D04MKB D04MKB DRUGTYPE Small molecular drug D04MKB DRUGINCH 1S/C23H26N2OS/c1-4-11-19(12-5-1)21-22(20-13-6-2-7-14-20)27-23(24-21)26-18-10-17-25-15-8-3-9-16-25/h1-2,4-7,11-14H,3,8-10,15-18H2 D04MKB DRUGINKE QRGQBMVHLMCOKC-UHFFFAOYSA-N D04MKB DRUGSMIL C1CCN(CC1)CCCOC2=NC(=C(S2)C3=CC=CC=C3)C4=CC=CC=C4 D04MKB HIGHSTAT Investigative D04MKK DRUG__ID D04MKK D04MKK DRUGTYPE Small molecular drug D04MKK DRUGINCH 1S/C15H11ClF3NO4/c1-8(14(21)22)23-10-2-4-11(5-3-10)24-13-12(16)6-9(7-20-13)15(17,18)19/h2-8H,1H3,(H,21,22) D04MKK DRUGINKE GOCUAJYOYBLQRH-UHFFFAOYSA-N D04MKK DRUGSMIL CC(C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl D04MKK HIGHSTAT Investigative D04MKQ DRUG__ID D04MKQ D04MKQ DRUGTYPE Small molecular drug D04MKQ DRUGINCH 1S/C7H8NO2P/c8-7(11(9)10)6-4-2-1-3-5-6/h1-5,8-10H D04MKQ DRUGINKE HYRMSZQUBBPTOQ-UHFFFAOYSA-N D04MKQ DRUGSMIL C1=CC=C(C=C1)C(=N)P(O)O D04MKQ HIGHSTAT Investigative D04MLE DRUG__ID D04MLE D04MLE DRUGCOMP AstraZeneca plc D04MLE DRUGINCH 1S/C21H20N6O3S2/c1-12-6-7-16(13(2)24-12)30-17-9-14(31-18-5-3-4-8-22-18)10-23-20(17)26-21-25-19(27-32-21)15(29)11-28/h3-10,15,28-29H,11H2,1-2H3,(H,23,25,26,27)/t15-/m1/s1 D04MLE DRUGINKE NARRNXGFBLOLIN-OAHLLOKOSA-N D04MLE DRUGSMIL CC1=NC(=C(C=C1)OC2=C(N=CC(=C2)SC3=CC=CC=N3)NC4=NC(=NS4)C(CO)O)C D04MLE HIGHSTAT Investigative D04MLU DRUG__ID D04MLU D04MLU DRUGTYPE Small molecular drug D04MLU DRUGINCH 1S/C17H27NO/c1-15-5-7-16(8-6-15)4-2-3-11-18-12-9-17(14-19)10-13-18/h5-8,17,19H,2-4,9-14H2,1H3 D04MLU DRUGINKE VTDHRHRPPVJGSU-UHFFFAOYSA-N D04MLU DRUGSMIL CC1=CC=C(C=C1)CCCCN2CCC(CC2)CO D04MLU HIGHSTAT Investigative D04MMG DRUG__ID D04MMG D04MMG DRUGTYPE Small molecular drug D04MMG DRUGINCH 1S/C24H18N6O2/c31-30(32)20-13-11-19(12-14-20)26-23-21-24(28-22(27-23)18-9-5-2-6-10-18)29(16-25-21)15-17-7-3-1-4-8-17/h1-14,16H,15H2,(H,26,27,28) D04MMG DRUGINKE AQQCBPZYBVKEFU-UHFFFAOYSA-N D04MMG DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C(N=C(N=C32)C4=CC=CC=C4)NC5=CC=C(C=C5)[N+](=O)[O-] D04MMG HIGHSTAT Investigative D04MSI DRUG__ID D04MSI D04MSI DRUGTYPE Small molecular drug D04MSI DRUGINCH 1S/C6H11NO4/c1-3(2-4(8)9)5(7)6(10)11/h3,5H,2,7H2,1H3,(H,8,9)(H,10,11) D04MSI DRUGINKE FHJNAFIJPFGZRI-UHFFFAOYSA-N D04MSI DRUGSMIL CC(CC(=O)O)C(C(=O)O)N D04MSI HIGHSTAT Investigative D04MVL DRUG__ID D04MVL D04MVL DRUGTYPE Small molecular drug D04MVL DRUGINCH 1S/C18H19NO/c1-11-6-7-13-10-15-16-12(8-9-19(15)2)4-3-5-14(16)17(13)18(11)20/h3-7,15,20H,8-10H2,1-2H3/t15-/m1/s1 D04MVL DRUGINKE YGOZTDLAUVOPMF-OAHLLOKOSA-N D04MVL DRUGSMIL CC1=C(C2=C(CC3C4=C(CCN3C)C=CC=C42)C=C1)O D04MVL HIGHSTAT Investigative D04MVR DRUG__ID D04MVR D04MVR DRUGTYPE Small molecular drug D04MVR DRUGINCH 1S/C19H18N4OS/c1-4-12-5-7-13(8-6-12)23-11-21-16-15-14(22(2)3)9-10-20-18(15)25-17(16)19(23)24/h5-11H,4H2,1-3H3 D04MVR DRUGINKE VCUKKMIXURRDKL-UHFFFAOYSA-N D04MVR DRUGSMIL CCC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=NC=CC(=C34)N(C)C D04MVR HIGHSTAT Investigative D04MYC DRUG__ID D04MYC D04MYC DRUGTYPE Small molecular drug D04MYC DRUGINCH 1S/C15H10F2N2S/c16-9-4-3-5-10(17)14(9)15-19-12-7-2-1-6-11(12)18-13(19)8-20-15/h1-7,15H,8H2 D04MYC DRUGINKE AMLBAOPYPUXEQF-UHFFFAOYSA-N D04MYC DRUGSMIL C1C2=NC3=CC=CC=C3N2C(S1)C4=C(C=CC=C4F)F D04MYC HIGHSTAT Investigative D04MYP DRUG__ID D04MYP D04MYP DRUGTYPE Small molecular drug D04MYP DRUGINCH 1S/C31H35N5O5/c32-24(18-21-13-15-23(37)16-14-21)31(41)36-17-7-12-26(36)30(40)34-25(19-20-8-3-1-4-9-20)29(39)35-27(28(33)38)22-10-5-2-6-11-22/h1-6,8-11,13-16,24-27,37H,7,12,17-19,32H2,(H2,33,38)(H,34,40)(H,35,39)/t24-,25-,26-,27-/m0/s1 D04MYP DRUGINKE UUUCKSPURQXDKV-FWEHEUNISA-N D04MYP DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C4=CC=CC=C4)C(=O)N D04MYP HIGHSTAT Investigative D04MYT DRUG__ID D04MYT D04MYT DRUGTYPE Small molecular drug D04MYT DRUGINCH 1S/C10H8N4/c1-3-11-10-9(2-4-12-10)8(1)7-5-13-14-6-7/h1-6H,(H,11,12)(H,13,14) D04MYT DRUGINKE FATFDRYYCYZBQB-UHFFFAOYSA-N D04MYT DRUGSMIL C1=CNC2=NC=CC(=C21)C3=CNN=C3 D04MYT HIGHSTAT Investigative D04MZK DRUG__ID D04MZK D04MZK DRUGTYPE Small molecular drug D04MZK DRUGINCH 1S/C15H10N2O2S/c18-15(13-7-4-10-20-13)19-14-9-8-12(16-17-14)11-5-2-1-3-6-11/h1-10H D04MZK DRUGINKE WIJDBDCYFCOSHK-UHFFFAOYSA-N D04MZK DRUGSMIL C1=CC=C(C=C1)C2=NN=C(C=C2)OC(=O)C3=CC=CS3 D04MZK HIGHSTAT Investigative D04NAL DRUG__ID D04NAL D04NAL DRUGTYPE Small molecular drug D04NAL DRUGINCH 1S/C20H24N4O3/c1-3-4-18-15(7-10-17(13(2)25)19(18)26)12-27-16-8-5-14(6-9-16)11-23-24-20(21)22/h5-11,26H,3-4,12H2,1-2H3,(H4,21,22,24)/b23-11- D04NAL DRUGINKE TUXHQPAMNGTVLT-KSEXSDGBSA-N D04NAL DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)COC2=CC=C(C=C2)C=NN=C(N)N D04NAL HIGHSTAT Investigative D04NBD DRUG__ID D04NBD D04NBD DRUGTYPE Small molecular drug D04NBD DRUGINCH 1S/C25H25N3O4/c1-2-3-16-32-20-14-10-18(11-15-20)24(30)27-28-23(17-8-12-19(29)13-9-17)26-22-7-5-4-6-21(22)25(28)31/h4-15,23,26,29H,2-3,16H2,1H3,(H,27,30) D04NBD DRUGINKE URGRPHVKOQXJLZ-UHFFFAOYSA-N D04NBD DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)NN2C(NC3=CC=CC=C3C2=O)C4=CC=C(C=C4)O D04NBD HIGHSTAT Investigative D04NBE DRUG__ID D04NBE D04NBE DRUGTYPE Small molecular drug D04NBE DRUGINCH 1S/C4H8O2/c1-4(6)2-3-5/h5H,2-3H2,1H3 D04NBE DRUGINKE LVSQXDHWDCMMRJ-UHFFFAOYSA-N D04NBE DRUGSMIL CC(=O)CCO D04NBE HIGHSTAT Investigative D04NDO DRUG__ID D04NDO D04NDO DRUGTYPE Small molecular drug D04NDO DRUGINCH 1S/C18H20FNO/c19-17-7-3-1-5-15(17)13-21-18-8-4-2-6-16(18)14-9-11-20-12-10-14/h1-8,14,20H,9-13H2 D04NDO DRUGINKE CDVPUDLPRZVZHB-UHFFFAOYSA-N D04NDO DRUGSMIL C1CNCCC1C2=CC=CC=C2OCC3=CC=CC=C3F D04NDO HIGHSTAT Investigative D04NGC DRUG__ID D04NGC D04NGC DRUGTYPE Small molecular drug D04NGC DRUGINCH 1S/C6H6O2S2/c1-9-5-3-2-4(10-5)6(7)8/h2-3H,1H3,(H,7,8) D04NGC DRUGINKE FWFWUSLBIIIIEN-UHFFFAOYSA-N D04NGC DRUGSMIL CSC1=CC=C(S1)C(=O)O D04NGC HIGHSTAT Investigative D04NGL DRUG__ID D04NGL D04NGL DRUGTYPE Small molecular drug D04NGL DRUGINCH 1S/C18H27NO2/c1-12(2)16-10-5-13(3)11-17(16)18(20)19-14-6-8-15(21-4)9-7-14/h6-9,12-13,16-17H,5,10-11H2,1-4H3,(H,19,20)/t13-,16+,17-/m1/s1 D04NGL DRUGINKE HNSGVPAAXJJOPQ-XOKHGSTOSA-N D04NGL DRUGSMIL CC1CCC(C(C1)C(=O)NC2=CC=C(C=C2)OC)C(C)C D04NGL HIGHSTAT Investigative D04NGS DRUG__ID D04NGS D04NGS DRUGTYPE Small molecular drug D04NGS DRUGINCH 1S/C15H12F2N6O3S/c16-10-2-1-3-11(17)12(10)13(24)23-14(18)21-15(22-23)20-8-4-6-9(7-5-8)27(19,25)26/h1-7H,(H2,19,25,26)(H3,18,20,21,22) D04NGS DRUGINKE KDKUVYLMPJIGKA-UHFFFAOYSA-N D04NGS DRUGSMIL C1=CC(=C(C(=C1)F)C(=O)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F D04NGS HIGHSTAT Investigative D04NJC DRUG__ID D04NJC D04NJC DRUGTYPE Small molecular drug D04NJC DRUGINCH 1S/C18H24N2O2/c1-22-16-4-2-15(3-5-16)19-17(21)20-18-9-12-6-13(10-18)8-14(7-12)11-18/h2-5,12-14H,6-11H2,1H3,(H2,19,20,21) D04NJC DRUGINKE SITQZMUGNIFVIS-UHFFFAOYSA-N D04NJC DRUGSMIL COC1=CC=C(C=C1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D04NJC HIGHSTAT Investigative D04NKQ DRUG__ID D04NKQ D04NKQ DRUGTYPE Small molecular drug D04NKQ DRUGINCH 1S/C17H18FNO/c18-14-5-7-15(8-6-14)20-17-4-2-1-3-16(17)13-9-11-19-12-10-13/h1-8,13,19H,9-12H2 D04NKQ DRUGINKE BXXRQIARNFYYBC-UHFFFAOYSA-N D04NKQ DRUGSMIL C1CNCCC1C2=CC=CC=C2OC3=CC=C(C=C3)F D04NKQ HIGHSTAT Investigative D04NLG DRUG__ID D04NLG D04NLG DRUGTYPE Small molecular drug D04NLG DRUGINCH 1S/C18H24N4O.ClH/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17;/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23);1H D04NLG DRUGINKE QYZRTBKYBJRGJB-UHFFFAOYSA-N D04NLG DRUGSMIL CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl D04NLG HIGHSTAT Investigative D04NOT DRUG__ID D04NOT D04NOT DRUGTYPE Small molecular drug D04NOT DRUGINCH 1S/C3H5BrO/c1-3(5)2-4/h2H2,1H3 D04NOT DRUGINKE VQFAIAKCILWQPZ-UHFFFAOYSA-N D04NOT DRUGSMIL CC(=O)CBr D04NOT HIGHSTAT Investigative D04NPE DRUG__ID D04NPE D04NPE DRUGTYPE Small molecular drug D04NPE DRUGINCH 1S/C21H18N2O5/c24-19(23-10-9-22-17(20(25)26)18(23)21(27)28)14-8-7-13-6-5-12-3-1-2-4-15(12)16(13)11-14/h1-8,11,17-18,22H,9-10H2,(H,25,26)(H,27,28)/t17-,18+/m0/s1 D04NPE DRUGINKE VVUAQPXBYDYTDF-ZWKOTPCHSA-N D04NPE DRUGSMIL C1CN(C(C(N1)C(=O)O)C(=O)O)C(=O)C2=CC3=C(C=CC4=CC=CC=C43)C=C2 D04NPE HIGHSTAT Investigative D04NSN DRUG__ID D04NSN D04NSN DRUGTYPE Small molecular drug D04NSN DRUGINCH 1S/C8H12N2O2S/c9-6-5-7-1-3-8(4-2-7)13(10,11)12/h1-4H,5-6,9H2,(H2,10,11,12) D04NSN DRUGINKE FXNSVEQMUYPYJS-UHFFFAOYSA-N D04NSN DRUGSMIL C1=CC(=CC=C1CCN)S(=O)(=O)N D04NSN HIGHSTAT Investigative D04NSP DRUG__ID D04NSP D04NSP DRUGTYPE Small molecular drug D04NSP DRUGINCH 1S/C13H18N2O4/c16-11-7-5-10(6-8-11)13(18)14-9-3-1-2-4-12(17)15-19/h5-8,16,19H,1-4,9H2,(H,14,18)(H,15,17) D04NSP DRUGINKE JORFILXLFWALBT-UHFFFAOYSA-N D04NSP DRUGSMIL C1=CC(=CC=C1C(=O)NCCCCCC(=O)NO)O D04NSP HIGHSTAT Investigative D04NWI DRUG__ID D04NWI D04NWI DRUGTYPE Small molecular drug D04NWI DRUGINCH 1S/C14H21N/c1-12-5-3-7-14(11-12)8-10-15-9-4-6-13(15)2/h3,5,7,11,13H,4,6,8-10H2,1-2H3/t13-/m1/s1 D04NWI DRUGINKE PXZKWHANTMQGIH-CYBMUJFWSA-N D04NWI DRUGSMIL CC1CCCN1CCC2=CC=CC(=C2)C D04NWI HIGHSTAT Investigative D04NZF DRUG__ID D04NZF D04NZF DRUGTYPE Small molecular drug D04NZF DRUGINCH 1S/C21H21N3.ClH/c1-2-24-20-9-4-3-8-18(20)19-13-16(10-11-21(19)24)14-22-15-17-7-5-6-12-23-17;/h3-13,22H,2,14-15H2,1H3;1H D04NZF DRUGINKE LTMOFUKBECEABM-UHFFFAOYSA-N D04NZF DRUGSMIL CCN1C2=C(C=C(C=C2)CNCC3=CC=CC=N3)C4=CC=CC=C41.Cl D04NZF HIGHSTAT Investigative D04ODG DRUG__ID D04ODG D04ODG DRUGTYPE Small molecular drug D04ODG DRUGINCH 1S/C15H19NO2/c1-4-15(10-11(2)3)13(17)16(14(15)18)12-8-6-5-7-9-12/h5-9,11H,4,10H2,1-3H3 D04ODG DRUGINKE IDCYZOAEGDFOSJ-UHFFFAOYSA-N D04ODG DRUGSMIL CCC1(C(=O)N(C1=O)C2=CC=CC=C2)CC(C)C D04ODG HIGHSTAT Investigative D04OHM DRUG__ID D04OHM D04OHM DRUGTYPE Small molecular drug D04OHM DRUGINCH 1S/C18H18O2/c19-16-9-5-14(6-10-16)18(13-3-1-2-4-13)15-7-11-17(20)12-8-15/h5-12,19-20H,1-4H2 D04OHM DRUGINKE GIGYKXHGYNZBEN-UHFFFAOYSA-N D04OHM DRUGSMIL C1CCC(=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C1 D04OHM HIGHSTAT Investigative D04OMK DRUG__ID D04OMK D04OMK DRUGTYPE Small molecular drug D04OMK DRUGINCH 1S/C17H19N3O3/c1-2-3-11-22-16-8-6-15(7-9-16)20-17(21)23-19-13-14-5-4-10-18-12-14/h4-10,12-13H,2-3,11H2,1H3,(H,20,21)/b19-13+ D04OMK DRUGINKE GPBQAYXYNOXDEZ-CPNJWEJPSA-N D04OMK DRUGSMIL CCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2 D04OMK HIGHSTAT Investigative D04OOK DRUG__ID D04OOK D04OOK DRUGTYPE Small molecular drug D04OOK DRUGINCH 1S/C23H25NO4S2/c1-19-8-12-22(13-9-19)29(25,26)17-24(16-21-6-4-3-5-7-21)18-30(27,28)23-14-10-20(2)11-15-23/h3-15H,16-18H2,1-2H3 D04OOK DRUGINKE KQKVTPWQOSNHBI-UHFFFAOYSA-N D04OOK DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)CN(CC2=CC=CC=C2)CS(=O)(=O)C3=CC=C(C=C3)C D04OOK HIGHSTAT Investigative D04OPE DRUG__ID D04OPE D04OPE DRUGTYPE Small molecular drug D04OPE DRUGINCH 1S/C20H16ClN3O3S/c1-13-3-9-17(10-4-13)28(25,26)24-18(11-12-22-24)19-14(2)27-23-20(19)15-5-7-16(21)8-6-15/h3-12H,1-2H3 D04OPE DRUGINKE WFFKVDICECGSHN-UHFFFAOYSA-N D04OPE DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C(=CC=N2)C3=C(ON=C3C4=CC=C(C=C4)Cl)C D04OPE HIGHSTAT Investigative D04OQZ DRUG__ID D04OQZ D04OQZ DRUGTYPE Small molecular drug D04OQZ DRUGINCH 1S/C5H13O8P/c6-1-3(7)5(9)4(8)2-13-14(10,11)12/h3-9H,1-2H2,(H2,10,11,12)/t3-,4-,5+/m1/s1 D04OQZ DRUGINKE VJDOAZKNBQCAGE-WDCZJNDASA-N D04OQZ DRUGSMIL C(C(C(C(COP(=O)(O)O)O)O)O)O D04OQZ HIGHSTAT Investigative D04ORY DRUG__ID D04ORY D04ORY DRUGTYPE Small molecular drug D04ORY DRUGINCH 1S/C13H14N2O2S/c1-10-2-6-12(7-3-10)15-18(16,17)13-8-4-11(14)5-9-13/h2-9,15H,14H2,1H3 D04ORY DRUGINKE QXIZWXNTAVXJNC-UHFFFAOYSA-N D04ORY DRUGSMIL CC1=CC=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N D04ORY HIGHSTAT Investigative D04OSU DRUG__ID D04OSU D04OSU DRUGTYPE Small molecular drug D04OSU DRUGINCH 1S/C52H76N2O13/c1-11-35-23-29(2)46(57)30(3)24-44(63-9)48-45(64-10)25-32(5)52(61,67-48)49(58)50(59)54-20-13-12-14-39(54)51(60)66-47(33(6)40(55)28-41(35)56)31(4)22-34-15-18-42(43(26-34)62-8)65-37-16-17-38-36(27-37)19-21-53(38)7/h16-17,19,21-23,27,30,32-35,39-40,42-48,55,57,61H,11-15,18,20,24-26,28H2,1-10H3/b29-23+,31-22+/t30-,32-,33-,34+,35-,39+,40+,42-,43-,44+,45+,46-,47-,48-,52-/m1/s1 D04OSU DRUGINKE APSPCHLQXFEUHG-CPBVNLROSA-N D04OSU DRUGSMIL CCC1C=C(C(C(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)OC5=CC6=C(C=C5)N(C=C6)C)C)O)C)OC)OC)C)O)C D04OSU HIGHSTAT Investigative D04OTF DRUG__ID D04OTF D04OTF DRUGTYPE Small molecular drug D04OTF DRUGINCH 1S/C9H10ClN3O3S/c1-17(15,16)7-4-5(2-3-6(7)10)8(14)13-9(11)12/h2-4H,1H3,(H4,11,12,13,14) D04OTF DRUGINKE AXVSLAVXNQSEKO-UHFFFAOYSA-N D04OTF DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)C(=O)N=C(N)N)Cl D04OTF HIGHSTAT Investigative D04OUJ DRUG__ID D04OUJ D04OUJ DRUGTYPE Small molecular drug D04OUJ DRUGINCH 1S/C14H30O7S/c15-1-2-16-3-4-17-5-6-18-7-8-19-9-10-20-11-12-21-13-14-22/h15,22H,1-14H2 D04OUJ DRUGINKE ACMBXVJDKVNCGH-UHFFFAOYSA-N D04OUJ DRUGSMIL C(COCCOCCOCCOCCOCCOCCS)O D04OUJ HIGHSTAT Investigative D04OWX DRUG__ID D04OWX D04OWX DRUGTYPE Small molecular drug D04OWX DRUGINCH 1S/C33H32N4O5/c38-28-26(42-32(29(28)39)37-21-34-27-30(37)35-20-36(31(27)40)18-22-16-17-22)19-41-33(23-10-4-1-5-11-23,24-12-6-2-7-13-24)25-14-8-3-9-15-25/h1-15,20-22,26,28-29,32,38-39H,16-19H2/t26-,28-,29-,32-/m1/s1 D04OWX DRUGINKE UTXUWUTZGDAURC-DWCTZGTLSA-N D04OWX DRUGSMIL C1CC1CN2C=NC3=C(C2=O)N=CN3C4C(C(C(O4)COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)O)O D04OWX HIGHSTAT Investigative D04OXY DRUG__ID D04OXY D04OXY DRUGTYPE Small molecular drug D04OXY DRUGINCH 1S/C11H8O3/c1-14-10-6-9(12)7-4-2-3-5-8(7)11(10)13/h2-6H,1H3 D04OXY DRUGINKE OBGBGHKYJAOXRR-UHFFFAOYSA-N D04OXY DRUGSMIL COC1=CC(=O)C2=CC=CC=C2C1=O D04OXY HIGHSTAT Investigative D04PAW DRUG__ID D04PAW D04PAW DRUGTYPE Small molecular drug D04PAW DRUGINCH 1S/C29H32N10O6/c1-39(15-18-14-32-25-23(33-18)24(30)36-29(31)37-25)19-9-7-17(8-10-19)26(41)35-20(28(43)44)11-12-22(40)34-21(27(42)38-45)13-16-5-3-2-4-6-16/h2-10,14,20-21,45H,11-13,15H2,1H3,(H,34,40)(H,35,41)(H,38,42)(H,43,44)(H4,30,31,32,36,37)/t20-,21-/m0/s1 D04PAW DRUGINKE QHQOEZXEZMHMER-SFTDATJTSA-N D04PAW DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)NC(CC4=CC=CC=C4)C(=O)NO)C(=O)O D04PAW HIGHSTAT Investigative D04PBA DRUG__ID D04PBA D04PBA DRUGTYPE Small molecular drug D04PBA DRUGINCH 1S/C17H20N2O/c20-17-8-4-7-16(13-17)19-11-9-18(10-12-19)14-15-5-2-1-3-6-15/h1-8,13,20H,9-12,14H2 D04PBA DRUGINKE BISVFNHMXVNVMG-UHFFFAOYSA-N D04PBA DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=CC(=CC=C3)O D04PBA HIGHSTAT Investigative D04PBD DRUG__ID D04PBD D04PBD DRUGTYPE Small molecular drug D04PBD DRUGINCH 1S/C19H19ClN4O/c20-16-12-14(19(25)18-15(16)4-3-7-22-18)13-23-8-10-24(11-9-23)17-5-1-2-6-21-17/h1-7,12,25H,8-11,13H2 D04PBD DRUGINKE OPEJNANYABTIGC-UHFFFAOYSA-N D04PBD DRUGSMIL C1CN(CCN1CC2=CC(=C3C=CC=NC3=C2O)Cl)C4=CC=CC=N4 D04PBD HIGHSTAT Investigative D04PBI DRUG__ID D04PBI D04PBI DRUGTYPE Small molecular drug D04PBI DRUGINCH 1S/C8H17N3O2/c1-2-7(10)11-5-3-4-6(9)8(12)13/h6H,2-5,9H2,1H3,(H2,10,11)(H,12,13)/t6-/m0/s1 D04PBI DRUGINKE ZYIBCZWVLDODOL-LURJTMIESA-N D04PBI DRUGSMIL CCC(=NCCCC(C(=O)O)N)N D04PBI HIGHSTAT Investigative D04PBZ DRUG__ID D04PBZ D04PBZ DRUGTYPE Small molecular drug D04PBZ DRUGINCH 1S/C13H11NOS/c1-10-14-12(9-16-10)7-6-11-4-3-5-13(8-11)15-2/h3-5,8-9H,1-2H3 D04PBZ DRUGINKE OFMNNPTVFPHRMM-UHFFFAOYSA-N D04PBZ DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)OC D04PBZ HIGHSTAT Investigative D04PDF DRUG__ID D04PDF D04PDF DRUGTYPE Small molecular drug D04PDF DRUGINCH 1S/C37H49N11O6/c1-21-31(50)47-30(20-23-10-13-24-6-2-3-7-25(24)18-23)35(54)46-27(8-4-16-42-36(38)39)32(51)45-28(9-5-17-43-37(40)41)33(52)48-29(34(53)44-21)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,21,27-30,49H,4-5,8-9,16-17,19-20H2,1H3,(H,44,53)(H,45,51)(H,46,54)(H,47,50)(H,48,52)(H4,38,39,42)(H4,40,41,43)/t21-,27-,28-,29+,30-/m0/s1 D04PDF DRUGINKE VWZBFEAQYFTPKH-JTIXJMNMSA-N D04PDF DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D04PDF HIGHSTAT Investigative D04PFN DRUG__ID D04PFN D04PFN DRUGTYPE Small molecular drug D04PFN DRUGINCH 1S/C10H15NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h6-7,9,11H,1,3-4H2,2H3,(H,12,13)(H,14,15)/p-2/t6-,7+,9-/m0/s1 D04PFN DRUGINKE VLSMHEGGTFMBBZ-OOZYFLPDSA-L D04PFN DRUGSMIL CC(=C)C1CNC(C1CC(=O)[O-])C(=O)[O-] D04PFN HIGHSTAT Investigative D04PHG DRUG__ID D04PHG D04PHG DRUGTYPE Small molecular drug D04PHG DRUGINCH 1S/C21H21FN2O2/c1-3-16-14(2)23-20(17-9-5-7-11-19(17)25)24(21(16)26)13-12-15-8-4-6-10-18(15)22/h4-11,25H,3,12-13H2,1-2H3 D04PHG DRUGINKE JYFJNCCRKBBRKZ-UHFFFAOYSA-N D04PHG DRUGSMIL CCC1=C(N=C(N(C1=O)CCC2=CC=CC=C2F)C3=CC=CC=C3O)C D04PHG HIGHSTAT Investigative D04PHR DRUG__ID D04PHR D04PHR DRUGTYPE Small molecular drug D04PHR DRUGINCH 1S/C17H17N5O/c1-4-21-15-12(6-5-9-18-15)16-19-10-11(2)22(16)13-7-8-14(23-3)20-17(13)21/h5-10H,4H2,1-3H3 D04PHR DRUGINKE WCIBELXOPRCLEG-UHFFFAOYSA-N D04PHR DRUGSMIL CCN1C2=C(C=CC=N2)C3=NC=C(N3C4=C1N=C(C=C4)OC)C D04PHR HIGHSTAT Investigative D04PJO DRUG__ID D04PJO D04PJO DRUGTYPE Small molecular drug D04PJO DRUGINCH 1S/C17H14N4/c1-11-5-4-6-12(9-11)21-10-14-13-7-2-3-8-15(13)19-17(18)16(14)20-21/h2-10H,1H3,(H2,18,19) D04PJO DRUGINKE NJFGXLMDWIXVEW-UHFFFAOYSA-N D04PJO DRUGSMIL CC1=CC(=CC=C1)N2C=C3C4=CC=CC=C4N=C(C3=N2)N D04PJO HIGHSTAT Investigative D04PKD DRUG__ID D04PKD D04PKD DRUGTYPE Small molecular drug D04PKD DRUGINCH 1S/C17H21NO6/c1-2-14(19)23-12-9-21-16-13(10-22-15(12)16)24-17(20)18-8-11-6-4-3-5-7-11/h3-7,12-13,15-16H,2,8-10H2,1H3,(H,18,20)/t12-,13+,15-,16-/m1/s1 D04PKD DRUGINKE FDUDHTXZERVRTN-OCVGTWLNSA-N D04PKD DRUGSMIL CCC(=O)OC1COC2C1OCC2OC(=O)NCC3=CC=CC=C3 D04PKD HIGHSTAT Investigative D04PKE DRUG__ID D04PKE D04PKE DRUGTYPE Small molecular drug D04PKE DRUGINCH 1S/C11H14N2O/c1-3-11(13-14)9(2)8-10-4-6-12-7-5-10/h4-8,11H,3H2,1-2H3/b9-8+ D04PKE DRUGINKE GOJJWAOCMJUGEU-CMDGGOBGSA-N D04PKE DRUGSMIL CCC(C(=CC1=CC=NC=C1)C)N=O D04PKE HIGHSTAT Investigative D04PKP DRUG__ID D04PKP D04PKP DRUGTYPE Small molecular drug D04PKP DRUGINCH 1S/C17H13N/c1-3-12-6-7-13-8-9-15(16(5-1)17(12)13)14-4-2-10-18-11-14/h1-5,8-11H,6-7H2 D04PKP DRUGINKE BWVFIMXEVGYZOM-UHFFFAOYSA-N D04PKP DRUGSMIL C1CC2=CC=C(C3=CC=CC1=C23)C4=CN=CC=C4 D04PKP HIGHSTAT Investigative D04PLB DRUG__ID D04PLB D04PLB DRUGTYPE Small molecular drug D04PLB DRUGINCH 1S/C14H10ClNO/c1-10-4-2-3-5-14(10)17-12-7-6-11(9-16)13(15)8-12/h2-8H,1H3 D04PLB DRUGINKE NOLQETBWRAYXMF-UHFFFAOYSA-N D04PLB DRUGSMIL CC1=CC=CC=C1OC2=CC(=C(C=C2)C#N)Cl D04PLB HIGHSTAT Investigative D04PLH DRUG__ID D04PLH D04PLH DRUGTYPE Small molecular drug D04PLH DRUGINCH 1S/C21H15N3O/c25-21(15-8-2-1-3-9-15)24-20-17-11-5-4-10-16(17)14-19(23-20)18-12-6-7-13-22-18/h1-14H,(H,23,24,25) D04PLH DRUGINKE FWRPUFITEHOETQ-UHFFFAOYSA-N D04PLH DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NC(=CC3=CC=CC=C32)C4=CC=CC=N4 D04PLH HIGHSTAT Investigative D04PMA DRUG__ID D04PMA D04PMA DRUGTYPE Small molecular drug D04PMA DRUGINCH 1S/C13H23F3O/c1-2-3-4-5-6-7-8-9-10-11-12(17)13(14,15)16/h2-11H2,1H3 D04PMA DRUGINKE ZSPZNVMNSATHGF-UHFFFAOYSA-N D04PMA DRUGSMIL CCCCCCCCCCCC(=O)C(F)(F)F D04PMA HIGHSTAT Investigative D04PMX DRUG__ID D04PMX D04PMX DRUGTYPE Small molecular drug D04PMX DRUGINCH 1S/C10H8O2/c11-8-5-7-3-1-2-4-9(7)10(12)6-8/h1-6,11-12H D04PMX DRUGINKE XOOMNEFVDUTJPP-UHFFFAOYSA-N D04PMX DRUGSMIL C1=CC=C2C(=C1)C=C(C=C2O)O D04PMX HIGHSTAT Investigative D04PNC DRUG__ID D04PNC D04PNC DRUGTYPE Small molecular drug D04PNC DRUGINCH 1S/C16H23NO/c18-16(13-15-9-5-2-6-10-15)17-12-11-14-7-3-1-4-8-14/h1,3-4,7-8,15H,2,5-6,9-13H2,(H,17,18) D04PNC DRUGINKE BDWDBZQULOREPW-UHFFFAOYSA-N D04PNC DRUGSMIL C1CCC(CC1)CC(=O)NCCC2=CC=CC=C2 D04PNC HIGHSTAT Investigative D04POA DRUG__ID D04POA D04POA DRUGTYPE Small molecular drug D04POA DRUGINCH 1S/C28H35N5O5/c29-21(16-19-10-12-20(34)13-11-19)27(37)33-15-5-9-24(33)26(36)31-22(17-18-6-2-1-3-7-18)28(38)32-14-4-8-23(32)25(30)35/h1-3,6-7,10-13,21-24,34H,4-5,8-9,14-17,29H2,(H2,30,35)(H,31,36)/t21?,22-,23?,24?/m0/s1 D04POA DRUGINKE LSQXZIUREIDSHZ-REDCPHJYSA-N D04POA DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D04POA HIGHSTAT Investigative D04POB DRUG__ID D04POB D04POB DRUGTYPE Small molecular drug D04POB DRUGINCH 1S/C8H10N2O3S/c1-6(11)10-7-2-4-8(5-3-7)14(9,12)13/h2-5H,1H3,(H,10,11)(H2,9,12,13) D04POB DRUGINKE PKOFBDHYTMYVGJ-UHFFFAOYSA-N D04POB DRUGSMIL CC(=O)NC1=CC=C(C=C1)S(=O)(=O)N D04POB HIGHSTAT Investigative D04POR DRUG__ID D04POR D04POR DRUGTYPE Small molecular drug D04POR DRUGINCH 1S/C29H40N2O3/c1-29-16-15-23-22-10-8-21(34-2)19-20(22)7-9-24(23)25(29)11-12-26(29)30-17-5-3-4-6-18-31-27(32)13-14-28(31)33/h8,10,13-14,19,23-26,30H,3-7,9,11-12,15-18H2,1-2H3/t23-,24-,25+,26+,29+/m1/s1 D04POR DRUGINKE LUFAORPFSVMJIW-ZRJUGLEFSA-N D04POR DRUGSMIL CC12CCC3C(C1CCC2NCCCCCCN4C(=O)C=CC4=O)CCC5=C3C=CC(=C5)OC D04POR HIGHSTAT Investigative D04PPP DRUG__ID D04PPP D04PPP DRUGTYPE Small molecular drug D04PPP DRUGINCH 1S/C46H60N2O4/c49-43(51-35-15-13-33-25-41-37-11-1-3-19-45(37,39(33)27-35)21-23-47(41)29-31-7-5-8-31)17-18-44(50)52-36-16-14-34-26-42-38-12-2-4-20-46(38,40(34)28-36)22-24-48(42)30-32-9-6-10-32/h13-16,27-28,31-32,37-38,41-42H,1-12,17-26,29-30H2/t37?,38?,41-,42-,45-,46-/m1/s1 D04PPP DRUGINKE XZOSATCOBKLHCF-JNDXSTKLSA-N D04PPP DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)CCC(=O)OC5=CC6=C(CC7C8C6(CCCC8)CCN7CC9CCC9)C=C5)CC1CCC1 D04PPP HIGHSTAT Investigative D04PQN DRUG__ID D04PQN D04PQN DRUGTYPE Small molecular drug D04PQN DRUGINCH 1S/C18H15N3O4/c1-11-2-4-12(5-3-11)9-20-18(23)17(22)15-10-19-16-7-6-13(21(24)25)8-14(15)16/h2-8,10,19H,9H2,1H3,(H,20,23) D04PQN DRUGINKE CXKKDMBQHWZSKG-UHFFFAOYSA-N D04PQN DRUGSMIL CC1=CC=C(C=C1)CNC(=O)C(=O)C2=CNC3=C2C=C(C=C3)[N+](=O)[O-] D04PQN HIGHSTAT Investigative D04PQX DRUG__ID D04PQX D04PQX DRUGTYPE Small molecular drug D04PQX DRUGINCH 1S/C15H12N2O/c1-18-14-2-3-15-12(9-14)8-13(10-17-15)11-4-6-16-7-5-11/h2-10H,1H3 D04PQX DRUGINKE BGNDYXHAEMNSOM-UHFFFAOYSA-N D04PQX DRUGSMIL COC1=CC2=CC(=CN=C2C=C1)C3=CC=NC=C3 D04PQX HIGHSTAT Investigative D04PSK DRUG__ID D04PSK D04PSK DRUGTYPE Small molecular drug D04PSK DRUGINCH 1S/C3H6N4O2S3/c1-10-3-6-5-2(11-3)7-12(4,8)9/h1H3,(H,5,7)(H2,4,8,9) D04PSK DRUGINKE AJEMPSSJQSOJKR-UHFFFAOYSA-N D04PSK DRUGSMIL CSC1=NN=C(S1)NS(=O)(=O)N D04PSK HIGHSTAT Investigative D04PTI DRUG__ID D04PTI D04PTI DRUGTYPE Small molecular drug D04PTI DRUGINCH 1S/C17H17NO4/c1-20-15-7-5-13(16(21-2)17(15)22-3)14(19)6-4-12-8-10-18-11-9-12/h4-11H,1-3H3/b6-4+ D04PTI DRUGINKE MPCORTUZMOUOQN-GQCTYLIASA-N D04PTI DRUGSMIL COC1=C(C(=C(C=C1)C(=O)C=CC2=CC=NC=C2)OC)OC D04PTI HIGHSTAT Investigative D04PUK DRUG__ID D04PUK D04PUK DRUGTYPE Small molecular drug D04PUK DRUGINCH 1S/C26H29NO/c28-26(24-14-8-3-9-15-24)17-20-27(21-18-26)19-16-25(22-10-4-1-5-11-22)23-12-6-2-7-13-23/h1-15,25,28H,16-21H2 D04PUK DRUGINKE VJCUYHKRHUNZBN-UHFFFAOYSA-N D04PUK DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)O)CCC(C3=CC=CC=C3)C4=CC=CC=C4 D04PUK HIGHSTAT Investigative D04PYQ DRUG__ID D04PYQ D04PYQ DRUGTYPE Small molecular drug D04PYQ DRUGINCH 1S/C14H19NO2/c1-4-8-15(9-5-1)10-12-11-16-13-6-2-3-7-14(13)17-12/h2-3,6-7,12H,1,4-5,8-11H2 D04PYQ DRUGINKE LYKMMUBOEFYJQG-UHFFFAOYSA-N D04PYQ DRUGSMIL C1CCN(CC1)CC2COC3=CC=CC=C3O2 D04PYQ HIGHSTAT Investigative D04QAC DRUG__ID D04QAC D04QAC DRUGTYPE Small molecular drug D04QAC DRUGINCH 1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7) D04QAC DRUGINKE BTCSSZJGUNDROE-UHFFFAOYSA-N D04QAC DRUGSMIL C(CC(=O)O)CN D04QAC HIGHSTAT Investigative D04QAD DRUG__ID D04QAD D04QAD DRUGTYPE Small molecular drug D04QAD DRUGINCH 1S/C20H20N2OS/c1-20(2,3)16-11-9-15(10-12-16)18(23)22-19-21-17(13-24-19)14-7-5-4-6-8-14/h4-13H,1-3H3,(H,21,22,23) D04QAD DRUGINKE JXOGYJOCFUSOPS-UHFFFAOYSA-N D04QAD DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NC2=NC(=CS2)C3=CC=CC=C3 D04QAD HIGHSTAT Investigative D04QAT DRUG__ID D04QAT D04QAT DRUGTYPE Small molecular drug D04QAT DRUGINCH 1S/C15H10F3NO/c1-10-2-5-12(6-3-10)20-13-7-4-11(9-19)14(8-13)15(16,17)18/h2-8H,1H3 D04QAT DRUGINKE NLEVNQCHSZMRKR-UHFFFAOYSA-N D04QAT DRUGSMIL CC1=CC=C(C=C1)OC2=CC(=C(C=C2)C#N)C(F)(F)F D04QAT HIGHSTAT Investigative D04QBM DRUG__ID D04QBM D04QBM DRUGTYPE Small molecular drug D04QBM DRUGINCH 1S/C25H29F2N5O3/c1-35-24(34)20(10-6-12-30-25(28)29)31-21(33)11-5-9-17-18-13-16(26)14-19(27)23(18)32-22(17)15-7-3-2-4-8-15/h2-4,7-8,13-14,20,32H,5-6,9-12H2,1H3,(H,31,33)(H4,28,29,30)/t20-/m0/s1 D04QBM DRUGINKE OPNMQSFIGUSHDH-FQEVSTJZSA-N D04QBM DRUGSMIL COC(=O)C(CCCN=C(N)N)NC(=O)CCCC1=C(NC2=C1C=C(C=C2F)F)C3=CC=CC=C3 D04QBM HIGHSTAT Investigative D04QCF DRUG__ID D04QCF D04QCF DRUGTYPE Small molecular drug D04QCF DRUGINCH 1S/C20H16N6S/c21-12-15(19-25-17-5-1-2-6-18(17)27-19)16-8-11-24-20(26-16)23-10-7-14-4-3-9-22-13-14/h1-6,8-9,11,13,15H,7,10H2,(H,23,24,26) D04QCF DRUGINKE RCYPVQCPYKNSTG-UHFFFAOYSA-N D04QCF DRUGSMIL C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4 D04QCF HIGHSTAT Investigative D04QDB DRUG__ID D04QDB D04QDB DRUGTYPE Small molecular drug D04QDB DRUGINCH 1S/C19H17F6N5O/c20-12-7-14(22)13(21)6-11(12)10-2-1-9(5-15(10)26)17(31)29-3-4-30-16(8-29)27-28-18(30)19(23,24)25/h1,6-7,10,15H,2-5,8,26H2/t10-,15+/m1/s1 D04QDB DRUGINKE NVVSPGQEXMJZIR-BMIGLBTASA-N D04QDB DRUGSMIL C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C3=CCC(C(C3)N)C4=CC(=C(C=C4F)F)F D04QDB HIGHSTAT Investigative D04QEO DRUG__ID D04QEO D04QEO DRUGTYPE Small molecular drug D04QEO DRUGINCH 1S/C38H46N4O6S2/c1-23-11-10-14-25(17-23)19-31(44)39-29(21-49-4)35(46)40-28(18-24-12-6-5-7-13-24)33(45)37(48)42-22-50-38(2,3)34(42)36(47)41-32-27-16-9-8-15-26(27)20-30(32)43/h5-17,28-30,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t28-,29-,30+,32-,33-,34+/m0/s1 D04QEO DRUGINKE RKUUAMZSZJEKQE-DYCNJNKSSA-N D04QEO DRUGSMIL CC1=CC(=CC=C1)CC(=O)NC(CSC)C(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D04QEO HIGHSTAT Investigative D04QFO DRUG__ID D04QFO D04QFO DRUGTYPE Small molecular drug D04QFO DRUGINCH 1S/C7H12N2/c8-7-4-5-2-1-3-6(5)9-7/h5-6H,1-4H2,(H2,8,9) D04QFO DRUGINKE BJTCDQQHCOHHOO-UHFFFAOYSA-N D04QFO DRUGSMIL C1CC2CC(=NC2C1)N D04QFO HIGHSTAT Investigative D04QFU DRUG__ID D04QFU D04QFU DRUGTYPE Small molecular drug D04QFU DRUGINCH 1S/C12H16O3S/c13-11-6-9(15-7-12(11)14)8-16-10-4-2-1-3-5-10/h6-7,10,14H,1-5,8H2 D04QFU DRUGINKE QOQLSVLZCVJKQA-UHFFFAOYSA-N D04QFU DRUGSMIL C1CCC(CC1)SCC2=CC(=O)C(=CO2)O D04QFU HIGHSTAT Investigative D04QHB DRUG__ID D04QHB D04QHB DRUGTYPE Small molecular drug D04QHB DRUGINCH 1S/C11H14N4/c12-8-10-6-7-13-11(15-10)14-9-4-2-1-3-5-9/h6-7,9H,1-5H2,(H,13,14,15) D04QHB DRUGINKE SOIZAJGZULPDSF-UHFFFAOYSA-N D04QHB DRUGSMIL C1CCC(CC1)NC2=NC=CC(=N2)C#N D04QHB HIGHSTAT Investigative D04QIA DRUG__ID D04QIA D04QIA DRUGTYPE Small molecular drug D04QIA DRUGINCH 1S/C36H47N3O5/c1-27(40)38-18-20-39-19-5-8-30-11-10-28(23-34(30)39)25-44-36-24-37-17-16-33(36)29-12-14-32(15-13-29)43-22-6-21-42-26-31-7-3-4-9-35(31)41-2/h3-4,7,9-15,23,33,36-37H,5-6,8,16-22,24-26H2,1-2H3,(H,38,40)/t33-,36+/m1/s1 D04QIA DRUGINKE YKAHCPSTICMMFK-ILFWFZRHSA-N D04QIA DRUGSMIL CC(=O)NCCN1CCCC2=C1C=C(C=C2)COC3CNCCC3C4=CC=C(C=C4)OCCCOCC5=CC=CC=C5OC D04QIA HIGHSTAT Investigative D04QJK DRUG__ID D04QJK D04QJK DRUGTYPE Small molecular drug D04QJK DRUGINCH 1S/C17H17FN4O2S/c18-11-7-10-12(8-13(11)21-5-3-19-4-6-21)22(9-1-2-9)17-14(15(10)23)16(24)20-25-17/h7-9,19H,1-6H2,(H,20,24) D04QJK DRUGINKE BEZDZMQEVWAVTH-UHFFFAOYSA-N D04QJK DRUGSMIL C1CC1N2C3=CC(=C(C=C3C(=O)C4=C2SNC4=O)F)N5CCNCC5 D04QJK HIGHSTAT Investigative D04QJY DRUG__ID D04QJY D04QJY DRUGTYPE Small molecular drug D04QJY DRUGINCH 1S/C14H18N2O5/c1-9(14(19)20)15-13(18)11(8-12(17)16-21)7-10-5-3-2-4-6-10/h2-6,9,11,21H,7-8H2,1H3,(H,15,18)(H,16,17)(H,19,20)/t9-,11+/m0/s1 D04QJY DRUGINKE OJCFZTVYDSKXNM-GXSJLCMTSA-N D04QJY DRUGSMIL CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)CC(=O)NO D04QJY HIGHSTAT Investigative D04QKN DRUG__ID D04QKN D04QKN DRUGTYPE Small molecular drug D04QKN DRUGINCH 1S/C15H17ClIN3O3/c1-2-14(22)19-3-5-20(6-4-19)15(23)9-18-12-8-11(17)10(16)7-13(12)21/h2,7-8,18,21H,1,3-6,9H2 D04QKN DRUGINKE JFIFBWVNHLXJFY-UHFFFAOYSA-N D04QKN DRUGSMIL C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I D04QKN HIGHSTAT Investigative D04QNI DRUG__ID D04QNI D04QNI DRUGTYPE Small molecular drug D04QNI DRUGINCH 1S/C28H38N2O9/c1-14(2)20-16(4)26(35)27(36,22(20)38-23(33)17-7-6-12-30-17)24(5)13-19(32)39-28(26)21(37-18(31)9-11-29)15(3)8-10-25(24,28)34/h6-7,12,14-15,21-22,30,34-36H,8-11,13,29H2,1-5H3/t15?,21-,22-,24+,25?,26?,27?,28?/m1/s1 D04QNI DRUGINKE NJCSEUYLWFFKSS-FCKNYIKNSA-N D04QNI DRUGSMIL CC1CCC2(C3(CC(=O)OC2(C1OC(=O)CCN)C4(C3(C(C(=C4C)C(C)C)OC(=O)C5=CC=CN5)O)O)C)O D04QNI HIGHSTAT Investigative D04QPK DRUG__ID D04QPK D04QPK DRUGTYPE Small molecular drug D04QPK DRUGINCH 1S/C15H12FN/c16-15-5-1-4-13-12(6-7-14(13)15)9-11-3-2-8-17-10-11/h1-5,8-10H,6-7H2/b12-9+ D04QPK DRUGINKE JKDSUQNXZNYUED-FMIVXFBMSA-N D04QPK DRUGSMIL C1CC2=C(C1=CC3=CN=CC=C3)C=CC=C2F D04QPK HIGHSTAT Investigative D04QRM DRUG__ID D04QRM D04QRM DRUGTYPE Small molecular drug D04QRM DRUGINCH 1S/C19H19N3O2/c1-13(14-7-3-2-4-8-14)20-18(23)12-11-17-21-16-10-6-5-9-15(16)19(24)22-17/h2-10,13H,11-12H2,1H3,(H,20,23)(H,21,22,24)/t13-/m0/s1 D04QRM DRUGINKE QIHBWVVVRYYYRO-ZDUSSCGKSA-N D04QRM DRUGSMIL CC(C1=CC=CC=C1)NC(=O)CCC2=NC3=CC=CC=C3C(=O)N2 D04QRM HIGHSTAT Investigative D04QRS DRUG__ID D04QRS D04QRS DRUGTYPE Small molecular drug D04QRS DRUGINCH 1S/C13H16N2/c1-15-12-5-3-2-4-10(12)11-6-8-14-9-7-13(11)15/h2-5,14H,6-9H2,1H3 D04QRS DRUGINKE ZBXDOQWPGBISAR-UHFFFAOYSA-N D04QRS DRUGSMIL CN1C2=C(CCNCC2)C3=CC=CC=C31 D04QRS HIGHSTAT Investigative D04QUB DRUG__ID D04QUB D04QUB DRUGTYPE Small molecular drug D04QUB DRUGINCH 1S/C23H28O8/c1-12(24)30-16-9-15(20(26)28-4)22(2)7-5-14-21(27)31-17(13-6-8-29-11-13)10-23(14,3)19(22)18(16)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3/t14-,15-,16-,17+,19-,22-,23-/m0/s1 D04QUB DRUGINKE OBSYBRPAKCASQB-KWMFLVSKSA-N D04QUB DRUGSMIL CC(=O)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D04QUB HIGHSTAT Investigative D04QUI DRUG__ID D04QUI D04QUI DRUGTYPE Small molecular drug D04QUI DRUGINCH 1S/C17H10BrIN2O4/c18-13-7-15-14(24-8-25-15)6-9(13)5-12-16(22)20-21(17(12)23)11-3-1-10(19)2-4-11/h1-7H,8H2,(H,20,22)/b12-5- D04QUI DRUGINKE WMFFHUYJLJSDEU-XGICHPGQSA-N D04QUI DRUGSMIL C1OC2=C(O1)C=C(C(=C2)C=C3C(=O)NN(C3=O)C4=CC=C(C=C4)I)Br D04QUI HIGHSTAT Investigative D04QUO DRUG__ID D04QUO D04QUO DRUGTYPE Small molecular drug D04QUO DRUGINCH 1S/C37H46N4O6S/c1-22-16-26(40(5)6)17-23(2)33(22)47-20-30(43)38-28(18-24-12-8-7-9-13-24)32(44)36(46)41-21-48-37(3,4)34(41)35(45)39-31-27-15-11-10-14-25(27)19-29(31)42/h7-17,28-29,31-32,34,42,44H,18-21H2,1-6H3,(H,38,43)(H,39,45)/t28-,29+,31-,32-,34+/m0/s1 D04QUO DRUGINKE MHHYVTRSEKCASG-ZYOXRPPDSA-N D04QUO DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)N(C)C D04QUO HIGHSTAT Investigative D04QVX DRUG__ID D04QVX D04QVX DRUGTYPE Small molecular drug D04QVX DRUGINCH 1S/C11H10N2OS/c1-8-7-12-11(15-8)13-10(14)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14) D04QVX DRUGINKE HEGBNFORMCPFKO-UHFFFAOYSA-N D04QVX DRUGSMIL CC1=CN=C(S1)NC(=O)C2=CC=CC=C2 D04QVX HIGHSTAT Investigative D04QWD DRUG__ID D04QWD D04QWD DRUGTYPE Small molecular drug D04QWD DRUGINCH 1S/C6H10O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-5,7-10H,1H2/t2-,3-,4+,5-/m1/s1 D04QWD DRUGINKE PHOQVHQSTUBQQK-SQOUGZDYSA-N D04QWD DRUGSMIL C(C1C(C(C(C(=O)O1)O)O)O)O D04QWD HIGHSTAT Investigative D04QWX DRUG__ID D04QWX D04QWX DRUGTYPE Small molecular drug D04QWX DRUGINCH 1S/C14H15ClN2/c1-14(2,12-6-4-8-17-10-12)13(15)11-5-3-7-16-9-11/h3-10,13H,1-2H3 D04QWX DRUGINKE VVJXUKVBHKTNGD-UHFFFAOYSA-N D04QWX DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CN=CC=C2)Cl D04QWX HIGHSTAT Investigative D04QYN DRUG__ID D04QYN D04QYN DRUGTYPE Small molecular drug D04QYN DRUGINCH 1S/C7H5N3OS/c12-7-10-9-6(11-7)5-1-3-8-4-2-5/h1-4H,(H,10,12) D04QYN DRUGINKE TXCXZVFDWQYTIC-UHFFFAOYSA-N D04QYN DRUGSMIL C1=CN=CC=C1C2=NNC(=S)O2 D04QYN HIGHSTAT Investigative D04RAW DRUG__ID D04RAW D04RAW DRUGTYPE Small molecular drug D04RAW DRUGINCH 1S/C23H19NO3/c25-21-15-22(24-10-12-26-13-11-24)27-23-19(6-3-7-20(21)23)18-9-8-16-4-1-2-5-17(16)14-18/h1-9,14-15H,10-13H2 D04RAW DRUGINKE OYLGZUQUTITVHN-UHFFFAOYSA-N D04RAW DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC5=CC=CC=C5C=C4 D04RAW HIGHSTAT Investigative D04RBG DRUG__ID D04RBG D04RBG DRUGTYPE Small molecular drug D04RBG DRUGINCH 1S/C21H15N5O3S2/c27-21-15(19-16(25-21)8-9-17-20(19)30-12-24-17)11-23-13-4-6-14(7-5-13)31(28,29)26-18-3-1-2-10-22-18/h1-12,25,27H,(H,22,26) D04RBG DRUGINKE CDNIYBIKHDLGMT-UHFFFAOYSA-N D04RBG DRUGSMIL C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=CC3=C(NC4=C3C5=C(C=C4)N=CS5)O D04RBG HIGHSTAT Investigative D04RBQ DRUG__ID D04RBQ D04RBQ DRUGTYPE Small molecular drug D04RBQ DRUGINCH 1S/C13H13NO/c15-11-3-4-12-10(7-11)2-1-9-5-6-14-8-13(9)12/h1-4,7,14-15H,5-6,8H2 D04RBQ DRUGINKE MWWTWCVGHVVXBZ-UHFFFAOYSA-N D04RBQ DRUGSMIL C1CNCC2=C1C=CC3=C2C=CC(=C3)O D04RBQ HIGHSTAT Investigative D04RBU DRUG__ID D04RBU D04RBU DRUGTYPE Small molecular drug D04RBU DRUGINCH 1S/C28H36N4O2/c1-2-12-31(23-10-11-24-21(19-23)7-5-9-27(24)33)16-13-30-14-17-32(18-15-30)28(34)26-20-22-6-3-4-8-25(22)29-26/h3-9,20,23,29,33H,2,10-19H2,1H3/t23-/m0/s1 D04RBU DRUGINKE DQMMOHPPKACCQN-QHCPKHFHSA-N D04RBU DRUGSMIL CCCN(CCN1CCN(CC1)C(=O)C2=CC3=CC=CC=C3N2)C4CCC5=C(C4)C=CC=C5O D04RBU HIGHSTAT Investigative D04RCR DRUG__ID D04RCR D04RCR DRUGTYPE Small molecular drug D04RCR DRUGINCH 1S/C9H11BO2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-6,8,11-12H,7H2/b8-4+ D04RCR DRUGINKE GMGWFDHLFMBIDS-XBXARRHUSA-N D04RCR DRUGSMIL B(C=CCC1=CC=CC=C1)(O)O D04RCR HIGHSTAT Investigative D04REX DRUG__ID D04REX D04REX DRUGTYPE Small molecular drug D04REX DRUGINCH 1S/C14H11FN2/c15-13-3-4-14-11(1-2-12(14)6-13)5-10-7-16-9-17-8-10/h3-9H,1-2H2/b11-5- D04REX DRUGINKE LEJPKWXGQFBXRX-WZUFQYTHSA-N D04REX DRUGSMIL C1CC(=CC2=CN=CN=C2)C3=C1C=C(C=C3)F D04REX HIGHSTAT Investigative D04RHI DRUG__ID D04RHI D04RHI DRUGTYPE Small molecular drug D04RHI DRUGINCH 1S/C25H30O7/c1-6-27-16-11-12-18(19(13-16)29-8-3)24-25(31-10-5)23(26)22-20(30-9-4)14-17(28-7-2)15-21(22)32-24/h11-15H,6-10H2,1-5H3 D04RHI DRUGINKE JVGSHXMDRPGOQM-UHFFFAOYSA-N D04RHI DRUGSMIL CCOC1=CC(=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OCC)OCC)OCC)OCC D04RHI HIGHSTAT Investigative D04RNU DRUG__ID D04RNU D04RNU DRUGTYPE Small molecular drug D04RNU DRUGINCH 1S/C11H11N5O2/c12-9-8(16-17)10(15-11(13)14-9)18-6-7-4-2-1-3-5-7/h1-5H,6H2,(H4,12,13,14,15) D04RNU DRUGINKE MBQPVHNJEDDVCF-UHFFFAOYSA-N D04RNU DRUGSMIL C1=CC=C(C=C1)COC2=NC(=NC(=C2N=O)N)N D04RNU HIGHSTAT Investigative D04RPI DRUG__ID D04RPI D04RPI DRUGTYPE Small molecular drug D04RPI DRUGINCH 1S/C40H44N6O5/c1-23-16-26(17-24(2)36(23)47)19-31(41)40(51)46-15-7-12-35(46)39(50)45-34(21-29-22-43-32-11-6-5-10-30(29)32)38(49)44-33(37(42)48)20-25-13-14-27-8-3-4-9-28(27)18-25/h3-6,8-11,13-14,16-18,22,31,33-35,43,47H,7,12,15,19-21,41H2,1-2H3,(H2,42,48)(H,44,49)(H,45,50)/t31-,33+,34-,35-/m0/s1 D04RPI DRUGINKE DAHITVLHYSLLFU-ZFOKTMFVSA-N D04RPI DRUGSMIL CC1=CC(=CC(=C1O)C)CC(C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC6=CC=CC=C6C=C5)C(=O)N)N D04RPI HIGHSTAT Investigative D04RQG DRUG__ID D04RQG D04RQG DRUGTYPE Small molecular drug D04RQG DRUGINCH 1S/C14H12N2O/c17-14-12-8-4-5-9-13(12)16(15-14)10-11-6-2-1-3-7-11/h1-9H,10H2,(H,15,17) D04RQG DRUGINKE SXPJFDSMKWLOAB-UHFFFAOYSA-N D04RQG DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=O)N2 D04RQG HIGHSTAT Investigative D04RQU DRUG__ID D04RQU D04RQU DRUGTYPE Small molecular drug D04RQU DRUGINCH 1S/C14H10N2O/c1-7-5-9-8-3-2-4-11-13(8)10(14(17)16-11)6-12(9)15-7/h2-6,15H,1H3,(H,16,17) D04RQU DRUGINKE ACTSTIBGWRUXHI-UHFFFAOYSA-N D04RQU DRUGSMIL CC1=CC2=C(N1)C=C3C4=C2C=CC=C4NC3=O D04RQU HIGHSTAT Investigative D04RSC DRUG__ID D04RSC D04RSC DRUGTYPE Small molecular drug D04RSC DRUGINCH 1S/C44H69N7O15/c1-22(2)17-29(47-42(63)31(21-36(57)58)49-41(62)30(18-23(3)4)48-39(60)27(45)13-15-34(53)54)33(52)19-25(7)38(59)51-37(24(5)6)43(64)46-28(14-16-35(55)56)40(61)50-32(44(65)66)20-26-11-9-8-10-12-26/h8-12,22-25,27-33,37,52H,13-21,45H2,1-7H3,(H,46,64)(H,47,63)(H,48,60)(H,49,62)(H,50,61)(H,51,59)(H,53,54)(H,55,56)(H,57,58)(H,65,66)/t25-,27+,28+,29+,30+,31+,32+,33+,37+/m1/s1 D04RSC DRUGINKE CFIWWTUUSMMDDA-IQRKPKHNSA-N D04RSC DRUGSMIL CC(C)CC(C(CC(C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)N D04RSC HIGHSTAT Investigative D04RTY DRUG__ID D04RTY D04RTY DRUGTYPE Small molecular drug D04RTY DRUGINCH 1S/C20H17NO4/c22-17-14(11-13-7-3-1-4-8-13)12-16(18(23)19(17)24)20(25)21-15-9-5-2-6-10-15/h1-10,12,22-24H,11H2,(H,21,25) D04RTY DRUGINKE QFCGWKILQYTRID-UHFFFAOYSA-N D04RTY DRUGSMIL C1=CC=C(C=C1)CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=CC=C3 D04RTY HIGHSTAT Investigative D04RUF DRUG__ID D04RUF D04RUF DRUGTYPE Small molecular drug D04RUF DRUGINCH 1S/C14H23NS/c1-4-13(15-5-2)11-12-7-9-14(10-8-12)16-6-3/h7-10,13,15H,4-6,11H2,1-3H3 D04RUF DRUGINKE FXAXBZLCZVSQJT-UHFFFAOYSA-N D04RUF DRUGSMIL CCC(CC1=CC=C(C=C1)SCC)NCC D04RUF HIGHSTAT Investigative D04RUS DRUG__ID D04RUS D04RUS DRUGTYPE Small molecular drug D04RUS DRUGINCH 1S/C33H35Cl2N3O6S/c1-33(2)30(31(42)37-27-21-12-7-6-11-20(21)16-25(27)39)38(18-45-33)32(43)28(41)24(15-19-9-4-3-5-10-19)36-26(40)17-44-29-22(34)13-8-14-23(29)35/h3-14,24-25,27-28,30,39,41H,15-18H2,1-2H3,(H,36,40)(H,37,42)/t24-,25+,27-,28-,30+/m0/s1 D04RUS DRUGINKE XMAMZSZKRBFNLW-UPZHSWQNSA-N D04RUS DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=C(C=CC=C3Cl)Cl)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D04RUS HIGHSTAT Investigative D04RVA DRUG__ID D04RVA D04RVA DRUGTYPE Small molecular drug D04RVA DRUGINCH 1S/C26H32N2O8S/c1-12(29)27-16-7-5-13-9-17(28-26-23(33)22(32)19(31)11-36-26)24(34-2)25(35-3)21(13)14-6-8-20(37-4)18(30)10-15(14)16/h6,8-10,16,19,22-23,26,28,31-33H,5,7,11H2,1-4H3,(H,27,29)/t16-,19+,22-,23-,26?/m0/s1 D04RVA DRUGINKE MCKYAFJMJJFRCX-NFKHFCJPSA-N D04RVA DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)NC4C(C(C(CO4)O)O)O D04RVA HIGHSTAT Investigative D04RVW DRUG__ID D04RVW D04RVW DRUGTYPE Small molecular drug D04RVW DRUGINCH 1S/C17H12N2S/c1-13-19-16(12-20-13)9-7-14-8-10-17(18-11-14)15-5-3-2-4-6-15/h2-6,8,10-12H,1H3 D04RVW DRUGINKE OUYHNXKLIHUODF-UHFFFAOYSA-N D04RVW DRUGSMIL CC1=NC(=CS1)C#CC2=CN=C(C=C2)C3=CC=CC=C3 D04RVW HIGHSTAT Investigative D04RYE DRUG__ID D04RYE D04RYE DRUGTYPE Small molecular drug D04RYE DRUGINCH 1S/C16H13N5OS/c1-8-3-5-10(6-4-8)21-7-18-12-11-14(17)19-9(2)20-15(11)23-13(12)16(21)22/h3-7H,1-2H3,(H2,17,19,20) D04RYE DRUGINKE RIMQNIZNDUNPQK-UHFFFAOYSA-N D04RYE DRUGSMIL CC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=NC(=NC(=C34)N)C D04RYE HIGHSTAT Investigative D04SAO DRUG__ID D04SAO D04SAO DRUGTYPE Small molecular drug D04SAO DRUGINCH 1S/C25H22O3/c1-2-23(19-6-4-3-5-7-19)25(21-13-15-22(26)16-14-21)20-11-8-18(9-12-20)10-17-24(27)28/h3-17,26H,2H2,1H3,(H,27,28)/b17-10+,25-23+ D04SAO DRUGINKE SCVIEONTACSLJA-YGCRUXFTSA-N D04SAO DRUGSMIL CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC=C(C=C2)O)C3=CC=CC=C3 D04SAO HIGHSTAT Investigative D04SCD DRUG__ID D04SCD D04SCD DRUGTYPE Small molecular drug D04SCD DRUGINCH 1S/C13H12ClNO3/c14-9-1-2-12-10(7-9)11(8-13(16)18-12)15-3-5-17-6-4-15/h1-2,7-8H,3-6H2 D04SCD DRUGINKE IKOYKMNERRYCAN-UHFFFAOYSA-N D04SCD DRUGSMIL C1COCCN1C2=CC(=O)OC3=C2C=C(C=C3)Cl D04SCD HIGHSTAT Investigative D04SCQ DRUG__ID D04SCQ D04SCQ DRUGTYPE Small molecular drug D04SCQ DRUGINCH 1S/C16H19N/c17-13-7-12-16(14-8-3-1-4-9-14)15-10-5-2-6-11-15/h1-6,8-11,16H,7,12-13,17H2 D04SCQ DRUGINKE MAAQGZFMFXQVOG-UHFFFAOYSA-N D04SCQ DRUGSMIL C1=CC=C(C=C1)C(CCCN)C2=CC=CC=C2 D04SCQ HIGHSTAT Investigative D04SDD DRUG__ID D04SDD D04SDD DRUGTYPE Small molecular drug D04SDD DRUGINCH 1S/C18H20IN5O4/c1-27-15-14(26)12(7-25)28-18(15)24-9-23-13-16(21-8-22-17(13)24)20-6-10-3-2-4-11(19)5-10/h2-5,8-9,12,14-15,18,25-26H,6-7H2,1H3,(H,20,21,22)/t12-,14-,15-,18-/m1/s1 D04SDD DRUGINKE OATZXEKAXIIRDK-SCFUHWHPSA-N D04SDD DRUGSMIL COC1C(C(OC1N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)CO)O D04SDD HIGHSTAT Investigative D04SEX DRUG__ID D04SEX D04SEX DRUGTYPE Small molecular drug D04SEX DRUGINCH 1S/C22H24O2/c1-3-13-9-15-11-17(23)6-8-20(15)22-14(4-2)10-16-12-18(24)5-7-19(16)21(13)22/h5-8,11-14,23-24H,3-4,9-10H2,1-2H3/t13-,14-/m1/s1 D04SEX DRUGINKE MASYAWHPJCQLSW-ZIAGYGMSSA-N D04SEX DRUGSMIL CCC1CC2=C(C=CC(=C2)O)C3=C1C4=C(CC3CC)C=C(C=C4)O D04SEX HIGHSTAT Investigative D04SFK DRUG__ID D04SFK D04SFK DRUGTYPE Small molecular drug D04SFK DRUGINCH 1S/C37H38N4O6/c38-30(19-26-15-17-29(42)18-16-26)36(45)41-23-28-14-8-7-13-27(28)22-33(41)35(44)39-31(20-24-9-3-1-4-10-24)34(43)40-32(37(46)47)21-25-11-5-2-6-12-25/h1-18,30-33,42H,19-23,38H2,(H,39,44)(H,40,43)(H,46,47)/t30-,31-,32-,33-/m0/s1 D04SFK DRUGINKE JYOUATXRHWNDDW-YRCZKMHPSA-N D04SFK DRUGSMIL C1C(N(CC2=CC=CC=C21)C(=O)C(CC3=CC=C(C=C3)O)N)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)O D04SFK HIGHSTAT Investigative D04SFM DRUG__ID D04SFM D04SFM DRUGTYPE Small molecular drug D04SFM DRUGINCH 1S/C28H25F2N3OS/c29-22-9-5-19(6-10-22)26(20-7-11-23(30)12-8-20)21-13-15-32(16-14-21)17-18-33-27(34)24-3-1-2-4-25(24)31-28(33)35/h1-12H,13-18H2,(H,31,35) D04SFM DRUGINKE ZCNBZFRECRPCKU-UHFFFAOYSA-N D04SFM DRUGSMIL C1CN(CCC1=C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCN4C(=O)C5=CC=CC=C5NC4=S D04SFM HIGHSTAT Investigative D04SHY DRUG__ID D04SHY D04SHY DRUGTYPE Small molecular drug D04SHY DRUGINCH 1S/C18H18N2O2/c1-2-18(20-8-7-19-12-20)14-5-3-13(4-6-14)15-9-16(21)11-17(22)10-15/h3-12,18,21-22H,2H2,1H3 D04SHY DRUGINKE VBHJJDVRMJRXQC-UHFFFAOYSA-N D04SHY DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC(=CC(=C2)O)O)N3C=CN=C3 D04SHY HIGHSTAT Investigative D04SIT DRUG__ID D04SIT D04SIT DRUGTYPE Small molecular drug D04SIT DRUGINCH 1S/C9H10BrF2N/c1-5(13)2-6-3-9(12)7(10)4-8(6)11/h3-5H,2,13H2,1H3 D04SIT DRUGINKE TWIJKLXSGANTJL-UHFFFAOYSA-N D04SIT DRUGSMIL CC(CC1=CC(=C(C=C1F)Br)F)N D04SIT HIGHSTAT Investigative D04SJC DRUG__ID D04SJC D04SJC DRUGTYPE Small molecular drug D04SJC DRUGINCH 1S/C13H18ClN3O2/c14-12-3-2-11(10-16-12)13(18)15-4-1-5-17-6-8-19-9-7-17/h2-3,10H,1,4-9H2,(H,15,18) D04SJC DRUGINKE CNQVNEPLCSJWDF-UHFFFAOYSA-N D04SJC DRUGSMIL C1COCCN1CCCNC(=O)C2=CN=C(C=C2)Cl D04SJC HIGHSTAT Investigative D04SKW DRUG__ID D04SKW D04SKW DRUGTYPE Small molecular drug D04SKW DRUGINCH 1S/C24H28N4O4/c1-3-25-11-9-21(29)27-15-5-7-17-19(13-15)24(32)20-14-16(6-8-18(20)23(17)31)28-22(30)10-12-26-4-2/h5-8,13-14,25-26H,3-4,9-12H2,1-2H3,(H,27,29)(H,28,30) D04SKW DRUGINKE HJVRZEPJBMFCNQ-UHFFFAOYSA-N D04SKW DRUGSMIL CCNCCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CCNCC D04SKW HIGHSTAT Investigative D04SLM DRUG__ID D04SLM D04SLM DRUGTYPE Small molecular drug D04SLM DRUGINCH 1S/C16H24O5/c1-10(2)5-6-12-14(3,21-12)16(18)13(19-4)11(17)7-8-15(16)9-20-15/h5,12-13,18H,6-9H2,1-4H3/t12-,13-,14+,15+,16+/m1/s1 D04SLM DRUGINKE NESRXFGQJARQNM-OWYFMNJBSA-N D04SLM DRUGSMIL CC(=CCC1C(O1)(C)C2(C(C(=O)CCC23CO3)OC)O)C D04SLM HIGHSTAT Investigative D04SMQ DRUG__ID D04SMQ D04SMQ DRUGTYPE Small molecular drug D04SMQ DRUGINCH 1S/C7H9N3O4/c8-4(6(12)13)3-10-2-1-5(11)9-7(10)14/h1-2,4H,3,8H2,(H,12,13)(H,9,11,14)/t4-/m0/s1 D04SMQ DRUGINKE FACUYWPMDKTVFU-BYPYZUCNSA-N D04SMQ DRUGSMIL C1=CN(C(=O)NC1=O)CC(C(=O)O)N D04SMQ HIGHSTAT Investigative D04SNH DRUG__ID D04SNH D04SNH DRUGTYPE Small molecular drug D04SNH DRUGINCH 1S/C12H12N2O3S/c13-18(16,17)12-9-14(7-6-11(12)15)8-10-4-2-1-3-5-10/h1-7,9H,8H2,(H2,13,16,17) D04SNH DRUGINKE WIIFYOJVUKTZDG-UHFFFAOYSA-N D04SNH DRUGSMIL C1=CC=C(C=C1)CN2C=CC(=O)C(=C2)S(=O)(=O)N D04SNH HIGHSTAT Investigative D04SPO DRUG__ID D04SPO D04SPO DRUGTYPE Small molecular drug D04SPO DRUGINCH 1S/C27H32O13/c1-35-15-6-3-13(4-7-15)5-8-19(30)38-17-9-14(10-28)20-21(17)16(25(34)36-2)12-37-26(20)40-27-24(33)23(32)22(31)18(11-29)39-27/h3-9,12,17-18,20-24,26-29,31-33H,10-11H2,1-2H3/b8-5+/t17-,18-,20-,21+,22-,23+,24-,26+,27+/m1/s1 D04SPO DRUGINKE VBHBNHXZBKWQNO-BIIYMWGFSA-N D04SPO DRUGSMIL COC1=CC=C(C=C1)C=CC(=O)OC2C=C(C3C2C(=COC3OC4C(C(C(C(O4)CO)O)O)O)C(=O)OC)CO D04SPO HIGHSTAT Investigative D04SPQ DRUG__ID D04SPQ D04SPQ DRUGTYPE Small molecular drug D04SPQ DRUGINCH 1S/C37H49N5O3/c1-8-9-18-42-35-29(16-11-17-39-35)32(26-14-10-15-28(20-26)45-19-12-13-23(2)3)34(36(42)43)41-37(44)40-33-30(24(4)5)21-27(38)22-31(33)25(6)7/h10-11,14-17,20-25H,8-9,12-13,18-19,38H2,1-7H3,(H2,40,41,44) D04SPQ DRUGINKE PRCCYAKPEIWHCQ-UHFFFAOYSA-N D04SPQ DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OCCCC(C)C D04SPQ HIGHSTAT Investigative D04SQY DRUG__ID D04SQY D04SQY DRUGTYPE Small molecular drug D04SQY DRUGINCH 1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1 D04SQY DRUGINKE ZESRJSPZRDMNHY-YFWFAHHUSA-N D04SQY DRUGSMIL CC12CCC3C(C1CCC2C(=O)CO)CCC4=CC(=O)CCC34C D04SQY HIGHSTAT Investigative D04STF DRUG__ID D04STF D04STF DRUGTYPE Small molecular drug D04STF DRUGINCH 1S/C22H14N2O2/c1-12-6-8-13(9-7-12)22-23-17-11-10-16-18(19(17)24-22)21(26)15-5-3-2-4-14(15)20(16)25/h2-11H,1H3,(H,23,24) D04STF DRUGINKE MRHQJLSJDVEZQP-UHFFFAOYSA-N D04STF DRUGSMIL CC1=CC=C(C=C1)C2=NC3=C(N2)C=CC4=C3C(=O)C5=CC=CC=C5C4=O D04STF HIGHSTAT Investigative D04SVT DRUG__ID D04SVT D04SVT DRUGTYPE Small molecular drug D04SVT DRUGINCH 1S/C31H34N8O2/c1-5-6-11-28-33-27-17-16-23(32-31(41)38(4)20(2)3)18-26(27)30(40)39(28)19-21-12-14-22(15-13-21)24-9-7-8-10-25(24)29-34-36-37-35-29/h7-10,12-18,20H,5-6,11,19H2,1-4H3,(H,32,41)(H,34,35,36,37) D04SVT DRUGINKE XUXPOYGCLABTCS-UHFFFAOYSA-N D04SVT DRUGSMIL CCCCC1=NC2=C(C=C(C=C2)NC(=O)N(C)C(C)C)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5 D04SVT HIGHSTAT Investigative D04SYM DRUG__ID D04SYM D04SYM DRUGTYPE Small molecular drug D04SYM DRUGINCH 1S/C8H12N2O7/c1-9-8(11)16-4-2-14-7-5(17-10(12)13)3-15-6(4)7/h4-7H,2-3H2,1H3,(H,9,11)/t4-,5+,6+,7+/m0/s1 D04SYM DRUGINKE DEDWFQACIHPQHF-BDVNFPICSA-N D04SYM DRUGSMIL CNC(=O)OC1COC2C1OCC2O[N+](=O)[O-] D04SYM HIGHSTAT Investigative D04SZR DRUG__ID D04SZR D04SZR DRUGTYPE Small molecular drug D04SZR DRUGINCH 1S/C13H16O4S/c14-12(15)10-5-3-9(4-6-10)8-11(13(16)17)2-1-7-18/h3-6,11,18H,1-2,7-8H2,(H,14,15)(H,16,17) D04SZR DRUGINKE WDVWCNCIBNEXCG-UHFFFAOYSA-N D04SZR DRUGSMIL C1=CC(=CC=C1CC(CCCS)C(=O)O)C(=O)O D04SZR HIGHSTAT Investigative D04TBB DRUG__ID D04TBB D04TBB DRUGTYPE Small molecular drug D04TBB DRUGINCH 1S/C15H22O3/c1-8-4-5-11-12(8)13-10(6-7-15(11,3)17)9(2)14(16)18-13/h4,9-13,17H,5-7H2,1-3H3/t9-,10-,11+,12-,13-,15-/m0/s1 D04TBB DRUGINKE CWACFPQPFUIHTR-WBSYEDSCSA-N D04TBB DRUGSMIL CC1C2CCC(C3CC=C(C3C2OC1=O)C)(C)O D04TBB HIGHSTAT Investigative D04TBJ DRUG__ID D04TBJ D04TBJ DRUGTYPE Small molecular drug D04TBJ DRUGINCH 1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6) D04TBJ DRUGINKE SUHOOTKUPISOBE-UHFFFAOYSA-N D04TBJ DRUGSMIL C(COP(=O)(O)O)N D04TBJ HIGHSTAT Investigative D04TDX DRUG__ID D04TDX D04TDX DRUGTYPE Small molecular drug D04TDX DRUGINCH 1S/C17H14N2O2/c1-21-13-8-5-11(6-9-13)15-10-7-12-3-2-4-14(17(18)20)16(12)19-15/h2-10H,1H3,(H2,18,20) D04TDX DRUGINKE HJJCORRFLXJIBM-UHFFFAOYSA-N D04TDX DRUGSMIL COC1=CC=C(C=C1)C2=NC3=C(C=CC=C3C(=O)N)C=C2 D04TDX HIGHSTAT Investigative D04TED DRUG__ID D04TED D04TED DRUGTYPE Small molecular drug D04TED DRUGINCH 1S/C37H49N11O6/c1-48-30(9-5-17-43-37(40)41)34(53)47-28(19-22-11-14-26(49)15-12-22)32(51)44-21-31(50)45-29(20-23-10-13-24-6-2-3-7-25(24)18-23)33(52)46-27(35(48)54)8-4-16-42-36(38)39/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,50)(H,46,52)(H,47,53)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30-/m0/s1 D04TED DRUGINKE ACYXHFQQOQRMGX-XJYHXZFBSA-N D04TED DRUGSMIL CN1C(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C1=O)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O)CCCN=C(N)N D04TED HIGHSTAT Investigative D04TGN DRUG__ID D04TGN D04TGN DRUGTYPE Small molecular drug D04TGN DRUGINCH 1S/C10H6O4/c11-9-6-3-1-2-4-8(6)14-5-7(9)10(12)13/h1-5H,(H,12,13) D04TGN DRUGINKE PCIITXGDSHXTSN-UHFFFAOYSA-N D04TGN DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=CO2)C(=O)O D04TGN HIGHSTAT Investigative D04TIO DRUG__ID D04TIO D04TIO DRUGTYPE Small molecular drug D04TIO DRUGINCH 1S/C36H47N11O6/c37-35(38)41-15-3-7-26-32(51)45-27(8-4-16-42-36(39)40)33(52)47-28(19-22-9-12-23-5-1-2-6-24(23)17-22)31(50)43-20-30(49)44-29(34(53)46-26)18-21-10-13-25(48)14-11-21/h1-2,5-6,9-14,17,26-29,48H,3-4,7-8,15-16,18-20H2,(H,43,50)(H,44,49)(H,45,51)(H,46,53)(H,47,52)(H4,37,38,41)(H4,39,40,42)/t26-,27-,28-,29+/m0/s1 D04TIO DRUGINKE MBXBICVKLVYNKD-XFTNXAEASA-N D04TIO DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC3=CC=CC=C3C=C2)CCCN=C(N)N)CCCN=C(N)N)CC4=CC=C(C=C4)O D04TIO HIGHSTAT Investigative D04TIS DRUG__ID D04TIS D04TIS DRUGTYPE Small molecular drug D04TIS DRUGINCH 1S/C12H28O7P2/c1-2-3-4-5-6-7-8-9-10-11-12(13,20(14,15)16)21(17,18)19/h13H,2-11H2,1H3,(H2,14,15,16)(H2,17,18,19) D04TIS DRUGINKE KKVZONPEMODBBG-UHFFFAOYSA-N D04TIS DRUGSMIL CCCCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O D04TIS HIGHSTAT Investigative D04TKG DRUG__ID D04TKG D04TKG DRUGTYPE Small molecular drug D04TKG DRUGINCH 1S/C25H38O3/c1-18(11-7-13-21-17-23(26)28-24(21)27)9-6-10-19(2)14-15-22-20(3)12-8-16-25(22,4)5/h10-11,17,24,27H,6-9,12-16H2,1-5H3/b18-11+,19-10+ D04TKG DRUGINKE JPWPYTMXSXYUPG-QZPYEDBESA-N D04TKG DRUGSMIL CC1=C(C(CCC1)(C)C)CCC(=CCCC(=CCCC2=CC(=O)OC2O)C)C D04TKG HIGHSTAT Investigative D04TLB DRUG__ID D04TLB D04TLB DRUGTYPE Small molecular drug D04TLB DRUGINCH 1S/C4H5N5O2/c5-2-1(9-11)3(10)8-4(6)7-2/h(H5,5,6,7,8,10) D04TLB DRUGINKE HVMRLFSFHWCUCG-UHFFFAOYSA-N D04TLB DRUGSMIL C1(=C(N=C(NC1=O)N)N)N=O D04TLB HIGHSTAT Investigative D04TLI DRUG__ID D04TLI D04TLI DRUGTYPE Small molecular drug D04TLI DRUGINCH 1S/C17H17N5O3S/c1-11-5-6-13(23)10-15(11)21-16-7-8-19-17(22-16)20-12-3-2-4-14(9-12)26(18,24)25/h2-10,23H,1H3,(H2,18,24,25)(H2,19,20,21,22) D04TLI DRUGINKE LKLIRPMEYRVLFV-UHFFFAOYSA-N D04TLI DRUGSMIL CC1=C(C=C(C=C1)O)NC2=NC(=NC=C2)NC3=CC(=CC=C3)S(=O)(=O)N D04TLI HIGHSTAT Investigative D04TMV DRUG__ID D04TMV D04TMV DRUGTYPE Small molecular drug D04TMV DRUGINCH 1S/C31H54N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-20,24-26,30,39,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/t19-,20-,24-,25-,26+,30-/m1/s1 D04TMV DRUGINKE HIVSMYZAMUNFKZ-PDQACDDGSA-N D04TMV DRUGSMIL CCCCCCCC(CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O)O D04TMV HIGHSTAT Investigative D04TNI DRUG__ID D04TNI D04TNI DRUGTYPE Small molecular drug D04TNI DRUGINCH 1S/C19H20FNO5/c1-14(19(22)25-11-5-6-12-26-21(23)24)16-9-10-17(18(20)13-16)15-7-3-2-4-8-15/h2-4,7-10,13-14H,5-6,11-12H2,1H3 D04TNI DRUGINKE DLWSRGHNJVLJAH-UHFFFAOYSA-N D04TNI DRUGSMIL CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)OCCCCO[N+](=O)[O-] D04TNI HIGHSTAT Investigative D04TPA DRUG__ID D04TPA D04TPA DRUGTYPE Small molecular drug D04TPA DRUGINCH 1S/C19H19N7O/c1-11-3-4-15(7-16(11)22-12(2)27)23-17-8-18(24-14-5-6-14)26-19(25-17)13(9-20)10-21-26/h3-4,7-8,10,14,24H,5-6H2,1-2H3,(H,22,27)(H,23,25) D04TPA DRUGINKE GDSQVLMYYCNAGP-UHFFFAOYSA-N D04TPA DRUGSMIL CC1=C(C=C(C=C1)NC2=NC3=C(C=NN3C(=C2)NC4CC4)C#N)NC(=O)C D04TPA HIGHSTAT Investigative D04TPC DRUG__ID D04TPC D04TPC DRUGTYPE Small molecular drug D04TPC DRUGINCH 1S/C19H29N5/c1-14(2)11-20-17-10-18(21-13-16-8-6-5-7-9-16)24-19(23-17)22-12-15(3)4/h5-10,14-15H,11-13H2,1-4H3,(H3,20,21,22,23,24) D04TPC DRUGINKE ZOQDUFOUNDLFCC-UHFFFAOYSA-N D04TPC DRUGSMIL CC(C)CNC1=NC(=NC(=C1)NCC2=CC=CC=C2)NCC(C)C D04TPC HIGHSTAT Investigative D04TPO DRUG__ID D04TPO D04TPO DRUGTYPE Small molecular drug D04TPO DRUGINCH 1S/C9H10ClN3/c1-5-8-6(10)3-2-4-7(8)13-9(11)12-5/h2-5H,1H3,(H3,11,12,13) D04TPO DRUGINKE XFMPGBXLGWZMQP-UHFFFAOYSA-N D04TPO DRUGSMIL CC1C2=C(C=CC=C2Cl)NC(=N1)N D04TPO HIGHSTAT Investigative D04TQF DRUG__ID D04TQF D04TQF DRUGTYPE Small molecular drug D04TQF DRUGINCH 1S/C22H22O2/c1-23-21-12-7-10-18(16-21)14-15-20-11-5-6-13-22(20)24-17-19-8-3-2-4-9-19/h2-13,16H,14-15,17H2,1H3 D04TQF DRUGINKE SDDBNQDQBZPCGB-UHFFFAOYSA-N D04TQF DRUGSMIL COC1=CC=CC(=C1)CCC2=CC=CC=C2OCC3=CC=CC=C3 D04TQF HIGHSTAT Investigative D04TSL DRUG__ID D04TSL D04TSL DRUGTYPE Small molecular drug D04TSL DRUGINCH 1S/C21H34O2/c1-4-13-21(2,3)18-10-7-17(8-11-18)20-15-19(23)12-9-16(20)6-5-14-22/h7-8,10-11,16,19-20,22-23H,4-6,9,12-15H2,1-3H3/t16-,19-,20-/m1/s1 D04TSL DRUGINKE VIGWEDJLUIAROG-NSISKUIASA-N D04TSL DRUGSMIL CCCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D04TSL HIGHSTAT Investigative D04TTB DRUG__ID D04TTB D04TTB DRUGTYPE Small molecular drug D04TTB DRUGINCH 1S/C30H48O4/c1-25(2)13-14-26(3)15-16-30(24(33)34)19(20(26)17-25)7-8-22-27(4)11-10-23(32)28(5,18-31)21(27)9-12-29(22,30)6/h7,20-23,31-32H,8-18H2,1-6H3,(H,33,34)/t20-,21?,22+,23+,26+,27-,28+,29+,30+/m0/s1 D04TTB DRUGINKE HQGWITLOHQUPBL-NFHCHMPHSA-N D04TTB DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1)C(=O)O)C)C D04TTB HIGHSTAT Investigative D04TTN DRUG__ID D04TTN D04TTN DRUGTYPE Small molecular drug D04TTN DRUGINCH 1S/C37H42N2O6.ClH/c1-38-14-12-25-19-35(43-4)32(40)21-28(25)30(38)16-23-6-9-27(10-7-23)45-37-18-24(8-11-34(37)42-3)17-31-29-22-33(41)36(44-5)20-26(29)13-15-39(31)2;/h6-11,18-22,30-31,40-41H,12-17H2,1-5H3;1H/t30-,31+;/m0./s1 D04TTN DRUGINKE NSNGMSCZFBHCEX-LBYXUWKHSA-N D04TTN DRUGSMIL CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)O)OC)O)OC.Cl D04TTN HIGHSTAT Investigative D04TTP DRUG__ID D04TTP D04TTP DRUGTYPE Small molecular drug D04TTP DRUGINCH 1S/C11H6Br2N2O/c12-6-3-7-9(10(13)11(6)16)5-1-2-14-4-8(5)15-7/h1-4,15-16H D04TTP DRUGINKE UNIUKKWPGRGSRQ-UHFFFAOYSA-N D04TTP DRUGSMIL C1=CN=CC2=C1C3=C(C(=C(C=C3N2)Br)O)Br D04TTP HIGHSTAT Investigative D04TVG DRUG__ID D04TVG D04TVG DRUGTYPE Small molecular drug D04TVG DRUGINCH 1S/C25H27ClN2O/c26-22-12-7-13-23(18-22)28-16-14-27(15-17-28)19-24(29)25(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-13,18,24-25,29H,14-17,19H2 D04TVG DRUGINKE QJHCTHPYUOXOGM-UHFFFAOYSA-N D04TVG DRUGSMIL C1CN(CCN1CC(C(C2=CC=CC=C2)C3=CC=CC=C3)O)C4=CC(=CC=C4)Cl D04TVG HIGHSTAT Investigative D04TVP DRUG__ID D04TVP D04TVP DRUGTYPE Small molecular drug D04TVP DRUGINCH 1S/C12H18N2O4/c1-8(15)17-7-3-6-13-9-4-2-5-10-11(9)12(16)14-18-10/h9,13H,2-7H2,1H3,(H,14,16) D04TVP DRUGINKE BQHOBAROVZNICB-UHFFFAOYSA-N D04TVP DRUGSMIL CC(=O)OCCCNC1CCCC2=C1C(=O)NO2 D04TVP HIGHSTAT Investigative D04TVU DRUG__ID D04TVU D04TVU DRUGTYPE Small molecular drug D04TVU DRUGINCH 1S/C18H28N2O2/c1-17-6-5-11(21)7-10(17)3-4-12-13-8-15(19)20-18(13,2)9-14(22)16(12)17/h10-13,16,21H,3-9H2,1-2H3,(H2,19,20)/t10-,11-,12+,13+,16-,17+,18+/m1/s1 D04TVU DRUGINKE LLAKESJIQFAQJA-NJYPJRCCSA-N D04TVU DRUGSMIL CC12CCC(CC1CCC3C2C(=O)CC4(C3CC(=N4)N)C)O D04TVU HIGHSTAT Investigative D04TWU DRUG__ID D04TWU D04TWU DRUGTYPE Small molecular drug D04TWU DRUGINCH 1S/C14H16O3/c1-16-13-9-5-8-12(15)14(13)17-10-11-6-3-2-4-7-11/h2-8,13-14H,9-10H2,1H3/t13-,14-/m1/s1 D04TWU DRUGINKE KGCDPLUOCMBBAM-ZIAGYGMSSA-N D04TWU DRUGSMIL COC1CC=CC(=O)C1OCC2=CC=CC=C2 D04TWU HIGHSTAT Investigative D04TWX DRUG__ID D04TWX D04TWX DRUGTYPE Small molecular drug D04TWX DRUGINCH 1S/C13H19NO2/c1-2-6-14-7-8-16-13(10-14)11-4-3-5-12(15)9-11/h3-5,9,13,15H,2,6-8,10H2,1H3/t13-/m0/s1 D04TWX DRUGINKE WYEGTIGJSHGEID-ZDUSSCGKSA-N D04TWX DRUGSMIL CCCN1CCOC(C1)C2=CC(=CC=C2)O D04TWX HIGHSTAT Investigative D04TXE DRUG__ID D04TXE D04TXE DRUGTYPE Small molecular drug D04TXE DRUGINCH 1S/C32H47N5O5/c1-31(2,3)42-30(41)36-26(22-24-16-10-8-11-17-24)27(38)37-32(4,23-25-18-12-9-13-19-25)28(39)34-20-14-6-5-7-15-21-35-29(33)40/h8-13,16-19,26H,5-7,14-15,20-23H2,1-4H3,(H,34,39)(H,36,41)(H,37,38)(H3,33,35,40)/t26-,32+/m0/s1 D04TXE DRUGINKE BYVRLIUFCGUMSP-XYFQYJLHSA-N D04TXE DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)(CC2=CC=CC=C2)C(=O)NCCCCCCCNC(=O)N D04TXE HIGHSTAT Investigative D04TZI DRUG__ID D04TZI D04TZI DRUGTYPE Small molecular drug D04TZI DRUGINCH 1S/C9H10FN/c10-9(6-8(9)11)7-4-2-1-3-5-7/h1-5,8H,6,11H2/t8-,9+/m1/s1 D04TZI DRUGINKE UJTQURLMCYMANH-BDAKNGLRSA-N D04TZI DRUGSMIL C1C(C1(C2=CC=CC=C2)F)N D04TZI HIGHSTAT Investigative D04TZR DRUG__ID D04TZR D04TZR DRUGTYPE Small molecular drug D04TZR DRUGINCH 1S/C23H26Cl2N2O4/c1-26(22(28)12-16-7-8-19(24)20(25)11-16)21(14-27-9-2-3-10-27)17-5-4-6-18(13-17)31-15-23(29)30/h4-8,11,13,21H,2-3,9-10,12,14-15H2,1H3,(H,29,30) D04TZR DRUGINKE JKYJSFISYHSNOE-UHFFFAOYSA-N D04TZR DRUGSMIL CN(C(CN1CCCC1)C2=CC(=CC=C2)OCC(=O)O)C(=O)CC3=CC(=C(C=C3)Cl)Cl D04TZR HIGHSTAT Investigative D04UAZ DRUG__ID D04UAZ D04UAZ DRUGCOMP Cytochroma Inc D04UAZ DRUGINCH 1S/C29H41NO3S/c1-20(15-17-34(30,33)25-9-5-4-6-10-25)26-13-14-27-22(8-7-16-29(26,27)3)11-12-23-18-24(31)19-28(32)21(23)2/h4-6,9-12,20,24,26-28,30-32H,2,7-8,13-19H2,1,3H3/b22-11+,23-12-/t20-,24-,26-,27+,28+,29-,34?/m1/s1 D04UAZ DRUGINKE FANCTJAFZSYTIS-IQUVVAJASA-N D04UAZ DRUGSMIL CC(CCS(=N)(=O)C1=CC=CC=C1)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D04UAZ HIGHSTAT Investigative D04UBQ DRUG__ID D04UBQ D04UBQ DRUGTYPE Small molecular drug D04UBQ DRUGINCH 1S/C11H8Cl2N6/c12-5-2-1-4(3-6(5)13)9-16-7-8(14)17-11(15)19-10(7)18-9/h1-3H,(H5,14,15,16,17,18,19) D04UBQ DRUGINKE GZDRYQKQDXYCQK-UHFFFAOYSA-N D04UBQ DRUGSMIL C1=CC(=C(C=C1C2=NC3=NC(=NC(=C3N2)N)N)Cl)Cl D04UBQ HIGHSTAT Investigative D04UBY DRUG__ID D04UBY D04UBY DRUGTYPE Small molecular drug D04UBY DRUGINCH 1S/C18H17NO3/c19-12-14-2-1-3-16(10-14)15-7-4-13(5-8-15)6-9-17(20)11-18(21)22/h1-5,7-8,10,17,20H,6,9,11H2,(H,21,22) D04UBY DRUGINKE WILNYVYWCSPWAP-UHFFFAOYSA-N D04UBY DRUGSMIL C1=CC(=CC(=C1)C2=CC=C(C=C2)CCC(CC(=O)O)O)C#N D04UBY HIGHSTAT Investigative D04UCF DRUG__ID D04UCF D04UCF DRUGTYPE Small molecular drug D04UCF DRUGINCH 1S/C21H22ClN7O2/c1-2-8-29-11-14-16-17(25-19(24-16)15-7-4-9-31-15)20(26-18(14)28-29)27-21(30)23-13-6-3-5-12(22)10-13/h3,5-6,10-11,15,17H,2,4,7-9H2,1H3,(H2,23,26,27,28,30) D04UCF DRUGINKE AQJYVSDITBKWSI-UHFFFAOYSA-N D04UCF DRUGSMIL CCCN1C=C2C3=NC(=NC3C(=NC2=N1)NC(=O)NC4=CC(=CC=C4)Cl)C5CCCO5 D04UCF HIGHSTAT Investigative D04UCV DRUG__ID D04UCV D04UCV DRUGTYPE Small molecular drug D04UCV DRUGINCH 1S/C11H11ClN2/c12-9-1-2-11-8(5-9)6-10-7-13-3-4-14(10)11/h1-2,5-6,13H,3-4,7H2 D04UCV DRUGINKE QKGDOWUCRMVFPY-UHFFFAOYSA-N D04UCV DRUGSMIL C1CN2C(=CC3=C2C=CC(=C3)Cl)CN1 D04UCV HIGHSTAT Investigative D04UDE DRUG__ID D04UDE D04UDE DRUGTYPE Small molecular drug D04UDE DRUGINCH 1S/C16H15N3O2/c1-10-4-5-11-6-7-12(8-13(11)17-10)16-18-14(20-2)9-15(19-16)21-3/h4-9H,1-3H3 D04UDE DRUGINKE BWVPGOLPFZULHO-UHFFFAOYSA-N D04UDE DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=NC(=CC(=N3)OC)OC D04UDE HIGHSTAT Investigative D04UDT DRUG__ID D04UDT D04UDT DRUGTYPE Small molecular drug D04UDT DRUGINCH 1S/C20H24N2O6/c1-11-15(18(23)27-6)17(13-8-7-9-14(10-13)22(25)26)16(12(2)21-11)19(24)28-20(3,4)5/h7-10,17,21H,1-6H3 D04UDT DRUGINKE YXPRKGBMFPQBDH-UHFFFAOYSA-N D04UDT DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC D04UDT HIGHSTAT Investigative D04UEN DRUG__ID D04UEN D04UEN DRUGTYPE Small molecular drug D04UEN DRUGINCH 1S/C11H19F3O2S/c1-2-3-4-5-6-7-8-17(16)9-10(15)11(12,13)14/h2-9H2,1H3 D04UEN DRUGINKE WVDSELHSQAACKS-UHFFFAOYSA-N D04UEN DRUGSMIL CCCCCCCCS(=O)CC(=O)C(F)(F)F D04UEN HIGHSTAT Investigative D04UFM DRUG__ID D04UFM D04UFM DRUGTYPE Small molecular drug D04UFM DRUGINCH 1S/C35H43N5O6/c1-20-14-25(41)12-11-24(20)18-30(33(44)38-29(32(37)43)17-23-8-5-4-6-9-23)39-34(45)31-10-7-13-40(31)35(46)28(36)19-27-21(2)15-26(42)16-22(27)3/h4-6,8-9,11-12,14-16,28-31,41-42H,7,10,13,17-19,36H2,1-3H3,(H2,37,43)(H,38,44)(H,39,45)/t28-,29-,30-,31-/m0/s1 D04UFM DRUGINKE VSPCTLNQMKBUFW-ORYMTKCHSA-N D04UFM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CCCC2C(=O)NC(CC3=C(C=C(C=C3)O)C)C(=O)NC(CC4=CC=CC=C4)C(=O)N)N)C)O D04UFM HIGHSTAT Investigative D04UGI DRUG__ID D04UGI D04UGI DRUGTYPE Small molecular drug D04UGI DRUGINCH 1S/C20H22N4O/c1-4-17-22-15-10-9-14(21-11-12-23(2)3)18-19(15)24(17)16-8-6-5-7-13(16)20(18)25/h5-10,21H,4,11-12H2,1-3H3 D04UGI DRUGINKE YUTJBINDHFWKND-UHFFFAOYSA-N D04UGI DRUGSMIL CCC1=NC2=C3N1C4=CC=CC=C4C(=O)C3=C(C=C2)NCCN(C)C D04UGI HIGHSTAT Investigative D04UHT DRUG__ID D04UHT D04UHT DRUGTYPE Small molecular drug D04UHT DRUGINCH 1S/C49H70N10O10S2/c1-27(2)41(49(68)69)59-48(67)40-26-71-70-25-39(57-42(61)28(3)51)47(66)55-36(21-29-11-5-4-6-12-29)44(63)56-38(23-31-24-52-34-14-8-7-13-33(31)34)46(65)53-35(15-9-10-20-50)43(62)54-37(45(64)58-40)22-30-16-18-32(60)19-17-30/h7-8,13-14,16-19,24,27-29,35-41,52,60H,4-6,9-12,15,20-23,25-26,50-51H2,1-3H3,(H,53,65)(H,54,62)(H,55,66)(H,56,63)(H,57,61)(H,58,64)(H,59,67)(H,68,69)/t28-,35-,36-,37-,38-,39-,40-,41-/m0/s1 D04UHT DRUGINKE BKBNRUZZGBUWOM-KOOAXUMWSA-N D04UHT DRUGSMIL CC(C)C(C(=O)O)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCCN)CC3=CNC4=CC=CC=C43)CC5CCCCC5)NC(=O)C(C)N D04UHT HIGHSTAT Investigative D04UIK DRUG__ID D04UIK D04UIK DRUGTYPE Small molecular drug D04UIK DRUGINCH 1S/C27H32N2O2/c30-26(28-21-6-2-1-3-7-21)31-22-12-11-20-16-25-23-8-4-5-13-27(23,24(20)17-22)14-15-29(25)18-19-9-10-19/h1-3,6-7,11-12,17,19,23,25H,4-5,8-10,13-16,18H2,(H,28,30) D04UIK DRUGINKE PNQVNINMHSUQSR-UHFFFAOYSA-N D04UIK DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)NC5=CC=CC=C5)CC6CC6 D04UIK HIGHSTAT Investigative D04UJI DRUG__ID D04UJI D04UJI DRUGTYPE Small molecular drug D04UJI DRUGINCH 1S/C11H9NO2/c13-11(12-14)10-6-5-8-3-1-2-4-9(8)7-10/h1-7,14H,(H,12,13) D04UJI DRUGINKE PCJLUGWQCHMMAG-UHFFFAOYSA-N D04UJI DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)NO D04UJI HIGHSTAT Investigative D04UJZ DRUG__ID D04UJZ D04UJZ DRUGTYPE Small molecular drug D04UJZ DRUGINCH 1S/C52H69N13O11/c1-3-32(2)43(50(73)74)64-48(71)42-17-11-25-65(42)49(72)41(27-36-29-56-31-59-36)62-46(69)39(60-47(70)40(26-33-18-20-37(66)21-19-33)61-44(67)35-14-9-22-55-28-35)15-7-8-23-57-45(68)38(16-10-24-58-51(53)54)63-52(75)76-30-34-12-5-4-6-13-34/h4-6,9,12-14,18-22,28-29,31-32,38-43,66H,3,7-8,10-11,15-17,23-27,30H2,1-2H3,(H,56,59)(H,57,68)(H,60,70)(H,61,67)(H,62,69)(H,63,75)(H,64,71)(H,73,74)(H4,53,54,58)/t32-,38-,39-,40-,41-,42-,43-/m0/s1 D04UJZ DRUGINKE UXGNARZDONUMMK-LRMQDCNJSA-N D04UJZ DRUGSMIL CCC(C)C(C(=O)O)NC(=O)C1CCCN1C(=O)C(CC2=CN=CN2)NC(=O)C(CCCCNC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C5=CN=CC=C5 D04UJZ HIGHSTAT Investigative D04ULI DRUG__ID D04ULI D04ULI DRUGTYPE Small molecular drug D04ULI DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1/i4T,7T,12T,15T,16T,17T,18T,19T D04ULI DRUGINKE PXGPLTODNUVGFL-WEMOGKSOSA-N D04ULI DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O D04ULI HIGHSTAT Investigative D04ULU DRUG__ID D04ULU D04ULU DRUGTYPE Small molecular drug D04ULU DRUGINCH 1S/C16H13N3O4/c20-15-7-2-1-6-14(15)18-9-8-13(17-16(18)21)11-4-3-5-12(10-11)19(22)23/h1-8,10,20H,9H2,(H,17,21) D04ULU DRUGINKE RCEFMOGVOYEGJN-UHFFFAOYSA-N D04ULU DRUGSMIL C1C=C(NC(=O)N1C2=CC=CC=C2O)C3=CC(=CC=C3)[N+](=O)[O-] D04ULU HIGHSTAT Investigative D04ULY DRUG__ID D04ULY D04ULY DRUGTYPE Small molecular drug D04ULY DRUGINCH 1S/C32H42N8O5S2/c1-37(2)21-22-38(3)20-18-33-31(41)28-15-10-19-39(28)47(44,45)26-16-17-27(29(23-26)40(42)43)35-36-32(46)34-30(24-11-6-4-7-12-24)25-13-8-5-9-14-25/h4-9,11-14,16-17,23,28,30,35H,10,15,18-22H2,1-3H3,(H,33,41)(H2,34,36,46)/t28-/m0/s1 D04ULY DRUGINKE ZIBIVIRBYMBEHZ-NDEPHWFRSA-N D04ULY DRUGSMIL CN(C)CCN(C)CCNC(=O)C1CCCN1S(=O)(=O)C2=CC(=C(C=C2)NNC(=S)NC(C3=CC=CC=C3)C4=CC=CC=C4)[N+](=O)[O-] D04ULY HIGHSTAT Investigative D04UMY DRUG__ID D04UMY D04UMY DRUGTYPE Small molecular drug D04UMY DRUGINCH 1S/C10H10N4O3S/c1-18(16,17)8-4-6(2-3-7(8)5-11)9(15)14-10(12)13/h2-4H,1H3,(H4,12,13,14,15) D04UMY DRUGINKE ASFBPCUWKPJTES-UHFFFAOYSA-N D04UMY DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)C(=O)N=C(N)N)C#N D04UMY HIGHSTAT Investigative D04UNE DRUG__ID D04UNE D04UNE DRUGTYPE Small molecular drug D04UNE DRUGINCH 1S/C15H25NO3/c1-12(2)16-10-14(18)11-19-15-7-5-13(6-8-15)4-3-9-17/h5-8,12,14,16-18H,3-4,9-11H2,1-2H3 D04UNE DRUGINKE RUZBBQNQBDCLPE-UHFFFAOYSA-N D04UNE DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)CCCO)O D04UNE HIGHSTAT Investigative D04UNQ DRUG__ID D04UNQ D04UNQ DRUGTYPE Small molecular drug D04UNQ DRUGINCH 1S/C9H10N6/c10-8-7(9(11)15-14-8)13-12-6-4-2-1-3-5-6/h1-5H,(H5,10,11,14,15) D04UNQ DRUGINKE BLXRKDXUWQFGAW-UHFFFAOYSA-N D04UNQ DRUGSMIL C1=CC=C(C=C1)N=NC2=C(NN=C2N)N D04UNQ HIGHSTAT Investigative D04UOP DRUG__ID D04UOP D04UOP DRUGTYPE Small molecular drug D04UOP DRUGINCH 1S/C15H25NO3/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6/h7-10,14,16-17H,1-6H3/t10-,14-/m0/s1 D04UOP DRUGINKE TWUSDDMONZULSC-HZMBPMFUSA-N D04UOP DRUGSMIL CC(C(C1=C(C=CC(=C1)OC)OC)O)NC(C)(C)C D04UOP HIGHSTAT Investigative D04UPQ DRUG__ID D04UPQ D04UPQ DRUGTYPE Small molecular drug D04UPQ DRUGINCH 1S/C16H12N2O/c17-10-5-6-11-9(7-10)8-14-12-3-1-2-4-13(12)16(19)18-15(11)14/h1-7H,8,17H2,(H,18,19) D04UPQ DRUGINKE BIBLEFNXUYTZIB-UHFFFAOYSA-N D04UPQ DRUGSMIL C1C2=C(C=CC(=C2)N)C3=C1C4=CC=CC=C4C(=O)N3 D04UPQ HIGHSTAT Investigative D04UPU DRUG__ID D04UPU D04UPU DRUGTYPE Small molecular drug D04UPU DRUGINCH 1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12) D04UPU DRUGINKE CFFZDZCDUFSOFZ-UHFFFAOYSA-N D04UPU DRUGSMIL C1=CC(=C(C=C1CC(=O)O)O)O D04UPU HIGHSTAT Investigative D04URI DRUG__ID D04URI D04URI DRUGTYPE Small molecular drug D04URI DRUGINCH 1S/C17H17NO6/c1-18-11-8(6-5-7-9(11)19)13(20)10-12(18)15(22-2)17(24-4)16(23-3)14(10)21/h5-7,19,21H,1-4H3 D04URI DRUGINKE QYPQTPVQPNLXHV-UHFFFAOYSA-N D04URI DRUGSMIL CN1C2=C(C=CC=C2O)C(=O)C3=C1C(=C(C(=C3O)OC)OC)OC D04URI HIGHSTAT Investigative D04USO DRUG__ID D04USO D04USO DRUGTYPE Small molecular drug D04USO DRUGINCH 1S/C17H14F3NO/c1-10-6-11(2)16(12(3)7-10)22-14-5-4-13(9-21)15(8-14)17(18,19)20/h4-8H,1-3H3 D04USO DRUGINKE XMMDWVWTOYZZAJ-UHFFFAOYSA-N D04USO DRUGSMIL CC1=CC(=C(C(=C1)C)OC2=CC(=C(C=C2)C#N)C(F)(F)F)C D04USO HIGHSTAT Investigative D04UTQ DRUG__ID D04UTQ D04UTQ DRUGTYPE Small molecular drug D04UTQ DRUGINCH 1S/C10H13N3/c1-13(2)10-11-7-8-5-3-4-6-9(8)12-10/h3-6H,7H2,1-2H3,(H,11,12) D04UTQ DRUGINKE MNTBAXGKERZVOZ-UHFFFAOYSA-N D04UTQ DRUGSMIL CN(C)C1=NCC2=CC=CC=C2N1 D04UTQ HIGHSTAT Investigative D04UUT DRUG__ID D04UUT D04UUT DRUGTYPE Small molecular drug D04UUT DRUGINCH 1S/C14H9N3O2/c18-14-15-10-5-2-1-4-9(10)12-8-11(16-17(12)14)13-6-3-7-19-13/h1-8H,(H,15,18) D04UUT DRUGINKE HWHAANIZIAJOCF-UHFFFAOYSA-N D04UUT DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NN3C(=O)N2)C4=CC=CO4 D04UUT HIGHSTAT Investigative D04UVC DRUG__ID D04UVC D04UVC DRUGTYPE Small molecular drug D04UVC DRUGINCH 1S/C19H23NO2/c1-14(2)17(15-9-5-4-6-10-15)13-20-19(21)16-11-7-8-12-18(16)22-3/h4-12,14,17H,13H2,1-3H3,(H,20,21) D04UVC DRUGINKE XVFLGHVOMBWJAC-UHFFFAOYSA-N D04UVC DRUGSMIL CC(C)C(CNC(=O)C1=CC=CC=C1OC)C2=CC=CC=C2 D04UVC HIGHSTAT Investigative D04UVL DRUG__ID D04UVL D04UVL DRUGTYPE Small molecular drug D04UVL DRUGINCH 1S/C12H11N3O/c13-10-5-1-2-6-11(10)15-12(16)9-4-3-7-14-8-9/h1-8H,13H2,(H,15,16) D04UVL DRUGINKE CEZRXCCXPZWXNX-UHFFFAOYSA-N D04UVL DRUGSMIL C1=CC=C(C(=C1)N)NC(=O)C2=CN=CC=C2 D04UVL HIGHSTAT Investigative D04UYB DRUG__ID D04UYB D04UYB DRUGTYPE Small molecular drug D04UYB DRUGINCH 1S/C19H18O11/c20-4-11-15(25)17(27)18(28)19(30-11)12-8(23)3-10-13(16(12)26)14(24)5-1-6(21)7(22)2-9(5)29-10/h1-3,11,15,17-23,25-28H,4H2/t11-,15-,17+,18-,19+/m1/s1 D04UYB DRUGINKE AEDDIBAIWPIIBD-ZJKJAXBQSA-N D04UYB DRUGSMIL C1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=C(C(=C3)O)C4C(C(C(C(O4)CO)O)O)O)O D04UYB HIGHSTAT Investigative D04UYO DRUG__ID D04UYO D04UYO DRUGTYPE Small molecular drug D04UYO DRUGINCH 1S/C18H26F3NO5S/c1-5-28(24,25)22(4)15-13-11-12(26-10-6-9-18(19,20)21)7-8-14(13)27-17(2,3)16(15)23/h7-8,11,15-16,23H,5-6,9-10H2,1-4H3/t15-,16+/m0/s1 D04UYO DRUGINKE YBZQPPIQXNWGEX-JKSUJKDBSA-N D04UYO DRUGSMIL CCS(=O)(=O)N(C)C1C(C(OC2=C1C=C(C=C2)OCCCC(F)(F)F)(C)C)O D04UYO HIGHSTAT Investigative D04UYZ DRUG__ID D04UYZ D04UYZ DRUGTYPE Small molecular drug D04UYZ DRUGINCH 1S/C13H14N2O/c1-10(11-6-3-2-4-7-11)15-13(16)12-8-5-9-14-12/h2-10,14H,1H3,(H,15,16) D04UYZ DRUGINKE ZCDCLWRYDWKALM-UHFFFAOYSA-N D04UYZ DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC=CN2 D04UYZ HIGHSTAT Investigative D04VBD DRUG__ID D04VBD D04VBD DRUGTYPE Small molecular drug D04VBD DRUGINCH 1S/C11H12BrN3O/c1-2-3-10(16)13-11-8-5-4-7(12)6-9(8)14-15-11/h4-6H,2-3H2,1H3,(H2,13,14,15,16) D04VBD DRUGINKE QQVNXRROZHWJNS-UHFFFAOYSA-N D04VBD DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)Br D04VBD HIGHSTAT Investigative D04VCE DRUG__ID D04VCE D04VCE DRUGTYPE Small molecular drug D04VCE DRUGINCH 1S/C26H20F9NO3/c27-24(28,29)23(37)14-36-21(16-5-2-7-18(13-16)39-26(33,34)35)11-10-20-19(8-3-9-22(20)36)15-4-1-6-17(12-15)38-25(30,31)32/h1-9,12-13,21,23,37H,10-11,14H2/t21-,23+/m1/s1 D04VCE DRUGINKE CMOJRCASVGGDKQ-GGAORHGYSA-N D04VCE DRUGSMIL C1CC2=C(C=CC=C2N(C1C3=CC(=CC=C3)OC(F)(F)F)CC(C(F)(F)F)O)C4=CC(=CC=C4)OC(F)(F)F D04VCE HIGHSTAT Investigative D04VFS DRUG__ID D04VFS D04VFS DRUGTYPE Small molecular drug D04VFS DRUGINCH 1S/C12H14O4S/c13-11(14)9-3-1-2-8(6-9)7-10(4-5-17)12(15)16/h1-3,6,10,17H,4-5,7H2,(H,13,14)(H,15,16) D04VFS DRUGINKE NTMSKDFHMVZFMA-UHFFFAOYSA-N D04VFS DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CCS)C(=O)O D04VFS HIGHSTAT Investigative D04VGL DRUG__ID D04VGL D04VGL DRUGTYPE Small molecular drug D04VGL DRUGINCH 1S/C19H21NO/c1-2-19(21)20-16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,2,12-13H2,1H3,(H,20,21) D04VGL DRUGINKE RCYLUNPFECYGDW-UHFFFAOYSA-N D04VGL DRUGSMIL CCC(=O)NC1CC(C2=CC=CC=C2C1)C3=CC=CC=C3 D04VGL HIGHSTAT Investigative D04VJE DRUG__ID D04VJE D04VJE DRUGTYPE Small molecular drug D04VJE DRUGINCH 1S/C22H21N3O2/c23-22(26)17-7-9-21(24-13-17)27-20-8-6-18-14-25(15-19(18)12-20)11-10-16-4-2-1-3-5-16/h1-9,12-13H,10-11,14-15H2,(H2,23,26) D04VJE DRUGINKE ACAQNMZIFFSQCU-UHFFFAOYSA-N D04VJE DRUGSMIL C1C2=C(CN1CCC3=CC=CC=C3)C=C(C=C2)OC4=NC=C(C=C4)C(=O)N D04VJE HIGHSTAT Investigative D04VNR DRUG__ID D04VNR D04VNR DRUGTYPE Small molecular drug D04VNR DRUGINCH 1S/C14H14N2/c1-2-4-13-9-11(5-6-12(13)3-1)10-14-15-7-8-16-14/h1-6,9H,7-8,10H2,(H,15,16) D04VNR DRUGINKE VIXRKFBKWOHVBR-UHFFFAOYSA-N D04VNR DRUGSMIL C1CN=C(N1)CC2=CC3=CC=CC=C3C=C2 D04VNR HIGHSTAT Investigative D04VNS DRUG__ID D04VNS D04VNS DRUGTYPE Small molecular drug D04VNS DRUGINCH 1S/C65H89N17O21S4/c1-31-53(91)79-51(32(2)84)62(100)74-39(23-48(67)86)64(102)80-18-6-11-45(80)60(98)72-37(24-50(88)89)55(93)76-41(52(68)90)27-104-106-29-43-59(97)75-40(26-83)56(94)73-38(22-34-14-16-35(85)17-15-34)63(101)82-20-8-13-47(82)65(103)81-19-7-12-46(81)61(99)78-44(30-107-105-28-42(57(95)77-43)70-49(87)25-66)58(96)71-36(54(92)69-31)21-33-9-4-3-5-10-33/h3-5,9-10,14-17,31-32,36-47,51,83-85H,6-8,11-13,18-30,66H2,1-2H3,(H2,67,86)(H2,68,90)(H,69,92)(H,70,87)(H,71,96)(H,72,98)(H,73,94)(H,74,100)(H,75,97)(H,76,93)(H,77,95)(H,78,99)(H,79,91)(H,88,89)/t31-,32+,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,51-/m0/s1 D04VNS DRUGINKE SVNSCQIKKAACJG-SBLJLSJOSA-N D04VNS DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(CSSCC3C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CSSCC(C(=O)N3)NC(=O)CN)C(=O)NC(C(=O)N1)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)CO)C(=O)N)CC(=O)O)CC(=O)N)C(C)O D04VNS HIGHSTAT Investigative D04VOI DRUG__ID D04VOI D04VOI DRUGTYPE Small molecular drug D04VOI DRUGINCH 1S/C17H26N4O2/c22-12-13-6-8-21(9-7-13)16-11-18-15(10-19-16)17(23)20-14-4-2-1-3-5-14/h10-11,13-14,22H,1-9,12H2,(H,20,23) D04VOI DRUGINKE JKQOZEOZKKMWQL-UHFFFAOYSA-N D04VOI DRUGSMIL C1CCC(CC1)NC(=O)C2=CN=C(C=N2)N3CCC(CC3)CO D04VOI HIGHSTAT Investigative D04VOM DRUG__ID D04VOM D04VOM DRUGTYPE Small molecular drug D04VOM DRUGINCH 1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21?,22?,24?,25?,29-,32?,35?/m1/s1 D04VOM DRUGINKE FVQSSYMRZKLFDR-QTZXECCPSA-N D04VOM DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC(C3=CC=CC=C3)NC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D04VOM HIGHSTAT Investigative D04VPF DRUG__ID D04VPF D04VPF DRUGTYPE Small molecular drug D04VPF DRUGINCH 1S/C3H4O3S/c4-2(1-7)3(5)6/h7H,1H2,(H,5,6) D04VPF DRUGINKE OJOLFAIGOXZBCI-UHFFFAOYSA-N D04VPF DRUGSMIL C(C(=O)C(=O)O)S D04VPF HIGHSTAT Investigative D04VPH DRUG__ID D04VPH D04VPH DRUGTYPE Small molecular drug D04VPH DRUGINCH 1S/C24H22N4O5/c1-3-33-24(32)20-11-17-10-16(8-9-18(17)26-20)21-12-19(27-28(21)2)22(29)25-13-14-4-6-15(7-5-14)23(30)31/h4-12,26H,3,13H2,1-2H3,(H,25,29)(H,30,31) D04VPH DRUGINKE MMJPVSDTLGFIQW-UHFFFAOYSA-N D04VPH DRUGSMIL CCOC(=O)C1=CC2=C(N1)C=CC(=C2)C3=CC(=NN3C)C(=O)NCC4=CC=C(C=C4)C(=O)O D04VPH HIGHSTAT Investigative D04VQM DRUG__ID D04VQM D04VQM DRUGTYPE Small molecular drug D04VQM DRUGINCH 1S/C13H9BrN2O2S2/c14-11-6-7-12(19-11)20(17,18)16-10-5-1-3-9-4-2-8-15-13(9)10/h1-8,16H D04VQM DRUGINKE BWZPDZRPJIBWAU-UHFFFAOYSA-N D04VQM DRUGSMIL C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(S3)Br)N=CC=C2 D04VQM HIGHSTAT Investigative D04VRY DRUG__ID D04VRY D04VRY DRUGTYPE Small molecular drug D04VRY DRUGINCH 1S/C20H15N3O5/c1-27-15-6-7-16-18(10-15)28-20(13-2-4-14(5-3-13)23(25)26)17(19(16)24)11-22-9-8-21-12-22/h2-10,12H,11H2,1H3 D04VRY DRUGINKE DTEZOESXMOWJRN-UHFFFAOYSA-N D04VRY DRUGSMIL COC1=CC2=C(C=C1)C(=O)C(=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])CN4C=CN=C4 D04VRY HIGHSTAT Investigative D04VSP DRUG__ID D04VSP D04VSP DRUGTYPE Small molecular drug D04VSP DRUGINCH 1S/C7H10N2O3S/c1-2-12-6-3-4-9-5-7(6)13(8,10)11/h3-5H,2H2,1H3,(H2,8,10,11) D04VSP DRUGINKE MQJPVIGZIDYFMM-UHFFFAOYSA-N D04VSP DRUGSMIL CCOC1=C(C=NC=C1)S(=O)(=O)N D04VSP HIGHSTAT Investigative D04VXP DRUG__ID D04VXP D04VXP DRUGTYPE Small molecular drug D04VXP DRUGINCH 1S/C11H13N3O/c1-3-13-11(9-2-8-15-10(1)9)14-6-4-12-5-7-14/h1-3,8,12H,4-7H2 D04VXP DRUGINKE LUIZVTKJWSGSPA-UHFFFAOYSA-N D04VXP DRUGSMIL C1CN(CCN1)C2=NC=CC3=C2C=CO3 D04VXP HIGHSTAT Investigative D04VYZ DRUG__ID D04VYZ D04VYZ DRUGTYPE Small molecular drug D04VYZ DRUGINCH 1S/C18H20N8O5/c19-15-12-16(25(8-20-12)17-14(29)13(28)11(7-27)31-17)22-18(21-15)30-6-5-26-10-4-2-1-3-9(10)23-24-26/h1-4,8,11,13-14,17,27-29H,5-7H2,(H2,19,21,22)/t11-,13-,14-,17-/m1/s1 D04VYZ DRUGINKE DNLYYBHYIBDUCX-LSCFUAHRSA-N D04VYZ DRUGSMIL C1=CC=C2C(=C1)N=NN2CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D04VYZ HIGHSTAT Investigative D04WBU DRUG__ID D04WBU D04WBU DRUGTYPE Small molecular drug D04WBU DRUGINCH 1S/C8H10N4O2/c1-3-12-7(13)5-6(10-4-9-5)11(2)8(12)14/h4H,3H2,1-2H3,(H,9,10) D04WBU DRUGINKE KVSRUALMCYFLEP-UHFFFAOYSA-N D04WBU DRUGSMIL CCN1C(=O)C2=C(N=CN2)N(C1=O)C D04WBU HIGHSTAT Investigative D04WCH DRUG__ID D04WCH D04WCH DRUGTYPE Small molecular drug D04WCH DRUGINCH 1S/C14H22N4O2/c1-4-7-16-10-15-12-11(16)13(19)18(9-6-3)14(20)17(12)8-5-2/h10H,4-9H2,1-3H3 D04WCH DRUGINKE PMJKNRZFAZJNRA-UHFFFAOYSA-N D04WCH DRUGSMIL CCCN1C=NC2=C1C(=O)N(C(=O)N2CCC)CCC D04WCH HIGHSTAT Investigative D04WFN DRUG__ID D04WFN D04WFN DRUGTYPE Small molecular drug D04WFN DRUGINCH 1S/C23H30N6O2/c1-3-29(4-2)22(30)17-10-12-18(13-11-17)26-23-27-20-19(24-15-25-20)21(28-23)31-14-16-8-6-5-7-9-16/h10-13,15-16H,3-9,14H2,1-2H3,(H2,24,25,26,27,28) D04WFN DRUGINKE XHEQSRJCJTWWAH-UHFFFAOYSA-N D04WFN DRUGSMIL CCN(CC)C(=O)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)OCC4CCCCC4)NC=N3 D04WFN HIGHSTAT Investigative D04WGR DRUG__ID D04WGR D04WGR DRUGTYPE Small molecular drug D04WGR DRUGINCH 1S/C18H11N3/c1-12-2-3-15-4-5-16(9-18(15)21-12)17-7-13(10-19)6-14(8-17)11-20/h2-9H,1H3 D04WGR DRUGINKE KVBFHKKSOXHZCJ-UHFFFAOYSA-N D04WGR DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)C#N D04WGR HIGHSTAT Investigative D04WHE DRUG__ID D04WHE D04WHE DRUGTYPE Small molecular drug D04WHE DRUGINCH 1S/C8H11N5/c1-2-3-13-5-12-6-7(9)10-4-11-8(6)13/h4-5H,2-3H2,1H3,(H2,9,10,11) D04WHE DRUGINKE QTULKOMMYIUZQD-UHFFFAOYSA-N D04WHE DRUGSMIL CCCN1C=NC2=C(N=CN=C21)N D04WHE HIGHSTAT Investigative D04WHH DRUG__ID D04WHH D04WHH DRUGTYPE Small molecular drug D04WHH DRUGINCH 1S/C16H15NO3/c1-2-3-11-8-13(19)9-14-15(11)20-16(17-14)10-4-6-12(18)7-5-10/h4-9,18-19H,2-3H2,1H3 D04WHH DRUGINKE VHUQNFQIHPMAAE-UHFFFAOYSA-N D04WHH DRUGSMIL CCCC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D04WHH HIGHSTAT Investigative D04WHO DRUG__ID D04WHO D04WHO DRUGTYPE Small molecular drug D04WHO DRUGINCH 1S/C27H25Cl2N5O4S/c28-20-10-9-19(15-21(20)29)39(37,38)34-23-4-2-1-3-22(23)33-27(36)24(34)16-25(35)30-12-11-17-5-7-18(8-6-17)26-31-13-14-32-26/h1-10,15,24H,11-14,16H2,(H,30,35)(H,31,32)(H,33,36)/t24-/m1/s1 D04WHO DRUGINKE HYJYRDCPGUEYND-XMMPIXPASA-N D04WHO DRUGSMIL C1CN=C(N1)C2=CC=C(C=C2)CCNC(=O)CC3C(=O)NC4=CC=CC=C4N3S(=O)(=O)C5=CC(=C(C=C5)Cl)Cl D04WHO HIGHSTAT Investigative D04WIA DRUG__ID D04WIA D04WIA DRUGTYPE Small molecular drug D04WIA DRUGINCH 1S/C15H10N4O/c20-15-17-11-6-2-1-5-10(11)14-9-13(18-19(14)15)12-7-3-4-8-16-12/h1-9H,(H,17,20) D04WIA DRUGINKE YUDPHONPFGCUGC-UHFFFAOYSA-N D04WIA DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NN3C(=O)N2)C4=CC=CC=N4 D04WIA HIGHSTAT Investigative D04WJN DRUG__ID D04WJN D04WJN DRUGTYPE Small molecular drug D04WJN DRUGINCH 1S/C17H12N2O2/c20-17-13-3-1-2-4-15(13)21-16-9-12(5-6-14(16)17)10-19-8-7-18-11-19/h1-9,11H,10H2 D04WJN DRUGINKE GFCUIFVKCOEHQN-UHFFFAOYSA-N D04WJN DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(O2)C=C(C=C3)CN4C=CN=C4 D04WJN HIGHSTAT Investigative D04WLH DRUG__ID D04WLH D04WLH DRUGTYPE Small molecular drug D04WLH DRUGINCH 1S/C21H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-16-20(22)18-21(23)17-19/h4-5,7-8,16-18,22-23H,2-3,6,9-15H2,1H3/b5-4-,8-7- D04WLH DRUGINKE UFMJCOLGRWKUKO-UTOQUPLUSA-N D04WLH DRUGSMIL CCCC=CCC=CCCCCCCCC1=CC(=CC(=C1)O)O D04WLH HIGHSTAT Investigative D04WPA DRUG__ID D04WPA D04WPA DRUGTYPE Small molecular drug D04WPA DRUGINCH 1S/C16H12F3N3S/c17-16(18,19)14-4-2-1-3-12(14)13(9-20)15(22)23-11-7-5-10(21)6-8-11/h1-8H,21-22H2/b15-13+ D04WPA DRUGINKE JLOXTZFYJNCPIS-FYWRMAATSA-N D04WPA DRUGSMIL C1=CC=C(C(=C1)C(=C(N)SC2=CC=C(C=C2)N)C#N)C(F)(F)F D04WPA HIGHSTAT Investigative D04WPM DRUG__ID D04WPM D04WPM DRUGTYPE Small molecular drug D04WPM DRUGINCH 1S/C24H20F7NO3/c25-22(26)24(30,31)35-20-11-4-6-16(12-20)14-32(15-21(33)23(27,28)29)17-7-5-10-19(13-17)34-18-8-2-1-3-9-18/h1-13,21-22,33H,14-15H2/t21-/m1/s1 D04WPM DRUGINKE XNYMOOHZPFZFJE-OAQYLSRUSA-N D04WPM DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)N(CC3=CC(=CC=C3)OC(C(F)F)(F)F)CC(C(F)(F)F)O D04WPM HIGHSTAT Investigative D04WRO DRUG__ID D04WRO D04WRO DRUGTYPE Small molecular drug D04WRO DRUGINCH 1S/C42H68N14O7/c1-3-25(2)34(40(63)52-30(35(45)58)14-7-8-20-43)56-37(60)31(15-10-22-51-42(48)49)53-38(61)33(24-27-16-18-28(57)19-17-27)55-39(62)32(23-26-11-5-4-6-12-26)54-36(59)29(44)13-9-21-50-41(46)47/h4-6,11-12,16-19,25,29-34,57H,3,7-10,13-15,20-24,43-44H2,1-2H3,(H2,45,58)(H,52,63)(H,53,61)(H,54,59)(H,55,62)(H,56,60)(H4,46,47,50)(H4,48,49,51)/t25-,29-,30-,31-,32-,33-,34-/m0/s1 D04WRO DRUGINKE NJUUHBQLRQTWGG-QQUOXUDESA-N D04WRO DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)N D04WRO HIGHSTAT Investigative D04WVG DRUG__ID D04WVG D04WVG DRUGTYPE Small molecular drug D04WVG DRUGINCH 1S/C18H29N7O7/c19-18(20)21-3-1-2-9-16(31)22-7-13(27)23-11(6-14(28)29)17(32)25-10-4-8(5-12(10)26)15(30)24-9/h8-12,26H,1-7H2,(H,22,31)(H,23,27)(H,24,30)(H,25,32)(H,28,29)(H4,19,20,21)/t8-,9-,10+,11-,12+/m0/s1 D04WVG DRUGINKE CFCPTSHVAOVLJR-HHHUOAJASA-N D04WVG DRUGSMIL C1C2CC(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O D04WVG HIGHSTAT Investigative D04WVV DRUG__ID D04WVV D04WVV DRUGTYPE Small molecular drug D04WVV DRUGINCH 1S/C19H23N3/c1-22-17(16-5-3-2-4-6-16)20-21-18(22)19-10-13-7-14(11-19)9-15(8-13)12-19/h2-6,13-15H,7-12H2,1H3 D04WVV DRUGINKE SPLKSRDVCTUAGF-UHFFFAOYSA-N D04WVV DRUGSMIL CN1C(=NN=C1C23CC4CC(C2)CC(C4)C3)C5=CC=CC=C5 D04WVV HIGHSTAT Investigative D04WWM DRUG__ID D04WWM D04WWM DRUGTYPE Small molecular drug D04WWM DRUGINCH 1S/C14H23N/c1-2-13(15-3-1)14-7-10-4-11(8-14)6-12(5-10)9-14/h10-13,15H,1-9H2 D04WWM DRUGINKE YVRRAISBZUMEJB-UHFFFAOYSA-N D04WWM DRUGSMIL C1CC(NC1)C23CC4CC(C2)CC(C4)C3 D04WWM HIGHSTAT Investigative D04WWO DRUG__ID D04WWO D04WWO DRUGTYPE Small molecular drug D04WWO DRUGINCH 1S/C25H28N4O4/c1-16-14-17(20-6-3-4-8-22(20)26-16)15-33-19-11-9-18(10-12-19)27-25(31)23-21(24(30)28-32)7-5-13-29(23)2/h3-4,6,8-12,14,21,23,32H,5,7,13,15H2,1-2H3,(H,27,31)(H,28,30)/t21-,23-/m0/s1 D04WWO DRUGINKE RJSKOAOWDAMMHR-GMAHTHKFSA-N D04WWO DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)COC3=CC=C(C=C3)NC(=O)C4C(CCCN4C)C(=O)NO D04WWO HIGHSTAT Investigative D04WXI DRUG__ID D04WXI D04WXI DRUGTYPE Small molecular drug D04WXI DRUGINCH 1S/C21H23FN6O/c22-16-8-6-15(7-9-16)18(19-5-1-2-10-25-19)12-20(29)28-21(23)26-11-3-4-17-13-24-14-27-17/h1-2,5-10,13-14,18H,3-4,11-12H2,(H,24,27)(H3,23,26,28,29) D04WXI DRUGINKE UTJRWVBWVPCMQL-UHFFFAOYSA-N D04WXI DRUGSMIL C1=CC=NC(=C1)C(CC(=O)NC(=NCCCC2=CN=CN2)N)C3=CC=C(C=C3)F D04WXI HIGHSTAT Investigative D04XBZ DRUG__ID D04XBZ D04XBZ DRUGTYPE Small molecular drug D04XBZ DRUGINCH 1S/C12H20NO3P/c1-2-3-5-10-12(13)17(14,15)16-11-8-6-4-7-9-11/h4,6-9,12H,2-3,5,10,13H2,1H3,(H,14,15) D04XBZ DRUGINKE DHJINNDLWRRCRC-UHFFFAOYSA-N D04XBZ DRUGSMIL CCCCCC(N)P(=O)(O)OC1=CC=CC=C1 D04XBZ HIGHSTAT Investigative D04XCB DRUG__ID D04XCB D04XCB DRUGTYPE Small molecular drug D04XCB DRUGINCH 1S/C19H31NO2/c1-2-3-4-5-6-7-8-16-9-11-17(12-10-16)13-14-18(20)15-19(21)22/h9-12,18H,2-8,13-15,20H2,1H3,(H,21,22) D04XCB DRUGINKE UDEAYIGFOWYIGY-UHFFFAOYSA-N D04XCB DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CC(=O)O)N D04XCB HIGHSTAT Investigative D04XDS DRUG__ID D04XDS D04XDS DRUGTYPE Small molecular drug D04XDS DRUGINCH 1S/C5H8O4/c6-4(7)2-1-3-5(8)9/h1-3H2,(H,6,7)(H,8,9) D04XDS DRUGINKE JFCQEDHGNNZCLN-UHFFFAOYSA-N D04XDS DRUGSMIL C(CC(=O)O)CC(=O)O D04XDS HIGHSTAT Investigative D04XED DRUG__ID D04XED D04XED DRUGTYPE Small molecular drug D04XED DRUGINCH 1S/C10H16O3/c1-6-4-8(12)9(13)10(2,3)7(6)5-11/h5,8-9,12-13H,4H2,1-3H3/t8-,9+/m1/s1 D04XED DRUGINKE YDOIHIWSLMXTHV-BDAKNGLRSA-N D04XED DRUGSMIL CC1=C(C(C(C(C1)O)O)(C)C)C=O D04XED HIGHSTAT Investigative D04XFN DRUG__ID D04XFN D04XFN DRUGTYPE Small molecular drug D04XFN DRUGINCH 1S/C21H21NO5/c23-19-15-21(22-8-10-24-11-9-22)27-20-14-17(6-7-18(19)20)26-13-12-25-16-4-2-1-3-5-16/h1-7,14-15H,8-13H2 D04XFN DRUGINKE WZUWDKBMBHSVAZ-UHFFFAOYSA-N D04XFN DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)OCCOC4=CC=CC=C4 D04XFN HIGHSTAT Investigative D04XGX DRUG__ID D04XGX D04XGX DRUGTYPE Small molecular drug D04XGX DRUGINCH 1S/C21H16O3/c1-23-19-9-5-3-7-15(19)12-16-13-18-17-8-4-2-6-14(17)10-11-20(18)24-21(16)22/h2-11,13H,12H2,1H3 D04XGX DRUGINKE VCXYTPBLXWPGOC-UHFFFAOYSA-N D04XGX DRUGSMIL COC1=CC=CC=C1CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O D04XGX HIGHSTAT Investigative D04XHX DRUG__ID D04XHX D04XHX DRUGTYPE Small molecular drug D04XHX DRUGINCH 1S/C37H49N11O6/c38-36(39)43-16-3-7-27-33(52)46-28(8-4-17-44-37(40)41)34(53)48-29(20-22-10-13-26(49)14-11-22)32(51)42-18-15-31(50)45-30(35(54)47-27)21-23-9-12-24-5-1-2-6-25(24)19-23/h1-2,5-6,9-14,19,27-30,49H,3-4,7-8,15-18,20-21H2,(H,42,51)(H,45,50)(H,46,52)(H,47,54)(H,48,53)(H4,38,39,43)(H4,40,41,44)/t27-,28+,29+,30-/m0/s1 D04XHX DRUGINKE LMVXXKJNXQKPHR-KJHMZRPRSA-N D04XHX DRUGSMIL C1CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CC3=CC=CC=C3C=C2)CCCN=C(N)N)CCCN=C(N)N)CC4=CC=C(C=C4)O D04XHX HIGHSTAT Investigative D04XJT DRUG__ID D04XJT D04XJT DRUGTYPE Small molecular drug D04XJT DRUGINCH 1S/C16H18O6/c1-18-13-6-5-10(7-12(13)17)22-11-8-14(19-2)16(21-4)15(9-11)20-3/h5-9,17H,1-4H3 D04XJT DRUGINKE OJRSPUQFMNDPAN-UHFFFAOYSA-N D04XJT DRUGSMIL COC1=C(C=C(C=C1)OC2=CC(=C(C(=C2)OC)OC)OC)O D04XJT HIGHSTAT Investigative D04XLX DRUG__ID D04XLX D04XLX DRUGTYPE Small molecular drug D04XLX DRUGINCH 1S/C19H16N6O/c20-18-23-15(14-9-5-2-6-10-14)16-17(24-18)25(12-22-16)19(26)21-11-13-7-3-1-4-8-13/h1-10,12H,11H2,(H,21,26)(H2,20,23,24) D04XLX DRUGINKE MNONTGDJIJLFPU-UHFFFAOYSA-N D04XLX DRUGSMIL C1=CC=C(C=C1)CNC(=O)N2C=NC3=C(N=C(N=C32)N)C4=CC=CC=C4 D04XLX HIGHSTAT Investigative D04XMZ DRUG__ID D04XMZ D04XMZ DRUGTYPE Small molecular drug D04XMZ DRUGINCH 1S/C14H17N3O5S3/c1-16-12-8-17(9-4-3-5-10(6-9)22-2)25(20,21)14-11(12)7-13(23-14)24(15,18)19/h3-7,12,16H,8H2,1-2H3,(H2,15,18,19)/t12-/m0/s1 D04XMZ DRUGINKE RMOXCYSVWCHXII-LBPRGKRZSA-N D04XMZ DRUGSMIL CNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C3=CC(=CC=C3)OC D04XMZ HIGHSTAT Investigative D04XNH DRUG__ID D04XNH D04XNH DRUGTYPE Small molecular drug D04XNH DRUGINCH 1S/C10H17NO2/c1-2-10(12)13-9-6-7-4-3-5-8(9)11-7/h7-9,11H,2-6H2,1H3 D04XNH DRUGINKE GSTSHGWHXRRCHO-UHFFFAOYSA-N D04XNH DRUGSMIL CCC(=O)OC1CC2CCCC1N2 D04XNH HIGHSTAT Investigative D04XNJ DRUG__ID D04XNJ D04XNJ DRUGTYPE Small molecular drug D04XNJ DRUGINCH 1S/C11H9N5/c12-10-9-6-15-16(11(9)14-7-13-10)8-4-2-1-3-5-8/h1-7H,(H2,12,13,14) D04XNJ DRUGINKE KKDPIZPUTYIBFX-UHFFFAOYSA-N D04XNJ DRUGSMIL C1=CC=C(C=C1)N2C3=NC=NC(=C3C=N2)N D04XNJ HIGHSTAT Investigative D04XOT DRUG__ID D04XOT D04XOT DRUGTYPE Small molecular drug D04XOT DRUGINCH 1S/C16H12O3/c1-10-5-6-15-13(7-10)14(18)9-16(19-15)11-3-2-4-12(17)8-11/h2-9,17H,1H3 D04XOT DRUGINKE BNOQFZSTTRNHCN-UHFFFAOYSA-N D04XOT DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC(=CC=C3)O D04XOT HIGHSTAT Investigative D04XPJ DRUG__ID D04XPJ D04XPJ DRUGTYPE Small molecular drug D04XPJ DRUGINCH 1S/C13H11NO2/c15-13(14-16)12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9,16H,(H,14,15) D04XPJ DRUGINKE JWLKPHOMARIZAB-UHFFFAOYSA-N D04XPJ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NO D04XPJ HIGHSTAT Investigative D04XPZ DRUG__ID D04XPZ D04XPZ DRUGTYPE Small molecular drug D04XPZ DRUGINCH 1S/C19H23NO2/c1-15(8-4-2-3-5-11-19(21)20-22)17-13-12-16-9-6-7-10-18(16)14-17/h6-7,9-10,12-14,22H,1-5,8,11H2,(H,20,21) D04XPZ DRUGINKE FMDUQUPDPRRDDD-UHFFFAOYSA-N D04XPZ DRUGSMIL C=C(CCCCCCC(=O)NO)C1=CC2=CC=CC=C2C=C1 D04XPZ HIGHSTAT Investigative D04XRV DRUG__ID D04XRV D04XRV DRUGTYPE Small molecular drug D04XRV DRUGINCH 1S/C15H9IN4/c16-12-5-1-3-10(7-12)14-9-13(19-20-17)8-11-4-2-6-18-15(11)14/h1-9H D04XRV DRUGINKE FZNQYXTXKRWFRF-UHFFFAOYSA-N D04XRV DRUGSMIL C1=CC(=CC(=C1)I)C2=C3C(=CC(=C2)N=[N+]=[N-])C=CC=N3 D04XRV HIGHSTAT Investigative D04XTP DRUG__ID D04XTP D04XTP DRUGTYPE Small molecular drug D04XTP DRUGINCH 1S/C25H36N4O6/c30-22(9-8-18-10-12-26-13-11-18)29-14-4-7-20(16-29)23(31)27-15-21(24(32)33)28-25(34)35-17-19-5-2-1-3-6-19/h1-3,5-6,18,20-21,26H,4,7-17H2,(H,27,31)(H,28,34)(H,32,33)/t20-,21+/m1/s1 D04XTP DRUGINKE MUWWGBUXCFRNCO-RTWAWAEBSA-N D04XTP DRUGSMIL C1CC(CN(C1)C(=O)CCC2CCNCC2)C(=O)NCC(C(=O)O)NC(=O)OCC3=CC=CC=C3 D04XTP HIGHSTAT Investigative D04XUV DRUG__ID D04XUV D04XUV DRUGTYPE Small molecular drug D04XUV DRUGINCH 1S/C18H21NO4/c1-2-3-4-5-7-14-10-11-18(17(20)12-14)23-16-9-6-8-15(13-16)19(21)22/h6,8-13,20H,2-5,7H2,1H3 D04XUV DRUGINKE ZPFZCOJDEYCPSH-UHFFFAOYSA-N D04XUV DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC(=C2)[N+](=O)[O-])O D04XUV HIGHSTAT Investigative D04XXE DRUG__ID D04XXE D04XXE DRUGTYPE Small molecular drug D04XXE DRUGINCH 1S/C21H26N2O2/c1-3-14-10-13-11-21(20(24)25-2)18-16(8-9-23(12-13)19(14)21)15-6-4-5-7-17(15)22-18/h4-7,13-14,19,22H,3,8-12H2,1-2H3/t13-,14-,19-,21+/m0/s1 D04XXE DRUGINKE NVVDQMVGALBDGE-KSWFMABOSA-N D04XXE DRUGSMIL CCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC D04XXE HIGHSTAT Investigative D04XZP DRUG__ID D04XZP D04XZP DRUGTYPE Small molecular drug D04XZP DRUGINCH 1S/C10H17NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h5-7,9,11H,3-4H2,1-2H3,(H,12,13)(H,14,15)/t6-,7+,9-/m0/s1 D04XZP DRUGINKE JQPDCKOQOOQUSC-OOZYFLPDSA-N D04XZP DRUGSMIL CC(C)C1CNC(C1CC(=O)O)C(=O)O D04XZP HIGHSTAT Investigative D04YCJ DRUG__ID D04YCJ D04YCJ DRUGTYPE Small molecular drug D04YCJ DRUGINCH 1S/C10H12FN3O/c1-6(12)5-14-10-7(4-13-14)2-3-8(15)9(10)11/h2-4,6,15H,5,12H2,1H3/t6-/m0/s1 D04YCJ DRUGINKE TZBBLWXEAUOTGZ-LURJTMIESA-N D04YCJ DRUGSMIL CC(CN1C2=C(C=CC(=C2F)O)C=N1)N D04YCJ HIGHSTAT Investigative D04YHZ DRUG__ID D04YHZ D04YHZ DRUGTYPE Small molecular drug D04YHZ DRUGINCH 1S/C14H12N2O2/c1-16-8-12-10(7-13(16)14(17)18-2)9-5-3-4-6-11(9)15-12/h3-8H,1-2H3/p+1 D04YHZ DRUGINKE UUMQQVGTICTWCW-UHFFFAOYSA-O D04YHZ DRUGSMIL C[N+]1=C(C=C2C3=CC=CC=C3NC2=C1)C(=O)OC D04YHZ HIGHSTAT Investigative D04YIV DRUG__ID D04YIV D04YIV DRUGTYPE Small molecular drug D04YIV DRUGINCH 1S/C8H9NO4S/c10-8(11)6-9-14(12,13)7-4-2-1-3-5-7/h1-5,9H,6H2,(H,10,11) D04YIV DRUGINKE WTSZSAHZIMPSDM-UHFFFAOYSA-N D04YIV DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NCC(=O)O D04YIV HIGHSTAT Investigative D04YNS DRUG__ID D04YNS D04YNS DRUGTYPE Small molecular drug D04YNS DRUGINCH 1S/C12H17NO2S/c1-9-4-2-3-5-10(9)8-16-7-6-11(13)12(14)15/h2-5,11H,6-8,13H2,1H3,(H,14,15) D04YNS DRUGINKE FWEMQWXSSVUTGP-UHFFFAOYSA-N D04YNS DRUGSMIL CC1=CC=CC=C1CSCCC(C(=O)O)N D04YNS HIGHSTAT Investigative D04YNW DRUG__ID D04YNW D04YNW DRUGTYPE Small molecular drug D04YNW DRUGINCH 1S/C18H24Cl2N2O.ClH/c19-16-7-6-14(11-17(16)20)12-18(23)22-10-2-1-5-15(22)13-21-8-3-4-9-21;/h6-7,11,15H,1-5,8-10,12-13H2;1H D04YNW DRUGINKE NGVLSOWJSUUYDE-UHFFFAOYSA-N D04YNW DRUGSMIL C1CCN(C(C1)CN2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl.Cl D04YNW HIGHSTAT Investigative D04YPP DRUG__ID D04YPP D04YPP DRUGTYPE Small molecular drug D04YPP DRUGINCH 1S/C16H13NO/c1-12-15(13-8-4-2-5-9-13)16(17-18-12)14-10-6-3-7-11-14/h2-11H,1H3 D04YPP DRUGINKE ZXIRUKJWLADSJS-UHFFFAOYSA-N D04YPP DRUGSMIL CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=CC=C3 D04YPP HIGHSTAT Investigative D04YQF DRUG__ID D04YQF D04YQF DRUGTYPE Small molecular drug D04YQF DRUGINCH 1S/C10H8N4/c1-2-4-8-7(3-1)12-10(13-8)9-5-6-11-14-9/h1-6H,(H,11,14)(H,12,13) D04YQF DRUGINKE IYTGPPNUOLLGBE-UHFFFAOYSA-N D04YQF DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=CC=NN3 D04YQF HIGHSTAT Investigative D04YTE DRUG__ID D04YTE D04YTE DRUGTYPE Small molecular drug D04YTE DRUGINCH 1S/C29H31NO7/c1-30(2)27(32)23-24(17-9-7-6-8-10-17)29(18-11-13-19(34-3)14-12-18)28(33,26(23)31)25-21(36-5)15-20(35-4)16-22(25)37-29/h6-16,23-24,26,31,33H,1-5H3/t23-,24-,26-,28+,29+/m1/s1 D04YTE DRUGINKE DAPAQENNNINUPW-IDAMAFBJSA-N D04YTE DRUGSMIL CN(C)C(=O)C1C(C2(C(C1O)(C3=C(O2)C=C(C=C3OC)OC)O)C4=CC=C(C=C4)OC)C5=CC=CC=C5 D04YTE HIGHSTAT Investigative D04YTO DRUG__ID D04YTO D04YTO DRUGTYPE Small molecular drug D04YTO DRUGINCH 1S/C15H12FN3/c1-10-3-2-4-12(7-10)19-15-13-8-11(16)5-6-14(13)17-9-18-15/h2-9H,1H3,(H,17,18,19) D04YTO DRUGINKE UBPLAEHESGUBAD-UHFFFAOYSA-N D04YTO DRUGSMIL CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C(C=C3)F D04YTO HIGHSTAT Investigative D04YUA DRUG__ID D04YUA D04YUA DRUGTYPE Small molecular drug D04YUA DRUGINCH 1S/C8H17FO2S/c1-2-3-4-5-6-7-8-12(9,10)11/h2-8H2,1H3 D04YUA DRUGINKE HMRWGKIZOBXNRB-UHFFFAOYSA-N D04YUA DRUGSMIL CCCCCCCCS(=O)(=O)F D04YUA HIGHSTAT Investigative D04YUM DRUG__ID D04YUM D04YUM DRUGTYPE Small molecular drug D04YUM DRUGINCH 1S/C9H13N5/c1-2-3-4-14-6-13-7-8(10)11-5-12-9(7)14/h5-6H,2-4H2,1H3,(H2,10,11,12) D04YUM DRUGINKE BKXMJMZKKNIYRD-UHFFFAOYSA-N D04YUM DRUGSMIL CCCCN1C=NC2=C(N=CN=C21)N D04YUM HIGHSTAT Investigative D04YVS DRUG__ID D04YVS D04YVS DRUGTYPE Small molecular drug D04YVS DRUGINCH 1S/C13H12N2O7S2/c14-23(17,18)21-11-6-4-9(5-7-11)13(16)10-2-1-3-12(8-10)22-24(15,19)20/h1-8H,(H2,14,17,18)(H2,15,19,20) D04YVS DRUGINKE NEMACRXQAFHGPF-UHFFFAOYSA-N D04YVS DRUGSMIL C1=CC(=CC(=C1)OS(=O)(=O)N)C(=O)C2=CC=C(C=C2)OS(=O)(=O)N D04YVS HIGHSTAT Investigative D04YWX DRUG__ID D04YWX D04YWX DRUGTYPE Small molecular drug D04YWX DRUGINCH 1S/C14H17NOS/c1-3-11-4-5-14-13(8-11)12(9-17-14)6-7-15-10(2)16/h4-5,8-9H,3,6-7H2,1-2H3,(H,15,16) D04YWX DRUGINKE PICRXJDULXLJCZ-UHFFFAOYSA-N D04YWX DRUGSMIL CCC1=CC2=C(C=C1)SC=C2CCNC(=O)C D04YWX HIGHSTAT Investigative D04YXB DRUG__ID D04YXB D04YXB DRUGTYPE Small molecular drug D04YXB DRUGINCH 1S/C14H10N2/c1-2-5-11(6-3-1)13-9-8-12-7-4-10-15-14(12)16-13/h1-10H D04YXB DRUGINKE SKVWGHJCDNDXAG-UHFFFAOYSA-N D04YXB DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C=CC=N3)C=C2 D04YXB HIGHSTAT Investigative D04YZZ DRUG__ID D04YZZ D04YZZ DRUGTYPE Small molecular drug D04YZZ DRUGINCH 1S/C52H63N11O7/c53-46(65)40-18-7-8-24-56-25-10-21-45(64)37-15-3-4-16-38(37)51(70)63-27-11-20-44(63)50(69)62-42(29-32-22-23-33-12-1-2-13-34(33)28-32)48(67)60-41(19-9-26-57-52(54)55)47(66)61-43(49(68)59-40)30-35-31-58-39-17-6-5-14-36(35)39/h1-6,12-17,22-23,28,31,40-44,56,58H,7-11,18-21,24-27,29-30H2,(H2,53,65)(H,59,68)(H,60,67)(H,61,66)(H,62,69)(H4,54,55,57)/t40-,41-,42+,43-,44-/m0/s1 D04YZZ DRUGINKE YUUZCRILYWDWPO-PURVKFDZSA-N D04YZZ DRUGSMIL C1CCNCCCC(=O)C2=CC=CC=C2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC4=CNC5=CC=CC=C54)CCCN=C(N)N)CC6=CC7=CC=CC=C7C=C6 D04YZZ HIGHSTAT Investigative D04ZAO DRUG__ID D04ZAO D04ZAO DRUGTYPE Small molecular drug D04ZAO DRUGINCH 1S/C5H4N4O/c10-5-4-3(1-8-9-4)6-2-7-5/h1-2H,(H,8,9)(H,6,7,10) D04ZAO DRUGINKE JFZSDNLQDTYVEE-UHFFFAOYSA-N D04ZAO DRUGSMIL C1=NNC2=C1N=CNC2=O D04ZAO HIGHSTAT Investigative D04ZBV DRUG__ID D04ZBV D04ZBV DRUGTYPE Small molecular drug D04ZBV DRUGINCH 1S/C22H16N4O3/c27-22(17-11-13-19(14-12-17)26(28)29)23-21-15-20(16-7-3-1-4-8-16)24-25(21)18-9-5-2-6-10-18/h1-15H,(H,23,27) D04ZBV DRUGINKE KIALCSMRIHRFPL-UHFFFAOYSA-N D04ZBV DRUGSMIL C1=CC=C(C=C1)C2=NN(C(=C2)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C4=CC=CC=C4 D04ZBV HIGHSTAT Investigative D04ZDD DRUG__ID D04ZDD D04ZDD DRUGTYPE Small molecular drug D04ZDD DRUGINCH 1S/C23H24O6/c1-23(2)9-8-13-17(29-23)7-6-14-21(24)16(12-28-22(13)14)15-10-19(26-4)20(27-5)11-18(15)25-3/h6-11,16H,12H2,1-5H3 D04ZDD DRUGINKE FHQIUPHJETXRLG-UHFFFAOYSA-N D04ZDD DRUGSMIL CC1(C=CC2=C(O1)C=CC3=C2OCC(C3=O)C4=CC(=C(C=C4OC)OC)OC)C D04ZDD HIGHSTAT Investigative D04ZDI DRUG__ID D04ZDI D04ZDI DRUGTYPE Small molecular drug D04ZDI DRUGINCH 1S/C17H18N2O3/c1-2-15(12-6-4-3-5-7-12)17(21)18-14-10-8-13(9-11-14)16(20)19-22/h3-11,15,22H,2H2,1H3,(H,18,21)(H,19,20)/t15-/m1/s1 D04ZDI DRUGINKE SPLALNOEMVSHPJ-OAHLLOKOSA-N D04ZDI DRUGSMIL CCC(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO D04ZDI HIGHSTAT Investigative D04ZFH DRUG__ID D04ZFH D04ZFH DRUGTYPE Small molecular drug D04ZFH DRUGINCH 1S/C20H16N2O/c1-2-6-16(7-3-1)23-17-12-10-15(11-13-17)14-20-21-18-8-4-5-9-19(18)22-20/h1-13H,14H2,(H,21,22) D04ZFH DRUGINKE HWTRVTWTEQIXOY-UHFFFAOYSA-N D04ZFH DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=CC=CC=C4N3 D04ZFH HIGHSTAT Investigative D04ZGF DRUG__ID D04ZGF D04ZGF DRUGTYPE Small molecular drug D04ZGF DRUGINCH 1S/C14H15N3/c1-3-12(6-9-17-10-8-15-11-17)13-4-2-7-16-14(13)5-1/h2-4,7-8,10-11H,1,5-6,9H2 D04ZGF DRUGINKE DJMSMHXCSIBVSA-UHFFFAOYSA-N D04ZGF DRUGSMIL C1CC2=C(C=CC=N2)C(=C1)CCN3C=CN=C3 D04ZGF HIGHSTAT Investigative D04ZGR DRUG__ID D04ZGR D04ZGR DRUGTYPE Small molecular drug D04ZGR DRUGINCH 1S/C15H11NO2/c17-15(16-18)12-8-7-11-6-5-10-3-1-2-4-13(10)14(11)9-12/h1-9,18H,(H,16,17) D04ZGR DRUGINKE NDIZNAOCRKZKMN-UHFFFAOYSA-N D04ZGR DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2C=C(C=C3)C(=O)NO D04ZGR HIGHSTAT Investigative D04ZIP DRUG__ID D04ZIP D04ZIP DRUGTYPE Small molecular drug D04ZIP DRUGINCH 1S/C13H8ClN/c14-13-12-6-5-9-3-1-2-4-10(9)11(12)7-8-15-13/h1-8H D04ZIP DRUGINKE SHQLTRRYZVBEMR-UHFFFAOYSA-N D04ZIP DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2C=CN=C3Cl D04ZIP HIGHSTAT Investigative D04ZIV DRUG__ID D04ZIV D04ZIV DRUGTYPE Small molecular drug D04ZIV DRUGINCH 1S/C19H21ClN6O2/c20-13-1-2-17(25-5-3-12(8-21)4-6-25)16(7-13)24-19(28)15-10-23-26-11-14(27)9-22-18(15)26/h1-2,7,9-12,27H,3-6,8,21H2,(H,24,28) D04ZIV DRUGINKE BNVZRFQNZWYPQH-UHFFFAOYSA-N D04ZIV DRUGSMIL C1CN(CCC1CN)C2=C(C=C(C=C2)Cl)NC(=O)C3=C4N=CC(=CN4N=C3)O D04ZIV HIGHSTAT Investigative D04ZJK DRUG__ID D04ZJK D04ZJK DRUGTYPE Small molecular drug D04ZJK DRUGINCH 1S/C52H76N6O4/c1-37-31-39-33-45-43(19-21-47(59)53-45)51(35-37)41(39)17-15-27-57(51)49(61)23-29-55(3)25-13-11-9-7-5-6-8-10-12-14-26-56(4)30-24-50(62)58-28-16-18-42-40-32-38(2)36-52(42,58)44-20-22-48(60)54-46(44)34-40/h19-22,31-32,39-42H,5-18,23-30,33-36H2,1-4H3,(H,53,59)(H,54,60)/t39?,40?,41-,42-,51-,52-/m1/s1 D04ZJK DRUGINKE TUYZMCKAYFZSRO-JDUDQBENSA-N D04ZJK DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4C(=O)CCN(C)CCCCCCCCCCCCN(C)CCC(=O)N5CCCC6C57CC(=CC6CC8=C7C=CC(=O)N8)C D04ZJK HIGHSTAT Investigative D04ZJL DRUG__ID D04ZJL D04ZJL DRUGTYPE Small molecular drug D04ZJL DRUGINCH 1S/C10H6BrNO3/c11-5-1-2-6-7(3-5)12-10(15)9(14)4-8(6)13/h1-4,13H,(H,12,14,15) D04ZJL DRUGINKE VCORQELOMRIIBS-UHFFFAOYSA-N D04ZJL DRUGSMIL C1=CC2=C(C=C1Br)NC(=O)C(=O)C=C2O D04ZJL HIGHSTAT Investigative D04ZJO DRUG__ID D04ZJO D04ZJO DRUGTYPE Small molecular drug D04ZJO DRUGINCH 1S/C16H20N2O/c1-10-7-11-8-14-13(4-5-15(19)18-14)16(9-10)12(11)3-2-6-17-16/h4-5,7,11-12,17H,2-3,6,8-9H2,1H3,(H,18,19)/t11?,12-,16-/m1/s1 D04ZJO DRUGINKE YYWGABLTRMRUIT-ZLXOECBPSA-N D04ZJO DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4 D04ZJO HIGHSTAT Investigative D04ZLZ DRUG__ID D04ZLZ D04ZLZ DRUGTYPE Small molecular drug D04ZLZ DRUGINCH 1S/C17H18N2O4/c18-15(17(21)22)10-16(20)19-13-6-8-14(9-7-13)23-11-12-4-2-1-3-5-12/h1-9,15H,10-11,18H2,(H,19,20)(H,21,22)/t15-/m0/s1 D04ZLZ DRUGINKE MKNOYEISPOGYTN-HNNXBMFYSA-N D04ZLZ DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)CC(C(=O)O)N D04ZLZ HIGHSTAT Investigative D04ZMM DRUG__ID D04ZMM D04ZMM DRUGTYPE Small molecular drug D04ZMM DRUGINCH 1S/C20H19N3O4/c1-26-17-10-15(11-18(12-17)27-2)19(24)22-23-20(25)21-16-8-7-13-5-3-4-6-14(13)9-16/h3-12H,1-2H3,(H,22,24)(H2,21,23,25) D04ZMM DRUGINKE IFQNPGNCFXITTG-UHFFFAOYSA-N D04ZMM DRUGSMIL COC1=CC(=CC(=C1)C(=O)NNC(=O)NC2=CC3=CC=CC=C3C=C2)OC D04ZMM HIGHSTAT Investigative D04ZMS DRUG__ID D04ZMS D04ZMS DRUGTYPE Small molecular drug D04ZMS DRUGINCH 1S/C22H25NO2/c24-22-19(16-25-21-9-5-4-8-20(21)22)15-23-12-10-18(11-13-23)14-17-6-2-1-3-7-17/h1-9,18-19H,10-16H2 D04ZMS DRUGINKE ODWZSCLUZWGCOH-UHFFFAOYSA-N D04ZMS DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4C3=O D04ZMS HIGHSTAT Investigative D04ZOI DRUG__ID D04ZOI D04ZOI DRUGTYPE Small molecular drug D04ZOI DRUGINCH 1S/C17H20N2/c1(2-4-9-13-17-14-18-15-19-17)3-6-10-16-11-7-5-8-12-16/h5,7-8,11-12,14-15H,1,3,6,9-10,13H2,(H,18,19) D04ZOI DRUGINKE MSBRTBBFZFRZEJ-UHFFFAOYSA-N D04ZOI DRUGSMIL C1=CC=C(C=C1)CCCCC#CCCC2=CN=CN2 D04ZOI HIGHSTAT Investigative D04ZPF DRUG__ID D04ZPF D04ZPF DRUGTYPE Small molecular drug D04ZPF DRUGINCH 1S/C18H20FNO/c1-13-6-7-16(19)18(12-13)21-17-5-3-2-4-15(17)14-8-10-20-11-9-14/h2-7,12,14,20H,8-11H2,1H3 D04ZPF DRUGINKE QPPDVPUFQFPJKK-UHFFFAOYSA-N D04ZPF DRUGSMIL CC1=CC(=C(C=C1)F)OC2=CC=CC=C2C3CCNCC3 D04ZPF HIGHSTAT Investigative D04ZPU DRUG__ID D04ZPU D04ZPU DRUGTYPE Small molecular drug D04ZPU DRUGINCH 1S/C13H12N2/c1-2-4-11-9-12(6-5-10(11)3-1)13-14-7-8-15-13/h1-6,9H,7-8H2,(H,14,15) D04ZPU DRUGINKE BGWRJAXPPYHIRG-UHFFFAOYSA-N D04ZPU DRUGSMIL C1CN=C(N1)C2=CC3=CC=CC=C3C=C2 D04ZPU HIGHSTAT Investigative D04ZQC DRUG__ID D04ZQC D04ZQC DRUGTYPE Small molecular drug D04ZQC DRUGINCH 1S/C15H14O6/c16-11-3-1-2-9(6-11)4-5-21-15(20)10-7-12(17)14(19)13(18)8-10/h1-3,6-8,16-19H,4-5H2 D04ZQC DRUGINKE VXELBUJPXRMMLF-UHFFFAOYSA-N D04ZQC DRUGSMIL C1=CC(=CC(=C1)O)CCOC(=O)C2=CC(=C(C(=C2)O)O)O D04ZQC HIGHSTAT Investigative D04ZQJ DRUG__ID D04ZQJ D04ZQJ DRUGTYPE Small molecular drug D04ZQJ DRUGINCH 1S/C18H14N2OS/c21-17(12-11-14-7-3-1-4-8-14)20-18-19-16(13-22-18)15-9-5-2-6-10-15/h1-13H,(H,19,20,21)/b12-11+ D04ZQJ DRUGINKE WOJRHCOBUKJCAJ-VAWYXSNFSA-N D04ZQJ DRUGSMIL C1=CC=C(C=C1)C=CC(=O)NC2=NC(=CS2)C3=CC=CC=C3 D04ZQJ HIGHSTAT Investigative D04ZQX DRUG__ID D04ZQX D04ZQX DRUGTYPE Small molecular drug D04ZQX DRUGINCH 1S/C24H33NO/c1-2-3-4-11-16-23(21-12-7-5-8-13-21)25-19-17-24(26,18-20-25)22-14-9-6-10-15-22/h5-10,12-15,23,26H,2-4,11,16-20H2,1H3 D04ZQX DRUGINKE VSTFKYJXYVRGDG-UHFFFAOYSA-N D04ZQX DRUGSMIL CCCCCCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D04ZQX HIGHSTAT Investigative D04ZSZ DRUG__ID D04ZSZ D04ZSZ DRUGCOMP Boehringer Ingelheim Corp D04ZSZ DRUGINCH 1S/C20H21N5O2/c1-23-11-8-17-16(23)9-12-24(17)20(27)25-15-7-3-2-5-13(15)19(26)22-14-6-4-10-21-18(14)25/h2-7,10,16-17H,8-9,11-12H2,1H3,(H,22,26) D04ZSZ DRUGINKE QBUPWEMXZYDTRC-UHFFFAOYSA-N D04ZSZ DRUGSMIL CN1CCC2C1CCN2C(=O)N3C4=CC=CC=C4C(=O)NC5=C3N=CC=C5 D04ZSZ HIGHSTAT Investigative D04ZTH DRUG__ID D04ZTH D04ZTH DRUGTYPE Small molecular drug D04ZTH DRUGINCH 1S/C14H9N3S2/c15-8-10-9(12-3-1-5-18-12)7-11(17-14(10)16)13-4-2-6-19-13/h1-7H,(H2,16,17) D04ZTH DRUGINKE NMMNXFUCSNOZLW-UHFFFAOYSA-N D04ZTH DRUGSMIL C1=CSC(=C1)C2=CC(=NC(=C2C#N)N)C3=CC=CS3 D04ZTH HIGHSTAT Investigative D04ZVO DRUG__ID D04ZVO D04ZVO DRUGCOMP ZS Pharma Inc D04ZVO DRUGINCH 1S/2Na.3H4O4Si.7H2O.Zr/c;;3*1-5(2,3)4;;;;;;;;/h;;3*1-4H;7*1H2;/q2*+1;;;;;;;;;;;/p-2 D04ZVO DRUGINKE FLPQPSFAQMBAMT-UHFFFAOYSA-L D04ZVO DRUGSMIL O.O.O.O.O.[OH-].[OH-].O[Si](O)(O)O.O[Si](O)(O)O.O[Si](O)(O)O.[Na+].[Na+].[Zr] D04ZVO HIGHSTAT Investigative D04ZWF DRUG__ID D04ZWF D04ZWF DRUGTYPE Small molecular drug D04ZWF DRUGINCH 1S/C20H17Cl2N9O2/c21-12-1-2-13(14(22)9-12)18-16(30-8-7-24-11-30)10-27-20(29-18)26-6-5-25-17-4-3-15(31(32)33)19(23)28-17/h1-4,7-11H,5-6H2,(H3,23,25,28)(H,26,27,29) D04ZWF DRUGINKE MDZCSIDIPDZWKL-UHFFFAOYSA-N D04ZWF DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C2=NC(=NC=C2N3C=CN=C3)NCCNC4=NC(=C(C=C4)[N+](=O)[O-])N D04ZWF HIGHSTAT Investigative D04ZWS DRUG__ID D04ZWS D04ZWS DRUGTYPE Small molecular drug D04ZWS DRUGINCH 1S/C20H28N2/c1-15(2)9-11-20-12-13-21-19(20)22(14-10-16(3)4)18-8-6-5-7-17(18)20/h5-10,19,21H,11-14H2,1-4H3 D04ZWS DRUGINKE TWRZIFGLJFJQJK-UHFFFAOYSA-N D04ZWS DRUGSMIL CC(=CCC12CCNC1N(C3=CC=CC=C23)CC=C(C)C)C D04ZWS HIGHSTAT Investigative D04ZYA DRUG__ID D04ZYA D04ZYA DRUGTYPE Small molecular drug D04ZYA DRUGINCH 1S/C14H19NO/c16-12-5-1-4-11(10-12)13-6-2-8-15-9-3-7-14(13)15/h1,4-5,10,13-14,16H,2-3,6-9H2/t13-,14?/m1/s1 D04ZYA DRUGINKE WOXUXMJHVREOKX-KWCCSABGSA-N D04ZYA DRUGSMIL C1CC(C2CCCN2C1)C3=CC(=CC=C3)O D04ZYA HIGHSTAT Investigative D04ZZQ DRUG__ID D04ZZQ D04ZZQ DRUGCOMP Vasopharm GmbH D04ZZQ DRUGINCH 1S/C18H12N6OS/c1-2-6-12(7-3-1)10-24-16-15(22-23-24)17(20-11-19-16)26-18-21-13-8-4-5-9-14(13)25-18/h1-9,11H,10H2 D04ZZQ DRUGINKE HZSOKHVVANONPV-UHFFFAOYSA-N D04ZZQ DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C(=NC=N3)SC4=NC5=CC=CC=C5O4)N=N2 D04ZZQ HIGHSTAT Investigative D04ZZU DRUG__ID D04ZZU D04ZZU DRUGTYPE Small molecular drug D04ZZU DRUGINCH 1S/C19H12ClNO2S/c20-13-6-5-7-14(12-13)23-19(22)21-15-8-1-3-10-17(15)24-18-11-4-2-9-16(18)21/h1-12H D04ZZU DRUGINKE IXZXEECBRFSNPQ-UHFFFAOYSA-N D04ZZU DRUGSMIL C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)OC4=CC(=CC=C4)Cl D04ZZU HIGHSTAT Investigative D05ABT DRUG__ID D05ABT D05ABT DRUGTYPE Small molecular drug D05ABT DRUGINCH 1S/C9H6N2O3/c12-6-8-9(10-14-11(8)13)7-4-2-1-3-5-7/h1-6H D05ABT DRUGINKE MNNADPGXJASGIU-UHFFFAOYSA-N D05ABT DRUGSMIL C1=CC=C(C=C1)C2=NO[N+](=C2C=O)[O-] D05ABT HIGHSTAT Investigative D05ACE DRUG__ID D05ACE D05ACE DRUGTYPE Small molecular drug D05ACE DRUGINCH 1S/C14H9Cl2N3/c15-11-3-1-10(2-4-11)14-9-17-18-19(14)13-7-5-12(16)6-8-13/h1-9H D05ACE DRUGINKE RXDUBIUDBWNEMF-UHFFFAOYSA-N D05ACE DRUGSMIL C1=CC(=CC=C1C2=CN=NN2C3=CC=C(C=C3)Cl)Cl D05ACE HIGHSTAT Investigative D05ADD DRUG__ID D05ADD D05ADD DRUGTYPE Small molecular drug D05ADD DRUGINCH 1S/C15H13FO3S/c16-13-8-6-12(7-9-13)15(17)10-11-20(18,19)14-4-2-1-3-5-14/h1-9H,10-11H2 D05ADD DRUGINKE DMAMKPWVVZCTDR-UHFFFAOYSA-N D05ADD DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CCC(=O)C2=CC=C(C=C2)F D05ADD HIGHSTAT Investigative D05AEG DRUG__ID D05AEG D05AEG DRUGTYPE Small molecular drug D05AEG DRUGINCH 1S/C13H11N3O/c1-8(17)15-13-6-10-9-4-2-3-5-11(9)16-12(10)7-14-13/h2-7,16H,1H3,(H,14,15,17) D05AEG DRUGINKE JZIFOHJMLBAWQZ-UHFFFAOYSA-N D05AEG DRUGSMIL CC(=O)NC1=NC=C2C(=C1)C3=CC=CC=C3N2 D05AEG HIGHSTAT Investigative D05AFI DRUG__ID D05AFI D05AFI DRUGTYPE Small molecular drug D05AFI DRUGINCH 1S/C24H34N2O4.2BrH/c1-25(2)13-15-29-23(27,17-25)21-9-5-19(6-10-21)20-7-11-22(12-8-20)24(28)18-26(3,4)14-16-30-24;;/h5-12,27-28H,13-18H2,1-4H3;2*1H/q+2;;/p-2 D05AFI DRUGINKE OPYKHUMNFAMIBL-UHFFFAOYSA-L D05AFI DRUGSMIL C[N+]1(CCOC(C1)(C2=CC=C(C=C2)C3=CC=C(C=C3)C4(C[N+](CCO4)(C)C)O)O)C.[Br-].[Br-] D05AFI HIGHSTAT Investigative D05AFV DRUG__ID D05AFV D05AFV DRUGTYPE Small molecular drug D05AFV DRUGINCH 1S/C31H33N5O5/c1-17-11-21(37)12-18(2)22(17)14-23(32)31(41)36-16-20-8-4-3-7-19(20)13-27(36)30(40)35-26(15-28(38)39)29-33-24-9-5-6-10-25(24)34-29/h3-12,23,26-27,37H,13-16,32H2,1-2H3,(H,33,34)(H,35,40)(H,38,39)/t23-,26-,27-/m0/s1 D05AFV DRUGINKE USVQTDLSVBRMCR-YGPDHOBYSA-N D05AFV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C4=NC5=CC=CC=C5N4)N)C)O D05AFV HIGHSTAT Investigative D05AFW DRUG__ID D05AFW D05AFW DRUGTYPE Small molecular drug D05AFW DRUGINCH 1S/C10H14N2S.ClH/c1-2-8-3-5-9(6-4-8)7-13-10(11)12;/h3-6H,2,7H2,1H3,(H3,11,12);1H D05AFW DRUGINKE FLLOBRZODSODRU-UHFFFAOYSA-N D05AFW DRUGSMIL CCC1=CC=C(C=C1)CSC(=N)N.Cl D05AFW HIGHSTAT Investigative D05AGK DRUG__ID D05AGK D05AGK DRUGTYPE Small molecular drug D05AGK DRUGINCH 1S/C20H24N4O5S/c25-19(15-6-8-16(9-7-15)24-12-10-21-11-13-24)22-14-18(20(26)27)23-30(28,29)17-4-2-1-3-5-17/h1-9,18,21,23H,10-14H2,(H,22,25)(H,26,27)/t18-/m0/s1 D05AGK DRUGINKE PXSDSRKJCWOYNE-SFHVURJKSA-N D05AGK DRUGSMIL C1CN(CCN1)C2=CC=C(C=C2)C(=O)NCC(C(=O)O)NS(=O)(=O)C3=CC=CC=C3 D05AGK HIGHSTAT Investigative D05AHZ DRUG__ID D05AHZ D05AHZ DRUGTYPE Small molecular drug D05AHZ DRUGINCH 1S/C12H17NO4S/c14-12(13-15)9-5-2-6-10-18(16,17)11-7-3-1-4-8-11/h1,3-4,7-8,15H,2,5-6,9-10H2,(H,13,14) D05AHZ DRUGINKE CUUZMQZWMSHEAR-UHFFFAOYSA-N D05AHZ DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CCCCCC(=O)NO D05AHZ HIGHSTAT Investigative D05AIN DRUG__ID D05AIN D05AIN DRUGTYPE Small molecular drug D05AIN DRUGINCH 1S/C18H21NO/c20-18-8-4-7-17(13-18)16-9-11-19(12-10-16)14-15-5-2-1-3-6-15/h1-8,13,16,20H,9-12,14H2 D05AIN DRUGINKE BPNZNQGAIFMNES-UHFFFAOYSA-N D05AIN DRUGSMIL C1CN(CCC1C2=CC(=CC=C2)O)CC3=CC=CC=C3 D05AIN HIGHSTAT Investigative D05AIT DRUG__ID D05AIT D05AIT DRUGTYPE Small molecular drug D05AIT DRUGINCH 1S/C15H10ClNOS/c16-15-8-7-14(19-15)13-6-2-5-12(17-13)10-3-1-4-11(18)9-10/h1-9,18H D05AIT DRUGINKE IYXPXDBFKHBESO-UHFFFAOYSA-N D05AIT DRUGSMIL C1=CC(=CC(=C1)O)C2=NC(=CC=C2)C3=CC=C(S3)Cl D05AIT HIGHSTAT Investigative D05AJJ DRUG__ID D05AJJ D05AJJ DRUGTYPE Small molecular drug D05AJJ DRUGINCH 1S/C17H13NO/c19-17-16-9-8-14(12-15(16)10-11-18-17)7-6-13-4-2-1-3-5-13/h1-5,8-9,12H,10-11H2,(H,18,19) D05AJJ DRUGINKE BOVJHNHRQNCDEQ-UHFFFAOYSA-N D05AJJ DRUGSMIL C1CNC(=O)C2=C1C=C(C=C2)C#CC3=CC=CC=C3 D05AJJ HIGHSTAT Investigative D05AJZ DRUG__ID D05AJZ D05AJZ DRUGTYPE Small molecular drug D05AJZ DRUGINCH 1S/C14H11BrN2/c1-17-9-13(10-4-6-16-7-5-10)12-3-2-11(15)8-14(12)17/h2-9H,1H3 D05AJZ DRUGINKE FSWMKLCDACNCRN-UHFFFAOYSA-N D05AJZ DRUGSMIL CN1C=C(C2=C1C=C(C=C2)Br)C3=CC=NC=C3 D05AJZ HIGHSTAT Investigative D05AMQ DRUG__ID D05AMQ D05AMQ DRUGTYPE Small molecular drug D05AMQ DRUGINCH 1S/C8H14N2O2S/c1-3-5-6-9-7(11)10(4-2)13-8(9)12/h3-6H2,1-2H3 D05AMQ DRUGINKE WTFFYZGCISALRI-UHFFFAOYSA-N D05AMQ DRUGSMIL CCCCN1C(=O)N(SC1=O)CC D05AMQ HIGHSTAT Investigative D05AMX DRUG__ID D05AMX D05AMX DRUGTYPE Small molecular drug D05AMX DRUGINCH 1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/t2-/m0/s1 D05AMX DRUGINKE XVOYSCVBGLVSOL-REOHCLBHSA-N D05AMX DRUGSMIL C(C(C(=O)O)N)S(=O)(=O)O D05AMX HIGHSTAT Investigative D05ANK DRUG__ID D05ANK D05ANK DRUGTYPE Small molecular drug D05ANK DRUGINCH 1S/C17H18N2/c1-19(12-14-7-3-2-4-8-14)13-16-11-15-9-5-6-10-17(15)18-16/h2-11,18H,12-13H2,1H3 D05ANK DRUGINKE YJDMPOSBUYNPGY-UHFFFAOYSA-N D05ANK DRUGSMIL CN(CC1=CC=CC=C1)CC2=CC3=CC=CC=C3N2 D05ANK HIGHSTAT Investigative D05ANN DRUG__ID D05ANN D05ANN DRUGTYPE Small molecular drug D05ANN DRUGINCH 1S/C26H25NO4/c28-18-8-7-15-11-20-26(29)12-17-16-3-1-2-4-19(16)30-22(17)24-25(26,21(15)23(18)31-24)9-10-27(20)13-14-5-6-14/h1-4,7-8,14,20,24,28-29H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1 D05ANN DRUGINKE ZHVWWEYETMPAMX-IFKAHUTRSA-N D05ANN DRUGSMIL C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8O6 D05ANN HIGHSTAT Investigative D05ANV DRUG__ID D05ANV D05ANV DRUGTYPE Small molecular drug D05ANV DRUGINCH 1S/C13H19N/c1-12-4-6-13(7-5-12)8-11-14-9-2-3-10-14/h4-7H,2-3,8-11H2,1H3 D05ANV DRUGINKE RLADTPQRCGVXDS-UHFFFAOYSA-N D05ANV DRUGSMIL CC1=CC=C(C=C1)CCN2CCCC2 D05ANV HIGHSTAT Investigative D05AOH DRUG__ID D05AOH D05AOH DRUGTYPE Small molecular drug D05AOH DRUGINCH 1S/C6H4INO4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H D05AOH DRUGINKE PSLSYWRHLJIBMS-UHFFFAOYSA-N D05AOH DRUGSMIL C1=CC(=CC(=C1)I(=O)=O)[N+](=O)[O-] D05AOH HIGHSTAT Investigative D05APC DRUG__ID D05APC D05APC DRUGTYPE Small molecular drug D05APC DRUGINCH 1S/C8H16N2/c1-3-4-7-6(2)5-8(9)10-7/h6-7H,3-5H2,1-2H3,(H2,9,10) D05APC DRUGINKE TYAICJLSMGBRPT-UHFFFAOYSA-N D05APC DRUGSMIL CCCC1C(CC(=N1)N)C D05APC HIGHSTAT Investigative D05APW DRUG__ID D05APW D05APW DRUGCOMP Abbott Laboratories D05APW DRUGINCH 1S/C23H27F3N4O/c1-22(2,3)11-10-15-12-17(23(24,25)26)9-8-16(15)13-27-21(31)29-19-6-5-7-20-18(19)14-28-30(20)4/h5-9,12,14H,10-11,13H2,1-4H3,(H2,27,29,31) D05APW DRUGINKE SMJCAASNPAKOIB-UHFFFAOYSA-N D05APW DRUGSMIL CC(C)(C)CCC1=C(C=CC(=C1)C(F)(F)F)CNC(=O)NC2=C3C=NN(C3=CC=C2)C D05APW HIGHSTAT Investigative D05APZ DRUG__ID D05APZ D05APZ DRUGTYPE Small molecular drug D05APZ DRUGINCH 1S/C34H29N7O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33/h1-13,18-19,21,25,38H,14-17,20H2,(H,39,42) D05APZ DRUGINKE IWCQHVUQEFDRIW-UHFFFAOYSA-N D05APZ DRUGSMIL C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8 D05APZ HIGHSTAT Investigative D05ARF DRUG__ID D05ARF D05ARF DRUGTYPE Small molecular drug D05ARF DRUGINCH 1S/C14H13N5/c15-13-6-12-11(8-16-13)14(19-9-18-12)17-7-10-4-2-1-3-5-10/h1-6,8-9H,7H2,(H2,15,16)(H,17,18,19) D05ARF DRUGINKE JBRBEQRTMVYDCU-UHFFFAOYSA-N D05ARF DRUGSMIL C1=CC=C(C=C1)CNC2=NC=NC3=CC(=NC=C32)N D05ARF HIGHSTAT Investigative D05ARI DRUG__ID D05ARI D05ARI DRUGTYPE Small molecular drug D05ARI DRUGINCH 1S/C10H17N3/c1-2-5-11-9-3-4-10-8(6-9)7-12-13-10/h7,9,11H,2-6H2,1H3,(H,12,13) D05ARI DRUGINKE PYXYUOJSCYNCKM-UHFFFAOYSA-N D05ARI DRUGSMIL CCCNC1CCC2=C(C1)C=NN2 D05ARI HIGHSTAT Investigative D05AVX DRUG__ID D05AVX D05AVX DRUGTYPE Small molecular drug D05AVX DRUGINCH 1S/C7H12O2/c1-3-4-5-7(9)6(2)8/h3-5H2,1-2H3 D05AVX DRUGINKE FJPGAMCQJNLTJC-UHFFFAOYSA-N D05AVX DRUGSMIL CCCCC(=O)C(=O)C D05AVX HIGHSTAT Investigative D05AZU DRUG__ID D05AZU D05AZU DRUGTYPE Small molecular drug D05AZU DRUGINCH 1S/C14H11N3O2/c15-9-10-6-7-12(13(18)8-10)17-14(19)16-11-4-2-1-3-5-11/h1-8,18H,(H2,16,17,19) D05AZU DRUGINKE XRZHCICQICNYCB-UHFFFAOYSA-N D05AZU DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=C(C=C(C=C2)C#N)O D05AZU HIGHSTAT Investigative D05AZW DRUG__ID D05AZW D05AZW DRUGTYPE Small molecular drug D05AZW DRUGINCH 1S/C30H32N2O7/c1-5-17-15-32-24-13-20(17)28(27(34)37-4,16-38-26(33)18-10-11-22(35-2)23(12-18)36-3)29-14-25(32)39-30(24,29)31-21-9-7-6-8-19(21)29/h5-12,20,24-25,31H,13-16H2,1-4H3/b17-5-/t20-,24-,25-,28-,29-,30-/m0/s1 D05AZW DRUGINKE NPAPHJSGCRCHBM-UMLFCLJTSA-N D05AZW DRUGSMIL CC=C1CN2C3CC1C(C45C3(NC6=CC=CC=C64)OC2C5)(COC(=O)C7=CC(=C(C=C7)OC)OC)C(=O)OC D05AZW HIGHSTAT Investigative D05BCJ DRUG__ID D05BCJ D05BCJ DRUGTYPE Small molecular drug D05BCJ DRUGINCH 1S/C16H20N2/c1-2-6-15(7-3-1)14-17-12-8-16(9-13-17)18-10-4-5-11-18/h1-7,10-11,16H,8-9,12-14H2 D05BCJ DRUGINKE UPRFZLANTXURKF-UHFFFAOYSA-N D05BCJ DRUGSMIL C1CN(CCC1N2C=CC=C2)CC3=CC=CC=C3 D05BCJ HIGHSTAT Investigative D05BCY DRUG__ID D05BCY D05BCY DRUGTYPE Small molecular drug D05BCY DRUGINCH 1S/C21H26O6S/c1-20-6-4-12-19(24)27-14(11-5-7-26-10-11)9-21(12,2)17(20)16(22)15(28)8-13(20)18(23)25-3/h5,7,10,12-15,17,28H,4,6,8-9H2,1-3H3/t12-,13-,14-,15+,17-,20-,21-/m0/s1 D05BCY DRUGINKE NGNBKFTYZQINBO-ZNKMMSAYSA-N D05BCY DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)S)C)C4=COC=C4 D05BCY HIGHSTAT Investigative D05BEL DRUG__ID D05BEL D05BEL DRUGTYPE Small molecular drug D05BEL DRUGINCH 1S/C8H12N2O2/c1-9-5-3-2-4-6-7(5)8(11)10-12-6/h5,9H,2-4H2,1H3,(H,10,11) D05BEL DRUGINKE UJAXSQRTPSSJPO-UHFFFAOYSA-N D05BEL DRUGSMIL CNC1CCCC2=C1C(=O)NO2 D05BEL HIGHSTAT Investigative D05BFC DRUG__ID D05BFC D05BFC DRUGTYPE Small molecular drug D05BFC DRUGINCH 1S/C14H14N3O12PS2/c1-7-13(19)9(5-18)10(6-29-30(20,21)22)14(15-7)17-16-11-4-8(31(23,24)25)2-3-12(11)32(26,27)28/h2-5,19H,6H2,1H3,(H2,20,21,22)(H,23,24,25)(H,26,27,28) D05BFC DRUGINKE XYBQYEJAMIDMPT-UHFFFAOYSA-N D05BFC DRUGSMIL CC1=C(C(=C(C(=N1)N=NC2=C(C=CC(=C2)S(=O)(=O)O)S(=O)(=O)O)COP(=O)(O)O)C=O)O D05BFC HIGHSTAT Investigative D05BHG DRUG__ID D05BHG D05BHG DRUGTYPE Small molecular drug D05BHG DRUGINCH 1S/C4H10NO6P/c1-2(3(5)4(6)7)11-12(8,9)10/h2-3H,5H2,1H3,(H,6,7)(H2,8,9,10)/t2-,3+/m0/s1 D05BHG DRUGINKE USRGIUJOYOXOQJ-STHAYSLISA-N D05BHG DRUGSMIL CC(C(C(=O)O)N)OP(=O)(O)O D05BHG HIGHSTAT Investigative D05BJY DRUG__ID D05BJY D05BJY DRUGTYPE Small molecular drug D05BJY DRUGINCH 1S/C28H30O12/c1-11-20(32)37-19-16(30)26-18-14(36-13(29)10-12-8-6-5-7-9-12)15(24(2,3)4)25(26)17(31)21(33)39-23(25)40-28(26,22(34)38-18)27(11,19)35/h5-9,11,14-19,23,30-31,35H,10H2,1-4H3/t11?,14-,15?,16?,17-,18?,19-,23?,25?,26?,27+,28-/m0/s1 D05BJY DRUGINKE IYWGNBBAQNQGIC-MAVMKJRYSA-N D05BJY DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5OC(=O)CC7=CC=CC=C7)C(C)(C)C)C(C(=O)OC6O4)O)O D05BJY HIGHSTAT Investigative D05BKG DRUG__ID D05BKG D05BKG DRUGTYPE Small molecular drug D05BKG DRUGINCH 1S/C13H21N6O4S/c1-24(3-2-18-22)4-7-9(20)10(21)13(23-7)19-6-17-8-11(14)15-5-16-12(8)19/h5-7,9-10,13,18,20-22H,2-4H2,1H3,(H2,14,15,16)/q+1/t7-,9-,10-,13-,24?/m1/s1 D05BKG DRUGINKE VJHFTTWXKUEKQP-VCZNENMGSA-N D05BKG DRUGSMIL C[S+](CCNO)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D05BKG HIGHSTAT Investigative D05BMA DRUG__ID D05BMA D05BMA DRUGTYPE Small molecular drug D05BMA DRUGINCH 1S/C19H29N5O2/c1-12(2)10-15(20)19(26)24-9-3-4-16(24)18(25)23-11-13-5-7-14(8-6-13)17(21)22/h5-8,12,15-16H,3-4,9-11,20H2,1-2H3,(H3,21,22)(H,23,25)/t15-,16+/m1/s1 D05BMA DRUGINKE XFNMDMGNNKIXBT-CVEARBPZSA-N D05BMA DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)NCC2=CC=C(C=C2)C(=N)N)N D05BMA HIGHSTAT Investigative D05BMD DRUG__ID D05BMD D05BMD DRUGTYPE Small molecular drug D05BMD DRUGINCH 1S/C9H11ClN2O3/c10-8-3-1-7(2-4-8)6-15-11-5-9(13)12-14/h1-4,11,14H,5-6H2,(H,12,13) D05BMD DRUGINKE DSHAKCWOEUEDGY-UHFFFAOYSA-N D05BMD DRUGSMIL C1=CC(=CC=C1CONCC(=O)NO)Cl D05BMD HIGHSTAT Investigative D05BMP DRUG__ID D05BMP D05BMP DRUGTYPE Small molecular drug D05BMP DRUGINCH 1S/C15H10N4S2/c16-15-19-12(14-18-7-8-20-14)13(21-15)10-5-6-17-11-4-2-1-3-9(10)11/h1-8H,(H2,16,19) D05BMP DRUGINKE JHZIIPPDVRVCNU-UHFFFAOYSA-N D05BMP DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)C3=C(N=C(S3)N)C4=NC=CS4 D05BMP HIGHSTAT Investigative D05BOD DRUG__ID D05BOD D05BOD DRUGTYPE Small molecular drug D05BOD DRUGINCH 1S/C8H13NO2/c9-8(7(10)11)4-5-1-2-6(8)3-5/h5-6H,1-4,9H2,(H,10,11) D05BOD DRUGINKE MPUVBVXDFRDIPT-UHFFFAOYSA-N D05BOD DRUGSMIL C1CC2CC1CC2(C(=O)O)N D05BOD HIGHSTAT Investigative D05BPM DRUG__ID D05BPM D05BPM DRUGTYPE Small molecular drug D05BPM DRUGINCH 1S/C15H11FN2O/c1-10-3-2-4-14(5-10)18-15(19)12-6-11(9-17)7-13(16)8-12/h2-8H,1H3,(H,18,19) D05BPM DRUGINKE JHLDQKUSWAUHCQ-UHFFFAOYSA-N D05BPM DRUGSMIL CC1=CC(=CC=C1)NC(=O)C2=CC(=CC(=C2)C#N)F D05BPM HIGHSTAT Investigative D05BPX DRUG__ID D05BPX D05BPX DRUGTYPE Small molecular drug D05BPX DRUGINCH 1S/C16H15N3O2S/c20-12-3-1-2-11(10-12)15-17-13-4-9-22-14(13)16(18-15)19-5-7-21-8-6-19/h1-4,9-10,20H,5-8H2 D05BPX DRUGINKE XXLAEKOWCYJOKK-UHFFFAOYSA-N D05BPX DRUGSMIL C1COCCN1C2=NC(=NC3=C2SC=C3)C4=CC(=CC=C4)O D05BPX HIGHSTAT Investigative D05BTF DRUG__ID D05BTF D05BTF DRUGTYPE Small molecular drug D05BTF DRUGINCH 1S/C25H47NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-19-22(27)24(29)26-21-18-17-20-23(28)30-25(2,3)4/h5-21H2,1-4H3,(H,26,29) D05BTF DRUGINKE RXNGZFCASMDLGP-UHFFFAOYSA-N D05BTF DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCCC(=O)OC(C)(C)C D05BTF HIGHSTAT Investigative D05BTG DRUG__ID D05BTG D05BTG DRUGTYPE Small molecular drug D05BTG DRUGINCH 1S/C20H23NO/c1-3-8-16(9-4-1)18-14-20(22-15-18)12-7-13-21-19(20)17-10-5-2-6-11-17/h1-6,8-11,18-19,21H,7,12-15H2/t18-,19?,20?/m1/s1 D05BTG DRUGINKE WJRYRJACQITXQC-XEVCZEQESA-N D05BTG DRUGSMIL C1CC2(CC(CO2)C3=CC=CC=C3)C(NC1)C4=CC=CC=C4 D05BTG HIGHSTAT Investigative D05BUX DRUG__ID D05BUX D05BUX DRUGTYPE Small molecular drug D05BUX DRUGINCH 1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9?,10-,11-,12?,13?/m1/s1 D05BUX DRUGINKE XRQDFNLINLXZLB-WFNKCNOUSA-N D05BUX DRUGSMIL CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C D05BUX HIGHSTAT Investigative D05BYD DRUG__ID D05BYD D05BYD DRUGTYPE Small molecular drug D05BYD DRUGINCH 1S/C20H29N3O3/c1-15(21)20(25)23-12-10-22(11-13-23)9-2-14-26-18-7-5-17(6-8-18)19(24)16-3-4-16/h5-8,15-16H,2-4,9-14,21H2,1H3/t15-/m1/s1 D05BYD DRUGINKE KPXVCGPCRXEDLT-OAHLLOKOSA-N D05BYD DRUGSMIL CC(C(=O)N1CCN(CC1)CCCOC2=CC=C(C=C2)C(=O)C3CC3)N D05BYD HIGHSTAT Investigative D05BZQ DRUG__ID D05BZQ D05BZQ DRUGTYPE Small molecular drug D05BZQ DRUGINCH 1S/C23H30O7/c1-5-29-16-10-15(20(25)27-4)22(2)8-6-14-21(26)30-17(13-7-9-28-12-13)11-23(14,3)19(22)18(16)24/h7,9,12,14-17,19H,5-6,8,10-11H2,1-4H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1 D05BZQ DRUGINKE IYIKKRWPZJDFNB-AGQYDFLVSA-N D05BZQ DRUGSMIL CCOC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D05BZQ HIGHSTAT Investigative D05CBG DRUG__ID D05CBG D05CBG DRUGTYPE Small molecular drug D05CBG DRUGINCH 1S/C10H9NO/c11-10-3-1-8(2-4-10)9-5-6-12-7-9/h1-7H,11H2 D05CBG DRUGINKE NSKKXDBWURWAOW-UHFFFAOYSA-N D05CBG DRUGSMIL C1=CC(=CC=C1C2=COC=C2)N D05CBG HIGHSTAT Investigative D05CCF DRUG__ID D05CCF D05CCF DRUGTYPE Small molecular drug D05CCF DRUGINCH 1S/C13H10ClN3O4/c14-9-6-10(12(18)7-11(9)17(20)21)16-13(19)15-8-4-2-1-3-5-8/h1-7,18H,(H2,15,16,19) D05CCF DRUGINKE ASMCVDDUQQZBFK-UHFFFAOYSA-N D05CCF DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=CC(=C(C=C2O)[N+](=O)[O-])Cl D05CCF HIGHSTAT Investigative D05CCT DRUG__ID D05CCT D05CCT DRUGTYPE Small molecular drug D05CCT DRUGINCH 1S/C16H18N3S/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13/h5-10H,1-4H3/q+1 D05CCT DRUGINKE RBTBFTRPCNLSDE-UHFFFAOYSA-N D05CCT DRUGSMIL CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2 D05CCT HIGHSTAT Investigative D05CDC DRUG__ID D05CDC D05CDC DRUGTYPE Small molecular drug D05CDC DRUGINCH 1S/C40H52O16/c1-18-16-39(48)26-14-15-35(8)25-12-13-27(46)50-17-38(25,19(2)51-20(3)41)31(53-22(5)43)28(52-21(4)42)29(35)36(26,9)32(54-23(6)44)33(55-24(7)45)37(39,10)40(30(18)56-40)34(47)49-11/h12-13,19,25-26,28-33,48H,1,14-17H2,2-11H3/t19?,25-,26+,28-,29-,30+,31-,32+,33-,35-,36-,37+,38+,39+,40-/m0/s1 D05CDC DRUGINKE VKDXHXWBOARFPD-IHWRNOMOSA-N D05CDC DRUGSMIL CC(C12COC(=O)C=CC1C3(CCC4C(C3C(C2OC(=O)C)OC(=O)C)(C(C(C5(C4(CC(=C)C6C5(O6)C(=O)OC)O)C)OC(=O)C)OC(=O)C)C)C)OC(=O)C D05CDC HIGHSTAT Investigative D05CEJ DRUG__ID D05CEJ D05CEJ DRUGTYPE Small molecular drug D05CEJ DRUGINCH 1S/C23H16ClN3O/c24-19-13-11-18(12-14-19)22(28)27-23-25-20(16-7-3-1-4-8-16)15-21(26-23)17-9-5-2-6-10-17/h1-15H,(H,25,26,27,28) D05CEJ DRUGINKE GXFPQKORTZOVLZ-UHFFFAOYSA-N D05CEJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=N2)NC(=O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4 D05CEJ HIGHSTAT Investigative D05CEM DRUG__ID D05CEM D05CEM DRUGTYPE Small molecular drug D05CEM DRUGINCH 1S/C22H25BrCl2N6O/c23-17-5-7-21(29-12-17)31(14-16-4-6-19(24)20(25)11-16)10-2-9-28-22(32)27-8-1-3-18-13-26-15-30-18/h4-7,11-13,15H,1-3,8-10,14H2,(H,26,30)(H2,27,28,32) D05CEM DRUGINKE QJDXAQZNKZDALD-UHFFFAOYSA-N D05CEM DRUGSMIL C1=CC(=C(C=C1CN(CCCNC(=O)NCCCC2=CN=CN2)C3=NC=C(C=C3)Br)Cl)Cl D05CEM HIGHSTAT Investigative D05CGI DRUG__ID D05CGI D05CGI DRUGTYPE Small molecular drug D05CGI DRUGINCH 1S/C22H25NO2/c24-21-15-19(25-22-9-5-4-8-20(21)22)16-23-12-10-18(11-13-23)14-17-6-2-1-3-7-17/h1-9,18-19H,10-16H2 D05CGI DRUGINKE SVALPNADURCFPN-UHFFFAOYSA-N D05CGI DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CC3CC(=O)C4=CC=CC=C4O3 D05CGI HIGHSTAT Investigative D05CLM DRUG__ID D05CLM D05CLM DRUGTYPE Small molecular drug D05CLM DRUGINCH 1S/C26H34F2N2O3S/c1-4-5-6-7-8-16-30(25(33)29-23-14-11-20(27)18-22(23)28)17-15-19-9-12-21(13-10-19)34-26(2,3)24(31)32/h9-14,18H,4-8,15-17H2,1-3H3,(H,29,33)(H,31,32) D05CLM DRUGINKE KYQNYMXQHLMADB-UHFFFAOYSA-N D05CLM DRUGSMIL CCCCCCCN(CCC1=CC=C(C=C1)SC(C)(C)C(=O)O)C(=O)NC2=C(C=C(C=C2)F)F D05CLM HIGHSTAT Investigative D05CND DRUG__ID D05CND D05CND DRUGTYPE Small molecular drug D05CND DRUGINCH 1S/C13H8N2O3S/c16-13-14-11-5-4-9(7-12(11)19-13)8-2-1-3-10(6-8)15(17)18/h1-7H,(H,14,16) D05CND DRUGINKE NGWRFPUBBONZGG-UHFFFAOYSA-N D05CND DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC3=C(C=C2)NC(=O)S3 D05CND HIGHSTAT Investigative D05CNT DRUG__ID D05CNT D05CNT DRUGTYPE Small molecular drug D05CNT DRUGINCH 1S/C27H36O5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(28)15-14-17-26(29)30)33-23-20-18-22(19-21-23)27(31)32/h6-7,9-13,16,18-21,24-25,28H,2-5,8,14-15,17H2,1H3,(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t24-,25+/m0/s1 D05CNT DRUGINKE PKJINWOACFYDQN-RBVMPENBSA-N D05CNT DRUGSMIL CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SC1=CC=C(C=C1)C(=O)O D05CNT HIGHSTAT Investigative D05COL DRUG__ID D05COL D05COL DRUGTYPE Small molecular drug D05COL DRUGINCH 1S/C21H26O7/c1-20-6-4-12-19(25)28-15(11-5-7-27-10-11)9-21(12,2)17(20)16(23)14(22)8-13(20)18(24)26-3/h5,7,10,12-15,17,22H,4,6,8-9H2,1-3H3/t12-,13-,14-,15-,17-,20-,21-/m0/s1 D05COL DRUGINKE BLTMVAIOAAGYAR-CEFSSPBYSA-N D05COL DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)O)C)C4=COC=C4 D05COL HIGHSTAT Investigative D05CQR DRUG__ID D05CQR D05CQR DRUGTYPE Small molecular drug D05CQR DRUGINCH 1S/C9H10BrN3O3S/c1-17(15,16)7-4-5(2-3-6(7)10)8(14)13-9(11)12/h2-4H,1H3,(H4,11,12,13,14) D05CQR DRUGINKE PWHJRANRUUKGBX-UHFFFAOYSA-N D05CQR DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)C(=O)N=C(N)N)Br D05CQR HIGHSTAT Investigative D05CRC DRUG__ID D05CRC D05CRC DRUGTYPE Small molecular drug D05CRC DRUGINCH 1S/C28H34N2O/c1-28(2,3)25-14-12-23(13-15-25)27(24-10-7-11-26(31)20-24)30-18-16-29(17-19-30)21-22-8-5-4-6-9-22/h4-15,20,27,31H,16-19,21H2,1-3H3 D05CRC DRUGINKE PNVIEMCZBRMSPB-UHFFFAOYSA-N D05CRC DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(C2=CC(=CC=C2)O)N3CCN(CC3)CC4=CC=CC=C4 D05CRC HIGHSTAT Investigative D05CRM DRUG__ID D05CRM D05CRM DRUGTYPE Small molecular drug D05CRM DRUGINCH 1S/C15H11Cl4NOS/c16-11-6-8-12(9-7-11)22-14(15(17,18)19)20-13(21)10-4-2-1-3-5-10/h1-9,14H,(H,20,21) D05CRM DRUGINKE NOXDIPWNQOTUAB-UHFFFAOYSA-N D05CRM DRUGSMIL C1=CC=C(C=C1)C(=O)NC(C(Cl)(Cl)Cl)SC2=CC=C(C=C2)Cl D05CRM HIGHSTAT Investigative D05CWG DRUG__ID D05CWG D05CWG DRUGTYPE Small molecular drug D05CWG DRUGINCH 1S/C26H28N4O9/c1-15-12-17(13-19-22(15)24(36)39-25(29-19)27-11-5-8-20(31)32)28-23(35)18(9-10-21(33)34)30-26(37)38-14-16-6-3-2-4-7-16/h2-4,6-7,12-13,18H,5,8-11,14H2,1H3,(H,27,29)(H,28,35)(H,30,37)(H,31,32)(H,33,34)/t18-/m0/s1 D05CWG DRUGINKE JLDVWXAMNKPCJI-SFHVURJKSA-N D05CWG DRUGSMIL CC1=CC(=CC2=C1C(=O)OC(=N2)NCCCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)OCC3=CC=CC=C3 D05CWG HIGHSTAT Investigative D05CYD DRUG__ID D05CYD D05CYD DRUGTYPE Small molecular drug D05CYD DRUGINCH 1S/C40H65N9O26P2/c1-16(32(58)44-18(3)38(63)64)43-35(61)21(8-6-7-12-41)47-36(62)22(9-10-26(53)54)46-33(59)17(2)42-34(60)19(4)71-31-27(45-20(5)51)39(73-23(14-50)29(31)56)74-77(68,69)75-76(66,67)70-15-24-28(55)30(57)37(72-24)49-13-11-25(52)48-40(49)65/h11,13,16-19,21-24,27-31,37,39,50,55-57H,6-10,12,14-15,41H2,1-5H3,(H,42,60)(H,43,61)(H,44,58)(H,45,51)(H,46,59)(H,47,62)(H,53,54)(H,63,64)(H,66,67)(H,68,69)(H,48,52,65) D05CYD DRUGINKE QAXSYKNMKWGHOF-UHFFFAOYSA-N D05CYD DRUGSMIL CC(C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(C)C(=O)O)NC(=O)C(C)OC1C(C(OC(C1O)CO)OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)NC(=O)C D05CYD HIGHSTAT Investigative D05CYJ DRUG__ID D05CYJ D05CYJ DRUGTYPE Small molecular drug D05CYJ DRUGINCH 1S/C18H18N2O/c1-20(2)17(21)12-15-14-10-6-7-11-16(14)19-18(15)13-8-4-3-5-9-13/h3-11,19H,12H2,1-2H3 D05CYJ DRUGINKE RVPIQASKQHYEBT-UHFFFAOYSA-N D05CYJ DRUGSMIL CN(C)C(=O)CC1=C(NC2=CC=CC=C21)C3=CC=CC=C3 D05CYJ HIGHSTAT Investigative D05DAE DRUG__ID D05DAE D05DAE DRUGTYPE Small molecular drug D05DAE DRUGINCH 1S/C10H9N3OS/c14-9(12-10-13-11-7-15-10)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H,12,13,14) D05DAE DRUGINKE VRCPUIHHVMQIHP-UHFFFAOYSA-N D05DAE DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=NN=CS2 D05DAE HIGHSTAT Investigative D05DAF DRUG__ID D05DAF D05DAF DRUGTYPE Small molecular drug D05DAF DRUGINCH 1S/C12H12N2O2S/c13-10-5-4-6-11(9-10)14-17(15,16)12-7-2-1-3-8-12/h1-9,14H,13H2 D05DAF DRUGINKE RUYQFOIEMVGGQT-UHFFFAOYSA-N D05DAF DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)N D05DAF HIGHSTAT Investigative D05DAG DRUG__ID D05DAG D05DAG DRUGTYPE Small molecular drug D05DAG DRUGINCH 1S/C10H11FN2/c11-8-1-2-10-9(5-8)7(3-4-12)6-13-10/h1-2,5-6,13H,3-4,12H2 D05DAG DRUGINKE ZKIORVIXEWIOGB-UHFFFAOYSA-N D05DAG DRUGSMIL C1=CC2=C(C=C1F)C(=CN2)CCN D05DAG HIGHSTAT Investigative D05DAN DRUG__ID D05DAN D05DAN DRUGTYPE Small molecular drug D05DAN DRUGINCH 1S/C18H26N6O2/c1-11-9-23(15-5-7-19-17(21-15)13(3)25)10-12(2)24(11)16-6-8-20-18(22-16)14(4)26/h5-8,11-14,25-26H,9-10H2,1-4H3/t11-,12+,13-,14-/m1/s1 D05DAN DRUGINKE ATNZXIACLONSSN-XJFOESAGSA-N D05DAN DRUGSMIL CC1CN(CC(N1C2=NC(=NC=C2)C(C)O)C)C3=NC(=NC=C3)C(C)O D05DAN HIGHSTAT Investigative D05DCQ DRUG__ID D05DCQ D05DCQ DRUGTYPE Small molecular drug D05DCQ DRUGINCH 1S/C15H14N4S/c1-3-7-12(8-4-1)11-20-15-17-14(18-19-15)16-13-9-5-2-6-10-13/h1-10H,11H2,(H2,16,17,18,19) D05DCQ DRUGINKE QBUZLNWDECJZMT-UHFFFAOYSA-N D05DCQ DRUGSMIL C1=CC=C(C=C1)CSC2=NNC(=N2)NC3=CC=CC=C3 D05DCQ HIGHSTAT Investigative D05DCW DRUG__ID D05DCW D05DCW DRUGTYPE Small molecular drug D05DCW DRUGINCH 1S/C15H12N6OS/c1-7-2-4-8(5-3-7)21-6-18-10-9-12(16)19-15(17)20-13(9)23-11(10)14(21)22/h2-6H,1H3,(H4,16,17,19,20) D05DCW DRUGINKE NGINYBBVZOLUBV-UHFFFAOYSA-N D05DCW DRUGSMIL CC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=NC(=NC(=C34)N)N D05DCW HIGHSTAT Investigative D05DDS DRUG__ID D05DDS D05DDS DRUGTYPE Small molecular drug D05DDS DRUGINCH 1S/C5H14O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h5H,3-4H2,1-2H3,(H,9,10)(H2,6,7,8) D05DDS DRUGINKE IPFXNYPSBSIFOB-UHFFFAOYSA-N D05DDS DRUGSMIL CC(C)CCOP(=O)(O)OP(=O)(O)O D05DDS HIGHSTAT Investigative D05DDU DRUG__ID D05DDU D05DDU DRUGTYPE Small molecular drug D05DDU DRUGINCH 1S/C16H13NO/c1-11-5-6-12-7-8-14(10-16(12)17-11)13-3-2-4-15(18)9-13/h2-10,18H,1H3 D05DDU DRUGINKE ONBWGZNKVDEPCB-UHFFFAOYSA-N D05DDU DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC=C3)O D05DDU HIGHSTAT Investigative D05DFJ DRUG__ID D05DFJ D05DFJ DRUGTYPE Small molecular drug D05DFJ DRUGINCH 1S/C6H5F2NO2S/c7-4-2-1-3-5(8)6(4)12(9,10)11/h1-3H,(H2,9,10,11) D05DFJ DRUGINKE RVVVGGCOFWWDEL-UHFFFAOYSA-N D05DFJ DRUGSMIL C1=CC(=C(C(=C1)F)S(=O)(=O)N)F D05DFJ HIGHSTAT Investigative D05DFO DRUG__ID D05DFO D05DFO DRUGTYPE Small molecular drug D05DFO DRUGINCH 1S/C25H41NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-25(27)26-23-19-21-24(28-2)22-20-23/h10-11,19-22H,3-9,12-18H2,1-2H3,(H,26,27)/b11-10- D05DFO DRUGINKE GVVBDSXGTXGHEV-KHPPLWFESA-N D05DFO DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC1=CC=C(C=C1)OC D05DFO HIGHSTAT Investigative D05DGE DRUG__ID D05DGE D05DGE DRUGTYPE Small molecular drug D05DGE DRUGINCH 1S/FH2O3P/c1-5(2,3)4/h(H2,2,3,4)/p-2 D05DGE DRUGINKE DWYMPOCYEZONEA-UHFFFAOYSA-L D05DGE DRUGSMIL [O-]P(=O)([O-])F D05DGE HIGHSTAT Investigative D05DHX DRUG__ID D05DHX D05DHX DRUGTYPE Small molecular drug D05DHX DRUGINCH 1S/C19H22O5/c1-9(2)17(21)24-16-15-11(4)18(22)23-13(15)8-10(3)12-6-7-14(20)19(12,16)5/h6-7,10,12-13,15-16H,1,4,8H2,2-3,5H3/t10-,12+,13-,15-,16-,19+/m1/s1 D05DHX DRUGINKE USRAFFQOAADTTD-OJIWXCRVSA-N D05DHX DRUGSMIL CC1CC2C(C(C3(C1C=CC3=O)C)OC(=O)C(=C)C)C(=C)C(=O)O2 D05DHX HIGHSTAT Investigative D05DIH DRUG__ID D05DIH D05DIH DRUGTYPE Small molecular drug D05DIH DRUGINCH 1S/C19H21NO2/c1-19(2,3)16-9-5-14(6-10-16)13-20-17-11-7-15(8-12-17)18(21)22-4/h5-13H,1-4H3 D05DIH DRUGINKE SONMMTHLONHMSH-UHFFFAOYSA-N D05DIH DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C=NC2=CC=C(C=C2)C(=O)OC D05DIH HIGHSTAT Investigative D05DIN DRUG__ID D05DIN D05DIN DRUGTYPE Small molecular drug D05DIN DRUGINCH 1S/C20H15NO3S/c1-23-16-10-4-5-11-17(16)24-20(22)21-14-8-2-6-12-18(14)25-19-13-7-3-9-15(19)21/h2-13H,1H3 D05DIN DRUGINKE KQZJYFLCWHHHIK-UHFFFAOYSA-N D05DIN DRUGSMIL COC1=CC=CC=C1OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D05DIN HIGHSTAT Investigative D05DMH DRUG__ID D05DMH D05DMH DRUGTYPE Small molecular drug D05DMH DRUGINCH 1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14,16-19H,4-12H2,1-3H3/t14-,16+,17-,18+,19+,20+,21-/m1/s1 D05DMH DRUGINKE XMRPGKVKISIQBV-XWOJZHJZSA-N D05DMH DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(=O)C4)C)C D05DMH HIGHSTAT Investigative D05DNU DRUG__ID D05DNU D05DNU DRUGTYPE Small molecular drug D05DNU DRUGINCH 1S/C35H42N4O6S/c1-20-14-24(36)15-21(2)31(20)45-18-28(41)37-26(16-22-10-6-5-7-11-22)30(42)34(44)39-19-46-35(3,4)32(39)33(43)38-29-25-13-9-8-12-23(25)17-27(29)40/h5-15,26-27,29-30,32,40,42H,16-19,36H2,1-4H3,(H,37,41)(H,38,43)/t26-,27+,29-,30-,32+/m0/s1 D05DNU DRUGINKE ABHNHNZCHPWXFW-RIQJEONASA-N D05DNU DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)N D05DNU HIGHSTAT Investigative D05DOM DRUG__ID D05DOM D05DOM DRUGTYPE Small molecular drug D05DOM DRUGINCH 1S/C2H3BrO2/c3-1-2(4)5/h1H2,(H,4,5) D05DOM DRUGINKE KDPAWGWELVVRCH-UHFFFAOYSA-N D05DOM DRUGSMIL C(C(=O)O)Br D05DOM HIGHSTAT Investigative D05DQF DRUG__ID D05DQF D05DQF DRUGTYPE Small molecular drug D05DQF DRUGINCH 1S/C10H10N2O/c11-10(13)7-12-6-5-8-3-1-2-4-9(8)12/h1-6H,7H2,(H2,11,13) D05DQF DRUGINKE IUUZMSMGSOUFTO-UHFFFAOYSA-N D05DQF DRUGSMIL C1=CC=C2C(=C1)C=CN2CC(=O)N D05DQF HIGHSTAT Investigative D05DRQ DRUG__ID D05DRQ D05DRQ DRUGTYPE Small molecular drug D05DRQ DRUGINCH 1S/C17H19N3O3/c1-3-19(4-2)14-11-9-13(10-12-14)18-17(21)15-7-5-6-8-16(15)20(22)23/h5-12H,3-4H2,1-2H3,(H,18,21) D05DRQ DRUGINKE ILACFEJISPLWOY-UHFFFAOYSA-N D05DRQ DRUGSMIL CCN(CC)C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2[N+](=O)[O-] D05DRQ HIGHSTAT Investigative D05DTN DRUG__ID D05DTN D05DTN DRUGTYPE Small molecular drug D05DTN DRUGINCH 1S/C9H14O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-8H,2-4,6H2,1H3/b7-5+ D05DTN DRUGINKE SEPPVOUBHWNCAW-FNORWQNLSA-N D05DTN DRUGSMIL CCCCCC(=O)C=CC=O D05DTN HIGHSTAT Investigative D05DUX DRUG__ID D05DUX D05DUX DRUGTYPE Small molecular drug D05DUX DRUGINCH 1S/C27H40O6/c1-15(28)31-24-16-7-8-21-26(4,12-9-20-25(2,3)10-6-11-27(20,21)5)18(16)14-19(32-24)17-13-22(29)33-23(17)30/h13,16,18-21,23-24,30H,6-12,14H2,1-5H3/t16-,18+,19+,20-,21-,23?,24+,26-,27-/m0/s1 D05DUX DRUGINKE RVWQZLJUVIFAOY-GQLPRRODSA-N D05DUX DRUGSMIL CC(=O)OC1C2CCC3C4(CCCC(C4CCC3(C2CC(O1)C5=CC(=O)OC5O)C)(C)C)C D05DUX HIGHSTAT Investigative D05DWG DRUG__ID D05DWG D05DWG DRUGTYPE Small molecular drug D05DWG DRUGINCH 1S/C24H46O11/c1-2-3-4-5-6-7-8-9-10-11-12-32-23-21(31)19(29)22(16(14-26)34-23)35-24-20(30)18(28)17(27)15(13-25)33-24/h15-31H,2-14H2,1H3/t15-,16-,17-,18+,19-,20-,21-,22-,23+,24-/m1/s1 D05DWG DRUGINKE NLEBIOOXCVAHBD-YHBSTRCHSA-N D05DWG DRUGSMIL CCCCCCCCCCCCOC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)CO)O)O)O)O)O D05DWG HIGHSTAT Investigative D05DXW DRUG__ID D05DXW D05DXW DRUGTYPE Small molecular drug D05DXW DRUGINCH 1S/C22H25NO/c1-3-4-9-14-23-16-20(19-12-7-8-13-21(19)23)22(24)15-18-11-6-5-10-17(18)2/h5-8,10-13,16H,3-4,9,14-15H2,1-2H3 D05DXW DRUGINKE YBIPNGRKUAVSBG-UHFFFAOYSA-N D05DXW DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3C D05DXW HIGHSTAT Investigative D05DYX DRUG__ID D05DYX D05DYX DRUGTYPE Small molecular drug D05DYX DRUGINCH 1S/C22H26ClN7O3/c1-13(2)30-12-17-18(21(30)32)25-22(26-19(17)24-16-6-4-15(23)5-7-16)29-10-8-28(9-11-29)20(31)14(3)27-33/h4-7,13,33H,8-12H2,1-3H3,(H,24,25,26)/b27-14- D05DYX DRUGINKE OYOSXTKSOATNNB-VYYCAZPPSA-N D05DYX DRUGSMIL CC(C)N1CC2=C(C1=O)N=C(N=C2NC3=CC=C(C=C3)Cl)N4CCN(CC4)C(=O)C(=NO)C D05DYX HIGHSTAT Investigative D05EBZ DRUG__ID D05EBZ D05EBZ DRUGTYPE Small molecular drug D05EBZ DRUGINCH 1S/C12H9N3O3S/c13-7-9-1-3-10(4-2-9)18-11-5-6-15-8-12(11)19(14,16)17/h1-6,8H,(H2,14,16,17) D05EBZ DRUGINKE SUYXGHCYAUOKRH-UHFFFAOYSA-N D05EBZ DRUGSMIL C1=CC(=CC=C1C#N)OC2=C(C=NC=C2)S(=O)(=O)N D05EBZ HIGHSTAT Investigative D05EDA DRUG__ID D05EDA D05EDA DRUGTYPE Small molecular drug D05EDA DRUGINCH 1S/C40H58N6O13S/c1-22(2)34(39(56)46-19-26(59-20-25-12-8-5-9-13-25)17-31(46)38(55)44-30(21-60)40(57)58)45-37(54)28(16-24-10-6-4-7-11-24)43-35(52)27(14-15-32(48)49)42-36(53)29(18-33(50)51)41-23(3)47/h5,8-9,12-13,22,24,26-31,34,60H,4,6-7,10-11,14-21H2,1-3H3,(H,41,47)(H,42,53)(H,43,52)(H,44,55)(H,45,54)(H,48,49)(H,50,51)(H,57,58)/t26-,27+,28+,29+,30?,31+,34+/m1/s1 D05EDA DRUGINKE UINXWQSPCZCPNY-MKVQYLHRSA-N D05EDA DRUGSMIL CC(C)C(C(=O)N1CC(CC1C(=O)NC(CS)C(=O)O)OCC2=CC=CC=C2)NC(=O)C(CC3CCCCC3)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D05EDA HIGHSTAT Investigative D05EDD DRUG__ID D05EDD D05EDD DRUGTYPE Small molecular drug D05EDD DRUGINCH 1S/C17H29N2O5P/c1-2-3-4-5-6-7-9-14-10-8-11-15(12-14)19-17(20)16(18)13-24-25(21,22)23/h8,10-12,16H,2-7,9,13,18H2,1H3,(H,19,20)(H2,21,22,23)/t16-/m1/s1 D05EDD DRUGINKE MRUSUGVVWGNKFE-MRXNPFEDSA-N D05EDD DRUGSMIL CCCCCCCCC1=CC(=CC=C1)NC(=O)C(COP(=O)(O)O)N D05EDD HIGHSTAT Investigative D05EDR DRUG__ID D05EDR D05EDR DRUGTYPE Small molecular drug D05EDR DRUGINCH 1S/C14H18N2O2/c1-9(7-15-10(2)17)13-8-16-14-5-4-11(18-3)6-12(13)14/h4-6,8-9,16H,7H2,1-3H3,(H,15,17) D05EDR DRUGINKE CKJPQNIMWAHOBV-UHFFFAOYSA-N D05EDR DRUGSMIL CC(CNC(=O)C)C1=CNC2=C1C=C(C=C2)OC D05EDR HIGHSTAT Investigative D05EDW DRUG__ID D05EDW D05EDW DRUGTYPE Small molecular drug D05EDW DRUGINCH 1S/C18H17NO3/c1-20-16-7-5-4-6-14(16)13-8-12-9-17(21-2)18(22-3)10-15(12)19-11-13/h4-11H,1-3H3 D05EDW DRUGINKE ZGHJQSABDREYEE-UHFFFAOYSA-N D05EDW DRUGSMIL COC1=CC=CC=C1C2=CN=C3C=C(C(=CC3=C2)OC)OC D05EDW HIGHSTAT Investigative D05EEV DRUG__ID D05EEV D05EEV DRUGTYPE Small molecular drug D05EEV DRUGINCH 1S/C19H24N2O3/c1-19(11-12-5-3-4-6-16(12)20-17(19)22)18(23)24-15-9-13-7-8-14(10-15)21(13)2/h3-6,13-15H,7-11H2,1-2H3,(H,20,22)/t13-,14+,15?,19-/m0/s1 D05EEV DRUGINKE HQZQXIVKGOJOLP-FKGKKHCZSA-N D05EEV DRUGSMIL CC1(CC2=CC=CC=C2NC1=O)C(=O)OC3CC4CCC(C3)N4C D05EEV HIGHSTAT Investigative D05EGR DRUG__ID D05EGR D05EGR DRUGTYPE Small molecular drug D05EGR DRUGINCH 1S/C22H17O4P/c23-21(18-13-12-15-6-1-2-8-17(15)14-18)22(27(24,25)26)20-11-5-9-16-7-3-4-10-19(16)20/h1-14,22H,(H2,24,25,26)/t22-/m1/s1 D05EGR DRUGINKE OFHMUASCSJJNNA-JOCHJYFZSA-N D05EGR DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)C(C3=CC=CC4=CC=CC=C43)P(=O)(O)O D05EGR HIGHSTAT Investigative D05EHE DRUG__ID D05EHE D05EHE DRUGTYPE Small molecular drug D05EHE DRUGINCH 1S/C37H38N2O7/c1-38-12-10-21-17-30(44-4)31-19-24(21)27(38)15-20-6-9-29(43-3)26(14-20)25-16-23(7-8-28(25)40)35(41)34-33-22(11-13-39(34)2)18-32(45-5)36(42)37(33)46-31/h6-9,14,16-19,27,34,40,42H,10-13,15H2,1-5H3/t27-,34+/m1/s1 D05EHE DRUGINKE RUAKOEPLVVXTGN-YJNPBZNESA-N D05EHE DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC(=C(C=C4)OC)C5=C(C=CC(=C5)C(=O)C6C7=C(O3)C(=C(C=C7CCN6C)OC)O)O)OC D05EHE HIGHSTAT Investigative D05EHM DRUG__ID D05EHM D05EHM DRUGTYPE Small molecular drug D05EHM DRUGINCH 1S/C3H5NO4/c5-2-4(8)1-3(6)7/h2,8H,1H2,(H,6,7) D05EHM DRUGINKE URJHVPKUWOUENU-UHFFFAOYSA-N D05EHM DRUGSMIL C(C(=O)O)N(C=O)O D05EHM HIGHSTAT Investigative D05EML DRUG__ID D05EML D05EML DRUGTYPE Small molecular drug D05EML DRUGINCH 1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27) D05EML DRUGINKE LQQIVYSCPWCSSD-UHFFFAOYSA-N D05EML DRUGSMIL C1CN(CCC1C2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4 D05EML HIGHSTAT Investigative D05EMT DRUG__ID D05EMT D05EMT DRUGTYPE Small molecular drug D05EMT DRUGINCH 1S/C14H6F4O2/c15-7-1-3-11(17)9(5-7)13(19)14(20)10-6-8(16)2-4-12(10)18/h1-6H D05EMT DRUGINKE IWSRHXHMXUIXCZ-UHFFFAOYSA-N D05EMT DRUGSMIL C1=CC(=C(C=C1F)C(=O)C(=O)C2=C(C=CC(=C2)F)F)F D05EMT HIGHSTAT Investigative D05EMX DRUG__ID D05EMX D05EMX DRUGTYPE Small molecular drug D05EMX DRUGINCH 1S/C14H11Cl2NO2/c15-10-5-6-11(16)13(8-10)17-12-4-2-1-3-9(12)7-14(18)19/h1-6,8,17H,7H2,(H,18,19) D05EMX DRUGINKE JSJQNYIFLKCXRE-UHFFFAOYSA-N D05EMX DRUGSMIL C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC(=C2)Cl)Cl D05EMX HIGHSTAT Investigative D05EOW DRUG__ID D05EOW D05EOW DRUGTYPE Small molecular drug D05EOW DRUGINCH 1S/C15H13NO2/c16-10-13(12-3-7-15(18)8-4-12)9-11-1-5-14(17)6-2-11/h1-8,13,17-18H,9H2 D05EOW DRUGINKE GHZHWDWADLAOIQ-UHFFFAOYSA-N D05EOW DRUGSMIL C1=CC(=CC=C1CC(C#N)C2=CC=C(C=C2)O)O D05EOW HIGHSTAT Investigative D05EPI DRUG__ID D05EPI D05EPI DRUGTYPE Small molecular drug D05EPI DRUGINCH 1S/C20H18N4O10/c25-19(21-11-1-5-13(6-2-11)23(27)28)33-15-9-31-18-16(10-32-17(15)18)34-20(26)22-12-3-7-14(8-4-12)24(29)30/h1-8,15-18H,9-10H2,(H,21,25)(H,22,26)/t15-,16+,17-,18-/m1/s1 D05EPI DRUGINKE DHXOUOFGQLLAMG-XMTFNYHQSA-N D05EPI DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NC3=CC=C(C=C3)[N+](=O)[O-])OC(=O)NC4=CC=C(C=C4)[N+](=O)[O-] D05EPI HIGHSTAT Investigative D05EPO DRUG__ID D05EPO D05EPO DRUGTYPE Small molecular drug D05EPO DRUGINCH 1S/C4H12NO3P/c1-2-3-4(5)9(6,7)8/h4H,2-3,5H2,1H3,(H2,6,7,8) D05EPO DRUGINKE UAEPDDGDPAPPHZ-UHFFFAOYSA-N D05EPO DRUGSMIL CCCC(N)P(=O)(O)O D05EPO HIGHSTAT Investigative D05EPY DRUG__ID D05EPY D05EPY DRUGTYPE Small molecular drug D05EPY DRUGINCH 1S/C14H24N2O5S3/c1-3-6-16-12-8-10(5-4-7-21-2)23(17,18)14-11(12)9-13(22-14)24(15,19)20/h9-10,12,16H,3-8H2,1-2H3,(H2,15,19,20)/t10-,12-/m0/s1 D05EPY DRUGINKE JNPHBSXNRNBLCV-JQWIXIFHSA-N D05EPY DRUGSMIL CCCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC D05EPY HIGHSTAT Investigative D05EQC DRUG__ID D05EQC D05EQC DRUGTYPE Small molecular drug D05EQC DRUGINCH 1S/C30H34N4O10S/c1-2-3-4-5-9-23(33-17-26(31-18-33)32-27(35)22-8-6-7-10-25(22)45(41,42)43)28(36)34-16-21(15-24(34)30(39)40)44-20-13-11-19(12-14-20)29(37)38/h6-8,10-14,17-18,21,23-24H,2-5,9,15-16H2,1H3,(H,32,35)(H,37,38)(H,39,40)(H,41,42,43)/t21-,23-,24-/m0/s1 D05EQC DRUGINKE HHFYOGBTLFTWQX-XWGVYQGASA-N D05EQC DRUGSMIL CCCCCCC(C(=O)N1CC(CC1C(=O)O)OC2=CC=C(C=C2)C(=O)O)N3C=C(N=C3)NC(=O)C4=CC=CC=C4S(=O)(=O)O D05EQC HIGHSTAT Investigative D05EQG DRUG__ID D05EQG D05EQG DRUGTYPE Small molecular drug D05EQG DRUGINCH 1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29) D05EQG DRUGINKE DKGZKTPJOSAWFA-UHFFFAOYSA-N D05EQG DRUGSMIL C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F D05EQG HIGHSTAT Investigative D05ERF DRUG__ID D05ERF D05ERF DRUGTYPE Small molecular drug D05ERF DRUGINCH 1S/C12H6ClN7O3/c13-5-1-6-8(2-7(5)19-3-14-15-4-19)20-10(11(21)16-6)17-9(18-20)12(22)23/h1-4H,(H,16,21)(H,22,23) D05ERF DRUGINKE QYMZRTSHYZACQA-UHFFFAOYSA-N D05ERF DRUGSMIL C1=C2C(=CC(=C1Cl)N3C=NN=C3)N4C(=NC(=N4)C(=O)O)C(=O)N2 D05ERF HIGHSTAT Investigative D05ETG DRUG__ID D05ETG D05ETG DRUGTYPE Small molecular drug D05ETG DRUGINCH 1S/C31H35N5O5/c32-24(18-21-13-15-23(37)16-14-21)31(41)36-17-7-12-26(36)30(40)34-25(19-20-8-3-1-4-9-20)29(39)35-27(28(33)38)22-10-5-2-6-11-22/h1-6,8-11,13-16,24-27,37H,7,12,17-19,32H2,(H2,33,38)(H,34,40)(H,35,39)/t24-,25-,26-,27+/m0/s1 D05ETG DRUGINKE UUUCKSPURQXDKV-YIPNQBBMSA-N D05ETG DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C4=CC=CC=C4)C(=O)N D05ETG HIGHSTAT Investigative D05ETM DRUG__ID D05ETM D05ETM DRUGTYPE Small molecular drug D05ETM DRUGINCH 1S/C19H24N2O/c1-22-18-12-6-5-10-16(18)14-21-17-11-7-13-20-19(17)15-8-3-2-4-9-15/h2-6,8-10,12,17,19-21H,7,11,13-14H2,1H3/t17-,19-/m0/s1 D05ETM DRUGINKE DTQNEFOKTXXQKV-HKUYNNGSSA-N D05ETM DRUGSMIL COC1=CC=CC=C1CNC2CCCNC2C3=CC=CC=C3 D05ETM HIGHSTAT Investigative D05ETN DRUG__ID D05ETN D05ETN DRUGTYPE Small molecular drug D05ETN DRUGINCH 1S/C15H13N3O3S/c1-10-5-6-11-3-2-4-13(15(11)18-10)21-12-7-8-17-9-14(12)22(16,19)20/h2-9H,1H3,(H2,16,19,20) D05ETN DRUGINKE LNNGPAKWWNABIA-UHFFFAOYSA-N D05ETN DRUGSMIL CC1=NC2=C(C=CC=C2OC3=C(C=NC=C3)S(=O)(=O)N)C=C1 D05ETN HIGHSTAT Investigative D05EWB DRUG__ID D05EWB D05EWB DRUGTYPE Small molecular drug D05EWB DRUGINCH 1S/C27H37F3N8O7/c1-14(2)26(27(28,29)30)24(45)37-16(9-6-10-33-25(31)32)21(42)34-13-19(39)35-18(12-20(40)41)22(43)36-17(23(44)38-26)11-15-7-4-3-5-8-15/h3-5,7-8,14,16-18H,6,9-13H2,1-2H3,(H,34,42)(H,35,39)(H,36,43)(H,37,45)(H,38,44)(H,40,41)(H4,31,32,33)/t16-,17+,18-,26-/m0/s1 D05EWB DRUGINKE VYIBTYZRYKIMKX-KTJGCZTMSA-N D05EWB DRUGSMIL CC(C)C1(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N)C(F)(F)F D05EWB HIGHSTAT Investigative D05EWD DRUG__ID D05EWD D05EWD DRUGTYPE Small molecular drug D05EWD DRUGINCH 1S/C21H23NO/c1-2-3-9-14-22-16-19(18-12-7-8-13-20(18)22)21(23)15-17-10-5-4-6-11-17/h4-8,10-13,16H,2-3,9,14-15H2,1H3 D05EWD DRUGINKE AMCPOEOUXQWESI-UHFFFAOYSA-N D05EWD DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3 D05EWD HIGHSTAT Investigative D05EWZ DRUG__ID D05EWZ D05EWZ DRUGTYPE Small molecular drug D05EWZ DRUGINCH 1S/C25H25NO4/c1-26-9-8-24-19-14-6-7-17(27)20(19)30-22(24)21(28)23(13-25(24,29)18(26)10-14)11-15-4-2-3-5-16(15)12-23/h2-7,18,22,27,29H,8-13H2,1H3/t18-,22+,24+,25-/m1/s1 D05EWZ DRUGINKE YJWDKWRVFJZBCJ-QVJDATKISA-N D05EWZ DRUGSMIL CN1CCC23C4C(=O)C5(CC6=CC=CC=C6C5)CC2(C1CC7=C3C(=C(C=C7)O)O4)O D05EWZ HIGHSTAT Investigative D05EXX DRUG__ID D05EXX D05EXX DRUGTYPE Small molecular drug D05EXX DRUGINCH 1S/C20H23NO6/c1-21-14(23)10-19-9-12(22)17(26-3)18(27-4)20(19,21)8-7-11-5-6-13(25-2)16(24)15(11)19/h5-6,24H,7-10H2,1-4H3/t19-,20-/m1/s1 D05EXX DRUGINKE CLWJGNIITFMBQR-WOJBJXKFSA-N D05EXX DRUGSMIL CN1C(=O)CC23C1(CCC4=C2C(=C(C=C4)OC)O)C(=C(C(=O)C3)OC)OC D05EXX HIGHSTAT Investigative D05EYA DRUG__ID D05EYA D05EYA DRUGTYPE Small molecular drug D05EYA DRUGINCH 1S/C14H8Cl2O2/c15-11-5-1-9(2-6-11)13(17)14(18)10-3-7-12(16)8-4-10/h1-8H D05EYA DRUGINKE XMAWUPHYEABFDR-UHFFFAOYSA-N D05EYA DRUGSMIL C1=CC(=CC=C1C(=O)C(=O)C2=CC=C(C=C2)Cl)Cl D05EYA HIGHSTAT Investigative D05EZE DRUG__ID D05EZE D05EZE DRUGTYPE Small molecular drug D05EZE DRUGINCH 1S/C34H41N5O5/c1-21-16-25(40)17-22(2)26(21)20-27(35)34(44)39-15-9-14-30(39)33(43)38-29(19-24-12-7-4-8-13-24)32(42)37-28(31(36)41)18-23-10-5-3-6-11-23/h3-8,10-13,16-17,27-30,40H,9,14-15,18-20,35H2,1-2H3,(H2,36,41)(H,37,42)(H,38,43)/t27-,28-,29-,30-/m0/s1 D05EZE DRUGINKE PJAMNQXPYIKTPE-KRCBVYEFSA-N D05EZE DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N)N)C)O D05EZE HIGHSTAT Investigative D05FBL DRUG__ID D05FBL D05FBL DRUGTYPE Small molecular drug D05FBL DRUGINCH 1S/C5H11O7P/c6-3-1-11-4(5(3)7)2-12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/t3-,4+,5+/m0/s1 D05FBL DRUGINKE CYZZKTRFOOKUMT-VPENINKCSA-N D05FBL DRUGSMIL C1C(C(C(O1)COP(=O)(O)O)O)O D05FBL HIGHSTAT Investigative D05FCO DRUG__ID D05FCO D05FCO DRUGTYPE Small molecular drug D05FCO DRUGINCH 1S/C12H11N/c1-2-6-11(5-1)8-9-12-7-3-4-10-13-12/h3-5,7,10H,1-2,6H2 D05FCO DRUGINKE PJMNINJICZHJJV-UHFFFAOYSA-N D05FCO DRUGSMIL C1CC=C(C1)C#CC2=CC=CC=N2 D05FCO HIGHSTAT Investigative D05FEJ DRUG__ID D05FEJ D05FEJ DRUGTYPE Small molecular drug D05FEJ DRUGINCH 1S/C21H23F3O2/c22-21(23,24)20(25)11-7-2-1-3-8-16-26-19-14-12-18(13-15-19)17-9-5-4-6-10-17/h4-6,9-10,12-15H,1-3,7-8,11,16H2 D05FEJ DRUGINKE SJSZPXVUCDJGAB-UHFFFAOYSA-N D05FEJ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCCC(=O)C(F)(F)F D05FEJ HIGHSTAT Investigative D05FEO DRUG__ID D05FEO D05FEO DRUGTYPE Small molecular drug D05FEO DRUGINCH 1S/C16H15N3O/c1-12(2)19-16(20)15-6-5-14(11-18-15)4-3-13-7-9-17-10-8-13/h5-12H,1-2H3,(H,19,20) D05FEO DRUGINKE STAFRSGTRKNXHF-UHFFFAOYSA-N D05FEO DRUGSMIL CC(C)NC(=O)C1=NC=C(C=C1)C#CC2=CC=NC=C2 D05FEO HIGHSTAT Investigative D05FEQ DRUG__ID D05FEQ D05FEQ DRUGTYPE Small molecular drug D05FEQ DRUGINCH 1S/C20H27NO/c22-16-7-6-15-11-19-17-3-1-2-8-20(17,18(15)12-16)9-10-21(19)13-14-4-5-14/h6-7,12,14,17,19,22H,1-5,8-11,13H2/t17-,19+,20+/m0/s1 D05FEQ DRUGINKE NLBUEDSBXVNAPB-DFQSSKMNSA-N D05FEQ DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)O)CC5CC5 D05FEQ HIGHSTAT Investigative D05FFB DRUG__ID D05FFB D05FFB DRUGTYPE Small molecular drug D05FFB DRUGINCH 1S/C17H14N2O/c1-9-14-8-18-6-5-12(14)10(2)17-16(9)13-7-11(20)3-4-15(13)19-17/h3-8,19-20H,1-2H3 D05FFB DRUGINKE QZTWUDDGLIDXSE-UHFFFAOYSA-N D05FFB DRUGSMIL CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)O)C D05FFB HIGHSTAT Investigative D05FFT DRUG__ID D05FFT D05FFT DRUGTYPE Small molecular drug D05FFT DRUGINCH 1S/C17H11ClFN5O/c1-2-3-16(25)24-15-7-11-14(8-20-15)21-9-22-17(11)23-10-4-5-13(19)12(18)6-10/h4-9H,1H3,(H,20,24,25)(H,21,22,23) D05FFT DRUGINKE DLPSDPPZXRJQOY-UHFFFAOYSA-N D05FFT DRUGSMIL CC#CC(=O)NC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl D05FFT HIGHSTAT Investigative D05FJM DRUG__ID D05FJM D05FJM DRUGTYPE Small molecular drug D05FJM DRUGINCH 1S/C21H26O3/c1-19(2)7-5-8-20(3)17(19)6-9-21(4)18(20)11-13-10-14(22)15(23)12-16(13)24-21/h10-12,17H,5-9H2,1-4H3/t17-,20-,21-/m0/s1 D05FJM DRUGINKE QLFLHSQZFRDPFM-YYWHXJBOSA-N D05FJM DRUGSMIL CC1(CCCC2(C1CCC3(C2=CC4=CC(=O)C(=O)C=C4O3)C)C)C D05FJM HIGHSTAT Investigative D05FKE DRUG__ID D05FKE D05FKE DRUGTYPE Small molecular drug D05FKE DRUGINCH 1S/C12H18N6/c1-2-5-18-9-16-10-11(14-8-15-12(10)18)17-6-3-13-4-7-17/h8-9,13H,2-7H2,1H3 D05FKE DRUGINKE BWJIAIMMFVYUQA-UHFFFAOYSA-N D05FKE DRUGSMIL CCCN1C=NC2=C1N=CN=C2N3CCNCC3 D05FKE HIGHSTAT Investigative D05FKT DRUG__ID D05FKT D05FKT DRUGTYPE Small molecular drug D05FKT DRUGINCH 1S/C35H33ClN2O3S/c1-22-17-28-31(41-21-27-14-11-25(19-37-27)24-7-5-4-6-8-24)16-15-29-32(28)33(42-22)30(18-35(2,3)34(39)40)38(29)20-23-9-12-26(36)13-10-23/h4-16,19,22H,17-18,20-21H2,1-3H3,(H,39,40) D05FKT DRUGINKE UWFKZJIWHDTXTG-UHFFFAOYSA-N D05FKT DRUGSMIL CC1CC2=C(C=CC3=C2C(=C(N3CC4=CC=C(C=C4)Cl)CC(C)(C)C(=O)O)S1)OCC5=NC=C(C=C5)C6=CC=CC=C6 D05FKT HIGHSTAT Investigative D05FLL DRUG__ID D05FLL D05FLL DRUGTYPE Small molecular drug D05FLL DRUGINCH 1S/C20H20O4/c1-11(2)3-4-12-7-15-18(9-17(12)22)23-10-16-14-6-5-13(21)8-19(14)24-20(15)16/h3,5-9,16,20-22H,4,10H2,1-2H3/t16-,20-/m0/s1 D05FLL DRUGINKE CYXCYFYWIZXENQ-JXFKEZNVSA-N D05FLL DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OCC3C2OC4=C3C=CC(=C4)O)C D05FLL HIGHSTAT Investigative D05FMD DRUG__ID D05FMD D05FMD DRUGTYPE Small molecular drug D05FMD DRUGINCH 1S/C7H5ClO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,(H,10,11) D05FMD DRUGINKE NKBASRXWGAGQDP-UHFFFAOYSA-N D05FMD DRUGSMIL C1=CC(=C(C=C1Cl)C(=O)O)O D05FMD HIGHSTAT Investigative D05FMK DRUG__ID D05FMK D05FMK DRUGTYPE Small molecular drug D05FMK DRUGINCH 1S/C13H17NS/c1-4-9-14-11(2)10-12-5-7-13(15-3)8-6-12/h1,5-8,11,14H,9-10H2,2-3H3 D05FMK DRUGINKE UPHGABWYFBVICE-UHFFFAOYSA-N D05FMK DRUGSMIL CC(CC1=CC=C(C=C1)SC)NCC#C D05FMK HIGHSTAT Investigative D05FMZ DRUG__ID D05FMZ D05FMZ DRUGTYPE Small molecular drug D05FMZ DRUGINCH 1S/C9H10N2/c10-5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5,10H2 D05FMZ DRUGINKE JXYGLMATGAAIBU-UHFFFAOYSA-N D05FMZ DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CN D05FMZ HIGHSTAT Investigative D05FNN DRUG__ID D05FNN D05FNN DRUGTYPE Small molecular drug D05FNN DRUGINCH 1S/C7H18N2O6S2/c8-16(10,11)14-6-4-2-1-3-5-7-15-17(9,12)13/h1-7H2,(H2,8,10,11)(H2,9,12,13) D05FNN DRUGINKE GOJJWDOZNKBUSR-UHFFFAOYSA-N D05FNN DRUGSMIL C(CCCOS(=O)(=O)N)CCCOS(=O)(=O)N D05FNN HIGHSTAT Investigative D05FOV DRUG__ID D05FOV D05FOV DRUGTYPE Small molecular drug D05FOV DRUGINCH 1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-20(18-22)19-23/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9- D05FOV DRUGINKE UPWGQKDVAURUGE-KTKRTIGZSA-N D05FOV DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OC(CO)CO D05FOV HIGHSTAT Investigative D05FPU DRUG__ID D05FPU D05FPU DRUGTYPE Small molecular drug D05FPU DRUGINCH 1S/C12H15NOS/c1-3-4-7-15-11-6-5-10(9-13)12(8-11)14-2/h5-6,8H,3-4,7H2,1-2H3 D05FPU DRUGINKE RUUKMZBJVWOJEZ-UHFFFAOYSA-N D05FPU DRUGSMIL CCCCSC1=CC(=C(C=C1)C#N)OC D05FPU HIGHSTAT Investigative D05FQF DRUG__ID D05FQF D05FQF DRUGTYPE Small molecular drug D05FQF DRUGINCH 1S/C22H29FO5/c23-20-14-21(25)19(18(20)10-6-1-2-7-11-22(26)27)13-12-16(24)15-28-17-8-4-3-5-9-17/h1,3-6,8-9,12-13,16,18-21,24-25H,2,7,10-11,14-15H2,(H,26,27)/b6-1-,13-12+/t16-,18-,19-,20-,21-/m1/s1 D05FQF DRUGINKE KDVWQPQZDKHFOC-PTRXCMEYSA-N D05FQF DRUGSMIL C1C(C(C(C1F)CC=CCCCC(=O)O)C=CC(COC2=CC=CC=C2)O)O D05FQF HIGHSTAT Investigative D05FQN DRUG__ID D05FQN D05FQN DRUGTYPE Small molecular drug D05FQN DRUGINCH 1S/C12H10N2O/c1-15-8-2-3-9-10-4-5-13-7-12(10)14-11(9)6-8/h2-7,14H,1H3 D05FQN DRUGINKE LMDPJJFWLNRVEH-UHFFFAOYSA-N D05FQN DRUGSMIL COC1=CC2=C(C=C1)C3=C(N2)C=NC=C3 D05FQN HIGHSTAT Investigative D05FRX DRUG__ID D05FRX D05FRX DRUGTYPE Small molecular drug D05FRX DRUGINCH 1S/C14H18Br2O3/c1-2-3-4-5-6-19-14-11(15)7-10(8-12(14)16)9-13(17)18/h7-8H,2-6,9H2,1H3,(H,17,18) D05FRX DRUGINKE VJKVJESSSPWLJY-UHFFFAOYSA-N D05FRX DRUGSMIL CCCCCCOC1=C(C=C(C=C1Br)CC(=O)O)Br D05FRX HIGHSTAT Investigative D05FUY DRUG__ID D05FUY D05FUY DRUGTYPE Small molecular drug D05FUY DRUGINCH 1S/C16H10Cl2O2/c17-13-8-11(9-1-4-12(19)5-2-9)7-10-3-6-14(20)16(18)15(10)13/h1-8,19-20H D05FUY DRUGINKE YTFVBUBYMJJWQZ-UHFFFAOYSA-N D05FUY DRUGSMIL C1=CC(=CC=C1C2=CC(=C3C(=C2)C=CC(=C3Cl)O)Cl)O D05FUY HIGHSTAT Investigative D05FWW DRUG__ID D05FWW D05FWW DRUGTYPE Small molecular drug D05FWW DRUGINCH 1S/C12H6Br4O5/c13-7-5(1-3(17)11(19)9(7)15)21-6-2-4(18)12(20)10(16)8(6)14/h1-2,17-20H D05FWW DRUGINKE USVLQGJGFKJBRW-UHFFFAOYSA-N D05FWW DRUGSMIL C1=C(C(=C(C(=C1OC2=C(C(=C(C(=C2)O)O)Br)Br)Br)Br)O)O D05FWW HIGHSTAT Investigative D05FXD DRUG__ID D05FXD D05FXD DRUGTYPE Small molecular drug D05FXD DRUGINCH 1S/C22H19N5O4/c1-12-8-9-13(28)10-14(12)16-11-26-18-19(25(2)22(30)24-20(18)29)23-21(26)27(16)15-6-4-5-7-17(15)31-3/h4-11,28H,1-3H3,(H,24,29,30) D05FXD DRUGINKE JTWMOWRMSZZHDR-UHFFFAOYSA-N D05FXD DRUGSMIL CC1=C(C=C(C=C1)O)C2=CN3C4=C(N=C3N2C5=CC=CC=C5OC)N(C(=O)NC4=O)C D05FXD HIGHSTAT Investigative D05FYR DRUG__ID D05FYR D05FYR DRUGTYPE Small molecular drug D05FYR DRUGINCH 1S/C59H82N16O11/c1-32(2)49(75-54(82)43(22-13-14-24-60)71-56(84)45(26-36-16-7-6-8-17-36)72-53(81)44(70-50(78)33(3)61)23-15-25-64-59(62)63)58(86)74-47(28-38-30-66-42-21-12-10-19-40(38)42)57(85)73-46(27-37-29-65-41-20-11-9-18-39(37)41)55(83)69-35(5)52(80)68-34(4)51(79)67-31-48(76)77/h6-12,16-21,29-30,32-35,43-47,49,65-66H,13-15,22-28,31,60-61H2,1-5H3,(H,67,79)(H,68,80)(H,69,83)(H,70,78)(H,71,84)(H,72,81)(H,73,85)(H,74,86)(H,75,82)(H,76,77)(H4,62,63,64)/t33-,34-,35-,43-,44-,45-,46-,47-,49-/m0/s1 D05FYR DRUGINKE BVRWWHKWGPOKPN-NXOPMQQOSA-N D05FYR DRUGSMIL CC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(C)C(=O)NC(C)C(=O)NCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)N D05FYR HIGHSTAT Investigative D05FZE DRUG__ID D05FZE D05FZE DRUGTYPE Small molecular drug D05FZE DRUGINCH 1S/C10H16N2O4/c1-10(2,3)7-5(8(13)12-16-7)4-6(11)9(14)15/h6H,4,11H2,1-3H3,(H,12,13)(H,14,15) D05FZE DRUGINKE PIXJURSCCVBKRF-UHFFFAOYSA-N D05FZE DRUGSMIL CC(C)(C)C1=C(C(=O)NO1)CC(C(=O)O)N D05FZE HIGHSTAT Investigative D05FZP DRUG__ID D05FZP D05FZP DRUGTYPE Small molecular drug D05FZP DRUGINCH 1S/C9H11BO4/c1-2-14-9(11)7-4-3-5-8(6-7)10(12)13/h3-6,12-13H,2H2,1H3 D05FZP DRUGINKE REHVCPNQQBDOJJ-UHFFFAOYSA-N D05FZP DRUGSMIL B(C1=CC(=CC=C1)C(=O)OCC)(O)O D05FZP HIGHSTAT Investigative D05GAT DRUG__ID D05GAT D05GAT DRUGTYPE Small molecular drug D05GAT DRUGINCH 1S/C41H65N13O10/c42-19-5-4-12-28(51-37(60)30-13-7-21-53(30)38(61)25(43)11-6-20-48-41(46)47)39(62)54-22-8-14-31(54)36(59)50-27(16-18-33(45)56)34(57)49-26(15-17-32(44)55)35(58)52-29(40(63)64)23-24-9-2-1-3-10-24/h1-3,9-10,25-31H,4-8,11-23,42-43H2,(H2,44,55)(H2,45,56)(H,49,57)(H,50,59)(H,51,60)(H,52,58)(H,63,64)(H4,46,47,48)/t25-,26-,27-,28-,29-,30-,31-/m0/s1 D05GAT DRUGINKE KPHDBQWTCKBKIL-XIJWKTHWSA-N D05GAT DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)N)C(=O)NC(CCCCN)C(=O)N2CCCC2C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)O D05GAT HIGHSTAT Investigative D05GBE DRUG__ID D05GBE D05GBE DRUGTYPE Small molecular drug D05GBE DRUGINCH 1S/C15H21NO/c17-15-6-3-4-12(10-15)13-7-8-14-5-1-2-9-16(14)11-13/h3-4,6,10,13-14,17H,1-2,5,7-9,11H2 D05GBE DRUGINKE GBPVZNJTTUIKKY-UHFFFAOYSA-N D05GBE DRUGSMIL C1CCN2CC(CCC2C1)C3=CC(=CC=C3)O D05GBE HIGHSTAT Investigative D05GBY DRUG__ID D05GBY D05GBY DRUGTYPE Small molecular drug D05GBY DRUGINCH 1S/C13H9NS/c1-2-4-13-10(3-1)7-12(8-14-13)11-5-6-15-9-11/h1-9H D05GBY DRUGINKE ZWOOWBWBVMAYGL-UHFFFAOYSA-N D05GBY DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)C3=CSC=C3 D05GBY HIGHSTAT Investigative D05GDD DRUG__ID D05GDD D05GDD DRUGTYPE Small molecular drug D05GDD DRUGINCH 1S/C20H22N4O/c1-3-23(4-2)12-11-21-15-9-10-16-19-18(15)20(25)14-7-5-6-8-17(14)24(19)13-22-16/h5-10,13,21H,3-4,11-12H2,1-2H3 D05GDD DRUGINKE MKCGFGOLLOOXDP-UHFFFAOYSA-N D05GDD DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=CC=CC=C4C2=O D05GDD HIGHSTAT Investigative D05GDP DRUG__ID D05GDP D05GDP DRUGTYPE Small molecular drug D05GDP DRUGINCH 1S/C12H14N2O/c1-15-8-2-3-9-10-4-5-13-7-12(10)14-11(9)6-8/h2-3,6,13-14H,4-5,7H2,1H3 D05GDP DRUGINKE SCIRNASYBOGBOO-UHFFFAOYSA-N D05GDP DRUGSMIL COC1=CC2=C(C=C1)C3=C(N2)CNCC3 D05GDP HIGHSTAT Investigative D05GFM DRUG__ID D05GFM D05GFM DRUGTYPE Small molecular drug D05GFM DRUGINCH 1S/C27H35N5O5/c1-17(31(2)26(36)21(28)15-19-10-12-20(33)13-11-19)25(35)30-22(16-18-7-4-3-5-8-18)27(37)32-14-6-9-23(32)24(29)34/h3-5,7-8,10-13,17,21-23,33H,6,9,14-16,28H2,1-2H3,(H2,29,34)(H,30,35)/t17?,21?,22-,23+/m0/s1 D05GFM DRUGINKE PAVMQNDNZSJTHU-LLLIPXRLSA-N D05GFM DRUGSMIL CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)N)N(C)C(=O)C(CC3=CC=C(C=C3)O)N D05GFM HIGHSTAT Investigative D05GGE DRUG__ID D05GGE D05GGE DRUGTYPE Small molecular drug D05GGE DRUGINCH 1S/C17H13NO3/c19-15-13-8-4-5-9-14(13)16(20)18(17(15)21)11-10-12-6-2-1-3-7-12/h1-9H,10-11H2 D05GGE DRUGINKE QORWHUYLLGKESS-UHFFFAOYSA-N D05GGE DRUGSMIL C1=CC=C(C=C1)CCN2C(=O)C3=CC=CC=C3C(=O)C2=O D05GGE HIGHSTAT Investigative D05GGH DRUG__ID D05GGH D05GGH DRUGTYPE Small molecular drug D05GGH DRUGINCH 1S/C12H16ClN3O2/c13-11-2-1-10(9-15-11)12(17)14-3-4-16-5-7-18-8-6-16/h1-2,9H,3-8H2,(H,14,17) D05GGH DRUGINKE DWSIBMFUHQAQMK-UHFFFAOYSA-N D05GGH DRUGSMIL C1COCCN1CCNC(=O)C2=CN=C(C=C2)Cl D05GGH HIGHSTAT Investigative D05GIB DRUG__ID D05GIB D05GIB DRUGTYPE Small molecular drug D05GIB DRUGINCH 1S/C40H45N5O7S2/c1-40(2)36(38(50)44-34-28-14-8-7-12-25(28)19-31(34)46)45(23-54-40)39(51)35(48)29(18-24-10-5-4-6-11-24)43-37(49)30(22-53-3)42-33(47)21-52-32-15-9-13-26-20-41-17-16-27(26)32/h4-17,20,29-31,34-36,46,48H,18-19,21-23H2,1-3H3,(H,42,47)(H,43,49)(H,44,50)/t29-,30-,31+,34-,35-,36+/m0/s1 D05GIB DRUGINKE NLPSIHQYIUXYOW-SHJYOGRKSA-N D05GIB DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)COC3=CC=CC4=C3C=CN=C4)O)C(=O)NC5C(CC6=CC=CC=C56)O)C D05GIB HIGHSTAT Investigative D05GIC DRUG__ID D05GIC D05GIC DRUGTYPE Small molecular drug D05GIC DRUGINCH 1S/C36H44N4O2/c41-26-12-13-31-28(21-26)27-14-17-37-32(33(27)38-31)29-23-36(42)16-8-4-1-2-5-9-18-39-20-15-30(29)35(24-39)22-25-11-7-3-6-10-19-40(25)34(35)36/h1,4,7,11-14,17,21,23,25,30,34,38,41-42H,2-3,5-6,8-10,15-16,18-20,22,24H2/b4-1-,11-7-/t25-,30-,34+,35-,36-/m0/s1 D05GIC DRUGINKE CANRNZBVKKQKEQ-FFMUKQARSA-N D05GIC DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCCC=C5)O)C6=NC=CC7=C6NC8=C7C=C(C=C8)O D05GIC HIGHSTAT Investigative D05GKC DRUG__ID D05GKC D05GKC DRUGTYPE Small molecular drug D05GKC DRUGINCH 1S/C18H24O5/c1-12-6-5-9-14(19)8-4-2-3-7-13-10-15(20)11-16(21)17(13)18(22)23-12/h10-12,20-21H,2-9H2,1H3/t12-/m0/s1 D05GKC DRUGINKE APJDQUGPCJRQRJ-LBPRGKRZSA-N D05GKC DRUGSMIL CC1CCCC(=O)CCCCCC2=C(C(=CC(=C2)O)O)C(=O)O1 D05GKC HIGHSTAT Investigative D05GMB DRUG__ID D05GMB D05GMB DRUGTYPE Small molecular drug D05GMB DRUGINCH 1S/C30H31N5O4/c1-33-14-16-35(17-15-33)19-26(36)34(2)23-11-9-22(10-12-23)31-28(20-6-4-3-5-7-20)27-24-13-8-21(30(38)39)18-25(24)32-29(27)37/h3-13,18,32,37H,14-17,19H2,1-2H3,(H,38,39) D05GMB DRUGINKE SDJMWYVJAVLZEG-UHFFFAOYSA-N D05GMB DRUGSMIL CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)O)O D05GMB HIGHSTAT Investigative D05GMW DRUG__ID D05GMW D05GMW DRUGTYPE Small molecular drug D05GMW DRUGINCH 1S/C15H10N2O2/c1-7-6-10-12(8-4-2-3-5-9(8)16-10)13-11(7)14(18)17-15(13)19/h2-6,16H,1H3,(H,17,18,19) D05GMW DRUGINKE DSCSSQAANWCYAP-UHFFFAOYSA-N D05GMW DRUGSMIL CC1=CC2=C(C3=CC=CC=C3N2)C4=C1C(=O)NC4=O D05GMW HIGHSTAT Investigative D05GOC DRUG__ID D05GOC D05GOC DRUGTYPE Small molecular drug D05GOC DRUGINCH 1S/C12H12FN3S2/c13-10-4-2-1-3-9(10)5-6-14-11(17)16-12-15-7-8-18-12/h1-4,7-8H,5-6H2,(H2,14,15,16,17) D05GOC DRUGINKE OQWSGTUKBXDUJN-UHFFFAOYSA-N D05GOC DRUGSMIL C1=CC=C(C(=C1)CCNC(=S)NC2=NC=CS2)F D05GOC HIGHSTAT Investigative D05GOP DRUG__ID D05GOP D05GOP DRUGTYPE Small molecular drug D05GOP DRUGINCH 1S/C20H21F3N2O2/c1-2-27-16-7-5-6-15(13-16)24-19(26)14-8-9-18(25-10-3-4-11-25)17(12-14)20(21,22)23/h5-9,12-13H,2-4,10-11H2,1H3,(H,24,26) D05GOP DRUGINKE KLFVWQCQUXXLOU-UHFFFAOYSA-N D05GOP DRUGSMIL CCOC1=CC=CC(=C1)NC(=O)C2=CC(=C(C=C2)N3CCCC3)C(F)(F)F D05GOP HIGHSTAT Investigative D05GPI DRUG__ID D05GPI D05GPI DRUGTYPE Small molecular drug D05GPI DRUGINCH 1S/C32H39NO3/c1-33(25-26-16-10-9-11-17-26)22-14-7-5-3-2-4-6-8-15-23-35-27-20-21-29-31(24-27)36-30-19-13-12-18-28(30)32(29)34/h9-13,16-21,24H,2-8,14-15,22-23,25H2,1H3 D05GPI DRUGINKE GQHNOERJFAPKTD-UHFFFAOYSA-N D05GPI DRUGSMIL CN(CCCCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D05GPI HIGHSTAT Investigative D05GPK DRUG__ID D05GPK D05GPK DRUGTYPE Small molecular drug D05GPK DRUGINCH 1S/C12H11BO2/c14-13(15)12-8-4-7-11(9-12)10-5-2-1-3-6-10/h1-9,14-15H D05GPK DRUGINKE GOXICVKOZJFRMB-UHFFFAOYSA-N D05GPK DRUGSMIL B(C1=CC(=CC=C1)C2=CC=CC=C2)(O)O D05GPK HIGHSTAT Investigative D05GPX DRUG__ID D05GPX D05GPX DRUGTYPE Small molecular drug D05GPX DRUGINCH 1S/C14H16N2O4/c1-8(17)16(19)12-10-6-9(7-15)4-5-11(10)20-14(2,3)13(12)18/h4-6,12-13,18-19H,1-3H3/t12-,13+/m1/s1 D05GPX DRUGINKE IWTCFIIOUXJOOV-OLZOCXBDSA-N D05GPX DRUGSMIL CC(=O)N(C1C(C(OC2=C1C=C(C=C2)C#N)(C)C)O)O D05GPX HIGHSTAT Investigative D05GQK DRUG__ID D05GQK D05GQK DRUGTYPE Small molecular drug D05GQK DRUGINCH 1S/C25H20FN3O/c1-29-23-13-7-4-10-19(23)24(18-9-2-5-11-20(18)26)28-22(25(29)30)14-16-15-27-21-12-6-3-8-17(16)21/h2-13,15,22,27H,14H2,1H3/t22-/m1/s1 D05GQK DRUGINKE CGBANSGENFERAT-JOCHJYFZSA-N D05GQK DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)CC3=CNC4=CC=CC=C43)C5=CC=CC=C5F D05GQK HIGHSTAT Investigative D05GQQ DRUG__ID D05GQQ D05GQQ DRUGTYPE Small molecular drug D05GQQ DRUGINCH 1S/C11H11BrN2/c12-7-1-2-10-9(5-7)8-3-4-13-6-11(8)14-10/h1-2,5,13-14H,3-4,6H2 D05GQQ DRUGINKE WUTVTUWSFMYRJK-UHFFFAOYSA-N D05GQQ DRUGSMIL C1CNCC2=C1C3=C(N2)C=CC(=C3)Br D05GQQ HIGHSTAT Investigative D05GRI DRUG__ID D05GRI D05GRI DRUGTYPE Small molecular drug D05GRI DRUGINCH 1S/C11H12O3/c1-8(12)3-4-9-5-6-10(13)11(7-9)14-2/h3-7,13H,1-2H3/b4-3+ D05GRI DRUGINKE AFWKBSMFXWNGRE-ONEGZZNKSA-N D05GRI DRUGSMIL CC(=O)C=CC1=CC(=C(C=C1)O)OC D05GRI HIGHSTAT Investigative D05GRZ DRUG__ID D05GRZ D05GRZ DRUGTYPE Small molecular drug D05GRZ DRUGINCH 1S/C16H24N2O3/c1-12-9-10-14(13(2)11-12)17-15(19)7-5-3-4-6-8-16(20)18-21/h9-11,21H,3-8H2,1-2H3,(H,17,19)(H,18,20) D05GRZ DRUGINKE MIPPPENLVLVVIQ-UHFFFAOYSA-N D05GRZ DRUGSMIL CC1=CC(=C(C=C1)NC(=O)CCCCCCC(=O)NO)C D05GRZ HIGHSTAT Investigative D05GSF DRUG__ID D05GSF D05GSF DRUGTYPE Small molecular drug D05GSF DRUGINCH 1S/C15H20N8O/c1-2-23-13-10(9-22-5-3-17-4-6-22)7-18-8-11(13)19-15(23)12-14(16)21-24-20-12/h7-8,17H,2-6,9H2,1H3,(H2,16,21) D05GSF DRUGINKE OXZLPOLYTISTQY-UHFFFAOYSA-N D05GSF DRUGSMIL CCN1C2=C(C=NC=C2CN3CCNCC3)N=C1C4=NON=C4N D05GSF HIGHSTAT Investigative D05GSS DRUG__ID D05GSS D05GSS DRUGTYPE Small molecular drug D05GSS DRUGINCH 1S/C20H18O4/c1-20(2)6-5-11-7-14-15-10-22-17-8-12(21)3-4-13(17)19(15)23-18(14)9-16(11)24-20/h3-9,15,19,21H,10H2,1-2H3 D05GSS DRUGINKE WTKJOOHYNMPGLE-UHFFFAOYSA-N D05GSS DRUGSMIL CC1(C=CC2=CC3=C(C=C2O1)OC4C3COC5=C4C=CC(=C5)O)C D05GSS HIGHSTAT Investigative D05GSZ DRUG__ID D05GSZ D05GSZ DRUGTYPE Small molecular drug D05GSZ DRUGINCH 1S/C21H15Cl2N3O5/c22-17-8-5-14(9-18(17)23)25-20(27)13-3-1-12(2-4-13)11-24-19-10-15(26(30)31)6-7-16(19)21(28)29/h1-10,24H,11H2,(H,25,27)(H,28,29) D05GSZ DRUGINKE HMZYRLHWICHTKH-UHFFFAOYSA-N D05GSZ DRUGSMIL C1=CC(=CC=C1CNC2=C(C=CC(=C2)[N+](=O)[O-])C(=O)O)C(=O)NC3=CC(=C(C=C3)Cl)Cl D05GSZ HIGHSTAT Investigative D05GUD DRUG__ID D05GUD D05GUD DRUGTYPE Small molecular drug D05GUD DRUGINCH 1S/C22H41NO4/c1-3-5-6-7-8-9-10-11-12-13-14-15-17-20(24)22(26)23-19-16-18-21(25)27-4-2/h3-19H2,1-2H3,(H,23,26) D05GUD DRUGINKE FMFKQXKYWWJNJS-UHFFFAOYSA-N D05GUD DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)OCC D05GUD HIGHSTAT Investigative D05GVL DRUG__ID D05GVL D05GVL DRUGTYPE Small molecular drug D05GVL DRUGINCH 1S/C16H13NO5S/c1-22-12-7-6-11-8-9-17(14(11)10-12)23(20,21)15-5-3-2-4-13(15)16(18)19/h2-10H,1H3,(H,18,19) D05GVL DRUGINKE HQQRNJVZOJLXOO-UHFFFAOYSA-N D05GVL DRUGSMIL COC1=CC2=C(C=C1)C=CN2S(=O)(=O)C3=CC=CC=C3C(=O)O D05GVL HIGHSTAT Investigative D05GVY DRUG__ID D05GVY D05GVY DRUGTYPE Small molecular drug D05GVY DRUGINCH 1S/C15H21NO2S/c1-13(17)19-12-8-3-2-7-11-15(18)16-14-9-5-4-6-10-14/h4-6,9-10H,2-3,7-8,11-12H2,1H3,(H,16,18) D05GVY DRUGINKE BNRRQLIZKKTJIO-UHFFFAOYSA-N D05GVY DRUGSMIL CC(=O)SCCCCCCC(=O)NC1=CC=CC=C1 D05GVY HIGHSTAT Investigative D05GWF DRUG__ID D05GWF D05GWF DRUGTYPE Small molecular drug D05GWF DRUGINCH 1S/C21H28FNO4/c1-13(2)23-12-20(15-4-6-16(22)7-5-15)19(14(23)3)9-8-17(24)10-18(25)11-21(26)27/h4-7,12-13,17-18,24-25H,8-11H2,1-3H3,(H,26,27)/p-1/t17-,18-/m1/s1 D05GWF DRUGINKE LJBGBXVAGFAMLZ-QZTJIDSGSA-M D05GWF DRUGSMIL CC1=C(C(=CN1C(C)C)C2=CC=C(C=C2)F)CCC(CC(CC(=O)[O-])O)O D05GWF HIGHSTAT Investigative D05GWI DRUG__ID D05GWI D05GWI DRUGTYPE Small molecular drug D05GWI DRUGINCH 1S/C16H14O2/c1-17-15-7-8-16(18-2)14-10-12-6-4-3-5-11(12)9-13(14)15/h3-10H,1-2H3 D05GWI DRUGINKE YCTBFSAWJWMRGO-UHFFFAOYSA-N D05GWI DRUGSMIL COC1=CC=C(C2=CC3=CC=CC=C3C=C12)OC D05GWI HIGHSTAT Investigative D05GWV DRUG__ID D05GWV D05GWV DRUGTYPE Small molecular drug D05GWV DRUGINCH 1S/C15H17NO3/c16-9-11-6-7-14(19-10-15(17)18)13(8-11)12-4-2-1-3-5-12/h6-8,12H,1-5,10H2,(H,17,18) D05GWV DRUGINKE YLYPWLBTNPRZEM-UHFFFAOYSA-N D05GWV DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)C#N)OCC(=O)O D05GWV HIGHSTAT Investigative D05GXK DRUG__ID D05GXK D05GXK DRUGTYPE Small molecular drug D05GXK DRUGINCH 1S/C24H32N8O7/c25-24(26)27-8-4-7-15-20(36)28-11-18(33)30-16(10-19(34)35)21(37)29-14-9-17(22(38)31-15)32(12-14)23(39)13-5-2-1-3-6-13/h1-3,5-6,14-17H,4,7-12H2,(H,28,36)(H,29,37)(H,30,33)(H,31,38)(H,34,35)(H4,25,26,27)/t14-,15+,16+,17+/m1/s1 D05GXK DRUGINKE UIBGFNHGJUQMPO-QZWWFDLISA-N D05GXK DRUGSMIL C1C2CN(C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N)C(=O)C3=CC=CC=C3 D05GXK HIGHSTAT Investigative D05GYF DRUG__ID D05GYF D05GYF DRUGTYPE Small molecular drug D05GYF DRUGINCH 1S/C11H22O11S2/c12-1-5(14)10(18)11(22-24(19,20)21)7(16)4-23-3-6(15)9(17)8(23)2-13/h5-18H,1-4H2/t5-,6+,7+,8+,9-,10+,11+,23?/m0/s1 D05GYF DRUGINKE YCUKGYWMYZBCGT-VLLNVTNWSA-N D05GYF DRUGSMIL C1C(C(C([S+]1CC(C(C(C(CO)O)O)OS(=O)(=O)[O-])O)CO)O)O D05GYF HIGHSTAT Investigative D05GYG DRUG__ID D05GYG D05GYG DRUGTYPE Small molecular drug D05GYG DRUGINCH 1S/C95H138N20O25S/c1-15-52(10)79(94(138)114-78(51(8)9)93(137)112-73(95(139)140)41-58-45-98-62-26-20-19-25-61(58)62)115-91(135)72(44-76(122)123)110-87(131)67(38-49(4)5)107-89(133)70(42-59-46-97-47-99-59)106-80(124)53(11)101-85(129)68(39-56-23-17-16-18-24-56)108-88(132)69(40-57-28-30-60(117)31-29-57)111-92(136)77(50(6)7)113-81(125)54(12)100-82(126)64(32-33-74(118)119)104-83(127)63(27-21-22-35-96)103-90(134)71(43-75(120)121)109-84(128)65(34-36-141-14)105-86(130)66(37-48(2)3)102-55(13)116/h16-20,23-26,28-31,45-54,63-73,77-79,98,117H,15,21-22,27,32-44,96H2,1-14H3,(H,97,99)(H,100,126)(H,101,129)(H,102,116)(H,103,134)(H,104,127)(H,105,130)(H,106,124)(H,107,133)(H,108,132)(H,109,128)(H,110,131)(H,111,136)(H,112,137)(H,113,125)(H,114,138)(H,115,135)(H,118,119)(H,120,121)(H,122,123)(H,139,140)/t52-,53-,54-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,77-,78-,79-/m0/s1 D05GYG DRUGINKE KBQLINQFUQUHIY-SGOWJZKMSA-N D05GYG DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CNC=N3)NC(=O)C(C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=O)C D05GYG HIGHSTAT Investigative D05GYO DRUG__ID D05GYO D05GYO DRUGTYPE Small molecular drug D05GYO DRUGINCH 1S/C32H36N3O9P/c1-21(36)33-27(17-23-12-15-28(44-20-30(37)38)29(18-23)45(41,42)43)31(39)34-26-9-5-6-16-35(32(26)40)19-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,18,26-27H,5-6,9,16-17,19-20H2,1H3,(H,33,36)(H,34,39)(H,37,38)(H2,41,42,43)/t26-,27-/m0/s1 D05GYO DRUGINKE MWEWSHNGVWABKG-SVBPBHIXSA-N D05GYO DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)OCC(=O)O)P(=O)(O)O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D05GYO HIGHSTAT Investigative D05GZI DRUG__ID D05GZI D05GZI DRUGTYPE Small molecular drug D05GZI DRUGINCH 1S/C15H14N2O/c1-2-11-7-9-12(10-8-11)16-15-17-13-5-3-4-6-14(13)18-15/h3-10H,2H2,1H3,(H,16,17) D05GZI DRUGINKE KKIDKWUGBUWNPR-UHFFFAOYSA-N D05GZI DRUGSMIL CCC1=CC=C(C=C1)NC2=NC3=CC=CC=C3O2 D05GZI HIGHSTAT Investigative D05HBF DRUG__ID D05HBF D05HBF DRUGTYPE Small molecular drug D05HBF DRUGINCH 1S/C15H10O4/c16-11-7-14(9-4-2-1-3-5-9)19-15-8-13(18)12(17)6-10(11)15/h1-8,17-18H D05HBF DRUGINKE GSAOUZGPXSGVRS-UHFFFAOYSA-N D05HBF DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=CC(=C(C=C3O2)O)O D05HBF HIGHSTAT Investigative D05HFC DRUG__ID D05HFC D05HFC DRUGTYPE Small molecular drug D05HFC DRUGINCH 1S/C14H18N2O/c1-9(2)10(3)17-12-6-4-5-11-7-8-13(15)16-14(11)12/h4-10H,1-3H3,(H2,15,16) D05HFC DRUGINKE UQTSQIVXJFEZMJ-UHFFFAOYSA-N D05HFC DRUGSMIL CC(C)C(C)OC1=CC=CC2=C1N=C(C=C2)N D05HFC HIGHSTAT Investigative D05HFD DRUG__ID D05HFD D05HFD DRUGTYPE Small molecular drug D05HFD DRUGINCH 1S/C11H9N3O/c1-6-2-3-8-7(4-6)5-9-10(12-8)14-11(15)13-9/h2-5H,1H3,(H2,12,13,14,15) D05HFD DRUGINKE BSAKVJKPJIQKNP-UHFFFAOYSA-N D05HFD DRUGSMIL CC1=CC2=CC3=C(NC(=O)N3)N=C2C=C1 D05HFD HIGHSTAT Investigative D05HFQ DRUG__ID D05HFQ D05HFQ DRUGTYPE Small molecular drug D05HFQ DRUGINCH 1S/C37H44N4O7S2/c1-37(2)33(35(47)40-31-26-15-8-7-13-24(26)19-29(31)43)41(21-50-37)36(48)32(45)27(17-22-10-5-4-6-11-22)39-34(46)28(20-49-3)38-30(44)18-23-12-9-14-25(42)16-23/h4-16,27-29,31-33,42-43,45H,17-21H2,1-3H3,(H,38,44)(H,39,46)(H,40,47)/t27-,28-,29+,31-,32-,33+/m0/s1 D05HFQ DRUGINKE RBPFZWDTXSAZMR-ACUZRORGSA-N D05HFQ DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC(=CC=C3)O)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D05HFQ HIGHSTAT Investigative D05HFW DRUG__ID D05HFW D05HFW DRUGTYPE Small molecular drug D05HFW DRUGINCH 1S/C18H16O8/c1-23-11-5-4-8(6-9(11)19)16-18(25-3)15(22)13-12(26-16)7-10(20)17(24-2)14(13)21/h4-7,19-21H,1-3H3 D05HFW DRUGINKE BZXULYMZYPRZOG-UHFFFAOYSA-N D05HFW DRUGSMIL COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C(=C3O)OC)O)OC)O D05HFW HIGHSTAT Investigative D05HIG DRUG__ID D05HIG D05HIG DRUGTYPE Small molecular drug D05HIG DRUGINCH 1S/C25H27NO2/c27-25(26-19-10-2-1-5-12-21-13-6-3-7-14-21)28-24-18-11-17-23(20-24)22-15-8-4-9-16-22/h3-4,6-9,11,13-18,20H,1-2,5,10,12,19H2,(H,26,27) D05HIG DRUGINKE MGXPWHVQDGCMAC-UHFFFAOYSA-N D05HIG DRUGSMIL C1=CC=C(C=C1)CCCCCCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D05HIG HIGHSTAT Investigative D05HJG DRUG__ID D05HJG D05HJG DRUGTYPE Small molecular drug D05HJG DRUGINCH 1S/C12H9NO/c14-12-10-6-2-4-8-3-1-5-9(7-13-12)11(8)10/h1-6H,7H2,(H,13,14) D05HJG DRUGINKE QGJHNXPHHOCUAH-UHFFFAOYSA-N D05HJG DRUGSMIL C1C2=CC=CC3=C2C(=CC=C3)C(=O)N1 D05HJG HIGHSTAT Investigative D05HJP DRUG__ID D05HJP D05HJP DRUGTYPE Small molecular drug D05HJP DRUGINCH 1S/C16H13N/c17-15-9-5-12(6-10-15)11-14-8-7-13-3-1-2-4-16(13)14/h1-11H,17H2/b14-11+ D05HJP DRUGINKE GISMNWZLKDONAA-SDNWHVSQSA-N D05HJP DRUGSMIL C1=CC=C2C(=C1)C=CC2=CC3=CC=C(C=C3)N D05HJP HIGHSTAT Investigative D05HJT DRUG__ID D05HJT D05HJT DRUGTYPE Small molecular drug D05HJT DRUGINCH 1S/C19H15NO5/c1-2-24-18(22)12-7-9-14(10-8-12)20-17(21)15-11-13-5-3-4-6-16(13)25-19(15)23/h3-11H,2H2,1H3,(H,20,21) D05HJT DRUGINKE MISJYZJMFQOBPG-UHFFFAOYSA-N D05HJT DRUGSMIL CCOC(=O)C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3OC2=O D05HJT HIGHSTAT Investigative D05HMW DRUG__ID D05HMW D05HMW DRUGTYPE Small molecular drug D05HMW DRUGINCH 1S/C15H23N3/c1-3-9-18(10-4-2)15-7-5-13(6-8-15)14(11-16)12-17/h15H,3-10H2,1-2H3 D05HMW DRUGINKE FGVSZVRUGNMGKP-UHFFFAOYSA-N D05HMW DRUGSMIL CCCN(CCC)C1CCC(=C(C#N)C#N)CC1 D05HMW HIGHSTAT Investigative D05HNB DRUG__ID D05HNB D05HNB DRUGTYPE Small molecular drug D05HNB DRUGINCH 1S/C30H28O10/c1-3-17-13-21(16(2)31)23(32)15-26(17)39-12-4-11-38-24-9-6-20-28(35)22-14-18(30(36)37)5-8-25(22)40-29(20)19(24)7-10-27(33)34/h5-6,8-9,13-15,32H,3-4,7,10-12H2,1-2H3,(H,33,34)(H,36,37) D05HNB DRUGINKE HGMXXGVRUCAMMK-UHFFFAOYSA-N D05HNB DRUGSMIL CCC1=CC(=C(C=C1OCCCOC2=C(C3=C(C=C2)C(=O)C4=C(O3)C=CC(=C4)C(=O)O)CCC(=O)O)O)C(=O)C D05HNB HIGHSTAT Investigative D05HOH DRUG__ID D05HOH D05HOH DRUGTYPE Small molecular drug D05HOH DRUGINCH 1S/C34H37N5O5/c1-39(34(44)28(35)18-23-12-15-27(40)16-13-23)21-31(41)37-30(19-22-7-3-2-4-8-22)33(43)38-29(32(36)42)20-24-11-14-25-9-5-6-10-26(25)17-24/h2-17,28-30,40H,18-21,35H2,1H3,(H2,36,42)(H,37,41)(H,38,43)/t28-,29+,30-/m0/s1 D05HOH DRUGINKE GNWOYARHUGPZGJ-JBOQNHBVSA-N D05HOH DRUGSMIL CN(CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)N)C(=O)C(CC4=CC=C(C=C4)O)N D05HOH HIGHSTAT Investigative D05HOO DRUG__ID D05HOO D05HOO DRUGTYPE Small molecular drug D05HOO DRUGINCH 1S/C6H5BrO/c7-5-3-1-2-4-6(5)8/h1-4,8H D05HOO DRUGINKE VADKRMSMGWJZCF-UHFFFAOYSA-N D05HOO DRUGSMIL C1=CC=C(C(=C1)O)Br D05HOO HIGHSTAT Investigative D05HOS DRUG__ID D05HOS D05HOS DRUGTYPE Small molecular drug D05HOS DRUGINCH 1S/C5H12N2O2/c1-3(2)4(6)5(8)7-9/h3-4,9H,6H2,1-2H3,(H,7,8)/t4-/m1/s1 D05HOS DRUGINKE USSBBYRBOWZYSB-SCSAIBSYSA-N D05HOS DRUGSMIL CC(C)C(C(=O)NO)N D05HOS HIGHSTAT Investigative D05HPB DRUG__ID D05HPB D05HPB DRUGTYPE Small molecular drug D05HPB DRUGINCH 1S/C15H20O4/c1-18-12-7-8-14(19-10-15(16)17)13(9-12)11-5-3-2-4-6-11/h7-9,11H,2-6,10H2,1H3,(H,16,17) D05HPB DRUGINKE PJEFVLZYUWCSGF-UHFFFAOYSA-N D05HPB DRUGSMIL COC1=CC(=C(C=C1)OCC(=O)O)C2CCCCC2 D05HPB HIGHSTAT Investigative D05HRK DRUG__ID D05HRK D05HRK DRUGTYPE Small molecular drug D05HRK DRUGINCH 1S/C16H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-13H2,1H3,(H,17,18) D05HRK DRUGINKE MECFGCCEVOFCNS-UHFFFAOYSA-N D05HRK DRUGSMIL CCCCCCCCCCCCCC#CC(=O)O D05HRK HIGHSTAT Investigative D05HRP DRUG__ID D05HRP D05HRP DRUGTYPE Small molecular drug D05HRP DRUGINCH 1S/C11H12N2O2/c1-11(6-9(14)13-10(11)15)7-2-4-8(12)5-3-7/h2-5H,6,12H2,1H3,(H,13,14,15) D05HRP DRUGINKE MAUIJSRGENXQBY-UHFFFAOYSA-N D05HRP DRUGSMIL CC1(CC(=O)NC1=O)C2=CC=C(C=C2)N D05HRP HIGHSTAT Investigative D05HUS DRUG__ID D05HUS D05HUS DRUGTYPE Small molecular drug D05HUS DRUGINCH 1S/C16H12FN/c1-11-5-6-12-7-8-14(10-16(12)18-11)13-3-2-4-15(17)9-13/h2-10H,1H3 D05HUS DRUGINKE BBNRSYMDJKFBOU-UHFFFAOYSA-N D05HUS DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC=C3)F D05HUS HIGHSTAT Investigative D05HUX DRUG__ID D05HUX D05HUX DRUGTYPE Small molecular drug D05HUX DRUGINCH 1S/C10H14N4O4/c15-7-3-13(4-8(16)11-7)1-2-14-5-9(17)12-10(18)6-14/h1-6H2,(H,11,15,16)(H,12,17,18) D05HUX DRUGINKE GBLIGNUYGOFIKS-UHFFFAOYSA-N D05HUX DRUGSMIL C1C(=O)NC(=O)CN1CCN2CC(=O)NC(=O)C2 D05HUX HIGHSTAT Investigative D05HVV DRUG__ID D05HVV D05HVV DRUGTYPE Small molecular drug D05HVV DRUGINCH 1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m1/s1 D05HVV DRUGINKE NEMGRZFTLSKBAP-GFCCVEGCSA-N D05HVV DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F D05HVV HIGHSTAT Investigative D05HWC DRUG__ID D05HWC D05HWC DRUGTYPE Small molecular drug D05HWC DRUGINCH 1S/C18H17NO3/c1-19-6-5-11-8-14-18(22-9-21-14)17-15(11)12(19)7-10-3-2-4-13(20)16(10)17/h2-4,8,12,20H,5-7,9H2,1H3/t12-/m1/s1 D05HWC DRUGINKE IKMXUUHNYQWZBC-GFCCVEGCSA-N D05HWC DRUGSMIL CN1CCC2=CC3=C(C4=C2C1CC5=C4C(=CC=C5)O)OCO3 D05HWC HIGHSTAT Investigative D05HXE DRUG__ID D05HXE D05HXE DRUGTYPE Small molecular drug D05HXE DRUGINCH 1S/C39H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h11-12,26-28,32-34,38,49-50H,4-10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b12-11-/t28-,32-,33-,34+,38-/m1/s1 D05HXE DRUGINKE XDUHQPOXLUAVEE-BPMMELMSSA-N D05HXE DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D05HXE HIGHSTAT Investigative D05HYV DRUG__ID D05HYV D05HYV DRUGTYPE Small molecular drug D05HYV DRUGINCH 1S/C29H29ClN4O5/c1-38-24-9-6-10-25(39-2)26(24)23-16-21(28(35)32-27(29(36)37)17-7-4-3-5-8-17)33-34(23)22-13-14-31-20-15-18(30)11-12-19(20)22/h6,9-17,27H,3-5,7-8H2,1-2H3,(H,32,35)(H,36,37)/t27-/m0/s1 D05HYV DRUGINKE PXNTUYAGLGTUKX-MHZLTWQESA-N D05HYV DRUGSMIL COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC(C5CCCCC5)C(=O)O D05HYV HIGHSTAT Investigative D05IBW DRUG__ID D05IBW D05IBW DRUGTYPE Small molecular drug D05IBW DRUGINCH 1S/C20H16Cl2N2O4/c21-7-5-17(25)23-11-1-3-13-15(9-11)20(28)16-10-12(24-18(26)6-8-22)2-4-14(16)19(13)27/h1-4,9-10H,5-8H2,(H,23,25)(H,24,26) D05IBW DRUGINKE ZOTZWUALAZOEAF-UHFFFAOYSA-N D05IBW DRUGSMIL C1=CC2=C(C=C1NC(=O)CCCl)C(=O)C3=C(C2=O)C=CC(=C3)NC(=O)CCCl D05IBW HIGHSTAT Investigative D05ICC DRUG__ID D05ICC D05ICC DRUGTYPE Small molecular drug D05ICC DRUGINCH 1S/C18H20FNO3/c1-2-3-12-22-15-10-8-14(9-11-15)13-20-18(21)23-17-7-5-4-6-16(17)19/h4-11H,2-3,12-13H2,1H3,(H,20,21) D05ICC DRUGINKE XSSVFUMMMRTXER-UHFFFAOYSA-N D05ICC DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CC=CC=C2F D05ICC HIGHSTAT Investigative D05ICE DRUG__ID D05ICE D05ICE DRUGTYPE Small molecular drug D05ICE DRUGINCH 1S/C8H18N4O2/c1-10-8(11-2)12-5-3-4-6(9)7(13)14/h6H,3-5,9H2,1-2H3,(H,13,14)(H2,10,11,12)/t6-/m0/s1 D05ICE DRUGINKE HVPFXCBJHIIJGS-LURJTMIESA-N D05ICE DRUGSMIL CNC(=NC)NCCCC(C(=O)O)N D05ICE HIGHSTAT Investigative D05ICF DRUG__ID D05ICF D05ICF DRUGTYPE Small molecular drug D05ICF DRUGINCH 1S/C16H14N2O2/c1-11-3-7-13(8-4-11)17-15(19)18(16(17)20)14-9-5-12(2)6-10-14/h3-10H,1-2H3 D05ICF DRUGINKE AZZFGWWOGRBVOV-UHFFFAOYSA-N D05ICF DRUGSMIL CC1=CC=C(C=C1)N2C(=O)N(C2=O)C3=CC=C(C=C3)C D05ICF HIGHSTAT Investigative D05IGJ DRUG__ID D05IGJ D05IGJ DRUGTYPE Small molecular drug D05IGJ DRUGINCH 1S/C20H16N2O2/c23-15-8-11-18-19(13-15)22-20(21-18)12-14-6-9-17(10-7-14)24-16-4-2-1-3-5-16/h1-11,13,23H,12H2,(H,21,22) D05IGJ DRUGINKE LVCCXJOSNNQODU-UHFFFAOYSA-N D05IGJ DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=C(N3)C=C(C=C4)O D05IGJ HIGHSTAT Investigative D05IGL DRUG__ID D05IGL D05IGL DRUGTYPE Small molecular drug D05IGL DRUGINCH 1S/C13H12Cl3N7O/c14-6-2-1-5(3-7(6)15)4-20-13(19)23-12(24)8-10(17)22-11(18)9(16)21-8/h1-3H,4H2,(H4,17,18,22)(H3,19,20,23,24) D05IGL DRUGINKE OSHKWEFWXCCNJR-UHFFFAOYSA-N D05IGL DRUGSMIL C1=CC(=C(C=C1CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N)Cl)Cl D05IGL HIGHSTAT Investigative D05IHR DRUG__ID D05IHR D05IHR DRUGTYPE Small molecular drug D05IHR DRUGINCH 1S/C18H15N/c1-2-6-13(7-3-1)18-16-9-5-4-8-14(16)15-10-11-19-12-17(15)18/h1-10,19H,11-12H2 D05IHR DRUGINKE KIUIXTNMEMKNGK-UHFFFAOYSA-N D05IHR DRUGSMIL C1C=C2C(=C(C3=CC=CC=C23)C4=CC=CC=C4)CN1 D05IHR HIGHSTAT Investigative D05IKY DRUG__ID D05IKY D05IKY DRUGTYPE Small molecular drug D05IKY DRUGINCH 1S/C20H37NO3/c1-2-3-4-15-18-21-19(22)16-13-11-9-7-5-6-8-10-12-14-17-20(23)24/h5,7H,2-4,6,8-18H2,1H3,(H,21,22)(H,23,24)/b7-5- D05IKY DRUGINKE RDDSCWVCGRBWBZ-ALCCZGGFSA-N D05IKY DRUGSMIL CCCCCCNC(=O)CCCCC=CCCCCCCC(=O)O D05IKY HIGHSTAT Investigative D05ILO DRUG__ID D05ILO D05ILO DRUGTYPE Small molecular drug D05ILO DRUGINCH 1S/C17H19ClN2O3/c18-14-3-1-2-13(8-14)11-23-15-6-4-12(5-7-15)9-20-16(10-21)17(19)22/h1-8,16,20-21H,9-11H2,(H2,19,22)/t16-/m1/s1 D05ILO DRUGINKE WYDCYPPIJUASJE-MRXNPFEDSA-N D05ILO DRUGSMIL C1=CC(=CC(=C1)Cl)COC2=CC=C(C=C2)CNC(CO)C(=O)N D05ILO HIGHSTAT Investigative D05IQL DRUG__ID D05IQL D05IQL DRUGTYPE Small molecular drug D05IQL DRUGINCH 1S/C17H16N2O2/c1-21-17(20)15-13-9-5-6-10-14(13)19-16(15)18-11-12-7-3-2-4-8-12/h2-10,18-19H,11H2,1H3 D05IQL DRUGINKE TWNCELFDSJZJAX-UHFFFAOYSA-N D05IQL DRUGSMIL COC(=O)C1=C(NC2=CC=CC=C21)NCC3=CC=CC=C3 D05IQL HIGHSTAT Investigative D05ITH DRUG__ID D05ITH D05ITH DRUGTYPE Small molecular drug D05ITH DRUGINCH 1S/C26H27N3O8/c1-11-10-29(14-9-15(30)20-18(17(11)14)23(31)26(2,28-20)25(33)37-6)24(32)13-7-12-8-16(34-3)21(35-4)22(36-5)19(12)27-13/h7-9,11,27-28,30H,10H2,1-6H3 D05ITH DRUGINKE WQAYQZWERWNDPV-UHFFFAOYSA-N D05ITH DRUGSMIL CC1CN(C2=CC(=C3C(=C12)C(=O)C(N3)(C)C(=O)OC)O)C(=O)C4=CC5=CC(=C(C(=C5N4)OC)OC)OC D05ITH HIGHSTAT Investigative D05IVD DRUG__ID D05IVD D05IVD DRUGTYPE Small molecular drug D05IVD DRUGINCH 1S/C20H10O7/c21-9-6-7-19-14-8(9)2-1-3-11(14)26-20(27-19)15-12(25-19)5-4-10(22)13(15)16(23)17-18(20)24-17/h1-7,17-18,22H/t17?,18?,19-,20+/m1/s1 D05IVD DRUGINKE YMTRIUFFDHMDKK-TUNPWDSISA-N D05IVD DRUGSMIL C1=CC2=C3C(=C1)OC45C6C(O6)C(=O)C7=C(C=CC(=C74)OC3(O5)C=CC2=O)O D05IVD HIGHSTAT Investigative D05IWY DRUG__ID D05IWY D05IWY DRUGTYPE Small molecular drug D05IWY DRUGINCH 1S/C23H24O6/c1-11(2)5-7-13-15(24)9-18-20(22(13)27)23(28)19-14(8-6-12(3)4)21(26)16(25)10-17(19)29-18/h5-6,9-10,24-27H,7-8H2,1-4H3 D05IWY DRUGINKE VEZXFTKZUMARDU-UHFFFAOYSA-N D05IWY DRUGSMIL CC(=CCC1=C(C2=C(C=C1O)OC3=C(C2=O)C(=C(C(=C3)O)O)CC=C(C)C)O)C D05IWY HIGHSTAT Investigative D05IXU DRUG__ID D05IXU D05IXU DRUGTYPE Small molecular drug D05IXU DRUGINCH 1S/C22H17N/c1-2-7-17(8-3-1)13-21-14-18-9-4-5-10-19(18)15-22(21)20-11-6-12-23-16-20/h1-12,14-16H,13H2 D05IXU DRUGINKE RPMMFOVAHREENB-UHFFFAOYSA-N D05IXU DRUGSMIL C1=CC=C(C=C1)CC2=CC3=CC=CC=C3C=C2C4=CN=CC=C4 D05IXU HIGHSTAT Investigative D05JAH DRUG__ID D05JAH D05JAH DRUGTYPE Small molecular drug D05JAH DRUGINCH 1S/C16H15NO2/c18-16(19)10-5-11-17-14-8-3-1-6-12(14)13-7-2-4-9-15(13)17/h1-4,6-9H,5,10-11H2,(H,18,19) D05JAH DRUGINKE HQAKVYGASUTQHH-UHFFFAOYSA-N D05JAH DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCC(=O)O D05JAH HIGHSTAT Investigative D05JAJ DRUG__ID D05JAJ D05JAJ DRUGTYPE Small molecular drug D05JAJ DRUGINCH 1S/C14H11N3O3S/c15-21(18,19)13-9-16-8-6-11(13)20-12-5-1-3-10-4-2-7-17-14(10)12/h1-9H,(H2,15,18,19) D05JAJ DRUGINKE YEXUPIWQHCCQQA-UHFFFAOYSA-N D05JAJ DRUGSMIL C1=CC2=C(C(=C1)OC3=C(C=NC=C3)S(=O)(=O)N)N=CC=C2 D05JAJ HIGHSTAT Investigative D05JAZ DRUG__ID D05JAZ D05JAZ DRUGTYPE Small molecular drug D05JAZ DRUGINCH 1S/C8H7ClFNO2/c9-5-3-4(1-2-6(5)10)7(11)8(12)13/h1-3,7H,11H2,(H,12,13) D05JAZ DRUGINKE DVSWHHQDQJPPBH-UHFFFAOYSA-N D05JAZ DRUGSMIL C1=CC(=C(C=C1C(C(=O)O)N)Cl)F D05JAZ HIGHSTAT Investigative D05JBZ DRUG__ID D05JBZ D05JBZ DRUGTYPE Small molecular drug D05JBZ DRUGINCH 1S/C10H15NO2/c12-9-11(13)8-4-7-10-5-2-1-3-6-10/h1-3,5-6,12-13H,4,7-9H2 D05JBZ DRUGINKE GELOPWXSYZDPJT-UHFFFAOYSA-N D05JBZ DRUGSMIL C1=CC=C(C=C1)CCCN(CO)O D05JBZ HIGHSTAT Investigative D05JGX DRUG__ID D05JGX D05JGX DRUGTYPE Small molecular drug D05JGX DRUGINCH 1S/C21H17NO3/c23-20(16-6-8-18(9-7-16)21(24)25)17-10-12-19(13-11-17)22-14-15-4-2-1-3-5-15/h1-13,22H,14H2,(H,24,25) D05JGX DRUGINKE HTOJJEGICHZIJA-UHFFFAOYSA-N D05JGX DRUGSMIL C1=CC=C(C=C1)CNC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C(=O)O D05JGX HIGHSTAT Investigative D05JHA DRUG__ID D05JHA D05JHA DRUGTYPE Small molecular drug D05JHA DRUGINCH 1S/C26H31N7O8S2/c27-18(9-14-3-7-17(34)8-4-14)24(37)32-21-13-43-42-12-20(23(28)36)31-26(39)19(30-22(35)11-29-25(21)38)10-15-1-5-16(6-2-15)33(40)41/h1-8,18-21,34H,9-13,27H2,(H2,28,36)(H,29,38)(H,30,35)(H,31,39)(H,32,37)/t18-,19-,20-,21-/m0/s1 D05JHA DRUGINKE NBZQMFLIMSGMAF-TUFLPTIASA-N D05JHA DRUGSMIL C1C(C(=O)NCC(=O)NC(C(=O)NC(CSS1)C(=O)N)CC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)C(CC3=CC=C(C=C3)O)N D05JHA HIGHSTAT Investigative D05JIO DRUG__ID D05JIO D05JIO DRUGTYPE Small molecular drug D05JIO DRUGINCH 1S/C10H12FN3/c1-7(12)6-14-10-4-9(11)3-2-8(10)5-13-14/h2-5,7H,6,12H2,1H3/t7-/m0/s1 D05JIO DRUGINKE OARAVURQNSHWSP-ZETCQYMHSA-N D05JIO DRUGSMIL CC(CN1C2=C(C=CC(=C2)F)C=N1)N D05JIO HIGHSTAT Investigative D05JIS DRUG__ID D05JIS D05JIS DRUGTYPE Small molecular drug D05JIS DRUGINCH 1S/C40H50N8O6/c1-4-26(2)34-40(54)48-32(19-12-22-42-48)39(53)47-31(18-11-21-41-47)37(51)45(3)33(25-28-16-9-6-10-17-28)38(52)46-23-13-20-30(46)36(50)43-29(35(49)44-34)24-27-14-7-5-8-15-27/h5-10,14-17,21-22,26,29-34H,4,11-13,18-20,23-25H2,1-3H3,(H,43,50)(H,44,49)/t26-,29+,30-,31-,32+,33+,34-/m0/s1 D05JIS DRUGINKE IFHSSGUGRIXWQU-NSTWBPGMSA-N D05JIS DRUGSMIL CCC(C)C1C(=O)N2C(CCC=N2)C(=O)N3C(CCC=N3)C(=O)N(C(C(=O)N4CCCC4C(=O)NC(C(=O)N1)CC5=CC=CC=C5)CC6=CC=CC=C6)C D05JIS HIGHSTAT Investigative D05JJL DRUG__ID D05JJL D05JJL DRUGTYPE Small molecular drug D05JJL DRUGINCH 1S/C58H113N29O13/c1-30(78-45(92)35(16-8-24-73-54(63)64)85-52(99)40-21-13-29-87(40)53(100)41(61)31(2)88)44(91)79-36(17-9-25-74-55(65)66)48(95)82-38(19-11-27-76-57(69)70)50(97)83-37(18-10-26-75-56(67)68)49(96)81-33(14-4-6-22-59)46(93)80-34(15-5-7-23-60)47(94)84-39(20-12-28-77-58(71)72)51(98)86-42(32(3)89)43(62)90/h30-42,88-89H,4-29,59-61H2,1-3H3,(H2,62,90)(H,78,92)(H,79,91)(H,80,93)(H,81,96)(H,82,95)(H,83,97)(H,84,94)(H,85,99)(H,86,98)(H4,63,64,73)(H4,65,66,74)(H4,67,68,75)(H4,69,70,76)(H4,71,72,77)/t30-,31+,32+,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-/m0/s1 D05JJL DRUGINKE XIHRZTWKTVFWSV-HQSWAJDZSA-N D05JJL DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)N)N)O D05JJL HIGHSTAT Investigative D05JKC DRUG__ID D05JKC D05JKC DRUGTYPE Small molecular drug D05JKC DRUGINCH 1S/C13H8ClNO3/c14-9-5-12-10(6-11(9)17)15-13(18-12)7-1-3-8(16)4-2-7/h1-6,16-17H D05JKC DRUGINKE FXPRHFKNZLXHRN-UHFFFAOYSA-N D05JKC DRUGSMIL C1=CC(=CC=C1C2=NC3=CC(=C(C=C3O2)Cl)O)O D05JKC HIGHSTAT Investigative D05JKG DRUG__ID D05JKG D05JKG DRUGTYPE Small molecular drug D05JKG DRUGINCH 1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25) D05JKG DRUGINKE MXFWWQICDIZSOA-UHFFFAOYSA-N D05JKG DRUGSMIL CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O D05JKG HIGHSTAT Investigative D05JKQ DRUG__ID D05JKQ D05JKQ DRUGTYPE Small molecular drug D05JKQ DRUGINCH 1S/C29H40N6O7/c1-3-4-12-23(26(36)32-24(28(38)42-2)13-8-9-18-30)33-29(39)34-25(19-20-10-6-5-7-11-20)27(37)31-21-14-16-22(17-15-21)35(40)41/h5-7,10-11,14-17,23-25H,3-4,8-9,12-13,18-19,30H2,1-2H3,(H,31,37)(H,32,36)(H2,33,34,39)/t23-,24+,25+/m1/s1 D05JKQ DRUGINKE KEATTYUTWJKTRT-DSITVLBTSA-N D05JKQ DRUGSMIL CCCCC(C(=O)NC(CCCCN)C(=O)OC)NC(=O)NC(CC1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-] D05JKQ HIGHSTAT Investigative D05JMJ DRUG__ID D05JMJ D05JMJ DRUGTYPE Small molecular drug D05JMJ DRUGINCH 1S/C30H38N4/c1-3-5-12-18-30(19-13-6-4-2)28-24(23-16-10-11-17-25(23)32-28)20-26(34-30)29-31-21-27(33-29)22-14-8-7-9-15-22/h7-11,14-17,21,26,32,34H,3-6,12-13,18-20H2,1-2H3,(H,31,33)/t26-/m1/s1 D05JMJ DRUGINKE DGSMSHNIDMODOQ-AREMUKBSSA-N D05JMJ DRUGSMIL CCCCCC1(C2=C(CC(N1)C3=NC=C(N3)C4=CC=CC=C4)C5=CC=CC=C5N2)CCCCC D05JMJ HIGHSTAT Investigative D05JPG DRUG__ID D05JPG D05JPG DRUGTYPE Small molecular drug D05JPG DRUGINCH 1S/C19H21N/c1-20-12-11-16-14-17(13-15-7-3-2-4-8-15)19-10-6-5-9-18(16)19/h2-10,14,17,20H,11-13H2,1H3 D05JPG DRUGINKE UHYPQIJLHJTNMK-UHFFFAOYSA-N D05JPG DRUGSMIL CNCCC1=CC(C2=CC=CC=C21)CC3=CC=CC=C3 D05JPG HIGHSTAT Investigative D05JPV DRUG__ID D05JPV D05JPV DRUGTYPE Small molecular drug D05JPV DRUGINCH 1S/C20H26O3/c1-2-3-4-5-6-7-8-9-10-17-11-13-18(14-12-17)19(21)15-16-20(22)23/h11-14H,2-8,15-16H2,1H3,(H,22,23) D05JPV DRUGINKE JJPRJMIBECZYNN-UHFFFAOYSA-N D05JPV DRUGSMIL CCCCCCCCC#CC1=CC=C(C=C1)C(=O)CCC(=O)O D05JPV HIGHSTAT Investigative D05JPW DRUG__ID D05JPW D05JPW DRUGTYPE Small molecular drug D05JPW DRUGINCH 1S/C14H11NO4/c1-18-12-7-10(17)6-11-13(12)19-14(15-11)8-2-4-9(16)5-3-8/h2-7,16-17H,1H3 D05JPW DRUGINKE RJJQKEPGOIGNSZ-UHFFFAOYSA-N D05JPW DRUGSMIL COC1=CC(=CC2=C1OC(=N2)C3=CC=C(C=C3)O)O D05JPW HIGHSTAT Investigative D05JQD DRUG__ID D05JQD D05JQD DRUGCOMP Maruho Co Ltd D05JQD DRUGINCH 1S/C6H12O3/c1-3-9-6(8)4-5(2)7/h5,7H,3-4H2,1-2H3 D05JQD DRUGINKE OMSUIQOIVADKIM-UHFFFAOYSA-N D05JQD DRUGSMIL CCOC(=O)CC(C)O D05JQD HIGHSTAT Investigative D05JRZ DRUG__ID D05JRZ D05JRZ DRUGTYPE Small molecular drug D05JRZ DRUGINCH 1S/C13H11N3O5S/c14-22(20,21)10-4-1-8(2-5-10)15-16-9-3-6-12(17)11(7-9)13(18)19/h1-7,17H,(H,18,19)(H2,14,20,21) D05JRZ DRUGINKE NBSRUZQXRUNPNY-UHFFFAOYSA-N D05JRZ DRUGSMIL C1=CC(=CC=C1N=NC2=CC(=C(C=C2)O)C(=O)O)S(=O)(=O)N D05JRZ HIGHSTAT Investigative D05JSY DRUG__ID D05JSY D05JSY DRUGTYPE Small molecular drug D05JSY DRUGINCH 1S/C46H58N2O4/c49-43(51-35-15-13-33-25-41-37-11-1-3-19-45(37,39(33)27-35)21-23-47(41)29-31-7-5-8-31)17-18-44(50)52-36-16-14-34-26-42-38-12-2-4-20-46(38,40(34)28-36)22-24-48(42)30-32-9-6-10-32/h13-18,27-28,31-32,37-38,41-42H,1-12,19-26,29-30H2/b18-17+/t37-,38-,41+,42+,45+,46+/m0/s1 D05JSY DRUGINKE AJIAOWVCYKDFGH-KBJNHENKSA-N D05JSY DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)C=CC(=O)OC5=CC6=C(CC7C8C6(CCCC8)CCN7CC9CCC9)C=C5)CC1CCC1 D05JSY HIGHSTAT Investigative D05JXE DRUG__ID D05JXE D05JXE DRUGTYPE Small molecular drug D05JXE DRUGINCH 1S/C20H40O2/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20(21)22/h16-19H,6-15H2,1-5H3,(H,21,22) D05JXE DRUGINKE RLCKHJSFHOZMDR-UHFFFAOYSA-N D05JXE DRUGSMIL CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)O D05JXE HIGHSTAT Investigative D05JYE DRUG__ID D05JYE D05JYE DRUGTYPE Small molecular drug D05JYE DRUGINCH 1S/C4H11O3P/c1-2-3-4-8(5,6)7/h2-4H2,1H3,(H2,5,6,7) D05JYE DRUGINKE UOKRBSXOBUKDGE-UHFFFAOYSA-N D05JYE DRUGSMIL CCCCP(=O)(O)O D05JYE HIGHSTAT Investigative D05JZQ DRUG__ID D05JZQ D05JZQ DRUGTYPE Small molecular drug D05JZQ DRUGINCH 1S/C12H17NO/c14-12-6-2-1-5-11(12)7-10-13-8-3-4-9-13/h1-2,5-6,14H,3-4,7-10H2 D05JZQ DRUGINKE MCYUAYDQGCYEGH-UHFFFAOYSA-N D05JZQ DRUGSMIL C1CCN(C1)CCC2=CC=CC=C2O D05JZQ HIGHSTAT Investigative D05JZS DRUG__ID D05JZS D05JZS DRUGTYPE Small molecular drug D05JZS DRUGINCH 1S/C9H9NO4/c11-7-3-1-2-6(4-7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13) D05JZS DRUGINKE XDOFWFNMYJRHEW-UHFFFAOYSA-N D05JZS DRUGSMIL C1=CC(=CC(=C1)O)C(=O)NCC(=O)O D05JZS HIGHSTAT Investigative D05KCN DRUG__ID D05KCN D05KCN DRUGTYPE Small molecular drug D05KCN DRUGINCH 1S/C13H11N3O/c17-13-11-6-1-2-7-12(11)15-16(13)9-10-5-3-4-8-14-10/h1-8,15H,9H2 D05KCN DRUGINKE NZOJCPNWISMMAJ-UHFFFAOYSA-N D05KCN DRUGSMIL C1=CC=C2C(=C1)C(=O)N(N2)CC3=CC=CC=N3 D05KCN HIGHSTAT Investigative D05KEE DRUG__ID D05KEE D05KEE DRUGTYPE Small molecular drug D05KEE DRUGINCH 1S/C18H32NO5P/c1-3-4-5-6-7-14-23-17-10-8-16(9-11-17)12-13-18(2,19)15-24-25(20,21)22/h8-11H,3-7,12-15,19H2,1-2H3,(H2,20,21,22)/t18-/m1/s1 D05KEE DRUGINKE NMRLBSIYIBOLLJ-GOSISDBHSA-N D05KEE DRUGSMIL CCCCCCCOC1=CC=C(C=C1)CCC(C)(COP(=O)(O)O)N D05KEE HIGHSTAT Investigative D05KEF DRUG__ID D05KEF D05KEF DRUGTYPE Small molecular drug D05KEF DRUGINCH 1S/C22H21N3/c1-15(2)13-20-24-21-18(16-9-5-3-6-10-16)14-19(23-22(21)25-20)17-11-7-4-8-12-17/h3-12,14-15H,13H2,1-2H3,(H,23,24,25) D05KEF DRUGINKE PPFWSQNEFCXMGP-UHFFFAOYSA-N D05KEF DRUGSMIL CC(C)CC1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D05KEF HIGHSTAT Investigative D05KFG DRUG__ID D05KFG D05KFG DRUGTYPE Small molecular drug D05KFG DRUGINCH 1S/C6H10O4/c7-5(8)3-1-2-4-6(9)10/h1-4H2,(H,7,8)(H,9,10)/p-2 D05KFG DRUGINKE WNLRTRBMVRJNCN-UHFFFAOYSA-L D05KFG DRUGSMIL C(CCC(=O)[O-])CC(=O)[O-] D05KFG HIGHSTAT Investigative D05KHS DRUG__ID D05KHS D05KHS DRUGTYPE Small molecular drug D05KHS DRUGINCH 1S/C6H5O3S.ClH.Hg/c7-10(8,9)6-4-2-1-3-5-6;;/h2-5H,(H,7,8,9);1H;/q;;+1/p-1 D05KHS DRUGINKE XXEBDPRHFAWOND-UHFFFAOYSA-M D05KHS DRUGSMIL C1=CC(=CC=C1S(=O)(=O)O)[Hg]Cl D05KHS HIGHSTAT Investigative D05KIF DRUG__ID D05KIF D05KIF DRUGTYPE Small molecular drug D05KIF DRUGINCH 1S/C24H30O8/c1-26-18-9-14(10-19(27-2)22(18)30-5)7-16-13-32-24(25)17(16)8-15-11-20(28-3)23(31-6)21(12-15)29-4/h9-12,16-17H,7-8,13H2,1-6H3/t16-,17+/m0/s1 D05KIF DRUGINKE VUNCHONBJWJYID-DLBZAZTESA-N D05KIF DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2COC(=O)C2CC3=CC(=C(C(=C3)OC)OC)OC D05KIF HIGHSTAT Investigative D05KIQ DRUG__ID D05KIQ D05KIQ DRUGTYPE Small molecular drug D05KIQ DRUGINCH 1S/C30H34N4O4/c1-19-13-24(35)14-20(2)25(19)16-26(31)30(38)34-18-22-10-8-7-9-21(22)15-27(34)29(37)32-17-28(36)33(3)23-11-5-4-6-12-23/h4-14,26-27,35H,15-18,31H2,1-3H3,(H,32,37)/t26-,27-/m0/s1 D05KIQ DRUGINKE CADRNJIFUDEZBB-SVBPBHIXSA-N D05KIQ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)N(C)C4=CC=CC=C4)N)C)O D05KIQ HIGHSTAT Investigative D05KJH DRUG__ID D05KJH D05KJH DRUGTYPE Small molecular drug D05KJH DRUGINCH 1S/C17H19NO3/c1-21-17-9-12-6-7-18-15(14(12)10-16(17)20)8-11-2-4-13(19)5-3-11/h2-5,9-10,15,18-20H,6-8H2,1H3/t15-/m0/s1 D05KJH DRUGINKE LVVKXRQZSRUVPY-HNNXBMFYSA-N D05KJH DRUGSMIL COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)O D05KJH HIGHSTAT Investigative D05KJX DRUG__ID D05KJX D05KJX DRUGTYPE Small molecular drug D05KJX DRUGINCH 1S/C14H16N6O3/c1-21-6-4-7(22-2)9(8(5-6)23-3)12-17-10-11(15)18-14(16)20-13(10)19-12/h4-5H,1-3H3,(H5,15,16,17,18,19,20) D05KJX DRUGINKE DGDMBWNOPVGWKG-UHFFFAOYSA-N D05KJX DRUGSMIL COC1=CC(=C(C(=C1)OC)C2=NC3=NC(=NC(=C3N2)N)N)OC D05KJX HIGHSTAT Investigative D05KJY DRUG__ID D05KJY D05KJY DRUGTYPE Small molecular drug D05KJY DRUGINCH 1S/C30H50O2/c1-19(2)20-10-15-30(18-31)17-16-28(6)21(25(20)30)8-9-23-27(5)13-12-24(32)26(3,4)22(27)11-14-29(23,28)7/h20-25,31-32H,1,8-18H2,2-7H3/t20-,21+,22-,23+,24-,25+,27-,28+,29+,30+/m0/s1 D05KJY DRUGINKE FVWJYYTZTCVBKE-ROUWMTJPSA-N D05KJY DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO D05KJY HIGHSTAT Investigative D05KKB DRUG__ID D05KKB D05KKB DRUGTYPE Small molecular drug D05KKB DRUGINCH 1S/C14H13NO5S/c1-19-12-7-5-10(6-8-12)14(16)11-3-2-4-13(9-11)20-21(15,17)18/h2-9H,1H3,(H2,15,17,18) D05KKB DRUGINKE ARBLJGHHCKHHLN-UHFFFAOYSA-N D05KKB DRUGSMIL COC1=CC=C(C=C1)C(=O)C2=CC(=CC=C2)OS(=O)(=O)N D05KKB HIGHSTAT Investigative D05KLE DRUG__ID D05KLE D05KLE DRUGTYPE Small molecular drug D05KLE DRUGINCH 1S/C19H18ClF4N3O3S/c1-11-10-26(16-4-3-13(21)9-14(16)19(22,23)24)6-7-27(11)31(29,30)17-5-2-12(18(25)28)8-15(17)20/h2-5,8-9,11H,6-7,10H2,1H3,(H2,25,28)/t11-/m1/s1 D05KLE DRUGINKE OMWNFYWEMXUREB-LLVKDONJSA-N D05KLE DRUGSMIL CC1CN(CCN1S(=O)(=O)C2=C(C=C(C=C2)C(=O)N)Cl)C3=C(C=C(C=C3)F)C(F)(F)F D05KLE HIGHSTAT Investigative D05KPH DRUG__ID D05KPH D05KPH DRUGTYPE Small molecular drug D05KPH DRUGINCH 1S/C121H168N26O33S4/c1-11-62(7)97(117(175)139-89(121(179)180)49-70-53-126-77-25-17-16-24-75(70)77)145-118(176)98(63(8)12-2)144-112(170)88(52-95(157)158)136-105(163)81(44-60(3)4)131-109(167)86(50-71-54-125-59-127-71)134-113(171)90-56-182-181-55-76(124)101(159)146-99(64(9)148)120(178)142-91-57-183-184-58-92(115(173)143-96(61(5)6)116(174)137-84(48-69-32-38-74(152)39-33-69)107(165)132-82(108(166)141-90)46-67-28-34-72(150)35-29-67)140-104(162)80(40-41-93(153)154)130-102(160)78(26-18-20-42-122)129-110(168)87(51-94(155)156)135-103(161)79(27-19-21-43-123)128-106(164)83(47-68-30-36-73(151)37-31-68)138-119(177)100(65(10)149)147-111(169)85(133-114(91)172)45-66-22-14-13-15-23-66/h13-17,22-25,28-39,53-54,59-65,76,78-92,96-100,126,148-152H,11-12,18-21,26-27,40-52,55-58,122-124H2,1-10H3,(H,125,127)(H,128,164)(H,129,168)(H,130,160)(H,131,167)(H,132,165)(H,133,172)(H,134,171)(H,135,161)(H,136,163)(H,137,174)(H,138,177)(H,139,175)(H,140,162)(H,141,166)(H,142,178)(H,143,173)(H,144,170)(H,145,176)(H,146,159)(H,147,169)(H,153,154)(H,155,156)(H,157,158)(H,179,180)/t62-,63-,64?,65?,76-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,96-,97-,98-,99-,100-/m0/s1 D05KPH DRUGINKE OQGZWNZGVYLIFX-XKIQDWPYSA-N D05KPH DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC6=CC=C(C=C6)O)CC7=CC=C(C=C7)O)C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CC8=CC=CC=C8)C(C)O)CC9=CC=C(C=C9)O)CCCCN)CC(=O)O)CCCCN)CCC(=O)O)C(C)O)N D05KPH HIGHSTAT Investigative D05KQC DRUG__ID D05KQC D05KQC DRUGTYPE Small molecular drug D05KQC DRUGINCH 1S/C8H4N4O6/c13-7-8(14)10-4-2-6(12(17)18)5(11(15)16)1-3(4)9-7/h1-2H,(H,9,13)(H,10,14) D05KQC DRUGINKE RWVIMCIPOAXUDG-UHFFFAOYSA-N D05KQC DRUGSMIL C1=C2C(=CC(=C1[N+](=O)[O-])[N+](=O)[O-])NC(=O)C(=O)N2 D05KQC HIGHSTAT Investigative D05KQF DRUG__ID D05KQF D05KQF DRUGTYPE Small molecular drug D05KQF DRUGINCH 1S/C14H22N2O16P2/c17-5-3-28-13(11(22)8(5)19)31-34(26,27)32-33(24,25)29-4-6-9(20)10(21)12(30-6)16-2-1-7(18)15-14(16)23/h1-2,5-6,8-13,17,19-22H,3-4H2,(H,24,25)(H,26,27)(H,15,18,23)/t5-,6-,8+,9-,10-,11-,12-,13-/m1/s1 D05KQF DRUGINKE DQQDLYVHOTZLOR-OCIMBMBZSA-N D05KQF DRUGSMIL C1C(C(C(C(O1)OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)O)O)O D05KQF HIGHSTAT Investigative D05KSC DRUG__ID D05KSC D05KSC DRUGTYPE Small molecular drug D05KSC DRUGINCH 1S/C18H16N4OS/c1-11-4-6-12(7-5-11)22-10-20-16-15-13(21(2)3)8-19-9-14(15)24-17(16)18(22)23/h4-10H,1-3H3 D05KSC DRUGINKE LPWKFUVWWQYLOD-UHFFFAOYSA-N D05KSC DRUGSMIL CC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=C3C(=CN=C4)N(C)C D05KSC HIGHSTAT Investigative D05KSW DRUG__ID D05KSW D05KSW DRUGTYPE Small molecular drug D05KSW DRUGINCH 1S/C17H15N3O/c21-17(18-11-10-13-6-2-1-3-7-13)16-12-19-14-8-4-5-9-15(14)20-16/h1-9,12H,10-11H2,(H,18,21) D05KSW DRUGINKE VCRCXANKNYQHIW-UHFFFAOYSA-N D05KSW DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C2=NC3=CC=CC=C3N=C2 D05KSW HIGHSTAT Investigative D05KTE DRUG__ID D05KTE D05KTE DRUGTYPE Small molecular drug D05KTE DRUGINCH 1S/C6H8O7.3Na/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3 D05KTE DRUGINKE HRXKRNGNAMMEHJ-UHFFFAOYSA-K D05KTE DRUGSMIL C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Na+].[Na+].[Na+] D05KTE HIGHSTAT Investigative D05KUM DRUG__ID D05KUM D05KUM DRUGTYPE Small molecular drug D05KUM DRUGINCH 1S/C16H18N4S/c1-11-10-12-15(20-8-6-17-7-9-20)18-13-4-2-3-5-14(13)19-16(12)21-11/h2-5,10,17,19H,6-9H2,1H3 D05KUM DRUGINKE FHPIXVHJEIZKJW-UHFFFAOYSA-N D05KUM DRUGSMIL CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCNCC4 D05KUM HIGHSTAT Investigative D05KVN DRUG__ID D05KVN D05KVN DRUGTYPE Small molecular drug D05KVN DRUGINCH 1S/C19H23N3O2/c23-18-16-9-5-6-10-17(16)19(24)22(18)13-8-4-2-1-3-7-12-21-14-11-20-15-21/h5-6,9-11,14-15H,1-4,7-8,12-13H2 D05KVN DRUGINKE UYNFUMGZMJRXFD-UHFFFAOYSA-N D05KVN DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CCCCCCCCN3C=CN=C3 D05KVN HIGHSTAT Investigative D05KWF DRUG__ID D05KWF D05KWF DRUGTYPE Small molecular drug D05KWF DRUGINCH 1S/C23H24O6/c1-10(2)6-7-12-19(25)14(24)8-13-20(26)17-15(29-22(12)13)9-16-18(21(17)27)23(4,5)11(3)28-16/h6,8-9,11,24-25,27H,7H2,1-5H3 D05KWF DRUGINKE ZYJVDWWKUSJAQY-UHFFFAOYSA-N D05KWF DRUGSMIL CC1C(C2=C(O1)C=C3C(=C2O)C(=O)C4=CC(=C(C(=C4O3)CC=C(C)C)O)O)(C)C D05KWF HIGHSTAT Investigative D05KWN DRUG__ID D05KWN D05KWN DRUGTYPE Small molecular drug D05KWN DRUGINCH 1S/C37H47N5O6S/c1-22-16-26(39-15-14-38)17-23(2)33(22)48-20-30(44)40-28(18-24-10-6-5-7-11-24)32(45)36(47)42-21-49-37(3,4)34(42)35(46)41-31-27-13-9-8-12-25(27)19-29(31)43/h5-13,16-17,28-29,31-32,34,39,43,45H,14-15,18-21,38H2,1-4H3,(H,40,44)(H,41,46)/t28-,29+,31-,32-,34+/m0/s1 D05KWN DRUGINKE KGNXIOMLRKTRJD-ZYOXRPPDSA-N D05KWN DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NCCN D05KWN HIGHSTAT Investigative D05KXP DRUG__ID D05KXP D05KXP DRUGTYPE Small molecular drug D05KXP DRUGINCH 1S/C26H34O5/c1-2-3-4-5-6-7-8-9-10-11-20-21(28)16-22(29)25-23(30)17-24(31-26(20)25)18-12-14-19(27)15-13-18/h12-16,24,27-29H,2-11,17H2,1H3/t24-/m0/s1 D05KXP DRUGINKE MQGTUCCMXKRAMD-DEOSSOPVSA-N D05KXP DRUGSMIL CCCCCCCCCCCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D05KXP HIGHSTAT Investigative D05KYE DRUG__ID D05KYE D05KYE DRUGTYPE Small molecular drug D05KYE DRUGINCH 1S/C22H24O4/c1-4-6-15-11-22(9-5-2)13(3)18(19(20(15)23)21(22)24)14-7-8-16-17(10-14)26-12-25-16/h4-5,7-8,10-11,13,18-19,21,24H,1-2,6,9,12H2,3H3/t13-,18+,19?,21+,22+/m1/s1 D05KYE DRUGINKE IELYWLBCFOCUNW-KUXMWZRESA-N D05KYE DRUGSMIL CC1C(C2C(C1(C=C(C2=O)CC=C)CC=C)O)C3=CC4=C(C=C3)OCO4 D05KYE HIGHSTAT Investigative D05KZH DRUG__ID D05KZH D05KZH DRUGTYPE Small molecular drug D05KZH DRUGINCH 1S/C8H19BrN.BrH/c1-10(2,3)8-6-4-5-7-9;/h4-8H2,1-3H3;1H/q+1;/p-1 D05KZH DRUGINKE GEIHNRASRNQTDE-UHFFFAOYSA-M D05KZH DRUGSMIL C[N+](C)(C)CCCCCBr.[Br-] D05KZH HIGHSTAT Investigative D05LBC DRUG__ID D05LBC D05LBC DRUGTYPE Small molecular drug D05LBC DRUGINCH 1S/C16H12N6O5/c23-21(24)9-1-3-11-13(5-9)19-15(17-11)7-27-8-16-18-12-4-2-10(22(25)26)6-14(12)20-16/h1-6H,7-8H2,(H,17,19)(H,18,20) D05LBC DRUGINKE ZQPXNYLXYNRFNP-UHFFFAOYSA-N D05LBC DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])NC(=N2)COCC3=NC4=C(N3)C=C(C=C4)[N+](=O)[O-] D05LBC HIGHSTAT Investigative D05LDI DRUG__ID D05LDI D05LDI DRUGTYPE Small molecular drug D05LDI DRUGINCH 1S/C30H48O3/c1-18-10-13-30(25(32)33)15-14-28(6)21(24(30)19(18)2)8-9-23-27(5)17-20(31)16-26(3,4)22(27)11-12-29(23,28)7/h8,18-20,22-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19-,20+,22-,23+,24-,27-,28+,29+,30-/m0/s1 D05LDI DRUGINKE DDHYEJNMSYDDTH-JJKIWFBPSA-N D05LDI DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)O)C)C)C2C1C)C)C(=O)O D05LDI HIGHSTAT Investigative D05LFV DRUG__ID D05LFV D05LFV DRUGTYPE Small molecular drug D05LFV DRUGINCH 1S/C9H12N2S.ClH/c1-7-2-4-8(5-3-7)6-12-9(10)11;/h2-5H,6H2,1H3,(H3,10,11);1H D05LFV DRUGINKE WTAFMQGTBRUAGV-UHFFFAOYSA-N D05LFV DRUGSMIL CC1=CC=C(C=C1)CSC(=N)N.Cl D05LFV HIGHSTAT Investigative D05LJC DRUG__ID D05LJC D05LJC DRUGTYPE Small molecular drug D05LJC DRUGINCH 1S/C18H20FNO/c19-17-8-4-7-16(15-9-11-20-12-10-15)18(17)21-13-14-5-2-1-3-6-14/h1-8,15,20H,9-13H2 D05LJC DRUGINKE ONPYWJJNTLFDAR-UHFFFAOYSA-N D05LJC DRUGSMIL C1CNCCC1C2=C(C(=CC=C2)F)OCC3=CC=CC=C3 D05LJC HIGHSTAT Investigative D05LJD DRUG__ID D05LJD D05LJD DRUGTYPE Small molecular drug D05LJD DRUGINCH 1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h9-10,12-14,16H,2-8,11,15,17-18H2,1H3,(H,22,23)/b10-9-,13-12-,16-14- D05LJD DRUGINKE ULMVEQWNDGUUBR-IEQFDQMRSA-N D05LJD DRUGSMIL CCCCCCCCC=CCC=CC=CC(=O)CCCC(=O)O D05LJD HIGHSTAT Investigative D05LJF DRUG__ID D05LJF D05LJF DRUGTYPE Small molecular drug D05LJF DRUGINCH 1S/C23H23BrN2O/c24-21-9-5-17(6-10-21)16-26-13-11-22(12-14-26)25-23(27)20-8-7-18-3-1-2-4-19(18)15-20/h1-10,15,22H,11-14,16H2,(H,25,27) D05LJF DRUGINKE WZCSZVSNRKEGGN-UHFFFAOYSA-N D05LJF DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)Br D05LJF HIGHSTAT Investigative D05LKO DRUG__ID D05LKO D05LKO DRUGTYPE Small molecular drug D05LKO DRUGINCH 1S/C19H24N2O/c1-22-19-10-6-5-9-17(19)15-18(16-7-3-2-4-8-16)21-13-11-20-12-14-21/h2-10,18,20H,11-15H2,1H3 D05LKO DRUGINKE PFTJCYRHNKTTTO-UHFFFAOYSA-N D05LKO DRUGSMIL COC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D05LKO HIGHSTAT Investigative D05LLI DRUG__ID D05LLI D05LLI DRUGTYPE Small molecular drug D05LLI DRUGINCH 1S/C46H60N12O8/c1-2-3-12-33-41(62)56-35(17-19-38(47)59)43(64)57-36(23-26-15-16-27-9-4-5-10-28(27)22-26)44(65)55-34(14-8-21-51-46(49)50)42(63)58-37(24-29-25-52-31-13-7-6-11-30(29)31)45(66)54-32(40(48)61)18-20-39(60)53-33/h4-7,9-11,13,15-16,22,25,32-37,52H,2-3,8,12,14,17-21,23-24H2,1H3,(H2,47,59)(H2,48,61)(H,53,60)(H,54,66)(H,55,65)(H,56,62)(H,57,64)(H,58,63)(H4,49,50,51)/t32-,33-,34-,35-,36+,37-/m0/s1 D05LLI DRUGINKE TUOOEJAUOYDGGA-BWBQVKFQSA-N D05LLI DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CCC(=O)N D05LLI HIGHSTAT Investigative D05LLJ DRUG__ID D05LLJ D05LLJ DRUGCOMP Merck & Co Inc D05LLJ DRUGINCH 1S/C15H25NO/c1-14(2,3)10-7-12(15(4,5)6)11(9-16)13(17)8-10/h7-8,17H,9,16H2,1-6H3 D05LLJ DRUGINKE ZUSLEOOZAITYGH-UHFFFAOYSA-N D05LLJ DRUGSMIL CC(C)(C)C1=CC(=C(C(=C1)O)CN)C(C)(C)C D05LLJ HIGHSTAT Investigative D05LLP DRUG__ID D05LLP D05LLP DRUGTYPE Small molecular drug D05LLP DRUGINCH 1S/C11H17NOS/c1-3-14-11-6-4-10(5-7-11)8-9(2)12-13/h4-7,9,12-13H,3,8H2,1-2H3 D05LLP DRUGINKE JDIRZPZVUPWDQO-UHFFFAOYSA-N D05LLP DRUGSMIL CCSC1=CC=C(C=C1)CC(C)NO D05LLP HIGHSTAT Investigative D05LLV DRUG__ID D05LLV D05LLV DRUGTYPE Small molecular drug D05LLV DRUGINCH 1S/C20H30O3/c1-2-19(21)17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20(22)23/h4-7,10-13,15,17,19,21H,2-3,8-9,14,16,18H2,1H3,(H,22,23)/b6-4-,7-5-,12-10-,13-11-,17-15+/t19-/m0/s1 D05LLV DRUGINKE LRWYBGFSVUBWMO-OKIFYYRFSA-N D05LLV DRUGSMIL CCC(C=CC=CCC=CCC=CCC=CCCCC(=O)O)O D05LLV HIGHSTAT Investigative D05LLX DRUG__ID D05LLX D05LLX DRUGTYPE Small molecular drug D05LLX DRUGINCH 1S/C11H14N2O3/c1-2-3-10(14)12-9-6-4-8(5-7-9)11(15)13-16/h4-7,16H,2-3H2,1H3,(H,12,14)(H,13,15) D05LLX DRUGINKE WASGGDMUCRMECJ-UHFFFAOYSA-N D05LLX DRUGSMIL CCCC(=O)NC1=CC=C(C=C1)C(=O)NO D05LLX HIGHSTAT Investigative D05LMB DRUG__ID D05LMB D05LMB DRUGTYPE Small molecular drug D05LMB DRUGINCH 1S/C8H11O4PS/c1-12-7-5-3-2-4-6(7)8(14)13(9,10)11/h2-5,8,14H,1H3,(H2,9,10,11) D05LMB DRUGINKE QXHIPTMANGQMPP-UHFFFAOYSA-N D05LMB DRUGSMIL COC1=CC=CC=C1C(P(=O)(O)O)S D05LMB HIGHSTAT Investigative D05LOY DRUG__ID D05LOY D05LOY DRUGTYPE Small molecular drug D05LOY DRUGINCH 1S/C21H25FN4O3S/c1-21(2,23)10-6-7-25(9-10)16-13(22)8-12-15(18(16)29-3)26(11-4-5-11)20-14(17(12)27)19(28)24-30-20/h8,10-11H,4-7,9,23H2,1-3H3,(H,24,28)/t10-/m1/s1 D05LOY DRUGINKE CECJUHKZSOSOJJ-SNVBAGLBSA-N D05LOY DRUGSMIL CC(C)(C1CCN(C1)C2=C(C=C3C(=C2OC)N(C4=C(C3=O)C(=O)NS4)C5CC5)F)N D05LOY HIGHSTAT Investigative D05LPK DRUG__ID D05LPK D05LPK DRUGTYPE Small molecular drug D05LPK DRUGINCH 1S/C4H8N2O/c1-3-2-6-4(5)7-3/h3H,2H2,1H3,(H2,5,6) D05LPK DRUGINKE ZHFKVNRMZIOKGZ-UHFFFAOYSA-N D05LPK DRUGSMIL CC1CN=C(O1)N D05LPK HIGHSTAT Investigative D05LQD DRUG__ID D05LQD D05LQD DRUGTYPE Small molecular drug D05LQD DRUGINCH 1S/C15H12O3/c1-8-4-3-5-11-13(8)10-6-7-12(16)9(2)14(10)18-15(11)17/h3-7,16H,1-2H3 D05LQD DRUGINKE PSZUCXJKMVSZSN-UHFFFAOYSA-N D05LQD DRUGSMIL CC1=C2C3=C(C(=C(C=C3)O)C)OC(=O)C2=CC=C1 D05LQD HIGHSTAT Investigative D05LRV DRUG__ID D05LRV D05LRV DRUGTYPE Small molecular drug D05LRV DRUGINCH 1S/C14H8O2S3/c15-6-9-5-14(17-8-9)13-4-3-12(19-13)11-2-1-10(7-16)18-11/h1-8H D05LRV DRUGINKE PYABIFKTOKMEQD-UHFFFAOYSA-N D05LRV DRUGSMIL C1=C(SC(=C1)C2=CC=C(S2)C3=CC(=CS3)C=O)C=O D05LRV HIGHSTAT Investigative D05LSF DRUG__ID D05LSF D05LSF DRUGTYPE Small molecular drug D05LSF DRUGINCH 1S/C20H32O3/c1-2-3-16-19(21)17-14-12-10-8-6-4-5-7-9-11-13-15-18-20(22)23/h4-5,8-11,14,17,19,21H,2-3,6-7,12-13,15-16,18H2,1H3,(H,22,23)/b5-4-,10-8-,11-9-,17-14- D05LSF DRUGINKE JEKNPVYFNMZRJG-UFINWASNSA-N D05LSF DRUGSMIL CCCCC(C=CCC=CCC=CCC=CCCCC(=O)O)O D05LSF HIGHSTAT Investigative D05LTW DRUG__ID D05LTW D05LTW DRUGTYPE Small molecular drug D05LTW DRUGINCH 1S/C14H6F4O2/c15-9-5-1-3-7(11(9)17)13(19)14(20)8-4-2-6-10(16)12(8)18/h1-6H D05LTW DRUGINKE LJRGNWLITYAYFC-UHFFFAOYSA-N D05LTW DRUGSMIL C1=CC(=C(C(=C1)F)F)C(=O)C(=O)C2=C(C(=CC=C2)F)F D05LTW HIGHSTAT Investigative D05LWE DRUG__ID D05LWE D05LWE DRUGTYPE Small molecular drug D05LWE DRUGINCH 1S/C23H29IO5/c24-16-7-10-18(11-8-16)28-15-17(25)9-12-20-19(21-13-14-22(20)29-21)5-3-1-2-4-6-23(26)27/h1,3,7-12,17,19-22,25H,2,4-6,13-15H2,(H,26,27)/b3-1+,12-9+/t17-,19-,20-,21+,22-/m1/s1/i24-2 D05LWE DRUGINKE UYFMSCHBODMWON-ZKBYQGIHSA-N D05LWE DRUGSMIL C1CC2C(C(C1O2)CC=CCCCC(=O)O)C=CC(COC3=CC=C(C=C3)I)O D05LWE HIGHSTAT Investigative D05LWK DRUG__ID D05LWK D05LWK DRUGTYPE Small molecular drug D05LWK DRUGINCH 1S/C30H18O4/c31-25-17-30(33-27-9-5-4-8-23(25)27)21-12-10-19(11-13-21)22-14-15-28-24(16-22)26(32)18-29(34-28)20-6-2-1-3-7-20/h1-18H D05LWK DRUGINKE YQQFWTHRAHFRMC-UHFFFAOYSA-N D05LWK DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=C(C=C4)C5=CC(=O)C6=CC=CC=C6O5 D05LWK HIGHSTAT Investigative D05LXA DRUG__ID D05LXA D05LXA DRUGTYPE Small molecular drug D05LXA DRUGINCH 1S/C19H20N2/c1-15(2)19(21-13-12-20-14-21)18-10-8-17(9-11-18)16-6-4-3-5-7-16/h3-15,19H,1-2H3 D05LXA DRUGINKE IYAQGZVBLONFOB-UHFFFAOYSA-N D05LXA DRUGSMIL CC(C)C(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D05LXA HIGHSTAT Investigative D05LXG DRUG__ID D05LXG D05LXG DRUGTYPE Small molecular drug D05LXG DRUGINCH 1S/C20H34N4O4/c25-19(27-23-17-11-5-3-6-12-17)21-15-9-1-2-10-16-22-20(26)28-24-18-13-7-4-8-14-18/h1-16H2,(H,21,25)(H,22,26) D05LXG DRUGINKE RXSVYGIGWRDVQC-UHFFFAOYSA-N D05LXG DRUGSMIL C1CCC(=NOC(=O)NCCCCCCNC(=O)ON=C2CCCCC2)CC1 D05LXG HIGHSTAT Investigative D05LXP DRUG__ID D05LXP D05LXP DRUGTYPE Small molecular drug D05LXP DRUGINCH 1S/C18H12N2/c1-3-7-14-11(5-1)12-9-10-16-17(18(12)20-14)13-6-2-4-8-15(13)19-16/h1-10,19-20H D05LXP DRUGINKE QQWXDAWSMPLECU-UHFFFAOYSA-N D05LXP DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C4=C(C=C3)NC5=CC=CC=C54 D05LXP HIGHSTAT Investigative D05LYC DRUG__ID D05LYC D05LYC DRUGTYPE Small molecular drug D05LYC DRUGINCH 1S/C14H15N7O/c15-7-11-1-2-13(19-9-11)18-6-5-17-10-14(22)21-12(8-16)3-4-20-21/h1-2,4,9,12,17H,3,5-6,10H2,(H,18,19) D05LYC DRUGINKE XNYVGGJJENHRBZ-UHFFFAOYSA-N D05LYC DRUGSMIL C1C=NN(C1C#N)C(=O)CNCCNC2=NC=C(C=C2)C#N D05LYC HIGHSTAT Investigative D05MAT DRUG__ID D05MAT D05MAT DRUGTYPE Small molecular drug D05MAT DRUGINCH 1S/C14H24N2O2/c17-3-1-2-15-13(18)16-14-7-10-4-11(8-14)6-12(5-10)9-14/h10-12,17H,1-9H2,(H2,15,16,18) D05MAT DRUGINKE QADGUCFKHPQVSD-UHFFFAOYSA-N D05MAT DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCCO D05MAT HIGHSTAT Investigative D05MBJ DRUG__ID D05MBJ D05MBJ DRUGTYPE Small molecular drug D05MBJ DRUGINCH 1S/C18H21NO3/c1-14(20)16-13-22-18(19-16)17(21)12-8-3-2-5-9-15-10-6-4-7-11-15/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D05MBJ DRUGINKE YLVGVXYZOJMUNJ-UHFFFAOYSA-N D05MBJ DRUGSMIL CC(=O)C1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2 D05MBJ HIGHSTAT Investigative D05MCK DRUG__ID D05MCK D05MCK DRUGTYPE Small molecular drug D05MCK DRUGINCH 1S/C14H9ClN2O/c15-13-7-6-10-12(18)8-11(16-14(10)17-13)9-4-2-1-3-5-9/h1-8H,(H,16,17,18) D05MCK DRUGINKE JSCUNIPKMPNPFX-UHFFFAOYSA-N D05MCK DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(N2)N=C(C=C3)Cl D05MCK HIGHSTAT Investigative D05MDB DRUG__ID D05MDB D05MDB DRUGTYPE Small molecular drug D05MDB DRUGINCH 1S/C22H21NO/c1-23(2)21(24)22(18-12-6-3-7-13-18,19-14-8-4-9-15-19)20-16-10-5-11-17-20/h3-17H,1-2H3 D05MDB DRUGINKE JGBIXOAQARJTNI-UHFFFAOYSA-N D05MDB DRUGSMIL CN(C)C(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3 D05MDB HIGHSTAT Investigative D05MDE DRUG__ID D05MDE D05MDE DRUGTYPE Small molecular drug D05MDE DRUGINCH 1S/C30H46N4O7S/c1-7-21(4)26(33-30(38)41-19-23-12-9-8-10-13-23)29(37)34-16-11-14-25(34)28(36)31-22(5)27(35)32-24(18-20(2)3)15-17-42(6,39)40/h8-10,12-13,15,17,20-22,24-26H,7,11,14,16,18-19H2,1-6H3,(H,31,36)(H,32,35)(H,33,38)/b17-15+/t21-,22-,24+,25-,26-/m0/s1 D05MDE DRUGINKE QUUKVNWZLKQWBG-DHJGLREUSA-N D05MDE DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC2=CC=CC=C2 D05MDE HIGHSTAT Investigative D05MDY DRUG__ID D05MDY D05MDY DRUGTYPE Small molecular drug D05MDY DRUGINCH 1S/C10H17NO2/c1-8-9(12)7-10(13-8)3-5-11(2)6-4-10/h8H,3-7H2,1-2H3 D05MDY DRUGINKE OODDNJQTVFMGCF-UHFFFAOYSA-N D05MDY DRUGSMIL CC1C(=O)CC2(O1)CCN(CC2)C D05MDY HIGHSTAT Investigative D05MEW DRUG__ID D05MEW D05MEW DRUGTYPE Small molecular drug D05MEW DRUGINCH 1S/C21H26N2O3/c1-25-19-12-17(13-20(14-19)26-2)21(24)22-18-8-10-23(11-9-18)15-16-6-4-3-5-7-16/h3-7,12-14,18H,8-11,15H2,1-2H3,(H,22,24) D05MEW DRUGINKE CBCISEXIJPDIBB-UHFFFAOYSA-N D05MEW DRUGSMIL COC1=CC(=CC(=C1)C(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC D05MEW HIGHSTAT Investigative D05MHL DRUG__ID D05MHL D05MHL DRUGTYPE Small molecular drug D05MHL DRUGINCH 1S/C21H15N3O2/c25-13-7-5-12(6-8-13)18-16-11-23-20-19(16)15(9-10-22-20)14-3-1-2-4-17(14)24-21(18)26/h1-11,18,25H,(H,22,23)(H,24,26) D05MHL DRUGINKE LGIBDQRYOFBMTC-UHFFFAOYSA-N D05MHL DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=CNC4=NC=C3)C(C(=O)N2)C5=CC=C(C=C5)O D05MHL HIGHSTAT Investigative D05MIV DRUG__ID D05MIV D05MIV DRUGTYPE Small molecular drug D05MIV DRUGINCH 1S/C17H17N3O/c1-3-15-16(12-8-10-18-11-9-12)20-17(19-15)13-4-6-14(21-2)7-5-13/h4-11H,3H2,1-2H3,(H,19,20) D05MIV DRUGINKE MYKGURNPAUBQLJ-UHFFFAOYSA-N D05MIV DRUGSMIL CCC1=C(N=C(N1)C2=CC=C(C=C2)OC)C3=CC=NC=C3 D05MIV HIGHSTAT Investigative D05MJO DRUG__ID D05MJO D05MJO DRUGTYPE Small molecular drug D05MJO DRUGINCH 1S/C14H16N4O2/c1-10-9-17(7-6-15-10)14-5-2-11-8-12(18(19)20)3-4-13(11)16-14/h2-5,8,10,15H,6-7,9H2,1H3 D05MJO DRUGINKE WIRIBEHWECMIRC-UHFFFAOYSA-N D05MJO DRUGSMIL CC1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)[N+](=O)[O-] D05MJO HIGHSTAT Investigative D05MJU DRUG__ID D05MJU D05MJU DRUGTYPE Small molecular drug D05MJU DRUGINCH 1S/C9H7IN2S/c10-6-2-1-3-7-5(6)4-8(13-7)9(11)12/h1-4H,(H3,11,12)/p+1 D05MJU DRUGINKE YERQOXAYAFWFEJ-UHFFFAOYSA-O D05MJU DRUGSMIL C1=CC2=C(C=C(S2)C(=[NH2+])N)C(=C1)I D05MJU HIGHSTAT Investigative D05MLT DRUG__ID D05MLT D05MLT DRUGTYPE Small molecular drug D05MLT DRUGINCH 1S/C18H23NO2/c1-2-3-4-5-6-14-7-12-18(17(20)13-14)21-16-10-8-15(19)9-11-16/h7-13,20H,2-6,19H2,1H3 D05MLT DRUGINKE ZURCHSRLJXKILX-UHFFFAOYSA-N D05MLT DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=C(C=C2)N)O D05MLT HIGHSTAT Investigative D05MPS DRUG__ID D05MPS D05MPS DRUGTYPE Small molecular drug D05MPS DRUGINCH 1S/C24H28N6O2/c1-16(2)30-15-27-21-22(25-13-17-5-9-19(31-3)10-6-17)28-24(29-23(21)30)26-14-18-7-11-20(32-4)12-8-18/h5-12,15-16H,13-14H2,1-4H3,(H2,25,26,28,29) D05MPS DRUGINKE IDCOTQWQVPRTNK-UHFFFAOYSA-N D05MPS DRUGSMIL CC(C)N1C=NC2=C(N=C(N=C21)NCC3=CC=C(C=C3)OC)NCC4=CC=C(C=C4)OC D05MPS HIGHSTAT Investigative D05MQE DRUG__ID D05MQE D05MQE DRUGTYPE Small molecular drug D05MQE DRUGINCH 1S/C15H12ClN/c16-15-5-1-4-13-12(6-7-14(13)15)9-11-3-2-8-17-10-11/h1-5,8-10H,6-7H2/b12-9- D05MQE DRUGINKE OAISOHCDZRMGCP-XFXZXTDPSA-N D05MQE DRUGSMIL C1CC2=C(C1=CC3=CN=CC=C3)C=CC=C2Cl D05MQE HIGHSTAT Investigative D05MQU DRUG__ID D05MQU D05MQU DRUGTYPE Small molecular drug D05MQU DRUGINCH 1S/C14H11F3N2O3S/c15-14(16,17)23(21,22)12-7-3-10(4-8-12)9-1-5-11(6-2-9)19-13(18)20/h1-8H,(H3,18,19,20) D05MQU DRUGINKE ISQOEHFLTNIEGX-UHFFFAOYSA-N D05MQU DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)S(=O)(=O)C(F)(F)F)NC(=O)N D05MQU HIGHSTAT Investigative D05MSG DRUG__ID D05MSG D05MSG DRUGTYPE Small molecular drug D05MSG DRUGINCH 1S/C35H45FN8O3/c1-23-18-24(19-26-21-37-40-31(23)26)20-30(33(45)42-14-8-27(9-15-42)41-12-3-2-4-13-41)38-34(46)43-16-10-28(11-17-43)44-22-25-6-5-7-29(36)32(25)39-35(44)47/h5-7,18-19,21,27-28,30H,2-4,8-17,20,22H2,1H3,(H,37,40)(H,38,46)(H,39,47)/t30-/m1/s1 D05MSG DRUGINKE HBOINTMVWRSZQS-SSEXGKCCSA-N D05MSG DRUGSMIL CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCC(CC3)N4CCCCC4)NC(=O)N5CCC(CC5)N6CC7=C(C(=CC=C7)F)NC6=O D05MSG HIGHSTAT Investigative D05MTA DRUG__ID D05MTA D05MTA DRUGTYPE Small molecular drug D05MTA DRUGINCH 1S/C22H38N2O2/c1-2-3-4-9-26-20-7-5-19(6-8-20)23-21(25)24-22-13-16-10-17(14-22)12-18(11-16)15-22/h16-20H,2-15H2,1H3,(H2,23,24,25) D05MTA DRUGINKE VIWCJPKZDQYQRJ-UHFFFAOYSA-N D05MTA DRUGSMIL CCCCCOC1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D05MTA HIGHSTAT Investigative D05MTY DRUG__ID D05MTY D05MTY DRUGTYPE Small molecular drug D05MTY DRUGINCH 1S/C26H20N2O6/c29-16-2-6-25(31)27-19-8-12-21(13-9-19)33-23-4-1-5-24(18-23)34-22-14-10-20(11-15-22)28-26(32)7-3-17-30/h1-18H,(H,27,31)(H,28,32)/b6-2-,7-3- D05MTY DRUGINKE BFNFDDZOFCRJTI-PORYWJCVSA-N D05MTY DRUGSMIL C1=CC(=CC(=C1)OC2=CC=C(C=C2)NC(=O)C=CC=O)OC3=CC=C(C=C3)NC(=O)C=CC=O D05MTY HIGHSTAT Investigative D05MUN DRUG__ID D05MUN D05MUN DRUGTYPE Small molecular drug D05MUN DRUGINCH 1S/C15H17F5O/c16-14(17,15(18,19)20)13(21)11-7-2-1-4-8-12-9-5-3-6-10-12/h3,5-6,9-10H,1-2,4,7-8,11H2 D05MUN DRUGINKE DTHPBVZMSGVQFQ-UHFFFAOYSA-N D05MUN DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C(C(F)(F)F)(F)F D05MUN HIGHSTAT Investigative D05MXI DRUG__ID D05MXI D05MXI DRUGTYPE Small molecular drug D05MXI DRUGINCH 1S/C29H24F3NO2/c30-29(31,32)25-8-5-19(6-9-25)22-7-10-26-23(15-22)16-24(28(34)35)17-27(26)21-3-1-18(2-4-21)20-11-13-33-14-12-20/h1-10,15-17,20,33H,11-14H2,(H,34,35) D05MXI DRUGINKE FOECKIWHCOYYFL-UHFFFAOYSA-N D05MXI DRUGSMIL C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F D05MXI HIGHSTAT Investigative D05MXM DRUG__ID D05MXM D05MXM DRUGTYPE Small molecular drug D05MXM DRUGINCH 1S/C14H20O3/c1-2-3-4-5-6-10-17-13-9-7-8-12(11-13)14(15)16/h7-9,11H,2-6,10H2,1H3,(H,15,16) D05MXM DRUGINKE FOFZVIUYGPBWLV-UHFFFAOYSA-N D05MXM DRUGSMIL CCCCCCCOC1=CC=CC(=C1)C(=O)O D05MXM HIGHSTAT Investigative D05MXO DRUG__ID D05MXO D05MXO DRUGTYPE Small molecular drug D05MXO DRUGINCH 1S/C20H32O6/c1-14(21)7-6-8-15(22)11-12-17-16(18(23)13-19(17)24)9-4-2-3-5-10-20(25)26/h2,4,11-12,14-17,19,21-22,24H,3,5-10,13H2,1H3,(H,25,26)/b4-2-,12-11+/t14-,15+,16-,17-,19-/m1/s1 D05MXO DRUGINKE WTJYDBMHYPQFNJ-ZUVVJKHESA-N D05MXO DRUGSMIL CC(CCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O)O D05MXO HIGHSTAT Investigative D05MYH DRUG__ID D05MYH D05MYH DRUGTYPE Small molecular drug D05MYH DRUGINCH 1S/C30H34FN5O3S/c1-2-36-28(26-8-4-5-9-27(26)33-30(36)35-18-6-3-7-19-35)20-29(37)32-21-22-10-14-24(15-11-22)34-40(38,39)25-16-12-23(31)13-17-25/h4-5,8-17,28,34H,2-3,6-7,18-21H2,1H3,(H,32,37) D05MYH DRUGINKE PEIFDCMYVCGNKX-UHFFFAOYSA-N D05MYH DRUGSMIL CCN1C(C2=CC=CC=C2N=C1N3CCCCC3)CC(=O)NCC4=CC=C(C=C4)NS(=O)(=O)C5=CC=C(C=C5)F D05MYH HIGHSTAT Investigative D05NAR DRUG__ID D05NAR D05NAR DRUGTYPE Small molecular drug D05NAR DRUGINCH 1S/C10H11NO4S/c1-2-7-15-10(12)8-3-5-9(6-4-8)16(11,13)14/h2-6H,1,7H2,(H2,11,13,14) D05NAR DRUGINKE VWKMDRWBZTWKNM-UHFFFAOYSA-N D05NAR DRUGSMIL C=CCOC(=O)C1=CC=C(C=C1)S(=O)(=O)N D05NAR HIGHSTAT Investigative D05NBK DRUG__ID D05NBK D05NBK DRUGTYPE Small molecular drug D05NBK DRUGINCH 1S/C16H23NO3/c17-9-15-11-6-7-13(18)16(19)12(11)8-14(20-15)10-4-2-1-3-5-10/h6-7,10,14-15,18-19H,1-5,8-9,17H2/t14-,15-/m0/s1 D05NBK DRUGINKE BOKASTZDGGZFET-GJZGRUSLSA-N D05NBK DRUGSMIL C1CCC(CC1)C2CC3=C(C=CC(=C3O)O)C(O2)CN D05NBK HIGHSTAT Investigative D05NBU DRUG__ID D05NBU D05NBU DRUGTYPE Small molecular drug D05NBU DRUGINCH 1S/C11H10ClN3S/c12-9-6-10(13)15-11(14-9)16-7-8-4-2-1-3-5-8/h1-6H,7H2,(H2,13,14,15) D05NBU DRUGINKE LGTXUPUULSWTNA-UHFFFAOYSA-N D05NBU DRUGSMIL C1=CC=C(C=C1)CSC2=NC(=CC(=N2)Cl)N D05NBU HIGHSTAT Investigative D05NEC DRUG__ID D05NEC D05NEC DRUGTYPE Small molecular drug D05NEC DRUGINCH 1S/C26H24N6/c1-30-12-14-31(15-13-30)21-8-6-19(7-9-21)20-16-28-26-24(17-29-32(26)18-20)22-10-11-27-25-5-3-2-4-23(22)25/h2-11,16-18H,12-15H2,1H3 D05NEC DRUGINKE XBGWAKUQSRNWMA-UHFFFAOYSA-N D05NEC DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3 D05NEC HIGHSTAT Investigative D05NED DRUG__ID D05NED D05NED DRUGTYPE Small molecular drug D05NED DRUGINCH 1S/C21H31N5Se/c1-2-10-25(19-8-9-20-21(17-19)27-23-22-20)14-11-24-12-15-26(16-13-24)18-6-4-3-5-7-18/h3-7,19H,2,8-17H2,1H3 D05NED DRUGINKE PFIKDGAKWFWZIM-UHFFFAOYSA-N D05NED DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)[Se]N=N4 D05NED HIGHSTAT Investigative D05NEG DRUG__ID D05NEG D05NEG DRUGTYPE Small molecular drug D05NEG DRUGINCH 1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-23-21-22(24)25/h6-7,9-10,12-13,15-16,23H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15- D05NEG DRUGINKE SYVLWSBAKCQOBP-DOFZRALJSA-N D05NEG DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCNCC(=O)O D05NEG HIGHSTAT Investigative D05NEM DRUG__ID D05NEM D05NEM DRUGTYPE Small molecular drug D05NEM DRUGINCH 1S/C20H15N5O/c26-20(22-15-8-2-1-3-9-15)25-19-16-10-4-5-11-17(16)23-18(24-19)14-7-6-12-21-13-14/h1-13H,(H2,22,23,24,25,26) D05NEM DRUGINKE GDOLLVJHBJTNPM-UHFFFAOYSA-N D05NEM DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=NC(=NC3=CC=CC=C32)C4=CN=CC=C4 D05NEM HIGHSTAT Investigative D05NET DRUG__ID D05NET D05NET DRUGTYPE Small molecular drug D05NET DRUGINCH 1S/C23H29N3/c1-2-6-21(7-3-1)22-11-9-20(10-12-22)13-15-25-16-18-26(19-17-25)23-8-4-5-14-24-23/h1-8,11,14,20H,9-10,12-13,15-19H2/t20-/m0/s1 D05NET DRUGINKE MQHGACGPMGUHSJ-FQEVSTJZSA-N D05NET DRUGSMIL C1CC(=CCC1CCN2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=C4 D05NET HIGHSTAT Investigative D05NFU DRUG__ID D05NFU D05NFU DRUGTYPE Small molecular drug D05NFU DRUGINCH 1S/C10H15BO2/c1-2-3-4-9-5-7-10(8-6-9)11(12)13/h5-8,12-13H,2-4H2,1H3 D05NFU DRUGINKE UGZUUTHZEATQAM-UHFFFAOYSA-N D05NFU DRUGSMIL B(C1=CC=C(C=C1)CCCC)(O)O D05NFU HIGHSTAT Investigative D05NIE DRUG__ID D05NIE D05NIE DRUGTYPE Small molecular drug D05NIE DRUGINCH 1S/C19H24N2O/c20-14-17-8-4-5-9-18(17)19(22)10-12-21(13-11-19)15-16-6-2-1-3-7-16/h1-9,22H,10-15,20H2 D05NIE DRUGINKE RPBRGKBDJGSAFB-UHFFFAOYSA-N D05NIE DRUGSMIL C1CN(CCC1(C2=CC=CC=C2CN)O)CC3=CC=CC=C3 D05NIE HIGHSTAT Investigative D05NKG DRUG__ID D05NKG D05NKG DRUGTYPE Small molecular drug D05NKG DRUGINCH 1S/C19H14N4O3/c20-7-1-2-11-3-5-17-15(8-11)19-14(10-18(24)21-17)13-9-12(23(25)26)4-6-16(13)22-19/h3-6,8-9,22H,1-2,10H2,(H,21,24) D05NKG DRUGINKE UBLFSMURWWWWMH-UHFFFAOYSA-N D05NKG DRUGSMIL C1C2=C(C3=C(C=CC(=C3)CCC#N)NC1=O)NC4=C2C=C(C=C4)[N+](=O)[O-] D05NKG HIGHSTAT Investigative D05NKX DRUG__ID D05NKX D05NKX DRUGTYPE Small molecular drug D05NKX DRUGINCH 1S/C55H78N14O11/c1-32(2)28-44(68(3)53(79)37(56)29-35-18-20-36(70)21-19-35)52(78)67-42(31-34-14-8-5-9-15-34)50(76)65-40(23-25-46(58)72)54(80)69-27-11-17-43(69)51(77)64-39(22-24-45(57)71)49(75)63-38(16-10-26-62-55(60)61)48(74)66-41(47(59)73)30-33-12-6-4-7-13-33/h4-9,12-15,18-21,32,37-44,70H,10-11,16-17,22-31,56H2,1-3H3,(H2,57,71)(H2,58,72)(H2,59,73)(H,63,75)(H,64,77)(H,65,76)(H,66,74)(H,67,78)(H4,60,61,62)/t37-,38-,39-,40-,41-,42-,43-,44-/m0/s1 D05NKX DRUGINKE UQGBICZACVFETI-YTAGXALCSA-N D05NKX DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCC(=O)N)C(=O)N2CCCC2C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N)N(C)C(=O)C(CC4=CC=C(C=C4)O)N D05NKX HIGHSTAT Investigative D05NSB DRUG__ID D05NSB D05NSB DRUGTYPE Small molecular drug D05NSB DRUGINCH 1S/C16H25NO/c18-16(17-4-2-1-3-5-17)15-13-7-11-6-12(9-13)10-14(15)8-11/h11-15H,1-10H2 D05NSB DRUGINKE AHSGKCRVZWMWDM-UHFFFAOYSA-N D05NSB DRUGSMIL C1CCN(CC1)C(=O)C2C3CC4CC(C3)CC2C4 D05NSB HIGHSTAT Investigative D05NSP DRUG__ID D05NSP D05NSP DRUGTYPE Small molecular drug D05NSP DRUGINCH 1S/C24H29F3N4O3/c1-16-12-17(2)15-30(14-16)11-3-10-28-21-9-4-18(13-22(21)31(33)34)23(32)29-20-7-5-19(6-8-20)24(25,26)27/h4-9,13,16-17,28H,3,10-12,14-15H2,1-2H3,(H,29,32) D05NSP DRUGINKE VWDZICDNGXUIKB-UHFFFAOYSA-N D05NSP DRUGSMIL CC1CC(CN(C1)CCCNC2=C(C=C(C=C2)C(=O)NC3=CC=C(C=C3)C(F)(F)F)[N+](=O)[O-])C D05NSP HIGHSTAT Investigative D05NTO DRUG__ID D05NTO D05NTO DRUGTYPE Small molecular drug D05NTO DRUGINCH 1S/C17H26INO3/c1-3-4-5-6-7-8-9-17(21)19-12-13-10-16(22-2)15(20)11-14(13)18/h10-11,20H,3-9,12H2,1-2H3,(H,19,21) D05NTO DRUGINKE AAORACFZMYMFCG-UHFFFAOYSA-N D05NTO DRUGSMIL CCCCCCCCC(=O)NCC1=CC(=C(C=C1I)O)OC D05NTO HIGHSTAT Investigative D05NTV DRUG__ID D05NTV D05NTV DRUGTYPE Small molecular drug D05NTV DRUGINCH 1S/C8H11N5O2/c9-4(5(14)15)7-1-8(2-7,3-7)6-10-12-13-11-6/h4H,1-3,9H2,(H,14,15)(H,10,11,12,13)/t4-,7?,8?/m1/s1 D05NTV DRUGINKE XYCORZCGVTXZFU-XOJFDHPMSA-N D05NTV DRUGSMIL C1C2(CC1(C2)C(C(=O)O)N)C3=NNN=N3 D05NTV HIGHSTAT Investigative D05NUC DRUG__ID D05NUC D05NUC DRUGTYPE Small molecular drug D05NUC DRUGINCH 1S/C33H42Cl2N8O4/c1-19(2)15-26(40-33(36)37)32(46)38-17-29(45)43-13-11-22(12-14-43)27-16-25(41-42(27)4)24-9-10-28(31(35)30(24)34)47-18-21-5-7-23(8-6-21)39-20(3)44/h5-10,16,19,22,26H,11-15,17-18H2,1-4H3,(H,38,46)(H,39,44)(H4,36,37,40)/t26-/m1/s1 D05NUC DRUGINKE VCXMTWSYQSVWRK-AREMUKBSSA-N D05NUC DRUGSMIL CC(C)CC(C(=O)NCC(=O)N1CCC(CC1)C2=CC(=NN2C)C3=C(C(=C(C=C3)OCC4=CC=C(C=C4)NC(=O)C)Cl)Cl)N=C(N)N D05NUC HIGHSTAT Investigative D05NWF DRUG__ID D05NWF D05NWF DRUGTYPE Small molecular drug D05NWF DRUGINCH 1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D05NWF DRUGINKE XTWYTFMLZFPYCI-KQYNXXCUSA-N D05NWF DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N D05NWF HIGHSTAT Investigative D05NWH DRUG__ID D05NWH D05NWH DRUGTYPE Small molecular drug D05NWH DRUGINCH 1S/C22H17F4N3O2/c1-31-20-9-13-4-6-29(19(13)11-18(20)22(24,25)26)21(30)28-17-8-15(7-16(23)10-17)14-3-2-5-27-12-14/h2-3,5,7-12H,4,6H2,1H3,(H,28,30) D05NWH DRUGINKE RRJLJKRFFRZRAF-UHFFFAOYSA-N D05NWH DRUGSMIL COC1=C(C=C2C(=C1)CCN2C(=O)NC3=CC(=CC(=C3)C4=CN=CC=C4)F)C(F)(F)F D05NWH HIGHSTAT Investigative D05NWM DRUG__ID D05NWM D05NWM DRUGTYPE Small molecular drug D05NWM DRUGINCH 1S/C19H18ClN3O4/c1-25-19(24)23(26-2)17-6-4-3-5-14(17)13-27-18-11-12-22(21-18)16-9-7-15(20)8-10-16/h3-12H,13H2,1-2H3 D05NWM DRUGINKE HZRSNVGNWUDEFX-UHFFFAOYSA-N D05NWM DRUGSMIL COC(=O)N(C1=CC=CC=C1COC2=NN(C=C2)C3=CC=C(C=C3)Cl)OC D05NWM HIGHSTAT Investigative D05NWQ DRUG__ID D05NWQ D05NWQ DRUGTYPE Small molecular drug D05NWQ DRUGINCH 1S/C13H7Cl3N2O3/c14-8-2-4-9(15)11(6-8)17-13(19)7-1-3-10(16)12(5-7)18(20)21/h1-6H,(H,17,19) D05NWQ DRUGINKE FYQHDHBGADAFGF-UHFFFAOYSA-N D05NWQ DRUGSMIL C1=CC(=C(C=C1C(=O)NC2=C(C=CC(=C2)Cl)Cl)[N+](=O)[O-])Cl D05NWQ HIGHSTAT Investigative D05NXQ DRUG__ID D05NXQ D05NXQ DRUGTYPE Small molecular drug D05NXQ DRUGINCH 1S/C18H21NO2/c1-2-7-17(8-3-1)21-18-11-9-16(10-12-18)20-14-15-6-4-5-13-19-15/h1-3,7-12,15,19H,4-6,13-14H2/t15-/m0/s1 D05NXQ DRUGINKE CSJNBXMUZIPBKQ-HNNXBMFYSA-N D05NXQ DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)OC3=CC=CC=C3 D05NXQ HIGHSTAT Investigative D05NXX DRUG__ID D05NXX D05NXX DRUGTYPE Small molecular drug D05NXX DRUGINCH 1S/C17H11N3O6S/c21-14-8-13(10-27-17-18-6-1-7-19-17)25-9-15(14)26-16(22)11-2-4-12(5-3-11)20(23)24/h1-9H,10H2 D05NXX DRUGINKE UASIRTUMPRQVFY-UHFFFAOYSA-N D05NXX DRUGSMIL C1=CN=C(N=C1)SCC2=CC(=O)C(=CO2)OC(=O)C3=CC=C(C=C3)[N+](=O)[O-] D05NXX HIGHSTAT Investigative D05NYR DRUG__ID D05NYR D05NYR DRUGTYPE Small molecular drug D05NYR DRUGINCH 1S/C40H50N4O6/c1-24-18-31(45)19-25(2)32(24)22-33(41)39(48)44-23-30-17-11-10-16-29(30)21-35(44)37(46)43-36(26(3)28-14-8-5-9-15-28)38(47)42-34(40(49)50)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,45H,5,8-9,14-15,20-23,41H2,1-3H3,(H,42,47)(H,43,46)(H,49,50)/t26-,33+,34+,35?,36-/m1/s1 D05NYR DRUGINKE GWHRSTGESQKJIQ-RUXLTPPNSA-N D05NYR DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)N)C)O D05NYR HIGHSTAT Investigative D05NZH DRUG__ID D05NZH D05NZH DRUGTYPE Small molecular drug D05NZH DRUGINCH 1S/C12H22N2O3/c1-17-11(15)8-5-9-13-12(16)14-10-6-3-2-4-7-10/h10H,2-9H2,1H3,(H2,13,14,16) D05NZH DRUGINKE QDXXGVVKSQMYHV-UHFFFAOYSA-N D05NZH DRUGSMIL COC(=O)CCCNC(=O)NC1CCCCC1 D05NZH HIGHSTAT Investigative D05NZI DRUG__ID D05NZI D05NZI DRUGTYPE Small molecular drug D05NZI DRUGINCH 1S/C23H28ClN3O2/c1-29-22-13-21(25)20(24)12-19(22)23(28)26-16-10-17-8-5-9-18(11-16)27(17)14-15-6-3-2-4-7-15/h2-4,6-7,12-13,16-18H,5,8-11,14,25H2,1H3,(H,26,28) D05NZI DRUGINKE BUPWFKLTAPZHIE-UHFFFAOYSA-N D05NZI DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CC3CCCC(C2)N3CC4=CC=CC=C4)Cl)N D05NZI HIGHSTAT Investigative D05OAE DRUG__ID D05OAE D05OAE DRUGTYPE Small molecular drug D05OAE DRUGINCH 1S/C25H36O5/c1-18(8-5-9-19(2)16-22-23(26)20(3)24(27)30-22)10-6-13-25(4,28)14-7-11-21-12-15-29-17-21/h10,12,15-17,19,26,28H,5-9,11,13-14H2,1-4H3/b18-10+,22-16-/t19-,25?/m0/s1 D05OAE DRUGINKE QFBUNOKEKXMSCV-UYYPKTQPSA-N D05OAE DRUGSMIL CC1=C(C(=CC(C)CCCC(=CCCC(C)(CCCC2=COC=C2)O)C)OC1=O)O D05OAE HIGHSTAT Investigative D05ODA DRUG__ID D05ODA D05ODA DRUGTYPE Small molecular drug D05ODA DRUGINCH 1S/C47H67N11O8/c1-6-28(3)27-53-43(63)36(14-11-23-52-47(49)50)56-45(65)38(26-40(60)61)57-46(66)41(29(4)7-2)58-44(64)37(15-10-22-51-30(5)48)55-39(59)24-31-16-20-35(21-17-31)54-42(62)34-19-18-32-12-8-9-13-33(32)25-34/h8-9,12-13,16-21,25,28-29,36-38,41H,6-7,10-11,14-15,22-24,26-27H2,1-5H3,(H2,48,51)(H,53,63)(H,54,62)(H,55,59)(H,56,65)(H,57,66)(H,58,64)(H,60,61)(H4,49,50,52)/t28-,29-,36-,37-,38-,41-/m0/s1 D05ODA DRUGINKE SSSOLDGLOKWDSV-VLDRZRDYSA-N D05ODA DRUGSMIL CCC(C)CNC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(CCCN=C(C)N)NC(=O)CC1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C=C2 D05ODA HIGHSTAT Investigative D05ODW DRUG__ID D05ODW D05ODW DRUGTYPE Small molecular drug D05ODW DRUGINCH 1S/C16H12O5/c17-8-1-2-9-12(3-8)18-6-11-10-4-14-15(20-7-19-14)5-13(10)21-16(9)11/h1-5,11,16-17H,6-7H2/t11-,16-/m0/s1 D05ODW DRUGINKE HUKSJTUUSUGIDC-ZBEGNZNMSA-N D05ODW DRUGSMIL C1C2C(C3=C(O1)C=C(C=C3)O)OC4=CC5=C(C=C24)OCO5 D05ODW HIGHSTAT Investigative D05OEV DRUG__ID D05OEV D05OEV DRUGTYPE Small molecular drug D05OEV DRUGINCH 1S/C12H12ClN7O/c13-8-10(15)19-9(14)7(18-8)11(21)20-12(16)17-6-4-2-1-3-5-6/h1-5H,(H4,14,15,19)(H3,16,17,20,21) D05OEV DRUGINKE NIOHELZQFBGCEO-UHFFFAOYSA-N D05OEV DRUGSMIL C1=CC=C(C=C1)N=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N D05OEV HIGHSTAT Investigative D05OFR DRUG__ID D05OFR D05OFR DRUGTYPE Small molecular drug D05OFR DRUGINCH 1S/C12H12N2OS/c1-9-8-13-12(16-9)14-11(15)7-10-5-3-2-4-6-10/h2-6,8H,7H2,1H3,(H,13,14,15) D05OFR DRUGINKE BZGKXQSOFFPEDI-UHFFFAOYSA-N D05OFR DRUGSMIL CC1=CN=C(S1)NC(=O)CC2=CC=CC=C2 D05OFR HIGHSTAT Investigative D05OHF DRUG__ID D05OHF D05OHF DRUGTYPE Small molecular drug D05OHF DRUGINCH 1S/C17H19NO3/c1-21-17-9-12-6-7-18-15(14(12)10-16(17)20)8-11-2-4-13(19)5-3-11/h2-5,9-10,15,18-20H,6-8H2,1H3/t15-/m1/s1 D05OHF DRUGINKE LVVKXRQZSRUVPY-OAHLLOKOSA-N D05OHF DRUGSMIL COC1=C(C=C2C(NCCC2=C1)CC3=CC=C(C=C3)O)O D05OHF HIGHSTAT Investigative D05OHM DRUG__ID D05OHM D05OHM DRUGTYPE Small molecular drug D05OHM DRUGINCH 1S/C42H46N2O8/c1-3-5-25-43(27-29-17-21-33(22-18-29)51-31-13-9-7-10-14-31)39(45)35-36(38(42(49)50)37(35)41(47)48)40(46)44(26-6-4-2)28-30-19-23-34(24-20-30)52-32-15-11-8-12-16-32/h7-24,35-38H,3-6,25-28H2,1-2H3,(H,47,48)(H,49,50)/t35-,36-,37-,38-/m0/s1 D05OHM DRUGINKE GNPHAOQLHRZODS-ZQWQDMLBSA-N D05OHM DRUGSMIL CCCCN(CC1=CC=C(C=C1)OC2=CC=CC=C2)C(=O)C3C(C(C3C(=O)O)C(=O)O)C(=O)N(CCCC)CC4=CC=C(C=C4)OC5=CC=CC=C5 D05OHM HIGHSTAT Investigative D05OHN DRUG__ID D05OHN D05OHN DRUGTYPE Small molecular drug D05OHN DRUGINCH 1S/C14H21NO2/c1-12(2)15-8-9-16-14(10-15)11-17-13-6-4-3-5-7-13/h3-7,12,14H,8-11H2,1-2H3 D05OHN DRUGINKE WCHHCBBPGSWTOB-UHFFFAOYSA-N D05OHN DRUGSMIL CC(C)N1CCOC(C1)COC2=CC=CC=C2 D05OHN HIGHSTAT Investigative D05OIF DRUG__ID D05OIF D05OIF DRUGTYPE Small molecular drug D05OIF DRUGINCH 1S/C7H13N3/c1-2-10-5-7(3-4-8)9-6-10/h5-6H,2-4,8H2,1H3 D05OIF DRUGINKE LIXGKSRWGHVUHT-UHFFFAOYSA-N D05OIF DRUGSMIL CCN1C=C(N=C1)CCN D05OIF HIGHSTAT Investigative D05OJY DRUG__ID D05OJY D05OJY DRUGTYPE Small molecular drug D05OJY DRUGINCH 1S/C27H32N2O8/c1-18-11-13-20-7-4-9-23(31)26(20)27(34)37-21(17-25(33)36-19(2)12-14-22(18)30)8-5-15-28-24(32)10-6-16-29-35-3/h4-7,9-12,14-16,19,21-22,30-31H,8,13,17H2,1-3H3,(H,28,32)/b10-6-,14-12+,15-5+,18-11-,29-16- D05OJY DRUGINKE JYHIHHYYXXKTTJ-JSFHDESQSA-N D05OJY DRUGSMIL CC1C=CC(C(=CCC2=C(C(=CC=C2)O)C(=O)OC(CC(=O)O1)CC=CNC(=O)C=CC=NOC)C)O D05OJY HIGHSTAT Investigative D05OLW DRUG__ID D05OLW D05OLW DRUGTYPE Small molecular drug D05OLW DRUGINCH 1S/C13H16N2O/c1-8(2)6-12-10-5-3-4-9(10)11(7-14)13(16)15-12/h8H,3-6H2,1-2H3,(H,15,16) D05OLW DRUGINKE QOUMCRXJXXVERM-UHFFFAOYSA-N D05OLW DRUGSMIL CC(C)CC1=C2CCCC2=C(C(=O)N1)C#N D05OLW HIGHSTAT Investigative D05OML DRUG__ID D05OML D05OML DRUGTYPE Small molecular drug D05OML DRUGINCH 1S/C8H6N2O2S/c11-6-3-1-2-5(4-6)7-9-10-8(13)12-7/h1-4,11H,(H,10,13) D05OML DRUGINKE CNOGHDSTUCQSOV-UHFFFAOYSA-N D05OML DRUGSMIL C1=CC(=CC(=C1)O)C2=NNC(=S)O2 D05OML HIGHSTAT Investigative D05OMR DRUG__ID D05OMR D05OMR DRUGTYPE Small molecular drug D05OMR DRUGINCH 1S/C14H11NO2/c1-17-14(16)9-6-7-11-10-4-2-3-5-12(10)15-13(11)8-9/h2-8,15H,1H3 D05OMR DRUGINKE WDNZNDZRMLZWNC-UHFFFAOYSA-N D05OMR DRUGSMIL COC(=O)C1=CC2=C(C=C1)C3=CC=CC=C3N2 D05OMR HIGHSTAT Investigative D05ONZ DRUG__ID D05ONZ D05ONZ DRUGTYPE Small molecular drug D05ONZ DRUGINCH 1S/C7H10FNO6P2/c8-7(16(10,11)12,17(13,14)15)4-6-2-1-3-9-5-6/h1-3,5H,4H2,(H2,10,11,12)(H2,13,14,15) D05ONZ DRUGINKE HHDUHWLBPDOLIL-UHFFFAOYSA-N D05ONZ DRUGSMIL C1=CC(=CN=C1)CC(F)(P(=O)(O)O)P(=O)(O)O D05ONZ HIGHSTAT Investigative D05OOA DRUG__ID D05OOA D05OOA DRUGTYPE Small molecular drug D05OOA DRUGINCH 1S/C17H21NO3/c1-3-5-6-9-21-17(20)14-11-18-15-8-7-12(4-2)10-13(15)16(14)19/h7-8,10-11H,3-6,9H2,1-2H3,(H,18,19) D05OOA DRUGINKE DEHHQRSKBIBSBX-UHFFFAOYSA-N D05OOA DRUGSMIL CCCCCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC D05OOA HIGHSTAT Investigative D05OPF DRUG__ID D05OPF D05OPF DRUGTYPE Small molecular drug D05OPF DRUGINCH 1S/C15H11N3O4S/c19-18(20)12-6-8-13(9-7-12)23(21,22)17-14-5-1-3-11-4-2-10-16-15(11)14/h1-10,17H D05OPF DRUGINKE HXWOKTOKXJLLRZ-UHFFFAOYSA-N D05OPF DRUGSMIL C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(C=C3)[N+](=O)[O-])N=CC=C2 D05OPF HIGHSTAT Investigative D05OPY DRUG__ID D05OPY D05OPY DRUGTYPE Small molecular drug D05OPY DRUGINCH 1S/C17H17N3/c1-2-7-14(8-3-1)9-6-12-18-17-15-10-4-5-11-16(15)19-13-20-17/h1-5,7-8,10-11,13H,6,9,12H2,(H,18,19,20) D05OPY DRUGINKE OAPMCZLOWYUSSD-UHFFFAOYSA-N D05OPY DRUGSMIL C1=CC=C(C=C1)CCCNC2=NC=NC3=CC=CC=C32 D05OPY HIGHSTAT Investigative D05OQF DRUG__ID D05OQF D05OQF DRUGTYPE Small molecular drug D05OQF DRUGINCH 1S/C13H8Cl2N2O3/c14-8-5-9(15)7-10(6-8)16-13(18)11-3-1-2-4-12(11)17(19)20/h1-7H,(H,16,18) D05OQF DRUGINKE RHMRIXDZQJDDKE-UHFFFAOYSA-N D05OQF DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)[N+](=O)[O-] D05OQF HIGHSTAT Investigative D05OTR DRUG__ID D05OTR D05OTR DRUGTYPE Small molecular drug D05OTR DRUGINCH 1S/C17H20N2O2/c1-13(17(18)20)19-11-14-7-9-16(10-8-14)21-12-15-5-3-2-4-6-15/h2-10,13,19H,11-12H2,1H3,(H2,18,20)/t13-/m0/s1 D05OTR DRUGINKE IEHDKRBHKAGVKZ-ZDUSSCGKSA-N D05OTR DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2 D05OTR HIGHSTAT Investigative D05OUG DRUG__ID D05OUG D05OUG DRUGTYPE Small molecular drug D05OUG DRUGINCH 1S/C20H13NO3/c21-18-16(24-12-6-2-1-3-7-12)11-10-15-17(18)20(23)14-9-5-4-8-13(14)19(15)22/h1-11H,21H2 D05OUG DRUGINKE LTBODPBDLZJCLH-UHFFFAOYSA-N D05OUG DRUGSMIL C1=CC=C(C=C1)OC2=C(C3=C(C=C2)C(=O)C4=CC=CC=C4C3=O)N D05OUG HIGHSTAT Investigative D05OUP DRUG__ID D05OUP D05OUP DRUGTYPE Small molecular drug D05OUP DRUGINCH 1S/C32H32N4O5/c1-2-18-35-20-34-29-26(30(35)39)33-21-36(29)31-28(38)27(37)25(41-31)19-40-32(22-12-6-3-7-13-22,23-14-8-4-9-15-23)24-16-10-5-11-17-24/h3-17,20-21,25,27-28,31,37-38H,2,18-19H2,1H3/t25-,27-,28-,31-/m1/s1 D05OUP DRUGINKE GTLQVJJXEZWWMS-QWOIFIOOSA-N D05OUP DRUGSMIL CCCN1C=NC2=C(C1=O)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)O)O D05OUP HIGHSTAT Investigative D05OUQ DRUG__ID D05OUQ D05OUQ DRUGTYPE Small molecular drug D05OUQ DRUGINCH 1S/C166H261N51O52S4/c1-15-84(9)130(159(261)211-116(78-220)154(256)206-110(68-125(227)228)150(252)191-97(38-27-54-182-165(176)177)139(241)205-112(70-127(231)232)152(254)215-132(88-42-44-91(45-43-88)269-273(266,267)268)161(263)197-100(48-58-270-12)135(237)185-75-124(226)190-106(64-89-72-184-94-35-21-20-33-92(89)94)146(248)195-101(49-59-271-13)141(243)204-111(69-126(229)230)151(253)198-103(133(173)235)63-87-31-18-17-19-32-87)213-143(245)98(39-28-55-183-166(178)179)192-147(249)107(65-90-73-180-80-187-90)201-153(255)115(77-219)210-157(259)119-41-30-57-217(119)163(265)113(71-128(233)234)207-145(247)105(62-82(5)6)200-149(251)109(67-122(172)224)203-140(242)99(46-47-120(170)222)193-144(246)104(61-81(3)4)199-148(250)108(66-121(171)223)202-138(240)96(36-23-25-52-168)196-158(260)129(83(7)8)212-160(262)131(85(10)16-2)214-155(257)117(79-221)208-142(244)102(50-60-272-14)194-137(239)95(37-26-53-181-164(174)175)189-123(225)74-186-136(238)114(76-218)209-156(258)118-40-29-56-216(118)162(264)86(11)188-134(236)93(169)34-22-24-51-167/h17-21,31-33,35,42-45,72-73,80-86,93,95-119,129-132,184,218-221H,15-16,22-30,34,36-41,46-71,74-79,167-169H2,1-14H3,(H2,170,222)(H2,171,223)(H2,172,224)(H2,173,235)(H,180,187)(H,185,237)(H,186,238)(H,188,236)(H,189,225)(H,190,226)(H,191,252)(H,192,249)(H,193,246)(H,194,239)(H,195,248)(H,196,260)(H,197,263)(H,198,253)(H,199,250)(H,200,251)(H,201,255)(H,202,240)(H,203,242)(H,204,243)(H,205,241)(H,206,256)(H,207,247)(H,208,244)(H,209,258)(H,210,259)(H,211,261)(H,212,262)(H,213,245)(H,214,257)(H,215,254)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H4,174,175,181)(H4,176,177,182)(H4,178,179,183)(H,266,267,268) D05OUQ DRUGINKE QFLBZJPOIZFFJQ-UHFFFAOYSA-N D05OUQ DRUGSMIL CCC(C)C(C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(C1=CC=C(C=C1)OS(=O)(=O)O)C(=O)NC(CCSC)C(=O)NCC(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC4=CC=CC=C4)C(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC5=CNC=N5)NC(=O)C(CO)NC(=O)C6CCCN6C(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CCSC)NC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CO)NC(=O)C7CCCN7C(=O)C(C)NC(=O)C(CCCCN)N D05OUQ HIGHSTAT Investigative D05OUY DRUG__ID D05OUY D05OUY DRUGTYPE Small molecular drug D05OUY DRUGINCH 1S/C13H19NO/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H2,14,15)/t10-/m1/s1 D05OUY DRUGINKE REUQKCDCQVNKLW-SNVBAGLBSA-N D05OUY DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)N D05OUY HIGHSTAT Investigative D05OVV DRUG__ID D05OVV D05OVV DRUGTYPE Small molecular drug D05OVV DRUGINCH 1S/C23H25N3O2/c27-23(26-28)13-3-1-2-8-16(19-14-24-21-11-6-4-9-17(19)21)20-15-25-22-12-7-5-10-18(20)22/h4-7,9-12,14-16,24-25,28H,1-3,8,13H2,(H,26,27) D05OVV DRUGINKE ZWBFOQJCRGCPED-UHFFFAOYSA-N D05OVV DRUGSMIL C1=CC=C2C(=C1)C(=CN2)C(CCCCCC(=O)NO)C3=CNC4=CC=CC=C43 D05OVV HIGHSTAT Investigative D05OXR DRUG__ID D05OXR D05OXR DRUGTYPE Small molecular drug D05OXR DRUGINCH 1S/C16H14N2O/c1-18-14-10-6-5-7-12(14)11-15(18)16(19)17-13-8-3-2-4-9-13/h2-11H,1H3,(H,17,19) D05OXR DRUGINKE BKBHWENOWTVWOA-UHFFFAOYSA-N D05OXR DRUGSMIL CN1C2=CC=CC=C2C=C1C(=O)NC3=CC=CC=C3 D05OXR HIGHSTAT Investigative D05OZR DRUG__ID D05OZR D05OZR DRUGTYPE Small molecular drug D05OZR DRUGINCH 1S/C7H9N3O/c8-6-3-1-5(2-4-6)7(11)10-9/h1-4H,8-9H2,(H,10,11) D05OZR DRUGINKE WPBZMCGPFHZRHJ-UHFFFAOYSA-N D05OZR DRUGSMIL C1=CC(=CC=C1C(=O)NN)N D05OZR HIGHSTAT Investigative D05OZZ DRUG__ID D05OZZ D05OZZ DRUGTYPE Small molecular drug D05OZZ DRUGINCH 1S/C14H12N2O4S/c17-14(16-18)10-15-21(19,20)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,15H,10H2 D05OZZ DRUGINKE OGRPZMQLAVBWPV-UHFFFAOYSA-N D05OZZ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)NCC(=O)N=O D05OZZ HIGHSTAT Investigative D05PBN DRUG__ID D05PBN D05PBN DRUGTYPE Small molecular drug D05PBN DRUGINCH 1S/C14H21N/c1-12-5-7-14(8-6-12)9-11-15-10-3-4-13(15)2/h5-8,13H,3-4,9-11H2,1-2H3/t13-/m1/s1 D05PBN DRUGINKE BFMXEUSPYLVDSY-CYBMUJFWSA-N D05PBN DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)C D05PBN HIGHSTAT Investigative D05PDF DRUG__ID D05PDF D05PDF DRUGTYPE Small molecular drug D05PDF DRUGINCH 1S/C22H23N3O5S/c1-4-12-23-22(27)17-14-24-18-11-10-15(13-16(18)21(17)26)31(28,29)25(3)19-8-6-7-9-20(19)30-5-2/h4,6-11,13-14H,1,5,12H2,2-3H3,(H,23,27)(H,24,26) D05PDF DRUGINKE IVIJZILSKWHMIO-UHFFFAOYSA-N D05PDF DRUGSMIL CCOC1=CC=CC=C1N(C)S(=O)(=O)C2=CC3=C(C=C2)NC=C(C3=O)C(=O)NCC=C D05PDF HIGHSTAT Investigative D05PHI DRUG__ID D05PHI D05PHI DRUGTYPE Small molecular drug D05PHI DRUGINCH 1S/C16H13NO2S/c1-19-13-9-7-12(8-10-13)16-17-15(18)14(20-16)11-5-3-2-4-6-11/h2-10,18H,1H3 D05PHI DRUGINKE YQAKORGQQCUKEJ-UHFFFAOYSA-N D05PHI DRUGSMIL COC1=CC=C(C=C1)C2=NC(=C(S2)C3=CC=CC=C3)O D05PHI HIGHSTAT Investigative D05PHX DRUG__ID D05PHX D05PHX DRUGTYPE Small molecular drug D05PHX DRUGINCH 1S/C12H10N2O/c1-7-6-10-11(15-12(13)14-10)9-5-3-2-4-8(7)9/h2-6H,1H3,(H2,13,14) D05PHX DRUGINKE JEGUERWMMMQFJV-UHFFFAOYSA-N D05PHX DRUGSMIL CC1=CC2=C(C3=CC=CC=C13)OC(=N2)N D05PHX HIGHSTAT Investigative D05PKR DRUG__ID D05PKR D05PKR DRUGTYPE Small molecular drug D05PKR DRUGINCH 1S/C33H36N4O3/c1-21(35)20-40-33(39)29(12-6-7-17-34)36-30(38)19-28-27-16-15-23-9-4-5-11-26(23)32(27)37-31(28)25-14-13-22-8-2-3-10-24(22)18-25/h2-5,8-11,13-16,18,21,29,37H,6-7,12,17,19-20,34-35H2,1H3,(H,36,38)/t21-,29-/m0/s1 D05PKR DRUGINKE NFVRGDRCCNEGBS-LGGPFLRQSA-N D05PKR DRUGSMIL CC(COC(=O)C(CCCCN)NC(=O)CC1=C(NC2=C1C=CC3=CC=CC=C32)C4=CC5=CC=CC=C5C=C4)N D05PKR HIGHSTAT Investigative D05PKT DRUG__ID D05PKT D05PKT DRUGTYPE Small molecular drug D05PKT DRUGINCH 1S/C23H19NO/c1-25-23-9-8-21-15-20(6-7-22(21)16-23)19-4-2-17(3-5-19)14-18-10-12-24-13-11-18/h2-13,15-16H,14H2,1H3 D05PKT DRUGINKE XDUUJWUQYXFHEK-UHFFFAOYSA-N D05PKT DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CC=C(C=C3)CC4=CC=NC=C4 D05PKT HIGHSTAT Investigative D05PLF DRUG__ID D05PLF D05PLF DRUGTYPE Small molecular drug D05PLF DRUGINCH 1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-5-7-11(14)8-6-10/h5-9,15H,1-4H3 D05PLF DRUGINKE IELBAACIVCODPI-UHFFFAOYSA-N D05PLF DRUGSMIL CC(C(=O)C1=CC=C(C=C1)Cl)NC(C)(C)C D05PLF HIGHSTAT Investigative D05PNI DRUG__ID D05PNI D05PNI DRUGTYPE Small molecular drug D05PNI DRUGINCH 1S/C15H18N2O12P2/c18-11-6-7-17(15(21)16-11)14-13(20)12(19)10(27-14)8-26-30(22,23)29-31(24,25)28-9-4-2-1-3-5-9/h1-7,10,12-14,19-20H,8H2,(H,22,23)(H,24,25)(H,16,18,21)/t10-,12-,13-,14-/m1/s1 D05PNI DRUGINKE ZHUWBKDWWGKIEN-FMKGYKFTSA-N D05PNI DRUGSMIL C1=CC=C(C=C1)OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O D05PNI HIGHSTAT Investigative D05PNO DRUG__ID D05PNO D05PNO DRUGTYPE Small molecular drug D05PNO DRUGINCH 1S/C10H8INO2/c11-5-6-12-8-4-2-1-3-7(8)9(13)10(12)14/h1-4H,5-6H2 D05PNO DRUGINKE OBYVXAUONRVYHA-UHFFFAOYSA-N D05PNO DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N2CCI D05PNO HIGHSTAT Investigative D05PNP DRUG__ID D05PNP D05PNP DRUGTYPE Small molecular drug D05PNP DRUGINCH 1S/C15H14O3/c16-12-5-1-10(2-6-12)14-8-4-11-3-7-13(17)9-15(11)18-14/h1-3,5-7,9,14,16-17H,4,8H2/t14-/m1/s1 D05PNP DRUGINKE YXMLGIGHGPSEKA-CQSZACIVSA-N D05PNP DRUGSMIL C1CC2=C(C=C(C=C2)O)OC1C3=CC=C(C=C3)O D05PNP HIGHSTAT Investigative D05PRS DRUG__ID D05PRS D05PRS DRUGTYPE Small molecular drug D05PRS DRUGINCH 1S/C7H6N2O2S2/c8-5-12-6-1-3-7(4-2-6)13(9,10)11/h1-4H,(H2,9,10,11) D05PRS DRUGINKE JAOXYZVWRQDPGB-UHFFFAOYSA-N D05PRS DRUGSMIL C1=CC(=CC=C1SC#N)S(=O)(=O)N D05PRS HIGHSTAT Investigative D05PSD DRUG__ID D05PSD D05PSD DRUGTYPE Small molecular drug D05PSD DRUGINCH 1S/C29H33N3O/c1-4-29(33)14-12-22-20-10-9-19-15-24-18(16-27(19,2)21(20)11-13-28(22,29)3)17-32-25-8-6-5-7-23(25)30-26(32)31-24/h1,5-8,17,19-22,33H,9-16H2,2-3H3/t19-,20+,21-,22-,27-,28-,29-/m0/s1 D05PSD DRUGINKE AIIXYCDTEGICEE-HZVAOYAWSA-N D05PSD DRUGSMIL CC12CCC3C(C1CCC2(C#C)O)CCC4C3(CC5=CN6C7=CC=CC=C7N=C6N=C5C4)C D05PSD HIGHSTAT Investigative D05PTT DRUG__ID D05PTT D05PTT DRUGTYPE Small molecular drug D05PTT DRUGINCH 1S/C18H16O8/c19-12-4-1-10(7-14(12)21)3-6-17(23)26-16(18(24)25)9-11-2-5-13(20)15(22)8-11/h1-8,16,19-22H,9H2,(H,24,25)/b6-3+/t16-/m1/s1 D05PTT DRUGINKE DOUMFZQKYFQNTF-WUTVXBCWSA-N D05PTT DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O D05PTT HIGHSTAT Investigative D05PVX DRUG__ID D05PVX D05PVX DRUGTYPE Small molecular drug D05PVX DRUGINCH 1S/C4H7BO2S/c6-5(7)4-2-1-3-8-4/h2,6-7H,1,3H2 D05PVX DRUGINKE HBWATGYSAHIWIX-UHFFFAOYSA-N D05PVX DRUGSMIL B(C1=CCCS1)(O)O D05PVX HIGHSTAT Investigative D05PXD DRUG__ID D05PXD D05PXD DRUGTYPE Small molecular drug D05PXD DRUGINCH 1S/C7H5O5P/c8-7(9)5-3-1-2-4-6(5)12-13(10)11/h1-4H,(H,8,9)/p-1 D05PXD DRUGINKE CEHNRTFNHMGQGW-UHFFFAOYSA-M D05PXD DRUGSMIL C1=CC=C(C(=C1)C(=O)[O-])OP(=O)=O D05PXD HIGHSTAT Investigative D05PXK DRUG__ID D05PXK D05PXK DRUGTYPE Small molecular drug D05PXK DRUGINCH 1S/C21H15N3O3/c1-26-16-6-7-17-19(10-16)27-21(15-4-2-14(11-22)3-5-15)18(20(17)25)12-24-9-8-23-13-24/h2-10,13H,12H2,1H3 D05PXK DRUGINKE MFAAEVRNWGIQOT-UHFFFAOYSA-N D05PXK DRUGSMIL COC1=CC2=C(C=C1)C(=O)C(=C(O2)C3=CC=C(C=C3)C#N)CN4C=CN=C4 D05PXK HIGHSTAT Investigative D05PYF DRUG__ID D05PYF D05PYF DRUGTYPE Small molecular drug D05PYF DRUGINCH 1S/C10H8N2O2S/c13-10(12-14)9-5-4-8(15-9)7-3-1-2-6-11-7/h1-6,14H,(H,12,13) D05PYF DRUGINKE ASGPYAWVOHEENA-UHFFFAOYSA-N D05PYF DRUGSMIL C1=CC=NC(=C1)C2=CC=C(S2)C(=O)NO D05PYF HIGHSTAT Investigative D05PYO DRUG__ID D05PYO D05PYO DRUGTYPE Small molecular drug D05PYO DRUGINCH 1S/C22H32O5/c1-2-3-9-14-19(23)15-10-6-4-5-7-11-16-20(24)21(25)17-12-8-13-18-22(26)27/h3-12,15-16,19-21,23-25H,2,13-14,17-18H2,1H3,(H,26,27)/b6-4-,7-5+,9-3-,12-8-,15-10+,16-11+/t19-,20-,21+/m1/s1 D05PYO DRUGINKE OIWTWACQMDFHJG-BJEBZIPWSA-N D05PYO DRUGSMIL CCC=CCC(C=CC=CC=CC=CC(C(CC=CCCC(=O)O)O)O)O D05PYO HIGHSTAT Investigative D05PZA DRUG__ID D05PZA D05PZA DRUGTYPE Small molecular drug D05PZA DRUGINCH 1S/C9H12N2.BrH/c1-8(10)11-7-9-5-3-2-4-6-9;/h2-6H,7H2,1H3,(H2,10,11);1H D05PZA DRUGINKE RUQJDXJQOUUQHG-UHFFFAOYSA-N D05PZA DRUGSMIL CC(=NCC1=CC=CC=C1)N.Br D05PZA HIGHSTAT Investigative D05PZL DRUG__ID D05PZL D05PZL DRUGTYPE Small molecular drug D05PZL DRUGINCH 1S/C12H10O2/c1-7-8(2)12(14)10-6-4-3-5-9(10)11(7)13/h3-6H,1-2H3 D05PZL DRUGINKE LGFDNUSAWCHVJN-UHFFFAOYSA-N D05PZL DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)C D05PZL HIGHSTAT Investigative D05PZV DRUG__ID D05PZV D05PZV DRUGTYPE Small molecular drug D05PZV DRUGINCH 1S/C15H11NOS2/c17-12-5-3-11(4-6-12)16-10-13-7-8-15(19-13)14-2-1-9-18-14/h1-10,17H D05PZV DRUGINKE UMPJRGAFFRSXRX-UHFFFAOYSA-N D05PZV DRUGSMIL C1=CSC(=C1)C2=CC=C(S2)C=NC3=CC=C(C=C3)O D05PZV HIGHSTAT Investigative D05QAD DRUG__ID D05QAD D05QAD DRUGTYPE Small molecular drug D05QAD DRUGINCH 1S/C26H36ClN3O5/c1-17(31)22(16-30-11-9-19(10-12-30)13-18-5-7-20(27)8-6-18)29-26(32)28-21-14-23(33-2)25(35-4)24(15-21)34-3/h5-8,14-15,17,19,22,31H,9-13,16H2,1-4H3,(H2,28,29,32)/t17?,22-/m0/s1 D05QAD DRUGINKE JYDVJNOBDUOZJC-UGNFMNBCSA-N D05QAD DRUGSMIL CC(C(CN1CCC(CC1)CC2=CC=C(C=C2)Cl)NC(=O)NC3=CC(=C(C(=C3)OC)OC)OC)O D05QAD HIGHSTAT Investigative D05QBF DRUG__ID D05QBF D05QBF DRUGTYPE Small molecular drug D05QBF DRUGINCH 1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 D05QBF DRUGINKE NFHRQQKPEBFUJK-HSZRJFAPSA-N D05QBF DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C3=CC4=CC=CC=C4N3)C5=CC=CC=C5 D05QBF HIGHSTAT Investigative D05QBX DRUG__ID D05QBX D05QBX DRUGTYPE Small molecular drug D05QBX DRUGINCH 1S/C13H11NO2/c15-13(14-16)12-8-4-7-11(9-12)10-5-2-1-3-6-10/h1-9,16H,(H,14,15) D05QBX DRUGINKE SEPGPMDDTZHYJV-UHFFFAOYSA-N D05QBX DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)C(=O)NO D05QBX HIGHSTAT Investigative D05QBZ DRUG__ID D05QBZ D05QBZ DRUGTYPE Small molecular drug D05QBZ DRUGINCH 1S/C24H27N5O2/c1-30-13-14-31-19-6-7-21-20(15-19)26-16-29(21)23-8-5-17-3-2-4-22(24(17)27-23)28-11-9-18(25)10-12-28/h2-8,15-16,18H,9-14,25H2,1H3 D05QBZ DRUGINKE DEEOXSOLTLIWMG-UHFFFAOYSA-N D05QBZ DRUGSMIL COCCOC1=CC2=C(C=C1)N(C=N2)C3=NC4=C(C=CC=C4N5CCC(CC5)N)C=C3 D05QBZ HIGHSTAT Investigative D05QCG DRUG__ID D05QCG D05QCG DRUGTYPE Small molecular drug D05QCG DRUGINCH 1S/C14H23N2O7P/c1-4-8(2)12(14(18)19)16-6-11-10(7-23-24(20,21)22)5-15-9(3)13(11)17/h5,8,12,16-17H,4,6-7H2,1-3H3,(H,18,19)(H2,20,21,22)/t8-,12+/m1/s1 D05QCG DRUGINKE GZZDWFDWHXPWJK-PELKAZGASA-N D05QCG DRUGSMIL CCC(C)C(C(=O)O)NCC1=C(C(=NC=C1COP(=O)(O)O)C)O D05QCG HIGHSTAT Investigative D05QEK DRUG__ID D05QEK D05QEK DRUGTYPE Small molecular drug D05QEK DRUGINCH 1S/C28H38N14O8S8/c29-55(43,44)27-37-35-25(53-27)39-57(47,48)21-7-3-19(4-8-21)33-23(51)31-11-1-13-41-15-17-42(18-16-41)14-2-12-32-24(52)34-20-5-9-22(10-6-20)58(49,50)40-26-36-38-28(54-26)56(30,45)46/h3-10H,1-2,11-18H2,(H,35,39)(H,36,40)(H2,29,43,44)(H2,30,45,46)(H2,31,33,51)(H2,32,34,52) D05QEK DRUGINKE OCNLOXNOURUUDD-UHFFFAOYSA-N D05QEK DRUGSMIL C1CN(CCN1CCCNC(=S)NC2=CC=C(C=C2)S(=O)(=O)NC3=NN=C(S3)S(=O)(=O)N)CCCNC(=S)NC4=CC=C(C=C4)S(=O)(=O)NC5=NN=C(S5)S(=O)(=O)N D05QEK HIGHSTAT Investigative D05QFR DRUG__ID D05QFR D05QFR DRUGTYPE Small molecular drug D05QFR DRUGINCH 1S/C13H20N2O7/c16-13(14-8-4-2-1-3-5-8)21-9-6-19-12-10(22-15(17)18)7-20-11(9)12/h8-12H,1-7H2,(H,14,16)/t9-,10+,11+,12+/m0/s1 D05QFR DRUGINKE HHQBHYZANLCQHI-IRCOFANPSA-N D05QFR DRUGSMIL C1CCC(CC1)NC(=O)OC2COC3C2OCC3O[N+](=O)[O-] D05QFR HIGHSTAT Investigative D05QIT DRUG__ID D05QIT D05QIT DRUGTYPE Small molecular drug D05QIT DRUGINCH 1S/C10H18O4/c11-9(12)7-5-3-1-2-4-6-8-10(13)14/h1-8H2,(H,11,12)(H,13,14) D05QIT DRUGINKE CXMXRPHRNRROMY-UHFFFAOYSA-N D05QIT DRUGSMIL C(CCCCC(=O)O)CCCC(=O)O D05QIT HIGHSTAT Investigative D05QJK DRUG__ID D05QJK D05QJK DRUGTYPE Small molecular drug D05QJK DRUGINCH 1S/C16H17N3O/c1-2-5-13(6-3-1)11-17-9-10-20-16-8-4-7-15-14(16)12-18-19-15/h1-8,12,17H,9-11H2,(H,18,19) D05QJK DRUGINKE WYGBVOBBNUHWLX-UHFFFAOYSA-N D05QJK DRUGSMIL C1=CC=C(C=C1)CNCCOC2=CC=CC3=C2C=NN3 D05QJK HIGHSTAT Investigative D05QJS DRUG__ID D05QJS D05QJS DRUGTYPE Small molecular drug D05QJS DRUGINCH 1S/C40H43N3O6/c44-25-7-5-21-13-27-39(46)15-23-24-16-40(47)28-14-22-6-8-26(45)34-30(22)38(40,10-12-43(28)18-20-3-4-20)36(49-34)32(24)41-31(23)35-37(39,29(21)33(25)48-35)9-11-42(27)17-19-1-2-19/h5-8,19-20,27-28,35-36,41,44-47H,1-4,9-18H2/t27-,28-,35+,36+,37+,38+,39-,40-/m1/s1 D05QJS DRUGINKE APSUXPSYBJVPPS-YAUKWVCOSA-N D05QJS DRUGSMIL C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C9C12CCN(C(C1(C8)O)CC1=C2C(=C(C=C1)O)O9)CC1CC1 D05QJS HIGHSTAT Investigative D05QKM DRUG__ID D05QKM D05QKM DRUGTYPE Small molecular drug D05QKM DRUGINCH 1S/C27H38N2O10/c1-13(2)24(34)19(38-18(31)15-7-6-10-29-15)25(35)20(4)12-23(33)21(24,5)27(25,36)26(39-23)17(37-16(30)11-28)14(3)8-9-22(20,26)32/h6-7,10,13-14,17,19,29,32-36H,8-9,11-12,28H2,1-5H3/t14?,17-,19-,20+,21?,22?,23?,24?,25?,26?,27?/m1/s1 D05QKM DRUGINKE XNUMBOKCFNVRAL-MPGPDOFNSA-N D05QKM DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CN)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O D05QKM HIGHSTAT Investigative D05QLT DRUG__ID D05QLT D05QLT DRUGTYPE Small molecular drug D05QLT DRUGINCH 1S/C13H9Cl2N5/c14-11-5-1-4-10(12(11)15)13-17-18-19-20(13)8-9-3-2-6-16-7-9/h1-7H,8H2 D05QLT DRUGINKE MMPAULQSJLVKHP-UHFFFAOYSA-N D05QLT DRUGSMIL C1=CC(=C(C(=C1)Cl)Cl)C2=NN=NN2CC3=CN=CC=C3 D05QLT HIGHSTAT Investigative D05QML DRUG__ID D05QML D05QML DRUGCOMP Kansas State University D05QML DRUGINCH 1S/C21H22F3N3O2/c1-13-7-10-27-19-16(26-9-4-8-25)12-17(28-2)20(18(13)19)29-15-6-3-5-14(11-15)21(22,23)24/h3,5-7,10-12,26H,4,8-9,25H2,1-2H3 D05QML DRUGINKE PPRRJSWOEFBRDQ-UHFFFAOYSA-N D05QML DRUGSMIL CC1=C2C(=C(C=C(C2=NC=C1)NCCCN)OC)OC3=CC=CC(=C3)C(F)(F)F D05QML HIGHSTAT Investigative D05QMN DRUG__ID D05QMN D05QMN DRUGTYPE Small molecular drug D05QMN DRUGINCH 1S/C17H14BrNO3/c1-20-16-9-13-14(10-17(16)21-2)19-7-6-15(13)22-12-5-3-4-11(18)8-12/h3-10H,1-2H3 D05QMN DRUGINKE OVJMXMWWASQPSL-UHFFFAOYSA-N D05QMN DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC(=CC=C3)Br D05QMN HIGHSTAT Investigative D05QNR DRUG__ID D05QNR D05QNR DRUGTYPE Small molecular drug D05QNR DRUGINCH 1S/C37H58N2O2/c1-3-36(32-18-16-20-34(40)28-32)22-10-14-26-38(30-36)24-12-8-6-5-7-9-13-25-39-27-15-11-23-37(4-2,31-39)33-19-17-21-35(41)29-33/h16-21,28-29,40-41H,3-15,22-27,30-31H2,1-2H3/t36-,37-/m1/s1 D05QNR DRUGINKE ZZKZUUMHRSWLQQ-FZNHDDJXSA-N D05QNR DRUGSMIL CCC1(CCCCN(C1)CCCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D05QNR HIGHSTAT Investigative D05QNV DRUG__ID D05QNV D05QNV DRUGTYPE Small molecular drug D05QNV DRUGINCH 1S/C24H22F3N7O3/c1-3-10-33-20-18(22(36)34(23(33)37)15-6-7-15)30-19(31-20)13-5-9-17(29-11-13)32(2)21(35)14-4-8-16(28-12-14)24(25,26)27/h4-5,8-9,11-12,15H,3,6-7,10H2,1-2H3,(H,30,31) D05QNV DRUGINKE IKIXRBGOWUFFBN-UHFFFAOYSA-N D05QNV DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)C3CC3)NC(=N2)C4=CN=C(C=C4)N(C)C(=O)C5=CN=C(C=C5)C(F)(F)F D05QNV HIGHSTAT Investigative D05QOF DRUG__ID D05QOF D05QOF DRUGTYPE Small molecular drug D05QOF DRUGINCH 1S/C16H17NO3/c17-9-15-11-6-7-13(18)16(19)12(11)8-14(20-15)10-4-2-1-3-5-10/h1-7,14-15,18-19H,8-9,17H2/t14-,15-/m1/s1 D05QOF DRUGINKE SUHGRZPINGKYNV-HUUCEWRRSA-N D05QOF DRUGSMIL C1C(OC(C2=C1C(=C(C=C2)O)O)CN)C3=CC=CC=C3 D05QOF HIGHSTAT Investigative D05QOR DRUG__ID D05QOR D05QOR DRUGTYPE Small molecular drug D05QOR DRUGINCH 1S/C10H8O4/c1-13-9-4-6-2-3-10(12)14-8(6)5-7(9)11/h2-5,11H,1H3 D05QOR DRUGINKE RODXRVNMMDRFIK-UHFFFAOYSA-N D05QOR DRUGSMIL COC1=C(C=C2C(=C1)C=CC(=O)O2)O D05QOR HIGHSTAT Investigative D05QPE DRUG__ID D05QPE D05QPE DRUGTYPE Small molecular drug D05QPE DRUGINCH 1S/C22H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,24H,2-5,8,11,14-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12- D05QPE DRUGINKE ULQWKETUACYZLI-QNEBEIHSSA-N D05QPE DRUGSMIL CCCCCC=CCC=CCC=CCCCCCCC(=O)NCCO D05QPE HIGHSTAT Investigative D05QPR DRUG__ID D05QPR D05QPR DRUGTYPE Small molecular drug D05QPR DRUGINCH 1S/C10H9FN2/c11-10-3-1-9(2-4-10)7-13-6-5-12-8-13/h1-6,8H,7H2 D05QPR DRUGINKE LOHJXVMUYVDWOW-UHFFFAOYSA-N D05QPR DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)F D05QPR HIGHSTAT Investigative D05QTG DRUG__ID D05QTG D05QTG DRUGTYPE Small molecular drug D05QTG DRUGINCH 1S/C20H18O4/c21-14-7-5-13(6-8-14)18-12-23-19-11-16(9-10-17(19)20(18)22)24-15-3-1-2-4-15/h5-12,15,21H,1-4H2 D05QTG DRUGINKE RFDBJXQLCPTPCX-UHFFFAOYSA-N D05QTG DRUGSMIL C1CCC(C1)OC2=CC3=C(C=C2)C(=O)C(=CO3)C4=CC=C(C=C4)O D05QTG HIGHSTAT Investigative D05QTJ DRUG__ID D05QTJ D05QTJ DRUGTYPE Small molecular drug D05QTJ DRUGINCH 1S/C13H17Cl3N4/c1-20(5-2-14)8-9-6-10(15)12(11(16)7-9)19-13-17-3-4-18-13/h6-7H,2-5,8H2,1H3,(H2,17,18,19) D05QTJ DRUGINKE XFDVJGKSQRUEEM-UHFFFAOYSA-N D05QTJ DRUGSMIL CN(CCCl)CC1=CC(=C(C(=C1)Cl)NC2=NCCN2)Cl D05QTJ HIGHSTAT Investigative D05QTT DRUG__ID D05QTT D05QTT DRUGTYPE Small molecular drug D05QTT DRUGINCH 1S/C26H31ClFN5O/c1-31-11-13-32(14-12-31)9-2-10-33(26(34)30-22-6-8-25(28)24(27)17-22)23-7-5-20-4-3-19(18-29)15-21(20)16-23/h3-4,6,8,15,17,23H,2,5,7,9-14,16H2,1H3,(H,30,34) D05QTT DRUGINKE GQGGDNLJDZHJKN-UHFFFAOYSA-N D05QTT DRUGSMIL CN1CCN(CC1)CCCN(C2CCC3=C(C2)C=C(C=C3)C#N)C(=O)NC4=CC(=C(C=C4)F)Cl D05QTT HIGHSTAT Investigative D05QTX DRUG__ID D05QTX D05QTX DRUGTYPE Small molecular drug D05QTX DRUGINCH 1S/C24H28ClN3O/c1-2-20-21-16-18(25)8-11-22(21)27-23(20)24(29)26-13-12-17-6-9-19(10-7-17)28-14-4-3-5-15-28/h6-11,16,27H,2-5,12-15H2,1H3,(H,26,29) D05QTX DRUGINKE AHFZDNYNXFMRFQ-UHFFFAOYSA-N D05QTX DRUGSMIL CCC1=C(NC2=C1C=C(C=C2)Cl)C(=O)NCCC3=CC=C(C=C3)N4CCCCC4 D05QTX HIGHSTAT Investigative D05QUG DRUG__ID D05QUG D05QUG DRUGTYPE Small molecular drug D05QUG DRUGINCH 1S/C17H14O2/c18-17-11-10-15-9-8-14(12-16(15)19-17)7-6-13-4-2-1-3-5-13/h1-5,8-12H,6-7H2 D05QUG DRUGINKE FQWWPSNGCTYUHH-UHFFFAOYSA-N D05QUG DRUGSMIL C1=CC=C(C=C1)CCC2=CC3=C(C=C2)C=CC(=O)O3 D05QUG HIGHSTAT Investigative D05QWQ DRUG__ID D05QWQ D05QWQ DRUGTYPE Small molecular drug D05QWQ DRUGINCH 1S/C50H54BF2N9O7S/c1-3-28-60-48-46(49(66)61(29-4-2)50(60)67)58-47(59-48)35-14-22-40(23-15-35)69-33-45(65)56-27-26-55-43(63)10-6-5-7-25-54-44(64)32-68-39-20-12-34(13-21-39)11-16-36-17-18-37(57-36)31-38-19-24-41(62(38)51(52)53)42-9-8-30-70-42/h8-9,11-24,30-31H,3-7,10,25-29,32-33H2,1-2H3,(H,54,64)(H,55,63)(H,56,65)(H,58,59)/b16-11+,37-31? D05QWQ DRUGINKE UTTCRXDXTRTMKH-ZXOXUTKXSA-N D05QWQ DRUGSMIL B(N1C(=CC=C1C2=CC=CS2)C=C3C=CC(=N3)C=CC4=CC=C(C=C4)OCC(=O)NCCCCCC(=O)NCCNC(=O)COC5=CC=C(C=C5)C6=NC7=C(N6)C(=O)N(C(=O)N7CCC)CCC)(F)F D05QWQ HIGHSTAT Investigative D05QXU DRUG__ID D05QXU D05QXU DRUGTYPE Small molecular drug D05QXU DRUGINCH 1S/C19H20N6O/c26-19(24-15-5-1-3-13(11-15)17-20-7-8-21-17)25-16-6-2-4-14(12-16)18-22-9-10-23-18/h1-6,11-12H,7-10H2,(H,20,21)(H,22,23)(H2,24,25,26) D05QXU DRUGINKE SCEVFJUWLLRELN-UHFFFAOYSA-N D05QXU DRUGSMIL C1CN=C(N1)C2=CC(=CC=C2)NC(=O)NC3=CC=CC(=C3)C4=NCCN4 D05QXU HIGHSTAT Investigative D05QYR DRUG__ID D05QYR D05QYR DRUGTYPE Small molecular drug D05QYR DRUGINCH 1S/C21H26O2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)19-13-15-20(16-14-19)21(22)23/h9-16H,2-8H2,1H3,(H,22,23) D05QYR DRUGINKE HXBKPYIEQLLNBK-UHFFFAOYSA-N D05QYR DRUGSMIL CCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)O D05QYR HIGHSTAT Investigative D05RAB DRUG__ID D05RAB D05RAB DRUGTYPE Small molecular drug D05RAB DRUGINCH 1S/C6H8N2O3S/c1-8-3-2-5(9)6(4-8)12(7,10)11/h2-4H,1H3,(H2,7,10,11) D05RAB DRUGINKE HTPSIFNKXNIAJZ-UHFFFAOYSA-N D05RAB DRUGSMIL CN1C=CC(=O)C(=C1)S(=O)(=O)N D05RAB HIGHSTAT Investigative D05RCG DRUG__ID D05RCG D05RCG DRUGTYPE Small molecular drug D05RCG DRUGINCH 1S/C26H30N6O4/c33-23(15-31-9-5-27-6-10-31)29-17-1-3-19-21(13-17)26(36)22-14-18(2-4-20(22)25(19)35)30-24(34)16-32-11-7-28-8-12-32/h1-4,13-14,27-28H,5-12,15-16H2,(H,29,33)(H,30,34) D05RCG DRUGINKE OBWFXMCXHJYGRS-UHFFFAOYSA-N D05RCG DRUGSMIL C1CN(CCN1)CC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CN5CCNCC5 D05RCG HIGHSTAT Investigative D05RCK DRUG__ID D05RCK D05RCK DRUGTYPE Small molecular drug D05RCK DRUGINCH 1S/C19H22O6/c1-10(2)18(22)24-14-8-13(9-20)7-5-6-11(3)16(21)17-15(14)12(4)19(23)25-17/h8-9,14-17,21H,1,3-7H2,2H3/b13-8+/t14-,15-,16+,17+/m1/s1 D05RCK DRUGINKE CCWGXWKAXMNGSZ-PBMXCAIQSA-N D05RCK DRUGSMIL CC(=C)C(=O)OC1C=C(CCCC(=C)C(C2C1C(=C)C(=O)O2)O)C=O D05RCK HIGHSTAT Investigative D05RDO DRUG__ID D05RDO D05RDO DRUGTYPE Small molecular drug D05RDO DRUGINCH 1S/C13H21N5O2/c1-3-4-5-20-6-10(9(2)19)18-8-17-11-12(14)15-7-16-13(11)18/h7-10,19H,3-6H2,1-2H3,(H2,14,15,16)/t9-,10?/m0/s1 D05RDO DRUGINKE JLZPQJZPCMKWRD-RGURZIINSA-N D05RDO DRUGSMIL CCCCOCC(C(C)O)N1C=NC2=C(N=CN=C21)N D05RDO HIGHSTAT Investigative D05RDP DRUG__ID D05RDP D05RDP DRUGTYPE Small molecular drug D05RDP DRUGINCH 1S/C18H14BrNO5S2/c19-11-5-7-12(8-6-11)27(24,25)20-15-9-16(26-10-17(21)22)18(23)14-4-2-1-3-13(14)15/h1-9,20,23H,10H2,(H,21,22) D05RDP DRUGINKE WUGANDSUVKXMEC-UHFFFAOYSA-N D05RDP DRUGSMIL C1=CC=C2C(=C1)C(=CC(=C2O)SCC(=O)O)NS(=O)(=O)C3=CC=C(C=C3)Br D05RDP HIGHSTAT Investigative D05REQ DRUG__ID D05REQ D05REQ DRUGTYPE Small molecular drug D05REQ DRUGINCH 1S/C14H15N3/c15-7-9-1-4-14-12(5-9)13(8-17-14)10-2-3-11(16)6-10/h1,4-5,8,10-11,17H,2-3,6,16H2 D05REQ DRUGINKE MBZJCLUPDBZVMZ-UHFFFAOYSA-N D05REQ DRUGSMIL C1CC(CC1C2=CNC3=C2C=C(C=C3)C#N)N D05REQ HIGHSTAT Investigative D05RFO DRUG__ID D05RFO D05RFO DRUGCOMP Abbott Laboratories D05RFO DRUGINCH 1S/C29H31ClN8O/c30-22-4-2-1-3-18(22)16-25-34-23-10-5-19(15-24(23)35-25)27-26-28(31)32-17-33-29(26)38(36-27)21-8-6-20(7-9-21)37-11-13-39-14-12-37/h1-5,10,15,17,20-21H,6-9,11-14,16H2,(H,34,35)(H2,31,32,33) D05RFO DRUGINKE DZHMNRMMNFEUNL-UHFFFAOYSA-N D05RFO DRUGSMIL C1CC(CCC1N2CCOCC2)N3C4=NC=NC(=C4C(=N3)C5=CC6=C(C=C5)N=C(N6)CC7=CC=CC=C7Cl)N D05RFO HIGHSTAT Investigative D05RGO DRUG__ID D05RGO D05RGO DRUGTYPE Small molecular drug D05RGO DRUGINCH 1S/C23H28N4O3/c24-21(28)19(14-16-8-3-1-4-9-16)26-23(30)20(15-17-10-5-2-6-11-17)27-22(29)18-12-7-13-25-18/h1-6,8-11,18-20,25H,7,12-15H2,(H2,24,28)(H,26,30)(H,27,29)/t18-,19-,20-/m0/s1 D05RGO DRUGINKE GQTQFZUTXSDLLQ-UFYCRDLUSA-N D05RGO DRUGSMIL C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)N D05RGO HIGHSTAT Investigative D05RGU DRUG__ID D05RGU D05RGU DRUGTYPE Small molecular drug D05RGU DRUGINCH 1S/C27H45NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-27(29)28-24-23-25-19-21-26(30-2)22-20-25/h10-11,19-22H,3-9,12-18,23-24H2,1-2H3,(H,28,29)/b11-10- D05RGU DRUGINKE LWJMRSYDIYWZOL-KHPPLWFESA-N D05RGU DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCC1=CC=C(C=C1)OC D05RGU HIGHSTAT Investigative D05RGW DRUG__ID D05RGW D05RGW DRUGTYPE Small molecular drug D05RGW DRUGINCH 1S/C10H17N3/c1-13-4-2-9(3-5-13)6-10-7-11-8-12-10/h7-9H,2-6H2,1H3,(H,11,12) D05RGW DRUGINKE KIAVPENCSGKVQP-UHFFFAOYSA-N D05RGW DRUGSMIL CN1CCC(CC1)CC2=CN=CN2 D05RGW HIGHSTAT Investigative D05RIE DRUG__ID D05RIE D05RIE DRUGTYPE Small molecular drug D05RIE DRUGINCH 1S/C14H11NO3/c16-13(10-5-2-1-3-6-10)11-7-4-8-12(9-11)14(17)15-18/h1-9,18H,(H,15,17) D05RIE DRUGINKE LAZDNRBVPKMJSY-UHFFFAOYSA-N D05RIE DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC(=CC=C2)C(=O)NO D05RIE HIGHSTAT Investigative D05RII DRUG__ID D05RII D05RII DRUGTYPE Small molecular drug D05RII DRUGINCH 1S/C20H21ClN2/c21-17-6-7-20-18(12-17)19(13-22-20)16-8-10-23(11-9-16)14-15-4-2-1-3-5-15/h1-7,12-13,16,22H,8-11,14H2 D05RII DRUGINKE NRIVFQIOYWIUPX-UHFFFAOYSA-N D05RII DRUGSMIL C1CN(CCC1C2=CNC3=C2C=C(C=C3)Cl)CC4=CC=CC=C4 D05RII HIGHSTAT Investigative D05RKH DRUG__ID D05RKH D05RKH DRUGTYPE Small molecular drug D05RKH DRUGINCH 1S/C11H14N4O/c1-8-6-9-10(13-7-14-11(9)16-8)15-4-2-12-3-5-15/h6-7,12H,2-5H2,1H3 D05RKH DRUGINKE MNCCXFCOQHVIEX-UHFFFAOYSA-N D05RKH DRUGSMIL CC1=CC2=C(N=CN=C2O1)N3CCNCC3 D05RKH HIGHSTAT Investigative D05RKS DRUG__ID D05RKS D05RKS DRUGTYPE Small molecular drug D05RKS DRUGINCH 1S/C17H21N/c1-18-14-8-13-17(15-9-4-2-5-10-15)16-11-6-3-7-12-16/h2-7,9-12,17-18H,8,13-14H2,1H3 D05RKS DRUGINKE GRKYNTKPAFRLLZ-UHFFFAOYSA-N D05RKS DRUGSMIL CNCCCC(C1=CC=CC=C1)C2=CC=CC=C2 D05RKS HIGHSTAT Investigative D05RLR DRUG__ID D05RLR D05RLR DRUGTYPE Small molecular drug D05RLR DRUGINCH 1S/C22H17ClN2/c23-21-15-8-7-14-20(21)22(25-17-9-16-24-25,18-10-3-1-4-11-18)19-12-5-2-6-13-19/h1-17H D05RLR DRUGINKE KBFUQFVFYYBHBT-UHFFFAOYSA-N D05RLR DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CC=N4 D05RLR HIGHSTAT Investigative D05ROV DRUG__ID D05ROV D05ROV DRUGTYPE Small molecular drug D05ROV DRUGINCH 1S/C19H22N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h2-7,9,13-14,18-19,22H,1,8,10-12H2 D05ROV DRUGINKE KMPWYEUPVWOPIM-UHFFFAOYSA-N D05ROV DRUGSMIL C=CC1CN2CCC1CC2C(C3=CC=NC4=CC=CC=C34)O D05ROV HIGHSTAT Investigative D05RPN DRUG__ID D05RPN D05RPN DRUGCOMP Bristol-Myers Squibb D05RPN DRUGINCH 1S/C33H43N5O3S2/c1-21-16-26(17-28(22(21)2)31(41)38-14-12-37(13-15-38)24(4)39)20-42-29-19-35-32(43-29)36-30(40)27-10-8-25(9-11-27)18-34-23(3)33(5,6)7/h8-11,16-17,19,23,34H,12-15,18,20H2,1-7H3,(H,35,36,40) D05RPN DRUGINKE DQPJVNQWPBLBAB-UHFFFAOYSA-N D05RPN DRUGSMIL CC1=CC(=CC(=C1C)C(=O)N2CCN(CC2)C(=O)C)CSC3=CN=C(S3)NC(=O)C4=CC=C(C=C4)CNC(C)C(C)(C)C D05RPN HIGHSTAT Investigative D05RRF DRUG__ID D05RRF D05RRF DRUGTYPE Small molecular drug D05RRF DRUGINCH 1S/C45H62N8O9/c1-23(2)19-32-39(56)50-37(25(5)6)43(60)51-36(24(3)4)42(59)49-34(20-27-14-16-29(55)17-15-27)45(62)53-18-10-13-35(53)41(58)47-33(40(57)52-38(26(7)54)44(61)48-32)21-28-22-46-31-12-9-8-11-30(28)31/h8-9,11-12,14-17,22-26,32-38,46,54-55H,10,13,18-21H2,1-7H3,(H,47,58)(H,48,61)(H,49,59)(H,50,56)(H,51,60)(H,52,57)/t26-,32+,33+,34+,35+,36+,37+,38+/m1/s1 D05RRF DRUGINKE COEPOBZXGUREGL-BYZYSQTKSA-N D05RRF DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CC3=CNC4=CC=CC=C43)CC5=CC=C(C=C5)O)C(C)C)C(C)C D05RRF HIGHSTAT Investigative D05RRI DRUG__ID D05RRI D05RRI DRUGTYPE Small molecular drug D05RRI DRUGINCH 1S/C14H11ClFNO4/c1-8(14(18)19)20-10-2-4-11(5-3-10)21-13-12(16)6-9(15)7-17-13/h2-8H,1H3,(H,18,19)/t8-/m1/s1 D05RRI DRUGINKE YUIKUTLBPMDDNQ-MRVPVSSYSA-N D05RRI DRUGSMIL CC(C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=N2)Cl)F D05RRI HIGHSTAT Investigative D05RRK DRUG__ID D05RRK D05RRK DRUGTYPE Small molecular drug D05RRK DRUGINCH 1S/C19H25N3O6/c20-13(11-12-5-2-1-3-6-12)18(26)22-10-4-7-15(22)17(25)21-14(19(27)28)8-9-16(23)24/h1-3,5-6,13-15H,4,7-11,20H2,(H,21,25)(H,23,24)(H,27,28)/t13-,14-,15-/m0/s1 D05RRK DRUGINKE QARPMYDMYVLFMW-KKUMJFAQSA-N D05RRK DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)NC(CCC(=O)O)C(=O)O D05RRK HIGHSTAT Investigative D05RRZ DRUG__ID D05RRZ D05RRZ DRUGTYPE Small molecular drug D05RRZ DRUGINCH 1S/C35H36N6O4/c1-24(2)40(28-21-19-26(20-22-28)38(3)4)31(42)23-39-29-17-11-12-18-30(29)41(27-15-9-6-10-16-27)34(44)32(33(39)43)37-35(45)36-25-13-7-5-8-14-25/h5-22,24,32H,23H2,1-4H3,(H2,36,37,45) D05RRZ DRUGINKE GESRVUYUMYPJBC-UHFFFAOYSA-N D05RRZ DRUGSMIL CC(C)N(C1=CC=C(C=C1)N(C)C)C(=O)CN2C3=CC=CC=C3N(C(=O)C(C2=O)NC(=O)NC4=CC=CC=C4)C5=CC=CC=C5 D05RRZ HIGHSTAT Investigative D05RSP DRUG__ID D05RSP D05RSP DRUGTYPE Small molecular drug D05RSP DRUGINCH 1S/C10H13NO4S2/c1-2-16-10(11-15-17(12,13)14)8-9-6-4-3-5-7-9/h3-7H,2,8H2,1H3,(H,12,13,14)/b11-10- D05RSP DRUGINKE VZFUNHITNWTQFU-KHPPLWFESA-N D05RSP DRUGSMIL CCSC(=NOS(=O)(=O)O)CC1=CC=CC=C1 D05RSP HIGHSTAT Investigative D05RSQ DRUG__ID D05RSQ D05RSQ DRUGTYPE Small molecular drug D05RSQ DRUGINCH 1S/C14H10FNO2/c15-11-6-7-13-12(8-11)16(14(17)18-13)9-10-4-2-1-3-5-10/h1-8H,9H2 D05RSQ DRUGINKE YYEOCYSVLLWJQE-UHFFFAOYSA-N D05RSQ DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C=CC(=C3)F)OC2=O D05RSQ HIGHSTAT Investigative D05RTH DRUG__ID D05RTH D05RTH DRUGTYPE Small molecular drug D05RTH DRUGINCH 1S/C28H39N3O8/c1-14-10-18-23(29)20(32)13-19(25(18)34)31-27(35)15(2)8-7-9-21(37-5)26(39-28(30)36)17(4)12-16(3)24(33)22(11-14)38-6/h7-10,12-13,16,21-22,24,26,32-34H,11,29H2,1-6H3,(H2,30,36)(H,31,35)/b9-7-,14-10-,15-8+,17-12+/t16-,21-,22-,24+,26-/m0/s1 D05RTH DRUGINKE VWTYNHIROMEOBP-PQMSMOMXSA-N D05RTH DRUGSMIL CC1C=C(C(C(C=CC=C(C(=O)NC2=CC(=C(C(=C2O)C=C(CC(C1O)OC)C)N)O)C)OC)OC(=O)N)C D05RTH HIGHSTAT Investigative D05RWU DRUG__ID D05RWU D05RWU DRUGTYPE Small molecular drug D05RWU DRUGINCH 1S/C21H18N2O/c1-2-15-8-10-16(11-9-15)18-12-13-19(22)20(14-18)23-21(24)17-6-4-3-5-7-17/h2-14H,1,22H2,(H,23,24) D05RWU DRUGINKE GUBGWFHGNFMNFP-UHFFFAOYSA-N D05RWU DRUGSMIL C=CC1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D05RWU HIGHSTAT Investigative D05RWZ DRUG__ID D05RWZ D05RWZ DRUGTYPE Small molecular drug D05RWZ DRUGINCH 1S/C8H10FNO3/c9-5-2-7(12)6(11)1-4(5)8(13)3-10/h1-2,8,11-13H,3,10H2/t8-/m0/s1 D05RWZ DRUGINKE SBUQBFTXTZSRMH-QMMMGPOBSA-N D05RWZ DRUGSMIL C1=C(C(=CC(=C1O)O)F)C(CN)O D05RWZ HIGHSTAT Investigative D05RXG DRUG__ID D05RXG D05RXG DRUGTYPE Small molecular drug D05RXG DRUGINCH 1S/C9H10N2O/c10-8-3-1-2-7-6(8)4-5-11-9(7)12/h1-3H,4-5,10H2,(H,11,12) D05RXG DRUGINKE RTPKPVYTPRJRBY-UHFFFAOYSA-N D05RXG DRUGSMIL C1CNC(=O)C2=C1C(=CC=C2)N D05RXG HIGHSTAT Investigative D05SAP DRUG__ID D05SAP D05SAP DRUGTYPE Small molecular drug D05SAP DRUGINCH 1S/C13H14N2O2S/c14-10-11-5-4-6-12(9-11)15-18(16,17)13-7-2-1-3-8-13/h1-9,15H,10,14H2 D05SAP DRUGINKE RMWBQRLIFOIUFM-UHFFFAOYSA-N D05SAP DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)CN D05SAP HIGHSTAT Investigative D05SBJ DRUG__ID D05SBJ D05SBJ DRUGTYPE Small molecular drug D05SBJ DRUGINCH 1S/C17H15NO3/c19-16-11-14(18-7-9-20-10-8-18)17-13-4-2-1-3-12(13)5-6-15(17)21-16/h1-6,11H,7-10H2 D05SBJ DRUGINKE BYCFTTKUJHROAO-UHFFFAOYSA-N D05SBJ DRUGSMIL C1COCCN1C2=CC(=O)OC3=C2C4=CC=CC=C4C=C3 D05SBJ HIGHSTAT Investigative D05SCE DRUG__ID D05SCE D05SCE DRUGTYPE Small molecular drug D05SCE DRUGINCH 1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30+,31-/m0/s1 D05SCE DRUGINKE TXGZJQLMVSIZEI-UQMAOPSPSA-N D05SCE DRUGSMIL CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C D05SCE HIGHSTAT Investigative D05SEV DRUG__ID D05SEV D05SEV DRUGTYPE Small molecular drug D05SEV DRUGINCH 1S/C33H24N2O/c36-30-13-7-12-29(22-30)33-34-31(27-18-14-25(15-19-27)23-8-3-1-4-9-23)32(35-33)28-20-16-26(17-21-28)24-10-5-2-6-11-24/h1-22,36H,(H,34,35) D05SEV DRUGINKE JTVSGRFYVCXWNC-UHFFFAOYSA-N D05SEV DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C3=C(N=C(N3)C4=CC(=CC=C4)O)C5=CC=C(C=C5)C6=CC=CC=C6 D05SEV HIGHSTAT Investigative D05SFA DRUG__ID D05SFA D05SFA DRUGTYPE Small molecular drug D05SFA DRUGINCH 1S/C22H30O5/c1-3-4-5-6-15(2)20(23)8-7-18-19-12-16(9-10-27-14-22(25)26)11-17(19)13-21(18)24/h9,15,17-21,23-24H,3,6,10-14H2,1-2H3,(H,25,26)/b16-9+/t15-,17-,18+,19-,20+,21+/m0/s1 D05SFA DRUGINKE ARUGKOZUKWAXDS-SEWALLKFSA-N D05SFA DRUGSMIL CCC#CCC(C)C(C#CC1C(CC2C1CC(=CCOCC(=O)O)C2)O)O D05SFA HIGHSTAT Investigative D05SGJ DRUG__ID D05SGJ D05SGJ DRUGTYPE Small molecular drug D05SGJ DRUGINCH 1S/C5H10O3.Na/c6-4-2-1-3-5(7)8;/h6H,1-4H2,(H,7,8);/q;+1/p-1 D05SGJ DRUGINKE ZJDDLWNQIJLIQU-UHFFFAOYSA-M D05SGJ DRUGSMIL C(CCO)CC(=O)[O-].[Na+] D05SGJ HIGHSTAT Investigative D05SGV DRUG__ID D05SGV D05SGV DRUGTYPE Small molecular drug D05SGV DRUGINCH 1S/C17H15NO3/c19-14-11-16(18-7-9-20-10-8-18)21-15-6-5-12-3-1-2-4-13(12)17(14)15/h1-6,11H,7-10H2 D05SGV DRUGINKE UEWQIWVPOFKCFX-UHFFFAOYSA-N D05SGV DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC4=CC=CC=C43 D05SGV HIGHSTAT Investigative D05SKE DRUG__ID D05SKE D05SKE DRUGTYPE Small molecular drug D05SKE DRUGINCH 1S/C13H9BrN2/c14-10-1-2-11-12(8-16-13(11)7-10)9-3-5-15-6-4-9/h1-8,16H D05SKE DRUGINKE KLYDZCDPTMADJL-UHFFFAOYSA-N D05SKE DRUGSMIL C1=CC2=C(C=C1Br)NC=C2C3=CC=NC=C3 D05SKE HIGHSTAT Investigative D05SLL DRUG__ID D05SLL D05SLL DRUGTYPE Small molecular drug D05SLL DRUGINCH 1S/C23H36O5/c1-5-9-11-20(7-3)27-22(25)18-13-17(16-24)14-19(15-18)23(26)28-21(8-4)12-10-6-2/h13-15,20-21,24H,5-12,16H2,1-4H3 D05SLL DRUGINKE ZBGSOGNHNSNOLN-UHFFFAOYSA-N D05SLL DRUGSMIL CCCCC(CC)OC(=O)C1=CC(=CC(=C1)CO)C(=O)OC(CC)CCCC D05SLL HIGHSTAT Investigative D05SLY DRUG__ID D05SLY D05SLY DRUGTYPE Small molecular drug D05SLY DRUGINCH 1S/C17H27NO2/c1-3-4-5-6-14-7-9-15(10-8-14)11-12-17(20)16(13-19)18-2/h7-12,16-20H,3-6,13H2,1-2H3/b12-11+/t16-,17+/m1/s1 D05SLY DRUGINKE JYEXUQKROPHSEF-SFDDJJRUSA-N D05SLY DRUGSMIL CCCCCC1=CC=C(C=C1)C=CC(C(CO)NC)O D05SLY HIGHSTAT Investigative D05SLZ DRUG__ID D05SLZ D05SLZ DRUGTYPE Small molecular drug D05SLZ DRUGINCH 1S/C17H14O4/c1-20-13-5-2-11(3-6-13)8-14-10-16(19)15-7-4-12(18)9-17(15)21-14/h2-7,9-10,18H,8H2,1H3 D05SLZ DRUGINKE SKFOCRVUNCGDHR-UHFFFAOYSA-N D05SLZ DRUGSMIL COC1=CC=C(C=C1)CC2=CC(=O)C3=C(O2)C=C(C=C3)O D05SLZ HIGHSTAT Investigative D05SNG DRUG__ID D05SNG D05SNG DRUGTYPE Small molecular drug D05SNG DRUGINCH 1S/C13H8FNS/c14-12-2-1-9-5-11(7-15-13(9)6-12)10-3-4-16-8-10/h1-8H D05SNG DRUGINKE OQYVAKAMHRACJL-UHFFFAOYSA-N D05SNG DRUGSMIL C1=CC(=CC2=NC=C(C=C21)C3=CSC=C3)F D05SNG HIGHSTAT Investigative D05SNR DRUG__ID D05SNR D05SNR DRUGTYPE Small molecular drug D05SNR DRUGINCH 1S/C10H13N3OS2/c1-2-3-4-5-15-10-12-8-7(9(14)13-10)16-6-11-8/h6H,2-5H2,1H3,(H,12,13,14) D05SNR DRUGINKE QONMYXCFINJDMT-UHFFFAOYSA-N D05SNR DRUGSMIL CCCCCSC1=NC2=C(C(=O)N1)SC=N2 D05SNR HIGHSTAT Investigative D05SNS DRUG__ID D05SNS D05SNS DRUGTYPE Small molecular drug D05SNS DRUGINCH 1S/C8H13NO6/c10-6(9-15)3-1-5(8(13)14)2-4-7(11)12/h5,15H,1-4H2,(H,9,10)(H,11,12)(H,13,14) D05SNS DRUGINKE HTZIUDNKEYUDDE-UHFFFAOYSA-N D05SNS DRUGSMIL C(CC(=O)NO)C(CCC(=O)O)C(=O)O D05SNS HIGHSTAT Investigative D05SOU DRUG__ID D05SOU D05SOU DRUGTYPE Small molecular drug D05SOU DRUGINCH 1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13+ D05SOU DRUGINKE NCYCYZXNIZJOKI-OVSJKPMPSA-N D05SOU DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=O)C)C D05SOU HIGHSTAT Investigative D05SQA DRUG__ID D05SQA D05SQA DRUGTYPE Small molecular drug D05SQA DRUGINCH 1S/C30H34O4/c1-18(2)7-10-21-11-14-26-25(15-21)29(32)27(30(33)34-26)24-16-22(12-8-19(3)4)28(31)23(17-24)13-9-20(5)6/h7-9,11,14-17,27,31H,10,12-13H2,1-6H3 D05SQA DRUGINKE XVMLCODOINIZIF-UHFFFAOYSA-N D05SQA DRUGSMIL CC(=CCC1=CC2=C(C=C1)OC(=O)C(C2=O)C3=CC(=C(C(=C3)CC=C(C)C)O)CC=C(C)C)C D05SQA HIGHSTAT Investigative D05SRQ DRUG__ID D05SRQ D05SRQ DRUGTYPE Small molecular drug D05SRQ DRUGINCH 1S/C12H6N2O4S2/c15-11(7-3-1-5-19-7)9-10(14(17)18-13-9)12(16)8-4-2-6-20-8/h1-6H D05SRQ DRUGINKE RUQGCDMXFBOTMW-UHFFFAOYSA-N D05SRQ DRUGSMIL C1=CSC(=C1)C(=O)C2=NO[N+](=C2C(=O)C3=CC=CS3)[O-] D05SRQ HIGHSTAT Investigative D05SSB DRUG__ID D05SSB D05SSB DRUGTYPE Small molecular drug D05SSB DRUGINCH 1S/C9H7NO3/c11-8-5-6-3-1-2-4-7(6)9(12)10(8)13/h1-4,13H,5H2 D05SSB DRUGINKE ZXAICCBFIBBVAR-UHFFFAOYSA-N D05SSB DRUGSMIL C1C2=CC=CC=C2C(=O)N(C1=O)O D05SSB HIGHSTAT Investigative D05SVA DRUG__ID D05SVA D05SVA DRUGTYPE Small molecular drug D05SVA DRUGINCH 1S/C8H12N2O2/c11-8-5-7(12-10-8)6-1-3-9-4-2-6/h5-6,9H,1-4H2,(H,10,11) D05SVA DRUGINKE YYOYGSTYWVHCJR-UHFFFAOYSA-N D05SVA DRUGSMIL C1CNCCC1C2=CC(=O)NO2 D05SVA HIGHSTAT Investigative D05SWR DRUG__ID D05SWR D05SWR DRUGTYPE Small molecular drug D05SWR DRUGINCH 1S/C14H10Cl2N2O4/c1-22-13-5-2-8(6-12(13)18(20)21)14(19)17-11-7-9(15)3-4-10(11)16/h2-7H,1H3,(H,17,19) D05SWR DRUGINKE NGRNRPWPJLMWBI-UHFFFAOYSA-N D05SWR DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2=C(C=CC(=C2)Cl)Cl)[N+](=O)[O-] D05SWR HIGHSTAT Investigative D05SWY DRUG__ID D05SWY D05SWY DRUGTYPE Small molecular drug D05SWY DRUGINCH 1S/C11H14N2O/c1-13(2)7-8-6-12-9-4-3-5-10(14)11(8)9/h3-6,12,14H,7H2,1-2H3 D05SWY DRUGINKE YJJMKVPZBCHYHD-UHFFFAOYSA-N D05SWY DRUGSMIL CN(C)CC1=CNC2=C1C(=CC=C2)O D05SWY HIGHSTAT Investigative D05SXF DRUG__ID D05SXF D05SXF DRUGTYPE Small molecular drug D05SXF DRUGINCH 1S/C22H20FN3O2/c1-13-18(16-5-3-4-6-17(16)25-13)19-20(22(28)26(2)21(19)27)24-12-11-14-7-9-15(23)10-8-14/h3-10,24-25H,11-12H2,1-2H3 D05SXF DRUGINKE ZKJAZFUFPPSFCO-UHFFFAOYSA-N D05SXF DRUGSMIL CC1=C(C2=CC=CC=C2N1)C3=C(C(=O)N(C3=O)C)NCCC4=CC=C(C=C4)F D05SXF HIGHSTAT Investigative D05SXU DRUG__ID D05SXU D05SXU DRUGTYPE Small molecular drug D05SXU DRUGINCH 1S/C18H13NO3/c20-17(19-16-8-4-3-7-15(16)18(21)22)14-10-9-12-5-1-2-6-13(12)11-14/h1-11H,(H,19,20)(H,21,22) D05SXU DRUGINKE BBJZKXXWFJLNRR-UHFFFAOYSA-N D05SXU DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)NC3=CC=CC=C3C(=O)O D05SXU HIGHSTAT Investigative D05SYL DRUG__ID D05SYL D05SYL DRUGTYPE Small molecular drug D05SYL DRUGINCH 1S/C17H17N3O3/c1-3-21-14-6-5-13(11-15(14)22-4-2)17-19-16(20-23-17)12-7-9-18-10-8-12/h5-11H,3-4H2,1-2H3 D05SYL DRUGINKE MMKXHTDCKLZHIM-UHFFFAOYSA-N D05SYL DRUGSMIL CCOC1=C(C=C(C=C1)C2=NC(=NO2)C3=CC=NC=C3)OCC D05SYL HIGHSTAT Investigative D05SYY DRUG__ID D05SYY D05SYY DRUGTYPE Small molecular drug D05SYY DRUGINCH 1S/C14H9BrN2O/c15-13-7-6-10-12(18)8-11(16-14(10)17-13)9-4-2-1-3-5-9/h1-8H,(H,16,17,18) D05SYY DRUGINKE ZVIMMGQTBAKKGA-UHFFFAOYSA-N D05SYY DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(N2)N=C(C=C3)Br D05SYY HIGHSTAT Investigative D05SZH DRUG__ID D05SZH D05SZH DRUGTYPE Small molecular drug D05SZH DRUGINCH 1S/C18H17F2N3O2/c1-3-4-5-25-17-11(8-21-18-12(17)9-22-23-18)16(24)15-13(19)6-10(2)7-14(15)20/h6-9H,3-5H2,1-2H3,(H,21,22,23) D05SZH DRUGINKE SCFMWQIQBVZOQR-UHFFFAOYSA-N D05SZH DRUGSMIL CCCCOC1=C(C=NC2=NNC=C12)C(=O)C3=C(C=C(C=C3F)C)F D05SZH HIGHSTAT Investigative D05SZP DRUG__ID D05SZP D05SZP DRUGTYPE Small molecular drug D05SZP DRUGINCH 1S/C17H15NO2/c1-13(19)18-16-10-8-15(9-11-16)17(20)12-7-14-5-3-2-4-6-14/h2-12H,1H3,(H,18,19)/b12-7+ D05SZP DRUGINKE CUYJTAUCYGHYLW-KPKJPENVSA-N D05SZP DRUGSMIL CC(=O)NC1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2 D05SZP HIGHSTAT Investigative D05TEW DRUG__ID D05TEW D05TEW DRUGTYPE Small molecular drug D05TEW DRUGINCH 1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2H,3-4,7H2,1H3,(H,8,9)/b5-2+ D05TEW DRUGINKE KQFBUAIXCIGKAP-GORDUTHDSA-N D05TEW DRUGSMIL CC=C(CCC(=O)O)N D05TEW HIGHSTAT Investigative D05TFE DRUG__ID D05TFE D05TFE DRUGTYPE Small molecular drug D05TFE DRUGINCH 1S/C12H11N3O/c1-9-7-8-11(16)12(13-9)15-14-10-5-3-2-4-6-10/h2-8,16H,1H3 D05TFE DRUGINKE LOCPVWIREQIGNQ-UHFFFAOYSA-N D05TFE DRUGSMIL CC1=NC(=C(C=C1)O)N=NC2=CC=CC=C2 D05TFE HIGHSTAT Investigative D05TFM DRUG__ID D05TFM D05TFM DRUGTYPE Small molecular drug D05TFM DRUGINCH 1S/C12H10N2OS/c1-2-10-13-8-5-7-16-12(8)11(14-10)9-4-3-6-15-9/h3-7H,2H2,1H3 D05TFM DRUGINKE UPHUXPVSRYTEBO-UHFFFAOYSA-N D05TFM DRUGSMIL CCC1=NC2=C(C(=N1)C3=CC=CO3)SC=C2 D05TFM HIGHSTAT Investigative D05TGQ DRUG__ID D05TGQ D05TGQ DRUGTYPE Small molecular drug D05TGQ DRUGINCH 1S/C23H24N6O4/c24-20-17-21(27-12-26-20)29(22-19(32)18(31)16(11-30)33-22)23(28-17)25-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,12,16,18-19,22,30-32H,10-11H2,(H,25,28)(H2,24,26,27)/t16-,18-,19-,22-/m1/s1 D05TGQ DRUGINKE YJLIKUSWRSEPSM-WGQQHEPDSA-N D05TGQ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CNC3=NC4=C(N=CN=C4N3C5C(C(C(O5)CO)O)O)N D05TGQ HIGHSTAT Investigative D05TGU DRUG__ID D05TGU D05TGU DRUGTYPE Small molecular drug D05TGU DRUGINCH 1S/C12H12F4O/c13-10(11(17)12(14,15)16)8-4-7-9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8H2 D05TGU DRUGINKE ZJWMBXPFXFSELY-UHFFFAOYSA-N D05TGU DRUGSMIL C1=CC=C(C=C1)CCCC(C(=O)C(F)(F)F)F D05TGU HIGHSTAT Investigative D05THD DRUG__ID D05THD D05THD DRUGTYPE Small molecular drug D05THD DRUGINCH 1S/C19H15NO4S/c21-19(20-22)17-8-4-5-9-18(17)25(23,24)16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13,22H,(H,20,21) D05THD DRUGINKE WQRJSSRVHCJAKB-UHFFFAOYSA-N D05THD DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)C3=CC=CC=C3C(=O)NO D05THD HIGHSTAT Investigative D05THI DRUG__ID D05THI D05THI DRUGTYPE Small molecular drug D05THI DRUGINCH 1S/C13H9Cl2NO3S/c14-10-4-6-12(7-5-10)20(18,19)16-13(17)9-2-1-3-11(15)8-9/h1-8H,(H,16,17) D05THI DRUGINKE OPPZHIMBWGDCCT-UHFFFAOYSA-N D05THI DRUGSMIL C1=CC(=CC(=C1)Cl)C(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl D05THI HIGHSTAT Investigative D05TKO DRUG__ID D05TKO D05TKO DRUGCOMP Shanghai Hengrui Pharmaceutical Co Ltd D05TKO DRUGINCH 1S/C19H18F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(30)6-10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10H,2-4,6,8,26H2,1H3/t10-/m1/s1 D05TKO DRUGINKE WIIAMRXFUJLYEF-SNVBAGLBSA-N D05TKO DRUGSMIL COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)CC(CC3=CC(=C(C=C3F)F)F)N D05TKO HIGHSTAT Investigative D05TLB DRUG__ID D05TLB D05TLB DRUGTYPE Small molecular drug D05TLB DRUGINCH 1S/C8H19NO3S/c1-2-3-4-5-6-7-8-12-13(9,10)11/h2-8H2,1H3,(H2,9,10,11) D05TLB DRUGINKE ZXWAFSSPWCHAJT-UHFFFAOYSA-N D05TLB DRUGSMIL CCCCCCCCOS(=O)(=O)N D05TLB HIGHSTAT Investigative D05TMJ DRUG__ID D05TMJ D05TMJ DRUGTYPE Small molecular drug D05TMJ DRUGINCH 1S/C20H15N5O/c26-20(22-14-8-2-1-3-9-14)25-18-15-10-4-5-11-16(15)23-19(24-18)17-12-6-7-13-21-17/h1-13H,(H2,22,23,24,25,26) D05TMJ DRUGINKE XZUXPDFYRHJJLN-UHFFFAOYSA-N D05TMJ DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=N4 D05TMJ HIGHSTAT Investigative D05TNT DRUG__ID D05TNT D05TNT DRUGTYPE Small molecular drug D05TNT DRUGINCH 1S/C16H16N4O/c1-16(2)8-12-13(9-17)15(18)20(19-14(12)10-21-16)11-6-4-3-5-7-11/h3-8H,10,18H2,1-2H3 D05TNT DRUGINKE XQJQZTOXHGIQCA-UHFFFAOYSA-N D05TNT DRUGSMIL CC1(C=C2C(=NN(C(=C2C#N)N)C3=CC=CC=C3)CO1)C D05TNT HIGHSTAT Investigative D05TNX DRUG__ID D05TNX D05TNX DRUGTYPE Small molecular drug D05TNX DRUGINCH 1S/C23H29F3O6/c24-23(25,26)15-6-5-7-17(12-15)32-14-16(27)10-11-19-18(20(28)13-21(19)29)8-3-1-2-4-9-22(30)31/h1,3,5-7,10-12,16,18-21,27-29H,2,4,8-9,13-14H2,(H,30,31)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1 D05TNX DRUGINKE WWSWYXNVCBLWNZ-QIZQQNKQSA-N D05TNX DRUGSMIL C1C(C(C(C1O)C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)CC=CCCCC(=O)O)O D05TNX HIGHSTAT Investigative D05TOY DRUG__ID D05TOY D05TOY DRUGTYPE Small molecular drug D05TOY DRUGINCH 1S/C36H45N5O5/c1-21-13-22(2)15-26(14-21)19-31(34(44)39-30(33(38)43)18-25-9-6-5-7-10-25)40-35(45)32-11-8-12-41(32)36(46)29(37)20-28-23(3)16-27(42)17-24(28)4/h5-7,9-10,13-17,29-32,42H,8,11-12,18-20,37H2,1-4H3,(H2,38,43)(H,39,44)(H,40,45)/t29-,30-,31-,32-/m0/s1 D05TOY DRUGINKE GBRVPIBAPYVZMY-YDPTYEFTSA-N D05TOY DRUGSMIL CC1=CC(=CC(=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N)C D05TOY HIGHSTAT Investigative D05TPU DRUG__ID D05TPU D05TPU DRUGTYPE Small molecular drug D05TPU DRUGINCH 1S/C14H16N6O3/c1-21-7-5-9(23-3)8(22-2)4-6(7)12-17-10-11(15)18-14(16)20-13(10)19-12/h4-5H,1-3H3,(H5,15,16,17,18,19,20) D05TPU DRUGINKE RPTOJQVHIPKIRX-UHFFFAOYSA-N D05TPU DRUGSMIL COC1=CC(=C(C=C1C2=NC3=NC(=NC(=C3N2)N)N)OC)OC D05TPU HIGHSTAT Investigative D05TQP DRUG__ID D05TQP D05TQP DRUGTYPE Small molecular drug D05TQP DRUGINCH 1S/C19H16ClNO2S2/c20-16-8-12-18(13-9-16)24-14-15-6-10-17(11-7-15)21-25(22,23)19-4-2-1-3-5-19/h1-13,21H,14H2 D05TQP DRUGINKE WQKPRWBYNOIBTL-UHFFFAOYSA-N D05TQP DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CSC3=CC=C(C=C3)Cl D05TQP HIGHSTAT Investigative D05TQX DRUG__ID D05TQX D05TQX DRUGTYPE Small molecular drug D05TQX DRUGINCH 1S/C20H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)24-21-18-19-22/h9-10,21-22H,2-8,11-19H2,1H3/b10-9- D05TQX DRUGINKE WVNBOVPUAYEKIK-KTKRTIGZSA-N D05TQX DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)ONCCO D05TQX HIGHSTAT Investigative D05TRN DRUG__ID D05TRN D05TRN DRUGTYPE Small molecular drug D05TRN DRUGINCH 1S/C14H19NO5S/c15-21(17,18)20-13-9-7-11(8-10-13)14(16)19-12-5-3-1-2-4-6-12/h7-10,12H,1-6H2,(H2,15,17,18) D05TRN DRUGINKE ZJGRMZILHPHGTJ-UHFFFAOYSA-N D05TRN DRUGSMIL C1CCCC(CC1)OC(=O)C2=CC=C(C=C2)OS(=O)(=O)N D05TRN HIGHSTAT Investigative D05TRX DRUG__ID D05TRX D05TRX DRUGTYPE Small molecular drug D05TRX DRUGINCH 1S/C14H18N2O2/c1-3-13-16-12-8-4-6-11(14(12)18-13)7-5-9-15-10(2)17/h4,6,8H,3,5,7,9H2,1-2H3,(H,15,17) D05TRX DRUGINKE UGHYQTDENFVMRW-UHFFFAOYSA-N D05TRX DRUGSMIL CCC1=NC2=CC=CC(=C2O1)CCCNC(=O)C D05TRX HIGHSTAT Investigative D05TVG DRUG__ID D05TVG D05TVG DRUGTYPE Small molecular drug D05TVG DRUGINCH 1S/C20H40BrO6P.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(23)27-17-18(22)16-19(21)28(24,25)26;/h18-19,22H,2-17H2,1H3,(H2,24,25,26);/q;+1/p-1/t18-,19?;/m0./s1 D05TVG DRUGINKE XCUPLWPVEJCIBO-HMEPSURWSA-M D05TVG DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(CC(P(=O)(O)[O-])Br)O.[Na+] D05TVG HIGHSTAT Investigative D05TVT DRUG__ID D05TVT D05TVT DRUGTYPE Small molecular drug D05TVT DRUGINCH 1S/C17H21NO3/c1-4-11-7-8-15-13(9-11)16(19)14(10-18-15)17(20)21-12(5-2)6-3/h7-10,12H,4-6H2,1-3H3,(H,18,19) D05TVT DRUGINKE OLWFMJLLBYGGKS-UHFFFAOYSA-N D05TVT DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OC(CC)CC D05TVT HIGHSTAT Investigative D05TVU DRUG__ID D05TVU D05TVU DRUGTYPE Small molecular drug D05TVU DRUGINCH 1S/C16H20N2O/c17-15-10-9-13-7-4-8-14(16(13)18-15)19-11-12-5-2-1-3-6-12/h4,7-10,12H,1-3,5-6,11H2,(H2,17,18) D05TVU DRUGINKE OTJOSBTUERTNPP-UHFFFAOYSA-N D05TVU DRUGSMIL C1CCC(CC1)COC2=CC=CC3=C2N=C(C=C3)N D05TVU HIGHSTAT Investigative D05TWV DRUG__ID D05TWV D05TWV DRUGTYPE Small molecular drug D05TWV DRUGINCH 1S/C16H23NO2/c1-12-7-6-8-13(11-12)15(16(18)19-3)14-9-4-5-10-17(14)2/h6-8,11,14-15H,4-5,9-10H2,1-3H3/t14-,15-/m1/s1 D05TWV DRUGINKE NEQATLAJGKQCLO-HUUCEWRRSA-N D05TWV DRUGSMIL CC1=CC(=CC=C1)C(C2CCCCN2C)C(=O)OC D05TWV HIGHSTAT Investigative D05TZE DRUG__ID D05TZE D05TZE DRUGTYPE Small molecular drug D05TZE DRUGINCH 1S/C16H24N2O2/c1-3-8-18(9-4-2)10-7-12-5-6-14(19)16-13(12)11-15(20)17-16/h5-6,19H,3-4,7-11H2,1-2H3,(H,17,20) D05TZE DRUGINKE PVIICBUWKXYFAA-UHFFFAOYSA-N D05TZE DRUGSMIL CCCN(CCC)CCC1=C2CC(=O)NC2=C(C=C1)O D05TZE HIGHSTAT Investigative D05TZK DRUG__ID D05TZK D05TZK DRUGTYPE Small molecular drug D05TZK DRUGINCH 1S/C26H24N3.CHF3O3S/c1-27(2)21-15-13-19(14-16-21)17-23-22-11-7-8-12-24(22)29-26(23)18-25(28(29)3)20-9-5-4-6-10-20;2-1(3,4)8(5,6)7/h4-18H,1-3H3;(H,5,6,7)/q+1;/p-1 D05TZK DRUGINKE GWIVOWYTVDQWOM-UHFFFAOYSA-M D05TZK DRUGSMIL C[N+]1=C(C=C2N1C3=CC=CC=C3C2=CC4=CC=C(C=C4)N(C)C)C5=CC=CC=C5.C(F)(F)(F)S(=O)(=O)[O-] D05TZK HIGHSTAT Investigative D05TZN DRUG__ID D05TZN D05TZN DRUGTYPE Small molecular drug D05TZN DRUGINCH 1S/C50H73N13O11/c51-22-8-7-17-33(52)42(66)58-34(18-9-23-55-50(53)54)46(70)63-26-12-21-40(63)48(72)62-25-10-19-38(62)44(68)56-29-41(65)57-35(27-31-13-3-1-4-14-31)43(67)60-37(30-64)47(71)61-24-11-20-39(61)45(69)59-36(49(73)74)28-32-15-5-2-6-16-32/h1-6,13-16,33-40,64H,7-12,17-30,51-52H2,(H,56,68)(H,57,65)(H,58,66)(H,59,69)(H,60,67)(H,73,74)(H4,53,54,55)/t33-,34-,35-,36-,37-,38-,39-,40-/m0/s1 D05TZN DRUGINKE AILVBOHFGXNHCC-TZPCGENMSA-N D05TZN DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)O D05TZN HIGHSTAT Investigative D05TZP DRUG__ID D05TZP D05TZP DRUGTYPE Small molecular drug D05TZP DRUGINCH 1S/C21H31NO4/c1-21(2,3)26-19(24)15-16-22-20(25)18(23)14-10-5-4-7-11-17-12-8-6-9-13-17/h6,8-9,12-13H,4-5,7,10-11,14-16H2,1-3H3,(H,22,25) D05TZP DRUGINKE BTVXYIHQAQOQLT-UHFFFAOYSA-N D05TZP DRUGSMIL CC(C)(C)OC(=O)CCNC(=O)C(=O)CCCCCCC1=CC=CC=C1 D05TZP HIGHSTAT Investigative D05UBB DRUG__ID D05UBB D05UBB DRUGTYPE Small molecular drug D05UBB DRUGINCH 1S/C14H14ClFN2OS/c1-8(2)12(9-3-5-10(15)6-4-9)13(19)18-14-17-7-11(16)20-14/h3-8,12H,1-2H3,(H,17,18,19)/t12-/m0/s1 D05UBB DRUGINKE VMELOMANPNYLFR-LBPRGKRZSA-N D05UBB DRUGSMIL CC(C)C(C1=CC=C(C=C1)Cl)C(=O)NC2=NC=C(S2)F D05UBB HIGHSTAT Investigative D05UGC DRUG__ID D05UGC D05UGC DRUGTYPE Small molecular drug D05UGC DRUGINCH 1S/C19H32N4O11/c1-7(17(30)23-10(16(20)29)4-5-12(26)27)21-18(31)8(2)33-15-13(22-9(3)25)19(32)34-11(6-24)14(15)28/h7-8,10-11,13-15,19,24,28,32H,4-6H2,1-3H3,(H2,20,29)(H,21,31)(H,22,25)(H,23,30)(H,26,27)/t7-,8+,10+,11+,13+,14+,15+,19+/m0/s1 D05UGC DRUGINKE BSOQXXWZTUDTEL-ZUYCGGNHSA-N D05UGC DRUGSMIL CC(C(=O)NC(CCC(=O)O)C(=O)N)NC(=O)C(C)OC1C(C(OC(C1O)CO)O)NC(=O)C D05UGC HIGHSTAT Investigative D05UHB DRUG__ID D05UHB D05UHB DRUGTYPE Small molecular drug D05UHB DRUGINCH 1S/C11H21N3O4/c1-6(8(12)15)13-9(16)7(2)14-10(17)18-11(3,4)5/h6-7H,1-5H3,(H2,12,15)(H,13,16)(H,14,17)/t6-,7-/m0/s1 D05UHB DRUGINKE OAXZAMSRJZWMEV-BQBZGAKWSA-N D05UHB DRUGSMIL CC(C(=O)N)NC(=O)C(C)NC(=O)OC(C)(C)C D05UHB HIGHSTAT Investigative D05UHO DRUG__ID D05UHO D05UHO DRUGTYPE Small molecular drug D05UHO DRUGINCH 1S/C13H21NS/c1-4-14-11(3)10-12-6-8-13(9-7-12)15-5-2/h6-9,11,14H,4-5,10H2,1-3H3 D05UHO DRUGINKE UKMQZNZTCNFILP-UHFFFAOYSA-N D05UHO DRUGSMIL CCNC(C)CC1=CC=C(C=C1)SCC D05UHO HIGHSTAT Investigative D05UJT DRUG__ID D05UJT D05UJT DRUGTYPE Small molecular drug D05UJT DRUGINCH 1S/C18H13F3N4O2/c19-18(20,21)27-14-6-4-13(5-7-14)25-16-9-15(23-10-24-16)11-2-1-3-12(8-11)17(22)26/h1-10H,(H2,22,26)(H,23,24,25) D05UJT DRUGINKE WEVYNIUIFUYDGI-UHFFFAOYSA-N D05UJT DRUGSMIL C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F D05UJT HIGHSTAT Investigative D05UJV DRUG__ID D05UJV D05UJV DRUGTYPE Small molecular drug D05UJV DRUGINCH 1S/C19H26N2O/c1-3-4-7-12-20-19-15-8-5-6-9-17(15)21-18-11-10-14(22-2)13-16(18)19/h10-11,13H,3-9,12H2,1-2H3,(H,20,21) D05UJV DRUGINKE KBBSAAQAJDSCGH-UHFFFAOYSA-N D05UJV DRUGSMIL CCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D05UJV HIGHSTAT Investigative D05UKJ DRUG__ID D05UKJ D05UKJ DRUGTYPE Small molecular drug D05UKJ DRUGINCH 1S/C27H41NO2/c1-15-11-24-25(28-14-15)17(3)27(30-24)10-8-20-21-6-5-18-12-19(29)7-9-26(18,4)23(21)13-22(20)16(27)2/h5,15,17,19-21,23-25,28-29H,6-14H2,1-4H3/t15-,17+,19-,20-,21-,23-,24+,25-,26-,27-/m0/s1 D05UKJ DRUGINKE QASFUMOKHFSJGL-LAFRSMQTSA-N D05UKJ DRUGSMIL CC1CC2C(C(C3(O2)CCC4C5CC=C6CC(CCC6(C5CC4=C3C)C)O)C)NC1 D05UKJ HIGHSTAT Investigative D05ULV DRUG__ID D05ULV D05ULV DRUGTYPE Small molecular drug D05ULV DRUGINCH 1S/C16H17NO/c1-18-16-8-4-7-13-14(16)9-11-5-2-3-6-12(11)15(13)10-17/h2-8,15H,9-10,17H2,1H3 D05ULV DRUGINKE ZJILWLYMMRQWLR-UHFFFAOYSA-N D05ULV DRUGSMIL COC1=CC=CC2=C1CC3=CC=CC=C3C2CN D05ULV HIGHSTAT Investigative D05UMA DRUG__ID D05UMA D05UMA DRUGTYPE Small molecular drug D05UMA DRUGINCH 1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m1/s1 D05UMA DRUGINKE ZEUITGRIYCTCEM-QGZVFWFLSA-N D05UMA DRUGSMIL CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32 D05UMA HIGHSTAT Investigative D05UPM DRUG__ID D05UPM D05UPM DRUGTYPE Small molecular drug D05UPM DRUGINCH 1S/C22H18O3/c23-21-9-5-4-8-20(21)22(24)15-12-17-10-13-19(14-11-17)25-16-18-6-2-1-3-7-18/h1-15,23H,16H2/b15-12+ D05UPM DRUGINKE PQZKTWBQDPHGOU-NTCAYCPXSA-N D05UPM DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)C=CC(=O)C3=CC=CC=C3O D05UPM HIGHSTAT Investigative D05UPS DRUG__ID D05UPS D05UPS DRUGTYPE Small molecular drug D05UPS DRUGINCH 1S/C16H15NO3/c1-10-5-14(18)6-11(2)15(10)4-3-12-7-13(16(19)20)9-17-8-12/h3-9,18H,1-2H3,(H,19,20)/b4-3+ D05UPS DRUGINKE QHRQJLLCYNFCCT-ONEGZZNKSA-N D05UPS DRUGSMIL CC1=CC(=CC(=C1C=CC2=CC(=CN=C2)C(=O)O)C)O D05UPS HIGHSTAT Investigative D05UQC DRUG__ID D05UQC D05UQC DRUGTYPE Small molecular drug D05UQC DRUGINCH 1S/C23H27FN2O3/c1-13(2)21-19(10-9-18-11-17(27)12-20(28)29-18)22(26-23(25-21)14(3)4)15-5-7-16(24)8-6-15/h5-10,13-14,17-18,27H,11-12H2,1-4H3/b10-9+/t17-,18-/m1/s1 D05UQC DRUGINKE UTOIEVWJKDLJGE-AQRBRUGDSA-N D05UQC DRUGSMIL CC(C)C1=NC(=NC(=C1C=CC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F)C(C)C D05UQC HIGHSTAT Investigative D05URH DRUG__ID D05URH D05URH DRUGTYPE Small molecular drug D05URH DRUGINCH 1S/C34H46O14/c1-4-5-6-7-11-19-25(36)46-27-26(37)32(47-28(29(38)39)33(44,30(40)41)34(27,48-32)31(42)43)20-13-18-24(45-22(3)35)21(2)14-12-17-23-15-9-8-10-16-23/h8-10,12,15-17,21,24,26-28,37,44H,4-7,11,13-14,18-20H2,1-3H3,(H,38,39)(H,40,41)(H,42,43)/b17-12+/t21?,24?,26-,27-,28-,32+,33-,34+/m1/s1 D05URH DRUGINKE CGQGIYLITCUENM-FRHZWACMSA-N D05URH DRUGSMIL CCCCCCCC(=O)OC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCCC(C(C)CC=CC3=CC=CC=C3)OC(=O)C)O D05URH HIGHSTAT Investigative D05URN DRUG__ID D05URN D05URN DRUGTYPE Small molecular drug D05URN DRUGINCH 1S/C2H6/c1-2/h1-2H3 D05URN DRUGINKE OTMSDBZUPAUEDD-UHFFFAOYSA-N D05URN DRUGSMIL CC D05URN HIGHSTAT Investigative D05USH DRUG__ID D05USH D05USH DRUGTYPE Small molecular drug D05USH DRUGINCH 1S/C12H16FN.ClH/c13-12-3-1-10(2-4-12)9-11-5-7-14-8-6-11;/h1-4,11,14H,5-9H2;1H D05USH DRUGINKE OJKWWANXBGLGQN-UHFFFAOYSA-N D05USH DRUGSMIL C1CNCCC1CC2=CC=C(C=C2)F.Cl D05USH HIGHSTAT Investigative D05USL DRUG__ID D05USL D05USL DRUGTYPE Small molecular drug D05USL DRUGINCH 1S/C21H17NO3S2/c23-14-12-16(25-20(13-14)22-8-10-24-11-9-22)15-4-3-7-19-21(15)27-18-6-2-1-5-17(18)26-19/h1-7,12-13H,8-11H2 D05USL DRUGINKE XRKYMMUGXMWDAO-UHFFFAOYSA-N D05USL DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4 D05USL HIGHSTAT Investigative D05UTC DRUG__ID D05UTC D05UTC DRUGTYPE Small molecular drug D05UTC DRUGINCH 1S/C15H17N3S/c1-12-7-8-14(17-11-12)18-15(19)16-10-9-13-5-3-2-4-6-13/h2-8,11H,9-10H2,1H3,(H2,16,17,18,19) D05UTC DRUGINKE FTLVKPIQAUANGB-UHFFFAOYSA-N D05UTC DRUGSMIL CC1=CN=C(C=C1)NC(=S)NCCC2=CC=CC=C2 D05UTC HIGHSTAT Investigative D05UTX DRUG__ID D05UTX D05UTX DRUGTYPE Small molecular drug D05UTX DRUGINCH 1S/C17H21N5O/c1-3-4-9-22-14(10-12-5-7-13(23-2)8-6-12)21-15-16(18)19-11-20-17(15)22/h5-8,11H,3-4,9-10H2,1-2H3,(H2,18,19,20) D05UTX DRUGINKE NVYATAJRTRFKSW-UHFFFAOYSA-N D05UTX DRUGSMIL CCCCN1C(=NC2=C(N=CN=C21)N)CC3=CC=C(C=C3)OC D05UTX HIGHSTAT Investigative D05UUA DRUG__ID D05UUA D05UUA DRUGTYPE Small molecular drug D05UUA DRUGINCH 1S/C12H14ClN/c13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)14/h1-5,7,10,12H,6,8,14H2/t10-,12+/m1/s1 D05UUA DRUGINKE UAUINBMLUPAKPF-PWSUYJOCSA-N D05UUA DRUGSMIL C1C=CCC(C1C2=CC=CC=C2Cl)N D05UUA HIGHSTAT Investigative D05UUW DRUG__ID D05UUW D05UUW DRUGTYPE Small molecular drug D05UUW DRUGINCH 1S/C19H20N2O/c1-20-10-12-21(13-11-20)17-14-15-6-2-4-8-18(15)22-19-9-5-3-7-16(17)19/h2-9,14H,10-13H2,1H3 D05UUW DRUGINKE ZCCUIFWJESTQQQ-UHFFFAOYSA-N D05UUW DRUGSMIL CN1CCN(CC1)C2=CC3=CC=CC=C3OC4=CC=CC=C42 D05UUW HIGHSTAT Investigative D05UWQ DRUG__ID D05UWQ D05UWQ DRUGTYPE Small molecular drug D05UWQ DRUGINCH 1S/C23H25N3O3S/c1-4-28-15-9-10-20-16(13-15)14(2)21(29-20)23(27)26-19(11-12-30-3)22-24-17-7-5-6-8-18(17)25-22/h5-10,13,19H,4,11-12H2,1-3H3,(H,24,25)(H,26,27) D05UWQ DRUGINKE AIMYRLXVAOYQLA-UHFFFAOYSA-N D05UWQ DRUGSMIL CCOC1=CC2=C(C=C1)OC(=C2C)C(=O)NC(CCSC)C3=NC4=CC=CC=C4N3 D05UWQ HIGHSTAT Investigative D05UWW DRUG__ID D05UWW D05UWW DRUGTYPE Small molecular drug D05UWW DRUGINCH 1S/C34H32N2O4S2/c1-21(41-31-23-11-3-7-15-27(23)39-28-16-8-4-12-24(28)31)33(37)35-19-20-36-34(38)22(2)42-32-25-13-5-9-17-29(25)40-30-18-10-6-14-26(30)32/h3-18,21-22,31-32H,19-20H2,1-2H3,(H,35,37)(H,36,38) D05UWW DRUGINKE KBXOGBYQKMAAIA-UHFFFAOYSA-N D05UWW DRUGSMIL CC(C(=O)NCCNC(=O)C(C)SC1C2=CC=CC=C2OC3=CC=CC=C13)SC4C5=CC=CC=C5OC6=CC=CC=C46 D05UWW HIGHSTAT Investigative D05UWZ DRUG__ID D05UWZ D05UWZ DRUGTYPE Small molecular drug D05UWZ DRUGINCH 1S/C34H26O23/c35-11-1-7(2-12(36)19(11)39)31(50)57-34-27(47)29-23(43)16(55-34)6-53-32(51)8-3-13(37)20(40)24(44)17(8)18-9(33(52)56-29)5-15(22(42)25(18)45)54-28-10(30(48)49)4-14(38)21(41)26(28)46/h1-5,16,23,27,29,34-47H,6H2,(H,48,49)/t16-,23-,27-,29+,34+/m1/s1 D05UWZ DRUGINKE AJIFASHLGBHDDS-GEFDNOIESA-N D05UWZ DRUGSMIL C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)OC6=C(C(=C(C=C6C(=O)O)O)O)O)O D05UWZ HIGHSTAT Investigative D05UYC DRUG__ID D05UYC D05UYC DRUGTYPE Small molecular drug D05UYC DRUGINCH 1S/C9H6O6/c10-7(11)4-2-1-3-5(8(12)13)6(4)9(14)15/h1-3H,(H,10,11)(H,12,13)(H,14,15) D05UYC DRUGINKE UJMDYLWCYJJYMO-UHFFFAOYSA-N D05UYC DRUGSMIL C1=CC(=C(C(=C1)C(=O)O)C(=O)O)C(=O)O D05UYC HIGHSTAT Investigative D05UZY DRUG__ID D05UZY D05UZY DRUGTYPE Small molecular drug D05UZY DRUGINCH 1S/C23H21FN2O5/c24-15-2-3-17-18(27)11-22(31-20(17)10-15)23(28)25-16-5-7-26(8-6-16)12-14-1-4-19-21(9-14)30-13-29-19/h1-4,9-11,16H,5-8,12-13H2,(H,25,28) D05UZY DRUGINKE FVFURMJFTAJXRH-UHFFFAOYSA-N D05UZY DRUGSMIL C1CN(CCC1NC(=O)C2=CC(=O)C3=C(O2)C=C(C=C3)F)CC4=CC5=C(C=C4)OCO5 D05UZY HIGHSTAT Investigative D05VAB DRUG__ID D05VAB D05VAB DRUGTYPE Small molecular drug D05VAB DRUGINCH 1S/C19H16F2N6O/c20-13-3-4-14(21)16-15(13)17(23)26-19(25-16)5-7-27(8-6-19)18(28)11-1-2-12(9-22)24-10-11/h1-4,10,25H,5-8H2,(H2,23,26) D05VAB DRUGINKE GIZYIOOBBUHOBS-UHFFFAOYSA-N D05VAB DRUGSMIL C1CN(CCC12NC3=C(C=CC(=C3C(=N2)N)F)F)C(=O)C4=CN=C(C=C4)C#N D05VAB HIGHSTAT Investigative D05VAN DRUG__ID D05VAN D05VAN DRUGTYPE Small molecular drug D05VAN DRUGINCH 1S/C14H15N3/c1-2-17-10-12(9-16-8-7-15-11-16)13-5-3-4-6-14(13)17/h3-8,10-11H,2,9H2,1H3 D05VAN DRUGINKE KIIFZBAPVHIJQJ-UHFFFAOYSA-N D05VAN DRUGSMIL CCN1C=C(C2=CC=CC=C21)CN3C=CN=C3 D05VAN HIGHSTAT Investigative D05VEC DRUG__ID D05VEC D05VEC DRUGTYPE Small molecular drug D05VEC DRUGINCH 1S/C18H29N7O6/c19-18(20)21-5-1-2-11-16(30)22-8-13(26)24-12(7-14(27)28)17(31)23-10-4-3-9(6-10)15(29)25-11/h9-12H,1-8H2,(H,22,30)(H,23,31)(H,24,26)(H,25,29)(H,27,28)(H4,19,20,21)/t9-,10+,11+,12+/m1/s1 D05VEC DRUGINKE SLTMEZLQPRTTBL-RHYQMDGZSA-N D05VEC DRUGSMIL C1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D05VEC HIGHSTAT Investigative D05VEH DRUG__ID D05VEH D05VEH DRUGTYPE Small molecular drug D05VEH DRUGINCH 1S/C78H105ClN18O13/c1-7-83-78(84-8-2)86-34-14-13-21-58(68(102)92-60(37-45(3)4)69(103)91-59(22-15-35-85-77(81)82)76(110)97-36-16-23-66(97)75(109)88-46(5)67(80)101)90-71(105)62(40-49-27-32-55(100)33-28-49)94-74(108)65(44-98)96-73(107)64(42-53-43-87-57-20-12-11-19-56(53)57)95-72(106)63(39-48-25-30-54(79)31-26-48)93-70(104)61(89-47(6)99)41-50-24-29-51-17-9-10-18-52(51)38-50/h9-12,17-20,24-33,38,43,45-46,58-66,87,98,100H,7-8,13-16,21-23,34-37,39-42,44H2,1-6H3,(H2,80,101)(H,88,109)(H,89,99)(H,90,105)(H,91,103)(H,92,102)(H,93,104)(H,94,108)(H,95,106)(H,96,107)(H4,81,82,85)(H2,83,84,86)/t46-,58-,59+,60+,61-,62+,63-,64-,65+,66+/m1/s1 D05VEH DRUGINKE OFQNFLLLCMQNEP-MIPXGPCFSA-N D05VEH DRUGSMIL CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)NCC D05VEH HIGHSTAT Investigative D05VEV DRUG__ID D05VEV D05VEV DRUGTYPE Small molecular drug D05VEV DRUGINCH 1S/C29H46N4O6S/c1-19(2)17-24(15-16-40(7,38)39)32-27(35)21(5)30-29(37)26(18-20(3)4)33-28(36)25(31-22(6)34)14-13-23-11-9-8-10-12-23/h8-12,15-16,19-21,24-26H,13-14,17-18H2,1-7H3,(H,30,37)(H,31,34)(H,32,35)(H,33,36)/b16-15+/t21-,24+,25-,26-/m0/s1 D05VEV DRUGINKE WUQZWLVEKPBGGU-WXIXLNPNSA-N D05VEV DRUGSMIL CC(C)CC(C=CS(=O)(=O)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)C D05VEV HIGHSTAT Investigative D05VFP DRUG__ID D05VFP D05VFP DRUGTYPE Small molecular drug D05VFP DRUGINCH 1S/C20H21NO3/c22-19(20-21-12-14-24-20)9-3-1-2-6-13-23-18-11-10-16-7-4-5-8-17(16)15-18/h4-5,7-8,10-12,14-15H,1-3,6,9,13H2 D05VFP DRUGINKE BKNPQEYYRAPRRP-UHFFFAOYSA-N D05VFP DRUGSMIL C1=CC=C2C=C(C=CC2=C1)OCCCCCCC(=O)C3=NC=CO3 D05VFP HIGHSTAT Investigative D05VGC DRUG__ID D05VGC D05VGC DRUGTYPE Small molecular drug D05VGC DRUGINCH 1S/C18H20FN5O4/c1-9-2-4-11(18(26)27)14(6-9)22-17(25)12(20)7-15-23-16(24-28-15)13-5-3-10(19)8-21-13/h3,5,8-9,12H,2,4,6-7,20H2,1H3,(H,22,25)(H,26,27)/t9-,12+/m1/s1 D05VGC DRUGINKE CDYGJIFOATYSNF-SKDRFNHKSA-N D05VGC DRUGSMIL CC1CCC(=C(C1)NC(=O)C(CC2=NC(=NO2)C3=NC=C(C=C3)F)N)C(=O)O D05VGC HIGHSTAT Investigative D05VJH DRUG__ID D05VJH D05VJH DRUGTYPE Small molecular drug D05VJH DRUGINCH 1S/C30H42N2O11/c1-15(2)27(38)22(42-21(35)17-8-7-13-32-17)28(39)23(4)14-26(37)24(27,5)30(28,40)29(43-26)20(16(3)11-12-25(23,29)36)41-19(34)10-9-18(33)31-6/h7-8,13,15-16,20,22,32,36-40H,9-12,14H2,1-6H3,(H,31,33)/t16?,20-,22-,23+,24?,25?,26?,27?,28?,29?,30?/m1/s1 D05VJH DRUGINKE RWAKHARTDYCRMC-QYQZIFBLSA-N D05VJH DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CCC(=O)NC)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O D05VJH HIGHSTAT Investigative D05VKW DRUG__ID D05VKW D05VKW DRUGTYPE Small molecular drug D05VKW DRUGINCH 1S/C26H28O10/c1-10(2)5-12-17(11(3)4)26(19-23(34)13(6-27)20(31)14(7-28)24(19)35)36-25-16(9-30)21(32)15(8-29)22(33)18(12)25/h6-12,17,26,31-35H,5H2,1-4H3/t12-,17-,26-/m1/s1 D05VKW DRUGINKE PHQDMQGEKNBIPF-RAFFTOIBSA-N D05VKW DRUGSMIL CC(C)CC1C(C(OC2=C(C(=C(C(=C12)O)C=O)O)C=O)C3=C(C(=C(C(=C3O)C=O)O)C=O)O)C(C)C D05VKW HIGHSTAT Investigative D05VLU DRUG__ID D05VLU D05VLU DRUGTYPE Small molecular drug D05VLU DRUGINCH 1S/C12HF9N2O/c13-1-2(14)6(18)10(7(19)3(1)15)22-23-11-8(20)4(16)5(17)9(21)12(11)24/h24H D05VLU DRUGINKE VNLIKHWBADHUKM-UHFFFAOYSA-N D05VLU DRUGSMIL C1(=C(C(=C(C(=C1F)F)F)F)O)N=NC2=C(C(=C(C(=C2F)F)F)F)F D05VLU HIGHSTAT Investigative D05VLV DRUG__ID D05VLV D05VLV DRUGTYPE Small molecular drug D05VLV DRUGINCH 1S/C20H15NOS/c1-14-7-6-8-15(13-14)20(22)21-16-9-2-4-11-18(16)23-19-12-5-3-10-17(19)21/h2-13H,1H3 D05VLV DRUGINKE JSMJNESPMFVMAA-UHFFFAOYSA-N D05VLV DRUGSMIL CC1=CC(=CC=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D05VLV HIGHSTAT Investigative D05VOG DRUG__ID D05VOG D05VOG DRUGTYPE Small molecular drug D05VOG DRUGINCH 1S/C24H31FO4/c25-21-15-23(27)20(9-3-1-2-4-10-24(28)29)19(21)11-12-22(26)18-13-16-7-5-6-8-17(16)14-18/h1,3,5-8,11-12,18-23,26-27H,2,4,9-10,13-15H2,(H,28,29)/b3-1-,12-11+/t19-,20-,21+,22+,23+/m1/s1 D05VOG DRUGINKE WTYSXBKKVNOOIX-JTGCGUAKSA-N D05VOG DRUGSMIL C1C(C(C(C1F)C=CC(C2CC3=CC=CC=C3C2)O)CC=CCCCC(=O)O)O D05VOG HIGHSTAT Investigative D05VOH DRUG__ID D05VOH D05VOH DRUGTYPE Small molecular drug D05VOH DRUGINCH 1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+ D05VOH DRUGINKE DKHGMERMDICWDU-GHDNBGIDSA-N D05VOH DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C D05VOH HIGHSTAT Investigative D05VQJ DRUG__ID D05VQJ D05VQJ DRUGTYPE Small molecular drug D05VQJ DRUGINCH 1S/C21H34N4S2/c1-21(2)15-25-18(14-27-20(25)24-21)13-26-19(22-16-9-5-3-6-10-16)23-17-11-7-4-8-12-17/h14,16-17H,3-13,15H2,1-2H3,(H,22,23) D05VQJ DRUGINKE OOSUDWRRWZVFEB-UHFFFAOYSA-N D05VQJ DRUGSMIL CC1(CN2C(=CSC2=N1)CSC(=NC3CCCCC3)NC4CCCCC4)C D05VQJ HIGHSTAT Investigative D05VRO DRUG__ID D05VRO D05VRO DRUGTYPE Small molecular drug D05VRO DRUGINCH 1S/C28H48OS/c1-23(2)13-11-21-30-22-12-18-25(4)15-9-8-14-24(3)16-10-17-26(5)19-20-27-28(6,7)29-27/h13-15,17,27H,8-12,16,18-22H2,1-7H3/b24-14?,25-15+,26-17+ D05VRO DRUGINKE SFOVLQYHQCMFTD-VLUDVKJZSA-N D05VRO DRUGSMIL CC(=CCCSCCCC(=CCCC=C(C)CCC=C(C)CCC1C(O1)(C)C)C)C D05VRO HIGHSTAT Investigative D05VSK DRUG__ID D05VSK D05VSK DRUGTYPE Small molecular drug D05VSK DRUGINCH 1S/C11H10O3/c1-2-13-10-7-8-5-3-4-6-9(8)14-11(10)12/h3-7H,2H2,1H3 D05VSK DRUGINKE PPGXDBJURPEKDZ-UHFFFAOYSA-N D05VSK DRUGSMIL CCOC1=CC2=CC=CC=C2OC1=O D05VSK HIGHSTAT Investigative D05VTT DRUG__ID D05VTT D05VTT DRUGTYPE Small molecular drug D05VTT DRUGINCH 1S/C14H14F3N/c15-14(16,17)11-3-1-9(2-4-11)10-7-12-5-6-13(8-10)18-12/h1-4,7,12-13,18H,5-6,8H2 D05VTT DRUGINKE TVAPTTJJXRUWFI-UHFFFAOYSA-N D05VTT DRUGSMIL C1CC2C=C(CC1N2)C3=CC=C(C=C3)C(F)(F)F D05VTT HIGHSTAT Investigative D05VUA DRUG__ID D05VUA D05VUA DRUGTYPE Small molecular drug D05VUA DRUGINCH 1S/C12H10O4/c1-7(13)9-5-8-3-4-12(14)16-10(8)6-11(9)15-2/h3-6H,1-2H3 D05VUA DRUGINKE QDWMZGNQFSIPKO-UHFFFAOYSA-N D05VUA DRUGSMIL CC(=O)C1=C(C=C2C(=C1)C=CC(=O)O2)OC D05VUA HIGHSTAT Investigative D05VUC DRUG__ID D05VUC D05VUC DRUGTYPE Small molecular drug D05VUC DRUGINCH 1S/C14H10F2O2/c15-11-7-3-1-5-9(11)13(17)14(18)10-6-2-4-8-12(10)16/h1-8,13,17H D05VUC DRUGINKE XQFHNDNXOUWJPU-UHFFFAOYSA-N D05VUC DRUGSMIL C1=CC=C(C(=C1)C(C(=O)C2=CC=CC=C2F)O)F D05VUC HIGHSTAT Investigative D05VVC DRUG__ID D05VVC D05VVC DRUGTYPE Small molecular drug D05VVC DRUGINCH 1S/C8H5ClN2O3/c9-4-1-2-5-6(3-4)10-8(13)11(14)7(5)12/h1-3,14H,(H,10,13) D05VVC DRUGINKE CRTPJJNXJPKDEZ-UHFFFAOYSA-N D05VVC DRUGSMIL C1=CC2=C(C=C1Cl)NC(=O)N(C2=O)O D05VVC HIGHSTAT Investigative D05VWZ DRUG__ID D05VWZ D05VWZ DRUGTYPE Small molecular drug D05VWZ DRUGINCH 1S/C12H12O6/c13-10(14)6-9(12(17)18)5-7-2-1-3-8(4-7)11(15)16/h1-4,9H,5-6H2,(H,13,14)(H,15,16)(H,17,18) D05VWZ DRUGINKE WCLWDNBZTFVGIR-UHFFFAOYSA-N D05VWZ DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CC(=O)O)C(=O)O D05VWZ HIGHSTAT Investigative D05VXX DRUG__ID D05VXX D05VXX DRUGTYPE Small molecular drug D05VXX DRUGINCH 1S/C16H16Cl2O2/c1-2-3-4-11-5-7-16(14(19)9-11)20-15-8-6-12(17)10-13(15)18/h5-10,19H,2-4H2,1H3 D05VXX DRUGINKE YJSDMDYNCMZAED-UHFFFAOYSA-N D05VXX DRUGSMIL CCCCC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D05VXX HIGHSTAT Investigative D05WDV DRUG__ID D05WDV D05WDV DRUGTYPE Small molecular drug D05WDV DRUGINCH 1S/C8H8BrNO2/c9-6-3-1-2-5(4-6)7(10)8(11)12/h1-4,7H,10H2,(H,11,12) D05WDV DRUGINKE MJPMYLPJAVQUQA-UHFFFAOYSA-N D05WDV DRUGSMIL C1=CC(=CC(=C1)Br)C(C(=O)O)N D05WDV HIGHSTAT Investigative D05WEF DRUG__ID D05WEF D05WEF DRUGTYPE Small molecular drug D05WEF DRUGINCH 1S/C17H13N3O4/c21-16(17(22)19-9-11-4-2-1-3-5-11)14-10-18-15-7-6-12(20(23)24)8-13(14)15/h1-8,10,18H,9H2,(H,19,22) D05WEF DRUGINKE JYXHNHBKWZQGLB-UHFFFAOYSA-N D05WEF DRUGSMIL C1=CC=C(C=C1)CNC(=O)C(=O)C2=CNC3=C2C=C(C=C3)[N+](=O)[O-] D05WEF HIGHSTAT Investigative D05WFQ DRUG__ID D05WFQ D05WFQ DRUGTYPE Small molecular drug D05WFQ DRUGINCH 1S/C17H16ClNOS/c1-19-8-9-20-15-10-12-4-2-3-5-16(12)21-17-7-6-13(18)11-14(15)17/h2-7,10-11,19H,8-9H2,1H3 D05WFQ DRUGINKE OVVBIIBBRZVPAL-UHFFFAOYSA-N D05WFQ DRUGSMIL CNCCOC1=CC2=CC=CC=C2SC3=C1C=C(C=C3)Cl D05WFQ HIGHSTAT Investigative D05WGA DRUG__ID D05WGA D05WGA DRUGTYPE Small molecular drug D05WGA DRUGINCH 1S/C12H12N2O2S/c1-16-10-4-2-9(3-5-10)8-11(15)14-12-13-6-7-17-12/h2-7H,8H2,1H3,(H,13,14,15) D05WGA DRUGINKE SPAPWVUPZKTBMH-UHFFFAOYSA-N D05WGA DRUGSMIL COC1=CC=C(C=C1)CC(=O)NC2=NC=CS2 D05WGA HIGHSTAT Investigative D05WHD DRUG__ID D05WHD D05WHD DRUGTYPE Small molecular drug D05WHD DRUGINCH 1S/C37H37N5O4/c1-26-11-13-27(14-12-26)30-7-3-4-8-31(30)36(45)38-29-17-15-28(16-18-29)37(46)41-20-19-34(43)42(33-10-6-5-9-32(33)41)25-35(44)40-23-21-39(2)22-24-40/h3-18H,19-25H2,1-2H3,(H,38,45) D05WHD DRUGINKE IOISKVCNGOOFMR-UHFFFAOYSA-N D05WHD DRUGSMIL CC1=CC=C(C=C1)C2=CC=CC=C2C(=O)NC3=CC=C(C=C3)C(=O)N4CCC(=O)N(C5=CC=CC=C54)CC(=O)N6CCN(CC6)C D05WHD HIGHSTAT Investigative D05WHM DRUG__ID D05WHM D05WHM DRUGTYPE Small molecular drug D05WHM DRUGINCH 1S/C22H25N7O5/c1-2-11(9-14-10-25-19-17(26-14)18(23)28-22(24)29-19)12-3-5-13(6-4-12)20(32)27-15(21(33)34)7-8-16(30)31/h3-6,10-11,15H,2,7-9H2,1H3,(H,27,32)(H,30,31)(H,33,34)(H4,23,24,25,28,29)/t11?,15-/m0/s1 D05WHM DRUGINKE FSIRXIHZBIXHKT-MHTVFEQDSA-N D05WHM DRUGSMIL CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D05WHM HIGHSTAT Investigative D05WKI DRUG__ID D05WKI D05WKI DRUGTYPE Small molecular drug D05WKI DRUGINCH 1S/C20H23NO2/c1-3-20(22)21-13-17-11-15-7-5-4-6-14(15)10-16-8-9-18(23-2)12-19(16)17/h4-9,12,17H,3,10-11,13H2,1-2H3,(H,21,22) D05WKI DRUGINKE FRJHLFANQUOSEH-UHFFFAOYSA-N D05WKI DRUGSMIL CCC(=O)NCC1CC2=CC=CC=C2CC3=C1C=C(C=C3)OC D05WKI HIGHSTAT Investigative D05WNC DRUG__ID D05WNC D05WNC DRUGTYPE Small molecular drug D05WNC DRUGINCH 1S/C46H59N11O9/c1-2-3-12-33-41(62)55-35(18-20-39(59)60)43(64)56-36(23-26-15-16-27-9-4-5-10-28(27)22-26)44(65)54-34(14-8-21-50-46(48)49)42(63)57-37(24-29-25-51-31-13-7-6-11-30(29)31)45(66)53-32(40(47)61)17-19-38(58)52-33/h4-7,9-11,13,15-16,22,25,32-37,51H,2-3,8,12,14,17-21,23-24H2,1H3,(H2,47,61)(H,52,58)(H,53,66)(H,54,65)(H,55,62)(H,56,64)(H,57,63)(H,59,60)(H4,48,49,50)/t32-,33-,34-,35-,36+,37-/m0/s1 D05WNC DRUGINKE PAILFUNFWZLMMN-BWBQVKFQSA-N D05WNC DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CCC(=O)O D05WNC HIGHSTAT Investigative D05WON DRUG__ID D05WON D05WON DRUGTYPE Small molecular drug D05WON DRUGINCH 1S/C17H16Cl3F3N2O3S/c1-25(2)5-6-28-15-9-11(3-4-12(15)18)24-29(26,27)16-13(19)7-10(8-14(16)20)17(21,22)23/h3-4,7-9,24H,5-6H2,1-2H3 D05WON DRUGINKE UIZHOFJFIOCYLH-UHFFFAOYSA-N D05WON DRUGSMIL CN(C)CCOC1=C(C=CC(=C1)NS(=O)(=O)C2=C(C=C(C=C2Cl)C(F)(F)F)Cl)Cl D05WON HIGHSTAT Investigative D05WPH DRUG__ID D05WPH D05WPH DRUGTYPE Small molecular drug D05WPH DRUGINCH 1S/C20H22N2O/c23-19(17-8-16-3-1-2-4-18(16)21-12-17)22-20-9-13-5-14(10-20)7-15(6-13)11-20/h1-4,8,12-15H,5-7,9-11H2,(H,22,23) D05WPH DRUGINKE FVQAOJSJLLDAKM-UHFFFAOYSA-N D05WPH DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)C4=CC5=CC=CC=C5N=C4 D05WPH HIGHSTAT Investigative D05WQF DRUG__ID D05WQF D05WQF DRUGTYPE Small molecular drug D05WQF DRUGINCH 1S/C9H8O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-6,10H,(H,11,12)/b6-5+ D05WQF DRUGINKE PMOWTIHVNWZYFI-AATRIKPKSA-N D05WQF DRUGSMIL C1=CC=C(C(=C1)C=CC(=O)O)O D05WQF HIGHSTAT Investigative D05WQN DRUG__ID D05WQN D05WQN DRUGTYPE Small molecular drug D05WQN DRUGINCH 1S/C16H20N2O/c1-11-9-13-10-14(7-8-15(13)17-11)18-16(19)12-5-3-2-4-6-12/h7-10,12,17H,2-6H2,1H3,(H,18,19) D05WQN DRUGINKE VFQGCSZINPSFBG-UHFFFAOYSA-N D05WQN DRUGSMIL CC1=CC2=C(N1)C=CC(=C2)NC(=O)C3CCCCC3 D05WQN HIGHSTAT Investigative D05WSM DRUG__ID D05WSM D05WSM DRUGTYPE Small molecular drug D05WSM DRUGINCH 1S/C29H32N4O3S/c1-2-37(35,36)32-24-15-16-26-25(19-24)27(29(34)31-26)28(22-9-5-3-6-10-22)30-23-13-11-21(12-14-23)20-33-17-7-4-8-18-33/h3,5-6,9-16,19,31-32,34H,2,4,7-8,17-18,20H2,1H3 D05WSM DRUGINKE HYHIYZMIFPJROG-UHFFFAOYSA-N D05WSM DRUGSMIL CCS(=O)(=O)NC1=CC2=C(C=C1)NC(=C2C(=NC3=CC=C(C=C3)CN4CCCCC4)C5=CC=CC=C5)O D05WSM HIGHSTAT Investigative D05WSU DRUG__ID D05WSU D05WSU DRUGTYPE Small molecular drug D05WSU DRUGINCH 1S/C8H12N2O7/c11-1-2-3(12)4(13)5(14)8(17-2)6(15)9-7(16)10-8/h2-5,11-14H,1H2,(H2,9,10,15,16)/t2-,3-,4+,5-,8+/m1/s1 D05WSU DRUGINKE QRXBDPYWCAAAAI-WWHASAIZSA-N D05WSU DRUGSMIL C(C1C(C(C(C2(O1)C(=O)NC(=O)N2)O)O)O)O D05WSU HIGHSTAT Investigative D05WTI DRUG__ID D05WTI D05WTI DRUGTYPE Small molecular drug D05WTI DRUGINCH 1S/C16H13N3/c1-2-7-12(8-3-1)17-16-14-10-11-6-4-5-9-13(11)15(14)18-19-16/h1-9H,10H2,(H2,17,18,19) D05WTI DRUGINKE HXUODZKNCJWKGP-UHFFFAOYSA-N D05WTI DRUGSMIL C1C2=CC=CC=C2C3=C1C(=NN3)NC4=CC=CC=C4 D05WTI HIGHSTAT Investigative D05WXF DRUG__ID D05WXF D05WXF DRUGTYPE Small molecular drug D05WXF DRUGINCH 1S/C12H14N4OS/c1-7-10(3-4-17)18-12-15-11-9(6-16(7)12)5-13-8(2)14-11/h5,17H,3-4,6H2,1-2H3 D05WXF DRUGINKE GTQXMAIXVFLYKF-UHFFFAOYSA-N D05WXF DRUGSMIL CC1=C(SC2=NC3=NC(=NC=C3CN12)C)CCO D05WXF HIGHSTAT Investigative D05WYN DRUG__ID D05WYN D05WYN DRUGTYPE Small molecular drug D05WYN DRUGINCH 1S/C17H23N3O2/c21-17-15-7-4-3-6-14(15)16(18-19-17)8-2-1-5-9-20-10-12-22-13-11-20/h3-4,6-7H,1-2,5,8-13H2,(H,19,21) D05WYN DRUGINKE OSFRDFHBAQDMGC-UHFFFAOYSA-N D05WYN DRUGSMIL C1COCCN1CCCCCC2=NNC(=O)C3=CC=CC=C32 D05WYN HIGHSTAT Investigative D05WZA DRUG__ID D05WZA D05WZA DRUGTYPE Small molecular drug D05WZA DRUGINCH 1S/C19H25NO/c21-19-13-11-18(12-14-19)10-6-16-20-15-5-4-9-17-7-2-1-3-8-17/h1-3,7-8,11-14,20-21H,4-6,9-10,15-16H2 D05WZA DRUGINKE NXJFACHOHAZIMY-UHFFFAOYSA-N D05WZA DRUGSMIL C1=CC=C(C=C1)CCCCNCCCC2=CC=C(C=C2)O D05WZA HIGHSTAT Investigative D05WZF DRUG__ID D05WZF D05WZF DRUGTYPE Small molecular drug D05WZF DRUGINCH 1S/C28H38FN5O6S/c1-34(2)41(38,39)32-16-4-3-8-24(25(35)26(36)31-19-22-7-5-15-30-18-22)33-27(37)40-20-28(13-6-14-28)17-21-9-11-23(29)12-10-21/h5,7,9-12,15,18,24,32H,3-4,6,8,13-14,16-17,19-20H2,1-2H3,(H,31,36)(H,33,37)/t24-/m0/s1 D05WZF DRUGINKE AAYZJXOZLLKNGZ-DEOSSOPVSA-N D05WZF DRUGSMIL CN(C)S(=O)(=O)NCCCCC(C(=O)C(=O)NCC1=CN=CC=C1)NC(=O)OCC2(CCC2)CC3=CC=C(C=C3)F D05WZF HIGHSTAT Investigative D05WZK DRUG__ID D05WZK D05WZK DRUGTYPE Small molecular drug D05WZK DRUGINCH 1S/C13H24O3/c1-8(2)11-6-5-9(3)7-12(11)16-13(15)10(4)14/h8-12,14H,5-7H2,1-4H3/t9-,10?,11+,12-/m1/s1 D05WZK DRUGINKE UJNOLBSYLSYIBM-SGUBAKSOSA-N D05WZK DRUGSMIL CC1CCC(C(C1)OC(=O)C(C)O)C(C)C D05WZK HIGHSTAT Investigative D05XAN DRUG__ID D05XAN D05XAN DRUGTYPE Small molecular drug D05XAN DRUGINCH 1S/C19H23NOS/c21-19(13-6-1-2-7-14-22)20-18-12-8-11-17(15-18)16-9-4-3-5-10-16/h3-5,8-12,15,22H,1-2,6-7,13-14H2,(H,20,21) D05XAN DRUGINKE VJSUVWGNKFMQET-UHFFFAOYSA-N D05XAN DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)CCCCCCS D05XAN HIGHSTAT Investigative D05XCV DRUG__ID D05XCV D05XCV DRUGTYPE Small molecular drug D05XCV DRUGINCH 1S/C36H40N6O5/c1-23(43)42-18-10-17-32(42)36(47)41-30(20-25-13-6-3-7-14-25)34(45)40-31(21-26-22-38-28-16-9-8-15-27(26)28)35(46)39-29(33(37)44)19-24-11-4-2-5-12-24/h2-9,11-16,22,29-32,38H,10,17-21H2,1H3,(H2,37,44)(H,39,46)(H,40,45)(H,41,47)/t29-,30-,31+,32+/m0/s1 D05XCV DRUGINKE WEBVKDVBAOYUMD-GASGPIRDSA-N D05XCV DRUGSMIL CC(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)N D05XCV HIGHSTAT Investigative D05XEF DRUG__ID D05XEF D05XEF DRUGTYPE Small molecular drug D05XEF DRUGINCH 1S/C15H20N2O2/c1-2-3-4-8-11-15(12-9-6-5-7-10-12)13(18)16-14(19)17-15/h5-7,9-10H,2-4,8,11H2,1H3,(H2,16,17,18,19) D05XEF DRUGINKE QUCQUPBUCULYGF-UHFFFAOYSA-N D05XEF DRUGSMIL CCCCCCC1(C(=O)NC(=O)N1)C2=CC=CC=C2 D05XEF HIGHSTAT Investigative D05XGF DRUG__ID D05XGF D05XGF DRUGTYPE Small molecular drug D05XGF DRUGINCH 1S/C25H27ClN6O4S/c1-2-11-32-24(33)21-23(29-25(32)34)28-22(27-21)18-5-9-20(10-6-18)37(35,36)31-14-12-30(13-15-31)16-17-3-7-19(26)8-4-17/h3-10H,2,11-16H2,1H3,(H,27,28)(H,29,34) D05XGF DRUGINKE JQZJACVYMPKVDS-UHFFFAOYSA-N D05XGF DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)CC5=CC=C(C=C5)Cl D05XGF HIGHSTAT Investigative D05XGI DRUG__ID D05XGI D05XGI DRUGTYPE Small molecular drug D05XGI DRUGINCH 1S/C9H11NO3/c10-8(9(12)13)5-6-2-1-3-7(11)4-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1 D05XGI DRUGINKE JZKXXXDKRQWDET-QMMMGPOBSA-N D05XGI DRUGSMIL C1=CC(=CC(=C1)O)CC(C(=O)O)N D05XGI HIGHSTAT Investigative D05XGR DRUG__ID D05XGR D05XGR DRUGTYPE Small molecular drug D05XGR DRUGINCH 1S/C18H22BrN3O3S/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16/h3-8,13,20H,9-12H2,1-2H3 D05XGR DRUGINKE OZYPUQNRUYTZDI-UHFFFAOYSA-N D05XGR DRUGSMIL CN1CCN(CC1)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)Br)OC D05XGR HIGHSTAT Investigative D05XGZ DRUG__ID D05XGZ D05XGZ DRUGTYPE Small molecular drug D05XGZ DRUGINCH 1S/C18H16O3/c1-20-17-9-15(10-18(11-17)21-2)13-3-4-14-8-16(19)6-5-12(14)7-13/h3-11,19H,1-2H3 D05XGZ DRUGINKE HYWKEQNSMAOKKU-UHFFFAOYSA-N D05XGZ DRUGSMIL COC1=CC(=CC(=C1)C2=CC3=C(C=C2)C=C(C=C3)O)OC D05XGZ HIGHSTAT Investigative D05XKT DRUG__ID D05XKT D05XKT DRUGTYPE Small molecular drug D05XKT DRUGINCH 1S/C15H11N3O2/c19-14(16-10-6-2-1-3-7-10)13-11-8-4-5-9-12(11)17-15(20)18-13/h1-9H,(H,16,19)(H,17,18,20) D05XKT DRUGINKE IBKXBRUBWALIOJ-UHFFFAOYSA-N D05XKT DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=NC(=O)NC3=CC=CC=C32 D05XKT HIGHSTAT Investigative D05XLD DRUG__ID D05XLD D05XLD DRUGTYPE Small molecular drug D05XLD DRUGINCH 1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)5-6-3-1-2-4-8-6/h1-4,7H,5H2,(H2,9,10,11)(H2,12,13,14) D05XLD DRUGINKE NGMZSXZBZNXBGX-UHFFFAOYSA-N D05XLD DRUGSMIL C1=CC=NC(=C1)CC(P(=O)(O)O)P(=O)(O)O D05XLD HIGHSTAT Investigative D05XMG DRUG__ID D05XMG D05XMG DRUGTYPE Small molecular drug D05XMG DRUGINCH 1S/C20H21N3O/c1-22(2)13-14-6-8-15(9-7-14)18-12-16-4-3-5-17-19(16)23(18)11-10-21-20(17)24/h3-9,12H,10-11,13H2,1-2H3,(H,21,24) D05XMG DRUGINKE PISBNXWDAGANOP-UHFFFAOYSA-N D05XMG DRUGSMIL CN(C)CC1=CC=C(C=C1)C2=CC3=C4N2CCNC(=O)C4=CC=C3 D05XMG HIGHSTAT Investigative D05XMM DRUG__ID D05XMM D05XMM DRUGTYPE Small molecular drug D05XMM DRUGINCH 1S/C18H28N2O2/c1-4-5-6-7-13-19-18(22)16-10-8-15(9-11-16)17(21)12-14-20(2)3/h8-11H,4-7,12-14H2,1-3H3,(H,19,22) D05XMM DRUGINKE BARBHIHQBFLEIN-UHFFFAOYSA-N D05XMM DRUGSMIL CCCCCCNC(=O)C1=CC=C(C=C1)C(=O)CCN(C)C D05XMM HIGHSTAT Investigative D05XNR DRUG__ID D05XNR D05XNR DRUGTYPE Small molecular drug D05XNR DRUGINCH 1S/C8H9NO/c10-7-1-2-8-6(5-7)3-4-9-8/h1-2,5,9-10H,3-4H2 D05XNR DRUGINKE MPCXQPXCYDDJSR-UHFFFAOYSA-N D05XNR DRUGSMIL C1CNC2=C1C=C(C=C2)O D05XNR HIGHSTAT Investigative D05XNS DRUG__ID D05XNS D05XNS DRUGTYPE Small molecular drug D05XNS DRUGINCH 1S/C19H16N2O/c1-14-7-5-12-18(20-14)21-19(22)17-11-6-10-16(13-17)15-8-3-2-4-9-15/h2-13H,1H3,(H,20,21,22) D05XNS DRUGINKE WRRMPYACQDSPSL-UHFFFAOYSA-N D05XNS DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CC=CC(=C2)C3=CC=CC=C3 D05XNS HIGHSTAT Investigative D05XPL DRUG__ID D05XPL D05XPL DRUGTYPE Small molecular drug D05XPL DRUGINCH 1S/C12H10N2/c1-14-7-6-10-9-4-2-3-5-11(9)13-12(10)8-14/h2-8H,1H3/p+1 D05XPL DRUGINKE UDHBHTHWWOQPBW-UHFFFAOYSA-O D05XPL DRUGSMIL C[N+]1=CC2=C(C=C1)C3=CC=CC=C3N2 D05XPL HIGHSTAT Investigative D05XPT DRUG__ID D05XPT D05XPT DRUGTYPE Small molecular drug D05XPT DRUGINCH 1S/C22H18O4/c1-15-13-16(14-21(23)24)7-12-20(15)22(25)17-8-10-19(11-9-17)26-18-5-3-2-4-6-18/h2-13H,14H2,1H3,(H,23,24) D05XPT DRUGINKE XPAYPQXQKZWIEL-UHFFFAOYSA-N D05XPT DRUGSMIL CC1=C(C=CC(=C1)CC(=O)O)C(=O)C2=CC=C(C=C2)OC3=CC=CC=C3 D05XPT HIGHSTAT Investigative D05XPU DRUG__ID D05XPU D05XPU DRUGTYPE Small molecular drug D05XPU DRUGINCH 1S/C28H38N6O6S/c1-17(32-27(39)21(29)14-19-8-10-20(35)11-9-19)26(38)31-16-24(36)33-23(15-18-6-4-3-5-7-18)28(40)34-22(25(30)37)12-13-41-2/h3-11,17,21-23,35H,12-16,29H2,1-2H3,(H2,30,37)(H,31,38)(H,32,39)(H,33,36)(H,34,40)/t17-,21-,22-,23-/m0/s1 D05XPU DRUGINKE ANZXICRKKYOVMY-ZMVGRULKSA-N D05XPU DRUGSMIL CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N D05XPU HIGHSTAT Investigative D05XPV DRUG__ID D05XPV D05XPV DRUGTYPE Small molecular drug D05XPV DRUGINCH 1S/C19H24N2O8S2/c1-26-14-9-17(27-2)15(18(10-14)28-3)6-7-31(24,25)12-13-8-16(21-30(5,22)23)19(29-4)20-11-13/h6-11,21H,12H2,1-5H3/b7-6+ D05XPV DRUGINKE HEBBDGMHRHUJRY-VOTSOKGWSA-N D05XPV DRUGSMIL COC1=CC(=C(C(=C1)OC)C=CS(=O)(=O)CC2=CC(=C(N=C2)OC)NS(=O)(=O)C)OC D05XPV HIGHSTAT Investigative D05XPW DRUG__ID D05XPW D05XPW DRUGTYPE Small molecular drug D05XPW DRUGINCH 1S/C16H28N2O6/c1-3-5-7-17-15(19)23-11-9-21-14-12(10-22-13(11)14)24-16(20)18-8-6-4-2/h11-14H,3-10H2,1-2H3,(H,17,19)(H,18,20)/t11-,12+,13-,14-/m1/s1 D05XPW DRUGINKE KFJGIBINELGQIA-XJFOESAGSA-N D05XPW DRUGSMIL CCCCNC(=O)OC1COC2C1OCC2OC(=O)NCCCC D05XPW HIGHSTAT Investigative D05XQD DRUG__ID D05XQD D05XQD DRUGTYPE Small molecular drug D05XQD DRUGINCH 1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4,7,13,16-17,26H,5-6,8-12H2,(H,21,27)(H,22,23,24)/t17-/m0/s1 D05XQD DRUGINKE ZKXZLIFRWWKZRY-KRWDZBQOSA-N D05XQD DRUGSMIL C1CN(CC2=CC=CC=C21)CC(CNC(=O)C3=CC(=NC=N3)NC4COC4)O D05XQD HIGHSTAT Investigative D05XRY DRUG__ID D05XRY D05XRY DRUGTYPE Small molecular drug D05XRY DRUGINCH 1S/C16H12O2/c17-15-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)16(15)18/h1-8H,9-10H2 D05XRY DRUGINKE FBFVXHNJGVOZPS-UHFFFAOYSA-N D05XRY DRUGSMIL C1CC2=CC=CC=C2C(=O)C(=O)C3=CC=CC=C31 D05XRY HIGHSTAT Investigative D05XRZ DRUG__ID D05XRZ D05XRZ DRUGTYPE Small molecular drug D05XRZ DRUGINCH 1S/C14H14N4O3.2ClH/c15-14(19)12-4-7-17(8-5-12)10-21-11-18-6-2-1-3-13(18)9-16-20;;/h1-9H,10-11H2,(H-,15,19);2*1H D05XRZ DRUGINKE QELSIJXWEROXOE-UHFFFAOYSA-N D05XRZ DRUGSMIL C1=CC=[N+](C(=C1)C=NO)COC[N+]2=CC=C(C=C2)C(=O)N.[Cl-].[Cl-] D05XRZ HIGHSTAT Investigative D05XSV DRUG__ID D05XSV D05XSV DRUGTYPE Small molecular drug D05XSV DRUGINCH 1S/C22H26O12/c1-6-14(26)31-13-10(24)20-12-8(30-7(2)23)9(18(3,4)5)19(20)11(25)15(27)33-17(19)34-22(20,16(28)32-12)21(6,13)29/h6,8-13,17,24-25,29H,1-5H3/t6?,8?,9?,10?,11-,12?,13-,17?,19?,20?,21+,22-/m0/s1 D05XSV DRUGINKE PTVXMWRAVPFHBG-OIYCRRHPSA-N D05XSV DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5OC(=O)C)C(C)(C)C)C(C(=O)OC6O4)O)O D05XSV HIGHSTAT Investigative D05XTX DRUG__ID D05XTX D05XTX DRUGTYPE Small molecular drug D05XTX DRUGINCH 1S/C33H36N4O8S/c1-33(2)30(31(41)35-28-22-13-7-6-12-21(22)17-25(28)38)36(19-46-33)32(42)29(40)23(16-20-10-4-3-5-11-20)34-27(39)18-45-26-15-9-8-14-24(26)37(43)44/h3-15,23,25,28-30,38,40H,16-19H2,1-2H3,(H,34,39)(H,35,41)/t23-,25+,28-,29-,30+/m0/s1 D05XTX DRUGINKE NJMYSVGWPKMYBH-OIRZSGMBSA-N D05XTX DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC=C3[N+](=O)[O-])O)C(=O)NC4C(CC5=CC=CC=C45)O)C D05XTX HIGHSTAT Investigative D05XVM DRUG__ID D05XVM D05XVM DRUGTYPE Small molecular drug D05XVM DRUGINCH 1S/C20H17NO2/c1-22-17-8-5-9-18-19(17)15-11-10-14(21)12-16(15)20(23-18)13-6-3-2-4-7-13/h2-12,20H,21H2,1H3 D05XVM DRUGINKE MVULNNIYAGEMCC-UHFFFAOYSA-N D05XVM DRUGSMIL COC1=CC=CC2=C1C3=C(C=C(C=C3)N)C(O2)C4=CC=CC=C4 D05XVM HIGHSTAT Investigative D05XWX DRUG__ID D05XWX D05XWX DRUGTYPE Small molecular drug D05XWX DRUGINCH 1S/C11H19N3O/c1-11(2,3)9(13)10(15)14-6-4-5-8(14)7-12/h8-9H,4-6,13H2,1-3H3/t8-,9+/m0/s1 D05XWX DRUGINKE XGNBIYXILDDDQR-DTWKUNHWSA-N D05XWX DRUGSMIL CC(C)(C)C(C(=O)N1CCCC1C#N)N D05XWX HIGHSTAT Investigative D05XXE DRUG__ID D05XXE D05XXE DRUGTYPE Small molecular drug D05XXE DRUGINCH 1S/C29H36N6O6S/c1-42-12-11-22(33-27(39)20(30)14-18-16-32-21-10-6-5-9-19(18)21)28(40)35-24(15-25(36)37)29(41)34-23(26(31)38)13-17-7-3-2-4-8-17/h2-10,16,20,22-24,32H,11-15,30H2,1H3,(H2,31,38)(H,33,39)(H,34,41)(H,35,40)(H,36,37)/t20-,22-,23-,24-/m0/s1 D05XXE DRUGINKE RGYLYUZOGHTBRF-BIHRQFPBSA-N D05XXE DRUGSMIL CSCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)N D05XXE HIGHSTAT Investigative D05XZF DRUG__ID D05XZF D05XZF DRUGTYPE Small molecular drug D05XZF DRUGINCH 1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1 D05XZF DRUGINKE XQYASZNUFDVMFH-CQSZACIVSA-N D05XZF DRUGSMIL CC1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F D05XZF HIGHSTAT Investigative D05XZM DRUG__ID D05XZM D05XZM DRUGTYPE Small molecular drug D05XZM DRUGINCH 1S/C7H9NO3S/c8-12(10,11)7-3-1-6(5-9)2-4-7/h1-4,9H,5H2,(H2,8,10,11) D05XZM DRUGINKE UULCVOIRJRJPQS-UHFFFAOYSA-N D05XZM DRUGSMIL C1=CC(=CC=C1CO)S(=O)(=O)N D05XZM HIGHSTAT Investigative D05YAR DRUG__ID D05YAR D05YAR DRUGTYPE Small molecular drug D05YAR DRUGINCH 1S/C10H18O/c1-9(2)8-4-6-10(3,11-9)7-5-8/h8H,4-7H2,1-3H3 D05YAR DRUGINKE WEEGYLXZBRQIMU-UHFFFAOYSA-N D05YAR DRUGSMIL CC1(C2CCC(O1)(CC2)C)C D05YAR HIGHSTAT Investigative D05YBO DRUG__ID D05YBO D05YBO DRUGTYPE Small molecular drug D05YBO DRUGINCH 1S/C39H59N5O9/c1-4-5-6-7-8-9-10-11-12-23-34(27(2)35(47)41-30-20-15-17-24-40-36(30)48)53-39(50)31(21-16-18-25-44(51)28(3)45)42-37(49)32-26-52-38(43-32)29-19-13-14-22-33(29)46/h13-14,19,22,26-27,30-31,34,46,51H,4-12,15-18,20-21,23-25H2,1-3H3,(H,40,48)(H,41,47)(H,42,49) D05YBO DRUGINKE ZRSRFOLUVALIAN-UHFFFAOYSA-N D05YBO DRUGSMIL CCCCCCCCCCCC(C(C)C(=O)NC1CCCCNC1=O)OC(=O)C(CCCCN(C(=O)C)O)NC(=O)C2=COC(=N2)C3=CC=CC=C3O D05YBO HIGHSTAT Investigative D05YCI DRUG__ID D05YCI D05YCI DRUGTYPE Small molecular drug D05YCI DRUGINCH 1S/C13H15NO4/c1-7-5-10(15)14-11-8(7)6-9(16-2)12(17-3)13(11)18-4/h5-6H,1-4H3,(H,14,15) D05YCI DRUGINKE JAKHLWMOJRMVRW-UHFFFAOYSA-N D05YCI DRUGSMIL CC1=CC(=O)NC2=C(C(=C(C=C12)OC)OC)OC D05YCI HIGHSTAT Investigative D05YCQ DRUG__ID D05YCQ D05YCQ DRUGTYPE Small molecular drug D05YCQ DRUGINCH 1S/C23H19ClN4O7S2.Na/c1-14-3-10-19(11-4-14)37(33,34)35-18-8-6-17(7-9-18)25-26-22-15(2)27-28(23(22)29)20-12-5-16(24)13-21(20)36(30,31)32;/h3-13,22H,1-2H3,(H,30,31,32);/q;+1 D05YCQ DRUGINKE DXKDBQWDRGRKGC-UHFFFAOYSA-N D05YCQ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3C(=NN(C3=O)C4=C(C=C(C=C4)Cl)S(=O)(=O)O)C.[Na+] D05YCQ HIGHSTAT Investigative D05YDK DRUG__ID D05YDK D05YDK DRUGTYPE Small molecular drug D05YDK DRUGINCH 1S/C16H20O5/c1-5-8-12(18)13-14(19)16(3,21-15(13)20-4)10-7-6-9-11(2)17/h5-11,17H,1-4H3/b8-5+,9-6+,10-7+ D05YDK DRUGINKE SDJFAZYNJXZUJT-DVJWZOGQSA-N D05YDK DRUGSMIL CC=CC(=O)C1=C(OC(C1=O)(C)C=CC=CC(C)O)OC D05YDK HIGHSTAT Investigative D05YFZ DRUG__ID D05YFZ D05YFZ DRUGTYPE Small molecular drug D05YFZ DRUGINCH 1S/C16H17N/c17-10-9-16-14-7-3-1-5-12(14)11-13-6-2-4-8-15(13)16/h1-8,16H,9-11,17H2 D05YFZ DRUGINKE OWPHKTVZEZNCMB-UHFFFAOYSA-N D05YFZ DRUGSMIL C1C2=CC=CC=C2C(C3=CC=CC=C31)CCN D05YFZ HIGHSTAT Investigative D05YHP DRUG__ID D05YHP D05YHP DRUGTYPE Small molecular drug D05YHP DRUGINCH 1S/C14H19NS/c1-4-10-15-13(5-2)11-12-6-8-14(16-3)9-7-12/h1,6-9,13,15H,5,10-11H2,2-3H3 D05YHP DRUGINKE LQQBIFPYEKWTOI-UHFFFAOYSA-N D05YHP DRUGSMIL CCC(CC1=CC=C(C=C1)SC)NCC#C D05YHP HIGHSTAT Investigative D05YHT DRUG__ID D05YHT D05YHT DRUGTYPE Small molecular drug D05YHT DRUGINCH 1S/C37H49N11O6/c1-48-21-31(50)44-29(20-23-10-13-24-6-2-3-7-25(24)18-23)34(53)46-27(8-4-16-42-36(38)39)32(51)45-28(9-5-17-43-37(40)41)33(52)47-30(35(48)54)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,50)(H,45,51)(H,46,53)(H,47,52)(H4,38,39,42)(H4,40,41,43)/t27-,28+,29-,30+/m0/s1 D05YHT DRUGINKE RVFLZIGZHRQETC-RRGQHJHPSA-N D05YHT DRUGSMIL CN1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1=O)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D05YHT HIGHSTAT Investigative D05YIK DRUG__ID D05YIK D05YIK DRUGTYPE Small molecular drug D05YIK DRUGINCH 1S/C7H18O7P2/c1-2-3-4-5-6-7(8,15(9,10)11)16(12,13)14/h8H,2-6H2,1H3,(H2,9,10,11)(H2,12,13,14) D05YIK DRUGINKE IJEGNOYPWRBKAE-UHFFFAOYSA-N D05YIK DRUGSMIL CCCCCCC(O)(P(=O)(O)O)P(=O)(O)O D05YIK HIGHSTAT Investigative D05YIU DRUG__ID D05YIU D05YIU DRUGTYPE Small molecular drug D05YIU DRUGINCH 1S/C14H9ClO3/c15-12-7-11(17)5-9-6-13(18-14(9)12)8-1-3-10(16)4-2-8/h1-7,16-17H D05YIU DRUGINKE OCILFYQUCSGLEE-UHFFFAOYSA-N D05YIU DRUGSMIL C1=CC(=CC=C1C2=CC3=CC(=CC(=C3O2)Cl)O)O D05YIU HIGHSTAT Investigative D05YJP DRUG__ID D05YJP D05YJP DRUGTYPE Small molecular drug D05YJP DRUGINCH 1S/C18H16N2O2/c1-2-22-18(21)16(12-19)13-20-17-10-6-9-15(11-17)14-7-4-3-5-8-14/h3-11,13,16H,2H2,1H3 D05YJP DRUGINKE ADNKWYMTGWSRNK-UHFFFAOYSA-N D05YJP DRUGSMIL CCOC(=O)C(C=NC1=CC=CC(=C1)C2=CC=CC=C2)C#N D05YJP HIGHSTAT Investigative D05YJR DRUG__ID D05YJR D05YJR DRUGTYPE Small molecular drug D05YJR DRUGINCH 1S/C24H28O7/c1-12(2)6-7-13-15(25)10-18-20(21(13)27)22(28)19-14(8-9-24(3,4)29)23(30-5)16(26)11-17(19)31-18/h6,10-11,25-27,29H,7-9H2,1-5H3 D05YJR DRUGINKE TYALNCRUIKOKGP-UHFFFAOYSA-N D05YJR DRUGSMIL CC(=CCC1=C(C2=C(C=C1O)OC3=C(C2=O)C(=C(C(=C3)O)OC)CCC(C)(C)O)O)C D05YJR HIGHSTAT Investigative D05YKW DRUG__ID D05YKW D05YKW DRUGTYPE Small molecular drug D05YKW DRUGINCH 1S/C17H19N2/c1-10-6-14-12(3)13(4)15-7-11(2)9-19(5)17(15)16(14)18-8-10/h6-9H,1-5H3/q+1 D05YKW DRUGINKE FQTUZNACZKILMC-UHFFFAOYSA-N D05YKW DRUGSMIL CC1=CC2=C(C3=C(C=C(C=[N+]3C)C)C(=C2C)C)N=C1 D05YKW HIGHSTAT Investigative D05YMD DRUG__ID D05YMD D05YMD DRUGTYPE Small molecular drug D05YMD DRUGINCH 1S/C47H76N14O8/c1-5-28(3)38(45(69)56-33(39(49)63)16-10-11-23-48)61-42(66)35(18-13-25-55-47(52)53)58-43(67)37(27-31-19-21-32(62)22-20-31)60-44(68)36(26-30-14-8-7-9-15-30)59-41(65)34(17-12-24-54-46(50)51)57-40(64)29(4)6-2/h7-9,14-15,19-22,28-29,33-38,62H,5-6,10-13,16-18,23-27,48H2,1-4H3,(H2,49,63)(H,56,69)(H,57,64)(H,58,67)(H,59,65)(H,60,68)(H,61,66)(H4,50,51,54)(H4,52,53,55)/t28-,29?,33-,34-,35-,36-,37-,38-/m0/s1 D05YMD DRUGINKE XDTYNZLRQJEAAQ-QABIKYMTSA-N D05YMD DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)CC D05YMD HIGHSTAT Investigative D05YMP DRUG__ID D05YMP D05YMP DRUGTYPE Small molecular drug D05YMP DRUGINCH 1S/C18H20N4O/c1-3-22-13(2)20-17(16(12-19)18(22)23)21-10-8-14-6-4-5-7-15(14)9-11-21/h4-7H,3,8-11H2,1-2H3 D05YMP DRUGINKE QNUVWRAGDSGAKX-UHFFFAOYSA-N D05YMP DRUGSMIL CCN1C(=NC(=C(C1=O)C#N)N2CCC3=CC=CC=C3CC2)C D05YMP HIGHSTAT Investigative D05YNT DRUG__ID D05YNT D05YNT DRUGTYPE Small molecular drug D05YNT DRUGINCH 1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1/i10T,11T/t10?,11?,18-,19-,22-,24-,25+,26- D05YNT DRUGINKE OIJXLIIMXHRJJH-ZXJLXYCOSA-N D05YNT DRUGSMIL CC(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O D05YNT HIGHSTAT Investigative D05YNW DRUG__ID D05YNW D05YNW DRUGTYPE Small molecular drug D05YNW DRUGINCH 1S/C15H13N/c1-2-4-15-13(3-1)5-6-14(15)11-12-7-9-16-10-8-12/h1-4,7-11H,5-6H2/b14-11+ D05YNW DRUGINKE ZHGWOEHABOMOSV-SDNWHVSQSA-N D05YNW DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=CC=CC=C31 D05YNW HIGHSTAT Investigative D05YQC DRUG__ID D05YQC D05YQC DRUGTYPE Small molecular drug D05YQC DRUGINCH 1S/C9H12NO4P/c1-2-7-3-5-8(6-4-7)10-9(11)15(12,13)14/h3-6H,2H2,1H3,(H,10,11)(H2,12,13,14) D05YQC DRUGINKE KGNSYMGWPCEFDZ-UHFFFAOYSA-N D05YQC DRUGSMIL CCC1=CC=C(C=C1)NC(=O)P(=O)(O)O D05YQC HIGHSTAT Investigative D05YQE DRUG__ID D05YQE D05YQE DRUGTYPE Small molecular drug D05YQE DRUGINCH 1S/C16H18N2O/c1-16(2,3)10-19-15-8-12-11-6-4-5-7-13(11)18-14(12)9-17-15/h4-9,18H,10H2,1-3H3 D05YQE DRUGINKE YABCOKXBPACNCE-UHFFFAOYSA-N D05YQE DRUGSMIL CC(C)(C)COC1=NC=C2C(=C1)C3=CC=CC=C3N2 D05YQE HIGHSTAT Investigative D05YUT DRUG__ID D05YUT D05YUT DRUGTYPE Small molecular drug D05YUT DRUGINCH 1S/C31H52O2/c1-20(2)10-9-11-21(3)23-15-19-31(22(4)32)25-12-13-26-28(5,6)27(33)16-17-29(26,7)24(25)14-18-30(23,31)8/h12,20-21,23-24,26-27,33H,9-11,13-19H2,1-8H3/t21-,23-,24?,26?,27+,29-,30-,31-/m1/s1 D05YUT DRUGINKE DZMAIPFWPZZKSY-MBDGPJGJSA-N D05YUT DRUGSMIL CC(C)CCCC(C)C1CCC2(C1(CCC3C2=CCC4C3(CCC(C4(C)C)O)C)C)C(=O)C D05YUT HIGHSTAT Investigative D05YXS DRUG__ID D05YXS D05YXS DRUGTYPE Small molecular drug D05YXS DRUGINCH 1S/C18H19NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,12,17,20H,7-9H2,1-2H3/t12-,17+,18+/m1/s1 D05YXS DRUGINKE ZKLXUUYLEHCAMF-UUWFMWQGSA-N D05YXS DRUGSMIL CN1CCC23C4C(=CC=C2C1CC5=C3C(=C(C=C5)O)O4)OC D05YXS HIGHSTAT Investigative D05YZC DRUG__ID D05YZC D05YZC DRUGTYPE Small molecular drug D05YZC DRUGINCH 1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30) D05YZC DRUGINKE NFHRQQKPEBFUJK-UHFFFAOYSA-N D05YZC DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C3=CC4=CC=CC=C4N3)C5=CC=CC=C5 D05YZC HIGHSTAT Investigative D05YZE DRUG__ID D05YZE D05YZE DRUGTYPE Small molecular drug D05YZE DRUGINCH 1S/C25H28O7/c1-24(2)6-5-12-7-14(15-10-20(29)25(3,4)32-23(15)22(12)31-24)18-11-17(28)21-16(27)8-13(26)9-19(21)30-18/h7-9,18,20,26-27,29H,5-6,10-11H2,1-4H3 D05YZE DRUGINKE ZAGCAZVMJBNNSU-UHFFFAOYSA-N D05YZE DRUGSMIL CC1(CCC2=CC(=C3CC(C(OC3=C2O1)(C)C)O)C4CC(=O)C5=C(C=C(C=C5O4)O)O)C D05YZE HIGHSTAT Investigative D05ZCX DRUG__ID D05ZCX D05ZCX DRUGTYPE Small molecular drug D05ZCX DRUGINCH 1S/C10H4O2S2/c11-7-8(12)10-6(2-4-14-10)5-1-3-13-9(5)7/h1-4H D05ZCX DRUGINKE MOUQKENTDKBOQJ-UHFFFAOYSA-N D05ZCX DRUGSMIL C1=CSC2=C1C3=C(C(=O)C2=O)SC=C3 D05ZCX HIGHSTAT Investigative D05ZDQ DRUG__ID D05ZDQ D05ZDQ DRUGTYPE Small molecular drug D05ZDQ DRUGINCH 1S/C16H14O2/c1-12-6-8-13(9-7-12)10-11-16(18)14-4-2-3-5-15(14)17/h2-11,17H,1H3/b11-10+ D05ZDQ DRUGINKE OOEWKJHFFYCQBM-ZHACJKMWSA-N D05ZDQ DRUGSMIL CC1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2O D05ZDQ HIGHSTAT Investigative D05ZFG DRUG__ID D05ZFG D05ZFG DRUGTYPE Small molecular drug D05ZFG DRUGINCH 1S/C17H17N/c1-3-7-13(8-4-1)16-15-11-18-12-17(15,16)14-9-5-2-6-10-14/h1-10,15-16,18H,11-12H2/t15-,16-,17+/m1/s1 D05ZFG DRUGINKE MVCAANSQOXMPQN-ZACQAIPSSA-N D05ZFG DRUGSMIL C1C2C(C2(CN1)C3=CC=CC=C3)C4=CC=CC=C4 D05ZFG HIGHSTAT Investigative D05ZGM DRUG__ID D05ZGM D05ZGM DRUGTYPE Small molecular drug D05ZGM DRUGINCH 1S/C13H19NO3/c15-13(14-16)10-6-1-2-7-11-17-12-8-4-3-5-9-12/h3-5,8-9,16H,1-2,6-7,10-11H2,(H,14,15) D05ZGM DRUGINKE IHTQKNINBYXIDN-UHFFFAOYSA-N D05ZGM DRUGSMIL C1=CC=C(C=C1)OCCCCCCC(=O)NO D05ZGM HIGHSTAT Investigative D05ZHQ DRUG__ID D05ZHQ D05ZHQ DRUGTYPE Small molecular drug D05ZHQ DRUGINCH 1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17) D05ZHQ DRUGINKE IOSAAWHGJUZBOG-UHFFFAOYSA-N D05ZHQ DRUGSMIL CCCCCCC(C(C)O)N1C=NC2=C(N=CN=C21)N D05ZHQ HIGHSTAT Investigative D05ZIH DRUG__ID D05ZIH D05ZIH DRUGTYPE Small molecular drug D05ZIH DRUGINCH 1S/C20H25NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,14-15,18,22-24H,1-2,5-10H2;1H/t14-,15-,18+,19+,20-;/m1./s1 D05ZIH DRUGINKE FSQFFCPJTDFOAN-CDHBEYIESA-N D05ZIH DRUGSMIL C1CC1CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O.Cl D05ZIH HIGHSTAT Investigative D05ZIP DRUG__ID D05ZIP D05ZIP DRUGTYPE Small molecular drug D05ZIP DRUGINCH 1S/C11H9BrN2O/c1-8-2-4-9(5-3-8)11(15)14-7-10(12)6-13-14/h2-7H,1H3 D05ZIP DRUGINKE ZIILQHVFVJLRAB-UHFFFAOYSA-N D05ZIP DRUGSMIL CC1=CC=C(C=C1)C(=O)N2C=C(C=N2)Br D05ZIP HIGHSTAT Investigative D05ZJC DRUG__ID D05ZJC D05ZJC DRUGTYPE Small molecular drug D05ZJC DRUGINCH 1S/C12H14Br2O3/c1-2-3-4-17-12-9(13)5-8(6-10(12)14)7-11(15)16/h5-6H,2-4,7H2,1H3,(H,15,16) D05ZJC DRUGINKE PDWWLSBHJFKDFA-UHFFFAOYSA-N D05ZJC DRUGSMIL CCCCOC1=C(C=C(C=C1Br)CC(=O)O)Br D05ZJC HIGHSTAT Investigative D05ZKW DRUG__ID D05ZKW D05ZKW DRUGTYPE Small molecular drug D05ZKW DRUGINCH 1S/C10H11Cl2N/c11-9-4-3-7-2-1-5-13-6-8(7)10(9)12/h3-4,13H,1-2,5-6H2 D05ZKW DRUGINKE IADAQXMUWITWNG-UHFFFAOYSA-N D05ZKW DRUGSMIL C1CC2=C(CNC1)C(=C(C=C2)Cl)Cl D05ZKW HIGHSTAT Investigative D05ZPJ DRUG__ID D05ZPJ D05ZPJ DRUGTYPE Small molecular drug D05ZPJ DRUGINCH 1S/C24H40N2O2/c1-6-26(7-2)22(28)19-10-9-17-16-8-11-20-24(4,15-13-21(27)25(20)5)18(16)12-14-23(17,19)3/h16-20H,6-15H2,1-5H3/t16-,17-,18-,19+,20+,23-,24+/m0/s1 D05ZPJ DRUGINKE GNWBLLYJQXKPIP-ZOGIJGBBSA-N D05ZPJ DRUGSMIL CCN(CC)C(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(=O)N4C)C)C D05ZPJ HIGHSTAT Investigative D05ZPO DRUG__ID D05ZPO D05ZPO DRUGTYPE Small molecular drug D05ZPO DRUGINCH 1S/C15H12O3/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-8,14,16H,9H2 D05ZPO DRUGINKE SWAJPHCXKPCPQZ-UHFFFAOYSA-N D05ZPO DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC=CC=C3 D05ZPO HIGHSTAT Investigative D05ZQO DRUG__ID D05ZQO D05ZQO DRUGTYPE Small molecular drug D05ZQO DRUGINCH 1S/C22H21NO3/c24-20-11-9-19(10-12-20)22(25)23-16-18-7-4-8-21(15-18)26-14-13-17-5-2-1-3-6-17/h1-12,15,24H,13-14,16H2,(H,23,25) D05ZQO DRUGINKE VZKHCMVEWLIXIC-UHFFFAOYSA-N D05ZQO DRUGSMIL C1=CC=C(C=C1)CCOC2=CC=CC(=C2)CNC(=O)C3=CC=C(C=C3)O D05ZQO HIGHSTAT Investigative D05ZRR DRUG__ID D05ZRR D05ZRR DRUGTYPE Small molecular drug D05ZRR DRUGINCH 1S/C16H14N6O/c17-11-4-1-3-10(7-11)8-22-9-19-14-13(12-5-2-6-23-12)20-16(18)21-15(14)22/h1-7,9H,8,17H2,(H2,18,20,21) D05ZRR DRUGINKE XBESCJVITPKCJA-UHFFFAOYSA-N D05ZRR DRUGSMIL C1=CC(=CC(=C1)N)CN2C=NC3=C(N=C(N=C32)N)C4=CC=CO4 D05ZRR HIGHSTAT Investigative D05ZTI DRUG__ID D05ZTI D05ZTI DRUGTYPE Small molecular drug D05ZTI DRUGINCH 1S/C7H7NO2/c8-7(10)5-2-1-3-6(9)4-5/h1-4,9H,(H2,8,10) D05ZTI DRUGINKE NGMMGKYJUWYIIG-UHFFFAOYSA-N D05ZTI DRUGSMIL C1=CC(=CC(=C1)O)C(=O)N D05ZTI HIGHSTAT Investigative D05ZUX DRUG__ID D05ZUX D05ZUX DRUGTYPE Small molecular drug D05ZUX DRUGINCH 1S/C24H29N3O3/c28-23(17-19-7-2-1-3-8-19)25-20-11-15-26(16-12-20)13-6-14-27-21-9-4-5-10-22(21)30-18-24(27)29/h1-5,7-10,20H,6,11-18H2,(H,25,28) D05ZUX DRUGINKE FLGSUSWMWSZVMP-UHFFFAOYSA-N D05ZUX DRUGSMIL C1CN(CCC1NC(=O)CC2=CC=CC=C2)CCCN3C(=O)COC4=CC=CC=C43 D05ZUX HIGHSTAT Investigative D05ZVR DRUG__ID D05ZVR D05ZVR DRUGTYPE Small molecular drug D05ZVR DRUGINCH 1S/C18H26N10O3/c1-27-9-11(6-12(27)16(30)23-4-3-14(19)20)26-17(31)13-5-10(8-28(13)2)25-15(29)7-24-18(21)22/h5-6,8-9H,3-4,7H2,1-2H3,(H3,19,20)(H,23,30)(H,25,29)(H,26,31)(H4,21,22,24) D05ZVR DRUGINKE IDBIFFKSXLYUOT-UHFFFAOYSA-N D05ZVR DRUGSMIL CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NCCC(=N)N)C)NC(=O)CN=C(N)N D05ZVR HIGHSTAT Investigative D05ZYA DRUG__ID D05ZYA D05ZYA DRUGTYPE Small molecular drug D05ZYA DRUGINCH 1S/C4H7BrN2O/c5-1-3-2-7-4(6)8-3/h3H,1-2H2,(H2,6,7) D05ZYA DRUGINKE DCJDVEKKUOXALB-UHFFFAOYSA-N D05ZYA DRUGSMIL C1C(OC(=N1)N)CBr D05ZYA HIGHSTAT Investigative D05ZYN DRUG__ID D05ZYN D05ZYN DRUGTYPE Small molecular drug D05ZYN DRUGINCH 1S/C12H17N5/c1-2-17-8-15-10-11(13-7-14-12(10)17)16-9-5-3-4-6-9/h7-9H,2-6H2,1H3,(H,13,14,16) D05ZYN DRUGINKE CDVHQRUOORNLKE-UHFFFAOYSA-N D05ZYN DRUGSMIL CCN1C=NC2=C(N=CN=C21)NC3CCCC3 D05ZYN HIGHSTAT Investigative D05ZYZ DRUG__ID D05ZYZ D05ZYZ DRUGTYPE Small molecular drug D05ZYZ DRUGINCH 1S/C26H27N3O4/c1-2-13-29-14-12-25-21-17-8-9-19(30)22(21)33-23(25)18(10-11-26(25,32)20(29)15-17)27-28-24(31)16-6-4-3-5-7-16/h2-9,20,23,30,32H,1,10-15H2,(H,28,31)/b27-18+/t20-,23+,25+,26-/m1/s1 D05ZYZ DRUGINKE AKXCFAYOTIEFOH-XTNAHFASSA-N D05ZYZ DRUGSMIL C=CCN1CCC23C4C(=NNC(=O)C5=CC=CC=C5)CCC2(C1CC6=C3C(=C(C=C6)O)O4)O D05ZYZ HIGHSTAT Investigative D06AAA DRUG__ID D06AAA D06AAA DRUGTYPE Small molecular drug D06AAA DRUGINCH 1S/C9H9ClFN/c10-7-3-1-6(2-4-7)9(11)5-8(9)12/h1-4,8H,5,12H2/t8-,9+/m1/s1 D06AAA DRUGINKE UTADHPUNQUNGFZ-BDAKNGLRSA-N D06AAA DRUGSMIL C1C(C1(C2=CC=C(C=C2)Cl)F)N D06AAA HIGHSTAT Investigative D06ABJ DRUG__ID D06ABJ D06ABJ DRUGTYPE Small molecular drug D06ABJ DRUGINCH 1S/C12H15FN2/c1-15(2)7-6-9-8-14-11-5-3-4-10(13)12(9)11/h3-5,8,14H,6-7H2,1-2H3 D06ABJ DRUGINKE ISJZKVWGUWBUFG-UHFFFAOYSA-N D06ABJ DRUGSMIL CN(C)CCC1=CNC2=C1C(=CC=C2)F D06ABJ HIGHSTAT Investigative D06ABL DRUG__ID D06ABL D06ABL DRUGTYPE Small molecular drug D06ABL DRUGINCH 1S/C26H33N5O5/c1-16(2)17-7-6-8-20(33-3)24(17)36-15-23(32)30-9-11-31(12-10-30)26-28-19-14-22(35-5)21(34-4)13-18(19)25(27)29-26/h6-8,13-14,16H,9-12,15H2,1-5H3,(H2,27,28,29) D06ABL DRUGINKE ZZMFJJDBKSYGRM-UHFFFAOYSA-N D06ABL DRUGSMIL CC(C)C1=C(C(=CC=C1)OC)OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC D06ABL HIGHSTAT Investigative D06ADL DRUG__ID D06ADL D06ADL DRUGTYPE Small molecular drug D06ADL DRUGINCH 1S/C14H13NO5S/c1-19-13-4-2-3-11(9-13)14(16)10-5-7-12(8-6-10)20-21(15,17)18/h2-9H,1H3,(H2,15,17,18) D06ADL DRUGINKE MCDUCTBYYJRLMG-UHFFFAOYSA-N D06ADL DRUGSMIL COC1=CC=CC(=C1)C(=O)C2=CC=C(C=C2)OS(=O)(=O)N D06ADL HIGHSTAT Investigative D06AFD DRUG__ID D06AFD D06AFD DRUGTYPE Small molecular drug D06AFD DRUGINCH 1S/C20H17NO2/c1-15-6-11-19(12-7-15)21(23)20(22)13-9-16-8-10-17-4-2-3-5-18(17)14-16/h2-14,23H,1H3/b13-9+ D06AFD DRUGINKE MXCQZPFMNOZXSH-UKTHLTGXSA-N D06AFD DRUGSMIL CC1=CC=C(C=C1)N(C(=O)C=CC2=CC3=CC=CC=C3C=C2)O D06AFD HIGHSTAT Investigative D06AFP DRUG__ID D06AFP D06AFP DRUGTYPE Small molecular drug D06AFP DRUGINCH 1S/C12H11NO2S/c14-12(13-15)8-16-11-6-5-9-3-1-2-4-10(9)7-11/h1-7,15H,8H2,(H,13,14) D06AFP DRUGINKE GNDJOJQVOFQQBM-UHFFFAOYSA-N D06AFP DRUGSMIL C1=CC=C2C=C(C=CC2=C1)SCC(=O)NO D06AFP HIGHSTAT Investigative D06AGN DRUG__ID D06AGN D06AGN DRUGTYPE Small molecular drug D06AGN DRUGINCH 1S/C18H13N3O3/c1-10(22)24-21-16-12-7-3-5-9-14(12)19-17(16)15-11-6-2-4-8-13(11)20-18(15)23/h2-9,20,23H,1H3/b21-16- D06AGN DRUGINKE SPLHCOMFUFSNNE-PGMHBOJBSA-N D06AGN DRUGSMIL CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=CC=CC=C43)O D06AGN HIGHSTAT Investigative D06AIQ DRUG__ID D06AIQ D06AIQ DRUGTYPE Small molecular drug D06AIQ DRUGINCH 1S/C15H21IN2O3/c1-3-18-8-4-5-10(18)9-17-15(20)13-12(21-2)7-6-11(16)14(13)19/h6-7,10,19H,3-5,8-9H2,1-2H3,(H,17,20)/t10-/m0/s1 D06AIQ DRUGINKE CANPFCFJURGKAX-JTQLQIEISA-N D06AIQ DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2O)I)OC D06AIQ HIGHSTAT Investigative D06AJH DRUG__ID D06AJH D06AJH DRUGTYPE Small molecular drug D06AJH DRUGINCH 1S/C14H12N2S/c1-10-9-17-14(15-10)16-13-8-4-6-11-5-2-3-7-12(11)13/h2-9H,1H3,(H,15,16) D06AJH DRUGINKE QNKLFDFMOINNIW-UHFFFAOYSA-N D06AJH DRUGSMIL CC1=CSC(=N1)NC2=CC=CC3=CC=CC=C32 D06AJH HIGHSTAT Investigative D06AJN DRUG__ID D06AJN D06AJN DRUGTYPE Small molecular drug D06AJN DRUGINCH 1S/C16H20O6P2/c17-23(18,19)16(24(20,21)22)8-4-5-13-9-11-15(12-10-13)14-6-2-1-3-7-14/h1-3,6-7,9-12,16H,4-5,8H2,(H2,17,18,19)(H2,20,21,22)/p-4 D06AJN DRUGINKE UQVFFWAGEQWWMP-UHFFFAOYSA-J D06AJN DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCCC(P(=O)([O-])[O-])P(=O)([O-])[O-] D06AJN HIGHSTAT Investigative D06AJP DRUG__ID D06AJP D06AJP DRUGTYPE Small molecular drug D06AJP DRUGINCH 1S/C16H10ClNO2/c17-12-3-1-2-10(8-12)4-5-11-6-7-14-13(9-11)15(19)16(20)18-14/h1-9H,(H,18,19,20)/b5-4+ D06AJP DRUGINKE ZKYUNESJTCRBIF-SNAWJCMRSA-N D06AJP DRUGSMIL C1=CC(=CC(=C1)Cl)C=CC2=CC3=C(C=C2)NC(=O)C3=O D06AJP HIGHSTAT Investigative D06AKB DRUG__ID D06AKB D06AKB DRUGTYPE Small molecular drug D06AKB DRUGINCH 1S/C18H15NO2/c20-17-9-7-14(8-10-17)13-3-5-15(6-4-13)18(21)16-2-1-11-19-12-16/h1-12,18,20-21H D06AKB DRUGINKE ZSARFSCMOGDZTE-UHFFFAOYSA-N D06AKB DRUGSMIL C1=CC(=CN=C1)C(C2=CC=C(C=C2)C3=CC=C(C=C3)O)O D06AKB HIGHSTAT Investigative D06AKW DRUG__ID D06AKW D06AKW DRUGTYPE Small molecular drug D06AKW DRUGINCH 1S/C13H13N3O2/c1-8-3-2-4-9(7-8)10-5-6-11(18-10)12(17)16-13(14)15/h2-7H,1H3,(H4,14,15,16,17) D06AKW DRUGINKE BBOVVXJXVOJLSK-UHFFFAOYSA-N D06AKW DRUGSMIL CC1=CC(=CC=C1)C2=CC=C(O2)C(=O)N=C(N)N D06AKW HIGHSTAT Investigative D06ALC DRUG__ID D06ALC D06ALC DRUGTYPE Small molecular drug D06ALC DRUGINCH 1S/C27H22O12/c28-15-5-1-12(9-18(15)31)10-20(26(34)35)38-21(33)8-4-13-2-7-17(30)25-22(13)23(27(36)37)24(39-25)14-3-6-16(29)19(32)11-14/h1-9,11,20,23-24,28-32H,10H2,(H,34,35)(H,36,37)/b8-4+/t20-,23+,24-/m1/s1 D06ALC DRUGINKE UJZQBMQZMKFSRV-RGKBJLTCSA-N D06ALC DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C3C(C(OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)O)O)O D06ALC HIGHSTAT Investigative D06AOY DRUG__ID D06AOY D06AOY DRUGTYPE Small molecular drug D06AOY DRUGINCH 1S/C18H12N2O2/c21-17-15(11-6-2-1-3-7-11)16(18(22)20-17)13-10-19-14-9-5-4-8-12(13)14/h1-10,19H,(H,20,21,22) D06AOY DRUGINKE HVQJGNALTWNDMX-UHFFFAOYSA-N D06AOY DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CNC4=CC=CC=C43 D06AOY HIGHSTAT Investigative D06AQG DRUG__ID D06AQG D06AQG DRUGTYPE Small molecular drug D06AQG DRUGINCH 1S/C16H11N5O2/c17-14-13-16(19-15(18-14)10-6-2-1-3-7-10)21(23)12-9-5-4-8-11(12)20(13)22/h1-9H,(H2,17,18,19) D06AQG DRUGINKE YWSUTRFYAQHJFZ-UHFFFAOYSA-N D06AQG DRUGSMIL C1=CC=C(C=C1)C2=NC3=[N+](C4=CC=CC=C4[N+](=C3C(=N2)N)[O-])[O-] D06AQG HIGHSTAT Investigative D06ATM DRUG__ID D06ATM D06ATM DRUGTYPE Small molecular drug D06ATM DRUGINCH 1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/t17-,18+/m0/s1 D06ATM DRUGINKE OTKJDMGTUTTYMP-ZWKOTPCHSA-N D06ATM DRUGSMIL CCCCCCCCCCCCCCCC(C(CO)N)O D06ATM HIGHSTAT Investigative D06AUB DRUG__ID D06AUB D06AUB DRUGTYPE Small molecular drug D06AUB DRUGINCH 1S/C17H18Cl2N2/c18-13-6-7-14(16(19)8-13)15-10-21(11-17(15)20)9-12-4-2-1-3-5-12/h1-8,15,17H,9-11,20H2 D06AUB DRUGINKE OHYGBKLWBNYXTE-UHFFFAOYSA-N D06AUB DRUGSMIL C1C(C(CN1CC2=CC=CC=C2)N)C3=C(C=C(C=C3)Cl)Cl D06AUB HIGHSTAT Investigative D06AUM DRUG__ID D06AUM D06AUM DRUGTYPE Small molecular drug D06AUM DRUGINCH 1S/C32H36N2O4/c1-23(35)33-17-15-27-9-5-7-25-11-13-29(21-31(25)27)37-19-3-4-20-38-30-14-12-26-8-6-10-28(32(26)22-30)16-18-34-24(2)36/h5-14,21-22H,3-4,15-20H2,1-2H3,(H,33,35)(H,34,36) D06AUM DRUGINKE AGGOYESCDGTCOY-UHFFFAOYSA-N D06AUM DRUGSMIL CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OCCCCOC3=CC4=C(C=CC=C4CCNC(=O)C)C=C3 D06AUM HIGHSTAT Investigative D06AUX DRUG__ID D06AUX D06AUX DRUGTYPE Small molecular drug D06AUX DRUGINCH 1S/C26H54NO7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-31-23-26(34-25(2)28)24-33-35(29,30)32-22-20-27(3,4)5/h26H,6-24H2,1-5H3 D06AUX DRUGINKE HVAUUPRFYPCOCA-UHFFFAOYSA-N D06AUX DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C D06AUX HIGHSTAT Investigative D06AVE DRUG__ID D06AVE D06AVE DRUGTYPE Small molecular drug D06AVE DRUGINCH 1S/C27H31N3/c1-16(2)26-25-14-21(7-4-17(25)10-11-30(26)3)24-15-23(24)20-8-5-19-13-22(27(28)29)9-6-18(19)12-20/h4-9,12-14,16,23-24,26H,10-11,15H2,1-3H3,(H3,28,29) D06AVE DRUGINKE FEPIUXBUJVISNN-UHFFFAOYSA-N D06AVE DRUGSMIL CC(C)C1C2=C(CCN1C)C=CC(=C2)C3CC3C4=CC5=C(C=C4)C=C(C=C5)C(=N)N D06AVE HIGHSTAT Investigative D06AVM DRUG__ID D06AVM D06AVM DRUGTYPE Small molecular drug D06AVM DRUGINCH 1S/C35H46N6O7/c1-21-30(19-34(46)48-21)40-32(44)17-25(9-5-6-13-36)39-35(47)31(16-24-20-37-29-12-4-3-11-28(24)29)41-33(45)18-26(38-22(2)42)14-23-8-7-10-27(43)15-23/h3-4,7-8,10-12,15,20-21,25-26,30-31,37,43H,5-6,9,13-14,16-19,36H2,1-2H3,(H,38,42)(H,39,47)(H,40,44)(H,41,45)/t21-,25+,26+,30-,31?/m1/s1 D06AVM DRUGINKE GQYXVIIYXPRQJK-JZYDGZRSSA-N D06AVM DRUGSMIL CC1C(CC(=O)O1)NC(=O)CC(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CC(CC4=CC(=CC=C4)O)NC(=O)C D06AVM HIGHSTAT Investigative D06AWX DRUG__ID D06AWX D06AWX DRUGTYPE Small molecular drug D06AWX DRUGINCH 1S/C24H18N2O4/c1-29-23(27)17-11-15-13-7-3-6-10-20(13)26-22(15)18(24(28)30-2)12-16-14-8-4-5-9-19(14)25-21(16)17/h3-12,25-26H,1-2H3/b15-11?,16-12?,17-11+,18-12+,21-17?,22-18? D06AWX DRUGINKE PVWALMHWUOWPPA-RPLHEXBESA-N D06AWX DRUGSMIL COC(=O)C1=CC2=C(C(=CC3=C1NC4=CC=CC=C43)C(=O)OC)NC5=CC=CC=C52 D06AWX HIGHSTAT Investigative D06AYL DRUG__ID D06AYL D06AYL DRUGTYPE Small molecular drug D06AYL DRUGINCH 1S/C25H30N2O3/c1-25-9-8-19-18-7-5-17(28)11-16(18)4-6-20(19)22(25)12-21(23(25)29)24(30)27-14-15-3-2-10-26-13-15/h2-3,5,7,10-11,13,19-23,28-29H,4,6,8-9,12,14H2,1H3,(H,27,30)/t19?,20?,21?,22?,23-,25-/m0/s1 D06AYL DRUGINKE JLDAJRITWUSQME-GYDLEPMTSA-N D06AYL DRUGSMIL CC12CCC3C(C1CC(C2O)C(=O)NCC4=CN=CC=C4)CCC5=C3C=CC(=C5)O D06AYL HIGHSTAT Investigative D06AYN DRUG__ID D06AYN D06AYN DRUGTYPE Small molecular drug D06AYN DRUGINCH 1S/C34H45NO8/c36-32(35-27-10-6-9-25(22-27)33(37)38)30-23-26(34(39)40)15-18-31(30)43-21-7-8-24-13-16-29(17-14-24)42-20-5-4-19-41-28-11-2-1-3-12-28/h13-18,23,25,27-28H,1-12,19-22H2,(H,35,36)(H,37,38)(H,39,40) D06AYN DRUGINKE HRJWSEPIRZRGCL-UHFFFAOYSA-N D06AYN DRUGSMIL C1CCC(CC1)OCCCCOC2=CC=C(C=C2)CCCOC3=C(C=C(C=C3)C(=O)O)C(=O)NC4CCCC(C4)C(=O)O D06AYN HIGHSTAT Investigative D06AZC DRUG__ID D06AZC D06AZC DRUGTYPE Small molecular drug D06AZC DRUGINCH 1S/C17H14N2O4/c1-23-16-6-5-14-12(9-18-10-15(14)17(16)20)7-11-3-2-4-13(8-11)19(21)22/h2-6,8-10,20H,7H2,1H3 D06AZC DRUGINKE DMEADVJDTWAEGN-UHFFFAOYSA-N D06AZC DRUGSMIL COC1=C(C2=C(C=C1)C(=CN=C2)CC3=CC(=CC=C3)[N+](=O)[O-])O D06AZC HIGHSTAT Investigative D06AZJ DRUG__ID D06AZJ D06AZJ DRUGTYPE Small molecular drug D06AZJ DRUGINCH 1S/C11H14N4/c12-8-11-13-7-6-10(15-11)14-9-4-2-1-3-5-9/h6-7,9H,1-5H2,(H,13,14,15) D06AZJ DRUGINKE UWPRHHHJGYCNGK-UHFFFAOYSA-N D06AZJ DRUGSMIL C1CCC(CC1)NC2=NC(=NC=C2)C#N D06AZJ HIGHSTAT Investigative D06BAC DRUG__ID D06BAC D06BAC DRUGTYPE Small molecular drug D06BAC DRUGINCH 1S/C11H11BrN2/c12-9-3-1-2-8-7-4-5-13-6-10(7)14-11(8)9/h1-3,13-14H,4-6H2 D06BAC DRUGINKE QDAJATJOFYZEDN-UHFFFAOYSA-N D06BAC DRUGSMIL C1CNCC2=C1C3=C(N2)C(=CC=C3)Br D06BAC HIGHSTAT Investigative D06BAU DRUG__ID D06BAU D06BAU DRUGTYPE Small molecular drug D06BAU DRUGINCH 1S/C51H69N13O11S2/c1-26(65)39(42(53)68)62-49(75)41-51(3,4)77-76-25-38(61-43(69)33(52)21-28-11-6-5-7-12-28)47(73)59-36(22-29-16-18-31(67)19-17-29)45(71)60-37(23-30-24-57-34-14-9-8-13-32(30)34)46(72)58-35(15-10-20-56-50(54)55)44(70)63-40(27(2)66)48(74)64-41/h5-9,11-14,16-19,24,26-27,33,35-41,57,65-67H,10,15,20-23,25,52H2,1-4H3,(H2,53,68)(H,58,72)(H,59,73)(H,60,71)(H,61,69)(H,62,75)(H,63,70)(H,64,74)(H4,54,55,56)/t26-,27-,33+,35+,36+,37+,38+,39+,40+,41-/m1/s1 D06BAU DRUGINKE OFMQLVRLOGHAJI-RWMSPKCPSA-N D06BAU DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D06BAU HIGHSTAT Investigative D06BBB DRUG__ID D06BBB D06BBB DRUGTYPE Small molecular drug D06BBB DRUGINCH 1S/C31H26N2O3/c1-2-27-30(22-12-5-3-6-13-22)31(23-14-7-4-8-15-23)32-33(27)28-19-10-9-18-26(28)24-16-11-17-25(20-24)36-21-29(34)35/h3-20H,2,21H2,1H3,(H,34,35) D06BBB DRUGINKE SJRVJRYZAQYCEE-UHFFFAOYSA-N D06BBB DRUGSMIL CCC1=C(C(=NN1C2=CC=CC=C2C3=CC(=CC=C3)OCC(=O)O)C4=CC=CC=C4)C5=CC=CC=C5 D06BBB HIGHSTAT Investigative D06BBI DRUG__ID D06BBI D06BBI DRUGTYPE Small molecular drug D06BBI DRUGINCH 1S/C13H19NO2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(15)14-16/h4-7,9-10,16H,8H2,1-3H3,(H,14,15)/t10-/m1/s1 D06BBI DRUGINKE BYPIURIATSUHDW-SNVBAGLBSA-N D06BBI DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)NO D06BBI HIGHSTAT Investigative D06BDB DRUG__ID D06BDB D06BDB DRUGTYPE Small molecular drug D06BDB DRUGINCH 1S/C16H19NO6/c1-10(18)22-12-8-20-15-13(9-21-14(12)15)23-16(19)17-7-11-5-3-2-4-6-11/h2-6,12-15H,7-9H2,1H3,(H,17,19)/t12-,13+,14-,15-/m1/s1 D06BDB DRUGINKE RMUIRACCZOGQBC-LXTVHRRPSA-N D06BDB DRUGSMIL CC(=O)OC1COC2C1OCC2OC(=O)NCC3=CC=CC=C3 D06BDB HIGHSTAT Investigative D06BDC DRUG__ID D06BDC D06BDC DRUGTYPE Small molecular drug D06BDC DRUGINCH 1S/C21H21N5O/c27-12-4-10-25-14-23-16-8-7-15(13-19(16)25)20-18-6-3-11-26(18)24-21(20)17-5-1-2-9-22-17/h1-2,5,7-9,13-14,27H,3-4,6,10-12H2 D06BDC DRUGINKE SYCWRTUPLPDKDX-UHFFFAOYSA-N D06BDC DRUGSMIL C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=CC5=C(C=C4)N=CN5CCCO D06BDC HIGHSTAT Investigative D06BDY DRUG__ID D06BDY D06BDY DRUGTYPE Small molecular drug D06BDY DRUGINCH 1S/C14H15NO4/c1-17-10-2-3-13-11(8-10)12(9-14(16)19-13)15-4-6-18-7-5-15/h2-3,8-9H,4-7H2,1H3 D06BDY DRUGINKE UEDWCBYLFYRZFY-UHFFFAOYSA-N D06BDY DRUGSMIL COC1=CC2=C(C=C1)OC(=O)C=C2N3CCOCC3 D06BDY HIGHSTAT Investigative D06BFB DRUG__ID D06BFB D06BFB DRUGTYPE Small molecular drug D06BFB DRUGINCH 1S/C30H48O4/c1-25(2)12-13-27(5)14-15-30(24(33)34)18(19(27)16-25)8-9-21-28(6)11-10-22(32)26(3,4)23(28)20(31)17-29(21,30)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20+,21+,22-,23?,27+,28+,29+,30+/m0/s1 D06BFB DRUGINKE LUJTWDWEYNWTBP-ULYQHCOQSA-N D06BFB DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CC(C5C4(CCC(C5(C)C)O)C)O)C)C2C1)C(=O)O)C)C D06BFB HIGHSTAT Investigative D06BFH DRUG__ID D06BFH D06BFH DRUGTYPE Small molecular drug D06BFH DRUGINCH 1S/C9H6FNO2/c10-6-1-2-7-5(3-6)4-8(11-7)9(12)13/h1-4,11H,(H,12,13) D06BFH DRUGINKE WTXBRZCVLDTWLP-UHFFFAOYSA-N D06BFH DRUGSMIL C1=CC2=C(C=C1F)C=C(N2)C(=O)O D06BFH HIGHSTAT Investigative D06BGU DRUG__ID D06BGU D06BGU DRUGTYPE Small molecular drug D06BGU DRUGINCH 1S/C12H17NO2/c1-3-5-7-10-9-13(12(10)15)11(14)8-6-4-2/h3-4,10H,1-2,5-9H2 D06BGU DRUGINKE GINOGVHXZZDXCD-UHFFFAOYSA-N D06BGU DRUGSMIL C=CCCC1CN(C1=O)C(=O)CCC=C D06BGU HIGHSTAT Investigative D06BHC DRUG__ID D06BHC D06BHC DRUGTYPE Small molecular drug D06BHC DRUGINCH 1S/C12H11IN2O2S/c13-9-1-5-11(6-2-9)15-18(16,17)12-7-3-10(14)4-8-12/h1-8,15H,14H2 D06BHC DRUGINKE GNYYVWOTRVNKCO-UHFFFAOYSA-N D06BHC DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)NC2=CC=C(C=C2)I D06BHC HIGHSTAT Investigative D06BHJ DRUG__ID D06BHJ D06BHJ DRUGTYPE Small molecular drug D06BHJ DRUGINCH 1S/C18H16O3/c1-11-7-8-13(9-12(11)2)10-15-17(19)14-5-3-4-6-16(14)21-18(15)20/h3-9,19H,10H2,1-2H3 D06BHJ DRUGINKE YGMVKOKEKHJHOV-UHFFFAOYSA-N D06BHJ DRUGSMIL CC1=C(C=C(C=C1)CC2=C(C3=CC=CC=C3OC2=O)O)C D06BHJ HIGHSTAT Investigative D06BIF DRUG__ID D06BIF D06BIF DRUGTYPE Small molecular drug D06BIF DRUGINCH 1S/C26H30FNO4/c1-17(2)26-23(13-12-21(29)14-22(30)15-25(31)32)24(18-8-10-19(27)11-9-18)16-28(26)20-6-4-3-5-7-20/h3-11,16-17,21-22,29-30H,12-15H2,1-2H3,(H,31,32)/p-1/t21-,22-/m1/s1 D06BIF DRUGINKE UBFHWBHHCSSZAB-FGZHOGPDSA-M D06BIF DRUGSMIL CC(C)C1=C(C(=CN1C2=CC=CC=C2)C3=CC=C(C=C3)F)CCC(CC(CC(=O)[O-])O)O D06BIF HIGHSTAT Investigative D06BJG DRUG__ID D06BJG D06BJG DRUGTYPE Small molecular drug D06BJG DRUGINCH 1S/C31H26F3N7O4/c1-3-26(42)35-17-27(43)38-21-8-5-9-22(13-21)41-30-36-15-24(16-37-30)40-29(45)25-14-23(11-10-18(25)2)39-28(44)19-6-4-7-20(12-19)31(32,33)34/h3-16H,1,17H2,2H3,(H,35,42)(H,38,43)(H,39,44)(H,40,45)(H,36,37,41) D06BJG DRUGINKE SMOPKEHQPPXRSH-UHFFFAOYSA-N D06BJG DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)C(=O)NC3=CN=C(N=C3)NC4=CC(=CC=C4)NC(=O)CNC(=O)C=C D06BJG HIGHSTAT Investigative D06BKA DRUG__ID D06BKA D06BKA DRUGTYPE Small molecular drug D06BKA DRUGINCH 1S/C20H21F3O3/c21-20(22,23)19(24)10-6-1-2-7-15-25-16-11-13-18(14-12-16)26-17-8-4-3-5-9-17/h3-5,8-9,11-14H,1-2,6-7,10,15H2 D06BKA DRUGINKE ZZPVOJAAHDFZNF-UHFFFAOYSA-N D06BKA DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)OCCCCCCC(=O)C(F)(F)F D06BKA HIGHSTAT Investigative D06BKP DRUG__ID D06BKP D06BKP DRUGTYPE Small molecular drug D06BKP DRUGINCH 1S/C37H63N3O6/c1-8-9-20-32(41)26(4)22-33(42)29(23-27-16-12-10-13-17-27)38-34(43)30(21-25(2)3)39-35(44)31(24-28-18-14-11-15-19-28)40-36(45)46-37(5,6)7/h11,14-15,18-19,25-27,29-33,41-42H,8-10,12-13,16-17,20-24H2,1-7H3,(H,38,43)(H,39,44)(H,40,45)/t26-,29+,30+,31+,32?,33+/m1/s1 D06BKP DRUGINKE DZSFYDAIURXYOI-YFUMYMLSSA-N D06BKP DRUGSMIL CCCCC(C(C)CC(C(CC1CCCCC1)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)OC(C)(C)C)O)O D06BKP HIGHSTAT Investigative D06BLF DRUG__ID D06BLF D06BLF DRUGTYPE Small molecular drug D06BLF DRUGINCH 1S/C8H12Br4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h5-8H,1-4H2 D06BLF DRUGINKE PQRRSJBLKOPVJV-UHFFFAOYSA-N D06BLF DRUGSMIL C1CC(C(CC1C(CBr)Br)Br)Br D06BLF HIGHSTAT Investigative D06BMN DRUG__ID D06BMN D06BMN DRUGTYPE Small molecular drug D06BMN DRUGINCH 1S/C32H30N4O5/c1-2-18-35-20-34-29-26(30(35)39)33-21-36(29)31-28(38)27(37)25(41-31)19-40-32(22-12-6-3-7-13-22,23-14-8-4-9-15-23)24-16-10-5-11-17-24/h2-17,20-21,25,27-28,31,37-38H,1,18-19H2/t25-,27-,28-,31-/m1/s1 D06BMN DRUGINKE WUKAFOPIIOGNJA-QWOIFIOOSA-N D06BMN DRUGSMIL C=CCN1C=NC2=C(C1=O)N=CN2C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)O)O D06BMN HIGHSTAT Investigative D06BMZ DRUG__ID D06BMZ D06BMZ DRUGTYPE Small molecular drug D06BMZ DRUGINCH 1S/C24H25NO2/c26-24(21-12-6-2-7-13-21,22-14-8-3-9-15-22)23(20-10-4-1-5-11-20)25-16-18-27-19-17-25/h1-15,23,26H,16-19H2 D06BMZ DRUGINKE HOPDHEHFNMVVFR-UHFFFAOYSA-N D06BMZ DRUGSMIL C1COCCN1C(C2=CC=CC=C2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O D06BMZ HIGHSTAT Investigative D06BNI DRUG__ID D06BNI D06BNI DRUGTYPE Small molecular drug D06BNI DRUGINCH 1S/C12H10N2O/c15-7-8-5-10-9-3-1-2-4-11(9)14-12(10)6-13-8/h1-6,14-15H,7H2 D06BNI DRUGINKE CPBYHTDUBNSBQM-UHFFFAOYSA-N D06BNI DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=NC(=C3)CO D06BNI HIGHSTAT Investigative D06BRA DRUG__ID D06BRA D06BRA DRUGTYPE Small molecular drug D06BRA DRUGINCH 1S/C44H55N9O10/c1-3-4-13-33(42(61)53-36(22-38(56)57)44(63)52-34(39(46)58)20-26-10-6-5-7-11-26)51-43(62)35(21-28-23-47-32-14-9-8-12-30(28)32)50-37(55)24-48-40(59)25(2)49-41(60)31(45)19-27-15-17-29(54)18-16-27/h5-12,14-18,23,25,31,33-36,47,54H,3-4,13,19-22,24,45H2,1-2H3,(H2,46,58)(H,48,59)(H,49,60)(H,50,55)(H,51,62)(H,52,63)(H,53,61)(H,56,57)/t25-,31+,33+,34+,35-,36+/m1/s1 D06BRA DRUGINKE LTNSZIYAGMZDDY-GUNATADUSA-N D06BRA DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N D06BRA HIGHSTAT Investigative D06BSD DRUG__ID D06BSD D06BSD DRUGTYPE Small molecular drug D06BSD DRUGINCH 1S/C44H50BF2N9O4S/c46-45(47)55-32(15-16-33(55)30-34-17-19-38(56(34)45)39-13-9-29-61-39)18-20-41(58)49-21-5-1-2-14-40(57)48-22-6-7-24-52-25-27-53(28-26-52)31-42(59)54-37-12-4-3-10-35(37)44(60)51-36-11-8-23-50-43(36)54/h3-4,8-13,15-17,19,23,29-30H,1-2,5-7,14,18,20-22,24-28,31H2,(H,48,57)(H,49,58)(H,51,60) D06BSD DRUGINKE AZMSBCBXXBLHQP-UHFFFAOYSA-N D06BSD DRUGSMIL [B-]1(N2C(=CC=C2CCC(=O)NCCCCCC(=O)NCCCCN3CCN(CC3)CC(=O)N4C5=CC=CC=C5C(=O)NC6=C4N=CC=C6)C=C7[N+]1=C(C=C7)C8=CC=CS8)(F)F D06BSD HIGHSTAT Investigative D06BSN DRUG__ID D06BSN D06BSN DRUGTYPE Small molecular drug D06BSN DRUGINCH 1S/C11H17NO8/c1-4(14)12-8-5(15)2-7(11(18)19)20-10(8)9(17)6(16)3-13/h2,5-6,8-10,13,15-17H,3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,8+,9+,10+/m0/s1 D06BSN DRUGINKE JINJZWSZQKHCIP-UFGQHTETSA-N D06BSN DRUGSMIL CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)O D06BSN HIGHSTAT Investigative D06BUM DRUG__ID D06BUM D06BUM DRUGTYPE Small molecular drug D06BUM DRUGINCH 1S/C7H7BO4/c9-7(10)5-1-3-6(4-2-5)8(11)12/h1-4,11-12H,(H,9,10) D06BUM DRUGINKE SIAVMDKGVRXFAX-UHFFFAOYSA-N D06BUM DRUGSMIL B(C1=CC=C(C=C1)C(=O)O)(O)O D06BUM HIGHSTAT Investigative D06BVH DRUG__ID D06BVH D06BVH DRUGTYPE Small molecular drug D06BVH DRUGINCH 1S/C17H12N4/c18-11-14-12-19-17(20-15-9-5-2-6-10-15)21-16(14)13-7-3-1-4-8-13/h1-10,12H,(H,19,20,21) D06BVH DRUGINKE KLNVGLIZGCKXCE-UHFFFAOYSA-N D06BVH DRUGSMIL C1=CC=C(C=C1)C2=NC(=NC=C2C#N)NC3=CC=CC=C3 D06BVH HIGHSTAT Investigative D06BWZ DRUG__ID D06BWZ D06BWZ DRUGTYPE Small molecular drug D06BWZ DRUGINCH 1S/C11H18ClN5S/c1-13-11-14-9(12)8(18-3)10(15-11)17-6-4-16(2)5-7-17/h4-7H2,1-3H3,(H,13,14,15) D06BWZ DRUGINKE ITYXRJDDBZMFAY-UHFFFAOYSA-N D06BWZ DRUGSMIL CNC1=NC(=C(C(=N1)Cl)SC)N2CCN(CC2)C D06BWZ HIGHSTAT Investigative D06BXT DRUG__ID D06BXT D06BXT DRUGTYPE Small molecular drug D06BXT DRUGINCH 1S/C27H26N2O3/c1-18-25(27(30)22-9-4-7-19-6-2-3-8-21(19)22)23-10-5-11-24-26(23)29(18)20(17-32-24)16-28-12-14-31-15-13-28/h2-11,20H,12-17H2,1H3 D06BXT DRUGINKE HQVHOQAKMCMIIM-UHFFFAOYSA-N D06BXT DRUGSMIL CC1=C(C2=C3N1C(COC3=CC=C2)CN4CCOCC4)C(=O)C5=CC=CC6=CC=CC=C65 D06BXT HIGHSTAT Investigative D06BYR DRUG__ID D06BYR D06BYR DRUGTYPE Small molecular drug D06BYR DRUGINCH 1S/C16H15NO4/c18-15(10-11-16(19)17-20)12-6-8-14(9-7-12)21-13-4-2-1-3-5-13/h1-9,20H,10-11H2,(H,17,19) D06BYR DRUGINKE NOELKUBXWDTLKR-UHFFFAOYSA-N D06BYR DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)CCC(=O)NO D06BYR HIGHSTAT Investigative D06BYY DRUG__ID D06BYY D06BYY DRUGTYPE Small molecular drug D06BYY DRUGINCH 1S/C22H25N3O2S/c1-27-18-8-7-17-4-2-5-20(19(17)16-18)25-13-11-24(12-14-25)10-9-23-22(26)21-6-3-15-28-21/h2-8,15-16H,9-14H2,1H3,(H,23,26) D06BYY DRUGINKE YFNZHCXOYLKDGU-UHFFFAOYSA-N D06BYY DRUGSMIL COC1=CC2=C(C=CC=C2N3CCN(CC3)CCNC(=O)C4=CC=CS4)C=C1 D06BYY HIGHSTAT Investigative D06CAL DRUG__ID D06CAL D06CAL DRUGTYPE Small molecular drug D06CAL DRUGINCH 1S/C22H22BrNO2/c1-12(2)13-6-7-19-16(8-13)14-4-3-5-15(14)22(24-19)17-9-20-21(10-18(17)23)26-11-25-20/h3-4,6-10,12,14-15,22,24H,5,11H2,1-2H3/t14-,15+,22-/m1/s1 D06CAL DRUGINKE QTOCPACSSHFGOY-ZCCHDVMBSA-N D06CAL DRUGSMIL CC(C)C1=CC2=C(C=C1)NC(C3C2C=CC3)C4=CC5=C(C=C4Br)OCO5 D06CAL HIGHSTAT Investigative D06CBR DRUG__ID D06CBR D06CBR DRUGTYPE Small molecular drug D06CBR DRUGINCH 1S/C11H10N2OS/c12-10(14)8-6-9(15-11(8)13)7-4-2-1-3-5-7/h1-6H,13H2,(H2,12,14) D06CBR DRUGINKE UHEGYTDIDBFUJD-UHFFFAOYSA-N D06CBR DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(S2)N)C(=O)N D06CBR HIGHSTAT Investigative D06CDG DRUG__ID D06CDG D06CDG DRUGTYPE Small molecular drug D06CDG DRUGINCH 1S/C25H33N3O4/c1-16(29)26-9-12-32-24(30)25-14-17-13-18(8-11-31-2)23(25)28(15-17)10-7-20-19-5-3-4-6-21(19)27-22(20)25/h3-6,17-18,23,27H,7-15H2,1-2H3,(H,26,29)/t17?,18-,23-,25+/m0/s1 D06CDG DRUGINKE PIPDTENSRZRDNA-BJASRFDRSA-N D06CDG DRUGSMIL CC(=O)NCCOC(=O)C12CC3CC(C1N(C3)CCC4=C2NC5=CC=CC=C45)CCOC D06CDG HIGHSTAT Investigative D06CDW DRUG__ID D06CDW D06CDW DRUGTYPE Small molecular drug D06CDW DRUGINCH 1S/C39H44O11/c1-21-14-30-37(45,34(21)44)19-26(20-48-31(42)18-25-12-13-28(41)29(16-25)47-6)15-27-33-36(4,5)39(33,50-23(3)40)35(22(2)38(27,30)46)49-32(43)17-24-10-8-7-9-11-24/h7-16,22,27,30,33,35,41,45-46H,17-20H2,1-6H3/t22-,27+,30-,33-,35-,37-,38-,39-/m1/s1 D06CDW DRUGINKE OGRGWTXWAZBJKF-JXWJAAHMSA-N D06CDW DRUGSMIL CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)COC(=O)CC5=CC(=C(C=C5)O)OC)O)C)O)OC(=O)C)OC(=O)CC6=CC=CC=C6 D06CDW HIGHSTAT Investigative D06CED DRUG__ID D06CED D06CED DRUGTYPE Small molecular drug D06CED DRUGINCH 1S/C16H11ClOS/c17-16-8-7-15(19-16)13-5-1-3-11(9-13)12-4-2-6-14(18)10-12/h1-10,18H D06CED DRUGINKE IBTNRYGKAUWUJS-UHFFFAOYSA-N D06CED DRUGSMIL C1=CC(=CC(=C1)C2=CC=C(S2)Cl)C3=CC(=CC=C3)O D06CED HIGHSTAT Investigative D06CGD DRUG__ID D06CGD D06CGD DRUGTYPE Small molecular drug D06CGD DRUGINCH 1S/C25H40N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-12,14,18-20,24,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/t14-,18-,19-,20+,24-/m1/s1 D06CGD DRUGINKE OJFDKHTZOUZBOS-CITAKDKDSA-N D06CGD DRUGSMIL CC(=O)CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D06CGD HIGHSTAT Investigative D06CGS DRUG__ID D06CGS D06CGS DRUGTYPE Small molecular drug D06CGS DRUGINCH 1S/C7H5O2.Hg/c8-7(9)6-4-2-1-3-5-6;/h2-5H,(H,8,9); D06CGS DRUGINKE FVFZSVRSDNUCGG-UHFFFAOYSA-N D06CGS DRUGSMIL C1=CC(=CC=C1C(=O)O)[Hg] D06CGS HIGHSTAT Investigative D06CHV DRUG__ID D06CHV D06CHV DRUGTYPE Small molecular drug D06CHV DRUGINCH 1S/C19H14N2/c1-2-6-16-14(5-1)11-12-20-19(16)10-9-15-13-21-18-8-4-3-7-17(15)18/h1-13,21H/b10-9+ D06CHV DRUGINKE GXWLLYOLXFYXAT-MDZDMXLPSA-N D06CHV DRUGSMIL C1=CC=C2C(=C1)C=CN=C2C=CC3=CNC4=CC=CC=C43 D06CHV HIGHSTAT Investigative D06CIH DRUG__ID D06CIH D06CIH DRUGTYPE Small molecular drug D06CIH DRUGINCH 1S/C25H22N2O4/c28-23(16-15-18-9-3-1-4-10-18)26-21-14-8-7-13-20(21)24(29)27-22(25(30)31)17-19-11-5-2-6-12-19/h1-16,22H,17H2,(H,26,28)(H,27,29)(H,30,31)/b16-15+ D06CIH DRUGINKE GKKJCDQBYJQSQR-FOCLMDBBSA-N D06CIH DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=CC=CC=C2NC(=O)C=CC3=CC=CC=C3 D06CIH HIGHSTAT Investigative D06CJP DRUG__ID D06CJP D06CJP DRUGTYPE Small molecular drug D06CJP DRUGINCH 1S/C10H10ClN5O2S/c11-8-4-15-9(16-10(12)13)7-3-5(19(14,17)18)1-2-6(7)8/h1-4H,(H2,14,17,18)(H4,12,13,15,16) D06CJP DRUGINKE FXVHAOFNNRNCRJ-UHFFFAOYSA-N D06CJP DRUGSMIL C1=CC2=C(C=C1S(=O)(=O)N)C(=NC=C2Cl)N=C(N)N D06CJP HIGHSTAT Investigative D06CMG DRUG__ID D06CMG D06CMG DRUGTYPE Small molecular drug D06CMG DRUGINCH 1S/C25H29N3O3/c1-17-22(19-14-23(29-2)25(31-4)24(15-19)30-3)13-20(16-27-17)18-5-7-21(8-6-18)28-11-9-26-10-12-28/h5-8,13-16,26H,9-12H2,1-4H3 D06CMG DRUGINKE BHUXVRVMMYAXKN-UHFFFAOYSA-N D06CMG DRUGSMIL CC1=C(C=C(C=N1)C2=CC=C(C=C2)N3CCNCC3)C4=CC(=C(C(=C4)OC)OC)OC D06CMG HIGHSTAT Investigative D06CMJ DRUG__ID D06CMJ D06CMJ DRUGTYPE Small molecular drug D06CMJ DRUGINCH 1S/C9H12ClN/c1-7(11)6-8-2-4-9(10)5-3-8/h2-5,7H,6,11H2,1H3 D06CMJ DRUGINKE WWPITPSIWMXDPE-UHFFFAOYSA-N D06CMJ DRUGSMIL CC(CC1=CC=C(C=C1)Cl)N D06CMJ HIGHSTAT Investigative D06CPD DRUG__ID D06CPD D06CPD DRUGTYPE Small molecular drug D06CPD DRUGINCH 1S/C9H10O5/c1-2-14-9(13)5-3-6(10)8(12)7(11)4-5/h3-4,10-12H,2H2,1H3 D06CPD DRUGINKE VFPFQHQNJCMNBZ-UHFFFAOYSA-N D06CPD DRUGSMIL CCOC(=O)C1=CC(=C(C(=C1)O)O)O D06CPD HIGHSTAT Investigative D06CPL DRUG__ID D06CPL D06CPL DRUGTYPE Small molecular drug D06CPL DRUGINCH 1S/C17H16N4O/c22-16(13-14-7-3-1-4-8-14)11-12-17-18-19-20-21(17)15-9-5-2-6-10-15/h1-10H,11-13H2 D06CPL DRUGINKE FPYZSRILLJGVMX-UHFFFAOYSA-N D06CPL DRUGSMIL C1=CC=C(C=C1)CC(=O)CCC2=NN=NN2C3=CC=CC=C3 D06CPL HIGHSTAT Investigative D06CQQ DRUG__ID D06CQQ D06CQQ DRUGTYPE Small molecular drug D06CQQ DRUGINCH 1S/C10H10O3/c11-9(6-7-10(12)13)8-4-2-1-3-5-8/h1-7,9,11H,(H,12,13)/b7-6+ D06CQQ DRUGINKE JJTRLNDAHGRZGZ-VOTSOKGWSA-N D06CQQ DRUGSMIL C1=CC=C(C=C1)C(C=CC(=O)O)O D06CQQ HIGHSTAT Investigative D06CSI DRUG__ID D06CSI D06CSI DRUGTYPE Small molecular drug D06CSI DRUGINCH 1S/C11H19N2O13P3/c1-6-3-13(11(16)12-10(6)15)9-2-7(14)8(25-9)4-24-27(17,18)5-28(19,20)26-29(21,22)23/h3,7-9,14H,2,4-5H2,1H3,(H,17,18)(H,19,20)(H,12,15,16)(H2,21,22,23)/t7-,8+,9+/m0/s1 D06CSI DRUGINKE AFUOLHFRDGMFSB-DJLDLDEBSA-N D06CSI DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O D06CSI HIGHSTAT Investigative D06CTS DRUG__ID D06CTS D06CTS DRUGTYPE Small molecular drug D06CTS DRUGINCH 1S/C4H3ClN2O4S2/c5-4-2(7(8)9)1-3(12-4)13(6,10)11/h1H,(H2,6,10,11) D06CTS DRUGINKE CKMLFNQCVNTKHN-UHFFFAOYSA-N D06CTS DRUGSMIL C1=C(SC(=C1[N+](=O)[O-])Cl)S(=O)(=O)N D06CTS HIGHSTAT Investigative D06CUF DRUG__ID D06CUF D06CUF DRUGTYPE Small molecular drug D06CUF DRUGINCH 1S/C14H16N2O5S2/c1-7-6-23-12(16-10(7)13(18)19)11(14(20)21)15-9(17)5-8-3-2-4-22-8/h2-4,11-12,16H,5-6H2,1H3,(H,15,17)(H,18,19)(H,20,21)/t11-,12-/m0/s1 D06CUF DRUGINKE JRYZEMHNDUZNMI-RYUDHWBXSA-N D06CUF DRUGSMIL CC1=C(NC(SC1)C(C(=O)O)NC(=O)CC2=CC=CS2)C(=O)O D06CUF HIGHSTAT Investigative D06CWR DRUG__ID D06CWR D06CWR DRUGTYPE Small molecular drug D06CWR DRUGINCH 1S/C20H15NO/c1-22-18-9-8-14-10-16(7-6-15(14)11-18)20-13-21-12-17-4-2-3-5-19(17)20/h2-13H,1H3 D06CWR DRUGINKE SGBOBLSELUHWRG-UHFFFAOYSA-N D06CWR DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CN=CC4=CC=CC=C43 D06CWR HIGHSTAT Investigative D06CWX DRUG__ID D06CWX D06CWX DRUGTYPE Small molecular drug D06CWX DRUGINCH 1S/C15H12O3/c1-18-12-7-3-5-10-8-9-4-2-6-11(16)13(9)15(17)14(10)12/h2-7,16H,8H2,1H3 D06CWX DRUGINKE KXNCIFRRMSGNPW-UHFFFAOYSA-N D06CWX DRUGSMIL COC1=CC=CC2=C1C(=O)C3=C(C2)C=CC=C3O D06CWX HIGHSTAT Investigative D06CXG DRUG__ID D06CXG D06CXG DRUGTYPE Small molecular drug D06CXG DRUGINCH 1S/C22H28N4/c1-3-12-23-21(5-1)20-9-7-19(8-10-20)11-14-25-15-17-26(18-16-25)22-6-2-4-13-24-22/h1-6,9,12-13,19H,7-8,10-11,14-18H2 D06CXG DRUGINKE KTGXACIWWLVCPX-UHFFFAOYSA-N D06CXG DRUGSMIL C1CC(=CCC1CCN2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=N4 D06CXG HIGHSTAT Investigative D06CXU DRUG__ID D06CXU D06CXU DRUGTYPE Small molecular drug D06CXU DRUGINCH 1S/C18H13Cl2N3O2/c19-13-5-11(6-14(20)8-13)9-22-18-21-4-3-15(23-18)12-1-2-16-17(7-12)25-10-24-16/h1-8H,9-10H2,(H,21,22,23) D06CXU DRUGINKE FFJGYBJUQCZAAY-UHFFFAOYSA-N D06CXU DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=NC(=NC=C3)NCC4=CC(=CC(=C4)Cl)Cl D06CXU HIGHSTAT Investigative D06DAY DRUG__ID D06DAY D06DAY DRUGTYPE Small molecular drug D06DAY DRUGINCH 1S/C17H15NO4/c19-14-11-16(18-6-9-20-10-7-18)22-17-12(14)3-1-4-13(17)15-5-2-8-21-15/h1-5,8,11H,6-7,9-10H2 D06DAY DRUGINKE KEXLPFOPRBRYIA-UHFFFAOYSA-N D06DAY DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CO4 D06DAY HIGHSTAT Investigative D06DBA DRUG__ID D06DBA D06DBA DRUGTYPE Small molecular drug D06DBA DRUGINCH 1S/C21H16N2O6S.Na/c1-29-12-8-6-11(7-9-12)23-15-10-16(30(26,27)28)19(22)18-17(15)20(24)13-4-2-3-5-14(13)21(18)25;/h2-10,23H,22H2,1H3,(H,26,27,28);/q;+1/p-1 D06DBA DRUGINKE UKZVMBMYDRZSBX-UHFFFAOYSA-M D06DBA DRUGSMIL COC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+] D06DBA HIGHSTAT Investigative D06DCK DRUG__ID D06DCK D06DCK DRUGTYPE Small molecular drug D06DCK DRUGINCH 1S/C27H21FN2O5/c28-19-6-18(27(31)10-22-15-34-26(11-27)35-22)7-21(8-19)33-13-16-1-2-23-24(17-3-4-32-14-17)9-20(12-29)30-25(23)5-16/h1-9,14,22,26,31H,10-11,13,15H2/t22-,26+,27-/m0/s1 D06DCK DRUGINKE GZOVJNIKHQXVIU-FDJWOJMMSA-N D06DCK DRUGSMIL C1C2COC(O2)CC1(C3=CC(=CC(=C3)F)OCC4=CC5=NC(=CC(=C5C=C4)C6=COC=C6)C#N)O D06DCK HIGHSTAT Investigative D06DDA DRUG__ID D06DDA D06DDA DRUGTYPE Small molecular drug D06DDA DRUGINCH 1S/C29H31NO8/c1-30-22(31)16-27-14-21(37-23(32)13-10-17-8-6-5-7-9-17)26(35-3)29(36-4)28(27,30)15-20(38-29)18-11-12-19(34-2)25(33)24(18)27/h5-13,20-21,26,33H,14-16H2,1-4H3/b13-10+/t20-,21-,26-,27+,28-,29+/m0/s1 D06DDA DRUGINKE KOKWRSAOHLOSAI-HXHZFJGXSA-N D06DDA DRUGSMIL CN1C(=O)CC23C14CC(C5=C2C(=C(C=C5)OC)O)OC4(C(C(C3)OC(=O)C=CC6=CC=CC=C6)OC)OC D06DDA HIGHSTAT Investigative D06DDT DRUG__ID D06DDT D06DDT DRUGTYPE Small molecular drug D06DDT DRUGINCH 1S/C16H18O3/c1-19-15-10-7-13(16(18)11-15)4-2-3-12-5-8-14(17)9-6-12/h5-11,17-18H,2-4H2,1H3 D06DDT DRUGINKE MSNVBURPCQDLEP-UHFFFAOYSA-N D06DDT DRUGSMIL COC1=CC(=C(C=C1)CCCC2=CC=C(C=C2)O)O D06DDT HIGHSTAT Investigative D06DEL DRUG__ID D06DEL D06DEL DRUGTYPE Small molecular drug D06DEL DRUGINCH 1S/C27H40O5/c1-16(12-21-15-27(4,31)25(30)32-21)22-9-10-23-18(6-5-11-26(22,23)3)7-8-19-13-20(28)14-24(29)17(19)2/h7-8,16,20-24,28-29,31H,2,5-6,9-15H2,1,3-4H3/b18-7+,19-8-/t16-,20-,21+,22-,23+,24+,26-,27-/m1/s1 D06DEL DRUGINKE WMYIVSWWSRCZFA-RWVJFQLJSA-N D06DEL DRUGSMIL CC(CC1CC(C(=O)O1)(C)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D06DEL HIGHSTAT Investigative D06DIH DRUG__ID D06DIH D06DIH DRUGTYPE Small molecular drug D06DIH DRUGINCH 1S/C20H22N6O6/c1-26(8-11-9-32-18-15(11)16(21)24-20(22)25-18)12-4-2-10(3-5-12)17(29)23-13(19(30)31)6-7-14(27)28/h2-5,9,13H,6-8H2,1H3,(H,23,29)(H,27,28)(H,30,31)(H4,21,22,24,25)/t13-/m0/s1 D06DIH DRUGINKE WXINNGCGSCFUCR-ZDUSSCGKSA-N D06DIH DRUGSMIL CN(CC1=COC2=NC(=NC(=C12)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D06DIH HIGHSTAT Investigative D06DKB DRUG__ID D06DKB D06DKB DRUGTYPE Small molecular drug D06DKB DRUGINCH 1S/C17H20ClN5O/c18-12-2-3-14-13(10-12)15-16(22-14)17(21-11-20-15)19-4-1-5-23-6-8-24-9-7-23/h2-3,10-11,22H,1,4-9H2,(H,19,20,21) D06DKB DRUGINKE ULJISGNQAXNPOC-UHFFFAOYSA-N D06DKB DRUGSMIL C1COCCN1CCCNC2=NC=NC3=C2NC4=C3C=C(C=C4)Cl D06DKB HIGHSTAT Investigative D06DMY DRUG__ID D06DMY D06DMY DRUGTYPE Small molecular drug D06DMY DRUGINCH 1S/C4H6O3/c1-3(2-5)4(6)7/h2-3H,1H3,(H,6,7)/p-1 D06DMY DRUGINKE VOKUMXABRRXHAR-UHFFFAOYSA-M D06DMY DRUGSMIL CC(C=O)C(=O)[O-] D06DMY HIGHSTAT Investigative D06DNH DRUG__ID D06DNH D06DNH DRUGTYPE Small molecular drug D06DNH DRUGINCH 1S/C21H24N4O2/c1-15-12-18(16(2)22-17-6-4-3-5-7-17)21-23-19(13-20(26)25(21)14-15)24-8-10-27-11-9-24/h3-7,12-14,16,22H,8-11H2,1-2H3 D06DNH DRUGINKE CPRAGQJXBLMUEL-UHFFFAOYSA-N D06DNH DRUGSMIL CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4 D06DNH HIGHSTAT Investigative D06DNN DRUG__ID D06DNN D06DNN DRUGTYPE Small molecular drug D06DNN DRUGINCH 1S/C24H24O3/c1-2-3-4-23(17-5-11-20(25)12-6-17)24(18-7-13-21(26)14-8-18)19-9-15-22(27)16-10-19/h5-16,25-27H,2-4H2,1H3 D06DNN DRUGINKE QMNAADNBEBCAEQ-UHFFFAOYSA-N D06DNN DRUGSMIL CCCCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O D06DNN HIGHSTAT Investigative D06DRD DRUG__ID D06DRD D06DRD DRUGTYPE Small molecular drug D06DRD DRUGINCH 1S/C26H18N4O6/c31-23-11-9-19(13-21(23)25(33)34)29-27-17-5-1-15(2-6-17)16-3-7-18(8-4-16)28-30-20-10-12-24(32)22(14-20)26(35)36/h1-14,31-32H,(H,33,34)(H,35,36) D06DRD DRUGINKE XFFSCOOTVXBLCK-UHFFFAOYSA-N D06DRD DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O)N=NC4=CC(=C(C=C4)O)C(=O)O D06DRD HIGHSTAT Investigative D06DRL DRUG__ID D06DRL D06DRL DRUGTYPE Small molecular drug D06DRL DRUGINCH 1S/C12H13N3O2S/c1-18(16,17)15-11-7-8-13-9-12(11)14-10-5-3-2-4-6-10/h2-9,14H,1H3,(H,13,15) D06DRL DRUGINKE QOJPQADRTOBBQV-UHFFFAOYSA-N D06DRL DRUGSMIL CS(=O)(=O)NC1=C(C=NC=C1)NC2=CC=CC=C2 D06DRL HIGHSTAT Investigative D06DRS DRUG__ID D06DRS D06DRS DRUGTYPE Small molecular drug D06DRS DRUGINCH 1S/C5H11N/c1-2-4-6-5-3-1/h6H,1-5H2 D06DRS DRUGINKE NQRYJNQNLNOLGT-UHFFFAOYSA-N D06DRS DRUGSMIL C1CCNCC1 D06DRS HIGHSTAT Investigative D06DRY DRUG__ID D06DRY D06DRY DRUGTYPE Small molecular drug D06DRY DRUGINCH 1S/C10H12N2O7/c11-10(9(18)19)3-5(8(16)17)12(4-10)6(13)1-2-7(14)15/h1-2,5H,3-4,11H2,(H,14,15)(H,16,17)(H,18,19)/b2-1+/t5-,10-/m0/s1 D06DRY DRUGINKE ZALHFQNLXQORTH-FGLATXDZSA-N D06DRY DRUGSMIL C1C(N(CC1(C(=O)O)N)C(=O)C=CC(=O)O)C(=O)O D06DRY HIGHSTAT Investigative D06DSE DRUG__ID D06DSE D06DSE DRUGTYPE Small molecular drug D06DSE DRUGINCH 1S/C54H57N9O9/c1-35(49(55)64)59-50(65)46(26-40-28-57-44-20-12-11-19-43(40)44)61-53(68)48(33-70-30-37-13-5-2-6-14-37)62-51(66)45(25-36-21-23-42(24-22-36)71-31-38-15-7-3-8-16-38)60-52(67)47(27-41-29-56-34-58-41)63-54(69)72-32-39-17-9-4-10-18-39/h2-24,28-29,34-35,45-48,57H,25-27,30-33H2,1H3,(H2,55,64)(H,56,58)(H,59,65)(H,60,67)(H,61,68)(H,62,66)(H,63,69)/t35-,45+,46+,47+,48+/m1/s1 D06DSE DRUGINKE LMBPTRXCFXWLRW-ZYIGOEBISA-N D06DSE DRUGSMIL CC(C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(COCC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)OCC5=CC=CC=C5)NC(=O)C(CC6=CN=CN6)NC(=O)OCC7=CC=CC=C7 D06DSE HIGHSTAT Investigative D06DSF DRUG__ID D06DSF D06DSF DRUGTYPE Small molecular drug D06DSF DRUGINCH 1S/C13H9N3O/c14-7-10-2-4-11(15-10)8-1-3-12-9(5-8)6-13(17)16-12/h1-5,15H,6H2,(H,16,17) D06DSF DRUGINKE TVDRXBFEEAXOTN-UHFFFAOYSA-N D06DSF DRUGSMIL C1C2=C(C=CC(=C2)C3=CC=C(N3)C#N)NC1=O D06DSF HIGHSTAT Investigative D06DSX DRUG__ID D06DSX D06DSX DRUGTYPE Small molecular drug D06DSX DRUGINCH 1S/C19H17NO4/c1-20-14-2-10-4-16-18(23-8-21-16)6-12(10)15(20)3-11-5-17-19(7-13(11)14)24-9-22-17/h4-7,14-15H,2-3,8-9H2,1H3/t14-,15-/m0/s1 D06DSX DRUGINKE PGINMPJZCWDQNT-GJZGRUSLSA-N D06DSX DRUGSMIL CN1C2CC3=CC4=C(C=C3C1CC5=CC6=C(C=C25)OCO6)OCO4 D06DSX HIGHSTAT Investigative D06DTC DRUG__ID D06DTC D06DTC DRUGTYPE Small molecular drug D06DTC DRUGINCH 1S/C28H28Cl2N2O3/c1-17(33)26(34)31-24-16-28(13-5-2-6-14-28)35-27-22(24)15-21(18-9-11-19(29)12-10-18)25(32-27)20-7-3-4-8-23(20)30/h3-4,7-12,15,17,24,33H,2,5-6,13-14,16H2,1H3,(H,31,34)/t17-,24?/m0/s1 D06DTC DRUGINKE CBNQOXMUNJAOJO-KEJDIYNNSA-N D06DTC DRUGSMIL CC(C(=O)NC1CC2(CCCCC2)OC3=C1C=C(C(=N3)C4=CC=CC=C4Cl)C5=CC=C(C=C5)Cl)O D06DTC HIGHSTAT Investigative D06DTQ DRUG__ID D06DTQ D06DTQ DRUGTYPE Small molecular drug D06DTQ DRUGINCH 1S/C13H9BrN2OS/c14-9-3-1-4-10(7-9)18(17)13-6-2-5-12(16)11(13)8-15/h1-7H,16H2 D06DTQ DRUGINKE JNNOSSLVLGASPM-UHFFFAOYSA-N D06DTQ DRUGSMIL C1=CC(=CC(=C1)Br)S(=O)C2=CC=CC(=C2C#N)N D06DTQ HIGHSTAT Investigative D06DTT DRUG__ID D06DTT D06DTT DRUGTYPE Small molecular drug D06DTT DRUGINCH 1S/C16H13FN2O/c1-19-14-9-5-3-7-12(14)16(18-10-15(19)20)11-6-2-4-8-13(11)17/h2-9H,10H2,1H3 D06DTT DRUGINKE YVTVBCWQHDDTGB-UHFFFAOYSA-N D06DTT DRUGSMIL CN1C(=O)CN=C(C2=CC=CC=C21)C3=CC=CC=C3F D06DTT HIGHSTAT Investigative D06DUE DRUG__ID D06DUE D06DUE DRUGTYPE Small molecular drug D06DUE DRUGINCH 1S/C5H7N3O5/c6-2(3(9)10)1-8-4(11)7-5(12)13-8/h2H,1,6H2,(H,9,10)(H,7,11,12)/t2-/m0/s1 D06DUE DRUGINKE ASNFTDCKZKHJSW-REOHCLBHSA-N D06DUE DRUGSMIL C(C(C(=O)O)N)N1C(=O)NC(=O)O1 D06DUE HIGHSTAT Investigative D06DVJ DRUG__ID D06DVJ D06DVJ DRUGTYPE Small molecular drug D06DVJ DRUGINCH 1S/C13H11NO5S/c14-20(17,18)19-12-6-2-4-10(8-12)13(16)9-3-1-5-11(15)7-9/h1-8,15H,(H2,14,17,18) D06DVJ DRUGINKE JDCIQZXDYFJKSG-UHFFFAOYSA-N D06DVJ DRUGSMIL C1=CC(=CC(=C1)O)C(=O)C2=CC(=CC=C2)OS(=O)(=O)N D06DVJ HIGHSTAT Investigative D06DWP DRUG__ID D06DWP D06DWP DRUGTYPE Small molecular drug D06DWP DRUGINCH 1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1 D06DWP DRUGINKE VGONTNSXDCQUGY-RRKCRQDMSA-N D06DWP DRUGSMIL C1C(C(OC1N2C=NC3=C2N=CNC3=O)CO)O D06DWP HIGHSTAT Investigative D06DWW DRUG__ID D06DWW D06DWW DRUGTYPE Small molecular drug D06DWW DRUGINCH 1S/C26H39N5O9/c1-13(2)20(26(39)40)30-22(35)14(3)28-25(38)21(15(4)32)31-24(37)18(10-11-19(33)34)29-23(36)17(27)12-16-8-6-5-7-9-16/h5-9,13-15,17-18,20-21,32H,10-12,27H2,1-4H3,(H,28,38)(H,29,36)(H,30,35)(H,31,37)(H,33,34)(H,39,40)/t14-,15?,17-,18-,20-,21-/m0/s1 D06DWW DRUGINKE ILLATSRMKXLBOS-HWJJFRRQSA-N D06DWW DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=CC=C1)N D06DWW HIGHSTAT Investigative D06DYN DRUG__ID D06DYN D06DYN DRUGTYPE Small molecular drug D06DYN DRUGINCH 1S/C19H34NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21H,2-8,13-16,20H2,1H3,(H2,22,23,24) D06DYN DRUGINKE LRFKWQGGENFBFO-UHFFFAOYSA-N D06DYN DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(COP(=O)(O)O)N D06DYN HIGHSTAT Investigative D06DYP DRUG__ID D06DYP D06DYP DRUGTYPE Small molecular drug D06DYP DRUGINCH 1S/C11H8O5/c1-15-8-4-2-3-6-5-7(10(12)13)11(14)16-9(6)8/h2-5H,1H3,(H,12,13) D06DYP DRUGINKE SFAPWVZFUHJZIC-UHFFFAOYSA-N D06DYP DRUGSMIL COC1=CC=CC2=C1OC(=O)C(=C2)C(=O)O D06DYP HIGHSTAT Investigative D06DZO DRUG__ID D06DZO D06DZO DRUGTYPE Small molecular drug D06DZO DRUGINCH 1S/C22H39NO/c1-2-3-4-5-6-7-8-9-10-11-21(24)23-22-15-18-12-19(16-22)14-20(13-18)17-22/h18-20H,2-17H2,1H3,(H,23,24) D06DZO DRUGINKE FRFKXRWIBACCCN-UHFFFAOYSA-N D06DZO DRUGSMIL CCCCCCCCCCCC(=O)NC12CC3CC(C1)CC(C3)C2 D06DZO HIGHSTAT Investigative D06EES DRUG__ID D06EES D06EES DRUGTYPE Small molecular drug D06EES DRUGINCH 1S/C28H37N5O7/c1-17(2)12-23(28(39)40)33-27(38)22(14-18-6-4-3-5-7-18)32-25(36)16-30-24(35)15-31-26(37)21(29)13-19-8-10-20(34)11-9-19/h3-11,17,21-23,34H,12-16,29H2,1-2H3,(H,30,35)(H,31,37)(H,32,36)(H,33,38)(H,39,40)/t21-,22-,23-/m0/s1 D06EES DRUGINKE URLZCHNOLZSCCA-VABKMULXSA-N D06EES DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N D06EES HIGHSTAT Investigative D06EGM DRUG__ID D06EGM D06EGM DRUGTYPE Small molecular drug D06EGM DRUGINCH 1S/C20H15Cl2N3O2/c21-17-6-5-15(9-18(17)22)25-10-12-3-4-14(8-13(12)11-25)24-19-16(20(26)27)2-1-7-23-19/h1-9H,10-11H2,(H,23,24)(H,26,27) D06EGM DRUGINKE WNXIPCSWXVTKQF-UHFFFAOYSA-N D06EGM DRUGSMIL C1C2=C(CN1C3=CC(=C(C=C3)Cl)Cl)C=C(C=C2)NC4=C(C=CC=N4)C(=O)O D06EGM HIGHSTAT Investigative D06EHE DRUG__ID D06EHE D06EHE DRUGTYPE Small molecular drug D06EHE DRUGINCH 1S/C10H14N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,9-10,15-18H,1H2,(H,11,12)/p+1/t4-,6-,7-,9+,10-/m1/s1 D06EHE DRUGINKE WGRXVKRHIMUTPD-YOHZANMFSA-O D06EHE DRUGSMIL C1=NC(C2=C(N1)[N+](=CN2)C3C(C(C(O3)CO)O)O)O D06EHE HIGHSTAT Investigative D06EHU DRUG__ID D06EHU D06EHU DRUGTYPE Small molecular drug D06EHU DRUGINCH 1S/C26H27NO2/c1-4-5-10-17-27-18(2)24(21-13-8-9-14-22(21)27)26(28)25-20-12-7-6-11-19(20)15-16-23(25)29-3/h6-9,11-16H,4-5,10,17H2,1-3H3 D06EHU DRUGINKE POCUOUJJUBHVTI-UHFFFAOYSA-N D06EHU DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)C3=C(C=CC4=CC=CC=C43)OC)C D06EHU HIGHSTAT Investigative D06EJS DRUG__ID D06EJS D06EJS DRUGTYPE Small molecular drug D06EJS DRUGINCH 1S/C44H60N6O4/c1-29-21-31-23-37-35(13-15-39(51)45-37)43(25-29)33(31)11-9-19-49(43)41(53)27-47(3)17-7-5-6-8-18-48(4)28-42(54)50-20-10-12-34-32-22-30(2)26-44(34,50)36-14-16-40(52)46-38(36)24-32/h13-16,21-22,31-34H,5-12,17-20,23-28H2,1-4H3,(H,45,51)(H,46,52)/t31?,32?,33-,34-,43-,44-/m1/s1 D06EJS DRUGINKE OSYUHORWAUGEMC-ZTZPCQEHSA-N D06EJS DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4C(=O)CN(C)CCCCCCN(C)CC(=O)N5CCCC6C57CC(=CC6CC8=C7C=CC(=O)N8)C D06EJS HIGHSTAT Investigative D06EJX DRUG__ID D06EJX D06EJX DRUGTYPE Small molecular drug D06EJX DRUGINCH 1S/C41H47N5O6S/c1-25-18-30(43-22-29-15-10-11-17-42-29)19-26(2)37(25)52-23-34(48)44-32(20-27-12-6-5-7-13-27)36(49)40(51)46-24-53-41(3,4)38(46)39(50)45-35-31-16-9-8-14-28(31)21-33(35)47/h5-19,32-33,35-36,38,43,47,49H,20-24H2,1-4H3,(H,44,48)(H,45,50)/t32-,33+,35-,36-,38+/m0/s1 D06EJX DRUGINKE IEOXTIHUYRYEJG-CTRNRRKFSA-N D06EJX DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NCC6=CC=CC=N6 D06EJX HIGHSTAT Investigative D06EPZ DRUG__ID D06EPZ D06EPZ DRUGTYPE Small molecular drug D06EPZ DRUGINCH 1S/C25H29ClN4O3/c1-17-5-2-3-13-29(17)14-4-12-27-23(31)19-8-11-21-22(15-19)28-25(33)30(24(21)32)16-18-6-9-20(26)10-7-18/h6-11,15,17H,2-5,12-14,16H2,1H3,(H,27,31)(H,28,33) D06EPZ DRUGINKE YMGCQAHDDYCKLB-UHFFFAOYSA-N D06EPZ DRUGSMIL CC1CCCCN1CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl D06EPZ HIGHSTAT Investigative D06ERH DRUG__ID D06ERH D06ERH DRUGTYPE Small molecular drug D06ERH DRUGINCH 1S/C15H12O/c16-15(14-9-5-2-6-10-14)12-11-13-7-3-1-4-8-13/h1-12H/b12-11+ D06ERH DRUGINKE DQFBYFPFKXHELB-VAWYXSNFSA-N D06ERH DRUGSMIL C1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2 D06ERH HIGHSTAT Investigative D06ESC DRUG__ID D06ESC D06ESC DRUGTYPE Small molecular drug D06ESC DRUGINCH 1S/C30H39N7O6/c1-17(2)11-24(28(32)41)37-30(43)25(13-19-14-33-23-6-4-3-5-21(19)23)36-27(40)16-34-26(39)15-35-29(42)22(31)12-18-7-9-20(38)10-8-18/h3-10,14,17,22,24-25,33,38H,11-13,15-16,31H2,1-2H3,(H2,32,41)(H,34,39)(H,35,42)(H,36,40)(H,37,43)/t22-,24-,25-/m0/s1 D06ESC DRUGINKE GNLQCAGQAYEHAM-HVCNVCAESA-N D06ESC DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N D06ESC HIGHSTAT Investigative D06ETD DRUG__ID D06ETD D06ETD DRUGTYPE Small molecular drug D06ETD DRUGINCH 1S/C15H11N3O2S/c19-12-8-6-11(7-9-12)14(20)17-15-16-13(18-21-15)10-4-2-1-3-5-10/h1-9,19H,(H,16,17,18,20) D06ETD DRUGINKE MIJWZALSSVTKAQ-UHFFFAOYSA-N D06ETD DRUGSMIL C1=CC=C(C=C1)C2=NSC(=N2)NC(=O)C3=CC=C(C=C3)O D06ETD HIGHSTAT Investigative D06ETG DRUG__ID D06ETG D06ETG DRUGTYPE Small molecular drug D06ETG DRUGINCH 1S/C12H13NO/c1-2-8-13-11-7-6-10-9(11)4-3-5-12(10)14/h2-5,8,11,14H,1,6-7H2/t11-/m1/s1 D06ETG DRUGINKE OFWOPQIDDNCCLL-LLVKDONJSA-N D06ETG DRUGSMIL C=CC=NC1CCC2=C1C=CC=C2O D06ETG HIGHSTAT Investigative D06EUA DRUG__ID D06EUA D06EUA DRUGTYPE Small molecular drug D06EUA DRUGINCH 1S/C9H10O4/c1-9-5-3-2-4(12-5)6(9)7(10)13-8(9)11/h4-6H,2-3H2,1H3/t4-,5+,6+,9+/m1/s1 D06EUA DRUGINKE RJXMWQSSXZMNIT-OLHMAJIHSA-N D06EUA DRUGSMIL CC12C3CCC(C1C(=O)OC2=O)O3 D06EUA HIGHSTAT Investigative D06EUJ DRUG__ID D06EUJ D06EUJ DRUGTYPE Small molecular drug D06EUJ DRUGINCH 1S/C14H15NO3/c1-2-3-8-18-14(17)11-9-15-12-7-5-4-6-10(12)13(11)16/h4-7,9H,2-3,8H2,1H3,(H,15,16) D06EUJ DRUGINKE LKWHYYPRQAIKDW-UHFFFAOYSA-N D06EUJ DRUGSMIL CCCCOC(=O)C1=CNC2=CC=CC=C2C1=O D06EUJ HIGHSTAT Investigative D06EUM DRUG__ID D06EUM D06EUM DRUGTYPE Small molecular drug D06EUM DRUGINCH 1S/C11H21NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h9-10H,1-8,12H2,(H,13,14) D06EUM DRUGINKE LGIVZSMPEFXNLH-UHFFFAOYSA-N D06EUM DRUGSMIL C1CCC(CC1)CCCC(C(=O)O)N D06EUM HIGHSTAT Investigative D06EWG DRUG__ID D06EWG D06EWG DRUGTYPE Small molecular drug D06EWG DRUGINCH 1S/CH2O2/c2-1-3/h1H,(H,2,3) D06EWG DRUGINKE BDAGIHXWWSANSR-UHFFFAOYSA-N D06EWG DRUGSMIL C(=O)O D06EWG HIGHSTAT Investigative D06EXH DRUG__ID D06EXH D06EXH DRUGTYPE Small molecular drug D06EXH DRUGINCH 1S/C7H14N2O/c1-3-5-6(4-2)10-7(8)9-5/h5-6H,3-4H2,1-2H3,(H2,8,9)/t5-,6-/m0/s1 D06EXH DRUGINKE KYKDCIRQVPPSOP-WDSKDSINSA-N D06EXH DRUGSMIL CCC1C(OC(=N1)N)CC D06EXH HIGHSTAT Investigative D06EZQ DRUG__ID D06EZQ D06EZQ DRUGTYPE Small molecular drug D06EZQ DRUGINCH 1S/C15H8N4O2/c20-14-9-8-6-3-1-2-4-7(6)18-12(8)13-11(16-5-17-13)10(9)15(21)19-14/h1-5,18H,(H,16,17)(H,19,20,21) D06EZQ DRUGINKE LBTREMHIJGMYQN-UHFFFAOYSA-N D06EZQ DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=C5C(=C3N2)NC=N5)C(=O)NC4=O D06EZQ HIGHSTAT Investigative D06FAK DRUG__ID D06FAK D06FAK DRUGTYPE Small molecular drug D06FAK DRUGINCH 1S/C18H20N2O2/c21-18(19-22)12-2-1-7-13-20-16-10-5-3-8-14(16)15-9-4-6-11-17(15)20/h3-6,8-11,22H,1-2,7,12-13H2,(H,19,21) D06FAK DRUGINKE SOMDVJCUFVPZKM-UHFFFAOYSA-N D06FAK DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCCC(=O)NO D06FAK HIGHSTAT Investigative D06FCT DRUG__ID D06FCT D06FCT DRUGTYPE Small molecular drug D06FCT DRUGINCH 1S/C36H45N3O7S2/c1-4-6-18-36(19-7-5-2)24-39(27-16-12-9-13-17-27)28-20-30(47-3)29(21-31(28)48(44,45)25-36)46-23-32(40)38-34(26-14-10-8-11-15-26)35(43)37-22-33(41)42/h8-17,20-21,34H,4-7,18-19,22-25H2,1-3H3,(H,37,43)(H,38,40)(H,41,42)/t34-/m1/s1 D06FCT DRUGINKE XFLQIRAKKLNXRQ-UUWRZZSWSA-N D06FCT DRUGSMIL CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)NC(C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC D06FCT HIGHSTAT Investigative D06FFD DRUG__ID D06FFD D06FFD DRUGTYPE Small molecular drug D06FFD DRUGINCH 1S/C14H8Br2O2/c15-11-5-1-9(2-6-11)13(17)14(18)10-3-7-12(16)8-4-10/h1-8H D06FFD DRUGINKE NYCBYBDDECLFPE-UHFFFAOYSA-N D06FFD DRUGSMIL C1=CC(=CC=C1C(=O)C(=O)C2=CC=C(C=C2)Br)Br D06FFD HIGHSTAT Investigative D06FFP DRUG__ID D06FFP D06FFP DRUGTYPE Small molecular drug D06FFP DRUGINCH 1S/C20H37N3O4/c1-7-8-9-16(12-24)22-19(26)18(11-14(4)5)23-20(27)17(10-13(2)3)21-15(6)25/h12-14,16-18H,7-11H2,1-6H3,(H,21,25)(H,22,26)(H,23,27)/t16-,17-,18-/m0/s1 D06FFP DRUGINKE FMYKJLXRRQTBOR-BZSNNMDCSA-N D06FFP DRUGSMIL CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C D06FFP HIGHSTAT Investigative D06FFZ DRUG__ID D06FFZ D06FFZ DRUGTYPE Small molecular drug D06FFZ DRUGINCH 1S/C27H28FN5O2/c1-3-32-13-15-33(16-14-32)20-10-7-18(8-11-20)27(34)29-26-22-12-9-19(17-23(22)30-31-26)21-5-4-6-24(35-2)25(21)28/h4-12,17H,3,13-16H2,1-2H3,(H2,29,30,31,34) D06FFZ DRUGINKE ANMVTYAYYHHSTF-UHFFFAOYSA-N D06FFZ DRUGSMIL CCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3C=CC(=C4)C5=C(C(=CC=C5)OC)F D06FFZ HIGHSTAT Investigative D06FHE DRUG__ID D06FHE D06FHE DRUGTYPE Small molecular drug D06FHE DRUGINCH 1S/C20H19N3/c1-2-22-12-10-17-14-18(8-9-19(17)22)20(23-13-11-21-15-23)16-6-4-3-5-7-16/h3-15,20H,2H2,1H3 D06FHE DRUGINKE WUILDCCEKAPXPV-UHFFFAOYSA-N D06FHE DRUGSMIL CCN1C=CC2=C1C=CC(=C2)C(C3=CC=CC=C3)N4C=CN=C4 D06FHE HIGHSTAT Investigative D06FHW DRUG__ID D06FHW D06FHW DRUGTYPE Small molecular drug D06FHW DRUGINCH 1S/C7H15N/c8-6-7-4-2-1-3-5-7/h7H,1-6,8H2 D06FHW DRUGINKE AVKNGPAMCBSNSO-UHFFFAOYSA-N D06FHW DRUGSMIL C1CCC(CC1)CN D06FHW HIGHSTAT Investigative D06FIF DRUG__ID D06FIF D06FIF DRUGTYPE Small molecular drug D06FIF DRUGINCH 1S/C21H30N2O/c1-8-18(9-2)23-19-12-16(6)22-21(17(19)7)24-20-14(4)10-13(3)11-15(20)5/h10-12,18H,8-9H2,1-7H3,(H,22,23) D06FIF DRUGINKE VIZBSVDBNLAVAW-UHFFFAOYSA-N D06FIF DRUGSMIL CCC(CC)NC1=C(C(=NC(=C1)C)OC2=C(C=C(C=C2C)C)C)C D06FIF HIGHSTAT Investigative D06FIK DRUG__ID D06FIK D06FIK DRUGTYPE Small molecular drug D06FIK DRUGINCH 1S/C26H22Cl2N2O3/c1-16-4-3-5-17(12-16)22(26(31)32)14-19-15-25(18-6-11-23(27)24(28)13-18)30(29-19)20-7-9-21(33-2)10-8-20/h3-13,15,22H,14H2,1-2H3,(H,31,32)/t22-/m0/s1 D06FIK DRUGINKE UZCIUKFEIOCAOC-QFIPXVFZSA-N D06FIK DRUGSMIL CC1=CC(=CC=C1)C(CC2=NN(C(=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=C(C=C4)OC)C(=O)O D06FIK HIGHSTAT Investigative D06FIQ DRUG__ID D06FIQ D06FIQ DRUGTYPE Small molecular drug D06FIQ DRUGINCH 1S/C18H20ClN5O/c19-13-7-4-8-14(9-13)22-18-23-16-15(20-11-21-16)17(24-18)25-10-12-5-2-1-3-6-12/h4,7-9,11-12H,1-3,5-6,10H2,(H2,20,21,22,23,24) D06FIQ DRUGINKE OUEGMEMDEAOAEG-UHFFFAOYSA-N D06FIQ DRUGSMIL C1CCC(CC1)COC2=NC(=NC3=C2NC=N3)NC4=CC(=CC=C4)Cl D06FIQ HIGHSTAT Investigative D06FLU DRUG__ID D06FLU D06FLU DRUGTYPE Small molecular drug D06FLU DRUGINCH 1S/C19H19Br2NO4/c1-22-5-4-8-13-11(22)6-10-9(7-12(25-2)17(23)16(10)21)14(13)19(26-3)18(24)15(8)20/h7,11,23-24H,4-6H2,1-3H3/t11-/m0/s1 D06FLU DRUGINKE FTUCKVYWXINSAK-NSHDSACASA-N D06FLU DRUGSMIL CN1CCC2=C3C1CC4=C(C(=C(C=C4C3=C(C(=C2Br)O)OC)OC)O)Br D06FLU HIGHSTAT Investigative D06FMH DRUG__ID D06FMH D06FMH DRUGTYPE Small molecular drug D06FMH DRUGINCH 1S/C9H14N3O7P/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(19-8)4-18-20(15,16)17/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 D06FMH DRUGINKE NCMVOABPESMRCP-SHYZEUOFSA-N D06FMH DRUGSMIL C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(O)O)O D06FMH HIGHSTAT Investigative D06FNK DRUG__ID D06FNK D06FNK DRUGTYPE Small molecular drug D06FNK DRUGINCH 1S/C18H22N2O4/c21-12-15-8-4-10-19(15)17(22)16-9-5-11-20(16)18(23)24-13-14-6-2-1-3-7-14/h1-3,6-7,12,15-16H,4-5,8-11,13H2/t15-,16-/m0/s1 D06FNK DRUGINKE ORZXYSPOAVJYRU-HOTGVXAUSA-N D06FNK DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)OCC3=CC=CC=C3)C=O D06FNK HIGHSTAT Investigative D06FNT DRUG__ID D06FNT D06FNT DRUGTYPE Small molecular drug D06FNT DRUGINCH 1S/C22H17N3O2/c1-27-17-11-9-15(10-12-17)22(26)25-21-18-7-3-2-6-16(18)14-20(24-21)19-8-4-5-13-23-19/h2-14H,1H3,(H,24,25,26) D06FNT DRUGINKE VLGYXUZBVKQWQO-UHFFFAOYSA-N D06FNT DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NC(=CC3=CC=CC=C32)C4=CC=CC=N4 D06FNT HIGHSTAT Investigative D06FPP DRUG__ID D06FPP D06FPP DRUGTYPE Small molecular drug D06FPP DRUGINCH 1S/C24H29NO2/c1-24-9-6-20-19-5-3-18(26)13-16(19)2-4-21(20)22(24)14-17(23(24)27)12-15-7-10-25-11-8-15/h3,5,7-8,10-11,13,17,20-23,26-27H,2,4,6,9,12,14H2,1H3/t17-,20?,21?,22?,23-,24-/m0/s1 D06FPP DRUGINKE HTDAGQQNWZEQOG-ZCTINNFXSA-N D06FPP DRUGSMIL CC12CCC3C(C1CC(C2O)CC4=CC=NC=C4)CCC5=C3C=CC(=C5)O D06FPP HIGHSTAT Investigative D06FRE DRUG__ID D06FRE D06FRE DRUGTYPE Small molecular drug D06FRE DRUGINCH 1S/C32H32F2O5/c1-19(2)30-27-6-4-3-5-22(27)15-28(32(30)39-18-26(36)16-25(35)17-29(37)38)31(20-7-11-23(33)12-8-20)21-9-13-24(34)14-10-21/h3-15,19,25-26,31,35-36H,16-18H2,1-2H3,(H,37,38)/p-1/t25-,26?/m1/s1 D06FRE DRUGINKE KMUHRPGZKRKKCZ-DCWQJPKNSA-M D06FRE DRUGSMIL CC(C)C1=C(C(=CC2=CC=CC=C21)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OCC(CC(CC(=O)[O-])O)O D06FRE HIGHSTAT Investigative D06FRZ DRUG__ID D06FRZ D06FRZ DRUGTYPE Small molecular drug D06FRZ DRUGINCH 1S/C22H28O8/c1-6-11(2)22(26)21(5)18-15(28-19(21)25)7-13(10-27-12(3)23)14-8-17(24)20(4,29-14)9-16(18)30-22/h7-8,11,15-16,18,26H,6,9-10H2,1-5H3/b13-7-/t11-,15-,16+,18?,20-,21-,22-/m1/s1 D06FRZ DRUGINKE UNFGCPCUYMXWDG-MRPVOENGSA-N D06FRZ DRUGSMIL CCC(C)C1(C2(C3C(O1)CC4(C(=O)C=C(O4)C(=CC3OC2=O)COC(=O)C)C)C)O D06FRZ HIGHSTAT Investigative D06FSR DRUG__ID D06FSR D06FSR DRUGTYPE Small molecular drug D06FSR DRUGINCH 1S/C10H8N2/c1-12-7-8(6-11)9-4-2-3-5-10(9)12/h2-5,7H,1H3 D06FSR DRUGINKE FBAXZPMXGBNBPE-UHFFFAOYSA-N D06FSR DRUGSMIL CN1C=C(C2=CC=CC=C21)C#N D06FSR HIGHSTAT Investigative D06FTI DRUG__ID D06FTI D06FTI DRUGTYPE Small molecular drug D06FTI DRUGINCH 1S/C15H14O2/c1-11(15(16)17)12-7-9-14(10-8-12)13-5-3-2-4-6-13/h2-11H,1H3,(H,16,17)/t11-/m0/s1 D06FTI DRUGINKE JALUUBQFLPUJMY-NSHDSACASA-N D06FTI DRUGSMIL CC(C1=CC=C(C=C1)C2=CC=CC=C2)C(=O)O D06FTI HIGHSTAT Investigative D06FUV DRUG__ID D06FUV D06FUV DRUGTYPE Small molecular drug D06FUV DRUGINCH 1S/C14H21NO/c1-2-8-15-9-4-6-13(11-15)12-5-3-7-14(16)10-12/h3,5,7,10,13,16H,2,4,6,8-9,11H2,1H3/t13-/m1/s1 D06FUV DRUGINKE HTSNFXAICLXZMA-CYBMUJFWSA-N D06FUV DRUGSMIL CCCN1CCCC(C1)C2=CC(=CC=C2)O D06FUV HIGHSTAT Investigative D06FWM DRUG__ID D06FWM D06FWM DRUGTYPE Small molecular drug D06FWM DRUGINCH 1S/C17H24N2O/c1-2-6-14(7-3-1)18-11-5-13-20-17-9-4-8-16-15(17)10-12-19-16/h4,8-10,12,14,18-19H,1-3,5-7,11,13H2 D06FWM DRUGINKE QVATUGJQJMJAPA-UHFFFAOYSA-N D06FWM DRUGSMIL C1CCC(CC1)NCCCOC2=CC=CC3=C2C=CN3 D06FWM HIGHSTAT Investigative D06FWY DRUG__ID D06FWY D06FWY DRUGTYPE Small molecular drug D06FWY DRUGINCH 1S/C28H33N5O3S/c1-5-33-26(24-8-6-7-9-25(24)30-28(33)32(3)4)18-27(34)29-19-21-12-14-22(15-13-21)31-37(35,36)23-16-10-20(2)11-17-23/h6-17,26,31H,5,18-19H2,1-4H3,(H,29,34) D06FWY DRUGINKE UBFZYFFOQNFRPD-UHFFFAOYSA-N D06FWY DRUGSMIL CCN1C(C2=CC=CC=C2N=C1N(C)C)CC(=O)NCC3=CC=C(C=C3)NS(=O)(=O)C4=CC=C(C=C4)C D06FWY HIGHSTAT Investigative D06FXI DRUG__ID D06FXI D06FXI DRUGTYPE Small molecular drug D06FXI DRUGINCH 1S/C9H12N2O3/c1-13-7-8-6-11(9(12)14-8)10-4-2-3-5-10/h2-5,8H,6-7H2,1H3/t8-/m0/s1 D06FXI DRUGINKE RWCYHUWSHCXNRR-QMMMGPOBSA-N D06FXI DRUGSMIL COCC1CN(C(=O)O1)N2C=CC=C2 D06FXI HIGHSTAT Investigative D06FXO DRUG__ID D06FXO D06FXO DRUGTYPE Small molecular drug D06FXO DRUGINCH 1S/C19H20N2O2S/c22-24(23,16-8-2-1-3-9-16)19-14-21(15-7-6-12-20-13-15)18-11-5-4-10-17(18)19/h1-5,8-11,14-15,20H,6-7,12-13H2 D06FXO DRUGINKE QAYPUMLPFJDPQW-UHFFFAOYSA-N D06FXO DRUGSMIL C1CC(CNC1)N2C=C(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4 D06FXO HIGHSTAT Investigative D06FYY DRUG__ID D06FYY D06FYY DRUGTYPE Small molecular drug D06FYY DRUGINCH 1S/C13H18FNO/c14-11-5-3-4-10(8-11)12(9-16)13-6-1-2-7-15-13/h3-5,8,12-13,15-16H,1-2,6-7,9H2/t12-,13-/m1/s1 D06FYY DRUGINKE AXNMDZNGNYLXHQ-CHWSQXEVSA-N D06FYY DRUGSMIL C1CCNC(C1)C(CO)C2=CC(=CC=C2)F D06FYY HIGHSTAT Investigative D06FZS DRUG__ID D06FZS D06FZS DRUGTYPE Small molecular drug D06FZS DRUGINCH 1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1 D06FZS DRUGINKE JVTAAEKCZFNVCJ-REOHCLBHSA-N D06FZS DRUGSMIL CC(C(=O)O)O D06FZS HIGHSTAT Investigative D06GAF DRUG__ID D06GAF D06GAF DRUGTYPE Small molecular drug D06GAF DRUGINCH 1S/C24H31BrN2O2/c1-3-5-9-17-27(18-10-6-4-2)24(29)22-12-8-7-11-21(22)23(28)26-20-15-13-19(25)14-16-20/h7-8,11-16H,3-6,9-10,17-18H2,1-2H3,(H,26,28) D06GAF DRUGINKE OITHNNNIGWHOAY-UHFFFAOYSA-N D06GAF DRUGSMIL CCCCCN(CCCCC)C(=O)C1=CC=CC=C1C(=O)NC2=CC=C(C=C2)Br D06GAF HIGHSTAT Investigative D06GAI DRUG__ID D06GAI D06GAI DRUGTYPE Small molecular drug D06GAI DRUGINCH 1S/C15H11ClN2/c16-13-6-8-14(9-7-13)18-10-15(17-11-18)12-4-2-1-3-5-12/h1-11H D06GAI DRUGINKE CPDGQKJPYYDYQG-UHFFFAOYSA-N D06GAI DRUGSMIL C1=CC=C(C=C1)C2=CN(C=N2)C3=CC=C(C=C3)Cl D06GAI HIGHSTAT Investigative D06GFH DRUG__ID D06GFH D06GFH DRUGTYPE Small molecular drug D06GFH DRUGINCH 1S/C18H31N2O4P/c1-2-3-4-5-6-7-9-15-10-8-11-16(14-15)20-18(21)17(19)12-13-25(22,23)24/h8,10-11,14,17H,2-7,9,12-13,19H2,1H3,(H,20,21)(H2,22,23,24)/t17-/m1/s1 D06GFH DRUGINKE FMLHSOGKNHADEE-QGZVFWFLSA-N D06GFH DRUGSMIL CCCCCCCCC1=CC(=CC=C1)NC(=O)C(CCP(=O)(O)O)N D06GFH HIGHSTAT Investigative D06GFV DRUG__ID D06GFV D06GFV DRUGTYPE Small molecular drug D06GFV DRUGINCH 1S/C12H18N2/c1-2-11(13)8-9-3-4-12-10(7-9)5-6-14-12/h3-4,7,11,14H,2,5-6,8,13H2,1H3 D06GFV DRUGINKE WHXRWSJORCUAFO-UHFFFAOYSA-N D06GFV DRUGSMIL CCC(CC1=CC2=C(C=C1)NCC2)N D06GFV HIGHSTAT Investigative D06GFZ DRUG__ID D06GFZ D06GFZ DRUGTYPE Small molecular drug D06GFZ DRUGINCH 1S/C49H57N11O6/c50-46(51)53-25-13-22-40(45(64)52-26-27-58-47(65)59(34-14-3-1-4-15-34)60(48(58)66)35-16-5-2-6-17-35)54-41(61)32-49(23-11-12-24-49)33-42(62)56-28-30-57(31-29-56)43-36-18-7-8-19-37(36)44(63)55-39-21-10-9-20-38(39)43/h1-10,14-21,40,43H,11-13,22-33H2,(H,52,64)(H,54,61)(H,55,63)(H4,50,51,53) D06GFZ DRUGINKE RSJAXPUYVJKAAA-UHFFFAOYSA-N D06GFZ DRUGSMIL C1CCC(C1)(CC(=O)NC(CCCN=C(N)N)C(=O)NCCN2C(=O)N(N(C2=O)C3=CC=CC=C3)C4=CC=CC=C4)CC(=O)N5CCN(CC5)C6C7=CC=CC=C7C(=O)NC8=CC=CC=C68 D06GFZ HIGHSTAT Investigative D06GGB DRUG__ID D06GGB D06GGB DRUGTYPE Small molecular drug D06GGB DRUGINCH 1S/C24H23NO2/c1-2-25-11-10-17-12-18(15-6-4-3-5-7-15)13-19-22(17)20(25)14-16-8-9-21(26)24(27)23(16)19/h3-9,12-13,20,26-27H,2,10-11,14H2,1H3/t20-/m1/s1 D06GGB DRUGINKE RJCYHSVPFFEYKA-HXUWFJFHSA-N D06GGB DRUGSMIL CCN1CCC2=C3C1CC4=C(C3=CC(=C2)C5=CC=CC=C5)C(=C(C=C4)O)O D06GGB HIGHSTAT Investigative D06GHM DRUG__ID D06GHM D06GHM DRUGTYPE Small molecular drug D06GHM DRUGINCH 1S/C28H36N4O4/c1-3-5-13-29-15-11-25(33)31-19-7-9-21-23(17-19)28(36)24-18-20(8-10-22(24)27(21)35)32-26(34)12-16-30-14-6-4-2/h7-10,17-18,29-30H,3-6,11-16H2,1-2H3,(H,31,33)(H,32,34) D06GHM DRUGINKE WKRXVGOZDDYFGG-UHFFFAOYSA-N D06GHM DRUGSMIL CCCCNCCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CCNCCCC D06GHM HIGHSTAT Investigative D06GIL DRUG__ID D06GIL D06GIL DRUGTYPE Small molecular drug D06GIL DRUGINCH 1S/C35H37N7O3/c1-4-22-21-41(30-14-8-6-11-26(22)30)35-40-39-33(42(35)31-16-15-24(44-2)19-32(31)45-3)29(38-34(43)28-13-9-17-36-28)18-23-20-37-27-12-7-5-10-25(23)27/h5-8,10-12,14-16,19-21,28-29,36-37H,4,9,13,17-18H2,1-3H3,(H,38,43)/t28-,29+/m0/s1 D06GIL DRUGINKE YAWJYESYIAWFJX-URLMMPGGSA-N D06GIL DRUGSMIL CCC1=CN(C2=CC=CC=C21)C3=NN=C(N3C4=C(C=C(C=C4)OC)OC)C(CC5=CNC6=CC=CC=C65)NC(=O)C7CCCN7 D06GIL HIGHSTAT Investigative D06GIV DRUG__ID D06GIV D06GIV DRUGTYPE Small molecular drug D06GIV DRUGINCH 1S/C14H13N3O2/c1-18-12-6-4-11(5-7-12)14-9-15-16-17(14)10-13-3-2-8-19-13/h2-9H,10H2,1H3 D06GIV DRUGINKE LLARZMIDMIEYKJ-UHFFFAOYSA-N D06GIV DRUGSMIL COC1=CC=C(C=C1)C2=CN=NN2CC3=CC=CO3 D06GIV HIGHSTAT Investigative D06GJO DRUG__ID D06GJO D06GJO DRUGTYPE Small molecular drug D06GJO DRUGINCH 1S/C16H14N2O2/c1-19-14-10-6-5-9-13(14)18-16-17-11-15(20-16)12-7-3-2-4-8-12/h2-11H,1H3,(H,17,18) D06GJO DRUGINKE DLHCYJIQXKETIN-UHFFFAOYSA-N D06GJO DRUGSMIL COC1=CC=CC=C1NC2=NC=C(O2)C3=CC=CC=C3 D06GJO HIGHSTAT Investigative D06GJP DRUG__ID D06GJP D06GJP DRUGTYPE Small molecular drug D06GJP DRUGINCH 1S/C29H20ClN7O11S3/c30-27-35-28(33-16-7-3-4-8-19(16)49(40,41)42)37-29(36-27)34-17-10-9-13(11-20(17)50(43,44)45)32-18-12-21(51(46,47)48)24(31)23-22(18)25(38)14-5-1-2-6-15(14)26(23)39/h1-12,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H2,33,34,35,36,37) D06GJP DRUGINKE YKCWQPZFAFZLBI-UHFFFAOYSA-N D06GJP DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O)N D06GJP HIGHSTAT Investigative D06GKL DRUG__ID D06GKL D06GKL DRUGTYPE Small molecular drug D06GKL DRUGINCH 1S/C5H9NO4/c1-6-3(5(9)10)2-4(7)8/h3,6H,2H2,1H3,(H,7,8)(H,9,10)/t3-/m1/s1 D06GKL DRUGINKE HOKKHZGPKSLGJE-GSVOUGTGSA-N D06GKL DRUGSMIL CNC(CC(=O)O)C(=O)O D06GKL HIGHSTAT Investigative D06GNE DRUG__ID D06GNE D06GNE DRUGTYPE Small molecular drug D06GNE DRUGINCH 1S/C12H15NO3/c1-9(14)11-3-2-10(8-12(11)15)13-4-6-16-7-5-13/h2-3,8,15H,4-7H2,1H3 D06GNE DRUGINKE YHKSBKQXCWHTQL-UHFFFAOYSA-N D06GNE DRUGSMIL CC(=O)C1=C(C=C(C=C1)N2CCOCC2)O D06GNE HIGHSTAT Investigative D06GNR DRUG__ID D06GNR D06GNR DRUGTYPE Small molecular drug D06GNR DRUGINCH 1S/C15H17N3O/c1-15(2,12-6-4-3-5-7-12)11-18-14(19)13-10-16-8-9-17-13/h3-10H,11H2,1-2H3,(H,18,19) D06GNR DRUGINKE HMOMSNPWNJNCOE-UHFFFAOYSA-N D06GNR DRUGSMIL CC(C)(CNC(=O)C1=NC=CN=C1)C2=CC=CC=C2 D06GNR HIGHSTAT Investigative D06GOE DRUG__ID D06GOE D06GOE DRUGTYPE Small molecular drug D06GOE DRUGINCH 1S/C23H24N6O7/c1-3-7-28-21-19(22(31)29(8-4-2)23(28)32)25-20(26-21)16-10-18(27-36-16)33-11-17(30)24-13-5-6-14-15(9-13)35-12-34-14/h5-6,9-10H,3-4,7-8,11-12H2,1-2H3,(H,24,30)(H,25,26) D06GOE DRUGINKE ZPOGAROKPIBRMR-UHFFFAOYSA-N D06GOE DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NO3)OCC(=O)NC4=CC5=C(C=C4)OCO5 D06GOE HIGHSTAT Investigative D06GOK DRUG__ID D06GOK D06GOK DRUGTYPE Small molecular drug D06GOK DRUGINCH 1S/C6H14O2/c1-5(7)4-6(2,3)8/h5,7-8H,4H2,1-3H3 D06GOK DRUGINKE SVTBMSDMJJWYQN-UHFFFAOYSA-N D06GOK DRUGSMIL CC(CC(C)(C)O)O D06GOK HIGHSTAT Investigative D06GPL DRUG__ID D06GPL D06GPL DRUGTYPE Small molecular drug D06GPL DRUGINCH 1S/C8H9F2NO2S/c1-6-2-4-7(5-3-6)8(9,10)14(11,12)13/h2-5H,1H3,(H2,11,12,13) D06GPL DRUGINKE QPMHTUPJLAWJAW-UHFFFAOYSA-N D06GPL DRUGSMIL CC1=CC=C(C=C1)C(F)(F)S(=O)(=O)N D06GPL HIGHSTAT Investigative D06GPP DRUG__ID D06GPP D06GPP DRUGTYPE Small molecular drug D06GPP DRUGINCH 1S/C16H17NO/c1-16(2,3)15(18)9-8-12-10-13-6-4-5-7-14(13)17-11-12/h4-11H,1-3H3/b9-8+ D06GPP DRUGINKE XROFVTPRFZVYMN-CMDGGOBGSA-N D06GPP DRUGSMIL CC(C)(C)C(=O)C=CC1=CC2=CC=CC=C2N=C1 D06GPP HIGHSTAT Investigative D06GQO DRUG__ID D06GQO D06GQO DRUGTYPE Small molecular drug D06GQO DRUGINCH 1S/C13H19N3O/c1-3-4-9-15-13(14)16-12(17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H3,14,15,16,17) D06GQO DRUGINKE ALSYKIYWLYFZIK-UHFFFAOYSA-N D06GQO DRUGSMIL CCCCN=C(N)NC(=O)C1=CC=C(C=C1)C D06GQO HIGHSTAT Investigative D06GQY DRUG__ID D06GQY D06GQY DRUGTYPE Small molecular drug D06GQY DRUGINCH 1S/C28H18N2O5S/c29-26-23(36(33,34)35)14-22(24-25(26)28(32)21-8-4-3-7-20(21)27(24)31)30-19-10-9-17-11-15-5-1-2-6-16(15)12-18(17)13-19/h1-14,30H,29H2,(H,33,34,35)/p-1 D06GQY DRUGINKE JXFRJOYKTCEJDG-UHFFFAOYSA-M D06GQY DRUGSMIL C1=CC=C2C=C3C=C(C=CC3=CC2=C1)NC4=CC(=C(C5=C4C(=O)C6=CC=CC=C6C5=O)N)S(=O)(=O)[O-] D06GQY HIGHSTAT Investigative D06GRP DRUG__ID D06GRP D06GRP DRUGTYPE Small molecular drug D06GRP DRUGINCH 1S/C29H23N3OS/c1-20-13-15-22(16-14-20)17-18-27(33)28-21(2)30-29(34-28)32-26(24-11-7-4-8-12-24)19-25(31-32)23-9-5-3-6-10-23/h3-19H,1-2H3/b18-17+ D06GRP DRUGINKE HDPZGEIGUACCAU-ISLYRVAYSA-N D06GRP DRUGSMIL CC1=CC=C(C=C1)C=CC(=O)C2=C(N=C(S2)N3C(=CC(=N3)C4=CC=CC=C4)C5=CC=CC=C5)C D06GRP HIGHSTAT Investigative D06GRW DRUG__ID D06GRW D06GRW DRUGTYPE Small molecular drug D06GRW DRUGINCH 1S/C22H19NO2/c1-23(25)22(24)21(19-15-9-4-10-16-19)20(17-11-5-2-6-12-17)18-13-7-3-8-14-18/h2-16,25H,1H3 D06GRW DRUGINKE ORTZIDPYVDIVSI-UHFFFAOYSA-N D06GRW DRUGSMIL CN(C(=O)C(=C(C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=CC=C3)O D06GRW HIGHSTAT Investigative D06GSY DRUG__ID D06GSY D06GSY DRUGTYPE Small molecular drug D06GSY DRUGINCH 1S/C14H11IO3S/c1-8(14(17)18)9-2-4-10(5-3-9)13(16)11-6-7-12(15)19-11/h2-8H,1H3,(H,17,18)/t8-/m0/s1 D06GSY DRUGINKE UIZPHGUBGPJBAR-QMMMGPOBSA-N D06GSY DRUGSMIL CC(C1=CC=C(C=C1)C(=O)C2=CC=C(S2)I)C(=O)O D06GSY HIGHSTAT Investigative D06GTI DRUG__ID D06GTI D06GTI DRUGTYPE Small molecular drug D06GTI DRUGINCH 1S/C27H30N8O4/c1-4-11-34-25-23(26(37)35(12-5-2)27(34)38)28-24(29-25)20-17-21(30-31(20)3)39-18-22(36)33-15-13-32(14-16-33)19-9-7-6-8-10-19/h4-10,17H,1-2,11-16,18H2,3H3,(H,28,29) D06GTI DRUGINKE HCIZQLZOFGBZIE-UHFFFAOYSA-N D06GTI DRUGSMIL CN1C(=CC(=N1)OCC(=O)N2CCN(CC2)C3=CC=CC=C3)C4=NC5=C(N4)C(=O)N(C(=O)N5CC=C)CC=C D06GTI HIGHSTAT Investigative D06GTS DRUG__ID D06GTS D06GTS DRUGTYPE Small molecular drug D06GTS DRUGINCH 1S/C23H15N3O2/c27-26(28)16-10-11-22-19(12-16)18(15-6-2-1-3-7-15)13-23(25-22)20-14-24-21-9-5-4-8-17(20)21/h1-14,24H D06GTS DRUGINKE LQGHUZLZFHCQPO-UHFFFAOYSA-N D06GTS DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC3=C2C=C(C=C3)[N+](=O)[O-])C4=CNC5=CC=CC=C54 D06GTS HIGHSTAT Investigative D06GUJ DRUG__ID D06GUJ D06GUJ DRUGTYPE Small molecular drug D06GUJ DRUGINCH 1S/C26H30O6/c1-15(2)6-7-18(16(3)4)12-20-23(30)14-24(32-5)25(26(20)31)21(28)11-9-17-8-10-19(27)13-22(17)29/h6,8-11,13-14,18,27,29-31H,3,7,12H2,1-2,4-5H3/b11-9+/t18-/m1/s1 D06GUJ DRUGINKE PIAPWPAWQGDOMN-SXAWMYDMSA-N D06GUJ DRUGSMIL CC(=CCC(CC1=C(C(=C(C=C1O)OC)C(=O)C=CC2=C(C=C(C=C2)O)O)O)C(=C)C)C D06GUJ HIGHSTAT Investigative D06GVN DRUG__ID D06GVN D06GVN DRUGTYPE Small molecular drug D06GVN DRUGINCH 1S/C31H50O5/c1-18-11-14-31(25(34)36-8)16-15-28(5)19(23(31)30(18,7)35)9-10-22-27(4)17-20(32)24(33)26(2,3)21(27)12-13-29(22,28)6/h9,18,20-24,32-33,35H,10-17H2,1-8H3/t18-,20-,21+,22-,23-,24+,27+,28-,29-,30-,31+/m1/s1 D06GVN DRUGINKE RQWXHGLRDYGNGZ-BPKREVGBSA-N D06GVN DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C)C(=O)OC D06GVN HIGHSTAT Investigative D06GWR DRUG__ID D06GWR D06GWR DRUGTYPE Small molecular drug D06GWR DRUGINCH 1S/C31H50O3/c1-20(26(33)34)10-9-11-21(2)29(6)18-19-30(7)23-12-13-24-27(3,4)25(32)15-16-28(24,5)22(23)14-17-31(29,30)8/h10,12,21-22,24-25,32H,9,11,13-19H2,1-8H3,(H,33,34)/b20-10+/t21-,22-,24-,25-,28+,29-,30+,31-/m0/s1 D06GWR DRUGINKE PSSOTMPEBLYOAS-MGULVPRESA-N D06GWR DRUGSMIL CC(CCC=C(C)C(=O)O)C1(CCC2(C1(CCC3C2=CCC4C3(CCC(C4(C)C)O)C)C)C)C D06GWR HIGHSTAT Investigative D06GXT DRUG__ID D06GXT D06GXT DRUGTYPE Small molecular drug D06GXT DRUGINCH 1S/C19H22O3/c20-16-4-2-1-3-15-8-12-18(21)19(13-15)22-17-10-6-14(5-9-16)7-11-17/h6-8,10-13,16,20-21H,1-5,9H2/t16-/m1/s1 D06GXT DRUGINKE JHRMYLCWJWLUQL-MRXNPFEDSA-N D06GXT DRUGSMIL C1CCC2=CC(=C(C=C2)O)OC3=CC=C(CCC(C1)O)C=C3 D06GXT HIGHSTAT Investigative D06GYH DRUG__ID D06GYH D06GYH DRUGTYPE Small molecular drug D06GYH DRUGINCH 1S/C14H6F6O2/c15-7-3-1-5(9(17)11(7)19)13(21)14(22)6-2-4-8(16)12(20)10(6)18/h1-4,13,21H D06GYH DRUGINKE ICSVRGYUGLAIDB-UHFFFAOYSA-N D06GYH DRUGSMIL C1=CC(=C(C(=C1C(C(=O)C2=C(C(=C(C=C2)F)F)F)O)F)F)F D06GYH HIGHSTAT Investigative D06GYI DRUG__ID D06GYI D06GYI DRUGTYPE Small molecular drug D06GYI DRUGINCH 1S/C7H10BNO3S/c10-7(9-5-8(11)12)4-6-2-1-3-13-6/h1-3,11-12H,4-5H2,(H,9,10) D06GYI DRUGINKE VXAPSUDMBNWYNC-UHFFFAOYSA-N D06GYI DRUGSMIL B(CNC(=O)CC1=CC=CS1)(O)O D06GYI HIGHSTAT Investigative D06GYO DRUG__ID D06GYO D06GYO DRUGTYPE Small molecular drug D06GYO DRUGINCH 1S/C18H31NO4/c1-2-3-4-11-14-17(19(22)23)15-12-9-7-5-6-8-10-13-16-18(20)21/h9,12,14H,2-8,10-11,13,15-16H2,1H3,(H,20,21)/b12-9-,17-14+ D06GYO DRUGINKE ZYFTUIURWQWFKQ-QIAGQCQHSA-N D06GYO DRUGSMIL CCCCCC=C(CC=CCCCCCCCC(=O)O)[N+](=O)[O-] D06GYO HIGHSTAT Investigative D06HDW DRUG__ID D06HDW D06HDW DRUGTYPE Small molecular drug D06HDW DRUGINCH 1S/C24H24N5O15P3/c25-21-17-22(27-11-26-21)29(12-28-17)23-19(31)20(16(41-23)10-40-46(36,37)44-47(38,39)43-45(33,34)35)42-24(32)15-8-6-14(7-9-15)18(30)13-4-2-1-3-5-13/h1-9,11-12,16,19-20,23,31H,10H2,(H,36,37)(H,38,39)(H2,25,26,27)(H2,33,34,35)/t16-,19-,20-,23-/m1/s1 D06HDW DRUGINKE AWJJLYZBWRIBCZ-UGTJMOTHSA-N D06HDW DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C(=O)OC3C(OC(C3O)N4C=NC5=C(N=CN=C54)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O D06HDW HIGHSTAT Investigative D06HFB DRUG__ID D06HFB D06HFB DRUGTYPE Small molecular drug D06HFB DRUGINCH 1S/C17H21F3O3/c1-14(2,3)9-7-10(15(4,5)6)12-11(8-9)16(22,13(21)23-12)17(18,19)20/h7-8,22H,1-6H3/t16-/m0/s1 D06HFB DRUGINKE RVNOANDLZIIFHB-INIZCTEOSA-N D06HFB DRUGSMIL CC(C)(C)C1=CC2=C(C(=C1)C(C)(C)C)OC(=O)C2(C(F)(F)F)O D06HFB HIGHSTAT Investigative D06HFV DRUG__ID D06HFV D06HFV DRUGTYPE Small molecular drug D06HFV DRUGINCH 1S/C14H11FN2/c15-13-3-4-14-11(1-2-12(14)6-13)5-10-7-16-9-17-8-10/h3-9H,1-2H2/b11-5+ D06HFV DRUGINKE LEJPKWXGQFBXRX-VZUCSPMQSA-N D06HFV DRUGSMIL C1CC(=CC2=CN=CN=C2)C3=C1C=C(C=C3)F D06HFV HIGHSTAT Investigative D06HHJ DRUG__ID D06HHJ D06HHJ DRUGTYPE Small molecular drug D06HHJ DRUGINCH 1S/C9H8BrN3/c10-7-3-1-2-4-8(7)13-9-11-5-6-12-9/h1-6H,(H2,11,12,13) D06HHJ DRUGINKE KHNAVCNEASQADL-UHFFFAOYSA-N D06HHJ DRUGSMIL C1=CC=C(C(=C1)NC2=NC=CN2)Br D06HHJ HIGHSTAT Investigative D06HIW DRUG__ID D06HIW D06HIW DRUGTYPE Small molecular drug D06HIW DRUGINCH 1S/C20H26O6/c1-12-5-4-6-13(2)10-17(26-20(24)15(11-22)7-8-21)18-14(3)19(23)25-16(18)9-12/h6-7,9,16-18,21-22H,3-5,8,10-11H2,1-2H3/b12-9+,13-6+,15-7+/t16-,17-,18+/m1/s1 D06HIW DRUGINKE VWJYWGYJIDQUEG-DKDOXNMLSA-N D06HIW DRUGSMIL CC1=CC2C(C(CC(=CCC1)C)OC(=O)C(=CCO)CO)C(=C)C(=O)O2 D06HIW HIGHSTAT Investigative D06HJB DRUG__ID D06HJB D06HJB DRUGTYPE Small molecular drug D06HJB DRUGINCH 1S/C15H18O3/c1-7-4-5-9-8(2)14(16)17-13(9)12-10(7)6-11-15(12,3)18-11/h9,11-13H,2,4-6H2,1,3H3/t9-,11+,12-,13-,15+/m0/s1 D06HJB DRUGINKE QXJYIGSXUBOSID-JZEMPJKHSA-N D06HJB DRUGSMIL CC1=C2CC3C(C2C4C(CC1)C(=C)C(=O)O4)(O3)C D06HJB HIGHSTAT Investigative D06HLH DRUG__ID D06HLH D06HLH DRUGTYPE Small molecular drug D06HLH DRUGINCH 1S/C17H16F3N/c1-16(2,3)10-4-6-12-13-7-5-11(17(18,19)20)9-15(13)21-14(12)8-10/h4-9,21H,1-3H3 D06HLH DRUGINKE XAQHCEWJSXOCDT-UHFFFAOYSA-N D06HLH DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C3=C(N2)C=C(C=C3)C(F)(F)F D06HLH HIGHSTAT Investigative D06HNA DRUG__ID D06HNA D06HNA DRUGTYPE Small molecular drug D06HNA DRUGINCH 1S/C33H49NO7/c1-6-33(4,5)31(37)40-27-16-21(3)30(41-32(38)34-19-22-10-8-7-9-11-22)26-14-12-20(2)25(29(26)27)15-13-24-17-23(35)18-28(36)39-24/h7-11,20-21,23-27,29-30,35H,6,12-19H2,1-5H3,(H,34,38)/t20-,21+,23+,24?,25-,26+,27-,29?,30+/m0/s1 D06HNA DRUGINKE ZUURLVDIZFDZJT-UQLLKHDVSA-N D06HNA DRUGSMIL CCC(C)(C)C(=O)OC1CC(C(C2C1C(C(CC2)C)CCC3CC(CC(=O)O3)O)OC(=O)NCC4=CC=CC=C4)C D06HNA HIGHSTAT Investigative D06HNS DRUG__ID D06HNS D06HNS DRUGTYPE Small molecular drug D06HNS DRUGINCH 1S/C5H7NO2/c1-2-3-6-4-5(7)8/h1,6H,3-4H2,(H,7,8) D06HNS DRUGINKE XSJLQGMTIHCDSS-UHFFFAOYSA-N D06HNS DRUGSMIL C#CCNCC(=O)O D06HNS HIGHSTAT Investigative D06HOI DRUG__ID D06HOI D06HOI DRUGTYPE Small molecular drug D06HOI DRUGINCH 1S/C23H28N6O3/c1-16-12-17-13-18(7-8-20(17)32-16)26-23(25-15-24)27-19-6-2-3-11-29(22(19)31)14-21(30)28-9-4-5-10-28/h7-8,12-13,19H,2-6,9-11,14H2,1H3,(H2,25,26,27)/t19-/m0/s1 D06HOI DRUGINKE BQUXAJWDRCSKFN-IBGZPJMESA-N D06HOI DRUGSMIL CC1=CC2=C(O1)C=CC(=C2)NC(=NC3CCCCN(C3=O)CC(=O)N4CCCC4)NC#N D06HOI HIGHSTAT Investigative D06HPV DRUG__ID D06HPV D06HPV DRUGTYPE Small molecular drug D06HPV DRUGINCH 1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26) D06HPV DRUGINKE NXFFJDQHYLNEJK-UHFFFAOYSA-N D06HPV DRUGSMIL CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F D06HPV HIGHSTAT Investigative D06HRX DRUG__ID D06HRX D06HRX DRUGTYPE Small molecular drug D06HRX DRUGINCH 1S/C30H18O10/c31-15-4-1-13(2-5-15)24-12-23(38)29-21(36)10-20(35)27(30(29)40-24)17-7-14(3-6-18(17)33)25-11-22(37)28-19(34)8-16(32)9-26(28)39-25/h1-12,31-36H D06HRX DRUGINKE YUSWMAULDXZHPY-UHFFFAOYSA-N D06HRX DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=CC(=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O)O D06HRX HIGHSTAT Investigative D06HSC DRUG__ID D06HSC D06HSC DRUGTYPE Small molecular drug D06HSC DRUGINCH 1S/C28H29N9O7/c29-28-35-23-22(26(41)36-28)32-18(14-31-23)13-30-17-8-6-16(7-9-17)24(39)34-19(27(42)43)10-11-21(38)33-20(25(40)37-44)12-15-4-2-1-3-5-15/h1-9,14,19-20,30,44H,10-13H2,(H,33,38)(H,34,39)(H,37,40)(H,42,43)(H3,29,31,35,36,41)/t19-,20-/m0/s1 D06HSC DRUGINKE WYBGJFMKGROIBY-PMACEKPBSA-N D06HSC DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NO)NC(=O)CCC(C(=O)O)NC(=O)C2=CC=C(C=C2)NCC3=CN=C4C(=N3)C(=O)NC(=N4)N D06HSC HIGHSTAT Investigative D06HTJ DRUG__ID D06HTJ D06HTJ DRUGTYPE Small molecular drug D06HTJ DRUGINCH 1S/C28H37N5S/c1-2-14-32(25-12-13-26-27(21-25)34-28(29)30-26)18-15-31-16-19-33(20-17-31)24-10-8-23(9-11-24)22-6-4-3-5-7-22/h3-11,25H,2,12-21H2,1H3,(H2,29,30)/t25-/m0/s1 D06HTJ DRUGINKE YDLWLYDTYNHXBM-VWLOTQADSA-N D06HTJ DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=C(C=C2)C3=CC=CC=C3)C4CCC5=C(C4)SC(=N5)N D06HTJ HIGHSTAT Investigative D06HUQ DRUG__ID D06HUQ D06HUQ DRUGTYPE Small molecular drug D06HUQ DRUGINCH 1S/C15H14N2O/c18-15-13-8-4-5-9-14(13)16-17(15)11-10-12-6-2-1-3-7-12/h1-9,16H,10-11H2 D06HUQ DRUGINKE HCKFBGZZOSOLAC-UHFFFAOYSA-N D06HUQ DRUGSMIL C1=CC=C(C=C1)CCN2C(=O)C3=CC=CC=C3N2 D06HUQ HIGHSTAT Investigative D06HVH DRUG__ID D06HVH D06HVH DRUGTYPE Small molecular drug D06HVH DRUGINCH 1S/C17H16Cl2N4O/c1-23-14-9(2-3-11(18)13(14)19)12-10(8-20)17(4-6-21-7-5-17)22-16(24)15(12)23/h2-3,10,21H,4-7H2,1H3,(H,22,24) D06HVH DRUGINKE OWAWOKKHZNRHGV-UHFFFAOYSA-N D06HVH DRUGSMIL CN1C2=C(C=CC(=C2Cl)Cl)C3=C1C(=O)NC4(C3C#N)CCNCC4 D06HVH HIGHSTAT Investigative D06HWI DRUG__ID D06HWI D06HWI DRUGTYPE Small molecular drug D06HWI DRUGINCH 1S/C30H34FN3O3/c1-4-33(5-2)19-18-32-29(35)27-25-8-6-7-9-26(25)30(36)34(20-21-10-14-23(31)15-11-21)28(27)22-12-16-24(37-3)17-13-22/h6-17,27-28H,4-5,18-20H2,1-3H3,(H,32,35) D06HWI DRUGINKE ACZABABCHZPYHY-UHFFFAOYSA-N D06HWI DRUGSMIL CCN(CC)CCNC(=O)C1C(N(C(=O)C2=CC=CC=C12)CC3=CC=C(C=C3)F)C4=CC=C(C=C4)OC D06HWI HIGHSTAT Investigative D06HYB DRUG__ID D06HYB D06HYB DRUGTYPE Small molecular drug D06HYB DRUGINCH 1S/C15H21ClN2O3/c1-20-14-10-13(17)12(16)9-11(14)15(19)21-8-7-18-5-3-2-4-6-18/h9-10H,2-8,17H2,1H3 D06HYB DRUGINKE RVFIAQAAZUEPPE-UHFFFAOYSA-N D06HYB DRUGSMIL COC1=CC(=C(C=C1C(=O)OCCN2CCCCC2)Cl)N D06HYB HIGHSTAT Investigative D06IAE DRUG__ID D06IAE D06IAE DRUGTYPE Small molecular drug D06IAE DRUGINCH 1S/C13H18ClN3O2/c14-12-2-4-15-10-11(12)13(18)16-3-1-5-17-6-8-19-9-7-17/h2,4,10H,1,3,5-9H2,(H,16,18) D06IAE DRUGINKE XYKBQKHBJFXZSH-UHFFFAOYSA-N D06IAE DRUGSMIL C1COCCN1CCCNC(=O)C2=C(C=CN=C2)Cl D06IAE HIGHSTAT Investigative D06IBV DRUG__ID D06IBV D06IBV DRUGTYPE Small molecular drug D06IBV DRUGINCH 1S/C13H26O6/c1-2-3-4-5-6-7-18-13-12(17)11(16)10(15)9(8-14)19-13/h9-17H,2-8H2,1H3/t9-,10-,11+,12-,13-/m1/s1 D06IBV DRUGINKE NIDYWHLDTIVRJT-UJPOAAIJSA-N D06IBV DRUGSMIL CCCCCCCOC1C(C(C(C(O1)CO)O)O)O D06IBV HIGHSTAT Investigative D06IDO DRUG__ID D06IDO D06IDO DRUGTYPE Small molecular drug D06IDO DRUGINCH 1S/C14H24N2O4/c1-4-10(5-2)20-12-7-9(14(18)19)6-11(15)13(12)16-8(3)17/h7,10-13H,4-6,15H2,1-3H3,(H,16,17)(H,18,19)/t11-,12+,13+/m0/s1 D06IDO DRUGINKE NENPYTRHICXVCS-YNEHKIRRSA-N D06IDO DRUGSMIL CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)O D06IDO HIGHSTAT Investigative D06IEN DRUG__ID D06IEN D06IEN DRUGTYPE Small molecular drug D06IEN DRUGINCH 1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8+/m1/s1 D06IEN DRUGINKE OVRNDRQMDRJTHS-PVFLNQBWSA-N D06IEN DRUGSMIL CC(=O)NC1C(C(C(OC1O)CO)O)O D06IEN HIGHSTAT Investigative D06IGJ DRUG__ID D06IGJ D06IGJ DRUGTYPE Small molecular drug D06IGJ DRUGINCH 1S/C14H23N/c1-2-15-8-11(1)14-12-4-9-3-10(6-12)7-13(14)5-9/h9-15H,1-8H2 D06IGJ DRUGINKE IULGEPJXNLPTSZ-UHFFFAOYSA-N D06IGJ DRUGSMIL C1CNCC1C2C3CC4CC(C3)CC2C4 D06IGJ HIGHSTAT Investigative D06IGT DRUG__ID D06IGT D06IGT DRUGTYPE Small molecular drug D06IGT DRUGINCH 1S/C19H22O2/c1-13(2)15-8-9-17-18(11-15)21-12-16(19(17)20)10-14-6-4-3-5-7-14/h3-9,11,13,16,19-20H,10,12H2,1-2H3/t16-,19+/m0/s1 D06IGT DRUGINKE OJNGOFXPXHHONH-QFBILLFUSA-N D06IGT DRUGSMIL CC(C)C1=CC2=C(C=C1)C(C(CO2)CC3=CC=CC=C3)O D06IGT HIGHSTAT Investigative D06IHG DRUG__ID D06IHG D06IHG DRUGTYPE Small molecular drug D06IHG DRUGINCH 1S/C18H33NO4/c1-2-3-4-5-8-11-14-17(19(22)23)15-12-9-6-7-10-13-16-18(20)21/h15H,2-14,16H2,1H3,(H,20,21)/b17-15+ D06IHG DRUGINKE WRADPCFZZWXOTI-BMRADRMJSA-N D06IHG DRUGSMIL CCCCCCCCC(=CCCCCCCCC(=O)O)[N+](=O)[O-] D06IHG HIGHSTAT Investigative D06III DRUG__ID D06III D06III DRUGTYPE Small molecular drug D06III DRUGINCH 1S/C8H10NO6P/c10-7(11)8(12,16(13,14)15)4-6-2-1-3-9-5-6/h1-3,5,12H,4H2,(H,10,11)(H2,13,14,15) D06III DRUGINKE FJVYPXVLXQXDHM-UHFFFAOYSA-N D06III DRUGSMIL C1=CC(=CN=C1)CC(C(=O)O)(O)P(=O)(O)O D06III HIGHSTAT Investigative D06IJI DRUG__ID D06IJI D06IJI DRUGTYPE Small molecular drug D06IJI DRUGINCH 1S/C30H41NO7/c1-6-9-21-24(14-11-20-12-15-26(30(33)34)38-27(20)21)36-17-8-18-37-25-16-13-23(29(32)31-19(3)4)28(35-5)22(25)10-7-2/h11,13-14,16,19,26H,6-10,12,15,17-18H2,1-5H3,(H,31,32)(H,33,34) D06IJI DRUGINKE LCOBFNPHFDALDJ-UHFFFAOYSA-N D06IJI DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)NC(C)C)OC)CCC D06IJI HIGHSTAT Investigative D06IJW DRUG__ID D06IJW D06IJW DRUGTYPE Small molecular drug D06IJW DRUGINCH 1S/C19H29NO2/c1-2-3-4-5-6-17-7-9-18(10-8-17)19(21)11-12-20-13-15-22-16-14-20/h7-10H,2-6,11-16H2,1H3 D06IJW DRUGINKE DRNLQHKMQJOYPM-UHFFFAOYSA-N D06IJW DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)CCN2CCOCC2 D06IJW HIGHSTAT Investigative D06IMK DRUG__ID D06IMK D06IMK DRUGTYPE Small molecular drug D06IMK DRUGINCH 1S/C14H19N3OS/c18-13-8-4-5-11(9-13)10-15-17-14(19)16-12-6-2-1-3-7-12/h4-5,8-10,12,18H,1-3,6-7H2,(H2,16,17,19)/b15-10+ D06IMK DRUGINKE GVMJJZTZCKCYTK-XNTDXEJSSA-N D06IMK DRUGSMIL C1CCC(CC1)NC(=S)NN=CC2=CC(=CC=C2)O D06IMK HIGHSTAT Investigative D06IMY DRUG__ID D06IMY D06IMY DRUGTYPE Small molecular drug D06IMY DRUGINCH 1S/C14H11NO3/c16-14(15-17)13-9-5-1-3-7-11(9)18-12-8-4-2-6-10(12)13/h1-8,13,17H,(H,15,16) D06IMY DRUGINKE ULUVQBMMAOHWSH-UHFFFAOYSA-N D06IMY DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C3O2)C(=O)NO D06IMY HIGHSTAT Investigative D06IOI DRUG__ID D06IOI D06IOI DRUGTYPE Small molecular drug D06IOI DRUGINCH 1S/C12H12N2O2S2/c13-18(15,16)12-8-14-7-6-11(12)17-9-10-4-2-1-3-5-10/h1-8H,9H2,(H2,13,15,16) D06IOI DRUGINKE FUJBJSOIYVUFSM-UHFFFAOYSA-N D06IOI DRUGSMIL C1=CC=C(C=C1)CSC2=C(C=NC=C2)S(=O)(=O)N D06IOI HIGHSTAT Investigative D06IOP DRUG__ID D06IOP D06IOP DRUGTYPE Small molecular drug D06IOP DRUGINCH 1S/C10H13NOS/c1-3-10(11-12)8(2)6-9-4-5-13-7-9/h4-7,10H,3H2,1-2H3/b8-6+ D06IOP DRUGINKE MTERIVIYUVDTBU-SOFGYWHQSA-N D06IOP DRUGSMIL CCC(C(=CC1=CSC=C1)C)N=O D06IOP HIGHSTAT Investigative D06IPT DRUG__ID D06IPT D06IPT DRUGTYPE Small molecular drug D06IPT DRUGINCH 1S/C17H14N2O2/c1-12(20)16(11-18)17(21)19-15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-10,20H,1H3,(H,19,21)/b16-12- D06IPT DRUGINKE MUVPBAIVOHJDOC-VBKFSLOCSA-N D06IPT DRUGSMIL CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C2=CC=CC=C2)O D06IPT HIGHSTAT Investigative D06IQB DRUG__ID D06IQB D06IQB DRUGTYPE Small molecular drug D06IQB DRUGINCH 1S/C9H6OS3/c10-7-3-1-6(2-4-7)8-5-9(11)13-12-8/h1-5,10H D06IQB DRUGINKE IWBBKLMHAILHAR-UHFFFAOYSA-N D06IQB DRUGSMIL C1=CC(=CC=C1C2=CC(=S)SS2)O D06IQB HIGHSTAT Investigative D06IRE DRUG__ID D06IRE D06IRE DRUGTYPE Small molecular drug D06IRE DRUGINCH 1S/C2H3Cl3O/c3-2(4,5)1-6/h6H,1H2 D06IRE DRUGINKE KPWDGTGXUYRARH-UHFFFAOYSA-N D06IRE DRUGSMIL C(C(Cl)(Cl)Cl)O D06IRE HIGHSTAT Investigative D06IUC DRUG__ID D06IUC D06IUC DRUGTYPE Small molecular drug D06IUC DRUGINCH 1S/C26H41N3.2BrH/c1-6-28(7-2)26-16-14-24(15-17-26)12-13-25-18-21-27(22-19-25)20-11-23-29(8-3,9-4)10-5;;/h12-19,21-22H,6-11,20,23H2,1-5H3;2*1H/q+2;;/p-2 D06IUC DRUGINKE HLNKJDYNEWLULB-UHFFFAOYSA-L D06IUC DRUGSMIL CCN(CC)C1=CC=C(C=C1)C=CC2=CC=[N+](C=C2)CCC[N+](CC)(CC)CC.[Br-].[Br-] D06IUC HIGHSTAT Investigative D06IVU DRUG__ID D06IVU D06IVU DRUGTYPE Small molecular drug D06IVU DRUGINCH 1S/C12H12N2OS/c1-9-8-16-12(13-9)14-11(15)7-10-5-3-2-4-6-10/h2-6,8H,7H2,1H3,(H,13,14,15) D06IVU DRUGINKE YUZOFWPNYHCMMW-UHFFFAOYSA-N D06IVU DRUGSMIL CC1=CSC(=N1)NC(=O)CC2=CC=CC=C2 D06IVU HIGHSTAT Investigative D06IWR DRUG__ID D06IWR D06IWR DRUGTYPE Small molecular drug D06IWR DRUGINCH 1S/C20H18N2O2/c1-24-17-9-5-8-15(12-17)16-10-11-18(21)19(13-16)22-20(23)14-6-3-2-4-7-14/h2-13H,21H2,1H3,(H,22,23) D06IWR DRUGINKE YILNPZMVPAGFAT-UHFFFAOYSA-N D06IWR DRUGSMIL COC1=CC=CC(=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D06IWR HIGHSTAT Investigative D06IXE DRUG__ID D06IXE D06IXE DRUGTYPE Small molecular drug D06IXE DRUGINCH 1S/C46H64N2O2/c1-3-19-45-21-23-47(31-33-9-7-10-33)43(39(45)13-1)27-35-15-17-37(29-41(35)45)49-25-5-6-26-50-38-18-16-36-28-44-40-14-2-4-20-46(40,42(36)30-38)22-24-48(44)32-34-11-8-12-34/h15-18,29-30,33-34,39-40,43-44H,1-14,19-28,31-32H2/t39-,40-,43+,44+,45+,46+/m0/s1 D06IXE DRUGINKE FETCHTUKZYXAPU-DODYBPFYSA-N D06IXE DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OCCCCOC5=CC6=C(CC7C8C6(CCCC8)CCN7CC9CCC9)C=C5)CC1CCC1 D06IXE HIGHSTAT Investigative D06IXI DRUG__ID D06IXI D06IXI DRUGTYPE Small molecular drug D06IXI DRUGINCH 1S/C20H40BrO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(23)27-17-18(22)16-19(21)28(24,25)26/h18-19,22H,2-17H2,1H3,(H2,24,25,26)/t18-,19?/m0/s1 D06IXI DRUGINKE HLVKVWDSLLFMSX-OYKVQYDMSA-N D06IXI DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(CC(P(=O)(O)O)Br)O D06IXI HIGHSTAT Investigative D06IYU DRUG__ID D06IYU D06IYU DRUGTYPE Small molecular drug D06IYU DRUGINCH 1S/C6H8N2O2S/c7-11(9,10)8-6-4-2-1-3-5-6/h1-5,8H,(H2,7,9,10) D06IYU DRUGINKE DEVUYWTZRXOMSI-UHFFFAOYSA-N D06IYU DRUGSMIL C1=CC=C(C=C1)NS(=O)(=O)N D06IYU HIGHSTAT Investigative D06JAT DRUG__ID D06JAT D06JAT DRUGTYPE Small molecular drug D06JAT DRUGINCH 1S/C8H12O8P2/c1-8(17(10,11)12,18(13,14)15)16-7-4-2-6(9)3-5-7/h2-5,9H,1H3,(H2,10,11,12)(H2,13,14,15) D06JAT DRUGINKE JKOCAAWWDVHWKB-UHFFFAOYSA-N D06JAT DRUGSMIL CC(OC1=CC=C(C=C1)O)(P(=O)(O)O)P(=O)(O)O D06JAT HIGHSTAT Investigative D06JBN DRUG__ID D06JBN D06JBN DRUGTYPE Small molecular drug D06JBN DRUGINCH 1S/C23H38O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)27-22(20-24)21-25/h6-7,9-10,12-13,15-16,22,24-25H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15- D06JBN DRUGINKE RCRCTBLIHCHWDZ-DOFZRALJSA-N D06JBN DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(CO)CO D06JBN HIGHSTAT Investigative D06JBP DRUG__ID D06JBP D06JBP DRUGTYPE Small molecular drug D06JBP DRUGINCH 1S/C18H15N3/c1-2-4-13(5-3-1)11-20-14-6-7-17-16(10-14)15-8-9-19-12-18(15)21-17/h1-10,12,20-21H,11H2 D06JBP DRUGINKE QLFFRGDGVGTTAT-UHFFFAOYSA-N D06JBP DRUGSMIL C1=CC=C(C=C1)CNC2=CC3=C(C=C2)NC4=C3C=CN=C4 D06JBP HIGHSTAT Investigative D06JCT DRUG__ID D06JCT D06JCT DRUGTYPE Small molecular drug D06JCT DRUGINCH 1S/C19H30O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17-22-18-15-16-19(20)21/h3-4,6-7,9-10,12-13H,2,5,8,11,14-18H2,1H3,(H,20,21)/b4-3-,7-6-,10-9-,13-12- D06JCT DRUGINKE JUGSAWFPXQSLMJ-LTKCOYKYSA-N D06JCT DRUGSMIL CCC=CCC=CCC=CCC=CCCSCCCC(=O)O D06JCT HIGHSTAT Investigative D06JFN DRUG__ID D06JFN D06JFN DRUGTYPE Small molecular drug D06JFN DRUGINCH 1S/C18H19BrN2O4S/c19-16-7-6-15(18(22)20-13-14-4-2-1-3-5-14)12-17(16)26(23,24)21-8-10-25-11-9-21/h1-7,12H,8-11,13H2,(H,20,22) D06JFN DRUGINKE DEVYAXBKQQLYGQ-UHFFFAOYSA-N D06JFN DRUGSMIL C1COCCN1S(=O)(=O)C2=C(C=CC(=C2)C(=O)NCC3=CC=CC=C3)Br D06JFN HIGHSTAT Investigative D06JLN DRUG__ID D06JLN D06JLN DRUGTYPE Small molecular drug D06JLN DRUGINCH 1S/C18H29N7O7/c19-18(20)21-3-1-2-9-16(31)22-7-13(27)23-11(6-14(28)29)17(32)25-10-4-8(5-12(10)26)15(30)24-9/h8-12,26H,1-7H2,(H,22,31)(H,23,27)(H,24,30)(H,25,32)(H,28,29)(H4,19,20,21)/t8-,9+,10+,11+,12+/m1/s1 D06JLN DRUGINKE CFCPTSHVAOVLJR-DGORSVRFSA-N D06JLN DRUGSMIL C1C2CC(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O D06JLN HIGHSTAT Investigative D06JMS DRUG__ID D06JMS D06JMS DRUGTYPE Small molecular drug D06JMS DRUGINCH 1S/C17H15NO2/c1-17(12-13-8-4-2-5-9-13)15(19)18(16(17)20)14-10-6-3-7-11-14/h2-11H,12H2,1H3 D06JMS DRUGINKE ZFHCQEMYYXRUAS-UHFFFAOYSA-N D06JMS DRUGSMIL CC1(C(=O)N(C1=O)C2=CC=CC=C2)CC3=CC=CC=C3 D06JMS HIGHSTAT Investigative D06JMV DRUG__ID D06JMV D06JMV DRUGTYPE Small molecular drug D06JMV DRUGINCH 1S/C26H25N7O2S/c1-31-19-28-15-24(31)18-32-17-23(13-21-12-20(14-27)8-9-25(21)32)33(16-22-6-2-4-10-29-22)36(34,35)26-7-3-5-11-30-26/h2-12,15,19,23H,13,16-18H2,1H3 D06JMV DRUGINKE GQLZRVHYGCXHSR-UHFFFAOYSA-N D06JMV DRUGSMIL CN1C=NC=C1CN2CC(CC3=C2C=CC(=C3)C#N)N(CC4=CC=CC=N4)S(=O)(=O)C5=CC=CC=N5 D06JMV HIGHSTAT Investigative D06JNW DRUG__ID D06JNW D06JNW DRUGTYPE Small molecular drug D06JNW DRUGINCH 1S/C17H14O7/c1-22-12-4-3-8(5-10(12)19)16-17(23-2)15(21)14-11(20)6-9(18)7-13(14)24-16/h3-7,18-20H,1-2H3 D06JNW DRUGINKE ZSPZNFOLWQEVQJ-UHFFFAOYSA-N D06JNW DRUGSMIL COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC)O D06JNW HIGHSTAT Investigative D06JOJ DRUG__ID D06JOJ D06JOJ DRUGTYPE Small molecular drug D06JOJ DRUGINCH 1S/C15H18N2O8/c18-9-3-1-8(2-4-9)7-11(14(23)24)17-15(25)16-10(13(21)22)5-6-12(19)20/h1-4,10-11,18H,5-7H2,(H,19,20)(H,21,22)(H,23,24)(H2,16,17,25)/t10-,11-/m0/s1 D06JOJ DRUGINKE QXWVJRPYHOYHHT-QWRGUYRKSA-N D06JOJ DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O)O D06JOJ HIGHSTAT Investigative D06JPP DRUG__ID D06JPP D06JPP DRUGTYPE Small molecular drug D06JPP DRUGINCH 1S/C15H15F3N2O/c1-2-8-3-4-19-12-7-13-10(5-9(8)12)11(15(16,17)18)6-14(21)20-13/h5-8,19H,2-4H2,1H3,(H,20,21) D06JPP DRUGINKE SZPPQFARTYXRKU-UHFFFAOYSA-N D06JPP DRUGSMIL CCC1CCNC2=C1C=C3C(=CC(=O)NC3=C2)C(F)(F)F D06JPP HIGHSTAT Investigative D06JPQ DRUG__ID D06JPQ D06JPQ DRUGTYPE Small molecular drug D06JPQ DRUGINCH 1S/C18H21N3O2/c1-3-21(4-2)16-9-5-14(6-10-16)13-19-20-18(23)15-7-11-17(22)12-8-15/h5-13,22H,3-4H2,1-2H3,(H,20,23)/b19-13+ D06JPQ DRUGINKE WLKOCYWYAWBGKY-CPNJWEJPSA-N D06JPQ DRUGSMIL CCN(CC)C1=CC=C(C=C1)C=NNC(=O)C2=CC=C(C=C2)O D06JPQ HIGHSTAT Investigative D06JVR DRUG__ID D06JVR D06JVR DRUGTYPE Small molecular drug D06JVR DRUGINCH 1S/C8H8N4O2S2/c9-16(13,14)12-8-11-10-7(15-8)6-4-2-1-3-5-6/h1-5H,(H,11,12)(H2,9,13,14) D06JVR DRUGINKE AYAZOMSTWAJWHN-UHFFFAOYSA-N D06JVR DRUGSMIL C1=CC=C(C=C1)C2=NN=C(S2)NS(=O)(=O)N D06JVR HIGHSTAT Investigative D06JXH DRUG__ID D06JXH D06JXH DRUGTYPE Small molecular drug D06JXH DRUGINCH 1S/C61H94N18O13S/c1-93-32-25-39(63)50(82)72-40(19-8-9-26-62)51(83)73-41(20-10-27-68-60(64)65)56(88)79-31-14-24-48(79)58(90)78-30-12-22-46(78)54(86)70-35-49(81)71-43(33-37-15-4-2-5-16-37)52(84)76-45(36-80)57(89)77-29-13-23-47(77)55(87)75-44(34-38-17-6-3-7-18-38)53(85)74-42(59(91)92)21-11-28-69-61(66)67/h2-7,15-18,39-48,80H,8-14,19-36,62-63H2,1H3,(H,70,86)(H,71,81)(H,72,82)(H,73,83)(H,74,85)(H,75,87)(H,76,84)(H,91,92)(H4,64,65,68)(H4,66,67,69)/t39-,40-,41-,42-,43-,44-,45-,46-,47-,48-/m0/s1 D06JXH DRUGINKE SSXPFNXUSFJJEI-BHEJXMHWSA-N D06JXH DRUGSMIL CSCCC(C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O)N D06JXH HIGHSTAT Investigative D06JYY DRUG__ID D06JYY D06JYY DRUGTYPE Small molecular drug D06JYY DRUGINCH 1S/C23H19NO/c1-25-22-10-8-17(9-11-22)13-21-14-18-5-2-3-6-19(18)15-23(21)20-7-4-12-24-16-20/h2-12,14-16H,13H2,1H3 D06JYY DRUGINKE GOGQHVZGANJJDF-UHFFFAOYSA-N D06JYY DRUGSMIL COC1=CC=C(C=C1)CC2=CC3=CC=CC=C3C=C2C4=CN=CC=C4 D06JYY HIGHSTAT Investigative D06JZQ DRUG__ID D06JZQ D06JZQ DRUGTYPE Small molecular drug D06JZQ DRUGINCH 1S/C10H14N2/c1-7(2)4-9-5-8(3)6-10(11)12-9/h4-6H,1-3H3,(H2,11,12) D06JZQ DRUGINKE BHPPONCQQUIFAK-UHFFFAOYSA-N D06JZQ DRUGSMIL CC1=CC(=NC(=C1)N)C=C(C)C D06JZQ HIGHSTAT Investigative D06KBO DRUG__ID D06KBO D06KBO DRUGTYPE Small molecular drug D06KBO DRUGINCH 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-/m0/s1 D06KBO DRUGINKE BHMBVRSPMRCCGG-OUTUXVNYSA-N D06KBO DRUGSMIL CCCCCC(C=CC1C(C(CC1=O)O)CC=CCCCC(=O)O)O D06KBO HIGHSTAT Investigative D06KCW DRUG__ID D06KCW D06KCW DRUGTYPE Small molecular drug D06KCW DRUGINCH 1S/C12H22N2O2/c13-12(14)7-2-1-4-9(8-15)10-5-3-6-11(10)16/h8-11,16H,1-7H2,(H3,13,14)/t9-,10+,11-/m0/s1 D06KCW DRUGINKE FCDJKFJACUMSOZ-AXFHLTTASA-N D06KCW DRUGSMIL C1CC(C(C1)O)C(CCCCC(=N)N)C=O D06KCW HIGHSTAT Investigative D06KDU DRUG__ID D06KDU D06KDU DRUGTYPE Small molecular drug D06KDU DRUGINCH 1S/C9H4Br4O2/c10-5-3-4(1-2-6(14)15)7(11)9(13)8(5)12/h1-3H,(H,14,15)/b2-1+ D06KDU DRUGINKE SVJQCVOKYJWUBC-OWOJBTEDSA-N D06KDU DRUGSMIL C1=C(C(=C(C(=C1Br)Br)Br)Br)C=CC(=O)O D06KDU HIGHSTAT Investigative D06KFX DRUG__ID D06KFX D06KFX DRUGTYPE Small molecular drug D06KFX DRUGINCH 1S/C34H35N5O4/c40-31-27(18-22-10-3-1-4-11-22)37-33(42)30-16-9-17-39(30)34(43)29(19-23-12-5-2-6-13-23)38-32(41)28(36-31)20-24-21-35-26-15-8-7-14-25(24)26/h1-8,10-15,21,27-30,35H,9,16-20H2,(H,36,40)(H,37,42)(H,38,41)/t27-,28-,29-,30+/m0/s1 D06KFX DRUGINKE GIZJWWQFOGQPRY-GCXHJFECSA-N D06KFX DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4=CNC5=CC=CC=C54)CC6=CC=CC=C6 D06KFX HIGHSTAT Investigative D06KHR DRUG__ID D06KHR D06KHR DRUGTYPE Small molecular drug D06KHR DRUGINCH 1S/28O.10V/q;;;;;;;;;;;;;;;;;;;;;;6*-1;;;;;;;;;; D06KHR DRUGINKE OSBWBKHFRWKREF-UHFFFAOYSA-N D06KHR DRUGSMIL [O-][V](=O)([O-])O[V]1(=O)O[V]2(=O)O[V]3(=O)O[V](=O)(O[V](=O)(O3)O[V](=O)([O-])[O-])O[V](=O)(O[V](=O)(O2)O1)O[V](=O)([O-])[O-] D06KHR HIGHSTAT Investigative D06KHW DRUG__ID D06KHW D06KHW DRUGTYPE Small molecular drug D06KHW DRUGINCH 1S/C22H22N6O2/c1-15(2)30-22(29)28-9-7-27(8-10-28)21-17(13-23)11-18(14-26-21)16-3-4-19-20(12-16)25-6-5-24-19/h3-6,11-12,14-15H,7-10H2,1-2H3 D06KHW DRUGINKE UVINGSLSDLUGKX-UHFFFAOYSA-N D06KHW DRUGSMIL CC(C)OC(=O)N1CCN(CC1)C2=C(C=C(C=N2)C3=CC4=NC=CN=C4C=C3)C#N D06KHW HIGHSTAT Investigative D06KJR DRUG__ID D06KJR D06KJR DRUGTYPE Small molecular drug D06KJR DRUGINCH 1S/C45H56F2N6O15/c1-24(54)48-32(23-36(59)60)43(65)49-29(18-20-35(57)58)41(63)53-38(37(26-13-7-3-8-14-26)27-15-9-4-10-16-27)44(66)50-28(17-19-34(55)56)40(62)52-31(21-25-11-5-2-6-12-25)42(64)51-30(22-33(46)47)39(61)45(67)68/h3-4,7-10,13-16,25,28-33,37-38H,2,5-6,11-12,17-23H2,1H3,(H,48,54)(H,49,65)(H,50,66)(H,51,64)(H,52,62)(H,53,63)(H,55,56)(H,57,58)(H,59,60)(H,67,68)/t28-,29-,30-,31-,32-,38-/m0/s1 D06KJR DRUGINKE FIGPTAABOPCRSH-BHTNCQBCSA-N D06KJR DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C1=CC=CC=C1)C2=CC=CC=C2)C(=O)NC(CCC(=O)O)C(=O)NC(CC3CCCCC3)C(=O)NC(CC(F)F)C(=O)C(=O)O D06KJR HIGHSTAT Investigative D06KKN DRUG__ID D06KKN D06KKN DRUGTYPE Small molecular drug D06KKN DRUGINCH 1S/C26H27N5O2/c1-2-9-27-22(4-1)26-25(24-5-3-11-31(24)29-26)21-8-10-28-23-18-19(6-7-20(21)23)33-17-14-30-12-15-32-16-13-30/h1-2,4,6-10,18H,3,5,11-17H2 D06KKN DRUGINKE IHLVSLOZUHKNMQ-UHFFFAOYSA-N D06KKN DRUGSMIL C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6 D06KKN HIGHSTAT Investigative D06KLQ DRUG__ID D06KLQ D06KLQ DRUGTYPE Small molecular drug D06KLQ DRUGINCH 1S/C26H30N4O2/c1-4-29-13-15-30(16-14-29)25-17-19(2)23-18-21(8-11-24(23)28-25)27-26(31)12-7-20-5-9-22(32-3)10-6-20/h5-12,17-18H,4,13-16H2,1-3H3,(H,27,31)/b12-7+ D06KLQ DRUGINKE BYSCWUNLAIWJED-KPKJPENVSA-N D06KLQ DRUGSMIL CCN1CCN(CC1)C2=NC3=C(C=C(C=C3)NC(=O)C=CC4=CC=C(C=C4)OC)C(=C2)C D06KLQ HIGHSTAT Investigative D06KMJ DRUG__ID D06KMJ D06KMJ DRUGTYPE Small molecular drug D06KMJ DRUGINCH 1S/C26H27ClN6O5/c1-28-25(38)26-10-16(26)20(21(36)22(26)37)33-13-32-19-23(30-12-31-24(19)33)29-11-14-6-5-8-17(27)15(14)7-3-2-4-9-18(34)35/h5-6,8,12-13,16,20-22,36-37H,2,4,9-11H2,1H3,(H,28,38)(H,34,35)(H,29,30,31)/t16-,20-,21+,22+,26+/m1/s1 D06KMJ DRUGINKE CYQQUPOETXXUCK-CSTWGOEFSA-N D06KMJ DRUGSMIL CNC(=O)C12CC1C(C(C2O)O)N3C=NC4=C(N=CN=C43)NCC5=C(C(=CC=C5)Cl)C#CCCCC(=O)O D06KMJ HIGHSTAT Investigative D06KMO DRUG__ID D06KMO D06KMO DRUGTYPE Small molecular drug D06KMO DRUGINCH 1S/C7H8BrNO2/c8-6-2-1-5(4-11-9)3-7(6)10/h1-3,10H,4,9H2 D06KMO DRUGINKE QNWOSJAGFSUDFE-UHFFFAOYSA-N D06KMO DRUGSMIL C1=CC(=C(C=C1CON)O)Br D06KMO HIGHSTAT Investigative D06KMP DRUG__ID D06KMP D06KMP DRUGTYPE Small molecular drug D06KMP DRUGINCH 1S/C12H8O4/c13-11(14)9-3-1-7-5-10(12(15)16)4-2-8(7)6-9/h1-6H,(H,13,14)(H,15,16) D06KMP DRUGINKE RXOHFPCZGPKIRD-UHFFFAOYSA-N D06KMP DRUGSMIL C1=CC2=C(C=CC(=C2)C(=O)O)C=C1C(=O)O D06KMP HIGHSTAT Investigative D06KNV DRUG__ID D06KNV D06KNV DRUGTYPE Small molecular drug D06KNV DRUGINCH 1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3 D06KNV DRUGINKE SVFXPTLYMIXFRX-UHFFFAOYSA-N D06KNV DRUGSMIL CNC1CC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl D06KNV HIGHSTAT Investigative D06KOT DRUG__ID D06KOT D06KOT DRUGTYPE Small molecular drug D06KOT DRUGINCH 1S/C5H11NO2/c6-4-2-1-3-5(7)8/h1-4,6H2,(H,7,8)/p+1 D06KOT DRUGINKE JJMDCOVWQOJGCB-UHFFFAOYSA-O D06KOT DRUGSMIL C(CC[NH3+])CC(=O)O D06KOT HIGHSTAT Investigative D06KQD DRUG__ID D06KQD D06KQD DRUGTYPE Small molecular drug D06KQD DRUGINCH 1S/C14H15NO2/c1-15(17)14(16)9-7-11-6-8-12-4-2-3-5-13(12)10-11/h2-6,8,10,17H,7,9H2,1H3 D06KQD DRUGINKE BLIBCDZMLZUBQT-UHFFFAOYSA-N D06KQD DRUGSMIL CN(C(=O)CCC1=CC2=CC=CC=C2C=C1)O D06KQD HIGHSTAT Investigative D06KQH DRUG__ID D06KQH D06KQH DRUGTYPE Small molecular drug D06KQH DRUGINCH 1S/C23H28FNO3/c24-21-10-6-9-20(17-21)23(26)27-16-5-4-13-25-14-11-22(12-15-25)28-18-19-7-2-1-3-8-19/h1-3,6-10,17,22H,4-5,11-16,18H2 D06KQH DRUGINKE YJPYLKLJKPTNBQ-UHFFFAOYSA-N D06KQH DRUGSMIL C1CN(CCC1OCC2=CC=CC=C2)CCCCOC(=O)C3=CC(=CC=C3)F D06KQH HIGHSTAT Investigative D06KSF DRUG__ID D06KSF D06KSF DRUGTYPE Small molecular drug D06KSF DRUGINCH 1S/C21H14ClFN6/c22-17-6-15(3-4-18(17)23)29-21-14(8-24)11-26-19-12-28-20(7-16(19)21)27-10-13-2-1-5-25-9-13/h1-7,9,11-12H,10H2,(H,26,29)(H,27,28) D06KSF DRUGINKE NMEUKWOOQOHUNA-UHFFFAOYSA-N D06KSF DRUGSMIL C1=CC(=CN=C1)CNC2=NC=C3C(=C2)C(=C(C=N3)C#N)NC4=CC(=C(C=C4)F)Cl D06KSF HIGHSTAT Investigative D06KTD DRUG__ID D06KTD D06KTD DRUGTYPE Small molecular drug D06KTD DRUGINCH 1S/C7H9N3O3S/c8-10-7(11)5-3-1-2-4-6(5)14(9,12)13/h1-4H,8H2,(H,10,11)(H2,9,12,13) D06KTD DRUGINKE YWPOXIABDFDDSR-UHFFFAOYSA-N D06KTD DRUGSMIL C1=CC=C(C(=C1)C(=O)NN)S(=O)(=O)N D06KTD HIGHSTAT Investigative D06KVV DRUG__ID D06KVV D06KVV DRUGTYPE Small molecular drug D06KVV DRUGINCH 1S/C5H11NO3/c7-2-3-5(9)4(8)1-6-3/h3-9H,1-2H2/t3-,4-,5-/m0/s1 D06KVV DRUGINKE OQEBIHBLFRADNM-YUPRTTJUSA-N D06KVV DRUGSMIL C1C(C(C(N1)CO)O)O D06KVV HIGHSTAT Investigative D06KVX DRUG__ID D06KVX D06KVX DRUGTYPE Small molecular drug D06KVX DRUGINCH 1S/C13H11NOS/c1-10-14-12(9-16-10)8-7-11-5-3-4-6-13(11)15-2/h3-6,9H,1-2H3 D06KVX DRUGINKE WOLUACOHPFWBIX-UHFFFAOYSA-N D06KVX DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CC=C2OC D06KVX HIGHSTAT Investigative D06KWA DRUG__ID D06KWA D06KWA DRUGTYPE Small molecular drug D06KWA DRUGINCH 1S/C27H25N3O5/c1-18(31)28-23(16-19-10-4-2-5-11-19)26(33)29-22-15-9-8-14-21(22)25(32)30-24(27(34)35)17-20-12-6-3-7-13-20/h2-16,24H,17H2,1H3,(H,28,31)(H,29,33)(H,30,32)(H,34,35)/b23-16+ D06KWA DRUGINKE GKGZJDOSLXUABF-XQNSMLJCSA-N D06KWA DRUGSMIL CC(=O)NC(=CC1=CC=CC=C1)C(=O)NC2=CC=CC=C2C(=O)NC(CC3=CC=CC=C3)C(=O)O D06KWA HIGHSTAT Investigative D06KWQ DRUG__ID D06KWQ D06KWQ DRUGTYPE Small molecular drug D06KWQ DRUGINCH 1S/C15H32N2S/c1-4-5-6-7-8-9-10-11-12-13-14-16-15(18)17(2)3/h4-14H2,1-3H3,(H,16,18) D06KWQ DRUGINKE ZZKLRJUYYVBOIF-UHFFFAOYSA-N D06KWQ DRUGSMIL CCCCCCCCCCCCNC(=S)N(C)C D06KWQ HIGHSTAT Investigative D06KYM DRUG__ID D06KYM D06KYM DRUGTYPE Small molecular drug D06KYM DRUGINCH 1S/C9H14N2/c1-3-11(2)8-9-5-4-6-10-7-9/h4-7H,3,8H2,1-2H3 D06KYM DRUGINKE DYIAIEHOHKXIMP-UHFFFAOYSA-N D06KYM DRUGSMIL CCN(C)CC1=CN=CC=C1 D06KYM HIGHSTAT Investigative D06KYP DRUG__ID D06KYP D06KYP DRUGTYPE Small molecular drug D06KYP DRUGINCH 1S/C8H10BrN5/c1-4(2)14-7-5(13-8(14)9)6(10)11-3-12-7/h3-4H,1-2H3,(H2,10,11,12) D06KYP DRUGINKE AFKIJCJUVRTHPD-UHFFFAOYSA-N D06KYP DRUGSMIL CC(C)N1C2=NC=NC(=C2N=C1Br)N D06KYP HIGHSTAT Investigative D06LBL DRUG__ID D06LBL D06LBL DRUGTYPE Small molecular drug D06LBL DRUGINCH 1S/C4H6O3/c1-3(5)2-4(6)7/h2H2,1H3,(H,6,7) D06LBL DRUGINKE WDJHALXBUFZDSR-UHFFFAOYSA-N D06LBL DRUGSMIL CC(=O)CC(=O)O D06LBL HIGHSTAT Investigative D06LCK DRUG__ID D06LCK D06LCK DRUGTYPE Small molecular drug D06LCK DRUGINCH 1S/C14H18FNO/c1-11(16-8-3-2-4-9-16)14(17)12-6-5-7-13(15)10-12/h5-7,10-11H,2-4,8-9H2,1H3 D06LCK DRUGINKE UDGISDAHRCDXMV-UHFFFAOYSA-N D06LCK DRUGSMIL CC(C(=O)C1=CC(=CC=C1)F)N2CCCCC2 D06LCK HIGHSTAT Investigative D06LED DRUG__ID D06LED D06LED DRUGTYPE Small molecular drug D06LED DRUGINCH 1S/C15H10O4/c16-12-7-6-10-11(9-4-2-1-3-5-9)8-13(17)19-15(10)14(12)18/h1-8,16,18H D06LED DRUGINKE JRVIIPJSVKTPBK-UHFFFAOYSA-N D06LED DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)OC3=C2C=CC(=C3O)O D06LED HIGHSTAT Investigative D06LFZ DRUG__ID D06LFZ D06LFZ DRUGTYPE Small molecular drug D06LFZ DRUGINCH 1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m1/s1 D06LFZ DRUGINKE GZCGUPFRVQAUEE-VANKVMQKSA-N D06LFZ DRUGSMIL C(C(C(C(C(C=O)O)O)O)O)O D06LFZ HIGHSTAT Investigative D06LHH DRUG__ID D06LHH D06LHH DRUGTYPE Small molecular drug D06LHH DRUGINCH 1S/C24H28N4O6S/c29-23(26-14-22(24(30)31)28-35(32,33)19-4-2-1-3-5-19)21-13-17-12-18(6-7-20(17)27-21)34-15-16-8-10-25-11-9-16/h1-7,12-13,16,22,25,27-28H,8-11,14-15H2,(H,26,29)(H,30,31)/t22-/m0/s1 D06LHH DRUGINKE CFKZYRJYUHWTIW-QFIPXVFZSA-N D06LHH DRUGSMIL C1CNCCC1COC2=CC3=C(C=C2)NC(=C3)C(=O)NCC(C(=O)O)NS(=O)(=O)C4=CC=CC=C4 D06LHH HIGHSTAT Investigative D06LJL DRUG__ID D06LJL D06LJL DRUGTYPE Small molecular drug D06LJL DRUGINCH 1S/C29H33FN6O4S/c1-39-25-14-23-24(15-26(25)40-11-3-8-36-9-6-19(17-37)7-10-36)32-18-33-28(23)35-29-31-16-22(41-29)13-27(38)34-21-5-2-4-20(30)12-21/h2,4-5,12,14-16,18-19,37H,3,6-11,13,17H2,1H3,(H,34,38)(H,31,32,33,35) D06LJL DRUGINKE QNJAKUMXJFWQOG-UHFFFAOYSA-N D06LJL DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=NC=C(S3)CC(=O)NC4=CC(=CC=C4)F)OCCCN5CCC(CC5)CO D06LJL HIGHSTAT Investigative D06LKH DRUG__ID D06LKH D06LKH DRUGTYPE Small molecular drug D06LKH DRUGINCH 1S/C17H30N8O9/c18-5-11(27)23-8(2-1-3-21-17(19)20)14(31)22-6-12(28)24-9(4-13(29)30)15(32)25-10(7-26)16(33)34/h8-10,26H,1-7,18H2,(H,22,31)(H,23,27)(H,24,28)(H,25,32)(H,29,30)(H,33,34)(H4,19,20,21)/t8-,9-,10-/m0/s1 D06LKH DRUGINKE RGNVSYKVCGAEHK-GUBZILKMSA-N D06LKH DRUGSMIL C(CC(C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)CN)CN=C(N)N D06LKH HIGHSTAT Investigative D06LLF DRUG__ID D06LLF D06LLF DRUGTYPE Small molecular drug D06LLF DRUGINCH 1S/C19H17NO2/c1-21-18-11-16-10-15(9-8-14-6-4-3-5-7-14)13-20-17(16)12-19(18)22-2/h3-13H,1-2H3/b9-8+ D06LLF DRUGINKE NQVBNOPSVRCGSI-CMDGGOBGSA-N D06LLF DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C=CC3=CC=CC=C3 D06LLF HIGHSTAT Investigative D06LNL DRUG__ID D06LNL D06LNL DRUGTYPE Small molecular drug D06LNL DRUGINCH 1S/C6H5IO2/c8-7(9)6-4-2-1-3-5-6/h1-5H D06LNL DRUGINKE BDOLQESNFGCNSC-UHFFFAOYSA-N D06LNL DRUGSMIL C1=CC=C(C=C1)I(=O)=O D06LNL HIGHSTAT Investigative D06LNX DRUG__ID D06LNX D06LNX DRUGTYPE Small molecular drug D06LNX DRUGINCH 1S/C11H12O4/c12-10(13)7-9(11(14)15)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,12,13)(H,14,15) D06LNX DRUGINKE GTOFKXZQQDSVFH-UHFFFAOYSA-N D06LNX DRUGSMIL C1=CC=C(C=C1)CC(CC(=O)O)C(=O)O D06LNX HIGHSTAT Investigative D06LPR DRUG__ID D06LPR D06LPR DRUGTYPE Small molecular drug D06LPR DRUGINCH 1S/C10H7N3O3/c14-10(8-4-2-1-3-5-8)12-7-9(6-11-12)13(15)16/h1-7H D06LPR DRUGINKE DLDKTRBBAKTGJH-UHFFFAOYSA-N D06LPR DRUGSMIL C1=CC=C(C=C1)C(=O)N2C=C(C=N2)[N+](=O)[O-] D06LPR HIGHSTAT Investigative D06LQH DRUG__ID D06LQH D06LQH DRUGTYPE Small molecular drug D06LQH DRUGINCH 1S/C19H21NO2/c1-2-9-20-10-8-12-4-3-5-14-17(12)15(20)11-13-6-7-16(21)19(22)18(13)14/h3-7,15,21-22H,2,8-11H2,1H3/t15-/m1/s1 D06LQH DRUGINKE BTGAJCKRXPNBFI-OAHLLOKOSA-N D06LQH DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O D06LQH HIGHSTAT Investigative D06LRC DRUG__ID D06LRC D06LRC DRUGTYPE Small molecular drug D06LRC DRUGINCH 1S/C20H20N2O6/c23-19(21-13-7-3-1-4-8-13)27-15-11-25-18-16(12-26-17(15)18)28-20(24)22-14-9-5-2-6-10-14/h1-10,15-18H,11-12H2,(H,21,23)(H,22,24)/t15-,16+,17-,18-/m1/s1 D06LRC DRUGINKE KDDHNJSIHIMRGH-XMTFNYHQSA-N D06LRC DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NC3=CC=CC=C3)OC(=O)NC4=CC=CC=C4 D06LRC HIGHSTAT Investigative D06LSC DRUG__ID D06LSC D06LSC DRUGTYPE Small molecular drug D06LSC DRUGINCH 1S/C34H36N2O6S/c37-33(32(25-28-15-7-2-8-16-28)36-34(38)41-26-29-17-9-3-10-18-29)35-30(22-21-27-13-5-1-6-14-27)23-24-43(39,40)42-31-19-11-4-12-20-31/h1-20,30,32H,21-26H2,(H,35,37)(H,36,38)/t30-,32-/m0/s1 D06LSC DRUGINKE SUGQHICXCRBQOI-CDZUIXILSA-N D06LSC DRUGSMIL C1=CC=C(C=C1)CCC(CCS(=O)(=O)OC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)NC(=O)OCC4=CC=CC=C4 D06LSC HIGHSTAT Investigative D06LUW DRUG__ID D06LUW D06LUW DRUGTYPE Small molecular drug D06LUW DRUGINCH 1S/C27H32N2O8/c1-18-11-13-20-7-4-9-23(31)26(20)27(34)37-21(17-25(33)36-19(2)12-14-22(18)30)8-5-15-28-24(32)10-6-16-29-35-3/h4-7,9-12,14-16,19,21-22,30-31H,8,13,17H2,1-3H3,(H,28,32)/b10-6+,14-12+,15-5+,18-11?,29-16- D06LUW DRUGINKE JYHIHHYYXXKTTJ-HPPATNPVSA-N D06LUW DRUGSMIL CC1C=CC(C(=CCC2=C(C(=CC=C2)O)C(=O)OC(CC(=O)O1)CC=CNC(=O)C=CC=NOC)C)O D06LUW HIGHSTAT Investigative D06LUX DRUG__ID D06LUX D06LUX DRUGTYPE Small molecular drug D06LUX DRUGINCH 1S/C17H30N2O4/c1-6-8-12-10-13(16(21)22)19-14(12)15(18-11(3)20)17(4,23-5)9-7-2/h6,8,12-15,19H,7,9-10H2,1-5H3,(H,18,20)(H,21,22)/b8-6-/t12-,13-,14-,15-,17+/m1/s1 D06LUX DRUGINKE UUVKABIGWGMYCE-FLMGFEAJSA-N D06LUX DRUGSMIL CCCC(C)(C(C1C(CC(N1)C(=O)O)C=CC)NC(=O)C)OC D06LUX HIGHSTAT Investigative D06LVE DRUG__ID D06LVE D06LVE DRUGTYPE Small molecular drug D06LVE DRUGINCH 1S/C6H6N2O4S/c7-13(11,12)6-3-1-5(2-4-6)8(9)10/h1-4H,(H2,7,11,12) D06LVE DRUGINKE QWKKYJLAUWFPDB-UHFFFAOYSA-N D06LVE DRUGSMIL C1=CC(=CC=C1[N+](=O)[O-])S(=O)(=O)N D06LVE HIGHSTAT Investigative D06LYY DRUG__ID D06LYY D06LYY DRUGTYPE Small molecular drug D06LYY DRUGINCH 1S/C44H88NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h42H,6-41H2,1-5H3/p+1/t42-/m1/s1 D06LYY DRUGINKE NRJAVPSFFCBXDT-HUESYALOSA-O D06LYY DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC D06LYY HIGHSTAT Investigative D06MAL DRUG__ID D06MAL D06MAL DRUGTYPE Small molecular drug D06MAL DRUGINCH 1S/C20H22O6/c1-6-10(2)18(22)25-15-9-20(5)16(21)8-13(26-20)11(3)7-14-17(15)12(4)19(23)24-14/h6-8,14-15,17H,4,9H2,1-3,5H3/b10-6+,11-7-/t14-,15-,17+,20-/m1/s1 D06MAL DRUGINKE QATUWZPYBIHFFR-GAZZCERVSA-N D06MAL DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=CC3C1C(=C)C(=O)O3)C)C D06MAL HIGHSTAT Investigative D06MBD DRUG__ID D06MBD D06MBD DRUGTYPE Small molecular drug D06MBD DRUGINCH 1S/C19H30N4S2/c1-3-7-15(8-4-1)21-18(22-16-9-5-2-6-10-16)24-13-17-14-25-19-20-11-12-23(17)19/h14-16H,1-13H2,(H,21,22) D06MBD DRUGINKE ZEZPDHKACVMMCD-UHFFFAOYSA-N D06MBD DRUGSMIL C1CCC(CC1)NC(=NC2CCCCC2)SCC3=CSC4=NCCN34 D06MBD HIGHSTAT Investigative D06MCJ DRUG__ID D06MCJ D06MCJ DRUGTYPE Small molecular drug D06MCJ DRUGINCH 1S/C19H16N2O2/c1-22-18-8-12-7-13(10-20-17(12)9-19(18)23-2)15-11-21-16-6-4-3-5-14(15)16/h3-11,21H,1-2H3 D06MCJ DRUGINKE CTHPHODXZDFNPE-UHFFFAOYSA-N D06MCJ DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CNC4=CC=CC=C43 D06MCJ HIGHSTAT Investigative D06MDX DRUG__ID D06MDX D06MDX DRUGTYPE Small molecular drug D06MDX DRUGINCH 1S/C21H18O3/c22-21(23)20(15-16-7-3-1-4-8-16)24-19-13-11-18(12-14-19)17-9-5-2-6-10-17/h1-14,20H,15H2,(H,22,23)/t20-/m0/s1 D06MDX DRUGINKE TZTPJJNNACUQQR-FQEVSTJZSA-N D06MDX DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)OC2=CC=C(C=C2)C3=CC=CC=C3 D06MDX HIGHSTAT Investigative D06MFY DRUG__ID D06MFY D06MFY DRUGTYPE Small molecular drug D06MFY DRUGINCH 1S/C20H23NO2/c22-20(23-15-16-9-3-1-4-10-16)19(17-11-5-2-6-12-17)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2/t18-,19-/m1/s1 D06MFY DRUGINKE MNFUKEWWCUWTRK-RTBURBONSA-N D06MFY DRUGSMIL C1CCNC(C1)C(C2=CC=CC=C2)C(=O)OCC3=CC=CC=C3 D06MFY HIGHSTAT Investigative D06MGJ DRUG__ID D06MGJ D06MGJ DRUGTYPE Small molecular drug D06MGJ DRUGINCH 1S/C18H21NO4S/c1-13(2)12-17(18(20)21)19-24(22,23)16-10-8-15(9-11-16)14-6-4-3-5-7-14/h3-11,13,17,19H,12H2,1-2H3,(H,20,21)/t17-/m1/s1 D06MGJ DRUGINKE FBSVJQQVDISETN-QGZVFWFLSA-N D06MGJ DRUGSMIL CC(C)CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)C2=CC=CC=C2 D06MGJ HIGHSTAT Investigative D06MGO DRUG__ID D06MGO D06MGO DRUGTYPE Small molecular drug D06MGO DRUGINCH 1S/C14H21NO/c1-12-6-5-10-15(12)11-9-13-7-3-4-8-14(13)16-2/h3-4,7-8,12H,5-6,9-11H2,1-2H3/t12-/m0/s1 D06MGO DRUGINKE KDVUGYDZNTZESD-LBPRGKRZSA-N D06MGO DRUGSMIL CC1CCCN1CCC2=CC=CC=C2OC D06MGO HIGHSTAT Investigative D06MLU DRUG__ID D06MLU D06MLU DRUGTYPE Small molecular drug D06MLU DRUGINCH 1S/C22H28O7/c1-25-20-9-15(10-21(26-2)22(20)27-3)7-17(12-24)16(11-23)6-14-4-5-18-19(8-14)29-13-28-18/h4-5,8-10,16-17,23-24H,6-7,11-13H2,1-3H3/t16-,17-/m0/s1 D06MLU DRUGINKE FDHFWHRGVDRJIK-IRXDYDNUSA-N D06MLU DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC(CO)C(CC2=CC3=C(C=C2)OCO3)CO D06MLU HIGHSTAT Investigative D06MMN DRUG__ID D06MMN D06MMN DRUGTYPE Small molecular drug D06MMN DRUGINCH 1S/C43H57NO15/c1-28(33(56-30(3)45)29(2)27-31-19-13-11-14-20-31)23-24-41-34(46)35(43(59-41,39(51)52)42(54,38(49)50)36(58-41)37(47)48)57-40(53)44-25-17-9-7-5-4-6-8-10-18-26-55-32-21-15-12-16-22-32/h11-16,19-22,29,33-36,46,54H,1,4-10,17-18,23-27H2,2-3H3,(H,44,53)(H,47,48)(H,49,50)(H,51,52)/t29-,33-,34-,35-,36?,41?,42?,43?/m1/s1 D06MMN DRUGINKE QOLHWXNSCZGWHK-BWBORTOCSA-N D06MMN DRUGSMIL CC(CC1=CC=CC=C1)C(C(=C)CCC23C(C(C(O2)(C(C(O3)C(=O)O)(C(=O)O)O)C(=O)O)OC(=O)NCCCCCCCCCCCOC4=CC=CC=C4)O)OC(=O)C D06MMN HIGHSTAT Investigative D06MNV DRUG__ID D06MNV D06MNV DRUGTYPE Small molecular drug D06MNV DRUGINCH 1S/C9H11N3S/c1-7(11-12-9(10)13)8-5-3-2-4-6-8/h2-6H,1H3,(H3,10,12,13)/b11-7- D06MNV DRUGINKE JMULZUQMMLAALR-XFFZJAGNSA-N D06MNV DRUGSMIL CC(=NNC(=S)N)C1=CC=CC=C1 D06MNV HIGHSTAT Investigative D06MNW DRUG__ID D06MNW D06MNW DRUGTYPE Small molecular drug D06MNW DRUGINCH 1S/C21H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-22-18-19-24-21/h9-10,18-19H,2-8,11-17H2,1H3/b10-9- D06MNW DRUGINKE WWYUNXGFLPTVRR-KTKRTIGZSA-N D06MNW DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NC=CO1 D06MNW HIGHSTAT Investigative D06MPP DRUG__ID D06MPP D06MPP DRUGTYPE Small molecular drug D06MPP DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(41)36-29-25-12-8-7-11-22(25)18-27(29)38)37(20-45-34)33(42)30(40)26(17-21-9-5-4-6-10-21)35-28(39)19-44-24-15-13-23(43-3)14-16-24/h4-16,26-27,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t26-,27+,29-,30-,31+/m0/s1 D06MPP DRUGINKE QGAHVOMMQMAYSQ-VFCPCCRCSA-N D06MPP DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=C(C=C3)OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D06MPP HIGHSTAT Investigative D06MQG DRUG__ID D06MQG D06MQG DRUGTYPE Small molecular drug D06MQG DRUGINCH 1S/C25H27NO2/c1-28-23-14-8-13-22(19-23)25(27)15-17-26(18-16-25)24(20-9-4-2-5-10-20)21-11-6-3-7-12-21/h2-14,19,24,27H,15-18H2,1H3 D06MQG DRUGINKE KFPUCANOYSPKNM-UHFFFAOYSA-N D06MQG DRUGSMIL COC1=CC=CC(=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D06MQG HIGHSTAT Investigative D06MRM DRUG__ID D06MRM D06MRM DRUGTYPE Small molecular drug D06MRM DRUGINCH 1S/C21H32O3/c1-13(22)21(24)11-8-18-16-5-4-14-12-15(23)6-9-19(14,2)17(16)7-10-20(18,21)3/h4,15-18,23-24H,5-12H2,1-3H3/t15-,16+,17-,18-,19-,20-,21-/m0/s1 D06MRM DRUGINKE JERGUCIJOXJXHF-TVWVXWENSA-N D06MRM DRUGSMIL CC(=O)C1(CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O D06MRM HIGHSTAT Investigative D06MRN DRUG__ID D06MRN D06MRN DRUGTYPE Small molecular drug D06MRN DRUGINCH 1S/C25H31N3O/c1-3-4-5-6-7-10-17-28(2)23-15-13-20(14-16-23)25(29)27-22-18-21-11-8-9-12-24(21)26-19-22/h8-9,11-16,18-19H,3-7,10,17H2,1-2H3,(H,27,29) D06MRN DRUGINKE YWPSOIQULJMWIC-UHFFFAOYSA-N D06MRN DRUGSMIL CCCCCCCCN(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D06MRN HIGHSTAT Investigative D06MTX DRUG__ID D06MTX D06MTX DRUGTYPE Small molecular drug D06MTX DRUGINCH 1S/C14H12N4O/c15-13(16)8-5-6-10-11(7-8)18-14(17-10)9-3-1-2-4-12(9)19/h1-7,19H,(H3,15,16)(H,17,18) D06MTX DRUGINKE URJKRCBBKTXOHS-UHFFFAOYSA-N D06MTX DRUGSMIL C1=CC=C(C(=C1)C2=NC3=C(N2)C=C(C=C3)C(=N)N)O D06MTX HIGHSTAT Investigative D06MUA DRUG__ID D06MUA D06MUA DRUGTYPE Small molecular drug D06MUA DRUGINCH 1S/C7H6INO2/c8-6-3-1-5(2-4-6)7(10)9-11/h1-4,11H,(H,9,10) D06MUA DRUGINKE HXIKIQLHKIBCOH-UHFFFAOYSA-N D06MUA DRUGSMIL C1=CC(=CC=C1C(=O)NO)I D06MUA HIGHSTAT Investigative D06MUL DRUG__ID D06MUL D06MUL DRUGTYPE Small molecular drug D06MUL DRUGINCH 1S/C18H18N2S2/c21-18(22-13-14-6-2-1-3-7-14)19-11-10-16-12-15-8-4-5-9-17(15)20-16/h1-9,12,20H,10-11,13H2,(H,19,21) D06MUL DRUGINKE UDMBZULQHCKYPT-UHFFFAOYSA-N D06MUL DRUGSMIL C1=CC=C(C=C1)CSC(=S)NCCC2=CC3=CC=CC=C3N2 D06MUL HIGHSTAT Investigative D06MWG DRUG__ID D06MWG D06MWG DRUGTYPE Small molecular drug D06MWG DRUGINCH 1S/C35H43N5O5/c1-21-10-7-8-13-25(21)19-30(33(43)38-29(32(37)42)18-24-11-5-4-6-12-24)39-34(44)31-14-9-15-40(31)35(45)28(36)20-27-22(2)16-26(41)17-23(27)3/h4-8,10-13,16-17,28-31,41H,9,14-15,18-20,36H2,1-3H3,(H2,37,42)(H,38,43)(H,39,44)/t28-,29-,30-,31-/m0/s1 D06MWG DRUGINKE ILQNJTWDEDHFTC-ORYMTKCHSA-N D06MWG DRUGSMIL CC1=CC=CC=C1CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N D06MWG HIGHSTAT Investigative D06MYD DRUG__ID D06MYD D06MYD DRUGTYPE Small molecular drug D06MYD DRUGINCH 1S/C44H57N9O13S/c1-4-25(2)38(51-42(59)37(24-67)46-26(3)54)43(60)49-35(22-29-12-18-32(55)19-13-29)40(57)47-33(7-5-6-20-45)39(56)48-34(21-27-8-14-30(15-9-27)52(63)64)41(58)50-36(44(61)62)23-28-10-16-31(17-11-28)53(65)66/h8-19,25,33-38,55,67H,4-7,20-24,45H2,1-3H3,(H,46,54)(H,47,57)(H,48,56)(H,49,60)(H,50,58)(H,51,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D06MYD DRUGINKE YTKNXUJJRVGMTM-LBNFHWTGSA-N D06MYD DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)NC(CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)O)NC(=O)C(CS)NC(=O)C D06MYD HIGHSTAT Investigative D06MYN DRUG__ID D06MYN D06MYN DRUGTYPE Small molecular drug D06MYN DRUGINCH 1S/C24H26N2O3/c27-21-16-26(15-17-7-3-1-4-8-17)24(29)22(21)23(28)25-20-13-11-19(12-14-20)18-9-5-2-6-10-18/h1,3-4,7-8,11-14,18,27H,2,5-6,9-10,15-16H2,(H,25,28) D06MYN DRUGINKE JKRIQNNJCFTRAF-UHFFFAOYSA-N D06MYN DRUGSMIL C1CCC(CC1)C2=CC=C(C=C2)NC(=O)C3=C(CN(C3=O)CC4=CC=CC=C4)O D06MYN HIGHSTAT Investigative D06MYZ DRUG__ID D06MYZ D06MYZ DRUGTYPE Small molecular drug D06MYZ DRUGINCH 1S/C16H24N2OS/c19-16(7-4-12-20)17-15-8-10-18(11-9-15)13-14-5-2-1-3-6-14/h1-3,5-6,15,20H,4,7-13H2,(H,17,19) D06MYZ DRUGINKE XNIXPLIQGKQSIE-UHFFFAOYSA-N D06MYZ DRUGSMIL C1CN(CCC1NC(=O)CCCS)CC2=CC=CC=C2 D06MYZ HIGHSTAT Investigative D06MZB DRUG__ID D06MZB D06MZB DRUGTYPE Small molecular drug D06MZB DRUGINCH 1S/C34H39N3O6S/c1-21-13-15-24(16-14-21)43-19-28(39)35-26(17-22-9-5-4-6-10-22)30(40)33(42)37-20-44-34(2,3)31(37)32(41)36-29-25-12-8-7-11-23(25)18-27(29)38/h4-16,26-27,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t26-,27+,29-,30-,31+/m0/s1 D06MZB DRUGINKE CJVKWQTVDIZBSG-VFCPCCRCSA-N D06MZB DRUGSMIL CC1=CC=C(C=C1)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D06MZB HIGHSTAT Investigative D06MZK DRUG__ID D06MZK D06MZK DRUGTYPE Small molecular drug D06MZK DRUGINCH 1S/C14H22O/c1-13(2,3)10-8-7-9-11(12(10)15)14(4,5)6/h7-9,15H,1-6H3 D06MZK DRUGINKE DKCPKDPYUFEZCP-UHFFFAOYSA-N D06MZK DRUGSMIL CC(C)(C)C1=C(C(=CC=C1)C(C)(C)C)O D06MZK HIGHSTAT Investigative D06NAM DRUG__ID D06NAM D06NAM DRUGTYPE Small molecular drug D06NAM DRUGINCH 1S/C17H22O2/c1-10(2)14-6-5-11(3)7-15(14)17-12(4)8-13(18)9-16(17)19/h7-9,14-15,18-19H,1,5-6H2,2-4H3/t14-,15+/m0/s1 D06NAM DRUGINKE KDZOUSULXZNDJH-LSDHHAIUSA-N D06NAM DRUGSMIL CC1=CC(C(CC1)C(=C)C)C2=C(C=C(C=C2C)O)O D06NAM HIGHSTAT Investigative D06NCQ DRUG__ID D06NCQ D06NCQ DRUGTYPE Small molecular drug D06NCQ DRUGINCH 1S/C5H4N4O/c10-5-4-3(1-8-9-4)6-2-7-5/h2H,1H2,(H,6,7,10) D06NCQ DRUGINKE OGCXIHWGXUQTCQ-UHFFFAOYSA-N D06NCQ DRUGSMIL C1C2=C(C(=O)NC=N2)N=N1 D06NCQ HIGHSTAT Investigative D06NDR DRUG__ID D06NDR D06NDR DRUGTYPE Small molecular drug D06NDR DRUGINCH 1S/C13H19ClN2O3/c1-2-3-4-12(13(17)15-18)16-19-9-10-5-7-11(14)8-6-10/h5-8,12,16,18H,2-4,9H2,1H3,(H,15,17) D06NDR DRUGINKE SUZRJMQBDIHWSQ-UHFFFAOYSA-N D06NDR DRUGSMIL CCCCC(C(=O)NO)NOCC1=CC=C(C=C1)Cl D06NDR HIGHSTAT Investigative D06NDT DRUG__ID D06NDT D06NDT DRUGTYPE Small molecular drug D06NDT DRUGINCH 1S/C15H11NO2/c17-13-3-1-2-10(7-13)12-6-11-4-5-14(18)8-15(11)16-9-12/h1-9,17-18H D06NDT DRUGINKE DQXYHOHBSRRAIV-UHFFFAOYSA-N D06NDT DRUGSMIL C1=CC(=CC(=C1)O)C2=CN=C3C=C(C=CC3=C2)O D06NDT HIGHSTAT Investigative D06NEB DRUG__ID D06NEB D06NEB DRUGTYPE Small molecular drug D06NEB DRUGINCH 1S/C35H50N4O6S/c1-24(2)21-29(19-20-46(6,44)45)37-34(42)32(23-28-15-11-8-12-16-28)39-35(43)31(22-25(3)4)38-33(41)30(36-26(5)40)18-17-27-13-9-7-10-14-27/h7-16,19-20,24-25,29-32H,17-18,21-23H2,1-6H3,(H,36,40)(H,37,42)(H,38,41)(H,39,43)/b20-19+/t29-,30+,31+,32+/m1/s1 D06NEB DRUGINKE UIUWSHIRBDIYGM-QLEUBDALSA-N D06NEB DRUGSMIL CC(C)CC(C=CS(=O)(=O)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(CCC2=CC=CC=C2)NC(=O)C D06NEB HIGHSTAT Investigative D06NEW DRUG__ID D06NEW D06NEW DRUGTYPE Small molecular drug D06NEW DRUGINCH 1S/C33H37N3O7S/c1-33(2)30(31(41)35-28-24-11-7-6-10-21(24)17-26(28)38)36(19-44-33)32(42)29(40)25(16-20-8-4-3-5-9-20)34-27(39)18-43-23-14-12-22(37)13-15-23/h3-15,25-26,28-30,37-38,40H,16-19H2,1-2H3,(H,34,39)(H,35,41)/t25-,26+,28-,29-,30+/m0/s1 D06NEW DRUGINKE QQMINRBEIWYLOV-DOWNBTJOSA-N D06NEW DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=C(C=C3)O)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D06NEW HIGHSTAT Investigative D06NFC DRUG__ID D06NFC D06NFC DRUGTYPE Small molecular drug D06NFC DRUGINCH 1S/C16H13FN2/c17-15-8-6-13(7-9-15)11-19-12-18-10-16(19)14-4-2-1-3-5-14/h1-10,12H,11H2 D06NFC DRUGINKE OLGSJJAJXFNAKF-UHFFFAOYSA-N D06NFC DRUGSMIL C1=CC=C(C=C1)C2=CN=CN2CC3=CC=C(C=C3)F D06NFC HIGHSTAT Investigative D06NGA DRUG__ID D06NGA D06NGA DRUGTYPE Small molecular drug D06NGA DRUGINCH 1S/C8H8N2O3S/c11-8-6-10(14(12,13)9-8)7-4-2-1-3-5-7/h1-5H,6H2,(H,9,11) D06NGA DRUGINKE LDCZCUKQWRZSDT-UHFFFAOYSA-N D06NGA DRUGSMIL C1C(=O)NS(=O)(=O)N1C2=CC=CC=C2 D06NGA HIGHSTAT Investigative D06NGQ DRUG__ID D06NGQ D06NGQ DRUGTYPE Small molecular drug D06NGQ DRUGINCH 1S/C17H18N2O/c18-9-8-14-11-19-17-7-6-15(10-16(14)17)20-12-13-4-2-1-3-5-13/h1-7,10-11,19H,8-9,12,18H2 D06NGQ DRUGINKE WKPDXBXNJWWWGQ-UHFFFAOYSA-N D06NGQ DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3CCN D06NGQ HIGHSTAT Investigative D06NGR DRUG__ID D06NGR D06NGR DRUGTYPE Small molecular drug D06NGR DRUGINCH 1S/C21H29N10O17P3/c1-29-6-31(17-10(29)18(36)28-21(23)27-17)20-14(35)12(33)8(46-20)3-44-50(39,40)48-51(41,42)47-49(37,38)43-2-7-11(32)13(34)19(45-7)30-5-26-9-15(22)24-4-25-16(9)30/h4-8,11-14,19-20,32-35H,2-3H2,1H3,(H7-,22,23,24,25,27,28,36,37,38,39,40,41,42)/p+1/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1 D06NGR DRUGINKE QQOHNVHGNZYSBP-XPWFQUROSA-O D06NGR DRUGSMIL CN1C=[N+](C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O D06NGR HIGHSTAT Investigative D06NHI DRUG__ID D06NHI D06NHI DRUGTYPE Small molecular drug D06NHI DRUGINCH 1S/C21H24N2O5/c1-3-26-19(20(24)25)14-15-8-10-16(11-9-15)27-13-12-23(2)21-22-17-6-4-5-7-18(17)28-21/h4-11,19H,3,12-14H2,1-2H3,(H,24,25) D06NHI DRUGINKE FJENKDXEWRLENI-UHFFFAOYSA-N D06NHI DRUGSMIL CCOC(CC1=CC=C(C=C1)OCCN(C)C2=NC3=CC=CC=C3O2)C(=O)O D06NHI HIGHSTAT Investigative D06NHS DRUG__ID D06NHS D06NHS DRUGTYPE Small molecular drug D06NHS DRUGINCH 1S/C22H16ClFN6O/c1-22(8-13-9-25-11-26-10-13)16-6-14(15-2-4-18(24)17(23)7-15)3-5-19(16)30(20(22)31)21-27-12-28-29-21/h2-7,9-12H,8H2,1H3,(H,27,28,29) D06NHS DRUGINKE OABSWPUPIHULMQ-UHFFFAOYSA-N D06NHS DRUGSMIL CC1(C2=C(C=CC(=C2)C3=CC(=C(C=C3)F)Cl)N(C1=O)C4=NC=NN4)CC5=CN=CN=C5 D06NHS HIGHSTAT Investigative D06NIP DRUG__ID D06NIP D06NIP DRUGTYPE Small molecular drug D06NIP DRUGINCH 1S/C47H59N9O10/c1-3-4-15-38(45(64)54-36(25-41(59)60)43(62)53-35(42(49)61)23-28-11-6-5-7-12-28)55(2)47(66)37(24-30-26-50-34-14-9-8-13-32(30)34)52-40(58)27-51-44(63)39-16-10-21-56(39)46(65)33(48)22-29-17-19-31(57)20-18-29/h5-9,11-14,17-20,26,33,35-39,50,57H,3-4,10,15-16,21-25,27,48H2,1-2H3,(H2,49,61)(H,51,63)(H,52,58)(H,53,62)(H,54,64)(H,59,60)/t33-,35-,36-,37-,38-,39-/m0/s1 D06NIP DRUGINKE XMLJSDGQSNTHPG-WYLSNLDWSA-N D06NIP DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N D06NIP HIGHSTAT Investigative D06NIS DRUG__ID D06NIS D06NIS DRUGTYPE Small molecular drug D06NIS DRUGINCH 1S/C18H22O2/c19-18-11-9-17(10-12-18)13-15-20-14-5-4-8-16-6-2-1-3-7-16/h1-3,6-7,9-12,19H,4-5,8,13-15H2 D06NIS DRUGINKE FCGUGQUECVRUCX-UHFFFAOYSA-N D06NIS DRUGSMIL C1=CC=C(C=C1)CCCCOCCC2=CC=C(C=C2)O D06NIS HIGHSTAT Investigative D06NKJ DRUG__ID D06NKJ D06NKJ DRUGTYPE Small molecular drug D06NKJ DRUGINCH 1S/C15H12N2O2/c1-19-12-9-5-8-11-13(12)16-14(17-15(11)18)10-6-3-2-4-7-10/h2-9H,1H3,(H,16,17,18) D06NKJ DRUGINKE XMLHWESTKAFTNA-UHFFFAOYSA-N D06NKJ DRUGSMIL COC1=CC=CC2=C1N=C(NC2=O)C3=CC=CC=C3 D06NKJ HIGHSTAT Investigative D06NMP DRUG__ID D06NMP D06NMP DRUGTYPE Small molecular drug D06NMP DRUGINCH 1S/C21H25ClN2O3.ClH/c1-26-19-13-17(14-20(15-19)27-2)21(25)24-11-9-23(10-12-24)8-7-16-3-5-18(22)6-4-16;/h3-6,13-15H,7-12H2,1-2H3;1H D06NMP DRUGINKE OGLXGFIBROXFPU-UHFFFAOYSA-N D06NMP DRUGSMIL COC1=CC(=CC(=C1)C(=O)N2CCN(CC2)CCC3=CC=C(C=C3)Cl)OC.Cl D06NMP HIGHSTAT Investigative D06NOJ DRUG__ID D06NOJ D06NOJ DRUGTYPE Small molecular drug D06NOJ DRUGINCH 1S/C10H12N5O5PS.C6H15N/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7;1-4-7(5-2)6-3/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13);4-6H2,1-3H3/t4?,6-,7-,10?,21?;/m0./s1 D06NOJ DRUGINKE OXIPZMKSNMRTIV-NOFBKVLNSA-N D06NOJ DRUGSMIL CC[NH+](CC)CC.C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)[O-] D06NOJ HIGHSTAT Investigative D06NQD DRUG__ID D06NQD D06NQD DRUGTYPE Small molecular drug D06NQD DRUGINCH 1S/C19H15N3/c1-13-7-9-14(10-8-13)16-11-18(15-5-3-2-4-6-15)22-19(21)17(16)12-20/h2-11H,1H3,(H2,21,22) D06NQD DRUGINKE ADSZRHDJWBZORK-UHFFFAOYSA-N D06NQD DRUGSMIL CC1=CC=C(C=C1)C2=CC(=NC(=C2C#N)N)C3=CC=CC=C3 D06NQD HIGHSTAT Investigative D06NRU DRUG__ID D06NRU D06NRU DRUGTYPE Small molecular drug D06NRU DRUGINCH 1S/C13H12ClN/c14-13-8-4-3-7-12(13)11-6-2-1-5-10(11)9-15/h1-8H,9,15H2 D06NRU DRUGINKE CQHFRBPHEMVDPT-UHFFFAOYSA-N D06NRU DRUGSMIL C1=CC=C(C(=C1)CN)C2=CC=CC=C2Cl D06NRU HIGHSTAT Investigative D06NRX DRUG__ID D06NRX D06NRX DRUGTYPE Small molecular drug D06NRX DRUGINCH 1S/C16H18N6O4/c17-13-10-14(21-16(20-13)19-8-4-2-1-3-5-8)22(7-18-10)15-12(25)11(24)9(6-23)26-15/h1-5,7,9,11-12,15,23-25H,6H2,(H3,17,19,20,21)/t9-,11-,12-,15-/m1/s1 D06NRX DRUGINKE SCNILGOVBBRMBK-SDBHATRESA-N D06NRX DRUGSMIL C1=CC=C(C=C1)NC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D06NRX HIGHSTAT Investigative D06NRZ DRUG__ID D06NRZ D06NRZ DRUGTYPE Small molecular drug D06NRZ DRUGINCH 1S/C17H14O6/c1-21-14-8-13-15(16(20)17(14)22-2)11(19)7-12(23-13)9-3-5-10(18)6-4-9/h3-8,18,20H,1-2H3 D06NRZ DRUGINKE ZIIAJIWLQUVGHB-UHFFFAOYSA-N D06NRZ DRUGSMIL COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)O)O)OC D06NRZ HIGHSTAT Investigative D06NST DRUG__ID D06NST D06NST DRUGTYPE Small molecular drug D06NST DRUGINCH 1S/C18H25NO/c1-12-17-9-14-5-6-15(20)10-16(14)18(12,2)7-8-19(17)11-13-3-4-13/h5-6,10,12-13,17,20H,3-4,7-9,11H2,1-2H3 D06NST DRUGINKE YQYVFVRQLZMJKJ-UHFFFAOYSA-N D06NST DRUGSMIL CC1C2CC3=C(C1(CCN2CC4CC4)C)C=C(C=C3)O D06NST HIGHSTAT Investigative D06NTB DRUG__ID D06NTB D06NTB DRUGTYPE Small molecular drug D06NTB DRUGINCH 1S/C15H20N2/c1-12-6-8-17(9-7-12)11-13-10-16-15-5-3-2-4-14(13)15/h2-5,10,12,16H,6-9,11H2,1H3 D06NTB DRUGINKE DGCGMYNLCDVYMB-UHFFFAOYSA-N D06NTB DRUGSMIL CC1CCN(CC1)CC2=CNC3=CC=CC=C32 D06NTB HIGHSTAT Investigative D06NUL DRUG__ID D06NUL D06NUL DRUGTYPE Small molecular drug D06NUL DRUGINCH 1S/C19H15FN4O/c1-25-14-10-15(21)23-19-17(14)16(11-6-8-22-9-7-11)18(24-19)12-2-4-13(20)5-3-12/h2-10H,1H3,(H3,21,23,24) D06NUL DRUGINKE ADQZGIYHFQQPRB-UHFFFAOYSA-N D06NUL DRUGSMIL COC1=CC(=NC2=C1C(=C(N2)C3=CC=C(C=C3)F)C4=CC=NC=C4)N D06NUL HIGHSTAT Investigative D06NUU DRUG__ID D06NUU D06NUU DRUGTYPE Small molecular drug D06NUU DRUGINCH 1S/C32H34N2/c1-5-13-27(14-6-1)31(28-15-7-2-8-16-28)21-22-33-23-25-34(26-24-33)32(29-17-9-3-10-18-29)30-19-11-4-12-20-30/h1-20,31-32H,21-26H2 D06NUU DRUGINKE CLZJJBZJUIWHJT-UHFFFAOYSA-N D06NUU DRUGSMIL C1CN(CCN1CCC(C2=CC=CC=C2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=CC=CC=C5 D06NUU HIGHSTAT Investigative D06NVX DRUG__ID D06NVX D06NVX DRUGTYPE Small molecular drug D06NVX DRUGINCH 1S/C11H9NO2S/c13-11(12-14)10-7-6-9(15-10)8-4-2-1-3-5-8/h1-7,14H,(H,12,13) D06NVX DRUGINKE XIQUFDAAPVAKOR-UHFFFAOYSA-N D06NVX DRUGSMIL C1=CC=C(C=C1)C2=CC=C(S2)C(=O)NO D06NVX HIGHSTAT Investigative D06NXC DRUG__ID D06NXC D06NXC DRUGTYPE Small molecular drug D06NXC DRUGINCH 1S/C26H22Cl3F3N2O3/c1-25(2)12-20(33-22(36)11-21(35)26(30,31)32)18-10-17(13-3-5-14(27)6-4-13)23(34-24(18)37-25)16-8-7-15(28)9-19(16)29/h3-10,20-21,35H,11-12H2,1-2H3,(H,33,36) D06NXC DRUGINKE ONIULYGRFWGEHO-UHFFFAOYSA-N D06NXC DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)NC(=O)CC(C(F)(F)F)O)C D06NXC HIGHSTAT Investigative D06NXK DRUG__ID D06NXK D06NXK DRUGTYPE Small molecular drug D06NXK DRUGINCH 1S/C16H20N2/c1-13-4-3-10-18(13)11-8-14-6-7-16-15(12-14)5-2-9-17-16/h2,5-7,9,12-13H,3-4,8,10-11H2,1H3/t13-/m1/s1 D06NXK DRUGINKE HUQYUKHHFHNJRR-CYBMUJFWSA-N D06NXK DRUGSMIL CC1CCCN1CCC2=CC3=C(C=C2)N=CC=C3 D06NXK HIGHSTAT Investigative D06NYB DRUG__ID D06NYB D06NYB DRUGTYPE Small molecular drug D06NYB DRUGINCH 1S/C8H4Cl2N2O2/c9-3-1-4(10)6-5(2-3)11-7(13)8(14)12-6/h1-2H,(H,11,13)(H,12,14) D06NYB DRUGINKE DBSHFABBWSZJLZ-UHFFFAOYSA-N D06NYB DRUGSMIL C1=C(C=C(C2=C1NC(=O)C(=O)N2)Cl)Cl D06NYB HIGHSTAT Investigative D06OAH DRUG__ID D06OAH D06OAH DRUGTYPE Small molecular drug D06OAH DRUGINCH 1S/C16H10BrN3O2/c17-8-5-6-9-12(7-8)19-16(21)13(9)15-14(20-22)10-3-1-2-4-11(10)18-15/h1-7,18-19,21H D06OAH DRUGINKE SAQUSDSPQYQNBG-UHFFFAOYSA-N D06OAH DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C(NC4=C3C=CC(=C4)Br)O)N=O D06OAH HIGHSTAT Investigative D06OAL DRUG__ID D06OAL D06OAL DRUGTYPE Small molecular drug D06OAL DRUGINCH 1S/C15H13NO3/c1-2-9-7-12(18)8-13-14(9)19-15(16-13)10-3-5-11(17)6-4-10/h3-8,17-18H,2H2,1H3 D06OAL DRUGINKE PRIKKCCDYUBJIV-UHFFFAOYSA-N D06OAL DRUGSMIL CCC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D06OAL HIGHSTAT Investigative D06OBP DRUG__ID D06OBP D06OBP DRUGTYPE Small molecular drug D06OBP DRUGINCH 1S/C9H19NO/c10-9(7-11)6-8-4-2-1-3-5-8/h8-9,11H,1-7,10H2/t9-/m0/s1 D06OBP DRUGINKE QWDRYURVUDZKSG-VIFPVBQESA-N D06OBP DRUGSMIL C1CCC(CC1)CC(CO)N D06OBP HIGHSTAT Investigative D06OBX DRUG__ID D06OBX D06OBX DRUGTYPE Small molecular drug D06OBX DRUGINCH 1S/C19H28O6/c1-10(2)16(20)24-14-9-18(5)6-7-19(22,25-18)11(3)8-13-15(14)12(4)17(21)23-13/h10-11,13-15,22H,4,6-9H2,1-3,5H3/t11-,13+,14+,15-,18-,19+/m0/s1 D06OBX DRUGINKE VKWNXJLVNFOOOS-QNIDSSLUSA-N D06OBX DRUGSMIL CC1CC2C(C(CC3(CCC1(O3)O)C)OC(=O)C(C)C)C(=C)C(=O)O2 D06OBX HIGHSTAT Investigative D06OFY DRUG__ID D06OFY D06OFY DRUGTYPE Small molecular drug D06OFY DRUGINCH 1S/C19H24N2O3/c22-17(23)8-12-1-3-16(4-2-12)20-18(24)21-19-9-13-5-14(10-19)7-15(6-13)11-19/h1-4,13-15H,5-11H2,(H,22,23)(H2,20,21,24) D06OFY DRUGINKE QDEKKGRIPYLLDK-UHFFFAOYSA-N D06OFY DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=C(C=C4)CC(=O)O D06OFY HIGHSTAT Investigative D06OGZ DRUG__ID D06OGZ D06OGZ DRUGTYPE Small molecular drug D06OGZ DRUGINCH 1S/C14H16N2O4S2/c1-8-7-22-13(16-12(8)14(19)20)10(6-17)15-11(18)5-9-3-2-4-21-9/h2-4,6,10,13,16H,5,7H2,1H3,(H,15,18)(H,19,20)/t10-,13-/m1/s1 D06OGZ DRUGINKE SFVACKBZMIZHCK-ZWNOBZJWSA-N D06OGZ DRUGSMIL CC1=C(NC(SC1)C(C=O)NC(=O)CC2=CC=CS2)C(=O)O D06OGZ HIGHSTAT Investigative D06OIU DRUG__ID D06OIU D06OIU DRUGTYPE Small molecular drug D06OIU DRUGINCH 1S/C15H23NO/c1-2-16-11-7-6-10-15(16)14(12-17)13-8-4-3-5-9-13/h3-5,8-9,14-15,17H,2,6-7,10-12H2,1H3/t14-,15-/m1/s1 D06OIU DRUGINKE BHAGCFGXKSMVPG-HUUCEWRRSA-N D06OIU DRUGSMIL CCN1CCCCC1C(CO)C2=CC=CC=C2 D06OIU HIGHSTAT Investigative D06OJI DRUG__ID D06OJI D06OJI DRUGTYPE Small molecular drug D06OJI DRUGINCH 1S/C10H14BrNO2/c1-6(12)3-7-4-10(14-2)8(11)5-9(7)13/h4-6,13H,3,12H2,1-2H3 D06OJI DRUGINKE YMEPEWSDHUFKSX-UHFFFAOYSA-N D06OJI DRUGSMIL CC(CC1=CC(=C(C=C1O)Br)OC)N D06OJI HIGHSTAT Investigative D06OKE DRUG__ID D06OKE D06OKE DRUGTYPE Small molecular drug D06OKE DRUGINCH 1S/C19H26N2O2/c1-20-18(22)23-14-7-6-13-11-17-15-5-3-4-8-19(15,16(13)12-14)9-10-21(17)2/h6-7,12,15,17H,3-5,8-11H2,1-2H3,(H,20,22) D06OKE DRUGINKE YJGQAUOQIDQXIT-UHFFFAOYSA-N D06OKE DRUGSMIL CNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3C)C=C1 D06OKE HIGHSTAT Investigative D06OLJ DRUG__ID D06OLJ D06OLJ DRUGTYPE Small molecular drug D06OLJ DRUGINCH 1S/C15H10BrCl4NOS/c16-10-3-1-9(2-4-10)13(22)21-14(15(18,19)20)23-12-7-5-11(17)6-8-12/h1-8,14H,(H,21,22) D06OLJ DRUGINKE APLQHKFABMHWHP-UHFFFAOYSA-N D06OLJ DRUGSMIL C1=CC(=CC=C1C(=O)NC(C(Cl)(Cl)Cl)SC2=CC=C(C=C2)Cl)Br D06OLJ HIGHSTAT Investigative D06OMD DRUG__ID D06OMD D06OMD DRUGTYPE Small molecular drug D06OMD DRUGINCH 1S/C15H13N3O/c1-10-3-4-11-5-6-12(9-13(11)17-10)15-16-8-7-14(18-15)19-2/h3-9H,1-2H3 D06OMD DRUGINKE RMLLQYDXXOIJNH-UHFFFAOYSA-N D06OMD DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=NC=CC(=N3)OC D06OMD HIGHSTAT Investigative D06ORM DRUG__ID D06ORM D06ORM DRUGTYPE Small molecular drug D06ORM DRUGINCH 1S/C25H25N5O3/c1-28(2)25-27-22-11-7-6-10-21(22)23(29(25)19-8-4-3-5-9-19)16-24(31)26-17-18-12-14-20(15-13-18)30(32)33/h3-15,23H,16-17H2,1-2H3,(H,26,31) D06ORM DRUGINKE HCOLRSVHDDZVKO-UHFFFAOYSA-N D06ORM DRUGSMIL CN(C)C1=NC2=CC=CC=C2C(N1C3=CC=CC=C3)CC(=O)NCC4=CC=C(C=C4)[N+](=O)[O-] D06ORM HIGHSTAT Investigative D06ORV DRUG__ID D06ORV D06ORV DRUGTYPE Small molecular drug D06ORV DRUGINCH 1S/C8H11BO2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-5,10-11H,6-7H2 D06ORV DRUGINKE VPRUMANMDWQMNF-UHFFFAOYSA-N D06ORV DRUGSMIL B(CCC1=CC=CC=C1)(O)O D06ORV HIGHSTAT Investigative D06OSB DRUG__ID D06OSB D06OSB DRUGTYPE Small molecular drug D06OSB DRUGINCH 1S/C15H17NO3/c1-4-10-5-6-13-11(7-10)14(17)12(8-16-13)15(18)19-9(2)3/h5-9H,4H2,1-3H3,(H,16,17) D06OSB DRUGINKE XGNSUAGLUGPMKD-UHFFFAOYSA-N D06OSB DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OC(C)C D06OSB HIGHSTAT Investigative D06OUR DRUG__ID D06OUR D06OUR DRUGTYPE Small molecular drug D06OUR DRUGINCH 1S/C16H22N2O/c1-3-18(4-2)12-11-17-15-9-10-16(19)14-8-6-5-7-13(14)15/h5-10,17,19H,3-4,11-12H2,1-2H3 D06OUR DRUGINKE LVUBFHBEMVTCJQ-UHFFFAOYSA-N D06OUR DRUGSMIL CCN(CC)CCNC1=CC=C(C2=CC=CC=C21)O D06OUR HIGHSTAT Investigative D06OVA DRUG__ID D06OVA D06OVA DRUGTYPE Small molecular drug D06OVA DRUGINCH 1S/C12H15NO4S/c1-2-3-4-9-17-12(14)10-5-7-11(8-6-10)18(13,15)16/h2,5-8H,1,3-4,9H2,(H2,13,15,16) D06OVA DRUGINKE IEMQKTRDDVFPKZ-UHFFFAOYSA-N D06OVA DRUGSMIL C=CCCCOC(=O)C1=CC=C(C=C1)S(=O)(=O)N D06OVA HIGHSTAT Investigative D06OVX DRUG__ID D06OVX D06OVX DRUGTYPE Small molecular drug D06OVX DRUGINCH 1S/C27H46O2/c1-18(7-6-14-25(2,3)29)22-10-11-23-21-9-8-19-17-20(28)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1 D06OVX DRUGINKE INBGSXNNRGWLJU-ZHHJOTBYSA-N D06OVX DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C D06OVX HIGHSTAT Investigative D06OWM DRUG__ID D06OWM D06OWM DRUGTYPE Small molecular drug D06OWM DRUGINCH 1S/C21H15N5O4/c22-11-15-7-4-8-16(9-15)25-20(29)24-13-17(27)10-18(26(24)21(25)30)19(28)23-12-14-5-2-1-3-6-14/h1-10H,12-13H2,(H,23,28) D06OWM DRUGINKE UPQJVNPKWQFAKQ-UHFFFAOYSA-N D06OWM DRUGSMIL C1C(=O)C=C(N2N1C(=O)N(C2=O)C3=CC=CC(=C3)C#N)C(=O)NCC4=CC=CC=C4 D06OWM HIGHSTAT Investigative D06OWS DRUG__ID D06OWS D06OWS DRUGTYPE Small molecular drug D06OWS DRUGINCH 1S/C27H23N3O3/c1-30(18-19-3-2-4-24(17-19)22-13-15-29-16-14-22)27(32)33-25-11-9-21(10-12-25)20-5-7-23(8-6-20)26(28)31/h2-17H,18H2,1H3,(H2,28,31) D06OWS DRUGINKE QTWNORFUQILKJL-UHFFFAOYSA-N D06OWS DRUGSMIL CN(CC1=CC(=CC=C1)C2=CC=NC=C2)C(=O)OC3=CC=C(C=C3)C4=CC=C(C=C4)C(=O)N D06OWS HIGHSTAT Investigative D06OXA DRUG__ID D06OXA D06OXA DRUGTYPE Small molecular drug D06OXA DRUGINCH 1S/C23H43NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-20(25)22(27)24-19-18-21(26)28-23(2,3)4/h5-19H2,1-4H3,(H,24,27) D06OXA DRUGINKE WSQKSMQAQMMUAU-UHFFFAOYSA-N D06OXA DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCC(=O)OC(C)(C)C D06OXA HIGHSTAT Investigative D06PAA DRUG__ID D06PAA D06PAA DRUGTYPE Small molecular drug D06PAA DRUGINCH 1S/C13H15N3S2/c1-10-2-4-11(5-3-10)6-7-14-12(17)16-13-15-8-9-18-13/h2-5,8-9H,6-7H2,1H3,(H2,14,15,16,17) D06PAA DRUGINKE SIJMMWOYIWBAFY-UHFFFAOYSA-N D06PAA DRUGSMIL CC1=CC=C(C=C1)CCNC(=S)NC2=NC=CS2 D06PAA HIGHSTAT Investigative D06PAK DRUG__ID D06PAK D06PAK DRUGTYPE Small molecular drug D06PAK DRUGINCH 1S/C7H9NO4S/c8-7(6(11)12)1-13-4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3?,4?,7+/m1/s1 D06PAK DRUGINKE QBHIOYZCUZBIEN-RSWQVWFLSA-N D06PAK DRUGSMIL C1C(C2C(C2S1)C(=O)O)(C(=O)O)N D06PAK HIGHSTAT Investigative D06PCE DRUG__ID D06PCE D06PCE DRUGTYPE Small molecular drug D06PCE DRUGINCH 1S/C18H32N2O15/c21-1-4-14(9(26)11(28)16(19-4)20-31)34-18-13(30)10(27)15(6(3-23)33-18)35-17-12(29)8(25)7(24)5(2-22)32-17/h4-15,17-18,21-31H,1-3H2,(H,19,20)/t4-,5+,6-,7+,8-,9-,10-,11+,12+,13-,14+,15-,17-,18+/m1/s1 D06PCE DRUGINKE AHRWQUNEPBVNOT-JUQSOTOUSA-N D06PCE DRUGSMIL C(C1C(C(C(C(=N1)NO)O)O)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)O)O)O)O)O D06PCE HIGHSTAT Investigative D06PFL DRUG__ID D06PFL D06PFL DRUGTYPE Small molecular drug D06PFL DRUGINCH 1S/C6H10N2/c1-5-2-3-8-6(7)4-5/h2H,3-4H2,1H3,(H2,7,8) D06PFL DRUGINKE ZOKOWWYVKANQNJ-UHFFFAOYSA-N D06PFL DRUGSMIL CC1=CCN=C(C1)N D06PFL HIGHSTAT Investigative D06PHE DRUG__ID D06PHE D06PHE DRUGTYPE Small molecular drug D06PHE DRUGINCH 1S/C11H14NO5P/c12-11(10(13)14,7-1-2-7)8-3-5-9(6-4-8)18(15,16)17/h3-7H,1-2,12H2,(H,13,14)(H2,15,16,17) D06PHE DRUGINKE IGODGTDUQSMDQU-UHFFFAOYSA-N D06PHE DRUGSMIL C1CC1C(C2=CC=C(C=C2)P(=O)(O)O)(C(=O)O)N D06PHE HIGHSTAT Investigative D06PHT DRUG__ID D06PHT D06PHT DRUGTYPE Small molecular drug D06PHT DRUGINCH 1S/C24H25NO/c26-24(22-14-8-3-9-15-22)16-18-25(19-17-24)23(20-10-4-1-5-11-20)21-12-6-2-7-13-21/h1-15,23,26H,16-19H2 D06PHT DRUGINKE PMLFKOKTRMHUPA-UHFFFAOYSA-N D06PHT DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D06PHT HIGHSTAT Investigative D06PIW DRUG__ID D06PIW D06PIW DRUGTYPE Small molecular drug D06PIW DRUGINCH 1S/C18H26N3O15P3/c22-15-13(11-33-38(28,29)36-39(30,31)35-37(25,26)27)34-17(16(15)23)21-9-8-14(19-18(21)24)20-32-10-4-7-12-5-2-1-3-6-12/h1-3,5-6,8-9,13,15-17,22-23H,4,7,10-11H2,(H,28,29)(H,30,31)(H,19,20,24)(H2,25,26,27)/t13-,15-,16-,17-/m1/s1 D06PIW DRUGINKE FAYLMQPZASAIOS-MWQQHZPXSA-N D06PIW DRUGSMIL C1=CC=C(C=C1)CCCONC2=NC(=O)N(C=C2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D06PIW HIGHSTAT Investigative D06PJD DRUG__ID D06PJD D06PJD DRUGTYPE Small molecular drug D06PJD DRUGINCH 1S/C18H20N2/c1-19-13-11-18(15-7-3-2-4-8-15)20-14-12-16-9-5-6-10-17(16)20/h2-10,12,14,18-19H,11,13H2,1H3 D06PJD DRUGINKE VDFAJYFMKVKZLC-UHFFFAOYSA-N D06PJD DRUGSMIL CNCCC(C1=CC=CC=C1)N2C=CC3=CC=CC=C32 D06PJD HIGHSTAT Investigative D06PJW DRUG__ID D06PJW D06PJW DRUGTYPE Small molecular drug D06PJW DRUGINCH 1S/C27H29FN8O3/c1-29-26(38)23-17(28)6-5-7-18(23)31-25-16-8-10-30-24(16)33-27(34-25)32-19-13-20-15(12-21(19)39-4)9-11-36(20)22(37)14-35(2)3/h5-8,10,12-13H,9,11,14H2,1-4H3,(H,29,38)(H3,30,31,32,33,34) D06PJW DRUGINKE HZTYDQRUAWIZRE-UHFFFAOYSA-N D06PJW DRUGSMIL CNC(=O)C1=C(C=CC=C1F)NC2=NC(=NC3=C2C=CN3)NC4=C(C=C5CCN(C5=C4)C(=O)CN(C)C)OC D06PJW HIGHSTAT Investigative D06PKJ DRUG__ID D06PKJ D06PKJ DRUGTYPE Small molecular drug D06PKJ DRUGINCH 1S/C11H17NO2/c1-8(12)6-9-7-10(13-2)4-5-11(9)14-3/h4-5,7-8H,6,12H2,1-3H3 D06PKJ DRUGINKE LATVFYDIBMDBSY-UHFFFAOYSA-N D06PKJ DRUGSMIL CC(CC1=C(C=CC(=C1)OC)OC)N D06PKJ HIGHSTAT Investigative D06PMR DRUG__ID D06PMR D06PMR DRUGTYPE Small molecular drug D06PMR DRUGINCH 1S/C21H24BrNO2/c1-23-14-21(24,25-20-5-3-2-4-19(20)23)17-10-6-15(7-11-17)16-8-12-18(22)13-9-16/h6-13,19-20,24H,2-5,14H2,1H3 D06PMR DRUGINKE CFDRWKHPJHJISG-UHFFFAOYSA-N D06PMR DRUGSMIL CN1CC(OC2C1CCCC2)(C3=CC=C(C=C3)C4=CC=C(C=C4)Br)O D06PMR HIGHSTAT Investigative D06PNU DRUG__ID D06PNU D06PNU DRUGTYPE Small molecular drug D06PNU DRUGINCH 1S/C39H46N8O4/c1-42-35(48)33(22-26-17-18-27-12-5-6-13-28(27)20-26)46-36(49)31(16-9-19-43-39(40)41)45-38(51)34(21-25-10-3-2-4-11-25)47-37(50)32-23-29-14-7-8-15-30(29)24-44-32/h2-8,10-15,17-18,20,31-34,44H,9,16,19,21-24H2,1H3,(H,42,48)(H,45,51)(H,46,49)(H,47,50)(H4,40,41,43)/t31-,32-,33-,34+/m0/s1 D06PNU DRUGINKE MCHDZFRIUNRJGL-GZXHTMMISA-N D06PNU DRUGSMIL CNC(=O)C(CC1=CC2=CC=CC=C2C=C1)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C4CC5=CC=CC=C5CN4 D06PNU HIGHSTAT Investigative D06PRC DRUG__ID D06PRC D06PRC DRUGTYPE Small molecular drug D06PRC DRUGINCH 1S/C24H26O6/c1-12(2)6-8-14-16(25)10-19-21(22(14)27)23(28)20-15(9-7-13(3)4)24(29-5)17(26)11-18(20)30-19/h6-7,10-11,25-27H,8-9H2,1-5H3 D06PRC DRUGINKE GNRIZKKCNOBBMO-UHFFFAOYSA-N D06PRC DRUGSMIL CC(=CCC1=C(C2=C(C=C1O)OC3=C(C2=O)C(=C(C(=C3)O)OC)CC=C(C)C)O)C D06PRC HIGHSTAT Investigative D06PRV DRUG__ID D06PRV D06PRV DRUGTYPE Small molecular drug D06PRV DRUGINCH 1S/C14H10ClNS/c1-10-4-2-3-5-13(10)17-14-7-6-11(9-16)8-12(14)15/h2-8H,1H3 D06PRV DRUGINKE XNDBEERQWNGTKH-UHFFFAOYSA-N D06PRV DRUGSMIL CC1=CC=CC=C1SC2=C(C=C(C=C2)C#N)Cl D06PRV HIGHSTAT Investigative D06PTC DRUG__ID D06PTC D06PTC DRUGTYPE Small molecular drug D06PTC DRUGINCH 1S/C17H17N/c1-15-9-8-14-17(18-15)13-7-3-6-12-16-10-4-2-5-11-16/h2,4-5,8-11,14H,3,6,12H2,1H3 D06PTC DRUGINKE NJJSTWRJIALOHE-UHFFFAOYSA-N D06PTC DRUGSMIL CC1=NC(=CC=C1)C#CCCCC2=CC=CC=C2 D06PTC HIGHSTAT Investigative D06PUS DRUG__ID D06PUS D06PUS DRUGTYPE Small molecular drug D06PUS DRUGINCH 1S/C14H9BrN2OS/c15-10-6-2-4-8-12(10)17-13(18)9-5-1-3-7-11(9)16-14(17)19/h1-8H,(H,16,19) D06PUS DRUGINKE FHKTYFZUNGXFGS-UHFFFAOYSA-N D06PUS DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C(=S)N2)C3=CC=CC=C3Br D06PUS HIGHSTAT Investigative D06PVF DRUG__ID D06PVF D06PVF DRUGTYPE Small molecular drug D06PVF DRUGINCH 1S/C16H34O5/c1-2-3-4-5-6-7-9-18-11-13-20-15-16-21-14-12-19-10-8-17/h17H,2-16H2,1H3 D06PVF DRUGINKE FEOZZFHAVXYAMB-UHFFFAOYSA-N D06PVF DRUGSMIL CCCCCCCCOCCOCCOCCOCCO D06PVF HIGHSTAT Investigative D06PVO DRUG__ID D06PVO D06PVO DRUGTYPE Small molecular drug D06PVO DRUGINCH 1S/C20H25NO/c1-2-19(17-9-5-3-6-10-17)21-15-13-20(22,14-16-21)18-11-7-4-8-12-18/h3-12,19,22H,2,13-16H2,1H3 D06PVO DRUGINKE YUOJNJIUXXIUHY-UHFFFAOYSA-N D06PVO DRUGSMIL CCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D06PVO HIGHSTAT Investigative D06PWI DRUG__ID D06PWI D06PWI DRUGTYPE Small molecular drug D06PWI DRUGINCH 1S/C15H17FN6O2S/c1-15(2,3)21-25(23,24)11-4-9(6-18-7-11)10-5-12(16)13-19-14(17)20-22(13)8-10/h4-8,21H,1-3H3,(H2,17,20) D06PWI DRUGINKE RXRZPHQBTHQXSV-UHFFFAOYSA-N D06PWI DRUGSMIL CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3C(=NC(=N3)N)C(=C2)F D06PWI HIGHSTAT Investigative D06PWM DRUG__ID D06PWM D06PWM DRUGTYPE Small molecular drug D06PWM DRUGINCH 1S/C14H20O2/c1-9(2)12-7-6-8-13(10(3)4)14(12)16-11(5)15/h6-10H,1-5H3 D06PWM DRUGINKE UVYYQAXNOURFPH-UHFFFAOYSA-N D06PWM DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)OC(=O)C D06PWM HIGHSTAT Investigative D06PWQ DRUG__ID D06PWQ D06PWQ DRUGTYPE Small molecular drug D06PWQ DRUGINCH 1S/C5H10N2O3/c1-7(3-5(9)10)4(8)2-6/h2-3,6H2,1H3,(H,9,10)/i4+2 D06PWQ DRUGINKE VYAMLSCELQQRAE-DOMIDYPGSA-N D06PWQ DRUGSMIL CN(CC(=O)O)C(=O)CN D06PWQ HIGHSTAT Investigative D06PXR DRUG__ID D06PXR D06PXR DRUGTYPE Small molecular drug D06PXR DRUGINCH 1S/C16H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h16H,2-15H2,1H3 D06PXR DRUGINKE NIOYUNMRJMEDGI-UHFFFAOYSA-N D06PXR DRUGSMIL CCCCCCCCCCCCCCCC=O D06PXR HIGHSTAT Investigative D06PXY DRUG__ID D06PXY D06PXY DRUGTYPE Small molecular drug D06PXY DRUGINCH 1S/C32H41N5O5/c1-17(2)12-25-29(39)36-11-7-10-26(36)32(41)37(25)30(40)31(42-32,18(3)4)34-28(38)20-13-22-21-8-6-9-23-27(21)19(15-33-23)14-24(22)35(5)16-20/h6,8-9,13,15,17-18,20,24-26,33,41H,7,10-12,14,16H2,1-5H3,(H,34,38)/t20-,24-,25+,26+,31-,32+/m1/s1 D06PXY DRUGINKE YDOTUXAWKBPQJW-NSLWYYNWSA-N D06PXY DRUGSMIL CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=CNC7=CC=CC(=C67)C5=C4)C)O D06PXY HIGHSTAT Investigative D06PYV DRUG__ID D06PYV D06PYV DRUGTYPE Small molecular drug D06PYV DRUGINCH 1S/C17H14N2O2/c1-10-5-4-6-11(9-10)19-15-14(18)16(20)12-7-2-3-8-13(12)17(15)21/h2-9,19H,18H2,1H3 D06PYV DRUGINKE REWOWOXSGLQOHC-UHFFFAOYSA-N D06PYV DRUGSMIL CC1=CC(=CC=C1)NC2=C(C(=O)C3=CC=CC=C3C2=O)N D06PYV HIGHSTAT Investigative D06PZE DRUG__ID D06PZE D06PZE DRUGTYPE Small molecular drug D06PZE DRUGINCH 1S/C16H12O7/c1-22-11-3-2-7(4-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3 D06PZE DRUGINKE FPLMIPQZHHQWHN-UHFFFAOYSA-N D06PZE DRUGSMIL COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O D06PZE HIGHSTAT Investigative D06PZK DRUG__ID D06PZK D06PZK DRUGTYPE Small molecular drug D06PZK DRUGINCH 1S/C17H21N2.HI/c1-4-19-14-6-5-7-17(19)13-10-15-8-11-16(12-9-15)18(2)3;/h5-14H,4H2,1-3H3;1H/q+1;/p-1 D06PZK DRUGINKE AMAXNNVXIBDEMV-UHFFFAOYSA-M D06PZK DRUGSMIL CC[N+]1=CC=CC=C1C=CC2=CC=C(C=C2)N(C)C.[I-] D06PZK HIGHSTAT Investigative D06PZU DRUG__ID D06PZU D06PZU DRUGTYPE Small molecular drug D06PZU DRUGINCH 1S/C16H13NO2/c1-10-6-7-15-12(8-10)14(18)9-16(19-15)11-4-2-3-5-13(11)17/h2-9H,17H2,1H3 D06PZU DRUGINKE FGXFHSSFMRVHFP-UHFFFAOYSA-N D06PZU DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3N D06PZU HIGHSTAT Investigative D06PZZ DRUG__ID D06PZZ D06PZZ DRUGTYPE Small molecular drug D06PZZ DRUGINCH 1S/C8H20N/c1-5-9(6-2,7-3)8-4/h5-8H2,1-4H3/q+1 D06PZZ DRUGINKE CBXCPBUEXACCNR-UHFFFAOYSA-N D06PZZ DRUGSMIL CC[N+](CC)(CC)CC D06PZZ HIGHSTAT Investigative D06QBJ DRUG__ID D06QBJ D06QBJ DRUGTYPE Small molecular drug D06QBJ DRUGINCH 1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1 D06QBJ DRUGINKE CMWRPDHVGMHLSZ-GFCCVEGCSA-N D06QBJ DRUGSMIL CC1CNC2=C(C(=O)N1)SC3=C2C4=C(C=C3)N=C(C=C4)C5=CN=C(C=C5)C D06QBJ HIGHSTAT Investigative D06QBK DRUG__ID D06QBK D06QBK DRUGTYPE Small molecular drug D06QBK DRUGINCH 1S/C38H49N5O6S/c1-23-17-27(40-16-15-39-5)18-24(2)34(23)49-21-31(45)41-29(19-25-11-7-6-8-12-25)33(46)37(48)43-22-50-38(3,4)35(43)36(47)42-32-28-14-10-9-13-26(28)20-30(32)44/h6-14,17-18,29-30,32-33,35,39-40,44,46H,15-16,19-22H2,1-5H3,(H,41,45)(H,42,47)/t29-,30+,32-,33-,35+/m0/s1 D06QBK DRUGINKE MGDBCLMLZKHXCE-WLYLRDIASA-N D06QBK DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NCCNC D06QBK HIGHSTAT Investigative D06QDX DRUG__ID D06QDX D06QDX DRUGTYPE Small molecular drug D06QDX DRUGINCH 1S/C45H52N6O10/c1-26(52)39(43(57)51-21-5-8-38(51)42(56)49-37(45(60)61)25-27-6-3-2-4-7-27)50-41(55)36(24-30-13-19-33(53)20-14-30)48-40(54)34(46)22-28-9-15-31(16-10-28)32-17-11-29(12-18-32)23-35(47)44(58)59/h2-4,6-7,9-20,26,34-39,52-53H,5,8,21-25,46-47H2,1H3,(H,48,54)(H,49,56)(H,50,55)(H,58,59)(H,60,61)/t26-,34+,35+,36+,37+,38?,39+/m1/s1 D06QDX DRUGINKE WOXOMROGQFUOGC-DWIRJLQSSA-N D06QDX DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=C(C=C4)C5=CC=C(C=C5)CC(C(=O)O)N)N)O D06QDX HIGHSTAT Investigative D06QEN DRUG__ID D06QEN D06QEN DRUGTYPE Small molecular drug D06QEN DRUGINCH 1S/C11H11N5/c1-16-5-4-6-8(16)3-2-7-9(6)10(12)15-11(13)14-7/h2-5H,1H3,(H4,12,13,14,15) D06QEN DRUGINKE WSISEVQVCUARDZ-UHFFFAOYSA-N D06QEN DRUGSMIL CN1C=CC2=C1C=CC3=C2C(=NC(=N3)N)N D06QEN HIGHSTAT Investigative D06QER DRUG__ID D06QER D06QER DRUGTYPE Small molecular drug D06QER DRUGINCH 1S/C23H30N2O3/c1-2-3-4-5-6-7-11-18-27-22-16-14-21(15-17-22)25-23(26)28-24-19-20-12-9-8-10-13-20/h8-10,12-17,19H,2-7,11,18H2,1H3,(H,25,26)/b24-19+ D06QER DRUGINKE GOOXRXVIMOMQCL-LYBHJNIJSA-N D06QER DRUGSMIL CCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D06QER HIGHSTAT Investigative D06QFO DRUG__ID D06QFO D06QFO DRUGTYPE Small molecular drug D06QFO DRUGINCH 1S/C10H10N2O/c11-6-9-3-4-10(13-9)8-2-1-5-12-7-8/h1-5,7H,6,11H2 D06QFO DRUGINKE LENAVORGWBTPJR-UHFFFAOYSA-N D06QFO DRUGSMIL C1=CC(=CN=C1)C2=CC=C(O2)CN D06QFO HIGHSTAT Investigative D06QGD DRUG__ID D06QGD D06QGD DRUGTYPE Small molecular drug D06QGD DRUGINCH 1S/C15H20N2O3/c1-2-5-14(16-10-3-4-11-16)15(18)12-6-8-13(9-7-12)17(19)20/h6-9,14H,2-5,10-11H2,1H3 D06QGD DRUGINKE NAHZCGQMXZCULW-UHFFFAOYSA-N D06QGD DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)[N+](=O)[O-])N2CCCC2 D06QGD HIGHSTAT Investigative D06QGJ DRUG__ID D06QGJ D06QGJ DRUGTYPE Small molecular drug D06QGJ DRUGINCH 1S/C19H22N2O2/c20-19(22)16-7-4-8-18(13-16)23-17-9-11-21(12-10-17)14-15-5-2-1-3-6-15/h1-8,13,17H,9-12,14H2,(H2,20,22) D06QGJ DRUGINKE IDSIUINGWBNUFD-UHFFFAOYSA-N D06QGJ DRUGSMIL C1CN(CCC1OC2=CC=CC(=C2)C(=O)N)CC3=CC=CC=C3 D06QGJ HIGHSTAT Investigative D06QID DRUG__ID D06QID D06QID DRUGTYPE Small molecular drug D06QID DRUGINCH 1S/C17H10Cl2N4/c18-12-5-1-10(2-6-12)14-15-17(21-9-20-15)23-16(22-14)11-3-7-13(19)8-4-11/h1-9H,(H,20,21,22,23) D06QID DRUGINKE WDBFJNSPOHEOFN-UHFFFAOYSA-N D06QID DRUGSMIL C1=CC(=CC=C1C2=C3C(=NC(=N2)C4=CC=C(C=C4)Cl)N=CN3)Cl D06QID HIGHSTAT Investigative D06QIQ DRUG__ID D06QIQ D06QIQ DRUGTYPE Small molecular drug D06QIQ DRUGINCH 1S/C17H18N2O/c18-11-14-1-2-15-3-4-17(10-16(15)9-14)20-12-13-5-7-19-8-6-13/h1-4,9-10,13,19H,5-8,12H2 D06QIQ DRUGINKE ZINGRQZUIVEPKX-UHFFFAOYSA-N D06QIQ DRUGSMIL C1CNCCC1COC2=CC3=C(C=CC(=C3)C#N)C=C2 D06QIQ HIGHSTAT Investigative D06QJM DRUG__ID D06QJM D06QJM DRUGTYPE Small molecular drug D06QJM DRUGINCH 1S/C21H27NO3.ClH/c1-17-2-4-18(5-3-17)16-21(24)10-12-22(13-11-21)14-15-25-20-8-6-19(23)7-9-20;/h2-9,23-24H,10-16H2,1H3;1H D06QJM DRUGINKE WFFZHKKSIDENAJ-UHFFFAOYSA-N D06QJM DRUGSMIL CC1=CC=C(C=C1)CC2(CCN(CC2)CCOC3=CC=C(C=C3)O)O.Cl D06QJM HIGHSTAT Investigative D06QJT DRUG__ID D06QJT D06QJT DRUGTYPE Small molecular drug D06QJT DRUGINCH 1S/C32H45N5O7/c1-20(2)17-25(33-32(42)44-19-24-15-11-8-12-16-24)28(38)34-26(21(3)4)29(39)36-37-31(41)35-27(22(5)6)30(40)43-18-23-13-9-7-10-14-23/h7-16,20-22,25-27H,17-19H2,1-6H3,(H,33,42)(H,34,38)(H,36,39)(H2,35,37,41) D06QJT DRUGINKE QYEUFPXQJIQXLI-UHFFFAOYSA-N D06QJT DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(C(C)C)C(=O)OCC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2 D06QJT HIGHSTAT Investigative D06QKD DRUG__ID D06QKD D06QKD DRUGTYPE Small molecular drug D06QKD DRUGINCH 1S/C13H19NO3/c1-9(2)14-5-6-17-13(8-14)10-3-4-11(15)12(16)7-10/h3-4,7,9,13,15-16H,5-6,8H2,1-2H3 D06QKD DRUGINKE SUYJAACXNVNFGP-UHFFFAOYSA-N D06QKD DRUGSMIL CC(C)N1CCOC(C1)C2=CC(=C(C=C2)O)O D06QKD HIGHSTAT Investigative D06QKW DRUG__ID D06QKW D06QKW DRUGTYPE Small molecular drug D06QKW DRUGINCH 1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15) D06QKW DRUGINKE YAORIDZYZDUZCM-UHFFFAOYSA-N D06QKW DRUGSMIL C1CC1C2=CC=CC=C2OCC3=NCCN3 D06QKW HIGHSTAT Investigative D06QLG DRUG__ID D06QLG D06QLG DRUGTYPE Small molecular drug D06QLG DRUGINCH 1S/C21H26N4O4/c1-14(24-21(29)18(22)12-15-8-10-17(26)11-9-15)20(28)23-13-19(27)25(2)16-6-4-3-5-7-16/h3-11,14,18,26H,12-13,22H2,1-2H3,(H,23,28)(H,24,29)/t14-,18+/m1/s1 D06QLG DRUGINKE OPRBFENCQHCQFV-KDOFPFPSSA-N D06QLG DRUGSMIL CC(C(=O)NCC(=O)N(C)C1=CC=CC=C1)NC(=O)C(CC2=CC=C(C=C2)O)N D06QLG HIGHSTAT Investigative D06QNN DRUG__ID D06QNN D06QNN DRUGTYPE Small molecular drug D06QNN DRUGINCH 1S/C17H13NO3/c19-16(18-11-12-6-2-1-3-7-12)14-10-13-8-4-5-9-15(13)21-17(14)20/h1-10H,11H2,(H,18,19) D06QNN DRUGINKE BEUWFLKNYNXOJA-UHFFFAOYSA-N D06QNN DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC3=CC=CC=C3OC2=O D06QNN HIGHSTAT Investigative D06QOX DRUG__ID D06QOX D06QOX DRUGTYPE Small molecular drug D06QOX DRUGINCH 1S/C22H14N2O2/c25-22-19-20(15-9-3-1-4-10-15)23-24(16-11-5-2-6-12-16)21(19)17-13-7-8-14-18(17)26-22/h1-14H D06QOX DRUGINKE ZPXTZMAWXDLUOO-UHFFFAOYSA-N D06QOX DRUGSMIL C1=CC=C(C=C1)C2=NN(C3=C2C(=O)OC4=CC=CC=C43)C5=CC=CC=C5 D06QOX HIGHSTAT Investigative D06QQS DRUG__ID D06QQS D06QQS DRUGTYPE Small molecular drug D06QQS DRUGINCH 1S/C21H26ClNO.C4H4O4/c1-21(17-7-4-3-5-8-17,18-10-12-19(22)13-11-18)24-16-14-20-9-6-15-23(20)2;5-3(6)1-2-4(7)8/h3-5,7-8,10-13,20H,6,9,14-16H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+/t20-,21-;/m1./s1 D06QQS DRUGINKE PMGQWSIVQFOFOQ-YKVZVUFRSA-N D06QQS DRUGSMIL CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCC[NH+]3C.C(=CC(=O)[O-])C(=O)O D06QQS HIGHSTAT Investigative D06QRI DRUG__ID D06QRI D06QRI DRUGTYPE Small molecular drug D06QRI DRUGINCH 1S/C16H15N3O/c1-19(2)15-9-8-12-14(20)10-13(17-16(12)18-15)11-6-4-3-5-7-11/h3-10H,1-2H3,(H,17,18,20) D06QRI DRUGINKE BEMRWFAUJDRLIY-UHFFFAOYSA-N D06QRI DRUGSMIL CN(C)C1=NC2=C(C=C1)C(=O)C=C(N2)C3=CC=CC=C3 D06QRI HIGHSTAT Investigative D06QRP DRUG__ID D06QRP D06QRP DRUGTYPE Small molecular drug D06QRP DRUGINCH 1S/C26H31FN4O4/c1-26(2,35)11-10-17(24(28)33)14-23(32)21(13-16-6-5-7-18(27)12-16)31-25(34)22-15-29-19-8-3-4-9-20(19)30-22/h3-9,12,15,17,21,23,32,35H,10-11,13-14H2,1-2H3,(H2,28,33)(H,31,34)/t17-,21+,23+/m1/s1 D06QRP DRUGINKE YEQJVHQCUDMXFG-FHZYATBESA-N D06QRP DRUGSMIL CC(C)(CCC(CC(C(CC1=CC(=CC=C1)F)NC(=O)C2=NC3=CC=CC=C3N=C2)O)C(=O)N)O D06QRP HIGHSTAT Investigative D06QTC DRUG__ID D06QTC D06QTC DRUGTYPE Small molecular drug D06QTC DRUGINCH 1S/C18H19N3O2/c19-18(23)17-10-21(12-20-17)15(11-22)9-8-14-6-3-5-13-4-1-2-7-16(13)14/h1-7,10,12,15,22H,8-9,11H2,(H2,19,23)/t15-/m1/s1 D06QTC DRUGINKE URGFTPMACWKJKU-OAHLLOKOSA-N D06QTC DRUGSMIL C1=CC=C2C(=C1)C=CC=C2CCC(CO)N3C=C(N=C3)C(=O)N D06QTC HIGHSTAT Investigative D06QUJ DRUG__ID D06QUJ D06QUJ DRUGTYPE Small molecular drug D06QUJ DRUGINCH 1S/C15H14N2O/c1-18-13-5-2-4-11(9-13)8-12-10-17-15-14(12)6-3-7-16-15/h2-7,9-10H,8H2,1H3,(H,16,17) D06QUJ DRUGINKE GHQCCHWTDLTMJT-UHFFFAOYSA-N D06QUJ DRUGSMIL COC1=CC=CC(=C1)CC2=CNC3=C2C=CC=N3 D06QUJ HIGHSTAT Investigative D06QUQ DRUG__ID D06QUQ D06QUQ DRUGTYPE Small molecular drug D06QUQ DRUGINCH 1S/C26H29N5O2/c1-33-22-4-2-3-19(15-22)23-16-31(26-24(23)25(27)28-17-29-26)20-7-5-18(6-8-20)9-12-30-13-10-21(32)11-14-30/h2-8,15-17,21,32H,9-14H2,1H3,(H2,27,28,29) D06QUQ DRUGINKE WUPXZZWTHIZICK-UHFFFAOYSA-N D06QUQ DRUGSMIL COC1=CC=CC(=C1)C2=CN(C3=NC=NC(=C23)N)C4=CC=C(C=C4)CCN5CCC(CC5)O D06QUQ HIGHSTAT Investigative D06QVB DRUG__ID D06QVB D06QVB DRUGTYPE Small molecular drug D06QVB DRUGINCH 1S/C16H13NO2S/c17-13-8-10-14(11-9-13)20(18,19)16-7-3-5-12-4-1-2-6-15(12)16/h1-11H,17H2 D06QVB DRUGINKE WJMHQZIDRDGGIY-UHFFFAOYSA-N D06QVB DRUGSMIL C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)C3=CC=C(C=C3)N D06QVB HIGHSTAT Investigative D06QWO DRUG__ID D06QWO D06QWO DRUGTYPE Small molecular drug D06QWO DRUGINCH 1S/C14H12O6/c1-6-3-10(16)12(17)14(6)8-4-7(19-2)5-9(15)11(8)13(18)20-14/h3-5,12,15,17H,1-2H3 D06QWO DRUGINKE ISNKGHIHBITAEG-UHFFFAOYSA-N D06QWO DRUGSMIL CC1=CC(=O)C(C12C3=C(C(=CC(=C3)OC)O)C(=O)O2)O D06QWO HIGHSTAT Investigative D06QXT DRUG__ID D06QXT D06QXT DRUGTYPE Small molecular drug D06QXT DRUGINCH 1S/C20H27NO/c22-20-13-11-19(12-14-20)15-17-21-16-7-2-1-4-8-18-9-5-3-6-10-18/h3,5-6,9-14,21-22H,1-2,4,7-8,15-17H2 D06QXT DRUGINKE GWYOLALPGDHNBU-UHFFFAOYSA-N D06QXT DRUGSMIL C1=CC=C(C=C1)CCCCCCNCCC2=CC=C(C=C2)O D06QXT HIGHSTAT Investigative D06QYM DRUG__ID D06QYM D06QYM DRUGTYPE Small molecular drug D06QYM DRUGINCH 1S/C20H24F4N2O3/c1-20(6-7-20)29-19(28)26-8-4-12(5-9-26)16(23)11-25-17(27)10-13-14(21)2-3-15(22)18(13)24/h2-3,12,16H,4-11H2,1H3,(H,25,27)/t16-/m1/s1 D06QYM DRUGINKE QCIKTRZVLCLGFT-MRXNPFEDSA-N D06QYM DRUGSMIL CC1(CC1)OC(=O)N2CCC(CC2)C(CNC(=O)CC3=C(C=CC(=C3F)F)F)F D06QYM HIGHSTAT Investigative D06QYV DRUG__ID D06QYV D06QYV DRUGTYPE Small molecular drug D06QYV DRUGINCH 1S/C30H28BrCl2N5O4/c1-18-28(31)38-15-5-6-24(29(38)35-18)42-17-21-22(32)12-13-23(27(21)33)37(4)26(40)16-34-25(39)14-9-19-7-10-20(11-8-19)30(41)36(2)3/h5-15H,16-17H2,1-4H3,(H,34,39)/b14-9+ D06QYV DRUGINKE NDOBHDUXUJNXHX-NTEUORMPSA-N D06QYV DRUGSMIL CC1=C(N2C=CC=C(C2=N1)OCC3=C(C=CC(=C3Cl)N(C)C(=O)CNC(=O)C=CC4=CC=C(C=C4)C(=O)N(C)C)Cl)Br D06QYV HIGHSTAT Investigative D06RAM DRUG__ID D06RAM D06RAM DRUGTYPE Small molecular drug D06RAM DRUGINCH 1S/C28H30O2S2/c1-26(2)11-12-27(3,4)24-17-22(9-10-23(24)26)28(31-13-14-32-28)21-8-7-18-15-20(25(29)30)6-5-19(18)16-21/h5-10,15-17H,11-14H2,1-4H3,(H,29,30) D06RAM DRUGINKE DPVGXUNWCVEIGT-UHFFFAOYSA-N D06RAM DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C3(SCCS3)C4=CC5=C(C=C4)C=C(C=C5)C(=O)O)(C)C)C D06RAM HIGHSTAT Investigative D06RBG DRUG__ID D06RBG D06RBG DRUGTYPE Small molecular drug D06RBG DRUGINCH 1S/C24H38O3/c1-15(4-9-22(26)27)19-7-8-20-18-6-5-16-14-17(25)10-12-23(16,2)21(18)11-13-24(19,20)3/h15-16,18-21H,4-14H2,1-3H3,(H,26,27)/t15-,16-,18+,19-,20+,21+,23+,24-/m1/s1 D06RBG DRUGINKE KIQFUORWRVZTHT-OPTMKGCMSA-N D06RBG DRUGSMIL CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(=O)C4)C)C D06RBG HIGHSTAT Investigative D06RCI DRUG__ID D06RCI D06RCI DRUGTYPE Small molecular drug D06RCI DRUGINCH 1S/C25H36O7/c1-18(16-19(2)11-9-14-20-12-6-4-7-13-20)10-5-3-8-15-21(23(28)29)25(32,24(30)31)17-22(26)27/h4,6-7,9,12-14,18-19,21,32H,3,5,8,10-11,15-17H2,1-2H3,(H,26,27)(H,28,29)(H,30,31)/b14-9+ D06RCI DRUGINKE DSEOFKAKDCUIFI-NTEUORMPSA-N D06RCI DRUGSMIL CC(CCCCCC(C(=O)O)C(CC(=O)O)(C(=O)O)O)CC(C)CC=CC1=CC=CC=C1 D06RCI HIGHSTAT Investigative D06RCT DRUG__ID D06RCT D06RCT DRUGTYPE Small molecular drug D06RCT DRUGINCH 1S/C20H22N6O5/c21-17-14-18(26(9-23-14)19-16(29)15(28)13(8-27)31-19)25-20(24-17)30-6-5-10-7-22-12-4-2-1-3-11(10)12/h1-4,7,9,13,15-16,19,22,27-29H,5-6,8H2,(H2,21,24,25)/t13-,15-,16-,19-/m1/s1 D06RCT DRUGINKE UIPASAROPWUJRQ-NVQRDWNXSA-N D06RCT DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D06RCT HIGHSTAT Investigative D06RFW DRUG__ID D06RFW D06RFW DRUGTYPE Small molecular drug D06RFW DRUGINCH 1S/C19H25N3/c1-13(2)15-5-9-17(10-6-15)21-19(20)22-18-11-7-16(8-12-18)14(3)4/h5-14H,1-4H3,(H3,20,21,22) D06RFW DRUGINKE WIULPOAMZNPPJM-UHFFFAOYSA-N D06RFW DRUGSMIL CC(C)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(C)C)N D06RFW HIGHSTAT Investigative D06RGX DRUG__ID D06RGX D06RGX DRUGTYPE Small molecular drug D06RGX DRUGINCH 1S/C19H20ClNO4/c1-25-17-8-7-15(20)12-16(17)19(24)21-11-10-14-4-2-13(3-5-14)6-9-18(22)23/h2-5,7-8,12H,6,9-11H2,1H3,(H,21,24)(H,22,23) D06RGX DRUGINKE AIEFQKOARQRACO-UHFFFAOYSA-N D06RGX DRUGSMIL COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)CCC(=O)O D06RGX HIGHSTAT Investigative D06RID DRUG__ID D06RID D06RID DRUGTYPE Small molecular drug D06RID DRUGINCH 1S/C14H16N2O/c1-2-6-11(7-3-1)17-14-12-8-4-5-9-13(12)15-10-16-14/h4-5,8-11H,1-3,6-7H2 D06RID DRUGINKE QNXOLVQGDILPJV-UHFFFAOYSA-N D06RID DRUGSMIL C1CCC(CC1)OC2=NC=NC3=CC=CC=C32 D06RID HIGHSTAT Investigative D06RIK DRUG__ID D06RIK D06RIK DRUGTYPE Small molecular drug D06RIK DRUGINCH 1S/C28H47NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-28(30)29-21-20-25-22-26(31-2)24-27(23-25)32-3/h11-12,22-24H,4-10,13-21H2,1-3H3,(H,29,30)/b12-11- D06RIK DRUGINKE HOCMLWROGBYBPA-QXMHVHEDSA-N D06RIK DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCC1=CC(=CC(=C1)OC)OC D06RIK HIGHSTAT Investigative D06RJQ DRUG__ID D06RJQ D06RJQ DRUGTYPE Small molecular drug D06RJQ DRUGINCH 1S/C17H27ClN2O2/c1-2-3-4-5-10-16(21)11-7-12-19-17(22)20-15-9-6-8-14(18)13-15/h6,8-9,13,16,21H,2-5,7,10-12H2,1H3,(H2,19,20,22) D06RJQ DRUGINKE ZDFKGBJPFGFBQJ-UHFFFAOYSA-N D06RJQ DRUGSMIL CCCCCCC(CCCNC(=O)NC1=CC(=CC=C1)Cl)O D06RJQ HIGHSTAT Investigative D06RKK DRUG__ID D06RKK D06RKK DRUGTYPE Small molecular drug D06RKK DRUGINCH 1S/C23H43NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(2)23(26)24-20-21-25/h15-16,19,25H,3-14,17-18,20-21H2,1-2H3,(H,24,26)/b16-15+,22-19+ D06RKK DRUGINKE SJZSLZDOZDKKND-JWGQYYPISA-N D06RKK DRUGSMIL CCCCCCCCCCCCCC=CCCC=C(C)C(=O)NCCO D06RKK HIGHSTAT Investigative D06RKS DRUG__ID D06RKS D06RKS DRUGTYPE Small molecular drug D06RKS DRUGINCH 1S/C10H12O3S/c1-2-9(11)8-14(12,13)10-6-4-3-5-7-10/h3-7H,2,8H2,1H3 D06RKS DRUGINKE SMYSSDAIMUTBFY-UHFFFAOYSA-N D06RKS DRUGSMIL CCC(=O)CS(=O)(=O)C1=CC=CC=C1 D06RKS HIGHSTAT Investigative D06RLF DRUG__ID D06RLF D06RLF DRUGTYPE Small molecular drug D06RLF DRUGINCH 1S/C2H6NO2P/c1-2(3)6(4)5/h3-5H,1H3 D06RLF DRUGINKE JIMKERQURQBVPW-UHFFFAOYSA-N D06RLF DRUGSMIL CC(=N)P(O)O D06RLF HIGHSTAT Investigative D06RNM DRUG__ID D06RNM D06RNM DRUGTYPE Small molecular drug D06RNM DRUGINCH 1S/C9H16N4S/c1-10-9(14)12-5-3-2-4-8-6-11-7-13-8/h6-7H,2-5H2,1H3,(H,11,13)(H2,10,12,14) D06RNM DRUGINKE HXRBAVXGYZUSED-UHFFFAOYSA-N D06RNM DRUGSMIL CNC(=S)NCCCCC1=CN=CN1 D06RNM HIGHSTAT Investigative D06ROA DRUG__ID D06ROA D06ROA DRUGTYPE Small molecular drug D06ROA DRUGINCH 1S/C16H24FNO/c1-3-9-18(10-4-2)12-5-6-13-14(11-12)16(19)8-7-15(13)17/h7-8,12,19H,3-6,9-11H2,1-2H3/t12-/m0/s1 D06ROA DRUGINKE FNKBVTBXFLSTPB-LBPRGKRZSA-N D06ROA DRUGSMIL CCCN(CCC)C1CCC2=C(C=CC(=C2C1)O)F D06ROA HIGHSTAT Investigative D06RPY DRUG__ID D06RPY D06RPY DRUGTYPE Small molecular drug D06RPY DRUGINCH 1S/C18H25N3/c1-3-16(4-2)20-11-13-21(14-12-20)18-10-9-15-7-5-6-8-17(15)19-18/h5-10,16H,3-4,11-14H2,1-2H3 D06RPY DRUGINKE FNSKLNDKQPXTIL-UHFFFAOYSA-N D06RPY DRUGSMIL CCC(CC)N1CCN(CC1)C2=NC3=CC=CC=C3C=C2 D06RPY HIGHSTAT Investigative D06RQV DRUG__ID D06RQV D06RQV DRUGTYPE Small molecular drug D06RQV DRUGINCH 1S/C14H13N3/c1-9-14(10-4-6-16-7-5-10)12-3-2-11(15)8-13(12)17-9/h2-8,17H,15H2,1H3 D06RQV DRUGINKE AAIHLDQORIUJKB-UHFFFAOYSA-N D06RQV DRUGSMIL CC1=C(C2=C(N1)C=C(C=C2)N)C3=CC=NC=C3 D06RQV HIGHSTAT Investigative D06RRD DRUG__ID D06RRD D06RRD DRUGTYPE Small molecular drug D06RRD DRUGINCH 1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13) D06RRD DRUGINKE TXCGAZHTZHNUAI-UHFFFAOYSA-N D06RRD DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl D06RRD HIGHSTAT Investigative D06RRT DRUG__ID D06RRT D06RRT DRUGTYPE Small molecular drug D06RRT DRUGINCH 1S/C19H27F3N4O5/c1-10(15(28)19(20,21)22)23-17(30)14-7-5-9-26(14)18(31)11(2)24-16(29)13-6-4-8-25(13)12(3)27/h10-11,13-14H,4-9H2,1-3H3,(H,23,30)(H,24,29)/t10-,11-,13-,14-/m0/s1 D06RRT DRUGINKE DLOFUPNOARUTLN-IMIFBBOLSA-N D06RRT DRUGSMIL CC(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C2CCCN2C(=O)C D06RRT HIGHSTAT Investigative D06RSD DRUG__ID D06RSD D06RSD DRUGTYPE Small molecular drug D06RSD DRUGINCH 1S/C16H12N4/c17-9-13-1-3-14(4-2-13)11-20-12-19-10-16(20)15-5-7-18-8-6-15/h1-8,10,12H,11H2 D06RSD DRUGINKE JQIVWNYGSDPIRG-UHFFFAOYSA-N D06RSD DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2C3=CC=NC=C3)C#N D06RSD HIGHSTAT Investigative D06RSF DRUG__ID D06RSF D06RSF DRUGTYPE Small molecular drug D06RSF DRUGINCH 1S/C12H17NO3S/c1-16-10-4-2-3-9(7-10)8-17-6-5-11(13)12(14)15/h2-4,7,11H,5-6,8,13H2,1H3,(H,14,15) D06RSF DRUGINKE WAUOPBRKRQFQTA-UHFFFAOYSA-N D06RSF DRUGSMIL COC1=CC=CC(=C1)CSCCC(C(=O)O)N D06RSF HIGHSTAT Investigative D06RSR DRUG__ID D06RSR D06RSR DRUGTYPE Small molecular drug D06RSR DRUGINCH 1S/C49H72N14O8/c1-3-30(2)40(47(71)58-35(41(51)65)18-10-11-25-50)63-44(68)37(20-13-27-57-49(54)55)60-45(69)39(29-32-21-23-34(64)24-22-32)62-46(70)38(28-31-14-6-4-7-15-31)61-43(67)36(19-12-26-56-48(52)53)59-42(66)33-16-8-5-9-17-33/h4-9,14-17,21-24,30,35-40,64H,3,10-13,18-20,25-29,50H2,1-2H3,(H2,51,65)(H,58,71)(H,59,66)(H,60,69)(H,61,67)(H,62,70)(H,63,68)(H4,52,53,56)(H4,54,55,57)/t30-,35-,36-,37-,38-,39-,40-/m0/s1 D06RSR DRUGINKE OBDOGETZOBOLDY-GCFINZEGSA-N D06RSR DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C3=CC=CC=C3 D06RSR HIGHSTAT Investigative D06RTA DRUG__ID D06RTA D06RTA DRUGTYPE Small molecular drug D06RTA DRUGINCH 1S/C32H48N2O2/c1-3-31(27-13-11-15-29(35)23-27)17-5-7-19-33(25-31)21-9-10-22-34-20-8-6-18-32(4-2,26-34)28-14-12-16-30(36)24-28/h11-16,23-24,35-36H,3-10,17-22,25-26H2,1-2H3/t31-,32-/m1/s1 D06RTA DRUGINKE QRRZAKFYWBRJNH-ROJLCIKYSA-N D06RTA DRUGSMIL CCC1(CCCCN(C1)CCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D06RTA HIGHSTAT Investigative D06RTP DRUG__ID D06RTP D06RTP DRUGTYPE Small molecular drug D06RTP DRUGINCH 1S/C46H61N11O7/c1-4-5-14-34-42(61)57-39(26(2)3)45(64)56-36(23-27-17-18-28-11-6-7-12-29(28)22-27)43(62)54-35(16-10-21-50-46(48)49)41(60)55-37(24-30-25-51-32-15-9-8-13-31(30)32)44(63)53-33(40(47)59)19-20-38(58)52-34/h6-9,11-13,15,17-18,22,25-26,33-37,39,51H,4-5,10,14,16,19-21,23-24H2,1-3H3,(H2,47,59)(H,52,58)(H,53,63)(H,54,62)(H,55,60)(H,56,64)(H,57,61)(H4,48,49,50)/t33-,34-,35-,36+,37-,39-/m0/s1 D06RTP DRUGINKE GVZTZLFKKLVBJF-JDABYTJISA-N D06RTP DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)C(C)C D06RTP HIGHSTAT Investigative D06RWH DRUG__ID D06RWH D06RWH DRUGTYPE Small molecular drug D06RWH DRUGINCH 1S/C15H16N2O2/c16-10-15(18)17-13-6-8-14(9-7-13)19-11-12-4-2-1-3-5-12/h1-9H,10-11,16H2,(H,17,18) D06RWH DRUGINKE YJPUATSIKWOSST-UHFFFAOYSA-N D06RWH DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)CN D06RWH HIGHSTAT Investigative D06SAT DRUG__ID D06SAT D06SAT DRUGCOMP University of Wisconsin-Milwaukee D06SAT DRUGINCH 1S/C21H16N4O2/c1-3-14-8-9-17-15(11-14)19(16-7-5-6-10-22-16)23-12-18-20(21(26)27-4-2)24-13-25(17)18/h1,5-11,13H,4,12H2,2H3 D06SAT DRUGINKE ZSEDMNMFODMQRD-UHFFFAOYSA-N D06SAT DRUGSMIL CCOC(=O)C1=C2CN=C(C3=C(N2C=N1)C=CC(=C3)C#C)C4=CC=CC=N4 D06SAT HIGHSTAT Investigative D06SCF DRUG__ID D06SCF D06SCF DRUGTYPE Small molecular drug D06SCF DRUGINCH 1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,34-35H,1-2,9-12H2,3-6H3,(H,37,42)(H,38,39)(H,40,41)/b24-13-,27-14-,28-15- D06SCF DRUGINKE RCNSAJSGRJSBKK-NSQVQWHSSA-N D06SCF DRUGSMIL CC1=C(C(=CC2=C(C(=C(N2)C=C3C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)NC1=CC4=NC(=O)C(=C4C)C=C)CCC(=O)O D06SCF HIGHSTAT Investigative D06SCS DRUG__ID D06SCS D06SCS DRUGTYPE Small molecular drug D06SCS DRUGINCH 1S/C13H8BrNO3/c14-10-5-9(17)6-11-12(10)18-13(15-11)7-1-3-8(16)4-2-7/h1-6,16-17H D06SCS DRUGINKE BAAILVWEAXFTSF-UHFFFAOYSA-N D06SCS DRUGSMIL C1=CC(=CC=C1C2=NC3=C(O2)C(=CC(=C3)O)Br)O D06SCS HIGHSTAT Investigative D06SDD DRUG__ID D06SDD D06SDD DRUGTYPE Small molecular drug D06SDD DRUGINCH 1S/C8H8FNO5/c9-8(6(14)15)3-2(11)1-7(10,4(3)8)5(12)13/h3-4H,1,10H2,(H,12,13)(H,14,15)/t3-,4-,7+,8-/m1/s1 D06SDD DRUGINKE KFAGJPNFERWZJA-JKBXLQNXSA-N D06SDD DRUGSMIL C1C(=O)C2C(C1(C(=O)O)N)C2(C(=O)O)F D06SDD HIGHSTAT Investigative D06SDG DRUG__ID D06SDG D06SDG DRUGTYPE Small molecular drug D06SDG DRUGINCH 1S/C45H63N11O11S2/c1-25(2)19-30-40(62)54-33(22-36(47)58)43(65)55-34(45(67)56-17-6-9-35(56)44(66)51-29(14-16-46)39(61)49-23-37(48)59)24-69-68-18-15-38(60)50-31(21-27-10-12-28(57)13-11-27)41(63)53-32(42(64)52-30)20-26-7-4-3-5-8-26/h3-5,7-8,10-13,25,29-35,57H,6,9,14-24,46H2,1-2H3,(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,64)(H,53,63)(H,54,62)(H,55,65)/t29-,30-,31-,32-,33-,34-,35-/m0/s1 D06SDG DRUGINKE VIYXBPSZIAMFAA-POFDKVPJSA-N D06SDG DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCN)C(=O)NCC(=O)N)CC(=O)N D06SDG HIGHSTAT Investigative D06SFA DRUG__ID D06SFA D06SFA DRUGTYPE Small molecular drug D06SFA DRUGINCH 1S/C16H14N2/c1-11-5-6-13(8-12(11)2)14-9-16-15(18-10-14)4-3-7-17-16/h3-10H,1-2H3 D06SFA DRUGINKE MGYKFCHFCGICOX-UHFFFAOYSA-N D06SFA DRUGSMIL CC1=C(C=C(C=C1)C2=CC3=C(C=CC=N3)N=C2)C D06SFA HIGHSTAT Investigative D06SGU DRUG__ID D06SGU D06SGU DRUGTYPE Small molecular drug D06SGU DRUGINCH 1S/C18H15F3N6O2/c1-2-27-16(28)13-15(25-17(27)29)24-14(23-13)11-7-22-26(9-11)8-10-4-3-5-12(6-10)18(19,20)21/h3-7,9H,2,8H2,1H3,(H,23,24)(H,25,29) D06SGU DRUGINKE OFXKKKKJJGJUBD-UHFFFAOYSA-N D06SGU DRUGSMIL CCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CN(N=C3)CC4=CC(=CC=C4)C(F)(F)F D06SGU HIGHSTAT Investigative D06SIH DRUG__ID D06SIH D06SIH DRUGTYPE Small molecular drug D06SIH DRUGINCH 1S/C4H7NO3/c5-3(1-2-6)4(7)8/h2-3H,1,5H2,(H,7,8)/t3-/m0/s1 D06SIH DRUGINKE HOSWPDPVFBCLSY-VKHMYHEASA-N D06SIH DRUGSMIL C(C=O)C(C(=O)[O-])[NH3+] D06SIH HIGHSTAT Investigative D06SKK DRUG__ID D06SKK D06SKK DRUGTYPE Small molecular drug D06SKK DRUGINCH 1S/C21H34O2/c1-5-6-7-13-21(2,3)17-11-12-19(20(15-17)23-4)16-9-8-10-18(22)14-16/h11-12,15-16,18,22H,5-10,13-14H2,1-4H3/t16-,18+/m0/s1 D06SKK DRUGINKE GZSDLXNECOWUFY-FUHWJXTLSA-N D06SKK DRUGSMIL CCCCCC(C)(C)C1=CC(=C(C=C1)C2CCCC(C2)O)OC D06SKK HIGHSTAT Investigative D06SKN DRUG__ID D06SKN D06SKN DRUGTYPE Small molecular drug D06SKN DRUGINCH 1S/C20H25NO3.CH4O3S.3H2O/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17;1-5(2,3)4;;;/h2-10,15,19,22-24H,11-14H2,1H3;1H3,(H,2,3,4);3*1H2/t15-,19+;;;;/m0..../s1 D06SKN DRUGINKE LUILKELNVBKKTG-ZOZJKLBQSA-N D06SKN DRUGSMIL CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)(C3=CC=CC=C3)O.CS(=O)(=O)O.O.O.O D06SKN HIGHSTAT Investigative D06SME DRUG__ID D06SME D06SME DRUGTYPE Small molecular drug D06SME DRUGINCH 1S/C11H11NO4S/c1-8-2-4-9(5-3-8)17(15,16)12-10(13)6-7-11(12)14/h2-7,10,13H,1H3 D06SME DRUGINKE LASNBXWNXQRYSO-UHFFFAOYSA-N D06SME DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C(C=CC2=O)O D06SME HIGHSTAT Investigative D06SMN DRUG__ID D06SMN D06SMN DRUGTYPE Small molecular drug D06SMN DRUGINCH 1S/C18H21NO/c1-2-5-15(6-3-1)13-16-8-10-18(11-9-16)20-14-17-7-4-12-19-17/h1-3,5-6,8-11,17,19H,4,7,12-14H2/t17-/m1/s1 D06SMN DRUGINKE NXNMORHGFGYRDN-QGZVFWFLSA-N D06SMN DRUGSMIL C1CC(NC1)COC2=CC=C(C=C2)CC3=CC=CC=C3 D06SMN HIGHSTAT Investigative D06SMY DRUG__ID D06SMY D06SMY DRUGTYPE Small molecular drug D06SMY DRUGINCH 1S/C16H25NO5S/c1-2-3-4-5-6-7-8-13-21-16(18)14-9-11-15(12-10-14)22-23(17,19)20/h9-12H,2-8,13H2,1H3,(H2,17,19,20) D06SMY DRUGINKE MIEAOZZHVJFVJY-UHFFFAOYSA-N D06SMY DRUGSMIL CCCCCCCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D06SMY HIGHSTAT Investigative D06SOQ DRUG__ID D06SOQ D06SOQ DRUGTYPE Small molecular drug D06SOQ DRUGINCH 1S/C17H14N8O2/c1-10-7-14(22-27-10)16-20-19-15-12-5-3-4-6-13(12)17(21-25(15)16)26-9-11-8-24(2)23-18-11/h3-8H,9H2,1-2H3 D06SOQ DRUGINKE NZMJFRXKGUCYNP-UHFFFAOYSA-N D06SOQ DRUGSMIL CC1=CC(=NO1)C2=NN=C3N2N=C(C4=CC=CC=C43)OCC5=CN(N=N5)C D06SOQ HIGHSTAT Investigative D06SPO DRUG__ID D06SPO D06SPO DRUGTYPE Small molecular drug D06SPO DRUGINCH 1S/C7H4Cl2O3/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2,10H,(H,11,12) D06SPO DRUGINKE CNJGWCQEGROXEE-UHFFFAOYSA-N D06SPO DRUGSMIL C1=C(C=C(C(=C1C(=O)O)O)Cl)Cl D06SPO HIGHSTAT Investigative D06SWV DRUG__ID D06SWV D06SWV DRUGTYPE Small molecular drug D06SWV DRUGINCH 1S/C4H10O3P/c1-3-6-8(5)7-4-2/h3-4H2,1-2H3/q+1 D06SWV DRUGINKE LXCYSACZTOKNNS-UHFFFAOYSA-N D06SWV DRUGSMIL CCO[P+](=O)OCC D06SWV HIGHSTAT Investigative D06SXN DRUG__ID D06SXN D06SXN DRUGTYPE Small molecular drug D06SXN DRUGINCH 1S/C18H14N2O/c1-12-3-4-14-5-6-15(10-18(14)20-12)16-7-13(11-19)8-17(9-16)21-2/h3-10H,1-2H3 D06SXN DRUGINKE UYKOUDWFOWHINO-UHFFFAOYSA-N D06SXN DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)OC D06SXN HIGHSTAT Investigative D06SYS DRUG__ID D06SYS D06SYS DRUGTYPE Small molecular drug D06SYS DRUGINCH 1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3 D06SYS DRUGINKE GEFQWZLICWMTKF-UHFFFAOYSA-N D06SYS DRUGSMIL CC(C(C1=CC(=C(C=C1)O)O)O)N D06SYS HIGHSTAT Investigative D06SZG DRUG__ID D06SZG D06SZG DRUGTYPE Small molecular drug D06SZG DRUGINCH 1S/C8H4Cl2N2O3/c9-4-1-3-6(2-5(4)10)11-8(14)12(15)7(3)13/h1-2,15H,(H,11,14) D06SZG DRUGINKE URXMQPMLTVUBON-UHFFFAOYSA-N D06SZG DRUGSMIL C1=C2C(=CC(=C1Cl)Cl)NC(=O)N(C2=O)O D06SZG HIGHSTAT Investigative D06SZI DRUG__ID D06SZI D06SZI DRUGTYPE Small molecular drug D06SZI DRUGINCH 1S/C21H26N2O2/c24-20-22-17-9-14-10-18-15-3-1-2-6-21(15,16(14)11-19(17)25-20)7-8-23(18)12-13-4-5-13/h9,11,13,15,18H,1-8,10,12H2,(H,22,24)/t15-,18+,21+/m0/s1 D06SZI DRUGINKE QLWCMBZVQJGYTM-RRMPHLOHSA-N D06SZI DRUGSMIL C1CCC23CCN(C(C2C1)CC4=CC5=C(C=C34)OC(=O)N5)CC6CC6 D06SZI HIGHSTAT Investigative D06TCC DRUG__ID D06TCC D06TCC DRUGTYPE Small molecular drug D06TCC DRUGINCH 1S/C19H17Cl2N3O2S/c20-14-1-4-16(5-2-14)27(25,26)24-11-9-23(10-12-24)19-7-8-22-18-13-15(21)3-6-17(18)19/h1-8,13H,9-12H2 D06TCC DRUGINKE GIEHIZKCIZLXLF-UHFFFAOYSA-N D06TCC DRUGSMIL C1CN(CCN1C2=C3C=CC(=CC3=NC=C2)Cl)S(=O)(=O)C4=CC=C(C=C4)Cl D06TCC HIGHSTAT Investigative D06TCX DRUG__ID D06TCX D06TCX DRUGTYPE Small molecular drug D06TCX DRUGINCH 1S/C23H16N4O/c24-16-17-11-13-19(14-12-17)23(28)25-22-15-21(18-7-3-1-4-8-18)26-27(22)20-9-5-2-6-10-20/h1-15H,(H,25,28) D06TCX DRUGINKE YOQRDFGCIVWWAO-UHFFFAOYSA-N D06TCX DRUGSMIL C1=CC=C(C=C1)C2=NN(C(=C2)NC(=O)C3=CC=C(C=C3)C#N)C4=CC=CC=C4 D06TCX HIGHSTAT Investigative D06TGR DRUG__ID D06TGR D06TGR DRUGTYPE Small molecular drug D06TGR DRUGINCH 1S/C19H17NO4/c21-14-4-1-3-13(11-14)15-5-2-6-16-17(22)12-18(24-19(15)16)20-7-9-23-10-8-20/h1-6,11-12,21H,7-10H2 D06TGR DRUGINKE WPUKKEMHTVGTFK-UHFFFAOYSA-N D06TGR DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC(=CC=C4)O D06TGR HIGHSTAT Investigative D06THS DRUG__ID D06THS D06THS DRUGTYPE Small molecular drug D06THS DRUGINCH 1S/C44H76N4O12/c1-11-34-44(8,56)39(53)30(6)47(9)24-26(2)23-43(7,55)40(28(4)37(51)29(5)41(54)59-34)60-42-38(52)33(22-27(3)58-42)48(10)25-31-18-20-32(21-19-31)45-35(49)16-14-12-13-15-17-36(50)46-57/h18-21,26-30,33-34,37-40,42,51-53,55-57H,11-17,22-25H2,1-10H3,(H,45,49)(H,46,50)/t26-,27-,28+,29-,30-,33+,34-,37+,38-,39-,40-,42+,43-,44-/m1/s1 D06THS DRUGINKE DJGOCARXUHEYRZ-AYWHDHSOSA-N D06THS DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)O)C)OC2C(C(CC(O2)C)N(C)CC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O D06THS HIGHSTAT Investigative D06TJC DRUG__ID D06TJC D06TJC DRUGTYPE Small molecular drug D06TJC DRUGINCH 1S/C8H15NO2S/c10-8(11)7(5-12)6-1-3-9-4-2-6/h6-7,9,12H,1-5H2,(H,10,11) D06TJC DRUGINKE AYOUKDACKXEDFA-UHFFFAOYSA-N D06TJC DRUGSMIL C1CNCCC1C(CS)C(=O)O D06TJC HIGHSTAT Investigative D06TLL DRUG__ID D06TLL D06TLL DRUGTYPE Small molecular drug D06TLL DRUGINCH 1S/C26H26N4O3/c1-29(2)11-6-12-30-15-20(18-13-16(33-3)9-10-22(18)30)24-23(25(31)28-26(24)32)19-14-27-21-8-5-4-7-17(19)21/h4-5,7-10,13-15,27H,6,11-12H2,1-3H3,(H,28,31,32) D06TLL DRUGINKE LLJJDLHGZUOMQP-UHFFFAOYSA-N D06TLL DRUGSMIL CN(C)CCCN1C=C(C2=C1C=CC(=C2)OC)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54 D06TLL HIGHSTAT Investigative D06TLQ DRUG__ID D06TLQ D06TLQ DRUGTYPE Small molecular drug D06TLQ DRUGINCH 1S/C27H30O10/c1-12(2)5-10-16-17(28)11-18(29)19-21(31)26(37-27-23(33)22(32)20(30)13(3)35-27)24(36-25(16)19)14-6-8-15(34-4)9-7-14/h5-9,11,13,20,22-23,27-30,32-33H,10H2,1-4H3/t13-,20-,22+,23+,27-/m0/s1 D06TLQ DRUGINKE NGMYNFJANBHLKA-LVKFHIPRSA-N D06TLQ DRUGSMIL CC1C(C(C(C(O1)OC2=C(OC3=C(C(=CC(=C3C2=O)O)O)CC=C(C)C)C4=CC=C(C=C4)OC)O)O)O D06TLQ HIGHSTAT Investigative D06TMM DRUG__ID D06TMM D06TMM DRUGTYPE Small molecular drug D06TMM DRUGINCH 1S/C23H21NO3/c1-16-8-14-21(15-9-16)27-17(2)23(26)24-20-12-10-19(11-13-20)22(25)18-6-4-3-5-7-18/h3-15,17H,1-2H3,(H,24,26)/t17-/m1/s1 D06TMM DRUGINKE XTAVVOHMWNRQKS-QGZVFWFLSA-N D06TMM DRUGSMIL CC1=CC=C(C=C1)OC(C)C(=O)NC2=CC=C(C=C2)C(=O)C3=CC=CC=C3 D06TMM HIGHSTAT Investigative D06TOI DRUG__ID D06TOI D06TOI DRUGTYPE Small molecular drug D06TOI DRUGINCH 1S/C22H26O3/c1-4-9-22(25)11-8-17-16-6-5-14-12-15(23)7-10-20(14,2)19(16)18(24)13-21(17,22)3/h5-7,10,12,16-19,24-25H,8,11,13H2,1-3H3/t16-,17-,18-,19+,20-,21-,22-/m0/s1 D06TOI DRUGINKE IXJKSIRTUSUXQC-ZXYIWLIBSA-N D06TOI DRUGSMIL CC#CC1(CCC2C1(CC(C3C2C=CC4=CC(=O)C=CC34C)O)C)O D06TOI HIGHSTAT Investigative D06TPF DRUG__ID D06TPF D06TPF DRUGTYPE Small molecular drug D06TPF DRUGINCH 1S/C6H6O3/c7-4-2-1-3-5(8)6(4)9/h1-3,7-9H D06TPF DRUGINKE WQGWDDDVZFFDIG-UHFFFAOYSA-N D06TPF DRUGSMIL C1=CC(=C(C(=C1)O)O)O D06TPF HIGHSTAT Investigative D06TQU DRUG__ID D06TQU D06TQU DRUGTYPE Small molecular drug D06TQU DRUGINCH 1S/C20H26Cl2N2O3/c21-17-4-3-15(11-18(17)22)12-19(25)24-8-5-20(26-9-10-27-20)13-16(24)14-23-6-1-2-7-23/h3-4,11,16H,1-2,5-10,12-14H2 D06TQU DRUGINKE LWUQHEXXEFUHHQ-UHFFFAOYSA-N D06TQU DRUGSMIL C1CCN(C1)CC2CC3(CCN2C(=O)CC4=CC(=C(C=C4)Cl)Cl)OCCO3 D06TQU HIGHSTAT Investigative D06TRS DRUG__ID D06TRS D06TRS DRUGTYPE Small molecular drug D06TRS DRUGINCH 1S/C10H9NS/c1-8-4-6-12-10(8)9-3-2-5-11-7-9/h2-7H,1H3 D06TRS DRUGINKE JIOQSJVEVFADJG-UHFFFAOYSA-N D06TRS DRUGSMIL CC1=C(SC=C1)C2=CN=CC=C2 D06TRS HIGHSTAT Investigative D06TSI DRUG__ID D06TSI D06TSI DRUGTYPE Small molecular drug D06TSI DRUGINCH 1S/C26H32N4O4/c1-3-11-27-13-9-23(31)29-17-5-7-19-21(15-17)26(34)22-16-18(6-8-20(22)25(19)33)30-24(32)10-14-28-12-4-2/h5-8,15-16,27-28H,3-4,9-14H2,1-2H3,(H,29,31)(H,30,32) D06TSI DRUGINKE JELVSCOBEUHNBV-UHFFFAOYSA-N D06TSI DRUGSMIL CCCNCCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CCNCCC D06TSI HIGHSTAT Investigative D06TSQ DRUG__ID D06TSQ D06TSQ DRUGTYPE Small molecular drug D06TSQ DRUGINCH 1S/C15H12N4O2S/c16-7-11-13(9-1-3-10(21)4-2-9)12(8-17)15(19-14(11)18)22-6-5-20/h1-4,20-21H,5-6H2,(H2,18,19) D06TSQ DRUGINKE GYIHPWFWFRELQC-UHFFFAOYSA-N D06TSQ DRUGSMIL C1=CC(=CC=C1C2=C(C(=NC(=C2C#N)SCCO)N)C#N)O D06TSQ HIGHSTAT Investigative D06TUB DRUG__ID D06TUB D06TUB DRUGTYPE Small molecular drug D06TUB DRUGINCH 1S/4O.Tc/q;;;-1; D06TUB DRUGINKE FXUHHSACBOWLSP-UHFFFAOYSA-N D06TUB DRUGSMIL [O-][Tc](=O)(=O)=O D06TUB HIGHSTAT Investigative D06TVS DRUG__ID D06TVS D06TVS DRUGTYPE Small molecular drug D06TVS DRUGINCH 1S/C14H20N2O3/c1-10(2)8-12(14(18)16-19)13(17)15-9-11-6-4-3-5-7-11/h3-7,10,12,19H,8-9H2,1-2H3,(H,15,17)(H,16,18) D06TVS DRUGINKE BOQZRPQZGWWCDJ-UHFFFAOYSA-N D06TVS DRUGSMIL CC(C)CC(C(=O)NCC1=CC=CC=C1)C(=O)NO D06TVS HIGHSTAT Investigative D06TXM DRUG__ID D06TXM D06TXM DRUGTYPE Small molecular drug D06TXM DRUGINCH 1S/C20H26ClN3O2S/c1-4-5-6-7-11-16(19(25)26)27-20-23-17(21)12-18(24-20)22-15-10-8-9-13(2)14(15)3/h8-10,12,16H,4-7,11H2,1-3H3,(H,25,26)(H,22,23,24) D06TXM DRUGINKE HVJBWTVMRIOTEL-UHFFFAOYSA-N D06TXM DRUGSMIL CCCCCCC(C(=O)O)SC1=NC(=CC(=N1)Cl)NC2=CC=CC(=C2C)C D06TXM HIGHSTAT Investigative D06TXS DRUG__ID D06TXS D06TXS DRUGTYPE Small molecular drug D06TXS DRUGINCH 1S/C15H12N4O/c20-15(18-11-6-2-1-3-7-11)19-14-12-8-4-5-9-13(12)16-10-17-14/h1-10H,(H2,16,17,18,19,20) D06TXS DRUGINKE IYKBZJSFOBYNTL-UHFFFAOYSA-N D06TXS DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=NC=NC3=CC=CC=C32 D06TXS HIGHSTAT Investigative D06TYA DRUG__ID D06TYA D06TYA DRUGTYPE Small molecular drug D06TYA DRUGINCH 1S/C18H14N4O3S/c1-24-11-4-2-10(3-5-11)22-9-21-15-13-14-12(25-7-6-19-14)8-20-17(13)26-16(15)18(22)23/h2-5,8-9,19H,6-7H2,1H3 D06TYA DRUGINKE KUCDOJMOTMEEOF-UHFFFAOYSA-N D06TYA DRUGSMIL COC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=NC=C5C(=C34)NCCO5 D06TYA HIGHSTAT Investigative D06UAX DRUG__ID D06UAX D06UAX DRUGTYPE Small molecular drug D06UAX DRUGINCH 1S/C39H45N5O/c1-42(25-11-4-12-26-43-27-13-14-28-43)39-41-36-20-10-9-19-35(36)37(29-38(45)40-30-31-15-5-2-6-16-31)44(39)34-23-21-33(22-24-34)32-17-7-3-8-18-32/h2-3,5-10,15-24,37H,4,11-14,25-30H2,1H3,(H,40,45) D06UAX DRUGINKE SXLKSZQOUGOJGV-UHFFFAOYSA-N D06UAX DRUGSMIL CN(CCCCCN1CCCC1)C2=NC3=CC=CC=C3C(N2C4=CC=C(C=C4)C5=CC=CC=C5)CC(=O)NCC6=CC=CC=C6 D06UAX HIGHSTAT Investigative D06UBB DRUG__ID D06UBB D06UBB DRUGTYPE Small molecular drug D06UBB DRUGINCH 1S/C11H14ClN/c1-13-7-5-9-3-2-4-11(12)10(9)6-8-13/h2-4H,5-8H2,1H3 D06UBB DRUGINKE RSRUDTPYRBLHEO-UHFFFAOYSA-N D06UBB DRUGSMIL CN1CCC2=C(CC1)C(=CC=C2)Cl D06UBB HIGHSTAT Investigative D06UBH DRUG__ID D06UBH D06UBH DRUGTYPE Small molecular drug D06UBH DRUGINCH 1S/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14+,15-,16+,17-,19+,20-,21+/m0/s1 D06UBH DRUGINKE DUHUCHOQIDJXAT-OLVMNOGESA-N D06UBH DRUGSMIL CC(=O)C1CCC2C1(CC(=O)C3C2CCC4C3(CCC(C4)O)C)C D06UBH HIGHSTAT Investigative D06UDN DRUG__ID D06UDN D06UDN DRUGTYPE Small molecular drug D06UDN DRUGINCH 1S/C24H23N3O5/c28-24(32-22-11-9-20(10-12-22)27(29)30)26-15-13-25(14-16-26)18-19-5-4-8-23(17-19)31-21-6-2-1-3-7-21/h1-12,17H,13-16,18H2 D06UDN DRUGINKE QNYRAEKLMNDRFY-UHFFFAOYSA-N D06UDN DRUGSMIL C1CN(CCN1CC2=CC(=CC=C2)OC3=CC=CC=C3)C(=O)OC4=CC=C(C=C4)[N+](=O)[O-] D06UDN HIGHSTAT Investigative D06UDU DRUG__ID D06UDU D06UDU DRUGTYPE Small molecular drug D06UDU DRUGINCH 1S/C18H20FNO/c1-13-2-7-17(14-8-10-20-11-9-14)18(12-13)21-16-5-3-15(19)4-6-16/h2-7,12,14,20H,8-11H2,1H3 D06UDU DRUGINKE MUPPOMFFBLBAKT-UHFFFAOYSA-N D06UDU DRUGSMIL CC1=CC(=C(C=C1)C2CCNCC2)OC3=CC=C(C=C3)F D06UDU HIGHSTAT Investigative D06UEK DRUG__ID D06UEK D06UEK DRUGTYPE Small molecular drug D06UEK DRUGINCH 1S/C18H16N2O3/c21-15-8-6-14(7-9-15)12-16-17(22)19-18(23)20(16)11-10-13-4-2-1-3-5-13/h1-9,12,21H,10-11H2,(H,19,22,23)/b16-12+ D06UEK DRUGINKE SXBULDIKCMKRBS-FOWTUZBSSA-N D06UEK DRUGSMIL C1=CC=C(C=C1)CCN2C(=CC3=CC=C(C=C3)O)C(=O)NC2=O D06UEK HIGHSTAT Investigative D06UEP DRUG__ID D06UEP D06UEP DRUGCOMP GenKyoTex SA D06UEP DRUGINCH 1S/C19H15ClN4O2/c1-12-18-15(10-17(25)23(12)11-13-6-4-5-9-21-13)22-24(19(18)26)16-8-3-2-7-14(16)20/h2-10,22H,11H2,1H3 D06UEP DRUGINKE DNKYHHFCPXKFIY-UHFFFAOYSA-N D06UEP DRUGSMIL CC1=C2C(=CC(=O)N1CC3=CC=CC=N3)NN(C2=O)C4=CC=CC=C4Cl D06UEP HIGHSTAT Investigative D06UGK DRUG__ID D06UGK D06UGK DRUGTYPE Small molecular drug D06UGK DRUGINCH 1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/t7-,8-,10-,11+,12-,13-,14-,15-,16-/m1/s1 D06UGK DRUGINKE LFTYTUAZOPRMMI-NESSUJCYSA-N D06UGK DRUGSMIL CC(=O)NC1C(C(C(OC1OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)CO)O)O D06UGK HIGHSTAT Investigative D06UHZ DRUG__ID D06UHZ D06UHZ DRUGTYPE Small molecular drug D06UHZ DRUGINCH 1S/C6H7O3PS/c7-10(8,9)5-3-1-2-4-6(5)11/h1-4,11H,(H2,7,8,9) D06UHZ DRUGINKE XUDMIKRWJYMQKD-UHFFFAOYSA-N D06UHZ DRUGSMIL C1=CC=C(C(=C1)P(=O)(O)O)S D06UHZ HIGHSTAT Investigative D06UIU DRUG__ID D06UIU D06UIU DRUGTYPE Small molecular drug D06UIU DRUGINCH 1S/C31H38O7/c1-16(2)15-19(22-27(36)30(4,5)29(38)31(6,7)28(22)37)21-24(33)17(3)25(34)23(26(21)35)20(32)14-13-18-11-9-8-10-12-18/h8-12,16,19,33-36H,13-15H2,1-7H3 D06UIU DRUGINKE LCFIVEWYLOYPOX-UHFFFAOYSA-N D06UIU DRUGSMIL CC1=C(C(=C(C(=C1O)C(=O)CCC2=CC=CC=C2)O)C(CC(C)C)C3=C(C(C(=O)C(C3=O)(C)C)(C)C)O)O D06UIU HIGHSTAT Investigative D06UJA DRUG__ID D06UJA D06UJA DRUGTYPE Small molecular drug D06UJA DRUGINCH 1S/C21H16BrN3O/c22-17-4-5-19-20(13-17)24-18(6-7-21(26)25-19)16-3-1-2-15(12-16)14-8-10-23-11-9-14/h1-5,8-13H,6-7H2,(H,25,26) D06UJA DRUGINKE BLAQAVITPVXJJS-UHFFFAOYSA-N D06UJA DRUGSMIL C1CC(=O)NC2=C(C=C(C=C2)Br)N=C1C3=CC=CC(=C3)C4=CC=NC=C4 D06UJA HIGHSTAT Investigative D06UKS DRUG__ID D06UKS D06UKS DRUGTYPE Small molecular drug D06UKS DRUGINCH 1S/C20H13ClN6/c21-16-6-1-2-7-17(16)25-20-13-8-9-22-10-15(13)12-4-3-5-14(18(12)26-20)19-23-11-24-27-19/h1-11H,(H,25,26)(H,23,24,27) D06UKS DRUGINKE WNOHFJIMKSDPHP-UHFFFAOYSA-N D06UKS DRUGSMIL C1=CC=C(C(=C1)NC2=C3C=CN=CC3=C4C=CC=C(C4=N2)C5=NC=NN5)Cl D06UKS HIGHSTAT Investigative D06UKY DRUG__ID D06UKY D06UKY DRUGTYPE Small molecular drug D06UKY DRUGINCH 1S/C16H16Cl2N2/c17-11-6-7-13(15(18)8-11)14-9-20(10-16(14)19)12-4-2-1-3-5-12/h1-8,14,16H,9-10,19H2 D06UKY DRUGINKE KQIXDQQTPCBRIX-UHFFFAOYSA-N D06UKY DRUGSMIL C1C(C(CN1C2=CC=CC=C2)N)C3=C(C=C(C=C3)Cl)Cl D06UKY HIGHSTAT Investigative D06UNX DRUG__ID D06UNX D06UNX DRUGTYPE Small molecular drug D06UNX DRUGINCH 1S/C30H30N4O3.Fe/c1-8-20-19(7)29-34-27(20)15-25-18(6)22(10-11-28(35)36)23(32-25)12-13-31-24(16(3)4)14-26-17(5)21(9-2)30(33-26)37-29;/h8-9,12-15H,1-3,10-11H2,4-7H3,(H2-,31,32,33,34,35,36);/q;+4/p-1 D06UNX DRUGINKE QNHRNHLUNLNYAK-UHFFFAOYSA-M D06UNX DRUGSMIL CC1=C(C2=[O+]C3=NC(=CC4=C(C(=C([N-]4)C=CN=C(C=C1[N-]2)C(=C)C)CCC(=O)O)C)C(=C3C)C=C)C=C.[Fe+4] D06UNX HIGHSTAT Investigative D06UOL DRUG__ID D06UOL D06UOL DRUGTYPE Small molecular drug D06UOL DRUGINCH 1S/C16H31NOS/c1-2-3-4-5-6-7-8-9-14-19-15-13-17-12-10-11-16(17)18/h2-15H2,1H3 D06UOL DRUGINKE VDPRSOCKHVPZRS-UHFFFAOYSA-N D06UOL DRUGSMIL CCCCCCCCCCSCCN1CCCC1=O D06UOL HIGHSTAT Investigative D06UPR DRUG__ID D06UPR D06UPR DRUGTYPE Small molecular drug D06UPR DRUGINCH 1S/C14H11NO5S/c16-14(11-6-8-12(9-7-11)15(17)18)10-21(19,20)13-4-2-1-3-5-13/h1-9H,10H2 D06UPR DRUGINKE GBLYERGOMLTORH-UHFFFAOYSA-N D06UPR DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CC(=O)C2=CC=C(C=C2)[N+](=O)[O-] D06UPR HIGHSTAT Investigative D06UPT DRUG__ID D06UPT D06UPT DRUGTYPE Small molecular drug D06UPT DRUGINCH 1S/C18H17N7/c1-10-11(9-23-17-15(10)16(19)24-18(20)25-17)8-22-14-6-2-5-13-12(14)4-3-7-21-13/h2-7,9,22H,8H2,1H3,(H4,19,20,23,24,25) D06UPT DRUGINKE KMSATRJZEXNGDP-UHFFFAOYSA-N D06UPT DRUGSMIL CC1=C2C(=NC(=NC2=NC=C1CNC3=CC=CC4=C3C=CC=N4)N)N D06UPT HIGHSTAT Investigative D06UQR DRUG__ID D06UQR D06UQR DRUGTYPE Small molecular drug D06UQR DRUGINCH 1S/C13H15NO4/c1-7-5-10(15)14-12-8(16-2)6-9(17-3)13(18-4)11(7)12/h5-6H,1-4H3,(H,14,15) D06UQR DRUGINKE YRUICGVVPDTGCH-UHFFFAOYSA-N D06UQR DRUGSMIL CC1=CC(=O)NC2=C1C(=C(C=C2OC)OC)OC D06UQR HIGHSTAT Investigative D06UTW DRUG__ID D06UTW D06UTW DRUGTYPE Small molecular drug D06UTW DRUGINCH 1S/C26H36O8/c1-5-6-10-32-15-33-19-12-18(23(28)30-4)25(2)9-7-17-24(29)34-20(16-8-11-31-14-16)13-26(17,3)22(25)21(19)27/h8,11,14,17-20,22H,5-7,9-10,12-13,15H2,1-4H3/t17-,18-,19-,20-,22-,25-,26-/m0/s1 D06UTW DRUGINKE SWDPRRWCLDGMFD-VHPHCEBOSA-N D06UTW DRUGSMIL CCCCOCOC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D06UTW HIGHSTAT Investigative D06UUK DRUG__ID D06UUK D06UUK DRUGTYPE Small molecular drug D06UUK DRUGINCH 1S/C6H9NO6/c7-3(6(12)13)1-2(4(8)9)5(10)11/h2-3H,1,7H2,(H,8,9)(H,10,11)(H,12,13)/t3-/m0/s1 D06UUK DRUGINKE UHBYWPGGCSDKFX-VKHMYHEASA-N D06UUK DRUGSMIL C(C(C(=O)O)C(=O)O)C(C(=O)O)N D06UUK HIGHSTAT Investigative D06UVF DRUG__ID D06UVF D06UVF DRUGTYPE Small molecular drug D06UVF DRUGINCH 1S/C6H17NO6P2/c1-2-3-4-7-5-6(14(8,9)10)15(11,12)13/h6-7H,2-5H2,1H3,(H2,8,9,10)(H2,11,12,13) D06UVF DRUGINKE HFKAJGBERMPCOS-UHFFFAOYSA-N D06UVF DRUGSMIL CCCCNCC(P(=O)(O)O)P(=O)(O)O D06UVF HIGHSTAT Investigative D06UVY DRUG__ID D06UVY D06UVY DRUGTYPE Small molecular drug D06UVY DRUGINCH 1S/C15H17N3O5/c16-10(14(21)18-12(15(22)23)6-13(19)20)5-8-7-17-11-4-2-1-3-9(8)11/h1-4,7,10,12,17H,5-6,16H2,(H,18,21)(H,19,20)(H,22,23)/t10-,12-/m0/s1 D06UVY DRUGINKE PEEAINPHPNDNGE-JQWIXIFHSA-N D06UVY DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC(=O)O)C(=O)O)N D06UVY HIGHSTAT Investigative D06UXW DRUG__ID D06UXW D06UXW DRUGTYPE Small molecular drug D06UXW DRUGINCH 1S/C36H62N4O2.4ClH/c1-41-35-23-13-11-21-33(35)31-39-29-19-9-7-17-27-37-25-15-5-3-4-6-16-26-38-28-18-8-10-20-30-40-32-34-22-12-14-24-36(34)42-2;;;;/h11-14,21-24,37-40H,3-10,15-20,25-32H2,1-2H3;4*1H D06UXW DRUGINKE CDKGGOUDHGSFAF-UHFFFAOYSA-N D06UXW DRUGSMIL COC1=CC=CC=C1CNCCCCCCNCCCCCCCCNCCCCCCNCC2=CC=CC=C2OC.Cl.Cl.Cl.Cl D06UXW HIGHSTAT Investigative D06UZK DRUG__ID D06UZK D06UZK DRUGTYPE Small molecular drug D06UZK DRUGINCH 1S/C8H10N2O2/c11-8(12)7-5-3-1-2-4-6(5)9-10-7/h1-4H2,(H,9,10)(H,11,12) D06UZK DRUGINKE LWXNHFZBFJMHGU-UHFFFAOYSA-N D06UZK DRUGSMIL C1CCC2=C(C1)C(=NN2)C(=O)O D06UZK HIGHSTAT Investigative D06VBN DRUG__ID D06VBN D06VBN DRUGTYPE Small molecular drug D06VBN DRUGINCH 1S/C17H18N2O3/c1-2-15(12-6-4-3-5-7-12)17(21)18-14-10-8-13(9-11-14)16(20)19-22/h3-11,15,22H,2H2,1H3,(H,18,21)(H,19,20) D06VBN DRUGINKE SPLALNOEMVSHPJ-UHFFFAOYSA-N D06VBN DRUGSMIL CCC(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO D06VBN HIGHSTAT Investigative D06VBQ DRUG__ID D06VBQ D06VBQ DRUGTYPE Small molecular drug D06VBQ DRUGINCH 1S/C19H18N2O5S2/c1-25-16-12-14(20-13-6-4-3-5-7-13)8-9-15(16)21-28(23,24)17-10-11-27-18(17)19(22)26-2/h3-12,20-21H,1-2H3 D06VBQ DRUGINKE NDFKBGWLUHKMFY-UHFFFAOYSA-N D06VBQ DRUGSMIL COC1=C(C=CC(=C1)NC2=CC=CC=C2)NS(=O)(=O)C3=C(SC=C3)C(=O)OC D06VBQ HIGHSTAT Investigative D06VDN DRUG__ID D06VDN D06VDN DRUGTYPE Small molecular drug D06VDN DRUGINCH 1S/C22H19F3N4O2/c1-13-10-15-7-9-29(18(15)11-17(13)22(23,24)25)21(30)28-16-5-6-20(27-12-16)31-19-4-3-8-26-14(19)2/h3-6,8,10-12H,7,9H2,1-2H3,(H,28,30) D06VDN DRUGINKE ZETBBVYSBABLHL-UHFFFAOYSA-N D06VDN DRUGSMIL CC1=CC2=C(C=C1C(F)(F)F)N(CC2)C(=O)NC3=CN=C(C=C3)OC4=C(N=CC=C4)C D06VDN HIGHSTAT Investigative D06VGD DRUG__ID D06VGD D06VGD DRUGTYPE Small molecular drug D06VGD DRUGINCH 1S/C12H6O2/c13-11-8-5-1-3-7-4-2-6-9(10(7)8)12(11)14/h1-6H D06VGD DRUGINKE AFPRJLBZLPBTPZ-UHFFFAOYSA-N D06VGD DRUGSMIL C1=CC2=C3C(=C1)C(=O)C(=O)C3=CC=C2 D06VGD HIGHSTAT Investigative D06VGG DRUG__ID D06VGG D06VGG DRUGTYPE Small molecular drug D06VGG DRUGINCH 1S/C26H19N3O6/c1-25-26(33,11-30)10-16(35-25)27-14-8-4-2-6-12(14)17-19-20(24(32)29(34)23(19)31)18-13-7-3-5-9-15(13)28(25)22(18)21(17)27/h2-9,16,30,33-34H,10-11H2,1H3/t16-,25-,26-/m0/s1 D06VGG DRUGINKE KNJUOEDHHOTPLA-LADPQGRPSA-N D06VGG DRUGSMIL CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(=O)N(C6=O)O)(CO)O D06VGG HIGHSTAT Investigative D06VIP DRUG__ID D06VIP D06VIP DRUGTYPE Small molecular drug D06VIP DRUGINCH 1S/C12H21N3O3/c1-8(2)9(10(16)14-7-6-13)15-11(17)18-12(3,4)5/h8-9H,7H2,1-5H3,(H,14,16)(H,15,17)/t9-/m0/s1 D06VIP DRUGINKE OHPJKVGJQUYVFQ-VIFPVBQESA-N D06VIP DRUGSMIL CC(C)C(C(=O)NCC#N)NC(=O)OC(C)(C)C D06VIP HIGHSTAT Investigative D06VNR DRUG__ID D06VNR D06VNR DRUGTYPE Small molecular drug D06VNR DRUGINCH 1S/C18H17NO3/c1-20-17-9-14-8-15(11-19-16(14)10-18(17)21-2)22-12-13-6-4-3-5-7-13/h3-11H,12H2,1-2H3 D06VNR DRUGINKE ZJIOVLLLFWQBKA-UHFFFAOYSA-N D06VNR DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)OCC3=CC=CC=C3 D06VNR HIGHSTAT Investigative D06VNT DRUG__ID D06VNT D06VNT DRUGTYPE Small molecular drug D06VNT DRUGINCH 1S/C5H8O3/c1-4(3-6)2-5(7)8/h2,6H,3H2,1H3,(H,7,8)/b4-2+ D06VNT DRUGINKE BERUOTKXCOOJJM-DUXPYHPUSA-N D06VNT DRUGSMIL CC(=CC(=O)O)CO D06VNT HIGHSTAT Investigative D06VOJ DRUG__ID D06VOJ D06VOJ DRUGTYPE Small molecular drug D06VOJ DRUGINCH 1S/C28H26Cl2FNO5/c1-16(32-26(33)14-20(28(36)37)15-27(34)35)22(11-17-7-10-23(29)24(30)12-17)19-8-9-21(25(31)13-19)18-5-3-2-4-6-18/h2-10,12-13,16,20,22H,11,14-15H2,1H3,(H,32,33)(H,34,35)(H,36,37)/t16-,20-,22+/m0/s1 D06VOJ DRUGINKE NBRLADMQSZWKGO-XUEUYAKLSA-N D06VOJ DRUGSMIL CC(C(CC1=CC(=C(C=C1)Cl)Cl)C2=CC(=C(C=C2)C3=CC=CC=C3)F)NC(=O)CC(CC(=O)O)C(=O)O D06VOJ HIGHSTAT Investigative D06VON DRUG__ID D06VON D06VON DRUGTYPE Small molecular drug D06VON DRUGINCH 1S/C8H11NS/c9-8(6-10)7-4-2-1-3-5-7/h1-5,8,10H,6,9H2/t8-/m1/s1 D06VON DRUGINKE BYWNHDXZFZXBLV-MRVPVSSYSA-N D06VON DRUGSMIL C1=CC=C(C=C1)C(CS)N D06VON HIGHSTAT Investigative D06VPR DRUG__ID D06VPR D06VPR DRUGTYPE Small molecular drug D06VPR DRUGINCH 1S/C19H20IN3O2S/c20-17-5-1-2-6-19(17)26(24,25)23-15-7-8-18-16(11-15)13(12-22-18)10-14-4-3-9-21-14/h1-2,5-8,11-12,14,21-23H,3-4,9-10H2/t14-/m1/s1 D06VPR DRUGINKE ZLTKHJVPOSETMR-CQSZACIVSA-N D06VPR DRUGSMIL C1CC(NC1)CC2=CNC3=C2C=C(C=C3)NS(=O)(=O)C4=CC=CC=C4I D06VPR HIGHSTAT Investigative D06VRA DRUG__ID D06VRA D06VRA DRUGTYPE Small molecular drug D06VRA DRUGINCH 1S/C28H24O2/c29-28-19-22-9-8-21-4-3-6-25(18-21)30-24-15-11-20(12-16-24)10-14-23-5-1-2-7-26(23)27(28)17-13-22/h1-7,11-13,15-19,29H,8-10,14H2 D06VRA DRUGINKE AWANYYTXBZWDHH-UHFFFAOYSA-N D06VRA DRUGSMIL C1CC2=CC=CC=C2C3=C(C=C(CCC4=CC(=CC=C4)OC5=CC=C1C=C5)C=C3)O D06VRA HIGHSTAT Investigative D06VSA DRUG__ID D06VSA D06VSA DRUGTYPE Small molecular drug D06VSA DRUGINCH 1S/C18H21NO4/c1-22-18(21)16-13-19-17(23-16)15(20)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D06VSA DRUGINKE BIKPWTFTYRRSPI-UHFFFAOYSA-N D06VSA DRUGSMIL COC(=O)C1=CN=C(O1)C(=O)CCCCCCC2=CC=CC=C2 D06VSA HIGHSTAT Investigative D06VST DRUG__ID D06VST D06VST DRUGTYPE Small molecular drug D06VST DRUGINCH 1S/C12H19NO/c1-11(12(2)14)7-3-4-8-13-9-5-6-10-13/h11H,5-10H2,1-2H3 D06VST DRUGINKE FFWLTEFDRQBMQC-UHFFFAOYSA-N D06VST DRUGSMIL CC(CC#CCN1CCCC1)C(=O)C D06VST HIGHSTAT Investigative D06VTW DRUG__ID D06VTW D06VTW DRUGTYPE Small molecular drug D06VTW DRUGINCH 1S/C37H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h24-26,30-32,36,47-48H,4-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/t26-,30-,31-,32+,36-/m1/s1 D06VTW DRUGINKE MNBKLUUYKPBKDU-BBECNAHFSA-N D06VTW DRUGSMIL CCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D06VTW HIGHSTAT Investigative D06VUC DRUG__ID D06VUC D06VUC DRUGTYPE Small molecular drug D06VUC DRUGINCH 1S/C11H13Cl2NO2S/c12-8-2-1-7(5-9(8)13)6-17-4-3-10(14)11(15)16/h1-2,5,10H,3-4,6,14H2,(H,15,16) D06VUC DRUGINKE FCRWKMQNOHHYCO-UHFFFAOYSA-N D06VUC DRUGSMIL C1=CC(=C(C=C1CSCCC(C(=O)O)N)Cl)Cl D06VUC HIGHSTAT Investigative D06VVV DRUG__ID D06VVV D06VVV DRUGTYPE Small molecular drug D06VVV DRUGINCH 1S/C14H13NO6/c16-11(17)7-3-6-10(14(20)21)15-12(18)8-4-1-2-5-9(8)13(15)19/h1-2,4-5,10H,3,6-7H2,(H,16,17)(H,20,21) D06VVV DRUGINKE WJNORNDVKYKEGX-UHFFFAOYSA-N D06VVV DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)C(CCCC(=O)O)C(=O)O D06VVV HIGHSTAT Investigative D06VWH DRUG__ID D06VWH D06VWH DRUGTYPE Small molecular drug D06VWH DRUGINCH 1S/C36H37ClN2O4/c1-35(2,3)20-32(40)33-28-18-27(43-22-26-15-12-24-8-6-7-9-29(24)38-26)16-17-30(28)39(21-23-10-13-25(37)14-11-23)31(33)19-36(4,5)34(41)42/h6-18H,19-22H2,1-5H3,(H,41,42) D06VWH DRUGINKE IUHIISLXVJPCRU-UHFFFAOYSA-N D06VWH DRUGSMIL CC(C)(C)CC(=O)C1=C(N(C2=C1C=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)CC5=CC=C(C=C5)Cl)CC(C)(C)C(=O)O D06VWH HIGHSTAT Investigative D06VXW DRUG__ID D06VXW D06VXW DRUGTYPE Small molecular drug D06VXW DRUGINCH 1S/C14H14O3/c1-15-13-7-12(8-14(9-13)16-2)4-3-11-5-6-17-10-11/h3-10H,1-2H3/b4-3+ D06VXW DRUGINKE UUOXVOMLPNADJK-ONEGZZNKSA-N D06VXW DRUGSMIL COC1=CC(=CC(=C1)C=CC2=COC=C2)OC D06VXW HIGHSTAT Investigative D06VYA DRUG__ID D06VYA D06VYA DRUGTYPE Small molecular drug D06VYA DRUGINCH 1S/C20H27NO2/c1-3-13-21(14-4-2)15-12-17-10-11-18(22)20(23)19(17)16-8-6-5-7-9-16/h5-11,22-23H,3-4,12-15H2,1-2H3 D06VYA DRUGINKE HDPTVXIDWCYRQU-UHFFFAOYSA-N D06VYA DRUGSMIL CCCN(CCC)CCC1=C(C(=C(C=C1)O)O)C2=CC=CC=C2 D06VYA HIGHSTAT Investigative D06VYT DRUG__ID D06VYT D06VYT DRUGTYPE Small molecular drug D06VYT DRUGINCH 1S/C6H10O10S/c7-1-2(8)4(16-17(12,13)14)6(11)15-3(1)5(9)10/h1-4,6-8,11H,(H,9,10)(H,12,13,14)/t1-,2-,3-,4+,6+/m1/s1 D06VYT DRUGINKE COJBCAMFZDFGFK-SZXBDDMQSA-N D06VYT DRUGSMIL C1(C(C(OC(C1OS(=O)(=O)O)O)C(=O)O)O)O D06VYT HIGHSTAT Investigative D06VYU DRUG__ID D06VYU D06VYU DRUGTYPE Small molecular drug D06VYU DRUGINCH 1S/C8H16N2S/c1-2-3-7-6-11-5-4-8(9)10-7/h7H,2-6H2,1H3,(H2,9,10)/t7-/m0/s1 D06VYU DRUGINKE SWOQAUBWIBZBLQ-ZETCQYMHSA-N D06VYU DRUGSMIL CCCC1CSCCC(=N1)N D06VYU HIGHSTAT Investigative D06VZE DRUG__ID D06VZE D06VZE DRUGTYPE Small molecular drug D06VZE DRUGINCH 1S/C20H30O2/c1-12-10-13-11-14(21)4-5-15(13)16-6-8-19(2)17(18(12)16)7-9-20(19,3)22/h11-12,15-18,22H,4-10H2,1-3H3/t12-,15+,16-,17+,18-,19+,20+/m1/s1 D06VZE DRUGINKE PTQMMNYJKCSPET-OMHQDGTGSA-N D06VZE DRUGSMIL CC1CC2=CC(=O)CCC2C3C1C4CCC(C4(CC3)C)(C)O D06VZE HIGHSTAT Investigative D06VZS DRUG__ID D06VZS D06VZS DRUGTYPE Small molecular drug D06VZS DRUGINCH 1S/C23H32O6S2/c1-29-14-17-6-3-2-5-16(17)7-8-18(24)9-10-19-20(25)13-21(26)23(19)31-12-4-11-30-15-22(27)28/h2-3,5-6,9-10,18-20,23-25H,4,7-8,11-15H2,1H3,(H,27,28)/b10-9+/t18-,19-,20+,23+/m0/s1 D06VZS DRUGINKE BVGVPUMSPSNRRQ-CNOJNPITSA-N D06VZS DRUGSMIL COCC1=CC=CC=C1CCC(C=CC2C(CC(=O)C2SCCCSCC(=O)O)O)O D06VZS HIGHSTAT Investigative D06WAL DRUG__ID D06WAL D06WAL DRUGTYPE Small molecular drug D06WAL DRUGINCH 1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1 D06WAL DRUGINKE IOUVKUPGCMBWBT-QNDFHXLGSA-N D06WAL DRUGSMIL C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2OC3C(C(C(C(O3)CO)O)O)O)O)O)O D06WAL HIGHSTAT Investigative D06WCI DRUG__ID D06WCI D06WCI DRUGTYPE Small molecular drug D06WCI DRUGINCH 1S/C137H207N41O39S3/c1-69(154-113(194)82(37-19-22-47-138)159-115(196)85(40-25-50-149-136(145)146)160-118(199)87(44-45-106(188)189)163-116(197)86(41-26-51-150-137(147)148)164-130(211)101-43-27-52-177(101)133(214)72(4)156-114(195)88(46-54-218-7)158-110(191)71(3)155-129(210)100-42-28-53-178(100)134(215)95(61-104(144)186)171-126(207)96(65-180)172-124(205)93(59-102(142)184)165-111(192)70(2)153-112(193)80(141)64-179)109(190)152-63-105(187)157-98-67-219-220-68-99(135(216)217)174-127(208)97(66-181)173-132(213)108(74(6)183)176-125(206)91(57-77-33-15-10-16-34-77)170-131(212)107(73(5)182)175-119(200)84(39-21-24-49-140)161-122(203)92(58-78-62-151-81-36-18-17-35-79(78)81)168-121(202)90(56-76-31-13-9-14-32-76)166-120(201)89(55-75-29-11-8-12-30-75)167-123(204)94(60-103(143)185)169-117(198)83(162-128(98)209)38-20-23-48-139/h8-18,29-36,62,69-74,80,82-101,107-108,151,179-183H,19-28,37-61,63-68,138-141H2,1-7H3,(H2,142,184)(H2,143,185)(H2,144,186)(H,152,190)(H,153,193)(H,154,194)(H,155,210)(H,156,195)(H,157,187)(H,158,191)(H,159,196)(H,160,199)(H,161,203)(H,162,209)(H,163,197)(H,164,211)(H,165,192)(H,166,201)(H,167,204)(H,168,202)(H,169,198)(H,170,212)(H,171,207)(H,172,205)(H,173,213)(H,174,208)(H,175,200)(H,176,206)(H,188,189)(H,216,217)(H4,145,146,149)(H4,147,148,150)/t69-,70-,71-,72-,73+,74+,80-,82-,83+,84-,85-,86-,87-,88-,89+,90-,91-,92+,93-,94-,95-,96-,97-,98+,99-,100-,101-,107+,108+/m0/s1 D06WCI DRUGINKE GGYTXJNZMFRSLX-OKOIUDDXSA-N D06WCI DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C6CCCN6C(=O)C(C)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C7CCCN7C(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CO)N)C(=O)O)CO)C(C)O)CC8=CC=CC=C8)O D06WCI HIGHSTAT Investigative D06WCT DRUG__ID D06WCT D06WCT DRUGTYPE Small molecular drug D06WCT DRUGINCH 1S/C21H21NO4/c23-19-15-21(22-9-12-24-13-10-22)26-20-14-17(6-7-18(19)20)25-11-8-16-4-2-1-3-5-16/h1-7,14-15H,8-13H2 D06WCT DRUGINKE KIOBMXIHRJGBLA-UHFFFAOYSA-N D06WCT DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)OCCC4=CC=CC=C4 D06WCT HIGHSTAT Investigative D06WGX DRUG__ID D06WGX D06WGX DRUGTYPE Small molecular drug D06WGX DRUGINCH 1S/C34H39N9O3/c1-21(44)41-14-16-42(17-15-41)24-9-11-25(12-10-24)43-33-30(32(35)36-20-37-33)31(39-43)23-8-13-26(29(19-23)46-3)38-34(45)28-18-22-6-4-5-7-27(22)40(28)2/h4-8,13,18-20,24-25H,9-12,14-17H2,1-3H3,(H,38,45)(H2,35,36,37) D06WGX DRUGINKE ZMNWFTYYYCSSTF-UHFFFAOYSA-N D06WGX DRUGSMIL CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=NC=NC(=C4C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)N D06WGX HIGHSTAT Investigative D06WIV DRUG__ID D06WIV D06WIV DRUGTYPE Small molecular drug D06WIV DRUGINCH 1S/C17H20N2/c1-2-6-14(7-3-1)17-9-5-4-8-15(17)12-19-16-10-11-18-13-16/h1-9,16,18-19H,10-13H2/t16-/m0/s1 D06WIV DRUGINKE DGKNIGATLZIOSX-INIZCTEOSA-N D06WIV DRUGSMIL C1CNCC1NCC2=CC=CC=C2C3=CC=CC=C3 D06WIV HIGHSTAT Investigative D06WJA DRUG__ID D06WJA D06WJA DRUGTYPE Small molecular drug D06WJA DRUGINCH 1S/C20H14ClN3O/c21-16-7-6-15(12-17(16)25)19-18(13-8-10-22-11-9-13)23-20(24-19)14-4-2-1-3-5-14/h1-12,25H,(H,23,24) D06WJA DRUGINKE WXJLXRNWMLWVFB-UHFFFAOYSA-N D06WJA DRUGSMIL C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC(=C(C=C4)Cl)O D06WJA HIGHSTAT Investigative D06WJC DRUG__ID D06WJC D06WJC DRUGTYPE Small molecular drug D06WJC DRUGINCH 1S/C24H24O4/c1-16-10-21(28-15-24(26)27)11-17(2)22(16)14-19-8-9-23(25)20(13-19)12-18-6-4-3-5-7-18/h3-11,13,25H,12,14-15H2,1-2H3,(H,26,27) D06WJC DRUGINKE JYHIGYLGYNCMGI-UHFFFAOYSA-N D06WJC DRUGSMIL CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)CC3=CC=CC=C3)C)OCC(=O)O D06WJC HIGHSTAT Investigative D06WLB DRUG__ID D06WLB D06WLB DRUGTYPE Small molecular drug D06WLB DRUGINCH 1S/C17H18N2O/c1-2-5-14(6-3-1)13-18-11-12-20-17-8-4-7-16-15(17)9-10-19-16/h1-10,18-19H,11-13H2 D06WLB DRUGINKE ZEHDEZWEFBOGNZ-UHFFFAOYSA-N D06WLB DRUGSMIL C1=CC=C(C=C1)CNCCOC2=CC=CC3=C2C=CN3 D06WLB HIGHSTAT Investigative D06WML DRUG__ID D06WML D06WML DRUGTYPE Small molecular drug D06WML DRUGINCH 1S/C17H15NO/c1-2-15-16(13-9-5-3-6-10-13)17(18-19-15)14-11-7-4-8-12-14/h3-12H,2H2,1H3 D06WML DRUGINKE MXTWADCRLRQMDW-UHFFFAOYSA-N D06WML DRUGSMIL CCC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=CC=C3 D06WML HIGHSTAT Investigative D06WMM DRUG__ID D06WMM D06WMM DRUGTYPE Small molecular drug D06WMM DRUGINCH 1S/C15H16N2O/c1-2-3-8-18-15-9-12-11-6-4-5-7-13(11)17-14(12)10-16-15/h4-7,9-10,17H,2-3,8H2,1H3 D06WMM DRUGINKE UARMCWOWRLFTFP-UHFFFAOYSA-N D06WMM DRUGSMIL CCCCOC1=NC=C2C(=C1)C3=CC=CC=C3N2 D06WMM HIGHSTAT Investigative D06WNK DRUG__ID D06WNK D06WNK DRUGTYPE Small molecular drug D06WNK DRUGINCH 1S/C16H15NOS/c1-11-5-4-6-12(2)16(11)19-14-8-7-13(10-17)15(9-14)18-3/h4-9H,1-3H3 D06WNK DRUGINKE AAYYOXKEPZBTIZ-UHFFFAOYSA-N D06WNK DRUGSMIL CC1=C(C(=CC=C1)C)SC2=CC(=C(C=C2)C#N)OC D06WNK HIGHSTAT Investigative D06WPP DRUG__ID D06WPP D06WPP DRUGTYPE Small molecular drug D06WPP DRUGINCH 1S/C20H15BrN2O3/c1-25-15-6-7-16-18(10-15)26-20(13-2-4-14(21)5-3-13)17(19(16)24)11-23-9-8-22-12-23/h2-10,12H,11H2,1H3 D06WPP DRUGINKE DWMSDWDWUCFTQZ-UHFFFAOYSA-N D06WPP DRUGSMIL COC1=CC2=C(C=C1)C(=O)C(=C(O2)C3=CC=C(C=C3)Br)CN4C=CN=C4 D06WPP HIGHSTAT Investigative D06WQP DRUG__ID D06WQP D06WQP DRUGTYPE Small molecular drug D06WQP DRUGINCH 1S/C17H24N4O4S/c1-13(2)10-26(24,25)11-15(17(23)21(4)20(3)12-18)19-16(22)14-8-6-5-7-9-14/h5-9,13,15H,10-11H2,1-4H3,(H,19,22)/t15-/m0/s1 D06WQP DRUGINKE UGAZRSHSXNNYTK-HNNXBMFYSA-N D06WQP DRUGSMIL CC(C)CS(=O)(=O)CC(C(=O)N(C)N(C)C#N)NC(=O)C1=CC=CC=C1 D06WQP HIGHSTAT Investigative D06WRC DRUG__ID D06WRC D06WRC DRUGTYPE Small molecular drug D06WRC DRUGINCH 1S/C39H54O5/c1-34(2)19-21-39(33(42)43)22-20-37(6)26(27(39)23-34)14-15-30-36(5)24-28(40)32(35(3,4)29(36)17-18-38(30,37)7)44-31(41)16-13-25-11-9-8-10-12-25/h8-14,16,27-30,32,40H,15,17-24H2,1-7H3,(H,42,43)/b16-13-/t27-,28+,29-,30+,32-,36-,37+,38+,39-/m0/s1 D06WRC DRUGINKE QYNZDAXHBDWWFS-GZOAODGCSA-N D06WRC DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)OC(=O)C=CC6=CC=CC=C6)O)C)C)C2C1)C)C(=O)O)C D06WRC HIGHSTAT Investigative D06WSN DRUG__ID D06WSN D06WSN DRUGTYPE Small molecular drug D06WSN DRUGINCH 1S/C18H19N3O/c19-12-15-8-4-10-21(15)18(22)17(20)11-14-7-3-6-13-5-1-2-9-16(13)14/h1-3,5-7,9,15,17H,4,8,10-11,20H2/t15-,17-/m0/s1 D06WSN DRUGINKE ZVRWNKCHASBEDZ-RDJZCZTQSA-N D06WSN DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC3=CC=CC=C32)N)C#N D06WSN HIGHSTAT Investigative D06WSW DRUG__ID D06WSW D06WSW DRUGTYPE Small molecular drug D06WSW DRUGINCH 1S/C18H33O19P/c19-1-4-8(22)14(12(26)16(28)33-4)36-18-13(27)15(9(23)5(2-20)34-18)37-17-11(25)10(24)7(21)6(35-17)3-32-38(29,30)31/h4-28H,1-3H2,(H2,29,30,31)/t4-,5-,6-,7-,8-,9-,10+,11+,12+,13+,14+,15+,16+,17-,18-/m1/s1 D06WSW DRUGINKE HDQMHAJOIVYOIP-NAVBLJQLSA-N D06WSW DRUGSMIL C(C1C(C(C(C(O1)O)O)OC2C(C(C(C(O2)CO)O)OC3C(C(C(C(O3)COP(=O)(O)O)O)O)O)O)O)O D06WSW HIGHSTAT Investigative D06WUE DRUG__ID D06WUE D06WUE DRUGTYPE Small molecular drug D06WUE DRUGINCH 1S/C11H9Cl2NO2S2/c1-7-2-4-8(5-3-7)14-18(15,16)9-6-10(12)17-11(9)13/h2-6,14H,1H3 D06WUE DRUGINKE OQWXAWNHXDPWGS-UHFFFAOYSA-N D06WUE DRUGSMIL CC1=CC=C(C=C1)NS(=O)(=O)C2=C(SC(=C2)Cl)Cl D06WUE HIGHSTAT Investigative D06WVV DRUG__ID D06WVV D06WVV DRUGTYPE Small molecular drug D06WVV DRUGINCH 1S/C13H11N3O4/c17-12-10(7-4-8-11(12)16(19)20)15-13(18)14-9-5-2-1-3-6-9/h1-8,17H,(H2,14,15,18) D06WVV DRUGINKE DZLCFOMBBDNYIQ-UHFFFAOYSA-N D06WVV DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=C(C(=CC=C2)[N+](=O)[O-])O D06WVV HIGHSTAT Investigative D06WXN DRUG__ID D06WXN D06WXN DRUGTYPE Small molecular drug D06WXN DRUGINCH 1S/C11H12N4O2/c1-15-9(2-3-12-15)6-4-7-8(5-6)13-14-10(7)11(16)17/h2-3,6H,4-5H2,1H3,(H,13,14)(H,16,17) D06WXN DRUGINKE ZAJBYTSUTBCMRM-UHFFFAOYSA-N D06WXN DRUGSMIL CN1C(=CC=N1)C2CC3=C(C2)NN=C3C(=O)O D06WXN HIGHSTAT Investigative D06WZG DRUG__ID D06WZG D06WZG DRUGTYPE Small molecular drug D06WZG DRUGINCH 1S/C13H12O4/c1-3-16-10-6-4-9-5-7-11(15)17-13(9)12(10)8(2)14/h4-7H,3H2,1-2H3 D06WZG DRUGINKE KWMPAFCHEJYQEQ-UHFFFAOYSA-N D06WZG DRUGSMIL CCOC1=C(C2=C(C=C1)C=CC(=O)O2)C(=O)C D06WZG HIGHSTAT Investigative D06XDA DRUG__ID D06XDA D06XDA DRUGTYPE Small molecular drug D06XDA DRUGINCH 1S/C16H24N2O2/c1-9-7-10(17)8-13-14(9)16(19)15-11-3-2-5-18(11)6-4-12(15)20-13/h9-12,15H,2-8,17H2,1H3/t9-,10-,11-,12+,15-/m0/s1 D06XDA DRUGINKE AOYSDZUESPFRDD-NAYUARGSSA-N D06XDA DRUGSMIL CC1CC(CC2=C1C(=O)C3C4CCCN4CCC3O2)N D06XDA HIGHSTAT Investigative D06XFP DRUG__ID D06XFP D06XFP DRUGTYPE Small molecular drug D06XFP DRUGINCH 1S/C18H25F3O2/c1-2-3-4-7-14-23-16-12-10-15(11-13-16)8-5-6-9-17(22)18(19,20)21/h10-13H,2-9,14H2,1H3 D06XFP DRUGINKE AKKQOQJOIIZUSW-UHFFFAOYSA-N D06XFP DRUGSMIL CCCCCCOC1=CC=C(C=C1)CCCCC(=O)C(F)(F)F D06XFP HIGHSTAT Investigative D06XFS DRUG__ID D06XFS D06XFS DRUGTYPE Small molecular drug D06XFS DRUGINCH 1S/C15H12N2/c1-11-4-5-12-6-7-13(9-15(12)17-11)14-3-2-8-16-10-14/h2-10H,1H3 D06XFS DRUGINKE MALXWWORFUKTKQ-UHFFFAOYSA-N D06XFS DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CN=CC=C3 D06XFS HIGHSTAT Investigative D06XGK DRUG__ID D06XGK D06XGK DRUGTYPE Small molecular drug D06XGK DRUGINCH 1S/C21H32O5S/c1-13(22)17-6-7-18-16-5-4-14-12-15(26-27(23,24)25)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19H,5-12H2,1-3H3,(H,23,24,25)/t15-,16-,17+,18-,19-,20-,21+/m0/s1 D06XGK DRUGINKE DIJBBUIOWGGQOP-QGVNFLHTSA-N D06XGK DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OS(=O)(=O)O)C)C D06XGK HIGHSTAT Investigative D06XGL DRUG__ID D06XGL D06XGL DRUGTYPE Small molecular drug D06XGL DRUGINCH 1S/C26H32N2O8S/c1-12(29)27-16-7-5-13-9-17(28-26-23(33)22(32)19(31)11-36-26)24(34-2)25(35-3)21(13)14-6-8-20(37-4)18(30)10-15(14)16/h6,8-10,16,19,22-23,26,28,31-33H,5,7,11H2,1-4H3,(H,27,29)/t16-,19+,22-,23+,26?/m0/s1 D06XGL DRUGINKE MCKYAFJMJJFRCX-PXSUQPJVSA-N D06XGL DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)NC4C(C(C(CO4)O)O)O D06XGL HIGHSTAT Investigative D06XIC DRUG__ID D06XIC D06XIC DRUGTYPE Small molecular drug D06XIC DRUGINCH 1S/C25H36O2/c1-15(2)18-8-9-24(4)10-11-25(5)13-19-16(3)12-21(27)22(19)17(14-26)6-7-20(25)23(18)24/h6,14,16,18-20,22-23H,1,7-13H2,2-5H3/b17-6-/t16-,18+,19-,20-,22-,23-,24-,25+/m0/s1 D06XIC DRUGINKE XAYQASOMEVLRKN-NOJNFTMQSA-N D06XIC DRUGSMIL CC1CC(=O)C2C1CC3(CCC4(CCC(C4C3CC=C2C=O)C(=C)C)C)C D06XIC HIGHSTAT Investigative D06XKX DRUG__ID D06XKX D06XKX DRUGTYPE Small molecular drug D06XKX DRUGINCH 1S/C25H25NO2/c1-2-11-26-12-10-18-13-19(16-6-4-3-5-7-16)14-20-23(18)21(26)15-17-8-9-22(27)25(28)24(17)20/h3-9,13-14,21,27-28H,2,10-12,15H2,1H3/t21-/m1/s1 D06XKX DRUGINKE DSINXCRDVCZBKB-OAQYLSRUSA-N D06XKX DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC(=C2)C5=CC=CC=C5)C(=C(C=C4)O)O D06XKX HIGHSTAT Investigative D06XMB DRUG__ID D06XMB D06XMB DRUGTYPE Small molecular drug D06XMB DRUGINCH 1S/C20H42NO3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-21-19-15-14-16-20(18-19)25(22,23)24/h19-21H,2-18H2,1H3,(H2,22,23,24) D06XMB DRUGINKE GFAWKWDBAGVYFO-UHFFFAOYSA-N D06XMB DRUGSMIL CCCCCCCCCCCCCCNC1CCCC(C1)P(=O)(O)O D06XMB HIGHSTAT Investigative D06XNP DRUG__ID D06XNP D06XNP DRUGTYPE Small molecular drug D06XNP DRUGINCH 1S/C15H24N2OS/c1-17(2)14-9-7-13(8-10-14)15(18)16-11-5-3-4-6-12-19/h7-10,19H,3-6,11-12H2,1-2H3,(H,16,18) D06XNP DRUGINKE XMUAFOWTSHBASP-UHFFFAOYSA-N D06XNP DRUGSMIL CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCS D06XNP HIGHSTAT Investigative D06XNT DRUG__ID D06XNT D06XNT DRUGTYPE Small molecular drug D06XNT DRUGINCH 1S/C15H16N2O3S/c16-21(19,20)14-8-6-13(7-9-14)11-17-15(18)10-12-4-2-1-3-5-12/h1-9H,10-11H2,(H,17,18)(H2,16,19,20) D06XNT DRUGINKE FTDLZZRRCJRQAA-UHFFFAOYSA-N D06XNT DRUGSMIL C1=CC=C(C=C1)CC(=O)NCC2=CC=C(C=C2)S(=O)(=O)N D06XNT HIGHSTAT Investigative D06XOI DRUG__ID D06XOI D06XOI DRUGTYPE Small molecular drug D06XOI DRUGINCH 1S/C18H23FN4O3.CH4O3S/c1-9-6-22(8-13(9)20)16-12(19)5-10-14(24)11(17(25)26)7-23(15(10)21-16)18(2,3)4;1-5(2,3)4/h5,7,9,13H,6,8,20H2,1-4H3,(H,25,26);1H3,(H,2,3,4)/t9-,13-;/m0./s1 D06XOI DRUGINKE CBTZIZOGRLKVTG-NAWISMDQSA-N D06XOI DRUGSMIL CC1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C(C)(C)C)C(=O)O)F.CS(=O)(=O)O D06XOI HIGHSTAT Investigative D06XQX DRUG__ID D06XQX D06XQX DRUGTYPE Small molecular drug D06XQX DRUGINCH 1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/t14-,19-,20-,21+,25-,27+/m1/s1 D06XQX DRUGINKE CABVTRNMFUVUDM-VRHQGPGLSA-N D06XQX DRUGSMIL CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CC(C)(CC(=O)O)O)O D06XQX HIGHSTAT Investigative D06XRS DRUG__ID D06XRS D06XRS DRUGTYPE Small molecular drug D06XRS DRUGINCH 1S/C16H17BrClNO/c1-2-19-10-13-9-14(17)5-8-16(13)20-11-12-3-6-15(18)7-4-12/h3-9,19H,2,10-11H2,1H3 D06XRS DRUGINKE ORVDFXFQIBURPI-UHFFFAOYSA-N D06XRS DRUGSMIL CCNCC1=C(C=CC(=C1)Br)OCC2=CC=C(C=C2)Cl D06XRS HIGHSTAT Investigative D06XSU DRUG__ID D06XSU D06XSU DRUGTYPE Small molecular drug D06XSU DRUGINCH 1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3-,4+,5-/m1/s1 D06XSU DRUGINKE RGHNJXZEOKUKBD-SQOUGZDYSA-N D06XSU DRUGSMIL C(C(C(C(C(C(=O)O)O)O)O)O)O D06XSU HIGHSTAT Investigative D06XTT DRUG__ID D06XTT D06XTT DRUGTYPE Small molecular drug D06XTT DRUGINCH 1S/C22H21NO3/c1-14-19(20(15(2)23-14)22(25)26-3)21(24)18-12-8-7-11-17(18)13-16-9-5-4-6-10-16/h4-12,23H,13H2,1-3H3 D06XTT DRUGINKE MDMWHKZANMNXTF-UHFFFAOYSA-N D06XTT DRUGSMIL CC1=C(C(=C(N1)C)C(=O)OC)C(=O)C2=CC=CC=C2CC3=CC=CC=C3 D06XTT HIGHSTAT Investigative D06XVV DRUG__ID D06XVV D06XVV DRUGTYPE Small molecular drug D06XVV DRUGINCH 1S/C8H6N2O2/c11-7-5-3-1-2-4-6(5)9-8(12)10-7/h1-4H,(H2,9,10,11,12) D06XVV DRUGINKE SDQJTWBNWQABLE-UHFFFAOYSA-N D06XVV DRUGSMIL C1=CC=C2C(=C1)C(=O)NC(=O)N2 D06XVV HIGHSTAT Investigative D06XXG DRUG__ID D06XXG D06XXG DRUGTYPE Small molecular drug D06XXG DRUGINCH 1S/C20H15F2NO/c21-16-12-10-15(11-13-16)20(19(23)24,14-6-2-1-3-7-14)17-8-4-5-9-18(17)22/h1-13H,(H2,23,24) D06XXG DRUGINKE UFALWTGZIJAUPP-UHFFFAOYSA-N D06XXG DRUGSMIL C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=CC=C3F)C(=O)N D06XXG HIGHSTAT Investigative D06XYZ DRUG__ID D06XYZ D06XYZ DRUGTYPE Small molecular drug D06XYZ DRUGINCH 1S/C21H14O4/c22-15-10-4-8-13-17(20(24)12-6-2-1-3-7-12)14-9-5-11-16(23)19(14)21(25)18(13)15/h1-11,17,22-23H D06XYZ DRUGINKE ZIWVGWPZACHOMW-UHFFFAOYSA-N D06XYZ DRUGSMIL C1=CC=C(C=C1)C(=O)C2C3=C(C(=CC=C3)O)C(=O)C4=C2C=CC=C4O D06XYZ HIGHSTAT Investigative D06YCQ DRUG__ID D06YCQ D06YCQ DRUGTYPE Small molecular drug D06YCQ DRUGINCH 1S/C44H34O20/c45-19-11-26(51)34-32(12-19)61-40(16-2-4-22(47)25(50)6-16)42(64-44(60)18-9-30(55)38(58)31(56)10-18)36(34)35-27(52)14-23(48)20-13-33(62-43(59)17-7-28(53)37(57)29(54)8-17)39(63-41(20)35)15-1-3-21(46)24(49)5-15/h1-12,14,33,36,39-40,42,45-58H,13H2/t33-,36?,39-,40-,42-/m1/s1 D06YCQ DRUGINKE KTLUHRSHFRODPS-ZMSZJQPBSA-N D06YCQ DRUGSMIL C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)OC(=O)C6=CC(=C(C(=C6)O)O)O)O)O)C7=CC(=C(C=C7)O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O D06YCQ HIGHSTAT Investigative D06YDQ DRUG__ID D06YDQ D06YDQ DRUGTYPE Small molecular drug D06YDQ DRUGINCH 1S/C14H21NO5S/c1-2-3-4-5-6-11-19-14(16)12-7-9-13(10-8-12)20-21(15,17)18/h7-10H,2-6,11H2,1H3,(H2,15,17,18) D06YDQ DRUGINKE XTVXDGYXZNQKRA-UHFFFAOYSA-N D06YDQ DRUGSMIL CCCCCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D06YDQ HIGHSTAT Investigative D06YDW DRUG__ID D06YDW D06YDW DRUGTYPE Small molecular drug D06YDW DRUGINCH 1S/C30H48O4/c1-18(2)19-9-14-30(25(33)34)16-15-28(5)20(24(19)30)7-8-22-26(3)12-11-23(32)27(4,17-31)21(26)10-13-29(22,28)6/h19-24,31-32H,1,7-17H2,2-6H3,(H,33,34)/t19-,20+,21+,22+,23-,24+,26-,27-,28+,29+,30-/m0/s1 D06YDW DRUGINKE HXWLKAXCQLXHML-WGOZWDAUSA-N D06YDW DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)CO)O)C)C(=O)O D06YDW HIGHSTAT Investigative D06YEB DRUG__ID D06YEB D06YEB DRUGTYPE Small molecular drug D06YEB DRUGINCH 1S/C22H19NOS/c1-16(17-9-3-2-4-10-17)15-22(24)23-18-11-5-7-13-20(18)25-21-14-8-6-12-19(21)23/h2-14,16H,15H2,1H3 D06YEB DRUGINKE WFXGFQNNLYOETN-UHFFFAOYSA-N D06YEB DRUGSMIL CC(CC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31)C4=CC=CC=C4 D06YEB HIGHSTAT Investigative D06YEV DRUG__ID D06YEV D06YEV DRUGTYPE Small molecular drug D06YEV DRUGINCH 1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5) D06YEV DRUGINKE OGGXGZAMXPVRFZ-UHFFFAOYSA-N D06YEV DRUGSMIL C[As](=O)(C)O D06YEV HIGHSTAT Investigative D06YGF DRUG__ID D06YGF D06YGF DRUGTYPE Small molecular drug D06YGF DRUGINCH 1S/C17H16O4/c18-15-8-6-14(12-16(15)19)7-9-17(20)21-11-10-13-4-2-1-3-5-13/h1-9,12,18-19H,10-11H2/b9-7+ D06YGF DRUGINKE SWUARLUWKZWEBQ-VQHVLOKHSA-N D06YGF DRUGSMIL C1=CC=C(C=C1)CCOC(=O)C=CC2=CC(=C(C=C2)O)O D06YGF HIGHSTAT Investigative D06YGT DRUG__ID D06YGT D06YGT DRUGTYPE Small molecular drug D06YGT DRUGINCH 1S/C13H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13(14)15/h2-12H2,1H3,(H,14,15) D06YGT DRUGINKE SZHOJFHSIKHZHA-UHFFFAOYSA-N D06YGT DRUGSMIL CCCCCCCCCCCCC(=O)O D06YGT HIGHSTAT Investigative D06YIB DRUG__ID D06YIB D06YIB DRUGTYPE Small molecular drug D06YIB DRUGINCH 1S/C21H25N5O6/c22-21-25-17-14(19(30)26-21)9-12(10-23-17)2-1-11-3-5-13(6-4-11)18(29)24-15(20(31)32)7-8-16(27)28/h3-6,12,15H,1-2,7-10H2,(H,24,29)(H,27,28)(H,31,32)(H4,22,23,25,26,30) D06YIB DRUGINKE ZUQBAQVRAURMCL-UHFFFAOYSA-N D06YIB DRUGSMIL C1C(CNC2=C1C(=O)NC(=N2)N)CCC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D06YIB HIGHSTAT Investigative D06YJN DRUG__ID D06YJN D06YJN DRUGTYPE Small molecular drug D06YJN DRUGINCH 1S/C12H14N4O2/c1-4-6-15-10-9(14(3)8-13-10)11(17)16(7-5-2)12(15)18/h4-5,8H,1-2,6-7H2,3H3 D06YJN DRUGINKE YAUBCZNTZIWFJS-UHFFFAOYSA-N D06YJN DRUGSMIL CN1C=NC2=C1C(=O)N(C(=O)N2CC=C)CC=C D06YJN HIGHSTAT Investigative D06YKH DRUG__ID D06YKH D06YKH DRUGTYPE Small molecular drug D06YKH DRUGINCH 1S/C11H5BrFNS/c12-11-14-10(7-15-11)5-4-8-2-1-3-9(13)6-8/h1-3,6-7H D06YKH DRUGINKE XPOUXVRKZDTDJY-UHFFFAOYSA-N D06YKH DRUGSMIL C1=CC(=CC(=C1)F)C#CC2=CSC(=N2)Br D06YKH HIGHSTAT Investigative D06YKU DRUG__ID D06YKU D06YKU DRUGTYPE Small molecular drug D06YKU DRUGINCH 1S/C15H10O3/c16-11-7-4-8-13-15(11)12(17)9-14(18-13)10-5-2-1-3-6-10/h1-9,16H D06YKU DRUGINKE IYBLVRRCNVHZQJ-UHFFFAOYSA-N D06YKU DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(C=CC=C3O2)O D06YKU HIGHSTAT Investigative D06YMS DRUG__ID D06YMS D06YMS DRUGTYPE Small molecular drug D06YMS DRUGINCH 1S/C29H39N5O7/c1-17(2)13-24(29(40)41)34-28(39)23(15-19-7-5-4-6-8-19)33-25(36)16-31-26(37)18(3)32-27(38)22(30)14-20-9-11-21(35)12-10-20/h4-12,17-18,22-24,35H,13-16,30H2,1-3H3,(H,31,37)(H,32,38)(H,33,36)(H,34,39)(H,40,41)/t18-,22+,23+,24-/m1/s1 D06YMS DRUGINKE ZHUJMSMQIPIPTF-IBURTVSXSA-N D06YMS DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)O)N D06YMS HIGHSTAT Investigative D06YMZ DRUG__ID D06YMZ D06YMZ DRUGTYPE Small molecular drug D06YMZ DRUGINCH 1S/C19H21N3O/c1-2-6-18(23)20-19-16-12-11-15(13-17(16)21-22-19)10-9-14-7-4-3-5-8-14/h3-5,7-8,11-13H,2,6,9-10H2,1H3,(H2,20,21,22,23) D06YMZ DRUGINKE FEGHHCWVRCSXNL-UHFFFAOYSA-N D06YMZ DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)CCC3=CC=CC=C3 D06YMZ HIGHSTAT Investigative D06YQD DRUG__ID D06YQD D06YQD DRUGTYPE Small molecular drug D06YQD DRUGINCH 1S/C24H27N3O/c1-16(2)13-14-25-24(28)21-15-26-22(19-9-5-17(3)6-10-19)23(27-21)20-11-7-18(4)8-12-20/h5-12,15-16H,13-14H2,1-4H3,(H,25,28) D06YQD DRUGINKE DGPFCWKIBMZBAP-UHFFFAOYSA-N D06YQD DRUGSMIL CC1=CC=C(C=C1)C2=NC=C(N=C2C3=CC=C(C=C3)C)C(=O)NCCC(C)C D06YQD HIGHSTAT Investigative D06YQR DRUG__ID D06YQR D06YQR DRUGTYPE Small molecular drug D06YQR DRUGINCH 1S/C8H17NO3/c1-2-3-5-7(11)8(12)6(10)4-9-5/h5-12H,2-4H2,1H3/t5-,6-,7+,8+/m1/s1 D06YQR DRUGINKE JFOGNLDWQBZRQJ-NGJRWZKOSA-N D06YQR DRUGSMIL CCCC1C(C(C(CN1)O)O)O D06YQR HIGHSTAT Investigative D06YQS DRUG__ID D06YQS D06YQS DRUGTYPE Small molecular drug D06YQS DRUGINCH 1S/C10H7FN2O3S/c11-7-3-1-2-4-8(7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D06YQS DRUGINKE AEDNYZQZIZUZTP-UHFFFAOYSA-N D06YQS DRUGSMIL C1=CC=C(C(=C1)F)S(=O)(=O)C2=NNC(=O)C=C2 D06YQS HIGHSTAT Investigative D06YTN DRUG__ID D06YTN D06YTN DRUGTYPE Small molecular drug D06YTN DRUGINCH 1S/C10H23O3P/c1-2-3-4-5-6-7-8-9-10-14(11,12)13/h2-10H2,1H3,(H2,11,12,13) D06YTN DRUGINKE DZQISOJKASMITI-UHFFFAOYSA-N D06YTN DRUGSMIL CCCCCCCCCCP(=O)(O)O D06YTN HIGHSTAT Investigative D06YUR DRUG__ID D06YUR D06YUR DRUGTYPE Small molecular drug D06YUR DRUGINCH 1S/C8H6FNO/c9-6-1-2-7-5(3-6)4-8(11)10-7/h1-3H,4H2,(H,10,11) D06YUR DRUGINKE DDIIYGHHUMKDGI-UHFFFAOYSA-N D06YUR DRUGSMIL C1C2=C(C=CC(=C2)F)NC1=O D06YUR HIGHSTAT Investigative D06YVE DRUG__ID D06YVE D06YVE DRUGTYPE Small molecular drug D06YVE DRUGINCH 1S/C24H23NO7S/c1-25-12-11-24-16-8-10-19(32-33(27,28)29)22(24)31-21-18(9-7-15(20(21)24)13-17(16)25)30-23(26)14-5-3-2-4-6-14/h2-10,16-17,19,22H,11-13H2,1H3,(H,27,28,29)/t16-,17+,19-,22-,24-/m0/s1 D06YVE DRUGINKE IQMPFHWIBSSPBS-MJFIPZRTSA-N D06YVE DRUGSMIL C[NH+]1CCC23C4C1CC5=C2C(=C(C=C5)OC(=O)C6=CC=CC=C6)OC3C(C=C4)OS(=O)(=O)[O-] D06YVE HIGHSTAT Investigative D06YWZ DRUG__ID D06YWZ D06YWZ DRUGTYPE Small molecular drug D06YWZ DRUGINCH 1S/C27H29NO3.ClH/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25;/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2;1H/t24-;/m1./s1 D06YWZ DRUGINKE OUTBWXJALMTPND-GJFSDDNBSA-N D06YWZ DRUGSMIL C1CC(CN(C1)CCC2=CC3=C(C=C2)OCO3)OC(C4=CC=CC=C4)C5=CC=CC=C5.Cl D06YWZ HIGHSTAT Investigative D06YXT DRUG__ID D06YXT D06YXT DRUGTYPE Small molecular drug D06YXT DRUGINCH 1S/C21H22N2O3.ClH/c24-21(25)19-12-7-13-23(16-19)14-15-26-22-20(17-8-3-1-4-9-17)18-10-5-2-6-11-18;/h1-6,8-12H,7,13-16H2,(H,24,25);1H D06YXT DRUGINKE YZYRTEYMUTWJPL-UHFFFAOYSA-N D06YXT DRUGSMIL C1CN(CC(=C1)C(=O)O)CCON=C(C2=CC=CC=C2)C3=CC=CC=C3.Cl D06YXT HIGHSTAT Investigative D06YYJ DRUG__ID D06YYJ D06YYJ DRUGTYPE Small molecular drug D06YYJ DRUGINCH 1S/C38H40N2O7/c1-39-9-7-23-15-25(19-27-33(23)29(39)17-21-3-5-31(41)37(43)35(21)27)46-13-11-45-12-14-47-26-16-24-8-10-40(2)30-18-22-4-6-32(42)38(44)36(22)28(20-26)34(24)30/h3-6,15-16,19-20,29-30,41-44H,7-14,17-18H2,1-2H3/t29-,30-/m1/s1 D06YYJ DRUGINKE GJLNFWNMAQBYPC-LOYHVIPDSA-N D06YYJ DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OCCOCCOC5=CC6=C7C(CC8=C(C7=C5)C(=C(C=C8)O)O)N(CC6)C)C(=C(C=C4)O)O D06YYJ HIGHSTAT Investigative D06YZB DRUG__ID D06YZB D06YZB DRUGTYPE Small molecular drug D06YZB DRUGINCH 1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1-,2-,3-,4-,5+,6+/m0/s1 D06YZB DRUGINKE MMWCIQZXVOZEGG-LKPKBOIGSA-N D06YZB DRUGSMIL C1(C(C(C(C(C1OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O)O)O D06YZB HIGHSTAT Investigative D06ZBT DRUG__ID D06ZBT D06ZBT DRUGTYPE Small molecular drug D06ZBT DRUGINCH 1S/C11H7BrN2S/c1-8-14-11(7-15-8)3-2-9-4-10(12)6-13-5-9/h4-7H,1H3 D06ZBT DRUGINKE SLLMZMSYBFFSLX-UHFFFAOYSA-N D06ZBT DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CN=C2)Br D06ZBT HIGHSTAT Investigative D06ZBV DRUG__ID D06ZBV D06ZBV DRUGTYPE Small molecular drug D06ZBV DRUGINCH 1S/C8H14N4O/c9-3-1-8(13)11-4-2-7-5-10-6-12-7/h5-6H,1-4,9H2,(H,10,12)(H,11,13) D06ZBV DRUGINKE ANRUJJLGVODXIK-UHFFFAOYSA-N D06ZBV DRUGSMIL C1=C(NC=N1)CCNC(=O)CCN D06ZBV HIGHSTAT Investigative D06ZCX DRUG__ID D06ZCX D06ZCX DRUGTYPE Small molecular drug D06ZCX DRUGINCH 1S/C26H23N3O4/c30-15-16-9-10-28-13-19(17-5-1-3-7-21(17)28)23-24(26(32)27-25(23)31)20-14-29(11-12-33-16)22-8-4-2-6-18(20)22/h1-8,13-14,16,30H,9-12,15H2,(H,27,31,32)/t16-/m0/s1 D06ZCX DRUGINKE BGVKOUSMQGMSDY-INIZCTEOSA-N D06ZCX DRUGSMIL C1CN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCOC1CO)C6=CC=CC=C65)C(=O)NC4=O D06ZCX HIGHSTAT Investigative D06ZDF DRUG__ID D06ZDF D06ZDF DRUGTYPE Small molecular drug D06ZDF DRUGINCH 1S/C37H65NO11/c1-14-26-20(4)28(39)21(5)30-18(2)16-37(10,49-30)33(48-35-29(40)25(38(11)12)15-19(3)44-35)22(6)31(23(7)34(42)46-26)47-27-17-36(9,43-13)32(41)24(8)45-27/h19-29,31-33,35,39-41H,14-17H2,1-13H3/t19-,20-,21-,22+,23-,24+,25+,26-,27+,28+,29-,31+,32+,33-,35+,36-,37+/m1/s1 D06ZDF DRUGINKE RVWZXQUMKFWVJM-GKMPZCCESA-N D06ZDF DRUGSMIL CCC1C(C(C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)C)C)C)O)C D06ZDF HIGHSTAT Investigative D06ZGS DRUG__ID D06ZGS D06ZGS DRUGTYPE Small molecular drug D06ZGS DRUGINCH 1S/C15H21N3S2/c19-13(18-14-16-1-2-20-14)17-9-15-6-10-3-11(7-15)5-12(4-10)8-15/h1-2,10-12H,3-9H2,(H2,16,17,18,19) D06ZGS DRUGINKE YVDWMGNODCFVJL-UHFFFAOYSA-N D06ZGS DRUGSMIL C1C2CC3CC1CC(C2)(C3)CNC(=S)NC4=NC=CS4 D06ZGS HIGHSTAT Investigative D06ZIE DRUG__ID D06ZIE D06ZIE DRUGTYPE Small molecular drug D06ZIE DRUGINCH 1S/C17H18O7/c1-7-14-11-4-9(16(20)22-11)10(21-8(2)18)5-13-17(3,24-13)6-12(14)23-15(7)19/h4,10-14H,1,5-6H2,2-3H3 D06ZIE DRUGINKE SLIMCFUYVZKJTC-UHFFFAOYSA-N D06ZIE DRUGSMIL CC(=O)OC1CC2C(O2)(CC3C(C4C=C1C(=O)O4)C(=C)C(=O)O3)C D06ZIE HIGHSTAT Investigative D06ZIO DRUG__ID D06ZIO D06ZIO DRUGTYPE Small molecular drug D06ZIO DRUGINCH 1S/C26H36N6O2/c33-25(21-5-2-6-21)28-11-3-10-27-24-23(20-8-9-20)17-29-26(31-24)30-22-7-1-4-19(16-22)18-32-12-14-34-15-13-32/h1,4,7,16-17,20-21H,2-3,5-6,8-15,18H2,(H,28,33)(H2,27,29,30,31) D06ZIO DRUGINKE UKBGBACORPRCGG-UHFFFAOYSA-N D06ZIO DRUGSMIL C1CC(C1)C(=O)NCCCNC2=NC(=NC=C2C3CC3)NC4=CC=CC(=C4)CN5CCOCC5 D06ZIO HIGHSTAT Investigative D06ZLJ DRUG__ID D06ZLJ D06ZLJ DRUGTYPE Small molecular drug D06ZLJ DRUGINCH 1S/C21H25NO3S/c1-5-15-17(21(24)26-8-4)16(6-2)22-19(14-12-10-9-11-13-14)18(15)20(23)25-7-3/h9-13H,5-8H2,1-4H3 D06ZLJ DRUGINKE WYZGZKCWULQWSH-UHFFFAOYSA-N D06ZLJ DRUGSMIL CCC1=C(C(=NC(=C1C(=O)OCC)C2=CC=CC=C2)CC)C(=O)SCC D06ZLJ HIGHSTAT Investigative D06ZLL DRUG__ID D06ZLL D06ZLL DRUGTYPE Small molecular drug D06ZLL DRUGINCH 1S/C18H17BrN4O2/c1-21-14(10-5-4-7-12-8-6-9-13(19)11-12)20-16-15(21)17(24)23(3)18(25)22(16)2/h4-11H,1-3H3/b7-4+,10-5+ D06ZLL DRUGINKE YJBUYKLAHVOOFW-HOZCHFDZSA-N D06ZLL DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC=CC3=CC(=CC=C3)Br D06ZLL HIGHSTAT Investigative D06ZMH DRUG__ID D06ZMH D06ZMH DRUGTYPE Small molecular drug D06ZMH DRUGINCH 1S/C13H13N3O3S/c14-20(18,19)12-8-4-7-11(9-12)16-13(17)15-10-5-2-1-3-6-10/h1-9H,(H2,14,18,19)(H2,15,16,17) D06ZMH DRUGINKE BXGWKSJDQKSXDR-UHFFFAOYSA-N D06ZMH DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=CC(=CC=C2)S(=O)(=O)N D06ZMH HIGHSTAT Investigative D06ZNI DRUG__ID D06ZNI D06ZNI DRUGTYPE Small molecular drug D06ZNI DRUGINCH 1S/C23H32O2/c1-22(2,3)13-15-12-20-19-7-5-14-11-16(24)6-8-17(14)18(19)9-10-23(20,4)21(15)25/h6,8,11,13,18-21,24-25H,5,7,9-10,12H2,1-4H3/b15-13+/t18?,19?,20?,21-,23-/m0/s1 D06ZNI DRUGINKE GJYCOULXILNZBK-LBIHAFKNSA-N D06ZNI DRUGSMIL CC12CCC3C(C1CC(=CC(C)(C)C)C2O)CCC4=C3C=CC(=C4)O D06ZNI HIGHSTAT Investigative D06ZNX DRUG__ID D06ZNX D06ZNX DRUGTYPE Small molecular drug D06ZNX DRUGINCH 1S/C20H14F3NO/c21-16-7-1-4-13(10-16)20(19(24)25,14-5-2-8-17(22)11-14)15-6-3-9-18(23)12-15/h1-12H,(H2,24,25) D06ZNX DRUGINKE NYTZBODQYAXXMZ-UHFFFAOYSA-N D06ZNX DRUGSMIL C1=CC(=CC(=C1)F)C(C2=CC(=CC=C2)F)(C3=CC(=CC=C3)F)C(=O)N D06ZNX HIGHSTAT Investigative D06ZOM DRUG__ID D06ZOM D06ZOM DRUGTYPE Small molecular drug D06ZOM DRUGINCH 1S/C17H12N2O2/c1-11-15-16(18-19(11)12-7-3-2-4-8-12)13-9-5-6-10-14(13)21-17(15)20/h2-10H,1H3 D06ZOM DRUGINKE VJSRCIFAUSKZHJ-UHFFFAOYSA-N D06ZOM DRUGSMIL CC1=C2C(=NN1C3=CC=CC=C3)C4=CC=CC=C4OC2=O D06ZOM HIGHSTAT Investigative D06ZPI DRUG__ID D06ZPI D06ZPI DRUGTYPE Small molecular drug D06ZPI DRUGINCH 1S/C20H23NO4/c1-3-9-21(2)10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12/h3-5,15,18,24H,1,6-11H2,2H3/p+1/t15-,18+,19+,20-,21-/m1/s1 D06ZPI DRUGINKE PCSQOABIHJXZMR-YNUHATHGSA-O D06ZPI DRUGSMIL C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC=C D06ZPI HIGHSTAT Investigative D06ZRX DRUG__ID D06ZRX D06ZRX DRUGTYPE Small molecular drug D06ZRX DRUGINCH 1S/C14H12O4/c15-11-4-3-10(14(18)8-11)2-1-9-5-12(16)7-13(17)6-9/h1-8,15-18H/b2-1+ D06ZRX DRUGINKE PDHAOJSHSJQANO-OWOJBTEDSA-N D06ZRX DRUGSMIL C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O D06ZRX HIGHSTAT Investigative D06ZSX DRUG__ID D06ZSX D06ZSX DRUGTYPE Small molecular drug D06ZSX DRUGINCH 1S/C17H17ClN2O2/c1-11(2)16(21)19-14-7-4-8-15(10-14)20-17(22)12-5-3-6-13(18)9-12/h3-11H,1-2H3,(H,19,21)(H,20,22) D06ZSX DRUGINKE ZXAGKBUSUTVPML-UHFFFAOYSA-N D06ZSX DRUGSMIL CC(C)C(=O)NC1=CC=CC(=C1)NC(=O)C2=CC(=CC=C2)Cl D06ZSX HIGHSTAT Investigative D06ZUA DRUG__ID D06ZUA D06ZUA DRUGTYPE Small molecular drug D06ZUA DRUGINCH 1S/C26H23N3O4S/c1-16-6-4-5-7-19(16)25(30)29-26(34)28-17-8-10-18(11-9-17)33-22-12-13-27-21-15-24(32-3)23(31-2)14-20(21)22/h4-15H,1-3H3,(H2,28,29,30,34) D06ZUA DRUGINKE ZXGIBSBJQLLUEE-UHFFFAOYSA-N D06ZUA DRUGSMIL CC1=CC=CC=C1C(=O)NC(=S)NC2=CC=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC D06ZUA HIGHSTAT Investigative D06ZVB DRUG__ID D06ZVB D06ZVB DRUGTYPE Small molecular drug D06ZVB DRUGINCH 1S/C4H8O2/c1-3(2)4(5)6/h3H,1-2H3,(H,5,6) D06ZVB DRUGINKE KQNPFQTWMSNSAP-UHFFFAOYSA-N D06ZVB DRUGSMIL CC(C)C(=O)O D06ZVB HIGHSTAT Investigative D06ZWQ DRUG__ID D06ZWQ D06ZWQ DRUGTYPE Small molecular drug D06ZWQ DRUGINCH 1S/C16H11N3O/c20-16-15-13(12-8-4-5-9-14(12)17-16)10-19(18-15)11-6-2-1-3-7-11/h1-10H,(H,17,20) D06ZWQ DRUGINKE ISMLHIIGSRUCOQ-UHFFFAOYSA-N D06ZWQ DRUGSMIL C1=CC=C(C=C1)N2C=C3C4=CC=CC=C4NC(=O)C3=N2 D06ZWQ HIGHSTAT Investigative D06ZWX DRUG__ID D06ZWX D06ZWX DRUGTYPE Small molecular drug D06ZWX DRUGINCH 1S/C15H23NO4/c1-8-3-9(2)15(20)11(4-8)12(17)5-10-6-13(18)16-14(19)7-10/h8-12,17H,3-7H2,1-2H3,(H,16,18,19)/t8-,9-,11-,12+/m0/s1 D06ZWX DRUGINKE YPHMISFOHDHNIV-FSZOTQKASA-N D06ZWX DRUGSMIL CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C D06ZWX HIGHSTAT Investigative D06ZYQ DRUG__ID D06ZYQ D06ZYQ DRUGTYPE Small molecular drug D06ZYQ DRUGINCH 1S/C20H24O6/c1-10(2)18(21)24-14-7-11(3)8-20(23-6)9-12(4)16(26-20)17-15(14)13(5)19(22)25-17/h8-9,14-17H,1,5,7H2,2-4,6H3/b11-8+/t14-,15+,16-,17-,20-/m0/s1 D06ZYQ DRUGINKE CSIBMGLPBAXXSG-FWTBDAJASA-N D06ZYQ DRUGSMIL CC1=CC2(C=C(C(O2)C3C(C(C1)OC(=O)C(=C)C)C(=C)C(=O)O3)C)OC D06ZYQ HIGHSTAT Investigative D06ZZM DRUG__ID D06ZZM D06ZZM DRUGTYPE Small molecular drug D06ZZM DRUGINCH 1S/C14H10ClNO/c1-10-4-2-3-5-13(10)17-14-7-6-11(9-16)8-12(14)15/h2-8H,1H3 D06ZZM DRUGINKE LMZHFUQMQDTSFO-UHFFFAOYSA-N D06ZZM DRUGSMIL CC1=CC=CC=C1OC2=C(C=C(C=C2)C#N)Cl D06ZZM HIGHSTAT Investigative D07AAZ DRUG__ID D07AAZ D07AAZ DRUGTYPE Small molecular drug D07AAZ DRUGINCH 1S/C11H13N/c1-2-4-10(5-3-1)11-6-8-12-9-7-11/h1-6,12H,7-9H2 D07AAZ DRUGINKE OMPXTQYWYRWWPH-UHFFFAOYSA-N D07AAZ DRUGSMIL C1CNCC=C1C2=CC=CC=C2 D07AAZ HIGHSTAT Investigative D07ABI DRUG__ID D07ABI D07ABI DRUGTYPE Small molecular drug D07ABI DRUGINCH 1S/C22H23NO/c1-2-4-21-17(3-1)13-19-14-20(5-6-22(19)21)24-12-9-18-15-23-10-7-16(18)8-11-23/h1-6,9,14,16H,7-8,10-13,15H2/b18-9+ D07ABI DRUGINKE VVZXRJARBWKUDG-GIJQJNRQSA-N D07ABI DRUGSMIL C1CN2CCC1C(=CCOC3=CC4=C(C=C3)C5=CC=CC=C5C4)C2 D07ABI HIGHSTAT Investigative D07ADR DRUG__ID D07ADR D07ADR DRUGTYPE Small molecular drug D07ADR DRUGINCH 1S/C18H24N6O/c1-13(2)24-12-21-15-16(20-11-14-7-4-3-5-8-14)22-18(23-17(15)24)19-9-6-10-25/h3-5,7-8,12-13,25H,6,9-11H2,1-2H3,(H2,19,20,22,23) D07ADR DRUGINKE OPQGFIAVPSXOBO-UHFFFAOYSA-N D07ADR DRUGSMIL CC(C)N1C=NC2=C(N=C(N=C21)NCCCO)NCC3=CC=CC=C3 D07ADR HIGHSTAT Investigative D07ADX DRUG__ID D07ADX D07ADX DRUGTYPE Small molecular drug D07ADX DRUGINCH 1S/C27H27N5/c1-31-10-12-32(13-11-31)18-19-2-4-20(5-3-19)23-15-24-25(17-30-27(24)29-16-23)21-6-7-26-22(14-21)8-9-28-26/h2-9,14-17,28H,10-13,18H2,1H3,(H,29,30) D07ADX DRUGINKE QKKIWEILHCXECO-UHFFFAOYSA-N D07ADX DRUGSMIL CN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(NC=C4C5=CC6=C(C=C5)NC=C6)N=C3 D07ADX HIGHSTAT Investigative D07AEC DRUG__ID D07AEC D07AEC DRUGTYPE Small molecular drug D07AEC DRUGINCH 1S/C19H28N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,13,15,21,26H,4,10-12H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 D07AEC DRUGINKE RMSINZVFNDWCCK-OAHLLOKOSA-N D07AEC DRUGSMIL CCC(CO)NC1=NC(=C2C(=N1)N(CN2)C(C)C)NCC3=CC=CC=C3 D07AEC HIGHSTAT Investigative D07AFA DRUG__ID D07AFA D07AFA DRUGTYPE Small molecular drug D07AFA DRUGINCH 1S/C15H13NO2S/c1-19(17,18)14-8-6-13(7-9-14)16-11-10-12-4-2-3-5-15(12)16/h2-11H,1H3 D07AFA DRUGINKE XRGCFRFZQVGLLT-UHFFFAOYSA-N D07AFA DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)N2C=CC3=CC=CC=C32 D07AFA HIGHSTAT Investigative D07AGM DRUG__ID D07AGM D07AGM DRUGTYPE Small molecular drug D07AGM DRUGINCH 1S/C7H10N2O2S/c1-9-6-2-4-7(5-3-6)12(8,10)11/h2-5,9H,1H3,(H2,8,10,11) D07AGM DRUGINKE FJVAYUUWTJKKNC-UHFFFAOYSA-N D07AGM DRUGSMIL CNC1=CC=C(C=C1)S(=O)(=O)N D07AGM HIGHSTAT Investigative D07AGU DRUG__ID D07AGU D07AGU DRUGTYPE Small molecular drug D07AGU DRUGINCH 1S/C10H8N2O/c11-10(13)8-5-1-3-7-4-2-6-12-9(7)8/h1-6H,(H2,11,13) D07AGU DRUGINKE HPQRQAOVNXWEEQ-UHFFFAOYSA-N D07AGU DRUGSMIL C1=CC2=C(C(=C1)C(=O)N)N=CC=C2 D07AGU HIGHSTAT Investigative D07AHG DRUG__ID D07AHG D07AHG DRUGTYPE Small molecular drug D07AHG DRUGINCH 1S/C28H42O5/c1-8-28(9-2,21-10-12-24(19(3)14-21)32-17-23(30)16-29)22-11-13-25(20(4)15-22)33-18-26(31)27(5,6)7/h10-15,23,26,29-31H,8-9,16-18H2,1-7H3 D07AHG DRUGINKE AIKLCYAFOOBGEV-UHFFFAOYSA-N D07AHG DRUGSMIL CCC(CC)(C1=CC(=C(C=C1)OCC(CO)O)C)C2=CC(=C(C=C2)OCC(C(C)(C)C)O)C D07AHG HIGHSTAT Investigative D07AIB DRUG__ID D07AIB D07AIB DRUGTYPE Small molecular drug D07AIB DRUGINCH 1S/C20H15N3O/c1-2-6-16(7-3-1)24-17-12-10-15(11-13-17)23-20-18-8-4-5-9-19(18)21-14-22-20/h1-14H,(H,21,22,23) D07AIB DRUGINKE RJOICMFRJBMONF-UHFFFAOYSA-N D07AIB DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)NC3=NC=NC4=CC=CC=C43 D07AIB HIGHSTAT Investigative D07ALG DRUG__ID D07ALG D07ALG DRUGTYPE Small molecular drug D07ALG DRUGINCH 1S/C17H20N6O4S/c1-5-27-17(24)18-15-9-14(21-23-11(3)19-20-16(15)23)12-7-6-10(2)13(8-12)22-28(4,25)26/h6-9,22H,5H2,1-4H3,(H,18,24) D07ALG DRUGINKE UYBRROMMFMPJAN-UHFFFAOYSA-N D07ALG DRUGSMIL CCOC(=O)NC1=CC(=NN2C1=NN=C2C)C3=CC(=C(C=C3)C)NS(=O)(=O)C D07ALG HIGHSTAT Investigative D07ALM DRUG__ID D07ALM D07ALM DRUGTYPE Small molecular drug D07ALM DRUGINCH 1S/C16H24ClN3O/c17-14-6-4-13(5-7-14)12-19-9-8-15(18)16(21)20-10-2-1-3-11-20/h4-7,15,19H,1-3,8-12,18H2/t15-/m0/s1 D07ALM DRUGINKE DNVZYSMOLXCOLY-HNNXBMFYSA-N D07ALM DRUGSMIL C1CCN(CC1)C(=O)C(CCNCC2=CC=C(C=C2)Cl)N D07ALM HIGHSTAT Investigative D07ANB DRUG__ID D07ANB D07ANB DRUGTYPE Small molecular drug D07ANB DRUGINCH 1S/C19H36O5/c1-3-5-7-9-11-13-18(21)23-16-17(15-20)24-19(22)14-12-10-8-6-4-2/h17,20H,3-16H2,1-2H3/t17-/m0/s1 D07ANB DRUGINKE ZQBULZYTDGUSSK-KRWDZBQOSA-N D07ANB DRUGSMIL CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC D07ANB HIGHSTAT Investigative D07ANY DRUG__ID D07ANY D07ANY DRUGTYPE Small molecular drug D07ANY DRUGINCH 1S/C6H6N4/c7-10-6-4-2-1-3-5(6)8-9-10/h1-4H,7H2 D07ANY DRUGINKE JCXKHYLLVKZPKE-UHFFFAOYSA-N D07ANY DRUGSMIL C1=CC=C2C(=C1)N=NN2N D07ANY HIGHSTAT Investigative D07APP DRUG__ID D07APP D07APP DRUGTYPE Small molecular drug D07APP DRUGINCH 1S/C13H13NO3/c15-11-9-13(14-5-7-16-8-6-14)17-12-4-2-1-3-10(11)12/h1-4,9H,5-8H2 D07APP DRUGINKE QNFWERYZJLBANZ-UHFFFAOYSA-N D07APP DRUGSMIL C1COCCN1C2=CC(=O)C3=CC=CC=C3O2 D07APP HIGHSTAT Investigative D07ARK DRUG__ID D07ARK D07ARK DRUGTYPE Small molecular drug D07ARK DRUGINCH 1S/C18H21NO2/c20-18(19(21)15-17-12-5-2-6-13-17)14-8-7-11-16-9-3-1-4-10-16/h1-6,9-10,12-13,21H,7-8,11,14-15H2 D07ARK DRUGINKE MXZUASJHVOWCLX-UHFFFAOYSA-N D07ARK DRUGSMIL C1=CC=C(C=C1)CCCCC(=O)N(CC2=CC=CC=C2)O D07ARK HIGHSTAT Investigative D07ARO DRUG__ID D07ARO D07ARO DRUGTYPE Small molecular drug D07ARO DRUGINCH 1S/C41H52N8O9/c1-23(2)11-12-25-16-26(13-14-33(25)51)38(55)31(22-50)47-35(53)20-45-40(57)37(24(3)4)48-36(54)21-44-39(56)32-10-7-15-49(32)41(58)30(46-34(52)18-42)17-27-19-43-29-9-6-5-8-28(27)29/h5-9,11,13-16,19,22,24,30-32,37-38,43,51,55H,10,12,17-18,20-21,42H2,1-4H3,(H,44,56)(H,45,57)(H,46,52)(H,47,53)(H,48,54)/t30-,31+,32-,37-,38+/m0/s1 D07ARO DRUGINKE MZGWPVIVGCXMPX-QFXPHGGCSA-N D07ARO DRUGSMIL CC(C)C(C(=O)NCC(=O)NC(C=O)C(C1=CC(=C(C=C1)O)CC=C(C)C)O)NC(=O)CNC(=O)C2CC=CN2C(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CN D07ARO HIGHSTAT Investigative D07ATW DRUG__ID D07ATW D07ATW DRUGTYPE Small molecular drug D07ATW DRUGINCH 1S/C9H17NO4/c1-4-2-6(12)7-9(14)8(13)5(3-11)10(4)7/h4-9,11-14H,2-3H2,1H3/t4-,5-,6-,7-,8-,9+/m1/s1 D07ATW DRUGINKE PIBHCJDPQRCONN-MVEQLIQHSA-N D07ATW DRUGSMIL CC1CC(C2N1C(C(C2O)O)CO)O D07ATW HIGHSTAT Investigative D07AUN DRUG__ID D07AUN D07AUN DRUGTYPE Small molecular drug D07AUN DRUGINCH 1S/C15H13NO3/c1-19-15(18)12-4-6-13(7-5-12)16-10-11-2-8-14(17)9-3-11/h2-10,17H,1H3 D07AUN DRUGINKE RMGZSIQUVXIPDP-UHFFFAOYSA-N D07AUN DRUGSMIL COC(=O)C1=CC=C(C=C1)N=CC2=CC=C(C=C2)O D07AUN HIGHSTAT Investigative D07AXL DRUG__ID D07AXL D07AXL DRUGTYPE Small molecular drug D07AXL DRUGINCH 1S/C17H12N2O3/c18-11-1-3-13-9(5-11)7-15(21-13)17(20)16-8-10-6-12(19)2-4-14(10)22-16/h1-8H,18-19H2 D07AXL DRUGINKE UMBJVNBINWLZLH-UHFFFAOYSA-N D07AXL DRUGSMIL C1=CC2=C(C=C1N)C=C(O2)C(=O)C3=CC4=C(O3)C=CC(=C4)N D07AXL HIGHSTAT Investigative D07AXO DRUG__ID D07AXO D07AXO DRUGTYPE Small molecular drug D07AXO DRUGINCH 1S/C14H15NO4/c1-17-12-4-2-3-10-11(9-13(16)19-14(10)12)15-5-7-18-8-6-15/h2-4,9H,5-8H2,1H3 D07AXO DRUGINKE QMOLGKOGXTXVPG-UHFFFAOYSA-N D07AXO DRUGSMIL COC1=CC=CC2=C1OC(=O)C=C2N3CCOCC3 D07AXO HIGHSTAT Investigative D07AYF DRUG__ID D07AYF D07AYF DRUGTYPE Small molecular drug D07AYF DRUGINCH 1S/C14H11NO2S/c1-17-14(16)15-10-6-2-4-8-12(10)18-13-9-5-3-7-11(13)15/h2-9H,1H3 D07AYF DRUGINKE WWHYODNLUNCVDI-UHFFFAOYSA-N D07AYF DRUGSMIL COC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D07AYF HIGHSTAT Investigative D07BAH DRUG__ID D07BAH D07BAH DRUGTYPE Small molecular drug D07BAH DRUGINCH 1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1 D07BAH DRUGINKE KWTSXDURSIMDCE-MRVPVSSYSA-N D07BAH DRUGSMIL CC(CC1=CC=CC=C1)N D07BAH HIGHSTAT Investigative D07BAO DRUG__ID D07BAO D07BAO DRUGTYPE Small molecular drug D07BAO DRUGINCH 1S/C12H13NO/c1-2-7-13-12-6-4-9-3-5-10(14)8-11(9)12/h1,3,5,8,12-14H,4,6-7H2/t12-/m1/s1 D07BAO DRUGINKE NRSDGDXUWMMUEV-GFCCVEGCSA-N D07BAO DRUGSMIL C#CCNC1CCC2=C1C=C(C=C2)O D07BAO HIGHSTAT Investigative D07BBR DRUG__ID D07BBR D07BBR DRUGTYPE Small molecular drug D07BBR DRUGINCH 1S/C16H10FNO/c17-10-5-6-11-9(7-10)8-14-12-3-1-2-4-13(12)16(19)18-15(11)14/h1-7H,8H2,(H,18,19) D07BBR DRUGINKE YZRNXEMHDKXRRA-UHFFFAOYSA-N D07BBR DRUGSMIL C1C2=C(C=CC(=C2)F)C3=C1C4=CC=CC=C4C(=O)N3 D07BBR HIGHSTAT Investigative D07BDQ DRUG__ID D07BDQ D07BDQ DRUGTYPE Small molecular drug D07BDQ DRUGINCH 1S/C33H45N3O6/c1-23(2)21-27(35-32(40)36-19-11-6-7-12-20-36)29(37)34-28(31(39)42-33(3,4)5)22-24-15-17-26(18-16-24)41-30(38)25-13-9-8-10-14-25/h8-10,13-18,23,27-28H,6-7,11-12,19-22H2,1-5H3,(H,34,37)(H,35,40)/t27-,28-/m0/s1 D07BDQ DRUGINKE IFZDICMQBAJLQQ-NSOVKSMOSA-N D07BDQ DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)OC(=O)C2=CC=CC=C2)C(=O)OC(C)(C)C)NC(=O)N3CCCCCC3 D07BDQ HIGHSTAT Investigative D07BFA DRUG__ID D07BFA D07BFA DRUGTYPE Small molecular drug D07BFA DRUGINCH 1S/C19H21NO4/c1-19(2,3)13-8-10-14(11-9-13)24-12-17(21)20-16-7-5-4-6-15(16)18(22)23/h4-11H,12H2,1-3H3,(H,20,21)(H,22,23) D07BFA DRUGINKE RZQIBGXCHZEONC-UHFFFAOYSA-N D07BFA DRUGSMIL CC(C)(C)C1=CC=C(C=C1)OCC(=O)NC2=CC=CC=C2C(=O)O D07BFA HIGHSTAT Investigative D07BFF DRUG__ID D07BFF D07BFF DRUGTYPE Small molecular drug D07BFF DRUGINCH 1S/C20H19NO3/c1-14-16(15-5-3-2-4-6-15)7-8-17-18(22)13-19(24-20(14)17)21-9-11-23-12-10-21/h2-8,13H,9-12H2,1H3 D07BFF DRUGINKE ZMYPEBFYGCAKQT-UHFFFAOYSA-N D07BFF DRUGSMIL CC1=C(C=CC2=C1OC(=CC2=O)N3CCOCC3)C4=CC=CC=C4 D07BFF HIGHSTAT Investigative D07BGB DRUG__ID D07BGB D07BGB DRUGTYPE Small molecular drug D07BGB DRUGINCH 1S/C13H18N2O3/c1-4-9-17-12-7-5-11(6-8-12)14-13(16)18-15-10(2)3/h5-8H,4,9H2,1-3H3,(H,14,16) D07BGB DRUGINKE DAVIGWYJZIPGFN-UHFFFAOYSA-N D07BGB DRUGSMIL CCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D07BGB HIGHSTAT Investigative D07BHS DRUG__ID D07BHS D07BHS DRUGTYPE Small molecular drug D07BHS DRUGINCH 1S/C21H15FO4/c22-19-12-14(13-20(23)24)6-11-18(19)21(25)15-7-9-17(10-8-15)26-16-4-2-1-3-5-16/h1-12H,13H2,(H,23,24) D07BHS DRUGINKE DXGWDHUXZJQMIN-UHFFFAOYSA-N D07BHS DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)C3=C(C=C(C=C3)CC(=O)O)F D07BHS HIGHSTAT Investigative D07BIF DRUG__ID D07BIF D07BIF DRUGTYPE Small molecular drug D07BIF DRUGINCH 1S/C3H8NO2P/c4-2-1-3-7(5)6/h1-4H2/p+1 D07BIF DRUGINKE MQIWYGZSHIXQIU-UHFFFAOYSA-O D07BIF DRUGSMIL C(CN)C[P+](=O)O D07BIF HIGHSTAT Investigative D07BJC DRUG__ID D07BJC D07BJC DRUGTYPE Small molecular drug D07BJC DRUGINCH 1S/C20H35NO3/c1-2-3-4-13-16-19(22)21-18-15-12-10-8-6-5-7-9-11-14-17-20(23)24/h2-6,8,10-18H2,1H3,(H,21,22)(H,23,24) D07BJC DRUGINKE UGVCHIUURWYSNO-UHFFFAOYSA-N D07BJC DRUGSMIL CCCCCCC(=O)NCCCCCCCC#CCCCC(=O)O D07BJC HIGHSTAT Investigative D07BKE DRUG__ID D07BKE D07BKE DRUGTYPE Small molecular drug D07BKE DRUGINCH 1S/C14H16N6O3/c1-21-7-4-6(5-8(22-2)10(7)23-3)12-17-9-11(15)18-14(16)20-13(9)19-12/h4-5H,1-3H3,(H5,15,16,17,18,19,20) D07BKE DRUGINKE QPWGTISXOSFSHJ-UHFFFAOYSA-N D07BKE DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2=NC3=NC(=NC(=C3N2)N)N D07BKE HIGHSTAT Investigative D07BKH DRUG__ID D07BKH D07BKH DRUGTYPE Small molecular drug D07BKH DRUGINCH 1S/C22H23NO3/c1-15(25)23-9-8-19-12-20(17-5-3-4-16(10-17)14-24)11-18-6-7-21(26-2)13-22(18)19/h3-7,10-13,24H,8-9,14H2,1-2H3,(H,23,25) D07BKH DRUGINKE BHDVJMSEODZSTD-UHFFFAOYSA-N D07BKH DRUGSMIL CC(=O)NCCC1=C2C=C(C=CC2=CC(=C1)C3=CC=CC(=C3)CO)OC D07BKH HIGHSTAT Investigative D07BKU DRUG__ID D07BKU D07BKU DRUGTYPE Small molecular drug D07BKU DRUGINCH 1S/C22H25N5O/c28-22(24-19-5-4-6-21-18(19)14-23-26-21)25-20-10-7-15-13-16(8-9-17(15)20)27-11-2-1-3-12-27/h4-6,8-9,13-14,20H,1-3,7,10-12H2,(H,23,26)(H2,24,25,28)/t20-/m1/s1 D07BKU DRUGINKE SVYGRCSOIPQXGO-HXUWFJFHSA-N D07BKU DRUGSMIL C1CCN(CC1)C2=CC3=C(C=C2)C(CC3)NC(=O)NC4=CC=CC5=C4C=NN5 D07BKU HIGHSTAT Investigative D07BLJ DRUG__ID D07BLJ D07BLJ DRUGTYPE Small molecular drug D07BLJ DRUGINCH 1S/C6H12N2S/c7-6-2-5-9-4-1-3-8-6/h1-5H2,(H2,7,8) D07BLJ DRUGINKE CMKCQRINBMEZKA-UHFFFAOYSA-N D07BLJ DRUGSMIL C1CN=C(CCSC1)N D07BLJ HIGHSTAT Investigative D07BMT DRUG__ID D07BMT D07BMT DRUGTYPE Small molecular drug D07BMT DRUGINCH 1S/C18H15N3O/c19-16-7-6-15(13-8-10-20-11-9-13)12-17(16)21-18(22)14-4-2-1-3-5-14/h1-12H,19H2,(H,21,22) D07BMT DRUGINKE HVVKXFHTJQLADE-UHFFFAOYSA-N D07BMT DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=NC=C3)N D07BMT HIGHSTAT Investigative D07BMX DRUG__ID D07BMX D07BMX DRUGTYPE Small molecular drug D07BMX DRUGINCH 1S/C10H13NO2S/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m1/s1 D07BMX DRUGINKE GHBAYRBVXCRIHT-SECBINFHSA-N D07BMX DRUGSMIL C1=CC=C(C=C1)CSCC(C(=O)O)N D07BMX HIGHSTAT Investigative D07BNM DRUG__ID D07BNM D07BNM DRUGTYPE Small molecular drug D07BNM DRUGINCH 1S/C10H14F2N5O4P/c11-10(12,22(19,20)21)3-1-2-4-17-5-14-6-7(17)15-9(13)16-8(6)18/h5H,1-4H2,(H2,19,20,21)(H3,13,15,16,18) D07BNM DRUGINKE JANQQPWTLXUSCD-UHFFFAOYSA-N D07BNM DRUGSMIL C1=NC2=C(N1CCCCC(F)(F)P(=O)(O)O)N=C(NC2=O)N D07BNM HIGHSTAT Investigative D07BNP DRUG__ID D07BNP D07BNP DRUGTYPE Small molecular drug D07BNP DRUGINCH 1S/C23H32N2O6/c1-3-30-23(29)18(10-6-9-17-14-16-8-4-5-12-20(16)31-17)24-15(2)21(26)25-13-7-11-19(25)22(27)28/h4-5,8,12,15,17-19,24H,3,6-7,9-11,13-14H2,1-2H3,(H,27,28)/t15-,17?,18?,19-/m0/s1 D07BNP DRUGINKE HTBXOXWJOIKINE-RXQRSOPUSA-N D07BNP DRUGSMIL CCOC(=O)C(CCCC1CC2=CC=CC=C2O1)NC(C)C(=O)N3CCCC3C(=O)O D07BNP HIGHSTAT Investigative D07BPA DRUG__ID D07BPA D07BPA DRUGTYPE Small molecular drug D07BPA DRUGINCH 1S/C20H15N3O/c24-19-8-4-7-18(13-19)23-14-21-22-20(23)17-11-9-16(10-12-17)15-5-2-1-3-6-15/h1-14,24H D07BPA DRUGINKE MENDTFDIUWAVMQ-UHFFFAOYSA-N D07BPA DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C3=NN=CN3C4=CC(=CC=C4)O D07BPA HIGHSTAT Investigative D07BPT DRUG__ID D07BPT D07BPT DRUGTYPE Small molecular drug D07BPT DRUGINCH 1S/C15H11N3O3/c1-9-3-2-4-12-13(9)16-14(17-15(12)19)10-5-7-11(8-6-10)18(20)21/h2-8H,1H3,(H,16,17,19) D07BPT DRUGINKE NSQTWPGTGYHDIM-UHFFFAOYSA-N D07BPT DRUGSMIL CC1=C2C(=CC=C1)C(=O)NC(=N2)C3=CC=C(C=C3)[N+](=O)[O-] D07BPT HIGHSTAT Investigative D07BQG DRUG__ID D07BQG D07BQG DRUGTYPE Small molecular drug D07BQG DRUGINCH 1S/C21H15BrO4/c22-17-7-11-19(12-8-17)26-18-9-5-16(6-10-18)21(25)15-3-1-14(2-4-15)13-20(23)24/h1-12H,13H2,(H,23,24) D07BQG DRUGINKE XVHMPUZJYISELN-UHFFFAOYSA-N D07BQG DRUGSMIL C1=CC(=CC=C1CC(=O)O)C(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)Br D07BQG HIGHSTAT Investigative D07BQN DRUG__ID D07BQN D07BQN DRUGTYPE Small molecular drug D07BQN DRUGINCH 1S/C22H22N2O/c25-22(16-18-8-7-14-23-17-18)24-15-13-21(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-12,14,17,21H,13,15-16H2,(H,24,25) D07BQN DRUGINKE FNEXDTNOFQXKRJ-UHFFFAOYSA-N D07BQN DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)CC2=CN=CC=C2)C3=CC=CC=C3 D07BQN HIGHSTAT Investigative D07BTU DRUG__ID D07BTU D07BTU DRUGTYPE Small molecular drug D07BTU DRUGINCH 1S/C11H11N5O3/c12-9-8(16(17)18)10(15-11(13)14-9)19-6-7-4-2-1-3-5-7/h1-5H,6H2,(H4,12,13,14,15) D07BTU DRUGINKE VLVHHGNPHBVEIG-UHFFFAOYSA-N D07BTU DRUGSMIL C1=CC=C(C=C1)COC2=NC(=NC(=C2[N+](=O)[O-])N)N D07BTU HIGHSTAT Investigative D07BXD DRUG__ID D07BXD D07BXD DRUGTYPE Small molecular drug D07BXD DRUGINCH 1S/C19H25NOS2/c1-12(2)18-16(9-15-7-13(3)6-14(4)8-15)10-17(20-19(18)21)23-11-22-5/h6-8,10,12H,9,11H2,1-5H3,(H,20,21) D07BXD DRUGINKE AGRSTTVMWWVJEL-UHFFFAOYSA-N D07BXD DRUGSMIL CC1=CC(=CC(=C1)CC2=C(C(=O)NC(=C2)SCSC)C(C)C)C D07BXD HIGHSTAT Investigative D07BXN DRUG__ID D07BXN D07BXN DRUGTYPE Small molecular drug D07BXN DRUGINCH 1S/C33H39N5O6/c1-20-16-25(40)14-11-23(20)19-28(31(42)36-27(30(35)41)18-21-6-3-2-4-7-21)37-32(43)29-8-5-15-38(29)33(44)26(34)17-22-9-12-24(39)13-10-22/h2-4,6-7,9-14,16,26-29,39-40H,5,8,15,17-19,34H2,1H3,(H2,35,41)(H,36,42)(H,37,43)/t26-,27-,28-,29-/m0/s1 D07BXN DRUGINKE NGVFBRDVYVEPFY-DZUOILHNSA-N D07BXN DRUGSMIL CC1=C(C=CC(=C1)O)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D07BXN HIGHSTAT Investigative D07BXV DRUG__ID D07BXV D07BXV DRUGTYPE Small molecular drug D07BXV DRUGINCH 1S/C21H28O3/c1-19(2)7-5-8-20(3)17(19)6-9-21(4)18(20)11-13-10-14(22)15(23)12-16(13)24-21/h10-12,17-18,22H,5-9H2,1-4H3/t17-,18+,20-,21-/m0/s1 D07BXV DRUGINKE LOCMLXSTDCXZFJ-YHELAOLJSA-N D07BXV DRUGSMIL CC1(CCCC2(C1CCC3(C2C=C4C=C(C(=O)C=C4O3)O)C)C)C D07BXV HIGHSTAT Investigative D07BYG DRUG__ID D07BYG D07BYG DRUGTYPE Small molecular drug D07BYG DRUGINCH 1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7-,9-6-,14-10+,15-11+/t18-,19-/m1/s1 D07BYG DRUGINKE VNYSSYRCGWBHLG-GEWAPNICSA-N D07BYG DRUGSMIL CCCCCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O D07BYG HIGHSTAT Investigative D07CAB DRUG__ID D07CAB D07CAB DRUGTYPE Small molecular drug D07CAB DRUGINCH 1S/C30H32N6O2S2/c1(17-37-29-27(31-39-33-29)25-19-35-13-9-23(25)10-14-35)3-21-5-7-22(8-6-21)4-2-18-38-30-28(32-40-34-30)26-20-36-15-11-24(26)12-16-36/h5-8,23-26H,9-20H2 D07CAB DRUGINKE ROEXPZFFOZZHOY-UHFFFAOYSA-N D07CAB DRUGSMIL C1CN2CCC1C(C2)C3=NSN=C3OCC#CC4=CC=C(C=C4)C#CCOC5=NSN=C5C6CN7CCC6CC7 D07CAB HIGHSTAT Investigative D07CBA DRUG__ID D07CBA D07CBA DRUGTYPE Small molecular drug D07CBA DRUGINCH 1S/C16H36N2O6S2/c17-25(19,20)23-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-24-26(18,21)22/h1-16H2,(H2,17,19,20)(H2,18,21,22) D07CBA DRUGINKE HZFWMHWDIQYXCO-UHFFFAOYSA-N D07CBA DRUGSMIL C(CCCCCCCCOS(=O)(=O)N)CCCCCCCOS(=O)(=O)N D07CBA HIGHSTAT Investigative D07CEB DRUG__ID D07CEB D07CEB DRUGTYPE Small molecular drug D07CEB DRUGINCH 1S/C18H18N2/c1-2-7-15(8-3-1)9-6-13-19-18-17-11-5-4-10-16(17)12-14-20-18/h1-5,7-8,10-12,14H,6,9,13H2,(H,19,20) D07CEB DRUGINKE ZRAIUMVYTFUMKD-UHFFFAOYSA-N D07CEB DRUGSMIL C1=CC=C(C=C1)CCCNC2=NC=CC3=CC=CC=C32 D07CEB HIGHSTAT Investigative D07CER DRUG__ID D07CER D07CER DRUGTYPE Small molecular drug D07CER DRUGINCH 1S/C17H13NO2/c19-16-10-11-17(20)18(16)12-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-11H,12H2 D07CER DRUGINKE LMMOMHSYMJTOJF-UHFFFAOYSA-N D07CER DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CN3C(=O)C=CC3=O D07CER HIGHSTAT Investigative D07CEU DRUG__ID D07CEU D07CEU DRUGTYPE Small molecular drug D07CEU DRUGINCH 1S/C21H20O10/c22-7-15-18(26)19(27)20(28)21(31-15)30-11-3-1-9(2-4-11)12-8-29-14-6-10(23)5-13(24)16(14)17(12)25/h1-6,8,15,18-24,26-28H,7H2/t15-,18-,19+,20-,21-/m1/s1 D07CEU DRUGINKE ISQRJFLLIDGZEP-CMWLGVBASA-N D07CEU DRUGSMIL C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)OC4C(C(C(C(O4)CO)O)O)O D07CEU HIGHSTAT Investigative D07CFJ DRUG__ID D07CFJ D07CFJ DRUGTYPE Small molecular drug D07CFJ DRUGINCH 1S/C11H9NO3/c1-2-9(13)12-8-6-4-3-5-7(8)10(14)11(12)15/h3-6H,2H2,1H3 D07CFJ DRUGINKE IHNYAHBLLCMRCD-UHFFFAOYSA-N D07CFJ DRUGSMIL CCC(=O)N1C2=CC=CC=C2C(=O)C1=O D07CFJ HIGHSTAT Investigative D07CFT DRUG__ID D07CFT D07CFT DRUGTYPE Small molecular drug D07CFT DRUGINCH 1S/C18H17NO3/c1-20-15-6-4-5-12(8-15)14-7-13-9-17(21-2)18(22-3)10-16(13)19-11-14/h4-11H,1-3H3 D07CFT DRUGINKE RIQQTUOYRGIOFQ-UHFFFAOYSA-N D07CFT DRUGSMIL COC1=CC=CC(=C1)C2=CN=C3C=C(C(=CC3=C2)OC)OC D07CFT HIGHSTAT Investigative D07CIU DRUG__ID D07CIU D07CIU DRUGTYPE Small molecular drug D07CIU DRUGINCH 1S/C25H27NO/c1-20-12-14-23(15-13-20)25(27)16-18-26(19-17-25)24(21-8-4-2-5-9-21)22-10-6-3-7-11-22/h2-15,24,27H,16-19H2,1H3 D07CIU DRUGINKE ZDADQNJEUZQHKH-UHFFFAOYSA-N D07CIU DRUGSMIL CC1=CC=C(C=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D07CIU HIGHSTAT Investigative D07CIW DRUG__ID D07CIW D07CIW DRUGTYPE Small molecular drug D07CIW DRUGINCH 1S/C20H22N2O6/c1-2-12-6-8-14(9-7-12)18(23)22-15-5-3-4-13(10-15)11-28-17(20(26)27)16(21)19(24)25/h3-10,16-17H,2,11,21H2,1H3,(H,22,23)(H,24,25)(H,26,27)/t16-,17-/m0/s1/i1T,2T/t2?,16-,17- D07CIW DRUGINKE GFSLJGCKUUCABJ-YQFXYRMXSA-N D07CIW DRUGSMIL CCC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)COC(C(C(=O)O)N)C(=O)O D07CIW HIGHSTAT Investigative D07CJR DRUG__ID D07CJR D07CJR DRUGTYPE Small molecular drug D07CJR DRUGINCH 1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16,19,21H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,13-12-,16-14+/t19-/m1/s1 D07CJR DRUGINKE KGIJOOYOSFUGPC-JGKLHWIESA-N D07CJR DRUGSMIL CCCCCC=CCC=CCC=CC=CC(CCCC(=O)O)O D07CJR HIGHSTAT Investigative D07COG DRUG__ID D07COG D07COG DRUGTYPE Small molecular drug D07COG DRUGINCH 1S/C18H11Cl2NO4/c19-10-6-13(20)15-12(16(18(24)25)21-14(15)7-10)8-11(17(22)23)9-4-2-1-3-5-9/h1-8,21H,(H,22,23)(H,24,25) D07COG DRUGINKE LPWVUDLZUVBQGP-UHFFFAOYSA-N D07COG DRUGSMIL C1=CC=C(C=C1)C(=CC2=C(NC3=C2C(=CC(=C3)Cl)Cl)C(=O)O)C(=O)O D07COG HIGHSTAT Investigative D07COX DRUG__ID D07COX D07COX DRUGTYPE Small molecular drug D07COX DRUGINCH 1S/C59H89N17O14/c1-3-34(2)47(60)53(85)72-41(32-77)50(82)69-37(19-10-24-65-58(61)62)54(86)76-28-14-23-45(76)56(88)75-27-12-21-43(75)51(83)67-31-46(79)68-39(29-35-15-6-4-7-16-35)48(80)73-42(33-78)55(87)74-26-13-22-44(74)52(84)71-40(30-36-17-8-5-9-18-36)49(81)70-38(57(89)90)20-11-25-66-59(63)64/h4-9,15-18,34,37-45,47,77-78H,3,10-14,19-33,60H2,1-2H3,(H,67,83)(H,68,79)(H,69,82)(H,70,81)(H,71,84)(H,72,85)(H,73,80)(H,89,90)(H4,61,62,65)(H4,63,64,66)/t34-,37-,38-,39-,40-,41-,42-,43-,44-,45-,47-/m0/s1 D07COX DRUGINKE GKCWYHPGFSRBQV-WRBAKOPXSA-N D07COX DRUGSMIL CCC(C)C(C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O)N D07COX HIGHSTAT Investigative D07CQD DRUG__ID D07CQD D07CQD DRUGTYPE Small molecular drug D07CQD DRUGINCH 1S/C19H25NS/c1-5-11-19(12-6-1,20-13-7-2-8-14-20)18-15-16-9-3-4-10-17(16)21-18/h3-4,9-10,15H,1-2,5-8,11-14H2 D07CQD DRUGINKE RGSVXQJPSWZXOP-UHFFFAOYSA-N D07CQD DRUGSMIL C1CCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCCC4 D07CQD HIGHSTAT Investigative D07CQI DRUG__ID D07CQI D07CQI DRUGTYPE Small molecular drug D07CQI DRUGINCH 1S/C8H9NO4S/c1-13-8(10)6-4-2-3-5-7(6)14(9,11)12/h2-5H,1H3,(H2,9,11,12) D07CQI DRUGINKE VSOOBQALJVLTBH-UHFFFAOYSA-N D07CQI DRUGSMIL COC(=O)C1=CC=CC=C1S(=O)(=O)N D07CQI HIGHSTAT Investigative D07CRG DRUG__ID D07CRG D07CRG DRUGTYPE Small molecular drug D07CRG DRUGINCH 1S/C9H7NO/c11-9-8-4-2-1-3-7(8)5-6-10-9/h1-6H,(H,10,11) D07CRG DRUGINKE VDBNYAPERZTOOF-UHFFFAOYSA-N D07CRG DRUGSMIL C1=CC=C2C(=C1)C=CNC2=O D07CRG HIGHSTAT Investigative D07CTI DRUG__ID D07CTI D07CTI DRUGTYPE Small molecular drug D07CTI DRUGINCH 1S/C17H11N3O4/c21-16-12-3-1-2-4-14(12)24-17-13(20(22)23)6-5-11(15(16)17)9-19-8-7-18-10-19/h1-8,10H,9H2 D07CTI DRUGINKE VKGUMSNSPMTJMS-UHFFFAOYSA-N D07CTI DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3O2)[N+](=O)[O-])CN4C=CN=C4 D07CTI HIGHSTAT Investigative D07CUI DRUG__ID D07CUI D07CUI DRUGTYPE Small molecular drug D07CUI DRUGINCH 1S/C12H21N3O6/c1-7(11(18)19)14-9(16)5-3-2-4-8(12(20)21)15-10(17)6-13/h7-8H,2-6,13H2,1H3,(H,14,16)(H,15,17)(H,18,19)(H,20,21)/t7-,8+/m1/s1 D07CUI DRUGINKE ZMQJQOKNTYQVHO-SFYZADRCSA-N D07CUI DRUGSMIL CC(C(=O)O)NC(=O)CCCCC(C(=O)O)NC(=O)CN D07CUI HIGHSTAT Investigative D07CUW DRUG__ID D07CUW D07CUW DRUGTYPE Small molecular drug D07CUW DRUGINCH 1S/C15H8BrNO4/c16-10-4-5-14-12(7-10)13(18)8-15(21-14)9-2-1-3-11(6-9)17(19)20/h1-8H D07CUW DRUGINKE IPHSQMSRIWZULE-UHFFFAOYSA-N D07CUW DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC(=O)C3=C(O2)C=CC(=C3)Br D07CUW HIGHSTAT Investigative D07CVE DRUG__ID D07CVE D07CVE DRUGTYPE Small molecular drug D07CVE DRUGINCH 1S/C39H51N9O10/c1-21(2)15-28(44-22(3)49)37(56)48-31(18-34(52)53)39(58)45-27(13-14-32(40)50)36(55)47-30(17-24-19-42-26-12-8-7-11-25(24)26)38(57)46-29(35(54)43-20-33(41)51)16-23-9-5-4-6-10-23/h4-12,19,21,27-31,42H,13-18,20H2,1-3H3,(H2,40,50)(H2,41,51)(H,43,54)(H,44,49)(H,45,58)(H,46,57)(H,47,55)(H,48,56)(H,52,53)/t27-,28-,29-,30-,31-/m0/s1 D07CVE DRUGINKE VTQMNICJVWMKEV-QKUYTOGTSA-N D07CVE DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)NCC(=O)N)NC(=O)C D07CVE HIGHSTAT Investigative D07CVG DRUG__ID D07CVG D07CVG DRUGTYPE Small molecular drug D07CVG DRUGINCH 1S/C10H12O2S/c11-10(12)9(7-13)6-8-4-2-1-3-5-8/h1-5,9,13H,6-7H2,(H,11,12) D07CVG DRUGINKE ZUEBVBPVXLQMQR-UHFFFAOYSA-N D07CVG DRUGSMIL C1=CC=C(C=C1)CC(CS)C(=O)O D07CVG HIGHSTAT Investigative D07CWJ DRUG__ID D07CWJ D07CWJ DRUGTYPE Small molecular drug D07CWJ DRUGINCH 1S/C14H13NO4S/c1-10-7-8-13(12(9-10)14(16)17)15-20(18,19)11-5-3-2-4-6-11/h2-9,15H,1H3,(H,16,17) D07CWJ DRUGINKE HXQLTRSIZRSFTR-UHFFFAOYSA-N D07CWJ DRUGSMIL CC1=CC(=C(C=C1)NS(=O)(=O)C2=CC=CC=C2)C(=O)O D07CWJ HIGHSTAT Investigative D07CYN DRUG__ID D07CYN D07CYN DRUGTYPE Small molecular drug D07CYN DRUGINCH 1S/C9H12N2O2S/c10-8-3-6-1-2-9(14(11,12)13)5-7(6)4-8/h1-2,5,8H,3-4,10H2,(H2,11,12,13) D07CYN DRUGINKE FVWXUWAWIYLUJG-UHFFFAOYSA-N D07CYN DRUGSMIL C1C(CC2=C1C=CC(=C2)S(=O)(=O)N)N D07CYN HIGHSTAT Investigative D07CZJ DRUG__ID D07CZJ D07CZJ DRUGTYPE Small molecular drug D07CZJ DRUGINCH 1S/C24H29NO2/c1-3-5-12-22(26)27-21-11-7-9-18-16-20-23-17(13-15-25(20)14-4-2)8-6-10-19(23)24(18)21/h6-11,20H,3-5,12-16H2,1-2H3/t20-/m1/s1 D07CZJ DRUGINKE JGCVBGVDWQJTDF-HXUWFJFHSA-N D07CZJ DRUGSMIL CCCCC(=O)OC1=CC=CC2=C1C3=CC=CC4=C3C(C2)N(CC4)CCC D07CZJ HIGHSTAT Investigative D07CZM DRUG__ID D07CZM D07CZM DRUGTYPE Small molecular drug D07CZM DRUGINCH 1S/C24H20F3N3O4S2/c25-24(26,27)18-7-4-8-21(15-18)36(32,33)14-13-35-23-29-28-22(31)30(23)19-9-11-20(12-10-19)34-16-17-5-2-1-3-6-17/h1-12,15H,13-14,16H2,(H,28,31) D07CZM DRUGINKE PCYFSRWJXFMTSN-UHFFFAOYSA-N D07CZM DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)N3C(=O)NN=C3SCCS(=O)(=O)C4=CC=CC(=C4)C(F)(F)F D07CZM HIGHSTAT Investigative D07DAK DRUG__ID D07DAK D07DAK DRUGTYPE Small molecular drug D07DAK DRUGINCH 1S/C20H24O11/c1-5-12(24)28-11-8(22)18-10-6(21)7(16(2,3)4)17(18)9(23)13(25)30-15(17)31-20(18,14(26)29-10)19(5,11)27/h5-11,15,21-23,27H,1-4H3/t5?,6-,7?,8?,9+,10?,11+,15?,17?,18?,19-,20+/m1/s1 D07DAK DRUGINKE AMOGMTLMADGEOQ-RNOCTPMTSA-N D07DAK DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O D07DAK HIGHSTAT Investigative D07DAP DRUG__ID D07DAP D07DAP DRUGTYPE Small molecular drug D07DAP DRUGINCH 1S/C14H14O4/c15-11-5-3-9(13(17)7-11)1-2-10-4-6-12(16)8-14(10)18/h3-8,15-18H,1-2H2 D07DAP DRUGINKE WKIFTWPZTZUMRN-UHFFFAOYSA-N D07DAP DRUGSMIL C1=CC(=C(C=C1O)O)CCC2=C(C=C(C=C2)O)O D07DAP HIGHSTAT Investigative D07DAX DRUG__ID D07DAX D07DAX DRUGTYPE Small molecular drug D07DAX DRUGINCH 1S/C14H6N2O6/c17-13-9-3-1-7(15(19)20)5-11(9)14(18)12-6-8(16(21)22)2-4-10(12)13/h1-6H D07DAX DRUGINKE XFLONXIGNOXKCG-UHFFFAOYSA-N D07DAX DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C3=C(C2=O)C=CC(=C3)[N+](=O)[O-] D07DAX HIGHSTAT Investigative D07DCN DRUG__ID D07DCN D07DCN DRUGTYPE Small molecular drug D07DCN DRUGINCH 1S/C16H19N3O2S/c20-22(21,16-7-2-1-3-8-16)18-14-5-4-6-15(13-14)19-11-9-17-10-12-19/h1-8,13,17-18H,9-12H2 D07DCN DRUGINKE KUAATZXIILUWMF-UHFFFAOYSA-N D07DCN DRUGSMIL C1CN(CCN1)C2=CC=CC(=C2)NS(=O)(=O)C3=CC=CC=C3 D07DCN HIGHSTAT Investigative D07DEY DRUG__ID D07DEY D07DEY DRUGTYPE Small molecular drug D07DEY DRUGINCH 1S/C13H18N2O/c14-9-11-4-1-3-10(7-11)8-12-5-2-6-15-13(12)16/h1,3-4,7,12H,2,5-6,8-9,14H2,(H,15,16) D07DEY DRUGINKE WOUBCSVRQLAOBC-UHFFFAOYSA-N D07DEY DRUGSMIL C1CC(C(=O)NC1)CC2=CC(=CC=C2)CN D07DEY HIGHSTAT Investigative D07DFD DRUG__ID D07DFD D07DFD DRUGTYPE Small molecular drug D07DFD DRUGINCH 1S/C22H30N2O2/c1-23-21(25)26-17-8-7-16-12-20-18-4-2-3-9-22(18,19(16)13-17)10-11-24(20)14-15-5-6-15/h7-8,13,15,18,20H,2-6,9-12,14H2,1H3,(H,23,25) D07DFD DRUGINKE SGHKXPYOPVKZJP-UHFFFAOYSA-N D07DFD DRUGSMIL CNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CC5)C=C1 D07DFD HIGHSTAT Investigative D07DGH DRUG__ID D07DGH D07DGH DRUGTYPE Small molecular drug D07DGH DRUGINCH 1S/C21H21N3O/c1-2-3-14-20(25)24-21-22-18(16-10-6-4-7-11-16)15-19(23-21)17-12-8-5-9-13-17/h4-13,15H,2-3,14H2,1H3,(H,22,23,24,25) D07DGH DRUGINKE USYDGSXEKYPSDH-UHFFFAOYSA-N D07DGH DRUGSMIL CCCCC(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D07DGH HIGHSTAT Investigative D07DGI DRUG__ID D07DGI D07DGI DRUGTYPE Small molecular drug D07DGI DRUGINCH 1S/C7H15N2O8P/c8-1-4(10)9-7-6(12)5(11)3(17-7)2-16-18(13,14)15/h3,5-7,11-12H,1-2,8H2,(H,9,10)(H2,13,14,15)/t3-,5-,6-,7-/m1/s1 D07DGI DRUGINKE OBQMLSFOUZUIOB-SHUUEZRQSA-N D07DGI DRUGSMIL C(C1C(C(C(O1)NC(=O)CN)O)O)OP(=O)(O)O D07DGI HIGHSTAT Investigative D07DGS DRUG__ID D07DGS D07DGS DRUGTYPE Small molecular drug D07DGS DRUGINCH 1S/C10H14O2/c1-3-11-9-5-7-10(8-6-9)12-4-2/h5-8H,3-4H2,1-2H3 D07DGS DRUGINKE VWGNFIQXBYRDCH-UHFFFAOYSA-N D07DGS DRUGSMIL CCOC1=CC=C(C=C1)OCC D07DGS HIGHSTAT Investigative D07DHN DRUG__ID D07DHN D07DHN DRUGTYPE Small molecular drug D07DHN DRUGINCH 1S/C8H4Br2N2O2/c9-3-1-4(10)6-5(2-3)11-7(13)8(14)12-6/h1-2H,(H,11,13)(H,12,14) D07DHN DRUGINKE KAMOVQVEAFPAHG-UHFFFAOYSA-N D07DHN DRUGSMIL C1=C(C=C(C2=C1NC(=O)C(=O)N2)Br)Br D07DHN HIGHSTAT Investigative D07DJS DRUG__ID D07DJS D07DJS DRUGTYPE Small molecular drug D07DJS DRUGINCH 1S/C21H20O11/c1-7-15(26)17(28)18(29)21(30-7)32-20-16(27)14-12(25)5-9(22)6-13(14)31-19(20)8-2-3-10(23)11(24)4-8/h2-7,15,17-18,21-26,28-29H,1H3/t7-,15-,17+,18+,21-/m0/s1 D07DJS DRUGINKE OXGUCUVFOIWWQJ-HQBVPOQASA-N D07DJS DRUGSMIL CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)O)O)O)O D07DJS HIGHSTAT Investigative D07DMN DRUG__ID D07DMN D07DMN DRUGTYPE Small molecular drug D07DMN DRUGINCH 1S/C16H20N2/c1-18(2)13-9-7-12(8-10-13)15-11-17-16-6-4-3-5-14(15)16/h3-7,11,13,17H,8-10H2,1-2H3 D07DMN DRUGINKE OLBSGDZXLHSPOR-UHFFFAOYSA-N D07DMN DRUGSMIL CN(C)C1CCC(=CC1)C2=CNC3=CC=CC=C32 D07DMN HIGHSTAT Investigative D07DNK DRUG__ID D07DNK D07DNK DRUGTYPE Small molecular drug D07DNK DRUGINCH 1S/C13H9NO5/c15-11(13(18)19)14-10-6-8-4-2-1-3-7(8)5-9(10)12(16)17/h1-6H,(H,14,15)(H,16,17)(H,18,19) D07DNK DRUGINKE DQBLKSRRWDWNKQ-UHFFFAOYSA-N D07DNK DRUGSMIL C1=CC=C2C=C(C(=CC2=C1)C(=O)O)NC(=O)C(=O)O D07DNK HIGHSTAT Investigative D07DNX DRUG__ID D07DNX D07DNX DRUGTYPE Small molecular drug D07DNX DRUGINCH 1S/C22H32N6O4S/c1-6-12-27-20-18(21(29)28(13-7-2)22(27)30)23-19(24-20)16-8-10-17(11-9-16)33(31,32)26(5)15-14-25(3)4/h8-11H,6-7,12-15H2,1-5H3,(H,23,24) D07DNX DRUGINKE RWNRBPFXDDCJTH-UHFFFAOYSA-N D07DNX DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)S(=O)(=O)N(C)CCN(C)C D07DNX HIGHSTAT Investigative D07DOE DRUG__ID D07DOE D07DOE DRUGTYPE Small molecular drug D07DOE DRUGINCH 1S/C15H21N5O5/c1-15(23)11(22)9(4-21)25-14(15)20-7-18-10-12(16-6-17-13(10)20)19-8-2-3-24-5-8/h6-9,11,14,21-23H,2-5H2,1H3,(H,16,17,19)/t8-,9-,11-,14-,15-/m1/s1 D07DOE DRUGINKE BPEIIXZHZSYVFH-LVSZHXFLSA-N D07DOE DRUGSMIL CC1(C(C(OC1N2C=NC3=C(N=CN=C32)NC4CCOC4)CO)O)O D07DOE HIGHSTAT Investigative D07DOW DRUG__ID D07DOW D07DOW DRUGTYPE Small molecular drug D07DOW DRUGINCH 1S/C11H10N2O/c1-9-5-2-3-6-10(9)11(14)13-8-4-7-12-13/h2-8H,1H3 D07DOW DRUGINKE RYSRFZOAAPABLM-UHFFFAOYSA-N D07DOW DRUGSMIL CC1=CC=CC=C1C(=O)N2C=CC=N2 D07DOW HIGHSTAT Investigative D07DPX DRUG__ID D07DPX D07DPX DRUGTYPE Small molecular drug D07DPX DRUGINCH 1S/C13H9ClN2O2S/c14-9-3-1-4-10(7-9)19(17,18)13-6-2-5-12(16)11(13)8-15/h1-7H,16H2 D07DPX DRUGINKE AJPMQLQIJVLDJP-UHFFFAOYSA-N D07DPX DRUGSMIL C1=CC(=CC(=C1)Cl)S(=O)(=O)C2=CC=CC(=C2C#N)N D07DPX HIGHSTAT Investigative D07DQJ DRUG__ID D07DQJ D07DQJ DRUGTYPE Small molecular drug D07DQJ DRUGINCH 1S/C16H13BrN2/c17-15-8-6-13(7-9-15)11-19-12-18-10-16(19)14-4-2-1-3-5-14/h1-10,12H,11H2 D07DQJ DRUGINKE LHMVBZUXJAMAAP-UHFFFAOYSA-N D07DQJ DRUGSMIL C1=CC=C(C=C1)C2=CN=CN2CC3=CC=C(C=C3)Br D07DQJ HIGHSTAT Investigative D07DQO DRUG__ID D07DQO D07DQO DRUGTYPE Small molecular drug D07DQO DRUGINCH 1S/C20H15N3O2/c24-20(17-13-21-18-9-5-4-8-16(17)18)23-14-10-11-19(22-12-14)25-15-6-2-1-3-7-15/h1-13,21H,(H,23,24) D07DQO DRUGINKE KBQZTNRCKHEJQM-UHFFFAOYSA-N D07DQO DRUGSMIL C1=CC=C(C=C1)OC2=NC=C(C=C2)NC(=O)C3=CNC4=CC=CC=C43 D07DQO HIGHSTAT Investigative D07DRJ DRUG__ID D07DRJ D07DRJ DRUGTYPE Small molecular drug D07DRJ DRUGINCH 1S/C17H13ClN2O4/c1-10(17(21)22)23-12-3-5-13(6-4-12)24-16-9-19-15-8-11(18)2-7-14(15)20-16/h2-10H,1H3,(H,21,22) D07DRJ DRUGINKE ABOOPXYCKNFDNJ-UHFFFAOYSA-N D07DRJ DRUGSMIL CC(C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=C(C=CC3=N2)Cl D07DRJ HIGHSTAT Investigative D07DRT DRUG__ID D07DRT D07DRT DRUGTYPE Small molecular drug D07DRT DRUGINCH 1S/C24H31N3O5S2/c1-18(28)25-15-7-3-6-10-24(29)27-16-22(23(33)17-27)26-34(30,31)21-13-11-20(12-14-21)32-19-8-4-2-5-9-19/h2,4-5,8-9,11-14,22-23,26,33H,3,6-7,10,15-17H2,1H3,(H,25,28)/t22-,23-/m0/s1 D07DRT DRUGINKE MUWDEQLPHWVPPA-GOTSBHOMSA-N D07DRT DRUGSMIL CC(=O)NCCCCCC(=O)N1CC(C(C1)S)NS(=O)(=O)C2=CC=C(C=C2)OC3=CC=CC=C3 D07DRT HIGHSTAT Investigative D07DTN DRUG__ID D07DTN D07DTN DRUGTYPE Small molecular drug D07DTN DRUGINCH 1S/C30H38N6O6/c31-22(16-18-7-9-21(37)10-8-18)27(40)34-24-6-3-15-33-25(38)12-11-23(26(32)39)35-29(42)30(36-28(24)41)14-13-19-4-1-2-5-20(19)17-30/h1-2,4-5,7-10,22-24,37H,3,6,11-17,31H2,(H2,32,39)(H,33,38)(H,34,40)(H,35,42)(H,36,41)/t22-,23-,24+,30-/m0/s1 D07DTN DRUGINKE IJZIWUAJVCVWNA-WAHOFHFDSA-N D07DTN DRUGSMIL C1CC(C(=O)NC2(CCC3=CC=CC=C3C2)C(=O)NC(CCC(=O)NC1)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D07DTN HIGHSTAT Investigative D07DUW DRUG__ID D07DUW D07DUW DRUGTYPE Small molecular drug D07DUW DRUGINCH 1S/C10H13N3O4S/c1-17-7-4-3-6(9(14)13-10(11)12)5-8(7)18(2,15)16/h3-5H,1-2H3,(H4,11,12,13,14) D07DUW DRUGINKE JWTRVDCAXVYZOB-UHFFFAOYSA-N D07DUW DRUGSMIL COC1=C(C=C(C=C1)C(=O)N=C(N)N)S(=O)(=O)C D07DUW HIGHSTAT Investigative D07DWS DRUG__ID D07DWS D07DWS DRUGTYPE Small molecular drug D07DWS DRUGINCH 1S/C17H19FN2O/c18-15-6-2-1-5-14(15)13-21-17-8-4-3-7-16(17)20-11-9-19-10-12-20/h1-8,19H,9-13H2 D07DWS DRUGINKE XMQIWPUGABPALG-UHFFFAOYSA-N D07DWS DRUGSMIL C1CN(CCN1)C2=CC=CC=C2OCC3=CC=CC=C3F D07DWS HIGHSTAT Investigative D07DYJ DRUG__ID D07DYJ D07DYJ DRUGTYPE Small molecular drug D07DYJ DRUGINCH 1S/C6H14N2O/c7-1-2-8-3-5-9-6-4-8/h1-7H2 D07DYJ DRUGINKE RWIVICVCHVMHMU-UHFFFAOYSA-N D07DYJ DRUGSMIL C1COCCN1CCN D07DYJ HIGHSTAT Investigative D07DZS DRUG__ID D07DZS D07DZS DRUGTYPE Small molecular drug D07DZS DRUGINCH 1S/C17H12N2OS4/c20-11(9-21-16-18-12-5-1-3-7-14(12)23-16)10-22-17-19-13-6-2-4-8-15(13)24-17/h1-8H,9-10H2 D07DZS DRUGINKE BWTBZOLHOSVREZ-UHFFFAOYSA-N D07DZS DRUGSMIL C1=CC=C2C(=C1)N=C(S2)SCC(=O)CSC3=NC4=CC=CC=C4S3 D07DZS HIGHSTAT Investigative D07EAB DRUG__ID D07EAB D07EAB DRUGTYPE Small molecular drug D07EAB DRUGINCH 1S/C21H33NO2/c1-2-3-4-5-6-7-8-9-18-10-12-19(13-11-18)16-22-15-14-20(17-22)21(23)24/h10-13,20H,2-9,14-17H2,1H3,(H,23,24) D07EAB DRUGINKE JXGNTXCFTVWCAS-UHFFFAOYSA-N D07EAB DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)CN2CCC(C2)C(=O)O D07EAB HIGHSTAT Investigative D07EAJ DRUG__ID D07EAJ D07EAJ DRUGTYPE Small molecular drug D07EAJ DRUGINCH 1S/C26H38O2/c1-19(11-13-22-18-23(27)14-16-25(22)28)8-6-9-20(2)12-15-24-21(3)10-7-17-26(24,4)5/h9,11,14,16,18,27-28H,6-8,10,12-13,15,17H2,1-5H3/b19-11+,20-9+ D07EAJ DRUGINKE KUTRNQZRJBENDY-ZQYJZOSASA-N D07EAJ DRUGSMIL CC1=C(C(CCC1)(C)C)CCC(=CCCC(=CCC2=C(C=CC(=C2)O)O)C)C D07EAJ HIGHSTAT Investigative D07ECH DRUG__ID D07ECH D07ECH DRUGTYPE Small molecular drug D07ECH DRUGINCH 1S/C15H9N5O5S2/c21-10-8-7(5-1-3-6(4-2-5)20(23)24)9-11(22)17-15(27)19-13(9)25-12(8)18-14(26)16-10/h1-4,7H,(H2,16,18,21,26)(H2,17,19,22,27) D07ECH DRUGINKE UYLYXNZSRMQYRO-UHFFFAOYSA-N D07ECH DRUGSMIL C1=CC(=CC=C1C2C3=C(NC(=S)NC3=O)OC4=C2C(=O)NC(=S)N4)[N+](=O)[O-] D07ECH HIGHSTAT Investigative D07EDG DRUG__ID D07EDG D07EDG DRUGTYPE Small molecular drug D07EDG DRUGINCH 1S/C15H9Cl2NO2/c16-11-6-5-9(7-12(11)17)8-18-13-4-2-1-3-10(13)14(19)15(18)20/h1-7H,8H2 D07EDG DRUGINKE KGRJPLRFGLMQMV-UHFFFAOYSA-N D07EDG DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N2CC3=CC(=C(C=C3)Cl)Cl D07EDG HIGHSTAT Investigative D07EFI DRUG__ID D07EFI D07EFI DRUGTYPE Small molecular drug D07EFI DRUGINCH 1S/C7H13N3S/c1-5(2)4-6(3)9-10-7(8)11/h4H,1-3H3,(H3,8,10,11)/b9-6- D07EFI DRUGINKE KSBSSDJKRMIXES-TWGQIWQCSA-N D07EFI DRUGSMIL CC(=CC(=NNC(=S)N)C)C D07EFI HIGHSTAT Investigative D07EGB DRUG__ID D07EGB D07EGB DRUGTYPE Small molecular drug D07EGB DRUGINCH 1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3 D07EGB DRUGINKE WFJIVOKAWHGMBH-UHFFFAOYSA-N D07EGB DRUGSMIL CCCCCCC1=C(C=C(C=C1)O)O D07EGB HIGHSTAT Investigative D07EGC DRUG__ID D07EGC D07EGC DRUGTYPE Small molecular drug D07EGC DRUGINCH 1S/C28H37NO7/c1-5-8-19-22(13-10-18-11-14-24(28(31)32)36-25(18)19)34-16-7-17-35-23-15-12-21(27(30)29-3)26(33-4)20(23)9-6-2/h10,12-13,15,24H,5-9,11,14,16-17H2,1-4H3,(H,29,30)(H,31,32) D07EGC DRUGINKE CIIUJGWVQJRIPP-UHFFFAOYSA-N D07EGC DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)NC)OC)CCC D07EGC HIGHSTAT Investigative D07EJK DRUG__ID D07EJK D07EJK DRUGTYPE Small molecular drug D07EJK DRUGINCH 1S/C12H9N3O/c13-5-10-1-3-11(4-2-10)7-15-9-14-6-12(15)8-16/h1-4,6,8-9H,7H2 D07EJK DRUGINKE AMUOEEKBBOOOCV-UHFFFAOYSA-N D07EJK DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2C=O)C#N D07EJK HIGHSTAT Investigative D07EMU DRUG__ID D07EMU D07EMU DRUGTYPE Small molecular drug D07EMU DRUGINCH 1S/C17H25NO/c19-17-9-5-4-8-16(17)18-12-10-15(11-13-18)14-6-2-1-3-7-14/h1-3,6-7,15-17,19H,4-5,8-13H2/i19T D07EMU DRUGINKE YSSBJODGIYRAMI-SETVJMCQSA-N D07EMU DRUGSMIL C1CCC(C(C1)N2CCC(CC2)C3=CC=CC=C3)O D07EMU HIGHSTAT Investigative D07EMX DRUG__ID D07EMX D07EMX DRUGTYPE Small molecular drug D07EMX DRUGINCH 1S/C7H17O3P/c1-6(7(2,3)4)10-11(5,8)9/h6H,1-5H3,(H,8,9)/t6-/m1/s1 D07EMX DRUGINKE BLALDUPQYCGKAG-ZCFIWIBFSA-N D07EMX DRUGSMIL CC(C(C)(C)C)OP(=O)(C)O D07EMX HIGHSTAT Investigative D07EOD DRUG__ID D07EOD D07EOD DRUGTYPE Small molecular drug D07EOD DRUGINCH 1S/C21H22N2O2/c1-14(24)23-9-8-17-11-18(15-4-3-5-19(22)12-15)10-16-6-7-20(25-2)13-21(16)17/h3-7,10-13H,8-9,22H2,1-2H3,(H,23,24) D07EOD DRUGINKE RUYDBTKHRKQOLY-UHFFFAOYSA-N D07EOD DRUGSMIL CC(=O)NCCC1=C2C=C(C=CC2=CC(=C1)C3=CC(=CC=C3)N)OC D07EOD HIGHSTAT Investigative D07EPU DRUG__ID D07EPU D07EPU DRUGTYPE Small molecular drug D07EPU DRUGINCH 1S/C23H26F3N5O2/c1-15-19-13-17(7-10-20(19)29-22(27-15)31(4)12-11-30(2)3)28-21(32)14-33-18-8-5-16(6-9-18)23(24,25)26/h5-10,13H,11-12,14H2,1-4H3,(H,28,32) D07EPU DRUGINKE ZALRLWFCZSVMRA-UHFFFAOYSA-N D07EPU DRUGSMIL CC1=C2C=C(C=CC2=NC(=N1)N(C)CCN(C)C)NC(=O)COC3=CC=C(C=C3)C(F)(F)F D07EPU HIGHSTAT Investigative D07ETD DRUG__ID D07ETD D07ETD DRUGTYPE Small molecular drug D07ETD DRUGINCH 1S/C17H19N5O5/c23-6-11-13(25)14(26)17(27-11)22-8-21-12-15(19-7-20-16(12)22)18-5-9-1-3-10(24)4-2-9/h1-4,7-8,11,13-14,17,23-26H,5-6H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1 D07ETD DRUGINKE UGVIXKXYLBAZND-LSCFUAHRSA-N D07ETD DRUGSMIL C1=CC(=CC=C1CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)O D07ETD HIGHSTAT Investigative D07ETF DRUG__ID D07ETF D07ETF DRUGTYPE Small molecular drug D07ETF DRUGINCH 1S/C20H22N2/c1-22-13-7-10-16(14-22)19-17-11-5-6-12-18(17)21-20(19)15-8-3-2-4-9-15/h2-6,8-9,11-12,16,21H,7,10,13-14H2,1H3 D07ETF DRUGINKE JRFXDRYERZNJFJ-UHFFFAOYSA-N D07ETF DRUGSMIL CN1CCCC(C1)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D07ETF HIGHSTAT Investigative D07EVI DRUG__ID D07EVI D07EVI DRUGTYPE Small molecular drug D07EVI DRUGINCH 1S/C17H17N5O7S/c23-5-11-13(24)14(25)17(29-11,21-8-20-12-15(21)18-7-19-16(12)26)30-6-9-3-1-2-4-10(9)22(27)28/h1-4,7-8,11,13-14,23-25H,5-6H2,(H,18,19,26)/t11-,13-,14-,17+/m1/s1 D07EVI DRUGINKE NVQXRTPYOZKYMZ-GDLHICMESA-N D07EVI DRUGSMIL C1=CC=C(C(=C1)CSC2(C(C(C(O2)CO)O)O)N3C=NC4=C3N=CNC4=O)[N+](=O)[O-] D07EVI HIGHSTAT Investigative D07EWF DRUG__ID D07EWF D07EWF DRUGTYPE Small molecular drug D07EWF DRUGINCH 1S/C18H17ClN4OS/c1-4-5-11-6-12(10-21-9-11)14-7-13(19)16(25-14)18(2)8-15(24)23(3)17(20)22-18/h6-7,9-10H,8H2,1-3H3,(H2,20,22)/t18-/m0/s1 D07EWF DRUGINKE IJYPXSRDUPWKPB-SFHVURJKSA-N D07EWF DRUGSMIL CC#CC1=CC(=CN=C1)C2=CC(=C(S2)C3(CC(=O)N(C(=N3)N)C)C)Cl D07EWF HIGHSTAT Investigative D07EYJ DRUG__ID D07EYJ D07EYJ DRUGTYPE Small molecular drug D07EYJ DRUGINCH 1S/C20H16FNO/c21-18-14-8-7-13-17(18)20(19(22)23,15-9-3-1-4-10-15)16-11-5-2-6-12-16/h1-14H,(H2,22,23) D07EYJ DRUGINKE YDVJKRJJBXTMCW-UHFFFAOYSA-N D07EYJ DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3F)C(=O)N D07EYJ HIGHSTAT Investigative D07FCB DRUG__ID D07FCB D07FCB DRUGTYPE Small molecular drug D07FCB DRUGINCH 1S/C19H23NO/c1-16(17-8-4-2-5-9-17)20-14-12-19(21,13-15-20)18-10-6-3-7-11-18/h2-11,16,21H,12-15H2,1H3 D07FCB DRUGINKE PKTJCXJTMHJHNK-UHFFFAOYSA-N D07FCB DRUGSMIL CC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D07FCB HIGHSTAT Investigative D07FDL DRUG__ID D07FDL D07FDL DRUGTYPE Small molecular drug D07FDL DRUGINCH 1S/C15H15NO/c1-10(17)16-14-8-12-6-2-4-11-5-3-7-13(9-14)15(11)12/h2-7,14H,8-9H2,1H3,(H,16,17) D07FDL DRUGINKE NSODBKSYAOTJPJ-UHFFFAOYSA-N D07FDL DRUGSMIL CC(=O)NC1CC2=CC=CC3=C2C(=CC=C3)C1 D07FDL HIGHSTAT Investigative D07FEO DRUG__ID D07FEO D07FEO DRUGTYPE Small molecular drug D07FEO DRUGINCH 1S/C25H21N3/c26-25(27-21-13-11-17-9-7-15-3-1-5-19(21)23(15)17)28-22-14-12-18-10-8-16-4-2-6-20(22)24(16)18/h1-6,11-14H,7-10H2,(H3,26,27,28) D07FEO DRUGINKE DPWVUEQXMOBVOQ-UHFFFAOYSA-N D07FEO DRUGSMIL C1CC2=CC=C(C3=CC=CC1=C23)NC(=NC4=CC=C5CCC6=C5C4=CC=C6)N D07FEO HIGHSTAT Investigative D07FFB DRUG__ID D07FFB D07FFB DRUGTYPE Small molecular drug D07FFB DRUGINCH 1S/C16H20N2O2/c1-9-6-10-7-12-11(2-3-14(20)18-12)16(8-9)15(10)13(19)4-5-17-16/h2-3,6,10,13,15,17,19H,4-5,7-8H2,1H3,(H,18,20)/t10-,13+,15-,16-/m0/s1 D07FFB DRUGINKE RGJUWLMFRYLAOJ-UXVLEFJLSA-N D07FFB DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2C(CCN4)O D07FFB HIGHSTAT Investigative D07FFL DRUG__ID D07FFL D07FFL DRUGTYPE Small molecular drug D07FFL DRUGINCH 1S/C22H17NO6S/c1-22-4-2-3-10-9-29-20(15(10)22)18(25)13-7-11-12(8-14(13)22)19(26)21-16(17(11)24)23-5-6-30(21,27)28/h7-9,23H,2-6H2,1H3/t22-/m0/s1 D07FFL DRUGINKE KJMXEMKLXNMFIG-QFIPXVFZSA-N D07FFL DRUGSMIL CC12CCCC3=COC(=C31)C(=O)C4=C2C=C5C(=C4)C(=O)C6=C(C5=O)S(=O)(=O)CCN6 D07FFL HIGHSTAT Investigative D07FGB DRUG__ID D07FGB D07FGB DRUGTYPE Small molecular drug D07FGB DRUGINCH 1S/C19H16N4/c1-12-3-7-14(8-4-12)16-17-19(21-11-20-17)23-18(22-16)15-9-5-13(2)6-10-15/h3-11H,1-2H3,(H,20,21,22,23) D07FGB DRUGINKE DEIRTPFLGXETKT-UHFFFAOYSA-N D07FGB DRUGSMIL CC1=CC=C(C=C1)C2=C3C(=NC(=N2)C4=CC=C(C=C4)C)N=CN3 D07FGB HIGHSTAT Investigative D07FGO DRUG__ID D07FGO D07FGO DRUGTYPE Small molecular drug D07FGO DRUGINCH 1S/C16H14O5/c17-9-1-3-12-11(5-6-16(19)20)13-4-2-10(18)8-15(13)21-14(12)7-9/h1-4,7-8,11,17-18H,5-6H2,(H,19,20) D07FGO DRUGINKE PFQGLFBMMPZYEU-UHFFFAOYSA-N D07FGO DRUGSMIL C1=CC2=C(C=C1O)OC3=C(C2CCC(=O)O)C=CC(=C3)O D07FGO HIGHSTAT Investigative D07FGX DRUG__ID D07FGX D07FGX DRUGTYPE Small molecular drug D07FGX DRUGINCH 1S/C21H15NO2/c23-20-17-8-4-5-9-19(17)24-21(16-6-2-1-3-7-16)18(20)14-15-10-12-22-13-11-15/h1-14,21H/b18-14+ D07FGX DRUGINKE YQBABXZFWNTIHJ-NBVRZTHBSA-N D07FGX DRUGSMIL C1=CC=C(C=C1)C2C(=CC3=CC=NC=C3)C(=O)C4=CC=CC=C4O2 D07FGX HIGHSTAT Investigative D07FGY DRUG__ID D07FGY D07FGY DRUGTYPE Small molecular drug D07FGY DRUGINCH 1S/C20H27N3O5S/c1-6-15-18(13(5)24)12(4)21-19(15)20(26)22-16-11-14(9-10-17(16)25)29(27,28)23(7-2)8-3/h9-11,21,25H,6-8H2,1-5H3,(H,22,26) D07FGY DRUGINKE DPBKLIVPNYGQQG-UHFFFAOYSA-N D07FGY DRUGSMIL CCC1=C(NC(=C1C(=O)C)C)C(=O)NC2=C(C=CC(=C2)S(=O)(=O)N(CC)CC)O D07FGY HIGHSTAT Investigative D07FJR DRUG__ID D07FJR D07FJR DRUGTYPE Small molecular drug D07FJR DRUGINCH 1S/C21H38N4O8/c1-6-7-10-22-14(8-9-15(27)28)19(30)25-17(13(5)26)20(31)23-12(4)18(29)24-16(11(2)3)21(32)33/h11-14,16-17,22,26H,6-10H2,1-5H3,(H,23,31)(H,24,29)(H,25,30)(H,27,28)(H,32,33)/t12-,13?,14-,16-,17-/m0/s1 D07FJR DRUGINKE DGLIBFYKWHJASP-UPKCPHKASA-N D07FJR DRUGSMIL CCCCNC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)O D07FJR HIGHSTAT Investigative D07FJU DRUG__ID D07FJU D07FJU DRUGTYPE Small molecular drug D07FJU DRUGINCH 1S/C12H18N2OS/c15-12(7-3-1-2-4-9-16)14-11-6-5-8-13-10-11/h5-6,8,10,16H,1-4,7,9H2,(H,14,15) D07FJU DRUGINKE SHPVLBRAGPXPLH-UHFFFAOYSA-N D07FJU DRUGSMIL C1=CC(=CN=C1)NC(=O)CCCCCCS D07FJU HIGHSTAT Investigative D07FKO DRUG__ID D07FKO D07FKO DRUGTYPE Small molecular drug D07FKO DRUGINCH 1S/C14H13NO6/c16-9-2-1-7(10(17)5-9)6-15-14(21)8-3-11(18)13(20)12(19)4-8/h1-5,16-20H,6H2,(H,15,21) D07FKO DRUGINKE NWUBAFGVRZLIOR-UHFFFAOYSA-N D07FKO DRUGSMIL C1=CC(=C(C=C1O)O)CNC(=O)C2=CC(=C(C(=C2)O)O)O D07FKO HIGHSTAT Investigative D07FLB DRUG__ID D07FLB D07FLB DRUGTYPE Small molecular drug D07FLB DRUGINCH 1S/C13H23N3O3/c1-5-6-7-10(11(17)15-9-8-14)16-12(18)19-13(2,3)4/h10H,5-7,9H2,1-4H3,(H,15,17)(H,16,18)/t10-/m0/s1 D07FLB DRUGINKE KXUSXCUMFSXFIW-JTQLQIEISA-N D07FLB DRUGSMIL CCCCC(C(=O)NCC#N)NC(=O)OC(C)(C)C D07FLB HIGHSTAT Investigative D07FLG DRUG__ID D07FLG D07FLG DRUGTYPE Small molecular drug D07FLG DRUGINCH 1S/C16H22O4/c1-3-5-11-19-15(17)13-9-7-8-10-14(13)16(18)20-12-6-4-2/h7-10H,3-6,11-12H2,1-2H3 D07FLG DRUGINKE DOIRQSBPFJWKBE-UHFFFAOYSA-N D07FLG DRUGSMIL CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC D07FLG HIGHSTAT Investigative D07FLX DRUG__ID D07FLX D07FLX DRUGTYPE Small molecular drug D07FLX DRUGINCH 1S/C21H34O6/c1-2-3-6-9-15(22)12-13-17-16(10-7-4-5-8-11-20(23)24)18-14-19(17)27-21(25)26-18/h4,7,15-19,22H,2-3,5-6,8-14H2,1H3,(H,23,24)/b7-4-/t15-,16+,17+,18-,19+/m0/s1 D07FLX DRUGINKE CVQLYMOSZQTFDP-NFUXFLSFSA-N D07FLX DRUGSMIL CCCCCC(CCC1C2CC(C1CC=CCCCC(=O)O)OC(=O)O2)O D07FLX HIGHSTAT Investigative D07FOH DRUG__ID D07FOH D07FOH DRUGTYPE Small molecular drug D07FOH DRUGINCH 1S/C14H23N/c1-15-4-2-3-14(15)12-6-10-5-11(8-12)9-13(14)7-10/h10-13H,2-9H2,1H3 D07FOH DRUGINKE NEVKUUKTVIGMHH-UHFFFAOYSA-N D07FOH DRUGSMIL CN1CCCC12C3CC4CC(C3)CC2C4 D07FOH HIGHSTAT Investigative D07FPQ DRUG__ID D07FPQ D07FPQ DRUGTYPE Small molecular drug D07FPQ DRUGINCH 1S/C5H8O2/c1-5(2-3-5)4(6)7/h2-3H2,1H3,(H,6,7) D07FPQ DRUGINKE DIZKLZKLNKQFGB-UHFFFAOYSA-N D07FPQ DRUGSMIL CC1(CC1)C(=O)O D07FPQ HIGHSTAT Investigative D07FPS DRUG__ID D07FPS D07FPS DRUGTYPE Small molecular drug D07FPS DRUGINCH 1S/C20H23ClO10/c1-5-12(24)28-11-8(22)18-10-6(21)7(16(2,3)4)17(18)9(23)13(25)30-15(17)31-20(18,14(26)29-10)19(5,11)27/h5-11,15,22-23,27H,1-4H3/t5?,6?,7?,8?,9-,10?,11-,15?,17?,18?,19+,20-/m0/s1 D07FPS DRUGINKE GXEIWFYPUUOBJY-UUSFTXJGSA-N D07FPS DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5Cl)C(C)(C)C)C(C(=O)OC6O4)O)O D07FPS HIGHSTAT Investigative D07FRX DRUG__ID D07FRX D07FRX DRUGTYPE Small molecular drug D07FRX DRUGINCH 1S/C9H6N2S2/c1-3-12-6-7(1)8-5-11-2-4-13-9(11)10-8/h1-6H D07FRX DRUGINKE QNYBFCDYFVERKH-UHFFFAOYSA-N D07FRX DRUGSMIL C1=CSC=C1C2=CN3C=CSC3=N2 D07FRX HIGHSTAT Investigative D07FSW DRUG__ID D07FSW D07FSW DRUGTYPE Small molecular drug D07FSW DRUGINCH 1S/C5H5N5O2/c6-4-8-2-1(3(11)10-4)7-5(12)9-2/h(H5,6,7,8,9,10,11,12) D07FSW DRUGINKE CLGFIVUFZRGQRP-UHFFFAOYSA-N D07FSW DRUGSMIL C12=C(NC(=O)N1)N=C(NC2=O)N D07FSW HIGHSTAT Investigative D07FTI DRUG__ID D07FTI D07FTI DRUGTYPE Small molecular drug D07FTI DRUGINCH 1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2 D07FTI DRUGINKE OTPSWLRZXRHDNX-UHFFFAOYSA-L D07FTI DRUGSMIL C1=CC=[N+](C(=C1)[S-])[O-].C1=CC=[N+](C(=C1)[S-])[O-].[Zn+2] D07FTI HIGHSTAT Investigative D07FUN DRUG__ID D07FUN D07FUN DRUGTYPE Small molecular drug D07FUN DRUGINCH 1S/C86H104Cl2N18O13/c1-4-5-26-66(84(117)106(86(119)73-30-18-37-105(73)83(116)63(91)41-53-21-15-33-93-46-53)85(118)72-29-17-36-104(72)82(115)61(89)25-13-14-35-95-75(108)54-22-16-34-94-47-54)98-77(110)67(38-50(2)3)100-79(112)69(43-55-48-96-64-27-11-9-23-57(55)64)102-78(111)68(42-51-19-7-6-8-20-51)101-80(113)70(44-56-49-97-65-28-12-10-24-58(56)65)103-81(114)71(45-74(92)107)99-76(109)62(90)40-52-31-32-59(87)60(88)39-52/h6-12,15-16,19-24,27-28,31-34,39,46-50,61-63,66-73,96-97H,4-5,13-14,17-18,25-26,29-30,35-38,40-45,89-91H2,1-3H3,(H2,92,107)(H,95,108)(H,98,110)(H,99,109)(H,100,112)(H,101,113)(H,102,111)(H,103,114)/t61-,62-,63+,66+,67+,68+,69-,70-,71+,72+,73+/m1/s1 D07FUN DRUGINKE AZZJAARMZMEIHY-BBKUSFMUSA-N D07FUN DRUGSMIL CCCCC(C(=O)N(C(=O)C1CCCN1C(=O)C(CCCCNC(=O)C2=CN=CC=C2)N)C(=O)C3CCCN3C(=O)C(CC4=CN=CC=C4)N)NC(=O)C(CC(C)C)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CC(=O)N)NC(=O)C(CC1=CC(=C(C=C1)Cl)Cl)N D07FUN HIGHSTAT Investigative D07FVL DRUG__ID D07FVL D07FVL DRUGTYPE Small molecular drug D07FVL DRUGINCH 1S/C3H6N2O/c4-3-5-1-2-6-3/h1-2H2,(H2,4,5) D07FVL DRUGINKE YAXGBZDYGZBRBQ-UHFFFAOYSA-N D07FVL DRUGSMIL C1COC(=N1)N D07FVL HIGHSTAT Investigative D07FVZ DRUG__ID D07FVZ D07FVZ DRUGTYPE Small molecular drug D07FVZ DRUGINCH 1S/C22H15ClN2O4/c23-14-9-10-18(24-20(27)17-7-3-4-8-19(17)26)13(11-14)12-25-21(28)15-5-1-2-6-16(15)22(25)29/h1-11,26H,12H2,(H,24,27) D07FVZ DRUGINKE UFOUABRZSDGGAZ-UHFFFAOYSA-N D07FVZ DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CC3=C(C=CC(=C3)Cl)NC(=O)C4=CC=CC=C4O D07FVZ HIGHSTAT Investigative D07FXC DRUG__ID D07FXC D07FXC DRUGTYPE Small molecular drug D07FXC DRUGINCH 1S/C15H13NO2/c1-17-14-8-4-9-15(12-14)18-11-5-7-13-6-2-3-10-16-13/h2-4,6,8-10,12H,11H2,1H3 D07FXC DRUGINKE NUGIZDIFZXSZAH-UHFFFAOYSA-N D07FXC DRUGSMIL COC1=CC(=CC=C1)OCC#CC2=CC=CC=N2 D07FXC HIGHSTAT Investigative D07FZA DRUG__ID D07FZA D07FZA DRUGTYPE Small molecular drug D07FZA DRUGINCH 1S/C25H31N7O4/c1-6-10-31-23-21(24(34)32(11-7-2)25(31)35)27-22(28-23)18-13-20(29-30(18)5)36-14-19(33)26-17-9-8-15(3)16(4)12-17/h8-9,12-13H,6-7,10-11,14H2,1-5H3,(H,26,33)(H,27,28) D07FZA DRUGINKE FCMUQGWJTIVYIU-UHFFFAOYSA-N D07FZA DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)NC4=CC(=C(C=C4)C)C D07FZA HIGHSTAT Investigative D07GAU DRUG__ID D07GAU D07GAU DRUGTYPE Small molecular drug D07GAU DRUGINCH 1S/C5H13NO9P2/c1-6(4-5(7)8)2-3-14-17(12,13)15-16(9,10)11/h2-4H2,1H3,(H,7,8)(H,12,13)(H2,9,10,11) D07GAU DRUGINKE YERUUUBBRAPJND-UHFFFAOYSA-N D07GAU DRUGSMIL CN(CCOP(=O)(O)OP(=O)(O)O)CC(=O)O D07GAU HIGHSTAT Investigative D07GBV DRUG__ID D07GBV D07GBV DRUGTYPE Small molecular drug D07GBV DRUGINCH 1S/C27H28N2/c1-3-9-21(10-4-1)15-18-29-19-16-22(17-20-29)26-24-13-7-8-14-25(24)28-27(26)23-11-5-2-6-12-23/h1-14,22,28H,15-20H2 D07GBV DRUGINKE MONKRYYJEIHBRU-UHFFFAOYSA-N D07GBV DRUGSMIL C1CN(CCC1C2=C(NC3=CC=CC=C32)C4=CC=CC=C4)CCC5=CC=CC=C5 D07GBV HIGHSTAT Investigative D07GCA DRUG__ID D07GCA D07GCA DRUGTYPE Small molecular drug D07GCA DRUGINCH 1S/C15H19ClO3/c16-12-7-8-14(19-10-15(17)18)13(9-12)11-5-3-1-2-4-6-11/h7-9,11H,1-6,10H2,(H,17,18) D07GCA DRUGINKE JEPDINCGXLHLDF-UHFFFAOYSA-N D07GCA DRUGSMIL C1CCCC(CC1)C2=C(C=CC(=C2)Cl)OCC(=O)O D07GCA HIGHSTAT Investigative D07GCR DRUG__ID D07GCR D07GCR DRUGTYPE Small molecular drug D07GCR DRUGINCH 1S/C17H14F3NS/c1-10-6-11(2)16(12(3)7-10)22-14-5-4-13(9-21)15(8-14)17(18,19)20/h4-8H,1-3H3 D07GCR DRUGINKE ZDVOQQIVWWNKSG-UHFFFAOYSA-N D07GCR DRUGSMIL CC1=CC(=C(C(=C1)C)SC2=CC(=C(C=C2)C#N)C(F)(F)F)C D07GCR HIGHSTAT Investigative D07GEL DRUG__ID D07GEL D07GEL DRUGTYPE Small molecular drug D07GEL DRUGINCH 1S/C23H34N4O6/c1-14(2)11-18-17(22(30)27-32)5-4-10-33-16-8-6-15(7-9-16)12-19(26-21(18)29)23(31)25-13-20(28)24-3/h6-9,14,17-19,32H,4-5,10-13H2,1-3H3,(H,24,28)(H,25,31)(H,26,29)(H,27,30)/t17-,18+,19-/m0/s1 D07GEL DRUGINKE HFAGTNGCAZYYLZ-OTWHNJEPSA-N D07GEL DRUGSMIL CC(C)CC1C(CCCOC2=CC=C(CC(NC1=O)C(=O)NCC(=O)NC)C=C2)C(=O)NO D07GEL HIGHSTAT Investigative D07GEN DRUG__ID D07GEN D07GEN DRUGTYPE Small molecular drug D07GEN DRUGINCH 1S/C7H5ClN2/c8-6-2-1-3-7-5(6)4-9-10-7/h1-4H,(H,9,10) D07GEN DRUGINKE CQTGQYVQJOJQCM-UHFFFAOYSA-N D07GEN DRUGSMIL C1=CC2=C(C=NN2)C(=C1)Cl D07GEN HIGHSTAT Investigative D07GFI DRUG__ID D07GFI D07GFI DRUGTYPE Small molecular drug D07GFI DRUGINCH 1S/C14H10O9/c15-7-2-1-6(10(17)12(7)19)14(22)23-9-4-5(13(20)21)3-8(16)11(9)18/h1-4,15-19H,(H,20,21) D07GFI DRUGINKE PTBZQGDFAUQSCW-UHFFFAOYSA-N D07GFI DRUGSMIL C1=CC(=C(C(=C1C(=O)OC2=CC(=CC(=C2O)O)C(=O)O)O)O)O D07GFI HIGHSTAT Investigative D07GGP DRUG__ID D07GGP D07GGP DRUGTYPE Small molecular drug D07GGP DRUGINCH 1S/C48H65N13O10/c1-27(2)19-37(47(69)60-71)58-46(68)39(22-31-24-51-26-53-31)55-41(63)25-61-18-10-9-15-36(48(61)70)57-42(64)28(3)54-45(67)38(21-30-23-52-34-14-8-7-13-32(30)34)59-44(66)35(16-17-40(50)62)56-43(65)33(49)20-29-11-5-4-6-12-29/h4-8,11-14,23-24,26-28,33,35-39,52,71H,9-10,15-22,25,49H2,1-3H3,(H2,50,62)(H,51,53)(H,54,67)(H,55,63)(H,56,65)(H,57,64)(H,58,68)(H,59,66)(H,60,69)/t28?,33-,35?,36?,37-,38?,39?/m1/s1 D07GGP DRUGINKE FARKOIUETYEQIK-DBJXSMFVSA-N D07GGP DRUGSMIL CC(C)CC(C(=O)NO)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)C(CC5=CC=CC=C5)N D07GGP HIGHSTAT Investigative D07GHW DRUG__ID D07GHW D07GHW DRUGTYPE Small molecular drug D07GHW DRUGINCH 1S/C28H38O7/c1-21(15-18-24(19-26(29)30)20-27(31)32)13-11-9-7-5-6-8-10-12-14-25(35-4)22(2)16-17-23(3)28(33)34/h6,8-12,15-19,21,25H,5,7,13-14,20H2,1-4H3,(H,29,30)(H,31,32)(H,33,34)/b8-6+,11-9+,12-10-,18-15+,22-16-,23-17+,24-19+/t21-,25+/m0/s1 D07GHW DRUGINKE SHCXABJSXUACKU-WUTQZGRKSA-N D07GHW DRUGSMIL CC(CC=CCCC=CC=CCC(C(=CC=C(C)C(=O)O)C)OC)C=CC(=CC(=O)O)CC(=O)O D07GHW HIGHSTAT Investigative D07GKK DRUG__ID D07GKK D07GKK DRUGTYPE Small molecular drug D07GKK DRUGINCH 1S/C28H28N2O4/c1-22-21-30(27(32)29-26(22)31)17-18-33-19-20-34-28(23-11-5-2-6-12-23,24-13-7-3-8-14-24)25-15-9-4-10-16-25/h2-16,21H,17-20H2,1H3,(H,29,31,32) D07GKK DRUGINKE XTVPTIAFWYQSSW-UHFFFAOYSA-N D07GKK DRUGSMIL CC1=CN(C(=O)NC1=O)CCOCCOC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D07GKK HIGHSTAT Investigative D07GLO DRUG__ID D07GLO D07GLO DRUGTYPE Small molecular drug D07GLO DRUGINCH 1S/C16H18N4O2/c1-2-3-12-10-16(19-8-6-17-7-9-19)18-15-5-4-13(20(21)22)11-14(12)15/h2,4-5,10-11,17H,1,3,6-9H2 D07GLO DRUGINKE MQKUUUQECTZPIV-UHFFFAOYSA-N D07GLO DRUGSMIL C=CCC1=CC(=NC2=C1C=C(C=C2)[N+](=O)[O-])N3CCNCC3 D07GLO HIGHSTAT Investigative D07GMY DRUG__ID D07GMY D07GMY DRUGTYPE Small molecular drug D07GMY DRUGINCH 1S/C19H22Cl2N4O/c20-14-4-3-13(9-15(14)21)10-18(26)25-8-5-16-19(23-12-22-16)17(25)11-24-6-1-2-7-24/h3-4,9,12,17H,1-2,5-8,10-11H2,(H,22,23) D07GMY DRUGINKE CJLJXCDVYJKDTR-UHFFFAOYSA-N D07GMY DRUGSMIL C1CCN(C1)CC2C3=C(CCN2C(=O)CC4=CC(=C(C=C4)Cl)Cl)NC=N3 D07GMY HIGHSTAT Investigative D07GOA DRUG__ID D07GOA D07GOA DRUGTYPE Small molecular drug D07GOA DRUGINCH 1S/C19H20N2O2/c22-16(19-21-18-17(23-19)13-8-14-20-18)12-7-2-1-4-9-15-10-5-3-6-11-15/h3,5-6,8,10-11,13-14H,1-2,4,7,9,12H2 D07GOA DRUGINKE OVFUWDCWLWBDJD-UHFFFAOYSA-N D07GOA DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC3=C(O2)C=CC=N3 D07GOA HIGHSTAT Investigative D07GOR DRUG__ID D07GOR D07GOR DRUGTYPE Small molecular drug D07GOR DRUGINCH 1S/C10H18O/c1-7(2)9-5-4-8(3)10(11)6-9/h8-11H,1,4-6H2,2-3H3 D07GOR DRUGINKE KRCZYMFUWVJCLI-UHFFFAOYSA-N D07GOR DRUGSMIL CC1CCC(CC1O)C(=C)C D07GOR HIGHSTAT Investigative D07GPQ DRUG__ID D07GPQ D07GPQ DRUGTYPE Small molecular drug D07GPQ DRUGINCH 1S/C64H77N13O6/c1-72(41-20-8-5-17-35-65-44-56(78)75-53-32-14-11-26-47(53)62(81)69-50-29-23-36-66-59(50)75)39-18-6-3-4-7-19-40-73(2)42-21-9-10-22-43-74(45-57(79)76-54-33-15-12-27-48(54)63(82)70-51-30-24-37-67-60(51)76)46-58(80)77-55-34-16-13-28-49(55)64(83)71-52-31-25-38-68-61(52)77/h11-16,23-34,36-38,65H,3-10,17-22,35,39-46H2,1-2H3,(H,69,81)(H,70,82)(H,71,83) D07GPQ DRUGINKE YUJOQEAGGUIMED-UHFFFAOYSA-N D07GPQ DRUGSMIL CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1C2=CC=CC=C2C(=O)NC3=C1N=CC=C3)CC(=O)N4C5=CC=CC=C5C(=O)NC6=C4N=CC=C6)CCCCCCNCC(=O)N7C8=CC=CC=C8C(=O)NC9=C7N=CC=C9 D07GPQ HIGHSTAT Investigative D07GQE DRUG__ID D07GQE D07GQE DRUGTYPE Small molecular drug D07GQE DRUGINCH 1S/C38H54N8O10/c1-20(2)31(37(55)41-19-29(40)48)46-38(56)32(21(3)4)45-35(53)27(15-16-30(49)50)43-36(54)28(18-23-9-7-6-8-10-23)44-33(51)22(5)42-34(52)26(39)17-24-11-13-25(47)14-12-24/h6-14,20-22,26-28,31-32,47H,15-19,39H2,1-5H3,(H2,40,48)(H,41,55)(H,42,52)(H,43,54)(H,44,51)(H,45,53)(H,46,56)(H,49,50)/t22-,26+,27+,28+,31+,32+/m1/s1 D07GQE DRUGINKE NUNBRHVOPFWRRG-RCEFDBTISA-N D07GQE DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)O)N D07GQE HIGHSTAT Investigative D07GQP DRUG__ID D07GQP D07GQP DRUGTYPE Small molecular drug D07GQP DRUGINCH 1S/C26H26Cl2N4O/c27-22-6-5-8-24(25(22)28)32-18-16-31(17-19-32)15-4-3-14-30-26(33)21-11-9-20(10-12-21)23-7-1-2-13-29-23/h1-13H,14-19H2,(H,30,33)/b4-3+ D07GQP DRUGINKE ZMYOIZHRXABMFZ-ONEGZZNKSA-N D07GQP DRUGSMIL C1CN(CCN1CC=CCNC(=O)C2=CC=C(C=C2)C3=CC=CC=N3)C4=C(C(=CC=C4)Cl)Cl D07GQP HIGHSTAT Investigative D07GRG DRUG__ID D07GRG D07GRG DRUGTYPE Small molecular drug D07GRG DRUGINCH 1S/C7H9NO5/c8-7(6(11)12)1-13-4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2-,3-,4+,7+/m1/s1 D07GRG DRUGINKE YASVRZWVUGJELU-MDASVERJSA-N D07GRG DRUGSMIL C1C(C2C(C2O1)C(=O)O)(C(=O)O)N D07GRG HIGHSTAT Investigative D07GRM DRUG__ID D07GRM D07GRM DRUGTYPE Small molecular drug D07GRM DRUGINCH 1S/C3H5NO7S/c4-1(2(5)6)3(7)11-12(8,9)10/h1H,4H2,(H,5,6)(H,8,9,10)/t1-/m0/s1 D07GRM DRUGINKE RZIKAUMRZOEFET-SFOWXEAESA-N D07GRM DRUGSMIL C(C(=O)O)(C(=O)OS(=O)(=O)O)N D07GRM HIGHSTAT Investigative D07GTX DRUG__ID D07GTX D07GTX DRUGTYPE Small molecular drug D07GTX DRUGINCH 1S/C11H9NO4/c13-8-3-1-2-7-4-5-9(14)12(11(7)8)6-10(15)16/h1-5,13H,6H2,(H,15,16) D07GTX DRUGINKE YRQSYBRKGTYSAL-UHFFFAOYSA-N D07GTX DRUGSMIL C1=CC2=C(C(=C1)O)N(C(=O)C=C2)CC(=O)O D07GTX HIGHSTAT Investigative D07GUB DRUG__ID D07GUB D07GUB DRUGTYPE Small molecular drug D07GUB DRUGINCH 1S/C11H13NO5/c12-8(10(13)14)9(11(15)16)17-6-7-4-2-1-3-5-7/h1-5,8-9H,6,12H2,(H,13,14)(H,15,16)/t8-,9-/m0/s1 D07GUB DRUGINKE BYOBCYXURWDEDS-IUCAKERBSA-N D07GUB DRUGSMIL C1=CC=C(C=C1)COC(C(C(=O)O)N)C(=O)O D07GUB HIGHSTAT Investigative D07GUX DRUG__ID D07GUX D07GUX DRUGTYPE Small molecular drug D07GUX DRUGINCH 1S/C16H11NO2/c18-15-13-9-8-12(10-14(13)17-16(15)19)7-6-11-4-2-1-3-5-11/h1-10H,(H,17,18,19)/b7-6+ D07GUX DRUGINKE ZQOJVXBKHOCLGH-VOTSOKGWSA-N D07GUX DRUGSMIL C1=CC=C(C=C1)C=CC2=CC3=C(C=C2)C(=O)C(=O)N3 D07GUX HIGHSTAT Investigative D07GXY DRUG__ID D07GXY D07GXY DRUGTYPE Small molecular drug D07GXY DRUGINCH 1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2 D07GXY DRUGINKE OQDPVLVUJFGPGQ-UHFFFAOYSA-N D07GXY DRUGSMIL C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4 D07GXY HIGHSTAT Investigative D07HBQ DRUG__ID D07HBQ D07HBQ DRUGTYPE Small molecular drug D07HBQ DRUGINCH 1S/C16H31N5/c1-11(2)8-17-14-7-15(18-9-12(3)4)21-16(20-14)19-10-13(5)6/h7,11-13H,8-10H2,1-6H3,(H3,17,18,19,20,21) D07HBQ DRUGINKE HVZSNANIMUMCPH-UHFFFAOYSA-N D07HBQ DRUGSMIL CC(C)CNC1=CC(=NC(=N1)NCC(C)C)NCC(C)C D07HBQ HIGHSTAT Investigative D07HBR DRUG__ID D07HBR D07HBR DRUGTYPE Small molecular drug D07HBR DRUGINCH 1S/C14H19O5P/c15-10-13-8-4-5-9-14(13)19-20(16,17)18-11-12-6-2-1-3-7-12/h4-5,8-10,12H,1-3,6-7,11H2,(H,16,17) D07HBR DRUGINKE YBEVTZVQKMYQPM-UHFFFAOYSA-N D07HBR DRUGSMIL C1CCC(CC1)COP(=O)(O)OC2=CC=CC=C2C=O D07HBR HIGHSTAT Investigative D07HET DRUG__ID D07HET D07HET DRUGTYPE Small molecular drug D07HET DRUGINCH 1S/C21H18N6/c1-16-14-27(25-24-16)12-11-26-15-23-20(18-5-3-2-4-6-18)21(26)19-9-7-17(13-22)8-10-19/h2-10,14-15H,11-12H2,1H3 D07HET DRUGINKE OAPIWVHFYSEARE-UHFFFAOYSA-N D07HET DRUGSMIL CC1=CN(N=N1)CCN2C=NC(=C2C3=CC=C(C=C3)C#N)C4=CC=CC=C4 D07HET HIGHSTAT Investigative D07HEZ DRUG__ID D07HEZ D07HEZ DRUGTYPE Small molecular drug D07HEZ DRUGINCH 1S/C13H10N2S/c14-9-11-12(15)7-4-8-13(11)16-10-5-2-1-3-6-10/h1-8H,15H2 D07HEZ DRUGINKE MPKFSGFZCBOCIQ-UHFFFAOYSA-N D07HEZ DRUGSMIL C1=CC=C(C=C1)SC2=CC=CC(=C2C#N)N D07HEZ HIGHSTAT Investigative D07HFF DRUG__ID D07HFF D07HFF DRUGTYPE Small molecular drug D07HFF DRUGINCH 1S/C17H14O2S/c1-11-3-5-12(6-4-11)15-10-17(20)14-8-7-13(18-2)9-16(14)19-15/h3-10H,1-2H3 D07HFF DRUGINKE HJUOMZBCQPCXHZ-UHFFFAOYSA-N D07HFF DRUGSMIL CC1=CC=C(C=C1)C2=CC(=S)C3=C(O2)C=C(C=C3)OC D07HFF HIGHSTAT Investigative D07HFU DRUG__ID D07HFU D07HFU DRUGTYPE Small molecular drug D07HFU DRUGINCH 1S/C22H31N3O/c1-23-21(26)24-17-8-7-16-12-20-18-4-2-3-9-22(18,19(16)13-17)10-11-25(20)14-15-5-6-15/h7-8,13,15,18,20H,2-6,9-12,14H2,1H3,(H2,23,24,26)/t18-,20+,22+/m0/s1 D07HFU DRUGINKE NXVBILHYMWWGLP-CZTZKLFOSA-N D07HFU DRUGSMIL CNC(=O)NC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CC5)C=C1 D07HFU HIGHSTAT Investigative D07HHD DRUG__ID D07HHD D07HHD DRUGTYPE Small molecular drug D07HHD DRUGINCH 1S/C22H32O5/c1-2-3-9-16-20(24)21(25)17-12-7-5-4-6-10-14-19(23)15-11-8-13-18-22(26)27/h3-12,14,17,19-21,23-25H,2,13,15-16,18H2,1H3,(H,26,27)/b6-4-,7-5+,9-3-,11-8-,14-10+,17-12+/t19-,20+,21-/m1/s1 D07HHD DRUGINKE IKFAUGXNBOBQDM-XFMPMKITSA-N D07HHD DRUGSMIL CCC=CCC(C(C=CC=CC=CC=CC(CC=CCCC(=O)O)O)O)O D07HHD HIGHSTAT Investigative D07HKU DRUG__ID D07HKU D07HKU DRUGTYPE Small molecular drug D07HKU DRUGINCH 1S/C15H16N4O2/c1-3-18-13-11(14(20)19(4-2)15(18)21)16-12(17-13)10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3,(H,16,17) D07HKU DRUGINKE LVSWNSHUTPWCNF-UHFFFAOYSA-N D07HKU DRUGSMIL CCN1C2=C(C(=O)N(C1=O)CC)NC(=N2)C3=CC=CC=C3 D07HKU HIGHSTAT Investigative D07HLC DRUG__ID D07HLC D07HLC DRUGTYPE Small molecular drug D07HLC DRUGINCH 1S/C12H13NO2/c1-12(2)10(14)13(11(12)15)8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3 D07HLC DRUGINKE LGZSEGMYAOALQU-UHFFFAOYSA-N D07HLC DRUGSMIL CC1(C(=O)N(C1=O)CC2=CC=CC=C2)C D07HLC HIGHSTAT Investigative D07HNL DRUG__ID D07HNL D07HNL DRUGTYPE Small molecular drug D07HNL DRUGINCH 1S/C17H13N3O3/c21-16(22)13-8-4-5-9-14(13)19-15-10-11-18-17(20-15)23-12-6-2-1-3-7-12/h1-11H,(H,21,22)(H,18,19,20) D07HNL DRUGINKE MQQUMLXYIRSXSZ-UHFFFAOYSA-N D07HNL DRUGSMIL C1=CC=C(C=C1)OC2=NC=CC(=N2)NC3=CC=CC=C3C(=O)O D07HNL HIGHSTAT Investigative D07HNM DRUG__ID D07HNM D07HNM DRUGTYPE Small molecular drug D07HNM DRUGINCH 1S/C11H12N4O2/c1-3-5-14-9-8(12-7-13-9)10(16)15(6-4-2)11(14)17/h3-4,7H,1-2,5-6H2,(H,12,13) D07HNM DRUGINKE NUZFZZOVBJUJQN-UHFFFAOYSA-N D07HNM DRUGSMIL C=CCN1C2=C(C(=O)N(C1=O)CC=C)NC=N2 D07HNM HIGHSTAT Investigative D07HPE DRUG__ID D07HPE D07HPE DRUGTYPE Small molecular drug D07HPE DRUGINCH 1S/C15H12N2O2S/c1-8-3-5-10(6-4-8)17-11-7-12(18)15-13(14(11)19)16-9(2)20-15/h3-7,17H,1-2H3 D07HPE DRUGINKE HFPLHASLIOXVGS-UHFFFAOYSA-N D07HPE DRUGSMIL CC1=CC=C(C=C1)NC2=CC(=O)C3=C(C2=O)N=C(S3)C D07HPE HIGHSTAT Investigative D07HQP DRUG__ID D07HQP D07HQP DRUGTYPE Small molecular drug D07HQP DRUGINCH 1S/C14H18N2O/c1-2-3-4-10-17-12-7-5-6-11-8-9-13(15)16-14(11)12/h5-9H,2-4,10H2,1H3,(H2,15,16) D07HQP DRUGINKE CTMPUINXCIZFAU-UHFFFAOYSA-N D07HQP DRUGSMIL CCCCCOC1=CC=CC2=C1N=C(C=C2)N D07HQP HIGHSTAT Investigative D07HQZ DRUG__ID D07HQZ D07HQZ DRUGTYPE Small molecular drug D07HQZ DRUGINCH 1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1/i3T3 D07HQZ DRUGINKE VAYOSLLFUXYJDT-QZGBZKRISA-N D07HQZ DRUGSMIL CCN(CC)C(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C D07HQZ HIGHSTAT Investigative D07HRP DRUG__ID D07HRP D07HRP DRUGTYPE Small molecular drug D07HRP DRUGINCH 1S/C49H66N10O9S/c1-31(60)54-39(49(66)59-21-11-18-41(59)46(63)56-38(16-8-10-20-51)45(62)55-37(44(61)52-2)15-7-9-19-50)30-69-27-26-68-25-24-67-23-22-58-29-35(33-13-4-6-17-40(33)58)43-42(47(64)57-48(43)65)34-28-53-36-14-5-3-12-32(34)36/h3-6,12-14,17,28-29,37-39,41,53H,7-11,15-16,18-27,30,50-51H2,1-2H3,(H,52,61)(H,54,60)(H,55,62)(H,56,63)(H,57,64,65)/t37-,38-,39-,41-/m0/s1 D07HRP DRUGINKE HOAREJUGBLUUJD-MJSJRNKMSA-N D07HRP DRUGSMIL CC(=O)NC(CSCCOCCOCCN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54)C(=O)N6CCCC6C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC D07HRP HIGHSTAT Investigative D07HSQ DRUG__ID D07HSQ D07HSQ DRUGTYPE Small molecular drug D07HSQ DRUGINCH 1S/C19H26N2O/c1-13(17-5-3-2-4-6-17)20-18(22)21-19-10-14-7-15(11-19)9-16(8-14)12-19/h2-6,13-16H,7-12H2,1H3,(H2,20,21,22)/t13-,14?,15?,16?,19?/m1/s1 D07HSQ DRUGINKE ODVZFEPLOWORBJ-PGBRGIIUSA-N D07HSQ DRUGSMIL CC(C1=CC=CC=C1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D07HSQ HIGHSTAT Investigative D07HTM DRUG__ID D07HTM D07HTM DRUGTYPE Small molecular drug D07HTM DRUGINCH 1S/C19H25NO6/c1-24-18-6-3-13(9-19(18)25-2)7-8-20-11-14(21)12-26-15-4-5-16(22)17(23)10-15/h3-6,9-10,14,20-23H,7-8,11-12H2,1-2H3 D07HTM DRUGINKE RFNBEBPVKCJZPV-UHFFFAOYSA-N D07HTM DRUGSMIL COC1=C(C=C(C=C1)CCNCC(COC2=CC(=C(C=C2)O)O)O)OC D07HTM HIGHSTAT Investigative D07HUH DRUG__ID D07HUH D07HUH DRUGTYPE Small molecular drug D07HUH DRUGINCH 1S/C15H24N2O3/c1-17(2)13-8-10-14(11-9-13)20-12-6-4-3-5-7-15(18)16-19/h8-11,19H,3-7,12H2,1-2H3,(H,16,18) D07HUH DRUGINKE UVUVYSYWSTVIBF-UHFFFAOYSA-N D07HUH DRUGSMIL CN(C)C1=CC=C(C=C1)OCCCCCCC(=O)NO D07HUH HIGHSTAT Investigative D07HVJ DRUG__ID D07HVJ D07HVJ DRUGTYPE Small molecular drug D07HVJ DRUGINCH 1S/C19H21N7O5/c20-16-13-17(26(9-22-13)18-15(29)14(28)12(7-27)31-18)24-19(23-16)30-6-5-25-8-21-10-3-1-2-4-11(10)25/h1-4,8-9,12,14-15,18,27-29H,5-7H2,(H2,20,23,24)/t12-,14-,15-,18-/m1/s1 D07HVJ DRUGINKE KTEOQJBVVWABJA-SCFUHWHPSA-N D07HVJ DRUGSMIL C1=CC=C2C(=C1)N=CN2CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D07HVJ HIGHSTAT Investigative D07HWB DRUG__ID D07HWB D07HWB DRUGTYPE Small molecular drug D07HWB DRUGINCH 1S/C34H24O22/c35-8-1-5-12(21(42)18(8)39)13-6(2-9(36)19(40)22(13)43)32(50)54-28(11(38)4-53-31(5)49)30-29-26(47)17-16(34(52)55-29)15(24(45)27(48)25(17)46)14-7(33(51)56-30)3-10(37)20(41)23(14)44/h1-3,11,26,28-30,35-48H,4H2/t11-,26+,28-,29+,30+/m1/s1 D07HWB DRUGINKE CHBITXAMNKHJCR-VGYCLGPVSA-N D07HWB DRUGSMIL C1C(C(OC(=O)C2=CC(=C(C(=C2C3=C(C(=C(C=C3C(=O)O1)O)O)O)O)O)O)C4C5C(C6=C(C(=C(C(=C6C(=O)O5)C7=C(C(=C(C=C7C(=O)O4)O)O)O)O)O)O)O)O D07HWB HIGHSTAT Investigative D07HWI DRUG__ID D07HWI D07HWI DRUGTYPE Small molecular drug D07HWI DRUGINCH 1S/C14H16N2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13-14H,15-16H2/t13-,14+ D07HWI DRUGINKE PONXTPCRRASWKW-OKILXGFUSA-N D07HWI DRUGSMIL C1=CC=C(C=C1)C(C(C2=CC=CC=C2)N)N D07HWI HIGHSTAT Investigative D07HWV DRUG__ID D07HWV D07HWV DRUGTYPE Small molecular drug D07HWV DRUGINCH 1S/C22H36O3/c1-2-3-12-15-20-18-19-21(25-20)16-13-10-8-6-4-5-7-9-11-14-17-22(23)24/h4,6,18-19H,2-3,5,7-17H2,1H3,(H,23,24)/b6-4- D07HWV DRUGINKE SJFMNLQBZCGDPV-XQRVVYSFSA-N D07HWV DRUGSMIL CCCCCC1=CC=C(O1)CCCCC=CCCCCCCC(=O)O D07HWV HIGHSTAT Investigative D07HXL DRUG__ID D07HXL D07HXL DRUGTYPE Small molecular drug D07HXL DRUGINCH 1S/C14H12F3NOS/c1-7-8(2)20-13(18)11(7)12(19)9-4-3-5-10(6-9)14(15,16)17/h3-6H,18H2,1-2H3 D07HXL DRUGINKE KKDKAWKYGCUOGR-UHFFFAOYSA-N D07HXL DRUGSMIL CC1=C(SC(=C1C(=O)C2=CC(=CC=C2)C(F)(F)F)N)C D07HXL HIGHSTAT Investigative D07HYL DRUG__ID D07HYL D07HYL DRUGTYPE Small molecular drug D07HYL DRUGINCH 1S/C14H14O4/c15-11-4-3-10(14(18)8-11)2-1-9-5-12(16)7-13(17)6-9/h3-8,15-18H,1-2H2 D07HYL DRUGINKE IEOZKGCYMAJAHS-UHFFFAOYSA-N D07HYL DRUGSMIL C1=CC(=C(C=C1O)O)CCC2=CC(=CC(=C2)O)O D07HYL HIGHSTAT Investigative D07HZQ DRUG__ID D07HZQ D07HZQ DRUGTYPE Small molecular drug D07HZQ DRUGINCH 1S/C19H25N7O14P2Se/c20-15-9-17(23-4-22-15)26(5-24-9)19-13(30)11(28)8(39-19)2-37-42(34,35)40-41(32,33)36-1-7-10(27)12(29)14(38-7)18-25-6(3-43-18)16(21)31/h3-5,7-8,10-14,19,27-30H,1-2H2,(H2,21,31)(H,32,33)(H,34,35)(H2,20,22,23)/t7-,8-,10-,11-,12-,13-,14-,19-/m1/s1 D07HZQ DRUGINKE SKNBJMQZTZPCPF-QZTLEVGFSA-N D07HZQ DRUGSMIL C1=C(N=C([Se]1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N D07HZQ HIGHSTAT Investigative D07IAK DRUG__ID D07IAK D07IAK DRUGTYPE Small molecular drug D07IAK DRUGINCH 1S/C31H34N6O4/c1-30(19-22-20-33-26-10-4-3-9-25(22)26,36-29(39)35-23-12-14-24(15-13-23)37(40)41)28(38)34-21-31(16-6-2-7-17-31)27-11-5-8-18-32-27/h3-5,8-15,18,20,33H,2,6-7,16-17,19,21H2,1H3,(H,34,38)(H2,35,36,39)/t30-/m0/s1 D07IAK DRUGINKE AFDXUTWMFMAQJO-PMERELPUSA-N D07IAK DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC3(CCCCC3)C4=CC=CC=N4)NC(=O)NC5=CC=C(C=C5)[N+](=O)[O-] D07IAK HIGHSTAT Investigative D07IBY DRUG__ID D07IBY D07IBY DRUGCOMP Synta Pharmaceuticals Corp D07IBY DRUGINCH 1S/C28H29N3O6.ClH/c1-33-23-11-10-18(13-22(23)31-28(32)21(29)12-17-8-6-5-7-9-17)20-16-30-37-26(20)19-14-24(34-2)27(36-4)25(15-19)35-3;/h5-11,13-16,21H,12,29H2,1-4H3,(H,31,32);1H/t21-;/m0./s1 D07IBY DRUGINKE DPEXZURXDJIYRS-BOXHHOBZSA-N D07IBY DRUGSMIL COC1=C(C=C(C=C1)C2=C(ON=C2)C3=CC(=C(C(=C3)OC)OC)OC)NC(=O)C(CC4=CC=CC=C4)N.Cl D07IBY HIGHSTAT Investigative D07ICD DRUG__ID D07ICD D07ICD DRUGTYPE Small molecular drug D07ICD DRUGINCH 1S/C26H31ClN2O8/c1-26(2,14-30)13-29-18-9-8-15(27)10-17(18)23(16-6-5-7-19(35-3)24(16)36-4)37-20(25(29)34)11-21(31)28-12-22(32)33/h5-10,20,23,30H,11-14H2,1-4H3,(H,28,31)(H,32,33)/t20-,23-/m1/s1 D07ICD DRUGINKE CONNCFGSWRVAOP-NFBKMPQASA-N D07ICD DRUGSMIL CC(C)(CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)NCC(=O)O)C3=C(C(=CC=C3)OC)OC)CO D07ICD HIGHSTAT Investigative D07ICV DRUG__ID D07ICV D07ICV DRUGTYPE Small molecular drug D07ICV DRUGINCH 1S/C25H26N4/c1-2-28-15-17-29(18-16-28)20-13-11-19(12-14-20)26-25-21-7-3-5-9-23(21)27-24-10-6-4-8-22(24)25/h3-14H,2,15-18H2,1H3,(H,26,27) D07ICV DRUGINKE CUVBGWMAORETGV-UHFFFAOYSA-N D07ICV DRUGSMIL CCN1CCN(CC1)C2=CC=C(C=C2)NC3=C4C=CC=CC4=NC5=CC=CC=C53 D07ICV HIGHSTAT Investigative D07ICW DRUG__ID D07ICW D07ICW DRUGTYPE Small molecular drug D07ICW DRUGINCH 1S/C45H57N9O10/c1-4-5-15-37(44(63)53-35(23-39(57)58)43(62)52-34(40(47)59)21-27-11-7-6-8-12-27)54(3)45(64)36(22-29-24-48-33-14-10-9-13-31(29)33)51-38(56)25-49-41(60)26(2)50-42(61)32(46)20-28-16-18-30(55)19-17-28/h6-14,16-19,24,26,32,34-37,48,55H,4-5,15,20-23,25,46H2,1-3H3,(H2,47,59)(H,49,60)(H,50,61)(H,51,56)(H,52,62)(H,53,63)(H,57,58)/t26-,32+,34+,35+,36-,37+/m1/s1 D07ICW DRUGINKE LFIFGNCFEBAIHA-JCOUAQLOSA-N D07ICW DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N D07ICW HIGHSTAT Investigative D07IGD DRUG__ID D07IGD D07IGD DRUGTYPE Small molecular drug D07IGD DRUGINCH 1S/C15H25N/c1-14(3-2-4-16-14)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13,16H,2-10H2,1H3 D07IGD DRUGINKE JQQSEBALQVRCLA-UHFFFAOYSA-N D07IGD DRUGSMIL CC1(CCCN1)C23CC4CC(C2)CC(C4)C3 D07IGD HIGHSTAT Investigative D07IHD DRUG__ID D07IHD D07IHD DRUGTYPE Small molecular drug D07IHD DRUGINCH 1S/C12H8N2O2/c13-5-8(6-14)9-2-1-7-3-11(15)12(16)4-10(7)9/h3-4,15-16H,1-2H2 D07IHD DRUGINKE CDYLNUVNFDZTEB-UHFFFAOYSA-N D07IHD DRUGSMIL C1CC(=C(C#N)C#N)C2=CC(=C(C=C21)O)O D07IHD HIGHSTAT Investigative D07IHM DRUG__ID D07IHM D07IHM DRUGTYPE Small molecular drug D07IHM DRUGINCH 1S/C27H26N2O3/c1-15(2)32-17-8-10-18-16(13-17)7-9-20-23(18)25-21(14-28-27(25)31)24-19-5-3-4-6-22(19)29(11-12-30)26(20)24/h3-6,8,10,13,15,30H,7,9,11-12,14H2,1-2H3,(H,28,31) D07IHM DRUGINKE HSWWFIPPMAFLPH-UHFFFAOYSA-N D07IHM DRUGSMIL CC(C)OC1=CC2=C(C=C1)C3=C(CC2)C4=C(C5=C3C(=O)NC5)C6=CC=CC=C6N4CCO D07IHM HIGHSTAT Investigative D07IHP DRUG__ID D07IHP D07IHP DRUGTYPE Small molecular drug D07IHP DRUGINCH 1S/C6H8N2O6S2/c7-15(9,10)13-5-2-1-3-6(4-5)14-16(8,11)12/h1-4H,(H2,7,9,10)(H2,8,11,12) D07IHP DRUGINKE NORJAZQSJATXMQ-UHFFFAOYSA-N D07IHP DRUGSMIL C1=CC(=CC(=C1)OS(=O)(=O)N)OS(=O)(=O)N D07IHP HIGHSTAT Investigative D07IHY DRUG__ID D07IHY D07IHY DRUGTYPE Small molecular drug D07IHY DRUGINCH 1S/C20H19N3O4S/c1-23(19-21-15-4-2-3-5-16(15)27-19)10-11-26-14-8-6-13(7-9-14)12-17-18(24)22-20(25)28-17/h2-9,17H,10-12H2,1H3,(H,22,24,25) D07IHY DRUGINKE ZYKPNHFCNSVFNF-UHFFFAOYSA-N D07IHY DRUGSMIL CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=NC4=CC=CC=C4O3 D07IHY HIGHSTAT Investigative D07IJU DRUG__ID D07IJU D07IJU DRUGTYPE Small molecular drug D07IJU DRUGINCH 1S/C9H16N2O/c12-9(8-4-3-5-10-8)11-6-1-2-7-11/h8,10H,1-7H2/t8-/m0/s1 D07IJU DRUGINKE HDLWINONZUFKQV-QMMMGPOBSA-N D07IJU DRUGSMIL C1CCN(C1)C(=O)C2CCCN2 D07IJU HIGHSTAT Investigative D07ILP DRUG__ID D07ILP D07ILP DRUGTYPE Small molecular drug D07ILP DRUGINCH 1S/C20H16N2O5/c1-2-20(26)14-7-16-17-11(5-10-6-12(23)3-4-15(10)21-17)8-22(16)18(24)13(14)9-27-19(20)25/h3-7,23,26H,2,8-9H2,1H3/t20-/m0/s1 D07ILP DRUGINKE HAWSQZCWOQZXHI-FQEVSTJZSA-N D07ILP DRUGSMIL CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)O)O D07ILP HIGHSTAT Investigative D07INO DRUG__ID D07INO D07INO DRUGTYPE Small molecular drug D07INO DRUGINCH 1S/C8H14N2/c9-8-7-4-2-1-3-6(7)5-10-8/h6-7H,1-5H2,(H2,9,10) D07INO DRUGINKE VVYRMIBCBFMCJN-UHFFFAOYSA-N D07INO DRUGSMIL C1CCC2C(C1)CN=C2N D07INO HIGHSTAT Investigative D07IOB DRUG__ID D07IOB D07IOB DRUGTYPE Small molecular drug D07IOB DRUGINCH 1S/C23H22N2O/c1-16-12-14-19(15-13-16)25-22(17(2)18-8-4-3-5-9-18)24-21-11-7-6-10-20(21)23(25)26/h3-15,17,22,24H,1-2H3 D07IOB DRUGINKE QZAOSZVJAXUJFE-UHFFFAOYSA-N D07IOB DRUGSMIL CC1=CC=C(C=C1)N2C(NC3=CC=CC=C3C2=O)C(C)C4=CC=CC=C4 D07IOB HIGHSTAT Investigative D07IOX DRUG__ID D07IOX D07IOX DRUGTYPE Small molecular drug D07IOX DRUGINCH 1S/C18H28ClNO/c1-5-6-7-8-12-16(20-18(2,3)4)17(21)14-10-9-11-15(19)13-14/h9-11,13,16,20H,5-8,12H2,1-4H3 D07IOX DRUGINKE HHZNTCLXZVSLGW-UHFFFAOYSA-N D07IOX DRUGSMIL CCCCCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D07IOX HIGHSTAT Investigative D07IOY DRUG__ID D07IOY D07IOY DRUGTYPE Small molecular drug D07IOY DRUGINCH 1S/C7H5NO4/c9-6(10)4-1-2-8-5(3-4)7(11)12/h1-3H,(H,9,10)(H,11,12) D07IOY DRUGINKE MJIVRKPEXXHNJT-UHFFFAOYSA-N D07IOY DRUGSMIL C1=CN=C(C=C1C(=O)O)C(=O)O D07IOY HIGHSTAT Investigative D07IPZ DRUG__ID D07IPZ D07IPZ DRUGTYPE Small molecular drug D07IPZ DRUGINCH 1S/C16H21N5O6/c1-8(23)4-3-5-10-18-14(20-26-2)11-15(19-10)21(7-17-11)16-13(25)12(24)9(6-22)27-16/h7-9,12-13,16,22-25H,4,6H2,1-2H3,(H,18,19,20)/t8?,9-,12-,13-,16-/m1/s1 D07IPZ DRUGINKE MVQXWIPZMVHVNF-WTBWQYLWSA-N D07IPZ DRUGSMIL CC(CC#CC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NOC)O D07IPZ HIGHSTAT Investigative D07IQG DRUG__ID D07IQG D07IQG DRUGTYPE Small molecular drug D07IQG DRUGINCH 1S/C17H11BrN2O2/c18-13-6-5-11(9-20-8-7-19-10-20)15-16(21)12-3-1-2-4-14(12)22-17(13)15/h1-8,10H,9H2 D07IQG DRUGINKE FSWPWGQUEZXZFV-UHFFFAOYSA-N D07IQG DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3O2)Br)CN4C=CN=C4 D07IQG HIGHSTAT Investigative D07IQR DRUG__ID D07IQR D07IQR DRUGTYPE Small molecular drug D07IQR DRUGINCH 1S/C20H18N4O3/c21-18(25)15-8-4-9-16(12-15)23-20(26)24-19-17(10-5-11-22-19)27-13-14-6-2-1-3-7-14/h1-12H,13H2,(H2,21,25)(H2,22,23,24,26) D07IQR DRUGINKE RLBJUMUHKDTSCO-UHFFFAOYSA-N D07IQR DRUGSMIL C1=CC=C(C=C1)COC2=C(N=CC=C2)NC(=O)NC3=CC=CC(=C3)C(=O)N D07IQR HIGHSTAT Investigative D07IQU DRUG__ID D07IQU D07IQU DRUGTYPE Small molecular drug D07IQU DRUGINCH 1S/C48H49N13O9S6/c1-8-24(37(65)49-12-20(5)62)51-38(66)28-15-73-46(56-28)32-18-74-45(58-32)26-11-10-23-36(50-26)27-13-75-48(53-27)35(22(7)64)61-41(69)31-17-76-47(57-31)33(19(3)4)59-39(67)30-16-72-44(55-30)25(9-2)52-42(70)34(21(6)63)60-40(68)29-14-71-43(23)54-29/h8-11,13-22,33-35,62-64H,12H2,1-7H3,(H,49,65)(H,51,66)(H,52,70)(H,59,67)(H,60,68)(H,61,69)/b24-8-,25-9-/t20-,21+,22+,33+,34-,35-/m0/s1 D07IQU DRUGINKE MQGFYNRGFWXAKA-GXSYYHJRSA-N D07IQU DRUGSMIL CC=C1C2=NC(=CS2)C(=O)NC(C3=NC(=CS3)C(=O)NC(C4=NC(=CS4)C5=C(C=CC(=N5)C6=NC(=CS6)C7=NC(=CS7)C(=O)NC(=CC)C(=O)NCC(C)O)C8=NC(=CS8)C(=O)NC(C(=O)N1)C(C)O)C(C)O)C(C)C D07IQU HIGHSTAT Investigative D07IRQ DRUG__ID D07IRQ D07IRQ DRUGTYPE Small molecular drug D07IRQ DRUGINCH 1S/C8H8O3/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5H,1H3,(H,9,10) D07IRQ DRUGINKE ZEYHEAKUIGZSGI-UHFFFAOYSA-N D07IRQ DRUGSMIL COC1=CC=C(C=C1)C(=O)O D07IRQ HIGHSTAT Investigative D07IRZ DRUG__ID D07IRZ D07IRZ DRUGTYPE Small molecular drug D07IRZ DRUGINCH 1S/C21H18O3S/c22-20(16-25(23,24)19-14-8-3-9-15-19)21(17-10-4-1-5-11-17)18-12-6-2-7-13-18/h1-15,21H,16H2 D07IRZ DRUGINKE SKWQLTIDKRSBES-UHFFFAOYSA-N D07IRZ DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)CS(=O)(=O)C3=CC=CC=C3 D07IRZ HIGHSTAT Investigative D07ISL DRUG__ID D07ISL D07ISL DRUGTYPE Small molecular drug D07ISL DRUGINCH 1S/C23H35N5OS/c1-3-10-27(18-8-9-19-22(17-18)30-23(24)25-19)14-11-26-12-15-28(16-13-26)20-6-4-5-7-21(20)29-2/h4-7,18H,3,8-17H2,1-2H3,(H2,24,25) D07ISL DRUGINKE WIZIUHWXARABLD-UHFFFAOYSA-N D07ISL DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2OC)C3CCC4=C(C3)SC(=N4)N D07ISL HIGHSTAT Investigative D07ITP DRUG__ID D07ITP D07ITP DRUGTYPE Small molecular drug D07ITP DRUGINCH 1S/C14H15ClN2OS/c1-9(2)12(10-3-5-11(15)6-4-10)13(18)17-14-16-7-8-19-14/h3-9,12H,1-2H3,(H,16,17,18)/t12-/m0/s1 D07ITP DRUGINKE AZYDQCGCBQYFSE-LBPRGKRZSA-N D07ITP DRUGSMIL CC(C)C(C1=CC=C(C=C1)Cl)C(=O)NC2=NC=CS2 D07ITP HIGHSTAT Investigative D07IUE DRUG__ID D07IUE D07IUE DRUGTYPE Small molecular drug D07IUE DRUGINCH 1S/C15H18N2O/c16-14-9-8-12-6-3-7-13(15(12)17-14)18-10-11-4-1-2-5-11/h3,6-9,11H,1-2,4-5,10H2,(H2,16,17) D07IUE DRUGINKE KGRRNRLJYPHJMT-UHFFFAOYSA-N D07IUE DRUGSMIL C1CCC(C1)COC2=CC=CC3=C2N=C(C=C3)N D07IUE HIGHSTAT Investigative D07IUX DRUG__ID D07IUX D07IUX DRUGTYPE Small molecular drug D07IUX DRUGINCH 1S/C14H12N2OS/c1-17-10-4-2-5-11(8-10)18-14-7-3-6-13(16)12(14)9-15/h2-8H,16H2,1H3 D07IUX DRUGINKE SHCOEGYZJNZDIW-UHFFFAOYSA-N D07IUX DRUGSMIL COC1=CC(=CC=C1)SC2=CC=CC(=C2C#N)N D07IUX HIGHSTAT Investigative D07IVD DRUG__ID D07IVD D07IVD DRUGTYPE Small molecular drug D07IVD DRUGINCH 1S/C18H19N3O/c1-2-6-17(22)19-18-15-10-9-14(12-16(15)20-21-18)11-13-7-4-3-5-8-13/h3-5,7-10,12H,2,6,11H2,1H3,(H2,19,20,21,22) D07IVD DRUGINKE UUOMNVRBMQQPLH-UHFFFAOYSA-N D07IVD DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)CC3=CC=CC=C3 D07IVD HIGHSTAT Investigative D07IWD DRUG__ID D07IWD D07IWD DRUGTYPE Small molecular drug D07IWD DRUGINCH 1S/C14H14O4/c1-18-12-8-3-2-5-9(12)14(17)13-10(15)6-4-7-11(13)16/h2-3,5,8,13H,4,6-7H2,1H3 D07IWD DRUGINKE ADJLOHOSFKJYEC-UHFFFAOYSA-N D07IWD DRUGSMIL COC1=CC=CC=C1C(=O)C2C(=O)CCCC2=O D07IWD HIGHSTAT Investigative D07IWK DRUG__ID D07IWK D07IWK DRUGTYPE Small molecular drug D07IWK DRUGINCH 1S/C6H7N5O/c1-11-2-8-3-4(11)9-6(7)10-5(3)12/h2H,1H3,(H3,7,9,10,12) D07IWK DRUGINKE UUWJNBOCAPUTBK-UHFFFAOYSA-N D07IWK DRUGSMIL CN1C=NC2=C1N=C(NC2=O)N D07IWK HIGHSTAT Investigative D07IWZ DRUG__ID D07IWZ D07IWZ DRUGTYPE Small molecular drug D07IWZ DRUGINCH 1S/C17H19N3/c1-20-6-5-11-7-12(18)9-13-16-10(3-2-4-14(16)19)8-15(20)17(11)13/h2-4,7,9,15H,5-6,8,18-19H2,1H3/t15-/m1/s1 D07IWZ DRUGINKE SBZULQRCMCHLCL-OAHLLOKOSA-N D07IWZ DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)N)C(=CC=C4)N D07IWZ HIGHSTAT Investigative D07IXP DRUG__ID D07IXP D07IXP DRUGTYPE Small molecular drug D07IXP DRUGINCH 1S/C17H17ClN6O2/c1-17(7-13(25)24(2)16(19)23-17)10-4-3-5-12(6-10)22-15(26)14-20-8-11(18)9-21-14/h3-6,8-9H,7H2,1-2H3,(H2,19,23)(H,22,26)/t17-/m0/s1 D07IXP DRUGINKE VZUGBLTVBZJZOE-KRWDZBQOSA-N D07IXP DRUGSMIL CC1(CC(=O)N(C(=N1)N)C)C2=CC(=CC=C2)NC(=O)C3=NC=C(C=N3)Cl D07IXP HIGHSTAT Investigative D07IYH DRUG__ID D07IYH D07IYH DRUGTYPE Small molecular drug D07IYH DRUGINCH 1S/C16H14O5/c1-20-11-6-12(18)16-13(19)8-14(21-15(16)7-11)9-2-4-10(17)5-3-9/h2-7,14,17-18H,8H2,1H3 D07IYH DRUGINKE DJOJDHGQRNZXQQ-UHFFFAOYSA-N D07IYH DRUGSMIL COC1=CC(=C2C(=O)CC(OC2=C1)C3=CC=C(C=C3)O)O D07IYH HIGHSTAT Investigative D07IYZ DRUG__ID D07IYZ D07IYZ DRUGTYPE Small molecular drug D07IYZ DRUGINCH 1S/C26H27NO4/c1-19-8-10-21(11-9-19)26(30)22-12-14-23(15-13-22)31-24(20-6-4-3-5-7-20)16-17-27(2)18-25(28)29/h3-15,24H,16-18H2,1-2H3,(H,28,29)/t24-/m1/s1 D07IYZ DRUGINKE HNBKNDFZJLEZLZ-XMMPIXPASA-N D07IYZ DRUGSMIL CC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)OC(CCN(C)CC(=O)O)C3=CC=CC=C3 D07IYZ HIGHSTAT Investigative D07IZR DRUG__ID D07IZR D07IZR DRUGTYPE Small molecular drug D07IZR DRUGINCH 1S/C33H38N6O6S2/c34-32(35)26-6-4-8-30(20-26)46(40,41)38-22-24-10-14-28(15-11-24)44-18-2-1-3-19-45-29-16-12-25(13-17-29)23-39-47(42,43)31-9-5-7-27(21-31)33(36)37/h4-17,20-21,38-39H,1-3,18-19,22-23H2,(H3,34,35)(H3,36,37) D07IZR DRUGINKE CTLMBCYIAXNYOG-UHFFFAOYSA-N D07IZR DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)NCC2=CC=C(C=C2)OCCCCCOC3=CC=C(C=C3)CNS(=O)(=O)C4=CC=CC(=C4)C(=N)N)C(=N)N D07IZR HIGHSTAT Investigative D07JAN DRUG__ID D07JAN D07JAN DRUGTYPE Small molecular drug D07JAN DRUGINCH 1S/C33H41Cl4N5O4/c1-38-31(43)18-22-5-4-11-42(33(22)45)26-8-12-41(13-9-26)14-10-27(21-6-7-28(36)29(37)17-21)30(39-46-3)20-40(2)32(44)23-15-24(34)19-25(35)16-23/h6-7,15-17,19,22,26-27H,4-5,8-14,18,20H2,1-3H3,(H,38,43)/b39-30-/t22-,27-/m1/s1 D07JAN DRUGINKE UITMLIVWRRGLLR-MSBPVHBISA-N D07JAN DRUGSMIL CNC(=O)CC1CCCN(C1=O)C2CCN(CC2)CCC(C3=CC(=C(C=C3)Cl)Cl)C(=NOC)CN(C)C(=O)C4=CC(=CC(=C4)Cl)Cl D07JAN HIGHSTAT Investigative D07JCA DRUG__ID D07JCA D07JCA DRUGTYPE Small molecular drug D07JCA DRUGINCH 1S/C13H25NO10/c15-1-4-7(17)10(20)8(18)5(14-4)3-23-13-12(22)11(21)9(19)6(2-16)24-13/h4-22H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11+,12-,13-/m1/s1 D07JCA DRUGINKE VCIPQQCYKMORDY-KBYFLBCBSA-N D07JCA DRUGSMIL C(C1C(C(C(C(N1)COC2C(C(C(C(O2)CO)O)O)O)O)O)O)O D07JCA HIGHSTAT Investigative D07JCO DRUG__ID D07JCO D07JCO DRUGTYPE Small molecular drug D07JCO DRUGINCH 1S/C12H9N3/c1-2-4-12-10(3-1)7-11(8-14-12)15-6-5-13-9-15/h1-9H D07JCO DRUGINKE SRUVTPIFNUPTIR-UHFFFAOYSA-N D07JCO DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)N3C=CN=C3 D07JCO HIGHSTAT Investigative D07JDC DRUG__ID D07JDC D07JDC DRUGTYPE Small molecular drug D07JDC DRUGINCH 1S/C10H14O/c1-7(2)9-5-4-8(3)10(11)6-9/h4-7,11H,1-3H3 D07JDC DRUGINKE RECUKUPTGUEGMW-UHFFFAOYSA-N D07JDC DRUGSMIL CC1=C(C=C(C=C1)C(C)C)O D07JDC HIGHSTAT Investigative D07JDD DRUG__ID D07JDD D07JDD DRUGTYPE Small molecular drug D07JDD DRUGINCH 1S/C30H32O7/c1-13(2)7-9-16-25(33)17(10-8-14(3)4)29-24(26(16)34)27(35)19-11-18(15(5)6)22-23(30(19)37-29)20(31)12-21(32)28(22)36/h7-8,12,18,31-34,36H,5,9-11H2,1-4,6H3/t18-/m1/s1 D07JDD DRUGINKE LAAYVNVIRVOBNR-GOSISDBHSA-N D07JDD DRUGSMIL CC(=CCC1=C(C(=C2C(=C1O)C(=O)C3=C(O2)C4=C(C(C3)C(=C)C)C(=C(C=C4O)O)O)CC=C(C)C)O)C D07JDD HIGHSTAT Investigative D07JDU DRUG__ID D07JDU D07JDU DRUGTYPE Small molecular drug D07JDU DRUGINCH 1S/C20H22BrF3N2O5S/c1-26-7-6-13(11-26)31-16-8-12(4-5-14(16)20(22,23)24)25-32(27,28)19-10-18(30-3)17(29-2)9-15(19)21/h4-5,8-10,13,25H,6-7,11H2,1-3H3/t13-/m1/s1 D07JDU DRUGINKE BPOWQJYAMDEAFF-CYBMUJFWSA-N D07JDU DRUGSMIL CN1CCC(C1)OC2=C(C=CC(=C2)NS(=O)(=O)C3=C(C=C(C(=C3)OC)OC)Br)C(F)(F)F D07JDU HIGHSTAT Investigative D07JDY DRUG__ID D07JDY D07JDY DRUGTYPE Small molecular drug D07JDY DRUGINCH 1S/C17H13N/c1-2-6-14(7-3-1)10-11-15-12-16-8-4-5-9-17(16)18-13-15/h1-13H/b11-10+ D07JDY DRUGINKE OHHPAEZEBAYVPW-ZHACJKMWSA-N D07JDY DRUGSMIL C1=CC=C(C=C1)C=CC2=CC3=CC=CC=C3N=C2 D07JDY HIGHSTAT Investigative D07JEY DRUG__ID D07JEY D07JEY DRUGTYPE Small molecular drug D07JEY DRUGINCH 1S/C17H10F4N2O4S/c18-7-1-2-8(11(3-7)27-6-13(24)25)17(26)22-5-12-23-15-14(21)9(19)4-10(20)16(15)28-12/h1-4H,5-6H2,(H,22,26)(H,24,25) D07JEY DRUGINKE ZCAGEXZTORJQDZ-UHFFFAOYSA-N D07JEY DRUGSMIL C1=CC(=C(C=C1F)OCC(=O)O)C(=O)NCC2=NC3=C(C(=CC(=C3S2)F)F)F D07JEY HIGHSTAT Investigative D07JGH DRUG__ID D07JGH D07JGH DRUGCOMP Palau Pharma SA D07JGH DRUGINCH 1S/C24H16F2N4/c1-30-14-20-21(15-2-6-18(25)7-3-15)22(16-10-12-27-13-11-16)23(28-24(20)29-30)17-4-8-19(26)9-5-17/h2-14H,1H3 D07JGH DRUGINKE VMAKTIDYMSNPOV-UHFFFAOYSA-N D07JGH DRUGSMIL CN1C=C2C(=C(C(=NC2=N1)C3=CC=C(C=C3)F)C4=CC=NC=C4)C5=CC=C(C=C5)F D07JGH HIGHSTAT Investigative D07JHG DRUG__ID D07JHG D07JHG DRUGTYPE Small molecular drug D07JHG DRUGINCH 1S/C12H12N6O/c13-8-3-1-2-7(4-8)5-19-11-9-10(16-6-15-9)17-12(14)18-11/h1-4,6H,5,13H2,(H3,14,15,16,17,18) D07JHG DRUGINKE QCEFDVCKQLVMCW-UHFFFAOYSA-N D07JHG DRUGSMIL C1=CC(=CC(=C1)N)COC2=NC(=NC3=C2NC=N3)N D07JHG HIGHSTAT Investigative D07JIQ DRUG__ID D07JIQ D07JIQ DRUGTYPE Small molecular drug D07JIQ DRUGINCH 1S/C29H37N7O6S/c1-16(2)10-22(28(41)42)35-27(40)21(12-17-6-4-3-5-7-17)34-25(38)15-32-24(37)14-33-26(39)19(30)11-18-8-9-20-23(13-18)43-29(31)36-20/h3-9,13,16,19,21-22H,10-12,14-15,30H2,1-2H3,(H2,31,36)(H,32,37)(H,33,39)(H,34,38)(H,35,40)(H,41,42)/t19-,21-,22-/m0/s1 D07JIQ DRUGINKE AHRIYJIWFATUOS-BVSLBCMMSA-N D07JIQ DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC3=C(C=C2)N=C(S3)N)N D07JIQ HIGHSTAT Investigative D07JKA DRUG__ID D07JKA D07JKA DRUGCOMP Senexis Ltd D07JKA DRUGINCH 1S/C21H18FN5O2/c22-20-5-4-16(10-15(20)12-23)26-21-24-13-19(14-25-21)29-18-3-1-2-17(11-18)27-6-8-28-9-7-27/h1-5,10-11,13-14H,6-9H2,(H,24,25,26) D07JKA DRUGINKE RQBIQZWMNRERQQ-UHFFFAOYSA-N D07JKA DRUGSMIL C1COCCN1C2=CC(=CC=C2)OC3=CN=C(N=C3)NC4=CC(=C(C=C4)F)C#N D07JKA HIGHSTAT Investigative D07JKB DRUG__ID D07JKB D07JKB DRUGTYPE Small molecular drug D07JKB DRUGINCH 1S/C15H15N5O2/c21-11-4-2-1-3-10(11)13-18-14-12(16-9-17-14)15(19-13)20-5-7-22-8-6-20/h1-4,9,21H,5-8H2,(H,16,17,18,19) D07JKB DRUGINKE SWYYAXGUDZLFKO-UHFFFAOYSA-N D07JKB DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=CC=C4O D07JKB HIGHSTAT Investigative D07JKK DRUG__ID D07JKK D07JKK DRUGTYPE Small molecular drug D07JKK DRUGINCH 1S/C20H20O6/c1-22-15-7-5-12(9-17(15)24-3)14-11-26-20(21)19(14)13-6-8-16(23-2)18(10-13)25-4/h5-10H,11H2,1-4H3 D07JKK DRUGINKE FGMQIGBHXSBGMS-UHFFFAOYSA-N D07JKK DRUGSMIL COC1=C(C=C(C=C1)C2=C(C(=O)OC2)C3=CC(=C(C=C3)OC)OC)OC D07JKK HIGHSTAT Investigative D07JLC DRUG__ID D07JLC D07JLC DRUGTYPE Small molecular drug D07JLC DRUGINCH 1S/C13H11IN2O/c1-9-4-2-7-12(15-9)16-13(17)10-5-3-6-11(14)8-10/h2-8H,1H3,(H,15,16,17) D07JLC DRUGINKE YFGDUEHHLUXXKH-UHFFFAOYSA-N D07JLC DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CC(=CC=C2)I D07JLC HIGHSTAT Investigative D07JLS DRUG__ID D07JLS D07JLS DRUGTYPE Small molecular drug D07JLS DRUGINCH 1S/C26H31N3O3/c1-32-24-17-29(16-23(24)30)25-8-7-20(22(27-25)15-19-5-3-2-4-6-19)9-12-26(31)18-28-13-10-21(26)11-14-28/h2-8,21,23-24,30-31H,10-11,13-18H2,1H3/t23-,24+,26-/m0/s1 D07JLS DRUGINKE NDEOTZXSBKCQLS-GSLIJJQTSA-N D07JLS DRUGSMIL COC1CN(CC1O)C2=NC(=C(C=C2)C#CC3(CN4CCC3CC4)O)CC5=CC=CC=C5 D07JLS HIGHSTAT Investigative D07JLV DRUG__ID D07JLV D07JLV DRUGTYPE Small molecular drug D07JLV DRUGINCH 1S/C42H64N8O8/c1-10-28(8)35(40(55)47-34(27(6)7)39(54)43-23-30-17-13-11-14-18-30)48-41(56)50-49-38(53)33(22-26(4)5)46-37(52)32(21-25(2)3)45-36(51)29(9)44-42(57)58-24-31-19-15-12-16-20-31/h11-20,25-29,32-35H,10,21-24H2,1-9H3,(H,43,54)(H,44,57)(H,45,51)(H,46,52)(H,47,55)(H,49,53)(H2,48,50,56) D07JLV DRUGINKE XSXSYDVWNYPPNF-UHFFFAOYSA-N D07JLV DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)NCC1=CC=CC=C1)NC(=O)NNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2 D07JLV HIGHSTAT Investigative D07JMB DRUG__ID D07JMB D07JMB DRUGTYPE Small molecular drug D07JMB DRUGINCH 1S/C19H33NO4/c1-2-3-6-9-17(21)13-11-16-12-14-18(22)20(16)15-8-5-4-7-10-19(23)24/h11,13,16-17,21H,2-10,12,14-15H2,1H3,(H,23,24)/b13-11+/t16-,17-/m0/s1 D07JMB DRUGINKE XOPMUDZOEKPBQZ-NSNJOPQOSA-N D07JMB DRUGSMIL CCCCCC(C=CC1CCC(=O)N1CCCCCCC(=O)O)O D07JMB HIGHSTAT Investigative D07JMJ DRUG__ID D07JMJ D07JMJ DRUGTYPE Small molecular drug D07JMJ DRUGINCH 1S/C9H13N3O2/c10-6-3-7-11-8-4-1-2-5-9(8)12(13)14/h1-2,4-5,11H,3,6-7,10H2/p+1 D07JMJ DRUGINKE GVGDDEYVTBKACE-UHFFFAOYSA-O D07JMJ DRUGSMIL C1=CC=C(C(=C1)NCCC[NH3+])[N+](=O)[O-] D07JMJ HIGHSTAT Investigative D07JMN DRUG__ID D07JMN D07JMN DRUGTYPE Small molecular drug D07JMN DRUGINCH 1S/C9H13N3/c1-2-4-11-9(3-1)12-7-5-10-6-8-12/h1-4,10H,5-8H2 D07JMN DRUGINKE GZRKXKUVVPSREJ-UHFFFAOYSA-N D07JMN DRUGSMIL C1CN(CCN1)C2=CC=CC=N2 D07JMN HIGHSTAT Investigative D07JMO DRUG__ID D07JMO D07JMO DRUGTYPE Small molecular drug D07JMO DRUGINCH 1S/C10H9BrN2/c11-10-3-1-2-9(6-10)7-13-5-4-12-8-13/h1-6,8H,7H2 D07JMO DRUGINKE BGYZLOIBJCHCTI-UHFFFAOYSA-N D07JMO DRUGSMIL C1=CC(=CC(=C1)Br)CN2C=CN=C2 D07JMO HIGHSTAT Investigative D07JNQ DRUG__ID D07JNQ D07JNQ DRUGTYPE Small molecular drug D07JNQ DRUGINCH 1S/C14H10N2O7S/c15-4-1-2-6(17)10-8(4)14(20)11-9(13(10)19)5(16)3-7(12(11)18)24(21,22)23/h1-3,17-18H,15-16H2,(H,21,22,23) D07JNQ DRUGINKE SPHQXPPVJCWUGX-UHFFFAOYSA-N D07JNQ DRUGSMIL C1=CC(=C2C(=C1N)C(=O)C3=C(C2=O)C(=CC(=C3O)S(=O)(=O)O)N)O D07JNQ HIGHSTAT Investigative D07JOZ DRUG__ID D07JOZ D07JOZ DRUGTYPE Small molecular drug D07JOZ DRUGINCH 1S/C18H13FO2/c19-17-11-15(8-9-18(17)21)13-6-4-12(5-7-13)14-2-1-3-16(20)10-14/h1-11,20-21H D07JOZ DRUGINKE JNOWDEFWQPRYLB-UHFFFAOYSA-N D07JOZ DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(C=C2)C3=CC(=C(C=C3)O)F D07JOZ HIGHSTAT Investigative D07JRA DRUG__ID D07JRA D07JRA DRUGTYPE Small molecular drug D07JRA DRUGINCH 1S/C19H16O2/c1-12(2)16-17(13-8-4-3-5-9-13)14-10-6-7-11-15(14)18(20)19(16)21/h3-12H,1-2H3 D07JRA DRUGINKE ZMFOKOSZYNMITK-UHFFFAOYSA-N D07JRA DRUGSMIL CC(C)C1=C(C2=CC=CC=C2C(=O)C1=O)C3=CC=CC=C3 D07JRA HIGHSTAT Investigative D07JRV DRUG__ID D07JRV D07JRV DRUGTYPE Small molecular drug D07JRV DRUGINCH 1S/C16H19NS/c1-17(2)12-13-18-16-11-7-6-10-15(16)14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3 D07JRV DRUGINKE CIOXNSHCQPHJOE-UHFFFAOYSA-N D07JRV DRUGSMIL CN(C)CCSC1=CC=CC=C1C2=CC=CC=C2 D07JRV HIGHSTAT Investigative D07JRW DRUG__ID D07JRW D07JRW DRUGTYPE Small molecular drug D07JRW DRUGINCH 1S/C27H38O3/c1-18(2)8-6-13-26(4)14-7-15-27(5)22(19(3)9-12-24(26)27)17-21-16-20(25(29)30)10-11-23(21)28/h8-11,16,22,24,28H,6-7,12-15,17H2,1-5H3,(H,29,30)/t22-,24-,26-,27+/m0/s1 D07JRW DRUGINKE IIMZFSAVKIVVHG-DAANFHMWSA-N D07JRW DRUGSMIL CC1=CCC2C(CCCC2(C1CC3=C(C=CC(=C3)C(=O)O)O)C)(C)CCC=C(C)C D07JRW HIGHSTAT Investigative D07JTZ DRUG__ID D07JTZ D07JTZ DRUGTYPE Small molecular drug D07JTZ DRUGINCH 1S/C26H29N3O/c30-26-23-13-7-9-21-10-8-14-24(25(21)23)29(26)16-6-2-5-15-27-17-19-28(20-18-27)22-11-3-1-4-12-22/h1,3-4,7-14H,2,5-6,15-20H2 D07JTZ DRUGINKE UPZHUDFDXXFEKG-UHFFFAOYSA-N D07JTZ DRUGSMIL C1CN(CCN1CCCCCN2C3=CC=CC4=C3C(=CC=C4)C2=O)C5=CC=CC=C5 D07JTZ HIGHSTAT Investigative D07JVU DRUG__ID D07JVU D07JVU DRUGCOMP Sandoz D07JVU THERCLAS Antiviral Agents D07JVU DRUGTYPE Protein/peptide drug D07JVU DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C D07JVU HIGHSTAT Investigative D07JXC DRUG__ID D07JXC D07JXC DRUGTYPE Small molecular drug D07JXC DRUGINCH 1S/C16H15F2N3O3/c1-2-24-16(23)14-13-8-20(6-5-17)15(22)11-7-10(18)3-4-12(11)21(13)9-19-14/h3-4,7,9H,2,5-6,8H2,1H3/i17-1 D07JXC DRUGINKE NRBIGDVWCXXFLI-SJPDSGJFSA-N D07JXC DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)CCF D07JXC HIGHSTAT Investigative D07JYF DRUG__ID D07JYF D07JYF DRUGTYPE Small molecular drug D07JYF DRUGINCH 1S/C7H5N3O4S2/c8-16(13,14)7-9-5-2-1-4(10(11)12)3-6(5)15-7/h1-3H,(H2,8,13,14) D07JYF DRUGINKE VDPWQQORTOWPSP-UHFFFAOYSA-N D07JYF DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])SC(=N2)S(=O)(=O)N D07JYF HIGHSTAT Investigative D07JZB DRUG__ID D07JZB D07JZB DRUGTYPE Small molecular drug D07JZB DRUGINCH 1S/C49H66N12O6/c1-28(2)21-38(43(51)62)57-45(64)39(22-29(3)4)59-48(67)42(25-32-27-56-37-19-11-9-16-34(32)37)61-46(65)40(23-30-13-6-5-7-14-30)60-47(66)41(24-31-26-55-36-18-10-8-15-33(31)36)58-44(63)35(50)17-12-20-54-49(52)53/h5-11,13-16,18-19,26-29,35,38-42,55-56H,12,17,20-25,50H2,1-4H3,(H2,51,62)(H,57,64)(H,58,63)(H,59,67)(H,60,66)(H,61,65)(H4,52,53,54)/t35-,38-,39-,40-,41+,42+/m0/s1 D07JZB DRUGINKE GHJBYAJFOUQNRR-MQYLJLIZSA-N D07JZB DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCN=C(N)N)N D07JZB HIGHSTAT Investigative D07JZS DRUG__ID D07JZS D07JZS DRUGTYPE Small molecular drug D07JZS DRUGINCH 1S/C28H34N6O6/c29-20(14-18-10-12-19(35)13-11-18)26(38)34-22-9-5-4-8-21(25(30)37)33-28(40)23(15-17-6-2-1-3-7-17)32-24(36)16-31-27(22)39/h1-7,10-13,20-23,35H,8-9,14-16,29H2,(H2,30,37)(H,31,39)(H,32,36)(H,33,40)(H,34,38)/b5-4-/t20-,21-,22+,23-/m0/s1 D07JZS DRUGINKE UYBFKIDGDVZVFM-ODCKOUNNSA-N D07JZS DRUGSMIL C1C=CCC(NC(=O)C(NC(=O)CNC(=O)C1NC(=O)C(CC2=CC=C(C=C2)O)N)CC3=CC=CC=C3)C(=O)N D07JZS HIGHSTAT Investigative D07KBF DRUG__ID D07KBF D07KBF DRUGTYPE Small molecular drug D07KBF DRUGINCH 1S/C18H21N3O3/c1-12-4-2-3-5-16(12)24-14-8-6-13(7-9-14)21-17(22)11-10-15(19)18(20)23/h2-9,15H,10-11,19H2,1H3,(H2,20,23)(H,21,22)/t15-/m0/s1 D07KBF DRUGINKE UHWCMHMPSGPFGU-HNNXBMFYSA-N D07KBF DRUGSMIL CC1=CC=CC=C1OC2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D07KBF HIGHSTAT Investigative D07KBZ DRUG__ID D07KBZ D07KBZ DRUGTYPE Small molecular drug D07KBZ DRUGINCH 1S/C39H73O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,37H,3-16,21-36H2,1-2H3,(H2,42,43,44)/b19-17-,20-18- D07KBZ DRUGINKE MHUWZNTUIIFHAS-CLFAGFIQSA-N D07KBZ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCC=CCCCCCCCC D07KBZ HIGHSTAT Investigative D07KDB DRUG__ID D07KDB D07KDB DRUGTYPE Small molecular drug D07KDB DRUGINCH 1S/C14H13NO/c1-10-12-7-6-11-4-2-3-5-13(11)15(12)9-8-14(10)16/h2-5,8-9H,6-7H2,1H3 D07KDB DRUGINKE POEIHRYHSHOMRL-UHFFFAOYSA-N D07KDB DRUGSMIL CC1=C2CCC3=CC=CC=C3N2C=CC1=O D07KDB HIGHSTAT Investigative D07KEV DRUG__ID D07KEV D07KEV DRUGTYPE Small molecular drug D07KEV DRUGINCH 1S/C20H18F2N4O2/c1-12-2-3-14(11-26(12)20(27)13-4-6-15(21)7-5-13)18-24-19(28-25-18)17-9-8-16(22)10-23-17/h4-10,12,14H,2-3,11H2,1H3/t12-,14+/m1/s1 D07KEV DRUGINKE JOBPCEDWVKYVKZ-OCCSQVGLSA-N D07KEV DRUGSMIL CC1CCC(CN1C(=O)C2=CC=C(C=C2)F)C3=NOC(=N3)C4=NC=C(C=C4)F D07KEV HIGHSTAT Investigative D07KJI DRUG__ID D07KJI D07KJI DRUGTYPE Small molecular drug D07KJI DRUGINCH 1S/C42H54O15/c1-27(33(54-29(3)43)28(2)26-30-18-12-10-13-19-30)23-24-40-34(45)35(42(57-40,39(50)51)41(52,38(48)49)36(56-40)37(46)47)55-32(44)22-16-8-6-4-5-7-9-17-25-53-31-20-14-11-15-21-31/h10-15,18-21,28,33-36,45,52H,1,4-9,16-17,22-26H2,2-3H3,(H,46,47)(H,48,49)(H,50,51)/t28-,33-,34-,35-,36?,40?,41?,42?/m1/s1 D07KJI DRUGINKE MNIPVWXWSPXERA-IDNZQHFXSA-N D07KJI DRUGSMIL CC(CC1=CC=CC=C1)C(C(=C)CCC23C(C(C(O2)(C(C(O3)C(=O)O)(C(=O)O)O)C(=O)O)OC(=O)CCCCCCCCCCOC4=CC=CC=C4)O)OC(=O)C D07KJI HIGHSTAT Investigative D07KMN DRUG__ID D07KMN D07KMN DRUGTYPE Small molecular drug D07KMN DRUGINCH 1S/C19H23NO5.ClH/c1-23-17-7-11(8-18(24-2)19(17)25-3)6-14-13-10-16(22)15(21)9-12(13)4-5-20-14;/h7-10,14,20-22H,4-6H2,1-3H3;1H D07KMN DRUGINKE UHSXRTHJCJGEKG-UHFFFAOYSA-N D07KMN DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2C3=CC(=C(C=C3CCN2)O)O.Cl D07KMN HIGHSTAT Investigative D07KNG DRUG__ID D07KNG D07KNG DRUGTYPE Small molecular drug D07KNG DRUGINCH 1S/C15H20O2/c1-10-5-4-6-11(2)9-14-13(8-7-10)12(3)15(16)17-14/h5,9,13-14H,3-4,6-8H2,1-2H3/b10-5+,11-9+/t13-,14+/m0/s1 D07KNG DRUGINKE HRYLQFBHBWLLLL-AHNJNIBGSA-N D07KNG DRUGSMIL CC1=CCCC(=CC2C(CC1)C(=C)C(=O)O2)C D07KNG HIGHSTAT Investigative D07KOY DRUG__ID D07KOY D07KOY DRUGTYPE Small molecular drug D07KOY DRUGINCH 1S/C17H18F3N3O2S/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3 D07KOY DRUGINKE FIDNKDVRTLFETI-UHFFFAOYSA-N D07KOY DRUGSMIL CC1(C(=O)N(C(=S)N1CCCCO)C2=CC(=C(C=C2)C#N)C(F)(F)F)C D07KOY HIGHSTAT Investigative D07KSR DRUG__ID D07KSR D07KSR DRUGTYPE Small molecular drug D07KSR DRUGINCH 1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6-,12-11+,16-8+,17-13+ D07KSR DRUGINKE NCYCYZXNIZJOKI-IOUUIBBYSA-N D07KSR DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=O)C)C D07KSR HIGHSTAT Investigative D07KTF DRUG__ID D07KTF D07KTF DRUGTYPE Small molecular drug D07KTF DRUGINCH 1S/C24H32O8/c1-5-29-13-31-17-10-16(21(26)28-4)23(2)8-6-15-22(27)32-18(14-7-9-30-12-14)11-24(15,3)20(23)19(17)25/h7,9,12,15-18,20H,5-6,8,10-11,13H2,1-4H3/t15-,16-,17-,18-,20-,23-,24-/m0/s1 D07KTF DRUGINKE ICVTXAUKIHJDGV-WFOQEEKOSA-N D07KTF DRUGSMIL CCOCOC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D07KTF HIGHSTAT Investigative D07KTP DRUG__ID D07KTP D07KTP DRUGTYPE Small molecular drug D07KTP DRUGINCH 1S/C18H16Cl2N4O/c19-14-6-15(20)8-16(7-14)24-18(25)22-9-13-3-1-12(2-4-13)5-17-10-21-11-23-17/h1-4,6-8,10-11H,5,9H2,(H,21,23)(H2,22,24,25) D07KTP DRUGINKE CXNCQFJNXQAFND-UHFFFAOYSA-N D07KTP DRUGSMIL C1=CC(=CC=C1CC2=CN=CN2)CNC(=O)NC3=CC(=CC(=C3)Cl)Cl D07KTP HIGHSTAT Investigative D07KVF DRUG__ID D07KVF D07KVF DRUGTYPE Small molecular drug D07KVF DRUGINCH 1S/C6H13N/c7-6-4-2-1-3-5-6/h6H,1-5,7H2 D07KVF DRUGINKE PAFZNILMFXTMIY-UHFFFAOYSA-N D07KVF DRUGSMIL C1CCC(CC1)N D07KVF HIGHSTAT Investigative D07KWO DRUG__ID D07KWO D07KWO DRUGTYPE Small molecular drug D07KWO DRUGINCH 1S/C29H34O2/c1-4-14-29(31)17-13-25-24-10-9-22-18-23(30)11-16-28(22,26(24)12-15-27(25,29)3)19-21-7-5-20(2)6-8-21/h5-8,12,18,24-25,31H,9-11,13,15-17,19H2,1-3H3/t24-,25-,27-,28+,29-/m0/s1 D07KWO DRUGINKE NSUUUQRFPXZFLI-ZPCMSWJYSA-N D07KWO DRUGSMIL CC#CC1(CCC2C1(CC=C3C2CCC4=CC(=O)CCC43CC5=CC=C(C=C5)C)C)O D07KWO HIGHSTAT Investigative D07KWZ DRUG__ID D07KWZ D07KWZ DRUGTYPE Small molecular drug D07KWZ DRUGINCH 1S/C28H38N4O3S/c1-26(2)21-8-10-28(26,24(15-21)31-25(33)16-22-17-29-19-30-22)18-36(34,35)32-13-11-27(12-14-32)9-7-20-5-3-4-6-23(20)27/h3-6,17,19,21,24H,7-16,18H2,1-2H3,(H,29,30)(H,31,33)/t21-,24+,28-/m1/s1 D07KWZ DRUGINKE VQAVBHLGXVZOKM-RASJMTDNSA-N D07KWZ DRUGSMIL CC1(C2CCC1(C(C2)NC(=O)CC3=CN=CN3)CS(=O)(=O)N4CCC5(CCC6=CC=CC=C65)CC4)C D07KWZ HIGHSTAT Investigative D07KXK DRUG__ID D07KXK D07KXK DRUGTYPE Small molecular drug D07KXK DRUGINCH 1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21+/m0/s1 D07KXK DRUGINKE WMBWREPUVVBILR-GHTZIAJQSA-N D07KXK DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O D07KXK HIGHSTAT Investigative D07KXZ DRUG__ID D07KXZ D07KXZ DRUGTYPE Small molecular drug D07KXZ DRUGINCH 1S/C8H6N2OS/c12-8-10-9-7(11-8)6-4-2-1-3-5-6/h1-5H,(H,10,12) D07KXZ DRUGINKE FOHWXVBZGSVUGO-UHFFFAOYSA-N D07KXZ DRUGSMIL C1=CC=C(C=C1)C2=NNC(=S)O2 D07KXZ HIGHSTAT Investigative D07KZA DRUG__ID D07KZA D07KZA DRUGTYPE Small molecular drug D07KZA DRUGINCH 1S/C6H13NO4S/c8-12(9,10)6-3-7-1-4-11-5-2-7/h1-6H2,(H,8,9,10) D07KZA DRUGINKE SXGZJKUKBWWHRA-UHFFFAOYSA-N D07KZA DRUGSMIL C1COCC[NH+]1CCS(=O)(=O)[O-] D07KZA HIGHSTAT Investigative D07KZL DRUG__ID D07KZL D07KZL DRUGTYPE Small molecular drug D07KZL DRUGINCH 1S/C28H35N3O9S/c1-19(2)16-23(27(35)31(17-25(32)33)41(37,38)22-13-11-21(39-3)12-14-22)29-26(34)24-10-7-15-30(24)28(36)40-18-20-8-5-4-6-9-20/h4-6,8-9,11-14,19,23-24H,7,10,15-18H2,1-3H3,(H,29,34)(H,32,33)/t23-,24-/m0/s1 D07KZL DRUGINKE QXROXWFFCFLRBZ-ZEQRLZLVSA-N D07KZL DRUGSMIL CC(C)CC(C(=O)N(CC(=O)O)S(=O)(=O)C1=CC=C(C=C1)OC)NC(=O)C2CCCN2C(=O)OCC3=CC=CC=C3 D07KZL HIGHSTAT Investigative D07KZW DRUG__ID D07KZW D07KZW DRUGTYPE Small molecular drug D07KZW DRUGINCH 1S/C28H29NO/c1-3-5-8-18-29-20-24(19-27(29)23-16-14-21(4-2)15-17-23)28(30)26-13-9-11-22-10-6-7-12-25(22)26/h6-7,9-17,19-20H,3-5,8,18H2,1-2H3 D07KZW DRUGINKE VJWBAPGRMUZBEH-UHFFFAOYSA-N D07KZW DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)CC)C(=O)C3=CC=CC4=CC=CC=C43 D07KZW HIGHSTAT Investigative D07LCC DRUG__ID D07LCC D07LCC DRUGTYPE Small molecular drug D07LCC DRUGINCH 1S/C19H24N2O3/c1-4-8-23-13-6-7-16-14(10-13)18-15(12-22-3)19(24-9-5-2)20-11-17(18)21-16/h6-7,10-11,21H,4-5,8-9,12H2,1-3H3 D07LCC DRUGINKE BTCRVOSPHNKQGJ-UHFFFAOYSA-N D07LCC DRUGSMIL CCCOC1=CC2=C(C=C1)NC3=CN=C(C(=C23)COC)OCCC D07LCC HIGHSTAT Investigative D07LCG DRUG__ID D07LCG D07LCG DRUGTYPE Small molecular drug D07LCG DRUGINCH 1S/C17H19NO/c1-2-3-7-14-10-12-15(13-11-14)17(19)18-16-8-5-4-6-9-16/h4-6,8-13H,2-3,7H2,1H3,(H,18,19) D07LCG DRUGINKE PNJHOPPVHVQWPM-UHFFFAOYSA-N D07LCG DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2 D07LCG HIGHSTAT Investigative D07LCM DRUG__ID D07LCM D07LCM DRUGTYPE Small molecular drug D07LCM DRUGINCH 1S/C13H19NO/c1-15-13-6-4-5-12(11-13)7-10-14-8-2-3-9-14/h4-6,11H,2-3,7-10H2,1H3 D07LCM DRUGINKE JLMYWUJQHKXCOU-UHFFFAOYSA-N D07LCM DRUGSMIL COC1=CC=CC(=C1)CCN2CCCC2 D07LCM HIGHSTAT Investigative D07LCU DRUG__ID D07LCU D07LCU DRUGTYPE Small molecular drug D07LCU DRUGINCH 1S/C18H18N2O/c21-18(17-13-15-10-4-5-11-16(15)20-17)19-12-6-9-14-7-2-1-3-8-14/h1-5,7-8,10-11,13,20H,6,9,12H2,(H,19,21) D07LCU DRUGINKE RUVMVFFYHGKXTD-UHFFFAOYSA-N D07LCU DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C2=CC3=CC=CC=C3N2 D07LCU HIGHSTAT Investigative D07LCW DRUG__ID D07LCW D07LCW DRUGTYPE Small molecular drug D07LCW DRUGINCH 1S/C8H9N5O2/c9-11-10-5-7-6-13(8(14)15-7)12-3-1-2-4-12/h1-4,7H,5-6H2/t7-/m1/s1 D07LCW DRUGINKE RJURJCGAHMMGOY-SSDOTTSWSA-N D07LCW DRUGSMIL C1C(OC(=O)N1N2C=CC=C2)CN=[N+]=[N-] D07LCW HIGHSTAT Investigative D07LDP DRUG__ID D07LDP D07LDP DRUGTYPE Small molecular drug D07LDP DRUGINCH 1S/C20H33NOSi/c22-23(19-11-4-1-5-12-19,20-13-6-2-7-14-20)18-10-17-21-15-8-3-9-16-21/h1,4-5,11-12,20,22H,2-3,6-10,13-18H2 D07LDP DRUGINKE QTBCATBNRIYMPB-UHFFFAOYSA-N D07LDP DRUGSMIL C1CCC(CC1)[Si](CCCN2CCCCC2)(C3=CC=CC=C3)O D07LDP HIGHSTAT Investigative D07LER DRUG__ID D07LER D07LER DRUGTYPE Small molecular drug D07LER DRUGINCH 1S/C21H27NO/c1-2-3-4-5-6-10-17-21(23)22-20-16-12-11-15-19(20)18-13-8-7-9-14-18/h7-9,11-16H,2-6,10,17H2,1H3,(H,22,23) D07LER DRUGINKE QOVZQINZWUSANF-UHFFFAOYSA-N D07LER DRUGSMIL CCCCCCCCC(=O)NC1=CC=CC=C1C2=CC=CC=C2 D07LER HIGHSTAT Investigative D07LFR DRUG__ID D07LFR D07LFR DRUGTYPE Small molecular drug D07LFR DRUGINCH 1S/C19H19NS/c1-2-4-15(5-3-1)13-19(9-10-20-14-19)17-6-7-18-16(12-17)8-11-21-18/h1-8,11-12,20H,9-10,13-14H2 D07LFR DRUGINKE VVROCSNBKQTQEO-UHFFFAOYSA-N D07LFR DRUGSMIL C1CNCC1(CC2=CC=CC=C2)C3=CC4=C(C=C3)SC=C4 D07LFR HIGHSTAT Investigative D07LFZ DRUG__ID D07LFZ D07LFZ DRUGTYPE Small molecular drug D07LFZ DRUGINCH 1S/C16H14N2S/c17-13-5-1-11(2-6-13)15-9-10-16(19-15)12-3-7-14(18)8-4-12/h1-10H,17-18H2 D07LFZ DRUGINKE QUVIYFJRWXKEKM-UHFFFAOYSA-N D07LFZ DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC=C(C=C3)N)N D07LFZ HIGHSTAT Investigative D07LHD DRUG__ID D07LHD D07LHD DRUGTYPE Small molecular drug D07LHD DRUGINCH 1S/C12H16N2O/c1-13(2)8-9-14-7-6-10-11(14)4-3-5-12(10)15/h3-7,15H,8-9H2,1-2H3 D07LHD DRUGINKE PKWAUGJGYFZHOE-UHFFFAOYSA-N D07LHD DRUGSMIL CN(C)CCN1C=CC2=C1C=CC=C2O D07LHD HIGHSTAT Investigative D07LIE DRUG__ID D07LIE D07LIE DRUGTYPE Small molecular drug D07LIE DRUGINCH 1S/C14H15NO2S/c15-10-9-12-5-4-8-14(11-12)18(16,17)13-6-2-1-3-7-13/h1-8,11H,9-10,15H2 D07LIE DRUGINKE PXOKRWBUDGQCDL-UHFFFAOYSA-N D07LIE DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CC=CC(=C2)CCN D07LIE HIGHSTAT Investigative D07LJH DRUG__ID D07LJH D07LJH DRUGTYPE Small molecular drug D07LJH DRUGINCH 1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3/i12-2 D07LJH DRUGINKE BGMZUEKZENQUJY-DACUFJSSSA-N D07LJH DRUGSMIL CC(CC1=CC(=C(C=C1OC)I)OC)N D07LJH HIGHSTAT Investigative D07LMB DRUG__ID D07LMB D07LMB DRUGTYPE Small molecular drug D07LMB DRUGINCH 1S/C20H16FN3O/c1-2-14-10-15(21)12-16(11-14)24-9-5-7-19-18(13-24)23-20(25-19)17-6-3-4-8-22-17/h1,3-4,6,8,10-12H,5,7,9,13H2 D07LMB DRUGINKE MVXAKOGJWVQPKC-UHFFFAOYSA-N D07LMB DRUGSMIL C#CC1=CC(=CC(=C1)F)N2CCCC3=C(C2)N=C(O3)C4=CC=CC=N4 D07LMB HIGHSTAT Investigative D07LMI DRUG__ID D07LMI D07LMI DRUGTYPE Small molecular drug D07LMI DRUGINCH 1S/C11H12N2/c1-10-12-7-8-13(10)9-11-5-3-2-4-6-11/h2-8H,9H2,1H3 D07LMI DRUGINKE FBHPRUXJQNWTEW-UHFFFAOYSA-N D07LMI DRUGSMIL CC1=NC=CN1CC2=CC=CC=C2 D07LMI HIGHSTAT Investigative D07LMK DRUG__ID D07LMK D07LMK DRUGTYPE Small molecular drug D07LMK DRUGINCH 1S/C9H8F3N3S/c10-9(11,12)7-4-2-1-3-6(7)5-14-15-8(13)16/h1-5H,(H3,13,15,16)/b14-5- D07LMK DRUGINKE IVJQRNPGHXNEJE-RZNTYIFUSA-N D07LMK DRUGSMIL C1=CC=C(C(=C1)C=NNC(=S)N)C(F)(F)F D07LMK HIGHSTAT Investigative D07LML DRUG__ID D07LML D07LML DRUGTYPE Small molecular drug D07LML DRUGINCH 1S/C12H15NO4S/c1-9-4-6-10(7-5-9)18(16,17)13-8-2-3-11(13)12(14)15/h4-7,11H,2-3,8H2,1H3,(H,14,15)/t11-/m1/s1 D07LML DRUGINKE CGPHGPCHVUSFFA-LLVKDONJSA-N D07LML DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCCC2C(=O)O D07LML HIGHSTAT Investigative D07LMV DRUG__ID D07LMV D07LMV DRUGTYPE Small molecular drug D07LMV DRUGINCH 1S/C18H20N2O3/c19-18(21)20(22)17-8-4-7-14-11-15(9-10-16(14)17)23-12-13-5-2-1-3-6-13/h1-3,5-6,9-11,17,22H,4,7-8,12H2,(H2,19,21) D07LMV DRUGINKE HGXVXGSOOPCMHM-UHFFFAOYSA-N D07LMV DRUGSMIL C1CC(C2=C(C1)C=C(C=C2)OCC3=CC=CC=C3)N(C(=O)N)O D07LMV HIGHSTAT Investigative D07LMZ DRUG__ID D07LMZ D07LMZ DRUGTYPE Small molecular drug D07LMZ DRUGINCH 1S/C2H7N/c1-3-2/h3H,1-2H3 D07LMZ DRUGINKE ROSDSFDQCJNGOL-UHFFFAOYSA-N D07LMZ DRUGSMIL CNC D07LMZ HIGHSTAT Investigative D07LNY DRUG__ID D07LNY D07LNY DRUGTYPE Small molecular drug D07LNY DRUGINCH 1S/C20H30O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-12+/t16-,17-,18+/m0/s1 D07LNY DRUGINKE MYHXHCUNDDAEOZ-FOSBLDSVSA-N D07LNY DRUGSMIL CCCCCC(C=CC1C=CC(=O)C1CC=CCCCC(=O)O)O D07LNY HIGHSTAT Investigative D07LQQ DRUG__ID D07LQQ D07LQQ DRUGTYPE Small molecular drug D07LQQ DRUGINCH 1S/C47H61N9O10/c1-3-5-15-35(53-43(62)33(48)22-29-18-20-31(57)21-19-29)44(63)51-27-40(58)52-38(24-30-26-50-34-17-11-10-14-32(30)34)46(65)54-36(16-6-4-2)45(64)56-39(25-41(59)60)47(66)55-37(42(49)61)23-28-12-8-7-9-13-28/h7-14,17-21,26,33,35-39,50,57H,3-6,15-16,22-25,27,48H2,1-2H3,(H2,49,61)(H,51,63)(H,52,58)(H,53,62)(H,54,65)(H,55,66)(H,56,64)(H,59,60)/t33-,35+,36-,37-,38-,39-/m0/s1 D07LQQ DRUGINKE YVOYRMXNVINXII-ULSNPNCNSA-N D07LQQ DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D07LQQ HIGHSTAT Investigative D07LQX DRUG__ID D07LQX D07LQX DRUGTYPE Small molecular drug D07LQX DRUGINCH 1S/C24H32FNO3/c1-2-3-4-5-6-7-8-9-12-19-28-21-17-15-20(16-18-21)26-24(27)29-23-14-11-10-13-22(23)25/h10-11,13-18H,2-9,12,19H2,1H3,(H,26,27) D07LQX DRUGINKE PDDXKUNCGFODGC-UHFFFAOYSA-N D07LQX DRUGSMIL CCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D07LQX HIGHSTAT Investigative D07LRJ DRUG__ID D07LRJ D07LRJ DRUGTYPE Small molecular drug D07LRJ DRUGINCH 1S/C20H22ClN3O3S2/c1-13-16-11-14(21)3-6-19(16)28-20(13)29(25,26)23-15-4-5-18(27-2)17(12-15)24-9-7-22-8-10-24/h3-6,11-12,22-23H,7-10H2,1-2H3 D07LRJ DRUGINKE LOCQRDBFWSXQQI-UHFFFAOYSA-N D07LRJ DRUGSMIL CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCNCC4 D07LRJ HIGHSTAT Investigative D07LRZ DRUG__ID D07LRZ D07LRZ DRUGTYPE Small molecular drug D07LRZ DRUGINCH 1S/C26H35NO2/c1-29-26(28)25(23-17-9-5-10-18-23)24-19-11-13-21-27(24)20-12-3-2-6-14-22-15-7-4-8-16-22/h4-5,7-10,15-18,24-25H,2-3,6,11-14,19-21H2,1H3/t24-,25-/m1/s1 D07LRZ DRUGINKE JMGUVGDMBREFCW-JWQCQUIFSA-N D07LRZ DRUGSMIL COC(=O)C(C1CCCCN1CCCCCCC2=CC=CC=C2)C3=CC=CC=C3 D07LRZ HIGHSTAT Investigative D07LSC DRUG__ID D07LSC D07LSC DRUGTYPE Small molecular drug D07LSC DRUGINCH 1S/C10H13FN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2 D07LSC DRUGINKE KIFCSMQTGWVMOD-UHFFFAOYSA-N D07LSC DRUGSMIL C1CN(CCN1)C2=CC(=CC=C2)F D07LSC HIGHSTAT Investigative D07LTB DRUG__ID D07LTB D07LTB DRUGTYPE Small molecular drug D07LTB DRUGINCH 1S/C16H12N2O4/c19-14-13(15(20)18-16(21)17-14)10-6-8-12(9-7-10)22-11-4-2-1-3-5-11/h1-9H,(H3,17,18,19,20,21) D07LTB DRUGINKE CVMFBMDAPZFQBR-UHFFFAOYSA-N D07LTB DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=C(NC(=O)NC3=O)O D07LTB HIGHSTAT Investigative D07LTR DRUG__ID D07LTR D07LTR DRUGTYPE Small molecular drug D07LTR DRUGINCH 1S/C17H20O2/c1-2-3-7-14-18-15-10-12-17(13-11-15)19-16-8-5-4-6-9-16/h4-6,8-13H,2-3,7,14H2,1H3 D07LTR DRUGINKE LFCVQUJWFGBKJK-UHFFFAOYSA-N D07LTR DRUGSMIL CCCCCOC1=CC=C(C=C1)OC2=CC=CC=C2 D07LTR HIGHSTAT Investigative D07LUI DRUG__ID D07LUI D07LUI DRUGTYPE Small molecular drug D07LUI DRUGINCH 1S/C16H12O2/c17-15-6-3-11(4-7-15)12-1-2-14-10-16(18)8-5-13(14)9-12/h1-10,17-18H D07LUI DRUGINKE SKPPZWVFPOQPOT-UHFFFAOYSA-N D07LUI DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C=C2)C=C(C=C3)O)O D07LUI HIGHSTAT Investigative D07LUR DRUG__ID D07LUR D07LUR DRUGTYPE Small molecular drug D07LUR DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6+/m1/s1 D07LUR DRUGINKE WQZGKKKJIJFFOK-PQMKYFCFSA-N D07LUR DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D07LUR HIGHSTAT Investigative D07LVT DRUG__ID D07LVT D07LVT DRUGTYPE Small molecular drug D07LVT DRUGINCH 1S/C24H29NO3/c1-18-8-10-20(11-9-18)24(22(26)28-2)16-21(24)17-25-14-12-23(27,13-15-25)19-6-4-3-5-7-19/h3-11,21,27H,12-17H2,1-2H3 D07LVT DRUGINKE BDSYECBSUUOPCT-UHFFFAOYSA-N D07LVT DRUGSMIL CC1=CC=C(C=C1)C2(CC2CN3CCC(CC3)(C4=CC=CC=C4)O)C(=O)OC D07LVT HIGHSTAT Investigative D07LXZ DRUG__ID D07LXZ D07LXZ DRUGTYPE Small molecular drug D07LXZ DRUGINCH 1S/C44H62N10O10S2/c1-25(2)18-34(42(62)50-32(15-17-66-4)40(60)51-33(38(46)58)22-37(56)57)52-44(64)36(21-28-23-47-24-48-28)54-43(63)35(20-26-8-6-5-7-9-26)53-41(61)31(14-16-65-3)49-39(59)30(45)19-27-10-12-29(55)13-11-27/h5-13,23-25,30-36,55H,14-22,45H2,1-4H3,(H2,46,58)(H,47,48)(H,49,59)(H,50,62)(H,51,60)(H,52,64)(H,53,61)(H,54,63)(H,56,57)/t30-,31-,32-,33-,34-,35-,36-/m0/s1 D07LXZ DRUGINKE BHSURCCZOBVHJJ-QJCLFNHPSA-N D07LXZ DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCSC)NC(=O)C(CC3=CC=C(C=C3)O)N D07LXZ HIGHSTAT Investigative D07LYJ DRUG__ID D07LYJ D07LYJ DRUGTYPE Small molecular drug D07LYJ DRUGINCH 1S/C23H16Cl2N2O3/c24-20-10-9-17(13-21(20)25)27-23(29)19(22(28)26-27)12-16-7-4-8-18(11-16)30-14-15-5-2-1-3-6-15/h1-13H,14H2,(H,26,28)/b19-12- D07LYJ DRUGINKE OSJPWEILZQFNPI-UNOMPAQXSA-N D07LYJ DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC(=C2)C=C3C(=O)NN(C3=O)C4=CC(=C(C=C4)Cl)Cl D07LYJ HIGHSTAT Investigative D07LYU DRUG__ID D07LYU D07LYU DRUGTYPE Small molecular drug D07LYU DRUGINCH 1S/C17H24N3O15P3/c21-14-12(10-32-37(27,28)35-38(29,30)34-36(24,25)26)33-16(15(14)22)20-8-6-13(18-17(20)23)19-31-9-7-11-4-2-1-3-5-11/h1-6,8,12,14-16,21-22H,7,9-10H2,(H,27,28)(H,29,30)(H,18,19,23)(H2,24,25,26)/t12-,14-,15-,16-/m1/s1 D07LYU DRUGINKE WREOTYWODABZMH-DTZQCDIJSA-N D07LYU DRUGSMIL C1=CC=C(C=C1)CCONC2=NC(=O)N(C=C2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D07LYU HIGHSTAT Investigative D07LYW DRUG__ID D07LYW D07LYW DRUGTYPE Small molecular drug D07LYW DRUGINCH 1S/C17H26N2O3S/c1-3-5-12(6-4-2)17(20)19-15-9-13-7-8-16(23(18,21)22)11-14(13)10-15/h7-8,11-12,15H,3-6,9-10H2,1-2H3,(H,19,20)(H2,18,21,22) D07LYW DRUGINKE XBYJCVDSFWJBSM-UHFFFAOYSA-N D07LYW DRUGSMIL CCCC(CCC)C(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D07LYW HIGHSTAT Investigative D07LZY DRUG__ID D07LZY D07LZY DRUGTYPE Small molecular drug D07LZY DRUGINCH 1S/C20H4Cl4I4O5/c21-10-8(9(20(31)32)11(22)13(24)12(10)23)7-3-1-5(25)16(29)14(27)18(3)33-19-4(7)2-6(26)17(30)15(19)28/h1-2,29H,(H,31,32) D07LZY DRUGINKE VDNLFJGJEQUWRB-UHFFFAOYSA-N D07LZY DRUGSMIL C1=C2C(=C3C=C(C(=O)C(=C3OC2=C(C(=C1I)O)I)I)I)C4=C(C(=C(C(=C4Cl)Cl)Cl)Cl)C(=O)O D07LZY HIGHSTAT Investigative D07MAF DRUG__ID D07MAF D07MAF DRUGTYPE Small molecular drug D07MAF DRUGINCH 1S/C18H29NO/c1-4-5-6-7-8-9-16-10-12-17(13-11-16)18(20)14-15-19(2)3/h10-13H,4-9,14-15H2,1-3H3 D07MAF DRUGINKE ANCSLKGKDIAGLN-UHFFFAOYSA-N D07MAF DRUGSMIL CCCCCCCC1=CC=C(C=C1)C(=O)CCN(C)C D07MAF HIGHSTAT Investigative D07MBC DRUG__ID D07MBC D07MBC DRUGTYPE Small molecular drug D07MBC DRUGINCH 1S/C20H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9- D07MBC DRUGINKE BOWVQLFMWHZBEF-KTKRTIGZSA-N D07MBC DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCO D07MBC HIGHSTAT Investigative D07MFG DRUG__ID D07MFG D07MFG DRUGTYPE Small molecular drug D07MFG DRUGINCH 1S/C31H31NO5/c1-22(33)32-18-17-26-6-4-5-25-13-16-29(21-30(25)26)37-20-3-2-19-36-28-14-11-24(12-15-28)23-7-9-27(10-8-23)31(34)35/h4-16,21H,2-3,17-20H2,1H3,(H,32,33)(H,34,35) D07MFG DRUGINKE VTMXSWVEWDJSKG-UHFFFAOYSA-N D07MFG DRUGSMIL CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OCCCCOC3=CC=C(C=C3)C4=CC=C(C=C4)C(=O)O D07MFG HIGHSTAT Investigative D07MFH DRUG__ID D07MFH D07MFH DRUGTYPE Small molecular drug D07MFH DRUGINCH 1S/C7H15N3O/c8-3-1-6-5-11-4-2-7(9)10-6/h6H,1-5,8H2,(H2,9,10) D07MFH DRUGINKE ZPHRNAHMHZVACD-UHFFFAOYSA-N D07MFH DRUGSMIL C1COCC(N=C1N)CCN D07MFH HIGHSTAT Investigative D07MGN DRUG__ID D07MGN D07MGN DRUGTYPE Small molecular drug D07MGN DRUGINCH 1S/C14H12N2O8/c15-13(21)23-3-5-6(4-24-14(16)22)12(20)10-8(18)2-1-7(17)9(10)11(5)19/h1-2,19-20H,3-4H2,(H2,15,21)(H2,16,22) D07MGN DRUGINKE VCZBTSKVAAVCJJ-UHFFFAOYSA-N D07MGN DRUGSMIL C1=CC(=O)C2=C(C(=C(C(=C2C1=O)O)COC(=O)N)COC(=O)N)O D07MGN HIGHSTAT Investigative D07MHL DRUG__ID D07MHL D07MHL DRUGTYPE Small molecular drug D07MHL DRUGINCH 1S/C30H30O4/c1-18-19(2)28-25(15-26(29(28)31)22-7-3-4-8-22)16-27(18)34-17-20-6-5-9-24(14-20)21-10-12-23(13-11-21)30(32)33/h5-6,9-14,16,22,26H,3-4,7-8,15,17H2,1-2H3,(H,32,33) D07MHL DRUGINKE KMKBEESNZAPKMP-UHFFFAOYSA-N D07MHL DRUGSMIL CC1=C(C=C2CC(C(=O)C2=C1C)C3CCCC3)OCC4=CC(=CC=C4)C5=CC=C(C=C5)C(=O)O D07MHL HIGHSTAT Investigative D07MHZ DRUG__ID D07MHZ D07MHZ DRUGTYPE Small molecular drug D07MHZ DRUGINCH 1S/C16H24N2O/c19-16(18-15-11-5-2-6-12-15)17-13-7-10-14-8-3-1-4-9-14/h1,3-4,8-9,15H,2,5-7,10-13H2,(H2,17,18,19) D07MHZ DRUGINKE HBTZVNKXMFGOOJ-UHFFFAOYSA-N D07MHZ DRUGSMIL C1CCC(CC1)NC(=O)NCCCC2=CC=CC=C2 D07MHZ HIGHSTAT Investigative D07MIE DRUG__ID D07MIE D07MIE DRUGTYPE Small molecular drug D07MIE DRUGINCH 1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14-/m1/s1 D07MIE DRUGINKE HSCJRCZFDFQWRP-JZMIEXBBSA-N D07MIE DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O D07MIE HIGHSTAT Investigative D07MJD DRUG__ID D07MJD D07MJD DRUGTYPE Small molecular drug D07MJD DRUGINCH 1S/C20H16O4S/c21-20(22)14-17-8-4-5-9-19(17)25(23,24)18-12-10-16(11-13-18)15-6-2-1-3-7-15/h1-13H,14H2,(H,21,22) D07MJD DRUGINKE HGICQEUHJFERNR-UHFFFAOYSA-N D07MJD DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)C3=CC=CC=C3CC(=O)O D07MJD HIGHSTAT Investigative D07MKJ DRUG__ID D07MKJ D07MKJ DRUGTYPE Small molecular drug D07MKJ DRUGINCH 1S/C13H10N4O3/c1-20-8-4-2-7(3-5-8)9-6-14-10-11(15-9)16-13(19)17-12(10)18/h2-6H,1H3,(H2,15,16,17,18,19) D07MKJ DRUGINKE LQVUFGDEIPMWPT-UHFFFAOYSA-N D07MKJ DRUGSMIL COC1=CC=C(C=C1)C2=CN=C3C(=N2)NC(=O)NC3=O D07MKJ HIGHSTAT Investigative D07MNG DRUG__ID D07MNG D07MNG DRUGTYPE Small molecular drug D07MNG DRUGINCH 1S/C2H7O4P/c1-2-6-7(3,4)5/h2H2,1H3,(H2,3,4,5) D07MNG DRUGINKE ZJXZSIYSNXKHEA-UHFFFAOYSA-N D07MNG DRUGSMIL CCOP(=O)(O)O D07MNG HIGHSTAT Investigative D07MQB DRUG__ID D07MQB D07MQB DRUGTYPE Small molecular drug D07MQB DRUGINCH 1S/C6H6FIN2O2S/c7-4-1-3(13(10,11)12)2-5(8)6(4)9/h1-2H,9H2,(H2,10,11,12) D07MQB DRUGINKE KDXNVSMWRXCNMY-UHFFFAOYSA-N D07MQB DRUGSMIL C1=C(C=C(C(=C1F)N)I)S(=O)(=O)N D07MQB HIGHSTAT Investigative D07MQF DRUG__ID D07MQF D07MQF DRUGTYPE Small molecular drug D07MQF DRUGINCH 1S/C21H39NO6/c1-2-3-4-10-13-17(24)14-11-8-6-5-7-9-12-15-18(25)19(26)21(22,16-23)20(27)28/h9,12,18-19,23,25-26H,2-8,10-11,13-16,22H2,1H3,(H,27,28)/b12-9+/t18-,19+,21+/m1/s1 D07MQF DRUGINKE ZZIKIHCNFWXKDY-GNTQXERDSA-N D07MQF DRUGSMIL CCCCCCC(=O)CCCCCCC=CCC(C(C(CO)(C(=O)O)N)O)O D07MQF HIGHSTAT Investigative D07MQJ DRUG__ID D07MQJ D07MQJ DRUGTYPE Small molecular drug D07MQJ DRUGINCH 1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-26(29)27-28-25(23-30-27)24-20-17-16-18-21-24/h9-10,16-18,20-21,23H,2-8,11-15,19,22H2,1H3/b10-9- D07MQJ DRUGINKE KOOKQMBHKMEODJ-KTKRTIGZSA-N D07MQJ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NC(=CO1)C2=CC=CC=C2 D07MQJ HIGHSTAT Investigative D07MRF DRUG__ID D07MRF D07MRF DRUGTYPE Small molecular drug D07MRF DRUGINCH 1S/C11H7N3O2/c15-14(16)11-5-8-7-3-1-2-4-9(7)13-10(8)6-12-11/h1-6,13H D07MRF DRUGINKE XQNOYQREYCKAIN-UHFFFAOYSA-N D07MRF DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NC=C3N2)[N+](=O)[O-] D07MRF HIGHSTAT Investigative D07MSJ DRUG__ID D07MSJ D07MSJ DRUGTYPE Small molecular drug D07MSJ DRUGINCH 1S/C26H36N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-24(29)26-28-22-25(30-26)23-19-17-18-21-27-23/h17-19,21-22H,2-8,11-16,20H2,1H3 D07MSJ DRUGINKE PFSWYEYBMPLGTD-UHFFFAOYSA-N D07MSJ DRUGSMIL CCCCCCCCC#CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2 D07MSJ HIGHSTAT Investigative D07MTB DRUG__ID D07MTB D07MTB DRUGTYPE Small molecular drug D07MTB DRUGINCH 1S/C23H22F3N3O3/c1-22(2,3)17-7-4-5-9-19(17)31-20-18(8-6-14-27-20)29-21(30)28-15-10-12-16(13-11-15)32-23(24,25)26/h4-14H,1-3H3,(H2,28,29,30) D07MTB DRUGINKE AHFLGPTXSIRAQK-UHFFFAOYSA-N D07MTB DRUGSMIL CC(C)(C)C1=CC=CC=C1OC2=C(C=CC=N2)NC(=O)NC3=CC=C(C=C3)OC(F)(F)F D07MTB HIGHSTAT Investigative D07MTM DRUG__ID D07MTM D07MTM DRUGTYPE Small molecular drug D07MTM DRUGINCH 1S/C6H7NO/c7-5-1-3-6(8)4-2-5/h1-4,8H,7H2 D07MTM DRUGINKE PLIKAWJENQZMHA-UHFFFAOYSA-N D07MTM DRUGSMIL C1=CC(=CC=C1N)O D07MTM HIGHSTAT Investigative D07MTU DRUG__ID D07MTU D07MTU DRUGTYPE Small molecular drug D07MTU DRUGINCH 1S/C30H48O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21+,22-,23-,24+,27+,28-,29-,30+/m1/s1 D07MTU DRUGINKE WCGUUGGRBIKTOS-XHINXETDSA-N D07MTU DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)O D07MTU HIGHSTAT Investigative D07MXA DRUG__ID D07MXA D07MXA DRUGTYPE Small molecular drug D07MXA DRUGINCH 1S/C14H22O4/c1-3-4-5-6-7-8-9-11-12(13(15)16)10(2)14(17)18-11/h11-12H,2-9H2,1H3,(H,15,16) D07MXA DRUGINKE VCWLZDVWHQVAJU-UHFFFAOYSA-N D07MXA DRUGSMIL CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O D07MXA HIGHSTAT Investigative D07MYE DRUG__ID D07MYE D07MYE DRUGTYPE Small molecular drug D07MYE DRUGINCH 1S/C9H9NO2/c11-9(10-12)7-6-8-4-2-1-3-5-8/h1-7,12H,(H,10,11)/b7-6+ D07MYE DRUGINKE UVDDFTZLVFIQFL-VOTSOKGWSA-N D07MYE DRUGSMIL C1=CC=C(C=C1)C=CC(=O)NO D07MYE HIGHSTAT Investigative D07NAH DRUG__ID D07NAH D07NAH DRUGTYPE Small molecular drug D07NAH DRUGINCH 1S/C13H10N2/c1-2-4-11-7-12(6-5-10(11)3-1)13-8-14-9-15-13/h1-9H,(H,14,15) D07NAH DRUGINKE CTUKWPHHWRYGEH-UHFFFAOYSA-N D07NAH DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CN=CN3 D07NAH HIGHSTAT Investigative D07NAY DRUG__ID D07NAY D07NAY DRUGTYPE Small molecular drug D07NAY DRUGINCH 1S/C15H10O7/c16-7-1-2-8-11(5-7)22-15(14(21)12(8)19)6-3-9(17)13(20)10(18)4-6/h1-5,16-18,20-21H D07NAY DRUGINKE SOEDEYVDCDYMMH-UHFFFAOYSA-N D07NAY DRUGSMIL C1=CC2=C(C=C1O)OC(=C(C2=O)O)C3=CC(=C(C(=C3)O)O)O D07NAY HIGHSTAT Investigative D07NBB DRUG__ID D07NBB D07NBB DRUGTYPE Small molecular drug D07NBB DRUGINCH 1S/C15H15BrN4O3/c1-18-11-12(19(2)15(22)20(3)13(11)21)17-14(18)23-8-9-5-4-6-10(16)7-9/h4-7H,8H2,1-3H3 D07NBB DRUGINKE UMXJQISLIGIYPW-UHFFFAOYSA-N D07NBB DRUGSMIL CN1C2=C(N=C1OCC3=CC(=CC=C3)Br)N(C(=O)N(C2=O)C)C D07NBB HIGHSTAT Investigative D07NDW DRUG__ID D07NDW D07NDW DRUGTYPE Small molecular drug D07NDW DRUGINCH 1S/C26H28N4O2/c1-17(2)20-10-12-21(13-11-20)24-15-28-30-19(4)23(14-27-25(24)30)26(31)29-18(3)16-32-22-8-6-5-7-9-22/h5-15,17-18H,16H2,1-4H3,(H,29,31)/t18-/m1/s1 D07NDW DRUGINKE DJSWNINDPRRCLC-GOSISDBHSA-N D07NDW DRUGSMIL CC1=C(C=NC2=C(C=NN12)C3=CC=C(C=C3)C(C)C)C(=O)NC(C)COC4=CC=CC=C4 D07NDW HIGHSTAT Investigative D07NFJ DRUG__ID D07NFJ D07NFJ DRUGTYPE Small molecular drug D07NFJ DRUGINCH 1S/C33H48N4O4/c1-4-6-18-34-30(39)22-29(38)28(21-25-12-8-7-9-13-25)35-33(41)31(24(3)5-2)36-32(40)27-16-14-26(15-17-27)23-37-19-10-11-20-37/h7-9,12-17,24,28-29,31,38H,4-6,10-11,18-23H2,1-3H3,(H,34,39)(H,35,41)(H,36,40)/t24-,28?,29?,31-/m0/s1 D07NFJ DRUGINKE XZUGYLKCDURJSJ-GBIMTFRJSA-N D07NFJ DRUGSMIL CCCCNC(=O)CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)CC)NC(=O)C2=CC=C(C=C2)CN3CCCC3)O D07NFJ HIGHSTAT Investigative D07NKO DRUG__ID D07NKO D07NKO DRUGTYPE Small molecular drug D07NKO DRUGINCH 1S/C5H8N2O2/c1-3(6)4-2-5(8)7-9-4/h2-3H,6H2,1H3,(H,7,8)/t3-/m1/s1 D07NKO DRUGINKE ICRYUJPBYIPXQF-GSVOUGTGSA-N D07NKO DRUGSMIL CC(C1=CC(=O)NO1)N D07NKO HIGHSTAT Investigative D07NMH DRUG__ID D07NMH D07NMH DRUGTYPE Small molecular drug D07NMH DRUGINCH 1S/C24H24BrNO/c25-22-13-11-21(12-14-22)24(27)15-17-26(18-16-24)23(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-14,23,27H,15-18H2 D07NMH DRUGINKE FIHWNAAGEWTLGW-UHFFFAOYSA-N D07NMH DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Br)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D07NMH HIGHSTAT Investigative D07NNN DRUG__ID D07NNN D07NNN DRUGTYPE Small molecular drug D07NNN DRUGINCH 1S/C55H79N13O14S2/c1-30(2)21-38(50(77)62-36(47(57)74)17-19-83-5)61-43(69)28-59-55(82)46(31(3)4)68-54(81)40(23-33-15-11-8-12-16-33)65-51(78)39(22-32-13-9-7-10-14-32)64-53(80)42(26-45(72)73)67-52(79)41(24-34-27-58-29-60-34)66-49(76)37(18-20-84-6)63-48(75)35(56)25-44(70)71/h7-16,27,29-31,35-42,46H,17-26,28,56H2,1-6H3,(H2,57,74)(H,58,60)(H,59,82)(H,61,69)(H,62,77)(H,63,75)(H,64,80)(H,65,78)(H,66,76)(H,67,79)(H,68,81)(H,70,71)(H,72,73)/t35-,36-,37-,38-,39-,40-,41-,42-,46-/m0/s1 D07NNN DRUGINKE NHXYSAFTNPANFK-HDMCBQFHSA-N D07NNN DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCSC)NC(=O)C(CC(=O)O)N D07NNN HIGHSTAT Investigative D07NQQ DRUG__ID D07NQQ D07NQQ DRUGTYPE Small molecular drug D07NQQ DRUGINCH 1S/C11H17N2O11PS/c1-3(14)22-5-4(12)6(24-25(19,20)21)10(9(16)17)2-26-11(18,8(13)15)7(5)23-10/h4-7,18H,2,12H2,1H3,(H2,13,15)(H,16,17)(H2,19,20,21)/t4-,5+,6+,7+,10+,11+/m0/s1 D07NQQ DRUGINKE UVAAUIDYGIWLMB-HGNFPZBQSA-N D07NQQ DRUGSMIL CC(=O)OC1C(C(C2(CSC(C1O2)(C(=O)N)O)C(=O)O)OP(=O)(O)O)N D07NQQ HIGHSTAT Investigative D07NSR DRUG__ID D07NSR D07NSR DRUGTYPE Small molecular drug D07NSR DRUGINCH 1S/C17H15NO3/c19-17-11-15(18-5-7-20-8-6-18)14-9-12-3-1-2-4-13(12)10-16(14)21-17/h1-4,9-11H,5-8H2 D07NSR DRUGINKE NEEAOCHOCYXDSE-UHFFFAOYSA-N D07NSR DRUGSMIL C1COCCN1C2=CC(=O)OC3=CC4=CC=CC=C4C=C23 D07NSR HIGHSTAT Investigative D07NSZ DRUG__ID D07NSZ D07NSZ DRUGTYPE Small molecular drug D07NSZ DRUGINCH 1S/C8H9ClN2S.ClH/c9-7-3-1-2-6(4-7)5-12-8(10)11;/h1-4H,5H2,(H3,10,11);1H D07NSZ DRUGINKE YKIYRIHELXCHJD-UHFFFAOYSA-N D07NSZ DRUGSMIL C1=CC(=CC(=C1)Cl)CSC(=N)N.Cl D07NSZ HIGHSTAT Investigative D07NVH DRUG__ID D07NVH D07NVH DRUGTYPE Small molecular drug D07NVH DRUGINCH 1S/C21H13ClF6N2O3S/c22-15-3-1-12(2-4-15)19(31)29-16-5-7-18(8-6-16)34(32,33)30-17-10-13(20(23,24)25)9-14(11-17)21(26,27)28/h1-11,30H,(H,29,31) D07NVH DRUGINKE VBZKJHSBGYDJAN-UHFFFAOYSA-N D07NVH DRUGSMIL C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)Cl D07NVH HIGHSTAT Investigative D07NVK DRUG__ID D07NVK D07NVK DRUGTYPE Small molecular drug D07NVK DRUGINCH 1S/C10H12N4O2S/c1-2-9(12-13-10(11)17)7-4-3-5-8(6-7)14(15)16/h3-6H,2H2,1H3,(H3,11,13,17)/b12-9+ D07NVK DRUGINKE BTQZWQBDFKXQEG-FMIVXFBMSA-N D07NVK DRUGSMIL CCC(=NNC(=S)N)C1=CC(=CC=C1)[N+](=O)[O-] D07NVK HIGHSTAT Investigative D07NYQ DRUG__ID D07NYQ D07NYQ DRUGTYPE Small molecular drug D07NYQ DRUGINCH 1S/C10H7NO2/c12-10(13)8-5-6-11-9-4-2-1-3-7(8)9/h1-6H,(H,12,13) D07NYQ DRUGINKE VQMSRUREDGBWKT-UHFFFAOYSA-N D07NYQ DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)C(=O)O D07NYQ HIGHSTAT Investigative D07NYR DRUG__ID D07NYR D07NYR DRUGTYPE Small molecular drug D07NYR DRUGINCH 1S/C26H31N7O4S/c27-25(28)20-5-4-19-3-2-18(14-21(19)15-20)16-33(38(36,37)17-24(34)35)23-8-6-22(7-9-23)31-10-1-11-32(13-12-31)26(29)30/h2-9,14-15H,1,10-13,16-17H2,(H3,27,28)(H3,29,30)(H,34,35) D07NYR DRUGINKE WDFHCLOWHSYIFO-UHFFFAOYSA-N D07NYR DRUGSMIL C1CN(CCN(C1)C(=N)N)C2=CC=C(C=C2)N(CC3=CC4=C(C=C3)C=CC(=C4)C(=N)N)S(=O)(=O)CC(=O)O D07NYR HIGHSTAT Investigative D07NYX DRUG__ID D07NYX D07NYX DRUGTYPE Small molecular drug D07NYX DRUGINCH 1S/C7H5NS/c1-2-4-7-6(3-1)8-5-9-7/h1-5H D07NYX DRUGINKE IOJUPLGTWVMSFF-UHFFFAOYSA-N D07NYX DRUGSMIL C1=CC=C2C(=C1)N=CS2 D07NYX HIGHSTAT Investigative D07OAC DRUG__ID D07OAC D07OAC DRUGTYPE Small molecular drug D07OAC DRUGINCH 1S/C10H13BrN6O3/c11-7-4-8(13)14-2-15-9(4)17(16-7)10-6(19)5(18)3(1-12)20-10/h2-3,5-6,10,18-19H,1,12H2,(H2,13,14,15)/t3-,5-,6-,10-/m1/s1 D07OAC DRUGINKE LTTBFVDMHCIDPM-BHBWVORQSA-N D07OAC DRUGSMIL C1=NC(=C2C(=N1)N(N=C2Br)C3C(C(C(O3)CN)O)O)N D07OAC HIGHSTAT Investigative D07OAF DRUG__ID D07OAF D07OAF DRUGTYPE Small molecular drug D07OAF DRUGINCH 1S/C14H19N3O3S/c1-21(19,20)17-13-10-3-2-4-11(14-15-7-8-16-14)9(10)5-6-12(13)18/h5-6,11,17-18H,2-4,7-8H2,1H3,(H,15,16) D07OAF DRUGINKE OQFCXJDXHCDLHX-UHFFFAOYSA-N D07OAF DRUGSMIL CS(=O)(=O)NC1=C(C=CC2=C1CCCC2C3=NCCN3)O D07OAF HIGHSTAT Investigative D07OAH DRUG__ID D07OAH D07OAH DRUGTYPE Small molecular drug D07OAH DRUGINCH 1S/C17H15N2/c1-18-11-5-7-12-14(18)9-10-16-17(12)13-6-3-4-8-15(13)19(16)2/h3-11H,1-2H3/q+1 D07OAH DRUGINKE IAQYIJJPLDSORP-UHFFFAOYSA-N D07OAH DRUGSMIL CN1C2=C(C3=C(C=C2)[N+](=CC=C3)C)C4=CC=CC=C41 D07OAH HIGHSTAT Investigative D07OAK DRUG__ID D07OAK D07OAK DRUGTYPE Small molecular drug D07OAK DRUGINCH 1S/C27H26N4O4/c1-29(2)12-14(32)13-31-19-10-9-15(35-4)11-17(19)21-23-22(26(33)28-27(23)34)20-16-7-5-6-8-18(16)30(3)24(20)25(21)31/h5-11,14,32H,12-13H2,1-4H3,(H,28,33,34) D07OAK DRUGINKE NYBAPNLYWRMTJL-UHFFFAOYSA-N D07OAK DRUGSMIL CN1C2=CC=CC=C2C3=C4C(=C5C6=C(C=CC(=C6)OC)N(C5=C31)CC(CN(C)C)O)C(=O)NC4=O D07OAK HIGHSTAT Investigative D07OAT DRUG__ID D07OAT D07OAT DRUGTYPE Small molecular drug D07OAT DRUGINCH 1S/C19H25ClN6O/c1-11(2)15(9-27)23-19-24-17(22-14-7-5-6-13(20)8-14)16-18(25-19)26(10-21-16)12(3)4/h5-8,10-12,15,27H,9H2,1-4H3,(H2,22,23,24,25)/t15-/m0/s1 D07OAT DRUGINKE PMXCMJLOPOFPBT-HNNXBMFYSA-N D07OAT DRUGSMIL CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC=C3)Cl D07OAT HIGHSTAT Investigative D07OAV DRUG__ID D07OAV D07OAV DRUGTYPE Small molecular drug D07OAV DRUGINCH 1S/C16H12O2/c1-2-4-12-8-14(7-11(12)3-1)13-5-6-15-16(9-13)18-10-17-15/h1-7,9H,8,10H2 D07OAV DRUGINKE JPKHJTXWUUOHEF-UHFFFAOYSA-N D07OAV DRUGSMIL C1C2=CC=CC=C2C=C1C3=CC4=C(C=C3)OCO4 D07OAV HIGHSTAT Investigative D07OBG DRUG__ID D07OBG D07OBG DRUGTYPE Small molecular drug D07OBG DRUGINCH 1S/C18H16ClNO2/c19-14-9-10-15-16(12-14)18(22)20(17(15)21)11-5-4-8-13-6-2-1-3-7-13/h1-3,6-7,9-10,12H,4-5,8,11H2 D07OBG DRUGINKE QQYWRVQHDFXEFG-UHFFFAOYSA-N D07OBG DRUGSMIL C1=CC=C(C=C1)CCCCN2C(=O)C3=C(C2=O)C=C(C=C3)Cl D07OBG HIGHSTAT Investigative D07OBI DRUG__ID D07OBI D07OBI DRUGTYPE Small molecular drug D07OBI DRUGINCH 1S/C14H23N3O6/c1-14(2)6-5-9(17(14)10(18)7-15)12(21)16-8(13(22)23)3-4-11(19)20/h8-9H,3-7,15H2,1-2H3,(H,16,21)(H,19,20)(H,22,23)/t8-,9+/m0/s1 D07OBI DRUGINKE KNUZCBVWBGSPRA-DTWKUNHWSA-N D07OBI DRUGSMIL CC1(CCC(N1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O)C D07OBI HIGHSTAT Investigative D07OCA DRUG__ID D07OCA D07OCA DRUGTYPE Small molecular drug D07OCA DRUGINCH 1S/C15H13F2N7O2S2/c16-10-2-1-3-11(17)12(10)21-15(27)24-13(18)22-14(23-24)20-8-4-6-9(7-5-8)28(19,25)26/h1-7H,(H,21,27)(H2,19,25,26)(H3,18,20,22,23) D07OCA DRUGINKE ARIOBGGRZJITQX-UHFFFAOYSA-N D07OCA DRUGSMIL C1=CC(=C(C(=C1)F)NC(=S)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F D07OCA HIGHSTAT Investigative D07ODE DRUG__ID D07ODE D07ODE DRUGTYPE Small molecular drug D07ODE DRUGINCH 1S/C10H9N3O/c14-10(9-6-7-11-13-9)12-8-4-2-1-3-5-8/h1-7H,(H,11,13)(H,12,14) D07ODE DRUGINKE WMZYZYFPPQOFKY-UHFFFAOYSA-N D07ODE DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC=NN2 D07ODE HIGHSTAT Investigative D07OKS DRUG__ID D07OKS D07OKS DRUGTYPE Small molecular drug D07OKS DRUGINCH 1S/C17H18O3/c1-18-13-8-4-6-11-10-12-7-5-9-14(19-2)16(12)17(20-3)15(11)13/h4-9,17H,10H2,1-3H3 D07OKS DRUGINKE SEFFBCQMWOLCMQ-UHFFFAOYSA-N D07OKS DRUGSMIL COC1C2=C(CC3=C1C(=CC=C3)OC)C=CC=C2OC D07OKS HIGHSTAT Investigative D07OKT DRUG__ID D07OKT D07OKT DRUGTYPE Small molecular drug D07OKT DRUGINCH 1S/C15H13NO2/c17-15(18)9-10-16-13-7-3-1-5-11(13)12-6-2-4-8-14(12)16/h1-8H,9-10H2,(H,17,18) D07OKT DRUGINKE ZAJJJOMMWPVJMH-UHFFFAOYSA-N D07OKT DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CCC(=O)O D07OKT HIGHSTAT Investigative D07OLL DRUG__ID D07OLL D07OLL DRUGTYPE Small molecular drug D07OLL DRUGINCH 1S/C12H11NO2S/c14-11-2-1-9(7-12(11)15)8-16-10-3-5-13-6-4-10/h1-7,14-15H,8H2 D07OLL DRUGINKE JVOZIFHFAIJCMB-UHFFFAOYSA-N D07OLL DRUGSMIL C1=CC(=C(C=C1CSC2=CC=NC=C2)O)O D07OLL HIGHSTAT Investigative D07OME DRUG__ID D07OME D07OME DRUGTYPE Small molecular drug D07OME DRUGINCH 1S/C7H8O3S/c1-10-6-2-4-7(5-3-6)11(8)9/h2-5H,1H3,(H,8,9)/p-1 D07OME DRUGINKE YVZWQPOTHRMEQW-UHFFFAOYSA-M D07OME DRUGSMIL COC1=CC=C(C=C1)S(=O)[O-] D07OME HIGHSTAT Investigative D07OMS DRUG__ID D07OMS D07OMS DRUGTYPE Small molecular drug D07OMS DRUGINCH 1S/C33H33NO12/c1-6-42-28(35)17-34-32(37)46-33(21-8-10-22(38-2)11-9-21)23(13-19-14-26(39-3)30(41-5)27(15-19)40-4)29(31(36)45-33)20-7-12-24-25(16-20)44-18-43-24/h7-12,14-16H,6,13,17-18H2,1-5H3,(H,34,37) D07OMS DRUGINKE CJWHCEUECPKIGE-UHFFFAOYSA-N D07OMS DRUGSMIL CCOC(=O)CNC(=O)OC1(C(=C(C(=O)O1)C2=CC3=C(C=C2)OCO3)CC4=CC(=C(C(=C4)OC)OC)OC)C5=CC=C(C=C5)OC D07OMS HIGHSTAT Investigative D07OMY DRUG__ID D07OMY D07OMY DRUGTYPE Small molecular drug D07OMY DRUGINCH 1S/C15H13N3O3S/c16-15(19)14-13(9-4-2-1-3-5-9)11-8-10(22(17,20)21)6-7-12(11)18-14/h1-8,18H,(H2,16,19)(H2,17,20,21) D07OMY DRUGINKE QMGMALTZHHCWGS-UHFFFAOYSA-N D07OMY DRUGSMIL C1=CC=C(C=C1)C2=C(NC3=C2C=C(C=C3)S(=O)(=O)N)C(=O)N D07OMY HIGHSTAT Investigative D07ONX DRUG__ID D07ONX D07ONX DRUGTYPE Small molecular drug D07ONX DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6-/m1/s1 D07ONX DRUGINKE WQZGKKKJIJFFOK-VFUOTHLCSA-N D07ONX DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D07ONX HIGHSTAT Investigative D07ONY DRUG__ID D07ONY D07ONY DRUGTYPE Small molecular drug D07ONY DRUGINCH 1S/C11H9ClN2O2/c12-8-3-1-2-7(4-8)5-9-6-10(11(15)16)14-13-9/h1-4,6H,5H2,(H,13,14)(H,15,16) D07ONY DRUGINKE UYMDSFKYOCEPFN-UHFFFAOYSA-N D07ONY DRUGSMIL C1=CC(=CC(=C1)Cl)CC2=CC(=NN2)C(=O)O D07ONY HIGHSTAT Investigative D07OOI DRUG__ID D07OOI D07OOI DRUGTYPE Small molecular drug D07OOI DRUGINCH 1S/C28H34N2O/c1-4-11-25(12-5-1)13-10-18-29-19-21-30(22-20-29)23-24-31-28(26-14-6-2-7-15-26)27-16-8-3-9-17-27/h1-9,11-12,14-17,28H,10,13,18-24H2 D07OOI DRUGINKE RAQPOZGWANIDQT-UHFFFAOYSA-N D07OOI DRUGSMIL C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=CC=C4 D07OOI HIGHSTAT Investigative D07OON DRUG__ID D07OON D07OON DRUGTYPE Small molecular drug D07OON DRUGINCH 1S/C9H16O2/c1-4-9(7(2)3)5-6-11-8(9)10/h7H,4-6H2,1-3H3 D07OON DRUGINKE RQXMJDAZNMCZLO-UHFFFAOYSA-N D07OON DRUGSMIL CCC1(CCOC1=O)C(C)C D07OON HIGHSTAT Investigative D07OOW DRUG__ID D07OOW D07OOW DRUGTYPE Small molecular drug D07OOW DRUGINCH 1S/C12H16N2O4/c1-6-4-14(11(18)13-10(6)17)12-2-8(12)7(5-15)9(16)3-12/h4,7-9,15-16H,2-3,5H2,1H3,(H,13,17,18)/t7-,8-,9-,12-/m0/s1 D07OOW DRUGINKE XRMLXZVSFIBRRJ-PEFMBERDSA-N D07OOW DRUGSMIL CC1=CN(C(=O)NC1=O)C23CC2C(C(C3)O)CO D07OOW HIGHSTAT Investigative D07OQF DRUG__ID D07OQF D07OQF DRUGTYPE Small molecular drug D07OQF DRUGINCH 1S/C17H10BrClO4/c18-9-10-4-5-15-11(6-10)7-14(17(21)23-15)16(20)22-13-3-1-2-12(19)8-13/h1-8H,9H2 D07OQF DRUGINKE RNWNTBMGGUARMR-UHFFFAOYSA-N D07OQF DRUGSMIL C1=CC(=CC(=C1)Cl)OC(=O)C2=CC3=C(C=CC(=C3)CBr)OC2=O D07OQF HIGHSTAT Investigative D07OQX DRUG__ID D07OQX D07OQX DRUGTYPE Small molecular drug D07OQX DRUGINCH 1S/C7H14N2S/c1-2-3-4-6-5-10-7(8)9-6/h6H,2-5H2,1H3,(H2,8,9) D07OQX DRUGINKE LRIFCAXPRJKRBE-UHFFFAOYSA-N D07OQX DRUGSMIL CCCCC1CSC(=N1)N D07OQX HIGHSTAT Investigative D07ORL DRUG__ID D07ORL D07ORL DRUGTYPE Small molecular drug D07ORL DRUGINCH 1S/C21H23FN8O/c1-31-7-6-30(12-14-8-15(22)9-18-16(14)11-24-27-18)21-23-5-4-19(26-21)25-20-10-17(28-29-20)13-2-3-13/h4-5,8-11,13H,2-3,6-7,12H2,1H3,(H,24,27)(H2,23,25,26,28,29) D07ORL DRUGINKE FTGUWURNNBVUBC-UHFFFAOYSA-N D07ORL DRUGSMIL COCCN(CC1=C2C=NNC2=CC(=C1)F)C3=NC=CC(=N3)NC4=NNC(=C4)C5CC5 D07ORL HIGHSTAT Investigative D07ORY DRUG__ID D07ORY D07ORY DRUGTYPE Small molecular drug D07ORY DRUGINCH 1S/C10H8Cl2N2/c11-9-3-8(4-10(12)5-9)6-14-2-1-13-7-14/h1-5,7H,6H2 D07ORY DRUGINKE RNVCIUBPHQDEID-UHFFFAOYSA-N D07ORY DRUGSMIL C1=CN(C=N1)CC2=CC(=CC(=C2)Cl)Cl D07ORY HIGHSTAT Investigative D07OSA DRUG__ID D07OSA D07OSA DRUGTYPE Small molecular drug D07OSA DRUGINCH 1S/C18H28ClN3O4S/c1-26-18-12-16(20)15(19)11-14(18)17(23)4-3-13-5-8-22(9-6-13)10-7-21-27(2,24)25/h11-13,21H,3-10,20H2,1-2H3 D07OSA DRUGINKE UATDVRSFFGFTAI-UHFFFAOYSA-N D07OSA DRUGSMIL COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CCNS(=O)(=O)C)Cl)N D07OSA HIGHSTAT Investigative D07OSK DRUG__ID D07OSK D07OSK DRUGTYPE Small molecular drug D07OSK DRUGINCH 1S/C18H18N2O3/c1-4-23-18(22)16-10(2)15(19-11(16)3)9-13-12-7-5-6-8-14(12)20-17(13)21/h5-9,19H,4H2,1-3H3,(H,20,21)/b13-9- D07OSK DRUGINKE PMUJUSJUVIXDQC-LCYFTJDESA-N D07OSK DRUGSMIL CCOC(=O)C1=C(NC(=C1C)C=C2C3=CC=CC=C3NC2=O)C D07OSK HIGHSTAT Investigative D07OSW DRUG__ID D07OSW D07OSW DRUGTYPE Small molecular drug D07OSW DRUGINCH 1S/C7H9O3PS/c8-11(9,10)7-4-2-1-3-6(7)5-12/h1-4,12H,5H2,(H2,8,9,10) D07OSW DRUGINKE MVLYXNMBKWWFNE-UHFFFAOYSA-N D07OSW DRUGSMIL C1=CC=C(C(=C1)CS)P(=O)(O)O D07OSW HIGHSTAT Investigative D07OVY DRUG__ID D07OVY D07OVY DRUGTYPE Small molecular drug D07OVY DRUGINCH 1S/C7H5IN2/c8-6-1-2-7-5(3-6)4-9-10-7/h1-4H,(H,9,10) D07OVY DRUGINKE CGCHCLICSHIAAM-UHFFFAOYSA-N D07OVY DRUGSMIL C1=CC2=C(C=C1I)C=NN2 D07OVY HIGHSTAT Investigative D07OXC DRUG__ID D07OXC D07OXC DRUGTYPE Small molecular drug D07OXC DRUGINCH 1S/C35H35FN4O5/c1-39-34(19-24-7-4-3-5-8-24)38-23-27(35(39)41)25-9-10-31(28(36)20-25)45-30-11-12-37-29-22-33(32(42-2)21-26(29)30)44-16-6-13-40-14-17-43-18-15-40/h3-5,7-12,20-23H,6,13-19H2,1-2H3 D07OXC DRUGINKE PEGWVOKOYYAQEV-UHFFFAOYSA-N D07OXC DRUGSMIL CN1C(=NC=C(C1=O)C2=CC(=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OCCCN5CCOCC5)OC)F)CC6=CC=CC=C6 D07OXC HIGHSTAT Investigative D07PAF DRUG__ID D07PAF D07PAF DRUGTYPE Small molecular drug D07PAF DRUGINCH 1S/C16H16N2O4/c1-11-5-3-6-12(9-11)18-16(20)22-14-8-4-7-13(10-14)17-15(19)21-2/h3-10H,1-2H3,(H,17,19)(H,18,20) D07PAF DRUGINKE IDOWTHOLJBTAFI-UHFFFAOYSA-N D07PAF DRUGSMIL CC1=CC(=CC=C1)NC(=O)OC2=CC=CC(=C2)NC(=O)OC D07PAF HIGHSTAT Investigative D07PAT DRUG__ID D07PAT D07PAT DRUGTYPE Small molecular drug D07PAT DRUGINCH 1S/C16H24ClN/c1-2-3-6-15(16-7-4-5-12-18-16)13-8-10-14(17)11-9-13/h8-11,15-16,18H,2-7,12H2,1H3 D07PAT DRUGINKE ZYPXTTXHMBCKFT-UHFFFAOYSA-N D07PAT DRUGSMIL CCCCC(C1CCCCN1)C2=CC=C(C=C2)Cl D07PAT HIGHSTAT Investigative D07PCS DRUG__ID D07PCS D07PCS DRUGTYPE Small molecular drug D07PCS DRUGINCH 1S/C14H15NO2/c1-10(14(16)15(2)17)12-8-7-11-5-3-4-6-13(11)9-12/h3-10,17H,1-2H3 D07PCS DRUGINKE HMSPAZCQILPMIK-UHFFFAOYSA-N D07PCS DRUGSMIL CC(C1=CC2=CC=CC=C2C=C1)C(=O)N(C)O D07PCS HIGHSTAT Investigative D07PHS DRUG__ID D07PHS D07PHS DRUGTYPE Small molecular drug D07PHS DRUGINCH 1S/C112H150N24O38S2/c1-55(2)41-69(122-103(165)77(49-89(149)150)131-106(168)79(51-91(153)154)129-98(160)70(42-59-19-10-8-11-20-59)123-105(167)78(50-90(151)152)130-100(162)73(45-62-52-115-65-24-15-14-23-64(62)65)126-96(158)67(34-39-175-6)118-58(5)139)97(159)127-74(46-84(113)141)101(163)125-72(43-60-21-12-9-13-22-60)107(169)133-92(57(4)138)109(171)116-53-85(142)119-68(35-40-176-7)110(172)136-38-18-27-83(136)112(174)135-37-17-26-82(135)108(170)117-56(3)94(156)121-75(47-87(145)146)102(164)120-66(32-33-86(143)144)95(157)128-76(48-88(147)148)104(166)124-71(44-61-28-30-63(140)31-29-61)99(161)132-80(54-137)111(173)134-36-16-25-81(134)93(114)155/h8-15,19-24,28-31,52,55-57,66-83,92,115,137-138,140H,16-18,25-27,32-51,53-54H2,1-7H3,(H2,113,141)(H2,114,155)(H,116,171)(H,117,170)(H,118,139)(H,119,142)(H,120,164)(H,121,156)(H,122,165)(H,123,167)(H,124,166)(H,125,163)(H,126,158)(H,127,159)(H,128,157)(H,129,160)(H,130,162)(H,131,168)(H,132,161)(H,133,169)(H,143,144)(H,145,146)(H,147,148)(H,149,150)(H,151,152)(H,153,154) D07PHS DRUGINKE XKTZWUACRZHVAN-UHFFFAOYSA-N D07PHS DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCSC)C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CO)C(=O)N5CCCC5C(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C(CCSC)NC(=O)C D07PHS HIGHSTAT Investigative D07PHT DRUG__ID D07PHT D07PHT DRUGTYPE Small molecular drug D07PHT DRUGINCH 1S/C18H16Cl2N2OS/c1-23-14-4-2-13(3-5-14)18(11-22-9-8-21-12-22)24-15-6-7-16(19)17(20)10-15/h2-10,12,18H,11H2,1H3 D07PHT DRUGINKE RUUOJGYNYNPAKU-UHFFFAOYSA-N D07PHT DRUGSMIL COC1=CC=C(C=C1)C(CN2C=CN=C2)SC3=CC(=C(C=C3)Cl)Cl D07PHT HIGHSTAT Investigative D07PHV DRUG__ID D07PHV D07PHV DRUGTYPE Small molecular drug D07PHV DRUGINCH 1S/C17H11BrN2O2/c18-13-6-5-11(9-20-8-7-19-10-20)17-15(13)16(21)12-3-1-2-4-14(12)22-17/h1-8,10H,9H2 D07PHV DRUGINKE DPCAMTPMSZHJLT-UHFFFAOYSA-N D07PHV DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3O2)CN4C=CN=C4)Br D07PHV HIGHSTAT Investigative D07PHW DRUG__ID D07PHW D07PHW DRUGTYPE Small molecular drug D07PHW DRUGINCH 1S/C9H17N3O2/c1-2-6(10)9(14)12-5-3-4-7(12)8(11)13/h6-7H,2-5,10H2,1H3,(H2,11,13)/t6-,7-/m0/s1 D07PHW DRUGINKE JNTYXKIFNYMZLM-BQBZGAKWSA-N D07PHW DRUGSMIL CCC(C(=O)N1CCCC1C(=O)N)N D07PHW HIGHSTAT Investigative D07PKH DRUG__ID D07PKH D07PKH DRUGTYPE Small molecular drug D07PKH DRUGINCH 1S/C23H30N2O/c1-17-11-10-12-18(2)20(17)22(26)24-21(19-13-6-5-7-14-19)23(25(3)4)15-8-9-16-23/h5-7,10-14,21H,8-9,15-16H2,1-4H3,(H,24,26)/t21-/m0/s1 D07PKH DRUGINKE BMXRRRIDMAIEKX-NRFANRHFSA-N D07PKH DRUGSMIL CC1=C(C(=CC=C1)C)C(=O)NC(C2=CC=CC=C2)C3(CCCC3)N(C)C D07PKH HIGHSTAT Investigative D07PLS DRUG__ID D07PLS D07PLS DRUGTYPE Small molecular drug D07PLS DRUGINCH 1S/C20H24FNO3/c1-2-3-4-5-8-15-24-17-13-11-16(12-14-17)22-20(23)25-19-10-7-6-9-18(19)21/h6-7,9-14H,2-5,8,15H2,1H3,(H,22,23) D07PLS DRUGINKE SHLSOZYYUDUBRA-UHFFFAOYSA-N D07PLS DRUGSMIL CCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D07PLS HIGHSTAT Investigative D07PMP DRUG__ID D07PMP D07PMP DRUGTYPE Small molecular drug D07PMP DRUGINCH 1S/C29H34N10O3/c1-3-39-27-24(34-35-39)26(37-16-18-42-19-17-37)32-25(33-27)20-4-8-22(9-5-20)30-29(41)31-23-10-6-21(7-11-23)28(40)38-14-12-36(2)13-15-38/h4-11H,3,12-19H2,1-2H3,(H2,30,31,41) D07PMP DRUGINKE ZAXFYGBKZSQBIV-UHFFFAOYSA-N D07PMP DRUGSMIL CCN1C2=C(C(=NC(=N2)C3=CC=C(C=C3)NC(=O)NC4=CC=C(C=C4)C(=O)N5CCN(CC5)C)N6CCOCC6)N=N1 D07PMP HIGHSTAT Investigative D07PNA DRUG__ID D07PNA D07PNA DRUGTYPE Small molecular drug D07PNA DRUGINCH 1S/C19H30N2O3S/c1-2-3-4-5-6-7-8-9-19(22)21-17-12-15-10-11-18(25(20,23)24)14-16(15)13-17/h10-11,14,17H,2-9,12-13H2,1H3,(H,21,22)(H2,20,23,24) D07PNA DRUGINKE CWOKTKYGRFERNA-UHFFFAOYSA-N D07PNA DRUGSMIL CCCCCCCCCC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D07PNA HIGHSTAT Investigative D07PNM DRUG__ID D07PNM D07PNM DRUGTYPE Small molecular drug D07PNM DRUGINCH 1S/C2H3NO/c1-3-2-4/h1H3 D07PNM DRUGINKE HAMGRBXTJNITHG-UHFFFAOYSA-N D07PNM DRUGSMIL CN=C=O D07PNM HIGHSTAT Investigative D07PPK DRUG__ID D07PPK D07PPK DRUGTYPE Small molecular drug D07PPK DRUGINCH 1S/C28H28N4O/c33-27(30-25-14-8-3-9-15-25)31-19-16-28(17-20-31,24-12-6-2-7-13-24)26-29-18-21-32(26)22-23-10-4-1-5-11-23/h1-15,18,21H,16-17,19-20,22H2,(H,30,33) D07PPK DRUGINKE SSXWGBNGZDJNOZ-UHFFFAOYSA-N D07PPK DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)C3=NC=CN3CC4=CC=CC=C4)C(=O)NC5=CC=CC=C5 D07PPK HIGHSTAT Investigative D07PPM DRUG__ID D07PPM D07PPM DRUGTYPE Small molecular drug D07PPM DRUGINCH 1S/C16H14Cl3N5O/c1-3-8-6-24-15(20-8)12-14(23(2)16(24)25)22-13(21-12)9-4-7(17)5-10(18)11(9)19/h4-5,8,20H,3,6H2,1-2H3/t8-/m1/s1 D07PPM DRUGINKE QYCXKYOTLRUVFA-MRVPVSSYSA-N D07PPM DRUGSMIL CCC1CN2C(=C3C(=NC(=N3)C4=C(C(=CC(=C4)Cl)Cl)Cl)N(C2=O)C)N1 D07PPM HIGHSTAT Investigative D07PSF DRUG__ID D07PSF D07PSF DRUGTYPE Small molecular drug D07PSF DRUGINCH 1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18-,19+/m1/s1 D07PSF DRUGINKE IXAQOQZEOGMIQS-JEWNPAEBSA-N D07PSF DRUGSMIL CCCCCC(C=CC=CC=CC=CC(C(CCCC(=O)O)O)O)O D07PSF HIGHSTAT Investigative D07PSG DRUG__ID D07PSG D07PSG DRUGTYPE Small molecular drug D07PSG DRUGINCH 1S/C18H24N2O/c1-3-9-16(10-4-1)17-15-19-18(21-17)11-5-8-14-20-12-6-2-7-13-20/h1,3-4,9-10,15H,2,5-8,11-14H2 D07PSG DRUGINKE XJINDZCEGQZNLD-UHFFFAOYSA-N D07PSG DRUGSMIL C1CCN(CC1)CCCCC2=NC=C(O2)C3=CC=CC=C3 D07PSG HIGHSTAT Investigative D07PSW DRUG__ID D07PSW D07PSW DRUGTYPE Small molecular drug D07PSW DRUGINCH 1S/C12H12N4/c13-12(14)16-11-8-10(6-7-15-11)9-4-2-1-3-5-9/h1-8H,(H4,13,14,15,16) D07PSW DRUGINKE LQYVUDQYWIIZAV-UHFFFAOYSA-N D07PSW DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC=C2)N=C(N)N D07PSW HIGHSTAT Investigative D07PTD DRUG__ID D07PTD D07PTD DRUGTYPE Small molecular drug D07PTD DRUGINCH 1S/C17H17N3O/c1-2-6-16(21)18-17-14-10-9-13(11-15(14)19-20-17)12-7-4-3-5-8-12/h3-5,7-11H,2,6H2,1H3,(H2,18,19,20,21) D07PTD DRUGINKE BVIWKIBBSPTOPO-UHFFFAOYSA-N D07PTD DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=CC=C3 D07PTD HIGHSTAT Investigative D07PXR DRUG__ID D07PXR D07PXR DRUGTYPE Small molecular drug D07PXR DRUGINCH 1S/C12H8FN3/c13-8-4-5-9-11(7-8)16-12(15-9)10-3-1-2-6-14-10/h1-7H,(H,15,16) D07PXR DRUGINKE AUSVDSQFCRIAEX-UHFFFAOYSA-N D07PXR DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(N2)C=C(C=C3)F D07PXR HIGHSTAT Investigative D07PYC DRUG__ID D07PYC D07PYC DRUGTYPE Small molecular drug D07PYC DRUGINCH 1S/C15H13N/c1-2-6-15-13(5-1)7-8-14(15)10-12-4-3-9-16-11-12/h1-6,9-11H,7-8H2/b14-10- D07PYC DRUGINKE WDSJJUYCBHIJRT-UVTDQMKNSA-N D07PYC DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=CC=CC=C31 D07PYC HIGHSTAT Investigative D07PYV DRUG__ID D07PYV D07PYV DRUGTYPE Small molecular drug D07PYV DRUGINCH 1S/C5H6N2/c6-5-3-1-2-4-7-5/h1-4H,(H2,6,7) D07PYV DRUGINKE ICSNLGPSRYBMBD-UHFFFAOYSA-N D07PYV DRUGSMIL C1=CC=NC(=C1)N D07PYV HIGHSTAT Investigative D07PZF DRUG__ID D07PZF D07PZF DRUGTYPE Small molecular drug D07PZF DRUGINCH 1S/C14H11Br2N3S/c15-11-5-1-3-9(7-11)13(18-19-14(17)20)10-4-2-6-12(16)8-10/h1-8H,(H3,17,19,20) D07PZF DRUGINKE DLNPHAFNMNLYRY-UHFFFAOYSA-N D07PZF DRUGSMIL C1=CC(=CC(=C1)Br)C(=NNC(=S)N)C2=CC(=CC=C2)Br D07PZF HIGHSTAT Investigative D07PZQ DRUG__ID D07PZQ D07PZQ DRUGTYPE Small molecular drug D07PZQ DRUGINCH 1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1 D07PZQ DRUGINKE BZQFBWGGLXLEPQ-REOHCLBHSA-N D07PZQ DRUGSMIL C(C(C(=O)O)N)OP(=O)(O)O D07PZQ HIGHSTAT Investigative D07QAX DRUG__ID D07QAX D07QAX DRUGTYPE Small molecular drug D07QAX DRUGINCH 1S/C25H26F2N2O4/c1-15(2)25-28-23(16-3-7-18(26)8-4-16)24(17-5-9-19(27)10-6-17)29(25)12-11-20(30)13-21(31)14-22(32)33/h3-12,15,20-21,30-31H,13-14H2,1-2H3,(H,32,33)/b12-11+/t20-,21+/m0/s1 D07QAX DRUGINKE GQOQQDINYJTQDY-LBNTZDJNSA-N D07QAX DRUGSMIL CC(C)C1=NC(=C(N1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D07QAX HIGHSTAT Investigative D07QBQ DRUG__ID D07QBQ D07QBQ DRUGTYPE Small molecular drug D07QBQ DRUGINCH 1S/C8H5ClN2O2/c9-4-1-2-5-6(3-4)11-8(13)7(12)10-5/h1-3H,(H,10,12)(H,11,13) D07QBQ DRUGINKE RNOLFZACEWWIHP-UHFFFAOYSA-N D07QBQ DRUGSMIL C1=CC2=C(C=C1Cl)NC(=O)C(=O)N2 D07QBQ HIGHSTAT Investigative D07QCC DRUG__ID D07QCC D07QCC DRUGTYPE Small molecular drug D07QCC DRUGINCH 1S/C14H16ClNS/c1-3-12-10-8-16(2)7-6-9-11(15)4-5-13(17-12)14(9)10/h4-5H,3,6-8H2,1-2H3 D07QCC DRUGINKE BAAUEDJUTZLMAN-UHFFFAOYSA-N D07QCC DRUGSMIL CCC1=C2CN(CCC3=C(C=CC(=C32)S1)Cl)C D07QCC HIGHSTAT Investigative D07QDU DRUG__ID D07QDU D07QDU DRUGTYPE Small molecular drug D07QDU DRUGINCH 1S/C33H36N2/c1-5-14-28(15-6-1)32(29-16-7-2-8-17-29)22-13-23-34-24-26-35(27-25-34)33(30-18-9-3-10-19-30)31-20-11-4-12-21-31/h1-12,14-21,32-33H,13,22-27H2 D07QDU DRUGINKE MICPQZJRSOUTGV-UHFFFAOYSA-N D07QDU DRUGSMIL C1CN(CCN1CCCC(C2=CC=CC=C2)C3=CC=CC=C3)C(C4=CC=CC=C4)C5=CC=CC=C5 D07QDU HIGHSTAT Investigative D07QEH DRUG__ID D07QEH D07QEH DRUGTYPE Small molecular drug D07QEH DRUGINCH 1S/C20H24O7/c1-8-9-5-13-19(7-10(9)25-15(8)23)12(21)6-11(18(2,3)4)20(19)14(22)16(24)27-17(20)26-13/h5,10-12,14,17,21-22H,6-7H2,1-4H3/t10-,11-,12-,14-,17+,19-,20-/m0/s1 D07QEH DRUGINKE SPCYYGUOUYOYPX-FUDPCSHESA-N D07QEH DRUGSMIL CC1=C2C=C3C4(CC2OC1=O)C(CC(C45C(C(=O)OC5O3)O)C(C)(C)C)O D07QEH HIGHSTAT Investigative D07QFN DRUG__ID D07QFN D07QFN DRUGTYPE Small molecular drug D07QFN DRUGINCH 1S/C15H13NO2/c1-11-3-6-13(7-4-11)18-14-8-5-12(10-16)9-15(14)17-2/h3-9H,1-2H3 D07QFN DRUGINKE YKRUICLEGSVULK-UHFFFAOYSA-N D07QFN DRUGSMIL CC1=CC=C(C=C1)OC2=C(C=C(C=C2)C#N)OC D07QFN HIGHSTAT Investigative D07QGN DRUG__ID D07QGN D07QGN DRUGTYPE Small molecular drug D07QGN DRUGINCH 1S/C15H10N4O/c20-15-16-12-9-5-4-8-11(12)14-17-13(18-19(14)15)10-6-2-1-3-7-10/h1-9H,(H,16,20) D07QGN DRUGINKE AXPGZURVLRWNBR-UHFFFAOYSA-N D07QGN DRUGSMIL C1=CC=C(C=C1)C2=NN3C(=N2)C4=CC=CC=C4NC3=O D07QGN HIGHSTAT Investigative D07QGQ DRUG__ID D07QGQ D07QGQ DRUGTYPE Small molecular drug D07QGQ DRUGINCH 1S/C41H63N5O9/c1-4-5-6-7-8-9-10-11-12-13-14-25-36(29(2)37(49)43-32-22-17-19-26-42-38(32)50)55-41(52)33(23-18-20-27-46(53)30(3)47)44-39(51)34-28-54-40(45-34)31-21-15-16-24-35(31)48/h15-16,21,24,28-29,32-33,36,48,53H,4-14,17-20,22-23,25-27H2,1-3H3,(H,42,50)(H,43,49)(H,44,51) D07QGQ DRUGINKE PIFYJYLXAXDUEB-UHFFFAOYSA-N D07QGQ DRUGSMIL CCCCCCCCCCCCCC(C(C)C(=O)NC1CCCCNC1=O)OC(=O)C(CCCCN(C(=O)C)O)NC(=O)C2=COC(=N2)C3=CC=CC=C3O D07QGQ HIGHSTAT Investigative D07QGX DRUG__ID D07QGX D07QGX DRUGTYPE Small molecular drug D07QGX DRUGINCH 1S/C8H7F2NO2/c9-4-1-2-5(6(10)3-4)7(11)8(12)13/h1-3,7H,11H2,(H,12,13) D07QGX DRUGINKE COIWYFIMAXMSKX-UHFFFAOYSA-N D07QGX DRUGSMIL C1=CC(=C(C=C1F)F)C(C(=O)O)N D07QGX HIGHSTAT Investigative D07QHM DRUG__ID D07QHM D07QHM DRUGTYPE Small molecular drug D07QHM DRUGINCH 1S/C7H5O2.Hg.H2O/c8-7(9)6-4-2-1-3-5-6;;/h2-5H,(H,8,9);;1H2 D07QHM DRUGINKE NBCQBGBECVUZMK-UHFFFAOYSA-N D07QHM DRUGSMIL C1=CC(=CC=C1C(=O)O)[Hg].O D07QHM HIGHSTAT Investigative D07QIU DRUG__ID D07QIU D07QIU DRUGTYPE Small molecular drug D07QIU DRUGINCH 1S/C14H14N2O3S/c1-19-13-6-2-11(3-7-13)10-16-12-4-8-14(9-5-12)20(15,17)18/h2-10H,1H3,(H2,15,17,18) D07QIU DRUGINKE MLUHDVSELBSKPI-UHFFFAOYSA-N D07QIU DRUGSMIL COC1=CC=C(C=C1)C=NC2=CC=C(C=C2)S(=O)(=O)N D07QIU HIGHSTAT Investigative D07QJD DRUG__ID D07QJD D07QJD DRUGTYPE Small molecular drug D07QJD DRUGINCH 1S/C17H28N8O6/c18-17(19)20-3-1-2-9-14(29)22-7-12(26)24-11(5-13(27)28)16(31)23-8-4-10(21-6-8)15(30)25-9/h8-11,21H,1-7H2,(H,22,29)(H,23,31)(H,24,26)(H,25,30)(H,27,28)(H4,18,19,20)/t8-,9+,10+,11+/m1/s1 D07QJD DRUGINKE RLABYQGJZRFBJA-RCWTZXSCSA-N D07QJD DRUGSMIL C1C2CNC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D07QJD HIGHSTAT Investigative D07QJJ DRUG__ID D07QJJ D07QJJ DRUGTYPE Small molecular drug D07QJJ DRUGINCH 1S/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8H D07QJJ DRUGINKE YCIMNLLNPGFGHC-UHFFFAOYSA-N D07QJJ DRUGSMIL C1=CC=C(C(=C1)O)O D07QJJ HIGHSTAT Investigative D07QJQ DRUG__ID D07QJQ D07QJQ DRUGTYPE Small molecular drug D07QJQ DRUGINCH 1S/C12H9NS/c1-10-13-12(9-14-10)8-7-11-5-3-2-4-6-11/h2-6,9H,1H3 D07QJQ DRUGINKE NZHWBWVBWDOSJY-UHFFFAOYSA-N D07QJQ DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CC=C2 D07QJQ HIGHSTAT Investigative D07QLZ DRUG__ID D07QLZ D07QLZ DRUGTYPE Small molecular drug D07QLZ DRUGINCH 1S/C46H59N9O6/c1-26(2)19-36(41(48)56)51-43(58)37(20-27(3)4)53-46(61)40(23-31-25-50-35-18-12-10-16-33(31)35)55-44(59)38(21-29-13-7-6-8-14-29)54-45(60)39(52-42(57)28(5)47)22-30-24-49-34-17-11-9-15-32(30)34/h6-18,24-28,36-40,49-50H,19-23,47H2,1-5H3,(H2,48,56)(H,51,58)(H,52,57)(H,53,61)(H,54,60)(H,55,59)/t28-,36-,37-,38-,39+,40+/m0/s1 D07QLZ DRUGINKE SHJLXMWODYAZLK-JKHVPLMQSA-N D07QLZ DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(C)N D07QLZ HIGHSTAT Investigative D07QMR DRUG__ID D07QMR D07QMR DRUGTYPE Small molecular drug D07QMR DRUGINCH 1S/C26H30N2O/c29-26(25-15-8-13-22-12-4-5-14-24(22)25)27-23-16-19-28(20-17-23)18-7-6-11-21-9-2-1-3-10-21/h1-5,8-10,12-15,23H,6-7,11,16-20H2,(H,27,29) D07QMR DRUGINKE JATDEOORDLHCRO-UHFFFAOYSA-N D07QMR DRUGSMIL C1CN(CCC1NC(=O)C2=CC=CC3=CC=CC=C32)CCCCC4=CC=CC=C4 D07QMR HIGHSTAT Investigative D07QMY DRUG__ID D07QMY D07QMY DRUGTYPE Small molecular drug D07QMY DRUGINCH 1S/C17H25ClN2O3/c1-11-6-12(2)10-20(9-11)4-5-23-17(21)13-7-14(18)15(19)8-16(13)22-3/h7-8,11-12H,4-6,9-10,19H2,1-3H3 D07QMY DRUGINKE BUEFUOFMOXJXAR-UHFFFAOYSA-N D07QMY DRUGSMIL CC1CC(CN(C1)CCOC(=O)C2=CC(=C(C=C2OC)N)Cl)C D07QMY HIGHSTAT Investigative D07QNN DRUG__ID D07QNN D07QNN DRUGTYPE Small molecular drug D07QNN DRUGINCH 1S/C14H19NO/c16-14(11-12-7-3-1-4-8-12)15-13-9-5-2-6-10-13/h1,3-4,7-8,13H,2,5-6,9-11H2,(H,15,16) D07QNN DRUGINKE ZFEBPJQSSNUJGT-UHFFFAOYSA-N D07QNN DRUGSMIL C1CCC(CC1)NC(=O)CC2=CC=CC=C2 D07QNN HIGHSTAT Investigative D07QOG DRUG__ID D07QOG D07QOG DRUGTYPE Small molecular drug D07QOG DRUGINCH 1S/C17H19NO3/c19-12-15-13-21-17(18-15)16(20)11-7-2-1-4-8-14-9-5-3-6-10-14/h3,5-6,9-10,12-13H,1-2,4,7-8,11H2 D07QOG DRUGINKE CLWIISIKUDVYMX-UHFFFAOYSA-N D07QOG DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)C=O D07QOG HIGHSTAT Investigative D07QPA DRUG__ID D07QPA D07QPA DRUGTYPE Small molecular drug D07QPA DRUGINCH 1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+ D07QPA DRUGINKE MBWXNTAXLNYFJB-LKUDQCMESA-N D07QPA DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C D07QPA HIGHSTAT Investigative D07QPV DRUG__ID D07QPV D07QPV DRUGTYPE Small molecular drug D07QPV DRUGINCH 1S/C19H14FN3O3/c20-14-6-5-11(10-16(14)23-17(24)7-8-18(23)25)9-15-12-3-1-2-4-13(12)19(26)22-21-15/h1-6,10H,7-9H2,(H,22,26) D07QPV DRUGINKE YQSZNYLPVBOGPO-UHFFFAOYSA-N D07QPV DRUGSMIL C1CC(=O)N(C1=O)C2=C(C=CC(=C2)CC3=NNC(=O)C4=CC=CC=C43)F D07QPV HIGHSTAT Investigative D07QQY DRUG__ID D07QQY D07QQY DRUGTYPE Small molecular drug D07QQY DRUGINCH 1S/C20H31NO3/c1-13(2)8-15-12-21-7-6-14-9-18(23-4)19(24-5)10-16(14)20(21,3)11-17(15)22/h9-10,13,15,17,22H,6-8,11-12H2,1-5H3/t15-,17-,20-/m0/s1/i4-1 D07QQY DRUGINKE QJPLBORGTBURBF-VEFADGFBSA-N D07QQY DRUGSMIL CC(C)CC1CN2CCC3=CC(=C(C=C3C2(CC1O)C)OC)OC D07QQY HIGHSTAT Investigative D07QSM DRUG__ID D07QSM D07QSM DRUGTYPE Small molecular drug D07QSM DRUGINCH 1S/C19H35NO4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-17(21)19(23)20-16-18(22)24-2/h3-16H2,1-2H3,(H,20,23) D07QSM DRUGINKE PZEVUHTWLYMLFR-UHFFFAOYSA-N D07QSM DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCC(=O)OC D07QSM HIGHSTAT Investigative D07QSV DRUG__ID D07QSV D07QSV DRUGTYPE Small molecular drug D07QSV DRUGINCH 1S/C5H10O3/c1-4(6)2-3-5(7)8/h4,6H,2-3H2,1H3,(H,7,8) D07QSV DRUGINKE FMHKPLXYWVCLME-UHFFFAOYSA-N D07QSV DRUGSMIL CC(CCC(=O)O)O D07QSV HIGHSTAT Investigative D07QUV DRUG__ID D07QUV D07QUV DRUGTYPE Small molecular drug D07QUV DRUGINCH 1S/C25H42O2/c1-4-5-6-7-8-17-25(2,3)22-14-11-21(12-15-22)24-19-23(27)16-13-20(24)10-9-18-26/h11-12,14-15,20,23-24,26-27H,4-10,13,16-19H2,1-3H3/t20-,23-,24-/m1/s1 D07QUV DRUGINKE RTPUPNNHNNHDQM-AGILITTLSA-N D07QUV DRUGSMIL CCCCCCCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D07QUV HIGHSTAT Investigative D07QUY DRUG__ID D07QUY D07QUY DRUGTYPE Small molecular drug D07QUY DRUGINCH 1S/C35H37N5O5/c1-45-25-15-13-23(14-16-25)18-28-32(41)37-29(20-24-21-36-27-11-6-5-10-26(24)27)33(42)39-30(19-22-8-3-2-4-9-22)35(44)40-17-7-12-31(40)34(43)38-28/h2-6,8-11,13-16,21,28-31,36H,7,12,17-20H2,1H3,(H,37,41)(H,38,43)(H,39,42)/t28-,29+,30-,31+/m0/s1 D07QUY DRUGINKE UWYXKSHDABLYGG-XFBWMNOSSA-N D07QUY DRUGSMIL COC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N2)CC4=CC=CC=C4)CC5=CNC6=CC=CC=C65 D07QUY HIGHSTAT Investigative D07QYU DRUG__ID D07QYU D07QYU DRUGTYPE Small molecular drug D07QYU DRUGINCH 1S/C14H14N3O12PS2/c1-7-13(19)9(5-18)10(6-29-30(20,21)22)14(15-7)17-16-11-3-2-8(31(23,24)25)4-12(11)32(26,27)28/h2-5,19H,6H2,1H3,(H2,20,21,22)(H,23,24,25)(H,26,27,28) D07QYU DRUGINKE PNFZSRRRZNXSMF-UHFFFAOYSA-N D07QYU DRUGSMIL CC1=C(C(=C(C(=N1)N=NC2=C(C=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)COP(=O)(O)O)C=O)O D07QYU HIGHSTAT Investigative D07RDB DRUG__ID D07RDB D07RDB DRUGTYPE Small molecular drug D07RDB DRUGINCH 1S/C18H19F2NO3/c1-2-3-10-23-15-7-4-13(5-8-15)12-21-18(22)24-17-9-6-14(19)11-16(17)20/h4-9,11H,2-3,10,12H2,1H3,(H,21,22) D07RDB DRUGINKE OHKUODJKULFCPB-UHFFFAOYSA-N D07RDB DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)OC2=C(C=C(C=C2)F)F D07RDB HIGHSTAT Investigative D07RDV DRUG__ID D07RDV D07RDV DRUGTYPE Small molecular drug D07RDV DRUGINCH 1S/C39H57N7O9/c1-9-25(6)32(36(50)43-31(24(4)5)37(51)54-8)44-38(52)46-45-35(49)30(21-27-16-12-10-13-17-27)42-34(48)29(20-23(2)3)41-33(47)26(7)40-39(53)55-22-28-18-14-11-15-19-28/h10-19,23-26,29-32H,9,20-22H2,1-8H3,(H,40,53)(H,41,47)(H,42,48)(H,43,50)(H,45,49)(H2,44,46,52) D07RDV DRUGINKE ONHOINLCWRTXCR-UHFFFAOYSA-N D07RDV DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2 D07RDV HIGHSTAT Investigative D07REK DRUG__ID D07REK D07REK DRUGTYPE Small molecular drug D07REK DRUGINCH 1S/C12H10O3/c1-2-15-11-7-10(13)12(14)9-6-4-3-5-8(9)11/h3-7H,2H2,1H3 D07REK DRUGINKE XPXODXIULRDWNT-UHFFFAOYSA-N D07REK DRUGSMIL CCOC1=CC(=O)C(=O)C2=CC=CC=C21 D07REK HIGHSTAT Investigative D07RFM DRUG__ID D07RFM D07RFM DRUGTYPE Small molecular drug D07RFM DRUGINCH 1S/C17H21NO/c19-17-10-8-16(9-11-17)12-14-18-13-4-7-15-5-2-1-3-6-15/h1-3,5-6,8-11,18-19H,4,7,12-14H2 D07RFM DRUGINKE SJSNYEZWGGSNKY-UHFFFAOYSA-N D07RFM DRUGSMIL C1=CC=C(C=C1)CCCNCCC2=CC=C(C=C2)O D07RFM HIGHSTAT Investigative D07RGP DRUG__ID D07RGP D07RGP DRUGTYPE Small molecular drug D07RGP DRUGINCH 1S/C47H76O18/c1-21(48)61-34-25(52)19-60-40(35(34)64-39-33(56)31(54)24(51)18-59-39)63-28-10-12-47-20-46(47)14-13-43(6)36(45(8)11-9-29(65-45)42(4,5)57)22(49)16-44(43,7)27(46)15-26(37(47)41(28,2)3)62-38-32(55)30(53)23(50)17-58-38/h22-40,49-57H,9-20H2,1-8H3/t22-,23+,24-,25+,26-,27-,28-,29+,30-,31-,32+,33+,34-,35+,36-,37-,38-,39-,40-,43+,44-,45+,46-,47+/m0/s1 D07RGP DRUGINKE BTTRQTJYXLOSMR-WEWBRACISA-N D07RGP DRUGSMIL CC(=O)OC1C(COC(C1OC2C(C(C(CO2)O)O)O)OC3CCC45CC46CCC7(C(C(CC7(C6CC(C5C3(C)C)OC8C(C(C(CO8)O)O)O)C)O)C9(CCC(O9)C(C)(C)O)C)C)O D07RGP HIGHSTAT Investigative D07RGV DRUG__ID D07RGV D07RGV DRUGTYPE Small molecular drug D07RGV DRUGINCH 1S/C21H24O7/c1-7-10-9(2)8-11-12(14(10)22)16(24)17-13(15(11)23)20(3,4)18(25)21(5,28-17)19(26)27-6/h8,13,17,22H,7H2,1-6H3 D07RGV DRUGINKE OHWPXNCKGWEEQM-UHFFFAOYSA-N D07RGV DRUGSMIL CCC1=C(C2=C(C=C1C)C(=O)C3C(C2=O)OC(C(=O)C3(C)C)(C)C(=O)OC)O D07RGV HIGHSTAT Investigative D07RIQ DRUG__ID D07RIQ D07RIQ DRUGTYPE Small molecular drug D07RIQ DRUGINCH 1S/C13H16N2O/c1-8-13-10(5-6-14-8)11-7-9(16-2)3-4-12(11)15-13/h3-4,7-8,14-15H,5-6H2,1-2H3 D07RIQ DRUGINKE RDUORFDQRFHYBF-UHFFFAOYSA-N D07RIQ DRUGSMIL CC1C2=C(CCN1)C3=C(N2)C=CC(=C3)OC D07RIQ HIGHSTAT Investigative D07RLD DRUG__ID D07RLD D07RLD DRUGTYPE Small molecular drug D07RLD DRUGINCH 1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1 D07RLD DRUGINKE KHWCHTKSEGGWEX-RRKCRQDMSA-N D07RLD DRUGSMIL C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O D07RLD HIGHSTAT Investigative D07RLW DRUG__ID D07RLW D07RLW DRUGTYPE Small molecular drug D07RLW DRUGINCH 1S/C11H11NO/c12-7-9-3-1-2-8-6-10(13)4-5-11(8)9/h1-6,13H,7,12H2 D07RLW DRUGINKE PFFJJFRURKJERG-UHFFFAOYSA-N D07RLW DRUGSMIL C1=CC2=C(C=CC(=C2)O)C(=C1)CN D07RLW HIGHSTAT Investigative D07ROK DRUG__ID D07ROK D07ROK DRUGTYPE Small molecular drug D07ROK DRUGINCH 1S/C16H22N2O/c1-2-6-13(5-1)17-10-4-12-19-16-8-3-7-15-14(16)9-11-18-15/h3,7-9,11,13,17-18H,1-2,4-6,10,12H2 D07ROK DRUGINKE IYOLOIDWTZSJFT-UHFFFAOYSA-N D07ROK DRUGSMIL C1CCC(C1)NCCCOC2=CC=CC3=C2C=CN3 D07ROK HIGHSTAT Investigative D07RPV DRUG__ID D07RPV D07RPV DRUGTYPE Small molecular drug D07RPV DRUGINCH 1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29) D07RPV DRUGINKE NBHPRWLFLUBAIE-UHFFFAOYSA-N D07RPV DRUGSMIL C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCNC(=O)C4=CC=C(C=C4)F D07RPV HIGHSTAT Investigative D07RQB DRUG__ID D07RQB D07RQB DRUGTYPE Small molecular drug D07RQB DRUGINCH 1S/C17H12N4/c18-17-19-15-8-7-14(10-16(15)20-21-17)13-6-5-11-3-1-2-4-12(11)9-13/h1-10H,(H2,18,19,21) D07RQB DRUGINKE XEBDWUZHTXSJGH-UHFFFAOYSA-N D07RQB DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC4=C(C=C3)N=C(N=N4)N D07RQB HIGHSTAT Investigative D07RQT DRUG__ID D07RQT D07RQT DRUGTYPE Small molecular drug D07RQT DRUGINCH 1S/C17H23NO2/c1-11-4-6-12(7-5-11)14-10-13-8-9-15(18(13)2)16(14)17(19)20-3/h4-7,13-16H,8-10H2,1-3H3 D07RQT DRUGINKE MMKZDDDDODERSJ-UHFFFAOYSA-N D07RQT DRUGSMIL CC1=CC=C(C=C1)C2CC3CCC(C2C(=O)OC)N3C D07RQT HIGHSTAT Investigative D07RRA DRUG__ID D07RRA D07RRA DRUGTYPE Small molecular drug D07RRA DRUGINCH 1S/C10H7N3S/c1-8-13-10(7-14-8)3-2-9-6-11-4-5-12-9/h4-7H,1H3 D07RRA DRUGINKE TZWSJNFDGNIKAZ-UHFFFAOYSA-N D07RRA DRUGSMIL CC1=NC(=CS1)C#CC2=NC=CN=C2 D07RRA HIGHSTAT Investigative D07RRH DRUG__ID D07RRH D07RRH DRUGTYPE Small molecular drug D07RRH DRUGINCH 1S/C11H23NO3/c1-3-4-5-8-7(2)10(14)11(15)9(6-13)12-8/h7-15H,3-6H2,1-2H3/t7-,8-,9+,10+,11-/m0/s1 D07RRH DRUGINKE CAVTXTZKYKUABF-DAWVFNFOSA-N D07RRH DRUGSMIL CCCCC1C(C(C(C(N1)CO)O)O)C D07RRH HIGHSTAT Investigative D07RRZ DRUG__ID D07RRZ D07RRZ DRUGTYPE Small molecular drug D07RRZ DRUGINCH 1S/C12H17NO3/c1-7(2)10-5-9(13(15)16)6-11(8(3)4)12(10)14/h5-8,14H,1-4H3 D07RRZ DRUGINKE BDOVQBSHXBPOLJ-UHFFFAOYSA-N D07RRZ DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)[N+](=O)[O-] D07RRZ HIGHSTAT Investigative D07RSA DRUG__ID D07RSA D07RSA DRUGTYPE Small molecular drug D07RSA DRUGINCH 1S/C24H21N3O2/c25-15-16-26-24(29)22(17-18-7-3-1-4-8-18)27-23(28)21-13-11-20(12-14-21)19-9-5-2-6-10-19/h1-14,22H,16-17H2,(H,26,29)(H,27,28)/t22-/m0/s1 D07RSA DRUGINKE DWFFMEGYLGKXHE-QFIPXVFZSA-N D07RSA DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=C(C=C2)C3=CC=CC=C3 D07RSA HIGHSTAT Investigative D07RSH DRUG__ID D07RSH D07RSH DRUGTYPE Small molecular drug D07RSH DRUGINCH 1S/C20H20O7/c1-22-11-6-7-13(14(8-11)24-3)19-20(26-5)18(21)17-15(25-4)9-12(23-2)10-16(17)27-19/h6-10H,1-5H3 D07RSH DRUGINKE KPJGABLCRGWDRB-UHFFFAOYSA-N D07RSH DRUGSMIL COC1=CC(=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3OC)OC)OC)OC D07RSH HIGHSTAT Investigative D07RTQ DRUG__ID D07RTQ D07RTQ DRUGTYPE Small molecular drug D07RTQ DRUGINCH 1S/C21H27N6O18P3/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(44-46(33,34)35)14(29)11(43-20)6-41-48(38,39)45-47(36,37)40-5-10-13(28)15(30)19(42-10)26-3-1-2-9(4-26)21(31)32/h1-4,7-8,10-11,13-16,19-20,28-30H,5-6H2,(H6-,22,23,24,31,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1 D07RTQ DRUGINKE QOTXBMGJKFVZRD-HISDBWNOSA-O D07RTQ DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=O)O D07RTQ HIGHSTAT Investigative D07RTV DRUG__ID D07RTV D07RTV DRUGTYPE Small molecular drug D07RTV DRUGINCH 1S/C17H15NOSe/c1-12-3-5-13(6-4-12)16-11-18-20-17(16)14-7-9-15(19-2)10-8-14/h3-11H,1-2H3 D07RTV DRUGINKE ZTXIFGCFDLCGKN-UHFFFAOYSA-N D07RTV DRUGSMIL CC1=CC=C(C=C1)C2=C([Se]N=C2)C3=CC=C(C=C3)OC D07RTV HIGHSTAT Investigative D07RXJ DRUG__ID D07RXJ D07RXJ DRUGTYPE Small molecular drug D07RXJ DRUGINCH 1S/C20H19NO4/c22-18(14-6-2-1-3-7-14)15-10-12-21(13-11-15)19(23)16-8-4-5-9-17(16)20(24)25/h1-9,15H,10-13H2,(H,24,25) D07RXJ DRUGINKE JLSQZICREOKKAN-UHFFFAOYSA-N D07RXJ DRUGSMIL C1CN(CCC1C(=O)C2=CC=CC=C2)C(=O)C3=CC=CC=C3C(=O)O D07RXJ HIGHSTAT Investigative D07RYR DRUG__ID D07RYR D07RYR DRUGTYPE Small molecular drug D07RYR DRUGINCH 1S/C19H23NO/c1-2-8-17(9-3-1)16-18-10-4-5-11-19(18)21-15-14-20-12-6-7-13-20/h1-5,8-11H,6-7,12-16H2 D07RYR DRUGINKE MNZXCYDDVWTITD-UHFFFAOYSA-N D07RYR DRUGSMIL C1CCN(C1)CCOC2=CC=CC=C2CC3=CC=CC=C3 D07RYR HIGHSTAT Investigative D07RZN DRUG__ID D07RZN D07RZN DRUGTYPE Small molecular drug D07RZN DRUGINCH 1S/C14H14N2O3S/c15-20(18,19)13-8-6-12(7-9-13)14(17)16-10-11-4-2-1-3-5-11/h1-9H,10H2,(H,16,17)(H2,15,18,19) D07RZN DRUGINKE CZKNSZUJCJHTTM-UHFFFAOYSA-N D07RZN DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC=C(C=C2)S(=O)(=O)N D07RZN HIGHSTAT Investigative D07SAA DRUG__ID D07SAA D07SAA DRUGTYPE Small molecular drug D07SAA DRUGINCH 1S/C12H14ClNO/c1-8(14-11-5-6-11)12(15)9-3-2-4-10(13)7-9/h2-4,7-8,11,14H,5-6H2,1H3 D07SAA DRUGINKE YKOZIWZLLJVPPD-UHFFFAOYSA-N D07SAA DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)NC2CC2 D07SAA HIGHSTAT Investigative D07SAF DRUG__ID D07SAF D07SAF DRUGTYPE Small molecular drug D07SAF DRUGINCH 1S/C15H17NO/c1-15(2,13-9-6-10-16-11-13)14(17)12-7-4-3-5-8-12/h3-11,14,17H,1-2H3 D07SAF DRUGINKE LCRMYPGRORRMNU-UHFFFAOYSA-N D07SAF DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CC=CC=C2)O D07SAF HIGHSTAT Investigative D07SAI DRUG__ID D07SAI D07SAI DRUGTYPE Small molecular drug D07SAI DRUGINCH 1S/C34H34N4O4.Co/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-2 D07SAI DRUGINKE AQTFKGDWFRRIHR-UHFFFAOYSA-L D07SAI DRUGSMIL CC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C(=C3CCC(=O)O)C)CCC(=O)O.[Co+2] D07SAI HIGHSTAT Investigative D07SCW DRUG__ID D07SCW D07SCW DRUGTYPE Small molecular drug D07SCW DRUGINCH 1S/C8H8O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,4-5,10-11H,3H2 D07SCW DRUGINKE IADQVXRMSNIUEL-UHFFFAOYSA-N D07SCW DRUGSMIL C1=CC(=C(C=C1CC=O)O)O D07SCW HIGHSTAT Investigative D07SEU DRUG__ID D07SEU D07SEU DRUGTYPE Small molecular drug D07SEU DRUGINCH 1S/C18H28O5/c1-12(8-13(2)9-14(3)10-17(20)21)6-4-5-7-16-15(11-19)18(22)23-16/h9-10,12,15-16,19H,4-8,11H2,1-3H3,(H,20,21)/b13-9+,14-10+/t12-,15-,16-/m1/s1 D07SEU DRUGINKE ODCZJZWSXPVLAW-KXCGKLMDSA-N D07SEU DRUGSMIL CC(CCCCC1C(C(=O)O1)CO)CC(=CC(=CC(=O)O)C)C D07SEU HIGHSTAT Investigative D07SFD DRUG__ID D07SFD D07SFD DRUGTYPE Small molecular drug D07SFD DRUGINCH 1S/C43H62N14O7/c1-2-3-14-30-37(60)54-31(16-9-20-49-42(45)46)38(61)56-33(22-25-11-5-4-6-12-25)40(63)55-32(17-10-21-50-43(47)48)39(62)57-34(23-26-24-51-28-15-8-7-13-27(26)28)41(64)53-29(36(44)59)18-19-35(58)52-30/h4-8,11-13,15,24,29-34,51H,2-3,9-10,14,16-23H2,1H3,(H2,44,59)(H,52,58)(H,53,64)(H,54,60)(H,55,63)(H,56,61)(H,57,62)(H4,45,46,49)(H4,47,48,50)/t29-,30-,31+,32-,33+,34-/m0/s1 D07SFD DRUGINKE OVCXMKITXFVUSL-AIQTWYNVSA-N D07SFD DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CCCN=C(N)N D07SFD HIGHSTAT Investigative D07SFI DRUG__ID D07SFI D07SFI DRUGTYPE Small molecular drug D07SFI DRUGINCH 1S/C7H8N2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H3,8,9) D07SFI DRUGINKE PXXJHWLDUBFPOL-UHFFFAOYSA-N D07SFI DRUGSMIL C1=CC=C(C=C1)C(=N)N D07SFI HIGHSTAT Investigative D07SFV DRUG__ID D07SFV D07SFV DRUGTYPE Small molecular drug D07SFV DRUGINCH 1S/C26H36N8O8/c27-26(28)29-8-4-7-16-22(38)30-13-20(35)31-17(12-21(36)37)23(39)33-18(11-15-5-2-1-3-6-15)25(41)34-9-10-42-14-19(34)24(40)32-16/h1-3,5-6,16-19H,4,7-14H2,(H,30,38)(H,31,35)(H,32,40)(H,33,39)(H,36,37)(H4,27,28,29)/t16-,17-,18+,19-/m0/s1 D07SFV DRUGINKE HKLGBIAIHDSNGD-OKYOBFRVSA-N D07SFV DRUGSMIL C1COCC2N1C(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)CC3=CC=CC=C3 D07SFV HIGHSTAT Investigative D07SGS DRUG__ID D07SGS D07SGS DRUGTYPE Small molecular drug D07SGS DRUGINCH 1S/C20H20N2O/c1-2-4-18(5-3-1)16-23-20-8-6-17(7-9-20)10-15-22-19-11-13-21-14-12-19/h1-9,11-14H,10,15-16H2,(H,21,22) D07SGS DRUGINKE WPBRSJXCRWSAHJ-UHFFFAOYSA-N D07SGS DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)CCNC3=CC=NC=C3 D07SGS HIGHSTAT Investigative D07SGT DRUG__ID D07SGT D07SGT DRUGTYPE Small molecular drug D07SGT DRUGINCH 1S/C10H9NO3S/c11-15(13,14)10-6-2-3-7-8(10)4-1-5-9(7)12/h1-6,12H,(H2,11,13,14) D07SGT DRUGINKE NFVBVKHGDDDCEA-UHFFFAOYSA-N D07SGT DRUGSMIL C1=CC2=C(C=CC=C2S(=O)(=O)N)C(=C1)O D07SGT HIGHSTAT Investigative D07SIA DRUG__ID D07SIA D07SIA DRUGTYPE Small molecular drug D07SIA DRUGINCH 1S/C7H9NO2S/c8-11(9,10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,8,9,10) D07SIA DRUGINKE ABOYDMHGKWRPFD-UHFFFAOYSA-N D07SIA DRUGSMIL C1=CC=C(C=C1)CS(=O)(=O)N D07SIA HIGHSTAT Investigative D07SKL DRUG__ID D07SKL D07SKL DRUGTYPE Small molecular drug D07SKL DRUGINCH 1S/C18H25N3O2.C2HF3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;3-2(4,5)1(6)7/h10-15,23H,1-7,9,20H2;(H,6,7)/t10?,11?,12-,13+,14+,15-,17?,18?;/m1./s1 D07SKL DRUGINKE KVBUVKKLNZGQEE-NHKADLRUSA-N D07SKL DRUGSMIL C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N.C(=O)(C(F)(F)F)O D07SKL HIGHSTAT Investigative D07SNW DRUG__ID D07SNW D07SNW DRUGTYPE Small molecular drug D07SNW DRUGINCH 1S/C22H26N2/c1-23(2)21-15-11-19(12-16-21)9-7-5-6-8-10-20-13-17-22(18-14-20)24(3)4/h5-18H,1-4H3/b6-5+,9-7+,10-8+ D07SNW DRUGINKE JGQHLETVKDCCET-NRIIQWGUSA-N D07SNW DRUGSMIL CN(C)C1=CC=C(C=C1)C=CC=CC=CC2=CC=C(C=C2)N(C)C D07SNW HIGHSTAT Investigative D07SOM DRUG__ID D07SOM D07SOM DRUGTYPE Small molecular drug D07SOM DRUGINCH 1S/C19H14N2O2/c22-18-15-8-4-5-9-17(15)23-19(14-6-2-1-3-7-14)16(18)12-21-11-10-20-13-21/h1-11,13H,12H2 D07SOM DRUGINKE CAKKGEJFZFTSEV-UHFFFAOYSA-N D07SOM DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)CN4C=CN=C4 D07SOM HIGHSTAT Investigative D07SOQ DRUG__ID D07SOQ D07SOQ DRUGTYPE Small molecular drug D07SOQ DRUGINCH 1S/C14H13N3O3S/c15-7-8-16-14(18)10-17-21(19,20)13-6-5-11-3-1-2-4-12(11)9-13/h1-6,9,17H,8,10H2,(H,16,18) D07SOQ DRUGINKE LVYWXNHSBUSHNC-UHFFFAOYSA-N D07SOQ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)NCC(=O)NCC#N D07SOQ HIGHSTAT Investigative D07SPC DRUG__ID D07SPC D07SPC DRUGTYPE Small molecular drug D07SPC DRUGINCH 1S/C15H17N3O6S2/c19-15(17-20)14(18-26(23,24)13-9-5-2-6-10-13)11-16-25(21,22)12-7-3-1-4-8-12/h1-10,14,16,18,20H,11H2,(H,17,19) D07SPC DRUGINKE WBWFDDZAXKMHEG-UHFFFAOYSA-N D07SPC DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NCC(C(=O)NO)NS(=O)(=O)C2=CC=CC=C2 D07SPC HIGHSTAT Investigative D07SQW DRUG__ID D07SQW D07SQW DRUGTYPE Small molecular drug D07SQW DRUGINCH 1S/C29H55N5O18/c30-3-11-23(51-28-20(43)19(42)17(40)13(5-36)47-28)18(41)15(34)27(45-11)50-24-14(6-37)48-29(21(24)44)52-25-16(39)7(31)1-8(32)22(25)49-26-9(33)2-10(38)12(4-35)46-26/h7-29,35-44H,1-6,30-34H2/t7-,8+,9-,10+,11+,12-,13-,14-,15-,16+,17-,18-,19+,20+,21-,22-,23-,24-,25-,26-,27-,28-,29+/m1/s1 D07SQW DRUGINKE DBLVDAUGBTYDFR-SWMBIRFSSA-N D07SQW DRUGSMIL C1C(C(C(C(C1N)OC2C(CC(C(O2)CO)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)OC5C(C(C(C(O5)CO)O)O)O)O)N)O)O)N D07SQW HIGHSTAT Investigative D07SRJ DRUG__ID D07SRJ D07SRJ DRUGTYPE Small molecular drug D07SRJ DRUGINCH 1S/C10H10N2O/c1-6-4-3-5-8-9(6)11-7(2)12-10(8)13/h3-5H,1-2H3,(H,11,12,13) D07SRJ DRUGINKE CJXMJXBJIWEHRP-UHFFFAOYSA-N D07SRJ DRUGSMIL CC1=C2C(=CC=C1)C(=O)NC(=N2)C D07SRJ HIGHSTAT Investigative D07SRW DRUG__ID D07SRW D07SRW DRUGTYPE Small molecular drug D07SRW DRUGINCH 1S/C32H40N10O5/c33-23(15-21-17-36-18-39-21)28(43)41-26(13-19-7-2-1-3-8-19)30(45)40-25(11-6-12-37-32(34)35)29(44)42-27(31(46)47)14-20-16-38-24-10-5-4-9-22(20)24/h1-5,7-10,16-18,23,25-27,38H,6,11-15,33H2,(H,36,39)(H,40,45)(H,41,43)(H,42,44)(H,46,47)(H4,34,35,37)/t23-,25-,26-,27-/m0/s1 D07SRW DRUGINKE CAYNQHPLZNPBIO-MNUOIFNESA-N D07SRW DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)C(CC4=CN=CN4)N D07SRW HIGHSTAT Investigative D07SRX DRUG__ID D07SRX D07SRX DRUGTYPE Small molecular drug D07SRX DRUGINCH 1S/C19H16ClN3O/c20-15-5-7-16(8-6-15)23-19(24)17-3-1-2-4-18(17)22-13-14-9-11-21-12-10-14/h1-12,22H,13H2,(H,23,24) D07SRX DRUGINKE GGPZCOONYBPZEW-UHFFFAOYSA-N D07SRX DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)Cl)NCC3=CC=NC=C3 D07SRX HIGHSTAT Investigative D07STC DRUG__ID D07STC D07STC DRUGTYPE Small molecular drug D07STC DRUGINCH 1S/C12H10FNO2/c13-10-5-1-2-6-11(10)14-7-3-4-9(14)8-12(15)16/h1-7H,8H2,(H,15,16) D07STC DRUGINKE XOJPIEDVJHMQEJ-UHFFFAOYSA-N D07STC DRUGSMIL C1=CC=C(C(=C1)N2C=CC=C2CC(=O)O)F D07STC HIGHSTAT Investigative D07SYG DRUG__ID D07SYG D07SYG DRUGTYPE Small molecular drug D07SYG DRUGINCH 1S/C8H9N/c1-2-4-8-6-9-5-7(8)3-1/h1-4,9H,5-6H2 D07SYG DRUGINKE GWVMLCQWXVFZCN-UHFFFAOYSA-N D07SYG DRUGSMIL C1C2=CC=CC=C2CN1 D07SYG HIGHSTAT Investigative D07SYP DRUG__ID D07SYP D07SYP DRUGTYPE Small molecular drug D07SYP DRUGINCH 1S/C22H24N4O5S.ClH/c1-32(28,29)25-16-3-5-21-17(13-16)20(27)14-22(30-21)7-10-26(11-8-22)9-6-15-2-4-18-19(12-15)24-31-23-18;/h2-5,12-13,25H,6-11,14H2,1H3;1H D07SYP DRUGINKE NHRIUQWDVKKIAZ-UHFFFAOYSA-N D07SYP DRUGSMIL CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)CCC4=CC5=NON=C5C=C4)CC2=O.Cl D07SYP HIGHSTAT Investigative D07SZF DRUG__ID D07SZF D07SZF DRUGTYPE Small molecular drug D07SZF DRUGINCH 1S/C13H21NS/c1-4-12(14-5-2)10-11-6-8-13(15-3)9-7-11/h6-9,12,14H,4-5,10H2,1-3H3 D07SZF DRUGINKE DVPCSQHSLVMBEG-UHFFFAOYSA-N D07SZF DRUGSMIL CCC(CC1=CC=C(C=C1)SC)NCC D07SZF HIGHSTAT Investigative D07TAJ DRUG__ID D07TAJ D07TAJ DRUGTYPE Small molecular drug D07TAJ DRUGINCH 1S/C13H12O5/c1-3-17-12(14)10-6-8-4-5-9(16-2)7-11(8)18-13(10)15/h4-7H,3H2,1-2H3 D07TAJ DRUGINKE FWFVXBZXJKTVGL-UHFFFAOYSA-N D07TAJ DRUGSMIL CCOC(=O)C1=CC2=C(C=C(C=C2)OC)OC1=O D07TAJ HIGHSTAT Investigative D07TAL DRUG__ID D07TAL D07TAL DRUGTYPE Small molecular drug D07TAL DRUGINCH 1S/C23H30N4O4/c1-14-20(25-13-26-21(14)30-19-7-6-10-24-15(19)2)29-18-11-16-8-9-17(12-18)27(16)22(28)31-23(3,4)5/h6-7,10,13,16-18H,8-9,11-12H2,1-5H3/t16-,17-/m0/s1 D07TAL DRUGINKE YKEGUYTXACKXKS-IRXDYDNUSA-N D07TAL DRUGSMIL CC1=C(N=CN=C1OC2CC3CCC(C2)N3C(=O)OC(C)(C)C)OC4=C(N=CC=C4)C D07TAL HIGHSTAT Investigative D07TCK DRUG__ID D07TCK D07TCK DRUGTYPE Small molecular drug D07TCK DRUGINCH 1S/C22H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-19(24)21(26)23-18-20(25)27-22(2,3)4/h5-18H2,1-4H3,(H,23,26) D07TCK DRUGINKE DQZNHZUPVFCAKC-UHFFFAOYSA-N D07TCK DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCC(=O)OC(C)(C)C D07TCK HIGHSTAT Investigative D07TDE DRUG__ID D07TDE D07TDE DRUGTYPE Small molecular drug D07TDE DRUGINCH 1S/C10H15N3O.ClH/c1-14-12-10(6-11)9-7-13-4-2-8(9)3-5-13;/h8-9H,2-5,7H2,1H3;1H/b12-10+; D07TDE DRUGINKE INJWRVWKJFJRFO-VHPXAQPISA-N D07TDE DRUGSMIL CON=C(C#N)C1CN2CCC1CC2.Cl D07TDE HIGHSTAT Investigative D07TDM DRUG__ID D07TDM D07TDM DRUGTYPE Small molecular drug D07TDM DRUGINCH 1S/C20H18O4/c1-20(2)8-7-14-16(24-20)6-5-12-15-10-22-17-9-11(21)3-4-13(17)19(15)23-18(12)14/h3-9,15,19,21H,10H2,1-2H3/t15-,19-/m0/s1 D07TDM DRUGINKE LWTDZKXXJRRKDG-KXBFYZLASA-N D07TDM DRUGSMIL CC1(C=CC2=C(O1)C=CC3=C2OC4C3COC5=C4C=CC(=C5)O)C D07TDM HIGHSTAT Investigative D07TEJ DRUG__ID D07TEJ D07TEJ DRUGTYPE Small molecular drug D07TEJ DRUGINCH 1S/C17H21N3/c1-2-4-16(5-3-1)17(20-12-10-19-11-13-20)14-15-6-8-18-9-7-15/h1-9,17,19H,10-14H2 D07TEJ DRUGINKE QVONDVLKKQSPCH-UHFFFAOYSA-N D07TEJ DRUGSMIL C1CN(CCN1)C(CC2=CC=NC=C2)C3=CC=CC=C3 D07TEJ HIGHSTAT Investigative D07TGS DRUG__ID D07TGS D07TGS DRUGTYPE Small molecular drug D07TGS DRUGINCH 1S/C20H16O2/c21-18-10-6-16(7-11-18)20(14-15-4-2-1-3-5-15)17-8-12-19(22)13-9-17/h1-14,21-22H D07TGS DRUGINKE CKNFKDYCAQZYBQ-UHFFFAOYSA-N D07TGS DRUGSMIL C1=CC=C(C=C1)C=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O D07TGS HIGHSTAT Investigative D07TGW DRUG__ID D07TGW D07TGW DRUGTYPE Small molecular drug D07TGW DRUGINCH 1S/C30H33N3O2/c1-22-29(24-11-15-27(34)16-12-24)31-33(26-13-17-28(35)18-14-26)30(22)25-9-7-23(8-10-25)6-5-21-32-19-3-2-4-20-32/h7-18,34-35H,2-6,19-21H2,1H3 D07TGW DRUGINKE XXRGLZUCVWZDBP-UHFFFAOYSA-N D07TGW DRUGSMIL CC1=C(N(N=C1C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C4=CC=C(C=C4)CCCN5CCCCC5 D07TGW HIGHSTAT Investigative D07THV DRUG__ID D07THV D07THV DRUGTYPE Small molecular drug D07THV DRUGINCH 1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1 D07THV DRUGINKE TXCIAUNLDRJGJZ-BILDWYJOSA-N D07THV DRUGSMIL CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=NC3=O)N)O)O)O D07THV HIGHSTAT Investigative D07TIJ DRUG__ID D07TIJ D07TIJ DRUGTYPE Small molecular drug D07TIJ DRUGINCH 1S/C16H12N2/c1-3-7-14-12(5-1)13-6-2-4-8-15(13)16(14)18-10-9-17-11-18/h1-11,16H D07TIJ DRUGINKE TULIZIRHYBBLAI-UHFFFAOYSA-N D07TIJ DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C32)N4C=CN=C4 D07TIJ HIGHSTAT Investigative D07TKE DRUG__ID D07TKE D07TKE DRUGTYPE Small molecular drug D07TKE DRUGINCH 1S/C20H25NO/c22-20(19-11-5-2-6-12-19)13-16-21(17-14-20)15-7-10-18-8-3-1-4-9-18/h1-6,8-9,11-12,22H,7,10,13-17H2 D07TKE DRUGINKE ZZUJERGWKSXINO-UHFFFAOYSA-N D07TKE DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)O)CCCC3=CC=CC=C3 D07TKE HIGHSTAT Investigative D07TKG DRUG__ID D07TKG D07TKG DRUGTYPE Small molecular drug D07TKG DRUGINCH 1S/C19H17BrN2O/c1-12(23)22-10-9-15-16-11-14(20)7-8-17(16)21-18(15)19(22)13-5-3-2-4-6-13/h2-8,11,19,21H,9-10H2,1H3 D07TKG DRUGINKE CBMFCUHTQKAALP-UHFFFAOYSA-N D07TKG DRUGSMIL CC(=O)N1CCC2=C(C1C3=CC=CC=C3)NC4=C2C=C(C=C4)Br D07TKG HIGHSTAT Investigative D07TLT DRUG__ID D07TLT D07TLT DRUGTYPE Small molecular drug D07TLT DRUGINCH 1S/C17H15NO/c1-18-16-10-12(19)7-9-14(16)15-8-6-11-4-2-3-5-13(11)17(15)18/h2-5,7,9-10,19H,6,8H2,1H3 D07TLT DRUGINKE MZXLONQJNNQZJT-UHFFFAOYSA-N D07TLT DRUGSMIL CN1C2=C(C=CC(=C2)O)C3=C1C4=CC=CC=C4CC3 D07TLT HIGHSTAT Investigative D07TMZ DRUG__ID D07TMZ D07TMZ DRUGTYPE Small molecular drug D07TMZ DRUGINCH 1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1 D07TMZ DRUGINKE KDXKERNSBIXSRK-YFKPBYRVSA-N D07TMZ DRUGSMIL C(CCN)CC(C(=O)O)N D07TMZ HIGHSTAT Investigative D07TOI DRUG__ID D07TOI D07TOI DRUGTYPE Small molecular drug D07TOI DRUGINCH 1S/C20H36N2O2/c1-2-3-5-8-24-9-6-4-7-21-19(23)22-20-13-16-10-17(14-20)12-18(11-16)15-20/h16-18H,2-15H2,1H3,(H2,21,22,23) D07TOI DRUGINKE UCGGVDAPMCFWNI-UHFFFAOYSA-N D07TOI DRUGSMIL CCCCCOCCCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D07TOI HIGHSTAT Investigative D07TPU DRUG__ID D07TPU D07TPU DRUGTYPE Small molecular drug D07TPU DRUGINCH 1S/C30H38O15/c1-14-23(36)24(37)25(38)30(42-14)45-28-26(39)29(41-10-9-16-3-6-17(32)19(34)11-16)43-21(13-31)27(28)44-22(35)8-5-15-4-7-18(33)20(12-15)40-2/h3-8,11-12,14,21,23-34,36-39H,9-10,13H2,1-2H3/b8-5+/t14-,21+,23-,24+,25+,26+,27+,28+,29+,30-/m0/s1 D07TPU DRUGINKE ZMYQRHSOVRDQDL-CPPDSBOHSA-N D07TPU DRUGSMIL CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)OC)CO)OCCC4=CC(=C(C=C4)O)O)O)O)O)O D07TPU HIGHSTAT Investigative D07TQF DRUG__ID D07TQF D07TQF DRUGTYPE Small molecular drug D07TQF DRUGINCH 1S/C20H23FO10/c1-5-12(24)28-11-8(22)18-10-6(21)7(16(2,3)4)17(18)9(23)13(25)30-15(17)31-20(18,14(26)29-10)19(5,11)27/h5-11,15,22-23,27H,1-4H3/t5?,6?,7?,8?,9-,10?,11-,15?,17?,18?,19+,20-/m0/s1 D07TQF DRUGINKE NKHCTSYWTBHOAK-UUSFTXJGSA-N D07TQF DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5F)C(C)(C)C)C(C(=O)OC6O4)O)O D07TQF HIGHSTAT Investigative D07TSE DRUG__ID D07TSE D07TSE DRUGTYPE Small molecular drug D07TSE DRUGINCH 1S/C9H14N2O11P2S/c12-5-1-2-11(9(25)10-5)8-7(14)6(13)4(21-8)3-20-24(18,19)22-23(15,16)17/h1-2,4,6-8,13-14H,3H2,(H,18,19)(H,10,12,25)(H2,15,16,17)/t4-,6-,7-,8-/m1/s1 D07TSE DRUGINKE BMJOHSBBMARQHC-XVFCMESISA-N D07TSE DRUGSMIL C1=CN(C(=S)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)O)O)O D07TSE HIGHSTAT Investigative D07TST DRUG__ID D07TST D07TST DRUGTYPE Small molecular drug D07TST DRUGINCH 1S/C11H19N3/c1-2-4-10(5-3-1)13-7-6-11-8-12-9-14-11/h8-10,13H,1-7H2,(H,12,14) D07TST DRUGINKE OKJFYIHINPOKMF-UHFFFAOYSA-N D07TST DRUGSMIL C1CCC(CC1)NCCC2=CN=CN2 D07TST HIGHSTAT Investigative D07TTR DRUG__ID D07TTR D07TTR DRUGTYPE Small molecular drug D07TTR DRUGINCH 1S/C23H17FN2O/c24-21-9-5-17(6-10-21)16-26(22-11-13-25-14-12-22)23(27)20-8-7-18-3-1-2-4-19(18)15-20/h1-15H,16H2 D07TTR DRUGINKE MQJXOIDGELXEHE-UHFFFAOYSA-N D07TTR DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)N(CC3=CC=C(C=C3)F)C4=CC=NC=C4 D07TTR HIGHSTAT Investigative D07TUX DRUG__ID D07TUX D07TUX DRUGTYPE Small molecular drug D07TUX DRUGINCH 1S/C14H12N2O3/c17-14-4-2-11-1-3-12(9-13(11)19-14)18-8-7-16-6-5-15-10-16/h1-6,9-10H,7-8H2 D07TUX DRUGINKE JUOCDQIZOPYANC-UHFFFAOYSA-N D07TUX DRUGSMIL C1=CC(=CC2=C1C=CC(=O)O2)OCCN3C=CN=C3 D07TUX HIGHSTAT Investigative D07TVA DRUG__ID D07TVA D07TVA DRUGTYPE Small molecular drug D07TVA DRUGINCH 1S/C16H18O2/c1-2-3-13-17-14-9-11-16(12-10-14)18-15-7-5-4-6-8-15/h4-12H,2-3,13H2,1H3 D07TVA DRUGINKE NSCFOXCKETUFMF-UHFFFAOYSA-N D07TVA DRUGSMIL CCCCOC1=CC=C(C=C1)OC2=CC=CC=C2 D07TVA HIGHSTAT Investigative D07TVE DRUG__ID D07TVE D07TVE DRUGTYPE Small molecular drug D07TVE DRUGINCH 1S/C8H8N6/c1-3-2-5-6(4(1)3)9-10-7(5)8-11-13-14-12-8/h3-4H,1-2H2,(H,9,10)(H,11,12,13,14) D07TVE DRUGINKE DKSPRNJUDCWTID-UHFFFAOYSA-N D07TVE DRUGSMIL C1C2C1C3=C(C2)C(=NN3)C4=NNN=N4 D07TVE HIGHSTAT Investigative D07TVI DRUG__ID D07TVI D07TVI DRUGTYPE Small molecular drug D07TVI DRUGINCH 1S/C14H14F3NO/c15-14(16,17)12-7-9(5-6-10(12)8-18)11-3-1-2-4-13(11)19/h5-7,11,13,19H,1-4H2/t11-,13-/m1/s1 D07TVI DRUGINKE MENRRRXHFQYXDW-DGCLKSJQSA-N D07TVI DRUGSMIL C1CCC(C(C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)O D07TVI HIGHSTAT Investigative D07TWQ DRUG__ID D07TWQ D07TWQ DRUGTYPE Small molecular drug D07TWQ DRUGINCH 1S/C32H39NO3/c1-21(2)15-30(28-17-22(3)16-23(4)18-28)33-25(6)29-19-26(11-12-27(29)13-14-32(34)35)20-36-31-10-8-7-9-24(31)5/h7-12,16-19,21,30,33H,6,13-15,20H2,1-5H3,(H,34,35)/t30-/m1/s1 D07TWQ DRUGINKE MIHNFQDPLQJFEZ-SSEXGKCCSA-N D07TWQ DRUGSMIL CC1=CC=CC=C1OCC2=CC(=C(C=C2)CCC(=O)O)C(=C)NC(CC(C)C)C3=CC(=CC(=C3)C)C D07TWQ HIGHSTAT Investigative D07TWV DRUG__ID D07TWV D07TWV DRUGTYPE Small molecular drug D07TWV DRUGINCH 1S/C17H14O/c1-2-6-14(7-3-1)13-18-17-11-10-15-8-4-5-9-16(15)12-17/h1-12H,13H2 D07TWV DRUGINKE WLTCCDHHWYAMCG-UHFFFAOYSA-N D07TWV DRUGSMIL C1=CC=C(C=C1)COC2=CC3=CC=CC=C3C=C2 D07TWV HIGHSTAT Investigative D07TXF DRUG__ID D07TXF D07TXF DRUGTYPE Small molecular drug D07TXF DRUGINCH 1S/C19H24ClNO3/c1-2-3-4-5-7-16-12-14-10-11-15(20)13-17(14)21(16)18(22)8-6-9-19(23)24/h10-13H,2-9H2,1H3,(H,23,24) D07TXF DRUGINKE KNTPSPKZGNVRML-UHFFFAOYSA-N D07TXF DRUGSMIL CCCCCCC1=CC2=C(N1C(=O)CCCC(=O)O)C=C(C=C2)Cl D07TXF HIGHSTAT Investigative D07TYK DRUG__ID D07TYK D07TYK DRUGTYPE Small molecular drug D07TYK DRUGINCH 1S/C11H17N4O12P3/c12-11-10(16)9-7(3-13-11)15(5-14-9)8-2-1-6(25-8)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h5-6,8H,1-4H2,(H2,12,13)(H,20,21)(H,22,23)(H2,17,18,19)/t6-,8+/m0/s1 D07TYK DRUGINKE UOKJOXGBXPVQIX-POYBYMJQSA-N D07TYK DRUGSMIL C1CC(OC1COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N2C=NC3=C2CN=C(C3=O)N D07TYK HIGHSTAT Investigative D07TYL DRUG__ID D07TYL D07TYL DRUGTYPE Small molecular drug D07TYL DRUGINCH 1S/C12H17N4OS/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15)/q+1 D07TYL DRUGINKE JZRWCGZRTZMZEH-UHFFFAOYSA-N D07TYL DRUGSMIL CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO D07TYL HIGHSTAT Investigative D07UBK DRUG__ID D07UBK D07UBK DRUGCOMP Astellas Pharma Inc D07UBK DRUGINCH 1S/C20H19N3O2/c24-14-19(17-4-2-1-3-5-17)23-20(25)22-18-8-6-15(7-9-18)16-10-12-21-13-11-16/h1-13,19,24H,14H2,(H2,22,23,25)/t19-/m1/s1 D07UBK DRUGINKE WDTFYYZHMRBVHK-LJQANCHMSA-N D07UBK DRUGSMIL C1=CC=C(C=C1)C(CO)NC(=O)NC2=CC=C(C=C2)C3=CC=NC=C3 D07UBK HIGHSTAT Investigative D07UBR DRUG__ID D07UBR D07UBR DRUGTYPE Small molecular drug D07UBR DRUGINCH 1S/C19H20N2O3/c22-18(20-12-15-9-5-2-6-10-15)17-13-24-19(23)16(21-17)11-14-7-3-1-4-8-14/h1-10,16-17,21H,11-13H2,(H,20,22)/t16-,17-/m0/s1 D07UBR DRUGINKE ORMAGLLOPOBCBO-IRXDYDNUSA-N D07UBR DRUGSMIL C1C(NC(C(=O)O1)CC2=CC=CC=C2)C(=O)NCC3=CC=CC=C3 D07UBR HIGHSTAT Investigative D07UCE DRUG__ID D07UCE D07UCE DRUGTYPE Small molecular drug D07UCE DRUGINCH 1S/C24H33NO/c1-3-9-22(10-4-1)13-7-19-26-20-8-16-25-17-14-24(15-18-25)21-23-11-5-2-6-12-23/h1-6,9-12,24H,7-8,13-21H2 D07UCE DRUGINKE XBQBYNHFYXHMHB-UHFFFAOYSA-N D07UCE DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CCCOCCCC3=CC=CC=C3 D07UCE HIGHSTAT Investigative D07UCF DRUG__ID D07UCF D07UCF DRUGTYPE Small molecular drug D07UCF DRUGINCH 1S/C9H5ClFNOS/c10-7-5-6(1-2-8(7)11)12-9(13)3-4-14-12/h1-5H D07UCF DRUGINKE OOOJWRSQJXGEDS-UHFFFAOYSA-N D07UCF DRUGSMIL C1=CC(=C(C=C1N2C(=O)C=CS2)Cl)F D07UCF HIGHSTAT Investigative D07UCQ DRUG__ID D07UCQ D07UCQ DRUGTYPE Small molecular drug D07UCQ DRUGINCH 1S/C7H9NO3S.Na/c9-12(10,11)6-8-7-4-2-1-3-5-7;/h1-5,8H,6H2,(H,9,10,11);/q;+1/p-1 D07UCQ DRUGINKE AJSINQAAKNYUDA-UHFFFAOYSA-M D07UCQ DRUGSMIL C1=CC=C(C=C1)NCS(=O)(=O)[O-].[Na+] D07UCQ HIGHSTAT Investigative D07UDT DRUG__ID D07UDT D07UDT DRUGTYPE Small molecular drug D07UDT DRUGINCH 1S/C27H22BrNO4S/c1-33-25-14-13-24(28)18-26(25)34(31,32)29-27(30)15-12-21-7-3-5-9-23(21)17-19-10-11-20-6-2-4-8-22(20)16-19/h2-16,18H,17H2,1H3,(H,29,30)/b15-12+ D07UDT DRUGINKE ODTKFNUPVBULRJ-NTCAYCPXSA-N D07UDT DRUGSMIL COC1=C(C=C(C=C1)Br)S(=O)(=O)NC(=O)C=CC2=CC=CC=C2CC3=CC4=CC=CC=C4C=C3 D07UDT HIGHSTAT Investigative D07UFK DRUG__ID D07UFK D07UFK DRUGTYPE Small molecular drug D07UFK DRUGINCH 1S/C32H27ClF2N4O7S/c1-4-11-47(43,44)37-25-10-9-24(34)29(30(25)35)31(40)23-17-38(16-20-13-27(45-2)28(46-3)14-26(20)39(41)42)32-22(23)12-19(15-36-32)18-5-7-21(33)8-6-18/h5-10,12-15,17,37H,4,11,16H2,1-3H3 D07UFK DRUGINKE JMMXKBJIBAVJSU-UHFFFAOYSA-N D07UFK DRUGSMIL CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CN(C3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)CC5=CC(=C(C=C5[N+](=O)[O-])OC)OC)F D07UFK HIGHSTAT Investigative D07UFO DRUG__ID D07UFO D07UFO DRUGTYPE Small molecular drug D07UFO DRUGINCH 1S/C20H32O3/c21-19-17-15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16-18-20(22)23/h1,3-4,6-7,9-10,12,21H,2,5,8,11,13-19H2,(H,22,23)/b3-1-,6-4-,9-7-,12-10- D07UFO DRUGINKE NNDIXBJHNLFJJP-DTLRTWKJSA-N D07UFO DRUGSMIL C(CCC=CCC=CCC=CCC=CCCCC(=O)O)CCO D07UFO HIGHSTAT Investigative D07UIO DRUG__ID D07UIO D07UIO DRUGTYPE Small molecular drug D07UIO DRUGINCH 1S/C19H36N2O3/c1-2-3-13-16-20-19(24)21-17-14-11-9-7-5-4-6-8-10-12-15-18(22)23/h5,7H,2-4,6,8-17H2,1H3,(H,22,23)(H2,20,21,24)/b7-5+ D07UIO DRUGINKE CVIWLKCFJOISPD-FNORWQNLSA-N D07UIO DRUGSMIL CCCCCNC(=O)NCCCCC=CCCCCCCC(=O)O D07UIO HIGHSTAT Investigative D07UJV DRUG__ID D07UJV D07UJV DRUGTYPE Small molecular drug D07UJV DRUGINCH 1S/C19H23NO7S/c1-10(21)25-14-5-3-11-9-13-12-4-6-15(27-28(22,23)24)18-19(12,7-8-20(13)2)16(11)17(14)26-18/h3,5,12-13,15,18H,4,6-9H2,1-2H3,(H,22,23,24)/t12-,13+,15-,18-,19-/m0/s1 D07UJV DRUGINKE YATYBWXTHXFYJT-SSTWWWIQSA-N D07UJV DRUGSMIL CC(=O)OC1=C2C3=C(CC4C5C3(CC[NH+]4C)C(O2)C(CC5)OS(=O)(=O)[O-])C=C1 D07UJV HIGHSTAT Investigative D07ULQ DRUG__ID D07ULQ D07ULQ DRUGTYPE Small molecular drug D07ULQ DRUGINCH 1S/C9H10N2O/c1-3-7-11(2)9(12)8-5-4-6-10-8/h1,4-6,10H,7H2,2H3 D07ULQ DRUGINKE IKQLCRCMGYGVMD-UHFFFAOYSA-N D07ULQ DRUGSMIL CN(CC#C)C(=O)C1=CC=CN1 D07ULQ HIGHSTAT Investigative D07UOF DRUG__ID D07UOF D07UOF DRUGTYPE Small molecular drug D07UOF DRUGINCH 1S/C31H40N8O7/c1-39-24(16-20-11-6-3-7-12-20)29(45)37-21(13-8-14-34-31(32)33)27(43)35-18-25(40)36-22(17-26(41)42)28(44)38-23(30(39)46)15-19-9-4-2-5-10-19/h2-7,9-12,21-24H,8,13-18H2,1H3,(H,35,43)(H,36,40)(H,37,45)(H,38,44)(H,41,42)(H4,32,33,34)/t21-,22-,23+,24-/m0/s1 D07UOF DRUGINKE ZILGGGDRKNJYPR-XQUALCHDSA-N D07UOF DRUGSMIL CN1C(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C1=O)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N)CC3=CC=CC=C3 D07UOF HIGHSTAT Investigative D07UTV DRUG__ID D07UTV D07UTV DRUGTYPE Small molecular drug D07UTV DRUGINCH 1S/C13H7Cl3N2O3/c14-8-5-10(16)11(6-9(8)15)17-13(19)7-3-1-2-4-12(7)18(20)21/h1-6H,(H,17,19) D07UTV DRUGINKE IWLWJYOQIYGDKH-UHFFFAOYSA-N D07UTV DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC(=C(C=C2Cl)Cl)Cl)[N+](=O)[O-] D07UTV HIGHSTAT Investigative D07UTZ DRUG__ID D07UTZ D07UTZ DRUGTYPE Small molecular drug D07UTZ DRUGINCH 1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1 D07UTZ DRUGINKE HNDVDQJCIGZPNO-YFKPBYRVSA-N D07UTZ DRUGSMIL C1=C(NC=N1)CC(C(=O)O)N D07UTZ HIGHSTAT Investigative D07UUQ DRUG__ID D07UUQ D07UUQ DRUGTYPE Small molecular drug D07UUQ DRUGINCH 1S/C18H20N2/c1-2-17-9-6-12-20(17)18-10-13-19(14-11-18)15-16-7-4-3-5-8-16/h1,3-9,12,18H,10-11,13-15H2 D07UUQ DRUGINKE CNGQSMFIQRDDKI-UHFFFAOYSA-N D07UUQ DRUGSMIL C#CC1=CC=CN1C2CCN(CC2)CC3=CC=CC=C3 D07UUQ HIGHSTAT Investigative D07UVN DRUG__ID D07UVN D07UVN DRUGTYPE Small molecular drug D07UVN DRUGINCH 1S/C15H15NO/c1-17-15-4-2-3-13(11-15)6-5-12-7-9-14(16)10-8-12/h2-11H,16H2,1H3/b6-5+ D07UVN DRUGINKE KQIPLUOUWQXDOT-AATRIKPKSA-N D07UVN DRUGSMIL COC1=CC=CC(=C1)C=CC2=CC=C(C=C2)N D07UVN HIGHSTAT Investigative D07UWD DRUG__ID D07UWD D07UWD DRUGTYPE Small molecular drug D07UWD DRUGINCH 1S/C23H34N4O8/c1-6-23(4)19(22(34)25-10-15(29)30)27-20(32)16(11(2)3)26-21(33)17(24-5)18(31)12-7-8-13(28)14(9-12)35-23/h7-9,11,16-19,24,28,31H,6,10H2,1-5H3,(H,25,34)(H,26,33)(H,27,32)(H,29,30)/t16-,17-,18+,19+,23+/m0/s1 D07UWD DRUGINKE GDXLZSYACWZHOC-ZNRYNLAGSA-N D07UWD DRUGSMIL CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C D07UWD HIGHSTAT Investigative D07UXB DRUG__ID D07UXB D07UXB DRUGTYPE Small molecular drug D07UXB DRUGINCH 1S/C20H34O6/c1-14(21)7-6-8-15(22)11-12-17-16(18(23)13-19(17)24)9-4-2-3-5-10-20(25)26/h11-12,14-17,19,21-22,24H,2-10,13H2,1H3,(H,25,26)/b12-11+/t14?,15-,16+,17+,19+/m0/s1 D07UXB DRUGINKE QVVXWHIDRKRPMO-LXCOYWBSSA-N D07UXB DRUGSMIL CC(CCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O)O D07UXB HIGHSTAT Investigative D07UXW DRUG__ID D07UXW D07UXW DRUGTYPE Small molecular drug D07UXW DRUGINCH 1S/C45H57N11O9/c1-2-3-12-32-40(61)56-36(23-38(58)59)44(65)54-34(21-25-15-16-26-9-4-5-10-27(26)20-25)42(63)53-33(14-8-19-49-45(47)48)41(62)55-35(22-28-24-50-30-13-7-6-11-29(28)30)43(64)52-31(39(46)60)17-18-37(57)51-32/h4-7,9-11,13,15-16,20,24,31-36,50H,2-3,8,12,14,17-19,21-23H2,1H3,(H2,46,60)(H,51,57)(H,52,64)(H,53,63)(H,54,65)(H,55,62)(H,56,61)(H,58,59)(H4,47,48,49)/t31-,32-,33-,34+,35-,36+/m0/s1 D07UXW DRUGINKE VKDMHINLWUJYEZ-XBWXEZBPSA-N D07UXW DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CC(=O)O D07UXW HIGHSTAT Investigative D07UYV DRUG__ID D07UYV D07UYV DRUGTYPE Small molecular drug D07UYV DRUGINCH 1S/C18H18BrN3O2/c1-3-23-16-9-14-15(10-17(16)24-4-2)20-11-21-18(14)22-13-7-5-6-12(19)8-13/h5-11H,3-4H2,1-2H3,(H,20,21,22) D07UYV DRUGINKE YXOXHAUUTIOBDA-UHFFFAOYSA-N D07UYV DRUGSMIL CCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCC D07UYV HIGHSTAT Investigative D07VBS DRUG__ID D07VBS D07VBS DRUGTYPE Small molecular drug D07VBS DRUGINCH 1S/C19H23N3O/c1-15-5-4-6-17(13-15)21-19(23)14-22-11-8-16(9-12-22)18-7-2-3-10-20-18/h2-7,10,13,16H,8-9,11-12,14H2,1H3,(H,21,23) D07VBS DRUGINKE JFCDMGGMCUKHST-UHFFFAOYSA-N D07VBS DRUGSMIL CC1=CC(=CC=C1)NC(=O)CN2CCC(CC2)C3=CC=CC=N3 D07VBS HIGHSTAT Investigative D07VCN DRUG__ID D07VCN D07VCN DRUGTYPE Small molecular drug D07VCN DRUGINCH 1S/C21H16O4/c1-2-23-21-16-10-11-24-18(16)13-19-20(21)17(22)12-15(25-19)9-8-14-6-4-3-5-7-14/h3-13H,2H2,1H3/b9-8+ D07VCN DRUGINKE TZRUAYHMQMKKLT-CMDGGOBGSA-N D07VCN DRUGSMIL CCOC1=C2C=COC2=CC3=C1C(=O)C=C(O3)C=CC4=CC=CC=C4 D07VCN HIGHSTAT Investigative D07VDJ DRUG__ID D07VDJ D07VDJ DRUGTYPE Small molecular drug D07VDJ DRUGINCH 1S/C5H12N2/c6-4-5-2-1-3-7-5/h5,7H,1-4,6H2/t5-/m0/s1 D07VDJ DRUGINKE AUKXFNABVHIUAC-YFKPBYRVSA-N D07VDJ DRUGSMIL C1CC(NC1)CN D07VDJ HIGHSTAT Investigative D07VEB DRUG__ID D07VEB D07VEB DRUGTYPE Small molecular drug D07VEB DRUGINCH 1S/C27H28BrF2NO4/c1-16(2)26-25(28)24(17-4-8-19(29)9-5-17)27(18-6-10-20(30)11-7-18)31(26)13-12-21(32)14-22(33)15-23(34)35-3/h4-13,16,21-22,32-33H,14-15H2,1-3H3/b13-12+/t21-,22-/m1/s1 D07VEB DRUGINKE MUTCAPXLKRYEPR-ITWZMISCSA-N D07VEB DRUGSMIL CC(C)C1=C(C(=C(N1C=CC(CC(CC(=O)OC)O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)Br D07VEB HIGHSTAT Investigative D07VEP DRUG__ID D07VEP D07VEP DRUGTYPE Small molecular drug D07VEP DRUGINCH 1S/C24H25NO10/c1-9-19(29)17(11(3)26)21-18(20(9)30)24(4)14(35-21)8-13(27)16(22(24)31)10(2)25-12(23(32)33)6-7-15(28)34-5/h8,12,25,29-30H,6-7H2,1-5H3,(H,32,33)/t12-,24-/m0/s1 D07VEP DRUGINKE KSWPDJNHLSRGKZ-MCFWBGNESA-N D07VEP DRUGSMIL CC1=C(C(=C2C(=C1O)C3(C(=CC(=O)C(=C(C)NC(CCC(=O)OC)C(=O)O)C3=O)O2)C)C(=O)C)O D07VEP HIGHSTAT Investigative D07VFC DRUG__ID D07VFC D07VFC DRUGTYPE Small molecular drug D07VFC DRUGINCH 1S/C9H13FN2/c1-6-3-8(5-7(2)10)12-9(11)4-6/h3-4,7H,5H2,1-2H3,(H2,11,12) D07VFC DRUGINKE MBHRCNFCHFHUKZ-UHFFFAOYSA-N D07VFC DRUGSMIL CC1=CC(=NC(=C1)N)CC(C)F D07VFC HIGHSTAT Investigative D07VGG DRUG__ID D07VGG D07VGG DRUGTYPE Small molecular drug D07VGG DRUGINCH 1S/C10H7NOS2/c12-9-8(14-10(13)11-9)6-7-4-2-1-3-5-7/h1-6H,(H,11,12,13)/b8-6- D07VGG DRUGINKE OONWCXLYKDWKOU-VURMDHGXSA-N D07VGG DRUGSMIL C1=CC=C(C=C1)C=C2C(=O)NC(=S)S2 D07VGG HIGHSTAT Investigative D07VGT DRUG__ID D07VGT D07VGT DRUGTYPE Small molecular drug D07VGT DRUGINCH 1S/C22H17NO/c24-22-8-7-20-14-19(5-6-21(20)15-22)18-3-1-16(2-4-18)13-17-9-11-23-12-10-17/h1-12,14-15,24H,13H2 D07VGT DRUGINKE OCQPVXWUPNNJIV-UHFFFAOYSA-N D07VGT DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC4=C(C=C3)C=C(C=C4)O D07VGT HIGHSTAT Investigative D07VHB DRUG__ID D07VHB D07VHB DRUGTYPE Small molecular drug D07VHB DRUGINCH 1S/C13H16N2O/c1-2-3-10-16-13-6-4-12(5-7-13)15-9-8-14-11-15/h4-9,11H,2-3,10H2,1H3 D07VHB DRUGINKE QJWFZZZHWWOBNM-UHFFFAOYSA-N D07VHB DRUGSMIL CCCCOC1=CC=C(C=C1)N2C=CN=C2 D07VHB HIGHSTAT Investigative D07VIO DRUG__ID D07VIO D07VIO DRUGTYPE Small molecular drug D07VIO DRUGINCH 1S/C24H25N5O2/c1-3-28(4-2)14-21(30)25-15-9-10-20-18(13-15)24(31)29-12-11-17-16-7-5-6-8-19(16)26-22(17)23(29)27-20/h5-10,13,26H,3-4,11-12,14H2,1-2H3,(H,25,30) D07VIO DRUGINKE IIFLCYXLKCVJJT-UHFFFAOYSA-N D07VIO DRUGSMIL CCN(CC)CC(=O)NC1=CC2=C(C=C1)N=C3C4=C(CCN3C2=O)C5=CC=CC=C5N4 D07VIO HIGHSTAT Investigative D07VJT DRUG__ID D07VJT D07VJT DRUGTYPE Small molecular drug D07VJT DRUGINCH 1S/C30H18O4/c31-25-17-30(33-27-12-5-4-11-23(25)27)22-10-6-9-20(15-22)21-13-14-28-24(16-21)26(32)18-29(34-28)19-7-2-1-3-8-19/h1-18H D07VJT DRUGINKE ATBFVHXRFRVXOQ-UHFFFAOYSA-N D07VJT DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC(=CC=C4)C5=CC(=O)C6=CC=CC=C6O5 D07VJT HIGHSTAT Investigative D07VPM DRUG__ID D07VPM D07VPM DRUGTYPE Small molecular drug D07VPM DRUGINCH 1S/C19H13NO3/c21-14-8-6-13(7-9-14)19-20-17-11-15(22)10-16(18(17)23-19)12-4-2-1-3-5-12/h1-11,21-22H D07VPM DRUGINKE OMOPCSHWHZVQPY-UHFFFAOYSA-N D07VPM DRUGSMIL C1=CC=C(C=C1)C2=C3C(=CC(=C2)O)N=C(O3)C4=CC=C(C=C4)O D07VPM HIGHSTAT Investigative D07VWC DRUG__ID D07VWC D07VWC DRUGTYPE Small molecular drug D07VWC DRUGINCH 1S/C19H14N2O4/c22-17-13-6-1-2-7-14(13)18(23)21(17)16(19(24)25)9-11-10-20-15-8-4-3-5-12(11)15/h1-8,10,16,20H,9H2,(H,24,25) D07VWC DRUGINKE HPTXLHAHLXOAKV-UHFFFAOYSA-N D07VWC DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)C(CC3=CNC4=CC=CC=C43)C(=O)O D07VWC HIGHSTAT Investigative D07VXQ DRUG__ID D07VXQ D07VXQ DRUGTYPE Small molecular drug D07VXQ DRUGINCH 1S/C17H13NO2/c19-15-5-1-3-12(9-15)14-7-8-17(18-11-14)13-4-2-6-16(20)10-13/h1-11,19-20H D07VXQ DRUGINKE GWBPLTAHNKSFLG-UHFFFAOYSA-N D07VXQ DRUGSMIL C1=CC(=CC(=C1)O)C2=CN=C(C=C2)C3=CC(=CC=C3)O D07VXQ HIGHSTAT Investigative D07VXX DRUG__ID D07VXX D07VXX DRUGTYPE Small molecular drug D07VXX DRUGINCH 1S/C13H20N2O3/c1-3-10(2)12(13(16)14-17)15-18-9-11-7-5-4-6-8-11/h4-8,10,12,15,17H,3,9H2,1-2H3,(H,14,16) D07VXX DRUGINKE OISVGEVVTLNTBZ-UHFFFAOYSA-N D07VXX DRUGSMIL CCC(C)C(C(=O)NO)NOCC1=CC=CC=C1 D07VXX HIGHSTAT Investigative D07VYX DRUG__ID D07VYX D07VYX DRUGTYPE Small molecular drug D07VYX DRUGINCH 1S/C24H32N2O2/c1-18(8-7-9-19(2)16-23(27)28-6)10-11-21-20(3)22(12-13-24(21,4)5)26-15-14-25-17-26/h7-11,14-17,22H,12-13H2,1-6H3/b9-7+,11-10+,18-8+,19-16+ D07VYX DRUGINKE LEOKNFOQHCUMCU-PFLBVIONSA-N D07VYX DRUGSMIL CC1=C(C(CCC1N2C=CN=C2)(C)C)C=CC(=CC=CC(=CC(=O)OC)C)C D07VYX HIGHSTAT Investigative D07VZG DRUG__ID D07VZG D07VZG DRUGTYPE Small molecular drug D07VZG DRUGINCH 1S/C10H15N3O/c1-14-12-10(6-11)9-7-13-4-2-8(9)3-5-13/h8-9H,2-5,7H2,1H3/b12-10+ D07VZG DRUGINKE IQWCBYSUUOFOMF-ZRDIBKRKSA-N D07VZG DRUGSMIL CON=C(C#N)C1CN2CCC1CC2 D07VZG HIGHSTAT Investigative D07WDQ DRUG__ID D07WDQ D07WDQ DRUGTYPE Small molecular drug D07WDQ DRUGINCH 1S/C7H7N5O2/c1-11-6(13)4-5(10-7(11)14)12(2)9-3-8-4/h3H,1-2H3 D07WDQ DRUGINKE SLGRAIAQIAUZAQ-UHFFFAOYSA-N D07WDQ DRUGSMIL CN1C2=NC(=O)N(C(=O)C2=NC=N1)C D07WDQ HIGHSTAT Investigative D07WFG DRUG__ID D07WFG D07WFG DRUGTYPE Small molecular drug D07WFG DRUGINCH 1S/C19H17BrN2O4S/c20-16-7-9-17(10-8-16)27(25,26)22-18(19(23)21-24)12-13-5-6-14-3-1-2-4-15(14)11-13/h1-11,18,22,24H,12H2,(H,21,23)/t18-/m1/s1 D07WFG DRUGINKE WJFADFOFCRGJHM-GOSISDBHSA-N D07WFG DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC(C(=O)NO)NS(=O)(=O)C3=CC=C(C=C3)Br D07WFG HIGHSTAT Investigative D07WFH DRUG__ID D07WFH D07WFH DRUGTYPE Small molecular drug D07WFH DRUGINCH 1S/C24H27NS2/c1-20-10-6-8-14-23(20)26-18-25(17-16-22-12-4-3-5-13-22)19-27-24-15-9-7-11-21(24)2/h3-15H,16-19H2,1-2H3 D07WFH DRUGINKE XPJBCYSDRUCTBK-UHFFFAOYSA-N D07WFH DRUGSMIL CC1=CC=CC=C1SCN(CCC2=CC=CC=C2)CSC3=CC=CC=C3C D07WFH HIGHSTAT Investigative D07WFU DRUG__ID D07WFU D07WFU DRUGTYPE Small molecular drug D07WFU DRUGINCH 1S/C15H14FN/c16-14(12-7-3-1-4-8-12)11-15(14,17)13-9-5-2-6-10-13/h1-10H,11,17H2/t14-,15-/m0/s1 D07WFU DRUGINKE OGVYLPHSSJTUKP-GJZGRUSLSA-N D07WFU DRUGSMIL C1C(C1(C2=CC=CC=C2)F)(C3=CC=CC=C3)N D07WFU HIGHSTAT Investigative D07WHV DRUG__ID D07WHV D07WHV DRUGTYPE Small molecular drug D07WHV DRUGINCH 1S/C10H20N2/c1-2-8-12(9-3-1)10-4-6-11-7-5-10/h10-11H,1-9H2 D07WHV DRUGINKE QDVBKXJMLILLLB-UHFFFAOYSA-N D07WHV DRUGSMIL C1CCN(CC1)C2CCNCC2 D07WHV HIGHSTAT Investigative D07WIB DRUG__ID D07WIB D07WIB DRUGTYPE Small molecular drug D07WIB DRUGINCH 1S/C6H8O8/c7-2(8)1-6(14,5(12)13)3(9)4(10)11/h3,9,14H,1H2,(H,7,8)(H,10,11)(H,12,13) D07WIB DRUGINKE ZMJBYMUCKBYSCP-UHFFFAOYSA-N D07WIB DRUGSMIL C(C(=O)O)C(C(C(=O)O)O)(C(=O)O)O D07WIB HIGHSTAT Investigative D07WIC DRUG__ID D07WIC D07WIC DRUGTYPE Small molecular drug D07WIC DRUGINCH 1S/C30H35N3O3/c34-29(32-16-18-36-19-17-32)24-8-5-13-33(21-24)25-11-14-31(15-12-25)30(35)28-26-9-3-1-6-22(26)20-23-7-2-4-10-27(23)28/h1-4,6-7,9-10,20,24-25H,5,8,11-19,21H2/t24-/m1/s1 D07WIC DRUGINKE LDQKDRLEMKIYMC-XMMPIXPASA-N D07WIC DRUGSMIL C1CC(CN(C1)C2CCN(CC2)C(=O)C3=C4C=CC=CC4=CC5=CC=CC=C53)C(=O)N6CCOCC6 D07WIC HIGHSTAT Investigative D07WIJ DRUG__ID D07WIJ D07WIJ DRUGTYPE Small molecular drug D07WIJ DRUGINCH 1S/C15H10F2O2/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-7,14H,8H2/t14-/m1/s1 D07WIJ DRUGINKE YKJLGNVYFBPKJK-CQSZACIVSA-N D07WIJ DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)F)C3=CC=C(C=C3)F D07WIJ HIGHSTAT Investigative D07WJX DRUG__ID D07WJX D07WJX DRUGTYPE Small molecular drug D07WJX DRUGINCH 1S/C20H39NO2S/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(23)24-18-17-21-19(2)22/h3-18H2,1-2H3,(H,21,22) D07WJX DRUGINKE GDVZALUOXPTSHD-UHFFFAOYSA-N D07WJX DRUGSMIL CCCCCCCCCCCCCCCC(=O)SCCNC(=O)C D07WJX HIGHSTAT Investigative D07WLT DRUG__ID D07WLT D07WLT DRUGTYPE Small molecular drug D07WLT DRUGINCH 1S/C15H13NO/c17-15-6-5-11-8-12(3-4-13(11)9-15)14-2-1-7-16-10-14/h1-4,7-8,10H,5-6,9H2 D07WLT DRUGINKE XMIVJNDWTQQRAQ-UHFFFAOYSA-N D07WLT DRUGSMIL C1CC2=C(CC1=O)C=CC(=C2)C3=CN=CC=C3 D07WLT HIGHSTAT Investigative D07WLU DRUG__ID D07WLU D07WLU DRUGTYPE Small molecular drug D07WLU DRUGINCH 1S/C27H24O18/c28-12-1-9(2-13(29)19(12)34)23(37)42-7-18-22(45-25(39)11-5-16(32)21(36)17(33)6-11)27(41,26(40)44-18)8-43-24(38)10-3-14(30)20(35)15(31)4-10/h1-6,18,22,26,28-36,40-41H,7-8H2/t18?,22?,26-,27?/m1/s1 D07WLU DRUGINKE KCQFLGUEZXYOER-IPKUFKRGSA-N D07WLU DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C(C(C(O2)O)(COC(=O)C3=CC(=C(C(=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O D07WLU HIGHSTAT Investigative D07WLV DRUG__ID D07WLV D07WLV DRUGTYPE Small molecular drug D07WLV DRUGINCH 1S/C12H25O4P/c1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h3-4H,2,5-12H2,1H3,(H2,13,14,15)/b4-3+ D07WLV DRUGINKE FSJUVXSBVQARLY-ONEGZZNKSA-N D07WLV DRUGSMIL CCC=CCCCCCCCCOP(=O)(O)O D07WLV HIGHSTAT Investigative D07WPL DRUG__ID D07WPL D07WPL DRUGTYPE Small molecular drug D07WPL DRUGINCH 1S/C9H8N2O/c10-8-3-1-2-7-6(8)4-5-11-9(7)12/h1-5H,10H2,(H,11,12) D07WPL DRUGINKE SVASVGVAQIVSEZ-UHFFFAOYSA-N D07WPL DRUGSMIL C1=CC2=C(C=CNC2=O)C(=C1)N D07WPL HIGHSTAT Investigative D07WPM DRUG__ID D07WPM D07WPM DRUGTYPE Small molecular drug D07WPM DRUGINCH 1S/C12H9NOS/c14-11-8-15-12-6-2-1-4-10(12)13-7-3-5-9(11)13/h1-7H,8H2 D07WPM DRUGINKE WRMQVQBFXFIZIY-UHFFFAOYSA-N D07WPM DRUGSMIL C1C(=O)C2=CC=CN2C3=CC=CC=C3S1 D07WPM HIGHSTAT Investigative D07WQA DRUG__ID D07WQA D07WQA DRUGTYPE Small molecular drug D07WQA DRUGINCH 1S/C10H8O9S3/c11-20(12,13)7-1-2-9-6(3-7)4-8(21(14,15)16)5-10(9)22(17,18)19/h1-5H,(H,11,12,13)(H,14,15,16)(H,17,18,19)/p-3 D07WQA DRUGINKE ZPBSAMLXSQCSOX-UHFFFAOYSA-K D07WQA DRUGSMIL C1=CC2=C(C=C(C=C2C=C1S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] D07WQA HIGHSTAT Investigative D07WQV DRUG__ID D07WQV D07WQV DRUGTYPE Small molecular drug D07WQV DRUGINCH 1S/C29H35NO5/c31-26-20-27(35-21-22-12-14-24(15-13-22)23-8-4-3-5-9-23)25(10-6-1-2-7-11-28(32)33)29(26)30-16-18-34-19-17-30/h1-5,8-9,12-15,25,27,29H,6-7,10-11,16-21H2,(H,32,33)/b2-1-/t25-,27-,29+/m0/s1 D07WQV DRUGINKE IOFUFYLETVNNRF-OSAZKUMMSA-N D07WQV DRUGSMIL C1COCCN1C2C(C(CC2=O)OCC3=CC=C(C=C3)C4=CC=CC=C4)CCC=CCCC(=O)O D07WQV HIGHSTAT Investigative D07WRP DRUG__ID D07WRP D07WRP DRUGTYPE Small molecular drug D07WRP DRUGINCH 1S/C35H47N7O5/c1-22(25-21-37-26-12-6-5-11-24(25)26)30(31(43)38-28(14-9-10-18-36)32(44)47-35(2,3)4)40-33(45)41-19-16-23(17-20-41)42-29-15-8-7-13-27(29)39-34(42)46/h5-8,11-13,15,21-23,28,30,37H,9-10,14,16-20,36H2,1-4H3,(H,38,43)(H,39,46)(H,40,45)/t22-,28-,30+/m0/s1 D07WRP DRUGINKE WFCIXKAZBUIFTR-PKIMSIDOSA-N D07WRP DRUGSMIL CC(C1=CNC2=CC=CC=C21)C(C(=O)NC(CCCCN)C(=O)OC(C)(C)C)NC(=O)N3CCC(CC3)N4C5=CC=CC=C5NC4=O D07WRP HIGHSTAT Investigative D07WSB DRUG__ID D07WSB D07WSB DRUGTYPE Small molecular drug D07WSB DRUGINCH 1S/C20H18N2O/c1-14-6-5-9-16(12-14)17-10-11-18(21)19(13-17)22-20(23)15-7-3-2-4-8-15/h2-13H,21H2,1H3,(H,22,23) D07WSB DRUGINKE VPXVDXWJQKJAAI-UHFFFAOYSA-N D07WSB DRUGSMIL CC1=CC(=CC=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D07WSB HIGHSTAT Investigative D07WXS DRUG__ID D07WXS D07WXS DRUGTYPE Small molecular drug D07WXS DRUGINCH 1S/C4H7NO2/c5-3-1-2-7-4(3)6/h3H,1-2,5H2 D07WXS DRUGINKE QJPWUUJVYOJNMH-UHFFFAOYSA-N D07WXS DRUGSMIL C1COC(=O)C1N D07WXS HIGHSTAT Investigative D07WXT DRUG__ID D07WXT D07WXT DRUGTYPE Small molecular drug D07WXT DRUGINCH 1S/ClH.Li/h1H;/q;+1/p-1 D07WXT DRUGINKE KWGKDLIKAYFUFQ-UHFFFAOYSA-M D07WXT DRUGSMIL [Li+].[Cl-] D07WXT HIGHSTAT Investigative D07XBD DRUG__ID D07XBD D07XBD DRUGTYPE Small molecular drug D07XBD DRUGINCH 1S/C17H14O2/c1-11-16-8-4-13(10-14(16)5-9-17(11)19)12-2-6-15(18)7-3-12/h2-10,18-19H,1H3 D07XBD DRUGINKE FGIUXCLAHODWKV-UHFFFAOYSA-N D07XBD DRUGSMIL CC1=C(C=CC2=C1C=CC(=C2)C3=CC=C(C=C3)O)O D07XBD HIGHSTAT Investigative D07XBW DRUG__ID D07XBW D07XBW DRUGTYPE Small molecular drug D07XBW DRUGINCH 1S/C13H9Cl2NO3S/c14-9-6-7-11(12(15)8-9)13(17)16-20(18,19)10-4-2-1-3-5-10/h1-8H,(H,16,17) D07XBW DRUGINKE TXHQSKPOVJIXCS-UHFFFAOYSA-N D07XBW DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC(=O)C2=C(C=C(C=C2)Cl)Cl D07XBW HIGHSTAT Investigative D07XCA DRUG__ID D07XCA D07XCA DRUGTYPE Small molecular drug D07XCA DRUGINCH 1S/C24H27N3O4S/c1-17(2)20-6-4-5-7-22(20)32-23-10-8-19(16-21(23)27(30)31)9-11-24(29)26-14-12-25(13-15-26)18(3)28/h4-11,16-17H,12-15H2,1-3H3/b11-9+ D07XCA DRUGINKE HTGGAYLWTDOFDK-PKNBQFBNSA-N D07XCA DRUGSMIL CC(C)C1=CC=CC=C1SC2=C(C=C(C=C2)C=CC(=O)N3CCN(CC3)C(=O)C)[N+](=O)[O-] D07XCA HIGHSTAT Investigative D07XCB DRUG__ID D07XCB D07XCB DRUGTYPE Small molecular drug D07XCB DRUGINCH 1S/C21H16N2O2/c24-20-18-13-7-8-14-19(18)22(15-16-9-3-1-4-10-16)21(25)23(20)17-11-5-2-6-12-17/h1-14H,15H2 D07XCB DRUGINKE CUMHESHKEAHQDE-UHFFFAOYSA-N D07XCB DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=O)N(C2=O)C4=CC=CC=C4 D07XCB HIGHSTAT Investigative D07XDL DRUG__ID D07XDL D07XDL DRUGTYPE Small molecular drug D07XDL DRUGINCH 1S/C15H12N2/c1-11(15-9-16-10-17-15)13-8-4-6-12-5-2-3-7-14(12)13/h2-10H,1H2,(H,16,17) D07XDL DRUGINKE RADFITYEEZIPNJ-UHFFFAOYSA-N D07XDL DRUGSMIL C=C(C1=CC=CC2=CC=CC=C21)C3=CN=CN3 D07XDL HIGHSTAT Investigative D07XEA DRUG__ID D07XEA D07XEA DRUGTYPE Small molecular drug D07XEA DRUGINCH 1S/C16H20N2O/c17-15-11-10-12-6-5-9-14(16(12)18-15)19-13-7-3-1-2-4-8-13/h5-6,9-11,13H,1-4,7-8H2,(H2,17,18) D07XEA DRUGINKE MGAFXFCQBHUFIL-UHFFFAOYSA-N D07XEA DRUGSMIL C1CCCC(CC1)OC2=CC=CC3=C2N=C(C=C3)N D07XEA HIGHSTAT Investigative D07XFL DRUG__ID D07XFL D07XFL DRUGTYPE Small molecular drug D07XFL DRUGINCH 1S/C31H41N3O3S/c1-37-29-13-12-26-8-4-6-25(20-28(26)21-29)23-32-22-24-14-17-34(18-15-24)19-16-33-38(35,36)31-11-5-9-27-7-2-3-10-30(27)31/h2-3,5,7,9-13,21,24-25,32-33H,4,6,8,14-20,22-23H2,1H3 D07XFL DRUGINKE ITJLZSOZZWEOJL-UHFFFAOYSA-N D07XFL DRUGSMIL COC1=CC2=C(CCCC(C2)CNCC3CCN(CC3)CCNS(=O)(=O)C4=CC=CC5=CC=CC=C54)C=C1 D07XFL HIGHSTAT Investigative D07XFT DRUG__ID D07XFT D07XFT DRUGTYPE Small molecular drug D07XFT DRUGINCH 1S/C8H15N4O14P3/c9-6(15)7-10-2-12(11-7)8-5(14)4(13)3(24-8)1-23-28(19,20)26-29(21,22)25-27(16,17)18/h2-5,8,13-14H,1H2,(H2,9,15)(H,19,20)(H,21,22)(H2,16,17,18)/t3-,4-,5-,8-/m1/s1 D07XFT DRUGINKE MMJOCKKLRMRSEQ-AFCXAGJDSA-N D07XFT DRUGSMIL C1=NC(=NN1C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)C(=O)N D07XFT HIGHSTAT Investigative D07XJB DRUG__ID D07XJB D07XJB DRUGTYPE Small molecular drug D07XJB DRUGINCH 1S/C17H18O6/c1-20-13-6-5-10(7-12(13)18)16(19)11-8-14(21-2)17(23-4)15(9-11)22-3/h5-9,18H,1-4H3 D07XJB DRUGINKE HSLFWBPRHXGUAN-UHFFFAOYSA-N D07XJB DRUGSMIL COC1=C(C=C(C=C1)C(=O)C2=CC(=C(C(=C2)OC)OC)OC)O D07XJB HIGHSTAT Investigative D07XJC DRUG__ID D07XJC D07XJC DRUGTYPE Small molecular drug D07XJC DRUGINCH 1S/C18H15NO3/c1-2-12-14-7-10(20)4-6-16(14)19-18-13-5-3-11(21)8-17(13)22-9-15(12)18/h3-8,20-21H,2,9H2,1H3 D07XJC DRUGINKE OGDCTCUVBBYZTK-UHFFFAOYSA-N D07XJC DRUGSMIL CCC1=C2COC3=C(C2=NC4=C1C=C(C=C4)O)C=CC(=C3)O D07XJC HIGHSTAT Investigative D07XKG DRUG__ID D07XKG D07XKG DRUGTYPE Small molecular drug D07XKG DRUGINCH 1S/C17H17N3O/c21-17-14-10-6-12-18-16(14)19-15(20-17)11-5-4-9-13-7-2-1-3-8-13/h1-3,6-8,10,12H,4-5,9,11H2,(H,18,19,20,21) D07XKG DRUGINKE KGCFTSWBCFAQQI-UHFFFAOYSA-N D07XKG DRUGSMIL C1=CC=C(C=C1)CCCCC2=NC3=C(C=CC=N3)C(=O)N2 D07XKG HIGHSTAT Investigative D07XLJ DRUG__ID D07XLJ D07XLJ DRUGTYPE Small molecular drug D07XLJ DRUGINCH 1S/C15H15N5/c16-14-12-8-11(6-7-13(12)19-15(17)20-14)18-9-10-4-2-1-3-5-10/h1-8,18H,9H2,(H4,16,17,19,20) D07XLJ DRUGINKE PTWJNRZKGULCMJ-UHFFFAOYSA-N D07XLJ DRUGSMIL C1=CC=C(C=C1)CNC2=CC3=C(C=C2)N=C(N=C3N)N D07XLJ HIGHSTAT Investigative D07XLQ DRUG__ID D07XLQ D07XLQ DRUGTYPE Small molecular drug D07XLQ DRUGINCH 1S/C23H19NO3/c1-27-19-14-10-17(11-15-19)7-6-16-8-12-18(13-9-16)24-22(25)20-4-2-3-5-21(20)23(24)26/h2-5,8-15H,6-7H2,1H3 D07XLQ DRUGINKE CRWGIKAUSJNKIC-UHFFFAOYSA-N D07XLQ DRUGSMIL COC1=CC=C(C=C1)CCC2=CC=C(C=C2)N3C(=O)C4=CC=CC=C4C3=O D07XLQ HIGHSTAT Investigative D07XMM DRUG__ID D07XMM D07XMM DRUGTYPE Small molecular drug D07XMM DRUGINCH 1S/C16H16N2O/c1-3-12-5-7-13(8-6-12)17-16-18-14-10-11(2)4-9-15(14)19-16/h4-10H,3H2,1-2H3,(H,17,18) D07XMM DRUGINKE NQAKLIGQCZLYKC-UHFFFAOYSA-N D07XMM DRUGSMIL CCC1=CC=C(C=C1)NC2=NC3=C(O2)C=CC(=C3)C D07XMM HIGHSTAT Investigative D07XMV DRUG__ID D07XMV D07XMV DRUGTYPE Small molecular drug D07XMV DRUGINCH 1S/C22H30N4O2S/c1-24(11-12-28-3)14-16-9-10-19-18(13-16)23-22-26(19)15-20(29-22)21(27)25(2)17-7-5-4-6-8-17/h9-10,13,15,17H,4-8,11-12,14H2,1-3H3 D07XMV DRUGINKE YDAIWUAWYILYPH-UHFFFAOYSA-N D07XMV DRUGSMIL CN(CCOC)CC1=CC2=C(C=C1)N3C=C(SC3=N2)C(=O)N(C)C4CCCCC4 D07XMV HIGHSTAT Investigative D07XNJ DRUG__ID D07XNJ D07XNJ DRUGTYPE Small molecular drug D07XNJ DRUGINCH 1S/C6H13O7P/c1-6(9,4-5(7)8)2-3-13-14(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H2,10,11,12)/t6-/m1/s1 D07XNJ DRUGINKE OKZYCXHTTZZYSK-ZCFIWIBFSA-N D07XNJ DRUGSMIL CC(CCOP(=O)(O)O)(CC(=O)O)O D07XNJ HIGHSTAT Investigative D07XQR DRUG__ID D07XQR D07XQR DRUGTYPE Small molecular drug D07XQR DRUGINCH 1S/C18H18Cl2N2O2/c1-11-3-5-13(19)9-15(11)21-17(23)7-8-18(24)22-16-10-14(20)6-4-12(16)2/h3-6,9-10H,7-8H2,1-2H3,(H,21,23)(H,22,24) D07XQR DRUGINKE GNEGOXDKOUMPJX-UHFFFAOYSA-N D07XQR DRUGSMIL CC1=C(C=C(C=C1)Cl)NC(=O)CCC(=O)NC2=C(C=CC(=C2)Cl)C D07XQR HIGHSTAT Investigative D07XTU DRUG__ID D07XTU D07XTU DRUGTYPE Small molecular drug D07XTU DRUGINCH 1S/C11H16INO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3 D07XTU DRUGINKE BGMZUEKZENQUJY-UHFFFAOYSA-N D07XTU DRUGSMIL CC(CC1=CC(=C(C=C1OC)I)OC)N D07XTU HIGHSTAT Investigative D07XUM DRUG__ID D07XUM D07XUM DRUGTYPE Small molecular drug D07XUM DRUGINCH 1S/C27H29F2N3O2/c1-34-27(33)25-4-2-14-30-26(25)32-18-16-31(17-19-32)15-3-5-24(20-6-10-22(28)11-7-20)21-8-12-23(29)13-9-21/h2,4,6-14,24H,3,5,15-19H2,1H3 D07XUM DRUGINKE NDCPNKXUTJGQQC-UHFFFAOYSA-N D07XUM DRUGSMIL COC(=O)C1=C(N=CC=C1)N2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D07XUM HIGHSTAT Investigative D07XUY DRUG__ID D07XUY D07XUY DRUGTYPE Small molecular drug D07XUY DRUGINCH 1S/C16H14O5/c1-8-11(18)6-12(19)15-13(20)7-14(21-16(8)15)9-2-4-10(17)5-3-9/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1 D07XUY DRUGINKE GMVYLXBMPRDZDR-AWEZNQCLSA-N D07XUY DRUGSMIL CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D07XUY HIGHSTAT Investigative D07XWB DRUG__ID D07XWB D07XWB DRUGTYPE Small molecular drug D07XWB DRUGINCH 1S/C14H16N2O2S/c1-2-3-8-16-14(17)18-12-6-4-11(5-7-12)13-15-9-10-19-13/h4-7,9-10H,2-3,8H2,1H3,(H,16,17) D07XWB DRUGINKE HIQUBTZOYOZSPC-UHFFFAOYSA-N D07XWB DRUGSMIL CCCCNC(=O)OC1=CC=C(C=C1)C2=NC=CS2 D07XWB HIGHSTAT Investigative D07XWC DRUG__ID D07XWC D07XWC DRUGTYPE Small molecular drug D07XWC DRUGINCH 1S/C20H21BrN8/c1-13-9-23-18-17(13)19(26-12-25-18)28-6-7-29(14(2)10-28)20(24-11-22)27-16-5-3-4-15(21)8-16/h3-5,8-9,12,14H,6-7,10H2,1-2H3,(H,24,27)(H,23,25,26)/t14-/m0/s1 D07XWC DRUGINKE KSECQYDNQYAZMQ-AWEZNQCLSA-N D07XWC DRUGSMIL CC1CN(CCN1C(=NC2=CC(=CC=C2)Br)NC#N)C3=NC=NC4=C3C(=CN4)C D07XWC HIGHSTAT Investigative D07XXK DRUG__ID D07XXK D07XXK DRUGTYPE Small molecular drug D07XXK DRUGINCH 1S/C16H12N2O3S/c19-15-10-11-16(18-17-15)22(20,21)14-9-5-4-8-13(14)12-6-2-1-3-7-12/h1-11H,(H,17,19) D07XXK DRUGINKE PICCQCWBQAQOHS-UHFFFAOYSA-N D07XXK DRUGSMIL C1=CC=C(C=C1)C2=CC=CC=C2S(=O)(=O)C3=NNC(=O)C=C3 D07XXK HIGHSTAT Investigative D07XXX DRUG__ID D07XXX D07XXX DRUGTYPE Small molecular drug D07XXX DRUGINCH 1S/C33H39N5O5/c34-26(20-24-13-16-25(39)17-14-24)33(43)38-19-7-12-29(38)32(42)37-28(21-23-10-5-2-6-11-23)31(41)36-27(30(35)40)18-15-22-8-3-1-4-9-22/h1-6,8-11,13-14,16-17,26-29,39H,7,12,15,18-21,34H2,(H2,35,40)(H,36,41)(H,37,42)/t26-,27-,28-,29-/m0/s1 D07XXX DRUGINKE KEZWZCZPOVYKBN-DZUOILHNSA-N D07XXX DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCC4=CC=CC=C4)C(=O)N D07XXX HIGHSTAT Investigative D07XZP DRUG__ID D07XZP D07XZP DRUGTYPE Small molecular drug D07XZP DRUGINCH 1S/C22H17N3O/c26-22(18-12-6-2-7-13-18)24-21-20(17-10-4-1-5-11-17)16-23-25(21)19-14-8-3-9-15-19/h1-16H,(H,24,26) D07XZP DRUGINKE HIJQHIKXNPDXIT-UHFFFAOYSA-N D07XZP DRUGSMIL C1=CC=C(C=C1)C2=C(N(N=C2)C3=CC=CC=C3)NC(=O)C4=CC=CC=C4 D07XZP HIGHSTAT Investigative D07XZT DRUG__ID D07XZT D07XZT DRUGTYPE Small molecular drug D07XZT DRUGINCH 1S/C9H15N3O11P2/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D07XZT DRUGINKE ZWIADYZPOWUWEW-XVFCMESISA-N D07XZT DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)O)O)O D07XZT HIGHSTAT Investigative D07YDN DRUG__ID D07YDN D07YDN DRUGTYPE Small molecular drug D07YDN DRUGINCH 1S/C16H12O7/c1-22-11-4-7(2-3-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3 D07YDN DRUGINKE IZQSVPBOUDKVDZ-UHFFFAOYSA-N D07YDN DRUGSMIL COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O D07YDN HIGHSTAT Investigative D07YFL DRUG__ID D07YFL D07YFL DRUGTYPE Small molecular drug D07YFL DRUGINCH 1S/C15H19N3O2/c1-3-13-11(4-7-16-10(2)19)15-12-6-9-20-14(12)5-8-18(15)17-13/h5,8H,3-4,6-7,9H2,1-2H3,(H,16,19) D07YFL DRUGINKE IZDHETWMKYCGAU-UHFFFAOYSA-N D07YFL DRUGSMIL CCC1=NN2C=CC3=C(C2=C1CCNC(=O)C)CCO3 D07YFL HIGHSTAT Investigative D07YFY DRUG__ID D07YFY D07YFY DRUGTYPE Small molecular drug D07YFY DRUGINCH 1S/C20H23N3O3/c1-14(24)22-18(13-16-10-6-3-7-11-16)20(26)23-17(19(21)25)12-15-8-4-2-5-9-15/h2-11,17-18H,12-13H2,1H3,(H2,21,25)(H,22,24)(H,23,26)/t17-,18-/m0/s1 D07YFY DRUGINKE MRIDWVSVNKEVEJ-ROUUACIJSA-N D07YFY DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)N D07YFY HIGHSTAT Investigative D07YGR DRUG__ID D07YGR D07YGR DRUGTYPE Small molecular drug D07YGR DRUGINCH 1S/C20H24N2O2/c1-24-20(23)19(17-7-3-2-4-8-17)18-9-5-6-14-22(18)15-16-10-12-21-13-11-16/h2-4,7-8,10-13,18-19H,5-6,9,14-15H2,1H3/t18-,19-/m1/s1 D07YGR DRUGINKE RLLOCIZJNXWKIC-RTBURBONSA-N D07YGR DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=NC=C2)C3=CC=CC=C3 D07YGR HIGHSTAT Investigative D07YJG DRUG__ID D07YJG D07YJG DRUGTYPE Small molecular drug D07YJG DRUGINCH 1S/C21H32N2.2BrH/c1(2-4-6-10-16-22-18-12-8-13-19-22)3-5-7-11-17-23-20-14-9-15-21-23;;/h8-9,12-15,18-21H,1-7,10-11,16-17H2;2*1H/q+2;;/p-2 D07YJG DRUGINKE RCBQYFFDMCXGIU-UHFFFAOYSA-L D07YJG DRUGSMIL C1=CC=[N+](C=C1)CCCCCCCCCCC[N+]2=CC=CC=C2.[Br-].[Br-] D07YJG HIGHSTAT Investigative D07YKU DRUG__ID D07YKU D07YKU DRUGTYPE Small molecular drug D07YKU DRUGINCH 1S/C12H10N2S2/c1-2-10-13-8-5-7-16-12(8)11(14-10)9-4-3-6-15-9/h3-7H,2H2,1H3 D07YKU DRUGINKE HTDFKCHXFHIXPU-UHFFFAOYSA-N D07YKU DRUGSMIL CCC1=NC2=C(C(=N1)C3=CC=CS3)SC=C2 D07YKU HIGHSTAT Investigative D07YNF DRUG__ID D07YNF D07YNF DRUGTYPE Small molecular drug D07YNF DRUGINCH 1S/C21H24FN3O2/c22-17-9-4-8-16(12-17)14-24-20(26)19-10-5-11-25(19)21(27)18(23)13-15-6-2-1-3-7-15/h1-4,6-9,12,18-19H,5,10-11,13-14,23H2,(H,24,26)/t18-,19+/m1/s1 D07YNF DRUGINKE JGZSVYZIJHGHMA-MOPGFXCFSA-N D07YNF DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)NCC3=CC(=CC=C3)F D07YNF HIGHSTAT Investigative D07YPS DRUG__ID D07YPS D07YPS DRUGTYPE Small molecular drug D07YPS DRUGINCH 1S/C13H10O3/c14-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)15/h1-8,14-15H D07YPS DRUGINKE HUYKZYIAFUBPAQ-UHFFFAOYSA-N D07YPS DRUGSMIL C1=CC=C(C(=C1)C(=O)C2=CC=C(C=C2)O)O D07YPS HIGHSTAT Investigative D07YQG DRUG__ID D07YQG D07YQG DRUGTYPE Small molecular drug D07YQG DRUGINCH 1S/C28H41NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-28(32)29-23-22-25-20-21-26(30)27(31)24-25/h6-7,9-10,12-13,15-16,20-21,24,30-31H,2-5,8,11,14,17-19,22-23H2,1H3,(H,29,32)/b7-6-,10-9-,13-12-,16-15- D07YQG DRUGINKE MVVPIAAVGAWJNQ-DOFZRALJSA-N D07YQG DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCC1=CC(=C(C=C1)O)O D07YQG HIGHSTAT Investigative D07YQY DRUG__ID D07YQY D07YQY DRUGTYPE Small molecular drug D07YQY DRUGINCH 1S/C26H25NO4/c1-30-23-13-20-17(12-22(23)28)8-9-19-18-10-11-27(14-16-6-4-3-5-7-16)15-21(18)25(29)26(31-2)24(19)20/h3-9,12-13,28-29H,10-11,14-15H2,1-2H3 D07YQY DRUGINKE ITXWZNATGXDCEV-UHFFFAOYSA-N D07YQY DRUGSMIL COC1=C(C=C2C=CC3=C4CCN(CC4=C(C(=C3C2=C1)OC)O)CC5=CC=CC=C5)O D07YQY HIGHSTAT Investigative D07YSJ DRUG__ID D07YSJ D07YSJ DRUGTYPE Small molecular drug D07YSJ DRUGINCH 1S/C6H16NO2P/c1-3-6(4-5-7)10(2,8)9/h6H,3-5,7H2,1-2H3,(H,8,9) D07YSJ DRUGINKE CCGFQGUALPHBIC-UHFFFAOYSA-N D07YSJ DRUGSMIL CCC(CCN)P(=O)(C)O D07YSJ HIGHSTAT Investigative D07YSQ DRUG__ID D07YSQ D07YSQ DRUGTYPE Small molecular drug D07YSQ DRUGINCH 1S/C15H17N3O5S2/c16-24(20,21)13-5-1-11(2-6-13)9-10-18-15(19)12-3-7-14(8-4-12)25(17,22)23/h1-8H,9-10H2,(H,18,19)(H2,16,20,21)(H2,17,22,23) D07YSQ DRUGINKE DTWPVNTYGDBHCV-UHFFFAOYSA-N D07YSQ DRUGSMIL C1=CC(=CC=C1CCNC(=O)C2=CC=C(C=C2)S(=O)(=O)N)S(=O)(=O)N D07YSQ HIGHSTAT Investigative D07YTL DRUG__ID D07YTL D07YTL DRUGTYPE Small molecular drug D07YTL DRUGINCH 1S/C21H21NO4/c1-20(2)15-10-7-13(11-16(15)21(3,4)19(20)26)17(23)22-14-8-5-12(6-9-14)18(24)25/h5-11H,1-4H3,(H,22,23)(H,24,25) D07YTL DRUGINKE KFBPBWUZXBYJDG-UHFFFAOYSA-N D07YTL DRUGSMIL CC1(C2=C(C=C(C=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)C(C1=O)(C)C)C D07YTL HIGHSTAT Investigative D07YUV DRUG__ID D07YUV D07YUV DRUGTYPE Small molecular drug D07YUV DRUGINCH 1S/C14H29O4P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-19(15,16)17/h5-6H,2-4,7-14H2,1H3,(H2,15,16,17)/b6-5+ D07YUV DRUGINKE UNBFYEIEMBSWCK-AATRIKPKSA-N D07YUV DRUGSMIL CCCCC=CCCCCCCCCOP(=O)(O)O D07YUV HIGHSTAT Investigative D07YXL DRUG__ID D07YXL D07YXL DRUGTYPE Small molecular drug D07YXL DRUGINCH 1S/C5H9F2NO2S/c6-5(7)11-2-1-3(8)4(9)10/h3,5H,1-2,8H2,(H,9,10)/t3-/m0/s1 D07YXL DRUGINKE YHBNXKYHZMAFED-VKHMYHEASA-N D07YXL DRUGSMIL C(CSC(F)F)C(C(=O)O)N D07YXL HIGHSTAT Investigative D07YXP DRUG__ID D07YXP D07YXP DRUGTYPE Small molecular drug D07YXP DRUGINCH 1S/C27H24N4/c1(6-16-30-24-10-4-2-8-20(24)22-12-14-28-18-26(22)30)7-17-31-25-11-5-3-9-21(25)23-13-15-29-19-27(23)31/h2-5,8-15,18-19H,1,6-7,16-17H2 D07YXP DRUGINKE MRZCXQWEBCLSNO-UHFFFAOYSA-N D07YXP DRUGSMIL C1=CC=C2C(=C1)C3=C(N2CCCCCN4C5=CC=CC=C5C6=C4C=NC=C6)C=NC=C3 D07YXP HIGHSTAT Investigative D07YZD DRUG__ID D07YZD D07YZD DRUGTYPE Small molecular drug D07YZD DRUGINCH 1S/C9H9N3O2/c13-12(14)8-3-1-2-7(6-8)9-10-4-5-11-9/h1-3,6H,4-5H2,(H,10,11) D07YZD DRUGINKE YSCJJOXSVFNSPY-UHFFFAOYSA-N D07YZD DRUGSMIL C1CN=C(N1)C2=CC(=CC=C2)[N+](=O)[O-] D07YZD HIGHSTAT Investigative D07YZZ DRUG__ID D07YZZ D07YZZ DRUGTYPE Small molecular drug D07YZZ DRUGINCH 1S/C8H16N2O4/c11-7(9-13)5-3-1-2-4-6-8(12)10-14/h13-14H,1-6H2,(H,9,11)(H,10,12) D07YZZ DRUGINKE IDQPVOFTURLJPT-UHFFFAOYSA-N D07YZZ DRUGSMIL C(CCCC(=O)NO)CCC(=O)NO D07YZZ HIGHSTAT Investigative D07ZAJ DRUG__ID D07ZAJ D07ZAJ DRUGTYPE Small molecular drug D07ZAJ DRUGINCH 1S/C45H85O19P3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(46)59-35-37(61-39(47)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)36-60-67(57,58)64-43-40(48)41(49)44(62-65(51,52)53)45(42(43)50)63-66(54,55)56/h17-20,37,40-45,48-50H,3-16,21-36H2,1-2H3,(H,57,58)(H2,51,52,53)(H2,54,55,56)/b19-17-,20-18-/t37-,40-,41+,42+,43-,44-,45-/m1/s1 D07ZAJ DRUGINKE IGQSAMXNWMLOOS-GGDMTQDZSA-N D07ZAJ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O)OC(=O)CCCCCCCC=CCCCCCCCC D07ZAJ HIGHSTAT Investigative D07ZAV DRUG__ID D07ZAV D07ZAV DRUGTYPE Small molecular drug D07ZAV DRUGINCH 1S/C10H14O3S/c1-2-3-4-14-7-8-5-9(11)10(12)6-13-8/h5-6,12H,2-4,7H2,1H3 D07ZAV DRUGINKE PJEUFTMKXABORH-UHFFFAOYSA-N D07ZAV DRUGSMIL CCCCSCC1=CC(=O)C(=CO1)O D07ZAV HIGHSTAT Investigative D07ZBH DRUG__ID D07ZBH D07ZBH DRUGTYPE Small molecular drug D07ZBH DRUGINCH 1S/C7H9NO/c8-5-6-1-3-7(9)4-2-6/h1-4,9H,5,8H2 D07ZBH DRUGINKE RQJDUEKERVZLLU-UHFFFAOYSA-N D07ZBH DRUGSMIL C1=CC(=CC=C1CN)O D07ZBH HIGHSTAT Investigative D07ZCD DRUG__ID D07ZCD D07ZCD DRUGTYPE Small molecular drug D07ZCD DRUGINCH 1S/C16H15N/c1-12-2-3-14-4-5-15(16(14)10-12)11-13-6-8-17-9-7-13/h2-3,6-11H,4-5H2,1H3/b15-11- D07ZCD DRUGINKE JRWJGUYEZHCVMC-PTNGSMBKSA-N D07ZCD DRUGSMIL CC1=CC2=C(CCC2=CC3=CC=NC=C3)C=C1 D07ZCD HIGHSTAT Investigative D07ZFN DRUG__ID D07ZFN D07ZFN DRUGTYPE Small molecular drug D07ZFN DRUGINCH 1S/C11H10BrN3O2/c1-6-2-4-7(5-3-6)13-9-8(12)10(16)15-11(17)14-9/h2-5H,1H3,(H3,13,14,15,16,17) D07ZFN DRUGINKE XCZQWOVVHWQUMF-UHFFFAOYSA-N D07ZFN DRUGSMIL CC1=CC=C(C=C1)NC2=C(C(=O)NC(=O)N2)Br D07ZFN HIGHSTAT Investigative D07ZGV DRUG__ID D07ZGV D07ZGV DRUGTYPE Small molecular drug D07ZGV DRUGINCH 1S/C26H25N5O6S/c1-36-18-10-4-15(5-11-18)13-29-25(34)22(16-6-8-17(32)9-7-16)31(14-19-3-2-12-37-19)26(35)23-20(27)21(24(28)33)30-38-23/h2-12,22,32H,13-14,27H2,1H3,(H2,28,33)(H,29,34) D07ZGV DRUGINKE TVONKIFIPYRNRD-UHFFFAOYSA-N D07ZGV DRUGSMIL COC1=CC=C(C=C1)CNC(=O)C(C2=CC=C(C=C2)O)N(CC3=CC=CO3)C(=O)C4=C(C(=NS4)C(=O)N)N D07ZGV HIGHSTAT Investigative D07ZHE DRUG__ID D07ZHE D07ZHE DRUGTYPE Small molecular drug D07ZHE DRUGINCH 1S/C6H6N2O4S/c7-13(11,12)6-3-1-2-5(4-6)8(9)10/h1-4H,(H2,7,11,12) D07ZHE DRUGINKE TXTQURPQLVHJRE-UHFFFAOYSA-N D07ZHE DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)[N+](=O)[O-] D07ZHE HIGHSTAT Investigative D07ZIG DRUG__ID D07ZIG D07ZIG DRUGTYPE Small molecular drug D07ZIG DRUGINCH 1S/C19H20N2O4/c20-16(9-12-5-7-15(22)8-6-12)18(23)21-11-14-4-2-1-3-13(14)10-17(21)19(24)25/h1-8,16-17,22H,9-11,20H2,(H,24,25)/t16-,17-/m0/s1 D07ZIG DRUGINKE VUOZTGVYOFFWCN-IRXDYDNUSA-N D07ZIG DRUGSMIL C1C(N(CC2=CC=CC=C21)C(=O)C(CC3=CC=C(C=C3)O)N)C(=O)O D07ZIG HIGHSTAT Investigative D07ZJM DRUG__ID D07ZJM D07ZJM DRUGTYPE Small molecular drug D07ZJM DRUGINCH 1S/C30H46O3/c1-25(2)12-14-30(24(32)33)15-13-28(6)20(21(30)18-25)8-9-23-27(5)17-19(31)16-26(3,4)22(27)10-11-29(23,28)7/h8,21-23H,9-18H2,1-7H3,(H,32,33)/t21-,22-,23+,27-,28+,29+,30-/m0/s1 D07ZJM DRUGINKE RHPBUWJZKONKCT-CDNBJWEZSA-N D07ZJM DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(=O)CC5(C)C)C)C)C2C1)C)C(=O)O)C D07ZJM HIGHSTAT Investigative D07ZJS DRUG__ID D07ZJS D07ZJS DRUGTYPE Small molecular drug D07ZJS DRUGINCH 1S/C19H23NO/c1-2-6-16(7-3-1)14-17-9-11-19(12-10-17)21-15-18-8-4-5-13-20-18/h1-3,6-7,9-12,18,20H,4-5,8,13-15H2 D07ZJS DRUGINKE YZRAMLLKPOGYCE-UHFFFAOYSA-N D07ZJS DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)CC3=CC=CC=C3 D07ZJS HIGHSTAT Investigative D07ZMW DRUG__ID D07ZMW D07ZMW DRUGTYPE Small molecular drug D07ZMW DRUGINCH 1S/C17H12N4S/c18-17-21-15(13-7-3-4-10-19-13)16(22-17)14-9-8-11-5-1-2-6-12(11)20-14/h1-10H,(H2,18,21) D07ZMW DRUGINKE XYMCAGVJYOESBU-UHFFFAOYSA-N D07ZMW DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)C3=C(N=C(S3)N)C4=CC=CC=N4 D07ZMW HIGHSTAT Investigative D07ZNO DRUG__ID D07ZNO D07ZNO DRUGTYPE Small molecular drug D07ZNO DRUGINCH 1S/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24+ D07ZNO DRUGINKE YYGNTYWPHWGJRM-AAJYLUCBSA-N D07ZNO DRUGSMIL CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C D07ZNO HIGHSTAT Investigative D07ZNP DRUG__ID D07ZNP D07ZNP DRUGTYPE Small molecular drug D07ZNP DRUGINCH 1S/C33H48N6O5/c1-3-22(2)29(38-30(40)27(19-23-8-5-4-6-9-23)37-31(41)28-12-15-36-44-28)32(42)35-21-25-10-7-11-26(18-25)33(43)39-16-13-24(20-34)14-17-39/h7,10-12,15,18,22-24,27,29H,3-6,8-9,13-14,16-17,19-21,34H2,1-2H3,(H,35,42)(H,37,41)(H,38,40)/t22?,27-,29-/m0/s1 D07ZNP DRUGINKE HXLQLJFWNKMGET-KCPQSXFMSA-N D07ZNP DRUGSMIL CCC(C)C(C(=O)NCC1=CC(=CC=C1)C(=O)N2CCC(CC2)CN)NC(=O)C(CC3CCCCC3)NC(=O)C4=CC=NO4 D07ZNP HIGHSTAT Investigative D07ZNR DRUG__ID D07ZNR D07ZNR DRUGTYPE Small molecular drug D07ZNR DRUGINCH 1S/C12HF9N2O/c13-1-2(14)4(16)10(5(17)3(1)15)22-23-11-6(18)8(20)12(24)9(21)7(11)19/h24H D07ZNR DRUGINKE JYNSAKFWNZEUTH-UHFFFAOYSA-N D07ZNR DRUGSMIL C1(=C(C(=C(C(=C1F)F)O)F)F)N=NC2=C(C(=C(C(=C2F)F)F)F)F D07ZNR HIGHSTAT Investigative D07ZOP DRUG__ID D07ZOP D07ZOP DRUGTYPE Small molecular drug D07ZOP DRUGINCH 1S/C16H23NO/c1-3-7-15(17-10-4-5-11-17)16(18)14-9-6-8-13(2)12-14/h6,8-9,12,15H,3-5,7,10-11H2,1-2H3 D07ZOP DRUGINKE HHSYAWUBPBEDMP-UHFFFAOYSA-N D07ZOP DRUGSMIL CCCC(C(=O)C1=CC=CC(=C1)C)N2CCCC2 D07ZOP HIGHSTAT Investigative D07ZQB DRUG__ID D07ZQB D07ZQB DRUGTYPE Small molecular drug D07ZQB DRUGINCH 1S/C20H24N6O5/c1-3-21-19(29)16-14(27)15(28)20(31-16)26-10-25-13-17(23-9-24-18(13)26)22-8-11-4-6-12(30-2)7-5-11/h4-7,9-10,14-16,20,27-28H,3,8H2,1-2H3,(H,21,29)(H,22,23,24)/t14-,15+,16-,20+/m0/s1 D07ZQB DRUGINKE BNXGNSTUSRFBCI-KSVNGYGVSA-N D07ZQB DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NCC4=CC=C(C=C4)OC)O)O D07ZQB HIGHSTAT Investigative D07ZQU DRUG__ID D07ZQU D07ZQU DRUGTYPE Small molecular drug D07ZQU DRUGINCH 1S/C12H17NO3/c1-9(14)13-7-3-4-10-5-6-11(15)12(8-10)16-2/h5-6,8,15H,3-4,7H2,1-2H3,(H,13,14) D07ZQU DRUGINKE YOLSQHAXCLGSKL-UHFFFAOYSA-N D07ZQU DRUGSMIL CC(=O)NCCCC1=CC(=C(C=C1)O)OC D07ZQU HIGHSTAT Investigative D07ZRG DRUG__ID D07ZRG D07ZRG DRUGTYPE Small molecular drug D07ZRG DRUGINCH 1S/C26H36N8O4S/c27-23(28)20-12-10-18(11-13-20)16-32-24(35)22-9-5-15-34(22)25(36)21(8-4-14-31-26(29)30)33-39(37,38)17-19-6-2-1-3-7-19/h1-3,6-7,10-13,21-22,33H,4-5,8-9,14-17H2,(H3,27,28)(H,32,35)(H4,29,30,31)/t21-,22+/m1/s1 D07ZRG DRUGINKE QKFCYPKTTJCUSZ-YADHBBJMSA-N D07ZRG DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NS(=O)(=O)CC2=CC=CC=C2)C(=O)NCC3=CC=C(C=C3)C(=N)N D07ZRG HIGHSTAT Investigative D07ZRU DRUG__ID D07ZRU D07ZRU DRUGTYPE Small molecular drug D07ZRU DRUGINCH 1S/C18H12Cl2N2O4/c19-7-15(23)21-9-1-3-11-13(5-9)18(26)14-6-10(22-16(24)8-20)2-4-12(14)17(11)25/h1-6H,7-8H2,(H,21,23)(H,22,24) D07ZRU DRUGINKE MKVRAGYBTIZOIV-UHFFFAOYSA-N D07ZRU DRUGSMIL C1=CC2=C(C=C1NC(=O)CCl)C(=O)C3=C(C2=O)C=CC(=C3)NC(=O)CCl D07ZRU HIGHSTAT Investigative D07ZTG DRUG__ID D07ZTG D07ZTG DRUGTYPE Small molecular drug D07ZTG DRUGINCH 1S/C23H39N3O6S2/c1-4-16(2)20(25-13-18(24)15-33)14-32-21(12-17-8-6-5-7-9-17)22(27)26-19(23(28)29)10-11-34(3,30)31/h5-9,16,18-21,25,33H,4,10-15,24H2,1-3H3,(H,26,27)(H,28,29)/t16-,18+,19-,20+,21-/m0/s1 D07ZTG DRUGINKE SIEXHGZWGJLLAC-OSTWSGHESA-N D07ZTG DRUGSMIL CCC(C)C(COC(CC1=CC=CC=C1)C(=O)NC(CCS(=O)(=O)C)C(=O)O)NCC(CS)N D07ZTG HIGHSTAT Investigative D07ZUI DRUG__ID D07ZUI D07ZUI DRUGTYPE Small molecular drug D07ZUI DRUGINCH 1S/C46H66N14O9S/c1-24(2)14-34(43(66)57-33(40(47)63)12-13-70-7)58-45(68)37(17-30-20-49-23-53-30)56-38(62)21-51-46(69)39(25(3)4)60-41(64)26(5)54-42(65)35(15-28-18-50-32-11-9-8-10-31(28)32)59-44(67)36(55-27(6)61)16-29-19-48-22-52-29/h8-11,18-20,22-26,33-37,39,50H,12-17,21H2,1-7H3,(H2,47,63)(H,48,52)(H,49,53)(H,51,69)(H,54,65)(H,55,61)(H,56,62)(H,57,66)(H,58,68)(H,59,67)(H,60,64)/t26-,33-,34-,35-,36-,37-,39-/m0/s1 D07ZUI DRUGINKE PESSCGOLEUORDO-IFIOYJEKSA-N D07ZUI DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C D07ZUI HIGHSTAT Investigative D07ZVP DRUG__ID D07ZVP D07ZVP DRUGTYPE Small molecular drug D07ZVP DRUGINCH 1S/C7H11N3S/c1-5-3-4-6(2)10(5)9-7(8)11/h3-4H,1-2H3,(H3,8,9,11) D07ZVP DRUGINKE XNQJQAUTZJGWDW-UHFFFAOYSA-N D07ZVP DRUGSMIL CC1=CC=C(N1NC(=S)N)C D07ZVP HIGHSTAT Investigative D07ZWN DRUG__ID D07ZWN D07ZWN DRUGTYPE Small molecular drug D07ZWN DRUGINCH 1S/C15H13NS/c1-10-5-11(2)14-7-13(8-16-15(14)6-10)12-3-4-17-9-12/h3-9H,1-2H3 D07ZWN DRUGINKE YXZQRTLGEGYVTJ-UHFFFAOYSA-N D07ZWN DRUGSMIL CC1=CC(=C2C=C(C=NC2=C1)C3=CSC=C3)C D07ZWN HIGHSTAT Investigative D07ZXR DRUG__ID D07ZXR D07ZXR DRUGTYPE Small molecular drug D07ZXR DRUGINCH 1S/C12H28N2O6S2/c13-21(15,16)19-11-9-7-5-3-1-2-4-6-8-10-12-20-22(14,17)18/h1-12H2,(H2,13,15,16)(H2,14,17,18) D07ZXR DRUGINKE ZTCHMZGWTCOWRR-UHFFFAOYSA-N D07ZXR DRUGSMIL C(CCCCCCOS(=O)(=O)N)CCCCCOS(=O)(=O)N D07ZXR HIGHSTAT Investigative D07ZYE DRUG__ID D07ZYE D07ZYE DRUGTYPE Small molecular drug D07ZYE DRUGINCH 1S/C28H38N8O6/c1-5-19(32-25(38)20(14-17(2)3)33-28(40)42-15-18-10-7-6-8-11-18)22(37)26(39)30-12-9-13-36-16-31-21-23(29)34-27(41-4)35-24(21)36/h6-8,10-11,16-17,19-20H,5,9,12-15H2,1-4H3,(H,30,39)(H,32,38)(H,33,40)(H2,29,34,35)/t19?,20-/m0/s1 D07ZYE DRUGINKE MBPXUEHDROHPFW-ANYOKISRSA-N D07ZYE DRUGSMIL CCC(C(=O)C(=O)NCCCN1C=NC2=C(N=C(N=C21)OC)N)NC(=O)C(CC(C)C)NC(=O)OCC3=CC=CC=C3 D07ZYE HIGHSTAT Investigative D07ZYL DRUG__ID D07ZYL D07ZYL DRUGTYPE Small molecular drug D07ZYL DRUGINCH 1S/C16H15NO/c1-18-15-4-5-16-13(2-3-14(16)11-15)10-12-6-8-17-9-7-12/h4-11H,2-3H2,1H3/b13-10- D07ZYL DRUGINKE VDGYNVYFCLIMOF-RAXLEYEMSA-N D07ZYL DRUGSMIL COC1=CC2=C(C=C1)C(=CC3=CC=NC=C3)CC2 D07ZYL HIGHSTAT Investigative D07ZZD DRUG__ID D07ZZD D07ZZD DRUGTYPE Small molecular drug D07ZZD DRUGINCH 1S/C14H17N3O/c1-2-4-13-12(3-1)15-14(18-13)17-10-9-16-7-5-11(17)6-8-16/h1-4,11H,5-10H2 D07ZZD DRUGINKE CXJLWJAYGMWLRR-UHFFFAOYSA-N D07ZZD DRUGSMIL C1CN2CCC1N(CC2)C3=NC4=CC=CC=C4O3 D07ZZD HIGHSTAT Investigative D07ZZG DRUG__ID D07ZZG D07ZZG DRUGTYPE Small molecular drug D07ZZG DRUGINCH 1S/C18H29NO4/c1-14(2)19-11-16(20)13-23-18-7-5-17(6-8-18)22-10-9-21-12-15-3-4-15/h5-8,14-16,19-20H,3-4,9-13H2,1-2H3 D07ZZG DRUGINKE JNDJPKHYZWRRIS-UHFFFAOYSA-N D07ZZG DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)OCCOCC2CC2)O D07ZZG HIGHSTAT Investigative D08AAP DRUG__ID D08AAP D08AAP DRUGTYPE Small molecular drug D08AAP DRUGINCH 1S/C18H14Cl2N4O/c1-25-14-9-7-13(8-10-14)17(12-5-3-2-4-6-12)23-22-15-11-21-24-18(20)16(15)19/h2-11H,1H3,(H,22,24)/b23-17+ D08AAP DRUGINKE XOZNAUCJQWYKHM-HAVVHWLPSA-N D08AAP DRUGSMIL COC1=CC=C(C=C1)C(=NNC2=CN=NC(=C2Cl)Cl)C3=CC=CC=C3 D08AAP HIGHSTAT Investigative D08ABU DRUG__ID D08ABU D08ABU DRUGTYPE Small molecular drug D08ABU DRUGINCH 1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21?,22+,23-,26-,27+,28+,29-,30-/m1/s1 D08ABU DRUGINKE MPDGHEJMBKOTSU-NFYGSHHYSA-N D08ABU DRUGSMIL CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C D08ABU HIGHSTAT Investigative D08ACB DRUG__ID D08ACB D08ACB DRUGTYPE Small molecular drug D08ACB DRUGINCH 1S/C27H43NO8/c1-14-4-7-18-22(3,31)26(34)17(12-28(18)11-14)24(33)13-25-16(23(24,32)10-20(26)30)6-5-15-21(25,2)9-8-19(29)27(15,35)36-25/h14-20,29-35H,4-13H2,1-3H3 D08ACB DRUGINKE MZHXYVMEVBEFAL-UHFFFAOYSA-N D08ACB DRUGSMIL CC1CCC2C(C3(C(CC4(C5CCC6C7(C5(CC4(C3CN2C1)O)OC6(C(CC7)O)O)C)O)O)O)(C)O D08ACB HIGHSTAT Investigative D08ADI DRUG__ID D08ADI D08ADI DRUGTYPE Small molecular drug D08ADI DRUGINCH 1S/C19H16ClNO/c1-14-8-17(16-5-3-7-21-12-16)11-19(9-14)22-13-15-4-2-6-18(20)10-15/h2-12H,13H2,1H3 D08ADI DRUGINKE XCVOOHGTUQHYAX-UHFFFAOYSA-N D08ADI DRUGSMIL CC1=CC(=CC(=C1)OCC2=CC(=CC=C2)Cl)C3=CN=CC=C3 D08ADI HIGHSTAT Investigative D08AES DRUG__ID D08AES D08AES DRUGTYPE Small molecular drug D08AES DRUGINCH 1S/C34H44Br2N4O8/c1-33(2,3)23-13-9-21(10-14-23)29(43)37-39-31(45)27(47-19-7-17-35)25(41)26(42)28(48-20-8-18-36)32(46)40-38-30(44)22-11-15-24(16-12-22)34(4,5)6/h7-18,25-28,41-42H,19-20H2,1-6H3,(H,37,43)(H,38,44)(H,39,45)(H,40,46)/b17-7+,18-8+/t25-,26-,27-,28-/m1/s1 D08AES DRUGINKE GBIFQWZWWHMHND-MNSGAQFXSA-N D08AES DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NNC(=O)C(C(C(C(C(=O)NNC(=O)C2=CC=C(C=C2)C(C)(C)C)OCC=CBr)O)O)OCC=CBr D08AES HIGHSTAT Investigative D08AFZ DRUG__ID D08AFZ D08AFZ DRUGTYPE Small molecular drug D08AFZ DRUGINCH 1S/C20H23NO/c1-16-7-9-19(10-8-16)20(22)21-13-11-18(12-14-21)15-17-5-3-2-4-6-17/h2-10,18H,11-15H2,1H3 D08AFZ DRUGINKE DVOLWKZEIDCCES-UHFFFAOYSA-N D08AFZ DRUGSMIL CC1=CC=C(C=C1)C(=O)N2CCC(CC2)CC3=CC=CC=C3 D08AFZ HIGHSTAT Investigative D08AGA DRUG__ID D08AGA D08AGA DRUGTYPE Small molecular drug D08AGA DRUGINCH 1S/C8H9IN2O/c9-6-3-7(5-10-4-6)12-8-1-2-11-8/h3-5,8,11H,1-2H2/t8-/m0/s1 D08AGA DRUGINKE KSOZTGQWGPTPSV-QMMMGPOBSA-N D08AGA DRUGSMIL C1CNC1OC2=CC(=CN=C2)I D08AGA HIGHSTAT Investigative D08AGH DRUG__ID D08AGH D08AGH DRUGTYPE Small molecular drug D08AGH DRUGINCH 1S/C22H22FN3O2S/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)/i23-1 D08AGH DRUGINKE SMYALUSCZJXWHG-VNRZBHCFSA-N D08AGH DRUGSMIL C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=S D08AGH HIGHSTAT Investigative D08AHA DRUG__ID D08AHA D08AHA DRUGTYPE Small molecular drug D08AHA DRUGINCH 1S/C16H15NO3/c17-14(16(19)20)10-11-6-8-13(9-7-11)15(18)12-4-2-1-3-5-12/h1-9,14H,10,17H2,(H,19,20)/t14-/m0/s1 D08AHA DRUGINKE TVIDEEHSOPHZBR-AWEZNQCLSA-N D08AHA DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)CC(C(=O)O)N D08AHA HIGHSTAT Investigative D08AID DRUG__ID D08AID D08AID DRUGTYPE Small molecular drug D08AID DRUGINCH 1S/C17H21NO3/c1-4-11(3)10-21-17(20)14-9-18-15-7-6-12(5-2)8-13(15)16(14)19/h6-9,11H,4-5,10H2,1-3H3,(H,18,19) D08AID DRUGINKE CXKHROTTYJSKQI-UHFFFAOYSA-N D08AID DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OCC(C)CC D08AID HIGHSTAT Investigative D08AIJ DRUG__ID D08AIJ D08AIJ DRUGTYPE Small molecular drug D08AIJ DRUGINCH 1S/C15H12O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-5,13,16-19H,6H2/t13-/m0/s1 D08AIJ DRUGINKE SBHXYTNGIZCORC-ZDUSSCGKSA-N D08AIJ DRUGSMIL C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(C=C3)O)O D08AIJ HIGHSTAT Investigative D08AJS DRUG__ID D08AJS D08AJS DRUGTYPE Small molecular drug D08AJS DRUGINCH 1S/C11H7ClN4O/c12-9-5-8(15-16-9)10-11(17)14-7-4-2-1-3-6(7)13-10/h1-5H,(H,14,17)(H,15,16) D08AJS DRUGINKE HKRYFPDYIBYUGZ-UHFFFAOYSA-N D08AJS DRUGSMIL C1=CC=C2C(=C1)NC(=O)C(=N2)C3=NNC(=C3)Cl D08AJS HIGHSTAT Investigative D08AKP DRUG__ID D08AKP D08AKP DRUGTYPE Small molecular drug D08AKP DRUGINCH 1S/C23H43NO3/c1-4-5-6-15-18-22(25)24(21(2)3)20-17-14-12-10-8-7-9-11-13-16-19-23(26)27/h8,10,21H,4-7,9,11-20H2,1-3H3,(H,26,27)/b10-8- D08AKP DRUGINKE SWWIYFCSVNBILX-NTMALXAHSA-N D08AKP DRUGSMIL CCCCCCC(=O)N(CCCCC=CCCCCCCC(=O)O)C(C)C D08AKP HIGHSTAT Investigative D08ALG DRUG__ID D08ALG D08ALG DRUGTYPE Small molecular drug D08ALG DRUGINCH 1S/C6H12N2/c7-6-4-2-1-3-5-8-6/h1-5H2,(H2,7,8) D08ALG DRUGINKE GTLJSJNKRLFVSJ-UHFFFAOYSA-N D08ALG DRUGSMIL C1CCC(=NCC1)N D08ALG HIGHSTAT Investigative D08ALW DRUG__ID D08ALW D08ALW DRUGTYPE Small molecular drug D08ALW DRUGINCH 1S/C38H62N6O8/c1-23(2)19-28(30(45)20-26(7)34(47)43-32(24(3)4)36(49)40-22-27-15-11-10-12-16-27)41-35(48)29-21-31(46)39-17-13-8-9-14-18-52-38(51)44-33(25(5)6)37(50)42-29/h10-12,15-16,23-26,28-30,32-33,45H,8-9,13-14,17-22H2,1-7H3,(H,39,46)(H,40,49)(H,41,48)(H,42,50)(H,43,47)(H,44,51)/t26-,28+,29+,30+,32+,33+/m1/s1 D08ALW DRUGINKE QJAPFAZHNSZLJE-CWURXVSKSA-N D08ALW DRUGSMIL CC(C)CC(C(CC(C)C(=O)NC(C(C)C)C(=O)NCC1=CC=CC=C1)O)NC(=O)C2CC(=O)NCCCCCCOC(=O)NC(C(=O)N2)C(C)C D08ALW HIGHSTAT Investigative D08AMH DRUG__ID D08AMH D08AMH DRUGTYPE Small molecular drug D08AMH DRUGINCH 1S/C4H8O2/c1-2-6-4-3-5-1/h1-4H2 D08AMH DRUGINKE RYHBNJHYFVUHQT-UHFFFAOYSA-N D08AMH DRUGSMIL C1COCCO1 D08AMH HIGHSTAT Investigative D08AOA DRUG__ID D08AOA D08AOA DRUGTYPE Small molecular drug D08AOA DRUGINCH 1S/C12H16N2O3S/c1-2-12(15)14-10-5-8-3-4-11(18(13,16)17)7-9(8)6-10/h3-4,7,10H,2,5-6H2,1H3,(H,14,15)(H2,13,16,17) D08AOA DRUGINKE PFHQSNAQKZORAY-UHFFFAOYSA-N D08AOA DRUGSMIL CCC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D08AOA HIGHSTAT Investigative D08AOD DRUG__ID D08AOD D08AOD DRUGTYPE Small molecular drug D08AOD DRUGINCH 1S/C9H14N2O4/c1-5-7(2-6(3-12)4-13)10-9(15)11-8(5)14/h6,12-13H,2-4H2,1H3,(H2,10,11,14,15) D08AOD DRUGINKE CLCPDSJUXHDRGX-UHFFFAOYSA-N D08AOD DRUGSMIL CC1=C(NC(=O)NC1=O)CC(CO)CO D08AOD HIGHSTAT Investigative D08AOG DRUG__ID D08AOG D08AOG DRUGTYPE Small molecular drug D08AOG DRUGINCH 1S/C16H16O3/c1-18-16(19-2,14-11-7-4-8-12-14)15(17)13-9-5-3-6-10-13/h3-12H,1-2H3 D08AOG DRUGINKE KWVGIHKZDCUPEU-UHFFFAOYSA-N D08AOG DRUGSMIL COC(C1=CC=CC=C1)(C(=O)C2=CC=CC=C2)OC D08AOG HIGHSTAT Investigative D08ARY DRUG__ID D08ARY D08ARY DRUGTYPE Small molecular drug D08ARY DRUGINCH 1S/C18H14N2O5/c21-13-7-17-16(24-10-25-17)6-12(13)18(20-4-3-19-8-20)11-1-2-14-15(5-11)23-9-22-14/h1-8,18,21H,9-10H2 D08ARY DRUGINKE SADZUGZPRKRGTC-UHFFFAOYSA-N D08ARY DRUGSMIL C1OC2=C(O1)C=C(C=C2)C(C3=CC4=C(C=C3O)OCO4)N5C=CN=C5 D08ARY HIGHSTAT Investigative D08ATQ DRUG__ID D08ATQ D08ATQ DRUGTYPE Small molecular drug D08ATQ DRUGINCH 1S/C18H20N4O2/c1-21(2)12-6-11-19-18-13-7-3-4-8-14(13)20-15-9-5-10-16(17(15)18)22(23)24/h3-5,7-10H,6,11-12H2,1-2H3,(H,19,20) D08ATQ DRUGINKE YMVWGSQGCWCDGW-UHFFFAOYSA-N D08ATQ DRUGSMIL CN(C)CCCNC1=C2C(=NC3=CC=CC=C31)C=CC=C2[N+](=O)[O-] D08ATQ HIGHSTAT Investigative D08ATZ DRUG__ID D08ATZ D08ATZ DRUGTYPE Small molecular drug D08ATZ DRUGINCH 1S/C18H8Cl2F4N4O/c19-15-9(6-10(21)16(20)26-15)11-7-12(29)28-17(25-11)13(8-4-2-1-3-5-8)14(27-28)18(22,23)24/h1-7,27H D08ATZ DRUGINKE ZOLHKPWSDFSDKA-UHFFFAOYSA-N D08ATZ DRUGSMIL C1=CC=C(C=C1)C2=C(NN3C2=NC(=CC3=O)C4=CC(=C(N=C4Cl)Cl)F)C(F)(F)F D08ATZ HIGHSTAT Investigative D08AWL DRUG__ID D08AWL D08AWL DRUGTYPE Small molecular drug D08AWL DRUGINCH 1S/C18H13NOS/c20-17-15-10-6-12-19(15)14-9-4-5-11-16(14)21-18(17)13-7-2-1-3-8-13/h1-12,18H D08AWL DRUGINKE NZZPYZUATMBWAV-UHFFFAOYSA-N D08AWL DRUGSMIL C1=CC=C(C=C1)C2C(=O)C3=CC=CN3C4=CC=CC=C4S2 D08AWL HIGHSTAT Investigative D08AWN DRUG__ID D08AWN D08AWN DRUGTYPE Small molecular drug D08AWN DRUGINCH 1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2/t15-/m0/s1 D08AWN DRUGINKE WIQRCHMSJFFONW-HNNXBMFYSA-N D08AWN DRUGSMIL C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F D08AWN HIGHSTAT Investigative D08AWZ DRUG__ID D08AWZ D08AWZ DRUGTYPE Small molecular drug D08AWZ DRUGINCH 1S/C44H57N9O13S/c1-4-25(2)38(51-42(59)37(24-67)46-26(3)54)43(60)49-35(22-28-10-16-31(17-11-28)53(65)66)40(57)47-33(7-5-6-20-45)39(56)48-34(21-27-8-14-30(15-9-27)52(63)64)41(58)50-36(44(61)62)23-29-12-18-32(55)19-13-29/h8-19,25,33-38,55,67H,4-7,20-24,45H2,1-3H3,(H,46,54)(H,47,57)(H,48,56)(H,49,60)(H,50,58)(H,51,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D08AWZ DRUGINKE BQZNGWRLXCQNSI-LBNFHWTGSA-N D08AWZ DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)[N+](=O)[O-])C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D08AWZ HIGHSTAT Investigative D08AXA DRUG__ID D08AXA D08AXA DRUGTYPE Small molecular drug D08AXA DRUGINCH 1S/C11H8N4/c1-2-5-13-9(3-1)11-14-8-4-6-12-7-10(8)15-11/h1-7H,(H,14,15) D08AXA DRUGINKE RCQLXXHLXWNHOU-UHFFFAOYSA-N D08AXA DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(N2)C=NC=C3 D08AXA HIGHSTAT Investigative D08AXB DRUG__ID D08AXB D08AXB DRUGTYPE Small molecular drug D08AXB DRUGINCH 1S/C19H31N3O7S/c1-11(23)20-13(7-8-16(24)25)17(26)21-14(9-12-5-3-2-4-6-12)18(27)22-15(10-30)19(28)29/h12-15,30H,2-10H2,1H3,(H,20,23)(H,21,26)(H,22,27)(H,24,25)(H,28,29)/t13-,14-,15-/m0/s1 D08AXB DRUGINKE JOZDKRPORTUAIW-KKUMJFAQSA-N D08AXB DRUGSMIL CC(=O)NC(CCC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O D08AXB HIGHSTAT Investigative D08AXT DRUG__ID D08AXT D08AXT DRUGTYPE Small molecular drug D08AXT DRUGINCH 1S/C16H12N6O3/c17-16-19-13(12-2-1-7-25-12)14-15(20-16)21(9-18-14)8-10-3-5-11(6-4-10)22(23)24/h1-7,9H,8H2,(H2,17,19,20) D08AXT DRUGINKE QAQYSXUIQQIGHU-UHFFFAOYSA-N D08AXT DRUGSMIL C1=COC(=C1)C2=C3C(=NC(=N2)N)N(C=N3)CC4=CC=C(C=C4)[N+](=O)[O-] D08AXT HIGHSTAT Investigative D08AYM DRUG__ID D08AYM D08AYM DRUGTYPE Small molecular drug D08AYM DRUGINCH 1S/C24H24FNO3/c1-26(17-24(27)28)16-15-23(20-7-11-21(25)12-8-20)29-22-13-9-19(10-14-22)18-5-3-2-4-6-18/h2-14,23H,15-17H2,1H3,(H,27,28) D08AYM DRUGINKE FDORQEIHOKEJNX-UHFFFAOYSA-N D08AYM DRUGSMIL CN(CCC(C1=CC=C(C=C1)F)OC2=CC=C(C=C2)C3=CC=CC=C3)CC(=O)O D08AYM HIGHSTAT Investigative D08AZK DRUG__ID D08AZK D08AZK DRUGTYPE Small molecular drug D08AZK DRUGINCH 1S/C15H12BrN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8+ D08AZK DRUGINKE QWAFSKBCSGIDRF-XYOKQWHBSA-N D08AZK DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)Br D08AZK HIGHSTAT Investigative D08AZT DRUG__ID D08AZT D08AZT DRUGTYPE Small molecular drug D08AZT DRUGINCH 1S/C17H22N2O2/c20-15-4-2-1-3-14(15)18-16(21)19-17-8-11-5-12(9-17)7-13(6-11)10-17/h1-4,11-13,20H,5-10H2,(H2,18,19,21) D08AZT DRUGINKE LYHYUDXVHBEHPM-UHFFFAOYSA-N D08AZT DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=CC=C4O D08AZT HIGHSTAT Investigative D08BAW DRUG__ID D08BAW D08BAW DRUGTYPE Small molecular drug D08BAW DRUGINCH 1S/C46H74N14O8/c1-4-13-37(62)55-33(17-11-24-53-45(49)50)40(64)58-35(26-29-14-7-6-8-15-29)43(67)59-36(27-30-19-21-31(61)22-20-30)42(66)57-34(18-12-25-54-46(51)52)41(65)60-38(28(3)5-2)44(68)56-32(39(48)63)16-9-10-23-47/h6-8,14-15,19-22,28,32-36,38,61H,4-5,9-13,16-18,23-27,47H2,1-3H3,(H2,48,63)(H,55,62)(H,56,68)(H,57,66)(H,58,64)(H,59,67)(H,60,65)(H4,49,50,53)(H4,51,52,54)/t28-,32-,33-,34-,35-,36-,38-/m0/s1 D08BAW DRUGINKE DPJOADTYQPSSOH-LWFLANIVSA-N D08BAW DRUGSMIL CCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)N D08BAW HIGHSTAT Investigative D08BCF DRUG__ID D08BCF D08BCF DRUGTYPE Small molecular drug D08BCF DRUGINCH 1S/C13H15N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2 D08BCF DRUGINKE XRXDAJYKGWNHTQ-UHFFFAOYSA-N D08BCF DRUGSMIL C1CN(CCN1)C2=NC3=CC=CC=C3C=C2 D08BCF HIGHSTAT Investigative D08BDI DRUG__ID D08BDI D08BDI DRUGTYPE Small molecular drug D08BDI DRUGINCH 1S/C13H13N3O2/c1-8-4-2-3-5-9(8)10-6-7-11(18-10)12(17)16-13(14)15/h2-7H,1H3,(H4,14,15,16,17) D08BDI DRUGINKE ACPWXEWIQCMXFE-UHFFFAOYSA-N D08BDI DRUGSMIL CC1=CC=CC=C1C2=CC=C(O2)C(=O)N=C(N)N D08BDI HIGHSTAT Investigative D08BFI DRUG__ID D08BFI D08BFI DRUGTYPE Small molecular drug D08BFI DRUGINCH 1S/C32H43FN6O10/c1-19(2)12-24(39-32(46)49-17-20-8-6-5-7-9-20)30(44)36-22(10-11-27(41)47-3)29(43)38-25(13-21-16-34-18-35-21)31(45)37-23(26(40)15-33)14-28(42)48-4/h5-9,16,18-19,22-25H,10-15,17H2,1-4H3,(H,34,35)(H,36,44)(H,37,45)(H,38,43)(H,39,46)/t22-,23-,24-,25-/m0/s1 D08BFI DRUGINKE YXRKBEPGVHOXSV-QORCZRPOSA-N D08BFI DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)OC)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)OCC2=CC=CC=C2 D08BFI HIGHSTAT Investigative D08BFU DRUG__ID D08BFU D08BFU DRUGTYPE Small molecular drug D08BFU DRUGINCH 1S/C21H20O11/c22-7-13-15(26)17(28)18(29)21(31-13)32-20-16(27)14-11(25)5-10(24)6-12(14)30-19(20)8-1-3-9(23)4-2-8/h1-6,13,15,17-18,21-26,28-29H,7H2/t13-,15-,17+,18-,21+/m1/s1 D08BFU DRUGINKE JPUKWEQWGBDDQB-QSOFNFLRSA-N D08BFU DRUGSMIL C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O D08BFU HIGHSTAT Investigative D08BGK DRUG__ID D08BGK D08BGK DRUGTYPE Small molecular drug D08BGK DRUGINCH 1S/C24H28ClN2O4/c1-29-17-8-15-16(9-18(17)30-2)26-21(28)10-19-22-14-7-20-24(15,23(22)26)4-5-27(20,12-25)11-13(14)3-6-31-19/h3,8-9,14,19-20,22-23H,4-7,10-12H2,1-2H3/q+1/t14-,19-,20-,22-,23-,24+,27?/m0/s1 D08BGK DRUGINKE GCEPQLWZBVGLQN-CQIPDZJVSA-N D08BGK DRUGSMIL COC1=C(C=C2C(=C1)C34CC[N+]5(C3CC6C7C4N2C(=O)CC7OCC=C6C5)CCl)OC D08BGK HIGHSTAT Investigative D08BGZ DRUG__ID D08BGZ D08BGZ DRUGTYPE Small molecular drug D08BGZ DRUGINCH 1S/C22H24FNO/c1-3-4-7-13-24-16(2)22(19-11-5-6-12-20(19)24)21(25)15-17-9-8-10-18(23)14-17/h5-6,8-12,14H,3-4,7,13,15H2,1-2H3 D08BGZ DRUGINKE STCKLQNFQVHGSM-UHFFFAOYSA-N D08BGZ DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)F)C D08BGZ HIGHSTAT Investigative D08BIP DRUG__ID D08BIP D08BIP DRUGTYPE Small molecular drug D08BIP DRUGINCH 1S/C9H9NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-4H,5-6H2,(H,10,11) D08BIP DRUGINKE TZOYXRMEFDYWDQ-UHFFFAOYSA-N D08BIP DRUGSMIL C1CC(=O)NC2=CC=CC=C21 D08BIP HIGHSTAT Investigative D08BJR DRUG__ID D08BJR D08BJR DRUGTYPE Small molecular drug D08BJR DRUGINCH 1S/C24H24N4O5S/c1-14(23-26-9-10-34-23)27-24(29)28-17-6-5-15(11-20(17)30-2)33-19-7-8-25-18-13-22(32-4)21(31-3)12-16(18)19/h5-14H,1-4H3,(H2,27,28,29) D08BJR DRUGINKE SHPFDGWALWEPGS-UHFFFAOYSA-N D08BJR DRUGSMIL CC(C1=NC=CS1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)OC D08BJR HIGHSTAT Investigative D08BKE DRUG__ID D08BKE D08BKE DRUGTYPE Small molecular drug D08BKE DRUGINCH 1S/C16H16F3NO9S/c17-16(18,19)30(23,24)29-15(22)28-11-8-26-12-10(7-25-13(11)12)27-14(21)20-6-9-4-2-1-3-5-9/h1-5,10-13H,6-8H2,(H,20,21)/t10-,11+,12+,13+/m0/s1 D08BKE DRUGINKE WOSIHMSPFKVEAI-UMSGYPCISA-N D08BKE DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)OS(=O)(=O)C(F)(F)F)OC(=O)NCC3=CC=CC=C3 D08BKE HIGHSTAT Investigative D08BKH DRUG__ID D08BKH D08BKH DRUGTYPE Small molecular drug D08BKH DRUGINCH 1S/C22H28N2O3/c1-26-10-8-15-11-14-12-22(21(25)27-2)19-17(7-9-24(13-14)20(15)22)16-5-3-4-6-18(16)23-19/h3-6,14-15,20,23H,7-13H2,1-2H3/t14-,15+,20+,22-/m1/s1 D08BKH DRUGINKE DTJQBBHYRQYDEG-SVBQBFEESA-N D08BKH DRUGSMIL COCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC D08BKH HIGHSTAT Investigative D08BLM DRUG__ID D08BLM D08BLM DRUGTYPE Small molecular drug D08BLM DRUGINCH 1S/C17H20N6/c1-21-7-9-22(10-8-21)16-15-17(19-12-18-16)23(13-20-15)11-14-5-3-2-4-6-14/h2-6,12-13H,7-11H2,1H3 D08BLM DRUGINKE JSSGUCJSJQMEEQ-UHFFFAOYSA-N D08BLM DRUGSMIL CN1CCN(CC1)C2=NC=NC3=C2N=CN3CC4=CC=CC=C4 D08BLM HIGHSTAT Investigative D08BLV DRUG__ID D08BLV D08BLV DRUGTYPE Small molecular drug D08BLV DRUGINCH 1S/C18H17NO2S/c1-12(2)21-18(20)16-17(22-13-8-4-3-5-9-13)14-10-6-7-11-15(14)19-16/h3-12,19H,1-2H3 D08BLV DRUGINKE CIEJDDRWESEPGF-UHFFFAOYSA-N D08BLV DRUGSMIL CC(C)OC(=O)C1=C(C2=CC=CC=C2N1)SC3=CC=CC=C3 D08BLV HIGHSTAT Investigative D08BMM DRUG__ID D08BMM D08BMM DRUGTYPE Small molecular drug D08BMM DRUGINCH 1S/C11H11Br2N5O/c12-7-4-8(18-9(7)13)10(19)15-3-1-2-6-5-16-11(14)17-6/h1-2,4-5,18H,3H2,(H,15,19)(H3,14,16,17)/b2-1+ D08BMM DRUGINKE QKJAXHBFQSBDAR-OWOJBTEDSA-N D08BMM DRUGSMIL C1=C(NC(=C1Br)Br)C(=O)NCC=CC2=CN=C(N2)N D08BMM HIGHSTAT Investigative D08BNV DRUG__ID D08BNV D08BNV DRUGTYPE Small molecular drug D08BNV DRUGINCH 1S/C16H14O3/c1-18-14-7-3-5-10-12(14)9-13-11(16(10)17)6-4-8-15(13)19-2/h3-8H,9H2,1-2H3 D08BNV DRUGINKE YNXDXUPTUFLKRN-UHFFFAOYSA-N D08BNV DRUGSMIL COC1=CC=CC2=C1CC3=C(C2=O)C=CC=C3OC D08BNV HIGHSTAT Investigative D08BNY DRUG__ID D08BNY D08BNY DRUGTYPE Small molecular drug D08BNY DRUGINCH 1S/C18H27NO2/c1-3-4-5-6-7-8-9-10-11-18(20)19-16-12-14-17(21-2)15-13-16/h10-15H,3-9H2,1-2H3,(H,19,20)/b11-10+ D08BNY DRUGINKE ZYKABORTQCIYBC-ZHACJKMWSA-N D08BNY DRUGSMIL CCCCCCCCC=CC(=O)NC1=CC=C(C=C1)OC D08BNY HIGHSTAT Investigative D08BOH DRUG__ID D08BOH D08BOH DRUGTYPE Small molecular drug D08BOH DRUGINCH 1S/C21H24O7/c1-25-17-8-12(4-5-16(17)22)6-14-11-28-21(24)15(14)7-13-9-18(26-2)20(23)19(10-13)27-3/h4-5,8-10,14-15,22-23H,6-7,11H2,1-3H3/t14-,15+/m1/s1 D08BOH DRUGINKE XMLWGUKRPGLJGA-CABCVRRESA-N D08BOH DRUGSMIL COC1=CC(=CC(=C1O)OC)CC2C(COC2=O)CC3=CC(=C(C=C3)O)OC D08BOH HIGHSTAT Investigative D08BOL DRUG__ID D08BOL D08BOL DRUGTYPE Small molecular drug D08BOL DRUGINCH 1S/C9H13NO2S/c10-6-7(5-9(11)12)4-8-2-1-3-13-8/h1-3,7H,4-6,10H2,(H,11,12) D08BOL DRUGINKE BSTBHLRENZEVEM-UHFFFAOYSA-N D08BOL DRUGSMIL C1=CSC(=C1)CC(CC(=O)O)CN D08BOL HIGHSTAT Investigative D08BOP DRUG__ID D08BOP D08BOP DRUGTYPE Small molecular drug D08BOP DRUGINCH 1S/C14H14N2O/c1-2-7-17-14-8-11-10-5-3-4-6-12(10)16-13(11)9-15-14/h3-6,8-9,16H,2,7H2,1H3 D08BOP DRUGINKE LPAODQAWVMEXKR-UHFFFAOYSA-N D08BOP DRUGSMIL CCCOC1=NC=C2C(=C1)C3=CC=CC=C3N2 D08BOP HIGHSTAT Investigative D08BPD DRUG__ID D08BPD D08BPD DRUGCOMP Entrechem D08BPD DRUGINCH 1S/C26H19N3O5/c1-26-23(31)15(30)10-16(34-26)28-13-8-4-2-6-11(13)17-19-20(25(33)27-24(19)32)18-12-7-3-5-9-14(12)29(26)22(18)21(17)28/h2-9,15-16,23,30-31H,10H2,1H3,(H,27,32,33)/t15-,16+,23+,26-/m0/s1 D08BPD DRUGINKE GWILJQBMYLXBHZ-RMRFZGCXSA-N D08BPD DRUGSMIL CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(=O)NC6=O)O)O D08BPD HIGHSTAT Investigative D08BPE DRUG__ID D08BPE D08BPE DRUGTYPE Small molecular drug D08BPE DRUGINCH 1S/C22H41NO3/c1-18(24)14-12-10-8-6-4-5-7-9-11-13-15-21-16-17-22(19(2)23-21)26-20(3)25/h19,21-23H,4-17H2,1-3H3/t19-,21+,22-/m1/s1 D08BPE DRUGINKE LRKWDKCSHJWJST-BAGYTPMASA-N D08BPE DRUGSMIL CC1C(CCC(N1)CCCCCCCCCCCCC(=O)C)OC(=O)C D08BPE HIGHSTAT Investigative D08BQI DRUG__ID D08BQI D08BQI DRUGTYPE Small molecular drug D08BQI DRUGINCH 1S/C13H16Br2O3/c1-2-3-4-5-18-13-10(14)6-9(7-11(13)15)8-12(16)17/h6-7H,2-5,8H2,1H3,(H,16,17) D08BQI DRUGINKE DMILDBSUKKQQDG-UHFFFAOYSA-N D08BQI DRUGSMIL CCCCCOC1=C(C=C(C=C1Br)CC(=O)O)Br D08BQI HIGHSTAT Investigative D08BRR DRUG__ID D08BRR D08BRR DRUGTYPE Small molecular drug D08BRR DRUGINCH 1S/C14H20O2/c1-4-10(2)8-12-6-5-7-13(9-12)11(3)14(15)16/h5-7,9-11H,4,8H2,1-3H3,(H,15,16) D08BRR DRUGINKE MKEVMCJZLHDVPO-UHFFFAOYSA-N D08BRR DRUGSMIL CCC(C)CC1=CC(=CC=C1)C(C)C(=O)O D08BRR HIGHSTAT Investigative D08BRZ DRUG__ID D08BRZ D08BRZ DRUGTYPE Small molecular drug D08BRZ DRUGINCH 1S/C15H14FNO3/c16-12-3-1-11(2-4-12)14-9-13(18)10-15(20-14)17-5-7-19-8-6-17/h1-4,9-10H,5-8H2 D08BRZ DRUGINKE PERAFXFTWFWDNO-UHFFFAOYSA-N D08BRZ DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=C(C=C3)F D08BRZ HIGHSTAT Investigative D08BSG DRUG__ID D08BSG D08BSG DRUGTYPE Small molecular drug D08BSG DRUGINCH 1S/C13H15IN2O/c14-12-5-3-11(4-6-12)9-17-7-1-2-13-8-15-10-16-13/h3-6,8,10H,1-2,7,9H2,(H,15,16) D08BSG DRUGINKE DCQNAFOCXVCDLB-UHFFFAOYSA-N D08BSG DRUGSMIL C1=CC(=CC=C1COCCCC2=CN=CN2)I D08BSG HIGHSTAT Investigative D08BSQ DRUG__ID D08BSQ D08BSQ DRUGTYPE Small molecular drug D08BSQ DRUGINCH 1S/C21H36O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-17(23)19-20(24)18(16-22)26-21(19)25/h18,22,24H,2-16H2,1H3/t18-/m1/s1 D08BSQ DRUGINKE KZTSLHQKWLYYAC-GOSISDBHSA-N D08BSQ DRUGSMIL CCCCCCCCCCCCCCCC(=O)C1=C(C(OC1=O)CO)O D08BSQ HIGHSTAT Investigative D08BST DRUG__ID D08BST D08BST DRUGTYPE Small molecular drug D08BST DRUGINCH 1S/C20H25NO4/c1-11(2)10-21-8-7-19-16-12-3-4-13(22)17(16)25-18(19)14(23)5-6-20(19,24)15(21)9-12/h3-4,11,15,18,22,24H,5-10H2,1-2H3/t15-,18+,19+,20-/m1/s1 D08BST DRUGINKE OEQLILQNMUXCHV-XFWGSAIBSA-N D08BST DRUGSMIL CC(C)CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O D08BST HIGHSTAT Investigative D08BTV DRUG__ID D08BTV D08BTV DRUGTYPE Small molecular drug D08BTV DRUGINCH 1S/C14H19N3OS/c18-13-9-5-4-6-11(13)10-15-17-14(19)16-12-7-2-1-3-8-12/h4-6,9-10,12,18H,1-3,7-8H2,(H2,16,17,19)/b15-10+ D08BTV DRUGINKE QEQOERHFAIIFBC-XNTDXEJSSA-N D08BTV DRUGSMIL C1CCC(CC1)NC(=S)NN=CC2=CC=CC=C2O D08BTV HIGHSTAT Investigative D08BUB DRUG__ID D08BUB D08BUB DRUGTYPE Small molecular drug D08BUB DRUGINCH 1S/C16H17N3O4/c17-16(20)10-18-9-12-3-7-15(8-4-12)23-11-13-1-5-14(6-2-13)19(21)22/h1-8,18H,9-11H2,(H2,17,20) D08BUB DRUGINKE RHNXUKDDIOAEGX-UHFFFAOYSA-N D08BUB DRUGSMIL C1=CC(=CC=C1CNCC(=O)N)OCC2=CC=C(C=C2)[N+](=O)[O-] D08BUB HIGHSTAT Investigative D08BXD DRUG__ID D08BXD D08BXD DRUGTYPE Small molecular drug D08BXD DRUGINCH 1S/C21H19F3N2O4S/c1-29-19-6-2-3-7-20(19)30-18-10-8-17(9-11-18)26(14-16-5-4-12-25-13-16)31(27,28)15-21(22,23)24/h2-13H,14-15H2,1H3 D08BXD DRUGINKE ALMACYDZFBMGOR-UHFFFAOYSA-N D08BXD DRUGSMIL COC1=CC=CC=C1OC2=CC=C(C=C2)N(CC3=CN=CC=C3)S(=O)(=O)CC(F)(F)F D08BXD HIGHSTAT Investigative D08BXK DRUG__ID D08BXK D08BXK DRUGTYPE Small molecular drug D08BXK DRUGINCH 1S/C16H18N2O/c1-11(2)7-8-19-16-9-13-12-5-3-4-6-14(12)18-15(13)10-17-16/h3-6,9-11,18H,7-8H2,1-2H3 D08BXK DRUGINKE LGSILYYIMNHYCP-UHFFFAOYSA-N D08BXK DRUGSMIL CC(C)CCOC1=NC=C2C(=C1)C3=CC=CC=C3N2 D08BXK HIGHSTAT Investigative D08BXO DRUG__ID D08BXO D08BXO DRUGTYPE Small molecular drug D08BXO DRUGINCH 1S/C20H20Cl2N4O2S/c1-12-13(2)25-28-19(12)26-29(3,4)16-8-5-14(6-9-16)23-20(27)24-15-7-10-17(21)18(22)11-15/h5-11,26H,3-4H2,1-2H3,(H2,23,24,27) D08BXO DRUGINKE ZRNSPTWPSVBOTC-UHFFFAOYSA-N D08BXO DRUGSMIL CC1=C(ON=C1C)NS(=C)(=C)C2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)Cl D08BXO HIGHSTAT Investigative D08CAB DRUG__ID D08CAB D08CAB DRUGTYPE Small molecular drug D08CAB DRUGINCH 1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m1/s1 D08CAB DRUGINKE CKLJMWTZIZZHCS-UWTATZPHSA-N D08CAB DRUGSMIL C(C(C(=O)O)N)C(=O)O D08CAB HIGHSTAT Investigative D08CBB DRUG__ID D08CBB D08CBB DRUGTYPE Small molecular drug D08CBB DRUGINCH 1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m1/s1 D08CBB DRUGINKE QIVBCDIJIAJPQS-SECBINFHSA-N D08CBB DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N D08CBB HIGHSTAT Investigative D08CEW DRUG__ID D08CEW D08CEW DRUGTYPE Small molecular drug D08CEW DRUGINCH 1S/C21H27F2N5O2/c22-21(23,16-8-4-3-5-9-16)18(29)13-11-17-12-14-20(30)28(17)15-7-2-1-6-10-19-24-26-27-25-19/h3-5,8-9,11,13,17-18,29H,1-2,6-7,10,12,14-15H2,(H,24,25,26,27)/b13-11+/t17-,18+/m0/s1 D08CEW DRUGINKE WPTLQOYLIXWRNN-SLKVGHROSA-N D08CEW DRUGSMIL C1CC(=O)N(C1C=CC(C(C2=CC=CC=C2)(F)F)O)CCCCCCC3=NNN=N3 D08CEW HIGHSTAT Investigative D08CFL DRUG__ID D08CFL D08CFL DRUGTYPE Small molecular drug D08CFL DRUGINCH 1S/C26H34O7/c1-18(2)13-14-20-25(3,33-20)24-23(30-4)19(15-16-26(24)17-31-26)32-22(29)12-10-8-6-5-7-9-11-21(27)28/h5-13,19-20,23-24H,14-17H2,1-4H3,(H,27,28)/b7-5+,8-6+,11-9+,12-10+/t19-,20-,23-,24-,25+,26+/m1/s1 D08CFL DRUGINKE NGGMYCMLYOUNGM-CSDLUJIJSA-N D08CFL DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C D08CFL HIGHSTAT Investigative D08CFM DRUG__ID D08CFM D08CFM DRUGTYPE Small molecular drug D08CFM DRUGINCH 1S/C27H37F3N8O7/c1-14(2)26(27(28,29)30)24(45)37-16(9-6-10-33-25(31)32)21(42)34-13-19(39)35-18(12-20(40)41)22(43)36-17(23(44)38-26)11-15-7-4-3-5-8-15/h3-5,7-8,14,16-18H,6,9-13H2,1-2H3,(H,34,42)(H,35,39)(H,36,43)(H,37,45)(H,38,44)(H,40,41)(H4,31,32,33)/t16-,17+,18-,26+/m0/s1 D08CFM DRUGINKE VYIBTYZRYKIMKX-ORVYPBFBSA-N D08CFM DRUGSMIL CC(C)C1(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N)C(F)(F)F D08CFM HIGHSTAT Investigative D08CID DRUG__ID D08CID D08CID DRUGTYPE Small molecular drug D08CID DRUGINCH 1S/C26H32N4O3/c31-24(27-14-17-28-15-8-3-9-16-28)29-18-19-30-23(20-29)26(33-25(30)32,21-10-4-1-5-11-21)22-12-6-2-7-13-22/h1-2,4-7,10-13,23H,3,8-9,14-20H2,(H,27,31) D08CID DRUGINKE JJDDRYMIPIEXKX-UHFFFAOYSA-N D08CID DRUGSMIL C1CCN(CC1)CCNC(=O)N2CCN3C(C2)C(OC3=O)(C4=CC=CC=C4)C5=CC=CC=C5 D08CID HIGHSTAT Investigative D08CIY DRUG__ID D08CIY D08CIY DRUGTYPE Small molecular drug D08CIY DRUGINCH 1S/C11H9N5O/c12-9-7-10(16-5-2-4-13-16)15-11(14-9)8-3-1-6-17-8/h1-7H,(H2,12,14,15) D08CIY DRUGINKE SSPIGFDAVQVRCH-UHFFFAOYSA-N D08CIY DRUGSMIL C1=CN(N=C1)C2=NC(=NC(=C2)N)C3=CC=CO3 D08CIY HIGHSTAT Investigative D08CJB DRUG__ID D08CJB D08CJB DRUGTYPE Small molecular drug D08CJB DRUGINCH 1S/C38H51N5O5/c1-23-15-29(44)16-24(2)31(23)20-33(39)36(46)41-13-9-5-6-10-14-42-37(47)35-19-27-11-7-8-12-28(27)22-43(35)38(48)34(40)21-32-25(3)17-30(45)18-26(32)4/h7-8,11-12,15-18,33-35,44-45H,5-6,9-10,13-14,19-22,39-40H2,1-4H3,(H,41,46)(H,42,47)/t33-,34-,35?/m0/s1 D08CJB DRUGINKE PKRAENCMWFWKSB-IEKJTBOOSA-N D08CJB DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NCCCCCCNC(=O)C2CC3=CC=CC=C3CN2C(=O)C(CC4=C(C=C(C=C4C)O)C)N)N)C)O D08CJB HIGHSTAT Investigative D08CKE DRUG__ID D08CKE D08CKE DRUGTYPE Small molecular drug D08CKE DRUGINCH 1S/C7H13FN2O2/c1-12-6(11)7(10,5-8)3-2-4-9/h2-3H,4-5,9-10H2,1H3/b3-2+ D08CKE DRUGINKE KIQXCFBLXGRXPY-NSCUHMNNSA-N D08CKE DRUGSMIL COC(=O)C(CF)(C=CCN)N D08CKE HIGHSTAT Investigative D08CKM DRUG__ID D08CKM D08CKM DRUGTYPE Small molecular drug D08CKM DRUGINCH 1S/C19H30N2O2S/c1-16-8-12-20(13-9-16)14-10-18-6-4-11-21(18)24(22,23)19-7-3-5-17(2)15-19/h3,5,7,15-16,18H,4,6,8-14H2,1-2H3/t18-/m1/s1 D08CKM DRUGINKE YVWGGGGMRDLOGA-GOSISDBHSA-N D08CKM DRUGSMIL CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)C D08CKM HIGHSTAT Investigative D08CLB DRUG__ID D08CLB D08CLB DRUGTYPE Small molecular drug D08CLB DRUGINCH 1S/C14H18O3/c15-14(16)10-17-13-9-5-4-8-12(13)11-6-2-1-3-7-11/h4-5,8-9,11H,1-3,6-7,10H2,(H,15,16) D08CLB DRUGINKE SIYNBMWECIIUOX-UHFFFAOYSA-N D08CLB DRUGSMIL C1CCC(CC1)C2=CC=CC=C2OCC(=O)O D08CLB HIGHSTAT Investigative D08CMQ DRUG__ID D08CMQ D08CMQ DRUGTYPE Small molecular drug D08CMQ DRUGINCH 1S/C9H18N2S/c1-7(2)5-8-6-12-4-3-9(10)11-8/h7-8H,3-6H2,1-2H3,(H2,10,11) D08CMQ DRUGINKE KMFANDQFKVBAJW-UHFFFAOYSA-N D08CMQ DRUGSMIL CC(C)CC1CSCCC(=N1)N D08CMQ HIGHSTAT Investigative D08CMW DRUG__ID D08CMW D08CMW DRUGTYPE Small molecular drug D08CMW DRUGINCH 1S/C15H15N5/c16-14-12-8-10(6-7-13(12)19-15(17)20-14)9-18-11-4-2-1-3-5-11/h1-8,18H,9H2,(H4,16,17,19,20) D08CMW DRUGINKE SQHNSLWKFCXHKZ-UHFFFAOYSA-N D08CMW DRUGSMIL C1=CC=C(C=C1)NCC2=CC3=C(C=C2)N=C(N=C3N)N D08CMW HIGHSTAT Investigative D08CNG DRUG__ID D08CNG D08CNG DRUGTYPE Small molecular drug D08CNG DRUGINCH 1S/C11H12N2O5S4/c12-21(15,16)10-4-8-9(14)6-13(5-7-2-1-3-19-7)22(17,18)11(8)20-10/h1-4,9,14H,5-6H2,(H2,12,15,16)/t9-/m0/s1 D08CNG DRUGINKE HHPUQNGRNUOYCD-VIFPVBQESA-N D08CNG DRUGSMIL C1C(C2=C(SC(=C2)S(=O)(=O)N)S(=O)(=O)N1CC3=CC=CS3)O D08CNG HIGHSTAT Investigative D08CNN DRUG__ID D08CNN D08CNN DRUGTYPE Small molecular drug D08CNN DRUGINCH 1S/C20H26N2S/c1-18-7-5-8-19(17-18)22-14-12-21(13-15-22)11-6-16-23-20-9-3-2-4-10-20/h2-5,7-10,17H,6,11-16H2,1H3 D08CNN DRUGINKE ZHUHEUSMACZXIP-UHFFFAOYSA-N D08CNN DRUGSMIL CC1=CC(=CC=C1)N2CCN(CC2)CCCSC3=CC=CC=C3 D08CNN HIGHSTAT Investigative D08CNS DRUG__ID D08CNS D08CNS DRUGTYPE Small molecular drug D08CNS DRUGINCH 1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13) D08CNS DRUGINKE NYMGNSNKLVNMIA-UHFFFAOYSA-N D08CNS DRUGSMIL CC(C)NNC(=O)C1=CC=NC=C1 D08CNS HIGHSTAT Investigative D08COD DRUG__ID D08COD D08COD DRUGTYPE Small molecular drug D08COD DRUGINCH 1S/C10H11NO3/c1-7(10(13)14)11-9(12)8-5-3-2-4-6-8/h2-7H,1H3,(H,11,12)(H,13,14)/t7-/m1/s1 D08COD DRUGINKE UAQVHNZEONHPQG-SSDOTTSWSA-N D08COD DRUGSMIL CC(C(=O)O)NC(=O)C1=CC=CC=C1 D08COD HIGHSTAT Investigative D08COK DRUG__ID D08COK D08COK DRUGTYPE Small molecular drug D08COK DRUGINCH 1S/C52H68N6O6/c1-33-23-41(59)24-34(2)43(33)29-45(53)51(63)57-31-39-19-13-11-17-37(39)27-47(57)49(61)55-21-15-9-7-5-6-8-10-16-22-56-50(62)48-28-38-18-12-14-20-40(38)32-58(48)52(64)46(54)30-44-35(3)25-42(60)26-36(44)4/h11-14,17-20,23-26,45-48,59-60H,5-10,15-16,21-22,27-32,53-54H2,1-4H3,(H,55,61)(H,56,62)/t45-,46-,47?,48?/m0/s1 D08COK DRUGINKE WGSCXEFFOVZNEM-QCSGVJIWSA-N D08COK DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCCCCCCCNC(=O)C4CC5=CC=CC=C5CN4C(=O)C(CC6=C(C=C(C=C6C)O)C)N)N)C)O D08COK HIGHSTAT Investigative D08CQQ DRUG__ID D08CQQ D08CQQ DRUGTYPE Small molecular drug D08CQQ DRUGINCH 1S/C15H11ClN2O/c1-9-5-12-14(19)7-13(18-15(12)17-8-9)10-3-2-4-11(16)6-10/h2-8H,1H3,(H,17,18,19) D08CQQ DRUGINKE FSWIIQLXZOJBSF-UHFFFAOYSA-N D08CQQ DRUGSMIL CC1=CC2=C(NC(=CC2=O)C3=CC(=CC=C3)Cl)N=C1 D08CQQ HIGHSTAT Investigative D08CSK DRUG__ID D08CSK D08CSK DRUGTYPE Small molecular drug D08CSK DRUGINCH 1S/C15H35NO6P2/c1-3-4-5-6-7-8-9-10-11-12-13-16(2)14-15(23(17,18)19)24(20,21)22/h15H,3-14H2,1-2H3,(H2,17,18,19)(H2,20,21,22) D08CSK DRUGINKE FQYMJTHEUPKDPQ-UHFFFAOYSA-N D08CSK DRUGSMIL CCCCCCCCCCCCN(C)CC(P(=O)(O)O)P(=O)(O)O D08CSK HIGHSTAT Investigative D08CTL DRUG__ID D08CTL D08CTL DRUGTYPE Small molecular drug D08CTL DRUGINCH 1S/C9H13N3O/c1-5-10-9(13-12-5)7-4-6-2-3-8(7)11-6/h6-8,11H,2-4H2,1H3/t6-,7-,8+/m1/s1 D08CTL DRUGINKE DCXSASGOFIVZCG-PRJMDXOYSA-N D08CTL DRUGSMIL CC1=NOC(=N1)C2CC3CCC2N3 D08CTL HIGHSTAT Investigative D08CXO DRUG__ID D08CXO D08CXO DRUGTYPE Small molecular drug D08CXO DRUGINCH 1S/C22H31NO3/c1-12(2)23-21(26)18-11-19-17-6-4-13-10-14(24)5-7-15(13)16(17)8-9-22(19,3)20(18)25/h5,7,10,12,16-20,24-25H,4,6,8-9,11H2,1-3H3,(H,23,26)/t16?,17?,18?,19?,20-,22-/m0/s1 D08CXO DRUGINKE MIXZPWBCEXVAQM-GFEBWMDQSA-N D08CXO DRUGSMIL CC(C)NC(=O)C1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O D08CXO HIGHSTAT Investigative D08CXZ DRUG__ID D08CXZ D08CXZ DRUGTYPE Small molecular drug D08CXZ DRUGINCH 1S/C29H30N4O3S/c1-17-11-21(34)12-18(2)22(17)14-23(30)29(36)33-16-20-8-4-3-7-19(20)13-25(33)28(35)31-15-27-32-24-9-5-6-10-26(24)37-27/h3-12,23,25,34H,13-16,30H2,1-2H3,(H,31,35)/t23-,25-/m0/s1 D08CXZ DRUGINKE AWMRTINMSUQIBM-ZCYQVOJMSA-N D08CXZ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=NC5=CC=CC=C5S4)N)C)O D08CXZ HIGHSTAT Investigative D08CYU DRUG__ID D08CYU D08CYU DRUGTYPE Small molecular drug D08CYU DRUGINCH 1S/C5H8O4S/c6-4(7)2-1-3(10)5(8)9/h3,10H,1-2H2,(H,6,7)(H,8,9) D08CYU DRUGINKE HWPIVZNZHAFMNA-UHFFFAOYSA-N D08CYU DRUGSMIL C(CC(=O)O)C(C(=O)O)S D08CYU HIGHSTAT Investigative D08CZD DRUG__ID D08CZD D08CZD DRUGTYPE Small molecular drug D08CZD DRUGINCH 1S/C8H13N3O2/c1-6-5-7(11-8(9)10-6)13-4-3-12-2/h5H,3-4H2,1-2H3,(H2,9,10,11) D08CZD DRUGINKE VCJHOFUOIQHNBC-UHFFFAOYSA-N D08CZD DRUGSMIL CC1=CC(=NC(=N1)N)OCCOC D08CZD HIGHSTAT Investigative D08CZE DRUG__ID D08CZE D08CZE DRUGTYPE Small molecular drug D08CZE DRUGINCH 1S/C12H18O4/c1-4-5-6-15-11(14)10-7-9(13)8-12(2,3)16-10/h7H,4-6,8H2,1-3H3 D08CZE DRUGINKE OKIJSNGRQAOIGZ-UHFFFAOYSA-N D08CZE DRUGSMIL CCCCOC(=O)C1=CC(=O)CC(O1)(C)C D08CZE HIGHSTAT Investigative D08CZT DRUG__ID D08CZT D08CZT DRUGTYPE Small molecular drug D08CZT DRUGINCH 1S/C19H20N2/c1-2-6-15(7-3-1)19-18(14-10-12-20-13-11-14)16-8-4-5-9-17(16)21-19/h1-9,14,20-21H,10-13H2 D08CZT DRUGINKE FWPAVENSJPMGJO-UHFFFAOYSA-N D08CZT DRUGSMIL C1CNCCC1C2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D08CZT HIGHSTAT Investigative D08DAE DRUG__ID D08DAE D08DAE DRUGTYPE Small molecular drug D08DAE DRUGINCH 1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1 D08DAE DRUGINKE OEYIOHPDSNJKLS-UHFFFAOYSA-N D08DAE DRUGSMIL C[N+](C)(C)CCO D08DAE HIGHSTAT Investigative D08DEG DRUG__ID D08DEG D08DEG DRUGTYPE Small molecular drug D08DEG DRUGINCH 1S/C9H6Cl2N2O/c10-6-2-1-5(3-7(6)11)8-4-9(14)13-12-8/h1-4H,(H2,12,13,14) D08DEG DRUGINKE ANMVQJHGOQOZLG-UHFFFAOYSA-N D08DEG DRUGSMIL C1=CC(=C(C=C1C2=CC(=O)NN2)Cl)Cl D08DEG HIGHSTAT Investigative D08DET DRUG__ID D08DET D08DET DRUGTYPE Small molecular drug D08DET DRUGINCH 1S/C15H23NO/c1-9-4-6-12(8-11(3)15(16)17)14-10(2)5-7-13(9)14/h8-9,12-13H,4-7H2,1-3H3,(H2,16,17)/b11-8+/t9-,12+,13-/m1/s1 D08DET DRUGINKE CQHOIXZTIWRKEB-SUKRRCERSA-N D08DET DRUGSMIL CC1CCC(C2=C(CCC12)C)C=C(C)C(=O)N D08DET HIGHSTAT Investigative D08DFY DRUG__ID D08DFY D08DFY DRUGTYPE Small molecular drug D08DFY DRUGINCH 1S/C22H34O4/c23-19(16-8-4-3-5-9-16)13-12-18-17(20-14-15-21(18)26-20)10-6-1-2-7-11-22(24)25/h1,6,12-13,16-21,23H,2-5,7-11,14-15H2,(H,24,25)/b6-1-,13-12+/t17-,18-,19+,20-,21+/m0/s1 D08DFY DRUGINKE CEHGUSRXHYTTPN-ZSMXBAJYSA-N D08DFY DRUGSMIL C1CCC(CC1)C(C=CC2C3CCC(C2CC=CCCCC(=O)O)O3)O D08DFY HIGHSTAT Investigative D08DHC DRUG__ID D08DHC D08DHC DRUGTYPE Small molecular drug D08DHC DRUGINCH 1S/C15H10F3NO/c1-10-4-2-3-5-14(10)20-12-7-6-11(9-19)13(8-12)15(16,17)18/h2-8H,1H3 D08DHC DRUGINKE PEOSULIFVYUPML-UHFFFAOYSA-N D08DHC DRUGSMIL CC1=CC=CC=C1OC2=CC(=C(C=C2)C#N)C(F)(F)F D08DHC HIGHSTAT Investigative D08DLP DRUG__ID D08DLP D08DLP DRUGTYPE Small molecular drug D08DLP DRUGINCH 1S/C19H20ClNO4/c1-21-5-4-10-15-12(21)6-9-7-13(22)14(24-2)8-11(9)16(15)19(25-3)18(23)17(10)20/h7-8,12,22-23H,4-6H2,1-3H3/t12-/m0/s1 D08DLP DRUGINKE HRPJZDTZANKXQI-LBPRGKRZSA-N D08DLP DRUGSMIL CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2Cl)O)OC)OC)O D08DLP HIGHSTAT Investigative D08DND DRUG__ID D08DND D08DND DRUGTYPE Small molecular drug D08DND DRUGINCH 1S/C42H59N11O7/c43-30-15-6-4-13-28(54)19-20-36(55)47-21-9-8-17-32(37(44)56)50-41(60)35(24-27-25-49-31-16-7-5-14-29(27)31)53-39(58)33(18-10-22-48-42(45)46)51-40(59)34(52-38(30)57)23-26-11-2-1-3-12-26/h1-3,5,7,11-12,14,16,25,30,32-35,49H,4,6,8-10,13,15,17-24,43H2,(H2,44,56)(H,47,55)(H,50,60)(H,51,59)(H,52,57)(H,53,58)(H4,45,46,48)/t30-,32-,33-,34+,35-/m0/s1 D08DND DRUGINKE HWDXGLQUFJWIAC-DIWSUELLSA-N D08DND DRUGSMIL C1CCC(=O)CCC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C1)N)CC2=CC=CC=C2)CCCN=C(N)N)CC3=CNC4=CC=CC=C43)C(=O)N D08DND HIGHSTAT Investigative D08DNK DRUG__ID D08DNK D08DNK DRUGTYPE Small molecular drug D08DNK DRUGINCH 1S/C7H8ClN3O/c8-5-1-3-6(4-2-5)10-7(9)11-12/h1-4,12H,(H3,9,10,11) D08DNK DRUGINKE JYBXKTLYOMPMQY-UHFFFAOYSA-N D08DNK DRUGSMIL C1=CC(=CC=C1N=C(N)NO)Cl D08DNK HIGHSTAT Investigative D08DOG DRUG__ID D08DOG D08DOG DRUGTYPE Small molecular drug D08DOG DRUGINCH 1S/C16H18N6/c1-21-6-8-22(9-7-21)15-10-14(19-16(18)20-15)13-4-2-12(11-17)3-5-13/h2-5,10H,6-9H2,1H3,(H2,18,19,20) D08DOG DRUGINKE QFKQUMBUFVKQBH-UHFFFAOYSA-N D08DOG DRUGSMIL CN1CCN(CC1)C2=NC(=NC(=C2)C3=CC=C(C=C3)C#N)N D08DOG HIGHSTAT Investigative D08DOY DRUG__ID D08DOY D08DOY DRUGTYPE Small molecular drug D08DOY DRUGINCH 1S/C17H23IN4O8S/c18-9-1-3-10(4-2-9)22(30)17(29)31-8-12(15(26)20-7-14(24)25)21-13(23)6-5-11(19)16(27)28/h1-4,11-12,17,29-30H,5-8,19H2,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t11-,12-,17?/m0/s1 D08DOY DRUGINKE SCHAHXXLASZJCD-FAGLKTCQSA-N D08DOY DRUGSMIL C1=CC(=CC=C1N(C(O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O)I D08DOY HIGHSTAT Investigative D08DPH DRUG__ID D08DPH D08DPH DRUGTYPE Small molecular drug D08DPH DRUGINCH 1S/C18H17ClN4O2/c1-21-14(10-5-4-7-12-8-6-9-13(19)11-12)20-16-15(21)17(24)23(3)18(25)22(16)2/h4-11H,1-3H3/b7-4+,10-5+ D08DPH DRUGINKE MINUIDFUFCXYDK-HOZCHFDZSA-N D08DPH DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC=CC3=CC(=CC=C3)Cl D08DPH HIGHSTAT Investigative D08DQL DRUG__ID D08DQL D08DQL DRUGTYPE Small molecular drug D08DQL DRUGINCH 1S/C16H16N2O4/c19-16(20)14-11-13(18(21)22)8-9-15(14)17-10-4-7-12-5-2-1-3-6-12/h1-3,5-6,8-9,11,17H,4,7,10H2,(H,19,20) D08DQL DRUGINKE WBSMIPAMAXNXFS-UHFFFAOYSA-N D08DQL DRUGSMIL C1=CC=C(C=C1)CCCNC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)O D08DQL HIGHSTAT Investigative D08DQZ DRUG__ID D08DQZ D08DQZ DRUGTYPE Small molecular drug D08DQZ DRUGINCH 1S/C4H8N2O/c1-3-2-7-4(5)6-3/h3H,2H2,1H3,(H2,5,6) D08DQZ DRUGINKE PIXPFRMNXPKTFS-UHFFFAOYSA-N D08DQZ DRUGSMIL CC1COC(=N1)N D08DQZ HIGHSTAT Investigative D08DRD DRUG__ID D08DRD D08DRD DRUGTYPE Small molecular drug D08DRD DRUGINCH 1S/C28H32O17/c1-8-16(32)20(36)22(38)27(42-8)41-7-14-17(33)21(37)23(39)28(44-14)45-26-19(35)15-13(6-12(31)25(40-2)18(15)34)43-24(26)9-3-4-10(29)11(30)5-9/h3-6,8,14,16-17,20-23,27-34,36-39H,7H2,1-2H3/t8-,14+,16-,17-,20+,21-,22+,23+,27+,28-/m0/s1 D08DRD DRUGINKE MLOJYABWNDVJMG-GBWWRXBVSA-N D08DRD DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=C(C3=O)C(=C(C(=C4)O)OC)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O D08DRD HIGHSTAT Investigative D08DSG DRUG__ID D08DSG D08DSG DRUGTYPE Small molecular drug D08DSG DRUGINCH 1S/C26H38N8O7/c1-14(2)21-25(41)32-16(9-6-10-29-26(27)28)22(38)30-13-19(35)31-18(12-20(36)37)23(39)33-17(24(40)34-21)11-15-7-4-3-5-8-15/h3-5,7-8,14,16-18,21H,6,9-13H2,1-2H3,(H,30,38)(H,31,35)(H,32,41)(H,33,39)(H,34,40)(H,36,37)(H4,27,28,29)/t16-,17+,18-,21?/m0/s1 D08DSG DRUGINKE YYQUWEHEBOMRPH-YQMJFVBQSA-N D08DSG DRUGSMIL CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N D08DSG HIGHSTAT Investigative D08DSJ DRUG__ID D08DSJ D08DSJ DRUGTYPE Small molecular drug D08DSJ DRUGINCH 1S/C22H18FN3OS2/c1-29(27)19-8-2-15(3-9-19)14-28-22-25-20(16-4-6-18(23)7-5-16)21(26-22)17-10-12-24-13-11-17/h2-13H,14H2,1H3,(H,25,26) D08DSJ DRUGINKE PRYUWQSCZBKGMW-UHFFFAOYSA-N D08DSJ DRUGSMIL CS(=O)C1=CC=C(C=C1)CSC2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F D08DSJ HIGHSTAT Investigative D08DUM DRUG__ID D08DUM D08DUM DRUGTYPE Small molecular drug D08DUM DRUGINCH 1S/C18H32N4O8/c1-8(2)13(18(29)30)21-15(26)9(3)20-17(28)14(10(4)23)22-16(27)11(19-5)6-7-12(24)25/h8-11,13-14,19,23H,6-7H2,1-5H3,(H,20,28)(H,21,26)(H,22,27)(H,24,25)(H,29,30)/t9-,10?,11-,13-,14-/m0/s1 D08DUM DRUGINKE LOKBVOQPMLVOAY-CGTOJEAQSA-N D08DUM DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC D08DUM HIGHSTAT Investigative D08DVL DRUG__ID D08DVL D08DVL DRUGTYPE Small molecular drug D08DVL DRUGINCH 1S/C18H17N5O/c1-12-5-2-3-8-15(12)22-16-9-10-20-18(23-16)21-14-7-4-6-13(11-14)17(19)24/h2-11H,1H3,(H2,19,24)(H2,20,21,22,23) D08DVL DRUGINKE ZUJLZMHZCZZHLN-UHFFFAOYSA-N D08DVL DRUGSMIL CC1=CC=CC=C1NC2=NC(=NC=C2)NC3=CC=CC(=C3)C(=O)N D08DVL HIGHSTAT Investigative D08DVV DRUG__ID D08DVV D08DVV DRUGTYPE Small molecular drug D08DVV DRUGINCH 1S/C24H33NO/c1-2-3-4-11-16-24(26)17-19-25(20-18-24)23(21-12-7-5-8-13-21)22-14-9-6-10-15-22/h5-10,12-15,23,26H,2-4,11,16-20H2,1H3 D08DVV DRUGINKE MJJFIAIFQWXWHK-UHFFFAOYSA-N D08DVV DRUGSMIL CCCCCCC1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)O D08DVV HIGHSTAT Investigative D08DXA DRUG__ID D08DXA D08DXA DRUGTYPE Small molecular drug D08DXA DRUGINCH 1S/C20H14N2O5S.Na/c21-18-15(28(25,26)27)10-14(22-11-6-2-1-3-7-11)16-17(18)20(24)13-9-5-4-8-12(13)19(16)23;/h1-10,22H,21H2,(H,25,26,27);/q;+1/p-1 D08DXA DRUGINKE LIKZXCROQGHXTI-UHFFFAOYSA-M D08DXA DRUGSMIL C1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+] D08DXA HIGHSTAT Investigative D08DZK DRUG__ID D08DZK D08DZK DRUGTYPE Small molecular drug D08DZK DRUGINCH 1S/C28H47NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-28(30)29-23-22-25-20-21-26(31-2)24-27(25)32-3/h11-12,20-21,24H,4-10,13-19,22-23H2,1-3H3,(H,29,30)/b12-11- D08DZK DRUGINKE YDMFQRINHJCRDN-QXMHVHEDSA-N D08DZK DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCC1=C(C=C(C=C1)OC)OC D08DZK HIGHSTAT Investigative D08EBC DRUG__ID D08EBC D08EBC DRUGTYPE Small molecular drug D08EBC DRUGINCH 1S/C11H12BrNO3/c12-3-4-16-11(15)6-8-1-2-10(13)5-9(8)7-14/h1-2,5,7H,3-4,6,13H2 D08EBC DRUGINKE SMKXVWWBCFWRMP-UHFFFAOYSA-N D08EBC DRUGSMIL C1=CC(=C(C=C1N)C=O)CC(=O)OCCBr D08EBC HIGHSTAT Investigative D08EBT DRUG__ID D08EBT D08EBT DRUGTYPE Small molecular drug D08EBT DRUGINCH 1S/C17H23N5O4/c1-3-4-5-6-7-11-20-15(18-2)12-16(21-11)22(9-19-12)17-14(25)13(24)10(8-23)26-17/h9-10,13-14,17,23-25H,3-5,8H2,1-2H3,(H,18,20,21)/t10-,13-,14-,17-/m1/s1 D08EBT DRUGINKE KOCIMZNSNPOGOP-IWCJZZDYSA-N D08EBT DRUGSMIL CCCCC#CC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC D08EBT HIGHSTAT Investigative D08ECP DRUG__ID D08ECP D08ECP DRUGTYPE Small molecular drug D08ECP DRUGINCH 1S/C6H11N3/c1-7-3-2-6-4-8-5-9-6/h4-5,7H,2-3H2,1H3,(H,8,9) D08ECP DRUGINKE PHSPJQZRQAJPPF-UHFFFAOYSA-N D08ECP DRUGSMIL CNCCC1=CN=CN1 D08ECP HIGHSTAT Investigative D08EDN DRUG__ID D08EDN D08EDN DRUGTYPE Small molecular drug D08EDN DRUGINCH 1S/C18H16N2O4.Na/c1-10-15(20-8-4-3-5-14(20)17(10)24-2)16(21)11-6-7-13(19)12(9-11)18(22)23;/h3-9H,19H2,1-2H3,(H,22,23);/q;+1/p-1 D08EDN DRUGINKE JFBMSTWZURKQOC-UHFFFAOYSA-M D08EDN DRUGSMIL CC1=C(N2C=CC=CC2=C1OC)C(=O)C3=CC(=C(C=C3)N)C(=O)[O-].[Na+] D08EDN HIGHSTAT Investigative D08EDV DRUG__ID D08EDV D08EDV DRUGTYPE Small molecular drug D08EDV DRUGINCH 1S/C20H17NO3S/c22-20(18-12-6-2-7-13-18)21(16-17-10-4-1-5-11-17)25(23,24)19-14-8-3-9-15-19/h1-15H,16H2 D08EDV DRUGINKE FRBJVLSQTZFTED-UHFFFAOYSA-N D08EDV DRUGSMIL C1=CC=C(C=C1)CN(C(=O)C2=CC=CC=C2)S(=O)(=O)C3=CC=CC=C3 D08EDV HIGHSTAT Investigative D08EGA DRUG__ID D08EGA D08EGA DRUGTYPE Small molecular drug D08EGA DRUGINCH 1S/C18H36N2O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-23(19,21)22/h6-7,9-10,20H,2-5,8,11-18H2,1H3,(H2,19,21,22)/b7-6-,10-9- D08EGA DRUGINKE DGNCNCVVPPGGNM-HZJYTTRNSA-N D08EGA DRUGSMIL CCCCCC=CCC=CCCCCCCCCNS(=O)(=O)N D08EGA HIGHSTAT Investigative D08EHR DRUG__ID D08EHR D08EHR DRUGTYPE Small molecular drug D08EHR DRUGINCH 1S/C24H27NO2/c1-24-9-8-20-19-7-5-18(26)12-16(19)4-6-21(20)22(24)13-17(23(24)27)11-15-3-2-10-25-14-15/h2-3,5,7,10-12,14,20-23,26-27H,4,6,8-9,13H2,1H3/b17-11+/t20?,21?,22?,23-,24-/m0/s1 D08EHR DRUGINKE FCVLVYMOBDNAMK-PLNMCULSSA-N D08EHR DRUGSMIL CC12CCC3C(C1CC(=CC4=CN=CC=C4)C2O)CCC5=C3C=CC(=C5)O D08EHR HIGHSTAT Investigative D08EJQ DRUG__ID D08EJQ D08EJQ DRUGTYPE Small molecular drug D08EJQ DRUGINCH 1S/C8H7F3N2O2/c9-8(10,11)5-1-3-6(4-2-5)12-7(14)13-15/h1-4,15H,(H2,12,13,14) D08EJQ DRUGINKE DRFSQRMYIQLAMQ-UHFFFAOYSA-N D08EJQ DRUGSMIL C1=CC(=CC=C1C(F)(F)F)NC(=O)NO D08EJQ HIGHSTAT Investigative D08EKQ DRUG__ID D08EKQ D08EKQ DRUGTYPE Small molecular drug D08EKQ DRUGINCH 1S/C19H20F4N2O/c20-16-7-5-14(6-8-16)17(25-11-9-24-10-12-25)13-15-3-1-2-4-18(15)26-19(21,22)23/h1-8,17,24H,9-13H2 D08EKQ DRUGINKE SQSFWPVYWBTHEX-UHFFFAOYSA-N D08EKQ DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2OC(F)(F)F)C3=CC=C(C=C3)F D08EKQ HIGHSTAT Investigative D08ELY DRUG__ID D08ELY D08ELY DRUGTYPE Small molecular drug D08ELY DRUGINCH 1S/C13H19NO4S/c1-2-3-7-12(10-13(15)14-16)19(17,18)11-8-5-4-6-9-11/h4-6,8-9,12,16H,2-3,7,10H2,1H3,(H,14,15) D08ELY DRUGINKE TUUMURVUDGZZQZ-UHFFFAOYSA-N D08ELY DRUGSMIL CCCCC(CC(=O)NO)S(=O)(=O)C1=CC=CC=C1 D08ELY HIGHSTAT Investigative D08EME DRUG__ID D08EME D08EME DRUGTYPE Small molecular drug D08EME DRUGINCH 1S/C19H14Cl2O2/c1-12-2-4-13(5-3-12)14-6-8-19(17(22)10-14)23-18-9-7-15(20)11-16(18)21/h2-11,22H,1H3 D08EME DRUGINKE MJKDRJABBJYCNP-UHFFFAOYSA-N D08EME DRUGSMIL CC1=CC=C(C=C1)C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D08EME HIGHSTAT Investigative D08EMG DRUG__ID D08EMG D08EMG DRUGTYPE Small molecular drug D08EMG DRUGINCH 1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m0/s1 D08EMG DRUGINKE VMWNQDUVQKEIOC-ZDUSSCGKSA-N D08EMG DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O D08EMG HIGHSTAT Investigative D08ERD DRUG__ID D08ERD D08ERD DRUGTYPE Small molecular drug D08ERD DRUGINCH 1S/C6H14O10P2/c1-6(9,4-5(7)8)2-3-15-18(13,14)16-17(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H,13,14)(H2,10,11,12)/t6-/m1/s1 D08ERD DRUGINKE SIGQQUBJQXSAMW-ZCFIWIBFSA-N D08ERD DRUGSMIL CC(CCOP(=O)(O)OP(=O)(O)O)(CC(=O)O)O D08ERD HIGHSTAT Investigative D08EUH DRUG__ID D08EUH D08EUH DRUGTYPE Small molecular drug D08EUH DRUGINCH 1S/C21H25N3O2/c22-18(14-16-8-3-1-4-9-16)21(26)24-13-7-12-19(24)20(25)23-15-17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15,22H2,(H,23,25)/t18-,19+/m1/s1 D08EUH DRUGINKE MEPJWLFTTFHOQO-MOPGFXCFSA-N D08EUH DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)NCC3=CC=CC=C3 D08EUH HIGHSTAT Investigative D08EXA DRUG__ID D08EXA D08EXA DRUGTYPE Small molecular drug D08EXA DRUGINCH 1S/C14H9N3S/c15-8-10-3-1-4-11(7-10)18-14-6-2-5-13(17)12(14)9-16/h1-7H,17H2 D08EXA DRUGINKE LZFWQHZSIBNMAA-UHFFFAOYSA-N D08EXA DRUGSMIL C1=CC(=CC(=C1)SC2=CC=CC(=C2C#N)N)C#N D08EXA HIGHSTAT Investigative D08EXR DRUG__ID D08EXR D08EXR DRUGTYPE Small molecular drug D08EXR DRUGINCH 1S/C32H41N5O5/c1-6-18(4)27-29(39)36-12-8-11-25(36)32(41)37(27)30(40)31(42-32,17(2)3)34-28(38)20-13-22-21-9-7-10-23-26(21)19(15-33-23)14-24(22)35(5)16-20/h7,9-10,13,15,17-18,20,24-25,27,33,41H,6,8,11-12,14,16H2,1-5H3,(H,34,38)/t18-,20+,24+,25-,27+,31+,32-/m0/s1 D08EXR DRUGINKE YYWXOXLDOMRDHW-SGVWFJRMSA-N D08EXR DRUGSMIL CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=CNC7=CC=CC(=C67)C5=C4)C)O D08EXR HIGHSTAT Investigative D08EYZ DRUG__ID D08EYZ D08EYZ DRUGTYPE Small molecular drug D08EYZ DRUGINCH 1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33+/m1/s1 D08EYZ DRUGINKE PGOLWKTUHWHYJS-KUAXMQRVSA-N D08EYZ DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D08EYZ HIGHSTAT Investigative D08EZA DRUG__ID D08EZA D08EZA DRUGTYPE Small molecular drug D08EZA DRUGINCH 1S/C19H13N3O4/c23-18-15-3-1-2-4-17(15)26-19(16(18)11-21-10-9-20-12-21)13-5-7-14(8-6-13)22(24)25/h1-10,12H,11H2 D08EZA DRUGINKE QRPSGPSYOIPDIF-UHFFFAOYSA-N D08EZA DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=C(O2)C3=CC=C(C=C3)[N+](=O)[O-])CN4C=CN=C4 D08EZA HIGHSTAT Investigative D08EZI DRUG__ID D08EZI D08EZI DRUGTYPE Small molecular drug D08EZI DRUGINCH 1S/C21H21N3O/c1-15(2)13-20(25)23-19-14-18(16-9-5-3-6-10-16)22-21(24-19)17-11-7-4-8-12-17/h3-12,14-15H,13H2,1-2H3,(H,22,23,24,25) D08EZI DRUGINKE LUPWFOJGRCESTC-UHFFFAOYSA-N D08EZI DRUGSMIL CC(C)CC(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D08EZI HIGHSTAT Investigative D08EZR DRUG__ID D08EZR D08EZR DRUGTYPE Small molecular drug D08EZR DRUGINCH 1S/C4H3IN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) D08EZR DRUGINKE KSNXJLQDQOIRIP-UHFFFAOYSA-N D08EZR DRUGSMIL C1=C(C(=O)NC(=O)N1)I D08EZR HIGHSTAT Investigative D08FAB DRUG__ID D08FAB D08FAB DRUGTYPE Small molecular drug D08FAB DRUGINCH 1S/C15H11N/c1-2-5-13-10-14(8-7-12(13)4-1)15-6-3-9-16-11-15/h1-11H D08FAB DRUGINKE JVWGLICJXUMGHN-UHFFFAOYSA-N D08FAB DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CN=CC=C3 D08FAB HIGHSTAT Investigative D08FBB DRUG__ID D08FBB D08FBB DRUGTYPE Small molecular drug D08FBB DRUGINCH 1S/C12H11NO3/c1-2-7-3-4-8-9(5-7)13-12(16)11(15)6-10(8)14/h3-6,14H,2H2,1H3,(H,13,15,16) D08FBB DRUGINKE FPLGJFSMGRDPES-UHFFFAOYSA-N D08FBB DRUGSMIL CCC1=CC2=C(C=C1)C(=CC(=O)C(=O)N2)O D08FBB HIGHSTAT Investigative D08FBM DRUG__ID D08FBM D08FBM DRUGTYPE Small molecular drug D08FBM DRUGINCH 1S/C20H16Cl2O2/c21-16-9-11-19(17(22)13-16)24-20-10-8-15(12-18(20)23)7-6-14-4-2-1-3-5-14/h1-5,8-13,23H,6-7H2 D08FBM DRUGINKE SOSAEWQXZFTNAQ-UHFFFAOYSA-N D08FBM DRUGSMIL C1=CC=C(C=C1)CCC2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D08FBM HIGHSTAT Investigative D08FDI DRUG__ID D08FDI D08FDI DRUGTYPE Small molecular drug D08FDI DRUGINCH 1S/C13H8N6/c14-9-10-4-3-5-11(8-10)13-16-18-19(17-13)12-6-1-2-7-15-12/h1-8H D08FDI DRUGINKE GHRSDAGWCBAULR-UHFFFAOYSA-N D08FDI DRUGSMIL C1=CC=NC(=C1)N2N=C(N=N2)C3=CC=CC(=C3)C#N D08FDI HIGHSTAT Investigative D08FEV DRUG__ID D08FEV D08FEV DRUGTYPE Small molecular drug D08FEV DRUGINCH 1S/C13H10N2OS/c1-9-15-12(8-17-9)6-5-10-3-2-4-11(7-10)13(14)16/h2-4,7-8H,1H3,(H2,14,16) D08FEV DRUGINKE WCIRCOOMYHNZHE-UHFFFAOYSA-N D08FEV DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)C(=O)N D08FEV HIGHSTAT Investigative D08FFH DRUG__ID D08FFH D08FFH DRUGTYPE Small molecular drug D08FFH DRUGINCH 1S/C17H18O4/c1-10(18)9-20-15-8-7-13-12-5-3-4-6-14(12)17(19)21-16(13)11(15)2/h7-8H,3-6,9H2,1-2H3 D08FFH DRUGINKE FPBPSCOEWNGWAT-UHFFFAOYSA-N D08FFH DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=C2CCCC3)OCC(=O)C D08FFH HIGHSTAT Investigative D08FGQ DRUG__ID D08FGQ D08FGQ DRUGTYPE Small molecular drug D08FGQ DRUGINCH 1S/C31H35N5O5/c32-24(18-21-13-15-23(37)16-14-21)31(41)36-17-7-12-26(36)29(39)35-27(22-10-5-2-6-11-22)30(40)34-25(28(33)38)19-20-8-3-1-4-9-20/h1-6,8-11,13-16,24-27,37H,7,12,17-19,32H2,(H2,33,38)(H,34,40)(H,35,39)/t24-,25-,26-,27+/m0/s1 D08FGQ DRUGINKE CLTFAZZUUWSIAO-YIPNQBBMSA-N D08FGQ DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(C3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N D08FGQ HIGHSTAT Investigative D08FGR DRUG__ID D08FGR D08FGR DRUGTYPE Small molecular drug D08FGR DRUGINCH 1S/C51H60N10O11/c1-26-36-41(64)61-51(6,45(68)55-38-32-21-13-11-19-30(32)31-20-12-14-22-33(31)38)48-58-37(28(3)72-48)40(63)60-50(5,44(67)54-34(42(65)69-7)23-15-16-24-52)47-57-35(27(2)71-47)39(62)59-49(4,46(56-36)70-26)43(66)53-25-29-17-9-8-10-18-29/h11-14,19-22,29,34,38H,8-10,15-18,23-25,52H2,1-7H3,(H,53,66)(H,54,67)(H,55,68)(H,59,62)(H,60,63)(H,61,64)/t34-,49-,50-,51-/m0/s1 D08FGR DRUGINKE DOHGPSDHRIKTDB-KBAHWNQNSA-N D08FGR DRUGSMIL CC1=C2C(=O)NC(C3=NC(=C(O3)C)C(=O)NC(C4=NC(=C(O4)C)C(=O)NC(C(=N2)O1)(C)C(=O)NCC5CCCCC5)(C)C(=O)NC(CCCCN)C(=O)OC)(C)C(=O)NC6C7=CC=CC=C7C8=CC=CC=C68 D08FGR HIGHSTAT Investigative D08FHU DRUG__ID D08FHU D08FHU DRUGTYPE Small molecular drug D08FHU DRUGINCH 1S/C14H17NO4/c1-8-6-11(16)15(2)12-9(8)7-10(17-3)13(18-4)14(12)19-5/h6-7H,1-5H3 D08FHU DRUGINKE QKOJIFYKROBOKN-UHFFFAOYSA-N D08FHU DRUGSMIL CC1=CC(=O)N(C2=C(C(=C(C=C12)OC)OC)OC)C D08FHU HIGHSTAT Investigative D08FLV DRUG__ID D08FLV D08FLV DRUGTYPE Small molecular drug D08FLV DRUGINCH 1S/C13H9NO3/c15-9-3-1-8(2-4-9)13-11-7-10(16)5-6-12(11)17-14-13/h1-7,15-16H D08FLV DRUGINKE SSWFRICEKZJJHY-UHFFFAOYSA-N D08FLV DRUGSMIL C1=CC(=CC=C1C2=NOC3=C2C=C(C=C3)O)O D08FLV HIGHSTAT Investigative D08FOJ DRUG__ID D08FOJ D08FOJ DRUGTYPE Small molecular drug D08FOJ DRUGINCH 1S/C19H14O2/c20-17-12-18(14-7-2-1-3-8-14)21-19-15-9-5-4-6-13(15)10-11-16(17)19/h1-11,18H,12H2 D08FOJ DRUGINKE QEVIKVQRCYXXSA-UHFFFAOYSA-N D08FOJ DRUGSMIL C1C(OC2=C(C1=O)C=CC3=CC=CC=C32)C4=CC=CC=C4 D08FOJ HIGHSTAT Investigative D08FOT DRUG__ID D08FOT D08FOT DRUGTYPE Small molecular drug D08FOT DRUGINCH 1S/C14H14N4O5S/c1-2-7-18-13(19)10-12(17-14(18)20)16-11(15-10)8-3-5-9(6-4-8)24(21,22)23/h3-6H,2,7H2,1H3,(H,15,16)(H,17,20)(H,21,22,23) D08FOT DRUGINKE UYDRRQPGDSIMNU-UHFFFAOYSA-N D08FOT DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=C(C=C3)S(=O)(=O)O D08FOT HIGHSTAT Investigative D08FOV DRUG__ID D08FOV D08FOV DRUGTYPE Small molecular drug D08FOV DRUGINCH 1S/C13H20ClN5O8P2/c1-15-11-10-12(18-13(14)17-11)19(6-16-10)4-7-2-8(5-26-28(20,21)22)9(3-7)27-29(23,24)25/h6-9H,2-5H2,1H3,(H,15,17,18)(H2,20,21,22)(H2,23,24,25)/t7-,8-,9+/m1/s1 D08FOV DRUGINKE LPZJKPSGEADHTQ-HLTSFMKQSA-N D08FOV DRUGSMIL CNC1=C2C(=NC(=N1)Cl)N(C=N2)CC3CC(C(C3)OP(=O)(O)O)COP(=O)(O)O D08FOV HIGHSTAT Investigative D08FPY DRUG__ID D08FPY D08FPY DRUGTYPE Small molecular drug D08FPY DRUGINCH 1S/C16H12O4/c1-8(17)13-9-4-2-6-11(18)14(9)16(20)15-10(13)5-3-7-12(15)19/h2-7,13,18-19H,1H3 D08FPY DRUGINKE JLVFGQSHNYEUIN-UHFFFAOYSA-N D08FPY DRUGSMIL CC(=O)C1C2=C(C(=CC=C2)O)C(=O)C3=C1C=CC=C3O D08FPY HIGHSTAT Investigative D08FQW DRUG__ID D08FQW D08FQW DRUGTYPE Small molecular drug D08FQW DRUGINCH 1S/C20H15NO2S/c1-14-7-6-8-15(13-14)23-20(22)21-16-9-2-4-11-18(16)24-19-12-5-3-10-17(19)21/h2-13H,1H3 D08FQW DRUGINKE NSTBBOKFDNCGRF-UHFFFAOYSA-N D08FQW DRUGSMIL CC1=CC(=CC=C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D08FQW HIGHSTAT Investigative D08FQX DRUG__ID D08FQX D08FQX DRUGTYPE Small molecular drug D08FQX DRUGINCH 1S/C41H47N5O6S/c1-25-17-30(43-22-28-13-10-16-42-21-28)18-26(2)37(25)52-23-34(48)44-32(19-27-11-6-5-7-12-27)36(49)40(51)46-24-53-41(3,4)38(46)39(50)45-35-31-15-9-8-14-29(31)20-33(35)47/h5-18,21,32-33,35-36,38,43,47,49H,19-20,22-24H2,1-4H3,(H,44,48)(H,45,50)/t32-,33+,35-,36-,38+/m0/s1 D08FQX DRUGINKE HBTCIJNHNMLBFP-CTRNRRKFSA-N D08FQX DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NCC6=CN=CC=C6 D08FQX HIGHSTAT Investigative D08FSC DRUG__ID D08FSC D08FSC DRUGTYPE Small molecular drug D08FSC DRUGINCH 1S/C15H12FNO4/c16-11-5-3-10(4-6-11)9-17-7-1-2-12(17)13(18)8-14(19)15(20)21/h1-7H,8-9H2,(H,20,21) D08FSC DRUGINKE PJIBKQJSMPMZCH-UHFFFAOYSA-N D08FSC DRUGSMIL C1=CN(C(=C1)C(=O)CC(=O)C(=O)O)CC2=CC=C(C=C2)F D08FSC HIGHSTAT Investigative D08FSF DRUG__ID D08FSF D08FSF DRUGTYPE Small molecular drug D08FSF DRUGINCH 1S/C8H8N4O2/c1-2-3-12-7(13)5-6(10-4-9-5)11-8(12)14/h2,4H,1,3H2,(H,9,10)(H,11,14) D08FSF DRUGINKE IPKIKTHDWDXHPU-UHFFFAOYSA-N D08FSF DRUGSMIL C=CCN1C(=O)C2=C(NC1=O)N=CN2 D08FSF HIGHSTAT Investigative D08FUK DRUG__ID D08FUK D08FUK DRUGTYPE Small molecular drug D08FUK DRUGINCH 1S/C12H16N2/c1-9-3-4-12-11(7-9)5-6-14(12)8-10(2)13/h3-7,10H,8,13H2,1-2H3 D08FUK DRUGINKE WETMFNBRIOBNTK-UHFFFAOYSA-N D08FUK DRUGSMIL CC1=CC2=C(C=C1)N(C=C2)CC(C)N D08FUK HIGHSTAT Investigative D08FWE DRUG__ID D08FWE D08FWE DRUGTYPE Small molecular drug D08FWE DRUGINCH 1S/C14H21N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h5-6,8-11,20H,3-4,7H2,1-2H3,(H2,15,16,17)/b6-5+/t10-,11+/m0/s1 D08FWE DRUGINKE QZMKAUPEGUOLDB-PFDYWKIBSA-N D08FWE DRUGSMIL CCCC=CCC(C(C)O)N1C=NC2=C(N=CN=C21)N D08FWE HIGHSTAT Investigative D08FXD DRUG__ID D08FXD D08FXD DRUGTYPE Small molecular drug D08FXD DRUGINCH 1S/C15H15N/c1-10(2)11-7-8-13-12-5-3-4-6-14(12)16-15(13)9-11/h3-10,16H,1-2H3 D08FXD DRUGINKE AMSCTVXMVALTQJ-UHFFFAOYSA-N D08FXD DRUGSMIL CC(C)C1=CC2=C(C=C1)C3=CC=CC=C3N2 D08FXD HIGHSTAT Investigative D08FXH DRUG__ID D08FXH D08FXH DRUGTYPE Small molecular drug D08FXH DRUGINCH 1S/C13H19NOS/c1-2-8-15-12-5-3-11(4-6-12)13-10-14-7-9-16-13/h3-6,13-14H,2,7-10H2,1H3 D08FXH DRUGINKE MHUSNQPPWZGBBB-UHFFFAOYSA-N D08FXH DRUGSMIL CCCOC1=CC=C(C=C1)C2CNCCS2 D08FXH HIGHSTAT Investigative D08FXW DRUG__ID D08FXW D08FXW DRUGTYPE Small molecular drug D08FXW DRUGINCH 1S/C9H13FN2/c1-7-5-8(3-2-4-10)12-9(11)6-7/h5-6H,2-4H2,1H3,(H2,11,12) D08FXW DRUGINKE UWBOFUBWKXYIJF-UHFFFAOYSA-N D08FXW DRUGSMIL CC1=CC(=NC(=C1)N)CCCF D08FXW HIGHSTAT Investigative D08FYQ DRUG__ID D08FYQ D08FYQ DRUGTYPE Small molecular drug D08FYQ DRUGINCH 1S/C28H30N2O5/c31-19-9-8-17-14-20-28-11-10-27(33,23(35-28)24(32)29-18-4-2-1-3-5-18)25-26(28,21(17)22(19)34-25)12-13-30(20)15-16-6-7-16/h1-5,8-9,16,20,23,25,31,33H,6-7,10-15H2,(H,29,32)/t20-,23+,25+,26-,27-,28+/m0/s1 D08FYQ DRUGINKE YYNRSCGPLWDLNI-PEBCJGEWSA-N D08FYQ DRUGSMIL C1CC1CN2CCC34C5C6(CCC3(C2CC7=C4C(=C(C=C7)O)O5)OC6C(=O)NC8=CC=CC=C8)O D08FYQ HIGHSTAT Investigative D08FZC DRUG__ID D08FZC D08FZC DRUGTYPE Small molecular drug D08FZC DRUGINCH 1S/C24H20O5/c1-3-26-15-9-11-19-21(13-15)28-22-14-16(27-4-2)10-12-20(22)24(19)18-8-6-5-7-17(18)23(25)29-24/h5-14H,3-4H2,1-2H3 D08FZC DRUGINKE XAPFGEPPWZRGFN-UHFFFAOYSA-N D08FZC DRUGSMIL CCOC1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)OCC)C5=CC=CC=C5C(=O)O3 D08FZC HIGHSTAT Investigative D08FZK DRUG__ID D08FZK D08FZK DRUGTYPE Small molecular drug D08FZK DRUGINCH 1S/C14H10N2O3/c17-14(8-7-12-5-1-2-9-15-12)11-4-3-6-13(10-11)16(18)19/h1-10H/b8-7+ D08FZK DRUGINKE BXQJHMCMOWDXJO-BQYQJAHWSA-N D08FZK DRUGSMIL C1=CC=NC(=C1)C=CC(=O)C2=CC(=CC=C2)[N+](=O)[O-] D08FZK HIGHSTAT Investigative D08FZN DRUG__ID D08FZN D08FZN DRUGTYPE Small molecular drug D08FZN DRUGINCH 1S/C13H13F3N2O/c1-2-5-17-8-3-4-11-9(6-8)10(13(14,15)16)7-12(19)18-11/h3-4,6-7,17H,2,5H2,1H3,(H,18,19) D08FZN DRUGINKE YGYHGNGCPLCHQH-UHFFFAOYSA-N D08FZN DRUGSMIL CCCNC1=CC2=C(C=C1)NC(=O)C=C2C(F)(F)F D08FZN HIGHSTAT Investigative D08FZQ DRUG__ID D08FZQ D08FZQ DRUGTYPE Small molecular drug D08FZQ DRUGINCH 1S/C18H24N2O3/c1-5-15-16(10-14-8-12(3)7-13(4)9-14)20(11-23-6-2)18(22)19-17(15)21/h7-9H,5-6,10-11H2,1-4H3,(H,19,21,22) D08FZQ DRUGINKE LNEPZLRCYLNOIU-UHFFFAOYSA-N D08FZQ DRUGSMIL CCC1=C(N(C(=O)NC1=O)COCC)CC2=CC(=CC(=C2)C)C D08FZQ HIGHSTAT Investigative D08FZR DRUG__ID D08FZR D08FZR DRUGTYPE Small molecular drug D08FZR DRUGINCH 1S/C15H13NO2S/c1-17-13-5-3-4-6-15(13)19-12-8-7-11(10-16)14(9-12)18-2/h3-9H,1-2H3 D08FZR DRUGINKE WQGGJJSMEMAVIF-UHFFFAOYSA-N D08FZR DRUGSMIL COC1=CC=CC=C1SC2=CC(=C(C=C2)C#N)OC D08FZR HIGHSTAT Investigative D08GDJ DRUG__ID D08GDJ D08GDJ DRUGTYPE Small molecular drug D08GDJ DRUGINCH 1S/C23H26N4O6S/c1-14(28)25-19(12-15-5-3-2-4-6-15)23(31)26-18(22(24)30)11-16-7-9-17(10-8-16)20-13-21(29)27-34(20,32)33/h2-10,18-20H,11-13H2,1H3,(H2,24,30)(H,25,28)(H,26,31)(H,27,29)/t18-,19-,20-/m0/s1 D08GDJ DRUGINKE UILYPHAKDBTKQV-UFYCRDLUSA-N D08GDJ DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)C3CC(=O)NS3(=O)=O)C(=O)N D08GDJ HIGHSTAT Investigative D08GEN DRUG__ID D08GEN D08GEN DRUGTYPE Small molecular drug D08GEN DRUGINCH 1S/C21H22O4/c1-5-21(2,3)17-12-15(20(25-4)13-19(17)24)8-11-18(23)14-6-9-16(22)10-7-14/h5-13,22,24H,1H2,2-4H3/b11-8+ D08GEN DRUGINKE KAZSKMJFUPEHHW-DHZHZOJOSA-N D08GEN DRUGSMIL CC(C)(C=C)C1=C(C=C(C(=C1)C=CC(=O)C2=CC=C(C=C2)O)OC)O D08GEN HIGHSTAT Investigative D08GFG DRUG__ID D08GFG D08GFG DRUGTYPE Small molecular drug D08GFG DRUGINCH 1S/C19H36O5/c1-3-5-7-9-11-13-18(21)23-16-17(15-20)24-19(22)14-12-10-8-6-4-2/h17,20H,3-16H2,1-2H3 D08GFG DRUGINKE ZQBULZYTDGUSSK-UHFFFAOYSA-N D08GFG DRUGSMIL CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC D08GFG HIGHSTAT Investigative D08GFY DRUG__ID D08GFY D08GFY DRUGTYPE Small molecular drug D08GFY DRUGINCH 1S/C3H8OS2/c1-5-3-6(2)4/h3H2,1-2H3 D08GFY DRUGINKE OTKFCIVOVKCFHR-UHFFFAOYSA-N D08GFY DRUGSMIL CSCS(=O)C D08GFY HIGHSTAT Investigative D08GJS DRUG__ID D08GJS D08GJS DRUGTYPE Small molecular drug D08GJS DRUGINCH 1S/C13H18N2O/c1-9(15(2)3)7-10-8-14-11-5-4-6-12(16)13(10)11/h4-6,8-9,14,16H,7H2,1-3H3 D08GJS DRUGINKE GRWDWEFPYLWISL-UHFFFAOYSA-N D08GJS DRUGSMIL CC(CC1=CNC2=C1C(=CC=C2)O)N(C)C D08GJS HIGHSTAT Investigative D08GKL DRUG__ID D08GKL D08GKL DRUGTYPE Small molecular drug D08GKL DRUGINCH 1S/C16H12INO2/c1-18-12-5-2-10(3-6-12)16-9-14(19)13-8-11(17)4-7-15(13)20-16/h2-9,18H,1H3 D08GKL DRUGINKE QIZWRTNISFPGTO-UHFFFAOYSA-N D08GKL DRUGSMIL CNC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)I D08GKL HIGHSTAT Investigative D08GKT DRUG__ID D08GKT D08GKT DRUGTYPE Small molecular drug D08GKT DRUGINCH 1S/C31H38N6O5/c1-5-41-26-18-22-24(19-27(26)42-6-2)32-30(36-13-15-40-16-14-36)33-28(22)35-11-9-21(10-12-35)37-29(38)23-17-20(3)7-8-25(23)34(4)31(37)39/h7-8,17-19,21H,5-6,9-16H2,1-4H3 D08GKT DRUGINKE MXOWYPVUVPQDNZ-UHFFFAOYSA-N D08GKT DRUGSMIL CCOC1=C(C=C2C(=C1)C(=NC(=N2)N3CCOCC3)N4CCC(CC4)N5C(=O)C6=C(C=CC(=C6)C)N(C5=O)C)OCC D08GKT HIGHSTAT Investigative D08GLJ DRUG__ID D08GLJ D08GLJ DRUGTYPE Small molecular drug D08GLJ DRUGINCH 1S/C8H10N4O2/c1-4-9-5-6(10-4)11(2)8(14)12(3)7(5)13/h1-3H3,(H,9,10) D08GLJ DRUGINKE WZBKGWBHAPBSBF-UHFFFAOYSA-N D08GLJ DRUGSMIL CC1=NC2=C(N1)C(=O)N(C(=O)N2C)C D08GLJ HIGHSTAT Investigative D08GLU DRUG__ID D08GLU D08GLU DRUGTYPE Small molecular drug D08GLU DRUGINCH 1S/C21H29NO/c1-4-5-6-7-14-21(2,3)17-10-13-19(20(23)15-17)16-8-11-18(22)12-9-16/h8-13,15,23H,4-7,14,22H2,1-3H3 D08GLU DRUGINKE SDBAMIYHTMYHHO-UHFFFAOYSA-N D08GLU DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CC=C(C=C2)N)O D08GLU HIGHSTAT Investigative D08GMO DRUG__ID D08GMO D08GMO DRUGTYPE Small molecular drug D08GMO DRUGINCH 1S/C15H12N4O/c16-10-6-4-9(5-7-10)13-8-18-12-3-1-2-11(15(17)20)14(12)19-13/h1-8H,16H2,(H2,17,20) D08GMO DRUGINKE JCXJUCVUESBKLT-UHFFFAOYSA-N D08GMO DRUGSMIL C1=CC(=C2C(=C1)N=CC(=N2)C3=CC=C(C=C3)N)C(=O)N D08GMO HIGHSTAT Investigative D08GOT DRUG__ID D08GOT D08GOT DRUGTYPE Small molecular drug D08GOT DRUGINCH 1S/C14H12ClNO2/c15-11-6-2-4-8-13(11)16-12-7-3-1-5-10(12)9-14(17)18/h1-8,16H,9H2,(H,17,18) D08GOT DRUGINKE RXRLPBIKRNGLJD-UHFFFAOYSA-N D08GOT DRUGSMIL C1=CC=C(C(=C1)CC(=O)O)NC2=CC=CC=C2Cl D08GOT HIGHSTAT Investigative D08GPU DRUG__ID D08GPU D08GPU DRUGTYPE Small molecular drug D08GPU DRUGINCH 1S/C16H16N4/c17-15-14-12(10-9-11-5-2-1-3-6-11)7-4-8-13(14)19-16(18)20-15/h1-8H,9-10H2,(H4,17,18,19,20) D08GPU DRUGINKE UIHMRPRVKDDARV-UHFFFAOYSA-N D08GPU DRUGSMIL C1=CC=C(C=C1)CCC2=C3C(=CC=C2)N=C(N=C3N)N D08GPU HIGHSTAT Investigative D08GTH DRUG__ID D08GTH D08GTH DRUGTYPE Small molecular drug D08GTH DRUGINCH 1S/C43H54N8O5/c1-25(2)18-35(39(45)52)48-41(54)36(19-26(3)4)50-43(56)38(22-29-24-47-34-17-11-9-15-31(29)34)51-42(55)37(20-27-12-6-5-7-13-27)49-40(53)32(44)21-28-23-46-33-16-10-8-14-30(28)33/h5-17,23-26,32,35-38,46-47H,18-22,44H2,1-4H3,(H2,45,52)(H,48,54)(H,49,53)(H,50,56)(H,51,55)/t32-,35+,36+,37+,38-/m1/s1 D08GTH DRUGINKE YFSSMBIPKDBQSL-CLZHSDMDSA-N D08GTH DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)N D08GTH HIGHSTAT Investigative D08GWQ DRUG__ID D08GWQ D08GWQ DRUGTYPE Small molecular drug D08GWQ DRUGINCH 1S/C19H16O2S/c1-12(2)16-18(21)17(20)14-10-6-7-11-15(14)19(16)22-13-8-4-3-5-9-13/h3-12H,1-2H3 D08GWQ DRUGINKE VHVWQYNOEGPBOE-UHFFFAOYSA-N D08GWQ DRUGSMIL CC(C)C1=C(C2=CC=CC=C2C(=O)C1=O)SC3=CC=CC=C3 D08GWQ HIGHSTAT Investigative D08GWS DRUG__ID D08GWS D08GWS DRUGTYPE Small molecular drug D08GWS DRUGINCH 1S/C29H36NO.BrH/c1-6-28(24-13-9-7-10-14-24)29(25-15-11-8-12-16-25)26-17-19-27(20-18-26)31-22-21-30(4,5)23(2)3;/h7-20,23H,6,21-22H2,1-5H3;1H/q+1;/p-1/b29-28-; D08GWS DRUGINKE VSVUDCODHCQATR-FJBFXRHMSA-M D08GWS DRUGSMIL CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCC[N+](C)(C)C(C)C)C3=CC=CC=C3.[Br-] D08GWS HIGHSTAT Investigative D08GZJ DRUG__ID D08GZJ D08GZJ DRUGCOMP Merck & Co Inc D08GZJ DRUGINCH 1S/C30H34F2N6O4/c1-29(2,41-3)23-16-34-26-22(10-9-18(17-38(23)26)19-6-4-8-21(31)24(19)32)35-27(39)37-14-11-30(12-15-37)20-7-5-13-33-25(20)36-28(40)42-30/h4-8,13,16,18,22H,9-12,14-15,17H2,1-3H3,(H,35,39)(H,33,36,40)/t18-,22-/m1/s1 D08GZJ DRUGINKE FAEQDNJQJXKVTM-XMSQKQJNSA-N D08GZJ DRUGSMIL CC(C)(C1=CN=C2N1CC(CCC2NC(=O)N3CCC4(CC3)C5=C(NC(=O)O4)N=CC=C5)C6=C(C(=CC=C6)F)F)OC D08GZJ HIGHSTAT Investigative D08GZK DRUG__ID D08GZK D08GZK DRUGTYPE Small molecular drug D08GZK DRUGINCH 1S/C25H25N5O7/c1-28-23(35)25(29(2)24(28)36)18-17(21(34)19-14(20(18)33)10(5-6-26)8-27-19)16-15-11(7-12(31)22(16)37-25)30(3,4)9-13(15)32/h7-8,13,32H,5-6,9,26H2,1-4H3,(H-,27,31,33,34)/p+1/t13-,25-/m1/s1 D08GZK DRUGINKE YOXFPJITBOPKPN-YMXBGEKHSA-O D08GZK DRUGSMIL CN1C(=O)C2(C3=C(C4=C5C(C[N+](C5=CC(=C4O2)O)(C)C)O)C(=O)C6=C(C3=O)C(=CN6)CCN)N(C1=O)C D08GZK HIGHSTAT Investigative D08HAM DRUG__ID D08HAM D08HAM DRUGTYPE Small molecular drug D08HAM DRUGINCH 1S/C11H9BrN2/c12-8-2-1-3-9-11(8)7-4-5-13-6-10(7)14-9/h1-3,6,14H,4-5H2 D08HAM DRUGINKE FTDSATOEKTYHMK-UHFFFAOYSA-N D08HAM DRUGSMIL C1CN=CC2=C1C3=C(N2)C=CC=C3Br D08HAM HIGHSTAT Investigative D08HBH DRUG__ID D08HBH D08HBH DRUGTYPE Small molecular drug D08HBH DRUGINCH 1S/C20H19N3O/c1-2-9-19(24)22-18-14-17(15-10-5-3-6-11-15)21-20(23-18)16-12-7-4-8-13-16/h3-8,10-14H,2,9H2,1H3,(H,21,22,23,24) D08HBH DRUGINKE UBJLQDSZSYHXLE-UHFFFAOYSA-N D08HBH DRUGSMIL CCCC(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D08HBH HIGHSTAT Investigative D08HBN DRUG__ID D08HBN D08HBN DRUGTYPE Small molecular drug D08HBN DRUGINCH 1S/C56H85N17O12/c57-24-8-7-18-36(58)46(76)67-37(19-9-25-63-55(59)60)51(81)73-29-13-23-44(73)53(83)72-28-11-21-42(72)49(79)65-32-45(75)66-39(30-34-14-3-1-4-15-34)47(77)70-41(33-74)52(82)71-27-12-22-43(71)50(80)69-40(31-35-16-5-2-6-17-35)48(78)68-38(54(84)85)20-10-26-64-56(61)62/h1-6,14-17,36-44,74H,7-13,18-33,57-58H2,(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,80)(H,70,77)(H,84,85)(H4,59,60,63)(H4,61,62,64)/t36-,37-,38-,39-,40-,41-,42-,43-,44-/m0/s1 D08HBN DRUGINKE FYSKZKQBTVLYEQ-FSLKYBNLSA-N D08HBN DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O D08HBN HIGHSTAT Investigative D08HCF DRUG__ID D08HCF D08HCF DRUGTYPE Small molecular drug D08HCF DRUGINCH 1S/C13H8ClNO3/c14-9-5-7(1-4-11(9)17)13-15-10-3-2-8(16)6-12(10)18-13/h1-6,16-17H D08HCF DRUGINKE YWMCWMCSJCYHBX-UHFFFAOYSA-N D08HCF DRUGSMIL C1=CC(=C(C=C1C2=NC3=C(O2)C=C(C=C3)O)Cl)O D08HCF HIGHSTAT Investigative D08HCY DRUG__ID D08HCY D08HCY DRUGTYPE Small molecular drug D08HCY DRUGINCH 1S/C22H16N4/c23-13-19-15-24-14-18(7-6-16-4-2-1-3-5-16)22(19)26-20-9-8-17-10-11-25-21(17)12-20/h1-12,14-15,25H,(H,24,26)/b7-6+ D08HCY DRUGINKE DDIZHXIEUONSME-VOTSOKGWSA-N D08HCY DRUGSMIL C1=CC=C(C=C1)C=CC2=CN=CC(=C2NC3=CC4=C(C=C3)C=CN4)C#N D08HCY HIGHSTAT Investigative D08HFG DRUG__ID D08HFG D08HFG DRUGTYPE Small molecular drug D08HFG DRUGINCH 1S/C15H13N5O/c16-14(21)10-8-12(11-6-7-18-15(17)20-11)19-13(10)9-4-2-1-3-5-9/h1-8,19H,(H2,16,21)(H2,17,18,20) D08HFG DRUGINKE VOQXQYXTZZHYBF-UHFFFAOYSA-N D08HFG DRUGSMIL C1=CC=C(C=C1)C2=C(C=C(N2)C3=NC(=NC=C3)N)C(=O)N D08HFG HIGHSTAT Investigative D08HFI DRUG__ID D08HFI D08HFI DRUGTYPE Small molecular drug D08HFI DRUGINCH 1S/C7H14N2O4S/c8-4(6(10)11)1-2-14-3-5(9)7(12)13/h4-5H,1-3,8-9H2,(H,10,11)(H,12,13) D08HFI DRUGINKE ILRYLPWNYFXEMH-UHFFFAOYSA-N D08HFI DRUGSMIL C(CSCC(C(=O)O)N)C(C(=O)O)N D08HFI HIGHSTAT Investigative D08HFK DRUG__ID D08HFK D08HFK DRUGTYPE Small molecular drug D08HFK DRUGINCH 1S/C13H9ClN2O/c14-9-6-7-12-11(8-9)16-13(17-12)15-10-4-2-1-3-5-10/h1-8H,(H,15,16) D08HFK DRUGINKE YWNAVPSABPGECL-UHFFFAOYSA-N D08HFK DRUGSMIL C1=CC=C(C=C1)NC2=NC3=C(O2)C=CC(=C3)Cl D08HFK HIGHSTAT Investigative D08HGK DRUG__ID D08HGK D08HGK DRUGTYPE Small molecular drug D08HGK DRUGINCH 1S/C17H14N2O2/c20-16(14-11-18-15-9-5-4-8-13(14)15)17(21)19-10-12-6-2-1-3-7-12/h1-9,11,18H,10H2,(H,19,21) D08HGK DRUGINKE HWOWPGLTTSFLOQ-UHFFFAOYSA-N D08HGK DRUGSMIL C1=CC=C(C=C1)CNC(=O)C(=O)C2=CNC3=CC=CC=C32 D08HGK HIGHSTAT Investigative D08HHA DRUG__ID D08HHA D08HHA DRUGTYPE Small molecular drug D08HHA DRUGINCH 1S/C10H9FN2/c11-10-3-1-2-9(6-10)7-13-5-4-12-8-13/h1-6,8H,7H2 D08HHA DRUGINKE CJNXVRZKOSWWND-UHFFFAOYSA-N D08HHA DRUGSMIL C1=CC(=CC(=C1)F)CN2C=CN=C2 D08HHA HIGHSTAT Investigative D08HKC DRUG__ID D08HKC D08HKC DRUGTYPE Small molecular drug D08HKC DRUGINCH 1S/C17H14OS/c1-11-3-6-13(7-4-11)15-10-17(19)14-8-5-12(2)9-16(14)18-15/h3-10H,1-2H3 D08HKC DRUGINKE LDIMKSQQZFWQLA-UHFFFAOYSA-N D08HKC DRUGSMIL CC1=CC=C(C=C1)C2=CC(=S)C3=C(O2)C=C(C=C3)C D08HKC HIGHSTAT Investigative D08HNJ DRUG__ID D08HNJ D08HNJ DRUGTYPE Small molecular drug D08HNJ DRUGINCH 1S/C19H20N2O/c22-19(18-14-16-11-4-5-12-17(16)21-18)20-13-7-6-10-15-8-2-1-3-9-15/h1-5,8-9,11-12,14,21H,6-7,10,13H2,(H,20,22) D08HNJ DRUGINKE LYMIBNDEHCKPTI-UHFFFAOYSA-N D08HNJ DRUGSMIL C1=CC=C(C=C1)CCCCNC(=O)C2=CC3=CC=CC=C3N2 D08HNJ HIGHSTAT Investigative D08HOJ DRUG__ID D08HOJ D08HOJ DRUGTYPE Small molecular drug D08HOJ DRUGINCH 1S/C10H13N/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-4,10H,5-7,11H2 D08HOJ DRUGINKE LCGFVWKNXLRFIF-UHFFFAOYSA-N D08HOJ DRUGSMIL C1CC2=CC=CC=C2CC1N D08HOJ HIGHSTAT Investigative D08HOK DRUG__ID D08HOK D08HOK DRUGTYPE Small molecular drug D08HOK DRUGINCH 1S/C22H27N5O5S/c1-22(2,3)32-21(28)26-11-9-16(10-12-26)31-20-18-13-25-27(19(18)23-14-24-20)15-5-7-17(8-6-15)33(4,29)30/h5-8,13-14,16H,9-12H2,1-4H3 D08HOK DRUGINKE LZCNLEZPKDPKSO-UHFFFAOYSA-N D08HOK DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)OC2=NC=NC3=C2C=NN3C4=CC=C(C=C4)S(=O)(=O)C D08HOK HIGHSTAT Investigative D08HPL DRUG__ID D08HPL D08HPL DRUGTYPE Small molecular drug D08HPL DRUGINCH 1S/C15H20N2O4S/c1-5-22(19,20)17(4)13-11-8-10(9-16)6-7-12(11)21-15(2,3)14(13)18/h6-8,13-14,18H,5H2,1-4H3/t13-,14+/m1/s1 D08HPL DRUGINKE HVSJHHXUORMCGK-KGLIPLIRSA-N D08HPL DRUGSMIL CCS(=O)(=O)N(C)C1C(C(OC2=C1C=C(C=C2)C#N)(C)C)O D08HPL HIGHSTAT Investigative D08HPU DRUG__ID D08HPU D08HPU DRUGTYPE Small molecular drug D08HPU DRUGINCH 1S/C16H15N/c1-12-9-13-5-2-3-6-14(13)10-16(12)15-7-4-8-17-11-15/h2-8,10-12H,9H2,1H3 D08HPU DRUGINKE ARDWAGDGUKXSPH-UHFFFAOYSA-N D08HPU DRUGSMIL CC1CC2=CC=CC=C2C=C1C3=CN=CC=C3 D08HPU HIGHSTAT Investigative D08HQB DRUG__ID D08HQB D08HQB DRUGTYPE Small molecular drug D08HQB DRUGINCH 1S/C11H17NOS2/c1-2-3-4-5-6-7-8-9-10(13)12-11(14)15-9/h7-8,13H,2-6H2,1H3,(H,12,14)/b8-7- D08HQB DRUGINKE FMOVNYUOJKHVOR-FPLPWBNLSA-N D08HQB DRUGSMIL CCCCCCC=CC1=C(NC(=S)S1)O D08HQB HIGHSTAT Investigative D08HRA DRUG__ID D08HRA D08HRA DRUGTYPE Small molecular drug D08HRA DRUGINCH 1S/C13H12O2S2/c1-17(14,15)13-8-5-11(6-9-13)4-7-12-3-2-10-16-12/h2-10H,1H3/b7-4+ D08HRA DRUGINKE JTGRXCMSCWBAQN-QPJJXVBHSA-N D08HRA DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C=CC2=CC=CS2 D08HRA HIGHSTAT Investigative D08HTJ DRUG__ID D08HTJ D08HTJ DRUGTYPE Small molecular drug D08HTJ DRUGINCH 1S/C18H19NO3/c1-19-6-5-11-7-12(22-2)9-13-16(11)14(19)8-10-3-4-15(20)18(21)17(10)13/h3-4,7,9,14,20-21H,5-6,8H2,1-2H3/t14-/m1/s1 D08HTJ DRUGINKE QGJWYJSOGNAUCY-CQSZACIVSA-N D08HTJ DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=C(C=C4)O)O D08HTJ HIGHSTAT Investigative D08HUX DRUG__ID D08HUX D08HUX DRUGTYPE Small molecular drug D08HUX DRUGINCH 1S/C21H20N2O/c24-21(19-12-7-14-22-16-19)23-15-13-20(17-8-3-1-4-9-17)18-10-5-2-6-11-18/h1-12,14,16,20H,13,15H2,(H,23,24) D08HUX DRUGINKE GDHXZIQAOUBZCC-UHFFFAOYSA-N D08HUX DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)C2=CN=CC=C2)C3=CC=CC=C3 D08HUX HIGHSTAT Investigative D08HYX DRUG__ID D08HYX D08HYX DRUGTYPE Small molecular drug D08HYX DRUGINCH 1S/C9H12N2/c1-2-3-4-5-6-9-7-10-8-11-9/h7-8H,2,5-6H2,1H3,(H,10,11) D08HYX DRUGINKE KXZPBLYVPNSMHH-UHFFFAOYSA-N D08HYX DRUGSMIL CCC#CCCC1=CN=CN1 D08HYX HIGHSTAT Investigative D08HZD DRUG__ID D08HZD D08HZD DRUGTYPE Small molecular drug D08HZD DRUGINCH 1S/C17H16N4/c18-17-16(7-3-9-20-17)21-11-13-4-1-5-14(10-13)15-6-2-8-19-12-15/h1-10,12,21H,11H2,(H2,18,20) D08HZD DRUGINKE NQSBHBFOOVYRNM-UHFFFAOYSA-N D08HZD DRUGSMIL C1=CC(=CC(=C1)C2=CN=CC=C2)CNC3=C(N=CC=C3)N D08HZD HIGHSTAT Investigative D08IBD DRUG__ID D08IBD D08IBD DRUGTYPE Small molecular drug D08IBD DRUGINCH 1S/C14H18ClNO/c15-12-7-4-8-13(10-12)16-14(17)9-11-5-2-1-3-6-11/h4,7-8,10-11H,1-3,5-6,9H2,(H,16,17) D08IBD DRUGINKE POFHQQJQPBOESX-UHFFFAOYSA-N D08IBD DRUGSMIL C1CCC(CC1)CC(=O)NC2=CC(=CC=C2)Cl D08IBD HIGHSTAT Investigative D08ICI DRUG__ID D08ICI D08ICI DRUGTYPE Small molecular drug D08ICI DRUGINCH 1S/C13H13NO5/c1-18-10-3-4-11-9(7-10)6-8(13(16)19-11)2-5-12(15)14-17/h3-4,6-7,17H,2,5H2,1H3,(H,14,15) D08ICI DRUGINKE JUDXBTMVZVWJNP-UHFFFAOYSA-N D08ICI DRUGSMIL COC1=CC2=C(C=C1)OC(=O)C(=C2)CCC(=O)NO D08ICI HIGHSTAT Investigative D08ICY DRUG__ID D08ICY D08ICY DRUGTYPE Small molecular drug D08ICY DRUGINCH 1S/C16H24N2O3/c1-2-13-9-11-14(12-10-13)17-15(19)7-5-3-4-6-8-16(20)18-21/h9-12,21H,2-8H2,1H3,(H,17,19)(H,18,20) D08ICY DRUGINKE OMRKYIIKVIYNKK-UHFFFAOYSA-N D08ICY DRUGSMIL CCC1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO D08ICY HIGHSTAT Investigative D08IDC DRUG__ID D08IDC D08IDC DRUGTYPE Small molecular drug D08IDC DRUGINCH 1S/C17H15NO2/c1-19-16-6-5-12-7-13(3-4-14(12)8-16)15-9-17(20-2)11-18-10-15/h3-11H,1-2H3 D08IDC DRUGINKE SEXSHORPOJSDHK-UHFFFAOYSA-N D08IDC DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CC(=CN=C3)OC D08IDC HIGHSTAT Investigative D08IDJ DRUG__ID D08IDJ D08IDJ DRUGTYPE Small molecular drug D08IDJ DRUGINCH 1S/C16H9N3O/c20-15-12-9-5-4-8-11(12)13-14(15)18-19-16(17-13)10-6-2-1-3-7-10/h1-9H D08IDJ DRUGINKE OERHOWFXDDHRBP-UHFFFAOYSA-N D08IDJ DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C(=O)C4=CC=CC=C43)N=N2 D08IDJ HIGHSTAT Investigative D08IEE DRUG__ID D08IEE D08IEE DRUGTYPE Small molecular drug D08IEE DRUGINCH 1S/C6H11NO3/c8-5-3-7-2-1-4(5)6(9)10/h4-5,7-8H,1-3H2,(H,9,10)/t4-,5+/m1/s1 D08IEE DRUGINKE ASDFUVTYTVOHPL-UHNVWZDZSA-N D08IEE DRUGSMIL C1CNCC(C1C(=O)O)O D08IEE HIGHSTAT Investigative D08IFQ DRUG__ID D08IFQ D08IFQ DRUGTYPE Small molecular drug D08IFQ DRUGINCH 1S/C13H15N/c1-2-4-10(5-3-1)11-8-12-6-7-13(9-11)14-12/h1-5,8,12-14H,6-7,9H2 D08IFQ DRUGINKE VHBRUQHAUJNUAM-UHFFFAOYSA-N D08IFQ DRUGSMIL C1CC2C=C(CC1N2)C3=CC=CC=C3 D08IFQ HIGHSTAT Investigative D08IGF DRUG__ID D08IGF D08IGF DRUGTYPE Small molecular drug D08IGF DRUGINCH 1S/C43H69NO13/c1-10-29-18-23(2)37(48)24(3)19-35(54-8)39-36(55-9)20-26(5)43(52,57-39)40(49)41(50)44-16-12-11-13-30(44)42(51)56-38(27(6)32(46)22-33(29)47)25(4)17-28-14-15-31(45)34(21-28)53-7/h17-18,24,26-32,34-39,45-46,48,52H,10-16,19-22H2,1-9H3/b23-18+,25-17+/t24-,26-,27-,28+,29-,30+,31-,32+,34-,35+,36+,37-,38-,39-,43-/m1/s1 D08IGF DRUGINKE NOQNPBXNHMZMTC-UGTSZWOVSA-N D08IGF DRUGSMIL CCC1C=C(C(C(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)O)C D08IGF HIGHSTAT Investigative D08IHM DRUG__ID D08IHM D08IHM DRUGTYPE Small molecular drug D08IHM DRUGINCH 1S/C10H13N5O4.2H2O.O.W/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;;;;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);2*1H2;;/q;;;;+2/p-2/t4-,6-,7+,10+;;;;/m0..../s1 D08IHM DRUGINKE YGGXZRZCGFLZPM-LRDMJOKZSA-L D08IHM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.O[W](=O)O D08IHM HIGHSTAT Investigative D08IIW DRUG__ID D08IIW D08IIW DRUGTYPE Small molecular drug D08IIW DRUGINCH 1S/C20H13F3N2O2/c21-20(22,23)27-15-7-5-14(6-8-15)18-16(11-13-3-1-9-24-12-13)19(26)17-4-2-10-25(17)18/h1-12,18H/b16-11- D08IIW DRUGINKE NUADOLYUKJMRKY-WJDWOHSUSA-N D08IIW DRUGSMIL C1=CC(=CN=C1)C=C2C(N3C=CC=C3C2=O)C4=CC=C(C=C4)OC(F)(F)F D08IIW HIGHSTAT Investigative D08ILW DRUG__ID D08ILW D08ILW DRUGTYPE Small molecular drug D08ILW DRUGINCH 1S/C19H21NO2/c21-19(22-18-9-5-2-6-10-18)20-17-13-11-16(12-14-17)15-7-3-1-4-8-15/h1,3-4,7-8,11-14,18H,2,5-6,9-10H2,(H,20,21) D08ILW DRUGINKE SSVRRVRYQFRADL-UHFFFAOYSA-N D08ILW DRUGSMIL C1CCC(CC1)OC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3 D08ILW HIGHSTAT Investigative D08ILX DRUG__ID D08ILX D08ILX DRUGTYPE Small molecular drug D08ILX DRUGINCH 1S/C16H14N2O/c1-11-9-13-10-14(7-8-15(13)17-11)18-16(19)12-5-3-2-4-6-12/h2-10,17H,1H3,(H,18,19) D08ILX DRUGINKE GXRAVFCYXQCDLO-UHFFFAOYSA-N D08ILX DRUGSMIL CC1=CC2=C(N1)C=CC(=C2)NC(=O)C3=CC=CC=C3 D08ILX HIGHSTAT Investigative D08INY DRUG__ID D08INY D08INY DRUGTYPE Small molecular drug D08INY DRUGINCH 1S/C16H13N3/c17-15-11-14(12-7-3-1-4-8-12)18-16(19-15)13-9-5-2-6-10-13/h1-11H,(H2,17,18,19) D08INY DRUGINKE PLXFRDQUOPPVHF-UHFFFAOYSA-N D08INY DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=N2)C3=CC=CC=C3)N D08INY HIGHSTAT Investigative D08IOV DRUG__ID D08IOV D08IOV DRUGTYPE Small molecular drug D08IOV DRUGINCH 1S/C15H17N3O3/c1-2-3-10-21-15-16-9-8-13(18-15)17-12-7-5-4-6-11(12)14(19)20/h4-9H,2-3,10H2,1H3,(H,19,20)(H,16,17,18) D08IOV DRUGINKE YTFVMUTWNFDKIY-UHFFFAOYSA-N D08IOV DRUGSMIL CCCCOC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O D08IOV HIGHSTAT Investigative D08IRN DRUG__ID D08IRN D08IRN DRUGTYPE Small molecular drug D08IRN DRUGINCH 1S/C23H20FN5O2/c1-14(29(31)23(25)30)15-2-4-18(5-3-15)22-27-20(16-6-8-19(24)9-7-16)21(28-22)17-10-12-26-13-11-17/h2-14,31H,1H3,(H2,25,30)(H,27,28) D08IRN DRUGINKE JVMAHSCWJIZBJE-UHFFFAOYSA-N D08IRN DRUGSMIL CC(C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)N(C(=O)N)O D08IRN HIGHSTAT Investigative D08ISK DRUG__ID D08ISK D08ISK DRUGTYPE Small molecular drug D08ISK DRUGINCH 1S/C12H13NO3/c1-7-4-11(14)13-12-9(7)5-8(15-2)6-10(12)16-3/h4-6H,1-3H3,(H,13,14) D08ISK DRUGINKE TZVDVDRNKWYRNO-UHFFFAOYSA-N D08ISK DRUGSMIL CC1=CC(=O)NC2=C1C=C(C=C2OC)OC D08ISK HIGHSTAT Investigative D08ISP DRUG__ID D08ISP D08ISP DRUGTYPE Small molecular drug D08ISP DRUGINCH 1S/C8H16N2/c1-3-4-7-5-8(9)10-6(7)2/h6-7H,3-5H2,1-2H3,(H2,9,10) D08ISP DRUGINKE KBOKLILFNBAIHC-UHFFFAOYSA-N D08ISP DRUGSMIL CCCC1CC(=NC1C)N D08ISP HIGHSTAT Investigative D08IWF DRUG__ID D08IWF D08IWF DRUGTYPE Small molecular drug D08IWF DRUGINCH 1S/C23H32N2O2/c1-24-22(26)27-18-9-8-17-13-21-19-7-2-3-10-23(19,20(17)14-18)11-12-25(21)15-16-5-4-6-16/h8-9,14,16,19,21H,2-7,10-13,15H2,1H3,(H,24,26) D08IWF DRUGINKE NHTWPKUCTUYFEM-UHFFFAOYSA-N D08IWF DRUGSMIL CNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CCC5)C=C1 D08IWF HIGHSTAT Investigative D08IXN DRUG__ID D08IXN D08IXN DRUGTYPE Small molecular drug D08IXN DRUGINCH 1S/C26H26N2O3/c29-19-8-7-15-11-20-26(30)12-17-16-3-1-2-4-18(16)27-22(17)24-25(26,21(15)23(19)31-24)9-10-28(20)13-14-5-6-14/h1-4,7-8,14,20,24,27,29-30H,5-6,9-13H2/t20-,24+,25+,26-/m1/s1 D08IXN DRUGINKE WIYUZYBFCWCCQJ-IFKAHUTRSA-N D08IXN DRUGSMIL C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8N6 D08IXN HIGHSTAT Investigative D08IXO DRUG__ID D08IXO D08IXO DRUGTYPE Small molecular drug D08IXO DRUGINCH 1S/C38H46N4O6S2/c1-23-12-8-9-15-25(23)20-31(44)39-29(21-49-4)35(46)40-28(18-24-13-6-5-7-14-24)33(45)37(48)42-22-50-38(2,3)34(42)36(47)41-32-27-17-11-10-16-26(27)19-30(32)43/h5-17,28-30,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t28-,29-,30+,32-,33-,34+/m0/s1 D08IXO DRUGINKE BUCXGTGXIGORNK-DYCNJNKSSA-N D08IXO DRUGSMIL CC1=CC=CC=C1CC(=O)NC(CSC)C(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D08IXO HIGHSTAT Investigative D08IXW DRUG__ID D08IXW D08IXW DRUGTYPE Small molecular drug D08IXW DRUGINCH 1S/C16H29N3O6S/c1-2-3-4-5-8-26-10-12(15(23)18-9-14(21)22)19-13(20)7-6-11(17)16(24)25/h11-12H,2-10,17H2,1H3,(H,18,23)(H,19,20)(H,21,22)(H,24,25)/t11-,12-/m0/s1 D08IXW DRUGINKE HXJDWCWJDCOHDG-RYUDHWBXSA-N D08IXW DRUGSMIL CCCCCCSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N D08IXW HIGHSTAT Investigative D08IZY DRUG__ID D08IZY D08IZY DRUGTYPE Small molecular drug D08IZY DRUGINCH 1S/C4H5NO5/c6-2(7)1-5-3(8)4(9)10/h1H2,(H,5,8)(H,6,7)(H,9,10) D08IZY DRUGINKE BIMZLRFONYSTPT-UHFFFAOYSA-N D08IZY DRUGSMIL C(C(=O)O)NC(=O)C(=O)O D08IZY HIGHSTAT Investigative D08JCC DRUG__ID D08JCC D08JCC DRUGTYPE Small molecular drug D08JCC DRUGINCH 1S/C11H9FN2O3S/c12-8-1-3-9(4-2-8)17-10-5-6-14-7-11(10)18(13,15)16/h1-7H,(H2,13,15,16) D08JCC DRUGINKE AJOXYVWAKWQVRZ-UHFFFAOYSA-N D08JCC DRUGSMIL C1=CC(=CC=C1OC2=C(C=NC=C2)S(=O)(=O)N)F D08JCC HIGHSTAT Investigative D08JCJ DRUG__ID D08JCJ D08JCJ DRUGTYPE Small molecular drug D08JCJ DRUGINCH 1S/C19H22O2/c1-18-9-7-15-14-6-4-13(20)11-12(14)3-5-16(15)17(18)8-10-19(18,2)21/h3-6,11,17,20-21H,7-10H2,1-2H3/t17-,18-,19+/m0/s1 D08JCJ DRUGINKE FQMQOMRDADWGJJ-GBESFXJTSA-N D08JCJ DRUGSMIL CC12CCC3=C(C1CCC2(C)O)C=CC4=C3C=CC(=C4)O D08JCJ HIGHSTAT Investigative D08JCK DRUG__ID D08JCK D08JCK DRUGTYPE Small molecular drug D08JCK DRUGINCH 1S/C14H19NO/c1-11(16)14(12-7-3-2-4-8-12)13-9-5-6-10-15-13/h2-4,7-8,13-15H,5-6,9-10H2,1H3 D08JCK DRUGINKE IYNBYQDXVFMDGE-UHFFFAOYSA-N D08JCK DRUGSMIL CC(=O)C(C1CCCCN1)C2=CC=CC=C2 D08JCK HIGHSTAT Investigative D08JCU DRUG__ID D08JCU D08JCU DRUGTYPE Small molecular drug D08JCU DRUGINCH 1S/C19H14FNOS/c20-16-9-6-15(7-10-16)8-11-17-12-13-19(14-21-17)23(22)18-4-2-1-3-5-18/h1-14H/b11-8+ D08JCU DRUGINKE YFWOOEBYKGJCJO-DHZHZOJOSA-N D08JCU DRUGSMIL C1=CC=C(C=C1)S(=O)C2=CN=C(C=C2)C=CC3=CC=C(C=C3)F D08JCU HIGHSTAT Investigative D08JCV DRUG__ID D08JCV D08JCV DRUGTYPE Small molecular drug D08JCV DRUGINCH 1S/C22H24ClNO/c1-3-4-9-14-24-16(2)22(18-11-6-8-13-20(18)24)21(25)15-17-10-5-7-12-19(17)23/h5-8,10-13H,3-4,9,14-15H2,1-2H3 D08JCV DRUGINKE JUWWNZZHFZTXED-UHFFFAOYSA-N D08JCV DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3Cl)C D08JCV HIGHSTAT Investigative D08JEI DRUG__ID D08JEI D08JEI DRUGTYPE Small molecular drug D08JEI DRUGINCH 1S/C14H10N2O3S/c17-13-7-8-14(16-15-13)20(18,19)12-6-5-10-3-1-2-4-11(10)9-12/h1-9H,(H,15,17) D08JEI DRUGINKE HXEYVOPGUKCHBE-UHFFFAOYSA-N D08JEI DRUGSMIL C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)C3=NNC(=O)C=C3 D08JEI HIGHSTAT Investigative D08JEK DRUG__ID D08JEK D08JEK DRUGTYPE Small molecular drug D08JEK DRUGINCH 1S/C69H91Cl2N15O13S/c1-38(2)31-51(61(92)80-50(13-9-29-76-69(74)75)68(99)86-30-10-14-57(86)67(98)77-39(3)59(73)90)81-60(91)49(12-7-8-28-72)79-63(94)53(34-43-20-26-47(89)27-21-43)83-66(97)56(36-87)85-65(96)55(35-44-37-100-58-15-6-5-11-48(44)58)84-64(95)54(33-42-18-24-46(71)25-19-42)82-62(93)52(78-40(4)88)32-41-16-22-45(70)23-17-41/h5-6,11,15-27,37-39,49-57,87,89H,7-10,12-14,28-36,72H2,1-4H3,(H2,73,90)(H,77,98)(H,78,88)(H,79,94)(H,80,92)(H,81,91)(H,82,93)(H,83,97)(H,84,95)(H,85,96)(H4,74,75,76)/t39-,49-,50-,51-,52-,53-,54-,55-,56-,57+/m0/s1 D08JEK DRUGINKE ONHXPWXXSUUCDR-IQZQIIRESA-N D08JEK DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CSC4=CC=CC=C43)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C D08JEK HIGHSTAT Investigative D08JFL DRUG__ID D08JFL D08JFL DRUGTYPE Small molecular drug D08JFL DRUGINCH 1S/C21H21NO2/c1-2-3-9-14-22-15-18(20(23)16-10-5-4-6-11-16)21(24)17-12-7-8-13-19(17)22/h4-8,10-13,15H,2-3,9,14H2,1H3 D08JFL DRUGINKE IEVKXDBTVSPAJD-UHFFFAOYSA-N D08JFL DRUGSMIL CCCCCN1C=C(C(=O)C2=CC=CC=C21)C(=O)C3=CC=CC=C3 D08JFL HIGHSTAT Investigative D08JGS DRUG__ID D08JGS D08JGS DRUGTYPE Small molecular drug D08JGS DRUGINCH 1S/C17H14N2O4/c1-22-16-8-12-7-13(10-18-15(12)9-17(16)23-2)11-3-5-14(6-4-11)19(20)21/h3-10H,1-2H3 D08JGS DRUGINKE FLEDIDSHIXDOQR-UHFFFAOYSA-N D08JGS DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=C(C=C3)[N+](=O)[O-] D08JGS HIGHSTAT Investigative D08JHR DRUG__ID D08JHR D08JHR DRUGTYPE Small molecular drug D08JHR DRUGINCH 1S/C13H24N2O2S/c1-2-3-14-18(16,17)15-13-11-5-9-4-10(7-11)8-12(13)6-9/h9-15H,2-8H2,1H3 D08JHR DRUGINKE HVLBCVJJDOICDV-UHFFFAOYSA-N D08JHR DRUGSMIL CCCNS(=O)(=O)NC1C2CC3CC(C2)CC1C3 D08JHR HIGHSTAT Investigative D08JKW DRUG__ID D08JKW D08JKW DRUGTYPE Small molecular drug D08JKW DRUGINCH 1S/C21H22N2O3/c1-21(2,3)16-7-9-18(10-8-16)25-14-19-13-23(20(24)26-19)17-6-4-5-15(11-17)12-22/h4-11,19H,13-14H2,1-3H3/t19-/m0/s1 D08JKW DRUGINKE YFJUDGZIRPWFBS-IBGZPJMESA-N D08JKW DRUGSMIL CC(C)(C)C1=CC=C(C=C1)OCC2CN(C(=O)O2)C3=CC=CC(=C3)C#N D08JKW HIGHSTAT Investigative D08JLB DRUG__ID D08JLB D08JLB DRUGTYPE Small molecular drug D08JLB DRUGINCH 1S/C18H20FNO/c19-16-7-4-8-17(18(16)15-9-11-20-12-10-15)21-13-14-5-2-1-3-6-14/h1-8,15,20H,9-13H2 D08JLB DRUGINKE WEBWNOZIRPUGTR-UHFFFAOYSA-N D08JLB DRUGSMIL C1CNCCC1C2=C(C=CC=C2F)OCC3=CC=CC=C3 D08JLB HIGHSTAT Investigative D08JLW DRUG__ID D08JLW D08JLW DRUGTYPE Small molecular drug D08JLW DRUGINCH 1S/C19H27N3O4S/c1-21-13-17(16-5-3-4-6-18(16)21)19(23)26-14-15-7-10-22(11-8-15)12-9-20-27(2,24)25/h3-6,13,15,20H,7-12,14H2,1-2H3 D08JLW DRUGINKE MOZPSIXKYJUTKI-UHFFFAOYSA-N D08JLW DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)OCC3CCN(CC3)CCNS(=O)(=O)C D08JLW HIGHSTAT Investigative D08JNG DRUG__ID D08JNG D08JNG DRUGTYPE Small molecular drug D08JNG DRUGINCH 1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7) D08JNG DRUGINKE OFOBLEOULBTSOW-UHFFFAOYSA-N D08JNG DRUGSMIL C(C(=O)O)C(=O)O D08JNG HIGHSTAT Investigative D08JNK DRUG__ID D08JNK D08JNK DRUGTYPE Small molecular drug D08JNK DRUGINCH 1S/C49H77N13O10S2/c1-5-27(3)40(60-39(65)23-30-16-10-11-19-36(30)74)46(70)57-32(22-29-14-8-7-9-15-29)44(68)61-41(28(4)6-2)47(71)58-33(24-37(50)63)43(67)59-34(26-73)48(72)62-21-13-18-35(62)45(69)56-31(17-12-20-54-49(52)53)42(66)55-25-38(51)64/h7-9,14-15,27-28,30-35,40-41,73H,5-6,10-13,16-26H2,1-4H3,(H2,50,63)(H2,51,64)(H,55,66)(H,56,69)(H,57,70)(H,58,71)(H,59,67)(H,60,65)(H,61,68)(H4,52,53,54)/t27-,28+,30?,31-,32-,33-,34-,35-,40-,41+/m0/s1 D08JNK DRUGINKE CNWFVLCMGVAHSD-HAEBMLOOSA-N D08JNK DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)CC3CCCCC3=S D08JNK HIGHSTAT Investigative D08JNO DRUG__ID D08JNO D08JNO DRUGTYPE Small molecular drug D08JNO DRUGINCH 1S/C15H16O4/c1-3-4-9-18-12-7-5-11-6-8-13(17)19-15(11)14(12)10(2)16/h5-8H,3-4,9H2,1-2H3 D08JNO DRUGINKE ULYJCIVHEFSJIF-UHFFFAOYSA-N D08JNO DRUGSMIL CCCCOC1=C(C2=C(C=C1)C=CC(=O)O2)C(=O)C D08JNO HIGHSTAT Investigative D08JOR DRUG__ID D08JOR D08JOR DRUGTYPE Small molecular drug D08JOR DRUGINCH 1S/C9H15N2.2BrH/c1-11(2,3)9-6-4-5-8(10)7-9;;/h4-7H,10H2,1-3H3;2*1H/q+1;; D08JOR DRUGINKE XSYKHNGMJVWEPB-UHFFFAOYSA-N D08JOR DRUGSMIL C[N+](C)(C)C1=CC=CC(=C1)N.Br.Br D08JOR HIGHSTAT Investigative D08JOS DRUG__ID D08JOS D08JOS DRUGTYPE Small molecular drug D08JOS DRUGINCH 1S/C20H27NO3/c1-20(2,13-12-16-6-4-5-7-19(16)24-3)21-14-18(23)15-8-10-17(22)11-9-15/h4-11,18,21-23H,12-14H2,1-3H3 D08JOS DRUGINKE QQNHGKXYJUREIZ-UHFFFAOYSA-N D08JOS DRUGSMIL CC(C)(CCC1=CC=CC=C1OC)NCC(C2=CC=C(C=C2)O)O D08JOS HIGHSTAT Investigative D08JPU DRUG__ID D08JPU D08JPU DRUGTYPE Small molecular drug D08JPU DRUGINCH 1S/C24H18N4O/c1-27-17-9-4-2-7-14(17)20-21-16(13-26-24(21)29)19-15-8-3-5-10-18(15)28(12-6-11-25)23(19)22(20)27/h2-5,7-10H,6,12-13H2,1H3,(H,26,29) D08JPU DRUGINKE VWVYILCFSYNJHF-UHFFFAOYSA-N D08JPU DRUGSMIL CN1C2=CC=CC=C2C3=C4C(=C5C6=CC=CC=C6N(C5=C31)CCC#N)CNC4=O D08JPU HIGHSTAT Investigative D08JSJ DRUG__ID D08JSJ D08JSJ DRUGTYPE Small molecular drug D08JSJ DRUGINCH 1S/C22H18N4O/c1-14-6-12-17(13-7-14)24-22-19-5-3-2-4-18(19)20(25-26-22)15-8-10-16(11-9-15)21(23)27/h2-13H,1H3,(H2,23,27)(H,24,26) D08JSJ DRUGINKE UTDXGHMGCXLCKT-UHFFFAOYSA-N D08JSJ DRUGSMIL CC1=CC=C(C=C1)NC2=NN=C(C3=CC=CC=C32)C4=CC=C(C=C4)C(=O)N D08JSJ HIGHSTAT Investigative D08JSR DRUG__ID D08JSR D08JSR DRUGTYPE Small molecular drug D08JSR DRUGINCH 1S/C4H9N3/c5-4-6-2-1-3-7-4/h1-3H2,(H3,5,6,7) D08JSR DRUGINKE PEHDFSFYZKSKGH-UHFFFAOYSA-N D08JSR DRUGSMIL C1CNC(=NC1)N D08JSR HIGHSTAT Investigative D08JUG DRUG__ID D08JUG D08JUG DRUGTYPE Small molecular drug D08JUG DRUGINCH 1S/C4H9NO2/c1-4(2,5)3(6)7/h5H2,1-2H3,(H,6,7) D08JUG DRUGINKE FUOOLUPWFVMBKG-UHFFFAOYSA-N D08JUG DRUGSMIL CC(C)(C(=O)O)N D08JUG HIGHSTAT Investigative D08JUO DRUG__ID D08JUO D08JUO DRUGCOMP Rottapharm Madaus D08JUO DRUGINCH 1S/C17H12N4/c1-2-4-13(5-3-1)17-19-11-14-10-15(6-7-16(14)20-17)21-9-8-18-12-21/h1-12H D08JUO DRUGINKE CSZGXYBGYFNSCO-UHFFFAOYSA-N D08JUO DRUGSMIL C1=CC=C(C=C1)C2=NC=C3C=C(C=CC3=N2)N4C=CN=C4 D08JUO HIGHSTAT Investigative D08JUQ DRUG__ID D08JUQ D08JUQ DRUGTYPE Small molecular drug D08JUQ DRUGINCH 1S/C18H14N4/c1-12-7-9-14(10-8-12)17-21-15(13-5-3-2-4-6-13)16-18(22-17)20-11-19-16/h2-11H,1H3,(H,19,20,21,22) D08JUQ DRUGINKE OPFZHJCGZXEIRY-UHFFFAOYSA-N D08JUQ DRUGSMIL CC1=CC=C(C=C1)C2=NC(=C3C(=N2)N=CN3)C4=CC=CC=C4 D08JUQ HIGHSTAT Investigative D08JUW DRUG__ID D08JUW D08JUW DRUGTYPE Small molecular drug D08JUW DRUGINCH 1S/C14H15N5O6S2/c1-5-3-26-11(18-7(5)12(21)22)9(13(23)24)17-10(20)8(19-25-2)6-4-27-14(15)16-6/h4,9,11H,1,3H2,2H3,(H2,15,16)(H,17,20)(H,21,22)(H,23,24)/b19-8+/t9-,11+/m0/s1 D08JUW DRUGINKE ZRDXEERHKBZJMY-VGMFVZOQSA-N D08JUW DRUGSMIL CON=C(C1=CSC(=N1)N)C(=O)NC(C2N=C(C(=C)CS2)C(=O)O)C(=O)O D08JUW HIGHSTAT Investigative D08JXN DRUG__ID D08JXN D08JXN DRUGTYPE Small molecular drug D08JXN DRUGINCH 1S/C23H23N5O3S/c29-22(27-23-24-8-15-32-23)17-5-3-6-18-20(17)26-21(25-18)16-4-1-2-7-19(16)31-14-11-28-9-12-30-13-10-28/h1-8,15H,9-14H2,(H,25,26)(H,24,27,29) D08JXN DRUGINKE BXSJTHFUADFIKS-UHFFFAOYSA-N D08JXN DRUGSMIL C1COCCN1CCOC2=CC=CC=C2C3=NC4=C(C=CC=C4N3)C(=O)NC5=NC=CS5 D08JXN HIGHSTAT Investigative D08JYT DRUG__ID D08JYT D08JYT DRUGTYPE Small molecular drug D08JYT DRUGINCH 1S/C23H40O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26-23(21-24)22-25/h6-7,9-10,12-13,15-16,23-25H,2-5,8,11,14,17-22H2,1H3/b7-6-,10-9-,13-12-,16-15- D08JYT DRUGINKE CUJUUWXZAQHCNC-DOFZRALJSA-N D08JYT DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCOC(CO)CO D08JYT HIGHSTAT Investigative D08JYX DRUG__ID D08JYX D08JYX DRUGTYPE Small molecular drug D08JYX DRUGINCH 1S/C21H21N5O6/c1-11(28)13-6-3-12(4-7-13)5-8-15-23-19(25-31-2)16-20(24-15)26(10-22-16)21-18(30)17(29)14(9-27)32-21/h3-4,6-7,10,14,17-18,21,27,29-30H,9H2,1-2H3,(H,23,24,25)/t14-,17-,18-,21-/m1/s1 D08JYX DRUGINKE MPFGTODTMYCUJG-HAXDFEGKSA-N D08JYX DRUGSMIL CC(=O)C1=CC=C(C=C1)C#CC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)NOC D08JYX HIGHSTAT Investigative D08KBV DRUG__ID D08KBV D08KBV DRUGTYPE Small molecular drug D08KBV DRUGINCH 1S/C22H24N2/c1-3-7-17(8-4-1)15-22-23-16-21(24-22)20-13-11-19(12-14-20)18-9-5-2-6-10-18/h2,5-6,9-14,16-17H,1,3-4,7-8,15H2,(H,23,24) D08KBV DRUGINKE LAHDQEJNOQBNSA-UHFFFAOYSA-N D08KBV DRUGSMIL C1CCC(CC1)CC2=NC=C(N2)C3=CC=C(C=C3)C4=CC=CC=C4 D08KBV HIGHSTAT Investigative D08KCA DRUG__ID D08KCA D08KCA DRUGTYPE Small molecular drug D08KCA DRUGINCH 1S/C20H38N6O4/c1-12(2)9-16(24-14(5)28)19(30)26-17(10-13(3)4)18(29)25-15(11-27)7-6-8-23-20(21)22/h11-13,15-17H,6-10H2,1-5H3,(H,24,28)(H,25,29)(H,26,30)(H4,21,22,23)/t15-,16-,17-/m0/s1 D08KCA DRUGINKE GDBQQVLCIARPGH-ULQDDVLXSA-N D08KCA DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C=O)NC(=O)C D08KCA HIGHSTAT Investigative D08KCZ DRUG__ID D08KCZ D08KCZ DRUGTYPE Small molecular drug D08KCZ DRUGINCH 1S/C16H30O5/c1-3-5-6-7-8-9-11-15(18)20-13-14(12-17)21-16(19)10-4-2/h14,17H,3-13H2,1-2H3/t14-/m0/s1 D08KCZ DRUGINKE JCEXPOMAGTUEEX-AWEZNQCLSA-N D08KCZ DRUGSMIL CCCCCCCCC(=O)OCC(CO)OC(=O)CCC D08KCZ HIGHSTAT Investigative D08KEZ DRUG__ID D08KEZ D08KEZ DRUGTYPE Small molecular drug D08KEZ DRUGINCH 1S/C4H10N2O3/c5-3(4(7)8)1-2-9-6/h3H,1-2,5-6H2,(H,7,8)/t3-/m0/s1 D08KEZ DRUGINKE FQPGMQABJNQLLF-VKHMYHEASA-N D08KEZ DRUGSMIL C(CON)C(C(=O)O)N D08KEZ HIGHSTAT Investigative D08KIG DRUG__ID D08KIG D08KIG DRUGTYPE Small molecular drug D08KIG DRUGINCH 1S/C17H17NO3/c1-2-21-17(20)18-16(19)15(13-9-5-3-6-10-13)14-11-7-4-8-12-14/h3-12,15H,2H2,1H3,(H,18,19,20) D08KIG DRUGINKE ILSZPWZFQHSKLW-UHFFFAOYSA-N D08KIG DRUGSMIL CCOC(=O)NC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2 D08KIG HIGHSTAT Investigative D08KJM DRUG__ID D08KJM D08KJM DRUGTYPE Small molecular drug D08KJM DRUGINCH 1S/C16H12N2O2S/c1-10-4-7-14-13(9-10)12-6-5-11-3-2-8-17-15(11)16(12)18-21(14,19)20/h2-9,18H,1H3 D08KJM DRUGINKE KYPLTYNYSYVGGA-UHFFFAOYSA-N D08KJM DRUGSMIL CC1=CC2=C(C=C1)S(=O)(=O)NC3=C2C=CC4=C3N=CC=C4 D08KJM HIGHSTAT Investigative D08KJN DRUG__ID D08KJN D08KJN DRUGTYPE Small molecular drug D08KJN DRUGINCH 1S/C21H19NO2/c23-21(22-15-14-17-8-3-1-4-9-17)24-20-13-7-12-19(16-20)18-10-5-2-6-11-18/h1-13,16H,14-15H2,(H,22,23) D08KJN DRUGINKE SYRRFVWOILIONB-UHFFFAOYSA-N D08KJN DRUGSMIL C1=CC=C(C=C1)CCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D08KJN HIGHSTAT Investigative D08KLH DRUG__ID D08KLH D08KLH DRUGTYPE Small molecular drug D08KLH DRUGINCH 1S/C12H14N2O3/c1-15-12(11-13-6-7-14-11)8-16-9-4-2-3-5-10(9)17-12/h2-5H,6-8H2,1H3,(H,13,14) D08KLH DRUGINKE HQGWKNGAKBPTBX-UHFFFAOYSA-N D08KLH DRUGSMIL COC1(COC2=CC=CC=C2O1)C3=NCCN3 D08KLH HIGHSTAT Investigative D08KLL DRUG__ID D08KLL D08KLL DRUGTYPE Small molecular drug D08KLL DRUGINCH 1S/C22H18Cl2O4/c23-18-9-3-1-6-16(18)13-27-20-11-5-8-15(12-21(25)26)22(20)28-14-17-7-2-4-10-19(17)24/h1-11H,12-14H2,(H,25,26) D08KLL DRUGINKE JDODANGOYUAOQT-UHFFFAOYSA-N D08KLL DRUGSMIL C1=CC=C(C(=C1)COC2=CC=CC(=C2OCC3=CC=CC=C3Cl)CC(=O)O)Cl D08KLL HIGHSTAT Investigative D08KLN DRUG__ID D08KLN D08KLN DRUGTYPE Small molecular drug D08KLN DRUGINCH 1S/C14H16N2/c15-13-8-6-11(7-9-13)4-5-12-2-1-3-14(16)10-12/h1-3,6-10H,4-5,15-16H2 D08KLN DRUGINKE INOLZHNXGZQKJJ-UHFFFAOYSA-N D08KLN DRUGSMIL C1=CC(=CC(=C1)N)CCC2=CC=C(C=C2)N D08KLN HIGHSTAT Investigative D08KNJ DRUG__ID D08KNJ D08KNJ DRUGTYPE Small molecular drug D08KNJ DRUGINCH 1S/C19H14Cl2O2/c1-12-3-2-4-13(9-12)14-5-7-19(17(22)10-14)23-18-8-6-15(20)11-16(18)21/h2-11,22H,1H3 D08KNJ DRUGINKE GFJKNHKOZLFIJW-UHFFFAOYSA-N D08KNJ DRUGSMIL CC1=CC(=CC=C1)C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D08KNJ HIGHSTAT Investigative D08KNP DRUG__ID D08KNP D08KNP DRUGTYPE Small molecular drug D08KNP DRUGINCH 1S/C30H33N2O4/c1-34-23-13-21-22(14-24(23)35-2)31-27(33)15-25-28-20-12-26-30(21,29(28)31)9-10-32(26,17-19(20)8-11-36-25)16-18-6-4-3-5-7-18/h3-8,13-14,20,25-26,28-29H,9-12,15-17H2,1-2H3/q+1/t20-,25-,26-,28-,29-,30+,32?/m0/s1 D08KNP DRUGINKE XFMQETLKDRNYRE-QIBSSCBHSA-N D08KNP DRUGSMIL COC1=C(C=C2C(=C1)C34CC[N+]5(C3CC6C7C4N2C(=O)CC7OCC=C6C5)CC8=CC=CC=C8)OC D08KNP HIGHSTAT Investigative D08KPK DRUG__ID D08KPK D08KPK DRUGTYPE Small molecular drug D08KPK DRUGINCH 1S/C34H33N3O3/c1-23(2)19-31(30-14-7-11-25-9-3-5-12-28(25)30)33(38)36-32-20-24(22-37-18-8-17-35-37)15-16-27(32)21-26-10-4-6-13-29(26)34(39)40/h3-18,20,23,31H,19,21-22H2,1-2H3,(H,36,38)(H,39,40) D08KPK DRUGINKE WXTQSWUTEXDKIF-UHFFFAOYSA-N D08KPK DRUGSMIL CC(C)CC(C1=CC=CC2=CC=CC=C21)C(=O)NC3=C(C=CC(=C3)CN4C=CC=N4)CC5=CC=CC=C5C(=O)O D08KPK HIGHSTAT Investigative D08KPQ DRUG__ID D08KPQ D08KPQ DRUGTYPE Small molecular drug D08KPQ DRUGINCH 1S/C22H24N2O3S/c1-26-20-14-18(9-10-19(20)27-16-17-6-3-2-4-7-17)15-24(12-11-23)22(25)21-8-5-13-28-21/h2-10,13-14H,11-12,15-16,23H2,1H3 D08KPQ DRUGINKE UOGGWHBYFVBUIY-UHFFFAOYSA-N D08KPQ DRUGSMIL COC1=C(C=CC(=C1)CN(CCN)C(=O)C2=CC=CS2)OCC3=CC=CC=C3 D08KPQ HIGHSTAT Investigative D08KQM DRUG__ID D08KQM D08KQM DRUGTYPE Small molecular drug D08KQM DRUGINCH 1S/C28H26FNO3/c1-15-7-6-8-17(26(15)29)13-22-24-18(25-21(33-22)12-11-20(31)27(25)32-5)9-10-19-23(24)16(2)14-28(3,4)30-19/h6-14,30-31H,1-5H3/b22-13- D08KQM DRUGINKE ACYYHAZVNHMRMQ-XKZIYDEJSA-N D08KQM DRUGSMIL CC1=C(C(=CC=C1)C=C2C3=C(C=CC4=C3C(=CC(N4)(C)C)C)C5=C(O2)C=CC(=C5OC)O)F D08KQM HIGHSTAT Investigative D08KRX DRUG__ID D08KRX D08KRX DRUGTYPE Small molecular drug D08KRX DRUGINCH 1S/C25H30N2O/c1-2-3-4-5-6-7-8-11-20-14-16-21(17-15-20)25(28)27-23-18-22-12-9-10-13-24(22)26-19-23/h9-10,12-19H,2-8,11H2,1H3,(H,27,28) D08KRX DRUGINKE LTHZASJBAIGTJL-UHFFFAOYSA-N D08KRX DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D08KRX HIGHSTAT Investigative D08KSQ DRUG__ID D08KSQ D08KSQ DRUGTYPE Small molecular drug D08KSQ DRUGINCH 1S/C11H9N5/c12-11-14-5-3-9(16-11)8-6-15-10-7(8)2-1-4-13-10/h1-6H,(H,13,15)(H2,12,14,16) D08KSQ DRUGINKE HQHSJJZIICGOIX-UHFFFAOYSA-N D08KSQ DRUGSMIL C1=CC2=C(NC=C2C3=NC(=NC=C3)N)N=C1 D08KSQ HIGHSTAT Investigative D08KUO DRUG__ID D08KUO D08KUO DRUGTYPE Small molecular drug D08KUO DRUGINCH 1S/C6H9NO6/c7-4(6(12)13)2(5(10)11)1-3(8)9/h2,4H,1,7H2,(H,8,9)(H,10,11)(H,12,13) D08KUO DRUGINKE BZJZJZZWFXEMRG-UHFFFAOYSA-N D08KUO DRUGSMIL C(C(C(C(=O)O)N)C(=O)O)C(=O)O D08KUO HIGHSTAT Investigative D08KWL DRUG__ID D08KWL D08KWL DRUGTYPE Small molecular drug D08KWL DRUGINCH 1S/C19H21NO2/c1-21-18-11-16-10-15(9-8-14-6-4-3-5-7-14)13-20-17(16)12-19(18)22-2/h10-14H,3-7H2,1-2H3 D08KWL DRUGINKE MBQNQJQVMOFJOD-UHFFFAOYSA-N D08KWL DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C#CC3CCCCC3 D08KWL HIGHSTAT Investigative D08KWS DRUG__ID D08KWS D08KWS DRUGTYPE Small molecular drug D08KWS DRUGINCH 1S/C18H22O2/c1-2-3-4-6-9-15-12-13-18(17(19)14-15)20-16-10-7-5-8-11-16/h5,7-8,10-14,19H,2-4,6,9H2,1H3 D08KWS DRUGINKE SXGQGHHNOWYMRT-UHFFFAOYSA-N D08KWS DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC=C2)O D08KWS HIGHSTAT Investigative D08KYB DRUG__ID D08KYB D08KYB DRUGTYPE Small molecular drug D08KYB DRUGINCH 1S/C16H14N2O2/c1-19-13-8-12(9-14(10-13)20-2)15-6-5-11-4-3-7-17-16(11)18-15/h3-10H,1-2H3 D08KYB DRUGINKE JUMXQELSAJZAIP-UHFFFAOYSA-N D08KYB DRUGSMIL COC1=CC(=CC(=C1)C2=NC3=C(C=CC=N3)C=C2)OC D08KYB HIGHSTAT Investigative D08KYH DRUG__ID D08KYH D08KYH DRUGTYPE Small molecular drug D08KYH DRUGINCH 1S/C23H27N3O/c1-3-4-5-8-15-26(2)21-13-11-18(12-14-21)23(27)25-20-16-19-9-6-7-10-22(19)24-17-20/h6-7,9-14,16-17H,3-5,8,15H2,1-2H3,(H,25,27) D08KYH DRUGINKE FIZXTSXGXVTGKK-UHFFFAOYSA-N D08KYH DRUGSMIL CCCCCCN(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D08KYH HIGHSTAT Investigative D08LAY DRUG__ID D08LAY D08LAY DRUGTYPE Small molecular drug D08LAY DRUGINCH 1S/C19H24N2O/c1-22-18-9-5-6-16(14-18)15-19(17-7-3-2-4-8-17)21-12-10-20-11-13-21/h2-9,14,19-20H,10-13,15H2,1H3 D08LAY DRUGINKE CTAHXNUPBZTDFO-UHFFFAOYSA-N D08LAY DRUGSMIL COC1=CC=CC(=C1)CC(C2=CC=CC=C2)N3CCNCC3 D08LAY HIGHSTAT Investigative D08LBC DRUG__ID D08LBC D08LBC DRUGTYPE Small molecular drug D08LBC DRUGINCH 1S/C23H27NO4/c1-4-5-9-24-10-8-15-16-7-6-14-11-19(25)20(27-2)12-17(14)21(16)23(28-3)22(26)18(15)13-24/h6-7,11-12,25-26H,4-5,8-10,13H2,1-3H3 D08LBC DRUGINKE XLVUNDMFFLQJMP-UHFFFAOYSA-N D08LBC DRUGSMIL CCCCN1CCC2=C3C=CC4=CC(=C(C=C4C3=C(C(=C2C1)O)OC)OC)O D08LBC HIGHSTAT Investigative D08LEB DRUG__ID D08LEB D08LEB DRUGTYPE Small molecular drug D08LEB DRUGINCH 1S/C23H17F3N2O4S/c1-13-8-20-21(11-18(13)23(24,25)26)28-22(29)12-19(27-20)16-6-2-4-14(9-16)15-5-3-7-17(10-15)33(30,31)32/h2-11H,12H2,1H3,(H,28,29)(H,30,31,32) D08LEB DRUGINKE FQNZBSFUVZKONP-UHFFFAOYSA-N D08LEB DRUGSMIL CC1=CC2=C(C=C1C(F)(F)F)NC(=O)CC(=N2)C3=CC=CC(=C3)C4=CC(=CC=C4)S(=O)(=O)O D08LEB HIGHSTAT Investigative D08LFC DRUG__ID D08LFC D08LFC DRUGTYPE Small molecular drug D08LFC DRUGINCH 1S/C4H12NO2P/c1-8(6,7)4-2-3-5/h2-5H2,1H3,(H,6,7) D08LFC DRUGINKE NHVRIDDXGZPJTJ-UHFFFAOYSA-N D08LFC DRUGSMIL CP(=O)(CCCN)O D08LFC HIGHSTAT Investigative D08LFT DRUG__ID D08LFT D08LFT DRUGTYPE Small molecular drug D08LFT DRUGINCH 1S/C6H6O2S/c7-9(8)6-4-2-1-3-5-6/h1-5H,(H,7,8)/p-1 D08LFT DRUGINKE JEHKKBHWRAXMCH-UHFFFAOYSA-M D08LFT DRUGSMIL C1=CC=C(C=C1)S(=O)[O-] D08LFT HIGHSTAT Investigative D08LIT DRUG__ID D08LIT D08LIT DRUGTYPE Small molecular drug D08LIT DRUGINCH 1S/C25H29N5O5/c1-14(30-12-18-8-19(31)7-6-16(18)9-20(26)24(30)34)23(33)28-21-10-15-4-2-3-5-17(15)11-29(25(21)35)13-22(27)32/h2-8,14,20-21,31H,9-13,26H2,1H3,(H2,27,32)(H,28,33)/t14-,20+,21+/m1/s1 D08LIT DRUGINKE ACFTTXWQZSBVGL-OREJSRFESA-N D08LIT DRUGSMIL CC(C(=O)NC1CC2=CC=CC=C2CN(C1=O)CC(=O)N)N3CC4=C(CC(C3=O)N)C=CC(=C4)O D08LIT HIGHSTAT Investigative D08LIU DRUG__ID D08LIU D08LIU DRUGCOMP Dharma Biomedical D08LIU DRUGINCH 1S/C30H46O4/c1-25(2)13-15-29(24(33)34)16-14-27(5)19(20(29)17-25)7-8-22-28(27,6)11-9-21-26(3,4)23(32)10-12-30(21,22)18-31/h7,20-22,31H,8-18H2,1-6H3,(H,33,34)/t20-,21-,22-,27+,28+,29-,30+/m0/s1 D08LIU DRUGINKE SEOWASFHYNYGBU-RHXAIUOTSA-N D08LIU DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)CO)C)C2C1)C)C(=O)O)C D08LIU HIGHSTAT Investigative D08LJJ DRUG__ID D08LJJ D08LJJ DRUGTYPE Small molecular drug D08LJJ DRUGINCH 1S/C15H8BrNO4/c16-9-5-6-14-11(7-9)13(18)8-15(21-14)10-3-1-2-4-12(10)17(19)20/h1-8H D08LJJ DRUGINKE GXUSNZYZTBJMIT-UHFFFAOYSA-N D08LJJ DRUGSMIL C1=CC=C(C(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)Br)[N+](=O)[O-] D08LJJ HIGHSTAT Investigative D08LLS DRUG__ID D08LLS D08LLS DRUGTYPE Small molecular drug D08LLS DRUGINCH 1S/C9H9BO4/c11-9(12)6-3-7-1-4-8(5-2-7)10(13)14/h1-6,13-14H,(H,11,12)/b6-3+ D08LLS DRUGINKE IEMLKNHGGSYOMP-ZZXKWVIFSA-N D08LLS DRUGSMIL B(C1=CC=C(C=C1)C=CC(=O)O)(O)O D08LLS HIGHSTAT Investigative D08LMT DRUG__ID D08LMT D08LMT DRUGTYPE Small molecular drug D08LMT DRUGINCH 1S/C18H38O6/c1-2-3-4-5-6-7-9-20-11-13-22-15-17-24-18-16-23-14-12-21-10-8-19/h19H,2-18H2,1H3 D08LMT DRUGINKE MJELOWOAIAAUJT-UHFFFAOYSA-N D08LMT DRUGSMIL CCCCCCCCOCCOCCOCCOCCOCCO D08LMT HIGHSTAT Investigative D08LNT DRUG__ID D08LNT D08LNT DRUGTYPE Small molecular drug D08LNT DRUGINCH 1S/C9H20NOS/c1-5-6-9(11)12-8-7-10(2,3)4/h5-8H2,1-4H3/q+1 D08LNT DRUGINKE AWBGQVBMGBZGLS-UHFFFAOYSA-N D08LNT DRUGSMIL CCCC(=O)SCC[N+](C)(C)C D08LNT HIGHSTAT Investigative D08LUJ DRUG__ID D08LUJ D08LUJ DRUGTYPE Small molecular drug D08LUJ DRUGINCH 1S/C25H35NO9/c1-12(2)22(31)17(34-16(28)14-7-6-10-26-14)23(32)18(4)11-21(30)19(22,5)25(23,33)24(35-21)15(27)13(3)8-9-20(18,24)29/h6-7,10,12-13,15,17,26-27,29-33H,8-9,11H2,1-5H3/t13-,15+,17+,18-,19+,20-,21-,22+,23+,24+,25+/m0/s1 D08LUJ DRUGINKE JJSYXNQGLHBRRK-SFEDZAPPSA-N D08LUJ DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1O)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O D08LUJ HIGHSTAT Investigative D08LVH DRUG__ID D08LVH D08LVH DRUGTYPE Small molecular drug D08LVH DRUGINCH 1S/C20H38O4/c1-19(2,15-17(21)22)13-11-9-7-5-6-8-10-12-14-20(3,4)16-18(23)24/h5-16H2,1-4H3,(H,21,22)(H,23,24) D08LVH DRUGINKE HYSMCRNFENOHJH-UHFFFAOYSA-N D08LVH DRUGSMIL CC(C)(CCCCCCCCCCC(C)(C)CC(=O)O)CC(=O)O D08LVH HIGHSTAT Investigative D08LVT DRUG__ID D08LVT D08LVT DRUGTYPE Small molecular drug D08LVT DRUGINCH 1S/C17H21NO3S/c1-17(2,3)13-18(14-7-5-4-6-8-14)22(20,21)16-11-9-15(19)10-12-16/h4-12,19H,13H2,1-3H3 D08LVT DRUGINKE QKNCIALYEAWCOU-UHFFFAOYSA-N D08LVT DRUGSMIL CC(C)(C)CN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O D08LVT HIGHSTAT Investigative D08LXU DRUG__ID D08LXU D08LXU DRUGTYPE Small molecular drug D08LXU DRUGINCH 1S/C26H30ClN3O4S/c1-16(2)15-35(33,34)28-22-11-12-24(31)30(26(22)18-5-7-19(27)8-6-18)20-9-10-21-17(3)13-25(32)29(4)23(21)14-20/h5-10,13-14,16,22,26,28H,11-12,15H2,1-4H3/t22-,26+/m0/s1 D08LXU DRUGINKE LVDRREOUMKACNJ-BKMJKUGQSA-N D08LXU DRUGSMIL CC1=CC(=O)N(C2=C1C=CC(=C2)N3C(C(CCC3=O)NS(=O)(=O)CC(C)C)C4=CC=C(C=C4)Cl)C D08LXU HIGHSTAT Investigative D08LZN DRUG__ID D08LZN D08LZN DRUGTYPE Small molecular drug D08LZN DRUGINCH 1S/C17H19N5S/c1-3-7-12(8-4-1)20-16-14-15(19-11-18-14)21-17(22-16)23-13-9-5-2-6-10-13/h2,5-6,9-12H,1,3-4,7-8H2,(H2,18,19,20,21,22) D08LZN DRUGINKE NFXCEGOWTIZWIH-UHFFFAOYSA-N D08LZN DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)SC4=CC=CC=C4 D08LZN HIGHSTAT Investigative D08MCE DRUG__ID D08MCE D08MCE DRUGTYPE Small molecular drug D08MCE DRUGINCH 1S/C17H18N2O/c20-17-15-11-4-5-12-16(15)18-19(17)13-7-6-10-14-8-2-1-3-9-14/h1-5,8-9,11-12,18H,6-7,10,13H2 D08MCE DRUGINKE VMGHZFARQGLROM-UHFFFAOYSA-N D08MCE DRUGSMIL C1=CC=C(C=C1)CCCCN2C(=O)C3=CC=CC=C3N2 D08MCE HIGHSTAT Investigative D08MDL DRUG__ID D08MDL D08MDL DRUGTYPE Small molecular drug D08MDL DRUGINCH 1S/C25H25N5O11P2/c31-24(16-9-5-2-6-10-16)29-22-19-23(27-13-26-22)30(14-28-19)25-21-20(39-18(40-21)11-15-7-3-1-4-8-15)17(38-25)12-37-43(35,36)41-42(32,33)34/h1-10,13-14,17-18,20-21,25H,11-12H2,(H,35,36)(H2,32,33,34)(H,26,27,29,31)/t17-,18-,20-,21-,25-/m1/s1 D08MDL DRUGINKE VXEHVAOFCPIBTQ-XXXKQHFZSA-N D08MDL DRUGSMIL C1=CC=C(C=C1)CC2OC3C(OC(C3O2)N4C=NC5=C(N=CN=C54)NC(=O)C6=CC=CC=C6)COP(=O)(O)OP(=O)(O)O D08MDL HIGHSTAT Investigative D08MEN DRUG__ID D08MEN D08MEN DRUGTYPE Small molecular drug D08MEN DRUGINCH 1S/C22H28N2O/c1-3-23(4-2)16-10-5-11-17-24-20-14-8-6-12-18(20)22(25)19-13-7-9-15-21(19)24/h6-9,12-15H,3-5,10-11,16-17H2,1-2H3 D08MEN DRUGINKE YCWGZWYJTIJTHX-UHFFFAOYSA-N D08MEN DRUGSMIL CCN(CC)CCCCCN1C2=CC=CC=C2C(=O)C3=CC=CC=C31 D08MEN HIGHSTAT Investigative D08MFC DRUG__ID D08MFC D08MFC DRUGTYPE Small molecular drug D08MFC DRUGINCH 1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1?,2-,3+,4-,5-,6?/m0/s1 D08MFC DRUGINKE INAPMGSXUVUWAF-LXOASSSBSA-L D08MFC DRUGSMIL C1(C(C(C(C(C1O)O)OP(=O)([O-])[O-])O)O)O D08MFC HIGHSTAT Investigative D08MHU DRUG__ID D08MHU D08MHU DRUGTYPE Small molecular drug D08MHU DRUGINCH 1S/C16H12O4/c17-11-3-1-10(2-4-11)7-13-9-15(19)14-8-12(18)5-6-16(14)20-13/h1-6,8-9,17-18H,7H2 D08MHU DRUGINKE LSIKXKVRDNWDKN-UHFFFAOYSA-N D08MHU DRUGSMIL C1=CC(=CC=C1CC2=CC(=O)C3=C(O2)C=CC(=C3)O)O D08MHU HIGHSTAT Investigative D08MJE DRUG__ID D08MJE D08MJE DRUGTYPE Small molecular drug D08MJE DRUGINCH 1S/C22H19NO3/c24-21(19-14-13-17-10-4-5-11-18(17)15-19)23-20(22(25)26)12-6-9-16-7-2-1-3-8-16/h1-11,13-15,20H,12H2,(H,23,24)(H,25,26)/b9-6+/t20-/m1/s1 D08MJE DRUGINKE OOTIJYFZZMIZHN-AQDCRGGLSA-N D08MJE DRUGSMIL C1=CC=C(C=C1)C=CCC(C(=O)O)NC(=O)C2=CC3=CC=CC=C3C=C2 D08MJE HIGHSTAT Investigative D08MKF DRUG__ID D08MKF D08MKF DRUGTYPE Small molecular drug D08MKF DRUGINCH 1S/2ClH.Ni/h2*1H;/q;;+2/p-2 D08MKF DRUGINKE QMMRZOWCJAIUJA-UHFFFAOYSA-L D08MKF DRUGSMIL Cl[Ni]Cl D08MKF HIGHSTAT Investigative D08MLH DRUG__ID D08MLH D08MLH DRUGCOMP University of Southern Denmark D08MLH DRUGINCH 1S/C23H23NO2/c1-17-5-2-3-8-22(17)20-7-4-6-19(15-20)16-24-21-12-9-18(10-13-21)11-14-23(25)26/h2-10,12-13,15,24H,11,14,16H2,1H3,(H,25,26) D08MLH DRUGINKE RUPXKSLKGSSZCP-UHFFFAOYSA-N D08MLH DRUGSMIL CC1=CC=CC=C1C2=CC=CC(=C2)CNC3=CC=C(C=C3)CCC(=O)O D08MLH HIGHSTAT Investigative D08MNG DRUG__ID D08MNG D08MNG DRUGTYPE Small molecular drug D08MNG DRUGINCH 1S/C12H16BrNO2/c1-15-10-5-9(13)12(16-2)8-4-3-7(6-14)11(8)10/h5,7H,3-4,6,14H2,1-2H3 D08MNG DRUGINKE HCLPGYNQMVSQIM-UHFFFAOYSA-N D08MNG DRUGSMIL COC1=CC(=C(C2=C1C(CC2)CN)OC)Br D08MNG HIGHSTAT Investigative D08MNO DRUG__ID D08MNO D08MNO DRUGTYPE Small molecular drug D08MNO DRUGINCH 1S/C23H38O5/c1-2-13-23(14-8-15-23)21(26)11-7-10-18-17(19(24)16-20(18)25)9-5-3-4-6-12-22(27)28/h7,10,17-18,20-21,25-26H,2-6,8-9,11-16H2,1H3,(H,27,28)/b10-7+/t17-,18-,20-,21+/m1/s1 D08MNO DRUGINKE PAYNQYXOKJDXAV-ZHIWTBQHSA-N D08MNO DRUGSMIL CCCC1(CCC1)C(CC=CC2C(CC(=O)C2CCCCCCC(=O)O)O)O D08MNO HIGHSTAT Investigative D08MOG DRUG__ID D08MOG D08MOG DRUGTYPE Small molecular drug D08MOG DRUGINCH 1S/C15H19NO/c1-3-11(4-2)16-14-9-10-15(17)13-8-6-5-7-12(13)14/h5-11,16-17H,3-4H2,1-2H3 D08MOG DRUGINKE LZQSUKJAJXHQLF-UHFFFAOYSA-N D08MOG DRUGSMIL CCC(CC)NC1=CC=C(C2=CC=CC=C21)O D08MOG HIGHSTAT Investigative D08MOJ DRUG__ID D08MOJ D08MOJ DRUGTYPE Small molecular drug D08MOJ DRUGINCH 1S/C3H3BrO3/c4-1-2(5)3(6)7/h1H2,(H,6,7)/p-1 D08MOJ DRUGINKE PRRZDZJYSJLDBS-UHFFFAOYSA-M D08MOJ DRUGSMIL C(C(=O)C(=O)[O-])Br D08MOJ HIGHSTAT Investigative D08MON DRUG__ID D08MON D08MON DRUGTYPE Small molecular drug D08MON DRUGINCH 1S/C18H16O3/c1-12-8-16(20-2)15-11-14(18(19)21-17(15)9-12)10-13-6-4-3-5-7-13/h3-9,11H,10H2,1-2H3 D08MON DRUGINKE AOPKGUPAQXHRKK-UHFFFAOYSA-N D08MON DRUGSMIL CC1=CC2=C(C=C(C(=O)O2)CC3=CC=CC=C3)C(=C1)OC D08MON HIGHSTAT Investigative D08MPL DRUG__ID D08MPL D08MPL DRUGTYPE Small molecular drug D08MPL DRUGINCH 1S/C14H14ClN4O8P/c1-7-13(21)9(5-20)10(6-27-28(24,25)26)14(16-7)18-17-12-4-8(19(22)23)2-3-11(12)15/h2-4,20-21H,5-6H2,1H3,(H2,24,25,26) D08MPL DRUGINKE RYOZMXBRDOGYMB-UHFFFAOYSA-N D08MPL DRUGSMIL CC1=C(C(=C(C(=N1)N=NC2=C(C=CC(=C2)[N+](=O)[O-])Cl)COP(=O)(O)O)CO)O D08MPL HIGHSTAT Investigative D08MRB DRUG__ID D08MRB D08MRB DRUGTYPE Small molecular drug D08MRB DRUGINCH 1S/C10H8N4/c11-10-9-8(12-5-13-9)6-3-1-2-4-7(6)14-10/h1-5H,(H2,11,14)(H,12,13) D08MRB DRUGINKE HQBUPOAKJGJGCD-UHFFFAOYSA-N D08MRB DRUGSMIL C1=CC=C2C(=C1)C3=C(C(=N2)N)NC=N3 D08MRB HIGHSTAT Investigative D08MRL DRUG__ID D08MRL D08MRL DRUGTYPE Small molecular drug D08MRL DRUGINCH 1S/C13H15NO/c1-2-9-14-12-7-8-13(15)11-6-4-3-5-10(11)12/h3-8,14-15H,2,9H2,1H3 D08MRL DRUGINKE FDQDPQDUXWRNKT-UHFFFAOYSA-N D08MRL DRUGSMIL CCCNC1=CC=C(C2=CC=CC=C21)O D08MRL HIGHSTAT Investigative D08MTZ DRUG__ID D08MTZ D08MTZ DRUGTYPE Small molecular drug D08MTZ DRUGINCH 1S/C16H12O4/c1-19-12-6-7-13-15(8-12)20-9-14(16(13)18)10-2-4-11(17)5-3-10/h2-9,17H,1H3 D08MTZ DRUGINKE LNIQZRIHAMVRJA-UHFFFAOYSA-N D08MTZ DRUGSMIL COC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O D08MTZ HIGHSTAT Investigative D08MUZ DRUG__ID D08MUZ D08MUZ DRUGTYPE Small molecular drug D08MUZ DRUGINCH 1S/C5H8O/c1-2-3-4-5-6/h3-5H,2H2,1H3/b4-3+ D08MUZ DRUGINKE DTCCTIQRPGSLPT-ONEGZZNKSA-N D08MUZ DRUGSMIL CCC=CC=O D08MUZ HIGHSTAT Investigative D08MXD DRUG__ID D08MXD D08MXD DRUGTYPE Small molecular drug D08MXD DRUGINCH 1S/C24H21FN4O2S/c1-15-26-21(22(32-15)18-11-5-6-12-19(18)25)24(30)29-13-7-10-17(29)14-20-27-28-23(31-20)16-8-3-2-4-9-16/h2-6,8-9,11-12,17H,7,10,13-14H2,1H3/t17-/m0/s1/i8T,9T D08MXD DRUGINKE HYBZWVLPALMACV-JQGZANCBSA-N D08MXD DRUGSMIL CC1=NC(=C(S1)C2=CC=CC=C2F)C(=O)N3CCCC3CC4=NN=C(O4)C5=CC=CC=C5 D08MXD HIGHSTAT Investigative D08MZY DRUG__ID D08MZY D08MZY DRUGTYPE Small molecular drug D08MZY DRUGINCH 1S/C18H12O9/c19-7-1-8(20)3-10(2-7)25-16-12(23)6-13(24)17-18(16)27-15-11(22)4-9(21)5-14(15)26-17/h1-6,19-24H D08MZY DRUGINKE PCZZRBGISTUIOA-UHFFFAOYSA-N D08MZY DRUGSMIL C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C=C4O3)O)O)O)O)O D08MZY HIGHSTAT Investigative D08NCP DRUG__ID D08NCP D08NCP DRUGTYPE Small molecular drug D08NCP DRUGINCH 1S/C22H26N4O3/c1-5-25(6-2)12-11-23-14-7-8-15-20-18(14)22(27)19-16(28-3)9-10-17(29-4)21(19)26(20)13-24-15/h7-10,13,23H,5-6,11-12H2,1-4H3 D08NCP DRUGINKE GVUCPNKYHGBWCF-UHFFFAOYSA-N D08NCP DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C=CC(=C4C2=O)OC)OC D08NCP HIGHSTAT Investigative D08NDV DRUG__ID D08NDV D08NDV DRUGTYPE Small molecular drug D08NDV DRUGINCH 1S/C16H20N2O2/c19-16(18-8-10-20-11-9-18)7-3-4-13-12-17-15-6-2-1-5-14(13)15/h1-2,5-6,12,17H,3-4,7-11H2 D08NDV DRUGINKE YFXYLXOHDNYDNC-UHFFFAOYSA-N D08NDV DRUGSMIL C1COCCN1C(=O)CCCC2=CNC3=CC=CC=C32 D08NDV HIGHSTAT Investigative D08NFA DRUG__ID D08NFA D08NFA DRUGTYPE Small molecular drug D08NFA DRUGINCH 1S/C24H34N2O3/c1-24-8-7-18-17-6-4-16(27)13-15(17)3-5-19(18)21(24)14-20(22(24)28)23(29)26-11-9-25(2)10-12-26/h4,6,13,18-22,27-28H,3,5,7-12,14H2,1-2H3/t18?,19?,20?,21?,22-,24-/m0/s1 D08NFA DRUGINKE VNXBDWUNAYPTRF-OOBULCBASA-N D08NFA DRUGSMIL CC12CCC3C(C1CC(C2O)C(=O)N4CCN(CC4)C)CCC5=C3C=CC(=C5)O D08NFA HIGHSTAT Investigative D08NFH DRUG__ID D08NFH D08NFH DRUGTYPE Small molecular drug D08NFH DRUGINCH 1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/t2-,3-,4-,5-/m1/s1 D08NFH DRUGINKE PQGCEDQWHSBAJP-TXICZTDVSA-N D08NFH DRUGSMIL C(C1C(C(C(O1)OP(=O)(O)OP(=O)(O)O)O)O)OP(=O)(O)O D08NFH HIGHSTAT Investigative D08NFP DRUG__ID D08NFP D08NFP DRUGTYPE Small molecular drug D08NFP DRUGINCH 1S/C21H15NO2/c23-18-9-4-8-16(12-18)19-13-17(15-6-2-1-3-7-15)14-20(22-19)21-10-5-11-24-21/h1-14,23H D08NFP DRUGINKE CYYONTBOQHHDLF-UHFFFAOYSA-N D08NFP DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC=CO3)C4=CC(=CC=C4)O D08NFP HIGHSTAT Investigative D08NIG DRUG__ID D08NIG D08NIG DRUGTYPE Small molecular drug D08NIG DRUGINCH 1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8-,17-13+ D08NIG DRUGINKE NCYCYZXNIZJOKI-MKOSUFFBSA-N D08NIG DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=O)C)C D08NIG HIGHSTAT Investigative D08NIT DRUG__ID D08NIT D08NIT DRUGTYPE Small molecular drug D08NIT DRUGINCH 1S/C30H20O11/c31-14-4-1-12(2-5-14)29-27(28(39)25-18(35)8-15(32)9-23(25)41-29)26-20(37)10-19(36)24-21(38)11-22(40-30(24)26)13-3-6-16(33)17(34)7-13/h1-11,27,29,31-37H/t27-,29+/m1/s1 D08NIT DRUGINKE GFWPWSNIXRDQJC-PXJZQJOASA-N D08NIT DRUGSMIL C1=CC(=CC=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC(=C(C=C6)O)O)O)O)O D08NIT HIGHSTAT Investigative D08NJB DRUG__ID D08NJB D08NJB DRUGTYPE Small molecular drug D08NJB DRUGINCH 1S/C28H33N5O7/c29-20(14-18-10-12-19(34)13-11-18)25(36)32-21-8-4-5-9-22(28(39)40)33-27(38)23(15-17-6-2-1-3-7-17)31-24(35)16-30-26(21)37/h1-7,10-13,20-23,34H,8-9,14-16,29H2,(H,30,37)(H,31,35)(H,32,36)(H,33,38)(H,39,40)/b5-4+/t20-,21+,22+,23-/m0/s1 D08NJB DRUGINKE VNZCTJLIVONUDE-KLGXLVMCSA-N D08NJB DRUGSMIL C1C=CCC(NC(=O)C(NC(=O)CNC(=O)C1NC(=O)C(CC2=CC=C(C=C2)O)N)CC3=CC=CC=C3)C(=O)O D08NJB HIGHSTAT Investigative D08NJD DRUG__ID D08NJD D08NJD DRUGTYPE Small molecular drug D08NJD DRUGINCH 1S/C94H152N38O19S2/c95-35-5-3-18-59-76(138)125-65(19-4-6-36-96)86(148)132-44-14-26-72(132)85(147)129-68(46-52-29-33-55(134)34-30-52)81(143)123-62(22-10-40-114-91(104)105)75(137)121-64(24-12-43-117-94(110)151)79(141)130-71(84(146)126-66(87(149)150)25-13-42-116-93(108)109)50-153-152-49-70(83(145)124-63(23-11-41-115-92(106)107)78(140)127-67(45-51-27-31-54(133)32-28-51)80(142)122-61(74(136)120-59)21-9-39-113-90(102)103)131-82(144)69(47-53-48-118-58-17-2-1-15-56(53)58)128-77(139)60(20-8-38-112-89(100)101)119-73(135)57(97)16-7-37-111-88(98)99/h1-2,15,17,27-34,48,57,59-72,118,133-134H,3-14,16,18-26,35-47,49-50,95-97H2,(H,119,135)(H,120,136)(H,121,137)(H,122,142)(H,123,143)(H,124,145)(H,125,138)(H,126,146)(H,127,140)(H,128,139)(H,129,147)(H,130,141)(H,131,144)(H,149,150)(H4,98,99,111)(H4,100,101,112)(H4,102,103,113)(H4,104,105,114)(H4,106,107,115)(H4,108,109,116)(H3,110,117,151)/t57-,59-,60-,61-,62-,63-,64-,65+,66-,67-,68-,69-,70-,71-,72-/m0/s1 D08NJD DRUGINKE ZFIUCXJWTNZDRW-UYROLUPNSA-N D08NJD DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CCCCN)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)CCCNC(=N)N)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)CCCNC(=O)N)CCCNC(=N)N)CC6=CC=C(C=C6)O D08NJD HIGHSTAT Investigative D08NJT DRUG__ID D08NJT D08NJT DRUGTYPE Small molecular drug D08NJT DRUGINCH 1S/C17H11BrN2/c1-11-2-3-13-4-5-14(9-17(13)20-11)15-6-12(10-19)7-16(18)8-15/h2-9H,1H3 D08NJT DRUGINKE UCLWCGCRIQDNMD-UHFFFAOYSA-N D08NJT DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)Br D08NJT HIGHSTAT Investigative D08NKL DRUG__ID D08NKL D08NKL DRUGTYPE Small molecular drug D08NKL DRUGINCH 1S/C16H12O13S2.2K/c1-26-11-4-7(2-3-9(11)17)15-16(29-31(23,24)25)14(19)13-10(18)5-8(6-12(13)27-15)28-30(20,21)22;;/h2-6,17-18H,1H3,(H,20,21,22)(H,23,24,25);;/q;2*+1/p-2 D08NKL DRUGINKE JILXHFDBMPFPLQ-UHFFFAOYSA-L D08NKL DRUGSMIL COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)OS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O.[K+].[K+] D08NKL HIGHSTAT Investigative D08NMS DRUG__ID D08NMS D08NMS DRUGTYPE Small molecular drug D08NMS DRUGINCH 1S/C22H20Cl2N6O/c1-13-17(11-25)20(16-6-5-14(23)10-18(16)24)30-12-19(29-22(30)28-13)21(31)27-9-7-15-4-2-3-8-26-15/h2-6,8,10,12H,7,9,11,25H2,1H3,(H,27,31) D08NMS DRUGINKE JGJABGSOYWQCSC-UHFFFAOYSA-N D08NMS DRUGSMIL CC1=NC2=NC(=CN2C(=C1CN)C3=C(C=C(C=C3)Cl)Cl)C(=O)NCCC4=CC=CC=N4 D08NMS HIGHSTAT Investigative D08NNF DRUG__ID D08NNF D08NNF DRUGTYPE Small molecular drug D08NNF DRUGINCH 1S/C17H16N2OS/c20-17(18-12-6-5-7-12)19-13-8-1-3-10-15(13)21-16-11-4-2-9-14(16)19/h1-4,8-12H,5-7H2,(H,18,20) D08NNF DRUGINKE KNYQZMOQFRAHIS-UHFFFAOYSA-N D08NNF DRUGSMIL C1CC(C1)NC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D08NNF HIGHSTAT Investigative D08NOP DRUG__ID D08NOP D08NOP DRUGTYPE Small molecular drug D08NOP DRUGINCH 1S/C16H14N2/c1-11-4-3-5-13(8-11)15-9-16-14(10-17-15)7-6-12(2)18-16/h3-10H,1-2H3 D08NOP DRUGINKE RXRAEDHCPCFPLI-UHFFFAOYSA-N D08NOP DRUGSMIL CC1=CC(=CC=C1)C2=NC=C3C=CC(=NC3=C2)C D08NOP HIGHSTAT Investigative D08NOS DRUG__ID D08NOS D08NOS DRUGTYPE Small molecular drug D08NOS DRUGINCH 1S/C44H60N6O12S/c1-4-25(2)37(42(59)47-31(22-27-14-8-5-9-15-27)40(57)48-33(24-63)44(61)62)49-43(60)38(36(28-16-10-6-11-17-28)29-18-12-7-13-19-29)50-39(56)30(20-21-34(52)53)46-41(58)32(23-35(54)55)45-26(3)51/h6-7,10-13,16-19,25,27,30-33,36-38,63H,4-5,8-9,14-15,20-24H2,1-3H3,(H,45,51)(H,46,58)(H,47,59)(H,48,57)(H,49,60)(H,50,56)(H,52,53)(H,54,55)(H,61,62)/t25-,30+,31+,32+,33-,37-,38+/m1/s1 D08NOS DRUGINKE ZZXPMGNPISOZPV-IFWKXTFSSA-N D08NOS DRUGSMIL CCC(C)C(C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(C(C2=CC=CC=C2)C3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D08NOS HIGHSTAT Investigative D08NQA DRUG__ID D08NQA D08NQA DRUGTYPE Small molecular drug D08NQA DRUGINCH 1S/C28H23ClF2N6O3/c1-32-27(40)28-11-17(28)22(23(38)24(28)39)37-13-34-21-25(33-12-15-3-2-4-16(29)9-15)35-20(36-26(21)37)8-6-14-5-7-18(30)19(31)10-14/h2-5,7,9-10,13,17,22-24,38-39H,11-12H2,1H3,(H,32,40)(H,33,35,36)/t17-,22-,23+,24+,28+/m1/s1 D08NQA DRUGINKE LYLLLJJYBWLGHW-CIZVZKTGSA-N D08NQA DRUGSMIL CNC(=O)C12CC1C(C(C2O)O)N3C=NC4=C(N=C(N=C43)C#CC5=CC(=C(C=C5)F)F)NCC6=CC(=CC=C6)Cl D08NQA HIGHSTAT Investigative D08NQM DRUG__ID D08NQM D08NQM DRUGTYPE Small molecular drug D08NQM DRUGINCH 1S/C12H7N3O2S/c16-11-10(18-12(17)15-11)6-7-1-2-8-9(5-7)14-4-3-13-8/h1-6H,(H,15,16,17)/b10-6- D08NQM DRUGINKE SQWZFLMPDUSYGV-POHAHGRESA-N D08NQM DRUGSMIL C1=CC2=NC=CN=C2C=C1C=C3C(=O)NC(=O)S3 D08NQM HIGHSTAT Investigative D08NQW DRUG__ID D08NQW D08NQW DRUGTYPE Small molecular drug D08NQW DRUGINCH 1S/C8H8ClNO3/c9-6-2-1-4(11)3-5(6)7(10)8(12)13/h1-3,7,11H,10H2,(H,12,13) D08NQW DRUGINKE UNIDAFCQFPGYJJ-UHFFFAOYSA-N D08NQW DRUGSMIL C1=CC(=C(C=C1O)C(C(=O)O)N)Cl D08NQW HIGHSTAT Investigative D08NRK DRUG__ID D08NRK D08NRK DRUGTYPE Small molecular drug D08NRK DRUGINCH 1S/C3H5/c1-2-3-1/h1H,2-3H2 D08NRK DRUGINKE XIPUIGPNIDKXJU-UHFFFAOYSA-N D08NRK DRUGSMIL C1C[CH]1 D08NRK HIGHSTAT Investigative D08NSS DRUG__ID D08NSS D08NSS DRUGTYPE Small molecular drug D08NSS DRUGINCH 1S/C29H42N4O6S/c1-4-5-6-7-23-8-10-24(11-9-23)28(34)30-25-12-14-26(15-13-25)40(37,38)33(27(22(2)3)29(35)31-36)17-16-32-18-20-39-21-19-32/h8-15,22,27,36H,4-7,16-21H2,1-3H3,(H,30,34)(H,31,35)/t27-/m1/s1 D08NSS DRUGINKE YJNCFXPJICILOK-HHHXNRCGSA-N D08NSS DRUGSMIL CCCCCC1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)N(CCN3CCOCC3)C(C(C)C)C(=O)NO D08NSS HIGHSTAT Investigative D08NTB DRUG__ID D08NTB D08NTB DRUGTYPE Small molecular drug D08NTB DRUGINCH 1S/C11H8Br2N2O2/c1-6(16)8(5-14)11(17)15-10-4-7(12)2-3-9(10)13/h2-4,16H,1H3,(H,15,17)/b8-6- D08NTB DRUGINKE UVSVTDVJQAJIFG-VURMDHGXSA-N D08NTB DRUGSMIL CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O D08NTB HIGHSTAT Investigative D08NUF DRUG__ID D08NUF D08NUF DRUGTYPE Small molecular drug D08NUF DRUGINCH 1S/C30H46O3/c1-25(2)14-15-27(5)16-17-30(24(32)33)19(20(27)18-25)8-9-22-28(6)12-11-23(31)26(3,4)21(28)10-13-29(22,30)7/h8,20-22H,9-18H2,1-7H3,(H,32,33)/t20-,21?,22+,27+,28-,29+,30+/m0/s1 D08NUF DRUGINKE DQHMTWAVBRLUSK-YHNOYPSGSA-N D08NUF DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1)C(=O)O)C)C D08NUF HIGHSTAT Investigative D08NWU DRUG__ID D08NWU D08NWU DRUGTYPE Small molecular drug D08NWU DRUGINCH 1S/C21H24N4O3/c1-4-24(5-2)11-10-22-13-6-7-14-19-17(13)21(27)18-15(26)8-9-16(28-3)20(18)25(19)12-23-14/h6-9,12,22,27H,4-5,10-11H2,1-3H3 D08NWU DRUGINKE CCUYKRLXKTWTGP-UHFFFAOYSA-N D08NWU DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C=CC(=O)C4=C2O)OC D08NWU HIGHSTAT Investigative D08NXC DRUG__ID D08NXC D08NXC DRUGTYPE Small molecular drug D08NXC DRUGINCH 1S/C24H23ClN2O2/c25-20-5-6-21-19(13-20)4-3-18-2-1-9-26-24(18)23(21)17-7-10-27(11-8-17)14-16-12-22(28)29-15-16/h1-2,5-6,9,12-13H,3-4,7-8,10-11,14-15H2 D08NXC DRUGINKE CHEQBNZJRBHHQT-UHFFFAOYSA-N D08NXC DRUGSMIL C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)CC4=CC(=O)OC4)C5=C1C=CC=N5 D08NXC HIGHSTAT Investigative D08NYF DRUG__ID D08NYF D08NYF DRUGTYPE Small molecular drug D08NYF DRUGINCH 1S/C12H10BrN3OS/c13-9-3-1-8(2-4-9)11-6-5-10(17-11)7-15-16-12(14)18/h1-7H,(H3,14,16,18)/b15-7+ D08NYF DRUGINKE ZCUMFDMDQURMSL-VIZOYTHASA-N D08NYF DRUGSMIL C1=CC(=CC=C1C2=CC=C(O2)C=NNC(=S)N)Br D08NYF HIGHSTAT Investigative D08NYN DRUG__ID D08NYN D08NYN DRUGTYPE Small molecular drug D08NYN DRUGINCH 1S/C18H26O5/c1-3-5-6-7-8-9-15(20)18-13(11-17(22)23-4-2)10-14(19)12-16(18)21/h10,12,19,21H,3-9,11H2,1-2H3 D08NYN DRUGINKE UVVWQQKSNZLUQA-UHFFFAOYSA-N D08NYN DRUGSMIL CCCCCCCC(=O)C1=C(C=C(C=C1O)O)CC(=O)OCC D08NYN HIGHSTAT Investigative D08NZE DRUG__ID D08NZE D08NZE DRUGTYPE Small molecular drug D08NZE DRUGINCH 1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1 D08NZE DRUGINKE SVFXPTLYMIXFRX-XJKSGUPXSA-N D08NZE DRUGSMIL CNC1CC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl D08NZE HIGHSTAT Investigative D08OAQ DRUG__ID D08OAQ D08OAQ DRUGTYPE Small molecular drug D08OAQ DRUGINCH 1S/C22H30O2/c1-5-6-7-8-14-22(2,3)18-12-13-20(21(23)16-18)17-10-9-11-19(15-17)24-4/h9-13,15-16,23H,5-8,14H2,1-4H3 D08OAQ DRUGINKE XKFBIUKAHKJONV-UHFFFAOYSA-N D08OAQ DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CC(=CC=C2)OC)O D08OAQ HIGHSTAT Investigative D08OBF DRUG__ID D08OBF D08OBF DRUGTYPE Small molecular drug D08OBF DRUGINCH 1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16) D08OBF DRUGINKE TUNFSRHWOTWDNC-UHFFFAOYSA-N D08OBF DRUGSMIL CCCCCCCCCCCCCC(=O)O D08OBF HIGHSTAT Investigative D08OBO DRUG__ID D08OBO D08OBO DRUGTYPE Small molecular drug D08OBO DRUGINCH 1S/C10H12N5O5PS.C6H15N/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7;1-4-7(5-2)6-3/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13);4-6H2,1-3H3 D08OBO DRUGINKE OXIPZMKSNMRTIV-UHFFFAOYSA-N D08OBO DRUGSMIL CCN(CC)CC.C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)O D08OBO HIGHSTAT Investigative D08OCG DRUG__ID D08OCG D08OCG DRUGTYPE Small molecular drug D08OCG DRUGINCH 1S/C22H26N4O4/c1-3-6-19-20(12-11-18(15(2)27)21(19)28)30-14-5-4-13-29-17-9-7-16(8-10-17)22-23-25-26-24-22/h7-12,28H,3-6,13-14H2,1-2H3,(H,23,24,25,26) D08OCG DRUGINKE FEEONEKLFGDWHR-UHFFFAOYSA-N D08OCG DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCCCCOC2=CC=C(C=C2)C3=NNN=N3 D08OCG HIGHSTAT Investigative D08OCL DRUG__ID D08OCL D08OCL DRUGTYPE Small molecular drug D08OCL DRUGINCH 1S/C16H14N4O2/c17-16(18)12-3-1-11(2-4-12)10-19-8-7-13-9-14(20(21)22)5-6-15(13)19/h1-9H,10H2,(H3,17,18) D08OCL DRUGINKE TYZQZZRAPZQXLG-UHFFFAOYSA-N D08OCL DRUGSMIL C1=CC(=CC=C1CN2C=CC3=C2C=CC(=C3)[N+](=O)[O-])C(=N)N D08OCL HIGHSTAT Investigative D08OCS DRUG__ID D08OCS D08OCS DRUGTYPE Small molecular drug D08OCS DRUGINCH 1S/C11H9N3O3/c1-8-2-4-9(5-3-8)11(15)13-7-6-10(12-13)14(16)17/h2-7H,1H3 D08OCS DRUGINKE PQRIEIACDJITID-UHFFFAOYSA-N D08OCS DRUGSMIL CC1=CC=C(C=C1)C(=O)N2C=CC(=N2)[N+](=O)[O-] D08OCS HIGHSTAT Investigative D08OFD DRUG__ID D08OFD D08OFD DRUGTYPE Small molecular drug D08OFD DRUGINCH 1S/C10H13N3S/c1-7-3-5-9(6-4-7)8(2)12-13-10(11)14/h3-6H,1-2H3,(H3,11,13,14)/b12-8- D08OFD DRUGINKE CLXMWTWYQLEKAI-WQLSENKSSA-N D08OFD DRUGSMIL CC1=CC=C(C=C1)C(=NNC(=S)N)C D08OFD HIGHSTAT Investigative D08OFG DRUG__ID D08OFG D08OFG DRUGTYPE Small molecular drug D08OFG DRUGINCH 1S/C17H19BrN6O2/c18-10-3-4-11-9(8-22-13(11)7-10)6-14-16(26)23-12(15(25)24-14)2-1-5-21-17(19)20/h3-4,6-8,12,22H,1-2,5H2,(H,23,26)(H,24,25)(H4,19,20,21)/b14-6-/t12-/m0/s1 D08OFG DRUGINKE YYFNNPXWRXQUPR-JVXNRYDGSA-N D08OFG DRUGSMIL C1=CC2=C(C=C1Br)NC=C2C=C3C(=O)NC(C(=O)N3)CCCN=C(N)N D08OFG HIGHSTAT Investigative D08OFS DRUG__ID D08OFS D08OFS DRUGTYPE Small molecular drug D08OFS DRUGINCH 1S/C9H11FN5O9P/c10-3-6(13-14-11)15(9(19)12-7(3)18)8-5(17)4(16)2(24-8)1-23-25(20,21)22/h2,4-5,8,16-17H,1H2,(H,12,18,19)(H2,20,21,22)/t2-,4-,5-,8-/m1/s1 D08OFS DRUGINKE ARRBQQMKVQEOHQ-UMMCILCDSA-N D08OFS DRUGSMIL C(C1C(C(C(O1)N2C(=C(C(=O)NC2=O)F)N=[N+]=[N-])O)O)OP(=O)(O)O D08OFS HIGHSTAT Investigative D08OHU DRUG__ID D08OHU D08OHU DRUGTYPE Small molecular drug D08OHU DRUGINCH 1S/C12H8F6N2/c13-11(14,15)9-3-8(6-20-2-1-19-7-20)4-10(5-9)12(16,17)18/h1-5,7H,6H2 D08OHU DRUGINKE XITLEILYHLIBPC-UHFFFAOYSA-N D08OHU DRUGSMIL C1=CN(C=N1)CC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F D08OHU HIGHSTAT Investigative D08OKP DRUG__ID D08OKP D08OKP DRUGTYPE Small molecular drug D08OKP DRUGINCH 1S/C16H12O3S/c17-12-3-1-2-10(8-12)15-6-7-16(20-15)11-4-5-13(18)14(19)9-11/h1-9,17-19H D08OKP DRUGINKE URXFYOORYZACQY-UHFFFAOYSA-N D08OKP DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC(=C(C=C3)O)O D08OKP HIGHSTAT Investigative D08OLL DRUG__ID D08OLL D08OLL DRUGTYPE Small molecular drug D08OLL DRUGINCH 1S/C13H17N3/c1-10-12-5-3-2-4-11(12)8-16(10)9-13-14-6-7-15-13/h2-5,10H,6-9H2,1H3,(H,14,15) D08OLL DRUGINKE SGOFAUSEYBZKDQ-UHFFFAOYSA-N D08OLL DRUGSMIL CC1C2=CC=CC=C2CN1CC3=NCCN3 D08OLL HIGHSTAT Investigative D08OLP DRUG__ID D08OLP D08OLP DRUGTYPE Small molecular drug D08OLP DRUGINCH 1S/C15H13N3O/c16-15(17)9-5-6-12-10(7-9)8-13(18-12)11-3-1-2-4-14(11)19/h1-8,18-19H,(H3,16,17)/p+1 D08OLP DRUGINKE JPGNPKIYCTXJPG-UHFFFAOYSA-O D08OLP DRUGSMIL C1=CC=C(C(=C1)C2=CC3=C(N2)C=CC(=C3)C(=[NH2+])N)O D08OLP HIGHSTAT Investigative D08OMB DRUG__ID D08OMB D08OMB DRUGTYPE Small molecular drug D08OMB DRUGINCH 1S/C17H17BrN3O5P/c1-9(10-5-7-11(18)8-6-10)19-17(27(24,25)26)12-3-2-4-13-14(12)21-16(23)15(22)20-13/h2-9,17,19H,1H3,(H,20,22)(H,21,23)(H2,24,25,26) D08OMB DRUGINKE XXZGNAZRWCBSBK-UHFFFAOYSA-N D08OMB DRUGSMIL CC(C1=CC=C(C=C1)Br)NC(C2=C3C(=CC=C2)NC(=O)C(=O)N3)P(=O)(O)O D08OMB HIGHSTAT Investigative D08OQO DRUG__ID D08OQO D08OQO DRUGTYPE Small molecular drug D08OQO DRUGINCH 1S/C12H14N2O/c1-8(2)15-10-5-3-4-9-6-7-11(13)14-12(9)10/h3-8H,1-2H3,(H2,13,14) D08OQO DRUGINKE IJQWZUBUZMKYCW-UHFFFAOYSA-N D08OQO DRUGSMIL CC(C)OC1=CC=CC2=C1N=C(C=C2)N D08OQO HIGHSTAT Investigative D08OQX DRUG__ID D08OQX D08OQX DRUGTYPE Small molecular drug D08OQX DRUGINCH 1S/C16H12O2S/c17-14-5-1-3-11(7-14)13-9-16(19-10-13)12-4-2-6-15(18)8-12/h1-10,17-18H D08OQX DRUGINKE FIVXNZZSAFLVFQ-UHFFFAOYSA-N D08OQX DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=CS2)C3=CC(=CC=C3)O D08OQX HIGHSTAT Investigative D08ORD DRUG__ID D08ORD D08ORD DRUGTYPE Small molecular drug D08ORD DRUGINCH 1S/C13H20N2O2S/c1-13(2,3)12-6-4-11(5-7-12)10-15-8-9-18(14,16)17/h4-7,10H,8-9H2,1-3H3,(H2,14,16,17) D08ORD DRUGINKE KYYQVPLISNAOAE-UHFFFAOYSA-N D08ORD DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C=NCCS(=O)(=O)N D08ORD HIGHSTAT Investigative D08ORG DRUG__ID D08ORG D08ORG DRUGTYPE Small molecular drug D08ORG DRUGINCH 1S/C12H11N3O/c13-5-10-1-3-11(4-2-10)7-15-9-14-6-12(15)8-16/h1-4,6,9,16H,7-8H2 D08ORG DRUGINKE ACFSBQWDVYWNRT-UHFFFAOYSA-N D08ORG DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2CO)C#N D08ORG HIGHSTAT Investigative D08ORM DRUG__ID D08ORM D08ORM DRUGTYPE Small molecular drug D08ORM DRUGINCH 1S/C22H36N4O9/c1-6-12(4)19(22(35)24-14(10-27)9-17(31)32)26-20(33)15(7-8-16(29)30)25-21(34)18(11(2)3)23-13(5)28/h10-12,14-15,18-19H,6-9H2,1-5H3,(H,23,28)(H,24,35)(H,25,34)(H,26,33)(H,29,30)(H,31,32)/t12-,14-,15-,18-,19-/m0/s1 D08ORM DRUGINKE KYUFGGNCJRWMDN-GOYXDOSHSA-N D08ORM DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)O)C=O)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C D08ORM HIGHSTAT Investigative D08ORS DRUG__ID D08ORS D08ORS DRUGTYPE Small molecular drug D08ORS DRUGINCH 1S/C23H31NO/c1-5-17-24(4)19(3)18-23(22(25)6-2,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h5,7-16,19,22,25H,1,6,17-18H2,2-4H3 D08ORS DRUGINKE HXWBPTAZQDKQKI-UHFFFAOYSA-N D08ORS DRUGSMIL CCC(C(CC(C)N(C)CC=C)(C1=CC=CC=C1)C2=CC=CC=C2)O D08ORS HIGHSTAT Investigative D08OSM DRUG__ID D08OSM D08OSM DRUGTYPE Small molecular drug D08OSM DRUGINCH 1S/C12H9NO/c1-2-4-12-10(3-1)11(7-13-12)9-5-6-14-8-9/h1-8,13H D08OSM DRUGINKE AFKNGDFJVAPDNN-UHFFFAOYSA-N D08OSM DRUGSMIL C1=CC=C2C(=C1)C(=CN2)C3=COC=C3 D08OSM HIGHSTAT Investigative D08OUR DRUG__ID D08OUR D08OUR DRUGTYPE Small molecular drug D08OUR DRUGINCH 1S/C14H17N3O/c15-14(18)13-8-4-7-11-9-12(16-17(11)13)10-5-2-1-3-6-10/h4,7-10H,1-3,5-6H2,(H2,15,18) D08OUR DRUGINKE YQKBVCBRJDUULG-UHFFFAOYSA-N D08OUR DRUGSMIL C1CCC(CC1)C2=NN3C(=C2)C=CC=C3C(=O)N D08OUR HIGHSTAT Investigative D08OUX DRUG__ID D08OUX D08OUX DRUGTYPE Small molecular drug D08OUX DRUGINCH 1S/C15H21IN2O2/c1-3-18-8-4-5-12(18)10-17-15(19)13-9-11(16)6-7-14(13)20-2/h6-7,9,12H,3-5,8,10H2,1-2H3,(H,17,19)/t12-/m1/s1 D08OUX DRUGINKE JHMTYLJMPBFCTD-GFCCVEGCSA-N D08OUX DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)I)OC D08OUX HIGHSTAT Investigative D08OYH DRUG__ID D08OYH D08OYH DRUGTYPE Small molecular drug D08OYH DRUGINCH 1S/C19H15NO8/c1-12(21)27-17-9-14(25-7-8-26-20(23)24)10-18-19(17)15(22)11-16(28-18)13-5-3-2-4-6-13/h2-6,9-11H,7-8H2,1H3 D08OYH DRUGINKE VQDIDXYXZUUTEY-UHFFFAOYSA-N D08OYH DRUGSMIL CC(=O)OC1=CC(=CC2=C1C(=O)C=C(O2)C3=CC=CC=C3)OCCO[N+](=O)[O-] D08OYH HIGHSTAT Investigative D08PDF DRUG__ID D08PDF D08PDF DRUGTYPE Small molecular drug D08PDF DRUGINCH 1S/C12H8N2/c1-2-4-11(5-3-1)6-7-12-8-13-10-14-9-12/h1-5,8-10H D08PDF DRUGINKE HSQDWKSXSIUOJC-UHFFFAOYSA-N D08PDF DRUGSMIL C1=CC=C(C=C1)C#CC2=CN=CN=C2 D08PDF HIGHSTAT Investigative D08PDK DRUG__ID D08PDK D08PDK DRUGTYPE Small molecular drug D08PDK DRUGINCH 1S/C16H11BrO2/c17-16-14-6-4-11(8-12(14)5-7-15(16)19)10-2-1-3-13(18)9-10/h1-9,18-19H D08PDK DRUGINKE WIVQIQQCUPQEGH-UHFFFAOYSA-N D08PDK DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)C(=C(C=C3)O)Br D08PDK HIGHSTAT Investigative D08PEM DRUG__ID D08PEM D08PEM DRUGTYPE Small molecular drug D08PEM DRUGINCH 1S/C6H15O13P3/c7-4-3(1-17-22(14,15)16)18-6(5(4)8)19-21(12,13)2-20(9,10)11/h3-8H,1-2H2,(H,12,13)(H2,9,10,11)(H2,14,15,16)/t3-,4-,5-,6-/m1/s1 D08PEM DRUGINKE JFMKBQDEISBIPL-KVTDHHQDSA-N D08PEM DRUGSMIL C(C1C(C(C(O1)OP(=O)(CP(=O)(O)O)O)O)O)OP(=O)(O)O D08PEM HIGHSTAT Investigative D08PEW DRUG__ID D08PEW D08PEW DRUGTYPE Small molecular drug D08PEW DRUGINCH 1S/C19H22N2/c1-2-8-16(9-3-1)10-6-7-13-20-15-18-14-17-11-4-5-12-19(17)21-18/h1-5,8-9,11-12,14,20-21H,6-7,10,13,15H2 D08PEW DRUGINKE OLWLANFDDNVPCZ-UHFFFAOYSA-N D08PEW DRUGSMIL C1=CC=C(C=C1)CCCCNCC2=CC3=CC=CC=C3N2 D08PEW HIGHSTAT Investigative D08PHY DRUG__ID D08PHY D08PHY DRUGTYPE Small molecular drug D08PHY DRUGINCH 1S/C9H9F2N/c10-7-3-1-6(2-4-7)9(11)5-8(9)12/h1-4,8H,5,12H2/t8-,9-/m0/s1 D08PHY DRUGINKE JCUGJWBVZNWAIJ-IUCAKERBSA-N D08PHY DRUGSMIL C1C(C1(C2=CC=C(C=C2)F)F)N D08PHY HIGHSTAT Investigative D08PIF DRUG__ID D08PIF D08PIF DRUGTYPE Small molecular drug D08PIF DRUGINCH 1S/C8H10OS/c1-9-8-4-2-7(6-10)3-5-8/h2-5,10H,6H2,1H3 D08PIF DRUGINKE PTDVPWWJRCOIIO-UHFFFAOYSA-N D08PIF DRUGSMIL COC1=CC=C(C=C1)CS D08PIF HIGHSTAT Investigative D08PJK DRUG__ID D08PJK D08PJK DRUGTYPE Small molecular drug D08PJK DRUGINCH 1S/C11H13N3O/c12-4-3-8-6-14-10-2-1-7(11(13)15)5-9(8)10/h1-2,5-6,14H,3-4,12H2,(H2,13,15)/i3T2,4T2 D08PJK DRUGINKE WKZLNEWVIAGNAW-DOMYTETQSA-N D08PJK DRUGSMIL C1=CC2=C(C=C1C(=O)N)C(=CN2)CCN D08PJK HIGHSTAT Investigative D08PKR DRUG__ID D08PKR D08PKR DRUGTYPE Small molecular drug D08PKR DRUGINCH 1S/C12H9N3/c1-2-12(15-6-5-14-9-15)7-10-3-4-13-8-11(1)10/h1-9H D08PKR DRUGINKE YACWDKFXWATANA-UHFFFAOYSA-N D08PKR DRUGSMIL C1=CC2=C(C=CN=C2)C=C1N3C=CN=C3 D08PKR HIGHSTAT Investigative D08PKS DRUG__ID D08PKS D08PKS DRUGTYPE Small molecular drug D08PKS DRUGINCH 1S/C8H20N4/c9-6-4-2-1-3-5-7-12-8(10)11/h1-7,9H2,(H4,10,11,12) D08PKS DRUGINKE YAOAMZOGXBMLFQ-UHFFFAOYSA-N D08PKS DRUGSMIL C(CCCN)CCCN=C(N)N D08PKS HIGHSTAT Investigative D08PLU DRUG__ID D08PLU D08PLU DRUGTYPE Small molecular drug D08PLU DRUGINCH 1S/C16H18N2/c1-3-18-15-7-5-4-6-13(15)14-10-12(11-17-2)8-9-16(14)18/h4-10,17H,3,11H2,1-2H3 D08PLU DRUGINKE LBPNOEAFWYTTEB-UHFFFAOYSA-N D08PLU DRUGSMIL CCN1C2=C(C=C(C=C2)CNC)C3=CC=CC=C31 D08PLU HIGHSTAT Investigative D08PMD DRUG__ID D08PMD D08PMD DRUGTYPE Small molecular drug D08PMD DRUGINCH 1S/C13H18N2O3/c16-12(15-18)9-5-2-6-10-14-13(17)11-7-3-1-4-8-11/h1,3-4,7-8,18H,2,5-6,9-10H2,(H,14,17)(H,15,16) D08PMD DRUGINKE WOSZGUVOSPLDAN-UHFFFAOYSA-N D08PMD DRUGSMIL C1=CC=C(C=C1)C(=O)NCCCCCC(=O)NO D08PMD HIGHSTAT Investigative D08PNF DRUG__ID D08PNF D08PNF DRUGTYPE Small molecular drug D08PNF DRUGINCH 1S/C16H15NO/c1-18-15-6-7-16-13(4-5-14(16)10-15)9-12-3-2-8-17-11-12/h2-3,6-11H,4-5H2,1H3/b13-9- D08PNF DRUGINKE HVRLSDXXVKSVBR-LCYFTJDESA-N D08PNF DRUGSMIL COC1=CC2=C(C=C1)C(=CC3=CN=CC=C3)CC2 D08PNF HIGHSTAT Investigative D08PUJ DRUG__ID D08PUJ D08PUJ DRUGTYPE Small molecular drug D08PUJ DRUGINCH 1S/C6H14BNO4/c8-5(6(9)10)3-1-2-4-7(11)12/h5,11-12H,1-4,8H2,(H,9,10)/t5-/m0/s1 D08PUJ DRUGINKE HFKKMXCOJQIYAH-YFKPBYRVSA-N D08PUJ DRUGSMIL B(CCCCC(C(=O)O)N)(O)O D08PUJ HIGHSTAT Investigative D08PVY DRUG__ID D08PVY D08PVY DRUGTYPE Small molecular drug D08PVY DRUGINCH 1S/C17H34N4O10/c18-2-6-10(24)12(26)8(21)16(28-6)30-14-5(20)1-4(19)9(23)15(14)31-17-13(27)11(25)7(3-22)29-17/h4-17,22-27H,1-3,18-21H2/t4-,5+,6-,7-,8-,9+,10-,11-,12-,13-,14-,15-,16-,17+/m1/s1 D08PVY DRUGINKE NSKGQURZWSPSBC-VVPCINPTSA-N D08PVY DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N D08PVY HIGHSTAT Investigative D08PWL DRUG__ID D08PWL D08PWL DRUGTYPE Small molecular drug D08PWL DRUGINCH 1S/C17H22N2O/c1-3-10-18-17-13-6-4-5-7-15(13)19-16-9-8-12(20-2)11-14(16)17/h8-9,11H,3-7,10H2,1-2H3,(H,18,19) D08PWL DRUGINKE GFBWOLCGRWIJDE-UHFFFAOYSA-N D08PWL DRUGSMIL CCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D08PWL HIGHSTAT Investigative D08PXU DRUG__ID D08PXU D08PXU DRUGTYPE Small molecular drug D08PXU DRUGINCH 1S/C8H10BrNO2S/c9-7-2-1-6(13-7)5(4-10)3-8(11)12/h1-2,5H,3-4,10H2,(H,11,12) D08PXU DRUGINKE AGSZIPFOQSAPON-UHFFFAOYSA-N D08PXU DRUGSMIL C1=C(SC(=C1)Br)C(CC(=O)O)CN D08PXU HIGHSTAT Investigative D08PYJ DRUG__ID D08PYJ D08PYJ DRUGTYPE Small molecular drug D08PYJ DRUGINCH 1S/C22H18O9/c1-3-22(30)7-10(24)12-13(16(22)21(29)31-2)20(28)14-15(19(12)27)18(26)11-8(17(14)25)5-4-6-9(11)23/h4-6,16,23,27-28,30H,3,7H2,1-2H3/t16-,22+/m0/s1 D08PYJ DRUGINKE FCUPTGDGQULLKX-KSFYIVLOSA-N D08PYJ DRUGSMIL CCC1(CC(=O)C2=C(C1C(=O)OC)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)O D08PYJ HIGHSTAT Investigative D08PZX DRUG__ID D08PZX D08PZX DRUGTYPE Small molecular drug D08PZX DRUGINCH 1S/C8H16N2S/c1-2-3-7-6-11-5-4-8(9)10-7/h7H,2-6H2,1H3,(H2,9,10)/t7-/m1/s1 D08PZX DRUGINKE SWOQAUBWIBZBLQ-SSDOTTSWSA-N D08PZX DRUGSMIL CCCC1CSCCC(=N1)N D08PZX HIGHSTAT Investigative D08QAH DRUG__ID D08QAH D08QAH DRUGTYPE Small molecular drug D08QAH DRUGINCH 1S/C17H18O2/c1-3-13-5-4-6-16(11-13)15-9-7-14(8-10-15)12(2)17(18)19/h4-12H,3H2,1-2H3,(H,18,19) D08QAH DRUGINKE NXNPVWSOBXWFAA-UHFFFAOYSA-N D08QAH DRUGSMIL CCC1=CC(=CC=C1)C2=CC=C(C=C2)C(C)C(=O)O D08QAH HIGHSTAT Investigative D08QBS DRUG__ID D08QBS D08QBS DRUGTYPE Small molecular drug D08QBS DRUGINCH 1S/C19H21F3N4/c1-12-18(11-24-17-4-3-14(20)10-17)25-26(6-2-5-23)19(12)13-7-15(21)9-16(22)8-13/h7-9,14,17,24H,2-4,6,10-11H2,1H3/t14-,17+/m1/s1 D08QBS DRUGINKE LJTOZIFFXNLWEQ-PBHICJAKSA-N D08QBS DRUGSMIL CC1=C(N(N=C1CNC2CCC(C2)F)CCC#N)C3=CC(=CC(=C3)F)F D08QBS HIGHSTAT Investigative D08QBU DRUG__ID D08QBU D08QBU DRUGTYPE Small molecular drug D08QBU DRUGINCH 1S/C27H31NO/c29-27(18-10-13-23-11-4-1-5-12-23)19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-9,11-12,14-17,26,29H,10,13,18-22H2 D08QBU DRUGINKE LBCGIDHKEKGBGS-UHFFFAOYSA-N D08QBU DRUGSMIL C1CN(CCC1(CCCC2=CC=CC=C2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D08QBU HIGHSTAT Investigative D08QCI DRUG__ID D08QCI D08QCI DRUGTYPE Small molecular drug D08QCI DRUGINCH 1S/C7H15O6P/c1-7(10,5-6(8)9)3-2-4-14(11,12)13/h10H,2-5H2,1H3,(H,8,9)(H2,11,12,13) D08QCI DRUGINKE XRCIRZGXKWCWNQ-UHFFFAOYSA-N D08QCI DRUGSMIL CC(CCCP(=O)(O)O)(CC(=O)O)O D08QCI HIGHSTAT Investigative D08QCQ DRUG__ID D08QCQ D08QCQ DRUGTYPE Small molecular drug D08QCQ DRUGINCH 1S/C15H19NS2/c1-15(2,3)13-9-17-14(18-10-13)12-6-4-11(8-16)5-7-12/h4-7,13-14H,9-10H2,1-3H3 D08QCQ DRUGINKE JBVUMTNJGGTVQA-UHFFFAOYSA-N D08QCQ DRUGSMIL CC(C)(C)C1CSC(SC1)C2=CC=C(C=C2)C#N D08QCQ HIGHSTAT Investigative D08QDL DRUG__ID D08QDL D08QDL DRUGTYPE Small molecular drug D08QDL DRUGINCH 1S/C5H10N2O3/c1-7(3-5(9)10)4(8)2-6/h2-3,6H2,1H3,(H,9,10)/i1-1 D08QDL DRUGINKE VYAMLSCELQQRAE-BJUDXGSMSA-N D08QDL DRUGSMIL CN(CC(=O)O)C(=O)CN D08QDL HIGHSTAT Investigative D08QKF DRUG__ID D08QKF D08QKF DRUGTYPE Small molecular drug D08QKF DRUGINCH 1S/C22H15Cl2NO2S/c23-15-8-6-14(7-9-15)13-25-19-11-10-16(24)12-18(19)21(20(25)22(26)27)28-17-4-2-1-3-5-17/h1-12H,13H2,(H,26,27) D08QKF DRUGINKE VUPOTURDKDMIGQ-UHFFFAOYSA-N D08QKF DRUGSMIL C1=CC=C(C=C1)SC2=C(N(C3=C2C=C(C=C3)Cl)CC4=CC=C(C=C4)Cl)C(=O)O D08QKF HIGHSTAT Investigative D08QKT DRUG__ID D08QKT D08QKT DRUGTYPE Small molecular drug D08QKT DRUGINCH 1S/C48H63N9O10/c1-4-6-16-36(54-44(63)34(49)23-30-19-21-32(58)22-20-30)45(64)52-28-41(59)53-39(25-31-27-51-35-17-12-11-15-33(31)35)48(67)57(3)40(18-7-5-2)47(66)56-38(26-42(60)61)46(65)55-37(43(50)62)24-29-13-9-8-10-14-29/h8-15,17,19-22,27,34,36-40,51,58H,4-7,16,18,23-26,28,49H2,1-3H3,(H2,50,62)(H,52,64)(H,53,59)(H,54,63)(H,55,65)(H,56,66)(H,60,61)/t34-,36+,37-,38-,39-,40-/m0/s1 D08QKT DRUGINKE KJQHRGYUFQCLJG-ACEPAJJMSA-N D08QKT DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N(C)C(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D08QKT HIGHSTAT Investigative D08QLC DRUG__ID D08QLC D08QLC DRUGTYPE Small molecular drug D08QLC DRUGINCH 1S/C14H9N3S/c15-8-10-4-1-2-6-13(10)18-14-7-3-5-12(17)11(14)9-16/h1-7H,17H2 D08QLC DRUGINKE HZXBXUYNSPXXOH-UHFFFAOYSA-N D08QLC DRUGSMIL C1=CC=C(C(=C1)C#N)SC2=CC=CC(=C2C#N)N D08QLC HIGHSTAT Investigative D08QPU DRUG__ID D08QPU D08QPU DRUGTYPE Small molecular drug D08QPU DRUGINCH 1S/C19H22ClNO/c20-18-9-6-17(7-10-18)14-21-12-13-22-19(15-21)11-8-16-4-2-1-3-5-16/h1-7,9-10,19H,8,11-15H2/t19-/m1/s1 D08QPU DRUGINKE CVKXGRRJHJHUFY-LJQANCHMSA-N D08QPU DRUGSMIL C1COC(CN1CC2=CC=C(C=C2)Cl)CCC3=CC=CC=C3 D08QPU HIGHSTAT Investigative D08QQR DRUG__ID D08QQR D08QQR DRUGTYPE Small molecular drug D08QQR DRUGINCH 1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6-/m0/s1 D08QQR DRUGINKE SHZGCJCMOBCMKK-KGJVWPDLSA-N D08QQR DRUGSMIL CC1C(C(C(C(O1)O)O)O)O D08QQR HIGHSTAT Investigative D08QSN DRUG__ID D08QSN D08QSN DRUGTYPE Small molecular drug D08QSN DRUGINCH 1S/C19H26Cl2N2O.CH4O3S/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23;1-5(2,3)4/h8-9,12,17-18H,2-7,10-11,13H2,1H3;1H3,(H,2,3,4)/t17-,18-;/m0./s1 D08QSN DRUGINKE OJPHNZCUXUUVKU-APTPAJQOSA-N D08QSN DRUGSMIL CN(C1CCCCC1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl.CS(=O)(=O)O D08QSN HIGHSTAT Investigative D08QVY DRUG__ID D08QVY D08QVY DRUGTYPE Small molecular drug D08QVY DRUGINCH 1S/C8H10N2O3/c11-6-7-5-10(8(12)13-7)9-3-1-2-4-9/h1-4,7,11H,5-6H2/t7-/m0/s1 D08QVY DRUGINKE SITMGBVDSOSSTH-ZETCQYMHSA-N D08QVY DRUGSMIL C1C(OC(=O)N1N2C=CC=C2)CO D08QVY HIGHSTAT Investigative D08QWR DRUG__ID D08QWR D08QWR DRUGTYPE Small molecular drug D08QWR DRUGINCH 1S/C15H12N2O/c18-15-13-9-5-4-8-12(13)14(16-17-15)10-11-6-2-1-3-7-11/h1-9H,10H2,(H,17,18) D08QWR DRUGINKE JUCCMEHWBGPJKS-UHFFFAOYSA-N D08QWR DRUGSMIL C1=CC=C(C=C1)CC2=NNC(=O)C3=CC=CC=C32 D08QWR HIGHSTAT Investigative D08QXD DRUG__ID D08QXD D08QXD DRUGTYPE Small molecular drug D08QXD DRUGINCH 1S/C22H21ClF3NO4S/c1-2-4-14-17(7-6-15-20(14)31-27-21(15)22(24,25)26)30-9-3-10-32-18-8-5-13(11-16(18)23)12-19(28)29/h5-8,11H,2-4,9-10,12H2,1H3,(H,28,29) D08QXD DRUGINKE TZBRFAASYWFUGK-UHFFFAOYSA-N D08QXD DRUGSMIL CCCC1=C(C=CC2=C1ON=C2C(F)(F)F)OCCCSC3=C(C=C(C=C3)CC(=O)O)Cl D08QXD HIGHSTAT Investigative D08QZD DRUG__ID D08QZD D08QZD DRUGTYPE Small molecular drug D08QZD DRUGINCH 1S/C30H24FN5O6/c1-41-30(40)19-9-12-24-22(14-19)35-28(42-24)26(38)23(13-17-5-3-2-4-6-17)34-25(37)16-36-27(33-15-21(32)29(36)39)18-7-10-20(31)11-8-18/h2-12,14-15,23H,13,16,32H2,1H3,(H,34,37) D08QZD DRUGINKE YGRSMPVCBHOYMS-UHFFFAOYSA-N D08QZD DRUGSMIL COC(=O)C1=CC2=C(C=C1)OC(=N2)C(=O)C(CC3=CC=CC=C3)NC(=O)CN4C(=NC=C(C4=O)N)C5=CC=C(C=C5)F D08QZD HIGHSTAT Investigative D08QZP DRUG__ID D08QZP D08QZP DRUGTYPE Small molecular drug D08QZP DRUGINCH 1S/C16H16N2/c1-2-6-13(7-3-1)11-17-12-15-10-14-8-4-5-9-16(14)18-15/h1-10,17-18H,11-12H2 D08QZP DRUGINKE CCDCVAKHGAIARI-UHFFFAOYSA-N D08QZP DRUGSMIL C1=CC=C(C=C1)CNCC2=CC3=CC=CC=C3N2 D08QZP HIGHSTAT Investigative D08RAZ DRUG__ID D08RAZ D08RAZ DRUGTYPE Small molecular drug D08RAZ DRUGINCH 1S/C21H20NO6.ClH/c1-22(2)6-5-11-7-15-16(26-9-25-15)8-13(11)18(22)19-12-3-4-14-20(27-10-24-14)17(12)21(23)28-19;/h3-4,7-8,18-19H,5-6,9-10H2,1-2H3;1H/q+1;/p-1/t18-,19+;/m0./s1 D08RAZ DRUGINKE RLJKFAMYSYWMND-GRTNUQQKSA-M D08RAZ DRUGSMIL C[N+]1(CCC2=CC3=C(C=C2C1C4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3)C.[Cl-] D08RAZ HIGHSTAT Investigative D08RCH DRUG__ID D08RCH D08RCH DRUGTYPE Small molecular drug D08RCH DRUGINCH 1S/C23H30N2O/c1-3-24(4-2)17-11-5-6-12-18-25-21-15-9-7-13-19(21)23(26)20-14-8-10-16-22(20)25/h7-10,13-16H,3-6,11-12,17-18H2,1-2H3 D08RCH DRUGINKE YHXSELHUXJAOLR-UHFFFAOYSA-N D08RCH DRUGSMIL CCN(CC)CCCCCCN1C2=CC=CC=C2C(=O)C3=CC=CC=C31 D08RCH HIGHSTAT Investigative D08RCQ DRUG__ID D08RCQ D08RCQ DRUGTYPE Small molecular drug D08RCQ DRUGINCH 1S/C17H15NOS/c1-12-3-5-13(6-4-12)16-11-18-20-17(16)14-7-9-15(19-2)10-8-14/h3-11H,1-2H3 D08RCQ DRUGINKE KPYJYWIFJYUIBB-UHFFFAOYSA-N D08RCQ DRUGSMIL CC1=CC=C(C=C1)C2=C(SN=C2)C3=CC=C(C=C3)OC D08RCQ HIGHSTAT Investigative D08RCS DRUG__ID D08RCS D08RCS DRUGTYPE Small molecular drug D08RCS DRUGINCH 1S/C11H13NOS/c1-3-6-14-10-5-4-9(8-12)11(7-10)13-2/h4-5,7H,3,6H2,1-2H3 D08RCS DRUGINKE SYEDQZDHJDTUDG-UHFFFAOYSA-N D08RCS DRUGSMIL CCCSC1=CC(=C(C=C1)C#N)OC D08RCS HIGHSTAT Investigative D08RDI DRUG__ID D08RDI D08RDI DRUGTYPE Small molecular drug D08RDI DRUGINCH 1S/C17H18BrN3O4S/c1-10-7-11(18)5-6-16(10)26(23,24)19-12-8-13-14(9-15(12)25-4)21(3)17(22)20(13)2/h5-9,19H,1-4H3 D08RDI DRUGINKE YUNQZQREIHWDQT-UHFFFAOYSA-N D08RDI DRUGSMIL CC1=C(C=CC(=C1)Br)S(=O)(=O)NC2=CC3=C(C=C2OC)N(C(=O)N3C)C D08RDI HIGHSTAT Investigative D08RFH DRUG__ID D08RFH D08RFH DRUGTYPE Small molecular drug D08RFH DRUGINCH 1S/C24H40N2O2/c27-23(26-24-13-18-10-19(14-24)12-20(11-18)15-24)25-21-6-8-22(9-7-21)28-16-17-4-2-1-3-5-17/h17-22H,1-16H2,(H2,25,26,27) D08RFH DRUGINKE IWFDYFIMYQSEQD-UHFFFAOYSA-N D08RFH DRUGSMIL C1CCC(CC1)COC2CCC(CC2)NC(=O)NC34CC5CC(C3)CC(C5)C4 D08RFH HIGHSTAT Investigative D08RGW DRUG__ID D08RGW D08RGW DRUGTYPE Small molecular drug D08RGW DRUGINCH 1S/C16H14N2S/c1-11-7-8-14-15(19)13(10-17-16(14)18-11)9-12-5-3-2-4-6-12/h2-8,10H,9H2,1H3,(H,17,18,19) D08RGW DRUGINKE JNNOALSYCGYTDY-UHFFFAOYSA-N D08RGW DRUGSMIL CC1=NC2=C(C=C1)C(=S)C(=CN2)CC3=CC=CC=C3 D08RGW HIGHSTAT Investigative D08RJC DRUG__ID D08RJC D08RJC DRUGTYPE Small molecular drug D08RJC DRUGINCH 1S/C29H42N2O2/c1-29(2,25-11-13-27(32)23(19-25)21-30-15-7-3-4-8-16-30)26-12-14-28(33)24(20-26)22-31-17-9-5-6-10-18-31/h11-14,19-20,32-33H,3-10,15-18,21-22H2,1-2H3 D08RJC DRUGINKE GHZGEEOGCPBASL-UHFFFAOYSA-N D08RJC DRUGSMIL CC(C)(C1=CC(=C(C=C1)O)CN2CCCCCC2)C3=CC(=C(C=C3)O)CN4CCCCCC4 D08RJC HIGHSTAT Investigative D08RKK DRUG__ID D08RKK D08RKK DRUGTYPE Small molecular drug D08RKK DRUGINCH 1S/HI/h1H/p-1 D08RKK DRUGINKE XMBWDFGMSWQBCA-UHFFFAOYSA-M D08RKK DRUGSMIL [I-] D08RKK HIGHSTAT Investigative D08RLR DRUG__ID D08RLR D08RLR DRUGTYPE Small molecular drug D08RLR DRUGINCH 1S/C16H18N4O4/c1-2-11(9-15(23)24)19-13(21)7-8-14(22)20-12-5-3-10(4-6-12)16(17)18/h1,3-6,11H,7-9H2,(H3,17,18)(H,19,21)(H,20,22)(H,23,24)/t11-/m1/s1 D08RLR DRUGINKE OUZLOTRPGMFLPN-LLVKDONJSA-N D08RLR DRUGSMIL C#CC(CC(=O)O)NC(=O)CCC(=O)NC1=CC=C(C=C1)C(=N)N D08RLR HIGHSTAT Investigative D08RLS DRUG__ID D08RLS D08RLS DRUGTYPE Small molecular drug D08RLS DRUGINCH 1S/C15H12N2/c1-11-4-2-5-13(10-11)14-8-7-12-6-3-9-16-15(12)17-14/h2-10H,1H3 D08RLS DRUGINKE VOPUZVINSLDWHQ-UHFFFAOYSA-N D08RLS DRUGSMIL CC1=CC(=CC=C1)C2=NC3=C(C=CC=N3)C=C2 D08RLS HIGHSTAT Investigative D08RMK DRUG__ID D08RMK D08RMK DRUGTYPE Small molecular drug D08RMK DRUGINCH 1S/C14H14N2O/c1-10-2-4-11(5-3-10)12-6-8-13(9-7-12)16-14(15)17/h2-9H,1H3,(H3,15,16,17) D08RMK DRUGINKE VXTBCYRTEKXSFH-UHFFFAOYSA-N D08RMK DRUGSMIL CC1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)N D08RMK HIGHSTAT Investigative D08RNW DRUG__ID D08RNW D08RNW DRUGTYPE Small molecular drug D08RNW DRUGINCH 1S/C15H23NO2/c1-2-3-4-5-9-12-15(18,14(16)17)13-10-7-6-8-11-13/h6-8,10-11,18H,2-5,9,12H2,1H3,(H2,16,17) D08RNW DRUGINKE FXKCDILPUXRDAT-UHFFFAOYSA-N D08RNW DRUGSMIL CCCCCCCC(C1=CC=CC=C1)(C(=O)N)O D08RNW HIGHSTAT Investigative D08ROT DRUG__ID D08ROT D08ROT DRUGTYPE Small molecular drug D08ROT DRUGINCH 1S/C10H13NO/c1-2-10(11-8-12)9-6-4-3-5-7-9/h3-8,10H,2H2,1H3,(H,11,12)/t10-/m1/s1 D08ROT DRUGINKE UERJGKDKJBSKQN-SNVBAGLBSA-N D08ROT DRUGSMIL CCC(C1=CC=CC=C1)NC=O D08ROT HIGHSTAT Investigative D08RPH DRUG__ID D08RPH D08RPH DRUGTYPE Small molecular drug D08RPH DRUGINCH 1S/C21H30N2/c22-17-8-7-16-12-20-18-6-1-2-9-21(18,19(16)13-17)10-11-23(20)14-15-4-3-5-15/h7-8,13,15,18,20H,1-6,9-12,14,22H2/t18-,20+,21+/m0/s1 D08RPH DRUGINKE HXKMQQLYEGWJQB-CEWLAPEOSA-N D08RPH DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)N)CC5CCC5 D08RPH HIGHSTAT Investigative D08RPN DRUG__ID D08RPN D08RPN DRUGTYPE Small molecular drug D08RPN DRUGINCH 1S/C11H9BrN2O/c1-8-3-2-4-9(5-8)11(15)14-7-10(12)6-13-14/h2-7H,1H3 D08RPN DRUGINKE WACJMZOPBBWBAJ-UHFFFAOYSA-N D08RPN DRUGSMIL CC1=CC(=CC=C1)C(=O)N2C=C(C=N2)Br D08RPN HIGHSTAT Investigative D08RPW DRUG__ID D08RPW D08RPW DRUGTYPE Small molecular drug D08RPW DRUGINCH 1S/C15H22N2O/c18-15(17-14-9-5-2-6-10-14)16-12-11-13-7-3-1-4-8-13/h1,3-4,7-8,14H,2,5-6,9-12H2,(H2,16,17,18) D08RPW DRUGINKE YJAMPQZPTKVFIU-UHFFFAOYSA-N D08RPW DRUGSMIL C1CCC(CC1)NC(=O)NCCC2=CC=CC=C2 D08RPW HIGHSTAT Investigative D08RQW DRUG__ID D08RQW D08RQW DRUGTYPE Small molecular drug D08RQW DRUGINCH 1S/C20H18F6N4O/c21-19(22,23)17(6-7-17)10-14-12-27-16(29-14)11-18(31,20(24,25)26)13-2-4-15(5-3-13)30-9-1-8-28-30/h1-5,8-9,12,31H,6-7,10-11H2,(H,27,29)/t18-/m0/s1 D08RQW DRUGINKE UJINBEQCDMOAHM-SFHVURJKSA-N D08RQW DRUGSMIL C1CC1(CC2=CN=C(N2)CC(C3=CC=C(C=C3)N4C=CC=N4)(C(F)(F)F)O)C(F)(F)F D08RQW HIGHSTAT Investigative D08RSU DRUG__ID D08RSU D08RSU DRUGTYPE Small molecular drug D08RSU DRUGINCH 1S/C16H24N4O2/c1-3-9-19-14-12(15(21)20(10-4-2)16(19)22)17-13(18-14)11-7-5-6-8-11/h11H,3-10H2,1-2H3,(H,17,18)/i1T,2T,9T,10T D08RSU DRUGINKE FFBDFADSZUINTG-LEZITTIZSA-N D08RSU DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CCCC3 D08RSU HIGHSTAT Investigative D08RVB DRUG__ID D08RVB D08RVB DRUGTYPE Small molecular drug D08RVB DRUGINCH 1S/C8H13N5O2/c14-8(15)6-3-5(1-2-9-6)4-7-10-12-13-11-7/h5-6,9H,1-4H2,(H,14,15)(H,10,11,12,13)/t5-,6+/m0/s1 D08RVB DRUGINKE FAAVTENFCLADRE-NTSWFWBYSA-N D08RVB DRUGSMIL C1CNC(CC1CC2=NNN=N2)C(=O)O D08RVB HIGHSTAT Investigative D08RYB DRUG__ID D08RYB D08RYB DRUGTYPE Small molecular drug D08RYB DRUGINCH 1S/C16H12ClNSe/c1-11-2-4-12(5-3-11)15-10-18-19-16(15)13-6-8-14(17)9-7-13/h2-10H,1H3 D08RYB DRUGINKE SIYWUUCHURNUOK-UHFFFAOYSA-N D08RYB DRUGSMIL CC1=CC=C(C=C1)C2=C([Se]N=C2)C3=CC=C(C=C3)Cl D08RYB HIGHSTAT Investigative D08RZB DRUG__ID D08RZB D08RZB DRUGTYPE Small molecular drug D08RZB DRUGINCH 1S/C17H16ClN5OS/c1-9-5-4-6-12(18)15(9)23-16(24)13-8-19-17(25-13)22-14-7-10(2)20-11(3)21-14/h4-8H,1-3H3,(H,23,24)(H,19,20,21,22) D08RZB DRUGINKE WFRLFWGASBLYTC-UHFFFAOYSA-N D08RZB DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)C)C D08RZB HIGHSTAT Investigative D08SAG DRUG__ID D08SAG D08SAG DRUGTYPE Small molecular drug D08SAG DRUGINCH 1S/C23H16O6/c24-10-5-6-11-12(7-10)22-21-20-18(11)14(25)8-15(26)19(20)16(27)9-23(21,28)13-3-1-2-4-17(13)29-22/h1-8,21-22,24-26,28H,9H2/t21-,22-,23-/m0/s1 D08SAG DRUGINKE CJDAIJHZTKDLTJ-VABKMULXSA-N D08SAG DRUGSMIL C1C(=O)C2=C(C=C(C3=C2C4C1(C5=CC=CC=C5OC4C6=C3C=CC(=C6)O)O)O)O D08SAG HIGHSTAT Investigative D08SBS DRUG__ID D08SBS D08SBS DRUGTYPE Small molecular drug D08SBS DRUGINCH 1S/C7H13N3O4S/c8-7(9)10-1-2-15-4(6(13)14)3-5(11)12/h4H,1-3H2,(H,11,12)(H,13,14)(H4,8,9,10) D08SBS DRUGINKE VKVCLXDFOQQABP-UHFFFAOYSA-N D08SBS DRUGSMIL C(CSC(CC(=O)O)C(=O)O)N=C(N)N D08SBS HIGHSTAT Investigative D08SCF DRUG__ID D08SCF D08SCF DRUGTYPE Small molecular drug D08SCF DRUGINCH 1S/C23H41N5O3/c1-2-7-22(30)28-21(18-19-8-10-20(29)11-9-19)23(31)27-17-6-16-26-14-4-3-13-25-15-5-12-24/h8-11,21,25-26,29H,2-7,12-18,24H2,1H3,(H,27,31)(H,28,30)/t21-/m0/s1 D08SCF DRUGINKE DTWANULJDRVTFI-NRFANRHFSA-N D08SCF DRUGSMIL CCCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCCCNCCCCNCCCN D08SCF HIGHSTAT Investigative D08SCH DRUG__ID D08SCH D08SCH DRUGTYPE Small molecular drug D08SCH DRUGINCH 1S/C10H15NS/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3 D08SCH DRUGINKE OLEWMKVPSUCNLG-UHFFFAOYSA-N D08SCH DRUGSMIL CC(CC1=CC=C(C=C1)SC)N D08SCH HIGHSTAT Investigative D08SCK DRUG__ID D08SCK D08SCK DRUGTYPE Small molecular drug D08SCK DRUGINCH 1S/C30H34N4O4/c1-19-12-24(35)13-20(2)25(19)15-26(31)29(37)33-27-14-22-10-6-7-11-23(22)17-34(30(27)38)18-28(36)32-16-21-8-4-3-5-9-21/h3-13,26-27,35H,14-18,31H2,1-2H3,(H,32,36)(H,33,37)/t26-,27-/m0/s1 D08SCK DRUGINKE HAQFBGNRXYPSQF-SVBPBHIXSA-N D08SCK DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC2CC3=CC=CC=C3CN(C2=O)CC(=O)NCC4=CC=CC=C4)N)C)O D08SCK HIGHSTAT Investigative D08SEK DRUG__ID D08SEK D08SEK DRUGTYPE Small molecular drug D08SEK DRUGINCH 1S/C23H23ClN4O3/c1-5-17(23(29)31-4)21-22-27-26-13(2)28(22)19-11-10-16(30-3)12-18(19)20(25-21)14-6-8-15(24)9-7-14/h6-12,17,21H,5H2,1-4H3/t17-,21+/m1/s1 D08SEK DRUGINKE WGMDCNPABCIZCD-UTKZUKDTSA-N D08SEK DRUGSMIL CCC(C1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C)C(=O)OC D08SEK HIGHSTAT Investigative D08SGF DRUG__ID D08SGF D08SGF DRUGTYPE Small molecular drug D08SGF DRUGINCH 1S/C34H44N6O5/c1-22(37-30(41)21-36-32(43)24-14-8-5-9-15-24)31(42)38-28(19-25-20-35-27-17-11-10-16-26(25)27)33(44)39-29(34(45)40(2)3)18-23-12-6-4-7-13-23/h4,6-7,10-13,16-17,20,22,24,28-29,35H,5,8-9,14-15,18-19,21H2,1-3H3,(H,36,43)(H,37,41)(H,38,42)(H,39,44)/t22-,28+,29-/m0/s1 D08SGF DRUGINKE IBHXDZADSPABSD-GJDOKZOISA-N D08SGF DRUGSMIL CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)N(C)C)NC(=O)CNC(=O)C4CCCCC4 D08SGF HIGHSTAT Investigative D08SGV DRUG__ID D08SGV D08SGV DRUGTYPE Small molecular drug D08SGV DRUGINCH 1S/C14H18N2O3/c1-10(18)15-5-4-11-9-16-14-3-2-12(8-13(11)14)19-7-6-17/h2-3,8-9,16-17H,4-7H2,1H3,(H,15,18) D08SGV DRUGINKE CZPLTTWZQPLXMQ-UHFFFAOYSA-N D08SGV DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)OCCO D08SGV HIGHSTAT Investigative D08SIJ DRUG__ID D08SIJ D08SIJ DRUGTYPE Small molecular drug D08SIJ DRUGINCH 1S/C16H21F3O2/c1-2-3-4-5-12-21-14-9-6-13(7-10-14)8-11-15(20)16(17,18)19/h6-7,9-10H,2-5,8,11-12H2,1H3 D08SIJ DRUGINKE UOOMUFUVLSIOFF-UHFFFAOYSA-N D08SIJ DRUGSMIL CCCCCCOC1=CC=C(C=C1)CCC(=O)C(F)(F)F D08SIJ HIGHSTAT Investigative D08SJF DRUG__ID D08SJF D08SJF DRUGTYPE Small molecular drug D08SJF DRUGINCH 1S/C16H13N5/c1-11-7-8-14-15(20-21-17)13(10-18-16(14)19-11)9-12-5-3-2-4-6-12/h2-8,10H,9H2,1H3 D08SJF DRUGINKE GFTOIPQCHLKALF-UHFFFAOYSA-N D08SJF DRUGSMIL CC1=NC2=NC=C(C(=C2C=C1)N=[N+]=[N-])CC3=CC=CC=C3 D08SJF HIGHSTAT Investigative D08SKU DRUG__ID D08SKU D08SKU DRUGTYPE Small molecular drug D08SKU DRUGINCH 1S/C18H26O3/c1-2-3-4-5-6-7-8-9-10-11-13-16-17(21-16)14-12-15-18(19)20/h16-17H,2-8,12,14-15H2,1H3,(H,19,20) D08SKU DRUGINKE XLDNBXDVNANPCY-UHFFFAOYSA-N D08SKU DRUGSMIL CCCCCCCCC#CC#CC1C(O1)CCCC(=O)O D08SKU HIGHSTAT Investigative D08SLS DRUG__ID D08SLS D08SLS DRUGTYPE Small molecular drug D08SLS DRUGINCH 1S/C21H25FN6/c22-17-8-6-16(7-9-17)19(20-5-1-2-11-25-20)10-13-27-21(23)26-12-3-4-18-14-24-15-28-18/h1-2,5-9,11,14-15,19H,3-4,10,12-13H2,(H,24,28)(H3,23,26,27) D08SLS DRUGINKE KZZIVOLMJPSDEP-UHFFFAOYSA-N D08SLS DRUGSMIL C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC=C(C=C3)F D08SLS HIGHSTAT Investigative D08SLZ DRUG__ID D08SLZ D08SLZ DRUGTYPE Small molecular drug D08SLZ DRUGINCH 1S/C15H21Cl2N/c1-2-5-12(15-6-3-4-9-18-15)11-7-8-13(16)14(17)10-11/h7-8,10,12,15,18H,2-6,9H2,1H3 D08SLZ DRUGINKE USGRALLMTYXJMV-UHFFFAOYSA-N D08SLZ DRUGSMIL CCCC(C1CCCCN1)C2=CC(=C(C=C2)Cl)Cl D08SLZ HIGHSTAT Investigative D08SMK DRUG__ID D08SMK D08SMK DRUGTYPE Small molecular drug D08SMK DRUGINCH 1S/C17H18N2O2S/c1-13-6-8-15(9-7-13)22(20,21)19-12-14(10-11-18)16-4-2-3-5-17(16)19/h2-9,12H,10-11,18H2,1H3 D08SMK DRUGINKE XKKWGBDMWUAPLE-UHFFFAOYSA-N D08SMK DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C=C(C3=CC=CC=C32)CCN D08SMK HIGHSTAT Investigative D08SND DRUG__ID D08SND D08SND DRUGTYPE Small molecular drug D08SND DRUGINCH 1S/C27H31NO4S/c1-21-14-24(20-33(30,31)27-7-3-2-4-8-27)16-26(15-21)32-19-23-11-9-22(10-12-23)17-28-13-5-6-25(28)18-29/h2-4,7-12,14-16,25,29H,5-6,13,17-20H2,1H3/t25-/m1/s1 D08SND DRUGINKE NPUXORBZRBIOMQ-RUZDIDTESA-N D08SND DRUGSMIL CC1=CC(=CC(=C1)OCC2=CC=C(C=C2)CN3CCCC3CO)CS(=O)(=O)C4=CC=CC=C4 D08SND HIGHSTAT Investigative D08SOE DRUG__ID D08SOE D08SOE DRUGTYPE Small molecular drug D08SOE DRUGINCH 1S/C28H24ClN3OS/c29-23-9-6-20(7-10-23)26-16-25-27(34-26)28(33)32(18-30-25)24-11-8-21-14-19(4-5-22(21)15-24)17-31-12-2-1-3-13-31/h4-11,14-16,18H,1-3,12-13,17H2 D08SOE DRUGINKE FJPBPFUKHDZYIJ-UHFFFAOYSA-N D08SOE DRUGSMIL C1CCN(CC1)CC2=CC3=C(C=C2)C=C(C=C3)N4C=NC5=C(C4=O)SC(=C5)C6=CC=C(C=C6)Cl D08SOE HIGHSTAT Investigative D08SPJ DRUG__ID D08SPJ D08SPJ DRUGTYPE Small molecular drug D08SPJ DRUGINCH 1S/C13H13NO/c15-12-7-8-14-11(9-12)6-5-10-3-1-2-4-13(10)14/h1-4,7-8,11H,5-6,9H2 D08SPJ DRUGINKE LNTWPSKEEYNUKK-UHFFFAOYSA-N D08SPJ DRUGSMIL C1CC2=CC=CC=C2N3C1CC(=O)C=C3 D08SPJ HIGHSTAT Investigative D08SPP DRUG__ID D08SPP D08SPP DRUGCOMP Nagase ChemteX Corp D08SPP DRUGINCH 1S/C30H33N3O4/c1-20-2-4-22(5-3-20)19-36-28(34)25-12-10-23(11-13-25)24-14-16-27(17-15-24)37-29(35)26-8-6-21(7-9-26)18-33-30(31)32/h2-5,10-17,21,26H,6-9,18-19H2,1H3,(H4,31,32,33) D08SPP DRUGINKE QAXCRGCVWYRJOA-UHFFFAOYSA-N D08SPP DRUGSMIL CC1=CC=C(C=C1)COC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)OC(=O)C4CCC(CC4)CN=C(N)N D08SPP HIGHSTAT Investigative D08SRB DRUG__ID D08SRB D08SRB DRUGTYPE Small molecular drug D08SRB DRUGINCH 1S/C16H14N2O2/c19-16(20-14-4-2-1-3-5-14)13-8-6-12(7-9-13)15-17-10-11-18-15/h1-9H,10-11H2,(H,17,18) D08SRB DRUGINKE KBQKAAWDURESJQ-UHFFFAOYSA-N D08SRB DRUGSMIL C1CN=C(N1)C2=CC=C(C=C2)C(=O)OC3=CC=CC=C3 D08SRB HIGHSTAT Investigative D08SSG DRUG__ID D08SSG D08SSG DRUGTYPE Small molecular drug D08SSG DRUGINCH 1S/C12H10N2S/c1-9-12(14-10(2)15-9)6-5-11-4-3-7-13-8-11/h3-4,7-8H,1-2H3 D08SSG DRUGINKE JDFSJBMBMZRXML-UHFFFAOYSA-N D08SSG DRUGSMIL CC1=C(N=C(S1)C)C#CC2=CN=CC=C2 D08SSG HIGHSTAT Investigative D08SSS DRUG__ID D08SSS D08SSS DRUGTYPE Small molecular drug D08SSS DRUGINCH 1S/C12H19NS/c1-3-8-14-12-6-4-11(5-7-12)9-10(2)13/h4-7,10H,3,8-9,13H2,1-2H3/t10-/m0/s1 D08SSS DRUGINKE HIOIYGZUYPHUTC-JTQLQIEISA-N D08SSS DRUGSMIL CCCSC1=CC=C(C=C1)CC(C)N D08SSS HIGHSTAT Investigative D08STR DRUG__ID D08STR D08STR DRUGTYPE Small molecular drug D08STR DRUGINCH 1S/C9H12N2O4/c1-5-6(12)4-8(15-5)11-3-2-7(13)10-9(11)14/h2-3,5-6,8,12H,4H2,1H3,(H,10,13,14)/t5-,6+,8-/m1/s1 D08STR DRUGINKE FDCFKLBIAIKUKB-GKROBHDKSA-N D08STR DRUGSMIL CC1C(CC(O1)N2C=CC(=O)NC2=O)O D08STR HIGHSTAT Investigative D08STW DRUG__ID D08STW D08STW DRUGTYPE Small molecular drug D08STW DRUGINCH 1S/C29H37N5O5/c1-32(25(18-19-7-3-2-4-8-19)29(39)33-15-5-9-23(33)26(31)36)28(38)24-10-6-16-34(24)27(37)22(30)17-20-11-13-21(35)14-12-20/h2-4,7-8,11-14,22-25,35H,5-6,9-10,15-18,30H2,1H3,(H2,31,36)/t22?,23?,24?,25-/m0/s1 D08STW DRUGINKE JAKBYSTWCHUQOK-DGGBHQDZSA-N D08STW DRUGSMIL CN(C(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)N)C(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D08STW HIGHSTAT Investigative D08SUH DRUG__ID D08SUH D08SUH DRUGTYPE Small molecular drug D08SUH DRUGINCH 1S/C19H19NO4/c1-21-16-6-5-12(8-17(16)22-2)14-7-13-9-18(23-3)19(24-4)10-15(13)20-11-14/h5-11H,1-4H3 D08SUH DRUGINKE BWIYMDQJIKNCMK-UHFFFAOYSA-N D08SUH DRUGSMIL COC1=C(C=C(C=C1)C2=CN=C3C=C(C(=CC3=C2)OC)OC)OC D08SUH HIGHSTAT Investigative D08SWN DRUG__ID D08SWN D08SWN DRUGTYPE Small molecular drug D08SWN DRUGINCH 1S/C16H23NO2/c1-11-8-12(2)10-13(9-11)15(16(18)19-3)14-6-4-5-7-17-14/h8-10,14-15,17H,4-7H2,1-3H3/t14-,15-/m1/s1 D08SWN DRUGINKE OQNVWHLLYQJVEV-HUUCEWRRSA-N D08SWN DRUGSMIL CC1=CC(=CC(=C1)C(C2CCCCN2)C(=O)OC)C D08SWN HIGHSTAT Investigative D08SYN DRUG__ID D08SYN D08SYN DRUGTYPE Small molecular drug D08SYN DRUGINCH 1S/C15H12FN3O/c1-2-13-4-3-5-14(18-13)19-15(20)11-6-10(9-17)7-12(16)8-11/h3-8H,2H2,1H3,(H,18,19,20) D08SYN DRUGINKE LBPUNEZWEHBQQO-UHFFFAOYSA-N D08SYN DRUGSMIL CCC1=NC(=CC=C1)NC(=O)C2=CC(=CC(=C2)C#N)F D08SYN HIGHSTAT Investigative D08SYX DRUG__ID D08SYX D08SYX DRUGTYPE Small molecular drug D08SYX DRUGINCH 1S/C22H17N3O/c1-16-8-2-5-12-20(16)25-21(14-13-17-9-6-7-15-23-17)24-19-11-4-3-10-18(19)22(25)26/h2-15H,1H3/b14-13+ D08SYX DRUGINKE MYGZNGAHFWOCLI-BUHFOSPRSA-N D08SYX DRUGSMIL CC1=CC=CC=C1N2C(=NC3=CC=CC=C3C2=O)C=CC4=CC=CC=N4 D08SYX HIGHSTAT Investigative D08TAN DRUG__ID D08TAN D08TAN DRUGTYPE Small molecular drug D08TAN DRUGINCH 1S/C4H8N2O2/c5-3-1-2-6(8)4(3)7/h3,8H,1-2,5H2/t3-/m1/s1 D08TAN DRUGINKE HCKUBNLZMKAEIN-GSVOUGTGSA-N D08TAN DRUGSMIL C1CN(C(=O)C1N)O D08TAN HIGHSTAT Investigative D08TBF DRUG__ID D08TBF D08TBF DRUGTYPE Small molecular drug D08TBF DRUGINCH 1S/C21H27NO3/c1-4-21(23)22-12-6-8-17-15-20(25-3)11-10-18(17)13-16-7-5-9-19(14-16)24-2/h5,7,9-11,14-15H,4,6,8,12-13H2,1-3H3,(H,22,23) D08TBF DRUGINKE GJRIGACGWLYZAO-UHFFFAOYSA-N D08TBF DRUGSMIL CCC(=O)NCCCC1=C(C=CC(=C1)OC)CC2=CC(=CC=C2)OC D08TBF HIGHSTAT Investigative D08TBI DRUG__ID D08TBI D08TBI DRUGTYPE Small molecular drug D08TBI DRUGINCH 1S/C18H17NO2S/c20-18(21-13-7-1-2-8-13)19-14-9-3-5-11-16(14)22-17-12-6-4-10-15(17)19/h3-6,9-13H,1-2,7-8H2 D08TBI DRUGINKE NFZAMIJBLBLKQJ-UHFFFAOYSA-N D08TBI DRUGSMIL C1CCC(C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D08TBI HIGHSTAT Investigative D08TBU DRUG__ID D08TBU D08TBU DRUGTYPE Small molecular drug D08TBU DRUGINCH 1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2 D08TBU DRUGINKE ZMISODWVFHHWNR-UHFFFAOYSA-N D08TBU DRUGSMIL C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O D08TBU HIGHSTAT Investigative D08TCV DRUG__ID D08TCV D08TCV DRUGTYPE Small molecular drug D08TCV DRUGINCH 1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1 D08TCV DRUGINKE CZMRCDWAGMRECN-UGDNZRGBSA-N D08TCV DRUGSMIL C(C1C(C(C(C(O1)OC2(C(C(C(O2)CO)O)O)CO)O)O)O)O D08TCV HIGHSTAT Investigative D08TCW DRUG__ID D08TCW D08TCW DRUGTYPE Small molecular drug D08TCW DRUGINCH 1S/C142H230N36O44S/c1-18-74(11)111(172-129(211)97(65-81-38-42-83(185)43-39-81)168-136(218)113(77(14)181)174-131(213)100(69-180)170-130(212)99(68-179)169-124(206)92(52-60-223-17)162-132(214)101-33-26-57-176(101)138(220)98(66-109(195)196)154-79(16)183)135(217)163-90(46-50-107(191)192)121(203)159-88(44-48-105(187)188)122(204)164-93(61-70(3)4)116(198)152-67-104(186)155-84(29-20-22-53-143)117(199)156-86(31-24-55-150-141(146)147)118(200)160-91(47-51-108(193)194)125(207)171-110(73(9)10)134(216)175-114(78(15)182)137(219)173-112(75(12)19-2)140(222)178-59-28-35-103(178)139(221)177-58-27-34-102(177)133(215)161-85(30-21-23-54-144)120(202)167-96(64-80-36-40-82(184)41-37-80)128(210)157-87(32-25-56-151-142(148)149)119(201)158-89(45-49-106(189)190)123(205)165-95(63-72(7)8)127(209)166-94(62-71(5)6)126(208)153-76(13)115(145)197/h36-43,70-78,84-103,110-114,179-182,184-185H,18-35,44-69,143-144H2,1-17H3,(H2,145,197)(H,152,198)(H,153,208)(H,154,183)(H,155,186)(H,156,199)(H,157,210)(H,158,201)(H,159,203)(H,160,200)(H,161,215)(H,162,214)(H,163,217)(H,164,204)(H,165,205)(H,166,209)(H,167,202)(H,168,218)(H,169,206)(H,170,212)(H,171,207)(H,172,211)(H,173,219)(H,174,213)(H,175,216)(H,187,188)(H,189,190)(H,191,192)(H,193,194)(H,195,196)(H4,146,147,150)(H4,148,149,151)/t74-,75-,76-,77+,78+,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,110-,111-,112-,113-,114-/m0/s1 D08TCW DRUGINKE ZXJCOYBPXOBJMU-HSQGJUDPSA-N D08TCW DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)CC)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCSC)NC(=O)C5CCCN5C(=O)C(CC(=O)O)NC(=O)C D08TCW HIGHSTAT Investigative D08TCX DRUG__ID D08TCX D08TCX DRUGTYPE Small molecular drug D08TCX DRUGINCH 1S/C19H24N2/c1-2-8-17(9-3-1)16-18-10-4-5-11-19(18)20-12-15-21-13-6-7-14-21/h1-5,8-11,20H,6-7,12-16H2 D08TCX DRUGINKE KMSBBZPJDRRRGH-UHFFFAOYSA-N D08TCX DRUGSMIL C1CCN(C1)CCNC2=CC=CC=C2CC3=CC=CC=C3 D08TCX HIGHSTAT Investigative D08TDE DRUG__ID D08TDE D08TDE DRUGTYPE Small molecular drug D08TDE DRUGINCH 1S/C9H16O4S/c10-8(11)5-4-7(9(12)13)3-1-2-6-14/h7,14H,1-6H2,(H,10,11)(H,12,13) D08TDE DRUGINKE QFKHEJQVTSTWPJ-UHFFFAOYSA-N D08TDE DRUGSMIL C(CCS)CC(CCC(=O)O)C(=O)O D08TDE HIGHSTAT Investigative D08TFH DRUG__ID D08TFH D08TFH DRUGTYPE Small molecular drug D08TFH DRUGINCH 1S/C22H19NO2/c24-22(23-20-13-17-9-4-5-10-18(17)14-20)25-21-12-6-11-19(15-21)16-7-2-1-3-8-16/h1-12,15,20H,13-14H2,(H,23,24) D08TFH DRUGINKE UEEYQEMKIXZIGW-UHFFFAOYSA-N D08TFH DRUGSMIL C1C(CC2=CC=CC=C21)NC(=O)OC3=CC=CC(=C3)C4=CC=CC=C4 D08TFH HIGHSTAT Investigative D08TFN DRUG__ID D08TFN D08TFN DRUGTYPE Small molecular drug D08TFN DRUGINCH 1S/C11H15NOS/c1-13-10-4-2-9(3-5-10)11-8-12-6-7-14-11/h2-5,11-12H,6-8H2,1H3 D08TFN DRUGINKE YAPWTYUHWOWUHY-UHFFFAOYSA-N D08TFN DRUGSMIL COC1=CC=C(C=C1)C2CNCCS2 D08TFN HIGHSTAT Investigative D08TFY DRUG__ID D08TFY D08TFY DRUGTYPE Small molecular drug D08TFY DRUGINCH 1S/C24H31NO/c26-24(22-14-8-3-9-15-22)16-18-25(19-17-24)23(20-10-4-1-5-11-20)21-12-6-2-7-13-21/h1-2,4-7,10-13,22-23,26H,3,8-9,14-19H2 D08TFY DRUGINKE RJWCOGYISGJIPN-UHFFFAOYSA-N D08TFY DRUGSMIL C1CCC(CC1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D08TFY HIGHSTAT Investigative D08TGC DRUG__ID D08TGC D08TGC DRUGTYPE Small molecular drug D08TGC DRUGINCH 1S/C12H16N5O8P/c13-12-15-9-6(10(19)16-12)14-3-17(9)11-8-7(4(1-18)23-11)24-5(25-8)2-26(20,21)22/h3-5,7-8,11,18H,1-2H2,(H2,20,21,22)(H3,13,15,16,19)/t4-,5-,7-,8-,11-/m1/s1 D08TGC DRUGINKE HYAPEMYRVFIHDJ-QWEIRQIHSA-N D08TGC DRUGSMIL C1=NC2=C(N1C3C4C(C(O3)CO)OC(O4)CP(=O)(O)O)N=C(NC2=O)N D08TGC HIGHSTAT Investigative D08TGQ DRUG__ID D08TGQ D08TGQ DRUGTYPE Small molecular drug D08TGQ DRUGINCH 1S/C15H21N5O5S/c16-8(15(23)24)2-4-26-5-9-10(21)11(22)14(25-9)20-3-1-7-12(17)18-6-19-13(7)20/h1,3,6,8-11,14,21-22H,2,4-5,16H2,(H,23,24)(H2,17,18,19)/t8-,9+,10+,11+,14+/m0/s1 D08TGQ DRUGINKE VIRPSVXGKGPXDV-NDXSAKOMSA-N D08TGQ DRUGSMIL C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CSCCC(C(=O)O)N)O)O D08TGQ HIGHSTAT Investigative D08TGY DRUG__ID D08TGY D08TGY DRUGTYPE Small molecular drug D08TGY DRUGINCH 1S/C5H12AsNO2S/c1-6(2)10-3-4(7)5(8)9/h4H,3,7H2,1-2H3,(H,8,9)/t4-/m1/s1 D08TGY DRUGINKE UKLXSOVDMSQHMM-SCSAIBSYSA-N D08TGY DRUGSMIL C[As](C)SCC(C(=O)O)N D08TGY HIGHSTAT Investigative D08TIJ DRUG__ID D08TIJ D08TIJ DRUGTYPE Small molecular drug D08TIJ DRUGINCH 1S/C16H24N2O3/c1-12-9-13(2)11-14(10-12)17-15(19)7-5-3-4-6-8-16(20)18-21/h9-11,21H,3-8H2,1-2H3,(H,17,19)(H,18,20) D08TIJ DRUGINKE PWVUDHKPAQOCJC-UHFFFAOYSA-N D08TIJ DRUGSMIL CC1=CC(=CC(=C1)NC(=O)CCCCCCC(=O)NO)C D08TIJ HIGHSTAT Investigative D08TJY DRUG__ID D08TJY D08TJY DRUGTYPE Small molecular drug D08TJY DRUGINCH 1S/C28H32N2O/c31-27(22-10-4-1-5-11-22)21-29-18-19-30-20-25(29)16-17-26(30)28(23-12-6-2-7-13-23)24-14-8-3-9-15-24/h1-15,25-28,31H,16-21H2/t25-,26-,27-/m0/s1 D08TJY DRUGINKE OWLHXXQEBCXCEF-QKDODKLFSA-N D08TJY DRUGSMIL C1CC(N2CCN(C1C2)CC(C3=CC=CC=C3)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D08TJY HIGHSTAT Investigative D08TKB DRUG__ID D08TKB D08TKB DRUGTYPE Small molecular drug D08TKB DRUGINCH 1S/C16H14N2O/c1-2-7-15(8-3-1)19-16-9-5-4-6-14(16)12-18-11-10-17-13-18/h1-11,13H,12H2 D08TKB DRUGINKE DFVDKHRBBOONAK-UHFFFAOYSA-N D08TKB DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC=C2CN3C=CN=C3 D08TKB HIGHSTAT Investigative D08TME DRUG__ID D08TME D08TME DRUGTYPE Small molecular drug D08TME DRUGINCH 1S/C16H10N2O4S/c19-17(20)13-5-1-11(2-6-13)15-9-10-16(23-15)12-3-7-14(8-4-12)18(21)22/h1-10H D08TME DRUGINKE FBNOZEYGTWFASC-UHFFFAOYSA-N D08TME DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC=C(C=C3)[N+](=O)[O-])[N+](=O)[O-] D08TME HIGHSTAT Investigative D08TMM DRUG__ID D08TMM D08TMM DRUGTYPE Small molecular drug D08TMM DRUGINCH 1S/C32H38N4O4S/c1-35-20-22-36(23-21-35)32(38)34-30(25-27-13-7-3-8-14-27)31(37)33-28(18-17-26-11-5-2-6-12-26)19-24-41(39,40)29-15-9-4-10-16-29/h2-16,19,24,28,30H,17-18,20-23,25H2,1H3,(H,33,37)(H,34,38)/b24-19+/t28-,30-/m0/s1 D08TMM DRUGINKE RHJLQMVZXQKJKB-FPHSVDBKSA-N D08TMM DRUGSMIL CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=CS(=O)(=O)C4=CC=CC=C4 D08TMM HIGHSTAT Investigative D08TNQ DRUG__ID D08TNQ D08TNQ DRUGTYPE Small molecular drug D08TNQ DRUGINCH 1S/C18H20N2O4/c19-16(18(22)23)10-11-17(21)20-14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16H,10-12,19H2,(H,20,21)(H,22,23)/t16-/m0/s1 D08TNQ DRUGINKE BYSBXIPCDJNEBG-INIZCTEOSA-N D08TNQ DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D08TNQ HIGHSTAT Investigative D08TQA DRUG__ID D08TQA D08TQA DRUGTYPE Small molecular drug D08TQA DRUGINCH 1S/C7H15NO5/c8-3-1-7(13,2-9)6(12)5(11)4(3)10/h3-6,9-13H,1-2,8H2/t3-,4-,5+,6-,7-/m0/s1 D08TQA DRUGINKE VDLOJRUTNRJDJO-ZYNSJIGGSA-N D08TQA DRUGSMIL C1C(C(C(C(C1(CO)O)O)O)O)N D08TQA HIGHSTAT Investigative D08TRD DRUG__ID D08TRD D08TRD DRUGTYPE Small molecular drug D08TRD DRUGINCH 1S/C20H33N2O/c1-22(2)15-13-21(14-16-22)17-20(23,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3,5-6,9-10,19,23H,4,7-8,11-17H2,1-2H3/q+1 D08TRD DRUGINKE ZRYHPQCHHOKSMD-UHFFFAOYSA-N D08TRD DRUGSMIL C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C D08TRD HIGHSTAT Investigative D08TSA DRUG__ID D08TSA D08TSA DRUGTYPE Small molecular drug D08TSA DRUGINCH 1S/C20H12ClN5O2/c21-13-8-9-15-14(11-13)18-23-17(16-7-4-10-28-16)25-26(18)20(22-15)24-19(27)12-5-2-1-3-6-12/h1-11H,(H,22,24,27) D08TSA DRUGINKE XIEBLXLGWFCYEP-UHFFFAOYSA-N D08TSA DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NC3=C(C=C(C=C3)Cl)C4=NC(=NN42)C5=CC=CO5 D08TSA HIGHSTAT Investigative D08TSE DRUG__ID D08TSE D08TSE DRUGTYPE Small molecular drug D08TSE DRUGINCH 1S/C24H33NO5Si/c1-14(26)29-23-20(30-31(5,6)24(2,3)4)9-15-7-8-25-12-16-10-18-19(28-13-27-18)11-17(16)21(23)22(15)25/h9-11,20-23H,7-8,12-13H2,1-6H3/t20-,21-,22+,23+/m0/s1 D08TSE DRUGINKE IQOBLYMQXROOIM-MYDTUXCISA-N D08TSE DRUGSMIL CC(=O)OC1C(C=C2CCN3C2C1C4=CC5=C(C=C4C3)OCO5)O[Si](C)(C)C(C)(C)C D08TSE HIGHSTAT Investigative D08TSK DRUG__ID D08TSK D08TSK DRUGTYPE Small molecular drug D08TSK DRUGINCH 1S/C33H52N6O4/c1-25-35-20-22-39(25)21-8-6-11-27-13-15-28(16-14-27)23-31(41)37-30(24-40)33(43)38-29(12-5-7-18-34)32(42)36-19-17-26-9-3-2-4-10-26/h13-16,20,22,26,29-30,40H,2-12,17-19,21,23-24,34H2,1H3,(H,36,42)(H,37,41)(H,38,43)/t29-,30-/m0/s1 D08TSK DRUGINKE WHLPIOSHBKQGHA-KYJUHHDHSA-N D08TSK DRUGSMIL CC1=NC=CN1CCCCC2=CC=C(C=C2)CC(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NCCC3CCCCC3 D08TSK HIGHSTAT Investigative D08TVG DRUG__ID D08TVG D08TVG DRUGTYPE Small molecular drug D08TVG DRUGINCH 1S/C12H11F2N3S2/c13-9-2-1-3-10(14)8(9)4-5-15-11(18)17-12-16-6-7-19-12/h1-3,6-7H,4-5H2,(H2,15,16,17,18) D08TVG DRUGINKE BLZZAJBLYALRNA-UHFFFAOYSA-N D08TVG DRUGSMIL C1=CC(=C(C(=C1)F)CCNC(=S)NC2=NC=CS2)F D08TVG HIGHSTAT Investigative D08TVU DRUG__ID D08TVU D08TVU DRUGTYPE Small molecular drug D08TVU DRUGINCH 1S/C24H24ClF3N6/c25-19-1-2-20(24(26,27)28)18(11-19)15-34-10-7-31-23-21(34)12-17(14-32-23)16-3-4-30-22(13-16)33-8-5-29-6-9-33/h1-4,11-14,29H,5-10,15H2,(H,31,32) D08TVU DRUGINKE AHZCYZMNFBGXAC-UHFFFAOYSA-N D08TVU DRUGSMIL C1CN(CCN1)C2=NC=CC(=C2)C3=CC4=C(NCCN4CC5=C(C=CC(=C5)Cl)C(F)(F)F)N=C3 D08TVU HIGHSTAT Investigative D08TWI DRUG__ID D08TWI D08TWI DRUGTYPE Small molecular drug D08TWI DRUGINCH 1S/C19H36N2O3/c1-2-3-4-13-16-20-19(24)21-17-14-11-9-7-5-6-8-10-12-15-18(22)23/h7,9H,2-6,8,10-17H2,1H3,(H,22,23)(H2,20,21,24)/b9-7- D08TWI DRUGINKE CQPDPYBIHJYCBO-CLFYSBASSA-N D08TWI DRUGSMIL CCCCCCNC(=O)NCCCC=CCCCCCCC(=O)O D08TWI HIGHSTAT Investigative D08TWJ DRUG__ID D08TWJ D08TWJ DRUGTYPE Small molecular drug D08TWJ DRUGINCH 1S/C21H38N6O5/c1-12(2)9-16(25-14(5)29)19(31)27-17(10-13(3)4)20(32)26-15(18(30)11-28)7-6-8-24-21(22)23/h11-13,15-17H,6-10H2,1-5H3,(H,25,29)(H,26,32)(H,27,31)(H4,22,23,24)/t15-,16-,17-/m0/s1 D08TWJ DRUGINKE SDHUBIMNNXCDCV-ULQDDVLXSA-N D08TWJ DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)C=O)NC(=O)C D08TWJ HIGHSTAT Investigative D08TWT DRUG__ID D08TWT D08TWT DRUGTYPE Small molecular drug D08TWT DRUGINCH 1S/C21H34O5/c1-2-3-7-10-16(23)12-13-18-17(11-8-5-4-6-9-14-22)19-15-20(18)26-21(24)25-19/h5,8,12-13,16-20,22-23H,2-4,6-7,9-11,14-15H2,1H3/b8-5-,13-12+/t16-,17+,18+,19-,20-/m0/s1 D08TWT DRUGINKE PTIUXNGGNGQHQK-KTEVXADTSA-N D08TWT DRUGSMIL CCCCCC(C=CC1C2CC(C1CC=CCCCCO)OC(=O)O2)O D08TWT HIGHSTAT Investigative D08TXL DRUG__ID D08TXL D08TXL DRUGTYPE Small molecular drug D08TXL DRUGINCH 1S/C22H30N2O2/c1-21(2)20(22(21,3)4)19(25)17-15-24(18-8-6-5-7-16(17)18)10-9-23-11-13-26-14-12-23/h5-8,15,20H,9-14H2,1-4H3 D08TXL DRUGINKE ZCFHOMLAFTWDFM-UHFFFAOYSA-N D08TXL DRUGSMIL CC1(C(C1(C)C)C(=O)C2=CN(C3=CC=CC=C32)CCN4CCOCC4)C D08TXL HIGHSTAT Investigative D08TZA DRUG__ID D08TZA D08TZA DRUGTYPE Small molecular drug D08TZA DRUGINCH 1S/C21H19NO3/c1-14-6-8-15(9-7-14)12-19(21(24)25)22-20(23)18-11-10-16-4-2-3-5-17(16)13-18/h2-11,13,19H,12H2,1H3,(H,22,23)(H,24,25)/t19-/m1/s1 D08TZA DRUGINKE AYMZFPGSRYDLJL-LJQANCHMSA-N D08TZA DRUGSMIL CC1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=CC3=CC=CC=C3C=C2 D08TZA HIGHSTAT Investigative D08UDC DRUG__ID D08UDC D08UDC DRUGTYPE Small molecular drug D08UDC DRUGINCH 1S/C8H16NO5P/c1-2-3-6(5-15(12,13)14)4-7(9)8(10)11/h4,7H,2-3,5,9H2,1H3,(H,10,11)(H2,12,13,14) D08UDC DRUGINKE ZEFQYTSQDVUMEU-UHFFFAOYSA-N D08UDC DRUGSMIL CCCC(=CC(C(=O)O)N)CP(=O)(O)O D08UDC HIGHSTAT Investigative D08UDY DRUG__ID D08UDY D08UDY DRUGTYPE Small molecular drug D08UDY DRUGINCH 1S/C10H12N2/c1-2-6-12-10(3-1)9-4-7-11-8-5-9/h1-4,6,11H,5,7-8H2 D08UDY DRUGINKE IVRPDZRVHKIBBG-UHFFFAOYSA-N D08UDY DRUGSMIL C1CNCC=C1C2=CC=CC=N2 D08UDY HIGHSTAT Investigative D08UET DRUG__ID D08UET D08UET DRUGTYPE Small molecular drug D08UET DRUGINCH 1S/C27H33N4/c1-4-31(3,5-2)17-9-16-30-26-19-22(29)13-15-24(26)23-14-12-21(28)18-25(23)27(30)20-10-7-6-8-11-20/h6-8,10-15,18-19,29H,4-5,9,16-17,28H2,1-3H3/q+1/p+1 D08UET DRUGINKE ZDWVWKDAWBGPDN-UHFFFAOYSA-O D08UET DRUGSMIL CC[N+](C)(CC)CCC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N D08UET HIGHSTAT Investigative D08UEU DRUG__ID D08UEU D08UEU DRUGTYPE Small molecular drug D08UEU DRUGINCH 1S/C9H10N2O4/c1-4(12)11-8-6(10)2-5(9(14)15)3-7(8)13/h2-3,13H,10H2,1H3,(H,11,12)(H,14,15) D08UEU DRUGINKE CALDTVBHJMBRTM-UHFFFAOYSA-N D08UEU DRUGSMIL CC(=O)NC1=C(C=C(C=C1O)C(=O)O)N D08UEU HIGHSTAT Investigative D08UHS DRUG__ID D08UHS D08UHS DRUGTYPE Small molecular drug D08UHS DRUGINCH 1S/C12H16N6S2/c1-7(15-17-11(13)19)9-3-5-10(6-4-9)8(2)16-18-12(14)20/h3-6H,1-2H3,(H3,13,17,19)(H3,14,18,20)/b15-7-,16-8- D08UHS DRUGINKE IFFLYNGBOLZAGJ-DUGOVBPYSA-N D08UHS DRUGSMIL CC(=NNC(=S)N)C1=CC=C(C=C1)C(=NNC(=S)N)C D08UHS HIGHSTAT Investigative D08UIO DRUG__ID D08UIO D08UIO DRUGTYPE Small molecular drug D08UIO DRUGINCH 1S/C21H24N2O2S/c1-2-6-14-23(13-5-1)15-16-24-17-9-11-18(12-10-17)25-21-22-19-7-3-4-8-20(19)26-21/h3-4,7-12H,1-2,5-6,13-16H2 D08UIO DRUGINKE JDZUDVCYJPNUKO-UHFFFAOYSA-N D08UIO DRUGSMIL C1CCCN(CC1)CCOC2=CC=C(C=C2)OC3=NC4=CC=CC=C4S3 D08UIO HIGHSTAT Investigative D08UKF DRUG__ID D08UKF D08UKF DRUGTYPE Small molecular drug D08UKF DRUGINCH 1S/C32H55NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-32(34)33-25-24-29-26-30(35-2)28-31(27-29)36-3/h11-12,26-28H,4-10,13-25H2,1-3H3,(H,33,34)/b12-11- D08UKF DRUGINKE WGUQNXILGCVNIV-QXMHVHEDSA-N D08UKF DRUGSMIL CCCCCCCCC=CCCCCCCCCCCCC(=O)NCCC1=CC(=CC(=C1)OC)OC D08UKF HIGHSTAT Investigative D08UML DRUG__ID D08UML D08UML DRUGTYPE Small molecular drug D08UML DRUGINCH 1S/C5H11N3S/c1-3-4(2)7-8-5(6)9/h3H2,1-2H3,(H3,6,8,9)/b7-4- D08UML DRUGINKE NCQXVINEPVAIDB-DAXSKMNVSA-N D08UML DRUGSMIL CCC(=NNC(=S)N)C D08UML HIGHSTAT Investigative D08UOB DRUG__ID D08UOB D08UOB DRUGTYPE Small molecular drug D08UOB DRUGINCH 1S/C14H4F6O2/c15-5-1-7(11(19)9(17)3-5)13(21)14(22)8-2-6(16)4-10(18)12(8)20/h1-4H D08UOB DRUGINKE KLUCLGJNULKHIS-UHFFFAOYSA-N D08UOB DRUGSMIL C1=C(C=C(C(=C1C(=O)C(=O)C2=C(C(=CC(=C2)F)F)F)F)F)F D08UOB HIGHSTAT Investigative D08UOW DRUG__ID D08UOW D08UOW DRUGTYPE Small molecular drug D08UOW DRUGINCH 1S/C19H15N3O3/c1-22-15(12-3-5-14(24-2)6-4-12)11-16-17(19(22)23)18(21-25-16)13-7-9-20-10-8-13/h3-11H,1-2H3 D08UOW DRUGINKE PDWYBOZNEVALOV-UHFFFAOYSA-N D08UOW DRUGSMIL CN1C(=CC2=C(C1=O)C(=NO2)C3=CC=NC=C3)C4=CC=C(C=C4)OC D08UOW HIGHSTAT Investigative D08UOX DRUG__ID D08UOX D08UOX DRUGTYPE Small molecular drug D08UOX DRUGINCH 1S/C17H24O2/c1-3-5-6-7-8-9-10-14-17(19)15-12-11-13-16(18)4-2/h4,10,14,16-19H,2-3,5-9H2,1H3/b14-10-/t16-,17+/m1/s1 D08UOX DRUGINKE QWCNQXNAFCBLLV-YWALDVPYSA-N D08UOX DRUGSMIL CCCCCCCC=CC(C#CC#CC(C=C)O)O D08UOX HIGHSTAT Investigative D08UPA DRUG__ID D08UPA D08UPA DRUGTYPE Small molecular drug D08UPA DRUGINCH 1S/C9H16O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3/b7-5+ D08UPA DRUGINKE JVJFIQYAHPMBBX-FNORWQNLSA-N D08UPA DRUGSMIL CCCCCC(C=CC=O)O D08UPA HIGHSTAT Investigative D08UQH DRUG__ID D08UQH D08UQH DRUGTYPE Small molecular drug D08UQH DRUGINCH 1S/C11H9N3O3/c15-11(7-13-6-5-12-8-13)9-1-3-10(4-2-9)14(16)17/h1-6,8H,7H2 D08UQH DRUGINKE SBPGWXSTCFNGPY-UHFFFAOYSA-N D08UQH DRUGSMIL C1=CC(=CC=C1C(=O)CN2C=CN=C2)[N+](=O)[O-] D08UQH HIGHSTAT Investigative D08UQU DRUG__ID D08UQU D08UQU DRUGTYPE Small molecular drug D08UQU DRUGINCH 1S/C18H19NO2/c1-19-7-6-12-8-13(21-2)10-14-17(12)15(19)9-11-4-3-5-16(20)18(11)14/h3-5,8,10,15,20H,6-7,9H2,1-2H3/t15-/m1/s1 D08UQU DRUGINKE UGNGRDRWDHJJJI-OAHLLOKOSA-N D08UQU DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=CC=C4)O D08UQU HIGHSTAT Investigative D08URT DRUG__ID D08URT D08URT DRUGTYPE Small molecular drug D08URT DRUGINCH 1S/C27H46O2/c1-17(2)25(29)11-6-18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-25,28-29H,6,8-16H2,1-5H3/t18-,20+,21+,22-,23+,24+,25+,26+,27-/m1/s1 D08URT DRUGINKE IOWMKBFJCNLRTC-XWXSNNQWSA-N D08URT DRUGSMIL CC(C)C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O D08URT HIGHSTAT Investigative D08URY DRUG__ID D08URY D08URY DRUGTYPE Small molecular drug D08URY DRUGINCH 1S/C10H13NO2/c1-10(11,9(12)13)7-8-5-3-2-4-6-8/h2-6H,7,11H2,1H3,(H,12,13) D08URY DRUGINKE HYOWVAAEQCNGLE-UHFFFAOYSA-N D08URY DRUGSMIL CC(CC1=CC=CC=C1)(C(=O)O)N D08URY HIGHSTAT Investigative D08USC DRUG__ID D08USC D08USC DRUGTYPE Small molecular drug D08USC DRUGINCH 1S/C15H10Br2N2/c16-11-2-1-3-13(8-11)19-15-14-9-12(17)5-4-10(14)6-7-18-15/h1-9H,(H,18,19) D08USC DRUGINKE FGMDNVCIUONADU-UHFFFAOYSA-N D08USC DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=CC3=C2C=C(C=C3)Br D08USC HIGHSTAT Investigative D08USK DRUG__ID D08USK D08USK DRUGTYPE Small molecular drug D08USK DRUGINCH 1S/C21H18N2O2/c1-14(24)16-8-5-9-17(12-16)18-10-11-19(22)20(13-18)23-21(25)15-6-3-2-4-7-15/h2-13H,22H2,1H3,(H,23,25) D08USK DRUGINKE CJDOOJYNFYUEAC-UHFFFAOYSA-N D08USK DRUGSMIL CC(=O)C1=CC=CC(=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D08USK HIGHSTAT Investigative D08UST DRUG__ID D08UST D08UST DRUGTYPE Small molecular drug D08UST DRUGINCH 1S/C23H39NO2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(2,3)21(25)22-24-19-20-26-22/h11-12,19-20H,4-10,13-18H2,1-3H3/b12-11- D08UST DRUGINKE UIQYHSVDCXHKSQ-QXMHVHEDSA-N D08UST DRUGSMIL CCCCCCCCC=CCCCCCCC(C)(C)C(=O)C1=NC=CO1 D08UST HIGHSTAT Investigative D08USX DRUG__ID D08USX D08USX DRUGTYPE Small molecular drug D08USX DRUGINCH 1S/C22H22N2O/c25-22(20-13-7-15-23-17-20)24-16-8-14-21(18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-7,9-13,15,17,21H,8,14,16H2,(H,24,25) D08USX DRUGINKE OIJGKBCGOHTERP-UHFFFAOYSA-N D08USX DRUGSMIL C1=CC=C(C=C1)C(CCCNC(=O)C2=CN=CC=C2)C3=CC=CC=C3 D08USX HIGHSTAT Investigative D08UVX DRUG__ID D08UVX D08UVX DRUGTYPE Small molecular drug D08UVX DRUGINCH 1S/C17H15N5O/c18-16(23)13-8-4-5-9-14(13)21-15-10-11-19-17(22-15)20-12-6-2-1-3-7-12/h1-11H,(H2,18,23)(H2,19,20,21,22) D08UVX DRUGINKE TVKTVNQGZQPCAT-UHFFFAOYSA-N D08UVX DRUGSMIL C1=CC=C(C=C1)NC2=NC=CC(=N2)NC3=CC=CC=C3C(=O)N D08UVX HIGHSTAT Investigative D08UWE DRUG__ID D08UWE D08UWE DRUGTYPE Small molecular drug D08UWE DRUGINCH 1S/C5H10N2O/c1-3-4(2)8-5(6)7-3/h3-4H,1-2H3,(H2,6,7)/t3-,4+/m0/s1 D08UWE DRUGINKE CBBZZWUQMBKNEY-IUYQGCFVSA-N D08UWE DRUGSMIL CC1C(OC(=N1)N)C D08UWE HIGHSTAT Investigative D08UWI DRUG__ID D08UWI D08UWI DRUGTYPE Small molecular drug D08UWI DRUGINCH 1S/C15H15NO/c1-15(2,13-9-6-10-16-11-13)14(17)12-7-4-3-5-8-12/h3-11H,1-2H3 D08UWI DRUGINKE GWWVZTFGCNLAOV-UHFFFAOYSA-N D08UWI DRUGSMIL CC(C)(C1=CN=CC=C1)C(=O)C2=CC=CC=C2 D08UWI HIGHSTAT Investigative D08UWO DRUG__ID D08UWO D08UWO DRUGTYPE Small molecular drug D08UWO DRUGINCH 1S/C26H38N6O3/c27-22(33)21(12-16-5-2-1-3-6-16)31-23(34)20(7-4-8-30-25(28)29)32-24(35)26-13-17-9-18(14-26)11-19(10-17)15-26/h1-3,5-6,17-21H,4,7-15H2,(H2,27,33)(H,31,34)(H,32,35)(H4,28,29,30)/t17?,18?,19?,20-,21-,26?/m0/s1 D08UWO DRUGINKE UMKHUSRDQFQHAK-RNJMTYCLSA-N D08UWO DRUGSMIL C1C2CC3CC1CC(C2)(C3)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=CC=C4)C(=O)N D08UWO HIGHSTAT Investigative D08UWZ DRUG__ID D08UWZ D08UWZ DRUGTYPE Small molecular drug D08UWZ DRUGINCH 1S/C22H21ClN2O6/c1-14-19(24-21(31-14)16-6-8-17(23)9-7-16)13-30-18-5-3-4-15(10-18)11-25(12-20(26)27)22(28)29-2/h3-10H,11-13H2,1-2H3,(H,26,27) D08UWZ DRUGINKE UJIBXDMNCMEJAY-UHFFFAOYSA-N D08UWZ DRUGSMIL CC1=C(N=C(O1)C2=CC=C(C=C2)Cl)COC3=CC=CC(=C3)CN(CC(=O)O)C(=O)OC D08UWZ HIGHSTAT Investigative D08UXT DRUG__ID D08UXT D08UXT DRUGTYPE Small molecular drug D08UXT DRUGINCH 1S/C14H19NO3/c1-3-4-11-18-13-8-5-12(6-9-13)7-10-14(16)15(2)17/h5-10,17H,3-4,11H2,1-2H3/b10-7+ D08UXT DRUGINKE HAQOPUCXUDNSDH-JXMROGBWSA-N D08UXT DRUGSMIL CCCCOC1=CC=C(C=C1)C=CC(=O)N(C)O D08UXT HIGHSTAT Investigative D08UYP DRUG__ID D08UYP D08UYP DRUGTYPE Small molecular drug D08UYP DRUGINCH 1S/C36H22O18/c37-12-1-13(38)3-15(2-12)49-31-22(44)10-25(47)34-35(31)54-30-21(43)8-17(9-27(30)52-34)48-28-19(41)6-16(7-20(28)42)50-32-23(45)11-24(46)33-36(32)53-29-18(40)4-14(39)5-26(29)51-33/h1-11,37-47H D08UYP DRUGINKE DRZQFGYIIYNNEC-UHFFFAOYSA-N D08UYP DRUGSMIL C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C=C4O3)OC5=C(C=C(C=C5O)OC6=C(C=C(C7=C6OC8=C(C=C(C=C8O7)O)O)O)O)O)O)O)O)O D08UYP HIGHSTAT Investigative D08UZJ DRUG__ID D08UZJ D08UZJ DRUGTYPE Small molecular drug D08UZJ DRUGINCH 1S/C15H21NO/c1-16-9-8-15(7-3-5-13(16)11-15)12-4-2-6-14(17)10-12/h2,4,6,10,13,17H,3,5,7-9,11H2,1H3 D08UZJ DRUGINKE ZQJGRSYDDMBMPJ-UHFFFAOYSA-N D08UZJ DRUGSMIL CN1CCC2(CCCC1C2)C3=CC(=CC=C3)O D08UZJ HIGHSTAT Investigative D08VBE DRUG__ID D08VBE D08VBE DRUGTYPE Small molecular drug D08VBE DRUGINCH 1S/C32H33N5O3/c1-34-11-13-36(14-12-34)32(38)29-20-35(19-28(29)27-8-4-6-24-5-2-3-7-26(24)27)18-25-16-33-21-37(25)17-23-9-10-30-31(15-23)40-22-39-30/h2-10,15-16,19-21,30-31H,11-14,17-18,22H2,1H3 D08VBE DRUGINKE VZWZHIJGBPHRDI-UHFFFAOYSA-N D08VBE DRUGSMIL CN1CCN(CC1)C(=O)C2=CN(C=C2C3=CC=CC4=CC=CC=C43)CC5=CN=CN5CC6=CC7C(C=C6)OCO7 D08VBE HIGHSTAT Investigative D08VDX DRUG__ID D08VDX D08VDX DRUGTYPE Small molecular drug D08VDX DRUGINCH 1S/C16H11ClO2/c17-16-8-12(10-1-4-13(18)5-2-10)7-11-3-6-14(19)9-15(11)16/h1-9,18-19H D08VDX DRUGINKE IVJIWGTXXHDRCU-UHFFFAOYSA-N D08VDX DRUGSMIL C1=CC(=CC=C1C2=CC(=C3C=C(C=CC3=C2)O)Cl)O D08VDX HIGHSTAT Investigative D08VGJ DRUG__ID D08VGJ D08VGJ DRUGTYPE Small molecular drug D08VGJ DRUGINCH 1S/C8H7Cl2N3/c9-5-1-2-6-4(7(5)10)3-12-8(11)13-6/h1-2H,3H2,(H3,11,12,13) D08VGJ DRUGINKE VBKOTIVQMCTTAQ-UHFFFAOYSA-N D08VGJ DRUGSMIL C1C2=C(C=CC(=C2Cl)Cl)NC(=N1)N D08VGJ HIGHSTAT Investigative D08VGL DRUG__ID D08VGL D08VGL DRUGTYPE Small molecular drug D08VGL DRUGINCH 1S/C27H21N3O7/c1-27-16(26(34)37-35-2)9-19(36-27)29-17-5-3-11(31)7-13(17)21-22-15(10-28-25(22)33)20-14-8-12(32)4-6-18(14)30(27)24(20)23(21)29/h3-8,16,19,31-32H,9-10H2,1-2H3,(H,28,33)/t16-,19-,27+/m1/s1 D08VGL DRUGINKE JKEBWJSRGQOXNU-TUZCJGOLSA-N D08VGL DRUGSMIL CC12C(CC(O1)N3C4=C(C=C(C=C4)O)C5=C6C(=C7C8=C(N2C7=C53)C=CC(=C8)O)CNC6=O)C(=O)OOC D08VGL HIGHSTAT Investigative D08VGM DRUG__ID D08VGM D08VGM DRUGTYPE Small molecular drug D08VGM DRUGINCH 1S/C17H22IN3O6S/c18-11-4-2-1-3-10(11)8-28-9-13(16(25)20-7-15(23)24)21-14(22)6-5-12(19)17(26)27/h1-4,12-13H,5-9,19H2,(H,20,25)(H,21,22)(H,23,24)(H,26,27)/t12-,13-/m0/s1 D08VGM DRUGINKE QFYJAEOZTBVJQM-STQMWFEESA-N D08VGM DRUGSMIL C1=CC=C(C(=C1)CSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)I D08VGM HIGHSTAT Investigative D08VHO DRUG__ID D08VHO D08VHO DRUGTYPE Small molecular drug D08VHO DRUGINCH 1S/C17H21NO2/c1-2-3-4-5-7-14-9-10-17(16(19)12-14)20-15-8-6-11-18-13-15/h6,8-13,19H,2-5,7H2,1H3 D08VHO DRUGINKE MMFBADBXBVJXTO-UHFFFAOYSA-N D08VHO DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CN=CC=C2)O D08VHO HIGHSTAT Investigative D08VLD DRUG__ID D08VLD D08VLD DRUGTYPE Small molecular drug D08VLD DRUGINCH 1S/C12H16F3NO2/c1-7(16)4-8-5-11(18-3)9(12(13,14)15)6-10(8)17-2/h5-7H,4,16H2,1-3H3 D08VLD DRUGINKE WPGOTSORDNBMHP-UHFFFAOYSA-N D08VLD DRUGSMIL CC(CC1=CC(=C(C=C1OC)C(F)(F)F)OC)N D08VLD HIGHSTAT Investigative D08VLG DRUG__ID D08VLG D08VLG DRUGTYPE Small molecular drug D08VLG DRUGINCH 1S/C22H30O2/c1-5-6-7-10-15-22(2,3)17-13-14-18(20(23)16-17)19-11-8-9-12-21(19)24-4/h8-9,11-14,16,23H,5-7,10,15H2,1-4H3 D08VLG DRUGINKE WXRCAYBWSXUGLS-UHFFFAOYSA-N D08VLG DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CC=CC=C2OC)O D08VLG HIGHSTAT Investigative D08VLT DRUG__ID D08VLT D08VLT DRUGTYPE Small molecular drug D08VLT DRUGINCH 1S/C20H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(21)15-16-20(22)23/h9-12,19H,2-8,13-16,21H2,1H3,(H,22,23) D08VLT DRUGINKE UUODWPRHRNIITI-UHFFFAOYSA-N D08VLT DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CCC(=O)O)N D08VLT HIGHSTAT Investigative D08VOC DRUG__ID D08VOC D08VOC DRUGTYPE Small molecular drug D08VOC DRUGINCH 1S/C53H64N8O7/c1-30-20-39(62)21-31(2)41(30)26-43(54)52(67)60-28-37-14-8-6-12-35(37)24-47(60)50(65)56-18-10-16-45-34(5)58-46(49(64)59-45)17-11-19-57-51(66)48-25-36-13-7-9-15-38(36)29-61(48)53(68)44(55)27-42-32(3)22-40(63)23-33(42)4/h6-9,12-15,20-23,43-44,47-48,62-63H,10-11,16-19,24-29,54-55H2,1-5H3,(H,56,65)(H,57,66)(H,59,64)/t43-,44-,47?,48?/m0/s1 D08VOC DRUGINKE NATWHSVYZBCLOS-OYVXWBFTSA-N D08VOC DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCC4=C(N=C(C(=O)N4)CCCNC(=O)C5CC6=CC=CC=C6CN5C(=O)C(CC7=C(C=C(C=C7C)O)C)N)C)N)C)O D08VOC HIGHSTAT Investigative D08VPN DRUG__ID D08VPN D08VPN DRUGTYPE Small molecular drug D08VPN DRUGINCH 1S/C9H14N2O11P2S/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(21-8)3-20-23(16,17)22-24(18,19)25/h1-2,4,6-8,13-14H,3H2,(H,16,17)(H,10,12,15)(H2,18,19,25)/t4-,6-,7-,8-/m1/s1 D08VPN DRUGINKE HFPQTPQWHHTLHT-XVFCMESISA-N D08VPN DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=S)(O)O)O)O D08VPN HIGHSTAT Investigative D08VQM DRUG__ID D08VQM D08VQM DRUGTYPE Small molecular drug D08VQM DRUGINCH 1S/C11H9ClN2OS/c12-7-3-1-6(2-4-7)9-5-8(13)10(16-9)11(14)15/h1-5H,13H2,(H2,14,15) D08VQM DRUGINKE MQYJPACEBWKWEH-UHFFFAOYSA-N D08VQM DRUGSMIL C1=CC(=CC=C1C2=CC(=C(S2)C(=O)N)N)Cl D08VQM HIGHSTAT Investigative D08VRJ DRUG__ID D08VRJ D08VRJ DRUGTYPE Small molecular drug D08VRJ DRUGINCH 1S/C33H38FN3O5/c1-33(17-24-18-35-28-5-3-2-4-27(24)28,31(40)36-26(16-29(38)39)15-19-6-8-25(34)9-7-19)37-32(41)42-30-22-11-20-10-21(13-22)14-23(30)12-20/h2-9,18,20-23,26,30,35H,10-17H2,1H3,(H,36,40)(H,37,41)(H,38,39)/t20?,21?,22?,23?,26?,30?,33-/m0/s1 D08VRJ DRUGINKE UZOOGOCMUARFDV-KEZCGYQASA-N D08VRJ DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=C(C=C3)F)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D08VRJ HIGHSTAT Investigative D08VRV DRUG__ID D08VRV D08VRV DRUGTYPE Small molecular drug D08VRV DRUGINCH 1S/C40H38O8/c1-22(2)4-14-29-35(45)20-26(21-36(29)46)39(47)37-31(25-8-12-28(42)13-9-25)18-23(3)19-32(37)38-34(44)17-15-30(40(38)48)33(43)16-7-24-5-10-27(41)11-6-24/h4-13,15-17,19-21,31-32,37,41-42,44-46,48H,14,18H2,1-3H3/b16-7+/t31-,32+,37-/m1/s1 D08VRV DRUGINKE MYKDNKGHXHALEF-SJIVMEQQSA-N D08VRV DRUGSMIL CC1=CC(C(C(C1)C2=CC=C(C=C2)O)C(=O)C3=CC(=C(C(=C3)O)CC=C(C)C)O)C4=C(C=CC(=C4O)C(=O)C=CC5=CC=C(C=C5)O)O D08VRV HIGHSTAT Investigative D08VTS DRUG__ID D08VTS D08VTS DRUGTYPE Small molecular drug D08VTS DRUGINCH 1S/C36H57N15O4/c1-36(2,3)28(32(55)50-25(6-4-16-45-33(39)40)30(53)47-19-23-12-14-24(15-13-23)29(37)38)51-31(54)26(7-5-17-46-34(41)42)49-27(52)18-21-8-10-22(11-9-21)20-48-35(43)44/h8-15,25-26,28H,4-7,16-20H2,1-3H3,(H3,37,38)(H,47,53)(H,49,52)(H,50,55)(H,51,54)(H4,39,40,45)(H4,41,42,46)(H4,43,44,48)/t25-,26-,28+/m0/s1 D08VTS DRUGINKE HXVPWVPTVOOCMV-UNCTUWKVSA-N D08VTS DRUGSMIL CC(C)(C)C(C(=O)NC(CCCN=C(N)N)C(=O)NCC1=CC=C(C=C1)C(=N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CC2=CC=C(C=C2)CN=C(N)N D08VTS HIGHSTAT Investigative D08VUM DRUG__ID D08VUM D08VUM DRUGTYPE Small molecular drug D08VUM DRUGINCH 1S/C19H28N2/c1-4-5-6-7-8-19-20-14-18(21-19)17-11-9-16(10-12-17)13-15(2)3/h9-12,14-15H,4-8,13H2,1-3H3,(H,20,21) D08VUM DRUGINKE DJDWXDSQUIVYCH-UHFFFAOYSA-N D08VUM DRUGSMIL CCCCCCC1=NC=C(N1)C2=CC=C(C=C2)CC(C)C D08VUM HIGHSTAT Investigative D08VUO DRUG__ID D08VUO D08VUO DRUGTYPE Small molecular drug D08VUO DRUGINCH 1S/C32H52O3/c1-9-35-26(34)32-16-14-27(2,3)20-23(32)22-10-11-25-29(6)19-21(33)18-28(4,5)24(29)12-13-31(25,8)30(22,7)15-17-32/h10,21,23-25,33H,9,11-20H2,1-8H3/t21-,23+,24+,25-,29+,30-,31-,32+/m1/s1 D08VUO DRUGINKE ZGVDWCUGEWKVJU-UMIBNUPHSA-N D08VUO DRUGSMIL CCOC(=O)C12CCC(CC1C3=CCC4C(C3(CC2)C)(CCC5C4(CC(CC5(C)C)O)C)C)(C)C D08VUO HIGHSTAT Investigative D08VUQ DRUG__ID D08VUQ D08VUQ DRUGTYPE Small molecular drug D08VUQ DRUGINCH 1S/C16H26N2O/c1-3-4-7-10-17-11-13-18(14-12-17)15-8-5-6-9-16(15)19-2/h5-6,8-9H,3-4,7,10-14H2,1-2H3 D08VUQ DRUGINKE KOQVTIBXMDYTOB-UHFFFAOYSA-N D08VUQ DRUGSMIL CCCCCN1CCN(CC1)C2=CC=CC=C2OC D08VUQ HIGHSTAT Investigative D08VVZ DRUG__ID D08VVZ D08VVZ DRUGTYPE Small molecular drug D08VVZ DRUGINCH 1S/C27H33N5O4S2/c1-4-8-36-26(33)31-20-11-19(12-23(14-20)34-3)16-28-25-15-22(32-6-9-35-10-7-32)13-21(30-25)18-37-27-29-17-24(5-2)38-27/h4,11-15,17H,1,5-10,16,18H2,2-3H3,(H,28,30)(H,31,33) D08VVZ DRUGINKE JNFARUXJNLDBCZ-UHFFFAOYSA-N D08VVZ DRUGSMIL CCC1=CN=C(S1)SCC2=NC(=CC(=C2)N3CCOCC3)NCC4=CC(=CC(=C4)OC)NC(=O)OCC=C D08VVZ HIGHSTAT Investigative D08VXF DRUG__ID D08VXF D08VXF DRUGTYPE Small molecular drug D08VXF DRUGINCH 1S/C12H17N5/c1-17-8-15-10-11(13-7-14-12(10)17)16-9-5-3-2-4-6-9/h7-9H,2-6H2,1H3,(H,13,14,16) D08VXF DRUGINKE YWCWGJZQICOVCA-UHFFFAOYSA-N D08VXF DRUGSMIL CN1C=NC2=C(N=CN=C21)NC3CCCCC3 D08VXF HIGHSTAT Investigative D08WAW DRUG__ID D08WAW D08WAW DRUGTYPE Small molecular drug D08WAW DRUGINCH 1S/C17H20N2O/c1-2-3-4-6-14-8-10-15(11-9-14)17(20)19-16-7-5-12-18-13-16/h5,7-13H,2-4,6H2,1H3,(H,19,20) D08WAW DRUGINKE DZLXEBWNAFQZQI-UHFFFAOYSA-N D08WAW DRUGSMIL CCCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 D08WAW HIGHSTAT Investigative D08WBB DRUG__ID D08WBB D08WBB DRUGTYPE Small molecular drug D08WBB DRUGINCH 1S/C26H23N3O3/c30-26(31)24(15-19-7-3-1-4-8-19)29-25-16-23(27-18-28-25)21-11-13-22(14-12-21)32-17-20-9-5-2-6-10-20/h1-14,16,18,24H,15,17H2,(H,30,31)(H,27,28,29)/t24-/m0/s1 D08WBB DRUGINKE RRYFPNITZGCUPZ-DEOSSOPVSA-N D08WBB DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)NC2=NC=NC(=C2)C3=CC=C(C=C3)OCC4=CC=CC=C4 D08WBB HIGHSTAT Investigative D08WDN DRUG__ID D08WDN D08WDN DRUGTYPE Small molecular drug D08WDN DRUGINCH 1S/C13H9NO3/c15-8-5-6-9(11(16)7-8)13-10-3-1-2-4-12(10)17-14-13/h1-7,15-16H D08WDN DRUGINKE JTGLWGSJTQMWBD-UHFFFAOYSA-N D08WDN DRUGSMIL C1=CC=C2C(=C1)C(=NO2)C3=C(C=C(C=C3)O)O D08WDN HIGHSTAT Investigative D08WDW DRUG__ID D08WDW D08WDW DRUGTYPE Small molecular drug D08WDW DRUGINCH 1S/C17H23Cl6N3O2S/c1-9(16(18,19)20)7-12(14(28)25-11(3)15-24-5-6-29-15)26(4)13(27)8-10(2)17(21,22)23/h5-6,9-12H,7-8H2,1-4H3,(H,25,28)/t9-,10-,11-,12-/m0/s1 D08WDW DRUGINKE BFVRAKVNXYQMID-BJDJZHNGSA-N D08WDW DRUGSMIL CC(CC(C(=O)NC(C)C1=NC=CS1)N(C)C(=O)CC(C)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl D08WDW HIGHSTAT Investigative D08WDY DRUG__ID D08WDY D08WDY DRUGTYPE Small molecular drug D08WDY DRUGINCH 1S/C18H18O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h2-5,10,16,19H,6-9H2,1H3/t16-,18-/m0/s1 D08WDY DRUGINKE PDRGHUMCVRDZLQ-WMZOPIPTSA-N D08WDY DRUGSMIL CC12CCC3=C(C1CCC2=O)C=CC4=C3C=CC(=C4)O D08WDY HIGHSTAT Investigative D08WEI DRUG__ID D08WEI D08WEI DRUGTYPE Small molecular drug D08WEI DRUGINCH 1S/C6H12N2S/c1-5-4-9-3-2-6(7)8-5/h5H,2-4H2,1H3,(H2,7,8) D08WEI DRUGINKE XAKJYXSNTIZTRW-UHFFFAOYSA-N D08WEI DRUGSMIL CC1CSCCC(=N1)N D08WEI HIGHSTAT Investigative D08WEV DRUG__ID D08WEV D08WEV DRUGTYPE Small molecular drug D08WEV DRUGINCH 1S/C17H15N3OS/c21-16(14-9-5-2-6-10-14)18-17-20-19-15(22-17)12-11-13-7-3-1-4-8-13/h1-10H,11-12H2,(H,18,20,21) D08WEV DRUGINKE LZMYTXMTFJGQJA-UHFFFAOYSA-N D08WEV DRUGSMIL C1=CC=C(C=C1)CCC2=NN=C(S2)NC(=O)C3=CC=CC=C3 D08WEV HIGHSTAT Investigative D08WFC DRUG__ID D08WFC D08WFC DRUGTYPE Small molecular drug D08WFC DRUGINCH 1S/C16H13N3O/c17-16-14(15(20)12-7-3-1-4-8-12)11-18-19(16)13-9-5-2-6-10-13/h1-11H,17H2 D08WFC DRUGINKE YMGWYPXWGVJIAJ-UHFFFAOYSA-N D08WFC DRUGSMIL C1=CC=C(C=C1)C(=O)C2=C(N(N=C2)C3=CC=CC=C3)N D08WFC HIGHSTAT Investigative D08WHC DRUG__ID D08WHC D08WHC DRUGTYPE Small molecular drug D08WHC DRUGINCH 1S/C11H12N2O/c14-8-11-3-1-2-10(6-11)7-13-5-4-12-9-13/h1-6,9,14H,7-8H2 D08WHC DRUGINKE TXQZIKDWFOLTSC-UHFFFAOYSA-N D08WHC DRUGSMIL C1=CC(=CC(=C1)CO)CN2C=CN=C2 D08WHC HIGHSTAT Investigative D08WHU DRUG__ID D08WHU D08WHU DRUGTYPE Small molecular drug D08WHU DRUGINCH 1S/C18H22N2O3/c21-16(22)14-1-3-15(4-2-14)19-17(23)20-18-8-11-5-12(9-18)7-13(6-11)10-18/h1-4,11-13H,5-10H2,(H,21,22)(H2,19,20,23) D08WHU DRUGINKE KBCDTFQYSZRNRK-UHFFFAOYSA-N D08WHU DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=C(C=C4)C(=O)O D08WHU HIGHSTAT Investigative D08WHV DRUG__ID D08WHV D08WHV DRUGTYPE Small molecular drug D08WHV DRUGINCH 1S/C9H18N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h2,7H,1,3-6,10H2,(H,14,15)(H3,11,12,13)/p+1/t7-/m0/s1 D08WHV DRUGINKE ZPQWZDPOLXVMOU-ZETCQYMHSA-O D08WHV DRUGSMIL C=CCNC(=[NH+]CCCC(C(=O)O)N)N D08WHV HIGHSTAT Investigative D08WIJ DRUG__ID D08WIJ D08WIJ DRUGTYPE Small molecular drug D08WIJ DRUGINCH 1S/C20H19NO4/c1-14-18(24-15-5-3-2-4-6-15)8-7-16-17(22)13-19(25-20(14)16)21-9-11-23-12-10-21/h2-8,13H,9-12H2,1H3 D08WIJ DRUGINKE OOXOMHKMWGSWSD-UHFFFAOYSA-N D08WIJ DRUGSMIL CC1=C(C=CC2=C1OC(=CC2=O)N3CCOCC3)OC4=CC=CC=C4 D08WIJ HIGHSTAT Investigative D08WKQ DRUG__ID D08WKQ D08WKQ DRUGTYPE Small molecular drug D08WKQ DRUGINCH 1S/C28H20ClN3OS/c1-19-27(26(33)17-14-20-12-15-23(29)16-13-20)34-28(30-19)32-25(22-10-6-3-7-11-22)18-24(31-32)21-8-4-2-5-9-21/h2-18H,1H3/b17-14+ D08WKQ DRUGINKE CDTBUKVBQVDVBD-SAPNQHFASA-N D08WKQ DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC=C(C=C5)Cl D08WKQ HIGHSTAT Investigative D08WNN DRUG__ID D08WNN D08WNN DRUGTYPE Small molecular drug D08WNN DRUGINCH 1S/C11H17N5O10P2S/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1/i27+2,28+2 D08WNN DRUGINKE WLMZTKAZJUWXCB-JLOOSCHCSA-N D08WNN DRUGSMIL CSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N D08WNN HIGHSTAT Investigative D08WNU DRUG__ID D08WNU D08WNU DRUGTYPE Small molecular drug D08WNU DRUGINCH 1S/C16H20INO2/c1-18-12-7-8-14(18)15(16(19)20-2)13(9-12)10-3-5-11(17)6-4-10/h3-6,12-15H,7-9H2,1-2H3/t12-,13+,14+,15-/m0/s1/i17-2 D08WNU DRUGINKE SIIICDNNMDMWCI-LRRSBLKXSA-N D08WNU DRUGSMIL CN1C2CCC1C(C(C2)C3=CC=C(C=C3)I)C(=O)OC D08WNU HIGHSTAT Investigative D08WOG DRUG__ID D08WOG D08WOG DRUGTYPE Small molecular drug D08WOG DRUGINCH 1S/C16H13ClN2O3/c1-20-14-7-12-13(8-15(14)21-2)18-9-19-16(12)22-11-5-3-4-10(17)6-11/h3-9H,1-2H3 D08WOG DRUGINKE XDUSWBSGDKRQAF-UHFFFAOYSA-N D08WOG DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)OC3=CC(=CC=C3)Cl)OC D08WOG HIGHSTAT Investigative D08WOV DRUG__ID D08WOV D08WOV DRUGTYPE Small molecular drug D08WOV DRUGINCH 1S/C13H15IN2O2/c1-8(17)15-6-5-10-11-7-9(18-2)3-4-12(11)16-13(10)14/h3-4,7,16H,5-6H2,1-2H3,(H,15,17)/i14-2 D08WOV DRUGINKE FJDDSMSDZHURBJ-XSBOKVBDSA-N D08WOV DRUGSMIL CC(=O)NCCC1=C(NC2=C1C=C(C=C2)OC)I D08WOV HIGHSTAT Investigative D08WQJ DRUG__ID D08WQJ D08WQJ DRUGTYPE Small molecular drug D08WQJ DRUGINCH 1S/C10H7N3O3/c14-10(8-4-2-1-3-5-8)12-7-6-9(11-12)13(15)16/h1-7H D08WQJ DRUGINKE MIWUBRDWBKJULS-UHFFFAOYSA-N D08WQJ DRUGSMIL C1=CC=C(C=C1)C(=O)N2C=CC(=N2)[N+](=O)[O-] D08WQJ HIGHSTAT Investigative D08WQM DRUG__ID D08WQM D08WQM DRUGTYPE Small molecular drug D08WQM DRUGINCH 1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/t5-,6+,7+,8+,9+,11+/m0/s1 D08WQM DRUGINKE SQVRNKJHWKZAKO-YRMXFSIDSA-N D08WQM DRUGSMIL CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)O)O D08WQM HIGHSTAT Investigative D08WQO DRUG__ID D08WQO D08WQO DRUGTYPE Small molecular drug D08WQO DRUGINCH 1S/C20H30N2/c1-3-5-8-14-18(15-9-6-4-2)20-21-16-19(22-20)17-12-10-7-11-13-17/h7,10-13,16,18H,3-6,8-9,14-15H2,1-2H3,(H,21,22) D08WQO DRUGINKE XYWGMJFQZHLYDO-UHFFFAOYSA-N D08WQO DRUGSMIL CCCCCC(CCCCC)C1=NC=C(N1)C2=CC=CC=C2 D08WQO HIGHSTAT Investigative D08WQV DRUG__ID D08WQV D08WQV DRUGTYPE Small molecular drug D08WQV DRUGINCH 1S/C26H43NO6/c1-14(4-7-22(31)27-13-23(32)33)17-5-6-18-24-19(12-21(30)26(17,18)3)25(2)9-8-16(28)10-15(25)11-20(24)29/h14-21,24,28-30H,4-13H2,1-3H3,(H,27,31)(H,32,33)/t14-,15+,16-,17-,18+,19+,20-,21+,24+,25+,26-/m1/s1 D08WQV DRUGINKE RFDAIACWWDREDC-FRVQLJSFSA-N D08WQV DRUGSMIL CC(CCC(=O)NCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C D08WQV HIGHSTAT Investigative D08WQW DRUG__ID D08WQW D08WQW DRUGTYPE Small molecular drug D08WQW DRUGINCH 1S/C21H19NO3/c23-19-14-20(25-21(15-19)22-10-12-24-13-11-22)18-8-6-17(7-9-18)16-4-2-1-3-5-16/h1-9,14-15H,10-13H2 D08WQW DRUGINKE MIZPDLBPZZKHCN-UHFFFAOYSA-N D08WQW DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=C(C=C3)C4=CC=CC=C4 D08WQW HIGHSTAT Investigative D08WRG DRUG__ID D08WRG D08WRG DRUGTYPE Small molecular drug D08WRG DRUGINCH 1S/C21H20N2O3/c1-15-6-2-4-8-18(15)22-10-12-23(13-11-22)20(24)17-14-16-7-3-5-9-19(16)26-21(17)25/h2-9,14H,10-13H2,1H3 D08WRG DRUGINKE IVCTUFTWYWRJLW-UHFFFAOYSA-N D08WRG DRUGSMIL CC1=CC=CC=C1N2CCN(CC2)C(=O)C3=CC4=CC=CC=C4OC3=O D08WRG HIGHSTAT Investigative D08WRU DRUG__ID D08WRU D08WRU DRUGTYPE Small molecular drug D08WRU DRUGINCH 1S/C21H46N2O2S/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-23-26(24,25)22-20-4-2/h22-23H,3-21H2,1-2H3 D08WRU DRUGINKE VOJRCUXNIZFQKR-UHFFFAOYSA-N D08WRU DRUGSMIL CCCCCCCCCCCCCCCCCCNS(=O)(=O)NCCC D08WRU HIGHSTAT Investigative D08WTR DRUG__ID D08WTR D08WTR DRUGTYPE Small molecular drug D08WTR DRUGINCH 1S/C17H26INO3/c1-12(2)7-5-4-6-8-17(21)19-11-13-9-16(22-3)15(20)10-14(13)18/h9-10,12,20H,4-8,11H2,1-3H3,(H,19,21) D08WTR DRUGINKE MGJQSBQUFTWMOG-UHFFFAOYSA-N D08WTR DRUGSMIL CC(C)CCCCCC(=O)NCC1=CC(=C(C=C1I)O)OC D08WTR HIGHSTAT Investigative D08WYO DRUG__ID D08WYO D08WYO DRUGCOMP Pierre Fabre SA D08WYO DRUGINCH 1S/C7H8N4S2/c8-6-10-11-7(13-6)9-4-5-2-1-3-12-5/h1-3H,4H2,(H2,8,10)(H,9,11) D08WYO DRUGINKE KYOKGDLJKFUPBK-UHFFFAOYSA-N D08WYO DRUGSMIL C1=CSC(=C1)CNC2=NN=C(S2)N D08WYO HIGHSTAT Investigative D08WZB DRUG__ID D08WZB D08WZB DRUGTYPE Small molecular drug D08WZB DRUGINCH 1S/C15H18N4O2/c16-13(15(17)21)7-8-14(20)18-11-3-5-12(6-4-11)19-9-1-2-10-19/h1-6,9-10,13H,7-8,16H2,(H2,17,21)(H,18,20)/t13-/m0/s1 D08WZB DRUGINKE XUUJHPOHRREVET-ZDUSSCGKSA-N D08WZB DRUGSMIL C1=CN(C=C1)C2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D08WZB HIGHSTAT Investigative D08XAW DRUG__ID D08XAW D08XAW DRUGTYPE Small molecular drug D08XAW DRUGINCH 1S/C9H4N3O13P3/c13-6-10-4-3-5-11(6)7-1-2-8-9(7,22-27(15,20-8)21-8)23-28(16,19-7)25-12(5)24-26(14,17-3)18-4/h1-2H2 D08XAW DRUGINKE VLAUHALXFDMKAB-UHFFFAOYSA-N D08XAW DRUGSMIL C1CC23C4(C15N6C7=C8C(=NC6=O)OP(=O)(O8)ON7OP(=O)(O5)O4)OP(=O)(O2)O3 D08XAW HIGHSTAT Investigative D08XBQ DRUG__ID D08XBQ D08XBQ DRUGTYPE Small molecular drug D08XBQ DRUGINCH 1S/C30H32N6O2S2/c1-4-21(6-2-16-37-29-27(31-39-33-29)25-19-35-12-8-23(25)9-13-35)18-22(5-1)7-3-17-38-30-28(32-40-34-30)26-20-36-14-10-24(26)11-15-36/h1,4-5,18,23-26H,8-17,19-20H2 D08XBQ DRUGINKE TYLFZULSDOOCRC-UHFFFAOYSA-N D08XBQ DRUGSMIL C1CN2CCC1C(C2)C3=NSN=C3OCC#CC4=CC(=CC=C4)C#CCOC5=NSN=C5C6CN7CCC6CC7 D08XBQ HIGHSTAT Investigative D08XCD DRUG__ID D08XCD D08XCD DRUGTYPE Small molecular drug D08XCD DRUGINCH 1S/C13H17NO2/c15-13(16)11-8-4-5-9-12(11)14-10-6-2-1-3-7-10/h4-5,8-10,14H,1-3,6-7H2,(H,15,16) D08XCD DRUGINKE JSXMFCCPQQJLCR-UHFFFAOYSA-N D08XCD DRUGSMIL C1CCC(CC1)NC2=CC=CC=C2C(=O)O D08XCD HIGHSTAT Investigative D08XEQ DRUG__ID D08XEQ D08XEQ DRUGTYPE Small molecular drug D08XEQ DRUGINCH 1S/C28H38N2O/c1-3-5-7-14-20-30(21-15-8-6-4-2)27(31)22-25-24-18-12-13-19-26(24)29-28(25)23-16-10-9-11-17-23/h9-13,16-19,29H,3-8,14-15,20-22H2,1-2H3 D08XEQ DRUGINKE GGNLGBYSSQXGBN-UHFFFAOYSA-N D08XEQ DRUGSMIL CCCCCCN(CCCCCC)C(=O)CC1=C(NC2=CC=CC=C21)C3=CC=CC=C3 D08XEQ HIGHSTAT Investigative D08XGH DRUG__ID D08XGH D08XGH DRUGTYPE Small molecular drug D08XGH DRUGINCH 1S/C22H20N2O5/c1-14-19(23-21(28-14)16-5-3-2-4-6-16)11-12-27-17-9-7-15(8-10-17)13-18-20(25)24-29-22(18)26/h2-10,18H,11-13H2,1H3,(H,24,25) D08XGH DRUGINKE QBQLYIISSRXYKL-UHFFFAOYSA-N D08XGH DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC4C(=O)NOC4=O D08XGH HIGHSTAT Investigative D08XGI DRUG__ID D08XGI D08XGI DRUGTYPE Small molecular drug D08XGI DRUGINCH 1S/C20H23NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19H,11-16H2 D08XGI DRUGINKE GEFOLRNTTIQKBZ-UHFFFAOYSA-N D08XGI DRUGSMIL C1CN(CCC1C(=O)C2=CC=CC=C2)CCC3=CC=CC=C3 D08XGI HIGHSTAT Investigative D08XGL DRUG__ID D08XGL D08XGL DRUGTYPE Small molecular drug D08XGL DRUGINCH 1S/C22H29NO/c24-18-21(20-13-5-2-6-14-20)22-15-7-8-16-23(22)17-9-12-19-10-3-1-4-11-19/h1-6,10-11,13-14,21-22,24H,7-9,12,15-18H2/t21-,22-/m1/s1 D08XGL DRUGINKE QQICWLNJJOCDRX-FGZHOGPDSA-N D08XGL DRUGSMIL C1CCN(C(C1)C(CO)C2=CC=CC=C2)CCCC3=CC=CC=C3 D08XGL HIGHSTAT Investigative D08XJX DRUG__ID D08XJX D08XJX DRUGTYPE Small molecular drug D08XJX DRUGINCH 1S/C18H16O3/c1-11-8-14-16(9-12(11)2)21-18(20)15(17(14)19)10-13-6-4-3-5-7-13/h3-9,19H,10H2,1-2H3 D08XJX DRUGINKE XYLBSWJPINWPSC-UHFFFAOYSA-N D08XJX DRUGSMIL CC1=CC2=C(C=C1C)OC(=O)C(=C2O)CC3=CC=CC=C3 D08XJX HIGHSTAT Investigative D08XKO DRUG__ID D08XKO D08XKO DRUGTYPE Small molecular drug D08XKO DRUGINCH 1S/C10H6ClN3O/c11-6-2-1-3-7-5(6)4-8-9(12-7)14-10(15)13-8/h1-4H,(H2,12,13,14,15) D08XKO DRUGINKE VZXBGYRONYENIL-UHFFFAOYSA-N D08XKO DRUGSMIL C1=CC2=NC3=C(C=C2C(=C1)Cl)NC(=O)N3 D08XKO HIGHSTAT Investigative D08XLL DRUG__ID D08XLL D08XLL DRUGTYPE Small molecular drug D08XLL DRUGINCH 1S/C20H30N2OS/c1-6-13(7-2)18(23)22-19-16(12-21)15-10-9-14(11-17(15)24-19)20(4,5)8-3/h13-14H,6-11H2,1-5H3,(H,22,23) D08XLL DRUGINKE SWIBDWBSJSJQHL-UHFFFAOYSA-N D08XLL DRUGSMIL CCC(CC)C(=O)NC1=C(C2=C(S1)CC(CC2)C(C)(C)CC)C#N D08XLL HIGHSTAT Investigative D08XLM DRUG__ID D08XLM D08XLM DRUGTYPE Small molecular drug D08XLM DRUGINCH 1S/C29H41N3O6/c1-6-7-15-30-26(34)18-24(33)23(16-20-11-9-8-10-12-20)31-29(36)27(19(2)3)32-28(35)22-14-13-21(37-4)17-25(22)38-5/h8-14,17,19,23-24,27,33H,6-7,15-16,18H2,1-5H3,(H,30,34)(H,31,36)(H,32,35)/t23?,24?,27-/m0/s1 D08XLM DRUGINKE FRRUPPDKKTVORB-CXTIUDGFSA-N D08XLM DRUGSMIL CCCCNC(=O)CC(C(CC1=CC=CC=C1)NC(=O)C(C(C)C)NC(=O)C2=C(C=C(C=C2)OC)OC)O D08XLM HIGHSTAT Investigative D08XML DRUG__ID D08XML D08XML DRUGTYPE Small molecular drug D08XML DRUGINCH 1S/C19H30O/c1-18-9-3-4-16(18)15-6-5-13-12-14(20)7-11-19(13,2)17(15)8-10-18/h3,9,13-17,20H,4-8,10-12H2,1-2H3/t13-,14+,15-,16-,17-,18-,19-/m0/s1 D08XML DRUGINKE KRVXMNNRSSQZJP-PHFHYRSDSA-N D08XML DRUGSMIL CC12CCC3C(C1CC=C2)CCC4C3(CCC(C4)O)C D08XML HIGHSTAT Investigative D08XMS DRUG__ID D08XMS D08XMS DRUGTYPE Small molecular drug D08XMS DRUGINCH 1S/C20H24N2O3/c23-19(13-6-1-2-7-14-20(24)22-25)21-18-12-8-11-17(15-18)16-9-4-3-5-10-16/h3-5,8-12,15,25H,1-2,6-7,13-14H2,(H,21,23)(H,22,24) D08XMS DRUGINKE RDYLEVRHTUDZCQ-UHFFFAOYSA-N D08XMS DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)CCCCCCC(=O)NO D08XMS HIGHSTAT Investigative D08XNQ DRUG__ID D08XNQ D08XNQ DRUGTYPE Small molecular drug D08XNQ DRUGINCH 1S/C54H71N15O9/c1-3-4-15-40(63-31(2)70)48(73)68-45-27-46(71)59-21-10-9-17-41(50(75)69-53(78)44(67-52(45)77)26-36-29-58-30-62-36)65-51(76)43(25-35-28-61-39-16-8-7-14-37(35)39)66-49(74)42(18-11-22-60-54(56)57)64-47(72)38(55)24-32-19-20-33-12-5-6-13-34(33)23-32/h5-8,12-14,16-17,19-20,23,29-30,35-36,38,40,42-45,61H,3-4,9-11,15,18,21-22,24-28,55H2,1-2H3,(H,59,71)(H,63,70)(H,64,72)(H,65,76)(H,66,74)(H,67,77)(H,68,73)(H4,56,57,60)(H,69,75,78)/b41-17+/t35?,36?,38-,40+,42+,43+,44+,45+/m1/s1 D08XNQ DRUGINKE ORTUTLYEGOSCRP-ATNXLWBUSA-N D08XNQ DRUGSMIL CCCCC(C(=O)NC1CC(=O)NCCCC=C(C(=O)NC(=O)C(NC1=O)CC2C=NC=N2)NC(=O)C(CC3CNC4=CC=CC=C34)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)NC(=O)C D08XNQ HIGHSTAT Investigative D08XPP DRUG__ID D08XPP D08XPP DRUGTYPE Small molecular drug D08XPP DRUGINCH 1S/C13H15N3/c14-16-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8,14H2,(H,15,16) D08XPP DRUGINKE DUEMTPVZWKGXAY-UHFFFAOYSA-N D08XPP DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NN D08XPP HIGHSTAT Investigative D08XPZ DRUG__ID D08XPZ D08XPZ DRUGTYPE Small molecular drug D08XPZ DRUGINCH 1S/C11H10N2O/c1-7-5-8-3-2-4-9(11(12)14)10(8)13-6-7/h2-6H,1H3,(H2,12,14) D08XPZ DRUGINKE BRQFPNHEOMCVCI-UHFFFAOYSA-N D08XPZ DRUGSMIL CC1=CC2=C(C(=CC=C2)C(=O)N)N=C1 D08XPZ HIGHSTAT Investigative D08XQI DRUG__ID D08XQI D08XQI DRUGTYPE Small molecular drug D08XQI DRUGINCH 1S/C10H14NO6P/c1-3-15-18(14,16-4-2)17-10-7-5-9(6-8-10)11(12)13/h5-8H,3-4H2,1-2H3 D08XQI DRUGINKE WYMSBXTXOHUIGT-UHFFFAOYSA-N D08XQI DRUGSMIL CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-] D08XQI HIGHSTAT Investigative D08XRH DRUG__ID D08XRH D08XRH DRUGTYPE Small molecular drug D08XRH DRUGINCH 1S/C12H19N2.HI/c1-14(2)10-8-13(9-11-14)12-6-4-3-5-7-12;/h3-7H,8-11H2,1-2H3;1H/q+1;/p-1 D08XRH DRUGINKE XFZJGFIKQCCLGK-UHFFFAOYSA-M D08XRH DRUGSMIL C[N+]1(CCN(CC1)C2=CC=CC=C2)C.[I-] D08XRH HIGHSTAT Investigative D08XRM DRUG__ID D08XRM D08XRM DRUGTYPE Small molecular drug D08XRM DRUGINCH 1S/C27H43N11O6/c1-15-22(41)35-18(5-3-11-32-26(28)29)23(42)36-19(6-4-12-33-27(30)31)24(43)37-20(13-16-7-9-17(39)10-8-16)25(44)38(2)14-21(40)34-15/h7-10,15,18-20,39H,3-6,11-14H2,1-2H3,(H,34,40)(H,35,41)(H,36,42)(H,37,43)(H4,28,29,32)(H4,30,31,33)/t15-,18-,19-,20+/m0/s1 D08XRM DRUGINKE DUPFTLXKUNVZDO-MVJPYGJCSA-N D08XRM DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(CC(=O)N1)C)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N D08XRM HIGHSTAT Investigative D08XTL DRUG__ID D08XTL D08XTL DRUGTYPE Small molecular drug D08XTL DRUGINCH 1S/C23H36N4O3/c1-19(2)30-21-9-4-3-8-20(21)26-16-14-25(15-17-26)12-7-11-24-22(28)18-27-13-6-5-10-23(27)29/h3-4,8-9,19H,5-7,10-18H2,1-2H3,(H,24,28) D08XTL DRUGINKE STMYXSKGGILJBE-UHFFFAOYSA-N D08XTL DRUGSMIL CC(C)OC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CN3CCCCC3=O D08XTL HIGHSTAT Investigative D08XVZ DRUG__ID D08XVZ D08XVZ DRUGTYPE Small molecular drug D08XVZ DRUGINCH 1S/C33H33N9O2/c43-30(42-18-16-41(17-19-42)27-5-2-24(3-6-27)32-35-11-1-12-36-32)22-40-15-10-25(21-40)33(44)37-26-4-7-29-28(20-26)31(39-38-29)23-8-13-34-14-9-23/h1-9,11-14,20,25H,10,15-19,21-22H2,(H,37,44)(H,38,39)/t25-/m1/s1 D08XVZ DRUGINKE HDAJDNHIBCDLQF-RUZDIDTESA-N D08XVZ DRUGSMIL C1CN(CC1C(=O)NC2=CC3=C(C=C2)NN=C3C4=CC=NC=C4)CC(=O)N5CCN(CC5)C6=CC=C(C=C6)C7=NC=CC=N7 D08XVZ HIGHSTAT Investigative D08XWS DRUG__ID D08XWS D08XWS DRUGTYPE Small molecular drug D08XWS DRUGINCH 1S/C28H34N4O6/c1-19-4-2-3-5-23(19)30-28(37)29-22-8-6-20(7-9-22)16-25(33)32-14-15-38-18-24(32)27(36)31-12-10-21(11-13-31)17-26(34)35/h2-9,21,24H,10-18H2,1H3,(H,34,35)(H2,29,30,37)/t24-/m0/s1 D08XWS DRUGINKE ITXAAOWFOURIHK-DEOSSOPVSA-N D08XWS DRUGSMIL CC1=CC=CC=C1NC(=O)NC2=CC=C(C=C2)CC(=O)N3CCOCC3C(=O)N4CCC(CC4)CC(=O)O D08XWS HIGHSTAT Investigative D08XXD DRUG__ID D08XXD D08XXD DRUGTYPE Small molecular drug D08XXD DRUGINCH 1S/C10H9NO/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6,12H,11H2 D08XXD DRUGINKE ABJQKDJOYSQVFX-UHFFFAOYSA-N D08XXD DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2O)N D08XXD HIGHSTAT Investigative D08XXE DRUG__ID D08XXE D08XXE DRUGTYPE Small molecular drug D08XXE DRUGINCH 1S/C2H5O6P/c3-2(4)1-8-9(5,6)7/h1H2,(H,3,4)(H2,5,6,7) D08XXE DRUGINKE ASCFNMCAHFUBCO-UHFFFAOYSA-N D08XXE DRUGSMIL C(C(=O)O)OP(=O)(O)O D08XXE HIGHSTAT Investigative D08XYK DRUG__ID D08XYK D08XYK DRUGTYPE Small molecular drug D08XYK DRUGINCH 1S/C27H32N2O9/c1-18-10-11-19-6-3-8-23(32)26(19)27(35)38-20(7-4-14-28-24(33)9-5-15-29-36-2)16-25(34)37-21(17-30)12-13-22(18)31/h3-6,8-10,12-15,20-22,30-32H,7,11,16-17H2,1-2H3,(H,28,33)/b9-5-,13-12+,14-4+,18-10-,29-15- D08XYK DRUGINKE JIRIKJKTSMGHQG-ZBKQNIHQSA-N D08XYK DRUGSMIL CC1=CCC2=C(C(=CC=C2)O)C(=O)OC(CC(=O)OC(C=CC1O)CO)CC=CNC(=O)C=CC=NOC D08XYK HIGHSTAT Investigative D08XYR DRUG__ID D08XYR D08XYR DRUGTYPE Small molecular drug D08XYR DRUGINCH 1S/C12H19NO2/c1-8-5-12(15-4)10(6-9(2)13)7-11(8)14-3/h5,7,9H,6,13H2,1-4H3 D08XYR DRUGINKE NTJQREUGJKIARY-UHFFFAOYSA-N D08XYR DRUGSMIL CC1=CC(=C(C=C1OC)CC(C)N)OC D08XYR HIGHSTAT Investigative D08XYV DRUG__ID D08XYV D08XYV DRUGTYPE Small molecular drug D08XYV DRUGINCH 1S/C15H28N2O3/c1-2-3-9-12-16-15(20)17-13-10-7-5-4-6-8-11-14(18)19/h4,6H,2-3,5,7-13H2,1H3,(H,18,19)(H2,16,17,20)/b6-4- D08XYV DRUGINKE ABERTDKHAIMZFF-XQRVVYSFSA-N D08XYV DRUGSMIL CCCCCNC(=O)NCCCCC=CCCC(=O)O D08XYV HIGHSTAT Investigative D08YCD DRUG__ID D08YCD D08YCD DRUGTYPE Small molecular drug D08YCD DRUGINCH 1S/C17H16N2/c1-14(19-12-11-18-13-19)15-7-9-17(10-8-15)16-5-3-2-4-6-16/h2-14H,1H3 D08YCD DRUGINKE XGUZZPBTOANTPR-UHFFFAOYSA-N D08YCD DRUGSMIL CC(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D08YCD HIGHSTAT Investigative D08YCE DRUG__ID D08YCE D08YCE DRUGTYPE Small molecular drug D08YCE DRUGINCH 1S/C15H15ClN4O3/c1-18-11-12(19(2)15(22)20(3)13(11)21)17-14(18)23-8-9-5-4-6-10(16)7-9/h4-7H,8H2,1-3H3 D08YCE DRUGINKE XCVMGVIPMZLFEU-UHFFFAOYSA-N D08YCE DRUGSMIL CN1C2=C(N=C1OCC3=CC(=CC=C3)Cl)N(C(=O)N(C2=O)C)C D08YCE HIGHSTAT Investigative D08YGM DRUG__ID D08YGM D08YGM DRUGTYPE Small molecular drug D08YGM DRUGINCH 1S/C22H25NO2/c24-22(25)20-13-7-15-23(17-20)16-8-14-21(18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-6,9-12,14,20H,7-8,13,15-17H2,(H,24,25) D08YGM DRUGINKE TXQKSMSLZVKQBI-UHFFFAOYSA-N D08YGM DRUGSMIL C1CC(CN(C1)CCC=C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)O D08YGM HIGHSTAT Investigative D08YGW DRUG__ID D08YGW D08YGW DRUGTYPE Small molecular drug D08YGW DRUGINCH 1S/C16H14N2/c1-3-7-14(8-4-1)12-18-13-17-11-16(18)15-9-5-2-6-10-15/h1-11,13H,12H2 D08YGW DRUGINKE AWZYHJQWJWUOHS-UHFFFAOYSA-N D08YGW DRUGSMIL C1=CC=C(C=C1)CN2C=NC=C2C3=CC=CC=C3 D08YGW HIGHSTAT Investigative D08YHA DRUG__ID D08YHA D08YHA DRUGTYPE Small molecular drug D08YHA DRUGINCH 1S/C15H12O3/c1-15(2)8-7-11-12(16)9-5-3-4-6-10(9)13(17)14(11)18-15/h3-8H,1-2H3 D08YHA DRUGINKE OWFHAMHRUCUSRM-UHFFFAOYSA-N D08YHA DRUGSMIL CC1(C=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O)C D08YHA HIGHSTAT Investigative D08YHD DRUG__ID D08YHD D08YHD DRUGTYPE Small molecular drug D08YHD DRUGINCH 1S/C13H15F3O/c14-13(15,16)12(17)10-6-2-5-9-11-7-3-1-4-8-11/h1,3-4,7-8H,2,5-6,9-10H2 D08YHD DRUGINKE OYIOJJUJKLHWGM-UHFFFAOYSA-N D08YHD DRUGSMIL C1=CC=C(C=C1)CCCCCC(=O)C(F)(F)F D08YHD HIGHSTAT Investigative D08YJE DRUG__ID D08YJE D08YJE DRUGTYPE Small molecular drug D08YJE DRUGINCH 1S/C24H31NO2/c1-27-24(26)23(21-15-6-3-7-16-21)22-17-9-11-19-25(22)18-10-8-14-20-12-4-2-5-13-20/h2-7,12-13,15-16,22-23H,8-11,14,17-19H2,1H3/t22-,23-/m1/s1 D08YJE DRUGINKE TYKSHJPRQWJNHO-DHIUTWEWSA-N D08YJE DRUGSMIL COC(=O)C(C1CCCCN1CCCCC2=CC=CC=C2)C3=CC=CC=C3 D08YJE HIGHSTAT Investigative D08YJF DRUG__ID D08YJF D08YJF DRUGTYPE Small molecular drug D08YJF DRUGINCH 1S/C14H19NO/c16-14(11-12-7-3-1-4-8-12)15-13-9-5-2-6-10-13/h2,5-6,9-10,12H,1,3-4,7-8,11H2,(H,15,16) D08YJF DRUGINKE WIFWWZGKYZCASF-UHFFFAOYSA-N D08YJF DRUGSMIL C1CCC(CC1)CC(=O)NC2=CC=CC=C2 D08YJF HIGHSTAT Investigative D08YJP DRUG__ID D08YJP D08YJP DRUGTYPE Small molecular drug D08YJP DRUGINCH 1S/C10H13FN2/c11-9-3-1-2-4-10(9)13-7-5-12-6-8-13/h1-4,12H,5-8H2 D08YJP DRUGINKE IVTZRJKKXSKXKO-UHFFFAOYSA-N D08YJP DRUGSMIL C1CN(CCN1)C2=CC=CC=C2F D08YJP HIGHSTAT Investigative D08YKN DRUG__ID D08YKN D08YKN DRUGTYPE Small molecular drug D08YKN DRUGINCH 1S/C21H15NOS/c23-18-9-4-8-16(12-18)17-13-19(15-6-2-1-3-7-15)22-20(14-17)21-10-5-11-24-21/h1-14,23H D08YKN DRUGINKE VNKCREXUIZRWPF-UHFFFAOYSA-N D08YKN DRUGSMIL C1=CC=C(C=C1)C2=NC(=CC(=C2)C3=CC(=CC=C3)O)C4=CC=CS4 D08YKN HIGHSTAT Investigative D08YLO DRUG__ID D08YLO D08YLO DRUGTYPE Small molecular drug D08YLO DRUGINCH 1S/C19H15FN2O/c20-16-9-6-13(7-10-16)15-8-11-17(21)18(12-15)22-19(23)14-4-2-1-3-5-14/h1-12H,21H2,(H,22,23) D08YLO DRUGINKE LKRDHRWKHHRCOQ-UHFFFAOYSA-N D08YLO DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=C(C=C3)F)N D08YLO HIGHSTAT Investigative D08YLW DRUG__ID D08YLW D08YLW DRUGTYPE Small molecular drug D08YLW DRUGINCH 1S/C27H34N2O8S/c1-12-22(32)23(33)24(34)27(37-12)29-18-10-14-6-8-17(28-13(2)30)16-11-19(31)20(38-5)9-7-15(16)21(14)26(36-4)25(18)35-3/h7,9-12,17,22-24,27,29,32-34H,6,8H2,1-5H3,(H,28,30)/t12-,17-,22+,23+,24-,27+/m0/s1 D08YLW DRUGINKE ZYVFSIDQHJSZKV-MPHDHXMWSA-N D08YLW DRUGSMIL CC1C(C(C(C(O1)NC2=C(C(=C3C(=C2)CCC(C4=CC(=O)C(=CC=C43)SC)NC(=O)C)OC)OC)O)O)O D08YLW HIGHSTAT Investigative D08YQT DRUG__ID D08YQT D08YQT DRUGTYPE Small molecular drug D08YQT DRUGINCH 1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D08YQT DRUGINKE BUZAJRPLUGXRAB-UHFFFAOYSA-N D08YQT DRUGSMIL CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I D08YQT HIGHSTAT Investigative D08YUQ DRUG__ID D08YUQ D08YUQ DRUGTYPE Small molecular drug D08YUQ DRUGINCH 1S/C44H58N10O10S/c1-4-25(2)38(52-42(61)37(24-65)47-26(3)55)43(62)50-35(22-28-10-16-31(56)17-11-28)40(59)48-33(7-5-6-20-45)39(58)49-34(21-27-8-14-30(15-9-27)53-54-46)41(60)51-36(44(63)64)23-29-12-18-32(57)19-13-29/h8-19,25,33-38,56-57,65H,4-7,20-24,45H2,1-3H3,(H,47,55)(H,48,59)(H,49,58)(H,50,62)(H,51,60)(H,52,61)(H,63,64)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D08YUQ DRUGINKE YGJYKNHKRWZTIL-LBNFHWTGSA-N D08YUQ DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)N=[N+]=[N-])C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D08YUQ HIGHSTAT Investigative D08YYV DRUG__ID D08YYV D08YYV DRUGTYPE Small molecular drug D08YYV DRUGINCH 1S/C37H49N11O6/c1-48-30(9-5-17-43-37(40)41)34(53)46-27(8-4-16-42-36(38)39)33(52)47-28(19-22-11-14-26(49)15-12-22)32(51)44-21-31(50)45-29(35(48)54)20-23-10-13-24-6-2-3-7-25(24)18-23/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,50)(H,46,53)(H,47,52)(H4,38,39,42)(H4,40,41,43)/t27-,28-,29+,30+/m1/s1 D08YYV DRUGINKE UYLRGPNGYHIOPK-XAZDILKDSA-N D08YYV DRUGSMIL CN1C(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C1=O)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O)CCCN=C(N)N)CCCN=C(N)N D08YYV HIGHSTAT Investigative D08YYX DRUG__ID D08YYX D08YYX DRUGTYPE Small molecular drug D08YYX DRUGINCH 1S/C14H15NO2/c15-9-8-11-6-7-12(16)14(17)13(11)10-4-2-1-3-5-10/h1-7,16-17H,8-9,15H2 D08YYX DRUGINKE DAKLNHHLHPIOPS-UHFFFAOYSA-N D08YYX DRUGSMIL C1=CC=C(C=C1)C2=C(C=CC(=C2O)O)CCN D08YYX HIGHSTAT Investigative D08YZM DRUG__ID D08YZM D08YZM DRUGTYPE Small molecular drug D08YZM DRUGINCH 1S/C10H13N5/c1-2-12-9-8(1)10(14-7-13-9)15-5-3-11-4-6-15/h1-2,7,11H,3-6H2,(H,12,13,14) D08YZM DRUGINKE LZSXQBNNRGZPES-UHFFFAOYSA-N D08YZM DRUGSMIL C1CN(CCN1)C2=NC=NC3=C2C=CN3 D08YZM HIGHSTAT Investigative D08ZAK DRUG__ID D08ZAK D08ZAK DRUGTYPE Small molecular drug D08ZAK DRUGINCH 1S/C40H53N9O6/c1-3-26(2)34(38(54)49-19-10-7-15-40(49,24-50)39(55)47-16-8-4-9-17-47)46-35(51)32(20-27-22-43-31-13-6-5-12-29(27)31)45-36(52)33-14-11-18-48(33)37(53)30(41)21-28-23-42-25-44-28/h3,5-6,12-13,22-26,30,32-34,43H,1,4,7-11,14-21,41H2,2H3,(H,42,44)(H,45,52)(H,46,51)/t26-,30+,32+,33-,34-,40-/m0/s1 D08ZAK DRUGINKE QHUGACUEEILSLD-NNWJBWDNSA-N D08ZAK DRUGSMIL CC(C=C)C(C(=O)N1CCCCC1(C=O)C(=O)N2CCCCC2)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C5CCCN5C(=O)C(CC6=CN=CN6)N D08ZAK HIGHSTAT Investigative D08ZAO DRUG__ID D08ZAO D08ZAO DRUGTYPE Small molecular drug D08ZAO DRUGINCH 1S/C6H8O6/c7-4(8)1-3(6(11)12)2-5(9)10/h3H,1-2H2,(H,7,8)(H,9,10)(H,11,12) D08ZAO DRUGINKE KQTIIICEAUMSDG-UHFFFAOYSA-N D08ZAO DRUGSMIL C(C(CC(=O)O)C(=O)O)C(=O)O D08ZAO HIGHSTAT Investigative D08ZBD DRUG__ID D08ZBD D08ZBD DRUGTYPE Small molecular drug D08ZBD DRUGINCH 1S/C15H9FN2O2S/c16-10-4-6-13-12(8-10)11-5-3-9-2-1-7-17-14(9)15(11)18-21(13,19)20/h1-8,18H D08ZBD DRUGINKE KNMYXLXOQAHLHK-UHFFFAOYSA-N D08ZBD DRUGSMIL C1=CC2=C(C3=C(C=C2)C4=C(C=CC(=C4)F)S(=O)(=O)N3)N=C1 D08ZBD HIGHSTAT Investigative D08ZCM DRUG__ID D08ZCM D08ZCM DRUGTYPE Small molecular drug D08ZCM DRUGINCH 1S/C20H26O2/c1-2-3-4-5-6-8-11-17-14-15-20(19(21)16-17)22-18-12-9-7-10-13-18/h7,9-10,12-16,21H,2-6,8,11H2,1H3 D08ZCM DRUGINKE JOWYBLIPWAMIHM-UHFFFAOYSA-N D08ZCM DRUGSMIL CCCCCCCCC1=CC(=C(C=C1)OC2=CC=CC=C2)O D08ZCM HIGHSTAT Investigative D08ZDD DRUG__ID D08ZDD D08ZDD DRUGTYPE Small molecular drug D08ZDD DRUGINCH 1S/C11H13NO4/c1-16-9-4-2-8(3-5-9)10(13)6-7-11(14)12-15/h2-5,15H,6-7H2,1H3,(H,12,14) D08ZDD DRUGINKE YUAIIHPYXRCTLQ-UHFFFAOYSA-N D08ZDD DRUGSMIL COC1=CC=C(C=C1)C(=O)CCC(=O)NO D08ZDD HIGHSTAT Investigative D08ZDM DRUG__ID D08ZDM D08ZDM DRUGCOMP University of Medicine; Dentistry of New Jersey D08ZDM DRUGINCH 1S/C27H45N2.HI/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-28-23-24-29(26(28)2)25-27-20-17-16-18-21-27;/h16-18,20-21,23-24H,3-15,19,22,25H2,1-2H3;1H/q+1;/p-1 D08ZDM DRUGINKE RVWOHCBHAGBLLT-UHFFFAOYSA-M D08ZDM DRUGSMIL CCCCCCCCCCCCCCCCN1C=C[N+](=C1C)CC2=CC=CC=C2.[I-] D08ZDM HIGHSTAT Investigative D08ZDP DRUG__ID D08ZDP D08ZDP DRUGTYPE Small molecular drug D08ZDP DRUGINCH 1S/C28H33NO/c1-2-3-10-23-15-17-26(18-16-23)28(30)19-21-29(22-20-28)27(24-11-6-4-7-12-24)25-13-8-5-9-14-25/h4-9,11-18,27,30H,2-3,10,19-22H2,1H3 D08ZDP DRUGINKE RVNGGHXLYIZGKP-UHFFFAOYSA-N D08ZDP DRUGSMIL CCCCC1=CC=C(C=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D08ZDP HIGHSTAT Investigative D08ZGG DRUG__ID D08ZGG D08ZGG DRUGCOMP Medicines for Malaria Venture D08ZGG DRUGINCH 1S/C18H24N4O4/c1-2-13-16(17(19)22-18(20)21-13)26-11-5-10-25-14-7-4-3-6-12(14)8-9-15(23)24/h3-4,6-7H,2,5,8-11H2,1H3,(H,23,24)(H4,19,20,21,22) D08ZGG DRUGINKE VDGXZSSDCDPCRF-UHFFFAOYSA-N D08ZGG DRUGSMIL CCC1=C(C(=NC(=N1)N)N)OCCCOC2=CC=CC=C2CCC(=O)O D08ZGG HIGHSTAT Investigative D08ZGW DRUG__ID D08ZGW D08ZGW DRUGTYPE Small molecular drug D08ZGW DRUGINCH 1S/C8H8ClNO2/c9-6-3-1-2-5(4-6)7(10)8(11)12/h1-4,7H,10H2,(H,11,12) D08ZGW DRUGINKE MGOUENCSVMAGSE-UHFFFAOYSA-N D08ZGW DRUGSMIL C1=CC(=CC(=C1)Cl)C(C(=O)O)N D08ZGW HIGHSTAT Investigative D08ZHT DRUG__ID D08ZHT D08ZHT DRUGTYPE Small molecular drug D08ZHT DRUGINCH 1S/C59H118N30O19/c60-23(7-1-13-78-54(66)67)45(97)84-20-31-37(92)39(94)34(88-49(101)27(64)11-5-17-82-58(74)75)51(103-31)106-42-30(87-48(100)26(63)10-4-16-81-57(72)73)19-29(86-47(99)25(62)9-3-15-80-56(70)71)36(91)44(42)108-53-41(96)43(33(22-90)105-53)107-52-35(89-50(102)28(65)12-6-18-83-59(76)77)40(95)38(93)32(104-52)21-85-46(98)24(61)8-2-14-79-55(68)69/h23-44,51-53,90-96H,1-22,60-65H2,(H,84,97)(H,85,98)(H,86,99)(H,87,100)(H,88,101)(H,89,102)(H4,66,67,78)(H4,68,69,79)(H4,70,71,80)(H4,72,73,81)(H4,74,75,82)(H4,76,77,83)/t23-,24-,25-,26-,27-,28-,29+,30-,31+,32-,33+,34+,35+,36-,37+,38+,39+,40+,41+,42+,43+,44+,51+,52?,53-/m0/s1 D08ZHT DRUGINKE KBPMSEXASFSGEI-WRBBICKQSA-N D08ZHT DRUGSMIL C1C(C(C(C(C1NC(=O)C(CCCN=C(N)N)N)OC2C(C(C(C(O2)CNC(=O)C(CCCN=C(N)N)N)O)O)NC(=O)C(CCCN=C(N)N)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CNC(=O)C(CCCN=C(N)N)N)O)O)NC(=O)C(CCCN=C(N)N)N)O)O)NC(=O)C(CCCN=C(N)N)N D08ZHT HIGHSTAT Investigative D08ZIA DRUG__ID D08ZIA D08ZIA DRUGTYPE Small molecular drug D08ZIA DRUGINCH 1S/C30H48O3/c1-25(2)12-14-30(24(32)33)15-13-28(6)20(21(30)18-25)8-9-23-27(5)17-19(31)16-26(3,4)22(27)10-11-29(23,28)7/h8,19,21-23,31H,9-18H2,1-7H3,(H,32,33)/t19-,21+,22+,23-,27+,28-,29-,30+/m1/s1 D08ZIA DRUGINKE UODITNOILLXLOO-VGWDZYRESA-N D08ZIA DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)O)C)C)C2C1)C)C(=O)O)C D08ZIA HIGHSTAT Investigative D08ZIS DRUG__ID D08ZIS D08ZIS DRUGTYPE Small molecular drug D08ZIS DRUGINCH 1S/C10H10N2S/c11-8-4-3-7(6-9(8)12)10-2-1-5-13-10/h1-6H,11-12H2 D08ZIS DRUGINKE XWTMGMKBRLLEFX-UHFFFAOYSA-N D08ZIS DRUGSMIL C1=CSC(=C1)C2=CC(=C(C=C2)N)N D08ZIS HIGHSTAT Investigative D08ZJM DRUG__ID D08ZJM D08ZJM DRUGTYPE Small molecular drug D08ZJM DRUGINCH 1S/C20H27NO2/c1-14(2)5-6-16-11-17-7-8-19(23-4)13-20(17)18(12-16)9-10-21-15(3)22/h7-8,11-14H,5-6,9-10H2,1-4H3,(H,21,22) D08ZJM DRUGINKE DGWFQLYAVLGONI-UHFFFAOYSA-N D08ZJM DRUGSMIL CC(C)CCC1=CC(=C2C=C(C=CC2=C1)OC)CCNC(=O)C D08ZJM HIGHSTAT Investigative D08ZLS DRUG__ID D08ZLS D08ZLS DRUGTYPE Small molecular drug D08ZLS DRUGINCH 1S/C20H16N2OS/c23-20(21-14-15-8-2-1-3-9-15)22-16-10-4-6-12-18(16)24-19-13-7-5-11-17(19)22/h1-13H,14H2,(H,21,23) D08ZLS DRUGINKE ZGPOCYPNYDVRTG-UHFFFAOYSA-N D08ZLS DRUGSMIL C1=CC=C(C=C1)CNC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D08ZLS HIGHSTAT Investigative D08ZMX DRUG__ID D08ZMX D08ZMX DRUGTYPE Small molecular drug D08ZMX DRUGINCH 1S/C15H17Cl2N3O2/c1-9(21)13(20-7-12(15(18)22)19-8-20)6-5-10-3-2-4-11(16)14(10)17/h2-4,7-9,13,21H,5-6H2,1H3,(H2,18,22)/t9-,13+/m0/s1 D08ZMX DRUGINKE HCJYSIGJDKNVRU-TVQRCGJNSA-N D08ZMX DRUGSMIL CC(C(CCC1=C(C(=CC=C1)Cl)Cl)N2C=C(N=C2)C(=O)N)O D08ZMX HIGHSTAT Investigative D08ZNS DRUG__ID D08ZNS D08ZNS DRUGTYPE Small molecular drug D08ZNS DRUGINCH 1S/C23H34O4/c1-21-8-5-16(24)12-15(21)3-4-19-18(21)6-9-22(2)17(7-10-23(19,22)26)14-11-20(25)27-13-14/h11,15-19,24,26H,3-10,12-13H2,1-2H3/t15-,16+,17-,18+,19-,21+,22-,23+/m1/s1 D08ZNS DRUGINKE XZTUSOXSLKTKJQ-CESUGQOBSA-N D08ZNS DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3(CCC4C5=CC(=O)OC5)O)C)O D08ZNS HIGHSTAT Investigative D08ZOV DRUG__ID D08ZOV D08ZOV DRUGTYPE Small molecular drug D08ZOV DRUGINCH 1S/C17H15NO4/c1-20-14-9-8-12(11-6-4-3-5-7-11)13-10-15(22-16(13)14)18-17(19)21-2/h3-10H,1-2H3,(H,18,19) D08ZOV DRUGINKE CJZGJASKUWFLQA-UHFFFAOYSA-N D08ZOV DRUGSMIL COC1=C2C(=C(C=C1)C3=CC=CC=C3)C=C(O2)NC(=O)OC D08ZOV HIGHSTAT Investigative D08ZRA DRUG__ID D08ZRA D08ZRA DRUGTYPE Small molecular drug D08ZRA DRUGINCH 1S/C11H11N/c12-8-10-6-3-5-9-4-1-2-7-11(9)10/h1-7H,8,12H2 D08ZRA DRUGINKE NVSYANRBXPURRQ-UHFFFAOYSA-N D08ZRA DRUGSMIL C1=CC=C2C(=C1)C=CC=C2CN D08ZRA HIGHSTAT Investigative D08ZTA DRUG__ID D08ZTA D08ZTA DRUGTYPE Small molecular drug D08ZTA DRUGINCH 1S/C9H16N2O/c1-9(8-10-12)6-4-5-7-11(2)3/h9H,6-8H2,1-3H3 D08ZTA DRUGINKE DMQFXDRNMHZPER-UHFFFAOYSA-N D08ZTA DRUGSMIL CC(CC#CCN(C)C)CN=O D08ZTA HIGHSTAT Investigative D08ZTK DRUG__ID D08ZTK D08ZTK DRUGTYPE Small molecular drug D08ZTK DRUGINCH 1S/C22H29N3O5/c1-16(26)23-19-5-3-4-6-21(19)30-15-18(27)14-24-9-11-25(12-10-24)17-7-8-20(28)22(13-17)29-2/h3-8,13,18,27-28H,9-12,14-15H2,1-2H3,(H,23,26) D08ZTK DRUGINKE MXZGRDMOUWOERR-UHFFFAOYSA-N D08ZTK DRUGSMIL CC(=O)NC1=CC=CC=C1OCC(CN2CCN(CC2)C3=CC(=C(C=C3)O)OC)O D08ZTK HIGHSTAT Investigative D08ZTZ DRUG__ID D08ZTZ D08ZTZ DRUGTYPE Small molecular drug D08ZTZ DRUGINCH 1S/C16H12ClNO/c1-19-15-7-5-12-9-11(4-6-14(12)16(15)17)13-3-2-8-18-10-13/h2-10H,1H3 D08ZTZ DRUGINKE BMTHOHYTXCPKJC-UHFFFAOYSA-N D08ZTZ DRUGSMIL COC1=C(C2=C(C=C1)C=C(C=C2)C3=CN=CC=C3)Cl D08ZTZ HIGHSTAT Investigative D08ZVM DRUG__ID D08ZVM D08ZVM DRUGTYPE Small molecular drug D08ZVM DRUGINCH 1S/C15H10ClN3O/c16-10-6-4-9(5-7-10)13-8-18-12-3-1-2-11(15(17)20)14(12)19-13/h1-8H,(H2,17,20) D08ZVM DRUGINKE FLYGLPYJEQPCFY-UHFFFAOYSA-N D08ZVM DRUGSMIL C1=CC(=C2C(=C1)N=CC(=N2)C3=CC=C(C=C3)Cl)C(=O)N D08ZVM HIGHSTAT Investigative D08ZWJ DRUG__ID D08ZWJ D08ZWJ DRUGTYPE Small molecular drug D08ZWJ DRUGINCH 1S/C17H13BrN2/c1-9-14-8-19-6-5-12(14)10(2)17-16(9)13-7-11(18)3-4-15(13)20-17/h3-8,20H,1-2H3 D08ZWJ DRUGINKE OSDDZVXUCKZOQA-UHFFFAOYSA-N D08ZWJ DRUGSMIL CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)Br)C D08ZWJ HIGHSTAT Investigative D08ZWM DRUG__ID D08ZWM D08ZWM DRUGTYPE Small molecular drug D08ZWM DRUGINCH 1S/C12H16N2O/c1-14(2)7-6-9-8-13-10-4-3-5-11(15)12(9)10/h3-5,8,13,15H,6-7H2,1-2H3 D08ZWM DRUGINKE SPCIYGNTAMCTRO-UHFFFAOYSA-N D08ZWM DRUGSMIL CN(C)CCC1=CNC2=C1C(=CC=C2)O D08ZWM HIGHSTAT Investigative D08ZYC DRUG__ID D08ZYC D08ZYC DRUGTYPE Small molecular drug D08ZYC DRUGINCH 1S/C22H21NO3/c24-22(25)14-11-17-9-12-19(13-10-17)23-16-18-5-4-8-21(15-18)26-20-6-2-1-3-7-20/h1-10,12-13,15,23H,11,14,16H2,(H,24,25) D08ZYC DRUGINKE DGENZVKCTGIDRZ-UHFFFAOYSA-N D08ZYC DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CNC3=CC=C(C=C3)CCC(=O)O D08ZYC HIGHSTAT Investigative D08ZZJ DRUG__ID D08ZZJ D08ZZJ DRUGTYPE Small molecular drug D08ZZJ DRUGINCH 1S/C16H20ClN3S/c1-10(2)6-7-19-9-12-13(17)4-5-14-15(12)20(8-11(19)3)16(21)18-14/h4-6,11H,7-9H2,1-3H3,(H,18,21)/t11-/m0/s1 D08ZZJ DRUGINKE ZNFFMCYSMBXZQU-NSHDSACASA-N D08ZZJ DRUGSMIL CC1CN2C3=C(C=CC(=C3CN1CC=C(C)C)Cl)NC2=S D08ZZJ HIGHSTAT Investigative D08ZZX DRUG__ID D08ZZX D08ZZX DRUGTYPE Small molecular drug D08ZZX DRUGINCH 1S/C10H9NO4/c1-14-7-4-2-3-6(5-7)8-9(12)11-15-10(8)13/h2-5,8H,1H3,(H,11,12) D08ZZX DRUGINKE GTLJNZXLCZDZRN-UHFFFAOYSA-N D08ZZX DRUGSMIL COC1=CC=CC(=C1)C2C(=O)NOC2=O D08ZZX HIGHSTAT Investigative D09AAZ DRUG__ID D09AAZ D09AAZ DRUGTYPE Small molecular drug D09AAZ DRUGINCH 1S/C12H19N3S2/c1-2-6-16-12-11(13-17-14-12)10-8-15-5-3-4-9(10)7-15/h9-10H,2-8H2,1H3/t9-,10-/m0/s1 D09AAZ DRUGINKE ZZGXRPGQPAPARK-UWVGGRQHSA-N D09AAZ DRUGSMIL CCCSC1=NSN=C1C2CN3CCCC2C3 D09AAZ HIGHSTAT Investigative D09ABM DRUG__ID D09ABM D09ABM DRUGTYPE Small molecular drug D09ABM DRUGINCH 1S/C17H20O2/c1-2-3-5-8-14-11-12-17(16(18)13-14)19-15-9-6-4-7-10-15/h4,6-7,9-13,18H,2-3,5,8H2,1H3 D09ABM DRUGINKE OJLYTHOKCYLPMA-UHFFFAOYSA-N D09ABM DRUGSMIL CCCCCC1=CC(=C(C=C1)OC2=CC=CC=C2)O D09ABM HIGHSTAT Investigative D09ACO DRUG__ID D09ACO D09ACO DRUGTYPE Small molecular drug D09ACO DRUGINCH 1S/C5H9NO2/c1-4(6)2-3-5(7)8/h2-4H,6H2,1H3,(H,7,8)/b3-2+/t4-/m0/s1 D09ACO DRUGINKE SCUXCFWYAJSHJI-ZPYNKGFJSA-N D09ACO DRUGSMIL CC(C=CC(=O)O)N D09ACO HIGHSTAT Investigative D09ADW DRUG__ID D09ADW D09ADW DRUGTYPE Small molecular drug D09ADW DRUGINCH 1S/C20H14F3N5O4S/c1-32-20-13-8-11(9-24-18(13)26-27-20)25-19(29)16-14(22)5-6-15(17(16)23)28-33(30,31)12-4-2-3-10(21)7-12/h2-9,28H,1H3,(H,25,29)(H,24,26,27) D09ADW DRUGINKE WGFNXGPBPIJYLI-UHFFFAOYSA-N D09ADW DRUGSMIL COC1=NNC2=C1C=C(C=N2)NC(=O)C3=C(C=CC(=C3F)NS(=O)(=O)C4=CC=CC(=C4)F)F D09ADW HIGHSTAT Investigative D09AED DRUG__ID D09AED D09AED DRUGTYPE Small molecular drug D09AED DRUGINCH 1S/C16H11NO3/c18-14-12-8-4-5-9-13(12)15(19)17(16(14)20)10-11-6-2-1-3-7-11/h1-9H,10H2 D09AED DRUGINKE MCRWFXGWJMDFON-UHFFFAOYSA-N D09AED DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C3=CC=CC=C3C(=O)C2=O D09AED HIGHSTAT Investigative D09AEV DRUG__ID D09AEV D09AEV DRUGTYPE Small molecular drug D09AEV DRUGINCH 1S/C72H90N8O6/c81-58-22-17-37-79-40-29-61(58)86-72-32-23-60(85-47-69-46-78-36-16-8-3-1-5-13-30-70(83,66(69)79)42-53(55(69)27-39-78)63-65-51(25-34-74-63)49-19-10-12-21-57(49)76-65)59(82)28-41-80(72)67-68(44-72)45-77-35-15-7-4-2-6-14-31-71(67,84)43-52(54(68)26-38-77)62-64-50(24-33-73-62)48-18-9-11-20-56(48)75-64/h1-2,5-6,9-12,18-21,24-25,33-34,42-43,54-55,58-61,66-67,75-76,81-84H,3-4,7-8,13-17,22-23,26-32,35-41,44-47H2/b5-1-,6-2-/t54-,55-,58+,59-,60+,61-,66+,67+,68-,69+,70-,71-,72+/m0/s1 D09AEV DRUGINKE QBYWKABDYAEEIS-VZMZVYMRSA-N D09AEV DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC56N4CCC(C(CC5)OCC78CN9CCCCC=CCCC(C7N1CCCC(C(O6)CC1)O)(C=C(C8CC9)C1=NC=CC2=C1NC1=CC=CC=C21)O)O)O)C1=NC=CC2=C1NC1=CC=CC=C21 D09AEV HIGHSTAT Investigative D09AFM DRUG__ID D09AFM D09AFM DRUGTYPE Small molecular drug D09AFM DRUGINCH 1S/C21H16N2O9S2.2Na/c24-19-9-15(33(27,28)29)7-11-5-13(1-3-17(11)19)22-21(26)23-14-2-4-18-12(6-14)8-16(10-20(18)25)34(30,31)32;;/h1-10,24-25H,(H2,22,23,26)(H,27,28,29)(H,30,31,32);;/q;2*+1/p-2 D09AFM DRUGINKE MOUNHKKCIGVIDI-UHFFFAOYSA-L D09AFM DRUGSMIL C1=CC2=C(C=C(C=C2C=C1NC(=O)NC3=CC4=CC(=CC(=C4C=C3)O)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+] D09AFM HIGHSTAT Investigative D09AHL DRUG__ID D09AHL D09AHL DRUGTYPE Small molecular drug D09AHL DRUGINCH 1S/C10H15N2O7P/c1-6-10(15)8(3-11-4-9(13)14)7(2-12-6)5-19-20(16,17)18/h2,11,15H,3-5H2,1H3,(H,13,14)(H2,16,17,18) D09AHL DRUGINKE FEVQWBMNLWUBTF-UHFFFAOYSA-N D09AHL DRUGSMIL CC1=NC=C(C(=C1O)CNCC(=O)O)COP(=O)(O)O D09AHL HIGHSTAT Investigative D09AHN DRUG__ID D09AHN D09AHN DRUGTYPE Small molecular drug D09AHN DRUGINCH 1S/C13H23N3O3/c1-9(2)8-10(11(17)15-7-6-14)16-12(18)19-13(3,4)5/h9-10H,7-8H2,1-5H3,(H,15,17)(H,16,18)/t10-/m0/s1 D09AHN DRUGINKE OMQSGXGRANQGLE-JTQLQIEISA-N D09AHN DRUGSMIL CC(C)CC(C(=O)NCC#N)NC(=O)OC(C)(C)C D09AHN HIGHSTAT Investigative D09AID DRUG__ID D09AID D09AID DRUGTYPE Small molecular drug D09AID DRUGINCH 1S/C28H35ClN6O3/c1-37-25-20-8-7-19(35-10-12-38-13-11-35)6-4-16(20)5-9-22(25)32-28-31-15-21(29)27(34-28)33-24-18-3-2-17(14-18)23(24)26(30)36/h2-3,5,9,15,17-19,23-24H,4,6-8,10-14H2,1H3,(H2,30,36)(H2,31,32,33,34)/t17-,18+,19+,23+,24-/m1/s1 D09AID DRUGINKE LAJAFFLJAJMYLK-CVOKMOJFSA-N D09AID DRUGSMIL COC1=C(C=CC2=C1CCC(CC2)N3CCOCC3)NC4=NC=C(C(=N4)NC5C6CC(C5C(=O)N)C=C6)Cl D09AID HIGHSTAT Investigative D09AKX DRUG__ID D09AKX D09AKX DRUGTYPE Small molecular drug D09AKX DRUGINCH 1S/C22H18N4O/c1-14-5-4-6-17(13-14)24-22-19-8-3-2-7-18(19)20(25-26-22)15-9-11-16(12-10-15)21(23)27/h2-13H,1H3,(H2,23,27)(H,24,26) D09AKX DRUGINKE JBCRRCQSLMCSLQ-UHFFFAOYSA-N D09AKX DRUGSMIL CC1=CC(=CC=C1)NC2=NN=C(C3=CC=CC=C32)C4=CC=C(C=C4)C(=O)N D09AKX HIGHSTAT Investigative D09ALJ DRUG__ID D09ALJ D09ALJ DRUGTYPE Small molecular drug D09ALJ DRUGINCH 1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1 D09ALJ DRUGINKE IKGXIBQEEMLURG-NVPNHPEKSA-N D09ALJ DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O D09ALJ HIGHSTAT Investigative D09AQJ DRUG__ID D09AQJ D09AQJ DRUGTYPE Small molecular drug D09AQJ DRUGINCH 1S/C24H37N5S/c1-2-12-28(21-10-11-22-23(19-21)30-24(25)26-22)14-7-6-13-27-15-17-29(18-16-27)20-8-4-3-5-9-20/h3-5,8-9,21H,2,6-7,10-19H2,1H3,(H2,25,26) D09AQJ DRUGINKE AHNMVVBJGPOWFW-UHFFFAOYSA-N D09AQJ DRUGSMIL CCCN(CCCCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)SC(=N4)N D09AQJ HIGHSTAT Investigative D09AQK DRUG__ID D09AQK D09AQK DRUGTYPE Small molecular drug D09AQK DRUGINCH 1S/C8H10NO5P/c9-7(8(10)11)5-1-3-6(4-2-5)15(12,13)14/h1-4,7H,9H2,(H,10,11)(H2,12,13,14) D09AQK DRUGINKE JRQRKFDFHAPMGQ-UHFFFAOYSA-N D09AQK DRUGSMIL C1=CC(=CC=C1C(C(=O)O)N)P(=O)(O)O D09AQK HIGHSTAT Investigative D09ATQ DRUG__ID D09ATQ D09ATQ DRUGTYPE Small molecular drug D09ATQ DRUGINCH 1S/C18H22NO6PS/c1-2-19-16-8-4-3-7-14(16)15-12-13(10-11-17(15)19)6-5-9-18(26(20,21)22)27(23,24)25/h3-4,7-8,10-12,18H,2,5-6,9H2,1H3,(H2,20,21,22)(H,23,24,25)/p-3 D09ATQ DRUGINKE ZZMVEURNXXVJQQ-UHFFFAOYSA-K D09ATQ DRUGSMIL CCN1C2=C(C=C(C=C2)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])C3=CC=CC=C31 D09ATQ HIGHSTAT Investigative D09AUL DRUG__ID D09AUL D09AUL DRUGTYPE Small molecular drug D09AUL DRUGINCH 1S/C18H15N5/c1-2-6-14(7-3-1)12-20-17-15-8-4-5-9-16(15)21-18(22-17)23-11-10-19-13-23/h1-11,13H,12H2,(H,20,21,22) D09AUL DRUGINKE FNTPEBIGZTYDQK-UHFFFAOYSA-N D09AUL DRUGSMIL C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)N4C=CN=C4 D09AUL HIGHSTAT Investigative D09AUU DRUG__ID D09AUU D09AUU DRUGTYPE Small molecular drug D09AUU DRUGINCH 1S/C18H25N/c1-13-6-7-14-12-17-15-5-3-4-8-18(15,16(14)11-13)9-10-19(17)2/h6-7,11,15,17H,3-5,8-10,12H2,1-2H3/t15-,17+,18+/m1/s1 D09AUU DRUGINKE KBEZZLAAKIIPFK-NJAFHUGGSA-N D09AUU DRUGSMIL CC1=CC2=C(CC3C4C2(CCCC4)CCN3C)C=C1 D09AUU HIGHSTAT Investigative D09AVG DRUG__ID D09AVG D09AVG DRUGTYPE Small molecular drug D09AVG DRUGINCH 1S/C14H19N3/c1-17-6-4-10(5-7-17)13-9-16-14-3-2-11(15)8-12(13)14/h2-3,8-10,16H,4-7,15H2,1H3 D09AVG DRUGINKE CKBJZDHVHHKARV-UHFFFAOYSA-N D09AVG DRUGSMIL CN1CCC(CC1)C2=CNC3=C2C=C(C=C3)N D09AVG HIGHSTAT Investigative D09AVL DRUG__ID D09AVL D09AVL DRUGTYPE Small molecular drug D09AVL DRUGINCH 1S/C15H18N2OS/c18-15-13(10-11-4-2-1-3-5-11)14(19-17-15)12-6-8-16-9-7-12/h1-5,12,16H,6-10H2,(H,17,18) D09AVL DRUGINKE VUKNNEXTWWCNCW-UHFFFAOYSA-N D09AVL DRUGSMIL C1CNCCC1C2=C(C(=O)NS2)CC3=CC=CC=C3 D09AVL HIGHSTAT Investigative D09AWB DRUG__ID D09AWB D09AWB DRUGTYPE Small molecular drug D09AWB DRUGINCH 1S/C21H24INO/c22-19-8-4-7-17-13-21(24)20(14-18(17)19)23-11-9-16(10-12-23)15-5-2-1-3-6-15/h1-8,16,20-21,24H,9-14H2/t20-,21-/m1/s1/i22-4 D09AWB DRUGINKE FHYAUNJNVMGZQN-YKBXEZAISA-N D09AWB DRUGSMIL C1CN(CCC1C2=CC=CC=C2)C3CC4=C(CC3O)C=CC=C4I D09AWB HIGHSTAT Investigative D09AXB DRUG__ID D09AXB D09AXB DRUGTYPE Small molecular drug D09AXB DRUGINCH 1S/C18H24Cl2O6/c19-13-8-7-12(15(20)9-13)5-3-1-2-4-6-14(21)10-18(26,17(24)25)11-16(22)23/h7-9,14,21,26H,1-6,10-11H2,(H,22,23)(H,24,25)/t14-,18+/m1/s1 D09AXB DRUGINKE NPZOIISFQXTCQN-KDOFPFPSSA-N D09AXB DRUGSMIL C1=CC(=C(C=C1Cl)Cl)CCCCCCC(CC(CC(=O)O)(C(=O)O)O)O D09AXB HIGHSTAT Investigative D09AYK DRUG__ID D09AYK D09AYK DRUGTYPE Small molecular drug D09AYK DRUGINCH 1S/C12H11NO3/c1-2-16-12(15)9-7-13-10-6-4-3-5-8(10)11(9)14/h3-7H,2H2,1H3,(H,13,14) D09AYK DRUGINKE YBEOYBKKSWUSBR-UHFFFAOYSA-N D09AYK DRUGSMIL CCOC(=O)C1=CNC2=CC=CC=C2C1=O D09AYK HIGHSTAT Investigative D09AYR DRUG__ID D09AYR D09AYR DRUGTYPE Small molecular drug D09AYR DRUGINCH 1S/C6H4N2O6/c9-5-2-3(7(11)12)1-4(6(5)10)8(13)14/h1-2,9-10H D09AYR DRUGINKE VDCDWNDTNSWDFJ-UHFFFAOYSA-N D09AYR DRUGSMIL C1=C(C=C(C(=C1[N+](=O)[O-])O)O)[N+](=O)[O-] D09AYR HIGHSTAT Investigative D09AZM DRUG__ID D09AZM D09AZM DRUGTYPE Small molecular drug D09AZM DRUGINCH 1S/C23H38O4/c1-3-4-7-16(2)12-19(24)10-11-20-21-14-17(8-5-6-9-23(26)27)13-18(21)15-22(20)25/h10-11,13,16,18-22,24-25H,3-9,12,14-15H2,1-2H3,(H,26,27)/b11-10+/t16-,18?,19+,20+,21?,22+/m0/s1 D09AZM DRUGINKE BPNIWRLPDMCZPC-ASUUCAAFSA-N D09AZM DRUGSMIL CCCCC(C)CC(C=CC1C(CC2C1CC(=C2)CCCCC(=O)O)O)O D09AZM HIGHSTAT Investigative D09AZO DRUG__ID D09AZO D09AZO DRUGTYPE Small molecular drug D09AZO DRUGINCH 1S/C20H18N2O/c1-14-5-11-18(12-6-14)22-20(23)17-9-7-16(8-10-17)19-15(2)4-3-13-21-19/h3-13H,1-2H3,(H,22,23) D09AZO DRUGINKE ACHPKRXTLZWRLG-UHFFFAOYSA-N D09AZO DRUGSMIL CC1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)C3=C(C=CC=N3)C D09AZO HIGHSTAT Investigative D09BEW DRUG__ID D09BEW D09BEW DRUGTYPE Small molecular drug D09BEW DRUGINCH 1S/C18H22N2O/c1-3-4-5-7-15-9-11-16(12-10-15)18(21)20(2)17-8-6-13-19-14-17/h6,8-14H,3-5,7H2,1-2H3 D09BEW DRUGINKE NOLPMCFMEHRJFY-UHFFFAOYSA-N D09BEW DRUGSMIL CCCCCC1=CC=C(C=C1)C(=O)N(C)C2=CN=CC=C2 D09BEW HIGHSTAT Investigative D09BGI DRUG__ID D09BGI D09BGI DRUGTYPE Small molecular drug D09BGI DRUGINCH 1S/C24H27N3O4S/c28-27(29)23-7-3-4-8-24(23)32(30,31)26-17-19-11-9-18(10-12-19)16-25-22-14-13-20-5-1-2-6-21(20)15-22/h1-8,13-15,18-19,25-26H,9-12,16-17H2 D09BGI DRUGINKE BPBPTEVVRMSHTB-UHFFFAOYSA-N D09BGI DRUGSMIL C1CC(CCC1CNC2=CC3=CC=CC=C3C=C2)CNS(=O)(=O)C4=CC=CC=C4[N+](=O)[O-] D09BGI HIGHSTAT Investigative D09BGX DRUG__ID D09BGX D09BGX DRUGTYPE Small molecular drug D09BGX DRUGINCH 1S/C12H17N4O4PS/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19)/p+1 D09BGX DRUGINKE HZSAJDVWZRBGIF-UHFFFAOYSA-O D09BGX DRUGSMIL CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)O D09BGX HIGHSTAT Investigative D09BIV DRUG__ID D09BIV D09BIV DRUGTYPE Small molecular drug D09BIV DRUGINCH 1S/C11H12N2/c1-2-4-10(5-3-1)6-7-11-12-8-9-13-11/h1-7H,8-9H2,(H,12,13)/b7-6+ D09BIV DRUGINKE IGISUADTPSLENQ-VOTSOKGWSA-N D09BIV DRUGSMIL C1CN=C(N1)C=CC2=CC=CC=C2 D09BIV HIGHSTAT Investigative D09BJN DRUG__ID D09BJN D09BJN DRUGTYPE Small molecular drug D09BJN DRUGINCH 1S/C13H16Cl2N2O/c14-9-5-4-8(7-10(9)15)12(13(16)18)11-3-1-2-6-17-11/h4-5,7,11-12,17H,1-3,6H2,(H2,16,18)/t11-,12-/m1/s1 D09BJN DRUGINKE OUZYXOJONCTZTI-VXGBXAGGSA-N D09BJN DRUGSMIL C1CCNC(C1)C(C2=CC(=C(C=C2)Cl)Cl)C(=O)N D09BJN HIGHSTAT Investigative D09BJW DRUG__ID D09BJW D09BJW DRUGTYPE Small molecular drug D09BJW DRUGINCH 1S/C15H17NO/c1-17-15-13-5-3-2-4-10(13)8-11-6-7-12(16)9-14(11)15/h2-5,8,12H,6-7,9,16H2,1H3 D09BJW DRUGINKE XZOPIEFNQZTGHL-UHFFFAOYSA-N D09BJW DRUGSMIL COC1=C2CC(CCC2=CC3=CC=CC=C31)N D09BJW HIGHSTAT Investigative D09BKM DRUG__ID D09BKM D09BKM DRUGTYPE Small molecular drug D09BKM DRUGINCH 1S/C18H30O3S/c1-3-5-7-9-11-16(10-8-6-4-2)17-12-14-18(15-13-17)22(19,20)21/h12-16H,3-11H2,1-2H3,(H,19,20,21) D09BKM DRUGINKE GHNRTXCRBJQVGN-UHFFFAOYSA-N D09BKM DRUGSMIL CCCCCCC(CCCCC)C1=CC=C(C=C1)S(=O)(=O)O D09BKM HIGHSTAT Investigative D09BKV DRUG__ID D09BKV D09BKV DRUGTYPE Small molecular drug D09BKV DRUGINCH 1S/C8H16N2S/c1-2-3-7-6-11-5-4-8(9)10-7/h7H,2-6H2,1H3,(H2,9,10) D09BKV DRUGINKE SWOQAUBWIBZBLQ-UHFFFAOYSA-N D09BKV DRUGSMIL CCCC1CSCCC(=N1)N D09BKV HIGHSTAT Investigative D09BLB DRUG__ID D09BLB D09BLB DRUGTYPE Small molecular drug D09BLB DRUGINCH 1S/C26H55N2O7P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-21-32-23-25(35-26(29)27-2)24-34-36(30,31)33-22-20-28(3,4)5/h25H,6-24H2,1-5H3,(H-,27,29,30,31)/t25-/m1/s1 D09BLB DRUGINKE FNFHZBKBDFRYHS-RUZDIDTESA-N D09BLB DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)NC D09BLB HIGHSTAT Investigative D09BNS DRUG__ID D09BNS D09BNS DRUGTYPE Small molecular drug D09BNS DRUGINCH 1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1 D09BNS DRUGINKE LDCYZAJDBXYCGN-VIFPVBQESA-N D09BNS DRUGSMIL C1=CC2=C(C=C1O)C(=CN2)CC(C(=O)O)N D09BNS HIGHSTAT Investigative D09BPC DRUG__ID D09BPC D09BPC DRUGTYPE Small molecular drug D09BPC DRUGINCH 1S/C9H19N3O2/c1-2-4-8(11)12-6-3-5-7(10)9(13)14/h7H,2-6,10H2,1H3,(H2,11,12)(H,13,14)/p+1/t7-/m0/s1 D09BPC DRUGINKE KRILJVOCVSUPMA-ZETCQYMHSA-O D09BPC DRUGSMIL CCCC(=[NH+]CCCC(C(=O)O)N)N D09BPC HIGHSTAT Investigative D09BQY DRUG__ID D09BQY D09BQY DRUGTYPE Small molecular drug D09BQY DRUGINCH 1S/C14H17N3O/c1-3-5-10-7-8-11-12(9-10)16-17-14(11)15-13(18)6-4-2/h3,5,7-9H,4,6H2,1-2H3,(H2,15,16,17,18)/b5-3+ D09BQY DRUGINKE KPYYGELCJSEEPK-HWKANZROSA-N D09BQY DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C=CC D09BQY HIGHSTAT Investigative D09BSE DRUG__ID D09BSE D09BSE DRUGTYPE Small molecular drug D09BSE DRUGINCH 1S/C19H20BrNO4/c1-21-5-4-10-15-12(21)6-9-7-13(22)14(24-2)8-11(9)16(15)19(25-3)18(23)17(10)20/h7-8,12,22-23H,4-6H2,1-3H3/t12-/m0/s1 D09BSE DRUGINKE ORZPHDSNVICTTE-LBPRGKRZSA-N D09BSE DRUGSMIL CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2Br)O)OC)OC)O D09BSE HIGHSTAT Investigative D09BUG DRUG__ID D09BUG D09BUG DRUGTYPE Small molecular drug D09BUG DRUGINCH 1S/C15H10O5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18H,6H2 D09BUG DRUGINKE YDQWDHRMZQUTBA-UHFFFAOYSA-N D09BUG DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)CO D09BUG HIGHSTAT Investigative D09BUM DRUG__ID D09BUM D09BUM DRUGTYPE Small molecular drug D09BUM DRUGINCH 1S/C14H19N3OS/c18-13-8-6-11(7-9-13)10-15-17-14(19)16-12-4-2-1-3-5-12/h6-10,12,18H,1-5H2,(H2,16,17,19)/b15-10+ D09BUM DRUGINKE GRDLPUUYRVMQPX-XNTDXEJSSA-N D09BUM DRUGSMIL C1CCC(CC1)NC(=S)NN=CC2=CC=C(C=C2)O D09BUM HIGHSTAT Investigative D09BVA DRUG__ID D09BVA D09BVA DRUGTYPE Small molecular drug D09BVA DRUGINCH 1S/C11H8O4/c1-6(12)9-4-7-2-3-8(13)5-10(7)15-11(9)14/h2-5,13H,1H3 D09BVA DRUGINKE BRQZHMHHZLRXOO-UHFFFAOYSA-N D09BVA DRUGSMIL CC(=O)C1=CC2=C(C=C(C=C2)O)OC1=O D09BVA HIGHSTAT Investigative D09BVH DRUG__ID D09BVH D09BVH DRUGTYPE Small molecular drug D09BVH DRUGINCH 1S/C10H8O2/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6,11-12H D09BVH DRUGINKE PCILLCXFKWDRMK-UHFFFAOYSA-N D09BVH DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2O)O D09BVH HIGHSTAT Investigative D09BWE DRUG__ID D09BWE D09BWE DRUGTYPE Small molecular drug D09BWE DRUGINCH 1S/C19H20N2O2S/c22-15-9-11-21(12-10-15)13-14-5-7-16(8-6-14)23-19-20-17-3-1-2-4-18(17)24-19/h1-8,15,22H,9-13H2 D09BWE DRUGINKE CFTXJKKITUELKJ-UHFFFAOYSA-N D09BWE DRUGSMIL C1CN(CCC1O)CC2=CC=C(C=C2)OC3=NC4=CC=CC=C4S3 D09BWE HIGHSTAT Investigative D09BWX DRUG__ID D09BWX D09BWX DRUGTYPE Small molecular drug D09BWX DRUGINCH 1S/C34H35N5O4/c40-31-27(18-22-10-3-1-4-11-22)37-33(42)30-16-9-17-39(30)34(43)29(19-23-12-5-2-6-13-23)38-32(41)28(36-31)20-24-21-35-26-15-8-7-14-25(24)26/h1-8,10-15,21,27-30,35H,9,16-20H2,(H,36,40)(H,37,42)(H,38,41)/t27-,28+,29-,30+/m0/s1 D09BWX DRUGINKE GIZJWWQFOGQPRY-RRGQHJHPSA-N D09BWX DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4=CNC5=CC=CC=C54)CC6=CC=CC=C6 D09BWX HIGHSTAT Investigative D09BXA DRUG__ID D09BXA D09BXA DRUGTYPE Small molecular drug D09BXA DRUGINCH 1S/C25H24F2N6O2/c1-3-35-16-11-19(26)18(20(27)12-16)14-33-21-6-4-5-17(21)23(32-33)25-29-13-22(34-2)24(31-25)30-15-7-9-28-10-8-15/h7-13H,3-6,14H2,1-2H3,(H,28,29,30,31) D09BXA DRUGINKE UJORPFQWUKFXIE-UHFFFAOYSA-N D09BXA DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C3=C(CCC3)C(=N2)C4=NC=C(C(=N4)NC5=CC=NC=C5)OC)F D09BXA HIGHSTAT Investigative D09BXH DRUG__ID D09BXH D09BXH DRUGTYPE Small molecular drug D09BXH DRUGINCH 1S/C15H21N3O3/c16-14-12(8-5-9-17-14)15(20)21-10-13(19)18-11-6-3-1-2-4-7-11/h5,8-9,11H,1-4,6-7,10H2,(H2,16,17)(H,18,19) D09BXH DRUGINKE YLZFUORCIVHHHD-UHFFFAOYSA-N D09BXH DRUGSMIL C1CCCC(CC1)NC(=O)COC(=O)C2=C(N=CC=C2)N D09BXH HIGHSTAT Investigative D09BYA DRUG__ID D09BYA D09BYA DRUGTYPE Small molecular drug D09BYA DRUGINCH 1S/C15H24N2/c1-2-3-7-13-12-17(11-10-15(13)16)14-8-5-4-6-9-14/h4-6,8-9,13,15H,2-3,7,10-12,16H2,1H3/t13-,15+/m0/s1 D09BYA DRUGINKE YRWPYATYRUCVQO-DZGCQCFKSA-N D09BYA DRUGSMIL CCCCC1CN(CCC1N)C2=CC=CC=C2 D09BYA HIGHSTAT Investigative D09BYB DRUG__ID D09BYB D09BYB DRUGTYPE Small molecular drug D09BYB DRUGINCH 1S/C14H21NO/c1-10-6-8-12(9-7-10)13(16)11(2)15-14(3,4)5/h6-9,11,15H,1-5H3 D09BYB DRUGINKE BMWDQBTXNBGORC-UHFFFAOYSA-N D09BYB DRUGSMIL CC1=CC=C(C=C1)C(=O)C(C)NC(C)(C)C D09BYB HIGHSTAT Investigative D09BYD DRUG__ID D09BYD D09BYD DRUGTYPE Small molecular drug D09BYD DRUGINCH 1S/C25H27NO/c1-20-10-8-9-15-23(20)25(27)16-18-26(19-17-25)24(21-11-4-2-5-12-21)22-13-6-3-7-14-22/h2-15,24,27H,16-19H2,1H3 D09BYD DRUGINKE WOOXDHAITFKPDQ-UHFFFAOYSA-N D09BYD DRUGSMIL CC1=CC=CC=C1C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D09BYD HIGHSTAT Investigative D09BYO DRUG__ID D09BYO D09BYO DRUGTYPE Small molecular drug D09BYO DRUGINCH 1S/C24H21Cl3N2O3/c1-24(2)11-20(28-21(31)12-30)18-10-17(13-3-5-14(25)6-4-13)22(29-23(18)32-24)16-8-7-15(26)9-19(16)27/h3-10,20,30H,11-12H2,1-2H3,(H,28,31) D09BYO DRUGINKE LGJVWHPVWBOBEW-UHFFFAOYSA-N D09BYO DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)NC(=O)CO)C D09BYO HIGHSTAT Investigative D09BYW DRUG__ID D09BYW D09BYW DRUGTYPE Small molecular drug D09BYW DRUGINCH 1S/C21H27N3O/c25-21(19-9-3-1-4-10-19)22-13-7-8-14-23-15-17-24(18-16-23)20-11-5-2-6-12-20/h1-6,9-12H,7-8,13-18H2,(H,22,25) D09BYW DRUGINKE SPKHLKULRLEZKZ-UHFFFAOYSA-N D09BYW DRUGSMIL C1CN(CCN1CCCCNC(=O)C2=CC=CC=C2)C3=CC=CC=C3 D09BYW HIGHSTAT Investigative D09BZV DRUG__ID D09BZV D09BZV DRUGTYPE Small molecular drug D09BZV DRUGINCH 1S/C20H25NO2/c22-19-6-8-20(9-7-19)23-15-14-21-12-10-18(11-13-21)16-17-4-2-1-3-5-17/h1-9,18,22H,10-16H2 D09BZV DRUGINKE CSOKNRXDEKJUFZ-UHFFFAOYSA-N D09BZV DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CCOC3=CC=C(C=C3)O D09BZV HIGHSTAT Investigative D09CAI DRUG__ID D09CAI D09CAI DRUGTYPE Small molecular drug D09CAI DRUGINCH 1S/C41H66O13/c1-21(2)36(51-34(47)20-31(45)35-27(8)39(48)52-40(35)49)38(50-10)32(46)19-30(44)26(7)29(43)13-11-24(5)37-25(6)16-18-41(54-37)17-15-23(4)33(53-41)14-12-22(3)28(9)42/h21-26,29,31-33,36-38,43,45-46H,11-20H2,1-10H3/t22-,23+,24+,25-,26-,29-,31+,32+,33-,36+,37-,38+,41+/m0/s1 D09CAI DRUGINKE RFCWHQNNCOJYTR-IRCAEPKSSA-N D09CAI DRUGSMIL CC1CCC2(CCC(C(O2)C(C)CCC(C(C)C(=O)CC(C(C(C(C)C)OC(=O)CC(C3=C(C(=O)OC3=O)C)O)OC)O)O)C)OC1CCC(C)C(=O)C D09CAI HIGHSTAT Investigative D09CFD DRUG__ID D09CFD D09CFD DRUGTYPE Small molecular drug D09CFD DRUGINCH 1S/C43H58N12O9/c1-5-23(3)35(37(44)59)54-38(60)29(12-9-18-47-43(45)46)52-39(61)31(21-34(57)58)53-41(63)36(24(4)6-2)55-19-17-30(42(55)64)51-33(56)20-25-13-15-26(16-14-25)49-40(62)32-22-48-27-10-7-8-11-28(27)50-32/h7-8,10-11,13-16,22-24,29-31,35-36H,5-6,9,12,17-21H2,1-4H3,(H2,44,59)(H,49,62)(H,51,56)(H,52,61)(H,53,63)(H,54,60)(H,57,58)(H4,45,46,47)/t23-,24-,29+,30+,31-,35-,36-/m0/s1 D09CFD DRUGINKE VINFYKMOVBYUSF-ZCWPROOASA-N D09CFD DRUGSMIL CCC(C)C(C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)CC)N1CCC(C1=O)NC(=O)CC2=CC=C(C=C2)NC(=O)C3=NC4=CC=CC=C4N=C3 D09CFD HIGHSTAT Investigative D09CFW DRUG__ID D09CFW D09CFW DRUGTYPE Small molecular drug D09CFW DRUGINCH 1S/C21H18N2O3S2/c1-23-17-13-14(20(24)22-11-10-15-5-4-12-27-15)8-9-19(17)28(26)18-7-3-2-6-16(18)21(23)25/h2-9,12-13H,10-11H2,1H3,(H,22,24)/t28-/m0/s1 D09CFW DRUGINKE YXLLQNMKIDBOGH-NDEPHWFRSA-N D09CFW DRUGSMIL CN1C2=C(C=CC(=C2)C(=O)NCCC3=CC=CS3)S(=O)C4=CC=CC=C4C1=O D09CFW HIGHSTAT Investigative D09CGH DRUG__ID D09CGH D09CGH DRUGTYPE Small molecular drug D09CGH DRUGINCH 1S/C13H20Cl2N2/c1-16(2)8-9-17(3)7-6-11-4-5-12(14)13(15)10-11/h4-5,10H,6-9H2,1-3H3 D09CGH DRUGINKE MGVRNMUKTZOQOW-UHFFFAOYSA-N D09CGH DRUGSMIL CN(C)CCN(C)CCC1=CC(=C(C=C1)Cl)Cl D09CGH HIGHSTAT Investigative D09CGL DRUG__ID D09CGL D09CGL DRUGTYPE Small molecular drug D09CGL DRUGINCH 1S/C14H14O3.Na/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10;/h3-9H,1-2H3,(H,15,16);/q;+1/p-1/t9-;/m0./s1 D09CGL DRUGINKE CDBRNDSHEYLDJV-FVGYRXGTSA-M D09CGL DRUGSMIL CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+] D09CGL HIGHSTAT Investigative D09CGV DRUG__ID D09CGV D09CGV DRUGTYPE Small molecular drug D09CGV DRUGINCH 1S/C13H12N2O/c1-8-13-10(5-6-15(8)2)11-7-9(16)3-4-12(11)14-13/h3-7,16H,1-2H3/p+1 D09CGV DRUGINKE ICPRLZDLIOARIN-UHFFFAOYSA-O D09CGV DRUGSMIL CC1=[N+](C=CC2=C1NC3=C2C=C(C=C3)O)C D09CGV HIGHSTAT Investigative D09CIX DRUG__ID D09CIX D09CIX DRUGTYPE Small molecular drug D09CIX DRUGINCH 1S/C27H31NO2/c29-27(30-26-20-13-19-25(22-26)24-17-10-6-11-18-24)28-21-12-4-2-1-3-7-14-23-15-8-5-9-16-23/h5-6,8-11,13,15-20,22H,1-4,7,12,14,21H2,(H,28,29) D09CIX DRUGINKE IKKKZTIUGOILBU-UHFFFAOYSA-N D09CIX DRUGSMIL C1=CC=C(C=C1)CCCCCCCCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D09CIX HIGHSTAT Investigative D09CKI DRUG__ID D09CKI D09CKI DRUGTYPE Small molecular drug D09CKI DRUGINCH 1S/C22H26N2O3/c1-4-14-12-24-10-9-16-15-7-5-6-8-19(15)23-21(16)20(24)11-17(14)18(13-26-2)22(25)27-3/h4-8,13-14,17,20,23H,1,9-12H2,2-3H3/b18-13+/t14-,17-,20-/m0/s1 D09CKI DRUGINKE TZUGIFAYWNNSAO-XPOGPMDLSA-N D09CKI DRUGSMIL COC=C(C1CC2C3=C(CCN2CC1C=C)C4=CC=CC=C4N3)C(=O)OC D09CKI HIGHSTAT Investigative D09CKP DRUG__ID D09CKP D09CKP DRUGTYPE Small molecular drug D09CKP DRUGINCH 1S/C6H10O2/c1-6(2)3-4-8-5(6)7/h3-4H2,1-2H3 D09CKP DRUGINKE UPVAIJPDWVTFKT-UHFFFAOYSA-N D09CKP DRUGSMIL CC1(CCOC1=O)C D09CKP HIGHSTAT Investigative D09CKV DRUG__ID D09CKV D09CKV DRUGTYPE Small molecular drug D09CKV DRUGINCH 1S/C13H19NO2S/c1-9-3-4-11(7-10(9)2)8-17-6-5-12(14)13(15)16/h3-4,7,12H,5-6,8,14H2,1-2H3,(H,15,16) D09CKV DRUGINKE HMCZVDYIAXLHNI-UHFFFAOYSA-N D09CKV DRUGSMIL CC1=C(C=C(C=C1)CSCCC(C(=O)O)N)C D09CKV HIGHSTAT Investigative D09CKZ DRUG__ID D09CKZ D09CKZ DRUGTYPE Small molecular drug D09CKZ DRUGINCH 1S/C26H34O2/c1-15-4-5-21-20(6-15)24-22(27)10-19(11-23(24)28-25(21,2)3)26-12-16-7-17(13-26)9-18(8-16)14-26/h4,10-11,16-18,20-21,27H,5-9,12-14H2,1-3H3/t16?,17?,18?,20-,21-,26?/m1/s1 D09CKZ DRUGINKE RPBMPWGKZFLMFN-OKFSJJLXSA-N D09CKZ DRUGSMIL CC1=CCC2C(C1)C3=C(C=C(C=C3OC2(C)C)C45CC6CC(C4)CC(C6)C5)O D09CKZ HIGHSTAT Investigative D09CLP DRUG__ID D09CLP D09CLP DRUGTYPE Small molecular drug D09CLP DRUGINCH 1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1 D09CLP DRUGINKE ZJUKTBDSGOFHSH-WFMPWKQPSA-N D09CLP DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CSCCC(C(=O)O)N)O)O)N D09CLP HIGHSTAT Investigative D09CMJ DRUG__ID D09CMJ D09CMJ DRUGTYPE Small molecular drug D09CMJ DRUGINCH 1S/C23H25N3O3S.ClH/c1-25-12-14-26(15-13-25)23(27)22-24-20(16-4-8-18(28-2)9-5-16)21(30-22)17-6-10-19(29-3)11-7-17;/h4-11H,12-15H2,1-3H3;1H D09CMJ DRUGINKE YWMAVHIKOAOSFM-UHFFFAOYSA-N D09CMJ DRUGSMIL CN1CCN(CC1)C(=O)C2=NC(=C(S2)C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC.Cl D09CMJ HIGHSTAT Investigative D09CNT DRUG__ID D09CNT D09CNT DRUGTYPE Small molecular drug D09CNT DRUGINCH 1S/C10H11N3OS2/c15-9(13-10-12-5-7-16-10)11-4-3-8-2-1-6-14-8/h1-2,5-7H,3-4H2,(H2,11,12,13,15) D09CNT DRUGINKE HSLMRTQANDUJDA-UHFFFAOYSA-N D09CNT DRUGSMIL C1=COC(=C1)CCNC(=S)NC2=NC=CS2 D09CNT HIGHSTAT Investigative D09CQC DRUG__ID D09CQC D09CQC DRUGTYPE Small molecular drug D09CQC DRUGINCH 1S/C13H9NO3/c15-9-3-1-8(2-4-9)13-14-11-6-5-10(16)7-12(11)17-13/h1-7,15-16H D09CQC DRUGINKE PDCFEVXISBNCNF-UHFFFAOYSA-N D09CQC DRUGSMIL C1=CC(=CC=C1C2=NC3=C(O2)C=C(C=C3)O)O D09CQC HIGHSTAT Investigative D09CQO DRUG__ID D09CQO D09CQO DRUGTYPE Small molecular drug D09CQO DRUGINCH 1S/C14H9N3S/c1-2-5-10-9(4-1)13-11(8-15-10)16-14(17-13)12-6-3-7-18-12/h1-8H,(H,16,17) D09CQO DRUGINKE APVZAVOHLAQECW-UHFFFAOYSA-N D09CQO DRUGSMIL C1=CC=C2C(=C1)C3=C(C=N2)NC(=N3)C4=CC=CS4 D09CQO HIGHSTAT Investigative D09CSB DRUG__ID D09CSB D09CSB DRUGTYPE Small molecular drug D09CSB DRUGINCH 1S/C4H6O/c1-2-3-4-5/h2-4H,1H3/b3-2+ D09CSB DRUGINKE MLUCVPSAIODCQM-NSCUHMNNSA-N D09CSB DRUGSMIL CC=CC=O D09CSB HIGHSTAT Investigative D09CSP DRUG__ID D09CSP D09CSP DRUGTYPE Small molecular drug D09CSP DRUGINCH 1S/C9H11NO4S/c10-15(13,14)8-4-1-7(2-5-8)3-6-9(11)12/h1-2,4-5H,3,6H2,(H,11,12)(H2,10,13,14) D09CSP DRUGINKE JUEONDBIBADVGD-UHFFFAOYSA-N D09CSP DRUGSMIL C1=CC(=CC=C1CCC(=O)O)S(=O)(=O)N D09CSP HIGHSTAT Investigative D09CSQ DRUG__ID D09CSQ D09CSQ DRUGTYPE Small molecular drug D09CSQ DRUGINCH 1S/C37H49N7O13/c1-19(2)31(36(55)40-20(3)32(51)42-25(37(56)57)13-14-29(47)48)44-35(54)27(16-22-9-11-23(45)12-10-22)41-28(46)18-39-34(53)26(15-21-7-5-4-6-8-21)43-33(52)24(38)17-30(49)50/h4-12,19-20,24-27,31,45H,13-18,38H2,1-3H3,(H,39,53)(H,40,55)(H,41,46)(H,42,51)(H,43,52)(H,44,54)(H,47,48)(H,49,50)(H,56,57)/t20-,24-,25-,26-,27-,31-/m0/s1 D09CSQ DRUGINKE RRCWAJVJCDGGKS-UQPWSHDPSA-N D09CSQ DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(=O)O)N D09CSQ HIGHSTAT Investigative D09CUJ DRUG__ID D09CUJ D09CUJ DRUGTYPE Small molecular drug D09CUJ DRUGINCH 1S/C8H10FNO3/c9-5-2-7(12)6(11)1-4(5)8(13)3-10/h1-2,8,11-13H,3,10H2 D09CUJ DRUGINKE SBUQBFTXTZSRMH-UHFFFAOYSA-N D09CUJ DRUGSMIL C1=C(C(=CC(=C1O)O)F)C(CN)O D09CUJ HIGHSTAT Investigative D09CVD DRUG__ID D09CVD D09CVD DRUGTYPE Small molecular drug D09CVD DRUGINCH 1S/C17H30F4O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(18)16(22)17(19,20)21/h15H,2-14H2,1H3 D09CVD DRUGINKE HCIDRHZIAMIVIL-UHFFFAOYSA-N D09CVD DRUGSMIL CCCCCCCCCCCCCCC(C(=O)C(F)(F)F)F D09CVD HIGHSTAT Investigative D09CVG DRUG__ID D09CVG D09CVG DRUGTYPE Small molecular drug D09CVG DRUGINCH 1S/C14H16ClN3/c15-12-3-1-10(2-4-12)13-9-14(18-17-13)11-5-7-16-8-6-11/h1-4,9,11,16H,5-8H2,(H,17,18) D09CVG DRUGINKE GELALLNTKKLQLM-UHFFFAOYSA-N D09CVG DRUGSMIL C1CNCCC1C2=CC(=NN2)C3=CC=C(C=C3)Cl D09CVG HIGHSTAT Investigative D09CVV DRUG__ID D09CVV D09CVV DRUGTYPE Small molecular drug D09CVV DRUGINCH 1S/C18H17NO3/c1-20-16-12-6-7-19-13-8-10-4-2-3-5-11(10)15(14(12)13)17-18(16)22-9-21-17/h2-5,13,19H,6-9H2,1H3/t13-/m1/s1 D09CVV DRUGINKE TYZKUSBTFHNPMV-CYBMUJFWSA-N D09CVV DRUGSMIL COC1=C2C(=C3C4=CC=CC=C4CC5C3=C1CCN5)OCO2 D09CVV HIGHSTAT Investigative D09CXQ DRUG__ID D09CXQ D09CXQ DRUGTYPE Small molecular drug D09CXQ DRUGINCH 1S/C15H18N2O/c1-3-11-10-6-9(2)8-15(11,16)12-4-5-14(18)17-13(12)7-10/h3-6,10H,7-8,16H2,1-2H3,(H,17,18) D09CXQ DRUGINKE ZRJBHWIHUMBLCN-UHFFFAOYSA-N D09CXQ DRUGSMIL CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3 D09CXQ HIGHSTAT Investigative D09CXX DRUG__ID D09CXX D09CXX DRUGTYPE Small molecular drug D09CXX DRUGINCH 1S/H4N2O3S/c1-6(4,5)2-3/h2-3H,(H2,1,4,5) D09CXX DRUGINKE FZTCJYJKHSXPEX-UHFFFAOYSA-N D09CXX DRUGSMIL NS(=O)(=O)NO D09CXX HIGHSTAT Investigative D09CYJ DRUG__ID D09CYJ D09CYJ DRUGTYPE Small molecular drug D09CYJ DRUGINCH 1S/C20H14O3/c21-19-16-10-3-4-11-18(16)23-20(22)17(19)12-14-8-5-7-13-6-1-2-9-15(13)14/h1-11,21H,12H2 D09CYJ DRUGINKE PRHLSJVWKOFWSE-UHFFFAOYSA-N D09CYJ DRUGSMIL C1=CC=C2C(=C1)C=CC=C2CC3=C(C4=CC=CC=C4OC3=O)O D09CYJ HIGHSTAT Investigative D09CZV DRUG__ID D09CZV D09CZV DRUGTYPE Small molecular drug D09CZV DRUGINCH 1S/CH3.Hg/h1H3;/q;+1 D09CZV DRUGINKE DBUXSCUEGJMZAE-UHFFFAOYSA-N D09CZV DRUGSMIL C[Hg+] D09CZV HIGHSTAT Investigative D09DAM DRUG__ID D09DAM D09DAM DRUGTYPE Small molecular drug D09DAM DRUGINCH 1S/C36H45N5O5/c1-23-17-29(43)18-24(2)30(23)20-31(37)36(46)41-22-28-14-8-7-13-27(28)19-33(41)35(45)40-32(15-9-10-16-38-25(3)42)34(44)39-21-26-11-5-4-6-12-26/h4-8,11-14,17-18,31-33,43H,9-10,15-16,19-22,37H2,1-3H3,(H,38,42)(H,39,44)(H,40,45) D09DAM DRUGINKE FSIMYSAKEXUAHH-UHFFFAOYSA-N D09DAM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)C)C(=O)NCC4=CC=CC=C4)N)C)O D09DAM HIGHSTAT Investigative D09DAP DRUG__ID D09DAP D09DAP DRUGTYPE Small molecular drug D09DAP DRUGINCH 1S/C16H14N4O4S/c1-24-12-6-7-13-14(8-12)19-16(18-13)25-9-15(21)17-10-2-4-11(5-3-10)20(22)23/h2-8H,9H2,1H3,(H,17,21)(H,18,19) D09DAP DRUGINKE LYQDSNOFTIZWAX-UHFFFAOYSA-N D09DAP DRUGSMIL COC1=CC2=C(C=C1)N=C(N2)SCC(=O)NC3=CC=C(C=C3)[N+](=O)[O-] D09DAP HIGHSTAT Investigative D09DBH DRUG__ID D09DBH D09DBH DRUGTYPE Small molecular drug D09DBH DRUGINCH 1S/C11H10N2OS/c14-10(13-11-12-6-7-15-11)8-9-4-2-1-3-5-9/h1-7H,8H2,(H,12,13,14) D09DBH DRUGINKE HYRZQLIFVQELLP-UHFFFAOYSA-N D09DBH DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=NC=CS2 D09DBH HIGHSTAT Investigative D09DEK DRUG__ID D09DEK D09DEK DRUGTYPE Small molecular drug D09DEK DRUGINCH 1S/C16H12O2/c17-15-6-3-11(4-7-15)13-2-1-12-5-8-16(18)10-14(12)9-13/h1-10,17-18H D09DEK DRUGINKE NSCZTZNRMFWAIY-UHFFFAOYSA-N D09DEK DRUGSMIL C1=CC(=CC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O D09DEK HIGHSTAT Investigative D09DGA DRUG__ID D09DGA D09DGA DRUGTYPE Small molecular drug D09DGA DRUGINCH 1S/C16H11N/c1-2-6-12-11(5-1)9-10-14-13-7-3-4-8-15(13)17-16(12)14/h1-10,17H D09DGA DRUGINKE MYKQKWIPLZEVOW-UHFFFAOYSA-N D09DGA DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2NC4=CC=CC=C34 D09DGA HIGHSTAT Investigative D09DGE DRUG__ID D09DGE D09DGE DRUGCOMP H Lee Moffitt Cancer Center and Research Institute D09DGE DRUGINCH 1S/C13H15N5O6/c14-10-6-7(20)4(11(15)23)1-18(12(6)17-3-16-10)13-9(22)8(21)5(2-19)24-13/h1,3,5,8-9,13,19,21-22H,2H2,(H2,15,23)(H2,14,16,17)/t5-,8-,9-,13-/m1/s1 D09DGE DRUGINKE SPBWHPXCWJLQRU-FITJORAGSA-N D09DGE DRUGSMIL C1=C(C(=O)C2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N)C(=O)N D09DGE HIGHSTAT Investigative D09DJX DRUG__ID D09DJX D09DJX DRUGTYPE Small molecular drug D09DJX DRUGINCH 1S/C30H46N4O2/c35-29-19-17-23-25(13-11-15-27(23)33-29)31-21-9-7-5-3-1-2-4-6-8-10-22-32-26-14-12-16-28-24(26)18-20-30(36)34-28/h17-20,25-26,31-32H,1-16,21-22H2,(H,33,35)(H,34,36)/t25-,26-/m0/s1 D09DJX DRUGINKE VFFGYPZORQBRNM-UIOOFZCWSA-N D09DJX DRUGSMIL C1CC(C2=C(C1)NC(=O)C=C2)NCCCCCCCCCCCCNC3CCCC4=C3C=CC(=O)N4 D09DJX HIGHSTAT Investigative D09DKC DRUG__ID D09DKC D09DKC DRUGTYPE Small molecular drug D09DKC DRUGINCH 1S/C19H20INO2/c20-18-11-16(22)8-7-14(18)9-10-21-12-15-6-5-13-3-1-2-4-17(13)19(15)23/h1-4,7-8,11,15,21-22H,5-6,9-10,12H2/i20-2 D09DKC DRUGINKE MIQRUWUVLIWVAW-STTHPYEQSA-N D09DKC DRUGSMIL C1CC2=CC=CC=C2C(=O)C1CNCCC3=C(C=C(C=C3)O)I D09DKC HIGHSTAT Investigative D09DLY DRUG__ID D09DLY D09DLY DRUGTYPE Small molecular drug D09DLY DRUGINCH 1S/C13H8Cl4N2O/c14-7-3-8(15)5-10(4-7)19-13(20)18-9-1-2-11(16)12(17)6-9/h1-6H,(H2,18,19,20) D09DLY DRUGINKE IMDDDJBDFZQNJH-UHFFFAOYSA-N D09DLY DRUGSMIL C1=CC(=C(C=C1NC(=O)NC2=CC(=CC(=C2)Cl)Cl)Cl)Cl D09DLY HIGHSTAT Investigative D09DMR DRUG__ID D09DMR D09DMR DRUGTYPE Small molecular drug D09DMR DRUGINCH 1S/C13H12N2O2S/c14-18(16,17)13-8-6-11(7-9-13)10-15-12-4-2-1-3-5-12/h1-10H,(H2,14,16,17) D09DMR DRUGINKE XUMZYVTUPBUWOY-UHFFFAOYSA-N D09DMR DRUGSMIL C1=CC=C(C=C1)N=CC2=CC=C(C=C2)S(=O)(=O)N D09DMR HIGHSTAT Investigative D09DNT DRUG__ID D09DNT D09DNT DRUGTYPE Small molecular drug D09DNT DRUGINCH 1S/C43H49N5O7S2/c1-43(2)39(41(53)47-37-32-20-11-10-15-28(32)22-35(37)49)48(26-57-43)42(54)38(51)33(21-27-13-6-4-7-14-27)46-40(52)34(25-56-3)45-36(50)24-55-31-19-12-18-30(23-31)44-29-16-8-5-9-17-29/h4-20,23,33-35,37-39,44,49,51H,21-22,24-26H2,1-3H3,(H,45,50)(H,46,52)(H,47,53)/t33-,34-,35+,37-,38-,39+/m0/s1 D09DNT DRUGINKE KAHOVIZPKWWDDX-GCELDIMASA-N D09DNT DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)COC3=CC=CC(=C3)NC4=CC=CC=C4)O)C(=O)NC5C(CC6=CC=CC=C56)O)C D09DNT HIGHSTAT Investigative D09DPC DRUG__ID D09DPC D09DPC DRUGTYPE Small molecular drug D09DPC DRUGINCH 1S/C18H24N2O2/c1-22-16-5-3-2-4-15(16)19-17(21)20-18-9-12-6-13(10-18)8-14(7-12)11-18/h2-5,12-14H,6-11H2,1H3,(H2,19,20,21) D09DPC DRUGINKE KVPRHLDYUVRHBP-UHFFFAOYSA-N D09DPC DRUGSMIL COC1=CC=CC=C1NC(=O)NC23CC4CC(C2)CC(C4)C3 D09DPC HIGHSTAT Investigative D09DQV DRUG__ID D09DQV D09DQV DRUGTYPE Small molecular drug D09DQV DRUGINCH 1S/C16H33O3P/c1-5-6-7-8-11-20(17,18)19-16-12-14(4)9-10-15(16)13(2)3/h13-16H,5-12H2,1-4H3,(H,17,18)/t14-,15+,16-/m0/s1 D09DQV DRUGINKE WAVIZOVSJOXCKT-XHSDSOJGSA-N D09DQV DRUGSMIL CCCCCCP(=O)(O)OC1CC(CCC1C(C)C)C D09DQV HIGHSTAT Investigative D09DRF DRUG__ID D09DRF D09DRF DRUGTYPE Small molecular drug D09DRF DRUGINCH 1S/C12H12N2O/c13-12-11(7-4-8-14-12)15-9-10-5-2-1-3-6-10/h1-8H,9H2,(H2,13,14) D09DRF DRUGINKE NMCBWICNRJLKKM-UHFFFAOYSA-N D09DRF DRUGSMIL C1=CC=C(C=C1)COC2=C(N=CC=C2)N D09DRF HIGHSTAT Investigative D09DRS DRUG__ID D09DRS D09DRS DRUGTYPE Small molecular drug D09DRS DRUGINCH 1S/C13H15NO3/c1-8-5-12(15)14(2)13-10(8)6-9(16-3)7-11(13)17-4/h5-7H,1-4H3 D09DRS DRUGINKE BYYQQWLTZFBHIQ-UHFFFAOYSA-N D09DRS DRUGSMIL CC1=CC(=O)N(C2=C1C=C(C=C2OC)OC)C D09DRS HIGHSTAT Investigative D09DSK DRUG__ID D09DSK D09DSK DRUGCOMP Merck & Co Inc D09DSK DRUGINCH 1S/C25H38O2/c1-6-7-8-9-14-24(2,3)19-11-12-20-21-15-18(17-26)10-13-22(21)25(4,5)27-23(20)16-19/h10-12,16,21-22,26H,6-9,13-15,17H2,1-5H3/t21-,22+/m0/s1 D09DSK DRUGINKE ORTVDISIJXKUAV-FCHUYYIVSA-N D09DSK DRUGSMIL CCCCCCC(C)(C)C1=CC2=C(C=C1)C3CC(=CCC3C(O2)(C)C)CO D09DSK HIGHSTAT Investigative D09DSZ DRUG__ID D09DSZ D09DSZ DRUGTYPE Small molecular drug D09DSZ DRUGINCH 1S/C7H7NS2/c9-7-8-5-3-1-2-4-6(5)10-7/h1-4,7-9H D09DSZ DRUGINKE PYVUUPVBIDIYPY-UHFFFAOYSA-N D09DSZ DRUGSMIL C1=CC=C2C(=C1)NC(S2)S D09DSZ HIGHSTAT Investigative D09DUE DRUG__ID D09DUE D09DUE DRUGTYPE Small molecular drug D09DUE DRUGINCH 1S/C22H31N3O/c23-21(26)24-17-8-7-16-12-20-18-6-1-2-9-22(18,19(16)13-17)10-11-25(20)14-15-4-3-5-15/h7-8,13,15,18,20H,1-6,9-12,14H2,(H3,23,24,26)/t18-,20+,22+/m0/s1 D09DUE DRUGINKE UYFRBZFZZCVVGT-CZTZKLFOSA-N D09DUE DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NC(=O)N)CC5CCC5 D09DUE HIGHSTAT Investigative D09DWA DRUG__ID D09DWA D09DWA DRUGTYPE Small molecular drug D09DWA DRUGINCH 1S/C20H15NOS/c1-14-8-2-3-9-15(14)20(22)21-16-10-4-6-12-18(16)23-19-13-7-5-11-17(19)21/h2-13H,1H3 D09DWA DRUGINKE PYIIIOAOKBCILO-UHFFFAOYSA-N D09DWA DRUGSMIL CC1=CC=CC=C1C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D09DWA HIGHSTAT Investigative D09DWM DRUG__ID D09DWM D09DWM DRUGTYPE Small molecular drug D09DWM DRUGINCH 1S/C17H28N2/c1-14(2)12-19(17-8-10-18-11-9-17)13-16-6-4-15(3)5-7-16/h4-7,14,17-18H,8-13H2,1-3H3 D09DWM DRUGINKE GBWQTSFXTHVNTA-UHFFFAOYSA-N D09DWM DRUGSMIL CC1=CC=C(C=C1)CN(CC(C)C)C2CCNCC2 D09DWM HIGHSTAT Investigative D09DXN DRUG__ID D09DXN D09DXN DRUGTYPE Small molecular drug D09DXN DRUGINCH 1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/t8-/m1/s1 D09DXN DRUGINKE YGPSJZOEDVAXAB-MRVPVSSYSA-N D09DXN DRUGSMIL C1=CC=C(C(=C1)C(=O)CC(C(=O)O)N)N D09DXN HIGHSTAT Investigative D09EAE DRUG__ID D09EAE D09EAE DRUGTYPE Small molecular drug D09EAE DRUGINCH 1S/C15H14N2O2/c1-8-5-9(2)16-14(8)7-12-11-6-10(18)3-4-13(11)17-15(12)19/h3-7,16,18H,1-2H3,(H,17,19)/b12-7- D09EAE DRUGINKE GUXYHZUGDWFOBA-GHXNOFRVSA-N D09EAE DRUGSMIL CC1=CC(=C(N1)C=C2C3=C(C=CC(=C3)O)NC2=O)C D09EAE HIGHSTAT Investigative D09EAO DRUG__ID D09EAO D09EAO DRUGTYPE Small molecular drug D09EAO DRUGINCH 1S/C15H8Cl2FNO/c16-11-3-1-2-10-13(6-7-19-15(10)11)20-14-5-4-9(18)8-12(14)17/h1-8H D09EAO DRUGINKE ZXLMSTBJMZJAAH-UHFFFAOYSA-N D09EAO DRUGSMIL C1=CC2=C(C=CN=C2C(=C1)Cl)OC3=C(C=C(C=C3)F)Cl D09EAO HIGHSTAT Investigative D09EBV DRUG__ID D09EBV D09EBV DRUGTYPE Small molecular drug D09EBV DRUGINCH 1S/C14H20O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-4,9-13H2,1H3,(H,15,16) D09EBV DRUGINKE UDDQRZKIDJCZJF-UHFFFAOYSA-N D09EBV DRUGSMIL CCCCC#CC#CCCCCCC(=O)O D09EBV HIGHSTAT Investigative D09EDP DRUG__ID D09EDP D09EDP DRUGTYPE Small molecular drug D09EDP DRUGINCH 1S/C4H3NO4/c6-3-2(4(7)8)1-9-5-3/h1H,(H,5,6)(H,7,8) D09EDP DRUGINKE JLPHBZYAQYOJND-UHFFFAOYSA-N D09EDP DRUGSMIL C1=C(C(=O)NO1)C(=O)O D09EDP HIGHSTAT Investigative D09EGQ DRUG__ID D09EGQ D09EGQ DRUGTYPE Small molecular drug D09EGQ DRUGINCH 1S/C11H18N2O10P2S/c14-7-1-2-13(11(26)12-7)10-9(16)8(15)6(23-10)5-22-25(20,21)4-3-24(17,18)19/h1-2,6,8-10,15-16H,3-5H2,(H,20,21)(H,12,14,26)(H2,17,18,19)/t6-,8+,9+,10-/m1/s1 D09EGQ DRUGINKE RCFKBLDZKDFBNO-DOWZNPNQSA-N D09EGQ DRUGSMIL C1=CN(C(=S)NC1=O)C2C(C(C(O2)COP(=O)(CCP(=O)(O)O)O)O)O D09EGQ HIGHSTAT Investigative D09EHR DRUG__ID D09EHR D09EHR DRUGTYPE Small molecular drug D09EHR DRUGINCH 1S/C6H6FO3PS/c7-4-1-2-6(12)5(3-4)11(8,9)10/h1-3,12H,(H2,8,9,10) D09EHR DRUGINKE RDAVYJKCJHOMSD-UHFFFAOYSA-N D09EHR DRUGSMIL C1=CC(=C(C=C1F)P(=O)(O)O)S D09EHR HIGHSTAT Investigative D09EMR DRUG__ID D09EMR D09EMR DRUGTYPE Small molecular drug D09EMR DRUGINCH 1S/C50H59N9O10/c1-2-3-17-38(48(67)59-42(27-44(62)63)50(69)57-39(45(52)64)24-30-12-6-4-7-13-30)56-49(68)41(26-33-28-53-37-18-11-10-16-35(33)37)55-43(61)29-54-47(66)40(25-31-14-8-5-9-15-31)58-46(65)36(51)23-32-19-21-34(60)22-20-32/h4-16,18-22,28,36,38-42,53,60H,2-3,17,23-27,29,51H2,1H3,(H2,52,64)(H,54,66)(H,55,61)(H,56,68)(H,57,69)(H,58,65)(H,59,67)(H,62,63)/t36-,38-,39-,40+,41+,42-/m0/s1 D09EMR DRUGINKE DWHRPZRXNRDAQF-KCTXSUAESA-N D09EMR DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N D09EMR HIGHSTAT Investigative D09EQN DRUG__ID D09EQN D09EQN DRUGTYPE Small molecular drug D09EQN DRUGINCH 1S/C13H19NO2S/c1-9-5-10(2)7-11(6-9)8-17-4-3-12(14)13(15)16/h5-7,12H,3-4,8,14H2,1-2H3,(H,15,16) D09EQN DRUGINKE XBQZUMGAFICQFC-UHFFFAOYSA-N D09EQN DRUGSMIL CC1=CC(=CC(=C1)CSCCC(C(=O)O)N)C D09EQN HIGHSTAT Investigative D09ERP DRUG__ID D09ERP D09ERP DRUGTYPE Small molecular drug D09ERP DRUGINCH 1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3 D09ERP DRUGINKE DIVQKHQLANKJQO-UHFFFAOYSA-N D09ERP DRUGSMIL COC1=C(C=CC(=C1)CCN)O D09ERP HIGHSTAT Investigative D09ESF DRUG__ID D09ESF D09ESF DRUGTYPE Small molecular drug D09ESF DRUGINCH 1S/C20H14N2O4/c1-11-15(20(25)22-10-12-5-4-8-21-9-12)16-17(23)13-6-2-3-7-14(13)18(24)19(16)26-11/h2-9H,10H2,1H3,(H,22,25) D09ESF DRUGINKE HSYUWLOZMGPYKC-UHFFFAOYSA-N D09ESF DRUGSMIL CC1=C(C2=C(O1)C(=O)C3=CC=CC=C3C2=O)C(=O)NCC4=CN=CC=C4 D09ESF HIGHSTAT Investigative D09ETC DRUG__ID D09ETC D09ETC DRUGTYPE Small molecular drug D09ETC DRUGINCH 1S/C13H19N5/c1-2-18-9-16-11-12(14-8-15-13(11)18)17-10-6-4-3-5-7-10/h8-10H,2-7H2,1H3,(H,14,15,17) D09ETC DRUGINKE ZKBBSCAFNVXZSZ-UHFFFAOYSA-N D09ETC DRUGSMIL CCN1C=NC2=C(N=CN=C21)NC3CCCCC3 D09ETC HIGHSTAT Investigative D09ETU DRUG__ID D09ETU D09ETU DRUGTYPE Small molecular drug D09ETU DRUGINCH 1S/C15H23NO3/c1-4-10-19-15-8-7-14(18-3)11-13(15)6-5-9-16-12(2)17/h7-8,11H,4-6,9-10H2,1-3H3,(H,16,17) D09ETU DRUGINKE WEZUVBIENKYWSC-UHFFFAOYSA-N D09ETU DRUGSMIL CCCOC1=C(C=C(C=C1)OC)CCCNC(=O)C D09ETU HIGHSTAT Investigative D09EUH DRUG__ID D09EUH D09EUH DRUGTYPE Small molecular drug D09EUH DRUGINCH 1S/C20H20O5/c1-11-14(12-3-4-16-17(5-12)24-10-23-16)6-13-8-20(11)9-18(22-2)15(21)7-19(20)25-13/h3-5,7,9,11,13-14H,6,8,10H2,1-2H3/t11-,13+,14+,20-/m1/s1 D09EUH DRUGINKE SXHVHWXETMBKPP-KXXATPMCSA-N D09EUH DRUGSMIL CC1C(CC2CC13C=C(C(=O)C=C3O2)OC)C4=CC5=C(C=C4)OCO5 D09EUH HIGHSTAT Investigative D09EVY DRUG__ID D09EVY D09EVY DRUGTYPE Small molecular drug D09EVY DRUGINCH 1S/C9H14N2O2/c1-6-8(13-11-9(6)12)7-2-4-10-5-3-7/h7,10H,2-5H2,1H3,(H,11,12) D09EVY DRUGINKE PACUXLHRGQUIQZ-UHFFFAOYSA-N D09EVY DRUGSMIL CC1=C(ONC1=O)C2CCNCC2 D09EVY HIGHSTAT Investigative D09EYO DRUG__ID D09EYO D09EYO DRUGTYPE Small molecular drug D09EYO DRUGINCH 1S/C20H14FNO4/c21-16-11-10-13(12-18(16)26-14-6-2-1-3-7-14)19(23)22-17-9-5-4-8-15(17)20(24)25/h1-12H,(H,22,23)(H,24,25) D09EYO DRUGINKE OPLSSBDEHIIFAG-UHFFFAOYSA-N D09EYO DRUGSMIL C1=CC=C(C=C1)OC2=C(C=CC(=C2)C(=O)NC3=CC=CC=C3C(=O)O)F D09EYO HIGHSTAT Investigative D09FAD DRUG__ID D09FAD D09FAD DRUGTYPE Small molecular drug D09FAD DRUGINCH 1S/C14H15NO3/c1-9(2)8-15-13(16)11-7-10-5-3-4-6-12(10)18-14(11)17/h3-7,9H,8H2,1-2H3,(H,15,16) D09FAD DRUGINKE BKVFDOZWDVAMFZ-UHFFFAOYSA-N D09FAD DRUGSMIL CC(C)CNC(=O)C1=CC2=CC=CC=C2OC1=O D09FAD HIGHSTAT Investigative D09FAO DRUG__ID D09FAO D09FAO DRUGTYPE Small molecular drug D09FAO DRUGINCH 1S/C32H47N3O5/c1-31(2,3)40-30(39)34-27(23-25-17-11-9-12-18-25)28(37)35-29(38)32(4,24-26-19-13-10-14-20-26)33-21-15-7-5-6-8-16-22-36/h9-14,17-20,27,33,36H,5-8,15-16,21-24H2,1-4H3,(H,34,39)(H,35,37,38)/t27-,32+/m0/s1 D09FAO DRUGINKE LLSVPRQAIHTVBK-QVWWMRLHSA-N D09FAO DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(=O)NC(=O)C(C)(CC2=CC=CC=C2)NCCCCCCCCO D09FAO HIGHSTAT Investigative D09FAU DRUG__ID D09FAU D09FAU DRUGTYPE Small molecular drug D09FAU DRUGINCH 1S/C32H44N4O/c37-31-21-20-24-27(18-13-19-28(24)36-31)33-22-11-5-3-1-2-4-6-12-23-34-32-25-14-7-9-16-29(25)35-30-17-10-8-15-26(30)32/h7,9,14,16,20-21,27,33H,1-6,8,10-13,15,17-19,22-23H2,(H,34,35)(H,36,37) D09FAU DRUGINKE ROTFGKJJMRTWBD-UHFFFAOYSA-N D09FAU DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCCCCCNC4CCCC5=C4C=CC(=O)N5 D09FAU HIGHSTAT Investigative D09FBD DRUG__ID D09FBD D09FBD DRUGTYPE Small molecular drug D09FBD DRUGINCH 1S/C19H22O6/c1-9(2)18(22)24-14-7-10(3)6-13(20)8-11(4)16(21)17-15(14)12(5)19(23)25-17/h6,8,14-17,21H,1,5,7H2,2-4H3/b10-6+,11-8-/t14-,15+,16-,17-/m0/s1 D09FBD DRUGINKE LXINRHXYVUTAMQ-UKKSPWLWSA-N D09FBD DRUGSMIL CC1=CC(=O)C=C(C(C2C(C(C1)OC(=O)C(=C)C)C(=C)C(=O)O2)O)C D09FBD HIGHSTAT Investigative D09FBN DRUG__ID D09FBN D09FBN DRUGTYPE Small molecular drug D09FBN DRUGINCH 1S/C15H15N5O2/c21-11-3-1-10(2-4-11)13-18-14-12(16-9-17-14)15(19-13)20-5-7-22-8-6-20/h1-4,9,21H,5-8H2,(H,16,17,18,19) D09FBN DRUGINKE PSGSPCJHCOUEEU-UHFFFAOYSA-N D09FBN DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=C(C=C4)O D09FBN HIGHSTAT Investigative D09FDV DRUG__ID D09FDV D09FDV DRUGTYPE Small molecular drug D09FDV DRUGINCH 1S/C23H30ClN3O3S/c1-3-16-31(29,30)27-14-12-23(13-15-27,18-8-5-4-6-9-18)17(2)26-22(28)21-19(24)10-7-11-20(21)25/h4-11,17H,3,12-16,25H2,1-2H3,(H,26,28)/t17-/m0/s1/i31+3 D09FDV DRUGINKE CPNFHRRINJHHNO-BMHXGNRYSA-N D09FDV DRUGSMIL CCCS(=O)(=O)N1CCC(CC1)(C2=CC=CC=C2)C(C)NC(=O)C3=C(C=CC=C3Cl)N D09FDV HIGHSTAT Investigative D09FDZ DRUG__ID D09FDZ D09FDZ DRUGTYPE Small molecular drug D09FDZ DRUGINCH 1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-15-10(13(11)18)5-6-12(17)14(15)19/h1-7,16-17,19H D09FDZ DRUGINKE BMZFZTMWBCFKSS-UHFFFAOYSA-N D09FDZ DRUGSMIL C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3O)O)O D09FDZ HIGHSTAT Investigative D09FEC DRUG__ID D09FEC D09FEC DRUGTYPE Small molecular drug D09FEC DRUGINCH 1S/C14H20N2O2/c1-18-13-9-7-12(8-10-13)16-14(17)15-11-5-3-2-4-6-11/h7-11H,2-6H2,1H3,(H2,15,16,17) D09FEC DRUGINKE KZOFCHITIRGEGY-UHFFFAOYSA-N D09FEC DRUGSMIL COC1=CC=C(C=C1)NC(=O)NC2CCCCC2 D09FEC HIGHSTAT Investigative D09FFE DRUG__ID D09FFE D09FFE DRUGTYPE Small molecular drug D09FFE DRUGINCH 1S/C20H20BrN3O2S/c21-18-8-6-16(7-9-18)3-2-11-22-13-14-24-27(25,26)20-5-1-4-17-15-23-12-10-19(17)20/h1-10,12,15,22,24H,11,13-14H2/b3-2+ D09FFE DRUGINKE ZKZXNDJNWUTGDK-NSCUHMNNSA-N D09FFE DRUGSMIL C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCNCC=CC3=CC=C(C=C3)Br D09FFE HIGHSTAT Investigative D09FGL DRUG__ID D09FGL D09FGL DRUGTYPE Small molecular drug D09FGL DRUGINCH 1S/C20H24N2O5S/c1-20(2,24)14-10-17(27-11-14)28(25,26)22-19(23)21-18-15-7-3-5-12(15)9-13-6-4-8-16(13)18/h9-11,24H,3-8H2,1-2H3,(H2,21,22,23) D09FGL DRUGINKE HUUSXLKCTQDPGL-UHFFFAOYSA-N D09FGL DRUGSMIL CC(C)(C1=COC(=C1)S(=O)(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4)O D09FGL HIGHSTAT Investigative D09FGQ DRUG__ID D09FGQ D09FGQ DRUGTYPE Small molecular drug D09FGQ DRUGINCH 1S/C15H27N5O5/c1-8(2)7-9(20-13(22)10-11(25-10)14(23)24)12(21)18-5-3-4-6-19-15(16)17/h8-11H,3-7H2,1-2H3,(H,18,21)(H,20,22)(H,23,24)(H4,16,17,19)/t9-,10-,11-/m0/s1 D09FGQ DRUGINKE LTLYEAJONXGNFG-DCAQKATOSA-N D09FGQ DRUGSMIL CC(C)CC(C(=O)NCCCCN=C(N)N)NC(=O)C1C(O1)C(=O)O D09FGQ HIGHSTAT Investigative D09FHA DRUG__ID D09FHA D09FHA DRUGTYPE Small molecular drug D09FHA DRUGINCH 1S/C14H21NO2/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-17-4/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1 D09FHA DRUGINKE UOURTTOYLTUYKY-LLVKDONJSA-N D09FHA DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)NOC D09FHA HIGHSTAT Investigative D09FHE DRUG__ID D09FHE D09FHE DRUGTYPE Small molecular drug D09FHE DRUGINCH 1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12-,13-,16-/m1/s1 D09FHE DRUGINKE BRSNNJIJEZWSBU-XNIJJKJLSA-N D09FHE DRUGSMIL C1=CC(=CC=C1CSC2=NC(=NC3=C2N=CN3C4C(C(C(O4)CO)O)O)N)[N+](=O)[O-] D09FHE HIGHSTAT Investigative D09FIC DRUG__ID D09FIC D09FIC DRUGTYPE Small molecular drug D09FIC DRUGINCH 1S/C19H22F2N2O/c20-19(21)24-18-9-5-4-8-16(18)14-17(15-6-2-1-3-7-15)23-12-10-22-11-13-23/h1-9,17,19,22H,10-14H2 D09FIC DRUGINKE VCVDPONUNCPTCQ-UHFFFAOYSA-N D09FIC DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2OC(F)F)C3=CC=CC=C3 D09FIC HIGHSTAT Investigative D09FJW DRUG__ID D09FJW D09FJW DRUGTYPE Small molecular drug D09FJW DRUGINCH 1S/C15H18Cl3NO/c1-4-14(10(3)15(14,17)18)13(20)19-9(2)11-5-7-12(16)8-6-11/h5-10H,4H2,1-3H3,(H,19,20) D09FJW DRUGINKE RXDMAYSSBPYBFW-UHFFFAOYSA-N D09FJW DRUGSMIL CCC1(C(C1(Cl)Cl)C)C(=O)NC(C)C2=CC=C(C=C2)Cl D09FJW HIGHSTAT Investigative D09FJY DRUG__ID D09FJY D09FJY DRUGTYPE Small molecular drug D09FJY DRUGINCH 1S/C25H27NO/c1-20-10-8-9-15-23(20)24(21-11-4-2-5-12-21)26-18-16-25(27,17-19-26)22-13-6-3-7-14-22/h2-15,24,27H,16-19H2,1H3 D09FJY DRUGINKE GBDUIWBXAKZJPC-UHFFFAOYSA-N D09FJY DRUGSMIL CC1=CC=CC=C1C(C2=CC=CC=C2)N3CCC(CC3)(C4=CC=CC=C4)O D09FJY HIGHSTAT Investigative D09FLC DRUG__ID D09FLC D09FLC DRUGTYPE Small molecular drug D09FLC DRUGINCH 1S/C24H27IN2O2/c1-27-13-12-24-11-3-2-4-20(24)22(27)14-16-5-10-19(15-21(16)24)29-23(28)26-18-8-6-17(25)7-9-18/h5-10,15,20,22H,2-4,11-14H2,1H3,(H,26,28)/t20-,22+,24+/m0/s1 D09FLC DRUGINKE YGDGBZQTGCWFHN-BGWNEDDSSA-N D09FLC DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC(=O)NC5=CC=C(C=C5)I D09FLC HIGHSTAT Investigative D09FMK DRUG__ID D09FMK D09FMK DRUGTYPE Small molecular drug D09FMK DRUGINCH 1S/C23H25IN2O3/c1-16-22(23(27)17-3-6-19(28-2)7-4-17)20-8-5-18(24)15-21(20)26(16)10-9-25-11-13-29-14-12-25/h3-8,15H,9-14H2,1-2H3 D09FMK DRUGINKE JHOTYHDSLIUKCJ-UHFFFAOYSA-N D09FMK DRUGSMIL CC1=C(C2=C(N1CCN3CCOCC3)C=C(C=C2)I)C(=O)C4=CC=C(C=C4)OC D09FMK HIGHSTAT Investigative D09FMZ DRUG__ID D09FMZ D09FMZ DRUGTYPE Small molecular drug D09FMZ DRUGINCH 1S/C16H12O3/c17-15-12-8-4-5-9-14(12)19-16(18)13(15)10-11-6-2-1-3-7-11/h1-9,17H,10H2 D09FMZ DRUGINKE AEIVRFFWQSJCAR-UHFFFAOYSA-N D09FMZ DRUGSMIL C1=CC=C(C=C1)CC2=C(C3=CC=CC=C3OC2=O)O D09FMZ HIGHSTAT Investigative D09FOD DRUG__ID D09FOD D09FOD DRUGTYPE Small molecular drug D09FOD DRUGINCH 1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m1/s1 D09FOD DRUGINKE ODKSFYDXXFIFQN-SCSAIBSYSA-N D09FOD DRUGSMIL C(CC(C(=O)O)N)CN=C(N)N D09FOD HIGHSTAT Investigative D09FOQ DRUG__ID D09FOQ D09FOQ DRUGTYPE Small molecular drug D09FOQ DRUGINCH 1S/C49H80N8O7/c1-33(2)23-40(45(60)51-29-36-21-16-22-37(24-36)31-57(7,8)9)53-44(59)28-43(58)39(25-34-17-12-10-13-18-34)54-46(61)42(27-38-30-50-32-52-38)56(6)47(62)41(26-35-19-14-11-15-20-35)55-48(63)64-49(3,4)5/h11,14,19,21,24,30,32-34,39-43,46,54,58,61H,10,12-13,15-18,20,22-23,25-29,31H2,1-9H3,(H3-,50,51,52,53,55,59,60,63)/p+2/t39-,40-,41-,42-,43-,46?/m0/s1 D09FOQ DRUGINKE DAWSYEXBFLQUER-SLMIJXFKSA-P D09FOQ DRUGSMIL CC(C)CC(C(=O)NCC1=CCCC(=C1)C[N+](C)(C)C)NC(=O)CC(C(CC2CCCCC2)NC(C(CC3=C[NH+]=CN3)N(C)C(=O)C(CC4=CC=CCC4)NC(=O)OC(C)(C)C)O)O D09FOQ HIGHSTAT Investigative D09FQL DRUG__ID D09FQL D09FQL DRUGTYPE Small molecular drug D09FQL DRUGINCH 1S/C20H24O4/c1-11-12(2)20(14-6-8-16(22)18(10-14)24-4)19(11)13-5-7-15(21)17(9-13)23-3/h5-12,19-22H,1-4H3/t11-,12-,19-,20-/m0/s1 D09FQL DRUGINKE QDBUCXMBHJMGCN-HIGYNYDNSA-N D09FQL DRUGSMIL CC1C(C(C1C2=CC(=C(C=C2)O)OC)C3=CC(=C(C=C3)O)OC)C D09FQL HIGHSTAT Investigative D09FQT DRUG__ID D09FQT D09FQT DRUGTYPE Small molecular drug D09FQT DRUGINCH 1S/C20H23N3O10/c1-5-12(26)30-11-8(24)18-10-6(22-23-21)7(16(2,3)4)17(18)9(25)13(27)32-15(17)33-20(18,14(28)31-10)19(5,11)29/h5-11,15,24-25,29H,1-4H3/t5?,6-,7?,8?,9-,10?,11-,15?,17?,18?,19+,20-/m0/s1 D09FQT DRUGINKE GLXZEIIDXFBXMR-AQPRMESZSA-N D09FQT DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5N=[N+]=[N-])C(C)(C)C)C(C(=O)OC6O4)O)O D09FQT HIGHSTAT Investigative D09FRL DRUG__ID D09FRL D09FRL DRUGTYPE Small molecular drug D09FRL DRUGINCH 1S/C29H28N4O3/c1-19-14-20(12-13-23(19)30)16-32-18-31-24-17-33(26(29(35)36)15-25(24)32)28(34)27(21-8-4-2-5-9-21)22-10-6-3-7-11-22/h2-14,18,26-27H,15-17,30H2,1H3,(H,35,36) D09FRL DRUGINKE KLVDUSUYBDMJKR-UHFFFAOYSA-N D09FRL DRUGSMIL CC1=C(C=CC(=C1)CN2C=NC3=C2CC(N(C3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)O)N D09FRL HIGHSTAT Investigative D09FTL DRUG__ID D09FTL D09FTL DRUGTYPE Small molecular drug D09FTL DRUGINCH 1S/C19H23NO3/c1-22-19(21)18(16-7-3-2-4-8-16)17-9-5-6-11-20(17)13-15-10-12-23-14-15/h2-4,7-8,10,12,14,17-18H,5-6,9,11,13H2,1H3/t17-,18-/m1/s1 D09FTL DRUGINKE GUHBNEJVQSVUMF-QZTJIDSGSA-N D09FTL DRUGSMIL COC(=O)C(C1CCCCN1CC2=COC=C2)C3=CC=CC=C3 D09FTL HIGHSTAT Investigative D09FTZ DRUG__ID D09FTZ D09FTZ DRUGTYPE Small molecular drug D09FTZ DRUGINCH 1S/C20H27N/c1-3-16-21(17-4-2)20-14-12-19(13-15-20)11-10-18-8-6-5-7-9-18/h5-9,12,20H,3-4,13-17H2,1-2H3 D09FTZ DRUGINKE QQFDMLZEFWKHHH-UHFFFAOYSA-N D09FTZ DRUGSMIL CCCN(CCC)C1CCC(=CC1)C#CC2=CC=CC=C2 D09FTZ HIGHSTAT Investigative D09FUO DRUG__ID D09FUO D09FUO DRUGTYPE Small molecular drug D09FUO DRUGINCH 1S/C20H19N5/c1-2-17(15-9-5-3-6-10-15)24-19-18-20(22-13-21-19)25(14-23-18)16-11-7-4-8-12-16/h3-14,17H,2H2,1H3,(H,21,22,24)/t17-/m1/s1 D09FUO DRUGINKE KOEVJHYBDHDPOK-QGZVFWFLSA-N D09FUO DRUGSMIL CCC(C1=CC=CC=C1)NC2=C3C(=NC=N2)N(C=N3)C4=CC=CC=C4 D09FUO HIGHSTAT Investigative D09FVG DRUG__ID D09FVG D09FVG DRUGTYPE Small molecular drug D09FVG DRUGINCH 1S/C22H26N2O4/c1-4-13-11-24-8-7-21-16-9-14(25)5-6-17(16)23(2)22(21)18(24)10-15(13)20(21,12-28-22)19(26)27-3/h4-6,9,15,18,25H,7-8,10-12H2,1-3H3/b13-4-/t15-,18-,20-,21-,22+/m0/s1 D09FVG DRUGINKE YILKZADAWNUTTB-QLWRWLBVSA-N D09FVG DRUGSMIL CC=C1CN2CCC34C5=C(C=CC(=C5)O)N(C36C2CC1C4(CO6)C(=O)OC)C D09FVG HIGHSTAT Investigative D09FWP DRUG__ID D09FWP D09FWP DRUGTYPE Small molecular drug D09FWP DRUGINCH 1S/C16H12O2/c17-14-8-7-11-9-13(6-5-12(11)10-14)15-3-1-2-4-16(15)18/h1-10,17-18H D09FWP DRUGINKE SMFVAKMYNVSVKJ-UHFFFAOYSA-N D09FWP DRUGSMIL C1=CC=C(C(=C1)C2=CC3=C(C=C2)C=C(C=C3)O)O D09FWP HIGHSTAT Investigative D09FXD DRUG__ID D09FXD D09FXD DRUGTYPE Small molecular drug D09FXD DRUGINCH 1S/C16H21ClIN3O4S/c1-3-26(23,24)20-11-4-6-21(7-5-11)16(22)10-19-14-9-13(18)12(17)8-15(14)25-2/h3,8-9,11,19-20H,1,4-7,10H2,2H3 D09FXD DRUGINKE ZGUSBCDCZNBNQT-UHFFFAOYSA-N D09FXD DRUGSMIL COC1=CC(=C(C=C1NCC(=O)N2CCC(CC2)NS(=O)(=O)C=C)I)Cl D09FXD HIGHSTAT Investigative D09FZD DRUG__ID D09FZD D09FZD DRUGTYPE Small molecular drug D09FZD DRUGINCH 1S/C24H26N2O/c27-24(22-11-10-20-8-4-5-9-21(20)18-22)25-23-13-16-26(17-14-23)15-12-19-6-2-1-3-7-19/h1-11,18,23H,12-17H2,(H,25,27) D09FZD DRUGINKE JJJGQIPMMVJBLD-UHFFFAOYSA-N D09FZD DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CCC4=CC=CC=C4 D09FZD HIGHSTAT Investigative D09FZW DRUG__ID D09FZW D09FZW DRUGTYPE Small molecular drug D09FZW DRUGINCH 1S/C13H8F3NO/c14-13(15,16)18-8-5-6-10-9-3-1-2-4-11(9)17-12(10)7-8/h1-7,17H D09FZW DRUGINKE AKPHYUFLAWJLFA-UHFFFAOYSA-N D09FZW DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)OC(F)(F)F D09FZW HIGHSTAT Investigative D09GBL DRUG__ID D09GBL D09GBL DRUGTYPE Small molecular drug D09GBL DRUGINCH 1S/C10H18O/c1-7(2)9-5-4-8(3)6-10(9)11/h8-11H,1,4-6H2,2-3H3/t8-,9+,10-/m1/s1 D09GBL DRUGINKE ZYTMANIQRDEHIO-KXUCPTDWSA-N D09GBL DRUGSMIL CC1CCC(C(C1)O)C(=C)C D09GBL HIGHSTAT Investigative D09GCE DRUG__ID D09GCE D09GCE DRUGTYPE Small molecular drug D09GCE DRUGINCH 1S/C17H19N3O5/c18-17(22)16(10-21)19-9-12-3-7-15(8-4-12)25-11-13-1-5-14(6-2-13)20(23)24/h1-8,16,19,21H,9-11H2,(H2,18,22)/t16-/m0/s1 D09GCE DRUGINKE XVFXQICJBNSYEW-INIZCTEOSA-N D09GCE DRUGSMIL C1=CC(=CC=C1CNC(CO)C(=O)N)OCC2=CC=C(C=C2)[N+](=O)[O-] D09GCE HIGHSTAT Investigative D09GEH DRUG__ID D09GEH D09GEH DRUGTYPE Small molecular drug D09GEH DRUGINCH 1S/C18H18N2/c1-2-18(20-13-12-19-14-20)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h3-14,18H,2H2,1H3 D09GEH DRUGINKE IGUCGOUQZFQHGU-UHFFFAOYSA-N D09GEH DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D09GEH HIGHSTAT Investigative D09GIL DRUG__ID D09GIL D09GIL DRUGTYPE Small molecular drug D09GIL DRUGINCH 1S/C11H10N2O3/c1-11(7-5-3-2-4-6-7)8(14)12-10(16)13-9(11)15/h2-6H,1H3,(H2,12,13,14,15,16) D09GIL DRUGINKE LSAOZCAKUIANSQ-UHFFFAOYSA-N D09GIL DRUGSMIL CC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2 D09GIL HIGHSTAT Investigative D09GJI DRUG__ID D09GJI D09GJI DRUGTYPE Small molecular drug D09GJI DRUGINCH 1S/C18H16N2O/c1-12(20-7-6-19-11-20)13-2-4-17-14(8-13)9-15-10-16(21)3-5-18(15)17/h2-8,10-12,21H,9H2,1H3 D09GJI DRUGINKE LVWQDZJSHTWZHR-UHFFFAOYSA-N D09GJI DRUGSMIL CC(C1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)O)N4C=CN=C4 D09GJI HIGHSTAT Investigative D09GKA DRUG__ID D09GKA D09GKA DRUGTYPE Small molecular drug D09GKA DRUGINCH 1S/C17H13NO4/c1-22-12-8-6-11(7-9-12)10-18-16(20)14-5-3-2-4-13(14)15(19)17(18)21/h2-9H,10H2,1H3 D09GKA DRUGINKE UJBONJNKVPTSPR-UHFFFAOYSA-N D09GKA DRUGSMIL COC1=CC=C(C=C1)CN2C(=O)C3=CC=CC=C3C(=O)C2=O D09GKA HIGHSTAT Investigative D09GKY DRUG__ID D09GKY D09GKY DRUGTYPE Small molecular drug D09GKY DRUGINCH 1S/C19H20N2OS/c22-19(20-14-8-2-1-3-9-14)21-15-10-4-6-12-17(15)23-18-13-7-5-11-16(18)21/h4-7,10-14H,1-3,8-9H2,(H,20,22) D09GKY DRUGINKE OKOVWMHSIFSGRG-UHFFFAOYSA-N D09GKY DRUGSMIL C1CCC(CC1)NC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D09GKY HIGHSTAT Investigative D09GLA DRUG__ID D09GLA D09GLA DRUGTYPE Small molecular drug D09GLA DRUGINCH 1S/C21H21N3O5S/c1-15-5-3-7-19(21(25)23-26)20(15)24(14-16-6-4-12-22-13-16)30(27,28)18-10-8-17(29-2)9-11-18/h3-13,26H,14H2,1-2H3,(H,23,25) D09GLA DRUGINKE AINJYWXKBKRQSX-UHFFFAOYSA-N D09GLA DRUGSMIL CC1=C(C(=CC=C1)C(=O)NO)N(CC2=CN=CC=C2)S(=O)(=O)C3=CC=C(C=C3)OC D09GLA HIGHSTAT Investigative D09GMG DRUG__ID D09GMG D09GMG DRUGTYPE Small molecular drug D09GMG DRUGINCH 1S/C14H14N2O2/c1-10-5-3-8-13(15-10)16-14(17)11-6-4-7-12(9-11)18-2/h3-9H,1-2H3,(H,15,16,17) D09GMG DRUGINKE RGDXTZSZZQXINX-UHFFFAOYSA-N D09GMG DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CC(=CC=C2)OC D09GMG HIGHSTAT Investigative D09GNM DRUG__ID D09GNM D09GNM DRUGTYPE Small molecular drug D09GNM DRUGINCH 1S/C19H19N3O2/c23-17-6-2-1-5-16(17)18(24)8-10-21-12-15-11-14(21)13-22(15)19-7-3-4-9-20-19/h1-10,14-15,23H,11-13H2/b10-8+/t14-,15-/m1/s1 D09GNM DRUGINKE INAICWLVUAKEPB-QSTFCLMHSA-N D09GNM DRUGSMIL C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O D09GNM HIGHSTAT Investigative D09GPV DRUG__ID D09GPV D09GPV DRUGTYPE Small molecular drug D09GPV DRUGINCH 1S/C30H48O5/c1-25(2)13-15-30(24(34)35)16-14-28(5)18(22(30)23(25)33)7-8-20-26(3)11-10-21(32)27(4,17-31)19(26)9-12-29(20,28)6/h7,19-23,31-33H,8-17H2,1-6H3,(H,34,35)/t19-,20-,21+,22-,23+,26+,27-,28-,29-,30+/m1/s1 D09GPV DRUGINKE TUOYZAJHBIXONX-CGSJAQJOSA-N D09GPV DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1O)C)C(=O)O)C D09GPV HIGHSTAT Investigative D09GQE DRUG__ID D09GQE D09GQE DRUGTYPE Small molecular drug D09GQE DRUGINCH 1S/C17H14O2S/c1-11-8-13(10-15(19)9-11)17-7-6-16(20-17)12-2-4-14(18)5-3-12/h2-10,18-19H,1H3 D09GQE DRUGINKE NWLAWEHHCISQCM-UHFFFAOYSA-N D09GQE DRUGSMIL CC1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC=C(C=C3)O D09GQE HIGHSTAT Investigative D09GQF DRUG__ID D09GQF D09GQF DRUGTYPE Small molecular drug D09GQF DRUGINCH 1S/C13H10N2O6/c16-6-1-2-7-8(5-6)12(19)14(11(7)18)9-3-4-10(17)15(21)13(9)20/h1-2,5,9,16,21H,3-4H2 D09GQF DRUGINKE RLBGOICZNMULCW-UHFFFAOYSA-N D09GQF DRUGSMIL C1CC(=O)N(C(=O)C1N2C(=O)C3=C(C2=O)C=C(C=C3)O)O D09GQF HIGHSTAT Investigative D09GQO DRUG__ID D09GQO D09GQO DRUGTYPE Small molecular drug D09GQO DRUGINCH 1S/C16H14N2O/c17-16-15(9-4-10-18-16)19-11-13-7-3-6-12-5-1-2-8-14(12)13/h1-10H,11H2,(H2,17,18) D09GQO DRUGINKE SZANYTFSQVBOBA-UHFFFAOYSA-N D09GQO DRUGSMIL C1=CC=C2C(=C1)C=CC=C2COC3=C(N=CC=C3)N D09GQO HIGHSTAT Investigative D09GQP DRUG__ID D09GQP D09GQP DRUGTYPE Small molecular drug D09GQP DRUGINCH 1S/C21H24N2O4/c1-12-7-16(24)8-13(2)17(12)10-18(22)20(25)23-11-15-6-4-3-5-14(15)9-19(23)21(26)27/h3-8,18-19,24H,9-11,22H2,1-2H3,(H,26,27)/t18-,19-/m0/s1 D09GQP DRUGINKE QBLVXTMPLLWZDE-OALUTQOASA-N D09GQP DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)O)N)C)O D09GQP HIGHSTAT Investigative D09GSD DRUG__ID D09GSD D09GSD DRUGTYPE Small molecular drug D09GSD DRUGINCH 1S/C29H31N5O3/c1-17-11-21(35)12-18(2)22(17)14-23(30)28(36)33-26-13-19-7-3-4-8-20(19)15-34(29(26)37)16-27-31-24-9-5-6-10-25(24)32-27/h3-12,23,26,35H,13-16,30H2,1-2H3,(H,31,32)(H,33,36)/t23-,26-/m0/s1 D09GSD DRUGINKE KNVMNIVKKSUNLC-OZXSUGGESA-N D09GSD DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC2CC3=CC=CC=C3CN(C2=O)CC4=NC5=CC=CC=C5N4)N)C)O D09GSD HIGHSTAT Investigative D09GTJ DRUG__ID D09GTJ D09GTJ DRUGTYPE Small molecular drug D09GTJ DRUGINCH 1S/C12H6N4O8S/c17-13(18)7-1-3-11(9(5-7)15(21)22)25-12-4-2-8(14(19)20)6-10(12)16(23)24/h1-6H D09GTJ DRUGINKE DMIUPZAMXYQKBR-UHFFFAOYSA-N D09GTJ DRUGSMIL C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-] D09GTJ HIGHSTAT Investigative D09GTN DRUG__ID D09GTN D09GTN DRUGTYPE Small molecular drug D09GTN DRUGINCH 1S/C10H6FN3O/c11-6-1-2-7-5(3-6)4-8-9(12-7)14-10(15)13-8/h1-4H,(H2,12,13,14,15) D09GTN DRUGINKE XTXHKKBSLRGOJD-UHFFFAOYSA-N D09GTN DRUGSMIL C1=CC2=NC3=C(C=C2C=C1F)NC(=O)N3 D09GTN HIGHSTAT Investigative D09GVB DRUG__ID D09GVB D09GVB DRUGTYPE Small molecular drug D09GVB DRUGINCH 1S/C21H22N2O2/c24-19(14-7-2-1-4-10-17-11-5-3-6-12-17)21-23-16-20(25-21)18-13-8-9-15-22-18/h3,5-6,8-9,11-13,15-16H,1-2,4,7,10,14H2 D09GVB DRUGINKE ILOIOIGZFHGSMS-UHFFFAOYSA-N D09GVB DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=C(O2)C3=CC=CC=N3 D09GVB HIGHSTAT Investigative D09GXF DRUG__ID D09GXF D09GXF DRUGTYPE Small molecular drug D09GXF DRUGINCH 1S/C14H19NO3S/c1-9(11-6-4-3-5-7-11)12(8-19)13(16)15-10(2)14(17)18/h3-7,9-10,12,19H,8H2,1-2H3,(H,15,16)(H,17,18)/t9-,10-,12-/m0/s1 D09GXF DRUGINKE ABBSOQIXYPZCKO-NHCYSSNCSA-N D09GXF DRUGSMIL CC(C1=CC=CC=C1)C(CS)C(=O)NC(C)C(=O)O D09GXF HIGHSTAT Investigative D09GXL DRUG__ID D09GXL D09GXL DRUGTYPE Small molecular drug D09GXL DRUGINCH 1S/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H3/t12-/m0/s1 D09GXL DRUGINKE KYVJVURXKAZJRK-LBPRGKRZSA-N D09GXL DRUGSMIL COC1=C(C=C2CC3C4=C(C2=C1)C(=C(C=C4CCN3)O)OC)O D09GXL HIGHSTAT Investigative D09GXM DRUG__ID D09GXM D09GXM DRUGTYPE Small molecular drug D09GXM DRUGINCH 1S/C28H31NO3/c1-29(21-22-12-6-5-7-13-22)18-10-3-2-4-11-19-31-23-16-17-25-27(20-23)32-26-15-9-8-14-24(26)28(25)30/h5-9,12-17,20H,2-4,10-11,18-19,21H2,1H3 D09GXM DRUGINKE JUEPMIFCYDBLJZ-UHFFFAOYSA-N D09GXM DRUGSMIL CN(CCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D09GXM HIGHSTAT Investigative D09GYC DRUG__ID D09GYC D09GYC DRUGTYPE Small molecular drug D09GYC DRUGINCH 1S/C14H9N3OS/c15-8-10-4-1-2-6-13(10)19(18)14-7-3-5-12(17)11(14)9-16/h1-7H,17H2 D09GYC DRUGINKE SAAMTBNDGHUYAE-UHFFFAOYSA-N D09GYC DRUGSMIL C1=CC=C(C(=C1)C#N)S(=O)C2=CC=CC(=C2C#N)N D09GYC HIGHSTAT Investigative D09GYH DRUG__ID D09GYH D09GYH DRUGTYPE Small molecular drug D09GYH DRUGINCH 1S/C18H14N2/c1-12-7-14(11-19)9-17(8-12)16-6-5-15-4-3-13(2)20-18(15)10-16/h3-10H,1-2H3 D09GYH DRUGINKE FSRORMXGJWDWBA-UHFFFAOYSA-N D09GYH DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)C D09GYH HIGHSTAT Investigative D09GZH DRUG__ID D09GZH D09GZH DRUGTYPE Small molecular drug D09GZH DRUGINCH 1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3/t13-/m1/s1 D09GZH DRUGINKE FELGMEQIXOGIFQ-CYBMUJFWSA-N D09GZH DRUGSMIL CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C D09GZH HIGHSTAT Investigative D09GZQ DRUG__ID D09GZQ D09GZQ DRUGTYPE Small molecular drug D09GZQ DRUGINCH 1S/C28H44N4O6S/c1-19(2)16-23(14-15-39(6,37)38)31-26(34)18-29-27(35)25(17-20(3)4)32-28(36)24(30-21(5)33)13-12-22-10-8-7-9-11-22/h7-11,14-15,19-20,23-25H,12-13,16-18H2,1-6H3,(H,29,35)(H,30,33)(H,31,34)(H,32,36)/b15-14+/t23-,24+,25+/m1/s1 D09GZQ DRUGINKE NYFDCVWCYDTELB-GNEZGTDISA-N D09GZQ DRUGSMIL CC(C)CC(C=CS(=O)(=O)C)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)C D09GZQ HIGHSTAT Investigative D09HAM DRUG__ID D09HAM D09HAM DRUGTYPE Small molecular drug D09HAM DRUGINCH 1S/C16H12N4/c17-16-15-13(12-8-4-5-9-14(12)18-16)10-20(19-15)11-6-2-1-3-7-11/h1-10H,(H2,17,18) D09HAM DRUGINKE MVHJGGYPZDDBQV-UHFFFAOYSA-N D09HAM DRUGSMIL C1=CC=C(C=C1)N2C=C3C4=CC=CC=C4N=C(C3=N2)N D09HAM HIGHSTAT Investigative D09HAX DRUG__ID D09HAX D09HAX DRUGTYPE Small molecular drug D09HAX DRUGINCH 1S/C20H20O6/c1-10(2)3-4-11-5-12(6-16(24)20(11)25)17-9-15(23)19-14(22)7-13(21)8-18(19)26-17/h3,5-8,17,21-22,24-25H,4,9H2,1-2H3/t17-/m0/s1 D09HAX DRUGINKE SFQIGPZCFNTPOD-KRWDZBQOSA-N D09HAX DRUGSMIL CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O)O)C D09HAX HIGHSTAT Investigative D09HBR DRUG__ID D09HBR D09HBR DRUGTYPE Small molecular drug D09HBR DRUGINCH 1S/C18H17N5O3S/c1-12-10-16(15(19)11-17(12)24)22-21-13-5-7-14(8-6-13)27(25,26)23-18-4-2-3-9-20-18/h2-11,24H,19H2,1H3,(H,20,23) D09HBR DRUGINKE DZTGIRNXWSZBIM-UHFFFAOYSA-N D09HBR DRUGSMIL CC1=CC(=C(C=C1O)N)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3 D09HBR HIGHSTAT Investigative D09HBX DRUG__ID D09HBX D09HBX DRUGTYPE Small molecular drug D09HBX DRUGINCH 1S/C9H10FN/c10-9(6-8(9)11)7-4-2-1-3-5-7/h1-5,8H,6,11H2/t8-,9-/m0/s1 D09HBX DRUGINKE UJTQURLMCYMANH-IUCAKERBSA-N D09HBX DRUGSMIL C1C(C1(C2=CC=CC=C2)F)N D09HBX HIGHSTAT Investigative D09HBZ DRUG__ID D09HBZ D09HBZ DRUGTYPE Small molecular drug D09HBZ DRUGINCH 1S/C15H12FN3S/c1-20-15-18-13(10-2-4-12(16)5-3-10)14(19-15)11-6-8-17-9-7-11/h2-9H,1H3,(H,18,19) D09HBZ DRUGINKE IKQIPPKRAFLUKQ-UHFFFAOYSA-N D09HBZ DRUGSMIL CSC1=NC(=C(N1)C2=CC=NC=C2)C3=CC=C(C=C3)F D09HBZ HIGHSTAT Investigative D09HET DRUG__ID D09HET D09HET DRUGTYPE Small molecular drug D09HET DRUGINCH 1S/C11H13NO4/c12-9(11(15)16)8(10(13)14)6-7-4-2-1-3-5-7/h1-5,8-9H,6,12H2,(H,13,14)(H,15,16)/t8-,9-/m0/s1 D09HET DRUGINKE KMVYGTIPJNGNRD-IUCAKERBSA-N D09HET DRUGSMIL C1=CC=C(C=C1)CC(C(C(=O)O)N)C(=O)O D09HET HIGHSTAT Investigative D09HFT DRUG__ID D09HFT D09HFT DRUGTYPE Small molecular drug D09HFT DRUGINCH 1S/C19H14FNO2S/c20-16-9-6-15(7-10-16)8-11-17-12-13-19(14-21-17)24(22,23)18-4-2-1-3-5-18/h1-14H/b11-8+ D09HFT DRUGINKE ANNXZFGXMGNRDN-DHZHZOJOSA-N D09HFT DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CN=C(C=C2)C=CC3=CC=C(C=C3)F D09HFT HIGHSTAT Investigative D09HGK DRUG__ID D09HGK D09HGK DRUGTYPE Small molecular drug D09HGK DRUGINCH 1S/C16H15NO/c1-18-15-4-5-16-13(2-3-14(16)11-15)10-12-6-8-17-9-7-12/h4-11H,2-3H2,1H3/b13-10+ D09HGK DRUGINKE VDGYNVYFCLIMOF-JLHYYAGUSA-N D09HGK DRUGSMIL COC1=CC2=C(C=C1)C(=CC3=CC=NC=C3)CC2 D09HGK HIGHSTAT Investigative D09HHW DRUG__ID D09HHW D09HHW DRUGTYPE Small molecular drug D09HHW DRUGINCH 1S/C18H18BrFN2O/c1-23-17-8-6-13(19)11-12(17)5-7-14-15(3-2-4-16(14)20)18-21-9-10-22-18/h2-4,6,8,11H,5,7,9-10H2,1H3,(H,21,22) D09HHW DRUGINKE WCPPZGPJRHLSKP-UHFFFAOYSA-N D09HHW DRUGSMIL COC1=C(C=C(C=C1)Br)CCC2=C(C=CC=C2F)C3=NCCN3 D09HHW HIGHSTAT Investigative D09HIM DRUG__ID D09HIM D09HIM DRUGTYPE Small molecular drug D09HIM DRUGINCH 1S/C34H35N3O4/c1-23-8-12-25(13-9-23)33(38)36-30-7-5-4-6-29(30)34(39)35-28-14-10-24(11-15-28)16-18-37-19-17-26-20-31(40-2)32(41-3)21-27(26)22-37/h4-15,20-21H,16-19,22H2,1-3H3,(H,35,39)(H,36,38) D09HIM DRUGINKE YKXTXQJFMGBJLD-UHFFFAOYSA-N D09HIM DRUGSMIL CC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2C(=O)NC3=CC=C(C=C3)CCN4CCC5=CC(=C(C=C5C4)OC)OC D09HIM HIGHSTAT Investigative D09HJL DRUG__ID D09HJL D09HJL DRUGTYPE Small molecular drug D09HJL DRUGINCH 1S/C14H18N2O/c1-9(15)7-10-8-16-12-4-5-13-11(14(10)12)3-2-6-17-13/h4-5,8-9,16H,2-3,6-7,15H2,1H3/t9-/m0/s1 D09HJL DRUGINKE VVHJUSGIUWQPIT-VIFPVBQESA-N D09HJL DRUGSMIL CC(CC1=CNC2=C1C3=C(C=C2)OCCC3)N D09HJL HIGHSTAT Investigative D09HKD DRUG__ID D09HKD D09HKD DRUGTYPE Small molecular drug D09HKD DRUGINCH 1S/C18H12N2O/c21-17-11-16(20-18-15(17)9-4-10-19-18)14-8-3-6-12-5-1-2-7-13(12)14/h1-11H,(H,19,20,21) D09HKD DRUGINKE PPEYNRXCXSJVHV-UHFFFAOYSA-N D09HKD DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C3=CC(=O)C4=C(N3)N=CC=C4 D09HKD HIGHSTAT Investigative D09HKR DRUG__ID D09HKR D09HKR DRUGTYPE Small molecular drug D09HKR DRUGINCH 1S/C13H18N2O8P2/c16-24(17,18)11(25(19,20)21)8-4-5-9-22-13-12(14-23-15-13)10-6-2-1-3-7-10/h1-3,6-7,11H,4-5,8-9H2,(H2,16,17,18)(H2,19,20,21) D09HKR DRUGINKE NPUHGRMCBDPTIW-UHFFFAOYSA-N D09HKR DRUGSMIL C1=CC=C(C=C1)C2=NON=C2OCCCCC(P(=O)(O)O)P(=O)(O)O D09HKR HIGHSTAT Investigative D09HLX DRUG__ID D09HLX D09HLX DRUGTYPE Small molecular drug D09HLX DRUGINCH 1S/C12H12N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-10H,1H3/q+1 D09HLX DRUGINKE FMGYKKMPNATWHP-UHFFFAOYSA-N D09HLX DRUGSMIL C[N+]1=CC=C(C=C1)C2=CC=CC=C2 D09HLX HIGHSTAT Investigative D09HNP DRUG__ID D09HNP D09HNP DRUGTYPE Small molecular drug D09HNP DRUGINCH 1S/C11H19N3O5S3/c1-3-13-9-7-14(4-5-19-2)22(17,18)11-8(9)6-10(20-11)21(12,15)16/h6,9,13H,3-5,7H2,1-2H3,(H2,12,15,16)/t9-/m0/s1 D09HNP DRUGINKE XACIEZJJSXJZMD-VIFPVBQESA-N D09HNP DRUGSMIL CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCOC D09HNP HIGHSTAT Investigative D09HOE DRUG__ID D09HOE D09HOE DRUGTYPE Small molecular drug D09HOE DRUGINCH 1S/C15H12FN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9- D09HOE DRUGINKE KVRYTKBSTLSXKC-XFXZXTDPSA-N D09HOE DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)F D09HOE HIGHSTAT Investigative D09HQH DRUG__ID D09HQH D09HQH DRUGTYPE Small molecular drug D09HQH DRUGINCH 1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,11,14-17,21H,3-6,8,10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1 D09HQH DRUGINKE RSIHSRDYCUFFLA-DYKIIFRCSA-N D09HQH DRUGSMIL CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C D09HQH HIGHSTAT Investigative D09HRX DRUG__ID D09HRX D09HRX DRUGTYPE Small molecular drug D09HRX DRUGINCH 1S/C22H15FN4O3/c23-18-8-4-5-9-20(18)26-21(14-19(25-26)15-6-2-1-3-7-15)24-22(28)16-10-12-17(13-11-16)27(29)30/h1-14H,(H,24,28) D09HRX DRUGINKE BRAZLURTFMCAHU-UHFFFAOYSA-N D09HRX DRUGSMIL C1=CC=C(C=C1)C2=NN(C(=C2)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C4=CC=CC=C4F D09HRX HIGHSTAT Investigative D09HSI DRUG__ID D09HSI D09HSI DRUGTYPE Small molecular drug D09HSI DRUGINCH 1S/C11H23N2O7PS/c1-11(2,7-20-21(17,18)19)9(15)10(16)13-4-3-8(14)12-5-6-22/h9,15,22H,3-7H2,1-2H3,(H,12,14)(H,13,16)(H2,17,18,19)/t9-/m0/s1 D09HSI DRUGINKE JDMUPRLRUUMCTL-VIFPVBQESA-N D09HSI DRUGSMIL CC(C)(COP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O D09HSI HIGHSTAT Investigative D09HWQ DRUG__ID D09HWQ D09HWQ DRUGTYPE Small molecular drug D09HWQ DRUGINCH 1S/C16H12O3S/c1-20(18,19)15-10-7-13(8-11-15)9-12-16(17)14-5-3-2-4-6-14/h2-8,10-11H,1H3 D09HWQ DRUGINKE OIHHELVXIPDXIK-UHFFFAOYSA-N D09HWQ DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C#CC(=O)C2=CC=CC=C2 D09HWQ HIGHSTAT Investigative D09HWZ DRUG__ID D09HWZ D09HWZ DRUGTYPE Small molecular drug D09HWZ DRUGINCH 1S/C22H20IN3O2/c1-28-20-10-9-18-22(26-20)17(11-12-24-19(27)13-23)21(25-18)16-8-4-6-14-5-2-3-7-15(14)16/h2-10,25H,11-13H2,1H3,(H,24,27)/i23-2 D09HWZ DRUGINKE ZYVDSJZCXRMXGR-FOKFMTIASA-N D09HWZ DRUGSMIL COC1=NC2=C(C=C1)NC(=C2CCNC(=O)CI)C3=CC=CC4=CC=CC=C43 D09HWZ HIGHSTAT Investigative D09HXU DRUG__ID D09HXU D09HXU DRUGTYPE Small molecular drug D09HXU DRUGINCH 1S/C15H13N3/c1-10-4-2-3-5-13(10)11-6-7-14-12(8-11)9-17-15(16)18-14/h2-9H,1H3,(H2,16,17,18) D09HXU DRUGINKE RAWAQXBVMDKSIO-UHFFFAOYSA-N D09HXU DRUGSMIL CC1=CC=CC=C1C2=CC3=CN=C(N=C3C=C2)N D09HXU HIGHSTAT Investigative D09HXX DRUG__ID D09HXX D09HXX DRUGTYPE Small molecular drug D09HXX DRUGINCH 1S/C21H17ClFN3O4S/c22-18-12-17(10-11-19(18)23)31(29,30)24-13-14-6-8-16(9-7-14)21(28)26-25-20(27)15-4-2-1-3-5-15/h1-12,24H,13H2,(H,25,27)(H,26,28) D09HXX DRUGINKE FYIBXBFDXNPBSF-UHFFFAOYSA-N D09HXX DRUGSMIL C1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=C(C=C2)CNS(=O)(=O)C3=CC(=C(C=C3)F)Cl D09HXX HIGHSTAT Investigative D09HZE DRUG__ID D09HZE D09HZE DRUGTYPE Small molecular drug D09HZE DRUGINCH 1S/C17H16N2O2S/c20-17(18-9-11-21-12-10-18)19-13-5-1-3-7-15(13)22-16-8-4-2-6-14(16)19/h1-8H,9-12H2 D09HZE DRUGINKE PWLGMYUBQYNSQV-UHFFFAOYSA-N D09HZE DRUGSMIL C1COCCN1C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D09HZE HIGHSTAT Investigative D09ICL DRUG__ID D09ICL D09ICL DRUGTYPE Small molecular drug D09ICL DRUGINCH 1S/C21H17Cl2NO2/c22-18-12-9-15(13-19(18)23)6-5-14-7-10-16(11-8-14)24-20-4-2-1-3-17(20)21(25)26/h1-4,7-13,24H,5-6H2,(H,25,26) D09ICL DRUGINKE ZCQOSCDABPVAFB-UHFFFAOYSA-N D09ICL DRUGSMIL C1=CC=C(C(=C1)C(=O)O)NC2=CC=C(C=C2)CCC3=CC(=C(C=C3)Cl)Cl D09ICL HIGHSTAT Investigative D09IEG DRUG__ID D09IEG D09IEG DRUGTYPE Small molecular drug D09IEG DRUGINCH 1S/C16H14N2O/c1-10-4-3-5-12(6-10)14-8-15(19)13-7-11(2)9-17-16(13)18-14/h3-9H,1-2H3,(H,17,18,19) D09IEG DRUGINKE KDLJOBRGZSEPQS-UHFFFAOYSA-N D09IEG DRUGSMIL CC1=CC(=CC=C1)C2=CC(=O)C3=C(N2)N=CC(=C3)C D09IEG HIGHSTAT Investigative D09IEN DRUG__ID D09IEN D09IEN DRUGTYPE Small molecular drug D09IEN DRUGINCH 1S/C28H36O4/c1-6-7-8-15-32-25-18-23-22(27(2,3)13-14-28(23,4)5)17-21(25)20-16-19(9-11-24(20)29)10-12-26(30)31/h9-12,16-18,29H,6-8,13-15H2,1-5H3,(H,30,31)/b12-10+ D09IEN DRUGINKE APJSHECCIRQQDV-ZRDIBKRKSA-N D09IEN DRUGSMIL CCCCCOC1=CC2=C(C=C1C3=C(C=CC(=C3)C=CC(=O)O)O)C(CCC2(C)C)(C)C D09IEN HIGHSTAT Investigative D09IEO DRUG__ID D09IEO D09IEO DRUGTYPE Small molecular drug D09IEO DRUGINCH 1S/C44H61N11O10/c45-29(15-7-19-48-44(46)47)40(61)55-22-10-18-35(55)42(63)54-21-8-16-33(54)38(59)49-25-36(57)50-30(23-27-11-3-1-4-12-27)37(58)52-32(26-56)41(62)53-20-9-17-34(53)39(60)51-31(43(64)65)24-28-13-5-2-6-14-28/h1-6,11-14,29-35,56H,7-10,15-26,45H2,(H,49,59)(H,50,57)(H,51,60)(H,52,58)(H,64,65)(H4,46,47,48) D09IEO DRUGINKE VCEHWDBVPZFHAG-UHFFFAOYSA-N D09IEO DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)O D09IEO HIGHSTAT Investigative D09IHE DRUG__ID D09IHE D09IHE DRUGTYPE Small molecular drug D09IHE DRUGINCH 1S/C17H20N8O2/c1-10-6-11(23-27-10)15-21-19-7-12-14(17(2,3)4)16(22-25(12)15)26-8-13-18-9-20-24(13)5/h6-7,9H,8H2,1-5H3 D09IHE DRUGINKE QYSYOGCIDRANAR-UHFFFAOYSA-N D09IHE DRUGSMIL CC1=CC(=NO1)C2=NN=CC3=C(C(=NN32)OCC4=NC=NN4C)C(C)(C)C D09IHE HIGHSTAT Investigative D09IHN DRUG__ID D09IHN D09IHN DRUGTYPE Small molecular drug D09IHN DRUGINCH 1S/C6H9NO2/c1-2-5(7)3-4-6(8)9/h1,5H,3-4,7H2,(H,8,9) D09IHN DRUGINKE BJNIHWSOVCDBHS-UHFFFAOYSA-N D09IHN DRUGSMIL C#CC(CCC(=O)O)N D09IHN HIGHSTAT Investigative D09IIH DRUG__ID D09IIH D09IIH DRUGTYPE Small molecular drug D09IIH DRUGINCH 1S/C17H18FNO/c18-16-8-4-7-15(13-9-11-19-12-10-13)17(16)20-14-5-2-1-3-6-14/h1-8,13,19H,9-12H2 D09IIH DRUGINKE WWIFVPBPYYVHTD-UHFFFAOYSA-N D09IIH DRUGSMIL C1CNCCC1C2=C(C(=CC=C2)F)OC3=CC=CC=C3 D09IIH HIGHSTAT Investigative D09IJN DRUG__ID D09IJN D09IJN DRUGTYPE Small molecular drug D09IJN DRUGINCH 1S/C17H14N2O2/c1-17(2)18-12-8-7-11-13(14(12)19-17)16(21)10-6-4-3-5-9(10)15(11)20/h3-8,20-21H,1-2H3 D09IJN DRUGINKE HQLMOIOGHONOJD-UHFFFAOYSA-N D09IJN DRUGSMIL CC1(N=C2C=CC3=C(C4=CC=CC=C4C(=C3C2=N1)O)O)C D09IJN HIGHSTAT Investigative D09IMK DRUG__ID D09IMK D09IMK DRUGTYPE Small molecular drug D09IMK DRUGINCH 1S/C34H55N5O8S/c1-10-23(4)29(38-33(44)47-21-25-14-12-11-13-15-25)32(43)37-27(16-17-28(40)39-34(6,7)8)31(42)35-24(5)30(41)36-26(20-22(2)3)18-19-48(9,45)46/h11-15,18-19,22-24,26-27,29H,10,16-17,20-21H2,1-9H3,(H,35,42)(H,36,41)(H,37,43)(H,38,44)(H,39,40)/b19-18+/t23-,24-,26+,27-,29-/m0/s1 D09IMK DRUGINKE YIFPZVMURBGBNU-NHVLHDLVSA-N D09IMK DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)NC(C)(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC1=CC=CC=C1 D09IMK HIGHSTAT Investigative D09INA DRUG__ID D09INA D09INA DRUGCOMP Hypha Discovery Ltd D09INA DRUGINCH 1S/C11H19NO5/c1-7(2)6-8(11(15)16)12-9(13)4-5-10(14)17-3/h7-8H,4-6H2,1-3H3,(H,12,13)(H,15,16)/t8-/m0/s1 D09INA DRUGINKE ISFKYPCVWAUFGD-QMMMGPOBSA-N D09INA DRUGSMIL CC(C)CC(C(=O)O)NC(=O)CCC(=O)OC D09INA HIGHSTAT Investigative D09IQG DRUG__ID D09IQG D09IQG DRUGTYPE Small molecular drug D09IQG DRUGINCH 1S/C42H56O14/c1-28(33(54-30(3)43)29(2)27-31-19-13-11-14-20-31)23-24-40-34(44)35(42(56-40,39(49)50)41(51,38(47)48)36(55-40)37(45)46)53-26-18-10-8-6-4-5-7-9-17-25-52-32-21-15-12-16-22-32/h11-16,19-22,29,33-36,44,51H,1,4-10,17-18,23-27H2,2-3H3,(H,45,46)(H,47,48)(H,49,50)/t29-,33-,34-,35-,36?,40?,41?,42?/m1/s1 D09IQG DRUGINKE QBTROWHSMGZXCV-RQURQNPSSA-N D09IQG DRUGSMIL CC(CC1=CC=CC=C1)C(C(=C)CCC23C(C(C(O2)(C(C(O3)C(=O)O)(C(=O)O)O)C(=O)O)OCCCCCCCCCCCOC4=CC=CC=C4)O)OC(=O)C D09IQG HIGHSTAT Investigative D09IQS DRUG__ID D09IQS D09IQS DRUGTYPE Small molecular drug D09IQS DRUGINCH 1S/C6H7N/c1-6-2-4-7-5-3-6/h2-5H,1H3 D09IQS DRUGINKE FKNQCJSGGFJEIZ-UHFFFAOYSA-N D09IQS DRUGSMIL CC1=CC=NC=C1 D09IQS HIGHSTAT Investigative D09IRF DRUG__ID D09IRF D09IRF DRUGTYPE Small molecular drug D09IRF DRUGINCH 1S/C25H36INO4/c1-25(2)17-13-20(25)19(7-5-3-4-6-8-24(30)31)22(14-17)27-15-18(28)11-16-9-10-23(29)21(26)12-16/h3,5,9-10,12,17-20,22,27-29H,4,6-8,11,13-15H2,1-2H3,(H,30,31)/b5-3+/i26-2 D09IRF DRUGINKE RCPAWLXQBMAVGJ-WEGMHNBISA-N D09IRF DRUGSMIL CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C D09IRF HIGHSTAT Investigative D09IRV DRUG__ID D09IRV D09IRV DRUGTYPE Small molecular drug D09IRV DRUGINCH 1S/C23H22N4/c1-4-10-16(11-5-1)19-20-23(26-21(24-19)17-12-6-2-7-13-17)27-22(25-20)18-14-8-3-9-15-18/h1-2,4-7,10-13,18H,3,8-9,14-15H2,(H,24,25,26,27) D09IRV DRUGINKE IGJKVZBNIOTBGI-UHFFFAOYSA-N D09IRV DRUGSMIL C1CCC(CC1)C2=NC3=NC(=NC(=C3N2)C4=CC=CC=C4)C5=CC=CC=C5 D09IRV HIGHSTAT Investigative D09ISB DRUG__ID D09ISB D09ISB DRUGTYPE Small molecular drug D09ISB DRUGINCH 1S/C5H12NO5P/c6-4(5(7)8)2-1-3-12(9,10)11/h4H,1-3,6H2,(H,7,8)(H2,9,10,11) D09ISB DRUGINKE VOROEQBFPPIACJ-UHFFFAOYSA-N D09ISB DRUGSMIL C(CC(C(=O)O)N)CP(=O)(O)O D09ISB HIGHSTAT Investigative D09ITI DRUG__ID D09ITI D09ITI DRUGTYPE Small molecular drug D09ITI DRUGINCH 1S/C36H44N4O2/c41-30-14-11-13-26-27-15-18-37-32(33(27)38-31(26)30)28-23-36(42)17-8-4-1-2-5-9-19-39-21-16-29(28)35(24-39)22-25-12-7-3-6-10-20-40(25)34(35)36/h1,4,7,11-15,18,23,25,29,34,38,41-42H,2-3,5-6,8-10,16-17,19-22,24H2/b4-1-,12-7-/t25-,29-,34+,35-,36-/m0/s1 D09ITI DRUGINKE AMSNINGPDSUBHZ-WAUQNXBMSA-N D09ITI DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCCC=C5)O)C6=NC=CC7=C6NC8=C7C=CC=C8O D09ITI HIGHSTAT Investigative D09ITX DRUG__ID D09ITX D09ITX DRUGTYPE Small molecular drug D09ITX DRUGINCH 1S/C20H18O3/c21-19-16(12-13-6-2-1-3-7-13)20(22)23-17-11-10-14-8-4-5-9-15(14)18(17)19/h1-3,6-7,10-11,21H,4-5,8-9,12H2 D09ITX DRUGINKE VVGMGNIOZFKXQQ-UHFFFAOYSA-N D09ITX DRUGSMIL C1CCC2=C(C1)C=CC3=C2C(=C(C(=O)O3)CC4=CC=CC=C4)O D09ITX HIGHSTAT Investigative D09IVQ DRUG__ID D09IVQ D09IVQ DRUGTYPE Small molecular drug D09IVQ DRUGINCH 1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1 D09IVQ DRUGINKE SRNWOUGRCWSEMX-ZQSHOCFMSA-N D09IVQ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)O)O)O)O)O)N D09IVQ HIGHSTAT Investigative D09IVS DRUG__ID D09IVS D09IVS DRUGTYPE Small molecular drug D09IVS DRUGINCH 1S/C4H10NO2P/c1-8(6,7)4-2-3-5/h3,5H,2,4H2,1H3,(H,6,7) D09IVS DRUGINKE CLJLMKDNJNIXPO-UHFFFAOYSA-N D09IVS DRUGSMIL CP(=O)(CCC=N)O D09IVS HIGHSTAT Investigative D09IWI DRUG__ID D09IWI D09IWI DRUGTYPE Small molecular drug D09IWI DRUGINCH 1S/C22H30N2O7/c1-2-12-31-16-6-4-15(5-7-16)18(26)8-9-20(28)23-10-3-11-24-13-19(27)22(30)21(29)17(24)14-25/h1,4-7,17,19,21-22,25,27,29-30H,3,8-14H2,(H,23,28)/t17-,19+,21-,22-/m1/s1 D09IWI DRUGINKE AAWCULUAQOJFJX-HGIWEUDGSA-N D09IWI DRUGSMIL C#CCOC1=CC=C(C=C1)C(=O)CCC(=O)NCCCN2CC(C(C(C2CO)O)O)O D09IWI HIGHSTAT Investigative D09JAB DRUG__ID D09JAB D09JAB DRUGTYPE Small molecular drug D09JAB DRUGINCH 1S/C11H9NO4/c13-9-4-5-10(14)12(9)8-3-1-2-7(6-8)11(15)16/h1-3,6H,4-5H2,(H,15,16) D09JAB DRUGINKE BEQRYKGDEGNALQ-UHFFFAOYSA-N D09JAB DRUGSMIL C1CC(=O)N(C1=O)C2=CC=CC(=C2)C(=O)O D09JAB HIGHSTAT Investigative D09JAO DRUG__ID D09JAO D09JAO DRUGTYPE Small molecular drug D09JAO DRUGINCH 1S/C5H11O7P/c1-3(6)5(8)4(7)2-12-13(9,10)11/h4-5,7-8H,2H2,1H3,(H2,9,10,11)/t4-,5-/m1/s1 D09JAO DRUGINKE AJPADPZSRRUGHI-RFZPGFLSSA-N D09JAO DRUGSMIL CC(=O)C(C(COP(=O)(O)O)O)O D09JAO HIGHSTAT Investigative D09JAR DRUG__ID D09JAR D09JAR DRUGTYPE Small molecular drug D09JAR DRUGINCH 1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1 D09JAR DRUGINKE BVKZGUZCCUSVTD-UHFFFAOYSA-M D09JAR DRUGSMIL C(=O)(O)[O-] D09JAR HIGHSTAT Investigative D09JCT DRUG__ID D09JCT D09JCT DRUGTYPE Small molecular drug D09JCT DRUGINCH 1S/C29H44N6O16S2/c1-13(36)30-18(11-23(43)44)28(49)33-15(4-7-21(39)40)25(46)34-17(9-10-53-2)27(48)32-14(3-6-20(37)38)24(45)31-16(5-8-22(41)42)26(47)35-19(12-52)29(50)51/h14-19,52H,3-12H2,1-2H3,(H,30,36)(H,31,45)(H,32,48)(H,33,49)(H,34,46)(H,35,47)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H,50,51)/t14-,15-,16-,17-,18-,19-/m0/s1 D09JCT DRUGINKE VGFHUYLCQHZNFZ-DYKIIFRCSA-N D09JCT DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CS)C(=O)O D09JCT HIGHSTAT Investigative D09JDH DRUG__ID D09JDH D09JDH DRUGTYPE Small molecular drug D09JDH DRUGINCH 1S/C39H53N7O7S/c1-24(2)21-29(36(50)42-27(34(40)48)18-20-54-3)44-38(52)32-15-10-19-46(32)39(53)31(23-26-13-8-5-9-14-26)45-37(51)30(22-25-11-6-4-7-12-25)43-35(49)28-16-17-33(47)41-28/h4-9,11-14,24,27-32H,10,15-23H2,1-3H3,(H2,40,48)(H,41,47)(H,42,50)(H,43,49)(H,44,52)(H,45,51)/t27-,28-,29-,30-,31-,32-/m0/s1 D09JDH DRUGINKE UUZURPUIMYJOIL-JNRWAQIZSA-N D09JDH DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C4CCC(=O)N4 D09JDH HIGHSTAT Investigative D09JER DRUG__ID D09JER D09JER DRUGTYPE Small molecular drug D09JER DRUGINCH 1S/C23H38O2/c1-4-5-6-15-23(2,3)20-12-9-19(10-13-20)22-17-21(25)14-11-18(22)8-7-16-24/h9-10,12-13,18,21-22,24-25H,4-8,11,14-17H2,1-3H3/t18-,21-,22-/m1/s1 D09JER DRUGINKE VAVUZZKKXHPBEZ-STZQEDGTSA-N D09JER DRUGSMIL CCCCCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D09JER HIGHSTAT Investigative D09JGO DRUG__ID D09JGO D09JGO DRUGTYPE Small molecular drug D09JGO DRUGINCH 1S/C36H68N12O8/c1-19(2)16-25(30(52)43-21(5)28(50)45-24(33(55)56)13-11-15-42-35(39)40)47-32(54)27(18-36(7,8)9)48-31(53)26(17-20(3)4)46-29(51)23(44-22(6)49)12-10-14-41-34(37)38/h19-21,23-27H,10-18H2,1-9H3,(H,43,52)(H,44,49)(H,45,50)(H,46,51)(H,47,54)(H,48,53)(H,55,56)(H4,37,38,41)(H4,39,40,42)/t21-,23-,24-,25-,26-,27-/m0/s1 D09JGO DRUGINKE VIJSPAIQWVPKQZ-BLECARSGSA-N D09JGO DRUGSMIL CC(C)CC(C(=O)NC(CC(C)(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C D09JGO HIGHSTAT Investigative D09JHA DRUG__ID D09JHA D09JHA DRUGTYPE Small molecular drug D09JHA DRUGINCH 1S/N3/c1-3-2/q-1 D09JHA DRUGINKE IVRMZWNICZWHMI-UHFFFAOYSA-N D09JHA DRUGSMIL [N-]=[N+]=[N-] D09JHA HIGHSTAT Investigative D09JHM DRUG__ID D09JHM D09JHM DRUGTYPE Small molecular drug D09JHM DRUGINCH 1S/C15H12ClN3O/c1-20-12-5-6-14-13(8-12)15(18-9-17-14)19-11-4-2-3-10(16)7-11/h2-9H,1H3,(H,17,18,19) D09JHM DRUGINKE JDEKFVYZUIPHET-UHFFFAOYSA-N D09JHM DRUGSMIL COC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Cl D09JHM HIGHSTAT Investigative D09JHT DRUG__ID D09JHT D09JHT DRUGTYPE Small molecular drug D09JHT DRUGINCH 1S/C26H30N4O3/c1-33-26(32)24(29-25(31)17-23-8-5-15-30(18-23)19-28-27)16-22-13-11-21(12-14-22)10-9-20-6-3-2-4-7-20/h2-4,6-7,11-14,19,23-24H,5,8,15-18,27H2,1H3,(H,29,31)/t23-,24+/m1/s1 D09JHT DRUGINKE YQDXLNDLKSCQKX-RPWUZVMVSA-N D09JHT DRUGSMIL COC(=O)C(CC1=CC=C(C=C1)C#CC2=CC=CC=C2)NC(=O)CC3CCCN(C3)C=NN D09JHT HIGHSTAT Investigative D09JHY DRUG__ID D09JHY D09JHY DRUGTYPE Small molecular drug D09JHY DRUGINCH 1S/C20H25NO3/c1-3-4-5-6-7-16-8-13-20(19(23)14-16)24-18-11-9-17(10-12-18)21-15(2)22/h8-14,23H,3-7H2,1-2H3,(H,21,22) D09JHY DRUGINKE MQSIKLFXBKTOER-UHFFFAOYSA-N D09JHY DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=C(C=C2)NC(=O)C)O D09JHY HIGHSTAT Investigative D09JII DRUG__ID D09JII D09JII DRUGTYPE Small molecular drug D09JII DRUGINCH 1S/C28H27ClO4S/c1-2-7-22-25(12-11-21-23(18-33-28(21)22)20-8-4-3-5-9-20)32-14-6-15-34-26-13-10-19(16-24(26)29)17-27(30)31/h3-5,8-13,16,18H,2,6-7,14-15,17H2,1H3,(H,30,31) D09JII DRUGINKE KAPDPGZDHUCILF-UHFFFAOYSA-N D09JII DRUGSMIL CCCC1=C(C=CC2=C1OC=C2C3=CC=CC=C3)OCCCSC4=C(C=C(C=C4)CC(=O)O)Cl D09JII HIGHSTAT Investigative D09JKT DRUG__ID D09JKT D09JKT DRUGTYPE Small molecular drug D09JKT DRUGINCH 1S/C17H14N4O2/c1-11(22)18-17-20-14-10-6-5-9-13(14)15(21-17)16(23)19-12-7-3-2-4-8-12/h2-10H,1H3,(H,19,23)(H,18,20,21,22) D09JKT DRUGINKE BQZOPXKHGPNWQR-UHFFFAOYSA-N D09JKT DRUGSMIL CC(=O)NC1=NC2=CC=CC=C2C(=N1)C(=O)NC3=CC=CC=C3 D09JKT HIGHSTAT Investigative D09JNN DRUG__ID D09JNN D09JNN DRUGTYPE Small molecular drug D09JNN DRUGINCH 1S/C18H23N5O/c1-13(24)15(10-6-5-9-14-7-3-2-4-8-14)23-12-22-16-17(19)20-11-21-18(16)23/h2-4,7-8,11-13,15,24H,5-6,9-10H2,1H3,(H2,19,20,21)/t13-,15+/m0/s1 D09JNN DRUGINKE HWARBJPXURXCIU-DZGCQCFKSA-N D09JNN DRUGSMIL CC(C(CCCCC1=CC=CC=C1)N2C=NC3=C(N=CN=C32)N)O D09JNN HIGHSTAT Investigative D09JOE DRUG__ID D09JOE D09JOE DRUGTYPE Small molecular drug D09JOE DRUGINCH 1S/C13H20N2O2/c1-10-8-13(17-3)11(9-12(10)16-2)15-6-4-14-5-7-15/h8-9,14H,4-7H2,1-3H3 D09JOE DRUGINKE XJDJQRVAYJTBHO-UHFFFAOYSA-N D09JOE DRUGSMIL CC1=CC(=C(C=C1OC)N2CCNCC2)OC D09JOE HIGHSTAT Investigative D09JOM DRUG__ID D09JOM D09JOM DRUGTYPE Small molecular drug D09JOM DRUGINCH 1S/C8H8Cl2N2S.BrH/c9-6-2-1-5(7(10)3-6)4-13-8(11)12;/h1-3H,4H2,(H3,11,12);1H D09JOM DRUGINKE BNMARKYIMABDPE-UHFFFAOYSA-N D09JOM DRUGSMIL C1=CC(=C(C=C1Cl)Cl)CSC(=N)N.Br D09JOM HIGHSTAT Investigative D09JPC DRUG__ID D09JPC D09JPC DRUGTYPE Small molecular drug D09JPC DRUGINCH 1S/C6H16N2/c7-5-3-1-2-4-6-8/h1-8H2 D09JPC DRUGINKE NAQMVNRVTILPCV-UHFFFAOYSA-N D09JPC DRUGSMIL C(CCCN)CCN D09JPC HIGHSTAT Investigative D09JQU DRUG__ID D09JQU D09JQU DRUGTYPE Small molecular drug D09JQU DRUGINCH 1S/C34H39NO8/c36-32(35-27-10-6-9-25(22-27)33(37)38)30-23-26(34(39)40)15-18-31(30)43-21-7-8-24-13-16-29(17-14-24)42-20-5-4-19-41-28-11-2-1-3-12-28/h1-3,11-18,23,25,27H,4-10,19-22H2,(H,35,36)(H,37,38)(H,39,40) D09JQU DRUGINKE GKPAULTWHHPIHX-UHFFFAOYSA-N D09JQU DRUGSMIL C1CC(CC(C1)NC(=O)C2=C(C=CC(=C2)C(=O)O)OCCCC3=CC=C(C=C3)OCCCCOC4=CC=CC=C4)C(=O)O D09JQU HIGHSTAT Investigative D09JRN DRUG__ID D09JRN D09JRN DRUGTYPE Small molecular drug D09JRN DRUGINCH 1S/C19H21N3/c20-15-17-6-4-5-16(13-17)14-19(18-7-2-1-3-8-18)22-11-9-21-10-12-22/h1-8,13,19,21H,9-12,14H2 D09JRN DRUGINKE JQQRBSOAFDAWGZ-UHFFFAOYSA-N D09JRN DRUGSMIL C1CN(CCN1)C(CC2=CC(=CC=C2)C#N)C3=CC=CC=C3 D09JRN HIGHSTAT Investigative D09JSA DRUG__ID D09JSA D09JSA DRUGTYPE Small molecular drug D09JSA DRUGINCH 1S/C17H27NO/c1-3-9-17(10-4-1)11-7-15-19-16-8-14-18-12-5-2-6-13-18/h1,3-4,9-10H,2,5-8,11-16H2 D09JSA DRUGINKE UYLNHGRGPLPMFD-UHFFFAOYSA-N D09JSA DRUGSMIL C1CCN(CC1)CCCOCCCC2=CC=CC=C2 D09JSA HIGHSTAT Investigative D09JSD DRUG__ID D09JSD D09JSD DRUGTYPE Small molecular drug D09JSD DRUGINCH 1S/C18H16O7/c1-6-14(22)12(8(3)20)16-13(15(6)23)18(4)10(25-16)5-9(21)11(7(2)19)17(18)24/h5,11,22-23H,1-4H3 D09JSD DRUGINKE CUCUKLJLRRAKFN-UHFFFAOYSA-N D09JSD DRUGSMIL CC1=C(C(=C2C(=C1O)C3(C(=CC(=O)C(C3=O)C(=O)C)O2)C)C(=O)C)O D09JSD HIGHSTAT Investigative D09JSK DRUG__ID D09JSK D09JSK DRUGTYPE Small molecular drug D09JSK DRUGINCH 1S/C4H6O3/c5-3-1-2-4(6)7/h3H,1-2H2,(H,6,7)/p-1 D09JSK DRUGINKE UIUJIQZEACWQSV-UHFFFAOYSA-M D09JSK DRUGSMIL C(CC(=O)[O-])C=O D09JSK HIGHSTAT Investigative D09JUD DRUG__ID D09JUD D09JUD DRUGTYPE Small molecular drug D09JUD DRUGINCH 1S/C20H21N5O3/c1-27-19-13-14(25-9-11-28-12-10-25)5-6-17(19)23-20(26)18-4-2-3-15(22-18)16-7-8-21-24-16/h2-8,13H,9-12H2,1H3,(H,21,24)(H,23,26) D09JUD DRUGINKE RAFFLDOJXQAJPF-UHFFFAOYSA-N D09JUD DRUGSMIL COC1=C(C=CC(=C1)N2CCOCC2)NC(=O)C3=CC=CC(=N3)C4=CC=NN4 D09JUD HIGHSTAT Investigative D09JXO DRUG__ID D09JXO D09JXO DRUGTYPE Small molecular drug D09JXO DRUGINCH 1S/C14H10BrN3/c1-9-5-6-11-8-16-13(18-14(11)17-9)10-3-2-4-12(15)7-10/h2-8H,1H3 D09JXO DRUGINKE QTHPZWOJWWROSA-UHFFFAOYSA-N D09JXO DRUGSMIL CC1=NC2=NC(=NC=C2C=C1)C3=CC(=CC=C3)Br D09JXO HIGHSTAT Investigative D09JXR DRUG__ID D09JXR D09JXR DRUGTYPE Small molecular drug D09JXR DRUGINCH 1S/C23H20Cl2N2O3S/c24-16-6-9-19(25)18(12-16)20-13-31-23(26-20)27(17-7-8-17)22(30)15(11-21(28)29)10-14-4-2-1-3-5-14/h1-6,9,12-13,15,17H,7-8,10-11H2,(H,28,29) D09JXR DRUGINKE LCRQPJWEPVZEBE-UHFFFAOYSA-N D09JXR DRUGSMIL C1CC1N(C2=NC(=CS2)C3=C(C=CC(=C3)Cl)Cl)C(=O)C(CC4=CC=CC=C4)CC(=O)O D09JXR HIGHSTAT Investigative D09JZG DRUG__ID D09JZG D09JZG DRUGTYPE Small molecular drug D09JZG DRUGINCH 1S/C11H15N/c1-2-7-11-9-12-8-4-3-6-10(11)5-1/h1-2,5,7,12H,3-4,6,8-9H2 D09JZG DRUGINKE QLEFVMRRZCGFFA-UHFFFAOYSA-N D09JZG DRUGSMIL C1CCNCC2=CC=CC=C2C1 D09JZG HIGHSTAT Investigative D09JZY DRUG__ID D09JZY D09JZY DRUGTYPE Small molecular drug D09JZY DRUGINCH 1S/C8H17NO2S/c1-7-5-4-6-8(2)9(7)12(3,10)11/h7-8H,4-6H2,1-3H3/t7-,8+ D09JZY DRUGINKE NDRNIFSBRLCSCZ-OCAPTIKFSA-N D09JZY DRUGSMIL CC1CCCC(N1S(=O)(=O)C)C D09JZY HIGHSTAT Investigative D09KBQ DRUG__ID D09KBQ D09KBQ DRUGTYPE Small molecular drug D09KBQ DRUGINCH 1S/C30H32ClF3N2O2/c1-35(2)27(37)29(22-9-5-3-6-10-22,23-11-7-4-8-12-23)17-20-36-18-15-28(38,16-19-36)24-13-14-26(31)25(21-24)30(32,33)34/h3-14,21,38H,15-20H2,1-2H3 D09KBQ DRUGINKE WPYGCZCMGMVGNO-UHFFFAOYSA-N D09KBQ DRUGSMIL CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)(C3=CC=CC=C3)C4=CC=CC=C4 D09KBQ HIGHSTAT Investigative D09KCU DRUG__ID D09KCU D09KCU DRUGTYPE Small molecular drug D09KCU DRUGINCH 1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h2H,1H3,(H,6,7)(H,8,9)/b3-2- D09KCU DRUGINKE HNEGQIOMVPPMNR-IHWYPQMZSA-N D09KCU DRUGSMIL CC(=CC(=O)O)C(=O)O D09KCU HIGHSTAT Investigative D09KDI DRUG__ID D09KDI D09KDI DRUGTYPE Small molecular drug D09KDI DRUGINCH 1S/C42H60N4O3/c1-4-26-46(37-24-30-45(31-25-37)33-38-39(48-2)21-16-22-40(38)49-3)28-15-7-5-6-14-27-44-29-23-36(32-44)42(41(43)47,34-17-10-8-11-18-34)35-19-12-9-13-20-35/h8-13,16-22,36-37H,4-7,14-15,23-33H2,1-3H3,(H2,43,47)/t36-/m1/s1 D09KDI DRUGINKE AXSAVLPYCZEECW-PSXMRANNSA-N D09KDI DRUGSMIL CCCN(CCCCCCCN1CCC(C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)C4CCN(CC4)CC5=C(C=CC=C5OC)OC D09KDI HIGHSTAT Investigative D09KDS DRUG__ID D09KDS D09KDS DRUGTYPE Small molecular drug D09KDS DRUGINCH 1S/C17H28N2O/c1-2-18-3-5-19(6-4-18)16(20)17-10-13-7-14(11-17)9-15(8-13)12-17/h13-15H,2-12H2,1H3 D09KDS DRUGINKE XOWWNQSYPPTVEH-UHFFFAOYSA-N D09KDS DRUGSMIL CCN1CCN(CC1)C(=O)C23CC4CC(C2)CC(C4)C3 D09KDS HIGHSTAT Investigative D09KEB DRUG__ID D09KEB D09KEB DRUGCOMP Portola Pharmaceuticals Inc D09KEB DRUGINCH 1S/C18H24N6O/c1-11-5-4-6-12(9-11)22-17-13(16(20)25)10-21-18(24-17)23-15-8-3-2-7-14(15)19/h4-6,9-10,14-15H,2-3,7-8,19H2,1H3,(H2,20,25)(H2,21,22,23,24)/t14-,15+/m0/s1 D09KEB DRUGINKE NZNTWOVDIXCHHS-LSDHHAIUSA-N D09KEB DRUGSMIL CC1=CC(=CC=C1)NC2=NC(=NC=C2C(=O)N)NC3CCCCC3N D09KEB HIGHSTAT Investigative D09KFJ DRUG__ID D09KFJ D09KFJ DRUGTYPE Small molecular drug D09KFJ DRUGINCH 1S/C25H38O2/c1-8-9-10-13-24(3,4)18-15-21(26-7)23-19-14-17(2)11-12-20(19)25(5,6)27-22(23)16-18/h14-16,19-20H,8-13H2,1-7H3/t19-,20-/m1/s1 D09KFJ DRUGINKE PUBXDTLETUTKIJ-WOJBJXKFSA-N D09KFJ DRUGSMIL CCCCCC(C)(C)C1=CC2=C(C3C=C(CCC3C(O2)(C)C)C)C(=C1)OC D09KFJ HIGHSTAT Investigative D09KFR DRUG__ID D09KFR D09KFR DRUGTYPE Small molecular drug D09KFR DRUGINCH 1S/C16H18N2O2S/c1-16(2)7-11-13(12(20)8-16)14(18-15(21)17-11)9-4-3-5-10(19)6-9/h3-6,14,19H,7-8H2,1-2H3,(H2,17,18,21)/t14-/m0/s1 D09KFR DRUGINKE RUOOPLOUUAYNPY-AWEZNQCLSA-N D09KFR DRUGSMIL CC1(CC2=C(C(NC(=S)N2)C3=CC(=CC=C3)O)C(=O)C1)C D09KFR HIGHSTAT Investigative D09KGN DRUG__ID D09KGN D09KGN DRUGTYPE Small molecular drug D09KGN DRUGINCH 1S/C3H11N3O7P2/c4-2(5)6-1-3(7,14(8,9)10)15(11,12)13/h7H,1H2,(H4,4,5,6)(H2,8,9,10)(H2,11,12,13) D09KGN DRUGINKE ZZHOMRYFXNLXOZ-UHFFFAOYSA-N D09KGN DRUGSMIL C(C(O)(P(=O)(O)O)P(=O)(O)O)N=C(N)N D09KGN HIGHSTAT Investigative D09KKF DRUG__ID D09KKF D09KKF DRUGTYPE Small molecular drug D09KKF DRUGINCH 1S/C7H7N3O/c8-7-9-5-2-1-4(11)3-6(5)10-7/h1-3,11H,(H3,8,9,10) D09KKF DRUGINKE FNSYWIPPPFVBAV-UHFFFAOYSA-N D09KKF DRUGSMIL C1=CC2=C(C=C1O)NC(=N2)N D09KKF HIGHSTAT Investigative D09KKU DRUG__ID D09KKU D09KKU DRUGTYPE Small molecular drug D09KKU DRUGINCH 1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1 D09KKU DRUGINKE VNYBTNPBYXSMOO-UHFFFAOYSA-M D09KKU DRUGSMIL C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-] D09KKU HIGHSTAT Investigative D09KQT DRUG__ID D09KQT D09KQT DRUGTYPE Small molecular drug D09KQT DRUGINCH 1S/C21H29N10O14P3S/c22-16-10-18(26-3-24-16)30(5-28-10)20-14(34)12(32)8(43-20)1-41-46(36,37)7-47(38,39)45-48(40,49)42-2-9-13(33)15(35)21(44-9)31-6-29-11-17(23)25-4-27-19(11)31/h3-6,8-9,12-15,20-21,32-35H,1-2,7H2,(H,36,37)(H,38,39)(H,40,49)(H2,22,24,26)(H2,23,25,27)/t8-,9-,12-,13-,14-,15-,20-,21-,48?/m1/s1 D09KQT DRUGINKE UJCWOSLCGXVJOD-VEBDTVEDSA-N D09KQT DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(CP(=O)(O)OP(=S)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O)N D09KQT HIGHSTAT Investigative D09KQZ DRUG__ID D09KQZ D09KQZ DRUGTYPE Small molecular drug D09KQZ DRUGINCH 1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10) D09KQZ DRUGINKE KPGXRSRHYNQIFN-UHFFFAOYSA-N D09KQZ DRUGSMIL C(CC(=O)O)C(=O)C(=O)O D09KQZ HIGHSTAT Investigative D09KRA DRUG__ID D09KRA D09KRA DRUGTYPE Small molecular drug D09KRA DRUGINCH 1S/C17H18INO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3/t15-/m1/s1/i18-2 D09KRA DRUGINKE JGBTWNOVLISURM-QFLNOARHSA-N D09KRA DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)O)I D09KRA HIGHSTAT Investigative D09KRH DRUG__ID D09KRH D09KRH DRUGTYPE Small molecular drug D09KRH DRUGINCH 1S/C15H21NO6/c1-8(4-3-5-9(2)14(19)20)11-7-16-13(15(21)22)10(11)6-12(17)18/h3-5,9-11,13,16H,6-7H2,1-2H3,(H,17,18)(H,19,20)(H,21,22)/b5-3+,8-4-/t9-,10+,11-,13+/m1/s1 D09KRH DRUGINKE VZFRNCSOCOPNDB-AOKDLOFSSA-N D09KRH DRUGSMIL CC(C=CC=C(C)C1CNC(C1CC(=O)O)C(=O)O)C(=O)O D09KRH HIGHSTAT Investigative D09KTF DRUG__ID D09KTF D09KTF DRUGTYPE Small molecular drug D09KTF DRUGINCH 1S/C17H19NO4S/c1-2-3-7-13-10-11-16(15(12-13)17(19)20)18-23(21,22)14-8-5-4-6-9-14/h4-6,8-12,18H,2-3,7H2,1H3,(H,19,20) D09KTF DRUGINKE GUFYXBDBRAROGG-UHFFFAOYSA-N D09KTF DRUGSMIL CCCCC1=CC(=C(C=C1)NS(=O)(=O)C2=CC=CC=C2)C(=O)O D09KTF HIGHSTAT Investigative D09KTN DRUG__ID D09KTN D09KTN DRUGTYPE Small molecular drug D09KTN DRUGINCH 1S/C32H52N6O13S/c1-16(2)12-21(36-28(46)19(8-10-24(39)40)34-27(45)18(33)14-26(43)44)30(48)35-20(9-11-25(41)42)29(47)37-22(13-17-6-4-3-5-7-17)31(49)38-23(15-52)32(50)51/h16-23,52H,3-15,33H2,1-2H3,(H,34,45)(H,35,48)(H,36,46)(H,37,47)(H,38,49)(H,39,40)(H,41,42)(H,43,44)(H,50,51)/t18-,19+,20-,21-,22-,23-/m0/s1 D09KTN DRUGINKE ZFRKNLVWQDBGEY-ZKPZVSKHSA-N D09KTN DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)N D09KTN HIGHSTAT Investigative D09KUE DRUG__ID D09KUE D09KUE DRUGTYPE Small molecular drug D09KUE DRUGINCH 1S/C27H33BrO5S/c1-26-13-11-19(29)15-17(26)3-8-21-22-9-10-24(27(22,2)14-12-23(21)26)25(30)16-33-34(31,32)20-6-4-18(28)5-7-20/h4-7,15,21-24H,3,8-14,16H2,1-2H3/t21-,22-,23-,24+,26-,27-/m0/s1 D09KUE DRUGINKE ZQNARVKYKGBJES-YNHSGCSHSA-N D09KUE DRUGSMIL CC12CCC3C(C1CCC2C(=O)COS(=O)(=O)C4=CC=C(C=C4)Br)CCC5=CC(=O)CCC35C D09KUE HIGHSTAT Investigative D09KUP DRUG__ID D09KUP D09KUP DRUGTYPE Small molecular drug D09KUP DRUGINCH 1S/C30H50O/c1-24(2)14-11-17-27(5)20-12-18-25(3)15-9-10-16-26(4)19-13-21-28(6)22-23-29-30(7,8)31-29/h14-16,20-21,29H,9-13,17-19,22-23H2,1-8H3/b25-15+,26-16+,27-20+,28-21+/t29-/m0/s1 D09KUP DRUGINKE QYIMSPSDBYKPPY-RSKUXYSASA-N D09KUP DRUGSMIL CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC1C(O1)(C)C)C)C)C D09KUP HIGHSTAT Investigative D09KUY DRUG__ID D09KUY D09KUY DRUGTYPE Small molecular drug D09KUY DRUGINCH 1S/C15H11ClN2/c1-10-7-8-12-13(16)9-14(18-15(12)17-10)11-5-3-2-4-6-11/h2-9H,1H3 D09KUY DRUGINKE CMSOCFLZPHQUAD-UHFFFAOYSA-N D09KUY DRUGSMIL CC1=NC2=C(C=C1)C(=CC(=N2)C3=CC=CC=C3)Cl D09KUY HIGHSTAT Investigative D09KZA DRUG__ID D09KZA D09KZA DRUGTYPE Small molecular drug D09KZA DRUGINCH 1S/C18H19N3O/c1-21-13-15(9-12-18(21)22)14-7-10-17(11-8-14)20-19-16-5-3-2-4-6-16/h2-8,10-11,15H,9,12-13H2,1H3 D09KZA DRUGINKE GUDNFCRTZUCEOP-UHFFFAOYSA-N D09KZA DRUGSMIL CN1CC(CCC1=O)C2=CC=C(C=C2)N=NC3=CC=CC=C3 D09KZA HIGHSTAT Investigative D09LAQ DRUG__ID D09LAQ D09LAQ DRUGTYPE Small molecular drug D09LAQ DRUGINCH 1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1 D09LAQ DRUGINKE ZOOGRGPOEVQQDX-UUOKFMHZSA-N D09LAQ DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C3N=C(NC4=O)N)O)OP(=O)(O1)O D09LAQ HIGHSTAT Investigative D09LDM DRUG__ID D09LDM D09LDM DRUGTYPE Small molecular drug D09LDM DRUGINCH 1S/C13H11NS/c1-10-4-3-5-12(8-10)6-7-13-9-15-11(2)14-13/h3-5,8-9H,1-2H3 D09LDM DRUGINKE LYHRSGPNRBPYDG-UHFFFAOYSA-N D09LDM DRUGSMIL CC1=CC(=CC=C1)C#CC2=CSC(=N2)C D09LDM HIGHSTAT Investigative D09LEK DRUG__ID D09LEK D09LEK DRUGTYPE Small molecular drug D09LEK DRUGINCH 1S/C15H13N3O3S/c16-22(19,20)13-8-6-12(7-9-13)18-15-17-10-14(21-15)11-4-2-1-3-5-11/h1-10H,(H,17,18)(H2,16,19,20) D09LEK DRUGINKE OKFOIEMZTIOWQH-UHFFFAOYSA-N D09LEK DRUGSMIL C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=C(C=C3)S(=O)(=O)N D09LEK HIGHSTAT Investigative D09LGT DRUG__ID D09LGT D09LGT DRUGTYPE Small molecular drug D09LGT DRUGINCH 1S/C51H82O20/c1-21-10-15-50(63-19-21)22(2)34-32(69-50)17-30-28-9-8-26-16-27(11-13-48(26,6)29(28)12-14-49(30,34)7)66-45-42(60)40(58)38(56)33(67-45)20-62-47-44(41(59)37(55)24(4)65-47)70-51(18-31(52)35(53)25(5)68-51)71-46-43(61)39(57)36(54)23(3)64-46/h8,21-25,27-47,52-61H,9-20H2,1-7H3 D09LGT DRUGINKE JXANHBVHGVNOQZ-UHFFFAOYSA-N D09LGT DRUGSMIL CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)COC8C(C(C(C(O8)C)O)O)OC9(CC(C(C(O9)C)O)O)OC2C(C(C(C(O2)C)O)O)O)O)O)O)C)C)C)OC1 D09LGT HIGHSTAT Investigative D09LHF DRUG__ID D09LHF D09LHF DRUGTYPE Small molecular drug D09LHF DRUGINCH 1S/C40H54N10O4/c41-40(42)44-19-11-16-33-38(53)50-34(21-28-23-45-32-15-10-9-14-31(28)32)36(51)17-7-2-1-3-8-18-37(52)48-30(22-29-24-43-26-47-29)25-46-35(39(54)49-33)20-27-12-5-4-6-13-27/h4-6,9-10,12-15,23-24,26,30,33-35,45-46H,1-3,7-8,11,16-22,25H2,(H,43,47)(H,48,52)(H,49,54)(H,50,53)(H4,41,42,44)/t30-,33-,34-,35-/m0/s1 D09LHF DRUGINKE VFJZBZLGBBBPQI-RONNFESSSA-N D09LHF DRUGSMIL C1CCCC(=O)C(NC(=O)C(NC(=O)C(NCC(NC(=O)CCC1)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54 D09LHF HIGHSTAT Investigative D09LKM DRUG__ID D09LKM D09LKM DRUGTYPE Small molecular drug D09LKM DRUGINCH 1S/C17H13N3OS/c1-21-15-4-2-12(3-5-15)14-8-18-17-16(9-19-20(17)10-14)13-6-7-22-11-13/h2-11H,1H3 D09LKM DRUGINKE HBWLNACPIFKNIP-UHFFFAOYSA-N D09LKM DRUGSMIL COC1=CC=C(C=C1)C2=CN3C(=C(C=N3)C4=CSC=C4)N=C2 D09LKM HIGHSTAT Investigative D09LMH DRUG__ID D09LMH D09LMH DRUGTYPE Small molecular drug D09LMH DRUGINCH 1S/C13H12N2O5S3/c1-20-11-4-2-3-10(8-11)15-6-5-9-7-12(22(14,16)17)21-13(9)23(15,18)19/h2-8H,1H3,(H2,14,16,17) D09LMH DRUGINKE FBBLOSCXOZYUSS-UHFFFAOYSA-N D09LMH DRUGSMIL COC1=CC=CC(=C1)N2C=CC3=C(S2(=O)=O)SC(=C3)S(=O)(=O)N D09LMH HIGHSTAT Investigative D09LPG DRUG__ID D09LPG D09LPG DRUGTYPE Small molecular drug D09LPG DRUGINCH 1S/C16H20N2O2/c1-11(19)18-7-3-4-12(10-18)15-9-17-16-6-5-13(20-2)8-14(15)16/h5-6,8-9,12,17H,3-4,7,10H2,1-2H3 D09LPG DRUGINKE RBINAFTXZHPTNU-UHFFFAOYSA-N D09LPG DRUGSMIL CC(=O)N1CCCC(C1)C2=CNC3=C2C=C(C=C3)OC D09LPG HIGHSTAT Investigative D09LPL DRUG__ID D09LPL D09LPL DRUGTYPE Small molecular drug D09LPL DRUGINCH 1S/C22H27ClN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12- D09LPL DRUGINKE XPLJEFSRINKZLC-ATVHPVEESA-N D09LPL DRUGSMIL CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)Cl)NC2=O)C D09LPL HIGHSTAT Investigative D09LQF DRUG__ID D09LQF D09LQF DRUGTYPE Small molecular drug D09LQF DRUGINCH 1S/C16H16N2O5/c1-10-4-5-14(15(6-10)18(20)21)16(19)17-11-7-12(22-2)9-13(8-11)23-3/h4-9H,1-3H3,(H,17,19) D09LQF DRUGINKE GFSKVJZKSAGFJY-UHFFFAOYSA-N D09LQF DRUGSMIL CC1=CC(=C(C=C1)C(=O)NC2=CC(=CC(=C2)OC)OC)[N+](=O)[O-] D09LQF HIGHSTAT Investigative D09LRA DRUG__ID D09LRA D09LRA DRUGTYPE Small molecular drug D09LRA DRUGINCH 1S/C120H182N38O43S6/c1-53(165)91-114(197)138-66(10-4-6-26-122)95(178)136-68(12-8-28-132-120(129)130)98(181)149-81(107(190)139-69(93(126)176)29-55-13-19-58(167)20-14-55)49-204-207-52-84-110(193)153-80-48-203-202-47-64(123)94(177)135-65(9-3-5-25-121)97(180)147-78(45-163)117(200)156-38-61(170)32-85(156)111(194)133-37-90(175)134-74(41-159)102(185)145-76(43-161)105(188)152-83(109(192)148-79(46-164)118(201)158-40-63(172)34-87(158)113(196)155-92(54(2)166)115(198)146-77(44-162)103(186)140-70(30-56-15-21-59(168)22-16-56)99(182)141-72(35-88(124)173)100(183)150-84)51-206-205-50-82(151-104(187)75(42-160)144-96(179)67(137-106(80)189)11-7-27-131-119(127)128)108(191)143-73(36-89(125)174)116(199)157-39-62(171)33-86(157)112(195)142-71(101(184)154-91)31-57-17-23-60(169)24-18-57/h13-24,53-54,61-87,91-92,159-172H,3-12,25-52,121-123H2,1-2H3,(H2,124,173)(H2,125,174)(H2,126,176)(H,133,194)(H,134,175)(H,135,177)(H,136,178)(H,137,189)(H,138,197)(H,139,190)(H,140,186)(H,141,182)(H,142,195)(H,143,191)(H,144,179)(H,145,185)(H,146,198)(H,147,180)(H,148,192)(H,149,181)(H,150,183)(H,151,187)(H,152,188)(H,153,193)(H,154,184)(H,155,196)(H4,127,128,131)(H4,129,130,132)/t53-,54-,61-,62-,63-,64+,65+,66+,67+,68+,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,91+,92+/m1/s1 D09LRA DRUGINKE FDQZTPPHJRQRQQ-NZPQQUJLSA-N D09LRA DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC(=O)C4CSSCC(C(=O)NC(C(=O)N5CC(CC5C(=O)N1)O)CO)NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C6CC(CN6C(=O)C(NC(=O)C(NC(=O)C(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4)CO)CCCNC(=N)N)NC2=O)N)CCCCN)CO)O)CO)CO)CC(=O)N)O)CC7=CC=C(C=C7)O)C(C)O)CCCCN)CCCNC(=N)N)C(=O)NC(CC8=CC=C(C=C8)O)C(=O)N)CC(=O)N)CC9=CC=C(C=C9)O)CO)O D09LRA HIGHSTAT Investigative D09LRO DRUG__ID D09LRO D09LRO DRUGTYPE Small molecular drug D09LRO DRUGINCH 1S/C24H24FNO/c25-22-13-7-12-21(18-22)24(27)14-16-26(17-15-24)23(19-8-3-1-4-9-19)20-10-5-2-6-11-20/h1-13,18,23,27H,14-17H2 D09LRO DRUGINKE AXBTYZPRVDTMRF-UHFFFAOYSA-N D09LRO DRUGSMIL C1CN(CCC1(C2=CC(=CC=C2)F)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D09LRO HIGHSTAT Investigative D09LSR DRUG__ID D09LSR D09LSR DRUGTYPE Small molecular drug D09LSR DRUGINCH 1S/C14H6F4O2/c15-9-1-7(2-10(16)5-9)13(19)14(20)8-3-11(17)6-12(18)4-8/h1-6H D09LSR DRUGINKE ZDXXQKFXZDPNLI-UHFFFAOYSA-N D09LSR DRUGSMIL C1=C(C=C(C=C1F)F)C(=O)C(=O)C2=CC(=CC(=C2)F)F D09LSR HIGHSTAT Investigative D09LUD DRUG__ID D09LUD D09LUD DRUGTYPE Small molecular drug D09LUD DRUGINCH 1S/C15H17N3O3S/c16-22(20,21)14-8-6-12(7-9-14)10-11-17-15(19)18-13-4-2-1-3-5-13/h1-9H,10-11H2,(H2,16,20,21)(H2,17,18,19) D09LUD DRUGINKE CQMWNAHSFVPGJL-UHFFFAOYSA-N D09LUD DRUGSMIL C1=CC=C(C=C1)NC(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N D09LUD HIGHSTAT Investigative D09LVG DRUG__ID D09LVG D09LVG DRUGTYPE Small molecular drug D09LVG DRUGINCH 1S/C16H15N/c17-15-9-5-12(6-10-15)11-14-8-7-13-3-1-2-4-16(13)14/h1-10,14H,11,17H2 D09LVG DRUGINKE CTQZYHBDQGUTCI-UHFFFAOYSA-N D09LVG DRUGSMIL C1=CC=C2C(C=CC2=C1)CC3=CC=C(C=C3)N D09LVG HIGHSTAT Investigative D09LVP DRUG__ID D09LVP D09LVP DRUGTYPE Small molecular drug D09LVP DRUGINCH 1S/C26H42N2O2/c1-24(23-29)28-25(30)19-15-12-10-8-6-4-5-7-9-11-13-16-20-26(2,3)21-17-14-18-22-27/h4-5,8-11,16,20,24,29H,6-7,12-15,17-19,21,23H2,1-3H3,(H,28,30)/b5-4-,10-8-,11-9-,20-16-/t24-/m1/s1 D09LVP DRUGINKE WZQHSBKOWZOASP-QLZKPENWSA-N D09LVP DRUGSMIL CC(CO)NC(=O)CCCC=CCC=CCC=CCC=CC(C)(C)CCCCC#N D09LVP HIGHSTAT Investigative D09LVX DRUG__ID D09LVX D09LVX DRUGTYPE Small molecular drug D09LVX DRUGINCH 1S/C20H14F3NO/c21-15-9-5-13(6-10-15)20(19(24)25,14-7-11-16(22)12-8-14)17-3-1-2-4-18(17)23/h1-12H,(H2,24,25) D09LVX DRUGINKE VDPKWHHLYDETTO-UHFFFAOYSA-N D09LVX DRUGSMIL C1=CC=C(C(=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N)F D09LVX HIGHSTAT Investigative D09LVY DRUG__ID D09LVY D09LVY DRUGTYPE Small molecular drug D09LVY DRUGINCH 1S/C15H21NO2S/c17-14(12-19)10-6-1-2-7-11-15(18)16-13-8-4-3-5-9-13/h3-5,8-9,19H,1-2,6-7,10-12H2,(H,16,18) D09LVY DRUGINKE UJRMRSNAFIQQLD-UHFFFAOYSA-N D09LVY DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)CS D09LVY HIGHSTAT Investigative D09LWR DRUG__ID D09LWR D09LWR DRUGTYPE Small molecular drug D09LWR DRUGINCH 1S/C16H18N2O3S/c17-22(20,21)15-8-6-13(7-9-15)10-11-18-16(19)12-14-4-2-1-3-5-14/h1-9H,10-12H2,(H,18,19)(H2,17,20,21) D09LWR DRUGINKE DIZLDASYQVXHTB-UHFFFAOYSA-N D09LWR DRUGSMIL C1=CC=C(C=C1)CC(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N D09LWR HIGHSTAT Investigative D09LXL DRUG__ID D09LXL D09LXL DRUGTYPE Small molecular drug D09LXL DRUGINCH 1S/C34H42BrN11O5/c1-19(47)43-29(15-23-17-39-18-42-23)33(51)46-28(13-20-8-10-22(35)11-9-20)32(50)44-26(7-4-12-40-34(37)38)31(49)45-27(30(36)48)14-21-16-41-25-6-3-2-5-24(21)25/h2-3,5-6,8-11,16-18,26-29,41H,4,7,12-15H2,1H3,(H2,36,48)(H,39,42)(H,43,47)(H,44,50)(H,45,49)(H,46,51)(H4,37,38,40)/t26-,27-,28+,29-/m0/s1 D09LXL DRUGINKE UDLFTFKLQRVSSE-FKWFRFQNSA-N D09LXL DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=C(C=C2)Br)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)N D09LXL HIGHSTAT Investigative D09LXQ DRUG__ID D09LXQ D09LXQ DRUGTYPE Small molecular drug D09LXQ DRUGINCH 1S/C7H8FN3O4/c8-3-1-11(2-4(9)6(13)14)7(15)10-5(3)12/h1,4H,2,9H2,(H,13,14)(H,10,12,15)/t4-/m0/s1 D09LXQ DRUGINKE DBWPFHJYSTVBCZ-BYPYZUCNSA-N D09LXQ DRUGSMIL C1=C(C(=O)NC(=O)N1CC(C(=O)O)N)F D09LXQ HIGHSTAT Investigative D09MAZ DRUG__ID D09MAZ D09MAZ DRUGTYPE Small molecular drug D09MAZ DRUGINCH 1S/C19H16BFN2O3S/c21-15-6-8-16(9-7-15)23-19(24)13-5-10-18(22-11-13)27-12-14-3-1-2-4-17(14)20(25)26/h1-11,25-26H,12H2,(H,23,24) D09MAZ DRUGINKE VZRIHFZJVIOJBE-UHFFFAOYSA-N D09MAZ DRUGSMIL B(C1=CC=CC=C1CSC2=NC=C(C=C2)C(=O)NC3=CC=C(C=C3)F)(O)O D09MAZ HIGHSTAT Investigative D09MBV DRUG__ID D09MBV D09MBV DRUGTYPE Small molecular drug D09MBV DRUGINCH 1S/C32H35N5O5/c1-18-12-22(38)13-19(2)23(18)15-24(33)32(42)37-17-21-9-5-4-8-20(21)14-28(37)31(41)35-26(16-29(39)40)30-34-25-10-6-7-11-27(25)36(30)3/h4-13,24,26,28,38H,14-17,33H2,1-3H3,(H,35,41)(H,39,40)/t24-,26-,28-/m0/s1 D09MBV DRUGINKE XFKPEXYNTQLONY-MPYJOUPCSA-N D09MBV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C4=NC5=CC=CC=C5N4C)N)C)O D09MBV HIGHSTAT Investigative D09MCN DRUG__ID D09MCN D09MCN DRUGTYPE Small molecular drug D09MCN DRUGINCH 1S/C29H52O5/c1-7-18(16(2)3)12-24(31)17(4)21-8-9-22-20-14-26(33)29(34)15-19(30)13-25(32)28(29,6)23(20)10-11-27(21,22)5/h16-26,30-34H,7-15H2,1-6H3/t17-,18+,19-,20?,21+,22?,23?,24+,25-,26+,27+,28-,29-/m0/s1 D09MCN DRUGINKE SENGWVUFOJLNFP-QDQFXZLYSA-N D09MCN DRUGSMIL CCC(CC(C(C)C1CCC2C1(CCC3C2CC(C4(C3(C(CC(C4)O)O)C)O)O)C)O)C(C)C D09MCN HIGHSTAT Investigative D09MDB DRUG__ID D09MDB D09MDB DRUGTYPE Small molecular drug D09MDB DRUGINCH 1S/C16H12ClNSe/c1-11-2-4-13(5-3-11)16-15(10-18-19-16)12-6-8-14(17)9-7-12/h2-10H,1H3 D09MDB DRUGINKE NMKXOVXYAQBXPT-UHFFFAOYSA-N D09MDB DRUGSMIL CC1=CC=C(C=C1)C2=C(C=N[Se]2)C3=CC=C(C=C3)Cl D09MDB HIGHSTAT Investigative D09MDO DRUG__ID D09MDO D09MDO DRUGTYPE Small molecular drug D09MDO DRUGINCH 1S/C17H20N2O2/c18-12-4-7-17(20)19-15-8-10-16(11-9-15)21-13-14-5-2-1-3-6-14/h1-3,5-6,8-11H,4,7,12-13,18H2,(H,19,20) D09MDO DRUGINKE QTWBKNVNGVYTNZ-UHFFFAOYSA-N D09MDO DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)CCCN D09MDO HIGHSTAT Investigative D09MGF DRUG__ID D09MGF D09MGF DRUGTYPE Small molecular drug D09MGF DRUGINCH 1S/C21H20O/c1-3-9-18(10-4-1)15-16-20-13-7-8-14-21(20)22-17-19-11-5-2-6-12-19/h1-14H,15-17H2 D09MGF DRUGINKE BMTUNIXXDMVUOW-UHFFFAOYSA-N D09MGF DRUGSMIL C1=CC=C(C=C1)CCC2=CC=CC=C2OCC3=CC=CC=C3 D09MGF HIGHSTAT Investigative D09MHS DRUG__ID D09MHS D09MHS DRUGTYPE Small molecular drug D09MHS DRUGINCH 1S/C27H34N2O9S/c1-12(31)28-16-7-5-13-9-17(29-27-24(35)23(34)22(33)19(11-30)38-27)25(36-2)26(37-3)21(13)14-6-8-20(39-4)18(32)10-15(14)16/h6,8-10,16,19,22-24,27,29-30,33-35H,5,7,11H2,1-4H3,(H,28,31)/t16-,19+,22+,23-,24+,27?/m0/s1 D09MHS DRUGINKE FPOIHQLRIKBTGP-DCWZWRKFSA-N D09MHS DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)NC4C(C(C(C(O4)CO)O)O)O D09MHS HIGHSTAT Investigative D09MLQ DRUG__ID D09MLQ D09MLQ DRUGTYPE Small molecular drug D09MLQ DRUGINCH 1S/C22H21NO6S/c1-12(2)21(22(24)25)23-30(26,27)15-6-7-16-17-10-14(18-8-4-13(3)28-18)5-9-19(17)29-20(16)11-15/h4-12,21,23H,1-3H3,(H,24,25)/t21-/m0/s1 D09MLQ DRUGINKE LLJREHOWNIBILL-NRFANRHFSA-N D09MLQ DRUGSMIL CC1=CC=C(O1)C2=CC3=C(C=C2)OC4=C3C=CC(=C4)S(=O)(=O)NC(C(C)C)C(=O)O D09MLQ HIGHSTAT Investigative D09MQF DRUG__ID D09MQF D09MQF DRUGTYPE Small molecular drug D09MQF DRUGINCH 1S/C17H19NO3/c1-19-15-10-13(11-16(20-2)17(15)21-3)5-4-12-6-8-14(18)9-7-12/h4-11H,18H2,1-3H3/b5-4+ D09MQF DRUGINKE MWXBWYJFAGYFKS-SNAWJCMRSA-N D09MQF DRUGSMIL COC1=CC(=CC(=C1OC)OC)C=CC2=CC=C(C=C2)N D09MQF HIGHSTAT Investigative D09MQZ DRUG__ID D09MQZ D09MQZ DRUGTYPE Small molecular drug D09MQZ DRUGINCH 1S/C17H14O2S/c1-19-15-8-4-13(5-9-15)17-11-10-16(20-17)12-2-6-14(18)7-3-12/h2-11,18H,1H3 D09MQZ DRUGINKE WNCPZRMABGADNX-UHFFFAOYSA-N D09MQZ DRUGSMIL COC1=CC=C(C=C1)C2=CC=C(S2)C3=CC=C(C=C3)O D09MQZ HIGHSTAT Investigative D09MSA DRUG__ID D09MSA D09MSA DRUGTYPE Small molecular drug D09MSA DRUGINCH 1S/C13H9Cl2NO3S/c14-10-3-1-9(2-4-10)13(17)16-20(18,19)12-7-5-11(15)6-8-12/h1-8H,(H,16,17) D09MSA DRUGINKE IZIJDUMIQKCMGD-UHFFFAOYSA-N D09MSA DRUGSMIL C1=CC(=CC=C1C(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl)Cl D09MSA HIGHSTAT Investigative D09MSF DRUG__ID D09MSF D09MSF DRUGTYPE Small molecular drug D09MSF DRUGINCH 1S/C16H17N/c1-16(2,3)11-8-9-13-12-6-4-5-7-14(12)17-15(13)10-11/h4-10,17H,1-3H3 D09MSF DRUGINKE FUFORZIUGGNDKM-UHFFFAOYSA-N D09MSF DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C3=CC=CC=C3N2 D09MSF HIGHSTAT Investigative D09MTV DRUG__ID D09MTV D09MTV DRUGTYPE Small molecular drug D09MTV DRUGINCH 1S/C12H13N3OS/c1-15(2)10-5-3-9(4-6-10)11(16)14-12-13-7-8-17-12/h3-8H,1-2H3,(H,13,14,16) D09MTV DRUGINKE RGXFQNTVZRGDNG-UHFFFAOYSA-N D09MTV DRUGSMIL CN(C)C1=CC=C(C=C1)C(=O)NC2=NC=CS2 D09MTV HIGHSTAT Investigative D09MVE DRUG__ID D09MVE D09MVE DRUGTYPE Small molecular drug D09MVE DRUGINCH 1S/C13H13N/c14-10-12-8-4-5-9-13(12)11-6-2-1-3-7-11/h1-9H,10,14H2 D09MVE DRUGINKE YHXKXVFQHWJYOD-UHFFFAOYSA-N D09MVE DRUGSMIL C1=CC=C(C=C1)C2=CC=CC=C2CN D09MVE HIGHSTAT Investigative D09MWG DRUG__ID D09MWG D09MWG DRUGTYPE Small molecular drug D09MWG DRUGINCH 1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14+,15+,16+,18+,19+/m1/s1 D09MWG DRUGINKE QGXBDMJGAMFCBF-BNSUEQOYSA-N D09MWG DRUGSMIL CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O D09MWG HIGHSTAT Investigative D09MXK DRUG__ID D09MXK D09MXK DRUGTYPE Small molecular drug D09MXK DRUGINCH 1S/C13H8F3N/c14-13(15,16)8-5-6-12-10(7-8)9-3-1-2-4-11(9)17-12/h1-7,17H D09MXK DRUGINKE JGFJDDMRCMCZMU-UHFFFAOYSA-N D09MXK DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=CC(=C3)C(F)(F)F D09MXK HIGHSTAT Investigative D09MXM DRUG__ID D09MXM D09MXM DRUGTYPE Small molecular drug D09MXM DRUGINCH 1S/C19H23NO5/c1-24-9-8-20-7-6-18-15-11-2-3-12(21)16(15)25-17(18)13(22)4-5-19(18,23)14(20)10-11/h2-3,14,17,21,23H,4-10H2,1H3/t14-,17+,18+,19-/m1/s1 D09MXM DRUGINKE PBGIBLLOMGURPS-GRGSLBFTSA-N D09MXM DRUGSMIL COCCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O D09MXM HIGHSTAT Investigative D09MYF DRUG__ID D09MYF D09MYF DRUGTYPE Small molecular drug D09MYF DRUGINCH 1S/C5H9NO3/c1-3(5(8)9)6-4(2)7/h3H,1-2H3,(H,6,7)(H,8,9)/t3-/m0/s1 D09MYF DRUGINKE KTHDTJVBEPMMGL-VKHMYHEASA-N D09MYF DRUGSMIL CC(C(=O)O)NC(=O)C D09MYF HIGHSTAT Investigative D09MYJ DRUG__ID D09MYJ D09MYJ DRUGTYPE Small molecular drug D09MYJ DRUGINCH 1S/C15H16N2O/c1-10(2)9-18-15-7-12-11-5-3-4-6-13(11)17-14(12)8-16-15/h3-8,10,17H,9H2,1-2H3 D09MYJ DRUGINKE KWHWSXISOMCUPZ-UHFFFAOYSA-N D09MYJ DRUGSMIL CC(C)COC1=NC=C2C(=C1)C3=CC=CC=C3N2 D09MYJ HIGHSTAT Investigative D09MYQ DRUG__ID D09MYQ D09MYQ DRUGTYPE Small molecular drug D09MYQ DRUGINCH 1S/C19H26O2/c1-11-15-10-12(20)6-8-18(15,2)14-7-9-19(3)13(17(11)14)4-5-16(19)21/h10-11,13-14,17H,4-9H2,1-3H3 D09MYQ DRUGINKE GYXFOOCGIVDNFH-UHFFFAOYSA-N D09MYQ DRUGSMIL CC1C2C3CCC(=O)C3(CCC2C4(C1=CC(=O)CC4)C)C D09MYQ HIGHSTAT Investigative D09NAJ DRUG__ID D09NAJ D09NAJ DRUGTYPE Small molecular drug D09NAJ DRUGINCH 1S/C23H34N3O10P/c1-11(2)8-16(26-37(33,34)36-23-20(29)19(28)18(27)12(3)35-23)21(30)25-17(22(31)32)9-13-10-24-15-7-5-4-6-14(13)15/h4-7,10-12,16-20,23-24,27-29H,8-9H2,1-3H3,(H,25,30)(H,31,32)(H2,26,33,34)/t12-,16-,17-,18-,19+,20+,23-/m0/s1 D09NAJ DRUGINKE ZPHBZEQOLSRPAK-XLCYBJAPSA-N D09NAJ DRUGSMIL CC1C(C(C(C(O1)OP(=O)(NC(CC(C)C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)O)O)O)O D09NAJ HIGHSTAT Investigative D09NBN DRUG__ID D09NBN D09NBN DRUGTYPE Small molecular drug D09NBN DRUGINCH 1S/C29H40F2N4O4/c1-20(2)25(21-13-8-7-9-14-21)39-28(38)35-29(3,19-22-15-12-16-23(30)24(22)31)26(36)33-17-10-5-4-6-11-18-34-27(32)37/h7-9,12-16,20,25H,4-6,10-11,17-19H2,1-3H3,(H,33,36)(H,35,38)(H3,32,34,37)/t25-,29+/m0/s1 D09NBN DRUGINKE IWEYVTFOHKCWJN-ABYGYWHVSA-N D09NBN DRUGSMIL CC(C)C(C1=CC=CC=C1)OC(=O)NC(C)(CC2=C(C(=CC=C2)F)F)C(=O)NCCCCCCCNC(=O)N D09NBN HIGHSTAT Investigative D09NBP DRUG__ID D09NBP D09NBP DRUGTYPE Small molecular drug D09NBP DRUGINCH 1S/C13H11BrN4S/c14-11-5-1-3-9(7-11)12(17-18-13(15)19)10-4-2-6-16-8-10/h1-8H,(H3,15,18,19)/b17-12- D09NBP DRUGINKE DPTPEKAUCAAQNG-ATVHPVEESA-N D09NBP DRUGSMIL C1=CC(=CC(=C1)Br)C(=NNC(=S)N)C2=CN=CC=C2 D09NBP HIGHSTAT Investigative D09NEH DRUG__ID D09NEH D09NEH DRUGTYPE Small molecular drug D09NEH DRUGINCH 1S/C21H20N2O3/c1-15-7-8-19-17(13-15)18(14-20(24)26-19)22-9-11-23(12-10-22)21(25)16-5-3-2-4-6-16/h2-8,13-14H,9-12H2,1H3 D09NEH DRUGINKE LSXVWZHPJRTGIV-UHFFFAOYSA-N D09NEH DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C=C2N3CCN(CC3)C(=O)C4=CC=CC=C4 D09NEH HIGHSTAT Investigative D09NEP DRUG__ID D09NEP D09NEP DRUGTYPE Small molecular drug D09NEP DRUGINCH 1S/C15H8Cl2O2/c16-10-6-7-12-11(8-10)14(18)13(17)15(19-12)9-4-2-1-3-5-9/h1-8H D09NEP DRUGINKE PTNKLWUWHUGKTA-UHFFFAOYSA-N D09NEP DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=C(O2)C=CC(=C3)Cl)Cl D09NEP HIGHSTAT Investigative D09NFD DRUG__ID D09NFD D09NFD DRUGTYPE Small molecular drug D09NFD DRUGINCH 1S/C27H31NO3/c1-28(2)18-20-31-25-16-12-23(13-17-25)27(22-10-14-24(30)15-11-22)26(9-6-19-29)21-7-4-3-5-8-21/h3-5,7-8,10-17,29-30H,6,9,18-20H2,1-2H3/b27-26- D09NFD DRUGINKE ZVSFNBNLNLXEFQ-RQZHXJHFSA-N D09NFD DRUGSMIL CN(C)CCOC1=CC=C(C=C1)C(=C(CCCO)C2=CC=CC=C2)C3=CC=C(C=C3)O D09NFD HIGHSTAT Investigative D09NFX DRUG__ID D09NFX D09NFX DRUGTYPE Small molecular drug D09NFX DRUGINCH 1S/C16H17N3O3/c1-2-10-21-15-7-5-14(6-8-15)19-16(20)22-18-12-13-4-3-9-17-11-13/h3-9,11-12H,2,10H2,1H3,(H,19,20)/b18-12+ D09NFX DRUGINKE RKEOSRSRXNLQCF-LDADJPATSA-N D09NFX DRUGSMIL CCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2 D09NFX HIGHSTAT Investigative D09NFY DRUG__ID D09NFY D09NFY DRUGTYPE Small molecular drug D09NFY DRUGINCH 1S/C21H28IN3O4/c22-14-7-9-15(10-8-14)24-21(28)25-23-13-17-16(18-11-12-19(17)29-18)5-3-1-2-4-6-20(26)27/h1,3,7-10,16-19,23H,2,4-6,11-13H2,(H,26,27)(H2,24,25,28)/b3-1-/t16-,17+,18+,19-/m1/s1/i22-2 D09NFY DRUGINKE AMZRVJWBVXWSAC-BYMOSMHDSA-N D09NFY DRUGSMIL C1CC2C(C(C1O2)CC=CCCCC(=O)O)CNNC(=O)NC3=CC=C(C=C3)I D09NFY HIGHSTAT Investigative D09NGN DRUG__ID D09NGN D09NGN DRUGTYPE Small molecular drug D09NGN DRUGINCH 1S/C8H8O5S/c9-8(10)7(14(11,12)13)6-4-2-1-3-5-6/h1-5,7H,(H,9,10)(H,11,12,13)/t7-/m1/s1 D09NGN DRUGINKE USNMCXDGQQVYSW-SSDOTTSWSA-N D09NGN DRUGSMIL C1=CC=C(C=C1)C(C(=O)O)S(=O)(=O)O D09NGN HIGHSTAT Investigative D09NIM DRUG__ID D09NIM D09NIM DRUGTYPE Small molecular drug D09NIM DRUGINCH 1S/C37H53NO3/c1-32(2)17-19-37(31(39)41-24-25-11-9-8-10-12-25)20-18-35(6)27(28(37)23-32)13-14-30-34(5)22-26(38-40)21-33(3,4)29(34)15-16-36(30,35)7/h8-13,26,28-30H,14-24H2,1-7H3/t26?,28-,29-,30+,34-,35+,36+,37-/m0/s1 D09NIM DRUGINKE UQAJJIWPUXUAMF-NUBQHGELSA-N D09NIM DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)N=O)C)C)C2C1)C)C(=O)OCC6=CC=CC=C6)C D09NIM HIGHSTAT Investigative D09NJF DRUG__ID D09NJF D09NJF DRUGTYPE Small molecular drug D09NJF DRUGINCH 1S/C2H3F3O/c3-2(4,5)1-6/h6H,1H2 D09NJF DRUGINKE RHQDFWAXVIIEBN-UHFFFAOYSA-N D09NJF DRUGSMIL C(C(F)(F)F)O D09NJF HIGHSTAT Investigative D09NNI DRUG__ID D09NNI D09NNI DRUGTYPE Small molecular drug D09NNI DRUGINCH 1S/C12H10N2O/c1-15-12-6-9-8-4-2-3-5-10(8)14-11(9)7-13-12/h2-7,14H,1H3 D09NNI DRUGINKE UFGGNIMGPVLCJZ-UHFFFAOYSA-N D09NNI DRUGSMIL COC1=NC=C2C(=C1)C3=CC=CC=C3N2 D09NNI HIGHSTAT Investigative D09NNS DRUG__ID D09NNS D09NNS DRUGTYPE Small molecular drug D09NNS DRUGINCH 1S/C17H18N2O5S/c18-25(22,23)15-11-12(17(20)21)10-14(19-8-4-5-9-19)16(15)24-13-6-2-1-3-7-13/h1-3,6-7,10-11H,4-5,8-9H2,(H,20,21)(H2,18,22,23) D09NNS DRUGINKE UJEWTUDSLQGTOA-UHFFFAOYSA-N D09NNS DRUGSMIL C1CCN(C1)C2=C(C(=CC(=C2)C(=O)O)S(=O)(=O)N)OC3=CC=CC=C3 D09NNS HIGHSTAT Investigative D09NNZ DRUG__ID D09NNZ D09NNZ DRUGTYPE Small molecular drug D09NNZ DRUGINCH 1S/C16H12Cl2N2O/c1-9-6-11-7-12(3-5-15(11)19-9)20-16(21)10-2-4-13(17)14(18)8-10/h2-8,19H,1H3,(H,20,21) D09NNZ DRUGINKE ICMYUZJRKLEKDA-UHFFFAOYSA-N D09NNZ DRUGSMIL CC1=CC2=C(N1)C=CC(=C2)NC(=O)C3=CC(=C(C=C3)Cl)Cl D09NNZ HIGHSTAT Investigative D09NOH DRUG__ID D09NOH D09NOH DRUGTYPE Small molecular drug D09NOH DRUGINCH 1S/C20H22O5/c1-11(2)3-8-14-15(22)9-16(23)19-17(24)10-18(25-20(14)19)12-4-6-13(21)7-5-12/h4-7,9,11,18,21-23H,3,8,10H2,1-2H3/t18-/m0/s1 D09NOH DRUGINKE UKBYGNGSGOXLFO-SFHVURJKSA-N D09NOH DRUGSMIL CC(C)CCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D09NOH HIGHSTAT Investigative D09NRX DRUG__ID D09NRX D09NRX DRUGTYPE Small molecular drug D09NRX DRUGINCH 1S/C7H14N2S/c1-2-6-5-10-4-3-7(8)9-6/h6H,2-5H2,1H3,(H2,8,9) D09NRX DRUGINKE BJFMNSRYUNDINA-UHFFFAOYSA-N D09NRX DRUGSMIL CCC1CSCCC(=N1)N D09NRX HIGHSTAT Investigative D09NSH DRUG__ID D09NSH D09NSH DRUGTYPE Small molecular drug D09NSH DRUGINCH 1S/C19H31ClN4/c20-18-10-8-17(9-11-18)16-24(19(21)22)15-5-3-1-2-4-12-23-13-6-7-14-23/h8-11H,1-7,12-16H2,(H3,21,22) D09NSH DRUGINKE ZRIVDXCYPBUSKL-UHFFFAOYSA-N D09NSH DRUGSMIL C1CCN(C1)CCCCCCCN(CC2=CC=C(C=C2)Cl)C(=N)N D09NSH HIGHSTAT Investigative D09NVT DRUG__ID D09NVT D09NVT DRUGTYPE Small molecular drug D09NVT DRUGINCH 1S/C20H20N4O2/c25-24(26)17-6-7-19-18(14-17)16(12-15-4-2-1-3-5-15)13-20(22-19)23-10-8-21-9-11-23/h1-7,13-14,21H,8-12H2 D09NVT DRUGINKE SOYBGJFHGGERLE-UHFFFAOYSA-N D09NVT DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)CC4=CC=CC=C4 D09NVT HIGHSTAT Investigative D09NXU DRUG__ID D09NXU D09NXU DRUGTYPE Small molecular drug D09NXU DRUGINCH 1S/C16H14N2/c1-3-11-5-2-6-14-13(15-9-17-10-18-15)8-7-12(4-1)16(11)14/h1-6,9-10,13H,7-8H2,(H,17,18) D09NXU DRUGINKE KFGFWNKBPWPCKX-UHFFFAOYSA-N D09NXU DRUGSMIL C1CC2=CC=CC3=C2C(=CC=C3)C1C4=CN=CN4 D09NXU HIGHSTAT Investigative D09OAH DRUG__ID D09OAH D09OAH DRUGTYPE Small molecular drug D09OAH DRUGINCH 1S/C18H10N2O.ClH/c21-18-13-6-2-4-8-15(13)20-10-9-12-11-5-1-3-7-14(11)19-16(12)17(18)20;/h1-10H;1H D09OAH DRUGINKE PWUOOJVYZQILBG-UHFFFAOYSA-N D09OAH DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C4=[N+](C=C3)C5=CC=CC=C5C4=O.[Cl-] D09OAH HIGHSTAT Investigative D09OBJ DRUG__ID D09OBJ D09OBJ DRUGTYPE Small molecular drug D09OBJ DRUGINCH 1S/C28H35N7O3S/c1-31-21(17-18-9-3-2-4-10-18)27(38)35-16-8-13-22(35)25(37)33-20(12-7-15-32-28(29)30)24(36)26-34-19-11-5-6-14-23(19)39-26/h2-6,9-11,14,20-22,31H,7-8,12-13,15-17H2,1H3,(H,33,37)(H4,29,30,32)/t20-,21+,22-/m0/s1 D09OBJ DRUGINKE QRBIRSCLEVEODD-BDTNDASRSA-N D09OBJ DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)C3=NC4=CC=CC=C4S3 D09OBJ HIGHSTAT Investigative D09OCY DRUG__ID D09OCY D09OCY DRUGTYPE Small molecular drug D09OCY DRUGINCH 1S/C36H40F3N5O6S2/c1-23-22-51-34(41-23)31-13-8-14-44(31)35(47)27-17-26(18-28(19-27)43(2)52(3,48)49)33(46)42-30(16-24-9-5-4-6-10-24)32(45)21-40-20-25-11-7-12-29(15-25)50-36(37,38)39/h4-7,9-12,15,17-19,22,30-32,40,45H,8,13-14,16,20-21H2,1-3H3,(H,42,46)/t30-,31+,32+/m0/s1 D09OCY DRUGINKE GUOONOJYWQOJJP-DCMFLLSESA-N D09OCY DRUGSMIL CC1=CSC(=N1)C2CCCN2C(=O)C3=CC(=CC(=C3)C(=O)NC(CC4=CC=CC=C4)C(CNCC5=CC(=CC=C5)OC(F)(F)F)O)N(C)S(=O)(=O)C D09OCY HIGHSTAT Investigative D09OGW DRUG__ID D09OGW D09OGW DRUGTYPE Small molecular drug D09OGW DRUGINCH 1S/C21H16N2O6S/c24-19-10-1-15(2-11-19)3-14-21(25)16-4-6-17(7-5-16)22-30(28,29)20-12-8-18(9-13-20)23(26)27/h1-14,22,24H/b14-3+ D09OGW DRUGINKE WQIGNJDEMJBAFL-LZWSPWQCSA-N D09OGW DRUGSMIL C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)[N+](=O)[O-])O D09OGW HIGHSTAT Investigative D09OHS DRUG__ID D09OHS D09OHS DRUGTYPE Small molecular drug D09OHS DRUGINCH 1S/C40H64O8/c1-7-9-11-13-15-17-19-21-32(42)47-36-28(4)39(46)30(24-29(26-41)25-38(45)31(39)23-27(3)35(38)44)34-37(5,6)40(34,36)48-33(43)22-20-18-16-14-12-10-8-2/h23-24,28,30-31,34,36,41,45-46H,7-22,25-26H2,1-6H3/t28-,30+,31-,34-,36-,38+,39-,40-/m1/s1 D09OHS DRUGINKE DGOSGFYDFDYMCW-OEFRVDPMSA-N D09OHS DRUGSMIL CCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)CCCCCCCCC)O)C D09OHS HIGHSTAT Investigative D09OIO DRUG__ID D09OIO D09OIO DRUGTYPE Small molecular drug D09OIO DRUGINCH 1S/C33H40O7/c1-2-3-4-5-6-7-8-9-10-11-26(36)32-28(38)20-27(37)31(33(32)39)25-19-29(21-12-14-22(34)15-13-21)40-30-18-23(35)16-17-24(25)30/h12-18,20,25,29,34-35,37-39H,2-11,19H2,1H3/t25-,29+/m1/s1 D09OIO DRUGINKE JGXZVDAPLSTBGZ-IRPSRAIASA-N D09OIO DRUGSMIL CCCCCCCCCCCC(=O)C1=C(C=C(C(=C1O)C2CC(OC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O)O)O D09OIO HIGHSTAT Investigative D09OKK DRUG__ID D09OKK D09OKK DRUGTYPE Small molecular drug D09OKK DRUGINCH 1S/C27H25NO/c1-17-9-5-6-10-19(17)15-24-26-21(20-11-7-8-12-23(20)29-24)13-14-22-25(26)18(2)16-27(3,4)28-22/h5-16,28H,1-4H3/b24-15- D09OKK DRUGINKE YXKBVHXOKVRRKO-IWIPYMOSSA-N D09OKK DRUGSMIL CC1=CC=CC=C1C=C2C3=C(C=CC4=C3C(=CC(N4)(C)C)C)C5=CC=CC=C5O2 D09OKK HIGHSTAT Investigative D09OKU DRUG__ID D09OKU D09OKU DRUGTYPE Small molecular drug D09OKU DRUGINCH 1S/C21H21FN4O/c1-12-16(9-14(10-17(12)22)19(27)23-15-3-4-15)13-5-8-26-18(11-13)24-25-20(26)21(2)6-7-21/h5,8-11,15H,3-4,6-7H2,1-2H3,(H,23,27) D09OKU DRUGINKE REGFSKAVJRCHTE-UHFFFAOYSA-N D09OKU DRUGSMIL CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=CC4=NN=C(N4C=C3)C5(CC5)C D09OKU HIGHSTAT Investigative D09OLH DRUG__ID D09OLH D09OLH DRUGTYPE Small molecular drug D09OLH DRUGINCH 1S/C18H14N2O2/c1-22-13-6-7-15-12(8-13)10-17(20-15)18(21)16-9-11-4-2-3-5-14(11)19-16/h2-10,19-20H,1H3 D09OLH DRUGINKE QTIQVLAVCXXZPS-UHFFFAOYSA-N D09OLH DRUGSMIL COC1=CC2=C(C=C1)NC(=C2)C(=O)C3=CC4=CC=CC=C4N3 D09OLH HIGHSTAT Investigative D09ONV DRUG__ID D09ONV D09ONV DRUGTYPE Small molecular drug D09ONV DRUGINCH 1S/C16H13N3O3/c20-15(18-13-7-3-4-8-17-13)16-9-11(16)14(19-21)10-5-1-2-6-12(10)22-16/h1-8,11,21H,9H2,(H,17,18,20)/b19-14+ D09ONV DRUGINKE NAPZSTOOVHXHKA-XMHGGMMESA-N D09ONV DRUGSMIL C1C2C1(OC3=CC=CC=C3C2=NO)C(=O)NC4=CC=CC=N4 D09ONV HIGHSTAT Investigative D09OOO DRUG__ID D09OOO D09OOO DRUGTYPE Small molecular drug D09OOO DRUGINCH 1S/C22H27NO3/c1-25-19-13-11-17(12-14-19)16-23-15-7-6-10-20(23)21(22(24)26-2)18-8-4-3-5-9-18/h3-5,8-9,11-14,20-21H,6-7,10,15-16H2,1-2H3/t20-,21-/m1/s1 D09OOO DRUGINKE PMKFGPNZRGUOSJ-NHCUHLMSSA-N D09OOO DRUGSMIL COC1=CC=C(C=C1)CN2CCCCC2C(C3=CC=CC=C3)C(=O)OC D09OOO HIGHSTAT Investigative D09OPA DRUG__ID D09OPA D09OPA DRUGTYPE Small molecular drug D09OPA DRUGINCH 1S/C20H20O5/c1-11(2)3-5-14-16(22)8-7-15-18(24)10-19(25-20(14)15)13-6-4-12(21)9-17(13)23/h3-4,6-9,19,21-23H,5,10H2,1-2H3/t19-/m0/s1 D09OPA DRUGINKE JJOUBYOHNYJCOU-IBGZPJMESA-N D09OPA DRUGSMIL CC(=CCC1=C(C=CC2=C1OC(CC2=O)C3=C(C=C(C=C3)O)O)O)C D09OPA HIGHSTAT Investigative D09OPL DRUG__ID D09OPL D09OPL DRUGTYPE Small molecular drug D09OPL DRUGINCH 1S/C18H18N2OS/c21-18(19-12-6-1-7-13-19)20-14-8-2-4-10-16(14)22-17-11-5-3-9-15(17)20/h2-5,8-11H,1,6-7,12-13H2 D09OPL DRUGINKE ZYAXTAFPNAMCKA-UHFFFAOYSA-N D09OPL DRUGSMIL C1CCN(CC1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D09OPL HIGHSTAT Investigative D09OSF DRUG__ID D09OSF D09OSF DRUGTYPE Small molecular drug D09OSF DRUGINCH 1S/2C21H29NO3.C4H6O6/c2*23-16-4-3-15-11-19-21(25)6-2-1-5-20(21,18(15)12-16)7-8-22(19)13-14-9-17(24)10-14;5-1(3(7)8)2(6)4(9)10/h2*3-4,12,14,17,19,23-25H,1-2,5-11,13H2;1-2,5-6H,(H,7,8)(H,9,10)/t;;1-,2-/m..1/s1 D09OSF DRUGINKE HIJHYZCQDMUGEP-CEAXSRTFSA-N D09OSF DRUGSMIL C1CCC2(C3CC4=C(C2(C1)CCN3CC5CC(C5)O)C=C(C=C4)O)O.C1CCC2(C3CC4=C(C2(C1)CCN3CC5CC(C5)O)C=C(C=C4)O)O.C(C(C(=O)O)O)(C(=O)O)O D09OSF HIGHSTAT Investigative D09OSN DRUG__ID D09OSN D09OSN DRUGTYPE Small molecular drug D09OSN DRUGINCH 1S/C12H11BO2/c14-13(15)12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9,14-15H D09OSN DRUGINKE XPEIJWZLPWNNOK-UHFFFAOYSA-N D09OSN DRUGSMIL B(C1=CC=C(C=C1)C2=CC=CC=C2)(O)O D09OSN HIGHSTAT Investigative D09OTM DRUG__ID D09OTM D09OTM DRUGTYPE Small molecular drug D09OTM DRUGINCH 1S/C5H9NO2/c1-2-3-4(6)5(7)8/h2,4H,1,3,6H2,(H,7,8)/t4-/m0/s1 D09OTM DRUGINKE WNNNWFKQCKFSDK-BYPYZUCNSA-N D09OTM DRUGSMIL C=CCC(C(=O)O)N D09OTM HIGHSTAT Investigative D09OWC DRUG__ID D09OWC D09OWC DRUGCOMP Sichuan University D09OWC DRUGINCH 1S/C11H9NO3S/c1-15-8-4-2-7(3-5-8)6-9-10(13)12-11(14)16-9/h2-6H,1H3,(H,12,13,14)/b9-6- D09OWC DRUGINKE VRUKGUBMRBLJJW-TWGQIWQCSA-N D09OWC DRUGSMIL COC1=CC=C(C=C1)C=C2C(=O)NC(=O)S2 D09OWC HIGHSTAT Investigative D09OWE DRUG__ID D09OWE D09OWE DRUGTYPE Small molecular drug D09OWE DRUGINCH 1S/C30H50O2/c1-19-10-15-30(18-31)17-16-28(6)21(25(30)20(19)2)8-9-23-27(5)13-12-24(32)26(3,4)22(27)11-14-29(23,28)7/h8,19-20,22-25,31-32H,9-18H2,1-7H3/t19-,20+,22+,23-,24+,25+,27+,28-,29-,30-/m1/s1 D09OWE DRUGINKE XUARCIYIVXVTAE-ZAPOICBTSA-N D09OWE DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)CO D09OWE HIGHSTAT Investigative D09OWF DRUG__ID D09OWF D09OWF DRUGTYPE Small molecular drug D09OWF DRUGINCH 1S/C17H18N2O4/c18-15(17(21)22)10-11-16(20)19-12-6-8-14(9-7-12)23-13-4-2-1-3-5-13/h1-9,15H,10-11,18H2,(H,19,20)(H,21,22)/t15-/m0/s1 D09OWF DRUGINKE YWTHXARKKQRUCI-HNNXBMFYSA-N D09OWF DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D09OWF HIGHSTAT Investigative D09OYA DRUG__ID D09OYA D09OYA DRUGTYPE Small molecular drug D09OYA DRUGINCH 1S/C11H14N2O/c1-7(12)4-8-6-13-11-3-2-9(14)5-10(8)11/h2-3,5-7,13-14H,4,12H2,1H3 D09OYA DRUGINKE LYPCGXKCQDYTFV-UHFFFAOYSA-N D09OYA DRUGSMIL CC(CC1=CNC2=C1C=C(C=C2)O)N D09OYA HIGHSTAT Investigative D09PBW DRUG__ID D09PBW D09PBW DRUGTYPE Small molecular drug D09PBW DRUGINCH 1S/C15H11FO2/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-8,14H,9H2/t14-/m1/s1 D09PBW DRUGINKE SZNYRENOXQIQMR-CQSZACIVSA-N D09PBW DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)F)C3=CC=CC=C3 D09PBW HIGHSTAT Investigative D09PCZ DRUG__ID D09PCZ D09PCZ DRUGTYPE Small molecular drug D09PCZ DRUGINCH 1S/C14H11ClN2O/c1-10-5-13(8-16)17-14(6-10)18-9-11-3-2-4-12(15)7-11/h2-7H,9H2,1H3 D09PCZ DRUGINKE IUJVMCIYVKHYBF-UHFFFAOYSA-N D09PCZ DRUGSMIL CC1=CC(=NC(=C1)OCC2=CC(=CC=C2)Cl)C#N D09PCZ HIGHSTAT Investigative D09PDD DRUG__ID D09PDD D09PDD DRUGTYPE Small molecular drug D09PDD DRUGINCH 1S/C13H11NO2/c15-13(14-16)8-6-10-5-7-11-3-1-2-4-12(11)9-10/h1-9,16H,(H,14,15)/b8-6+ D09PDD DRUGINKE NJQJPKBDKOPBGI-SOFGYWHQSA-N D09PDD DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C=CC(=O)NO D09PDD HIGHSTAT Investigative D09PDT DRUG__ID D09PDT D09PDT DRUGTYPE Small molecular drug D09PDT DRUGINCH 1S/C49H57N11O7/c50-42(61)37-17-7-8-22-53-43(62)34-14-3-4-15-35(34)48(67)60-24-10-19-41(60)47(66)59-39(26-29-20-21-30-11-1-2-12-31(30)25-29)45(64)57-38(18-9-23-54-49(51)52)44(63)58-40(46(65)56-37)27-32-28-55-36-16-6-5-13-33(32)36/h1-6,11-16,20-21,25,28,37-41,55H,7-10,17-19,22-24,26-27H2,(H2,50,61)(H,53,62)(H,56,65)(H,57,64)(H,58,63)(H,59,66)(H4,51,52,54)/t37-,38-,39+,40-,41-/m0/s1 D09PDT DRUGINKE VWRQHODLDKRSNP-LIZQXKDQSA-N D09PDT DRUGSMIL C1CCNC(=O)C2=CC=CC=C2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC4=CNC5=CC=CC=C54)CCCN=C(N)N)CC6=CC7=CC=CC=C7C=C6 D09PDT HIGHSTAT Investigative D09PEZ DRUG__ID D09PEZ D09PEZ DRUGTYPE Small molecular drug D09PEZ DRUGINCH 1S/C13H13N5O4/c19-17(20)10-7-9-1-2-12(16-5-3-14-4-6-16)15-13(9)11(8-10)18(21)22/h1-2,7-8,14H,3-6H2 D09PEZ DRUGINKE LDLAXAIDSVRAEY-UHFFFAOYSA-N D09PEZ DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3C=C2)[N+](=O)[O-])[N+](=O)[O-] D09PEZ HIGHSTAT Investigative D09PGC DRUG__ID D09PGC D09PGC DRUGTYPE Small molecular drug D09PGC DRUGINCH 1S/C19H20N2O4/c1-2-4-18-17(3-1)20-19(25-18)24-16-7-5-15(6-8-16)23-14-11-21-9-12-22-13-10-21/h1-8H,9-14H2 D09PGC DRUGINKE NVSWCWWHQRVUDU-UHFFFAOYSA-N D09PGC DRUGSMIL C1COCCN1CCOC2=CC=C(C=C2)OC3=NC4=CC=CC=C4O3 D09PGC HIGHSTAT Investigative D09PHV DRUG__ID D09PHV D09PHV DRUGTYPE Small molecular drug D09PHV DRUGINCH 1S/C32H26O10/c1-13-7-18(33)26-22(41-13)10-15-9-20(38-4)28(31(40-6)23(15)29(26)35)25-17-11-16(37-3)12-21(39-5)24(17)30(36)27-19(34)8-14(2)42-32(25)27/h7-12,35-36H,1-6H3 D09PHV DRUGINKE QAHRSPAZSGMZMT-UHFFFAOYSA-N D09PHV DRUGSMIL CC1=CC(=O)C2=C(O1)C=C3C=C(C(=C(C3=C2O)OC)C4=C5C(=C(C6=C4C=C(C=C6OC)OC)O)C(=O)C=C(O5)C)OC D09PHV HIGHSTAT Investigative D09PIF DRUG__ID D09PIF D09PIF DRUGTYPE Small molecular drug D09PIF DRUGINCH 1S/C10H13N3/c1-8-4-2-3-5-9(8)13-10-11-6-7-12-10/h2-5H,6-7H2,1H3,(H2,11,12,13) D09PIF DRUGINKE WLQWOUULTDRZTQ-UHFFFAOYSA-N D09PIF DRUGSMIL CC1=CC=CC=C1NC2=NCCN2 D09PIF HIGHSTAT Investigative D09PIN DRUG__ID D09PIN D09PIN DRUGTYPE Small molecular drug D09PIN DRUGINCH 1S/C32H32N4O3/c1-20-16-25(30-33-21(2)39-34-30)8-9-26(20)22-4-6-23(7-5-22)31(37)36-13-10-24-17-29-27(18-28(24)36)32(19-38-29)11-14-35(3)15-12-32/h4-9,16-18H,10-15,19H2,1-3H3 D09PIN DRUGINKE ATQMRMGXINTJHV-UHFFFAOYSA-N D09PIN DRUGSMIL CC1=C(C=CC(=C1)C2=NOC(=N2)C)C3=CC=C(C=C3)C(=O)N4CCC5=CC6=C(C=C54)C7(CCN(CC7)C)CO6 D09PIN HIGHSTAT Investigative D09PIQ DRUG__ID D09PIQ D09PIQ DRUGTYPE Small molecular drug D09PIQ DRUGINCH 1S/C27H27NO2/c1-3-4-7-16-28-19-22(18-26(28)21-12-8-13-23(17-21)30-2)27(29)25-15-9-11-20-10-5-6-14-24(20)25/h5-6,8-15,17-19H,3-4,7,16H2,1-2H3 D09PIQ DRUGINKE RGYBGMOZXHKLRI-UHFFFAOYSA-N D09PIQ DRUGSMIL CCCCCN1C=C(C=C1C2=CC(=CC=C2)OC)C(=O)C3=CC=CC4=CC=CC=C43 D09PIQ HIGHSTAT Investigative D09PJF DRUG__ID D09PJF D09PJF DRUGTYPE Small molecular drug D09PJF DRUGINCH 1S/C25H35N3O/c1-2-12-27(24-10-8-21-9-11-25(29)20-22(21)19-24)16-13-26-14-17-28(18-15-26)23-6-4-3-5-7-23/h3-7,9,11,20,24,29H,2,8,10,12-19H2,1H3/t24-/m1/s1 D09PJF DRUGINKE POVCSYONXDMZKL-XMMPIXPASA-N D09PJF DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)C=C(C=C4)O D09PJF HIGHSTAT Investigative D09PLA DRUG__ID D09PLA D09PLA DRUGTYPE Small molecular drug D09PLA DRUGINCH 1S/C18H29N7O6/c19-18(20)21-5-1-2-11-16(30)22-8-13(26)24-12(7-14(27)28)17(31)23-10-4-3-9(6-10)15(29)25-11/h9-12H,1-8H2,(H,22,30)(H,23,31)(H,24,26)(H,25,29)(H,27,28)(H4,19,20,21)/t9-,10+,11-,12-/m0/s1 D09PLA DRUGINKE SLTMEZLQPRTTBL-USZNOCQGSA-N D09PLA DRUGSMIL C1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D09PLA HIGHSTAT Investigative D09PLJ DRUG__ID D09PLJ D09PLJ DRUGTYPE Small molecular drug D09PLJ DRUGINCH 1S/C12H9N3S/c13-12-11-9(14-7-15-12)6-10(16-11)8-4-2-1-3-5-8/h1-7H,(H2,13,14,15) D09PLJ DRUGINKE WQVHTLKGGYMXIO-UHFFFAOYSA-N D09PLJ DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(S2)C(=NC=N3)N D09PLJ HIGHSTAT Investigative D09PLT DRUG__ID D09PLT D09PLT DRUGTYPE Small molecular drug D09PLT DRUGINCH 1S/C16H17N/c1-16(2,3)11-8-9-15-13(10-11)12-6-4-5-7-14(12)17-15/h4-10,17H,1-3H3 D09PLT DRUGINKE TYXSZNGDCCGIBO-UHFFFAOYSA-N D09PLT DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)NC3=CC=CC=C32 D09PLT HIGHSTAT Investigative D09PNQ DRUG__ID D09PNQ D09PNQ DRUGTYPE Small molecular drug D09PNQ DRUGINCH 1S/C3H6O3/c4-1-3(6)2-5/h1,3,5-6H,2H2 D09PNQ DRUGINKE MNQZXJOMYWMBOU-UHFFFAOYSA-N D09PNQ DRUGSMIL C(C(C=O)O)O D09PNQ HIGHSTAT Investigative D09PNV DRUG__ID D09PNV D09PNV DRUGTYPE Small molecular drug D09PNV DRUGINCH 1S/C25H35NO6S.C6H14N4O2.H2O/c1-3-4-7-15-26(16-8-17-32-2)25(29)22(12-14-24(27)28)19-33(30,31)23-13-11-20-9-5-6-10-21(20)18-23;7-4(5(11)12)2-1-3-10-6(8)9;/h5-6,9-11,13,18,22H,3-4,7-8,12,14-17,19H2,1-2H3,(H,27,28);4H,1-3,7H2,(H,11,12)(H4,8,9,10);1H2 D09PNV DRUGINKE XIGWXYNWZKIGCQ-UHFFFAOYSA-N D09PNV DRUGSMIL CCCCCN(CCCOC)C(=O)C(CCC(=O)O)CS(=O)(=O)C1=CC2=CC=CC=C2C=C1.C(CC(C(=O)O)N)CN=C(N)N.O D09PNV HIGHSTAT Investigative D09PTR DRUG__ID D09PTR D09PTR DRUGTYPE Small molecular drug D09PTR DRUGINCH 1S/C22H25N3O3S/c1-12(18-13-7-4-5-9-16(13)25(2)22(18)28)19-20(14-8-6-10-17(14)26)23-15(11-29-3)21(27)24-19/h4-7,9-10,12,15,18-19,23H,8,11H2,1-3H3,(H,24,27)/b20-14+/t12-,15-,18-,19-/m0/s1 D09PTR DRUGINKE UAPDNDKYPBHNQT-WVPMBWLTSA-N D09PTR DRUGSMIL CC(C1C2=CC=CC=C2N(C1=O)C)C3C(=C4CC=CC4=O)NC(C(=O)N3)CSC D09PTR HIGHSTAT Investigative D09PUF DRUG__ID D09PUF D09PUF DRUGTYPE Small molecular drug D09PUF DRUGINCH 1S/C19H25NO5S/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-17(25-26(20,22)23)16(24-2)10-14(11)12/h9-10,12-13,15H,3-8H2,1-2H3,(H2,20,22,23)/t12-,13+,15-,19-/m0/s1 D09PUF DRUGINKE BTQHAWWINOTNQQ-QPWUGHHJSA-N D09PUF DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=CC(=C(C=C34)OC)OS(=O)(=O)N D09PUF HIGHSTAT Investigative D09PUW DRUG__ID D09PUW D09PUW DRUGTYPE Small molecular drug D09PUW DRUGINCH 1S/C19H14O5/c1-21-13-3-5-15-11(7-13)9-17(23-15)19(20)18-10-12-8-14(22-2)4-6-16(12)24-18/h3-10H,1-2H3 D09PUW DRUGINKE HEAUVWMQZFRPLK-UHFFFAOYSA-N D09PUW DRUGSMIL COC1=CC2=C(C=C1)OC(=C2)C(=O)C3=CC4=C(O3)C=CC(=C4)OC D09PUW HIGHSTAT Investigative D09PWJ DRUG__ID D09PWJ D09PWJ DRUGTYPE Small molecular drug D09PWJ DRUGINCH 1S/C19H26Cl2N2O/c1-19(2,3)4-5-23-10-16-15(17(16)11-23)9-22-18(24)12-6-13(20)8-14(21)7-12/h6-8,15-17H,4-5,9-11H2,1-3H3,(H,22,24)/t15?,16-,17+ D09PWJ DRUGINKE GSJIGYLGKSBYBC-ALOPSCKCSA-N D09PWJ DRUGSMIL CC(C)(C)CCN1CC2C(C1)C2CNC(=O)C3=CC(=CC(=C3)Cl)Cl D09PWJ HIGHSTAT Investigative D09PWX DRUG__ID D09PWX D09PWX DRUGTYPE Small molecular drug D09PWX DRUGINCH 1S/C7H7NO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)(H2,8,11,12) D09PWX DRUGINKE UCAGLBKTLXCODC-UHFFFAOYSA-N D09PWX DRUGSMIL C1=CC(=CC=C1C(=O)O)S(=O)(=O)N D09PWX HIGHSTAT Investigative D09PXU DRUG__ID D09PXU D09PXU DRUGTYPE Small molecular drug D09PXU DRUGINCH 1S/C15H14O3/c1-8-12-7-18-15-9(2)14(17)6-4-11(15)10(12)3-5-13(8)16/h3-6,16-17H,7H2,1-2H3 D09PXU DRUGINKE UCANDFJLKWPIBP-UHFFFAOYSA-N D09PXU DRUGSMIL CC1=C(C=CC2=C1COC3=C2C=CC(=C3C)O)O D09PXU HIGHSTAT Investigative D09PZD DRUG__ID D09PZD D09PZD DRUGTYPE Small molecular drug D09PZD DRUGINCH 1S/C55H93N19O14S2/c1-28(2)23-37-50(84)74-43(30(5)75)52(86)69-35(15-9-10-20-56)47(81)67-33(16-11-21-63-54(59)60)45(79)65-25-41(77)66-34(17-12-22-64-55(61)62)46(80)68-36(18-19-40(58)76)48(82)73-42(29(3)4)51(85)72-39(53(87)88)27-90-89-26-32(57)44(78)70-38(49(83)71-37)24-31-13-7-6-8-14-31/h6-8,13-14,28-30,32-39,42-43,75H,9-12,15-27,56-57H2,1-5H3,(H2,58,76)(H,65,79)(H,66,77)(H,67,81)(H,68,80)(H,69,86)(H,70,78)(H,71,83)(H,72,85)(H,73,82)(H,74,84)(H,87,88)(H4,59,60,63)(H4,61,62,64)/t30-,32+,33+,34+,35+,36+,37+,38+,39+,42+,43+/m1/s1 D09PZD DRUGINKE JOEHPBQVSCDCHE-BKGQOYFSSA-N D09PZD DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)N)C(=O)O)C(C)C)CCC(=O)N)CCCN=C(N)N)CCCN=C(N)N)CCCCN)C(C)O D09PZD HIGHSTAT Investigative D09PZT DRUG__ID D09PZT D09PZT DRUGTYPE Peptide D09PZT DRUGINCH 1S/C54H77N13O9/c1-7-54(6,56)53(76)66-43(26-37-29-58-31-60-37)52(75)67-20-14-19-44(67)51(74)65-41(24-35-17-12-9-13-18-35)49(72)64-42(25-36-28-57-30-59-36)50(73)62-38(21-32(2)3)45(68)27-46(69)61-40(22-33(4)5)48(71)63-39(47(55)70)23-34-15-10-8-11-16-34/h8-13,15-18,28-33,38-45,68H,7,14,19-27,56H2,1-6H3,(H2,55,70)(H,57,59)(H,58,60)(H,61,69)(H,62,73)(H,63,71)(H,64,72)(H,65,74)(H,66,76)/t38?,39-,40-,41-,42-,43-,44-,45?,54-/m0/s1 D09PZT DRUGINKE YLFGKFNAVPVWDW-AJEFLBOZSA-N D09PZT DRUGSMIL CCC(C)(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CN=CN4)C(=O)NC(CC(C)C)C(CC(=O)NC(CC(C)C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)O)N D09PZT HIGHSTAT Investigative D09QBA DRUG__ID D09QBA D09QBA DRUGTYPE Small molecular drug D09QBA DRUGINCH 1S/C25H22N2O3/c1-30-15-7-9-16-14(12-15)6-8-18-21(16)23-19(13-26-25(23)29)22-17-4-2-3-5-20(17)27(10-11-28)24(18)22/h2-5,7,9,12,28H,6,8,10-11,13H2,1H3,(H,26,29) D09QBA DRUGINKE QMLALHXGVBGFIC-UHFFFAOYSA-N D09QBA DRUGSMIL COC1=CC2=C(C=C1)C3=C(CC2)C4=C(C5=C3C(=O)NC5)C6=CC=CC=C6N4CCO D09QBA HIGHSTAT Investigative D09QCD DRUG__ID D09QCD D09QCD DRUGTYPE Small molecular drug D09QCD DRUGINCH 1S/C25H27N5O/c1-29(2)25-28-22-11-7-6-10-21(22)23(30(25)20-8-4-3-5-9-20)16-24(31)27-17-18-12-14-19(26)15-13-18/h3-15,23H,16-17,26H2,1-2H3,(H,27,31) D09QCD DRUGINKE ADQNFSXMHBVQJA-UHFFFAOYSA-N D09QCD DRUGSMIL CN(C)C1=NC2=CC=CC=C2C(N1C3=CC=CC=C3)CC(=O)NCC4=CC=C(C=C4)N D09QCD HIGHSTAT Investigative D09QDC DRUG__ID D09QDC D09QDC DRUGTYPE Small molecular drug D09QDC DRUGINCH 1S/C12H32N4O3P2/c1-9(2)13-20(17,14-10(3)4)19-21(18,15-11(5)6)16-12(7)8/h9-12H,1-8H3,(H2,13,14,17)(H2,15,16,18) D09QDC DRUGINKE IOIMDJXKIMCMIG-UHFFFAOYSA-N D09QDC DRUGSMIL CC(C)NP(=O)(NC(C)C)OP(=O)(NC(C)C)NC(C)C D09QDC HIGHSTAT Investigative D09QDY DRUG__ID D09QDY D09QDY DRUGTYPE Small molecular drug D09QDY DRUGINCH 1S/C13H12N2/c1-2-4-13-10(3-1)5-6-11(13)7-12-8-14-9-15-12/h1-4,7-9H,5-6H2,(H,14,15)/b11-7- D09QDY DRUGINKE FXLOWXDBTSZJFZ-XFFZJAGNSA-N D09QDY DRUGSMIL C1CC(=CC2=CN=CN2)C3=CC=CC=C31 D09QDY HIGHSTAT Investigative D09QHC DRUG__ID D09QHC D09QHC DRUGTYPE Small molecular drug D09QHC DRUGINCH 1S/C6H7NO2S/c7-10(8,9)6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) D09QHC DRUGINKE KHBQMWCZKVMBLN-UHFFFAOYSA-N D09QHC DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)N D09QHC HIGHSTAT Investigative D09QIA DRUG__ID D09QIA D09QIA DRUGTYPE Small molecular drug D09QIA DRUGINCH 1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-8,11-17H2,1H3,(H,19,20) D09QIA DRUGINKE RGTIBVZDHOMOKC-UHFFFAOYSA-N D09QIA DRUGSMIL CCCCCCCCC#CCCCCCCCC(=O)O D09QIA HIGHSTAT Investigative D09QIC DRUG__ID D09QIC D09QIC DRUGTYPE Small molecular drug D09QIC DRUGINCH 1S/C26H40N4O8/c1-15(2)21(26(37)38)29-23(34)16(3)28-25(36)22(17(4)31)30-24(35)19(12-13-20(32)33)27-14-8-11-18-9-6-5-7-10-18/h5-7,9-10,15-17,19,21-22,27,31H,8,11-14H2,1-4H3,(H,28,36)(H,29,34)(H,30,35)(H,32,33)(H,37,38)/t16-,17?,19-,21-,22-/m0/s1 D09QIC DRUGINKE UKIJAHRPMGIIOF-DYKQHQKNSA-N D09QIC DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCCC1=CC=CC=C1 D09QIC HIGHSTAT Investigative D09QJS DRUG__ID D09QJS D09QJS DRUGTYPE Small molecular drug D09QJS DRUGINCH 1S/C31H41NO7/c1-4-6-23-26(14-10-21-9-11-22(39-29(21)23)12-16-28(33)34)37-17-5-18-38-27-15-13-24(31(35)32-2)30(36-3)25(27)19-20-7-8-20/h10,13-15,20,22H,4-9,11-12,16-19H2,1-3H3,(H,32,35)(H,33,34)/t22-/m1/s1 D09QJS DRUGINKE YWYUQSGYKDEAMJ-JOCHJYFZSA-N D09QJS DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)CCC(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)NC)OC)CC4CC4 D09QJS HIGHSTAT Investigative D09QKH DRUG__ID D09QKH D09QKH DRUGTYPE Small molecular drug D09QKH DRUGINCH 1S/C17H14IN3OS/c18-14-9-5-4-8-13(14)16(22)19-17-21-20-15(23-17)11-10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,21,22) D09QKH DRUGINKE SLBMNZPBYUAWPO-UHFFFAOYSA-N D09QKH DRUGSMIL C1=CC=C(C=C1)CCC2=NN=C(S2)NC(=O)C3=CC=CC=C3I D09QKH HIGHSTAT Investigative D09QLB DRUG__ID D09QLB D09QLB DRUGTYPE Small molecular drug D09QLB DRUGINCH 1S/C13H12N4O5S/c1-16-11-9(12(18)17(2)13(16)19)14-10(15-11)7-3-5-8(6-4-7)23(20,21)22/h3-6H,1-2H3,(H,14,15)(H,20,21,22) D09QLB DRUGINKE LXJSJIXZOAMHTG-UHFFFAOYSA-N D09QLB DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CC=C(C=C3)S(=O)(=O)O D09QLB HIGHSTAT Investigative D09QOB DRUG__ID D09QOB D09QOB DRUGTYPE Small molecular drug D09QOB DRUGINCH 1S/C22H21ClN4O3/c1-12(22(28)30-4)19-21-26-25-13(2)27(21)18-10-9-16(29-3)11-17(18)20(24-19)14-5-7-15(23)8-6-14/h5-12,19H,1-4H3/t12-,19+/m1/s1 D09QOB DRUGINKE FENXDXHDXYVGRJ-BLVKFPJESA-N D09QOB DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)OC)C(=NC2C(C)C(=O)OC)C4=CC=C(C=C4)Cl D09QOB HIGHSTAT Investigative D09QOE DRUG__ID D09QOE D09QOE DRUGTYPE Small molecular drug D09QOE DRUGINCH 1S/C18H22Cl2NO3P/c1-13(15-7-8-17(19)18(20)9-15)21-10-16(22)12-25(23,24)11-14-5-3-2-4-6-14/h2-9,13,16,21-22H,10-12H2,1H3,(H,23,24)/t13-,16-/m0/s1 D09QOE DRUGINKE ZODSPDOOCZZEIM-BBRMVZONSA-N D09QOE DRUGSMIL CC(C1=CC(=C(C=C1)Cl)Cl)NCC(CP(=O)(CC2=CC=CC=C2)O)O D09QOE HIGHSTAT Investigative D09QPH DRUG__ID D09QPH D09QPH DRUGTYPE Small molecular drug D09QPH DRUGINCH 1S/C25H22Cl2O12/c1-8-15(26)20(38-19-10(23(33)36-3)7-12(29)17(30)18(19)31)14-21(16(8)27)39-25(22(14)32)11(24(34)37-4)5-9(28)6-13(25)35-2/h5-7,12,17-19,29-31H,1-4H3/t12-,17-,18+,19-,25+/m1/s1 D09QPH DRUGINKE LNGFWDFUPRZMJI-VEHFIHCQSA-N D09QPH DRUGSMIL CC1=C(C2=C(C(=C1Cl)OC3C(C(C(C=C3C(=O)OC)O)O)O)C(=O)C4(O2)C(=CC(=O)C=C4OC)C(=O)OC)Cl D09QPH HIGHSTAT Investigative D09QPT DRUG__ID D09QPT D09QPT DRUGTYPE Small molecular drug D09QPT DRUGINCH 1S/C13H10N2O/c1-8-14-11-7-6-9-4-2-3-5-10(9)12(11)13(16)15-8/h2-7H,1H3,(H,14,15,16) D09QPT DRUGINKE HVULCQPSGYYROI-UHFFFAOYSA-N D09QPT DRUGSMIL CC1=NC2=C(C3=CC=CC=C3C=C2)C(=O)N1 D09QPT HIGHSTAT Investigative D09QPV DRUG__ID D09QPV D09QPV DRUGTYPE Small molecular drug D09QPV DRUGINCH 1S/C48H62N10O7/c1-27(2)20-37(43(51)60)54-45(62)38(21-28(3)4)56-48(65)41(24-31-26-53-36-17-11-9-15-33(31)36)58-46(63)39(22-29-12-6-5-7-13-29)57-47(64)40(55-44(61)34(49)18-19-42(50)59)23-30-25-52-35-16-10-8-14-32(30)35/h5-17,25-28,34,37-41,52-53H,18-24,49H2,1-4H3,(H2,50,59)(H2,51,60)(H,54,62)(H,55,61)(H,56,65)(H,57,64)(H,58,63)/t34-,37-,38-,39-,40+,41+/m0/s1 D09QPV DRUGINKE KUAWHJJXPITBED-QBZLXUEESA-N D09QPV DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)N)N D09QPV HIGHSTAT Investigative D09QRL DRUG__ID D09QRL D09QRL DRUGTYPE Small molecular drug D09QRL DRUGINCH 1S/C16H17N/c1-17-11-10-14-8-5-9-15(16(14)12-17)13-6-3-2-4-7-13/h2-9H,10-12H2,1H3 D09QRL DRUGINKE XBKQADUXVZAYDY-UHFFFAOYSA-N D09QRL DRUGSMIL CN1CCC2=C(C1)C(=CC=C2)C3=CC=CC=C3 D09QRL HIGHSTAT Investigative D09QSO DRUG__ID D09QSO D09QSO DRUGTYPE Small molecular drug D09QSO DRUGINCH 1S/C21H27NO/c23-17-20(19-11-5-2-6-12-19)21-13-7-8-15-22(21)16-14-18-9-3-1-4-10-18/h1-6,9-12,20-21,23H,7-8,13-17H2/t20-,21-/m1/s1 D09QSO DRUGINKE BWPOQJVXDJYEQS-NHCUHLMSSA-N D09QSO DRUGSMIL C1CCN(C(C1)C(CO)C2=CC=CC=C2)CCC3=CC=CC=C3 D09QSO HIGHSTAT Investigative D09QSY DRUG__ID D09QSY D09QSY DRUGTYPE Small molecular drug D09QSY DRUGINCH 1S/C13H24O3/c1-9(2)12-5-4-10(3)6-13(12)15-8-11(7-14)16-13/h9-12,14H,4-8H2,1-3H3 D09QSY DRUGINKE ZBJCYZPANVLBRK-UHFFFAOYSA-N D09QSY DRUGSMIL CC1CCC(C2(C1)OCC(O2)CO)C(C)C D09QSY HIGHSTAT Investigative D09QTC DRUG__ID D09QTC D09QTC DRUGTYPE Small molecular drug D09QTC DRUGINCH 1S/C18H17NO4/c1-20-12-5-4-6-13(9-12)23-16-7-8-19-15-11-18(22-3)17(21-2)10-14(15)16/h4-11H,1-3H3 D09QTC DRUGINKE SORFICSDHDADIC-UHFFFAOYSA-N D09QTC DRUGSMIL COC1=CC(=CC=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC D09QTC HIGHSTAT Investigative D09QUN DRUG__ID D09QUN D09QUN DRUGTYPE Small molecular drug D09QUN DRUGINCH 1S/C19H23FN2O2/c1-13(19(2,3)4)22-18(23)15-8-9-17(21-11-15)24-12-14-6-5-7-16(20)10-14/h5-11,13H,12H2,1-4H3,(H,22,23)/t13-/m1/s1 D09QUN DRUGINKE VOYBJCDMLJODRK-CYBMUJFWSA-N D09QUN DRUGSMIL CC(C(C)(C)C)NC(=O)C1=CN=C(C=C1)OCC2=CC(=CC=C2)F D09QUN HIGHSTAT Investigative D09QVD DRUG__ID D09QVD D09QVD DRUGTYPE Small molecular drug D09QVD DRUGINCH 1S/C11H14BrNO2S/c12-9-4-2-1-3-8(9)7-16-6-5-10(13)11(14)15/h1-4,10H,5-7,13H2,(H,14,15) D09QVD DRUGINKE MWUVRUMWNBKYCW-UHFFFAOYSA-N D09QVD DRUGSMIL C1=CC=C(C(=C1)CSCCC(C(=O)O)N)Br D09QVD HIGHSTAT Investigative D09QXR DRUG__ID D09QXR D09QXR DRUGTYPE Small molecular drug D09QXR DRUGINCH 1S/C9H12O2/c10-7-9(11)6-8-4-2-1-3-5-8/h1-5,9-11H,6-7H2/t9-/m0/s1 D09QXR DRUGINKE JHWQMXKQJVAWKI-VIFPVBQESA-N D09QXR DRUGSMIL C1=CC=C(C=C1)CC(CO)O D09QXR HIGHSTAT Investigative D09QZJ DRUG__ID D09QZJ D09QZJ DRUGTYPE Small molecular drug D09QZJ DRUGINCH 1S/C22H35BN4O5/c1-16(28)25-18(15-17-9-4-2-5-10-17)22(30)27-14-8-11-19(27)21(29)26-20(23(31)32)12-6-3-7-13-24/h2,4-5,9-10,18-20,31-32H,3,6-8,11-15,24H2,1H3,(H,25,28)(H,26,29)/t18-,19+,20+/m1/s1 D09QZJ DRUGINKE AILSWIBFGYYZTK-AABGKKOBSA-N D09QZJ DRUGSMIL B(C(CCCCCN)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)C)(O)O D09QZJ HIGHSTAT Investigative D09QZL DRUG__ID D09QZL D09QZL DRUGTYPE Small molecular drug D09QZL DRUGINCH 1S/C13H9Cl2NO3/c14-8-2-4-12(10(17)6-8)19-11-3-1-7(13(16)18)5-9(11)15/h1-6,17H,(H2,16,18) D09QZL DRUGINKE XMCNGTFAEHHMRY-UHFFFAOYSA-N D09QZL DRUGSMIL C1=CC(=C(C=C1C(=O)N)Cl)OC2=C(C=C(C=C2)Cl)O D09QZL HIGHSTAT Investigative D09QZM DRUG__ID D09QZM D09QZM DRUGTYPE Small molecular drug D09QZM DRUGINCH 1S/C15H17NO/c16-10-14-7-8-15(17-14)13-6-5-11-3-1-2-4-12(11)9-13/h1-6,9,14-15H,7-8,10,16H2 D09QZM DRUGINKE BVTKYAZPIRQNNS-UHFFFAOYSA-N D09QZM DRUGSMIL C1CC(OC1CN)C2=CC3=CC=CC=C3C=C2 D09QZM HIGHSTAT Investigative D09RAM DRUG__ID D09RAM D09RAM DRUGTYPE Small molecular drug D09RAM DRUGINCH 1S/C16H13NOS/c17-13-5-1-11(2-6-13)15-9-10-16(19-15)12-3-7-14(18)8-4-12/h1-10,18H,17H2 D09RAM DRUGINKE NTAJNMDKXYZMKZ-UHFFFAOYSA-N D09RAM DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC=C(C=C3)O)N D09RAM HIGHSTAT Investigative D09RCL DRUG__ID D09RCL D09RCL DRUGTYPE Small molecular drug D09RCL DRUGINCH 1S/C17H18INO2/c18-14-7-4-8-15(11-14)21-17(13-5-2-1-3-6-13)16-12-19-9-10-20-16/h1-8,11,16-17,19H,9-10,12H2/t16-,17+/m1/s1 D09RCL DRUGINKE DUYCYXZOEGDUNB-SJORKVTESA-N D09RCL DRUGSMIL C1COC(CN1)C(C2=CC=CC=C2)OC3=CC(=CC=C3)I D09RCL HIGHSTAT Investigative D09REF DRUG__ID D09REF D09REF DRUGTYPE Small molecular drug D09REF DRUGINCH 1S/C18H19NO5/c1-9(20)24-18-13(21)4-10-2-3-19-7-11-5-14-15(23-8-22-14)6-12(11)16(18)17(10)19/h4-6,13,16-18,21H,2-3,7-8H2,1H3/t13-,16-,17+,18+/m0/s1 D09REF DRUGINKE BIGUPJIJZYZJMV-VIBAHUMZSA-N D09REF DRUGSMIL CC(=O)OC1C(C=C2CCN3C2C1C4=CC5=C(C=C4C3)OCO5)O D09REF HIGHSTAT Investigative D09RES DRUG__ID D09RES D09RES DRUGTYPE Small molecular drug D09RES DRUGINCH 1S/C15H10N2O/c1-17-12-8-4-7-11-13(12)14(16-17)9-5-2-3-6-10(9)15(11)18/h2-8H,1H3 D09RES DRUGINKE ODZGYELAMAOARP-UHFFFAOYSA-N D09RES DRUGSMIL CN1C2=CC=CC3=C2C(=N1)C4=CC=CC=C4C3=O D09RES HIGHSTAT Investigative D09RFE DRUG__ID D09RFE D09RFE DRUGTYPE Small molecular drug D09RFE DRUGINCH 1S/C15H10N4O/c16-10-14-15(18-19-17-14)11-6-8-13(9-7-11)20-12-4-2-1-3-5-12/h1-9H,(H,17,18,19) D09RFE DRUGINKE LHOBXXROLCTUBM-UHFFFAOYSA-N D09RFE DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=NNN=C3C#N D09RFE HIGHSTAT Investigative D09RGM DRUG__ID D09RGM D09RGM DRUGTYPE Small molecular drug D09RGM DRUGINCH 1S/C22H31NO4S2/c1-4-5-6-7-16-23(17-28(24,25)21-12-8-19(2)9-13-21)18-29(26,27)22-14-10-20(3)11-15-22/h8-15H,4-7,16-18H2,1-3H3 D09RGM DRUGINKE JNUXLFWPSMEIDT-UHFFFAOYSA-N D09RGM DRUGSMIL CCCCCCN(CS(=O)(=O)C1=CC=C(C=C1)C)CS(=O)(=O)C2=CC=C(C=C2)C D09RGM HIGHSTAT Investigative D09RGZ DRUG__ID D09RGZ D09RGZ DRUGTYPE Small molecular drug D09RGZ DRUGINCH 1S/C18H25N4O20P3/c23-9-1-3-21(17(29)19-9)15-13(27)11(25)7(39-15)5-37-43(31,32)41-45(35,36)42-44(33,34)38-6-8-12(26)14(28)16(40-8)22-4-2-10(24)20-18(22)30/h1-4,7-8,11-16,25-28H,5-6H2,(H,31,32)(H,33,34)(H,35,36)(H,19,23,29)(H,20,24,30)/p-3/t7-,8+,11+,12-,13?,14?,15-,16-/m1/s1 D09RGZ DRUGINKE JPNWHMPVXHYIKN-VRXVDWQRSA-K D09RGZ DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O D09RGZ HIGHSTAT Investigative D09RIC DRUG__ID D09RIC D09RIC DRUGTYPE Small molecular drug D09RIC DRUGINCH 1S/C24H26ClN3O2/c1-4-27(5-2)21(29)13-14-24(17-9-11-18(25)12-10-17)22-19(7-6-8-20(22)30-3)23-26-15-16-28(23)24/h6-12,15-16H,4-5,13-14H2,1-3H3 D09RIC DRUGINKE YBTRRYYNHWVJLG-UHFFFAOYSA-N D09RIC DRUGSMIL CCN(CC)C(=O)CCC1(C2=C(C=CC=C2OC)C3=NC=CN31)C4=CC=C(C=C4)Cl D09RIC HIGHSTAT Investigative D09RJH DRUG__ID D09RJH D09RJH DRUGTYPE Small molecular drug D09RJH DRUGINCH 1S/C18H19ClN2/c1-2-10-5-11-7-12(6-10)17-16(8-11)21-15-9-13(19)3-4-14(15)18(17)20/h3-5,9,11-12H,2,6-8H2,1H3,(H2,20,21) D09RJH DRUGINKE QTPHSDHUHXUYFE-UHFFFAOYSA-N D09RJH DRUGSMIL CCC1=CC2CC(C1)C3=C(C4=C(C=C(C=C4)Cl)N=C3C2)N D09RJH HIGHSTAT Investigative D09RJT DRUG__ID D09RJT D09RJT DRUGTYPE Small molecular drug D09RJT DRUGINCH 1S/C16H23NO3/c1-9-7-10(18)8-13-14(9)16(19)15-11-3-2-5-17(11)6-4-12(15)20-13/h9-12,15,18H,2-8H2,1H3/t9-,10-,11-,12+,15-/m0/s1 D09RJT DRUGINKE WNDBXOYUMYCREE-NAYUARGSSA-N D09RJT DRUGSMIL CC1CC(CC2=C1C(=O)C3C4CCCN4CCC3O2)O D09RJT HIGHSTAT Investigative D09RKA DRUG__ID D09RKA D09RKA DRUGTYPE Small molecular drug D09RKA DRUGINCH 1S/C15H22N2O3/c1-2-20-15(19)17-11-6-9-14(18)16-12-10-13-7-4-3-5-8-13/h3-5,7-8H,2,6,9-12H2,1H3,(H,16,18)(H,17,19) D09RKA DRUGINKE HTOYBIILVCHURC-UHFFFAOYSA-N D09RKA DRUGSMIL CCOC(=O)NCCCC(=O)NCCC1=CC=CC=C1 D09RKA HIGHSTAT Investigative D09RKX DRUG__ID D09RKX D09RKX DRUGTYPE Small molecular drug D09RKX DRUGINCH 1S/C16H17N5O/c1-3-11-9-21-15(17-11)12-14(20(2)16(21)22)19-13(18-12)10-7-5-4-6-8-10/h4-8,11,17H,3,9H2,1-2H3/t11-/m1/s1 D09RKX DRUGINKE XNWDEMWJNJVCBD-LLVKDONJSA-N D09RKX DRUGSMIL CCC1CN2C(=C3C(=NC(=N3)C4=CC=CC=C4)N(C2=O)C)N1 D09RKX HIGHSTAT Investigative D09RNF DRUG__ID D09RNF D09RNF DRUGTYPE Small molecular drug D09RNF DRUGINCH 1S/C27H23ClO2/c1-27(2)15-14-22(19-6-4-3-5-7-19)23-16-18(9-13-24(23)27)8-10-20-11-12-21(26(29)30)17-25(20)28/h3-14,16-17H,15H2,1-2H3,(H,29,30)/b10-8+ D09RNF DRUGINKE FRTYVAKGTFXRNY-CSKARUKUSA-N D09RNF DRUGSMIL CC1(CC=C(C2=C1C=CC(=C2)C=CC3=C(C=C(C=C3)C(=O)O)Cl)C4=CC=CC=C4)C D09RNF HIGHSTAT Investigative D09RNK DRUG__ID D09RNK D09RNK DRUGTYPE Small molecular drug D09RNK DRUGINCH 1S/C18H12N2/c1-2-4-17(5-3-1)18-10-8-15(9-11-18)6-7-16-12-19-14-20-13-16/h1-5,8-14H D09RNK DRUGINKE WSPLFBLWQURLSJ-UHFFFAOYSA-N D09RNK DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C#CC3=CN=CN=C3 D09RNK HIGHSTAT Investigative D09ROG DRUG__ID D09ROG D09ROG DRUGTYPE Small molecular drug D09ROG DRUGINCH 1S/C15H20N2O/c16-13-14-5-7-15(8-6-14)18-12-4-11-17-9-2-1-3-10-17/h5-8H,1-4,9-12H2 D09ROG DRUGINKE RHMNKKOAWUCDRK-UHFFFAOYSA-N D09ROG DRUGSMIL C1CCN(CC1)CCCOC2=CC=C(C=C2)C#N D09ROG HIGHSTAT Investigative D09ROS DRUG__ID D09ROS D09ROS DRUGTYPE Small molecular drug D09ROS DRUGINCH 1S/C22H26FN5O6S/c1-22(2,3)34-21(30)27-9-7-13(8-10-27)33-19-17-18(24-12-25-19)28(20(29)26-17)16-6-5-14(11-15(16)23)35(4,31)32/h5-6,11-13H,7-10H2,1-4H3,(H,26,29) D09ROS DRUGINKE AXLNAZYMBNKFJO-UHFFFAOYSA-N D09ROS DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)OC2=NC=NC3=C2NC(=O)N3C4=C(C=C(C=C4)S(=O)(=O)C)F D09ROS HIGHSTAT Investigative D09ROV DRUG__ID D09ROV D09ROV DRUGTYPE Small molecular drug D09ROV DRUGINCH 1S/C22H24ClN3O5S/c23-16-6-10-20(11-7-16)32(29,30)25-22(28)24-26-17-8-9-18(26)14-19(13-17)31-21(27)12-15-4-2-1-3-5-15/h1-7,10-11,17-19H,8-9,12-14H2,(H2,24,25,28)/t17-,18+,19? D09ROV DRUGINKE JLAXGKPNMOZKMF-DFNIBXOVSA-N D09ROV DRUGSMIL C1CC2CC(CC1N2NC(=O)NS(=O)(=O)C3=CC=C(C=C3)Cl)OC(=O)CC4=CC=CC=C4 D09ROV HIGHSTAT Investigative D09ROW DRUG__ID D09ROW D09ROW DRUGTYPE Small molecular drug D09ROW DRUGINCH 1S/C16H14O4/c1-10(2)5-7-19-16-14-12(6-8-18-14)9-11-3-4-13(17)20-15(11)16/h3-6,8-9H,7H2,1-2H3 D09ROW DRUGINKE OLOOJGVNMBJLLR-UHFFFAOYSA-N D09ROW DRUGSMIL CC(=CCOC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2)C D09ROW HIGHSTAT Investigative D09RPR DRUG__ID D09RPR D09RPR DRUGTYPE Small molecular drug D09RPR DRUGINCH 1S/C13H6F2N2S/c14-6-13-17-12(8-18-13)2-1-9-3-10(7-16)5-11(15)4-9/h3-5,8H,6H2 D09RPR DRUGINKE WTLBLIGPXACYET-UHFFFAOYSA-N D09RPR DRUGSMIL C1=C(C=C(C=C1C#N)F)C#CC2=CSC(=N2)CF D09RPR HIGHSTAT Investigative D09RPU DRUG__ID D09RPU D09RPU DRUGTYPE Small molecular drug D09RPU DRUGINCH 1S/C18H32O16/c19-1-4-7(22)8(23)12(27)17(31-4)34-15-6(3-21)32-18(13(28)10(15)25)33-14-5(2-20)30-16(29)11(26)9(14)24/h4-29H,1-3H2/t4-,5-,6-,7+,8+,9-,10-,11-,12-,13-,14-,15+,16?,17+,18+/m1/s1 D09RPU DRUGINKE FYGDTMLNYKFZSV-YXENHOCSSA-N D09RPU DRUGSMIL C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)O)O D09RPU HIGHSTAT Investigative D09RPY DRUG__ID D09RPY D09RPY DRUGTYPE Small molecular drug D09RPY DRUGINCH 1S/C19H22O2/c1-13(2)16-11-8-12-17(14(3)4)18(16)21-19(20)15-9-6-5-7-10-15/h5-14H,1-4H3 D09RPY DRUGINKE FWWZVJVOMUKVKV-UHFFFAOYSA-N D09RPY DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)OC(=O)C2=CC=CC=C2 D09RPY HIGHSTAT Investigative D09RQD DRUG__ID D09RQD D09RQD DRUGTYPE Small molecular drug D09RQD DRUGINCH 1S/C7H12O/c1-6(5-8)4-7-2-3-7/h5-7H,2-4H2,1H3/t6-/m0/s1 D09RQD DRUGINKE NOQCSSAEKDLHCI-LURJTMIESA-N D09RQD DRUGSMIL CC(CC1CC1)C=O D09RQD HIGHSTAT Investigative D09RRF DRUG__ID D09RRF D09RRF DRUGTYPE Small molecular drug D09RRF DRUGINCH 1S/C17H20FNO4S/c1-3-4-7-22-8-9-23-15-11(2)24-16(19-15)12-5-6-13(17(20)21)14(18)10-12/h5-6,10H,3-4,7-9H2,1-2H3,(H,20,21) D09RRF DRUGINKE HSAOETBFVAWNRP-UHFFFAOYSA-N D09RRF DRUGSMIL CCCCOCCOC1=C(SC(=N1)C2=CC(=C(C=C2)C(=O)O)F)C D09RRF HIGHSTAT Investigative D09RSL DRUG__ID D09RSL D09RSL DRUGTYPE Small molecular drug D09RSL DRUGINCH 1S/C45H73N13O9/c1-8-26(4)35(39(62)55-33(41(64)65)22-25(2)3)57-37(60)32(23-27-24-52-29-15-10-9-14-28(27)29)54-38(61)34-18-13-21-58(34)40(63)31(17-12-20-51-43(48)49)53-36(59)30(16-11-19-50-42(46)47)56-44(66)67-45(5,6)7/h9-10,14-15,24-26,30-35,52H,8,11-13,16-23H2,1-7H3,(H,53,59)(H,54,61)(H,55,62)(H,56,66)(H,57,60)(H,64,65)(H4,46,47,50)(H4,48,49,51)/t26-,30-,31-,32-,33-,34-,35-/m0/s1 D09RSL DRUGINKE KOHSYJYVCLITLX-OLPQHFNPSA-N D09RSL DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)OC(C)(C)C D09RSL HIGHSTAT Investigative D09RUY DRUG__ID D09RUY D09RUY DRUGTYPE Small molecular drug D09RUY DRUGINCH 1S/C27H34N2/c1-2-6-20(7-3-1)18-28-23-12-11-22-16-26-24-8-4-5-13-27(24,25(22)17-23)14-15-29(26)19-21-9-10-21/h1-3,6-7,11-12,17,21,24,26,28H,4-5,8-10,13-16,18-19H2/t24-,26+,27+/m0/s1 D09RUY DRUGINKE CDLAPAAACNSKLQ-WYMJOSIYSA-N D09RUY DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NCC5=CC=CC=C5)CC6CC6 D09RUY HIGHSTAT Investigative D09RWW DRUG__ID D09RWW D09RWW DRUGTYPE Small molecular drug D09RWW DRUGINCH 1S/C17H19NO3/c1-2-11-7-8-15-13(9-11)16(19)14(10-18-15)17(20)21-12-5-3-4-6-12/h7-10,12H,2-6H2,1H3,(H,18,19) D09RWW DRUGINKE XLRFFZMGTKMUJJ-UHFFFAOYSA-N D09RWW DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OC3CCCC3 D09RWW HIGHSTAT Investigative D09RXJ DRUG__ID D09RXJ D09RXJ DRUGTYPE Small molecular drug D09RXJ DRUGINCH 1S/C20H15NO5/c22-17-11-5-10-16(18(17)20(24)25)21-19(23)13-6-4-9-15(12-13)26-14-7-2-1-3-8-14/h1-12,22H,(H,21,23)(H,24,25) D09RXJ DRUGINKE QXBHJJXXAXXUEZ-UHFFFAOYSA-N D09RXJ DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)C(=O)NC3=C(C(=CC=C3)O)C(=O)O D09RXJ HIGHSTAT Investigative D09RXU DRUG__ID D09RXU D09RXU DRUGTYPE Small molecular drug D09RXU DRUGINCH 1S/C18H20N4/c1-2-5-14(6-3-1)13-17-20-15-7-4-8-16(18(15)21-17)22-11-9-19-10-12-22/h1-8,19H,9-13H2,(H,20,21) D09RXU DRUGINKE YTVICZASURPPDE-UHFFFAOYSA-N D09RXU DRUGSMIL C1CN(CCN1)C2=CC=CC3=C2N=C(N3)CC4=CC=CC=C4 D09RXU HIGHSTAT Investigative D09RYG DRUG__ID D09RYG D09RYG DRUGTYPE Small molecular drug D09RYG DRUGINCH 1S/C36H44N4O2/c41-35-16-7-3-1-2-4-8-19-39-21-15-29(34(24-39)23-36-17-13-25(42-36)10-9-20-40(36)33(34)35)28(22-35)31-32-27(14-18-37-31)26-11-5-6-12-30(26)38-32/h1,3,5-6,11-12,14,18,22,25,29,33,38,41H,2,4,7-10,13,15-17,19-21,23-24H2/b3-1-/t25-,29?,33+,34-,35-,36+/m0/s1 D09RYG DRUGINKE CLKZPQNKNPCQGL-NZGBLPSWSA-N D09RYG DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC56N4CCCC(O5)CC6)O)C7=NC=CC8=C7NC9=CC=CC=C89 D09RYG HIGHSTAT Investigative D09RYV DRUG__ID D09RYV D09RYV DRUGTYPE Small molecular drug D09RYV DRUGINCH 1S/C23H25N5O3S/c1-27-8-10-28(11-9-27)17-5-3-16(4-6-17)25-23-26-22(24)21(32-23)20(29)15-2-7-18-19(14-15)31-13-12-30-18/h2-7,14H,8-13,24H2,1H3,(H,25,26) D09RYV DRUGINKE YGEYFDLYGXSZCP-UHFFFAOYSA-N D09RYV DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC(=C(S3)C(=O)C4=CC5=C(C=C4)OCCO5)N D09RYV HIGHSTAT Investigative D09RZQ DRUG__ID D09RZQ D09RZQ DRUGTYPE Small molecular drug D09RZQ DRUGINCH 1S/C21H19N3O2S/c1-2-27(25,26)24(16-18-5-4-12-23-15-18)21-7-3-6-20(13-21)19-10-8-17(14-22)9-11-19/h3-13,15H,2,16H2,1H3 D09RZQ DRUGINKE HDVYXILCBYGKGU-UHFFFAOYSA-N D09RZQ DRUGSMIL CCS(=O)(=O)N(CC1=CN=CC=C1)C2=CC=CC(=C2)C3=CC=C(C=C3)C#N D09RZQ HIGHSTAT Investigative D09RZX DRUG__ID D09RZX D09RZX DRUGTYPE Small molecular drug D09RZX DRUGINCH 1S/C20H26O7/c1-11-5-4-6-14(9-21)8-17-18(13(3)20(25)27-17)16(7-11)26-19(24)12(2)15(23)10-22/h5,8,15-18,21-23H,2-4,6-7,9-10H2,1H3/b11-5+,14-8-/t15-,16-,17+,18+/m0/s1 D09RZX DRUGINKE ZTDFZLVUIVPZDU-QGNHJMHWSA-N D09RZX DRUGSMIL CC1=CCCC(=CC2C(C(C1)OC(=O)C(=C)C(CO)O)C(=C)C(=O)O2)CO D09RZX HIGHSTAT Investigative D09SBU DRUG__ID D09SBU D09SBU DRUGTYPE Small molecular drug D09SBU DRUGINCH 1S/C28H31N5O4/c1-17-28(37)33-13-7-12-24(33)27(36)32-22(14-18-8-3-2-4-9-18)26(35)31-23(25(34)30-17)15-19-16-29-21-11-6-5-10-20(19)21/h2-6,8-11,16-17,22-24,29H,7,12-15H2,1H3,(H,30,34)(H,31,35)(H,32,36)/t17-,22-,23+,24+/m0/s1 D09SBU DRUGINKE OTUDCPUMJPNZRR-UYGLSEIWSA-N D09SBU DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5 D09SBU HIGHSTAT Investigative D09SCS DRUG__ID D09SCS D09SCS DRUGTYPE Small molecular drug D09SCS DRUGINCH 1S/C26H42O3/c1-4-5-6-7-12-26(2,3)20-10-11-22(25(29)15-20)24-16-21(28)14-19-9-8-18(17-27)13-23(19)24/h10-11,15,18-19,21,23-24,27-29H,4-9,12-14,16-17H2,1-3H3/t18-,19-,21+,23+,24-/m0/s1 D09SCS DRUGINKE ZAELPWSCABXXAB-NWXGMGMZSA-N D09SCS DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CC(CC3C2CC(CC3)CO)O)O D09SCS HIGHSTAT Investigative D09SFJ DRUG__ID D09SFJ D09SFJ DRUGTYPE Small molecular drug D09SFJ DRUGINCH 1S/C17H12ClN3OS2/c1-21-7-12(16(23)20-17(21)22)14-11-4-3-10(18)6-9(11)2-5-13-15(14)19-8-24-13/h2-8,14H,1H3,(H,20,22,23) D09SFJ DRUGINKE ZDHQVQVNOIWLNX-UHFFFAOYSA-N D09SFJ DRUGSMIL CN1C=C(C(=S)NC1=O)C2C3=C(C=CC4=C2N=CS4)C=C(C=C3)Cl D09SFJ HIGHSTAT Investigative D09SFY DRUG__ID D09SFY D09SFY DRUGTYPE Small molecular drug D09SFY DRUGINCH 1S/C9H12N2O3S/c10-15(13,14)6-5-11-7-8-1-3-9(12)4-2-8/h1-4,7,12H,5-6H2,(H2,10,13,14) D09SFY DRUGINKE IDKQYIBAMQLGRT-UHFFFAOYSA-N D09SFY DRUGSMIL C1=CC(=CC=C1C=NCCS(=O)(=O)N)O D09SFY HIGHSTAT Investigative D09SIW DRUG__ID D09SIW D09SIW DRUGTYPE Small molecular drug D09SIW DRUGINCH 1S/C12H18O3S/c1-2-3-4-5-6-16-9-10-7-11(13)12(14)8-15-10/h7-8,14H,2-6,9H2,1H3 D09SIW DRUGINKE TWEMRPGKBWBOSQ-UHFFFAOYSA-N D09SIW DRUGSMIL CCCCCCSCC1=CC(=O)C(=CO1)O D09SIW HIGHSTAT Investigative D09SJY DRUG__ID D09SJY D09SJY DRUGTYPE Small molecular drug D09SJY DRUGINCH 1S/C15H13NO2/c1-11-5-3-4-6-14(11)18-13-8-7-12(10-16)15(9-13)17-2/h3-9H,1-2H3 D09SJY DRUGINKE QZFFCZYDLZAYFR-UHFFFAOYSA-N D09SJY DRUGSMIL CC1=CC=CC=C1OC2=CC(=C(C=C2)C#N)OC D09SJY HIGHSTAT Investigative D09SOY DRUG__ID D09SOY D09SOY DRUGTYPE Small molecular drug D09SOY DRUGINCH 1S/C16H15N3O/c1-19-14(20)16(18-15(19)17,12-8-4-2-5-9-12)13-10-6-3-7-11-13/h2-11H,1H3,(H2,17,18) D09SOY DRUGINKE RNWLAFWLSSMCLN-UHFFFAOYSA-N D09SOY DRUGSMIL CN1C(=O)C(N=C1N)(C2=CC=CC=C2)C3=CC=CC=C3 D09SOY HIGHSTAT Investigative D09SUO DRUG__ID D09SUO D09SUO DRUGTYPE Small molecular drug D09SUO DRUGINCH 1S/C13H10O2/c14-13-8-6-11-10-4-2-1-3-9(10)5-7-12(11)15-13/h1-5,7H,6,8H2 D09SUO DRUGINKE ISFPDBUKMJDAJH-UHFFFAOYSA-N D09SUO DRUGSMIL C1CC(=O)OC2=C1C3=CC=CC=C3C=C2 D09SUO HIGHSTAT Investigative D09SUP DRUG__ID D09SUP D09SUP DRUGTYPE Small molecular drug D09SUP DRUGINCH 1S/C40H62ClN13O7S/c1-22(55)49-26(9-5-17-47-39(43)44)34(57)53-30(20-23-7-3-2-4-8-23)36(59)51-28-15-16-32-54(38(28)61)31(21-62-32)37(60)50-27(10-6-18-48-40(45)46)35(58)52-29(33(42)56)19-24-11-13-25(41)14-12-24/h11-14,23,26-32H,2-10,15-21H2,1H3,(H2,42,56)(H,49,55)(H,50,60)(H,51,59)(H,52,58)(H,53,57)(H4,43,44,47)(H4,45,46,48)/t26-,27+,28+,29+,30-,31+,32?/m0/s1 D09SUP DRUGINKE TVMPRXGFXMXJRH-DLYPAOLNSA-N D09SUP DRUGSMIL CC(=O)NC(CCCN=C(N)N)C(=O)NC(CC1CCCCC1)C(=O)NC2CCC3N(C2=O)C(CS3)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)Cl)C(=O)N D09SUP HIGHSTAT Investigative D09SUZ DRUG__ID D09SUZ D09SUZ DRUGTYPE Small molecular drug D09SUZ DRUGINCH 1S/C15H12N4O/c16-15-18-12-9-5-4-8-11(12)13(19-15)14(20)17-10-6-2-1-3-7-10/h1-9H,(H,17,20)(H2,16,18,19) D09SUZ DRUGINKE FXATZDLBKVHWOG-UHFFFAOYSA-N D09SUZ DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=NC(=NC3=CC=CC=C32)N D09SUZ HIGHSTAT Investigative D09SVH DRUG__ID D09SVH D09SVH DRUGTYPE Small molecular drug D09SVH DRUGINCH 1S/C14H20N2O4/c17-12(9-5-2-6-10-13(18)16-20)14(19)15-11-7-3-1-4-8-11/h1,3-4,7-8,12,17,20H,2,5-6,9-10H2,(H,15,19)(H,16,18) D09SVH DRUGINKE ZJKUBOBFXFZYHR-UHFFFAOYSA-N D09SVH DRUGSMIL C1=CC=C(C=C1)NC(=O)C(CCCCCC(=O)NO)O D09SVH HIGHSTAT Investigative D09SVQ DRUG__ID D09SVQ D09SVQ DRUGTYPE Small molecular drug D09SVQ DRUGINCH 1S/C13H9NO/c1-2-6-11-10(5-1)9-14-15-13-8-4-3-7-12(11)13/h1-9H D09SVQ DRUGINKE RVSGRNKUJJUAPV-UHFFFAOYSA-N D09SVQ DRUGSMIL C1=CC=C2C(=C1)C=NOC3=CC=CC=C23 D09SVQ HIGHSTAT Investigative D09SWM DRUG__ID D09SWM D09SWM DRUGTYPE Small molecular drug D09SWM DRUGINCH 1S/C22H31NO3/c1-18-8-6-16-14(15(18)7-9-20(18,3)25)5-10-22-19(16,2)11-13(12-23)17(24)21(22,4)26-22/h14-16,24-25H,5-11H2,1-4H3/t14-,15-,16-,18-,19+,20-,21+,22-/m0/s1 D09SWM DRUGINKE CETKWEWBSMKADK-GSXVSZIWSA-N D09SWM DRUGSMIL CC12CCC3C(C1CCC2(C)O)CCC45C3(CC(=C(C4(O5)C)O)C#N)C D09SWM HIGHSTAT Investigative D09SXJ DRUG__ID D09SXJ D09SXJ DRUGCOMP Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences D09SXJ DRUGINCH 1S/C59H94N20O21S2/c1-24(52(91)77-38(27(4)82)54(93)70-15-9-37-74-32(22-101-37)56-75-31(21-102-56)53(92)69-13-7-12-66-10-5-6-11-67-14-8-35(61)83)40(85)26(3)73-55(94)39(76-50-25(2)48(63)78-51(79-50)29(16-36(62)84)71-17-28(60)49(64)90)45(30-18-68-23-72-30)98-58-47(43(88)41(86)33(19-80)97-58)99-57-44(89)46(100-59(65)95)42(87)34(20-81)96-57/h18,21-24,26-29,33-34,38-47,57-58,66-67,71,80-82,85-89H,5-17,19-20,60H2,1-4H3,(H2,61,83)(H2,62,84)(H2,64,90)(H2,65,95)(H,68,72)(H,69,92)(H,70,93)(H,73,94)(H,77,91)(H3,63,76,78,79)/t24?,26?,27?,28?,29?,33-,34+,38?,39+,40?,41+,42+,43-,44-,45?,46-,47-,57-,58-/m0/s1 D09SXJ DRUGINKE KARUSHFAXMKMET-FOGSEAEJSA-N D09SXJ DRUGSMIL CC1=C(N=C(N=C1NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCCNCCCCNCCC(=O)N)O)C(CC(=O)N)NCC(C(=O)N)N)N D09SXJ HIGHSTAT Investigative D09SXM DRUG__ID D09SXM D09SXM DRUGTYPE Small molecular drug D09SXM DRUGINCH 1S/C17H18N4O/c1-11-6-8-13(9-7-11)12(2)19-17(22)20-15-4-3-5-16-14(15)10-18-21-16/h3-10,12H,1-2H3,(H,18,21)(H2,19,20,22)/t12-/m1/s1 D09SXM DRUGINKE SHOUDGQMQHLAFL-GFCCVEGCSA-N D09SXM DRUGSMIL CC1=CC=C(C=C1)C(C)NC(=O)NC2=CC=CC3=C2C=NN3 D09SXM HIGHSTAT Investigative D09SXN DRUG__ID D09SXN D09SXN DRUGTYPE Small molecular drug D09SXN DRUGINCH 1S/C5H12NO5P/c1-5(6,4(7)8)2-3-12(9,10)11/h2-3,6H2,1H3,(H,7,8)(H2,9,10,11)/t5-/m0/s1 D09SXN DRUGINKE HONKEGXLWUDTCF-YFKPBYRVSA-N D09SXN DRUGSMIL CC(CCP(=O)(O)O)(C(=O)O)N D09SXN HIGHSTAT Investigative D09SYK DRUG__ID D09SYK D09SYK DRUGTYPE Small molecular drug D09SYK DRUGINCH 1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20) D09SYK DRUGINKE IBYCYJFUEJQSMK-UHFFFAOYSA-N D09SYK DRUGSMIL CCN=C1NC2=C(C=C(C=C2)Cl)C(O1)(C)C3=CC=CC=C3 D09SYK HIGHSTAT Investigative D09SYW DRUG__ID D09SYW D09SYW DRUGTYPE Small molecular drug D09SYW DRUGINCH 1S/C15H14N2O4/c18-14(17-20)10-16-15(19)11-6-8-13(9-7-11)21-12-4-2-1-3-5-12/h1-9,20H,10H2,(H,16,19)(H,17,18) D09SYW DRUGINKE NBSITGWGPCATOG-UHFFFAOYSA-N D09SYW DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC(=O)NO D09SYW HIGHSTAT Investigative D09SZG DRUG__ID D09SZG D09SZG DRUGTYPE Small molecular drug D09SZG DRUGINCH 1S/C19H28N2O4S/c1-3-4-6-11-16(26)18(23)21-15(12-14-9-7-5-8-10-14)17(22)20-13(2)19(24)25/h5,7-10,13,15-16,26H,3-4,6,11-12H2,1-2H3,(H,20,22)(H,21,23)(H,24,25)/t13-,15-,16-/m0/s1 D09SZG DRUGINKE GOIYKVXXGCPHQU-BPUTZDHNSA-N D09SZG DRUGSMIL CCCCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)O)S D09SZG HIGHSTAT Investigative D09SZL DRUG__ID D09SZL D09SZL DRUGTYPE Small molecular drug D09SZL DRUGINCH 1S/C9H18O2S/c1-8(2,3)9(10)4-6-12(11)7-5-9/h10H,4-7H2,1-3H3 D09SZL DRUGINKE BKPWCHDEUGQJRG-UHFFFAOYSA-N D09SZL DRUGSMIL CC(C)(C)C1(CCS(=O)CC1)O D09SZL HIGHSTAT Investigative D09TBA DRUG__ID D09TBA D09TBA DRUGTYPE Small molecular drug D09TBA DRUGINCH 1S/C11H9ClN2O2/c12-9-8(10(15)14-11(16)13-9)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,13,14,15,16) D09TBA DRUGINKE LWRITIARHSTBLU-UHFFFAOYSA-N D09TBA DRUGSMIL C1=CC=C(C=C1)CC2=C(NC(=O)NC2=O)Cl D09TBA HIGHSTAT Investigative D09TBE DRUG__ID D09TBE D09TBE DRUGTYPE Small molecular drug D09TBE DRUGINCH 1S/C20H14O4/c1-22-20-15-9-10-23-17(15)12-18-19(20)16(21)11-14(24-18)8-7-13-5-3-2-4-6-13/h2-12H,1H3/b8-7+ D09TBE DRUGINKE HTBFQFPYNPJVLO-BQYQJAHWSA-N D09TBE DRUGSMIL COC1=C2C=COC2=CC3=C1C(=O)C=C(O3)C=CC4=CC=CC=C4 D09TBE HIGHSTAT Investigative D09TCT DRUG__ID D09TCT D09TCT DRUGTYPE Small molecular drug D09TCT DRUGINCH 1S/C37H45N7O6/c1-22(2)16-30(34(39)47)43-36(49)31(18-23-8-4-3-5-9-23)44-37(50)32(19-25-20-40-29-11-7-6-10-27(25)29)42-33(46)21-41-35(48)28(38)17-24-12-14-26(45)15-13-24/h3-15,20,22,28,30-32,40,45H,16-19,21,38H2,1-2H3,(H2,39,47)(H,41,48)(H,42,46)(H,43,49)(H,44,50)/t28-,30-,31-,32-/m0/s1 D09TCT DRUGINKE VGMSMMKQRJOPQL-MCEBTLFFSA-N D09TCT DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=C(C=C4)O)N D09TCT HIGHSTAT Investigative D09TDI DRUG__ID D09TDI D09TDI DRUGTYPE Small molecular drug D09TDI DRUGINCH 1S/C18H27NO2/c1-3-19(4-2)14-15-21-17(20)18(12-8-9-13-18)16-10-6-5-7-11-16/h5-7,10-11H,3-4,8-9,12-15H2,1-2H3 D09TDI DRUGINKE OFAIGZWCDGNZGT-UHFFFAOYSA-N D09TDI DRUGSMIL CCN(CC)CCOC(=O)C1(CCCC1)C2=CC=CC=C2 D09TDI HIGHSTAT Investigative D09TDK DRUG__ID D09TDK D09TDK DRUGTYPE Small molecular drug D09TDK DRUGINCH 1S/C14H9N3O/c1-9-13(6-12(8-16)14(18)17-9)11-4-2-10(7-15)3-5-11/h2-6H,1H3,(H,17,18) D09TDK DRUGINKE NMIRAZSAZYNODX-UHFFFAOYSA-N D09TDK DRUGSMIL CC1=C(C=C(C(=O)N1)C#N)C2=CC=C(C=C2)C#N D09TDK HIGHSTAT Investigative D09TDY DRUG__ID D09TDY D09TDY DRUGTYPE Small molecular drug D09TDY DRUGINCH 1S/C27H23N5O3/c33-22-10-17-13-32(21-5-1-4-20(30-22)24(17)21)14-23(34)29-18-7-6-15-11-27(12-16(15)9-18)19-3-2-8-28-25(19)31-26(27)35/h1-9,17H,10-14H2,(H,29,34)(H,30,33)(H,28,31,35)/t17?,27-/m0/s1 D09TDY DRUGINKE YMMTXWRRJUTBEI-LYTHVRBOSA-N D09TDY DRUGSMIL C1C2CN(C3=CC=CC(=C23)NC1=O)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4 D09TDY HIGHSTAT Investigative D09TES DRUG__ID D09TES D09TES DRUGTYPE Small molecular drug D09TES DRUGINCH 1S/C11H13NO4S/c1-7(13)12-10-4-8-2-3-11(17(14,15)16)6-9(8)5-10/h2-3,6,10H,4-5H2,1H3,(H,12,13)(H,14,15,16) D09TES DRUGINKE YEEWPYLDOKFULS-UHFFFAOYSA-N D09TES DRUGSMIL CC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)O D09TES HIGHSTAT Investigative D09TFN DRUG__ID D09TFN D09TFN DRUGTYPE Small molecular drug D09TFN DRUGINCH 1S/C30H26F2N4O5/c1-5-40-28-16-36(23-8-6-18(31)12-17(23)2)35-29(28)30(37)34-19-7-9-25(21(32)13-19)41-24-10-11-33-22-15-27(39-4)26(38-3)14-20(22)24/h6-16H,5H2,1-4H3,(H,34,37) D09TFN DRUGINKE ISPBCAXOSOLFME-UHFFFAOYSA-N D09TFN DRUGSMIL CCOC1=CN(N=C1C(=O)NC2=CC(=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)F)C5=C(C=C(C=C5)F)C D09TFN HIGHSTAT Investigative D09TJK DRUG__ID D09TJK D09TJK DRUGTYPE Small molecular drug D09TJK DRUGINCH 1S/C16H14N2O3/c17-11-12-2-1-3-13(8-12)15-9-14(19)10-16(21-15)18-4-6-20-7-5-18/h1-3,8-10H,4-7H2 D09TJK DRUGINKE IBXUISQIAHYEGD-UHFFFAOYSA-N D09TJK DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC(=C3)C#N D09TJK HIGHSTAT Investigative D09TKC DRUG__ID D09TKC D09TKC DRUGTYPE Small molecular drug D09TKC DRUGINCH 1S/C18H18N2O2S/c1-20-10-11-22-18(21,12-20)14-8-6-13(7-9-14)17-19-15-4-2-3-5-16(15)23-17/h2-9,21H,10-12H2,1H3 D09TKC DRUGINKE PJEBUKBZVKAKLF-UHFFFAOYSA-N D09TKC DRUGSMIL CN1CCOC(C1)(C2=CC=C(C=C2)C3=NC4=CC=CC=C4S3)O D09TKC HIGHSTAT Investigative D09TKG DRUG__ID D09TKG D09TKG DRUGTYPE Small molecular drug D09TKG DRUGINCH 1S/C8H11N3O2S/c1-2-4-11-7-3-5-10-6-8(7)14(9,12)13/h2-3,5-6H,1,4H2,(H,10,11)(H2,9,12,13) D09TKG DRUGINKE HYUSVYAJBKXAKB-UHFFFAOYSA-N D09TKG DRUGSMIL C=CCNC1=C(C=NC=C1)S(=O)(=O)N D09TKG HIGHSTAT Investigative D09TKN DRUG__ID D09TKN D09TKN DRUGTYPE Small molecular drug D09TKN DRUGINCH 1S/C27H32FNO4/c1-17(2)27-24(14-13-22(30)15-23(31)16-25(32)33)26(19-9-11-20(28)12-10-19)18(3)29(27)21-7-5-4-6-8-21/h4-12,17,22-23,30-31H,13-16H2,1-3H3,(H,32,33)/p-1/t22-,23-/m1/s1 D09TKN DRUGINKE JHURQXGATCGLIV-DHIUTWEWSA-M D09TKN DRUGSMIL CC1=C(C(=C(N1C2=CC=CC=C2)C(C)C)CCC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F D09TKN HIGHSTAT Investigative D09TNA DRUG__ID D09TNA D09TNA DRUGTYPE Small molecular drug D09TNA DRUGINCH 1S/C16H16N4/c17-14-3-1-2-11(8-14)10-20-7-6-12-9-13(16(18)19)4-5-15(12)20/h1-9H,10,17H2,(H3,18,19) D09TNA DRUGINKE PHWLXNIGOXPBJT-UHFFFAOYSA-N D09TNA DRUGSMIL C1=CC(=CC(=C1)N)CN2C=CC3=C2C=CC(=C3)C(=N)N D09TNA HIGHSTAT Investigative D09TNC DRUG__ID D09TNC D09TNC DRUGTYPE Small molecular drug D09TNC DRUGINCH 1S/C34H42N6O9/c1-3-4-14-27(33(48)39-25(17-29(42)43)32(47)38-24(31(35)46)15-20-10-6-5-7-11-20)40(2)34(49)26(37-28(41)18-30(44)45)16-21-19-36-23-13-9-8-12-22(21)23/h5-13,19,24-27,36H,3-4,14-18H2,1-2H3,(H2,35,46)(H,37,41)(H,38,47)(H,39,48)(H,42,43)(H,44,45)/t24-,25-,26-,27-/m0/s1 D09TNC DRUGINKE QUSCQANKQSFCGJ-FWEHEUNISA-N D09TNC DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CC(=O)O D09TNC HIGHSTAT Investigative D09TNR DRUG__ID D09TNR D09TNR DRUGCOMP Kirin Brewery Co Ltd D09TNR DRUGINCH 1S/C30H35N3O4/c1-30(2,3)21-5-7-22(8-6-21)33-23-9-11-24(12-10-23)37-27-13-14-32-26-20-29(28(35-4)19-25(26)27)36-18-16-31-15-17-34/h5-14,19-20,31,33-34H,15-18H2,1-4H3 D09TNR DRUGINKE VQCDZFWRGXFUMS-UHFFFAOYSA-N D09TNR DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC2=CC=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OCCNCCO)OC D09TNR HIGHSTAT Investigative D09TQE DRUG__ID D09TQE D09TQE DRUGTYPE Small molecular drug D09TQE DRUGINCH 1S/C13H8FNO3/c14-9-5-7(1-3-11(9)17)13-15-10-6-8(16)2-4-12(10)18-13/h1-6,16-17H D09TQE DRUGINKE GOGMBKCQZDIOLM-UHFFFAOYSA-N D09TQE DRUGSMIL C1=CC(=C(C=C1C2=NC3=C(O2)C=CC(=C3)O)F)O D09TQE HIGHSTAT Investigative D09TQO DRUG__ID D09TQO D09TQO DRUGTYPE Small molecular drug D09TQO DRUGINCH 1S/C88H138N26O44/c1-7-34(6)61(77(138)103-41(12-10-20-98-88(96)97)63(124)107-48(23-35(78(139)140)79(141)142)69(130)100-40(11-8-9-19-89)64(125)113-54(31-115)76(137)104-45(62(95)123)28-57(93)118)114-75(136)47(22-33(4)5)106-70(131)49(24-36(80(143)144)81(145)146)109-67(128)44(14-17-56(92)117)102-74(135)53(29-58(94)119)112-73(134)51(26-38(84(151)152)85(153)154)110-66(127)43(13-16-55(91)116)101-68(129)46(21-32(2)3)105-71(132)52(27-39(86(155)156)87(157)158)111-72(133)50(25-37(82(147)148)83(149)150)108-65(126)42(15-18-60(121)122)99-59(120)30-90/h32-54,61,115H,7-31,89-90H2,1-6H3,(H2,91,116)(H2,92,117)(H2,93,118)(H2,94,119)(H2,95,123)(H,99,120)(H,100,130)(H,101,129)(H,102,135)(H,103,138)(H,104,137)(H,105,132)(H,106,131)(H,107,124)(H,108,126)(H,109,128)(H,110,127)(H,111,133)(H,112,134)(H,113,125)(H,114,136)(H,121,122)(H,139,140)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,149,150)(H,151,152)(H,153,154)(H,155,156)(H,157,158)(H4,96,97,98)/t34-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,61-/m0/s1 D09TQO DRUGINKE HTBKFGWATIYCSF-QGXIKSNHSA-N D09TQO DRUGSMIL CCC(C)C(C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C(=O)O)C(=O)O)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CN D09TQO HIGHSTAT Investigative D09TQP DRUG__ID D09TQP D09TQP DRUGTYPE Small molecular drug D09TQP DRUGINCH 1S/C16H12N2/c1-2-6-11(7-3-1)15-14-10-12-8-4-5-9-13(12)16(14)18-17-15/h1-9H,10H2,(H,17,18) D09TQP DRUGINKE NZNCUNCNFCUBOK-UHFFFAOYSA-N D09TQP DRUGSMIL C1C2=CC=CC=C2C3=C1C(=NN3)C4=CC=CC=C4 D09TQP HIGHSTAT Investigative D09TRN DRUG__ID D09TRN D09TRN DRUGTYPE Small molecular drug D09TRN DRUGINCH 1S/C5H7N/c1-2-4-6-5-3-1/h1-4,6H,5H2 D09TRN DRUGINKE MMWRGWQTAMNAFC-UHFFFAOYSA-N D09TRN DRUGSMIL C1C=CC=CN1 D09TRN HIGHSTAT Investigative D09TSC DRUG__ID D09TSC D09TSC DRUGTYPE Small molecular drug D09TSC DRUGINCH 1S/C28H26N4O2/c1-30-12-16-11-23-24(19-8-4-6-10-22(19)32(23)14-17(16)13-30)26-25(27(33)29-28(26)34)20-15-31(2)21-9-5-3-7-18(20)21/h3-10,15-17H,11-14H2,1-2H3,(H,29,33,34)/t16-,17+/m0/s1 D09TSC DRUGINKE SAYMBMAHSBYKKR-DLBZAZTESA-N D09TSC DRUGSMIL CN1CC2CC3=C(C4=CC=CC=C4N3CC2C1)C5=C(C(=O)NC5=O)C6=CN(C7=CC=CC=C76)C D09TSC HIGHSTAT Investigative D09TTI DRUG__ID D09TTI D09TTI DRUGTYPE Small molecular drug D09TTI DRUGINCH 1S/C4H10N2O2/c5-2-1-3(6)4(7)8/h3H,1-2,5-6H2,(H,7,8) D09TTI DRUGINKE OGNSCSPNOLGXSM-UHFFFAOYSA-N D09TTI DRUGSMIL C(CN)C(C(=O)O)N D09TTI HIGHSTAT Investigative D09TTR DRUG__ID D09TTR D09TTR DRUGTYPE Small molecular drug D09TTR DRUGINCH 1S/C12H14N2/c1-2-5-12(6-3-1)7-4-9-14-10-8-13-11-14/h1-3,5-6,8,10-11H,4,7,9H2 D09TTR DRUGINKE DDGQVFKVBFAACE-UHFFFAOYSA-N D09TTR DRUGSMIL C1=CC=C(C=C1)CCCN2C=CN=C2 D09TTR HIGHSTAT Investigative D09TUB DRUG__ID D09TUB D09TUB DRUGTYPE Small molecular drug D09TUB DRUGINCH 1S/C20H20O4/c1-13(2)3-6-15-11-14(4-9-18(15)22)5-10-19(23)17-8-7-16(21)12-20(17)24/h3-5,7-12,21-22,24H,6H2,1-2H3/b10-5+ D09TUB DRUGINKE TVUGLERLRIQATC-BJMVGYQFSA-N D09TUB DRUGSMIL CC(=CCC1=C(C=CC(=C1)C=CC(=O)C2=C(C=C(C=C2)O)O)O)C D09TUB HIGHSTAT Investigative D09TVH DRUG__ID D09TVH D09TVH DRUGCOMP TCH Pharmaceuticals D09TVH DRUGINCH 1S/C31H30N2O2/c1-2-32-29(31(34)35-27-21-13-6-14-22-27)28(25-17-9-4-10-18-25)33(23-24-15-7-3-8-16-24)30(32)26-19-11-5-12-20-26/h3-22,28-30H,2,23H2,1H3/t28-,29-,30?/m1/s1 D09TVH DRUGINKE XNGZTFZUVIAPCL-HPSQJEMFSA-N D09TVH DRUGSMIL CCN1C(C(N(C1C2=CC=CC=C2)CC3=CC=CC=C3)C4=CC=CC=C4)C(=O)OC5=CC=CC=C5 D09TVH HIGHSTAT Investigative D09TVP DRUG__ID D09TVP D09TVP DRUGTYPE Small molecular drug D09TVP DRUGINCH 1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5)/p-1 D09TVP DRUGINKE OGGXGZAMXPVRFZ-UHFFFAOYSA-M D09TVP DRUGSMIL C[As](=O)(C)[O-] D09TVP HIGHSTAT Investigative D09TWW DRUG__ID D09TWW D09TWW DRUGTYPE Small molecular drug D09TWW DRUGINCH 1S/C23H29FO5/c24-16-7-10-18(11-8-16)28-15-17(25)9-12-20-19(21-13-14-22(20)29-21)5-3-1-2-4-6-23(26)27/h1,3,7-12,17,19-22,25H,2,4-6,13-15H2,(H,26,27)/b3-1-,12-9+/t17-,19+,20+,21-,22+/m0/s1 D09TWW DRUGINKE JEUSDRLWFSRHSX-XUEDOEMRSA-N D09TWW DRUGSMIL C1CC2C(C(C1O2)CC=CCCCC(=O)O)C=CC(COC3=CC=C(C=C3)F)O D09TWW HIGHSTAT Investigative D09UBS DRUG__ID D09UBS D09UBS DRUGTYPE Small molecular drug D09UBS DRUGINCH 1S/C17H19Cl2N3O/c18-14-8-5-9-15(19)17(14)16(10-22-12-20-11-21-22)23-13-6-3-1-2-4-7-13/h5,8-13H,1-4,6-7H2/b16-10- D09UBS DRUGINKE STCVFKBRXOEQRF-YBEGLDIGSA-N D09UBS DRUGSMIL C1CCCC(CC1)OC(=CN2C=NC=N2)C3=C(C=CC=C3Cl)Cl D09UBS HIGHSTAT Investigative D09UDF DRUG__ID D09UDF D09UDF DRUGTYPE Small molecular drug D09UDF DRUGINCH 1S/C10H5ClN2S2/c11-10-12-6-3-5-15-9(6)8(13-10)7-2-1-4-14-7/h1-5H D09UDF DRUGINKE GFDPXLUZWJSHBL-UHFFFAOYSA-N D09UDF DRUGSMIL C1=CSC(=C1)C2=NC(=NC3=C2SC=C3)Cl D09UDF HIGHSTAT Investigative D09UKS DRUG__ID D09UKS D09UKS DRUGTYPE Small molecular drug D09UKS DRUGINCH 1S/C22H29N3S/c23-21-24-18-12-17-15(11-20(18)26-21)10-19-16-6-1-2-7-22(16,17)8-9-25(19)13-14-4-3-5-14/h11-12,14,16,19H,1-10,13H2,(H2,23,24)/t16-,19+,22+/m0/s1 D09UKS DRUGINKE HEIQNYAVPBPIJD-DKZVUGQWSA-N D09UKS DRUGSMIL C1CCC23CCN(C(C2C1)CC4=CC5=C(C=C34)N=C(S5)N)CC6CCC6 D09UKS HIGHSTAT Investigative D09ULA DRUG__ID D09ULA D09ULA DRUGTYPE Small molecular drug D09ULA DRUGINCH 1S/C24H29N3O2/c1-18-5-3-6-23(19(18)2)27-14-12-26(13-15-27)11-4-16-29-21-9-7-20-8-10-24(28)25-22(20)17-21/h3,5-10,17H,4,11-16H2,1-2H3,(H,25,28) D09ULA DRUGINKE RRLWEQBPSAFVAS-UHFFFAOYSA-N D09ULA DRUGSMIL CC1=C(C(=CC=C1)N2CCN(CC2)CCCOC3=CC4=C(C=C3)C=CC(=O)N4)C D09ULA HIGHSTAT Investigative D09ULU DRUG__ID D09ULU D09ULU DRUGTYPE Small molecular drug D09ULU DRUGINCH 1S/C14H15NO3S/c1-2-15(12-6-4-3-5-7-12)19(17,18)14-10-8-13(16)9-11-14/h3-11,16H,2H2,1H3 D09ULU DRUGINKE VGVYBVTUILCGFQ-UHFFFAOYSA-N D09ULU DRUGSMIL CCN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O D09ULU HIGHSTAT Investigative D09UND DRUG__ID D09UND D09UND DRUGTYPE Small molecular drug D09UND DRUGINCH 1S/C28H24O2/c29-27-18-12-22-6-5-20-8-14-24(15-9-20)26-4-2-1-3-23(26)13-7-21-10-16-25(17-11-21)30-28(27)19-22/h1-4,8-12,14-19,29H,5-7,13H2 D09UND DRUGINKE CTGIBRGBEVEPID-UHFFFAOYSA-N D09UND DRUGSMIL C1CC2=CC(=C(C=C2)O)OC3=CC=C(CCC4=CC=CC=C4C5=CC=C1C=C5)C=C3 D09UND HIGHSTAT Investigative D09UQM DRUG__ID D09UQM D09UQM DRUGTYPE Small molecular drug D09UQM DRUGINCH 1S/C7H6Cl2N2O2/c8-5-2-1-4(3-6(5)9)10-7(12)11-13/h1-3,13H,(H2,10,11,12) D09UQM DRUGINKE VKYZMAVGJARVPE-UHFFFAOYSA-N D09UQM DRUGSMIL C1=CC(=C(C=C1NC(=O)NO)Cl)Cl D09UQM HIGHSTAT Investigative D09UQU DRUG__ID D09UQU D09UQU DRUGTYPE Small molecular drug D09UQU DRUGINCH 1S/C32H35NO5/c1-34-24-11-13-28-29(20-24)37-18-14-27-26-12-10-25(35-2)21-30(26)38-32(31(27)28)22-6-8-23(9-7-22)36-19-17-33-15-4-3-5-16-33/h6-13,20-21,32H,3-5,14-19H2,1-2H3/t32-/m1/s1 D09UQU DRUGINKE IFCSDJGUXGRSFR-JGCGQSQUSA-N D09UQU DRUGSMIL COC1=CC2=C(C=C1)C3=C(C(O2)C4=CC=C(C=C4)OCCN5CCCCC5)C6=C(C=C(C=C6)OC)OCC3 D09UQU HIGHSTAT Investigative D09USO DRUG__ID D09USO D09USO DRUGTYPE Small molecular drug D09USO DRUGINCH 1S/C13H15NO6P2/c15-21(16,17)13(22(18,19)20)14-12-8-4-7-11(9-12)10-5-2-1-3-6-10/h1-9,13-14H,(H2,15,16,17)(H2,18,19,20) D09USO DRUGINKE IXFMBXNLOHKCPT-UHFFFAOYSA-N D09USO DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)NC(P(=O)(O)O)P(=O)(O)O D09USO HIGHSTAT Investigative D09UTR DRUG__ID D09UTR D09UTR DRUGTYPE Small molecular drug D09UTR DRUGINCH 1S/C13H9ClN2S/c14-9-4-6-10(7-5-9)17-13-3-1-2-12(16)11(13)8-15/h1-7H,16H2 D09UTR DRUGINKE GYICYNRXLTUTRB-UHFFFAOYSA-N D09UTR DRUGSMIL C1=CC(=C(C(=C1)SC2=CC=C(C=C2)Cl)C#N)N D09UTR HIGHSTAT Investigative D09UUC DRUG__ID D09UUC D09UUC DRUGTYPE Small molecular drug D09UUC DRUGINCH 1S/C41H55N11O7/c42-36(55)29-14-6-7-19-45-34(53)17-18-35(54)52-21-9-16-33(52)40(59)51-31(22-25-10-2-1-3-11-25)38(57)49-30(15-8-20-46-41(43)44)37(56)50-32(39(58)48-29)23-26-24-47-28-13-5-4-12-27(26)28/h1-5,10-13,24,29-33,47H,6-9,14-23H2,(H2,42,55)(H,45,53)(H,48,58)(H,49,57)(H,50,56)(H,51,59)(H4,43,44,46)/t29-,30+,31-,32-,33+/m0/s1 D09UUC DRUGINKE RSZGGZUMSYSTES-HJCKZFGESA-N D09UUC DRUGSMIL C1CCNC(=O)CCC(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC=CC=C5 D09UUC HIGHSTAT Investigative D09UVB DRUG__ID D09UVB D09UVB DRUGTYPE Small molecular drug D09UVB DRUGINCH 1S/C19H25F3N4O/c1-14(24-11-10-17-12-23-13-25-17)4-2-3-5-18(27)26-16-8-6-15(7-9-16)19(20,21)22/h6-9,12-14,24H,2-5,10-11H2,1H3,(H,23,25)(H,26,27) D09UVB DRUGINKE PMKJGGBYYNEYPA-UHFFFAOYSA-N D09UVB DRUGSMIL CC(CCCCC(=O)NC1=CC=C(C=C1)C(F)(F)F)NCCC2=CN=CN2 D09UVB HIGHSTAT Investigative D09UWI DRUG__ID D09UWI D09UWI DRUGTYPE Small molecular drug D09UWI DRUGINCH 1S/C16H12O2S/c17-13-5-1-11(2-6-13)15-9-10-16(19-15)12-3-7-14(18)8-4-12/h1-10,17-18H D09UWI DRUGINKE KZMOBYGIRBRCFV-UHFFFAOYSA-N D09UWI DRUGSMIL C1=CC(=CC=C1C2=CC=C(S2)C3=CC=C(C=C3)O)O D09UWI HIGHSTAT Investigative D09UXA DRUG__ID D09UXA D09UXA DRUGTYPE Small molecular drug D09UXA DRUGINCH 1S/C10H19NO2/c1-7-3-10(6-11,4-8(7)2)5-9(12)13/h7-8H,3-6,11H2,1-2H3,(H,12,13)/t7-,8-/m0/s1 D09UXA DRUGINKE IUVMAUQEZFTTFB-YUMQZZPRSA-N D09UXA DRUGSMIL CC1CC(CC1C)(CC(=O)O)CN D09UXA HIGHSTAT Investigative D09UXZ DRUG__ID D09UXZ D09UXZ DRUGTYPE Small molecular drug D09UXZ DRUGINCH 1S/C12H12N2O2/c15-12(16)11-8-10(13-14-11)7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H,13,14)(H,15,16) D09UXZ DRUGINKE HHEBXMNODWRUEV-UHFFFAOYSA-N D09UXZ DRUGSMIL C1=CC=C(C=C1)CCC2=CC(=NN2)C(=O)O D09UXZ HIGHSTAT Investigative D09VFQ DRUG__ID D09VFQ D09VFQ DRUGTYPE Small molecular drug D09VFQ DRUGINCH 1S/C23H17N3O2/c1-26(2)14-9-7-13(8-10-14)23-24-18-12-11-17-19(20(18)25-23)22(28)16-6-4-3-5-15(16)21(17)27/h3-12H,1-2H3,(H,24,25) D09VFQ DRUGINKE ILPRDEDKIAQCMC-UHFFFAOYSA-N D09VFQ DRUGSMIL CN(C)C1=CC=C(C=C1)C2=NC3=C(N2)C=CC4=C3C(=O)C5=CC=CC=C5C4=O D09VFQ HIGHSTAT Investigative D09VHW DRUG__ID D09VHW D09VHW DRUGTYPE Small molecular drug D09VHW DRUGINCH 1S/C5H5N3O2/c6-4(9)3-5(10)8-2-1-7-3/h1-2H,(H2,6,9)(H,8,10) D09VHW DRUGINKE SZPBAPFUXAADQV-UHFFFAOYSA-N D09VHW DRUGSMIL C1=CN=C(C(=O)N1)C(=O)N D09VHW HIGHSTAT Investigative D09VJI DRUG__ID D09VJI D09VJI DRUGTYPE Small molecular drug D09VJI DRUGINCH 1S/C37H50N2O10/c1-7-38-17-34(18-49-32(42)20-10-8-9-11-23(20)39-26(40)14-19(2)31(39)41)13-12-25(46-4)36-22-15-21-24(45-3)16-35(43,27(22)28(21)47-5)37(44,33(36)38)30(48-6)29(34)36/h8-11,19,21-22,24-25,27-30,33,43-44H,7,12-18H2,1-6H3/t19-,21+,22+,24-,25-,27+,28-,29+,30-,33-,34-,35+,36-,37+/m0/s1 D09VJI DRUGINKE XLTANAWLDBYGFU-VTLKBQQISA-N D09VJI DRUGSMIL CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N8C(=O)CC(C8=O)C D09VJI HIGHSTAT Investigative D09VKI DRUG__ID D09VKI D09VKI DRUGTYPE Small molecular drug D09VKI DRUGINCH 1S/C20H32O4/c1-2-3-4-5-6-10-13-18-19(24-18)16-15-17(21)12-9-7-8-11-14-20(22)23/h6-7,9-10,15-19,21H,2-5,8,11-14H2,1H3,(H,22,23)/b9-7-,10-6-,16-15+/t17?,18-,19?/m0/s1 D09VKI DRUGINKE SGTUOBURCVMACZ-UIKNIFMXSA-N D09VKI DRUGSMIL CCCCCC=CCC1C(O1)C=CC(CC=CCCCC(=O)O)O D09VKI HIGHSTAT Investigative D09VLE DRUG__ID D09VLE D09VLE DRUGTYPE Small molecular drug D09VLE DRUGINCH 1S/C28H24O/c1-2-7-28-24(5-1)15-10-22-13-18-26(19-14-22)29-27-6-3-4-23(20-27)9-8-21-11-16-25(28)17-12-21/h1-7,11-14,16-20H,8-10,15H2 D09VLE DRUGINKE VHGMCOKOKWHSEA-UHFFFAOYSA-N D09VLE DRUGSMIL C1CC2=CC(=CC=C2)OC3=CC=C(CCC4=CC=CC=C4C5=CC=C1C=C5)C=C3 D09VLE HIGHSTAT Investigative D09VMS DRUG__ID D09VMS D09VMS DRUGTYPE Small molecular drug D09VMS DRUGINCH 1S/C22H26O7/c1-24-19-9-14(10-20(25-2)21(19)26-3)7-16-15(11-27-22(16)23)6-13-4-5-17-18(8-13)29-12-28-17/h4-5,8-10,15-16,22-23H,6-7,11-12H2,1-3H3/t15-,16+,22?/m0/s1 D09VMS DRUGINKE SOCNBZCAGNYAED-OKFXBHNASA-N D09VMS DRUGSMIL COC1=CC(=CC(=C1OC)OC)CC2C(COC2O)CC3=CC4=C(C=C3)OCO4 D09VMS HIGHSTAT Investigative D09VOI DRUG__ID D09VOI D09VOI DRUGTYPE Small molecular drug D09VOI DRUGINCH 1S/C16H28N4O8/c21-13(22)9-17-1-2-18(10-14(23)24)5-6-20(12-16(27)28)8-7-19(4-3-17)11-15(25)26/h1-12H2,(H,21,22)(H,23,24)(H,25,26)(H,27,28) D09VOI DRUGINKE WDLRUFUQRNWCPK-UHFFFAOYSA-N D09VOI DRUGSMIL C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O D09VOI HIGHSTAT Investigative D09VOP DRUG__ID D09VOP D09VOP DRUGTYPE Small molecular drug D09VOP DRUGINCH 1S/C21H24N6O6/c1-31-11-2-3-13-12(6-11)10(7-23-13)4-5-32-21-25-18(22)15-19(26-21)27(9-24-15)20-17(30)16(29)14(8-28)33-20/h2-3,6-7,9,14,16-17,20,23,28-30H,4-5,8H2,1H3,(H2,22,25,26)/t14-,16-,17-,20-/m1/s1 D09VOP DRUGINKE HIDGDYNRSPJOMR-WVSUBDOOSA-N D09VOP DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D09VOP HIGHSTAT Investigative D09VPA DRUG__ID D09VPA D09VPA DRUGTYPE Small molecular drug D09VPA DRUGINCH 1S/C15H12BrN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9+ D09VPA DRUGINKE MNQUPNOEJZVKRD-FMIVXFBMSA-N D09VPA DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)Br D09VPA HIGHSTAT Investigative D09VPJ DRUG__ID D09VPJ D09VPJ DRUGTYPE Small molecular drug D09VPJ DRUGINCH 1S/C15H10F2N2/c1-9-2-3-10-4-5-14(19-15(10)18-9)11-6-12(16)8-13(17)7-11/h2-8H,1H3 D09VPJ DRUGINKE ODEYWYKLTXXLRT-UHFFFAOYSA-N D09VPJ DRUGSMIL CC1=NC2=C(C=C1)C=CC(=N2)C3=CC(=CC(=C3)F)F D09VPJ HIGHSTAT Investigative D09VPP DRUG__ID D09VPP D09VPP DRUGTYPE Small molecular drug D09VPP DRUGINCH 1S/C30H46O4/c1-17-8-13-30(25(33)34)15-14-28(6)19(23(30)18(17)2)16-20(31)24-27(5)11-10-22(32)26(3,4)21(27)9-12-29(24,28)7/h16-18,21-24,32H,8-15H2,1-7H3,(H,33,34)/t17-,18+,21+,22+,23+,24-,27+,28-,29-,30+/m1/s1 D09VPP DRUGINKE MDQJVSLVPQYJLP-HUWCOUCRSA-N D09VPP DRUGSMIL CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)O D09VPP HIGHSTAT Investigative D09VQM DRUG__ID D09VQM D09VQM DRUGTYPE Small molecular drug D09VQM DRUGINCH 1S/C27H32O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-7,10,16,18,20-30,32-36H,8-9H2,1H3/t10-,16-,18+,20-,21+,22+,23-,24+,25+,26-,27+/m0/s1 D09VQM DRUGINKE DFPMSGMNTNDNHN-ZPHOTFPESA-N D09VQM DRUGSMIL CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O D09VQM HIGHSTAT Investigative D09VQZ DRUG__ID D09VQZ D09VQZ DRUGTYPE Small molecular drug D09VQZ DRUGINCH 1S/C18H13F2N/c19-17-6-5-16(12-18(17)20)15-3-1-13(2-4-15)11-14-7-9-21-10-8-14/h1-10,12H,11H2 D09VQZ DRUGINKE KREPMUWCVWQPGH-UHFFFAOYSA-N D09VQZ DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)F)F D09VQZ HIGHSTAT Investigative D09VRT DRUG__ID D09VRT D09VRT DRUGTYPE Small molecular drug D09VRT DRUGINCH 1S/C25H27NO/c27-25(23-14-8-3-9-15-23)16-18-26(19-17-25)24(22-12-6-2-7-13-22)20-21-10-4-1-5-11-21/h1-15,24,27H,16-20H2 D09VRT DRUGINKE FEOIETAFCTYQIE-UHFFFAOYSA-N D09VRT DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)O)C(CC3=CC=CC=C3)C4=CC=CC=C4 D09VRT HIGHSTAT Investigative D09VRX DRUG__ID D09VRX D09VRX DRUGTYPE Small molecular drug D09VRX DRUGINCH 1S/C16H12N4/c1-10-5-4-8-13-15(10)20-16(19-13)14-9-17-11-6-2-3-7-12(11)18-14/h2-9H,1H3,(H,19,20) D09VRX DRUGINKE HQNVISKJTIKRQJ-UHFFFAOYSA-N D09VRX DRUGSMIL CC1=C2C(=CC=C1)NC(=N2)C3=NC4=CC=CC=C4N=C3 D09VRX HIGHSTAT Investigative D09VSK DRUG__ID D09VSK D09VSK DRUGTYPE Small molecular drug D09VSK DRUGINCH 1S/C15H14N2/c16-13-7-5-11(6-8-13)9-12-10-17-15-4-2-1-3-14(12)15/h1-8,10,17H,9,16H2 D09VSK DRUGINKE KDXYOBVEKNURNB-UHFFFAOYSA-N D09VSK DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC3=CC=C(C=C3)N D09VSK HIGHSTAT Investigative D09VSL DRUG__ID D09VSL D09VSL DRUGTYPE Small molecular drug D09VSL DRUGINCH 1S/C17H29N3O/c21-16(19-11-12-1-3-18-4-2-12)20-17-8-13-5-14(9-17)7-15(6-13)10-17/h12-15,18H,1-11H2,(H2,19,20,21) D09VSL DRUGINKE ZQMNKAGVCNSSIW-UHFFFAOYSA-N D09VSL DRUGSMIL C1CNCCC1CNC(=O)NC23CC4CC(C2)CC(C4)C3 D09VSL HIGHSTAT Investigative D09VTJ DRUG__ID D09VTJ D09VTJ DRUGTYPE Small molecular drug D09VTJ DRUGINCH 1S/C35H52O4/c1-22(2)13-12-19-33(11)27(16-14-23(3)4)21-34(20-18-25(7)8)30(37)28(17-15-24(5)6)31(38)35(33,32(34)39)29(36)26(9)10/h13-15,18,26-27,37H,12,16-17,19-21H2,1-11H3/t27-,33+,34+,35-/m0/s1 D09VTJ DRUGINKE KGSZHKRKHXOAMG-HQKKAZOISA-N D09VTJ DRUGSMIL CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C D09VTJ HIGHSTAT Investigative D09VTR DRUG__ID D09VTR D09VTR DRUGTYPE Small molecular drug D09VTR DRUGINCH 1S/C15H23NO2S/c1-15(2,3)12-6-4-11(5-7-12)10-19-9-8-13(16)14(17)18/h4-7,13H,8-10,16H2,1-3H3,(H,17,18) D09VTR DRUGINKE BAHGAZBQXUXBJR-UHFFFAOYSA-N D09VTR DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CSCCC(C(=O)O)N D09VTR HIGHSTAT Investigative D09VTV DRUG__ID D09VTV D09VTV DRUGTYPE Small molecular drug D09VTV DRUGINCH 1S/C33H51N2O6P.H3N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-33(36)35-31(28-41-42(37,38)39)26-29-21-23-32(24-22-29)40-27-30-19-17-18-25-34-30;/h9-10,17-19,21-25,31H,2-8,11-16,20,26-28H2,1H3,(H,35,36)(H2,37,38,39);1H3/b10-9-;/t31-;/m1./s1 D09VTV DRUGINKE CIWOPVRNKVCACF-FJRCUGBNSA-N D09VTV DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC(CC1=CC=C(C=C1)OCC2=CC=CC=N2)COP(=O)(O)[O-].[NH4+] D09VTV HIGHSTAT Investigative D09VTY DRUG__ID D09VTY D09VTY DRUGTYPE Small molecular drug D09VTY DRUGINCH 1S/C24H30N4O/c1-17(2)28-22-7-5-4-6-20(22)21-16-19(8-9-23(21)28)26-24(29)27(3)15-12-18-10-13-25-14-11-18/h8-11,13-14,16-17H,4-7,12,15H2,1-3H3,(H,26,29) D09VTY DRUGINKE YLNOMVNCZMWDST-UHFFFAOYSA-N D09VTY DRUGSMIL CC(C)N1C2=C(CCCC2)C3=C1C=CC(=C3)NC(=O)N(C)CCC4=CC=NC=C4 D09VTY HIGHSTAT Investigative D09VWK DRUG__ID D09VWK D09VWK DRUGTYPE Small molecular drug D09VWK DRUGINCH 1S/C18H18O/c1-12-5-4-6-13(9-12)14-7-8-15-16(10-14)18(2,3)11-17(15)19/h4-10H,11H2,1-3H3 D09VWK DRUGINKE IQXQUXAACBOTRO-UHFFFAOYSA-N D09VWK DRUGSMIL CC1=CC(=CC=C1)C2=CC3=C(C=C2)C(=O)CC3(C)C D09VWK HIGHSTAT Investigative D09VYB DRUG__ID D09VYB D09VYB DRUGTYPE Small molecular drug D09VYB DRUGINCH 1S/C15H15N3O6/c16-11(14(22)23)8-17-6-5-12(19)18(15(17)24)7-9-3-1-2-4-10(9)13(20)21/h1-6,11H,7-8,16H2,(H,20,21)(H,22,23)/t11-/m0/s1 D09VYB DRUGINKE UUIYULWYHDSXHL-NSHDSACASA-N D09VYB DRUGSMIL C1=CC=C(C(=C1)CN2C(=O)C=CN(C2=O)CC(C(=O)O)N)C(=O)O D09VYB HIGHSTAT Investigative D09VYW DRUG__ID D09VYW D09VYW DRUGTYPE Small molecular drug D09VYW DRUGINCH 1S/C30H46O4/c1-17-8-11-26(3)14-15-28(5)19(23(26)18(17)2)16-20(31)24-27(4)12-10-22(32)30(7,25(33)34)21(27)9-13-29(24,28)6/h16-18,21-24,32H,8-15H2,1-7H3,(H,33,34)/t17-,18+,21-,22-,23+,24-,26-,27+,28-,29-,30-/m1/s1 D09VYW DRUGINKE YIMHGPSYDOGBPI-YZCVQEKWSA-N D09VYW DRUGSMIL CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C D09VYW HIGHSTAT Investigative D09WBJ DRUG__ID D09WBJ D09WBJ DRUGTYPE Small molecular drug D09WBJ DRUGINCH 1S/C18H19ClN4/c19-15-4-6-17(7-5-15)22-11-9-21(10-12-22)14-16-13-18-3-1-2-8-23(18)20-16/h1-8,13H,9-12,14H2 D09WBJ DRUGINKE DTRXURJDKOYCCD-UHFFFAOYSA-N D09WBJ DRUGSMIL C1CN(CCN1CC2=NN3C=CC=CC3=C2)C4=CC=C(C=C4)Cl D09WBJ HIGHSTAT Investigative D09WBM DRUG__ID D09WBM D09WBM DRUGTYPE Small molecular drug D09WBM DRUGINCH 1S/C86H97Cl3N10O26.2H3O4P/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114;2*1-5(2,3)4/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117);2*(H3,1,2,3,4)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66+,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-;;/m0../s1 D09WBM DRUGINKE PWTROOMOPLCZHB-UBFSLMEUSA-N D09WBM DRUGSMIL CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C(C=C1)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O.OP(=O)(O)O.OP(=O)(O)O D09WBM HIGHSTAT Investigative D09WCC DRUG__ID D09WCC D09WCC DRUGCOMP Molecular Partners AG D09WCC DRUGINCH 1S/C8H9BrO2/c1-10-7-3-6(9)4-8(5-7)11-2/h3-5H,1-2H3 D09WCC DRUGINKE KRWRFIMBWRVMKE-UHFFFAOYSA-N D09WCC DRUGSMIL COC1=CC(=CC(=C1)Br)OC D09WCC HIGHSTAT Investigative D09WED DRUG__ID D09WED D09WED DRUGTYPE Small molecular drug D09WED DRUGINCH 1S/C40H38O9/c1-21(2)4-11-28-34(45)18-24(19-35(28)46)39(48)37-30(27-12-10-26(42)20-36(27)47)16-22(3)17-31(37)38-33(44)15-13-29(40(38)49)32(43)14-7-23-5-8-25(41)9-6-23/h4-10,12-15,17-20,30-31,37,41-42,44-47,49H,11,16H2,1-3H3/b14-7+/t30-,31+,37-/m1/s1 D09WED DRUGINKE PXFKYAIDSYKIJA-DLBCFTNOSA-N D09WED DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=CC(=C(C(=C3)O)CC=C(C)C)O)C4=C(C=CC(=C4O)C(=O)C=CC5=CC=C(C=C5)O)O D09WED HIGHSTAT Investigative D09WEK DRUG__ID D09WEK D09WEK DRUGTYPE Small molecular drug D09WEK DRUGINCH 1S/C20H15ClN2O/c21-18-8-4-7-17-19(15-9-11-16(24)12-10-15)22-23(20(17)18)13-14-5-2-1-3-6-14/h1-12,24H,13H2 D09WEK DRUGINKE DPRKSCQCEZRMAF-UHFFFAOYSA-N D09WEK DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C=CC=C3Cl)C(=N2)C4=CC=C(C=C4)O D09WEK HIGHSTAT Investigative D09WIL DRUG__ID D09WIL D09WIL DRUGTYPE Small molecular drug D09WIL DRUGINCH 1S/C25H30ClN3O3S/c26-20-4-6-22(7-5-20)32-23-11-16-28(17-12-23)15-10-21-2-1-14-29(21)33(30,31)24-8-3-19-9-13-27-25(19)18-24/h3-9,13,18,21,23,27H,1-2,10-12,14-17H2/t21-/m1/s1 D09WIL DRUGINKE QEGMGDYIJDZJCI-OAQYLSRUSA-N D09WIL DRUGSMIL C1CC(N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)OC5=CC=C(C=C5)Cl D09WIL HIGHSTAT Investigative D09WJO DRUG__ID D09WJO D09WJO DRUGTYPE Small molecular drug D09WJO DRUGINCH 1S/C8H11NO2S/c9-5-6(4-8(10)11)7-2-1-3-12-7/h1-3,6H,4-5,9H2,(H,10,11) D09WJO DRUGINKE QDVRXIPQICAUFK-UHFFFAOYSA-N D09WJO DRUGSMIL C1=CSC(=C1)C(CC(=O)O)CN D09WJO HIGHSTAT Investigative D09WNM DRUG__ID D09WNM D09WNM DRUGTYPE Small molecular drug D09WNM DRUGINCH 1S/C14H13O5P/c15-10-13-8-4-5-9-14(13)19-20(16,17)18-11-12-6-2-1-3-7-12/h1-10H,11H2,(H,16,17) D09WNM DRUGINKE PWDTUFYQEUEVQD-UHFFFAOYSA-N D09WNM DRUGSMIL C1=CC=C(C=C1)COP(=O)(O)OC2=CC=CC=C2C=O D09WNM HIGHSTAT Investigative D09WOX DRUG__ID D09WOX D09WOX DRUGTYPE Small molecular drug D09WOX DRUGINCH 1S/C17H12N2O2S/c18-11-14-15(19)8-4-10-17(14)22(20,21)16-9-3-6-12-5-1-2-7-13(12)16/h1-10H,19H2 D09WOX DRUGINKE BMSIRAVUGDDUKN-UHFFFAOYSA-N D09WOX DRUGSMIL C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)C3=CC=CC(=C3C#N)N D09WOX HIGHSTAT Investigative D09WPX DRUG__ID D09WPX D09WPX DRUGTYPE Small molecular drug D09WPX DRUGINCH 1S/C18H10FN5O/c19-13-7-5-11(6-8-13)16-12(9-20)10-21-17(23-16)24-18-22-14-3-1-2-4-15(14)25-18/h1-8,10H,(H,21,22,23,24) D09WPX DRUGINKE OBFRNKSPNQSVFR-UHFFFAOYSA-N D09WPX DRUGSMIL C1=CC=C2C(=C1)N=C(O2)NC3=NC=C(C(=N3)C4=CC=C(C=C4)F)C#N D09WPX HIGHSTAT Investigative D09WQL DRUG__ID D09WQL D09WQL DRUGTYPE Small molecular drug D09WQL DRUGINCH 1S/C9H9N3/c1-3-10-4-2-8(1)5-9-6-11-7-12-9/h1-4,6-7H,5H2,(H,11,12) D09WQL DRUGINKE DFVSGZHJSIEEQQ-UHFFFAOYSA-N D09WQL DRUGSMIL C1=CN=CC=C1CC2=CN=CN2 D09WQL HIGHSTAT Investigative D09WQW DRUG__ID D09WQW D09WQW DRUGTYPE Small molecular drug D09WQW DRUGINCH 1S/C13H24N2O3/c16-12(17)9-5-2-6-10-14-13(18)15-11-7-3-1-4-8-11/h11H,1-10H2,(H,16,17)(H2,14,15,18) D09WQW DRUGINKE KFTVEPYSUSWBRD-UHFFFAOYSA-N D09WQW DRUGSMIL C1CCC(CC1)NC(=O)NCCCCCC(=O)O D09WQW HIGHSTAT Investigative D09WSG DRUG__ID D09WSG D09WSG DRUGTYPE Small molecular drug D09WSG DRUGINCH 1S/C29H34O8/c1-28-11-9-20-27(32)37-23(19-10-12-34-16-19)14-29(20,2)25(28)24(30)22(13-21(28)26(31)33-3)36-17-35-15-18-7-5-4-6-8-18/h4-8,10,12,16,20-23,25H,9,11,13-15,17H2,1-3H3/t20-,21-,22-,23-,25-,28-,29-/m0/s1 D09WSG DRUGINKE UEIIMJAHRTUJMW-ZZIVESEQSA-N D09WSG DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOCC4=CC=CC=C4)C)C5=COC=C5 D09WSG HIGHSTAT Investigative D09WSJ DRUG__ID D09WSJ D09WSJ DRUGTYPE Small molecular drug D09WSJ DRUGINCH 1S/C10H23NO3S/c1-2-3-4-5-6-7-8-9-10-14-15(11,12)13/h2-10H2,1H3,(H2,11,12,13) D09WSJ DRUGINKE JBKMRMOTMJVNML-UHFFFAOYSA-N D09WSJ DRUGSMIL CCCCCCCCCCOS(=O)(=O)N D09WSJ HIGHSTAT Investigative D09WUP DRUG__ID D09WUP D09WUP DRUGTYPE Small molecular drug D09WUP DRUGINCH 1S/C25H28O8/c1-15(2)4-9-18-20(31-12-10-26)14-19(28)21-22(29)25(32-13-11-27)23(33-24(18)21)16-5-7-17(30-3)8-6-16/h4-8,14,26-28H,9-13H2,1-3H3 D09WUP DRUGINKE WTJGVHRGWYENBZ-UHFFFAOYSA-N D09WUP DRUGSMIL CC(=CCC1=C(C=C(C2=C1OC(=C(C2=O)OCCO)C3=CC=C(C=C3)OC)O)OCCO)C D09WUP HIGHSTAT Investigative D09WVP DRUG__ID D09WVP D09WVP DRUGTYPE Small molecular drug D09WVP DRUGINCH 1S/C24H36N4O8/c1-13(2)19(24(35)36)27-21(32)14(3)26-23(34)20(15(4)29)28-22(33)17(10-11-18(30)31)25-12-16-8-6-5-7-9-16/h5-9,13-15,17,19-20,25,29H,10-12H2,1-4H3,(H,26,34)(H,27,32)(H,28,33)(H,30,31)(H,35,36)/t14-,15?,17-,19-,20-/m0/s1 D09WVP DRUGINKE DETDSGXQMKQDNJ-VFWSWVEUSA-N D09WVP DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCC1=CC=CC=C1 D09WVP HIGHSTAT Investigative D09WVS DRUG__ID D09WVS D09WVS DRUGTYPE Small molecular drug D09WVS DRUGINCH 1S/C22H29NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,20-22,24H,8,13-17H2,1H3/t20-,21+,22-/m1/s1 D09WVS DRUGINKE MUSFCRGEWKAWEE-BHIFYINESA-N D09WVS DRUGSMIL CN1C(CCCC1CC(C2=CC=CC=C2)O)CCC3=CC=CC=C3 D09WVS HIGHSTAT Investigative D09WVV DRUG__ID D09WVV D09WVV DRUGTYPE Small molecular drug D09WVV DRUGINCH 1S/C4H13N3/c5-1-3-7-4-2-6/h7H,1-6H2 D09WVV DRUGINKE RPNUMPOLZDHAAY-UHFFFAOYSA-N D09WVV DRUGSMIL C(CNCCN)N D09WVV HIGHSTAT Investigative D09WWY DRUG__ID D09WWY D09WWY DRUGTYPE Small molecular drug D09WWY DRUGINCH 1S/C25H38O4/c1-4-5-16-14-17-15-18(26)6-10-23(17,2)19-7-11-24(3)20(22(16)19)8-12-25(24,29)13-9-21(27)28/h15-16,19-20,22,29H,4-14H2,1-3H3,(H,27,28)/t16-,19+,20+,22-,23+,24+,25-/m1/s1 D09WWY DRUGINKE DNHCHRGCTVRAFT-JEHIOXJOSA-N D09WWY DRUGSMIL CCCC1CC2=CC(=O)CCC2(C3C1C4CCC(C4(CC3)C)(CCC(=O)O)O)C D09WWY HIGHSTAT Investigative D09WYF DRUG__ID D09WYF D09WYF DRUGTYPE Small molecular drug D09WYF DRUGINCH 1S/C18H22N2O/c1-2-3-4-6-15-8-10-16(11-9-15)13-18(21)20-17-7-5-12-19-14-17/h5,7-12,14H,2-4,6,13H2,1H3,(H,20,21) D09WYF DRUGINKE VYJQGHFNPZKVTQ-UHFFFAOYSA-N D09WYF DRUGSMIL CCCCCC1=CC=C(C=C1)CC(=O)NC2=CN=CC=C2 D09WYF HIGHSTAT Investigative D09WYM DRUG__ID D09WYM D09WYM DRUGTYPE Small molecular drug D09WYM DRUGINCH 1S/C16H15NO2/c1-17(19)16(18)11-10-13-6-5-9-15(12-13)14-7-3-2-4-8-14/h2-12,19H,1H3/b11-10+ D09WYM DRUGINKE CXMSWAWAJRLYBE-ZHACJKMWSA-N D09WYM DRUGSMIL CN(C(=O)C=CC1=CC(=CC=C1)C2=CC=CC=C2)O D09WYM HIGHSTAT Investigative D09WYY DRUG__ID D09WYY D09WYY DRUGTYPE Small molecular drug D09WYY DRUGINCH 1S/C10H17N2O14P3/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/t6-,7+,8+/m0/s1 D09WYY DRUGINKE NHVNXKFIZYSCEB-XLPZGREQSA-N D09WYY DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O D09WYY HIGHSTAT Investigative D09XAM DRUG__ID D09XAM D09XAM DRUGTYPE Small molecular drug D09XAM DRUGINCH 1S/C21H32F2/c1-13-4-7-17-16-6-5-14-12-15(22)8-10-20(14,2)18(16)9-11-21(17,3)19(13)23/h5,13,15-19H,4,6-12H2,1-3H3/t13-,15+,16?,17?,18?,19+,20+,21+/m1/s1 D09XAM DRUGINKE UEILQXVVJHZGQK-KYFJQHFKSA-N D09XAM DRUGSMIL CC1CCC2C3CC=C4CC(CCC4(C3CCC2(C1F)C)C)F D09XAM HIGHSTAT Investigative D09XDR DRUG__ID D09XDR D09XDR DRUGCOMP Vision 7 GmbH D09XDR DRUGINCH 1S/C13H12O4/c1-2-3-8-6-10(14)9-4-5-11-13(12(9)17-8)16-7-15-11/h4-6H,2-3,7H2,1H3 D09XDR DRUGINKE ZLSMKNSRCLUQBA-UHFFFAOYSA-N D09XDR DRUGSMIL CCCC1=CC(=O)C2=C(O1)C3=C(C=C2)OCO3 D09XDR HIGHSTAT Investigative D09XED DRUG__ID D09XED D09XED DRUGTYPE Small molecular drug D09XED DRUGINCH 1S/C31H30Cl2N6O6S/c32-24-15-35-16-25(33)28(24)30(41)37-21-9-7-18(8-10-21)12-26(31(42)43)38-29(40)27-13-22(36-20-4-2-5-20)17-39(27)46(44,45)23-6-1-3-19(11-23)14-34/h1,3,6-11,15-16,20,22,26-27,36H,2,4-5,12-13,17H2,(H,37,41)(H,38,40)(H,42,43)/t22-,26+,27+/m1/s1 D09XED DRUGINKE USYYNLPEWBGIMJ-ICTDUYRTSA-N D09XED DRUGSMIL C1CC(C1)NC2CC(N(C2)S(=O)(=O)C3=CC=CC(=C3)C#N)C(=O)NC(CC4=CC=C(C=C4)NC(=O)C5=C(C=NC=C5Cl)Cl)C(=O)O D09XED HIGHSTAT Investigative D09XFQ DRUG__ID D09XFQ D09XFQ DRUGTYPE Small molecular drug D09XFQ DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(42)36-29-25-11-7-6-10-23(25)17-27(29)39)37(20-45-34)33(43)30(41)26(16-21-8-4-3-5-9-21)35-28(40)19-44-24-14-12-22(18-38)13-15-24/h3-15,26-27,29-31,38-39,41H,16-20H2,1-2H3,(H,35,40)(H,36,42)/t26-,27+,29-,30-,31+/m0/s1 D09XFQ DRUGINKE RJJNWINGYKEUKL-VFCPCCRCSA-N D09XFQ DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=C(C=C3)CO)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D09XFQ HIGHSTAT Investigative D09XHA DRUG__ID D09XHA D09XHA DRUGTYPE Small molecular drug D09XHA DRUGINCH 1S/C6H14N4O3/c7-4(5(11)12)2-1-3-9-6(8)10-13/h4,13H,1-3,7H2,(H,11,12)(H3,8,9,10) D09XHA DRUGINKE FQWRAVYMZULPNK-UHFFFAOYSA-N D09XHA DRUGSMIL C(CC(C(=O)O)N)CN=C(N)NO D09XHA HIGHSTAT Investigative D09XIE DRUG__ID D09XIE D09XIE DRUGTYPE Small molecular drug D09XIE DRUGINCH 1S/C21H15NO/c22-15-20(16-7-3-1-4-8-16)21(17-9-5-2-6-10-17)18-11-13-19(23)14-12-18/h1-14,23H/b21-20- D09XIE DRUGINKE ASWQVWZGOMLNRM-MRCUWXFGSA-N D09XIE DRUGSMIL C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)O)C#N D09XIE HIGHSTAT Investigative D09XIL DRUG__ID D09XIL D09XIL DRUGTYPE Small molecular drug D09XIL DRUGINCH 1S/C24H24FN5O3/c1-33-21-10-7-18(8-11-21)29-14-15-13-26-23(27-17-4-2-16(25)3-5-17)28-22(15)30(24(29)32)19-6-9-20(31)12-19/h2-5,7-8,10-11,13,19-20,31H,6,9,12,14H2,1H3,(H,26,27,28)/t19-,20-/m1/s1 D09XIL DRUGINKE KXEMINRANVTICS-WOJBJXKFSA-N D09XIL DRUGSMIL COC1=CC=C(C=C1)N2CC3=CN=C(N=C3N(C2=O)C4CCC(C4)O)NC5=CC=C(C=C5)F D09XIL HIGHSTAT Investigative D09XJH DRUG__ID D09XJH D09XJH DRUGTYPE Small molecular drug D09XJH DRUGINCH 1S/C30H29F2NO9/c31-17-5-1-15(2-6-17)22(34)14-13-21-23(33(28(21)38)19-9-7-18(32)8-10-19)16-3-11-20(12-4-16)41-30-26(37)24(35)25(36)27(42-30)29(39)40/h1-12,21-27,30,34-37H,13-14H2,(H,39,40)/t21-,22+,23-,24+,25+,26-,27+,30-/m1/s1 D09XJH DRUGINKE UOFYCFMTERCNEW-ADEYADIWSA-N D09XJH DRUGSMIL C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)OC5C(C(C(C(O5)C(=O)O)O)O)O D09XJH HIGHSTAT Investigative D09XJJ DRUG__ID D09XJJ D09XJJ DRUGTYPE Small molecular drug D09XJJ DRUGINCH 1S/C33H30N2O3/c36-31-29-21-25(32(37)34-19-7-13-23-9-3-1-4-10-23)15-17-27(29)28-18-16-26(22-30(28)31)33(38)35-20-8-14-24-11-5-2-6-12-24/h1-6,9-12,15-18,21-22H,7-8,13-14,19-20H2,(H,34,37)(H,35,38) D09XJJ DRUGINKE OKGPGSVMCACUID-UHFFFAOYSA-N D09XJJ DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C2=CC3=C(C=C2)C4=C(C3=O)C=C(C=C4)C(=O)NCCCC5=CC=CC=C5 D09XJJ HIGHSTAT Investigative D09XKC DRUG__ID D09XKC D09XKC DRUGTYPE Small molecular drug D09XKC DRUGINCH 1S/C16H15BrF2N4OS/c1-20-15(24)11-3-4-12(18)10(14(11)19)6-7-21-16(25)23-13-5-2-9(17)8-22-13/h2-5,8H,6-7H2,1H3,(H,20,24)(H2,21,22,23,25) D09XKC DRUGINKE YHRQSPRSRROVMC-UHFFFAOYSA-N D09XKC DRUGSMIL CNC(=O)C1=C(C(=C(C=C1)F)CCNC(=S)NC2=NC=C(C=C2)Br)F D09XKC HIGHSTAT Investigative D09XKH DRUG__ID D09XKH D09XKH DRUGTYPE Small molecular drug D09XKH DRUGINCH 1S/C15H12O6/c16-7-1-2-9(10(18)3-7)13-6-12(20)15-11(19)4-8(17)5-14(15)21-13/h1-5,13,16-19H,6H2/t13-/m0/s1 D09XKH DRUGINKE QBLQLKNOKUHRCH-ZDUSSCGKSA-N D09XKH DRUGSMIL C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=C(C=C(C=C3)O)O D09XKH HIGHSTAT Investigative D09XLT DRUG__ID D09XLT D09XLT DRUGTYPE Small molecular drug D09XLT DRUGINCH 1S/C21H34O4/c1-2-3-6-9-17(22)13-12-16-14-18-15-20(25-18)19(16)10-7-4-5-8-11-21(23)24/h4,7,12-13,16-20,22H,2-3,5-6,8-11,14-15H2,1H3,(H,23,24)/b7-4-,13-12+/t16-,17-,18-,19+,20-/m0/s1 D09XLT DRUGINKE HAJUMEFPOWPAQL-IGUVKOCZSA-N D09XLT DRUGSMIL CCCCCC(C=CC1CC2CC(C1CC=CCCCC(=O)O)O2)O D09XLT HIGHSTAT Investigative D09XLZ DRUG__ID D09XLZ D09XLZ DRUGTYPE Small molecular drug D09XLZ DRUGINCH 1S/C21H15NO4/c23-19(14-6-8-17(9-7-14)21(25)26)15-10-12-18(13-11-15)22-20(24)16-4-2-1-3-5-16/h1-13H,(H,22,24)(H,25,26) D09XLZ DRUGINKE FKMULXSKUTZDBD-UHFFFAOYSA-N D09XLZ DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C(=O)O D09XLZ HIGHSTAT Investigative D09XOC DRUG__ID D09XOC D09XOC DRUGTYPE Small molecular drug D09XOC DRUGINCH 1S/C15H21BrO/c1-2-3-4-5-6-13-7-9-14(10-8-13)15(17)11-12-16/h7-10H,2-6,11-12H2,1H3 D09XOC DRUGINKE IKJXBCMGQCDIDG-UHFFFAOYSA-N D09XOC DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)CCBr D09XOC HIGHSTAT Investigative D09XQR DRUG__ID D09XQR D09XQR DRUGTYPE Small molecular drug D09XQR DRUGINCH 1S/C37H67NO13.C12H13NO5S/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-7(14)13-9(11(16)17)6-19-12(18)8-4-2-3-5-10(8)15/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;2-5,9,15H,6H2,1H3,(H,13,14)(H,16,17)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;9-/m10/s1 D09XQR DRUGINKE CEKAAZRHRXXWDX-CQWDQVLCSA-N D09XQR DRUGSMIL CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O.CC(=O)NC(CSC(=O)C1=CC=CC=C1O)C(=O)O D09XQR HIGHSTAT Investigative D09XSB DRUG__ID D09XSB D09XSB DRUGTYPE Small molecular drug D09XSB DRUGINCH 1S/C16H11NO2/c18-15-13-10-12(8-9-14(13)17-16(15)19)7-6-11-4-2-1-3-5-11/h1-10H,(H,17,18,19)/b7-6+ D09XSB DRUGINKE KJZBRZRRHIURGP-VOTSOKGWSA-N D09XSB DRUGSMIL C1=CC=C(C=C1)C=CC2=CC3=C(C=C2)NC(=O)C3=O D09XSB HIGHSTAT Investigative D09XSI DRUG__ID D09XSI D09XSI DRUGTYPE Small molecular drug D09XSI DRUGINCH 1S/C30H30NO5/c1-32-27-11-10-21-16-26-24-18-29-28(35-20-36-29)17-22(24)12-13-31(26)19-25(21)30(27)34-15-7-3-6-14-33-23-8-4-2-5-9-23/h2,4-5,8-11,16-19H,3,6-7,12-15,20H2,1H3/q+1 D09XSI DRUGINKE DIJNAHNGFYBCMU-UHFFFAOYSA-N D09XSI DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCCOC6=CC=CC=C6 D09XSI HIGHSTAT Investigative D09XUQ DRUG__ID D09XUQ D09XUQ DRUGTYPE Small molecular drug D09XUQ DRUGINCH 1S/C13H20O3S2/c1-3-4-12(9-10-17)18(14,15)13-7-5-11(16-2)6-8-13/h5-8,12,17H,3-4,9-10H2,1-2H3 D09XUQ DRUGINKE SHMJSERYBLZGBT-UHFFFAOYSA-N D09XUQ DRUGSMIL CCCC(CCS)S(=O)(=O)C1=CC=C(C=C1)OC D09XUQ HIGHSTAT Investigative D09XVU DRUG__ID D09XVU D09XVU DRUGTYPE Small molecular drug D09XVU DRUGINCH 1S/C20H18N4/c1-23-13-11-17(15-7-3-5-9-19(15)23)21-22-18-12-14-24(2)20-10-6-4-8-16(18)20/h3-14H,1-2H3/b21-17+,22-18+ D09XVU DRUGINKE NZJOSTCMDPAPOD-KSTNYAOJSA-N D09XVU DRUGSMIL CN1C=CC(=NN=C2C=CN(C3=CC=CC=C23)C)C4=CC=CC=C41 D09XVU HIGHSTAT Investigative D09XVY DRUG__ID D09XVY D09XVY DRUGTYPE Small molecular drug D09XVY DRUGINCH 1S/C21H19NO2/c1-16-7-9-17(10-8-16)15-22-21(23)18-11-13-20(14-12-18)24-19-5-3-2-4-6-19/h2-14H,15H2,1H3,(H,22,23) D09XVY DRUGINKE ZMFAZMUZJXZNMY-UHFFFAOYSA-N D09XVY DRUGSMIL CC1=CC=C(C=C1)CNC(=O)C2=CC=C(C=C2)OC3=CC=CC=C3 D09XVY HIGHSTAT Investigative D09XWL DRUG__ID D09XWL D09XWL DRUGTYPE Small molecular drug D09XWL DRUGINCH 1S/C14H18FNO/c1-10(16-13-7-2-3-8-13)14(17)11-5-4-6-12(15)9-11/h4-6,9-10,13,16H,2-3,7-8H2,1H3 D09XWL DRUGINKE CFVHNYYHCCJXDK-UHFFFAOYSA-N D09XWL DRUGSMIL CC(C(=O)C1=CC(=CC=C1)F)NC2CCCC2 D09XWL HIGHSTAT Investigative D09XWS DRUG__ID D09XWS D09XWS DRUGTYPE Small molecular drug D09XWS DRUGINCH 1S/C10H10N4O2S/c1-16-8-4-2-7(3-5-8)12-9(15)13-10-14-11-6-17-10/h2-6H,1H3,(H2,12,13,14,15) D09XWS DRUGINKE WRRMEHJVEKNTQJ-UHFFFAOYSA-N D09XWS DRUGSMIL COC1=CC=C(C=C1)NC(=O)NC2=NN=CS2 D09XWS HIGHSTAT Investigative D09XXN DRUG__ID D09XXN D09XXN DRUGTYPE Small molecular drug D09XXN DRUGINCH 1S/C16H17NO2/c18-15-11-5-4-10-14(15)16(19)17-12-6-9-13-7-2-1-3-8-13/h1-5,7-8,10-11,18H,6,9,12H2,(H,17,19) D09XXN DRUGINKE NCGDIICSZWHCQX-UHFFFAOYSA-N D09XXN DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C2=CC=CC=C2O D09XXN HIGHSTAT Investigative D09XYZ DRUG__ID D09XYZ D09XYZ DRUGTYPE Small molecular drug D09XYZ DRUGINCH 1S/C9H9NO4/c1-6(11)14-10-9(13)7-4-2-3-5-8(7)12/h2-5,12H,1H3,(H,10,13) D09XYZ DRUGINKE PCFWLDHLJWUGSU-UHFFFAOYSA-N D09XYZ DRUGSMIL CC(=O)ONC(=O)C1=CC=CC=C1O D09XYZ HIGHSTAT Investigative D09YAL DRUG__ID D09YAL D09YAL DRUGTYPE Small molecular drug D09YAL DRUGINCH 1S/C13H19NO2S/c1-13(2,3)11-8-10(15)9-12(17-11)14-4-6-16-7-5-14/h8-9H,4-7H2,1-3H3 D09YAL DRUGINKE HCEFXOMYHGQVRM-UHFFFAOYSA-N D09YAL DRUGSMIL CC(C)(C)C1=CC(=O)C=C(S1)N2CCOCC2 D09YAL HIGHSTAT Investigative D09YBA DRUG__ID D09YBA D09YBA DRUGTYPE Small molecular drug D09YBA DRUGINCH 1S/C20H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18(21)19(22)16-14-17-20(23)24/h7-13,15,18-19,21-22H,2-6,14,16-17H2,1H3,(H,23,24)/b8-7+,10-9+,12-11+,15-13+/t18-,19+/m1/s1 D09YBA DRUGINKE SJIRTDBAYKOBAL-COJKCNNISA-N D09YBA DRUGSMIL CCCCCCC=CC=CC=CC=CC(C(CCCC(=O)O)O)O D09YBA HIGHSTAT Investigative D09YBC DRUG__ID D09YBC D09YBC DRUGTYPE Small molecular drug D09YBC DRUGINCH 1S/C37H55N5O10/c1-4-5-6-7-8-9-10-21-32(25(2)33(45)38-28-18-13-16-23-42(50)36(28)47)52-37(48)29(19-14-15-22-41(49)26(3)43)39-34(46)30-24-51-35(40-30)27-17-11-12-20-31(27)44/h11-12,17,20,24-25,28-29,32,44,49-50H,4-10,13-16,18-19,21-23H2,1-3H3,(H,38,45)(H,39,46) D09YBC DRUGINKE LGOZXNLEMXJIMS-UHFFFAOYSA-N D09YBC DRUGSMIL CCCCCCCCCC(C(C)C(=O)NC1CCCCN(C1=O)O)OC(=O)C(CCCCN(C(=O)C)O)NC(=O)C2=COC(=N2)C3=CC=CC=C3O D09YBC HIGHSTAT Investigative D09YBN DRUG__ID D09YBN D09YBN DRUGTYPE Small molecular drug D09YBN DRUGINCH 1S/C12H18OS/c14-11-7-2-1-6-10-13-12-8-4-3-5-9-12/h3-5,8-9,14H,1-2,6-7,10-11H2 D09YBN DRUGINKE QUBILGABLBGKPV-UHFFFAOYSA-N D09YBN DRUGSMIL C1=CC=C(C=C1)OCCCCCCS D09YBN HIGHSTAT Investigative D09YCW DRUG__ID D09YCW D09YCW DRUGTYPE Small molecular drug D09YCW DRUGINCH 1S/C9H13NO2S/c1-6-2-3-8(13-6)7(5-10)4-9(11)12/h2-3,7H,4-5,10H2,1H3,(H,11,12) D09YCW DRUGINKE RPNWEWXYTFWDTR-UHFFFAOYSA-N D09YCW DRUGSMIL CC1=CC=C(S1)C(CC(=O)O)CN D09YCW HIGHSTAT Investigative D09YEQ DRUG__ID D09YEQ D09YEQ DRUGTYPE Small molecular drug D09YEQ DRUGINCH 1S/C24H20F3N3O/c1-13-7-21-22(11-19(13)24(25,26)27)30-23(31)12-20(29-21)17-6-4-5-16(10-17)18-8-14(2)28-15(3)9-18/h4-11H,12H2,1-3H3,(H,30,31) D09YEQ DRUGINKE LYTVXCQQTLUEQR-UHFFFAOYSA-N D09YEQ DRUGSMIL CC1=CC2=C(C=C1C(F)(F)F)NC(=O)CC(=N2)C3=CC=CC(=C3)C4=CC(=NC(=C4)C)C D09YEQ HIGHSTAT Investigative D09YGD DRUG__ID D09YGD D09YGD DRUGTYPE Small molecular drug D09YGD DRUGINCH 1S/C21H18N2O4S/c22-17-6-12-20(13-7-17)28(26,27)23-18-8-4-16(5-9-18)21(25)14-3-15-1-10-19(24)11-2-15/h1-14,23-24H,22H2/b14-3+ D09YGD DRUGINKE HMCALLLWIUWUTM-LZWSPWQCSA-N D09YGD DRUGSMIL C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)N)O D09YGD HIGHSTAT Investigative D09YHQ DRUG__ID D09YHQ D09YHQ DRUGTYPE Small molecular drug D09YHQ DRUGINCH 1S/C13H8ClNO/c14-10-4-3-8-1-2-9-5-6-15-13(16)12(9)11(8)7-10/h1-7H,(H,15,16) D09YHQ DRUGINKE XSQDWQSZUGGKPF-UHFFFAOYSA-N D09YHQ DRUGSMIL C1=CC2=C(C3=C1C=CC(=C3)Cl)C(=O)NC=C2 D09YHQ HIGHSTAT Investigative D09YHS DRUG__ID D09YHS D09YHS DRUGTYPE Small molecular drug D09YHS DRUGINCH 1S/C15H17NS/c1-12(16)11-13-7-9-15(10-8-13)17-14-5-3-2-4-6-14/h2-10,12H,11,16H2,1H3 D09YHS DRUGINKE FPOOXERVBCKPAG-UHFFFAOYSA-N D09YHS DRUGSMIL CC(CC1=CC=C(C=C1)SC2=CC=CC=C2)N D09YHS HIGHSTAT Investigative D09YJS DRUG__ID D09YJS D09YJS DRUGTYPE Small molecular drug D09YJS DRUGINCH 1S/C15H14O6/c16-11-4-2-1-3-9(11)5-6-21-15(20)10-7-12(17)14(19)13(18)8-10/h1-4,7-8,16-19H,5-6H2 D09YJS DRUGINKE BFCLPURLRKZMCC-UHFFFAOYSA-N D09YJS DRUGSMIL C1=CC=C(C(=C1)CCOC(=O)C2=CC(=C(C(=C2)O)O)O)O D09YJS HIGHSTAT Investigative D09YKH DRUG__ID D09YKH D09YKH DRUGTYPE Small molecular drug D09YKH DRUGINCH 1S/C26H30O6/c1-15(2)6-7-16-10-18(11-17(25(16)31-5)8-9-26(3,4)30)22-14-21(29)24-20(28)12-19(27)13-23(24)32-22/h6,8-13,22,27-28,30H,7,14H2,1-5H3/b9-8+/t22-/m0/s1 D09YKH DRUGINKE BOBWTYODGOYWRC-UVIRAJKCSA-N D09YKH DRUGSMIL CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)C=CC(C)(C)O)OC)C D09YKH HIGHSTAT Investigative D09YLF DRUG__ID D09YLF D09YLF DRUGTYPE Small molecular drug D09YLF DRUGINCH 1S/C17H16N4O/c18-17(19)21-16-15-10-14(7-6-13(15)8-9-20-16)22-11-12-4-2-1-3-5-12/h1-10H,11H2,(H4,18,19,20,21) D09YLF DRUGINKE XOCIIIGBOXCOGZ-UHFFFAOYSA-N D09YLF DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)C=CN=C3N=C(N)N D09YLF HIGHSTAT Investigative D09YLY DRUG__ID D09YLY D09YLY DRUGTYPE Small molecular drug D09YLY DRUGINCH 1S/C20H20N2O6/c23-19(14-6-8-21-9-7-14)27-15-11-25-18-16(12-26-17(15)18)28-20(24)22-10-13-4-2-1-3-5-13/h1-9,15-18H,10-12H2,(H,22,24)/t15-,16+,17-,18-/m1/s1 D09YLY DRUGINKE CPCJEEMJBNMGOE-XMTFNYHQSA-N D09YLY DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NCC3=CC=CC=C3)OC(=O)C4=CC=NC=C4 D09YLY HIGHSTAT Investigative D09YOY DRUG__ID D09YOY D09YOY DRUGTYPE Small molecular drug D09YOY DRUGINCH 1S/C15H28N4O3/c1-4-9(5-2)13(18-8(3)20)11-6-10(14(21)22)7-12(11)19-15(16)17/h9-13H,4-7H2,1-3H3,(H,18,20)(H,21,22)(H4,16,17,19)/t10?,11-,12-,13?/m1/s1 D09YOY DRUGINKE FOCBRFMNUQOMCY-QZQSVVMZSA-N D09YOY DRUGSMIL CCC(CC)C(C1CC(CC1N=C(N)N)C(=O)O)NC(=O)C D09YOY HIGHSTAT Investigative D09YQM DRUG__ID D09YQM D09YQM DRUGTYPE Small molecular drug D09YQM DRUGINCH 1S/C18H31N7O5/c1-18(2,3)22-16(29)23-7-9-24(10-8-23)17(30)25-12(14(27)28)11(13(25)26)5-4-6-21-15(19)20/h11-12H,4-10H2,1-3H3,(H,22,29)(H,27,28)(H4,19,20,21)/t11-,12+/m1/s1 D09YQM DRUGINKE MFTQITSPGQORDA-NEPJUHHUSA-N D09YQM DRUGSMIL CC(C)(C)NC(=O)N1CCN(CC1)C(=O)N2C(C(C2=O)CCCN=C(N)N)C(=O)O D09YQM HIGHSTAT Investigative D09YRL DRUG__ID D09YRL D09YRL DRUGTYPE Small molecular drug D09YRL DRUGINCH 1S/C4H9N3O3/c5-1-3(8)6-2-4(9)7-10/h10H,1-2,5H2,(H,6,8)(H,7,9) D09YRL DRUGINKE NXTDAODSZSXXAY-UHFFFAOYSA-N D09YRL DRUGSMIL C(C(=O)NCC(=O)NO)N D09YRL HIGHSTAT Investigative D09YUL DRUG__ID D09YUL D09YUL DRUGTYPE Small molecular drug D09YUL DRUGINCH 1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-12)14-7-3-5-11-4-1-2-6-13(11)14/h1-7,10,15H,8-9H2/b12-10+ D09YUL DRUGINKE BYUCSFWXCMTYOI-ZRDIBKRKSA-N D09YUL DRUGSMIL C1CC(=CBr)OC(=O)C1C2=CC=CC3=CC=CC=C32 D09YUL HIGHSTAT Investigative D09YVA DRUG__ID D09YVA D09YVA DRUGTYPE Small molecular drug D09YVA DRUGINCH 1S/C15H19N3O/c1-17-8-10-18(11-9-17)14-7-6-12-4-3-5-13(19-2)15(12)16-14/h3-7H,8-11H2,1-2H3 D09YVA DRUGINKE XPBCUYLZAWCBJJ-UHFFFAOYSA-N D09YVA DRUGSMIL CN1CCN(CC1)C2=NC3=C(C=CC=C3OC)C=C2 D09YVA HIGHSTAT Investigative D09YVN DRUG__ID D09YVN D09YVN DRUGTYPE Small molecular drug D09YVN DRUGINCH 1S/C19H21N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,12,21H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t12-/m0/s1 D09YVN DRUGINKE OZRNSSUDZOLUSN-LBPRGKRZSA-N D09YVN DRUGSMIL C1C(=NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D09YVN HIGHSTAT Investigative D09YVT DRUG__ID D09YVT D09YVT DRUGTYPE Small molecular drug D09YVT DRUGINCH 1S/C15H10O7/c16-7-3-1-6(2-4-7)14-13(21)12(20)10-8(17)5-9(18)11(19)15(10)22-14/h1-5,16-19,21H D09YVT DRUGINKE ZDOTZEDNGNPOEW-UHFFFAOYSA-N D09YVT DRUGSMIL C1=CC(=CC=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)O)O)O D09YVT HIGHSTAT Investigative D09YVU DRUG__ID D09YVU D09YVU DRUGTYPE Small molecular drug D09YVU DRUGINCH 1S/C16H16N2O/c17-8-3-4-11-10-12-7-9-18-16(19)15(12)14-6-2-1-5-13(11)14/h1-2,5-7,9-10H,3-4,8,17H2,(H,18,19) D09YVU DRUGINKE LBNJYZFAUIDIPA-UHFFFAOYSA-N D09YVU DRUGSMIL C1=CC=C2C(=C1)C(=CC3=C2C(=O)NC=C3)CCCN D09YVU HIGHSTAT Investigative D09YVZ DRUG__ID D09YVZ D09YVZ DRUGTYPE Small molecular drug D09YVZ DRUGINCH 1S/C21H26N2O3/c1-2-3-4-5-9-16-25-20-14-12-19(13-15-20)23-21(24)26-22-17-18-10-7-6-8-11-18/h6-8,10-15,17H,2-5,9,16H2,1H3,(H,23,24)/b22-17+ D09YVZ DRUGINKE QGTJCMKYCHZBTK-OQKWZONESA-N D09YVZ DRUGSMIL CCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D09YVZ HIGHSTAT Investigative D09YXV DRUG__ID D09YXV D09YXV DRUGTYPE Small molecular drug D09YXV DRUGINCH 1S/C16H15NO/c1-18-15-6-7-16-13(4-5-14(16)10-15)9-12-3-2-8-17-11-12/h2-3,6-11H,4-5H2,1H3/b13-9+ D09YXV DRUGINKE HVRLSDXXVKSVBR-UKTHLTGXSA-N D09YXV DRUGSMIL COC1=CC2=C(C=C1)C(=CC3=CN=CC=C3)CC2 D09YXV HIGHSTAT Investigative D09ZAL DRUG__ID D09ZAL D09ZAL DRUGTYPE Small molecular drug D09ZAL DRUGINCH 1S/C13H17N/c1-12(2)11-8-14-9-13(11,12)10-6-4-3-5-7-10/h3-7,11,14H,8-9H2,1-2H3 D09ZAL DRUGINKE GCPODIFNAITRSC-UHFFFAOYSA-N D09ZAL DRUGSMIL CC1(C2C1(CNC2)C3=CC=CC=C3)C D09ZAL HIGHSTAT Investigative D09ZAT DRUG__ID D09ZAT D09ZAT DRUGTYPE Small molecular drug D09ZAT DRUGINCH 1S/C16H15Cl2NO/c1-19-16-8-12(9-2-5-14(17)15(18)6-9)11-4-3-10(20)7-13(11)16/h2-7,12,16,19-20H,8H2,1H3 D09ZAT DRUGINKE QAOIAICAGBDCEV-UHFFFAOYSA-N D09ZAT DRUGSMIL CNC1CC(C2=C1C=C(C=C2)O)C3=CC(=C(C=C3)Cl)Cl D09ZAT HIGHSTAT Investigative D09ZDQ DRUG__ID D09ZDQ D09ZDQ DRUGTYPE Small molecular drug D09ZDQ DRUGINCH 1S/C7H8N2O/c1-2-6(10-5-1)7-8-3-4-9-7/h1-2,5H,3-4H2,(H,8,9) D09ZDQ DRUGINKE IOTMYJAUZMRWCJ-UHFFFAOYSA-N D09ZDQ DRUGSMIL C1CN=C(N1)C2=CC=CO2 D09ZDQ HIGHSTAT Investigative D09ZGN DRUG__ID D09ZGN D09ZGN DRUGTYPE Small molecular drug D09ZGN DRUGINCH 1S/C19H33N/c1-3-5-7-9-10-11-13-15-19-17-16-18(20-19)14-12-8-6-4-2/h3-4,18H,1-2,5-17H2 D09ZGN DRUGINKE JRNMZRPLKGPMHB-UHFFFAOYSA-N D09ZGN DRUGSMIL C=CCCCCCCCC1=NC(CC1)CCCCC=C D09ZGN HIGHSTAT Investigative D09ZHX DRUG__ID D09ZHX D09ZHX DRUGTYPE Small molecular drug D09ZHX DRUGINCH 1S/C19H13BrN2O2/c20-14-7-5-13(6-8-14)19-16(11-22-10-9-21-12-22)18(23)15-3-1-2-4-17(15)24-19/h1-10,12H,11H2 D09ZHX DRUGINKE VPZRWXUJDQPWSY-UHFFFAOYSA-N D09ZHX DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=C(O2)C3=CC=C(C=C3)Br)CN4C=CN=C4 D09ZHX HIGHSTAT Investigative D09ZIU DRUG__ID D09ZIU D09ZIU DRUGTYPE Small molecular drug D09ZIU DRUGINCH 1S/C11H13N/c1-2-4-9(5-3-1)11-6-10(11)7-12-8-11/h1-5,10,12H,6-8H2 D09ZIU DRUGINKE HYXPTPHIWQWOQF-UHFFFAOYSA-N D09ZIU DRUGSMIL C1C2C1(CNC2)C3=CC=CC=C3 D09ZIU HIGHSTAT Investigative D09ZIW DRUG__ID D09ZIW D09ZIW DRUGTYPE Small molecular drug D09ZIW DRUGINCH 1S/C30H28O9/c1-18(17-39-29(36)14-5-19-4-11-26(34)28(15-19)38-2)3-9-22-25(33)13-10-23(30(22)37)24(32)12-7-20-6-8-21(31)16-27(20)35/h3-8,10-16,31,33-35,37H,9,17H2,1-2H3/b12-7+,14-5+,18-3+ D09ZIW DRUGINKE OFKHJNZDWNKYOY-MNYVGDBSSA-N D09ZIW DRUGSMIL CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=C(C=C(C=C2)O)O)O)COC(=O)C=CC3=CC(=C(C=C3)O)OC D09ZIW HIGHSTAT Investigative D09ZJW DRUG__ID D09ZJW D09ZJW DRUGTYPE Small molecular drug D09ZJW DRUGINCH 1S/C7H7ClS/c8-7-3-1-6(5-9)2-4-7/h1-4,9H,5H2 D09ZJW DRUGINKE GKQXPTHQTXCXEV-UHFFFAOYSA-N D09ZJW DRUGSMIL C1=CC(=CC=C1CS)Cl D09ZJW HIGHSTAT Investigative D09ZKY DRUG__ID D09ZKY D09ZKY DRUGTYPE Small molecular drug D09ZKY DRUGINCH 1S/C20H13BrF3N3O2S/c21-13-4-2-1-3-11(13)9-29-16-8-17(30-18(16)19(25)28)27-10-26-14-6-5-12(7-15(14)27)20(22,23)24/h1-8,10H,9H2,(H2,25,28) D09ZKY DRUGINKE LOKKVFGDJAVMLU-UHFFFAOYSA-N D09ZKY DRUGSMIL C1=CC=C(C(=C1)COC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)C(F)(F)F)C(=O)N)Br D09ZKY HIGHSTAT Investigative D09ZMS DRUG__ID D09ZMS D09ZMS DRUGTYPE Small molecular drug D09ZMS DRUGINCH 1S/C9H14N3O6P/c10-7-3-4-12(9(13)11-7)8-2-1-6(18-8)5-17-19(14,15)16/h3-4,6,8H,1-2,5H2,(H2,10,11,13)(H2,14,15,16)/t6-,8+/m0/s1 D09ZMS DRUGINKE RAJMXAZJKUGYGW-POYBYMJQSA-N D09ZMS DRUGSMIL C1CC(OC1COP(=O)(O)O)N2C=CC(=NC2=O)N D09ZMS HIGHSTAT Investigative D09ZNU DRUG__ID D09ZNU D09ZNU DRUGTYPE Small molecular drug D09ZNU DRUGINCH 1S/C14H12N2O3/c17-13(10-4-2-1-3-5-10)15-12-8-6-11(7-9-12)14(18)16-19/h1-9,19H,(H,15,17)(H,16,18) D09ZNU DRUGINKE QXGMQWWJCBVFOF-UHFFFAOYSA-N D09ZNU DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO D09ZNU HIGHSTAT Investigative D09ZNV DRUG__ID D09ZNV D09ZNV DRUGTYPE Small molecular drug D09ZNV DRUGINCH 1S/C17H12N2O3/c20-15(21)9-12-10-5-1-3-7-13(10)19-14-8-4-2-6-11(14)17(22)18-16(12)19/h1-8H,9H2,(H,18,22)(H,20,21) D09ZNV DRUGINKE INSBKYCYLCEBOD-UHFFFAOYSA-N D09ZNV DRUGSMIL C1=CC=C2C(=C1)C(=C3N2C4=CC=CC=C4C(=O)N3)CC(=O)O D09ZNV HIGHSTAT Investigative D09ZOA DRUG__ID D09ZOA D09ZOA DRUGTYPE Small molecular drug D09ZOA DRUGINCH 1S/C14H14N2O4S/c17-14(16-18)10-15-21(19,20)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,15,18H,10H2,(H,16,17) D09ZOA DRUGINKE NKGRTRASISLCCZ-UHFFFAOYSA-N D09ZOA DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)NCC(=O)NO D09ZOA HIGHSTAT Investigative D09ZPM DRUG__ID D09ZPM D09ZPM DRUGTYPE Small molecular drug D09ZPM DRUGINCH 1S/C10H11N3O2/c1-12-7-4-3-6(9(11)14)5-8(7)13(2)10(12)15/h3-5H,1-2H3,(H2,11,14) D09ZPM DRUGINKE BRBLVCVSNVSPMT-UHFFFAOYSA-N D09ZPM DRUGSMIL CN1C2=C(C=C(C=C2)C(=O)N)N(C1=O)C D09ZPM HIGHSTAT Investigative D09ZQW DRUG__ID D09ZQW D09ZQW DRUGTYPE Small molecular drug D09ZQW DRUGINCH 1S/C14H17Cl2NO2/c1-19-14(18)13(12-4-2-3-5-17-12)9-6-10(15)8-11(16)7-9/h6-8,12-13,17H,2-5H2,1H3/t12-,13-/m1/s1 D09ZQW DRUGINKE DRFWSKBVUOJFQQ-CHWSQXEVSA-N D09ZQW DRUGSMIL COC(=O)C(C1CCCCN1)C2=CC(=CC(=C2)Cl)Cl D09ZQW HIGHSTAT Investigative D09ZSA DRUG__ID D09ZSA D09ZSA DRUGTYPE Small molecular drug D09ZSA DRUGINCH 1S/C17H20ClN3O3.ClH/c1-20-14-7-11(18)6-12(16(14)24-9-15(20)22)17(23)19-13-8-21-4-2-10(13)3-5-21;/h6-7,10,13H,2-5,8-9H2,1H3,(H,19,23);1H D09ZSA DRUGINKE DBMKBKPJYAHLQP-UHFFFAOYSA-N D09ZSA DRUGSMIL CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4.Cl D09ZSA HIGHSTAT Investigative D09ZSK DRUG__ID D09ZSK D09ZSK DRUGTYPE Small molecular drug D09ZSK DRUGINCH 1S/C12H11N3O2/c13-12(14)15-11(16)10-7-6-9(17-10)8-4-2-1-3-5-8/h1-7H,(H4,13,14,15,16) D09ZSK DRUGINKE SYROHGCLRGCTIR-UHFFFAOYSA-N D09ZSK DRUGSMIL C1=CC=C(C=C1)C2=CC=C(O2)C(=O)N=C(N)N D09ZSK HIGHSTAT Investigative D09ZSV DRUG__ID D09ZSV D09ZSV DRUGTYPE Small molecular drug D09ZSV DRUGINCH 1S/C9H7BrO4/c10-7-1-2-8(6(3-7)4-11)14-5-9(12)13/h1-4H,5H2,(H,12,13) D09ZSV DRUGINKE KXRYNWDCFUKVNN-UHFFFAOYSA-N D09ZSV DRUGSMIL C1=CC(=C(C=C1Br)C=O)OCC(=O)O D09ZSV HIGHSTAT Investigative D09ZUN DRUG__ID D09ZUN D09ZUN DRUGTYPE Small molecular drug D09ZUN DRUGINCH 1S/C15H24O2/c1-14(2,3)11-8-10(17-7)9-12(13(11)16)15(4,5)6/h8-9,16H,1-7H3 D09ZUN DRUGINKE SLUKQUGVTITNSY-UHFFFAOYSA-N D09ZUN DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)OC D09ZUN HIGHSTAT Investigative D09ZUW DRUG__ID D09ZUW D09ZUW DRUGTYPE Small molecular drug D09ZUW DRUGINCH 1S/C27H34N6O5/c1-27(2,3)31-24(34)20-15-32(11-12-33(20)26(35)38-16-17-9-7-6-8-10-17)25-29-19-14-22(37-5)21(36-4)13-18(19)23(28)30-25/h6-10,13-14,20H,11-12,15-16H2,1-5H3,(H,31,34)(H2,28,29,30)/t20-/m0/s1 D09ZUW DRUGINKE CGWOIDCAGBKOQL-FQEVSTJZSA-N D09ZUW DRUGSMIL CC(C)(C)NC(=O)C1CN(CCN1C(=O)OCC2=CC=CC=C2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC D09ZUW HIGHSTAT Investigative D09ZUX DRUG__ID D09ZUX D09ZUX DRUGTYPE Small molecular drug D09ZUX DRUGINCH 1S/C13H12F6O/c14-10(11(20)12(15,16)13(17,18)19)8-4-7-9-5-2-1-3-6-9/h1-3,5-6,10H,4,7-8H2 D09ZUX DRUGINKE NOYVSSPMDRUWCC-UHFFFAOYSA-N D09ZUX DRUGSMIL C1=CC=C(C=C1)CCCC(C(=O)C(C(F)(F)F)(F)F)F D09ZUX HIGHSTAT Investigative D09ZVJ DRUG__ID D09ZVJ D09ZVJ DRUGCOMP Universite de Sherbrooke D09ZVJ DRUGINCH 1S/C61H87N13O12/c1-5-36(2)51(58(84)85)71-53(79)45(31-39-25-26-40-18-9-10-19-41(40)30-39)69-54(80)46(35-75)70-59(86)61(4,33-38-16-7-6-8-17-38)72-50(77)34-66-55(81)48-24-15-29-73(48)57(83)49-32-42-20-11-12-23-47(42)74(49)56(82)44(22-14-28-65-60(63)64)68-52(78)43(21-13-27-62)67-37(3)76/h6-10,16-19,25-26,30,36,42-49,51,75H,5,11-15,20-24,27-29,31-35,62H2,1-4H3,(H,66,81)(H,67,76)(H,68,78)(H,69,80)(H,70,86)(H,71,79)(H,72,77)(H,84,85)(H4,63,64,65)/t36-,42-,43-,44-,45+,46-,47-,48-,49-,51-,61-/m0/s1 D09ZVJ DRUGINKE JDPPVMXSBUBLMX-IRXBPQMASA-N D09ZVJ DRUGSMIL CCC(C)C(C(=O)O)NC(=O)C(CC1=CC2=CC=CC=C2C=C1)NC(=O)C(CO)NC(=O)C(C)(CC3=CC=CC=C3)NC(=O)CNC(=O)C4CCCN4C(=O)C5CC6CCCCC6N5C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN)NC(=O)C D09ZVJ HIGHSTAT Investigative D09ZZI DRUG__ID D09ZZI D09ZZI DRUGTYPE Small molecular drug D09ZZI DRUGINCH 1S/C6H5ClO/c7-5-3-1-2-4-6(5)8/h1-4,8H D09ZZI DRUGINKE ISPYQTSUDJAMAB-UHFFFAOYSA-N D09ZZI DRUGSMIL C1=CC=C(C(=C1)O)Cl D09ZZI HIGHSTAT Investigative D0A0CG DRUG__ID D0A0CG D0A0CG DRUGTYPE Small molecular drug D0A0CG DRUGINCH 1S/C23H24O2S/c1-23-9-8-19-18-7-5-16(24)11-14(18)4-6-20(19)21(23)13-15(22(23)25)12-17-3-2-10-26-17/h2-3,5,7,10-12,19-21,24H,4,6,8-9,13H2,1H3/b15-12+/t19?,20?,21?,23-/m0/s1 D0A0CG DRUGINKE NTDFYDJSLAOTRY-LUYQZUMISA-N D0A0CG DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=CS4)C2=O)CCC5=C3C=CC(=C5)O D0A0CG HIGHSTAT Investigative D0A0CZ DRUG__ID D0A0CZ D0A0CZ DRUGTYPE Small molecular drug D0A0CZ DRUGINCH 1S/C17H14O4S/c1-11-6-8-12(9-7-11)22(20,21)16-10-15(18)13-4-2-3-5-14(13)17(16)19/h2-10,18-19H,1H3 D0A0CZ DRUGINKE CYYDOKQRZQTSOL-UHFFFAOYSA-N D0A0CZ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C(C3=CC=CC=C3C(=C2)O)O D0A0CZ HIGHSTAT Investigative D0A0DN DRUG__ID D0A0DN D0A0DN DRUGTYPE Small molecular drug D0A0DN DRUGINCH 1S/C21H24N4O2.ClH/c1-3-24(4-2)11-5-10-22-16-7-8-17-20-19(16)21(27)15-12-14(26)6-9-18(15)25(20)13-23-17;/h6-9,12-13,22,26H,3-5,10-11H2,1-2H3;1H D0A0DN DRUGINKE JOPXSOWZGARKAE-UHFFFAOYSA-N D0A0DN DRUGSMIL CCN(CC)CCCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=C(C=C4)O.Cl D0A0DN HIGHSTAT Investigative D0A0DS DRUG__ID D0A0DS D0A0DS DRUGTYPE Small molecular drug D0A0DS DRUGINCH 1S/C24H26N2O2/c27-24(28)22-8-4-3-7-21(22)19-12-9-17(10-13-19)11-14-23-25-16-20(26-23)15-18-5-1-2-6-18/h3-4,7-10,12-13,16,18H,1-2,5-6,11,14-15H2,(H,25,26)(H,27,28) D0A0DS DRUGINKE OENIXTHWZWFYIV-UHFFFAOYSA-N D0A0DS DRUGSMIL C1CCC(C1)CC2=CN=C(N2)CCC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O D0A0DS HIGHSTAT Investigative D0A0ED DRUG__ID D0A0ED D0A0ED DRUGTYPE Small molecular drug D0A0ED DRUGINCH 1S/C28H37FN2O/c1-3-5-7-11-19-31(20-12-8-6-4-2)27(32)21-25-24-13-9-10-14-26(24)30-28(25)22-15-17-23(29)18-16-22/h9-10,13-18,30H,3-8,11-12,19-21H2,1-2H3 D0A0ED DRUGINKE VUWXAQFLTSBUDB-UHFFFAOYSA-N D0A0ED DRUGSMIL CCCCCCN(CCCCCC)C(=O)CC1=C(NC2=CC=CC=C21)C3=CC=C(C=C3)F D0A0ED HIGHSTAT Investigative D0A0EI DRUG__ID D0A0EI D0A0EI DRUGCOMP Molecular Partners AG D0A0EI DRUGINCH 1S/C4H8O3/c1-3(7-2)4(5)6/h3H,1-2H3,(H,5,6) D0A0EI DRUGINKE ICPWFHKNYYRBSZ-UHFFFAOYSA-N D0A0EI DRUGSMIL CC(C(=O)O)OC D0A0EI HIGHSTAT Investigative D0A0FK DRUG__ID D0A0FK D0A0FK DRUGTYPE Small molecular drug D0A0FK DRUGINCH 1S/C17H17ClN2/c1-9-4-10-6-11(5-9)16-15(7-10)20-14-8-12(18)2-3-13(14)17(16)19/h2-4,8,10-11H,5-7H2,1H3,(H2,19,20) D0A0FK DRUGINKE UKCBMHDZLYYTMI-UHFFFAOYSA-N D0A0FK DRUGSMIL CC1=CC2CC(C1)C3=C(C4=C(C=C(C=C4)Cl)N=C3C2)N D0A0FK HIGHSTAT Investigative D0A0FY DRUG__ID D0A0FY D0A0FY DRUGTYPE Small molecular drug D0A0FY DRUGINCH 1S/C14H13NO5S/c1-20-10-6-8-11(9-7-10)21(18,19)13-5-3-2-4-12(13)14(16)15-17/h2-9,17H,1H3,(H,15,16) D0A0FY DRUGINKE QPFIKHZWPMXTRS-UHFFFAOYSA-N D0A0FY DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)C2=CC=CC=C2C(=O)NO D0A0FY HIGHSTAT Investigative D0A0GA DRUG__ID D0A0GA D0A0GA DRUGTYPE Small molecular drug D0A0GA DRUGINCH 1S/C19H16N4O2/c1-24-14-7-3-12(4-8-14)16-17-19(21-11-20-17)23-18(22-16)13-5-9-15(25-2)10-6-13/h3-11H,1-2H3,(H,20,21,22,23) D0A0GA DRUGINKE ZGJSQGNKCRURQW-UHFFFAOYSA-N D0A0GA DRUGSMIL COC1=CC=C(C=C1)C2=C3C(=NC(=N2)C4=CC=C(C=C4)OC)N=CN3 D0A0GA HIGHSTAT Investigative D0A0GD DRUG__ID D0A0GD D0A0GD DRUGTYPE Small molecular drug D0A0GD DRUGINCH 1S/C14H28O3/c1-2-3-4-5-6-7-8-9-10-11-13(15)12-14(16)17/h13,15H,2-12H2,1H3,(H,16,17)/t13-/m1/s1 D0A0GD DRUGINKE ATRNZOYKSNPPBF-CYBMUJFWSA-N D0A0GD DRUGSMIL CCCCCCCCCCCC(CC(=O)O)O D0A0GD HIGHSTAT Investigative D0A0JL DRUG__ID D0A0JL D0A0JL DRUGTYPE Small molecular drug D0A0JL DRUGINCH 1S/C10H6N2O2/c11-5-8(6-12)3-7-1-2-9(13)10(14)4-7/h1-4,13-14H D0A0JL DRUGINKE VTJXFTPMFYAJJU-UHFFFAOYSA-N D0A0JL DRUGSMIL C1=CC(=C(C=C1C=C(C#N)C#N)O)O D0A0JL HIGHSTAT Investigative D0A0JU DRUG__ID D0A0JU D0A0JU DRUGTYPE Small molecular drug D0A0JU DRUGINCH 1S/C18H23N3O2S/c1-2-24(22,23)21-16-10-6-9-15(11-16)18(17-12-19-13-20-17)14-7-4-3-5-8-14/h6,9-13,21H,2-5,7-8H2,1H3,(H,19,20) D0A0JU DRUGINKE MTZVJHSZYMWIAG-UHFFFAOYSA-N D0A0JU DRUGSMIL CCS(=O)(=O)NC1=CC=CC(=C1)C(=C2CCCCC2)C3=CN=CN3 D0A0JU HIGHSTAT Investigative D0A0KE DRUG__ID D0A0KE D0A0KE DRUGTYPE Small molecular drug D0A0KE DRUGINCH 1S/C15H15BrN2/c1-17-10-8-15(13-3-2-9-18-11-13)12-4-6-14(16)7-5-12/h2-9,11,17H,10H2,1H3/b15-8- D0A0KE DRUGINKE AZFZKANGXPSDEA-NVNXTCNLSA-N D0A0KE DRUGSMIL CNCC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2 D0A0KE HIGHSTAT Investigative D0A0KP DRUG__ID D0A0KP D0A0KP DRUGTYPE Small molecular drug D0A0KP DRUGINCH 1S/C19H26N2O4S/c1-19(2,12-14-7-5-4-6-8-14)20-13-18(23)15-9-10-17(22)16(11-15)21-26(3,24)25/h4-11,18,20-23H,12-13H2,1-3H3 D0A0KP DRUGINKE XJBCFFLVLOPYBV-UHFFFAOYSA-N D0A0KP DRUGSMIL CC(C)(CC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)NS(=O)(=O)C)O D0A0KP HIGHSTAT Investigative D0A0LE DRUG__ID D0A0LE D0A0LE DRUGTYPE Small molecular drug D0A0LE DRUGINCH 1S/C15H10N2S/c1-10-17-14-8-13(5-6-15(14)18-10)12-4-2-3-11(7-12)9-16/h2-8H,1H3 D0A0LE DRUGINKE QCTQEXSACACMOJ-UHFFFAOYSA-N D0A0LE DRUGSMIL CC1=NC2=C(S1)C=CC(=C2)C3=CC=CC(=C3)C#N D0A0LE HIGHSTAT Investigative D0A0LZ DRUG__ID D0A0LZ D0A0LZ DRUGTYPE Small molecular drug D0A0LZ DRUGINCH 1S/C20H24N2O/c21-20(23)19(17-11-5-2-6-12-17)18-13-7-8-14-22(18)15-16-9-3-1-4-10-16/h1-6,9-12,18-19H,7-8,13-15H2,(H2,21,23)/t18-,19-/m1/s1 D0A0LZ DRUGINKE UMTRWYIEQNNYPX-RTBURBONSA-N D0A0LZ DRUGSMIL C1CCN(C(C1)C(C2=CC=CC=C2)C(=O)N)CC3=CC=CC=C3 D0A0LZ HIGHSTAT Investigative D0A0OJ DRUG__ID D0A0OJ D0A0OJ DRUGTYPE Small molecular drug D0A0OJ DRUGINCH 1S/C6H14O12P2/c7-1-2(8)4(10)6(18-20(14,15)16)5(3(1)9)17-19(11,12)13/h1-10H,(H2,11,12,13)(H2,14,15,16)/t1-,2+,3-,4-,5+,6+/m0/s1 D0A0OJ DRUGINKE MCKAJXMRULSUKI-UZAAGFTCSA-N D0A0OJ DRUGSMIL C1(C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O)O D0A0OJ HIGHSTAT Investigative D0A0RO DRUG__ID D0A0RO D0A0RO DRUGTYPE Small molecular drug D0A0RO DRUGINCH 1S/C12H13N3/c13-12-11(7-4-8-14-12)15-9-10-5-2-1-3-6-10/h1-8,15H,9H2,(H2,13,14) D0A0RO DRUGINKE MUKAGFLFIMVSQN-UHFFFAOYSA-N D0A0RO DRUGSMIL C1=CC=C(C=C1)CNC2=C(N=CC=C2)N D0A0RO HIGHSTAT Investigative D0A0RR DRUG__ID D0A0RR D0A0RR DRUGTYPE Small molecular drug D0A0RR DRUGINCH 1S/C16H26N5O18P3/c17-13-7-14(19-3-18-13)21(4-20-7)15-12(39-42(31,32)33)9(5(1-22)34-15)36-16-8(24)11(38-41(28,29)30)10(6(2-23)35-16)37-40(25,26)27/h3-6,8-12,15-16,22-24H,1-2H2,(H2,17,18,19)(H2,25,26,27)(H2,28,29,30)(H2,31,32,33)/t5-,6-,8-,9-,10-,11-,12-,15-,16-/m1/s1 D0A0RR DRUGINKE RENVITLQVBEFDT-MZQFDOALSA-N D0A0RR DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)OC4C(C(C(C(O4)CO)OP(=O)(O)O)OP(=O)(O)O)O)OP(=O)(O)O)N D0A0RR HIGHSTAT Investigative D0A0RT DRUG__ID D0A0RT D0A0RT DRUGTYPE Small molecular drug D0A0RT DRUGINCH 1S/C24H34O2/c1-13(2)19-9-17(10-20(14(3)4)23(19)25)18-11-21(15(5)6)24(26)22(12-18)16(7)8/h9-16,25-26H,1-8H3 D0A0RT DRUGINKE QAISRHCMPQROAX-UHFFFAOYSA-N D0A0RT DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)C2=CC(=C(C(=C2)C(C)C)O)C(C)C D0A0RT HIGHSTAT Investigative D0A0UC DRUG__ID D0A0UC D0A0UC DRUGTYPE Small molecular drug D0A0UC DRUGINCH 1S/C13H13Cl2N/c14-12-6-5-10(7-13(12)15)11(8-16)9-3-1-2-4-9/h5-7,9,11H,1-4H2 D0A0UC DRUGINKE MWISMDNUXLOMTQ-UHFFFAOYSA-N D0A0UC DRUGSMIL C1CCC(C1)C(C#N)C2=CC(=C(C=C2)Cl)Cl D0A0UC HIGHSTAT Investigative D0A0UL DRUG__ID D0A0UL D0A0UL DRUGTYPE Small molecular drug D0A0UL DRUGINCH 1S/C21H34O5/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25/h5,7,12,14,16-18,22,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25)/b7-5-,14-12+/t16-,17-,18+,21+/m1/s1 D0A0UL DRUGINKE CTXLUMAOXBULOZ-QEQARHSSSA-N D0A0UL DRUGSMIL CCCCCC(C)(C=CC1C(C(CC1=O)O)CC=CCCCC(=O)O)O D0A0UL HIGHSTAT Investigative D0A0UW DRUG__ID D0A0UW D0A0UW DRUGTYPE Small molecular drug D0A0UW DRUGINCH 1S/C18H14N2O2/c1-21-17-9-16-13(7-14(17)18-10-19-11-22-18)8-15(20-16)12-5-3-2-4-6-12/h2-11,20H,1H3 D0A0UW DRUGINKE BESGGLGAKGKEOC-UHFFFAOYSA-N D0A0UW DRUGSMIL COC1=C(C=C2C=C(NC2=C1)C3=CC=CC=C3)C4=CN=CO4 D0A0UW HIGHSTAT Investigative D0A0VT DRUG__ID D0A0VT D0A0VT DRUGTYPE Small molecular drug D0A0VT DRUGINCH 1S/C8H11N5/c1-2-3-13-5-12-8-6(13)7(9)10-4-11-8/h4-5H,2-3H2,1H3,(H2,9,10,11) D0A0VT DRUGINKE RKILQGBFRKICCA-UHFFFAOYSA-N D0A0VT DRUGSMIL CCCN1C=NC2=NC=NC(=C21)N D0A0VT HIGHSTAT Investigative D0A0YX DRUG__ID D0A0YX D0A0YX DRUGTYPE Small molecular drug D0A0YX DRUGINCH 1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9) D0A0YX DRUGINKE CVHZOJJKTDOEJC-UHFFFAOYSA-N D0A0YX DRUGSMIL C1=CC=C2C(=C1)C(=O)NS2(=O)=O D0A0YX HIGHSTAT Investigative D0A0YZ DRUG__ID D0A0YZ D0A0YZ DRUGTYPE Small molecular drug D0A0YZ DRUGINCH 1S/C14H7ClFN3O5/c15-10-5-7(1-3-11(10)16)18-14(21)9(13(20)17-18)6-8-2-4-12(24-8)19(22)23/h1-6H,(H,17,20)/b9-6- D0A0YZ DRUGINKE MSYMKEYWUWVZQY-TWGQIWQCSA-N D0A0YZ DRUGSMIL C1=CC(=C(C=C1N2C(=O)C(=CC3=CC=C(O3)[N+](=O)[O-])C(=O)N2)Cl)F D0A0YZ HIGHSTAT Investigative D0A1CM DRUG__ID D0A1CM D0A1CM DRUGTYPE Small molecular drug D0A1CM DRUGINCH 1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H D0A1CM DRUGINKE AFSDNFLWKVMVRB-UHFFFAOYSA-N D0A1CM DRUGSMIL C1=C2C3=C(C(=C1O)O)OC(=O)C4=CC(=C(C(=C43)OC2=O)O)O D0A1CM HIGHSTAT Investigative D0A1DE DRUG__ID D0A1DE D0A1DE DRUGTYPE Small molecular drug D0A1DE DRUGINCH 1S/C29H30FN3O2/c1-35-25-12-8-21(9-13-25)14-17-32-18-15-23(16-19-32)28(34)29-31-26-4-2-3-5-27(26)33(29)20-22-6-10-24(30)11-7-22/h2-13,23H,14-20H2,1H3 D0A1DE DRUGINKE DIPBPGRFGZKMEF-UHFFFAOYSA-N D0A1DE DRUGSMIL COC1=CC=C(C=C1)CCN2CCC(CC2)C(=O)C3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F D0A1DE HIGHSTAT Investigative D0A1DU DRUG__ID D0A1DU D0A1DU DRUGTYPE Small molecular drug D0A1DU DRUGINCH 1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-2 D0A1DU DRUGINKE XPPKVPWEQAFLFU-UHFFFAOYSA-L D0A1DU DRUGSMIL OP(=O)([O-])OP(=O)(O)[O-] D0A1DU HIGHSTAT Investigative D0A1FE DRUG__ID D0A1FE D0A1FE DRUGTYPE Small molecular drug D0A1FE DRUGINCH 1S/C24H26F3N3O5/c1-14(2)10-22(34)35-16-5-3-4-15(11-16)12-20(31)30-9-8-28-23-17(18(30)13-21(32)33)6-7-19(29-23)24(25,26)27/h3-7,11,14,18H,8-10,12-13H2,1-2H3,(H,28,29)(H,32,33)/t18-/m1/s1 D0A1FE DRUGINKE CJLZUKCACMUYFP-GOSISDBHSA-N D0A1FE DRUGSMIL CC(C)CC(=O)OC1=CC=CC(=C1)CC(=O)N2CCNC3=C(C2CC(=O)O)C=CC(=N3)C(F)(F)F D0A1FE HIGHSTAT Investigative D0A1FL DRUG__ID D0A1FL D0A1FL DRUGTYPE Small molecular drug D0A1FL DRUGINCH 1S/C5H9O7P/c6-4(7)2-1-3(5(8)9)13(10,11)12/h3H,1-2H2,(H,6,7)(H,8,9)(H2,10,11,12) D0A1FL DRUGINKE HHRBAERKINHBJK-UHFFFAOYSA-N D0A1FL DRUGSMIL C(CC(=O)O)C(C(=O)O)P(=O)(O)O D0A1FL HIGHSTAT Investigative D0A1GE DRUG__ID D0A1GE D0A1GE DRUGTYPE Small molecular drug D0A1GE DRUGINCH 1S/C14H15NO2/c1-11-3-4-13(16-2)9-14(11)17-10-12-5-7-15-8-6-12/h3-9H,10H2,1-2H3 D0A1GE DRUGINKE MBHBRRBLXCXQKV-UHFFFAOYSA-N D0A1GE DRUGSMIL CC1=C(C=C(C=C1)OC)OCC2=CC=NC=C2 D0A1GE HIGHSTAT Investigative D0A1GQ DRUG__ID D0A1GQ D0A1GQ DRUGTYPE Small molecular drug D0A1GQ DRUGINCH 1S/C7H14N2O4/c8-4(6(10)11)2-1-3-5(9)7(12)13/h4-5H,1-3,8-9H2,(H,10,11)(H,12,13)/t4-,5+ D0A1GQ DRUGINKE GMKMEZVLHJARHF-SYDPRGILSA-N D0A1GQ DRUGSMIL C(CC(C(=O)O)N)CC(C(=O)O)N D0A1GQ HIGHSTAT Investigative D0A1HH DRUG__ID D0A1HH D0A1HH DRUGTYPE Small molecular drug D0A1HH DRUGINCH 1S/C19H24N2/c1-16-7-5-6-10-18(16)15-19(17-8-3-2-4-9-17)21-13-11-20-12-14-21/h2-10,19-20H,11-15H2,1H3 D0A1HH DRUGINKE XPYLNZBNFQMTKZ-UHFFFAOYSA-N D0A1HH DRUGSMIL CC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D0A1HH HIGHSTAT Investigative D0A1IR DRUG__ID D0A1IR D0A1IR DRUGTYPE Small molecular drug D0A1IR DRUGINCH 1S/C22H45N2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-24-20-16-23(17-21-24)18-22-24/h2-22H2,1H3/q+1 D0A1IR DRUGINKE YPKLQHHICPWJRD-UHFFFAOYSA-N D0A1IR DRUGSMIL CCCCCCCCCCCCCCCC[N+]12CCN(CC1)CC2 D0A1IR HIGHSTAT Investigative D0A1JP DRUG__ID D0A1JP D0A1JP DRUGTYPE Small molecular drug D0A1JP DRUGINCH 1S/C27H30ClNO3/c1-4-29(5-2)17-18-32-23-14-11-20(12-15-23)26(27(28)21-9-7-6-8-10-21)22-13-16-24(30)25(19-22)31-3/h6-16,19,30H,4-5,17-18H2,1-3H3/b27-26- D0A1JP DRUGINKE QRVWKOHAAHLWBP-RQZHXJHFSA-N D0A1JP DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC(=C(C=C3)O)OC D0A1JP HIGHSTAT Investigative D0A1MW DRUG__ID D0A1MW D0A1MW DRUGTYPE Small molecular drug D0A1MW DRUGINCH 1S/C34H47NO11/c1-7-35-15-31(16-41-3)20(37)13-21(42-4)33-19-14-32(40)28(45-30(39)18-11-9-8-10-12-18)22(19)34(46-17(2)36,27(38)29(32)44-6)23(26(33)35)24(43-5)25(31)33/h8-12,19-29,37-38,40H,7,13-16H2,1-6H3/t19-,20-,21+,22-,23+,24+,25-,26?,27+,28-,29+,31+,32-,33+,34-/m1/s1 D0A1MW DRUGINKE XFSBVAOIAHNAPC-XTHSEXKGSA-N D0A1MW DRUGSMIL CCN1CC2(C(CC(C34C2C(C(C31)C5(C6C4CC(C6OC(=O)C7=CC=CC=C7)(C(C5O)OC)O)OC(=O)C)OC)OC)O)COC D0A1MW HIGHSTAT Investigative D0A1PW DRUG__ID D0A1PW D0A1PW DRUGTYPE Small molecular drug D0A1PW DRUGINCH 1S/C5H8O3/c1-4(6)2-3-5(7)8/h2-3H2,1H3,(H,7,8) D0A1PW DRUGINKE JOOXCMJARBKPKM-UHFFFAOYSA-N D0A1PW DRUGSMIL CC(=O)CCC(=O)O D0A1PW HIGHSTAT Investigative D0A1QJ DRUG__ID D0A1QJ D0A1QJ DRUGTYPE Small molecular drug D0A1QJ DRUGINCH 1S/Te D0A1QJ DRUGINKE PORWMNRCUJJQNO-UHFFFAOYSA-N D0A1QJ DRUGSMIL [Te] D0A1QJ HIGHSTAT Investigative D0A1QK DRUG__ID D0A1QK D0A1QK DRUGTYPE Small molecular drug D0A1QK DRUGINCH 1S/C18H23NO4S2/c20-17(4-2-1-3-15-7-8-24-25-15)19-14-6-5-12-10-16(18(21)22)23-11-13(12)9-14/h5-6,9,15-16H,1-4,7-8,10-11H2,(H,19,20)(H,21,22)/t15-,16+/m1/s1 D0A1QK DRUGINKE KRQHPRIBLJFGIT-CVEARBPZSA-N D0A1QK DRUGSMIL C1CSSC1CCCCC(=O)NC2=CC3=C(CC(OC3)C(=O)O)C=C2 D0A1QK HIGHSTAT Investigative D0A1QQ DRUG__ID D0A1QQ D0A1QQ DRUGTYPE Small molecular drug D0A1QQ DRUGINCH 1S/C20H13Cl2N3O2/c1-27-18-9-7-13(11-23-18)25-17-5-3-2-4-14(17)19(20(25)26)24-12-6-8-15(21)16(22)10-12/h2-11H,1H3 D0A1QQ DRUGINKE YZFBJQVMOLTGFZ-UHFFFAOYSA-N D0A1QQ DRUGSMIL COC1=NC=C(C=C1)N2C3=CC=CC=C3C(=NC4=CC(=C(C=C4)Cl)Cl)C2=O D0A1QQ HIGHSTAT Investigative D0A1RE DRUG__ID D0A1RE D0A1RE DRUGTYPE Small molecular drug D0A1RE DRUGINCH 1S/C15H14O4/c1-9-7-15(17)19-14-8-10(5-6-11(9)14)18-13-4-2-3-12(13)16/h5-8,13H,2-4H2,1H3 D0A1RE DRUGINKE UDCMJKJFGCMHHR-UHFFFAOYSA-N D0A1RE DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2)OC3CCCC3=O D0A1RE HIGHSTAT Investigative D0A1RG DRUG__ID D0A1RG D0A1RG DRUGTYPE Small molecular drug D0A1RG DRUGINCH 1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3-,4-,5-/m1/s1 D0A1RG DRUGINKE SRBFZHDQGSBBOR-TXICZTDVSA-N D0A1RG DRUGSMIL C1C(C(C(C(O1)O)O)O)O D0A1RG HIGHSTAT Investigative D0A1SJ DRUG__ID D0A1SJ D0A1SJ DRUGTYPE Small molecular drug D0A1SJ DRUGINCH 1S/C24H30O8/c1-5-29-20-10-14(11-21-23(20)32-13-31-21)6-16-12-30-24(25)17(16)7-15-8-18(26-2)22(28-4)19(9-15)27-3/h8-11,16-17,24-25H,5-7,12-13H2,1-4H3/t16-,17+,24?/m0/s1 D0A1SJ DRUGINKE PPKABVGOUVBEEX-HSQXHLSASA-N D0A1SJ DRUGSMIL CCOC1=CC(=CC2=C1OCO2)CC3COC(C3CC4=CC(=C(C(=C4)OC)OC)OC)O D0A1SJ HIGHSTAT Investigative D0A1SO DRUG__ID D0A1SO D0A1SO DRUGTYPE Small molecular drug D0A1SO DRUGINCH 1S/C14H11NO2/c16-14(13-9-5-2-6-10-13)17-15-11-12-7-3-1-4-8-12/h1-11H/b15-11+ D0A1SO DRUGINKE OILVJUHCCAKJGC-RVDMUPIBSA-N D0A1SO DRUGSMIL C1=CC=C(C=C1)C=NOC(=O)C2=CC=CC=C2 D0A1SO HIGHSTAT Investigative D0A1SP DRUG__ID D0A1SP D0A1SP DRUGTYPE Small molecular drug D0A1SP DRUGINCH 1S/C27H27NO4/c1-2-6-20-18-24(32-23-7-4-3-5-8-23)10-12-26(20)31-14-13-22-17-21-15-19(16-27(29)30)9-11-25(21)28-22/h3-5,7-12,15,17-18,28H,2,6,13-14,16H2,1H3,(H,29,30) D0A1SP DRUGINKE DFFOSEJNFZUOSK-UHFFFAOYSA-N D0A1SP DRUGSMIL CCCC1=C(C=CC(=C1)OC2=CC=CC=C2)OCCC3=CC4=C(N3)C=CC(=C4)CC(=O)O D0A1SP HIGHSTAT Investigative D0A1TG DRUG__ID D0A1TG D0A1TG DRUGTYPE Small molecular drug D0A1TG DRUGINCH 1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1 D0A1TG DRUGINKE RDHQFKQIGNGIED-MRVPVSSYSA-N D0A1TG DRUGSMIL CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C D0A1TG HIGHSTAT Investigative D0A1UB DRUG__ID D0A1UB D0A1UB DRUGTYPE Small molecular drug D0A1UB DRUGINCH 1S/C8H17NO4/c1-2-9-3-6(11)8(13)7(12)5(9)4-10/h5-8,10-13H,2-4H2,1H3/t5-,6+,7-,8-/m1/s1 D0A1UB DRUGINKE DAYOICKCVBMUPS-ULAWRXDQSA-N D0A1UB DRUGSMIL CCN1CC(C(C(C1CO)O)O)O D0A1UB HIGHSTAT Investigative D0A1UL DRUG__ID D0A1UL D0A1UL DRUGCOMP RaQualia Pharma Inc D0A1UL DRUGINCH 1S/C21H13ClF6N2O5S/c22-17-9-14(20(23,24)25)10-29-18(17)30(11-12-1-5-15(6-2-12)35-21(26,27)28)36(33,34)16-7-3-13(4-8-16)19(31)32/h1-10H,11H2,(H,31,32) D0A1UL DRUGINKE IJGQFZYYEHCCIZ-UHFFFAOYSA-N D0A1UL DRUGSMIL C1=CC(=CC=C1CN(C2=C(C=C(C=N2)C(F)(F)F)Cl)S(=O)(=O)C3=CC=C(C=C3)C(=O)O)OC(F)(F)F D0A1UL HIGHSTAT Investigative D0A1WQ DRUG__ID D0A1WQ D0A1WQ DRUGTYPE Small molecular drug D0A1WQ DRUGINCH 1S/C20H21N3O2/c21-14-18-8-4-5-9-19(18)22-10-12-23(13-11-22)20(24)16-25-15-17-6-2-1-3-7-17/h1-9H,10-13,15-16H2 D0A1WQ DRUGINKE LTPGKAICNBCBPT-UHFFFAOYSA-N D0A1WQ DRUGSMIL C1CN(CCN1C2=CC=CC=C2C#N)C(=O)COCC3=CC=CC=C3 D0A1WQ HIGHSTAT Investigative D0A1WR DRUG__ID D0A1WR D0A1WR DRUGTYPE Small molecular drug D0A1WR DRUGINCH 1S/C31H33NO7S2/c1-6-38-31(33)29-15-14-27(39-29)20-32(41(36,37)30-22(3)16-21(2)17-23(30)4)19-24-10-12-25(13-11-24)26-8-7-9-28(18-26)40(5,34)35/h7-18H,6,19-20H2,1-5H3 D0A1WR DRUGINKE HDZWHJYZJWLTAG-UHFFFAOYSA-N D0A1WR DRUGSMIL CCOC(=O)C1=CC=C(O1)CN(CC2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C)S(=O)(=O)C4=C(C=C(C=C4C)C)C D0A1WR HIGHSTAT Investigative D0A1XG DRUG__ID D0A1XG D0A1XG DRUGTYPE Small molecular drug D0A1XG DRUGINCH 1S/C27H37N7O6/c28-20(15-18-8-10-19(35)11-9-18)24(38)33-21(7-4-13-32-27(29)30)26(40)34-22(16-17-5-2-1-3-6-17)25(39)31-14-12-23(36)37/h1-3,5-6,8-11,20-22,35H,4,7,12-16,28H2,(H,31,39)(H,33,38)(H,34,40)(H,36,37)(H4,29,30,32)/t20-,21-,22-/m0/s1 D0A1XG DRUGINKE XNBYETXMULNTPG-FKBYEOEOSA-N D0A1XG DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCCC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CC=C(C=C2)O)N D0A1XG HIGHSTAT Investigative D0A1XH DRUG__ID D0A1XH D0A1XH DRUGTYPE Small molecular drug D0A1XH DRUGINCH 1S/C17H18Cl2O2/c1-3-11(2)8-12-4-6-17(15(20)9-12)21-16-7-5-13(18)10-14(16)19/h4-7,9-11,20H,3,8H2,1-2H3 D0A1XH DRUGINKE LHFFQFRAOUEGEB-UHFFFAOYSA-N D0A1XH DRUGSMIL CCC(C)CC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D0A1XH HIGHSTAT Investigative D0A1YQ DRUG__ID D0A1YQ D0A1YQ DRUGTYPE Small molecular drug D0A1YQ DRUGINCH 1S/C19H12Cl2N2O2/c1-23-9-13(11-4-2-3-5-15(11)23)17-16(18(24)22-19(17)25)12-7-6-10(20)8-14(12)21/h2-9H,1H3,(H,22,24,25) D0A1YQ DRUGINKE JCSGFHVFHSKIJH-UHFFFAOYSA-N D0A1YQ DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl D0A1YQ HIGHSTAT Investigative D0A2AF DRUG__ID D0A2AF D0A2AF DRUGTYPE Small molecular drug D0A2AF DRUGINCH 1S/C13H15N/c1-3-10-14(2)13-9-8-11-6-4-5-7-12(11)13/h1,4-7,13H,8-10H2,2H3/t13-/m1/s1 D0A2AF DRUGINKE CSVGVHNFFZWQJU-CYBMUJFWSA-N D0A2AF DRUGSMIL CN(CC#C)C1CCC2=CC=CC=C12 D0A2AF HIGHSTAT Investigative D0A2BC DRUG__ID D0A2BC D0A2BC DRUGTYPE Small molecular drug D0A2BC DRUGINCH 1S/C26H44O2/c1-4-5-6-7-8-9-18-26(2,3)23-15-12-22(13-16-23)25-20-24(28)17-14-21(25)11-10-19-27/h12-13,15-16,21,24-25,27-28H,4-11,14,17-20H2,1-3H3/t21-,24-,25-/m1/s1 D0A2BC DRUGINKE ZWVZYXMEZOIWEQ-NQHRYMMQSA-N D0A2BC DRUGSMIL CCCCCCCCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D0A2BC HIGHSTAT Investigative D0A2BE DRUG__ID D0A2BE D0A2BE DRUGTYPE Small molecular drug D0A2BE DRUGINCH 1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25) D0A2BE DRUGINKE BVPWJMCABCPUQY-UHFFFAOYSA-N D0A2BE DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CCN(CC2)CC3=CC=CC=C3)Cl)N D0A2BE HIGHSTAT Investigative D0A2EE DRUG__ID D0A2EE D0A2EE DRUGTYPE Small molecular drug D0A2EE DRUGINCH 1S/C10H8O3/c11-9-8(6-13-10(9)12)7-4-2-1-3-5-7/h1-5,8H,6H2 D0A2EE DRUGINKE WYGILTLZANOLBZ-UHFFFAOYSA-N D0A2EE DRUGSMIL C1C(C(=O)C(=O)O1)C2=CC=CC=C2 D0A2EE HIGHSTAT Investigative D0A2FM DRUG__ID D0A2FM D0A2FM DRUGTYPE Small molecular drug D0A2FM DRUGINCH 1S/C12H9N3O3S/c16-10-5-6-11(15-14-10)19(17,18)12-7-8-3-1-2-4-9(8)13-12/h1-7,13H,(H,14,16) D0A2FM DRUGINKE HXNAGYMCTAINEA-UHFFFAOYSA-N D0A2FM DRUGSMIL C1=CC=C2C(=C1)C=C(N2)S(=O)(=O)C3=NNC(=O)C=C3 D0A2FM HIGHSTAT Investigative D0A2GB DRUG__ID D0A2GB D0A2GB DRUGTYPE Small molecular drug D0A2GB DRUGINCH 1S/C16H22N2O2/c1-2-3-4-10-16(11-9-14(19)18-15(16)20)12-5-7-13(17)8-6-12/h5-8H,2-4,9-11,17H2,1H3,(H,18,19,20) D0A2GB DRUGINKE VFLOMQQDKBQIOE-UHFFFAOYSA-N D0A2GB DRUGSMIL CCCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N D0A2GB HIGHSTAT Investigative D0A2GI DRUG__ID D0A2GI D0A2GI DRUGTYPE Small molecular drug D0A2GI DRUGINCH 1S/C22H20N4O2/c23-22(24)26-25-14-17-5-4-8-20(13-17)28-15-16-9-11-19(12-10-16)21(27)18-6-2-1-3-7-18/h1-14H,15H2,(H4,23,24,26)/b25-14- D0A2GI DRUGINKE ROCDIHAUKUGXMY-QFEZKATASA-N D0A2GI DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)COC3=CC=CC(=C3)C=NN=C(N)N D0A2GI HIGHSTAT Investigative D0A2GN DRUG__ID D0A2GN D0A2GN DRUGTYPE Small molecular drug D0A2GN DRUGINCH 1S/C16H11FOS/c17-13-5-1-3-11(9-13)15-7-8-16(19-15)12-4-2-6-14(18)10-12/h1-10,18H D0A2GN DRUGINKE BZEWIGQYBSBQAI-UHFFFAOYSA-N D0A2GN DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC(=CC=C3)F D0A2GN HIGHSTAT Investigative D0A2HS DRUG__ID D0A2HS D0A2HS DRUGCOMP Oregon Health Sciences University; DesignMedix Inc D0A2HS DRUGINCH 1S/C25H34ClN3O2/c1-5-27(6-2)13-14-29-23-17-19(26)9-11-21(23)25(30)22-12-10-20(18-24(22)29)31-16-15-28(7-3)8-4/h9-12,17-18H,5-8,13-16H2,1-4H3 D0A2HS DRUGINKE HBYNOUHPMCAFIO-UHFFFAOYSA-N D0A2HS DRUGSMIL CCN(CC)CCN1C2=C(C=CC(=C2)OCCN(CC)CC)C(=O)C3=C1C=C(C=C3)Cl D0A2HS HIGHSTAT Investigative D0A2IQ DRUG__ID D0A2IQ D0A2IQ DRUGTYPE Small molecular drug D0A2IQ DRUGINCH 1S/C10H14N5O7P/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(22-8)4-21-23(18,19)20/h3,6-8H,2,4H2,1H3,(H,12,16,17)(H2,18,19,20)/t6-,7+,8+/m0/s1 D0A2IQ DRUGINKE OIFWQOKDSPDILA-XLPZGREQSA-N D0A2IQ DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)N=[N+]=[N-] D0A2IQ HIGHSTAT Investigative D0A2JV DRUG__ID D0A2JV D0A2JV DRUGTYPE Small molecular drug D0A2JV DRUGINCH 1S/C21H17N3O4S2/c1-12-2-8-16-18(10-12)29-21(24-16)14-5-9-17(19(11-14)30(26,27)28)23-20(25)13-3-6-15(22)7-4-13/h2-11H,22H2,1H3,(H,23,25)(H,26,27,28) D0A2JV DRUGINKE OINIYAOVPXPWNV-UHFFFAOYSA-N D0A2JV DRUGSMIL CC1=CC2=C(C=C1)N=C(S2)C3=CC(=C(C=C3)NC(=O)C4=CC=C(C=C4)N)S(=O)(=O)O D0A2JV HIGHSTAT Investigative D0A2KN DRUG__ID D0A2KN D0A2KN DRUGTYPE Small molecular drug D0A2KN DRUGINCH 1S/C18H19IN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21)/i19-2 D0A2KN DRUGINKE OOEUHRGMLFVKQO-GBVACIEGSA-N D0A2KN DRUGSMIL C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)I D0A2KN HIGHSTAT Investigative D0A2KT DRUG__ID D0A2KT D0A2KT DRUGTYPE Small molecular drug D0A2KT DRUGINCH 1S/C21H26NO2.HI/c1-22(2)15-13-19(14-16-22)24-21(23)20(17-9-5-3-6-10-17)18-11-7-4-8-12-18;/h3-12,19-20H,13-16H2,1-2H3;1H/q+1;/p-1 D0A2KT DRUGINKE WWJHRSCUAQPFQO-UHFFFAOYSA-M D0A2KT DRUGSMIL C[N+]1(CCC(CC1)OC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)C.[I-] D0A2KT HIGHSTAT Investigative D0A2KW DRUG__ID D0A2KW D0A2KW DRUGTYPE Small molecular drug D0A2KW DRUGINCH 1S/C20H16Br2N2O/c21-16-10-6-14(7-11-16)19(15-8-12-17(22)13-9-15)24-20(25)23-18-4-2-1-3-5-18/h1-13,19H,(H2,23,24,25) D0A2KW DRUGINKE MNUYZVNTMQHNEW-UHFFFAOYSA-N D0A2KW DRUGSMIL C1=CC=C(C=C1)NC(=O)NC(C2=CC=C(C=C2)Br)C3=CC=C(C=C3)Br D0A2KW HIGHSTAT Investigative D0A2LP DRUG__ID D0A2LP D0A2LP DRUGTYPE Small molecular drug D0A2LP DRUGINCH 1S/C16H14N2/c1-11-4-3-5-14(10-11)15-9-8-13-7-6-12(2)17-16(13)18-15/h3-10H,1-2H3 D0A2LP DRUGINKE RJHUNTTZZMJQOV-UHFFFAOYSA-N D0A2LP DRUGSMIL CC1=CC(=CC=C1)C2=NC3=C(C=CC(=N3)C)C=C2 D0A2LP HIGHSTAT Investigative D0A2NK DRUG__ID D0A2NK D0A2NK DRUGTYPE Small molecular drug D0A2NK DRUGINCH 1S/C31H37NO10/c1-16(33)38-15-30(5)22-13-24(40-18(3)35)31(6)27(29(22,4)10-9-23(30)39-17(2)34)26(36)25-21(42-31)12-20(41-28(25)37)19-8-7-11-32-14-19/h7-8,11-12,14,22-24,26-27,36H,9-10,13,15H2,1-6H3/t22-,23+,24+,26+,27-,29+,30+,31-/m1/s1 D0A2NK DRUGINKE PMMQOFWSZRQWEV-RVTXXDJVSA-N D0A2NK DRUGSMIL CC(=O)OCC1(C(CCC2(C1CC(C3(C2C(C4=C(O3)C=C(OC4=O)C5=CN=CC=C5)O)C)OC(=O)C)C)OC(=O)C)C D0A2NK HIGHSTAT Investigative D0A2OH DRUG__ID D0A2OH D0A2OH DRUGTYPE Small molecular drug D0A2OH DRUGINCH 1S/C23H24O6/c1-6-23(4,5)18-14(24)10-16-17(21(18)28)20(27)13-9-15(25)19(26)12(22(13)29-16)8-7-11(2)3/h6-7,9-10,24-26,28H,1,8H2,2-5H3 D0A2OH DRUGINKE LVKPSBFBKBJJOB-UHFFFAOYSA-N D0A2OH DRUGSMIL CC(=CCC1=C2C(=CC(=C1O)O)C(=O)C3=C(O2)C=C(C(=C3O)C(C)(C)C=C)O)C D0A2OH HIGHSTAT Investigative D0A2PD DRUG__ID D0A2PD D0A2PD DRUGTYPE Small molecular drug D0A2PD DRUGINCH 1S/C6H7N2O2S.Hg/c7-5-1-3-6(4-2-5)11(8,9)10;/h1,3-4H,7H2,(H2,8,9,10); D0A2PD DRUGINKE KGGLGSZFQPTPPT-UHFFFAOYSA-N D0A2PD DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)[Hg])N D0A2PD HIGHSTAT Investigative D0A2QP DRUG__ID D0A2QP D0A2QP DRUGTYPE Small molecular drug D0A2QP DRUGINCH 1S/C8H9NO2/c1-9(11)8(10)7-5-3-2-4-6-7/h2-6,11H,1H3 D0A2QP DRUGINKE DDSSLJHUWRMSSP-UHFFFAOYSA-N D0A2QP DRUGSMIL CN(C(=O)C1=CC=CC=C1)O D0A2QP HIGHSTAT Investigative D0A2SA DRUG__ID D0A2SA D0A2SA DRUGTYPE Small molecular drug D0A2SA DRUGINCH 1S/C16H13NO2/c1-2-11-17-13-8-4-6-10-15(13)19-14-9-5-3-7-12(14)16(17)18/h2-10H,1,11H2 D0A2SA DRUGINKE QANXXCPLBYYJSG-UHFFFAOYSA-N D0A2SA DRUGSMIL C=CCN1C2=CC=CC=C2OC3=CC=CC=C3C1=O D0A2SA HIGHSTAT Investigative D0A2SK DRUG__ID D0A2SK D0A2SK DRUGTYPE Small molecular drug D0A2SK DRUGINCH 1S/C22H36N2O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-22(25)21-18-17-20-23-24-21/h9-10,17-18,20H,2-8,11-16,19H2,1H3/b10-9- D0A2SK DRUGINKE REQRZXMTFPJHJQ-KTKRTIGZSA-N D0A2SK DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NN=CC=C1 D0A2SK HIGHSTAT Investigative D0A2SY DRUG__ID D0A2SY D0A2SY DRUGTYPE Small molecular drug D0A2SY DRUGINCH 1S/C25H28N4O2/c1-18-16-20(4-6-22(18)19-8-10-26-11-9-19)25(30)27-21-5-7-24(31-3)23(17-21)29-14-12-28(2)13-15-29/h4-11,16-17H,12-15H2,1-3H3,(H,27,30)/i2T3 D0A2SY DRUGINKE GNOXPYACARZYMW-BHTRQJOGSA-N D0A2SY DRUGSMIL CC1=C(C=CC(=C1)C(=O)NC2=CC(=C(C=C2)OC)N3CCN(CC3)C)C4=CC=NC=C4 D0A2SY HIGHSTAT Investigative D0A2TJ DRUG__ID D0A2TJ D0A2TJ DRUGCOMP Universita degli Studi di Siena D0A2TJ DRUGINCH 1S/C28H19NO3/c1-18(30)31-28-24-14-7-15-29(24)25-16-20-9-2-3-10-21(20)17-26(25)32-27(28)23-13-6-11-19-8-4-5-12-22(19)23/h2-17H,1H3 D0A2TJ DRUGINKE STVDRIIZTGYIMM-UHFFFAOYSA-N D0A2TJ DRUGSMIL CC(=O)OC1=C(OC2=CC3=CC=CC=C3C=C2N4C1=CC=C4)C5=CC=CC6=CC=CC=C65 D0A2TJ HIGHSTAT Investigative D0A2UX DRUG__ID D0A2UX D0A2UX DRUGTYPE Small molecular drug D0A2UX DRUGINCH 1S/C17H14N2O7S3/c1-11(20)19-15-7-5-13(17(9-15)29(24,25)26)3-2-12-4-6-14(18-10-27)8-16(12)28(21,22)23/h2-9H,1H3,(H,19,20)(H,21,22,23)(H,24,25,26)/b3-2+ D0A2UX DRUGINKE YJCCSLGGODRWKK-NSCUHMNNSA-N D0A2UX DRUGSMIL CC(=O)NC1=CC(=C(C=C1)C=CC2=C(C=C(C=C2)N=C=S)S(=O)(=O)O)S(=O)(=O)O D0A2UX HIGHSTAT Investigative D0A2WH DRUG__ID D0A2WH D0A2WH DRUGTYPE Small molecular drug D0A2WH DRUGINCH 1S/C9H12N4O2/c1-2-3-4-13-8(14)6-7(11-5-10-6)12-9(13)15/h5H,2-4H2,1H3,(H,10,11)(H,12,15) D0A2WH DRUGINKE HZPVRRDNEDXPAJ-UHFFFAOYSA-N D0A2WH DRUGSMIL CCCCN1C(=O)C2=C(NC1=O)N=CN2 D0A2WH HIGHSTAT Investigative D0A2WT DRUG__ID D0A2WT D0A2WT DRUGTYPE Small molecular drug D0A2WT DRUGINCH 1S/C8H13N3/c1-6-7(2-3-10-6)8-4-9-5-11-8/h4-7,10H,2-3H2,1H3,(H,9,11)/t6-,7+/m1/s1 D0A2WT DRUGINKE FLOJCNYYPGNYBP-RQJHMYQMSA-N D0A2WT DRUGSMIL CC1C(CCN1)C2=CN=CN2 D0A2WT HIGHSTAT Investigative D0A2YG DRUG__ID D0A2YG D0A2YG DRUGTYPE Small molecular drug D0A2YG DRUGINCH 1S/C12H13NS/c1-13-9-10-5-2-3-6-11(10)12-7-4-8-14-12/h2-8,13H,9H2,1H3 D0A2YG DRUGINKE MRKJJEJYTBOUTH-UHFFFAOYSA-N D0A2YG DRUGSMIL CNCC1=CC=CC=C1C2=CC=CS2 D0A2YG HIGHSTAT Investigative D0A2ZH DRUG__ID D0A2ZH D0A2ZH DRUGTYPE Small molecular drug D0A2ZH DRUGINCH 1S/C17H13BrO7/c18-11-3-6-14(25-9-16(21)22)13(7-11)17(23)10-1-4-12(5-2-10)24-8-15(19)20/h1-7H,8-9H2,(H,19,20)(H,21,22) D0A2ZH DRUGINKE PTQLZKRWKHXUJU-UHFFFAOYSA-N D0A2ZH DRUGSMIL C1=CC(=CC=C1C(=O)C2=C(C=CC(=C2)Br)OCC(=O)O)OCC(=O)O D0A2ZH HIGHSTAT Investigative D0A3CB DRUG__ID D0A3CB D0A3CB DRUGTYPE Small molecular drug D0A3CB DRUGINCH 1S/C13H9ClN2S/c14-10-4-1-2-6-13(10)17-12-7-3-5-11(16)9(12)8-15/h1-7H,16H2 D0A3CB DRUGINKE ICAGMNDXSMYTTM-UHFFFAOYSA-N D0A3CB DRUGSMIL C1=CC=C(C(=C1)SC2=CC=CC(=C2C#N)N)Cl D0A3CB HIGHSTAT Investigative D0A3DE DRUG__ID D0A3DE D0A3DE DRUGTYPE Small molecular drug D0A3DE DRUGINCH 1S/C32H31ClN4O5/c1-41-27-4-3-5-28(42-2)29(27)26-16-24(36-37(26)25-8-9-34-23-15-21(33)6-7-22(23)25)30(38)35-32(31(39)40)19-11-17-10-18(13-19)14-20(32)12-17/h3-9,15-20H,10-14H2,1-2H3,(H,35,38)(H,39,40)/i1T3,2T3 D0A3DE DRUGINKE DYLJVOXRWLXDIG-VQBNBCTGSA-N D0A3DE DRUGSMIL COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O D0A3DE HIGHSTAT Investigative D0A3FF DRUG__ID D0A3FF D0A3FF DRUGTYPE Small molecular drug D0A3FF DRUGINCH 1S/C7H14O6/c1-12-7-6(11)5(10)4(9)3(2-8)13-7/h3-11H,2H2,1H3/t3-,4-,5+,6-,7+/m1/s1 D0A3FF DRUGINKE HOVAGTYPODGVJG-ZFYZTMLRSA-N D0A3FF DRUGSMIL COC1C(C(C(C(O1)CO)O)O)O D0A3FF HIGHSTAT Investigative D0A3JR DRUG__ID D0A3JR D0A3JR DRUGTYPE Small molecular drug D0A3JR DRUGINCH 1S/C14H13ClN2O3S/c15-12-9-11(21(16,19)20)6-7-13(12)17-14(18)8-10-4-2-1-3-5-10/h1-7,9H,8H2,(H,17,18)(H2,16,19,20) D0A3JR DRUGINKE PCTUCNXXOLZRTM-UHFFFAOYSA-N D0A3JR DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=C(C=C(C=C2)S(=O)(=O)N)Cl D0A3JR HIGHSTAT Investigative D0A3KA DRUG__ID D0A3KA D0A3KA DRUGTYPE Small molecular drug D0A3KA DRUGINCH 1S/C24H29F3O8/c1-22-6-4-14-21(30)35-17(13-5-7-32-10-13)9-23(14,2)19(22)18(28)16(8-15(22)20(29)31-3)34-12-33-11-24(25,26)27/h5,7,10,14-17,19H,4,6,8-9,11-12H2,1-3H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1 D0A3KA DRUGINKE RUKCGYZDLPIDHQ-AGQYDFLVSA-N D0A3KA DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOCC(F)(F)F)C)C4=COC=C4 D0A3KA HIGHSTAT Investigative D0A3QB DRUG__ID D0A3QB D0A3QB DRUGTYPE Small molecular drug D0A3QB DRUGINCH 1S/C34H26Br4N4O8/c35-21-9-17-1-3-27(21)49-29-15-19(11-23(37)31(29)43)6-8-40-33(45)25(41-47)13-18-2-4-28(22(36)10-18)50-30-16-20(12-24(38)32(30)44)14-26(42-48)34(46)39-7-5-17/h1-5,7,9-12,15-16,43-44,47-48H,6,8,13-14H2,(H,39,46)(H,40,45)/b7-5+,41-25+,42-26+ D0A3QB DRUGINKE ZDBNBLMYAGHTJD-HIHPLZGUSA-N D0A3QB DRUGSMIL C1CNC(=O)C(=NO)CC2=CC(=C(C=C2)OC3=C(C(=CC(=C3)CC(=NO)C(=O)NC=CC4=CC(=C(C=C4)OC5=C(C(=CC1=C5)Br)O)Br)Br)O)Br D0A3QB HIGHSTAT Investigative D0A3QM DRUG__ID D0A3QM D0A3QM DRUGTYPE Small molecular drug D0A3QM DRUGINCH 1S/C8H10N4S/c1-6(11-12-8(9)13)7-3-2-4-10-5-7/h2-5H,1H3,(H3,9,12,13)/b11-6- D0A3QM DRUGINKE PFDWFNDHRREIDD-WDZFZDKYSA-N D0A3QM DRUGSMIL CC(=NNC(=S)N)C1=CN=CC=C1 D0A3QM HIGHSTAT Investigative D0A3QO DRUG__ID D0A3QO D0A3QO DRUGTYPE Small molecular drug D0A3QO DRUGINCH 1S/C3H9N3O3S/c4-3(5)6-1-2-10(7,8)9/h1-2H2,(H4,4,5,6)(H,7,8,9) D0A3QO DRUGINKE JKLRIMRKZBSSED-UHFFFAOYSA-N D0A3QO DRUGSMIL C(CS(=O)(=O)O)N=C(N)N D0A3QO HIGHSTAT Investigative D0A3TE DRUG__ID D0A3TE D0A3TE DRUGTYPE Small molecular drug D0A3TE DRUGINCH 1S/C18H13NS/c1-2-7-14(8-3-1)18-13-15-9-6-12-19(15)16-10-4-5-11-17(16)20-18/h1-13H D0A3TE DRUGINKE XBVRXEAOFZWJAH-UHFFFAOYSA-N D0A3TE DRUGSMIL C1=CC=C(C=C1)C2=CC3=CC=CN3C4=CC=CC=C4S2 D0A3TE HIGHSTAT Investigative D0A3XB DRUG__ID D0A3XB D0A3XB DRUGTYPE Small molecular drug D0A3XB DRUGINCH 1S/C19H23N3S/c1-2-10-20-19(5-1)22-13-11-21(12-14-22)17-8-6-16(7-9-17)18-4-3-15-23-18/h1-6,10,15,17H,7-9,11-14H2 D0A3XB DRUGINKE CXONTQZSVJEICK-UHFFFAOYSA-N D0A3XB DRUGSMIL C1CC(=CCC1N2CCN(CC2)C3=CC=CC=N3)C4=CC=CS4 D0A3XB HIGHSTAT Investigative D0A3YH DRUG__ID D0A3YH D0A3YH DRUGTYPE Small molecular drug D0A3YH DRUGINCH 1S/C25H33N5O5/c1-16(30(3)24(34)20(26)13-18-9-11-19(31)12-10-18)23(33)28-21(14-17-7-5-4-6-8-17)25(35)29(2)15-22(27)32/h4-12,16,20-21,31H,13-15,26H2,1-3H3,(H2,27,32)(H,28,33)/t16-,20+,21+/m1/s1 D0A3YH DRUGINKE GRHNSLXBGRDMSP-CZAAIQMYSA-N D0A3YH DRUGSMIL CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N(C)CC(=O)N)N(C)C(=O)C(CC2=CC=C(C=C2)O)N D0A3YH HIGHSTAT Investigative D0A3YK DRUG__ID D0A3YK D0A3YK DRUGTYPE Small molecular drug D0A3YK DRUGINCH 1S/C22H24N2/c1-2-7-20(8-3-1)22(24-14-12-23-13-15-24)17-18-10-11-19-6-4-5-9-21(19)16-18/h1-11,16,22-23H,12-15,17H2 D0A3YK DRUGINKE HSPJWADLPHSZQN-UHFFFAOYSA-N D0A3YK DRUGSMIL C1CN(CCN1)C(CC2=CC3=CC=CC=C3C=C2)C4=CC=CC=C4 D0A3YK HIGHSTAT Investigative D0A3YN DRUG__ID D0A3YN D0A3YN DRUGTYPE Small molecular drug D0A3YN DRUGINCH 1S/C34H31Cl2N7O5/c1-21(44)40-29-14-10-22(17-38-29)11-15-30(45)39-18-31(46)42(2)26-13-12-25(35)24(32(26)36)20-48-28-9-6-8-27-33(28)41-34(47-3)43(27)19-23-7-4-5-16-37-23/h4-17H,18-20H2,1-3H3,(H,39,45)(H,38,40,44)/b15-11+ D0A3YN DRUGINKE KXMCFJQQOFOBKN-RVDMUPIBSA-N D0A3YN DRUGSMIL CC(=O)NC1=NC=C(C=C1)C=CC(=O)NCC(=O)N(C)C2=C(C(=C(C=C2)Cl)COC3=CC=CC4=C3N=C(N4CC5=CC=CC=N5)OC)Cl D0A3YN HIGHSTAT Investigative D0A4AB DRUG__ID D0A4AB D0A4AB DRUGTYPE Small molecular drug D0A4AB DRUGINCH 1S/C12H11N3/c1-2-4-10-9(3-1)5-6-11(15-10)12-13-7-8-14-12/h1-6H,7-8H2,(H,13,14) D0A4AB DRUGINKE OSUVWJGCKQEMHK-UHFFFAOYSA-N D0A4AB DRUGSMIL C1CN=C(N1)C2=NC3=CC=CC=C3C=C2 D0A4AB HIGHSTAT Investigative D0A4AL DRUG__ID D0A4AL D0A4AL DRUGTYPE Small molecular drug D0A4AL DRUGINCH 1S/C23H29N5O13P2/c1-10-12-5-38-23(32)14(12)16(29)11(19(10)37-2)3-4-39-42(33,34)9-43(35,36)40-6-13-17(30)18(31)22(41-13)28-8-27-15-20(24)25-7-26-21(15)28/h7-8,13,17-18,22,29-31H,3-6,9H2,1-2H3,(H,33,34)(H,35,36)(H2,24,25,26)/t13-,17-,18-,22-/m1/s1 D0A4AL DRUGINKE AMYUZLUBFKOUEX-JKWAKEATSA-N D0A4AL DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CCOP(=O)(CP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O D0A4AL HIGHSTAT Investigative D0A4DR DRUG__ID D0A4DR D0A4DR DRUGTYPE Small molecular drug D0A4DR DRUGINCH 1S/C11H11NO2/c1-11(7-9(13)12-10(11)14)8-5-3-2-4-6-8/h2-6H,7H2,1H3,(H,12,13,14) D0A4DR DRUGINKE UDESUGJZUFALAM-UHFFFAOYSA-N D0A4DR DRUGSMIL CC1(CC(=O)NC1=O)C2=CC=CC=C2 D0A4DR HIGHSTAT Investigative D0A4EA DRUG__ID D0A4EA D0A4EA DRUGTYPE Small molecular drug D0A4EA DRUGINCH 1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9- D0A4EA DRUGINKE ZQPPMHVWECSIRJ-KTKRTIGZSA-N D0A4EA DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)O D0A4EA HIGHSTAT Investigative D0A4FA DRUG__ID D0A4FA D0A4FA DRUGTYPE Small molecular drug D0A4FA DRUGINCH 1S/C12H12N2O/c15-12(11-7-4-8-13-11)14-9-10-5-2-1-3-6-10/h1-8,13H,9H2,(H,14,15) D0A4FA DRUGINKE PSYQATYJXPGBDC-UHFFFAOYSA-N D0A4FA DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC=CN2 D0A4FA HIGHSTAT Investigative D0A4FU DRUG__ID D0A4FU D0A4FU DRUGTYPE Small molecular drug D0A4FU DRUGINCH 1S/C16H23NO3/c1-2-5-14-6-3-4-7-16(14)20-13-15(18)12-17-8-10-19-11-9-17/h2-4,6-7,15,18H,1,5,8-13H2 D0A4FU DRUGINKE BKDPODVOOWQEGE-UHFFFAOYSA-N D0A4FU DRUGSMIL C=CCC1=CC=CC=C1OCC(CN2CCOCC2)O D0A4FU HIGHSTAT Investigative D0A4GE DRUG__ID D0A4GE D0A4GE DRUGTYPE Small molecular drug D0A4GE DRUGINCH 1S/C17H17NO2/c19-15-9-12-5-6-18-14-8-11-4-2-1-3-10(11)7-13(16(12)14)17(15)20/h1-4,9,14,18-20H,5-8H2 D0A4GE DRUGINKE SVRDMCXMTWERHI-UHFFFAOYSA-N D0A4GE DRUGSMIL C1CNC2CC3=CC=CC=C3CC4=C2C1=CC(=C4O)O D0A4GE HIGHSTAT Investigative D0A4HF DRUG__ID D0A4HF D0A4HF DRUGTYPE Small molecular drug D0A4HF DRUGINCH 1S/C14H11F2NO2/c15-11-5-1-3-9(7-11)13(14(18)17-19)10-4-2-6-12(16)8-10/h1-8,13,19H,(H,17,18) D0A4HF DRUGINKE OCJJUBQJPOHGBE-UHFFFAOYSA-N D0A4HF DRUGSMIL C1=CC(=CC(=C1)F)C(C2=CC(=CC=C2)F)C(=O)NO D0A4HF HIGHSTAT Investigative D0A4HS DRUG__ID D0A4HS D0A4HS DRUGTYPE Small molecular drug D0A4HS DRUGINCH 1S/C7H9BO3/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5,9-10H,1H3 D0A4HS DRUGINKE VOAAEKKFGLPLLU-UHFFFAOYSA-N D0A4HS DRUGSMIL B(C1=CC=C(C=C1)OC)(O)O D0A4HS HIGHSTAT Investigative D0A4IY DRUG__ID D0A4IY D0A4IY DRUGTYPE Small molecular drug D0A4IY DRUGINCH 1S/CH5N3O/c2-1(5)4-3/h3H2,(H3,2,4,5) D0A4IY DRUGINKE DUIOPKIIICUYRZ-UHFFFAOYSA-N D0A4IY DRUGSMIL C(=O)(N)NN D0A4IY HIGHSTAT Investigative D0A4KW DRUG__ID D0A4KW D0A4KW DRUGTYPE Small molecular drug D0A4KW DRUGINCH 1S/C17H14N2O2/c18-15-7-6-13(14-8-9-21-11-14)10-16(15)19-17(20)12-4-2-1-3-5-12/h1-11H,18H2,(H,19,20) D0A4KW DRUGINKE MHJRDSWPLXKJLI-UHFFFAOYSA-N D0A4KW DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=COC=C3)N D0A4KW HIGHSTAT Investigative D0A4LH DRUG__ID D0A4LH D0A4LH DRUGTYPE Small molecular drug D0A4LH DRUGINCH 1S/C21H17NO3S/c1-15-10-12-16(13-11-15)26(24,25)22-14-21(23)19-8-3-2-6-17(19)18-7-4-5-9-20(18)22/h2-13H,14H2,1H3 D0A4LH DRUGINKE KCIOJLFKVQHRPU-UHFFFAOYSA-N D0A4LH DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CC(=O)C3=CC=CC=C3C4=CC=CC=C42 D0A4LH HIGHSTAT Investigative D0A4LM DRUG__ID D0A4LM D0A4LM DRUGTYPE Small molecular drug D0A4LM DRUGINCH 1S/C15H13NO3S2/c1-10(7-11-5-3-2-4-6-11)8-12-14(19)16(9-13(17)18)15(20)21-12/h2-8H,9H2,1H3,(H,17,18)/b10-7-,12-8+ D0A4LM DRUGINKE CHNUOJQWGUIOLD-MITUOZDPSA-N D0A4LM DRUGSMIL CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O D0A4LM HIGHSTAT Investigative D0A4LW DRUG__ID D0A4LW D0A4LW DRUGTYPE Small molecular drug D0A4LW DRUGINCH 1S/C19H23NO/c1-14(2)13-16-9-11-17(12-10-16)15(3)19(21)20-18-7-5-4-6-8-18/h4-12,14-15H,13H2,1-3H3,(H,20,21)/t15-/m1/s1 D0A4LW DRUGINKE UHKIXOMKDZNTLI-OAHLLOKOSA-N D0A4LW DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)NC2=CC=CC=C2 D0A4LW HIGHSTAT Investigative D0A4MK DRUG__ID D0A4MK D0A4MK DRUGTYPE Small molecular drug D0A4MK DRUGINCH 1S/C23H25Cl2N7O4/c1-4-8-31-21-19(22(34)32(9-5-2)23(31)35)27-20(28-21)16-11-18(29-30(16)3)36-12-17(33)26-13-6-7-14(24)15(25)10-13/h6-7,10-11H,4-5,8-9,12H2,1-3H3,(H,26,33)(H,27,28) D0A4MK DRUGINKE OESRCCUPNGDTIR-UHFFFAOYSA-N D0A4MK DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)NC4=CC(=C(C=C4)Cl)Cl D0A4MK HIGHSTAT Investigative D0A4ML DRUG__ID D0A4ML D0A4ML DRUGTYPE Small molecular drug D0A4ML DRUGINCH 1S/C24H22O2/c1-2-3-7-23-24(21-6-4-5-8-22(21)26-23)19-11-9-17(10-12-19)18-13-15-20(25)16-14-18/h4-6,8-16,25H,2-3,7H2,1H3 D0A4ML DRUGINKE JIBMWJCMDPEYQP-UHFFFAOYSA-N D0A4ML DRUGSMIL CCCCC1=C(C2=CC=CC=C2O1)C3=CC=C(C=C3)C4=CC=C(C=C4)O D0A4ML HIGHSTAT Investigative D0A4MM DRUG__ID D0A4MM D0A4MM DRUGTYPE Small molecular drug D0A4MM DRUGINCH 1S/C8H13NO7P2/c1-9-4-2-3-7(6-9)5-8(10,17(11,12)13)18(14,15)16/h2-4,6,10H,5H2,1H3,(H3-,11,12,13,14,15,16)/p+1 D0A4MM DRUGINKE BBNRLGQPSIXFHZ-UHFFFAOYSA-O D0A4MM DRUGSMIL C[N+]1=CC=CC(=C1)CC(O)(P(=O)(O)O)P(=O)(O)O D0A4MM HIGHSTAT Investigative D0A4NO DRUG__ID D0A4NO D0A4NO DRUGTYPE Small molecular drug D0A4NO DRUGINCH 1S/C30H38N4O4S2/c1-7-9-14-38-30(35)33-40(36,37)29-25(17-24(39-29)15-19(3)4)23-12-10-22(11-13-23)18-34-26(8-2)32-27-20(5)16-21(6)31-28(27)34/h10-13,16-17,19H,7-9,14-15,18H2,1-6H3,(H,33,35) D0A4NO DRUGINKE RINPELQWLUGERM-UHFFFAOYSA-N D0A4NO DRUGSMIL CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C(=NC4=C3N=C(C=C4C)C)CC D0A4NO HIGHSTAT Investigative D0A4TC DRUG__ID D0A4TC D0A4TC DRUGTYPE Small molecular drug D0A4TC DRUGINCH 1S/C18H23N3O5S/c1-13(2)17(18(22)20-23)21(12-14-5-4-10-19-11-14)27(24,25)16-8-6-15(26-3)7-9-16/h4-11,13,17,23H,12H2,1-3H3,(H,20,22)/t17-/m1/s1 D0A4TC DRUGINKE BSIZUMJRKYHEBR-QGZVFWFLSA-N D0A4TC DRUGSMIL CC(C)C(C(=O)NO)N(CC1=CN=CC=C1)S(=O)(=O)C2=CC=C(C=C2)OC D0A4TC HIGHSTAT Investigative D0A4TF DRUG__ID D0A4TF D0A4TF DRUGTYPE Small molecular drug D0A4TF DRUGINCH 1S/C36H34N4O4/c1-43-33-20-25-16-18-40(23-28(25)21-34(33)44-2)17-15-24-11-13-29(14-12-24)38-36(42)30-8-4-6-10-32(30)39-35(41)27-19-26-7-3-5-9-31(26)37-22-27/h3-14,19-22H,15-18,23H2,1-2H3,(H,38,42)(H,39,41) D0A4TF DRUGINKE TZASTBIDWCFCGN-UHFFFAOYSA-N D0A4TF DRUGSMIL COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC D0A4TF HIGHSTAT Investigative D0A4TS DRUG__ID D0A4TS D0A4TS DRUGTYPE Small molecular drug D0A4TS DRUGINCH 1S/C14H25NO3/c1-5-18-14(17)15-13(16)12-8-10(4)6-7-11(12)9(2)3/h9-12H,5-8H2,1-4H3,(H,15,16,17)/t10-,11+,12-/m1/s1 D0A4TS DRUGINKE AOTWCRSILVRYCS-GRYCIOLGSA-N D0A4TS DRUGSMIL CCOC(=O)NC(=O)C1CC(CCC1C(C)C)C D0A4TS HIGHSTAT Investigative D0A4UQ DRUG__ID D0A4UQ D0A4UQ DRUGTYPE Small molecular drug D0A4UQ DRUGINCH 1S/C15H8Br2O2/c16-10-3-1-2-9(6-10)15-8-13(18)12-7-11(17)4-5-14(12)19-15/h1-8H D0A4UQ DRUGINKE UIPGLQFPZVUUQW-UHFFFAOYSA-N D0A4UQ DRUGSMIL C1=CC(=CC(=C1)Br)C2=CC(=O)C3=C(O2)C=CC(=C3)Br D0A4UQ HIGHSTAT Investigative D0A4VS DRUG__ID D0A4VS D0A4VS DRUGTYPE Small molecular drug D0A4VS DRUGINCH 1S/C21H29FN2O2/c22-18-3-5-19(6-4-18)26-8-2-1-7-23-20(25)24-21-12-15-9-16(13-21)11-17(10-15)14-21/h3-6,15-17H,1-2,7-14H2,(H2,23,24,25) D0A4VS DRUGINKE PVCKSZSZTVYJKW-UHFFFAOYSA-N D0A4VS DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCCCOC4=CC=C(C=C4)F D0A4VS HIGHSTAT Investigative D0A4XA DRUG__ID D0A4XA D0A4XA DRUGTYPE Small molecular drug D0A4XA DRUGINCH 1S/C14H10N2O2S/c17-11-5-1-3-9(7-11)13-15-14(19-16-13)10-4-2-6-12(18)8-10/h1-8,17-18H D0A4XA DRUGINKE OYXDKVOVGLCIIZ-UHFFFAOYSA-N D0A4XA DRUGSMIL C1=CC(=CC(=C1)O)C2=NSC(=N2)C3=CC(=CC=C3)O D0A4XA HIGHSTAT Investigative D0A4XL DRUG__ID D0A4XL D0A4XL DRUGTYPE Small molecular drug D0A4XL DRUGINCH 1S/C6H11N3/c1-9-4-6(2-3-7)8-5-9/h4-5H,2-3,7H2,1H3 D0A4XL DRUGINKE FHQDWPCFSJMNCT-UHFFFAOYSA-N D0A4XL DRUGSMIL CN1C=C(N=C1)CCN D0A4XL HIGHSTAT Investigative D0A4ZR DRUG__ID D0A4ZR D0A4ZR DRUGTYPE Small molecular drug D0A4ZR DRUGINCH 1S/C15H26N2O2/c1-3-15(4-2)13(18)17-14(19-15)16-12-10-8-6-5-7-9-11-12/h12H,3-11H2,1-2H3,(H,16,17,18) D0A4ZR DRUGINKE RCJPILQMNSKTFG-UHFFFAOYSA-N D0A4ZR DRUGSMIL CCC1(C(=O)NC(=NC2CCCCCCC2)O1)CC D0A4ZR HIGHSTAT Investigative D0A5AT DRUG__ID D0A5AT D0A5AT DRUGTYPE Small molecular drug D0A5AT DRUGINCH 1S/C34H39N3O6S/c1-21-11-7-10-16-27(21)43-19-28(39)35-25(17-22-12-5-4-6-13-22)30(40)33(42)37-20-44-34(2,3)31(37)32(41)36-29-24-15-9-8-14-23(24)18-26(29)38/h4-16,25-26,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t25-,26+,29-,30-,31+/m0/s1 D0A5AT DRUGINKE LXIUKNRDJTWBGH-XPLSERNMSA-N D0A5AT DRUGSMIL CC1=CC=CC=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D0A5AT HIGHSTAT Investigative D0A5BH DRUG__ID D0A5BH D0A5BH DRUGTYPE Small molecular drug D0A5BH DRUGINCH 1S/C31H48O3/c1-21(11-13-24-19-25(32)14-15-27(24)33)9-7-10-23(3)28(34)20-26-22(2)12-16-29-30(4,5)17-8-18-31(26,29)6/h11-12,14-15,19,23,26,28-29,32-34H,7-10,13,16-18,20H2,1-6H3/b21-11+/t23-,26+,28-,29+,31-/m1/s1 D0A5BH DRUGINKE JZTPEJICPYCDGH-JWMGXGOZSA-N D0A5BH DRUGSMIL CC1=CCC2C(CCCC2(C1CC(C(C)CCCC(=CCC3=C(C=CC(=C3)O)O)C)O)C)(C)C D0A5BH HIGHSTAT Investigative D0A5CD DRUG__ID D0A5CD D0A5CD DRUGTYPE Small molecular drug D0A5CD DRUGINCH 1S/C24H33NO3/c1-4-25(5-2)22(27)14-16-13-21-20-8-6-15-12-17(26)7-9-18(15)19(20)10-11-24(21,3)23(16)28/h7,9,12,16,19-21,26H,4-6,8,10-11,13-14H2,1-3H3/t16?,19?,20?,21?,24-/m0/s1 D0A5CD DRUGINKE NUYXZZNRVPOMFS-HEYBVSAXSA-N D0A5CD DRUGSMIL CCN(CC)C(=O)CC1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D0A5CD HIGHSTAT Investigative D0A5CN DRUG__ID D0A5CN D0A5CN DRUGTYPE Small molecular drug D0A5CN DRUGINCH 1S/C9H13NOS2/c1-2-3-4-5-6-7-8(11)10-9(12)13-7/h5-6,11H,2-4H2,1H3,(H,10,12)/b6-5- D0A5CN DRUGINKE NRLPFFHZVUFORL-WAYWQWQTSA-N D0A5CN DRUGSMIL CCCCC=CC1=C(NC(=S)S1)O D0A5CN HIGHSTAT Investigative D0A5ET DRUG__ID D0A5ET D0A5ET DRUGTYPE Small molecular drug D0A5ET DRUGINCH 1S/C20H27NO/c22-20-14-12-19(13-15-20)11-7-17-21-16-6-2-5-10-18-8-3-1-4-9-18/h1,3-4,8-9,12-15,21-22H,2,5-7,10-11,16-17H2 D0A5ET DRUGINKE HCVJFVZXTLAHRT-UHFFFAOYSA-N D0A5ET DRUGSMIL C1=CC=C(C=C1)CCCCCNCCCC2=CC=C(C=C2)O D0A5ET HIGHSTAT Investigative D0A5FO DRUG__ID D0A5FO D0A5FO DRUGTYPE Small molecular drug D0A5FO DRUGINCH 1S/C26H16N2O2S2/c29-25(27-17-9-1-5-13-21(17)31-22-14-6-2-10-18(22)27)26(30)28-19-11-3-7-15-23(19)32-24-16-8-4-12-20(24)28/h1-16H D0A5FO DRUGINKE LWNPJAXCRSELQF-UHFFFAOYSA-N D0A5FO DRUGSMIL C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)C(=O)N4C5=CC=CC=C5SC6=CC=CC=C64 D0A5FO HIGHSTAT Investigative D0A5GJ DRUG__ID D0A5GJ D0A5GJ DRUGTYPE Small molecular drug D0A5GJ DRUGINCH 1S/C32H42N4O4/c1-3-22(2)28(31(39)36-19-16-32(17-20-36)15-13-24-11-7-8-12-25(24)32)35-29(37)26(21-23-9-5-4-6-10-23)34-30(38)27-14-18-33-40-27/h7-8,11-15,18,22-23,26,28H,3-6,9-10,16-17,19-21H2,1-2H3,(H,34,38)(H,35,37)/t22-,26+,28+/m1/s1 D0A5GJ DRUGINKE DCUDDCGUKZLQLN-ZEZZXZOMSA-N D0A5GJ DRUGSMIL CCC(C)C(C(=O)N1CCC2(CC1)C=CC3=CC=CC=C23)NC(=O)C(CC4CCCCC4)NC(=O)C5=CC=NO5 D0A5GJ HIGHSTAT Investigative D0A5GM DRUG__ID D0A5GM D0A5GM DRUGTYPE Small molecular drug D0A5GM DRUGINCH 1S/C13H14N6O2/c1-20-6-3-4-8(21-2)7(5-6)11-16-9-10(14)17-13(15)19-12(9)18-11/h3-5H,1-2H3,(H5,14,15,16,17,18,19) D0A5GM DRUGINKE FFAMOOJMNMXIFW-UHFFFAOYSA-N D0A5GM DRUGSMIL COC1=CC(=C(C=C1)OC)C2=NC3=NC(=NC(=C3N2)N)N D0A5GM HIGHSTAT Investigative D0A5IW DRUG__ID D0A5IW D0A5IW DRUGTYPE Small molecular drug D0A5IW DRUGINCH 1S/C44H58N8O12S/c1-4-25(2)38(51-42(59)37(24-65)46-26(3)53)43(60)49-35(21-27-8-14-30(15-9-27)52(63)64)40(57)47-33(7-5-6-20-45)39(56)48-34(22-28-10-16-31(54)17-11-28)41(58)50-36(44(61)62)23-29-12-18-32(55)19-13-29/h8-19,25,33-38,54-55,65H,4-7,20-24,45H2,1-3H3,(H,46,53)(H,47,57)(H,48,56)(H,49,60)(H,50,58)(H,51,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D0A5IW DRUGINKE IFJPPNMSIWSRDX-LBNFHWTGSA-N D0A5IW DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)[N+](=O)[O-])C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D0A5IW HIGHSTAT Investigative D0A5IX DRUG__ID D0A5IX D0A5IX DRUGTYPE Small molecular drug D0A5IX DRUGINCH 1S/C6H14O10P2/c1-6(9,4-5(7)8)2-3-15-18(13,14)16-17(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H,13,14)(H2,10,11,12) D0A5IX DRUGINKE SIGQQUBJQXSAMW-UHFFFAOYSA-N D0A5IX DRUGSMIL CC(CCOP(=O)(O)OP(=O)(O)O)(CC(=O)O)O D0A5IX HIGHSTAT Investigative D0A5JU DRUG__ID D0A5JU D0A5JU DRUGTYPE Small molecular drug D0A5JU DRUGINCH 1S/C16H25NO2/c18-16(17-4-2-1-3-5-17)19-15-13-7-11-6-12(9-13)10-14(15)8-11/h11-15H,1-10H2 D0A5JU DRUGINKE VAQVMFMOXWTAGF-UHFFFAOYSA-N D0A5JU DRUGSMIL C1CCN(CC1)C(=O)OC2C3CC4CC(C3)CC2C4 D0A5JU HIGHSTAT Investigative D0A5KG DRUG__ID D0A5KG D0A5KG DRUGTYPE Small molecular drug D0A5KG DRUGINCH 1S/C11H14N8O4/c1-13-8-5-9(16-11(15-8)17-18-12)19(3-14-5)10-7(22)6(21)4(2-20)23-10/h3-4,6-7,10,20-22H,2H2,1H3,(H,13,15,16)/t4-,6-,7-,10-/m1/s1 D0A5KG DRUGINKE CAQREKOGAXNCLL-KQYNXXCUSA-N D0A5KG DRUGSMIL CNC1=C2C(=NC(=N1)N=[N+]=[N-])N(C=N2)C3C(C(C(O3)CO)O)O D0A5KG HIGHSTAT Investigative D0A5KP DRUG__ID D0A5KP D0A5KP DRUGTYPE Small molecular drug D0A5KP DRUGINCH 1S/C20H27N3O2/c1-2-3-8-19(23-11-13-25-14-12-23)20(24,17-6-4-9-21-15-17)18-7-5-10-22-16-18/h4-7,9-10,15-16,19,24H,2-3,8,11-14H2,1H3 D0A5KP DRUGINKE MHMGSQRAIMZTJJ-UHFFFAOYSA-N D0A5KP DRUGSMIL CCCCC(C(C1=CN=CC=C1)(C2=CN=CC=C2)O)N3CCOCC3 D0A5KP HIGHSTAT Investigative D0A5LS DRUG__ID D0A5LS D0A5LS DRUGTYPE Small molecular drug D0A5LS DRUGINCH 1S/C13H17ClN2O3/c14-11-7-5-10(6-8-11)13(18)15-9-3-1-2-4-12(17)16-19/h5-8,19H,1-4,9H2,(H,15,18)(H,16,17) D0A5LS DRUGINKE YYCQNZBMCNSCKG-UHFFFAOYSA-N D0A5LS DRUGSMIL C1=CC(=CC=C1C(=O)NCCCCCC(=O)NO)Cl D0A5LS HIGHSTAT Investigative D0A5LY DRUG__ID D0A5LY D0A5LY DRUGTYPE Small molecular drug D0A5LY DRUGINCH 1S/C17H18ClN3O4S/c18-15-6-7-17(16(12-15)21(22)23)26(24,25)20-10-8-19(9-11-20)13-14-4-2-1-3-5-14/h1-7,12H,8-11,13H2 D0A5LY DRUGINKE ZNLVYSJQUMALEO-UHFFFAOYSA-N D0A5LY DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)S(=O)(=O)C3=C(C=C(C=C3)Cl)[N+](=O)[O-] D0A5LY HIGHSTAT Investigative D0A5MA DRUG__ID D0A5MA D0A5MA DRUGTYPE Small molecular drug D0A5MA DRUGINCH 1S/C25H32N2O5.Na/c1-2-3-6-13-26-24(30)19-15-31-25(27-19)23-18(20-10-11-21(23)32-20)14-17-8-5-4-7-16(17)9-12-22(28)29;/h4-5,7-8,15,18,20-21,23H,2-3,6,9-14H2,1H3,(H,26,30)(H,28,29);/q;+1/p-1/t18-,20+,21+,23-;/m0./s1 D0A5MA DRUGINKE WOHSQDNIXPEQAE-SLWCZEQYSA-M D0A5MA DRUGSMIL CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)[O-])O3.[Na+] D0A5MA HIGHSTAT Investigative D0A5MG DRUG__ID D0A5MG D0A5MG DRUGTYPE Small molecular drug D0A5MG DRUGINCH 1S/C19H19N3O2S2/c1-24-16-12-14(25-2)9-10-15(16)18(23)20-19-22-21-17(26-19)11-8-13-6-4-3-5-7-13/h3-7,9-10,12H,8,11H2,1-2H3,(H,20,22,23) D0A5MG DRUGINKE JYHRBJVBNRDAJX-UHFFFAOYSA-N D0A5MG DRUGSMIL COC1=C(C=CC(=C1)SC)C(=O)NC2=NN=C(S2)CCC3=CC=CC=C3 D0A5MG HIGHSTAT Investigative D0A5MU DRUG__ID D0A5MU D0A5MU DRUGTYPE Small molecular drug D0A5MU DRUGINCH 1S/C26H36N2O8/c1-28-8-7-26-15(18(28)9-13-3-4-14(30)10-16(13)26)5-6-17(25(26)35-2)27-21(31)11-19-22(32)24(34)23(33)20(12-29)36-19/h3-6,10,15,17-20,22-25,29-30,32-34H,7-9,11-12H2,1-2H3,(H,27,31)/t15-,17+,18+,19?,20?,22?,23?,24?,25?,26-/m0/s1 D0A5MU DRUGINKE RSJUYYKJXWPIQQ-LEBYPUKTSA-N D0A5MU DRUGSMIL CN1CCC23C(C1CC4=C2C=C(C=C4)O)C=CC(C3OC)NC(=O)CC5C(C(C(C(O5)CO)O)O)O D0A5MU HIGHSTAT Investigative D0A5MV DRUG__ID D0A5MV D0A5MV DRUGTYPE Small molecular drug D0A5MV DRUGINCH 1S/C24H26O3/c1-2-3-4-8-11-22(18-23(25)26)24(27)21-16-14-20(15-17-21)13-12-19-9-6-5-7-10-19/h5-7,9-10,14-17,22H,2-4,8,11,18H2,1H3,(H,25,26) D0A5MV DRUGINKE RPSYWEPJQQLLJN-UHFFFAOYSA-N D0A5MV DRUGSMIL CCCCCCC(CC(=O)O)C(=O)C1=CC=C(C=C1)C#CC2=CC=CC=C2 D0A5MV HIGHSTAT Investigative D0A5NN DRUG__ID D0A5NN D0A5NN DRUGCOMP Ecopia BioSciences Inc D0A5NN DRUGINCH 1S/C46H68N4O10/c1-30(21-15-12-13-20-28-50(6)46(47)48)22-16-14-17-23-31(2)29-34(5)41(59-45-40(55)38(53)39(54)42(60-45)44(57)58)32(3)24-18-10-8-7-9-11-19-25-33(4)43(56)49-37-35(51)26-27-36(37)52/h7-12,15-16,18-19,22,24-25,29-32,38-42,45,51,53-55H,13-14,17,20-21,23,26-28H2,1-6H3,(H3,47,48)(H,49,56)(H,57,58)/b9-7+,10-8+,15-12+,19-11+,22-16+,24-18+,33-25+,34-29+/t30?,31?,32?,38-,39-,40+,41?,42-,45+/m0/s1 D0A5NN DRUGINKE JZUVOAOWVXOKMW-BRUGUNMHSA-N D0A5NN DRUGSMIL CC(CCCC=CC(C)CC=CCCCN(C)C(=N)N)C=C(C)C(C(C)C=CC=CC=CC=CC=C(C)C(=O)NC1=C(CCC1=O)O)OC2C(C(C(C(O2)C(=O)O)O)O)O D0A5NN HIGHSTAT Investigative D0A5OS DRUG__ID D0A5OS D0A5OS DRUGTYPE Small molecular drug D0A5OS DRUGINCH 1S/C14H8N2O4/c17-11-5-6-12(18)15(11)9-1-2-10(4-3-9)16-13(19)7-8-14(16)20/h1-8H D0A5OS DRUGINKE AQGZJQNZNONGKY-UHFFFAOYSA-N D0A5OS DRUGSMIL C1=CC(=CC=C1N2C(=O)C=CC2=O)N3C(=O)C=CC3=O D0A5OS HIGHSTAT Investigative D0A5QP DRUG__ID D0A5QP D0A5QP DRUGTYPE Small molecular drug D0A5QP DRUGINCH 1S/C20H15N3O/c24-20(16-11-5-2-6-12-16)22-19-18(15-9-3-1-4-10-15)21-17-13-7-8-14-23(17)19/h1-14H,(H,22,24) D0A5QP DRUGINKE MFEAOWRPVOQOEV-UHFFFAOYSA-N D0A5QP DRUGSMIL C1=CC=C(C=C1)C2=C(N3C=CC=CC3=N2)NC(=O)C4=CC=CC=C4 D0A5QP HIGHSTAT Investigative D0A5RA DRUG__ID D0A5RA D0A5RA DRUGTYPE Small molecular drug D0A5RA DRUGINCH 1S/C21H34O5S/c1-13(22)17-6-7-18-16-5-4-14-12-15(26-27(23,24)25)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19H,4-12H2,1-3H3,(H,23,24,25)/t14-,15+,16?,17?,18?,19?,20+,21-/m1/s1 D0A5RA DRUGINKE MENQCIVHHONJLU-ACWDEBGSSA-N D0A5RA DRUGSMIL CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)OS(=O)(=O)O)C)C D0A5RA HIGHSTAT Investigative D0A5TD DRUG__ID D0A5TD D0A5TD DRUGTYPE Small molecular drug D0A5TD DRUGINCH 1S/C25H18FNS/c26-21-10-4-3-9-20(21)25-16-23(27-22-11-5-6-12-24(22)28-25)19-14-13-17-7-1-2-8-18(17)15-19/h1-15,25H,16H2 D0A5TD DRUGINKE WXTPJZLDXSZFPY-UHFFFAOYSA-N D0A5TD DRUGSMIL C1C(SC2=CC=CC=C2N=C1C3=CC4=CC=CC=C4C=C3)C5=CC=CC=C5F D0A5TD HIGHSTAT Investigative D0A5WN DRUG__ID D0A5WN D0A5WN DRUGTYPE Small molecular drug D0A5WN DRUGINCH 1S/C27H43N3O8S2/c1-18(2)17-21(15-16-39(8,34)35)29-25(32)20(4)28-26(33)23(13-14-24(31)38-27(5,6)7)30-40(36,37)22-11-9-19(3)10-12-22/h9-12,15-16,18,20-21,23,30H,13-14,17H2,1-8H3,(H,28,33)(H,29,32)/b16-15+/t20-,21+,23-/m0/s1 D0A5WN DRUGINKE RSODQDWVGCCUGL-HSNUOWKJSA-N D0A5WN DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(CCC(=O)OC(C)(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C D0A5WN HIGHSTAT Investigative D0A5XB DRUG__ID D0A5XB D0A5XB DRUGTYPE Small molecular drug D0A5XB DRUGINCH 1S/C8H9NO5S/c9-15(10,11)12-5-8-13-6-3-1-2-4-7(6)14-8/h1-4,8H,5H2,(H2,9,10,11) D0A5XB DRUGINKE UAXDMVNWVLYKAY-UHFFFAOYSA-N D0A5XB DRUGSMIL C1=CC=C2C(=C1)OC(O2)COS(=O)(=O)N D0A5XB HIGHSTAT Investigative D0A5XG DRUG__ID D0A5XG D0A5XG DRUGTYPE Small molecular drug D0A5XG DRUGINCH 1S/C28H27NO6/c1-17(2)25-14-21(15-26-18(3)11-24(12-19(26)4)35-16-27(30)31)13-22(28(25)32)8-5-20-6-9-23(10-7-20)29(33)34/h6-7,9-14,17,32H,15-16H2,1-4H3,(H,30,31) D0A5XG DRUGINKE IXMROOKFPWGDGF-UHFFFAOYSA-N D0A5XG DRUGSMIL CC1=CC(=CC(=C1CC2=CC(=C(C(=C2)C(C)C)O)C#CC3=CC=C(C=C3)[N+](=O)[O-])C)OCC(=O)O D0A5XG HIGHSTAT Investigative D0A5XY DRUG__ID D0A5XY D0A5XY DRUGTYPE Small molecular drug D0A5XY DRUGINCH 1S/C14H9BrClNO3/c15-12-4-2-1-3-11(12)14(19)20-17-13(18)9-5-7-10(16)8-6-9/h1-8H,(H,17,18) D0A5XY DRUGINKE XBZVDYJKCJLDSB-UHFFFAOYSA-N D0A5XY DRUGSMIL C1=CC=C(C(=C1)C(=O)ONC(=O)C2=CC=C(C=C2)Cl)Br D0A5XY HIGHSTAT Investigative D0A5ZF DRUG__ID D0A5ZF D0A5ZF DRUGTYPE Small molecular drug D0A5ZF DRUGINCH 1S/C12H14N2O2/c1-3-12(4-2)10(15)14(11(12)16)9-6-5-7-13-8-9/h5-8H,3-4H2,1-2H3 D0A5ZF DRUGINKE OHEZXQVPDSACCJ-UHFFFAOYSA-N D0A5ZF DRUGSMIL CCC1(C(=O)N(C1=O)C2=CN=CC=C2)CC D0A5ZF HIGHSTAT Investigative D0A6AA DRUG__ID D0A6AA D0A6AA DRUGTYPE Small molecular drug D0A6AA DRUGINCH 1S/C14H9NO2S/c1-2-18-7-9(1)11-3-10-4-13-14(17-8-16-13)5-12(10)15-6-11/h1-7H,8H2 D0A6AA DRUGINKE YSBLLMHIZDPXPM-UHFFFAOYSA-N D0A6AA DRUGSMIL C1OC2=CC3=CC(=CN=C3C=C2O1)C4=CSC=C4 D0A6AA HIGHSTAT Investigative D0A6AX DRUG__ID D0A6AX D0A6AX DRUGTYPE Small molecular drug D0A6AX DRUGINCH 1S/C14H13N3O2/c1-2-19-14(18)17-13-7-10-9-5-3-4-6-11(9)16-12(10)8-15-13/h3-8,16H,2H2,1H3,(H,15,17,18) D0A6AX DRUGINKE ABHBEIYQTPYXQQ-UHFFFAOYSA-N D0A6AX DRUGSMIL CCOC(=O)NC1=NC=C2C(=C1)C3=CC=CC=C3N2 D0A6AX HIGHSTAT Investigative D0A6BH DRUG__ID D0A6BH D0A6BH DRUGTYPE Small molecular drug D0A6BH DRUGINCH 1S/C20H21N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,7,12-13H,5-6,8-9H2,(H,23,30)(H,28,29)(H,32,33)(H3,21,24,25,31)/t12-,13-/m1/s1 D0A6BH DRUGINKE BHJAPJNOACHPNI-CHWSQXEVSA-N D0A6BH DRUGSMIL C1C2C=NC3=C(N2CN1C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)NC(=N3)N D0A6BH HIGHSTAT Investigative D0A6CB DRUG__ID D0A6CB D0A6CB DRUGTYPE Small molecular drug D0A6CB DRUGINCH 1S/C20H23NO3/c22-19(10-6-1-2-7-11-20(23)21-24)18-14-12-17(13-15-18)16-8-4-3-5-9-16/h3-5,8-9,12-15,24H,1-2,6-7,10-11H2,(H,21,23) D0A6CB DRUGINKE LZZJBJLIOVNVKE-UHFFFAOYSA-N D0A6CB DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCCCCCC(=O)NO D0A6CB HIGHSTAT Investigative D0A6CS DRUG__ID D0A6CS D0A6CS DRUGTYPE Small molecular drug D0A6CS DRUGINCH 1S/C14H20BrN5O2/c1-14(2)19-12(16)18-13(17)20(14)22-9-3-8-21-11-6-4-10(15)5-7-11/h4-7H,3,8-9H2,1-2H3,(H4,16,17,18,19) D0A6CS DRUGINKE MPXYCOHVHSXSDC-UHFFFAOYSA-N D0A6CS DRUGSMIL CC1(N=C(N=C(N1OCCCOC2=CC=C(C=C2)Br)N)N)C D0A6CS HIGHSTAT Investigative D0A6FX DRUG__ID D0A6FX D0A6FX DRUGTYPE Small molecular drug D0A6FX DRUGINCH 1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h11-12H,2-8,13-17H2,1H3,(H,19,20)/b12-11+ D0A6FX DRUGINKE BWSIKEZDJMZITO-VAWYXSNFSA-N D0A6FX DRUGSMIL CCCCCCCCC#CC=CCCCCCC(=O)O D0A6FX HIGHSTAT Investigative D0A6FZ DRUG__ID D0A6FZ D0A6FZ DRUGTYPE Small molecular drug D0A6FZ DRUGINCH 1S/C51H90N14O8/c1-28(2)23-38(59-33(11)66)46(69)62-40(25-30(5)6)48(71)64-41(26-31(7)8)49(72)63-39(24-29(3)4)47(70)60-37(16-14-22-57-51(55)56)45(68)65-42(32(9)10)50(73)61-36(15-12-13-21-52)44(67)58-27-34-17-19-35(20-18-34)43(53)54/h17-20,28-32,36-42H,12-16,21-27,52H2,1-11H3,(H3,53,54)(H,58,67)(H,59,66)(H,60,70)(H,61,73)(H,62,69)(H,63,72)(H,64,71)(H,65,68)(H4,55,56,57)/t36-,37-,38-,39-,40-,41-,42-/m0/s1 D0A6FZ DRUGINKE UFNWIBYSOUCSGW-FVMQRRFMSA-N D0A6FZ DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC1=CC=C(C=C1)C(=N)N)NC(=O)C D0A6FZ HIGHSTAT Investigative D0A6GK DRUG__ID D0A6GK D0A6GK DRUGTYPE Small molecular drug D0A6GK DRUGINCH 1S/C9H7Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-5H,(H2,12,13,14) D0A6GK DRUGINKE JMIQFISPBOHMQG-UHFFFAOYSA-N D0A6GK DRUGSMIL C1=CC(=C(C(=C1)Cl)NC2=NC=CN2)Cl D0A6GK HIGHSTAT Investigative D0A6HS DRUG__ID D0A6HS D0A6HS DRUGTYPE Small molecular drug D0A6HS DRUGINCH 1S/C7H6N2O3S2/c8-14(11,12)7-9-5-2-1-4(10)3-6(5)13-7/h1-3,10H,(H2,8,11,12) D0A6HS DRUGINKE NOOBQTYVTDBXTL-UHFFFAOYSA-N D0A6HS DRUGSMIL C1=CC2=C(C=C1O)SC(=N2)S(=O)(=O)N D0A6HS HIGHSTAT Investigative D0A6IO DRUG__ID D0A6IO D0A6IO DRUGTYPE Small molecular drug D0A6IO DRUGINCH 1S/C21H20N8O3/c1-3-10-28-12-15-17(26-28)24-20(25-21(30)22-13-6-8-14(31-2)9-7-13)29-19(15)23-18(27-29)16-5-4-11-32-16/h4-9,11-12H,3,10H2,1-2H3,(H2,22,24,25,26,30) D0A6IO DRUGINKE CJRNHKSLHHWUAB-UHFFFAOYSA-N D0A6IO DRUGSMIL CCCN1C=C2C(=N1)N=C(N3C2=NC(=N3)C4=CC=CO4)NC(=O)NC5=CC=C(C=C5)OC D0A6IO HIGHSTAT Investigative D0A6IQ DRUG__ID D0A6IQ D0A6IQ DRUGTYPE Small molecular drug D0A6IQ DRUGINCH 1S/C11H12IN3/c12-9-3-1-2-8(6-9)11-14-7-10(15-11)4-5-13/h1-3,6-7H,4-5,13H2,(H,14,15) D0A6IQ DRUGINKE OPICWPJAKDPOOB-UHFFFAOYSA-N D0A6IQ DRUGSMIL C1=CC(=CC(=C1)I)C2=NC=C(N2)CCN D0A6IQ HIGHSTAT Investigative D0A6JX DRUG__ID D0A6JX D0A6JX DRUGTYPE Small molecular drug D0A6JX DRUGINCH 1S/C9H11N5/c10-8-7-9(12-4-11-8)14(5-13-7)6-2-1-3-6/h4-6H,1-3H2,(H2,10,11,12) D0A6JX DRUGINKE JGFAEEKLMAWINF-UHFFFAOYSA-N D0A6JX DRUGSMIL C1CC(C1)N2C=NC3=C(N=CN=C32)N D0A6JX HIGHSTAT Investigative D0A6LB DRUG__ID D0A6LB D0A6LB DRUGTYPE Small molecular drug D0A6LB DRUGINCH 1S/C13H19N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h5-6,14H,1-4,7-10H2 D0A6LB DRUGINKE OHJFBSROVXQKFQ-UHFFFAOYSA-N D0A6LB DRUGSMIL C1CCC2=C(C1)C=CC(=N2)N3CCNCC3 D0A6LB HIGHSTAT Investigative D0A6LX DRUG__ID D0A6LX D0A6LX DRUGTYPE Small molecular drug D0A6LX DRUGINCH 1S/C11H11N3O2/c15-10-6-9(13-11(16)14-10)12-7-8-4-2-1-3-5-8/h1-6H,7H2,(H3,12,13,14,15,16) D0A6LX DRUGINKE NORSBFZJRBPBQZ-UHFFFAOYSA-N D0A6LX DRUGSMIL C1=CC=C(C=C1)CNC2=CC(=O)NC(=O)N2 D0A6LX HIGHSTAT Investigative D0A6MF DRUG__ID D0A6MF D0A6MF DRUGTYPE Small molecular drug D0A6MF DRUGINCH 1S/C30H32O5/c1-6-19(4)26(32)25-27(33)21-14-16-30(5,15-10-11-18(2)3)35-28(21)24-22(17-23(31)34-29(24)25)20-12-8-7-9-13-20/h7-9,11-14,16-17,19,33H,6,10,15H2,1-5H3 D0A6MF DRUGINKE GEYVIFNRNUBPHZ-UHFFFAOYSA-N D0A6MF DRUGSMIL CCC(C)C(=O)C1=C2C(=C3C(=C1O)C=CC(O3)(C)CCC=C(C)C)C(=CC(=O)O2)C4=CC=CC=C4 D0A6MF HIGHSTAT Investigative D0A6NQ DRUG__ID D0A6NQ D0A6NQ DRUGTYPE Small molecular drug D0A6NQ DRUGINCH 1S/C27H26O3/c28-25-6-5-22(20-1-2-21-11-23(26(29)30)4-3-19(21)10-20)12-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30) D0A6NQ DRUGINKE LDGIHZJOIQSHPB-UHFFFAOYSA-N D0A6NQ DRUGSMIL C1C2CC3CC1CC(C2)(C3)C4=C(C=CC(=C4)C5=CC6=C(C=C5)C=C(C=C6)C(=O)O)O D0A6NQ HIGHSTAT Investigative D0A6OF DRUG__ID D0A6OF D0A6OF DRUGTYPE Small molecular drug D0A6OF DRUGINCH 1S/C16H27N7O4.O.Tc/c1-12(20-24)15(2,3)18-7-6-8-19-16(4,5)13(21-25)11-22-10-9-17-14(22)23(26)27;;/h9-10,24-25H,6-8,11H2,1-5H3;;/q-2;;+3/p-1/b20-12+,21-13+;;/i;;1+1 D0A6OF DRUGINKE BACDTMMAFRHWHW-KTZCKAEQSA-M D0A6OF DRUGSMIL [H+].CC(=N[O-])C(C)(C)[N-]CCC[N-]C(C)(C)C(=N[O-])CN1C=CN=C1[N+](=O)[O-].O=[Tc+3] D0A6OF HIGHSTAT Investigative D0A6OO DRUG__ID D0A6OO D0A6OO DRUGTYPE Small molecular drug D0A6OO DRUGINCH 1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36?/m0/s1 D0A6OO DRUGINKE TTZHDVOVKQGIBA-IAAJYNJHSA-N D0A6OO DRUGSMIL CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3 D0A6OO HIGHSTAT Investigative D0A6RL DRUG__ID D0A6RL D0A6RL DRUGTYPE Small molecular drug D0A6RL DRUGINCH 1S/C20H17NO2/c22-20(21-15-16-8-3-1-4-9-16)23-19-13-7-12-18(14-19)17-10-5-2-6-11-17/h1-14H,15H2,(H,21,22) D0A6RL DRUGINKE OSVRGOZPWLNARR-UHFFFAOYSA-N D0A6RL DRUGSMIL C1=CC=C(C=C1)CNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D0A6RL HIGHSTAT Investigative D0A6RM DRUG__ID D0A6RM D0A6RM DRUGTYPE Small molecular drug D0A6RM DRUGINCH 1S/C9H20NO2P/c1-2-3-6-13(11,12)9-5-4-8(10)7-9/h8-9H,2-7,10H2,1H3,(H,11,12)/t8-,9-/m1/s1 D0A6RM DRUGINKE UQGQAMARAMOEID-RKDXNWHRSA-N D0A6RM DRUGSMIL CCCCP(=O)(C1CCC(C1)N)O D0A6RM HIGHSTAT Investigative D0A6RU DRUG__ID D0A6RU D0A6RU DRUGTYPE Small molecular drug D0A6RU DRUGINCH 1S/C7H5ClN2/c8-6-3-1-2-5-4-9-10-7(5)6/h1-4H,(H,9,10) D0A6RU DRUGINKE WIYOYUQVNPTVQG-UHFFFAOYSA-N D0A6RU DRUGSMIL C1=CC2=C(C(=C1)Cl)NN=C2 D0A6RU HIGHSTAT Investigative D0A6YP DRUG__ID D0A6YP D0A6YP DRUGTYPE Small molecular drug D0A6YP DRUGINCH 1S/C17H14FNO2/c1-20-16-8-12-6-13(11-4-3-5-14(18)7-11)10-19-15(12)9-17(16)21-2/h3-10H,1-2H3 D0A6YP DRUGINKE UECRIUGPTSAZMC-UHFFFAOYSA-N D0A6YP DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC(=CC=C3)F D0A6YP HIGHSTAT Investigative D0A6YW DRUG__ID D0A6YW D0A6YW DRUGTYPE Small molecular drug D0A6YW DRUGINCH 1S/C15H13NO2/c1-18-14-5-3-13(4-6-14)15(17)7-2-12-8-10-16-11-9-12/h2-11H,1H3/b7-2+ D0A6YW DRUGINKE OHXOJKQHTRABPQ-FARCUNLSSA-N D0A6YW DRUGSMIL COC1=CC=C(C=C1)C(=O)C=CC2=CC=NC=C2 D0A6YW HIGHSTAT Investigative D0A6ZC DRUG__ID D0A6ZC D0A6ZC DRUGTYPE Small molecular drug D0A6ZC DRUGINCH 1S/C12H19N3S2/c1-3-4-8-16-12-11(13-17-14-12)10-6-5-7-15(2)9-10/h6H,3-5,7-9H2,1-2H3/i1-1 D0A6ZC DRUGINKE SFXHHGRYNXLPKT-BJUDXGSMSA-N D0A6ZC DRUGSMIL CCCCSC1=NSN=C1C2=CCCN(C2)C D0A6ZC HIGHSTAT Investigative D0A6ZK DRUG__ID D0A6ZK D0A6ZK DRUGTYPE Small molecular drug D0A6ZK DRUGINCH 1S/C10H12O2/c1-7(2)8-5-3-4-6-9(11)10(8)12/h3-7H,1-2H3,(H,11,12) D0A6ZK DRUGINKE TUFYVOCKVJOUIR-UHFFFAOYSA-N D0A6ZK DRUGSMIL CC(C)C1=C(C(=O)C=CC=C1)O D0A6ZK HIGHSTAT Investigative D0A7AK DRUG__ID D0A7AK D0A7AK DRUGTYPE Small molecular drug D0A7AK DRUGINCH 1S/C20H19NO/c1-2-7-17(8-3-1)12-13-19-10-4-5-11-20(19)22-16-18-9-6-14-21-15-18/h1-11,14-15H,12-13,16H2 D0A7AK DRUGINKE WUVSQVHZKKJEHX-UHFFFAOYSA-N D0A7AK DRUGSMIL C1=CC=C(C=C1)CCC2=CC=CC=C2OCC3=CN=CC=C3 D0A7AK HIGHSTAT Investigative D0A7ER DRUG__ID D0A7ER D0A7ER DRUGTYPE Small molecular drug D0A7ER DRUGINCH 1S/C12H21N3O3/c1-5-6-9(10(16)14-8-7-13)15-11(17)18-12(2,3)4/h9H,5-6,8H2,1-4H3,(H,14,16)(H,15,17)/t9-/m0/s1 D0A7ER DRUGINKE PBHMIOPVNIIFHR-VIFPVBQESA-N D0A7ER DRUGSMIL CCCC(C(=O)NCC#N)NC(=O)OC(C)(C)C D0A7ER HIGHSTAT Investigative D0A7FI DRUG__ID D0A7FI D0A7FI DRUGTYPE Small molecular drug D0A7FI DRUGINCH 1S/C20H22BrNO2/c21-18-10-6-16(7-11-18)15-4-8-17(9-5-15)20(23)14-22-12-2-1-3-19(22)13-24-20/h4-11,19,23H,1-3,12-14H2 D0A7FI DRUGINKE IFRLXVCJEQULMZ-UHFFFAOYSA-N D0A7FI DRUGSMIL C1CCN2CC(OCC2C1)(C3=CC=C(C=C3)C4=CC=C(C=C4)Br)O D0A7FI HIGHSTAT Investigative D0A7FQ DRUG__ID D0A7FQ D0A7FQ DRUGTYPE Small molecular drug D0A7FQ DRUGINCH 1S/C11H9FN6/c12-6-1-3-7(4-2-6)16-11-8-9(13)14-5-15-10(8)17-18-11/h1-5H,(H4,13,14,15,16,17,18) D0A7FQ DRUGINKE UQPMANVRZYYQMD-UHFFFAOYSA-N D0A7FQ DRUGSMIL C1=CC(=CC=C1NC2=C3C(=NC=NC3=NN2)N)F D0A7FQ HIGHSTAT Investigative D0A7GH DRUG__ID D0A7GH D0A7GH DRUGCOMP Anchor Therapeutics Inc D0A7GH DRUGINCH 1S/C104H178N26O25S2/c1-9-10-11-12-13-14-15-16-17-18-19-20-21-35-84(136)116-75(46-53-156-7)88(140)115-60-85(137)117-78(57-65-36-40-67(133)41-37-65)97(149)123-74(44-45-83(108)135)94(146)119-69(30-22-25-48-105)89(141)118-70(31-23-26-49-106)90(142)125-77(55-62(2)3)96(148)121-73(34-29-52-114-104(111)112)93(145)129-82(61-131)100(152)124-76(47-54-157-8)95(147)130-87(64(6)132)101(153)127-80(59-86(138)139)99(151)120-71(32-24-27-50-107)91(143)126-79(58-66-38-42-68(134)43-39-66)98(150)122-72(33-28-51-113-103(109)110)92(144)128-81(102(154)155)56-63(4)5/h36-43,62-64,69-82,87,131-134H,9-35,44-61,105-107H2,1-8H3,(H2,108,135)(H,115,140)(H,116,136)(H,117,137)(H,118,141)(H,119,146)(H,120,151)(H,121,148)(H,122,150)(H,123,149)(H,124,152)(H,125,142)(H,126,143)(H,127,153)(H,128,144)(H,129,145)(H,130,147)(H,138,139)(H,154,155)(H4,109,110,113)(H4,111,112,114)/t64-,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79+,80+,81+,82+,87+/m1/s1 D0A7GH DRUGINKE YMLOFEANRZSEGQ-QNHYGVTPSA-N D0A7GH DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC(CCSC)C(=O)NCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)O D0A7GH HIGHSTAT Investigative D0A7GO DRUG__ID D0A7GO D0A7GO DRUGTYPE Small molecular drug D0A7GO DRUGINCH 1S/C15H24N2O2/c1-11(2)8-9-17-15(19)14(18)13(16)10-12-6-4-3-5-7-12/h3-7,11,13-14,18H,8-10,16H2,1-2H3,(H,17,19)/t13-,14+/m1/s1 D0A7GO DRUGINKE WABAJXKDQWZIOJ-KGLIPLIRSA-N D0A7GO DRUGSMIL CC(C)CCNC(=O)C(C(CC1=CC=CC=C1)N)O D0A7GO HIGHSTAT Investigative D0A7GW DRUG__ID D0A7GW D0A7GW DRUGTYPE Small molecular drug D0A7GW DRUGINCH 1S/C19H24N2O/c1-2-13-21(18-9-11-20-12-10-18)19(22)17-8-7-15-5-3-4-6-16(15)14-17/h3-8,14,18,20H,2,9-13H2,1H3 D0A7GW DRUGINKE KPOGSLKDEJXGPM-UHFFFAOYSA-N D0A7GW DRUGSMIL CCCN(C1CCNCC1)C(=O)C2=CC3=CC=CC=C3C=C2 D0A7GW HIGHSTAT Investigative D0A7HM DRUG__ID D0A7HM D0A7HM DRUGTYPE Small molecular drug D0A7HM DRUGINCH 1S/C9H14N2O/c1-11(2)6-7-12-9-4-3-5-10-8-9/h3-5,8H,6-7H2,1-2H3 D0A7HM DRUGINKE NNKLMOMWOOXRDH-UHFFFAOYSA-N D0A7HM DRUGSMIL CN(C)CCOC1=CN=CC=C1 D0A7HM HIGHSTAT Investigative D0A7IF DRUG__ID D0A7IF D0A7IF DRUGTYPE Small molecular drug D0A7IF DRUGINCH 1S/C10H8N2O2S/c13-10(12-14)9-2-1-8(15-9)7-3-5-11-6-4-7/h1-6,14H,(H,12,13) D0A7IF DRUGINKE MDIKAACRDOZAQR-UHFFFAOYSA-N D0A7IF DRUGSMIL C1=CN=CC=C1C2=CC=C(S2)C(=O)NO D0A7IF HIGHSTAT Investigative D0A7NH DRUG__ID D0A7NH D0A7NH DRUGTYPE Small molecular drug D0A7NH DRUGINCH 1S/C16H19NO/c18-16-11-10-15(13-8-4-5-9-14(13)16)17-12-6-2-1-3-7-12/h4-5,8-12,17-18H,1-3,6-7H2 D0A7NH DRUGINKE JNIUFYOCOKGFDL-UHFFFAOYSA-N D0A7NH DRUGSMIL C1CCC(CC1)NC2=CC=C(C3=CC=CC=C32)O D0A7NH HIGHSTAT Investigative D0A7PA DRUG__ID D0A7PA D0A7PA DRUGTYPE Small molecular drug D0A7PA DRUGINCH 1S/C16H17NO2/c1-18-15-9-8-13(16(11-15)19-2)7-6-12-4-3-5-14(17)10-12/h3-11H,17H2,1-2H3/b7-6+ D0A7PA DRUGINKE YTHARJUESQVNDD-VOTSOKGWSA-N D0A7PA DRUGSMIL COC1=CC(=C(C=C1)C=CC2=CC(=CC=C2)N)OC D0A7PA HIGHSTAT Investigative D0A7PU DRUG__ID D0A7PU D0A7PU DRUGTYPE Small molecular drug D0A7PU DRUGINCH 1S/C15H10ClNOS/c16-15-5-4-14(19-15)11-6-7-17-13(9-11)10-2-1-3-12(18)8-10/h1-9,18H D0A7PU DRUGINKE MOVQEDAJQOEYIC-UHFFFAOYSA-N D0A7PU DRUGSMIL C1=CC(=CC(=C1)O)C2=NC=CC(=C2)C3=CC=C(S3)Cl D0A7PU HIGHSTAT Investigative D0A7SR DRUG__ID D0A7SR D0A7SR DRUGTYPE Small molecular drug D0A7SR DRUGINCH 1S/C15H23N3O2/c1-10(2)8-12(16)15(20)18-13(14(17)19)9-11-6-4-3-5-7-11/h3-7,10,12-13H,8-9,16H2,1-2H3,(H2,17,19)(H,18,20)/t12-,13-/m0/s1 D0A7SR DRUGINKE HVNQCDIUFGAINF-STQMWFEESA-N D0A7SR DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)N D0A7SR HIGHSTAT Investigative D0A7US DRUG__ID D0A7US D0A7US DRUGTYPE Small molecular drug D0A7US DRUGINCH 1S/C17H18Cl2O2/c1-11(2)3-4-12-5-7-17(15(20)9-12)21-16-8-6-13(18)10-14(16)19/h5-11,20H,3-4H2,1-2H3 D0A7US DRUGINKE CODNLKSZUDXSLW-UHFFFAOYSA-N D0A7US DRUGSMIL CC(C)CCC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D0A7US HIGHSTAT Investigative D0A7WB DRUG__ID D0A7WB D0A7WB DRUGTYPE Small molecular drug D0A7WB DRUGINCH 1S/C16H12O4/c17-12-4-11(5-13(18)7-12)9-1-2-10-3-14(19)8-16(20)15(10)6-9/h1-8,17-20H D0A7WB DRUGINKE VMEOGCASIHYHCW-UHFFFAOYSA-N D0A7WB DRUGSMIL C1=CC(=CC2=C(C=C(C=C21)O)O)C3=CC(=CC(=C3)O)O D0A7WB HIGHSTAT Investigative D0A7XQ DRUG__ID D0A7XQ D0A7XQ DRUGCOMP Onconova Therapeutics Inc D0A7XQ DRUGINCH 1S/C16H13BrO3S/c17-14-7-1-11(2-8-14)9-21-10-15(18)12-3-5-13(6-4-12)16(19)20/h1-8H,9-10H2,(H,19,20) D0A7XQ DRUGINKE KTQGMLFAHVKKNV-UHFFFAOYSA-N D0A7XQ DRUGSMIL C1=CC(=CC=C1CSCC(=O)C2=CC=C(C=C2)C(=O)O)Br D0A7XQ HIGHSTAT Investigative D0A7YE DRUG__ID D0A7YE D0A7YE DRUGTYPE Small molecular drug D0A7YE DRUGINCH 1S/C20H25NO/c1-2-3-4-5-9-16-20(22)21-19-15-11-10-14-18(19)17-12-7-6-8-13-17/h6-8,10-15H,2-5,9,16H2,1H3,(H,21,22) D0A7YE DRUGINKE CLTPDJWVYAJEKC-UHFFFAOYSA-N D0A7YE DRUGSMIL CCCCCCCC(=O)NC1=CC=CC=C1C2=CC=CC=C2 D0A7YE HIGHSTAT Investigative D0A7YH DRUG__ID D0A7YH D0A7YH DRUGTYPE Small molecular drug D0A7YH DRUGINCH 1S/C30H26O6/c1-16-11-22(17-3-6-19(31)7-4-17)29-24(12-16)23-13-18-5-10-28(33)35-25(18)15-27(23)36-30(29)21-9-8-20(32)14-26(21)34-2/h3-10,12-15,22,24,29-32H,11H2,1-2H3/t22-,24-,29-,30+/m0/s1 D0A7YH DRUGINKE PRFNZHGCOFIZAC-ZKQAZLPASA-N D0A7YH DRUGSMIL CC1=CC2C(C(C1)C3=CC=C(C=C3)O)C(OC4=C2C=C5C=CC(=O)OC5=C4)C6=C(C=C(C=C6)O)OC D0A7YH HIGHSTAT Investigative D0A7ZH DRUG__ID D0A7ZH D0A7ZH DRUGTYPE Small molecular drug D0A7ZH DRUGINCH 1S/C14H12F2N2O3S/c15-12-3-1-2-10(13(12)16)8-18-14(19)9-4-6-11(7-5-9)22(17,20)21/h1-7H,8H2,(H,18,19)(H2,17,20,21) D0A7ZH DRUGINKE QASSMVGOSBNFQY-UHFFFAOYSA-N D0A7ZH DRUGSMIL C1=CC(=C(C(=C1)F)F)CNC(=O)C2=CC=C(C=C2)S(=O)(=O)N D0A7ZH HIGHSTAT Investigative D0A8AL DRUG__ID D0A8AL D0A8AL DRUGCOMP University of Louisville D0A8AL DRUGINCH 1S/C17H12N2O/c20-17(14-9-11-18-12-10-14)8-7-15-6-5-13-3-1-2-4-16(13)19-15/h1-12H/b8-7+ D0A8AL DRUGINKE UJJUKZPBUMCSJZ-BQYQJAHWSA-N D0A8AL DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)C=CC(=O)C3=CC=NC=C3 D0A8AL HIGHSTAT Investigative D0A8BJ DRUG__ID D0A8BJ D0A8BJ DRUGTYPE Small molecular drug D0A8BJ DRUGINCH 1S/C14H12N2OS/c1-10-4-2-5-11(8-10)18(17)14-7-3-6-13(16)12(14)9-15/h2-8H,16H2,1H3 D0A8BJ DRUGINKE VIFDNSNSPURBMX-UHFFFAOYSA-N D0A8BJ DRUGSMIL CC1=CC(=CC=C1)S(=O)C2=CC=CC(=C2C#N)N D0A8BJ HIGHSTAT Investigative D0A8CS DRUG__ID D0A8CS D0A8CS DRUGTYPE Small molecular drug D0A8CS DRUGINCH 1S/C15H14N2O2/c1-2-15-13-9-12(19)7-8-14(13)16-17(15)10-3-5-11(18)6-4-10/h3-9,18-19H,2H2,1H3 D0A8CS DRUGINKE XBMVVMYGKMGLJX-UHFFFAOYSA-N D0A8CS DRUGSMIL CCC1=C2C=C(C=CC2=NN1C3=CC=C(C=C3)O)O D0A8CS HIGHSTAT Investigative D0A8EK DRUG__ID D0A8EK D0A8EK DRUGTYPE Small molecular drug D0A8EK DRUGINCH 1S/C18H22N6O4/c19-11-3-1-10(2-4-11)5-6-20-16-13-17(22-8-21-16)24(9-23-13)18-15(27)14(26)12(7-25)28-18/h1-4,8-9,12,14-15,18,25-27H,5-7,19H2,(H,20,21,22)/t12-,14-,15-,18-/m1/s1 D0A8EK DRUGINKE XTPOZVLRZZIEBW-SCFUHWHPSA-N D0A8EK DRUGSMIL C1=CC(=CC=C1CCNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D0A8EK HIGHSTAT Investigative D0A8EU DRUG__ID D0A8EU D0A8EU DRUGTYPE Small molecular drug D0A8EU DRUGINCH 1S/C5H11NO2/c1-4(6)2-3-5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1 D0A8EU DRUGINKE ABSTXSZPGHDTAF-SCSAIBSYSA-N D0A8EU DRUGSMIL CC(CCC(=O)O)N D0A8EU HIGHSTAT Investigative D0A8HW DRUG__ID D0A8HW D0A8HW DRUGTYPE Small molecular drug D0A8HW DRUGINCH 1S/C16H15ClN2O3S/c17-13-4-1-10(2-5-13)16(20)19-14-7-11-3-6-15(23(18,21)22)9-12(11)8-14/h1-6,9,14H,7-8H2,(H,19,20)(H2,18,21,22) D0A8HW DRUGINKE BJLRENUWWOPZIL-UHFFFAOYSA-N D0A8HW DRUGSMIL C1C(CC2=C1C=CC(=C2)S(=O)(=O)N)NC(=O)C3=CC=C(C=C3)Cl D0A8HW HIGHSTAT Investigative D0A8HX DRUG__ID D0A8HX D0A8HX DRUGTYPE Small molecular drug D0A8HX DRUGINCH 1S/C13H13N7/c1-6-3-2-4-7(5-6)8-10(14)18-12-9(17-8)11(15)19-13(16)20-12/h2-5H,1H3,(H6,14,15,16,18,19,20) D0A8HX DRUGINKE YCKFHKBIDNIARX-UHFFFAOYSA-N D0A8HX DRUGSMIL CC1=CC(=CC=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N D0A8HX HIGHSTAT Investigative D0A8MD DRUG__ID D0A8MD D0A8MD DRUGTYPE Small molecular drug D0A8MD DRUGINCH 1S/C7H4I2O3/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2,10H,(H,11,12) D0A8MD DRUGINKE DHZVWQPHNWDCFS-UHFFFAOYSA-N D0A8MD DRUGSMIL C1=C(C=C(C(=C1C(=O)O)O)I)I D0A8MD HIGHSTAT Investigative D0A8MN DRUG__ID D0A8MN D0A8MN DRUGTYPE Small molecular drug D0A8MN DRUGINCH 1S/C23H19NO2/c1-25-20-12-8-18(9-13-20)23(19-10-14-21(26-2)15-11-19)22(16-24)17-6-4-3-5-7-17/h3-15H,1-2H3 D0A8MN DRUGINKE RQZZPWWADAMYCL-UHFFFAOYSA-N D0A8MN DRUGSMIL COC1=CC=C(C=C1)C(=C(C#N)C2=CC=CC=C2)C3=CC=C(C=C3)OC D0A8MN HIGHSTAT Investigative D0A8NB DRUG__ID D0A8NB D0A8NB DRUGTYPE Small molecular drug D0A8NB DRUGINCH 1S/C15H19N3O/c1-2-9-19-14-4-3-13-15(18-14)12(10-17-13)11-5-7-16-8-6-11/h3-5,10,16-17H,2,6-9H2,1H3 D0A8NB DRUGINKE KWQWBZIGHIOKIO-UHFFFAOYSA-N D0A8NB DRUGSMIL CCCOC1=NC2=C(C=C1)NC=C2C3=CCNCC3 D0A8NB HIGHSTAT Investigative D0A8NN DRUG__ID D0A8NN D0A8NN DRUGCOMP Creabilis Therapeutics SpA D0A8NN DRUGINCH 1S/C14H18O2/c1-11-5-7-12(8-6-11)14(13(15)16)9-3-2-4-10-14/h5-8H,2-4,9-10H2,1H3,(H,15,16) D0A8NN DRUGINKE BEVYUARQHKRBMH-UHFFFAOYSA-N D0A8NN DRUGSMIL CC1=CC=C(C=C1)C2(CCCCC2)C(=O)O D0A8NN HIGHSTAT Investigative D0A8OV DRUG__ID D0A8OV D0A8OV DRUGTYPE Small molecular drug D0A8OV DRUGINCH 1S/C13H15N3O2/c1-10(17)16-12(13(18)15-8-7-14)9-11-5-3-2-4-6-11/h2-6,12H,8-9H2,1H3,(H,15,18)(H,16,17)/t12-/m0/s1 D0A8OV DRUGINKE ITHLBMBCVIAAIX-LBPRGKRZSA-N D0A8OV DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)NCC#N D0A8OV HIGHSTAT Investigative D0A8OW DRUG__ID D0A8OW D0A8OW DRUGTYPE Small molecular drug D0A8OW DRUGINCH 1S/C26H34O3/c1-25(2)13-4-14-26(3)21-10-6-17(15-18(21)9-12-23(25)26)5-7-19-16-20(24(28)29)8-11-22(19)27/h5,8,11,16,23,27H,4,6-7,9-10,12-15H2,1-3H3,(H,28,29)/b17-5-/t23-,26+/m1/s1 D0A8OW DRUGINKE DJADSIGWJIXULZ-IJOJHBLOSA-N D0A8OW DRUGSMIL CC1(CCCC2(C1CCC3=C2CCC(=CCC4=C(C=CC(=C4)C(=O)O)O)C3)C)C D0A8OW HIGHSTAT Investigative D0A8OX DRUG__ID D0A8OX D0A8OX DRUGTYPE Small molecular drug D0A8OX DRUGINCH 1S/C33H50N2O2/c1-3-32(28-14-12-16-30(36)24-28)18-6-10-22-34(26-32)20-8-5-9-21-35-23-11-7-19-33(4-2,27-35)29-15-13-17-31(37)25-29/h12-17,24-25,36-37H,3-11,18-23,26-27H2,1-2H3/t32-,33?/m1/s1 D0A8OX DRUGINKE XNVOHDDYQCZZQX-KWRHIPAJSA-N D0A8OX DRUGSMIL CCC1(CCCCN(C1)CCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0A8OX HIGHSTAT Investigative D0A8PD DRUG__ID D0A8PD D0A8PD DRUGTYPE Small molecular drug D0A8PD DRUGINCH 1S/C29H60NO7P/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-27(2)24-34-25-29(37-28(3)31)26-36-38(32,33)35-23-22-30(4,5)6/h27,29H,7-26H2,1-6H3 D0A8PD DRUGINKE CIVAIADZNGBFHP-UHFFFAOYSA-N D0A8PD DRUGSMIL CCCCCCCCCCCCCCCCC(C)COCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C D0A8PD HIGHSTAT Investigative D0A8PI DRUG__ID D0A8PI D0A8PI DRUGTYPE Small molecular drug D0A8PI DRUGINCH 1S/C19H36N4O6/c1-9-28-18(27)23-22-16(25)14(12(4)5)21-15(24)13(10-11(2)3)20-17(26)29-19(6,7)8/h11-14H,9-10H2,1-8H3,(H,20,26)(H,21,24)(H,22,25)(H,23,27) D0A8PI DRUGINKE CCIRNXXUWFWJAR-UHFFFAOYSA-N D0A8PI DRUGSMIL CCOC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C D0A8PI HIGHSTAT Investigative D0A8PV DRUG__ID D0A8PV D0A8PV DRUGTYPE Small molecular drug D0A8PV DRUGINCH 1S/C32H27F4N5O3/c1-3-44-24-11-9-23(10-12-24)41-30(39-29-25(31(41)43)7-5-15-38-29)20(2)40(19-22-6-4-14-37-18-22)28(42)17-21-8-13-27(33)26(16-21)32(34,35)36/h4-16,18,20H,3,17,19H2,1-2H3/t20-/m1/s1 D0A8PV DRUGINKE XMRGQUDUVGRCBS-HXUWFJFHSA-N D0A8PV DRUGSMIL CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2C(C)N(CC4=CN=CC=C4)C(=O)CC5=CC(=C(C=C5)F)C(F)(F)F D0A8PV HIGHSTAT Investigative D0A8QA DRUG__ID D0A8QA D0A8QA DRUGTYPE Small molecular drug D0A8QA DRUGINCH 1S/C16H10ClN3/c1-10-2-3-11-4-5-12(7-15(11)20-10)14-6-13(8-18)16(17)19-9-14/h2-7,9H,1H3 D0A8QA DRUGINKE FCXAJLFDBPZDJD-UHFFFAOYSA-N D0A8QA DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=C(N=C3)Cl)C#N D0A8QA HIGHSTAT Investigative D0A8WJ DRUG__ID D0A8WJ D0A8WJ DRUGTYPE Small molecular drug D0A8WJ DRUGINCH 1S/C35H30O11/c1-15-8-22(19-4-2-16(36)10-25(19)40)31(34(44)20-5-3-17(37)11-26(20)41)23(9-15)32-24(39)7-6-21(35(32)45)29-14-28(43)33-27(42)12-18(38)13-30(33)46-29/h2-7,9-13,22-23,29,31,36-42,45H,8,14H2,1H3/t22-,23-,29-,31-/m0/s1 D0A8WJ DRUGINKE ZEZOBFSLMMTYFF-HQSFFLIMSA-N D0A8WJ DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C=CC(=C4O)C5CC(=O)C6=C(C=C(C=C6O5)O)O)O D0A8WJ HIGHSTAT Investigative D0A8WP DRUG__ID D0A8WP D0A8WP DRUGTYPE Small molecular drug D0A8WP DRUGINCH 1S/C18H15N3O/c19-17(20)14-8-6-13-11-15(9-7-12(13)10-14)18(22)21-16-4-2-1-3-5-16/h1-11H,(H3,19,20)(H,21,22) D0A8WP DRUGINKE AECPTICWHONWNW-UHFFFAOYSA-N D0A8WP DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC3=C(C=C2)C=C(C=C3)C(=N)N D0A8WP HIGHSTAT Investigative D0A8ZM DRUG__ID D0A8ZM D0A8ZM DRUGTYPE Small molecular drug D0A8ZM DRUGINCH 1S/C5H12BNO4S/c7-4(5(8)9)3-12-2-1-6(10)11/h4,10-11H,1-3,7H2,(H,8,9)/t4-/m0/s1 D0A8ZM DRUGINKE OTJHLDXXJHAZTN-BYPYZUCNSA-N D0A8ZM DRUGSMIL B(CCSCC(C(=O)O)N)(O)O D0A8ZM HIGHSTAT Investigative D0A8ZS DRUG__ID D0A8ZS D0A8ZS DRUGTYPE Small molecular drug D0A8ZS DRUGINCH 1S/C48H78N14O8/c1-5-29(4)39(46(70)57-34(40(50)64)17-11-12-24-49)62-43(67)36(19-14-26-56-48(53)54)59-44(68)38(28-31-20-22-33(63)23-21-31)61-45(69)37(27-30-15-9-8-10-16-30)60-42(66)35(18-13-25-55-47(51)52)58-41(65)32(6-2)7-3/h8-10,15-16,20-23,29,32,34-39,63H,5-7,11-14,17-19,24-28,49H2,1-4H3,(H2,50,64)(H,57,70)(H,58,65)(H,59,68)(H,60,66)(H,61,69)(H,62,67)(H4,51,52,55)(H4,53,54,56)/t29-,34-,35-,36-,37-,38-,39-/m0/s1 D0A8ZS DRUGINKE ZOGNSEAXOALIEC-ICJZXESVSA-N D0A8ZS DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC)CC D0A8ZS HIGHSTAT Investigative D0A9AJ DRUG__ID D0A9AJ D0A9AJ DRUGTYPE Small molecular drug D0A9AJ DRUGINCH 1S/C34H47N7O10/c1-18(2)12-24(33(49)41-28(19(3)43)34(50)51)39-32(48)25(15-20-8-5-4-6-9-20)38-27(44)16-37-31(47)26(17-42)40-30(46)23(35)14-21-10-7-11-22(13-21)29(36)45/h4-11,13,18-19,23-26,28,42-43H,12,14-17,35H2,1-3H3,(H2,36,45)(H,37,47)(H,38,44)(H,39,48)(H,40,46)(H,41,49)(H,50,51)/t19-,23+,24+,25+,26+,28+/m1/s1 D0A9AJ DRUGINKE LGORGTYVVSKEOB-KXJTVXFKSA-N D0A9AJ DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(CO)NC(=O)C(CC2=CC(=CC=C2)C(=O)N)N D0A9AJ HIGHSTAT Investigative D0A9BK DRUG__ID D0A9BK D0A9BK DRUGTYPE Small molecular drug D0A9BK DRUGINCH 1S/C7H13NO/c1-7(2)5-4-6(9)8(7)3/h4-5H2,1-3H3 D0A9BK DRUGINKE YARDEGUIPATLSG-UHFFFAOYSA-N D0A9BK DRUGSMIL CC1(CCC(=O)N1C)C D0A9BK HIGHSTAT Investigative D0A9BZ DRUG__ID D0A9BZ D0A9BZ DRUGTYPE Small molecular drug D0A9BZ DRUGINCH 1S/C25H28N6O4S/c1-2-12-31-24(32)21-23(28-25(31)33)27-22(26-21)19-8-10-20(11-9-19)36(34,35)30-15-13-29(14-16-30)17-18-6-4-3-5-7-18/h3-11H,2,12-17H2,1H3,(H,26,27)(H,28,33) D0A9BZ DRUGINKE HHNGYTVWOXXKET-UHFFFAOYSA-N D0A9BZ DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)CC5=CC=CC=C5 D0A9BZ HIGHSTAT Investigative D0A9CK DRUG__ID D0A9CK D0A9CK DRUGTYPE Small molecular drug D0A9CK DRUGINCH 1S/C32H30ClN3O7/c33-22-10-8-19(9-11-22)23-13-21(23)17-42-32(31(40)41)15-26(37)29(39)27(16-32)43-28(38)14-25(20-5-2-1-3-6-20)36-18-35-30-24(36)7-4-12-34-30/h1-12,14,18,21,23,26-27,29,37,39H,13,15-17H2,(H,40,41)/b25-14-/t21-,23+,26+,27+,29+,32-/m0/s1 D0A9CK DRUGINKE MYXPHMOLFCUDIL-MLFVSVOESA-N D0A9CK DRUGSMIL C1C(C1C2=CC=C(C=C2)Cl)COC3(CC(C(C(C3)OC(=O)C=C(C4=CC=CC=C4)N5C=NC6=C5C=CC=N6)O)O)C(=O)O D0A9CK HIGHSTAT Investigative D0A9CZ DRUG__ID D0A9CZ D0A9CZ DRUGTYPE Small molecular drug D0A9CZ DRUGINCH 1S/C20H20O4/c1-11(2)3-5-14-17(22)8-7-13-16-10-23-18-9-12(21)4-6-15(18)20(16)24-19(13)14/h3-4,6-9,16,20-22H,5,10H2,1-2H3/t16-,20-/m0/s1 D0A9CZ DRUGINKE OFWYIUYVHYPQNX-JXFKEZNVSA-N D0A9CZ DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3C2COC4=C3C=CC(=C4)O)O)C D0A9CZ HIGHSTAT Investigative D0A9EA DRUG__ID D0A9EA D0A9EA DRUGTYPE Small molecular drug D0A9EA DRUGINCH 1S/C36H44N4O6/c1-36(19-27-20-37-30-10-6-5-9-29(27)30,40-35(45)46-33-25-14-23-13-24(16-25)17-26(33)15-23)34(44)39-28(18-22-7-3-2-4-8-22)21-38-31(41)11-12-32(42)43/h2-10,20,23-26,28,33,37H,11-19,21H2,1H3,(H,38,41)(H,39,44)(H,40,45)(H,42,43)/t23?,24?,25?,26?,28-,33?,36-/m0/s1 D0A9EA DRUGINKE HAQJDPAHYIINDW-HXWIKMKJSA-N D0A9EA DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CNC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0A9EA HIGHSTAT Investigative D0A9ED DRUG__ID D0A9ED D0A9ED DRUGTYPE Small molecular drug D0A9ED DRUGINCH 1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3 D0A9ED DRUGINKE BQXQGZPYHWWCEB-UHFFFAOYSA-N D0A9ED DRUGSMIL CC(C)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O D0A9ED HIGHSTAT Investigative D0A9HL DRUG__ID D0A9HL D0A9HL DRUGTYPE Small molecular drug D0A9HL DRUGINCH 1S/C8H8N2O/c1-10-7-5-3-2-4-6(7)8(11)9-10/h2-5H,1H3,(H,9,11) D0A9HL DRUGINKE ONNIFDMRZCMQQM-UHFFFAOYSA-N D0A9HL DRUGSMIL CN1C2=CC=CC=C2C(=O)N1 D0A9HL HIGHSTAT Investigative D0A9HM DRUG__ID D0A9HM D0A9HM DRUGTYPE Small molecular drug D0A9HM DRUGINCH 1S/C17H13NO3/c1-11-6-8-12(9-7-11)15(19)10-18-14-5-3-2-4-13(14)16(20)17(18)21/h2-9H,10H2,1H3 D0A9HM DRUGINKE PJQULSIUMHBSSF-UHFFFAOYSA-N D0A9HM DRUGSMIL CC1=CC=C(C=C1)C(=O)CN2C3=CC=CC=C3C(=O)C2=O D0A9HM HIGHSTAT Investigative D0A9HU DRUG__ID D0A9HU D0A9HU DRUGTYPE Small molecular drug D0A9HU DRUGINCH 1S/C12H10ClNO2/c13-8-5-6-12(10(15)7-8)16-11-4-2-1-3-9(11)14/h1-7,15H,14H2 D0A9HU DRUGINKE HJXYQHRZHJFAGC-UHFFFAOYSA-N D0A9HU DRUGSMIL C1=CC=C(C(=C1)N)OC2=C(C=C(C=C2)Cl)O D0A9HU HIGHSTAT Investigative D0A9IB DRUG__ID D0A9IB D0A9IB DRUGTYPE Small molecular drug D0A9IB DRUGINCH 1S/C14H12F3N/c1-18-13-8-4-11(5-9-13)10-2-6-12(7-3-10)14(15,16)17/h2-9,18H,1H3 D0A9IB DRUGINKE KPEUWXDPXPGBFC-UHFFFAOYSA-N D0A9IB DRUGSMIL CNC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F D0A9IB HIGHSTAT Investigative D0A9IM DRUG__ID D0A9IM D0A9IM DRUGTYPE Small molecular drug D0A9IM DRUGINCH 1S/C32H44N4O/c37-31-21-20-24-27(18-13-19-28(24)36-31)33-22-11-5-3-1-2-4-6-12-23-34-32-25-14-7-9-16-29(25)35-30-17-10-8-15-26(30)32/h7,9,14,16,20-21,27,33H,1-6,8,10-13,15,17-19,22-23H2,(H,34,35)(H,36,37)/t27-/m1/s1 D0A9IM DRUGINKE ROTFGKJJMRTWBD-HHHXNRCGSA-N D0A9IM DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCCCCCNC4CCCC5=C4C=CC(=O)N5 D0A9IM HIGHSTAT Investigative D0A9MY DRUG__ID D0A9MY D0A9MY DRUGTYPE Small molecular drug D0A9MY DRUGINCH 1S/C17H18N4O/c1-2-3-16(22)19-17-14-9-6-12(10-15(14)20-21-17)11-4-7-13(18)8-5-11/h4-10H,2-3,18H2,1H3,(H2,19,20,21,22) D0A9MY DRUGINKE DCCRABAZYMVLJU-UHFFFAOYSA-N D0A9MY DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=C(C=C3)N D0A9MY HIGHSTAT Investigative D0A9NE DRUG__ID D0A9NE D0A9NE DRUGTYPE Small molecular drug D0A9NE DRUGINCH 1S/C16H12O5/c17-10-2-3-12-14(19)8-11(21-16(12)7-10)5-9-1-4-13(18)15(20)6-9/h1-4,6-8,17-18,20H,5H2 D0A9NE DRUGINKE AERADEZJMNEWMZ-UHFFFAOYSA-N D0A9NE DRUGSMIL C1=CC(=C(C=C1CC2=CC(=O)C3=C(O2)C=C(C=C3)O)O)O D0A9NE HIGHSTAT Investigative D0A9PS DRUG__ID D0A9PS D0A9PS DRUGTYPE Small molecular drug D0A9PS DRUGINCH 1S/C22H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-20-21-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15- D0A9PS DRUGINKE LGEQQWMQCRIYKG-DOFZRALJSA-N D0A9PS DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO D0A9PS HIGHSTAT Investigative D0A9QT DRUG__ID D0A9QT D0A9QT DRUGTYPE Small molecular drug D0A9QT DRUGINCH 1S/C24H32N2O2S/c1-25-17-20-16-21(28-13-3-10-26-11-14-27-15-12-26)6-9-23(20)24(18-25)19-4-7-22(29-2)8-5-19/h4-9,16,24H,3,10-15,17-18H2,1-2H3/t24-/m0/s1 D0A9QT DRUGINKE XYYGFCDTBHAUSN-DEOSSOPVSA-N D0A9QT DRUGSMIL CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCOCC3)C4=CC=C(C=C4)SC D0A9QT HIGHSTAT Investigative D0A9RM DRUG__ID D0A9RM D0A9RM DRUGTYPE Small molecular drug D0A9RM DRUGINCH 1S/C16H12O5/c1-20-11-6-13(18)15-14(7-11)21-8-12(16(15)19)9-2-4-10(17)5-3-9/h2-8,17-18H,1H3 D0A9RM DRUGINKE KQMVAGISDHMXJJ-UHFFFAOYSA-N D0A9RM DRUGSMIL COC1=CC(=C2C(=C1)OC=C(C2=O)C3=CC=C(C=C3)O)O D0A9RM HIGHSTAT Investigative D0A9UF DRUG__ID D0A9UF D0A9UF DRUGTYPE Small molecular drug D0A9UF DRUGINCH 1S/C17H17NO/c19-15-8-13-5-6-18-16-10-12-4-2-1-3-11(12)7-14(9-15)17(13)16/h1-4,8-9,16,18-19H,5-7,10H2 D0A9UF DRUGINKE ZCATUTKNMGBMKU-UHFFFAOYSA-N D0A9UF DRUGSMIL C1CNC2CC3=CC=CC=C3CC4=CC(=CC1=C24)O D0A9UF HIGHSTAT Investigative D0A9WC DRUG__ID D0A9WC D0A9WC DRUGTYPE Small molecular drug D0A9WC DRUGINCH 1S/C13H15N3OS2/c1-17-11-4-2-3-10(9-11)5-6-14-12(18)16-13-15-7-8-19-13/h2-4,7-9H,5-6H2,1H3,(H2,14,15,16,18) D0A9WC DRUGINKE TXUPZNCSUKFSFG-UHFFFAOYSA-N D0A9WC DRUGSMIL COC1=CC=CC(=C1)CCNC(=S)NC2=NC=CS2 D0A9WC HIGHSTAT Investigative D0A9WP DRUG__ID D0A9WP D0A9WP DRUGTYPE Small molecular drug D0A9WP DRUGINCH 1S/C11H15N5O4/c12-11-15-5-3(1-13-7(5)10(20)16-11)6-9(19)8(18)4(2-17)14-6/h1,4,6,8-9,13-14,17-19H,2H2,(H3,12,15,16,20)/t4-,6+,8-,9+/m1/s1 D0A9WP DRUGINKE KBIDJCVAURJXFG-PVEDRDFWSA-N D0A9WP DRUGSMIL C1=C(C2=C(N1)C(=O)NC(=N2)N)C3C(C(C(N3)CO)O)O D0A9WP HIGHSTAT Investigative D0A9WT DRUG__ID D0A9WT D0A9WT DRUGTYPE Small molecular drug D0A9WT DRUGINCH 1S/C20H21N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,8-9,12-13,22H,5-7H2,(H,24,31)(H,29,30)(H,33,34)(H3,21,25,26,32)/t12-,13-/m1/s1 D0A9WT DRUGINKE CJLRPFSRJZBYFE-CHWSQXEVSA-N D0A9WT DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2C=NC3=C(N2C=O)C(=O)NC(=N3)N D0A9WT HIGHSTAT Investigative D0A9ZP DRUG__ID D0A9ZP D0A9ZP DRUGTYPE Small molecular drug D0A9ZP DRUGINCH 1S/C23H15ClN4/c24-16-8-10-17(11-9-16)26-23-21-6-2-1-5-20(21)22(27-28-23)19-7-3-4-15-14-25-13-12-18(15)19/h1-14H,(H,26,28) D0A9ZP DRUGINKE RXWBASVYZOFLRF-UHFFFAOYSA-N D0A9ZP DRUGSMIL C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)C4=CC=CC5=C4C=CN=C5 D0A9ZP HIGHSTAT Investigative D0A9ZQ DRUG__ID D0A9ZQ D0A9ZQ DRUGTYPE Small molecular drug D0A9ZQ DRUGINCH 1S/C21H16N2O2/c1-3-8-16(9-4-1)20-15-22-21(25-20)23-17-10-7-13-19(14-17)24-18-11-5-2-6-12-18/h1-15H,(H,22,23) D0A9ZQ DRUGINKE JTIZQZSOCSALNJ-UHFFFAOYSA-N D0A9ZQ DRUGSMIL C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC(=CC=C3)OC4=CC=CC=C4 D0A9ZQ HIGHSTAT Investigative D0AA4O DRUG__ID D0AA4O D0AA4O DRUGTYPE Small molecular drug D0AA4O DRUGINCH 1S/C20H30ClN3O2S3/c1-23(2)12-14-29-28-13-9-22-20(26)16-7-10-24(11-8-16)19(25)15-27-18-5-3-17(21)4-6-18/h3-6,16H,7-15H2,1-2H3,(H,22,26) D0AA4O DRUGINKE WEEYMZOUPNIHLG-UHFFFAOYSA-N D0AA4O DRUGSMIL CN(C)CCSSCCNC(=O)C1CCN(CC1)C(=O)CSC2=CC=C(C=C2)Cl D0AA4O HIGHSTAT Investigative D0AA8E DRUG__ID D0AA8E D0AA8E DRUGTYPE Small molecular drug D0AA8E DRUGINCH 1S/C6H2N4O4S/c11-9(12)3-1-4-6(8-15-7-4)5(2-3)10(13)14/h1-2H D0AA8E DRUGINKE BYLOIWCTRDPRTP-UHFFFAOYSA-N D0AA8E DRUGSMIL C1=C(C=C(C2=NSN=C21)[N+](=O)[O-])[N+](=O)[O-] D0AA8E HIGHSTAT Investigative D0AA9A DRUG__ID D0AA9A D0AA9A DRUGTYPE Small molecular drug D0AA9A DRUGINCH 1S/C19H34N4O/c20-12-6-15-21-13-4-5-14-22-16-7-17-23-19(24)11-10-18-8-2-1-3-9-18/h1-3,8-9,21-22H,4-7,10-17,20H2,(H,23,24) D0AA9A DRUGINKE GLVZEIGFWZGDFV-UHFFFAOYSA-N D0AA9A DRUGSMIL C1=CC=C(C=C1)CCC(=O)NCCCNCCCCNCCCN D0AA9A HIGHSTAT Investigative D0AC2H DRUG__ID D0AC2H D0AC2H DRUGTYPE Small molecular drug D0AC2H DRUGINCH 1S/C6H11NO2/c8-6(9)5-1-3-7-4-2-5/h5,7H,1-4H2,(H,8,9) D0AC2H DRUGINKE SRJOCJYGOFTFLH-UHFFFAOYSA-N D0AC2H DRUGSMIL C1CNCCC1C(=O)O D0AC2H HIGHSTAT Investigative D0AD1L DRUG__ID D0AD1L D0AD1L DRUGTYPE Small molecular drug D0AD1L DRUGINCH 1S/C16H18NO5P/c17-15(16(18)19)9-11-4-3-6-12(8-11)14-7-2-1-5-13(14)10-23(20,21)22/h1-8,15H,9-10,17H2,(H,18,19)(H2,20,21,22) D0AD1L DRUGINKE NCEGJIHRQBRVJQ-UHFFFAOYSA-N D0AD1L DRUGSMIL C1=CC=C(C(=C1)CP(=O)(O)O)C2=CC=CC(=C2)CC(C(=O)O)N D0AD1L HIGHSTAT Investigative D0AD3U DRUG__ID D0AD3U D0AD3U DRUGTYPE Small molecular drug D0AD3U DRUGINCH 1S/C13H8FNO3/c14-9-5-7(1-4-11(9)17)13-15-10-3-2-8(16)6-12(10)18-13/h1-6,16-17H D0AD3U DRUGINKE LMARQOUQPBAFEB-UHFFFAOYSA-N D0AD3U DRUGSMIL C1=CC(=C(C=C1C2=NC3=C(O2)C=C(C=C3)O)F)O D0AD3U HIGHSTAT Investigative D0AD7P DRUG__ID D0AD7P D0AD7P DRUGTYPE Small molecular drug D0AD7P DRUGINCH 1S/C30H34N4O10S/c1-2-3-4-5-9-23(33-17-26(31-18-33)32-27(35)22-8-6-7-10-25(22)45(41,42)43)28(36)34-16-21(15-24(34)30(39)40)44-20-13-11-19(12-14-20)29(37)38/h6-8,10-14,17-18,21,23-24H,2-5,9,15-16H2,1H3,(H,32,35)(H,37,38)(H,39,40)(H,41,42,43)/t21-,23+,24-/m0/s1 D0AD7P DRUGINKE HHFYOGBTLFTWQX-QTJGBDASSA-N D0AD7P DRUGSMIL CCCCCCC(C(=O)N1CC(CC1C(=O)O)OC2=CC=C(C=C2)C(=O)O)N3C=C(N=C3)NC(=O)C4=CC=CC=C4S(=O)(=O)O D0AD7P HIGHSTAT Investigative D0AD8G DRUG__ID D0AD8G D0AD8G DRUGTYPE Small molecular drug D0AD8G DRUGINCH 1S/C15H15NO3S/c1-2-12-16(13-6-4-3-5-7-13)20(18,19)15-10-8-14(17)9-11-15/h2-11,17H,1,12H2 D0AD8G DRUGINKE CZEIYINPLQLEHQ-UHFFFAOYSA-N D0AD8G DRUGSMIL C=CCN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O D0AD8G HIGHSTAT Investigative D0AE9M DRUG__ID D0AE9M D0AE9M DRUGTYPE Small molecular drug D0AE9M DRUGINCH 1S/C17H19N3/c1-2-3-13-19(16-8-11-18-12-9-16)20-14-10-15-6-4-5-7-17(15)20/h4-12,14H,2-3,13H2,1H3 D0AE9M DRUGINKE OSRPQIAWURAKDF-UHFFFAOYSA-N D0AE9M DRUGSMIL CCCCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32 D0AE9M HIGHSTAT Investigative D0AF1J DRUG__ID D0AF1J D0AF1J DRUGTYPE Small molecular drug D0AF1J DRUGINCH 1S/C15H18N4OS/c20-15(16-9-8-11-4-2-1-3-5-11)17-12-6-7-13-14(10-12)21-19-18-13/h4,6-7,10H,1-3,5,8-9H2,(H2,16,17,20) D0AF1J DRUGINKE GGXCUZHEJUJACD-UHFFFAOYSA-N D0AF1J DRUGSMIL C1CCC(=CC1)CCNC(=O)NC2=CC3=C(C=C2)N=NS3 D0AF1J HIGHSTAT Investigative D0AF3A DRUG__ID D0AF3A D0AF3A DRUGTYPE Small molecular drug D0AF3A DRUGINCH 1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35-36H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42) D0AF3A DRUGINKE ZCFFYALKHPIRKJ-UHFFFAOYSA-N D0AF3A DRUGSMIL CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C D0AF3A HIGHSTAT Investigative D0AG1Q DRUG__ID D0AG1Q D0AG1Q DRUGTYPE Small molecular drug D0AG1Q DRUGINCH 1S/C11H11N5O/c1-7-6-14-10(12)9(15-7)11(17)16-8-4-2-3-5-13-8/h2-6H,1H3,(H2,12,14)(H,13,16,17) D0AG1Q DRUGINKE NAQODRYELYCKDS-UHFFFAOYSA-N D0AG1Q DRUGSMIL CC1=CN=C(C(=N1)C(=O)NC2=CC=CC=N2)N D0AG1Q HIGHSTAT Investigative D0AG8B DRUG__ID D0AG8B D0AG8B DRUGTYPE Small molecular drug D0AG8B DRUGINCH 1S/C17H15NO2S/c19-15-11-16(18-7-9-21-10-8-18)20-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2 D0AG8B DRUGINKE IIWOVJPSKUAWDA-UHFFFAOYSA-N D0AG8B DRUGSMIL C1CSCCN1C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0AG8B HIGHSTAT Investigative D0AH1B DRUG__ID D0AH1B D0AH1B DRUGTYPE Small molecular drug D0AH1B DRUGINCH 1S/C16H15N/c1-12-4-2-6-16-14(7-8-15(12)16)10-13-5-3-9-17-11-13/h2-6,9-11H,7-8H2,1H3/b14-10- D0AH1B DRUGINKE ORCOWTSQEFCEFC-UVTDQMKNSA-N D0AH1B DRUGSMIL CC1=C2CCC(=CC3=CN=CC=C3)C2=CC=C1 D0AH1B HIGHSTAT Investigative D0AH1H DRUG__ID D0AH1H D0AH1H DRUGTYPE Small molecular drug D0AH1H DRUGINCH 1S/C3H7N3O2/c4-3(5)6-1-2(7)8/h1H2,(H,7,8)(H4,4,5,6) D0AH1H DRUGINKE BPMFZUMJYQTVII-UHFFFAOYSA-N D0AH1H DRUGSMIL C(C(=O)O)N=C(N)N D0AH1H HIGHSTAT Investigative D0AH2V DRUG__ID D0AH2V D0AH2V DRUGCOMP Romark Laboratories LC D0AH2V DRUGINCH 1S/C18H13BrO6/c1-2-24-18(23)17-14(9-4-3-5-10(19)6-9)16(22)15-12(21)7-11(20)8-13(15)25-17/h3-8,20-21H,2H2,1H3 D0AH2V DRUGINKE PXFKQPIDCKZUID-UHFFFAOYSA-N D0AH2V DRUGSMIL CCOC(=O)C1=C(C(=O)C2=C(C=C(C=C2O1)O)O)C3=CC(=CC=C3)Br D0AH2V HIGHSTAT Investigative D0AH5T DRUG__ID D0AH5T D0AH5T DRUGTYPE Small molecular drug D0AH5T DRUGINCH 1S/C17H27NO2/c1-5-7-18(8-6-2)15-9-13-11-16(19-3)17(20-4)12-14(13)10-15/h11-12,15H,5-10H2,1-4H3 D0AH5T DRUGINKE UOLJKAPABHXFRE-UHFFFAOYSA-N D0AH5T DRUGSMIL CCCN(CCC)C1CC2=CC(=C(C=C2C1)OC)OC D0AH5T HIGHSTAT Investigative D0AH8Q DRUG__ID D0AH8Q D0AH8Q DRUGTYPE Small molecular drug D0AH8Q DRUGINCH 1S/C13H13N5OS/c1-2-9(20-7-1)11-16-12-10(14-8-15-12)13(17-11)18-3-5-19-6-4-18/h1-2,7-8H,3-6H2,(H,14,15,16,17) D0AH8Q DRUGINKE WKJDCMFOOMWIQG-UHFFFAOYSA-N D0AH8Q DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=CS4 D0AH8Q HIGHSTAT Investigative D0AI8F DRUG__ID D0AI8F D0AI8F DRUGTYPE Small molecular drug D0AI8F DRUGINCH 1S/C10H12BrN5/c11-10-15-7-8(12)13-5-14-9(7)16(10)6-3-1-2-4-6/h5-6H,1-4H2,(H2,12,13,14) D0AI8F DRUGINKE UIZPGNXMMMDTHD-UHFFFAOYSA-N D0AI8F DRUGSMIL C1CCC(C1)N2C3=NC=NC(=C3N=C2Br)N D0AI8F HIGHSTAT Investigative D0AJ3C DRUG__ID D0AJ3C D0AJ3C DRUGTYPE Small molecular drug D0AJ3C DRUGINCH 1S/C15H20ClN3O2/c1-21-14-7-12(17)11(16)6-10(14)15(20)18-13-8-19-4-2-9(13)3-5-19/h6-7,9,13H,2-5,8,17H2,1H3,(H,18,20)/t13-/m0/s1 D0AJ3C DRUGINKE FEROPKNOYKURCJ-ZDUSSCGKSA-N D0AJ3C DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CN3CCC2CC3)Cl)N D0AJ3C HIGHSTAT Investigative D0AJ4T DRUG__ID D0AJ4T D0AJ4T DRUGTYPE Small molecular drug D0AJ4T DRUGINCH 1S/C7H7O5P/c8-5-6-3-1-2-4-7(6)12-13(9,10)11/h1-5H,(H2,9,10,11) D0AJ4T DRUGINKE BYNSFVCWJXZPOW-UHFFFAOYSA-N D0AJ4T DRUGSMIL C1=CC=C(C(=C1)C=O)OP(=O)(O)O D0AJ4T HIGHSTAT Investigative D0AJ5G DRUG__ID D0AJ5G D0AJ5G DRUGTYPE Small molecular drug D0AJ5G DRUGINCH 1S/C24H24N2O7/c1-3-30-24(29)15(2)33-19-6-4-5-18-17(19)9-10-26(23(18)28)14-22(27)25-16-7-8-20-21(13-16)32-12-11-31-20/h4-10,13,15H,3,11-12,14H2,1-2H3,(H,25,27) D0AJ5G DRUGINKE KWMBIIQCLUIHDI-UHFFFAOYSA-N D0AJ5G DRUGSMIL CCOC(=O)C(C)OC1=CC=CC2=C1C=CN(C2=O)CC(=O)NC3=CC4=C(C=C3)OCCO4 D0AJ5G HIGHSTAT Investigative D0AJ9D DRUG__ID D0AJ9D D0AJ9D DRUGTYPE Small molecular drug D0AJ9D DRUGINCH 1S/C41H47N5O6/c1-27-21-33(47)22-28(2)34(27)24-35(42)40(50)46-25-31-16-10-9-15-30(31)23-37(46)39(49)45-36(38(48)44-32-17-7-4-8-18-32)19-11-12-20-43-41(51)52-26-29-13-5-3-6-14-29/h3-10,13-18,21-22,35-37,47H,11-12,19-20,23-26,42H2,1-2H3,(H,43,51)(H,44,48)(H,45,49) D0AJ9D DRUGINKE MJVSDWUKXXUPBE-UHFFFAOYSA-N D0AJ9D DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)OCC4=CC=CC=C4)C(=O)NC5=CC=CC=C5)N)C)O D0AJ9D HIGHSTAT Investigative D0AK4K DRUG__ID D0AK4K D0AK4K DRUGTYPE Small molecular drug D0AK4K DRUGINCH 1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3,6-7,9-13,15H,4-5,8H2,1H3,(H,27,30)(H,28,29) D0AK4K DRUGINKE MTDIMKNAJUQTIO-UHFFFAOYSA-N D0AK4K DRUGSMIL CC(C1=CC=C(C2=CC=CC=C21)F)C(=O)NC3=C(C=CC(=C3)C#N)CCCC(=O)O D0AK4K HIGHSTAT Investigative D0AK8Q DRUG__ID D0AK8Q D0AK8Q DRUGTYPE Small molecular drug D0AK8Q DRUGINCH 1S/C15H13NO2/c17-15(16-18)11-8-12-6-9-14(10-7-12)13-4-2-1-3-5-13/h1-11,18H,(H,16,17)/b11-8+ D0AK8Q DRUGINKE YMXJQEHWXZULBO-DHZHZOJOSA-N D0AK8Q DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C=CC(=O)NO D0AK8Q HIGHSTAT Investigative D0AK9S DRUG__ID D0AK9S D0AK9S DRUGTYPE Small molecular drug D0AK9S DRUGINCH 1S/C13H15BrN2O/c14-12-5-3-11(4-6-12)9-16-10-15-8-13(16)2-1-7-17/h3-6,8,10,17H,1-2,7,9H2 D0AK9S DRUGINKE HNOJMJNDVRPLSW-UHFFFAOYSA-N D0AK9S DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2CCCO)Br D0AK9S HIGHSTAT Investigative D0AK9X DRUG__ID D0AK9X D0AK9X DRUGTYPE Small molecular drug D0AK9X DRUGINCH 1S/C8H10ClNO2S/c9-7-2-1-6(13-7)5(4-10)3-8(11)12/h1-2,5H,3-4,10H2,(H,11,12) D0AK9X DRUGINKE CDFQDLUHBLZCGL-UHFFFAOYSA-N D0AK9X DRUGSMIL C1=C(SC(=C1)Cl)C(CC(=O)O)CN D0AK9X HIGHSTAT Investigative D0AL2D DRUG__ID D0AL2D D0AL2D DRUGTYPE Small molecular drug D0AL2D DRUGINCH 1S/C13H12N2O7S2/c14-23(17,18)21-11-5-1-9(2-6-11)13(16)10-3-7-12(8-4-10)22-24(15,19)20/h1-8H,(H2,14,17,18)(H2,15,19,20) D0AL2D DRUGINKE NKZRLSJYBCVOGN-UHFFFAOYSA-N D0AL2D DRUGSMIL C1=CC(=CC=C1C(=O)C2=CC=C(C=C2)OS(=O)(=O)N)OS(=O)(=O)N D0AL2D HIGHSTAT Investigative D0AL2E DRUG__ID D0AL2E D0AL2E DRUGTYPE Small molecular drug D0AL2E DRUGINCH 1S/C13H11N3/c14-12-3-1-2-10-11(8-16-13(10)12)9-4-6-15-7-5-9/h1-8,16H,14H2 D0AL2E DRUGINKE NVYSWJKBWRBXSR-UHFFFAOYSA-N D0AL2E DRUGSMIL C1=CC2=C(C(=C1)N)NC=C2C3=CC=NC=C3 D0AL2E HIGHSTAT Investigative D0AL3G DRUG__ID D0AL3G D0AL3G DRUGTYPE Small molecular drug D0AL3G DRUGINCH 1S/C10H8Cl2N2/c11-9-2-1-8(5-10(9)12)6-14-4-3-13-7-14/h1-5,7H,6H2 D0AL3G DRUGINKE AYZFQKPOALRPNQ-UHFFFAOYSA-N D0AL3G DRUGSMIL C1=CC(=C(C=C1CN2C=CN=C2)Cl)Cl D0AL3G HIGHSTAT Investigative D0AM2Z DRUG__ID D0AM2Z D0AM2Z DRUGTYPE Small molecular drug D0AM2Z DRUGINCH 1S/C14H18N2O2/c1-2-8-14(9-7-12(17)16-13(14)18)10-3-5-11(15)6-4-10/h3-6H,2,7-9,15H2,1H3,(H,16,17,18) D0AM2Z DRUGINKE CKRTXCPPNWSZFC-UHFFFAOYSA-N D0AM2Z DRUGSMIL CCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N D0AM2Z HIGHSTAT Investigative D0AN2Q DRUG__ID D0AN2Q D0AN2Q DRUGTYPE Small molecular drug D0AN2Q DRUGINCH 1S/C38H42N2O6/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)17-23-7-10-27(11-8-23)45-33-19-24(9-12-31(33)41-3)18-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30+/m0/s1 D0AN2Q DRUGINKE WVTKBKWTSCPRNU-XZWHSSHBSA-N D0AN2Q DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC D0AN2Q HIGHSTAT Investigative D0AN6L DRUG__ID D0AN6L D0AN6L DRUGTYPE Small molecular drug D0AN6L DRUGINCH 1S/C28H22FN5O2.ClH/c1-5-18-7-6-8-25-26(18)21(16-34(25)28(36)32(3)4)27(35)19-9-10-20(22(29)13-19)15-33-17(2)31-23-14-30-12-11-24(23)33;/h1,6-14,16H,15H2,2-4H3;1H D0AN6L DRUGINKE AWRGBOKANQBIBM-UHFFFAOYSA-N D0AN6L DRUGSMIL CC1=NC2=C(N1CC3=C(C=C(C=C3)C(=O)C4=CN(C5=CC=CC(=C54)C#C)C(=O)N(C)C)F)C=CN=C2.Cl D0AN6L HIGHSTAT Investigative D0AN7U DRUG__ID D0AN7U D0AN7U DRUGTYPE Small molecular drug D0AN7U DRUGINCH 1S/C19H20N2O5/c22-9-8-20-6-3-7-21-13-10-14(23)15-16(19(13)26)18(25)12-5-2-1-4-11(12)17(15)24/h1-2,4-5,10,20-23,26H,3,6-9H2 D0AN7U DRUGINKE VKQCDUDECMFRJO-UHFFFAOYSA-N D0AN7U DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=C(C(=C3C2=O)O)NCCCNCCO)O D0AN7U HIGHSTAT Investigative D0AO5D DRUG__ID D0AO5D D0AO5D DRUGTYPE Small molecular drug D0AO5D DRUGINCH 1S/C10H15N3/c1-8(12)13-7-10-4-2-3-9(5-10)6-11/h2-5H,6-7,11H2,1H3,(H2,12,13) D0AO5D DRUGINKE RODUKNYOEVZQPR-UHFFFAOYSA-N D0AO5D DRUGSMIL CC(=NCC1=CC=CC(=C1)CN)N D0AO5D HIGHSTAT Investigative D0AO6T DRUG__ID D0AO6T D0AO6T DRUGTYPE Small molecular drug D0AO6T DRUGINCH 1S/C17H13F2NO2/c1-21-16-7-11-5-12(9-20-15(11)8-17(16)22-2)10-3-4-13(18)14(19)6-10/h3-9H,1-2H3 D0AO6T DRUGINKE RETQZWLIOAJIRM-UHFFFAOYSA-N D0AO6T DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC(=C(C=C3)F)F D0AO6T HIGHSTAT Investigative D0AP5M DRUG__ID D0AP5M D0AP5M DRUGTYPE Small molecular drug D0AP5M DRUGINCH 1S/C17H19F3O6P2/c18-17(19,20)15-10-8-14(9-11-15)13-6-4-12(5-7-13)2-1-3-16(27(21,22)23)28(24,25)26/h4-11,16H,1-3H2,(H2,21,22,23)(H2,24,25,26)/p-4 D0AP5M DRUGINKE UPZLJSDZIBONGH-UHFFFAOYSA-J D0AP5M DRUGSMIL C1=CC(=CC=C1CCCC(P(=O)([O-])[O-])P(=O)([O-])[O-])C2=CC=C(C=C2)C(F)(F)F D0AP5M HIGHSTAT Investigative D0AP6N DRUG__ID D0AP6N D0AP6N DRUGTYPE Small molecular drug D0AP6N DRUGINCH 1S/C16H24N2O/c1-4-5-10-18-12-13(9-11-17(2)3)16-14(18)7-6-8-15(16)19/h6-8,12,19H,4-5,9-11H2,1-3H3 D0AP6N DRUGINKE HVOYRIYIBILDHN-UHFFFAOYSA-N D0AP6N DRUGSMIL CCCCN1C=C(C2=C1C=CC=C2O)CCN(C)C D0AP6N HIGHSTAT Investigative D0AQ3K DRUG__ID D0AQ3K D0AQ3K DRUGTYPE Small molecular drug D0AQ3K DRUGINCH 1S/C30H35NO3/c1-31(23-24-14-8-7-9-15-24)20-12-5-3-2-4-6-13-21-33-25-18-19-27-29(22-25)34-28-17-11-10-16-26(28)30(27)32/h7-11,14-19,22H,2-6,12-13,20-21,23H2,1H3 D0AQ3K DRUGINKE QDYNPKJXQNLYFL-UHFFFAOYSA-N D0AQ3K DRUGSMIL CN(CCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D0AQ3K HIGHSTAT Investigative D0AR0H DRUG__ID D0AR0H D0AR0H DRUGTYPE Small molecular drug D0AR0H DRUGINCH 1S/C30H49N3.2BrH/c1-6-11-23-32(24-12-7-2)30-18-16-28(17-19-30)14-15-29-20-25-31(26-21-29)22-13-27-33(8-3,9-4)10-5;;/h14-21,25-26H,6-13,22-24,27H2,1-5H3;2*1H/q+2;;/p-2 D0AR0H DRUGINKE VZUVCAGXYLMFEC-UHFFFAOYSA-L D0AR0H DRUGSMIL CCCCN(CCCC)C1=CC=C(C=C1)C=CC2=CC=[N+](C=C2)CCC[N+](CC)(CC)CC.[Br-].[Br-] D0AR0H HIGHSTAT Investigative D0AR1Y DRUG__ID D0AR1Y D0AR1Y DRUGTYPE Small molecular drug D0AR1Y DRUGINCH 1S/C16H12N2O4/c19-13-5-6-14(20)17(13)9-11-1-2-12(4-3-11)10-18-15(21)7-8-16(18)22/h1-8H,9-10H2 D0AR1Y DRUGINKE XFRPTDABLAIJMY-UHFFFAOYSA-N D0AR1Y DRUGSMIL C1=CC(=CC=C1CN2C(=O)C=CC2=O)CN3C(=O)C=CC3=O D0AR1Y HIGHSTAT Investigative D0AR4P DRUG__ID D0AR4P D0AR4P DRUGTYPE Small molecular drug D0AR4P DRUGINCH 1S/C14H15N5O/c20-7-6-15-13-12-14(17-9-16-13)19(10-18-12)8-11-4-2-1-3-5-11/h1-5,9-10,20H,6-8H2,(H,15,16,17) D0AR4P DRUGINKE ZOVSVHTVIDXQPS-UHFFFAOYSA-N D0AR4P DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C(N=CN=C32)NCCO D0AR4P HIGHSTAT Investigative D0AS0V DRUG__ID D0AS0V D0AS0V DRUGTYPE Small molecular drug D0AS0V DRUGINCH 1S/C10H6O4/c11-5-1-2-6(12)10-8(14)4-3-7(13)9(5)10/h1-4,11-12H D0AS0V DRUGINKE RQNVIKXOOKXAJQ-UHFFFAOYSA-N D0AS0V DRUGSMIL C1=CC(=C2C(=O)C=CC(=O)C2=C1O)O D0AS0V HIGHSTAT Investigative D0AS9Q DRUG__ID D0AS9Q D0AS9Q DRUGTYPE Small molecular drug D0AS9Q DRUGINCH 1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21+,24+,25+,26-/m1/s1 D0AS9Q DRUGINKE GHCZAUBVMUEKKP-XROMFQGDSA-N D0AS9Q DRUGSMIL CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C D0AS9Q HIGHSTAT Investigative D0AT2Z DRUG__ID D0AT2Z D0AT2Z DRUGTYPE Small molecular drug D0AT2Z DRUGINCH 1S/C15H14N4S/c16-10-6-13(17)15-14(7-10)18-8-11(19-15)9-20-12-4-2-1-3-5-12/h1-8H,9,16-17H2 D0AT2Z DRUGINKE PBRHNJQCRCVADQ-UHFFFAOYSA-N D0AT2Z DRUGSMIL C1=CC=C(C=C1)SCC2=NC3=C(C=C(C=C3N=C2)N)N D0AT2Z HIGHSTAT Investigative D0AT3U DRUG__ID D0AT3U D0AT3U DRUGTYPE Small molecular drug D0AT3U DRUGINCH 1S/C21H21N3O/c1-2-6-16-14-19(22)18-13-17(10-11-20(18)23-16)24-21(25)12-9-15-7-4-3-5-8-15/h3-5,7-14H,2,6H2,1H3,(H2,22,23)(H,24,25)/b12-9+ D0AT3U DRUGINKE PWQSXBRFDPQGOC-FMIVXFBMSA-N D0AT3U DRUGSMIL CCCC1=CC(=C2C=C(C=CC2=N1)NC(=O)C=CC3=CC=CC=C3)N D0AT3U HIGHSTAT Investigative D0AT5L DRUG__ID D0AT5L D0AT5L DRUGTYPE Small molecular drug D0AT5L DRUGINCH 1S/C18H20IN7O4/c1-21-17(29)14-12(27)13(28)18(30-14)26-7-25-11-15(23-6-24-16(11)26)22-5-8-2-3-10(20)9(19)4-8/h2-4,6-7,12-14,18,27-28H,5,20H2,1H3,(H,21,29)(H,22,23,24)/t12-,13+,14-,18+/m0/s1/i19-2 D0AT5L DRUGINKE LOGOEBMHHXYBID-WBKNRDRNSA-N D0AT5L DRUGSMIL CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=C(C=C4)N)I)O)O D0AT5L HIGHSTAT Investigative D0AT5N DRUG__ID D0AT5N D0AT5N DRUGTYPE Small molecular drug D0AT5N DRUGINCH 1S/C30H30F2N4O2/c1-20(37)33-24-7-4-6-22(18-24)21-12-16-35(17-13-21)14-5-15-36-30(38)26-9-3-2-8-25(26)29(34-36)23-10-11-27(31)28(32)19-23/h2-4,6-11,18-19,21H,5,12-17H2,1H3,(H,33,37) D0AT5N DRUGINKE YVVMAGRTTSOPEO-UHFFFAOYSA-N D0AT5N DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCCN3C(=O)C4=CC=CC=C4C(=N3)C5=CC(=C(C=C5)F)F D0AT5N HIGHSTAT Investigative D0AT6Z DRUG__ID D0AT6Z D0AT6Z DRUGTYPE Small molecular drug D0AT6Z DRUGINCH 1S/C19H36N2O3/c1-2-20-19(24)21-17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18(22)23/h7,9H,2-6,8,10-17H2,1H3,(H,22,23)(H2,20,21,24)/b9-7- D0AT6Z DRUGINKE OUFBVXMGWWCVFO-CLFYSBASSA-N D0AT6Z DRUGSMIL CCNC(=O)NCCCCC=CCCCCCCCCCC(=O)O D0AT6Z HIGHSTAT Investigative D0AU0F DRUG__ID D0AU0F D0AU0F DRUGTYPE Small molecular drug D0AU0F DRUGINCH 1S/C14H21N7OS/c1-10-12(20-9-18-10)6-23-7-13(22)21-14(15)17-4-2-3-11-5-16-8-19-11/h5,8-9H,2-4,6-7H2,1H3,(H,16,19)(H,18,20)(H3,15,17,21,22) D0AU0F DRUGINKE ZOBGKPFWPWGQOI-UHFFFAOYSA-N D0AU0F DRUGSMIL CC1=C(N=CN1)CSCC(=O)NC(=NCCCC2=CN=CN2)N D0AU0F HIGHSTAT Investigative D0AU0M DRUG__ID D0AU0M D0AU0M DRUGTYPE Small molecular drug D0AU0M DRUGINCH 1S/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3+ D0AU0M DRUGINKE NGSWKAQJJWESNS-ZZXKWVIFSA-N D0AU0M DRUGSMIL C1=CC(=CC=C1C=CC(=O)O)O D0AU0M HIGHSTAT Investigative D0AU4H DRUG__ID D0AU4H D0AU4H DRUGTYPE Small molecular drug D0AU4H DRUGINCH 1S/C12H18N4O7P2S/c1-8-11(3-4-22-25(20,21)23-24(17,18)19)26-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H4-,13,14,15,17,18,19,20,21)/p+1 D0AU4H DRUGINKE AYEKOFBPNLCAJY-UHFFFAOYSA-O D0AU4H DRUGSMIL CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)O D0AU4H HIGHSTAT Investigative D0AU6T DRUG__ID D0AU6T D0AU6T DRUGTYPE Small molecular drug D0AU6T DRUGINCH 1S/C15H20N2O2/c1-15(2,18-3)9-10-19-12-6-4-5-11-7-8-13(16)17-14(11)12/h4-8H,9-10H2,1-3H3,(H2,16,17) D0AU6T DRUGINKE LPHQANHABFNXJD-UHFFFAOYSA-N D0AU6T DRUGSMIL CC(C)(CCOC1=CC=CC2=C1N=C(C=C2)N)OC D0AU6T HIGHSTAT Investigative D0AU7Y DRUG__ID D0AU7Y D0AU7Y DRUGTYPE Small molecular drug D0AU7Y DRUGINCH 1S/C17H13N3O/c1-11-6-8-12(9-7-11)15-10-16-13-4-2-3-5-14(13)18-17(21)20(16)19-15/h2-10H,1H3,(H,18,21) D0AU7Y DRUGINKE MEMISOHEHYPPHH-UHFFFAOYSA-N D0AU7Y DRUGSMIL CC1=CC=C(C=C1)C2=NN3C(=C2)C4=CC=CC=C4NC3=O D0AU7Y HIGHSTAT Investigative D0AV1T DRUG__ID D0AV1T D0AV1T DRUGTYPE Small molecular drug D0AV1T DRUGINCH 1S/C22H36INO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15- D0AV1T DRUGINKE KOHVJRAXSGONGW-DOFZRALJSA-N D0AV1T DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCI D0AV1T HIGHSTAT Investigative D0AV3M DRUG__ID D0AV3M D0AV3M DRUGTYPE Small molecular drug D0AV3M DRUGINCH 1S/C16H18N2O/c1-11(2)12-3-5-13(6-4-12)14-7-9-15(10-8-14)18-16(17)19/h3-11H,1-2H3,(H3,17,18,19) D0AV3M DRUGINKE COFIGWCWVNQCFO-UHFFFAOYSA-N D0AV3M DRUGSMIL CC(C)C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)N D0AV3M HIGHSTAT Investigative D0AW4G DRUG__ID D0AW4G D0AW4G DRUGTYPE Small molecular drug D0AW4G DRUGINCH 1S/C7H6BNO2/c9-5-6-1-3-7(4-2-6)8(10)11/h1-4,10-11H D0AW4G DRUGINKE CEBAHYWORUOILU-UHFFFAOYSA-N D0AW4G DRUGSMIL B(C1=CC=C(C=C1)C#N)(O)O D0AW4G HIGHSTAT Investigative D0AW4P DRUG__ID D0AW4P D0AW4P DRUGTYPE Small molecular drug D0AW4P DRUGINCH 1S/C14H10F2O2/c15-11-5-1-3-9(7-11)13(17)14(18)10-4-2-6-12(16)8-10/h1-8,13,17H D0AW4P DRUGINKE AELVPDSJUJGTJH-UHFFFAOYSA-N D0AW4P DRUGSMIL C1=CC(=CC(=C1)F)C(C(=O)C2=CC(=CC=C2)F)O D0AW4P HIGHSTAT Investigative D0AW4W DRUG__ID D0AW4W D0AW4W DRUGTYPE Small molecular drug D0AW4W DRUGINCH 1S/C21H20O3/c1-22-17-10-8-15(9-11-17)20-6-4-5-7-21(20)16-12-18(23-2)14-19(13-16)24-3/h4-14H,1-3H3 D0AW4W DRUGINKE YTEAKYDIQLKHMB-UHFFFAOYSA-N D0AW4W DRUGSMIL COC1=CC=C(C=C1)C2=CC=CC=C2C3=CC(=CC(=C3)OC)OC D0AW4W HIGHSTAT Investigative D0AW4X DRUG__ID D0AW4X D0AW4X DRUGTYPE Small molecular drug D0AW4X DRUGINCH 1S/C23H23BrN2O/c24-19-8-3-5-17(15-19)16-26-13-11-20(12-14-26)25-23(27)22-10-4-7-18-6-1-2-9-21(18)22/h1-10,15,20H,11-14,16H2,(H,25,27) D0AW4X DRUGINKE USZMCEOIEOTIGM-UHFFFAOYSA-N D0AW4X DRUGSMIL C1CN(CCC1NC(=O)C2=CC=CC3=CC=CC=C32)CC4=CC(=CC=C4)Br D0AW4X HIGHSTAT Investigative D0AW6C DRUG__ID D0AW6C D0AW6C DRUGTYPE Small molecular drug D0AW6C DRUGINCH 1S/C15H12N2O4S/c18-15(14-10-11-6-4-5-9-13(11)21-14)16-17-22(19,20)12-7-2-1-3-8-12/h1-10,17H,(H,16,18) D0AW6C DRUGINKE AMGAILKMHSFVNJ-UHFFFAOYSA-N D0AW6C DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NNC(=O)C2=CC3=CC=CC=C3O2 D0AW6C HIGHSTAT Investigative D0AW7G DRUG__ID D0AW7G D0AW7G DRUGTYPE Small molecular drug D0AW7G DRUGINCH 1S/C10H8BrN3O2/c11-6-2-1-3-7(4-6)12-8-5-9(15)14-10(16)13-8/h1-5H,(H3,12,13,14,15,16) D0AW7G DRUGINKE CFLHCISOVMSSHJ-UHFFFAOYSA-N D0AW7G DRUGSMIL C1=CC(=CC(=C1)Br)NC2=CC(=O)NC(=O)N2 D0AW7G HIGHSTAT Investigative D0AW7Q DRUG__ID D0AW7Q D0AW7Q DRUGTYPE Small molecular drug D0AW7Q DRUGINCH 1S/C17H12N2O2/c20-17-13-3-1-2-4-15(13)21-16-6-5-12(9-14(16)17)10-19-8-7-18-11-19/h1-9,11H,10H2 D0AW7Q DRUGINKE FWPREHSGJHCERR-UHFFFAOYSA-N D0AW7Q DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(O2)C=CC(=C3)CN4C=CN=C4 D0AW7Q HIGHSTAT Investigative D0AX0K DRUG__ID D0AX0K D0AX0K DRUGTYPE Small molecular drug D0AX0K DRUGINCH 1S/C21H29N3O/c1-17(2)25-20-10-7-13-22-21(20)23(3)19-11-14-24(15-12-19)16-18-8-5-4-6-9-18/h4-10,13,17,19H,11-12,14-16H2,1-3H3 D0AX0K DRUGINKE WFLHEXUTTRRXFJ-UHFFFAOYSA-N D0AX0K DRUGSMIL CC(C)OC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=CC=C3 D0AX0K HIGHSTAT Investigative D0AX7B DRUG__ID D0AX7B D0AX7B DRUGTYPE Small molecular drug D0AX7B DRUGINCH 1S/C20H21F3O2/c21-20(22,23)19(24)10-6-1-2-7-15-25-18-13-11-17(12-14-18)16-8-4-3-5-9-16/h3-5,8-9,11-14H,1-2,6-7,10,15H2 D0AX7B DRUGINKE LRVOZKXSFOOZRP-UHFFFAOYSA-N D0AX7B DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)C(F)(F)F D0AX7B HIGHSTAT Investigative D0AY0F DRUG__ID D0AY0F D0AY0F DRUGTYPE Small molecular drug D0AY0F DRUGINCH 1S/C22H26N4O2S/c1-22(2,3)16-8-6-15(7-9-16)13-23-17-10-11-19-18(12-17)21-20(14-24-25(21)4)29(27,28)26(19)5/h6-12,14,23H,13H2,1-5H3 D0AY0F DRUGINKE AVFJKWOKOZKXRX-UHFFFAOYSA-N D0AY0F DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CNC2=CC3=C(C=C2)N(S(=O)(=O)C4=C3N(N=C4)C)C D0AY0F HIGHSTAT Investigative D0AY4E DRUG__ID D0AY4E D0AY4E DRUGTYPE Small molecular drug D0AY4E DRUGINCH 1S/C16H15N/c1-12-4-5-14-6-7-15(16(14)9-12)10-13-3-2-8-17-11-13/h2-5,8-11H,6-7H2,1H3/b15-10+ D0AY4E DRUGINKE INXZXCKRUCKCJE-XNTDXEJSSA-N D0AY4E DRUGSMIL CC1=CC2=C(CCC2=CC3=CN=CC=C3)C=C1 D0AY4E HIGHSTAT Investigative D0AY5T DRUG__ID D0AY5T D0AY5T DRUGTYPE Small molecular drug D0AY5T DRUGINCH 1S/C21H16ClN3O3/c22-14-10-13(24-19(26)15-3-1-2-8-23-15)6-7-16(14)25-20(27)17-11-4-5-12(9-11)18(17)21(25)28/h1-8,10-12,17-18H,9H2,(H,24,26)/t11-,12+,17-,18?/m1/s1 D0AY5T DRUGINKE LJUABYFUJVRUSJ-KNGMQDLYSA-N D0AY5T DRUGSMIL C1C2C=CC1C3C2C(=O)N(C3=O)C4=C(C=C(C=C4)NC(=O)C5=CC=CC=N5)Cl D0AY5T HIGHSTAT Investigative D0AZ0Y DRUG__ID D0AZ0Y D0AZ0Y DRUGTYPE Small molecular drug D0AZ0Y DRUGINCH 1S/C16H12O3/c17-14-4-3-10-5-11(1-2-12(10)6-14)13-7-15(18)9-16(19)8-13/h1-9,17-19H D0AZ0Y DRUGINKE CKQUMNKKOYTAST-UHFFFAOYSA-N D0AZ0Y DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=CC(=C3)O)O D0AZ0Y HIGHSTAT Investigative D0AZ4T DRUG__ID D0AZ4T D0AZ4T DRUGTYPE Small molecular drug D0AZ4T DRUGINCH 1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)/p-1 D0AZ4T DRUGINKE UFIVEPVSAGBUSI-UHFFFAOYSA-M D0AZ4T DRUGSMIL C1C(NC(=O)NC1=O)C(=O)[O-] D0AZ4T HIGHSTAT Investigative D0AZ7V DRUG__ID D0AZ7V D0AZ7V DRUGTYPE Small molecular drug D0AZ7V DRUGINCH 1S/C12H11ClFN3S2/c13-9-2-1-3-10(14)8(9)4-5-15-11(18)17-12-16-6-7-19-12/h1-3,6-7H,4-5H2,(H2,15,16,17,18) D0AZ7V DRUGINKE DLYWQFUMFDBURV-UHFFFAOYSA-N D0AZ7V DRUGSMIL C1=CC(=C(C(=C1)Cl)CCNC(=S)NC2=NC=CS2)F D0AZ7V HIGHSTAT Investigative D0B0DP DRUG__ID D0B0DP D0B0DP DRUGTYPE Small molecular drug D0B0DP DRUGINCH 1S/C18H20N2O4/c19-13(12-18(22)23)6-11-17(21)20-14-7-9-16(10-8-14)24-15-4-2-1-3-5-15/h1-5,7-10,13H,6,11-12,19H2,(H,20,21)(H,22,23)/t13-/m0/s1 D0B0DP DRUGINKE YAELJSOADOXCDL-ZDUSSCGKSA-N D0B0DP DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)CCC(CC(=O)O)N D0B0DP HIGHSTAT Investigative D0B0EL DRUG__ID D0B0EL D0B0EL DRUGTYPE Small molecular drug D0B0EL DRUGINCH 1S/C11H12ClNO/c1-8(9(2)13-14)7-10-3-5-11(12)6-4-10/h3-7,14H,1-2H3/b8-7+,13-9- D0B0EL DRUGINKE MHTJEUOFLVQMCL-UFVXJIOISA-N D0B0EL DRUGSMIL CC(=CC1=CC=C(C=C1)Cl)C(=NO)C D0B0EL HIGHSTAT Investigative D0B0ES DRUG__ID D0B0ES D0B0ES DRUGTYPE Small molecular drug D0B0ES DRUGINCH 1S/C13H17ClN2O/c14-10-5-4-8-12(9-10)16-13(17)15-11-6-2-1-3-7-11/h4-5,8-9,11H,1-3,6-7H2,(H2,15,16,17) D0B0ES DRUGINKE WUPWWTKSYQSCFQ-UHFFFAOYSA-N D0B0ES DRUGSMIL C1CCC(CC1)NC(=O)NC2=CC(=CC=C2)Cl D0B0ES HIGHSTAT Investigative D0B0IJ DRUG__ID D0B0IJ D0B0IJ DRUGTYPE Small molecular drug D0B0IJ DRUGINCH 1S/C5H9NS2/c7-5(8)6-3-1-2-4-6/h1-4H2,(H,7,8) D0B0IJ DRUGINKE VSWDORGPIHIGNW-UHFFFAOYSA-N D0B0IJ DRUGSMIL C1CCN(C1)C(=S)S D0B0IJ HIGHSTAT Investigative D0B0IO DRUG__ID D0B0IO D0B0IO DRUGTYPE Small molecular drug D0B0IO DRUGINCH 1S/C15H15N3O3/c1-2-20-14-7-5-13(6-8-14)18-15(19)21-17-11-12-4-3-9-16-10-12/h3-11H,2H2,1H3,(H,18,19)/b17-11+ D0B0IO DRUGINKE LKOKEOYUZBYMCC-GZTJUZNOSA-N D0B0IO DRUGSMIL CCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2 D0B0IO HIGHSTAT Investigative D0B0JK DRUG__ID D0B0JK D0B0JK DRUGTYPE Small molecular drug D0B0JK DRUGINCH 1S/C12H27OP/c1-4-5-6-7-8-9-10-11-12-14(2,3)13/h4-12H2,1-3H3 D0B0JK DRUGINKE GSVLCKASFMVUSW-UHFFFAOYSA-N D0B0JK DRUGSMIL CCCCCCCCCCP(=O)(C)C D0B0JK HIGHSTAT Investigative D0B0KP DRUG__ID D0B0KP D0B0KP DRUGTYPE Small molecular drug D0B0KP DRUGINCH 1S/C24H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-21(27)24-26-23-22(28-24)19-17-20-25-23/h17,19-20H,2-8,11-16,18H2,1H3 D0B0KP DRUGINKE DBMKKVSGBYKSFI-UHFFFAOYSA-N D0B0KP DRUGSMIL CCCCCCCCC#CCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2 D0B0KP HIGHSTAT Investigative D0B0LC DRUG__ID D0B0LC D0B0LC DRUGTYPE Small molecular drug D0B0LC DRUGINCH 1S/C15H13N3O/c1-2-8-17-13(3-1)11-19-15-6-4-14(5-7-15)18-10-9-16-12-18/h1-10,12H,11H2 D0B0LC DRUGINKE IMJROXJEYNKELD-UHFFFAOYSA-N D0B0LC DRUGSMIL C1=CC=NC(=C1)COC2=CC=C(C=C2)N3C=CN=C3 D0B0LC HIGHSTAT Investigative D0B0LU DRUG__ID D0B0LU D0B0LU DRUGTYPE Small molecular drug D0B0LU DRUGINCH 1S/C5H10N2O6P2S/c8-14(9,10)4(15(11,12)13)3-16-5-6-1-2-7-5/h1-2,4H,3H2,(H,6,7)(H2,8,9,10)(H2,11,12,13) D0B0LU DRUGINKE KVMQBCIVXMEYRO-UHFFFAOYSA-N D0B0LU DRUGSMIL C1=CN=C(N1)SCC(P(=O)(O)O)P(=O)(O)O D0B0LU HIGHSTAT Investigative D0B0MU DRUG__ID D0B0MU D0B0MU DRUGTYPE Small molecular drug D0B0MU DRUGINCH 1S/C18H34N2O4/c1-2-3-12-15-19-18(23)20-24-16-13-10-8-6-4-5-7-9-11-14-17(21)22/h6,8H,2-5,7,9-16H2,1H3,(H,21,22)(H2,19,20,23)/b8-6- D0B0MU DRUGINKE QHNVLXQJNGLGOO-VURMDHGXSA-N D0B0MU DRUGSMIL CCCCCNC(=O)NOCCCC=CCCCCCCC(=O)O D0B0MU HIGHSTAT Investigative D0B0NO DRUG__ID D0B0NO D0B0NO DRUGTYPE Small molecular drug D0B0NO DRUGINCH 1S/C27H37Cl2N3O4/c1-17(2)23(31-27(33)30-20-14-24(34-3)26(36-5)25(15-20)35-4)16-32-10-8-18(9-11-32)12-19-6-7-21(28)22(29)13-19/h6-7,13-15,17-18,23H,8-12,16H2,1-5H3,(H2,30,31,33)/t23-/m0/s1 D0B0NO DRUGINKE FQHUEFRHSWYBQS-QHCPKHFHSA-N D0B0NO DRUGSMIL CC(C)C(CN1CCC(CC1)CC2=CC(=C(C=C2)Cl)Cl)NC(=O)NC3=CC(=C(C(=C3)OC)OC)OC D0B0NO HIGHSTAT Investigative D0B0NW DRUG__ID D0B0NW D0B0NW DRUGTYPE Small molecular drug D0B0NW DRUGINCH 1S/C12H19N5O2/c18-12(19)10-5-9-3-7(1-2-8(9)6-13-10)4-11-14-16-17-15-11/h7-10,13H,1-6H2,(H,18,19)(H,14,15,16,17)/t7-,8-,9+,10-/m1/s1 D0B0NW DRUGINKE ACTONBBIVMTUAJ-DOLQZWNJSA-N D0B0NW DRUGSMIL C1CC2CNC(CC2CC1CC3=NNN=N3)C(=O)O D0B0NW HIGHSTAT Investigative D0B0PI DRUG__ID D0B0PI D0B0PI DRUGTYPE Small molecular drug D0B0PI DRUGINCH 1S/C15H25N/c1-2-4-16-14(3-1)15-12-6-10-5-11(8-12)9-13(15)7-10/h10-16H,1-9H2 D0B0PI DRUGINKE XNMHSNFFGAZILT-UHFFFAOYSA-N D0B0PI DRUGSMIL C1CCNC(C1)C2C3CC4CC(C3)CC2C4 D0B0PI HIGHSTAT Investigative D0B0PP DRUG__ID D0B0PP D0B0PP DRUGTYPE Small molecular drug D0B0PP DRUGINCH 1S/C15H17N/c16-12-11-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,15H,11-12,16H2 D0B0PP DRUGINKE KISZTEOELCMZPY-UHFFFAOYSA-N D0B0PP DRUGSMIL C1=CC=C(C=C1)C(CCN)C2=CC=CC=C2 D0B0PP HIGHSTAT Investigative D0B0QS DRUG__ID D0B0QS D0B0QS DRUGTYPE Small molecular drug D0B0QS DRUGINCH 1S/C18H17NO3/c20-16-12-17(19-8-3-10-21-11-9-19)22-18-14-5-2-1-4-13(14)6-7-15(16)18/h1-2,4-7,12H,3,8-11H2 D0B0QS DRUGINKE NVGTWFCMXLHRJF-UHFFFAOYSA-N D0B0QS DRUGSMIL C1CN(CCOC1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0B0QS HIGHSTAT Investigative D0B0QW DRUG__ID D0B0QW D0B0QW DRUGTYPE Small molecular drug D0B0QW DRUGINCH 1S/C24H29N5O5/c1-3-4-5-6-15-7-9-16(10-8-15)11-12-18-26-22(28-33-2)19-23(27-18)29(14-25-19)24-21(32)20(31)17(13-30)34-24/h7-10,14,17,20-21,24,30-32H,3-6,13H2,1-2H3,(H,26,27,28)/t17-,20-,21-,24-/m1/s1 D0B0QW DRUGINKE SQMZMNPGRAKQJD-FGSUIDRYSA-N D0B0QW DRUGSMIL CCCCCC1=CC=C(C=C1)C#CC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)NOC D0B0QW HIGHSTAT Investigative D0B0QY DRUG__ID D0B0QY D0B0QY DRUGTYPE Small molecular drug D0B0QY DRUGINCH 1S/C15H19N5O5/c16-13-10-14(18-6-17-13)20(7-19-10)15-12(24)11(23)8(25-15)4-2-1-3-5-9(21)22/h2,4,6-8,11-12,15,23-24H,1,3,5H2,(H,21,22)(H2,16,17,18)/b4-2+/t8-,11-,12-,15-/m1/s1 D0B0QY DRUGINKE HAGCQDHTBHGTQC-VLCWARKCSA-N D0B0QY DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C=CCCCC(=O)O)O)O)N D0B0QY HIGHSTAT Investigative D0B0SD DRUG__ID D0B0SD D0B0SD DRUGTYPE Small molecular drug D0B0SD DRUGINCH 1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5)/p-1 D0B0SD DRUGINKE XBDQKXXYIPTUBI-UHFFFAOYSA-M D0B0SD DRUGSMIL CCC(=O)[O-] D0B0SD HIGHSTAT Investigative D0B0SV DRUG__ID D0B0SV D0B0SV DRUGTYPE Small molecular drug D0B0SV DRUGINCH 1S/C6H13NO11S2/c8-4-2(1-17-20(14,15)16)18-6(10)3(5(4)9)7-19(11,12)13/h2-10H,1H2,(H,11,12,13)(H,14,15,16)/t2-,3-,4-,5-,6+/m1/s1 D0B0SV DRUGINKE DQTRACMFIGDHSN-UKFBFLRUSA-N D0B0SV DRUGSMIL C(C1C(C(C(C(O1)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O D0B0SV HIGHSTAT Investigative D0B0TK DRUG__ID D0B0TK D0B0TK DRUGTYPE Small molecular drug D0B0TK DRUGINCH 1S/C15H18O8/c1-12(2,3)14(20)4-6-13(5-7(16)21-6)10(19)23-11-15(13,14)8(17)9(18)22-11/h6,8,11,17,20H,4-5H2,1-3H3/t6-,8-,11-,13-,14+,15+/m0/s1 D0B0TK DRUGINKE MOLPUWBMSBJXER-YDGSQGCISA-N D0B0TK DRUGSMIL CC(C)(C)C1(CC2C3(C14C(C(=O)OC4OC3=O)O)CC(=O)O2)O D0B0TK HIGHSTAT Investigative D0B0TX DRUG__ID D0B0TX D0B0TX DRUGTYPE Small molecular drug D0B0TX DRUGINCH 1S/C9H12BrN5/c1-5(2)3-15-8-6(14-9(15)10)7(11)12-4-13-8/h4-5H,3H2,1-2H3,(H2,11,12,13) D0B0TX DRUGINKE RLPKQFORPDRBQT-UHFFFAOYSA-N D0B0TX DRUGSMIL CC(C)CN1C2=NC=NC(=C2N=C1Br)N D0B0TX HIGHSTAT Investigative D0B0UI DRUG__ID D0B0UI D0B0UI DRUGTYPE Small molecular drug D0B0UI DRUGINCH 1S/C20H23N9O5/c1-29(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(30)28-34/h2-5,8,13,34H,6-7,9H2,1H3,(H,25,31)(H,28,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1 D0B0UI DRUGINKE YUQBNZUBNMWBAQ-ZDUSSCGKSA-N D0B0UI DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)NO)C(=O)O D0B0UI HIGHSTAT Investigative D0B0UR DRUG__ID D0B0UR D0B0UR DRUGTYPE Small molecular drug D0B0UR DRUGINCH 1S/C17H17ClN5O6PS/c1-26-13-12-10(6-27-30(24,25)29-12)28-16(13)23-15-11(14(19)20-7-21-15)22-17(23)31-9-4-2-8(18)3-5-9/h2-5,7,10,12-13,16H,6H2,1H3,(H,24,25)(H2,19,20,21)/t10-,12-,13-,16-/m1/s1 D0B0UR DRUGINKE BCGHHRAUZWOTNH-XNIJJKJLSA-N D0B0UR DRUGSMIL COC1C2C(COP(=O)(O2)O)OC1N3C4=NC=NC(=C4N=C3SC5=CC=C(C=C5)Cl)N D0B0UR HIGHSTAT Investigative D0B0UZ DRUG__ID D0B0UZ D0B0UZ DRUGTYPE Small molecular drug D0B0UZ DRUGINCH 1S/C17H19N5O/c23-13-5-6-17(18-11-13)22-9-7-21(8-10-22)12-16-19-14-3-1-2-4-15(14)20-16/h1-6,11,23H,7-10,12H2,(H,19,20) D0B0UZ DRUGINKE CBDXXUZXRDBOGH-UHFFFAOYSA-N D0B0UZ DRUGSMIL C1CN(CCN1CC2=NC3=CC=CC=C3N2)C4=NC=C(C=C4)O D0B0UZ HIGHSTAT Investigative D0B0WU DRUG__ID D0B0WU D0B0WU DRUGTYPE Small molecular drug D0B0WU DRUGINCH 1S/C9H20NO2P/c1-2-3-6-13(11,12)9-5-4-8(10)7-9/h8-9H,2-7,10H2,1H3,(H,11,12)/t8-,9+/m0/s1 D0B0WU DRUGINKE UQGQAMARAMOEID-DTWKUNHWSA-N D0B0WU DRUGSMIL CCCCP(=O)(C1CCC(C1)N)O D0B0WU HIGHSTAT Investigative D0B0XK DRUG__ID D0B0XK D0B0XK DRUGTYPE Small molecular drug D0B0XK DRUGINCH 1S/C14H13N3O/c1-2-16-9-8-14(18)17-13(16)10-12(15-17)11-6-4-3-5-7-11/h3-10H,2H2,1H3 D0B0XK DRUGINKE JEWOUZIOCRUZPT-UHFFFAOYSA-N D0B0XK DRUGSMIL CCN1C=CC(=O)N2C1=CC(=N2)C3=CC=CC=C3 D0B0XK HIGHSTAT Investigative D0B0XX DRUG__ID D0B0XX D0B0XX DRUGTYPE Small molecular drug D0B0XX DRUGINCH 1S/C57H76N8O9/c1-34(2)28-43(49(67)33-50(68)60-45(29-35(3)4)53(70)62-44(52(58)69)30-38-18-10-8-11-19-38)61-56(73)51(36(5)6)64-54(71)46(31-39-20-12-9-13-21-39)63-55(72)48-26-17-27-65(48)57(74)47(59-37(7)66)32-41-24-16-23-40-22-14-15-25-42(40)41/h8-16,18-25,34-36,43-49,51,67H,17,26-33H2,1-7H3,(H2,58,69)(H,59,66)(H,60,68)(H,61,73)(H,62,70)(H,63,72)(H,64,71)/t43-,44-,45-,46-,47-,48-,49-,51-/m0/s1 D0B0XX DRUGINKE WBMREBMOCPFYEP-FKUHLYKMSA-N D0B0XX DRUGSMIL CC(C)CC(C(CC(=O)NC(CC(C)C)C(=O)NC(CC1=CC=CC=C1)C(=O)N)O)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=CC5=CC=CC=C54)NC(=O)C D0B0XX HIGHSTAT Investigative D0B0ZM DRUG__ID D0B0ZM D0B0ZM DRUGTYPE Small molecular drug D0B0ZM DRUGINCH 1S/C19H22N2OS/c1-3-13-20(14-4-2)19(22)21-15-9-5-7-11-17(15)23-18-12-8-6-10-16(18)21/h5-12H,3-4,13-14H2,1-2H3 D0B0ZM DRUGINKE VELWLEWVSKZOLN-UHFFFAOYSA-N D0B0ZM DRUGSMIL CCCN(CCC)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0B0ZM HIGHSTAT Investigative D0B0ZQ DRUG__ID D0B0ZQ D0B0ZQ DRUGTYPE Small molecular drug D0B0ZQ DRUGINCH 1S/C29H20ClN7O11S3.3Na/c30-27-35-28(33-13-4-3-5-15(10-13)49(40,41)42)37-29(36-27)34-18-9-8-14(11-20(18)50(43,44)45)32-19-12-21(51(46,47)48)24(31)23-22(19)25(38)16-6-1-2-7-17(16)26(23)39;;;/h1-12,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H2,33,34,35,36,37);;;/q;3*+1/p-3 D0B0ZQ DRUGINKE VZPXDCIISFTYOM-UHFFFAOYSA-K D0B0ZQ DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC5=NC(=NC(=N5)NC6=CC(=CC=C6)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+].[Na+] D0B0ZQ HIGHSTAT Investigative D0B1AK DRUG__ID D0B1AK D0B1AK DRUGTYPE Small molecular drug D0B1AK DRUGINCH 1S/C8H7N3S/c9-7(10)6-4-5-2-1-3-11-8(5)12-6/h1-4H,(H3,9,10)/p+1 D0B1AK DRUGINKE GZEJMYFXZMUAEC-UHFFFAOYSA-O D0B1AK DRUGSMIL C1=CC2=C(N=C1)SC(=C2)C(=[NH2+])N D0B1AK HIGHSTAT Investigative D0B1BQ DRUG__ID D0B1BQ D0B1BQ DRUGTYPE Small molecular drug D0B1BQ DRUGINCH 1S/C19H35F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(23)19(20,21)22/h2-17H2,1H3 D0B1BQ DRUGINKE SYQIFPOSGNRRCM-UHFFFAOYSA-N D0B1BQ DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)C(F)(F)F D0B1BQ HIGHSTAT Investigative D0B1CL DRUG__ID D0B1CL D0B1CL DRUGTYPE Small molecular drug D0B1CL DRUGINCH 1S/C15H13NO2/c1-17-13-6-7-14-11(8-13)9-15(18-14)10-2-4-12(16)5-3-10/h2-9H,16H2,1H3 D0B1CL DRUGINKE GICMHQJTKXNMGB-UHFFFAOYSA-N D0B1CL DRUGSMIL COC1=CC2=C(C=C1)OC(=C2)C3=CC=C(C=C3)N D0B1CL HIGHSTAT Investigative D0B1CM DRUG__ID D0B1CM D0B1CM DRUGTYPE Small molecular drug D0B1CM DRUGINCH 1S/C17H20O5/c1-19-14-6-5-11(8-13(14)18)7-12-9-15(20-2)17(22-4)16(10-12)21-3/h5-6,8-10,18H,7H2,1-4H3 D0B1CM DRUGINKE JFZDWXGLUXEEAY-UHFFFAOYSA-N D0B1CM DRUGSMIL COC1=C(C=C(C=C1)CC2=CC(=C(C(=C2)OC)OC)OC)O D0B1CM HIGHSTAT Investigative D0B1FM DRUG__ID D0B1FM D0B1FM DRUGTYPE Small molecular drug D0B1FM DRUGINCH 1S/C13H13Cl2N/c14-12-4-1-8(7-13(12)15)9-5-10-2-3-11(6-9)16-10/h1,4-5,7,10-11,16H,2-3,6H2 D0B1FM DRUGINKE WNTMTTVEDFGEMS-UHFFFAOYSA-N D0B1FM DRUGSMIL C1CC2C=C(CC1N2)C3=CC(=C(C=C3)Cl)Cl D0B1FM HIGHSTAT Investigative D0B1FV DRUG__ID D0B1FV D0B1FV DRUGTYPE Small molecular drug D0B1FV DRUGINCH 1S/C38H42N2O6.ClH/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)17-23-7-10-27(11-8-23)45-33-19-24(9-12-31(33)41-3)18-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34;/h7-12,19-22,29-30H,13-18H2,1-6H3;1H/t29-,30+;/m0./s1 D0B1FV DRUGINKE RJAXUPVPTQWJKH-XCCPJCIBSA-N D0B1FV DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC.Cl D0B1FV HIGHSTAT Investigative D0B1GJ DRUG__ID D0B1GJ D0B1GJ DRUGTYPE Small molecular drug D0B1GJ DRUGINCH 1S/C22H25NO2/c1-3-12-23-13-11-15-7-5-9-17-21(15)18(23)14-16-8-6-10-19(22(16)17)25-20(24)4-2/h5-10,18H,3-4,11-14H2,1-2H3/t18-/m1/s1 D0B1GJ DRUGINKE FKAOLIWLWAYCIA-GOSISDBHSA-N D0B1GJ DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC=C2)C(=CC=C4)OC(=O)CC D0B1GJ HIGHSTAT Investigative D0B1HP DRUG__ID D0B1HP D0B1HP DRUGTYPE Small molecular drug D0B1HP DRUGINCH 1S/C13H9NO3/c15-9-3-1-8(2-4-9)13-11-6-5-10(16)7-12(11)17-14-13/h1-7,15-16H D0B1HP DRUGINKE DPKXDXRRZZTHNM-UHFFFAOYSA-N D0B1HP DRUGSMIL C1=CC(=CC=C1C2=NOC3=C2C=CC(=C3)O)O D0B1HP HIGHSTAT Investigative D0B1JC DRUG__ID D0B1JC D0B1JC DRUGTYPE Small molecular drug D0B1JC DRUGINCH 1S/C34H41N5O5/c1-38(2)34(44)29(22-24-12-7-4-8-13-24)37-31(41)28(21-23-10-5-3-6-11-23)36-32(42)30-14-9-19-39(30)33(43)27(35)20-25-15-17-26(40)18-16-25/h3-8,10-13,15-18,27-30,40H,9,14,19-22,35H2,1-2H3,(H,36,42)(H,37,41)/t27-,28-,29-,30-/m0/s1 D0B1JC DRUGINKE KRABRQBOUFODOG-KRCBVYEFSA-N D0B1JC DRUGSMIL CN(C)C(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0B1JC HIGHSTAT Investigative D0B1JM DRUG__ID D0B1JM D0B1JM DRUGTYPE Small molecular drug D0B1JM DRUGINCH 1S/C14H13NO5S/c1-19-13-5-3-2-4-12(13)14(16)10-6-8-11(9-7-10)20-21(15,17)18/h2-9H,1H3,(H2,15,17,18) D0B1JM DRUGINKE IREHNQRSDKSAOR-UHFFFAOYSA-N D0B1JM DRUGSMIL COC1=CC=CC=C1C(=O)C2=CC=C(C=C2)OS(=O)(=O)N D0B1JM HIGHSTAT Investigative D0B1KJ DRUG__ID D0B1KJ D0B1KJ DRUGTYPE Small molecular drug D0B1KJ DRUGINCH 1S/C16H23NO2/c1-3-12-7-9-13(10-8-12)15(16(18)19-2)14-6-4-5-11-17-14/h7-10,14-15,17H,3-6,11H2,1-2H3/t14-,15-/m1/s1 D0B1KJ DRUGINKE WNIYTNIFAQJHLP-HUUCEWRRSA-N D0B1KJ DRUGSMIL CCC1=CC=C(C=C1)C(C2CCCCN2)C(=O)OC D0B1KJ HIGHSTAT Investigative D0B1KT DRUG__ID D0B1KT D0B1KT DRUGTYPE Small molecular drug D0B1KT DRUGINCH 1S/C14H17IN4O2/c1-7(2)8-4-11(20-3)9(15)5-10(8)21-12-6-18-14(17)19-13(12)16/h4-7H,1-3H3,(H4,16,17,18,19) D0B1KT DRUGINKE AATPYXMXFBBKFO-UHFFFAOYSA-N D0B1KT DRUGSMIL CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)I)OC D0B1KT HIGHSTAT Investigative D0B1LR DRUG__ID D0B1LR D0B1LR DRUGTYPE Small molecular drug D0B1LR DRUGINCH 1S/C10H8N4S/c11-6-1-2-7-8(3-6)14-10(13-7)9-4-15-5-12-9/h1-5H,11H2,(H,13,14) D0B1LR DRUGINKE CUDHOGCHOXYXRZ-UHFFFAOYSA-N D0B1LR DRUGSMIL C1=CC2=C(C=C1N)NC(=N2)C3=CSC=N3 D0B1LR HIGHSTAT Investigative D0B1NY DRUG__ID D0B1NY D0B1NY DRUGTYPE Small molecular drug D0B1NY DRUGINCH 1S/C17H32N4O3/c1-4-6-11(7-5-2)15(20-10(3)22)13-8-12(16(23)24)9-14(13)21-17(18)19/h11-15H,4-9H2,1-3H3,(H,20,22)(H,23,24)(H4,18,19,21)/t12?,13-,14-,15?/m1/s1 D0B1NY DRUGINKE VUROMZOEXLKRSQ-PIOWNMBXSA-N D0B1NY DRUGSMIL CCCC(CCC)C(C1CC(CC1N=C(N)N)C(=O)O)NC(=O)C D0B1NY HIGHSTAT Investigative D0B1PE DRUG__ID D0B1PE D0B1PE DRUGTYPE Small molecular drug D0B1PE DRUGINCH 1S/C16H12Cl2N2O/c1-20-14-7-6-12(18)8-13(14)16(19-9-15(20)21)10-2-4-11(17)5-3-10/h2-8H,9H2,1H3 D0B1PE DRUGINKE PUMYFTJOWAJIKF-UHFFFAOYSA-N D0B1PE DRUGSMIL CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=C(C=C3)Cl D0B1PE HIGHSTAT Investigative D0B1QM DRUG__ID D0B1QM D0B1QM DRUGTYPE Small molecular drug D0B1QM DRUGINCH 1S/C26H28F3N3O2/c1-19-23(25(33)30-22-10-5-9-21(17-22)26(27,28)29)18-24(20-7-3-2-4-8-20)32(19)12-6-11-31-13-15-34-16-14-31/h2-5,7-10,17-18H,6,11-16H2,1H3,(H,30,33) D0B1QM DRUGINKE NCZYSQOTAYFTNM-UHFFFAOYSA-N D0B1QM DRUGSMIL CC1=C(C=C(N1CCCN2CCOCC2)C3=CC=CC=C3)C(=O)NC4=CC=CC(=C4)C(F)(F)F D0B1QM HIGHSTAT Investigative D0B1RV DRUG__ID D0B1RV D0B1RV DRUGTYPE Small molecular drug D0B1RV DRUGINCH 1S/C15H16N4/c16-14-13-12(10-7-3-4-8-11(10)17-14)18-15(19-13)9-5-1-2-6-9/h3-4,7-9H,1-2,5-6H2,(H2,16,17)(H,18,19) D0B1RV DRUGINKE KPONPDGMNFNBFA-UHFFFAOYSA-N D0B1RV DRUGSMIL C1CCC(C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)N D0B1RV HIGHSTAT Investigative D0B1SW DRUG__ID D0B1SW D0B1SW DRUGTYPE Small molecular drug D0B1SW DRUGINCH 1S/C28H24N2O6/c1-35-25-15-17(11-13-23(25)29-21-9-5-3-7-19(21)27(31)32)18-12-14-24(26(16-18)36-2)30-22-10-6-4-8-20(22)28(33)34/h3-16,29-30H,1-2H3,(H,31,32)(H,33,34) D0B1SW DRUGINKE IQZIRNIZQHVBMB-UHFFFAOYSA-N D0B1SW DRUGSMIL COC1=C(C=CC(=C1)C2=CC(=C(C=C2)NC3=CC=CC=C3C(=O)O)OC)NC4=CC=CC=C4C(=O)O D0B1SW HIGHSTAT Investigative D0B1TQ DRUG__ID D0B1TQ D0B1TQ DRUGTYPE Small molecular drug D0B1TQ DRUGINCH 1S/C9H6ClNO2/c1-4-2-3-5(10)6-7(4)11-9(13)8(6)12/h2-3H,1H3,(H,11,12,13) D0B1TQ DRUGINKE MWCJCUFHPFXQLS-UHFFFAOYSA-N D0B1TQ DRUGSMIL CC1=C2C(=C(C=C1)Cl)C(=O)C(=O)N2 D0B1TQ HIGHSTAT Investigative D0B1TS DRUG__ID D0B1TS D0B1TS DRUGTYPE Small molecular drug D0B1TS DRUGINCH 1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)/p-1 D0B1TS DRUGINKE PXQPEWDEAKTCGB-UHFFFAOYSA-M D0B1TS DRUGSMIL C1=C(NC(=O)NC1=O)C(=O)[O-] D0B1TS HIGHSTAT Investigative D0B1WB DRUG__ID D0B1WB D0B1WB DRUGTYPE Small molecular drug D0B1WB DRUGINCH 1S/C14H29NO3/c1-2-3-4-5-6-7-8-9-11-13(17)14(18)12(16)10-15-11/h11-18H,2-10H2,1H3/t11-,12-,13+,14+/m1/s1 D0B1WB DRUGINKE WVYPOMDXOXCTJU-MQYQWHSLSA-N D0B1WB DRUGSMIL CCCCCCCCCC1C(C(C(CN1)O)O)O D0B1WB HIGHSTAT Investigative D0B1WD DRUG__ID D0B1WD D0B1WD DRUGTYPE Small molecular drug D0B1WD DRUGINCH 1S/C18H15NO3/c1-2-12-7-9-14(10-8-12)19-17(20)15-11-13-5-3-4-6-16(13)22-18(15)21/h3-11H,2H2,1H3,(H,19,20) D0B1WD DRUGINKE CCRNXJJERVYHEO-UHFFFAOYSA-N D0B1WD DRUGSMIL CCC1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3OC2=O D0B1WD HIGHSTAT Investigative D0B1WF DRUG__ID D0B1WF D0B1WF DRUGTYPE Small molecular drug D0B1WF DRUGINCH 1S/C21H25NO2/c1-24-21(23)20(18-12-6-3-7-13-18)19-14-8-9-15-22(19)16-17-10-4-2-5-11-17/h2-7,10-13,19-20H,8-9,14-16H2,1H3/t19-,20-/m1/s1 D0B1WF DRUGINKE BUSOTANDABQRSW-WOJBJXKFSA-N D0B1WF DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=CC=C2)C3=CC=CC=C3 D0B1WF HIGHSTAT Investigative D0B1XN DRUG__ID D0B1XN D0B1XN DRUGTYPE Small molecular drug D0B1XN DRUGINCH 1S/C24H16O4/c25-23(19-4-2-1-3-5-19)20-12-8-17(9-13-20)16-6-10-18(11-7-16)21-14-15-22(28-21)24(26)27/h1-15H,(H,26,27) D0B1XN DRUGINKE UKLDRYNCWUIPPD-UHFFFAOYSA-N D0B1XN DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C4=CC=C(O4)C(=O)O D0B1XN HIGHSTAT Investigative D0B1XZ DRUG__ID D0B1XZ D0B1XZ DRUGTYPE Small molecular drug D0B1XZ DRUGINCH 1S/C16H13FO3/c1-19-12-6-7-13-14(18)9-15(20-16(13)8-12)10-2-4-11(17)5-3-10/h2-8,15H,9H2,1H3 D0B1XZ DRUGINKE LIINIWOYEGBFDA-UHFFFAOYSA-N D0B1XZ DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)F D0B1XZ HIGHSTAT Investigative D0B1YM DRUG__ID D0B1YM D0B1YM DRUGTYPE Small molecular drug D0B1YM DRUGINCH 1S/C36H26Br2O10/c1-3-4-10(40)6-12-18-17-11(5-9(2)39)31(37)35(47)29-23(17)27-25-19(13(41)7-15(43)21(25)33(29)45)20-14(42)8-16(44)22-26(20)28(27)24(18)30(34(22)46)36(48)32(12)38/h7-10,39-40,43-48H,3-6H2,1-2H3/t9-,10+/m0/s1 D0B1YM DRUGINKE PGSCEVFXDRXNMP-VHSXEESVSA-N D0B1YM DRUGSMIL CCCC(CC1=C2C3=C(C(=C(C4=C(C5=C6C(=C7C(=O)C=C(C8=C7C(=C2C(=C8O)C(=C1Br)O)C6=C34)O)C(=O)C=C5O)O)O)Br)CC(C)O)O D0B1YM HIGHSTAT Investigative D0B1YW DRUG__ID D0B1YW D0B1YW DRUGTYPE Small molecular drug D0B1YW DRUGINCH 1S/C14H14N4O2/c1-2-8-18-13(19)10-12(17-14(18)20)16-11(15-10)9-6-4-3-5-7-9/h3-7H,2,8H2,1H3,(H,15,16)(H,17,20) D0B1YW DRUGINKE LNATVXLECNOWHK-UHFFFAOYSA-N D0B1YW DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=CC=C3 D0B1YW HIGHSTAT Investigative D0B2AH DRUG__ID D0B2AH D0B2AH DRUGTYPE Small molecular drug D0B2AH DRUGINCH 1S/C18H21Cl2N5O2/c1-10-16(12-5-13(19)7-14(20)6-12)17-21-11(2)22-18(25(17)24-10)23-15(8-26-3)9-27-4/h5-7,15H,8-9H2,1-4H3,(H,21,22,23) D0B2AH DRUGINKE RHSNHBGJLLYGNA-UHFFFAOYSA-N D0B2AH DRUGSMIL CC1=NN2C(=C1C3=CC(=CC(=C3)Cl)Cl)N=C(N=C2NC(COC)COC)C D0B2AH HIGHSTAT Investigative D0B2BD DRUG__ID D0B2BD D0B2BD DRUGTYPE Small molecular drug D0B2BD DRUGINCH 1S/C9H9N3OS2/c14-8(12-9-10-3-5-15-9)11-6-7-2-1-4-13-7/h1-5H,6H2,(H2,10,11,12,14) D0B2BD DRUGINKE OLLCKULTVXOISU-UHFFFAOYSA-N D0B2BD DRUGSMIL C1=COC(=C1)CNC(=S)NC2=NC=CS2 D0B2BD HIGHSTAT Investigative D0B2BO DRUG__ID D0B2BO D0B2BO DRUGTYPE Small molecular drug D0B2BO DRUGINCH 1S/C9H11NS/c1-2-4-9-8(3-1)7-10-5-6-11-9/h1-4,10H,5-7H2 D0B2BO DRUGINKE SUBDEKBXSIKCSA-UHFFFAOYSA-N D0B2BO DRUGSMIL C1CSC2=CC=CC=C2CN1 D0B2BO HIGHSTAT Investigative D0B2FE DRUG__ID D0B2FE D0B2FE DRUGTYPE Small molecular drug D0B2FE DRUGINCH 1S/C14H13N3/c1-2-6-12-9-13(17-14(10-15)16-12)11-7-4-3-5-8-11/h3-5,7-9H,2,6H2,1H3 D0B2FE DRUGINKE IUPDRSKJKKTVKP-UHFFFAOYSA-N D0B2FE DRUGSMIL CCCC1=CC(=NC(=N1)C#N)C2=CC=CC=C2 D0B2FE HIGHSTAT Investigative D0B2FM DRUG__ID D0B2FM D0B2FM DRUGTYPE Small molecular drug D0B2FM DRUGINCH 1S/C21H36N6O8/c1-11(2)7-13(25-15(29)8-22)21(35)27-6-4-5-14(27)19(33)26-18(12(3)28)20(34)24-9-16(30)23-10-17(31)32/h11-14,18,28H,4-10,22H2,1-3H3,(H,23,30)(H,24,34)(H,25,29)(H,26,33)(H,31,32)/t12-,13+,14+,18+/m1/s1 D0B2FM DRUGINKE FYPRIKVHHVQETD-COJSNBRMSA-N D0B2FM DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)NC(C(C)O)C(=O)NCC(=O)NCC(=O)O)NC(=O)CN D0B2FM HIGHSTAT Investigative D0B2GK DRUG__ID D0B2GK D0B2GK DRUGTYPE Small molecular drug D0B2GK DRUGINCH 1S/C16H12N4O/c1-10-3-4-12-9-18-15(20-16(12)19-10)13-5-11(8-17)6-14(7-13)21-2/h3-7,9H,1-2H3 D0B2GK DRUGINKE NGRPBCOEAPBKCI-UHFFFAOYSA-N D0B2GK DRUGSMIL CC1=NC2=NC(=NC=C2C=C1)C3=CC(=CC(=C3)C#N)OC D0B2GK HIGHSTAT Investigative D0B2GS DRUG__ID D0B2GS D0B2GS DRUGTYPE Small molecular drug D0B2GS DRUGINCH 1S/C10H14N2O2/c1-14-7-2-3-9(12)8(6-7)10(13)4-5-11/h2-3,6H,4-5,11-12H2,1H3 D0B2GS DRUGINKE DFZXDYZPSYJYBU-UHFFFAOYSA-N D0B2GS DRUGSMIL COC1=CC(=C(C=C1)N)C(=O)CCN D0B2GS HIGHSTAT Investigative D0B2JC DRUG__ID D0B2JC D0B2JC DRUGTYPE Small molecular drug D0B2JC DRUGINCH 1S/C15H14BrN3S/c1-10-5-7-11(8-6-10)14(18-19-15(17)20)12-3-2-4-13(16)9-12/h2-9H,1H3,(H3,17,19,20)/b18-14+ D0B2JC DRUGINKE IOXFIFMULNCUSH-NBVRZTHBSA-N D0B2JC DRUGSMIL CC1=CC=C(C=C1)C(=NNC(=S)N)C2=CC(=CC=C2)Br D0B2JC HIGHSTAT Investigative D0B2JG DRUG__ID D0B2JG D0B2JG DRUGTYPE Small molecular drug D0B2JG DRUGINCH 1S/C15H10F3NO/c1-10-3-2-4-12(7-10)20-13-6-5-11(9-19)14(8-13)15(16,17)18/h2-8H,1H3 D0B2JG DRUGINKE RKGPWAIQCDEIFV-UHFFFAOYSA-N D0B2JG DRUGSMIL CC1=CC(=CC=C1)OC2=CC(=C(C=C2)C#N)C(F)(F)F D0B2JG HIGHSTAT Investigative D0B2JV DRUG__ID D0B2JV D0B2JV DRUGTYPE Small molecular drug D0B2JV DRUGINCH 1S/C22H25NO4/c1-4-8-23-9-7-14-15-6-5-13-10-18(24)19(26-2)11-16(13)20(15)22(27-3)21(25)17(14)12-23/h5-6,10-11,24-25H,4,7-9,12H2,1-3H3 D0B2JV DRUGINKE IFMOVFFRZLWNFZ-UHFFFAOYSA-N D0B2JV DRUGSMIL CCCN1CCC2=C3C=CC4=CC(=C(C=C4C3=C(C(=C2C1)O)OC)OC)O D0B2JV HIGHSTAT Investigative D0B2LP DRUG__ID D0B2LP D0B2LP DRUGTYPE Small molecular drug D0B2LP DRUGINCH 1S/C13H7FN6/c14-10-5-9(8-15)6-11(7-10)20-18-13(17-19-20)12-3-1-2-4-16-12/h1-7H D0B2LP DRUGINKE NNUSSUPIQZLYJW-UHFFFAOYSA-N D0B2LP DRUGSMIL C1=CC=NC(=C1)C2=NN(N=N2)C3=CC(=CC(=C3)C#N)F D0B2LP HIGHSTAT Investigative D0B2MN DRUG__ID D0B2MN D0B2MN DRUGTYPE Small molecular drug D0B2MN DRUGINCH 1S/C176H285N47O49/c1-23-93(15)138(217-146(243)98(20)194-159(256)124(78-137(237)238)210-167(264)126(82-225)214-147(244)107(180)77-104-79-187-86-190-104)169(266)212-123(74-101-38-26-25-27-39-101)164(261)220-140(99(21)229)171(268)202-114(57-60-135(183)235)153(250)200-113(56-59-134(182)234)154(251)209-122(76-103-49-53-106(232)54-50-103)163(260)215-127(83-226)166(263)198-110(42-30-33-63-179)150(247)205-120(73-92(13)14)161(258)206-117(70-89(7)8)157(254)191-95(17)143(240)196-108(40-28-31-61-177)149(246)204-116(69-88(5)6)156(253)192-96(18)144(241)203-119(72-91(11)12)160(257)201-112(55-58-133(181)233)152(249)197-109(41-29-32-62-178)151(248)208-121(75-102-47-51-105(231)52-48-102)162(259)207-118(71-90(9)10)158(255)193-97(19)145(242)213-128(84-227)168(265)218-139(94(16)24-2)170(267)211-115(68-87(3)4)148(245)189-80-136(236)195-125(81-224)165(262)199-111(43-34-64-188-176(185)186)155(252)219-141(100(22)230)172(269)216-129(85-228)173(270)222-66-36-45-131(222)175(272)223-67-37-46-132(223)174(271)221-65-35-44-130(221)142(184)239/h25-27,38-39,47-54,79,86-100,107-132,138-141,224-232H,23-24,28-37,40-46,55-78,80-85,177-180H2,1-22H3,(H2,181,233)(H2,182,234)(H2,183,235)(H2,184,239)(H,187,190)(H,189,245)(H,191,254)(H,192,253)(H,193,255)(H,194,256)(H,195,236)(H,196,240)(H,197,249)(H,198,263)(H,199,262)(H,200,250)(H,201,257)(H,202,268)(H,203,241)(H,204,246)(H,205,247)(H,206,258)(H,207,259)(H,208,248)(H,209,251)(H,210,264)(H,211,267)(H,212,266)(H,213,242)(H,214,244)(H,215,260)(H,216,269)(H,217,243)(H,218,265)(H,219,252)(H,220,261)(H,237,238)(H4,185,186,188)/t93-,94-,95-,96-,97-,98-,99+,100+,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,138-,139-,140-,141-/m0/s1 D0B2MN DRUGINKE SSAAJZQUEUTACT-MDBKHZGBSA-N D0B2MN DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(C(C)CC)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N D0B2MN HIGHSTAT Investigative D0B2NE DRUG__ID D0B2NE D0B2NE DRUGTYPE Small molecular drug D0B2NE DRUGINCH 1S/C20H20N6O4/c1-21-17-13-18(25-12(24-17)9-8-11-6-4-3-5-7-11)26(10-23-13)20-15(28)14(27)16(30-20)19(29)22-2/h3-7,10,14-16,20,27-28H,1-2H3,(H,22,29)(H,21,24,25)/t14-,15+,16-,20+/m0/s1 D0B2NE DRUGINKE PAFSPMXSTBOTSN-KSVNGYGVSA-N D0B2NE DRUGSMIL CNC1=C2C(=NC(=N1)C#CC3=CC=CC=C3)N(C=N2)C4C(C(C(O4)C(=O)NC)O)O D0B2NE HIGHSTAT Investigative D0B2NG DRUG__ID D0B2NG D0B2NG DRUGTYPE Small molecular drug D0B2NG DRUGINCH 1S/C13H8Br2O5/c14-7-1-5(3-9(16)12(7)19)11(18)6-2-8(15)13(20)10(17)4-6/h1-4,16-17,19-20H D0B2NG DRUGINKE QWGGKBRLOGNRAY-UHFFFAOYSA-N D0B2NG DRUGSMIL C1=C(C=C(C(=C1O)O)Br)C(=O)C2=CC(=C(C(=C2)Br)O)O D0B2NG HIGHSTAT Investigative D0B2PW DRUG__ID D0B2PW D0B2PW DRUGTYPE Small molecular drug D0B2PW DRUGINCH 1S/C74H100ClN15O14/c1-43(2)35-57(66(96)84-56(19-10-11-32-79-44(3)4)73(103)90-34-14-20-63(90)72(102)81-45(5)64(76)94)85-65(95)55(18-9-12-33-80-74(77)104)83-68(98)59(38-48-24-29-54(93)30-25-48)88-71(101)62(42-91)89-70(100)61(40-50-15-13-31-78-41-50)87-69(99)60(37-47-22-27-53(75)28-23-47)86-67(97)58(82-46(6)92)39-49-21-26-51-16-7-8-17-52(51)36-49/h7-8,13,15-17,21-31,36,41,43-45,55-63,79,91,93H,9-12,14,18-20,32-35,37-40,42H2,1-6H3,(H2,76,94)(H,81,102)(H,82,92)(H,83,98)(H,84,96)(H,85,95)(H,86,97)(H,87,99)(H,88,101)(H,89,100)(H3,77,80,104)/t45?,55-,56+,57+,58-,59+,60+,61-,62+,63-/m1/s1 D0B2PW DRUGINKE NOENHWMKHNSHGX-FAZSUBJTSA-N D0B2PW DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C D0B2PW HIGHSTAT Investigative D0B2RW DRUG__ID D0B2RW D0B2RW DRUGTYPE Small molecular drug D0B2RW DRUGINCH 1S/C28H53NO4/c1-4-7-9-10-11-12-13-14-15-16-17-18-23-26(30)28(32)29-25(21-8-5-2)22-19-20-24-27(31)33-6-3/h25H,4-24H2,1-3H3,(H,29,32)/t25-/m0/s1 D0B2RW DRUGINKE HEZLMGZNPUCJHH-VWLOTQADSA-N D0B2RW DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NC(CCCC)CCCCC(=O)OCC D0B2RW HIGHSTAT Investigative D0B2TV DRUG__ID D0B2TV D0B2TV DRUGTYPE Small molecular drug D0B2TV DRUGINCH 1S/C10H12FNO/c1-13-8-4-2-7(3-5-8)10(11)6-9(10)12/h2-5,9H,6,12H2,1H3/t9-,10+/m1/s1 D0B2TV DRUGINKE IFVJHRWUMHINNO-ZJUUUORDSA-N D0B2TV DRUGSMIL COC1=CC=C(C=C1)C2(CC2N)F D0B2TV HIGHSTAT Investigative D0B2UM DRUG__ID D0B2UM D0B2UM DRUGTYPE Small molecular drug D0B2UM DRUGINCH 1S/C17H15NO/c1-12-7-8-18-11-17(12)15-4-3-14-10-16(19-2)6-5-13(14)9-15/h3-11H,1-2H3 D0B2UM DRUGINKE DBZOUPBQQHJUKL-UHFFFAOYSA-N D0B2UM DRUGSMIL CC1=C(C=NC=C1)C2=CC3=C(C=C2)C=C(C=C3)OC D0B2UM HIGHSTAT Investigative D0B2VW DRUG__ID D0B2VW D0B2VW DRUGTYPE Small molecular drug D0B2VW DRUGINCH 1S/C6H11NO4/c1-3(5(8)9)2-4(7)6(10)11/h3-4H,2,7H2,1H3,(H,8,9)(H,10,11)/t3-,4+/m1/s1 D0B2VW DRUGINKE KRKRAOXTGDJWNI-DMTCNVIQSA-N D0B2VW DRUGSMIL CC(CC(C(=O)O)N)C(=O)O D0B2VW HIGHSTAT Investigative D0B2WX DRUG__ID D0B2WX D0B2WX DRUGTYPE Small molecular drug D0B2WX DRUGINCH 1S/C16H14N2O2/c1-10-4-3-5-13-14(10)17-15(18-16(13)19)11-6-8-12(20-2)9-7-11/h3-9H,1-2H3,(H,17,18,19) D0B2WX DRUGINKE HTLUBFSSIMOABR-UHFFFAOYSA-N D0B2WX DRUGSMIL CC1=C2C(=CC=C1)C(=O)NC(=N2)C3=CC=C(C=C3)OC D0B2WX HIGHSTAT Investigative D0B2WZ DRUG__ID D0B2WZ D0B2WZ DRUGTYPE Small molecular drug D0B2WZ DRUGINCH 1S/C6H12N2O3/c1-8(2)7-5(9)3-4-6(10)11/h3-4H2,1-2H3,(H,7,9)(H,10,11) D0B2WZ DRUGINKE NOQGZXFMHARMLW-UHFFFAOYSA-N D0B2WZ DRUGSMIL CN(C)NC(=O)CCC(=O)O D0B2WZ HIGHSTAT Investigative D0B2XN DRUG__ID D0B2XN D0B2XN DRUGTYPE Small molecular drug D0B2XN DRUGINCH 1S/C13H11NO4S/c14-19(16,17)18-12-8-6-11(7-9-12)13(15)10-4-2-1-3-5-10/h1-9H,(H2,14,16,17) D0B2XN DRUGINKE LWUJBMNPWUQTGS-UHFFFAOYSA-N D0B2XN DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)OS(=O)(=O)N D0B2XN HIGHSTAT Investigative D0B2YF DRUG__ID D0B2YF D0B2YF DRUGTYPE Small molecular drug D0B2YF DRUGINCH 1S/C28H32N4O4/c33-25(17-31-11-3-1-4-12-31)29-19-7-9-21-23(15-19)28(36)24-16-20(8-10-22(24)27(21)35)30-26(34)18-32-13-5-2-6-14-32/h7-10,15-16H,1-6,11-14,17-18H2,(H,29,33)(H,30,34) D0B2YF DRUGINKE IOHQNFPYEZQWLH-UHFFFAOYSA-N D0B2YF DRUGSMIL C1CCN(CC1)CC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CN5CCCCC5 D0B2YF HIGHSTAT Investigative D0B2YN DRUG__ID D0B2YN D0B2YN DRUGTYPE Small molecular drug D0B2YN DRUGINCH 1S/C8H19NO6P2/c10-16(11,12)8(17(13,14)15)6-9-7-4-2-1-3-5-7/h7-9H,1-6H2,(H2,10,11,12)(H2,13,14,15) D0B2YN DRUGINKE OAHUDYBQKIUBMC-UHFFFAOYSA-N D0B2YN DRUGSMIL C1CCC(CC1)NCC(P(=O)(O)O)P(=O)(O)O D0B2YN HIGHSTAT Investigative D0B2ZB DRUG__ID D0B2ZB D0B2ZB DRUGTYPE Small molecular drug D0B2ZB DRUGINCH 1S/C22H24O8/c1-25-16-6-12(7-17(26-2)20(16)23)4-14-10-28-22(24)15(14)5-13-8-18(27-3)21-19(9-13)29-11-30-21/h6-9,14-15,23H,4-5,10-11H2,1-3H3/t14-,15+/m0/s1 D0B2ZB DRUGINKE LSSNBHGWOAHIQS-LSDHHAIUSA-N D0B2ZB DRUGSMIL COC1=CC(=CC(=C1O)OC)CC2COC(=O)C2CC3=CC4=C(C(=C3)OC)OCO4 D0B2ZB HIGHSTAT Investigative D0B2ZJ DRUG__ID D0B2ZJ D0B2ZJ DRUGTYPE Small molecular drug D0B2ZJ DRUGINCH 1S/C22H23NO3/c24-21(22-23-14-16-26-22)13-6-1-2-7-15-25-20-12-8-11-19(17-20)18-9-4-3-5-10-18/h3-5,8-12,14,16-17H,1-2,6-7,13,15H2 D0B2ZJ DRUGINKE HWZHDGRMABBYOV-UHFFFAOYSA-N D0B2ZJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)OCCCCCCC(=O)C3=NC=CO3 D0B2ZJ HIGHSTAT Investigative D0B3AR DRUG__ID D0B3AR D0B3AR DRUGTYPE Small molecular drug D0B3AR DRUGINCH 1S/C10H7F3N2/c11-10(12,13)8-3-1-2-4-9(8)15-6-5-14-7-15/h1-7H D0B3AR DRUGINKE WZBWBNCQUTXYEL-UHFFFAOYSA-N D0B3AR DRUGSMIL C1=CC=C(C(=C1)C(F)(F)F)N2C=CN=C2 D0B3AR HIGHSTAT Investigative D0B3BJ DRUG__ID D0B3BJ D0B3BJ DRUGTYPE Small molecular drug D0B3BJ DRUGINCH 1S/C34H46N4O6/c1-7-18-38(19-8-2)29(22-25-14-16-26(39)17-15-25)31(41)37-34(5,6)33(44)36-27(21-24-12-10-9-11-13-24)30(40)35-28(32(42)43)20-23(3)4/h7-17,23,27-29,39H,1-2,18-22H2,3-6H3,(H,35,40)(H,36,44)(H,37,41)(H,42,43)/t27-,28-,29-/m0/s1 D0B3BJ DRUGINKE BGJPRBZZLWCLJW-AWCRTANDSA-N D0B3BJ DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)(C)NC(=O)C(CC2=CC=C(C=C2)O)N(CC=C)CC=C D0B3BJ HIGHSTAT Investigative D0B3FI DRUG__ID D0B3FI D0B3FI DRUGTYPE Small molecular drug D0B3FI DRUGINCH 1S/C22H37F2N3O7/c1-8-12(4)16(27-21(33)34-22(5,6)7)19(30)26-14(9-11(2)3)18(29)25-13(10-15(23)24)17(28)20(31)32/h11-16H,8-10H2,1-7H3,(H,25,29)(H,26,30)(H,27,33)(H,31,32)/t12?,13?,14-,16-/m0/s1 D0B3FI DRUGINKE JOMMVUMCDVMUOS-UJJWPFCGSA-N D0B3FI DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC(F)F)C(=O)C(=O)O)NC(=O)OC(C)(C)C D0B3FI HIGHSTAT Investigative D0B3GP DRUG__ID D0B3GP D0B3GP DRUGTYPE Small molecular drug D0B3GP DRUGINCH 1S/C13H11Cl2N3O/c14-10-3-1-8(11(15)5-10)6-18-13(19)9-2-4-12(16)17-7-9/h1-5,7H,6H2,(H2,16,17)(H,18,19) D0B3GP DRUGINKE PWGDOYQXBPVPGB-UHFFFAOYSA-N D0B3GP DRUGSMIL C1=CC(=C(C=C1Cl)Cl)CNC(=O)C2=CN=C(C=C2)N D0B3GP HIGHSTAT Investigative D0B3HH DRUG__ID D0B3HH D0B3HH DRUGTYPE Small molecular drug D0B3HH DRUGINCH 1S/C20H25NO2/c1-4-14-11-17-12-16(7-10-19(17)21-13(14)2)20(22)15-5-8-18(23-3)9-6-15/h7,10-12,15,18H,4-6,8-9H2,1-3H3 D0B3HH DRUGINKE VEURHZYLLRSEGL-UHFFFAOYSA-N D0B3HH DRUGSMIL CCC1=C(N=C2C=CC(=CC2=C1)C(=O)C3CCC(CC3)OC)C D0B3HH HIGHSTAT Investigative D0B3JB DRUG__ID D0B3JB D0B3JB DRUGTYPE Small molecular drug D0B3JB DRUGINCH 1S/C17H18N2O/c1-17(2,3)15-11-20-16(19-15)18-14-10-6-8-12-7-4-5-9-13(12)14/h4-11H,1-3H3,(H,18,19) D0B3JB DRUGINKE RDWFLGKWZJPVFQ-UHFFFAOYSA-N D0B3JB DRUGSMIL CC(C)(C)C1=COC(=N1)NC2=CC=CC3=CC=CC=C32 D0B3JB HIGHSTAT Investigative D0B3LN DRUG__ID D0B3LN D0B3LN DRUGTYPE Small molecular drug D0B3LN DRUGINCH 1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m1/s1 D0B3LN DRUGINKE COLNVLDHVKWLRT-MRVPVSSYSA-N D0B3LN DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)N D0B3LN HIGHSTAT Investigative D0B3MG DRUG__ID D0B3MG D0B3MG DRUGTYPE Small molecular drug D0B3MG DRUGINCH 1S/C10H15N3O4/c11-7-1-2-13(10(17)12-7)6-3-5(4-14)8(15)9(6)16/h1-2,5-6,8-9,14-16H,3-4H2,(H2,11,12,17)/t5-,6-,8-,9+/m1/s1 D0B3MG DRUGINKE UAZJPMMKWBPACD-GCXDCGAKSA-N D0B3MG DRUGSMIL C1C(C(C(C1N2C=CC(=NC2=O)N)O)O)CO D0B3MG HIGHSTAT Investigative D0B3NZ DRUG__ID D0B3NZ D0B3NZ DRUGTYPE Small molecular drug D0B3NZ DRUGINCH 1S/C23H16N2O2S/c26-20(17-12-6-2-7-13-17)21-19(16-10-4-1-5-11-16)24-23(28-21)25-22(27)18-14-8-3-9-15-18/h1-15H,(H,24,25,27) D0B3NZ DRUGINKE PCQHQQZQXRSVDE-UHFFFAOYSA-N D0B3NZ DRUGSMIL C1=CC=C(C=C1)C2=C(SC(=N2)NC(=O)C3=CC=CC=C3)C(=O)C4=CC=CC=C4 D0B3NZ HIGHSTAT Investigative D0B3PC DRUG__ID D0B3PC D0B3PC DRUGTYPE Small molecular drug D0B3PC DRUGINCH 1S/C28H34Cl2N2O2/c1-32(18-19-6-4-2-3-5-7-19)14-12-22(13-15-32)31-28(33)27-23-16-20(29)8-10-25(23)34-26-11-9-21(30)17-24(26)27/h8-11,16-17,19,22,27H,2-7,12-15,18H2,1H3/p+1 D0B3PC DRUGINKE AHYGVFSLUXGXSH-UHFFFAOYSA-O D0B3PC DRUGSMIL C[N+]1(CCC(CC1)NC(=O)C2C3=C(C=CC(=C3)Cl)OC4=C2C=C(C=C4)Cl)CC5CCCCCC5 D0B3PC HIGHSTAT Investigative D0B3QN DRUG__ID D0B3QN D0B3QN DRUGTYPE Small molecular drug D0B3QN DRUGINCH 1S/C16H14O2/c1-11-7-8-13-14(17)10-15(18-16(13)9-11)12-5-3-2-4-6-12/h2-9,15H,10H2,1H3/t15-/m1/s1 D0B3QN DRUGINKE FNOKOVWLKVWYRY-OAHLLOKOSA-N D0B3QN DRUGSMIL CC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=CC=C3 D0B3QN HIGHSTAT Investigative D0B3UE DRUG__ID D0B3UE D0B3UE DRUGTYPE Small molecular drug D0B3UE DRUGINCH 1S/C10H13N5/c11-9-8-10(13-5-12-9)15(6-14-8)7-3-1-2-4-7/h5-7H,1-4H2,(H2,11,12,13) D0B3UE DRUGINKE KTJWHJNBTXITCB-UHFFFAOYSA-N D0B3UE DRUGSMIL C1CCC(C1)N2C=NC3=C(N=CN=C32)N D0B3UE HIGHSTAT Investigative D0B3UG DRUG__ID D0B3UG D0B3UG DRUGTYPE Small molecular drug D0B3UG DRUGINCH 1S/C15H14N2S/c1-12-4-6-13(7-5-12)9-17-10-14(16-11-17)15-3-2-8-18-15/h2-8,10-11H,9H2,1H3 D0B3UG DRUGINKE UMOFOLLUKPBVQG-UHFFFAOYSA-N D0B3UG DRUGSMIL CC1=CC=C(C=C1)CN2C=C(N=C2)C3=CC=CS3 D0B3UG HIGHSTAT Investigative D0B3UN DRUG__ID D0B3UN D0B3UN DRUGTYPE Small molecular drug D0B3UN DRUGINCH 1S/C35H35BrClN4O10P/c36-24-8-10-27(11-9-24)52(49,50)19-23(34(47)40-29(13-15-32(44)45)35(48)39-28(33(38)46)12-14-31(42)43)17-26-18-30(41-51-26)21-6-4-20(5-7-21)22-2-1-3-25(37)16-22/h1-11,16,18,23,28-29H,12-15,17,19H2,(H2,38,46)(H,39,48)(H,40,47)(H,42,43)(H,44,45)(H,49,50)/t23-,28+,29+/m1/s1 D0B3UN DRUGINKE PTUCPHGSAFOJAU-MGONOCMRSA-N D0B3UN DRUGSMIL C1=CC(=CC(=C1)Cl)C2=CC=C(C=C2)C3=NOC(=C3)CC(CP(=O)(C4=CC=C(C=C4)Br)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N D0B3UN HIGHSTAT Investigative D0B3US DRUG__ID D0B3US D0B3US DRUGTYPE Small molecular drug D0B3US DRUGINCH 1S/C29H46N4O9S2/c1-8-20(4)25(33-29(37)42-17-22-12-10-9-11-13-22)28(36)32-24(18-44(7,40)41)27(35)30-21(5)26(34)31-23(16-19(2)3)14-15-43(6,38)39/h9-15,19-21,23-25H,8,16-18H2,1-7H3,(H,30,35)(H,31,34)(H,32,36)(H,33,37)/b15-14+/t20-,21-,23+,24-,25-/m0/s1 D0B3US DRUGINKE HIMUOMBMABFMIW-VHISICEBSA-N D0B3US DRUGSMIL CCC(C)C(C(=O)NC(CS(=O)(=O)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC1=CC=CC=C1 D0B3US HIGHSTAT Investigative D0B3WF DRUG__ID D0B3WF D0B3WF DRUGTYPE Small molecular drug D0B3WF DRUGINCH 1S/C21H30N4O8/c1-10(2)17(25-19(30)14(22)8-12-4-6-13(26)7-5-12)20(31)23-11(3)18(29)24-15(21(32)33)9-16(27)28/h4-7,10-11,14-15,17,26H,8-9,22H2,1-3H3,(H,23,31)(H,24,29)(H,25,30)(H,27,28)(H,32,33)/t11-,14-,15-,17-/m0/s1 D0B3WF DRUGINKE XVZUMQAMCYSUMS-SIUGBPQLSA-N D0B3WF DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)N D0B3WF HIGHSTAT Investigative D0B3WX DRUG__ID D0B3WX D0B3WX DRUGTYPE Small molecular drug D0B3WX DRUGINCH 1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+ D0B3WX DRUGINKE RSUVYMGADVXGOU-BUHFOSPRSA-N D0B3WX DRUGSMIL CN(C)CCCSC1=CC=CC=C1NC(=O)C=CC2=CC=CC=C2 D0B3WX HIGHSTAT Investigative D0B3XP DRUG__ID D0B3XP D0B3XP DRUGTYPE Small molecular drug D0B3XP DRUGINCH 1S/C17H14N2O4S/c18-16-3-1-2-12-10-14(8-9-15(12)16)24(22,23)19-13-6-4-11(5-7-13)17(20)21/h1-10,19H,18H2,(H,20,21) D0B3XP DRUGINKE BAYMNCHSODLCJV-UHFFFAOYSA-N D0B3XP DRUGSMIL C1=CC2=C(C=CC(=C2)S(=O)(=O)NC3=CC=C(C=C3)C(=O)O)C(=C1)N D0B3XP HIGHSTAT Investigative D0B3ZB DRUG__ID D0B3ZB D0B3ZB DRUGTYPE Small molecular drug D0B3ZB DRUGINCH 1S/C18H12BrN3O3/c1-9(23)25-22-16-12-4-2-3-5-13(12)20-17(16)15-11-7-6-10(19)8-14(11)21-18(15)24/h2-8,21,24H,1H3/b22-16+ D0B3ZB DRUGINKE HUDSYNWJCPDHLL-CJLVFECKSA-N D0B3ZB DRUGSMIL CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC(=C4)Br)O D0B3ZB HIGHSTAT Investigative D0B3ZM DRUG__ID D0B3ZM D0B3ZM DRUGTYPE Small molecular drug D0B3ZM DRUGINCH 1S/C12H17NOS/c14-12(9-5-2-6-10-15)13-11-7-3-1-4-8-11/h1,3-4,7-8,15H,2,5-6,9-10H2,(H,13,14) D0B3ZM DRUGINKE IFUHTURYMZWNNJ-UHFFFAOYSA-N D0B3ZM DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCS D0B3ZM HIGHSTAT Investigative D0B4CA DRUG__ID D0B4CA D0B4CA DRUGTYPE Small molecular drug D0B4CA DRUGINCH 1S/C16H10FNO3/c17-11-4-2-1-3-9(11)12-6-14(19)10-5-15-16(21-8-20-15)7-13(10)18-12/h1-7H,8H2,(H,18,19) D0B4CA DRUGINKE ZMYDAPJHGNEFGQ-UHFFFAOYSA-N D0B4CA DRUGSMIL C1OC2=C(O1)C=C3C(=C2)C(=O)C=C(N3)C4=CC=CC=C4F D0B4CA HIGHSTAT Investigative D0B4CJ DRUG__ID D0B4CJ D0B4CJ DRUGTYPE Small molecular drug D0B4CJ DRUGINCH 1S/C19H17NO3/c21-17-13-19(20-8-10-22-11-9-20)23-18-7-6-15(12-16(17)18)14-4-2-1-3-5-14/h1-7,12-13H,8-11H2 D0B4CJ DRUGINKE FGDAUGYDQLYAKT-UHFFFAOYSA-N D0B4CJ DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=CC=C4 D0B4CJ HIGHSTAT Investigative D0B4CQ DRUG__ID D0B4CQ D0B4CQ DRUGTYPE Small molecular drug D0B4CQ DRUGINCH 1S/C20H20N2O2/c1-2-10-21-20(24)17-13-22-18-9-8-15(12-16(18)19(17)23)11-14-6-4-3-5-7-14/h3-9,12-13H,2,10-11H2,1H3,(H,21,24)(H,22,23) D0B4CQ DRUGINKE RZALWHUVJLYKIZ-UHFFFAOYSA-N D0B4CQ DRUGSMIL CCCNC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC3=CC=CC=C3 D0B4CQ HIGHSTAT Investigative D0B4CV DRUG__ID D0B4CV D0B4CV DRUGTYPE Small molecular drug D0B4CV DRUGINCH 1S/C9H16N2O3/c12-8(13)6-10-9(14)11-7-4-2-1-3-5-7/h7H,1-6H2,(H,12,13)(H2,10,11,14) D0B4CV DRUGINKE NVORCMBCUHQRDL-UHFFFAOYSA-N D0B4CV DRUGSMIL C1CCC(CC1)NC(=O)NCC(=O)O D0B4CV HIGHSTAT Investigative D0B4DP DRUG__ID D0B4DP D0B4DP DRUGTYPE Small molecular drug D0B4DP DRUGINCH 1S/C14H14N2/c1-2-4-13-11-16(10-7-12(13)3-1)14-5-8-15-9-6-14/h1-6,8-9H,7,10-11H2 D0B4DP DRUGINKE CIOBWNSCGKJAQU-UHFFFAOYSA-N D0B4DP DRUGSMIL C1CN(CC2=CC=CC=C21)C3=CC=NC=C3 D0B4DP HIGHSTAT Investigative D0B4DT DRUG__ID D0B4DT D0B4DT DRUGTYPE Small molecular drug D0B4DT DRUGINCH 1S/C29H33NO3/c1-30(22-23-13-7-6-8-14-23)19-11-4-2-3-5-12-20-32-24-17-18-26-28(21-24)33-27-16-10-9-15-25(27)29(26)31/h6-10,13-18,21H,2-5,11-12,19-20,22H2,1H3 D0B4DT DRUGINKE QDZBIUGFNUHGNM-UHFFFAOYSA-N D0B4DT DRUGSMIL CN(CCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D0B4DT HIGHSTAT Investigative D0B4FN DRUG__ID D0B4FN D0B4FN DRUGTYPE Small molecular drug D0B4FN DRUGINCH 1S/C15H21NO/c1-2-8-14(16-11-6-7-12-16)15(17)13-9-4-3-5-10-13/h3-5,9-10,14H,2,6-8,11-12H2,1H3 D0B4FN DRUGINKE YDIIDRWHPFMLGR-UHFFFAOYSA-N D0B4FN DRUGSMIL CCCC(C(=O)C1=CC=CC=C1)N2CCCC2 D0B4FN HIGHSTAT Investigative D0B4GJ DRUG__ID D0B4GJ D0B4GJ DRUGTYPE Small molecular drug D0B4GJ DRUGINCH 1S/C15H27F3O2S/c1-2-3-4-5-6-7-8-9-10-11-12-21(20)13-14(19)15(16,17)18/h2-13H2,1H3 D0B4GJ DRUGINKE HIQQJIUOQKSANW-UHFFFAOYSA-N D0B4GJ DRUGSMIL CCCCCCCCCCCCS(=O)CC(=O)C(F)(F)F D0B4GJ HIGHSTAT Investigative D0B4GP DRUG__ID D0B4GP D0B4GP DRUGTYPE Small molecular drug D0B4GP DRUGINCH 1S/C19H30N2O3/c1-4-5-6-7-8-9-10-15-23-18-13-11-17(12-14-18)20-19(22)24-21-16(2)3/h11-14H,4-10,15H2,1-3H3,(H,20,22) D0B4GP DRUGINKE JNUCPQPMMFLJDL-UHFFFAOYSA-N D0B4GP DRUGSMIL CCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D0B4GP HIGHSTAT Investigative D0B4GV DRUG__ID D0B4GV D0B4GV DRUGTYPE Small molecular drug D0B4GV DRUGINCH 1S/C9H7NO2/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5H,10H2 D0B4GV DRUGINKE AHZAKFLOHIRCDU-UHFFFAOYSA-N D0B4GV DRUGSMIL C1=CC=C2C(=C1)C(=CC(=O)O2)N D0B4GV HIGHSTAT Investigative D0B4GX DRUG__ID D0B4GX D0B4GX DRUGTYPE Small molecular drug D0B4GX DRUGINCH 1S/C19H23N3OS/c23-9-10-24-19-21-17-8-4-3-7-16(17)18(22-19)20-15-11-13-5-1-2-6-14(13)12-15/h1-2,5-6,15,23H,3-4,7-12H2,(H,20,21,22) D0B4GX DRUGINKE VZJHTQZXSTXJNO-UHFFFAOYSA-N D0B4GX DRUGSMIL C1CCC2=C(C1)C(=NC(=N2)SCCO)NC3CC4=CC=CC=C4C3 D0B4GX HIGHSTAT Investigative D0B4IN DRUG__ID D0B4IN D0B4IN DRUGTYPE Small molecular drug D0B4IN DRUGINCH 1S/C26H22N4O6S4/c27-39(33,34)19-13-9-17(10-14-19)29-25(31)21-5-1-3-7-23(21)37-38-24-8-4-2-6-22(24)26(32)30-18-11-15-20(16-12-18)40(28,35)36/h1-16H,(H,29,31)(H,30,32)(H2,27,33,34)(H2,28,35,36) D0B4IN DRUGINKE FVGJPHFQQMQGFQ-UHFFFAOYSA-N D0B4IN DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)N)SSC3=CC=CC=C3C(=O)NC4=CC=C(C=C4)S(=O)(=O)N D0B4IN HIGHSTAT Investigative D0B4JS DRUG__ID D0B4JS D0B4JS DRUGTYPE Small molecular drug D0B4JS DRUGINCH 1S/C16H17N3S/c17-16(20)19-18-15(14-9-5-2-6-10-14)12-11-13-7-3-1-4-8-13/h1-10H,11-12H2,(H3,17,19,20)/b18-15- D0B4JS DRUGINKE AEHHXKHHRMBYLD-SDXDJHTJSA-N D0B4JS DRUGSMIL C1=CC=C(C=C1)CCC(=NNC(=S)N)C2=CC=CC=C2 D0B4JS HIGHSTAT Investigative D0B4JU DRUG__ID D0B4JU D0B4JU DRUGTYPE Small molecular drug D0B4JU DRUGINCH 1S/C29H43N9O8/c1-16(2)11-19-26(44)34-14-22(39)35-18(9-6-10-32-29(30)31)25(43)33-15-23(40)36-21(13-24(41)42)28(46)38-20(27(45)37-19)12-17-7-4-3-5-8-17/h3-5,7-8,16,18-21H,6,9-15H2,1-2H3,(H,33,43)(H,34,44)(H,35,39)(H,36,40)(H,37,45)(H,38,46)(H,41,42)(H4,30,31,32)/t18-,19-,20+,21-/m0/s1 D0B4JU DRUGINKE VRTNUMBPIBDYLD-BURNTYAHSA-N D0B4JU DRUGSMIL CC(C)CC1C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N D0B4JU HIGHSTAT Investigative D0B4KG DRUG__ID D0B4KG D0B4KG DRUGTYPE Small molecular drug D0B4KG DRUGINCH 1S/C17H16F3NO4/c1-2-3-10-24-13-5-7-14(8-6-13)25-16-9-4-12(17(18,19)20)11-15(16)21(22)23/h4-9,11H,2-3,10H2,1H3 D0B4KG DRUGINKE AOQOXPPRTCVMPF-UHFFFAOYSA-N D0B4KG DRUGSMIL CCCCOC1=CC=C(C=C1)OC2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-] D0B4KG HIGHSTAT Investigative D0B4LD DRUG__ID D0B4LD D0B4LD DRUGTYPE Small molecular drug D0B4LD DRUGINCH 1S/C16H19N/c1-17(2)12-11-14-7-6-10-16(13-14)15-8-4-3-5-9-15/h3-10,13H,11-12H2,1-2H3 D0B4LD DRUGINKE ZMTHYJFLTGNPHJ-UHFFFAOYSA-N D0B4LD DRUGSMIL CN(C)CCC1=CC(=CC=C1)C2=CC=CC=C2 D0B4LD HIGHSTAT Investigative D0B4PH DRUG__ID D0B4PH D0B4PH DRUGTYPE Small molecular drug D0B4PH DRUGINCH 1S/C14H12BrN5/c15-8-2-1-3-9(4-8)20-14-10-5-11(16)12(17)6-13(10)18-7-19-14/h1-7H,16-17H2,(H,18,19,20) D0B4PH DRUGINKE ADXSZLCTQCWMTE-UHFFFAOYSA-N D0B4PH DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=CC(=C(C=C32)N)N D0B4PH HIGHSTAT Investigative D0B4SF DRUG__ID D0B4SF D0B4SF DRUGTYPE Small molecular drug D0B4SF DRUGINCH 1S/C14H23N7S/c1-11-13(21-10-19-11)8-22-6-5-18-14(15)17-4-2-3-12-7-16-9-20-12/h7,9-10H,2-6,8H2,1H3,(H,16,20)(H,19,21)(H3,15,17,18) D0B4SF DRUGINKE MURRAGMMNAYLNA-UHFFFAOYSA-N D0B4SF DRUGSMIL CC1=C(N=CN1)CSCCNC(=NCCCC2=CN=CN2)N D0B4SF HIGHSTAT Investigative D0B4SJ DRUG__ID D0B4SJ D0B4SJ DRUGTYPE Small molecular drug D0B4SJ DRUGINCH 1S/C17H30N2O5/c1-5-6-8-12(11-14(20)18-23)15(21)19-10-7-9-13(19)16(22)24-17(2,3)4/h12-13,23H,5-11H2,1-4H3,(H,18,20)/t12-,13+/m1/s1 D0B4SJ DRUGINKE XNOOIEVKOZAJEO-OLZOCXBDSA-N D0B4SJ DRUGSMIL CCCCC(CC(=O)NO)C(=O)N1CCCC1C(=O)OC(C)(C)C D0B4SJ HIGHSTAT Investigative D0B4SL DRUG__ID D0B4SL D0B4SL DRUGTYPE Small molecular drug D0B4SL DRUGINCH 1S/C23H31N5OS/c1-3-10-27(18-8-9-19-22(17-18)30-23(24)25-19)14-11-26-12-15-28(16-13-26)20-6-4-5-7-21(20)29-2/h1,4-7,18H,8-17H2,2H3,(H2,24,25) D0B4SL DRUGINKE GUCAXHFLECNGRL-UHFFFAOYSA-N D0B4SL DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(CC#C)C3CCC4=C(C3)SC(=N4)N D0B4SL HIGHSTAT Investigative D0B4SQ DRUG__ID D0B4SQ D0B4SQ DRUGTYPE Small molecular drug D0B4SQ DRUGINCH 1S/C43H68N12O8/c1-3-23(2)34(38(60)54-43(40(62)63)27-18-25-17-26(20-27)21-28(43)19-25)53-36(58)32(22-24-10-12-29(56)13-11-24)52-37(59)33-9-6-16-55(33)39(61)31(8-5-15-50-42(47)48)51-35(57)30(44)7-4-14-49-41(45)46/h10-13,23,25-28,30-34,56H,3-9,14-22,44H2,1-2H3,(H,51,57)(H,52,59)(H,53,58)(H,54,60)(H,62,63)(H4,45,46,49)(H4,47,48,50)/t23-,25?,26?,27?,28?,30-,31-,32-,33-,34-,43?/m0/s1 D0B4SQ DRUGINKE CMCIRTPGPAKLJS-YTNDVNQYSA-N D0B4SQ DRUGSMIL CCC(C)C(C(=O)NC1(C2CC3CC(C2)CC1C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C5CCCN5C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N D0B4SQ HIGHSTAT Investigative D0B4SU DRUG__ID D0B4SU D0B4SU DRUGTYPE Small molecular drug D0B4SU DRUGINCH 1S/C18H16ClN3O2/c1-11-9-15(13-5-3-4-6-14(13)20-11)21-18(23)22-16-10-12(19)7-8-17(16)24-2/h3-10H,1-2H3,(H2,20,21,22,23) D0B4SU DRUGINKE YBLWOZUPHDKFOT-UHFFFAOYSA-N D0B4SU DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)NC(=O)NC3=C(C=CC(=C3)Cl)OC D0B4SU HIGHSTAT Investigative D0B4VE DRUG__ID D0B4VE D0B4VE DRUGTYPE Small molecular drug D0B4VE DRUGINCH 1S/C15H12O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-9,15H,10H2 D0B4VE DRUGINKE ZONYXWQDUYMKFB-UHFFFAOYSA-N D0B4VE DRUGSMIL C1C(OC2=CC=CC=C2C1=O)C3=CC=CC=C3 D0B4VE HIGHSTAT Investigative D0B4WZ DRUG__ID D0B4WZ D0B4WZ DRUGTYPE Small molecular drug D0B4WZ DRUGINCH 1S/C18H17NO2/c1-2-18(13-14-9-5-3-6-10-14)16(20)19(17(18)21)15-11-7-4-8-12-15/h3-12H,2,13H2,1H3 D0B4WZ DRUGINKE FWZVCEYFFJOHOK-UHFFFAOYSA-N D0B4WZ DRUGSMIL CCC1(C(=O)N(C1=O)C2=CC=CC=C2)CC3=CC=CC=C3 D0B4WZ HIGHSTAT Investigative D0B4ZT DRUG__ID D0B4ZT D0B4ZT DRUGTYPE Small molecular drug D0B4ZT DRUGINCH 1S/C10H21NO/c1-7(2)10(5,8(3)4)9(12)11-6/h7-8H,1-6H3,(H,11,12) D0B4ZT DRUGINKE RWAXQWRDVUOOGG-UHFFFAOYSA-N D0B4ZT DRUGSMIL CC(C)C(C)(C(C)C)C(=O)NC D0B4ZT HIGHSTAT Investigative D0B5AG DRUG__ID D0B5AG D0B5AG DRUGTYPE Small molecular drug D0B5AG DRUGINCH 1S/C15H15NO/c16-14-10-15(13-9-5-4-8-12(13)14)17-11-6-2-1-3-7-11/h1-9,14-15H,10,16H2/t14-,15+/m1/s1 D0B5AG DRUGINKE AFPFOKAYUJMERG-CABCVRRESA-N D0B5AG DRUGSMIL C1C(C2=CC=CC=C2C1OC3=CC=CC=C3)N D0B5AG HIGHSTAT Investigative D0B5BG DRUG__ID D0B5BG D0B5BG DRUGTYPE Small molecular drug D0B5BG DRUGINCH 1S/C12H11N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H3,13,14,15,16,17) D0B5BG DRUGINKE KRWMERLEINMZFT-UHFFFAOYSA-N D0B5BG DRUGSMIL C1=CC=C(C=C1)COC2=NC(=NC3=C2NC=N3)N D0B5BG HIGHSTAT Investigative D0B5CR DRUG__ID D0B5CR D0B5CR DRUGTYPE Small molecular drug D0B5CR DRUGINCH 1S/C15H13ClN4/c16-11-7-5-10(6-8-11)9-14-15(20-17)19-13-4-2-1-3-12(13)18-14/h1-8H,9,17H2,(H,19,20) D0B5CR DRUGINKE SMGDWLQUFKXCFA-UHFFFAOYSA-N D0B5CR DRUGSMIL C1=CC=C2C(=C1)N=C(C(=N2)NN)CC3=CC=C(C=C3)Cl D0B5CR HIGHSTAT Investigative D0B5FC DRUG__ID D0B5FC D0B5FC DRUGTYPE Small molecular drug D0B5FC DRUGINCH 1S/C17H12F9NO3S/c18-14(19,20)10-27(31(29,30)13-4-2-1-3-5-13)12-8-6-11(7-9-12)15(28,16(21,22)23)17(24,25)26/h1-9,28H,10H2 D0B5FC DRUGINKE SGIWFELWJPNFDH-UHFFFAOYSA-N D0B5FC DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O D0B5FC HIGHSTAT Investigative D0B5GC DRUG__ID D0B5GC D0B5GC DRUGCOMP NeuProtect Pty Ltd D0B5GC DRUGINCH 1S/C15H10O3/c16-13-11-8-4-5-9-12(11)18-15(14(13)17)10-6-2-1-3-7-10/h1-9,17H D0B5GC DRUGINKE HVQAJTFOCKOKIN-UHFFFAOYSA-N D0B5GC DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=CC=CC=C3O2)O D0B5GC HIGHSTAT Investigative D0B5HD DRUG__ID D0B5HD D0B5HD DRUGTYPE Small molecular drug D0B5HD DRUGINCH 1S/C12H4Cl2F6N4OS/c13-5-1-4(11(15,16)17)2-6(14)8(5)24-10(22)9(7(3-21)23-24)26(25)12(18,19)20/h1-2H,22H2 D0B5HD DRUGINKE ZOCSXAVNDGMNBV-UHFFFAOYSA-N D0B5HD DRUGSMIL C1=C(C=C(C(=C1Cl)N2C(=C(C(=N2)C#N)S(=O)C(F)(F)F)N)Cl)C(F)(F)F D0B5HD HIGHSTAT Investigative D0B5IL DRUG__ID D0B5IL D0B5IL DRUGTYPE Small molecular drug D0B5IL DRUGINCH 1S/C19H28N2O5/c1-13(2)10-11-20-18(25)15(9-8-14-6-4-3-5-7-14)21-19(26)16(22)12-17(23)24/h3-7,13,15-16,22H,8-12H2,1-2H3,(H,20,25)(H,21,26)(H,23,24)/t15-,16+/m1/s1 D0B5IL DRUGINKE KVZMXOVSHIMGNA-CVEARBPZSA-N D0B5IL DRUGSMIL CC(C)CCNC(=O)C(CCC1=CC=CC=C1)NC(=O)C(CC(=O)O)O D0B5IL HIGHSTAT Investigative D0B5MF DRUG__ID D0B5MF D0B5MF DRUGTYPE Small molecular drug D0B5MF DRUGINCH 1S/C2H6N2/c3-1-2-4/h1,3H,2,4H2 D0B5MF DRUGINKE AXQVKDQRBAXYBP-UHFFFAOYSA-N D0B5MF DRUGSMIL C(C=N)N D0B5MF HIGHSTAT Investigative D0B5MU DRUG__ID D0B5MU D0B5MU DRUGTYPE Small molecular drug D0B5MU DRUGINCH 1S/C19H27IN2O4/c1-2-3-6-22-7-4-13(5-8-22)12-26-19(23)14-11-15(20)16(21)18-17(14)24-9-10-25-18/h11,13H,2-10,12,21H2,1H3 D0B5MU DRUGINKE FCKKCDRMGKXQDK-UHFFFAOYSA-N D0B5MU DRUGSMIL CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)N)I D0B5MU HIGHSTAT Investigative D0B5MZ DRUG__ID D0B5MZ D0B5MZ DRUGTYPE Small molecular drug D0B5MZ DRUGINCH 1S/C15H20N2O2/c1-2-3-9-15(10-8-13(18)17-14(15)19)11-4-6-12(16)7-5-11/h4-7H,2-3,8-10,16H2,1H3,(H,17,18,19) D0B5MZ DRUGINKE HECRHMWBGLSDHM-UHFFFAOYSA-N D0B5MZ DRUGSMIL CCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N D0B5MZ HIGHSTAT Investigative D0B5OK DRUG__ID D0B5OK D0B5OK DRUGTYPE Small molecular drug D0B5OK DRUGINCH 1S/C15H11NO2/c1-18-15(17)13-8-10-14(16-11-13)9-7-12-5-3-2-4-6-12/h2-6,8,10-11H,1H3 D0B5OK DRUGINKE DRFBUAIOGNADQC-UHFFFAOYSA-N D0B5OK DRUGSMIL COC(=O)C1=CN=C(C=C1)C#CC2=CC=CC=C2 D0B5OK HIGHSTAT Investigative D0B5RX DRUG__ID D0B5RX D0B5RX DRUGTYPE Small molecular drug D0B5RX DRUGINCH 1S/C22H23NO/c24-21(22-11-16-7-17(12-22)9-18(8-16)13-22)6-5-15-10-19-3-1-2-4-20(19)23-14-15/h1-6,10,14,16-18H,7-9,11-13H2/b6-5+ D0B5RX DRUGINKE IHMKNCCPYWKVEH-AATRIKPKSA-N D0B5RX DRUGSMIL C1C2CC3CC1CC(C2)(C3)C(=O)C=CC4=CC5=CC=CC=C5N=C4 D0B5RX HIGHSTAT Investigative D0B5SF DRUG__ID D0B5SF D0B5SF DRUGTYPE Small molecular drug D0B5SF DRUGINCH 1S/C13H17N3/c1-10-3-4-12(7-11(10)2)15-6-5-13-8-14-9-16-13/h3-4,7-9,15H,5-6H2,1-2H3,(H,14,16) D0B5SF DRUGINKE GHCPLWBMALOXTM-UHFFFAOYSA-N D0B5SF DRUGSMIL CC1=C(C=C(C=C1)NCCC2=CN=CN2)C D0B5SF HIGHSTAT Investigative D0B5ST DRUG__ID D0B5ST D0B5ST DRUGTYPE Small molecular drug D0B5ST DRUGINCH 1S/C10H14BrNS/c1-12(2)6-7-13-10-5-3-4-9(11)8-10/h3-5,8H,6-7H2,1-2H3 D0B5ST DRUGINKE LIEFSMJAVJRLBQ-UHFFFAOYSA-N D0B5ST DRUGSMIL CN(C)CCSC1=CC(=CC=C1)Br D0B5ST HIGHSTAT Investigative D0B5VN DRUG__ID D0B5VN D0B5VN DRUGTYPE Small molecular drug D0B5VN DRUGINCH 1S/C30H34BrF3N4O7S/c1-16(2)23(25(39)30(32,33)34)35-28(42)22-6-5-15-38(22)29(43)24(17(3)4)36-26(40)18-7-9-19(10-8-18)27(41)37-46(44,45)21-13-11-20(31)12-14-21/h7-14,16-17,22-24H,5-6,15H2,1-4H3,(H,35,42)(H,36,40)(H,37,41) D0B5VN DRUGINKE UUWIYANOKPHUQZ-UHFFFAOYSA-N D0B5VN DRUGSMIL CC(C)C(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C2=CC=C(C=C2)C(=O)NS(=O)(=O)C3=CC=C(C=C3)Br D0B5VN HIGHSTAT Investigative D0B5ZA DRUG__ID D0B5ZA D0B5ZA DRUGTYPE Small molecular drug D0B5ZA DRUGINCH 1S/C8H7NO4/c10-6(11)4-5-2-1-3-9-7(5)8(12)13/h1-3H,4H2,(H,10,11)(H,12,13) D0B5ZA DRUGINKE HQPMJFFEXJELOQ-UHFFFAOYSA-N D0B5ZA DRUGSMIL C1=CC(=C(N=C1)C(=O)O)CC(=O)O D0B5ZA HIGHSTAT Investigative D0B6CA DRUG__ID D0B6CA D0B6CA DRUGTYPE Small molecular drug D0B6CA DRUGINCH 1S/C11H16N2/c1-2-9-13(8-1)10-5-11-3-6-12-7-4-11/h3-4,6-7H,1-2,5,8-10H2 D0B6CA DRUGINKE GNJYGFKCUMGKOY-UHFFFAOYSA-N D0B6CA DRUGSMIL C1CCN(C1)CCC2=CC=NC=C2 D0B6CA HIGHSTAT Investigative D0B6FM DRUG__ID D0B6FM D0B6FM DRUGTYPE Small molecular drug D0B6FM DRUGINCH 1S/C12H17NOS/c1-14-11-5-6-12(15-2)9-4-3-8(13)7-10(9)11/h5-6,8H,3-4,7,13H2,1-2H3 D0B6FM DRUGINKE YCSXMTWSPWKFIE-UHFFFAOYSA-N D0B6FM DRUGSMIL COC1=C2CC(CCC2=C(C=C1)SC)N D0B6FM HIGHSTAT Investigative D0B6IQ DRUG__ID D0B6IQ D0B6IQ DRUGTYPE Small molecular drug D0B6IQ DRUGINCH 1S/C15H14N2OS/c1-16(2)15(18)17-11-7-3-5-9-13(11)19-14-10-6-4-8-12(14)17/h3-10H,1-2H3 D0B6IQ DRUGINKE JVEMOBBCUXTLCS-UHFFFAOYSA-N D0B6IQ DRUGSMIL CN(C)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0B6IQ HIGHSTAT Investigative D0B6KT DRUG__ID D0B6KT D0B6KT DRUGTYPE Small molecular drug D0B6KT DRUGINCH 1S/C14H16N6O/c1-19-8-10(6-18-19)11-7-15-13-12(11)14(17-9-16-13)20-2-4-21-5-3-20/h6-9H,2-5H2,1H3,(H,15,16,17) D0B6KT DRUGINKE VNWKCLDQBNSJJO-UHFFFAOYSA-N D0B6KT DRUGSMIL CN1C=C(C=N1)C2=CNC3=C2C(=NC=N3)N4CCOCC4 D0B6KT HIGHSTAT Investigative D0B6MV DRUG__ID D0B6MV D0B6MV DRUGTYPE Small molecular drug D0B6MV DRUGINCH 1S/C16H18N4O4/c1-18-12-13(19(2)16(22)20(3)14(12)21)17-15(18)24-9-10-6-5-7-11(8-10)23-4/h5-8H,9H2,1-4H3 D0B6MV DRUGINKE SDEMBXFOALFRQD-UHFFFAOYSA-N D0B6MV DRUGSMIL CN1C2=C(N=C1OCC3=CC(=CC=C3)OC)N(C(=O)N(C2=O)C)C D0B6MV HIGHSTAT Investigative D0B6OH DRUG__ID D0B6OH D0B6OH DRUGTYPE Small molecular drug D0B6OH DRUGINCH 1S/C18H22O5/c1-20-15-8-7-12(9-14(15)19)5-6-13-10-16(21-2)18(23-4)17(11-13)22-3/h5-10,13,19H,11H2,1-4H3/b6-5- D0B6OH DRUGINKE YHCKDJOSGUSXBN-WAYWQWQTSA-N D0B6OH DRUGSMIL COC1=C(C(=CC(C1)C=CC2=CC(=C(C=C2)OC)O)OC)OC D0B6OH HIGHSTAT Investigative D0B6PX DRUG__ID D0B6PX D0B6PX DRUGTYPE Small molecular drug D0B6PX DRUGINCH 1S/C25H35N3O3/c1-27(2)11-13-31-24(29)25-15-17-14-18(9-12-30-3)23(25)28(16-17)10-8-20-19-6-4-5-7-21(19)26-22(20)25/h4-7,17-18,23,26H,8-16H2,1-3H3/t17?,18-,23?,25+/m0/s1 D0B6PX DRUGINKE NLVQALDWFSJMGA-WXPGHXCBSA-N D0B6PX DRUGSMIL CN(C)CCOC(=O)C12CC3CC(C1N(C3)CCC4=C2NC5=CC=CC=C45)CCOC D0B6PX HIGHSTAT Investigative D0B6QP DRUG__ID D0B6QP D0B6QP DRUGTYPE Small molecular drug D0B6QP DRUGINCH 1S/C17H17NO2.ClH/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;/h2-6,13,19-20H,7-9H2,1H3;1H/t13-;/m1./s1 D0B6QP DRUGINKE SKYZYDSNJIOXRL-BTQNPOSSSA-N D0B6QP DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.Cl D0B6QP HIGHSTAT Investigative D0B6SA DRUG__ID D0B6SA D0B6SA DRUGTYPE Small molecular drug D0B6SA DRUGINCH 1S/C23H33NO3/c1-13(2)24-21(26)12-15-11-20-19-6-4-14-10-16(25)5-7-17(14)18(19)8-9-23(20,3)22(15)27/h5,7,10,13,15,18-20,22,25,27H,4,6,8-9,11-12H2,1-3H3,(H,24,26)/t15?,18?,19?,20?,22-,23-/m0/s1 D0B6SA DRUGINKE FKSICUOFJYPFSV-XWFZVRCUSA-N D0B6SA DRUGSMIL CC(C)NC(=O)CC1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O D0B6SA HIGHSTAT Investigative D0B6SF DRUG__ID D0B6SF D0B6SF DRUGTYPE Small molecular drug D0B6SF DRUGINCH 1S/C22H16O2S/c23-18-10-4-8-16(12-18)21-14-20(15-6-2-1-3-7-15)22(25-21)17-9-5-11-19(24)13-17/h1-14,23-24H D0B6SF DRUGINKE ZQUCGOXYEIRCOX-UHFFFAOYSA-N D0B6SF DRUGSMIL C1=CC=C(C=C1)C2=C(SC(=C2)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0B6SF HIGHSTAT Investigative D0B6UU DRUG__ID D0B6UU D0B6UU DRUGTYPE Small molecular drug D0B6UU DRUGINCH 1S/C22H27NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,15-16,20-22,24H,8,13-14,17H2,1H3/b16-15+/t20-,21+,22+/m0/s1 D0B6UU DRUGINKE IKYXUFYHDWVXST-OWHMEISOSA-N D0B6UU DRUGSMIL CN1C(CCCC1C=CC2=CC=CC=C2)CC(C3=CC=CC=C3)O D0B6UU HIGHSTAT Investigative D0B6VI DRUG__ID D0B6VI D0B6VI DRUGTYPE Small molecular drug D0B6VI DRUGINCH 1S/C11H10N2O4S/c14-10-8-6-7(2-3-9(8)12-11(10)15)18(16,17)13-4-1-5-13/h2-3,6H,1,4-5H2,(H,12,14,15) D0B6VI DRUGINKE VEHTUFDNCGHBFH-UHFFFAOYSA-N D0B6VI DRUGSMIL C1CN(C1)S(=O)(=O)C2=CC3=C(C=C2)NC(=O)C3=O D0B6VI HIGHSTAT Investigative D0B6WH DRUG__ID D0B6WH D0B6WH DRUGTYPE Small molecular drug D0B6WH DRUGINCH 1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1/i1T3 D0B6WH DRUGINKE PWVXXGRKLHYWKM-YWMWWHSFSA-N D0B6WH DRUGSMIL CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4 D0B6WH HIGHSTAT Investigative D0B6WX DRUG__ID D0B6WX D0B6WX DRUGTYPE Small molecular drug D0B6WX DRUGINCH 1S/C16H25N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/t4-,5+,7+,8+,9+,10+,11-,14+,15?/m0/s1 D0B6WX DRUGINKE LQEBEXMHBLQMDB-QIXZNPMTSA-N D0B6WX DRUGSMIL CC1C(C(C(C(O1)OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=NC4=C3N=C(NC4=O)N)O)O)O)O)O D0B6WX HIGHSTAT Investigative D0B7EP DRUG__ID D0B7EP D0B7EP DRUGTYPE Small molecular drug D0B7EP DRUGINCH 1S/C20H24O7/c1-10(2)19(23)26-15-8-13(9-21)14(25-5)7-6-11(3)17(22)18-16(15)12(4)20(24)27-18/h8-9,14-18,22H,1,3-4,6-7H2,2,5H3/b13-8+/t14-,15-,16-,17+,18+/m1/s1 D0B7EP DRUGINKE JYJDQGQWAQKPAO-FLTPFCGOSA-N D0B7EP DRUGSMIL CC(=C)C(=O)OC1C=C(C(CCC(=C)C(C2C1C(=C)C(=O)O2)O)OC)C=O D0B7EP HIGHSTAT Investigative D0B7GU DRUG__ID D0B7GU D0B7GU DRUGTYPE Small molecular drug D0B7GU DRUGINCH 1S/C17H21NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,13,16,19-20H,3,5-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1 D0B7GU DRUGINKE IJVCSMSMFSCRME-KBQPJGBKSA-N D0B7GU DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(CC4)O D0B7GU HIGHSTAT Investigative D0B7MW DRUG__ID D0B7MW D0B7MW DRUGTYPE Small molecular drug D0B7MW DRUGINCH 1S/C35H26N4O21S6.6Na/c40-33(38-25-7-9-27(63(49,50)51)23-13-21(61(43,44)45)15-29(31(23)25)65(55,56)57)17-3-1-5-19(11-17)36-35(42)37-20-6-2-4-18(12-20)34(41)39-26-8-10-28(64(52,53)54)24-14-22(62(46,47)48)16-30(32(24)26)66(58,59)60;;;;;;/h1-16H,(H,38,40)(H,39,41)(H2,36,37,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)(H,55,56,57)(H,58,59,60);;;;;;/q;6*+1/p-6 D0B7MW DRUGINKE FMQURVHYTBGYSQ-UHFFFAOYSA-H D0B7MW DRUGSMIL C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(=O)NC3=C4C(=CC(=CC4=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)NC5=C6C(=CC(=CC6=C(C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0B7MW HIGHSTAT Investigative D0B7OW DRUG__ID D0B7OW D0B7OW DRUGTYPE Small molecular drug D0B7OW DRUGINCH 1S/C16H14O5/c1-20-11-6-12(18)16-13(19)8-14(21-15(16)7-11)9-2-4-10(17)5-3-9/h2-7,14,17-18H,8H2,1H3/t14-/m0/s1 D0B7OW DRUGINKE DJOJDHGQRNZXQQ-AWEZNQCLSA-N D0B7OW DRUGSMIL COC1=CC(=C2C(=O)CC(OC2=C1)C3=CC=C(C=C3)O)O D0B7OW HIGHSTAT Investigative D0B7WF DRUG__ID D0B7WF D0B7WF DRUGTYPE Small molecular drug D0B7WF DRUGINCH 1S/C8H8O4/c9-6-1-3-7(4-2-6)12-5-8(10)11/h1-4,9H,5H2,(H,10,11) D0B7WF DRUGINKE PKGWLCZTTHWKIZ-UHFFFAOYSA-N D0B7WF DRUGSMIL C1=CC(=CC=C1O)OCC(=O)O D0B7WF HIGHSTAT Investigative D0B7WO DRUG__ID D0B7WO D0B7WO DRUGTYPE Small molecular drug D0B7WO DRUGINCH 1S/C12H19N2O15P3/c1-2-3-6(27-31(22,23)29-32(24,25)28-30(19,20)21)10-8(16)9(17)11(26-10)14-5-4-7(15)13-12(14)18/h2-6,8-11,16-17H,1H3,(H,22,23)(H,24,25)(H,13,15,18)(H2,19,20,21)/b3-2+/t6?,8-,9-,10+,11?/m0/s1 D0B7WO DRUGINKE XLORWTLPILWCFG-GPJQKZQFSA-N D0B7WO DRUGSMIL CC=CC(C1C(C(C(O1)N2C=CC(=O)NC2=O)O)O)OP(=O)(O)OP(=O)(O)OP(=O)(O)O D0B7WO HIGHSTAT Investigative D0B7ZB DRUG__ID D0B7ZB D0B7ZB DRUGTYPE Small molecular drug D0B7ZB DRUGINCH 1S/C12H12N4/c1-8(2)9-3-5-10(6-4-9)12-11(7-13)14-16-15-12/h3-6,8H,1-2H3,(H,14,15,16) D0B7ZB DRUGINKE WEMPWGDVLUDOBY-UHFFFAOYSA-N D0B7ZB DRUGSMIL CC(C)C1=CC=C(C=C1)C2=NNN=C2C#N D0B7ZB HIGHSTAT Investigative D0B8AN DRUG__ID D0B8AN D0B8AN DRUGTYPE Small molecular drug D0B8AN DRUGINCH 1S/C30H27NO/c1-2-3-8-18-31-21-26(30(32)28-15-9-13-23-11-6-7-14-27(23)28)20-29(31)25-17-16-22-10-4-5-12-24(22)19-25/h4-7,9-17,19-21H,2-3,8,18H2,1H3 D0B8AN DRUGINKE WYOWIOBJNTYRNN-UHFFFAOYSA-N D0B8AN DRUGSMIL CCCCCN1C=C(C=C1C2=CC3=CC=CC=C3C=C2)C(=O)C4=CC=CC5=CC=CC=C54 D0B8AN HIGHSTAT Investigative D0B8AQ DRUG__ID D0B8AQ D0B8AQ DRUGTYPE Small molecular drug D0B8AQ DRUGINCH 1S/C11H17NO/c1-11(13)7-3-2-4-8-12-9-5-6-10-12/h3,5-10H2,1H3 D0B8AQ DRUGINKE DBUFGNBWZXFABF-UHFFFAOYSA-N D0B8AQ DRUGSMIL CC(=O)CCC#CCN1CCCC1 D0B8AQ HIGHSTAT Investigative D0B8BC DRUG__ID D0B8BC D0B8BC DRUGTYPE Small molecular drug D0B8BC DRUGINCH 1S/C13H14ClN3/c14-11-2-3-12-10(9-11)1-4-13(16-12)17-7-5-15-6-8-17/h1-4,9,15H,5-8H2 D0B8BC DRUGINKE GSFXEINORRSYJW-UHFFFAOYSA-N D0B8BC DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C2)C=C(C=C3)Cl D0B8BC HIGHSTAT Investigative D0B8CU DRUG__ID D0B8CU D0B8CU DRUGTYPE Small molecular drug D0B8CU DRUGINCH 1S/C13H14N2O5S3/c1-20-11-4-2-3-10(8-11)15-6-5-9-7-12(22(14,16)17)21-13(9)23(15,18)19/h2-4,7-8H,5-6H2,1H3,(H2,14,16,17) D0B8CU DRUGINKE ICIXQGGQPKFQRL-UHFFFAOYSA-N D0B8CU DRUGSMIL COC1=CC=CC(=C1)N2CCC3=C(S2(=O)=O)SC(=C3)S(=O)(=O)N D0B8CU HIGHSTAT Investigative D0B8DE DRUG__ID D0B8DE D0B8DE DRUGTYPE Small molecular drug D0B8DE DRUGINCH 1S/C14H10N2O2/c17-13-6-10-5-11(9-1-3-15-4-2-9)8-16-12(10)7-14(13)18/h1-8,17-18H D0B8DE DRUGINKE PWPSIWFFYVGDHO-UHFFFAOYSA-N D0B8DE DRUGSMIL C1=CN=CC=C1C2=CN=C3C=C(C(=CC3=C2)O)O D0B8DE HIGHSTAT Investigative D0B8DR DRUG__ID D0B8DR D0B8DR DRUGTYPE Small molecular drug D0B8DR DRUGINCH 1S/C19H18O5/c1-3-22-13-10-14(20)16-15(11-13)24-18(12-8-6-5-7-9-12)19(17(16)21)23-4-2/h5-11,20H,3-4H2,1-2H3 D0B8DR DRUGINKE ZPEWNDIPSPULBP-UHFFFAOYSA-N D0B8DR DRUGSMIL CCOC1=CC(=C2C(=C1)OC(=C(C2=O)OCC)C3=CC=CC=C3)O D0B8DR HIGHSTAT Investigative D0B8EP DRUG__ID D0B8EP D0B8EP DRUGTYPE Small molecular drug D0B8EP DRUGINCH 1S/C20H15Cl3N2O/c21-15-5-1-13(2-6-15)19(14-3-7-16(22)8-4-14)25-20(26)24-18-11-9-17(23)10-12-18/h1-12,19H,(H2,24,25,26) D0B8EP DRUGINKE IQLQNNIZPSPERD-UHFFFAOYSA-N D0B8EP DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)NC(=O)NC3=CC=C(C=C3)Cl)Cl D0B8EP HIGHSTAT Investigative D0B8FZ DRUG__ID D0B8FZ D0B8FZ DRUGTYPE Small molecular drug D0B8FZ DRUGINCH 1S/C13H15N3S2/c17-12(16-13-15-9-10-18-13)14-8-4-7-11-5-2-1-3-6-11/h1-3,5-6,9-10H,4,7-8H2,(H2,14,15,16,17) D0B8FZ DRUGINKE AYXFDRTXLUHLOL-UHFFFAOYSA-N D0B8FZ DRUGSMIL C1=CC=C(C=C1)CCCNC(=S)NC2=NC=CS2 D0B8FZ HIGHSTAT Investigative D0B8GI DRUG__ID D0B8GI D0B8GI DRUGTYPE Small molecular drug D0B8GI DRUGINCH 1S/C16H22N2O2/c1-2-3-4-5-9-12-16(13-10-7-6-8-11-13)14(19)17-15(20)18-16/h6-8,10-11H,2-5,9,12H2,1H3,(H2,17,18,19,20) D0B8GI DRUGINKE UKJJKBMGJSMVEV-UHFFFAOYSA-N D0B8GI DRUGSMIL CCCCCCCC1(C(=O)NC(=O)N1)C2=CC=CC=C2 D0B8GI HIGHSTAT Investigative D0B8GR DRUG__ID D0B8GR D0B8GR DRUGTYPE Small molecular drug D0B8GR DRUGINCH 1S/C37H46N10O5/c1-23(48)44-32(20-28-21-41-22-43-28)36(52)47-31(18-24-9-4-3-5-10-24)35(51)45-29(13-8-16-42-37(38)39)34(50)46-30(33(49)40-2)19-25-14-15-26-11-6-7-12-27(26)17-25/h3-7,9-12,14-15,17,21-22,29-32H,8,13,16,18-20H2,1-2H3,(H,40,49)(H,41,43)(H,44,48)(H,45,51)(H,46,50)(H,47,52)(H4,38,39,42)/t29-,30-,31+,32-/m0/s1 D0B8GR DRUGINKE KXPKJVIQPPHENQ-IHZBLBIESA-N D0B8GR DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NC D0B8GR HIGHSTAT Investigative D0B8GY DRUG__ID D0B8GY D0B8GY DRUGTYPE Small molecular drug D0B8GY DRUGINCH 1S/C20H19N3O/c1-13-4-8-15(9-5-13)18-19(16-10-6-14(2)7-11-16)23-17(12-22-18)20(24)21-3/h4-12H,1-3H3,(H,21,24) D0B8GY DRUGINKE PRXVUGFMELNVTA-UHFFFAOYSA-N D0B8GY DRUGSMIL CC1=CC=C(C=C1)C2=NC=C(N=C2C3=CC=C(C=C3)C)C(=O)NC D0B8GY HIGHSTAT Investigative D0B8HU DRUG__ID D0B8HU D0B8HU DRUGTYPE Small molecular drug D0B8HU DRUGINCH 1S/C12H9NO3/c1-2-7-13-11(15)9-6-4-3-5-8(9)10(14)12(13)16/h2-6H,1,7H2 D0B8HU DRUGINKE RFPACNBGGYBCGT-UHFFFAOYSA-N D0B8HU DRUGSMIL C=CCN1C(=O)C2=CC=CC=C2C(=O)C1=O D0B8HU HIGHSTAT Investigative D0B8JD DRUG__ID D0B8JD D0B8JD DRUGTYPE Small molecular drug D0B8JD DRUGINCH 1S/C8H12NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2,10-11H,3-4H2,1H3,(H2,12,13,14) D0B8JD DRUGINKE WHOMFKWHIQZTHY-UHFFFAOYSA-N D0B8JD DRUGSMIL CC1=NC=C(C(=C1O)CO)COP(=O)(O)O D0B8JD HIGHSTAT Investigative D0B8MY DRUG__ID D0B8MY D0B8MY DRUGTYPE Small molecular drug D0B8MY DRUGINCH 1S/C52H72N2O4/c55-49(57-41-23-21-39-31-47-43-17-7-9-25-51(43,45(39)33-41)27-29-53(47)35-37-13-11-14-37)19-5-3-1-2-4-6-20-50(56)58-42-24-22-40-32-48-44-18-8-10-26-52(44,46(40)34-42)28-30-54(48)36-38-15-12-16-38/h21-24,33-34,37-38,43-44,47-48H,1-20,25-32,35-36H2/t43-,44-,47+,48+,51+,52+/m0/s1 D0B8MY DRUGINKE LWMXWHIOMHIBJP-SPKNWQAQSA-N D0B8MY DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)CCCCCCCCC(=O)OC5=CC6=C(CC7C8C6(CCCC8)CCN7CC9CCC9)C=C5)CC1CCC1 D0B8MY HIGHSTAT Investigative D0B8PD DRUG__ID D0B8PD D0B8PD DRUGTYPE Small molecular drug D0B8PD DRUGINCH 1S/C13H15ClN2O2/c1-8(17)15-4-3-9-7-16-12-6-11(14)13(18-2)5-10(9)12/h5-7,16H,3-4H2,1-2H3,(H,15,17) D0B8PD DRUGINKE LUINDDOUWHRIPW-UHFFFAOYSA-N D0B8PD DRUGSMIL CC(=O)NCCC1=CNC2=CC(=C(C=C21)OC)Cl D0B8PD HIGHSTAT Investigative D0B8PE DRUG__ID D0B8PE D0B8PE DRUGTYPE Small molecular drug D0B8PE DRUGINCH 1S/C16H14O4/c1-19-12-5-6-13-14(18)9-15(20-16(13)8-12)10-3-2-4-11(17)7-10/h2-8,15,17H,9H2,1H3 D0B8PE DRUGINKE YETISVQJYRETIF-UHFFFAOYSA-N D0B8PE DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC(=CC=C3)O D0B8PE HIGHSTAT Investigative D0B8RC DRUG__ID D0B8RC D0B8RC DRUGTYPE Small molecular drug D0B8RC DRUGINCH 1S/C16H24N2O3/c1-12-9-10-13(2)14(11-12)17-15(19)7-5-3-4-6-8-16(20)18-21/h9-11,21H,3-8H2,1-2H3,(H,17,19)(H,18,20) D0B8RC DRUGINKE QLSOBWNGPFAWKY-UHFFFAOYSA-N D0B8RC DRUGSMIL CC1=CC(=C(C=C1)C)NC(=O)CCCCCCC(=O)NO D0B8RC HIGHSTAT Investigative D0B8RN DRUG__ID D0B8RN D0B8RN DRUGTYPE Small molecular drug D0B8RN DRUGINCH 1S/C19H22O7/c1-10(2)17(22)25-13-7-12(8-20)5-4-6-19(9-24-19)16(21)15-14(13)11(3)18(23)26-15/h7-8,13-16,21H,1,3-6,9H2,2H3/b12-7+/t13-,14-,15+,16-,19-/m1/s1 D0B8RN DRUGINKE OGCMEEKAZKEDQP-USTFYIHISA-N D0B8RN DRUGSMIL CC(=C)C(=O)OC1C=C(CCCC2(CO2)C(C3C1C(=C)C(=O)O3)O)C=O D0B8RN HIGHSTAT Investigative D0B8RQ DRUG__ID D0B8RQ D0B8RQ DRUGTYPE Small molecular drug D0B8RQ DRUGINCH 1S/C21H21N3O/c1-3-15(2)21(25)24-19-14-18(16-10-6-4-7-11-16)22-20(23-19)17-12-8-5-9-13-17/h4-15H,3H2,1-2H3,(H,22,23,24,25) D0B8RQ DRUGINKE OWPSSUJQRJLQHE-UHFFFAOYSA-N D0B8RQ DRUGSMIL CCC(C)C(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D0B8RQ HIGHSTAT Investigative D0B8SE DRUG__ID D0B8SE D0B8SE DRUGTYPE Small molecular drug D0B8SE DRUGINCH 1S/C10H22NO2P/c11-7-4-8-14(12,13)9-10-5-2-1-3-6-10/h10H,1-9,11H2,(H,12,13) D0B8SE DRUGINKE XOESDNIUAWGCLU-UHFFFAOYSA-N D0B8SE DRUGSMIL C1CCC(CC1)CP(=O)(CCCN)O D0B8SE HIGHSTAT Investigative D0B8SS DRUG__ID D0B8SS D0B8SS DRUGTYPE Small molecular drug D0B8SS DRUGINCH 1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m1/s1 D0B8SS DRUGINKE IHNKQIMGVNPMTC-RUZDIDTESA-N D0B8SS DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O D0B8SS HIGHSTAT Investigative D0B8TJ DRUG__ID D0B8TJ D0B8TJ DRUGTYPE Small molecular drug D0B8TJ DRUGINCH 1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20) D0B8TJ DRUGINKE XNYZHCFCZNMTFY-UHFFFAOYSA-N D0B8TJ DRUGSMIL C1=CC(=CC=C1C(=N)N)NN=NC2=CC=C(C=C2)C(=N)N D0B8TJ HIGHSTAT Investigative D0B8VW DRUG__ID D0B8VW D0B8VW DRUGTYPE Small molecular drug D0B8VW DRUGINCH 1S/C37H49N11O6/c1-48-30(20-23-10-13-24-6-2-3-7-25(24)18-23)35(54)46-28(9-5-17-43-37(40)41)33(52)45-27(8-4-16-42-36(38)39)34(53)47-29(32(51)44-21-31(48)50)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,51)(H,45,52)(H,46,54)(H,47,53)(H4,38,39,42)(H4,40,41,43)/t27-,28-,29+,30-/m0/s1 D0B8VW DRUGINKE XUKFERKCRCTLBJ-ZXYZSCNASA-N D0B8VW DRUGSMIL CN1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC1=O)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D0B8VW HIGHSTAT Investigative D0B8WQ DRUG__ID D0B8WQ D0B8WQ DRUGTYPE Small molecular drug D0B8WQ DRUGINCH 1S/C27H34N4O5/c28-15-7-6-12-22(30-23(26(33)34)14-13-18-8-2-1-3-9-18)25(32)31-24(27(35)36)16-19-17-29-21-11-5-4-10-20(19)21/h1-5,8-11,17,22-24,29-30H,6-7,12-16,28H2,(H,31,32)(H,33,34)(H,35,36)/t22-,23-,24+/m0/s1 D0B8WQ DRUGINKE JXNGDSIPMBNTNL-KMDXXIMOSA-N D0B8WQ DRUGSMIL C1=CC=C(C=C1)CCC(C(=O)O)NC(CCCCN)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O D0B8WQ HIGHSTAT Investigative D0B8YX DRUG__ID D0B8YX D0B8YX DRUGTYPE Small molecular drug D0B8YX DRUGINCH 1S/C15H12O2/c1-11-7-9-13(10-8-11)15(17)14(16)12-5-3-2-4-6-12/h2-10H,1H3 D0B8YX DRUGINKE QKFICTUTRIMBEX-UHFFFAOYSA-N D0B8YX DRUGSMIL CC1=CC=C(C=C1)C(=O)C(=O)C2=CC=CC=C2 D0B8YX HIGHSTAT Investigative D0B9BU DRUG__ID D0B9BU D0B9BU DRUGTYPE Small molecular drug D0B9BU DRUGINCH 1S/C17H14ClF2IN2O2/c18-12-7-10(21)3-6-14(12)22-16-11(4-5-13(19)15(16)20)17(24)23-25-8-9-1-2-9/h3-7,9,22H,1-2,8H2,(H,23,24) D0B9BU DRUGINKE GFMMXOIFOQCCGU-UHFFFAOYSA-N D0B9BU DRUGSMIL C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl D0B9BU HIGHSTAT Investigative D0B9CC DRUG__ID D0B9CC D0B9CC DRUGTYPE Small molecular drug D0B9CC DRUGINCH 1S/C14H14N4O2/c1-17-12-11(15-9-16-12)13(19)18(14(17)20)8-7-10-5-3-2-4-6-10/h2-6,9H,7-8H2,1H3,(H,15,16) D0B9CC DRUGINKE FVUNKKIGHICYFX-UHFFFAOYSA-N D0B9CC DRUGSMIL CN1C2=C(C(=O)N(C1=O)CCC3=CC=CC=C3)NC=N2 D0B9CC HIGHSTAT Investigative D0B9DR DRUG__ID D0B9DR D0B9DR DRUGTYPE Small molecular drug D0B9DR DRUGINCH 1S/C16H19IN2/c17-16-7-4-10-19(16)15-8-11-18(12-9-15)13-14-5-2-1-3-6-14/h1-7,10,15H,8-9,11-13H2 D0B9DR DRUGINKE LZMIVAWAFVXKJL-UHFFFAOYSA-N D0B9DR DRUGSMIL C1CN(CCC1N2C=CC=C2I)CC3=CC=CC=C3 D0B9DR HIGHSTAT Investigative D0B9EV DRUG__ID D0B9EV D0B9EV DRUGTYPE Small molecular drug D0B9EV DRUGINCH 1S/C17H20NO6P/c19-17(18-20)16(25(21,22)23)11-5-7-13-6-4-10-15(12-13)24-14-8-2-1-3-9-14/h1-4,6,8-10,12,16,20H,5,7,11H2,(H,18,19)(H2,21,22,23) D0B9EV DRUGINKE HGDWHTASNMRJMP-UHFFFAOYSA-N D0B9EV DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CCCC(C(=O)NO)P(=O)(O)O D0B9EV HIGHSTAT Investigative D0B9EZ DRUG__ID D0B9EZ D0B9EZ DRUGTYPE Small molecular drug D0B9EZ DRUGINCH 1S/C18H17NO2/c20-16-12-17(19-10-4-1-5-11-19)21-18-14-7-3-2-6-13(14)8-9-15(16)18/h2-3,6-9,12H,1,4-5,10-11H2 D0B9EZ DRUGINKE MAIHLQWUOLIOEP-UHFFFAOYSA-N D0B9EZ DRUGSMIL C1CCN(CC1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0B9EZ HIGHSTAT Investigative D0B9FP DRUG__ID D0B9FP D0B9FP DRUGTYPE Small molecular drug D0B9FP DRUGINCH 1S/C14H11ClN2O5/c1-8(9-2-4-10(15)5-3-9)12-6-11(16(19)20)7-13(14(12)18)17(21)22/h2-8,18H,1H3/t8-/m1/s1 D0B9FP DRUGINKE MOZUMFSUQQHSCO-MRVPVSSYSA-N D0B9FP DRUGSMIL CC(C1=CC=C(C=C1)Cl)C2=C(C(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])O D0B9FP HIGHSTAT Investigative D0B9HX DRUG__ID D0B9HX D0B9HX DRUGTYPE Small molecular drug D0B9HX DRUGINCH 1S/C21H28O3/c1-3-24-12-14-11-19-18-6-4-13-10-15(22)5-7-16(13)17(18)8-9-21(19,2)20(14)23/h5,7,10,14,17-19,22H,3-4,6,8-9,11-12H2,1-2H3/t14-,17?,18?,19?,21+/m1/s1 D0B9HX DRUGINKE UOFWRCJSMZKWLE-NCHCSYJDSA-N D0B9HX DRUGSMIL CCOCC1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D0B9HX HIGHSTAT Investigative D0B9IA DRUG__ID D0B9IA D0B9IA DRUGTYPE Small molecular drug D0B9IA DRUGINCH 1S/C20H22O7/c1-7-10-9(2)8-11-12(15(10)21)17(23)14-13(16(11)22)19(3,4)27-20(14,26-6)18(24)25-5/h8,21H,7H2,1-6H3 D0B9IA DRUGINKE DSYKJFFQHNSURC-UHFFFAOYSA-N D0B9IA DRUGSMIL CCC1=C(C2=C(C=C1C)C(=O)C3=C(C2=O)C(OC3(C)C)(C(=O)OC)OC)O D0B9IA HIGHSTAT Investigative D0B9IX DRUG__ID D0B9IX D0B9IX DRUGTYPE Small molecular drug D0B9IX DRUGINCH 1S/C10H11N3S/c11-10(14)13-12-8-4-7-9-5-2-1-3-6-9/h1-8H,(H3,11,13,14)/b7-4+,12-8- D0B9IX DRUGINKE SHUQFXIRXYXNOZ-JHLWKMQHSA-N D0B9IX DRUGSMIL C1=CC=C(C=C1)C=CC=NNC(=S)N D0B9IX HIGHSTAT Investigative D0B9LI DRUG__ID D0B9LI D0B9LI DRUGTYPE Small molecular drug D0B9LI DRUGINCH 1S/C20H24N2O2/c1-24-20(23)19(16-9-3-2-4-10-16)18-12-6-8-14-22(18)15-17-11-5-7-13-21-17/h2-5,7,9-11,13,18-19H,6,8,12,14-15H2,1H3/t18-,19-/m1/s1 D0B9LI DRUGINKE AZQUBJDTVAIXBC-RTBURBONSA-N D0B9LI DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=CC=N2)C3=CC=CC=C3 D0B9LI HIGHSTAT Investigative D0B9MY DRUG__ID D0B9MY D0B9MY DRUGTYPE Small molecular drug D0B9MY DRUGINCH 1S/C10H9N7/c11-7-6-9(17-10(12)15-7)16-8(14-6)5-1-3-13-4-2-5/h1-4H,(H5,11,12,14,15,16,17) D0B9MY DRUGINKE FRFATUHEQSVWHE-UHFFFAOYSA-N D0B9MY DRUGSMIL C1=CN=CC=C1C2=NC3=NC(=NC(=C3N2)N)N D0B9MY HIGHSTAT Investigative D0B9NH DRUG__ID D0B9NH D0B9NH DRUGTYPE Small molecular drug D0B9NH DRUGINCH 1S/C42H57N11O9/c1-2-3-13-29-37(58)51-31(17-19-35(55)56)39(60)52-32(21-24-10-5-4-6-11-24)40(61)50-30(15-9-20-46-42(44)45)38(59)53-33(22-25-23-47-27-14-8-7-12-26(25)27)41(62)49-28(36(43)57)16-18-34(54)48-29/h4-8,10-12,14,23,28-33,47H,2-3,9,13,15-22H2,1H3,(H2,43,57)(H,48,54)(H,49,62)(H,50,61)(H,51,58)(H,52,60)(H,53,59)(H,55,56)(H4,44,45,46)/t28-,29-,30-,31+,32+,33-/m0/s1 D0B9NH DRUGINKE ZIKRFHYQHLHVCP-HSPZZYPGSA-N D0B9NH DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CCC(=O)O D0B9NH HIGHSTAT Investigative D0B9RI DRUG__ID D0B9RI D0B9RI DRUGTYPE Small molecular drug D0B9RI DRUGINCH 1S/C17H14O3/c1-19-15-8-5-9-16-14(15)11-13(17(18)20-16)10-12-6-3-2-4-7-12/h2-9,11H,10H2,1H3 D0B9RI DRUGINKE XJSXZFXFKVCTQS-UHFFFAOYSA-N D0B9RI DRUGSMIL COC1=CC=CC2=C1C=C(C(=O)O2)CC3=CC=CC=C3 D0B9RI HIGHSTAT Investigative D0B9SJ DRUG__ID D0B9SJ D0B9SJ DRUGTYPE Small molecular drug D0B9SJ DRUGINCH 1S/C14H11NO5S2/c1-20-14(19)13-8(15-11(16)4-5-12(17)18)7-10(22-13)9-3-2-6-21-9/h2-7H,1H3,(H,15,16)(H,17,18)/b5-4+ D0B9SJ DRUGINKE GJODSFZNKNHKML-SNAWJCMRSA-N D0B9SJ DRUGSMIL COC(=O)C1=C(C=C(S1)C2=CC=CS2)NC(=O)C=CC(=O)O D0B9SJ HIGHSTAT Investigative D0B9SS DRUG__ID D0B9SS D0B9SS DRUGTYPE Small molecular drug D0B9SS DRUGINCH 1S/C17H15NO/c1-12-6-7-13-8-9-15(11-17(13)18-12)14-4-3-5-16(10-14)19-2/h3-11H,1-2H3 D0B9SS DRUGINKE JQAHRDJGLFSZFY-UHFFFAOYSA-N D0B9SS DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC=C3)OC D0B9SS HIGHSTAT Investigative D0B9TN DRUG__ID D0B9TN D0B9TN DRUGTYPE Small molecular drug D0B9TN DRUGINCH 1S/C10H14BrNS/c1-12(2)7-8-13-10-6-4-3-5-9(10)11/h3-6H,7-8H2,1-2H3 D0B9TN DRUGINKE WXAWOWHEHSIUMN-UHFFFAOYSA-N D0B9TN DRUGSMIL CN(C)CCSC1=CC=CC=C1Br D0B9TN HIGHSTAT Investigative D0B9TV DRUG__ID D0B9TV D0B9TV DRUGTYPE Small molecular drug D0B9TV DRUGINCH 1S/C18H21N/c1-19(2)16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,12-13H2,1-2H3/t16-,18+/m1/s1 D0B9TV DRUGINKE DXJUCAUQIHNOAF-AEFFLSMTSA-N D0B9TV DRUGSMIL CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3 D0B9TV HIGHSTAT Investigative D0B9UU DRUG__ID D0B9UU D0B9UU DRUGTYPE Small molecular drug D0B9UU DRUGINCH 1S/C11H8Cl3FN4/c12-4-1-5(9(14)6(13)2-4)8-7(3-15)18-11(17)19-10(8)16/h1-2H,3H2,(H4,16,17,18,19) D0B9UU DRUGINKE QEDNOUAODRFJQN-UHFFFAOYSA-N D0B9UU DRUGSMIL C1=C(C=C(C(=C1C2=C(N=C(N=C2N)N)CF)Cl)Cl)Cl D0B9UU HIGHSTAT Investigative D0B9UW DRUG__ID D0B9UW D0B9UW DRUGTYPE Small molecular drug D0B9UW DRUGINCH 1S/C21H21N3O4/c22-19(21(23)26)9-10-20(25)24-16-3-7-18(8-4-16)28-17-5-1-14(2-6-17)15-11-12-27-13-15/h1-8,11-13,19H,9-10,22H2,(H2,23,26)(H,24,25)/t19-/m0/s1 D0B9UW DRUGINKE LYOSKDSEWRJQAH-IBGZPJMESA-N D0B9UW DRUGSMIL C1=CC(=CC=C1C2=COC=C2)OC3=CC=C(C=C3)NC(=O)CCC(C(=O)N)N D0B9UW HIGHSTAT Investigative D0B9VV DRUG__ID D0B9VV D0B9VV DRUGTYPE Small molecular drug D0B9VV DRUGINCH 1S/C25H36O4/c1-16-6-5-7-21-24(16,3)12-10-17(2)25(21,4)13-11-18-8-9-20(28-15-18)19-14-22(26)29-23(19)27/h8,14,17,20-21,23,27H,1,5-7,9-13,15H2,2-4H3/t17-,20?,21-,23?,24-,25-/m1/s1 D0B9VV DRUGINKE CVAZWHZRZNYCOV-ILKJNQADSA-N D0B9VV DRUGSMIL CC1CCC2(C(C1(C)CCC3=CCC(OC3)C4=CC(=O)OC4O)CCCC2=C)C D0B9VV HIGHSTAT Investigative D0B9XL DRUG__ID D0B9XL D0B9XL DRUGTYPE Small molecular drug D0B9XL DRUGINCH 1S/C16H16N2S/c1-2-16(18-9-8-17-12-18)14-5-3-13(4-6-14)15-7-10-19-11-15/h3-12,16H,2H2,1H3 D0B9XL DRUGINKE JCRCIQARESXRFA-UHFFFAOYSA-N D0B9XL DRUGSMIL CCC(C1=CC=C(C=C1)C2=CSC=C2)N3C=CN=C3 D0B9XL HIGHSTAT Investigative D0B9YO DRUG__ID D0B9YO D0B9YO DRUGTYPE Small molecular drug D0B9YO DRUGINCH 1S/C12H16O2S/c13-12(14)11(7-4-8-15)9-10-5-2-1-3-6-10/h1-3,5-6,11,15H,4,7-9H2,(H,13,14) D0B9YO DRUGINKE QTCRNIDSGWSKLN-UHFFFAOYSA-N D0B9YO DRUGSMIL C1=CC=C(C=C1)CC(CCCS)C(=O)O D0B9YO HIGHSTAT Investigative D0B9YR DRUG__ID D0B9YR D0B9YR DRUGTYPE Small molecular drug D0B9YR DRUGINCH 1S/C13H13N5O/c1-2-19-10-4-6-15-12-11(10)8(7-17-12)9-3-5-16-13(14)18-9/h3-7H,2H2,1H3,(H,15,17)(H2,14,16,18) D0B9YR DRUGINKE CJJMNECGBUPMAV-UHFFFAOYSA-N D0B9YR DRUGSMIL CCOC1=C2C(=CNC2=NC=C1)C3=NC(=NC=C3)N D0B9YR HIGHSTAT Investigative D0B9ZE DRUG__ID D0B9ZE D0B9ZE DRUGTYPE Small molecular drug D0B9ZE DRUGINCH 1S/C17H29N3O9S2/c1-3-8(2)11(19-14(21)13(30)10(18)5-7-31(27,28)29)15(22)20-6-4-9(16(23)24)12(20)17(25)26/h8-13,30H,3-7,18H2,1-2H3,(H,19,21)(H,23,24)(H,25,26)(H,27,28,29)/t8-,9?,10-,11+,12+,13-/m1/s1 D0B9ZE DRUGINKE HUWSZNZAROKDRZ-RRLWZMAJSA-N D0B9ZE DRUGSMIL CCC(C)C(C(=O)N1CCC(C1C(=O)O)C(=O)O)NC(=O)C(C(CCS(=O)(=O)O)N)S D0B9ZE HIGHSTAT Investigative D0B9ZK DRUG__ID D0B9ZK D0B9ZK DRUGTYPE Small molecular drug D0B9ZK DRUGINCH 1S/C16H17NO/c1-18-13-6-7-15-12(9-13)8-11-4-2-3-5-14(11)16(15)10-17/h2-7,9,16H,8,10,17H2,1H3 D0B9ZK DRUGINKE DTEPCKRLYVEVEM-UHFFFAOYSA-N D0B9ZK DRUGSMIL COC1=CC2=C(C=C1)C(C3=CC=CC=C3C2)CN D0B9ZK HIGHSTAT Investigative D0B9ZZ DRUG__ID D0B9ZZ D0B9ZZ DRUGTYPE Small molecular drug D0B9ZZ DRUGINCH 1S/C10H25NO6P2/c1-2-3-4-5-6-7-8-11-9-10(18(12,13)14)19(15,16)17/h10-11H,2-9H2,1H3,(H2,12,13,14)(H2,15,16,17) D0B9ZZ DRUGINKE NTUHKTMOLKDMDP-UHFFFAOYSA-N D0B9ZZ DRUGSMIL CCCCCCCCNCC(P(=O)(O)O)P(=O)(O)O D0B9ZZ HIGHSTAT Investigative D0BA7Q DRUG__ID D0BA7Q D0BA7Q DRUGTYPE Small molecular drug D0BA7Q DRUGINCH 1S/C12H10N4O2/c1-16-11(17)8-10(15-12(16)18)14-9(13-8)7-5-3-2-4-6-7/h2-6H,1H3,(H,13,14)(H,15,18) D0BA7Q DRUGINKE UOOOWRVLSKCKGJ-UHFFFAOYSA-N D0BA7Q DRUGSMIL CN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=CC=C3 D0BA7Q HIGHSTAT Investigative D0BB0O DRUG__ID D0BB0O D0BB0O DRUGTYPE Small molecular drug D0BB0O DRUGINCH 1S/C11H17N5O10P2S/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1 D0BB0O DRUGINKE WLMZTKAZJUWXCB-KQYNXXCUSA-N D0BB0O DRUGSMIL CSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N D0BB0O HIGHSTAT Investigative D0BB2U DRUG__ID D0BB2U D0BB2U DRUGTYPE Small molecular drug D0BB2U DRUGINCH 1S/C15H10O4/c16-13(10-4-2-1-3-5-10)14(17)11-6-8-12(9-7-11)15(18)19/h1-9H,(H,18,19) D0BB2U DRUGINKE MWJHDSAAGSURCA-UHFFFAOYSA-N D0BB2U DRUGSMIL C1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)C(=O)O D0BB2U HIGHSTAT Investigative D0BB7F DRUG__ID D0BB7F D0BB7F DRUGTYPE Small molecular drug D0BB7F DRUGINCH 1S/C20H20N2O/c1-2-3-5-15-8-10-16(11-9-15)20(23)22-19-7-4-6-17-14-21-13-12-18(17)19/h4,6-14H,2-3,5H2,1H3,(H,22,23) D0BB7F DRUGINKE FBFHYVLRXNNMSE-UHFFFAOYSA-N D0BB7F DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C=CN=C3 D0BB7F HIGHSTAT Investigative D0BC2N DRUG__ID D0BC2N D0BC2N DRUGTYPE Small molecular drug D0BC2N DRUGINCH 1S/C13H21N3O6/c14-7-10(17)16-6-2-1-3-9(16)12(20)15-8(13(21)22)4-5-11(18)19/h8-9H,1-7,14H2,(H,15,20)(H,18,19)(H,21,22)/t8-,9-/m0/s1 D0BC2N DRUGINKE NEMPLRJUKFPLSV-IUCAKERBSA-N D0BC2N DRUGSMIL C1CCN(C(C1)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)CN D0BC2N HIGHSTAT Investigative D0BC7P DRUG__ID D0BC7P D0BC7P DRUGTYPE Small molecular drug D0BC7P DRUGINCH 1S/C16H11N3S/c17-10-13-12(15-7-4-8-20-15)9-14(19-16(13)18)11-5-2-1-3-6-11/h1-9H,(H2,18,19) D0BC7P DRUGINKE WFWGQLLRRFDTHC-UHFFFAOYSA-N D0BC7P DRUGSMIL C1=CC=C(C=C1)C2=NC(=C(C(=C2)C3=CC=CS3)C#N)N D0BC7P HIGHSTAT Investigative D0BD0K DRUG__ID D0BD0K D0BD0K DRUGTYPE Small molecular drug D0BD0K DRUGINCH 1S/C12H12N4O2S/c13-9-1-3-10(4-2-9)15-16-11-5-7-12(8-6-11)19(14,17)18/h1-8H,13H2,(H2,14,17,18) D0BD0K DRUGINKE JSHXITVMUADQEA-UHFFFAOYSA-N D0BD0K DRUGSMIL C1=CC(=CC=C1N)N=NC2=CC=C(C=C2)S(=O)(=O)N D0BD0K HIGHSTAT Investigative D0BD3G DRUG__ID D0BD3G D0BD3G DRUGTYPE Small molecular drug D0BD3G DRUGINCH 1S/C18H19BrClNO2/c19-16-3-6-18(23-13-14-1-4-17(20)5-2-14)15(11-16)12-21-7-9-22-10-8-21/h1-6,11H,7-10,12-13H2 D0BD3G DRUGINKE JUKUHNUKMFGLIK-UHFFFAOYSA-N D0BD3G DRUGSMIL C1COCCN1CC2=C(C=CC(=C2)Br)OCC3=CC=C(C=C3)Cl D0BD3G HIGHSTAT Investigative D0BD6A DRUG__ID D0BD6A D0BD6A DRUGTYPE Small molecular drug D0BD6A DRUGINCH 1S/C30H37N5O2/c1-23-11-19-34(37)24(2)28(23)29(36)32-20-14-30(3,15-21-32)33-17-12-26(13-18-33)35(25-8-5-4-6-9-25)27-10-7-16-31-22-27/h4-11,16,19,22,26H,12-15,17-18,20-21H2,1-3H3 D0BD6A DRUGINKE DDVVRHNNOPQPGB-UHFFFAOYSA-N D0BD6A DRUGSMIL CC1=C(C(=[N+](C=C1)[O-])C)C(=O)N2CCC(CC2)(C)N3CCC(CC3)N(C4=CC=CC=C4)C5=CN=CC=C5 D0BD6A HIGHSTAT Investigative D0BE0S DRUG__ID D0BE0S D0BE0S DRUGTYPE Small molecular drug D0BE0S DRUGINCH 1S/C13H15N/c1-10(14)9-12-7-4-6-11-5-2-3-8-13(11)12/h2-8,10H,9,14H2,1H3 D0BE0S DRUGINKE ODTJDLMNBKMVGR-UHFFFAOYSA-N D0BE0S DRUGSMIL CC(CC1=CC=CC2=CC=CC=C21)N D0BE0S HIGHSTAT Investigative D0BF3Y DRUG__ID D0BF3Y D0BF3Y DRUGTYPE Small molecular drug D0BF3Y DRUGINCH 1S/C18H13FO2/c19-17-9-8-15(11-18(17)21)13-6-4-12(5-7-13)14-2-1-3-16(20)10-14/h1-11,20-21H D0BF3Y DRUGINKE MCDQJOWWXZILHP-UHFFFAOYSA-N D0BF3Y DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(C=C2)C3=CC(=C(C=C3)F)O D0BF3Y HIGHSTAT Investigative D0BG5H DRUG__ID D0BG5H D0BG5H DRUGTYPE Small molecular drug D0BG5H DRUGINCH 1S/C18H28N2O3S.ClH/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18;/h2,5-6,14-16,21H,3-4,7-13H2,1H3;1H/t16-;/m1./s1 D0BG5H DRUGINKE XQCJOYZLWFNDIO-PKLMIRHRSA-N D0BG5H DRUGSMIL CC1CCN(CC1)CCC2CCCN2S(=O)(=O)C3=CC=CC(=C3)O.Cl D0BG5H HIGHSTAT Investigative D0BH2T DRUG__ID D0BH2T D0BH2T DRUGTYPE Small molecular drug D0BH2T DRUGINCH 1S/C15H12O5/c16-10-3-1-9(14(19)7-10)2-6-13(18)12-5-4-11(17)8-15(12)20/h1-8,16-17,19-20H/b6-2+ D0BH2T DRUGINKE ZWTDXYUDJYDHJR-QHHAFSJGSA-N D0BH2T DRUGSMIL C1=CC(=C(C=C1O)O)C=CC(=O)C2=C(C=C(C=C2)O)O D0BH2T HIGHSTAT Investigative D0BH6B DRUG__ID D0BH6B D0BH6B DRUGTYPE Small molecular drug D0BH6B DRUGINCH 1S/C22H20O11/c1-30-21(29)20-18(27)17(26)19(28)22(33-20)31-11-6-12(24)16-13(25)8-14(32-15(16)7-11)9-2-4-10(23)5-3-9/h2-8,17-20,22-24,26-28H,1H3/t17-,18-,19+,20-,22+/m0/s1 D0BH6B DRUGINKE XXKIWCKZQFBXIR-SXFAUFNYSA-N D0BH6B DRUGSMIL COC(=O)C1C(C(C(C(O1)OC2=CC(=C3C(=C2)OC(=CC3=O)C4=CC=C(C=C4)O)O)O)O)O D0BH6B HIGHSTAT Investigative D0BH7S DRUG__ID D0BH7S D0BH7S DRUGTYPE Small molecular drug D0BH7S DRUGINCH 1S/C12H10N4S/c1-2-4-9(5-3-1)6-17-12-10-11(14-7-13-10)15-8-16-12/h1-5,7-8H,6H2,(H,13,14,15,16) D0BH7S DRUGINKE ULIQGBPQLPCTAJ-UHFFFAOYSA-N D0BH7S DRUGSMIL C1=CC=C(C=C1)CSC2=NC=NC3=C2NC=N3 D0BH7S HIGHSTAT Investigative D0BH8K DRUG__ID D0BH8K D0BH8K DRUGTYPE Small molecular drug D0BH8K DRUGINCH 1S/C37H49N11O6/c1-21-31(50)47-30(20-23-10-13-24-6-2-3-7-25(24)18-23)35(54)46-27(8-4-16-42-36(38)39)32(51)45-28(9-5-17-43-37(40)41)33(52)48-29(34(53)44-21)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,21,27-30,49H,4-5,8-9,16-17,19-20H2,1H3,(H,44,53)(H,45,51)(H,46,54)(H,47,50)(H,48,52)(H4,38,39,42)(H4,40,41,43)/t21-,27-,28+,29+,30-/m0/s1 D0BH8K DRUGINKE VWZBFEAQYFTPKH-DXQNDIIUSA-N D0BH8K DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D0BH8K HIGHSTAT Investigative D0BI0Z DRUG__ID D0BI0Z D0BI0Z DRUGTYPE Small molecular drug D0BI0Z DRUGINCH 1S/C21H20N2O/c24-21(23-19-12-7-15-22-16-19)14-13-20(17-8-3-1-4-9-17)18-10-5-2-6-11-18/h1-12,15-16,20H,13-14H2,(H,23,24) D0BI0Z DRUGINKE CEQRPUYSSDGEML-UHFFFAOYSA-N D0BI0Z DRUGSMIL C1=CC=C(C=C1)C(CCC(=O)NC2=CN=CC=C2)C3=CC=CC=C3 D0BI0Z HIGHSTAT Investigative D0BI4T DRUG__ID D0BI4T D0BI4T DRUGTYPE Small molecular drug D0BI4T DRUGINCH 1S/C29H44F2N6O2/c1-21(2)36-14-7-22(8-15-36)32-27-23-19-25(38-3)26(39-18-6-13-35-11-4-5-12-35)20-24(23)33-28(34-27)37-16-9-29(30,31)10-17-37/h19-22H,4-18H2,1-3H3,(H,32,33,34) D0BI4T DRUGINKE RNAMYOYQYRYFQY-UHFFFAOYSA-N D0BI4T DRUGSMIL CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F D0BI4T HIGHSTAT Investigative D0BI5Y DRUG__ID D0BI5Y D0BI5Y DRUGTYPE Small molecular drug D0BI5Y DRUGINCH 1S/C14H13NS/c15-9-12-10-5-1-3-7-13(10)16-14-8-4-2-6-11(12)14/h1-8,12H,9,15H2 D0BI5Y DRUGINKE MYNBESFWFGVQQB-UHFFFAOYSA-N D0BI5Y DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C3S2)CN D0BI5Y HIGHSTAT Investigative D0BI8T DRUG__ID D0BI8T D0BI8T DRUGTYPE Small molecular drug D0BI8T DRUGINCH 1S/C22H33N3O6/c1-13(2)10-16(12-19(26)25-30)20(27)24-18(11-14(3)4)21(28)23-17-8-6-15(7-9-17)22(29)31-5/h6-9,13-14,16,18,30H,10-12H2,1-5H3,(H,23,28)(H,24,27)(H,25,26)/t16-,18+/m1/s1 D0BI8T DRUGINKE CEEASCNCHQSPKF-AEFFLSMTSA-N D0BI8T DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(CC(C)C)C(=O)NC1=CC=C(C=C1)C(=O)OC D0BI8T HIGHSTAT Investigative D0BK2Y DRUG__ID D0BK2Y D0BK2Y DRUGTYPE Small molecular drug D0BK2Y DRUGINCH 1S/C16H23ClN2O3S/c17-13-5-7-14(8-6-13)23(20,21)18-15-3-1-2-4-16(15)19-9-11-22-12-10-19/h5-8,15-16,18H,1-4,9-12H2 D0BK2Y DRUGINKE AYQCZQKMGKDZPS-UHFFFAOYSA-N D0BK2Y DRUGSMIL C1CCC(C(C1)NS(=O)(=O)C2=CC=C(C=C2)Cl)N3CCOCC3 D0BK2Y HIGHSTAT Investigative D0BK8V DRUG__ID D0BK8V D0BK8V DRUGTYPE Small molecular drug D0BK8V DRUGINCH 1S/C10H16N5O11P3/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(24-7)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h4-7H,1-3H2,(H,19,20)(H,21,22)(H2,11,12,13)(H2,16,17,18)/t6-,7+/m0/s1 D0BK8V DRUGINKE OAKPWEUQDVLTCN-NKWVEPMBSA-N D0BK8V DRUGSMIL C1CC(OC1COP(=O)(O)OP(=O)(O)OP(=O)(O)O)N2C=NC3=C(N=CN=C32)N D0BK8V HIGHSTAT Investigative D0BL0O DRUG__ID D0BL0O D0BL0O DRUGTYPE Small molecular drug D0BL0O DRUGINCH 1S/C22H15ClN4O/c1-15-5-7-18(22(28)26-20-4-2-3-19(23)12-20)11-17(15)8-6-16-13-24-21-9-10-25-27(21)14-16/h2-5,7,9-14H,1H3,(H,26,28) D0BL0O DRUGINKE PSBGROLQRNSAMY-UHFFFAOYSA-N D0BL0O DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC=C2)Cl)C#CC3=CN4C(=CC=N4)N=C3 D0BL0O HIGHSTAT Investigative D0BM0M DRUG__ID D0BM0M D0BM0M DRUGTYPE Small molecular drug D0BM0M DRUGINCH 1S/C17H26N2O/c1-5-19(6-2)16(20)17(12-15(17)13-18(3)4)14-10-8-7-9-11-14/h7-11,15H,5-6,12-13H2,1-4H3 D0BM0M DRUGINKE NMRSWXVEITZBIQ-UHFFFAOYSA-N D0BM0M DRUGSMIL CCN(CC)C(=O)C1(CC1CN(C)C)C2=CC=CC=C2 D0BM0M HIGHSTAT Investigative D0BM2T DRUG__ID D0BM2T D0BM2T DRUGTYPE Small molecular drug D0BM2T DRUGINCH 1S/C29H23N3O8S/c30-41(38,39)20-6-1-16(2-7-20)11-12-31-29(37)32-17-3-8-21(24(13-17)28(35)36)27-22-9-4-18(33)14-25(22)40-26-15-19(34)5-10-23(26)27/h1-10,13-15,33H,11-12H2,(H,35,36)(H2,30,38,39)(H2,31,32,37) D0BM2T DRUGINKE IYBVEUKFGRJHGL-UHFFFAOYSA-N D0BM2T DRUGSMIL C1=CC(=CC=C1CCNC(=O)NC2=CC(=C(C=C2)C3=C4C=CC(=O)C=C4OC5=C3C=CC(=C5)O)C(=O)O)S(=O)(=O)N D0BM2T HIGHSTAT Investigative D0BM4F DRUG__ID D0BM4F D0BM4F DRUGTYPE Small molecular drug D0BM4F DRUGINCH 1S/C15H12N2O/c1-3-7-12(8-4-1)14-11-16-15(18-14)17-13-9-5-2-6-10-13/h1-11H,(H,16,17) D0BM4F DRUGINKE HFICAVMUTYFODG-UHFFFAOYSA-N D0BM4F DRUGSMIL C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC=C3 D0BM4F HIGHSTAT Investigative D0BM7O DRUG__ID D0BM7O D0BM7O DRUGTYPE Small molecular drug D0BM7O DRUGINCH 1S/C29H26Cl4N4O2/c30-26-4-1-5-27(31)24(26)20-38-34-18-22-8-14-36(15-9-22)12-3-13-37-16-10-23(11-17-37)19-35-39-21-25-28(32)6-2-7-29(25)33/h1-2,4-11,14-19H,3,12-13,20-21H2/q+2/b34-18-,35-19- D0BM7O DRUGINKE RAHLDBGBLYIYDN-OQWDZDEYSA-N D0BM7O DRUGSMIL C1=CC(=C(C(=C1)Cl)CON=CC2=CC=[N+](C=C2)CCC[N+]3=CC=C(C=C3)C=NOCC4=C(C=CC=C4Cl)Cl)Cl D0BM7O HIGHSTAT Investigative D0BN1U DRUG__ID D0BN1U D0BN1U DRUGTYPE Small molecular drug D0BN1U DRUGINCH 1S/C22H30O5/c23-18(16-27-19-8-4-3-5-9-19)14-12-17-13-15-21(24)20(17)10-6-1-2-7-11-22(25)26/h3-5,8-9,12,14,17-18,20,23H,1-2,6-7,10-11,13,15-16H2,(H,25,26)/b14-12+/t17-,18+,20+/m0/s1 D0BN1U DRUGINKE NZGFSDWJUZOAAX-KAVAACISSA-N D0BN1U DRUGSMIL C1CC(=O)C(C1C=CC(COC2=CC=CC=C2)O)CCCCCCC(=O)O D0BN1U HIGHSTAT Investigative D0BN4U DRUG__ID D0BN4U D0BN4U DRUGTYPE Small molecular drug D0BN4U DRUGINCH 1S/C11H17NO6/c12-6(9(13)14)4-11(10(15)16)5-8-7(18-11)2-1-3-17-8/h6-8H,1-5,12H2,(H,13,14)(H,15,16)/p-1/t6-,7+,8+,11+/m0/s1 D0BN4U DRUGINKE RZIYCCQNKHONBB-PRKAOEEVSA-M D0BN4U DRUGSMIL C1CC2C(CC(O2)(CC(C(=O)[O-])[NH3+])C(=O)[O-])OC1 D0BN4U HIGHSTAT Investigative D0BN7E DRUG__ID D0BN7E D0BN7E DRUGTYPE Small molecular drug D0BN7E DRUGINCH 1S/C12H14N2OS/c1-8(2)10-11(15)14-12(16-10)13-9-6-4-3-5-7-9/h3-8,15H,1-2H3,(H,13,14) D0BN7E DRUGINKE RCZXLRFUEUEYCI-UHFFFAOYSA-N D0BN7E DRUGSMIL CC(C)C1=C(N=C(S1)NC2=CC=CC=C2)O D0BN7E HIGHSTAT Investigative D0BN9C DRUG__ID D0BN9C D0BN9C DRUGTYPE Small molecular drug D0BN9C DRUGINCH 1S/C37H38N2O8.ClH/c1-38-12-11-24-18-33(46-5)35(42)36(47-32-19-25-23(17-31(32)45-4)10-13-39(2)37(25)43)34(24)28(38)16-21-7-9-30(44-3)27(14-21)26-15-22(20-40)6-8-29(26)41;/h6-9,14-15,17-20,28,41-42H,10-13,16H2,1-5H3;1H/t28-;/m0./s1 D0BN9C DRUGINKE UOCXQPQQPWZQIB-JCOPYZAKSA-N D0BN9C DRUGSMIL CN1CCC2=CC(=C(C(=C2C1CC3=CC(=C(C=C3)OC)C4=C(C=CC(=C4)C=O)O)OC5=C(C=C6CCN(C(=O)C6=C5)C)OC)O)OC.Cl D0BN9C HIGHSTAT Investigative D0BO6C DRUG__ID D0BO6C D0BO6C DRUGTYPE Small molecular drug D0BO6C DRUGINCH 1S/C22H17N3O/c26-22(18-12-6-2-7-13-18)23-21-16-20(17-10-4-1-5-11-17)24-25(21)19-14-8-3-9-15-19/h1-16H,(H,23,26) D0BO6C DRUGINKE AYVLYDAJDALPHK-UHFFFAOYSA-N D0BO6C DRUGSMIL C1=CC=C(C=C1)C2=NN(C(=C2)NC(=O)C3=CC=CC=C3)C4=CC=CC=C4 D0BO6C HIGHSTAT Investigative D0BO9W DRUG__ID D0BO9W D0BO9W DRUGTYPE Small molecular drug D0BO9W DRUGINCH 1S/C13H14N2O3S/c1-2-19(16,17)15-12-8-9-14-10-13(12)18-11-6-4-3-5-7-11/h3-10H,2H2,1H3,(H,14,15) D0BO9W DRUGINKE FOUBNASCZPSQBW-UHFFFAOYSA-N D0BO9W DRUGSMIL CCS(=O)(=O)NC1=C(C=NC=C1)OC2=CC=CC=C2 D0BO9W HIGHSTAT Investigative D0BP3E DRUG__ID D0BP3E D0BP3E DRUGTYPE Small molecular drug D0BP3E DRUGINCH 1S/C15H31F2O3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(16,17)21(18,19)20/h2-14H2,1H3,(H2,18,19,20) D0BP3E DRUGINKE YGXPAGSHLFJKFV-UHFFFAOYSA-N D0BP3E DRUGSMIL CCCCCCCCCCCCCCC(F)(F)P(=O)(O)O D0BP3E HIGHSTAT Investigative D0BR1D DRUG__ID D0BR1D D0BR1D DRUGTYPE Small molecular drug D0BR1D DRUGINCH 1S/C7H4N2O7/c10-5-2-3(8(13)14)1-4(9(15)16)6(5)7(11)12/h1-2,10H,(H,11,12) D0BR1D DRUGINKE AQBLBIVMAAUENI-UHFFFAOYSA-N D0BR1D DRUGSMIL C1=C(C=C(C(=C1[N+](=O)[O-])C(=O)O)O)[N+](=O)[O-] D0BR1D HIGHSTAT Investigative D0BR1V DRUG__ID D0BR1V D0BR1V DRUGTYPE Small molecular drug D0BR1V DRUGINCH 1S/C21H17NO4S/c23-19-13-6-16(7-14-19)8-15-21(24)17-9-11-18(12-10-17)22-27(25,26)20-4-2-1-3-5-20/h1-15,22-23H/b15-8+ D0BR1V DRUGINKE CJSVUASMASROSS-OVCLIPMQSA-N D0BR1V DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C(=O)C=CC3=CC=C(C=C3)O D0BR1V HIGHSTAT Investigative D0BS2Q DRUG__ID D0BS2Q D0BS2Q DRUGTYPE Small molecular drug D0BS2Q DRUGINCH 1S/C39H61N11O12S2/c1-6-19(4)31(49-37(60)25(46-33(56)23(40)16-63)12-21-7-9-22(52)10-8-21)38(61)50-32(20(5)51)39(62)47-26(13-28(41)53)36(59)48-27(17-64)35(58)44-15-30(55)45-24(11-18(2)3)34(57)43-14-29(42)54/h7-10,16,18-20,23-27,31-32,51-52,64H,6,11-15,17,40H2,1-5H3,(H2,41,53)(H2,42,54)(H,43,57)(H,44,58)(H,45,55)(H,46,56)(H,47,62)(H,48,59)(H,49,60)(H,50,61)/t19-,20+,23-,24-,25-,26-,27-,31-,32-/m0/s1 D0BS2Q DRUGINKE SJRRTEZQOSELMP-IKNHWLCZSA-N D0BS2Q DRUGSMIL CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(C=S)N D0BS2Q HIGHSTAT Investigative D0BS6Q DRUG__ID D0BS6Q D0BS6Q DRUGTYPE Small molecular drug D0BS6Q DRUGINCH 1S/C22H27N9O4/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34) D0BS6Q DRUGINKE UPBAOYRENQEPJO-UHFFFAOYSA-N D0BS6Q DRUGSMIL CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCC(=N)N)C)C)NC=O D0BS6Q HIGHSTAT Investigative D0BS6R DRUG__ID D0BS6R D0BS6R DRUGTYPE Small molecular drug D0BS6R DRUGINCH 1S/C33H39N9O2/c1-39-14-16-41(17-15-39)23-9-11-24(12-10-23)42-32-29(31(34)35-20-36-32)30(38-42)22-8-13-25(28(19-22)44-3)37-33(43)27-18-21-6-4-5-7-26(21)40(27)2/h4-8,13,18-20,23-24H,9-12,14-17H2,1-3H3,(H,37,43)(H2,34,35,36) D0BS6R DRUGINKE STVKLDUINKMZFE-UHFFFAOYSA-N D0BS6R DRUGSMIL CN1CCN(CC1)C2CCC(CC2)N3C4=NC=NC(=C4C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)N D0BS6R HIGHSTAT Investigative D0BS7G DRUG__ID D0BS7G D0BS7G DRUGTYPE Small molecular drug D0BS7G DRUGINCH 1S/C26H40O2/c1-8-9-10-11-14-25(3,4)19-16-22(27-7)24-20-15-18(2)12-13-21(20)26(5,6)28-23(24)17-19/h12,16-17,20-21H,8-11,13-15H2,1-7H3/t20-,21-/m1/s1 D0BS7G DRUGINKE SUFMHSFGODDLKI-NHCUHLMSSA-N D0BS7G DRUGSMIL CCCCCCC(C)(C)C1=CC2=C(C3CC(=CCC3C(O2)(C)C)C)C(=C1)OC D0BS7G HIGHSTAT Investigative D0BT1A DRUG__ID D0BT1A D0BT1A DRUGTYPE Small molecular drug D0BT1A DRUGINCH 1S/C7H10N2/c8-5-4-7-3-1-2-6-9-7/h1-3,6H,4-5,8H2 D0BT1A DRUGINKE XPQIPUZPSLAZDV-UHFFFAOYSA-N D0BT1A DRUGSMIL C1=CC=NC(=C1)CCN D0BT1A HIGHSTAT Investigative D0BT1W DRUG__ID D0BT1W D0BT1W DRUGTYPE Small molecular drug D0BT1W DRUGINCH 1S/C17H12O2S/c1-11-6-8-12(9-7-11)20-16-10-15(18)13-4-2-3-5-14(13)17(16)19/h2-10H,1H3 D0BT1W DRUGINKE IHRGUZGBIGODSC-UHFFFAOYSA-N D0BT1W DRUGSMIL CC1=CC=C(C=C1)SC2=CC(=O)C3=CC=CC=C3C2=O D0BT1W HIGHSTAT Investigative D0BT5E DRUG__ID D0BT5E D0BT5E DRUGTYPE Small molecular drug D0BT5E DRUGINCH 1S/C13H12F3N3S2/c14-13(15,16)10-8-21-12(18-10)19-11(20)17-7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,17,18,19,20) D0BT5E DRUGINKE PIOSJSRPZNUBFE-UHFFFAOYSA-N D0BT5E DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC(=CS2)C(F)(F)F D0BT5E HIGHSTAT Investigative D0BU5K DRUG__ID D0BU5K D0BU5K DRUGTYPE Small molecular drug D0BU5K DRUGINCH 1S/C28H36O4/c1-15-13-21-26(4,24(32)22(15)30)10-12-27(5)20-8-7-17-16(2)23(31)19(29)14-18(17)25(20,3)9-11-28(21,27)6/h7-8,14-15,21,24,31-32H,9-13H2,1-6H3/t15-,21-,24-,25+,26-,27-,28+/m1/s1 D0BU5K DRUGINKE QIRUFAFQGKOTKA-ZRWKYKNNSA-N D0BU5K DRUGSMIL CC1CC2C(CCC3(C2(CCC4(C3=CC=C5C4=CC(=O)C(=C5C)O)C)C)C)(C(C1=O)O)C D0BU5K HIGHSTAT Investigative D0BU5N DRUG__ID D0BU5N D0BU5N DRUGTYPE Small molecular drug D0BU5N DRUGINCH 1S/C17H11ClN2/c1-11-2-3-13-4-5-14(9-17(13)20-11)15-6-12(10-19)7-16(18)8-15/h2-9H,1H3 D0BU5N DRUGINKE NJKOTXYVFGIDOL-UHFFFAOYSA-N D0BU5N DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)Cl D0BU5N HIGHSTAT Investigative D0BU5X DRUG__ID D0BU5X D0BU5X DRUGTYPE Small molecular drug D0BU5X DRUGINCH 1S/C13H15NOS/c1-15-13-7-12(6-5-11(13)8-14)16-9-10-3-2-4-10/h5-7,10H,2-4,9H2,1H3 D0BU5X DRUGINKE VLNPFRWDACXANC-UHFFFAOYSA-N D0BU5X DRUGSMIL COC1=C(C=CC(=C1)SCC2CCC2)C#N D0BU5X HIGHSTAT Investigative D0BU6J DRUG__ID D0BU6J D0BU6J DRUGTYPE Small molecular drug D0BU6J DRUGINCH 1S/C30H48O4/c1-17-10-13-30(25(33)34)15-14-28(6)19(23(30)18(17)2)8-9-22-27(5)16-20(31)24(32)26(3,4)21(27)11-12-29(22,28)7/h8,17-18,20-24,31-32H,9-16H2,1-7H3,(H,33,34)/t17-,18+,20+,21+,22-,23+,24-,27+,28-,29-,30+/m1/s1 D0BU6J DRUGINKE HFGSQOYIOKBQOW-FEZPFBHMSA-N D0BU6J DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)O D0BU6J HIGHSTAT Investigative D0BU6T DRUG__ID D0BU6T D0BU6T DRUGTYPE Small molecular drug D0BU6T DRUGINCH 1S/C18H14N4/c19-17-16-15(13-7-3-1-4-8-13)11-22(18(16)21-12-20-17)14-9-5-2-6-10-14/h1-12H,(H2,19,20,21) D0BU6T DRUGINKE AFVGAHBUCVDPPI-UHFFFAOYSA-N D0BU6T DRUGSMIL C1=CC=C(C=C1)C2=CN(C3=NC=NC(=C23)N)C4=CC=CC=C4 D0BU6T HIGHSTAT Investigative D0BU8W DRUG__ID D0BU8W D0BU8W DRUGTYPE Small molecular drug D0BU8W DRUGINCH 1S/C23H18F3N7O2S/c1-12(27)20(34)28-10-13-4-2-5-14(8-13)33-17(9-18(32-33)23(24,25)26)22-31-30-21(35-22)15-6-3-7-16-19(15)36-11-29-16/h2-9,11-12H,10,27H2,1H3,(H,28,34)/t12-/m0/s1 D0BU8W DRUGINKE KODBDIFHMBDFOH-LBPRGKRZSA-N D0BU8W DRUGSMIL CC(C(=O)NCC1=CC(=CC=C1)N2C(=CC(=N2)C(F)(F)F)C3=NN=C(O3)C4=C5C(=CC=C4)N=CS5)N D0BU8W HIGHSTAT Investigative D0BV8A DRUG__ID D0BV8A D0BV8A DRUGTYPE Small molecular drug D0BV8A DRUGINCH 1S/C21H27NO10/c1-6-13(25)29-12-9(23)19-11-7(22-5)8(17(2,3)4)18(19)10(24)14(26)31-16(18)32-21(19,15(27)30-11)20(6,12)28/h6-12,16,22-24,28H,1-5H3/t6?,7-,8?,9?,10-,11?,12-,16?,18?,19?,20+,21-/m0/s1 D0BV8A DRUGINKE IFVRBXXBLQUPAA-WOBCBQRJSA-N D0BV8A DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5NC)C(C)(C)C)C(C(=O)OC6O4)O)O D0BV8A HIGHSTAT Investigative D0BV8M DRUG__ID D0BV8M D0BV8M DRUGTYPE Small molecular drug D0BV8M DRUGINCH 1S/C18H21N3O2/c19-15(11-13-7-3-1-4-8-13)18(23)21-16(17(20)22)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H2,20,22)(H,21,23)/t15-,16+/m1/s1 D0BV8M DRUGINKE XXPXQEQOAZMUDD-CVEARBPZSA-N D0BV8M DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)N D0BV8M HIGHSTAT Investigative D0BV8Y DRUG__ID D0BV8Y D0BV8Y DRUGTYPE Small molecular drug D0BV8Y DRUGINCH 1S/C17H18N2O3S/c1-9(2)16-19-18-15(23-16)8-21-12-5-6-13-10(3)11(4)17(20)22-14(13)7-12/h5-7,9H,8H2,1-4H3 D0BV8Y DRUGINKE HQTNJPCZUQAYAB-UHFFFAOYSA-N D0BV8Y DRUGSMIL CC1=C(C(=O)OC2=C1C=CC(=C2)OCC3=NN=C(S3)C(C)C)C D0BV8Y HIGHSTAT Investigative D0BW0V DRUG__ID D0BW0V D0BW0V DRUGTYPE Small molecular drug D0BW0V DRUGINCH 1S/C18H20N2/c1-19-12-11-15(14-7-3-2-4-8-14)17-13-20-18-10-6-5-9-16(17)18/h2-10,13,15,19-20H,11-12H2,1H3 D0BW0V DRUGINKE HYXMIUGYZHSSJS-UHFFFAOYSA-N D0BW0V DRUGSMIL CNCCC(C1=CC=CC=C1)C2=CNC3=CC=CC=C32 D0BW0V HIGHSTAT Investigative D0BW1H DRUG__ID D0BW1H D0BW1H DRUGTYPE Small molecular drug D0BW1H DRUGINCH 1S/C16H21NO2/c1-2-3-4-5-6-9-13-12-16(18)14-10-7-8-11-15(14)17(13)19/h7-8,10-12,19H,2-6,9H2,1H3 D0BW1H DRUGINKE ICTVCUOZYWNYHM-UHFFFAOYSA-N D0BW1H DRUGSMIL CCCCCCCC1=CC(=O)C2=CC=CC=C2N1O D0BW1H HIGHSTAT Investigative D0BW4G DRUG__ID D0BW4G D0BW4G DRUGTYPE Small molecular drug D0BW4G DRUGINCH 1S/C27H27N5O4/c1-34-24-16-22-23(17-25(24)35-2)28-18-29-26(22)31-12-14-32(15-13-31)27(33)30-19-8-10-21(11-9-19)36-20-6-4-3-5-7-20/h3-11,16-18H,12-15H2,1-2H3,(H,30,33) D0BW4G DRUGINKE INTPTKHSGKBHHW-UHFFFAOYSA-N D0BW4G DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)N3CCN(CC3)C(=O)NC4=CC=C(C=C4)OC5=CC=CC=C5)OC D0BW4G HIGHSTAT Investigative D0BW7P DRUG__ID D0BW7P D0BW7P DRUGTYPE Small molecular drug D0BW7P DRUGINCH 1S/C27H34N4O3/c1-3-22(28-2)25(32)29-23-16-10-15-21-17-18-24(31(21)26(23)33)27(34)30(19-11-6-4-7-12-19)20-13-8-5-9-14-20/h4-9,11-14,21-24,28H,3,10,15-18H2,1-2H3,(H,29,32)/t21-,22-,23-,24-/m0/s1 D0BW7P DRUGINKE MIWHOUGMEANWCH-ZJZGAYNASA-N D0BW7P DRUGSMIL CCC(C(=O)NC1CCCC2CCC(N2C1=O)C(=O)N(C3=CC=CC=C3)C4=CC=CC=C4)NC D0BW7P HIGHSTAT Investigative D0BW9V DRUG__ID D0BW9V D0BW9V DRUGTYPE Small molecular drug D0BW9V DRUGINCH 1S/C20H24IN3O/c1-4-24(5-2)20(25)12-9-14-13-7-6-8-16-18(13)15(19(21)22-16)10-17(14)23(3)11-12/h6-9,12,17,22H,4-5,10-11H2,1-3H3/t12-,17-/m1/s1/i21-2 D0BW9V DRUGINKE OBCUQRYIGTWROI-YUPRZBKSSA-N D0BW9V DRUGSMIL CCN(CC)C(=O)C1CN(C2CC3=C(NC4=CC=CC(=C34)C2=C1)I)C D0BW9V HIGHSTAT Investigative D0BY6E DRUG__ID D0BY6E D0BY6E DRUGTYPE Small molecular drug D0BY6E DRUGINCH 1S/C15H10N2O4/c18-14-10-7-4-8-11(17(20)21)13(10)16-15(19)12(14)9-5-2-1-3-6-9/h1-8H,(H2,16,18,19) D0BY6E DRUGINKE XWRIMEVQDODFAZ-UHFFFAOYSA-N D0BY6E DRUGSMIL C1=CC=C(C=C1)C2=C(C3=C(C(=CC=C3)[N+](=O)[O-])NC2=O)O D0BY6E HIGHSTAT Investigative D0BY9X DRUG__ID D0BY9X D0BY9X DRUGTYPE Small molecular drug D0BY9X DRUGINCH 1S/C23H25N3O/c1-23(2,3)17-8-9-18-15(13-17)7-10-21(18)26-22(27)25-20-6-4-5-16-14-24-12-11-19(16)20/h4-6,8-9,11-14,21H,7,10H2,1-3H3,(H2,25,26,27)/t21-/m1/s1 D0BY9X DRUGINKE VPSCJCQPUGKRNC-OAQYLSRUSA-N D0BY9X DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C(CC2)NC(=O)NC3=CC=CC4=C3C=CN=C4 D0BY9X HIGHSTAT Investigative D0BZ3S DRUG__ID D0BZ3S D0BZ3S DRUGTYPE Small molecular drug D0BZ3S DRUGINCH 1S/C17H13N5/c1-3-7-13(8-4-1)21-16-15-17(19-11-18-16)22(12-20-15)14-9-5-2-6-10-14/h1-12H,(H,18,19,21) D0BZ3S DRUGINKE UKZXHZUTIYUUII-UHFFFAOYSA-N D0BZ3S DRUGSMIL C1=CC=C(C=C1)NC2=C3C(=NC=N2)N(C=N3)C4=CC=CC=C4 D0BZ3S HIGHSTAT Investigative D0C0AS DRUG__ID D0C0AS D0C0AS DRUGTYPE Small molecular drug D0C0AS DRUGINCH 1S/C20H24Cl2N4/c1-5-7-10-25(6-2)18-11-13(3)23-20-19(14(4)24-26(18)20)16-9-8-15(21)12-17(16)22/h8-9,11-12H,5-7,10H2,1-4H3 D0C0AS DRUGINKE DVFPSRARRBNMBH-UHFFFAOYSA-N D0C0AS DRUGSMIL CCCCN(CC)C1=CC(=NC2=C(C(=NN12)C)C3=C(C=C(C=C3)Cl)Cl)C D0C0AS HIGHSTAT Investigative D0C0DM DRUG__ID D0C0DM D0C0DM DRUGTYPE Small molecular drug D0C0DM DRUGINCH 1S/C13H8Br4O4/c14-8-4(2-6(18)12(20)10(8)16)1-5-3-7(19)13(21)11(17)9(5)15/h2-3,18-21H,1H2 D0C0DM DRUGINKE WIAKRAUTQVUHHL-UHFFFAOYSA-N D0C0DM DRUGSMIL C1=C(C(=C(C(=C1O)O)Br)Br)CC2=CC(=C(C(=C2Br)Br)O)O D0C0DM HIGHSTAT Investigative D0C0FH DRUG__ID D0C0FH D0C0FH DRUGTYPE Small molecular drug D0C0FH DRUGINCH 1S/C13H13N/c1-2-6-12(7-3-1)9-10-13-8-4-5-11-14-13/h4-6,8,11H,1-3,7H2 D0C0FH DRUGINKE ZWQFPYQWWDBORG-UHFFFAOYSA-N D0C0FH DRUGSMIL C1CCC(=CC1)C#CC2=CC=CC=N2 D0C0FH HIGHSTAT Investigative D0C0FK DRUG__ID D0C0FK D0C0FK DRUGTYPE Small molecular drug D0C0FK DRUGINCH 1S/C13H12N2OS/c14-11-6-10(17)7-12(16)13(11)15-8-9-4-2-1-3-5-9/h1-8,16-17H,14H2 D0C0FK DRUGINKE ZHJMODAVTYPZRG-UHFFFAOYSA-N D0C0FK DRUGSMIL C1=CC=C(C=C1)C=NC2=C(C=C(C=C2O)S)N D0C0FK HIGHSTAT Investigative D0C0FU DRUG__ID D0C0FU D0C0FU DRUGTYPE Small molecular drug D0C0FU DRUGINCH 1S/C15H19ClO3/c1-18-15(17)10-19-14-8-7-12(16)9-13(14)11-5-3-2-4-6-11/h7-9,11H,2-6,10H2,1H3 D0C0FU DRUGINKE AZDVRVGZFMVXTH-UHFFFAOYSA-N D0C0FU DRUGSMIL COC(=O)COC1=C(C=C(C=C1)Cl)C2CCCCC2 D0C0FU HIGHSTAT Investigative D0C0GL DRUG__ID D0C0GL D0C0GL DRUGTYPE Small molecular drug D0C0GL DRUGINCH 1S/C13H18BrNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 D0C0GL DRUGINKE GIDJZDYNVHMFAH-UHFFFAOYSA-N D0C0GL DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Br)NC(C)(C)C D0C0GL HIGHSTAT Investigative D0C0HN DRUG__ID D0C0HN D0C0HN DRUGTYPE Small molecular drug D0C0HN DRUGINCH 1S/C8H5ClN2O2S/c9-6-5(4-2-1-3-14-4)7(12)11-8(13)10-6/h1-3H,(H2,10,11,12,13) D0C0HN DRUGINKE DPKZWAVQBQNTIP-UHFFFAOYSA-N D0C0HN DRUGSMIL C1=CSC(=C1)C2=C(NC(=O)NC2=O)Cl D0C0HN HIGHSTAT Investigative D0C0HP DRUG__ID D0C0HP D0C0HP DRUGTYPE Small molecular drug D0C0HP DRUGINCH 1S/C37H46N4O/c1-24-18-25(2)20-29(19-24)35-34(26(3)22-39-17-14-27-12-15-38-16-13-27)32-21-30(8-11-33(32)40-35)37(4,5)36(42)41-23-28-6-9-31(41)10-7-28/h8,11-13,15-16,18-21,26,28,31,39-40H,6-7,9-10,14,17,22-23H2,1-5H3/t26-,28?,31?/m1/s1 D0C0HP DRUGINKE GGVFLXSCFPVLMS-WPCLDFDBSA-N D0C0HP DRUGSMIL CC1=CC(=CC(=C1)C2=C(C3=C(N2)C=CC(=C3)C(C)(C)C(=O)N4CC5CCC4CC5)C(C)CNCCC6=CC=NC=C6)C D0C0HP HIGHSTAT Investigative D0C0KJ DRUG__ID D0C0KJ D0C0KJ DRUGTYPE Small molecular drug D0C0KJ DRUGINCH 1S/C23H37NO5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-21(30-18-19(24)23(28)29)20(25)15-14-17-22(26)27/h6-7,9-13,16,19-21,25H,2-5,8,14-15,17-18,24H2,1H3,(H,26,27)(H,28,29)/b7-6-,10-9-,12-11+,16-13+/t19-,20-,21+/m0/s1 D0C0KJ DRUGINKE OTZRAYGBFWZKMX-FRFVZSDQSA-N D0C0KJ DRUGSMIL CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)O)N D0C0KJ HIGHSTAT Investigative D0C0LG DRUG__ID D0C0LG D0C0LG DRUGTYPE Small molecular drug D0C0LG DRUGINCH 1S/C24H26N2O/c1-18(19-7-3-2-4-8-19)26-15-13-23(14-16-26)25-24(27)22-12-11-20-9-5-6-10-21(20)17-22/h2-12,17-18,23H,13-16H2,1H3,(H,25,27) D0C0LG DRUGINKE LVIBIBUWEMTPMC-UHFFFAOYSA-N D0C0LG DRUGSMIL CC(C1=CC=CC=C1)N2CCC(CC2)NC(=O)C3=CC4=CC=CC=C4C=C3 D0C0LG HIGHSTAT Investigative D0C0MP DRUG__ID D0C0MP D0C0MP DRUGTYPE Small molecular drug D0C0MP DRUGINCH 1S/C11H14N2O2/c1-14-9-4-3-8(7-10(9)15-2)11-12-5-6-13-11/h3-4,7H,5-6H2,1-2H3,(H,12,13) D0C0MP DRUGINKE NXHHUAOYFMCRFK-UHFFFAOYSA-N D0C0MP DRUGSMIL COC1=C(C=C(C=C1)C2=NCCN2)OC D0C0MP HIGHSTAT Investigative D0C0NS DRUG__ID D0C0NS D0C0NS DRUGTYPE Small molecular drug D0C0NS DRUGINCH 1S/C29H34O10/c1-25(15-30)8-7-22(31)27(3)28(25,33)10-9-26(2)29(27,34)14-17-19(39-26)13-18(38-24(17)32)16-11-20(35-4)23(37-6)21(12-16)36-5/h7-8,11-13,30,33-34H,9-10,14-15H2,1-6H3/t25-,26+,27-,28+,29+/m0/s1 D0C0NS DRUGINKE PXIKKOJKOBCLTQ-XPLNXOJDSA-N D0C0NS DRUGSMIL CC12CCC3(C(C=CC(=O)C3(C1(CC4=C(O2)C=C(OC4=O)C5=CC(=C(C(=C5)OC)OC)OC)O)C)(C)CO)O D0C0NS HIGHSTAT Investigative D0C0OT DRUG__ID D0C0OT D0C0OT DRUGTYPE Small molecular drug D0C0OT DRUGINCH 1S/C14H11NO5/c16-11-7-6-10(13(14(11)18)15(19)20)12(17)8-9-4-2-1-3-5-9/h1-7,16,18H,8H2 D0C0OT DRUGINKE WQKGHRQZAOQUHW-UHFFFAOYSA-N D0C0OT DRUGSMIL C1=CC=C(C=C1)CC(=O)C2=C(C(=C(C=C2)O)O)[N+](=O)[O-] D0C0OT HIGHSTAT Investigative D0C0PL DRUG__ID D0C0PL D0C0PL DRUGTYPE Small molecular drug D0C0PL DRUGINCH 1S/C15H14BrF2N3OS/c1-22-12-4-3-11(17)10(14(12)18)6-7-19-15(23)21-13-5-2-9(16)8-20-13/h2-5,8H,6-7H2,1H3,(H2,19,20,21,23) D0C0PL DRUGINKE HINMFTUIHCBZCY-UHFFFAOYSA-N D0C0PL DRUGSMIL COC1=C(C(=C(C=C1)F)CCNC(=S)NC2=NC=C(C=C2)Br)F D0C0PL HIGHSTAT Investigative D0C0TI DRUG__ID D0C0TI D0C0TI DRUGTYPE Small molecular drug D0C0TI DRUGINCH 1S/C28H34N6O4/c35-25(5-11-33-13-7-29-8-14-33)31-19-1-3-21-23(17-19)28(38)24-18-20(2-4-22(24)27(21)37)32-26(36)6-12-34-15-9-30-10-16-34/h1-4,17-18,29-30H,5-16H2,(H,31,35)(H,32,36) D0C0TI DRUGINKE NXAKQSOMJQXBST-UHFFFAOYSA-N D0C0TI DRUGSMIL C1CN(CCN1)CCC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CCN5CCNCC5 D0C0TI HIGHSTAT Investigative D0C0TN DRUG__ID D0C0TN D0C0TN DRUGTYPE Small molecular drug D0C0TN DRUGINCH 1S/C23H20N2O/c1-16-12-13-18-14-15-20(23(26)22(18)24-16)21(17-8-4-2-5-9-17)25-19-10-6-3-7-11-19/h2-15,21,25-26H,1H3 D0C0TN DRUGINKE WEENRMPCSWFMTE-UHFFFAOYSA-N D0C0TN DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2O)C(C3=CC=CC=C3)NC4=CC=CC=C4 D0C0TN HIGHSTAT Investigative D0C0UB DRUG__ID D0C0UB D0C0UB DRUGTYPE Small molecular drug D0C0UB DRUGINCH 1S/C13H11N3/c1-9-5-6-10-12(8-9)16-13(15-10)11-4-2-3-7-14-11/h2-8H,1H3,(H,15,16) D0C0UB DRUGINKE HFYFOFMVURXVSD-UHFFFAOYSA-N D0C0UB DRUGSMIL CC1=CC2=C(C=C1)N=C(N2)C3=CC=CC=N3 D0C0UB HIGHSTAT Investigative D0C0UM DRUG__ID D0C0UM D0C0UM DRUGTYPE Small molecular drug D0C0UM DRUGINCH 1S/C14H24N2/c1-3-11-16(12-4-2)14-7-5-13(6-8-14)9-10-15/h9,14H,3-8,11-12H2,1-2H3 D0C0UM DRUGINKE FMKZTRTUGPXJFV-UHFFFAOYSA-N D0C0UM DRUGSMIL CCCN(CCC)C1CCC(=CC#N)CC1 D0C0UM HIGHSTAT Investigative D0C0VP DRUG__ID D0C0VP D0C0VP DRUGTYPE Small molecular drug D0C0VP DRUGINCH 1S/C36H58N2.2C2HF3O2/c1-2-5-9-13-17-21-29-37-31-24-28-36(34-37)26-20-16-12-8-4-6-10-14-18-22-30-38-32-23-27-35(33-38)25-19-15-11-7-3-1;2*3-2(4,5)1(6)7/h1-2,23-24,27-28,31-34H,3-22,25-26,29-30H2;2*(H,6,7)/q+2;;/p-2/b2-1+;; D0C0VP DRUGINKE LUAUOMZCZVKFMM-SEPHDYHBSA-L D0C0VP DRUGSMIL C1CCCCCC[N+]2=CC=CC(=C2)CCCCCCC=CCCCCCC[N+]3=CC=CC(=C3)CCCCC1.C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-] D0C0VP HIGHSTAT Investigative D0C0XU DRUG__ID D0C0XU D0C0XU DRUGTYPE Small molecular drug D0C0XU DRUGINCH 1S/C21H30N2O/c1-3-4-5-6-9-14-22-21-17-10-7-8-11-19(17)23-20-13-12-16(24-2)15-18(20)21/h12-13,15H,3-11,14H2,1-2H3,(H,22,23) D0C0XU DRUGINKE XRCKCYUZWSKFGD-UHFFFAOYSA-N D0C0XU DRUGSMIL CCCCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D0C0XU HIGHSTAT Investigative D0C1AN DRUG__ID D0C1AN D0C1AN DRUGTYPE Small molecular drug D0C1AN DRUGINCH 1S/C39H54N8O10/c1-20(2)31(36(55)42-19-29(41)49)46-37(56)32(21(3)4)45-35(54)28(17-30(50)51)44-38(57)39(15-14-24-8-6-7-9-25(24)18-39)47-33(52)22(5)43-34(53)27(40)16-23-10-12-26(48)13-11-23/h6-13,20-22,27-28,31-32,48H,14-19,40H2,1-5H3,(H2,41,49)(H,42,55)(H,43,53)(H,44,57)(H,45,54)(H,46,56)(H,47,52)(H,50,51)/t22-,27+,28+,31+,32+,39?/m1/s1 D0C1AN DRUGINKE WCJNWJPRBIKFOI-RKPARCAKSA-N D0C1AN DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C1(CCC2=CC=CC=C2C1)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N D0C1AN HIGHSTAT Investigative D0C1AU DRUG__ID D0C1AU D0C1AU DRUGTYPE Small molecular drug D0C1AU DRUGINCH 1S/C18H14N2O4/c21-19(22)17-11-7-15(8-12-17)5-3-1-2-4-6-16-9-13-18(14-10-16)20(23)24/h1-14H/b2-1+,5-3+,6-4+ D0C1AU DRUGINKE OYPMHQIMQGZDHK-CRQXNEITSA-N D0C1AU DRUGSMIL C1=CC(=CC=C1C=CC=CC=CC2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-] D0C1AU HIGHSTAT Investigative D0C1BE DRUG__ID D0C1BE D0C1BE DRUGTYPE Small molecular drug D0C1BE DRUGINCH 1S/C18H17NO2/c1-12-4-6-13(7-5-12)15-8-14-9-17(20-2)18(21-3)10-16(14)19-11-15/h4-11H,1-3H3 D0C1BE DRUGINKE CMEIVVNDSVPQKC-UHFFFAOYSA-N D0C1BE DRUGSMIL CC1=CC=C(C=C1)C2=CN=C3C=C(C(=CC3=C2)OC)OC D0C1BE HIGHSTAT Investigative D0C1DG DRUG__ID D0C1DG D0C1DG DRUGTYPE Small molecular drug D0C1DG DRUGINCH 1S/C19H13NO4S/c21-19(22)15-9-3-6-12-18(15)25(23,24)20-16-10-4-1-7-13(16)14-8-2-5-11-17(14)20/h1-12H,(H,21,22) D0C1DG DRUGINKE WVHKYPINALNKJJ-UHFFFAOYSA-N D0C1DG DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2S(=O)(=O)C4=CC=CC=C4C(=O)O D0C1DG HIGHSTAT Investigative D0C1DQ DRUG__ID D0C1DQ D0C1DQ DRUGTYPE Small molecular drug D0C1DQ DRUGINCH 1S/C13H8N4OS/c18-13-8(3-7-4-14-5-15-7)11-9(17-13)1-2-10-12(11)19-6-16-10/h1-6H,(H,14,15)(H,17,18)/b8-3- D0C1DQ DRUGINKE VFBGXTUGODTSPK-BAQGIRSFSA-N D0C1DQ DRUGSMIL C1=CC2=C(C3=C1NC(=O)C3=CC4=CN=CN4)SC=N2 D0C1DQ HIGHSTAT Investigative D0C1EF DRUG__ID D0C1EF D0C1EF DRUGTYPE Small molecular drug D0C1EF DRUGINCH 1S/C15H14N4O2/c1-20-9-5-7-10(8-6-9)21-12-4-2-3-11-13(12)14(16)19-15(17)18-11/h2-8H,1H3,(H4,16,17,18,19) D0C1EF DRUGINKE CPZJZAIZIMCJRC-UHFFFAOYSA-N D0C1EF DRUGSMIL COC1=CC=C(C=C1)OC2=CC=CC3=C2C(=NC(=N3)N)N D0C1EF HIGHSTAT Investigative D0C1EP DRUG__ID D0C1EP D0C1EP DRUGTYPE Small molecular drug D0C1EP DRUGINCH 1S/C19H14N2O/c1-2-7-14(8-3-1)15-9-6-10-16(13-15)20-19-17-11-4-5-12-18(17)22-21-19/h1-13H,(H,20,21) D0C1EP DRUGINKE RPYFHXRGVNEECB-UHFFFAOYSA-N D0C1EP DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)NC3=NOC4=CC=CC=C43 D0C1EP HIGHSTAT Investigative D0C1EQ DRUG__ID D0C1EQ D0C1EQ DRUGTYPE Small molecular drug D0C1EQ DRUGINCH 1S/C16H16O2S/c17-16(18)12-19-11-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9H,10-12H2,(H,17,18) D0C1EQ DRUGINKE VNCUHIXOCDBZGU-UHFFFAOYSA-N D0C1EQ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCSCC(=O)O D0C1EQ HIGHSTAT Investigative D0C1FY DRUG__ID D0C1FY D0C1FY DRUGTYPE Small molecular drug D0C1FY DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1 D0C1FY DRUGINKE WQZGKKKJIJFFOK-GASJEMHNSA-N D0C1FY DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D0C1FY HIGHSTAT Investigative D0C1GO DRUG__ID D0C1GO D0C1GO DRUGTYPE Small molecular drug D0C1GO DRUGINCH 1S/C16H11BrF3N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25) D0C1GO DRUGINKE OYZKFVIVPRQRQQ-UHFFFAOYSA-N D0C1GO DRUGSMIL C1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)Br D0C1GO HIGHSTAT Investigative D0C1LI DRUG__ID D0C1LI D0C1LI DRUGTYPE Small molecular drug D0C1LI DRUGINCH 1S/C29H37N3O/c1-4-16-30(2)23-27-20-26-21-28(12-13-29(26)31(27)3)33-19-8-11-24-14-17-32(18-15-24)22-25-9-6-5-7-10-25/h1,5-7,9-10,12-13,20-21,24H,8,11,14-19,22-23H2,2-3H3 D0C1LI DRUGINKE ADCBAOTWERXLAP-UHFFFAOYSA-N D0C1LI DRUGSMIL CN1C2=C(C=C(C=C2)OCCCC3CCN(CC3)CC4=CC=CC=C4)C=C1CN(C)CC#C D0C1LI HIGHSTAT Investigative D0C1NP DRUG__ID D0C1NP D0C1NP DRUGTYPE Small molecular drug D0C1NP DRUGINCH 1S/C13H13NO5/c1-13(2)11(16)14(12(17)19-13)10(15)8-4-6-9(18-3)7-5-8/h4-7H,1-3H3 D0C1NP DRUGINKE ZYRNCIWULACSEK-UHFFFAOYSA-N D0C1NP DRUGSMIL CC1(C(=O)N(C(=O)O1)C(=O)C2=CC=C(C=C2)OC)C D0C1NP HIGHSTAT Investigative D0C1NU DRUG__ID D0C1NU D0C1NU DRUGTYPE Small molecular drug D0C1NU DRUGINCH 1S/C14H10Cl2N2O3/c1-8-12(3-2-4-13(8)18(20)21)14(19)17-11-6-9(15)5-10(16)7-11/h2-7H,1H3,(H,17,19) D0C1NU DRUGINKE NKIJNFMSYDSAJK-UHFFFAOYSA-N D0C1NU DRUGSMIL CC1=C(C=CC=C1[N+](=O)[O-])C(=O)NC2=CC(=CC(=C2)Cl)Cl D0C1NU HIGHSTAT Investigative D0C1OB DRUG__ID D0C1OB D0C1OB DRUGTYPE Small molecular drug D0C1OB DRUGINCH 1S/C4H8N2/c5-4-2-1-3-6-4/h1-3H2,(H2,5,6) D0C1OB DRUGINKE NJBMZYSKLWQXLJ-UHFFFAOYSA-N D0C1OB DRUGSMIL C1CC(=NC1)N D0C1OB HIGHSTAT Investigative D0C1PC DRUG__ID D0C1PC D0C1PC DRUGTYPE Small molecular drug D0C1PC DRUGINCH 1S/C3H6FO6P/c4-1-2(3(5)6)10-11(7,8)9/h2H,1H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1 D0C1PC DRUGINKE BNOCDEBUFVJMQI-REOHCLBHSA-N D0C1PC DRUGSMIL C(C(C(=O)O)OP(=O)(O)O)F D0C1PC HIGHSTAT Investigative D0C1PS DRUG__ID D0C1PS D0C1PS DRUGTYPE Small molecular drug D0C1PS DRUGINCH 1S/C8H11N5O/c9-7-6-8(11-4-10-7)13(5-12-6)2-1-3-14/h4-5,14H,1-3H2,(H2,9,10,11) D0C1PS DRUGINKE BLZBVHFRNUTFCH-UHFFFAOYSA-N D0C1PS DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CCCO)N D0C1PS HIGHSTAT Investigative D0C1RY DRUG__ID D0C1RY D0C1RY DRUGTYPE Small molecular drug D0C1RY DRUGINCH 1S/C25H34N6O9/c26-12-19(32)29-17(11-15-5-2-1-3-6-15)25(40)31-10-4-7-18(31)24(39)30-16(8-9-21(34)35)23(38)28-13-20(33)27-14-22(36)37/h1-3,5-6,16-18H,4,7-14,26H2,(H,27,33)(H,28,38)(H,29,32)(H,30,39)(H,34,35)(H,36,37)/t16-,17-,18-/m0/s1 D0C1RY DRUGINKE WXUQGIGEEDNHIW-BZSNNMDCSA-N D0C1RY DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)NC(=O)CN)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NCC(=O)O D0C1RY HIGHSTAT Investigative D0C1SE DRUG__ID D0C1SE D0C1SE DRUGTYPE Small molecular drug D0C1SE DRUGINCH 1S/C11H12N2/c1-2-4-11-9(3-1)7-10-8-12-5-6-13(10)11/h1-4,7,12H,5-6,8H2 D0C1SE DRUGINKE AEIDURNZWCNQIM-UHFFFAOYSA-N D0C1SE DRUGSMIL C1CN2C(=CC3=CC=CC=C32)CN1 D0C1SE HIGHSTAT Investigative D0C1TS DRUG__ID D0C1TS D0C1TS DRUGTYPE Small molecular drug D0C1TS DRUGINCH 1S/C21H27FN6O6S/c1-13-8-9-16(27-35(33,34)12-14-5-2-3-6-15(14)22)19(30)28(13)11-18(29)26-17(20(31)32)7-4-10-25-21(23)24/h2-3,5-6,8-9,17,27H,4,7,10-12H2,1H3,(H,26,29)(H,31,32)(H4,23,24,25)/t17-/m1/s1 D0C1TS DRUGINKE QTGRXIGBXXVLEH-QGZVFWFLSA-N D0C1TS DRUGSMIL CC1=CC=C(C(=O)N1CC(=O)NC(CCCN=C(N)N)C(=O)O)NS(=O)(=O)CC2=CC=CC=C2F D0C1TS HIGHSTAT Investigative D0C1UM DRUG__ID D0C1UM D0C1UM DRUGTYPE Small molecular drug D0C1UM DRUGINCH 1S/C22H23NO4/c1-26-12-5-6-13-14(8-12)15-9-19(24)20(27-2)10-16(15)17-11-23-7-3-4-18(23)22(25)21(13)17/h5-6,8-10,18,22,24-25H,3-4,7,11H2,1-2H3/t18-,22+/m0/s1 D0C1UM DRUGINKE CMFIDYCYVJWPPL-PGRDOPGGSA-N D0C1UM DRUGSMIL COC1=CC2=C(C=C1)C3=C(CN4CCCC4C3O)C5=CC(=C(C=C52)O)OC D0C1UM HIGHSTAT Investigative D0C1VA DRUG__ID D0C1VA D0C1VA DRUGTYPE Small molecular drug D0C1VA DRUGINCH 1S/C13H13N3O2/c17-12-7-11(15-13(18)16-12)14-10-5-4-8-2-1-3-9(8)6-10/h4-7H,1-3H2,(H3,14,15,16,17,18) D0C1VA DRUGINKE CVUMGFDAIXWWCV-UHFFFAOYSA-N D0C1VA DRUGSMIL C1CC2=C(C1)C=C(C=C2)NC3=CC(=O)NC(=O)N3 D0C1VA HIGHSTAT Investigative D0C1XE DRUG__ID D0C1XE D0C1XE DRUGTYPE Small molecular drug D0C1XE DRUGINCH 1S/C19H23NO/c1-2-6-16(7-3-1)14-17-9-11-19(12-10-17)21-15-18-8-4-5-13-20-18/h1-3,6-7,9-12,18,20H,4-5,8,13-15H2/t18-/m1/s1 D0C1XE DRUGINKE YZRAMLLKPOGYCE-GOSISDBHSA-N D0C1XE DRUGSMIL C1CCNC(C1)COC2=CC=C(C=C2)CC3=CC=CC=C3 D0C1XE HIGHSTAT Investigative D0C1XI DRUG__ID D0C1XI D0C1XI DRUGTYPE Small molecular drug D0C1XI DRUGINCH 1S/C14H15NO2S/c1-3-7-12-13(17-10(2)16)15-14(18-12)11-8-5-4-6-9-11/h4-6,8-9H,3,7H2,1-2H3 D0C1XI DRUGINKE PNDOMGBHENBUGB-UHFFFAOYSA-N D0C1XI DRUGSMIL CCCC1=C(N=C(S1)C2=CC=CC=C2)OC(=O)C D0C1XI HIGHSTAT Investigative D0C2DM DRUG__ID D0C2DM D0C2DM DRUGTYPE Small molecular drug D0C2DM DRUGINCH 1S/C32H30FN3O2/c1-21(36(2)20-22-8-15-27(33)16-9-22)34-28-17-14-26-18-30(37)31(29(26)19-28)35-32(38)25-12-10-24(11-13-25)23-6-4-3-5-7-23/h3-17,19,30-31,37H,18,20H2,1-2H3,(H,35,38)/t30-,31-/m1/s1 D0C2DM DRUGINKE KOQVBYSCBCRVQJ-FIRIVFDPSA-N D0C2DM DRUGSMIL CC(=NC1=CC2=C(CC(C2NC(=O)C3=CC=C(C=C3)C4=CC=CC=C4)O)C=C1)N(C)CC5=CC=C(C=C5)F D0C2DM HIGHSTAT Investigative D0C2DN DRUG__ID D0C2DN D0C2DN DRUGTYPE Small molecular drug D0C2DN DRUGINCH 1S/C29H49O12P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(31)40-22(20-30)21-39-42(37,38)41-29-27(35)25(33)24(32)26(34)28(29)36/h6-7,9-10,12-13,15-16,22,24-30,32-36H,2-5,8,11,14,17-21H2,1H3,(H,37,38)/p-1/b7-6-,10-9-,13-12-,16-15- D0C2DN DRUGINKE OKEQUIXTUXJQNT-DOFZRALJSA-M D0C2DN DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(CO)COP(=O)([O-])OC1C(C(C(C(C1O)O)O)O)O D0C2DN HIGHSTAT Investigative D0C2FM DRUG__ID D0C2FM D0C2FM DRUGTYPE Small molecular drug D0C2FM DRUGINCH 1S/C15H13NO/c1-12-5-3-7-14(16-12)10-9-13-6-4-8-15(11-13)17-2/h3-8,11H,1-2H3 D0C2FM DRUGINKE STDHINPODVHROK-UHFFFAOYSA-N D0C2FM DRUGSMIL CC1=NC(=CC=C1)C#CC2=CC(=CC=C2)OC D0C2FM HIGHSTAT Investigative D0C2FS DRUG__ID D0C2FS D0C2FS DRUGTYPE Small molecular drug D0C2FS DRUGINCH 1S/C7H12O4S/c8-6(9)2-1-5(3-4-12)7(10)11/h5,12H,1-4H2,(H,8,9)(H,10,11) D0C2FS DRUGINKE SMGZBRVSYVJHCB-UHFFFAOYSA-N D0C2FS DRUGSMIL C(CC(=O)O)C(CCS)C(=O)O D0C2FS HIGHSTAT Investigative D0C2GE DRUG__ID D0C2GE D0C2GE DRUGTYPE Small molecular drug D0C2GE DRUGINCH 1S/C25H26ClN5O/c1-2-31-13-9-18(10-14-31)29-19-7-8-21-20(15-19)23(25(32)30-21)22(24-27-11-12-28-24)16-3-5-17(26)6-4-16/h3-8,11-12,15,18,29H,2,9-10,13-14H2,1H3,(H,27,28)(H,30,32) D0C2GE DRUGINKE XHCPCYVQXFHJAU-UHFFFAOYSA-N D0C2GE DRUGSMIL CCN1CCC(CC1)NC2=CC3=C(C=C2)NC(=O)C3=C(C4=CC=C(C=C4)Cl)C5=NC=CN5 D0C2GE HIGHSTAT Investigative D0C2GR DRUG__ID D0C2GR D0C2GR DRUGTYPE Small molecular drug D0C2GR DRUGINCH 1S/C16H13FN2O2S/c1-11-2-8-14(9-3-11)19-15(20)18(16(21)22-19)10-12-4-6-13(17)7-5-12/h2-9H,10H2,1H3 D0C2GR DRUGINKE QUIIIYITNGOFEI-UHFFFAOYSA-N D0C2GR DRUGSMIL CC1=CC=C(C=C1)N2C(=O)N(C(=O)S2)CC3=CC=C(C=C3)F D0C2GR HIGHSTAT Investigative D0C2GW DRUG__ID D0C2GW D0C2GW DRUGTYPE Small molecular drug D0C2GW DRUGINCH 1S/C29H39NO7/c1-6-9-20-23(14-11-19-12-15-25(29(32)33)37-26(19)20)35-17-8-18-36-24-16-13-22(28(31)30(3)4)27(34-5)21(24)10-7-2/h11,13-14,16,25H,6-10,12,15,17-18H2,1-5H3,(H,32,33) D0C2GW DRUGINKE DHAATERTHLJWHW-UHFFFAOYSA-N D0C2GW DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)N(C)C)OC)CCC D0C2GW HIGHSTAT Investigative D0C2IE DRUG__ID D0C2IE D0C2IE DRUGTYPE Small molecular drug D0C2IE DRUGINCH 1S/C18H17N3O/c1-13(14-7-3-2-4-8-14)11-20-18(22)17-12-19-15-9-5-6-10-16(15)21-17/h2-10,12-13H,11H2,1H3,(H,20,22) D0C2IE DRUGINKE UWOAOBCILHACGX-UHFFFAOYSA-N D0C2IE DRUGSMIL CC(CNC(=O)C1=NC2=CC=CC=C2N=C1)C3=CC=CC=C3 D0C2IE HIGHSTAT Investigative D0C2JS DRUG__ID D0C2JS D0C2JS DRUGTYPE Small molecular drug D0C2JS DRUGINCH 1S/C19H18ClN5OS/c1-9-10(2)27-19-16(9)17(12-4-6-13(20)7-5-12)22-14(8-15(21)26)18-24-23-11(3)25(18)19/h4-7,14H,8H2,1-3H3,(H2,21,26)/t14-/m0/s1 D0C2JS DRUGINKE QECMENZMDBOLDR-AWEZNQCLSA-N D0C2JS DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)N)C4=CC=C(C=C4)Cl)C D0C2JS HIGHSTAT Investigative D0C2KD DRUG__ID D0C2KD D0C2KD DRUGTYPE Small molecular drug D0C2KD DRUGINCH 1S/C13H17N3O5/c17-12(15-19)4-2-1-3-9-14-13(18)10-5-7-11(8-6-10)16(20)21/h5-8,19H,1-4,9H2,(H,14,18)(H,15,17) D0C2KD DRUGINKE GDAAHZPABCCCFD-UHFFFAOYSA-N D0C2KD DRUGSMIL C1=CC(=CC=C1C(=O)NCCCCCC(=O)NO)[N+](=O)[O-] D0C2KD HIGHSTAT Investigative D0C2KK DRUG__ID D0C2KK D0C2KK DRUGTYPE Small molecular drug D0C2KK DRUGINCH 1S/C19H19NO5/c1-21-12-7-13(22-2)9-14(8-12)25-17-5-6-20-16-11-19(24-4)18(23-3)10-15(16)17/h5-11H,1-4H3 D0C2KK DRUGINKE RNXKKASQCMYWCJ-UHFFFAOYSA-N D0C2KK DRUGSMIL COC1=CC(=CC(=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC)OC D0C2KK HIGHSTAT Investigative D0C2KS DRUG__ID D0C2KS D0C2KS DRUGTYPE Small molecular drug D0C2KS DRUGINCH 1S/C29H39N3O4/c1-28(26(34)31-24-8-4-5-9-25(24)33,16-21-17-30-23-7-3-2-6-22(21)23)32-27(35)36-29-13-18-10-19(14-29)12-20(11-18)15-29/h2-3,6-7,17-20,24-25,30,33H,4-5,8-16H2,1H3,(H,31,34)(H,32,35)/t18?,19?,20?,24-,25-,28+,29?/m0/s1 D0C2KS DRUGINKE UOFRODPUIMDZTB-HDCXSGMISA-N D0C2KS DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC3CCCCC3O)NC(=O)OC45CC6CC(C4)CC(C6)C5 D0C2KS HIGHSTAT Investigative D0C2NK DRUG__ID D0C2NK D0C2NK DRUGTYPE Small molecular drug D0C2NK DRUGINCH 1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2 D0C2NK DRUGINKE WIQRCHMSJFFONW-UHFFFAOYSA-N D0C2NK DRUGSMIL C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F D0C2NK HIGHSTAT Investigative D0C2NQ DRUG__ID D0C2NQ D0C2NQ DRUGTYPE Small molecular drug D0C2NQ DRUGINCH 1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/p+1/t7-,8-/m0/s1 D0C2NQ DRUGINKE FKCMADOPPWWGNZ-YUMQZZPRSA-O D0C2NQ DRUGSMIL B(C1CCCN1C(=O)C(C(C)C)[NH3+])(O)O D0C2NQ HIGHSTAT Investigative D0C2PD DRUG__ID D0C2PD D0C2PD DRUGTYPE Small molecular drug D0C2PD DRUGINCH 1S/C24H25N3O7S/c1-26-19-13-18(25-35(29,30)17-10-11-21(32-4)23(12-17)33-5)22(14-20(19)27(2)24(26)28)34-16-8-6-15(31-3)7-9-16/h6-14,25H,1-5H3 D0C2PD DRUGINKE KNVIUMWNYXDULF-UHFFFAOYSA-N D0C2PD DRUGSMIL CN1C2=C(C=C(C(=C2)NS(=O)(=O)C3=CC(=C(C=C3)OC)OC)OC4=CC=C(C=C4)OC)N(C1=O)C D0C2PD HIGHSTAT Investigative D0C2SF DRUG__ID D0C2SF D0C2SF DRUGTYPE Small molecular drug D0C2SF DRUGINCH 1S/C9H5ClN4/c10-7-3-1-6(2-4-7)9-8(5-11)12-14-13-9/h1-4H,(H,12,13,14) D0C2SF DRUGINKE KBDVIKMDRWVMPM-UHFFFAOYSA-N D0C2SF DRUGSMIL C1=CC(=CC=C1C2=NNN=C2C#N)Cl D0C2SF HIGHSTAT Investigative D0C2UJ DRUG__ID D0C2UJ D0C2UJ DRUGTYPE Small molecular drug D0C2UJ DRUGINCH 1S/C10H12ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1 D0C2UJ DRUGINKE BIXYYZIIJIXVFW-UUOKFMHZSA-N D0C2UJ DRUGSMIL C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N D0C2UJ HIGHSTAT Investigative D0C2UQ DRUG__ID D0C2UQ D0C2UQ DRUGTYPE Small molecular drug D0C2UQ DRUGINCH 1S/C28H34N2O2/c31-27(29-22-9-2-1-3-10-22)32-23-13-12-21-17-26-24-11-4-5-14-28(24,25(21)18-23)15-16-30(26)19-20-7-6-8-20/h1-3,9-10,12-13,18,20,24,26H,4-8,11,14-17,19H2,(H,29,31) D0C2UQ DRUGINKE UDWPHJLFGHTIHV-UHFFFAOYSA-N D0C2UQ DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)NC5=CC=CC=C5)CC6CCC6 D0C2UQ HIGHSTAT Investigative D0C2VP DRUG__ID D0C2VP D0C2VP DRUGTYPE Small molecular drug D0C2VP DRUGINCH 1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31) D0C2VP DRUGINKE ZNOVTXRBGFNYRX-UHFFFAOYSA-N D0C2VP DRUGSMIL CN1C(CNC2=C1C(=O)NC(=N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0C2VP HIGHSTAT Investigative D0C2WX DRUG__ID D0C2WX D0C2WX DRUGTYPE Small molecular drug D0C2WX DRUGINCH 1S/C13H11ClO3/c14-9-5-2-1-4-8(9)13(17)12-10(15)6-3-7-11(12)16/h1-2,4-5,12H,3,6-7H2 D0C2WX DRUGINKE TYJXBELAFWQDPT-UHFFFAOYSA-N D0C2WX DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2=CC=CC=C2Cl D0C2WX HIGHSTAT Investigative D0C2XT DRUG__ID D0C2XT D0C2XT DRUGTYPE Small molecular drug D0C2XT DRUGINCH 1S/C23H17F3N4O4/c1-10-17(11(2)34-30-10)13-8-14-20(29-22(13)32-3)19-15(9-27-14)28-21(31)18(19)12-6-4-5-7-16(12)33-23(24,25)26/h4-9,18H,1-3H3,(H,28,31) D0C2XT DRUGINKE WWSIFGSLYORAET-UHFFFAOYSA-N D0C2XT DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=NC=C4C(=C3N=C2OC)C(C(=O)N4)C5=CC=CC=C5OC(F)(F)F D0C2XT HIGHSTAT Investigative D0C2YL DRUG__ID D0C2YL D0C2YL DRUGTYPE Small molecular drug D0C2YL DRUGINCH 1S/C6H14O11P2/c7-5-3(1-15-18(9,10)11)17-4(6(5)8)2-16-19(12,13)14/h3-8H,1-2H2,(H2,9,10,11)(H2,12,13,14)/t3-,4+,5-,6-/m1/s1 D0C2YL DRUGINKE WSMBXSQDFPTODV-JGWLITMVSA-N D0C2YL DRUGSMIL C(C1C(C(C(O1)COP(=O)(O)O)O)O)OP(=O)(O)O D0C2YL HIGHSTAT Investigative D0C2ZW DRUG__ID D0C2ZW D0C2ZW DRUGTYPE Small molecular drug D0C2ZW DRUGINCH 1S/C27H33N5O5/c28-20(16-17-10-12-19(33)13-11-17)26(36)32-15-5-9-22(32)25(35)30-23(18-6-2-1-3-7-18)27(37)31-14-4-8-21(31)24(29)34/h1-3,6-7,10-13,20-23,33H,4-5,8-9,14-16,28H2,(H2,29,34)(H,30,35)/t20-,21-,22-,23-/m0/s1 D0C2ZW DRUGINKE QTYFABXBYBNUEU-MLCQCVOFSA-N D0C2ZW DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(C3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D0C2ZW HIGHSTAT Investigative D0C3AD DRUG__ID D0C3AD D0C3AD DRUGTYPE Small molecular drug D0C3AD DRUGINCH 1S/C25H23N5O2/c31-25(29-20-9-13-32-14-10-20)18-6-4-17(5-7-18)23-15-19(8-12-27-23)21-16-28-30-24(21)22-3-1-2-11-26-22/h1-8,11-12,15-16,20H,9-10,13-14H2,(H,28,30)(H,29,31) D0C3AD DRUGINKE SAGZIBJAQGBRQA-UHFFFAOYSA-N D0C3AD DRUGSMIL C1COCCC1NC(=O)C2=CC=C(C=C2)C3=NC=CC(=C3)C4=C(NN=C4)C5=CC=CC=N5 D0C3AD HIGHSTAT Investigative D0C3AG DRUG__ID D0C3AG D0C3AG DRUGTYPE Small molecular drug D0C3AG DRUGINCH 1S/C12H5Br5O2/c13-5-1-2-8(6(14)3-5)19-9-4-7(15)10(16)11(17)12(9)18/h1-4,18H D0C3AG DRUGINKE FSIJSYKTNOYMTQ-UHFFFAOYSA-N D0C3AG DRUGSMIL C1=CC(=C(C=C1Br)Br)OC2=CC(=C(C(=C2O)Br)Br)Br D0C3AG HIGHSTAT Investigative D0C3AJ DRUG__ID D0C3AJ D0C3AJ DRUGTYPE Small molecular drug D0C3AJ DRUGINCH 1S/C16H18N2O2/c19-16(15-7-10-3-1-2-4-14(10)18-15)20-13-8-11-5-6-12(9-13)17-11/h1-4,7,11-13,17-18H,5-6,8-9H2/t11-,12-/m1/s1 D0C3AJ DRUGINKE JTIOAVUBNSKIPD-VXGBXAGGSA-N D0C3AJ DRUGSMIL C1CC2CC(CC1N2)OC(=O)C3=CC4=CC=CC=C4N3 D0C3AJ HIGHSTAT Investigative D0C3AR DRUG__ID D0C3AR D0C3AR DRUGTYPE Small molecular drug D0C3AR DRUGINCH 1S/C8H8ClN3/c9-6-3-1-2-5-4-11-8(10)12-7(5)6/h1-3H,4H2,(H3,10,11,12) D0C3AR DRUGINKE AWSSYPVAGZEEAA-UHFFFAOYSA-N D0C3AR DRUGSMIL C1C2=C(C(=CC=C2)Cl)NC(=N1)N D0C3AR HIGHSTAT Investigative D0C3CS DRUG__ID D0C3CS D0C3CS DRUGTYPE Small molecular drug D0C3CS DRUGINCH 1S/C8H4F4N2/c1-2-3-4(9)5(10)6(11)7(12)8(3)14-13-2/h1H3,(H,13,14) D0C3CS DRUGINKE MEHLPQAUVAMMPE-UHFFFAOYSA-N D0C3CS DRUGSMIL CC1=C2C(=C(C(=C(C2=NN1)F)F)F)F D0C3CS HIGHSTAT Investigative D0C3EX DRUG__ID D0C3EX D0C3EX DRUGTYPE Small molecular drug D0C3EX DRUGINCH 1S/C19H30N2O/c1-2-3-4-5-6-7-8-13-22-17-9-10-19-18(14-17)16(11-12-20)15-21-19/h9-10,14-15,21H,2-8,11-13,20H2,1H3 D0C3EX DRUGINKE YHSMSRREJYOGQJ-UHFFFAOYSA-N D0C3EX DRUGSMIL CCCCCCCCCOC1=CC2=C(C=C1)NC=C2CCN D0C3EX HIGHSTAT Investigative D0C3HQ DRUG__ID D0C3HQ D0C3HQ DRUGTYPE Small molecular drug D0C3HQ DRUGINCH 1S/C26H27N3O4/c1-3-4-17-33-21-15-11-19(12-16-21)25(30)28-29-24(18-9-13-20(32-2)14-10-18)27-23-8-6-5-7-22(23)26(29)31/h5-16,24,27H,3-4,17H2,1-2H3,(H,28,30) D0C3HQ DRUGINKE XORVAHQXRDLSFT-UHFFFAOYSA-N D0C3HQ DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)NN2C(NC3=CC=CC=C3C2=O)C4=CC=C(C=C4)OC D0C3HQ HIGHSTAT Investigative D0C3ID DRUG__ID D0C3ID D0C3ID DRUGTYPE Small molecular drug D0C3ID DRUGINCH 1S/C23H17N3O/c27-22(19-14-8-3-9-15-19)26-23-24-20(17-10-4-1-5-11-17)16-21(25-23)18-12-6-2-7-13-18/h1-16H,(H,24,25,26,27) D0C3ID DRUGINKE YAAODHHMHPMCPL-UHFFFAOYSA-N D0C3ID DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=N2)NC(=O)C3=CC=CC=C3)C4=CC=CC=C4 D0C3ID HIGHSTAT Investigative D0C3IS DRUG__ID D0C3IS D0C3IS DRUGTYPE Small molecular drug D0C3IS DRUGINCH 1S/C26H27N5O2/c32-23(11-14-30-12-4-1-5-13-30)27-17-8-9-22-20(16-17)26(33)31-15-10-19-18-6-2-3-7-21(18)28-24(19)25(31)29-22/h2-3,6-9,16,28H,1,4-5,10-15H2,(H,27,32) D0C3IS DRUGINKE SJTYFVUMCWQRRK-UHFFFAOYSA-N D0C3IS DRUGSMIL C1CCN(CC1)CCC(=O)NC2=CC3=C(C=C2)N=C4C5=C(CCN4C3=O)C6=CC=CC=C6N5 D0C3IS HIGHSTAT Investigative D0C3JV DRUG__ID D0C3JV D0C3JV DRUGTYPE Small molecular drug D0C3JV DRUGINCH 1S/C14H16N2O6/c17-11-1-2-12(18)15(11)5-7-21-9-10-22-8-6-16-13(19)3-4-14(16)20/h1-4H,5-10H2 D0C3JV DRUGINKE FERLGYOHRKHQJP-UHFFFAOYSA-N D0C3JV DRUGSMIL C1=CC(=O)N(C1=O)CCOCCOCCN2C(=O)C=CC2=O D0C3JV HIGHSTAT Investigative D0C3JX DRUG__ID D0C3JX D0C3JX DRUGTYPE Small molecular drug D0C3JX DRUGINCH 1S/C16H11BrN4O/c17-11-1-2-14-15(8-11)21-16(22)4-3-13(20-14)10-5-6-19-12(7-10)9-18/h1-2,5-8H,3-4H2,(H,21,22) D0C3JX DRUGINKE JNLRDCDCGXPNKH-UHFFFAOYSA-N D0C3JX DRUGSMIL C1CC(=O)NC2=C(C=CC(=C2)Br)N=C1C3=CC(=NC=C3)C#N D0C3JX HIGHSTAT Investigative D0C3KE DRUG__ID D0C3KE D0C3KE DRUGTYPE Small molecular drug D0C3KE DRUGINCH 1S/C15H11ClN2O2/c16-8-14(19)9-3-4-13-11(6-9)12(15(20)18-13)7-10-2-1-5-17-10/h1-7,17H,8H2,(H,18,20)/b12-7- D0C3KE DRUGINKE SEPHEVMRHYRRLS-GHXNOFRVSA-N D0C3KE DRUGSMIL C1=CNC(=C1)C=C2C3=C(C=CC(=C3)C(=O)CCl)NC2=O D0C3KE HIGHSTAT Investigative D0C3QE DRUG__ID D0C3QE D0C3QE DRUGTYPE Small molecular drug D0C3QE DRUGINCH 1S/C17H16N4O/c18-17(19)21-16-14-7-4-8-15(13(14)9-10-20-16)22-11-12-5-2-1-3-6-12/h1-10H,11H2,(H4,18,19,20,21) D0C3QE DRUGINKE KMGPZVZUHUMNQX-UHFFFAOYSA-N D0C3QE DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC3=C2C=CN=C3N=C(N)N D0C3QE HIGHSTAT Investigative D0C3SJ DRUG__ID D0C3SJ D0C3SJ DRUGTYPE Small molecular drug D0C3SJ DRUGINCH 1S/C12H17NO2S/c1-9(2)11-7-10(14)8-12(16-11)13-3-5-15-6-4-13/h7-9H,3-6H2,1-2H3 D0C3SJ DRUGINKE AWDQFPIPWUUVQD-UHFFFAOYSA-N D0C3SJ DRUGSMIL CC(C)C1=CC(=O)C=C(S1)N2CCOCC2 D0C3SJ HIGHSTAT Investigative D0C3SL DRUG__ID D0C3SL D0C3SL DRUGTYPE Small molecular drug D0C3SL DRUGINCH 1S/C28H42O2/c1-25(2,3)19-13-17(14-20(23(19)29)26(4,5)6)18-15-21(27(7,8)9)24(30)22(16-18)28(10,11)12/h13-16,29-30H,1-12H3 D0C3SL DRUGINKE GSOYMOAPJZYXTB-UHFFFAOYSA-N D0C3SL DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C D0C3SL HIGHSTAT Investigative D0C3VI DRUG__ID D0C3VI D0C3VI DRUGTYPE Small molecular drug D0C3VI DRUGINCH 1S/C33H46N4O5/c1-23(2)21-27(35-32(41)37-19-11-6-7-12-20-37)29(38)34-28(30(39)36-33(3,4)5)22-24-15-17-26(18-16-24)42-31(40)25-13-9-8-10-14-25/h8-10,13-18,23,27-28H,6-7,11-12,19-22H2,1-5H3,(H,34,38)(H,35,41)(H,36,39)/t27-,28-/m0/s1 D0C3VI DRUGINKE RASCVEWVRJPMSU-NSOVKSMOSA-N D0C3VI DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)OC(=O)C2=CC=CC=C2)C(=O)NC(C)(C)C)NC(=O)N3CCCCCC3 D0C3VI HIGHSTAT Investigative D0C3WS DRUG__ID D0C3WS D0C3WS DRUGCOMP EyeCyte Inc D0C3WS DRUGINCH 1S/C29H29F3O3/c1-17(33)18-3-5-19(6-4-18)24-16-27(2)25(11-12-28(27,35)13-14-29(30,31)32)23-9-7-20-15-21(34)8-10-22(20)26(23)24/h3-6,15,23-25,35H,7-12,16H2,1-2H3/t23-,24+,25-,27-,28+/m0/s1 D0C3WS DRUGINKE PBOYEGPKOBYDAP-YTFMROOWSA-N D0C3WS DRUGSMIL CC(=O)C1=CC=C(C=C1)C2CC3(C(CCC3(C#CC(F)(F)F)O)C4C2=C5CCC(=O)C=C5CC4)C D0C3WS HIGHSTAT Investigative D0C3WY DRUG__ID D0C3WY D0C3WY DRUGTYPE Small molecular drug D0C3WY DRUGINCH 1S/C16H11NO2/c18-15-13(11-7-3-1-4-8-11)14(16(19)17-15)12-9-5-2-6-10-12/h1-10H,(H,17,18,19) D0C3WY DRUGINKE WADCPEMKIBAJHH-UHFFFAOYSA-N D0C3WY DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=CC=C3 D0C3WY HIGHSTAT Investigative D0C3XF DRUG__ID D0C3XF D0C3XF DRUGTYPE Small molecular drug D0C3XF DRUGINCH 1S/C22H30N2O/c1-2-3-4-5-6-7-8-9-11-19-13-15-20(16-14-19)22(25)24-21-12-10-17-23-18-21/h10,12-18H,2-9,11H2,1H3,(H,24,25) D0C3XF DRUGINKE QIODTOXMQFMJNV-UHFFFAOYSA-N D0C3XF DRUGSMIL CCCCCCCCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 D0C3XF HIGHSTAT Investigative D0C3XU DRUG__ID D0C3XU D0C3XU DRUGTYPE Small molecular drug D0C3XU DRUGINCH 1S/C14H18O2/c1-8-6-7-10-4-3-5-11-9(2)14(15)16-13(11)12(8)10/h6,10-13H,2-5,7H2,1H3/t10-,11+,12+,13+/m1/s1 D0C3XU DRUGINKE PFGQZVWFUUWHOT-VOAKCMCISA-N D0C3XU DRUGSMIL CC1=CCC2C1C3C(CCC2)C(=C)C(=O)O3 D0C3XU HIGHSTAT Investigative D0C3YJ DRUG__ID D0C3YJ D0C3YJ DRUGTYPE Small molecular drug D0C3YJ DRUGINCH 1S/C19H26O4/c1-12(2)8-7-9-13(3)10-11-15-14(4)16(20)18(22-5)19(23-6)17(15)21/h8,10H,7,9,11H2,1-6H3/b13-10+ D0C3YJ DRUGINKE SQQWBSBBCSFQGC-JLHYYAGUSA-N D0C3YJ DRUGSMIL CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)CCC=C(C)C D0C3YJ HIGHSTAT Investigative D0C4AE DRUG__ID D0C4AE D0C4AE DRUGTYPE Small molecular drug D0C4AE DRUGINCH 1S/C19H20N2O2S/c22-24(23,16-6-2-1-3-7-16)19-14-21(15-10-12-20-13-11-15)18-9-5-4-8-17(18)19/h1-9,14-15,20H,10-13H2 D0C4AE DRUGINKE VDJWPWVFSZYDTQ-UHFFFAOYSA-N D0C4AE DRUGSMIL C1CNCCC1N2C=C(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4 D0C4AE HIGHSTAT Investigative D0C4CG DRUG__ID D0C4CG D0C4CG DRUGTYPE Small molecular drug D0C4CG DRUGINCH 1S/C22H36ClNO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25) D0C4CG DRUGINKE SCJNCDSAIRBRIA-UHFFFAOYSA-N D0C4CG DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCCl D0C4CG HIGHSTAT Investigative D0C4DE DRUG__ID D0C4DE D0C4DE DRUGTYPE Small molecular drug D0C4DE DRUGINCH 1S/C21H26Cl2N4O2/c22-12-19(24)25-10-4-9-18-20(28)27(21(29)26-18)13-14-5-3-6-15(11-14)16-7-1-2-8-17(16)23/h1-3,5-8,11,18-20,25,28H,4,9-10,12-13,24H2,(H,26,29) D0C4DE DRUGINKE TXEBWPPWSVMYOA-UHFFFAOYSA-N D0C4DE DRUGSMIL C1=CC=C(C(=C1)C2=CC=CC(=C2)CN3C(C(NC3=O)CCCNC(CCl)N)O)Cl D0C4DE HIGHSTAT Investigative D0C4GE DRUG__ID D0C4GE D0C4GE DRUGTYPE Small molecular drug D0C4GE DRUGINCH 1S/C11H18N2O7/c1-4(15)13-8-5(12)2-7(11(18)19)20-10(8)9(17)6(16)3-14/h2,5-6,8-10,14,16-17H,3,12H2,1H3,(H,13,15)(H,18,19)/t5-,6+,8+,9+,10+/m0/s1 D0C4GE DRUGINKE NKENBBIXEGPQLS-UFGQHTETSA-N D0C4GE DRUGSMIL CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N D0C4GE HIGHSTAT Investigative D0C4KD DRUG__ID D0C4KD D0C4KD DRUGTYPE Small molecular drug D0C4KD DRUGINCH 1S/C14H11BrN2O2/c1-18-11-5-6-13-12(8-11)17-14(19-13)16-10-4-2-3-9(15)7-10/h2-8H,1H3,(H,16,17) D0C4KD DRUGINKE ACSVVIUPZPFHSQ-UHFFFAOYSA-N D0C4KD DRUGSMIL COC1=CC2=C(C=C1)OC(=N2)NC3=CC(=CC=C3)Br D0C4KD HIGHSTAT Investigative D0C4NA DRUG__ID D0C4NA D0C4NA DRUGTYPE Small molecular drug D0C4NA DRUGINCH 1S/C17H17NO3S/c19-12-18-15(17(20)21)11-22-16(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,12,15-16H,11H2,(H,18,19)(H,20,21) D0C4NA DRUGINKE QUWUQXPHWCHJIS-UHFFFAOYSA-N D0C4NA DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)SCC(C(=O)O)NC=O D0C4NA HIGHSTAT Investigative D0C4OV DRUG__ID D0C4OV D0C4OV DRUGTYPE Small molecular drug D0C4OV DRUGINCH 1S/C19H15N3O/c1-23-18-12-14(8-9-15(18)16-6-2-4-10-20-16)17-13-22-11-5-3-7-19(22)21-17/h2-13H,1H3 D0C4OV DRUGINKE DNCGFJANVDVZIZ-UHFFFAOYSA-N D0C4OV DRUGSMIL COC1=C(C=CC(=C1)C2=CN3C=CC=CC3=N2)C4=CC=CC=N4 D0C4OV HIGHSTAT Investigative D0C4PT DRUG__ID D0C4PT D0C4PT DRUGTYPE Small molecular drug D0C4PT DRUGINCH 1S/C31H50O/c1-8-10-11-22-29(16-9-2)23-15-21-27(4)18-13-12-17-26(3)19-14-20-28(5)24-25-30-31(6,7)32-30/h8-10,17-18,20,23,30H,2,11-16,19,21-22,24-25H2,1,3-7H3/b10-8-,26-17+,27-18+,28-20+,29-23- D0C4PT DRUGINKE DOTTUEYUTNVWMJ-KSTFQPQISA-N D0C4PT DRUGSMIL CC=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC1C(O1)(C)C)C)CC=C D0C4PT HIGHSTAT Investigative D0C4QH DRUG__ID D0C4QH D0C4QH DRUGTYPE Small molecular drug D0C4QH DRUGINCH 1S/C33H39N5O5/c1-21-8-5-6-11-24(21)20-28(31(41)36-27(30(35)40)19-22-9-3-2-4-10-22)37-32(42)29-12-7-17-38(29)33(43)26(34)18-23-13-15-25(39)16-14-23/h2-6,8-11,13-16,26-29,39H,7,12,17-20,34H2,1H3,(H2,35,40)(H,36,41)(H,37,42)/t26-,27-,28-,29-/m0/s1 D0C4QH DRUGINKE LJUZIHDRCVUPHL-DZUOILHNSA-N D0C4QH DRUGSMIL CC1=CC=CC=C1CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0C4QH HIGHSTAT Investigative D0C4VG DRUG__ID D0C4VG D0C4VG DRUGTYPE Small molecular drug D0C4VG DRUGINCH 1S/C4H9O8P/c5-2(3(6)4(7)8)1-12-13(9,10)11/h2-3,5-6H,1H2,(H,7,8)(H2,9,10,11)/t2-,3-/m1/s1 D0C4VG DRUGINKE ZCZXOHUILRHRQJ-PWNYCUMCSA-N D0C4VG DRUGSMIL C(C(C(C(=O)O)O)O)OP(=O)(O)O D0C4VG HIGHSTAT Investigative D0C4VX DRUG__ID D0C4VX D0C4VX DRUGTYPE Small molecular drug D0C4VX DRUGINCH 1S/C16H15ClN2O/c1-2-10-19-16-13(4-3-5-14(16)17)15(18-19)11-6-8-12(20)9-7-11/h3-9,20H,2,10H2,1H3 D0C4VX DRUGINKE OEWGFWIYFTVVAZ-UHFFFAOYSA-N D0C4VX DRUGSMIL CCCN1C2=C(C=CC=C2Cl)C(=N1)C3=CC=C(C=C3)O D0C4VX HIGHSTAT Investigative D0C4XQ DRUG__ID D0C4XQ D0C4XQ DRUGTYPE Small molecular drug D0C4XQ DRUGINCH 1S/C29H33F2NO/c30-27-13-9-25(10-14-27)29(26-11-15-28(31)16-12-26)33-22-21-32-19-17-24(18-20-32)8-4-7-23-5-2-1-3-6-23/h1-3,5-6,9-16,24,29H,4,7-8,17-22H2 D0C4XQ DRUGINKE VMIZSAUBUHOYHI-UHFFFAOYSA-N D0C4XQ DRUGSMIL C1CN(CCC1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0C4XQ HIGHSTAT Investigative D0C5AD DRUG__ID D0C5AD D0C5AD DRUGTYPE Small molecular drug D0C5AD DRUGINCH 1S/C12H10N6O5/c13-12(16-18(21)22)15-14-7-10-4-5-11(23-10)8-2-1-3-9(6-8)17(19)20/h1-7H,(H3,13,15,16)/b14-7+ D0C5AD DRUGINKE RODAAYVFYDKHGT-VGOFMYFVSA-N D0C5AD DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC=C(O2)C=NN=C(N)N[N+](=O)[O-] D0C5AD HIGHSTAT Investigative D0C5FN DRUG__ID D0C5FN D0C5FN DRUGTYPE Small molecular drug D0C5FN DRUGINCH 1S/C10H20BN2O12P2/c1-22-4-2-13(10(17)12-8(4)16)9-7(15)6(14)5(24-9)3-23-26(11,18)25-27(19,20)21/h4-7,9,14-15H,2-3H2,1,11H3,(H,12,16,17)(H2,19,20,21)/q-1/t4?,5-,6+,7+,9?,26-/m1/s1 D0C5FN DRUGINKE YXHXVAMQDBFYRD-ANTPIODHSA-N D0C5FN DRUGSMIL [BH3-]P(=O)(OCC1C(C(C(O1)N2CC(C(=O)NC2=O)OC)O)O)OP(=O)(O)O D0C5FN HIGHSTAT Investigative D0C5FY DRUG__ID D0C5FY D0C5FY DRUGTYPE Small molecular drug D0C5FY DRUGINCH 1S/C14H10O4/c1-7-12(16)5-4-10-9-3-2-8(15)6-11(9)14(17)18-13(7)10/h2-6,15-16H,1H3 D0C5FY DRUGINKE JVSYWKIVBHXUKB-UHFFFAOYSA-N D0C5FY DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=C2C=CC(=C3)O)O D0C5FY HIGHSTAT Investigative D0C5GF DRUG__ID D0C5GF D0C5GF DRUGTYPE Small molecular drug D0C5GF DRUGINCH 1S/C19H22N2O/c1-21(2)12-11-16-17-13-15(22-3)9-10-18(17)20-19(16)14-7-5-4-6-8-14/h4-10,13,20H,11-12H2,1-3H3 D0C5GF DRUGINKE VSGPGYWZVPDDSK-UHFFFAOYSA-N D0C5GF DRUGSMIL CN(C)CCC1=C(NC2=C1C=C(C=C2)OC)C3=CC=CC=C3 D0C5GF HIGHSTAT Investigative D0C5GW DRUG__ID D0C5GW D0C5GW DRUGTYPE Small molecular drug D0C5GW DRUGINCH 1S/C13H18N2O/c16-13(14-11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h1,3-4,7-8,12H,2,5-6,9-10H2,(H2,14,15,16) D0C5GW DRUGINKE WPLYTRWMCWBZEN-UHFFFAOYSA-N D0C5GW DRUGSMIL C1CCC(CC1)NC(=O)NC2=CC=CC=C2 D0C5GW HIGHSTAT Investigative D0C5HP DRUG__ID D0C5HP D0C5HP DRUGTYPE Small molecular drug D0C5HP DRUGINCH 1S/C13H9BrN2S/c14-9-3-1-4-10(7-9)17-13-6-2-5-12(16)11(13)8-15/h1-7H,16H2 D0C5HP DRUGINKE DAHSRCREKZVLOW-UHFFFAOYSA-N D0C5HP DRUGSMIL C1=CC(=CC(=C1)Br)SC2=CC=CC(=C2C#N)N D0C5HP HIGHSTAT Investigative D0C5JP DRUG__ID D0C5JP D0C5JP DRUGTYPE Small molecular drug D0C5JP DRUGINCH 1S/C11H13O7P/c12-10(13)8-3-1-2-7(4-8)5-9(11(14)15)6-19(16,17)18/h1-4,9H,5-6H2,(H,12,13)(H,14,15)(H2,16,17,18) D0C5JP DRUGINKE JQOYXWMDISLLFO-UHFFFAOYSA-N D0C5JP DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CP(=O)(O)O)C(=O)O D0C5JP HIGHSTAT Investigative D0C5LO DRUG__ID D0C5LO D0C5LO DRUGTYPE Small molecular drug D0C5LO DRUGINCH 1S/C18H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-8,13-17H2,1H3,(H,19,20) D0C5LO DRUGINKE LDZUDUYCHODRLO-UHFFFAOYSA-N D0C5LO DRUGSMIL CCCCCCCCC#CC#CCCCCCC(=O)O D0C5LO HIGHSTAT Investigative D0C5RC DRUG__ID D0C5RC D0C5RC DRUGTYPE Small molecular drug D0C5RC DRUGINCH 1S/C36H42N8O5/c1-49-25-15-13-23(14-16-25)19-30(43-36(38)39)35(48)44-17-7-12-31(44)34(47)42-29(20-24-21-40-27-11-6-5-10-26(24)27)33(46)41-28(32(37)45)18-22-8-3-2-4-9-22/h2-6,8-11,13-16,21,28-31,40H,7,12,17-20H2,1H3,(H2,37,45)(H,41,46)(H,42,47)(H4,38,39,43)/t28-,29-,30-,31-/m0/s1 D0C5RC DRUGINKE QKBVJESURFKHSK-ORYMTKCHSA-N D0C5RC DRUGSMIL COC1=CC=C(C=C1)CC(C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)N)N=C(N)N D0C5RC HIGHSTAT Investigative D0C5RQ DRUG__ID D0C5RQ D0C5RQ DRUGTYPE Small molecular drug D0C5RQ DRUGINCH 1S/C28H31F3N2O3/c1-5-33(6-2)17-18-36-25-16-15-24(19-26(25)35-4)32(3)27(34)22-9-7-20(8-10-22)21-11-13-23(14-12-21)28(29,30)31/h7-16,19H,5-6,17-18H2,1-4H3 D0C5RQ DRUGINKE JAIIZWCZERLWEK-UHFFFAOYSA-N D0C5RQ DRUGSMIL CCN(CC)CCOC1=C(C=C(C=C1)N(C)C(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)OC D0C5RQ HIGHSTAT Investigative D0C5RZ DRUG__ID D0C5RZ D0C5RZ DRUGTYPE Small molecular drug D0C5RZ DRUGINCH 1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2 D0C5RZ DRUGINKE DZGWFCGJZKJUFP-UHFFFAOYSA-N D0C5RZ DRUGSMIL C1=CC(=CC=C1CCN)O D0C5RZ HIGHSTAT Investigative D0C5SV DRUG__ID D0C5SV D0C5SV DRUGTYPE Small molecular drug D0C5SV DRUGINCH 1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9- D0C5SV DRUGINKE DTOSIQBPPRVQHS-PDBXOOCHSA-N D0C5SV DRUGSMIL CCC=CCC=CCC=CCCCCCCCC(=O)O D0C5SV HIGHSTAT Investigative D0C5XB DRUG__ID D0C5XB D0C5XB DRUGTYPE Small molecular drug D0C5XB DRUGINCH 1S/C15H9FO2/c16-11-6-7-14-12(8-11)13(17)9-15(18-14)10-4-2-1-3-5-10/h1-9H D0C5XB DRUGINKE OUYOSBQKQPUNJK-UHFFFAOYSA-N D0C5XB DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)F D0C5XB HIGHSTAT Investigative D0C5XQ DRUG__ID D0C5XQ D0C5XQ DRUGTYPE Small molecular drug D0C5XQ DRUGINCH 1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3 D0C5XQ DRUGINKE ZSTKHSQDNIGFLM-UHFFFAOYSA-N D0C5XQ DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)OC D0C5XQ HIGHSTAT Investigative D0C5ZP DRUG__ID D0C5ZP D0C5ZP DRUGTYPE Small molecular drug D0C5ZP DRUGINCH 1S/C14H14N2O5S/c1-22(19,20)15-13-8-7-12(16(17)18)9-14(13)21-10-11-5-3-2-4-6-11/h2-9,15H,10H2,1H3 D0C5ZP DRUGINKE XDQFGDRBMTXPFY-UHFFFAOYSA-N D0C5ZP DRUGSMIL CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OCC2=CC=CC=C2 D0C5ZP HIGHSTAT Investigative D0C6AP DRUG__ID D0C6AP D0C6AP DRUGTYPE Small molecular drug D0C6AP DRUGINCH 1S/C15H12O3/c1-9-6-13(17)7-11-8-14(18-15(9)11)10-2-4-12(16)5-3-10/h2-8,16-17H,1H3 D0C6AP DRUGINKE FUWUZPRNKPGRGX-UHFFFAOYSA-N D0C6AP DRUGSMIL CC1=CC(=CC2=C1OC(=C2)C3=CC=C(C=C3)O)O D0C6AP HIGHSTAT Investigative D0C6BP DRUG__ID D0C6BP D0C6BP DRUGTYPE Small molecular drug D0C6BP DRUGINCH 1S/C26H38N4/c1(9-15-27-17-21-29(22-18-27)25-11-5-3-6-12-25)2-10-16-28-19-23-30(24-20-28)26-13-7-4-8-14-26/h3-8,11-14H,1-2,9-10,15-24H2 D0C6BP DRUGINKE ORESESSHUCUUFK-UHFFFAOYSA-N D0C6BP DRUGSMIL C1CN(CCN1CCCCCCN2CCN(CC2)C3=CC=CC=C3)C4=CC=CC=C4 D0C6BP HIGHSTAT Investigative D0C6BU DRUG__ID D0C6BU D0C6BU DRUGTYPE Small molecular drug D0C6BU DRUGINCH 1S/C14H10O/c15-14-12-7-3-1-5-10(12)9-11-6-2-4-8-13(11)14/h1-8H,9H2 D0C6BU DRUGINKE RJGDLRCDCYRQOQ-UHFFFAOYSA-N D0C6BU DRUGSMIL C1C2=CC=CC=C2C(=O)C3=CC=CC=C31 D0C6BU HIGHSTAT Investigative D0C6BY DRUG__ID D0C6BY D0C6BY DRUGTYPE Small molecular drug D0C6BY DRUGINCH 1S/C18H17FN4O/c1-11-5-4-6-16(20-11)22-18(24)17-12(2)23(13(3)21-17)15-9-7-14(19)8-10-15/h4-10H,1-3H3,(H,20,22,24) D0C6BY DRUGINKE YQFYIHPLHNEXNE-UHFFFAOYSA-N D0C6BY DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=C(N(C(=N2)C)C3=CC=C(C=C3)F)C D0C6BY HIGHSTAT Investigative D0C6CZ DRUG__ID D0C6CZ D0C6CZ DRUGTYPE Small molecular drug D0C6CZ DRUGINCH 1S/C19H23NO3/c1-19(2,3)20-11-13(21)12-22-16-9-6-10-17-18(16)14-7-4-5-8-15(14)23-17/h4-10,13,20-21H,11-12H2,1-3H3 D0C6CZ DRUGINKE HGDYQUMVUUMEFM-UHFFFAOYSA-N D0C6CZ DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1C3=CC=CC=C3O2)O D0C6CZ HIGHSTAT Investigative D0C6ED DRUG__ID D0C6ED D0C6ED DRUGTYPE Small molecular drug D0C6ED DRUGINCH 1S/C6H8N2O6S2/c7-15(9,10)13-5-1-2-6(4-3-5)14-16(8,11)12/h1-4H,(H2,7,9,10)(H2,8,11,12) D0C6ED DRUGINKE BPEJBYDTMVTZIA-UHFFFAOYSA-N D0C6ED DRUGSMIL C1=CC(=CC=C1OS(=O)(=O)N)OS(=O)(=O)N D0C6ED HIGHSTAT Investigative D0C6EW DRUG__ID D0C6EW D0C6EW DRUGTYPE Small molecular drug D0C6EW DRUGINCH 1S/C21H30N4O8/c1-5-21(3)17(20(32)23-9-14(27)28)25-18(30)10(2)24-19(31)15(22-4)16(29)11-6-7-12(26)13(8-11)33-21/h6-8,10,15-17,22,26,29H,5,9H2,1-4H3,(H,23,32)(H,24,31)(H,25,30)(H,27,28)/t10-,15-,16+,17+,21+/m0/s1 D0C6EW DRUGINKE XAJYTGHEDODUTC-KILRJQPKSA-N D0C6EW DRUGSMIL CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2)O)O1)O)NC)C)C(=O)NCC(=O)O)C D0C6EW HIGHSTAT Investigative D0C6FW DRUG__ID D0C6FW D0C6FW DRUGTYPE Small molecular drug D0C6FW DRUGINCH 1S/C11H14N2O4S/c12-10(11(14)15)4-5-18-7-8-2-1-3-9(6-8)13(16)17/h1-3,6,10H,4-5,7,12H2,(H,14,15) D0C6FW DRUGINKE OLFRZJABCSLPAK-UHFFFAOYSA-N D0C6FW DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])CSCCC(C(=O)O)N D0C6FW HIGHSTAT Investigative D0C6HH DRUG__ID D0C6HH D0C6HH DRUGTYPE Small molecular drug D0C6HH DRUGINCH 1S/C5H5BFNO2/c7-5-2-1-4(3-8-5)6(9)10/h1-3,9-10H D0C6HH DRUGINKE OJBYZWHAPXIJID-UHFFFAOYSA-N D0C6HH DRUGSMIL B(C1=CN=C(C=C1)F)(O)O D0C6HH HIGHSTAT Investigative D0C6IE DRUG__ID D0C6IE D0C6IE DRUGTYPE Small molecular drug D0C6IE DRUGINCH 1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6) D0C6IE DRUGINKE XOAAWQZATWQOTB-UHFFFAOYSA-N D0C6IE DRUGSMIL C(CS(=O)(=O)O)N D0C6IE HIGHSTAT Investigative D0C6JG DRUG__ID D0C6JG D0C6JG DRUGTYPE Small molecular drug D0C6JG DRUGINCH 1S/C15H13NS/c1-13-7-5-8-14(16-13)9-6-12-17-15-10-3-2-4-11-15/h2-5,7-8,10-11H,12H2,1H3 D0C6JG DRUGINKE QPGKAVMWBQPWGX-UHFFFAOYSA-N D0C6JG DRUGSMIL CC1=NC(=CC=C1)C#CCSC2=CC=CC=C2 D0C6JG HIGHSTAT Investigative D0C6KI DRUG__ID D0C6KI D0C6KI DRUGTYPE Small molecular drug D0C6KI DRUGINCH 1S/C16H13ClFN3O2/c1-22-14-6-10-13(7-15(14)23-2)19-8-20-16(10)21-12-4-3-9(17)5-11(12)18/h3-8H,1-2H3,(H,19,20,21) D0C6KI DRUGINKE YHUIUSRCUKUUQA-UHFFFAOYSA-N D0C6KI DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=C(C=C(C=C3)Cl)F)OC D0C6KI HIGHSTAT Investigative D0C6KQ DRUG__ID D0C6KQ D0C6KQ DRUGTYPE Small molecular drug D0C6KQ DRUGINCH 1S/C15H22IN3O4S/c1-3-19-8-4-5-10(19)9-18-15(20)13-11(23-2)6-7-12(14(13)16)24(17,21)22/h6-7,10H,3-5,8-9H2,1-2H3,(H,18,20)(H2,17,21,22)/t10-/m0/s1 D0C6KQ DRUGINKE HCKMONAVUWHQOT-JTQLQIEISA-N D0C6KQ DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2I)S(=O)(=O)N)OC D0C6KQ HIGHSTAT Investigative D0C6LS DRUG__ID D0C6LS D0C6LS DRUGTYPE Small molecular drug D0C6LS DRUGINCH 1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-30(23,31)27-29(21,22)26-28(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,31)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-,30?/m1/s1 D0C6LS DRUGINKE ROYJKVPBJVNHCQ-VWJVIAGJSA-N D0C6LS DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=S)(O)OP(=O)(O)OP(=O)(O)O)O)O)N D0C6LS HIGHSTAT Investigative D0C6OD DRUG__ID D0C6OD D0C6OD DRUGTYPE Small molecular drug D0C6OD DRUGINCH 1S/C13H9ClN2O5S/c14-10-3-7-12(8-4-10)22(20,21)15-13(17)9-1-5-11(6-2-9)16(18)19/h1-8H,(H,15,17) D0C6OD DRUGINKE NOPPJNVGKXKZSN-UHFFFAOYSA-N D0C6OD DRUGSMIL C1=CC(=CC=C1C(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl)[N+](=O)[O-] D0C6OD HIGHSTAT Investigative D0C6QF DRUG__ID D0C6QF D0C6QF DRUGTYPE Small molecular drug D0C6QF DRUGINCH 1S/C19H35N/c1-3-5-7-9-10-11-13-15-19-17-16-18(20-19)14-12-8-6-4-2/h3-4,18-20H,1-2,5-17H2 D0C6QF DRUGINKE YCQNSAJAZIVRFR-UHFFFAOYSA-N D0C6QF DRUGSMIL C=CCCCCCCCC1CCC(N1)CCCCC=C D0C6QF HIGHSTAT Investigative D0C6QI DRUG__ID D0C6QI D0C6QI DRUGTYPE Small molecular drug D0C6QI DRUGINCH 1S/C38H46O7/c1-23(39)43-27-13-9-25-11-15-31-35(3,29(25)21-27)17-7-19-37(31,5)33(41)45-34(42)38(6)20-8-18-36(4)30-22-28(44-24(2)40)14-10-26(30)12-16-32(36)38/h9-10,13-14,21-22,31-32H,7-8,11-12,15-20H2,1-6H3/t31-,32-,35-,36-,37+,38+/m1/s1 D0C6QI DRUGINKE OUJQRQRBNRGQTC-SPGSYPTKSA-N D0C6QI DRUGSMIL CC(=O)OC1=CC2=C(CCC3C2(CCCC3(C)C(=O)OC(=O)C4(CCCC5(C4CCC6=C5C=C(C=C6)OC(=O)C)C)C)C)C=C1 D0C6QI HIGHSTAT Investigative D0C6QS DRUG__ID D0C6QS D0C6QS DRUGTYPE Small molecular drug D0C6QS DRUGINCH 1S/C41H28O27/c42-13-1-8(2-14(43)24(13)48)34(54)67-39-33-32-30(64-38(58)12-6-19(47)41(61)40(59,60)23(12)22-11(37(57)66-33)5-17(46)27(51)31(22)68-41)18(63-39)7-62-35(55)9-3-15(44)25(49)28(52)20(9)21-10(36(56)65-32)4-16(45)26(50)29(21)53/h1-6,18,23,30,32-33,39,42-46,48-53,59-61H,7H2/t18-,23+,30-,32+,33-,39+,41+/m1/s1 D0C6QS DRUGINKE JQQBXPCJFAKSPG-SVYIMCMUSA-N D0C6QS DRUGSMIL C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7C(=CC(=O)C(C7(O)O)(O6)O)C(=O)O3)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O D0C6QS HIGHSTAT Investigative D0C6RO DRUG__ID D0C6RO D0C6RO DRUGTYPE Small molecular drug D0C6RO DRUGINCH 1S/3Na.4O.V/q3*+1;;3*-1; D0C6RO DRUGINKE IHIXIJGXTJIKRB-UHFFFAOYSA-N D0C6RO DRUGSMIL [O-][V](=O)([O-])[O-].[Na+].[Na+].[Na+] D0C6RO HIGHSTAT Investigative D0C6UR DRUG__ID D0C6UR D0C6UR DRUGTYPE Small molecular drug D0C6UR DRUGINCH 1S/C28H34NO.BrH/c1-5-27(23-13-9-7-10-14-23)28(24-15-11-8-12-16-24)25-17-19-26(20-18-25)30-22-21-29(3,4)6-2;/h7-20H,5-6,21-22H2,1-4H3;1H/q+1;/p-1/b28-27-; D0C6UR DRUGINKE BXPXDYCXXNBOQW-LXCLTORNSA-M D0C6UR DRUGSMIL CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCC[N+](C)(C)CC)C3=CC=CC=C3.[Br-] D0C6UR HIGHSTAT Investigative D0C6US DRUG__ID D0C6US D0C6US DRUGTYPE Small molecular drug D0C6US DRUGINCH 1S/C16H15NO/c1-18-16-5-4-14-10-13(2-3-15(14)11-16)12-6-8-17-9-7-12/h4-11H,2-3H2,1H3 D0C6US DRUGINKE QCWIENOGGDTTEN-UHFFFAOYSA-N D0C6US DRUGSMIL COC1=CC2=C(C=C1)C=C(CC2)C3=CC=NC=C3 D0C6US HIGHSTAT Investigative D0C6WN DRUG__ID D0C6WN D0C6WN DRUGTYPE Small molecular drug D0C6WN DRUGINCH 1S/C17H16O4/c1-20-13-9-7-12(17(11-13)21-2)8-10-16(19)14-5-3-4-6-15(14)18/h3-11,18H,1-2H3/b10-8+ D0C6WN DRUGINKE ORIBPRISLKRPRQ-CSKARUKUSA-N D0C6WN DRUGSMIL COC1=CC(=C(C=C1)C=CC(=O)C2=CC=CC=C2O)OC D0C6WN HIGHSTAT Investigative D0C6WO DRUG__ID D0C6WO D0C6WO DRUGTYPE Small molecular drug D0C6WO DRUGINCH 1S/C16H16N2O2/c1-3-10(2)20-16(19)14-8-12-11-6-4-5-7-13(11)18-15(12)9-17-14/h4-10,18H,3H2,1-2H3 D0C6WO DRUGINKE HRNSOLSYHZMSCD-UHFFFAOYSA-N D0C6WO DRUGSMIL CCC(C)OC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D0C6WO HIGHSTAT Investigative D0C6YC DRUG__ID D0C6YC D0C6YC DRUGTYPE Small molecular drug D0C6YC DRUGINCH 1S/C22H13NO3/c24-19-13-21(14-7-9-23-10-8-14)26-22-16-5-2-1-4-15(16)17(12-18(19)22)20-6-3-11-25-20/h1-13H D0C6YC DRUGINKE YYRINQRAIIGEQV-UHFFFAOYSA-N D0C6YC DRUGSMIL C1=CC=C2C(=C1)C(=CC3=C2OC(=CC3=O)C4=CC=NC=C4)C5=CC=CO5 D0C6YC HIGHSTAT Investigative D0C7AS DRUG__ID D0C7AS D0C7AS DRUGTYPE Small molecular drug D0C7AS DRUGINCH 1S/C21H20N2O3/c24-19-10-11-20(25)17(12-19)14-22-18-8-6-16(7-9-18)21(26)23-13-15-4-2-1-3-5-15/h1-12,22,24-25H,13-14H2,(H,23,26) D0C7AS DRUGINKE QQMFNDVDKBSOEC-UHFFFAOYSA-N D0C7AS DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC=C(C=C2)NCC3=C(C=CC(=C3)O)O D0C7AS HIGHSTAT Investigative D0C7ED DRUG__ID D0C7ED D0C7ED DRUGTYPE Small molecular drug D0C7ED DRUGINCH 1S/C27H32N4O3/c1-17-25(31-27(33)21-6-9-24(10-7-21)34-16-20-4-5-20)11-8-22-14-23(15-30-26(17)22)18(2)28-12-13-29-19(3)32/h6-11,14-15,18,20,28H,4-5,12-13,16H2,1-3H3,(H,29,32)(H,31,33)/t18-/m1/s1 D0C7ED DRUGINKE HRYQXLHGNOJEHH-GOSISDBHSA-N D0C7ED DRUGSMIL CC1=C(C=CC2=CC(=CN=C12)C(C)NCCNC(=O)C)NC(=O)C3=CC=C(C=C3)OCC4CC4 D0C7ED HIGHSTAT Investigative D0C7FL DRUG__ID D0C7FL D0C7FL DRUGTYPE Small molecular drug D0C7FL DRUGINCH 1S/C14H15N/c15-11-14(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,14H,11,15H2 D0C7FL DRUGINKE RXMTUVIKZRXSSM-UHFFFAOYSA-N D0C7FL DRUGSMIL C1=CC=C(C=C1)C(CN)C2=CC=CC=C2 D0C7FL HIGHSTAT Investigative D0C7GB DRUG__ID D0C7GB D0C7GB DRUGTYPE Small molecular drug D0C7GB DRUGINCH 1S/C11H16N2O/c14-11-5-1-2-7-13(11)9-10-4-3-6-12-8-10/h1-2,5,7,10,12H,3-4,6,8-9H2 D0C7GB DRUGINKE CRXGPVZZFUWGAF-UHFFFAOYSA-N D0C7GB DRUGSMIL C1CC(CNC1)CN2C=CC=CC2=O D0C7GB HIGHSTAT Investigative D0C7GT DRUG__ID D0C7GT D0C7GT DRUGTYPE Small molecular drug D0C7GT DRUGINCH 1S/C18H15NO2/c1-19(21)18(20)11-7-13-6-10-17-15(12-13)9-8-14-4-2-3-5-16(14)17/h2-12,21H,1H3/b11-7+ D0C7GT DRUGINKE YYXIRZNCGWVYCR-YRNVUSSQSA-N D0C7GT DRUGSMIL CN(C(=O)C=CC1=CC2=C(C=C1)C3=CC=CC=C3C=C2)O D0C7GT HIGHSTAT Investigative D0C7JC DRUG__ID D0C7JC D0C7JC DRUGTYPE Small molecular drug D0C7JC DRUGINCH 1S/C10H8N2OS/c13-12-7-9-3-4-10(14-9)8-2-1-5-11-6-8/h1-6H,7H2 D0C7JC DRUGINKE JUZUBCBEFKWHQP-UHFFFAOYSA-N D0C7JC DRUGSMIL C1=CC(=CN=C1)C2=CC=C(S2)CN=O D0C7JC HIGHSTAT Investigative D0C7LS DRUG__ID D0C7LS D0C7LS DRUGTYPE Small molecular drug D0C7LS DRUGINCH 1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1 D0C7LS DRUGINKE QGWNDRXFNXRZMB-UUOKFMHZSA-N D0C7LS DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N D0C7LS HIGHSTAT Investigative D0C7LY DRUG__ID D0C7LY D0C7LY DRUGTYPE Small molecular drug D0C7LY DRUGINCH 1S/C30H32N6/c1-30(2,3)23-10-8-22(9-11-23)29-33-25-5-4-6-27(28(25)34-29)36-17-15-35(16-18-36)20-21-7-12-24-26(19-21)32-14-13-31-24/h4-14,19H,15-18,20H2,1-3H3,(H,33,34) D0C7LY DRUGINKE AVEVJMZJJJDOCI-UHFFFAOYSA-N D0C7LY DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C2=NC3=C(N2)C=CC=C3N4CCN(CC4)CC5=CC6=NC=CN=C6C=C5 D0C7LY HIGHSTAT Investigative D0C7MP DRUG__ID D0C7MP D0C7MP DRUGTYPE Small molecular drug D0C7MP DRUGINCH 1S/C21H29N3O/c22-20(25)23-16-7-6-15-11-19-17-3-1-2-8-21(17,18(15)12-16)9-10-24(19)13-14-4-5-14/h6-7,12,14,17,19H,1-5,8-11,13H2,(H3,22,23,25)/t17-,19+,21+/m0/s1 D0C7MP DRUGINKE HEUGOTHWUMOSSR-FBBABVLZSA-N D0C7MP DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NC(=O)N)CC5CC5 D0C7MP HIGHSTAT Investigative D0C7NV DRUG__ID D0C7NV D0C7NV DRUGTYPE Small molecular drug D0C7NV DRUGINCH 1S/C30H50O3/c1-6-30(33,7-2)18-9-8-11-21(3)26-15-16-27-23(12-10-17-29(26,27)5)13-14-24-19-25(31)20-28(32)22(24)4/h13-14,21,25-28,31-33H,4,6-12,15-20H2,1-3,5H3/b23-13+,24-14+/t21?,25-,26?,27+,28+,29-/m1/s1 D0C7NV DRUGINKE DFOWDEBIOXYKFC-WIAGJZICSA-N D0C7NV DRUGSMIL CCC(CC)(CCCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O D0C7NV HIGHSTAT Investigative D0C7PD DRUG__ID D0C7PD D0C7PD DRUGTYPE Small molecular drug D0C7PD DRUGINCH 1S/C12H12N2O/c1-15-8-2-3-11-10(6-8)9-4-5-13-7-12(9)14-11/h2-3,6-7,14H,4-5H2,1H3 D0C7PD DRUGINKE BJODVFITWMPYMU-UHFFFAOYSA-N D0C7PD DRUGSMIL COC1=CC2=C(C=C1)NC3=C2CCN=C3 D0C7PD HIGHSTAT Investigative D0C7PK DRUG__ID D0C7PK D0C7PK DRUGTYPE Small molecular drug D0C7PK DRUGINCH 1S/C12H19NO2/c1-10(2)13-8-11(14)9-15-12-6-4-3-5-7-12/h3-7,10-11,13-14H,8-9H2,1-2H3 D0C7PK DRUGINKE ONXLHKFGTDDVLQ-UHFFFAOYSA-N D0C7PK DRUGSMIL CC(C)NCC(COC1=CC=CC=C1)O D0C7PK HIGHSTAT Investigative D0C7PT DRUG__ID D0C7PT D0C7PT DRUGTYPE Small molecular drug D0C7PT DRUGINCH 1S/C9H13FN3O9P/c10-3-6(11)13(9(17)12-7(3)16)8-5(15)4(14)2(22-8)1-21-23(18,19)20/h2,4-5,8,14-15H,1,11H2,(H,12,16,17)(H2,18,19,20)/t2-,4-,5-,8-/m1/s1 D0C7PT DRUGINKE OLBMCLUPWOAIRA-UMMCILCDSA-N D0C7PT DRUGSMIL C(C1C(C(C(O1)N2C(=C(C(=O)NC2=O)F)N)O)O)OP(=O)(O)O D0C7PT HIGHSTAT Investigative D0C7PY DRUG__ID D0C7PY D0C7PY DRUGTYPE Small molecular drug D0C7PY DRUGINCH 1S/C14H31NO/c1-4-5-6-7-8-9-10-11-12-13-14-15(2,3)16/h4-14H2,1-3H3 D0C7PY DRUGINKE SYELZBGXAIXKHU-UHFFFAOYSA-N D0C7PY DRUGSMIL CCCCCCCCCCCC[N+](C)(C)[O-] D0C7PY HIGHSTAT Investigative D0C7PZ DRUG__ID D0C7PZ D0C7PZ DRUGTYPE Small molecular drug D0C7PZ DRUGINCH 1S/C6H8N2O2/c1-4-5(2-6(9)10)8-3-7-4/h3H,2H2,1H3,(H,7,8)(H,9,10) D0C7PZ DRUGINKE BINCHKHDIQXADS-UHFFFAOYSA-N D0C7PZ DRUGSMIL CC1=C(N=CN1)CC(=O)O D0C7PZ HIGHSTAT Investigative D0C7RS DRUG__ID D0C7RS D0C7RS DRUGTYPE Small molecular drug D0C7RS DRUGINCH 1S/C16H13NO3S/c18-21(19,20)15-11-5-7-12-6-4-10-14(16(12)15)17-13-8-2-1-3-9-13/h1-11,17H,(H,18,19,20) D0C7RS DRUGINKE FWEOQOXTVHGIFQ-UHFFFAOYSA-N D0C7RS DRUGSMIL C1=CC=C(C=C1)NC2=CC=CC3=C2C(=CC=C3)S(=O)(=O)O D0C7RS HIGHSTAT Investigative D0C7SE DRUG__ID D0C7SE D0C7SE DRUGTYPE Small molecular drug D0C7SE DRUGINCH 1S/C29H32F2N2O2/c1-19(2)29(34)32-23-7-4-20(3)26(16-23)22-12-14-33(15-13-22)18-21-5-8-24(9-6-21)35-25-10-11-27(30)28(31)17-25/h4-11,16-17,19,22H,12-15,18H2,1-3H3,(H,32,34) D0C7SE DRUGINKE VMLZFUVIKCGATC-UHFFFAOYSA-N D0C7SE DRUGSMIL CC1=C(C=C(C=C1)NC(=O)C(C)C)C2CCN(CC2)CC3=CC=C(C=C3)OC4=CC(=C(C=C4)F)F D0C7SE HIGHSTAT Investigative D0C7TX DRUG__ID D0C7TX D0C7TX DRUGTYPE Small molecular drug D0C7TX DRUGINCH 1S/C14H11N3O/c1-10-4-2-7-13(16-10)17-14(18)12-6-3-5-11(8-12)9-15/h2-8H,1H3,(H,16,17,18) D0C7TX DRUGINKE HRIDAJBBAATPGT-UHFFFAOYSA-N D0C7TX DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CC=CC(=C2)C#N D0C7TX HIGHSTAT Investigative D0C7WG DRUG__ID D0C7WG D0C7WG DRUGTYPE Small molecular drug D0C7WG DRUGINCH 1S/C12H11N3O3S/c13-19(17,18)12-3-1-2-10(8-12)15-14-9-4-6-11(16)7-5-9/h1-8,16H,(H2,13,17,18) D0C7WG DRUGINKE HJVKSSWMWPZDOV-UHFFFAOYSA-N D0C7WG DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)N=NC2=CC=C(C=C2)O D0C7WG HIGHSTAT Investigative D0C7WN DRUG__ID D0C7WN D0C7WN DRUGTYPE Small molecular drug D0C7WN DRUGINCH 1S/C2H4O/c1-2-3/h2H,1H3 D0C7WN DRUGINKE IKHGUXGNUITLKF-UHFFFAOYSA-N D0C7WN DRUGSMIL CC=O D0C7WN HIGHSTAT Investigative D0C7YL DRUG__ID D0C7YL D0C7YL DRUGTYPE Small molecular drug D0C7YL DRUGINCH 1S/C10H11N3/c11-10-3-1-2-9(6-10)7-13-5-4-12-8-13/h1-6,8H,7,11H2 D0C7YL DRUGINKE HOZXQBSHRUITCX-UHFFFAOYSA-N D0C7YL DRUGSMIL C1=CC(=CC(=C1)N)CN2C=CN=C2 D0C7YL HIGHSTAT Investigative D0C7YS DRUG__ID D0C7YS D0C7YS DRUGTYPE Small molecular drug D0C7YS DRUGINCH 1S/C12H18N2O5/c1-2-3-7-5-14(12(18)13-11(7)17)10-4-8(16)9(6-15)19-10/h5,8-10,15-16H,2-4,6H2,1H3,(H,13,17,18)/t8-,9+,10+/m0/s1 D0C7YS DRUGINKE MBERTAKFBYOAHR-IVZWLZJFSA-N D0C7YS DRUGSMIL CCCC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O D0C7YS HIGHSTAT Investigative D0C8BV DRUG__ID D0C8BV D0C8BV DRUGTYPE Small molecular drug D0C8BV DRUGINCH 1S/C11H13N3O2S/c12-5-7-14-17(15,16)11-3-1-2-9-8-13-6-4-10(9)11/h1-4,6,8,14H,5,7,12H2 D0C8BV DRUGINKE DCVZSHVZGVWQKV-UHFFFAOYSA-N D0C8BV DRUGSMIL C1=CC2=C(C=CN=C2)C(=C1)S(=O)(=O)NCCN D0C8BV HIGHSTAT Investigative D0C8CR DRUG__ID D0C8CR D0C8CR DRUGTYPE Small molecular drug D0C8CR DRUGINCH 1S/C11H9N3/c12-7-1-2-10-9(5-7)8-3-4-13-6-11(8)14-10/h1-6,14H,12H2 D0C8CR DRUGINKE PPCJCNSRVOYTKC-UHFFFAOYSA-N D0C8CR DRUGSMIL C1=CC2=C(C=C1N)C3=C(N2)C=NC=C3 D0C8CR HIGHSTAT Investigative D0C8EO DRUG__ID D0C8EO D0C8EO DRUGTYPE Small molecular drug D0C8EO DRUGINCH 1S/C14H13NOS/c1-16-12-4-5-14-10(6-12)2-3-11(14)7-13-8-15-9-17-13/h4-9H,2-3H2,1H3/b11-7+ D0C8EO DRUGINKE YBVSJXCRZPLUNH-YRNVUSSQSA-N D0C8EO DRUGSMIL COC1=CC2=C(C=C1)C(=CC3=CN=CS3)CC2 D0C8EO HIGHSTAT Investigative D0C8FY DRUG__ID D0C8FY D0C8FY DRUGTYPE Small molecular drug D0C8FY DRUGINCH 1S/C26H27NO4/c1-4-30-25(28)22-18(3)27-24(20-14-10-7-11-15-20)23(26(29)31-5-2)21(22)17-16-19-12-8-6-9-13-19/h6-17,21,27H,4-5H2,1-3H3/b17-16+ D0C8FY DRUGINKE XCXCNPNUEPMYRS-WUKNDPDISA-N D0C8FY DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C=CC2=CC=CC=C2)C(=O)OCC)C3=CC=CC=C3)C D0C8FY HIGHSTAT Investigative D0C8HK DRUG__ID D0C8HK D0C8HK DRUGTYPE Small molecular drug D0C8HK DRUGINCH 1S/C18H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h13-14H,2-8,15-17H2,1H3,(H,19,20)/b14-13+ D0C8HK DRUGINKE IGVKWAAPMVVTFX-BUHFOSPRSA-N D0C8HK DRUGSMIL CCCCCCCCC#CC#CC=CCCCC(=O)O D0C8HK HIGHSTAT Investigative D0C8HN DRUG__ID D0C8HN D0C8HN DRUGTYPE Small molecular drug D0C8HN DRUGINCH 1S/C19H36N2O2S/c1-2-3-13-16-20-19(24)21-17-14-11-9-7-5-4-6-8-10-12-15-18(22)23/h5,7H,2-4,6,8-17H2,1H3,(H,22,23)(H2,20,21,24)/b7-5- D0C8HN DRUGINKE XZCDMUCBAMBZQK-ALCCZGGFSA-N D0C8HN DRUGSMIL CCCCCNC(=S)NCCCCC=CCCCCCCC(=O)O D0C8HN HIGHSTAT Investigative D0C8IB DRUG__ID D0C8IB D0C8IB DRUGTYPE Small molecular drug D0C8IB DRUGINCH 1S/C11H19N3O2/c1-3-9(2)14-11(15)16-6-4-5-10-7-12-8-13-10/h7-9H,3-6H2,1-2H3,(H,12,13)(H,14,15)/t9-/m1/s1 D0C8IB DRUGINKE RSHJCGZZSGNBHO-SECBINFHSA-N D0C8IB DRUGSMIL CCC(C)NC(=O)OCCCC1=CN=CN1 D0C8IB HIGHSTAT Investigative D0C8KC DRUG__ID D0C8KC D0C8KC DRUGTYPE Small molecular drug D0C8KC DRUGINCH 1S/C13H15NO3/c1-8-7-11(15)14(2)13-10(17-4)6-5-9(16-3)12(8)13/h5-7H,1-4H3 D0C8KC DRUGINKE FTGZPMFPUDKJBX-UHFFFAOYSA-N D0C8KC DRUGSMIL CC1=CC(=O)N(C2=C(C=CC(=C12)OC)OC)C D0C8KC HIGHSTAT Investigative D0C8LA DRUG__ID D0C8LA D0C8LA DRUGTYPE Small molecular drug D0C8LA DRUGINCH 1S/C21H34N6O6S/c1-2-3-12-34(32,33)25-17(21(30)31)14-23-19(28)16-13-18-20(29)26(10-11-27(18)24-16)9-6-15-4-7-22-8-5-15/h13,15,17,22,25H,2-12,14H2,1H3,(H,23,28)(H,30,31)/t17-/m0/s1 D0C8LA DRUGINKE FXBDPMBWPSLDQZ-KRWDZBQOSA-N D0C8LA DRUGSMIL CCCCS(=O)(=O)NC(CNC(=O)C1=NN2CCN(C(=O)C2=C1)CCC3CCNCC3)C(=O)O D0C8LA HIGHSTAT Investigative D0C8MK DRUG__ID D0C8MK D0C8MK DRUGTYPE Small molecular drug D0C8MK DRUGINCH 1S/C25H19NO4S/c27-19-15-23(26-11-13-28-14-12-26)30-24-16(5-3-7-18(19)24)17-6-4-10-22-25(17)29-20-8-1-2-9-21(20)31-22/h1-10,15H,11-14H2 D0C8MK DRUGINKE IAMQVMPIHMBYSY-UHFFFAOYSA-N D0C8MK DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=C5C(=CC=C4)SC6=CC=CC=C6O5 D0C8MK HIGHSTAT Investigative D0C8MT DRUG__ID D0C8MT D0C8MT DRUGTYPE Small molecular drug D0C8MT DRUGINCH 1S/C17H18N2O/c18-10-9-14-11-19-17-15(14)7-4-8-16(17)20-12-13-5-2-1-3-6-13/h1-8,11,19H,9-10,12,18H2 D0C8MT DRUGINKE JOYGWYISRWPUIM-UHFFFAOYSA-N D0C8MT DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC3=C2NC=C3CCN D0C8MT HIGHSTAT Investigative D0C8ON DRUG__ID D0C8ON D0C8ON DRUGTYPE Small molecular drug D0C8ON DRUGINCH 1S/C14H9NO2/c15-11-7-3-6-10-12(11)14(17)9-5-2-1-4-8(9)13(10)16/h1-7H,15H2 D0C8ON DRUGINKE KHUFHLFHOQVFGB-UHFFFAOYSA-N D0C8ON DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)N D0C8ON HIGHSTAT Investigative D0C8RD DRUG__ID D0C8RD D0C8RD DRUGTYPE Small molecular drug D0C8RD DRUGINCH 1S/C13H14N2O/c1-15(10-11-6-3-2-4-7-11)13(16)12-8-5-9-14-12/h2-9,14H,10H2,1H3 D0C8RD DRUGINKE HDVIQRKATXBZHO-UHFFFAOYSA-N D0C8RD DRUGSMIL CN(CC1=CC=CC=C1)C(=O)C2=CC=CN2 D0C8RD HIGHSTAT Investigative D0C8SX DRUG__ID D0C8SX D0C8SX DRUGTYPE Small molecular drug D0C8SX DRUGINCH 1S/C15H15NO/c16-15-9-14(15)11-6-4-10(5-7-11)12-2-1-3-13(17)8-12/h1-8,14-15,17H,9,16H2/t14-,15+/m1/s1 D0C8SX DRUGINKE DSOJSZXQRJGBCW-CABCVRRESA-N D0C8SX DRUGSMIL C1C(C1N)C2=CC=C(C=C2)C3=CC(=CC=C3)O D0C8SX HIGHSTAT Investigative D0C8UF DRUG__ID D0C8UF D0C8UF DRUGTYPE Small molecular drug D0C8UF DRUGINCH 1S/C20H18Cl2N2O7S/c21-14-1-4-16(5-2-14)32(29,30)24-10-18(25)23-9-13(20(24)28)7-12-8-15(22)3-6-17(12)31-11-19(26)27/h1-6,8,13H,7,9-11H2,(H,23,25)(H,26,27) D0C8UF DRUGINKE MZKGVXPHEXNJSG-UHFFFAOYSA-N D0C8UF DRUGSMIL C1C(C(=O)N(CC(=O)N1)S(=O)(=O)C2=CC=C(C=C2)Cl)CC3=C(C=CC(=C3)Cl)OCC(=O)O D0C8UF HIGHSTAT Investigative D0C8UV DRUG__ID D0C8UV D0C8UV DRUGTYPE Small molecular drug D0C8UV DRUGINCH 1S/C16H18N2O2S/c19-21(20,15-4-2-1-3-5-15)16-8-6-14(7-9-16)18-12-10-17-11-13-18/h1-9,17H,10-13H2 D0C8UV DRUGINKE SZAOHADKAZDUGT-UHFFFAOYSA-N D0C8UV DRUGSMIL C1CN(CCN1)C2=CC=C(C=C2)S(=O)(=O)C3=CC=CC=C3 D0C8UV HIGHSTAT Investigative D0C8WL DRUG__ID D0C8WL D0C8WL DRUGTYPE Small molecular drug D0C8WL DRUGINCH 1S/C16H23IN2O3/c1-4-19-7-5-6-12(19)10-18-16(20)13-8-11(17)9-14(21-2)15(13)22-3/h8-9,12H,4-7,10H2,1-3H3,(H,18,20)/t12-/m0/s1 D0C8WL DRUGINKE APNNSBJHVTUORL-LBPRGKRZSA-N D0C8WL DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C(=CC(=C2)I)OC)OC D0C8WL HIGHSTAT Investigative D0C8ZY DRUG__ID D0C8ZY D0C8ZY DRUGTYPE Small molecular drug D0C8ZY DRUGINCH 1S/C10H9BO2/c12-11(13)10-6-5-8-3-1-2-4-9(8)7-10/h1-7,12-13H D0C8ZY DRUGINKE KPTRDYONBVUWPD-UHFFFAOYSA-N D0C8ZY DRUGSMIL B(C1=CC2=CC=CC=C2C=C1)(O)O D0C8ZY HIGHSTAT Investigative D0C9AD DRUG__ID D0C9AD D0C9AD DRUGTYPE Small molecular drug D0C9AD DRUGINCH 1S/C15H10ClNO2/c16-11-7-5-10(6-8-11)9-17-13-4-2-1-3-12(13)14(18)15(17)19/h1-8H,9H2 D0C9AD DRUGINKE VEBLIIOSJXGVAW-UHFFFAOYSA-N D0C9AD DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N2CC3=CC=C(C=C3)Cl D0C9AD HIGHSTAT Investigative D0C9BH DRUG__ID D0C9BH D0C9BH DRUGTYPE Small molecular drug D0C9BH DRUGINCH 1S/C35H37ClN2O11/c1-16(2)7-9-18-15-19(10-13-22(18)39)31(42)38-25-26(40)20-11-14-23(24(36)28(20)47-33(25)44)46-34-27(41)29(30(45-6)35(4,5)49-34)48-32(43)21-12-8-17(3)37-21/h7-8,10-15,27,29-30,34,37,39-41H,9H2,1-6H3,(H,38,42)/t27-,29+,30-,34-/m1/s1 D0C9BH DRUGINKE FJAQNRBDVKIIKK-LFLQOBSNSA-N D0C9BH DRUGSMIL CC1=CC=C(N1)C(=O)OC2C(C(OC(C2OC)(C)C)OC3=C(C4=C(C=C3)C(=C(C(=O)O4)NC(=O)C5=CC(=C(C=C5)O)CC=C(C)C)O)Cl)O D0C9BH HIGHSTAT Investigative D0C9BZ DRUG__ID D0C9BZ D0C9BZ DRUGTYPE Small molecular drug D0C9BZ DRUGINCH 1S/C23H26N2O2S/c1-14-7-9-20(10-8-14)28(26,27)22-18(5)13-19(6)24-23(22)25-21-16(3)11-15(2)12-17(21)4/h7-13H,1-6H3,(H,24,25) D0C9BZ DRUGINKE IJUWFQLWCMTNLD-UHFFFAOYSA-N D0C9BZ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C(N=C(C=C2C)C)NC3=C(C=C(C=C3C)C)C D0C9BZ HIGHSTAT Investigative D0C9DC DRUG__ID D0C9DC D0C9DC DRUGTYPE Small molecular drug D0C9DC DRUGINCH 1S/C9H9Cl2N/c10-8-2-1-6-3-4-12-5-7(6)9(8)11/h1-2,12H,3-5H2 D0C9DC DRUGINKE WFPUBEDBBOGGIQ-UHFFFAOYSA-N D0C9DC DRUGSMIL C1CNCC2=C1C=CC(=C2Cl)Cl D0C9DC HIGHSTAT Investigative D0C9DP DRUG__ID D0C9DP D0C9DP DRUGTYPE Small molecular drug D0C9DP DRUGINCH 1S/C20H19F3N4O2/c21-20(22,23)13-3-6-15(7-4-13)29-12-18(28)24-14-5-8-16-17(11-14)26-19(25-16)27-9-1-2-10-27/h3-8,11H,1-2,9-10,12H2,(H,24,28)(H,25,26) D0C9DP DRUGINKE UWZAIHJEZDRIJB-UHFFFAOYSA-N D0C9DP DRUGSMIL C1CCN(C1)C2=NC3=C(N2)C=C(C=C3)NC(=O)COC4=CC=C(C=C4)C(F)(F)F D0C9DP HIGHSTAT Investigative D0C9DS DRUG__ID D0C9DS D0C9DS DRUGTYPE Small molecular drug D0C9DS DRUGINCH 1S/C21H34O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22)23-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-20H2,1-2H3/b8-7-,11-10-,14-13-,17-16- D0C9DS DRUGINKE OFIDNKMQBYGNIW-ZKWNWVNESA-N D0C9DS DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC D0C9DS HIGHSTAT Investigative D0C9FH DRUG__ID D0C9FH D0C9FH DRUGTYPE Small molecular drug D0C9FH DRUGINCH 1S/C12H9N3OS/c1-9(16)14-12-15-11(8-17-12)5-4-10-3-2-6-13-7-10/h2-3,6-8H,1H3,(H,14,15,16) D0C9FH DRUGINKE LNYMBABMFUHLAP-UHFFFAOYSA-N D0C9FH DRUGSMIL CC(=O)NC1=NC(=CS1)C#CC2=CN=CC=C2 D0C9FH HIGHSTAT Investigative D0C9FK DRUG__ID D0C9FK D0C9FK DRUGTYPE Small molecular drug D0C9FK DRUGINCH 1S/C26H20F9NO3/c27-24(28,29)23(37)14-36-21(16-5-2-7-18(13-16)39-26(33,34)35)11-10-20-19(8-3-9-22(20)36)15-4-1-6-17(12-15)38-25(30,31)32/h1-9,12-13,21,23,37H,10-11,14H2/t21-,23-/m1/s1 D0C9FK DRUGINKE CMOJRCASVGGDKQ-FYYLOGMGSA-N D0C9FK DRUGSMIL C1CC2=C(C=CC=C2N(C1C3=CC(=CC=C3)OC(F)(F)F)CC(C(F)(F)F)O)C4=CC(=CC=C4)OC(F)(F)F D0C9FK HIGHSTAT Investigative D0C9FO DRUG__ID D0C9FO D0C9FO DRUGTYPE Small molecular drug D0C9FO DRUGINCH 1S/C17H19NO4/c19-14(16-18-12-15(22-16)17(20)21)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2,(H,20,21) D0C9FO DRUGINKE YYZORCCDLMGZTQ-UHFFFAOYSA-N D0C9FO DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=C(O2)C(=O)O D0C9FO HIGHSTAT Investigative D0C9GI DRUG__ID D0C9GI D0C9GI DRUGTYPE Small molecular drug D0C9GI DRUGINCH 1S/C16H11FO2/c1-10-2-4-11(5-3-10)15-9-14(18)13-7-6-12(17)8-16(13)19-15/h2-9H,1H3 D0C9GI DRUGINKE NGYCVQPULTXSDL-UHFFFAOYSA-N D0C9GI DRUGSMIL CC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)F D0C9GI HIGHSTAT Investigative D0C9GO DRUG__ID D0C9GO D0C9GO DRUGTYPE Small molecular drug D0C9GO DRUGINCH 1S/C34H54N6O14S/c1-17(2)13-22(38-29(48)20(9-11-26(42)43)37-33(52)24(15-28(46)47)35-18(3)41)31(50)36-21(10-12-27(44)45)30(49)39-23(14-19-7-5-4-6-8-19)32(51)40-25(16-55)34(53)54/h17,19-25,55H,4-16H2,1-3H3,(H,35,41)(H,36,50)(H,37,52)(H,38,48)(H,39,49)(H,40,51)(H,42,43)(H,44,45)(H,46,47)(H,53,54)/t20-,21-,22-,23-,24-,25-/m0/s1 D0C9GO DRUGINKE SYHFABLPDKKGNQ-OOPVGHQCSA-N D0C9GO DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0C9GO HIGHSTAT Investigative D0C9HB DRUG__ID D0C9HB D0C9HB DRUGTYPE Small molecular drug D0C9HB DRUGINCH 1S/C26H32N4O4/c1-15(2)11-27-13-23(31)29-17-5-7-19-21(9-17)26(34)22-10-18(6-8-20(22)25(19)33)30-24(32)14-28-12-16(3)4/h5-10,15-16,27-28H,11-14H2,1-4H3,(H,29,31)(H,30,32) D0C9HB DRUGINKE BTABHVPIAAKKHL-UHFFFAOYSA-N D0C9HB DRUGSMIL CC(C)CNCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CNCC(C)C D0C9HB HIGHSTAT Investigative D0C9II DRUG__ID D0C9II D0C9II DRUGTYPE Small molecular drug D0C9II DRUGINCH 1S/C25H34O8.ClH/c1-6-31-14(2)32-18-11-17(22(27)29-5)24(3)9-7-16-23(28)33-19(15-8-10-30-13-15)12-25(16,4)21(24)20(18)26;/h8,10,13-14,16-19,21H,6-7,9,11-12H2,1-5H3;1H/t14?,16-,17-,18-,19-,21-,24-,25-;/m0./s1 D0C9II DRUGINKE ZGLSOBCUTUFGHE-LMEMKYRVSA-N D0C9II DRUGSMIL CCOC(C)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC.Cl D0C9II HIGHSTAT Investigative D0C9KC DRUG__ID D0C9KC D0C9KC DRUGTYPE Small molecular drug D0C9KC DRUGINCH 1S/C15H9ClO4/c16-9-3-1-2-8(4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,17-18H D0C9KC DRUGINKE NKDPIBPNSMKOPN-UHFFFAOYSA-N D0C9KC DRUGSMIL C1=CC(=CC(=C1)Cl)C2=COC3=CC(=CC(=C3C2=O)O)O D0C9KC HIGHSTAT Investigative D0C9KZ DRUG__ID D0C9KZ D0C9KZ DRUGTYPE Small molecular drug D0C9KZ DRUGINCH 1S/C18H14O2/c19-17-10-8-14(9-11-17)13-4-6-15(7-5-13)16-2-1-3-18(20)12-16/h1-12,19-20H D0C9KZ DRUGINKE RPJZTMNVHGSNCA-UHFFFAOYSA-N D0C9KZ DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(C=C2)C3=CC=C(C=C3)O D0C9KZ HIGHSTAT Investigative D0C9LF DRUG__ID D0C9LF D0C9LF DRUGTYPE Small molecular drug D0C9LF DRUGINCH 1S/C18H32O8P2/c1-2-3-4-5-6-7-8-9-13-26-17-12-10-11-16(14-17)15-18(19,27(20,21)22)28(23,24)25/h10-12,14,19H,2-9,13,15H2,1H3,(H2,20,21,22)(H2,23,24,25) D0C9LF DRUGINKE MHLLAPRPDYGFFU-UHFFFAOYSA-N D0C9LF DRUGSMIL CCCCCCCCCCOC1=CC=CC(=C1)CC(O)(P(=O)(O)O)P(=O)(O)O D0C9LF HIGHSTAT Investigative D0C9NE DRUG__ID D0C9NE D0C9NE DRUGTYPE Small molecular drug D0C9NE DRUGINCH 1S/C9H11N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h2-3,6,15-16H,1H3,(H3,10,11,13,14,17)/t3-,6-/m1/s1 D0C9NE DRUGINKE LHQIJBMDNUYRAM-AWFVSMACSA-N D0C9NE DRUGSMIL CC(C(C1=CN=C2C(=N1)C(=O)NC(=N2)N)O)O D0C9NE HIGHSTAT Investigative D0C9OT DRUG__ID D0C9OT D0C9OT DRUGTYPE Small molecular drug D0C9OT DRUGINCH 1S/C12H12F3N3O/c1-2-3-10(19)16-11-8-5-4-7(12(13,14)15)6-9(8)17-18-11/h4-6H,2-3H2,1H3,(H2,16,17,18,19) D0C9OT DRUGINKE RVYSDAGRNRYYML-UHFFFAOYSA-N D0C9OT DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C(F)(F)F D0C9OT HIGHSTAT Investigative D0C9QW DRUG__ID D0C9QW D0C9QW DRUGTYPE Small molecular drug D0C9QW DRUGINCH 1S/C16H15NO2/c1-17(2)13-5-3-11(4-6-13)16-10-12-9-14(18)7-8-15(12)19-16/h3-10,18H,1-2H3 D0C9QW DRUGINKE ZEWYMVJDOSXOEG-UHFFFAOYSA-N D0C9QW DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC3=C(O2)C=CC(=C3)O D0C9QW HIGHSTAT Investigative D0C9RO DRUG__ID D0C9RO D0C9RO DRUGTYPE Small molecular drug D0C9RO DRUGINCH 1S/C13H16N2/c1-15-9-5-8-13(15)11-14-10-12-6-3-2-4-7-12/h2-9,14H,10-11H2,1H3 D0C9RO DRUGINKE RFBDIJWXYJNKSB-UHFFFAOYSA-N D0C9RO DRUGSMIL CN1C=CC=C1CNCC2=CC=CC=C2 D0C9RO HIGHSTAT Investigative D0C9TY DRUG__ID D0C9TY D0C9TY DRUGTYPE Small molecular drug D0C9TY DRUGINCH 1S/C19H20N2O/c1-2-4-14(5-3-1)16-10-15-11-19(22-18(15)20-12-16)13-21-8-6-17(19)7-9-21/h1-5,10,12,17H,6-9,11,13H2/t19-/m0/s1 D0C9TY DRUGINKE GIRLVGYIIVFTLI-IBGZPJMESA-N D0C9TY DRUGSMIL C1CN2CCC1C3(C2)CC4=C(O3)N=CC(=C4)C5=CC=CC=C5 D0C9TY HIGHSTAT Investigative D0C9TZ DRUG__ID D0C9TZ D0C9TZ DRUGTYPE Small molecular drug D0C9TZ DRUGINCH 1S/C14H21NO2S/c1-3-8-15-9-7-13(11-15)12-5-4-6-14(10-12)18(2,16)17/h4-6,10,13H,3,7-9,11H2,1-2H3 D0C9TZ DRUGINKE RJYDYJIGFDPBRL-UHFFFAOYSA-N D0C9TZ DRUGSMIL CCCN1CCC(C1)C2=CC(=CC=C2)S(=O)(=O)C D0C9TZ HIGHSTAT Investigative D0C9UF DRUG__ID D0C9UF D0C9UF DRUGTYPE Small molecular drug D0C9UF DRUGINCH 1S/C27H29FN4O/c28-22-9-5-21(6-10-22)19-32-26-4-2-1-3-25(26)30-27(32)29-23-14-17-31(18-15-23)16-13-20-7-11-24(33)12-8-20/h1-12,23,33H,13-19H2,(H,29,30) D0C9UF DRUGINKE LAGYWHSFHIMTPE-UHFFFAOYSA-N D0C9UF DRUGSMIL C1CN(CCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)CCC5=CC=C(C=C5)O D0C9UF HIGHSTAT Investigative D0C9VH DRUG__ID D0C9VH D0C9VH DRUGTYPE Small molecular drug D0C9VH DRUGINCH 1S/C9H16N2O/c1-9(12)11(4)8-6-5-7-10(2)3/h7-8H2,1-4H3 D0C9VH DRUGINKE FPUURHVXHFAVKC-UHFFFAOYSA-N D0C9VH DRUGSMIL CC(=O)N(C)CC#CCN(C)C D0C9VH HIGHSTAT Investigative D0C9VN DRUG__ID D0C9VN D0C9VN DRUGTYPE Small molecular drug D0C9VN DRUGINCH 1S/C16H15NO2/c1-2-11-17-13-8-4-6-10-15(13)19-14-9-5-3-7-12(14)16(17)18/h3-10H,2,11H2,1H3 D0C9VN DRUGINKE OGPOBJPKGVLINB-UHFFFAOYSA-N D0C9VN DRUGSMIL CCCN1C2=CC=CC=C2OC3=CC=CC=C3C1=O D0C9VN HIGHSTAT Investigative D0C9WW DRUG__ID D0C9WW D0C9WW DRUGTYPE Small molecular drug D0C9WW DRUGINCH 1S/C17H11ClO4/c18-13-3-1-2-11(6-13)10-21-14-4-5-15-12(9-19)7-17(20)22-16(15)8-14/h1-9H,10H2 D0C9WW DRUGINKE ZOCADHRNWNJARU-UHFFFAOYSA-N D0C9WW DRUGSMIL C1=CC(=CC(=C1)Cl)COC2=CC3=C(C=C2)C(=CC(=O)O3)C=O D0C9WW HIGHSTAT Investigative D0C9XD DRUG__ID D0C9XD D0C9XD DRUGTYPE Small molecular drug D0C9XD DRUGINCH 1S/C23H26O4/c1-22(2)9-14(24)20(15(25)10-22)19-13-7-5-6-8-17(13)27-18-12-23(3,4)11-16(26)21(18)19/h5-8,19-20H,9-12H2,1-4H3 D0C9XD DRUGINKE XQDXIHYKAGHZRX-UHFFFAOYSA-N D0C9XD DRUGSMIL CC1(CC(=O)C(C(=O)C1)C2C3=CC=CC=C3OC4=C2C(=O)CC(C4)(C)C)C D0C9XD HIGHSTAT Investigative D0C9XK DRUG__ID D0C9XK D0C9XK DRUGTYPE Small molecular drug D0C9XK DRUGINCH 1S/C13H9NO4/c15-8-2-3-9-12(6-8)18-13(14-9)7-1-4-10(16)11(17)5-7/h1-6,15-17H D0C9XK DRUGINKE QSWPVNMCVFYCHT-UHFFFAOYSA-N D0C9XK DRUGSMIL C1=CC(=C(C=C1C2=NC3=C(O2)C=C(C=C3)O)O)O D0C9XK HIGHSTAT Investigative D0C9XW DRUG__ID D0C9XW D0C9XW DRUGTYPE Small molecular drug D0C9XW DRUGINCH 1S/C14H26N4/c1-4-7-8-12-11-13(15-9-5-2)18-14(17-12)16-10-6-3/h11H,4-10H2,1-3H3,(H2,15,16,17,18) D0C9XW DRUGINKE UYWCDBMUBBSZOJ-UHFFFAOYSA-N D0C9XW DRUGSMIL CCCCC1=CC(=NC(=N1)NCCC)NCCC D0C9XW HIGHSTAT Investigative D0C9ZE DRUG__ID D0C9ZE D0C9ZE DRUGTYPE Small molecular drug D0C9ZE DRUGINCH 1S/C14H17NO2/c16-14(10-5-2-1-3-6-10)17-13-9-11-7-4-8-12(13)15-11/h1-3,5-6,11-13,15H,4,7-9H2 D0C9ZE DRUGINKE AKLGENRCHBXEKW-UHFFFAOYSA-N D0C9ZE DRUGSMIL C1CC2CC(C(C1)N2)OC(=O)C3=CC=CC=C3 D0C9ZE HIGHSTAT Investigative D0C9ZN DRUG__ID D0C9ZN D0C9ZN DRUGTYPE Small molecular drug D0C9ZN DRUGINCH 1S/C14H13N5/c1-9-7-11(3-5-15-9)13-17-14(19-18-13)12-4-6-16-10(2)8-12/h3-8H,1-2H3,(H,17,18,19) D0C9ZN DRUGINKE VTUBKJFCLVZEFR-UHFFFAOYSA-N D0C9ZN DRUGSMIL CC1=NC=CC(=C1)C2=NC(=NN2)C3=CC(=NC=C3)C D0C9ZN HIGHSTAT Investigative D0C9ZY DRUG__ID D0C9ZY D0C9ZY DRUGTYPE Small molecular drug D0C9ZY DRUGINCH 1S/C8H8O3/c1-11-8-6(5-9)3-2-4-7(8)10/h2-5,10H,1H3 D0C9ZY DRUGINKE GRIWJVSWLJHHEM-UHFFFAOYSA-N D0C9ZY DRUGSMIL COC1=C(C=CC=C1O)C=O D0C9ZY HIGHSTAT Investigative D0CA7B DRUG__ID D0CA7B D0CA7B DRUGCOMP St Petersburg Institute of Experimental Medicine D0CA7B DRUGINCH 1S/C10H9NO4/c1-7(11(12)13)4-8-2-3-9-10(5-8)15-6-14-9/h2-5H,6H2,1H3/b7-4+ D0CA7B DRUGINKE CCEVJKZHAJJQJR-QPJJXVBHSA-N D0CA7B DRUGSMIL CC(=CC1=CC2=C(C=C1)OCO2)[N+](=O)[O-] D0CA7B HIGHSTAT Investigative D0CA9H DRUG__ID D0CA9H D0CA9H DRUGTYPE Small molecular drug D0CA9H DRUGINCH 1S/C29H35N3O/c33-29(30-24-25-12-4-1-5-13-25)18-8-3-11-19-31-20-22-32(23-21-31)28-17-10-9-16-27(28)26-14-6-2-7-15-26/h1-2,4-7,9-10,12-17H,3,8,11,18-24H2,(H,30,33) D0CA9H DRUGINKE LQFAQQWXFSOOQJ-UHFFFAOYSA-N D0CA9H DRUGSMIL C1CN(CCN1CCCCCC(=O)NCC2=CC=CC=C2)C3=CC=CC=C3C4=CC=CC=C4 D0CA9H HIGHSTAT Investigative D0CB9B DRUG__ID D0CB9B D0CB9B DRUGTYPE Small molecular drug D0CB9B DRUGINCH 1S/C9H6N4S2/c10-9-12-5-1-3-14-7(5)6(13-9)8-11-2-4-15-8/h1-4H,(H2,10,12,13) D0CB9B DRUGINKE CLNBBLGSLDNSMF-UHFFFAOYSA-N D0CB9B DRUGSMIL C1=CSC2=C1N=C(N=C2C3=NC=CS3)N D0CB9B HIGHSTAT Investigative D0CC0B DRUG__ID D0CC0B D0CC0B DRUGTYPE Small molecular drug D0CC0B DRUGINCH 1S/C7H14N2O4/c8-5(6(10)11)3-1-2-4-9-7(12)13/h5,9H,1-4,8H2,(H,10,11)(H,12,13)/t5-/m0/s1 D0CC0B DRUGINKE PWIKLEYMFKCERQ-YFKPBYRVSA-N D0CC0B DRUGSMIL C(CCNC(=O)O)CC(C(=O)O)N D0CC0B HIGHSTAT Investigative D0CC6R DRUG__ID D0CC6R D0CC6R DRUGTYPE Small molecular drug D0CC6R DRUGINCH 1S/C16H11FO2/c17-16-9-14(19)5-6-15(16)12-2-1-11-8-13(18)4-3-10(11)7-12/h1-9,18-19H D0CC6R DRUGINKE MAFQDFZNSVYFEW-UHFFFAOYSA-N D0CC6R DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=C(C=C(C=C3)O)F D0CC6R HIGHSTAT Investigative D0CE3R DRUG__ID D0CE3R D0CE3R DRUGTYPE Small molecular drug D0CE3R DRUGINCH 1S/C19H21N3O3S/c1-22(2)26(24,25)14-7-8-18-15(11-14)16(19(23)21-18)10-13-9-12-5-3-4-6-17(12)20-13/h7-11,20H,3-6H2,1-2H3,(H,21,23)/b16-10- D0CE3R DRUGINKE LOGJQOUIVKBFGH-YBEGLDIGSA-N D0CE3R DRUGSMIL CN(C)S(=O)(=O)C1=CC2=C(C=C1)NC(=O)C2=CC3=CC4=C(N3)CCCC4 D0CE3R HIGHSTAT Investigative D0CE5B DRUG__ID D0CE5B D0CE5B DRUGTYPE Small molecular drug D0CE5B DRUGINCH 1S/C27H21Cl2F6N3O2/c1-40-20-3-5-24-21(12-20)16(13-36-24)6-7-38(14-15-2-4-22(28)23(29)8-15)25(39)37-19-10-17(26(30,31)32)9-18(11-19)27(33,34)35/h2-5,8-13,36H,6-7,14H2,1H3,(H,37,39) D0CE5B DRUGINKE FAXDMTURZKFXIY-UHFFFAOYSA-N D0CE5B DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCN(CC3=CC(=C(C=C3)Cl)Cl)C(=O)NC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D0CE5B HIGHSTAT Investigative D0CF3B DRUG__ID D0CF3B D0CF3B DRUGTYPE Small molecular drug D0CF3B DRUGINCH 1S/C41H62N10O10/c1-6-22(3)18-33(55)46-24(5)36(57)49-28-21-45-32(54)15-13-26(19-25-12-14-30(52)31(53)20-25)47-38(59)34(23(4)7-2)50-39(60)35(56)27(10-8-16-44-41(42)43)48-37(58)29-11-9-17-51(29)40(28)61/h12-15,20,22-24,26-29,34,52-53H,6-11,16-19,21H2,1-5H3,(H,45,54)(H,46,55)(H,47,59)(H,48,58)(H,49,57)(H,50,60)(H4,42,43,44)/b15-13+/t22?,23-,24+,26-,27+,28+,29+,34+/m1/s1 D0CF3B DRUGINKE GPMPQICWVQKULK-TUTRKGMZSA-N D0CF3B DRUGSMIL CCC(C)CC(=O)NC(C)C(=O)NC1CNC(=O)C=CC(NC(=O)C(NC(=O)C(=O)C(NC(=O)C2CCCN2C1=O)CCCN=C(N)N)C(C)CC)CC3=CC(=C(C=C3)O)O D0CF3B HIGHSTAT Investigative D0CF9B DRUG__ID D0CF9B D0CF9B DRUGTYPE Small molecular drug D0CF9B DRUGINCH 1S/C13H7Cl2NS/c14-11-4-9-3-10(8-1-2-17-7-8)6-16-13(9)5-12(11)15/h1-7H D0CF9B DRUGINKE KNQSFKNTYMKKOR-UHFFFAOYSA-N D0CF9B DRUGSMIL C1=CSC=C1C2=CN=C3C=C(C(=CC3=C2)Cl)Cl D0CF9B HIGHSTAT Investigative D0CG2Y DRUG__ID D0CG2Y D0CG2Y DRUGTYPE Small molecular drug D0CG2Y DRUGINCH 1S/C16H18N2O/c1-2-5-14(6-3-1)19-16-15(7-4-10-18-16)13-8-11-17-12-9-13/h1-7,10,13,17H,8-9,11-12H2 D0CG2Y DRUGINKE LKVOLTSPLLAMPJ-UHFFFAOYSA-N D0CG2Y DRUGSMIL C1CNCCC1C2=C(N=CC=C2)OC3=CC=CC=C3 D0CG2Y HIGHSTAT Investigative D0CG7Q DRUG__ID D0CG7Q D0CG7Q DRUGTYPE Small molecular drug D0CG7Q DRUGINCH 1S/C15H28N4O4/c1-8(2)7-10(16)12(20)15(23)19-6-4-5-11(19)14(22)18-9(3)13(17)21/h8-12,20H,4-7,16H2,1-3H3,(H2,17,21)(H,18,22)/t9-,10-,11-,12+/m0/s1 D0CG7Q DRUGINKE PDGQBIYMLALKTR-FIQHERPVSA-N D0CG7Q DRUGSMIL CC(C)CC(C(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)O)N D0CG7Q HIGHSTAT Investigative D0CH0K DRUG__ID D0CH0K D0CH0K DRUGTYPE Small molecular drug D0CH0K DRUGINCH 1S/C26H38N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-24(29)26-28-22-25(30-26)23-19-17-18-21-27-23/h9-10,17-19,21-22H,2-8,11-16,20H2,1H3/b10-9- D0CH0K DRUGINKE MTEOAQVTLKPFRA-KTKRTIGZSA-N D0CH0K DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2 D0CH0K HIGHSTAT Investigative D0CH7U DRUG__ID D0CH7U D0CH7U DRUGTYPE Small molecular drug D0CH7U DRUGINCH 1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(27-29(17,18)19)6(16)4(26-10)1-25-31(23,24)28-30(20,21)22/h2-4,6-7,10,16H,1H2,(H,23,24)(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1 D0CH7U DRUGINKE YPTPYQSAVGGMFN-KQYNXXCUSA-N D0CH7U DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)OP(=O)(O)O)N D0CH7U HIGHSTAT Investigative D0CI3A DRUG__ID D0CI3A D0CI3A DRUGTYPE Small molecular drug D0CI3A DRUGINCH 1S/C9H10INO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1 D0CI3A DRUGINKE UQTZMGFTRHFAAM-ZETCQYMHSA-N D0CI3A DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)I)O D0CI3A HIGHSTAT Investigative D0CI3C DRUG__ID D0CI3C D0CI3C DRUGTYPE Small molecular drug D0CI3C DRUGINCH 1S/C21H21NO5/c1-22-8-7-13(17(26)11-22)19-14(23)9-15(24)20-16(25)10-18(27-21(19)20)12-5-3-2-4-6-12/h2-6,9-10,13,17,23-24,26H,7-8,11H2,1H3/p+1 D0CI3C DRUGINKE PGWURUYAKNYOPM-UHFFFAOYSA-O D0CI3C DRUGSMIL C[NH+]1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4)O)O D0CI3C HIGHSTAT Investigative D0CI6E DRUG__ID D0CI6E D0CI6E DRUGTYPE Small molecular drug D0CI6E DRUGINCH 1S/C40H52O16/c1-18-16-39(48)26-14-15-35(8)25-12-13-27(46)50-17-38(25,19(2)51-20(3)41)31(53-22(5)43)28(52-21(4)42)29(35)36(26,9)32(54-23(6)44)33(55-24(7)45)37(39,10)40(30(18)56-40)34(47)49-11/h12-13,19,25-26,28-33,48H,1,14-17H2,2-11H3/t19-,25?,26?,28+,29?,30-,31+,32-,33+,35+,36+,37-,38-,39-,40?/m1/s1 D0CI6E DRUGINKE VKDXHXWBOARFPD-MDAQDJAWSA-N D0CI6E DRUGSMIL CC(C12COC(=O)C=CC1C3(CCC4C(C3C(C2OC(=O)C)OC(=O)C)(C(C(C5(C4(CC(=C)C6C5(O6)C(=O)OC)O)C)OC(=O)C)OC(=O)C)C)C)OC(=O)C D0CI6E HIGHSTAT Investigative D0CI9W DRUG__ID D0CI9W D0CI9W DRUGCOMP GlaxoSmithKline plc D0CI9W DRUGINCH 1S/C20H29F3N4O/c1-15(2)25-8-3-9-27(13-12-25)19(28)16-6-10-26(11-7-16)17-4-5-18(24-14-17)20(21,22)23/h4-5,14-16H,3,6-13H2,1-2H3 D0CI9W DRUGINKE AHHPKVQYHXNBQN-UHFFFAOYSA-N D0CI9W DRUGSMIL CC(C)N1CCCN(CC1)C(=O)C2CCN(CC2)C3=CN=C(C=C3)C(F)(F)F D0CI9W HIGHSTAT Investigative D0CJ6P DRUG__ID D0CJ6P D0CJ6P DRUGTYPE Small molecular drug D0CJ6P DRUGINCH 1S/C22H33NO2/c1-2-3-4-5-6-7-8-9-10-13-16-23-18-19(17-22(24)25)20-14-11-12-15-21(20)23/h11-12,14-15,18H,2-10,13,16-17H2,1H3,(H,24,25) D0CJ6P DRUGINKE BFCFBVXYQIIZAF-UHFFFAOYSA-N D0CJ6P DRUGSMIL CCCCCCCCCCCCN1C=C(C2=CC=CC=C21)CC(=O)O D0CJ6P HIGHSTAT Investigative D0CJ7L DRUG__ID D0CJ7L D0CJ7L DRUGTYPE Small molecular drug D0CJ7L DRUGINCH 1S/C18H21NO2/c20-18(19-21)11-5-3-1-2-4-8-15-12-13-16-9-6-7-10-17(16)14-15/h4,6-10,12-14,21H,1-3,5,11H2,(H,19,20)/b8-4+ D0CJ7L DRUGINKE PGGPUSMJSOKMEA-XBXARRHUSA-N D0CJ7L DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C=CCCCCCC(=O)NO D0CJ7L HIGHSTAT Investigative D0CK8C DRUG__ID D0CK8C D0CK8C DRUGTYPE Small molecular drug D0CK8C DRUGINCH 1S/C52H62N8O9/c1-32(2)25-42(49(65)59-44(52(68)69-31-36-15-8-5-9-16-36)28-37-29-54-41-18-11-10-17-39(37)41)58-50(66)45-19-12-24-60(45)51(67)43(27-34-13-6-4-7-14-34)57-46(62)30-55-47(63)33(3)56-48(64)40(53)26-35-20-22-38(61)23-21-35/h4-11,13-18,20-23,29,32-33,40,42-45,54,61H,12,19,24-28,30-31,53H2,1-3H3,(H,55,63)(H,56,64)(H,57,62)(H,58,66)(H,59,65)/t33-,40+,42+,43+,44+,45+/m1/s1 D0CK8C DRUGINKE AWLKNBWKVMBAKT-FDXPNMITSA-N D0CK8C DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OCC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D0CK8C HIGHSTAT Investigative D0CK9K DRUG__ID D0CK9K D0CK9K DRUGTYPE Small molecular drug D0CK9K DRUGINCH 1S/C15H22N2O/c1-5-14-12(8-9-17(2)3)13-10-11(18-4)6-7-15(13)16-14/h6-7,10,16H,5,8-9H2,1-4H3 D0CK9K DRUGINKE ZEYRDXUWJDGTLD-UHFFFAOYSA-N D0CK9K DRUGSMIL CCC1=C(C2=C(N1)C=CC(=C2)OC)CCN(C)C D0CK9K HIGHSTAT Investigative D0CM6T DRUG__ID D0CM6T D0CM6T DRUGTYPE Small molecular drug D0CM6T DRUGINCH 1S/C22H22N4O/c1-15-21-11-17(7-8-22(21)26-25-15)18-10-20(13-24-12-18)27-14-19(23)9-16-5-3-2-4-6-16/h2-8,10-13,19H,9,14,23H2,1H3,(H,25,26)/t19-/m0/s1 D0CM6T DRUGINKE BPNUQXPIQBZCMR-IBGZPJMESA-N D0CM6T DRUGSMIL CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CC=CC=C4)N D0CM6T HIGHSTAT Investigative D0CN8Z DRUG__ID D0CN8Z D0CN8Z DRUGTYPE Small molecular drug D0CN8Z DRUGINCH 1S/C14H4F6O2/c15-7-1-5(2-8(16)11(7)19)13(21)14(22)6-3-9(17)12(20)10(18)4-6/h1-4H D0CN8Z DRUGINKE FMFHXBPXDZLEKC-UHFFFAOYSA-N D0CN8Z DRUGSMIL C1=C(C=C(C(=C1F)F)F)C(=O)C(=O)C2=CC(=C(C(=C2)F)F)F D0CN8Z HIGHSTAT Investigative D0CO5S DRUG__ID D0CO5S D0CO5S DRUGTYPE Small molecular drug D0CO5S DRUGINCH 1S/C10H15ClN2O2/c1-2-3-4-5-6-7-8(11)12-10(15)13-9(7)14/h2-6H2,1H3,(H2,12,13,14,15) D0CO5S DRUGINKE KRFZZHACLHGMCH-UHFFFAOYSA-N D0CO5S DRUGSMIL CCCCCCC1=C(NC(=O)NC1=O)Cl D0CO5S HIGHSTAT Investigative D0CO6T DRUG__ID D0CO6T D0CO6T DRUGTYPE Small molecular drug D0CO6T DRUGINCH 1S/C25H18Cl3N3O3/c1-12(32)21-23(29-13(2)33)19-11-18(14-4-6-15(26)7-5-14)22(30-24(19)31(3)25(21)34)17-9-8-16(27)10-20(17)28/h4-11H,1-3H3,(H,29,33) D0CO6T DRUGINKE VHSIAYLBCLUAFT-UHFFFAOYSA-N D0CO6T DRUGSMIL CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C D0CO6T HIGHSTAT Investigative D0CP1J DRUG__ID D0CP1J D0CP1J DRUGTYPE Small molecular drug D0CP1J DRUGINCH 1S/C29H30F2N4O2/c30-24-9-5-20(6-10-24)28(21-7-11-25(31)12-8-21)34-15-13-33(14-16-34)27(36)17-26(32)29(37)35-18-22-3-1-2-4-23(22)19-35/h1-12,26,28H,13-19,32H2/t26-/m0/s1 D0CP1J DRUGINKE ZKIQFLSGMMYCGS-SANMLTNESA-N D0CP1J DRUGSMIL C1CN(CCN1C(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C(=O)CC(C(=O)N4CC5=CC=CC=C5C4)N D0CP1J HIGHSTAT Investigative D0CP3M DRUG__ID D0CP3M D0CP3M DRUGTYPE Small molecular drug D0CP3M DRUGINCH 1S/C7H2Br4N2/c8-2-3(9)5(11)7-6(4(2)10)12-1-13-7/h1H,(H,12,13) D0CP3M DRUGINKE LOEIRDBRYBHAJB-UHFFFAOYSA-N D0CP3M DRUGSMIL C1=NC2=C(N1)C(=C(C(=C2Br)Br)Br)Br D0CP3M HIGHSTAT Investigative D0CQ1J DRUG__ID D0CQ1J D0CQ1J DRUGTYPE Small molecular drug D0CQ1J DRUGINCH 1S/C8H10ClN5O2/c9-5-4(12-8(16)13-6(5)15)3-14-2-1-11-7(14)10/h1-2,7,11H,3,10H2,(H2,12,13,15,16) D0CQ1J DRUGINKE VDNGDZIPDSUEKT-UHFFFAOYSA-N D0CQ1J DRUGSMIL C1=CN(C(N1)N)CC2=C(C(=O)NC(=O)N2)Cl D0CQ1J HIGHSTAT Investigative D0CQ3A DRUG__ID D0CQ3A D0CQ3A DRUGTYPE Small molecular drug D0CQ3A DRUGINCH 1S/3C4H9.Sn/c3*1-3-4-2;/h3*1,3-4H2,2H3; D0CQ3A DRUGINKE PIILXFBHQILWPS-UHFFFAOYSA-N D0CQ3A DRUGSMIL CCCC[Sn](CCCC)CCCC D0CQ3A HIGHSTAT Investigative D0CQ5F DRUG__ID D0CQ5F D0CQ5F DRUGTYPE Small molecular drug D0CQ5F DRUGINCH 1S/C15H16O4/c1-6-4-5-8-7(2)14(17)18-12(8)10-9(6)11(16)13-15(10,3)19-13/h8,10,12-13H,2,4-5H2,1,3H3/t8-,10-,12-,13+,15-/m0/s1 D0CQ5F DRUGINKE IQFFYNSHANWLIR-FJKOOJNLSA-N D0CQ5F DRUGSMIL CC1=C2C(C3C(CC1)C(=C)C(=O)O3)C4(C(C2=O)O4)C D0CQ5F HIGHSTAT Investigative D0CQ6I DRUG__ID D0CQ6I D0CQ6I DRUGTYPE Small molecular drug D0CQ6I DRUGINCH 1S/C13H10N2S/c1-3-11-6-12(8-14-7-11)4-5-13-9-16-10(2)15-13/h3,6-9H,1H2,2H3 D0CQ6I DRUGINKE BZJCMXLEGBDDGI-UHFFFAOYSA-N D0CQ6I DRUGSMIL CC1=NC(=CS1)C#CC2=CN=CC(=C2)C=C D0CQ6I HIGHSTAT Investigative D0CR6B DRUG__ID D0CR6B D0CR6B DRUGTYPE Small molecular drug D0CR6B DRUGINCH 1S/C20H13N3O2/c21-11-14-5-7-15(8-6-14)20-17(12-23-10-9-22-13-23)19(24)16-3-1-2-4-18(16)25-20/h1-10,13H,12H2 D0CR6B DRUGINKE IOBDYJIIOAQKGQ-UHFFFAOYSA-N D0CR6B DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=C(O2)C3=CC=C(C=C3)C#N)CN4C=CN=C4 D0CR6B HIGHSTAT Investigative D0CR6M DRUG__ID D0CR6M D0CR6M DRUGTYPE Small molecular drug D0CR6M DRUGINCH 1S/C13H12BrNO3/c1-3-18-13(17)11-7(2)15-10-5-4-8(14)6-9(10)12(11)16/h4-6H,3H2,1-2H3,(H,15,16) D0CR6M DRUGINKE OWQFPNVJMALXNK-UHFFFAOYSA-N D0CR6M DRUGSMIL CCOC(=O)C1=C(NC2=C(C1=O)C=C(C=C2)Br)C D0CR6M HIGHSTAT Investigative D0CR8V DRUG__ID D0CR8V D0CR8V DRUGTYPE Small molecular drug D0CR8V DRUGINCH 1S/C16H14O6/c1-21-14-4-8(2-3-10(14)18)13-7-12(20)16-11(19)5-9(17)6-15(16)22-13/h2-6,13,17-19H,7H2,1H3/t13-/m0/s1 D0CR8V DRUGINKE FTODBIPDTXRIGS-ZDUSSCGKSA-N D0CR8V DRUGSMIL COC1=C(C=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O D0CR8V HIGHSTAT Investigative D0CS4I DRUG__ID D0CS4I D0CS4I DRUGTYPE Small molecular drug D0CS4I DRUGINCH 1S/C21H34O5/c1-3-4-9-13-21(2,26)14-12-17-16(18(22)15-19(17)23)10-7-5-6-8-11-20(24)25/h5,7,12,14,16-18,22,26H,3-4,6,8-11,13,15H2,1-2H3,(H,24,25)/b7-5-,14-12+/t16-,17-,18+,21-/m1/s1 D0CS4I DRUGINKE CTXLUMAOXBULOZ-BKVRKCTKSA-N D0CS4I DRUGSMIL CCCCCC(C)(C=CC1C(C(CC1=O)O)CC=CCCCC(=O)O)O D0CS4I HIGHSTAT Investigative D0CT1F DRUG__ID D0CT1F D0CT1F DRUGTYPE Small molecular drug D0CT1F DRUGINCH 1S/C16H28O3/c1-13(10-7-11-16(3,4)19-5)8-6-9-14(2)12-15(17)18/h6,9,12-13H,7-8,10-11H2,1-5H3,(H,17,18)/b9-6+,14-12+ D0CT1F DRUGINKE MNYBEULOKRVZKY-TZOAMJEDSA-N D0CT1F DRUGSMIL CC(CCCC(C)(C)OC)CC=CC(=CC(=O)O)C D0CT1F HIGHSTAT Investigative D0CT7P DRUG__ID D0CT7P D0CT7P DRUGTYPE Small molecular drug D0CT7P DRUGINCH 1S/C16H13N3S/c1-12-5-4-6-13(11-12)20-15-8-10-18-16(19-15)14-7-2-3-9-17-14/h2-11H,1H3 D0CT7P DRUGINKE LUFGLBRBPWCPQS-UHFFFAOYSA-N D0CT7P DRUGSMIL CC1=CC(=CC=C1)SC2=NC(=NC=C2)C3=CC=CC=N3 D0CT7P HIGHSTAT Investigative D0CT8A DRUG__ID D0CT8A D0CT8A DRUGTYPE Small molecular drug D0CT8A DRUGINCH 1S/C18H23N3O2/c1-3-22-16-10-5-13(11-17(16)23-4-2)12-21-15-8-6-14(7-9-15)18(19)20/h5-11,21H,3-4,12H2,1-2H3,(H3,19,20) D0CT8A DRUGINKE KWXVDUACPKJCCN-UHFFFAOYSA-N D0CT8A DRUGSMIL CCOC1=C(C=C(C=C1)CNC2=CC=C(C=C2)C(=N)N)OCC D0CT8A HIGHSTAT Investigative D0CT9V DRUG__ID D0CT9V D0CT9V DRUGTYPE Small molecular drug D0CT9V DRUGINCH 1S/C15H11NO2/c17-15(16-18)13-6-5-12-7-10-3-1-2-4-11(10)8-14(12)9-13/h1-9,18H,(H,16,17) D0CT9V DRUGINKE YGGCUZPPJKJWPE-UHFFFAOYSA-N D0CT9V DRUGSMIL C1=CC=C2C=C3C=C(C=CC3=CC2=C1)C(=O)NO D0CT9V HIGHSTAT Investigative D0CU3I DRUG__ID D0CU3I D0CU3I DRUGTYPE Small molecular drug D0CU3I DRUGINCH 1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h11-12H,2-8,13-17H2,1H3,(H,19,20)/b12-11- D0CU3I DRUGINKE BWSIKEZDJMZITO-QXMHVHEDSA-N D0CU3I DRUGSMIL CCCCCCCCC#CC=CCCCCCC(=O)O D0CU3I HIGHSTAT Investigative D0CU4Q DRUG__ID D0CU4Q D0CU4Q DRUGTYPE Small molecular drug D0CU4Q DRUGINCH 1S/C4H9NO2S/c1-8-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1 D0CU4Q DRUGINKE IDIDJDIHTAOVLG-VKHMYHEASA-N D0CU4Q DRUGSMIL CSCC(C(=O)O)N D0CU4Q HIGHSTAT Investigative D0CU9Y DRUG__ID D0CU9Y D0CU9Y DRUGTYPE Small molecular drug D0CU9Y DRUGINCH 1S/C9H11NO2/c1-6-4-2-3-5-7(6)8(10)9(11)12/h2-5,8H,10H2,1H3,(H,11,12)/t8-/m0/s1 D0CU9Y DRUGINKE FLYIRERUSAMCDQ-QMMMGPOBSA-N D0CU9Y DRUGSMIL CC1=CC=CC=C1C(C(=O)O)N D0CU9Y HIGHSTAT Investigative D0CW1Q DRUG__ID D0CW1Q D0CW1Q DRUGTYPE Small molecular drug D0CW1Q DRUGINCH 1S/C17H15NO3/c1-19-16-10-13-14(11-17(16)20-2)18-9-8-15(13)21-12-6-4-3-5-7-12/h3-11H,1-2H3 D0CW1Q DRUGINKE ZQNTXGWAYYJCOZ-UHFFFAOYSA-N D0CW1Q DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=CC=C3 D0CW1Q HIGHSTAT Investigative D0CW3A DRUG__ID D0CW3A D0CW3A DRUGTYPE Small molecular drug D0CW3A DRUGINCH 1S/C14H12O6S.K/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(8-11)20-21(17,18)19;/h1-9,15-16H,(H,17,18,19);/q;+1/p-1/b2-1+; D0CW3A DRUGINKE ZWGAYYADLYCXQH-TYYBGVCCSA-M D0CW3A DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)OS(=O)(=O)[O-])O)O.[K+] D0CW3A HIGHSTAT Investigative D0CW4T DRUG__ID D0CW4T D0CW4T DRUGTYPE Small molecular drug D0CW4T DRUGINCH 1S/C22H36O5/c1-4-5-8-11-17(26-2)14-15-19-18(20(23)16-21(19)27-3)12-9-6-7-10-13-22(24)25/h6,9,14-15,17-19,21H,4-5,7-8,10-13,16H2,1-3H3,(H,24,25)/b9-6-,15-14+/t17-,18+,19+,21+/m0/s1 D0CW4T DRUGINKE MXDQOCKVVLKVJS-QKIVIXBWSA-N D0CW4T DRUGSMIL CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)OC)OC D0CW4T HIGHSTAT Investigative D0CX4E DRUG__ID D0CX4E D0CX4E DRUGTYPE Small molecular drug D0CX4E DRUGINCH 1S/C14H13NO3/c16-13(17)7-9-15-8-6-12(10-15)14(18)11-4-2-1-3-5-11/h1-6,8,10H,7,9H2,(H,16,17) D0CX4E DRUGINKE SZVSICYEXHCWBP-UHFFFAOYSA-N D0CX4E DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CN(C=C2)CCC(=O)O D0CX4E HIGHSTAT Investigative D0CX4W DRUG__ID D0CX4W D0CX4W DRUGTYPE Small molecular drug D0CX4W DRUGINCH 1S/C27H45N7O3/c1-31(2)15-16-36-17-18-37-25-20-23-22(19-24(25)35-5)26(28-21-7-11-33(4)12-8-21)30-27(29-23)34-10-6-9-32(3)13-14-34/h19-21H,6-18H2,1-5H3,(H,28,29,30) D0CX4W DRUGINKE AULLUGALUBVBDD-UHFFFAOYSA-N D0CX4W DRUGSMIL CN1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)NC4CCN(CC4)C)OC)OCCOCCN(C)C D0CX4W HIGHSTAT Investigative D0CX7I DRUG__ID D0CX7I D0CX7I DRUGTYPE Small molecular drug D0CX7I DRUGINCH 1S/C14H18N2S/c1-10-6-5-7-11(8-10)15-13-16-12(9-17-13)14(2,3)4/h5-9H,1-4H3,(H,15,16) D0CX7I DRUGINKE JCIZSRYCZWHMQK-UHFFFAOYSA-N D0CX7I DRUGSMIL CC1=CC(=CC=C1)NC2=NC(=CS2)C(C)(C)C D0CX7I HIGHSTAT Investigative D0CX7N DRUG__ID D0CX7N D0CX7N DRUGTYPE Small molecular drug D0CX7N DRUGINCH 1S/C8H10BrN5O/c9-8-13-5-6(10)11-4-12-7(5)14(8)2-1-3-15/h4,15H,1-3H2,(H2,10,11,12) D0CX7N DRUGINKE MUZYIFHIQGFDMZ-UHFFFAOYSA-N D0CX7N DRUGSMIL C1=NC(=C2C(=N1)N(C(=N2)Br)CCCO)N D0CX7N HIGHSTAT Investigative D0CY6E DRUG__ID D0CY6E D0CY6E DRUGTYPE Small molecular drug D0CY6E DRUGINCH 1S/C14H15NO2S/c15-11-10-12-6-8-14(9-7-12)18(16,17)13-4-2-1-3-5-13/h1-9H,10-11,15H2 D0CY6E DRUGINKE YNFGKNGJUDQMQL-UHFFFAOYSA-N D0CY6E DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)CCN D0CY6E HIGHSTAT Investigative D0CZ3C DRUG__ID D0CZ3C D0CZ3C DRUGTYPE Small molecular drug D0CZ3C DRUGINCH 1S/C9H13N2O8P/c12-5-3-8(11-2-1-7(13)10-9(11)14)19-6(5)4-18-20(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 D0CZ3C DRUGINKE JSRLJPSBLDHEIO-SHYZEUOFSA-N D0CZ3C DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(O)O)O D0CZ3C HIGHSTAT Investigative D0D0BI DRUG__ID D0D0BI D0D0BI DRUGTYPE Small molecular drug D0D0BI DRUGINCH 1S/C6Cl4O2/c7-1-2(8)6(12)4(10)3(9)5(1)11 D0D0BI DRUGINKE UGNWTBMOAKPKBL-UHFFFAOYSA-N D0D0BI DRUGSMIL C1(=C(C(=O)C(=C(C1=O)Cl)Cl)Cl)Cl D0D0BI HIGHSTAT Investigative D0D0BO DRUG__ID D0D0BO D0D0BO DRUGTYPE Small molecular drug D0D0BO DRUGINCH 1S/C12H17N3O4S/c13-20(17,18)11-3-1-10(2-4-11)14-12(16)9-15-5-7-19-8-6-15/h1-4H,5-9H2,(H,14,16)(H2,13,17,18) D0D0BO DRUGINKE ZKUIDNFBWWVULC-UHFFFAOYSA-N D0D0BO DRUGSMIL C1COCCN1CC(=O)NC2=CC=C(C=C2)S(=O)(=O)N D0D0BO HIGHSTAT Investigative D0D0DR DRUG__ID D0D0DR D0D0DR DRUGTYPE Small molecular drug D0D0DR DRUGINCH 1S/C12H13FN2/c13-12-5-3-11(4-6-12)2-1-8-15-9-7-14-10-15/h3-7,9-10H,1-2,8H2 D0D0DR DRUGINKE BEKCOALNZLRGJA-UHFFFAOYSA-N D0D0DR DRUGSMIL C1=CC(=CC=C1CCCN2C=CN=C2)F D0D0DR HIGHSTAT Investigative D0D0DV DRUG__ID D0D0DV D0D0DV DRUGTYPE Small molecular drug D0D0DV DRUGINCH 1S/C11H10BrN3O2/c12-8-9(14-11(17)15-10(8)16)13-6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,13,14,15,16,17) D0D0DV DRUGINKE SLPLXDQXLWOWDS-UHFFFAOYSA-N D0D0DV DRUGSMIL C1=CC=C(C=C1)CNC2=C(C(=O)NC(=O)N2)Br D0D0DV HIGHSTAT Investigative D0D0DW DRUG__ID D0D0DW D0D0DW DRUGTYPE Small molecular drug D0D0DW DRUGINCH 1S/C16H13BrN4O/c17-13-6-4-11(5-7-13)8-19-16(22)21-14-3-1-2-12-9-18-10-20-15(12)14/h1-7,9-10H,8H2,(H2,19,21,22) D0D0DW DRUGINKE HUPXBWYDCNIXNH-UHFFFAOYSA-N D0D0DW DRUGSMIL C1=CC2=CN=CN=C2C(=C1)NC(=O)NCC3=CC=C(C=C3)Br D0D0DW HIGHSTAT Investigative D0D0FQ DRUG__ID D0D0FQ D0D0FQ DRUGTYPE Small molecular drug D0D0FQ DRUGINCH 1S/C24H19ClO7/c1-5-11-12(24(30)32-4)8-13-16(20(11)27)22(29)17-14(26)7-10-6-9(2)19(25)23(31-3)15(10)18(17)21(13)28/h6-8,26-27H,5H2,1-4H3 D0D0FQ DRUGINKE NFJVYTZFJNVKBA-UHFFFAOYSA-N D0D0FQ DRUGSMIL CCC1=C(C=C2C(=C1O)C(=O)C3=C(C=C4C=C(C(=C(C4=C3C2=O)OC)Cl)C)O)C(=O)OC D0D0FQ HIGHSTAT Investigative D0D0FV DRUG__ID D0D0FV D0D0FV DRUGTYPE Small molecular drug D0D0FV DRUGINCH 1S/C12H18N2/c1-11-5-4-9-14(11)10-7-12-6-2-3-8-13-12/h2-3,6,8,11H,4-5,7,9-10H2,1H3/t11-/m1/s1 D0D0FV DRUGINKE ICWSPDRNRGQWAB-LLVKDONJSA-N D0D0FV DRUGSMIL CC1CCCN1CCC2=CC=CC=N2 D0D0FV HIGHSTAT Investigative D0D0FX DRUG__ID D0D0FX D0D0FX DRUGTYPE Small molecular drug D0D0FX DRUGINCH 1S/C20H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19(23)20-22-21-18-24-20/h9-10,18H,2-8,11-17H2,1H3/b10-9- D0D0FX DRUGINKE JPZIIIRVMJASPM-KTKRTIGZSA-N D0D0FX DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NN=CO1 D0D0FX HIGHSTAT Investigative D0D0JE DRUG__ID D0D0JE D0D0JE DRUGTYPE Small molecular drug D0D0JE DRUGINCH 1S/C17H15NO2Se/c1-19-14-7-3-12(4-8-14)16-11-18-21-17(16)13-5-9-15(20-2)10-6-13/h3-11H,1-2H3 D0D0JE DRUGINKE QSLNOYIPCSNQKT-UHFFFAOYSA-N D0D0JE DRUGSMIL COC1=CC=C(C=C1)C2=C([Se]N=C2)C3=CC=C(C=C3)OC D0D0JE HIGHSTAT Investigative D0D0JU DRUG__ID D0D0JU D0D0JU DRUGTYPE Small molecular drug D0D0JU DRUGINCH 1S/C12H26OS2/c1-3-5-7-9-11-14-15(13)12-10-8-6-4-2/h3-12H2,1-2H3 D0D0JU DRUGINKE FBPVGCZBKKKGRF-UHFFFAOYSA-N D0D0JU DRUGSMIL CCCCCCSS(=O)CCCCCC D0D0JU HIGHSTAT Investigative D0D0KT DRUG__ID D0D0KT D0D0KT DRUGTYPE Small molecular drug D0D0KT DRUGINCH 1S/C15H16N2O/c18-15(14-9-5-10-16-12-14)17-11-4-8-13-6-2-1-3-7-13/h1-3,5-7,9-10,12H,4,8,11H2,(H,17,18) D0D0KT DRUGINKE DGVNUZBITSWBPL-UHFFFAOYSA-N D0D0KT DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C2=CN=CC=C2 D0D0KT HIGHSTAT Investigative D0D0LD DRUG__ID D0D0LD D0D0LD DRUGTYPE Small molecular drug D0D0LD DRUGINCH 1S/C23H26F3N3O3S/c1-15(2)14-20(22(30)28-13-12-27)29-21(23(24,25)26)18-6-4-16(5-7-18)17-8-10-19(11-9-17)33(3,31)32/h4-11,15,20-21,29H,13-14H2,1-3H3,(H,28,30)/t20-,21-/m0/s1 D0D0LD DRUGINKE VYFDSJLOCIGIKP-SFTDATJTSA-N D0D0LD DRUGSMIL CC(C)CC(C(=O)NCC#N)NC(C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)C)C(F)(F)F D0D0LD HIGHSTAT Investigative D0D0NG DRUG__ID D0D0NG D0D0NG DRUGTYPE Small molecular drug D0D0NG DRUGINCH 1S/C15H19NO4/c17-14(18)12-6-8-13(9-7-12)20-15(19)16-10-11-4-2-1-3-5-11/h6-9,11H,1-5,10H2,(H,16,19)(H,17,18) D0D0NG DRUGINKE UTXJJIRQAYXELZ-UHFFFAOYSA-N D0D0NG DRUGSMIL C1CCC(CC1)CNC(=O)OC2=CC=C(C=C2)C(=O)O D0D0NG HIGHSTAT Investigative D0D0OD DRUG__ID D0D0OD D0D0OD DRUGTYPE Small molecular drug D0D0OD DRUGINCH 1S/C21H24N2O/c1-21(2,3)13-14-22-20(24)17-8-10-18(11-9-17)23-15-12-16-6-4-5-7-19(16)23/h4-12,15H,13-14H2,1-3H3,(H,22,24) D0D0OD DRUGINKE WFFDNQLEAMWQBV-UHFFFAOYSA-N D0D0OD DRUGSMIL CC(C)(C)CCNC(=O)C1=CC=C(C=C1)N2C=CC3=CC=CC=C32 D0D0OD HIGHSTAT Investigative D0D0OX DRUG__ID D0D0OX D0D0OX DRUGTYPE Small molecular drug D0D0OX DRUGINCH 1S/C20H18N2O4/c1-3-17(23)21-11-5-7-13-15(9-11)20(26)16-10-12(22-18(24)4-2)6-8-14(16)19(13)25/h5-10H,3-4H2,1-2H3,(H,21,23)(H,22,24) D0D0OX DRUGINKE FNUQOQZYSRMGQN-UHFFFAOYSA-N D0D0OX DRUGSMIL CCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CC D0D0OX HIGHSTAT Investigative D0D0PV DRUG__ID D0D0PV D0D0PV DRUGTYPE Small molecular drug D0D0PV DRUGINCH 1S/C24H38N7O19P3S/c1-24(2,19(37)22(38)27-4-3-13(32)26-5-6-54-15(35)7-14(33)34)9-47-53(44,45)50-52(42,43)46-8-12-18(49-51(39,40)41)17(36)23(48-12)31-11-30-16-20(25)28-10-29-21(16)31/h10-12,17-19,23,36-37H,3-9H2,1-2H3,(H,26,32)(H,27,38)(H,33,34)(H,42,43)(H,44,45)(H2,25,28,29)(H2,39,40,41)/t12-,17-,18-,19+,23-/m1/s1 D0D0PV DRUGINKE LTYOQGRJFJAKNA-DVVLENMVSA-N D0D0PV DRUGSMIL CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCSC(=O)CC(=O)O)O D0D0PV HIGHSTAT Investigative D0D0RJ DRUG__ID D0D0RJ D0D0RJ DRUGCOMP University of Texas Southwestern Medical Center D0D0RJ DRUGINCH 1S/C19H17N3O2S2/c23-26(24,22-17-9-5-2-6-10-17)18-13-11-16(12-14-18)21-19(25)20-15-7-3-1-4-8-15/h1-14,22H,(H2,20,21,25) D0D0RJ DRUGINKE HNDRSTUKPCLQLT-UHFFFAOYSA-N D0D0RJ DRUGSMIL C1=CC=C(C=C1)NC(=S)NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=C3 D0D0RJ HIGHSTAT Investigative D0D0SC DRUG__ID D0D0SC D0D0SC DRUGTYPE Small molecular drug D0D0SC DRUGINCH 1S/C12H17N3O3/c16-11-2-1-10(9-14-11)12(17)13-3-4-15-5-7-18-8-6-15/h1-2,9H,3-8H2,(H,13,17)(H,14,16) D0D0SC DRUGINKE BNPSDTRXYVPPCU-UHFFFAOYSA-N D0D0SC DRUGSMIL C1COCCN1CCNC(=O)C2=CNC(=O)C=C2 D0D0SC HIGHSTAT Investigative D0D0TO DRUG__ID D0D0TO D0D0TO DRUGTYPE Small molecular drug D0D0TO DRUGINCH 1S/C5H10N2/c6-5-3-1-2-4-7-5/h1-4H2,(H2,6,7) D0D0TO DRUGINKE DHGUMNJVFYRSIG-UHFFFAOYSA-N D0D0TO DRUGSMIL C1CCN=C(C1)N D0D0TO HIGHSTAT Investigative D0D0UP DRUG__ID D0D0UP D0D0UP DRUGTYPE Small molecular drug D0D0UP DRUGINCH 1S/C22H23NOS/c24-22(20-12-7-17-25-20)13-15-23(16-14-22)21(18-8-3-1-4-9-18)19-10-5-2-6-11-19/h1-12,17,21,24H,13-16H2 D0D0UP DRUGINKE LBJDYBPTWNSHBS-UHFFFAOYSA-N D0D0UP DRUGSMIL C1CN(CCC1(C2=CC=CS2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0D0UP HIGHSTAT Investigative D0D0XP DRUG__ID D0D0XP D0D0XP DRUGTYPE Small molecular drug D0D0XP DRUGINCH 1S/C18H21NO6S/c1-19-8-7-18-11-4-6-14(25-26(20,21)22)17(18)24-16-13(23-2)5-3-10(15(16)18)9-12(11)19/h3-6,11-12,14,17H,7-9H2,1-2H3,(H,20,21,22)/t11-,12+,14-,17-,18-/m0/s1 D0D0XP DRUGINKE JIYGLXDCNSTUSY-XSSYPUMDSA-N D0D0XP DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)OS(=O)(=O)O D0D0XP HIGHSTAT Investigative D0D0ZQ DRUG__ID D0D0ZQ D0D0ZQ DRUGTYPE Small molecular drug D0D0ZQ DRUGINCH 1S/C14H15N5O/c1-8(2)20-11-4-6-16-13-12(11)9(7-18-13)10-3-5-17-14(15)19-10/h3-8H,1-2H3,(H,16,18)(H2,15,17,19) D0D0ZQ DRUGINKE YRURITXEWXPMAI-UHFFFAOYSA-N D0D0ZQ DRUGSMIL CC(C)OC1=C2C(=CNC2=NC=C1)C3=NC(=NC=C3)N D0D0ZQ HIGHSTAT Investigative D0D1CV DRUG__ID D0D1CV D0D1CV DRUGTYPE Small molecular drug D0D1CV DRUGINCH 1S/C13H19NO5S/c1-2-3-4-5-10-18-13(15)11-6-8-12(9-7-11)19-20(14,16)17/h6-9H,2-5,10H2,1H3,(H2,14,16,17) D0D1CV DRUGINKE PJIPMHPXRQOHKO-UHFFFAOYSA-N D0D1CV DRUGSMIL CCCCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D0D1CV HIGHSTAT Investigative D0D1EE DRUG__ID D0D1EE D0D1EE DRUGTYPE Small molecular drug D0D1EE DRUGINCH 1S/C20H24O10/c1-6-12(23)27-7-5-17-11-8(21)9(16(2,3)4)18(17)10(22)13(24)29-15(18)30-20(17,14(25)28-11)19(6,7)26/h6-11,15,21-22,26H,5H2,1-4H3/t6-,7+,8-,9+,10+,11-,15+,17?,18+,19-,20-/m1/s1 D0D1EE DRUGINKE LMEHVEUFNRJAAV-XNSMQBOTSA-N D0D1EE DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O D0D1EE HIGHSTAT Investigative D0D1EU DRUG__ID D0D1EU D0D1EU DRUGTYPE Small molecular drug D0D1EU DRUGINCH 1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m1/s1 D0D1EU DRUGINKE AYXYPKUFHZROOJ-SSDOTTSWSA-N D0D1EU DRUGSMIL CC(C)CC(CC(=O)O)CN D0D1EU HIGHSTAT Investigative D0D1FK DRUG__ID D0D1FK D0D1FK DRUGTYPE Small molecular drug D0D1FK DRUGINCH 1S/C9H9O6P/c1-6-2-7(4-10)9(8(3-6)5-11)15-16(12,13)14/h2-5H,1H3,(H2,12,13,14) D0D1FK DRUGINKE NAYNUXXSJZLKPW-UHFFFAOYSA-N D0D1FK DRUGSMIL CC1=CC(=C(C(=C1)C=O)OP(=O)(O)O)C=O D0D1FK HIGHSTAT Investigative D0D1FT DRUG__ID D0D1FT D0D1FT DRUGTYPE Small molecular drug D0D1FT DRUGINCH 1S/C22H21ClN6O2/c1-2-3-8-18-24-20(23)19(22(30)31)29(18)13-14-9-11-15(12-10-14)16-6-4-5-7-17(16)21-25-27-28-26-21/h4-7,9-12H,2-3,8,13H2,1H3,(H,30,31)(H,25,26,27,28) D0D1FT DRUGINKE ZEUXAIYYDDCIRX-UHFFFAOYSA-N D0D1FT DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)Cl D0D1FT HIGHSTAT Investigative D0D1GI DRUG__ID D0D1GI D0D1GI DRUGTYPE Small molecular drug D0D1GI DRUGINCH 1S/C16H11N3/c17-11-13-4-3-5-14(10-13)15-7-9-19(12-15)16-6-1-2-8-18-16/h1-10,12H D0D1GI DRUGINKE GXXRNNGNWUNPKZ-UHFFFAOYSA-N D0D1GI DRUGSMIL C1=CC=NC(=C1)N2C=CC(=C2)C3=CC=CC(=C3)C#N D0D1GI HIGHSTAT Investigative D0D1HC DRUG__ID D0D1HC D0D1HC DRUGTYPE Small molecular drug D0D1HC DRUGINCH 1S/C13H13NO5S/c1-9-3-5-11(6-4-9)20(17,18)14-12(16)7-8-13(14)19-10(2)15/h3-8,13H,1-2H3 D0D1HC DRUGINKE JVIFWMPUUHEQPE-UHFFFAOYSA-N D0D1HC DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C(C=CC2=O)OC(=O)C D0D1HC HIGHSTAT Investigative D0D1KA DRUG__ID D0D1KA D0D1KA DRUGTYPE Small molecular drug D0D1KA DRUGINCH 1S/C17H11NO2/c18-10-14-8-16(20)7-13-5-4-12(9-17(13)14)11-2-1-3-15(19)6-11/h1-9,19-20H D0D1KA DRUGINKE PBXARVUJEROSCH-UHFFFAOYSA-N D0D1KA DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C(C=C3C=C2)O)C#N D0D1KA HIGHSTAT Investigative D0D1KK DRUG__ID D0D1KK D0D1KK DRUGTYPE Small molecular drug D0D1KK DRUGINCH 1S/C18H21NO2/c20-18(16-9-5-2-6-10-16,17-14-19-11-12-21-17)13-15-7-3-1-4-8-15/h1-10,17,19-20H,11-14H2/t17-,18+/m0/s1 D0D1KK DRUGINKE VGJFVJKZCAUGKE-ZWKOTPCHSA-N D0D1KK DRUGSMIL C1COC(CN1)C(CC2=CC=CC=C2)(C3=CC=CC=C3)O D0D1KK HIGHSTAT Investigative D0D1KZ DRUG__ID D0D1KZ D0D1KZ DRUGTYPE Small molecular drug D0D1KZ DRUGINCH 1S/C10H9NO/c1-11-6-8(7-12)9-4-2-3-5-10(9)11/h2-7H,1H3 D0D1KZ DRUGINKE KXYBYRKRRGSZCX-UHFFFAOYSA-N D0D1KZ DRUGSMIL CN1C=C(C2=CC=CC=C21)C=O D0D1KZ HIGHSTAT Investigative D0D1LB DRUG__ID D0D1LB D0D1LB DRUGTYPE Small molecular drug D0D1LB DRUGINCH 1S/C22H18O5/c23-15-8-6-14(7-9-15)20-12-19(26)21-18(25)11-17(24)16(22(21)27-20)10-13-4-2-1-3-5-13/h1-9,11,20,23-25H,10,12H2/t20-/m0/s1 D0D1LB DRUGINKE JCMOCGVRZVEPSS-FQEVSTJZSA-N D0D1LB DRUGSMIL C1C(OC2=C(C(=CC(=C2C1=O)O)O)CC3=CC=CC=C3)C4=CC=C(C=C4)O D0D1LB HIGHSTAT Investigative D0D1NQ DRUG__ID D0D1NQ D0D1NQ DRUGTYPE Small molecular drug D0D1NQ DRUGINCH 1S/C20H25NO10/c1-5-12(24)28-11-8(22)18-10-6(21)7(16(2,3)4)17(18)9(23)13(25)30-15(17)31-20(18,14(26)29-10)19(5,11)27/h5-11,15,22-23,27H,21H2,1-4H3/t5?,6-,7?,8?,9-,10?,11-,15?,17?,18?,19+,20-/m0/s1 D0D1NQ DRUGINKE OONDPNQTNMFTRA-AQPRMESZSA-N D0D1NQ DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5N)C(C)(C)C)C(C(=O)OC6O4)O)O D0D1NQ HIGHSTAT Investigative D0D1ON DRUG__ID D0D1ON D0D1ON DRUGTYPE Small molecular drug D0D1ON DRUGINCH 1S/C18H19N5O2/c1-10-12(9-21-17-15(10)16(19)22-18(20)23-17)5-4-11-8-13(24-2)6-7-14(11)25-3/h4-9H,1-3H3,(H4,19,20,21,22,23)/b5-4- D0D1ON DRUGINKE WNDJHUNKXPAREB-PLNGDYQASA-N D0D1ON DRUGSMIL CC1=C2C(=NC(=NC2=NC=C1C=CC3=C(C=CC(=C3)OC)OC)N)N D0D1ON HIGHSTAT Investigative D0D1PE DRUG__ID D0D1PE D0D1PE DRUGTYPE Small molecular drug D0D1PE DRUGINCH 1S/C12H12N2O/c1-15-8-2-3-9-10-4-5-13-7-12(10)14-11(9)6-8/h2-3,6-7,14H,4-5H2,1H3 D0D1PE DRUGINKE VTEZDUSEJVSZGQ-UHFFFAOYSA-N D0D1PE DRUGSMIL COC1=CC2=C(C=C1)C3=C(N2)C=NCC3 D0D1PE HIGHSTAT Investigative D0D1PR DRUG__ID D0D1PR D0D1PR DRUGTYPE Small molecular drug D0D1PR DRUGINCH 1S/C20H23NO3/c1-3-7-21-8-6-13-9-14(24-2)11-15-18(13)16(21)10-12-4-5-17(22)20(23)19(12)15/h4-5,9,11,16,22-23H,3,6-8,10H2,1-2H3/t16-/m1/s1 D0D1PR DRUGINKE WNNMRMNAGNMVEW-MRXNPFEDSA-N D0D1PR DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=C(C=C4)O)O D0D1PR HIGHSTAT Investigative D0D1RU DRUG__ID D0D1RU D0D1RU DRUGTYPE Small molecular drug D0D1RU DRUGINCH 1S/C13H11N3/c1-2-4-13-11(3-1)7-10-16(13)15-12-5-8-14-9-6-12/h1-10H,(H,14,15) D0D1RU DRUGINKE YFXZWVUZIPQSKX-UHFFFAOYSA-N D0D1RU DRUGSMIL C1=CC=C2C(=C1)C=CN2NC3=CC=NC=C3 D0D1RU HIGHSTAT Investigative D0D1VB DRUG__ID D0D1VB D0D1VB DRUGTYPE Small molecular drug D0D1VB DRUGINCH 1S/C36H39N5O5/c37-29(20-24-13-16-28(42)17-14-24)36(46)41-18-6-11-32(41)35(45)40-31(21-23-7-2-1-3-8-23)34(44)39-30(33(38)43)22-25-12-15-26-9-4-5-10-27(26)19-25/h1-5,7-10,12-17,19,29-32,42H,6,11,18,20-22,37H2,(H2,38,43)(H,39,44)(H,40,45)/t29-,30+,31-,32-/m0/s1 D0D1VB DRUGINKE UHSIKTZSFPWTDC-RACKDBBVSA-N D0D1VB DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC5=CC=CC=C5C=C4)C(=O)N D0D1VB HIGHSTAT Investigative D0D1YW DRUG__ID D0D1YW D0D1YW DRUGTYPE Small molecular drug D0D1YW DRUGINCH 1S/C18H12N6O/c25-18-12-10-13(19-20-17(12)21-22-18)15-14-8-4-5-9-24(14)23-16(15)11-6-2-1-3-7-11/h1-10H,(H2,20,21,22,25) D0D1YW DRUGINKE QMBDONCHHMIWFJ-UHFFFAOYSA-N D0D1YW DRUGSMIL C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=NN=C5C(=C4)C(=O)NN5 D0D1YW HIGHSTAT Investigative D0D2CU DRUG__ID D0D2CU D0D2CU DRUGTYPE Small molecular drug D0D2CU DRUGINCH 1S/C18H19NO2/c1-10-7-12-5-6-19(2)14-9-11-3-4-15(20)18(21)17(11)13(8-10)16(12)14/h3-4,7-8,14,20-21H,5-6,9H2,1-2H3/t14-/m1/s1 D0D2CU DRUGINKE QRJZCXSRTBCYIW-CQSZACIVSA-N D0D2CU DRUGSMIL CC1=CC2=C3C(CC4=C(C3=C1)C(=C(C=C4)O)O)N(CC2)C D0D2CU HIGHSTAT Investigative D0D2EF DRUG__ID D0D2EF D0D2EF DRUGTYPE Small molecular drug D0D2EF DRUGINCH 1S/C6H11NO2/c8-6(9)5-2-1-3-7-4-5/h5,7H,1-4H2,(H,8,9)/t5-/m1/s1 D0D2EF DRUGINKE XJLSEXAGTJCILF-RXMQYKEDSA-N D0D2EF DRUGSMIL C1CC(CNC1)C(=O)O D0D2EF HIGHSTAT Investigative D0D2ET DRUG__ID D0D2ET D0D2ET DRUGTYPE Small molecular drug D0D2ET DRUGINCH 1S/C49H66N12O10/c1-28(2)20-40(49(70)71-4)60-47(68)39(23-32-25-52-27-54-32)56-42(63)26-61-19-11-10-16-37(48(61)69)58-43(64)29(3)55-46(67)38(22-31-24-53-35-15-9-8-14-33(31)35)59-45(66)36(17-18-41(51)62)57-44(65)34(50)21-30-12-6-5-7-13-30/h5-9,12-15,24-25,27-29,34,36-40,53H,10-11,16-23,26,50H2,1-4H3,(H2,51,62)(H,52,54)(H,55,67)(H,56,63)(H,57,65)(H,58,64)(H,59,66)(H,60,68)/t29?,34-,36?,37?,38?,39?,40?/m1/s1 D0D2ET DRUGINKE LRJRTIDXMDONHY-UEHPUAOMSA-N D0D2ET DRUGSMIL CC(C)CC(C(=O)OC)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)C(CC5=CC=CC=C5)N D0D2ET HIGHSTAT Investigative D0D2FB DRUG__ID D0D2FB D0D2FB DRUGTYPE Small molecular drug D0D2FB DRUGINCH 1S/C21H15NO3/c23-20-18-11-4-5-12-19(18)21(24)22(20)16-9-6-10-17(13-16)25-14-15-7-2-1-3-8-15/h1-13H,14H2 D0D2FB DRUGINKE KEXVEOJPANROJT-UHFFFAOYSA-N D0D2FB DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC(=C2)N3C(=O)C4=CC=CC=C4C3=O D0D2FB HIGHSTAT Investigative D0D2FC DRUG__ID D0D2FC D0D2FC DRUGTYPE Small molecular drug D0D2FC DRUGINCH 1S/C19H24ClN7/c1-2-27-11-22-16-17(23-13-7-5-6-12(20)10-13)25-19(26-18(16)27)24-15-9-4-3-8-14(15)21/h5-7,10-11,14-15H,2-4,8-9,21H2,1H3,(H2,23,24,25,26)/t14-,15+/m0/s1 D0D2FC DRUGINKE UTBSBSOBZHXMHI-LSDHHAIUSA-N D0D2FC DRUGSMIL CCN1C=NC2=C(N=C(N=C21)NC3CCCCC3N)NC4=CC(=CC=C4)Cl D0D2FC HIGHSTAT Investigative D0D2FP DRUG__ID D0D2FP D0D2FP DRUGTYPE Small molecular drug D0D2FP DRUGINCH 1S/C23H25N3O/c1-23(2,3)17-8-9-18-15(13-17)7-10-21(18)26-22(27)25-20-6-4-5-16-14-24-12-11-19(16)20/h4-6,8-9,11-14,21H,7,10H2,1-3H3,(H2,25,26,27)/t21-/m1/s1/i5T,6T D0D2FP DRUGINKE VPSCJCQPUGKRNC-ZVVBTKFUSA-N D0D2FP DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C(CC2)NC(=O)NC3=CC=CC4=C3C=CN=C4 D0D2FP HIGHSTAT Investigative D0D2GL DRUG__ID D0D2GL D0D2GL DRUGTYPE Small molecular drug D0D2GL DRUGINCH 1S/C9H12NO5P/c1-9(10,8(11)12)6-2-4-7(5-3-6)16(13,14)15/h2-5H,10H2,1H3,(H,11,12)(H2,13,14,15) D0D2GL DRUGINKE PAONCRJPUQXPRW-UHFFFAOYSA-N D0D2GL DRUGSMIL CC(C1=CC=C(C=C1)P(=O)(O)O)(C(=O)O)N D0D2GL HIGHSTAT Investigative D0D2HH DRUG__ID D0D2HH D0D2HH DRUGTYPE Small molecular drug D0D2HH DRUGINCH 1S/C14H6F6O2/c15-5-1-7(11(19)9(17)3-5)13(21)14(22)8-2-6(16)4-10(18)12(8)20/h1-4,13,21H D0D2HH DRUGINKE FWTYPBLNNIDCIZ-UHFFFAOYSA-N D0D2HH DRUGSMIL C1=C(C=C(C(=C1C(C(=O)C2=C(C(=CC(=C2)F)F)F)O)F)F)F D0D2HH HIGHSTAT Investigative D0D2JA DRUG__ID D0D2JA D0D2JA DRUGTYPE Small molecular drug D0D2JA DRUGINCH 1S/C12H11BO3/c14-13(15)10-6-8-12(9-7-10)16-11-4-2-1-3-5-11/h1-9,14-15H D0D2JA DRUGINKE KFXUHRXGLWUOJT-UHFFFAOYSA-N D0D2JA DRUGSMIL B(C1=CC=C(C=C1)OC2=CC=CC=C2)(O)O D0D2JA HIGHSTAT Investigative D0D2JB DRUG__ID D0D2JB D0D2JB DRUGTYPE Small molecular drug D0D2JB DRUGINCH 1S/C59H95N15O18S/c1-30(2)24-38(53(86)66-35(49(63)82)20-23-93-7)65-44(77)28-64-58(91)47(31(3)4)72-55(88)39(25-33-14-9-8-10-15-33)69-52(85)37(18-19-43(62)76)67-54(87)40(27-46(80)81)70-56(89)41(29-75)71-51(84)36(16-11-12-21-60)68-57(90)42-17-13-22-74(42)59(92)48(32(5)6)73-50(83)34(61)26-45(78)79/h8-10,14-15,30-32,34-42,47-48,75H,11-13,16-29,60-61H2,1-7H3,(H2,62,76)(H2,63,82)(H,64,91)(H,65,77)(H,66,86)(H,67,87)(H,68,90)(H,69,85)(H,70,89)(H,71,84)(H,72,88)(H,73,83)(H,78,79)(H,80,81) D0D2JB DRUGINKE NXTPETCPVNEEOP-UHFFFAOYSA-N D0D2JB DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C(CC(=O)O)N D0D2JB HIGHSTAT Investigative D0D2JH DRUG__ID D0D2JH D0D2JH DRUGTYPE Small molecular drug D0D2JH DRUGINCH 1S/C15H10F2O2/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-7,14H,8H2 D0D2JH DRUGINKE YKJLGNVYFBPKJK-UHFFFAOYSA-N D0D2JH DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)F)C3=CC=C(C=C3)F D0D2JH HIGHSTAT Investigative D0D2KE DRUG__ID D0D2KE D0D2KE DRUGTYPE Small molecular drug D0D2KE DRUGINCH 1S/C11H15NOS/c13-11(8-4-5-9-14)12-10-6-2-1-3-7-10/h1-3,6-7,14H,4-5,8-9H2,(H,12,13) D0D2KE DRUGINKE AGRMYYLOBIRRKQ-UHFFFAOYSA-N D0D2KE DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCS D0D2KE HIGHSTAT Investigative D0D2MN DRUG__ID D0D2MN D0D2MN DRUGTYPE Small molecular drug D0D2MN DRUGINCH 1S/C20H30O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18,21H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7-,9-6-,14-10+,15-11+/t18-/m0/s1 D0D2MN DRUGINKE MLZJFLKEKVDNAZ-XPKTZJOPSA-N D0D2MN DRUGSMIL CCCCCC=CCC(C=CC=CC=CC(=O)CCCC(=O)O)O D0D2MN HIGHSTAT Investigative D0D2MS DRUG__ID D0D2MS D0D2MS DRUGTYPE Small molecular drug D0D2MS DRUGINCH 1S/C12H15N5O3/c1-5-6(2-18)9(19)10(20)8(5)17-4-16-7-11(13)14-3-15-12(7)17/h3-4,6,8-10,18-20H,1-2H2,(H2,13,14,15)/t6-,8+,9+,10-/m0/s1 D0D2MS DRUGINKE REGXGANNNMTWAW-ZQNVIIHSSA-N D0D2MS DRUGSMIL C=C1C(C(C(C1N2C=NC3=C(N=CN=C32)N)O)O)CO D0D2MS HIGHSTAT Investigative D0D2MV DRUG__ID D0D2MV D0D2MV DRUGTYPE Small molecular drug D0D2MV DRUGINCH 1S/C10H13N3O2S/c11-10(12)13-7-3-1-2-6(4-7)8(5-16)9(14)15/h1-4,8,16H,5H2,(H,14,15)(H4,11,12,13)/t8-/m1/s1 D0D2MV DRUGINKE YHBCRXAIIVZWEW-MRVPVSSYSA-N D0D2MV DRUGSMIL C1=CC(=CC(=C1)N=C(N)N)C(CS)C(=O)O D0D2MV HIGHSTAT Investigative D0D2NV DRUG__ID D0D2NV D0D2NV DRUGTYPE Small molecular drug D0D2NV DRUGINCH 1S/C6H11NO2/c8-6(9)3-5-1-2-7-4-5/h5,7H,1-4H2,(H,8,9) D0D2NV DRUGINKE OUENRUZPZZFMCA-UHFFFAOYSA-N D0D2NV DRUGSMIL C1CNCC1CC(=O)O D0D2NV HIGHSTAT Investigative D0D2OM DRUG__ID D0D2OM D0D2OM DRUGTYPE Small molecular drug D0D2OM DRUGINCH 1S/C16H19N5O/c1-10-3-5-12(6-4-10)7-13(11(2)22)21-9-20-14-15(17)18-8-19-16(14)21/h3-6,8-9,11,13,22H,7H2,1-2H3,(H2,17,18,19)/t11-,13+/m0/s1 D0D2OM DRUGINKE BHZLBHHOPOAOSL-WCQYABFASA-N D0D2OM DRUGSMIL CC1=CC=C(C=C1)CC(C(C)O)N2C=NC3=C(N=CN=C32)N D0D2OM HIGHSTAT Investigative D0D2PJ DRUG__ID D0D2PJ D0D2PJ DRUGTYPE Small molecular drug D0D2PJ DRUGINCH 1S/C14H15NO3/c1-3-9-5-6-12-10(7-9)13(16)11(8-15-12)14(17)18-4-2/h5-8H,3-4H2,1-2H3,(H,15,16) D0D2PJ DRUGINKE ZFOFJXFVCJQXBL-UHFFFAOYSA-N D0D2PJ DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OCC D0D2PJ HIGHSTAT Investigative D0D2PL DRUG__ID D0D2PL D0D2PL DRUGTYPE Small molecular drug D0D2PL DRUGINCH 1S/C10H10N2O/c1-13-8-4-2-3-7-5-6-9(11)12-10(7)8/h2-6H,1H3,(H2,11,12) D0D2PL DRUGINKE PMXFKGCLUAFLMH-UHFFFAOYSA-N D0D2PL DRUGSMIL COC1=CC=CC2=C1N=C(C=C2)N D0D2PL HIGHSTAT Investigative D0D2SE DRUG__ID D0D2SE D0D2SE DRUGTYPE Small molecular drug D0D2SE DRUGINCH 1S/C21H33F7O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(29)19(22,23)20(24,25)21(26,27)28/h9-10H,2-8,11-17H2,1H3/b10-9- D0D2SE DRUGINKE CAINANTZOVVNLF-KTKRTIGZSA-N D0D2SE DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C(C(C(F)(F)F)(F)F)(F)F D0D2SE HIGHSTAT Investigative D0D2ST DRUG__ID D0D2ST D0D2ST DRUGTYPE Small molecular drug D0D2ST DRUGINCH 1S/C14H12N2/c1-10-14(11-6-8-15-9-7-11)12-4-2-3-5-13(12)16-10/h2-9,16H,1H3 D0D2ST DRUGINKE NMPHKIHQOKMIKF-UHFFFAOYSA-N D0D2ST DRUGSMIL CC1=C(C2=CC=CC=C2N1)C3=CC=NC=C3 D0D2ST HIGHSTAT Investigative D0D2UA DRUG__ID D0D2UA D0D2UA DRUGTYPE Small molecular drug D0D2UA DRUGINCH 1S/C22H22N2O5S/c25-21(26)15-20(22(27)23-13-12-16-6-2-1-3-7-16)24-30(28,29)19-11-10-17-8-4-5-9-18(17)14-19/h1-11,14,20,24H,12-13,15H2,(H,23,27)(H,25,26)/t20-/m0/s1 D0D2UA DRUGINKE VMYREBYTVVSDDK-FQEVSTJZSA-N D0D2UA DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C(CC(=O)O)NS(=O)(=O)C2=CC3=CC=CC=C3C=C2 D0D2UA HIGHSTAT Investigative D0D2US DRUG__ID D0D2US D0D2US DRUGTYPE Small molecular drug D0D2US DRUGINCH 1S/C17H24N2O4/c1-2-13-23-15(11-7-4-8-12-16(20)19-22)17(21)18-14-9-5-3-6-10-14/h2-3,5-6,9-10,15,22H,1,4,7-8,11-13H2,(H,18,21)(H,19,20) D0D2US DRUGINKE KPKWEJNZWZGOID-UHFFFAOYSA-N D0D2US DRUGSMIL C=CCOC(CCCCCC(=O)NO)C(=O)NC1=CC=CC=C1 D0D2US HIGHSTAT Investigative D0D2WC DRUG__ID D0D2WC D0D2WC DRUGTYPE Small molecular drug D0D2WC DRUGINCH 1S/C7H14N2/c1-3-6-4-5(2)7(8)9-6/h5-6H,3-4H2,1-2H3,(H2,8,9) D0D2WC DRUGINKE WPWKHPKZOKESJR-UHFFFAOYSA-N D0D2WC DRUGSMIL CCC1CC(C(=N1)N)C D0D2WC HIGHSTAT Investigative D0D2WN DRUG__ID D0D2WN D0D2WN DRUGTYPE Small molecular drug D0D2WN DRUGINCH 1S/C12H19NS/c1-4-11(13-2)9-10-5-7-12(14-3)8-6-10/h5-8,11,13H,4,9H2,1-3H3 D0D2WN DRUGINKE JMLCRWOWZIZAEU-UHFFFAOYSA-N D0D2WN DRUGSMIL CCC(CC1=CC=C(C=C1)SC)NC D0D2WN HIGHSTAT Investigative D0D2XH DRUG__ID D0D2XH D0D2XH DRUGTYPE Small molecular drug D0D2XH DRUGINCH 1S/C15H14N2O3S/c1-20-15-4-2-3-14-13(15)9-10-17(14)21(18,19)12-7-5-11(16)6-8-12/h2-10H,16H2,1H3 D0D2XH DRUGINKE ITHFAYACRWTMMR-UHFFFAOYSA-N D0D2XH DRUGSMIL COC1=CC=CC2=C1C=CN2S(=O)(=O)C3=CC=C(C=C3)N D0D2XH HIGHSTAT Investigative D0D2YR DRUG__ID D0D2YR D0D2YR DRUGTYPE Small molecular drug D0D2YR DRUGINCH 1S/C12H14N2/c1-14-11-5-3-2-4-9(11)10-6-7-13-8-12(10)14/h2-5,13H,6-8H2,1H3 D0D2YR DRUGINKE STMNLEHELVDDKF-UHFFFAOYSA-N D0D2YR DRUGSMIL CN1C2=C(CCNC2)C3=CC=CC=C31 D0D2YR HIGHSTAT Investigative D0D2ZH DRUG__ID D0D2ZH D0D2ZH DRUGTYPE Small molecular drug D0D2ZH DRUGINCH 1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3 D0D2ZH DRUGINKE LBOJYSIDWZQNJS-UHFFFAOYSA-N D0D2ZH DRUGSMIL CC12C3=CC=CC=C3CC(N1)C4=CC=CC=C24 D0D2ZH HIGHSTAT Investigative D0D2ZM DRUG__ID D0D2ZM D0D2ZM DRUGTYPE Small molecular drug D0D2ZM DRUGINCH 1S/C35H46N4O6/c1-33(2)24-16-17-34(33,3)28(18-24)45-32(44)39-35(4,19-23-20-36-26-13-9-8-12-25(23)26)31(43)37-21-27(22-10-6-5-7-11-22)38-29(40)14-15-30(41)42/h5-13,23-24,27-28,36H,14-21H2,1-4H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t23?,24-,27-,28?,34+,35+/m0/s1 D0D2ZM DRUGINKE VVGZQXYPBDZOLL-KROHXGCPSA-N D0D2ZM DRUGSMIL CC1(C2CCC1(C(C2)OC(=O)NC(C)(CC3CNC4=CC=CC=C34)C(=O)NCC(C5=CC=CC=C5)NC(=O)CCC(=O)O)C)C D0D2ZM HIGHSTAT Investigative D0D3AS DRUG__ID D0D3AS D0D3AS DRUGTYPE Small molecular drug D0D3AS DRUGINCH 1S/C19H13N3O3/c23-22(24)14-8-11-17-18(12-14)21-19(20-17)13-6-9-16(10-7-13)25-15-4-2-1-3-5-15/h1-12H,(H,20,21) D0D3AS DRUGINKE ZBWXPJPIZQAKGA-UHFFFAOYSA-N D0D3AS DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=NC4=C(N3)C=C(C=C4)[N+](=O)[O-] D0D3AS HIGHSTAT Investigative D0D3BP DRUG__ID D0D3BP D0D3BP DRUGTYPE Small molecular drug D0D3BP DRUGINCH 1S/C13H10BrN5/c14-10-6-8-4-2-1-3-7(8)5-9(10)11-17-12(15)19-13(16)18-11/h1-6H,(H4,15,16,17,18,19) D0D3BP DRUGINKE RXSSKAZHCZWJPP-UHFFFAOYSA-N D0D3BP DRUGSMIL C1=CC=C2C=C(C(=CC2=C1)C3=NC(=NC(=N3)N)N)Br D0D3BP HIGHSTAT Investigative D0D3CS DRUG__ID D0D3CS D0D3CS DRUGTYPE Small molecular drug D0D3CS DRUGINCH 1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12) D0D3CS DRUGINKE LEHOTFFKMJEONL-UHFFFAOYSA-N D0D3CS DRUGSMIL C12=C(NC(=O)N1)NC(=O)NC2=O D0D3CS HIGHSTAT Investigative D0D3FF DRUG__ID D0D3FF D0D3FF DRUGTYPE Small molecular drug D0D3FF DRUGINCH 1S/C12H8N2/c1-2-5-11(6-3-1)7-8-12-13-9-4-10-14-12/h1-6,9-10H D0D3FF DRUGINKE JGGFEZRQOSIEGG-UHFFFAOYSA-N D0D3FF DRUGSMIL C1=CC=C(C=C1)C#CC2=NC=CC=N2 D0D3FF HIGHSTAT Investigative D0D3FV DRUG__ID D0D3FV D0D3FV DRUGTYPE Small molecular drug D0D3FV DRUGINCH 1S/C16H17N/c1-16(2,3)13-9-6-8-12-11-7-4-5-10-14(11)17-15(12)13/h4-10,17H,1-3H3 D0D3FV DRUGINKE BKPDQETYXNGMRE-UHFFFAOYSA-N D0D3FV DRUGSMIL CC(C)(C)C1=CC=CC2=C1NC3=CC=CC=C23 D0D3FV HIGHSTAT Investigative D0D3GF DRUG__ID D0D3GF D0D3GF DRUGTYPE Small molecular drug D0D3GF DRUGINCH 1S/C20H35N3O/c1-2-3-6-23-7-4-18(5-8-23)21-19(24)22-20-12-15-9-16(13-20)11-17(10-15)14-20/h15-18H,2-14H2,1H3,(H2,21,22,24) D0D3GF DRUGINKE FTNAVCVMGWLLJE-UHFFFAOYSA-N D0D3GF DRUGSMIL CCCCN1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D0D3GF HIGHSTAT Investigative D0D3HB DRUG__ID D0D3HB D0D3HB DRUGTYPE Small molecular drug D0D3HB DRUGINCH 1S/C14H12N4O3S/c15-22(20,21)10-7-5-9(6-8-10)16-14(19)13-11-3-1-2-4-12(11)17-18-13/h1-8H,(H,16,19)(H,17,18)(H2,15,20,21) D0D3HB DRUGINKE MNHPHKFLWAPNOV-UHFFFAOYSA-N D0D3HB DRUGSMIL C1=CC=C2C(=C1)C(=NN2)C(=O)NC3=CC=C(C=C3)S(=O)(=O)N D0D3HB HIGHSTAT Investigative D0D3MR DRUG__ID D0D3MR D0D3MR DRUGTYPE Small molecular drug D0D3MR DRUGINCH 1S/C13H8OS3/c14-7-9-6-13(16-8-9)12-4-3-11(17-12)10-2-1-5-15-10/h1-8H D0D3MR DRUGINKE IAQDUXQCKAZHSN-UHFFFAOYSA-N D0D3MR DRUGSMIL C1=CSC(=C1)C2=CC=C(S2)C3=CC(=CS3)C=O D0D3MR HIGHSTAT Investigative D0D3NV DRUG__ID D0D3NV D0D3NV DRUGTYPE Small molecular drug D0D3NV DRUGINCH 1S/C16H25NO/c18-15(17-4-2-1-3-5-17)16-9-12-6-13(10-16)8-14(7-12)11-16/h12-14H,1-11H2 D0D3NV DRUGINKE BURUIZXRHQWZQI-UHFFFAOYSA-N D0D3NV DRUGSMIL C1CCN(CC1)C(=O)C23CC4CC(C2)CC(C4)C3 D0D3NV HIGHSTAT Investigative D0D3OF DRUG__ID D0D3OF D0D3OF DRUGTYPE Small molecular drug D0D3OF DRUGINCH 1S/C12H17BrN2O2/c1-16-11-8-10(12(17-2)7-9(11)13)15-5-3-14-4-6-15/h7-8,14H,3-6H2,1-2H3 D0D3OF DRUGINKE JLAQUWGWRNMYGA-UHFFFAOYSA-N D0D3OF DRUGSMIL COC1=CC(=C(C=C1N2CCNCC2)OC)Br D0D3OF HIGHSTAT Investigative D0D3OV DRUG__ID D0D3OV D0D3OV DRUGTYPE Small molecular drug D0D3OV DRUGINCH 1S/C41H58N6O13/c1-23(2)34(39(57)47-21-27(60-22-26-12-8-5-9-13-26)19-31(47)38(56)46-41(16-17-41)40(58)59)45-37(55)29(18-25-10-6-4-7-11-25)44-35(53)28(14-15-32(49)50)43-36(54)30(20-33(51)52)42-24(3)48/h5,8-9,12-13,23,25,27-31,34H,4,6-7,10-11,14-22H2,1-3H3,(H,42,48)(H,43,54)(H,44,53)(H,45,55)(H,46,56)(H,49,50)(H,51,52)(H,58,59)/t27-,28-,29-,30-,31-,34-/m0/s1 D0D3OV DRUGINKE DDYNDQYNGBVAAZ-HWKKFYSMSA-N D0D3OV DRUGSMIL CC(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2)C(=O)O)OCC3=CC=CC=C3)NC(=O)C(CC4CCCCC4)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0D3OV HIGHSTAT Investigative D0D3OX DRUG__ID D0D3OX D0D3OX DRUGTYPE Small molecular drug D0D3OX DRUGINCH 1S/C12H10N4O4/c13-12(14)15-11(17)10-6-5-9(20-10)7-3-1-2-4-8(7)16(18)19/h1-6H,(H4,13,14,15,17) D0D3OX DRUGINKE KLPHIGVDYLBNDU-UHFFFAOYSA-N D0D3OX DRUGSMIL C1=CC=C(C(=C1)C2=CC=C(O2)C(=O)N=C(N)N)[N+](=O)[O-] D0D3OX HIGHSTAT Investigative D0D3PY DRUG__ID D0D3PY D0D3PY DRUGTYPE Small molecular drug D0D3PY DRUGINCH 1S/C14H10Cl2O3S/c15-12-7-6-10(8-13(12)16)14(17)9-20(18,19)11-4-2-1-3-5-11/h1-8H,9H2 D0D3PY DRUGINKE LZBIUNZNOUZDPA-UHFFFAOYSA-N D0D3PY DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CC(=O)C2=CC(=C(C=C2)Cl)Cl D0D3PY HIGHSTAT Investigative D0D3PZ DRUG__ID D0D3PZ D0D3PZ DRUGTYPE Small molecular drug D0D3PZ DRUGINCH 1S/C17H25N3O/c1-3-8-20(9-4-2)10-7-14-12-19-16-6-5-13(17(18)21)11-15(14)16/h5-6,11-12,19H,3-4,7-10H2,1-2H3,(H2,18,21) D0D3PZ DRUGINKE DPXOFRGRKPFZOD-UHFFFAOYSA-N D0D3PZ DRUGSMIL CCCN(CCC)CCC1=CNC2=C1C=C(C=C2)C(=O)N D0D3PZ HIGHSTAT Investigative D0D3QA DRUG__ID D0D3QA D0D3QA DRUGTYPE Small molecular drug D0D3QA DRUGINCH 1S/C24H18N4/c1-16-6-4-8-18(14-16)26-24-22-10-3-2-9-21(22)23(27-28-24)20-11-5-7-17-15-25-13-12-19(17)20/h2-15H,1H3,(H,26,28) D0D3QA DRUGINKE KGVVWWXTGNZBAX-UHFFFAOYSA-N D0D3QA DRUGSMIL CC1=CC(=CC=C1)NC2=NN=C(C3=CC=CC=C32)C4=CC=CC5=C4C=CN=C5 D0D3QA HIGHSTAT Investigative D0D3QE DRUG__ID D0D3QE D0D3QE DRUGTYPE Small molecular drug D0D3QE DRUGINCH 1S/C16H20N2O/c1-2-5-15(18-10-3-4-11-18)16(19)14-8-6-13(12-17)7-9-14/h6-9,15H,2-5,10-11H2,1H3 D0D3QE DRUGINKE AQQRGNNYEPRIIF-UHFFFAOYSA-N D0D3QE DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)C#N)N2CCCC2 D0D3QE HIGHSTAT Investigative D0D3RL DRUG__ID D0D3RL D0D3RL DRUGTYPE Small molecular drug D0D3RL DRUGINCH 1S/C29H25F3N8O/c1-17-3-4-20(9-19(17)7-8-39-16-36-25-26(37-22-5-6-22)33-14-34-27(25)39)28(41)38-23-10-21(29(30,31)32)11-24(12-23)40-13-18(2)35-15-40/h3-4,7-16,22H,5-6H2,1-2H3,(H,38,41)(H,33,34,37)/b8-7+ D0D3RL DRUGINKE XQBYDVRVYRYLCH-BQYQJAHWSA-N D0D3RL DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)C=CN4C=NC5=C(N=CN=C54)NC6CC6 D0D3RL HIGHSTAT Investigative D0D3TB DRUG__ID D0D3TB D0D3TB DRUGTYPE Small molecular drug D0D3TB DRUGINCH 1S/C19H23NO3/c1-3-9-20-10-8-19-7-6-14(21)11-16(19)23-18-15(22-2)5-4-13(12-20)17(18)19/h3-7,14,16,21H,1,8-12H2,2H3/t14-,16-,19-/m0/s1 D0D3TB DRUGINKE BQESVZIPHFRYNG-QOKNQOGYSA-N D0D3TB DRUGSMIL COC1=C2C3=C(CN(CCC34C=CC(CC4O2)O)CC=C)C=C1 D0D3TB HIGHSTAT Investigative D0D3TG DRUG__ID D0D3TG D0D3TG DRUGTYPE Small molecular drug D0D3TG DRUGINCH 1S/C19H35N/c1-3-5-7-9-10-11-13-15-19-17-16-18(20-19)14-12-8-6-4-2/h4,19H,2-3,5-17H2,1H3 D0D3TG DRUGINKE NNAFMHTUNBLVDA-UHFFFAOYSA-N D0D3TG DRUGSMIL CCCCCCCCCC1CCC(=N1)CCCCC=C D0D3TG HIGHSTAT Investigative D0D3UB DRUG__ID D0D3UB D0D3UB DRUGTYPE Small molecular drug D0D3UB DRUGINCH 1S/C27H30N2O/c1-17(2)16-29-10-9-27-15-25-20(11-19-5-3-4-6-24(19)28-25)12-23(27)26(29)13-18-7-8-21(30)14-22(18)27/h3-8,11,14,17,23,26,30H,9-10,12-13,15-16H2,1-2H3/t23-,26+,27+/m0/s1 D0D3UB DRUGINKE LRXLXNDXXNBZCL-HUROMRQRSA-N D0D3UB DRUGSMIL CC(C)CN1CCC23CC4=NC5=CC=CC=C5C=C4CC2C1CC6=C3C=C(C=C6)O D0D3UB HIGHSTAT Investigative D0D3WR DRUG__ID D0D3WR D0D3WR DRUGTYPE Small molecular drug D0D3WR DRUGINCH 1S/C16H13N5O/c17-16-19-13(12-7-4-8-22-12)14-15(20-16)21(10-18-14)9-11-5-2-1-3-6-11/h1-8,10H,9H2,(H2,17,19,20) D0D3WR DRUGINKE FZKKCBUDFSOYPA-UHFFFAOYSA-N D0D3WR DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C(N=C(N=C32)N)C4=CC=CO4 D0D3WR HIGHSTAT Investigative D0D3XC DRUG__ID D0D3XC D0D3XC DRUGTYPE Small molecular drug D0D3XC DRUGINCH 1S/C9H7NO2S/c11-9(10-12)8-5-6-3-1-2-4-7(6)13-8/h1-5,12H,(H,10,11) D0D3XC DRUGINKE UGJNLGFANIDLSB-UHFFFAOYSA-N D0D3XC DRUGSMIL C1=CC=C2C(=C1)C=C(S2)C(=O)NO D0D3XC HIGHSTAT Investigative D0D3YL DRUG__ID D0D3YL D0D3YL DRUGTYPE Small molecular drug D0D3YL DRUGINCH 1S/C16H14N2O/c1-12-6-5-9-14(10-12)18-16-17-11-15(19-16)13-7-3-2-4-8-13/h2-11H,1H3,(H,17,18) D0D3YL DRUGINKE XLGKHWGSIZWZNN-UHFFFAOYSA-N D0D3YL DRUGSMIL CC1=CC(=CC=C1)NC2=NC=C(O2)C3=CC=CC=C3 D0D3YL HIGHSTAT Investigative D0D3YN DRUG__ID D0D3YN D0D3YN DRUGTYPE Small molecular drug D0D3YN DRUGINCH 1S/C19H21ClN2S/c1-21-8-10-22(11-9-21)17-12-14-4-2-3-5-18(14)23-19-7-6-15(20)13-16(17)19/h2-7,13,17H,8-12H2,1H3 D0D3YN DRUGINKE XRYLGRGAWQSVQW-UHFFFAOYSA-N D0D3YN DRUGSMIL CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)Cl D0D3YN HIGHSTAT Investigative D0D4AE DRUG__ID D0D4AE D0D4AE DRUGTYPE Small molecular drug D0D4AE DRUGINCH 1S/C22H17N3O3/c1-28-20-11-3-2-10-19(20)22(27)25-18-9-5-8-17(13-18)24-21(26)16-7-4-6-15(12-16)14-23/h2-13H,1H3,(H,24,26)(H,25,27) D0D4AE DRUGINKE YTAQUZZUBZVOFI-UHFFFAOYSA-N D0D4AE DRUGSMIL COC1=CC=CC=C1C(=O)NC2=CC=CC(=C2)NC(=O)C3=CC=CC(=C3)C#N D0D4AE HIGHSTAT Investigative D0D4AU DRUG__ID D0D4AU D0D4AU DRUGTYPE Small molecular drug D0D4AU DRUGINCH 1S/C19H23NO5/c1-20-9-8-17-7-6-14(24-3)19(22)18(17,20)10-13(25-19)11-4-5-12(23-2)16(21)15(11)17/h4-6,13,21-22H,7-10H2,1-3H3/t13-,17+,18-,19-/m0/s1 D0D4AU DRUGINKE MLEYOIRGICHLGN-PZGXJPJSSA-N D0D4AU DRUGSMIL CN1CCC23C14CC(C5=C2C(=C(C=C5)OC)O)OC4(C(=CC3)OC)O D0D4AU HIGHSTAT Investigative D0D4FV DRUG__ID D0D4FV D0D4FV DRUGTYPE Small molecular drug D0D4FV DRUGINCH 1S/C26H30O6/c1-14(2)6-7-16(15(3)4)10-19-20(28)12-21(29)25-22(30)13-24(32-26(19)25)18-9-8-17(27)11-23(18)31-5/h6,8-9,11-12,16,24,27-29H,3,7,10,13H2,1-2,4-5H3/t16-,24+/m1/s1 D0D4FV DRUGINKE YLTPWCZXKJSORQ-GYCJOSAFSA-N D0D4FV DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C D0D4FV HIGHSTAT Investigative D0D4HG DRUG__ID D0D4HG D0D4HG DRUGTYPE Small molecular drug D0D4HG DRUGINCH 1S/C23H16N4O/c24-16-17-8-7-11-19(14-17)23(28)25-22-15-21(18-9-3-1-4-10-18)26-27(22)20-12-5-2-6-13-20/h1-15H,(H,25,28) D0D4HG DRUGINKE BKUIZWILNWHFHD-UHFFFAOYSA-N D0D4HG DRUGSMIL C1=CC=C(C=C1)C2=NN(C(=C2)NC(=O)C3=CC=CC(=C3)C#N)C4=CC=CC=C4 D0D4HG HIGHSTAT Investigative D0D4HH DRUG__ID D0D4HH D0D4HH DRUGTYPE Small molecular drug D0D4HH DRUGINCH 1S/C22H25NO2/c1-3-4-9-14-23-16-19(18-11-6-7-12-20(18)23)21(24)15-17-10-5-8-13-22(17)25-2/h5-8,10-13,16H,3-4,9,14-15H2,1-2H3 D0D4HH DRUGINKE FFLSJIQJQKDDCM-UHFFFAOYSA-N D0D4HH DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3OC D0D4HH HIGHSTAT Investigative D0D4IG DRUG__ID D0D4IG D0D4IG DRUGTYPE Small molecular drug D0D4IG DRUGINCH 1S/C8H3Cl3N2O2/c9-2-1-3-6(5(11)4(2)10)13-8(15)7(14)12-3/h1H,(H,12,14)(H,13,15) D0D4IG DRUGINKE MVCXAPXDPCEJBN-UHFFFAOYSA-N D0D4IG DRUGSMIL C1=C2C(=C(C(=C1Cl)Cl)Cl)NC(=O)C(=O)N2 D0D4IG HIGHSTAT Investigative D0D4IJ DRUG__ID D0D4IJ D0D4IJ DRUGTYPE Small molecular drug D0D4IJ DRUGINCH 1S/C19H23NO2/c1-2-3-4-8-14-20-19(21)22-18-13-9-12-17(15-18)16-10-6-5-7-11-16/h5-7,9-13,15H,2-4,8,14H2,1H3,(H,20,21) D0D4IJ DRUGINKE QPTMPZNXKZNQMF-UHFFFAOYSA-N D0D4IJ DRUGSMIL CCCCCCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2 D0D4IJ HIGHSTAT Investigative D0D4LF DRUG__ID D0D4LF D0D4LF DRUGTYPE Small molecular drug D0D4LF DRUGINCH 1S/C14H9Cl2F3N2O2/c15-8-2-4-12(22)11(6-8)21-13(23)20-10-5-7(14(17,18)19)1-3-9(10)16/h1-6,22H,(H2,20,21,23) D0D4LF DRUGINKE OUDXRNQPVSMGDW-UHFFFAOYSA-N D0D4LF DRUGSMIL C1=CC(=C(C=C1C(F)(F)F)NC(=O)NC2=C(C=CC(=C2)Cl)O)Cl D0D4LF HIGHSTAT Investigative D0D4MM DRUG__ID D0D4MM D0D4MM DRUGTYPE Small molecular drug D0D4MM DRUGINCH 1S/C14H11IN2O2/c1-2-19-14(18)12-6-10-9-5-8(15)3-4-11(9)17-13(10)7-16-12/h3-7,17H,2H2,1H3 D0D4MM DRUGINKE LTYUPBZLKIUGQX-UHFFFAOYSA-N D0D4MM DRUGSMIL CCOC(=O)C1=NC=C2C(=C1)C3=C(N2)C=CC(=C3)I D0D4MM HIGHSTAT Investigative D0D4NS DRUG__ID D0D4NS D0D4NS DRUGTYPE Small molecular drug D0D4NS DRUGINCH 1S/C14H9N5/c1-2-4-10-9(3-1)16-8-13(17-10)14-18-11-5-6-15-7-12(11)19-14/h1-8H,(H,18,19) D0D4NS DRUGINKE UYUCQGUDIHPICB-UHFFFAOYSA-N D0D4NS DRUGSMIL C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=NC=C4 D0D4NS HIGHSTAT Investigative D0D4OV DRUG__ID D0D4OV D0D4OV DRUGTYPE Small molecular drug D0D4OV DRUGINCH 1S/C8H20N2O6S2/c9-17(11,12)15-7-5-3-1-2-4-6-8-16-18(10,13)14/h1-8H2,(H2,9,11,12)(H2,10,13,14) D0D4OV DRUGINKE IPTXSYCLIWBHBX-UHFFFAOYSA-N D0D4OV DRUGSMIL C(CCCCOS(=O)(=O)N)CCCOS(=O)(=O)N D0D4OV HIGHSTAT Investigative D0D4QL DRUG__ID D0D4QL D0D4QL DRUGTYPE Small molecular drug D0D4QL DRUGINCH 1S/C8H7N3O/c9-8(12)5-1-2-6-7(3-5)11-4-10-6/h1-4H,(H2,9,12)(H,10,11) D0D4QL DRUGINKE FNLQDVXHDNFXIY-UHFFFAOYSA-N D0D4QL DRUGSMIL C1=CC2=C(C=C1C(=O)N)NC=N2 D0D4QL HIGHSTAT Investigative D0D4RW DRUG__ID D0D4RW D0D4RW DRUGTYPE Small molecular drug D0D4RW DRUGINCH 1S/C14H16N2O4S/c17-13-11-9-10(5-6-12(11)15-14(13)18)21(19,20)16-7-3-1-2-4-8-16/h5-6,9H,1-4,7-8H2,(H,15,17,18) D0D4RW DRUGINKE MLWAHVYFMDBXBL-UHFFFAOYSA-N D0D4RW DRUGSMIL C1CCCN(CC1)S(=O)(=O)C2=CC3=C(C=C2)NC(=O)C3=O D0D4RW HIGHSTAT Investigative D0D4SI DRUG__ID D0D4SI D0D4SI DRUGTYPE Small molecular drug D0D4SI DRUGINCH 1S/C30H48O4/c1-18-9-14-30(25(33)34)16-15-28(5)20(24(30)19(18)2)7-8-22-26(3)12-11-23(32)27(4,17-31)21(26)10-13-29(22,28)6/h7,18-19,21-24,31-32H,8-17H2,1-6H3,(H,33,34)/t18-,19+,21-,22-,23+,24+,26+,27-,28-,29-,30+/m1/s1 D0D4SI DRUGINKE NZCULBURCGAPSF-OQCQIIONSA-N D0D4SI DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1C)C)C(=O)O D0D4SI HIGHSTAT Investigative D0D4SK DRUG__ID D0D4SK D0D4SK DRUGTYPE Small molecular drug D0D4SK DRUGINCH 1S/C13H12Cl2N2/c14-7-5-9(15)12-11(6-7)17-10-4-2-1-3-8(10)13(12)16/h5-6H,1-4H2,(H2,16,17) D0D4SK DRUGINKE ISUJWDYWYFLQFP-UHFFFAOYSA-N D0D4SK DRUGSMIL C1CCC2=NC3=C(C(=CC(=C3)Cl)Cl)C(=C2C1)N D0D4SK HIGHSTAT Investigative D0D4SO DRUG__ID D0D4SO D0D4SO DRUGTYPE Small molecular drug D0D4SO DRUGINCH 1S/C24H28N2O/c1-2-3-4-5-6-7-10-19-13-15-20(16-14-19)24(27)26-22-17-21-11-8-9-12-23(21)25-18-22/h8-9,11-18H,2-7,10H2,1H3,(H,26,27) D0D4SO DRUGINKE QXGPHMISVLJYDS-UHFFFAOYSA-N D0D4SO DRUGSMIL CCCCCCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D0D4SO HIGHSTAT Investigative D0D4TY DRUG__ID D0D4TY D0D4TY DRUGTYPE Small molecular drug D0D4TY DRUGINCH 1S/C11H16BN5O9P2S/c1-29-11-15-8(13)5-9(16-11)17(3-14-5)10-7(19)6(18)4(25-10)2-24-27(12,20)26-28(21,22)23/h3-4,6-7,10,18-19H,2H2,1H3,(H2,13,15,16)(H2,21,22,23)/q-1/t4-,6+,7+,10?,27-/m1/s1 D0D4TY DRUGINKE GHMYGRHRUJMVLH-CHJYMILRSA-N D0D4TY DRUGSMIL [B-]P(=O)(OCC1C(C(C(O1)N2C=NC3=C(N=C(N=C32)SC)N)O)O)OP(=O)(O)O D0D4TY HIGHSTAT Investigative D0D4US DRUG__ID D0D4US D0D4US DRUGTYPE Small molecular drug D0D4US DRUGINCH 1S/C7H5BrN2/c8-6-2-1-3-7-5(6)4-9-10-7/h1-4H,(H,9,10) D0D4US DRUGINKE KJIODOACRIRBPB-UHFFFAOYSA-N D0D4US DRUGSMIL C1=CC2=C(C=NN2)C(=C1)Br D0D4US HIGHSTAT Investigative D0D4ZL DRUG__ID D0D4ZL D0D4ZL DRUGTYPE Small molecular drug D0D4ZL DRUGINCH 1S/C34H54O7/c1-6-7-8-9-10-11-12-13-14-15-16-17-27(36)41-30-23(3)33(39)25(28-31(4,5)34(28,30)40)19-24(21-35)20-32(38)26(33)18-22(2)29(32)37/h18-19,23,25-26,28,30,35,38-40H,6-17,20-21H2,1-5H3/t23-,25+,26-,28-,30-,32-,33-,34-/m1/s1 D0D4ZL DRUGINKE XLCISDOVNFLSGO-VONOSFMSSA-N D0D4ZL DRUGSMIL CCCCCCCCCCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)O)O)C D0D4ZL HIGHSTAT Investigative D0D5BI DRUG__ID D0D5BI D0D5BI DRUGTYPE Small molecular drug D0D5BI DRUGINCH 1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-19(23-18)16-14-17-20(21)22/h6-7,9-10,12-13,18-19H,2-5,8,11,14-17H2,1H3,(H,21,22)/b7-6-,10-9-,13-12- D0D5BI DRUGINKE VBQNSZQZRAGRIX-QNEBEIHSSA-N D0D5BI DRUGSMIL CCCCCC=CCC=CCC=CCC1C(O1)CCCC(=O)O D0D5BI HIGHSTAT Investigative D0D5GN DRUG__ID D0D5GN D0D5GN DRUGTYPE Small molecular drug D0D5GN DRUGINCH 1S/C38H46N4O7S2/c1-38(2)34(36(47)41-32-26-16-10-8-14-24(26)19-29(32)43)42(22-51-38)37(48)33(45)27(18-23-12-6-5-7-13-23)40-35(46)28(21-50-4)39-31(44)20-25-15-9-11-17-30(25)49-3/h5-17,27-29,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t27-,28-,29+,32-,33-,34+/m0/s1 D0D5GN DRUGINKE IJOKPTZPLSVFMX-CPPBRJAYSA-N D0D5GN DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC=CC=C3OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0D5GN HIGHSTAT Investigative D0D5HM DRUG__ID D0D5HM D0D5HM DRUGTYPE Small molecular drug D0D5HM DRUGINCH 1S/C9H4BrCl2NO2/c10-7-6-4(12)1-3(11)2-5(6)13-9(15)8(7)14/h1-2,14H,(H,13,15) D0D5HM DRUGINKE HDPAPMXBVVKNAQ-UHFFFAOYSA-N D0D5HM DRUGSMIL C1=C(C=C(C2=C1NC(=O)C(=C2Br)O)Cl)Cl D0D5HM HIGHSTAT Investigative D0D5HQ DRUG__ID D0D5HQ D0D5HQ DRUGTYPE Small molecular drug D0D5HQ DRUGINCH 1S/C20H10BrN3O2/c21-8-5-6-10-12(7-8)23-18-14(10)16-15(19(25)24-20(16)26)13-9-3-1-2-4-11(9)22-17(13)18/h1-7,22-23H,(H,24,25,26) D0D5HQ DRUGINKE NMFKDDRQSNVETB-UHFFFAOYSA-N D0D5HQ DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=C5C6=C(C=C(C=C6)Br)NC5=C3N2)C(=O)NC4=O D0D5HQ HIGHSTAT Investigative D0D5IV DRUG__ID D0D5IV D0D5IV DRUGTYPE Small molecular drug D0D5IV DRUGINCH 1S/C24H28F3N3O4/c1-15(2)8-11-34-17-5-3-4-16(12-17)13-21(31)30-10-9-28-23-18(19(30)14-22(32)33)6-7-20(29-23)24(25,26)27/h3-7,12,15,19H,8-11,13-14H2,1-2H3,(H,28,29)(H,32,33)/t19-/m1/s1 D0D5IV DRUGINKE DFAPMGLBHDJMNX-LJQANCHMSA-N D0D5IV DRUGSMIL CC(C)CCOC1=CC=CC(=C1)CC(=O)N2CCNC3=C(C2CC(=O)O)C=CC(=N3)C(F)(F)F D0D5IV HIGHSTAT Investigative D0D5KD DRUG__ID D0D5KD D0D5KD DRUGTYPE Small molecular drug D0D5KD DRUGINCH 1S/C12H15NO2S/c1-2-15-10-5-3-9(4-6-10)11-7-13-12(14)8-16-11/h3-6,11H,2,7-8H2,1H3,(H,13,14) D0D5KD DRUGINKE CBRYZPDPVZGCMA-UHFFFAOYSA-N D0D5KD DRUGSMIL CCOC1=CC=C(C=C1)C2CNC(=O)CS2 D0D5KD HIGHSTAT Investigative D0D5KZ DRUG__ID D0D5KZ D0D5KZ DRUGTYPE Small molecular drug D0D5KZ DRUGINCH 1S/C32H32N4O2/c1-3-9-24(10-4-1)17-18-33-31-29-28(25-11-5-2-6-12-25)30(38-32(29)35-23-34-31)26-13-15-27(16-14-26)37-22-21-36-19-7-8-20-36/h1-6,9-16,23H,7-8,17-22H2,(H,33,34,35) D0D5KZ DRUGINKE CYXPHNZJEDAZDD-UHFFFAOYSA-N D0D5KZ DRUGSMIL C1CCN(C1)CCOC2=CC=C(C=C2)C3=C(C4=C(N=CN=C4O3)NCCC5=CC=CC=C5)C6=CC=CC=C6 D0D5KZ HIGHSTAT Investigative D0D5NP DRUG__ID D0D5NP D0D5NP DRUGTYPE Small molecular drug D0D5NP DRUGINCH 1S/C10H16ClN5O6P2/c1-12-8-7-9(15-10(11)14-8)16(5-13-7)2-6(3-23(17,18)19)4-24(20,21)22/h5-6H,2-4H2,1H3,(H,12,14,15)(H2,17,18,19)(H2,20,21,22) D0D5NP DRUGINKE FFBIISIICFTESN-UHFFFAOYSA-N D0D5NP DRUGSMIL CNC1=C2C(=NC(=N1)Cl)N(C=N2)CC(CP(=O)(O)O)CP(=O)(O)O D0D5NP HIGHSTAT Investigative D0D5OG DRUG__ID D0D5OG D0D5OG DRUGTYPE Small molecular drug D0D5OG DRUGINCH 1S/C30H40O4/c1-8-30(6,7)25-16-22(26(31)18-27(25)32)11-9-10-21-17-28(33)29(34)24(15-13-20(4)5)23(21)14-12-19(2)3/h8,12-13,16-18,31-34H,1,9-11,14-15H2,2-7H3 D0D5OG DRUGINKE YCJJCTRPAGXWGX-UHFFFAOYSA-N D0D5OG DRUGSMIL CC(=CCC1=C(C(=C(C=C1CCCC2=CC(=C(C=C2O)O)C(C)(C)C=C)O)O)CC=C(C)C)C D0D5OG HIGHSTAT Investigative D0D5OY DRUG__ID D0D5OY D0D5OY DRUGTYPE Small molecular drug D0D5OY DRUGINCH 1S/C23H44FO6P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(25)30-20-21(29-2)19-22(24)31(26,27)28/h10-11,21-22H,3-9,12-20H2,1-2H3,(H2,26,27,28)/b11-10+/t21-,22?/m0/s1 D0D5OY DRUGINKE KGVHPTQYUKZZPY-VXECIVMWSA-N D0D5OY DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(CC(F)P(=O)(O)O)OC D0D5OY HIGHSTAT Investigative D0D5QP DRUG__ID D0D5QP D0D5QP DRUGTYPE Small molecular drug D0D5QP DRUGINCH 1S/C25H33NO5S/c1-22(2)19-8-10-24(22,25(29,15-19)16-21(27)28)17-32(30,31)26-13-11-23(12-14-26)9-7-18-5-3-4-6-20(18)23/h3-7,9,19,29H,8,10-17H2,1-2H3,(H,27,28) D0D5QP DRUGINKE XKVDTEPESVJNPJ-UHFFFAOYSA-N D0D5QP DRUGSMIL CC1(C2CCC1(C(C2)(CC(=O)O)O)CS(=O)(=O)N3CCC4(CC3)C=CC5=CC=CC=C45)C D0D5QP HIGHSTAT Investigative D0D5QS DRUG__ID D0D5QS D0D5QS DRUGTYPE Small molecular drug D0D5QS DRUGINCH 1S/C19H34NO3P/c1-2-3-4-5-6-7-8-10-18-11-13-19(14-12-18)17-20-15-9-16-24(21,22)23/h11-14,20H,2-10,15-17H2,1H3,(H2,21,22,23) D0D5QS DRUGINKE IYOGKTIRIRHPOH-UHFFFAOYSA-N D0D5QS DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)CNCCCP(=O)(O)O D0D5QS HIGHSTAT Investigative D0D5QT DRUG__ID D0D5QT D0D5QT DRUGTYPE Small molecular drug D0D5QT DRUGINCH 1S/C9H6BrF3O/c10-5-6-2-1-3-7(4-6)8(14)9(11,12)13/h1-4H,5H2 D0D5QT DRUGINKE PJBFZGACRBKRKV-UHFFFAOYSA-N D0D5QT DRUGSMIL C1=CC(=CC(=C1)C(=O)C(F)(F)F)CBr D0D5QT HIGHSTAT Investigative D0D5QV DRUG__ID D0D5QV D0D5QV DRUGTYPE Small molecular drug D0D5QV DRUGINCH 1S/C15H23NO2/c1-16(2)11-13-6-3-4-9-15(13,18)12-7-5-8-14(17)10-12/h5,7-8,10,13,17-18H,3-4,6,9,11H2,1-2H3/t13-,15+/m1/s1 D0D5QV DRUGINKE UWJUQVWARXYRCG-HIFRSBDPSA-N D0D5QV DRUGSMIL CN(C)CC1CCCCC1(C2=CC(=CC=C2)O)O D0D5QV HIGHSTAT Investigative D0D5SK DRUG__ID D0D5SK D0D5SK DRUGTYPE Small molecular drug D0D5SK DRUGINCH 1S/C19H25NO2/c1-3-19-8-9-20(11-13-4-5-13)17(12(19)2)18(22)15-7-6-14(21)10-16(15)19/h6-7,10,12-13,17,21H,3-5,8-9,11H2,1-2H3/t12-,17-,19-/m1/s1 D0D5SK DRUGINKE SEJUQQOPVAUETF-QHLBDZCJSA-N D0D5SK DRUGSMIL CCC12CCN(C(C1C)C(=O)C3=C2C=C(C=C3)O)CC4CC4 D0D5SK HIGHSTAT Investigative D0D5SP DRUG__ID D0D5SP D0D5SP DRUGTYPE Small molecular drug D0D5SP DRUGINCH 1S/C24H45NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-24(4,29-22)23(27)25-20(2)19-28-21(3)26/h20,22H,5-19H2,1-4H3,(H,25,27)/t20?,22-,24+/m1/s1 D0D5SP DRUGINKE MILXVDLKZSMGBO-ZUBLCLOHSA-N D0D5SP DRUGSMIL CCCCCCCCCCCCCCCC1C(O1)(C)C(=O)NC(C)COC(=O)C D0D5SP HIGHSTAT Investigative D0D5VD DRUG__ID D0D5VD D0D5VD DRUGTYPE Small molecular drug D0D5VD DRUGINCH 1S/C34H35N5O5/c40-24-14-12-22(13-15-24)17-27-31(41)36-28(19-23-20-35-26-10-5-4-9-25(23)26)32(42)38-29(18-21-7-2-1-3-8-21)34(44)39-16-6-11-30(39)33(43)37-27/h1-5,7-10,12-15,20,27-30,35,40H,6,11,16-19H2,(H,36,41)(H,37,43)(H,38,42)/t27-,28+,29-,30+/m0/s1 D0D5VD DRUGINKE YMZQUJVCPUZHJG-RRGQHJHPSA-N D0D5VD DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4=CNC5=CC=CC=C54)CC6=CC=C(C=C6)O D0D5VD HIGHSTAT Investigative D0D5XC DRUG__ID D0D5XC D0D5XC DRUGTYPE Small molecular drug D0D5XC DRUGINCH 1S/CH2S3.2Na/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2 D0D5XC DRUGINKE USAIOOFEIMNEDN-UHFFFAOYSA-L D0D5XC DRUGSMIL C(=S)([S-])[S-].[Na+].[Na+] D0D5XC HIGHSTAT Investigative D0D5XX DRUG__ID D0D5XX D0D5XX DRUGTYPE Small molecular drug D0D5XX DRUGINCH 1S/C20H36N8O6/c1-9(2)14(18(32)27-12(5)19(33)34)28-16(30)11(4)25-15(29)10(3)26-17(31)13(21)7-6-8-24-20(22)23/h9-10,12-14H,4,6-8,21H2,1-3,5H3,(H,25,29)(H,26,31)(H,27,32)(H,28,30)(H,33,34)(H4,22,23,24)/t10-,12-,13-,14-/m0/s1 D0D5XX DRUGINKE VZQHRKZCAZCACO-PYJNHQTQSA-N D0D5XX DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)O)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)N D0D5XX HIGHSTAT Investigative D0D5YP DRUG__ID D0D5YP D0D5YP DRUGTYPE Small molecular drug D0D5YP DRUGINCH 1S/C11H6O4/c12-10-2-1-6-9(15-10)5-8-7(11(6)13)3-4-14-8/h1-5,13H D0D5YP DRUGINKE GIJHDGJRTUSBJR-UHFFFAOYSA-N D0D5YP DRUGSMIL C1=CC(=O)OC2=CC3=C(C=CO3)C(=C21)O D0D5YP HIGHSTAT Investigative D0D5ZL DRUG__ID D0D5ZL D0D5ZL DRUGTYPE Small molecular drug D0D5ZL DRUGINCH 1S/C16H12N2O/c19-15-9-12-10-5-1-3-7-13(10)18-16(12)11-6-2-4-8-14(11)17-15/h1-8,18H,9H2,(H,17,19) D0D5ZL DRUGINKE VGMDAWVZNAXVDG-UHFFFAOYSA-N D0D5ZL DRUGSMIL C1C2=C(C3=CC=CC=C3NC1=O)NC4=CC=CC=C24 D0D5ZL HIGHSTAT Investigative D0D6BH DRUG__ID D0D6BH D0D6BH DRUGTYPE Small molecular drug D0D6BH DRUGINCH 1S/C20H18O2/c21-19-13-17(11-15-7-3-1-4-8-15)18(14-20(19)22)12-16-9-5-2-6-10-16/h1-10,13-14,21-22H,11-12H2 D0D6BH DRUGINKE SQDMOCPHIXUCCE-UHFFFAOYSA-N D0D6BH DRUGSMIL C1=CC=C(C=C1)CC2=CC(=C(C=C2CC3=CC=CC=C3)O)O D0D6BH HIGHSTAT Investigative D0D6DH DRUG__ID D0D6DH D0D6DH DRUGTYPE Small molecular drug D0D6DH DRUGINCH 1S/C20H16N2O3/c1-25-19-10-13(5-7-18(19)23)12-4-6-15-16(11-14-3-2-8-21-14)20(24)22-17(15)9-12/h2-11,21,23H,1H3,(H,22,24)/b16-11- D0D6DH DRUGINKE AYSXURJZVXBSRV-WJDWOHSUSA-N D0D6DH DRUGSMIL COC1=C(C=CC(=C1)C2=CC3=C(C=C2)C(=CC4=CC=CN4)C(=O)N3)O D0D6DH HIGHSTAT Investigative D0D6FC DRUG__ID D0D6FC D0D6FC DRUGTYPE Small molecular drug D0D6FC DRUGINCH 1S/C14H16N2O2S/c15-11-10-12-6-8-13(9-7-12)16-19(17,18)14-4-2-1-3-5-14/h1-9,16H,10-11,15H2 D0D6FC DRUGINKE PRODIAPRPOSQSM-UHFFFAOYSA-N D0D6FC DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCN D0D6FC HIGHSTAT Investigative D0D6FR DRUG__ID D0D6FR D0D6FR DRUGTYPE Small molecular drug D0D6FR DRUGINCH 1S/C17H12N2O2S/c18-11-15-16(19)6-3-7-17(15)22(20,21)14-9-8-12-4-1-2-5-13(12)10-14/h1-10H,19H2 D0D6FR DRUGINKE SSBDRFPTUIJDHD-UHFFFAOYSA-N D0D6FR DRUGSMIL C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)C3=CC=CC(=C3C#N)N D0D6FR HIGHSTAT Investigative D0D6GI DRUG__ID D0D6GI D0D6GI DRUGTYPE Small molecular drug D0D6GI DRUGINCH 1S/C21H12ClF5N2O/c22-17-10-14(1-7-18(17)24)20(30,21(25,26)27)13-2-8-19-12(9-13)11-28-29(19)16-5-3-15(23)4-6-16/h1-11,30H D0D6GI DRUGINKE DAXGWLCLIPNRDH-UHFFFAOYSA-N D0D6GI DRUGSMIL C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=C(C=C4)F)Cl)(C(F)(F)F)O)C=N2)F D0D6GI HIGHSTAT Investigative D0D6HB DRUG__ID D0D6HB D0D6HB DRUGTYPE Small molecular drug D0D6HB DRUGINCH 1S/C20H18O4/c1-13(21)23-11-19-15-7-3-5-9-17(15)20(12-24-14(2)22)18-10-6-4-8-16(18)19/h3-10H,11-12H2,1-2H3 D0D6HB DRUGINKE BVPQUFPFMVPKTA-UHFFFAOYSA-N D0D6HB DRUGSMIL CC(=O)OCC1=C2C=CC=CC2=C(C3=CC=CC=C31)COC(=O)C D0D6HB HIGHSTAT Investigative D0D6HI DRUG__ID D0D6HI D0D6HI DRUGTYPE Small molecular drug D0D6HI DRUGINCH 1S/C15H16N2O/c1-3-12-10-17-14(4-2)15(12)18-13-7-5-11(9-16)6-8-13/h5-8,10,17H,3-4H2,1-2H3 D0D6HI DRUGINKE XXYHXMUPGLKKGE-UHFFFAOYSA-N D0D6HI DRUGSMIL CCC1=CNC(=C1OC2=CC=C(C=C2)C#N)CC D0D6HI HIGHSTAT Investigative D0D6IK DRUG__ID D0D6IK D0D6IK DRUGTYPE Small molecular drug D0D6IK DRUGINCH 1S/C13H19NO2/c1-3-13(15)14-9-5-7-11-6-4-8-12(10-11)16-2/h4,6,8,10H,3,5,7,9H2,1-2H3,(H,14,15) D0D6IK DRUGINKE VVTCACGOXCPEPB-UHFFFAOYSA-N D0D6IK DRUGSMIL CCC(=O)NCCCC1=CC(=CC=C1)OC D0D6IK HIGHSTAT Investigative D0D6IU DRUG__ID D0D6IU D0D6IU DRUGTYPE Small molecular drug D0D6IU DRUGINCH 1S/C18H16N2O2/c21-17(15-12-20-16-9-5-4-8-14(15)16)18(22)19-11-10-13-6-2-1-3-7-13/h1-9,12,20H,10-11H2,(H,19,22) D0D6IU DRUGINKE USGVPHMVQJFJJD-UHFFFAOYSA-N D0D6IU DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C(=O)C2=CNC3=CC=CC=C32 D0D6IU HIGHSTAT Investigative D0D6KZ DRUG__ID D0D6KZ D0D6KZ DRUGTYPE Small molecular drug D0D6KZ DRUGINCH 1S/C28H30N2O5/c31-19-9-8-17-14-20-28-11-10-27(33,23(35-28)24(32)29-18-4-2-1-3-5-18)25-26(28,21(17)22(19)34-25)12-13-30(20)15-16-6-7-16/h1-5,8-9,16,20,23,25,31,33H,6-7,10-15H2,(H,29,32)/t20-,23+,25-,26+,27+,28-/m1/s1 D0D6KZ DRUGINKE YYNRSCGPLWDLNI-VQBGKWCDSA-N D0D6KZ DRUGSMIL C1CC1CN2CCC34C5C6(CCC3(C2CC7=C4C(=C(C=C7)O)O5)OC6C(=O)NC8=CC=CC=C8)O D0D6KZ HIGHSTAT Investigative D0D6LH DRUG__ID D0D6LH D0D6LH DRUGTYPE Small molecular drug D0D6LH DRUGINCH 1S/C29H25N5O/c1-33-18-15-25(16-19-33)30-22-11-13-24(14-12-22)32-29(35)21-7-9-23(10-8-21)31-27-17-20-34(2)28-6-4-3-5-26(27)28/h3-20H,1-2H3,(H,32,35)/p+2 D0D6LH DRUGINKE PMCURUPNDHFYCG-UHFFFAOYSA-P D0D6LH DRUGSMIL C[N+]1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=CC=[N+](C5=CC=CC=C45)C D0D6LH HIGHSTAT Investigative D0D6MH DRUG__ID D0D6MH D0D6MH DRUGTYPE Small molecular drug D0D6MH DRUGINCH 1S/C20H22N4O3/c1-25-16-6-3-13(4-7-16)12-27-17-8-5-14(10-18(17)26-2)9-15-11-23-20(22)24-19(15)21/h3-8,10-11H,9,12H2,1-2H3,(H4,21,22,23,24) D0D6MH DRUGINKE MYQAUKPBNJWPIE-UHFFFAOYSA-N D0D6MH DRUGSMIL COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC D0D6MH HIGHSTAT Investigative D0D6MZ DRUG__ID D0D6MZ D0D6MZ DRUGTYPE Small molecular drug D0D6MZ DRUGINCH 1S/C11H15NO2/c1-9(13)11(12)8-14-7-10-5-3-2-4-6-10/h2-6,11H,7-8,12H2,1H3/t11-/m0/s1 D0D6MZ DRUGINKE ISLRAQPEXPIKDJ-NSHDSACASA-N D0D6MZ DRUGSMIL CC(=O)C(COCC1=CC=CC=C1)N D0D6MZ HIGHSTAT Investigative D0D6OA DRUG__ID D0D6OA D0D6OA DRUGTYPE Small molecular drug D0D6OA DRUGINCH 1S/C17H21NO6S/c1-18-7-6-17-10-3-5-13(24-25(20,21)22)16(17)23-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,13,16,19H,3,5-8H2,1H3,(H,20,21,22)/t10-,11+,13-,16-,17-/m0/s1 D0D6OA DRUGINKE QTALQTUQMLSRSG-KBQPJGBKSA-N D0D6OA DRUGSMIL C[NH+]1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(CC4)OS(=O)(=O)[O-] D0D6OA HIGHSTAT Investigative D0D6OH DRUG__ID D0D6OH D0D6OH DRUGTYPE Small molecular drug D0D6OH DRUGINCH 1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3/t18-,20-,22-/m1/s1 D0D6OH DRUGINKE YNZFFALZMRAPHQ-SYYKKAFVSA-N D0D6OH DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CC(CCC2CCCO)O)O D0D6OH HIGHSTAT Investigative D0D6OR DRUG__ID D0D6OR D0D6OR DRUGTYPE Small molecular drug D0D6OR DRUGINCH 1S/C17H19NOS/c1-2-4-14(5-3-1)13-19-16-8-6-15(7-9-16)17-12-18-10-11-20-17/h1-9,17-18H,10-13H2 D0D6OR DRUGINKE JTMKALFHDSWYGH-UHFFFAOYSA-N D0D6OR DRUGSMIL C1CSC(CN1)C2=CC=C(C=C2)OCC3=CC=CC=C3 D0D6OR HIGHSTAT Investigative D0D6PC DRUG__ID D0D6PC D0D6PC DRUGTYPE Small molecular drug D0D6PC DRUGINCH 1S/C27H26F3N5O5/c1-4-39-25(37)21-15(2)33-16(3)22(23(21)19-7-5-6-8-20(19)27(28,29)30)26(38)40-14-13-32-24(36)17-9-11-18(12-10-17)34-35-31/h5-12,23,33H,4,13-14H2,1-3H3,(H,32,36) D0D6PC DRUGINKE SWMHKFTXBOJETC-UHFFFAOYSA-N D0D6PC DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C(F)(F)F)C(=O)OCCNC(=O)C3=CC=C(C=C3)N=[N+]=[N-])C)C D0D6PC HIGHSTAT Investigative D0D6QI DRUG__ID D0D6QI D0D6QI DRUGTYPE Small molecular drug D0D6QI DRUGINCH 1S/C16H13ClN2O/c1-10-7-12-9-14(5-6-15(12)18-10)19-16(20)11-3-2-4-13(17)8-11/h2-9,18H,1H3,(H,19,20) D0D6QI DRUGINKE SSPHXZNBIVJTMG-UHFFFAOYSA-N D0D6QI DRUGSMIL CC1=CC2=C(N1)C=CC(=C2)NC(=O)C3=CC(=CC=C3)Cl D0D6QI HIGHSTAT Investigative D0D6TB DRUG__ID D0D6TB D0D6TB DRUGTYPE Small molecular drug D0D6TB DRUGINCH 1S/C12H18N2O2/c15-11(12-14-8-9-16-12)3-1-2-10-4-6-13-7-5-10/h8-10,13H,1-7H2 D0D6TB DRUGINKE PKVYQZQOXHRPTR-UHFFFAOYSA-N D0D6TB DRUGSMIL C1CNCCC1CCCC(=O)C2=NC=CO2 D0D6TB HIGHSTAT Investigative D0D6UC DRUG__ID D0D6UC D0D6UC DRUGTYPE Small molecular drug D0D6UC DRUGINCH 1S/C19H15FO2S/c1-23-16-5-2-12(3-6-16)8-13-9-14(10-19(21)22)18-11-15(20)4-7-17(13)18/h2-9,11H,10H2,1H3,(H,21,22)/b13-8- D0D6UC DRUGINKE NEQPIGQSLNSVDO-JYRVWZFOSA-N D0D6UC DRUGSMIL CSC1=CC=C(C=C1)C=C2C=C(C3=C2C=CC(=C3)F)CC(=O)O D0D6UC HIGHSTAT Investigative D0D6UL DRUG__ID D0D6UL D0D6UL DRUGTYPE Small molecular drug D0D6UL DRUGINCH 1S/C13H14N2O6S3/c1-21-9-4-2-8(3-5-9)15-7-11(16)10-6-12(23(14,17)18)22-13(10)24(15,19)20/h2-6,11,16H,7H2,1H3,(H2,14,17,18)/t11-/m0/s1 D0D6UL DRUGINKE ZWTSOJQGEWPWGO-NSHDSACASA-N D0D6UL DRUGSMIL COC1=CC=C(C=C1)N2CC(C3=C(S2(=O)=O)SC(=C3)S(=O)(=O)N)O D0D6UL HIGHSTAT Investigative D0D6UR DRUG__ID D0D6UR D0D6UR DRUGTYPE Small molecular drug D0D6UR DRUGINCH 1S/C10H6O3S/c11-9(12)7-5-6-3-1-2-4-8(6)14-10(7)13/h1-5H,(H,11,12) D0D6UR DRUGINKE CIMFYGICTNZOPT-UHFFFAOYSA-N D0D6UR DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)S2)C(=O)O D0D6UR HIGHSTAT Investigative D0D6XV DRUG__ID D0D6XV D0D6XV DRUGTYPE Small molecular drug D0D6XV DRUGINCH 1S/C27H38O4/c1-16(12-22-13-17(2)26(30)31-22)23-9-10-24-19(6-5-11-27(23,24)4)7-8-20-14-21(28)15-25(29)18(20)3/h7-8,16,21-25,28-29H,2-3,5-6,9-15H2,1,4H3/b19-7+,20-8-/t16-,21-,22+,23-,24+,25+,27-/m1/s1 D0D6XV DRUGINKE SAODSJHDCZTVAT-CZADFQNYSA-N D0D6XV DRUGSMIL CC(CC1CC(=C)C(=O)O1)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C D0D6XV HIGHSTAT Investigative D0D7AS DRUG__ID D0D7AS D0D7AS DRUGTYPE Small molecular drug D0D7AS DRUGINCH 1S/C12H9NO2S/c14-12(10-5-2-1-3-6-10)15-13-9-11-7-4-8-16-11/h1-9H/b13-9+ D0D7AS DRUGINKE VRGHYBJYCUKCSY-UKTHLTGXSA-N D0D7AS DRUGSMIL C1=CC=C(C=C1)C(=O)ON=CC2=CC=CS2 D0D7AS HIGHSTAT Investigative D0D7CM DRUG__ID D0D7CM D0D7CM DRUGTYPE Small molecular drug D0D7CM DRUGINCH 1S/C19H21N3O2/c1-13(23)18(22-11-17(19(20)24)21-12-22)10-9-15-7-4-6-14-5-2-3-8-16(14)15/h2-8,11-13,18,23H,9-10H2,1H3,(H2,20,24)/t13-,18+/m0/s1 D0D7CM DRUGINKE OODDZQQDDOVCFD-SCLBCKFNSA-N D0D7CM DRUGSMIL CC(C(CCC1=CC=CC2=CC=CC=C21)N3C=C(N=C3)C(=O)N)O D0D7CM HIGHSTAT Investigative D0D7DC DRUG__ID D0D7DC D0D7DC DRUGTYPE Small molecular drug D0D7DC DRUGINCH 1S/C20H14Cl2N2O2/c21-14-6-3-5-13(11-14)19(25)23-15-7-4-8-16(12-15)24-20(26)17-9-1-2-10-18(17)22/h1-12H,(H,23,25)(H,24,26) D0D7DC DRUGINKE IKCXGGCLQZZTJZ-UHFFFAOYSA-N D0D7DC DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC=CC(=C2)NC(=O)C3=CC(=CC=C3)Cl)Cl D0D7DC HIGHSTAT Investigative D0D7ES DRUG__ID D0D7ES D0D7ES DRUGTYPE Small molecular drug D0D7ES DRUGINCH 1S/C14H14N2O3/c17-14(16-18)15-12-6-8-13(9-7-12)19-10-11-4-2-1-3-5-11/h1-9,18H,10H2,(H2,15,16,17) D0D7ES DRUGINKE PQXBDBGXKAZUEX-UHFFFAOYSA-N D0D7ES DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)NO D0D7ES HIGHSTAT Investigative D0D7FB DRUG__ID D0D7FB D0D7FB DRUGTYPE Small molecular drug D0D7FB DRUGINCH 1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9-/m0/s1 D0D7FB DRUGINKE ODZBBRURCPAEIQ-RNVICZODSA-N D0D7FB DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)C=CBr)CO)O D0D7FB HIGHSTAT Investigative D0D7FN DRUG__ID D0D7FN D0D7FN DRUGTYPE Small molecular drug D0D7FN DRUGINCH 1S/C14H9NO4/c16-13(10-4-2-1-3-5-10)14(17)11-6-8-12(9-7-11)15(18)19/h1-9H D0D7FN DRUGINKE GPDKREBNFFEDHW-UHFFFAOYSA-N D0D7FN DRUGSMIL C1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)[N+](=O)[O-] D0D7FN HIGHSTAT Investigative D0D7FX DRUG__ID D0D7FX D0D7FX DRUGTYPE Small molecular drug D0D7FX DRUGINCH 1S/C10H13NO2/c11-9(10(12)13)7-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13) D0D7FX DRUGINKE JTTHKOPSMAVJFE-UHFFFAOYSA-N D0D7FX DRUGSMIL C1=CC=C(C=C1)CCC(C(=O)O)N D0D7FX HIGHSTAT Investigative D0D7GG DRUG__ID D0D7GG D0D7GG DRUGTYPE Small molecular drug D0D7GG DRUGINCH 1S/C24H22N2/c1-3-7-20(8-4-1)17-24(26-16-15-25-19-26)18-21-11-13-23(14-12-21)22-9-5-2-6-10-22/h1-16,19,24H,17-18H2 D0D7GG DRUGINKE BHZGAVDQPKAVLD-UHFFFAOYSA-N D0D7GG DRUGSMIL C1=CC=C(C=C1)CC(CC2=CC=C(C=C2)C3=CC=CC=C3)N4C=CN=C4 D0D7GG HIGHSTAT Investigative D0D7GL DRUG__ID D0D7GL D0D7GL DRUGTYPE Small molecular drug D0D7GL DRUGINCH 1S/C7H6O2/c8-6-4-2-1-3-5-7(6)9/h1-5H,(H,8,9) D0D7GL DRUGINKE MDYOLVRUBBJPFM-UHFFFAOYSA-N D0D7GL DRUGSMIL C1=CC=C(C(=O)C=C1)O D0D7GL HIGHSTAT Investigative D0D7HR DRUG__ID D0D7HR D0D7HR DRUGTYPE Small molecular drug D0D7HR DRUGINCH 1S/C22H17ClN4O2/c23-13-5-6-17-15(9-13)16(10-25-17)19-20(22(29)26-21(19)28)27-11-12(7-8-24)14-3-1-2-4-18(14)27/h1-6,9-11,25H,7-8,24H2,(H,26,28,29) D0D7HR DRUGINKE UPHCEKNUUNYTFE-UHFFFAOYSA-N D0D7HR DRUGSMIL C1=CC=C2C(=C1)C(=CN2C3=C(C(=O)NC3=O)C4=CNC5=C4C=C(C=C5)Cl)CCN D0D7HR HIGHSTAT Investigative D0D7HU DRUG__ID D0D7HU D0D7HU DRUGTYPE Small molecular drug D0D7HU DRUGINCH 1S/C14H18N4O/c19-13(14-15-17-18-16-14)11-7-2-1-4-8-12-9-5-3-6-10-12/h3,5-6,9-10H,1-2,4,7-8,11H2,(H,15,16,17,18) D0D7HU DRUGINKE JVOYAZCLPXVADL-UHFFFAOYSA-N D0D7HU DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NNN=N2 D0D7HU HIGHSTAT Investigative D0D7HZ DRUG__ID D0D7HZ D0D7HZ DRUGTYPE Small molecular drug D0D7HZ DRUGINCH 1S/C9H13N/c1-7(2)8-3-5-9(10)6-4-8/h3-7H,10H2,1-2H3 D0D7HZ DRUGINKE LRTFPLFDLJYEKT-UHFFFAOYSA-N D0D7HZ DRUGSMIL CC(C)C1=CC=C(C=C1)N D0D7HZ HIGHSTAT Investigative D0D7ID DRUG__ID D0D7ID D0D7ID DRUGTYPE Small molecular drug D0D7ID DRUGINCH 1S/C17H34N2O/c1-2-3-4-5-6-7-8-12-15-18-17(20)19-16-13-10-9-11-14-16/h16H,2-15H2,1H3,(H2,18,19,20) D0D7ID DRUGINKE LPXYBLIRYGCMPQ-UHFFFAOYSA-N D0D7ID DRUGSMIL CCCCCCCCCCNC(=O)NC1CCCCC1 D0D7ID HIGHSTAT Investigative D0D7IQ DRUG__ID D0D7IQ D0D7IQ DRUGTYPE Small molecular drug D0D7IQ DRUGINCH 1S/C18H21NO2S/c20-18(13-19-10-2-1-4-16(19)12-21-18)15-8-6-14(7-9-15)17-5-3-11-22-17/h3,5-9,11,16,20H,1-2,4,10,12-13H2 D0D7IQ DRUGINKE DXCCBGQUDIVOAH-UHFFFAOYSA-N D0D7IQ DRUGSMIL C1CCN2CC(OCC2C1)(C3=CC=C(C=C3)C4=CC=CS4)O D0D7IQ HIGHSTAT Investigative D0D7KE DRUG__ID D0D7KE D0D7KE DRUGTYPE Small molecular drug D0D7KE DRUGINCH 1S/C21H16FNO4S/c22-17-6-12-20(13-7-17)28(26,27)23-18-8-4-16(5-9-18)21(25)14-3-15-1-10-19(24)11-2-15/h1-14,23-24H/b14-3+ D0D7KE DRUGINKE SRDYAWAEKAHCHN-LZWSPWQCSA-N D0D7KE DRUGSMIL C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3)F)O D0D7KE HIGHSTAT Investigative D0D7MN DRUG__ID D0D7MN D0D7MN DRUGTYPE Small molecular drug D0D7MN DRUGINCH 1S/C23H15NOS/c25-23(18-11-7-9-16-8-1-2-10-17(16)18)24-19-12-3-5-14-21(19)26-22-15-6-4-13-20(22)24/h1-15H D0D7MN DRUGINKE JJKRMXKTTVOCBF-UHFFFAOYSA-N D0D7MN DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C(=O)N3C4=CC=CC=C4SC5=CC=CC=C53 D0D7MN HIGHSTAT Investigative D0D7MP DRUG__ID D0D7MP D0D7MP DRUGTYPE Small molecular drug D0D7MP DRUGINCH 1S/C21H38O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(22)24-19-20-18-23-20/h9-10,20H,2-8,11-19H2,1H3/b10-9- D0D7MP DRUGINKE VWYIWOYBERNXLX-KTKRTIGZSA-N D0D7MP DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC1CO1 D0D7MP HIGHSTAT Investigative D0D7OR DRUG__ID D0D7OR D0D7OR DRUGTYPE Small molecular drug D0D7OR DRUGINCH 1S/C25H29FO2/c1-15-9-10-20-19(11-15)23-21(27)13-17(14-22(23)28-25(20,4)5)24(2,3)16-7-6-8-18(26)12-16/h6-9,12-14,19-20,27H,10-11H2,1-5H3/t19-,20-/m1/s1 D0D7OR DRUGINKE IKKCHJJZMJZQEO-WOJBJXKFSA-N D0D7OR DRUGSMIL CC1=CCC2C(C1)C3=C(C=C(C=C3OC2(C)C)C(C)(C)C4=CC(=CC=C4)F)O D0D7OR HIGHSTAT Investigative D0D7PF DRUG__ID D0D7PF D0D7PF DRUGTYPE Small molecular drug D0D7PF DRUGINCH 1S/C10H15N3O2/c14-9-3-4-11-10(15)13(9)8-7-12-5-1-2-6-12/h3-4H,1-2,5-8H2,(H,11,15) D0D7PF DRUGINKE XKWFMZHWDROEIH-UHFFFAOYSA-N D0D7PF DRUGSMIL C1CCN(C1)CCN2C(=O)C=CNC2=O D0D7PF HIGHSTAT Investigative D0D7PK DRUG__ID D0D7PK D0D7PK DRUGTYPE Small molecular drug D0D7PK DRUGINCH 1S/C6H12N2/c1-5-2-3-8-6(7)4-5/h5H,2-4H2,1H3,(H2,7,8) D0D7PK DRUGINKE GGDLOMFAKKVDPT-UHFFFAOYSA-N D0D7PK DRUGSMIL CC1CCN=C(C1)N D0D7PK HIGHSTAT Investigative D0D7QH DRUG__ID D0D7QH D0D7QH DRUGTYPE Small molecular drug D0D7QH DRUGINCH 1S/C28H41NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-28(31)29-24-25-21-22-26(30)27(23-25)32-2/h7-8,10-11,13-14,16-17,21-23,30H,3-6,9,12,15,18-20,24H2,1-2H3,(H,29,31)/b8-7-,11-10-,14-13-,17-16- D0D7QH DRUGINKE QVLMCRFQGHWOPM-ZKWNWVNESA-N D0D7QH DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCC1=CC(=C(C=C1)O)OC D0D7QH HIGHSTAT Investigative D0D7UA DRUG__ID D0D7UA D0D7UA DRUGTYPE Small molecular drug D0D7UA DRUGINCH 1S/C15H16O3S2/c16-20(17,12-4-11-19)15-9-7-14(8-10-15)18-13-5-2-1-3-6-13/h1-3,5-10,19H,4,11-12H2 D0D7UA DRUGINKE CTVWOVYWOFCAMW-UHFFFAOYSA-N D0D7UA DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)S(=O)(=O)CCCS D0D7UA HIGHSTAT Investigative D0D7YL DRUG__ID D0D7YL D0D7YL DRUGTYPE Small molecular drug D0D7YL DRUGINCH 1S/C17H13N/c1-3-12-6-8-15(14-5-2-10-18-11-14)16-9-7-13(4-1)17(12)16/h1-6,8,10-11H,7,9H2 D0D7YL DRUGINKE CKORXOPHZBFEPV-UHFFFAOYSA-N D0D7YL DRUGSMIL C1CC2=C(C=CC3=C2C1=CC=C3)C4=CN=CC=C4 D0D7YL HIGHSTAT Investigative D0D7ZL DRUG__ID D0D7ZL D0D7ZL DRUGTYPE Small molecular drug D0D7ZL DRUGINCH 1S/C18H14N2O2/c1-22-13-7-6-12-9-17(20-15(12)10-13)18(21)16-8-11-4-2-3-5-14(11)19-16/h2-10,19-20H,1H3 D0D7ZL DRUGINKE RSMLCEQJLGXMPQ-UHFFFAOYSA-N D0D7ZL DRUGSMIL COC1=CC2=C(C=C1)C=C(N2)C(=O)C3=CC4=CC=CC=C4N3 D0D7ZL HIGHSTAT Investigative D0D8AK DRUG__ID D0D8AK D0D8AK DRUGTYPE Small molecular drug D0D8AK DRUGINCH 1S/C43H58N10O9/c1-4-25(2)36-40(60)49-29(22-28-14-17-30(54)18-15-28)16-19-34(55)47-24-32(51-38(58)26(3)48-35(56)23-27-10-6-5-7-11-27)42(62)53-21-9-13-33(53)39(59)50-31(37(57)41(61)52-36)12-8-20-46-43(44)45/h5-7,10-11,14-19,25-26,29,31-33,36,54H,4,8-9,12-13,20-24H2,1-3H3,(H,47,55)(H,48,56)(H,49,60)(H,50,59)(H,51,58)(H,52,61)(H4,44,45,46)/b19-16+/t25-,26+,29-,31+,32+,33+,36+/m1/s1 D0D8AK DRUGINKE JAVOTTCUBDNFEA-YFQACERUSA-N D0D8AK DRUGSMIL CCC(C)C1C(=O)NC(C=CC(=O)NCC(C(=O)N2CCCC2C(=O)NC(C(=O)C(=O)N1)CCCN=C(N)N)NC(=O)C(C)NC(=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)O D0D8AK HIGHSTAT Investigative D0D8AN DRUG__ID D0D8AN D0D8AN DRUGTYPE Small molecular drug D0D8AN DRUGINCH 1S/C20H25NO3/c22-14-6-5-13-10-15-20(23)7-1-2-16-19(20,17(13)18(14)24-16)8-9-21(15)11-12-3-4-12/h5-6,12,15-16,22-23H,1-4,7-11H2/t15-,16+,19-,20-/m1/s1 D0D8AN DRUGINKE XBPQMXFKKJADMC-WOUAJJJCSA-N D0D8AN DRUGSMIL C1CC2C34CCN(C(C3(C1)O)CC5=C4C(=C(C=C5)O)O2)CC6CC6 D0D8AN HIGHSTAT Investigative D0D8CZ DRUG__ID D0D8CZ D0D8CZ DRUGTYPE Small molecular drug D0D8CZ DRUGINCH 1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1 D0D8CZ DRUGINKE SUYVUBYJARFZHO-RRKCRQDMSA-N D0D8CZ DRUGSMIL C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O D0D8CZ HIGHSTAT Investigative D0D8DA DRUG__ID D0D8DA D0D8DA DRUGCOMP Kaken Pharmaceutical Co Ltd D0D8DA DRUGINCH 1S/C24H30F2N4O3/c1-14-6-5-7-16(12-14)15(2)18(31)11-10-17-19(32)13-20-23(17)24(25,26)21(33-20)8-3-4-9-22-27-29-30-28-22/h5-8,10-12,15,17-20,23,31-32H,3-4,9,13H2,1-2H3,(H,27,28,29,30)/b11-10+,21-8-/t15-,17+,18-,19-,20+,23-/m1/s1 D0D8DA DRUGINKE KSELABKNBIUMGG-YGBAREPYSA-N D0D8DA DRUGSMIL CC1=CC(=CC=C1)C(C)C(C=CC2C(CC3C2C(C(=CCCCC4=NNN=N4)O3)(F)F)O)O D0D8DA HIGHSTAT Investigative D0D8DZ DRUG__ID D0D8DZ D0D8DZ DRUGTYPE Small molecular drug D0D8DZ DRUGINCH 1S/C41H46N6O5/c1-26-20-31(48)21-27(2)32(26)23-33(42)40(50)47-24-30-15-7-6-14-29(30)22-37(47)39(49)46-36(38-44-34-16-8-9-17-35(34)45-38)18-10-11-19-43-41(51)52-25-28-12-4-3-5-13-28/h3-9,12-17,20-21,33,36-37,48H,10-11,18-19,22-25,42H2,1-2H3,(H,43,51)(H,44,45)(H,46,49) D0D8DZ DRUGINKE ZHRKDWCBKIOLKI-UHFFFAOYSA-N D0D8DZ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)OCC4=CC=CC=C4)C5=NC6=CC=CC=C6N5)N)C)O D0D8DZ HIGHSTAT Investigative D0D8FE DRUG__ID D0D8FE D0D8FE DRUGTYPE Small molecular drug D0D8FE DRUGINCH 1S/C43H58O6/c1-27(2)13-11-15-31(9)16-18-33-26-42(23-20-29(5)6)38(47)36(37(46)32-17-19-34(44)35(45)25-32)39(48)43(40(42)49,24-21-30(7)8)41(33,10)22-12-14-28(3)4/h13-14,16-17,19-21,25,33,44-46H,11-12,15,18,22-24,26H2,1-10H3/b31-16+,37-36+/t33-,41+,42-,43+/m0/s1 D0D8FE DRUGINKE HIGOXQQRSUDJCL-KJLWUZBSSA-N D0D8FE DRUGSMIL CC(=CCCC(=CCC1CC2(C(=O)C(=C(C3=CC(=C(C=C3)O)O)O)C(=O)C(C2=O)(C1(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)C)C D0D8FE HIGHSTAT Investigative D0D8FW DRUG__ID D0D8FW D0D8FW DRUGTYPE Small molecular drug D0D8FW DRUGINCH 1S/C26H30N2O4/c1-20(23-11-7-4-8-12-23)32-26(29)28(16-15-27)18-22-13-14-24(25(17-22)30-2)31-19-21-9-5-3-6-10-21/h3-14,17,20H,15-16,18-19,27H2,1-2H3/t20-/m1/s1 D0D8FW DRUGINKE URRBLVUOXIGNQR-HXUWFJFHSA-N D0D8FW DRUGSMIL CC(C1=CC=CC=C1)OC(=O)N(CCN)CC2=CC(=C(C=C2)OCC3=CC=CC=C3)OC D0D8FW HIGHSTAT Investigative D0D8FZ DRUG__ID D0D8FZ D0D8FZ DRUGTYPE Small molecular drug D0D8FZ DRUGINCH 1S/C18H20N2O3/c21-17(19-12-11-14-7-3-1-4-8-14)16(18(22)20-23)13-15-9-5-2-6-10-15/h1-10,16,23H,11-13H2,(H,19,21)(H,20,22) D0D8FZ DRUGINKE GJBWQDWUWPUOOP-UHFFFAOYSA-N D0D8FZ DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C(CC2=CC=CC=C2)C(=O)NO D0D8FZ HIGHSTAT Investigative D0D8GU DRUG__ID D0D8GU D0D8GU DRUGTYPE Small molecular drug D0D8GU DRUGINCH 1S/C16H15N/c1-12-2-3-14-4-5-15(16(14)10-12)11-13-6-8-17-9-7-13/h2-3,6-11H,4-5H2,1H3/b15-11+ D0D8GU DRUGINKE JRWJGUYEZHCVMC-RVDMUPIBSA-N D0D8GU DRUGSMIL CC1=CC2=C(CCC2=CC3=CC=NC=C3)C=C1 D0D8GU HIGHSTAT Investigative D0D8GV DRUG__ID D0D8GV D0D8GV DRUGTYPE Small molecular drug D0D8GV DRUGINCH 1S/C25H28F3N3O3/c1-16-23(19-5-8-21(27)22(28)15-19)31(25(33)34-16)24(32)29-11-2-12-30-13-9-18(10-14-30)17-3-6-20(26)7-4-17/h3-8,15-16,18,23H,2,9-14H2,1H3,(H,29,32)/t16-,23+/m0/s1 D0D8GV DRUGINKE DTYAFBJXWWLRMA-QMHKHESXSA-N D0D8GV DRUGSMIL CC1C(N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F D0D8GV HIGHSTAT Investigative D0D8IH DRUG__ID D0D8IH D0D8IH DRUGTYPE Small molecular drug D0D8IH DRUGINCH 1S/C19H14N2OS/c22-19(20-14-8-2-1-3-9-14)21-15-10-4-6-12-17(15)23-18-13-7-5-11-16(18)21/h1-13H,(H,20,22) D0D8IH DRUGINKE YNMBQQBSDFDHFH-UHFFFAOYSA-N D0D8IH DRUGSMIL C1=CC=C(C=C1)NC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0D8IH HIGHSTAT Investigative D0D8IS DRUG__ID D0D8IS D0D8IS DRUGTYPE Small molecular drug D0D8IS DRUGINCH 1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1 D0D8IS DRUGINKE GHCZAUBVMUEKKP-GYPHWSFCSA-N D0D8IS DRUGSMIL CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C D0D8IS HIGHSTAT Investigative D0D8JU DRUG__ID D0D8JU D0D8JU DRUGTYPE Small molecular drug D0D8JU DRUGINCH 1S/C18H16N2O/c21-18(16-8-4-10-19-13-16,17-9-5-11-20-14-17)12-15-6-2-1-3-7-15/h1-11,13-14,21H,12H2 D0D8JU DRUGINKE ISJDJRMNDVLGMU-UHFFFAOYSA-N D0D8JU DRUGSMIL C1=CC=C(C=C1)CC(C2=CN=CC=C2)(C3=CN=CC=C3)O D0D8JU HIGHSTAT Investigative D0D8KN DRUG__ID D0D8KN D0D8KN DRUGTYPE Small molecular drug D0D8KN DRUGINCH 1S/C13H16N2O/c16-8-4-7-13-9-14-11-15(13)10-12-5-2-1-3-6-12/h1-3,5-6,9,11,16H,4,7-8,10H2 D0D8KN DRUGINKE TZVJUMCHCPZGTM-UHFFFAOYSA-N D0D8KN DRUGSMIL C1=CC=C(C=C1)CN2C=NC=C2CCCO D0D8KN HIGHSTAT Investigative D0D8LQ DRUG__ID D0D8LQ D0D8LQ DRUGTYPE Small molecular drug D0D8LQ DRUGINCH 1S/C14H10BrN3O2/c15-10-3-1-2-4-11(10)17-14(20)18-12-6-5-9(8-16)7-13(12)19/h1-7,19H,(H2,17,18,20) D0D8LQ DRUGINKE VIKJECVSALYBJB-UHFFFAOYSA-N D0D8LQ DRUGSMIL C1=CC=C(C(=C1)NC(=O)NC2=C(C=C(C=C2)C#N)O)Br D0D8LQ HIGHSTAT Investigative D0D8MA DRUG__ID D0D8MA D0D8MA DRUGTYPE Small molecular drug D0D8MA DRUGINCH 1S/C15H13ClN2O2/c1-10-6-2-5-9-13(10)17-15(20)18-14(19)11-7-3-4-8-12(11)16/h2-9H,1H3,(H2,17,18,19,20) D0D8MA DRUGINKE BXURYJIVZUMNBL-UHFFFAOYSA-N D0D8MA DRUGSMIL CC1=CC=CC=C1NC(=O)NC(=O)C2=CC=CC=C2Cl D0D8MA HIGHSTAT Investigative D0D8MH DRUG__ID D0D8MH D0D8MH DRUGTYPE Small molecular drug D0D8MH DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15?,16?,17-,18?,19+/m1/s1 D0D8MH DRUGINKE PXGPLTODNUVGFL-CXMQRTRKSA-N D0D8MH DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O D0D8MH HIGHSTAT Investigative D0D8NM DRUG__ID D0D8NM D0D8NM DRUGTYPE Small molecular drug D0D8NM DRUGINCH 1S/C13H17NO3S/c14-12(15)10-4-1-3-9(7-10)8-11(13(16)17)5-2-6-18/h1,3-4,7,11,18H,2,5-6,8H2,(H2,14,15)(H,16,17) D0D8NM DRUGINKE AGWUXZTVEYUITF-UHFFFAOYSA-N D0D8NM DRUGSMIL C1=CC(=CC(=C1)C(=O)N)CC(CCCS)C(=O)O D0D8NM HIGHSTAT Investigative D0D8OR DRUG__ID D0D8OR D0D8OR DRUGTYPE Small molecular drug D0D8OR DRUGINCH 1S/C7H6BNO2/c9-5-6-2-1-3-7(4-6)8(10)11/h1-4,10-11H D0D8OR DRUGINKE XDBHWPLGGBLUHH-UHFFFAOYSA-N D0D8OR DRUGSMIL B(C1=CC(=CC=C1)C#N)(O)O D0D8OR HIGHSTAT Investigative D0D8OY DRUG__ID D0D8OY D0D8OY DRUGTYPE Small molecular drug D0D8OY DRUGINCH 1S/C24H20F3N7O/c1-14-2-3-16(23(35)33-19-11-17(6-8-28-19)24(25,26)27)10-15(14)7-9-34-13-31-20-21(32-18-4-5-18)29-12-30-22(20)34/h2-3,6-13,18H,4-5H2,1H3,(H,28,33,35)(H,29,30,32)/b9-7+ D0D8OY DRUGINKE PPHMKXKASWTCSZ-VQHVLOKHSA-N D0D8OY DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=NC=CC(=C2)C(F)(F)F)C=CN3C=NC4=C(N=CN=C43)NC5CC5 D0D8OY HIGHSTAT Investigative D0D8PZ DRUG__ID D0D8PZ D0D8PZ DRUGTYPE Small molecular drug D0D8PZ DRUGINCH 1S/C19H26O2/c1-5-6-13-10-16(20)18-14-9-12(2)7-8-15(14)19(3,4)21-17(18)11-13/h9-11,14-15,20H,5-8H2,1-4H3/t14-,15-/m1/s1 D0D8PZ DRUGINKE ZROLHBHDLIHEMS-HUUCEWRRSA-N D0D8PZ DRUGSMIL CCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O D0D8PZ HIGHSTAT Investigative D0D8QO DRUG__ID D0D8QO D0D8QO DRUGTYPE Small molecular drug D0D8QO DRUGINCH 1S/C40H38O10/c1-20(2)4-9-26-32(44)14-12-28(38(26)48)40(50)36-29(25-10-8-24(42)19-35(25)47)16-21(3)17-30(36)37-33(45)15-11-27(39(37)49)31(43)13-6-22-5-7-23(41)18-34(22)46/h4-8,10-15,17-19,29-30,36,41-42,44-49H,9,16H2,1-3H3/b13-6+ D0D8QO DRUGINKE KBAPHKOHTBBCTO-AWNIVKPZSA-N D0D8QO DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C(=C(C=C3)O)CC=C(C)C)O)C4=C(C=CC(=C4O)C(=O)C=CC5=C(C=C(C=C5)O)O)O D0D8QO HIGHSTAT Investigative D0D8QY DRUG__ID D0D8QY D0D8QY DRUGTYPE Small molecular drug D0D8QY DRUGINCH 1S/C10H8BrN3O2/c11-6-1-3-7(4-2-6)12-8-5-9(15)14-10(16)13-8/h1-5H,(H3,12,13,14,15,16) D0D8QY DRUGINKE KVJLEUZMCGNFGQ-UHFFFAOYSA-N D0D8QY DRUGSMIL C1=CC(=CC=C1NC2=CC(=O)NC(=O)N2)Br D0D8QY HIGHSTAT Investigative D0D8WN DRUG__ID D0D8WN D0D8WN DRUGTYPE Small molecular drug D0D8WN DRUGINCH 1S/C12H11N5/c1-17-8-15-10-11(13-7-14-12(10)17)16-9-5-3-2-4-6-9/h2-8H,1H3,(H,13,14,16) D0D8WN DRUGINKE STTSYIXNIOADQX-UHFFFAOYSA-N D0D8WN DRUGSMIL CN1C=NC2=C(N=CN=C21)NC3=CC=CC=C3 D0D8WN HIGHSTAT Investigative D0D8WQ DRUG__ID D0D8WQ D0D8WQ DRUGTYPE Small molecular drug D0D8WQ DRUGINCH 1S/C12H22N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h5-10,17,19-20H,2-3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,7-,8+,9-,10-/m1/s1 D0D8WQ DRUGINKE DAAUVSVERFXBSX-WHSUVHHGSA-N D0D8WQ DRUGSMIL CC(=O)NC1C(CC(OC1C(C(CO)O)O)C(=O)O)N=C(N)N D0D8WQ HIGHSTAT Investigative D0D8XF DRUG__ID D0D8XF D0D8XF DRUGTYPE Small molecular drug D0D8XF DRUGINCH 1S/C9H10O5/c1-14-7-4-5(2-3-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13) D0D8XF DRUGINKE CGQCWMIAEPEHNQ-UHFFFAOYSA-N D0D8XF DRUGSMIL COC1=C(C=CC(=C1)C(C(=O)O)O)O D0D8XF HIGHSTAT Investigative D0D8YE DRUG__ID D0D8YE D0D8YE DRUGTYPE Small molecular drug D0D8YE DRUGINCH 1S/C15H13NO/c1-17-15-5-4-11-7-13(8-14(11)9-15)12-3-2-6-16-10-12/h2-6,8-10H,7H2,1H3 D0D8YE DRUGINKE KPJYOCDWGFDTFR-UHFFFAOYSA-N D0D8YE DRUGSMIL COC1=CC2=C(CC(=C2)C3=CN=CC=C3)C=C1 D0D8YE HIGHSTAT Investigative D0D8YG DRUG__ID D0D8YG D0D8YG DRUGTYPE Small molecular drug D0D8YG DRUGINCH 1S/C17H21N5O2/c1-12(23)14(9-24-8-7-13-5-3-2-4-6-13)22-11-21-15-16(18)19-10-20-17(15)22/h2-6,10-12,14,23H,7-9H2,1H3,(H2,18,19,20)/t12-,14?/m0/s1 D0D8YG DRUGINKE AGLLOYCRAOLWDZ-NBFOIZRFSA-N D0D8YG DRUGSMIL CC(C(COCCC1=CC=CC=C1)N2C=NC3=C(N=CN=C32)N)O D0D8YG HIGHSTAT Investigative D0D8YP DRUG__ID D0D8YP D0D8YP DRUGTYPE Small molecular drug D0D8YP DRUGINCH 1S/C12H18N2/c1-13-7-9-14(10-8-13)11-12-5-3-2-4-6-12/h2-6H,7-11H2,1H3 D0D8YP DRUGINKE MLJOKPBESJWYGL-UHFFFAOYSA-N D0D8YP DRUGSMIL CN1CCN(CC1)CC2=CC=CC=C2 D0D8YP HIGHSTAT Investigative D0D8YY DRUG__ID D0D8YY D0D8YY DRUGTYPE Small molecular drug D0D8YY DRUGINCH 1S/C16H26N2/c1-14(2)12-18(16-8-10-17-11-9-16)13-15-6-4-3-5-7-15/h3-7,14,16-17H,8-13H2,1-2H3 D0D8YY DRUGINKE LDELVNUHOAVIQP-UHFFFAOYSA-N D0D8YY DRUGSMIL CC(C)CN(CC1=CC=CC=C1)C2CCNCC2 D0D8YY HIGHSTAT Investigative D0D8ZN DRUG__ID D0D8ZN D0D8ZN DRUGTYPE Small molecular drug D0D8ZN DRUGINCH 1S/C23H19ClN2O3/c1-13-5-7-17(10-15(13)3)26-23(28)19(22(27)25-26)12-18-8-9-21(29-18)16-6-4-14(2)20(24)11-16/h4-12H,1-3H3,(H,25,27)/b19-12- D0D8ZN DRUGINKE GCEFTTIUEIKKPW-UNOMPAQXSA-N D0D8ZN DRUGSMIL CC1=C(C=C(C=C1)N2C(=O)C(=CC3=CC=C(O3)C4=CC(=C(C=C4)C)Cl)C(=O)N2)C D0D8ZN HIGHSTAT Investigative D0D9AA DRUG__ID D0D9AA D0D9AA DRUGTYPE Small molecular drug D0D9AA DRUGINCH 1S/C41H32N6O29S8.8Na/c48-37(44-29-5-1-25(77(53,54)55)15-33(29)81(65,66)67)19-9-20(38(49)45-30-6-2-26(78(56,57)58)16-34(30)82(68,69)70)12-23(11-19)42-41(52)43-24-13-21(39(50)46-31-7-3-27(79(59,60)61)17-35(31)83(71,72)73)10-22(14-24)40(51)47-32-8-4-28(80(62,63)64)18-36(32)84(74,75)76;;;;;;;;/h1-18H,(H,44,48)(H,45,49)(H,46,50)(H,47,51)(H2,42,43,52)(H,53,54,55)(H,56,57,58)(H,59,60,61)(H,62,63,64)(H,65,66,67)(H,68,69,70)(H,71,72,73)(H,74,75,76);;;;;;;;/q;8*+1/p-8 D0D9AA DRUGINKE KCBZSNWCUJBMHF-UHFFFAOYSA-F D0D9AA DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C2=CC(=CC(=C2)NC(=O)NC3=CC(=CC(=C3)C(=O)NC4=C(C=C(C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)NC5=C(C=C(C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)NC6=C(C=C(C=C6)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] D0D9AA HIGHSTAT Investigative D0D9AS DRUG__ID D0D9AS D0D9AS DRUGTYPE Small molecular drug D0D9AS DRUGINCH 1S/C46H66N12O9/c1-5-27(4)38(57-40(61)33(21-29-15-17-31(59)18-16-29)53-42(63)37(26(2)3)56-39(60)32(47)13-9-19-51-46(48)49)43(64)54-34(23-30-24-50-25-52-30)44(65)58-20-10-14-36(58)41(62)55-35(45(66)67)22-28-11-7-6-8-12-28/h6-8,11-12,15-18,24-27,32-38,59H,5,9-10,13-14,19-23,47H2,1-4H3,(H,50,52)(H,53,63)(H,54,64)(H,55,62)(H,56,60)(H,57,61)(H,66,67)(H4,48,49,51)/t27-,32-,33-,34-,35-,36-,37-,38-/m0/s1 D0D9AS DRUGINKE QMMRCKSBBNJCMR-KMZPNFOHSA-N D0D9AS DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)N D0D9AS HIGHSTAT Investigative D0D9BB DRUG__ID D0D9BB D0D9BB DRUGTYPE Small molecular drug D0D9BB DRUGINCH 1S/C23H24N2O/c26-23(21-13-7-8-16-24-21)14-17-25(18-15-23)22(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-13,16,22,26H,14-15,17-18H2 D0D9BB DRUGINKE RQPLUPANAPAMMF-UHFFFAOYSA-N D0D9BB DRUGSMIL C1CN(CCC1(C2=CC=CC=N2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0D9BB HIGHSTAT Investigative D0D9FA DRUG__ID D0D9FA D0D9FA DRUGTYPE Small molecular drug D0D9FA DRUGINCH 1S/C17H18INO2/c18-14-6-8-15(9-7-14)21-17(13-4-2-1-3-5-13)16-12-19-10-11-20-16/h1-9,16-17,19H,10-12H2/t16-,17+/m1/s1 D0D9FA DRUGINKE SFIZDMBLVRMOCD-SJORKVTESA-N D0D9FA DRUGSMIL C1COC(CN1)C(C2=CC=CC=C2)OC3=CC=C(C=C3)I D0D9FA HIGHSTAT Investigative D0D9FR DRUG__ID D0D9FR D0D9FR DRUGTYPE Small molecular drug D0D9FR DRUGINCH 1S/C15H12BrN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9- D0D9FR DRUGINKE MNQUPNOEJZVKRD-XFXZXTDPSA-N D0D9FR DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)Br D0D9FR HIGHSTAT Investigative D0D9GS DRUG__ID D0D9GS D0D9GS DRUGTYPE Small molecular drug D0D9GS DRUGINCH 1S/C15H18N2O2/c18-14(15-16-12-19-17-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D0D9GS DRUGINKE YLPRJWHRSWGCQQ-UHFFFAOYSA-N D0D9GS DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NOC=N2 D0D9GS HIGHSTAT Investigative D0D9JB DRUG__ID D0D9JB D0D9JB DRUGCOMP University of Texas Health Science Center San Antonio D0D9JB DRUGINCH 1S/C16H15F2N3Si.C9H9N3O2/c1-22(12-21-11-19-10-20-21,15-6-2-13(17)3-7-15)16-8-4-14(18)5-9-16;1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-11H,12H2,1H3;2-5H,1H3,(H2,10,11,12,13) D0D9JB DRUGINKE VQLYBLABXAHUDN-UHFFFAOYSA-N D0D9JB DRUGSMIL COC(=O)NC1=NC2=CC=CC=C2N1.C[Si](CN1C=NC=N1)(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D0D9JB HIGHSTAT Investigative D0D9JL DRUG__ID D0D9JL D0D9JL DRUGTYPE Small molecular drug D0D9JL DRUGINCH 1S/C13H19N/c1-12-5-4-6-13(11-12)7-10-14-8-2-3-9-14/h4-6,11H,2-3,7-10H2,1H3 D0D9JL DRUGINKE AXQOVIUHTPHFNE-UHFFFAOYSA-N D0D9JL DRUGSMIL CC1=CC(=CC=C1)CCN2CCCC2 D0D9JL HIGHSTAT Investigative D0D9LT DRUG__ID D0D9LT D0D9LT DRUGTYPE Small molecular drug D0D9LT DRUGINCH 1S/C5H10N2/c1-4-2-3-5(6)7-4/h4H,2-3H2,1H3,(H2,6,7) D0D9LT DRUGINKE DDQFWSHGBVMBEM-UHFFFAOYSA-N D0D9LT DRUGSMIL CC1CCC(=N1)N D0D9LT HIGHSTAT Investigative D0D9MW DRUG__ID D0D9MW D0D9MW DRUGTYPE Small molecular drug D0D9MW DRUGINCH 1S/C19H18N2O/c1-2-5-14-8-10-15(11-9-14)19(22)21-17-12-16-6-3-4-7-18(16)20-13-17/h3-4,6-13H,2,5H2,1H3,(H,21,22) D0D9MW DRUGINKE ACMQNRGXOSFSMZ-UHFFFAOYSA-N D0D9MW DRUGSMIL CCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D0D9MW HIGHSTAT Investigative D0D9NQ DRUG__ID D0D9NQ D0D9NQ DRUGTYPE Small molecular drug D0D9NQ DRUGINCH 1S/C17H15N3O6S2.Na/c1-10-7-11(18)5-6-15(10)20-19-12-8-14-13(17(9-12)28(24,25)26)3-2-4-16(14)27(21,22)23;/h2-9H,18H2,1H3,(H,21,22,23)(H,24,25,26);/q;+1 D0D9NQ DRUGINKE ZOQLBEREMFTVSI-UHFFFAOYSA-N D0D9NQ DRUGSMIL CC1=C(C=CC(=C1)N)N=NC2=CC3=C(C=CC=C3S(=O)(=O)O)C(=C2)S(=O)(=O)O.[Na+] D0D9NQ HIGHSTAT Investigative D0D9NT DRUG__ID D0D9NT D0D9NT DRUGTYPE Small molecular drug D0D9NT DRUGINCH 1S/C10H14O3S/c1-10(2,3)8-4-6-9(7-5-8)14(11,12)13/h4-7H,1-3H3,(H,11,12,13) D0D9NT DRUGINKE LZQMCUIWYRQLOG-UHFFFAOYSA-N D0D9NT DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)O D0D9NT HIGHSTAT Investigative D0D9NX DRUG__ID D0D9NX D0D9NX DRUGTYPE Small molecular drug D0D9NX DRUGINCH 1S/C19H18O2/c20-18(13-11-16-7-3-1-4-8-16)15-19(21)14-12-17-9-5-2-6-10-17/h1-11,13H,12,14-15H2/b13-11+ D0D9NX DRUGINKE WKUKRFYTEUQNEF-ACCUITESSA-N D0D9NX DRUGSMIL C1=CC=C(C=C1)CCC(=O)CC(=O)C=CC2=CC=CC=C2 D0D9NX HIGHSTAT Investigative D0D9OC DRUG__ID D0D9OC D0D9OC DRUGTYPE Small molecular drug D0D9OC DRUGINCH 1S/C6H6ClN5/c1-8-4-3-5(10-2-9-3)12-6(7)11-4/h2H,1H3,(H2,8,9,10,11,12) D0D9OC DRUGINKE RIAVUEFUPHOGJY-UHFFFAOYSA-N D0D9OC DRUGSMIL CNC1=NC(=NC2=C1NC=N2)Cl D0D9OC HIGHSTAT Investigative D0D9ON DRUG__ID D0D9ON D0D9ON DRUGTYPE Small molecular drug D0D9ON DRUGINCH 1S/C9H10INO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1 D0D9ON DRUGINKE PZNQZSRPDOEBMS-QMMMGPOBSA-N D0D9ON DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)I D0D9ON HIGHSTAT Investigative D0D9PD DRUG__ID D0D9PD D0D9PD DRUGTYPE Small molecular drug D0D9PD DRUGINCH 1S/C27H27Cl2N5O2/c1-33-8-10-34(11-9-33)7-5-4-6-18-12-23-20(13-25(18)35-2)27(19(16-30)17-31-23)32-24-15-26(36-3)22(29)14-21(24)28/h12-15,17H,5,7-11H2,1-3H3,(H,31,32) D0D9PD DRUGINKE ZJDFSJYCAFMEGH-UHFFFAOYSA-N D0D9PD DRUGSMIL CN1CCN(CC1)CCC#CC2=CC3=NC=C(C(=C3C=C2OC)NC4=CC(=C(C=C4Cl)Cl)OC)C#N D0D9PD HIGHSTAT Investigative D0D9PI DRUG__ID D0D9PI D0D9PI DRUGTYPE Small molecular drug D0D9PI DRUGINCH 1S/C8H18O5/c9-1-3-11-5-7-13-8-6-12-4-2-10/h9-10H,1-8H2 D0D9PI DRUGINKE UWHCKJMYHZGTIT-UHFFFAOYSA-N D0D9PI DRUGSMIL C(COCCOCCOCCO)O D0D9PI HIGHSTAT Investigative D0D9RF DRUG__ID D0D9RF D0D9RF DRUGTYPE Small molecular drug D0D9RF DRUGINCH 1S/C19H19N3O3/c1-6-12-7-8-14-13(9-12)17(23)21(5)10-15-16(20-11-22(14)15)18(24)25-19(2,3)4/h1,7-9,11H,10H2,2-5H3 D0D9RF DRUGINKE YTUMMZANIYQNOM-UHFFFAOYSA-N D0D9RF DRUGSMIL CC(C)(C)OC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)C#C)C D0D9RF HIGHSTAT Investigative D0D9RL DRUG__ID D0D9RL D0D9RL DRUGTYPE Small molecular drug D0D9RL DRUGINCH 1S/C13H18N2O/c1-13-6-7-14(2)12(13)15(3)11-5-4-9(16)8-10(11)13/h4-5,8,12,16H,6-7H2,1-3H3/t12-,13+/m1/s1 D0D9RL DRUGINKE HKGWQUVGHPDEBZ-OLZOCXBDSA-N D0D9RL DRUGSMIL CC12CCN(C1N(C3=C2C=C(C=C3)O)C)C D0D9RL HIGHSTAT Investigative D0D9RN DRUG__ID D0D9RN D0D9RN DRUGTYPE Small molecular drug D0D9RN DRUGINCH 1S/C13H13NO4/c15-9-1-2-10-11(16)8-13(18-12(10)7-9)14-3-5-17-6-4-14/h1-2,7-8,15H,3-6H2 D0D9RN DRUGINKE ULTRFFGNTUDFJW-UHFFFAOYSA-N D0D9RN DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)O D0D9RN HIGHSTAT Investigative D0D9TU DRUG__ID D0D9TU D0D9TU DRUGTYPE Small molecular drug D0D9TU DRUGINCH 1S/C21H19NO6/c23-16-6-8-19(25)14(9-16)12-22(11-13-3-1-2-4-18(13)24)15-5-7-20(26)17(10-15)21(27)28/h1-10,23-26H,11-12H2,(H,27,28) D0D9TU DRUGINKE ULTTYPMRMMDONC-UHFFFAOYSA-N D0D9TU DRUGSMIL C1=CC=C(C(=C1)CN(CC2=C(C=CC(=C2)O)O)C3=CC(=C(C=C3)O)C(=O)O)O D0D9TU HIGHSTAT Investigative D0D9YL DRUG__ID D0D9YL D0D9YL DRUGTYPE Small molecular drug D0D9YL DRUGINCH 1S/C13H12N4O2/c1-16-11-10(14-8-15-11)12(18)17(13(16)19)7-9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H,14,15) D0D9YL DRUGINKE YAYRUHPCXIPTID-UHFFFAOYSA-N D0D9YL DRUGSMIL CN1C2=C(C(=O)N(C1=O)CC3=CC=CC=C3)NC=N2 D0D9YL HIGHSTAT Investigative D0D9YU DRUG__ID D0D9YU D0D9YU DRUGTYPE Small molecular drug D0D9YU DRUGINCH 1S/C24H27NO7/c1-22(7-6-17(28)25-18-14(26)4-3-13(19(18)29)21(30)31)16(27)5-8-24-10-12-9-15(20(22)24)32-23(12,2)11-24/h3-5,8,12,15,20,26,29H,6-7,9-11H2,1-2H3,(H,25,28)(H,30,31)/t12-,15+,20+,22-,23+,24+/m1/s1 D0D9YU DRUGINKE CSOMAHTTWTVBFL-OFBLZTNGSA-N D0D9YU DRUGSMIL CC12CC34CC1CC(C3C(C(=O)C=C4)(C)CCC(=O)NC5=C(C=CC(=C5O)C(=O)O)O)O2 D0D9YU HIGHSTAT Investigative D0D9YW DRUG__ID D0D9YW D0D9YW DRUGTYPE Small molecular drug D0D9YW DRUGINCH 1S/C28H30N4O4/c1-18-16-22(27-29-19(2)36-31-27)10-12-24(18)20-6-8-21(9-7-20)28(33)30-23-11-13-25(34-5)26(17-23)35-15-14-32(3)4/h6-13,16-17H,14-15H2,1-5H3,(H,30,33) D0D9YW DRUGINKE JRNUKVFYILMMLX-UHFFFAOYSA-N D0D9YW DRUGSMIL CC1=C(C=CC(=C1)C2=NOC(=N2)C)C3=CC=C(C=C3)C(=O)NC4=CC(=C(C=C4)OC)OCCN(C)C D0D9YW HIGHSTAT Investigative D0DA1E DRUG__ID D0DA1E D0DA1E DRUGTYPE Small molecular drug D0DA1E DRUGINCH 1S/C20H19ClN2O3S/c1-3-20(24)18-12-19(14-4-6-15(21)7-5-14)23(13(18)2)16-8-10-17(11-9-16)27(22,25)26/h4-12H,3H2,1-2H3,(H2,22,25,26) D0DA1E DRUGINKE ABACVOXFUHDKNZ-UHFFFAOYSA-N D0DA1E DRUGSMIL CCC(=O)C1=C(N(C(=C1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)S(=O)(=O)N)C D0DA1E HIGHSTAT Investigative D0DA9T DRUG__ID D0DA9T D0DA9T DRUGTYPE Small molecular drug D0DA9T DRUGINCH 1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m1/s1 D0DA9T DRUGINKE JVTAAEKCZFNVCJ-UWTATZPHSA-N D0DA9T DRUGSMIL CC(C(=O)O)O D0DA9T HIGHSTAT Investigative D0DB2N DRUG__ID D0DB2N D0DB2N DRUGTYPE Small molecular drug D0DB2N DRUGINCH 1S/C19H20O7/c1-6-9-8(2)7-10-11(14(9)20)16(22)13-12(15(10)21)18(3,4)26-19(13,24)17(23)25-5/h7,20,24H,6H2,1-5H3 D0DB2N DRUGINKE YRVWWGFREKZPIN-UHFFFAOYSA-N D0DB2N DRUGSMIL CCC1=C(C2=C(C=C1C)C(=O)C3=C(C2=O)C(OC3(C)C)(C(=O)OC)O)O D0DB2N HIGHSTAT Investigative D0DB7A DRUG__ID D0DB7A D0DB7A DRUGTYPE Small molecular drug D0DB7A DRUGINCH 1S/C8H11N5/c1-5(2)13-4-12-6-7(9)10-3-11-8(6)13/h3-5H,1-2H3,(H2,9,10,11) D0DB7A DRUGINKE BCMZIPWCRGOWEV-UHFFFAOYSA-N D0DB7A DRUGSMIL CC(C)N1C=NC2=C(N=CN=C21)N D0DB7A HIGHSTAT Investigative D0DB8W DRUG__ID D0DB8W D0DB8W DRUGTYPE Small molecular drug D0DB8W DRUGINCH 1S/C32H36N4O6/c33-25(18-23-13-15-24(37)16-14-23)31(40)36-17-7-12-28(36)30(39)34-26(19-21-8-3-1-4-9-21)29(38)35-27(32(41)42)20-22-10-5-2-6-11-22/h1-6,8-11,13-16,25-28,37H,7,12,17-20,33H2,(H,34,39)(H,35,38)(H,41,42)/t25-,26-,27-,28-/m0/s1 D0DB8W DRUGINKE SDJCVHZDMZOUDX-LJWNLINESA-N D0DB8W DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)O D0DB8W HIGHSTAT Investigative D0DB9T DRUG__ID D0DB9T D0DB9T DRUGTYPE Small molecular drug D0DB9T DRUGINCH 1S/C17H18N2OS/c1-17(2,3)18-16(20)19-12-8-4-6-10-14(12)21-15-11-7-5-9-13(15)19/h4-11H,1-3H3,(H,18,20) D0DB9T DRUGINKE VEHORJYPKNVWKA-UHFFFAOYSA-N D0DB9T DRUGSMIL CC(C)(C)NC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0DB9T HIGHSTAT Investigative D0DC1P DRUG__ID D0DC1P D0DC1P DRUGTYPE Small molecular drug D0DC1P DRUGINCH 1S/C16H24FNO/c17-10-9-15-5-7-16(8-6-15)19-14-4-13-18-11-2-1-3-12-18/h5-8H,1-4,9-14H2 D0DC1P DRUGINKE CKQQSVANJMAKBB-UHFFFAOYSA-N D0DC1P DRUGSMIL C1CCN(CC1)CCCOC2=CC=C(C=C2)CCF D0DC1P HIGHSTAT Investigative D0DC3E DRUG__ID D0DC3E D0DC3E DRUGTYPE Small molecular drug D0DC3E DRUGINCH 1S/C16H12N2O2/c19-13-5-1-3-11(7-13)15-9-18-16(10-17-15)12-4-2-6-14(20)8-12/h1-10,19-20H D0DC3E DRUGINKE NBGGRQZLXLTPFA-UHFFFAOYSA-N D0DC3E DRUGSMIL C1=CC(=CC(=C1)O)C2=CN=C(C=N2)C3=CC(=CC=C3)O D0DC3E HIGHSTAT Investigative D0DC3N DRUG__ID D0DC3N D0DC3N DRUGTYPE Small molecular drug D0DC3N DRUGINCH 1S/C21H38O6P2/c1-17(2)9-7-11-19(5)13-15-21(28(22,23)24,29(25,26)27)16-14-20(6)12-8-10-18(3)4/h9-10,13-14H,7-8,11-12,15-16H2,1-6H3,(H2,22,23,24)(H2,25,26,27)/b19-13+,20-14+ D0DC3N DRUGINKE SQERRIVHBWCION-IWGRKNQJSA-N D0DC3N DRUGSMIL CC(=CCCC(=CCC(CC=C(C)CCC=C(C)C)(P(=O)(O)O)P(=O)(O)O)C)C D0DC3N HIGHSTAT Investigative D0DC4E DRUG__ID D0DC4E D0DC4E DRUGTYPE Small molecular drug D0DC4E DRUGINCH 1S/C17H13N3O3/c1-10-18-17(20-23-10)19-16(21)15-11-6-2-4-8-13(11)22-14-9-5-3-7-12(14)15/h2-9,15H,1H3,(H,19,20,21) D0DC4E DRUGINKE KXBNLKGEYKHKAO-UHFFFAOYSA-N D0DC4E DRUGSMIL CC1=NC(=NO1)NC(=O)C2C3=CC=CC=C3OC4=CC=CC=C24 D0DC4E HIGHSTAT Investigative D0DD7N DRUG__ID D0DD7N D0DD7N DRUGTYPE Small molecular drug D0DD7N DRUGINCH 1S/C20H22N8O5.H2O/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);1H2/t13-;/m0./s1 D0DD7N DRUGINKE FPJYMUQSRFJSEW-ZOWNYOTGSA-N D0DD7N DRUGSMIL CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.O D0DD7N HIGHSTAT Investigative D0DD9E DRUG__ID D0DD9E D0DD9E DRUGTYPE Small molecular drug D0DD9E DRUGINCH 1S/C9H18N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h2,7H,1,3-6,10H2,(H,14,15)(H3,11,12,13)/t7-/m0/s1 D0DD9E DRUGINKE ZPQWZDPOLXVMOU-ZETCQYMHSA-N D0DD9E DRUGSMIL C=CCNC(=NCCCC(C(=O)O)N)N D0DD9E HIGHSTAT Investigative D0DE8K DRUG__ID D0DE8K D0DE8K DRUGTYPE Small molecular drug D0DE8K DRUGINCH 1S/C17H18ClN3/c1-21-9-10(5-6-19)7-12-11-3-2-4-14-16(11)13(8-15(12)21)17(18)20-14/h2-4,10,12,15,20H,5,7-9H2,1H3/t10-,12-,15-/m1/s1 D0DE8K DRUGINKE JKAHWGPTNVUTNB-IXPVHAAZSA-N D0DE8K DRUGSMIL CN1CC(CC2C1CC3=C(NC4=CC=CC2=C34)Cl)CC#N D0DE8K HIGHSTAT Investigative D0DE9L DRUG__ID D0DE9L D0DE9L DRUGTYPE Small molecular drug D0DE9L DRUGINCH 1S/C26H24FNO/c1-2-3-6-15-28-18-21(17-25(28)20-11-7-12-22(27)16-20)26(29)24-14-8-10-19-9-4-5-13-23(19)24/h4-5,7-14,16-18H,2-3,6,15H2,1H3 D0DE9L DRUGINKE OCOICOMCAJNSCA-UHFFFAOYSA-N D0DE9L DRUGSMIL CCCCCN1C=C(C=C1C2=CC(=CC=C2)F)C(=O)C3=CC=CC4=CC=CC=C43 D0DE9L HIGHSTAT Investigative D0DF1Z DRUG__ID D0DF1Z D0DF1Z DRUGTYPE Small molecular drug D0DF1Z DRUGINCH 1S/C13H10O3/c14-13(15)10-5-4-8-12(9-10)16-11-6-2-1-3-7-11/h1-9H,(H,14,15) D0DF1Z DRUGINKE NXTDJHZGHOFSQG-UHFFFAOYSA-N D0DF1Z DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)C(=O)O D0DF1Z HIGHSTAT Investigative D0DF3Z DRUG__ID D0DF3Z D0DF3Z DRUGTYPE Small molecular drug D0DF3Z DRUGINCH 1S/C17H17N3O2/c1-11-5-4-6-12(7-11)20-17-13-8-15(21-2)16(22-3)9-14(13)18-10-19-17/h4-10H,1-3H3,(H,18,19,20) D0DF3Z DRUGINKE RSVNNWQHWIOIOC-UHFFFAOYSA-N D0DF3Z DRUGSMIL CC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OC)OC D0DF3Z HIGHSTAT Investigative D0DG5A DRUG__ID D0DG5A D0DG5A DRUGTYPE Small molecular drug D0DG5A DRUGINCH 1S/C12H18N2/c1-11(2)7-5-3-4-6-8-12-9-13-10-14-12/h9-11H,5-8H2,1-2H3,(H,13,14) D0DG5A DRUGINKE FGSZNBGTIGFMGN-UHFFFAOYSA-N D0DG5A DRUGSMIL CC(C)CCC#CCCC1=CN=CN1 D0DG5A HIGHSTAT Investigative D0DH9G DRUG__ID D0DH9G D0DH9G DRUGTYPE Small molecular drug D0DH9G DRUGINCH 1S/C11H15N.ClH/c1-2-6-10(7-3-1)11-8-4-5-9-12-11;/h1-3,6-7,11-12H,4-5,8-9H2;1H D0DH9G DRUGINKE YNQTWZUWWFUKSN-UHFFFAOYSA-N D0DH9G DRUGSMIL C1CCNC(C1)C2=CC=CC=C2.Cl D0DH9G HIGHSTAT Investigative D0DI4I DRUG__ID D0DI4I D0DI4I DRUGTYPE Small molecular drug D0DI4I DRUGINCH 1S/C19H20N2O5/c20-16(19(24)25)10-11-18(23)21-14-6-8-15(9-7-14)26-12-17(22)13-4-2-1-3-5-13/h1-9,16H,10-12,20H2,(H,21,23)(H,24,25)/t16-/m0/s1 D0DI4I DRUGINKE JXSYVANIFASLIX-INIZCTEOSA-N D0DI4I DRUGSMIL C1=CC=C(C=C1)C(=O)COC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D0DI4I HIGHSTAT Investigative D0DI7W DRUG__ID D0DI7W D0DI7W DRUGTYPE Small molecular drug D0DI7W DRUGINCH 1S/C6H10N2/c1-5-2-3-8-6(7)4-5/h4H,2-3H2,1H3,(H2,7,8) D0DI7W DRUGINKE SRTDZDDEFUNXJL-UHFFFAOYSA-N D0DI7W DRUGSMIL CC1=CC(=NCC1)N D0DI7W HIGHSTAT Investigative D0DJ3R DRUG__ID D0DJ3R D0DJ3R DRUGTYPE Small molecular drug D0DJ3R DRUGINCH 1S/C13H10N2O2/c16-12-3-6-17-13-7-10(1-2-11(12)13)8-15-5-4-14-9-15/h1-7,9H,8H2 D0DJ3R DRUGINKE KLOFOSXNENLIKT-UHFFFAOYSA-N D0DJ3R DRUGSMIL C1=CC2=C(C=C1CN3C=CN=C3)OC=CC2=O D0DJ3R HIGHSTAT Investigative D0DJ6G DRUG__ID D0DJ6G D0DJ6G DRUGTYPE Small molecular drug D0DJ6G DRUGINCH 1S/C21H21NO2/c1-2-3-5-15-8-10-17(11-9-15)21(24)22-20-7-4-6-16-12-13-18(23)14-19(16)20/h4,6-14,23H,2-3,5H2,1H3,(H,22,24) D0DJ6G DRUGINKE KSWNGABTIMONPN-UHFFFAOYSA-N D0DJ6G DRUGSMIL CCCCC1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C=C(C=C3)O D0DJ6G HIGHSTAT Investigative D0DK9S DRUG__ID D0DK9S D0DK9S DRUGTYPE Small molecular drug D0DK9S DRUGINCH 1S/C17H17NO4/c1-2-3-8-21-16-9-11(4-7-14(16)20)17-18-13-6-5-12(19)10-15(13)22-17/h4-7,9-10,19-20H,2-3,8H2,1H3 D0DK9S DRUGINKE BJVMSZRSXULFSB-UHFFFAOYSA-N D0DK9S DRUGSMIL CCCCOC1=C(C=CC(=C1)C2=NC3=C(O2)C=C(C=C3)O)O D0DK9S HIGHSTAT Investigative D0DL1F DRUG__ID D0DL1F D0DL1F DRUGTYPE Small molecular drug D0DL1F DRUGINCH 1S/C6H17NO6P2/c1-6(2,3)7-4-5(14(8,9)10)15(11,12)13/h5,7H,4H2,1-3H3,(H2,8,9,10)(H2,11,12,13) D0DL1F DRUGINKE XGRIOZQTBVXIFW-UHFFFAOYSA-N D0DL1F DRUGSMIL CC(C)(C)NCC(P(=O)(O)O)P(=O)(O)O D0DL1F HIGHSTAT Investigative D0DL4Y DRUG__ID D0DL4Y D0DL4Y DRUGTYPE Small molecular drug D0DL4Y DRUGINCH 1S/C20H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21/h6-7,9-10,12-13,15-16,20H,2-5,8,11,14,17-19H2,1H3/b7-6+,10-9+,13-12+,16-15+ D0DL4Y DRUGINKE XTZSIVLWZNRBAB-CGRWFSSPSA-N D0DL4Y DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC=O D0DL4Y HIGHSTAT Investigative D0DL6J DRUG__ID D0DL6J D0DL6J DRUGTYPE Small molecular drug D0DL6J DRUGINCH 1S/C23H19N5O2/c24-17-11-15-8-10-28-20(15)18(12-17)19(14-5-2-1-3-6-14)26-21(23(28)30)27-22(29)16-7-4-9-25-13-16/h1-7,9,11-13,21H,8,10,24H2,(H,27,29)/t21-/m0/s1 D0DL6J DRUGINKE XGXOSJSGDNPEEF-NRFANRHFSA-N D0DL6J DRUGSMIL C1CN2C(=O)C(N=C(C3=CC(=CC1=C32)N)C4=CC=CC=C4)NC(=O)C5=CN=CC=C5 D0DL6J HIGHSTAT Investigative D0DM5S DRUG__ID D0DM5S D0DM5S DRUGTYPE Small molecular drug D0DM5S DRUGINCH 1S/C19H26ClN7O/c1-10(2)15(8-28)24-19-25-17(23-14-6-12(20)5-13(21)7-14)16-18(26-19)27(9-22-16)11(3)4/h5-7,9-11,15,28H,8,21H2,1-4H3,(H2,23,24,25,26) D0DM5S DRUGINKE RAMROQQYRRQPDL-UHFFFAOYSA-N D0DM5S DRUGSMIL CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC(=C3)N)Cl D0DM5S HIGHSTAT Investigative D0DM6F DRUG__ID D0DM6F D0DM6F DRUGTYPE Small molecular drug D0DM6F DRUGINCH 1S/C26H25N5O2/c27-12-19-5-4-17-10-25(19)33-21-7-6-18-2-1-3-24(22(18)11-21)31-9-8-23(26(31)32)29-14-20-13-28-16-30(20)15-17/h4-7,10-11,13,16,23-24,29H,1-3,8-9,14-15H2/t23-,24-/m1/s1 D0DM6F DRUGINKE VWNBOOIWICWEPL-DNQXCXABSA-N D0DM6F DRUGSMIL C1CC2C3=C(C1)C=CC(=C3)OC4=C(C=CC(=C4)CN5C=NC=C5CNC6CCN2C6=O)C#N D0DM6F HIGHSTAT Investigative D0DN6A DRUG__ID D0DN6A D0DN6A DRUGTYPE Small molecular drug D0DN6A DRUGINCH 1S/C46H56N6O6/c1-27-17-35(53)18-28(2)37(27)23-39(47)45(57)51-25-33-13-7-5-11-31(33)21-41(51)43(55)49-15-9-10-16-50-44(56)42-22-32-12-6-8-14-34(32)26-52(42)46(58)40(48)24-38-29(3)19-36(54)20-30(38)4/h5-8,11-14,17-20,39-42,53-54H,9-10,15-16,21-26,47-48H2,1-4H3,(H,49,55)(H,50,56)/t39-,40-,41?,42?/m0/s1 D0DN6A DRUGINKE JSRJJBASKHLXAZ-YZNAZWRISA-N D0DN6A DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCNC(=O)C4CC5=CC=CC=C5CN4C(=O)C(CC6=C(C=C(C=C6C)O)C)N)N)C)O D0DN6A HIGHSTAT Investigative D0DO1T DRUG__ID D0DO1T D0DO1T DRUGTYPE Small molecular drug D0DO1T DRUGINCH 1S/C20H15ClN2O/c21-16-5-3-15(4-6-16)18-13-23-11-1-2-19(23)20(24)17(18)12-14-7-9-22-10-8-14/h1-12,18H,13H2/b17-12- D0DO1T DRUGINKE OMGJLQMHGRFTAP-ATVHPVEESA-N D0DO1T DRUGSMIL C1C(C(=CC2=CC=NC=C2)C(=O)C3=CC=CN31)C4=CC=C(C=C4)Cl D0DO1T HIGHSTAT Investigative D0DO6P DRUG__ID D0DO6P D0DO6P DRUGTYPE Small molecular drug D0DO6P DRUGINCH 1S/C19H27NO2/c1-13-18-10-14-5-6-15(21)11-17(14)19(13,2)7-8-20(18)12-16-4-3-9-22-16/h5-6,11,13,16,18,21H,3-4,7-10,12H2,1-2H3/t13?,16-,18-,19-/m1/s1 D0DO6P DRUGINKE NLKLXMMOJZHSCB-SENCRUMESA-N D0DO6P DRUGSMIL CC1C2CC3=C(C1(CCN2CC4CCCO4)C)C=C(C=C3)O D0DO6P HIGHSTAT Investigative D0DO9W DRUG__ID D0DO9W D0DO9W DRUGTYPE Small molecular drug D0DO9W DRUGINCH 1S/C9H12N2O2/c10-8(9(11)13)5-6-1-3-7(12)4-2-6/h1-4,8,12H,5,10H2,(H2,11,13)/t8-/m0/s1 D0DO9W DRUGINKE PQFMNVGMJJMLAE-QMMMGPOBSA-N D0DO9W DRUGSMIL C1=CC(=CC=C1CC(C(=O)N)N)O D0DO9W HIGHSTAT Investigative D0DP8I DRUG__ID D0DP8I D0DP8I DRUGTYPE Small molecular drug D0DP8I DRUGINCH 1S/C23H27N5O4/c1-30-19-12-14-15(13-20(19)31-2)25-23(26-21(14)24)28-10-9-27(16-6-3-4-7-17(16)28)22(29)18-8-5-11-32-18/h5,8,11-13,16-17H,3-4,6-7,9-10H2,1-2H3,(H2,24,25,26)/t16-,17+/m0/s1 D0DP8I DRUGINKE XBRXTUGRUXGBPX-DLBZAZTESA-N D0DP8I DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(C4C3CCCC4)C(=O)C5=CC=CO5)N)OC D0DP8I HIGHSTAT Investigative D0DP9F DRUG__ID D0DP9F D0DP9F DRUGTYPE Small molecular drug D0DP9F DRUGINCH 1S/C15H11NO2/c17-15(16-18)12-7-8-14-11(9-12)6-5-10-3-1-2-4-13(10)14/h1-9,18H,(H,16,17) D0DP9F DRUGINKE ADTGPCGDULHFEP-UHFFFAOYSA-N D0DP9F DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C(=O)NO D0DP9F HIGHSTAT Investigative D0DQ2G DRUG__ID D0DQ2G D0DQ2G DRUGTYPE Small molecular drug D0DQ2G DRUGINCH 1S/C10H14O2/c1-10(2,3)8-6-7(11)4-5-9(8)12/h4-6,11-12H,1-3H3 D0DQ2G DRUGINKE BGNXCDMCOKJUMV-UHFFFAOYSA-N D0DQ2G DRUGSMIL CC(C)(C)C1=C(C=CC(=C1)O)O D0DQ2G HIGHSTAT Investigative D0DQ3F DRUG__ID D0DQ3F D0DQ3F DRUGTYPE Small molecular drug D0DQ3F DRUGINCH 1S/C28H29NO/c1-3-5-10-18-29-20-23(19-27(29)25-16-9-6-12-21(25)4-2)28(30)26-17-11-14-22-13-7-8-15-24(22)26/h6-9,11-17,19-20H,3-5,10,18H2,1-2H3 D0DQ3F DRUGINKE SNWJCZXZSGPAJM-UHFFFAOYSA-N D0DQ3F DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2CC)C(=O)C3=CC=CC4=CC=CC=C43 D0DQ3F HIGHSTAT Investigative D0DQ4D DRUG__ID D0DQ4D D0DQ4D DRUGTYPE Small molecular drug D0DQ4D DRUGINCH 1S/C8H15NO/c1-7-4-3-5-9(6-7)8(2)10/h7H,3-6H2,1-2H3/t7-/m1/s1 D0DQ4D DRUGINKE XKFPNHDGLSYZRC-SSDOTTSWSA-N D0DQ4D DRUGSMIL CC1CCCN(C1)C(=O)C D0DQ4D HIGHSTAT Investigative D0DQ6Z DRUG__ID D0DQ6Z D0DQ6Z DRUGTYPE Small molecular drug D0DQ6Z DRUGINCH 1S/C10H6O2/c11-9-5-6-10(12)8-4-2-1-3-7(8)9/h1-6H D0DQ6Z DRUGINKE FRASJONUBLZVQX-UHFFFAOYSA-N D0DQ6Z DRUGSMIL C1=CC=C2C(=O)C=CC(=O)C2=C1 D0DQ6Z HIGHSTAT Investigative D0DR7A DRUG__ID D0DR7A D0DR7A DRUGTYPE Small molecular drug D0DR7A DRUGINCH 1S/C20H16N2OS/c1-14-10-12-15(13-11-14)21-20(23)22-16-6-2-4-8-18(16)24-19-9-5-3-7-17(19)22/h2-13H,1H3,(H,21,23) D0DR7A DRUGINKE AGRMZLFVKVZKOP-UHFFFAOYSA-N D0DR7A DRUGSMIL CC1=CC=C(C=C1)NC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0DR7A HIGHSTAT Investigative D0DR8N DRUG__ID D0DR8N D0DR8N DRUGTYPE Small molecular drug D0DR8N DRUGINCH 1S/C15H10BrN3O/c16-8-3-4-11-9(6-8)10-7-13(20)18-12-2-1-5-17-15(12)14(10)19-11/h1-6,19H,7H2,(H,18,20) D0DR8N DRUGINKE NTSBZVCEIVPKBJ-UHFFFAOYSA-N D0DR8N DRUGSMIL C1C2=C(C3=C(C=CC=N3)NC1=O)NC4=C2C=C(C=C4)Br D0DR8N HIGHSTAT Investigative D0DS0O DRUG__ID D0DS0O D0DS0O DRUGTYPE Small molecular drug D0DS0O DRUGINCH 1S/C17H14O5/c1-19-14-6-10(20-8-11-9-21-11)7-15-16(14)17(18)12-4-2-3-5-13(12)22-15/h2-7,11H,8-9H2,1H3 D0DS0O DRUGINKE DTYOZZZAYPACPN-UHFFFAOYSA-N D0DS0O DRUGSMIL COC1=CC(=CC2=C1C(=O)C3=CC=CC=C3O2)OCC4CO4 D0DS0O HIGHSTAT Investigative D0DS7F DRUG__ID D0DS7F D0DS7F DRUGTYPE Small molecular drug D0DS7F DRUGINCH 1S/C10H15NS/c11-10(8-12)7-6-9-4-2-1-3-5-9/h1-5,10,12H,6-8,11H2/t10-/m0/s1 D0DS7F DRUGINKE OMEJZTIVCZZOPI-JTQLQIEISA-N D0DS7F DRUGSMIL C1=CC=C(C=C1)CCC(CS)N D0DS7F HIGHSTAT Investigative D0DS7W DRUG__ID D0DS7W D0DS7W DRUGTYPE Small molecular drug D0DS7W DRUGINCH 1S/C16H18ClN3O2S/c1-13-4-6-14(7-5-13)23(21,22)20-11-9-19(10-12-20)16-15(17)3-2-8-18-16/h2-8H,9-12H2,1H3 D0DS7W DRUGINKE DAJKQJMXMSAPCV-UHFFFAOYSA-N D0DS7W DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl D0DS7W HIGHSTAT Investigative D0DT4R DRUG__ID D0DT4R D0DT4R DRUGTYPE Small molecular drug D0DT4R DRUGINCH 1S/C20H25BrN4O6/c1-30-14-8-11(7-13-10-24-20(23)25-18(13)22)9-15(17(14)21)31-6-2-3-12(19(28)29)4-5-16(26)27/h8-10,12H,2-7H2,1H3,(H,26,27)(H,28,29)(H4,22,23,24,25)/p-1/t12-/m0/s1 D0DT4R DRUGINKE SZAVCZNFKJSWRN-LBPRGKRZSA-M D0DT4R DRUGSMIL COC1=C(C(=CC(=C1)CC2=C[NH+]=C(N=C2N)N)OCCCC(CCC(=O)[O-])C(=O)[O-])Br D0DT4R HIGHSTAT Investigative D0DT5K DRUG__ID D0DT5K D0DT5K DRUGTYPE Small molecular drug D0DT5K DRUGINCH 1S/C13H13N3OS/c1-17-12-7-6-9-4-2-3-5-10(9)11(12)8-15-16-13(14)18/h2-8H,1H3,(H3,14,16,18)/b15-8+ D0DT5K DRUGINKE DXTYDDVJOBCCHE-OVCLIPMQSA-N D0DT5K DRUGSMIL COC1=C(C2=CC=CC=C2C=C1)C=NNC(=S)N D0DT5K HIGHSTAT Investigative D0DU3J DRUG__ID D0DU3J D0DU3J DRUGTYPE Small molecular drug D0DU3J DRUGINCH 1S/C21H22O5/c1-12(2)4-5-13-8-14(9-20(25-3)21(13)24)18-11-17(23)16-7-6-15(22)10-19(16)26-18/h4,6-10,18,22,24H,5,11H2,1-3H3/t18-/m0/s1 D0DU3J DRUGINKE GZTDFKLABHOHBU-SFHVURJKSA-N D0DU3J DRUGSMIL CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(O2)C=C(C=C3)O)OC)O)C D0DU3J HIGHSTAT Investigative D0DU4B DRUG__ID D0DU4B D0DU4B DRUGTYPE Small molecular drug D0DU4B DRUGINCH 1S/C4H9N3S/c1-2-3-6-7-4(5)8/h3H,2H2,1H3,(H3,5,7,8)/b6-3- D0DU4B DRUGINKE SREKQYKLPZJBJG-UTCJRWHESA-N D0DU4B DRUGSMIL CCC=NNC(=S)N D0DU4B HIGHSTAT Investigative D0DU5S DRUG__ID D0DU5S D0DU5S DRUGTYPE Small molecular drug D0DU5S DRUGINCH 1S/C52H76N5O2P/c1-4-7-35-60(36-8-5-2,37-9-6-3)40-42-29-32-47(33-30-42)53-50(58)49-38-43-23-19-20-24-44(43)39-57(49)51(59)48(34-31-41-21-13-10-14-22-41)56-52(54-45-25-15-11-16-26-45)55-46-27-17-12-18-28-46/h10,13-14,19-24,29-30,32-33,45-46,48-49H,4-9,11-12,15-18,25-28,31,34-40H2,1-3H3,(H2-,53,54,55,56,58)/p+2/t48-,49?/m0/s1 D0DU5S DRUGINKE NILAWIULNZSYHS-GIIAILMYSA-P D0DU5S DRUGSMIL CCCC[P+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)C2CC3=CC=CC=C3CN2C(=O)C(CCC4=CC=CC=C4)NC(=[NH+]C5CCCCC5)NC6CCCCC6 D0DU5S HIGHSTAT Investigative D0DV9Z DRUG__ID D0DV9Z D0DV9Z DRUGTYPE Small molecular drug D0DV9Z DRUGINCH 1S/C14H15N2O/c1-15-7-6-11-12-8-10(17-3)4-5-13(12)16(2)14(11)9-15/h4-9H,1-3H3/q+1 D0DV9Z DRUGINKE DSZQQMUYRCNRKS-UHFFFAOYSA-N D0DV9Z DRUGSMIL CN1C2=C(C=C(C=C2)OC)C3=C1C=[N+](C=C3)C D0DV9Z HIGHSTAT Investigative D0DW2F DRUG__ID D0DW2F D0DW2F DRUGTYPE Small molecular drug D0DW2F DRUGINCH 1S/C9H11FIN2O9P/c10-3-6(11)13(9(17)12-7(3)16)8-5(15)4(14)2(22-8)1-21-23(18,19)20/h2,4-5,8,14-15H,1H2,(H,12,16,17)(H2,18,19,20)/t2-,4-,5-,8-/m1/s1 D0DW2F DRUGINKE NJSVPTGGTXIMLP-UMMCILCDSA-N D0DW2F DRUGSMIL C(C1C(C(C(O1)N2C(=C(C(=O)NC2=O)F)I)O)O)OP(=O)(O)O D0DW2F HIGHSTAT Investigative D0DW4J DRUG__ID D0DW4J D0DW4J DRUGTYPE Small molecular drug D0DW4J DRUGINCH 1S/C13H8O4/c14-13(15)8-5-6-11-12(7-8)17-10-4-2-1-3-9(10)16-11/h1-7H,(H,14,15) D0DW4J DRUGINKE MCNODAPWJQPAIE-UHFFFAOYSA-N D0DW4J DRUGSMIL C1=CC=C2C(=C1)OC3=C(O2)C=C(C=C3)C(=O)O D0DW4J HIGHSTAT Investigative D0DW9J DRUG__ID D0DW9J D0DW9J DRUGTYPE Small molecular drug D0DW9J DRUGINCH 1S/C14H8F2O2/c15-11-5-1-9(2-6-11)13(17)14(18)10-3-7-12(16)8-4-10/h1-8H D0DW9J DRUGINKE BRKULQOUSCHDGS-UHFFFAOYSA-N D0DW9J DRUGSMIL C1=CC(=CC=C1C(=O)C(=O)C2=CC=C(C=C2)F)F D0DW9J HIGHSTAT Investigative D0DX0R DRUG__ID D0DX0R D0DX0R DRUGTYPE Small molecular drug D0DX0R DRUGINCH 1S/C18H19NO3/c1-21-17-12-7-8-19-13-9-10-5-3-4-6-11(10)15(14(12)13)16(20)18(17)22-2/h3-6,13,19-20H,7-9H2,1-2H3/t13-/m1/s1 D0DX0R DRUGINKE XLXSXOHBVGWKMT-CYBMUJFWSA-N D0DX0R DRUGSMIL COC1=C(C(=C2C3=CC=CC=C3CC4C2=C1CCN4)O)OC D0DX0R HIGHSTAT Investigative D0DX3V DRUG__ID D0DX3V D0DX3V DRUGTYPE Small molecular drug D0DX3V DRUGINCH 1S/C12H11N3O2/c1-2-17-8-3-4-9-7(5-8)6-10-11(13-9)15-12(16)14-10/h3-6H,2H2,1H3,(H2,13,14,15,16) D0DX3V DRUGINKE SBMFEGWRZYIWGG-UHFFFAOYSA-N D0DX3V DRUGSMIL CCOC1=CC2=CC3=C(NC(=O)N3)N=C2C=C1 D0DX3V HIGHSTAT Investigative D0DX6U DRUG__ID D0DX6U D0DX6U DRUGTYPE Small molecular drug D0DX6U DRUGINCH 1S/C19H23ClN4O/c1-3-16-6-4-5-9-24(16)19(25)14-10-17(20)18(22-11-14)23-15-8-7-13(2)21-12-15/h7-8,10-12,16H,3-6,9H2,1-2H3,(H,22,23)/t16-/m1/s1 D0DX6U DRUGINKE QABUURICQJOWID-MRXNPFEDSA-N D0DX6U DRUGSMIL CCC1CCCCN1C(=O)C2=CC(=C(N=C2)NC3=CN=C(C=C3)C)Cl D0DX6U HIGHSTAT Investigative D0DX8A DRUG__ID D0DX8A D0DX8A DRUGTYPE Small molecular drug D0DX8A DRUGINCH 1S/C7H9ClN2O2/c1-2-3-4-5(8)9-7(12)10-6(4)11/h2-3H2,1H3,(H2,9,10,11,12) D0DX8A DRUGINKE DTSULQDNDBSJQV-UHFFFAOYSA-N D0DX8A DRUGSMIL CCCC1=C(NC(=O)NC1=O)Cl D0DX8A HIGHSTAT Investigative D0DX8T DRUG__ID D0DX8T D0DX8T DRUGTYPE Small molecular drug D0DX8T DRUGINCH 1S/C17H18N2O2/c1-12(2)14-5-3-13(4-6-14)11-18-19-17(21)15-7-9-16(20)10-8-15/h3-12,20H,1-2H3,(H,19,21)/b18-11+ D0DX8T DRUGINKE IKPPIUNQWSRCOZ-WOJGMQOQSA-N D0DX8T DRUGSMIL CC(C)C1=CC=C(C=C1)C=NNC(=O)C2=CC=C(C=C2)O D0DX8T HIGHSTAT Investigative D0DY1C DRUG__ID D0DY1C D0DY1C DRUGTYPE Small molecular drug D0DY1C DRUGINCH 1S/C11H19NO3S/c13-10-8(7-16)5-3-1-2-4-6-9(12-10)11(14)15/h8-9,16H,1-7H2,(H,12,13)(H,14,15) D0DY1C DRUGINKE MWNHNWDDMZYRSH-UHFFFAOYSA-N D0DY1C DRUGSMIL C1CCCC(NC(=O)C(CC1)CS)C(=O)O D0DY1C HIGHSTAT Investigative D0DY4E DRUG__ID D0DY4E D0DY4E DRUGTYPE Small molecular drug D0DY4E DRUGINCH 1S/C17H15F6N5O/c18-16(19,20)11-3-4-13(25-10-11)26-15(29)28-8-6-27(7-9-28)14-12(17(21,22)23)2-1-5-24-14/h1-5,10H,6-9H2,(H,25,26,29) D0DY4E DRUGINKE JFRYYGVYCWYIDQ-UHFFFAOYSA-N D0DY4E DRUGSMIL C1CN(CCN1C2=C(C=CC=N2)C(F)(F)F)C(=O)NC3=NC=C(C=C3)C(F)(F)F D0DY4E HIGHSTAT Investigative D0DY5G DRUG__ID D0DY5G D0DY5G DRUGTYPE Small molecular drug D0DY5G DRUGINCH 1S/C16H14F3N3OS/c1-24-14-7-10-4-6-22(13(10)8-12(14)16(17,18)19)15(23)21-11-3-2-5-20-9-11/h2-3,5,7-9H,4,6H2,1H3,(H,21,23) D0DY5G DRUGINKE OQZOXHCRSXYSPM-UHFFFAOYSA-N D0DY5G DRUGSMIL CSC1=C(C=C2C(=C1)CCN2C(=O)NC3=CN=CC=C3)C(F)(F)F D0DY5G HIGHSTAT Investigative D0DY9U DRUG__ID D0DY9U D0DY9U DRUGTYPE Small molecular drug D0DY9U DRUGINCH 1S/C9H12N2O3S2/c10-16(13,14)8-3-1-7(2-4-8)11-9(12)5-6-15/h1-4,15H,5-6H2,(H,11,12)(H2,10,13,14) D0DY9U DRUGINKE QGPJKQACZFKJBW-UHFFFAOYSA-N D0DY9U DRUGSMIL C1=CC(=CC=C1NC(=O)CCS)S(=O)(=O)N D0DY9U HIGHSTAT Investigative D0DZ1K DRUG__ID D0DZ1K D0DZ1K DRUGTYPE Small molecular drug D0DZ1K DRUGINCH 1S/C21H13FN2O7S.Na/c22-9-5-6-13(12(7-9)21(27)28)24-14-8-15(32(29,30)31)18(23)17-16(14)19(25)10-3-1-2-4-11(10)20(17)26;/h1-8,24H,23H2,(H,27,28)(H,29,30,31);/q;+1/p-1 D0DZ1K DRUGINKE MRYMOKKNOJHNGA-UHFFFAOYSA-M D0DZ1K DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=C(C=C(C=C4)F)C(=O)O)S(=O)(=O)[O-])N.[Na+] D0DZ1K HIGHSTAT Investigative D0E0AA DRUG__ID D0E0AA D0E0AA DRUGTYPE Small molecular drug D0E0AA DRUGINCH 1S/C24H22Cl2N2O3/c1-24(2)12-20(27-21(30)13-29)18-11-17(14-7-9-15(25)10-8-14)22(28-23(18)31-24)16-5-3-4-6-19(16)26/h3-11,20,29H,12-13H2,1-2H3,(H,27,30) D0E0AA DRUGINKE XFJREZUFRMFGKX-UHFFFAOYSA-N D0E0AA DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl)NC(=O)CO)C D0E0AA HIGHSTAT Investigative D0E0BU DRUG__ID D0E0BU D0E0BU DRUGTYPE Small molecular drug D0E0BU DRUGINCH 1S/C11H8N2O5/c14-9(11(17)18)13-8-4-7-5(1-2-12-7)3-6(8)10(15)16/h1-4,12H,(H,13,14)(H,15,16)(H,17,18) D0E0BU DRUGINKE AHWMERGBWWROMM-UHFFFAOYSA-N D0E0BU DRUGSMIL C1=CNC2=CC(=C(C=C21)C(=O)O)NC(=O)C(=O)O D0E0BU HIGHSTAT Investigative D0E0CV DRUG__ID D0E0CV D0E0CV DRUGTYPE Small molecular drug D0E0CV DRUGINCH 1S/C23H22N4O8/c24-23-26-16-6-1-11(10-15(16)20(31)27-23)9-14(21(32)33)12-2-4-13(5-3-12)19(30)25-17(22(34)35)7-8-18(28)29/h1-6,10,14,17H,7-9H2,(H,25,30)(H,28,29)(H,32,33)(H,34,35)(H3,24,26,27,31)/t14-,17+/m1/s1 D0E0CV DRUGINKE DAOQLLQRJAXMGY-PBHICJAKSA-N D0E0CV DRUGSMIL C1=CC(=CC=C1C(CC2=CC3=C(C=C2)N=C(NC3=O)N)C(=O)O)C(=O)NC(CCC(=O)O)C(=O)O D0E0CV HIGHSTAT Investigative D0E0DQ DRUG__ID D0E0DQ D0E0DQ DRUGTYPE Small molecular drug D0E0DQ DRUGINCH 1S/C18H18N4O2/c1-21(2)8-7-19-13-4-5-14-17-16(13)18(24)12-9-11(23)3-6-15(12)22(17)10-20-14/h3-6,9-10,19,23H,7-8H2,1-2H3 D0E0DQ DRUGINKE QKYXFJYABODRFA-UHFFFAOYSA-N D0E0DQ DRUGSMIL CN(C)CCNC1=C2C3=C(C=C1)N=CN3C4=C(C2=O)C=C(C=C4)O D0E0DQ HIGHSTAT Investigative D0E0DR DRUG__ID D0E0DR D0E0DR DRUGTYPE Small molecular drug D0E0DR DRUGINCH 1S/C14H16N2O2S/c15-10-9-12-5-4-6-13(11-12)16-19(17,18)14-7-2-1-3-8-14/h1-8,11,16H,9-10,15H2 D0E0DR DRUGINKE SMDOJINITBXUQJ-UHFFFAOYSA-N D0E0DR DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)CCN D0E0DR HIGHSTAT Investigative D0E0DY DRUG__ID D0E0DY D0E0DY DRUGTYPE Small molecular drug D0E0DY DRUGINCH 1S/C10H23O4P/c1-2-3-4-5-6-7-8-9-10-14-15(11,12)13/h2-10H2,1H3,(H2,11,12,13) D0E0DY DRUGINKE SCIGVHCNNXTQDB-UHFFFAOYSA-N D0E0DY DRUGSMIL CCCCCCCCCCOP(=O)(O)O D0E0DY HIGHSTAT Investigative D0E0EQ DRUG__ID D0E0EQ D0E0EQ DRUGTYPE Small molecular drug D0E0EQ DRUGINCH 1S/C13H14O3/c1-5-13(2,3)16-12(14)10-6-8-11(15-4)9-7-10/h1,6-9H,2-4H3 D0E0EQ DRUGINKE WRGOVRZCLGHFFF-UHFFFAOYSA-N D0E0EQ DRUGSMIL CC(C)(C#C)OC(=O)C1=CC=C(C=C1)OC D0E0EQ HIGHSTAT Investigative D0E0HK DRUG__ID D0E0HK D0E0HK DRUGTYPE Small molecular drug D0E0HK DRUGINCH 1S/C6H10O4S/c7-5(8)2-1-4(3-11)6(9)10/h4,11H,1-3H2,(H,7,8)(H,9,10) D0E0HK DRUGINKE LDFDXRPEWZHIML-UHFFFAOYSA-N D0E0HK DRUGSMIL C(CC(=O)O)C(CS)C(=O)O D0E0HK HIGHSTAT Investigative D0E0HT DRUG__ID D0E0HT D0E0HT DRUGTYPE Small molecular drug D0E0HT DRUGINCH 1S/C11H11ClO3/c1-2-3-8-6-9(12)4-5-10(8)15-7-11(13)14/h2,4-6H,1,3,7H2,(H,13,14) D0E0HT DRUGINKE SUGLMNNOLUZPQE-UHFFFAOYSA-N D0E0HT DRUGSMIL C=CCC1=C(C=CC(=C1)Cl)OCC(=O)O D0E0HT HIGHSTAT Investigative D0E0JC DRUG__ID D0E0JC D0E0JC DRUGTYPE Small molecular drug D0E0JC DRUGINCH 1S/C22H23NO2/c24-20(16-10-2-1-5-11-18-12-6-3-7-13-18)22-23-17-21(25-22)19-14-8-4-9-15-19/h3-4,6-9,12-15,17H,1-2,5,10-11,16H2 D0E0JC DRUGINKE GEHXWVPLQWJJQM-UHFFFAOYSA-N D0E0JC DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=C(O2)C3=CC=CC=C3 D0E0JC HIGHSTAT Investigative D0E0JN DRUG__ID D0E0JN D0E0JN DRUGTYPE Small molecular drug D0E0JN DRUGINCH 1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29-/m0/s1 D0E0JN DRUGINKE YVPXVXANRNDGTA-VMPREFPWSA-N D0E0JN DRUGSMIL CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3 D0E0JN HIGHSTAT Investigative D0E0JU DRUG__ID D0E0JU D0E0JU DRUGTYPE Small molecular drug D0E0JU DRUGINCH 1S/C23H38O/c1-4-5-6-7-8-9-17-23(2,3)21-15-13-19(14-16-21)20-11-10-12-22(24)18-20/h13-16,20,22,24H,4-12,17-18H2,1-3H3/t20-,22+/m0/s1 D0E0JU DRUGINKE DQKOXMDLNBLQTB-RBBKRZOGSA-N D0E0JU DRUGSMIL CCCCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0E0JU HIGHSTAT Investigative D0E0KG DRUG__ID D0E0KG D0E0KG DRUGTYPE Small molecular drug D0E0KG DRUGINCH 1S/C10H13N/c1-8-6-9-4-2-3-5-10(9)7-11-8/h2-5,8,11H,6-7H2,1H3/t8-/m1/s1 D0E0KG DRUGINKE UEKQPSAKUNXFHL-MRVPVSSYSA-N D0E0KG DRUGSMIL CC1CC2=CC=CC=C2CN1 D0E0KG HIGHSTAT Investigative D0E0LI DRUG__ID D0E0LI D0E0LI DRUGTYPE Small molecular drug D0E0LI DRUGINCH 1S/C20H26N10O13P2/c21-15-9-17(25-3-23-15)29(5-27-9)19-12(33)11(32)8(41-19)2-39-44(35,36)43-45(37,38)42-14-7(1-31)40-20(13(14)34)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20+/m1/s1 D0E0LI DRUGINKE FHISWBUCBBVWGG-SNESVTBZSA-N D0E0LI DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OC4C(OC(C4O)N5C=NC6=C(N=CN=C65)N)CO)O)O)N D0E0LI HIGHSTAT Investigative D0E0LL DRUG__ID D0E0LL D0E0LL DRUGTYPE Small molecular drug D0E0LL DRUGINCH 1S/C29H46O2/c1-7-20(18(2)3)16-27(31)19(4)24-10-11-25-23-9-8-21-17-22(30)12-14-28(21,5)26(23)13-15-29(24,25)6/h13,17-20,23-25,27,31H,7-12,14-16H2,1-6H3/t19-,20+,23?,24+,25?,27+,28-,29+/m0/s1 D0E0LL DRUGINKE AHQRPBWVJHINRW-XHVUHYHXSA-N D0E0LL DRUGSMIL CCC(CC(C(C)C1CCC2C1(CC=C3C2CCC4=CC(=O)CCC43C)C)O)C(C)C D0E0LL HIGHSTAT Investigative D0E0OF DRUG__ID D0E0OF D0E0OF DRUGTYPE Small molecular drug D0E0OF DRUGINCH 1S/C26H36O8/c1-24(2,3)33-14-32-18-11-17(22(28)30-6)25(4)9-7-16-23(29)34-19(15-8-10-31-13-15)12-26(16,5)21(25)20(18)27/h8,10,13,16-19,21H,7,9,11-12,14H2,1-6H3/t16-,17-,18-,19-,21-,25-,26-/m0/s1 D0E0OF DRUGINKE CWFMTHRKTLKOGU-PEVIRZATSA-N D0E0OF DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOC(C)(C)C)C)C4=COC=C4 D0E0OF HIGHSTAT Investigative D0E0OJ DRUG__ID D0E0OJ D0E0OJ DRUGTYPE Small molecular drug D0E0OJ DRUGINCH 1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1 D0E0OJ DRUGINKE OLXZPDWKRNYJJZ-RRKCRQDMSA-N D0E0OJ DRUGSMIL C1C(C(OC1N2C=NC3=C(N=CN=C32)N)CO)O D0E0OJ HIGHSTAT Investigative D0E0QG DRUG__ID D0E0QG D0E0QG DRUGTYPE Small molecular drug D0E0QG DRUGINCH 1S/C6H13N3O2S/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12) D0E0QG DRUGINKE BKGWACHYAMTLAF-UHFFFAOYSA-N D0E0QG DRUGSMIL C(CC(C(=O)O)N)CNC(=S)N D0E0QG HIGHSTAT Investigative D0E0QT DRUG__ID D0E0QT D0E0QT DRUGTYPE Small molecular drug D0E0QT DRUGINCH 1S/C16H10N2O3/c19-16-12-4-2-1-3-11(12)14-7-9-5-6-10(18(20)21)8-13(9)15(14)17-16/h1-6,8H,7H2,(H,17,19) D0E0QT DRUGINKE SWBDUXDIPMGDNO-UHFFFAOYSA-N D0E0QT DRUGSMIL C1C2=C(C=C(C=C2)[N+](=O)[O-])C3=C1C4=CC=CC=C4C(=O)N3 D0E0QT HIGHSTAT Investigative D0E0RW DRUG__ID D0E0RW D0E0RW DRUGTYPE Small molecular drug D0E0RW DRUGINCH 1S/C10H8O4/c1-13-9-5-8-6(4-7(9)11)2-3-10(12)14-8/h2-5,11H,1H3 D0E0RW DRUGINKE SYTYLPHCLSSCOJ-UHFFFAOYSA-N D0E0RW DRUGSMIL COC1=C(C=C2C=CC(=O)OC2=C1)O D0E0RW HIGHSTAT Investigative D0E0TA DRUG__ID D0E0TA D0E0TA DRUGTYPE Small molecular drug D0E0TA DRUGINCH 1S/C19H15NO2/c21-18-12-11-16(14-7-3-1-4-8-14)13-17(18)20-19(22)15-9-5-2-6-10-15/h1-13,21H,(H,20,22) D0E0TA DRUGINKE INXWGOLWSBWSOQ-UHFFFAOYSA-N D0E0TA DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C=C2)O)NC(=O)C3=CC=CC=C3 D0E0TA HIGHSTAT Investigative D0E0TD DRUG__ID D0E0TD D0E0TD DRUGTYPE Small molecular drug D0E0TD DRUGINCH 1S/C22H22N2O2/c23-22(25)19-8-12-21(13-9-19)26-20-10-6-18(7-11-20)16-24-15-14-17-4-2-1-3-5-17/h1-13,24H,14-16H2,(H2,23,25) D0E0TD DRUGINKE FARQYUHOSNLRKV-UHFFFAOYSA-N D0E0TD DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC=C(C=C2)OC3=CC=C(C=C3)C(=O)N D0E0TD HIGHSTAT Investigative D0E0TK DRUG__ID D0E0TK D0E0TK DRUGTYPE Small molecular drug D0E0TK DRUGINCH 1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h1-2,5-7H,(H,8,9)/p-2/t2-/m1/s1 D0E0TK DRUGINKE QFBHYOKSQPPXHZ-UWTATZPHSA-L D0E0TK DRUGSMIL C(=C(O)[O-])C(C(=O)[O-])O D0E0TK HIGHSTAT Investigative D0E0VN DRUG__ID D0E0VN D0E0VN DRUGTYPE Small molecular drug D0E0VN DRUGINCH 1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5-,6-/m0/s1 D0E0VN DRUGINKE SHZGCJCMOBCMKK-QYESYBIKSA-N D0E0VN DRUGSMIL CC1C(C(C(C(O1)O)O)O)O D0E0VN HIGHSTAT Investigative D0E0XV DRUG__ID D0E0XV D0E0XV DRUGTYPE Small molecular drug D0E0XV DRUGINCH 1S/C12H10FN3O2S/c13-7-3-1-6(2-4-7)9-5-8(10(14)17)11(19-9)16-12(15)18/h1-5H,(H2,14,17)(H3,15,16,18) D0E0XV DRUGINKE SAYGKHKXGCPTLX-UHFFFAOYSA-N D0E0XV DRUGSMIL C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F D0E0XV HIGHSTAT Investigative D0E0ZS DRUG__ID D0E0ZS D0E0ZS DRUGTYPE Small molecular drug D0E0ZS DRUGINCH 1S/C20H18N2O/c1-15(23)22-20-4-2-3-19(14-20)18-7-5-16(6-8-18)13-17-9-11-21-12-10-17/h2-12,14H,13H2,1H3,(H,22,23) D0E0ZS DRUGINKE HURKLDLRCGKBKL-UHFFFAOYSA-N D0E0ZS DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2=CC=C(C=C2)CC3=CC=NC=C3 D0E0ZS HIGHSTAT Investigative D0E0ZV DRUG__ID D0E0ZV D0E0ZV DRUGTYPE Small molecular drug D0E0ZV DRUGINCH 1S/C25H25N5O2/c31-22(15-29-11-4-1-5-12-29)26-16-8-9-21-19(14-16)25(32)30-13-10-18-17-6-2-3-7-20(17)27-23(18)24(30)28-21/h2-3,6-9,14,27H,1,4-5,10-13,15H2,(H,26,31) D0E0ZV DRUGINKE QCNQXHWYZYJQDL-UHFFFAOYSA-N D0E0ZV DRUGSMIL C1CCN(CC1)CC(=O)NC2=CC3=C(C=C2)N=C4C5=C(CCN4C3=O)C6=CC=CC=C6N5 D0E0ZV HIGHSTAT Investigative D0E1BR DRUG__ID D0E1BR D0E1BR DRUGTYPE Small molecular drug D0E1BR DRUGINCH 1S/C16H17F2O7PS/c17-12-4-6-13(7-5-12)25-14-8-9-15(18)11(10-14)2-1-3-16(26(19,20)21)27(22,23)24/h4-10,16H,1-3H2,(H2,19,20,21)(H,22,23,24)/p-3 D0E1BR DRUGINKE GNVJUODFQNFGPT-UHFFFAOYSA-K D0E1BR DRUGSMIL C1=CC(=CC=C1OC2=CC(=C(C=C2)F)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])F D0E1BR HIGHSTAT Investigative D0E1DB DRUG__ID D0E1DB D0E1DB DRUGTYPE Small molecular drug D0E1DB DRUGINCH 1S/C4H8N2O2/c5-2-3-1-4(7)6-8-3/h3H,1-2,5H2,(H,6,7)/t3-/m0/s1 D0E1DB DRUGINKE ZHCZZTNIHDWRNS-VKHMYHEASA-N D0E1DB DRUGSMIL C1C(ONC1=O)CN D0E1DB HIGHSTAT Investigative D0E1EC DRUG__ID D0E1EC D0E1EC DRUGTYPE Small molecular drug D0E1EC DRUGINCH 1S/C61H84N16O13S/c1-32(2)50(60(89)66-30-49(80)70-45(27-37-29-64-31-67-37)58(87)73-43(25-35-13-8-7-9-14-35)57(86)71-40(52(63)81)22-24-91-6)75-53(82)34(5)68-56(85)44(26-36-28-65-39-16-11-10-15-38(36)39)74-54(83)42(18-20-47(62)78)72-59(88)46-17-12-23-77(46)61(90)51(33(3)4)76-55(84)41-19-21-48(79)69-41/h7-11,13-16,28-29,31-34,40-46,50-51,65H,12,17-27,30H2,1-6H3,(H2,62,78)(H2,63,81)(H,64,67)(H,66,89)(H,68,85)(H,69,79)(H,70,80)(H,71,86)(H,72,88)(H,73,87)(H,74,83)(H,75,82)(H,76,84) D0E1EC DRUGINKE AUOCWSNQHWTPIJ-UHFFFAOYSA-N D0E1EC DRUGSMIL CC(C)C(C(=O)NCC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCSC)C(=O)N)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)C5CCCN5C(=O)C(C(C)C)NC(=O)C6CCC(=O)N6 D0E1EC HIGHSTAT Investigative D0E1FQ DRUG__ID D0E1FQ D0E1FQ DRUGTYPE Small molecular drug D0E1FQ DRUGINCH 1S/C38H49N5O5/c1-22(2)28-14-9-11-23(3)30(28)21-33(36(46)41-32(35(40)45)19-26-12-7-6-8-13-26)42-37(47)34-15-10-16-43(34)38(48)31(39)20-29-24(4)17-27(44)18-25(29)5/h6-9,11-14,17-18,22,31-34,44H,10,15-16,19-21,39H2,1-5H3,(H2,40,45)(H,41,46)(H,42,47)/t31-,32-,33-,34-/m0/s1 D0E1FQ DRUGINKE PUIMPGYMFMJIOK-CUPIEXAXSA-N D0E1FQ DRUGSMIL CC1=C(C(=CC=C1)C(C)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N D0E1FQ HIGHSTAT Investigative D0E1HP DRUG__ID D0E1HP D0E1HP DRUGTYPE Small molecular drug D0E1HP DRUGINCH 1S/C21H15Cl3O2/c22-17-7-1-14(2-8-17)21(13-20(25)26,15-3-9-18(23)10-4-15)16-5-11-19(24)12-6-16/h1-12H,13H2,(H,25,26) D0E1HP DRUGINKE LHIVWYJOCNGZRI-UHFFFAOYSA-N D0E1HP DRUGSMIL C1=CC(=CC=C1C(CC(=O)O)(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)Cl D0E1HP HIGHSTAT Investigative D0E1IO DRUG__ID D0E1IO D0E1IO DRUGTYPE Small molecular drug D0E1IO DRUGINCH 1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/t2-/m0/s1 D0E1IO DRUGINKE HLKXYZVTANABHZ-REOHCLBHSA-N D0E1IO DRUGSMIL C(C(C(=O)O)NC(=O)N)C(=O)O D0E1IO HIGHSTAT Investigative D0E1KX DRUG__ID D0E1KX D0E1KX DRUGTYPE Small molecular drug D0E1KX DRUGINCH 1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3 D0E1KX DRUGINKE ZMXDDKWLCZADIW-UHFFFAOYSA-N D0E1KX DRUGSMIL CN(C)C=O D0E1KX HIGHSTAT Investigative D0E1NH DRUG__ID D0E1NH D0E1NH DRUGTYPE Small molecular drug D0E1NH DRUGINCH 1S/C9H21NO2/c11-8-6-4-2-1-3-5-7-10-9-12/h10-12H,1-9H2 D0E1NH DRUGINKE SJEVZMRZAJQYFZ-UHFFFAOYSA-N D0E1NH DRUGSMIL C(CCCCO)CCCNCO D0E1NH HIGHSTAT Investigative D0E1NK DRUG__ID D0E1NK D0E1NK DRUGTYPE Small molecular drug D0E1NK DRUGINCH 1S/C18H15NO2/c1-19(21)18(20)11-7-13-6-8-15-10-9-14-4-2-3-5-16(14)17(15)12-13/h2-12,21H,1H3/b11-7+ D0E1NK DRUGINKE IPSMBZZRHPTXDJ-YRNVUSSQSA-N D0E1NK DRUGSMIL CN(C(=O)C=CC1=CC2=C(C=CC3=CC=CC=C32)C=C1)O D0E1NK HIGHSTAT Investigative D0E1OC DRUG__ID D0E1OC D0E1OC DRUGTYPE Small molecular drug D0E1OC DRUGINCH 1S/C23H22FNO4/c24-18-10-6-9-17(13-18)22(29-15-20(25)23(26)27)19-11-4-5-12-21(19)28-14-16-7-2-1-3-8-16/h1-13,20,22H,14-15,25H2,(H,26,27)/t20-,22?/m0/s1 D0E1OC DRUGINKE ADUSZEGHFWRTQS-AIBWNMTMSA-N D0E1OC DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC=C2C(C3=CC(=CC=C3)F)OCC(C(=O)O)N D0E1OC HIGHSTAT Investigative D0E1PL DRUG__ID D0E1PL D0E1PL DRUGTYPE Small molecular drug D0E1PL DRUGINCH 1S/C20H22ClF2N3O/c1-14-2-4-16(25-11-14)12-24-13-20(23)6-8-26(9-7-20)19(27)15-3-5-18(22)17(21)10-15/h2-5,10-11,24H,6-9,12-13H2,1H3 D0E1PL DRUGINKE PKZXLMVXBZICTF-UHFFFAOYSA-N D0E1PL DRUGSMIL CC1=CN=C(C=C1)CNCC2(CCN(CC2)C(=O)C3=CC(=C(C=C3)F)Cl)F D0E1PL HIGHSTAT Investigative D0E1QI DRUG__ID D0E1QI D0E1QI DRUGTYPE Small molecular drug D0E1QI DRUGINCH 1S/C28H30ClN5O4S/c1-17-25(30-18(2)26(17)28(36)34-12-10-32(3)11-13-34)16-23-22-15-21(8-9-24(22)31-27(23)35)39(37,38)33(4)20-7-5-6-19(29)14-20/h5-9,14-16,30H,10-13H2,1-4H3,(H,31,35)/b23-16- D0E1QI DRUGINKE FPYJSJDOHRDAMT-KQWNVCNZSA-N D0E1QI DRUGSMIL CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O D0E1QI HIGHSTAT Investigative D0E1QP DRUG__ID D0E1QP D0E1QP DRUGTYPE Small molecular drug D0E1QP DRUGINCH 1S/C13H14N2O/c14-13(16)10-6-3-5-9-8-4-1-2-7-11(8)15-12(9)10/h1-2,4,7,10,15H,3,5-6H2,(H2,14,16) D0E1QP DRUGINKE YMLOFDJHJSQCSN-UHFFFAOYSA-N D0E1QP DRUGSMIL C1CC(C2=C(C1)C3=CC=CC=C3N2)C(=O)N D0E1QP HIGHSTAT Investigative D0E1RX DRUG__ID D0E1RX D0E1RX DRUGTYPE Small molecular drug D0E1RX DRUGINCH 1S/C20H25NO/c1-2-9-18(10-3-1)17-19-11-4-5-12-20(19)22-16-8-15-21-13-6-7-14-21/h1-5,9-12H,6-8,13-17H2 D0E1RX DRUGINKE SECXHJRGBAZUCO-UHFFFAOYSA-N D0E1RX DRUGSMIL C1CCN(C1)CCCOC2=CC=CC=C2CC3=CC=CC=C3 D0E1RX HIGHSTAT Investigative D0E1UA DRUG__ID D0E1UA D0E1UA DRUGTYPE Small molecular drug D0E1UA DRUGINCH 1S/C10H20O3/c1-2-3-4-5-6-7-8-9(11)10(12)13/h9,11H,2-8H2,1H3,(H,12,13) D0E1UA DRUGINKE GHPVDCPCKSNJDR-UHFFFAOYSA-N D0E1UA DRUGSMIL CCCCCCCCC(C(=O)O)O D0E1UA HIGHSTAT Investigative D0E1UG DRUG__ID D0E1UG D0E1UG DRUGTYPE Small molecular drug D0E1UG DRUGINCH 1S/C31H50O3/c1-26(2)15-16-28(5)17-18-31(25(33)34-8)20(21(28)19-26)9-10-23-29(6)13-12-24(32)27(3,4)22(29)11-14-30(23,31)7/h9,21-24,32H,10-19H2,1-8H3/t21-,22?,23+,24-,28+,29-,30+,31+/m0/s1 D0E1UG DRUGINKE HEDYWHFMTAMIIX-IPZPPPCKSA-N D0E1UG DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C(=O)OC)C)C D0E1UG HIGHSTAT Investigative D0E1XD DRUG__ID D0E1XD D0E1XD DRUGTYPE Small molecular drug D0E1XD DRUGINCH 1S/C6H8BNO2/c8-6-3-1-2-5(4-6)7(9)10/h1-4,9-10H,8H2 D0E1XD DRUGINKE JMZFEHDNIAQMNB-UHFFFAOYSA-N D0E1XD DRUGSMIL B(C1=CC(=CC=C1)N)(O)O D0E1XD HIGHSTAT Investigative D0E1YE DRUG__ID D0E1YE D0E1YE DRUGTYPE Small molecular drug D0E1YE DRUGINCH 1S/C27H34N6O11/c28-22(5-1-3-16-30-27(38)44-21-13-11-20(12-14-21)33(41)42)24(34)31-23(25(35)36)6-2-4-15-29-26(37)43-17-18-7-9-19(10-8-18)32(39)40/h7-14,22-23H,1-6,15-17,28H2,(H,29,37)(H,30,38)(H,31,34)(H,35,36) D0E1YE DRUGINKE AJUWOKKXEQNXLT-UHFFFAOYSA-N D0E1YE DRUGSMIL C1=CC(=CC=C1COC(=O)NCCCCC(C(=O)[O-])NC(=O)C(CCCCNC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])[NH3+])[N+](=O)[O-] D0E1YE HIGHSTAT Investigative D0E1YQ DRUG__ID D0E1YQ D0E1YQ DRUGTYPE Small molecular drug D0E1YQ DRUGINCH 1S/C17H20N2O3/c18-16(21)14-12-22-17(19-14)15(20)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2,(H2,18,21) D0E1YQ DRUGINKE ZOLDFPZCQMAAPD-UHFFFAOYSA-N D0E1YQ DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)C(=O)N D0E1YQ HIGHSTAT Investigative D0E1ZS DRUG__ID D0E1ZS D0E1ZS DRUGTYPE Small molecular drug D0E1ZS DRUGINCH 1S/C24H26O4/c1-15(2)5-4-6-16(3)7-10-20-21(12-19(26)13-22(20)27)24-11-17-8-9-18(25)14-23(17)28-24/h5,7-9,11-14,25-27H,4,6,10H2,1-3H3/b16-7+ D0E1ZS DRUGINKE KGOOVUKZICPAIZ-FRKPEAEDSA-N D0E1ZS DRUGSMIL CC(=CCCC(=CCC1=C(C=C(C=C1O)O)C2=CC3=C(O2)C=C(C=C3)O)C)C D0E1ZS HIGHSTAT Investigative D0E2AC DRUG__ID D0E2AC D0E2AC DRUGTYPE Small molecular drug D0E2AC DRUGINCH 1S/C14H30O6/c1-3-15-5-7-17-9-11-19-13-14-20-12-10-18-8-6-16-4-2/h3-14H2,1-2H3 D0E2AC DRUGINKE IXFAFGFZFQHRLB-UHFFFAOYSA-N D0E2AC DRUGSMIL CCOCCOCCOCCOCCOCCOCC D0E2AC HIGHSTAT Investigative D0E2BH DRUG__ID D0E2BH D0E2BH DRUGTYPE Small molecular drug D0E2BH DRUGINCH 1S/C6H10N4O4/c11-1-2-3(12)4(13)5(14)6-7-8-9-10(2)6/h2-5,11-14H,1H2/t2-,3-,4+,5-/m1/s1 D0E2BH DRUGINKE UCJXQRFJERKPOZ-SQOUGZDYSA-N D0E2BH DRUGSMIL C(C1C(C(C(C2=NN=NN12)O)O)O)O D0E2BH HIGHSTAT Investigative D0E2BI DRUG__ID D0E2BI D0E2BI DRUGTYPE Small molecular drug D0E2BI DRUGINCH 1S/C21H18FNO2/c1-2-15-7-9-16(10-8-15)17-11-13-18(14-12-17)23-21(24)25-20-6-4-3-5-19(20)22/h3-14H,2H2,1H3,(H,23,24) D0E2BI DRUGINKE XHWBLLJZJZYEES-UHFFFAOYSA-N D0E2BI DRUGSMIL CCC1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)OC3=CC=CC=C3F D0E2BI HIGHSTAT Investigative D0E2FV DRUG__ID D0E2FV D0E2FV DRUGTYPE Small molecular drug D0E2FV DRUGINCH 1S/C13H13N5/c14-12-11-13(16-8-15-12)18(9-17-11)7-6-10-4-2-1-3-5-10/h1-5,8-9H,6-7H2,(H2,14,15,16) D0E2FV DRUGINKE MALQBKDZBRRFOM-UHFFFAOYSA-N D0E2FV DRUGSMIL C1=CC=C(C=C1)CCN2C=NC3=C(N=CN=C32)N D0E2FV HIGHSTAT Investigative D0E2FY DRUG__ID D0E2FY D0E2FY DRUGTYPE Small molecular drug D0E2FY DRUGINCH 1S/C13H20N2O/c1-11(2)16-13-6-4-3-5-12(13)15-9-7-14-8-10-15/h3-6,11,14H,7-10H2,1-2H3 D0E2FY DRUGINKE QJULELIONYLITF-UHFFFAOYSA-N D0E2FY DRUGSMIL CC(C)OC1=CC=CC=C1N2CCNCC2 D0E2FY HIGHSTAT Investigative D0E2GV DRUG__ID D0E2GV D0E2GV DRUGTYPE Small molecular drug D0E2GV DRUGINCH 1S/C22H31NO4Si/c1-22(2,3)28(4,5)27-18-8-13-6-7-23-11-14-9-16-17(26-12-25-16)10-15(14)19(20(13)23)21(18)24/h8-10,18-21,24H,6-7,11-12H2,1-5H3/t18-,19-,20+,21+/m0/s1 D0E2GV DRUGINKE RLYPONLPAHPYMG-UWHLTILDSA-N D0E2GV DRUGSMIL CC(C)(C)[Si](C)(C)OC1C=C2CCN3C2C(C1O)C4=CC5=C(C=C4C3)OCO5 D0E2GV HIGHSTAT Investigative D0E2IG DRUG__ID D0E2IG D0E2IG DRUGTYPE Small molecular drug D0E2IG DRUGINCH 1S/C14H4F6O2/c15-5-3-6(11(19)9(18)4-5)13(21)14(22)10-7(16)1-2-8(17)12(10)20/h1-4H D0E2IG DRUGINKE NHBDBTHCQQXYBY-UHFFFAOYSA-N D0E2IG DRUGSMIL C1=CC(=C(C(=C1F)C(=O)C(=O)C2=C(C(=CC(=C2)F)F)F)F)F D0E2IG HIGHSTAT Investigative D0E2IH DRUG__ID D0E2IH D0E2IH DRUGTYPE Small molecular drug D0E2IH DRUGINCH 1S/C26H24N2O4/c29-24-16-17-28(25(30)27-24)20-31-18-19-32-26(21-10-4-1-5-11-21,22-12-6-2-7-13-22)23-14-8-3-9-15-23/h1-17H,18-20H2,(H,27,29,30) D0E2IH DRUGINKE QEKAGWDUKXATPZ-UHFFFAOYSA-N D0E2IH DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCCOCN4C=CC(=O)NC4=O D0E2IH HIGHSTAT Investigative D0E2IR DRUG__ID D0E2IR D0E2IR DRUGTYPE Small molecular drug D0E2IR DRUGINCH 1S/H3N/h1H3/p+1 D0E2IR DRUGINKE QGZKDVFQNNGYKY-UHFFFAOYSA-O D0E2IR DRUGSMIL [NH4+] D0E2IR HIGHSTAT Investigative D0E2KC DRUG__ID D0E2KC D0E2KC DRUGTYPE Small molecular drug D0E2KC DRUGINCH 1S/C13H10F3NO3S/c14-13(15,16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)20-21(17,18)19/h1-8H,(H2,17,18,19) D0E2KC DRUGINKE CRJUOWWINLUIRE-UHFFFAOYSA-N D0E2KC DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)OS(=O)(=O)N)C(F)(F)F D0E2KC HIGHSTAT Investigative D0E2LR DRUG__ID D0E2LR D0E2LR DRUGTYPE Small molecular drug D0E2LR DRUGINCH 1S/C21H25N3/c1-2-6-18(7-3-1)16-24-14-12-17(13-15-24)10-11-21-19-8-4-5-9-20(19)22-23-21/h1-9,17H,10-16H2,(H,22,23) D0E2LR DRUGINKE NPZKLBFCTYVTBS-UHFFFAOYSA-N D0E2LR DRUGSMIL C1CN(CCC1CCC2=C3C=CC=CC3=NN2)CC4=CC=CC=C4 D0E2LR HIGHSTAT Investigative D0E2LU DRUG__ID D0E2LU D0E2LU DRUGTYPE Small molecular drug D0E2LU DRUGINCH 1S/C19H13N3O2/c1-22-15-8-10(23)6-7-11(15)17-18-14(9-16(24)19(17)22)20-12-4-2-3-5-13(12)21-18/h2-9,20,24H,1H3 D0E2LU DRUGINKE ZWIWQBZCWUMNMU-UHFFFAOYSA-N D0E2LU DRUGSMIL CN1C2=CC(=O)C=CC2=C3C1=C(C=C4C3=NC5=CC=CC=C5N4)O D0E2LU HIGHSTAT Investigative D0E2OG DRUG__ID D0E2OG D0E2OG DRUGTYPE Small molecular drug D0E2OG DRUGINCH 1S/C48H63N9O10/c1-4-6-16-36(54-44(63)34(49)23-30-19-21-32(58)22-20-30)45(64)52-28-41(59)53-39(25-31-27-51-35-17-12-11-15-33(31)35)48(67)57(3)40(18-7-5-2)47(66)56-38(26-42(60)61)46(65)55-37(43(50)62)24-29-13-9-8-10-14-29/h8-15,17,19-22,27,34,36-40,51,58H,4-7,16,18,23-26,28,49H2,1-3H3,(H2,50,62)(H,52,64)(H,53,59)(H,54,63)(H,55,65)(H,56,66)(H,60,61)/t34-,36+,37-,38-,39+,40-/m0/s1 D0E2OG DRUGINKE KJQHRGYUFQCLJG-KOPATMAISA-N D0E2OG DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N(C)C(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D0E2OG HIGHSTAT Investigative D0E2RV DRUG__ID D0E2RV D0E2RV DRUGTYPE Small molecular drug D0E2RV DRUGINCH 1S/C18H26N2O2/c1-2-3-4-5-6-12-18(13-11-16(21)20-17(18)22)14-7-9-15(19)10-8-14/h7-10H,2-6,11-13,19H2,1H3,(H,20,21,22) D0E2RV DRUGINKE OSRMOQHQZPPFAZ-UHFFFAOYSA-N D0E2RV DRUGSMIL CCCCCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N D0E2RV HIGHSTAT Investigative D0E2SI DRUG__ID D0E2SI D0E2SI DRUGTYPE Small molecular drug D0E2SI DRUGINCH 1S/C25H27NO4S/c1-2-29-25-19(12-8-14-27)20(21-16-31-23-13-7-6-11-18(21)23)15-22(30-25)24(28)26-17-9-4-3-5-10-17/h3-7,9-11,13,15-16,19-20,25,27H,2,8,12,14H2,1H3,(H,26,28)/t19-,20+,25-/m0/s1 D0E2SI DRUGINKE DPIFUIZFNOZKRB-DFIYOIEZSA-N D0E2SI DRUGSMIL CCOC1C(C(C=C(O1)C(=O)NC2=CC=CC=C2)C3=CSC4=CC=CC=C43)CCCO D0E2SI HIGHSTAT Investigative D0E2UQ DRUG__ID D0E2UQ D0E2UQ DRUGTYPE Small molecular drug D0E2UQ DRUGINCH 1S/C10H15N5O13P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(27-29(17,18)19)4(26-10)1-25-30(20,21)28-31(22,23)24/h2-4,6-7,10,16H,1H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)(H,22,23,24)/t4-,6-,7-,10-/m1/s1 D0E2UQ DRUGINKE GACDQMDRPRGCTN-KQYNXXCUSA-N D0E2UQ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OS(=O)(=O)O)OP(=O)(O)O)O)N D0E2UQ HIGHSTAT Investigative D0E2VC DRUG__ID D0E2VC D0E2VC DRUGTYPE Small molecular drug D0E2VC DRUGINCH 1S/C10H11NO/c1-7-3-2-4-9-8(7)5-6-11-10(9)12/h2-4H,5-6H2,1H3,(H,11,12) D0E2VC DRUGINKE RLLZPXDJYADIEU-UHFFFAOYSA-N D0E2VC DRUGSMIL CC1=C2CCNC(=O)C2=CC=C1 D0E2VC HIGHSTAT Investigative D0E2WX DRUG__ID D0E2WX D0E2WX DRUGTYPE Small molecular drug D0E2WX DRUGINCH 1S/C5H3FN2O4/c6-1-2(4(10)11)7-5(12)8-3(1)9/h(H,10,11)(H2,7,8,9,12) D0E2WX DRUGINKE SEHFUALWMUWDKS-UHFFFAOYSA-N D0E2WX DRUGSMIL C1(=C(NC(=O)NC1=O)C(=O)O)F D0E2WX HIGHSTAT Investigative D0E2XM DRUG__ID D0E2XM D0E2XM DRUGTYPE Small molecular drug D0E2XM DRUGINCH 1S/C38H44N4O2/c1-26(43)44-33-16-12-15-29-30-17-19-39-35(36(30)40-34(29)33)31-23-27-13-8-4-2-3-6-10-20-41-22-18-32(31)38(25-41)24-28-14-9-5-7-11-21-42(28)37(27)38/h2,4,9,12-17,19,23,28,32,37,40H,3,5-8,10-11,18,20-22,24-25H2,1H3/b4-2-,14-9-,27-13-/t28-,32?,37-,38-/m0/s1 D0E2XM DRUGINKE XANHIHHFYZZCBY-CVNPAURDSA-N D0E2XM DRUGSMIL CC(=O)OC1=CC=CC2=C1NC3=C2C=CN=C3C4=CC5=CCC=CCCCCN6CCC4C7(C6)C5N8CCCCC=CC8C7 D0E2XM HIGHSTAT Investigative D0E2XP DRUG__ID D0E2XP D0E2XP DRUGTYPE Small molecular drug D0E2XP DRUGINCH 1S/C28H42N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(32)29-21-20-24-23-30-27-19-18-25(31)22-26(24)27/h6-7,9-10,18-19,22-23,30-31H,2-5,8,11-17,20-21H2,1H3,(H,29,32)/b7-6-,10-9- D0E2XP DRUGINKE YJVMJUDLMFBYFZ-HZJYTTRNSA-N D0E2XP DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O D0E2XP HIGHSTAT Investigative D0E2XW DRUG__ID D0E2XW D0E2XW DRUGTYPE Small molecular drug D0E2XW DRUGINCH 1S/C11H12FN/c12-11-6-10(11,7-13-8-11)9-4-2-1-3-5-9/h1-5,13H,6-8H2 D0E2XW DRUGINKE OSYUYUPNSGSVAL-UHFFFAOYSA-N D0E2XW DRUGSMIL C1C2(C1(CNC2)F)C3=CC=CC=C3 D0E2XW HIGHSTAT Investigative D0E3AL DRUG__ID D0E3AL D0E3AL DRUGTYPE Small molecular drug D0E3AL DRUGINCH 1S/C24H29Cl2N3O2/c25-20-5-3-6-22(24(20)26)29-13-4-12-28(14-15-29)11-1-2-16-31-19-9-7-18-8-10-23(30)27-21(18)17-19/h3,5-7,9,17H,1-2,4,8,10-16H2,(H,27,30) D0E3AL DRUGINKE NGCKUAWDNUFNBB-UHFFFAOYSA-N D0E3AL DRUGSMIL C1CN(CCN(C1)C2=C(C(=CC=C2)Cl)Cl)CCCCOC3=CC4=C(CCC(=O)N4)C=C3 D0E3AL HIGHSTAT Investigative D0E3CB DRUG__ID D0E3CB D0E3CB DRUGTYPE Small molecular drug D0E3CB DRUGINCH 1S/C14H13N3O4/c15-14(16)17-4-3-7-8-1-2-11(19)10(6-18)12(8)21-13(20)9(7)5-17/h1-2,6,19H,3-5H2,(H3,15,16) D0E3CB DRUGINKE YPBDMIVAGFLWPR-UHFFFAOYSA-N D0E3CB DRUGSMIL C1CN(CC2=C1C3=C(C(=C(C=C3)O)C=O)OC2=O)C(=N)N D0E3CB HIGHSTAT Investigative D0E3CO DRUG__ID D0E3CO D0E3CO DRUGTYPE Small molecular drug D0E3CO DRUGINCH 1S/C16H16N2O/c1-3-12-6-4-5-7-13(12)17-16-18-14-10-11(2)8-9-15(14)19-16/h4-10H,3H2,1-2H3,(H,17,18) D0E3CO DRUGINKE KQXHDGZITMHOPQ-UHFFFAOYSA-N D0E3CO DRUGSMIL CCC1=CC=CC=C1NC2=NC3=C(O2)C=CC(=C3)C D0E3CO HIGHSTAT Investigative D0E3DF DRUG__ID D0E3DF D0E3DF DRUGTYPE Small molecular drug D0E3DF DRUGINCH 1S/C17H18INO2/c18-14-8-4-5-9-15(14)21-17(13-6-2-1-3-7-13)16-12-19-10-11-20-16/h1-9,16-17,19H,10-12H2/t16-,17+/m1/s1 D0E3DF DRUGINKE BHMLFPOTZYRDKA-SJORKVTESA-N D0E3DF DRUGSMIL C1COC(CN1)C(C2=CC=CC=C2)OC3=CC=CC=C3I D0E3DF HIGHSTAT Investigative D0E3DM DRUG__ID D0E3DM D0E3DM DRUGTYPE Small molecular drug D0E3DM DRUGINCH 1S/C15H17NO/c1-2-4-14-9-12(5-6-13(14)3-1)11-17-15-7-8-16-10-15/h1-6,9,15-16H,7-8,10-11H2/t15-/m0/s1 D0E3DM DRUGINKE IQZVBBALTJFFCB-HNNXBMFYSA-N D0E3DM DRUGSMIL C1CNCC1OCC2=CC3=CC=CC=C3C=C2 D0E3DM HIGHSTAT Investigative D0E3ET DRUG__ID D0E3ET D0E3ET DRUGTYPE Small molecular drug D0E3ET DRUGINCH 1S/C22H26O4/c1-4-5-6-7-10-22(2,3)14-11-18(24)20-17-13-15(23)8-9-16(17)21(25)26-19(20)12-14/h8-9,11-13,23-24H,4-7,10H2,1-3H3 D0E3ET DRUGINKE BWKBVEVEQOCSCF-UHFFFAOYSA-N D0E3ET DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C(=C1)OC(=O)C3=C2C=C(C=C3)O)O D0E3ET HIGHSTAT Investigative D0E3FK DRUG__ID D0E3FK D0E3FK DRUGTYPE Small molecular drug D0E3FK DRUGINCH 1S/C14H15N5O2/c1-20-6-7-21-11-3-5-16-13-12(11)9(8-18-13)10-2-4-17-14(15)19-10/h2-5,8H,6-7H2,1H3,(H,16,18)(H2,15,17,19) D0E3FK DRUGINKE NFOHQNIARGGZFN-UHFFFAOYSA-N D0E3FK DRUGSMIL COCCOC1=C2C(=CNC2=NC=C1)C3=NC(=NC=C3)N D0E3FK HIGHSTAT Investigative D0E3FR DRUG__ID D0E3FR D0E3FR DRUGTYPE Small molecular drug D0E3FR DRUGINCH 1S/C17H14F2N4O/c1-11-9-16(23(22-11)13-5-3-2-4-6-13)21-17(24)20-12-7-8-14(18)15(19)10-12/h2-10H,1H3,(H2,20,21,24) D0E3FR DRUGINKE IEKSMUSSYJUQMY-UHFFFAOYSA-N D0E3FR DRUGSMIL CC1=NN(C(=C1)NC(=O)NC2=CC(=C(C=C2)F)F)C3=CC=CC=C3 D0E3FR HIGHSTAT Investigative D0E3GI DRUG__ID D0E3GI D0E3GI DRUGTYPE Small molecular drug D0E3GI DRUGINCH 1S/C20H18O8P2/c21-20(29(22,23)24,30(25,26)27)12-13-5-3-6-14(11-13)15-8-4-9-17-16-7-1-2-10-18(16)28-19(15)17/h1-11,21H,12H2,(H2,22,23,24)(H2,25,26,27) D0E3GI DRUGINKE BYVXAUZOTGITQZ-UHFFFAOYSA-N D0E3GI DRUGSMIL C1=CC=C2C(=C1)C3=C(O2)C(=CC=C3)C4=CC=CC(=C4)CC(O)(P(=O)(O)O)P(=O)(O)O D0E3GI HIGHSTAT Investigative D0E3HC DRUG__ID D0E3HC D0E3HC DRUGTYPE Small molecular drug D0E3HC DRUGINCH 1S/C23H24N4OS/c1-2-9-26(10-3-1)11-12-28-21-6-4-18(5-7-21)20-14-24-23-22(15-25-27(23)16-20)19-8-13-29-17-19/h4-8,13-17H,1-3,9-12H2 D0E3HC DRUGINKE VOYMOBPSYVKQGF-UHFFFAOYSA-N D0E3HC DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CSC=C5)N=C3 D0E3HC HIGHSTAT Investigative D0E3IK DRUG__ID D0E3IK D0E3IK DRUGTYPE Small molecular drug D0E3IK DRUGINCH 1S/C10H14N2O5S/c1-3-6-17-10-7-8(12(13)14)4-5-9(10)11-18(2,15)16/h4-5,7,11H,3,6H2,1-2H3 D0E3IK DRUGINKE GUPXOWXEFMIHHE-UHFFFAOYSA-N D0E3IK DRUGSMIL CCCOC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C D0E3IK HIGHSTAT Investigative D0E3KD DRUG__ID D0E3KD D0E3KD DRUGTYPE Small molecular drug D0E3KD DRUGINCH 1S/C18H12N2O/c21-15-4-1-12(2-5-15)14-9-16-17-11-19-8-7-13(17)3-6-18(16)20-10-14/h1-11,21H D0E3KD DRUGINKE IUSSGTWHFMSCOY-UHFFFAOYSA-N D0E3KD DRUGSMIL C1=CC2=C(C=C(C=N2)C3=CC=C(C=C3)O)C4=C1C=CN=C4 D0E3KD HIGHSTAT Investigative D0E3LA DRUG__ID D0E3LA D0E3LA DRUGTYPE Small molecular drug D0E3LA DRUGINCH 1S/C17H30N2O/c1-2-3-4-5-6-7-8-15-9-11-17(12-10-15)19-13-16(18)14-20/h9-12,16,19-20H,2-8,13-14,18H2,1H3/t16-/m1/s1 D0E3LA DRUGINKE RCARSJSFSXRXLF-MRXNPFEDSA-N D0E3LA DRUGSMIL CCCCCCCCC1=CC=C(C=C1)NCC(CO)N D0E3LA HIGHSTAT Investigative D0E3NT DRUG__ID D0E3NT D0E3NT DRUGTYPE Small molecular drug D0E3NT DRUGINCH 1S/C23H13Cl2N3O2/c24-15-6-8-19(25)18(12-15)22-9-7-16(30-22)11-14(13-26)23(29)28-21-5-1-4-20-17(21)3-2-10-27-20/h1-12H,(H,28,29)/b14-11+ D0E3NT DRUGINKE SVENPFFEMUOOGK-SDNWHVSQSA-N D0E3NT DRUGSMIL C1=CC2=C(C=CC=N2)C(=C1)NC(=O)C(=CC3=CC=C(O3)C4=C(C=CC(=C4)Cl)Cl)C#N D0E3NT HIGHSTAT Investigative D0E3OH DRUG__ID D0E3OH D0E3OH DRUGTYPE Small molecular drug D0E3OH DRUGINCH 1S/C13H15NO2S/c14-9-11-4-1-3-10(7-11)8-12(13(15)16)5-2-6-17/h1,3-4,7,12,17H,2,5-6,8H2,(H,15,16) D0E3OH DRUGINKE PCFBGUNMCCWACH-UHFFFAOYSA-N D0E3OH DRUGSMIL C1=CC(=CC(=C1)C#N)CC(CCCS)C(=O)O D0E3OH HIGHSTAT Investigative D0E3OL DRUG__ID D0E3OL D0E3OL DRUGTYPE Small molecular drug D0E3OL DRUGINCH 1S/C20H22N4/c1-23-12-14-24(15-13-23)17-8-6-16(7-9-17)22-20-10-11-21-19-5-3-2-4-18(19)20/h2-11H,12-15H2,1H3,(H,21,22) D0E3OL DRUGINKE RXXDJBWYJTWSKV-UHFFFAOYSA-N D0E3OL DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=CC=NC4=CC=CC=C43 D0E3OL HIGHSTAT Investigative D0E3OY DRUG__ID D0E3OY D0E3OY DRUGTYPE Small molecular drug D0E3OY DRUGINCH 1S/C27H24F3NO/c1-2-3-8-16-31-18-20(17-25(31)23-13-6-7-15-24(23)27(28,29)30)26(32)22-14-9-11-19-10-4-5-12-21(19)22/h4-7,9-15,17-18H,2-3,8,16H2,1H3 D0E3OY DRUGINKE CYPUIQJYGVOHMM-UHFFFAOYSA-N D0E3OY DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2C(F)(F)F)C(=O)C3=CC=CC4=CC=CC=C43 D0E3OY HIGHSTAT Investigative D0E3OZ DRUG__ID D0E3OZ D0E3OZ DRUGTYPE Small molecular drug D0E3OZ DRUGINCH 1S/C14H14N4O3/c19-15-9-13-1-5-17(6-2-13)11-21-12-18-7-3-14(4-8-18)10-16-20/h1-10H,11-12H2/p+2 D0E3OZ DRUGINKE HIGRLDNHDGYWQJ-UHFFFAOYSA-P D0E3OZ DRUGSMIL C1=C[N+](=CC=C1C=NO)COC[N+]2=CC=C(C=C2)C=NO D0E3OZ HIGHSTAT Investigative D0E3PF DRUG__ID D0E3PF D0E3PF DRUGTYPE Small molecular drug D0E3PF DRUGINCH 1S/C13H15N3OS2/c1-17-11-4-2-10(3-5-11)6-7-14-12(18)16-13-15-8-9-19-13/h2-5,8-9H,6-7H2,1H3,(H2,14,15,16,18) D0E3PF DRUGINKE HJPBSTWTSQIWNI-UHFFFAOYSA-N D0E3PF DRUGSMIL COC1=CC=C(C=C1)CCNC(=S)NC2=NC=CS2 D0E3PF HIGHSTAT Investigative D0E3SB DRUG__ID D0E3SB D0E3SB DRUGTYPE Small molecular drug D0E3SB DRUGINCH 1S/C26H27NO3/c1-25(2)11-12-26(3,4)22-15-19(9-10-21(22)25)23(27-30)18-7-5-17-14-20(24(28)29)8-6-16(17)13-18/h5-10,13-15,30H,11-12H2,1-4H3,(H,28,29)/b27-23+ D0E3SB DRUGINKE RNZIUDLOJHVHLZ-SLEBQGDGSA-N D0E3SB DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(=NO)C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)(C)C)C D0E3SB HIGHSTAT Investigative D0E3ST DRUG__ID D0E3ST D0E3ST DRUGTYPE Small molecular drug D0E3ST DRUGINCH 1S/C14H20N2O/c1-2-15-8-10-16(11-9-15)14(17)12-13-6-4-3-5-7-13/h3-7H,2,8-12H2,1H3 D0E3ST DRUGINKE ZKLSFAKJJJDQSA-UHFFFAOYSA-N D0E3ST DRUGSMIL CCN1CCN(CC1)C(=O)CC2=CC=CC=C2 D0E3ST HIGHSTAT Investigative D0E3TC DRUG__ID D0E3TC D0E3TC DRUGTYPE Small molecular drug D0E3TC DRUGINCH 1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 D0E3TC DRUGINKE HKSZLNNOFSGOKW-FYTWVXJKSA-N D0E3TC DRUGSMIL CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC D0E3TC HIGHSTAT Investigative D0E3VJ DRUG__ID D0E3VJ D0E3VJ DRUGTYPE Small molecular drug D0E3VJ DRUGINCH 1S/C4H8N4O2S3/c1-2-11-4-7-6-3(12-4)8-13(5,9)10/h2H2,1H3,(H,6,8)(H2,5,9,10) D0E3VJ DRUGINKE CHUOTDNKSODBJL-UHFFFAOYSA-N D0E3VJ DRUGSMIL CCSC1=NN=C(S1)NS(=O)(=O)N D0E3VJ HIGHSTAT Investigative D0E3VR DRUG__ID D0E3VR D0E3VR DRUGTYPE Small molecular drug D0E3VR DRUGINCH 1S/C16H28N4O8S/c1-2-3-4-7-20(28)16(27)29-9-11(14(24)18-8-13(22)23)19-12(21)6-5-10(17)15(25)26/h10-11,28H,2-9,17H2,1H3,(H,18,24)(H,19,21)(H,22,23)(H,25,26)/t10-,11-/m0/s1 D0E3VR DRUGINKE BRWDWFHRRYLIDE-QWRGUYRKSA-N D0E3VR DRUGSMIL CCCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D0E3VR HIGHSTAT Investigative D0E3WH DRUG__ID D0E3WH D0E3WH DRUGTYPE Small molecular drug D0E3WH DRUGINCH 1S/C16H15NO/c1-13-8-10-16(11-9-13)18-12-4-7-15-6-3-5-14(2)17-15/h3,5-6,8-11H,12H2,1-2H3 D0E3WH DRUGINKE GMIZGDGVYPBQCS-UHFFFAOYSA-N D0E3WH DRUGSMIL CC1=CC=C(C=C1)OCC#CC2=CC=CC(=N2)C D0E3WH HIGHSTAT Investigative D0E3WT DRUG__ID D0E3WT D0E3WT DRUGTYPE Small molecular drug D0E3WT DRUGINCH 1S/C17H13NO2S/c19-15(20)11-14-16(12-7-3-1-4-8-12)18-17(21-14)13-9-5-2-6-10-13/h1-10H,11H2,(H,19,20) D0E3WT DRUGINKE WNGOHXAHAKLKAR-UHFFFAOYSA-N D0E3WT DRUGSMIL C1=CC=C(C=C1)C2=C(SC(=N2)C3=CC=CC=C3)CC(=O)O D0E3WT HIGHSTAT Investigative D0E4AB DRUG__ID D0E4AB D0E4AB DRUGTYPE Small molecular drug D0E4AB DRUGINCH 1S/C18H13FN2O2/c19-16-8-4-3-7-15(16)18(23)21-20-17(22)14-10-9-12-5-1-2-6-13(12)11-14/h1-11H,(H,20,22)(H,21,23) D0E4AB DRUGINKE BHGKYYRQGUSTGE-UHFFFAOYSA-N D0E4AB DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)NNC(=O)C3=CC=CC=C3F D0E4AB HIGHSTAT Investigative D0E4AN DRUG__ID D0E4AN D0E4AN DRUGTYPE Small molecular drug D0E4AN DRUGINCH 1S/C6H13O10P/c7-2(1-16-17(13,14)15)3(8)4(9)5(10)6(11)12/h2-5,7-10H,1H2,(H,11,12)(H2,13,14,15)/t2-,3-,4+,5-/m1/s1 D0E4AN DRUGINKE BIRSGZKFKXLSJQ-SQOUGZDYSA-N D0E4AN DRUGSMIL C(C(C(C(C(C(=O)O)O)O)O)O)OP(=O)(O)O D0E4AN HIGHSTAT Investigative D0E4BT DRUG__ID D0E4BT D0E4BT DRUGTYPE Small molecular drug D0E4BT DRUGINCH 1S/C15H18N4S/c1-2-4-13(5-3-1)12-17-14-6-7-16-15(18-14)19-8-10-20-11-9-19/h1-7H,8-12H2,(H,16,17,18) D0E4BT DRUGINKE SPJWTUJGKPIRMF-UHFFFAOYSA-N D0E4BT DRUGSMIL C1CSCCN1C2=NC=CC(=N2)NCC3=CC=CC=C3 D0E4BT HIGHSTAT Investigative D0E4DR DRUG__ID D0E4DR D0E4DR DRUGTYPE Small molecular drug D0E4DR DRUGINCH 1S/C7H10N4O6P2/c12-18(13,14)6(19(15,16)17)2-11-4-10-5-1-8-3-9-7(5)11/h1,3-4,6H,2H2,(H2,12,13,14)(H2,15,16,17) D0E4DR DRUGINKE JGHPTTVGCUEGGI-UHFFFAOYSA-N D0E4DR DRUGSMIL C1=C2C(=NC=N1)N(C=N2)CC(P(=O)(O)O)P(=O)(O)O D0E4DR HIGHSTAT Investigative D0E4FJ DRUG__ID D0E4FJ D0E4FJ DRUGTYPE Small molecular drug D0E4FJ DRUGINCH 1S/C18H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h9-10,18H,2-8,11-17H2,1H3/b10-9+ D0E4FJ DRUGINKE ZENZJGDPWWLORF-MDZDMXLPSA-N D0E4FJ DRUGSMIL CCCCCCCCC=CCCCCCCCC=O D0E4FJ HIGHSTAT Investigative D0E4GM DRUG__ID D0E4GM D0E4GM DRUGTYPE Small molecular drug D0E4GM DRUGINCH 1S/C27H27N2O9P/c1-16-12-29(26(31)28-25(16)30)22-11-10-19(36-22)15-35-39(32)34-14-18-7-5-9-21(24(18)38-39)20-8-4-6-17-13-33-27(2,3)37-23(17)20/h4-12,19,22H,13-15H2,1-3H3,(H,28,30,31)/t19-,22+,39?/m0/s1 D0E4GM DRUGINKE CCBOYGOTQIYLJA-CATCILLUSA-N D0E4GM DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)COP3(=O)OCC4=C(O3)C(=CC=C4)C5=CC=CC6=C5OC(OC6)(C)C D0E4GM HIGHSTAT Investigative D0E4HB DRUG__ID D0E4HB D0E4HB DRUGTYPE Small molecular drug D0E4HB DRUGINCH 1S/C15H17N3S/c1-3-7-12(8-4-1)14-11-19-15(16-14)18-17-13-9-5-2-6-10-13/h1,3-4,7-8,11H,2,5-6,9-10H2,(H,16,18) D0E4HB DRUGINKE RQMWJSWLKXHIEZ-UHFFFAOYSA-N D0E4HB DRUGSMIL C1CCC(=NNC2=NC(=CS2)C3=CC=CC=C3)CC1 D0E4HB HIGHSTAT Investigative D0E4JL DRUG__ID D0E4JL D0E4JL DRUGTYPE Small molecular drug D0E4JL DRUGINCH 1S/C19H25NOS.ClH/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21;/h3-7,13,16,21H,2,8-12,14H2,1H3;1H/t16-;/m0./s1 D0E4JL DRUGINKE CEXBONHIOKGWNU-NTISSMGPSA-N D0E4JL DRUGSMIL CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O.Cl D0E4JL HIGHSTAT Investigative D0E4JU DRUG__ID D0E4JU D0E4JU DRUGTYPE Small molecular drug D0E4JU DRUGINCH 1S/C14H13NO2/c1-15(17)14(16)9-7-11-6-8-12-4-2-3-5-13(12)10-11/h2-10,17H,1H3/b9-7+ D0E4JU DRUGINKE CORKVTFWNIPMDF-VQHVLOKHSA-N D0E4JU DRUGSMIL CN(C(=O)C=CC1=CC2=CC=CC=C2C=C1)O D0E4JU HIGHSTAT Investigative D0E4JX DRUG__ID D0E4JX D0E4JX DRUGTYPE Small molecular drug D0E4JX DRUGINCH 1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21?,22?,24?,25?,29-,32?,35+/m1/s1 D0E4JX DRUGINKE FVQSSYMRZKLFDR-UKWUEPKQSA-N D0E4JX DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC(C3=CC=CC=C3)NC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0E4JX HIGHSTAT Investigative D0E4KI DRUG__ID D0E4KI D0E4KI DRUGTYPE Small molecular drug D0E4KI DRUGINCH 1S/C15H17F4N3O2/c1-2-10(20)14(24)22-11-5-3-4-9(16)8(11)6-12(22)13(23)21-7-15(17,18)19/h3-5,10,12H,2,6-7,20H2,1H3,(H,21,23)/t10-,12+/m0/s1 D0E4KI DRUGINKE GNYDXSHWPPTVEX-CMPLNLGQSA-N D0E4KI DRUGSMIL CCC(C(=O)N1C(CC2=C1C=CC=C2F)C(=O)NCC(F)(F)F)N D0E4KI HIGHSTAT Investigative D0E4LB DRUG__ID D0E4LB D0E4LB DRUGTYPE Small molecular drug D0E4LB DRUGINCH 1S/C17H20N6O5/c1-27-22-15-12-16(21-11(20-15)6-4-2-3-5-7-18)23(9-19-12)17-14(26)13(25)10(8-24)28-17/h9-10,13-14,17,24-26H,2-3,5,8H2,1H3,(H,20,21,22)/t10-,13-,14-,17-/m1/s1 D0E4LB DRUGINKE SNWMEUXNYSKHNP-IWCJZZDYSA-N D0E4LB DRUGSMIL CONC1=C2C(=NC(=N1)C#CCCCC#N)N(C=N2)C3C(C(C(O3)CO)O)O D0E4LB HIGHSTAT Investigative D0E4LC DRUG__ID D0E4LC D0E4LC DRUGTYPE Small molecular drug D0E4LC DRUGINCH 1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35) D0E4LC DRUGINKE PEPOAPKYASCEKL-UHFFFAOYSA-N D0E4LC DRUGSMIL CC(C)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)NC5=CC=CC6=C5C=CC=N6)OC D0E4LC HIGHSTAT Investigative D0E4LU DRUG__ID D0E4LU D0E4LU DRUGTYPE Small molecular drug D0E4LU DRUGINCH 1S/C18H16FN3/c19-16-5-3-14(4-6-16)17-18(15-7-9-20-10-8-15)22(12-21-17)11-13-1-2-13/h3-10,12-13H,1-2,11H2 D0E4LU DRUGINKE ROKOFZNQCIIJMI-UHFFFAOYSA-N D0E4LU DRUGSMIL C1CC1CN2C=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F D0E4LU HIGHSTAT Investigative D0E4OT DRUG__ID D0E4OT D0E4OT DRUGTYPE Small molecular drug D0E4OT DRUGINCH 1S/C22H36O2/c1-4-5-14-22(2,3)19-11-8-18(9-12-19)21-16-20(24)13-10-17(21)7-6-15-23/h8-9,11-12,17,20-21,23-24H,4-7,10,13-16H2,1-3H3/t17-,20-,21-/m1/s1 D0E4OT DRUGINKE RSOWKGHGGWKLRF-DUXKGJEZSA-N D0E4OT DRUGSMIL CCCCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D0E4OT HIGHSTAT Investigative D0E4SM DRUG__ID D0E4SM D0E4SM DRUGTYPE Small molecular drug D0E4SM DRUGINCH 1S/C21H14N2O8/c24-19(12-4-3-5-13(10-12)23(29)30)22-17-6-1-2-7-18(17)31-14-8-9-15(20(25)26)16(11-14)21(27)28/h1-11H,(H,22,24)(H,25,26)(H,27,28) D0E4SM DRUGINKE NAQUAVBNIYTIIS-UHFFFAOYSA-N D0E4SM DRUGSMIL C1=CC=C(C(=C1)NC(=O)C2=CC(=CC=C2)[N+](=O)[O-])OC3=CC(=C(C=C3)C(=O)O)C(=O)O D0E4SM HIGHSTAT Investigative D0E4UI DRUG__ID D0E4UI D0E4UI DRUGTYPE Small molecular drug D0E4UI DRUGINCH 1S/C4H5N5O3/c5-2-1(9(11)12)3(10)8-4(6)7-2/h(H5,5,6,7,8,10) D0E4UI DRUGINKE XNFGVBWYGFPSDN-UHFFFAOYSA-N D0E4UI DRUGSMIL C1(=C(N=C(NC1=O)N)N)[N+](=O)[O-] D0E4UI HIGHSTAT Investigative D0E4UT DRUG__ID D0E4UT D0E4UT DRUGTYPE Small molecular drug D0E4UT DRUGINCH 1S/C9H11N5/c1-2-3-4-14-6-13-7-8(10)11-5-12-9(7)14/h2,5-6H,1,3-4H2,(H2,10,11,12) D0E4UT DRUGINKE LMZZJSTVOIDJFV-UHFFFAOYSA-N D0E4UT DRUGSMIL C=CCCN1C=NC2=C(N=CN=C21)N D0E4UT HIGHSTAT Investigative D0E4YP DRUG__ID D0E4YP D0E4YP DRUGTYPE Small molecular drug D0E4YP DRUGINCH 1S/C33H38N2O2.HI/c1-24-7-11-27(12-8-24)28-14-13-26-5-4-6-29(22-30(26)21-28)33(36)34-31-15-9-25(10-16-31)23-35(2,3)32-17-19-37-20-18-32;/h7-16,21-22,32H,4-6,17-20,23H2,1-3H3;1H D0E4YP DRUGINKE AYXBAIULRDEVAS-UHFFFAOYSA-N D0E4YP DRUGSMIL CC1=CC=C(C=C1)C2=CC3=C(CCCC(=C3)C(=O)NC4=CC=C(C=C4)C[N+](C)(C)C5CCOCC5)C=C2.[I-] D0E4YP HIGHSTAT Investigative D0E4YW DRUG__ID D0E4YW D0E4YW DRUGTYPE Small molecular drug D0E4YW DRUGINCH 1S/C14H22F2N5O12P3S/c1-2-3-37-13-19-10(17)7-11(20-13)21(5-18-7)12-9(23)8(22)6(32-12)4-31-36(29,30)33-35(27,28)14(15,16)34(24,25)26/h5-6,8-9,12,22-23H,2-4H2,1H3,(H,27,28)(H,29,30)(H2,17,19,20)(H2,24,25,26)/t6-,8-,9-,12-/m1/s1 D0E4YW DRUGINKE ZQXUQOHLHUWLSA-WOUKDFQISA-N D0E4YW DRUGSMIL CCCSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(F)(F)P(=O)(O)O)O)O)O)N D0E4YW HIGHSTAT Investigative D0E5CF DRUG__ID D0E5CF D0E5CF DRUGTYPE Small molecular drug D0E5CF DRUGINCH 1S/C13H23F3OS/c1-2-3-4-5-6-7-8-9-10-18-11-12(17)13(14,15)16/h2-11H2,1H3 D0E5CF DRUGINKE PGAJDYUDVRIKCP-UHFFFAOYSA-N D0E5CF DRUGSMIL CCCCCCCCCCSCC(=O)C(F)(F)F D0E5CF HIGHSTAT Investigative D0E5CI DRUG__ID D0E5CI D0E5CI DRUGTYPE Small molecular drug D0E5CI DRUGINCH 1S/C10H13N5/c1-5-14(6-2-11-1)9-10-13-4-8-15(10)7-3-12-9/h3-4,7-8,11H,1-2,5-6H2 D0E5CI DRUGINKE NSHLOJVJEGEMSF-UHFFFAOYSA-N D0E5CI DRUGSMIL C1CN(CCN1)C2=NC=CN3C2=NC=C3 D0E5CI HIGHSTAT Investigative D0E5EB DRUG__ID D0E5EB D0E5EB DRUGTYPE Small molecular drug D0E5EB DRUGINCH 1S/C8H15N3/c9-5-3-1-2-4-8-6-10-7-11-8/h6-7H,1-5,9H2,(H,10,11) D0E5EB DRUGINKE MZCJWLAXZRFUPI-UHFFFAOYSA-N D0E5EB DRUGSMIL C1=C(NC=N1)CCCCCN D0E5EB HIGHSTAT Investigative D0E5EW DRUG__ID D0E5EW D0E5EW DRUGTYPE Small molecular drug D0E5EW DRUGINCH 1S/C15H12N2O/c1-10-6-5-9-12-13(10)16-14(17-15(12)18)11-7-3-2-4-8-11/h2-9H,1H3,(H,16,17,18) D0E5EW DRUGINKE WLZJEOODSSBWMB-UHFFFAOYSA-N D0E5EW DRUGSMIL CC1=C2C(=CC=C1)C(=O)NC(=N2)C3=CC=CC=C3 D0E5EW HIGHSTAT Investigative D0E5FV DRUG__ID D0E5FV D0E5FV DRUGTYPE Small molecular drug D0E5FV DRUGINCH 1S/C20H18O6/c1-10(2)3-4-11-7-12(5-6-14(11)22)20-19(25)18(24)17-15(23)8-13(21)9-16(17)26-20/h3,5-9,21-23,25H,4H2,1-2H3 D0E5FV DRUGINKE PGCKDCPTJAQQSQ-UHFFFAOYSA-N D0E5FV DRUGSMIL CC(=CCC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)C D0E5FV HIGHSTAT Investigative D0E5HC DRUG__ID D0E5HC D0E5HC DRUGTYPE Small molecular drug D0E5HC DRUGINCH 1S/C12H13NO3/c1-16-9-3-4-11-10(6-9)8(7-13-11)2-5-12(14)15/h3-4,6-7,13H,2,5H2,1H3,(H,14,15) D0E5HC DRUGINKE ZLSZCJIWILJKMR-UHFFFAOYSA-N D0E5HC DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCC(=O)O D0E5HC HIGHSTAT Investigative D0E5IM DRUG__ID D0E5IM D0E5IM DRUGTYPE Small molecular drug D0E5IM DRUGINCH 1S/C16H12O10S/c1-24-11-4-7(2-3-9(11)18)15-16(26-27(21,22)23)14(20)13-10(19)5-8(17)6-12(13)25-15/h2-6,17-19H,1H3,(H,21,22,23) D0E5IM DRUGINKE CZFNXFXZXWDYMZ-UHFFFAOYSA-N D0E5IM DRUGSMIL COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OS(=O)(=O)O)O D0E5IM HIGHSTAT Investigative D0E5IP DRUG__ID D0E5IP D0E5IP DRUGTYPE Small molecular drug D0E5IP DRUGINCH 1S/C16H14BrN3O3/c1-22-14-6-10-12(7-15(14)23-2)18-8-19-16(10)20-9-3-4-13(21)11(17)5-9/h3-8,21H,1-2H3,(H,18,19,20) D0E5IP DRUGINKE CBIAKDAYHRWZCU-UHFFFAOYSA-N D0E5IP DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)O)Br)OC D0E5IP HIGHSTAT Investigative D0E5MB DRUG__ID D0E5MB D0E5MB DRUGTYPE Small molecular drug D0E5MB DRUGINCH 1S/C17H17ClO4S/c1-2-3-16(17(19)20)23(21,22)15-10-6-13(7-11-15)12-4-8-14(18)9-5-12/h4-11,16H,2-3H2,1H3,(H,19,20) D0E5MB DRUGINKE JGNJABZIGHTRNB-UHFFFAOYSA-N D0E5MB DRUGSMIL CCCC(C(=O)O)S(=O)(=O)C1=CC=C(C=C1)C2=CC=C(C=C2)Cl D0E5MB HIGHSTAT Investigative D0E5MK DRUG__ID D0E5MK D0E5MK DRUGTYPE Small molecular drug D0E5MK DRUGINCH 1S/C15H9Cl2NSe/c16-12-5-1-10(2-6-12)14-9-18-19-15(14)11-3-7-13(17)8-4-11/h1-9H D0E5MK DRUGINKE QKBSSPQBZVKIAU-UHFFFAOYSA-N D0E5MK DRUGSMIL C1=CC(=CC=C1C2=C([Se]N=C2)C3=CC=C(C=C3)Cl)Cl D0E5MK HIGHSTAT Investigative D0E5QB DRUG__ID D0E5QB D0E5QB DRUGTYPE Small molecular drug D0E5QB DRUGINCH 1S/C37H45NO8/c1-41-33-11-6-4-9-29(33)24-43-16-7-17-44-31-14-12-27(13-15-31)37-35(20-38-21-36(37)46-25-30(40)22-39)45-23-26-18-28-8-3-5-10-32(28)34(19-26)42-2/h3-6,8-15,18-19,30,35-40H,7,16-17,20-25H2,1-2H3/t30-,35+,36-,37-/m1/s1 D0E5QB DRUGINKE QYBJMSXQFYUZHD-ZLWKXDTISA-N D0E5QB DRUGSMIL COC1=CC=CC=C1COCCCOC2=CC=C(C=C2)C3C(CNCC3OCC(CO)O)OCC4=CC5=CC=CC=C5C(=C4)OC D0E5QB HIGHSTAT Investigative D0E5QE DRUG__ID D0E5QE D0E5QE DRUGTYPE Small molecular drug D0E5QE DRUGINCH 1S/C13H12N2O/c1-7-6-10-11(8(2)13(7)16)12-9(15-10)4-3-5-14-12/h3-6,15-16H,1-2H3 D0E5QE DRUGINKE ISLNUDFCPIKSRK-UHFFFAOYSA-N D0E5QE DRUGSMIL CC1=CC2=C(C(=C1O)C)C3=C(N2)C=CC=N3 D0E5QE HIGHSTAT Investigative D0E5QN DRUG__ID D0E5QN D0E5QN DRUGTYPE Small molecular drug D0E5QN DRUGINCH 1S/C24H31IN5O7P/c1-15(16-6-5-7-17(10-16)24(34)35)28-13-18(31)14-38(36,37)9-4-2-3-8-27-23(33)19-11-20(25)21(29-30-26)12-22(19)32/h5-7,10-12,15,18,28,31-32H,2-4,8-9,13-14H2,1H3,(H,27,33)(H,34,35)(H,36,37)/t15-,18+/m1/s1 D0E5QN DRUGINKE IHFUJPDKHJTHGQ-QAPCUYQASA-N D0E5QN DRUGSMIL CC(C1=CC(=CC=C1)C(=O)O)NCC(CP(=O)(CCCCCNC(=O)C2=CC(=C(C=C2O)N=[N+]=[N-])I)O)O D0E5QN HIGHSTAT Investigative D0E5UQ DRUG__ID D0E5UQ D0E5UQ DRUGTYPE Small molecular drug D0E5UQ DRUGINCH 1S/C9H4N4O4/c10-3-4-1-5-6(2-7(4)13(16)17)12-9(15)8(14)11-5/h1-2H,(H,11,14)(H,12,15) D0E5UQ DRUGINKE RPXVIAFEQBNEAX-UHFFFAOYSA-N D0E5UQ DRUGSMIL C1=C(C(=CC2=C1NC(=O)C(=O)N2)[N+](=O)[O-])C#N D0E5UQ HIGHSTAT Investigative D0E5VT DRUG__ID D0E5VT D0E5VT DRUGTYPE Small molecular drug D0E5VT DRUGINCH 1S/C16H13N/c1-2-6-12-11(5-1)9-10-14-13-7-3-4-8-15(13)17-16(12)14/h1-8,17H,9-10H2 D0E5VT DRUGINKE UPUQYBJFFYMNQK-UHFFFAOYSA-N D0E5VT DRUGSMIL C1CC2=C(C3=CC=CC=C31)NC4=CC=CC=C24 D0E5VT HIGHSTAT Investigative D0E5WS DRUG__ID D0E5WS D0E5WS DRUGTYPE Small molecular drug D0E5WS DRUGINCH 1S/C17H14O2/c1-11-3-6-13(7-4-11)17-10-15(18)14-9-12(2)5-8-16(14)19-17/h3-10H,1-2H3 D0E5WS DRUGINKE RDMTVGAVRNFIEE-UHFFFAOYSA-N D0E5WS DRUGSMIL CC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)C D0E5WS HIGHSTAT Investigative D0E5XM DRUG__ID D0E5XM D0E5XM DRUGTYPE Small molecular drug D0E5XM DRUGINCH 1S/C7H13N3/c8-4-2-1-3-7-5-9-6-10-7/h5-6H,1-4,8H2,(H,9,10) D0E5XM DRUGINKE VJSUMPPMFYQOMP-UHFFFAOYSA-N D0E5XM DRUGSMIL C1=C(NC=N1)CCCCN D0E5XM HIGHSTAT Investigative D0E5ZP DRUG__ID D0E5ZP D0E5ZP DRUGTYPE Small molecular drug D0E5ZP DRUGINCH 1S/C9H4F3NO2/c10-9(11,12)5-3-1-2-4-6(5)13-8(15)7(4)14/h1-3H,(H,13,14,15) D0E5ZP DRUGINKE MXLDJTXXAYVWDF-UHFFFAOYSA-N D0E5ZP DRUGSMIL C1=CC2=C(C(=C1)C(F)(F)F)NC(=O)C2=O D0E5ZP HIGHSTAT Investigative D0E6BA DRUG__ID D0E6BA D0E6BA DRUGTYPE Small molecular drug D0E6BA DRUGINCH 1S/C8H2Cl3N3O2/c9-3-1-4-6(5(2-3)14(15)16)13-8(11)7(10)12-4/h1-2H D0E6BA DRUGINKE DUBINERALUDRHX-UHFFFAOYSA-N D0E6BA DRUGSMIL C1=C(C=C(C2=C1N=C(C(=N2)Cl)Cl)[N+](=O)[O-])Cl D0E6BA HIGHSTAT Investigative D0E6BI DRUG__ID D0E6BI D0E6BI DRUGTYPE Small molecular drug D0E6BI DRUGINCH 1S/C12H16N4O3S/c1-20-3-6-10(17)11(18)8(16-6)5-2-13-9-7(5)14-4-15-12(9)19/h2,4,6,8,10-11,13,16-18H,3H2,1H3,(H,14,15,19)/t6-,8+,10-,11+/m1/s1 D0E6BI DRUGINKE CEGIKIXYDFDYDN-RXDXJJGDSA-N D0E6BI DRUGSMIL CSCC1C(C(C(N1)C2=CNC3=C2N=CNC3=O)O)O D0E6BI HIGHSTAT Investigative D0E6GC DRUG__ID D0E6GC D0E6GC DRUGTYPE Small molecular drug D0E6GC DRUGINCH 1S/C16H16N4O/c1-2-3-15(21)18-16-13-5-4-12(10-14(13)19-20-16)11-6-8-17-9-7-11/h4-10H,2-3H2,1H3,(H2,18,19,20,21) D0E6GC DRUGINKE BBNQSWZLWJBJIN-UHFFFAOYSA-N D0E6GC DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=NC=C3 D0E6GC HIGHSTAT Investigative D0E6GG DRUG__ID D0E6GG D0E6GG DRUGTYPE Small molecular drug D0E6GG DRUGINCH 1S/C19H19NO4/c1-2-3-12-23-19(22)20-18(21)17-13-8-4-6-10-15(13)24-16-11-7-5-9-14(16)17/h4-11,17H,2-3,12H2,1H3,(H,20,21,22) D0E6GG DRUGINKE RQBUXEUMZZQUFY-UHFFFAOYSA-N D0E6GG DRUGSMIL CCCCOC(=O)NC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13 D0E6GG HIGHSTAT Investigative D0E6GH DRUG__ID D0E6GH D0E6GH DRUGTYPE Small molecular drug D0E6GH DRUGINCH 1S/C29H33NO4/c31-22-11-10-21-17-24-29(33-16-4-7-19-5-2-1-3-6-19)13-12-23(32)27-28(29,25(21)26(22)34-27)14-15-30(24)18-20-8-9-20/h1-3,5-6,10-11,20,24,27,31H,4,7-9,12-18H2/t24-,27+,28+,29-/m1/s1 D0E6GH DRUGINKE KOXWKZKLXNZQAO-ZLPBPMGLSA-N D0E6GH DRUGSMIL C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)OCCCC7=CC=CC=C7 D0E6GH HIGHSTAT Investigative D0E6IT DRUG__ID D0E6IT D0E6IT DRUGTYPE Small molecular drug D0E6IT DRUGINCH 1S/C29H38N6O7/c1-17(2)11-23(29(41)42)35-28(40)22(14-18-7-4-3-5-8-18)34-25(37)16-32-24(36)15-33-27(39)21(30)13-19-9-6-10-20(12-19)26(31)38/h3-10,12,17,21-23H,11,13-16,30H2,1-2H3,(H2,31,38)(H,32,36)(H,33,39)(H,34,37)(H,35,40)(H,41,42)/t21-,22-,23-/m0/s1 D0E6IT DRUGINKE MKAKAIMBENCCEJ-VABKMULXSA-N D0E6IT DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC(=CC=C2)C(=O)N)N D0E6IT HIGHSTAT Investigative D0E6JS DRUG__ID D0E6JS D0E6JS DRUGTYPE Small molecular drug D0E6JS DRUGINCH 1S/C22H36O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-17-15-18-20(23)21(19)22(24)25/h15,17-18,23H,2-14,16H2,1H3,(H,24,25) D0E6JS DRUGINKE ADFWQBGTDJIESE-UHFFFAOYSA-N D0E6JS DRUGSMIL CCCCCCCCCCCCCCCC1=C(C(=CC=C1)O)C(=O)O D0E6JS HIGHSTAT Investigative D0E6JX DRUG__ID D0E6JX D0E6JX DRUGTYPE Small molecular drug D0E6JX DRUGINCH 1S/C33H38N4O6S/c1-33(2)30(31(41)36-28-24-11-7-6-10-21(24)17-26(28)38)37(19-44-33)32(42)29(40)25(16-20-8-4-3-5-9-20)35-27(39)18-43-23-14-12-22(34)13-15-23/h3-15,25-26,28-30,38,40H,16-19,34H2,1-2H3,(H,35,39)(H,36,41)/t25-,26+,28-,29-,30+/m0/s1 D0E6JX DRUGINKE YGKGGCBHYIMPFH-DOWNBTJOSA-N D0E6JX DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=C(C=C3)N)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0E6JX HIGHSTAT Investigative D0E6NW DRUG__ID D0E6NW D0E6NW DRUGTYPE Small molecular drug D0E6NW DRUGINCH 1S/C13H18N2O/c1-9(14)8-15-6-4-10-2-3-12-11(13(10)15)5-7-16-12/h2-3,9H,4-8,14H2,1H3/t9-/m0/s1 D0E6NW DRUGINKE OBQZQQHWYDPMDY-VIFPVBQESA-N D0E6NW DRUGSMIL CC(CN1CCC2=C1C3=C(C=C2)OCC3)N D0E6NW HIGHSTAT Investigative D0E6ON DRUG__ID D0E6ON D0E6ON DRUGTYPE Small molecular drug D0E6ON DRUGINCH 1S/C17H21N5O/c1-11-4-3-5-13(8-11)6-7-14(12(2)23)22-10-21-15-16(18)19-9-20-17(15)22/h3-5,8-10,12,14,23H,6-7H2,1-2H3,(H2,18,19,20)/t12-,14+/m0/s1 D0E6ON DRUGINKE VVISVMDMFZVYMH-GXTWGEPZSA-N D0E6ON DRUGSMIL CC1=CC(=CC=C1)CCC(C(C)O)N2C=NC3=C(N=CN=C32)N D0E6ON HIGHSTAT Investigative D0E6PQ DRUG__ID D0E6PQ D0E6PQ DRUGTYPE Small molecular drug D0E6PQ DRUGINCH 1S/C17H18FNO/c18-15-7-4-8-16(20-14-5-2-1-3-6-14)17(15)13-9-11-19-12-10-13/h1-8,13,19H,9-12H2 D0E6PQ DRUGINKE PTVWULKTBHSTNS-UHFFFAOYSA-N D0E6PQ DRUGSMIL C1CNCCC1C2=C(C=CC=C2F)OC3=CC=CC=C3 D0E6PQ HIGHSTAT Investigative D0E6RE DRUG__ID D0E6RE D0E6RE DRUGCOMP Lifelike Biomatic D0E6RE DRUGINCH 1S/C18H29N3O4S/c1-5-21-9-7-8-13(21)12-20-18(22)14-10-17(26(23,24)6-2)15(19-3)11-16(14)25-4/h10-11,13,19H,5-9,12H2,1-4H3,(H,20,22) D0E6RE DRUGINKE NXKXZXNNWRYXRE-UHFFFAOYSA-N D0E6RE DRUGSMIL CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)NC)S(=O)(=O)CC D0E6RE HIGHSTAT Investigative D0E6SO DRUG__ID D0E6SO D0E6SO DRUGTYPE Small molecular drug D0E6SO DRUGINCH 1S/C41H30O26/c42-15-1-10(2-16(43)26(15)50)36(57)65-34-33-23(9-62-39(60)13-7-21(48)29(53)31(55)24(13)25-14(40(61)64-33)8-22(49)30(54)32(25)56)63-41(67-38(59)12-5-19(46)28(52)20(47)6-12)35(34)66-37(58)11-3-17(44)27(51)18(45)4-11/h1-8,23,33-35,41-56H,9H2 D0E6SO DRUGINKE JCGHAEBIBSEQAD-UHFFFAOYSA-N D0E6SO DRUGSMIL C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)O1)O)O)O)O)O)O D0E6SO HIGHSTAT Investigative D0E6TO DRUG__ID D0E6TO D0E6TO DRUGTYPE Small molecular drug D0E6TO DRUGINCH 1S/C20H20O3/c1-3-4-10-22-16-7-5-6-15(12-16)20-13-18(21)17-11-14(2)8-9-19(17)23-20/h5-9,11-13H,3-4,10H2,1-2H3 D0E6TO DRUGINKE CFRCJBWAEQSCHB-UHFFFAOYSA-N D0E6TO DRUGSMIL CCCCOC1=CC=CC(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)C D0E6TO HIGHSTAT Investigative D0E7AZ DRUG__ID D0E7AZ D0E7AZ DRUGTYPE Small molecular drug D0E7AZ DRUGINCH 1S/C10H16N8S2/c1-14-9(16-6-11)15-2-3-19-4-7-5-20-10(17-7)18-8(12)13/h5H,2-4H2,1H3,(H2,14,15,16)(H4,12,13,17,18) D0E7AZ DRUGINKE YDDXVAXDYKBWDX-UHFFFAOYSA-N D0E7AZ DRUGSMIL CN=C(NCCSCC1=CSC(=N1)N=C(N)N)NC#N D0E7AZ HIGHSTAT Investigative D0E7BQ DRUG__ID D0E7BQ D0E7BQ DRUGTYPE Small molecular drug D0E7BQ DRUGINCH 1S/C10H13N5O2/c1-5-6(16)2-7(17-5)15-4-14-8-9(11)12-3-13-10(8)15/h3-7,16H,2H2,1H3,(H2,11,12,13)/t5-,6+,7-/m1/s1 D0E7BQ DRUGINKE FFHPXOJTVQDVMO-DSYKOEDSSA-N D0E7BQ DRUGSMIL CC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)O D0E7BQ HIGHSTAT Investigative D0E7BU DRUG__ID D0E7BU D0E7BU DRUGTYPE Small molecular drug D0E7BU DRUGINCH 1S/C44H55N5O7/c1-27-23-39(50)47-37-25-29(20-21-30(27)37)46-40(51)36(19-12-22-45-42(53)56-44(2,3)4)48-41(52)38(24-28-13-6-5-7-14-28)49-43(54)55-26-35-33-17-10-8-15-31(33)32-16-9-11-18-34(32)35/h8-11,15-18,20-21,23,25,28,31,33,35-36,38H,5-7,12-14,19,22,24,26H2,1-4H3,(H,45,53)(H,46,51)(H,47,50)(H,48,52)(H,49,54)/t31?,33?,35?,36-,38-/m0/s1 D0E7BU DRUGINKE DSRPDMJWEFCXMI-GHKFOJCISA-N D0E7BU DRUGSMIL CC1=CC(=O)NC2=C1C=CC(=C2)NC(=O)C(CCCNC(=O)OC(C)(C)C)NC(=O)C(CC3CCCCC3)NC(=O)OCC4C5C=CC=CC5C6=CC=CC=C46 D0E7BU HIGHSTAT Investigative D0E7ES DRUG__ID D0E7ES D0E7ES DRUGTYPE Small molecular drug D0E7ES DRUGINCH 1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1 D0E7ES DRUGINKE UHDGCWIWMRVCDJ-XVFCMESISA-N D0E7ES DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O D0E7ES HIGHSTAT Investigative D0E7FU DRUG__ID D0E7FU D0E7FU DRUGTYPE Small molecular drug D0E7FU DRUGINCH 1S/C15H13N3O2S/c16-12-7-1-2-9-14(12)21(19,20)18-13-8-3-5-11-6-4-10-17-15(11)13/h1-10,18H,16H2 D0E7FU DRUGINKE NIOOKXAMJQVDGB-UHFFFAOYSA-N D0E7FU DRUGSMIL C1=CC=C(C(=C1)N)S(=O)(=O)NC2=CC=CC3=C2N=CC=C3 D0E7FU HIGHSTAT Investigative D0E7LU DRUG__ID D0E7LU D0E7LU DRUGTYPE Small molecular drug D0E7LU DRUGINCH 1S/C8H9NO4/c9-7(8(12)13)4-1-5(10)3-6(11)2-4/h1-3,7,10-11H,9H2,(H,12,13) D0E7LU DRUGINKE HOOWCUZPEFNHDT-UHFFFAOYSA-N D0E7LU DRUGSMIL C1=C(C=C(C=C1O)O)C(C(=O)O)N D0E7LU HIGHSTAT Investigative D0E7NL DRUG__ID D0E7NL D0E7NL DRUGTYPE Small molecular drug D0E7NL DRUGINCH 1S/C40H50N4O6/c1-24-18-31(45)19-25(2)32(24)22-33(41)39(48)44-23-30-17-11-10-16-29(30)21-35(44)37(46)43-36(26(3)28-14-8-5-9-15-28)38(47)42-34(40(49)50)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,45H,5,8-9,14-15,20-23,41H2,1-3H3,(H,42,47)(H,43,46)(H,49,50)/t26-,33-,34-,35?,36-/m0/s1 D0E7NL DRUGINKE GWHRSTGESQKJIQ-VERNRBRGSA-N D0E7NL DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)N)C)O D0E7NL HIGHSTAT Investigative D0E7NO DRUG__ID D0E7NO D0E7NO DRUGTYPE Small molecular drug D0E7NO DRUGINCH 1S/C10H20O2/c1-2-3-4-5-6-7-8-9-10(11)12/h2-9H2,1H3,(H,11,12) D0E7NO DRUGINKE GHVNFZFCNZKVNT-UHFFFAOYSA-N D0E7NO DRUGSMIL CCCCCCCCCC(=O)O D0E7NO HIGHSTAT Investigative D0E7PY DRUG__ID D0E7PY D0E7PY DRUGTYPE Small molecular drug D0E7PY DRUGINCH 1S/C13H8BrF2N5/c14-7-1-2-9-8(3-7)13-17-5-19-21(13)4-10-11(12(15)16)18-6-20(9)10/h1-3,5-6,12H,4H2 D0E7PY DRUGINKE AFJRYPJIKHMNGL-UHFFFAOYSA-N D0E7PY DRUGSMIL C1C2=C(N=CN2C3=C(C=C(C=C3)Br)C4=NC=NN41)C(F)F D0E7PY HIGHSTAT Investigative D0E7RI DRUG__ID D0E7RI D0E7RI DRUGTYPE Small molecular drug D0E7RI DRUGINCH 1S/C23H28N2/c1-18-11-13-21(14-12-18)25-17-20(22-9-5-6-10-23(22)25)16-24-15-19-7-3-2-4-8-19/h5-6,9-14,17,19,24H,2-4,7-8,15-16H2,1H3 D0E7RI DRUGINKE MMIJMYOYKAKQPN-UHFFFAOYSA-N D0E7RI DRUGSMIL CC1=CC=C(C=C1)N2C=C(C3=CC=CC=C32)CNCC4CCCCC4 D0E7RI HIGHSTAT Investigative D0E7SH DRUG__ID D0E7SH D0E7SH DRUGTYPE Small molecular drug D0E7SH DRUGINCH 1S/C9H13ClN2O2/c1-2-3-4-5-6-7(10)11-9(14)12-8(6)13/h2-5H2,1H3,(H2,11,12,13,14) D0E7SH DRUGINKE XCFUGRSUKUUBGJ-UHFFFAOYSA-N D0E7SH DRUGSMIL CCCCCC1=C(NC(=O)NC1=O)Cl D0E7SH HIGHSTAT Investigative D0E7TO DRUG__ID D0E7TO D0E7TO DRUGTYPE Small molecular drug D0E7TO DRUGINCH 1S/C9H10BrN3S/c1-6(12-13-9(11)14)7-2-4-8(10)5-3-7/h2-5H,1H3,(H3,11,13,14)/b12-6- D0E7TO DRUGINKE OKNJXRBJRXAECS-SDQBBNPISA-N D0E7TO DRUGSMIL CC(=NNC(=S)N)C1=CC=C(C=C1)Br D0E7TO HIGHSTAT Investigative D0E7UH DRUG__ID D0E7UH D0E7UH DRUGTYPE Small molecular drug D0E7UH DRUGINCH 1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1- D0E7UH DRUGINKE VZCYOOQTPOCHFL-UPHRSURJSA-N D0E7UH DRUGSMIL C(=CC(=O)O)C(=O)O D0E7UH HIGHSTAT Investigative D0E7UW DRUG__ID D0E7UW D0E7UW DRUGTYPE Small molecular drug D0E7UW DRUGINCH 1S/C22H24N2O4S/c25-20(14-23-21(26)19(29)13-15-7-3-1-4-8-15)24-17(11-12-18(24)22(27)28)16-9-5-2-6-10-16/h1-10,17-19,29H,11-14H2,(H,23,26)(H,27,28)/t17-,18+,19+/m1/s1 D0E7UW DRUGINKE ZWDQTNWLXALTOV-QYZOEREBSA-N D0E7UW DRUGSMIL C1CC(N(C1C2=CC=CC=C2)C(=O)CNC(=O)C(CC3=CC=CC=C3)S)C(=O)O D0E7UW HIGHSTAT Investigative D0E7VO DRUG__ID D0E7VO D0E7VO DRUGTYPE Small molecular drug D0E7VO DRUGINCH 1S/C19H20FN7O/c1-11(2)28-18-8-17(25-26-18)27-10-22-15-6-7-16(24-19(15)27)23-12(3)14-5-4-13(20)9-21-14/h4-12H,1-3H3,(H,23,24)(H,25,26)/t12-/m0/s1 D0E7VO DRUGINKE FZBVNCFBCNXULH-LBPRGKRZSA-N D0E7VO DRUGSMIL CC(C)OC1=NNC(=C1)N2C=NC3=C2N=C(C=C3)NC(C)C4=NC=C(C=C4)F D0E7VO HIGHSTAT Investigative D0E7XR DRUG__ID D0E7XR D0E7XR DRUGTYPE Small molecular drug D0E7XR DRUGINCH 1S/C36H44N4O6S/c1-21-15-25(37-5)16-22(2)32(21)46-19-29(42)38-27(17-23-11-7-6-8-12-23)31(43)35(45)40-20-47-36(3,4)33(40)34(44)39-30-26-14-10-9-13-24(26)18-28(30)41/h6-16,27-28,30-31,33,37,41,43H,17-20H2,1-5H3,(H,38,42)(H,39,44)/t27-,28+,30-,31-,33+/m0/s1 D0E7XR DRUGINKE MFQZSFZGLACSHP-LPOYSWGPSA-N D0E7XR DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NC D0E7XR HIGHSTAT Investigative D0E7YE DRUG__ID D0E7YE D0E7YE DRUGTYPE Small molecular drug D0E7YE DRUGINCH 1S/C23H16N4/c1-4-10-16(11-5-1)19-20-23(26-21(24-19)17-12-6-2-7-13-17)27-22(25-20)18-14-8-3-9-15-18/h1-15H,(H,24,25,26,27) D0E7YE DRUGINKE UHWGSYGCZUMSMO-UHFFFAOYSA-N D0E7YE DRUGSMIL C1=CC=C(C=C1)C2=C3C(=NC(=N2)C4=CC=CC=C4)N=C(N3)C5=CC=CC=C5 D0E7YE HIGHSTAT Investigative D0E7YK DRUG__ID D0E7YK D0E7YK DRUGTYPE Small molecular drug D0E7YK DRUGINCH 1S/C11H14ClNO2/c12-10-3-1-8(2-4-10)9(5-6-13)7-11(14)15/h1-4,9H,5-7,13H2,(H,14,15)/t9-/m1/s1 D0E7YK DRUGINKE QXAGSDSDBMVSQR-SECBINFHSA-N D0E7YK DRUGSMIL C1=CC(=CC=C1C(CCN)CC(=O)O)Cl D0E7YK HIGHSTAT Investigative D0E8CC DRUG__ID D0E8CC D0E8CC DRUGTYPE Small molecular drug D0E8CC DRUGINCH 1S/C8H8N4O4S3/c9-18(13,14)8-11-10-7(17-8)12-19(15,16)6-4-2-1-3-5-6/h1-5H,(H,10,12)(H2,9,13,14) D0E8CC DRUGINKE PWDGTQXZLNDOKS-UHFFFAOYSA-N D0E8CC DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=NN=C(S2)S(=O)(=O)N D0E8CC HIGHSTAT Investigative D0E8DM DRUG__ID D0E8DM D0E8DM DRUGTYPE Small molecular drug D0E8DM DRUGINCH 1S/C15H10N4/c16-9-12-4-3-5-14(8-12)19-11-13(10-18-19)15-6-1-2-7-17-15/h1-8,10-11H D0E8DM DRUGINKE SLFBHONCPFNHGU-UHFFFAOYSA-N D0E8DM DRUGSMIL C1=CC=NC(=C1)C2=CN(N=C2)C3=CC=CC(=C3)C#N D0E8DM HIGHSTAT Investigative D0E8DX DRUG__ID D0E8DX D0E8DX DRUGTYPE Small molecular drug D0E8DX DRUGINCH 1S/C14H12N2S/c17-14-6-4-11-8-10(3-5-13(11)16-14)12-2-1-7-15-9-12/h1-3,5,7-9H,4,6H2,(H,16,17) D0E8DX DRUGINKE BBIRVEDVKRWBOZ-UHFFFAOYSA-N D0E8DX DRUGSMIL C1CC(=S)NC2=C1C=C(C=C2)C3=CN=CC=C3 D0E8DX HIGHSTAT Investigative D0E8FG DRUG__ID D0E8FG D0E8FG DRUGTYPE Small molecular drug D0E8FG DRUGINCH 1S/C21H29NS/c1-2-8-14-21(13-7-1,22-15-9-3-4-10-16-22)20-17-18-11-5-6-12-19(18)23-20/h5-6,11-12,17H,1-4,7-10,13-16H2 D0E8FG DRUGINKE SHYAOKYYAHMSCY-UHFFFAOYSA-N D0E8FG DRUGSMIL C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCCCC4 D0E8FG HIGHSTAT Investigative D0E8HU DRUG__ID D0E8HU D0E8HU DRUGTYPE Small molecular drug D0E8HU DRUGINCH 1S/C10H12FN/c11-6-10-5-8-3-1-2-4-9(8)7-12-10/h1-4,10,12H,5-7H2 D0E8HU DRUGINKE SLBKHMRNZGCZIO-UHFFFAOYSA-N D0E8HU DRUGSMIL C1C(NCC2=CC=CC=C21)CF D0E8HU HIGHSTAT Investigative D0E8IE DRUG__ID D0E8IE D0E8IE DRUGTYPE Small molecular drug D0E8IE DRUGINCH 1S/C17H11NO5/c19-15(18-12-7-5-10(6-8-12)16(20)21)13-9-11-3-1-2-4-14(11)23-17(13)22/h1-9H,(H,18,19)(H,20,21) D0E8IE DRUGINKE IMGLCZZPWOJMLB-UHFFFAOYSA-N D0E8IE DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)O2)C(=O)NC3=CC=C(C=C3)C(=O)O D0E8IE HIGHSTAT Investigative D0E8IH DRUG__ID D0E8IH D0E8IH DRUGTYPE Small molecular drug D0E8IH DRUGINCH 1S/C17H14O3/c1-11-7-8-16-13(9-11)14(18)10-17(20-16)12-5-3-4-6-15(12)19-2/h3-10H,1-2H3 D0E8IH DRUGINKE QEIHFNZSIRWEBX-UHFFFAOYSA-N D0E8IH DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3OC D0E8IH HIGHSTAT Investigative D0E8IJ DRUG__ID D0E8IJ D0E8IJ DRUGTYPE Small molecular drug D0E8IJ DRUGINCH 1S/C17H12N2O/c1-11-2-3-13-4-5-14(9-17(13)19-11)15-6-12(10-18)7-16(20)8-15/h2-9,20H,1H3 D0E8IJ DRUGINKE DYISJDYQAJMMQY-UHFFFAOYSA-N D0E8IJ DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)O D0E8IJ HIGHSTAT Investigative D0E8JM DRUG__ID D0E8JM D0E8JM DRUGTYPE Small molecular drug D0E8JM DRUGINCH 1S/C3H7NO4S/c4-2(3(5)6)1-9(7)8/h2H,1,4H2,(H,5,6)(H,7,8)/t2-/m0/s1 D0E8JM DRUGINKE ADVPTQAUNPRNPO-REOHCLBHSA-N D0E8JM DRUGSMIL C(C(C(=O)O)N)S(=O)O D0E8JM HIGHSTAT Investigative D0E8KF DRUG__ID D0E8KF D0E8KF DRUGTYPE Small molecular drug D0E8KF DRUGINCH 1S/C9H12N2O2/c1-3-13-9-6-4-5-8(11-9)10-7(2)12/h4-6H,3H2,1-2H3,(H,10,11,12) D0E8KF DRUGINKE NSIROEGSOFOSDV-UHFFFAOYSA-N D0E8KF DRUGSMIL CCOC1=CC=CC(=N1)NC(=O)C D0E8KF HIGHSTAT Investigative D0E8KR DRUG__ID D0E8KR D0E8KR DRUGTYPE Small molecular drug D0E8KR DRUGINCH 1S/C13H19N3O3/c17-12(15-11-7-5-6-10-14-11)8-3-1-2-4-9-13(18)16-19/h5-7,10,19H,1-4,8-9H2,(H,16,18)(H,14,15,17) D0E8KR DRUGINKE UVYVSYPVDVIKCC-UHFFFAOYSA-N D0E8KR DRUGSMIL C1=CC=NC(=C1)NC(=O)CCCCCCC(=O)NO D0E8KR HIGHSTAT Investigative D0E8RA DRUG__ID D0E8RA D0E8RA DRUGTYPE Small molecular drug D0E8RA DRUGINCH 1S/C8H10BrN5O2/c9-8-13-5-6(10)11-3-12-7(5)14(8)1-4(16)2-15/h3-4,15-16H,1-2H2,(H2,10,11,12) D0E8RA DRUGINKE XXTHNUCUAMMCPB-UHFFFAOYSA-N D0E8RA DRUGSMIL C1=NC(=C2C(=N1)N(C(=N2)Br)CC(CO)O)N D0E8RA HIGHSTAT Investigative D0E8TW DRUG__ID D0E8TW D0E8TW DRUGTYPE Small molecular drug D0E8TW DRUGINCH 1S/C15H24N2O16P2S.2Na/c18-3-5-8(20)10(22)12(24)14(31-5)32-35(27,28)33-34(25,26)29-4-6-9(21)11(23)13(30-6)17-2-1-7(19)16-15(17)36;;/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,25,26)(H,27,28)(H,16,19,36);;/q;2*+1/p-2/t5-,6-,8-,9-,10+,11-,12-,13-,14-;;/m1../s1 D0E8TW DRUGINKE TYVFMVSNSGMZPA-QBNUFUENSA-L D0E8TW DRUGSMIL C1=CN(C(=S)NC1=O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])OC3C(C(C(C(O3)CO)O)O)O)O)O.[Na+].[Na+] D0E8TW HIGHSTAT Investigative D0E8UH DRUG__ID D0E8UH D0E8UH DRUGTYPE Small molecular drug D0E8UH DRUGINCH 1S/C31H41N5O5S2/c1-31(2)30(40)34-24(21-41-20-22-12-5-3-6-13-22)29(39)36-18-11-15-25(36)28(38)33-23(27(37)35-31)14-7-4-10-19-42-43-26-16-8-9-17-32-26/h3,5-6,8-9,12-13,16-17,23-25H,4,7,10-11,14-15,18-21H2,1-2H3,(H,33,38)(H,34,40)(H,35,37)/t23-,24-,25+/m0/s1 D0E8UH DRUGINKE UAUCMCUCWAXYRK-CCDWMCETSA-N D0E8UH DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)COCC4=CC=CC=C4)C D0E8UH HIGHSTAT Investigative D0E8VD DRUG__ID D0E8VD D0E8VD DRUGTYPE Small molecular drug D0E8VD DRUGINCH 1S/C25H28O5/c1-13(2)5-6-16-19(26)8-7-15-18-12-28-21-11-20-14(10-22(27)25(3,4)30-20)9-17(21)24(18)29-23(15)16/h5,7-9,11,18,22,24,26-27H,6,10,12H2,1-4H3/t18-,22?,24-/m0/s1 D0E8VD DRUGINKE HAOOQCMPFMLAJM-HRKCMRQESA-N D0E8VD DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3C2COC4=C3C=C5CC(C(OC5=C4)(C)C)O)O)C D0E8VD HIGHSTAT Investigative D0E8ZH DRUG__ID D0E8ZH D0E8ZH DRUGTYPE Small molecular drug D0E8ZH DRUGINCH 1S/C25H24N6O/c1-30-10-12-31(13-11-30)18-5-9-21-23(15-18)29-25(27-21)17-4-8-20-22(14-17)28-24(26-20)16-2-6-19(32)7-3-16/h2-9,14-15,32H,10-13H2,1H3,(H,26,28)(H,27,29) D0E8ZH DRUGINKE INAAIJLSXJJHOZ-UHFFFAOYSA-N D0E8ZH DRUGSMIL CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC=C(C=C6)O D0E8ZH HIGHSTAT Investigative D0E9AL DRUG__ID D0E9AL D0E9AL DRUGTYPE Small molecular drug D0E9AL DRUGINCH 1S/C20H20O7P2/c21-20(28(22,23)24,29(25,26)27)14-15-5-4-8-19(13-15)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27) D0E9AL DRUGINKE MPBUFKZCEBTBSK-UHFFFAOYSA-N D0E9AL DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=CC(=C3)CC(O)(P(=O)(O)O)P(=O)(O)O D0E9AL HIGHSTAT Investigative D0E9AY DRUG__ID D0E9AY D0E9AY DRUGTYPE Small molecular drug D0E9AY DRUGINCH 1S/C23H32O4/c1-15(2)8-6-9-16(3)10-7-11-17(4)12-13-19-20(24)14-18(5)21(22(19)25)23(26)27/h8,10,12,14,24-25H,6-7,9,11,13H2,1-5H3,(H,26,27)/b16-10+,17-12+ D0E9AY DRUGINKE QPIZDZGIXDKCRC-JTCWOHKRSA-N D0E9AY DRUGSMIL CC1=CC(=C(C(=C1C(=O)O)O)CC=C(C)CCC=C(C)CCC=C(C)C)O D0E9AY HIGHSTAT Investigative D0E9CG DRUG__ID D0E9CG D0E9CG DRUGTYPE Small molecular drug D0E9CG DRUGINCH 1S/C17H16N2O2/c1-2-12-18-15-11-7-6-10-14(15)16(20)19(17(18)21)13-8-4-3-5-9-13/h3-11H,2,12H2,1H3 D0E9CG DRUGINKE HDWMSIFMWUKWBC-UHFFFAOYSA-N D0E9CG DRUGSMIL CCCN1C2=CC=CC=C2C(=O)N(C1=O)C3=CC=CC=C3 D0E9CG HIGHSTAT Investigative D0E9CT DRUG__ID D0E9CT D0E9CT DRUGTYPE Small molecular drug D0E9CT DRUGINCH 1S/C26H23N3O/c30-26(19-9-10-24-18(17-19)11-12-27-24)29-15-13-28(14-16-29)25-22-7-3-1-5-20(22)21-6-2-4-8-23(21)25/h1-12,17,25,27H,13-16H2 D0E9CT DRUGINKE YYMZSGIXLQPFAC-UHFFFAOYSA-N D0E9CT DRUGSMIL C1CN(CCN1C2C3=CC=CC=C3C4=CC=CC=C24)C(=O)C5=CC6=C(C=C5)NC=C6 D0E9CT HIGHSTAT Investigative D0E9DD DRUG__ID D0E9DD D0E9DD DRUGTYPE Small molecular drug D0E9DD DRUGINCH 1S/C27H38N4O6/c1-16(2)23-27(37)28-18(4)25(35)30-21(15-19-11-7-5-8-12-19)26(36)29-20(17(3)24(34)31-23)13-9-6-10-14-22(32)33/h5-9,11-12,16-18,20-21,23H,10,13-15H2,1-4H3,(H,28,37)(H,29,36)(H,30,35)(H,31,34)(H,32,33)/b9-6-/t17-,18+,20+,21+,23+/m0/s1 D0E9DD DRUGINKE DMXROUYLQHFRCS-GIORXHJXSA-N D0E9DD DRUGSMIL CC1C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C)CC2=CC=CC=C2)CC=CCCC(=O)O D0E9DD HIGHSTAT Investigative D0E9DE DRUG__ID D0E9DE D0E9DE DRUGTYPE Small molecular drug D0E9DE DRUGINCH 1S/C24H21F3N4OS/c1-23(2,3)17-7-4-5-9-19(17)32-20-18(8-6-14-28-20)29-22-31-30-21(33-22)15-10-12-16(13-11-15)24(25,26)27/h4-14H,1-3H3,(H,29,31) D0E9DE DRUGINKE ROIKEXLVELZTIZ-UHFFFAOYSA-N D0E9DE DRUGSMIL CC(C)(C)C1=CC=CC=C1OC2=C(C=CC=N2)NC3=NN=C(S3)C4=CC=C(C=C4)C(F)(F)F D0E9DE HIGHSTAT Investigative D0E9DI DRUG__ID D0E9DI D0E9DI DRUGTYPE Small molecular drug D0E9DI DRUGINCH 1S/C18H14N4/c1-13-7-9-16(10-8-13)21-18-20-12-15(11-19)17(22-18)14-5-3-2-4-6-14/h2-10,12H,1H3,(H,20,21,22) D0E9DI DRUGINKE OBWJJSHWDHTFAP-UHFFFAOYSA-N D0E9DI DRUGSMIL CC1=CC=C(C=C1)NC2=NC=C(C(=N2)C3=CC=CC=C3)C#N D0E9DI HIGHSTAT Investigative D0E9EH DRUG__ID D0E9EH D0E9EH DRUGTYPE Small molecular drug D0E9EH DRUGINCH 1S/C17H25F3N4O5/c1-8(13(26)17(18,19)20)22-15(28)12-6-5-7-24(12)16(29)10(3)23-14(27)9(2)21-11(4)25/h8-10,12H,5-7H2,1-4H3,(H,21,25)(H,22,28)(H,23,27)/t8-,9-,10-,12-/m0/s1 D0E9EH DRUGINKE WGJCUKQNQHAXLF-GMOBBJLQSA-N D0E9EH DRUGSMIL CC(C(=O)C(F)(F)F)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(C)NC(=O)C D0E9EH HIGHSTAT Investigative D0E9FD DRUG__ID D0E9FD D0E9FD DRUGTYPE Small molecular drug D0E9FD DRUGINCH 1S/C22H31N5O4S/c1-9-31-15-11-10-13(32(29,30)26-22(5,6)7)12-14(15)19-23-16-17(20(28)24-19)27(8)25-18(16)21(2,3)4/h10-12,26H,9H2,1-8H3,(H,23,24,28) D0E9FD DRUGINKE VMVZVLPMWCBOFI-UHFFFAOYSA-N D0E9FD DRUGSMIL CCOC1=C(C=C(C=C1)S(=O)(=O)NC(C)(C)C)C2=NC3=C(C(=O)N2)N(N=C3C(C)(C)C)C D0E9FD HIGHSTAT Investigative D0E9HC DRUG__ID D0E9HC D0E9HC DRUGTYPE Small molecular drug D0E9HC DRUGINCH 1S/C20H16Cl2N2O/c21-16-10-6-14(7-11-16)19(15-8-12-17(22)13-9-15)24-20(25)23-18-4-2-1-3-5-18/h1-13,19H,(H2,23,24,25) D0E9HC DRUGINKE VLXCCHGDBPKKAK-UHFFFAOYSA-N D0E9HC DRUGSMIL C1=CC=C(C=C1)NC(=O)NC(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl D0E9HC HIGHSTAT Investigative D0E9HW DRUG__ID D0E9HW D0E9HW DRUGTYPE Small molecular drug D0E9HW DRUGINCH 1S/C25H34O8/c1-5-9-31-14-32-18-11-17(22(27)29-4)24(2)8-6-16-23(28)33-19(15-7-10-30-13-15)12-25(16,3)21(24)20(18)26/h7,10,13,16-19,21H,5-6,8-9,11-12,14H2,1-4H3/t16-,17-,18-,19-,21-,24-,25-/m0/s1 D0E9HW DRUGINKE WNDQODUGHMFWNT-BYDLNXCSSA-N D0E9HW DRUGSMIL CCCOCOC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D0E9HW HIGHSTAT Investigative D0E9HY DRUG__ID D0E9HY D0E9HY DRUGTYPE Small molecular drug D0E9HY DRUGINCH 1S/C18H13ClF6N2O3/c1-9(15(28)26-14-4-2-13(19)3-5-14)30-27-16(29)10-6-11(17(20,21)22)8-12(7-10)18(23,24)25/h2-9H,1H3,(H,26,28)(H,27,29) D0E9HY DRUGINKE DSMXVSGJIDFLKP-UHFFFAOYSA-N D0E9HY DRUGSMIL CC(C(=O)NC1=CC=C(C=C1)Cl)ONC(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F D0E9HY HIGHSTAT Investigative D0E9IM DRUG__ID D0E9IM D0E9IM DRUGTYPE Small molecular drug D0E9IM DRUGINCH 1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m1/s1 D0E9IM DRUGINKE CKLJMWTZIZZHCS-UWTATZPHSA-M D0E9IM DRUGSMIL C(C(C(=O)[O-])N)C(=O)O D0E9IM HIGHSTAT Investigative D0E9JD DRUG__ID D0E9JD D0E9JD DRUGTYPE Small molecular drug D0E9JD DRUGINCH 1S/C23H24F2N2O2/c1-23(2,3)29-22(28)27-14-17(19-12-18(24)8-9-20(19)25)11-15-10-16-6-4-5-7-21(16)26-13-15/h4-10,12-13,17H,11,14H2,1-3H3,(H,27,28)/t17-/m1/s1 D0E9JD DRUGINKE IRFHMTUHTBSEBK-QGZVFWFLSA-N D0E9JD DRUGSMIL CC(C)(C)OC(=O)NCC(CC1=CC2=CC=CC=C2N=C1)C3=C(C=CC(=C3)F)F D0E9JD HIGHSTAT Investigative D0E9JR DRUG__ID D0E9JR D0E9JR DRUGTYPE Small molecular drug D0E9JR DRUGINCH 1S/C13H11N3O2/c1-2-18-13(17)9(7-14)12-8-15-10-5-3-4-6-11(10)16-12/h3-6,8-9H,2H2,1H3 D0E9JR DRUGINKE KKQBQZXMEPUMLX-UHFFFAOYSA-N D0E9JR DRUGSMIL CCOC(=O)C(C#N)C1=NC2=CC=CC=C2N=C1 D0E9JR HIGHSTAT Investigative D0E9KB DRUG__ID D0E9KB D0E9KB DRUGTYPE Small molecular drug D0E9KB DRUGINCH 1S/C21H29N3O2/c1-3-5-15-25-19-11-7-17(8-12-19)23-21(22)24-18-9-13-20(14-10-18)26-16-6-4-2/h7-14H,3-6,15-16H2,1-2H3,(H3,22,23,24) D0E9KB DRUGINKE UEKORNPZBHKKRD-UHFFFAOYSA-N D0E9KB DRUGSMIL CCCCOC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)OCCCC)N D0E9KB HIGHSTAT Investigative D0E9LJ DRUG__ID D0E9LJ D0E9LJ DRUGTYPE Small molecular drug D0E9LJ DRUGINCH 1S/C15H23N5O14P2/c16-13-9-14(18-4-17-13)20(5-19-9)15-12(26)11(25)8(33-15)3-32-36(29,30)34-35(27,28)31-2-7(23)10(24)6(22)1-21/h1,4-8,10-12,15,22-26H,2-3H2,(H,27,28)(H,29,30)(H2,16,17,18)/t6-,7+,8+,10-,11+,12+,15+/m0/s1 D0E9LJ DRUGINKE PWJFNRJRHXWEPT-AOOZFPJJSA-N D0E9LJ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OCC(C(C(C=O)O)O)O)O)O)N D0E9LJ HIGHSTAT Investigative D0E9MC DRUG__ID D0E9MC D0E9MC DRUGTYPE Small molecular drug D0E9MC DRUGINCH 1S/C21H24N2/c1-2-3-9-15-22-20-14-16-23(17-18-10-5-4-6-11-18)21-13-8-7-12-19(20)21/h4-8,10-14,16H,2-3,9,15,17H2,1H3 D0E9MC DRUGINKE MMGAVKCAGQCFHS-UHFFFAOYSA-N D0E9MC DRUGSMIL CCCCCN=C1C=CN(C2=CC=CC=C12)CC3=CC=CC=C3 D0E9MC HIGHSTAT Investigative D0E9NJ DRUG__ID D0E9NJ D0E9NJ DRUGTYPE Small molecular drug D0E9NJ DRUGINCH 1S/C17H15NO5/c1-11(19)18-12-7-9-13(10-8-12)21-17(2)22-15-6-4-3-5-14(15)16(20)23-17/h3-10H,1-2H3,(H,18,19) D0E9NJ DRUGINKE ZAPRLADYRFPQSH-UHFFFAOYSA-N D0E9NJ DRUGSMIL CC(=O)NC1=CC=C(C=C1)OC2(OC3=CC=CC=C3C(=O)O2)C D0E9NJ HIGHSTAT Investigative D0E9NT DRUG__ID D0E9NT D0E9NT DRUGTYPE Small molecular drug D0E9NT DRUGINCH 1S/C7H6O5/c8-4-2-1-3(7(11)12)5(9)6(4)10/h1-2,8-10H,(H,11,12) D0E9NT DRUGINKE BRRSNXCXLSVPFC-UHFFFAOYSA-N D0E9NT DRUGSMIL C1=CC(=C(C(=C1C(=O)O)O)O)O D0E9NT HIGHSTAT Investigative D0E9ON DRUG__ID D0E9ON D0E9ON DRUGTYPE Small molecular drug D0E9ON DRUGINCH 1S/C20H31BN4O5/c1-14(26)23-16(13-15-7-3-2-4-8-15)20(28)25-12-6-9-17(25)19(27)24-18(21(29)30)10-5-11-22/h2-4,7-8,16-18,29-30H,5-6,9-13,22H2,1H3,(H,23,26)(H,24,27)/t16-,17+,18+/m1/s1 D0E9ON DRUGINKE YKWKWNKWBGQECF-SQNIBIBYSA-N D0E9ON DRUGSMIL B(C(CCCN)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)C)(O)O D0E9ON HIGHSTAT Investigative D0E9PL DRUG__ID D0E9PL D0E9PL DRUGTYPE Small molecular drug D0E9PL DRUGINCH 1S/C10H7FN2O2/c11-8-7(6-4-2-1-3-5-6)9(14)13-10(15)12-8/h1-5H,(H2,12,13,14,15) D0E9PL DRUGINKE BMLADZLRZDTUAA-UHFFFAOYSA-N D0E9PL DRUGSMIL C1=CC=C(C=C1)C2=C(NC(=O)NC2=O)F D0E9PL HIGHSTAT Investigative D0E9QX DRUG__ID D0E9QX D0E9QX DRUGTYPE Small molecular drug D0E9QX DRUGINCH 1S/C19H23N5O4/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-16(27)15(26)13(8-25)28-19/h2-6,9-11,13,15-16,19,25-27H,7-8H2,1H3,(H,20,21,23)/t11-,13+,15+,16+,19+/m0/s1 D0E9QX DRUGINKE RIRGCFBBHQEQQH-KFAHYOAQSA-N D0E9QX DRUGSMIL CC(CC1=CC=CC=C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D0E9QX HIGHSTAT Investigative D0E9SR DRUG__ID D0E9SR D0E9SR DRUGTYPE Small molecular drug D0E9SR DRUGINCH 1S/C14H16ClN3O/c1-17-4-6-18(7-5-17)14(19)13-9-10-8-11(15)2-3-12(10)16-13/h2-3,8-9,16H,4-7H2,1H3 D0E9SR DRUGINKE HUQJRYMLJBBEDO-UHFFFAOYSA-N D0E9SR DRUGSMIL CN1CCN(CC1)C(=O)C2=CC3=C(N2)C=CC(=C3)Cl D0E9SR HIGHSTAT Investigative D0E9TE DRUG__ID D0E9TE D0E9TE DRUGTYPE Small molecular drug D0E9TE DRUGINCH 1S/C29H31ClN2O6/c1-36-24-7-3-5-20(29(24)37-2)28-21-16-19(30)8-9-22(21)32-12-4-6-23(32)25(38-28)17-26(33)31-13-10-18(11-14-31)15-27(34)35/h3-9,12,16,18,25,28H,10-11,13-15,17H2,1-2H3,(H,34,35)/t25-,28-/m1/s1 D0E9TE DRUGINKE MSSQOQPKGAMUSY-LEAFIULHSA-N D0E9TE DRUGSMIL COC1=CC=CC(=C1OC)C2C3=C(C=CC(=C3)Cl)N4C=CC=C4C(O2)CC(=O)N5CCC(CC5)CC(=O)O D0E9TE HIGHSTAT Investigative D0E9TU DRUG__ID D0E9TU D0E9TU DRUGTYPE Small molecular drug D0E9TU DRUGINCH 1S/C20H18O5/c1-11(2)8-14(21)19-16(23)10-15(22)18-13(9-17(24)25-20(18)19)12-6-4-3-5-7-12/h3-7,9-11,22-23H,8H2,1-2H3 D0E9TU DRUGINKE GKEWZBRIASMMCY-UHFFFAOYSA-N D0E9TU DRUGSMIL CC(C)CC(=O)C1=C(C=C(C2=C1OC(=O)C=C2C3=CC=CC=C3)O)O D0E9TU HIGHSTAT Investigative D0E9UX DRUG__ID D0E9UX D0E9UX DRUGTYPE Small molecular drug D0E9UX DRUGINCH 1S/C24H23F3N4O2/c25-24(26,27)19-6-7-22(29-15-19)33-21-5-1-3-18(14-21)13-17-8-11-31(12-9-17)23(32)30-20-4-2-10-28-16-20/h1-7,10,14-17H,8-9,11-13H2,(H,30,32) D0E9UX DRUGINKE NBOJHRYUGLRASX-UHFFFAOYSA-N D0E9UX DRUGSMIL C1CN(CCC1CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=CN=CC=C4 D0E9UX HIGHSTAT Investigative D0E9VU DRUG__ID D0E9VU D0E9VU DRUGTYPE Small molecular drug D0E9VU DRUGINCH 1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3/t5-,9-/m0/s1 D0E9VU DRUGINKE GEFQWZLICWMTKF-CDUCUWFYSA-N D0E9VU DRUGSMIL CC(C(C1=CC(=C(C=C1)O)O)O)N D0E9VU HIGHSTAT Investigative D0E9WX DRUG__ID D0E9WX D0E9WX DRUGTYPE Small molecular drug D0E9WX DRUGINCH 1S/C13H11BrN2/c14-11-3-4-13-9(5-11)1-2-10(13)6-12-7-15-8-16-12/h3-8H,1-2H2,(H,15,16)/b10-6+ D0E9WX DRUGINKE SNWLVVNOSVKKRA-UXBLZVDNSA-N D0E9WX DRUGSMIL C1CC(=CC2=CN=CN2)C3=C1C=C(C=C3)Br D0E9WX HIGHSTAT Investigative D0EA7Z DRUG__ID D0EA7Z D0EA7Z DRUGTYPE Small molecular drug D0EA7Z DRUGINCH 1S/C11H15N3/c1-2-5-9-8-6-3-4-7-10(8)14-11(12)13-9/h3-4,6-7,9H,2,5H2,1H3,(H3,12,13,14) D0EA7Z DRUGINKE GMMVLHFFOQJVPH-UHFFFAOYSA-N D0EA7Z DRUGSMIL CCCC1C2=CC=CC=C2NC(=N1)N D0EA7Z HIGHSTAT Investigative D0EB4X DRUG__ID D0EB4X D0EB4X DRUGTYPE Small molecular drug D0EB4X DRUGINCH 1S/C19H16N2O2/c1-2-3-8-15-20-14-10-9-13-16(17(14)21-15)19(23)12-7-5-4-6-11(12)18(13)22/h4-7,9-10H,2-3,8H2,1H3,(H,20,21) D0EB4X DRUGINKE DSPOAQONKLYCKM-UHFFFAOYSA-N D0EB4X DRUGSMIL CCCCC1=NC2=C(N1)C=CC3=C2C(=O)C4=CC=CC=C4C3=O D0EB4X HIGHSTAT Investigative D0EB9H DRUG__ID D0EB9H D0EB9H DRUGTYPE Small molecular drug D0EB9H DRUGINCH 1S/C19H16N2O/c1-3-22-18-9-14(12-20)8-17(10-18)16-7-6-15-5-4-13(2)21-19(15)11-16/h4-11H,3H2,1-2H3 D0EB9H DRUGINKE QGNKITVJGNCQSU-UHFFFAOYSA-N D0EB9H DRUGSMIL CCOC1=CC(=CC(=C1)C2=CC3=C(C=CC(=N3)C)C=C2)C#N D0EB9H HIGHSTAT Investigative D0EB9U DRUG__ID D0EB9U D0EB9U DRUGTYPE Small molecular drug D0EB9U DRUGINCH 1S/C7H13N3S/c8-7(11)10-9-6-4-2-1-3-5-6/h1-5H2,(H3,8,10,11) D0EB9U DRUGINKE GYRDZVHNPFBIST-UHFFFAOYSA-N D0EB9U DRUGSMIL C1CCC(=NNC(=S)N)CC1 D0EB9U HIGHSTAT Investigative D0EC0B DRUG__ID D0EC0B D0EC0B DRUGTYPE Small molecular drug D0EC0B DRUGINCH 1S/C13H10FN/c1-8-2-4-10-11-7-9(14)3-5-12(11)15-13(10)6-8/h2-7,15H,1H3 D0EC0B DRUGINKE YMJCUFBPZUBEGB-UHFFFAOYSA-N D0EC0B DRUGSMIL CC1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)F D0EC0B HIGHSTAT Investigative D0EC6B DRUG__ID D0EC6B D0EC6B DRUGTYPE Small molecular drug D0EC6B DRUGINCH 1S/C16H29NO/c1-4-5-6-7-8-9-10-11-12-13-16(18)17-14-15(2)3/h10-13,15H,4-9,14H2,1-3H3,(H,17,18)/b11-10+,13-12+ D0EC6B DRUGINKE BBRMJCAPNGJKEM-AQASXUMVSA-N D0EC6B DRUGSMIL CCCCCCCC=CC=CC(=O)NCC(C)C D0EC6B HIGHSTAT Investigative D0ED2I DRUG__ID D0ED2I D0ED2I DRUGTYPE Small molecular drug D0ED2I DRUGINCH 1S/C29H32N4O4/c1-18-12-23(34)13-19(2)24(18)15-25(30)29(37)33-17-21-9-7-6-8-20(21)14-26(33)28(36)31-16-27(35)32-22-10-4-3-5-11-22/h3-13,25-26,34H,14-17,30H2,1-2H3,(H,31,36)(H,32,35)/t25-,26-/m0/s1 D0ED2I DRUGINKE JQERUKPESNWSQA-UIOOFZCWSA-N D0ED2I DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NC4=CC=CC=C4)N)C)O D0ED2I HIGHSTAT Investigative D0EE0Q DRUG__ID D0EE0Q D0EE0Q DRUGTYPE Small molecular drug D0EE0Q DRUGINCH 1S/C25H24N2O/c1-2-3-6-15-27-18-21(16-24(27)20-11-8-14-26-17-20)25(28)23-13-7-10-19-9-4-5-12-22(19)23/h4-5,7-14,16-18H,2-3,6,15H2,1H3 D0EE0Q DRUGINKE MPQYTRCOFXNOTB-UHFFFAOYSA-N D0EE0Q DRUGSMIL CCCCCN1C=C(C=C1C2=CN=CC=C2)C(=O)C3=CC=CC4=CC=CC=C43 D0EE0Q HIGHSTAT Investigative D0EE4C DRUG__ID D0EE4C D0EE4C DRUGTYPE Small molecular drug D0EE4C DRUGINCH 1S/C6H14O12P2/c7-1-2(8)6(18-20(14,15)16)4(10)3(9)5(1)17-19(11,12)13/h1-10H,(H2,11,12,13)(H2,14,15,16)/p-4/t1-,2-,3-,4+,5?,6?/m1/s1 D0EE4C DRUGINKE PELZSPZCXGTUMR-MBEOBJKWSA-J D0EE4C DRUGSMIL C1(C(C(C(C(C1OP(=O)([O-])[O-])O)O)OP(=O)([O-])[O-])O)O D0EE4C HIGHSTAT Investigative D0EE6A DRUG__ID D0EE6A D0EE6A DRUGTYPE Small molecular drug D0EE6A DRUGINCH 1S/C20H16F3N3O/c21-20(22,23)15-4-3-5-16(12-15)26-19(27)17-6-1-2-7-18(17)25-13-14-8-10-24-11-9-14/h1-12,25H,13H2,(H,26,27) D0EE6A DRUGINKE BLAFVGLBBOPRLP-UHFFFAOYSA-N D0EE6A DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NCC3=CC=NC=C3 D0EE6A HIGHSTAT Investigative D0EG5G DRUG__ID D0EG5G D0EG5G DRUGTYPE Small molecular drug D0EG5G DRUGINCH 1S/C21H12Cl2F4N2O/c22-17-3-1-2-16(19(17)23)20(30,21(25,26)27)13-4-9-18-12(10-13)11-28-29(18)15-7-5-14(24)6-8-15/h1-11,30H D0EG5G DRUGINKE SGKVPHOMCZNDPT-UHFFFAOYSA-N D0EG5G DRUGSMIL C1=CC(=C(C(=C1)Cl)Cl)C(C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)(C(F)(F)F)O D0EG5G HIGHSTAT Investigative D0EG7I DRUG__ID D0EG7I D0EG7I DRUGTYPE Small molecular drug D0EG7I DRUGINCH 1S/C35H43N5O5/c1-22-17-28(42)18-23(2)29(22)20-30(36)35(45)40-21-26-12-8-7-11-25(26)19-32(40)34(44)39-31(15-9-10-16-37-24(3)41)33(43)38-27-13-5-4-6-14-27/h4-8,11-14,17-18,30-32,42H,9-10,15-16,19-21,36H2,1-3H3,(H,37,41)(H,38,43)(H,39,44) D0EG7I DRUGINKE VCTWEJIUVCJXEY-UHFFFAOYSA-N D0EG7I DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)C)C(=O)NC4=CC=CC=C4)N)C)O D0EG7I HIGHSTAT Investigative D0EG8X DRUG__ID D0EG8X D0EG8X DRUGTYPE Small molecular drug D0EG8X DRUGINCH 1S/C4H10NO2PS/c1-9-3-2-4(5)8(6)7/h4H,2-3,5H2,1H3/p+1/t4-/m1/s1 D0EG8X DRUGINKE BSTOZABDPPHMGK-SCSAIBSYSA-O D0EG8X DRUGSMIL CSCCC(N)[P+](=O)O D0EG8X HIGHSTAT Investigative D0EH0S DRUG__ID D0EH0S D0EH0S DRUGTYPE Small molecular drug D0EH0S DRUGINCH 1S/C12H10O4/c1-2-8(13)11-9(14)5-3-7-4-6-10(15)16-12(7)11/h3-6,14H,2H2,1H3 D0EH0S DRUGINKE DVLIOVBNBOBBGS-UHFFFAOYSA-N D0EH0S DRUGSMIL CCC(=O)C1=C(C=CC2=C1OC(=O)C=C2)O D0EH0S HIGHSTAT Investigative D0EH1F DRUG__ID D0EH1F D0EH1F DRUGTYPE Small molecular drug D0EH1F DRUGINCH 1S/C16H14N4O2/c17-16(18)13-4-5-15-12(9-13)6-7-19(15)10-11-2-1-3-14(8-11)20(21)22/h1-9H,10H2,(H3,17,18) D0EH1F DRUGINKE SHTQZODGNRZEIP-UHFFFAOYSA-N D0EH1F DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])CN2C=CC3=C2C=CC(=C3)C(=N)N D0EH1F HIGHSTAT Investigative D0EH5Z DRUG__ID D0EH5Z D0EH5Z DRUGTYPE Small molecular drug D0EH5Z DRUGINCH 1S/C18H23NO3/c1-20-16-12-15(8-10-19)13-17(21-2)18(16)22-11-9-14-6-4-3-5-7-14/h3-7,12-13H,8-11,19H2,1-2H3 D0EH5Z DRUGINKE FKXBCTFKCKEDNI-UHFFFAOYSA-N D0EH5Z DRUGSMIL COC1=CC(=CC(=C1OCCC2=CC=CC=C2)OC)CCN D0EH5Z HIGHSTAT Investigative D0EH6L DRUG__ID D0EH6L D0EH6L DRUGTYPE Small molecular drug D0EH6L DRUGINCH 1S/C22H19N3O2/c1-13-3-7-15(8-4-13)23-19-11-17-18(22(27)25-21(17)26)12-20(19)24-16-9-5-14(2)6-10-16/h3-12,23-24H,1-2H3,(H,25,26,27) D0EH6L DRUGINKE KSZXNFIEZNOXCC-UHFFFAOYSA-N D0EH6L DRUGSMIL CC1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)C D0EH6L HIGHSTAT Investigative D0EI5V DRUG__ID D0EI5V D0EI5V DRUGTYPE Small molecular drug D0EI5V DRUGINCH 1S/C34H32N4O14P2/c1-19-13-37(33(41)35-31(19)39)27-11-9-23(49-27)17-47-53(43)45-15-21-5-3-7-25(29(21)51-53)26-8-4-6-22-16-46-54(44,52-30(22)26)48-18-24-10-12-28(50-24)38-14-20(2)32(40)36-34(38)42/h3-14,23-24,27-28H,15-18H2,1-2H3,(H,35,39,41)(H,36,40,42)/t23-,24-,27+,28+,53?,54?/m0/s1 D0EI5V DRUGINKE KHOMSKKMHVGQFN-QIKIAYFISA-N D0EI5V DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)COP3(=O)OCC4=C(O3)C(=CC=C4)C5=CC=CC6=C5OP(=O)(OC6)OCC7C=CC(O7)N8C=C(C(=O)NC8=O)C D0EI5V HIGHSTAT Investigative D0EI6X DRUG__ID D0EI6X D0EI6X DRUGTYPE Small molecular drug D0EI6X DRUGINCH 1S/C12H9N3O/c13-7-5-10-11(14-6-7)8-3-1-2-4-9(8)12(16)15-10/h1-6H,13H2,(H,15,16) D0EI6X DRUGINKE PSWYPUADRXNJGE-UHFFFAOYSA-N D0EI6X DRUGSMIL C1=CC=C2C(=C1)C3=C(C=C(C=N3)N)NC2=O D0EI6X HIGHSTAT Investigative D0EI8V DRUG__ID D0EI8V D0EI8V DRUGTYPE Small molecular drug D0EI8V DRUGINCH 1S/C16H18F3N3O2S/c1-4-10(2)20-15-21-13(9-14(22-15)16(17,18)19)11-5-7-12(8-6-11)25(3,23)24/h5-10H,4H2,1-3H3,(H,20,21,22) D0EI8V DRUGINKE BHAFHAMADYHYPJ-UHFFFAOYSA-N D0EI8V DRUGSMIL CCC(C)NC1=NC(=CC(=N1)C(F)(F)F)C2=CC=C(C=C2)S(=O)(=O)C D0EI8V HIGHSTAT Investigative D0EI9B DRUG__ID D0EI9B D0EI9B DRUGTYPE Small molecular drug D0EI9B DRUGINCH 1S/C19H18O2/c1-13-8-17-12-21-18(20)19(17,10-13)11-14-6-7-15-4-2-3-5-16(15)9-14/h2-7,9,17H,1,8,10-12H2/t17-,19+/m1/s1 D0EI9B DRUGINKE CVIRWLJKDBYYOG-MJGOQNOKSA-N D0EI9B DRUGSMIL C=C1CC2COC(=O)C2(C1)CC3=CC4=CC=CC=C4C=C3 D0EI9B HIGHSTAT Investigative D0EJ9B DRUG__ID D0EJ9B D0EJ9B DRUGTYPE Small molecular drug D0EJ9B DRUGINCH 1S/C6H7BO2/c8-7(9)6-4-2-1-3-5-6/h1-5,8-9H D0EJ9B DRUGINKE HXITXNWTGFUOAU-UHFFFAOYSA-N D0EJ9B DRUGSMIL B(C1=CC=CC=C1)(O)O D0EJ9B HIGHSTAT Investigative D0EK0G DRUG__ID D0EK0G D0EK0G DRUGTYPE Small molecular drug D0EK0G DRUGINCH 1S/C17H13NO3/c1-21-13-9-7-12(8-10-13)15-14(16(19)18-17(15)20)11-5-3-2-4-6-11/h2-10H,1H3,(H,18,19,20) D0EK0G DRUGINKE PXJXUZZVGCBPLM-UHFFFAOYSA-N D0EK0G DRUGSMIL COC1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=CC=C3 D0EK0G HIGHSTAT Investigative D0EK5U DRUG__ID D0EK5U D0EK5U DRUGTYPE Small molecular drug D0EK5U DRUGINCH 1S/C19H23NO2/c1-19-7-6-15-14-5-3-13(21)8-11(14)2-4-16(15)17(19)9-12(10-20)18(19)22/h3,5,8,12,15-18,21-22H,2,4,6-7,9H2,1H3/t12-,15-,16-,17+,18+,19+/m1/s1 D0EK5U DRUGINKE IWVYOPUBSXDPSW-IEQBIMPXSA-N D0EK5U DRUGSMIL CC12CCC3C(C1CC(C2O)C#N)CCC4=C3C=CC(=C4)O D0EK5U HIGHSTAT Investigative D0EK6F DRUG__ID D0EK6F D0EK6F DRUGTYPE Small molecular drug D0EK6F DRUGINCH 1S/C12H9N3/c1-10-9-13-15-12(14-10)8-7-11-5-3-2-4-6-11/h2-6,9H,1H3 D0EK6F DRUGINKE PXUGAXNBWJVVQY-UHFFFAOYSA-N D0EK6F DRUGSMIL CC1=CN=NC(=N1)C#CC2=CC=CC=C2 D0EK6F HIGHSTAT Investigative D0EK6P DRUG__ID D0EK6P D0EK6P DRUGTYPE Small molecular drug D0EK6P DRUGINCH 1S/C6H10N2O4/c7-6(5(11)12)1-3(4(9)10)8-2-6/h3,8H,1-2,7H2,(H,9,10)(H,11,12)/t3-,6-/m1/s1 D0EK6P DRUGINKE XZFMJVJDSYRWDQ-AWFVSMACSA-N D0EK6P DRUGSMIL C1C(NCC1(C(=O)O)N)C(=O)O D0EK6P HIGHSTAT Investigative D0EK7H DRUG__ID D0EK7H D0EK7H DRUGTYPE Small molecular drug D0EK7H DRUGINCH 1S/C8H3Cl2NO2/c9-3-1-2-4(10)6-5(3)7(12)8(13)11-6/h1-2H,(H,11,12,13) D0EK7H DRUGINKE NUXYYWOWNFEMNH-UHFFFAOYSA-N D0EK7H DRUGSMIL C1=CC(=C2C(=C1Cl)C(=O)C(=O)N2)Cl D0EK7H HIGHSTAT Investigative D0EK8U DRUG__ID D0EK8U D0EK8U DRUGTYPE Small molecular drug D0EK8U DRUGINCH 1S/C9H12NO5P/c11-9(10-7-16(12,13)14)15-6-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,10,11)(H2,12,13,14) D0EK8U DRUGINKE WUNKRZNFNIYEPN-UHFFFAOYSA-N D0EK8U DRUGSMIL C1=CC=C(C=C1)COC(=O)NCP(=O)(O)O D0EK8U HIGHSTAT Investigative D0EK9K DRUG__ID D0EK9K D0EK9K DRUGCOMP Ligand Pharmaceuticals Inc D0EK9K DRUGINCH 1S/C28H37ClN8O2/c1-5-22-17-36(25-19(4)32-24(15-31-25)26-33-34-28(39-26)30-6-2)18(3)16-37(22)23-11-13-35(14-12-23)27(38)20-7-9-21(29)10-8-20/h7-10,15,18,22-23H,5-6,11-14,16-17H2,1-4H3,(H,30,34)/t18-,22+/m1/s1 D0EK9K DRUGINKE MDHIGNOFHUSPMA-GCJKJVERSA-N D0EK9K DRUGSMIL CCC1CN(C(CN1C2CCN(CC2)C(=O)C3=CC=C(C=C3)Cl)C)C4=NC=C(N=C4C)C5=NN=C(O5)NCC D0EK9K HIGHSTAT Investigative D0EK9T DRUG__ID D0EK9T D0EK9T DRUGTYPE Small molecular drug D0EK9T DRUGINCH 1S/C15H12N2S/c16-15(17)14-9-12-11(7-4-8-13(12)18-14)10-5-2-1-3-6-10/h1-9H,(H3,16,17) D0EK9T DRUGINKE HKXOXDHVUZHJFV-UHFFFAOYSA-N D0EK9T DRUGSMIL C1=CC=C(C=C1)C2=C3C=C(SC3=CC=C2)C(=N)N D0EK9T HIGHSTAT Investigative D0EL1Y DRUG__ID D0EL1Y D0EL1Y DRUGTYPE Small molecular drug D0EL1Y DRUGINCH 1S/C15H11NO3/c17-12-6-4-10(5-7-12)14-9-16-15(19-14)11-2-1-3-13(18)8-11/h1-9,17-18H D0EL1Y DRUGINKE QWBAQAYKEITCRE-UHFFFAOYSA-N D0EL1Y DRUGSMIL C1=CC(=CC(=C1)O)C2=NC=C(O2)C3=CC=C(C=C3)O D0EL1Y HIGHSTAT Investigative D0EL3A DRUG__ID D0EL3A D0EL3A DRUGTYPE Small molecular drug D0EL3A DRUGINCH 1S/C26H42N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-25(29)27-22-23-18-20-24(21-19-23)26(30)28-31/h9-10,18-21,31H,2-8,11-17,22H2,1H3,(H,27,29)(H,28,30)/b10-9- D0EL3A DRUGINKE SINCREJZYIHLQD-KTKRTIGZSA-N D0EL3A DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC=C(C=C1)C(=O)NO D0EL3A HIGHSTAT Investigative D0EM1C DRUG__ID D0EM1C D0EM1C DRUGTYPE Small molecular drug D0EM1C DRUGINCH 1S/C20H14ClN3O2/c21-14-4-8-16(9-5-14)26-15-6-1-12(2-7-15)20-23-17-10-3-13(19(22)25)11-18(17)24-20/h1-11H,(H2,22,25)(H,23,24) D0EM1C DRUGINKE UXGJAOIJSROTTN-UHFFFAOYSA-N D0EM1C DRUGSMIL C1=CC(=CC=C1C2=NC3=C(N2)C=C(C=C3)C(=O)N)OC4=CC=C(C=C4)Cl D0EM1C HIGHSTAT Investigative D0EM9A DRUG__ID D0EM9A D0EM9A DRUGTYPE Small molecular drug D0EM9A DRUGINCH 1S/C33H46N6O10/c1-18(2)13-24(32(47)39-28(19(3)41)33(48)49)37-31(46)25(15-20-7-5-4-6-8-20)36-27(43)16-35-30(45)26(17-40)38-29(44)23(34)14-21-9-11-22(42)12-10-21/h4-12,18-19,23-26,28,40-42H,13-17,34H2,1-3H3,(H,35,45)(H,36,43)(H,37,46)(H,38,44)(H,39,47)(H,48,49)/t19-,23+,24+,25+,26-,28+/m1/s1 D0EM9A DRUGINKE PKSODCLCMBUCPW-LVNBQDLPSA-N D0EM9A DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(CO)NC(=O)C(CC2=CC=C(C=C2)O)N D0EM9A HIGHSTAT Investigative D0EN7L DRUG__ID D0EN7L D0EN7L DRUGTYPE Small molecular drug D0EN7L DRUGINCH 1S/C5H9N3S/c1-2-3-4-7-8-5(6)9/h2-4H,1H3,(H3,6,8,9)/b3-2+,7-4- D0EN7L DRUGINKE OWTTWSQTSRNFHY-SWBALALESA-N D0EN7L DRUGSMIL CC=CC=NNC(=S)N D0EN7L HIGHSTAT Investigative D0EN7T DRUG__ID D0EN7T D0EN7T DRUGTYPE Small molecular drug D0EN7T DRUGINCH 1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21) D0EN7T DRUGINKE PAHGJZDQXIOYTH-UHFFFAOYSA-N D0EN7T DRUGSMIL CC(C)CCCC(C)CCCC(C)CCCC(C)C(=O)O D0EN7T HIGHSTAT Investigative D0EO4F DRUG__ID D0EO4F D0EO4F DRUGTYPE Small molecular drug D0EO4F DRUGINCH 1S/C26H28N4O3S/c1-18-6-5-7-19(16-18)20-17-34-24-23(20)25(31)30(26(32)27-24)15-12-28-10-13-29(14-11-28)21-8-3-4-9-22(21)33-2/h3-9,16-17H,10-15H2,1-2H3,(H,27,32) D0EO4F DRUGINKE PANBMHHKBRMYAL-UHFFFAOYSA-N D0EO4F DRUGSMIL CC1=CC(=CC=C1)C2=CSC3=C2C(=O)N(C(=O)N3)CCN4CCN(CC4)C5=CC=CC=C5OC D0EO4F HIGHSTAT Investigative D0EO5P DRUG__ID D0EO5P D0EO5P DRUGTYPE Small molecular drug D0EO5P DRUGINCH 1S/C20H26N2/c1-2-17-8-6-7-11-19(17)16-20(18-9-4-3-5-10-18)22-14-12-21-13-15-22/h3-11,20-21H,2,12-16H2,1H3 D0EO5P DRUGINKE USQDYFAONFKQLW-UHFFFAOYSA-N D0EO5P DRUGSMIL CCC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D0EO5P HIGHSTAT Investigative D0EP1G DRUG__ID D0EP1G D0EP1G DRUGTYPE Small molecular drug D0EP1G DRUGINCH 1S/C12H9N3O/c16-12-10(5-8-6-13-7-14-8)9-3-1-2-4-11(9)15-12/h1-7H,(H,13,14)(H,15,16)/b10-5- D0EP1G DRUGINKE VEEGZPWAAPPXRB-YHYXMXQVSA-N D0EP1G DRUGSMIL C1=CC=C2C(=C1)C(=CC3=CN=CN3)C(=O)N2 D0EP1G HIGHSTAT Investigative D0EQ1Z DRUG__ID D0EQ1Z D0EQ1Z DRUGTYPE Small molecular drug D0EQ1Z DRUGINCH 1S/C22H23NO6/c1-14-7-5-6-10-16(14)21(24)28-17-12-26-20-18(13-27-19(17)20)29-22(25)23-11-15-8-3-2-4-9-15/h2-10,17-20H,11-13H2,1H3,(H,23,25)/t17-,18+,19-,20-/m1/s1 D0EQ1Z DRUGINKE XMIPVPSZMVVUST-IYWMVGAKSA-N D0EQ1Z DRUGSMIL CC1=CC=CC=C1C(=O)OC2COC3C2OCC3OC(=O)NCC4=CC=CC=C4 D0EQ1Z HIGHSTAT Investigative D0EQ4T DRUG__ID D0EQ4T D0EQ4T DRUGTYPE Small molecular drug D0EQ4T DRUGINCH 1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1 D0EQ4T DRUGINKE XKMLYUALXHKNFT-UUOKFMHZSA-N D0EQ4T DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N D0EQ4T HIGHSTAT Investigative D0EQ8X DRUG__ID D0EQ8X D0EQ8X DRUGTYPE Small molecular drug D0EQ8X DRUGINCH 1S/C18H16O2/c1-2-6-13-9-10-17-15(11-13)16(19)12-18(20-17)14-7-4-3-5-8-14/h3-5,7-12H,2,6H2,1H3 D0EQ8X DRUGINKE PKMXZOUCSSZIGB-UHFFFAOYSA-N D0EQ8X DRUGSMIL CCCC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3 D0EQ8X HIGHSTAT Investigative D0ER0L DRUG__ID D0ER0L D0ER0L DRUGTYPE Small molecular drug D0ER0L DRUGINCH 1S/C15H18N2O2/c18-15-13(10-11-4-2-1-3-5-11)14(19-17-15)12-6-8-16-9-7-12/h1-5,12,16H,6-10H2,(H,17,18) D0ER0L DRUGINKE UQASDRGKIOGECB-UHFFFAOYSA-N D0ER0L DRUGSMIL C1CNCCC1C2=C(C(=O)NO2)CC3=CC=CC=C3 D0ER0L HIGHSTAT Investigative D0ER1D DRUG__ID D0ER1D D0ER1D DRUGTYPE Small molecular drug D0ER1D DRUGINCH 1S/C17H14O3/c1-11-6-7-16-14(8-11)15(18)10-17(20-16)12-4-3-5-13(9-12)19-2/h3-10H,1-2H3 D0ER1D DRUGINKE GPLWNAUILJELBH-UHFFFAOYSA-N D0ER1D DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC(=CC=C3)OC D0ER1D HIGHSTAT Investigative D0ER1G DRUG__ID D0ER1G D0ER1G DRUGTYPE Small molecular drug D0ER1G DRUGINCH 1S/C6H11NO3/c8-5-1-2-7-3-4(5)6(9)10/h4-5,7-8H,1-3H2,(H,9,10)/t4-,5+/m0/s1 D0ER1G DRUGINKE DAMFVOCECLPLSI-CRCLSJGQSA-N D0ER1G DRUGSMIL C1CNCC(C1O)C(=O)O D0ER1G HIGHSTAT Investigative D0ER5C DRUG__ID D0ER5C D0ER5C DRUGTYPE Small molecular drug D0ER5C DRUGINCH 1S/C13H12N2O/c1-14-6-5-10-11-7-9(16)3-4-12(11)15(2)13(10)8-14/h3-8H,1-2H3/p+1 D0ER5C DRUGINKE OEJPDCAOADNKRJ-UHFFFAOYSA-O D0ER5C DRUGSMIL CN1C2=C(C=C(C=C2)O)C3=C1C=[N+](C=C3)C D0ER5C HIGHSTAT Investigative D0ES2U DRUG__ID D0ES2U D0ES2U DRUGTYPE Small molecular drug D0ES2U DRUGINCH 1S/C35H33N5O4S/c41-32(29-22-26-14-7-8-16-28(26)37-29)38-30(23-45-33-27(35(43)44)15-9-17-36-33)34(42)40-20-18-39(19-21-40)31(24-10-3-1-4-11-24)25-12-5-2-6-13-25/h1-17,22,30-31,37H,18-21,23H2,(H,38,41)(H,43,44)/t30-/m0/s1 D0ES2U DRUGINKE JWXZKQOPZVEJHR-PMERELPUSA-N D0ES2U DRUGSMIL C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)C(CSC4=C(C=CC=N4)C(=O)O)NC(=O)C5=CC6=CC=CC=C6N5 D0ES2U HIGHSTAT Investigative D0ES2Y DRUG__ID D0ES2Y D0ES2Y DRUGTYPE Small molecular drug D0ES2Y DRUGINCH 1S/C16H20N2O/c1-11-5-2-3-7-13(11)19-14-8-4-6-12-9-10-15(17)18-16(12)14/h4,6,8-11,13H,2-3,5,7H2,1H3,(H2,17,18) D0ES2Y DRUGINKE MXXMNBSDHISKHW-UHFFFAOYSA-N D0ES2Y DRUGSMIL CC1CCCCC1OC2=CC=CC3=C2N=C(C=C3)N D0ES2Y HIGHSTAT Investigative D0ES5A DRUG__ID D0ES5A D0ES5A DRUGTYPE Small molecular drug D0ES5A DRUGINCH 1S/C14H11ClN4O4/c15-9-13(10-4-2-1-3-5-10)17-16-12-7-6-11(18(20)21)8-14(12)19(22)23/h1-8,16H,9H2 D0ES5A DRUGINKE HNLCJXKVYWWDTN-UHFFFAOYSA-N D0ES5A DRUGSMIL C1=CC=C(C=C1)C(=NNC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])CCl D0ES5A HIGHSTAT Investigative D0ES5X DRUG__ID D0ES5X D0ES5X DRUGTYPE Small molecular drug D0ES5X DRUGINCH 1S/C21H21N3O4S/c1-2-29(26,27)24(15-16-4-3-13-23-14-16)18-7-11-20(12-8-18)28-19-9-5-17(6-10-19)21(22)25/h3-14H,2,15H2,1H3,(H2,22,25) D0ES5X DRUGINKE VCBPWPYIGXFKDH-UHFFFAOYSA-N D0ES5X DRUGSMIL CCS(=O)(=O)N(CC1=CN=CC=C1)C2=CC=C(C=C2)OC3=CC=C(C=C3)C(=O)N D0ES5X HIGHSTAT Investigative D0ES6Z DRUG__ID D0ES6Z D0ES6Z DRUGTYPE Small molecular drug D0ES6Z DRUGINCH 1S/C17H20O2/c1-2-3-4-5-6-7-10-15-11-8-9-12-16(15)13-14-17(18)19/h8-9,11-14H,2-6H2,1H3,(H,18,19)/b14-13+ D0ES6Z DRUGINKE KRDSGPLHVQJFLM-BUHFOSPRSA-N D0ES6Z DRUGSMIL CCCCCCC#CC1=CC=CC=C1C=CC(=O)O D0ES6Z HIGHSTAT Investigative D0ES7P DRUG__ID D0ES7P D0ES7P DRUGTYPE Small molecular drug D0ES7P DRUGINCH 1S/C40H51N5O5/c1-24-18-31(46)19-25(2)32(24)22-33(41)40(50)45-23-30-17-11-10-16-29(30)21-35(45)38(48)44-36(26(3)28-14-8-5-9-15-28)39(49)43-34(37(42)47)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,46H,5,8-9,14-15,20-23,41H2,1-3H3,(H2,42,47)(H,43,49)(H,44,48)/t26-,33+,34+,35?,36+/m1/s1 D0ES7P DRUGINKE KIHHZGQBWZPIMS-IAEIRYAQSA-N D0ES7P DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)N)N)C)O D0ES7P HIGHSTAT Investigative D0ET0J DRUG__ID D0ET0J D0ET0J DRUGTYPE Small molecular drug D0ET0J DRUGINCH 1S/C13H15N3S2/c1-16(13-15-9-10-18-13)12(17)14-8-7-11-5-3-2-4-6-11/h2-6,9-10H,7-8H2,1H3,(H,14,17) D0ET0J DRUGINKE SZLHGPJAYQWUEP-UHFFFAOYSA-N D0ET0J DRUGSMIL CN(C1=NC=CS1)C(=S)NCCC2=CC=CC=C2 D0ET0J HIGHSTAT Investigative D0ET0T DRUG__ID D0ET0T D0ET0T DRUGTYPE Small molecular drug D0ET0T DRUGINCH 1S/C23H28O7S/c1-12(24)31-17-9-15(20(26)28-4)22(2)7-5-14-21(27)30-16(13-6-8-29-11-13)10-23(14,3)19(22)18(17)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3/t14-,15-,16-,17+,19-,22-,23-/m0/s1 D0ET0T DRUGINKE SIUXIXPAKGOVLQ-KWMFLVSKSA-N D0ET0T DRUGSMIL CC(=O)SC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D0ET0T HIGHSTAT Investigative D0ET2F DRUG__ID D0ET2F D0ET2F DRUGTYPE Small molecular drug D0ET2F DRUGINCH 1S/C7H7NO2/c1-5-2-6(7(9)10)4-8-3-5/h2-4H,1H3,(H,9,10) D0ET2F DRUGINKE DJDHHXDFKSLEQY-UHFFFAOYSA-N D0ET2F DRUGSMIL CC1=CC(=CN=C1)C(=O)O D0ET2F HIGHSTAT Investigative D0ET4S DRUG__ID D0ET4S D0ET4S DRUGTYPE Small molecular drug D0ET4S DRUGINCH 1S/C16H12N2O2/c1-19-15-10-12(7-6-11(15)8-9-17)16-18-13-4-2-3-5-14(13)20-16/h2-7,10H,8H2,1H3 D0ET4S DRUGINKE LWSOZPNJUFEDJU-UHFFFAOYSA-N D0ET4S DRUGSMIL COC1=C(C=CC(=C1)C2=NC3=CC=CC=C3O2)CC#N D0ET4S HIGHSTAT Investigative D0EU0L DRUG__ID D0EU0L D0EU0L DRUGCOMP King Saud University D0EU0L DRUGINCH 1S/C10H12N2O3S/c1-2-15-9(14)7-6-16-10-11-8(13)4-3-5-12(7)10/h6H,2-5H2,1H3 D0EU0L DRUGINKE UXGPDPNGDCOQBY-UHFFFAOYSA-N D0EU0L DRUGSMIL CCOC(=O)C1=CSC2=NC(=O)CCCN12 D0EU0L HIGHSTAT Investigative D0EU9W DRUG__ID D0EU9W D0EU9W DRUGTYPE Small molecular drug D0EU9W DRUGINCH 1S/C15H14O4S/c1-19-13-7-5-6-12(10-13)15(16)11-20(17,18)14-8-3-2-4-9-14/h2-10H,11H2,1H3 D0EU9W DRUGINKE HHEJEAZSXBXRPO-UHFFFAOYSA-N D0EU9W DRUGSMIL COC1=CC=CC(=C1)C(=O)CS(=O)(=O)C2=CC=CC=C2 D0EU9W HIGHSTAT Investigative D0EV1I DRUG__ID D0EV1I D0EV1I DRUGTYPE Small molecular drug D0EV1I DRUGINCH 1S/C22H32N4O2/c1-27-19-13-17-18(14-20(19)28-2)25-22(24-16-11-7-8-12-16)26-21(17)23-15-9-5-3-4-6-10-15/h13-16H,3-12H2,1-2H3,(H2,23,24,25,26) D0EV1I DRUGINKE HZBKRPBMAVNOCZ-UHFFFAOYSA-N D0EV1I DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)NC3CCCC3)NC4CCCCCC4)OC D0EV1I HIGHSTAT Investigative D0EV3O DRUG__ID D0EV3O D0EV3O DRUGTYPE Small molecular drug D0EV3O DRUGINCH 1S/C19H34N4O8/c1-6-20-12(7-8-13(25)26)17(28)23-15(11(5)24)18(29)21-10(4)16(27)22-14(9(2)3)19(30)31/h9-12,14-15,20,24H,6-8H2,1-5H3,(H,21,29)(H,22,27)(H,23,28)(H,25,26)(H,30,31)/t10-,11?,12-,14-,15-/m0/s1 D0EV3O DRUGINKE MEXXBWHVPQDHNP-FYOXFVTASA-N D0EV3O DRUGSMIL CCNC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)O D0EV3O HIGHSTAT Investigative D0EV6B DRUG__ID D0EV6B D0EV6B DRUGTYPE Small molecular drug D0EV6B DRUGINCH 1S/C19H27N5O/c20-17(21)23-16-3-1-12(2-4-16)11-22-18(25)24-19-8-13-5-14(9-19)7-15(6-13)10-19/h1-4,13-15H,5-11H2,(H4,20,21,23)(H2,22,24,25) D0EV6B DRUGINKE YQPLKJCBEOVDBS-UHFFFAOYSA-N D0EV6B DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCC4=CC=C(C=C4)N=C(N)N D0EV6B HIGHSTAT Investigative D0EV7U DRUG__ID D0EV7U D0EV7U DRUGTYPE Small molecular drug D0EV7U DRUGINCH 1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1 D0EV7U DRUGINKE BASFYRLYJAZPPL-UONOGXRCSA-N D0EV7U DRUGSMIL C1CNCCC1NC2CC2C3=CC=CC=C3 D0EV7U HIGHSTAT Investigative D0EW3L DRUG__ID D0EW3L D0EW3L DRUGTYPE Small molecular drug D0EW3L DRUGINCH 1S/C15H12O5/c16-10-3-4-11(14(19)8-10)12(17)5-1-9-2-6-13(18)15(20)7-9/h1-8,16,18-20H/b5-1+ D0EW3L DRUGINKE AYMYWHCQALZEGT-ORCRQEGFSA-N D0EW3L DRUGSMIL C1=CC(=C(C=C1C=CC(=O)C2=C(C=C(C=C2)O)O)O)O D0EW3L HIGHSTAT Investigative D0EW6H DRUG__ID D0EW6H D0EW6H DRUGTYPE Small molecular drug D0EW6H DRUGINCH 1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1 D0EW6H DRUGINKE GWNVDXQDILPJIG-NXOLIXFESA-N D0EW6H DRUGSMIL CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N D0EW6H HIGHSTAT Investigative D0EW9J DRUG__ID D0EW9J D0EW9J DRUGTYPE Small molecular drug D0EW9J DRUGINCH 1S/C21H16N4O/c26-21-16-11-20(25-18(16)6-8-23-21)14-5-7-22-19(10-14)15-9-13-3-1-2-4-17(13)24-12-15/h1-5,7,9-12,25H,6,8H2,(H,23,26) D0EW9J DRUGINKE OWFLADWRSCINST-UHFFFAOYSA-N D0EW9J DRUGSMIL C1CNC(=O)C2=C1NC(=C2)C3=CC(=NC=C3)C4=CC5=CC=CC=C5N=C4 D0EW9J HIGHSTAT Investigative D0EX1R DRUG__ID D0EX1R D0EX1R DRUGTYPE Small molecular drug D0EX1R DRUGINCH 1S/C35H54N2O2/c1-3-34(30-16-14-18-32(38)26-30)20-8-12-24-36(28-34)22-10-6-5-7-11-23-37-25-13-9-21-35(4-2,29-37)31-17-15-19-33(39)27-31/h14-19,26-27,38-39H,3-13,20-25,28-29H2,1-2H3/t34-,35-/m1/s1 D0EX1R DRUGINKE VZGOFBLWSLPNDR-VSJLXWSYSA-N D0EX1R DRUGSMIL CCC1(CCCCN(C1)CCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0EX1R HIGHSTAT Investigative D0EX2M DRUG__ID D0EX2M D0EX2M DRUGTYPE Small molecular drug D0EX2M DRUGINCH 1S/C18H21ClN2/c19-17-8-4-5-15(13-17)14-18(16-6-2-1-3-7-16)21-11-9-20-10-12-21/h1-8,13,18,20H,9-12,14H2 D0EX2M DRUGINKE LTKQGPSHVUGDKE-UHFFFAOYSA-N D0EX2M DRUGSMIL C1CN(CCN1)C(CC2=CC(=CC=C2)Cl)C3=CC=CC=C3 D0EX2M HIGHSTAT Investigative D0EX4L DRUG__ID D0EX4L D0EX4L DRUGTYPE Small molecular drug D0EX4L DRUGINCH 1S/C13H12O4/c1-15-13(14)5-3-2-4-10-6-7-11-12(8-10)17-9-16-11/h2-8H,9H2,1H3/b4-2+,5-3+ D0EX4L DRUGINKE VOZJBFJHMHRLDN-ZUVMSYQZSA-N D0EX4L DRUGSMIL COC(=O)C=CC=CC1=CC2=C(C=C1)OCO2 D0EX4L HIGHSTAT Investigative D0EX7J DRUG__ID D0EX7J D0EX7J DRUGTYPE Small molecular drug D0EX7J DRUGINCH 1S/C21H34O2/c1-5-6-7-13-21(2,3)17-11-12-19(20(15-17)23-4)16-9-8-10-18(22)14-16/h11-12,15-16,18,22H,5-10,13-14H2,1-4H3/t16-,18-/m0/s1 D0EX7J DRUGINKE GZSDLXNECOWUFY-WMZOPIPTSA-N D0EX7J DRUGSMIL CCCCCC(C)(C)C1=CC(=C(C=C1)C2CCCC(C2)O)OC D0EX7J HIGHSTAT Investigative D0EX7S DRUG__ID D0EX7S D0EX7S DRUGTYPE Small molecular drug D0EX7S DRUGINCH 1S/C23H16N4O/c24-15-17-8-7-11-19(14-17)23(28)26-22-21(18-9-3-1-4-10-18)16-25-27(22)20-12-5-2-6-13-20/h1-14,16H,(H,26,28) D0EX7S DRUGINKE ZNMCOYKAPQGPBZ-UHFFFAOYSA-N D0EX7S DRUGSMIL C1=CC=C(C=C1)C2=C(N(N=C2)C3=CC=CC=C3)NC(=O)C4=CC=CC(=C4)C#N D0EX7S HIGHSTAT Investigative D0EX9Q DRUG__ID D0EX9Q D0EX9Q DRUGTYPE Small molecular drug D0EX9Q DRUGINCH 1S/C15H23NO4S/c1-3-5-13(6-4-2)15(17)20-11-12-7-9-14(10-8-12)21(16,18)19/h7-10,13H,3-6,11H2,1-2H3,(H2,16,18,19) D0EX9Q DRUGINKE MSITXBOMUACCFV-UHFFFAOYSA-N D0EX9Q DRUGSMIL CCCC(CCC)C(=O)OCC1=CC=C(C=C1)S(=O)(=O)N D0EX9Q HIGHSTAT Investigative D0EY2F DRUG__ID D0EY2F D0EY2F DRUGTYPE Small molecular drug D0EY2F DRUGINCH 1S/C12H10O4/c1-2-9(13)8-5-7-3-4-12(15)16-11(7)6-10(8)14/h3-6,14H,2H2,1H3 D0EY2F DRUGINKE GJOCMGDMAGUOKE-UHFFFAOYSA-N D0EY2F DRUGSMIL CCC(=O)C1=C(C=C2C(=C1)C=CC(=O)O2)O D0EY2F HIGHSTAT Investigative D0EZ2W DRUG__ID D0EZ2W D0EZ2W DRUGTYPE Small molecular drug D0EZ2W DRUGINCH 1S/C26H36Cl2N4O3.ClH/c1-30-12-14-31(15-13-30)23(33)5-4-22(29-24(34)19-16-20(27)18-21(28)17-19)25(35)32-10-8-26(9-11-32)6-2-3-7-26;/h16-18,22H,2-15H2,1H3,(H,29,34);1H D0EZ2W DRUGINKE FXORBQJCRPUVDJ-UHFFFAOYSA-N D0EZ2W DRUGSMIL CN1CCN(CC1)C(=O)CCC(C(=O)N2CCC3(CCCC3)CC2)NC(=O)C4=CC(=CC(=C4)Cl)Cl.Cl D0EZ2W HIGHSTAT Investigative D0F0AU DRUG__ID D0F0AU D0F0AU DRUGTYPE Small molecular drug D0F0AU DRUGINCH 1S/C7H7N3OS/c1-3-4-2-5(6(8)11)12-7(4)10-9-3/h2H,1H3,(H2,8,11)(H,9,10) D0F0AU DRUGINKE MELHJKUYOBXOER-UHFFFAOYSA-N D0F0AU DRUGSMIL CC1=C2C=C(SC2=NN1)C(=O)N D0F0AU HIGHSTAT Investigative D0F0AX DRUG__ID D0F0AX D0F0AX DRUGTYPE Small molecular drug D0F0AX DRUGINCH 1S/C11H10BrN5O2/c12-6-3-5-4(7-10(19)17-11(13)16-7)1-2-14-9(18)8(5)15-6/h3,15H,1-2H2,(H,14,18)(H3,13,16,17,19)/b7-4- D0F0AX DRUGINKE ATBAETXFFCOZOY-DAXSKMNVSA-N D0F0AX DRUGSMIL C1CNC(=O)C2=C(C1=C3C(=O)NC(=N3)N)C=C(N2)Br D0F0AX HIGHSTAT Investigative D0F0BB DRUG__ID D0F0BB D0F0BB DRUGTYPE Small molecular drug D0F0BB DRUGINCH 1S/C11H16O/c1-8-5-6-9(10(12)7-8)11(2,3)4/h5-7,12H,1-4H3 D0F0BB DRUGINKE XOUQAVYLRNOXDO-UHFFFAOYSA-N D0F0BB DRUGSMIL CC1=CC(=C(C=C1)C(C)(C)C)O D0F0BB HIGHSTAT Investigative D0F0BS DRUG__ID D0F0BS D0F0BS DRUGTYPE Small molecular drug D0F0BS DRUGINCH 1S/C21H23Cl2NO/c1-24-18-10-11-19(24)13-20(12-18)25-21(14-2-6-16(22)7-3-14)15-4-8-17(23)9-5-15/h2-9,18-21H,10-13H2,1H3 D0F0BS DRUGINKE DAAKBMHWKLVSKY-UHFFFAOYSA-N D0F0BS DRUGSMIL CN1C2CCC1CC(C2)OC(C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl D0F0BS HIGHSTAT Investigative D0F0EI DRUG__ID D0F0EI D0F0EI DRUGTYPE Small molecular drug D0F0EI DRUGINCH 1S/C17H12O3/c18-16-7-6-13-8-12(4-5-14(13)10-16)11-2-1-3-15(9-11)17(19)20/h1-10,18H,(H,19,20) D0F0EI DRUGINKE QKQDCOMEKVAYFS-UHFFFAOYSA-N D0F0EI DRUGSMIL C1=CC(=CC(=C1)C(=O)O)C2=CC3=C(C=C2)C=C(C=C3)O D0F0EI HIGHSTAT Investigative D0F0IA DRUG__ID D0F0IA D0F0IA DRUGTYPE Small molecular drug D0F0IA DRUGINCH 1S/C20H24N4/c1-15-7-8-17(13-16(15)2)24-11-9-23(10-12-24)14-20-21-18-5-3-4-6-19(18)22-20/h3-8,13H,9-12,14H2,1-2H3,(H,21,22) D0F0IA DRUGINKE SAQMCVDGOIRQTC-UHFFFAOYSA-N D0F0IA DRUGSMIL CC1=C(C=C(C=C1)N2CCN(CC2)CC3=NC4=CC=CC=C4N3)C D0F0IA HIGHSTAT Investigative D0F0JI DRUG__ID D0F0JI D0F0JI DRUGTYPE Small molecular drug D0F0JI DRUGINCH 1S/C24H39NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-24(26)25-23-20-17-16-18-21-23/h9-10,16-18,20-21H,2-8,11-15,19,22H2,1H3,(H,25,26)/b10-9+ D0F0JI DRUGINKE YPUOCYKJOLQYQS-MDZDMXLPSA-N D0F0JI DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC1=CC=CC=C1 D0F0JI HIGHSTAT Investigative D0F0JU DRUG__ID D0F0JU D0F0JU DRUGTYPE Small molecular drug D0F0JU DRUGINCH 1S/C17H15NO2S/c1-19-14-7-3-12(4-8-14)16-11-18-21-17(16)13-5-9-15(20-2)10-6-13/h3-11H,1-2H3 D0F0JU DRUGINKE COPANKICKKUPAC-UHFFFAOYSA-N D0F0JU DRUGSMIL COC1=CC=C(C=C1)C2=C(SN=C2)C3=CC=C(C=C3)OC D0F0JU HIGHSTAT Investigative D0F0KS DRUG__ID D0F0KS D0F0KS DRUGTYPE Small molecular drug D0F0KS DRUGINCH 1S/C10H12N2O2S/c13-9(11-6-7-15)10(14)12-8-4-2-1-3-5-8/h1-5,15H,6-7H2,(H,11,13)(H,12,14) D0F0KS DRUGINKE NDECTIXXLKUOQM-UHFFFAOYSA-N D0F0KS DRUGSMIL C1=CC=C(C=C1)NC(=O)C(=O)NCCS D0F0KS HIGHSTAT Investigative D0F0KV DRUG__ID D0F0KV D0F0KV DRUGTYPE Small molecular drug D0F0KV DRUGINCH 1S/C15H15NO2.ClH/c1-9-10(2)15(18)13(11(3)14(9)17)7-12-5-4-6-16-8-12;/h4-6,8H,7H2,1-3H3;1H D0F0KV DRUGINKE FBOCJGYMOAAFSO-UHFFFAOYSA-N D0F0KV DRUGSMIL CC1=C(C(=O)C(=C(C1=O)C)CC2=CN=CC=C2)C.Cl D0F0KV HIGHSTAT Investigative D0F0MP DRUG__ID D0F0MP D0F0MP DRUGTYPE Small molecular drug D0F0MP DRUGINCH 1S/C23H26ClNO4S/c1-3-6-17-20(9-8-16-19(4-2)25-29-23(16)17)28-11-5-12-30-21-10-7-15(13-18(21)24)14-22(26)27/h7-10,13H,3-6,11-12,14H2,1-2H3,(H,26,27) D0F0MP DRUGINKE LBEYMGDIPDOUKK-UHFFFAOYSA-N D0F0MP DRUGSMIL CCCC1=C(C=CC2=C1ON=C2CC)OCCCSC3=C(C=C(C=C3)CC(=O)O)Cl D0F0MP HIGHSTAT Investigative D0F0PY DRUG__ID D0F0PY D0F0PY DRUGTYPE Small molecular drug D0F0PY DRUGINCH 1S/C40H64N2O2/c1-3-39(35-21-19-23-37(43)31-35)25-13-17-29-41(33-39)27-15-11-9-7-5-6-8-10-12-16-28-42-30-18-14-26-40(4-2,34-42)36-22-20-24-38(44)32-36/h19-24,31-32,43-44H,3-18,25-30,33-34H2,1-2H3/t39-,40-/m1/s1 D0F0PY DRUGINKE ZWQWXPDQHDYQPH-XRSDMRJBSA-N D0F0PY DRUGSMIL CCC1(CCCCN(C1)CCCCCCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0F0PY HIGHSTAT Investigative D0F0UA DRUG__ID D0F0UA D0F0UA DRUGTYPE Small molecular drug D0F0UA DRUGINCH 1S/C19H19N5O3S2/c25-18(14(11-28)7-6-13-4-2-1-3-5-13)21-17(19(26)27)16-9-8-15(29-16)10-24-12-20-22-23-24/h1-5,8-9,12,14,28H,6-7,10-11H2,(H,26,27) D0F0UA DRUGINKE DUKDFMPUZRDWLT-UHFFFAOYSA-N D0F0UA DRUGSMIL C1=CC=C(C=C1)CCC(CS)C(=O)N=C(C2=CC=C(S2)CN3C=NN=N3)C(=O)O D0F0UA HIGHSTAT Investigative D0F0VD DRUG__ID D0F0VD D0F0VD DRUGTYPE Small molecular drug D0F0VD DRUGINCH 1S/C21H24N4O2/c22-11-16-15(14-6-8-24-9-7-14)10-17(25-21(16)23)20-18(26)2-1-3-19(20)27-12-13-4-5-13/h1-3,10,13-14,24,26H,4-9,12H2,(H2,23,25) D0F0VD DRUGINKE DYVFBWXIOCLHPP-UHFFFAOYSA-N D0F0VD DRUGSMIL C1CC1COC2=CC=CC(=C2C3=NC(=C(C(=C3)C4CCNCC4)C#N)N)O D0F0VD HIGHSTAT Investigative D0F0XZ DRUG__ID D0F0XZ D0F0XZ DRUGTYPE Small molecular drug D0F0XZ DRUGINCH 1S/C16H13F3N6O/c17-16(18,19)10-6-12(21-11-3-4-11)25-13(7-10)22-15(24-25)23-14(26)9-2-1-5-20-8-9/h1-2,5-8,11,21H,3-4H2,(H,23,24,26) D0F0XZ DRUGINKE XUKGFHHTSUKORV-UHFFFAOYSA-N D0F0XZ DRUGSMIL C1CC1NC2=CC(=CC3=NC(=NN23)NC(=O)C4=CN=CC=C4)C(F)(F)F D0F0XZ HIGHSTAT Investigative D0F0ZX DRUG__ID D0F0ZX D0F0ZX DRUGTYPE Small molecular drug D0F0ZX DRUGINCH 1S/C7H17N3S/c1-10(2)5-3-4-6-11-7(8)9/h3-6H2,1-2H3,(H3,8,9) D0F0ZX DRUGINKE UFYJLJINUGVUHO-UHFFFAOYSA-N D0F0ZX DRUGSMIL CN(C)CCCCSC(=N)N D0F0ZX HIGHSTAT Investigative D0F1AS DRUG__ID D0F1AS D0F1AS DRUGTYPE Small molecular drug D0F1AS DRUGINCH 1S/C6H6N4O2/c1-10-5(11)3-4(8-2-7-3)9-6(10)12/h2H,1H3,(H,7,8)(H,9,12) D0F1AS DRUGINKE MVOYJPOZRLFTCP-UHFFFAOYSA-N D0F1AS DRUGSMIL CN1C(=O)C2=C(NC1=O)N=CN2 D0F1AS HIGHSTAT Investigative D0F1BD DRUG__ID D0F1BD D0F1BD DRUGTYPE Small molecular drug D0F1BD DRUGINCH 1S/C16H11NO2/c18-15-10-11-16(19)17(15)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-11H D0F1BD DRUGINKE RXWKCYQPTDVVSI-UHFFFAOYSA-N D0F1BD DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)N3C(=O)C=CC3=O D0F1BD HIGHSTAT Investigative D0F1EB DRUG__ID D0F1EB D0F1EB DRUGTYPE Small molecular drug D0F1EB DRUGINCH 1S/C30H31ClN2O4/c1-36-23-10-7-20-16-24-30(32-25(35)11-6-18-4-8-21(31)9-5-18)13-12-22(34)28-29(30,26(20)27(23)37-28)14-15-33(24)17-19-2-3-19/h4-11,19,24,28H,2-3,12-17H2,1H3,(H,32,35)/b11-6+/t24-,28+,29+,30-/m1/s1 D0F1EB DRUGINKE LZSMGMMAKBCSRL-WDJVXPEUSA-N D0F1EB DRUGSMIL COC1=C2C3=C(CC4C5(C3(CCN4CC6CC6)C(O2)C(=O)CC5)NC(=O)C=CC7=CC=C(C=C7)Cl)C=C1 D0F1EB HIGHSTAT Investigative D0F1FN DRUG__ID D0F1FN D0F1FN DRUGTYPE Small molecular drug D0F1FN DRUGINCH 1S/C12H16N2/c1-13(2)9-10-14-8-7-11-5-3-4-6-12(11)14/h3-8H,9-10H2,1-2H3 D0F1FN DRUGINKE PSHKCPACSIZILK-UHFFFAOYSA-N D0F1FN DRUGSMIL CN(C)CCN1C=CC2=CC=CC=C21 D0F1FN HIGHSTAT Investigative D0F1IS DRUG__ID D0F1IS D0F1IS DRUGTYPE Small molecular drug D0F1IS DRUGINCH 1S/C32H41N5O6/c1-21-27(30(38)42-4)29(28(22(2)34-21)31(39)43-5)23-10-8-11-24(20-23)35-32(40)33-14-9-15-36-16-18-37(19-17-36)25-12-6-7-13-26(25)41-3/h6-8,10-13,20,29,34H,9,14-19H2,1-5H3,(H2,33,35,40) D0F1IS DRUGINKE HSUYTMPXLKOBTD-UHFFFAOYSA-N D0F1IS DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)NC(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OC)C(=O)OC D0F1IS HIGHSTAT Investigative D0F1KM DRUG__ID D0F1KM D0F1KM DRUGTYPE Small molecular drug D0F1KM DRUGINCH 1S/C15H13NO2/c1-18-14-8-5-12(6-9-14)15(17)10-7-13-4-2-3-11-16-13/h2-11H,1H3/b10-7+ D0F1KM DRUGINKE PUUXTLUBRGYYIL-JXMROGBWSA-N D0F1KM DRUGSMIL COC1=CC=C(C=C1)C(=O)C=CC2=CC=CC=N2 D0F1KM HIGHSTAT Investigative D0F1KR DRUG__ID D0F1KR D0F1KR DRUGTYPE Small molecular drug D0F1KR DRUGINCH 1S/C26H22N2O2/c1-18(19-9-3-2-4-10-19)28-26(30)22-13-7-8-14-24(22)27-17-23-21-12-6-5-11-20(21)15-16-25(23)29/h2-18,29H,1H3,(H,28,30)/t18-/m0/s1 D0F1KR DRUGINKE UXJFDYIHRJGPFS-SFHVURJKSA-N D0F1KR DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC=CC=C2N=CC3=C(C=CC4=CC=CC=C43)O D0F1KR HIGHSTAT Investigative D0F1LA DRUG__ID D0F1LA D0F1LA DRUGTYPE Small molecular drug D0F1LA DRUGINCH 1S/C33H33N3O7S2/c1-35(2)29-13-5-11-26-24(29)9-7-15-31(26)44(39,40)34-28(33(37)38)21-22-17-19-23(20-18-22)43-45(41,42)32-16-8-10-25-27(32)12-6-14-30(25)36(3)4/h5-20,28,34H,21H2,1-4H3,(H,37,38)/t28-/m0/s1 D0F1LA DRUGINKE LUBOPDUYHWABFG-NDEPHWFRSA-N D0F1LA DRUGSMIL CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NC(CC3=CC=C(C=C3)OS(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)C(=O)O D0F1LA HIGHSTAT Investigative D0F1RL DRUG__ID D0F1RL D0F1RL DRUGTYPE Small molecular drug D0F1RL DRUGINCH 1S/C7H8BrO3PS/c8-6-3-1-5(2-4-6)7(13)12(9,10)11/h1-4,7,13H,(H2,9,10,11) D0F1RL DRUGINKE UIINFAMEMQXUIX-UHFFFAOYSA-N D0F1RL DRUGSMIL C1=CC(=CC=C1C(P(=O)(O)O)S)Br D0F1RL HIGHSTAT Investigative D0F1RU DRUG__ID D0F1RU D0F1RU DRUGTYPE Small molecular drug D0F1RU DRUGINCH 1S/C19H19NO5/c1-21-15-6-5-7-16(19(15)24-4)25-14-8-9-20-13-11-18(23-3)17(22-2)10-12(13)14/h5-11H,1-4H3 D0F1RU DRUGINKE NQWDTJUCVNPURX-UHFFFAOYSA-N D0F1RU DRUGSMIL COC1=C(C(=CC=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC)OC D0F1RU HIGHSTAT Investigative D0F1SI DRUG__ID D0F1SI D0F1SI DRUGTYPE Small molecular drug D0F1SI DRUGINCH 1S/C13H13N5OS/c1-6-20-7-9(1)11-16-12-10(14-8-15-12)13(17-11)18-2-4-19-5-3-18/h1,6-8H,2-5H2,(H,14,15,16,17) D0F1SI DRUGINKE SQTGJTBXJLFTBF-UHFFFAOYSA-N D0F1SI DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CSC=C4 D0F1SI HIGHSTAT Investigative D0F1SN DRUG__ID D0F1SN D0F1SN DRUGTYPE Small molecular drug D0F1SN DRUGINCH 1S/C26H26ClNO5/c1-4-13-28-25(30)20-7-5-6-8-21(20)26(28,18-9-11-19(27)12-10-18)33-16-17-14-22(31-2)24(29)23(15-17)32-3/h5-12,14-15,29H,4,13,16H2,1-3H3 D0F1SN DRUGINKE NDIKZCQEKGERHF-UHFFFAOYSA-N D0F1SN DRUGSMIL CCCN1C(=O)C2=CC=CC=C2C1(C3=CC=C(C=C3)Cl)OCC4=CC(=C(C(=C4)OC)O)OC D0F1SN HIGHSTAT Investigative D0F1SS DRUG__ID D0F1SS D0F1SS DRUGTYPE Small molecular drug D0F1SS DRUGINCH 1S/C23H31NO2/c1-20(2)18(25)10-11-21(3)22(4)14(9-12-23(20,21)26)13-16-15-7-5-6-8-17(15)24-19(16)22/h5-8,14,18,24-26H,9-13H2,1-4H3/t14-,18+,21+,22+,23+/m0/s1 D0F1SS DRUGINKE QJRNEHJGTLWRJJ-BVYMYZFFSA-N D0F1SS DRUGSMIL CC1(C(CCC2(C1(CCC3C2(C4=C(C3)C5=CC=CC=C5N4)C)O)C)O)C D0F1SS HIGHSTAT Investigative D0F1TU DRUG__ID D0F1TU D0F1TU DRUGTYPE Small molecular drug D0F1TU DRUGINCH 1S/C24H20P/c1-5-13-21(14-6-1)25(22-15-7-2-8-16-22,23-17-9-3-10-18-23)24-19-11-4-12-20-24/h1-20H/q+1 D0F1TU DRUGINKE USFPINLPPFWTJW-UHFFFAOYSA-N D0F1TU DRUGSMIL C1=CC=C(C=C1)[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D0F1TU HIGHSTAT Investigative D0F1UD DRUG__ID D0F1UD D0F1UD DRUGTYPE Small molecular drug D0F1UD DRUGINCH 1S/C15H25BO2/c1-2-3-4-5-6-7-8-9-14-10-12-15(13-11-14)16(17)18/h10-13,17-18H,2-9H2,1H3 D0F1UD DRUGINKE VONVJOGSLHAKOX-UHFFFAOYSA-N D0F1UD DRUGSMIL B(C1=CC=C(C=C1)CCCCCCCCC)(O)O D0F1UD HIGHSTAT Investigative D0F1VP DRUG__ID D0F1VP D0F1VP DRUGTYPE Small molecular drug D0F1VP DRUGINCH 1S/C19H17N3O4/c1-11(19(25)26)20-17(23)13-7-3-5-9-15(13)22-18(24)16-10-12-6-2-4-8-14(12)21-16/h2-11,21H,1H3,(H,20,23)(H,22,24)(H,25,26) D0F1VP DRUGINKE GNVBTLURHXQVAD-UHFFFAOYSA-N D0F1VP DRUGSMIL CC(C(=O)O)NC(=O)C1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3N2 D0F1VP HIGHSTAT Investigative D0F1VR DRUG__ID D0F1VR D0F1VR DRUGTYPE Small molecular drug D0F1VR DRUGINCH 1S/C12H7Br3O3/c13-6-1-3-8(16)10(5-6)18-12-9(17)4-2-7(14)11(12)15/h1-5,16-17H D0F1VR DRUGINKE MQTQEJZMDKSDNZ-UHFFFAOYSA-N D0F1VR DRUGSMIL C1=CC(=C(C=C1Br)OC2=C(C=CC(=C2Br)Br)O)O D0F1VR HIGHSTAT Investigative D0F1XE DRUG__ID D0F1XE D0F1XE DRUGTYPE Small molecular drug D0F1XE DRUGINCH 1S/C5H11N3S/c1-4(2)3-7-8-5(6)9/h3-4H,1-2H3,(H3,6,8,9)/b7-3- D0F1XE DRUGINKE ISGCVMPYARLSFM-CLTKARDFSA-N D0F1XE DRUGSMIL CC(C)C=NNC(=S)N D0F1XE HIGHSTAT Investigative D0F1ZE DRUG__ID D0F1ZE D0F1ZE DRUGTYPE Small molecular drug D0F1ZE DRUGINCH 1S/C18H14N2O/c21-18-16-10-3-4-11-17(16)19-20(18)12-14-8-5-7-13-6-1-2-9-15(13)14/h1-11,19H,12H2 D0F1ZE DRUGINKE SXKBSXCUDSHBDF-UHFFFAOYSA-N D0F1ZE DRUGSMIL C1=CC=C2C(=C1)C=CC=C2CN3C(=O)C4=CC=CC=C4N3 D0F1ZE HIGHSTAT Investigative D0F2DC DRUG__ID D0F2DC D0F2DC DRUGTYPE Small molecular drug D0F2DC DRUGINCH 1S/C10H12FN/c1-7-2-4-8(5-3-7)10(11)6-9(10)12/h2-5,9H,6,12H2,1H3/t9-,10-/m0/s1 D0F2DC DRUGINKE JEBMWAUALYWCIW-UWVGGRQHSA-N D0F2DC DRUGSMIL CC1=CC=C(C=C1)C2(CC2N)F D0F2DC HIGHSTAT Investigative D0F2GG DRUG__ID D0F2GG D0F2GG DRUGTYPE Small molecular drug D0F2GG DRUGINCH 1S/C9H10ClNO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13) D0F2GG DRUGINKE NIGWMJHCCYYCSF-UHFFFAOYSA-N D0F2GG DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)Cl D0F2GG HIGHSTAT Investigative D0F2HJ DRUG__ID D0F2HJ D0F2HJ DRUGTYPE Small molecular drug D0F2HJ DRUGINCH 1S/C18H25N3O4/c1-2-3-7-12-19-17(23)13-15(18(24)21-25)20-16(22)11-10-14-8-5-4-6-9-14/h4-6,8-11,15,25H,2-3,7,12-13H2,1H3,(H,19,23)(H,20,22)(H,21,24)/b11-10+/t15-/m1/s1 D0F2HJ DRUGINKE GEWJSTSZXRZGCY-AUECHBEKSA-N D0F2HJ DRUGSMIL CCCCCNC(=O)CC(C(=O)NO)NC(=O)C=CC1=CC=CC=C1 D0F2HJ HIGHSTAT Investigative D0F2KL DRUG__ID D0F2KL D0F2KL DRUGTYPE Small molecular drug D0F2KL DRUGINCH 1S/C15H10N2/c1-12-4-2-7-15(17-12)9-8-13-5-3-6-14(10-13)11-16/h2-7,10H,1H3 D0F2KL DRUGINKE FKODYULBKPINFM-UHFFFAOYSA-N D0F2KL DRUGSMIL CC1=NC(=CC=C1)C#CC2=CC(=CC=C2)C#N D0F2KL HIGHSTAT Investigative D0F2ME DRUG__ID D0F2ME D0F2ME DRUGTYPE Small molecular drug D0F2ME DRUGINCH 1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1 D0F2ME DRUGINKE QTBSBXVTEAMEQO-UHFFFAOYSA-M D0F2ME DRUGSMIL CC(=O)[O-] D0F2ME HIGHSTAT Investigative D0F2MP DRUG__ID D0F2MP D0F2MP DRUGTYPE Small molecular drug D0F2MP DRUGINCH 1S/C25H21N5O/c1-2-4-24-22(3-1)21(9-10-26-24)23-16-28-30-17-19(15-27-25(23)30)18-5-7-20(8-6-18)29-11-13-31-14-12-29/h1-10,15-17H,11-14H2 D0F2MP DRUGINKE SZVLDZCYMADNPG-UHFFFAOYSA-N D0F2MP DRUGSMIL C1COCCN1C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3 D0F2MP HIGHSTAT Investigative D0F2SM DRUG__ID D0F2SM D0F2SM DRUGTYPE Small molecular drug D0F2SM DRUGINCH 1S/C16H13FO3/c1-19-12-6-7-13-14(18)9-15(20-16(13)8-12)10-2-4-11(17)5-3-10/h2-8,15H,9H2,1H3/t15-/m1/s1 D0F2SM DRUGINKE LIINIWOYEGBFDA-OAHLLOKOSA-N D0F2SM DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)F D0F2SM HIGHSTAT Investigative D0F2SQ DRUG__ID D0F2SQ D0F2SQ DRUGTYPE Small molecular drug D0F2SQ DRUGINCH 1S/C10H21O3PS/c1-2-3-4-5-6-7-8-9-10-13-14(11,12)15/h2H,1,3-10H2,(H2,11,12,15) D0F2SQ DRUGINKE LWVBJTXDTCXEJG-UHFFFAOYSA-N D0F2SQ DRUGSMIL C=CCCCCCCCCOP(=S)(O)O D0F2SQ HIGHSTAT Investigative D0F2VL DRUG__ID D0F2VL D0F2VL DRUGTYPE Small molecular drug D0F2VL DRUGINCH 1S/C12H11N3O/c13-12-14-9-6-5-7-3-1-2-4-8(7)10(9)11(16)15-12/h1-4H,5-6H2,(H3,13,14,15,16) D0F2VL DRUGINKE VXKOVZZJDGUSEF-UHFFFAOYSA-N D0F2VL DRUGSMIL C1CC2=C(C3=CC=CC=C31)C(=O)NC(=N2)N D0F2VL HIGHSTAT Investigative D0F2WA DRUG__ID D0F2WA D0F2WA DRUGTYPE Small molecular drug D0F2WA DRUGINCH 1S/C22H24F3N5O7/c23-22(24,25)16(33)12(2-1-3-13-17(26)29-21(27)30-19(13)35)10-4-6-11(7-5-10)18(34)28-14(20(36)37)8-9-15(31)32/h4-7,12,14H,1-3,8-9H2,(H,28,34)(H,31,32)(H,36,37)(H5,26,27,29,30,35) D0F2WA DRUGINKE GMLVQBYTPQKEQF-UHFFFAOYSA-N D0F2WA DRUGSMIL C1=CC(=CC=C1C(CCCC2=C(N=C(NC2=O)N)N)C(=O)C(F)(F)F)C(=O)NC(CCC(=O)O)C(=O)O D0F2WA HIGHSTAT Investigative D0F2WQ DRUG__ID D0F2WQ D0F2WQ DRUGTYPE Small molecular drug D0F2WQ DRUGINCH 1S/C9H6O6/c10-7(11)4-1-5(8(12)13)3-6(2-4)9(14)15/h1-3H,(H,10,11)(H,12,13)(H,14,15) D0F2WQ DRUGINKE QMKYBPDZANOJGF-UHFFFAOYSA-N D0F2WQ DRUGSMIL C1=C(C=C(C=C1C(=O)O)C(=O)O)C(=O)O D0F2WQ HIGHSTAT Investigative D0F2XI DRUG__ID D0F2XI D0F2XI DRUGTYPE Small molecular drug D0F2XI DRUGINCH 1S/C18H17BrN2O2S/c19-12-6-4-11(5-7-12)18-15-3-1-2-14(15)16-10-13(24(20,22)23)8-9-17(16)21-18/h1-2,4-10,14-15,18,21H,3H2,(H2,20,22,23) D0F2XI DRUGINKE YNCXHXYZTLIZTO-UHFFFAOYSA-N D0F2XI DRUGSMIL C1C=CC2C1C(NC3=C2C=C(C=C3)S(=O)(=O)N)C4=CC=C(C=C4)Br D0F2XI HIGHSTAT Investigative D0F2XZ DRUG__ID D0F2XZ D0F2XZ DRUGTYPE Small molecular drug D0F2XZ DRUGINCH 1S/C12H18N2/c1-11-5-4-9-14(11)10-7-12-6-2-3-8-13-12/h2-3,6,8,11H,4-5,7,9-10H2,1H3/t11-/m0/s1 D0F2XZ DRUGINKE ICWSPDRNRGQWAB-NSHDSACASA-N D0F2XZ DRUGSMIL CC1CCCN1CCC2=CC=CC=N2 D0F2XZ HIGHSTAT Investigative D0F2YC DRUG__ID D0F2YC D0F2YC DRUGTYPE Small molecular drug D0F2YC DRUGINCH 1S/C16H14N2O2/c19-15-17(11-13-7-3-1-4-8-13)16(20)18(15)12-14-9-5-2-6-10-14/h1-10H,11-12H2 D0F2YC DRUGINKE PGIXYPNBNAOYHW-UHFFFAOYSA-N D0F2YC DRUGSMIL C1=CC=C(C=C1)CN2C(=O)N(C2=O)CC3=CC=CC=C3 D0F2YC HIGHSTAT Investigative D0F3AN DRUG__ID D0F3AN D0F3AN DRUGTYPE Small molecular drug D0F3AN DRUGINCH 1S/C19H24ClN5O3S/c1-10-13-15(21)16(17(27)22-11-3-4-11)29-19(13)23-18(14(10)20)28-9-12(26)25-7-5-24(2)6-8-25/h11H,3-9,21H2,1-2H3,(H,22,27) D0F3AN DRUGINKE TYTGOXSAAQWLPJ-UHFFFAOYSA-N D0F3AN DRUGSMIL CC1=C2C(=C(SC2=NC(=C1Cl)OCC(=O)N3CCN(CC3)C)C(=O)NC4CC4)N D0F3AN HIGHSTAT Investigative D0F3AR DRUG__ID D0F3AR D0F3AR DRUGTYPE Small molecular drug D0F3AR DRUGINCH 1S/C16H14N2/c1-2-13(16-10-17-11-18-16)15-9-5-7-12-6-3-4-8-14(12)15/h2-11H,1H3,(H,17,18)/b13-2- D0F3AR DRUGINKE VDVBKYMIYSQNPM-SILLCRNTSA-N D0F3AR DRUGSMIL CC=C(C1=CC=CC2=CC=CC=C21)C3=CN=CN3 D0F3AR HIGHSTAT Investigative D0F3CA DRUG__ID D0F3CA D0F3CA DRUGTYPE Small molecular drug D0F3CA DRUGINCH 1S/C9H4Cl2O2/c10-7-5-3-1-2-4-6(5)9(12)13-8(7)11/h1-4H D0F3CA DRUGINKE SUGXUUGGLDCZKB-UHFFFAOYSA-N D0F3CA DRUGSMIL C1=CC=C2C(=C1)C(=C(OC2=O)Cl)Cl D0F3CA HIGHSTAT Investigative D0F3CH DRUG__ID D0F3CH D0F3CH DRUGTYPE Small molecular drug D0F3CH DRUGINCH 1S/C24H23NO2/c1-4-14-25-16(2)23(21-9-5-6-11-22(21)25)24(26)20-10-7-8-17-15-18(27-3)12-13-19(17)20/h5-13,15H,4,14H2,1-3H3 D0F3CH DRUGINKE PJQIBVPPWAUFQB-UHFFFAOYSA-N D0F3CH DRUGSMIL CCCN1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=C3C=CC(=C4)OC)C D0F3CH HIGHSTAT Investigative D0F3CO DRUG__ID D0F3CO D0F3CO DRUGTYPE Small molecular drug D0F3CO DRUGINCH 1S/C6H6O4/c7-2-4-1-5(8)6(9)3-10-4/h1,3,7,9H,2H2 D0F3CO DRUGINKE BEJNERDRQOWKJM-UHFFFAOYSA-N D0F3CO DRUGSMIL C1=C(OC=C(C1=O)O)CO D0F3CO HIGHSTAT Investigative D0F3CS DRUG__ID D0F3CS D0F3CS DRUGTYPE Small molecular drug D0F3CS DRUGINCH 1S/C10H13NO/c1-8(12)10(11)7-9-5-3-2-4-6-9/h2-6,10H,7,11H2,1H3/t10-/m0/s1 D0F3CS DRUGINKE RTUDQBPZFFIRAD-JTQLQIEISA-N D0F3CS DRUGSMIL CC(=O)C(CC1=CC=CC=C1)N D0F3CS HIGHSTAT Investigative D0F3KP DRUG__ID D0F3KP D0F3KP DRUGTYPE Small molecular drug D0F3KP DRUGINCH 1S/CH3NOS/c2-1(3)4/h(H3,2,3,4)/p-1 D0F3KP DRUGINKE GNVMUORYQLCPJZ-UHFFFAOYSA-M D0F3KP DRUGSMIL C(=O)(N)[S-] D0F3KP HIGHSTAT Investigative D0F3PF DRUG__ID D0F3PF D0F3PF DRUGTYPE Small molecular drug D0F3PF DRUGINCH 1S/C23H33N3O/c27-22(25-23-13-18-10-19(14-23)12-20(11-18)15-23)24-21-6-8-26(9-7-21)16-17-4-2-1-3-5-17/h1-5,18-21H,6-16H2,(H2,24,25,27) D0F3PF DRUGINKE SZCGIFNKYJVHTL-UHFFFAOYSA-N D0F3PF DRUGSMIL C1CN(CCC1NC(=O)NC23CC4CC(C2)CC(C4)C3)CC5=CC=CC=C5 D0F3PF HIGHSTAT Investigative D0F3QP DRUG__ID D0F3QP D0F3QP DRUGTYPE Small molecular drug D0F3QP DRUGINCH 1S/C20H18O4/c1-20(2)12-11-16-18(24-20)10-8-15(19(16)23)17(22)9-5-13-3-6-14(21)7-4-13/h3-12,21,23H,1-2H3/b9-5+ D0F3QP DRUGINKE IQHPDUUSMBMDGN-WEVVVXLNSA-N D0F3QP DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)C=CC3=CC=C(C=C3)O)C D0F3QP HIGHSTAT Investigative D0F3RN DRUG__ID D0F3RN D0F3RN DRUGTYPE Small molecular drug D0F3RN DRUGINCH 1S/C14H9ClO2/c15-12-8-6-11(7-9-12)14(17)13(16)10-4-2-1-3-5-10/h1-9H D0F3RN DRUGINKE QDCKVAZDINMMHO-UHFFFAOYSA-N D0F3RN DRUGSMIL C1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)Cl D0F3RN HIGHSTAT Investigative D0F3TM DRUG__ID D0F3TM D0F3TM DRUGTYPE Small molecular drug D0F3TM DRUGINCH 1S/C23H18N2O3/c26-22-19(13-10-16-7-4-14-24-21(16)22)20(15-5-2-1-3-6-15)25-18-11-8-17(9-12-18)23(27)28/h1-14,20,25-26H,(H,27,28) D0F3TM DRUGINKE PSCFZETTYRDCRM-UHFFFAOYSA-N D0F3TM DRUGSMIL C1=CC=C(C=C1)C(C2=C(C3=C(C=CC=N3)C=C2)O)NC4=CC=C(C=C4)C(=O)O D0F3TM HIGHSTAT Investigative D0F3UR DRUG__ID D0F3UR D0F3UR DRUGTYPE Small molecular drug D0F3UR DRUGINCH 1S/C14H14N2O2S/c1-11-2-4-12(5-3-11)10-16-13-6-8-14(9-7-13)19(15,17)18/h2-10H,1H3,(H2,15,17,18) D0F3UR DRUGINKE SOHFVFXITPDEDK-UHFFFAOYSA-N D0F3UR DRUGSMIL CC1=CC=C(C=C1)C=NC2=CC=C(C=C2)S(=O)(=O)N D0F3UR HIGHSTAT Investigative D0F3VE DRUG__ID D0F3VE D0F3VE DRUGTYPE Small molecular drug D0F3VE DRUGINCH 1S/C18H12N2O2/c1-22-12-8-6-11(7-9-12)16-10-15-17(20-19-16)13-4-2-3-5-14(13)18(15)21/h2-10H,1H3 D0F3VE DRUGINKE HXQRIHGYIOARQJ-UHFFFAOYSA-N D0F3VE DRUGSMIL COC1=CC=C(C=C1)C2=NN=C3C4=CC=CC=C4C(=O)C3=C2 D0F3VE HIGHSTAT Investigative D0F3VX DRUG__ID D0F3VX D0F3VX DRUGTYPE Small molecular drug D0F3VX DRUGINCH 1S/C13H16N2O2/c1-9(8-16-2)17-11-5-3-4-10-6-7-12(14)15-13(10)11/h3-7,9H,8H2,1-2H3,(H2,14,15) D0F3VX DRUGINKE HFVYCRXMQPWHFZ-UHFFFAOYSA-N D0F3VX DRUGSMIL CC(COC)OC1=CC=CC2=C1N=C(C=C2)N D0F3VX HIGHSTAT Investigative D0F3VZ DRUG__ID D0F3VZ D0F3VZ DRUGTYPE Small molecular drug D0F3VZ DRUGINCH 1S/C16H29N3O2/c1-2-15(20)19-11-9-14(10-12-19)18-16(21)17-13-7-5-3-4-6-8-13/h13-14H,2-12H2,1H3,(H2,17,18,21) D0F3VZ DRUGINKE VEXSVFHEOLIFHA-UHFFFAOYSA-N D0F3VZ DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2CCCCCC2 D0F3VZ HIGHSTAT Investigative D0F3WR DRUG__ID D0F3WR D0F3WR DRUGTYPE Small molecular drug D0F3WR DRUGINCH 1S/C16H16O3S/c1-19-14-9-5-6-12(10-14)11-20-15(16(17)18)13-7-3-2-4-8-13/h2-10,15H,11H2,1H3,(H,17,18) D0F3WR DRUGINKE DCWDBUYRVFMPPL-UHFFFAOYSA-N D0F3WR DRUGSMIL COC1=CC=CC(=C1)CSC(C2=CC=CC=C2)C(=O)O D0F3WR HIGHSTAT Investigative D0F3XG DRUG__ID D0F3XG D0F3XG DRUGTYPE Small molecular drug D0F3XG DRUGINCH 1S/C27H27NO/c1-3-4-7-16-28-19-23(18-26(28)22-13-8-10-20(2)17-22)27(29)25-15-9-12-21-11-5-6-14-24(21)25/h5-6,8-15,17-19H,3-4,7,16H2,1-2H3 D0F3XG DRUGINKE SHCDXHJKMSBCOQ-UHFFFAOYSA-N D0F3XG DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC(=C2)C)C(=O)C3=CC=CC4=CC=CC=C43 D0F3XG HIGHSTAT Investigative D0F3XQ DRUG__ID D0F3XQ D0F3XQ DRUGTYPE Small molecular drug D0F3XQ DRUGINCH 1S/C25H31ClN2O5/c1-30-23-15-21(27)20(26)14-19(23)25(29)33-16-18-6-9-28(10-7-18)8-2-3-17-4-5-22-24(13-17)32-12-11-31-22/h4-5,13-15,18H,2-3,6-12,16,27H2,1H3 D0F3XQ DRUGINKE AJVNZBQUOHOEQO-UHFFFAOYSA-N D0F3XQ DRUGSMIL COC1=CC(=C(C=C1C(=O)OCC2CCN(CC2)CCCC3=CC4=C(C=C3)OCCO4)Cl)N D0F3XQ HIGHSTAT Investigative D0F3XT DRUG__ID D0F3XT D0F3XT DRUGTYPE Small molecular drug D0F3XT DRUGINCH 1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3,6,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,6-/m0/s1 D0F3XT DRUGINKE FEMXZDUTFRTWPE-DZSWIPIPSA-N D0F3XT DRUGSMIL CC(C(C1=NC2=C(NC1)N=C(NC2=O)N)O)O D0F3XT HIGHSTAT Investigative D0F4AN DRUG__ID D0F4AN D0F4AN DRUGTYPE Small molecular drug D0F4AN DRUGINCH 1S/C24H34N2O2/c1-2-25-23(27)28-19-10-9-18-14-22-20-8-3-4-11-24(20,21(18)15-19)12-13-26(22)16-17-6-5-7-17/h9-10,15,17,20,22H,2-8,11-14,16H2,1H3,(H,25,27) D0F4AN DRUGINKE CDJRHRPFKCSONV-UHFFFAOYSA-N D0F4AN DRUGSMIL CCNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CCC5)C=C1 D0F4AN HIGHSTAT Investigative D0F4BE DRUG__ID D0F4BE D0F4BE DRUGTYPE Small molecular drug D0F4BE DRUGINCH 1S/C22H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)26-23-20-21-24/h6-7,9-10,12-13,15-16,23-24H,2-5,8,11,14,17-21H2,1H3/b7-6-,10-9-,13-12-,16-15- D0F4BE DRUGINKE XNXCXJJVMFVWDO-DOFZRALJSA-N D0F4BE DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)ONCCO D0F4BE HIGHSTAT Investigative D0F4BX DRUG__ID D0F4BX D0F4BX DRUGTYPE Small molecular drug D0F4BX DRUGINCH 1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m1/s1 D0F4BX DRUGINKE SSQJFGMEZBFMNV-WOJBJXKFSA-N D0F4BX DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O D0F4BX HIGHSTAT Investigative D0F4EL DRUG__ID D0F4EL D0F4EL DRUGTYPE Small molecular drug D0F4EL DRUGINCH 1S/C20H19N3O4/c1-23-15(7-13-3-5-17-19(9-13)27-11-25-17)14(22-20(23)21)6-12-2-4-16-18(8-12)26-10-24-16/h2-5,8-9H,6-7,10-11H2,1H3,(H2,21,22) D0F4EL DRUGINKE CHUHMZZQHYOKBF-UHFFFAOYSA-N D0F4EL DRUGSMIL CN1C(=C(N=C1N)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 D0F4EL HIGHSTAT Investigative D0F4EN DRUG__ID D0F4EN D0F4EN DRUGTYPE Small molecular drug D0F4EN DRUGINCH 1S/C16H11N3/c1-2-6-13(7-3-1)19-11-12-10-17-15-9-5-4-8-14(15)16(12)18-19/h1-11H D0F4EN DRUGINKE GUVLEBBZKMQLIY-UHFFFAOYSA-N D0F4EN DRUGSMIL C1=CC=C(C=C1)N2C=C3C=NC4=CC=CC=C4C3=N2 D0F4EN HIGHSTAT Investigative D0F4FK DRUG__ID D0F4FK D0F4FK DRUGTYPE Small molecular drug D0F4FK DRUGINCH 1S/C16H17N3O3S.CH4O3S/c17-16(18)23-10-9-12-3-7-15(8-4-12)22-11-13-1-5-14(6-2-13)19(20)21;1-5(2,3)4/h1-8H,9-11H2,(H3,17,18);1H3,(H,2,3,4) D0F4FK DRUGINKE WGIKEBHIKKWJLG-UHFFFAOYSA-N D0F4FK DRUGSMIL CS(=O)(=O)O.C1=CC(=CC=C1CCSC(=N)N)OCC2=CC=C(C=C2)[N+](=O)[O-] D0F4FK HIGHSTAT Investigative D0F4HT DRUG__ID D0F4HT D0F4HT DRUGTYPE Small molecular drug D0F4HT DRUGINCH 1S/C24H23NO2S/c1-3-24(26-2,23-25-13-14-28-23)21-9-6-10-22(16-21)27-17-18-11-12-19-7-4-5-8-20(19)15-18/h4-16H,3,17H2,1-2H3 D0F4HT DRUGINKE XYRDHZXSQUWVCD-UHFFFAOYSA-N D0F4HT DRUGSMIL CCC(C1=CC(=CC=C1)OCC2=CC3=CC=CC=C3C=C2)(C4=NC=CS4)OC D0F4HT HIGHSTAT Investigative D0F4KL DRUG__ID D0F4KL D0F4KL DRUGTYPE Small molecular drug D0F4KL DRUGINCH 1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9) D0F4KL DRUGINKE RWQNBRDOKXIBIV-UHFFFAOYSA-N D0F4KL DRUGSMIL CC1=CNC(=O)NC1=O D0F4KL HIGHSTAT Investigative D0F4MF DRUG__ID D0F4MF D0F4MF DRUGTYPE Small molecular drug D0F4MF DRUGINCH 1S/C16H17NO2/c1-18-15-5-3-4-13(16(15)19-2)9-6-12-7-10-14(17)11-8-12/h3-11H,17H2,1-2H3/b9-6+ D0F4MF DRUGINKE WSPBGPLITZFWJL-RMKNXTFCSA-N D0F4MF DRUGSMIL COC1=CC=CC(=C1OC)C=CC2=CC=C(C=C2)N D0F4MF HIGHSTAT Investigative D0F4NA DRUG__ID D0F4NA D0F4NA DRUGTYPE Small molecular drug D0F4NA DRUGINCH 1S/C14H9F3INO/c15-14(16,17)10-3-1-9(2-4-10)13(20)19-12-7-5-11(18)6-8-12/h1-8H,(H,19,20) D0F4NA DRUGINKE VTVLWVLMDYRPGZ-UHFFFAOYSA-N D0F4NA DRUGSMIL C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)I)C(F)(F)F D0F4NA HIGHSTAT Investigative D0F4NK DRUG__ID D0F4NK D0F4NK DRUGTYPE Small molecular drug D0F4NK DRUGINCH 1S/C20H20O8P2/c21-20(29(22,23)24,30(25,26)27)14-28-19-11-5-10-18(13-19)17-9-4-8-16(12-17)15-6-2-1-3-7-15/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27) D0F4NK DRUGINKE NWIARQRYIRVYCM-UHFFFAOYSA-N D0F4NK DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)C3=CC(=CC=C3)OCC(O)(P(=O)(O)O)P(=O)(O)O D0F4NK HIGHSTAT Investigative D0F4QX DRUG__ID D0F4QX D0F4QX DRUGTYPE Small molecular drug D0F4QX DRUGINCH 1S/C8H5F3O2S/c9-8(10,11)7(13)4-5(12)6-2-1-3-14-6/h1-3H,4H2 D0F4QX DRUGINKE TXBBUSUXYMIVOS-UHFFFAOYSA-N D0F4QX DRUGSMIL C1=CSC(=C1)C(=O)CC(=O)C(F)(F)F D0F4QX HIGHSTAT Investigative D0F4UT DRUG__ID D0F4UT D0F4UT DRUGTYPE Small molecular drug D0F4UT DRUGINCH 1S/C16H16O3S/c17-16(18)12-20(19)11-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9H,10-12H2,(H,17,18) D0F4UT DRUGINKE JPUWBNMOSGBVRW-UHFFFAOYSA-N D0F4UT DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCS(=O)CC(=O)O D0F4UT HIGHSTAT Investigative D0F4WJ DRUG__ID D0F4WJ D0F4WJ DRUGTYPE Small molecular drug D0F4WJ DRUGINCH 1S/C22H33F3O2/c1-2-3-4-5-6-7-8-11-18-27-20-16-14-19(15-17-20)12-9-10-13-21(26)22(23,24)25/h14-17H,2-13,18H2,1H3 D0F4WJ DRUGINKE LRMSMLKRXXVPRC-UHFFFAOYSA-N D0F4WJ DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)CCCCC(=O)C(F)(F)F D0F4WJ HIGHSTAT Investigative D0F4WQ DRUG__ID D0F4WQ D0F4WQ DRUGTYPE Small molecular drug D0F4WQ DRUGINCH 1S/C16H13N3O2S/c20-19(21)14-7-6-13(11-18-9-8-17-12-18)16(10-14)22-15-4-2-1-3-5-15/h1-10,12H,11H2 D0F4WQ DRUGINKE FOCINXPGESCYHX-UHFFFAOYSA-N D0F4WQ DRUGSMIL C1=CC=C(C=C1)SC2=C(C=CC(=C2)[N+](=O)[O-])CN3C=CN=C3 D0F4WQ HIGHSTAT Investigative D0F4XB DRUG__ID D0F4XB D0F4XB DRUGTYPE Small molecular drug D0F4XB DRUGINCH 1S/C14H9N3O2/c15-8-10-9(12-3-1-5-18-12)7-11(17-14(10)16)13-4-2-6-19-13/h1-7H,(H2,16,17) D0F4XB DRUGINKE BDULELAUBSFJFH-UHFFFAOYSA-N D0F4XB DRUGSMIL C1=COC(=C1)C2=CC(=NC(=C2C#N)N)C3=CC=CO3 D0F4XB HIGHSTAT Investigative D0F4ZW DRUG__ID D0F4ZW D0F4ZW DRUGTYPE Small molecular drug D0F4ZW DRUGINCH 1S/C6HF13NO2S.Na/c7-1(8,3(11,12)5(15,16)17)2(9,10)4(13,14)6(18,19)23(20,21)22;/h(H-,20,21,22);/q-1;+1 D0F4ZW DRUGINKE WEVJDFCVPBPCIK-UHFFFAOYSA-N D0F4ZW DRUGSMIL C(C(C(C(F)(F)S(=O)(=O)[NH-])(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F.[Na+] D0F4ZW HIGHSTAT Investigative D0F5AC DRUG__ID D0F5AC D0F5AC DRUGTYPE Small molecular drug D0F5AC DRUGINCH 1S/C17H12N2O2/c20-16-13-5-1-2-7-15(13)21-17-12(4-3-6-14(16)17)10-19-9-8-18-11-19/h1-9,11H,10H2 D0F5AC DRUGINKE SWNOXHJBMDOXFE-UHFFFAOYSA-N D0F5AC DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC=CC(=C3O2)CN4C=CN=C4 D0F5AC HIGHSTAT Investigative D0F5AJ DRUG__ID D0F5AJ D0F5AJ DRUGTYPE Small molecular drug D0F5AJ DRUGINCH 1S/C10H13N5O3/c11-9-6-10(13-2-12-9)15(3-14-6)4-1-5(16)8(18)7(4)17/h2-5,7-8,16-18H,1H2,(H2,11,12,13)/t4-,5+,7+,8-/m1/s1 D0F5AJ DRUGINKE VFKHECGAEJNAMV-HETMPLHPSA-N D0F5AJ DRUGSMIL C1C(C(C(C1O)O)O)N2C=NC3=C(N=CN=C32)N D0F5AJ HIGHSTAT Investigative D0F5AQ DRUG__ID D0F5AQ D0F5AQ DRUGTYPE Small molecular drug D0F5AQ DRUGINCH 1S/C19H22N4/c1-2-4-15(5-3-1)6-7-18-14-20-10-11-23(18)17-8-9-19-16(12-17)13-21-22-19/h1-5,8-9,12-13,18,20H,6-7,10-11,14H2,(H,21,22) D0F5AQ DRUGINKE OOXRIQOVBUMMQG-UHFFFAOYSA-N D0F5AQ DRUGSMIL C1CN(C(CN1)CCC2=CC=CC=C2)C3=CC4=C(C=C3)NN=C4 D0F5AQ HIGHSTAT Investigative D0F5BD DRUG__ID D0F5BD D0F5BD DRUGTYPE Small molecular drug D0F5BD DRUGINCH 1S/C16H15N3O2/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2/p+1 D0F5BD DRUGINKE BVRDQVRQVGRNHG-UHFFFAOYSA-O D0F5BD DRUGSMIL C1COCCN1C2=CC(=O)N3C=CC4=CC=CC=C4C3=[NH+]2 D0F5BD HIGHSTAT Investigative D0F5BY DRUG__ID D0F5BY D0F5BY DRUGTYPE Small molecular drug D0F5BY DRUGINCH 1S/C12H16N4O2/c1-3-4-5-18-12-9(7-13)10(14)6-11(16-12)15-8(2)17/h6H,3-5H2,1-2H3,(H3,14,15,16,17) D0F5BY DRUGINKE BOEQDOKWKLSDFP-UHFFFAOYSA-N D0F5BY DRUGSMIL CCCCOC1=C(C(=CC(=N1)NC(=O)C)N)C#N D0F5BY HIGHSTAT Investigative D0F5EI DRUG__ID D0F5EI D0F5EI DRUGTYPE Small molecular drug D0F5EI DRUGINCH 1S/C12H9BrN4/c13-7-1-2-10-8(5-7)9(6-16-10)11-3-4-15-12(14)17-11/h1-6,16H,(H2,14,15,17) D0F5EI DRUGINKE PKQJCYXKRNGUKQ-UHFFFAOYSA-N D0F5EI DRUGSMIL C1=CC2=C(C=C1Br)C(=CN2)C3=NC(=NC=C3)N D0F5EI HIGHSTAT Investigative D0F5EJ DRUG__ID D0F5EJ D0F5EJ DRUGTYPE Small molecular drug D0F5EJ DRUGINCH 1S/C24H32ClN3OS2/c25-17-10-11-20-22(16-17)28-21-8-3-2-7-19(21)24(20)27-14-5-13-26-23(29)9-4-1-6-18-12-15-30-31-18/h10-11,16,18H,1-9,12-15H2,(H,26,29)(H,27,28) D0F5EJ DRUGINKE QVGXTQPZHCDXRZ-UHFFFAOYSA-N D0F5EJ DRUGSMIL C1CCC2=NC3=C(C=CC(=C3)Cl)C(=C2C1)NCCCNC(=O)CCCCC4CCSS4 D0F5EJ HIGHSTAT Investigative D0F5JY DRUG__ID D0F5JY D0F5JY DRUGTYPE Small molecular drug D0F5JY DRUGINCH 1S/C14H12ClN3O3/c1-7-9(3-2-8(6-16)11(7)15)18-13(20)12-10(19)4-5-17(12)14(18)21/h2-3,10,12,19H,4-5H2,1H3/t10-,12+/m1/s1 D0F5JY DRUGINKE KEJORAMIZFOODM-PWSUYJOCSA-N D0F5JY DRUGSMIL CC1=C(C=CC(=C1Cl)C#N)N2C(=O)C3C(CCN3C2=O)O D0F5JY HIGHSTAT Investigative D0F5KY DRUG__ID D0F5KY D0F5KY DRUGTYPE Small molecular drug D0F5KY DRUGINCH 1S/C22H21ClN2S/c1-16-9-8-14-19(23)21(16)25-22(26)24-20(18-12-6-3-7-13-18)15-17-10-4-2-5-11-17/h2-14,20H,15H2,1H3,(H2,24,25,26) D0F5KY DRUGINKE LHTLPGOZLLOCIS-UHFFFAOYSA-N D0F5KY DRUGSMIL CC1=C(C(=CC=C1)Cl)NC(=S)NC(CC2=CC=CC=C2)C3=CC=CC=C3 D0F5KY HIGHSTAT Investigative D0F5LH DRUG__ID D0F5LH D0F5LH DRUGTYPE Small molecular drug D0F5LH DRUGINCH 1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3 D0F5LH DRUGINKE XIQVNETUBQGFHX-UHFFFAOYSA-N D0F5LH DRUGSMIL CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O D0F5LH HIGHSTAT Investigative D0F5MA DRUG__ID D0F5MA D0F5MA DRUGTYPE Small molecular drug D0F5MA DRUGINCH 1S/C22H20Cl2N2O4/c23-9-1-3-19(27)25-13-5-7-15-17(11-13)22(30)18-12-14(6-8-16(18)21(15)29)26-20(28)4-2-10-24/h5-8,11-12H,1-4,9-10H2,(H,25,27)(H,26,28) D0F5MA DRUGINKE OWZXQHSZHVLBPE-UHFFFAOYSA-N D0F5MA DRUGSMIL C1=CC2=C(C=C1NC(=O)CCCCl)C(=O)C3=C(C2=O)C=CC(=C3)NC(=O)CCCCl D0F5MA HIGHSTAT Investigative D0F5MZ DRUG__ID D0F5MZ D0F5MZ DRUGTYPE Small molecular drug D0F5MZ DRUGINCH 1S/C16H10F3NO/c17-16(18,19)14-7-2-1-6-13(14)11-4-3-5-12(8-11)15-9-21-10-20-15/h1-10H D0F5MZ DRUGINKE SRZDIBWHWBVAAW-UHFFFAOYSA-N D0F5MZ DRUGSMIL C1=CC=C(C(=C1)C2=CC(=CC=C2)C3=COC=N3)C(F)(F)F D0F5MZ HIGHSTAT Investigative D0F5NJ DRUG__ID D0F5NJ D0F5NJ DRUGTYPE Small molecular drug D0F5NJ DRUGINCH 1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3 D0F5NJ DRUGINKE SHXWCVYOXRDMCX-UHFFFAOYSA-N D0F5NJ DRUGSMIL CC(CC1=CC2=C(C=C1)OCO2)NC D0F5NJ HIGHSTAT Investigative D0F5QL DRUG__ID D0F5QL D0F5QL DRUGTYPE Small molecular drug D0F5QL DRUGINCH 1S/C31H43N5O5/c1-31(2,3)22-17-21(12-13-26(22)37)19-25-29(40)34-16-14-27(38)33-15-8-7-11-24(30(41)36-25)35-28(39)23(32)18-20-9-5-4-6-10-20/h4-6,9-10,12-13,17,23-25,37H,7-8,11,14-16,18-19,32H2,1-3H3,(H,33,38)(H,34,40)(H,35,39)(H,36,41)/t23-,24-,25-/m0/s1 D0F5QL DRUGINKE RRXAKVUZGASTMY-SDHOMARFSA-N D0F5QL DRUGSMIL CC(C)(C)C1=C(C=CC(=C1)CC2C(=O)NCCC(=O)NCCCCC(C(=O)N2)NC(=O)C(CC3=CC=CC=C3)N)O D0F5QL HIGHSTAT Investigative D0F5SO DRUG__ID D0F5SO D0F5SO DRUGTYPE Small molecular drug D0F5SO DRUGINCH 1S/C17H16N2O3/c18-15(17(21)22)9-16(20)19-12-5-6-14-11(8-12)7-10-3-1-2-4-13(10)14/h1-6,8,15H,7,9,18H2,(H,19,20)(H,21,22)/t15-/m0/s1 D0F5SO DRUGINKE QDIIRLCSVINDSC-HNNXBMFYSA-N D0F5SO DRUGSMIL C1C2=CC=CC=C2C3=C1C=C(C=C3)NC(=O)CC(C(=O)O)N D0F5SO HIGHSTAT Investigative D0F5TA DRUG__ID D0F5TA D0F5TA DRUGTYPE Small molecular drug D0F5TA DRUGINCH 1S/C15H15N3/c1-2-17(14-7-10-16-11-8-14)18-12-9-13-5-3-4-6-15(13)18/h3-12H,2H2,1H3 D0F5TA DRUGINKE RBKZPZVPVZNIMS-UHFFFAOYSA-N D0F5TA DRUGSMIL CCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32 D0F5TA HIGHSTAT Investigative D0F5TV DRUG__ID D0F5TV D0F5TV DRUGTYPE Small molecular drug D0F5TV DRUGINCH 1S/C10H17N3O6S.Na/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16;/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19);/t5-,6-;/m0./s1 D0F5TV DRUGINKE KJQNSWHBRKOGHW-GEMLJDPKSA-N D0F5TV DRUGSMIL C(CC(=O)NC(CS)C(=O)NCC(=O)O)C(C(=O)O)N.[Na] D0F5TV HIGHSTAT Investigative D0F5TZ DRUG__ID D0F5TZ D0F5TZ DRUGTYPE Small molecular drug D0F5TZ DRUGINCH 1S/C20H23N5O/c1-12-7-14(10-22-9-12)17-11-23-19(24-15-3-5-21-6-4-15)18-16(17)8-13(2)20(26)25-18/h7-11,15,21H,3-6H2,1-2H3,(H,23,24)(H,25,26) D0F5TZ DRUGINKE PAGDGWOISBNVEC-UHFFFAOYSA-N D0F5TZ DRUGSMIL CC1=CC(=CN=C1)C2=CN=C(C3=C2C=C(C(=O)N3)C)NC4CCNCC4 D0F5TZ HIGHSTAT Investigative D0F5VY DRUG__ID D0F5VY D0F5VY DRUGTYPE Small molecular drug D0F5VY DRUGINCH 1S/C14H7NO4/c16-13-11-4-2-1-3-9(11)10-6-5-8(15(18)19)7-12(10)14(13)17/h1-7H D0F5VY DRUGINKE KNAXWOBOCVVMST-UHFFFAOYSA-N D0F5VY DRUGSMIL C1=CC=C2C(=C1)C3=C(C=C(C=C3)[N+](=O)[O-])C(=O)C2=O D0F5VY HIGHSTAT Investigative D0F5WP DRUG__ID D0F5WP D0F5WP DRUGTYPE Small molecular drug D0F5WP DRUGINCH 1S/C9H11N3O/c10-3-4-12-9-5-8(13)2-1-7(9)6-11-12/h1-2,5-6,13H,3-4,10H2 D0F5WP DRUGINKE RVQKKYXTHSVLLB-UHFFFAOYSA-N D0F5WP DRUGSMIL C1=CC2=C(C=C1O)N(N=C2)CCN D0F5WP HIGHSTAT Investigative D0F5WV DRUG__ID D0F5WV D0F5WV DRUGTYPE Small molecular drug D0F5WV DRUGINCH 1S/C38H38N4O7/c43-33(40-20-38-17-22-8-23(18-38)10-24(9-22)19-38)30-16-31-25(6-7-39-31)15-29(30)34(44)42-32(11-21-4-2-1-3-5-21)35(45)41-28-13-26(36(46)47)12-27(14-28)37(48)49/h1-7,12-16,22-24,32,39H,8-11,17-20H2,(H,40,43)(H,41,45)(H,42,44)(H,46,47)(H,48,49)/t22?,23?,24?,32-,38?/m0/s1 D0F5WV DRUGINKE DKYQJTXTKSMTHK-FGLZHOHTSA-N D0F5WV DRUGSMIL C1C2CC3CC1CC(C2)(C3)CNC(=O)C4=C(C=C5C=CNC5=C4)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7=CC(=CC(=C7)C(=O)O)C(=O)O D0F5WV HIGHSTAT Investigative D0F5XQ DRUG__ID D0F5XQ D0F5XQ DRUGTYPE Small molecular drug D0F5XQ DRUGINCH 1S/C15H26N2O2/c18-4-2-1-3-16-14(19)17-15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13,18H,1-10H2,(H2,16,17,19) D0F5XQ DRUGINKE GVVAZSZYNJNYGI-UHFFFAOYSA-N D0F5XQ DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCCCO D0F5XQ HIGHSTAT Investigative D0F5YU DRUG__ID D0F5YU D0F5YU DRUGTYPE Small molecular drug D0F5YU DRUGINCH 1S/C15H12ClN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9- D0F5YU DRUGINKE NFCDNDMUSHGWSU-XFXZXTDPSA-N D0F5YU DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)Cl D0F5YU HIGHSTAT Investigative D0F5ZW DRUG__ID D0F5ZW D0F5ZW DRUGTYPE Small molecular drug D0F5ZW DRUGINCH 1S/C18H15Cl2N5O3/c19-10-6-12(20)17-13(7-10)22-15(18(27)28)8-14(17)23-16(26)5-9-1-3-11(4-2-9)24-25-21/h1-4,6-7,14-15,22H,5,8H2,(H,23,26)(H,27,28) D0F5ZW DRUGINKE OVAIIHUWSLJJPO-UHFFFAOYSA-N D0F5ZW DRUGSMIL C1C(C2=C(C=C(C=C2Cl)Cl)NC1C(=O)O)NC(=O)CC3=CC=C(C=C3)N=[N+]=[N-] D0F5ZW HIGHSTAT Investigative D0F6AI DRUG__ID D0F6AI D0F6AI DRUGTYPE Small molecular drug D0F6AI DRUGINCH 1S/C28H36O3/c1-16-13-23-25(3,15-21(16)30)9-11-27(5)22-8-7-18-17(2)24(31)20(29)14-19(18)26(22,4)10-12-28(23,27)6/h7-8,14,16,23,31H,9-13,15H2,1-6H3/t16-,23-,25+,26+,27-,28+/m1/s1 D0F6AI DRUGINKE WSTYNZDAOAEEKG-GWJSGULQSA-N D0F6AI DRUGSMIL CC1CC2C(CCC3(C2(CCC4(C3=CC=C5C4=CC(=O)C(=C5C)O)C)C)C)(CC1=O)C D0F6AI HIGHSTAT Investigative D0F6CD DRUG__ID D0F6CD D0F6CD DRUGTYPE Small molecular drug D0F6CD DRUGINCH 1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2 D0F6CD DRUGINKE QZAYGJVTTNCVMB-UHFFFAOYSA-N D0F6CD DRUGSMIL C1=CC2=C(C=C1O)C(=CN2)CCN D0F6CD HIGHSTAT Investigative D0F6EJ DRUG__ID D0F6EJ D0F6EJ DRUGTYPE Small molecular drug D0F6EJ DRUGINCH 1S/C15H11FN2S/c1-9-18-14-7-11(2-3-15(14)19-9)12-4-10(8-17)5-13(16)6-12/h2-7,9,18H,1H3 D0F6EJ DRUGINKE DUFLWBPOXGXKEK-UHFFFAOYSA-N D0F6EJ DRUGSMIL CC1NC2=C(S1)C=CC(=C2)C3=CC(=CC(=C3)C#N)F D0F6EJ HIGHSTAT Investigative D0F6EZ DRUG__ID D0F6EZ D0F6EZ DRUGTYPE Small molecular drug D0F6EZ DRUGINCH 1S/C16H18N4O2/c17-15(18)20-14-8-6-12(7-9-14)10-19-16(21)22-11-13-4-2-1-3-5-13/h1-9H,10-11H2,(H,19,21)(H4,17,18,20) D0F6EZ DRUGINKE NXBMHZOVQPKBKA-UHFFFAOYSA-N D0F6EZ DRUGSMIL C1=CC=C(C=C1)COC(=O)NCC2=CC=C(C=C2)N=C(N)N D0F6EZ HIGHSTAT Investigative D0F6FZ DRUG__ID D0F6FZ D0F6FZ DRUGTYPE Small molecular drug D0F6FZ DRUGINCH 1S/C18H16N4O/c1-3-17(23)21-14-7-8-15-16(10-14)19-11-20-18(15)22-13-6-4-5-12(2)9-13/h3-11H,1H2,2H3,(H,21,23)(H,19,20,22) D0F6FZ DRUGINKE FAGJCAQBJKSOOS-UHFFFAOYSA-N D0F6FZ DRUGSMIL CC1=CC(=CC=C1)NC2=NC=NC3=C2C=CC(=C3)NC(=O)C=C D0F6FZ HIGHSTAT Investigative D0F6GB DRUG__ID D0F6GB D0F6GB DRUGTYPE Small molecular drug D0F6GB DRUGINCH 1S/C16H17ClN2O/c17-14-5-1-2-6-15(14)20-16-13(4-3-9-19-16)12-7-10-18-11-8-12/h1-6,9,12,18H,7-8,10-11H2 D0F6GB DRUGINKE OLCRHPXGKWMFIP-UHFFFAOYSA-N D0F6GB DRUGSMIL C1CNCCC1C2=C(N=CC=C2)OC3=CC=CC=C3Cl D0F6GB HIGHSTAT Investigative D0F6GP DRUG__ID D0F6GP D0F6GP DRUGTYPE Small molecular drug D0F6GP DRUGINCH 1S/C19H22N4O2S/c1-14-3-6-16(7-4-14)26(24,25)19-17-13-15(5-8-18(17)20-21-19)23-11-9-22(2)10-12-23/h3-8,13H,9-12H2,1-2H3,(H,20,21) D0F6GP DRUGINKE DAXBNFVWZYVXTC-UHFFFAOYSA-N D0F6GP DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C3C=C(C=CC3=NN2)N4CCN(CC4)C D0F6GP HIGHSTAT Investigative D0F6GX DRUG__ID D0F6GX D0F6GX DRUGTYPE Small molecular drug D0F6GX DRUGINCH 1S/C40H48N8O6/c1-25(49)45-34(23-27-15-18-31(50)19-16-27)38(53)48-35(22-26-9-4-3-5-10-26)39(54)46-32(13-8-20-44-40(41)42)37(52)47-33(36(51)43-2)24-28-14-17-29-11-6-7-12-30(29)21-28/h3-7,9-12,14-19,21,32-35,50H,8,13,20,22-24H2,1-2H3,(H,43,51)(H,45,49)(H,46,54)(H,47,52)(H,48,53)(H4,41,42,44)/t32-,33-,34-,35+/m0/s1 D0F6GX DRUGINKE QVTMGASDQFBYLJ-AYXCPNKJSA-N D0F6GX DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NC D0F6GX HIGHSTAT Investigative D0F6NZ DRUG__ID D0F6NZ D0F6NZ DRUGTYPE Small molecular drug D0F6NZ DRUGINCH 1S/C26H29N7O2S/c1-6-17(7-2)35-18-10-15(3)23(16(4)11-18)20-12-19(22-14-30-26(36-22)33-25(34)27-5)31-24(32-20)21-13-28-8-9-29-21/h8-14,17H,6-7H2,1-5H3,(H2,27,30,33,34) D0F6NZ DRUGINKE RYXLLTGGHCFCFK-UHFFFAOYSA-N D0F6NZ DRUGSMIL CCC(CC)OC1=CC(=C(C(=C1)C)C2=NC(=NC(=C2)C3=CN=C(S3)NC(=O)NC)C4=NC=CN=C4)C D0F6NZ HIGHSTAT Investigative D0F6OK DRUG__ID D0F6OK D0F6OK DRUGTYPE Small molecular drug D0F6OK DRUGINCH 1S/C7H15NO2/c1-5(2)4-6(8-3)7(9)10/h5-6,8H,4H2,1-3H3,(H,9,10)/t6-/m1/s1 D0F6OK DRUGINKE XJODGRWDFZVTKW-ZCFIWIBFSA-N D0F6OK DRUGSMIL CC(C)CC(C(=O)O)NC D0F6OK HIGHSTAT Investigative D0F6RH DRUG__ID D0F6RH D0F6RH DRUGTYPE Small molecular drug D0F6RH DRUGINCH 1S/C13H20O3S/c1-2-3-4-5-6-7-17-10-11-8-12(14)13(15)9-16-11/h8-9,15H,2-7,10H2,1H3 D0F6RH DRUGINKE ZRHZWPMLQKIVHQ-UHFFFAOYSA-N D0F6RH DRUGSMIL CCCCCCCSCC1=CC(=O)C(=CO1)O D0F6RH HIGHSTAT Investigative D0F6TM DRUG__ID D0F6TM D0F6TM DRUGTYPE Small molecular drug D0F6TM DRUGINCH 1S/C11H9NO4/c13-8-2-3-9-7(5-8)1-4-10(14)12(9)6-11(15)16/h1-5,13H,6H2,(H,15,16) D0F6TM DRUGINKE VDYFIKQEBBKQES-UHFFFAOYSA-N D0F6TM DRUGSMIL C1=CC2=C(C=CC(=O)N2CC(=O)O)C=C1O D0F6TM HIGHSTAT Investigative D0F6TS DRUG__ID D0F6TS D0F6TS DRUGTYPE Small molecular drug D0F6TS DRUGINCH 1S/C115H160N26O32S4/c1-11-59(9)93(113(170)132-82(115(172)173)41-64-46-120-71-27-19-17-25-68(64)71)141-114(171)94(60(10)12-2)140-105(162)81(44-91(150)151)130-99(156)75(37-57(5)6)125-103(160)79(42-65-47-118-55-121-65)128-109(166)86-52-175-174-51-69(117)95(152)133-83(48-142)108(165)138-87-53-176-177-54-88(111(168)139-92(58(7)8)112(169)131-77(39-62-29-31-66(145)32-30-62)100(157)126-76(101(158)137-86)38-61-22-14-13-15-23-61)136-97(154)73(33-34-89(146)147)123-96(153)72(28-20-21-35-116)122-104(161)80(43-90(148)149)129-98(155)74(36-56(3)4)124-102(159)78(40-63-45-119-70-26-18-16-24-67(63)70)127-106(163)84(49-143)134-107(164)85(50-144)135-110(87)167/h13-19,22-27,29-32,45-47,55-60,69,72-88,92-94,119-120,142-145H,11-12,20-21,28,33-44,48-54,116-117H2,1-10H3,(H,118,121)(H,122,161)(H,123,153)(H,124,159)(H,125,160)(H,126,157)(H,127,163)(H,128,166)(H,129,155)(H,130,156)(H,131,169)(H,132,170)(H,133,152)(H,134,164)(H,135,167)(H,136,154)(H,137,158)(H,138,165)(H,139,168)(H,140,162)(H,141,171)(H,146,147)(H,148,149)(H,150,151)(H,172,173)/t59-,60-,69-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,92-,93-,94-/m0/s1 D0F6TS DRUGINKE MLFJHYIHIKEBTQ-IYRKOGFYSA-N D0F6TS DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CO)CO)CC8=CNC9=CC=CC=C98)CC(C)C)CC(=O)O)CCCCN)CCC(=O)O)CO)N D0F6TS HIGHSTAT Investigative D0F6VI DRUG__ID D0F6VI D0F6VI DRUGTYPE Small molecular drug D0F6VI DRUGINCH 1S/C12H17NO3/c1-9(14)13-7-3-4-10-8-11(16-2)5-6-12(10)15/h5-6,8,15H,3-4,7H2,1-2H3,(H,13,14) D0F6VI DRUGINKE OMOWUWLCRNGXCM-UHFFFAOYSA-N D0F6VI DRUGSMIL CC(=O)NCCCC1=C(C=CC(=C1)OC)O D0F6VI HIGHSTAT Investigative D0F6VM DRUG__ID D0F6VM D0F6VM DRUGTYPE Small molecular drug D0F6VM DRUGINCH 1S/C25H25N5O2/c31-22(10-13-29-11-3-4-12-29)26-16-7-8-21-19(15-16)25(32)30-14-9-18-17-5-1-2-6-20(17)27-23(18)24(30)28-21/h1-2,5-8,15,27H,3-4,9-14H2,(H,26,31) D0F6VM DRUGINKE QEZVUWPDYKSHCV-UHFFFAOYSA-N D0F6VM DRUGSMIL C1CCN(C1)CCC(=O)NC2=CC3=C(C=C2)N=C4C5=C(CCN4C3=O)C6=CC=CC=C6N5 D0F6VM HIGHSTAT Investigative D0F6YB DRUG__ID D0F6YB D0F6YB DRUGTYPE Small molecular drug D0F6YB DRUGINCH 1S/C14H9FN2O/c15-12-7-10(9-16)6-11(8-12)14(18)17-13-4-2-1-3-5-13/h1-8H,(H,17,18) D0F6YB DRUGINKE MCCCAUONCIKYRV-UHFFFAOYSA-N D0F6YB DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC(=CC(=C2)C#N)F D0F6YB HIGHSTAT Investigative D0F6ZC DRUG__ID D0F6ZC D0F6ZC DRUGTYPE Small molecular drug D0F6ZC DRUGINCH 1S/C14H15NO3/c1-10-3-2-4-11-12(16)9-13(18-14(10)11)15-5-7-17-8-6-15/h2-4,9H,5-8H2,1H3 D0F6ZC DRUGINKE OHUSJSSDFKPFTJ-UHFFFAOYSA-N D0F6ZC DRUGSMIL CC1=C2C(=CC=C1)C(=O)C=C(O2)N3CCOCC3 D0F6ZC HIGHSTAT Investigative D0F6ZH DRUG__ID D0F6ZH D0F6ZH DRUGTYPE Small molecular drug D0F6ZH DRUGINCH 1S/C16H12O/c17-16-7-3-6-14(11-16)15-9-8-12-4-1-2-5-13(12)10-15/h1-11,17H D0F6ZH DRUGINKE FQDQJXSIUCYJDC-UHFFFAOYSA-N D0F6ZH DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC(=CC=C3)O D0F6ZH HIGHSTAT Investigative D0F7BE DRUG__ID D0F7BE D0F7BE DRUGTYPE Small molecular drug D0F7BE DRUGINCH 1S/C13H15N5O2S2/c1-14-10(19)9(7-8-5-3-2-4-6-8)15-11(20)16-12-17-18-13(21)22-12/h2-6,9H,7H2,1H3,(H,14,19)(H,18,21)(H2,15,16,17,20)/t9-/m0/s1 D0F7BE DRUGINKE RKWXKADYTDWZIJ-VIFPVBQESA-N D0F7BE DRUGSMIL CNC(=O)C(CC1=CC=CC=C1)NC(=O)NC2=NNC(=S)S2 D0F7BE HIGHSTAT Investigative D0F7BO DRUG__ID D0F7BO D0F7BO DRUGCOMP MondoBIOTECH Holding AG D0F7BO DRUGINCH 1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83) D0F7BO DRUGINKE WHNFPRLDDSXQCL-UHFFFAOYSA-N D0F7BO DRUGSMIL CC(C)C(C(=O)N)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C D0F7BO HIGHSTAT Investigative D0F7BV DRUG__ID D0F7BV D0F7BV DRUGTYPE Small molecular drug D0F7BV DRUGINCH 1S/C19H22N2O2/c22-16(13-20-11-9-15-5-2-1-3-6-15)14-23-19-8-4-7-18-17(19)10-12-21-18/h1-8,10,12,16,20-22H,9,11,13-14H2 D0F7BV DRUGINKE MDPRLCKPDFRPJV-UHFFFAOYSA-N D0F7BV DRUGSMIL C1=CC=C(C=C1)CCNCC(COC2=CC=CC3=C2C=CN3)O D0F7BV HIGHSTAT Investigative D0F7DM DRUG__ID D0F7DM D0F7DM DRUGTYPE Small molecular drug D0F7DM DRUGINCH 1S/C13H16N3O8P/c17-2-6-11-12(24-7(23-11)3-25(19,20)21)10(22-6)5-1-14-9-8(5)15-4-16-13(9)18/h1,4,6-7,10-12,14,17H,2-3H2,(H,15,16,18)(H2,19,20,21)/t6-,7-,10+,11-,12+/m1/s1 D0F7DM DRUGINKE ZOEDLCUBOBTIHG-USQSKNHBSA-N D0F7DM DRUGSMIL C1=C(C2=C(N1)C(=O)NC=N2)C3C4C(C(O3)CO)OC(O4)CP(=O)(O)O D0F7DM HIGHSTAT Investigative D0F7DQ DRUG__ID D0F7DQ D0F7DQ DRUGTYPE Small molecular drug D0F7DQ DRUGINCH 1S/C21H18O2/c1-23-20(22)21(17-11-5-2-6-12-17,18-13-7-3-8-14-18)19-15-9-4-10-16-19/h2-16H,1H3 D0F7DQ DRUGINKE ZPGOQUZHRVSLML-UHFFFAOYSA-N D0F7DQ DRUGSMIL COC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3 D0F7DQ HIGHSTAT Investigative D0F7IW DRUG__ID D0F7IW D0F7IW DRUGTYPE Small molecular drug D0F7IW DRUGINCH 1S/C19H27F3O2/c1-2-3-4-5-6-7-9-16-11-13-17(14-12-16)24-15-8-10-18(23)19(20,21)22/h11-14H,2-10,15H2,1H3 D0F7IW DRUGINKE UMRJNULJIAZHAL-UHFFFAOYSA-N D0F7IW DRUGSMIL CCCCCCCCC1=CC=C(C=C1)OCCCC(=O)C(F)(F)F D0F7IW HIGHSTAT Investigative D0F7JK DRUG__ID D0F7JK D0F7JK DRUGTYPE Small molecular drug D0F7JK DRUGINCH 1S/C16H14N2O/c1-18(13-8-3-2-4-9-13)16(19)15-11-12-7-5-6-10-14(12)17-15/h2-11,17H,1H3 D0F7JK DRUGINKE MIHVSSWKZWMTEP-UHFFFAOYSA-N D0F7JK DRUGSMIL CN(C1=CC=CC=C1)C(=O)C2=CC3=CC=CC=C3N2 D0F7JK HIGHSTAT Investigative D0F7KC DRUG__ID D0F7KC D0F7KC DRUGTYPE Small molecular drug D0F7KC DRUGINCH 1S/C12H10O4/c1-7(13)11-9(15-2)5-3-8-4-6-10(14)16-12(8)11/h3-6H,1-2H3 D0F7KC DRUGINKE OTYBDEHZHXKGBO-UHFFFAOYSA-N D0F7KC DRUGSMIL CC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OC D0F7KC HIGHSTAT Investigative D0F7KG DRUG__ID D0F7KG D0F7KG DRUGTYPE Small molecular drug D0F7KG DRUGINCH 1S/C14H17N3O2S/c1-16(2)11-5-3-10(4-6-11)9-12-13(18)17(8-7-15)14(19)20-12/h3-6,9H,7-8,15H2,1-2H3/b12-9- D0F7KG DRUGINKE BOQIVKJIDMTNLR-XFXZXTDPSA-N D0F7KG DRUGSMIL CN(C)C1=CC=C(C=C1)C=C2C(=O)N(C(=O)S2)CCN D0F7KG HIGHSTAT Investigative D0F7NU DRUG__ID D0F7NU D0F7NU DRUGTYPE Small molecular drug D0F7NU DRUGINCH 1S/C9H15F3O2S/c1-2-3-4-5-6-15(14)7-8(13)9(10,11)12/h2-7H2,1H3 D0F7NU DRUGINKE LSJUTEXGKKBNFU-UHFFFAOYSA-N D0F7NU DRUGSMIL CCCCCCS(=O)CC(=O)C(F)(F)F D0F7NU HIGHSTAT Investigative D0F7OX DRUG__ID D0F7OX D0F7OX DRUGTYPE Small molecular drug D0F7OX DRUGINCH 1S/C15H14N2O3/c1-19-14-9-7-13(8-10-14)17-15(18)20-16-11-12-5-3-2-4-6-12/h2-11H,1H3,(H,17,18)/b16-11+ D0F7OX DRUGINKE TZKNCCSAQUKSHR-LFIBNONCSA-N D0F7OX DRUGSMIL COC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D0F7OX HIGHSTAT Investigative D0F7QZ DRUG__ID D0F7QZ D0F7QZ DRUGTYPE Small molecular drug D0F7QZ DRUGINCH 1S/C8H9BO2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7,10-11H/b7-6+ D0F7QZ DRUGINKE VKIJXFIYBAYHOE-VOTSOKGWSA-N D0F7QZ DRUGSMIL B(C=CC1=CC=CC=C1)(O)O D0F7QZ HIGHSTAT Investigative D0F7SE DRUG__ID D0F7SE D0F7SE DRUGTYPE Small molecular drug D0F7SE DRUGINCH 1S/C26H36N8O8/c27-26(28)29-8-4-7-16-22(38)30-13-20(35)31-17(12-21(36)37)23(39)33-18(11-15-5-2-1-3-6-15)25(41)34-9-10-42-14-19(34)24(40)32-16/h1-3,5-6,16-19H,4,7-14H2,(H,30,38)(H,31,35)(H,32,40)(H,33,39)(H,36,37)(H4,27,28,29)/t16-,17-,18+,19+/m0/s1 D0F7SE DRUGINKE HKLGBIAIHDSNGD-INDMIFKZSA-N D0F7SE DRUGSMIL C1COCC2N1C(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)CC3=CC=CC=C3 D0F7SE HIGHSTAT Investigative D0F7SO DRUG__ID D0F7SO D0F7SO DRUGTYPE Small molecular drug D0F7SO DRUGINCH 1S/C9H8N2O2S/c10-14(12,13)8-5-1-3-7-4-2-6-11-9(7)8/h1-6H,(H2,10,12,13) D0F7SO DRUGINKE ZTYZEUXZHGOXRT-UHFFFAOYSA-N D0F7SO DRUGSMIL C1=CC2=C(C(=C1)S(=O)(=O)N)N=CC=C2 D0F7SO HIGHSTAT Investigative D0F7UW DRUG__ID D0F7UW D0F7UW DRUGTYPE Small molecular drug D0F7UW DRUGINCH 1S/C19H22O7/c1-10(2)17(22)25-13-7-12(8-20)5-4-6-19(9-24-19)16(21)15-14(13)11(3)18(23)26-15/h7-8,13-16,21H,1,3-6,9H2,2H3/b12-7-/t13-,14-,15+,16-,19-/m1/s1 D0F7UW DRUGINKE OGCMEEKAZKEDQP-UPZPYLOFSA-N D0F7UW DRUGSMIL CC(=C)C(=O)OC1C=C(CCCC2(CO2)C(C3C1C(=C)C(=O)O3)O)C=O D0F7UW HIGHSTAT Investigative D0F7XJ DRUG__ID D0F7XJ D0F7XJ DRUGTYPE Small molecular drug D0F7XJ DRUGINCH 1S/C24H32N2O4/c1-28-10-8-17-13-16-14-24(23(27)30-12-11-29-2)21-19(7-9-26(15-16)22(17)24)18-5-3-4-6-20(18)25-21/h3-6,16-17,22,25H,7-15H2,1-2H3/t16?,17-,22-,24+/m0/s1 D0F7XJ DRUGINKE OLFXZBDPKBSIPG-SAJNPJMVSA-N D0F7XJ DRUGSMIL COCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OCCOC D0F7XJ HIGHSTAT Investigative D0F7XM DRUG__ID D0F7XM D0F7XM DRUGTYPE Small molecular drug D0F7XM DRUGINCH 1S/C20H32O4/c1-2-3-4-5-6-9-13-18(21)14-10-7-8-11-15-19(22)16-12-17-20(23)24/h6-11,14-15,18-19,21-22H,2-5,12-13,16-17H2,1H3,(H,23,24)/b8-7+,9-6-,14-10+,15-11-/t18-,19+/m0/s1 D0F7XM DRUGINKE VNYSSYRCGWBHLG-CBBLYLIKSA-N D0F7XM DRUGSMIL CCCCCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O D0F7XM HIGHSTAT Investigative D0F7ZK DRUG__ID D0F7ZK D0F7ZK DRUGTYPE Small molecular drug D0F7ZK DRUGINCH 1S/C17H17NO3/c19-15-12-16(7-6-14-4-2-1-3-5-14)21-17(13-15)18-8-10-20-11-9-18/h1-7,12-13H,8-11H2/b7-6+ D0F7ZK DRUGINKE ZJOMZZQTJIYOSC-VOTSOKGWSA-N D0F7ZK DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C=CC3=CC=CC=C3 D0F7ZK HIGHSTAT Investigative D0F8AP DRUG__ID D0F8AP D0F8AP DRUGTYPE Small molecular drug D0F8AP DRUGINCH 1S/C11H8N2O/c14-11-5-8-7-3-1-2-4-9(7)13-10(8)6-12-11/h1-6,13H,(H,12,14) D0F8AP DRUGINKE UDTDJSXOXQLKGM-UHFFFAOYSA-N D0F8AP DRUGSMIL C1=CC=C2C(=C1)C3=CC(=O)NC=C3N2 D0F8AP HIGHSTAT Investigative D0F8AR DRUG__ID D0F8AR D0F8AR DRUGTYPE Small molecular drug D0F8AR DRUGINCH 1S/C37H38N3O7P/c41-35(39-33(36(42)43)22-29-23-38-32-19-11-10-18-31(29)32)30(20-26-12-4-1-5-13-26)25-48(45,46)34(21-27-14-6-2-7-15-27)40-37(44)47-24-28-16-8-3-9-17-28/h1-19,23,30,33-34,38H,20-22,24-25H2,(H,39,41)(H,40,44)(H,42,43)(H,45,46)/t30?,33-,34+/m0/s1 D0F8AR DRUGINKE WWTBZEKOSBFBEM-SPWPXUSOSA-N D0F8AR DRUGSMIL C1=CC=C(C=C1)CC(CP(=O)(C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)O)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)O D0F8AR HIGHSTAT Investigative D0F8AX DRUG__ID D0F8AX D0F8AX DRUGTYPE Small molecular drug D0F8AX DRUGINCH 1S/C21H25NO/c23-21(19-11-12-19)13-15-22(16-14-21)20(17-7-3-1-4-8-17)18-9-5-2-6-10-18/h1-10,19-20,23H,11-16H2 D0F8AX DRUGINKE DWUKNKDABPWVAE-UHFFFAOYSA-N D0F8AX DRUGSMIL C1CC1C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D0F8AX HIGHSTAT Investigative D0F8CC DRUG__ID D0F8CC D0F8CC DRUGTYPE Small molecular drug D0F8CC DRUGINCH 1S/C24H28O3/c1-23(2)13-14-24(3,4)20-15-18(10-11-19(20)23)21(25)12-7-16-5-8-17(9-6-16)22(26)27/h5-12,15,21,25H,13-14H2,1-4H3,(H,26,27)/b12-7+ D0F8CC DRUGINKE QCSYBKHFYYISTQ-KPKJPENVSA-N D0F8CC DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(C=CC3=CC=C(C=C3)C(=O)O)O)(C)C)C D0F8CC HIGHSTAT Investigative D0F8CD DRUG__ID D0F8CD D0F8CD DRUGTYPE Small molecular drug D0F8CD DRUGINCH 1S/C33H39N5O5/c1-22(30(40)35-21-25-11-6-3-7-12-25)36-31(41)28(20-23-9-4-2-5-10-23)37-32(42)29-13-8-18-38(29)33(43)27(34)19-24-14-16-26(39)17-15-24/h2-7,9-12,14-17,22,27-29,39H,8,13,18-21,34H2,1H3,(H,35,40)(H,36,41)(H,37,42)/t22-,27+,28+,29+/m1/s1 D0F8CD DRUGINKE FFJZWXQQTXSXFM-GDNYIZLESA-N D0F8CD DRUGSMIL CC(C(=O)NCC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0F8CD HIGHSTAT Investigative D0F8CH DRUG__ID D0F8CH D0F8CH DRUGTYPE Small molecular drug D0F8CH DRUGINCH 1S/C9H10N2O3/c1-5(12)11-8-3-2-6(9(13)14)4-7(8)10/h2-4H,10H2,1H3,(H,11,12)(H,13,14) D0F8CH DRUGINKE MJMLUICFHWSBQZ-UHFFFAOYSA-N D0F8CH DRUGSMIL CC(=O)NC1=C(C=C(C=C1)C(=O)O)N D0F8CH HIGHSTAT Investigative D0F8CV DRUG__ID D0F8CV D0F8CV DRUGTYPE Small molecular drug D0F8CV DRUGINCH 1S/C26H35N5O6/c1-17(30-25(36)21(27)14-19-8-10-20(33)11-9-19)24(35)29-16-23(34)31(2)22(26(37)28-12-13-32)15-18-6-4-3-5-7-18/h3-11,17,21-22,32-33H,12-16,27H2,1-2H3,(H,28,37)(H,29,35)(H,30,36)/t17-,21+,22+/m1/s1 D0F8CV DRUGINKE HPZJMUBDEAMBFI-WTNAPCKOSA-N D0F8CV DRUGSMIL CC(C(=O)NCC(=O)N(C)C(CC1=CC=CC=C1)C(=O)NCCO)NC(=O)C(CC2=CC=C(C=C2)O)N D0F8CV HIGHSTAT Investigative D0F8IB DRUG__ID D0F8IB D0F8IB DRUGTYPE Small molecular drug D0F8IB DRUGINCH 1S/C30H30O11/c1-12-7-19-24(17(33)11-30(4,41-19)28-15(31)9-21(35)39-28)26(37)22(12)14-5-6-18-23(25(14)36)16(32)10-29(3,40-18)27-13(2)8-20(34)38-27/h5-7,13,15,27-28,31,36-37H,8-11H2,1-4H3/t13-,15+,27+,28+,29+,30-/m0/s1 D0F8IB DRUGINKE YSURVZRGQKOUAG-QXBVHLSASA-N D0F8IB DRUGSMIL CC1CC(=O)OC1C2(CC(=O)C3=C(O2)C=CC(=C3O)C4=C(C5=C(C=C4C)OC(CC5=O)(C)C6C(CC(=O)O6)O)O)C D0F8IB HIGHSTAT Investigative D0F8JO DRUG__ID D0F8JO D0F8JO DRUGTYPE Small molecular drug D0F8JO DRUGINCH 1S/C23H30N2O2/c1-17(7-6-8-18(2)15-22(26)27)9-10-20-19(3)21(11-12-23(20,4)5)25-14-13-24-16-25/h6-10,13-16,21H,11-12H2,1-5H3,(H,26,27)/b8-6+,10-9+,17-7+,18-15+ D0F8JO DRUGINKE MRFBVQCSZMKBFY-UBFIAYEVSA-N D0F8JO DRUGSMIL CC1=C(C(CCC1N2C=CN=C2)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C D0F8JO HIGHSTAT Investigative D0F8LS DRUG__ID D0F8LS D0F8LS DRUGTYPE Small molecular drug D0F8LS DRUGINCH 1S/C18H17FN2O/c19-16-7-3-6-15-17(12-8-10-14(22)11-9-12)20-21(18(15)16)13-4-1-2-5-13/h3,6-11,13,22H,1-2,4-5H2 D0F8LS DRUGINKE IYPUUNMLLKLEOH-UHFFFAOYSA-N D0F8LS DRUGSMIL C1CCC(C1)N2C3=C(C=CC=C3F)C(=N2)C4=CC=C(C=C4)O D0F8LS HIGHSTAT Investigative D0F8OH DRUG__ID D0F8OH D0F8OH DRUGTYPE Small molecular drug D0F8OH DRUGINCH 1S/C35H41N3O8S/c1-35(2)32(33(42)37-29-23-14-9-8-13-22(23)18-25(29)39)38(20-47-35)34(43)30(41)24(17-21-11-6-5-7-12-21)36-28(40)19-46-31-26(44-3)15-10-16-27(31)45-4/h5-16,24-25,29-30,32,39,41H,17-20H2,1-4H3,(H,36,40)(H,37,42)/t24-,25+,29-,30-,32+/m0/s1 D0F8OH DRUGINKE UXPUZKDVSUQPJT-GBHWDNFXSA-N D0F8OH DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=C(C=CC=C3OC)OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0F8OH HIGHSTAT Investigative D0F8QJ DRUG__ID D0F8QJ D0F8QJ DRUGTYPE Small molecular drug D0F8QJ DRUGINCH 1S/C16H10O7/c1-21-6-2-10(19)14-12(3-6)23-16(20)13-7-4-8(17)9(18)5-11(7)22-15(13)14/h2-5,17-19H,1H3 D0F8QJ DRUGINKE XQDCKJKKMFWXGB-UHFFFAOYSA-N D0F8QJ DRUGSMIL COC1=CC(=C2C(=C1)OC(=O)C3=C2OC4=CC(=C(C=C43)O)O)O D0F8QJ HIGHSTAT Investigative D0F8SA DRUG__ID D0F8SA D0F8SA DRUGTYPE Small molecular drug D0F8SA DRUGINCH 1S/C22H29NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,20-22,24H,8,13-17H2,1H3/t20-,21+,22-/m0/s1 D0F8SA DRUGINKE MUSFCRGEWKAWEE-BDTNDASRSA-N D0F8SA DRUGSMIL CN1C(CCCC1CC(C2=CC=CC=C2)O)CCC3=CC=CC=C3 D0F8SA HIGHSTAT Investigative D0F8TG DRUG__ID D0F8TG D0F8TG DRUGTYPE Small molecular drug D0F8TG DRUGINCH 1S/C19H20FN3/c1-22-8-10-23(11-9-22)19-17-5-3-2-4-14(17)12-15-6-7-16(20)13-18(15)21-19/h2-7,13H,8-12H2,1H3 D0F8TG DRUGINKE OBWGMKKHCLHVIE-UHFFFAOYSA-N D0F8TG DRUGSMIL CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F D0F8TG HIGHSTAT Investigative D0F8TZ DRUG__ID D0F8TZ D0F8TZ DRUGTYPE Small molecular drug D0F8TZ DRUGINCH 1S/C13H16O4S/c14-12(15)10-4-1-3-9(7-10)8-11(13(16)17)5-2-6-18/h1,3-4,7,11,18H,2,5-6,8H2,(H,14,15)(H,16,17) D0F8TZ DRUGINKE JKPYNGWTXQIZFC-UHFFFAOYSA-N D0F8TZ DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CCCS)C(=O)O D0F8TZ HIGHSTAT Investigative D0F8VS DRUG__ID D0F8VS D0F8VS DRUGTYPE Small molecular drug D0F8VS DRUGINCH 1S/C7H16N4O2/c8-5(6(12)13)3-1-2-4-11-7(9)10/h5H,1-4,8H2,(H,12,13)(H4,9,10,11)/t5-/m0/s1 D0F8VS DRUGINKE QUOGESRFPZDMMT-YFKPBYRVSA-N D0F8VS DRUGSMIL C(CCN=C(N)N)CC(C(=O)O)N D0F8VS HIGHSTAT Investigative D0F8YO DRUG__ID D0F8YO D0F8YO DRUGTYPE Small molecular drug D0F8YO DRUGINCH 1S/C12H16O3/c1-3-11(13)10-6-4-5-9(7-10)8(2)12(14)15/h4-8,11,13H,3H2,1-2H3,(H,14,15) D0F8YO DRUGINKE HTWFANVWNDWYRH-UHFFFAOYSA-N D0F8YO DRUGSMIL CCC(C1=CC=CC(=C1)C(C)C(=O)O)O D0F8YO HIGHSTAT Investigative D0F8ZI DRUG__ID D0F8ZI D0F8ZI DRUGTYPE Small molecular drug D0F8ZI DRUGINCH 1S/C18H18N2O2/c21-18-16-4-2-1-3-14(16)15-6-5-13(11-17(15)19-18)12-20-7-9-22-10-8-20/h1-6,11H,7-10,12H2,(H,19,21) D0F8ZI DRUGINKE YRZWAGRTCFCAAG-UHFFFAOYSA-N D0F8ZI DRUGSMIL C1COCCN1CC2=CC3=C(C=C2)C4=CC=CC=C4C(=O)N3 D0F8ZI HIGHSTAT Investigative D0F9AM DRUG__ID D0F9AM D0F9AM DRUGTYPE Small molecular drug D0F9AM DRUGINCH 1S/C18H21N3O5/c1-2-19(12-11-15-3-5-16(6-4-15)20(22)23)13-14-26-18-9-7-17(8-10-18)21(24)25/h3-10H,2,11-14H2,1H3 D0F9AM DRUGINKE DNTKZECWRGSWKD-UHFFFAOYSA-N D0F9AM DRUGSMIL CCN(CCC1=CC=C(C=C1)[N+](=O)[O-])CCOC2=CC=C(C=C2)[N+](=O)[O-] D0F9AM HIGHSTAT Investigative D0F9DD DRUG__ID D0F9DD D0F9DD DRUGTYPE Small molecular drug D0F9DD DRUGINCH 1S/C26H26FN7O4S/c1-39(36,37)12-11-38-22-14-30-26(32-25(22)31-20-9-10-29-13-18(20)24(28)35)23-17-6-4-8-21(17)34(33-23)15-16-5-2-3-7-19(16)27/h2-3,5,7,9-10,13-14H,4,6,8,11-12,15H2,1H3,(H2,28,35)(H,29,30,31,32) D0F9DD DRUGINKE FFVPQWXBEUUBMF-UHFFFAOYSA-N D0F9DD DRUGSMIL CS(=O)(=O)CCOC1=CN=C(N=C1NC2=C(C=NC=C2)C(=O)N)C3=NN(C4=C3CCC4)CC5=CC=CC=C5F D0F9DD HIGHSTAT Investigative D0F9FG DRUG__ID D0F9FG D0F9FG DRUGTYPE Small molecular drug D0F9FG DRUGINCH 1S/C27H38O3/c1-18(2)8-6-13-26(4)14-7-15-27(5)22(19(3)9-12-24(26)27)17-21-16-20(25(29)30)10-11-23(21)28/h8-11,16,22,24,28H,6-7,12-15,17H2,1-5H3,(H,29,30)/t22-,24+,26+,27-/m1/s1 D0F9FG DRUGINKE IIMZFSAVKIVVHG-PPKJMBTNSA-N D0F9FG DRUGSMIL CC1=CCC2C(CCCC2(C1CC3=C(C=CC(=C3)C(=O)O)O)C)(C)CCC=C(C)C D0F9FG HIGHSTAT Investigative D0F9JF DRUG__ID D0F9JF D0F9JF DRUGTYPE Small molecular drug D0F9JF DRUGINCH 1S/C25H22N4O3/c30-22-14-13-19(26-29(22)20-11-5-4-10-18(20)16-23(31)32)24-21-12-6-7-15-28(21)27-25(24)17-8-2-1-3-9-17/h1-3,6-9,12-15H,4-5,10-11,16H2,(H,31,32) D0F9JF DRUGINKE AHLONZJYCGNSFG-UHFFFAOYSA-N D0F9JF DRUGSMIL C1CCC(=C(C1)CC(=O)O)N2C(=O)C=CC(=N2)C3=C4C=CC=CN4N=C3C5=CC=CC=C5 D0F9JF HIGHSTAT Investigative D0F9KV DRUG__ID D0F9KV D0F9KV DRUGTYPE Small molecular drug D0F9KV DRUGINCH 1S/C41H28O26/c42-13-1-8(2-14(43)24(13)48)36(57)67-41-35-34(65-39(60)11-5-17(46)27(51)31(55)22(11)23-12(40(61)66-35)6-18(47)28(52)32(23)56)33-19(63-41)7-62-37(58)9-3-15(44)25(49)29(53)20(9)21-10(38(59)64-33)4-16(45)26(50)30(21)54/h1-6,19,33-35,41-56H,7H2/t19-,33-,34+,35-,41+/m1/s1 D0F9KV DRUGINKE SWRFKGRMQVLMKA-JIZJWZDPSA-N D0F9KV DRUGSMIL C1C2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O3)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O D0F9KV HIGHSTAT Investigative D0F9KX DRUG__ID D0F9KX D0F9KX DRUGTYPE Small molecular drug D0F9KX DRUGINCH 1S/C14H15N3S/c18-14(17-13-8-4-5-10-15-13)16-11-9-12-6-2-1-3-7-12/h1-8,10H,9,11H2,(H2,15,16,17,18) D0F9KX DRUGINKE GVKFCKWGWXJWMN-UHFFFAOYSA-N D0F9KX DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=CC=CC=N2 D0F9KX HIGHSTAT Investigative D0F9LO DRUG__ID D0F9LO D0F9LO DRUGTYPE Small molecular drug D0F9LO DRUGINCH 1S/C16H18ClNO2/c17-15-12-20-16(18-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D0F9LO DRUGINKE HEJGWGQTJYVGGY-UHFFFAOYSA-N D0F9LO DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)Cl D0F9LO HIGHSTAT Investigative D0F9LX DRUG__ID D0F9LX D0F9LX DRUGTYPE Small molecular drug D0F9LX DRUGINCH 1S/C20H30O3/c1-2-19(21)17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20(22)23/h4-7,10-13,15,17,19,21H,2-3,8-9,14,16,18H2,1H3,(H,22,23)/b6-4-,7-5-,12-10-,13-11-,17-15+/t19-/m1/s1 D0F9LX DRUGINKE LRWYBGFSVUBWMO-UAAZXLHOSA-N D0F9LX DRUGSMIL CCC(C=CC=CCC=CCC=CCC=CCCCC(=O)O)O D0F9LX HIGHSTAT Investigative D0F9MQ DRUG__ID D0F9MQ D0F9MQ DRUGTYPE Small molecular drug D0F9MQ DRUGINCH 1S/C13H20N2O5S/c1-3-4-5-6-9-20-13-10-11(15(16)17)7-8-12(13)14-21(2,18)19/h7-8,10,14H,3-6,9H2,1-2H3 D0F9MQ DRUGINKE ZYLWBHCVEZSQJB-UHFFFAOYSA-N D0F9MQ DRUGSMIL CCCCCCOC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C D0F9MQ HIGHSTAT Investigative D0F9NL DRUG__ID D0F9NL D0F9NL DRUGTYPE Small molecular drug D0F9NL DRUGINCH 1S/C20H32O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19,23H,2-6,12,15-16,18H2,1H3,(H,21,22)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1 D0F9NL DRUGINKE ZIOZYRSDNLNNNJ-LQWMCKPYSA-N D0F9NL DRUGSMIL CCCCCC=CCC(C=CC=CCC=CCCCC(=O)O)OO D0F9NL HIGHSTAT Investigative D0F9OP DRUG__ID D0F9OP D0F9OP DRUGTYPE Small molecular drug D0F9OP DRUGINCH 1S/C15H16Br2N4O4/c1-24-12-9(16)4-15(13(22)11(12)17)5-10(21-25-15)14(23)19-3-2-8-6-18-7-20-8/h4,6-7,13,22H,2-3,5H2,1H3,(H,18,20)(H,19,23) D0F9OP DRUGINKE MDUQIEXQKMPARD-UHFFFAOYSA-N D0F9OP DRUGSMIL COC1=C(C(C2(CC(=NO2)C(=O)NCCC3=CN=CN3)C=C1Br)O)Br D0F9OP HIGHSTAT Investigative D0F9PM DRUG__ID D0F9PM D0F9PM DRUGTYPE Small molecular drug D0F9PM DRUGINCH 1S/C42H41ClN2O4S/c1-29-11-9-12-30(2)38(29)28-50(48,49)44-26-25-40-36(18-10-13-31-19-21-34(22-20-31)42(46)47)37-27-35(43)23-24-39(37)45(40)41(32-14-5-3-6-15-32)33-16-7-4-8-17-33/h3-9,11-12,14-17,19-24,27,41,44H,10,13,18,25-26,28H2,1-2H3,(H,46,47) D0F9PM DRUGINKE YOFBEFNLUYVWRR-UHFFFAOYSA-N D0F9PM DRUGSMIL CC1=C(C(=CC=C1)C)CS(=O)(=O)NCCC2=C(C3=C(N2C(C4=CC=CC=C4)C5=CC=CC=C5)C=CC(=C3)Cl)CCCC6=CC=C(C=C6)C(=O)O D0F9PM HIGHSTAT Investigative D0F9QT DRUG__ID D0F9QT D0F9QT DRUGTYPE Small molecular drug D0F9QT DRUGINCH 1S/C18H25N5O/c19-18-21-16-12(17(22-18)23-9-7-20-8-10-23)5-6-14-15(16)11-3-1-2-4-13(11)24-14/h11,13,20H,1-10H2,(H2,19,21,22)/t11-,13+/m0/s1 D0F9QT DRUGINKE DJKJVWJQAVGLHJ-WCQYABFASA-N D0F9QT DRUGSMIL C1CCC2C(C1)C3=C(O2)CCC4=C3N=C(N=C4N5CCNCC5)N D0F9QT HIGHSTAT Investigative D0F9QY DRUG__ID D0F9QY D0F9QY DRUGTYPE Small molecular drug D0F9QY DRUGINCH 1S/C14H10F2N2/c15-13-5-1-3-11(7-13)9-17-18-10-12-4-2-6-14(16)8-12/h1-10H/b17-9+,18-10+ D0F9QY DRUGINKE YYMCVDNIIFNDJK-BEQMOXJMSA-N D0F9QY DRUGSMIL C1=CC(=CC(=C1)F)C=NN=CC2=CC(=CC=C2)F D0F9QY HIGHSTAT Investigative D0F9RO DRUG__ID D0F9RO D0F9RO DRUGTYPE Small molecular drug D0F9RO DRUGINCH 1S/C30H48O4/c1-17-10-13-30(25(33)34)15-14-28(6)19(23(30)18(17)2)8-9-22-27(5)16-20(31)24(32)26(3,4)21(27)11-12-29(22,28)7/h8,17-18,20-24,31-32H,9-16H2,1-7H3,(H,33,34)/t17-,18+,20-,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1 D0F9RO DRUGINKE HFGSQOYIOKBQOW-ZSDYHTTISA-N D0F9RO DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1C)C)C(=O)O D0F9RO HIGHSTAT Investigative D0F9XO DRUG__ID D0F9XO D0F9XO DRUGTYPE Small molecular drug D0F9XO DRUGINCH 1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1 D0F9XO DRUGINKE FNKQXYHWGSIFBK-RPDRRWSUSA-N D0F9XO DRUGSMIL CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O D0F9XO HIGHSTAT Investigative D0F9YV DRUG__ID D0F9YV D0F9YV DRUGTYPE Small molecular drug D0F9YV DRUGINCH 1S/C15H15N3O2/c1-10-2-8-13(9-3-10)20-14(19)11-4-6-12(7-5-11)18-15(16)17/h2-9H,1H3,(H4,16,17,18) D0F9YV DRUGINKE OELAPCOUDOSGBC-UHFFFAOYSA-N D0F9YV DRUGSMIL CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N D0F9YV HIGHSTAT Investigative D0F9YZ DRUG__ID D0F9YZ D0F9YZ DRUGTYPE Small molecular drug D0F9YZ DRUGINCH 1S/C12H24O12S2/c13-1-5(15)10(19)11(20)12(24-26(21,22)23)7(17)4-25-3-6(16)9(18)8(25)2-14/h5-20H,1-4H2/t5-,6+,7+,8+,9-,10+,11+,12+,25?/m0/s1 D0F9YZ DRUGINKE OMKXVFDVAGCPBS-GTEYUELZSA-N D0F9YZ DRUGSMIL C1C(C(C([S+]1CC(C(C(C(C(CO)O)O)O)OS(=O)(=O)[O-])O)CO)O)O D0F9YZ HIGHSTAT Investigative D0F9ZW DRUG__ID D0F9ZW D0F9ZW DRUGTYPE Small molecular drug D0F9ZW DRUGINCH 1S/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15) D0F9ZW DRUGINKE MVAWJSIDNICKHF-UHFFFAOYSA-N D0F9ZW DRUGSMIL CC(=O)NCCC1=CNC2=C1C=C(C=C2)O D0F9ZW HIGHSTAT Investigative D0FA2N DRUG__ID D0FA2N D0FA2N DRUGCOMP Harbor BioSciences Inc D0FA2N DRUGINCH 1S/C19H30O4/c1-18-5-3-11(20)7-10(18)8-14(21)16-12(18)4-6-19(2)13(16)9-15(22)17(19)23/h8,11-17,20-23H,3-7,9H2,1-2H3/t11-,12-,13-,14-,15+,16+,17-,18-,19-/m0/s1 D0FA2N DRUGINKE DBJXJRIEZQPLSN-WGNZAZMQSA-N D0FA2N DRUGSMIL CC12CCC(CC1=CC(C3C2CCC4(C3CC(C4O)O)C)O)O D0FA2N HIGHSTAT Investigative D0FB7S DRUG__ID D0FB7S D0FB7S DRUGTYPE Small molecular drug D0FB7S DRUGINCH 1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-25,28-29H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,24+,25+,26+,27-/m1/s1 D0FB7S DRUGINKE OYXZMSRRJOYLLO-KGZHIOMZSA-N D0FB7S DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C D0FB7S HIGHSTAT Investigative D0FC4Y DRUG__ID D0FC4Y D0FC4Y DRUGTYPE Small molecular drug D0FC4Y DRUGINCH 1S/C23H23N7O2S/c1-5-25-22(31)30-23-27-12-19(33-23)16-10-17(20-13(2)8-15(32-4)9-14(20)3)29-21(28-16)18-11-24-6-7-26-18/h6-12H,5H2,1-4H3,(H2,25,27,30,31) D0FC4Y DRUGINKE WUCYRTXFXRZKSV-UHFFFAOYSA-N D0FC4Y DRUGSMIL CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C D0FC4Y HIGHSTAT Investigative D0FC7L DRUG__ID D0FC7L D0FC7L DRUGTYPE Small molecular drug D0FC7L DRUGINCH 1S/C12H15N3/c13-9-11-7-4-8-12(15-11)14-10-5-2-1-3-6-10/h4,7-8,10H,1-3,5-6H2,(H,14,15) D0FC7L DRUGINKE IBXQOGXYFIMECI-UHFFFAOYSA-N D0FC7L DRUGSMIL C1CCC(CC1)NC2=CC=CC(=N2)C#N D0FC7L HIGHSTAT Investigative D0FD6Z DRUG__ID D0FD6Z D0FD6Z DRUGTYPE Small molecular drug D0FD6Z DRUGINCH 1S/C16H11FO2/c17-16-8-12(10-1-4-13(18)5-2-10)7-11-3-6-14(19)9-15(11)16/h1-9,18-19H D0FD6Z DRUGINKE KBQSRNQTSRTYGN-UHFFFAOYSA-N D0FD6Z DRUGSMIL C1=CC(=CC=C1C2=CC(=C3C=C(C=CC3=C2)O)F)O D0FD6Z HIGHSTAT Investigative D0FD8G DRUG__ID D0FD8G D0FD8G DRUGTYPE Small molecular drug D0FD8G DRUGINCH 1S/C14H13BO2/c16-15(17)11-10-12-6-8-14(9-7-12)13-4-2-1-3-5-13/h1-11,16-17H/b11-10+ D0FD8G DRUGINKE NTRGFVQIGQYKIL-ZHACJKMWSA-N D0FD8G DRUGSMIL B(C=CC1=CC=C(C=C1)C2=CC=CC=C2)(O)O D0FD8G HIGHSTAT Investigative D0FD8Q DRUG__ID D0FD8Q D0FD8Q DRUGTYPE Small molecular drug D0FD8Q DRUGINCH 1S/C33H33FN2O4/c34-26-13-15-27(16-14-26)36-31(18-17-28(37)20-29(38)21-32(39)40)30-8-4-7-25(33(30)35-36)19-22-9-11-24(12-10-22)23-5-2-1-3-6-23/h1-3,5-6,9-18,25,28-29,37-38H,4,7-8,19-21H2,(H,39,40)/p-1/b18-17+/t25?,28-,29-/m1/s1 D0FD8Q DRUGINKE LRLBHWLNEJHHLJ-CDTDMYBXSA-M D0FD8Q DRUGSMIL C1CC(C2=NN(C(=C2C1)C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F)CC4=CC=C(C=C4)C5=CC=CC=C5 D0FD8Q HIGHSTAT Investigative D0FD9M DRUG__ID D0FD9M D0FD9M DRUGTYPE Small molecular drug D0FD9M DRUGINCH 1S/C26H38ClN3O5S/c1-20-17-24(27)8-7-22(20)6-5-21-9-13-29(14-10-21)36(34,35)18-26(30(33)19-31)11-15-28(16-12-26)25(32)23-3-2-4-23/h7-8,17,19,21,23,33H,2-6,9-16,18H2,1H3 D0FD9M DRUGINKE SIXCEPSXNLUZTE-UHFFFAOYSA-N D0FD9M DRUGSMIL CC1=C(C=CC(=C1)Cl)CCC2CCN(CC2)S(=O)(=O)CC3(CCN(CC3)C(=O)C4CCC4)N(C=O)O D0FD9M HIGHSTAT Investigative D0FE7A DRUG__ID D0FE7A D0FE7A DRUGTYPE Small molecular drug D0FE7A DRUGINCH 1S/C19H29ClN2O2/c1-3-4-9-22-10-7-14(8-11-22)5-6-18(23)15-12-16(20)17(21)13-19(15)24-2/h12-14H,3-11,21H2,1-2H3 D0FE7A DRUGINKE JBHLYIVFFLNISJ-UHFFFAOYSA-N D0FE7A DRUGSMIL CCCCN1CCC(CC1)CCC(=O)C2=CC(=C(C=C2OC)N)Cl D0FE7A HIGHSTAT Investigative D0FF0Z DRUG__ID D0FF0Z D0FF0Z DRUGTYPE Small molecular drug D0FF0Z DRUGINCH 1S/C18H14N2/c1-2-5-15(6-3-1)9-10-16-7-4-8-17(11-16)12-18-13-19-14-20-18/h1-8,11,13-14H,12H2,(H,19,20) D0FF0Z DRUGINKE VIPAIZRIFZFESY-UHFFFAOYSA-N D0FF0Z DRUGSMIL C1=CC=C(C=C1)C#CC2=CC=CC(=C2)CC3=CN=CN3 D0FF0Z HIGHSTAT Investigative D0FF3D DRUG__ID D0FF3D D0FF3D DRUGTYPE Small molecular drug D0FF3D DRUGINCH 1S/C11H12N2O2/c1-8-7-12-11(14)13(8)9-3-5-10(15-2)6-4-9/h3-7H,1-2H3,(H,12,14) D0FF3D DRUGINKE NHUPEUMBGMETKD-UHFFFAOYSA-N D0FF3D DRUGSMIL CC1=CNC(=O)N1C2=CC=C(C=C2)OC D0FF3D HIGHSTAT Investigative D0FF4M DRUG__ID D0FF4M D0FF4M DRUGTYPE Small molecular drug D0FF4M DRUGINCH 1S/C13H15NO/c15-13-11-7-2-1-5-9(11)10-6-3-4-8-12(10)14-13/h1-2,5,7,10,12H,3-4,6,8H2,(H,14,15) D0FF4M DRUGINKE CQQBPJQEIHYWQX-UHFFFAOYSA-N D0FF4M DRUGSMIL C1CCC2C(C1)C3=CC=CC=C3C(=O)N2 D0FF4M HIGHSTAT Investigative D0FF9F DRUG__ID D0FF9F D0FF9F DRUGTYPE Small molecular drug D0FF9F DRUGINCH 1S/C8H12N2O2/c1-2-3-4-6-5-7(8(11)12)10-9-6/h5H,2-4H2,1H3,(H,9,10)(H,11,12) D0FF9F DRUGINKE ZJTXSGLJNBAMJS-UHFFFAOYSA-N D0FF9F DRUGSMIL CCCCC1=CC(=NN1)C(=O)O D0FF9F HIGHSTAT Investigative D0FH1V DRUG__ID D0FH1V D0FH1V DRUGTYPE Small molecular drug D0FH1V DRUGINCH 1S/C19H28N2O6S3/c1-19-8-7-12-13(15(19)5-6-18(19)27-30(21,24)25)4-3-11-9-16(26-29(20,22)23)17(28-2)10-14(11)12/h9-10,12-13,15,18H,3-8H2,1-2H3,(H2,20,22,23)(H2,21,24,25)/t12-,13+,15-,18-,19-/m0/s1 D0FH1V DRUGINKE DWVUBFTWKROFPD-SSTWWWIQSA-N D0FH1V DRUGSMIL CC12CCC3C(C1CCC2OS(=O)(=O)N)CCC4=CC(=C(C=C34)SC)OS(=O)(=O)N D0FH1V HIGHSTAT Investigative D0FH3M DRUG__ID D0FH3M D0FH3M DRUGTYPE Small molecular drug D0FH3M DRUGINCH 1S/C17H17N3O2.ClH/c1-20(12-7-5-4-6-8-12)17-13-9-15(21-2)16(22-3)10-14(13)18-11-19-17;/h4-11H,1-3H3;1H D0FH3M DRUGINKE LPXMNVUTNCZLBT-UHFFFAOYSA-N D0FH3M DRUGSMIL CN(C1=CC=CC=C1)C2=NC=NC3=CC(=C(C=C32)OC)OC.Cl D0FH3M HIGHSTAT Investigative D0FH5A DRUG__ID D0FH5A D0FH5A DRUGTYPE Small molecular drug D0FH5A DRUGINCH 1S/C12H8N2O/c1-7-13-6-10-8-4-2-3-5-9(8)12(15)11(10)14-7/h2-6H,1H3 D0FH5A DRUGINKE QMXCHNWJZQMLGG-UHFFFAOYSA-N D0FH5A DRUGSMIL CC1=NC=C2C3=CC=CC=C3C(=O)C2=N1 D0FH5A HIGHSTAT Investigative D0FH7B DRUG__ID D0FH7B D0FH7B DRUGTYPE Small molecular drug D0FH7B DRUGINCH 1S/C21H26N2O2.ClH/c22-21(23-13-7-2-8-14-23)15-18(24)16-25-20-12-6-5-11-19(20)17-9-3-1-4-10-17;/h1,3-6,9-12,18,22,24H,2,7-8,13-16H2;1H D0FH7B DRUGINKE WWHGFIXWBLHHQB-UHFFFAOYSA-N D0FH7B DRUGSMIL C1CCN(CC1)C(=N)CC(COC2=CC=CC=C2C3=CC=CC=C3)O.Cl D0FH7B HIGHSTAT Investigative D0FH9J DRUG__ID D0FH9J D0FH9J DRUGTYPE Small molecular drug D0FH9J DRUGINCH 1S/C20H20ClN5/c21-16-4-2-5-17(14-16)24-20-23-8-7-19(25-20)15-3-1-6-18(13-15)26-11-9-22-10-12-26/h1-8,13-14,22H,9-12H2,(H,23,24,25) D0FH9J DRUGINKE UGXVRWRXHWTSCU-UHFFFAOYSA-N D0FH9J DRUGSMIL C1CN(CCN1)C2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC(=CC=C4)Cl D0FH9J HIGHSTAT Investigative D0FI1I DRUG__ID D0FI1I D0FI1I DRUGTYPE Small molecular drug D0FI1I DRUGINCH 1S/C15H13NO2/c1-11-5-3-4-6-13(11)18-14-8-7-12(10-16)9-15(14)17-2/h3-9H,1-2H3 D0FI1I DRUGINKE VDMHQBDHJWOOTF-UHFFFAOYSA-N D0FI1I DRUGSMIL CC1=CC=CC=C1OC2=C(C=C(C=C2)C#N)OC D0FI1I HIGHSTAT Investigative D0FI2F DRUG__ID D0FI2F D0FI2F DRUGTYPE Small molecular drug D0FI2F DRUGINCH 1S/C20H24N2O4/c23-19(22-25)14-8-7-13-18(26-15-16-9-3-1-4-10-16)20(24)21-17-11-5-2-6-12-17/h1-6,9-12,18,25H,7-8,13-15H2,(H,21,24)(H,22,23) D0FI2F DRUGINKE DGQYQVJKMZAQBV-UHFFFAOYSA-N D0FI2F DRUGSMIL C1=CC=C(C=C1)COC(CCCCC(=O)NO)C(=O)NC2=CC=CC=C2 D0FI2F HIGHSTAT Investigative D0FI2L DRUG__ID D0FI2L D0FI2L DRUGTYPE Small molecular drug D0FI2L DRUGINCH 1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1 D0FI2L DRUGINKE FNXPTCITVCRFRK-UMMCILCDSA-N D0FI2L DRUGSMIL C(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)N=C2N)O)O)O D0FI2L HIGHSTAT Investigative D0FI4X DRUG__ID D0FI4X D0FI4X DRUGTYPE Small molecular drug D0FI4X DRUGINCH 1S/C18H23NO2/c1-2-3-4-5-7-14-10-11-18(17(20)12-14)21-16-9-6-8-15(19)13-16/h6,8-13,20H,2-5,7,19H2,1H3 D0FI4X DRUGINKE ZRRRBQYWHBBQGE-UHFFFAOYSA-N D0FI4X DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC(=C2)N)O D0FI4X HIGHSTAT Investigative D0FI7B DRUG__ID D0FI7B D0FI7B DRUGTYPE Small molecular drug D0FI7B DRUGINCH 1S/C27H48O3/c1-16(2)7-6-8-17(3)20-9-10-21-25-22(15-24(30)27(20,21)5)26(4)12-11-19(28)13-18(26)14-23(25)29/h16-25,28-30H,6-15H2,1-5H3/t17-,18+,19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1 D0FI7B DRUGINKE RIVQQZVHIVNQFH-XJZYBRFWSA-N D0FI7B DRUGSMIL CC(C)CCCC(C)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C D0FI7B HIGHSTAT Investigative D0FI9G DRUG__ID D0FI9G D0FI9G DRUGTYPE Small molecular drug D0FI9G DRUGINCH 1S/C17H12N2O2.ClH/c20-11-3-4-14-13(9-11)12-5-7-18-6-1-2-10-8-15(21)19(14)17(12)16(10)18;/h3-5,7-9H,1-2,6H2;1H D0FI9G DRUGINKE NTHWONPMICHNIA-UHFFFAOYSA-N D0FI9G DRUGSMIL C1CC2=CC(=O)N3C4=C(C=C(C=C4)O)C5=C3C2=[N+](C1)C=C5.[Cl-] D0FI9G HIGHSTAT Investigative D0FJ1I DRUG__ID D0FJ1I D0FJ1I DRUGTYPE Small molecular drug D0FJ1I DRUGINCH 1S/C25H23Cl3N2O3/c1-25(2)13-21(29-22(32)9-10-31)19-12-18(14-3-5-15(26)6-4-14)23(30-24(19)33-25)17-8-7-16(27)11-20(17)28/h3-8,11-12,21,31H,9-10,13H2,1-2H3,(H,29,32) D0FJ1I DRUGINKE CQVVMULTZQAZBA-UHFFFAOYSA-N D0FJ1I DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)NC(=O)CCO)C D0FJ1I HIGHSTAT Investigative D0FJ7G DRUG__ID D0FJ7G D0FJ7G DRUGTYPE Small molecular drug D0FJ7G DRUGINCH 1S/C16H12BrF2NO3S/c17-10-2-1-9(13(19)5-10)7-20-16(24)12-4-3-11(18)6-14(12)23-8-15(21)22/h1-6H,7-8H2,(H,20,24)(H,21,22) D0FJ7G DRUGINKE JCZUIWYXULSXSW-UHFFFAOYSA-N D0FJ7G DRUGSMIL C1=CC(=C(C=C1F)OCC(=O)O)C(=S)NCC2=C(C=C(C=C2)Br)F D0FJ7G HIGHSTAT Investigative D0FK0A DRUG__ID D0FK0A D0FK0A DRUGTYPE Small molecular drug D0FK0A DRUGINCH 1S/C12H14N6/c13-10-9-11(18-12(14)17-10)15-6-8(16-9)7-4-2-1-3-5-7/h1-5,8,16H,6H2,(H5,13,14,15,17,18)/t8-/m0/s1 D0FK0A DRUGINKE VEKRIXRQADJFAG-QMMMGPOBSA-N D0FK0A DRUGSMIL C1C(NC2=C(N=C(N=C2N1)N)N)C3=CC=CC=C3 D0FK0A HIGHSTAT Investigative D0FK3W DRUG__ID D0FK3W D0FK3W DRUGTYPE Small molecular drug D0FK3W DRUGINCH 1S/C13H8BrN3/c14-11-5-1-3-9(7-11)12-16-8-10-4-2-6-15-13(10)17-12/h1-8H D0FK3W DRUGINKE KOBJRMNXIZSOES-UHFFFAOYSA-N D0FK3W DRUGSMIL C1=CC(=CC(=C1)Br)C2=NC=C3C=CC=NC3=N2 D0FK3W HIGHSTAT Investigative D0FK5Z DRUG__ID D0FK5Z D0FK5Z DRUGTYPE Small molecular drug D0FK5Z DRUGINCH 1S/C24H26N2O/c27-24(23-12-6-10-20-9-4-5-11-22(20)23)25-21-14-17-26(18-15-21)16-13-19-7-2-1-3-8-19/h1-12,21H,13-18H2,(H,25,27) D0FK5Z DRUGINKE BTQGBMYNQGZVOI-UHFFFAOYSA-N D0FK5Z DRUGSMIL C1CN(CCC1NC(=O)C2=CC=CC3=CC=CC=C32)CCC4=CC=CC=C4 D0FK5Z HIGHSTAT Investigative D0FK6J DRUG__ID D0FK6J D0FK6J DRUGTYPE Small molecular drug D0FK6J DRUGINCH 1S/C27H32N2O8/c1-18-11-13-20-7-4-9-23(31)26(20)27(34)37-21(17-25(33)36-19(2)12-14-22(18)30)8-5-15-28-24(32)10-6-16-29-35-3/h4-7,9-12,14-16,19,21-22,30-31H,8,13,17H2,1-3H3,(H,28,32)/b10-6+,14-12-,15-5+,18-11-,29-16- D0FK6J DRUGINKE JYHIHHYYXXKTTJ-PZRNTLOJSA-N D0FK6J DRUGSMIL CC1C=CC(C(=CCC2=C(C(=CC=C2)O)C(=O)OC(CC(=O)O1)CC=CNC(=O)C=CC=NOC)C)O D0FK6J HIGHSTAT Investigative D0FK6T DRUG__ID D0FK6T D0FK6T DRUGTYPE Small molecular drug D0FK6T DRUGINCH 1S/C18H23N3/c1-4-8-17-15(5-1)9-10-18(19-17)21-13-11-20(12-14-21)16-6-2-3-7-16/h1,4-5,8-10,16H,2-3,6-7,11-14H2 D0FK6T DRUGINKE JGCMOVVEQUHZRT-UHFFFAOYSA-N D0FK6T DRUGSMIL C1CCC(C1)N2CCN(CC2)C3=NC4=CC=CC=C4C=C3 D0FK6T HIGHSTAT Investigative D0FL1D DRUG__ID D0FL1D D0FL1D DRUGTYPE Small molecular drug D0FL1D DRUGINCH 1S/C26H26N2/c1-3-10-20(11-4-1)18-28-17-9-14-22(19-28)25-23-15-7-8-16-24(23)27-26(25)21-12-5-2-6-13-21/h1-8,10-13,15-16,22,27H,9,14,17-19H2 D0FL1D DRUGINKE RXGPCIHYSMKIRI-UHFFFAOYSA-N D0FL1D DRUGSMIL C1CC(CN(C1)CC2=CC=CC=C2)C3=C(NC4=CC=CC=C43)C5=CC=CC=C5 D0FL1D HIGHSTAT Investigative D0FL7O DRUG__ID D0FL7O D0FL7O DRUGTYPE Small molecular drug D0FL7O DRUGINCH 1S/C26H34N2/c1-3-5-8-14-24(15-9-6-4-2)26-27-20-25(28-26)23-18-16-22(17-19-23)21-12-10-7-11-13-21/h7,10-13,16-20,24H,3-6,8-9,14-15H2,1-2H3,(H,27,28) D0FL7O DRUGINKE FAJKZAIMTCYING-UHFFFAOYSA-N D0FL7O DRUGSMIL CCCCCC(CCCCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3 D0FL7O HIGHSTAT Investigative D0FN5D DRUG__ID D0FN5D D0FN5D DRUGTYPE Small molecular drug D0FN5D DRUGINCH 1S/C14H11F2NO2/c15-11-5-1-9(2-6-11)13(14(18)17-19)10-3-7-12(16)8-4-10/h1-8,13,19H,(H,17,18) D0FN5D DRUGINKE HHJNWMNXSDYVHL-UHFFFAOYSA-N D0FN5D DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)F)C(=O)NO)F D0FN5D HIGHSTAT Investigative D0FN7C DRUG__ID D0FN7C D0FN7C DRUGTYPE Small molecular drug D0FN7C DRUGINCH 1S/C11H12O5S2/c12-8-4-2-1-3-7(8)11(17-5-9(13)14)18-6-10(15)16/h1-4,11-12H,5-6H2,(H,13,14)(H,15,16) D0FN7C DRUGINKE DNZSITNGPBYEIL-UHFFFAOYSA-N D0FN7C DRUGSMIL C1=CC=C(C(=C1)C(SCC(=O)O)SCC(=O)O)O D0FN7C HIGHSTAT Investigative D0FN7I DRUG__ID D0FN7I D0FN7I DRUGTYPE Small molecular drug D0FN7I DRUGINCH 1S/C15H26N2O/c1-16(2)11-5-13-18-15-8-6-14(7-9-15)10-12-17(3)4/h6-9H,5,10-13H2,1-4H3 D0FN7I DRUGINKE DXZMBOOTLSIFGN-UHFFFAOYSA-N D0FN7I DRUGSMIL CN(C)CCCOC1=CC=C(C=C1)CCN(C)C D0FN7I HIGHSTAT Investigative D0FO2B DRUG__ID D0FO2B D0FO2B DRUGTYPE Small molecular drug D0FO2B DRUGINCH 1S/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H D0FO2B DRUGINKE MCJGNVYPOGVAJF-UHFFFAOYSA-N D0FO2B DRUGSMIL C1=CC2=C(C(=C1)O)N=CC=C2 D0FO2B HIGHSTAT Investigative D0FO2K DRUG__ID D0FO2K D0FO2K DRUGTYPE Small molecular drug D0FO2K DRUGINCH 1S/C20H15N3O3/c24-15(25)11-21-19-17-16(13-7-3-1-4-8-13)18(14-9-5-2-6-10-14)26-20(17)23-12-22-19/h1-10,12H,11H2,(H,24,25)(H,21,22,23) D0FO2K DRUGINKE VXTCEUDVOCLEJG-UHFFFAOYSA-N D0FO2K DRUGSMIL C1=CC=C(C=C1)C2=C(OC3=NC=NC(=C23)NCC(=O)O)C4=CC=CC=C4 D0FO2K HIGHSTAT Investigative D0FO4J DRUG__ID D0FO4J D0FO4J DRUGTYPE Small molecular drug D0FO4J DRUGINCH 1S/C7H11F3OS/c1-2-3-4-12-5-6(11)7(8,9)10/h2-5H2,1H3 D0FO4J DRUGINKE PEBSSHOGFAFMQB-UHFFFAOYSA-N D0FO4J DRUGSMIL CCCCSCC(=O)C(F)(F)F D0FO4J HIGHSTAT Investigative D0FP5F DRUG__ID D0FP5F D0FP5F DRUGTYPE Small molecular drug D0FP5F DRUGINCH 1S/C14H24N2O6/c1-3-5-15-13(17)21-9-7-19-12-10(8-20-11(9)12)22-14(18)16-6-4-2/h9-12H,3-8H2,1-2H3,(H,15,17)(H,16,18)/t9-,10+,11-,12-/m1/s1 D0FP5F DRUGINKE FHZOSQQIPPAAMJ-WRWGMCAJSA-N D0FP5F DRUGSMIL CCCNC(=O)OC1COC2C1OCC2OC(=O)NCCC D0FP5F HIGHSTAT Investigative D0FQ1Z DRUG__ID D0FQ1Z D0FQ1Z DRUGTYPE Small molecular drug D0FQ1Z DRUGINCH 1S/C19H24N2O/c1-2-13-12-21-10-8-14(13)11-18(21)19(22)16-7-9-20-17-6-4-3-5-15(16)17/h3-7,9,13-14,18-19,22H,2,8,10-12H2,1H3 D0FQ1Z DRUGINKE WFJNHVWTKZUUTR-UHFFFAOYSA-N D0FQ1Z DRUGSMIL CCC1CN2CCC1CC2C(C3=CC=NC4=CC=CC=C34)O D0FQ1Z HIGHSTAT Investigative D0FQ2N DRUG__ID D0FQ2N D0FQ2N DRUGTYPE Small molecular drug D0FQ2N DRUGINCH 1S/C12H7N3S/c16-7-14-12-5-9-8-3-1-2-4-10(8)15-11(9)6-13-12/h1-6,15H D0FQ2N DRUGINKE NEOUOHDNZDRDNJ-UHFFFAOYSA-N D0FQ2N DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NC=C3N2)N=C=S D0FQ2N HIGHSTAT Investigative D0FQ3G DRUG__ID D0FQ3G D0FQ3G DRUGTYPE Small molecular drug D0FQ3G DRUGINCH 1S/C33H40N8O6/c1-19-29(44)41-26(16-20-9-12-24(42)13-10-20)30(45)37-18-28(43)39-27(17-21-8-11-22-5-2-3-6-23(22)15-21)32(47)40-25(31(46)38-19)7-4-14-36-33(34)35/h2-3,5-6,8-13,15,19,25-27,42H,4,7,14,16-18H2,1H3,(H,37,45)(H,38,46)(H,39,43)(H,40,47)(H,41,44)(H4,34,35,36)/t19-,25+,26-,27+/m1/s1 D0FQ3G DRUGINKE KSQLRHSLMODJAS-ABXDHCHGSA-N D0FQ3G DRUGSMIL CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O D0FQ3G HIGHSTAT Investigative D0FQ3N DRUG__ID D0FQ3N D0FQ3N DRUGTYPE Small molecular drug D0FQ3N DRUGINCH 1S/C13H8O4/c14-9-6-5-8-11(15)7-3-1-2-4-10(7)17-13(8)12(9)16/h1-6,14,16H D0FQ3N DRUGINKE YFVCSEXMOBEPQB-UHFFFAOYSA-N D0FQ3N DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(O2)C(=C(C=C3)O)O D0FQ3N HIGHSTAT Investigative D0FR3X DRUG__ID D0FR3X D0FR3X DRUGTYPE Small molecular drug D0FR3X DRUGINCH 1S/C17H19ClN2O3/c18-14-3-1-2-13(8-14)11-23-15-6-4-12(5-7-15)9-20-16(10-21)17(19)22/h1-8,16,20-21H,9-11H2,(H2,19,22)/t16-/m0/s1 D0FR3X DRUGINKE WYDCYPPIJUASJE-INIZCTEOSA-N D0FR3X DRUGSMIL C1=CC(=CC(=C1)Cl)COC2=CC=C(C=C2)CNC(CO)C(=O)N D0FR3X HIGHSTAT Investigative D0FR4S DRUG__ID D0FR4S D0FR4S DRUGTYPE Small molecular drug D0FR4S DRUGINCH 1S/C4H7N3O2/c5-2-1-3-4(8)7-9-6-3/h1-2,5H2,(H,7,8) D0FR4S DRUGINKE LGTWAFYEFVSZIU-UHFFFAOYSA-N D0FR4S DRUGSMIL C(CN)C1=NONC1=O D0FR4S HIGHSTAT Investigative D0FR6J DRUG__ID D0FR6J D0FR6J DRUGTYPE Small molecular drug D0FR6J DRUGINCH 1S/C15H16N2O3S2/c1-9(14(19)20)17-13(18)12(22-15(17)21)8-10-4-6-11(7-5-10)16(2)3/h4-9H,1-3H3,(H,19,20)/b12-8- D0FR6J DRUGINKE XGTGMKYGVNHPTC-WQLSENKSSA-N D0FR6J DRUGSMIL CC(C(=O)O)N1C(=O)C(=CC2=CC=C(C=C2)N(C)C)SC1=S D0FR6J HIGHSTAT Investigative D0FR8Z DRUG__ID D0FR8Z D0FR8Z DRUGTYPE Small molecular drug D0FR8Z DRUGINCH 1S/C33H52N6O14S2/c1-17(40)34-23(15-27(45)46)32(51)36-19(8-10-25(41)42)28(47)37-21(12-13-55-2)30(49)35-20(9-11-26(43)44)29(48)38-22(14-18-6-4-3-5-7-18)31(50)39-24(16-54)33(52)53/h18-24,54H,3-16H2,1-2H3,(H,34,40)(H,35,49)(H,36,51)(H,37,47)(H,38,48)(H,39,50)(H,41,42)(H,43,44)(H,45,46)(H,52,53)/t19-,20-,21-,22-,23-,24-/m0/s1 D0FR8Z DRUGINKE QFFHVIGQVJVQSD-BTNSXGMBSA-N D0FR8Z DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O D0FR8Z HIGHSTAT Investigative D0FS3L DRUG__ID D0FS3L D0FS3L DRUGTYPE Small molecular drug D0FS3L DRUGINCH 1S/C12H14O6/c13-5-7-1-3-8(4-2-7)18-12-11(16)10(15)9(14)6-17-12/h1-5,9-12,14-16H,6H2/t9-,10-,11-,12+/m1/s1 D0FS3L DRUGINKE QGBRWWHJQCFYEI-KKOKHZNYSA-N D0FS3L DRUGSMIL C1C(C(C(C(O1)OC2=CC=C(C=C2)C=O)O)O)O D0FS3L HIGHSTAT Investigative D0FS4V DRUG__ID D0FS4V D0FS4V DRUGTYPE Small molecular drug D0FS4V DRUGINCH 1S/C50H61N7O12/c1-28(34-17-19-36(20-18-34)35-15-11-31(12-16-35)24-38(51)50(67)68)42(52)47(64)54-39(25-32-13-21-37(59)22-14-32)45(62)55-43(29(2)58)49(66)57-23-7-10-40(57)46(63)56-44(48(65)53-26-41(60)61)30(3)69-27-33-8-5-4-6-9-33/h4-6,8-9,11-22,28-30,38-40,42-44,58-59H,7,10,23-27,51-52H2,1-3H3,(H,53,65)(H,54,64)(H,55,62)(H,56,63)(H,60,61)(H,67,68)/t28?,29-,30-,38+,39+,40+,42+,43+,44+/m1/s1 D0FS4V DRUGINKE MGKWXTIOHURCAH-LZDYDXGASA-N D0FS4V DRUGSMIL CC(C1=CC=C(C=C1)C2=CC=C(C=C2)CC(C(=O)O)N)C(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(C(C)O)C(=O)N4CCCC4C(=O)NC(C(C)OCC5=CC=CC=C5)C(=O)NCC(=O)O)N D0FS4V HIGHSTAT Investigative D0FT0J DRUG__ID D0FT0J D0FT0J DRUGTYPE Small molecular drug D0FT0J DRUGINCH 1S/C5H12NO5P/c6-4(5(7)8)2-1-3-12(9,10)11/h4H,1-3,6H2,(H,7,8)(H2,9,10,11)/t4-/m1/s1 D0FT0J DRUGINKE VOROEQBFPPIACJ-SCSAIBSYSA-N D0FT0J DRUGSMIL C(CC(C(=O)O)N)CP(=O)(O)O D0FT0J HIGHSTAT Investigative D0FT5V DRUG__ID D0FT5V D0FT5V DRUGTYPE Small molecular drug D0FT5V DRUGINCH 1S/C16H21NO2/c1-10-4-2-6-12-14(10)16(18)15-11-5-3-8-17(11)9-7-13(15)19-12/h2,6,10-11,13,15H,3-5,7-9H2,1H3/t10-,11-,13+,15-/m0/s1 D0FT5V DRUGINKE RETGXUCYBMOWOH-MEDZGJRSSA-N D0FT5V DRUGSMIL CC1CC=CC2=C1C(=O)C3C4CCCN4CCC3O2 D0FT5V HIGHSTAT Investigative D0FT9J DRUG__ID D0FT9J D0FT9J DRUGTYPE Small molecular drug D0FT9J DRUGINCH 1S/C35H43N5O5/c1-21-16-22(2)27(23(3)17-21)20-30(33(43)38-29(32(37)42)19-24-8-5-4-6-9-24)39-34(44)31-10-7-15-40(31)35(45)28(36)18-25-11-13-26(41)14-12-25/h4-6,8-9,11-14,16-17,28-31,41H,7,10,15,18-20,36H2,1-3H3,(H2,37,42)(H,38,43)(H,39,44)/t28-,29-,30-,31-/m0/s1 D0FT9J DRUGINKE KFLSQRYJYCLKBS-ORYMTKCHSA-N D0FT9J DRUGSMIL CC1=CC(=C(C(=C1)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N)C D0FT9J HIGHSTAT Investigative D0FU2V DRUG__ID D0FU2V D0FU2V DRUGTYPE Small molecular drug D0FU2V DRUGINCH 1S/C25H35N3O/c1-2-13-27(23-11-12-24-21(20-23)7-6-10-25(24)29)17-14-26-15-18-28(19-16-26)22-8-4-3-5-9-22/h3-10,23,29H,2,11-20H2,1H3/t23-/m1/s1 D0FU2V DRUGINKE ACDYFMOSSUKHJD-HSZRJFAPSA-N D0FU2V DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=C(C3)C=CC=C4O D0FU2V HIGHSTAT Investigative D0FU5E DRUG__ID D0FU5E D0FU5E DRUGTYPE Small molecular drug D0FU5E DRUGINCH 1S/C13H15FN2/c14-12-2-1-10-3-9(4-11(10)6-12)5-13-7-15-8-16-13/h1-2,6,8-9,13H,3-5,7H2,(H,15,16) D0FU5E DRUGINKE HBMJQYDGBNSZMC-UHFFFAOYSA-N D0FU5E DRUGSMIL C1C(CC2=C1C=CC(=C2)F)CC3CN=CN3 D0FU5E HIGHSTAT Investigative D0FU7Y DRUG__ID D0FU7Y D0FU7Y DRUGTYPE Small molecular drug D0FU7Y DRUGINCH 1S/C7H11NO6/c9-5(8-14)3-4(7(12)13)1-2-6(10)11/h4,14H,1-3H2,(H,8,9)(H,10,11)(H,12,13) D0FU7Y DRUGINKE PILHIJIJVLWKNF-UHFFFAOYSA-N D0FU7Y DRUGSMIL C(CC(=O)O)C(CC(=O)NO)C(=O)O D0FU7Y HIGHSTAT Investigative D0FV6M DRUG__ID D0FV6M D0FV6M DRUGTYPE Small molecular drug D0FV6M DRUGINCH 1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1/i3D2,6D D0FV6M DRUGINKE WTDRDQBEARUVNC-QZRTVAIESA-N D0FV6M DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)O)O D0FV6M HIGHSTAT Investigative D0FV7K DRUG__ID D0FV7K D0FV7K DRUGTYPE Small molecular drug D0FV7K DRUGINCH 1S/C15H14N2/c16-14-7-5-12(6-8-14)11-17-10-9-13-3-1-2-4-15(13)17/h1-10H,11,16H2 D0FV7K DRUGINKE CRNJIXJRSKNGTP-UHFFFAOYSA-N D0FV7K DRUGSMIL C1=CC=C2C(=C1)C=CN2CC3=CC=C(C=C3)N D0FV7K HIGHSTAT Investigative D0FV9Y DRUG__ID D0FV9Y D0FV9Y DRUGTYPE Small molecular drug D0FV9Y DRUGINCH 1S/C20H27N7O5S2/c1-27(17(29)12-25-34(31,32)14-6-3-2-4-7-14)13-16(28)26-15(8-5-9-24-20(21)22)18(30)19-23-10-11-33-19/h2-4,6-7,10-11,15,25H,5,8-9,12-13H2,1H3,(H,26,28)(H4,21,22,24)/t15-/m0/s1 D0FV9Y DRUGINKE GJNJUHMPYZAMBU-HNNXBMFYSA-N D0FV9Y DRUGSMIL CN(CC(=O)NC(CCCN=C(N)N)C(=O)C1=NC=CS1)C(=O)CNS(=O)(=O)C2=CC=CC=C2 D0FV9Y HIGHSTAT Investigative D0FW2W DRUG__ID D0FW2W D0FW2W DRUGTYPE Small molecular drug D0FW2W DRUGINCH 1S/C18H11Cl2FO2/c19-13-4-8-17(15(20)10-13)23-18-7-3-12(9-16(18)22)11-1-5-14(21)6-2-11/h1-10,22H D0FW2W DRUGINKE LFNMTUYVBXAAKI-UHFFFAOYSA-N D0FW2W DRUGSMIL C1=CC(=CC=C1C2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O)F D0FW2W HIGHSTAT Investigative D0FW8K DRUG__ID D0FW8K D0FW8K DRUGTYPE Small molecular drug D0FW8K DRUGINCH 1S/C3H5N5O2/c4-1(3(9)10)2-5-7-8-6-2/h1H,4H2,(H,9,10)(H,5,6,7,8) D0FW8K DRUGINKE UKBRUIZWQZHXFL-UHFFFAOYSA-N D0FW8K DRUGSMIL C1(=NNN=N1)C(C(=O)O)N D0FW8K HIGHSTAT Investigative D0FX3J DRUG__ID D0FX3J D0FX3J DRUGTYPE Small molecular drug D0FX3J DRUGINCH 1S/C12H20N4O8S/c1-16(24)12(23)25-5-7(10(20)14-4-9(18)19)15-8(17)3-2-6(13)11(21)22/h6-7,24H,2-5,13H2,1H3,(H,14,20)(H,15,17)(H,18,19)(H,21,22)/t6-,7-/m0/s1 D0FX3J DRUGINKE RITFSVQFPRZDHQ-BQBZGAKWSA-N D0FX3J DRUGSMIL CN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D0FX3J HIGHSTAT Investigative D0FX4W DRUG__ID D0FX4W D0FX4W DRUGTYPE Small molecular drug D0FX4W DRUGINCH 1S/C10H17N2O2/c1-12(2,3)7-4-5-8-13-10-6-9-14-11-10/h6-9H2,1-3H3/q+1 D0FX4W DRUGINKE WXXOCGISBCTWPW-UHFFFAOYSA-N D0FX4W DRUGSMIL C[N+](C)(C)CC#CCOC1=NOCC1 D0FX4W HIGHSTAT Investigative D0FZ6A DRUG__ID D0FZ6A D0FZ6A DRUGTYPE Small molecular drug D0FZ6A DRUGINCH 1S/C12H27O4P/c1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h2-12H2,1H3,(H2,13,14,15)/p-2 D0FZ6A DRUGINKE TVACALAUIQMRDF-UHFFFAOYSA-L D0FZ6A DRUGSMIL CCCCCCCCCCCCOP(=O)([O-])[O-] D0FZ6A HIGHSTAT Investigative D0FZ7W DRUG__ID D0FZ7W D0FZ7W DRUGTYPE Small molecular drug D0FZ7W DRUGINCH 1S/C10H7NO3/c1-11-9(13)7-5-3-2-4-6(7)8(12)10(11)14/h2-5H,1H3 D0FZ7W DRUGINKE LSVJISCDJHIYOW-UHFFFAOYSA-N D0FZ7W DRUGSMIL CN1C(=O)C2=CC=CC=C2C(=O)C1=O D0FZ7W HIGHSTAT Investigative D0G0CJ DRUG__ID D0G0CJ D0G0CJ DRUGTYPE Small molecular drug D0G0CJ DRUGINCH 1S/C14H18BrNO/c1-10(16-13-7-2-3-8-13)14(17)11-5-4-6-12(15)9-11/h4-6,9-10,13,16H,2-3,7-8H2,1H3 D0G0CJ DRUGINKE ZZWUEOYQVWAKCJ-UHFFFAOYSA-N D0G0CJ DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Br)NC2CCCC2 D0G0CJ HIGHSTAT Investigative D0G0ED DRUG__ID D0G0ED D0G0ED DRUGTYPE Small molecular drug D0G0ED DRUGINCH 1S/C24H23N2O9P/c1-14-10-26(24(30)25-23(14)29)20-9-8-17(34-20)13-33-36(31)32-12-16-5-3-7-19(22(16)35-36)18-6-2-4-15(11-27)21(18)28/h2-10,17,20,27-28H,11-13H2,1H3,(H,25,29,30)/t17-,20+,36?/m0/s1 D0G0ED DRUGINKE ONCMROQDJNEQJX-AVINKISOSA-N D0G0ED DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)COP3(=O)OCC4=C(O3)C(=CC=C4)C5=CC=CC(=C5O)CO D0G0ED HIGHSTAT Investigative D0G0EE DRUG__ID D0G0EE D0G0EE DRUGTYPE Small molecular drug D0G0EE DRUGINCH 1S/C9H8N2S/c12-8-3-1-2-7(4-8)9-5-10-6-11-9/h1-6,12H,(H,10,11) D0G0EE DRUGINKE GZDISEVTMUIDGB-UHFFFAOYSA-N D0G0EE DRUGSMIL C1=CC(=CC(=C1)S)C2=CN=CN2 D0G0EE HIGHSTAT Investigative D0G0FJ DRUG__ID D0G0FJ D0G0FJ DRUGTYPE Small molecular drug D0G0FJ DRUGINCH 1S/C6H9N3O2S/c7-9-5-3-1-2-4-6(5)12(8,10)11/h1-4,9H,7H2,(H2,8,10,11) D0G0FJ DRUGINKE CTEZEDIMFASQNI-UHFFFAOYSA-N D0G0FJ DRUGSMIL C1=CC=C(C(=C1)NN)S(=O)(=O)N D0G0FJ HIGHSTAT Investigative D0G0GZ DRUG__ID D0G0GZ D0G0GZ DRUGTYPE Small molecular drug D0G0GZ DRUGINCH 1S/C14H12N2OS/c1-15-14(17)16-10-6-2-4-8-12(10)18-13-9-5-3-7-11(13)16/h2-9H,1H3,(H,15,17) D0G0GZ DRUGINKE VBZPZJCWSNLVCY-UHFFFAOYSA-N D0G0GZ DRUGSMIL CNC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0G0GZ HIGHSTAT Investigative D0G0HK DRUG__ID D0G0HK D0G0HK DRUGTYPE Small molecular drug D0G0HK DRUGINCH 1S/C24H32N4O4/c1-17-12-18(2)16-27(15-17)11-5-10-25-22-9-8-19(13-23(22)28(30)31)24(29)26-20-6-4-7-21(14-20)32-3/h4,6-9,13-14,17-18,25H,5,10-12,15-16H2,1-3H3,(H,26,29) D0G0HK DRUGINKE LRAMWMMVZIGQPU-UHFFFAOYSA-N D0G0HK DRUGSMIL CC1CC(CN(C1)CCCNC2=C(C=C(C=C2)C(=O)NC3=CC(=CC=C3)OC)[N+](=O)[O-])C D0G0HK HIGHSTAT Investigative D0G0HP DRUG__ID D0G0HP D0G0HP DRUGTYPE Small molecular drug D0G0HP DRUGINCH 1S/C25H36O12/c1-11(26)35-14-9-13(19(29)32-4)23(2)8-7-12-20(30)36-15(10-24(12,3)17(23)16(14)27)25(31)18(28)21(33-5)37-22(25)34-6/h12-15,17-18,21-22,28,31H,7-10H2,1-6H3/t12-,13-,14-,15?,17-,18+,21+,22-,23-,24-,25+/m0/s1 D0G0HP DRUGINKE QEBAQEQKIKWXTO-CKKULBRGSA-N D0G0HP DRUGSMIL CC(=O)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4(C(C(OC4OC)OC)O)O)C)C(=O)OC D0G0HP HIGHSTAT Investigative D0G0IQ DRUG__ID D0G0IQ D0G0IQ DRUGTYPE Small molecular drug D0G0IQ DRUGINCH 1S/C18H21N5/c1-13-5-6-15-14(12-13)18(23-10-8-22(2)9-11-23)21-16-4-3-7-19-17(16)20-15/h3-7,12H,8-11H2,1-2H3,(H,19,20) D0G0IQ DRUGINKE MMCMKWDIEUZMQB-UHFFFAOYSA-N D0G0IQ DRUGSMIL CC1=CC2=C(C=C1)NC3=C(C=CC=N3)N=C2N4CCN(CC4)C D0G0IQ HIGHSTAT Investigative D0G0JA DRUG__ID D0G0JA D0G0JA DRUGTYPE Small molecular drug D0G0JA DRUGINCH 1S/C33H36N4O8S/c1-33(2)30(31(41)35-28-24-14-7-6-11-21(24)16-26(28)38)36(19-46-33)32(42)29(40)25(15-20-9-4-3-5-10-20)34-27(39)18-45-23-13-8-12-22(17-23)37(43)44/h3-14,17,25-26,28-30,38,40H,15-16,18-19H2,1-2H3,(H,34,39)(H,35,41)/t25-,26+,28-,29-,30+/m0/s1 D0G0JA DRUGINKE RFMOODWRTXUAKX-DOWNBTJOSA-N D0G0JA DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC(=C3)[N+](=O)[O-])O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0G0JA HIGHSTAT Investigative D0G0JC DRUG__ID D0G0JC D0G0JC DRUGTYPE Small molecular drug D0G0JC DRUGINCH 1S/C12H12N2/c1-2-6-12(7-3-1)14-10-11-5-4-8-13-9-11/h1-9,14H,10H2 D0G0JC DRUGINKE BJXLHKJBRORJJJ-UHFFFAOYSA-N D0G0JC DRUGSMIL C1=CC=C(C=C1)NCC2=CN=CC=C2 D0G0JC HIGHSTAT Investigative D0G0KN DRUG__ID D0G0KN D0G0KN DRUGTYPE Small molecular drug D0G0KN DRUGINCH 1S/C18H17NO3/c1-20-15-6-4-12(5-7-15)14-8-13-9-17(21-2)18(22-3)10-16(13)19-11-14/h4-11H,1-3H3 D0G0KN DRUGINKE UNALZVYBWFUPTL-UHFFFAOYSA-N D0G0KN DRUGSMIL COC1=CC=C(C=C1)C2=CN=C3C=C(C(=CC3=C2)OC)OC D0G0KN HIGHSTAT Investigative D0G0KQ DRUG__ID D0G0KQ D0G0KQ DRUGTYPE Small molecular drug D0G0KQ DRUGINCH 1S/C23H16N2O2/c26-23(21-13-15-6-4-5-9-19(15)24-21)22-14-16-12-18(10-11-20(16)25-22)27-17-7-2-1-3-8-17/h1-14,24-25H D0G0KQ DRUGINKE XSKBJPGCRXDUEV-UHFFFAOYSA-N D0G0KQ DRUGSMIL C1=CC=C(C=C1)OC2=CC3=C(C=C2)NC(=C3)C(=O)C4=CC5=CC=CC=C5N4 D0G0KQ HIGHSTAT Investigative D0G0MZ DRUG__ID D0G0MZ D0G0MZ DRUGTYPE Small molecular drug D0G0MZ DRUGINCH 1S/C27H24N2O9/c30-26(38-21-5-3-20(4-6-21)29(32)33)28-11-9-17(10-12-28)27(31,18-1-7-22-24(13-18)36-15-34-22)19-2-8-23-25(14-19)37-16-35-23/h1-8,13-14,17,31H,9-12,15-16H2 D0G0MZ DRUGINKE SEGYOKHGGFKMCX-UHFFFAOYSA-N D0G0MZ DRUGSMIL C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)(C4=CC5=C(C=C4)OCO5)O)C(=O)OC6=CC=C(C=C6)[N+](=O)[O-] D0G0MZ HIGHSTAT Investigative D0G0NB DRUG__ID D0G0NB D0G0NB DRUGTYPE Small molecular drug D0G0NB DRUGINCH 1S/C11H16N2/c1-8(12)6-9-2-3-11-10(7-9)4-5-13-11/h2-3,7-8,13H,4-6,12H2,1H3 D0G0NB DRUGINKE YAVKNEHUAXPRSK-UHFFFAOYSA-N D0G0NB DRUGSMIL CC(CC1=CC2=C(C=C1)NCC2)N D0G0NB HIGHSTAT Investigative D0G0OF DRUG__ID D0G0OF D0G0OF DRUGTYPE Small molecular drug D0G0OF DRUGINCH 1S/C15H20N2O3/c18-15(17-19)5-3-1-2-4-10-20-13-6-7-14-12(11-13)8-9-16-14/h6-9,11,16,19H,1-5,10H2,(H,17,18) D0G0OF DRUGINKE YJOHRQFBXILUHS-UHFFFAOYSA-N D0G0OF DRUGSMIL C1=CC2=C(C=CN2)C=C1OCCCCCCC(=O)NO D0G0OF HIGHSTAT Investigative D0G0OP DRUG__ID D0G0OP D0G0OP DRUGTYPE Small molecular drug D0G0OP DRUGINCH 1S/C10H13ClN2O3/c1-7(10(14)12-15)13-16-6-8-2-4-9(11)5-3-8/h2-5,7,13,15H,6H2,1H3,(H,12,14) D0G0OP DRUGINKE JNDVWCINXNIDOF-UHFFFAOYSA-N D0G0OP DRUGSMIL CC(C(=O)NO)NOCC1=CC=C(C=C1)Cl D0G0OP HIGHSTAT Investigative D0G0OV DRUG__ID D0G0OV D0G0OV DRUGTYPE Small molecular drug D0G0OV DRUGINCH 1S/C17H15N/c1-2-6-14(7-3-1)10-12-16-13-11-15-8-4-5-9-17(15)18-16/h1-3,6-7,11,13H,4-5,8-9H2 D0G0OV DRUGINKE WGJNWKPVRLKAIF-UHFFFAOYSA-N D0G0OV DRUGSMIL C1CCC2=C(C1)C=CC(=N2)C#CC3=CC=CC=C3 D0G0OV HIGHSTAT Investigative D0G0TP DRUG__ID D0G0TP D0G0TP DRUGTYPE Small molecular drug D0G0TP DRUGINCH 1S/C14H19N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-4,7H2,1-2H3,(H2,15,16,17)/t10-,11+/m0/s1 D0G0TP DRUGINKE GXOXTRCBYSFJKS-WDEREUQCSA-N D0G0TP DRUGSMIL CCCC#CCC(C(C)O)N1C=NC2=C(N=CN=C21)N D0G0TP HIGHSTAT Investigative D0G0WC DRUG__ID D0G0WC D0G0WC DRUGTYPE Small molecular drug D0G0WC DRUGINCH 1S/C15H11BrN2/c1-10-5-6-11-7-8-14(18-15(11)17-10)12-3-2-4-13(16)9-12/h2-9H,1H3 D0G0WC DRUGINKE YAOUIVOXDAAEBA-UHFFFAOYSA-N D0G0WC DRUGSMIL CC1=NC2=C(C=C1)C=CC(=N2)C3=CC(=CC=C3)Br D0G0WC HIGHSTAT Investigative D0G0XB DRUG__ID D0G0XB D0G0XB DRUGTYPE Small molecular drug D0G0XB DRUGINCH 1S/C15H7F6N/c16-14(17,18)12-4-2-1-3-11(12)9-5-6-10(8-22)13(7-9)15(19,20)21/h1-7H D0G0XB DRUGINKE LVFYAAITUNIVMI-UHFFFAOYSA-N D0G0XB DRUGSMIL C1=CC=C(C(=C1)C2=CC(=C(C=C2)C#N)C(F)(F)F)C(F)(F)F D0G0XB HIGHSTAT Investigative D0G0ZI DRUG__ID D0G0ZI D0G0ZI DRUGTYPE Small molecular drug D0G0ZI DRUGINCH 1S/C7H7BO2/c9-8-7-4-2-1-3-6(7)5-10-8/h1-4,9H,5H2 D0G0ZI DRUGINKE XOQABDOICLHPIS-UHFFFAOYSA-N D0G0ZI DRUGSMIL B1(C2=CC=CC=C2CO1)O D0G0ZI HIGHSTAT Investigative D0G0ZQ DRUG__ID D0G0ZQ D0G0ZQ DRUGTYPE Small molecular drug D0G0ZQ DRUGINCH 1S/C15H13NO2S/c1-17-13-7-10-6-11(15-4-3-5-19-15)9-16-12(10)8-14(13)18-2/h3-9H,1-2H3 D0G0ZQ DRUGINKE DWCZKFGISHBMCE-UHFFFAOYSA-N D0G0ZQ DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=CS3 D0G0ZQ HIGHSTAT Investigative D0G1AF DRUG__ID D0G1AF D0G1AF DRUGTYPE Small molecular drug D0G1AF DRUGINCH 1S/C35H41N3O7S/c1-20-14-24(39)15-21(2)31(20)45-18-28(41)36-26(16-22-10-6-5-7-11-22)30(42)34(44)38-19-46-35(3,4)32(38)33(43)37-29-25-13-9-8-12-23(25)17-27(29)40/h5-15,26-27,29-30,32,39-40,42H,16-19H2,1-4H3,(H,36,41)(H,37,43)/t26-,27+,29-,30-,32+/m0/s1 D0G1AF DRUGINKE RFANRLZGSPNNFF-RIQJEONASA-N D0G1AF DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)O D0G1AF HIGHSTAT Investigative D0G1CK DRUG__ID D0G1CK D0G1CK DRUGTYPE Small molecular drug D0G1CK DRUGINCH 1S/C33H39N3O5/c1-33(18-25-19-34-28-10-6-5-9-27(25)28,31(39)35-26(17-29(37)38)16-20-7-3-2-4-8-20)36-32(40)41-30-23-12-21-11-22(14-23)15-24(30)13-21/h2-10,19,21-24,26,30,34H,11-18H2,1H3,(H,35,39)(H,36,40)(H,37,38)/t21?,22?,23?,24?,26-,30?,33-/m1/s1 D0G1CK DRUGINKE PGOLWKTUHWHYJS-HMYZUHDZSA-N D0G1CK DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0G1CK HIGHSTAT Investigative D0G1DN DRUG__ID D0G1DN D0G1DN DRUGTYPE Small molecular drug D0G1DN DRUGINCH 1S/C16H12OS/c17-14-8-4-7-13(11-14)16-10-9-15(18-16)12-5-2-1-3-6-12/h1-11,17H D0G1DN DRUGINKE DVGFXRZFDOGHJL-UHFFFAOYSA-N D0G1DN DRUGSMIL C1=CC=C(C=C1)C2=CC=C(S2)C3=CC(=CC=C3)O D0G1DN HIGHSTAT Investigative D0G1DS DRUG__ID D0G1DS D0G1DS DRUGTYPE Small molecular drug D0G1DS DRUGINCH 1S/C4H5ClN4O2.ClH/c5-1-2(9-6)7-4(11)8-3(1)10;/h6H2,(H3,7,8,9,10,11);1H D0G1DS DRUGINKE CEUAYFMFBGNGQD-UHFFFAOYSA-N D0G1DS DRUGSMIL C1(=C(NC(=O)NC1=O)NN)Cl.Cl D0G1DS HIGHSTAT Investigative D0G1DW DRUG__ID D0G1DW D0G1DW DRUGTYPE Small molecular drug D0G1DW DRUGINCH 1S/C13H11F3N2O2S/c14-13(15,16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)18-21(17,19)20/h1-8,18H,(H2,17,19,20) D0G1DW DRUGINKE WELQTBDQZUFHMC-UHFFFAOYSA-N D0G1DW DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)NS(=O)(=O)N)C(F)(F)F D0G1DW HIGHSTAT Investigative D0G1EX DRUG__ID D0G1EX D0G1EX DRUGTYPE Small molecular drug D0G1EX DRUGINCH 1S/C29H37N5O4S2/c1-29(2)28(38)32-24(20-12-5-3-6-13-20)27(37)34-18-11-15-22(34)26(36)31-21(25(35)33-29)14-7-4-10-19-39-40-23-16-8-9-17-30-23/h3,5-6,8-9,12-13,16-17,21-22,24H,4,7,10-11,14-15,18-19H2,1-2H3,(H,31,36)(H,32,38)(H,33,35)/t21-,22+,24-/m0/s1 D0G1EX DRUGINKE MAESVPGWPSVAHM-ZDXQCDESSA-N D0G1EX DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)C4=CC=CC=C4)C D0G1EX HIGHSTAT Investigative D0G1IF DRUG__ID D0G1IF D0G1IF DRUGTYPE Small molecular drug D0G1IF DRUGINCH 1S/C38H42N4O6/c1-3-15-41-17-13-35-29-21-5-7-25(43)31(29)47-33(35)23(9-11-37(35,45)27(41)19-21)39-40-24-10-12-38(46)28-20-22-6-8-26(44)32-30(22)36(38,34(24)48-32)14-18-42(28)16-4-2/h3-8,27-28,33-34,43-46H,1-2,9-20H2/b39-23+,40-24+/t27-,28-,33+,34+,35+,36+,37-,38-/m1/s1 D0G1IF DRUGINKE AJPSBXJNFJCCBI-YOHUGVJRSA-N D0G1IF DRUGSMIL C=CCN1CCC23C4C(=NN=C5CCC6(C7CC8=C9C6(C5OC9=C(C=C8)O)CCN7CC=C)O)CCC2(C1CC1=C3C(=C(C=C1)O)O4)O D0G1IF HIGHSTAT Investigative D0G1JJ DRUG__ID D0G1JJ D0G1JJ DRUGTYPE Small molecular drug D0G1JJ DRUGINCH 1S/C17H26N2O2/c20-15-14(3-1-2-4-18-15)19-16(21)17-8-11-5-12(9-17)7-13(6-11)10-17/h11-14H,1-10H2,(H,18,20)(H,19,21)/t11?,12?,13?,14-,17?/m0/s1 D0G1JJ DRUGINKE FRJOFURBYVCNEN-ZZTKBFGJSA-N D0G1JJ DRUGSMIL C1CCNC(=O)C(C1)NC(=O)C23CC4CC(C2)CC(C4)C3 D0G1JJ HIGHSTAT Investigative D0G1LN DRUG__ID D0G1LN D0G1LN DRUGTYPE Small molecular drug D0G1LN DRUGINCH 1S/C17H21NO/c1-9-6-10(2)14(11(3)7-9)16-15-12-4-5-13(8-12)17(15)19-18-16/h6-7,12-13,15,17H,4-5,8H2,1-3H3 D0G1LN DRUGINKE WKLZNTYMDOPBSE-UHFFFAOYSA-N D0G1LN DRUGSMIL CC1=CC(=C(C(=C1)C)C2=NOC3C2C4CCC3C4)C D0G1LN HIGHSTAT Investigative D0G1OW DRUG__ID D0G1OW D0G1OW DRUGTYPE Small molecular drug D0G1OW DRUGINCH 1S/C27H30O16/c1-8-17(33)20(36)22(38)26(39-8)43-25-21(37)18(34)15(7-28)41-27(25)42-24-19(35)16-13(32)5-10(29)6-14(16)40-23(24)9-2-3-11(30)12(31)4-9/h2-6,8,15,17-18,20-22,25-34,36-38H,7H2,1H3/t8-,15+,17-,18-,20+,21-,22+,25+,26-,27-/m0/s1 D0G1OW DRUGINKE FYBMGZSDYDNBFX-KLUVJTJFSA-N D0G1OW DRUGSMIL CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)CO)O)O)O)O)O D0G1OW HIGHSTAT Investigative D0G1UE DRUG__ID D0G1UE D0G1UE DRUGTYPE Small molecular drug D0G1UE DRUGINCH 1S/C7H10N2O4/c1-3-4(6(10)9-13-3)2-5(8)7(11)12/h5H,2,8H2,1H3,(H,9,10)(H,11,12) D0G1UE DRUGINKE UUDAMDVQRQNNHZ-UHFFFAOYSA-N D0G1UE DRUGSMIL CC1=C(C(=O)NO1)CC(C(=O)O)N D0G1UE HIGHSTAT Investigative D0G1XC DRUG__ID D0G1XC D0G1XC DRUGTYPE Small molecular drug D0G1XC DRUGINCH 1S/C33H31N3O9S/c1-13-19(37)11-18-23(26(13)38)30(42)25-24(27(18)39)29(41)22-17(31(25)45-2)9-8-14-10-15(21(32(43)44)28(40)20(14)22)12-34-36-33(46)35-16-6-4-3-5-7-16/h10-12,16,37-38,40-41H,3-9H2,1-2H3,(H,43,44)(H2,35,36,46)/b34-12+ D0G1XC DRUGINKE FVWBMJCLBWIYFZ-PONZDJLKSA-N D0G1XC DRUGSMIL CC1=C(C=C2C(=C1O)C(=O)C3=C(C4=C(C5=C(C(=C(C=C5CC4)C=NNC(=S)NC6CCCCC6)C(=O)O)O)C(=C3C2=O)O)OC)O D0G1XC HIGHSTAT Investigative D0G1XL DRUG__ID D0G1XL D0G1XL DRUGTYPE Small molecular drug D0G1XL DRUGINCH 1S/C37H54N6O10/c1-21(2)16-27(35(50)43-31(22(3)44)36(51)52)41-34(49)28(18-23-10-8-7-9-11-23)40-30(46)19-39-33(48)29(20-53-37(4,5)6)42-32(47)26(38)17-24-12-14-25(45)15-13-24/h7-15,21-22,26-29,31,44-45H,16-20,38H2,1-6H3,(H,39,48)(H,40,46)(H,41,49)(H,42,47)(H,43,50)(H,51,52)/t22-,26+,27+,28+,29-,31+/m1/s1 D0G1XL DRUGINKE DOMQMNWQZKXZCU-GUVNKXFDSA-N D0G1XL DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)N D0G1XL HIGHSTAT Investigative D0G1XP DRUG__ID D0G1XP D0G1XP DRUGTYPE Small molecular drug D0G1XP DRUGINCH 1S/C15H21Cl2NO/c1-5-6-13(18-15(2,3)4)14(19)10-7-8-11(16)12(17)9-10/h7-9,13,18H,5-6H2,1-4H3 D0G1XP DRUGINKE VBQDZZHUUPHQGQ-UHFFFAOYSA-N D0G1XP DRUGSMIL CCCC(C(=O)C1=CC(=C(C=C1)Cl)Cl)NC(C)(C)C D0G1XP HIGHSTAT Investigative D0G2AK DRUG__ID D0G2AK D0G2AK DRUGTYPE Small molecular drug D0G2AK DRUGINCH 1S/C23H19N3O2/c1-28-22-20(23(27)26-25-17-12-6-3-7-13-17)18-14-8-9-15-19(18)24-21(22)16-10-4-2-5-11-16/h2-15,25H,1H3,(H,26,27) D0G2AK DRUGINKE WQHSKTAHWLQAGK-UHFFFAOYSA-N D0G2AK DRUGSMIL COC1=C(C2=CC=CC=C2N=C1C3=CC=CC=C3)C(=O)NNC4=CC=CC=C4 D0G2AK HIGHSTAT Investigative D0G2BN DRUG__ID D0G2BN D0G2BN DRUGTYPE Small molecular drug D0G2BN DRUGINCH 1S/C31H35N5O5/c32-24(18-21-13-15-23(37)16-14-21)31(41)36-17-7-12-26(36)29(39)35-27(22-10-5-2-6-11-22)30(40)34-25(28(33)38)19-20-8-3-1-4-9-20/h1-6,8-11,13-16,24-27,37H,7,12,17-19,32H2,(H2,33,38)(H,34,40)(H,35,39)/t24-,25-,26-,27-/m0/s1 D0G2BN DRUGINKE CLTFAZZUUWSIAO-FWEHEUNISA-N D0G2BN DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(C3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)N D0G2BN HIGHSTAT Investigative D0G2BS DRUG__ID D0G2BS D0G2BS DRUGTYPE Small molecular drug D0G2BS DRUGINCH 1S/C14H17N3/c1-16-8-10-17(11-9-16)14-7-6-12-4-2-3-5-13(12)15-14/h2-7H,8-11H2,1H3 D0G2BS DRUGINKE HOMWNUXPSJQSSU-UHFFFAOYSA-N D0G2BS DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3C=C2 D0G2BS HIGHSTAT Investigative D0G2CP DRUG__ID D0G2CP D0G2CP DRUGTYPE Small molecular drug D0G2CP DRUGINCH 1S/C18H19ClN4/c19-16-4-6-17(7-5-16)22-11-9-21(10-12-22)14-15-13-20-23-8-2-1-3-18(15)23/h1-8,13H,9-12,14H2 D0G2CP DRUGINKE XVPRVMIFXXOEFR-UHFFFAOYSA-N D0G2CP DRUGSMIL C1CN(CCN1CC2=C3C=CC=CN3N=C2)C4=CC=C(C=C4)Cl D0G2CP HIGHSTAT Investigative D0G2CT DRUG__ID D0G2CT D0G2CT DRUGTYPE Small molecular drug D0G2CT DRUGINCH 1S/C16H10N2O5S/c19-15-9-3-1-2-4-11(9)17-14(15)13-10-7-8(24(21,22)23)5-6-12(10)18-16(13)20/h1-7,18,20H,(H,21,22,23) D0G2CT DRUGINKE BYYOTMYLPPUWCF-UHFFFAOYSA-N D0G2CT DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=N2)C3=C(NC4=C3C=C(C=C4)S(=O)(=O)O)O D0G2CT HIGHSTAT Investigative D0G2CY DRUG__ID D0G2CY D0G2CY DRUGTYPE Small molecular drug D0G2CY DRUGINCH 1S/C6H9NO/c1-2-3-5-4-7-6(5)8/h2,5H,1,3-4H2,(H,7,8) D0G2CY DRUGINKE XWLCLNCCEDQVSS-UHFFFAOYSA-N D0G2CY DRUGSMIL C=CCC1CNC1=O D0G2CY HIGHSTAT Investigative D0G2DQ DRUG__ID D0G2DQ D0G2DQ DRUGTYPE Small molecular drug D0G2DQ DRUGINCH 1S/C8H4N2O4/c11-7-5-3-4(10(13)14)1-2-6(5)9-8(7)12/h1-3H,(H,9,11,12) D0G2DQ DRUGINKE UNMYHYODJHKLOC-UHFFFAOYSA-N D0G2DQ DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C(=O)C(=O)N2 D0G2DQ HIGHSTAT Investigative D0G2EF DRUG__ID D0G2EF D0G2EF DRUGTYPE Small molecular drug D0G2EF DRUGINCH 1S/C11H9BrN2/c12-9-3-1-2-8-7-4-5-13-6-10(7)14-11(8)9/h1-3,6,14H,4-5H2 D0G2EF DRUGINKE BHLUQLWTEJKCOP-UHFFFAOYSA-N D0G2EF DRUGSMIL C1CN=CC2=C1C3=C(N2)C(=CC=C3)Br D0G2EF HIGHSTAT Investigative D0G2EQ DRUG__ID D0G2EQ D0G2EQ DRUGTYPE Small molecular drug D0G2EQ DRUGINCH 1S/C23H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)24-21-20-22(21)25/h6-7,9-10,12-13,15-16,21-22,25H,2-5,8,11,14,17-20H2,1H3,(H,24,26)/b7-6-,10-9-,13-12-,16-15-/t21-,22-/m0/s1 D0G2EQ DRUGINKE LZHCSJBKBARIFQ-NILUWUTCSA-N D0G2EQ DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1CC1O D0G2EQ HIGHSTAT Investigative D0G2GA DRUG__ID D0G2GA D0G2GA DRUGTYPE Small molecular drug D0G2GA DRUGINCH 1S/C19H26ClN7O/c1-10(2)15(8-28)24-19-25-17(23-14-6-12(20)5-13(21)7-14)16-18(26-19)27(9-22-16)11(3)4/h5-7,9-11,15,28H,8,21H2,1-4H3,(H2,23,24,25,26)/t15-/m0/s1 D0G2GA DRUGINKE RAMROQQYRRQPDL-HNNXBMFYSA-N D0G2GA DRUGSMIL CC(C)C(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NC3=CC(=CC(=C3)N)Cl D0G2GA HIGHSTAT Investigative D0G2HT DRUG__ID D0G2HT D0G2HT DRUGTYPE Small molecular drug D0G2HT DRUGINCH 1S/C19H23NO2S/c1-23(21,22)19-9-5-8-18(14-19)17-10-12-20(13-11-17)15-16-6-3-2-4-7-16/h2-9,14,17H,10-13,15H2,1H3 D0G2HT DRUGINKE KOPPWFMKOOMORI-UHFFFAOYSA-N D0G2HT DRUGSMIL CS(=O)(=O)C1=CC=CC(=C1)C2CCN(CC2)CC3=CC=CC=C3 D0G2HT HIGHSTAT Investigative D0G2JG DRUG__ID D0G2JG D0G2JG DRUGTYPE Small molecular drug D0G2JG DRUGINCH 1S/C16H23FN4O2/c1-2-9-21-15(22)12-14(20(16(21)23)10-5-8-17)19-13(18-12)11-6-3-4-7-11/h11H,2-10H2,1H3,(H,18,19)/i17-1 D0G2JG DRUGINKE GGGMDKJPUXTDAW-SJPDSGJFSA-N D0G2JG DRUGSMIL CCCN1C(=O)C2=C(N=C(N2)C3CCCC3)N(C1=O)CCCF D0G2JG HIGHSTAT Investigative D0G2JV DRUG__ID D0G2JV D0G2JV DRUGTYPE Small molecular drug D0G2JV DRUGINCH 1S/C17H19NO3/c1-19-15-10-13(17(21-3)16(11-15)20-2)7-4-12-5-8-14(18)9-6-12/h4-11H,18H2,1-3H3/b7-4+ D0G2JV DRUGINKE SRZFJBWGNUYOJJ-QPJJXVBHSA-N D0G2JV DRUGSMIL COC1=CC(=C(C(=C1)OC)OC)C=CC2=CC=C(C=C2)N D0G2JV HIGHSTAT Investigative D0G2LF DRUG__ID D0G2LF D0G2LF DRUGTYPE Small molecular drug D0G2LF DRUGINCH 1S/C16H16/c1-3-9-15(10-4-1)13-7-8-14-16-11-5-2-6-12-16/h1-7,9-13H,8,14H2/b13-7+ D0G2LF DRUGINKE NJJOGKAVAWZLAU-NTUHNPAUSA-N D0G2LF DRUGSMIL C1=CC=C(C=C1)CCC=CC2=CC=CC=C2 D0G2LF HIGHSTAT Investigative D0G2LQ DRUG__ID D0G2LQ D0G2LQ DRUGTYPE Small molecular drug D0G2LQ DRUGINCH 1S/C11H9ClN2O2/c12-8-3-1-7(2-4-8)5-9-6-10(11(15)16)14-13-9/h1-4,6H,5H2,(H,13,14)(H,15,16) D0G2LQ DRUGINKE YKKXGQMJMUSFFP-UHFFFAOYSA-N D0G2LQ DRUGSMIL C1=CC(=CC=C1CC2=CC(=NN2)C(=O)O)Cl D0G2LQ HIGHSTAT Investigative D0G2MM DRUG__ID D0G2MM D0G2MM DRUGTYPE Small molecular drug D0G2MM DRUGINCH 1S/C6H13N/c7-6-4-2-1-3-5-6/h6H,1-5,7H2/p+1 D0G2MM DRUGINKE PAFZNILMFXTMIY-UHFFFAOYSA-O D0G2MM DRUGSMIL C1CCC(CC1)[NH3+] D0G2MM HIGHSTAT Investigative D0G2MU DRUG__ID D0G2MU D0G2MU DRUGTYPE Small molecular drug D0G2MU DRUGINCH 1S/C14H10O/c15-14-9-10-5-1-2-6-11(10)12-7-3-4-8-13(12)14/h1-9,15H D0G2MU DRUGINKE DZKIUEHLEXLYKM-UHFFFAOYSA-N D0G2MU DRUGSMIL C1=CC=C2C(=C1)C=C(C3=CC=CC=C23)O D0G2MU HIGHSTAT Investigative D0G2NF DRUG__ID D0G2NF D0G2NF DRUGTYPE Small molecular drug D0G2NF DRUGINCH 1S/C10H19N3O2/c1-2-7(11)10(15)13-6-4-3-5-8(13)9(12)14/h7-8H,2-6,11H2,1H3,(H2,12,14)/t7-,8+/m0/s1 D0G2NF DRUGINKE CRFULCBPWYMTAL-JGVFFNPUSA-N D0G2NF DRUGSMIL CCC(C(=O)N1CCCCC1C(=O)N)N D0G2NF HIGHSTAT Investigative D0G2OJ DRUG__ID D0G2OJ D0G2OJ DRUGTYPE Small molecular drug D0G2OJ DRUGINCH 1S/C20H24O11/c1-5-12(24)28-11-8(22)18-10-6(21)7(16(2,3)4)17(18)9(23)13(25)30-15(17)31-20(18,14(26)29-10)19(5,11)27/h5-11,15,21-23,27H,1-4H3/t5-,6-,7+,8-,9+,10-,11+,15+,17+,18-,19-,20-/m1/s1 D0G2OJ DRUGINKE AMOGMTLMADGEOQ-PYLUGNSCSA-N D0G2OJ DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)O)O D0G2OJ HIGHSTAT Investigative D0G2QG DRUG__ID D0G2QG D0G2QG DRUGTYPE Small molecular drug D0G2QG DRUGINCH 1S/C16H23NO3/c1-3-4-10-15(12-18)17-16(19)20-13(2)11-14-8-6-5-7-9-14/h5-9,12-13,15H,3-4,10-11H2,1-2H3,(H,17,19)/t13-,15-/m0/s1 D0G2QG DRUGINKE WNKGMQLRHKONID-ZFWWWQNUSA-N D0G2QG DRUGSMIL CCCCC(C=O)NC(=O)OC(C)CC1=CC=CC=C1 D0G2QG HIGHSTAT Investigative D0G2QW DRUG__ID D0G2QW D0G2QW DRUGTYPE Small molecular drug D0G2QW DRUGINCH 1S/C25H23ClFNO3/c1-14(2)25-20(9-8-19-12-18(29)13-23(30)31-19)24(15-3-6-17(27)7-4-15)21-11-16(26)5-10-22(21)28-25/h3-11,14,18-19,29H,12-13H2,1-2H3/b9-8+/t18-,19-/m1/s1 D0G2QW DRUGINKE FRJJJAKBRKABFA-TYFAACHXSA-N D0G2QW DRUGSMIL CC(C)C1=NC2=C(C=C(C=C2)Cl)C(=C1C=CC3CC(CC(=O)O3)O)C4=CC=C(C=C4)F D0G2QW HIGHSTAT Investigative D0G2RB DRUG__ID D0G2RB D0G2RB DRUGTYPE Small molecular drug D0G2RB DRUGINCH 1S/C44H52N4O14/c1-25(2)41(55)33(61-32(50)29-17-12-20-45-29)42(56)37(4)24-40(54)38(41,5)44(42,57)43(62-40)31(26(3)18-19-39(37,43)53)60-30(49)21-46-34(47-35(51)58-22-27-13-8-6-9-14-27)48-36(52)59-23-28-15-10-7-11-16-28/h6-17,20,25-26,31,33,45,53-57H,18-19,21-24H2,1-5H3,(H2,46,47,48,51,52)/t26?,31-,33-,37+,38?,39?,40?,41?,42?,43?,44?/m1/s1 D0G2RB DRUGINKE NQGUDUOLYOZNBB-UTTPSZOSSA-N D0G2RB DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CN=C(NC(=O)OCC6=CC=CC=C6)NC(=O)OCC7=CC=CC=C7)O4)O)O)OC(=O)C8=CC=CN8)(C(C)C)O)C)O)C)O D0G2RB HIGHSTAT Investigative D0G2RY DRUG__ID D0G2RY D0G2RY DRUGTYPE Small molecular drug D0G2RY DRUGINCH 1S/C13H14N4O/c14-13-16-11(7-12(18)17-13)15-10-5-4-8-2-1-3-9(8)6-10/h4-7H,1-3H2,(H4,14,15,16,17,18) D0G2RY DRUGINKE YUPQFUXJUXRXOG-UHFFFAOYSA-N D0G2RY DRUGSMIL C1CC2=C(C1)C=C(C=C2)NC3=CC(=O)NC(=N3)N D0G2RY HIGHSTAT Investigative D0G2UY DRUG__ID D0G2UY D0G2UY DRUGCOMP Institute For Hepatitis & Virus Research D0G2UY DRUGINCH 1S/C16H12Cl2FN5/c17-10-6-4-9(5-7-10)13-8-14(24-16(20-13)21-22-23-24)15-11(18)2-1-3-12(15)19/h1-7,13-14H,8H2,(H,20,21,23) D0G2UY DRUGINKE BRBZPYDLUUWBCD-UHFFFAOYSA-N D0G2UY DRUGSMIL C1C(NC2=NN=NN2C1C3=C(C=CC=C3Cl)F)C4=CC=C(C=C4)Cl D0G2UY HIGHSTAT Investigative D0G2VC DRUG__ID D0G2VC D0G2VC DRUGTYPE Small molecular drug D0G2VC DRUGINCH 1S/C32H31N3O5/c1-3-4-5-10-15-39-30(37)32(38)16-23-34-21-13-8-6-11-18(21)25-26-20(17-33-29(26)36)24-19-12-7-9-14-22(19)35(28(24)27(25)34)31(32,2)40-23/h6-9,11-14,23,38H,3-5,10,15-17H2,1-2H3,(H,33,36)/t23-,31+,32+/m0/s1 D0G2VC DRUGINKE ZHEHVZXPFVXKEY-RUAOOFDTSA-N D0G2VC DRUGSMIL CCCCCCOC(=O)C1(CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)C1(O2)C)CNC6=O)O D0G2VC HIGHSTAT Investigative D0G2XI DRUG__ID D0G2XI D0G2XI DRUGTYPE Small molecular drug D0G2XI DRUGINCH 1S/C15H13N3O/c19-15-8-6-14(7-9-15)18-11-13(16-17-18)10-12-4-2-1-3-5-12/h1-9,11,19H,10H2 D0G2XI DRUGINKE ZSQDQVRTOOCIEW-UHFFFAOYSA-N D0G2XI DRUGSMIL C1=CC=C(C=C1)CC2=CN(N=N2)C3=CC=C(C=C3)O D0G2XI HIGHSTAT Investigative D0G2YV DRUG__ID D0G2YV D0G2YV DRUGTYPE Small molecular drug D0G2YV DRUGINCH 1S/C21H25NO4.ClH/c1-22(11-12-2-3-12)16-10-13-4-5-14(23)18-17(13)20-8-9-25-21(16,20)7-6-15(24)19(20)26-18;/h4-5,12,16,19,23H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-;/m1./s1 D0G2YV DRUGINKE BJCCGWJRMXDEPD-OPHZJPRHSA-N D0G2YV DRUGSMIL CN(CC1CC1)C2CC3=C4C(=C(C=C3)O)OC5C46C2(CCC5=O)OCC6.Cl D0G2YV HIGHSTAT Investigative D0G3BI DRUG__ID D0G3BI D0G3BI DRUGTYPE Small molecular drug D0G3BI DRUGINCH 1S/C11H8O4/c1-6-2-3-9-7(4-6)5-8(10(12)13)11(14)15-9/h2-5H,1H3,(H,12,13) D0G3BI DRUGINKE FJICLQQBBFWGMZ-UHFFFAOYSA-N D0G3BI DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C(=C2)C(=O)O D0G3BI HIGHSTAT Investigative D0G3BJ DRUG__ID D0G3BJ D0G3BJ DRUGTYPE Small molecular drug D0G3BJ DRUGINCH 1S/C27H32O6/c1-14-12-26-15(2)10-19-20(25(19,3)4)18(22(26)30)11-17(13-28)21(29)27(26,32)23(14)33-24(31)16-8-6-5-7-9-16/h5-9,11-12,15,18-21,23,28-29,32H,10,13H2,1-4H3/t15-,18+,19-,20+,21-,23+,26?,27+/m1/s1 D0G3BJ DRUGINKE VYLJAGRINUHTSF-KTOZFIMGSA-N D0G3BJ DRUGSMIL CC1CC2C(C2(C)C)C3C=C(C(C4(C1(C3=O)C=C(C4OC(=O)C5=CC=CC=C5)C)O)O)CO D0G3BJ HIGHSTAT Investigative D0G3BY DRUG__ID D0G3BY D0G3BY DRUGTYPE Small molecular drug D0G3BY DRUGINCH 1S/C17H14N4O/c1-21(14-5-3-2-4-6-14)17(22)20-13-7-8-15-12(10-18)11-19-16(15)9-13/h2-9,11,19H,1H3,(H,20,22) D0G3BY DRUGINKE QBNNBKXETLRTHU-UHFFFAOYSA-N D0G3BY DRUGSMIL CN(C1=CC=CC=C1)C(=O)NC2=CC3=C(C=C2)C(=CN3)C#N D0G3BY HIGHSTAT Investigative D0G3CQ DRUG__ID D0G3CQ D0G3CQ DRUGTYPE Small molecular drug D0G3CQ DRUGINCH 1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1 D0G3CQ DRUGINKE LIEMBEWXEZJEEZ-INEUFUBQSA-N D0G3CQ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CC(C(C(=O)O)O)O)N D0G3CQ HIGHSTAT Investigative D0G3GE DRUG__ID D0G3GE D0G3GE DRUGTYPE Small molecular drug D0G3GE DRUGINCH 1S/C34H41Cl2N11O5/c1-18(48)44-29(14-21-16-40-17-43-21)33(52)47-28(12-19-8-9-23(35)24(36)11-19)32(51)45-26(7-4-10-41-34(38)39)31(50)46-27(30(37)49)13-20-15-42-25-6-3-2-5-22(20)25/h2-3,5-6,8-9,11,15-17,26-29,42H,4,7,10,12-14H2,1H3,(H2,37,49)(H,40,43)(H,44,48)(H,45,51)(H,46,50)(H,47,52)(H4,38,39,41)/t26-,27-,28+,29-/m0/s1 D0G3GE DRUGINKE ULVZZVUTBBXNBL-FKWFRFQNSA-N D0G3GE DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC(=C(C=C2)Cl)Cl)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)N D0G3GE HIGHSTAT Investigative D0G3IT DRUG__ID D0G3IT D0G3IT DRUGTYPE Small molecular drug D0G3IT DRUGINCH 1S/C14H12F3N3OS/c1-13(2)11(21)20(12(22)19(13)3)9-5-4-8(7-18)10(6-9)14(15,16)17/h4-6H,1-3H3 D0G3IT DRUGINKE HLBUAKQNKJTEIU-UHFFFAOYSA-N D0G3IT DRUGSMIL CC1(C(=O)N(C(=S)N1C)C2=CC(=C(C=C2)C#N)C(F)(F)F)C D0G3IT HIGHSTAT Investigative D0G3MD DRUG__ID D0G3MD D0G3MD DRUGTYPE Small molecular drug D0G3MD DRUGINCH 1S/C15H17N3O2/c19-15(20)11-17-7-9-18(10-8-17)14-6-5-12-3-1-2-4-13(12)16-14/h1-6H,7-11H2,(H,19,20) D0G3MD DRUGINKE HCRXUFYSLPXCDW-UHFFFAOYSA-N D0G3MD DRUGSMIL C1CN(CCN1CC(=O)O)C2=NC3=CC=CC=C3C=C2 D0G3MD HIGHSTAT Investigative D0G3OY DRUG__ID D0G3OY D0G3OY DRUGTYPE Small molecular drug D0G3OY DRUGINCH 1S/C21H25N3/c1-22-15-14-19-16-23-21(24-19)13-12-20(17-8-4-2-5-9-17)18-10-6-3-7-11-18/h2-11,16,20,22H,12-15H2,1H3,(H,23,24) D0G3OY DRUGINKE YMVWDVNGNLXSKR-UHFFFAOYSA-N D0G3OY DRUGSMIL CNCCC1=CN=C(N1)CCC(C2=CC=CC=C2)C3=CC=CC=C3 D0G3OY HIGHSTAT Investigative D0G3RD DRUG__ID D0G3RD D0G3RD DRUGTYPE Small molecular drug D0G3RD DRUGINCH 1S/C14H16N2/c1-14(2,13-6-4-8-16-11-13)9-12-5-3-7-15-10-12/h3-8,10-11H,9H2,1-2H3 D0G3RD DRUGINKE PKJNPGGSGKBGGS-UHFFFAOYSA-N D0G3RD DRUGSMIL CC(C)(CC1=CN=CC=C1)C2=CN=CC=C2 D0G3RD HIGHSTAT Investigative D0G3RN DRUG__ID D0G3RN D0G3RN DRUGTYPE Small molecular drug D0G3RN DRUGINCH 1S/C13H14Cl2N4O/c1-18-2-4-19(5-3-18)12-13(20)17-11-7-9(15)8(14)6-10(11)16-12/h6-7H,2-5H2,1H3,(H,17,20) D0G3RN DRUGINKE MFJVHWQDKIEBCM-UHFFFAOYSA-N D0G3RN DRUGSMIL CN1CCN(CC1)C2=NC3=CC(=C(C=C3NC2=O)Cl)Cl D0G3RN HIGHSTAT Investigative D0G3RZ DRUG__ID D0G3RZ D0G3RZ DRUGTYPE Small molecular drug D0G3RZ DRUGINCH 1S/C10H15N7/c1-16-2-4-17(5-3-16)9-7-8(13-6-12-7)14-10(11)15-9/h6H,2-5H2,1H3,(H3,11,12,13,14,15) D0G3RZ DRUGINKE HZZXEPZFOVOWIN-UHFFFAOYSA-N D0G3RZ DRUGSMIL CN1CCN(CC1)C2=NC(=NC3=C2NC=N3)N D0G3RZ HIGHSTAT Investigative D0G3SF DRUG__ID D0G3SF D0G3SF DRUGTYPE Small molecular drug D0G3SF DRUGINCH 1S/C12H13N3O2S/c1-8-7-18-12(13-8)15-11(16)14-9-3-5-10(17-2)6-4-9/h3-7H,1-2H3,(H2,13,14,15,16) D0G3SF DRUGINKE DEHFWCRYQNJICK-UHFFFAOYSA-N D0G3SF DRUGSMIL CC1=CSC(=N1)NC(=O)NC2=CC=C(C=C2)OC D0G3SF HIGHSTAT Investigative D0G3SL DRUG__ID D0G3SL D0G3SL DRUGTYPE Small molecular drug D0G3SL DRUGINCH 1S/C27H22O19/c28-5-12-19-18(35)21(25(42-12)45-22(36)6-1-9(29)16(33)10(30)2-6)44-23(37)7-3-11(31)17(34)20-14(7)15-8(24(38)43-19)4-13(32)26(39,40)27(15,41)46-20/h1-4,12,15,18-19,21,25,28-31,33-35,39-41H,5H2/t12-,15+,18+,19-,21-,25+,27?/m1/s1 D0G3SL DRUGINKE CXTMLIMZRPKULL-YXYYPBJFSA-N D0G3SL DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OC2C3C(C(C(O2)CO)OC(=O)C4=CC(=O)C(C5(C4C6=C(O5)C(=C(C=C6C(=O)O3)O)O)O)(O)O)O D0G3SL HIGHSTAT Investigative D0G3SZ DRUG__ID D0G3SZ D0G3SZ DRUGTYPE Small molecular drug D0G3SZ DRUGINCH 1S/C15H14O6/c1-7-3-11(16)12(17)6-9(7)10-4-8(21-2)5-13(18)14(10)15(19)20/h3-6,16-18H,1-2H3,(H,19,20) D0G3SZ DRUGINKE ADPBTBPPIIKLEH-UHFFFAOYSA-N D0G3SZ DRUGSMIL CC1=CC(=C(C=C1C2=C(C(=CC(=C2)OC)O)C(=O)O)O)O D0G3SZ HIGHSTAT Investigative D0G3TK DRUG__ID D0G3TK D0G3TK DRUGTYPE Small molecular drug D0G3TK DRUGINCH 1S/C15H10O6/c16-8-3-1-7(2-4-8)15-14(20)13(19)12-10(18)5-9(17)6-11(12)21-15/h1-6,16-18,20H D0G3TK DRUGINKE IYRMWMYZSQPJKC-UHFFFAOYSA-N D0G3TK DRUGSMIL C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O D0G3TK HIGHSTAT Investigative D0G3TV DRUG__ID D0G3TV D0G3TV DRUGTYPE Small molecular drug D0G3TV DRUGINCH 1S/C25H34N4O3S/c1-19-8-7-9-23(20(19)2)28-14-16-29(17-15-28)25(30)22-18-21(33(31,32)26(3)4)10-11-24(22)27-12-5-6-13-27/h7-11,18H,5-6,12-17H2,1-4H3 D0G3TV DRUGINKE VRSJAHQGJHDACS-UHFFFAOYSA-N D0G3TV DRUGSMIL CC1=C(C(=CC=C1)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)S(=O)(=O)N(C)C)N4CCCC4)C D0G3TV HIGHSTAT Investigative D0G3VE DRUG__ID D0G3VE D0G3VE DRUGTYPE Small molecular drug D0G3VE DRUGINCH 1S/C15H17NO2S/c1-3-4-10-13-14(18-11(2)17)16-15(19-13)12-8-6-5-7-9-12/h5-9H,3-4,10H2,1-2H3 D0G3VE DRUGINKE NEOJOUJFNJKBMX-UHFFFAOYSA-N D0G3VE DRUGSMIL CCCCC1=C(N=C(S1)C2=CC=CC=C2)OC(=O)C D0G3VE HIGHSTAT Investigative D0G3YZ DRUG__ID D0G3YZ D0G3YZ DRUGTYPE Small molecular drug D0G3YZ DRUGINCH 1S/C17H18O3/c18-16(12-17(19)20)11-8-13-6-9-15(10-7-13)14-4-2-1-3-5-14/h1-7,9-10,16,18H,8,11-12H2,(H,19,20) D0G3YZ DRUGINKE ILGSIIFHQGOKKV-UHFFFAOYSA-N D0G3YZ DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(CC(=O)O)O D0G3YZ HIGHSTAT Investigative D0G3ZH DRUG__ID D0G3ZH D0G3ZH DRUGTYPE Small molecular drug D0G3ZH DRUGINCH 1S/C15H20N4O3S/c16-23(21,22)18-11-3-1-2-9-14(20)19-13-8-4-6-12-7-5-10-17-15(12)13/h4-8,10,18H,1-3,9,11H2,(H,19,20)(H2,16,21,22) D0G3ZH DRUGINKE IQEBALPYRTUOEG-UHFFFAOYSA-N D0G3ZH DRUGSMIL C1=CC2=C(C(=C1)NC(=O)CCCCCNS(=O)(=O)N)N=CC=C2 D0G3ZH HIGHSTAT Investigative D0G4BG DRUG__ID D0G4BG D0G4BG DRUGTYPE Small molecular drug D0G4BG DRUGINCH 1S/C8H10N2/c1-2-5-9-7-8-4-3-6-10-8/h1,3-4,6,9-10H,5,7H2 D0G4BG DRUGINKE KRAVBWUZLLIIPH-UHFFFAOYSA-N D0G4BG DRUGSMIL C#CCNCC1=CC=CN1 D0G4BG HIGHSTAT Investigative D0G4BW DRUG__ID D0G4BW D0G4BW DRUGTYPE Small molecular drug D0G4BW DRUGINCH 1S/C17H11ClN4O2S/c18-9-1-3-10(4-2-9)22-8-21-14-12-13-11(24-6-5-19-13)7-20-16(12)25-15(14)17(22)23/h1-4,7-8,19H,5-6H2 D0G4BW DRUGINKE FODONWGPMXPGNC-UHFFFAOYSA-N D0G4BW DRUGSMIL C1COC2=CN=C3C(=C2N1)C4=C(S3)C(=O)N(C=N4)C5=CC=C(C=C5)Cl D0G4BW HIGHSTAT Investigative D0G4CG DRUG__ID D0G4CG D0G4CG DRUGTYPE Small molecular drug D0G4CG DRUGINCH 1S/C11H19N2O/c1-13(2,3)10-5-4-8-12-9-6-7-11(12)14/h6-10H2,1-3H3/q+1 D0G4CG DRUGINKE CANZROMYQDHYHR-UHFFFAOYSA-N D0G4CG DRUGSMIL C[N+](C)(C)CC#CCN1CCCC1=O D0G4CG HIGHSTAT Investigative D0G4CI DRUG__ID D0G4CI D0G4CI DRUGTYPE Small molecular drug D0G4CI DRUGINCH 1S/C3H4O2/c1-3(5)2-4/h2H,1H3 D0G4CI DRUGINKE AIJULSRZWUXGPQ-UHFFFAOYSA-N D0G4CI DRUGSMIL CC(=O)C=O D0G4CI HIGHSTAT Investigative D0G4CJ DRUG__ID D0G4CJ D0G4CJ DRUGTYPE Small molecular drug D0G4CJ DRUGINCH 1S/C15H15NO3/c17-14(18)7-4-9-16-10-8-13(11-16)15(19)12-5-2-1-3-6-12/h1-3,5-6,8,10-11H,4,7,9H2,(H,17,18) D0G4CJ DRUGINKE DMGGHIOFOITOLX-UHFFFAOYSA-N D0G4CJ DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CN(C=C2)CCCC(=O)O D0G4CJ HIGHSTAT Investigative D0G4CS DRUG__ID D0G4CS D0G4CS DRUGTYPE Small molecular drug D0G4CS DRUGINCH 1S/C25H29ClN6O3/c1-3-32-18-10-9-17(22(35-2)15(18)5-4-6-19(32)33)29-25-28-12-16(26)24(31-25)30-21-14-8-7-13(11-14)20(21)23(27)34/h7-10,12-14,20-21H,3-6,11H2,1-2H3,(H2,27,34)(H2,28,29,30,31)/t13-,14+,20+,21-/m1/s1 D0G4CS DRUGINKE GLGNXYJARSMNGJ-VKTIVEEGSA-N D0G4CS DRUGSMIL CCN1C(=O)CCCC2=C1C=CC(=C2OC)NC3=NC=C(C(=N3)NC4C5CC(C4C(=O)N)C=C5)Cl D0G4CS HIGHSTAT Investigative D0G4ET DRUG__ID D0G4ET D0G4ET DRUGTYPE Small molecular drug D0G4ET DRUGINCH 1S/C8H10O5/c1-2-3-4-5(7(10)11)6(9)8(12)13-4/h4-5H,2-3H2,1H3,(H,10,11)/t4-,5-/m0/s1 D0G4ET DRUGINKE AKWJFOMNTDKSRR-WHFBIAKZSA-N D0G4ET DRUGSMIL CCCC1C(C(=O)C(=O)O1)C(=O)O D0G4ET HIGHSTAT Investigative D0G4FA DRUG__ID D0G4FA D0G4FA DRUGTYPE Small molecular drug D0G4FA DRUGINCH 1S/C25H27NO2/c1-28-23-14-12-22(13-15-23)25(27)16-18-26(19-17-25)24(20-8-4-2-5-9-20)21-10-6-3-7-11-21/h2-15,24,27H,16-19H2,1H3 D0G4FA DRUGINKE UWUHHENFQBTZCW-UHFFFAOYSA-N D0G4FA DRUGSMIL COC1=CC=C(C=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D0G4FA HIGHSTAT Investigative D0G4GB DRUG__ID D0G4GB D0G4GB DRUGTYPE Small molecular drug D0G4GB DRUGINCH 1S/C8H7ClO/c9-6-8(10)7-4-2-1-3-5-7/h1-5H,6H2 D0G4GB DRUGINKE IMACFCSSMIZSPP-UHFFFAOYSA-N D0G4GB DRUGSMIL C1=CC=C(C=C1)C(=O)CCl D0G4GB HIGHSTAT Investigative D0G4HR DRUG__ID D0G4HR D0G4HR DRUGTYPE Small molecular drug D0G4HR DRUGINCH 1S/C15H11NO7S/c17-15(18)12-3-7-14(8-4-12)24(21,22)23-13-5-1-11(2-6-13)9-10-16(19)20/h1-10H,(H,17,18)/b10-9+ D0G4HR DRUGINKE JJLJZGDGOYIKBT-MDZDMXLPSA-N D0G4HR DRUGSMIL C1=CC(=CC=C1C=C[N+](=O)[O-])OS(=O)(=O)C2=CC=C(C=C2)C(=O)O D0G4HR HIGHSTAT Investigative D0G4JB DRUG__ID D0G4JB D0G4JB DRUGCOMP NeuroSearch A/S D0G4JB DRUGINCH 1S/C17H16ClN7/c1-10-8-11(2)25(23-10)17-21-15(14-16(22-17)24(3)9-19-14)20-13-6-4-12(18)5-7-13/h4-9H,1-3H3,(H,20,21,22) D0G4JB DRUGINKE DVQOPNIPUIOXHU-UHFFFAOYSA-N D0G4JB DRUGSMIL CC1=CC(=NN1C2=NC(=C3C(=N2)N(C=N3)C)NC4=CC=C(C=C4)Cl)C D0G4JB HIGHSTAT Investigative D0G4JS DRUG__ID D0G4JS D0G4JS DRUGTYPE Small molecular drug D0G4JS DRUGINCH 1S/C13H11N5O/c19-13(17-12-3-1-2-6-14-12)16-10-5-4-9-8-15-18-11(9)7-10/h1-8H,(H,15,18)(H2,14,16,17,19) D0G4JS DRUGINKE YGKMQQVUBKWTIJ-UHFFFAOYSA-N D0G4JS DRUGSMIL C1=CC=NC(=C1)NC(=O)NC2=CC3=C(C=C2)C=NN3 D0G4JS HIGHSTAT Investigative D0G4KB DRUG__ID D0G4KB D0G4KB DRUGTYPE Small molecular drug D0G4KB DRUGINCH 1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m1/s1/i6T,12T D0G4KB DRUGINKE VOKSWYLNZZRQPF-BXKNQVALSA-N D0G4KB DRUGSMIL CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O D0G4KB HIGHSTAT Investigative D0G4KT DRUG__ID D0G4KT D0G4KT DRUGTYPE Small molecular drug D0G4KT DRUGINCH 1S/C22H30O2/c1-13(2)10-15-12-20-19-6-4-14-11-16(23)5-7-17(14)18(19)8-9-22(20,3)21(15)24/h5,7,10-11,13,18-21,23-24H,4,6,8-9,12H2,1-3H3/b15-10+/t18-,19-,20+,21+,22+/m1/s1 D0G4KT DRUGINKE NOFDRMUQQIVAPE-PIEVVZFUSA-N D0G4KT DRUGSMIL CC(C)C=C1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O D0G4KT HIGHSTAT Investigative D0G4LX DRUG__ID D0G4LX D0G4LX DRUGTYPE Small molecular drug D0G4LX DRUGINCH 1S/C29H32N4O3S/c1-19(2)16-32-17-21-11-6-7-12-23(21)33-29(34)35-18-25(20-9-4-3-5-10-20)36-24-13-8-14-26-22(24)15-27(37-26)28(30)31/h3-15,19,25,32H,16-18H2,1-2H3,(H3,30,31)(H,33,34) D0G4LX DRUGINKE QGLTXLFHFVMPJH-UHFFFAOYSA-N D0G4LX DRUGSMIL CC(C)CNCC1=CC=CC=C1NC(=O)OCC(C2=CC=CC=C2)OC3=C4C=C(SC4=CC=C3)C(=N)N D0G4LX HIGHSTAT Investigative D0G4NM DRUG__ID D0G4NM D0G4NM DRUGTYPE Small molecular drug D0G4NM DRUGINCH 1S/C30H39N5O7S2/c1-29(2)23(34-25(38)20(31)14-18-10-12-19(36)13-11-18)27(40)32-16-22(37)33-21(15-17-8-6-5-7-9-17)26(39)35-24(28(41)42)30(3,4)44-43-29/h5-13,20-21,23-24,36H,14-16,31H2,1-4H3,(H,32,40)(H,33,37)(H,34,38)(H,35,39)(H,41,42)/t20-,21-,23-,24-/m0/s1 D0G4NM DRUGINKE MCMMCRYPQBNCPH-WMIMKTLMSA-N D0G4NM DRUGSMIL CC1(C(C(=O)NCC(=O)NC(C(=O)NC(C(SS1)(C)C)C(=O)O)CC2=CC=CC=C2)NC(=O)C(CC3=CC=C(C=C3)O)N)C D0G4NM HIGHSTAT Investigative D0G4PZ DRUG__ID D0G4PZ D0G4PZ DRUGTYPE Small molecular drug D0G4PZ DRUGINCH 1S/C24H20N2O/c27-24(25-16-15-18-9-3-1-4-10-18)21-17-23(19-11-5-2-6-12-19)26-22-14-8-7-13-20(21)22/h1-14,17H,15-16H2,(H,25,27) D0G4PZ DRUGINKE LVSGZPVWALHPET-UHFFFAOYSA-N D0G4PZ DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C2=CC(=NC3=CC=CC=C32)C4=CC=CC=C4 D0G4PZ HIGHSTAT Investigative D0G4RG DRUG__ID D0G4RG D0G4RG DRUGTYPE Small molecular drug D0G4RG DRUGINCH 1S/C17H15NO3/c19-16-11-15(18-7-9-20-10-8-18)14-6-5-12-3-1-2-4-13(12)17(14)21-16/h1-6,11H,7-10H2 D0G4RG DRUGINKE QPPKEHFJUVBRAD-UHFFFAOYSA-N D0G4RG DRUGSMIL C1COCCN1C2=CC(=O)OC3=C2C=CC4=CC=CC=C43 D0G4RG HIGHSTAT Investigative D0G4SU DRUG__ID D0G4SU D0G4SU DRUGTYPE Small molecular drug D0G4SU DRUGINCH 1S/C19H32N2/c1-2-8-19(7-1)17-11-20(9-15-3-4-15)12-18(19)14-21(13-17)10-16-5-6-16/h15-18H,1-14H2 D0G4SU DRUGINKE CTIRHWCPXYGDGF-UHFFFAOYSA-N D0G4SU DRUGSMIL C1CCC2(C1)C3CN(CC2CN(C3)CC4CC4)CC5CC5 D0G4SU HIGHSTAT Investigative D0G4VV DRUG__ID D0G4VV D0G4VV DRUGTYPE Small molecular drug D0G4VV DRUGINCH 1S/C21H19ClFNO6S3/c1-14(24-31(2,25)26)15-7-10-17(11-8-15)32(27,28)20-12-9-16(22)13-21(20)33(29,30)19-6-4-3-5-18(19)23/h3-14,24H,1-2H3/t14-/m0/s1 D0G4VV DRUGINKE BQYPKXDCTROOHB-AWEZNQCLSA-N D0G4VV DRUGSMIL CC(C1=CC=C(C=C1)S(=O)(=O)C2=C(C=C(C=C2)Cl)S(=O)(=O)C3=CC=CC=C3F)NS(=O)(=O)C D0G4VV HIGHSTAT Investigative D0G4WF DRUG__ID D0G4WF D0G4WF DRUGTYPE Small molecular drug D0G4WF DRUGINCH 1S/C19H18O2/c1-11-5-7-15(8-6-11)17-10-16(20)19-14(4)13(3)12(2)9-18(19)21-17/h5-10H,1-4H3 D0G4WF DRUGINKE CMMLREBGPOOVPU-UHFFFAOYSA-N D0G4WF DRUGSMIL CC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3C)C)C D0G4WF HIGHSTAT Investigative D0G4ZG DRUG__ID D0G4ZG D0G4ZG DRUGTYPE Small molecular drug D0G4ZG DRUGINCH 1S/C26H36FNO4/c1-17(2)26-23(13-12-21(29)14-22(30)15-25(31)32)24(18-8-10-19(27)11-9-18)16-28(26)20-6-4-3-5-7-20/h8-11,16-17,20-22,29-30H,3-7,12-15H2,1-2H3,(H,31,32)/p-1/t21-,22-/m1/s1 D0G4ZG DRUGINKE RODBEKUWCLMBSW-FGZHOGPDSA-M D0G4ZG DRUGSMIL CC(C)C1=C(C(=CN1C2CCCCC2)C3=CC=C(C=C3)F)CCC(CC(CC(=O)[O-])O)O D0G4ZG HIGHSTAT Investigative D0G4ZL DRUG__ID D0G4ZL D0G4ZL DRUGTYPE Small molecular drug D0G4ZL DRUGINCH 1S/C6H12N2/c1-4-3-8-6(7)5(4)2/h4-5H,3H2,1-2H3,(H2,7,8) D0G4ZL DRUGINKE YVPMIGCVKYQACC-UHFFFAOYSA-N D0G4ZL DRUGSMIL CC1CN=C(C1C)N D0G4ZL HIGHSTAT Investigative D0G4ZT DRUG__ID D0G4ZT D0G4ZT DRUGTYPE Small molecular drug D0G4ZT DRUGINCH 1S/C22H23Cl2NO4/c1-22(2,3)12-25-17-9-8-13(23)10-15(17)20(14-6-4-5-7-16(14)24)29-18(21(25)28)11-19(26)27/h4-10,18,20H,11-12H2,1-3H3,(H,26,27) D0G4ZT DRUGINKE BHDQOMHFEOHAQK-UHFFFAOYSA-N D0G4ZT DRUGSMIL CC(C)(C)CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)O)C3=CC=CC=C3Cl D0G4ZT HIGHSTAT Investigative D0G5CI DRUG__ID D0G5CI D0G5CI DRUGTYPE Small molecular drug D0G5CI DRUGINCH 1S/C22H30N5O17P3/c23-19-13-20(25-8-24-19)27(9-26-13)21-18(44-47(36,37)38)15(11(39-21)6-10-4-2-1-3-5-10)41-22-14(29)17(43-46(33,34)35)16(12(7-28)40-22)42-45(30,31)32/h1-5,8-9,11-12,14-18,21-22,28-29H,6-7H2,(H2,23,24,25)(H2,30,31,32)(H2,33,34,35)(H2,36,37,38)/p-6/t11-,12-,14-,15-,16-,17-,18-,21-,22-/m1/s1 D0G5CI DRUGINKE HQEPXXWNKLEIRE-NYCICKCISA-H D0G5CI DRUGSMIL C1=CC=C(C=C1)CC2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)OP(=O)([O-])[O-])OC5C(C(C(C(O5)CO)OP(=O)([O-])[O-])OP(=O)([O-])[O-])O D0G5CI HIGHSTAT Investigative D0G5CP DRUG__ID D0G5CP D0G5CP DRUGTYPE Small molecular drug D0G5CP DRUGINCH 1S/C18H15NO2/c1-21-18-10-9-16(12-19-18)14-7-5-13(6-8-14)15-3-2-4-17(20)11-15/h2-12,20H,1H3 D0G5CP DRUGINKE JEDOKEGGMJNKGY-UHFFFAOYSA-N D0G5CP DRUGSMIL COC1=NC=C(C=C1)C2=CC=C(C=C2)C3=CC(=CC=C3)O D0G5CP HIGHSTAT Investigative D0G5DH DRUG__ID D0G5DH D0G5DH DRUGTYPE Small molecular drug D0G5DH DRUGINCH 1S/C22H22N2O3S/c1-13-7-6-8-14(2)19(13)23-22(27)20(18-12-11-15(3)28-18)24-21(26)16-9-4-5-10-17(16)25/h4-12,20,25H,1-3H3,(H,23,27)(H,24,26) D0G5DH DRUGINKE AHTURLVFIJHCLS-UHFFFAOYSA-N D0G5DH DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)C(C2=CC=C(S2)C)NC(=O)C3=CC=CC=C3O D0G5DH HIGHSTAT Investigative D0G5DU DRUG__ID D0G5DU D0G5DU DRUGTYPE Small molecular drug D0G5DU DRUGINCH 1S/C20H33NO/c1-2-8-19-12-15-21(16-13-19)14-7-18-22-17-6-11-20-9-4-3-5-10-20/h3-5,9-10,19H,2,6-8,11-18H2,1H3 D0G5DU DRUGINKE STTDWMNBHHXZBO-UHFFFAOYSA-N D0G5DU DRUGSMIL CCCC1CCN(CC1)CCCOCCCC2=CC=CC=C2 D0G5DU HIGHSTAT Investigative D0G5FV DRUG__ID D0G5FV D0G5FV DRUGTYPE Small molecular drug D0G5FV DRUGINCH 1S/C72H85N19O18S5/c1-14-26(3)47-63(105)78-30(7)57(99)75-28(5)56(98)76-31(8)58(100)91-72-19-18-40(66-85-43(22-111-66)59(101)77-29(6)55(97)74-27(4)54(73)96)81-52(72)42-21-112-67(83-42)49(34(11)109-69(107)41-20-37(32(9)92)36-16-17-39(79-47)51(95)50(36)80-41)89-60(102)44-24-113-68(86-44)53(71(13,108)35(12)94)90-62(104)45-23-110-65(84-45)38(15-2)82-64(106)48(33(10)93)88-61(103)46-25-114-70(72)87-46/h15-17,20-22,24-26,30-35,39,45,47-49,51-53,79,92-95,108H,4-6,14,18-19,23H2,1-3,7-13H3,(H2,73,96)(H,74,97)(H,75,99)(H,76,98)(H,77,101)(H,78,105)(H,82,106)(H,88,103)(H,89,102)(H,90,104)(H,91,100)/b38-15+ D0G5FV DRUGINKE NSFFHOGKXHRQEW-DVRIZHICSA-N D0G5FV DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(=C)C(=O)NC(C(=O)NC23CCC(=NC2C4=CSC(=N4)C(C(OC(=O)C5=NC6=C(C=CC(C6O)N1)C(=C5)C(C)O)C)NC(=O)C7=CSC(=N7)C(NC(=O)C8CSC(=N8)C(=CC)NC(=O)C(NC(=O)C9=CSC3=N9)C(C)O)C(C)(C(C)O)O)C1=NC(=CS1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C D0G5FV HIGHSTAT Investigative D0G5GV DRUG__ID D0G5GV D0G5GV DRUGTYPE Small molecular drug D0G5GV DRUGINCH 1S/C13H15IN2O/c14-12-5-3-11(4-6-12)9-17-7-1-2-13-8-15-10-16-13/h3-6,8,10H,1-2,7,9H2,(H,15,16)/i14-4 D0G5GV DRUGINKE DCQNAFOCXVCDLB-CKVWVWRJSA-N D0G5GV DRUGSMIL C1=CC(=CC=C1COCCCC2=CN=CN2)I D0G5GV HIGHSTAT Investigative D0G5JW DRUG__ID D0G5JW D0G5JW DRUGCOMP 3SBio Inc D0G5JW DRUGINCH 1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1 D0G5JW DRUGINKE OXCMYAYHXIHQOA-UHFFFAOYSA-N D0G5JW DRUGSMIL CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+] D0G5JW HIGHSTAT Investigative D0G5LZ DRUG__ID D0G5LZ D0G5LZ DRUGTYPE Small molecular drug D0G5LZ DRUGINCH 1S/C19H14N4O3S2/c1-12-6-8-13(9-7-12)28(25,26)23-16-10-17(27-19-20-11-21-22-19)18(24)15-5-3-2-4-14(15)16/h2-11H,1H3,(H,20,21,22) D0G5LZ DRUGINKE HDOKKAMQZREOLG-UHFFFAOYSA-N D0G5LZ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N=C2C=C(C(=O)C3=CC=CC=C32)SC4=NC=NN4 D0G5LZ HIGHSTAT Investigative D0G5MS DRUG__ID D0G5MS D0G5MS DRUGTYPE Small molecular drug D0G5MS DRUGINCH 1S/C24H26O7/c1-11(2)6-7-12-19-16(9-14(25)23(12)29-5)30-17-10-15-13(21(27)20(17)22(19)28)8-18(26)24(3,4)31-15/h6,9-10,18,25-27H,7-8H2,1-5H3 D0G5MS DRUGINKE KCMPFWGUVNEDHW-UHFFFAOYSA-N D0G5MS DRUGSMIL CC(=CCC1=C(C(=CC2=C1C(=O)C3=C(C4=C(C=C3O2)OC(C(C4)O)(C)C)O)O)OC)C D0G5MS HIGHSTAT Investigative D0G5MT DRUG__ID D0G5MT D0G5MT DRUGTYPE Small molecular drug D0G5MT DRUGINCH 1S/C20H34O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12,14,16-18,21H,2-11,13,15H2,1H3,(H,23,24)/b14-12+/t16-,17-,18+/m0/s1 D0G5MT DRUGINKE DPNOTBLPQOITGU-LDDQNKHRSA-N D0G5MT DRUGSMIL CCCCCC(C=CC1CCC(=O)C1CCCCCCC(=O)O)O D0G5MT HIGHSTAT Investigative D0G5NE DRUG__ID D0G5NE D0G5NE DRUGTYPE Small molecular drug D0G5NE DRUGINCH 1S/C16H17ClN4O2/c1-19-12(8-7-10-5-4-6-11(17)9-10)18-14-13(19)15(22)21(3)16(23)20(14)2/h4-9,13-14H,1-3H3/b8-7+ D0G5NE DRUGINKE SIKKJYKLUJCDNQ-BQYQJAHWSA-N D0G5NE DRUGSMIL CN1C2C(N=C1C=CC3=CC(=CC=C3)Cl)N(C(=O)N(C2=O)C)C D0G5NE HIGHSTAT Investigative D0G5OV DRUG__ID D0G5OV D0G5OV DRUGTYPE Small molecular drug D0G5OV DRUGINCH 1S/C16H14FN3O/c1-16(2)11-6-9(7-12(17)14(11)19-15(16)21)13-5-4-10(8-18)20(13)3/h4-7H,1-3H3,(H,19,21) D0G5OV DRUGINKE KIOOLNRTWPFVHX-UHFFFAOYSA-N D0G5OV DRUGSMIL CC1(C2=C(C(=CC(=C2)C3=CC=C(N3C)C#N)F)NC1=O)C D0G5OV HIGHSTAT Investigative D0G5PT DRUG__ID D0G5PT D0G5PT DRUGTYPE Small molecular drug D0G5PT DRUGINCH 1S/C15H12O4/c16-8-2-4-11-13(5-8)18-7-12-10-3-1-9(17)6-14(10)19-15(11)12/h1-6,12,15-17H,7H2/t12-,15-/m0/s1 D0G5PT DRUGINKE ODMIEGVTNZNSLD-WFASDCNBSA-N D0G5PT DRUGSMIL C1C2C(C3=C(O1)C=C(C=C3)O)OC4=C2C=CC(=C4)O D0G5PT HIGHSTAT Investigative D0G5QX DRUG__ID D0G5QX D0G5QX DRUGTYPE Small molecular drug D0G5QX DRUGINCH 1S/C15H16N4O2.2BrH/c20-16-12-14-2-8-18(9-3-14)6-1-7-19-10-4-15(5-11-19)13-17-21;;/h2-5,8-13H,1,6-7H2;2*1H D0G5QX DRUGINKE JHZHWVQTOXIXIV-UHFFFAOYSA-N D0G5QX DRUGSMIL C1=C[N+](=CC=C1C=NO)CCC[N+]2=CC=C(C=C2)C=NO.[Br-].[Br-] D0G5QX HIGHSTAT Investigative D0G5RH DRUG__ID D0G5RH D0G5RH DRUGTYPE Small molecular drug D0G5RH DRUGINCH 1S/C16H21NO2/c1-17-12-8-9-14(17)15(16(18)19-2)13(10-12)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13-,14?,15+/m1/s1 D0G5RH DRUGINKE OMBOXYLBBHNWHL-VOFREWHGSA-N D0G5RH DRUGSMIL CN1C2CCC1C(C(C2)C3=CC=CC=C3)C(=O)OC D0G5RH HIGHSTAT Investigative D0G5SM DRUG__ID D0G5SM D0G5SM DRUGTYPE Small molecular drug D0G5SM DRUGINCH 1S/C29H50O3/c1-7-19(17(2)3)14-26(31)18(4)23-10-11-24-22-9-8-20-15-21(30)16-27(32)29(20,6)25(22)12-13-28(23,24)5/h8,17-19,21-27,30-32H,7,9-16H2,1-6H3/t18-,19+,21+,22?,23+,24?,25?,26+,27-,28+,29-/m0/s1 D0G5SM DRUGINKE UNBKHVKAEFBHAN-IWAMNEIESA-N D0G5SM DRUGSMIL CCC(CC(C(C)C1CCC2C1(CCC3C2CC=C4C3(C(CC(C4)O)O)C)C)O)C(C)C D0G5SM HIGHSTAT Investigative D0G5TD DRUG__ID D0G5TD D0G5TD DRUGTYPE Small molecular drug D0G5TD DRUGINCH 1S/C14H21NO/c1-12-5-4-9-15(12)10-8-13-6-3-7-14(11-13)16-2/h3,6-7,11-12H,4-5,8-10H2,1-2H3/t12-/m0/s1 D0G5TD DRUGINKE INKHQVYBVMGBHD-LBPRGKRZSA-N D0G5TD DRUGSMIL CC1CCCN1CCC2=CC(=CC=C2)OC D0G5TD HIGHSTAT Investigative D0G5TL DRUG__ID D0G5TL D0G5TL DRUGTYPE Small molecular drug D0G5TL DRUGINCH 1S/C14H14N2O/c1-9-14-11(6-7-15(9)2)12-8-10(17)4-5-13(12)16(14)3/h4-8H,1-3H3/p+1 D0G5TL DRUGINKE CHMZSXAIQRLCLX-UHFFFAOYSA-O D0G5TL DRUGSMIL CC1=[N+](C=CC2=C1N(C3=C2C=C(C=C3)O)C)C D0G5TL HIGHSTAT Investigative D0G5UD DRUG__ID D0G5UD D0G5UD DRUGTYPE Small molecular drug D0G5UD DRUGINCH 1S/C31H35N3O8S/c1-31(2,3)21-12-16-24(17-13-21)43(37,38)34-29-27(42-26-9-7-6-8-25(26)40-5)30(41-19-22(36)18-35)33-28(32-29)20-10-14-23(39-4)15-11-20/h6-17,22,35-36H,18-19H2,1-5H3,(H,32,33,34)/t22-/m1/s1 D0G5UD DRUGINKE DRIHNVYRUGBDHI-JOCHJYFZSA-N D0G5UD DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC=C(C=C3)OC)OCC(CO)O)OC4=CC=CC=C4OC D0G5UD HIGHSTAT Investigative D0G5VD DRUG__ID D0G5VD D0G5VD DRUGTYPE Small molecular drug D0G5VD DRUGINCH 1S/C14H9N3O4/c18-11-3-1-2-10-12(11)15-13(16-14(10)19)8-4-6-9(7-5-8)17(20)21/h1-7,18H,(H,15,16,19) D0G5VD DRUGINKE FKPMZNSEGYFIDN-UHFFFAOYSA-N D0G5VD DRUGSMIL C1=CC2=C(C(=C1)O)N=C(NC2=O)C3=CC=C(C=C3)[N+](=O)[O-] D0G5VD HIGHSTAT Investigative D0G5VO DRUG__ID D0G5VO D0G5VO DRUGTYPE Small molecular drug D0G5VO DRUGINCH 1S/C15H17N5O2/c21-9-5-4-8-20-10-16-12-13(20)18-15(19-14(12)22)17-11-6-2-1-3-7-11/h1-3,6-7,10,21H,4-5,8-9H2,(H2,17,18,19,22) D0G5VO DRUGINKE JHBXNPBKSPYOFT-UHFFFAOYSA-N D0G5VO DRUGSMIL C1=CC=C(C=C1)NC2=NC3=C(C(=O)N2)N=CN3CCCCO D0G5VO HIGHSTAT Investigative D0G5YA DRUG__ID D0G5YA D0G5YA DRUGTYPE Small molecular drug D0G5YA DRUGINCH 1S/C17H19ClN2O2/c1-12(17(19)21)20-10-13-4-8-16(9-5-13)22-11-14-2-6-15(18)7-3-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1 D0G5YA DRUGINKE JAJNPDROJVQSPW-LBPRGKRZSA-N D0G5YA DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=C(C=C2)Cl D0G5YA HIGHSTAT Investigative D0G5YI DRUG__ID D0G5YI D0G5YI DRUGTYPE Small molecular drug D0G5YI DRUGINCH 1S/C17H12N2O/c20-17(15-9-11-5-1-3-7-13(11)18-15)16-10-12-6-2-4-8-14(12)19-16/h1-10,18-19H D0G5YI DRUGINKE GQJIQKLWZMQQGO-UHFFFAOYSA-N D0G5YI DRUGSMIL C1=CC=C2C(=C1)C=C(N2)C(=O)C3=CC4=CC=CC=C4N3 D0G5YI HIGHSTAT Investigative D0G5ZF DRUG__ID D0G5ZF D0G5ZF DRUGTYPE Small molecular drug D0G5ZF DRUGINCH 1S/C18H18N6O5/c1-28-23-16-13-17(22-12(21-16)6-5-10-4-2-3-7-19-10)24(9-20-13)18-15(27)14(26)11(8-25)29-18/h2-4,7,9,11,14-15,18,25-27H,8H2,1H3,(H,21,22,23)/t11-,14-,15-,18-/m1/s1 D0G5ZF DRUGINKE CMMXTSNUEHRJEY-XKLVTHTNSA-N D0G5ZF DRUGSMIL CONC1=C2C(=NC(=N1)C#CC3=CC=CC=N3)N(C=N2)C4C(C(C(O4)CO)O)O D0G5ZF HIGHSTAT Investigative D0G6AQ DRUG__ID D0G6AQ D0G6AQ DRUGTYPE Small molecular drug D0G6AQ DRUGINCH 1S/C11H12BrN3/c12-9-3-1-2-8(6-9)11-14-7-10(15-11)4-5-13/h1-3,6-7H,4-5,13H2,(H,14,15) D0G6AQ DRUGINKE VSKJPAMQPJDPLL-UHFFFAOYSA-N D0G6AQ DRUGSMIL C1=CC(=CC(=C1)Br)C2=NC=C(N2)CCN D0G6AQ HIGHSTAT Investigative D0G6BG DRUG__ID D0G6BG D0G6BG DRUGTYPE Small molecular drug D0G6BG DRUGINCH 1S/C20H14O2/c21-20-16(12-14-6-2-1-3-7-14)13-18-17-9-5-4-8-15(17)10-11-19(18)22-20/h1-11,13H,12H2 D0G6BG DRUGINKE OOALWLFUSOVWMV-UHFFFAOYSA-N D0G6BG DRUGSMIL C1=CC=C(C=C1)CC2=CC3=C(C=CC4=CC=CC=C43)OC2=O D0G6BG HIGHSTAT Investigative D0G6BI DRUG__ID D0G6BI D0G6BI DRUGTYPE Small molecular drug D0G6BI DRUGINCH 1S/C20H21BrN6O5/c21-10-1-2-11-9(6-23-12(11)5-10)3-4-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)13(7-28)32-19/h1-2,5-6,8,13,15-16,19,23,28-30H,3-4,7H2,(H2,22,25,26)/t13-,15-,16-,19-/m1/s1 D0G6BI DRUGINKE OXLUZSPXALFOBX-NVQRDWNXSA-N D0G6BI DRUGSMIL C1=CC2=C(C=C1Br)NC=C2CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0G6BI HIGHSTAT Investigative D0G6BJ DRUG__ID D0G6BJ D0G6BJ DRUGTYPE Small molecular drug D0G6BJ DRUGINCH 1S/C14H17Cl2NO/c1-18-9-13-7-14(13,4-5-17-8-13)10-2-3-11(15)12(16)6-10/h2-3,6,17H,4-5,7-9H2,1H3/t13-,14-/m1/s1 D0G6BJ DRUGINKE ICXJGCSEMJXNQF-ZIAGYGMSSA-N D0G6BJ DRUGSMIL COCC12CC1(CCNC2)C3=CC(=C(C=C3)Cl)Cl D0G6BJ HIGHSTAT Investigative D0G6BU DRUG__ID D0G6BU D0G6BU DRUGCOMP US Army Medical Research Institute of Infectious Diseases D0G6BU DRUGINCH 1S/C11H18N4O6/c12-11(13)14-5-1-2-6(9(18)19)15-7(10(20)21)3-4-8(16)17/h1,5-7,15H,2-4H2,(H,16,17)(H,18,19)(H,20,21)(H4,12,13,14)/p+2/b5-1+/t6-,7+/m0/s1 D0G6BU DRUGINKE DZPHZEAZEBNTEK-NOCGQDKXSA-P D0G6BU DRUGSMIL C(CC(=O)O)C(C(=O)O)[NH2+]C(CC=C[NH+]=C(N)N)C(=O)O D0G6BU HIGHSTAT Investigative D0G6CD DRUG__ID D0G6CD D0G6CD DRUGTYPE Small molecular drug D0G6CD DRUGINCH 1S/C26H32N4O4/c1-5-29(6-2)15-23(31)27-17-9-11-19-21(13-17)26(34)22-14-18(10-12-20(22)25(19)33)28-24(32)16-30(7-3)8-4/h9-14H,5-8,15-16H2,1-4H3,(H,27,31)(H,28,32) D0G6CD DRUGINKE ZNVJTQUBGZVROG-UHFFFAOYSA-N D0G6CD DRUGSMIL CCN(CC)CC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CN(CC)CC D0G6CD HIGHSTAT Investigative D0G6CU DRUG__ID D0G6CU D0G6CU DRUGTYPE Small molecular drug D0G6CU DRUGINCH 1S/C3H10O6P2/c4-10(5,6)2-1-3-11(7,8)9/h1-3H2,(H2,4,5,6)(H2,7,8,9) D0G6CU DRUGINKE PUVMVPFLXCHEOY-UHFFFAOYSA-N D0G6CU DRUGSMIL C(CP(=O)(O)O)CP(=O)(O)O D0G6CU HIGHSTAT Investigative D0G6DH DRUG__ID D0G6DH D0G6DH DRUGTYPE Small molecular drug D0G6DH DRUGINCH 1S/C21H19N3O3S/c25-20(23-27)15-9-7-14(8-10-15)13-24-18-6-2-1-5-17(18)22-21(26)19(24)12-16-4-3-11-28-16/h1-11,19,27H,12-13H2,(H,22,26)(H,23,25)/t19-/m1/s1 D0G6DH DRUGINKE HBEDNENASUYMPO-LJQANCHMSA-N D0G6DH DRUGSMIL C1=CC=C2C(=C1)NC(=O)C(N2CC3=CC=C(C=C3)C(=O)NO)CC4=CC=CS4 D0G6DH HIGHSTAT Investigative D0G6DS DRUG__ID D0G6DS D0G6DS DRUGTYPE Small molecular drug D0G6DS DRUGINCH 1S/C15H20N2O/c1-2-3-4-5-11-18-13-8-6-7-12-9-10-14(16)17-15(12)13/h6-10H,2-5,11H2,1H3,(H2,16,17) D0G6DS DRUGINKE SBZZEIZRHJBKKE-UHFFFAOYSA-N D0G6DS DRUGSMIL CCCCCCOC1=CC=CC2=C1N=C(C=C2)N D0G6DS HIGHSTAT Investigative D0G6HC DRUG__ID D0G6HC D0G6HC DRUGTYPE Small molecular drug D0G6HC DRUGINCH 1S/C42H68N8O11/c1-9-25(6)36(41(59)48-35(24(4)5)42(60)61-8)49-40(58)32-16-13-17-50(32)21-33(53)28(19-27-14-11-10-12-15-27)45-38(56)30(20-34(43)54)47-37(55)29(18-23(2)3)46-39(57)31(22-51)44-26(7)52/h10-12,14-15,23-25,28-33,35-36,51,53H,9,13,16-22H2,1-8H3,(H2,43,54)(H,44,52)(H,45,56)(H,46,57)(H,47,55)(H,48,59)(H,49,58)/t25-,28?,29-,30-,31-,32-,33?,35-,36-/m0/s1 D0G6HC DRUGINKE MJOXWVYKMFPFPL-AIVXTZMUSA-N D0G6HC DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)C1CCCN1CC(C(CC2=CC=CC=C2)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C)O D0G6HC HIGHSTAT Investigative D0G6IG DRUG__ID D0G6IG D0G6IG DRUGTYPE Small molecular drug D0G6IG DRUGINCH 1S/C16H19NO3/c1-3-5-8-20-16(19)13-10-17-14-7-6-11(4-2)9-12(14)15(13)18/h6-7,9-10H,3-5,8H2,1-2H3,(H,17,18) D0G6IG DRUGINKE CJTBJWFADVNZQZ-UHFFFAOYSA-N D0G6IG DRUGSMIL CCCCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC D0G6IG HIGHSTAT Investigative D0G6IO DRUG__ID D0G6IO D0G6IO DRUGTYPE Small molecular drug D0G6IO DRUGINCH 1S/C7H7BrN2O2/c8-5-1-3-6(4-2-5)9-7(11)10-12/h1-4,12H,(H2,9,10,11) D0G6IO DRUGINKE QFELVVGTIKGYJL-UHFFFAOYSA-N D0G6IO DRUGSMIL C1=CC(=CC=C1NC(=O)NO)Br D0G6IO HIGHSTAT Investigative D0G6JM DRUG__ID D0G6JM D0G6JM DRUGTYPE Small molecular drug D0G6JM DRUGINCH 1S/C24H28O2/c1-16(14-17-6-8-18(9-7-17)22(25)26)19-10-11-20-21(15-19)24(4,5)13-12-23(20,2)3/h6-11,14-15H,12-13H2,1-5H3,(H,25,26)/b16-14+ D0G6JM DRUGINKE FOIVPCKZDPCJJY-JQIJEIRASA-N D0G6JM DRUGSMIL CC(=CC1=CC=C(C=C1)C(=O)O)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C D0G6JM HIGHSTAT Investigative D0G6MA DRUG__ID D0G6MA D0G6MA DRUGTYPE Small molecular drug D0G6MA DRUGINCH 1S/C16H11FO3/c1-19-12-6-7-13-14(18)9-15(20-16(13)8-12)10-2-4-11(17)5-3-10/h2-9H,1H3 D0G6MA DRUGINKE FQRUARKLFVTIIK-UHFFFAOYSA-N D0G6MA DRUGSMIL COC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC=C(C=C3)F D0G6MA HIGHSTAT Investigative D0G6NV DRUG__ID D0G6NV D0G6NV DRUGTYPE Small molecular drug D0G6NV DRUGINCH 1S/C15H14N2O3S/c1-20-13-5-2-11-8-9-17(15(11)10-13)21(18,19)14-6-3-12(16)4-7-14/h2-10H,16H2,1H3 D0G6NV DRUGINKE DMQUSAAOCWRTQX-UHFFFAOYSA-N D0G6NV DRUGSMIL COC1=CC2=C(C=C1)C=CN2S(=O)(=O)C3=CC=C(C=C3)N D0G6NV HIGHSTAT Investigative D0G6NY DRUG__ID D0G6NY D0G6NY DRUGTYPE Small molecular drug D0G6NY DRUGINCH 1S/C17H18N2S/c1-17(2,3)15-11-20-16(19-15)18-14-10-6-8-12-7-4-5-9-13(12)14/h4-11H,1-3H3,(H,18,19) D0G6NY DRUGINKE TXEFBOQHGSOELC-UHFFFAOYSA-N D0G6NY DRUGSMIL CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=CC=CC=C32 D0G6NY HIGHSTAT Investigative D0G6OW DRUG__ID D0G6OW D0G6OW DRUGTYPE Small molecular drug D0G6OW DRUGINCH 1S/C7H2F4O2.Na/c8-2-1-3(9)6(11)4(5(2)10)7(12)13;/h1H,(H,12,13);/q;+1/p-1 D0G6OW DRUGINKE ZESSIGXSSUUGNU-UHFFFAOYSA-M D0G6OW DRUGSMIL C1=C(C(=C(C(=C1F)F)C(=O)[O-])F)F.[Na+] D0G6OW HIGHSTAT Investigative D0G6PS DRUG__ID D0G6PS D0G6PS DRUGTYPE Small molecular drug D0G6PS DRUGINCH 1S/C33H32F2N2O5/c1-19(2)36-28(15-14-24(38)17-25(39)18-29(40)41)30(20-10-12-21(34)13-11-20)31-26-8-3-4-9-27(26)37(33(42)32(31)36)23-7-5-6-22(35)16-23/h3-13,16,19,24-25,38-39H,14-15,17-18H2,1-2H3,(H,40,41)/p-1/t24-,25-/m1/s1 D0G6PS DRUGINKE BJKPZWFEYXVKOA-JWQCQUIFSA-M D0G6PS DRUGSMIL CC(C)N1C(=C(C2=C1C(=O)N(C3=CC=CC=C32)C4=CC(=CC=C4)F)C5=CC=C(C=C5)F)CCC(CC(CC(=O)[O-])O)O D0G6PS HIGHSTAT Investigative D0G6QL DRUG__ID D0G6QL D0G6QL DRUGTYPE Small molecular drug D0G6QL DRUGINCH 1S/C13H10N2/c1-2-4-12-9-13(6-5-11(12)3-1)15-8-7-14-10-15/h1-10H D0G6QL DRUGINKE LHAAPZJTEBPKBJ-UHFFFAOYSA-N D0G6QL DRUGSMIL C1=CC=C2C=C(C=CC2=C1)N3C=CN=C3 D0G6QL HIGHSTAT Investigative D0G6RI DRUG__ID D0G6RI D0G6RI DRUGTYPE Small molecular drug D0G6RI DRUGINCH 1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13) D0G6RI DRUGINKE KKADPXVIOXHVKN-UHFFFAOYSA-N D0G6RI DRUGSMIL C1=CC(=CC=C1CC(=O)C(=O)O)O D0G6RI HIGHSTAT Investigative D0G6RN DRUG__ID D0G6RN D0G6RN DRUGTYPE Small molecular drug D0G6RN DRUGINCH 1S/C12H13NO3/c14-11(13-10-8-16-12(10)15)7-6-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H,13,14)/t10-/m0/s1 D0G6RN DRUGINKE UUEMOTWYJKOUPP-JTQLQIEISA-N D0G6RN DRUGSMIL C1C(C(=O)O1)NC(=O)CCC2=CC=CC=C2 D0G6RN HIGHSTAT Investigative D0G6SA DRUG__ID D0G6SA D0G6SA DRUGTYPE Small molecular drug D0G6SA DRUGINCH 1S/C17H15NO2/c1-19-16-9-13-8-14(12-6-4-3-5-7-12)11-18-15(13)10-17(16)20-2/h3-11H,1-2H3 D0G6SA DRUGINKE NZSMBYIPLGDVEM-UHFFFAOYSA-N D0G6SA DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=CC=C3 D0G6SA HIGHSTAT Investigative D0G6SL DRUG__ID D0G6SL D0G6SL DRUGTYPE Small molecular drug D0G6SL DRUGINCH 1S/C24H18O4/c1-27-19-12-13-21-20(16-19)22(25)23(26)24(28-21,18-10-6-3-7-11-18)15-14-17-8-4-2-5-9-17/h2-13,16,23,26H,1H3 D0G6SL DRUGINKE ITOHYACNWAMSCT-UHFFFAOYSA-N D0G6SL DRUGSMIL COC1=CC2=C(C=C1)OC(C(C2=O)O)(C#CC3=CC=CC=C3)C4=CC=CC=C4 D0G6SL HIGHSTAT Investigative D0G6SP DRUG__ID D0G6SP D0G6SP DRUGTYPE Small molecular drug D0G6SP DRUGINCH 1S/C37H46N4O6S/c1-6-38-26-16-22(2)33(23(3)17-26)47-20-30(43)39-28(18-24-12-8-7-9-13-24)32(44)36(46)41-21-48-37(4,5)34(41)35(45)40-31-27-15-11-10-14-25(27)19-29(31)42/h7-17,28-29,31-32,34,38,42,44H,6,18-21H2,1-5H3,(H,39,43)(H,40,45)/t28-,29+,31-,32-,34+/m0/s1 D0G6SP DRUGINKE MWCQAFKRDJYAQP-ZYOXRPPDSA-N D0G6SP DRUGSMIL CCNC1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0G6SP HIGHSTAT Investigative D0G6VT DRUG__ID D0G6VT D0G6VT DRUGTYPE Small molecular drug D0G6VT DRUGINCH 1S/C20H21IN6O5/c21-10-1-2-12-11(5-10)9(6-23-12)3-4-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)13(7-28)32-19/h1-2,5-6,8,13,15-16,19,23,28-30H,3-4,7H2,(H2,22,25,26)/t13-,15-,16-,19-/m1/s1 D0G6VT DRUGINKE RPHVWFYWABZLPJ-NVQRDWNXSA-N D0G6VT DRUGSMIL C1=CC2=C(C=C1I)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0G6VT HIGHSTAT Investigative D0G6WQ DRUG__ID D0G6WQ D0G6WQ DRUGTYPE Small molecular drug D0G6WQ DRUGINCH 1S/C16H33O3P/c1-5-6-7-8-11-20(17,18)19-16-12-14(4)9-10-15(16)13(2)3/h13-16H,5-12H2,1-4H3,(H,17,18)/t14-,15+,16-/m1/s1 D0G6WQ DRUGINKE WAVIZOVSJOXCKT-OWCLPIDISA-N D0G6WQ DRUGSMIL CCCCCCP(=O)(O)OC1CC(CCC1C(C)C)C D0G6WQ HIGHSTAT Investigative D0G6XS DRUG__ID D0G6XS D0G6XS DRUGTYPE Small molecular drug D0G6XS DRUGINCH 1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6?/m0/s1 D0G6XS DRUGINKE SHZGCJCMOBCMKK-DHVFOXMCSA-N D0G6XS DRUGSMIL CC1C(C(C(C(O1)O)O)O)O D0G6XS HIGHSTAT Investigative D0G6XT DRUG__ID D0G6XT D0G6XT DRUGTYPE Small molecular drug D0G6XT DRUGINCH 1S/C19H38O11P2/c1-3-5-7-9-11-13-18(20)27-15-17(16-28-32(25,26)30-31(22,23)24)29-19(21)14-12-10-8-6-4-2/h17H,3-16H2,1-2H3,(H,25,26)(H2,22,23,24)/t17-/m1/s1 D0G6XT DRUGINKE MBDSUZSCJLRKPC-QGZVFWFLSA-N D0G6XT DRUGSMIL CCCCCCCC(=O)OCC(COP(=O)(O)OP(=O)(O)O)OC(=O)CCCCCCC D0G6XT HIGHSTAT Investigative D0G7CG DRUG__ID D0G7CG D0G7CG DRUGTYPE Small molecular drug D0G7CG DRUGINCH 1S/C17H26N3O15P/c18-9-1-2-20(16(29)19-9)14-12(26)11(25)8(33-14)5-32-36(30,31)35-17(15(27)28)3-6(22)10(24)13(34-17)7(23)4-21/h1-2,6-8,10-14,21-26H,3-5H2,(H,27,28)(H,30,31)(H2,18,19,29)/t6-,7-,8-,10-,11-,12-,13-,14-,17-/m1/s1 D0G7CG DRUGINKE YWWJKULNWGRYAS-UOVSKDHASA-N D0G7CG DRUGSMIL C1C(C(C(OC1(C(=O)O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=NC3=O)N)O)O)C(CO)O)O)O D0G7CG HIGHSTAT Investigative D0G7DF DRUG__ID D0G7DF D0G7DF DRUGTYPE Small molecular drug D0G7DF DRUGINCH 1S/C25H27NO/c1-20-9-8-12-22(19-20)24(21-10-4-2-5-11-21)26-17-15-25(27,16-18-26)23-13-6-3-7-14-23/h2-14,19,24,27H,15-18H2,1H3 D0G7DF DRUGINKE ODFDCTDNLNJAAY-UHFFFAOYSA-N D0G7DF DRUGSMIL CC1=CC(=CC=C1)C(C2=CC=CC=C2)N3CCC(CC3)(C4=CC=CC=C4)O D0G7DF HIGHSTAT Investigative D0G7FB DRUG__ID D0G7FB D0G7FB DRUGTYPE Small molecular drug D0G7FB DRUGINCH 1S/C21H27N3S/c22-20-23-17-11-16-14(10-19(17)25-20)9-18-15-3-1-2-6-21(15,16)7-8-24(18)12-13-4-5-13/h10-11,13,15,18H,1-9,12H2,(H2,22,23)/t15-,18+,21+/m0/s1 D0G7FB DRUGINKE OQGLRMIBYLADSW-RRMPHLOHSA-N D0G7FB DRUGSMIL C1CCC23CCN(C(C2C1)CC4=CC5=C(C=C34)N=C(S5)N)CC6CC6 D0G7FB HIGHSTAT Investigative D0G7GF DRUG__ID D0G7GF D0G7GF DRUGTYPE Small molecular drug D0G7GF DRUGINCH 1S/C21H29NO/c1-4-5-6-7-13-21(2,3)17-11-12-19(20(23)15-17)16-9-8-10-18(22)14-16/h8-12,14-15,23H,4-7,13,22H2,1-3H3 D0G7GF DRUGINKE GWRWPRMABCQODZ-UHFFFAOYSA-N D0G7GF DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2=CC(=CC=C2)N)O D0G7GF HIGHSTAT Investigative D0G7HF DRUG__ID D0G7HF D0G7HF DRUGTYPE Small molecular drug D0G7HF DRUGINCH 1S/C15H20O2/c1-2-3-4-5-6-12-7-9-13(10-8-12)15(16)14-11-17-14/h7-10,14H,2-6,11H2,1H3 D0G7HF DRUGINKE MHFYINHLDHITER-UHFFFAOYSA-N D0G7HF DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)C2CO2 D0G7HF HIGHSTAT Investigative D0G7HN DRUG__ID D0G7HN D0G7HN DRUGTYPE Small molecular drug D0G7HN DRUGINCH 1S/C7H5IO4/c9-7(10)5-1-3-6(4-2-5)8(11)12/h1-4H,(H,9,10) D0G7HN DRUGINKE OCPGBAXIXDSOBI-UHFFFAOYSA-N D0G7HN DRUGSMIL C1=CC(=CC=C1C(=O)O)I(=O)=O D0G7HN HIGHSTAT Investigative D0G7HQ DRUG__ID D0G7HQ D0G7HQ DRUGTYPE Small molecular drug D0G7HQ DRUGINCH 1S/C6H12F2O10P2/c1-5(11,6(7,8)4(9)10)2-3-17-20(15,16)18-19(12,13)14/h11H,2-3H2,1H3,(H,9,10)(H,15,16)(H2,12,13,14) D0G7HQ DRUGINKE TYAGFMDNISQMRJ-UHFFFAOYSA-N D0G7HQ DRUGSMIL CC(CCOP(=O)(O)OP(=O)(O)O)(C(C(=O)O)(F)F)O D0G7HQ HIGHSTAT Investigative D0G7IR DRUG__ID D0G7IR D0G7IR DRUGTYPE Small molecular drug D0G7IR DRUGINCH 1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8) D0G7IR DRUGINKE OPTASPLRGRRNAP-UHFFFAOYSA-N D0G7IR DRUGSMIL C1=C(NC(=O)N=C1)N D0G7IR HIGHSTAT Investigative D0G7LE DRUG__ID D0G7LE D0G7LE DRUGTYPE Small molecular drug D0G7LE DRUGINCH 1S/C19H23NO2S/c21-23(22,18-9-5-2-6-10-18)19-12-15-20(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19H,11-16H2 D0G7LE DRUGINKE XFTLHKDSWBEMSE-UHFFFAOYSA-N D0G7LE DRUGSMIL C1CN(CCC1S(=O)(=O)C2=CC=CC=C2)CCC3=CC=CC=C3 D0G7LE HIGHSTAT Investigative D0G7MC DRUG__ID D0G7MC D0G7MC DRUGTYPE Small molecular drug D0G7MC DRUGINCH 1S/C17H21NO2/c1-2-3-4-5-8-14-10-11-16(15(19)13-14)20-17-9-6-7-12-18-17/h6-7,9-13,19H,2-5,8H2,1H3 D0G7MC DRUGINKE GGLAALKBNDMDTG-UHFFFAOYSA-N D0G7MC DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC=N2)O D0G7MC HIGHSTAT Investigative D0G7NE DRUG__ID D0G7NE D0G7NE DRUGTYPE Small molecular drug D0G7NE DRUGINCH 1S/C14H10N2O2/c15-7-1-3-9-11(5-7)14(18)12-6-8(16)2-4-10(12)13(9)17/h1-6H,15-16H2 D0G7NE DRUGINKE KJNHYKBXQOSFJR-UHFFFAOYSA-N D0G7NE DRUGSMIL C1=CC2=C(C=C1N)C(=O)C3=C(C2=O)C=CC(=C3)N D0G7NE HIGHSTAT Investigative D0G7NW DRUG__ID D0G7NW D0G7NW DRUGTYPE Small molecular drug D0G7NW DRUGINCH 1S/C19H21N3S/c1-14(12-21(2)3)13-22-16-6-4-5-7-18(16)23-19-9-8-15(11-20)10-17(19)22/h4-10,14H,12-13H2,1-3H3 D0G7NW DRUGINKE SLFGIOIONGJGRT-UHFFFAOYSA-N D0G7NW DRUGSMIL CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)C#N)CN(C)C D0G7NW HIGHSTAT Investigative D0G7OZ DRUG__ID D0G7OZ D0G7OZ DRUGTYPE Small molecular drug D0G7OZ DRUGINCH 1S/C26H34O5S/c27-23(28)18-19-32-25(24(29)26(30)31)22-17-11-10-16-21(22)15-9-4-2-1-3-6-12-20-13-7-5-8-14-20/h5,7-8,10-11,13-14,16-17,24-25,29H,1-4,6,9,12,15,18-19H2,(H,27,28)(H,30,31)/t24-,25-/m1/s1 D0G7OZ DRUGINKE PZIFPMYXXCAOCC-JWQCQUIFSA-N D0G7OZ DRUGSMIL C1=CC=C(C=C1)CCCCCCCCC2=CC=CC=C2C(C(C(=O)O)O)SCCC(=O)O D0G7OZ HIGHSTAT Investigative D0G7PB DRUG__ID D0G7PB D0G7PB DRUGTYPE Small molecular drug D0G7PB DRUGINCH 1S/C22H31NO3/c1-4-23(3)21(26)18-12-19-17-7-5-13-11-14(24)6-8-15(13)16(17)9-10-22(19,2)20(18)25/h6,8,11,16-20,24-25H,4-5,7,9-10,12H2,1-3H3/t16?,17?,18?,19?,20-,22-/m0/s1 D0G7PB DRUGINKE UVOQIEBXUFHOKA-GFEBWMDQSA-N D0G7PB DRUGSMIL CCN(C)C(=O)C1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O D0G7PB HIGHSTAT Investigative D0G7QJ DRUG__ID D0G7QJ D0G7QJ DRUGTYPE Small molecular drug D0G7QJ DRUGINCH 1S/C20H20N4O6/c25-18(26)4-6-22-19(27)13-7-14(10-17(9-13)24(29)30)20(28)23-16-2-1-12-3-5-21-11-15(12)8-16/h1-2,7-10,21H,3-6,11H2,(H,22,27)(H,23,28)(H,25,26) D0G7QJ DRUGINKE VGPKJRDGGNBIGH-UHFFFAOYSA-N D0G7QJ DRUGSMIL C1CNCC2=C1C=CC(=C2)NC(=O)C3=CC(=CC(=C3)C(=O)NCCC(=O)O)[N+](=O)[O-] D0G7QJ HIGHSTAT Investigative D0G7QT DRUG__ID D0G7QT D0G7QT DRUGTYPE Small molecular drug D0G7QT DRUGINCH 1S/C14H15ClN2/c1-9-14(10-4-6-16-7-5-10)12-8-11(15)2-3-13(12)17-9/h2-4,8,16-17H,5-7H2,1H3 D0G7QT DRUGINKE BPPGPYJBCVXILI-UHFFFAOYSA-N D0G7QT DRUGSMIL CC1=C(C2=C(N1)C=CC(=C2)Cl)C3=CCNCC3 D0G7QT HIGHSTAT Investigative D0G7RA DRUG__ID D0G7RA D0G7RA DRUGTYPE Small molecular drug D0G7RA DRUGINCH 1S/C16H11ClOS2/c1-10-2-4-12(5-3-10)15-14(16(18)20-19-15)11-6-8-13(17)9-7-11/h2-9H,1H3 D0G7RA DRUGINKE NLGIFTIQVVCDPR-UHFFFAOYSA-N D0G7RA DRUGSMIL CC1=CC=C(C=C1)C2=C(C(=O)SS2)C3=CC=C(C=C3)Cl D0G7RA HIGHSTAT Investigative D0G7RE DRUG__ID D0G7RE D0G7RE DRUGTYPE Small molecular drug D0G7RE DRUGINCH 1S/C35H42N4O6/c1-35(18-26-19-36-28-10-6-5-9-27(26)28,39-34(44)45-32-24-14-21-13-22(16-24)17-25(32)15-21)33(43)37-20-29(23-7-3-2-4-8-23)38-30(40)11-12-31(41)42/h2-10,19,21-22,24-25,29,32,36H,11-18,20H2,1H3,(H,37,43)(H,38,40)(H,39,44)(H,41,42)/t21?,22?,24?,25?,29-,32?,35-/m0/s1 D0G7RE DRUGINKE FVQSSYMRZKLFDR-ZTHIAPAOSA-N D0G7RE DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC(C3=CC=CC=C3)NC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0G7RE HIGHSTAT Investigative D0G7TT DRUG__ID D0G7TT D0G7TT DRUGTYPE Small molecular drug D0G7TT DRUGINCH 1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/t3-/m1/s1 D0G7TT DRUGINKE DDOQBQRIEWHWBT-GSVOUGTGSA-N D0G7TT DRUGSMIL C(CP(=O)(O)O)C(C(=O)O)N D0G7TT HIGHSTAT Investigative D0G8AG DRUG__ID D0G8AG D0G8AG DRUGTYPE Small molecular drug D0G8AG DRUGINCH 1S/C12H15N3O2S/c1-7-14-10-11(17)8(13-4-5-15(2)3)6-9(16)12(10)18-7/h6,13H,4-5H2,1-3H3 D0G8AG DRUGINKE MTUYOFGUEXWKLC-UHFFFAOYSA-N D0G8AG DRUGSMIL CC1=NC2=C(S1)C(=O)C=C(C2=O)NCCN(C)C D0G8AG HIGHSTAT Investigative D0G8BN DRUG__ID D0G8BN D0G8BN DRUGTYPE Small molecular drug D0G8BN DRUGINCH 1S/C19H21ClN2O2S/c20-16-5-3-13(4-6-16)7-8-21-19(25)22-9-1-2-14-10-17(23)18(24)11-15(14)12-22/h3-6,10-11,23-24H,1-2,7-9,12H2,(H,21,25) D0G8BN DRUGINKE DRCMAZOSEIMCHM-UHFFFAOYSA-N D0G8BN DRUGSMIL C1CC2=CC(=C(C=C2CN(C1)C(=S)NCCC3=CC=C(C=C3)Cl)O)O D0G8BN HIGHSTAT Investigative D0G8BT DRUG__ID D0G8BT D0G8BT DRUGTYPE Small molecular drug D0G8BT DRUGINCH 1S/C11H10N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,7,13H,5-6H2 D0G8BT DRUGINKE NTYXKFHKVREUMR-UHFFFAOYSA-N D0G8BT DRUGSMIL C1CN=CC2=C1C3=CC=CC=C3N2 D0G8BT HIGHSTAT Investigative D0G8CV DRUG__ID D0G8CV D0G8CV DRUGTYPE Small molecular drug D0G8CV DRUGINCH 1S/C24H27FN4O2/c1-16-24(30)27-21-5-2-6-22(23(21)31-16)29-12-10-28(11-13-29)9-3-4-17-15-26-20-8-7-18(25)14-19(17)20/h2,5-8,14-16,26H,3-4,9-13H2,1H3,(H,27,30)/t16-/m1/s1 D0G8CV DRUGINKE SDAMYSWGWHXMRT-MRXNPFEDSA-N D0G8CV DRUGSMIL CC1C(=O)NC2=C(O1)C(=CC=C2)N3CCN(CC3)CCCC4=CNC5=C4C=C(C=C5)F D0G8CV HIGHSTAT Investigative D0G8FF DRUG__ID D0G8FF D0G8FF DRUGTYPE Small molecular drug D0G8FF DRUGINCH 1S/C22H17NO3S/c24-14-16-6-1-2-11-19(16)27-13-5-12-23-21(25)17-9-3-7-15-8-4-10-18(20(15)17)22(23)26/h1-4,6-11,14H,5,12-13H2 D0G8FF DRUGINKE IYUOFUODBWFCBK-UHFFFAOYSA-N D0G8FF DRUGSMIL C1=CC=C(C(=C1)C=O)SCCCN2C(=O)C3=CC=CC4=C3C(=CC=C4)C2=O D0G8FF HIGHSTAT Investigative D0G8FT DRUG__ID D0G8FT D0G8FT DRUGTYPE Small molecular drug D0G8FT DRUGINCH 1S/C15H18N2/c1-12-11-15(17-9-5-2-6-10-17)16-14-8-4-3-7-13(12)14/h3-4,7-8,11H,2,5-6,9-10H2,1H3 D0G8FT DRUGINKE USYRQXDHKXGTCK-UHFFFAOYSA-N D0G8FT DRUGSMIL CC1=CC(=NC2=CC=CC=C12)N3CCCCC3 D0G8FT HIGHSTAT Investigative D0G8FU DRUG__ID D0G8FU D0G8FU DRUGTYPE Small molecular drug D0G8FU DRUGINCH 1S/C21H28N4O3S/c1-14(2)18-10-5-15(3)13-19(18)20(26)24-16-6-8-17(9-7-16)29(27,28)25-21-22-11-4-12-23-21/h4,6-9,11-12,14-15,18-19H,5,10,13H2,1-3H3,(H,24,26)(H,22,23,25)/t15-,18+,19-/m1/s1 D0G8FU DRUGINKE IIVDSKOVPRNBND-AYOQOUSVSA-N D0G8FU DRUGSMIL CC1CCC(C(C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC=CC=N3)C(C)C D0G8FU HIGHSTAT Investigative D0G8GA DRUG__ID D0G8GA D0G8GA DRUGTYPE Small molecular drug D0G8GA DRUGINCH 1S/C11H9N5/c12-10-9-11(14-6-13-10)16(7-15-9)8-4-2-1-3-5-8/h1-7H,(H2,12,13,14) D0G8GA DRUGINKE QOZYZBRNUYGQNF-UHFFFAOYSA-N D0G8GA DRUGSMIL C1=CC=C(C=C1)N2C=NC3=C(N=CN=C32)N D0G8GA HIGHSTAT Investigative D0G8GL DRUG__ID D0G8GL D0G8GL DRUGTYPE Small molecular drug D0G8GL DRUGINCH 1S/C19H22O6/c1-10(2)18(22)24-14-8-13(9-20)7-5-6-11(3)16(21)17-15(14)12(4)19(23)25-17/h8-9,14-17,21H,1,3-7H2,2H3/b13-8-/t14-,15-,16+,17+/m1/s1 D0G8GL DRUGINKE CCWGXWKAXMNGSZ-KSKPACDFSA-N D0G8GL DRUGSMIL CC(=C)C(=O)OC1C=C(CCCC(=C)C(C2C1C(=C)C(=O)O2)O)C=O D0G8GL HIGHSTAT Investigative D0G8HD DRUG__ID D0G8HD D0G8HD DRUGTYPE Small molecular drug D0G8HD DRUGINCH 1S/C13H11NO4S/c14-19(16,17)18-12-8-4-7-11(9-12)13(15)10-5-2-1-3-6-10/h1-9H,(H2,14,16,17) D0G8HD DRUGINKE WRPUJPPBHRVDQK-UHFFFAOYSA-N D0G8HD DRUGSMIL C1=CC=C(C=C1)C(=O)C2=CC(=CC=C2)OS(=O)(=O)N D0G8HD HIGHSTAT Investigative D0G8HM DRUG__ID D0G8HM D0G8HM DRUGTYPE Small molecular drug D0G8HM DRUGINCH 1S/C13H17IN2O/c14-10-6-8-12(9-7-10)16-13(17)15-11-4-2-1-3-5-11/h6-9,11H,1-5H2,(H2,15,16,17) D0G8HM DRUGINKE AQTBUVAFYDVTFD-UHFFFAOYSA-N D0G8HM DRUGSMIL C1CCC(CC1)NC(=O)NC2=CC=C(C=C2)I D0G8HM HIGHSTAT Investigative D0G8IA DRUG__ID D0G8IA D0G8IA DRUGTYPE Small molecular drug D0G8IA DRUGINCH 1S/C59H73N7O7S2/c1-38-54-43(37-74-38)57(69)61-46-16-12-13-17-49(46)66(54)53(68)36-63-30-28-62(29-31-63)25-15-11-9-7-6-8-10-14-24-60-52(67)33-39-18-20-47-44(32-39)58(2,3)55-41-35-42-51(73-50(41)22-26-64(47)55)23-27-65-48-21-19-40(75(70,71)72)34-45(48)59(4,5)56(42)65/h12-13,16-21,32,34-35,37,50-51H,6-11,14-15,22-31,33,36H2,1-5H3,(H4-,60,61,67,69,70,71,72)/p-2 D0G8IA DRUGINKE DGPHRPUJPHDIPO-UHFFFAOYSA-L D0G8IA DRUGSMIL CC1=C2C(=CS1)C(=O)NC3=CC=CC=C3N2C(=O)CN4CCN(CC4)CCCCCCCCCCNC(=O)CC5=CC6=C(C=C5)N7CCC8C(=C7C6(C)C)C=C9C(O8)CC[N+]1=C9C(C2=C1C=CC(=C2)S([O-])([O-])[O-])(C)C D0G8IA HIGHSTAT Investigative D0G8IH DRUG__ID D0G8IH D0G8IH DRUGTYPE Small molecular drug D0G8IH DRUGINCH 1S/C11H11NO/c1-12-10-6-7-11(13)9-5-3-2-4-8(9)10/h2-7,12-13H,1H3 D0G8IH DRUGINKE YEJJUWPHXGQPCZ-UHFFFAOYSA-N D0G8IH DRUGSMIL CNC1=CC=C(C2=CC=CC=C21)O D0G8IH HIGHSTAT Investigative D0G8JI DRUG__ID D0G8JI D0G8JI DRUGTYPE Small molecular drug D0G8JI DRUGINCH 1S/C26H38N8O7/c1-14(2)21-25(41)32-16(9-6-10-29-26(27)28)23(39)33-18(12-20(36)37)22(38)30-13-19(35)31-17(24(40)34-21)11-15-7-4-3-5-8-15/h3-5,7-8,14,16-18,21H,6,9-13H2,1-2H3,(H,30,38)(H,31,35)(H,32,41)(H,33,39)(H,34,40)(H,36,37)(H4,27,28,29)/t16-,17+,18+,21+/m1/s1 D0G8JI DRUGINKE PWWDFRZRXPLJAN-WKRCXCSHSA-N D0G8JI DRUGSMIL CC(C)C1C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N D0G8JI HIGHSTAT Investigative D0G8KA DRUG__ID D0G8KA D0G8KA DRUGTYPE Small molecular drug D0G8KA DRUGINCH 1S/C24H18ClF3N4O3/c1-15-14-22(32(31-15)20-8-4-2-6-18(20)25)34-21-9-5-3-7-19(21)30-23(33)29-16-10-12-17(13-11-16)35-24(26,27)28/h2-14H,1H3,(H2,29,30,33) D0G8KA DRUGINKE SAIPZPCGTLOMFE-UHFFFAOYSA-N D0G8KA DRUGSMIL CC1=NN(C(=C1)OC2=CC=CC=C2NC(=O)NC3=CC=C(C=C3)OC(F)(F)F)C4=CC=CC=C4Cl D0G8KA HIGHSTAT Investigative D0G8KT DRUG__ID D0G8KT D0G8KT DRUGTYPE Small molecular drug D0G8KT DRUGINCH 1S/C19H18N2O/c1-21-13-12-20-19(21)18(22)14-17(15-8-4-2-5-9-15)16-10-6-3-7-11-16/h2-14,18,22H,1H3 D0G8KT DRUGINKE ZNOUJOFQAABUAP-UHFFFAOYSA-N D0G8KT DRUGSMIL CN1C=CN=C1C(C=C(C2=CC=CC=C2)C3=CC=CC=C3)O D0G8KT HIGHSTAT Investigative D0G8LB DRUG__ID D0G8LB D0G8LB DRUGTYPE Small molecular drug D0G8LB DRUGINCH 1S/C13H16NO5.Hg.Na.H2O/c1-9(18-2)7-14-13(17)10-5-3-4-6-11(10)19-8-12(15)16;;;/h3-6,9H,1,7-8H2,2H3,(H,14,17)(H,15,16);;;1H2/q;;+1;/p-1 D0G8LB DRUGINKE QGGPRJRKWYRGKR-UHFFFAOYSA-M D0G8LB DRUGSMIL COC(CNC(=O)C1=CC=CC=C1OCC(=O)[O-])C[Hg].O.[Na+] D0G8LB HIGHSTAT Investigative D0G8NI DRUG__ID D0G8NI D0G8NI DRUGTYPE Small molecular drug D0G8NI DRUGINCH 1S/C16H22N4O2/c1-9(2)12-7-14(22-4)13(21-3)6-10(12)5-11-8-19-16(18)20-15(11)17/h6-9H,5H2,1-4H3,(H4,17,18,19,20) D0G8NI DRUGINKE PYNPWUIBJMVRIG-UHFFFAOYSA-N D0G8NI DRUGSMIL CC(C)C1=CC(=C(C=C1CC2=CN=C(N=C2N)N)OC)OC D0G8NI HIGHSTAT Investigative D0G8OD DRUG__ID D0G8OD D0G8OD DRUGTYPE Small molecular drug D0G8OD DRUGINCH 1S/C16H21N3O3/c1-12(2)10-14(15(20)18-9-8-17)19-16(21)22-11-13-6-4-3-5-7-13/h3-7,12,14H,9-11H2,1-2H3,(H,18,20)(H,19,21)/t14-/m0/s1 D0G8OD DRUGINKE UFXQLUZNMRVTPU-AWEZNQCLSA-N D0G8OD DRUGSMIL CC(C)CC(C(=O)NCC#N)NC(=O)OCC1=CC=CC=C1 D0G8OD HIGHSTAT Investigative D0G8SW DRUG__ID D0G8SW D0G8SW DRUGTYPE Small molecular drug D0G8SW DRUGINCH 1S/C18H21N3O3/c1-12-2-6-14(7-3-12)24-15-8-4-13(5-9-15)21-17(22)11-10-16(19)18(20)23/h2-9,16H,10-11,19H2,1H3,(H2,20,23)(H,21,22)/t16-/m0/s1 D0G8SW DRUGINKE SNPCQHHCCJNFNQ-INIZCTEOSA-N D0G8SW DRUGSMIL CC1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D0G8SW HIGHSTAT Investigative D0G8TL DRUG__ID D0G8TL D0G8TL DRUGTYPE Small molecular drug D0G8TL DRUGINCH 1S/C49H61N11O6/c1-28(2)18-39(44(51)61)56-46(63)40(19-29(3)4)58-49(66)43(22-32-25-54-38-17-11-9-15-35(32)38)60-47(64)41(20-30-12-6-5-7-13-30)59-48(65)42(21-31-24-53-37-16-10-8-14-34(31)37)57-45(62)36(50)23-33-26-52-27-55-33/h5-17,24-29,36,39-43,53-54H,18-23,50H2,1-4H3,(H2,51,61)(H,52,55)(H,56,63)(H,57,62)(H,58,66)(H,59,65)(H,60,64)/t36-,39-,40-,41-,42+,43+/m0/s1 D0G8TL DRUGINKE RGMLIBBPSJGIRX-XLAQBFAFSA-N D0G8TL DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC6=CN=CN6)N D0G8TL HIGHSTAT Investigative D0G8TM DRUG__ID D0G8TM D0G8TM DRUGTYPE Small molecular drug D0G8TM DRUGINCH 1S/C10H7BrO4S/c1-10(5-2-8(11)16-4-5)7(12)3-6(15-10)9(13)14/h2-4H,1H3,(H,13,14) D0G8TM DRUGINKE WJDLYZAOTHNUJX-UHFFFAOYSA-N D0G8TM DRUGSMIL CC1(C(=O)C=C(O1)C(=O)O)C2=CSC(=C2)Br D0G8TM HIGHSTAT Investigative D0G8UA DRUG__ID D0G8UA D0G8UA DRUGTYPE Small molecular drug D0G8UA DRUGINCH 1S/C18H22N2O/c21-18-9-5-4-8-16(18)14-17(15-6-2-1-3-7-15)20-12-10-19-11-13-20/h1-9,17,19,21H,10-14H2/t17-/m1/s1 D0G8UA DRUGINKE SBKGLFTUHHUCII-QGZVFWFLSA-N D0G8UA DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2O)C3=CC=CC=C3 D0G8UA HIGHSTAT Investigative D0G8VF DRUG__ID D0G8VF D0G8VF DRUGTYPE Small molecular drug D0G8VF DRUGINCH 1S/C27H22N2/c1-3-8-22(9-4-1)24-12-16-26(17-13-24)28-20-7-21-29-27-18-14-25(15-19-27)23-10-5-2-6-11-23/h1-21,28H/b20-7+,29-21? D0G8VF DRUGINKE NMTVOLGEUFUEOW-UUBFXEKFSA-N D0G8VF DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)NC=CC=NC3=CC=C(C=C3)C4=CC=CC=C4 D0G8VF HIGHSTAT Investigative D0G8VU DRUG__ID D0G8VU D0G8VU DRUGTYPE Small molecular drug D0G8VU DRUGINCH 1S/C20H22N4O/c1-16-5-4-7-17(13-16)20(25)22-15-23-9-11-24(12-10-23)19-8-3-2-6-18(19)14-21/h2-8,13H,9-12,15H2,1H3,(H,22,25) D0G8VU DRUGINKE DNULYRGWTFLJQL-UHFFFAOYSA-N D0G8VU DRUGSMIL CC1=CC(=CC=C1)C(=O)NCN2CCN(CC2)C3=CC=CC=C3C#N D0G8VU HIGHSTAT Investigative D0G8XJ DRUG__ID D0G8XJ D0G8XJ DRUGTYPE Small molecular drug D0G8XJ DRUGINCH 1S/C17H22ClN5O3/c18-5-11-13(24)14(25)17(26-11)23-7-21-12-15(19-6-20-16(12)23)22-10-4-8-1-2-9(10)3-8/h6-11,13-14,17,24-25H,1-5H2,(H,19,20,22) D0G8XJ DRUGINKE PVJGDYDNVNCGBT-UHFFFAOYSA-N D0G8XJ DRUGSMIL C1CC2CC1CC2NC3=C4C(=NC=N3)N(C=N4)C5C(C(C(O5)CCl)O)O D0G8XJ HIGHSTAT Investigative D0G8XL DRUG__ID D0G8XL D0G8XL DRUGTYPE Small molecular drug D0G8XL DRUGINCH 1S/C11H7N3O2/c12-5-8-2-1-3-10(4-8)14-7-9(6-13-14)11(15)16/h1-4,6-7H,(H,15,16) D0G8XL DRUGINKE FFNALGQEMPFZAF-UHFFFAOYSA-N D0G8XL DRUGSMIL C1=CC(=CC(=C1)N2C=C(C=N2)C(=O)O)C#N D0G8XL HIGHSTAT Investigative D0G8XR DRUG__ID D0G8XR D0G8XR DRUGTYPE Small molecular drug D0G8XR DRUGINCH 1S/C12H17IO/c1-7(2)10-5-9(13)6-11(8(3)4)12(10)14/h5-8,14H,1-4H3 D0G8XR DRUGINKE JMJHJCFWTNRPEI-UHFFFAOYSA-N D0G8XR DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)I D0G8XR HIGHSTAT Investigative D0G8ZD DRUG__ID D0G8ZD D0G8ZD DRUGTYPE Small molecular drug D0G8ZD DRUGINCH 1S/C22H19N3/c1-16(17-10-4-2-5-11-17)23-22-19-14-8-9-15-20(19)24-21(25-22)18-12-6-3-7-13-18/h2-16H,1H3,(H,23,24,25)/t16-/m1/s1 D0G8ZD DRUGINKE AEXWSMVZORVWML-MRXNPFEDSA-N D0G8ZD DRUGSMIL CC(C1=CC=CC=C1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4 D0G8ZD HIGHSTAT Investigative D0G9AI DRUG__ID D0G9AI D0G9AI DRUGTYPE Small molecular drug D0G9AI DRUGINCH 1S/C16H20N4O4/c17-11(7-9-8-19-12-4-2-1-3-10(9)12)15(22)20-13(16(23)24)5-6-14(18)21/h1-4,8,11,13,19H,5-7,17H2,(H2,18,21)(H,20,22)(H,23,24)/t11-,13-/m0/s1 D0G9AI DRUGINKE NZCPCJCJZHKFGZ-AAEUAGOBSA-N D0G9AI DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCC(=O)N)C(=O)O)N D0G9AI HIGHSTAT Investigative D0G9EU DRUG__ID D0G9EU D0G9EU DRUGTYPE Small molecular drug D0G9EU DRUGINCH 1S/C17H26O/c1-4-17(2,3)15-10-8-13(9-11-15)14-6-5-7-16(18)12-14/h8-11,14,16,18H,4-7,12H2,1-3H3/t14-,16-/m1/s1 D0G9EU DRUGINKE NGNJEMWGXAUJKO-GDBMZVCRSA-N D0G9EU DRUGSMIL CCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0G9EU HIGHSTAT Investigative D0G9FQ DRUG__ID D0G9FQ D0G9FQ DRUGTYPE Small molecular drug D0G9FQ DRUGINCH 1S/C30H47NO3/c1-18-10-13-30(25(32)33)15-14-28(6)21(24(30)19(18)2)8-9-23-27(5)17-20(31-34)16-26(3,4)22(27)11-12-29(23,28)7/h8,18-20,22-24H,9-17H2,1-7H3,(H,32,33)/t18-,19+,20?,22+,23-,24+,27+,28-,29-,30+/m1/s1 D0G9FQ DRUGINKE YUEQLEDAPGIQNH-POPBXVHQSA-N D0G9FQ DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)N=O)C)C)C2C1C)C)C(=O)O D0G9FQ HIGHSTAT Investigative D0G9IP DRUG__ID D0G9IP D0G9IP DRUGTYPE Small molecular drug D0G9IP DRUGINCH 1S/C20H24O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h2-5,8,11,14,17-19H2,1H3,(H,21,22) D0G9IP DRUGINKE MGLDCXPLYOWQRP-UHFFFAOYSA-N D0G9IP DRUGSMIL CCCCCC#CCC#CCC#CCC#CCCCC(=O)O D0G9IP HIGHSTAT Investigative D0G9KD DRUG__ID D0G9KD D0G9KD DRUGTYPE Small molecular drug D0G9KD DRUGINCH 1S/C18H12BrN3/c19-14-6-3-7-15(10-14)22-18-16-8-12-4-1-2-5-13(12)9-17(16)20-11-21-18/h1-11H,(H,20,21,22) D0G9KD DRUGINKE BUVKJPOCMOXSSQ-UHFFFAOYSA-N D0G9KD DRUGSMIL C1=CC=C2C=C3C(=CC2=C1)C(=NC=N3)NC4=CC(=CC=C4)Br D0G9KD HIGHSTAT Investigative D0G9LM DRUG__ID D0G9LM D0G9LM DRUGTYPE Small molecular drug D0G9LM DRUGINCH 1S/C5H10N2O4/c6-3(5(9)10)1-2-4(8)7-11/h3,11H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1 D0G9LM DRUGINKE YVGZXTQJQNXIAU-VKHMYHEASA-N D0G9LM DRUGSMIL C(CC(=O)NO)C(C(=O)O)N D0G9LM HIGHSTAT Investigative D0G9LW DRUG__ID D0G9LW D0G9LW DRUGTYPE Small molecular drug D0G9LW DRUGINCH 1S/C16H18FO7PS/c17-14-8-1-2-9-15(14)24-13-7-3-5-12(11-13)6-4-10-16(25(18,19)20)26(21,22)23/h1-3,5,7-9,11,16H,4,6,10H2,(H2,18,19,20)(H,21,22,23)/p-3 D0G9LW DRUGINKE OHYIVSIWKOMZPF-UHFFFAOYSA-K D0G9LW DRUGSMIL C1=CC=C(C(=C1)OC2=CC=CC(=C2)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-])F D0G9LW HIGHSTAT Investigative D0G9NE DRUG__ID D0G9NE D0G9NE DRUGTYPE Small molecular drug D0G9NE DRUGINCH 1S/C16H22N2O3S/c17-22(20,21)13-7-8-14-12(10-13)6-9-15(14)18-16(19)11-4-2-1-3-5-11/h7-8,10-11,15H,1-6,9H2,(H,18,19)(H2,17,20,21) D0G9NE DRUGINKE XUDBTOFDMYBQSW-UHFFFAOYSA-N D0G9NE DRUGSMIL C1CCC(CC1)C(=O)NC2CCC3=C2C=CC(=C3)S(=O)(=O)N D0G9NE HIGHSTAT Investigative D0G9NS DRUG__ID D0G9NS D0G9NS DRUGTYPE Small molecular drug D0G9NS DRUGINCH 1S/C16H13N3O3/c20-10-19(12-7-5-11(6-8-12)16(21)22)9-15-17-13-3-1-2-4-14(13)18-15/h1-8,10H,9H2,(H,17,18)(H,21,22) D0G9NS DRUGINKE FSCLGIGYPFWUHQ-UHFFFAOYSA-N D0G9NS DRUGSMIL C1=CC=C2C(=C1)NC(=N2)CN(C=O)C3=CC=C(C=C3)C(=O)O D0G9NS HIGHSTAT Investigative D0G9UX DRUG__ID D0G9UX D0G9UX DRUGTYPE Small molecular drug D0G9UX DRUGINCH 1S/C16H16NO6P/c18-16(19)13(17-9-24(20,21)22)7-10-5-6-12-11-3-1-2-4-14(11)23-15(12)8-10/h1-6,8,13,17H,7,9H2,(H,18,19)(H2,20,21,22) D0G9UX DRUGINKE CRUVAUSVWLATAE-UHFFFAOYSA-N D0G9UX DRUGSMIL C1=CC=C2C(=C1)C3=C(O2)C=C(C=C3)CC(C(=O)O)NCP(=O)(O)O D0G9UX HIGHSTAT Investigative D0G9WE DRUG__ID D0G9WE D0G9WE DRUGTYPE Small molecular drug D0G9WE DRUGINCH 1S/C31H42N2O6/c1-18-16-32-19(2)25(18)26(35)38-20(3)22-8-9-30-23-7-6-21-14-29(36)11-10-27(21,4)31(23,39-29)24(34)15-28(22,30)17-33(5)12-13-37-30/h7-8,16,20-21,24,32,34,36H,6,9-15,17H2,1-5H3/t20-,21+,24+,27-,28-,29+,30-,31-/m0/s1 D0G9WE DRUGINKE ISNYUQWBWALXEY-OMIQOYQYSA-N D0G9WE DRUGSMIL CC1=CNC(=C1C(=O)OC(C)C2=CCC34C2(CC(C56C3=CCC7C5(CCC(C7)(O6)O)C)O)CN(CCO4)C)C D0G9WE HIGHSTAT Investigative D0G9WP DRUG__ID D0G9WP D0G9WP DRUGTYPE Small molecular drug D0G9WP DRUGINCH 1S/C14H11NO/c16-14-6-4-11-8-10(3-5-13(11)14)12-2-1-7-15-9-12/h1-3,5,7-9H,4,6H2 D0G9WP DRUGINKE QNSOPUXDEXJMIY-UHFFFAOYSA-N D0G9WP DRUGSMIL C1CC(=O)C2=C1C=C(C=C2)C3=CN=CC=C3 D0G9WP HIGHSTAT Investigative D0G9WX DRUG__ID D0G9WX D0G9WX DRUGTYPE Small molecular drug D0G9WX DRUGINCH 1S/C15H12N2S2/c18-15-17-16-14(19-15)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13H,(H,17,18) D0G9WX DRUGINKE NYLCTMQHPFIJCL-UHFFFAOYSA-N D0G9WX DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C3=NNC(=S)S3 D0G9WX HIGHSTAT Investigative D0G9XX DRUG__ID D0G9XX D0G9XX DRUGTYPE Small molecular drug D0G9XX DRUGINCH 1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1 D0G9XX DRUGINKE LTFMZDNNPPEQNG-KVQBGUIXSA-N D0G9XX DRUGSMIL C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)O)O D0G9XX HIGHSTAT Investigative D0G9YL DRUG__ID D0G9YL D0G9YL DRUGTYPE Small molecular drug D0G9YL DRUGINCH 1S/C30H23Cl2NO4/c1-17(2)29-24(28(33-37-29)27-25(31)7-4-8-26(27)32)16-36-21-12-9-18(10-13-21)19-11-14-22-20(15-19)5-3-6-23(22)30(34)35/h3-15,17H,16H2,1-2H3,(H,34,35) D0G9YL DRUGINKE TUOXXRMLFZBSTB-UHFFFAOYSA-N D0G9YL DRUGSMIL CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC=C(C=C3)C4=CC5=C(C=C4)C(=CC=C5)C(=O)O D0G9YL HIGHSTAT Investigative D0GA0Y DRUG__ID D0GA0Y D0GA0Y DRUGTYPE Small molecular drug D0GA0Y DRUGINCH 1S/C15H13N3O/c1-9-3-2-4-12-13(9)17-14(18-15(12)19)10-5-7-11(16)8-6-10/h2-8H,16H2,1H3,(H,17,18,19) D0GA0Y DRUGINKE RFMIZKCQNUDSTO-UHFFFAOYSA-N D0GA0Y DRUGSMIL CC1=C2C(=CC=C1)C(=O)NC(=N2)C3=CC=C(C=C3)N D0GA0Y HIGHSTAT Investigative D0GA4M DRUG__ID D0GA4M D0GA4M DRUGTYPE Small molecular drug D0GA4M DRUGINCH 1S/C15H10N4/c16-9-12-4-3-5-13(8-12)14-10-18-19(11-14)15-6-1-2-7-17-15/h1-8,10-11H D0GA4M DRUGINKE WCEMBGUJGXXYCF-UHFFFAOYSA-N D0GA4M DRUGSMIL C1=CC=NC(=C1)N2C=C(C=N2)C3=CC=CC(=C3)C#N D0GA4M HIGHSTAT Investigative D0GB8I DRUG__ID D0GB8I D0GB8I DRUGTYPE Small molecular drug D0GB8I DRUGINCH 1S/C15H22N2O3/c1-11(2)10-13(15(19)17-20)14(18)16-9-8-12-6-4-3-5-7-12/h3-7,11,13,20H,8-10H2,1-2H3,(H,16,18)(H,17,19) D0GB8I DRUGINKE WODYKKMWHBZSIB-UHFFFAOYSA-N D0GB8I DRUGSMIL CC(C)CC(C(=O)NCCC1=CC=CC=C1)C(=O)NO D0GB8I HIGHSTAT Investigative D0GB8J DRUG__ID D0GB8J D0GB8J DRUGTYPE Small molecular drug D0GB8J DRUGINCH 1S/C8H15NO2/c9-7(8(10)11)6-4-2-1-3-5-6/h6-7H,1-5,9H2,(H,10,11)/t7-/m0/s1 D0GB8J DRUGINKE WAMWSIDTKSNDCU-ZETCQYMHSA-N D0GB8J DRUGSMIL C1CCC(CC1)C(C(=O)O)N D0GB8J HIGHSTAT Investigative D0GC1Y DRUG__ID D0GC1Y D0GC1Y DRUGTYPE Small molecular drug D0GC1Y DRUGINCH 1S/C6H13N5O4/c7-4(5(12)13)2-1-3-9-6(8)10-11(14)15/h4H,1-3,7H2,(H,12,13)(H3,8,9,10)/t4-/m0/s1 D0GC1Y DRUGINKE MRAUNPAHJZDYCK-BYPYZUCNSA-N D0GC1Y DRUGSMIL C(CC(C(=O)O)N)CN=C(N)N[N+](=O)[O-] D0GC1Y HIGHSTAT Investigative D0GC5Y DRUG__ID D0GC5Y D0GC5Y DRUGTYPE Small molecular drug D0GC5Y DRUGINCH 1S/C25H23ClF3N5O3/c26-19-15-17(10-12-20(19)37-25(27,28)29)24-34-33-22(36-24)8-1-2-13-30-21(35)7-3-6-18-11-9-16-5-4-14-31-23(16)32-18/h4-5,9-12,14-15H,1-3,6-8,13H2,(H,30,35) D0GC5Y DRUGINKE RCSBCWXPGSPJNF-UHFFFAOYSA-N D0GC5Y DRUGSMIL C1=CC2=C(N=C1)N=C(C=C2)CCCC(=O)NCCCCC3=NN=C(O3)C4=CC(=C(C=C4)OC(F)(F)F)Cl D0GC5Y HIGHSTAT Investigative D0GC7S DRUG__ID D0GC7S D0GC7S DRUGTYPE Small molecular drug D0GC7S DRUGINCH 1S/C21H16N4O/c26-21(23-16-9-2-1-3-10-16)25-20-17-11-5-4-8-15(17)14-19(24-20)18-12-6-7-13-22-18/h1-14H,(H2,23,24,25,26) D0GC7S DRUGINKE IJXVHHOSRPNGFG-UHFFFAOYSA-N D0GC7S DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=NC(=CC3=CC=CC=C32)C4=CC=CC=N4 D0GC7S HIGHSTAT Investigative D0GC9B DRUG__ID D0GC9B D0GC9B DRUGTYPE Small molecular drug D0GC9B DRUGINCH 1S/C51H67N7O15S.2H3N/c1-6-8-18-38(55-47(64)40(58-50(67)72-51(3,4)5)27-33-21-23-35(24-22-33)73-74(68,69)70)45(62)53-31-43(59)54-41(28-34-30-52-37-20-14-13-17-36(34)37)48(65)56-39(19-9-7-2)46(63)57-42(29-44(60)61)49(66)71-26-25-32-15-11-10-12-16-32;;/h10-17,20-24,30,38-42,52H,6-9,18-19,25-29,31H2,1-5H3,(H,53,62)(H,54,59)(H,55,64)(H,56,65)(H,57,63)(H,58,67)(H,60,61)(H,68,69,70);2*1H3/t38-,39-,40-,41-,42-;;/m0../s1 D0GC9B DRUGINKE NKUXFWRTWZIEIT-IKSUPOOSSA-N D0GC9B DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)OCCC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)OC(C)(C)C.N.N D0GC9B HIGHSTAT Investigative D0GD5G DRUG__ID D0GD5G D0GD5G DRUGTYPE Small molecular drug D0GD5G DRUGINCH 1S/C22H40N8O5/c23-10-2-1-6-14(24)19(32)30-13-5-9-17(30)20(33)29-12-4-8-16(29)18(31)28-15(21(34)35)7-3-11-27-22(25)26/h14-17H,1-13,23-24H2,(H,28,31)(H,34,35)(H4,25,26,27)/t14-,15-,16-,17-/m0/s1 D0GD5G DRUGINKE CKFCCXJQYNXYHI-QAETUUGQSA-N D0GD5G DRUGSMIL C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCCN)N)C(=O)NC(CCCN=C(N)N)C(=O)O D0GD5G HIGHSTAT Investigative D0GD8Y DRUG__ID D0GD8Y D0GD8Y DRUGTYPE Small molecular drug D0GD8Y DRUGINCH 1S/C18H16N6S2/c19-9-11(17(23)25-15-7-3-1-5-13(15)21)12(10-20)18(24)26-16-8-4-2-6-14(16)22/h1-8H,21-24H2/b17-11+,18-12+ D0GD8Y DRUGINKE DVEXZJFMOKTQEZ-JYFOCSDGSA-N D0GD8Y DRUGSMIL C1=CC=C(C(=C1)N)SC(=C(C#N)C(=C(N)SC2=CC=CC=C2N)C#N)N D0GD8Y HIGHSTAT Investigative D0GD9G DRUG__ID D0GD9G D0GD9G DRUGTYPE Small molecular drug D0GD9G DRUGINCH 1S/C22H24ClNO/c1-3-4-7-14-24-16(2)22(19-8-5-6-9-20(19)24)21(25)15-17-10-12-18(23)13-11-17/h5-6,8-13H,3-4,7,14-15H2,1-2H3 D0GD9G DRUGINKE ZFTOVDKPJSCPEE-UHFFFAOYSA-N D0GD9G DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)Cl)C D0GD9G HIGHSTAT Investigative D0GE3O DRUG__ID D0GE3O D0GE3O DRUGTYPE Small molecular drug D0GE3O DRUGINCH 1S/C20H27NO3/c1-2-3-4-5-6-7-8-11-14-21-18-13-10-9-12-16(18)17(20(21)24)15-19(22)23/h9-10,12-13,15H,2-8,11,14H2,1H3,(H,22,23)/b17-15+ D0GE3O DRUGINKE LIUQXAWYSKFADK-BMRADRMJSA-N D0GE3O DRUGSMIL CCCCCCCCCCN1C2=CC=CC=C2C(=CC(=O)O)C1=O D0GE3O HIGHSTAT Investigative D0GE4A DRUG__ID D0GE4A D0GE4A DRUGTYPE Small molecular drug D0GE4A DRUGINCH 1S/C14H16N2O2/c1-2-3-8-15-14(18)13(17)11-9-16-12-7-5-4-6-10(11)12/h4-7,9,16H,2-3,8H2,1H3,(H,15,18) D0GE4A DRUGINKE XTLXOIBNXHXNBR-UHFFFAOYSA-N D0GE4A DRUGSMIL CCCCNC(=O)C(=O)C1=CNC2=CC=CC=C21 D0GE4A HIGHSTAT Investigative D0GE8S DRUG__ID D0GE8S D0GE8S DRUGTYPE Small molecular drug D0GE8S DRUGINCH 1S/C18H16N2O6/c1-10-13(9-26-12-6-4-11(5-7-12)20(23)24)16-17(19(10)2)14(21)8-15(25-3)18(16)22/h4-8H,9H2,1-3H3 D0GE8S DRUGINKE IBLWSLZYYZHSRG-UHFFFAOYSA-N D0GE8S DRUGSMIL CC1=C(C2=C(N1C)C(=O)C=C(C2=O)OC)COC3=CC=C(C=C3)[N+](=O)[O-] D0GE8S HIGHSTAT Investigative D0GE9U DRUG__ID D0GE9U D0GE9U DRUGTYPE Small molecular drug D0GE9U DRUGINCH 1S/C10H9NO/c11-10-3-1-2-8(6-10)9-4-5-12-7-9/h1-7H,11H2 D0GE9U DRUGINKE LQDARHFLRKPAMM-UHFFFAOYSA-N D0GE9U DRUGSMIL C1=CC(=CC(=C1)N)C2=COC=C2 D0GE9U HIGHSTAT Investigative D0GF4I DRUG__ID D0GF4I D0GF4I DRUGTYPE Small molecular drug D0GF4I DRUGINCH 1S/C9H15N2O14P3S/c12-6-4(3-22-27(18,19)25-28(20,21)24-26(15,16)17)23-8(7(6)13)11-2-1-5(29)10-9(11)14/h1-2,4,6-8,12-13H,3H2,(H,18,19)(H,20,21)(H,10,14,29)(H2,15,16,17)/t4-,6-,7-,8-/m1/s1 D0GF4I DRUGINKE GKVHYBAWZAYQDO-XVFCMESISA-N D0GF4I DRUGSMIL C1=CN(C(=O)NC1=S)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O D0GF4I HIGHSTAT Investigative D0GF9J DRUG__ID D0GF9J D0GF9J DRUGTYPE Small molecular drug D0GF9J DRUGINCH 1S/C15H12O4/c16-15(17)8-10-5-6-13-14(7-10)18-9-11-3-1-2-4-12(11)19-13/h1-7H,8-9H2,(H,16,17) D0GF9J DRUGINKE QTBPZEAQRRAFFF-UHFFFAOYSA-N D0GF9J DRUGSMIL C1C2=CC=CC=C2OC3=C(O1)C=C(C=C3)CC(=O)O D0GF9J HIGHSTAT Investigative D0GG2J DRUG__ID D0GG2J D0GG2J DRUGTYPE Small molecular drug D0GG2J DRUGINCH 1S/C19H20F4N2O/c20-16-7-3-2-6-15(16)17(25-11-9-24-10-12-25)13-14-5-1-4-8-18(14)26-19(21,22)23/h1-8,17,24H,9-13H2 D0GG2J DRUGINKE WARUECLCXNMKJR-UHFFFAOYSA-N D0GG2J DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2OC(F)(F)F)C3=CC=CC=C3F D0GG2J HIGHSTAT Investigative D0GG4T DRUG__ID D0GG4T D0GG4T DRUGTYPE Small molecular drug D0GG4T DRUGINCH 1S/C25H23NO/c1-2-3-16-26-18-21(17-24(26)20-11-5-4-6-12-20)25(27)23-15-9-13-19-10-7-8-14-22(19)23/h4-15,17-18H,2-3,16H2,1H3 D0GG4T DRUGINKE PTIAQHRJOQEMCO-UHFFFAOYSA-N D0GG4T DRUGSMIL CCCCN1C=C(C=C1C2=CC=CC=C2)C(=O)C3=CC=CC4=CC=CC=C43 D0GG4T HIGHSTAT Investigative D0GG6X DRUG__ID D0GG6X D0GG6X DRUGTYPE Small molecular drug D0GG6X DRUGINCH 1S/C35H34O11/c1-5-17(2)12-18(3)6-9-22(38)14-25-30(35(45,19(4)36)33(43)31(25)41)24-16-27(40)26(39)15-23(24)29-32(42)28(46-34(29)44)13-20-7-10-21(37)11-8-20/h6-13,15-17,33,37,39-40,42-43,45H,5,14H2,1-4H3/b9-6+,18-12+,28-13- D0GG6X DRUGINKE YACYONYLJTYMLP-AIXQLNHRSA-N D0GG6X DRUGSMIL CCC(C)C=C(C)C=CC(=O)CC1=C(C(C(C1=O)O)(C(=O)C)O)C2=CC(=C(C=C2C3=C(C(=CC4=CC=C(C=C4)O)OC3=O)O)O)O D0GG6X HIGHSTAT Investigative D0GG7Z DRUG__ID D0GG7Z D0GG7Z DRUGTYPE Small molecular drug D0GG7Z DRUGINCH 1S/C32H39NO4/c1-8-27(2,3)20-10-9-11-21-24(20)19-16-18-12-13-31(35)23-17-22(34)26-28(4,5)37-32(23,36-26)15-14-29(31,6)30(18,7)25(19)33-21/h8-11,17-18,26,33,35H,1,12-16H2,2-7H3/t18-,26-,29+,30+,31+,32-/m0/s1 D0GG7Z DRUGINKE YVDJBQQJIDPRKP-SLUQHKSNSA-N D0GG7Z DRUGSMIL CC1(C2C(=O)C=C3C4(CCC5CC6=C(C5(C4(CCC3(O2)O1)C)C)NC7=CC=CC(=C67)C(C)(C)C=C)O)C D0GG7Z HIGHSTAT Investigative D0GG9W DRUG__ID D0GG9W D0GG9W DRUGTYPE Small molecular drug D0GG9W DRUGINCH 1S/C22H18ClN3O4/c1-25-9-20(27)26-17(22(25)28)4-11-5-18-19(30-10-29-18)7-13(11)21(26)15-8-24-16-3-2-12(23)6-14(15)16/h2-3,5-8,17,21,24H,4,9-10H2,1H3/t17-,21-/m0/s1 D0GG9W DRUGINKE FSEZESVJDPKRDS-UWJYYQICSA-N D0GG9W DRUGSMIL CN1CC(=O)N2C(C1=O)CC3=CC4=C(C=C3C2C5=CNC6=C5C=C(C=C6)Cl)OCO4 D0GG9W HIGHSTAT Investigative D0GH1I DRUG__ID D0GH1I D0GH1I DRUGTYPE Small molecular drug D0GH1I DRUGINCH 1S/C19H18O4/c1-12(2)10-22-15-7-8-16-18(9-15)23-11-17(19(16)21)13-3-5-14(20)6-4-13/h3-9,11-12,20H,10H2,1-2H3 D0GH1I DRUGINKE WYYSKWHYOXHLTB-UHFFFAOYSA-N D0GH1I DRUGSMIL CC(C)COC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O D0GH1I HIGHSTAT Investigative D0GH9J DRUG__ID D0GH9J D0GH9J DRUGTYPE Small molecular drug D0GH9J DRUGINCH 1S/C19H41O5PS/c1-3-5-7-9-11-13-15-22-17-19(18-24-25(20,21)26)23-16-14-12-10-8-6-4-2/h19H,3-18H2,1-2H3,(H2,20,21,26)/t19-/m0/s1 D0GH9J DRUGINKE PLCCQSPJUXGEHV-IBGZPJMESA-N D0GH9J DRUGSMIL CCCCCCCCOCC(COP(=S)(O)O)OCCCCCCCC D0GH9J HIGHSTAT Investigative D0GI1D DRUG__ID D0GI1D D0GI1D DRUGTYPE Small molecular drug D0GI1D DRUGINCH 1S/C14H16Cl2N2O2/c15-11-6-5-8(7-12(11)16)18-14(20)10-4-2-1-3-9(10)13(17)19/h5-7,9-10H,1-4H2,(H2,17,19)(H,18,20)/t9-,10+/m1/s1 D0GI1D DRUGINKE AVKZWCJNDWOBAM-ZJUUUORDSA-N D0GI1D DRUGSMIL C1CCC(C(C1)C(=O)N)C(=O)NC2=CC(=C(C=C2)Cl)Cl D0GI1D HIGHSTAT Investigative D0GI2R DRUG__ID D0GI2R D0GI2R DRUGTYPE Small molecular drug D0GI2R DRUGINCH 1S/C9H9ClN2O2S2/c10-7-1-2-9-8(3-7)6(5-15-9)4-12-16(11,13)14/h1-3,5,12H,4H2,(H2,11,13,14) D0GI2R DRUGINKE PURBZUVIUSNPGZ-UHFFFAOYSA-N D0GI2R DRUGSMIL C1=CC2=C(C=C1Cl)C(=CS2)CNS(=O)(=O)N D0GI2R HIGHSTAT Investigative D0GI5V DRUG__ID D0GI5V D0GI5V DRUGTYPE Small molecular drug D0GI5V DRUGINCH 1S/C21H22ClF3N2O/c1-27-13-6-5-12-17(27)19(14-8-3-2-4-9-14)26-20(28)15-10-7-11-16(18(15)22)21(23,24)25/h2-4,7-11,17,19H,5-6,12-13H2,1H3,(H,26,28)/t17-,19-/m0/s1 D0GI5V DRUGINKE XPXKFXNVIAOBEI-HKUYNNGSSA-N D0GI5V DRUGSMIL CN1CCCCC1C(C2=CC=CC=C2)NC(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl D0GI5V HIGHSTAT Investigative D0GI7S DRUG__ID D0GI7S D0GI7S DRUGTYPE Small molecular drug D0GI7S DRUGINCH 1S/C10H13N/c1-2-4-9(5-3-1)10-6-7-11-8-10/h1-5,10-11H,6-8H2 D0GI7S DRUGINKE PRRFFTYUBPGHLE-UHFFFAOYSA-N D0GI7S DRUGSMIL C1CNCC1C2=CC=CC=C2 D0GI7S HIGHSTAT Investigative D0GI9S DRUG__ID D0GI9S D0GI9S DRUGTYPE Small molecular drug D0GI9S DRUGINCH 1S/C5H13NS2/c1-8-3-2-5(6)4-7/h5,7H,2-4,6H2,1H3/t5-/m0/s1 D0GI9S DRUGINKE NSPBTQHSHXESOT-YFKPBYRVSA-N D0GI9S DRUGSMIL CSCCC(CS)N D0GI9S HIGHSTAT Investigative D0GJ1E DRUG__ID D0GJ1E D0GJ1E DRUGTYPE Small molecular drug D0GJ1E DRUGINCH 1S/C14H18BrNO3/c15-12-9-7-11(8-10-12)13(17)5-3-1-2-4-6-14(18)16-19/h7-10,19H,1-6H2,(H,16,18) D0GJ1E DRUGINKE RFYYZRFJBNAHCG-UHFFFAOYSA-N D0GJ1E DRUGSMIL C1=CC(=CC=C1C(=O)CCCCCCC(=O)NO)Br D0GJ1E HIGHSTAT Investigative D0GJ7J DRUG__ID D0GJ7J D0GJ7J DRUGTYPE Small molecular drug D0GJ7J DRUGINCH 1S/C18H14Cl4N2O/c19-12-4-5-13(17(22)8-12)18(9-24-7-6-23-11-24)25-10-14-15(20)2-1-3-16(14)21/h1-8,11,18H,9-10H2 D0GJ7J DRUGINKE MPIPASJGOJYODL-UHFFFAOYSA-N D0GJ7J DRUGSMIL C1=CC(=C(C(=C1)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl D0GJ7J HIGHSTAT Investigative D0GJ8U DRUG__ID D0GJ8U D0GJ8U DRUGTYPE Small molecular drug D0GJ8U DRUGINCH 1S/C16H21N3O2/c20-16-14-6-2-1-5-13(14)15(17-18-16)7-3-4-8-19-9-11-21-12-10-19/h1-2,5-6H,3-4,7-12H2,(H,18,20) D0GJ8U DRUGINKE BMGFFXOJQJDSQN-UHFFFAOYSA-N D0GJ8U DRUGSMIL C1COCCN1CCCCC2=NNC(=O)C3=CC=CC=C32 D0GJ8U HIGHSTAT Investigative D0GK6Q DRUG__ID D0GK6Q D0GK6Q DRUGTYPE Small molecular drug D0GK6Q DRUGINCH 1S/C24H31IN5O7P/c1-15(16-6-5-7-17(10-16)24(34)35)28-13-18(31)14-38(36,37)9-4-2-3-8-27-23(33)19-11-20(25)21(29-30-26)12-22(19)32/h5-7,10-12,15,18,28,31-32H,2-4,8-9,13-14H2,1H3,(H,27,33)(H,34,35)(H,36,37)/t15-,18+/m1/s1/i25-2 D0GK6Q DRUGINKE IHFUJPDKHJTHGQ-DQPKGEOYSA-N D0GK6Q DRUGSMIL CC(C1=CC(=CC=C1)C(=O)O)NCC(CP(=O)(CCCCCNC(=O)C2=CC(=C(C=C2O)N=[N+]=[N-])I)O)O D0GK6Q HIGHSTAT Investigative D0GK7A DRUG__ID D0GK7A D0GK7A DRUGTYPE Small molecular drug D0GK7A DRUGINCH 1S/C30H47N5O2/c1-22(2)35-17-12-24(13-18-35)31-30-25-20-27(36-3)28(37-19-9-16-34-14-7-8-15-34)21-26(25)32-29(33-30)23-10-5-4-6-11-23/h20-24H,4-19H2,1-3H3,(H,31,32,33) D0GK7A DRUGINKE QOECJCJVIMVJGX-UHFFFAOYSA-N D0GK7A DRUGSMIL CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5 D0GK7A HIGHSTAT Investigative D0GL0L DRUG__ID D0GL0L D0GL0L DRUGTYPE Small molecular drug D0GL0L DRUGINCH 1S/C21H15N3/c1-2-8-16(9-3-1)21(24-15-22-14-23-24)19-12-6-4-10-17(19)18-11-5-7-13-20(18)21/h1-15H D0GL0L DRUGINKE KVOFEYRUEAXEJQ-UHFFFAOYSA-N D0GL0L DRUGSMIL C1=CC=C(C=C1)C2(C3=CC=CC=C3C4=CC=CC=C42)N5C=NC=N5 D0GL0L HIGHSTAT Investigative D0GL2X DRUG__ID D0GL2X D0GL2X DRUGTYPE Small molecular drug D0GL2X DRUGINCH 1S/C15H16N2O/c18-15(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10H,11-12H2,(H2,16,17,18) D0GL2X DRUGINKE KATOLVAXCGIBLO-UHFFFAOYSA-N D0GL2X DRUGSMIL C1=CC=C(C=C1)CNC(=O)NCC2=CC=CC=C2 D0GL2X HIGHSTAT Investigative D0GL9I DRUG__ID D0GL9I D0GL9I DRUGTYPE Small molecular drug D0GL9I DRUGINCH 1S/C6H14N4O3/c7-4(5(11)12)2-1-3-9-6(8)10-13/h4,13H,1-3,7H2,(H,11,12)(H3,8,9,10)/t4-/m0/s1 D0GL9I DRUGINKE FQWRAVYMZULPNK-BYPYZUCNSA-N D0GL9I DRUGSMIL C(CC(C(=O)O)N)CN=C(N)NO D0GL9I HIGHSTAT Investigative D0GM1P DRUG__ID D0GM1P D0GM1P DRUGTYPE Small molecular drug D0GM1P DRUGINCH 1S/C19H23NO3/c1-2-3-4-8-15-22-17-13-11-16(12-14-17)20-19(21)23-18-9-6-5-7-10-18/h5-7,9-14H,2-4,8,15H2,1H3,(H,20,21) D0GM1P DRUGINKE ORPQZENLUNAGOE-UHFFFAOYSA-N D0GM1P DRUGSMIL CCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2 D0GM1P HIGHSTAT Investigative D0GM8V DRUG__ID D0GM8V D0GM8V DRUGTYPE Small molecular drug D0GM8V DRUGINCH 1S/C29H42N4O10/c1-14(2)26(38)20(42-19(35)16-7-6-11-32-16)27(39)22(4)13-25(37)23(26,5)29(27,40)28(43-25)18(15(3)8-10-24(22,28)36)41-17(34)9-12-33-21(30)31/h6-7,11,14-15,18,20,32,36-40H,8-10,12-13H2,1-5H3,(H4,30,31,33)/t15?,18-,20-,22+,23?,24?,25?,26?,27?,28?,29?/m1/s1 D0GM8V DRUGINKE ZCZPMYVYWWNDNA-IYRTUPHRSA-N D0GM8V DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CCN=C(N)N)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O D0GM8V HIGHSTAT Investigative D0GN3E DRUG__ID D0GN3E D0GN3E DRUGTYPE Small molecular drug D0GN3E DRUGINCH 1S/C17H12N2/c1-3-7-16-12(5-1)9-13(10-18-16)15-11-19-17-8-4-2-6-14(15)17/h1-11,19H D0GN3E DRUGINKE BJQHKICYZOBROI-UHFFFAOYSA-N D0GN3E DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)C3=CNC4=CC=CC=C43 D0GN3E HIGHSTAT Investigative D0GN5Z DRUG__ID D0GN5Z D0GN5Z DRUGTYPE Small molecular drug D0GN5Z DRUGINCH 1S/C15H10O5/c16-9-2-3-10-13(7-9)20-14(15(10)19)6-8-1-4-11(17)12(18)5-8/h1-7,16-18H/b14-6- D0GN5Z DRUGINKE RGNXWPVNPFAADO-NSIKDUERSA-N D0GN5Z DRUGSMIL C1=CC(=C(C=C1C=C2C(=O)C3=C(O2)C=C(C=C3)O)O)O D0GN5Z HIGHSTAT Investigative D0GN9K DRUG__ID D0GN9K D0GN9K DRUGTYPE Small molecular drug D0GN9K DRUGINCH 1S/C38H46N12O6/c39-32(51)26-13-6-7-15-44-36(55)30-31(43-18-17-42-30)37(56)50-28(19-22-9-2-1-3-10-22)34(53)48-27(14-8-16-45-38(40)41)33(52)49-29(35(54)47-26)20-23-21-46-25-12-5-4-11-24(23)25/h1-5,9-12,17-18,21,26-29,46H,6-8,13-16,19-20H2,(H2,39,51)(H,44,55)(H,47,54)(H,48,53)(H,49,52)(H,50,56)(H4,40,41,45)/t26-,27-,28+,29-/m0/s1 D0GN9K DRUGINKE JJPMYGFCLXEQSM-FKWFRFQNSA-N D0GN9K DRUGSMIL C1CCNC(=O)C2=NC=CN=C2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC=CC=C5 D0GN9K HIGHSTAT Investigative D0GP1I DRUG__ID D0GP1I D0GP1I DRUGTYPE Small molecular drug D0GP1I DRUGINCH 1S/C20H25N3O2/c1-21-11-8-20(22(2)19(21)24)9-12-23-10-7-15-14-5-3-4-6-17(14)25-18(15)16(23)13-20/h3-6,16H,7-13H2,1-2H3/t16-,20+/m1/s1/i1T3 D0GP1I DRUGINKE JRDUBBHIPPPSLP-NFEZXYISSA-N D0GP1I DRUGSMIL CN1CCC2(CCN3CCC4=C(C3C2)OC5=CC=CC=C45)N(C1=O)C D0GP1I HIGHSTAT Investigative D0GP7D DRUG__ID D0GP7D D0GP7D DRUGTYPE Small molecular drug D0GP7D DRUGINCH 1S/C16H10O7/c17-10-4-1-8-7(3-6-12(19)20)9-2-5-11(18)14(22)16(9)23-15(8)13(10)21/h1-6,17,21-22H,(H,19,20)/b6-3+ D0GP7D DRUGINKE HVUVBNCTBKJHHZ-ZZXKWVIFSA-N D0GP7D DRUGSMIL C1=CC(=C(C2=C1C(=C3C=CC(=O)C(=C3O2)O)C=CC(=O)O)O)O D0GP7D HIGHSTAT Investigative D0GQ1S DRUG__ID D0GQ1S D0GQ1S DRUGTYPE Small molecular drug D0GQ1S DRUGINCH 1S/C17H18N2O4/c1-5-9-15-10-6-13(21-2)14(22-3)7-11(10)19-12(15)8-18-16(9)17(20)23-4/h6-8,19H,5H2,1-4H3 D0GQ1S DRUGINKE GADIKQPUNWAMEB-UHFFFAOYSA-N D0GQ1S DRUGSMIL CCC1=C2C3=CC(=C(C=C3NC2=CN=C1C(=O)OC)OC)OC D0GQ1S HIGHSTAT Investigative D0GQ2G DRUG__ID D0GQ2G D0GQ2G DRUGTYPE Small molecular drug D0GQ2G DRUGINCH 1S/C17H15N3O3/c1-4-11-6-7-13-12(8-11)16(21)19(3)9-14-15(17(22)23-5-2)18-10-20(13)14/h1,6-8,10H,5,9H2,2-3H3 D0GQ2G DRUGINKE WDTNKNNGHGOKBH-UHFFFAOYSA-N D0GQ2G DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)C#C)C D0GQ2G HIGHSTAT Investigative D0GQ9A DRUG__ID D0GQ9A D0GQ9A DRUGTYPE Small molecular drug D0GQ9A DRUGINCH 1S/C6H7AsO3.2Na/c8-7(9,10)6-4-2-1-3-5-6;;/h1-5H,(H2,8,9,10);;/q;2*+1/p-2 D0GQ9A DRUGINKE IDQWLYXYOJVSLB-UHFFFAOYSA-L D0GQ9A DRUGSMIL C1=CC=C(C=C1)[As](=O)([O-])[O-].[Na+].[Na+] D0GQ9A HIGHSTAT Investigative D0GR5L DRUG__ID D0GR5L D0GR5L DRUGTYPE Small molecular drug D0GR5L DRUGINCH 1S/C23H25NO2/c1-6-8-18-22-15(21-17(25-5)9-7-10-19(21)26-18)11-12-16-20(22)14(2)13-23(3,4)24-16/h6-7,9-13,18,24H,1,8H2,2-5H3 D0GR5L DRUGINKE CZSDJYXNNJQXBB-UHFFFAOYSA-N D0GR5L DRUGSMIL CC1=CC(NC2=C1C3=C(C=C2)C4=C(C=CC=C4OC)OC3CC=C)(C)C D0GR5L HIGHSTAT Investigative D0GR6H DRUG__ID D0GR6H D0GR6H DRUGTYPE Small molecular drug D0GR6H DRUGINCH 1S/C22H16N4O2/c27-20(15-9-3-1-4-10-15)26-22-24-18-14-8-7-13-17(18)19(25-22)21(28)23-16-11-5-2-6-12-16/h1-14H,(H,23,28)(H,24,25,26,27) D0GR6H DRUGINKE RQQPFMNLXURQFV-UHFFFAOYSA-N D0GR6H DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NC3=CC=CC=C3C(=N2)C(=O)NC4=CC=CC=C4 D0GR6H HIGHSTAT Investigative D0GR9O DRUG__ID D0GR9O D0GR9O DRUGTYPE Small molecular drug D0GR9O DRUGINCH 1S/C27H40O3/c1-8-9-10-11-15-30-27-24(20(4)5)17-23(19(2)3)18-25(27)22(7)14-12-13-21(6)16-26(28)29/h12-14,16-20H,8-11,15H2,1-7H3,(H,28,29)/b13-12+,21-16+,22-14- D0GR9O DRUGINKE VTUYATVOWGSQFU-AQIGWABESA-N D0GR9O DRUGSMIL CCCCCCOC1=C(C=C(C=C1C(=CC=CC(=CC(=O)O)C)C)C(C)C)C(C)C D0GR9O HIGHSTAT Investigative D0GS0O DRUG__ID D0GS0O D0GS0O DRUGTYPE Small molecular drug D0GS0O DRUGINCH 1S/C5H11NO3/c7-2-3-5(9)4(8)1-6-3/h3-9H,1-2H2/t3-,4-,5-/m1/s1 D0GS0O DRUGINKE OQEBIHBLFRADNM-UOWFLXDJSA-N D0GS0O DRUGSMIL C1C(C(C(N1)CO)O)O D0GS0O HIGHSTAT Investigative D0GS1B DRUG__ID D0GS1B D0GS1B DRUGTYPE Small molecular drug D0GS1B DRUGINCH 1S/C16H20N2O3/c1-13(19)21-16-12-18(15-5-3-2-4-14(15)16)7-6-17-8-10-20-11-9-17/h2-5,12H,6-11H2,1H3 D0GS1B DRUGINKE WNJZFVIJUKGTLU-UHFFFAOYSA-N D0GS1B DRUGSMIL CC(=O)OC1=CN(C2=CC=CC=C21)CCN3CCOCC3 D0GS1B HIGHSTAT Investigative D0GS9E DRUG__ID D0GS9E D0GS9E DRUGTYPE Small molecular drug D0GS9E DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6?/m1/s1 D0GS9E DRUGINKE WQZGKKKJIJFFOK-QTVWNMPRSA-N D0GS9E DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D0GS9E HIGHSTAT Investigative D0GT8N DRUG__ID D0GT8N D0GT8N DRUGTYPE Small molecular drug D0GT8N DRUGINCH 1S/C20H21N5/c1-20(2,3)25-19-17(18(21)22-12-23-19)16(24-25)11-14-9-6-8-13-7-4-5-10-15(13)14/h4-10,12H,11H2,1-3H3,(H2,21,22,23) D0GT8N DRUGINKE GDQXJQSQYMMKRA-UHFFFAOYSA-N D0GT8N DRUGSMIL CC(C)(C)N1C2=NC=NC(=C2C(=N1)CC3=CC=CC4=CC=CC=C43)N D0GT8N HIGHSTAT Investigative D0GU4M DRUG__ID D0GU4M D0GU4M DRUGTYPE Small molecular drug D0GU4M DRUGINCH 1S/C17H14O2S/c1-13-6-9-16(10-7-13)20(18,19)17-11-8-14-4-2-3-5-15(14)12-17/h2-12H,1H3 D0GU4M DRUGINKE UOUHDIZYOCFQKG-UHFFFAOYSA-N D0GU4M DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=CC3=CC=CC=C3C=C2 D0GU4M HIGHSTAT Investigative D0GU5E DRUG__ID D0GU5E D0GU5E DRUGTYPE Small molecular drug D0GU5E DRUGINCH 1S/C12H14N2O2S/c13-7-9-2-1-3-10(6-9)8-17-5-4-11(14)12(15)16/h1-3,6,11H,4-5,8,14H2,(H,15,16) D0GU5E DRUGINKE HDBDOMDCBCMSJT-UHFFFAOYSA-N D0GU5E DRUGSMIL C1=CC(=CC(=C1)C#N)CSCCC(C(=O)O)N D0GU5E HIGHSTAT Investigative D0GV9Q DRUG__ID D0GV9Q D0GV9Q DRUGTYPE Small molecular drug D0GV9Q DRUGINCH 1S/C6H11NO3S/c1-11-3-2-5(6(9)10)7-4-8/h4-5H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m0/s1 D0GV9Q DRUGINKE PYUSHNKNPOHWEZ-YFKPBYRVSA-N D0GV9Q DRUGSMIL CSCCC(C(=O)O)NC=O D0GV9Q HIGHSTAT Investigative D0GW2Y DRUG__ID D0GW2Y D0GW2Y DRUGTYPE Small molecular drug D0GW2Y DRUGINCH 1S/C21H30O4/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22/h11,15-17,22,25H,3-10,12H2,1-2H3/t15-,16+,17+,19+,20+,21+/m1/s1 D0GW2Y DRUGINKE WHBHBVVOGNECLV-OBQKJFGGSA-N D0GW2Y DRUGSMIL CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C(=O)CO)O)C D0GW2Y HIGHSTAT Investigative D0GW4Q DRUG__ID D0GW4Q D0GW4Q DRUGTYPE Small molecular drug D0GW4Q DRUGINCH 1S/C20H13Cl2FN4O/c1-27-18-11(9-14(19(27)28)17-15(21)3-2-4-16(17)22)10-24-20(26-18)25-13-7-5-12(23)6-8-13/h2-10H,1H3,(H,24,25,26) D0GW4Q DRUGINKE ZSHRAUSJZQDIJR-UHFFFAOYSA-N D0GW4Q DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC=C(C=C4)F D0GW4Q HIGHSTAT Investigative D0GW6V DRUG__ID D0GW6V D0GW6V DRUGTYPE Small molecular drug D0GW6V DRUGINCH 1S/C47H66N12O11/c1-50-26-38(61)53-31(16-8-20-51-47(48)49)43(66)59-23-11-19-37(59)45(68)58-22-9-17-35(58)41(64)52-27-39(62)54-32(24-29-12-4-2-5-13-29)40(63)56-34(28-60)44(67)57-21-10-18-36(57)42(65)55-33(46(69)70)25-30-14-6-3-7-15-30/h2-7,12-15,31-37,50,60H,8-11,16-28H2,1H3,(H,52,64)(H,53,61)(H,54,62)(H,55,65)(H,56,63)(H,69,70)(H4,48,49,51)/t31-,32-,33+,34-,35-,36-,37-/m0/s1 D0GW6V DRUGINKE YIUBSFCQATYQJB-VCMDLEIESA-N D0GW6V DRUGSMIL CNCC(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)O D0GW6V HIGHSTAT Investigative D0GX2A DRUG__ID D0GX2A D0GX2A DRUGTYPE Small molecular drug D0GX2A DRUGINCH 1S/C18H12O10/c1-5-2-8(21)6(3-19)13-9(5)16(23)27-14-7(4-20)12(22)10-11(15(14)26-13)18(25)28-17(10)24/h2-3,18,20-22,25H,4H2,1H3 D0GX2A DRUGINKE QQTKVXCQLZIJPP-UHFFFAOYSA-N D0GX2A DRUGSMIL CC1=CC(=C(C2=C1C(=O)OC3=C(O2)C4=C(C(=C3CO)O)C(=O)OC4O)C=O)O D0GX2A HIGHSTAT Investigative D0GX5C DRUG__ID D0GX5C D0GX5C DRUGTYPE Small molecular drug D0GX5C DRUGINCH 1S/C17H14FN5O2S/c1-22(2)15-12-13-14(26-16(12)20-7-19-15)17(24)23(8-21-13)11-5-4-9(25-3)6-10(11)18/h4-8H,1-3H3 D0GX5C DRUGINKE XUSKBQJCEPMVBM-UHFFFAOYSA-N D0GX5C DRUGSMIL CN(C)C1=C2C3=C(C(=O)N(C=N3)C4=C(C=C(C=C4)OC)F)SC2=NC=N1 D0GX5C HIGHSTAT Investigative D0GX7G DRUG__ID D0GX7G D0GX7G DRUGTYPE Small molecular drug D0GX7G DRUGINCH 1S/C9H19N3O2/c1-2-4-8(11)12-6-3-5-7(10)9(13)14/h7H,2-6,10H2,1H3,(H2,11,12)(H,13,14)/t7-/m0/s1 D0GX7G DRUGINKE KRILJVOCVSUPMA-ZETCQYMHSA-N D0GX7G DRUGSMIL CCCC(=NCCCC(C(=O)O)N)N D0GX7G HIGHSTAT Investigative D0GY8R DRUG__ID D0GY8R D0GY8R DRUGTYPE Small molecular drug D0GY8R DRUGINCH 1S/C15H21NO/c1-12-7-6-8-14(11-12)15(17)13(2)16-9-4-3-5-10-16/h6-8,11,13H,3-5,9-10H2,1-2H3 D0GY8R DRUGINKE VMEDIUSDIYRUSA-UHFFFAOYSA-N D0GY8R DRUGSMIL CC1=CC(=CC=C1)C(=O)C(C)N2CCCCC2 D0GY8R HIGHSTAT Investigative D0H0AO DRUG__ID D0H0AO D0H0AO DRUGTYPE Small molecular drug D0H0AO DRUGINCH 1S/C22H17NO4/c1-25-19-13-12-17(15-8-4-2-5-9-15)18-14-20(27-21(18)19)23-22(24)26-16-10-6-3-7-11-16/h2-14H,1H3,(H,23,24) D0H0AO DRUGINKE LJHDOOYWZIWTJW-UHFFFAOYSA-N D0H0AO DRUGSMIL COC1=C2C(=C(C=C1)C3=CC=CC=C3)C=C(O2)NC(=O)OC4=CC=CC=C4 D0H0AO HIGHSTAT Investigative D0H0AT DRUG__ID D0H0AT D0H0AT DRUGTYPE Small molecular drug D0H0AT DRUGINCH 1S/C17H13NO3S/c1-21-15-8-4-13(5-9-15)17-11-10-16(22-17)12-2-6-14(7-3-12)18(19)20/h2-11H,1H3 D0H0AT DRUGINKE JNOACYJDBPZIMJ-UHFFFAOYSA-N D0H0AT DRUGSMIL COC1=CC=C(C=C1)C2=CC=C(S2)C3=CC=C(C=C3)[N+](=O)[O-] D0H0AT HIGHSTAT Investigative D0H0BD DRUG__ID D0H0BD D0H0BD DRUGTYPE Small molecular drug D0H0BD DRUGINCH 1S/C21H22N2O2/c24-18-10-16-19-13-9-17-21(6-7-22(17)11-12(13)5-8-25-16)14-3-1-2-4-15(14)23(18)20(19)21/h1-5,13,16-17,19-20H,6-11H2/t13-,16-,17-,19-,20-,21+/m0/s1 D0H0BD DRUGINKE QMGVPVSNSZLJIA-FVWCLLPLSA-N D0H0BD DRUGSMIL C1CN2CC3=CCOC4CC(=O)N5C6C4C3CC2C61C7=CC=CC=C75 D0H0BD HIGHSTAT Investigative D0H0DC DRUG__ID D0H0DC D0H0DC DRUGTYPE Small molecular drug D0H0DC DRUGINCH 1S/C50H59N9O8S2/c51-23-13-12-22-38-45(61)56-41(26-33-18-8-3-9-19-33)48(64)59-43(50(66)67)30-69-68-29-36(52)44(60)55-39(24-31-14-4-1-5-15-31)46(62)57-40(25-32-16-6-2-7-17-32)47(63)58-42(49(65)54-38)27-34-28-53-37-21-11-10-20-35(34)37/h1-11,14-21,28,36,38-43,53H,12-13,22-27,29-30,51-52H2,(H,54,65)(H,55,60)(H,56,61)(H,57,62)(H,58,63)(H,59,64)(H,66,67)/t36-,38+,39-,40+,41+,42+,43+/m1/s1 D0H0DC DRUGINKE NQJATBPHPBJDPZ-CEDQUOLKSA-N D0H0DC DRUGSMIL C1C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)O)CC2=CC=CC=C2)CCCCN)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)N D0H0DC HIGHSTAT Investigative D0H0DP DRUG__ID D0H0DP D0H0DP DRUGTYPE Small molecular drug D0H0DP DRUGINCH 1S/C21H24N2O4S/c1-11(24)23-16-7-5-12-9-15(22)20(26-2)21(27-3)19(12)13-6-8-18(28-4)17(25)10-14(13)16/h6,8-10,16H,5,7,22H2,1-4H3,(H,23,24)/t16-/m0/s1 D0H0DP DRUGINKE HGWINWYVDWEKKX-INIZCTEOSA-N D0H0DP DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)N D0H0DP HIGHSTAT Investigative D0H0EC DRUG__ID D0H0EC D0H0EC DRUGTYPE Small molecular drug D0H0EC DRUGINCH 1S/C21H14ClN3O/c22-17-9-5-6-14(12-23)21(17)24-20(26)13-25-18-10-3-1-7-15(18)16-8-2-4-11-19(16)25/h1-11H,13H2,(H,24,26) D0H0EC DRUGINKE ZDAKKNHUWVTCRS-UHFFFAOYSA-N D0H0EC DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3N2CC(=O)NC4=C(C=CC=C4Cl)C#N D0H0EC HIGHSTAT Investigative D0H0FG DRUG__ID D0H0FG D0H0FG DRUGTYPE Small molecular drug D0H0FG DRUGINCH 1S/C21H25NO3/c23-21(22-14-8-5-9-15-22)11-7-4-2-1-3-6-10-18-12-13-19-20(16-18)25-17-24-19/h2,4,6-7,10-13,16H,1,3,5,8-9,14-15,17H2/b4-2+,10-6+,11-7+ D0H0FG DRUGINKE KAYVDASZRFLFRZ-PQECNABGSA-N D0H0FG DRUGSMIL C1CCN(CC1)C(=O)C=CC=CCCC=CC2=CC3=C(C=C2)OCO3 D0H0FG HIGHSTAT Investigative D0H0GZ DRUG__ID D0H0GZ D0H0GZ DRUGTYPE Small molecular drug D0H0GZ DRUGINCH 1S/C17H13NO3/c1-11-6-8-13(9-7-11)18-16(19)14-10-12-4-2-3-5-15(12)21-17(14)20/h2-10H,1H3,(H,18,19) D0H0GZ DRUGINKE RYYPYTSGWXNKDU-UHFFFAOYSA-N D0H0GZ DRUGSMIL CC1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3OC2=O D0H0GZ HIGHSTAT Investigative D0H0HM DRUG__ID D0H0HM D0H0HM DRUGTYPE Small molecular drug D0H0HM DRUGINCH 1S/C14H9ClN2O/c15-9-5-7-10(8-6-9)16-13-11-3-1-2-4-12(11)17-14(13)18/h1-8H,(H,16,17,18) D0H0HM DRUGINKE CPOOLXVTWFEFNO-UHFFFAOYSA-N D0H0HM DRUGSMIL C1=CC=C2C(=C1)C(=NC3=CC=C(C=C3)Cl)C(=O)N2 D0H0HM HIGHSTAT Investigative D0H0HR DRUG__ID D0H0HR D0H0HR DRUGTYPE Small molecular drug D0H0HR DRUGINCH 1S/C35H28F3N5O2/c1-2-32(44)42-15-13-41(14-16-42)31-11-9-26(19-28(31)35(36,37)38)43-33(45)12-8-24-20-40-30-10-7-22(18-27(30)34(24)43)25-17-23-5-3-4-6-29(23)39-21-25/h3-12,17-21H,2,13-16H2,1H3 D0H0HR DRUGINKE AKCRNFFTGXBONI-UHFFFAOYSA-N D0H0HR DRUGSMIL CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F D0H0HR HIGHSTAT Investigative D0H0IZ DRUG__ID D0H0IZ D0H0IZ DRUGTYPE Small molecular drug D0H0IZ DRUGINCH 1S/C14H16N2O2S/c15-10-9-12-5-4-8-14(11-12)19(17,18)16-13-6-2-1-3-7-13/h1-8,11,16H,9-10,15H2 D0H0IZ DRUGINKE STRFPXFHEXRQFY-UHFFFAOYSA-N D0H0IZ DRUGSMIL C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)CCN D0H0IZ HIGHSTAT Investigative D0H0KP DRUG__ID D0H0KP D0H0KP DRUGTYPE Small molecular drug D0H0KP DRUGINCH 1S/C22H23N3O2/c23-22(26)19-10-13-21(25-16-19)27-20-11-8-17(9-12-20)7-4-14-24-15-18-5-2-1-3-6-18/h1-3,5-6,8-13,16,24H,4,7,14-15H2,(H2,23,26) D0H0KP DRUGINKE FZBJOVYOONJNIG-UHFFFAOYSA-N D0H0KP DRUGSMIL C1=CC=C(C=C1)CNCCCC2=CC=C(C=C2)OC3=NC=C(C=C3)C(=O)N D0H0KP HIGHSTAT Investigative D0H0LP DRUG__ID D0H0LP D0H0LP DRUGTYPE Small molecular drug D0H0LP DRUGINCH 1S/C24H26Cl2N6/c1-30-8-10-31(11-9-30)23-5-2-17(14-28-23)18-13-22-24(29-15-18)27-6-7-32(22)16-19-12-20(25)3-4-21(19)26/h2-5,12-15H,6-11,16H2,1H3,(H,27,29) D0H0LP DRUGINKE CSYSNPSPLOLFFI-UHFFFAOYSA-N D0H0LP DRUGSMIL CN1CCN(CC1)C2=NC=C(C=C2)C3=CC4=C(NCCN4CC5=C(C=CC(=C5)Cl)Cl)N=C3 D0H0LP HIGHSTAT Investigative D0H0NE DRUG__ID D0H0NE D0H0NE DRUGTYPE Small molecular drug D0H0NE DRUGINCH 1S/C10H16O2/c1-7-3-4-8(2)10(7)5-6-12-9(10)11/h7-8H,3-6H2,1-2H3 D0H0NE DRUGINKE CQORSWAIFJDWPQ-UHFFFAOYSA-N D0H0NE DRUGSMIL CC1CCC(C12CCOC2=O)C D0H0NE HIGHSTAT Investigative D0H0OO DRUG__ID D0H0OO D0H0OO DRUGTYPE Small molecular drug D0H0OO DRUGINCH 1S/C74H115N21O17/c1-40(2)34-53(91-68(107)54(36-44-18-10-8-11-19-44)86-58(100)39-84-57(99)38-85-62(101)48(76)35-46-25-27-47(97)28-26-46)67(106)89-51(24-17-33-83-74(80)81)63(102)87-50(23-16-32-82-73(78)79)64(103)90-52(29-30-56(77)98)65(104)92-55(37-45-20-12-9-13-21-45)69(108)88-49(22-14-15-31-75)66(105)93-59(41(3)4)70(109)94-60(42(5)6)71(110)95-61(43(7)96)72(111)112/h8-13,18-21,25-28,40-43,48-55,59-61,96-97H,14-17,22-24,29-39,75-76H2,1-7H3,(H2,77,98)(H,84,99)(H,85,101)(H,86,100)(H,87,102)(H,88,108)(H,89,106)(H,90,103)(H,91,107)(H,92,104)(H,93,105)(H,94,109)(H,95,110)(H,111,112)(H4,78,79,82)(H4,80,81,83)/t43-,48+,49+,50+,51+,52+,53+,54+,55+,59+,60+,61+/m1/s1 D0H0OO DRUGINKE AGTSSZRZBSNTGQ-ITZCFHCWSA-N D0H0OO DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N D0H0OO HIGHSTAT Investigative D0H0PL DRUG__ID D0H0PL D0H0PL DRUGTYPE Small molecular drug D0H0PL DRUGINCH 1S/C24H33N3O2/c1-14(2)27-13-15-11-21-18(17-6-4-8-20(27)23(15)17)10-16(12-26(21)3)24(29)25-19-7-5-9-22(19)28/h4,6,8,13-14,16,18-19,21-22,28H,5,7,9-12H2,1-3H3,(H,25,29)/t16-,18?,19+,21-,22-/m1/s1 D0H0PL DRUGINKE IMSDOBUYDTVEHN-LUKLFJNJSA-N D0H0PL DRUGSMIL CC(C)N1C=C2CC3C(CC(CN3C)C(=O)NC4CCCC4O)C5=C2C1=CC=C5 D0H0PL HIGHSTAT Investigative D0H0PQ DRUG__ID D0H0PQ D0H0PQ DRUGTYPE Small molecular drug D0H0PQ DRUGINCH 1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6) D0H0PQ DRUGINKE FFQKYPRQEYGKAF-UHFFFAOYSA-N D0H0PQ DRUGSMIL C(=O)(N)OP(=O)(O)O D0H0PQ HIGHSTAT Investigative D0H0SE DRUG__ID D0H0SE D0H0SE DRUGTYPE Small molecular drug D0H0SE DRUGINCH 1S/C18H14O9/c19-8-1-9(20)3-12(2-8)26-18-15(25)6-11(22)7-16(18)27-17-13(23)4-10(21)5-14(17)24/h1-7,19-25H D0H0SE DRUGINKE OXFVHFABBAINFL-UHFFFAOYSA-N D0H0SE DRUGSMIL C1=C(C=C(C=C1O)OC2=C(C=C(C=C2OC3=C(C=C(C=C3O)O)O)O)O)O D0H0SE HIGHSTAT Investigative D0H0WL DRUG__ID D0H0WL D0H0WL DRUGTYPE Small molecular drug D0H0WL DRUGINCH 1S/C13H14N4S/c18-13(17-12-10-14-8-9-15-12)16-7-6-11-4-2-1-3-5-11/h1-5,8-10H,6-7H2,(H2,15,16,17,18) D0H0WL DRUGINKE CDHPKLQOWLHDSH-UHFFFAOYSA-N D0H0WL DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC=CN=C2 D0H0WL HIGHSTAT Investigative D0H1BF DRUG__ID D0H1BF D0H1BF DRUGTYPE Small molecular drug D0H1BF DRUGINCH 1S/C10H12N5O5PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(19-10)1-18-21(17,22)20-7/h2-4,6-7,10,16H,1H2,(H,17,22)(H2,11,12,13)/t4-,6+,7+,10+,21?/m1/s1 D0H1BF DRUGINKE SMPNJFHAPJOHPP-LSSDEPPKSA-N D0H1BF DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=S)(O1)O D0H1BF HIGHSTAT Investigative D0H1BU DRUG__ID D0H1BU D0H1BU DRUGTYPE Small molecular drug D0H1BU DRUGINCH 1S/C30H34N4O4/c1-19-12-24(35)13-20(2)25(19)15-26(31)30(38)34-18-23-11-7-6-10-22(23)14-27(34)29(37)33-17-28(36)32-16-21-8-4-3-5-9-21/h3-13,26-27,35H,14-18,31H2,1-2H3,(H,32,36)(H,33,37)/t26-,27-/m0/s1 D0H1BU DRUGINKE SYOVEDOWOXNOJG-SVBPBHIXSA-N D0H1BU DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC(=O)NCC4=CC=CC=C4)N)C)O D0H1BU HIGHSTAT Investigative D0H1BY DRUG__ID D0H1BY D0H1BY DRUGTYPE Small molecular drug D0H1BY DRUGINCH 1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,12-13H,9H2/t12-,13+ D0H1BY DRUGINKE HIZKPJUTKKJDGA-BETUJISGSA-N D0H1BY DRUGSMIL C1=CC=C2C(=C1)C(=O)C(C(=O)O2)CC3C(=O)C4=CC=CC=C4OC3=O D0H1BY HIGHSTAT Investigative D0H1CO DRUG__ID D0H1CO D0H1CO DRUGTYPE Small molecular drug D0H1CO DRUGINCH 1S/C17H11NO2/c19-12-8-9-15-16(10-12)20-17(18-15)14-7-3-5-11-4-1-2-6-13(11)14/h1-10,19H D0H1CO DRUGINKE LYJKLNQQSXCGDI-UHFFFAOYSA-N D0H1CO DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C3=NC4=C(O3)C=C(C=C4)O D0H1CO HIGHSTAT Investigative D0H1DV DRUG__ID D0H1DV D0H1DV DRUGTYPE Small molecular drug D0H1DV DRUGINCH 1S/C25H21N3O/c1-17-8-12-19(13-9-17)23-24(20-14-10-18(2)11-15-20)28-22(16-26-23)25(29)27-21-6-4-3-5-7-21/h3-16H,1-2H3,(H,27,29) D0H1DV DRUGINKE AKCXCZPEESTMSV-UHFFFAOYSA-N D0H1DV DRUGSMIL CC1=CC=C(C=C1)C2=NC=C(N=C2C3=CC=C(C=C3)C)C(=O)NC4=CC=CC=C4 D0H1DV HIGHSTAT Investigative D0H1EB DRUG__ID D0H1EB D0H1EB DRUGTYPE Small molecular drug D0H1EB DRUGINCH 1S/C23H29FO5/c1-18(17-29-20-15-13-19(24)14-16-20)9-6-4-2-3-5-7-10-21(25)22(26)11-8-12-23(27)28/h2-7,9-10,13-16,18,21-22,25-26H,8,11-12,17H2,1H3,(H,27,28)/b4-2-,5-3+,9-6+,10-7+/t18-,21+,22-/m0/s1 D0H1EB DRUGINKE SGFIFYSIHRWSCE-LLXPRBAESA-N D0H1EB DRUGSMIL CC(COC1=CC=C(C=C1)F)C=CC=CC=CC=CC(C(CCCC(=O)O)O)O D0H1EB HIGHSTAT Investigative D0H1EI DRUG__ID D0H1EI D0H1EI DRUGTYPE Small molecular drug D0H1EI DRUGINCH 1S/C21H18O4/c22-20-10-9-16-19(25-20)14-18-17(11-13-23-18)21(16)24-12-5-4-8-15-6-2-1-3-7-15/h1-3,6-7,9-11,13-14H,4-5,8,12H2 D0H1EI DRUGINKE JJAWGNIQEOFURP-UHFFFAOYSA-N D0H1EI DRUGSMIL C1=CC=C(C=C1)CCCCOC2=C3C=CC(=O)OC3=CC4=C2C=CO4 D0H1EI HIGHSTAT Investigative D0H1FZ DRUG__ID D0H1FZ D0H1FZ DRUGTYPE Small molecular drug D0H1FZ DRUGINCH 1S/C11H22O4S2/c1-4-6-10(7-5-2)11(12)15-8-9-16-17(3,13)14/h10H,4-9H2,1-3H3 D0H1FZ DRUGINKE ZHKBCGORMGLCBI-UHFFFAOYSA-N D0H1FZ DRUGSMIL CCCC(CCC)C(=O)OCCSS(=O)(=O)C D0H1FZ HIGHSTAT Investigative D0H1GQ DRUG__ID D0H1GQ D0H1GQ DRUGTYPE Small molecular drug D0H1GQ DRUGINCH 1S/C17H17N3O/c21-11-10-18-17-16(12-13-6-2-1-3-7-13)19-14-8-4-5-9-15(14)20-17/h1-9,21H,10-12H2,(H,18,20) D0H1GQ DRUGINKE SNVOYVYEVPVVNG-UHFFFAOYSA-N D0H1GQ DRUGSMIL C1=CC=C(C=C1)CC2=NC3=CC=CC=C3N=C2NCCO D0H1GQ HIGHSTAT Investigative D0H1GU DRUG__ID D0H1GU D0H1GU DRUGTYPE Small molecular drug D0H1GU DRUGINCH 1S/C3H7NO4S/c4-2(3(5)6)1-9(7)8/h2H,1,4H2,(H,5,6)(H,7,8)/p-1/t2-/m0/s1 D0H1GU DRUGINKE ADVPTQAUNPRNPO-REOHCLBHSA-M D0H1GU DRUGSMIL C(C(C(=O)O)N)S(=O)[O-] D0H1GU HIGHSTAT Investigative D0H1II DRUG__ID D0H1II D0H1II DRUGTYPE Small molecular drug D0H1II DRUGINCH 1S/C17H14N4O/c1-21-11-12(10-18)15-8-7-14(9-16(15)21)20-17(22)19-13-5-3-2-4-6-13/h2-9,11H,1H3,(H2,19,20,22) D0H1II DRUGINKE DKHWZIZMXRFFLI-UHFFFAOYSA-N D0H1II DRUGSMIL CN1C=C(C2=C1C=C(C=C2)NC(=O)NC3=CC=CC=C3)C#N D0H1II HIGHSTAT Investigative D0H1JX DRUG__ID D0H1JX D0H1JX DRUGTYPE Small molecular drug D0H1JX DRUGINCH 1S/C25H26O4/c1-14(2)5-7-16-11-19-23(12-22(16)27)28-13-20-17-9-10-21(26)18(8-6-15(3)4)24(17)29-25(19)20/h5-6,9-12,26-27H,7-8,13H2,1-4H3 D0H1JX DRUGINKE VNTSSLCFFUCTNP-UHFFFAOYSA-N D0H1JX DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OCC3=C2OC4=C3C=CC(=C4CC=C(C)C)O)C D0H1JX HIGHSTAT Investigative D0H1LK DRUG__ID D0H1LK D0H1LK DRUGTYPE Small molecular drug D0H1LK DRUGINCH 1S/C10H10N2O2/c11-7-3-1-6(2-4-7)8-5-9(13)12-10(8)14/h1-4,8H,5,11H2,(H,12,13,14) D0H1LK DRUGINKE AFLGSUFOCCZEEZ-UHFFFAOYSA-N D0H1LK DRUGSMIL C1C(C(=O)NC1=O)C2=CC=C(C=C2)N D0H1LK HIGHSTAT Investigative D0H1MV DRUG__ID D0H1MV D0H1MV DRUGCOMP Molteni Therapeutics Srl D0H1MV DRUGINCH 1S/C68H64N12O4.4ClH.Zn/c1-77(2,3)41-21-13-25-45(37-41)81-53-33-17-29-49-57(53)65-69-61(49)74-66-59-51(31-19-35-55(59)83-47-27-15-23-43(39-47)79(7,8)9)63(71-66)76-68-60-52(32-20-36-56(60)84-48-28-16-24-44(40-48)80(10,11)12)64(72-68)75-67-58-50(62(70-67)73-65)30-18-34-54(58)82-46-26-14-22-42(38-46)78(4,5)6;;;;;/h13-40H,1-12H3;4*1H;/q+2;;;;;+2/p-4 D0H1MV DRUGINKE DDEIKYBCLKKXJC-UHFFFAOYSA-J D0H1MV DRUGSMIL C[N+](C)(C)C1=CC(=CC=C1)OC2=CC=CC3=C2C4=NC5=NC(=NC6=C7C=CC=C(C7=C([N-]6)N=C8C9=C(C(=CC=C9)OC1=CC=CC(=C1)[N+](C)(C)C)C(=N8)N=C3[N-]4)OC1=CC=CC(=C1)[N+](C)(C)C)C1=C5C=CC=C1OC1=CC=CC(=C1)[N+](C)(C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2] D0H1MV HIGHSTAT Investigative D0H1NU DRUG__ID D0H1NU D0H1NU DRUGTYPE Small molecular drug D0H1NU DRUGINCH 1S/C23H28ClNO3/c24-21-10-8-20(9-11-21)23(26)27-17-5-4-14-25-15-12-22(13-16-25)28-18-19-6-2-1-3-7-19/h1-3,6-11,22H,4-5,12-18H2 D0H1NU DRUGINKE ZUARKRNDJKGEIT-UHFFFAOYSA-N D0H1NU DRUGSMIL C1CN(CCC1OCC2=CC=CC=C2)CCCCOC(=O)C3=CC=C(C=C3)Cl D0H1NU HIGHSTAT Investigative D0H1OK DRUG__ID D0H1OK D0H1OK DRUGTYPE Small molecular drug D0H1OK DRUGINCH 1S/C26H25Cl2N5O/c1-17-15-18(24-21(27)5-4-6-22(24)28)16-23-25(17)30-26(32-31-23)29-19-7-9-20(10-8-19)34-14-13-33-11-2-3-12-33/h4-10,15-16H,2-3,11-14H2,1H3,(H,29,30,32) D0H1OK DRUGINKE OTTCBLPTHPBEEX-UHFFFAOYSA-N D0H1OK DRUGSMIL CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OCCN4CCCC4)C5=C(C=CC=C5Cl)Cl D0H1OK HIGHSTAT Investigative D0H1VB DRUG__ID D0H1VB D0H1VB DRUGTYPE Small molecular drug D0H1VB DRUGINCH 1S/C16H20S2/c1-5-12-6-8-13(9-7-12)15-17-10-14(11-18-15)16(2,3)4/h1,6-9,14-15H,10-11H2,2-4H3 D0H1VB DRUGINKE HKLYPSSDHPAOJM-UHFFFAOYSA-N D0H1VB DRUGSMIL CC(C)(C)C1CSC(SC1)C2=CC=C(C=C2)C#C D0H1VB HIGHSTAT Investigative D0H1VJ DRUG__ID D0H1VJ D0H1VJ DRUGTYPE Small molecular drug D0H1VJ DRUGINCH 1S/C9H16N3O12P3.Na/c10-7-3-4-12(9(13)11-7)8-2-1-6(22-8)5-21-26(17,18)24-27(19,20)23-25(14,15)16;/h3-4,6,8H,1-2,5H2,(H,17,18)(H,19,20)(H2,10,11,13)(H2,14,15,16);/q;+1/p-1/t6-,8+;/m0./s1 D0H1VJ DRUGINKE LOOMQRBEBYCFPP-QDOHZIMISA-M D0H1VJ DRUGSMIL C1CC(OC1COP(=O)([O-])OP(=O)(O)OP(=O)(O)O)N2C=CC(=NC2=O)N.[Na+] D0H1VJ HIGHSTAT Investigative D0H1VT DRUG__ID D0H1VT D0H1VT DRUGTYPE Small molecular drug D0H1VT DRUGINCH 1S/C9H10FN/c10-9(6-8(9)11)7-4-2-1-3-5-7/h1-5,8H,6,11H2/t8-,9+/m0/s1 D0H1VT DRUGINKE UJTQURLMCYMANH-DTWKUNHWSA-N D0H1VT DRUGSMIL C1C(C1(C2=CC=CC=C2)F)N D0H1VT HIGHSTAT Investigative D0H1VY DRUG__ID D0H1VY D0H1VY DRUGTYPE Small molecular drug D0H1VY DRUGINCH 1S/C20H32N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-21-20(26)17-15(23)14-16(24)18(19(17)25)22(27)28/h14,23-25H,2-13H2,1H3,(H,21,26) D0H1VY DRUGINKE MSWMANFKQVMQAR-UHFFFAOYSA-N D0H1VY DRUGSMIL CCCCCCCCCCCCCNC(=O)C1=C(C(=C(C=C1O)O)[N+](=O)[O-])O D0H1VY HIGHSTAT Investigative D0H1WR DRUG__ID D0H1WR D0H1WR DRUGTYPE Small molecular drug D0H1WR DRUGINCH 1S/C9H12N2O2S/c10-14(12,13)9-2-1-7-3-4-11-6-8(7)5-9/h1-2,5,11H,3-4,6H2,(H2,10,12,13) D0H1WR DRUGINKE UGLLZXSYRBMNOS-UHFFFAOYSA-N D0H1WR DRUGSMIL C1CNCC2=C1C=CC(=C2)S(=O)(=O)N D0H1WR HIGHSTAT Investigative D0H1WV DRUG__ID D0H1WV D0H1WV DRUGTYPE Small molecular drug D0H1WV DRUGINCH 1S/C29H34O4/c1-19(2)7-5-8-20(3)9-6-10-21(4)11-14-25-26(16-24(31)17-27(25)32)29-15-22-12-13-23(30)18-28(22)33-29/h7,9,11-13,15-18,30-32H,5-6,8,10,14H2,1-4H3/b20-9-,21-11- D0H1WV DRUGINKE YUFBSQFJPYHMTK-QUYCRGELSA-N D0H1WV DRUGSMIL CC(=CCCC(=CCCC(=CCC1=C(C=C(C=C1O)O)C2=CC3=C(O2)C=C(C=C3)O)C)C)C D0H1WV HIGHSTAT Investigative D0H1YK DRUG__ID D0H1YK D0H1YK DRUGTYPE Small molecular drug D0H1YK DRUGINCH 1S/C10H14N2O4S4/c13-7(14)5-19-9(17)11-1-2-12(4-3-11)10(18)20-6-8(15)16/h1-6H2,(H,13,14)(H,15,16) D0H1YK DRUGINKE DWMIVTUQXUDODL-UHFFFAOYSA-N D0H1YK DRUGSMIL C1CN(CCN1C(=S)SCC(=O)O)C(=S)SCC(=O)O D0H1YK HIGHSTAT Investigative D0H1ZT DRUG__ID D0H1ZT D0H1ZT DRUGTYPE Small molecular drug D0H1ZT DRUGINCH 1S/C33H37N3O7S/c1-33(2)30(31(41)35-28-24-14-7-6-11-21(24)16-26(28)38)36(19-44-33)32(42)29(40)25(15-20-9-4-3-5-10-20)34-27(39)18-43-23-13-8-12-22(37)17-23/h3-14,17,25-26,28-30,37-38,40H,15-16,18-19H2,1-2H3,(H,34,39)(H,35,41)/t25-,26+,28-,29-,30+/m0/s1 D0H1ZT DRUGINKE KSGNCVYBLWHGKD-DOWNBTJOSA-N D0H1ZT DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC(=C3)O)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0H1ZT HIGHSTAT Investigative D0H2BL DRUG__ID D0H2BL D0H2BL DRUGTYPE Small molecular drug D0H2BL DRUGINCH 1S/C20H19NO4/c22-18-13-20(21-8-10-23-11-9-21)25-19-12-16(6-7-17(18)19)24-14-15-4-2-1-3-5-15/h1-7,12-13H,8-11,14H2 D0H2BL DRUGINKE KUCJYOZKCJHLND-UHFFFAOYSA-N D0H2BL DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)OCC4=CC=CC=C4 D0H2BL HIGHSTAT Investigative D0H2CI DRUG__ID D0H2CI D0H2CI DRUGTYPE Small molecular drug D0H2CI DRUGINCH 1S/C23H30O8/c1-22-7-5-14-21(26)31-17(13-6-8-29-11-13)10-23(14,2)19(22)18(24)16(30-12-27-3)9-15(22)20(25)28-4/h6,8,11,14-17,19H,5,7,9-10,12H2,1-4H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1 D0H2CI DRUGINKE KFVUSZPWUZBAPF-AGQYDFLVSA-N D0H2CI DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOC)C)C4=COC=C4 D0H2CI HIGHSTAT Investigative D0H2CM DRUG__ID D0H2CM D0H2CM DRUGTYPE Small molecular drug D0H2CM DRUGINCH 1S/C16H16N6O/c1-8(2)22-16-13(15(17)18-7-19-16)14(21-22)12-6-9-5-10(23)3-4-11(9)20-12/h3-8,20,23H,1-2H3,(H2,17,18,19) D0H2CM DRUGINKE MFAQYJIYDMLAIM-UHFFFAOYSA-N D0H2CM DRUGSMIL CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(N3)C=CC(=C4)O)N D0H2CM HIGHSTAT Investigative D0H2CS DRUG__ID D0H2CS D0H2CS DRUGTYPE Small molecular drug D0H2CS DRUGINCH 1S/C2H6N2O/c3-1-2(4)5/h1,3H2,(H2,4,5) D0H2CS DRUGINKE BEBCJVAWIBVWNZ-UHFFFAOYSA-N D0H2CS DRUGSMIL C(C(=O)N)N D0H2CS HIGHSTAT Investigative D0H2DD DRUG__ID D0H2DD D0H2DD DRUGTYPE Small molecular drug D0H2DD DRUGINCH 1S/C9H5BrN4/c10-7-3-1-6(2-4-7)9-8(5-11)12-14-13-9/h1-4H,(H,12,13,14) D0H2DD DRUGINKE SKCRCHJZYFYITH-UHFFFAOYSA-N D0H2DD DRUGSMIL C1=CC(=CC=C1C2=NNN=C2C#N)Br D0H2DD HIGHSTAT Investigative D0H2FI DRUG__ID D0H2FI D0H2FI DRUGTYPE Small molecular drug D0H2FI DRUGINCH 1S/C16H11NO4/c18-13-5-1-10(2-6-13)11-3-7-14-12(9-11)4-8-15(19)16(14)17(20)21/h1-9,18-19H D0H2FI DRUGINKE MYVOVZDBAWARDP-UHFFFAOYSA-N D0H2FI DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C=C2)C(=C(C=C3)O)[N+](=O)[O-])O D0H2FI HIGHSTAT Investigative D0H2GH DRUG__ID D0H2GH D0H2GH DRUGTYPE Small molecular drug D0H2GH DRUGINCH 1S/C16H25N/c1-4-9-17-10-5-6-16(12-17)15-8-7-13(2)14(3)11-15/h7-8,11,16H,4-6,9-10,12H2,1-3H3 D0H2GH DRUGINKE WKCUEEXFTZSNLI-UHFFFAOYSA-N D0H2GH DRUGSMIL CCCN1CCCC(C1)C2=CC(=C(C=C2)C)C D0H2GH HIGHSTAT Investigative D0H2HC DRUG__ID D0H2HC D0H2HC DRUGTYPE Small molecular drug D0H2HC DRUGINCH 1S/C21H24N2O2S2/c1-13-8-11-26-19(13)15(20-14(2)9-12-27-20)5-4-10-22-16-6-3-7-17-18(16)21(24)23-25-17/h5,8-9,11-12,16,22H,3-4,6-7,10H2,1-2H3,(H,23,24) D0H2HC DRUGINKE TYXWOLAOXRISSO-UHFFFAOYSA-N D0H2HC DRUGSMIL CC1=C(SC=C1)C(=CCCNC2CCCC3=C2C(=O)NO3)C4=C(C=CS4)C D0H2HC HIGHSTAT Investigative D0H2IA DRUG__ID D0H2IA D0H2IA DRUGTYPE Small molecular drug D0H2IA DRUGINCH 1S/C19H30NO5P/c1-14(16-8-5-9-17(10-16)19(22)23)20-11-18(21)13-26(24,25)12-15-6-3-2-4-7-15/h5,8-10,14-15,18,20-21H,2-4,6-7,11-13H2,1H3,(H,22,23)(H,24,25)/t14-,18+/m1/s1 D0H2IA DRUGINKE JCFULPDIJOVUHP-KDOFPFPSSA-N D0H2IA DRUGSMIL CC(C1=CC(=CC=C1)C(=O)O)NCC(CP(=O)(CC2CCCCC2)O)O D0H2IA HIGHSTAT Investigative D0H2IT DRUG__ID D0H2IT D0H2IT DRUGTYPE Small molecular drug D0H2IT DRUGINCH 1S/C22H27N3O/c1-16-7-8-18(15-17(16)2)25-13-11-24(12-14-25)10-9-21-19-5-3-4-6-20(19)22(26)23-21/h3-8,15,21H,9-14H2,1-2H3,(H,23,26)/t21-/m1/s1 D0H2IT DRUGINKE WQEPZBNLBWDIRZ-OAQYLSRUSA-N D0H2IT DRUGSMIL CC1=C(C=C(C=C1)N2CCN(CC2)CCC3C4=CC=CC=C4C(=O)N3)C D0H2IT HIGHSTAT Investigative D0H2KD DRUG__ID D0H2KD D0H2KD DRUGTYPE Small molecular drug D0H2KD DRUGINCH 1S/C13H15N3O/c17-13(16-7-5-14-6-8-16)12-9-10-3-1-2-4-11(10)15-12/h1-4,9,14-15H,5-8H2 D0H2KD DRUGINKE FIVCRRVYLAXYFC-UHFFFAOYSA-N D0H2KD DRUGSMIL C1CN(CCN1)C(=O)C2=CC3=CC=CC=C3N2 D0H2KD HIGHSTAT Investigative D0H2LN DRUG__ID D0H2LN D0H2LN DRUGTYPE Small molecular drug D0H2LN DRUGINCH 1S/C20H35NO2/c1-3-4-5-6-7-8-9-18-10-12-19(13-11-18)14-15-20(21,16-22)17-23-2/h10-13,22H,3-9,14-17,21H2,1-2H3/t20-/m1/s1 D0H2LN DRUGINKE YEYZALQTJCVXIJ-HXUWFJFHSA-N D0H2LN DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(COC)N D0H2LN HIGHSTAT Investigative D0H2LT DRUG__ID D0H2LT D0H2LT DRUGTYPE Small molecular drug D0H2LT DRUGINCH 1S/C10H12ClNO2/c11-9-4-2-1-3-8(9)7(6-12)5-10(13)14/h1-4,7H,5-6,12H2,(H,13,14) D0H2LT DRUGINKE RNSIJRUPQJHCBR-UHFFFAOYSA-N D0H2LT DRUGSMIL C1=CC=C(C(=C1)C(CC(=O)O)CN)Cl D0H2LT HIGHSTAT Investigative D0H2MF DRUG__ID D0H2MF D0H2MF DRUGTYPE Small molecular drug D0H2MF DRUGINCH 1S/C19H20N4O2/c1-21-16(24)11-23-18(14-6-7-14)19(17(22-23)13-4-5-13)25-15-8-2-12(10-20)3-9-15/h2-3,8-9,13-14H,4-7,11H2,1H3,(H,21,24) D0H2MF DRUGINKE PQGLAOODCQDRAR-UHFFFAOYSA-N D0H2MF DRUGSMIL CNC(=O)CN1C(=C(C(=N1)C2CC2)OC3=CC=C(C=C3)C#N)C4CC4 D0H2MF HIGHSTAT Investigative D0H2NH DRUG__ID D0H2NH D0H2NH DRUGTYPE Small molecular drug D0H2NH DRUGINCH 1S/C20H29FN6O3/c1-4-25-20(29)26(23-22-25)12-11-24-10-9-17(15(2)13-24)27(19(28)14-30-3)18-8-6-5-7-16(18)21/h5-8,15,17H,4,9-14H2,1-3H3/t15-,17+/m1/s1 D0H2NH DRUGINKE KKMGCTVJCQYQPV-WBVHZDCISA-N D0H2NH DRUGSMIL CCN1C(=O)N(N=N1)CCN2CCC(C(C2)C)N(C3=CC=CC=C3F)C(=O)COC D0H2NH HIGHSTAT Investigative D0H2OA DRUG__ID D0H2OA D0H2OA DRUGTYPE Small molecular drug D0H2OA DRUGINCH 1S/C8H15FN2O2/c1-2-13-7(12)8(11,6-9)4-3-5-10/h3-4H,2,5-6,10-11H2,1H3/b4-3+ D0H2OA DRUGINKE RQVGWIPBGFYUQU-ONEGZZNKSA-N D0H2OA DRUGSMIL CCOC(=O)C(CF)(C=CCN)N D0H2OA HIGHSTAT Investigative D0H2PA DRUG__ID D0H2PA D0H2PA DRUGTYPE Small molecular drug D0H2PA DRUGINCH 1S/C19H29N3O6/c1-19(2,3)15(18(26)20-4)21-17(25)14(13(10-23)16(24)22-27)11-6-8-12(28-5)9-7-11/h6-9,13-15,23,27H,10H2,1-5H3,(H,20,26)(H,21,25)(H,22,24)/t13-,14+,15+/m0/s1 D0H2PA DRUGINKE IOLRUMINDIUCLJ-RRFJBIMHSA-N D0H2PA DRUGSMIL CC(C)(C)C(C(=O)NC)NC(=O)C(C1=CC=C(C=C1)OC)C(CO)C(=O)NO D0H2PA HIGHSTAT Investigative D0H2PE DRUG__ID D0H2PE D0H2PE DRUGTYPE Small molecular drug D0H2PE DRUGINCH 1S/C19H15N3/c1-3-7-14(8-4-1)19-17-12-11-16(13-18(17)21-22-19)20-15-9-5-2-6-10-15/h1-13,20H,(H,21,22) D0H2PE DRUGINKE UCZOJYXXXUINID-UHFFFAOYSA-N D0H2PE DRUGSMIL C1=CC=C(C=C1)C2=NNC3=C2C=CC(=C3)NC4=CC=CC=C4 D0H2PE HIGHSTAT Investigative D0H2RD DRUG__ID D0H2RD D0H2RD DRUGTYPE Small molecular drug D0H2RD DRUGINCH 1S/C23H31NO/c25-19-22(21-14-5-2-6-15-21)23-16-8-10-18-24(23)17-9-7-13-20-11-3-1-4-12-20/h1-6,11-12,14-15,22-23,25H,7-10,13,16-19H2/t22-,23-/m1/s1 D0H2RD DRUGINKE MGISPZACVQKKJZ-DHIUTWEWSA-N D0H2RD DRUGSMIL C1CCN(C(C1)C(CO)C2=CC=CC=C2)CCCCC3=CC=CC=C3 D0H2RD HIGHSTAT Investigative D0H2RF DRUG__ID D0H2RF D0H2RF DRUGTYPE Small molecular drug D0H2RF DRUGINCH 1S/C36H45N5O5/c1-22(2)27-12-7-9-23(3)28(27)21-31(34(44)39-30(33(38)43)20-24-10-5-4-6-11-24)40-35(45)32-13-8-18-41(32)36(46)29(37)19-25-14-16-26(42)17-15-25/h4-7,9-12,14-17,22,29-32,42H,8,13,18-21,37H2,1-3H3,(H2,38,43)(H,39,44)(H,40,45)/t29-,30-,31-,32-/m0/s1 D0H2RF DRUGINKE ZMMDWGMVKHLYTG-YDPTYEFTSA-N D0H2RF DRUGSMIL CC1=C(C(=CC=C1)C(C)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0H2RF HIGHSTAT Investigative D0H2RZ DRUG__ID D0H2RZ D0H2RZ DRUGTYPE Small molecular drug D0H2RZ DRUGINCH 1S/C7H14O2/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H,8,9) D0H2RZ DRUGINKE MNWFXJYAOYHMED-UHFFFAOYSA-N D0H2RZ DRUGSMIL CCCCCCC(=O)O D0H2RZ HIGHSTAT Investigative D0H2SL DRUG__ID D0H2SL D0H2SL DRUGTYPE Small molecular drug D0H2SL DRUGINCH 1S/C12H15BrO3/c1-12(2,3)9-6-8(13)4-5-10(9)16-7-11(14)15/h4-6H,7H2,1-3H3,(H,14,15) D0H2SL DRUGINKE GCBNGPDJYUPSBS-UHFFFAOYSA-N D0H2SL DRUGSMIL CC(C)(C)C1=C(C=CC(=C1)Br)OCC(=O)O D0H2SL HIGHSTAT Investigative D0H2TS DRUG__ID D0H2TS D0H2TS DRUGTYPE Small molecular drug D0H2TS DRUGINCH 1S/C18H20FNO/c19-16-5-3-6-17(12-16)21-13-15-4-1-2-7-18(15)14-8-10-20-11-9-14/h1-7,12,14,20H,8-11,13H2 D0H2TS DRUGINKE LGSKMJOUAMVJKK-UHFFFAOYSA-N D0H2TS DRUGSMIL C1CNCCC1C2=CC=CC=C2COC3=CC(=CC=C3)F D0H2TS HIGHSTAT Investigative D0H2TZ DRUG__ID D0H2TZ D0H2TZ DRUGTYPE Small molecular drug D0H2TZ DRUGINCH 1S/C11H18N5O13P3/c12-11-14-8-5(9(19)15-11)13-2-16(8)10-7(18)6(17)4(28-10)1-27-30(20,21)3-31(22,23)29-32(24,25)26/h2,4,6-7,10,17-18H,1,3H2,(H,20,21)(H,22,23)(H2,24,25,26)(H3,12,14,15,19)/t4-,6-,7-,10-/m1/s1 D0H2TZ DRUGINKE GXTIEXDFEKYVGY-KQYNXXCUSA-N D0H2TZ DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O)O)N=C(NC2=O)N D0H2TZ HIGHSTAT Investigative D0H2UG DRUG__ID D0H2UG D0H2UG DRUGTYPE Small molecular drug D0H2UG DRUGINCH 1S/C23H34N2O/c1-3-4-5-6-7-8-11-16-24-23-19-12-9-10-13-21(19)25-22-15-14-18(26-2)17-20(22)23/h14-15,17H,3-13,16H2,1-2H3,(H,24,25) D0H2UG DRUGINKE CMKNYPAMAODIKM-UHFFFAOYSA-N D0H2UG DRUGSMIL CCCCCCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D0H2UG HIGHSTAT Investigative D0H2UM DRUG__ID D0H2UM D0H2UM DRUGTYPE Small molecular drug D0H2UM DRUGINCH 1S/C15H10BrNO4S/c16-11-5-6-13-10(9-11)7-8-17(13)22(20,21)14-4-2-1-3-12(14)15(18)19/h1-9H,(H,18,19) D0H2UM DRUGINKE RGZDWZUMVMDEAG-UHFFFAOYSA-N D0H2UM DRUGSMIL C1=CC=C(C(=C1)C(=O)O)S(=O)(=O)N2C=CC3=C2C=CC(=C3)Br D0H2UM HIGHSTAT Investigative D0H2UT DRUG__ID D0H2UT D0H2UT DRUGTYPE Small molecular drug D0H2UT DRUGINCH 1S/C23H26N2O4/c1-27-16-8-14-15(9-17(16)28-2)25-20(26)10-18-21-13-7-19-23(14,22(21)25)4-5-24(19)11-12(13)3-6-29-18/h3,8-9,13,18-19,21-22H,4-7,10-11H2,1-2H3/t13-,18-,19-,21-,22-,23+/m0/s1 D0H2UT DRUGINKE RRKTZKIUPZVBMF-IBTVXLQLSA-N D0H2UT DRUGSMIL COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC D0H2UT HIGHSTAT Investigative D0H2VA DRUG__ID D0H2VA D0H2VA DRUGTYPE Small molecular drug D0H2VA DRUGINCH 1S/C16H12N4O3S/c17-6-10-14(9-1-2-12-13(5-9)23-8-22-12)11(7-18)16(20-15(10)19)24-4-3-21/h1-2,5,21H,3-4,8H2,(H2,19,20) D0H2VA DRUGINKE KQKVGJJOJHCKQA-UHFFFAOYSA-N D0H2VA DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=C(C(=NC(=C3C#N)SCCO)N)C#N D0H2VA HIGHSTAT Investigative D0H2VW DRUG__ID D0H2VW D0H2VW DRUGTYPE Small molecular drug D0H2VW DRUGINCH 1S/C31H31N3O/c35-31(32-29(25-13-5-1-6-14-25)26-15-7-2-8-16-26)34-23-21-33(22-24-34)30(27-17-9-3-10-18-27)28-19-11-4-12-20-28/h1-20,29-30H,21-24H2,(H,32,35) D0H2VW DRUGINKE PPVBMJIAJXVQFX-UHFFFAOYSA-N D0H2VW DRUGSMIL C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NC(C4=CC=CC=C4)C5=CC=CC=C5 D0H2VW HIGHSTAT Investigative D0H2VY DRUG__ID D0H2VY D0H2VY DRUGTYPE Small molecular drug D0H2VY DRUGINCH 1S/C12H12N6/c13-10-9-11(18-12(14)17-10)16-8(15-9)6-7-4-2-1-3-5-7/h1-5H,6H2,(H5,13,14,15,16,17,18) D0H2VY DRUGINKE AFWYNOWVYKOMGZ-UHFFFAOYSA-N D0H2VY DRUGSMIL C1=CC=C(C=C1)CC2=NC3=NC(=NC(=C3N2)N)N D0H2VY HIGHSTAT Investigative D0H2WQ DRUG__ID D0H2WQ D0H2WQ DRUGTYPE Small molecular drug D0H2WQ DRUGINCH 1S/C13H21N3/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12/h9-10,13H,2-8H2,1H3,(H,14,15)/t10-,13-/m1/s1 D0H2WQ DRUGINKE FTSUPYGMFAPCFZ-ZWNOBZJWSA-N D0H2WQ DRUGSMIL CCCN1CCCC2C1CC3=C(C2)NN=C3 D0H2WQ HIGHSTAT Investigative D0H2XJ DRUG__ID D0H2XJ D0H2XJ DRUGTYPE Small molecular drug D0H2XJ DRUGINCH 1S/C7H12OS/c1-3-7(2)4-5-9-6(7)8/h3-5H2,1-2H3 D0H2XJ DRUGINKE PSYRIJIIQVMBLR-UHFFFAOYSA-N D0H2XJ DRUGSMIL CCC1(CCSC1=O)C D0H2XJ HIGHSTAT Investigative D0H2YM DRUG__ID D0H2YM D0H2YM DRUGTYPE Small molecular drug D0H2YM DRUGINCH 1S/C27H46O2/c1-18(17-28)6-5-7-19(2)23-10-11-24-22-9-8-20-16-21(29)12-14-26(20,3)25(22)13-15-27(23,24)4/h8,18-19,21-25,28-29H,5-7,9-17H2,1-4H3/t18-,19-,21+,22+,23-,24+,25+,26+,27-/m1/s1 D0H2YM DRUGINKE FYHRJWMENCALJY-YSQMORBQSA-N D0H2YM DRUGSMIL CC(CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO D0H2YM HIGHSTAT Investigative D0H2YT DRUG__ID D0H2YT D0H2YT DRUGTYPE Small molecular drug D0H2YT DRUGINCH 1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 D0H2YT DRUGINKE GRSZFWQUAKGDAV-KQYNXXCUSA-N D0H2YT DRUGSMIL C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O D0H2YT HIGHSTAT Investigative D0H3BC DRUG__ID D0H3BC D0H3BC DRUGTYPE Small molecular drug D0H3BC DRUGINCH 1S/C26H27NO3/c1-27(19-20-10-4-2-5-11-20)16-8-3-9-17-29-21-14-15-23-25(18-21)30-24-13-7-6-12-22(24)26(23)28/h2,4-7,10-15,18H,3,8-9,16-17,19H2,1H3 D0H3BC DRUGINKE NDUSIOVFIPORBY-UHFFFAOYSA-N D0H3BC DRUGSMIL CN(CCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D0H3BC HIGHSTAT Investigative D0H3CQ DRUG__ID D0H3CQ D0H3CQ DRUGTYPE Small molecular drug D0H3CQ DRUGINCH 1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3/i1T3 D0H3CQ DRUGINKE ITJNARMNRKSWTA-RLXJOQACSA-N D0H3CQ DRUGSMIL CNCCC(C1=CC=CC=C1)OC2=CC=CC=C2OC D0H3CQ HIGHSTAT Investigative D0H3CW DRUG__ID D0H3CW D0H3CW DRUGTYPE Small molecular drug D0H3CW DRUGINCH 1S/C12H11BrClNO/c1-15-5-4-7-9(14)2-3-10-11(7)8(6-15)12(13)16-10/h2-3H,4-6H2,1H3 D0H3CW DRUGINKE NYGANYRUZQPPGP-UHFFFAOYSA-N D0H3CW DRUGSMIL CN1CCC2=C(C=CC3=C2C(=C(O3)Br)C1)Cl D0H3CW HIGHSTAT Investigative D0H3DT DRUG__ID D0H3DT D0H3DT DRUGTYPE Small molecular drug D0H3DT DRUGINCH 1S/C17H15NO/c1-12-5-6-14-7-8-16(10-17(14)18-12)15-4-2-3-13(9-15)11-19/h2-10,19H,11H2,1H3 D0H3DT DRUGINKE IPRCARTWCVTTOP-UHFFFAOYSA-N D0H3DT DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC(=C3)CO D0H3DT HIGHSTAT Investigative D0H3DY DRUG__ID D0H3DY D0H3DY DRUGTYPE Small molecular drug D0H3DY DRUGINCH 1S/C6H9N3/c7-5-1-4(5)6-2-8-3-9-6/h2-5H,1,7H2,(H,8,9)/t4-,5-/m0/s1 D0H3DY DRUGINKE OWWNABDDYQLERE-WHFBIAKZSA-N D0H3DY DRUGSMIL C1C(C1N)C2=CN=CN2 D0H3DY HIGHSTAT Investigative D0H3EJ DRUG__ID D0H3EJ D0H3EJ DRUGTYPE Small molecular drug D0H3EJ DRUGINCH 1S/C43H66N8O14/c1-21(2)18-29(48-41(62)30(20-32(45)52)49-42(63)35(22(3)4)51-39(60)27(44)14-16-33(53)54)36(57)25-12-9-13-26(25)38(59)46-23(5)37(58)47-28(15-17-34(55)56)40(61)50-31(43(64)65)19-24-10-7-6-8-11-24/h6-8,10-11,21-23,25-31,35-36,57H,9,12-20,44H2,1-5H3,(H2,45,52)(H,46,59)(H,47,58)(H,48,62)(H,49,63)(H,50,61)(H,51,60)(H,53,54)(H,55,56)(H,64,65)/t23-,25+,26+,27-,28-,29-,30-,31-,35-,36-/m0/s1 D0H3EJ DRUGINKE SEJYUEISOCTKKB-SABPYFDQSA-N D0H3EJ DRUGSMIL CC(C)CC(C(C1CCCC1C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)O)O)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)N D0H3EJ HIGHSTAT Investigative D0H3EV DRUG__ID D0H3EV D0H3EV DRUGTYPE Small molecular drug D0H3EV DRUGINCH 1S/C16H11N3O3/c20-15-8-12-11-7-9(19(21)22)5-6-14(11)18-16(12)10-3-1-2-4-13(10)17-15/h1-7,18H,8H2,(H,17,20) D0H3EV DRUGINKE OLUKILHGKRVDCT-UHFFFAOYSA-N D0H3EV DRUGSMIL C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)[N+](=O)[O-] D0H3EV HIGHSTAT Investigative D0H3FH DRUG__ID D0H3FH D0H3FH DRUGTYPE Small molecular drug D0H3FH DRUGINCH 1S/C17H12IN3O/c18-13-4-5-15-16(9-13)21-17(22)7-6-14(20-15)12-3-1-2-11(8-12)10-19/h1-5,8-9H,6-7H2,(H,21,22) D0H3FH DRUGINKE SJYIGECDHTXFFG-UHFFFAOYSA-N D0H3FH DRUGSMIL C1CC(=O)NC2=C(C=CC(=C2)I)N=C1C3=CC=CC(=C3)C#N D0H3FH HIGHSTAT Investigative D0H3GI DRUG__ID D0H3GI D0H3GI DRUGTYPE Small molecular drug D0H3GI DRUGINCH 1S/C20H21NO/c1-15-6-8-16(9-7-15)18-14-20(10-12-21-13-11-20)22-19-5-3-2-4-17(18)19/h2-9,14,21H,10-13H2,1H3 D0H3GI DRUGINKE YDXKUUFNKUXOBE-UHFFFAOYSA-N D0H3GI DRUGSMIL CC1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=CC=CC=C42 D0H3GI HIGHSTAT Investigative D0H3IJ DRUG__ID D0H3IJ D0H3IJ DRUGTYPE Small molecular drug D0H3IJ DRUGINCH 1S/C6H13O9P/c7-1-3(8)5(10)6(11)4(9)2-15-16(12,13)14/h4-7,9-11H,1-2H2,(H2,12,13,14)/t4-,5-,6-/m1/s1 D0H3IJ DRUGINKE GSXOAOHZAIYLCY-HSUXUTPPSA-N D0H3IJ DRUGSMIL C(C(C(C(C(=O)CO)O)O)O)OP(=O)(O)O D0H3IJ HIGHSTAT Investigative D0H3KU DRUG__ID D0H3KU D0H3KU DRUGTYPE Small molecular drug D0H3KU DRUGINCH 1S/C16H25NO/c1-3-10-17(11-4-2)14-8-9-15-13(12-14)6-5-7-16(15)18/h5-7,14,18H,3-4,8-12H2,1-2H3 D0H3KU DRUGINKE MDBWEQVKJDMEMK-UHFFFAOYSA-N D0H3KU DRUGSMIL CCCN(CCC)C1CCC2=C(C1)C=CC=C2O D0H3KU HIGHSTAT Investigative D0H3LE DRUG__ID D0H3LE D0H3LE DRUGTYPE Small molecular drug D0H3LE DRUGINCH 1S/C14H11N3/c1-10-7-8-12-9-15-13(17-14(12)16-10)11-5-3-2-4-6-11/h2-9H,1H3 D0H3LE DRUGINKE KWVJWWRUSUZAGY-UHFFFAOYSA-N D0H3LE DRUGSMIL CC1=NC2=NC(=NC=C2C=C1)C3=CC=CC=C3 D0H3LE HIGHSTAT Investigative D0H3LF DRUG__ID D0H3LF D0H3LF DRUGTYPE Small molecular drug D0H3LF DRUGINCH 1S/C16H21N3/c1-13(2)18-9-11-19(12-10-18)16-8-7-14-5-3-4-6-15(14)17-16/h3-8,13H,9-12H2,1-2H3 D0H3LF DRUGINKE WICRMWNIFYTKBK-UHFFFAOYSA-N D0H3LF DRUGSMIL CC(C)N1CCN(CC1)C2=NC3=CC=CC=C3C=C2 D0H3LF HIGHSTAT Investigative D0H3LU DRUG__ID D0H3LU D0H3LU DRUGTYPE Small molecular drug D0H3LU DRUGINCH 1S/C22H16N2/c1-14-16-11-12-23-22(15-7-3-2-4-8-15)18(16)13-19-17-9-5-6-10-20(17)24-21(14)19/h2-13,24H,1H3 D0H3LU DRUGINKE ORUPXFHZHTYMFL-UHFFFAOYSA-N D0H3LU DRUGSMIL CC1=C2C(=CC3=C1C=CN=C3C4=CC=CC=C4)C5=CC=CC=C5N2 D0H3LU HIGHSTAT Investigative D0H3MO DRUG__ID D0H3MO D0H3MO DRUGTYPE Small molecular drug D0H3MO DRUGINCH 1S/C10H12F3N/c1-7(14)5-8-3-2-4-9(6-8)10(11,12)13/h2-4,6-7H,5,14H2,1H3/t7-/m1/s1 D0H3MO DRUGINKE MLBHFBKZUPLWBD-SSDOTTSWSA-N D0H3MO DRUGSMIL CC(CC1=CC(=CC=C1)C(F)(F)F)N D0H3MO HIGHSTAT Investigative D0H3NA DRUG__ID D0H3NA D0H3NA DRUGTYPE Small molecular drug D0H3NA DRUGINCH 1S/C11H8N2S/c1-2-8(10-6-12-7-13-10)9-4-5-14-11(9)3-1/h1-7H,(H,12,13) D0H3NA DRUGINKE QRRRICPYXPJYEH-UHFFFAOYSA-N D0H3NA DRUGSMIL C1=CC(=C2C=CSC2=C1)C3=CN=CN3 D0H3NA HIGHSTAT Investigative D0H3NS DRUG__ID D0H3NS D0H3NS DRUGTYPE Small molecular drug D0H3NS DRUGINCH 1S/C10H6O4/c11-9(12)7-5-6-3-1-2-4-8(6)14-10(7)13/h1-5H,(H,11,12) D0H3NS DRUGINKE ACMLKANOGIVEPB-UHFFFAOYSA-N D0H3NS DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)O2)C(=O)O D0H3NS HIGHSTAT Investigative D0H3OP DRUG__ID D0H3OP D0H3OP DRUGTYPE Small molecular drug D0H3OP DRUGINCH 1S/C14H13N/c1-2-10-7-8-12-11-5-3-4-6-13(11)15-14(12)9-10/h3-9,15H,2H2,1H3 D0H3OP DRUGINKE MLTJHZTUKWUPTG-UHFFFAOYSA-N D0H3OP DRUGSMIL CCC1=CC2=C(C=C1)C3=CC=CC=C3N2 D0H3OP HIGHSTAT Investigative D0H3OZ DRUG__ID D0H3OZ D0H3OZ DRUGCOMP Ipsen D0H3OZ DRUGINCH 1S/C44H58N8O2S2/c45-35(43(53)51-23-21-49-27-37(33-17-9-3-10-18-33)47-41(49)39(51)25-31-13-5-1-6-14-31)29-55-56-30-36(46)44(54)52-24-22-50-28-38(34-19-11-4-12-20-34)48-42(50)40(52)26-32-15-7-2-8-16-32/h3-4,9-12,17-20,27-28,31-32,35-36,39-40H,1-2,5-8,13-16,21-26,29-30,45-46H2/t35-,36-,39-,40-/m0/s1 D0H3OZ DRUGINKE GGDNOAWICIHSAW-KEAHXZLPSA-N D0H3OZ DRUGSMIL C1CCC(CC1)CC2C3=NC(=CN3CCN2C(=O)C(CSSCC(C(=O)N4CCN5C=C(N=C5C4CC6CCCCC6)C7=CC=CC=C7)N)N)C8=CC=CC=C8 D0H3OZ HIGHSTAT Investigative D0H3QK DRUG__ID D0H3QK D0H3QK DRUGTYPE Small molecular drug D0H3QK DRUGINCH 1S/C22H29N3O/c23-15-11-22(26)25(20-9-5-2-6-10-20)21-13-17-24(18-14-21)16-12-19-7-3-1-4-8-19/h1-10,21H,11-18,23H2 D0H3QK DRUGINKE WBHIZNRNVFOZMJ-UHFFFAOYSA-N D0H3QK DRUGSMIL C1CN(CCC1N(C2=CC=CC=C2)C(=O)CCN)CCC3=CC=CC=C3 D0H3QK HIGHSTAT Investigative D0H3QX DRUG__ID D0H3QX D0H3QX DRUGTYPE Small molecular drug D0H3QX DRUGINCH 1S/C16H11N3O3S/c20-15(12-6-8-13(9-7-12)19(21)22)18-16-17-14(10-23-16)11-4-2-1-3-5-11/h1-10H,(H,17,18,20) D0H3QX DRUGINKE LLSUVHOZHQEGJS-UHFFFAOYSA-N D0H3QX DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC=C(C=C3)[N+](=O)[O-] D0H3QX HIGHSTAT Investigative D0H3RD DRUG__ID D0H3RD D0H3RD DRUGTYPE Small molecular drug D0H3RD DRUGINCH 1S/C17H14IN3OS/c18-14-9-7-13(8-10-14)16(22)19-17-21-20-15(23-17)11-6-12-4-2-1-3-5-12/h1-5,7-10H,6,11H2,(H,19,21,22) D0H3RD DRUGINKE ISVOIGTWCBLSQY-UHFFFAOYSA-N D0H3RD DRUGSMIL C1=CC=C(C=C1)CCC2=NN=C(S2)NC(=O)C3=CC=C(C=C3)I D0H3RD HIGHSTAT Investigative D0H3RQ DRUG__ID D0H3RQ D0H3RQ DRUGTYPE Small molecular drug D0H3RQ DRUGINCH 1S/C17H13BrO3/c1-10-7-12-9-14(11-3-5-13(20-2)6-4-11)17(19)21-16(12)15(18)8-10/h3-9H,1-2H3 D0H3RQ DRUGINKE QMFYGKBIXCRXNB-UHFFFAOYSA-N D0H3RQ DRUGSMIL CC1=CC2=C(C(=C1)Br)OC(=O)C(=C2)C3=CC=C(C=C3)OC D0H3RQ HIGHSTAT Investigative D0H3SL DRUG__ID D0H3SL D0H3SL DRUGTYPE Small molecular drug D0H3SL DRUGINCH 1S/C31H29N5O6/c37-21-34-25-19-33-30(23-12-5-2-6-13-23)36(31(25)41)20-27(39)35-24(18-22-10-3-1-4-11-22)29(40)26(38)14-9-17-42-28-15-7-8-16-32-28/h1-8,10-13,15-16,19,21,24H,9,14,17-18,20H2,(H,34,37)(H,35,39) D0H3SL DRUGINKE QOANBAXBOLUAFA-UHFFFAOYSA-N D0H3SL DRUGSMIL C1=CC=C(C=C1)CC(C(=O)C(=O)CCCOC2=CC=CC=N2)NC(=O)CN3C(=NC=C(C3=O)NC=O)C4=CC=CC=C4 D0H3SL HIGHSTAT Investigative D0H3TC DRUG__ID D0H3TC D0H3TC DRUGTYPE Small molecular drug D0H3TC DRUGINCH 1S/C15H19NO3/c1-5-18-14-7-12(10(3)17)6-13(8-14)15-9(2)16-19-11(15)4/h6-8,10,17H,5H2,1-4H3 D0H3TC DRUGINKE AONNGYBECNOVTK-UHFFFAOYSA-N D0H3TC DRUGSMIL CCOC1=CC(=CC(=C1)C(C)O)C2=C(ON=C2C)C D0H3TC HIGHSTAT Investigative D0H3UI DRUG__ID D0H3UI D0H3UI DRUGTYPE Small molecular drug D0H3UI DRUGINCH 1S/C11H8N2O/c1-14-11-4-2-9(3-5-11)6-10(7-12)8-13/h2-6H,1H3 D0H3UI DRUGINKE UOHFCPXBKJPCAD-UHFFFAOYSA-N D0H3UI DRUGSMIL COC1=CC=C(C=C1)C=C(C#N)C#N D0H3UI HIGHSTAT Investigative D0H3VZ DRUG__ID D0H3VZ D0H3VZ DRUGTYPE Small molecular drug D0H3VZ DRUGINCH 1S/C23H30O7S/c1-22-7-5-14-21(26)30-17(13-6-8-28-11-13)10-23(14,2)19(22)18(24)16(29-12-31-4)9-15(22)20(25)27-3/h6,8,11,14-17,19H,5,7,9-10,12H2,1-4H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1 D0H3VZ DRUGINKE IEZYEEBKOXBUJC-AGQYDFLVSA-N D0H3VZ DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCSC)C)C4=COC=C4 D0H3VZ HIGHSTAT Investigative D0H3WJ DRUG__ID D0H3WJ D0H3WJ DRUGTYPE Small molecular drug D0H3WJ DRUGINCH 1S/C21H17NOS/c1-15(16-9-3-2-4-10-16)21(23)22-17-11-5-7-13-19(17)24-20-14-8-6-12-18(20)22/h2-15H,1H3 D0H3WJ DRUGINKE JSTQBEJYZPIVJU-UHFFFAOYSA-N D0H3WJ DRUGSMIL CC(C1=CC=CC=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0H3WJ HIGHSTAT Investigative D0H3XF DRUG__ID D0H3XF D0H3XF DRUGTYPE Small molecular drug D0H3XF DRUGINCH 1S/C18H13N3O/c22-18-16-15(13-7-3-1-4-8-13)11-21(17(16)19-12-20-18)14-9-5-2-6-10-14/h1-12H,(H,19,20,22) D0H3XF DRUGINKE YTLWLZPZXNOVGS-UHFFFAOYSA-N D0H3XF DRUGSMIL C1=CC=C(C=C1)C2=CN(C3=C2C(=O)NC=N3)C4=CC=CC=C4 D0H3XF HIGHSTAT Investigative D0H3YR DRUG__ID D0H3YR D0H3YR DRUGTYPE Small molecular drug D0H3YR DRUGINCH 1S/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1/i7T D0H3YR DRUGINKE MQTUXRKNJYPMCG-FZQCOGARSA-N D0H3YR DRUGSMIL C1CC(C1)N(C2CCC2)C3CC4=C(C=CC(=C4OC3)F)C(=O)N D0H3YR HIGHSTAT Investigative D0H4AD DRUG__ID D0H4AD D0H4AD DRUGTYPE Small molecular drug D0H4AD DRUGINCH 1S/C13H18BrNO/c1-9(15-13(2,3)4)12(16)10-5-7-11(14)8-6-10/h5-9,15H,1-4H3 D0H4AD DRUGINKE QYLKSFXBRALDIS-UHFFFAOYSA-N D0H4AD DRUGSMIL CC(C(=O)C1=CC=C(C=C1)Br)NC(C)(C)C D0H4AD HIGHSTAT Investigative D0H4BJ DRUG__ID D0H4BJ D0H4BJ DRUGTYPE Small molecular drug D0H4BJ DRUGINCH 1S/C9H20NO2/c1-7-9(11)5-8(12-7)6-10(2,3)4/h7-9,11H,5-6H2,1-4H3/q+1/t7-,8-,9+/m0/s1 D0H4BJ DRUGINKE UQOFGTXDASPNLL-XHNCKOQMSA-N D0H4BJ DRUGSMIL CC1C(CC(O1)C[N+](C)(C)C)O D0H4BJ HIGHSTAT Investigative D0H4BT DRUG__ID D0H4BT D0H4BT DRUGTYPE Small molecular drug D0H4BT DRUGINCH 1S/C12H11NO2S/c1-16(14,15)11-7-5-10(6-8-11)12-4-2-3-9-13-12/h2-9H,1H3 D0H4BT DRUGINKE PCRZBBOIGHSIEX-UHFFFAOYSA-N D0H4BT DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=CC=CC=N2 D0H4BT HIGHSTAT Investigative D0H4CF DRUG__ID D0H4CF D0H4CF DRUGTYPE Small molecular drug D0H4CF DRUGINCH 1S/C12H12N4O2S/c13-9-4-6-10(7-5-9)15-16-11-2-1-3-12(8-11)19(14,17)18/h1-8H,13H2,(H2,14,17,18) D0H4CF DRUGINKE VAOWCMBATGAWIO-UHFFFAOYSA-N D0H4CF DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)N=NC2=CC=C(C=C2)N D0H4CF HIGHSTAT Investigative D0H4DF DRUG__ID D0H4DF D0H4DF DRUGTYPE Small molecular drug D0H4DF DRUGINCH 1S/C104H151N25O26S/c1-54(2)39-70(91(142)113-52-87(139)129-37-20-27-80(129)103(154)120-69(33-35-82(107)134)93(144)119-68(32-34-81(106)133)94(145)124-76(44-61-23-16-13-17-24-61)99(150)123-74(43-60-21-14-12-15-22-60)92(143)112-51-86(138)116-71(40-55(3)4)95(146)118-67(89(109)140)36-38-156-11)121-96(147)72(41-56(5)6)122-98(149)75(45-62-28-30-64(132)31-29-62)117-85(137)50-111-90(141)58(9)114-102(153)79(53-130)127-100(151)78(47-83(108)135)125-97(148)73(42-57(7)8)126-104(155)88(59(10)131)128-101(152)77(115-84(136)48-105)46-63-49-110-66-26-19-18-25-65(63)66/h12-19,21-26,28-31,49,54-59,67-80,88,110,130-132H,20,27,32-48,50-53,105H2,1-11H3,(H2,106,133)(H2,107,134)(H2,108,135)(H2,109,140)(H,111,141)(H,112,143)(H,113,142)(H,114,153)(H,115,136)(H,116,138)(H,117,137)(H,118,146)(H,119,144)(H,120,154)(H,121,147)(H,122,149)(H,123,150)(H,124,145)(H,125,148)(H,126,155)(H,127,151)(H,128,152)/t58-,59+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,88-/m0/s1 D0H4DF DRUGINKE TZOJVPDIYKRJSM-GKPUQKAJSA-N D0H4DF DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)CN D0H4DF HIGHSTAT Investigative D0H4DW DRUG__ID D0H4DW D0H4DW DRUGTYPE Small molecular drug D0H4DW DRUGINCH 1S/C13H12N2/c1-2-15-12-6-4-3-5-10(12)11-7-8-14-9-13(11)15/h3-9H,2H2,1H3 D0H4DW DRUGINKE BMGUCVPPDGYFRV-UHFFFAOYSA-N D0H4DW DRUGSMIL CCN1C2=CC=CC=C2C3=C1C=NC=C3 D0H4DW HIGHSTAT Investigative D0H4EK DRUG__ID D0H4EK D0H4EK DRUGTYPE Small molecular drug D0H4EK DRUGINCH 1S/C32H39F3N8O7/c1-43-28(49)23(15-19-9-4-2-5-10-19)41-27(48)22(16-25(45)46)40-24(44)18-39-26(47)21(13-8-14-38-30(36)37)42-29(50)31(43,32(33,34)35)17-20-11-6-3-7-12-20/h2-7,9-12,21-23H,8,13-18H2,1H3,(H,39,47)(H,40,44)(H,41,48)(H,42,50)(H,45,46)(H4,36,37,38)/t21-,22-,23+,31+/m0/s1 D0H4EK DRUGINKE IKBMFRHCMUKOBA-ZAUAPEEVSA-N D0H4EK DRUGSMIL CN1C(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C1(CC2=CC=CC=C2)C(F)(F)F)CCCN=C(N)N)CC(=O)O)CC3=CC=CC=C3 D0H4EK HIGHSTAT Investigative D0H4GQ DRUG__ID D0H4GQ D0H4GQ DRUGTYPE Small molecular drug D0H4GQ DRUGINCH 1S/C21H23N3O3Si/c1-5-27-21(26)18-19-17-8-10-23(17)20(25)15-12-14(9-11-28(2,3)4)6-7-16(15)24(19)13-22-18/h6-7,12-13,17H,5,8,10H2,1-4H3/t17-/m0/s1 D0H4GQ DRUGINKE SNBBNIBMHQGUBE-KRWDZBQOSA-N D0H4GQ DRUGSMIL CCOC(=O)C1=C2C3CCN3C(=O)C4=C(N2C=N1)C=CC(=C4)C#C[Si](C)(C)C D0H4GQ HIGHSTAT Investigative D0H4ID DRUG__ID D0H4ID D0H4ID DRUGTYPE Small molecular drug D0H4ID DRUGINCH 1S/C11H19N3O2/c1-3-9(2)14-11(15)16-6-4-5-10-7-12-8-13-10/h7-9H,3-6H2,1-2H3,(H,12,13)(H,14,15)/t9-/m0/s1 D0H4ID DRUGINKE RSHJCGZZSGNBHO-VIFPVBQESA-N D0H4ID DRUGSMIL CCC(C)NC(=O)OCCCC1=CN=CN1 D0H4ID HIGHSTAT Investigative D0H4JB DRUG__ID D0H4JB D0H4JB DRUGTYPE Small molecular drug D0H4JB DRUGINCH 1S/C17H15NO3/c1-20-16-8-12-7-13(11-3-5-14(19)6-4-11)10-18-15(12)9-17(16)21-2/h3-10,19H,1-2H3 D0H4JB DRUGINKE GVQYSEHILFQSHO-UHFFFAOYSA-N D0H4JB DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=C(C=C3)O D0H4JB HIGHSTAT Investigative D0H4LP DRUG__ID D0H4LP D0H4LP DRUGTYPE Small molecular drug D0H4LP DRUGINCH 1S/C25H23F3N4O4/c1-15-5-6-18(14-30-15)36-17-4-2-3-16(11-17)12-22(33)32-10-9-29-24-19(20(32)13-23(34)35)7-8-21(31-24)25(26,27)28/h2-8,11,14,20H,9-10,12-13H2,1H3,(H,29,31)(H,34,35)/t20-/m1/s1 D0H4LP DRUGINKE PPSMYAUEJRADFE-HXUWFJFHSA-N D0H4LP DRUGSMIL CC1=NC=C(C=C1)OC2=CC=CC(=C2)CC(=O)N3CCNC4=C(C3CC(=O)O)C=CC(=N4)C(F)(F)F D0H4LP HIGHSTAT Investigative D0H4MB DRUG__ID D0H4MB D0H4MB DRUGTYPE Small molecular drug D0H4MB DRUGINCH 1S/C6H12N2O/c7-6(9)5-1-3-8-4-2-5/h5,8H,1-4H2,(H2,7,9) D0H4MB DRUGINKE DPBWFNDFMCCGGJ-UHFFFAOYSA-N D0H4MB DRUGSMIL C1CNCCC1C(=O)N D0H4MB HIGHSTAT Investigative D0H4MO DRUG__ID D0H4MO D0H4MO DRUGTYPE Small molecular drug D0H4MO DRUGINCH 1S/C7H17NO7P2/c9-7(16(10,11)12,17(13,14)15)5-6-3-1-2-4-8-6/h6,8-9H,1-5H2,(H2,10,11,12)(H2,13,14,15) D0H4MO DRUGINKE GKUBJNUBGKBXKR-UHFFFAOYSA-N D0H4MO DRUGSMIL C1CCNC(C1)CC(O)(P(=O)(O)O)P(=O)(O)O D0H4MO HIGHSTAT Investigative D0H4MV DRUG__ID D0H4MV D0H4MV DRUGTYPE Small molecular drug D0H4MV DRUGINCH 1S/C14H12N2O/c1-10-7-8-13-12(9-10)16-14(17-13)15-11-5-3-2-4-6-11/h2-9H,1H3,(H,15,16) D0H4MV DRUGINKE SJERMAXXFIXBCQ-UHFFFAOYSA-N D0H4MV DRUGSMIL CC1=CC2=C(C=C1)OC(=N2)NC3=CC=CC=C3 D0H4MV HIGHSTAT Investigative D0H4NK DRUG__ID D0H4NK D0H4NK DRUGTYPE Small molecular drug D0H4NK DRUGINCH 1S/C8H11N5/c9-7(10)13-8(11)12-6-4-2-1-3-5-6/h1-5H,(H6,9,10,11,12,13) D0H4NK DRUGINKE CUQCMXFWIMOWRP-UHFFFAOYSA-N D0H4NK DRUGSMIL C1=CC=C(C=C1)N=C(N)N=C(N)N D0H4NK HIGHSTAT Investigative D0H4NR DRUG__ID D0H4NR D0H4NR DRUGTYPE Small molecular drug D0H4NR DRUGINCH 1S/C25H36Cl2N4O8/c1-12(2)20(25(38)39)30-22(35)13(3)29-24(37)21(14(4)32)31-23(36)18(7-8-19(33)34)28-10-9-15-5-6-16(26)17(27)11-15/h5-6,11-14,18,20-21,28,32H,7-10H2,1-4H3,(H,29,37)(H,30,35)(H,31,36)(H,33,34)(H,38,39)/t13-,14?,18-,20-,21-/m0/s1 D0H4NR DRUGINKE QVZKLLUMEYWUMT-WHJBMRRRSA-N D0H4NR DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCC1=CC(=C(C=C1)Cl)Cl D0H4NR HIGHSTAT Investigative D0H4PN DRUG__ID D0H4PN D0H4PN DRUGTYPE Small molecular drug D0H4PN DRUGINCH 1S/C13H15N3S2/c1-2-11(10-6-4-3-5-7-10)15-12(17)16-13-14-8-9-18-13/h3-9,11H,2H2,1H3,(H2,14,15,16,17) D0H4PN DRUGINKE PBDIRHCFDNJKQO-UHFFFAOYSA-N D0H4PN DRUGSMIL CCC(C1=CC=CC=C1)NC(=S)NC2=NC=CS2 D0H4PN HIGHSTAT Investigative D0H4QM DRUG__ID D0H4QM D0H4QM DRUGTYPE Small molecular drug D0H4QM DRUGINCH 1S/C26H31N7O3S/c1-26(2,3)30-25(34)17-33(37(35,36)23-6-5-9-28-14-23)21-11-20-10-19(12-27)7-8-24(20)32(15-21)16-22-13-29-18-31(22)4/h5-10,13-14,18,21H,11,15-17H2,1-4H3,(H,30,34) D0H4QM DRUGINKE YCXGDFGCNDASCM-UHFFFAOYSA-N D0H4QM DRUGSMIL CC(C)(C)NC(=O)CN(C1CC2=C(C=CC(=C2)C#N)N(C1)CC3=CN=CN3C)S(=O)(=O)C4=CN=CC=C4 D0H4QM HIGHSTAT Investigative D0H4RE DRUG__ID D0H4RE D0H4RE DRUGTYPE Small molecular drug D0H4RE DRUGINCH 1S/C19H21N5O/c1-3-24(4-2)18-21-16-13-9-8-12-15(16)17(22-18)23-19(25)20-14-10-6-5-7-11-14/h5-13H,3-4H2,1-2H3,(H2,20,21,22,23,25) D0H4RE DRUGINKE OACDZTWEJRHLMO-UHFFFAOYSA-N D0H4RE DRUGSMIL CCN(CC)C1=NC2=CC=CC=C2C(=N1)NC(=O)NC3=CC=CC=C3 D0H4RE HIGHSTAT Investigative D0H4SC DRUG__ID D0H4SC D0H4SC DRUGTYPE Small molecular drug D0H4SC DRUGINCH 1S/C19H15BrN2O/c20-16-9-6-13(7-10-16)15-8-11-17(21)18(12-15)22-19(23)14-4-2-1-3-5-14/h1-12H,21H2,(H,22,23) D0H4SC DRUGINKE MPUICDSEVNEGIC-UHFFFAOYSA-N D0H4SC DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=C(C=C3)Br)N D0H4SC HIGHSTAT Investigative D0H4UN DRUG__ID D0H4UN D0H4UN DRUGTYPE Small molecular drug D0H4UN DRUGINCH 1S/C18H17ClN6/c19-15-2-4-18-22-16(13-25(18)11-15)12-23-5-7-24(8-6-23)17-3-1-14(9-20)10-21-17/h1-4,10-11,13H,5-8,12H2 D0H4UN DRUGINKE UGDJVSURAKMIPU-UHFFFAOYSA-N D0H4UN DRUGSMIL C1CN(CCN1CC2=CN3C=C(C=CC3=N2)Cl)C4=NC=C(C=C4)C#N D0H4UN HIGHSTAT Investigative D0H4US DRUG__ID D0H4US D0H4US DRUGTYPE Small molecular drug D0H4US DRUGINCH 1S/C17H18O3/c1-2-13-8-10-15(11-9-13)20-16(17(18)19)12-14-6-4-3-5-7-14/h3-11,16H,2,12H2,1H3,(H,18,19)/t16-/m0/s1 D0H4US DRUGINKE CJMVTSLLWMPEKQ-INIZCTEOSA-N D0H4US DRUGSMIL CCC1=CC=C(C=C1)OC(CC2=CC=CC=C2)C(=O)O D0H4US HIGHSTAT Investigative D0H4VB DRUG__ID D0H4VB D0H4VB DRUGTYPE Small molecular drug D0H4VB DRUGINCH 1S/C21H20FN3O3/c1-12-7-13(22)3-4-19(12)28-11-14-8-15(20(27-2)10-24-14)18-9-16-17(25-18)5-6-23-21(16)26/h3-4,7-10,25H,5-6,11H2,1-2H3,(H,23,26) D0H4VB DRUGINKE WYOFSHLAFWJJAZ-UHFFFAOYSA-N D0H4VB DRUGSMIL CC1=C(C=CC(=C1)F)OCC2=CC(=C(C=N2)OC)C3=CC4=C(N3)CCNC4=O D0H4VB HIGHSTAT Investigative D0H4YH DRUG__ID D0H4YH D0H4YH DRUGTYPE Small molecular drug D0H4YH DRUGINCH 1S/C21H20O3/c1-22-19-9-7-15(8-10-19)16-5-4-6-17(11-16)18-12-20(23-2)14-21(13-18)24-3/h4-14H,1-3H3 D0H4YH DRUGINKE MDKFFJFTEBNHAN-UHFFFAOYSA-N D0H4YH DRUGSMIL COC1=CC=C(C=C1)C2=CC(=CC=C2)C3=CC(=CC(=C3)OC)OC D0H4YH HIGHSTAT Investigative D0H4YP DRUG__ID D0H4YP D0H4YP DRUGTYPE Small molecular drug D0H4YP DRUGINCH 1S/C20H14O3/c21-19-16-7-3-4-8-18(16)23-20(22)17(19)12-13-9-10-14-5-1-2-6-15(14)11-13/h1-11,21H,12H2 D0H4YP DRUGINKE UHCUHNQBQRRJOC-UHFFFAOYSA-N D0H4YP DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC3=C(C4=CC=CC=C4OC3=O)O D0H4YP HIGHSTAT Investigative D0H4YW DRUG__ID D0H4YW D0H4YW DRUGTYPE Small molecular drug D0H4YW DRUGINCH 1S/C10H12O2/c1-7(2)8-4-3-5-9(11)10(12)6-8/h3-7H,1-2H3,(H,11,12) D0H4YW DRUGINKE FUWUEFKEXZQKKA-UHFFFAOYSA-N D0H4YW DRUGSMIL CC(C)C1=CC(=O)C(=CC=C1)O D0H4YW HIGHSTAT Investigative D0H5BG DRUG__ID D0H5BG D0H5BG DRUGTYPE Small molecular drug D0H5BG DRUGINCH 1S/C17H16BrNO/c18-15-8-6-12(11-4-2-1-3-5-11)14-10-17(20)16(19)9-7-13(14)15/h1-6,8,16H,7,9-10,19H2 D0H5BG DRUGINKE XFZZDIHCNHYESF-UHFFFAOYSA-N D0H5BG DRUGSMIL C1CC2=C(C=CC(=C2CC(=O)C1N)C3=CC=CC=C3)Br D0H5BG HIGHSTAT Investigative D0H5CE DRUG__ID D0H5CE D0H5CE DRUGTYPE Small molecular drug D0H5CE DRUGINCH 1S/C17H12N4S/c18-17-21-15(11-4-3-8-19-10-11)16(22-17)13-7-9-20-14-6-2-1-5-12(13)14/h1-10H,(H2,18,21) D0H5CE DRUGINKE SSOAVUCQSQRZGQ-UHFFFAOYSA-N D0H5CE DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)C3=C(N=C(S3)N)C4=CN=CC=C4 D0H5CE HIGHSTAT Investigative D0H5EP DRUG__ID D0H5EP D0H5EP DRUGTYPE Small molecular drug D0H5EP DRUGINCH 1S/C19H20N2O2S/c22-24(23,16-6-2-1-3-7-16)21-14-18(15-10-12-20-13-11-15)17-8-4-5-9-19(17)21/h1-9,14-15,20H,10-13H2 D0H5EP DRUGINKE CACLUIQWYMWMBO-UHFFFAOYSA-N D0H5EP DRUGSMIL C1CNCCC1C2=CN(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4 D0H5EP HIGHSTAT Investigative D0H5FY DRUG__ID D0H5FY D0H5FY DRUGTYPE Small molecular drug D0H5FY DRUGINCH 1S/C21H30O4/c22-19(14-5-2-1-3-6-14)11-10-17-18-13-15(7-4-8-21(24)25)16(18)9-12-20(17)23/h7,14,16-20,22-23H,1-6,8-9,12-13H2,(H,24,25)/b15-7+/t16-,17-,18-,19+,20-/m0/s1 D0H5FY DRUGINKE LOWIKMYPLIPDBI-VQWMHQLJSA-N D0H5FY DRUGSMIL C1CCC(CC1)C(C#CC2C(CCC3C2CC3=CCCC(=O)O)O)O D0H5FY HIGHSTAT Investigative D0H5HI DRUG__ID D0H5HI D0H5HI DRUGTYPE Small molecular drug D0H5HI DRUGINCH 1S/C17H18O3/c1-9-13(18)7-5-11-12-6-8-14(19)10(2)16(12)20-17(3,4)15(9)11/h5-8,18-19H,1-4H3 D0H5HI DRUGINKE XQLSNCGISMACFD-UHFFFAOYSA-N D0H5HI DRUGSMIL CC1=C(C=CC2=C1C(OC3=C2C=CC(=C3C)O)(C)C)O D0H5HI HIGHSTAT Investigative D0H5HP DRUG__ID D0H5HP D0H5HP DRUGTYPE Small molecular drug D0H5HP DRUGINCH 1S/C14H8ClNO2/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6H,16H2 D0H5HP DRUGINKE AWACQBFBMROGQC-UHFFFAOYSA-N D0H5HP DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)Cl)N D0H5HP HIGHSTAT Investigative D0H5II DRUG__ID D0H5II D0H5II DRUGTYPE Small molecular drug D0H5II DRUGINCH 1S/C15H12O4/c1-17-14-11(7-8-12-15(14)19-9-18-12)13(16)10-5-3-2-4-6-10/h2-8H,9H2,1H3 D0H5II DRUGINKE SUKAEERDMQPLMM-UHFFFAOYSA-N D0H5II DRUGSMIL COC1=C(C=CC2=C1OCO2)C(=O)C3=CC=CC=C3 D0H5II HIGHSTAT Investigative D0H5MV DRUG__ID D0H5MV D0H5MV DRUGTYPE Small molecular drug D0H5MV DRUGINCH 1S/C8H8N2O/c1-2-5-10-8(11)7-4-3-6-9-7/h1,3-4,6,9H,5H2,(H,10,11) D0H5MV DRUGINKE AXGVGNDEKWILLM-UHFFFAOYSA-N D0H5MV DRUGSMIL C#CCNC(=O)C1=CC=CN1 D0H5MV HIGHSTAT Investigative D0H5RS DRUG__ID D0H5RS D0H5RS DRUGTYPE Small molecular drug D0H5RS DRUGINCH 1S/C16H19NO2/c18-15(16-17-12-13-19-16)11-7-2-1-4-8-14-9-5-3-6-10-14/h3,5-6,9-10,12-13H,1-2,4,7-8,11H2 D0H5RS DRUGINKE GWMQJJIAUUBGNE-UHFFFAOYSA-N D0H5RS DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=CO2 D0H5RS HIGHSTAT Investigative D0H5WN DRUG__ID D0H5WN D0H5WN DRUGTYPE Small molecular drug D0H5WN DRUGINCH 1S/C16H17NO2/c1-12(2)17-16(18)19-15-10-6-9-14(11-15)13-7-4-3-5-8-13/h3-12H,1-2H3,(H,17,18) D0H5WN DRUGINKE AOMCLMJYDMDVOF-UHFFFAOYSA-N D0H5WN DRUGSMIL CC(C)NC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2 D0H5WN HIGHSTAT Investigative D0H5WV DRUG__ID D0H5WV D0H5WV DRUGTYPE Small molecular drug D0H5WV DRUGINCH 1S/C34H44N6O5/c35-34(36)39-16-14-24(21-39)13-15-37-31(43)29-19-25-11-12-26(41)20-28(25)40(29)33(45)27(17-22-7-3-1-4-8-22)38-32(44)30(42)18-23-9-5-2-6-10-23/h1-10,14,25-30,41-42H,11-13,15-21H2,(H3,35,36)(H,37,43)(H,38,44)/t25-,26+,27+,28-,29-,30+/m0/s1 D0H5WV DRUGINKE YNAKQOCSOOKXJP-VCNFNBSBSA-N D0H5WV DRUGSMIL C1CC(CC2C1CC(N2C(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CC=CC=C4)O)C(=O)NCCC5=CCN(C5)C(=N)N)O D0H5WV HIGHSTAT Investigative D0H5WY DRUG__ID D0H5WY D0H5WY DRUGTYPE Small molecular drug D0H5WY DRUGINCH 1S/C5H4N4O2S2/c12-4-8-6-2(10-4)1-3-7-9-5(13)11-3/h1H2,(H,8,12)(H,9,13) D0H5WY DRUGINKE FIBRGBFKOVAXHJ-UHFFFAOYSA-N D0H5WY DRUGSMIL C(C1=NNC(=S)O1)C2=NNC(=S)O2 D0H5WY HIGHSTAT Investigative D0H5XD DRUG__ID D0H5XD D0H5XD DRUGTYPE Small molecular drug D0H5XD DRUGINCH 1S/C11H11NO5/c13-9(4-5-10(14)15)12-8-3-1-2-7(6-8)11(16)17/h1-3,6H,4-5H2,(H,12,13)(H,14,15)(H,16,17) D0H5XD DRUGINKE IKRKGFIXYILHIJ-UHFFFAOYSA-N D0H5XD DRUGSMIL C1=CC(=CC(=C1)NC(=O)CCC(=O)O)C(=O)O D0H5XD HIGHSTAT Investigative D0H5XP DRUG__ID D0H5XP D0H5XP DRUGTYPE Small molecular drug D0H5XP DRUGINCH 1S/C8H10O3S/c1-2-12-5-6-3-7(9)8(10)4-11-6/h3-4,10H,2,5H2,1H3 D0H5XP DRUGINKE BOZGBIVLELURMD-UHFFFAOYSA-N D0H5XP DRUGSMIL CCSCC1=CC(=O)C(=CO1)O D0H5XP HIGHSTAT Investigative D0H5XR DRUG__ID D0H5XR D0H5XR DRUGTYPE Small molecular drug D0H5XR DRUGINCH 1S/C14H17N3O/c1-3-11-6-12-13(18-11)5-4-10-7-16-17(14(10)12)8-9(2)15/h4-7,9H,3,8,15H2,1-2H3/t9-/m0/s1 D0H5XR DRUGINKE QLOOWOVVZLBYHU-VIFPVBQESA-N D0H5XR DRUGSMIL CCC1=CC2=C(O1)C=CC3=C2N(N=C3)CC(C)N D0H5XR HIGHSTAT Investigative D0H6AA DRUG__ID D0H6AA D0H6AA DRUGTYPE Small molecular drug D0H6AA DRUGINCH 1S/C20H23NO7S/c1-3-16(22)26-14-6-4-11-10-13-12-5-7-15(28-29(23,24)25)19-20(12,8-9-21(13)2)17(11)18(14)27-19/h4-7,12-13,15,19H,3,8-10H2,1-2H3,(H,23,24,25)/t12-,13+,15-,19-,20-/m0/s1 D0H6AA DRUGINKE LWKYBVFQVUJKDT-ILIJTDRLSA-N D0H6AA DRUGSMIL CCC(=O)OC1=C2C3=C(CC4C5C3(CC[NH+]4C)C(O2)C(C=C5)OS(=O)(=O)[O-])C=C1 D0H6AA HIGHSTAT Investigative D0H6BG DRUG__ID D0H6BG D0H6BG DRUGTYPE Small molecular drug D0H6BG DRUGINCH 1S/C17H14N2O3/c20-16(18-11-6-2-1-3-7-11)17-10-13(17)15(19-21)12-8-4-5-9-14(12)22-17/h1-9,13,21H,10H2,(H,18,20)/b19-15- D0H6BG DRUGINKE FPXPIEZPAXSELW-CYVLTUHYSA-N D0H6BG DRUGSMIL C1C2C1(OC3=CC=CC=C3C2=NO)C(=O)NC4=CC=CC=C4 D0H6BG HIGHSTAT Investigative D0H6BV DRUG__ID D0H6BV D0H6BV DRUGTYPE Small molecular drug D0H6BV DRUGINCH 1S/C19H29NO3/c1-2-3-4-5-14-23-18-8-6-17(7-9-18)19(21)10-11-20-12-15-22-16-13-20/h6-9H,2-5,10-16H2,1H3 D0H6BV DRUGINKE VJZCZCUEZMGVCL-UHFFFAOYSA-N D0H6BV DRUGSMIL CCCCCCOC1=CC=C(C=C1)C(=O)CCN2CCOCC2 D0H6BV HIGHSTAT Investigative D0H6CK DRUG__ID D0H6CK D0H6CK DRUGTYPE Small molecular drug D0H6CK DRUGINCH 1S/C25H28N4O4/c1-17-14-19(21-4-2-3-5-22(21)27-17)16-33-20-8-6-18(7-9-20)24(31)28-25(15-23(30)29-32)10-12-26-13-11-25/h2-9,14,26,32H,10-13,15-16H2,1H3,(H,28,31)(H,29,30) D0H6CK DRUGINKE BODLESUVCQEUII-UHFFFAOYSA-N D0H6CK DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)COC3=CC=C(C=C3)C(=O)NC4(CCNCC4)CC(=O)NO D0H6CK HIGHSTAT Investigative D0H6CQ DRUG__ID D0H6CQ D0H6CQ DRUGTYPE Small molecular drug D0H6CQ DRUGINCH 1S/C14H15N5O/c1-2-7-20-11-4-6-16-13-12(11)9(8-18-13)10-3-5-17-14(15)19-10/h3-6,8H,2,7H2,1H3,(H,16,18)(H2,15,17,19) D0H6CQ DRUGINKE ZHMRPXZRUZLCNL-UHFFFAOYSA-N D0H6CQ DRUGSMIL CCCOC1=C2C(=CNC2=NC=C1)C3=NC(=NC=C3)N D0H6CQ HIGHSTAT Investigative D0H6DA DRUG__ID D0H6DA D0H6DA DRUGTYPE Small molecular drug D0H6DA DRUGINCH 1S/C13H22N4O5S/c14-7(3-4-10(15)18)11(19)16-8(6-23)12(20)17-5-1-2-9(17)13(21)22/h7-9,23H,1-6,14H2,(H2,15,18)(H,16,19)(H,21,22)/t7-,8-,9-/m0/s1 D0H6DA DRUGINKE QFTRCUPCARNIPZ-CIUDSAMLSA-N D0H6DA DRUGSMIL C1CC(N(C1)C(=O)C(CS)NC(=O)C(CCC(=O)N)N)C(=O)O D0H6DA HIGHSTAT Investigative D0H6DL DRUG__ID D0H6DL D0H6DL DRUGTYPE Small molecular drug D0H6DL DRUGINCH 1S/C21H16N2O2/c24-20-19(16-10-4-1-5-11-16)22(17-12-6-2-7-13-17)21(25)23(20)18-14-8-3-9-15-18/h1-15,19H D0H6DL DRUGINKE YEGAYNNVHYHYEO-UHFFFAOYSA-N D0H6DL DRUGSMIL C1=CC=C(C=C1)C2C(=O)N(C(=O)N2C3=CC=CC=C3)C4=CC=CC=C4 D0H6DL HIGHSTAT Investigative D0H6DZ DRUG__ID D0H6DZ D0H6DZ DRUGTYPE Small molecular drug D0H6DZ DRUGINCH 1S/C22H43O6PS/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22(23)27-19-21(26-2)20-28-29(24,25)30/h10-11,21H,3-9,12-20H2,1-2H3,(H2,24,25,30)/b11-10-/t21-/m0/s1 D0H6DZ DRUGINKE FCVJYKICQNLXAX-XPTLAUCJSA-N D0H6DZ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=S)(O)O)OC D0H6DZ HIGHSTAT Investigative D0H6FG DRUG__ID D0H6FG D0H6FG DRUGTYPE Small molecular drug D0H6FG DRUGINCH 1S/C21H36FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-21H2,1-2H3/b8-7-,11-10-,14-13-,17-16- D0H6FG DRUGINKE KWKZCGMJGHHOKJ-ZKWNWVNESA-N D0H6FG DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCP(=O)(OC)F D0H6FG HIGHSTAT Investigative D0H6GW DRUG__ID D0H6GW D0H6GW DRUGTYPE Small molecular drug D0H6GW DRUGINCH 1S/C19H24N2O/c1-2-3-4-5-6-8-16-10-12-17(13-11-16)19(22)21-18-9-7-14-20-15-18/h7,9-15H,2-6,8H2,1H3,(H,21,22) D0H6GW DRUGINKE XRYFRVDOZOSYGN-UHFFFAOYSA-N D0H6GW DRUGSMIL CCCCCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 D0H6GW HIGHSTAT Investigative D0H6JC DRUG__ID D0H6JC D0H6JC DRUGTYPE Small molecular drug D0H6JC DRUGINCH 1S/C7H6N2O/c10-7-5-3-1-2-4-6(5)8-9-7/h1-4H,(H2,8,9,10) D0H6JC DRUGINKE SWEICGMKXPNXNU-UHFFFAOYSA-N D0H6JC DRUGSMIL C1=CC=C2C(=C1)C(=O)NN2 D0H6JC HIGHSTAT Investigative D0H6KD DRUG__ID D0H6KD D0H6KD DRUGTYPE Small molecular drug D0H6KD DRUGINCH 1S/C23H26IN5O5/c24-17-7-13(1-4-20(17)30)8-19(23(26)33)29-21(31)11-28-22(32)12-34-15-2-3-18-16(9-15)14(5-6-25)10-27-18/h1-4,7,9-10,19,27,30H,5-6,8,11-12,25H2,(H2,26,33)(H,28,32)(H,29,31)/t19-/m0/s1/i24-2 D0H6KD DRUGINKE JVQSCVCNDUJMMW-BYWNROPASA-N D0H6KD DRUGSMIL C1=CC(=C(C=C1CC(C(=O)N)NC(=O)CNC(=O)COC2=CC3=C(C=C2)NC=C3CCN)I)O D0H6KD HIGHSTAT Investigative D0H6LQ DRUG__ID D0H6LQ D0H6LQ DRUGTYPE Small molecular drug D0H6LQ DRUGINCH 1S/C35H40FN3O6S/c1-20-14-24(36)15-21(2)31(20)45-18-28(41)37-26(16-22-10-6-5-7-11-22)30(42)34(44)39-19-46-35(3,4)32(39)33(43)38-29-25-13-9-8-12-23(25)17-27(29)40/h5-15,26-27,29-30,32,40,42H,16-19H2,1-4H3,(H,37,41)(H,38,43)/t26-,27+,29-,30-,32+/m0/s1 D0H6LQ DRUGINKE CCRMGTSJDCJISE-RIQJEONASA-N D0H6LQ DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)F D0H6LQ HIGHSTAT Investigative D0H6MC DRUG__ID D0H6MC D0H6MC DRUGTYPE Small molecular drug D0H6MC DRUGINCH 1S/C8H7NO2/c10-7-3-5-1-2-9-6(5)4-8(7)11/h1-4,9-11H D0H6MC DRUGINKE SGNZYJXNUURYCH-UHFFFAOYSA-N D0H6MC DRUGSMIL C1=CNC2=CC(=C(C=C21)O)O D0H6MC HIGHSTAT Investigative D0H6MZ DRUG__ID D0H6MZ D0H6MZ DRUGTYPE Small molecular drug D0H6MZ DRUGINCH 1S/C14H26N4/c1-6-12-7-13(15-8-10(2)3)18-14(17-12)16-9-11(4)5/h7,10-11H,6,8-9H2,1-5H3,(H2,15,16,17,18) D0H6MZ DRUGINKE MQGNVQNFJZWUAO-UHFFFAOYSA-N D0H6MZ DRUGSMIL CCC1=CC(=NC(=N1)NCC(C)C)NCC(C)C D0H6MZ HIGHSTAT Investigative D0H6OO DRUG__ID D0H6OO D0H6OO DRUGTYPE Small molecular drug D0H6OO DRUGINCH 1S/C15H11FN4O2S/c16-11-3-1-10(2-4-11)14(22)9-23-15-17-18-19-20(15)12-5-7-13(21)8-6-12/h1-8,21H,9H2 D0H6OO DRUGINKE WROGOTHXLJWPOD-UHFFFAOYSA-N D0H6OO DRUGSMIL C1=CC(=CC=C1C(=O)CSC2=NN=NN2C3=CC=C(C=C3)O)F D0H6OO HIGHSTAT Investigative D0H6QL DRUG__ID D0H6QL D0H6QL DRUGTYPE Small molecular drug D0H6QL DRUGINCH 1S/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10) D0H6QL DRUGINKE HBROZNQEVUILML-UHFFFAOYSA-N D0H6QL DRUGSMIL C1=CC=C(C(=C1)C(=O)NO)O D0H6QL HIGHSTAT Investigative D0H6TX DRUG__ID D0H6TX D0H6TX DRUGTYPE Small molecular drug D0H6TX DRUGINCH 1S/C17H18N4O/c1-11-6-8-13(9-7-11)12(2)19-17(22)20-15-4-3-5-16-14(15)10-18-21-16/h3-10,12H,1-2H3,(H,18,21)(H2,19,20,22)/t12-/m0/s1 D0H6TX DRUGINKE SHOUDGQMQHLAFL-LBPRGKRZSA-N D0H6TX DRUGSMIL CC1=CC=C(C=C1)C(C)NC(=O)NC2=CC=CC3=C2C=NN3 D0H6TX HIGHSTAT Investigative D0H6UA DRUG__ID D0H6UA D0H6UA DRUGTYPE Small molecular drug D0H6UA DRUGINCH 1S/C12H19NO/c1-3-8-14-12-6-4-11(5-7-12)9-10(2)13/h4-7,10H,3,8-9,13H2,1-2H3 D0H6UA DRUGINKE NVNUOGJMXPVHLF-UHFFFAOYSA-N D0H6UA DRUGSMIL CCCOC1=CC=C(C=C1)CC(C)N D0H6UA HIGHSTAT Investigative D0H6UX DRUG__ID D0H6UX D0H6UX DRUGTYPE Small molecular drug D0H6UX DRUGINCH 1S/C38H49N5O6S/c1-23-17-27(42(5)16-15-39)18-24(2)34(23)49-21-31(45)40-29(19-25-11-7-6-8-12-25)33(46)37(48)43-22-50-38(3,4)35(43)36(47)41-32-28-14-10-9-13-26(28)20-30(32)44/h6-14,17-18,29-30,32-33,35,44,46H,15-16,19-22,39H2,1-5H3,(H,40,45)(H,41,47)/t29-,30+,32-,33-,35+/m0/s1 D0H6UX DRUGINKE DQMDEHSLPXZFSC-WLYLRDIASA-N D0H6UX DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)N(C)CCN D0H6UX HIGHSTAT Investigative D0H6VK DRUG__ID D0H6VK D0H6VK DRUGTYPE Small molecular drug D0H6VK DRUGINCH 1S/C12H13N3O2/c1-2-8-4-3-5-9(6-8)13-10-7-11(16)15-12(17)14-10/h3-7H,2H2,1H3,(H3,13,14,15,16,17) D0H6VK DRUGINKE RFKOQVWQIOZRDE-UHFFFAOYSA-N D0H6VK DRUGSMIL CCC1=CC(=CC=C1)NC2=CC(=O)NC(=O)N2 D0H6VK HIGHSTAT Investigative D0H6WG DRUG__ID D0H6WG D0H6WG DRUGTYPE Small molecular drug D0H6WG DRUGINCH 1S/C10H14N2O3S2/c1-8-3-2-4-9(7-8)17(14,15)12-10(13)11-5-6-16/h2-4,7,16H,5-6H2,1H3,(H2,11,12,13) D0H6WG DRUGINKE CALOUQXNCIXXTN-UHFFFAOYSA-N D0H6WG DRUGSMIL CC1=CC(=CC=C1)S(=O)(=O)NC(=O)NCCS D0H6WG HIGHSTAT Investigative D0H6WV DRUG__ID D0H6WV D0H6WV DRUGTYPE Small molecular drug D0H6WV DRUGINCH 1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1 D0H6WV DRUGINKE HDZZVAMISRMYHH-KCGFPETGSA-N D0H6WV DRUGSMIL C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CO)O)O D0H6WV HIGHSTAT Investigative D0H6YF DRUG__ID D0H6YF D0H6YF DRUGTYPE Small molecular drug D0H6YF DRUGINCH 1S/C13H15IN2O2/c1-8(17)15-6-5-10-11-7-9(18-2)3-4-12(11)16-13(10)14/h3-4,7,16H,5-6H2,1-2H3,(H,15,17) D0H6YF DRUGINKE FJDDSMSDZHURBJ-UHFFFAOYSA-N D0H6YF DRUGSMIL CC(=O)NCCC1=C(NC2=C1C=C(C=C2)OC)I D0H6YF HIGHSTAT Investigative D0H6YH DRUG__ID D0H6YH D0H6YH DRUGTYPE Small molecular drug D0H6YH DRUGINCH 1S/C15H18N2/c1-2-6-12(7-3-1)17-15-10-11-16-14-9-5-4-8-13(14)15/h4-5,8-12H,1-3,6-7H2,(H,16,17) D0H6YH DRUGINKE XRSBCRPPSASDNY-UHFFFAOYSA-N D0H6YH DRUGSMIL C1CCC(CC1)NC2=CC=NC3=CC=CC=C32 D0H6YH HIGHSTAT Investigative D0H6ZP DRUG__ID D0H6ZP D0H6ZP DRUGTYPE Small molecular drug D0H6ZP DRUGINCH 1S/C25H19N7/c1-16-4-2-7-21(30-16)25-24(18-8-9-20-22(13-18)28-11-10-27-20)31-23(32-25)15-29-19-6-3-5-17(12-19)14-26/h2-13,29H,15H2,1H3,(H,31,32) D0H6ZP DRUGINKE SVFWZNDJPVECNU-UHFFFAOYSA-N D0H6ZP DRUGSMIL CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC(=C3)C#N)C4=CC5=NC=CN=C5C=C4 D0H6ZP HIGHSTAT Investigative D0H7AZ DRUG__ID D0H7AZ D0H7AZ DRUGCOMP Novexel SA D0H7AZ DRUGINCH 1S/C56H79N9O13/c1-4-5-6-7-8-12-25-78-41-21-19-37(20-22-41)36-15-17-38(18-16-36)50(71)60-42-27-39(58-24-23-57)29-59-54(75)48-49(70)33(2)30-65(48)55(76)43(32-66)61-53(74)47(45(69)26-35-13-10-9-11-14-35)63-52(73)44-28-40(68)31-64(44)56(77)46(34(3)67)62-51(42)72/h9-11,13-22,33-34,39-40,42-49,58,66-70H,4-8,12,23-32,57H2,1-3H3,(H,59,75)(H,60,71)(H,61,74)(H,62,72)(H,63,73)/t33-,34+,39?,40+,42?,43+,44-,45+,46-,47-,48-,49-/m0/s1 D0H7AZ DRUGINKE JYBUOENGZWTZGU-JZCGONIASA-N D0H7AZ DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NC3CC(CNC(=O)C4C(C(CN4C(=O)C(NC(=O)C(NC(=O)C5CC(CN5C(=O)C(NC3=O)C(C)O)O)C(CC6=CC=CC=C6)O)CO)C)O)NCCN D0H7AZ HIGHSTAT Investigative D0H7BH DRUG__ID D0H7BH D0H7BH DRUGTYPE Small molecular drug D0H7BH DRUGINCH 1S/C26H23N5O3/c1-17-7-5-12-31-23(17)29-24-21(26(31)33)15-20(25(32)28-16-19-10-6-14-34-19)22(27)30(24)13-11-18-8-3-2-4-9-18/h2-10,12,14-15,27H,11,13,16H2,1H3,(H,28,32) D0H7BH DRUGINKE AINLDDVHMMTZDO-UHFFFAOYSA-N D0H7BH DRUGSMIL CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CCC4=CC=CC=C4)C(=O)NCC5=CC=CO5 D0H7BH HIGHSTAT Investigative D0H7DQ DRUG__ID D0H7DQ D0H7DQ DRUGTYPE Small molecular drug D0H7DQ DRUGINCH 1S/C24H21N5O2/c30-23-21(22(24(31)27-23)26-17-7-2-1-3-8-17)19-15-29(20-10-5-4-9-18(19)20)13-6-12-28-14-11-25-16-28/h1-5,7-11,14-16H,6,12-13H2,(H2,26,27,30,31) D0H7DQ DRUGINKE KIWODJBCHRADND-UHFFFAOYSA-N D0H7DQ DRUGSMIL C1=CC=C(C=C1)NC2=C(C(=O)NC2=O)C3=CN(C4=CC=CC=C43)CCCN5C=CN=C5 D0H7DQ HIGHSTAT Investigative D0H7EB DRUG__ID D0H7EB D0H7EB DRUGTYPE Small molecular drug D0H7EB DRUGINCH 1S/C39H66N12O8/c1-6-23(4)31(34(55)49-29(37(58)59)20-22(2)3)50(5)35(56)28(21-24-13-15-25(52)16-14-24)48-33(54)30-12-9-19-51(30)36(57)27(11-8-18-46-39(43)44)47-32(53)26(40)10-7-17-45-38(41)42/h13-16,22-23,26-31,52H,6-12,17-21,40H2,1-5H3,(H,47,53)(H,48,54)(H,49,55)(H,58,59)(H4,41,42,45)(H4,43,44,46)/t23-,26-,27-,28-,29-,30-,31-/m0/s1 D0H7EB DRUGINKE AGCKRBKIEACUSP-VGPFALITSA-N D0H7EB DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)N(C)C(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N D0H7EB HIGHSTAT Investigative D0H7FP DRUG__ID D0H7FP D0H7FP DRUGTYPE Small molecular drug D0H7FP DRUGINCH 1S/C21H32N6O3/c1-16(25-30)15-26(13-4-9-17-7-2-3-8-17)21(29)27-14-5-10-18(27)19(28)24-20-22-11-6-12-23-20/h6,11-12,17-18,25,30H,1-5,7-10,13-15H2,(H,22,23,24,28)/t18-/m0/s1 D0H7FP DRUGINKE RQNVLLHARFXNPH-SFHVURJKSA-N D0H7FP DRUGSMIL C=C(CN(CCCC1CCCC1)C(=O)N2CCCC2C(=O)NC3=NC=CC=N3)NO D0H7FP HIGHSTAT Investigative D0H7JJ DRUG__ID D0H7JJ D0H7JJ DRUGTYPE Small molecular drug D0H7JJ DRUGINCH 1S/H3NO3S.Na/c1-5(2,3)4;/h(H3,1,2,3,4);/q;+1/p-1 D0H7JJ DRUGINKE QDWYPRSFEZRKDK-UHFFFAOYSA-M D0H7JJ DRUGSMIL NS(=O)(=O)[O-].[Na+] D0H7JJ HIGHSTAT Investigative D0H7KP DRUG__ID D0H7KP D0H7KP DRUGTYPE Small molecular drug D0H7KP DRUGINCH 1S/C4H11NO3P/c1-9(7,8)4(6)2-3-5/h7-8H,2-3,5H2,1H3/q+1 D0H7KP DRUGINKE XRHWOLGPXAOKPF-UHFFFAOYSA-N D0H7KP DRUGSMIL C[P+](C(=O)CCN)(O)O D0H7KP HIGHSTAT Investigative D0H7MF DRUG__ID D0H7MF D0H7MF DRUGTYPE Small molecular drug D0H7MF DRUGINCH 1S/C17H11FN2O/c18-12-5-6-14-11(7-12)9-16(20-14)17(21)15-8-10-3-1-2-4-13(10)19-15/h1-9,19-20H D0H7MF DRUGINKE HXWDONFZGUZRTN-UHFFFAOYSA-N D0H7MF DRUGSMIL C1=CC=C2C(=C1)C=C(N2)C(=O)C3=CC4=C(N3)C=CC(=C4)F D0H7MF HIGHSTAT Investigative D0H7NB DRUG__ID D0H7NB D0H7NB DRUGTYPE Small molecular drug D0H7NB DRUGINCH 1S/C12H14ClNS/c1-14-8-10(4-7-12(14)15)9-2-5-11(13)6-3-9/h2-3,5-6,10H,4,7-8H2,1H3 D0H7NB DRUGINKE FTCLELCCXKHRQL-UHFFFAOYSA-N D0H7NB DRUGSMIL CN1CC(CCC1=S)C2=CC=C(C=C2)Cl D0H7NB HIGHSTAT Investigative D0H7NV DRUG__ID D0H7NV D0H7NV DRUGTYPE Small molecular drug D0H7NV DRUGINCH 1S/C27H46O3/c1-17(16-28)6-5-7-18(2)21-8-9-22-25-23(11-13-27(21,22)4)26(3)12-10-20(29)14-19(26)15-24(25)30/h15,17-18,20-25,28-30H,5-14,16H2,1-4H3/t17-,18-,20+,21-,22+,23+,24+,25+,26+,27-/m1/s1 D0H7NV DRUGINKE RXMHNAKZMGJANZ-BMOLSTJGSA-N D0H7NV DRUGSMIL CC(CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C)CO D0H7NV HIGHSTAT Investigative D0H7OP DRUG__ID D0H7OP D0H7OP DRUGTYPE Small molecular drug D0H7OP DRUGINCH 1S/C22H23NO4/c1-4-8-23-9-7-14-15-6-5-13-10-18(24)19(26-2)11-16(13)20(15)22(27-3)21(25)17(14)12-23/h4-6,10-11,24-25H,1,7-9,12H2,2-3H3 D0H7OP DRUGINKE GFTFQCRSRIGURP-UHFFFAOYSA-N D0H7OP DRUGSMIL COC1=C(C=C2C=CC3=C4CCN(CC4=C(C(=C3C2=C1)OC)O)CC=C)O D0H7OP HIGHSTAT Investigative D0H7PC DRUG__ID D0H7PC D0H7PC DRUGTYPE Small molecular drug D0H7PC DRUGINCH 1S/C17H18Br2FN3O3S/c1-26-16-3-2-12(10-15(16)23-6-4-21-5-7-23)27(24,25)22-14-9-11(18)8-13(20)17(14)19/h2-3,8-10,21-22H,4-7H2,1H3 D0H7PC DRUGINKE BLWHAZZXRHTFJE-UHFFFAOYSA-N D0H7PC DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)NC2=C(C(=CC(=C2)Br)F)Br)N3CCNCC3 D0H7PC HIGHSTAT Investigative D0H7PI DRUG__ID D0H7PI D0H7PI DRUGTYPE Small molecular drug D0H7PI DRUGINCH 1S/C14H21NS/c1-3-12(15-13-6-7-13)10-11-4-8-14(16-2)9-5-11/h4-5,8-9,12-13,15H,3,6-7,10H2,1-2H3 D0H7PI DRUGINKE WWIGSCWWTFIJCJ-UHFFFAOYSA-N D0H7PI DRUGSMIL CCC(CC1=CC=C(C=C1)SC)NC2CC2 D0H7PI HIGHSTAT Investigative D0H7PR DRUG__ID D0H7PR D0H7PR DRUGTYPE Small molecular drug D0H7PR DRUGINCH 1S/C9H4Cl3NO2/c10-3-1-4(11)6-5(2-3)13-9(15)8(14)7(6)12/h1-2,14H,(H,13,15) D0H7PR DRUGINKE NRMJPXWRZZNIDJ-UHFFFAOYSA-N D0H7PR DRUGSMIL C1=C(C=C(C2=C1NC(=O)C(=C2Cl)O)Cl)Cl D0H7PR HIGHSTAT Investigative D0H7QA DRUG__ID D0H7QA D0H7QA DRUGTYPE Small molecular drug D0H7QA DRUGINCH 1S/C13H18N2O3/c1-10-5-4-6-11(9-10)14-12(16)7-2-3-8-13(17)15-18/h4-6,9,18H,2-3,7-8H2,1H3,(H,14,16)(H,15,17) D0H7QA DRUGINKE QJSROQKJUVLPRM-UHFFFAOYSA-N D0H7QA DRUGSMIL CC1=CC(=CC=C1)NC(=O)CCCCC(=O)NO D0H7QA HIGHSTAT Investigative D0H7RH DRUG__ID D0H7RH D0H7RH DRUGTYPE Small molecular drug D0H7RH DRUGINCH 1S/C37H40N2O6/c1-38-12-10-23-18-32(43-4)33-20-25(23)28(38)16-21-6-8-30(40)26(14-21)27-15-22(7-9-31(27)42-3)17-29-35-24(11-13-39(29)2)19-34(44-5)36(41)37(35)45-33/h6-9,14-15,18-20,28-29,40-41H,10-13,16-17H2,1-5H3/t28-,29+/m1/s1 D0H7RH DRUGINKE MNNXIEANPHEHSB-WDYNHAJCSA-N D0H7RH DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC(=C(C=C4)O)C5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC D0H7RH HIGHSTAT Investigative D0H7RN DRUG__ID D0H7RN D0H7RN DRUGTYPE Small molecular drug D0H7RN DRUGINCH 1S/C20H25N3S/c1-2-10-21-20(5-1)23-13-11-22(12-14-23)16-17-6-8-18(9-7-17)19-4-3-15-24-19/h1-5,8,10,15,17H,6-7,9,11-14,16H2 D0H7RN DRUGINKE QFAVGTOUBHVISF-UHFFFAOYSA-N D0H7RN DRUGSMIL C1CC(=CCC1CN2CCN(CC2)C3=CC=CC=N3)C4=CC=CS4 D0H7RN HIGHSTAT Investigative D0H7RV DRUG__ID D0H7RV D0H7RV DRUGTYPE Small molecular drug D0H7RV DRUGINCH 1S/C20H28N2O3S/c1-15-7-5-8-16(2)22(15)14-18(23)13-21-26(24,25)20-12-6-10-17-9-3-4-11-19(17)20/h3-4,6,9-12,15-16,18,21,23H,5,7-8,13-14H2,1-2H3/t15-,16+,18-/m1/s1/i10T D0H7RV DRUGINKE GJXFPIGLCXZHTN-LDHSEPLKSA-N D0H7RV DRUGSMIL CC1CCCC(N1CC(CNS(=O)(=O)C2=CC=CC3=CC=CC=C32)O)C D0H7RV HIGHSTAT Investigative D0H7UQ DRUG__ID D0H7UQ D0H7UQ DRUGTYPE Small molecular drug D0H7UQ DRUGINCH 1S/C13H13NO2/c15-13(14-16)8-6-10-5-7-11-3-1-2-4-12(11)9-10/h1-5,7,9,16H,6,8H2,(H,14,15) D0H7UQ DRUGINKE FUEAAJNBAJRTSE-UHFFFAOYSA-N D0H7UQ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CCC(=O)NO D0H7UQ HIGHSTAT Investigative D0H7WK DRUG__ID D0H7WK D0H7WK DRUGTYPE Small molecular drug D0H7WK DRUGINCH 1S/C30H35NO6/c1-34-26-12-6-23(7-13-26)30(24-8-14-27(35-2)15-9-24,25-10-16-28(36-3)17-11-25)37-20-19-31-18-4-5-22(21-31)29(32)33/h6-17,22H,4-5,18-21H2,1-3H3,(H,32,33)/t22-/m0/s1 D0H7WK DRUGINKE VDLDUZLDZBVOAS-QFIPXVFZSA-N D0H7WK DRUGSMIL COC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC)(C3=CC=C(C=C3)OC)OCCN4CCCC(C4)C(=O)O D0H7WK HIGHSTAT Investigative D0H7ZS DRUG__ID D0H7ZS D0H7ZS DRUGTYPE Small molecular drug D0H7ZS DRUGINCH 1S/C15H15FN2O3S/c1-2-22(20,21)12-6-3-10(4-7-12)11-5-8-14(13(16)9-11)18-15(17)19/h3-9H,2H2,1H3,(H3,17,18,19) D0H7ZS DRUGINKE FGSMXSWRTDKBBK-UHFFFAOYSA-N D0H7ZS DRUGSMIL CCS(=O)(=O)C1=CC=C(C=C1)C2=CC(=C(C=C2)NC(=O)N)F D0H7ZS HIGHSTAT Investigative D0H8AI DRUG__ID D0H8AI D0H8AI DRUGTYPE Small molecular drug D0H8AI DRUGINCH 1S/C78H121N21O20/c1-7-43(6)63(73(115)96-57(76(118)119)37-42(4)5)97-70(112)55(39-45-21-25-47(101)26-22-45)95-72(114)59-18-13-35-99(59)75(117)52(16-11-33-86-78(83)84)90-64(106)48(15-10-32-85-77(81)82)89-71(113)58-17-12-34-98(58)74(116)51(14-8-9-31-79)91-69(111)56(40-60(80)102)94-66(108)50(28-30-62(104)105)88-68(110)54(38-44-19-23-46(100)24-20-44)93-67(109)53(36-41(2)3)92-65(107)49-27-29-61(103)87-49/h19-26,41-43,48-59,63,100-101H,7-18,27-40,79H2,1-6H3,(H2,80,102)(H,87,103)(H,88,110)(H,89,113)(H,90,106)(H,91,111)(H,92,107)(H,93,109)(H,94,108)(H,95,114)(H,96,115)(H,97,112)(H,104,105)(H,118,119)(H4,81,82,85)(H4,83,84,86)/t43-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,63-/m0/s1 D0H8AI DRUGINKE PCJGZPGTCUMMOT-ISULXFBGSA-N D0H8AI DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC(C)C)NC(=O)C5CCC(=O)N5 D0H8AI HIGHSTAT Investigative D0H8AW DRUG__ID D0H8AW D0H8AW DRUGTYPE Small molecular drug D0H8AW DRUGINCH 1S/C18H21N5O3/c1-24-14-6-10(7-15(25-2)16(14)26-3)9-21-11-4-5-13-12(8-11)17(19)23-18(20)22-13/h4-8,21H,9H2,1-3H3,(H4,19,20,22,23) D0H8AW DRUGINKE YYJWQABXDCUJEF-UHFFFAOYSA-N D0H8AW DRUGSMIL COC1=CC(=CC(=C1OC)OC)CNC2=CC3=C(C=C2)N=C(N=C3N)N D0H8AW HIGHSTAT Investigative D0H8CC DRUG__ID D0H8CC D0H8CC DRUGTYPE Small molecular drug D0H8CC DRUGINCH 1S/C10H16N2O2/c1-10(2,3)14-9(13)8-5-4-6-12(8)7-11/h8H,4-6H2,1-3H3 D0H8CC DRUGINKE BFXLWVDZNFZGJO-UHFFFAOYSA-N D0H8CC DRUGSMIL CC(C)(C)OC(=O)C1CCCN1C#N D0H8CC HIGHSTAT Investigative D0H8EO DRUG__ID D0H8EO D0H8EO DRUGTYPE Small molecular drug D0H8EO DRUGINCH 1S/C13H15NO2/c1-3-13(4-2)11(15)14(12(13)16)10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3 D0H8EO DRUGINKE KDXSTYUPRNLDGW-UHFFFAOYSA-N D0H8EO DRUGSMIL CCC1(C(=O)N(C1=O)C2=CC=CC=C2)CC D0H8EO HIGHSTAT Investigative D0H8FG DRUG__ID D0H8FG D0H8FG DRUGTYPE Small molecular drug D0H8FG DRUGINCH 1S/C22H30O3/c1-20(2)8-6-9-21(3)18(20)7-10-22(4)19(21)12-14-11-17(24-5)15(23)13-16(14)25-22/h11-13,18-19H,6-10H2,1-5H3/t18-,19+,21-,22-/m0/s1 D0H8FG DRUGINKE ZBJMJNFORKVCHU-MXNKGDRCSA-N D0H8FG DRUGSMIL CC1(CCCC2(C1CCC3(C2C=C4C=C(C(=O)C=C4O3)OC)C)C)C D0H8FG HIGHSTAT Investigative D0H8ID DRUG__ID D0H8ID D0H8ID DRUGTYPE Small molecular drug D0H8ID DRUGINCH 1S/C23H35NO2.CH4O3S/c1-5-6-7-8-18(25)11-12-23(3)21-15-17-9-10-19(26)16-20(17)22(23,2)13-14-24(21)4;1-5(2,3)4/h9-10,16,21,26H,5-8,11-15H2,1-4H3;1H3,(H,2,3,4)/t21-,22+,23-;/m1./s1 D0H8ID DRUGINKE CQSTVPYARYSBNS-HZLAGBECSA-N D0H8ID DRUGSMIL CCCCCC(=O)CCC1(C2CC3=C(C1(CCN2C)C)C=C(C=C3)O)C.CS(=O)(=O)O D0H8ID HIGHSTAT Investigative D0H8IT DRUG__ID D0H8IT D0H8IT DRUGTYPE Small molecular drug D0H8IT DRUGINCH 1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12?,13-,16-,17-,18+,22-/m1/s1 D0H8IT DRUGINKE MZFOKIKEPGUZEN-FBMOWMAESA-N D0H8IT DRUGSMIL CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D0H8IT HIGHSTAT Investigative D0H8KI DRUG__ID D0H8KI D0H8KI DRUGTYPE Small molecular drug D0H8KI DRUGINCH 1S/C110H170N34O24/c1-9-59(7)87(111)103(165)133-73-39-41-85(149)127-55-81(99(161)139-79(53-63-27-35-67(147)36-28-63)97(159)131-71(19-13-45-125-109(119)120)93(155)137-77(49-57(3)4)95(157)129-69(17-11-43-123-107(115)116)91(153)135-75(89(113)151)51-61-23-31-65(145)32-24-61)142-102(164)84-22-16-48-144(84)106(168)74(134-104(166)88(112)60(8)10-2)40-42-86(150)128-56-82(141-101(163)83-21-15-47-143(83)105(73)167)100(162)140-80(54-64-29-37-68(148)38-30-64)98(160)132-72(20-14-46-126-110(121)122)94(156)138-78(50-58(5)6)96(158)130-70(18-12-44-124-108(117)118)92(154)136-76(90(114)152)52-62-25-33-66(146)34-26-62/h23-38,57-60,69-84,87-88,145-148H,9-22,39-56,111-112H2,1-8H3,(H2,113,151)(H2,114,152)(H,127,149)(H,128,150)(H,129,157)(H,130,158)(H,131,159)(H,132,160)(H,133,165)(H,134,166)(H,135,153)(H,136,154)(H,137,155)(H,138,156)(H,139,161)(H,140,162)(H,141,163)(H,142,164)(H4,115,116,123)(H4,117,118,124)(H4,119,120,125)(H4,121,122,126)/t59-,60-,69-,70-,71-,72-,73-,74+,75-,76-,77-,78-,79-,80-,81-,82+,83-,84-,87-,88-/m0/s1 D0H8KI DRUGINKE RJRBRCCJETZJLT-VHUVHYDGSA-N D0H8KI DRUGSMIL CCC(C)C(C(=NC1CCC(=NCC(N=C(C2CCCN2C(=O)C(CCC(=NCC(N=C(C3CCCN3C1=O)O)C(=NC(CC4=CC=C(C=C4)O)C(=NC(CCCNC(=N)N)C(=NC(CC(C)C)C(=NC(CCCNC(=N)N)C(=NC(CC5=CC=C(C=C5)O)C(=N)O)O)O)O)O)O)O)N=C(C(C(C)CC)N)O)O)C(=NC(CC6=CC=C(C=C6)O)C(=NC(CCCNC(=N)N)C(=NC(CC(C)C)C(=NC(CCCNC(=N)N)C(=NC(CC7=CC=C(C=C7)O)C(=N)O)O)O)O)O)O)O)O)N D0H8KI HIGHSTAT Investigative D0H8RU DRUG__ID D0H8RU D0H8RU DRUGTYPE Small molecular drug D0H8RU DRUGINCH 1S/C21H16F3NO2/c22-21(23,24)17-10-6-15(7-11-17)14-25-20(26)16-8-12-19(13-9-16)27-18-4-2-1-3-5-18/h1-13H,14H2,(H,25,26) D0H8RU DRUGINKE JDGSUZBWUUXJCN-UHFFFAOYSA-N D0H8RU DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC3=CC=C(C=C3)C(F)(F)F D0H8RU HIGHSTAT Investigative D0H8TE DRUG__ID D0H8TE D0H8TE DRUGTYPE Small molecular drug D0H8TE DRUGINCH 1S/C31H51N11O8/c1-17(2)14-22(27(46)40-24(18(3)4)28(47)41-42-30(48)37-19(5)25(44)36-15-23(32)43)38-26(45)21(12-9-13-35-29(33)34)39-31(49)50-16-20-10-7-6-8-11-20/h6-8,10-11,17-19,21-22,24H,9,12-16H2,1-5H3,(H2,32,43)(H,36,44)(H,38,45)(H,39,49)(H,40,46)(H,41,47)(H4,33,34,35)(H2,37,42,48) D0H8TE DRUGINKE QPGAIIGEIAEEEV-UHFFFAOYSA-N D0H8TE DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(C)C(=O)NCC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1 D0H8TE HIGHSTAT Investigative D0H8WY DRUG__ID D0H8WY D0H8WY DRUGTYPE Small molecular drug D0H8WY DRUGINCH 1S/C23H20F3N3O3S/c1-13(27)22-20(32-11-14-6-4-5-7-15(14)23(24,25)26)10-21(33-22)29-12-28-16-8-18(30-2)19(31-3)9-17(16)29/h4-10,12H,1,11,27H2,2-3H3 D0H8WY DRUGINKE SYQIMXCJFHFKLG-UHFFFAOYSA-N D0H8WY DRUGSMIL COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=C)N)OCC4=CC=CC=C4C(F)(F)F)OC D0H8WY HIGHSTAT Investigative D0H8XQ DRUG__ID D0H8XQ D0H8XQ DRUGTYPE Small molecular drug D0H8XQ DRUGINCH 1S/C19H22BrNOS/c1-3-14(2)16-6-10-18(11-7-16)21-19(22)13-23-12-15-4-8-17(20)9-5-15/h4-11,14H,3,12-13H2,1-2H3,(H,21,22) D0H8XQ DRUGINKE QKUYZJOTWYRWNF-UHFFFAOYSA-N D0H8XQ DRUGSMIL CCC(C)C1=CC=C(C=C1)NC(=O)CSCC2=CC=C(C=C2)Br D0H8XQ HIGHSTAT Investigative D0H8XV DRUG__ID D0H8XV D0H8XV DRUGTYPE Small molecular drug D0H8XV DRUGINCH 1S/C20H24N2/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20/h4-10,12,15H,11,13-14H2,1-3H3/t15-/m0/s1 D0H8XV DRUGINKE MVMQESMQSYOVGV-HNNXBMFYSA-N D0H8XV DRUGSMIL CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C D0H8XV HIGHSTAT Investigative D0H8ZT DRUG__ID D0H8ZT D0H8ZT DRUGTYPE Small molecular drug D0H8ZT DRUGINCH 1S/C19H19ClN2O/c20-17-8-4-7-16-18(13-9-11-15(23)12-10-13)21-22(19(16)17)14-5-2-1-3-6-14/h4,7-12,14,23H,1-3,5-6H2 D0H8ZT DRUGINKE JFMIDTYLHCPZPL-UHFFFAOYSA-N D0H8ZT DRUGSMIL C1CCC(CC1)N2C3=C(C=CC=C3Cl)C(=N2)C4=CC=C(C=C4)O D0H8ZT HIGHSTAT Investigative D0H9AX DRUG__ID D0H9AX D0H9AX DRUGTYPE Small molecular drug D0H9AX DRUGINCH 1S/C25H29N9O2/c1-33(24-29-31-32-30-24)18-12-8-11-17(15-18)26-25(36)28-22-23(35)34(2)20-14-7-6-13-19(20)21(27-22)16-9-4-3-5-10-16/h6-8,11-16,22H,3-5,9-10H2,1-2H3,(H2,26,28,36)(H,29,30,31,32)/t22-/m0/s1 D0H9AX DRUGINKE MYPNMQPMQUAOTH-QFIPXVFZSA-N D0H9AX DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC(=CC=C3)N(C)C4=NNN=N4)C5CCCCC5 D0H9AX HIGHSTAT Investigative D0H9BL DRUG__ID D0H9BL D0H9BL DRUGTYPE Small molecular drug D0H9BL DRUGINCH 1S/C27H22O12/c28-16-5-1-14(9-18(16)30)11-22(26(33)34)37-23(32)8-3-13-2-7-20-21(10-13)39-25(27(35)36)24(38-20)15-4-6-17(29)19(31)12-15/h1-10,12,22,24-25,28-31H,11H2,(H,33,34)(H,35,36)/b8-3+/t22-,24+,25+/m1/s1 D0H9BL DRUGINKE KPKHMGUZUPELJC-RXYMDKBQSA-N D0H9BL DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC3=C(C=C2)OC(C(O3)C(=O)O)C4=CC(=C(C=C4)O)O)O)O D0H9BL HIGHSTAT Investigative D0H9BP DRUG__ID D0H9BP D0H9BP DRUGTYPE Small molecular drug D0H9BP DRUGINCH 1S/C21H28N6O4/c1-3-11-26-19-17(20(29)27(12-4-2)21(26)30)24-18(25-19)14-5-7-15(8-6-14)31-13-16(28)23-10-9-22/h5-8H,3-4,9-13,22H2,1-2H3,(H,23,28)(H,24,25) D0H9BP DRUGINKE FIQGIOAELHTLHM-UHFFFAOYSA-N D0H9BP DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCN D0H9BP HIGHSTAT Investigative D0H9DB DRUG__ID D0H9DB D0H9DB DRUGTYPE Small molecular drug D0H9DB DRUGINCH 1S/C25H21NO3/c27-23-17-24(26-13-15-28-16-14-26)29-25-21(11-6-12-22(23)25)20-10-5-4-9-19(20)18-7-2-1-3-8-18/h1-12,17H,13-16H2 D0H9DB DRUGINKE VKLCRMQPVMPSKE-UHFFFAOYSA-N D0H9DB DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4C5=CC=CC=C5 D0H9DB HIGHSTAT Investigative D0H9DJ DRUG__ID D0H9DJ D0H9DJ DRUGTYPE Small molecular drug D0H9DJ DRUGINCH 1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D0H9DJ DRUGINKE DJJCXFVJDGTHFX-XVFCMESISA-N D0H9DJ DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O D0H9DJ HIGHSTAT Investigative D0H9DS DRUG__ID D0H9DS D0H9DS DRUGTYPE Small molecular drug D0H9DS DRUGINCH 1S/C14H21NO2/c16-14(15-17)12-8-3-1-2-5-9-13-10-6-4-7-11-13/h4,6-7,10-11,17H,1-3,5,8-9,12H2,(H,15,16) D0H9DS DRUGINKE JUCDFXVDGUXPMJ-UHFFFAOYSA-N D0H9DS DRUGSMIL C1=CC=C(C=C1)CCCCCCCC(=O)NO D0H9DS HIGHSTAT Investigative D0H9EY DRUG__ID D0H9EY D0H9EY DRUGTYPE Small molecular drug D0H9EY DRUGINCH 1S/C16H22ClN5O4/c1-16(25)11(24)9(6-23)26-14(16)22-7-18-10-12(19-8-4-2-3-5-8)20-15(17)21-13(10)22/h7-9,11,14,23-25H,2-6H2,1H3,(H,19,20,21)/t9-,11-,14-,16-/m1/s1 D0H9EY DRUGINKE MMPAUXMIDJWGFO-ROMFRFKVSA-N D0H9EY DRUGSMIL CC1(C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)NC4CCCC4)CO)O)O D0H9EY HIGHSTAT Investigative D0H9GP DRUG__ID D0H9GP D0H9GP DRUGTYPE Small molecular drug D0H9GP DRUGINCH 1S/C21H27N3S/c1-2-11-22-21(5-1)24-15-13-23(14-16-24)12-10-18-6-8-19(9-7-18)20-4-3-17-25-20/h1-5,8,11,17-18H,6-7,9-10,12-16H2 D0H9GP DRUGINKE AAFWZBAPCZZXNP-UHFFFAOYSA-N D0H9GP DRUGSMIL C1CC(=CCC1CCN2CCN(CC2)C3=CC=CC=N3)C4=CC=CS4 D0H9GP HIGHSTAT Investigative D0H9IH DRUG__ID D0H9IH D0H9IH DRUGTYPE Small molecular drug D0H9IH DRUGINCH 1S/C14H21NO/c1-12-5-4-9-15(12)10-8-13-6-3-7-14(11-13)16-2/h3,6-7,11-12H,4-5,8-10H2,1-2H3/t12-/m1/s1 D0H9IH DRUGINKE INKHQVYBVMGBHD-GFCCVEGCSA-N D0H9IH DRUGSMIL CC1CCCN1CCC2=CC(=CC=C2)OC D0H9IH HIGHSTAT Investigative D0H9NZ DRUG__ID D0H9NZ D0H9NZ DRUGTYPE Small molecular drug D0H9NZ DRUGINCH 1S/C18H22N2O/c1-2-4-15(5-3-1)12-16-6-8-18(9-7-16)21-14-17-13-19-10-11-20-17/h1-9,17,19-20H,10-14H2 D0H9NZ DRUGINKE NQEDMJQVVYPBBZ-UHFFFAOYSA-N D0H9NZ DRUGSMIL C1CNC(CN1)COC2=CC=C(C=C2)CC3=CC=CC=C3 D0H9NZ HIGHSTAT Investigative D0H9QG DRUG__ID D0H9QG D0H9QG DRUGTYPE Small molecular drug D0H9QG DRUGINCH 1S/C18H30N2O2S/c1-15-8-11-20(12-9-15)13-10-17(3)19(4)23(21,22)18-7-5-6-16(2)14-18/h5-7,14-15,17H,8-13H2,1-4H3/t17-/m1/s1 D0H9QG DRUGINKE AGVNHDNTFYHZNL-QGZVFWFLSA-N D0H9QG DRUGSMIL CC1CCN(CC1)CCC(C)N(C)S(=O)(=O)C2=CC=CC(=C2)C D0H9QG HIGHSTAT Investigative D0H9TO DRUG__ID D0H9TO D0H9TO DRUGTYPE Small molecular drug D0H9TO DRUGINCH 1S/C14H10N2O/c17-13-2-1-11-7-12(9-16-14(11)8-13)10-3-5-15-6-4-10/h1-9,17H D0H9TO DRUGINKE NYQMESYHKIIFEI-UHFFFAOYSA-N D0H9TO DRUGSMIL C1=CC(=CC2=NC=C(C=C21)C3=CC=NC=C3)O D0H9TO HIGHSTAT Investigative D0H9UT DRUG__ID D0H9UT D0H9UT DRUGTYPE Small molecular drug D0H9UT DRUGINCH 1S/CH3NO2/c2-1(3)4/h2H2,(H,3,4) D0H9UT DRUGINKE KXDHJXZQYSOELW-UHFFFAOYSA-N D0H9UT DRUGSMIL C(=O)(N)O D0H9UT HIGHSTAT Investigative D0H9VQ DRUG__ID D0H9VQ D0H9VQ DRUGTYPE Small molecular drug D0H9VQ DRUGINCH 1S/C11H21N3O2/c1-2-3-5-8(12)11(16)14-7-4-6-9(14)10(13)15/h8-9H,2-7,12H2,1H3,(H2,13,15)/t8-,9-/m0/s1 D0H9VQ DRUGINKE AXARLGGBMIBEIZ-IUCAKERBSA-N D0H9VQ DRUGSMIL CCCCC(C(=O)N1CCCC1C(=O)N)N D0H9VQ HIGHSTAT Investigative D0H9VW DRUG__ID D0H9VW D0H9VW DRUGTYPE Small molecular drug D0H9VW DRUGINCH 1S/C13H21NOS2/c1-2-3-4-5-6-7-8-9-10-11-12(15)14-13(16)17-11/h9-10,15H,2-8H2,1H3,(H,14,16)/b10-9- D0H9VW DRUGINKE PVHZHDOPGHHBGQ-KTKRTIGZSA-N D0H9VW DRUGSMIL CCCCCCCCC=CC1=C(NC(=S)S1)O D0H9VW HIGHSTAT Investigative D0HA0U DRUG__ID D0HA0U D0HA0U DRUGTYPE Small molecular drug D0HA0U DRUGINCH 1S/C28H24O3/c29-24-12-15-26-22-9-3-19(4-10-22)1-2-21-8-16-27(30)28(17-21)31-25-13-6-20(7-14-25)5-11-23(26)18-24/h3-4,6-10,12-18,29-30H,1-2,5,11H2 D0HA0U DRUGINKE VSXIMYQGZUVRSK-UHFFFAOYSA-N D0HA0U DRUGSMIL C1CC2=CC(=C(C=C2)O)OC3=CC=C(CCC4=C(C=CC(=C4)O)C5=CC=C1C=C5)C=C3 D0HA0U HIGHSTAT Investigative D0HA1K DRUG__ID D0HA1K D0HA1K DRUGTYPE Small molecular drug D0HA1K DRUGINCH 1S/C18H20N2O4/c19-16(10-11-17(21)22)18(23)20-14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16H,10-12,19H2,(H,20,23)(H,21,22)/t16-/m0/s1 D0HA1K DRUGINKE IYYBWKOXCQKLHX-INIZCTEOSA-N D0HA1K DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)C(CCC(=O)O)N D0HA1K HIGHSTAT Investigative D0HA6Y DRUG__ID D0HA6Y D0HA6Y DRUGTYPE Small molecular drug D0HA6Y DRUGINCH 1S/C16H21ClN2O4/c1-19-4-2-10(3-5-19)9-23-16(20)11-8-12(17)13(18)15-14(11)21-6-7-22-15/h8,10H,2-7,9,18H2,1H3/i1-1 D0HA6Y DRUGINKE FWDOTRBSNDBFMN-BJUDXGSMSA-N D0HA6Y DRUGSMIL CN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)N)Cl D0HA6Y HIGHSTAT Investigative D0HB5V DRUG__ID D0HB5V D0HB5V DRUGCOMP Ardane Therapeutics Inc D0HB5V DRUGINCH 1S/C96H174N44O23S2/c1-49(2)71(89(162)163)139-85(158)65-31-32-69(144)118-44-33-70(145)117-36-9-6-19-58(84(157)140-72(50(3)141)88(161)136-65)129-77(150)57(18-5-8-35-98)135-86(159)66(45-51-27-29-52(142)30-28-51)137-87(160)67(46-68(101)143)138-83(156)56(17-4-7-34-97)127-74(147)53(99)47-164-165-48-54(100)75(148)128-59(21-11-38-120-91(105)106)78(151)131-61(23-13-40-122-93(109)110)80(153)133-63(25-15-42-124-95(113)114)82(155)134-64(26-16-43-125-96(115)116)81(154)132-62(24-14-41-123-94(111)112)79(152)130-60(22-12-39-121-92(107)108)76(149)126-55(73(102)146)20-10-37-119-90(103)104/h27-30,49-50,53-67,71-72,141-142H,4-26,31-48,97-100H2,1-3H3,(H2,101,143)(H2,102,146)(H,117,145)(H,118,144)(H,126,149)(H,127,147)(H,128,148)(H,129,150)(H,130,152)(H,131,151)(H,132,154)(H,133,153)(H,134,155)(H,135,159)(H,136,161)(H,137,160)(H,138,156)(H,139,158)(H,140,157)(H,162,163)(H4,103,104,119)(H4,105,106,120)(H4,107,108,121)(H4,109,110,122)(H4,111,112,123)(H4,113,114,124)(H4,115,116,125)/t50-,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,63+,64+,65+,66+,67+,71+,72+/m1/s1 D0HB5V DRUGINKE YVHNLJSCOYUIPK-YPBSVZMPSA-N D0HB5V DRUGSMIL CC(C)C(C(=O)O)N=C(C1CCC(=NCCC(=NCCCCC(C(=NC(C(=N1)O)C(C)O)O)N=C(C(CCCCN)N=C(C(CC2=CC=C(C=C2)O)N=C(C(CC(=N)O)N=C(C(CCCCN)N=C(C(CSSCC(C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=N)O)O)O)O)O)O)O)O)N)N)O)O)O)O)O)O)O)O D0HB5V HIGHSTAT Investigative D0HB6O DRUG__ID D0HB6O D0HB6O DRUGTYPE Small molecular drug D0HB6O DRUGINCH 1S/C31H42N6O7/c1-17(2)10-25(31(43)44)37-30(42)24(13-20-8-6-5-7-9-20)36-27(39)16-34-26(38)15-35-29(41)23(32)14-22-18(3)11-21(28(33)40)12-19(22)4/h5-9,11-12,17,23-25H,10,13-16,32H2,1-4H3,(H2,33,40)(H,34,38)(H,35,41)(H,36,39)(H,37,42)(H,43,44)/t23-,24-,25-/m0/s1 D0HB6O DRUGINKE AYRRYHMNASIQTF-SDHOMARFSA-N D0HB6O DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NCC(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)O)N)C)C(=O)N D0HB6O HIGHSTAT Investigative D0HB9G DRUG__ID D0HB9G D0HB9G DRUGTYPE Small molecular drug D0HB9G DRUGINCH 1S/C8H5F4NO2/c1-15-7-5(11)3(9)2(8(13)14)4(10)6(7)12/h1H3,(H2,13,14) D0HB9G DRUGINKE JTXPTSGPUNTKSM-UHFFFAOYSA-N D0HB9G DRUGSMIL COC1=C(C(=C(C(=C1F)F)C(=O)N)F)F D0HB9G HIGHSTAT Investigative D0HC3H DRUG__ID D0HC3H D0HC3H DRUGTYPE Small molecular drug D0HC3H DRUGINCH 1S/C21H29NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20,23H,5,16H2,1-4H3 D0HC3H DRUGINKE QIRAYNIFEOXSPW-UHFFFAOYSA-N D0HC3H DRUGSMIL CCC(C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O D0HC3H HIGHSTAT Investigative D0HC9P DRUG__ID D0HC9P D0HC9P DRUGTYPE Small molecular drug D0HC9P DRUGINCH 1S/C28H24O15/c29-9-18-21(36)23(38)26(42-27(39)11-5-15(33)20(35)16(34)6-11)28(41-18)43-25-22(37)19-14(32)7-13(31)8-17(19)40-24(25)10-1-3-12(30)4-2-10/h1-8,18,21,23,26,28-36,38H,9H2/t18-,21-,23+,26-,28+/m1/s1 D0HC9P DRUGINKE UWIQWJHBYRTKAL-KQOASZHBSA-N D0HC9P DRUGSMIL C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)O D0HC9P HIGHSTAT Investigative D0HC9U DRUG__ID D0HC9U D0HC9U DRUGTYPE Small molecular drug D0HC9U DRUGINCH 1S/C17H11N3O4/c21-16-13-3-1-2-4-15(13)24-17-11(9-19-6-5-18-10-19)7-12(20(22)23)8-14(16)17/h1-8,10H,9H2 D0HC9U DRUGINKE FTWURRJWFIOKBA-UHFFFAOYSA-N D0HC9U DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC(=CC(=C3O2)CN4C=CN=C4)[N+](=O)[O-] D0HC9U HIGHSTAT Investigative D0HD2G DRUG__ID D0HD2G D0HD2G DRUGTYPE Small molecular drug D0HD2G DRUGINCH 1S/C15H14O5/c16-10-4-1-9(2-5-10)3-6-12(18)15-13(19)7-11(17)8-14(15)20/h1-2,4-5,7-8,16-17,19-20H,3,6H2 D0HD2G DRUGINKE VGEREEWJJVICBM-UHFFFAOYSA-N D0HD2G DRUGSMIL C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2O)O)O)O D0HD2G HIGHSTAT Investigative D0HD9P DRUG__ID D0HD9P D0HD9P DRUGTYPE Small molecular drug D0HD9P DRUGINCH 1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15- D0HD9P DRUGINKE YZXBAPSDXZZRGB-DOFZRALJSA-N D0HD9P DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)O D0HD9P HIGHSTAT Investigative D0HE0E DRUG__ID D0HE0E D0HE0E DRUGTYPE Small molecular drug D0HE0E DRUGINCH 1S/C20H19N3O2/c24-14-22-9-11-23(12-10-22)16-7-5-15(6-8-16)13-18-17-3-1-2-4-19(17)21-20(18)25/h1-8,13-14H,9-12H2,(H,21,25)/b18-13- D0HE0E DRUGINKE ZNFJBJDODKHWED-AQTBWJFISA-N D0HE0E DRUGSMIL C1CN(CCN1C=O)C2=CC=C(C=C2)C=C3C4=CC=CC=C4NC3=O D0HE0E HIGHSTAT Investigative D0HE4S DRUG__ID D0HE4S D0HE4S DRUGTYPE Small molecular drug D0HE4S DRUGINCH 1S/C17H24N4O2S/c1-20(2)24(22,23)19-12-8-14-13-5-4-6-15-17(13)11(9-18-15)7-16(14)21(3)10-12/h4-6,9,12,14,16,18-19H,7-8,10H2,1-3H3/t12-,14+,16+/m0/s1 D0HE4S DRUGINKE VUEGYUOUAAVYAS-JGGQBBKZSA-N D0HE4S DRUGSMIL CN1CC(CC2C1CC3=CNC4=CC=CC2=C34)NS(=O)(=O)N(C)C D0HE4S HIGHSTAT Investigative D0HF0A DRUG__ID D0HF0A D0HF0A DRUGTYPE Small molecular drug D0HF0A DRUGINCH 1S/C29H24BrN3O4/c1-17-7-12-22-21(15-17)27(19-5-3-2-4-6-19)28(29(37)31-22)23-16-24(18-8-10-20(30)11-9-18)33(32-23)25(34)13-14-26(35)36/h2-12,15,24,28H,13-14,16H2,1H3,(H,35,36) D0HF0A DRUGINKE ACUGSRUCGXYFTL-UHFFFAOYSA-N D0HF0A DRUGSMIL CC1=CC2=C(C(C(=O)N=C2C=C1)C3=NN(C(C3)C4=CC=C(C=C4)Br)C(=O)CCC(=O)O)C5=CC=CC=C5 D0HF0A HIGHSTAT Investigative D0HF0I DRUG__ID D0HF0I D0HF0I DRUGTYPE Small molecular drug D0HF0I DRUGINCH 1S/C33H39N5O5/c1-35-30(40)27(20-22-9-4-2-5-10-22)36-31(41)28(21-23-11-6-3-7-12-23)37-32(42)29-13-8-18-38(29)33(43)26(34)19-24-14-16-25(39)17-15-24/h2-7,9-12,14-17,26-29,39H,8,13,18-21,34H2,1H3,(H,35,40)(H,36,41)(H,37,42)/t26-,27-,28-,29-/m0/s1 D0HF0I DRUGINKE WEITVBLLGNOHNQ-DZUOILHNSA-N D0HF0I DRUGSMIL CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0HF0I HIGHSTAT Investigative D0HF1N DRUG__ID D0HF1N D0HF1N DRUGTYPE Small molecular drug D0HF1N DRUGINCH 1S/C11H15NO/c1-3-12-9(2)11(13)10-7-5-4-6-8-10/h4-9,12H,3H2,1-2H3 D0HF1N DRUGINKE LYMHIBZGTAPASQ-UHFFFAOYSA-N D0HF1N DRUGSMIL CCNC(C)C(=O)C1=CC=CC=C1 D0HF1N HIGHSTAT Investigative D0HF4I DRUG__ID D0HF4I D0HF4I DRUGTYPE Small molecular drug D0HF4I DRUGINCH 1S/C12H14N2OS/c1-15-11-2-4-12(5-3-11)16-7-6-10-8-13-9-14-10/h2-5,8-9H,6-7H2,1H3,(H,13,14) D0HF4I DRUGINKE MFQHSSADNRVZAE-UHFFFAOYSA-N D0HF4I DRUGSMIL COC1=CC=C(C=C1)SCCC2=CN=CN2 D0HF4I HIGHSTAT Investigative D0HG4U DRUG__ID D0HG4U D0HG4U DRUGTYPE Small molecular drug D0HG4U DRUGINCH 1S/C23H21NO2/c1-24-10-9-16-11-17(14-5-3-2-4-6-14)12-18-21(16)19(24)13-15-7-8-20(25)23(26)22(15)18/h2-8,11-12,19,25-26H,9-10,13H2,1H3/t19-/m1/s1 D0HG4U DRUGINKE NJWHLJABYCIZPL-LJQANCHMSA-N D0HG4U DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)C5=CC=CC=C5)C(=C(C=C4)O)O D0HG4U HIGHSTAT Investigative D0HH3R DRUG__ID D0HH3R D0HH3R DRUGTYPE Small molecular drug D0HH3R DRUGINCH 1S/C27H24F3N3O2/c28-27(29,30)19-7-5-8-20(17-19)31-25-23-11-1-2-12-24(23)33(26(25)34)21-9-6-10-22(18-21)35-16-15-32-13-3-4-14-32/h1-2,5-12,17-18H,3-4,13-16H2 D0HH3R DRUGINKE HXCJZIBJTFITNI-UHFFFAOYSA-N D0HH3R DRUGSMIL C1CCN(C1)CCOC2=CC=CC(=C2)N3C4=CC=CC=C4C(=NC5=CC=CC(=C5)C(F)(F)F)C3=O D0HH3R HIGHSTAT Investigative D0HH6A DRUG__ID D0HH6A D0HH6A DRUGTYPE Small molecular drug D0HH6A DRUGINCH 1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-20(24-17)25-18)10-7-4-5-8-11-19(22)23/h4,7,12-13,15-18,20-21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/b7-4-,13-12+/t15-,16+,17+,18-,20+/m0/s1 D0HH6A DRUGINKE DSNBHJFQCNUKMA-SCKDECHMSA-N D0HH6A DRUGSMIL CCCCCC(C=CC1C(C2CC(O2)O1)CC=CCCCC(=O)O)O D0HH6A HIGHSTAT Investigative D0HH9N DRUG__ID D0HH9N D0HH9N DRUGTYPE Small molecular drug D0HH9N DRUGINCH 1S/C27H48/c1-19(2)9-8-10-20(3)23-14-15-24-22-13-12-21-11-6-7-17-26(21,4)25(22)16-18-27(23,24)5/h19-25H,6-18H2,1-5H3/t20-,21?,22+,23-,24+,25+,26+,27-/m1/s1 D0HH9N DRUGINKE XIIAYQZJNBULGD-LDHZKLTISA-N D0HH9N DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4C3(CCCC4)C)C D0HH9N HIGHSTAT Investigative D0HI5B DRUG__ID D0HI5B D0HI5B DRUGTYPE Small molecular drug D0HI5B DRUGINCH 1S/C17H23N3O/c1-2-3-4-13-5-7-15(8-6-13)17-19-16(20-21-17)14-9-11-18-12-10-14/h9-13,15H,2-8H2,1H3 D0HI5B DRUGINKE OAVLEYPTWABFLF-UHFFFAOYSA-N D0HI5B DRUGSMIL CCCCC1CCC(CC1)C2=NC(=NO2)C3=CC=NC=C3 D0HI5B HIGHSTAT Investigative D0HI6O DRUG__ID D0HI6O D0HI6O DRUGTYPE Small molecular drug D0HI6O DRUGINCH 1S/C20H19N3O3S/c24-19-17(27-20(25)22-19)12-14-6-8-16(9-7-14)26-13-15-4-3-11-23(15)18-5-1-2-10-21-18/h1-2,5-10,12,15H,3-4,11,13H2,(H,22,24,25)/b17-12- D0HI6O DRUGINKE GRLCJTHTWOJWJS-ATVHPVEESA-N D0HI6O DRUGSMIL C1CC(N(C1)C2=CC=CC=N2)COC3=CC=C(C=C3)C=C4C(=O)NC(=O)S4 D0HI6O HIGHSTAT Investigative D0HK5B DRUG__ID D0HK5B D0HK5B DRUGTYPE Small molecular drug D0HK5B DRUGINCH 1S/C19H17N7O/c20-19-23-17-14(18-22-16(24-26(18)19)15-9-5-11-27-15)12-21-25(17)10-4-8-13-6-2-1-3-7-13/h1-3,5-7,9,11-12H,4,8,10H2,(H2,20,23) D0HK5B DRUGINKE XMXGGIWSFRIOKL-UHFFFAOYSA-N D0HK5B DRUGSMIL C1=CC=C(C=C1)CCCN2C3=C(C=N2)C4=NC(=NN4C(=N3)N)C5=CC=CO5 D0HK5B HIGHSTAT Investigative D0HL7Q DRUG__ID D0HL7Q D0HL7Q DRUGTYPE Small molecular drug D0HL7Q DRUGINCH 1S/C38H45N9O6/c1-53-26-15-13-24(14-16-26)19-31(46-38(40)41)37(52)47-17-7-12-32(47)36(51)43-22-33(48)44-30(20-25-21-42-28-11-6-5-10-27(25)28)35(50)45-29(34(39)49)18-23-8-3-2-4-9-23/h2-6,8-11,13-16,21,29-32,42H,7,12,17-20,22H2,1H3,(H2,39,49)(H,43,51)(H,44,48)(H,45,50)(H4,40,41,46)/t29-,30-,31-,32+/m0/s1 D0HL7Q DRUGINKE OEGSFHSEWVWDGF-RTNMLALUSA-N D0HL7Q DRUGSMIL COC1=CC=C(C=C1)CC(C(=O)N2CCCC2C(=O)NCC(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)N)N=C(N)N D0HL7Q HIGHSTAT Investigative D0HL9S DRUG__ID D0HL9S D0HL9S DRUGTYPE Small molecular drug D0HL9S DRUGINCH 1S/C10H11N3/c11-10-3-1-9(2-4-10)7-13-6-5-12-8-13/h1-6,8H,7,11H2 D0HL9S DRUGINKE DGHAOTHIDTUSJY-UHFFFAOYSA-N D0HL9S DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)N D0HL9S HIGHSTAT Investigative D0HM5W DRUG__ID D0HM5W D0HM5W DRUGTYPE Small molecular drug D0HM5W DRUGINCH 1S/C14H11BrN4/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,16H2,(H,17,18,19) D0HM5W DRUGINKE IZQHULBHKPGOAP-UHFFFAOYSA-N D0HM5W DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)N D0HM5W HIGHSTAT Investigative D0HM8Y DRUG__ID D0HM8Y D0HM8Y DRUGTYPE Small molecular drug D0HM8Y DRUGINCH 1S/C14H10O4/c1-7-11(16)5-4-10-9-3-2-8(15)6-12(9)18-14(17)13(7)10/h2-6,15-16H,1H3 D0HM8Y DRUGINKE UQGMRVBIHYSKJN-UHFFFAOYSA-N D0HM8Y DRUGSMIL CC1=C(C=CC2=C1C(=O)OC3=C2C=CC(=C3)O)O D0HM8Y HIGHSTAT Investigative D0HN0R DRUG__ID D0HN0R D0HN0R DRUGTYPE Small molecular drug D0HN0R DRUGINCH 1S/C16H22N2O3S/c17-22(20,21)15-7-6-12-8-14(9-13(12)10-15)18-16(19)11-4-2-1-3-5-11/h6-7,10-11,14H,1-5,8-9H2,(H,18,19)(H2,17,20,21) D0HN0R DRUGINKE PUAFUZDTMVHXBP-UHFFFAOYSA-N D0HN0R DRUGSMIL C1CCC(CC1)C(=O)NC2CC3=C(C2)C=C(C=C3)S(=O)(=O)N D0HN0R HIGHSTAT Investigative D0HN2M DRUG__ID D0HN2M D0HN2M DRUGTYPE Small molecular drug D0HN2M DRUGINCH 1S/C83H139FN32O21/c1-44(67(125)107-54(22-14-34-98-80(92)93)70(128)108-51(19-8-11-31-85)69(127)111-55(23-15-35-99-81(94)95)71(129)109-52(20-9-12-32-86)72(130)112-58(39-61(90)120)75(133)106-50(66(91)124)29-30-60(89)119)104-77(135)59(43-117)113-73(131)53(21-10-13-33-87)110-74(132)56(24-16-36-100-82(96)97)114-79(137)83(3,4)116-64(123)42-103-78(136)65(45(2)118)115-76(134)57(38-47-25-27-48(84)28-26-47)105-63(122)41-101-62(121)40-102-68(126)49(88)37-46-17-6-5-7-18-46/h5-7,17-18,25-28,44-45,49-59,65,117-118H,8-16,19-24,29-43,85-88H2,1-4H3,(H2,89,119)(H2,90,120)(H2,91,124)(H,101,121)(H,102,126)(H,103,136)(H,104,135)(H,105,122)(H,106,133)(H,107,125)(H,108,128)(H,109,129)(H,110,132)(H,111,127)(H,112,130)(H,113,131)(H,114,137)(H,115,134)(H,116,123)(H4,92,93,98)(H4,94,95,99)(H4,96,97,100)/t44-,45+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,65-/m0/s1 D0HN2M DRUGINKE GVIRJSRJRJCCJE-HCYVKCTOSA-N D0HN2M DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CC1=CC=C(C=C1)F)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0HN2M HIGHSTAT Investigative D0HO0W DRUG__ID D0HO0W D0HO0W DRUGTYPE Small molecular drug D0HO0W DRUGINCH 1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7-/m0/s1 D0HO0W DRUGINKE XQFRJNBWHJMXHO-XVMARJQXSA-N D0HO0W DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O D0HO0W HIGHSTAT Investigative D0HO1O DRUG__ID D0HO1O D0HO1O DRUGTYPE Small molecular drug D0HO1O DRUGINCH 1S/C33H32N2O3/c1-23-10-9-13-25(18-23)21-34-22-30(36)29(19-24-11-3-2-4-12-24)35-33(37)28-20-26-14-5-7-16-31(26)38-32-17-8-6-15-27(28)32/h2-18,20,29-30,34,36H,19,21-22H2,1H3,(H,35,37)/t29-,30+/m0/s1 D0HO1O DRUGINKE BNWZCXDHHPBQOX-XZWHSSHBSA-N D0HO1O DRUGSMIL CC1=CC(=CC=C1)CNCC(C(CC2=CC=CC=C2)NC(=O)C3=CC4=CC=CC=C4OC5=CC=CC=C53)O D0HO1O HIGHSTAT Investigative D0HO7I DRUG__ID D0HO7I D0HO7I DRUGTYPE Small molecular drug D0HO7I DRUGINCH 1S/C17H15NO2/c1-2-4-12-10(3-1)7-13-15-11(5-6-18-13)8-14-17(16(12)15)20-9-19-14/h1-4,8,13,18H,5-7,9H2/t13-/m1/s1 D0HO7I DRUGINKE VZTUKBKUWSHDFM-CYBMUJFWSA-N D0HO7I DRUGSMIL C1CNC2CC3=CC=CC=C3C4=C2C1=CC5=C4OCO5 D0HO7I HIGHSTAT Investigative D0HP1O DRUG__ID D0HP1O D0HP1O DRUGTYPE Small molecular drug D0HP1O DRUGINCH 1S/C27H38N6O2/c1-3-16-31(17-4-2)20-21-10-7-8-18-32(21)19-15-29-27(35)33-24-13-6-5-11-22(24)26(34)30-23-12-9-14-28-25(23)33/h5-6,9,11-14,21H,3-4,7-8,10,15-20H2,1-2H3,(H,29,35)(H,30,34) D0HP1O DRUGINKE MZDYABXXPZNUCT-UHFFFAOYSA-N D0HP1O DRUGSMIL CCCN(CCC)CC1CCCCN1CCNC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4 D0HP1O HIGHSTAT Investigative D0HP2H DRUG__ID D0HP2H D0HP2H DRUGTYPE Small molecular drug D0HP2H DRUGINCH 1S/C23H30FNO3/c1-2-3-4-5-6-7-8-11-18-27-20-16-14-19(15-17-20)25-23(26)28-22-13-10-9-12-21(22)24/h9-10,12-17H,2-8,11,18H2,1H3,(H,25,26) D0HP2H DRUGINKE PWZMFAZZDZNTOQ-UHFFFAOYSA-N D0HP2H DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D0HP2H HIGHSTAT Investigative D0HP5B DRUG__ID D0HP5B D0HP5B DRUGTYPE Small molecular drug D0HP5B DRUGINCH 1S/C28H25ClFN5O3S2.2ClH/c1-40(36,37)10-9-31-14-27-35-25(16-39-27)19-5-7-24-22(12-19)28(33-17-32-24)34-21-6-8-26(23(29)13-21)38-15-18-3-2-4-20(30)11-18;;/h2-8,11-13,16-17,31H,9-10,14-15H2,1H3,(H,32,33,34);2*1H D0HP5B DRUGINKE WIMITXDBYLKRKB-UHFFFAOYSA-N D0HP5B DRUGSMIL CS(=O)(=O)CCNCC1=NC(=CS1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.Cl.Cl D0HP5B HIGHSTAT Investigative D0HQ0E DRUG__ID D0HQ0E D0HQ0E DRUGTYPE Small molecular drug D0HQ0E DRUGINCH 1S/C22H30Cl2N2O2/c1-25(21(27)14-16-5-6-17(23)18(24)13-16)19-7-9-22(8-4-12-28-22)15-20(19)26-10-2-3-11-26/h5-6,13,19-20H,2-4,7-12,14-15H2,1H3/t19-,20-,22-/m0/s1 D0HQ0E DRUGINKE NYKCGQQJNVPOLU-ONTIZHBOSA-N D0HQ0E DRUGSMIL CN(C1CCC2(CCCO2)CC1N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl D0HQ0E HIGHSTAT Investigative D0HQ1I DRUG__ID D0HQ1I D0HQ1I DRUGTYPE Small molecular drug D0HQ1I DRUGINCH 1S/C16H13N5O/c1-10-6-15(21-16(19-10)17-9-18-21)20-13-7-11-4-2-3-5-12(11)8-14(13)22/h2-9,20,22H,1H3 D0HQ1I DRUGINKE OMQCQQGZRWJBCI-UHFFFAOYSA-N D0HQ1I DRUGSMIL CC1=NC2=NC=NN2C(=C1)NC3=CC4=CC=CC=C4C=C3O D0HQ1I HIGHSTAT Investigative D0HQ4M DRUG__ID D0HQ4M D0HQ4M DRUGTYPE Small molecular drug D0HQ4M DRUGINCH 1S/C15H32FO2P/c1-4-5-6-7-8-9-10-11-12-13-14-19(16,17)18-15(2)3/h15H,4-14H2,1-3H3 D0HQ4M DRUGINKE SFRALHFBKRAJPW-UHFFFAOYSA-N D0HQ4M DRUGSMIL CCCCCCCCCCCCP(=O)(OC(C)C)F D0HQ4M HIGHSTAT Investigative D0HR0O DRUG__ID D0HR0O D0HR0O DRUGTYPE Small molecular drug D0HR0O DRUGINCH 1S/C20H14F3NO/c21-16-7-1-13(2-8-16)20(19(24)25,14-3-9-17(22)10-4-14)15-5-11-18(23)12-6-15/h1-12H,(H2,24,25) D0HR0O DRUGINKE NEYVEJOLUVXNDA-UHFFFAOYSA-N D0HR0O DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N)F D0HR0O HIGHSTAT Investigative D0HR1V DRUG__ID D0HR1V D0HR1V DRUGTYPE Small molecular drug D0HR1V DRUGINCH 1S/C14H14INO2/c15-13-9-10(7-8-16)1-6-14(13)18-12-4-2-11(17)3-5-12/h1-6,9,17H,7-8,16H2 D0HR1V DRUGINKE XIINYOJWNGOUPF-UHFFFAOYSA-N D0HR1V DRUGSMIL C1=CC(=CC=C1O)OC2=C(C=C(C=C2)CCN)I D0HR1V HIGHSTAT Investigative D0HR7O DRUG__ID D0HR7O D0HR7O DRUGTYPE Small molecular drug D0HR7O DRUGINCH 1S/C27H33NO2/c1-27-13-12-23-22-11-9-21(29)15-18(22)6-10-24(23)25(27)16-19(26(27)30)14-17-4-7-20(8-5-17)28(2)3/h4-5,7-9,11,14-15,23-26,29-30H,6,10,12-13,16H2,1-3H3/b19-14+/t23?,24?,25?,26-,27-/m0/s1 D0HR7O DRUGINKE HUZDSTZYTXBRMO-BACVCVEMSA-N D0HR7O DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=C(C=C4)N(C)C)C2O)CCC5=C3C=CC(=C5)O D0HR7O HIGHSTAT Investigative D0HR8H DRUG__ID D0HR8H D0HR8H DRUGTYPE Small molecular drug D0HR8H DRUGINCH 1S/C4H5IN2O2/c5-2-1-6-4(9)7-3(2)8/h2H,1H2,(H2,6,7,8,9)/t2-/m0/s1 D0HR8H DRUGINKE YGKCTZPSAOUUMT-REOHCLBHSA-N D0HR8H DRUGSMIL C1C(C(=O)NC(=O)N1)I D0HR8H HIGHSTAT Investigative D0HR8L DRUG__ID D0HR8L D0HR8L DRUGTYPE Small molecular drug D0HR8L DRUGINCH 1S/C16H12O2/c17-14-5-1-3-11(10-14)12-7-8-15-13(9-12)4-2-6-16(15)18/h1-10,17-18H D0HR8L DRUGINKE HXKYTCGOCJUQSE-UHFFFAOYSA-N D0HR8L DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)C(=CC=C3)O D0HR8L HIGHSTAT Investigative D0HR9S DRUG__ID D0HR9S D0HR9S DRUGTYPE Small molecular drug D0HR9S DRUGINCH 1S/C20H14ClN3O/c21-16-7-3-13(4-8-16)18-19(15-2-1-11-22-12-15)24-20(23-18)14-5-9-17(25)10-6-14/h1-12,25H,(H,23,24) D0HR9S DRUGINKE GOSRVAHFGDUDAX-UHFFFAOYSA-N D0HR9S DRUGSMIL C1=CC(=CN=C1)C2=C(NC(=N2)C3=CC=C(C=C3)O)C4=CC=C(C=C4)Cl D0HR9S HIGHSTAT Investigative D0HS3M DRUG__ID D0HS3M D0HS3M DRUGTYPE Small molecular drug D0HS3M DRUGINCH 1S/C7H9N5S/c1-5(11-12-7(8)13)6-4-9-2-3-10-6/h2-4H,1H3,(H3,8,12,13)/b11-5- D0HS3M DRUGINKE LNRWBLGPWCJQEM-WZUFQYTHSA-N D0HS3M DRUGSMIL CC(=NNC(=S)N)C1=NC=CN=C1 D0HS3M HIGHSTAT Investigative D0HS5P DRUG__ID D0HS5P D0HS5P DRUGTYPE Small molecular drug D0HS5P DRUGINCH 1S/C21H20N2/c1-15(19-11-6-9-16-7-2-4-10-20(16)19)22-14-18-13-17-8-3-5-12-21(17)23-18/h2-13,15,22-23H,14H2,1H3/t15-/m1/s1 D0HS5P DRUGINKE JLPWXRZETODYFC-OAHLLOKOSA-N D0HS5P DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)NCC3=CC4=CC=CC=C4N3 D0HS5P HIGHSTAT Investigative D0HT2D DRUG__ID D0HT2D D0HT2D DRUGTYPE Small molecular drug D0HT2D DRUGINCH 1S/C37H48N6O14S2/c1-19(44)38-27(17-31(49)50)36(55)40-23(9-11-29(45)46)32(51)41-25(13-14-59-2)34(53)39-24(10-12-30(47)48)33(52)42-26(35(54)43-28(18-58)37(56)57)16-20-7-8-21-5-3-4-6-22(21)15-20/h3-8,15,23-28,58H,9-14,16-18H2,1-2H3,(H,38,44)(H,39,53)(H,40,55)(H,41,51)(H,42,52)(H,43,54)(H,45,46)(H,47,48)(H,49,50)(H,56,57)/t23-,24-,25-,26-,27-,28-/m0/s1 D0HT2D DRUGINKE FCGQLGIFPLXKQV-QUQVWLGBSA-N D0HT2D DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC2=CC=CC=C2C=C1)C(=O)NC(CS)C(=O)O D0HT2D HIGHSTAT Investigative D0HU4J DRUG__ID D0HU4J D0HU4J DRUGTYPE Small molecular drug D0HU4J DRUGINCH 1S/C10H13NS/c1-2-4-9(5-3-1)10-8-11-6-7-12-10/h1-5,10-11H,6-8H2 D0HU4J DRUGINKE SRYHBJDVLOEJNP-UHFFFAOYSA-N D0HU4J DRUGSMIL C1CSC(CN1)C2=CC=CC=C2 D0HU4J HIGHSTAT Investigative D0HV3A DRUG__ID D0HV3A D0HV3A DRUGTYPE Small molecular drug D0HV3A DRUGINCH 1S/C17H19FN4S/c1-11-9-13-16(22-7-5-21(2)6-8-22)19-15-10-12(18)3-4-14(15)20-17(13)23-11/h3-4,9-10,20H,5-8H2,1-2H3 D0HV3A DRUGINKE JBHUBOISLBWHAR-UHFFFAOYSA-N D0HV3A DRUGSMIL CC1=CC2=C(S1)NC3=C(C=C(C=C3)F)N=C2N4CCN(CC4)C D0HV3A HIGHSTAT Investigative D0HV5D DRUG__ID D0HV5D D0HV5D DRUGTYPE Small molecular drug D0HV5D DRUGINCH 1S/C14H15N3O/c1-14(2,12-6-4-8-16-10-12)13(17-18)11-5-3-7-15-9-11/h3-10,13H,1-2H3 D0HV5D DRUGINKE CJLBATLINTYVRN-UHFFFAOYSA-N D0HV5D DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CN=CC=C2)N=O D0HV5D HIGHSTAT Investigative D0HV6H DRUG__ID D0HV6H D0HV6H DRUGTYPE Small molecular drug D0HV6H DRUGINCH 1S/C28H34N6O6/c29-20(14-18-10-12-19(35)13-11-18)26(38)34-22-9-5-4-8-21(25(30)37)33-28(40)23(15-17-6-2-1-3-7-17)32-24(36)16-31-27(22)39/h1-7,10-13,20-23,35H,8-9,14-16,29H2,(H2,30,37)(H,31,39)(H,32,36)(H,33,40)(H,34,38)/b5-4+/t20-,21+,22+,23-/m0/s1 D0HV6H DRUGINKE UYBFKIDGDVZVFM-KLGXLVMCSA-N D0HV6H DRUGSMIL C1C=CCC(NC(=O)C(NC(=O)CNC(=O)C1NC(=O)C(CC2=CC=C(C=C2)O)N)CC3=CC=CC=C3)C(=O)N D0HV6H HIGHSTAT Investigative D0HW3Y DRUG__ID D0HW3Y D0HW3Y DRUGTYPE Small molecular drug D0HW3Y DRUGINCH 1S/C9H7NO5/c11-5-2-1-4-3-6(12)9(13)8(7(4)5)10(14)15/h3,12-13H,1-2H2 D0HW3Y DRUGINKE ULOQNEJBWLIGHK-UHFFFAOYSA-N D0HW3Y DRUGSMIL C1CC(=O)C2=C(C(=C(C=C21)O)O)[N+](=O)[O-] D0HW3Y HIGHSTAT Investigative D0HX0D DRUG__ID D0HX0D D0HX0D DRUGTYPE Small molecular drug D0HX0D DRUGINCH 1S/C34H32N4O4.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);/q-4;+4/b25-13-,26-13?,27-14?,28-15-,29-14-,30-15?,31-16?,32-16-; D0HX0D DRUGINKE VWEYNEFKXXWVHZ-QPPPNFCJSA-N D0HX0D DRUGSMIL CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=C(C(=C([N-]5)C=C1[N-]2)C=C)C)[N-]4)C=C)C)C)CCC(=O)O)CCC(=O)O.[Sn+4] D0HX0D HIGHSTAT Investigative D0HZ3Q DRUG__ID D0HZ3Q D0HZ3Q DRUGTYPE Small molecular drug D0HZ3Q DRUGINCH 1S/C19H32O5/c1-3-4-5-6-7-8-9-10-11-12-13-17(23-15(2)20)16-14-18(21)24-19(16)22/h14,17,19,22H,3-13H2,1-2H3 D0HZ3Q DRUGINKE QDXHMXIOLIYZHD-UHFFFAOYSA-N D0HZ3Q DRUGSMIL CCCCCCCCCCCCC(C1=CC(=O)OC1O)OC(=O)C D0HZ3Q HIGHSTAT Investigative D0HZ8U DRUG__ID D0HZ8U D0HZ8U DRUGTYPE Small molecular drug D0HZ8U DRUGINCH 1S/C19H10N2O3/c22-18-13-5-3-4-10-11(19(23)24)8-9-12(16(10)13)17-20-14-6-1-2-7-15(14)21(17)18/h1-9H,(H,23,24) D0HZ8U DRUGINKE MYKOWOGZBMOVBJ-UHFFFAOYSA-N D0HZ8U DRUGSMIL C1=CC=C2C(=C1)N=C3N2C(=O)C4=CC=CC5=C(C=CC3=C54)C(=O)O D0HZ8U HIGHSTAT Investigative D0HZ9X DRUG__ID D0HZ9X D0HZ9X DRUGTYPE Small molecular drug D0HZ9X DRUGINCH 1S/C13H11N3O/c17-13-11-5-1-2-6-12(11)15-16(13)9-10-4-3-7-14-8-10/h1-8,15H,9H2 D0HZ9X DRUGINKE SKZAIZCDZYPCRF-UHFFFAOYSA-N D0HZ9X DRUGSMIL C1=CC=C2C(=C1)C(=O)N(N2)CC3=CN=CC=C3 D0HZ9X HIGHSTAT Investigative D0I0AA DRUG__ID D0I0AA D0I0AA DRUGTYPE Small molecular drug D0I0AA DRUGINCH 1S/C3H4O/c1-2-3-4/h2-3H,1H2 D0I0AA DRUGINKE HGINCPLSRVDWNT-UHFFFAOYSA-N D0I0AA DRUGSMIL C=CC=O D0I0AA HIGHSTAT Investigative D0I0AQ DRUG__ID D0I0AQ D0I0AQ DRUGTYPE Small molecular drug D0I0AQ DRUGINCH 1S/C20H19NO4/c1-20(2)13-9-10(22)5-6-11(13)14-15-12(7-8-21-19(15)20)17(24-3)18(25-4)16(14)23/h5-9,22-23H,1-4H3 D0I0AQ DRUGINKE CUEIWVZJOPCMPT-UHFFFAOYSA-N D0I0AQ DRUGSMIL CC1(C2=C(C=CC(=C2)O)C3=C(C(=C(C4=C3C1=NC=C4)OC)OC)O)C D0I0AQ HIGHSTAT Investigative D0I0BV DRUG__ID D0I0BV D0I0BV DRUGTYPE Small molecular drug D0I0BV DRUGINCH 1S/C13H14O4/c1-4-13(17-10(3)15)11-5-7-12(8-6-11)16-9(2)14/h4-8,13H,1H2,2-3H3/t13-/m0/s1 D0I0BV DRUGINKE JAMQIUWGGBSIKZ-ZDUSSCGKSA-N D0I0BV DRUGSMIL CC(=O)OC1=CC=C(C=C1)C(C=C)OC(=O)C D0I0BV HIGHSTAT Investigative D0I0CU DRUG__ID D0I0CU D0I0CU DRUGTYPE Small molecular drug D0I0CU DRUGINCH 1S/C16H6N2O4/c19-13-7-3-1-2-4-8(7)14(20)11-9(13)5-6-10-12(11)18-16(22)15(21)17-10/h1-6H D0I0CU DRUGINKE RVDWAIRPSDRIMH-UHFFFAOYSA-N D0I0CU DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=NC(=O)C(=O)N=C4C=C3 D0I0CU HIGHSTAT Investigative D0I0EN DRUG__ID D0I0EN D0I0EN DRUGTYPE Small molecular drug D0I0EN DRUGINCH 1S/C27H34N2O9/c1-3-13-16(17(11-30)26(35)36-2)10-19-21-15(14-6-4-5-7-18(14)28-21)8-9-29(19)25(13)38-27-24(34)23(33)22(32)20(12-31)37-27/h3-7,11,13,16,19-20,22-25,27-28,30-34H,1,8-10,12H2,2H3/b17-11-/t13-,16-,19-,20-,22-,23+,24-,25-,27+/m0/s1 D0I0EN DRUGINKE XAYUCVICBPYPRE-LPRPFWDGSA-N D0I0EN DRUGSMIL COC(=O)C(=CO)C1CC2C3=C(CCN2C(C1C=C)OC4C(C(C(C(O4)CO)O)O)O)C5=CC=CC=C5N3 D0I0EN HIGHSTAT Investigative D0I0GL DRUG__ID D0I0GL D0I0GL DRUGTYPE Small molecular drug D0I0GL DRUGINCH 1S/C17H14FNO2/c1-20-16-8-12-7-13(11-3-5-14(18)6-4-11)10-19-15(12)9-17(16)21-2/h3-10H,1-2H3 D0I0GL DRUGINKE UKJTWBAIJVXDSM-UHFFFAOYSA-N D0I0GL DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=C(C=C3)F D0I0GL HIGHSTAT Investigative D0I0HL DRUG__ID D0I0HL D0I0HL DRUGTYPE Small molecular drug D0I0HL DRUGINCH 1S/C29H36O7/c1-25-6-7-26(2,24(35)36)14-19(25)29(5)11-9-27(3)15-12-17(31)22(32)21(23(33)34)20(15)16(30)13-18(27)28(29,4)10-8-25/h12-13,19,31-32H,6-11,14H2,1-5H3,(H,33,34)(H,35,36)/t19-,25-,26-,27+,28-,29+/m1/s1 D0I0HL DRUGINKE IGEUWSSSLAVCIX-GPQUBRLFSA-N D0I0HL DRUGSMIL CC12CCC(CC1C3(CCC4(C5=CC(=C(C(=C5C(=O)C=C4C3(CC2)C)C(=O)O)O)O)C)C)(C)C(=O)O D0I0HL HIGHSTAT Investigative D0I0IM DRUG__ID D0I0IM D0I0IM DRUGTYPE Small molecular drug D0I0IM DRUGINCH 1S/C24H38O6/c1-5-15(3)24(29)30-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-18(25)12-19(26)13-22(27)28/h6-7,14-17,19-21,23,26H,5,8-13H2,1-4H3,(H,27,28)/t14-,15-,16-,17-,19+,20-,21-,23?/m0/s1 D0I0IM DRUGINKE OOKAZRDERJMRCJ-KOUAFAAESA-N D0I0IM DRUGSMIL CCC(C)C(=O)OC1CC(CC2C1C(C(C=C2)C)CCC(=O)CC(CC(=O)O)O)C D0I0IM HIGHSTAT Investigative D0I0KV DRUG__ID D0I0KV D0I0KV DRUGTYPE Small molecular drug D0I0KV DRUGINCH 1S/C23H30O2/c1-22(2,3)13-15-12-20-19-7-5-14-11-16(24)6-8-17(14)18(19)9-10-23(20,4)21(15)25/h6,8,11,13,18-20,24H,5,7,9-10,12H2,1-4H3/b15-13+/t18?,19?,20?,23-/m0/s1 D0I0KV DRUGINKE FSXMOAXUKSPGCO-MIWZRYNRSA-N D0I0KV DRUGSMIL CC12CCC3C(C1CC(=CC(C)(C)C)C2=O)CCC4=C3C=CC(=C4)O D0I0KV HIGHSTAT Investigative D0I0LW DRUG__ID D0I0LW D0I0LW DRUGTYPE Small molecular drug D0I0LW DRUGINCH 1S/C40H72N12O8/c1-23(2)14-16-27(48-37(58)29(20-24(3)4)47-33(54)17-15-25-10-6-5-7-11-25)36(57)51-30(22-41)39(60)52-19-9-13-31(52)38(59)49-26(12-8-18-46-40(44)45)35(56)50-28(34(43)55)21-32(42)53/h23-31H,5-22,41H2,1-4H3,(H2,42,53)(H2,43,55)(H,47,54)(H,48,58)(H,49,59)(H,50,56)(H,51,57)(H4,44,45,46)/t26-,27-,28-,29-,30-,31-/m0/s1 D0I0LW DRUGINKE KAFZOLYKKCWUBI-HPMAGDRPSA-N D0I0LW DRUGSMIL CC(C)CCC(C(=O)NC(CN)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C(CC(C)C)NC(=O)CCC2CCCCC2 D0I0LW HIGHSTAT Investigative D0I0MJ DRUG__ID D0I0MJ D0I0MJ DRUGTYPE Small molecular drug D0I0MJ DRUGINCH 1S/C26H27N5O10.ClH/c1-16-21(25(33)39-11-5-12-41-31(37)38)23(18-6-3-8-20(14-18)30(35)36)22(17(2)29-16)26(34)40-13-10-28-24(32)19-7-4-9-27-15-19;/h3-4,6-9,14-15,23,29H,5,10-13H2,1-2H3,(H,28,32);1H D0I0MJ DRUGINKE MWVXLKFCDZXILL-UHFFFAOYSA-N D0I0MJ DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCNC(=O)C2=CN=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCCO[N+](=O)[O-].Cl D0I0MJ HIGHSTAT Investigative D0I0ML DRUG__ID D0I0ML D0I0ML DRUGTYPE Small molecular drug D0I0ML DRUGINCH 1S/C15H17N/c1-12-5-2-3-8-15(12)14-7-4-6-13(11-14)9-10-16/h2-8,11H,9-10,16H2,1H3 D0I0ML DRUGINKE KQRAKUVQYREATE-UHFFFAOYSA-N D0I0ML DRUGSMIL CC1=CC=CC=C1C2=CC=CC(=C2)CCN D0I0ML HIGHSTAT Investigative D0I0MR DRUG__ID D0I0MR D0I0MR DRUGTYPE Small molecular drug D0I0MR DRUGINCH 1S/C19H33F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(23)19(20,21)22/h9-10H,2-8,11-17H2,1H3/b10-9- D0I0MR DRUGINKE SOJGXPSMVNTNQL-KTKRTIGZSA-N D0I0MR DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C(F)(F)F D0I0MR HIGHSTAT Investigative D0I0MU DRUG__ID D0I0MU D0I0MU DRUGTYPE Small molecular drug D0I0MU DRUGINCH 1S/C31H50N4O7S/c1-9-22(6)27(35-31(39)42-19-24-13-11-10-12-14-24)30(38)34-26(18-21(4)5)29(37)32-23(7)28(36)33-25(17-20(2)3)15-16-43(8,40)41/h10-16,20-23,25-27H,9,17-19H2,1-8H3,(H,32,37)(H,33,36)(H,34,38)(H,35,39)/b16-15+/t22-,23-,25+,26-,27-/m0/s1 D0I0MU DRUGINKE PXJWGKDQRNBYKI-HUHPYHTRSA-N D0I0MU DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC1=CC=CC=C1 D0I0MU HIGHSTAT Investigative D0I0NY DRUG__ID D0I0NY D0I0NY DRUGTYPE Small molecular drug D0I0NY DRUGINCH 1S/C25H37N5O4/c1-27-19(15-16-7-4-3-5-8-16)25(34)30-14-6-9-20(30)23(32)29-21(22(31)24(33)28-2)17-10-12-18(26)13-11-17/h3-5,7-8,17-21,27H,6,9-15,26H2,1-2H3,(H,28,33)(H,29,32)/t17?,18?,19-,20+,21+/m1/s1 D0I0NY DRUGINKE ISJCFAFNSYZJRO-KJFGXLEFSA-N D0I0NY DRUGSMIL CNC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(C3CCC(CC3)N)C(=O)C(=O)NC D0I0NY HIGHSTAT Investigative D0I0OH DRUG__ID D0I0OH D0I0OH DRUGTYPE Small molecular drug D0I0OH DRUGINCH 1S/C9H12FN2O8P/c10-4-2-12(9(15)11-8(4)14)7-1-5(13)6(20-7)3-19-21(16,17)18/h2,5-7,13H,1,3H2,(H,11,14,15)(H2,16,17,18)/t5-,6+,7+/m0/s1 D0I0OH DRUGINKE HFEKDTCAMMOLQP-RRKCRQDMSA-N D0I0OH DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)F)COP(=O)(O)O)O D0I0OH HIGHSTAT Investigative D0I0QH DRUG__ID D0I0QH D0I0QH DRUGTYPE Small molecular drug D0I0QH DRUGINCH 1S/C6H13FO10P2/c7-4-6(10,3-5(8)9)1-2-16-19(14,15)17-18(11,12)13/h10H,1-4H2,(H,8,9)(H,14,15)(H2,11,12,13)/t6-/m1/s1 D0I0QH DRUGINKE YIGLDWRZXXHIGZ-ZCFIWIBFSA-N D0I0QH DRUGSMIL C(COP(=O)(O)OP(=O)(O)O)C(CC(=O)O)(CF)O D0I0QH HIGHSTAT Investigative D0I0SH DRUG__ID D0I0SH D0I0SH DRUGCOMP Kyoto Pharmaceutical Industries Ltd D0I0SH DRUGINCH 1S/C29H28N2O4/c1-20-26(30-28(35-20)22-10-6-3-7-11-22)14-15-34-25-13-12-23-17-27(29(32)33)31(19-24(23)16-25)18-21-8-4-2-5-9-21/h2-13,16,27H,14-15,17-19H2,1H3,(H,32,33) D0I0SH DRUGINKE KJGKZLYGWWKIAK-UHFFFAOYSA-N D0I0SH DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC4=C(CC(N(C4)CC5=CC=CC=C5)C(=O)O)C=C3 D0I0SH HIGHSTAT Investigative D0I0SK DRUG__ID D0I0SK D0I0SK DRUGTYPE Small molecular drug D0I0SK DRUGINCH 1S/C11H14ClNO2S/c12-9-3-1-8(2-4-9)7-16-6-5-10(13)11(14)15/h1-4,10H,5-7,13H2,(H,14,15) D0I0SK DRUGINKE ALRMSMDJCRNGNM-UHFFFAOYSA-N D0I0SK DRUGSMIL C1=CC(=CC=C1CSCCC(C(=O)O)N)Cl D0I0SK HIGHSTAT Investigative D0I0UI DRUG__ID D0I0UI D0I0UI DRUGTYPE Small molecular drug D0I0UI DRUGINCH 1S/C27H23NO3/c1-18(22-15-8-12-19-9-2-5-13-23(19)22)26(29)28-25-16-7-4-11-21(25)17-20-10-3-6-14-24(20)27(30)31/h2-16,18H,17H2,1H3,(H,28,29)(H,30,31) D0I0UI DRUGINKE BLJLWFKNTKAUDA-UHFFFAOYSA-N D0I0UI DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)C(=O)NC3=CC=CC=C3CC4=CC=CC=C4C(=O)O D0I0UI HIGHSTAT Investigative D0I0UW DRUG__ID D0I0UW D0I0UW DRUGTYPE Small molecular drug D0I0UW DRUGINCH 1S/C16H25N/c1-15-8-10-16(11-9-15)7-3-6-14-17-12-4-2-5-13-17/h8-11H,2-7,12-14H2,1H3 D0I0UW DRUGINKE ZJZNOPQUDXUEDU-UHFFFAOYSA-N D0I0UW DRUGSMIL CC1=CC=C(C=C1)CCCCN2CCCCC2 D0I0UW HIGHSTAT Investigative D0I0WF DRUG__ID D0I0WF D0I0WF DRUGTYPE Small molecular drug D0I0WF DRUGINCH 1S/C25H20O10/c1-32-16-8-12(4-7-14(16)28)22-18(10-26)34-24-17(33-22)9-15(29)19-20(30)21(31)23(35-25(19)24)11-2-5-13(27)6-3-11/h2-9,18,22,26-29,31H,10H2,1H3/t18-,22-/m1/s1 D0I0WF DRUGINKE POVCYOFRCMBMKD-XMSQKQJNSA-N D0I0WF DRUGSMIL COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C4=C3OC(=C(C4=O)O)C5=CC=C(C=C5)O)O)CO)O D0I0WF HIGHSTAT Investigative D0I0WP DRUG__ID D0I0WP D0I0WP DRUGTYPE Small molecular drug D0I0WP DRUGINCH 1S/C16H14N2OS/c1-18(13-7-9-14(19)10-8-13)16-17-15(11-20-16)12-5-3-2-4-6-12/h2-11,19H,1H3 D0I0WP DRUGINKE XDKOSPFALAXPJO-UHFFFAOYSA-N D0I0WP DRUGSMIL CN(C1=CC=C(C=C1)O)C2=NC(=CS2)C3=CC=CC=C3 D0I0WP HIGHSTAT Investigative D0I0XA DRUG__ID D0I0XA D0I0XA DRUGTYPE Small molecular drug D0I0XA DRUGINCH 1S/C15H25N5O2/c1-4-20(8-7-19(2)3)14(21)11-17-10-13-9-12(15(16)22)5-6-18-13/h5-6,9,17H,4,7-8,10-11H2,1-3H3,(H2,16,22) D0I0XA DRUGINKE PNFMVADNCOGWME-UHFFFAOYSA-N D0I0XA DRUGSMIL CCN(CCN(C)C)C(=O)CNCC1=NC=CC(=C1)C(=O)N D0I0XA HIGHSTAT Investigative D0I0YE DRUG__ID D0I0YE D0I0YE DRUGTYPE Small molecular drug D0I0YE DRUGINCH 1S/C22H21NO/c24-22(20-14-8-3-9-15-20)23-17-16-21(18-10-4-1-5-11-18)19-12-6-2-7-13-19/h1-15,21H,16-17H2,(H,23,24) D0I0YE DRUGINKE NSSSSHDNQFPODZ-UHFFFAOYSA-N D0I0YE DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)C2=CC=CC=C2)C3=CC=CC=C3 D0I0YE HIGHSTAT Investigative D0I1AC DRUG__ID D0I1AC D0I1AC DRUGTYPE Small molecular drug D0I1AC DRUGINCH 1S/C11H9ClN2O/c1-8-4-2-3-5-10(8)11(15)14-7-9(12)6-13-14/h2-7H,1H3 D0I1AC DRUGINKE LBFRMVGIANQWAQ-UHFFFAOYSA-N D0I1AC DRUGSMIL CC1=CC=CC=C1C(=O)N2C=C(C=N2)Cl D0I1AC HIGHSTAT Investigative D0I1AF DRUG__ID D0I1AF D0I1AF DRUGTYPE Small molecular drug D0I1AF DRUGINCH 1S/C18H13NO3/c1-2-12-14-7-10(20)4-6-16(14)19-18-13-5-3-11(21)8-17(13)22-9-15(12)18/h2-8,20-21H,1,9H2 D0I1AF DRUGINKE SDQIIVSWOGDEKO-UHFFFAOYSA-N D0I1AF DRUGSMIL C=CC1=C2COC3=C(C2=NC4=C1C=C(C=C4)O)C=CC(=C3)O D0I1AF HIGHSTAT Investigative D0I1BA DRUG__ID D0I1BA D0I1BA DRUGTYPE Small molecular drug D0I1BA DRUGINCH 1S/C17H32N4O4/c1-4-6-10(7-5-2)14(20-9(3)22)13-12(21-17(18)19)8-11(15(13)23)16(24)25/h10-15,23H,4-8H2,1-3H3,(H,20,22)(H,24,25)(H4,18,19,21)/t11-,12+,13+,14-,15+/m0/s1 D0I1BA DRUGINKE IIZTWIZWLKRAMW-VYDRJRHOSA-N D0I1BA DRUGSMIL CCCC(CCC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C D0I1BA HIGHSTAT Investigative D0I1BJ DRUG__ID D0I1BJ D0I1BJ DRUGTYPE Small molecular drug D0I1BJ DRUGINCH 1S/C38H43N5O5/c1-23-18-26(19-24(2)34(23)44)20-30(39)38(48)43-17-9-16-33(43)37(47)42-32(21-25-10-4-3-5-11-25)36(46)41-31(35(40)45)22-28-14-8-13-27-12-6-7-15-29(27)28/h3-8,10-15,18-19,30-33,44H,9,16-17,20-22,39H2,1-2H3,(H2,40,45)(H,41,46)(H,42,47)/t30-,31+,32-,33-/m0/s1 D0I1BJ DRUGINKE UOSWQKPDVGZIDQ-YGXYGYJOSA-N D0I1BJ DRUGSMIL CC1=CC(=CC(=C1O)C)CC(C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC5=CC=CC=C54)C(=O)N)N D0I1BJ HIGHSTAT Investigative D0I1EE DRUG__ID D0I1EE D0I1EE DRUGTYPE Small molecular drug D0I1EE DRUGINCH 1S/C49H57N7O12S3/c1-29-42-35(28-69-29)48(59)53-38-12-8-9-13-39(38)56(42)40(57)27-55-24-22-54(23-25-55)21-11-7-5-3-2-4-6-10-20-52-47(58)30-14-15-31(34(26-30)49(60)61)41-32-16-18-36(50)45(70(62,63)64)43(32)68-44-33(41)17-19-37(51)46(44)71(65,66)67/h8-9,12-19,26,28,50,62-67H,2-7,10-11,20-25,27,51H2,1H3,(H,52,58)(H,53,59)(H,60,61)/p-6 D0I1EE DRUGINKE SRLBGILQMKQWSJ-UHFFFAOYSA-H D0I1EE DRUGSMIL CC1=C2C(=CS1)C(=O)NC3=CC=CC=C3N2C(=O)CN4CCN(CC4)CCCCCCCCCCNC(=O)C5=CC(=C(C=C5)C6=C7C=CC(=N)C(=C7OC8=C6C=CC(=C8S([O-])([O-])[O-])N)S([O-])([O-])[O-])C(=O)O D0I1EE HIGHSTAT Investigative D0I1EP DRUG__ID D0I1EP D0I1EP DRUGTYPE Small molecular drug D0I1EP DRUGINCH 1S/C18H16O5/c1-20-12-9-13(21-2)15-14(10-12)23-17(18(22-3)16(15)19)11-7-5-4-6-8-11/h4-10H,1-3H3 D0I1EP DRUGINKE CBTHKWVPSIGKMI-UHFFFAOYSA-N D0I1EP DRUGSMIL COC1=CC2=C(C(=C1)OC)C(=O)C(=C(O2)C3=CC=CC=C3)OC D0I1EP HIGHSTAT Investigative D0I1FJ DRUG__ID D0I1FJ D0I1FJ DRUGTYPE Small molecular drug D0I1FJ DRUGINCH 1S/C16H22N8O/c1-2-24-14-10(8-20-11-3-5-18-6-4-11)7-19-9-12(14)21-16(24)13-15(17)23-25-22-13/h7,9,11,18,20H,2-6,8H2,1H3,(H2,17,23) D0I1FJ DRUGINKE MBCJUIJWPYUEBX-UHFFFAOYSA-N D0I1FJ DRUGSMIL CCN1C2=C(C=NC=C2CNC3CCNCC3)N=C1C4=NON=C4N D0I1FJ HIGHSTAT Investigative D0I1GV DRUG__ID D0I1GV D0I1GV DRUGTYPE Small molecular drug D0I1GV DRUGINCH 1S/C26H31N3OS/c1-26(2,15-22-14-21-9-3-4-11-25(21)31-22)28-17-24(30)23-10-6-12-29(23)18-20-8-5-7-19(13-20)16-27/h3-5,7-9,11,13-14,23-24,28,30H,6,10,12,15,17-18H2,1-2H3/t23-,24-/m1/s1 D0I1GV DRUGINKE HCLQARMRCPEALF-DNQXCXABSA-N D0I1GV DRUGSMIL CC(C)(CC1=CC2=CC=CC=C2S1)NCC(C3CCCN3CC4=CC(=CC=C4)C#N)O D0I1GV HIGHSTAT Investigative D0I1HM DRUG__ID D0I1HM D0I1HM DRUGCOMP Curemark LLC D0I1HM DRUGINCH 1S/C20H22N2O2/c23-20-22(18-8-4-5-9-19(18)24-20)15-14-21-12-10-17(11-13-21)16-6-2-1-3-7-16/h1-9,17H,10-15H2 D0I1HM DRUGINKE DSXGXHVTSKGARP-UHFFFAOYSA-N D0I1HM DRUGSMIL C1CN(CCC1C2=CC=CC=C2)CCN3C4=CC=CC=C4OC3=O D0I1HM HIGHSTAT Investigative D0I1IK DRUG__ID D0I1IK D0I1IK DRUGTYPE Small molecular drug D0I1IK DRUGINCH 1S/C18H12FN3O3/c1-9(23)25-22-16-10-5-2-3-8-13(10)20-17(16)14-11-6-4-7-12(19)15(11)21-18(14)24/h2-8,21,24H,1H3/b22-16- D0I1IK DRUGINKE NFIUKUJUBYCMTC-JWGURIENSA-N D0I1IK DRUGSMIL CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC=C4F)O D0I1IK HIGHSTAT Investigative D0I1IW DRUG__ID D0I1IW D0I1IW DRUGTYPE Small molecular drug D0I1IW DRUGINCH 1S/C20H21FN6O5/c21-10-1-2-12-11(5-10)9(6-23-12)3-4-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)13(7-28)32-19/h1-2,5-6,8,13,15-16,19,23,28-30H,3-4,7H2,(H2,22,25,26)/t13-,15-,16-,19-/m1/s1 D0I1IW DRUGINKE VEJNLHIDLOHNST-NVQRDWNXSA-N D0I1IW DRUGSMIL C1=CC2=C(C=C1F)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0I1IW HIGHSTAT Investigative D0I1LR DRUG__ID D0I1LR D0I1LR DRUGTYPE Small molecular drug D0I1LR DRUGINCH 1S/C17H15NO3S/c19-15-10-16(18-5-7-20-8-6-18)21-17-13(2-1-3-14(15)17)12-4-9-22-11-12/h1-4,9-11H,5-8H2 D0I1LR DRUGINKE MHMBRJOWOVNUNC-UHFFFAOYSA-N D0I1LR DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CSC=C4 D0I1LR HIGHSTAT Investigative D0I1ME DRUG__ID D0I1ME D0I1ME DRUGTYPE Small molecular drug D0I1ME DRUGINCH 1S/C22H27NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,15-16,20-22,24H,8,13-14,17H2,1H3/b16-15+/t20-,21+,22-/m1/s1 D0I1ME DRUGINKE IKYXUFYHDWVXST-LRGONLHBSA-N D0I1ME DRUGSMIL CN1C(CCCC1C=CC2=CC=CC=C2)CC(C3=CC=CC=C3)O D0I1ME HIGHSTAT Investigative D0I1NG DRUG__ID D0I1NG D0I1NG DRUGTYPE Small molecular drug D0I1NG DRUGINCH 1S/C21H21N3O2/c22-21(25)18-8-11-20(24-15-18)26-19-9-6-17(7-10-19)14-23-13-12-16-4-2-1-3-5-16/h1-11,15,23H,12-14H2,(H2,22,25) D0I1NG DRUGINKE XPIWSPZHJZLUGI-UHFFFAOYSA-N D0I1NG DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC=C(C=C2)OC3=NC=C(C=C3)C(=O)N D0I1NG HIGHSTAT Investigative D0I1NU DRUG__ID D0I1NU D0I1NU DRUGTYPE Small molecular drug D0I1NU DRUGINCH 1S/C12H26N4O6/c13-2-5-8(18)9(19)6(16)12(21-5)22-11-4(15)1-3(14)7(17)10(11)20/h3-12,17-20H,1-2,13-16H2/t3-,4+,5-,6-,7+,8-,9-,10-,11-,12-/m1/s1 D0I1NU DRUGINKE SYJXFKPQNSDJLI-HKEUSBCWSA-N D0I1NU DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)O)O)N D0I1NU HIGHSTAT Investigative D0I1NX DRUG__ID D0I1NX D0I1NX DRUGTYPE Small molecular drug D0I1NX DRUGINCH 1S/C22H20O3/c1-2-21(15-3-9-18(23)10-4-15)22(16-5-11-19(24)12-6-16)17-7-13-20(25)14-8-17/h3-14,23-25H,2H2,1H3 D0I1NX DRUGINKE CUXRGANZEHBODX-UHFFFAOYSA-N D0I1NX DRUGSMIL CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=C(C=C3)O D0I1NX HIGHSTAT Investigative D0I1OJ DRUG__ID D0I1OJ D0I1OJ DRUGTYPE Small molecular drug D0I1OJ DRUGINCH 1S/C32H54N2O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-32(35)33-30-22-24-31(25-23-30)34-26-28-36-29-27-34/h9-10,22-25H,2-8,11-21,26-29H2,1H3,(H,33,35)/b10-9- D0I1OJ DRUGINKE BNCLSGYMSOUADZ-KTKRTIGZSA-N D0I1OJ DRUGSMIL CCCCCCCCC=CCCCCCCCCCCCC(=O)NC1=CC=C(C=C1)N2CCOCC2 D0I1OJ HIGHSTAT Investigative D0I1QF DRUG__ID D0I1QF D0I1QF DRUGTYPE Small molecular drug D0I1QF DRUGINCH 1S/C17H25NO/c19-17-9-5-4-8-16(17)18-12-10-15(11-13-18)14-6-2-1-3-7-14/h1-3,6-7,15-17,19H,4-5,8-13H2 D0I1QF DRUGINKE YSSBJODGIYRAMI-UHFFFAOYSA-N D0I1QF DRUGSMIL C1CCC(C(C1)N2CCC(CC2)C3=CC=CC=C3)O D0I1QF HIGHSTAT Investigative D0I1RB DRUG__ID D0I1RB D0I1RB DRUGTYPE Small molecular drug D0I1RB DRUGINCH 1S/C7H10N2O2/c8-4-2-1-3-5-6(4)7(10)9-11-5/h4H,1-3,8H2,(H,9,10) D0I1RB DRUGINKE OAJLTKZYCPGQMS-UHFFFAOYSA-N D0I1RB DRUGSMIL C1CC(C2=C(C1)ONC2=O)N D0I1RB HIGHSTAT Investigative D0I1RG DRUG__ID D0I1RG D0I1RG DRUGTYPE Small molecular drug D0I1RG DRUGINCH 1S/C18H20N2O/c1-15-7-9-16(10-8-15)18(21)20-13-11-19(12-14-20)17-5-3-2-4-6-17/h2-10H,11-14H2,1H3 D0I1RG DRUGINKE MPTWQLUMMRYFPO-UHFFFAOYSA-N D0I1RG DRUGSMIL CC1=CC=C(C=C1)C(=O)N2CCN(CC2)C3=CC=CC=C3 D0I1RG HIGHSTAT Investigative D0I1RP DRUG__ID D0I1RP D0I1RP DRUGTYPE Small molecular drug D0I1RP DRUGINCH 1S/C15H10FNO4S/c16-12-5-3-6-13-10(12)8-9-17(13)22(20,21)14-7-2-1-4-11(14)15(18)19/h1-9H,(H,18,19) D0I1RP DRUGINKE YQOPLEXTOUMMNP-UHFFFAOYSA-N D0I1RP DRUGSMIL C1=CC=C(C(=C1)C(=O)O)S(=O)(=O)N2C=CC3=C2C=CC=C3F D0I1RP HIGHSTAT Investigative D0I1SI DRUG__ID D0I1SI D0I1SI DRUGTYPE Small molecular drug D0I1SI DRUGINCH 1S/C16H17NO2/c1-18-15-10-7-13(16(11-15)19-2)6-3-12-4-8-14(17)9-5-12/h3-11H,17H2,1-2H3/b6-3+ D0I1SI DRUGINKE CPBHGSOSBBDXHN-ZZXKWVIFSA-N D0I1SI DRUGSMIL COC1=CC(=C(C=C1)C=CC2=CC=C(C=C2)N)OC D0I1SI HIGHSTAT Investigative D0I1SZ DRUG__ID D0I1SZ D0I1SZ DRUGTYPE Small molecular drug D0I1SZ DRUGINCH 1S/C10H13N5/c1-7(2)3-4-11-9-8-10(13-5-12-8)15-6-14-9/h3,5-6H,4H2,1-2H3,(H2,11,12,13,14,15) D0I1SZ DRUGINKE HYVABZIGRDEKCD-UHFFFAOYSA-N D0I1SZ DRUGSMIL CC(=CCNC1=NC=NC2=C1NC=N2)C D0I1SZ HIGHSTAT Investigative D0I1TB DRUG__ID D0I1TB D0I1TB DRUGTYPE Small molecular drug D0I1TB DRUGINCH 1S/C22H15N3/c1-15-7-8-16-9-10-18(12-21(16)25-15)20-11-19(13-23)22(24-14-20)17-5-3-2-4-6-17/h2-12,14H,1H3 D0I1TB DRUGINKE NENPIXNGFVWRLL-UHFFFAOYSA-N D0I1TB DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=C(N=C3)C4=CC=CC=C4)C#N D0I1TB HIGHSTAT Investigative D0I1UF DRUG__ID D0I1UF D0I1UF DRUGTYPE Small molecular drug D0I1UF DRUGINCH 1S/C34H24O22/c35-8-1-5-12(21(42)18(8)39)13-6(2-9(36)19(40)22(13)43)32(50)54-28(11(38)4-53-31(5)49)30-29-26(47)17-16(34(52)55-29)15(24(45)27(48)25(17)46)14-7(33(51)56-30)3-10(37)20(41)23(14)44/h1-3,11,26,28-30,35-48H,4H2/t11-,26-,28-,29+,30+/m1/s1 D0I1UF DRUGINKE CHBITXAMNKHJCR-JNUHSSLSSA-N D0I1UF DRUGSMIL C1C(C(OC(=O)C2=CC(=C(C(=C2C3=C(C(=C(C=C3C(=O)O1)O)O)O)O)O)O)C4C5C(C6=C(C(=C(C(=C6C(=O)O5)C7=C(C(=C(C=C7C(=O)O4)O)O)O)O)O)O)O)O D0I1UF HIGHSTAT Investigative D0I1WN DRUG__ID D0I1WN D0I1WN DRUGTYPE Small molecular drug D0I1WN DRUGINCH 1S/C21H14N2O4/c24-18-9-10-19(25)22(18)16-5-1-14(2-6-16)13-15-3-7-17(8-4-15)23-20(26)11-12-21(23)27/h1-12H,13H2 D0I1WN DRUGINKE XQUPVDVFXZDTLT-UHFFFAOYSA-N D0I1WN DRUGSMIL C1=CC(=CC=C1CC2=CC=C(C=C2)N3C(=O)C=CC3=O)N4C(=O)C=CC4=O D0I1WN HIGHSTAT Investigative D0I1XT DRUG__ID D0I1XT D0I1XT DRUGTYPE Small molecular drug D0I1XT DRUGINCH 1S/C14H14N2O2S/c15-19(17,18)14-8-6-13(7-9-14)11-16-10-12-4-2-1-3-5-12/h1-10H,11H2,(H2,15,17,18) D0I1XT DRUGINKE IUUNKBLBYPIGMX-UHFFFAOYSA-N D0I1XT DRUGSMIL C1=CC=C(C=C1)C=NCC2=CC=C(C=C2)S(=O)(=O)N D0I1XT HIGHSTAT Investigative D0I1YH DRUG__ID D0I1YH D0I1YH DRUGTYPE Small molecular drug D0I1YH DRUGINCH 1S/C18H15NO/c20-18-3-1-2-17(13-18)16-6-4-14(5-7-16)12-15-8-10-19-11-9-15/h1-11,13,20H,12H2 D0I1YH DRUGINKE GFIBJCSJSOCGMM-UHFFFAOYSA-N D0I1YH DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(C=C2)CC3=CC=NC=C3 D0I1YH HIGHSTAT Investigative D0I1ZN DRUG__ID D0I1ZN D0I1ZN DRUGTYPE Small molecular drug D0I1ZN DRUGINCH 1S/C36H40N6O5/c1-23(43)39-29(19-24-11-4-2-5-12-24)34(45)40-30(21-26-22-38-28-16-9-8-15-27(26)28)35(46)41-31(20-25-13-6-3-7-14-25)36(47)42-18-10-17-32(42)33(37)44/h2-9,11-16,22,29-32,38H,10,17-21H2,1H3,(H2,37,44)(H,39,43)(H,40,45)(H,41,46)/t29-,30+,31-,32+/m0/s1 D0I1ZN DRUGINKE FCKYLHYBJRMIPQ-MLMSKLGMSA-N D0I1ZN DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC4=CC=CC=C4)C(=O)N5CCCC5C(=O)N D0I1ZN HIGHSTAT Investigative D0I2AF DRUG__ID D0I2AF D0I2AF DRUGTYPE Small molecular drug D0I2AF DRUGINCH 1S/C13H10N4O/c14-13(18)10-7-4-8-11-12(10)16-17(15-11)9-5-2-1-3-6-9/h1-8H,(H2,14,18) D0I2AF DRUGINKE LALFCNWFYNSGHS-UHFFFAOYSA-N D0I2AF DRUGSMIL C1=CC=C(C=C1)N2N=C3C=CC=C(C3=N2)C(=O)N D0I2AF HIGHSTAT Investigative D0I2AG DRUG__ID D0I2AG D0I2AG DRUGTYPE Small molecular drug D0I2AG DRUGINCH 1S/C17H21BrN4O8S/c18-9-1-3-10(4-2-9)22(30)17(29)31-8-12(15(26)20-7-14(24)25)21-13(23)6-5-11(19)16(27)28/h1-4,11-12,30H,5-8,19H2,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t11-,12-/m0/s1 D0I2AG DRUGINKE IQPLOQWSCZRUCA-RYUDHWBXSA-N D0I2AG DRUGSMIL C1=CC(=CC=C1N(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O)Br D0I2AG HIGHSTAT Investigative D0I2CE DRUG__ID D0I2CE D0I2CE DRUGTYPE Small molecular drug D0I2CE DRUGINCH 1S/C34H35N5O5/c40-24-11-6-10-22(16-24)18-29-34(44)39-15-7-14-30(39)33(43)37-27(17-21-8-2-1-3-9-21)31(41)36-28(32(42)38-29)19-23-20-35-26-13-5-4-12-25(23)26/h1-6,8-13,16,20,27-30,35,40H,7,14-15,17-19H2,(H,36,41)(H,37,43)(H,38,42)/t27-,28+,29-,30+/m0/s1 D0I2CE DRUGINKE NMGCCCXRAFVYBR-RRGQHJHPSA-N D0I2CE DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC(=CC=C3)O)CC4=CNC5=CC=CC=C54)CC6=CC=CC=C6 D0I2CE HIGHSTAT Investigative D0I2DB DRUG__ID D0I2DB D0I2DB DRUGTYPE Small molecular drug D0I2DB DRUGINCH 1S/C20H14N2O7S2/c23-22(16-10-14-6-2-4-8-18(14)20(12-16)31(27,28)29)21-15-9-13-5-1-3-7-17(13)19(11-15)30(24,25)26/h1-12H,(H,24,25,26)(H,27,28,29) D0I2DB DRUGINKE JOYRCGQZVNLGGX-UHFFFAOYSA-N D0I2DB DRUGSMIL C1=CC=C2C(=C1)C=C(C=C2S(=O)(=O)O)N=[N+](C3=CC4=CC=CC=C4C(=C3)S(=O)(=O)O)[O-] D0I2DB HIGHSTAT Investigative D0I2DF DRUG__ID D0I2DF D0I2DF DRUGTYPE Small molecular drug D0I2DF DRUGINCH 1S/C16H19N3O3S/c1-12-4-10-15(11-5-12)23(21,22)18-16(20)17-13-6-8-14(9-7-13)19(2)3/h4-11H,1-3H3,(H2,17,18,20) D0I2DF DRUGINKE GRIAZRCYPXFJJF-UHFFFAOYSA-N D0I2DF DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2=CC=C(C=C2)N(C)C D0I2DF HIGHSTAT Investigative D0I2EL DRUG__ID D0I2EL D0I2EL DRUGTYPE Small molecular drug D0I2EL DRUGINCH 1S/C22H26FN5O5S/c1-22(2,3)33-21(29)27-9-7-14(8-10-27)32-20-16-12-26-28(19(16)24-13-25-20)18-6-5-15(11-17(18)23)34(4,30)31/h5-6,11-14H,7-10H2,1-4H3 D0I2EL DRUGINKE FEAQKOJMPVAIBR-UHFFFAOYSA-N D0I2EL DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)OC2=NC=NC3=C2C=NN3C4=C(C=C(C=C4)S(=O)(=O)C)F D0I2EL HIGHSTAT Investigative D0I2EQ DRUG__ID D0I2EQ D0I2EQ DRUGTYPE Small molecular drug D0I2EQ DRUGINCH 1S/C19H15N3/c1-13-20-18-16(14-8-4-2-5-9-14)12-17(22-19(18)21-13)15-10-6-3-7-11-15/h2-12H,1H3,(H,20,21,22) D0I2EQ DRUGINKE HKDKOLLILMBGNN-UHFFFAOYSA-N D0I2EQ DRUGSMIL CC1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D0I2EQ HIGHSTAT Investigative D0I2FC DRUG__ID D0I2FC D0I2FC DRUGTYPE Small molecular drug D0I2FC DRUGINCH 1S/C31H34N2O8/c1-6-17-15-33-24-13-20(17)29(28(35)39-5,16-40-27(34)18-11-22(36-2)26(38-4)23(12-18)37-3)30-14-25(33)41-31(24,30)32-21-10-8-7-9-19(21)30/h6-12,20,24-25,32H,13-16H2,1-5H3/b17-6+/t20-,24-,25-,29-,30-,31-/m0/s1 D0I2FC DRUGINKE CLCDMQIWPVOTMQ-RKJOYVLNSA-N D0I2FC DRUGSMIL CC=C1CN2C3CC1C(C45C3(NC6=CC=CC=C64)OC2C5)(COC(=O)C7=CC(=C(C(=C7)OC)OC)OC)C(=O)OC D0I2FC HIGHSTAT Investigative D0I2FZ DRUG__ID D0I2FZ D0I2FZ DRUGTYPE Small molecular drug D0I2FZ DRUGINCH 1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26) D0I2FZ DRUGINKE QTCFYQHZJIIHBS-UHFFFAOYSA-N D0I2FZ DRUGSMIL C1COCCN1CCN2C3=CC=CC=C3N=C2NC(=O)C4=CC(=CC=C4)[N+](=O)[O-] D0I2FZ HIGHSTAT Investigative D0I2GK DRUG__ID D0I2GK D0I2GK DRUGTYPE Small molecular drug D0I2GK DRUGINCH 1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m1/s1 D0I2GK DRUGINKE AUYYCJSJGJYCDS-GFCCVEGCSA-N D0I2GK DRUGSMIL C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O D0I2GK HIGHSTAT Investigative D0I2GP DRUG__ID D0I2GP D0I2GP DRUGTYPE Small molecular drug D0I2GP DRUGINCH 1S/C16H19N3S/c1-12-7-9-13(10-8-12)15-11-20-16(17-15)19-18-14-5-3-2-4-6-14/h7-11H,2-6H2,1H3,(H,17,19) D0I2GP DRUGINKE KHLVZVWWHKJADP-UHFFFAOYSA-N D0I2GP DRUGSMIL CC1=CC=C(C=C1)C2=CSC(=N2)NN=C3CCCCC3 D0I2GP HIGHSTAT Investigative D0I2IS DRUG__ID D0I2IS D0I2IS DRUGTYPE Small molecular drug D0I2IS DRUGINCH 1S/C7H16O3/c1-2-3-4-6(9)7(10)5-8/h6-10H,2-5H2,1H3 D0I2IS DRUGINKE HXYCHJFUBNTKQR-UHFFFAOYSA-N D0I2IS DRUGSMIL CCCCC(C(CO)O)O D0I2IS HIGHSTAT Investigative D0I2JX DRUG__ID D0I2JX D0I2JX DRUGTYPE Small molecular drug D0I2JX DRUGINCH 1S/C21H20N2O/c1-14(2)13-24-20-9-16(12-22)8-19(10-20)18-7-6-17-5-4-15(3)23-21(17)11-18/h4-11,14H,13H2,1-3H3 D0I2JX DRUGINKE HPDNDHJWHRZLDU-UHFFFAOYSA-N D0I2JX DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)OCC(C)C D0I2JX HIGHSTAT Investigative D0I2KC DRUG__ID D0I2KC D0I2KC DRUGTYPE Small molecular drug D0I2KC DRUGINCH 1S/C17H14N2O2/c18-14-9-8-13(16-7-4-10-21-16)11-15(14)19-17(20)12-5-2-1-3-6-12/h1-11H,18H2,(H,19,20) D0I2KC DRUGINKE POPIQEQSLAJUGU-UHFFFAOYSA-N D0I2KC DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=CO3)N D0I2KC HIGHSTAT Investigative D0I2MU DRUG__ID D0I2MU D0I2MU DRUGTYPE Small molecular drug D0I2MU DRUGINCH 1S/C13H19N5O2/c1-8(2)7-18-10-9(11(19)16-13(18)20)14-12(15-10)17-5-3-4-6-17/h8H,3-7H2,1-2H3,(H,14,15)(H,16,19,20) D0I2MU DRUGINKE KHQOTPZSYMSVHB-UHFFFAOYSA-N D0I2MU DRUGSMIL CC(C)CN1C2=C(C(=O)NC1=O)NC(=N2)N3CCCC3 D0I2MU HIGHSTAT Investigative D0I2NX DRUG__ID D0I2NX D0I2NX DRUGTYPE Small molecular drug D0I2NX DRUGINCH 1S/C21H20N2O3S/c1-16-11-13-18(14-12-16)27(25,26)23-20-10-6-5-9-19(20)21(24)22-15-17-7-3-2-4-8-17/h2-14,23H,15H2,1H3,(H,22,24) D0I2NX DRUGINKE ASKBFNKCMLTGPX-UHFFFAOYSA-N D0I2NX DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC3=CC=CC=C3 D0I2NX HIGHSTAT Investigative D0I2RW DRUG__ID D0I2RW D0I2RW DRUGTYPE Small molecular drug D0I2RW DRUGINCH 1S/C10H4Cl2O2/c11-7-8(12)10(14)6-4-2-1-3-5(6)9(7)13/h1-4H D0I2RW DRUGINKE SVPKNMBRVBMTLB-UHFFFAOYSA-N D0I2RW DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=C(C2=O)Cl)Cl D0I2RW HIGHSTAT Investigative D0I2UC DRUG__ID D0I2UC D0I2UC DRUGTYPE Small molecular drug D0I2UC DRUGINCH 1S/C20H22N2/c1-22-12-9-17-13-18(7-8-19(17)22)20(10-11-21-15-20)14-16-5-3-2-4-6-16/h2-9,12-13,21H,10-11,14-15H2,1H3 D0I2UC DRUGINKE OSXVIZKTSFAUPG-UHFFFAOYSA-N D0I2UC DRUGSMIL CN1C=CC2=C1C=CC(=C2)C3(CCNC3)CC4=CC=CC=C4 D0I2UC HIGHSTAT Investigative D0I2UE DRUG__ID D0I2UE D0I2UE DRUGTYPE Small molecular drug D0I2UE DRUGINCH 1S/C17H12N2OS/c20-16-13-5-1-2-7-15(13)21-17-12(4-3-6-14(16)17)10-19-9-8-18-11-19/h1-9,11H,10H2 D0I2UE DRUGINKE QHPHZBRQVQYOFQ-UHFFFAOYSA-N D0I2UE DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC=CC(=C3S2)CN4C=CN=C4 D0I2UE HIGHSTAT Investigative D0I2UH DRUG__ID D0I2UH D0I2UH DRUGTYPE Small molecular drug D0I2UH DRUGINCH 1S/C18H15N3/c1-14-4-2-3-5-17(14)18-11-20-13-21(18)12-16-8-6-15(10-19)7-9-16/h2-9,11,13H,12H2,1H3 D0I2UH DRUGINKE PMVNVHAWQMXUIC-UHFFFAOYSA-N D0I2UH DRUGSMIL CC1=CC=CC=C1C2=CN=CN2CC3=CC=C(C=C3)C#N D0I2UH HIGHSTAT Investigative D0I2VE DRUG__ID D0I2VE D0I2VE DRUGTYPE Small molecular drug D0I2VE DRUGINCH 1S/C41H43Cl2F2N7O3/c42-32-9-6-10-33(43)31(32)25-52-24-28(23-51-17-4-5-18-51)30-13-12-29(21-38(30)52)48-41(55)50-37(20-27-11-14-34(44)35(45)19-27)40(54)49-36(15-16-46)39(53)47-22-26-7-2-1-3-8-26/h1-3,6-14,19,21,24,36-37H,4-5,15-18,20,22-23,25,46H2,(H,47,53)(H,49,54)(H2,48,50,55)/t36-,37-/m0/s1 D0I2VE DRUGINKE SWPAWRHBFNDXEU-BCRBLDSWSA-N D0I2VE DRUGSMIL C1CCN(C1)CC2=CN(C3=C2C=CC(=C3)NC(=O)NC(CC4=CC(=C(C=C4)F)F)C(=O)NC(CCN)C(=O)NCC5=CC=CC=C5)CC6=C(C=CC=C6Cl)Cl D0I2VE HIGHSTAT Investigative D0I2WQ DRUG__ID D0I2WQ D0I2WQ DRUGTYPE Small molecular drug D0I2WQ DRUGINCH 1S/C26H33NO2/c1-3-5-6-7-14-24(28)29-23-13-9-11-20-18-22-25-19(15-17-27(22)16-4-2)10-8-12-21(25)26(20)23/h8-13,22H,3-7,14-18H2,1-2H3/t22-/m1/s1 D0I2WQ DRUGINKE KWMUKPVHQQVHLC-JOCHJYFZSA-N D0I2WQ DRUGSMIL CCCCCCC(=O)OC1=CC=CC2=C1C3=CC=CC4=C3C(C2)N(CC4)CCC D0I2WQ HIGHSTAT Investigative D0I2XG DRUG__ID D0I2XG D0I2XG DRUGTYPE Small molecular drug D0I2XG DRUGINCH 1S/C41H63N5O10/c1-4-5-6-7-8-9-10-11-12-13-14-25-36(29(2)37(49)42-32-22-17-20-27-46(54)40(32)51)56-41(52)33(23-18-19-26-45(53)30(3)47)43-38(50)34-28-55-39(44-34)31-21-15-16-24-35(31)48/h15-16,21,24,28-29,32-33,36,48,53-54H,4-14,17-20,22-23,25-27H2,1-3H3,(H,42,49)(H,43,50) D0I2XG DRUGINKE CILDOHPTQUQJJM-UHFFFAOYSA-N D0I2XG DRUGSMIL CCCCCCCCCCCCCC(C(C)C(=O)NC1CCCCN(C1=O)O)OC(=O)C(CCCCN(C(=O)C)O)NC(=O)C2=COC(=N2)C3=CC=CC=C3O D0I2XG HIGHSTAT Investigative D0I3EE DRUG__ID D0I3EE D0I3EE DRUGTYPE Small molecular drug D0I3EE DRUGINCH 1S/C27H22N2O3/c1-31-19-11-9-17(10-12-19)25-22(15-28)27(29)32-24-14-18(13-23(30)26(24)25)21-8-4-6-16-5-2-3-7-20(16)21/h2-12,18,25H,13-14,29H2,1H3 D0I3EE DRUGINKE YBMGNDPBARCLFT-UHFFFAOYSA-N D0I3EE DRUGSMIL COC1=CC=C(C=C1)C2C(=C(OC3=C2C(=O)CC(C3)C4=CC=CC5=CC=CC=C54)N)C#N D0I3EE HIGHSTAT Investigative D0I3EQ DRUG__ID D0I3EQ D0I3EQ DRUGTYPE Small molecular drug D0I3EQ DRUGINCH 1S/C14H15ClN2OS/c1-9(2)12(10-3-5-11(15)6-4-10)13(18)17-14-16-7-8-19-14/h3-9,12H,1-2H3,(H,16,17,18) D0I3EQ DRUGINKE AZYDQCGCBQYFSE-UHFFFAOYSA-N D0I3EQ DRUGSMIL CC(C)C(C1=CC=C(C=C1)Cl)C(=O)NC2=NC=CS2 D0I3EQ HIGHSTAT Investigative D0I3EY DRUG__ID D0I3EY D0I3EY DRUGTYPE Small molecular drug D0I3EY DRUGINCH 1S/C13H11N3/c14-13-11-8-10(6-7-12(11)15-16-13)9-4-2-1-3-5-9/h1-8H,(H3,14,15,16) D0I3EY DRUGINKE ZCUSNQPYUNLATP-UHFFFAOYSA-N D0I3EY DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(C=C2)NN=C3N D0I3EY HIGHSTAT Investigative D0I3HE DRUG__ID D0I3HE D0I3HE DRUGTYPE Small molecular drug D0I3HE DRUGINCH 1S/C16H18BrN5O/c1-2-3-12-13-15(21-16-18-8-9-22(13,16)23)20-14(19-12)10-4-6-11(17)7-5-10/h4-7,14,19H,2-3,8-9H2,1H3,(H,18,20,21) D0I3HE DRUGINKE ZNDCTDCMCKTYLC-UHFFFAOYSA-N D0I3HE DRUGSMIL CCCC1=C2C(=NC(N1)C3=CC=C(C=C3)Br)NC4=NCC[N+]24[O-] D0I3HE HIGHSTAT Investigative D0I3IO DRUG__ID D0I3IO D0I3IO DRUGTYPE Small molecular drug D0I3IO DRUGINCH 1S/C21H18FNO3/c22-17-6-3-15(4-7-17)1-2-16-5-8-20-18(13-16)19(24)14-21(26-20)23-9-11-25-12-10-23/h1-8,13-14H,9-12H2/b2-1+ D0I3IO DRUGINKE MGIIGLFUKQWDHF-OWOJBTEDSA-N D0I3IO DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C=CC4=CC=C(C=C4)F D0I3IO HIGHSTAT Investigative D0I3IZ DRUG__ID D0I3IZ D0I3IZ DRUGTYPE Small molecular drug D0I3IZ DRUGINCH 1S/C14H13BrClNO/c15-12-3-6-14(11(7-12)8-17)18-9-10-1-4-13(16)5-2-10/h1-7H,8-9,17H2 D0I3IZ DRUGINKE YKPADUDRSOXMQB-UHFFFAOYSA-N D0I3IZ DRUGSMIL C1=CC(=CC=C1COC2=C(C=C(C=C2)Br)CN)Cl D0I3IZ HIGHSTAT Investigative D0I3KR DRUG__ID D0I3KR D0I3KR DRUGTYPE Small molecular drug D0I3KR DRUGINCH 1S/C23H21ClN2O3/c24-19-8-10-20(11-9-19)25-22(27)18-6-2-12-26(15-18)23(28)17-5-1-4-16(14-17)21-7-3-13-29-21/h1,3-5,7-11,13-14,18H,2,6,12,15H2,(H,25,27) D0I3KR DRUGINKE HERLZBNILRVHQN-UHFFFAOYSA-N D0I3KR DRUGSMIL C1CC(CN(C1)C(=O)C2=CC=CC(=C2)C3=CC=CO3)C(=O)NC4=CC=C(C=C4)Cl D0I3KR HIGHSTAT Investigative D0I3LL DRUG__ID D0I3LL D0I3LL DRUGTYPE Small molecular drug D0I3LL DRUGINCH 1S/C30H26O6/c1-16-11-23(21-9-8-20(32)14-26(21)34-2)29-24(12-16)22-13-18-5-10-28(33)35-25(18)15-27(22)36-30(29)17-3-6-19(31)7-4-17/h3-10,12-15,23-24,29-32H,11H2,1-2H3/t23-,24-,29-,30+/m0/s1 D0I3LL DRUGINKE YECGSLHMDGBPTB-PPSLNNBKSA-N D0I3LL DRUGSMIL CC1=CC2C(C(C1)C3=C(C=C(C=C3)O)OC)C(OC4=C2C=C5C=CC(=O)OC5=C4)C6=CC=C(C=C6)O D0I3LL HIGHSTAT Investigative D0I3LQ DRUG__ID D0I3LQ D0I3LQ DRUGTYPE Small molecular drug D0I3LQ DRUGINCH 1S/C24H32O8/c1-24-9-8-14-13-5-3-12(25)10-11(13)2-4-15(14)16(24)6-7-17(24)31-23-20(28)18(26)19(27)21(32-23)22(29)30/h3,5,10,14-21,23,25-28H,2,4,6-9H2,1H3,(H,29,30)/t14-,15-,16+,17+,18+,19+,20-,21+,23-,24+/m1/s1 D0I3LQ DRUGINKE MTKNDAQYHASLID-QXYWQCSFSA-N D0I3LQ DRUGSMIL CC12CCC3C(C1CCC2OC4C(C(C(C(O4)C(=O)O)O)O)O)CCC5=C3C=CC(=C5)O D0I3LQ HIGHSTAT Investigative D0I3PD DRUG__ID D0I3PD D0I3PD DRUGTYPE Small molecular drug D0I3PD DRUGINCH 1S/C27H28N4O.ClH/c1-4-31(5-2)17-18-16-19(14-15-24(18)32)28-25-20-10-6-8-12-22(20)29-26-21-11-7-9-13-23(21)30(3)27(25)26;/h6-16,32H,4-5,17H2,1-3H3,(H,28,29);1H D0I3PD DRUGINKE IAPNUOYAHQHYQR-UHFFFAOYSA-N D0I3PD DRUGSMIL CCN(CC)CC1=C(C=CC(=C1)NC2=C3C(=NC4=CC=CC=C42)C5=CC=CC=C5N3C)O.Cl D0I3PD HIGHSTAT Investigative D0I3TN DRUG__ID D0I3TN D0I3TN DRUGTYPE Small molecular drug D0I3TN DRUGINCH 1S/C8H13N3/c9-7-3-1-2-6(7)8-4-10-5-11-8/h4-7H,1-3,9H2,(H,10,11)/t6-,7-/m0/s1 D0I3TN DRUGINKE MUHUWRJWVGDFJX-BQBZGAKWSA-N D0I3TN DRUGSMIL C1CC(C(C1)N)C2=CN=CN2 D0I3TN HIGHSTAT Investigative D0I3TX DRUG__ID D0I3TX D0I3TX DRUGTYPE Small molecular drug D0I3TX DRUGINCH 1S/C28H29Cl2NO3/c1-18(14-28(33)34)13-27(32)31-19(2)23(16-21-9-12-25(29)26(30)17-21)11-8-20-7-10-22-5-3-4-6-24(22)15-20/h3-12,15,17-19,23H,13-14,16H2,1-2H3,(H,31,32)(H,33,34)/b11-8+/t18-,19+,23-/m1/s1 D0I3TX DRUGINKE LVRZMZFXRFKCCY-KSYFVSBMSA-N D0I3TX DRUGSMIL CC(CC(=O)NC(C)C(CC1=CC(=C(C=C1)Cl)Cl)C=CC2=CC3=CC=CC=C3C=C2)CC(=O)O D0I3TX HIGHSTAT Investigative D0I3UA DRUG__ID D0I3UA D0I3UA DRUGTYPE Small molecular drug D0I3UA DRUGINCH 1S/C16H9NO/c18-16-13-6-2-1-5-11(13)12-7-3-4-10-8-9-17-15(16)14(10)12/h1-9H D0I3UA DRUGINKE GHWKWAMIXPOYPG-UHFFFAOYSA-N D0I3UA DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC4=C3C(=NC=C4)C2=O D0I3UA HIGHSTAT Investigative D0I3US DRUG__ID D0I3US D0I3US DRUGTYPE Small molecular drug D0I3US DRUGINCH 1S/C38H48N4O2/c1-40-34-28(15-13-16-32(34)44-2)29-17-20-39-33(35(29)40)30-25-38(43)19-10-6-3-4-7-11-21-41-23-18-31(30)37(26-41)24-27-14-9-5-8-12-22-42(27)36(37)38/h3,6,9,13-17,20,25,27,31,36,43H,4-5,7-8,10-12,18-19,21-24,26H2,1-2H3/b6-3-,14-9-/t27-,31?,36+,37-,38-/m0/s1 D0I3US DRUGINKE LANFUCOONSVQMQ-MCMDJTBWSA-N D0I3US DRUGSMIL CN1C2=C(C=CC=C2OC)C3=C1C(=NC=C3)C4=CC5(CCC=CCCCCN6CCC4C7(C6)C5N8CCCCC=CC8C7)O D0I3US HIGHSTAT Investigative D0I3XA DRUG__ID D0I3XA D0I3XA DRUGTYPE Small molecular drug D0I3XA DRUGINCH 1S/C16H18N2O2/c19-16(12-3-4-12)13-5-7-15(8-6-13)20-9-1-2-14-10-17-11-18-14/h5-8,10-12H,1-4,9H2,(H,17,18) D0I3XA DRUGINKE ACQBHJXEAYTHCY-UHFFFAOYSA-N D0I3XA DRUGSMIL C1CC1C(=O)C2=CC=C(C=C2)OCCCC3=CN=CN3 D0I3XA HIGHSTAT Investigative D0I3XN DRUG__ID D0I3XN D0I3XN DRUGTYPE Small molecular drug D0I3XN DRUGINCH 1S/C6H6BNO4/c9-7(10)5-1-3-6(4-2-5)8(11)12/h1-4,9-10H D0I3XN DRUGINKE NSFJAFZHYOAMHL-UHFFFAOYSA-N D0I3XN DRUGSMIL B(C1=CC=C(C=C1)[N+](=O)[O-])(O)O D0I3XN HIGHSTAT Investigative D0I3XV DRUG__ID D0I3XV D0I3XV DRUGTYPE Small molecular drug D0I3XV DRUGINCH 1S/C23H29NO/c1-18-8-4-5-9-20(18)10-7-14-24-15-13-23(3,19(2)17-24)21-11-6-12-22(25)16-21/h4-12,16,19,25H,13-15,17H2,1-3H3/b10-7+/t19-,23+/m0/s1 D0I3XV DRUGINKE FJFLDQXXCJUUBR-XECBNOGISA-N D0I3XV DRUGSMIL CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC=CC3=CC=CC=C3C D0I3XV HIGHSTAT Investigative D0I3XZ DRUG__ID D0I3XZ D0I3XZ DRUGTYPE Small molecular drug D0I3XZ DRUGINCH 1S/C17H12N2O3/c20-11-1-3-13-9(5-11)7-15(18-13)17(22)16-8-10-6-12(21)2-4-14(10)19-16/h1-8,18-21H D0I3XZ DRUGINKE NIMIWWQLOGNYHD-UHFFFAOYSA-N D0I3XZ DRUGSMIL C1=CC2=C(C=C1O)C=C(N2)C(=O)C3=CC4=C(N3)C=CC(=C4)O D0I3XZ HIGHSTAT Investigative D0I3ZP DRUG__ID D0I3ZP D0I3ZP DRUGTYPE Small molecular drug D0I3ZP DRUGINCH 1S/C5H10N2O/c6-5-4-8-3-1-2-7-5/h1-4H2,(H2,6,7) D0I3ZP DRUGINKE WKPUJGILMQAMEH-UHFFFAOYSA-N D0I3ZP DRUGSMIL C1CN=C(COC1)N D0I3ZP HIGHSTAT Investigative D0I4AF DRUG__ID D0I4AF D0I4AF DRUGTYPE Small molecular drug D0I4AF DRUGINCH 1S/C27H27Cl3N2O3/c1-26(2,14-33)25(34)31-22-13-27(3,4)35-24-20(22)12-19(15-5-7-16(28)8-6-15)23(32-24)18-10-9-17(29)11-21(18)30/h5-12,22,33H,13-14H2,1-4H3,(H,31,34) D0I4AF DRUGINKE BRSUJFVKAISEFW-UHFFFAOYSA-N D0I4AF DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)NC(=O)C(C)(C)CO)C D0I4AF HIGHSTAT Investigative D0I4BC DRUG__ID D0I4BC D0I4BC DRUGTYPE Small molecular drug D0I4BC DRUGINCH 1S/C16H19N/c1-2-6-16-13-14(7-8-15(16)5-1)9-12-17-10-3-4-11-17/h1-2,5-8,13H,3-4,9-12H2 D0I4BC DRUGINKE BUFGWZZSSJWXIJ-UHFFFAOYSA-N D0I4BC DRUGSMIL C1CCN(C1)CCC2=CC3=CC=CC=C3C=C2 D0I4BC HIGHSTAT Investigative D0I4BZ DRUG__ID D0I4BZ D0I4BZ DRUGTYPE Small molecular drug D0I4BZ DRUGINCH 1S/C15H20ClN3O2/c1-21-14-7-12(17)11(16)6-10(14)15(20)18-13-8-19-4-2-9(13)3-5-19/h6-7,9,13H,2-5,8,17H2,1H3,(H,18,20)/t13-/m1/s1 D0I4BZ DRUGINKE FEROPKNOYKURCJ-CYBMUJFWSA-N D0I4BZ DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CN3CCC2CC3)Cl)N D0I4BZ HIGHSTAT Investigative D0I4DG DRUG__ID D0I4DG D0I4DG DRUGTYPE Small molecular drug D0I4DG DRUGINCH 1S/C30H50O7/c1-15(2)28(35)20(7)23(32)12-21(31)10-9-16(3)26-18(5)14-30(8)25(34)13-24(33)19(6)27(30)22(26)11-17(4)29(36)37/h9,11,14-15,19-28,31-35H,10,12-13H2,1-8H3,(H,36,37)/b16-9+,17-11+/t19-,20-,21-,22-,23+,24+,25+,26+,27+,28-,30+/m0/s1 D0I4DG DRUGINKE ZNAYXHSDZPSFLO-UWXUHECCSA-N D0I4DG DRUGSMIL CC1C(CC(C2(C1C(C(C(=C2)C)C(=CCC(CC(C(C)C(C(C)C)O)O)O)C)C=C(C)C(=O)O)C)O)O D0I4DG HIGHSTAT Investigative D0I4DJ DRUG__ID D0I4DJ D0I4DJ DRUGTYPE Small molecular drug D0I4DJ DRUGINCH 1S/C21H28N2O2/c1-18(24)22-14-15-23(2)20-12-8-13-21(17-20)25-16-7-6-11-19-9-4-3-5-10-19/h3-5,8-10,12-13,17H,6-7,11,14-16H2,1-2H3,(H,22,24) D0I4DJ DRUGINKE VJIVACBGAAEDPS-UHFFFAOYSA-N D0I4DJ DRUGSMIL CC(=O)NCCN(C)C1=CC(=CC=C1)OCCCCC2=CC=CC=C2 D0I4DJ HIGHSTAT Investigative D0I4FF DRUG__ID D0I4FF D0I4FF DRUGTYPE Small molecular drug D0I4FF DRUGINCH 1S/C20H32O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,18-19,21-23H,1-2,6,10-12,15-17H2,(H,24,25)/b5-4+,7-3-,13-8+,14-9-/t18-,19-/m1/s1 D0I4FF DRUGINKE PTJFJXLGRSTECQ-PSPARDEHSA-N D0I4FF DRUGSMIL C(CCC=CCC(C=CC=CC=CC(CCCC(=O)O)O)O)CCO D0I4FF HIGHSTAT Investigative D0I4FP DRUG__ID D0I4FP D0I4FP DRUGTYPE Small molecular drug D0I4FP DRUGINCH 1S/C20H19N7/c1-25-12-16(10-23-25)7-8-27-14-22-19(18-11-24-26(2)13-18)20(27)17-5-3-15(9-21)4-6-17/h3-6,10-14H,7-8H2,1-2H3 D0I4FP DRUGINKE RRZVGDGTWNQAPW-UHFFFAOYSA-N D0I4FP DRUGSMIL CN1C=C(C=N1)CCN2C=NC(=C2C3=CC=C(C=C3)C#N)C4=CN(N=C4)C D0I4FP HIGHSTAT Investigative D0I4HT DRUG__ID D0I4HT D0I4HT DRUGTYPE Small molecular drug D0I4HT DRUGINCH 1S/C18H18N2O2/c21-18-16(17(22-20-18)13-8-10-19-11-9-13)15-7-3-5-12-4-1-2-6-14(12)15/h1-7,13,19H,8-11H2,(H,20,21) D0I4HT DRUGINKE WDMOSRJVOUIQMD-UHFFFAOYSA-N D0I4HT DRUGSMIL C1CNCCC1C2=C(C(=O)NO2)C3=CC=CC4=CC=CC=C43 D0I4HT HIGHSTAT Investigative D0I4KB DRUG__ID D0I4KB D0I4KB DRUGTYPE Small molecular drug D0I4KB DRUGINCH 1S/C16H23N3O2/c1-3-15(20)19-10-8-14(9-11-19)18-16(21)17-13-6-4-12(2)5-7-13/h4-7,14H,3,8-11H2,1-2H3,(H2,17,18,21) D0I4KB DRUGINKE JYILGCQJFUIUHF-UHFFFAOYSA-N D0I4KB DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2=CC=C(C=C2)C D0I4KB HIGHSTAT Investigative D0I4LL DRUG__ID D0I4LL D0I4LL DRUGTYPE Small molecular drug D0I4LL DRUGINCH 1S/C14H9N3O3S/c15-8-10-1-6-14(12(7-10)9-16)11-2-4-13(5-3-11)20-21(17,18)19/h1-7H,(H2,17,18,19) D0I4LL DRUGINKE VQTYXLRQENRZOV-UHFFFAOYSA-N D0I4LL DRUGSMIL C1=CC(=CC=C1C2=C(C=C(C=C2)C#N)C#N)OS(=O)(=O)N D0I4LL HIGHSTAT Investigative D0I4LX DRUG__ID D0I4LX D0I4LX DRUGTYPE Small molecular drug D0I4LX DRUGINCH 1S/C19H22N2OS/c1-4-20(5-2)14(3)19(22)21-15-10-6-8-12-17(15)23-18-13-9-7-11-16(18)21/h6-14H,4-5H2,1-3H3 D0I4LX DRUGINKE QCEWCMMSOWEHFC-UHFFFAOYSA-N D0I4LX DRUGSMIL CCN(CC)C(C)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0I4LX HIGHSTAT Investigative D0I4ME DRUG__ID D0I4ME D0I4ME DRUGTYPE Small molecular drug D0I4ME DRUGINCH 1S/C11H15NO3/c1-7(12)3-8-4-9(13-2)11-10(5-8)14-6-15-11/h4-5,7H,3,6,12H2,1-2H3 D0I4ME DRUGINKE YQYUWUKDEVZFDB-UHFFFAOYSA-N D0I4ME DRUGSMIL CC(CC1=CC2=C(C(=C1)OC)OCO2)N D0I4ME HIGHSTAT Investigative D0I4NN DRUG__ID D0I4NN D0I4NN DRUGTYPE Small molecular drug D0I4NN DRUGINCH 1S/C5H4Br2N2O/c6-2-1-3(5(8)10)9-4(2)7/h1,9H,(H2,8,10) D0I4NN DRUGINKE VTWHNVAKXBNGFV-UHFFFAOYSA-N D0I4NN DRUGSMIL C1=C(NC(=C1Br)Br)C(=O)N D0I4NN HIGHSTAT Investigative D0I4OV DRUG__ID D0I4OV D0I4OV DRUGTYPE Small molecular drug D0I4OV DRUGINCH 1S/C11H11NS/c12-8-9-3-5-10(6-4-9)11-2-1-7-13-11/h1-7H,8,12H2 D0I4OV DRUGINKE YKNLMMDEWQZCLJ-UHFFFAOYSA-N D0I4OV DRUGSMIL C1=CSC(=C1)C2=CC=C(C=C2)CN D0I4OV HIGHSTAT Investigative D0I4PC DRUG__ID D0I4PC D0I4PC DRUGTYPE Small molecular drug D0I4PC DRUGINCH 1S/C55H80N20O18S4/c1-25-44(83)72-36-21-95-97-22-37(73-45(84)29(56)9-10-42(80)81)52(91)74-38(51(90)69-33(16-40(57)78)54(93)75-12-4-8-39(75)53(92)65-25)23-96-94-20-35(43(58)82)71-50(89)34(19-76)70-48(87)31(14-26-5-2-6-28(77)13-26)67-49(88)32(15-27-17-61-24-64-27)68-47(86)30(7-3-11-62-55(59)60)66-41(79)18-63-46(36)85/h2,5-6,13,17,24-25,29-39,76-77H,3-4,7-12,14-16,18-23,56H2,1H3,(H2,57,78)(H2,58,82)(H,61,64)(H,63,85)(H,65,92)(H,66,79)(H,67,88)(H,68,86)(H,69,90)(H,70,87)(H,71,89)(H,72,83)(H,73,84)(H,74,91)(H,80,81)(H4,59,60,62)/t25-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-/m0/s1 D0I4PC DRUGINKE CSUQNJQRLCOOSR-NAKBKFBQSA-N D0I4PC DRUGSMIL CC1C(=O)NC2CSSCC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC2=O)CCCN=C(N)N)CC3=CN=CN3)CC4=CC(=CC=C4)O)CO)C(=O)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)NC(=O)C(CCC(=O)O)N D0I4PC HIGHSTAT Investigative D0I4RK DRUG__ID D0I4RK D0I4RK DRUGTYPE Small molecular drug D0I4RK DRUGINCH 1S/C15H15NO2/c1-15(14(17)16-18,12-8-4-2-5-9-12)13-10-6-3-7-11-13/h2-11,18H,1H3,(H,16,17) D0I4RK DRUGINKE LDAQHFMKFUATRE-UHFFFAOYSA-N D0I4RK DRUGSMIL CC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)NO D0I4RK HIGHSTAT Investigative D0I4TO DRUG__ID D0I4TO D0I4TO DRUGTYPE Small molecular drug D0I4TO DRUGINCH 1S/C17H17NOS/c18-11-10-16(17-9-4-12-20-17)19-15-8-3-6-13-5-1-2-7-14(13)15/h1-9,12,16H,10-11,18H2/t16-/m0/s1 D0I4TO DRUGINKE ZMXLKLOJDLMZFC-INIZCTEOSA-N D0I4TO DRUGSMIL C1=CC=C2C(=C1)C=CC=C2OC(CCN)C3=CC=CS3 D0I4TO HIGHSTAT Investigative D0I4UU DRUG__ID D0I4UU D0I4UU DRUGTYPE Small molecular drug D0I4UU DRUGINCH 1S/C13H16N2/c1-2-6-12(7-3-1)8-4-5-9-13-10-14-11-15-13/h1-3,6-7,10-11H,4-5,8-9H2,(H,14,15) D0I4UU DRUGINKE BQTXNCXSCSNHGA-UHFFFAOYSA-N D0I4UU DRUGSMIL C1=CC=C(C=C1)CCCCC2=CN=CN2 D0I4UU HIGHSTAT Investigative D0I4VT DRUG__ID D0I4VT D0I4VT DRUGTYPE Small molecular drug D0I4VT DRUGINCH 1S/C14H18F3N/c1-2-7-18-8-6-12(10-18)11-4-3-5-13(9-11)14(15,16)17/h3-5,9,12H,2,6-8,10H2,1H3 D0I4VT DRUGINKE YATKXAPVZGTXAR-UHFFFAOYSA-N D0I4VT DRUGSMIL CCCN1CCC(C1)C2=CC(=CC=C2)C(F)(F)F D0I4VT HIGHSTAT Investigative D0I4YK DRUG__ID D0I4YK D0I4YK DRUGTYPE Small molecular drug D0I4YK DRUGINCH 1S/C23H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-23(26)24-22(2)21-25/h7-8,10-11,13-14,16-17,22,25H,3-6,9,12,15,18-21H2,1-2H3,(H,24,26)/b8-7-,11-10-,14-13-,17-16-/t22-/m1/s1 D0I4YK DRUGINKE SQKRUBZPTNJQEM-FQPARAGTSA-N D0I4YK DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC(C)CO D0I4YK HIGHSTAT Investigative D0I5BY DRUG__ID D0I5BY D0I5BY DRUGTYPE Small molecular drug D0I5BY DRUGINCH 1S/C31H37F3N8O7/c32-31(33,34)30(16-19-10-5-2-6-11-19)28(49)41-20(12-7-13-37-29(35)36)25(46)38-17-23(43)39-22(15-24(44)45)26(47)40-21(27(48)42-30)14-18-8-3-1-4-9-18/h1-6,8-11,20-22H,7,12-17H2,(H,38,46)(H,39,43)(H,40,47)(H,41,49)(H,42,48)(H,44,45)(H4,35,36,37)/t20-,21+,22-,30-/m0/s1 D0I5BY DRUGINKE QAYABLFYSHKUBR-QKFZZCAYSA-N D0I5BY DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)(CC2=CC=CC=C2)C(F)(F)F)CC3=CC=CC=C3)CC(=O)O D0I5BY HIGHSTAT Investigative D0I5CS DRUG__ID D0I5CS D0I5CS DRUGTYPE Small molecular drug D0I5CS DRUGINCH 1S/C32H36N6O5/c1-31(18-22-19-33-27-9-5-4-8-26(22)27,37-30(40)36-23-10-12-24(13-11-23)38(41)42)29(39)35-21-32(16-6-3-7-17-32)28-15-14-25(43-2)20-34-28/h4-5,8-15,19-20,33H,3,6-7,16-18,21H2,1-2H3,(H,35,39)(H2,36,37,40)/t31-/m0/s1 D0I5CS DRUGINKE NNFUWNLENRUDHR-HKBQPEDESA-N D0I5CS DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NCC3(CCCCC3)C4=NC=C(C=C4)OC)NC(=O)NC5=CC=C(C=C5)[N+](=O)[O-] D0I5CS HIGHSTAT Investigative D0I5CT DRUG__ID D0I5CT D0I5CT DRUGTYPE Small molecular drug D0I5CT DRUGINCH 1S/C6H11N3S/c1-4-5(2-3-7)10-6(8)9-4/h2-3,7H2,1H3,(H2,8,9) D0I5CT DRUGINKE LHVRFUVVRXGZPV-UHFFFAOYSA-N D0I5CT DRUGSMIL CC1=C(SC(=N1)N)CCN D0I5CT HIGHSTAT Investigative D0I5CZ DRUG__ID D0I5CZ D0I5CZ DRUGTYPE Small molecular drug D0I5CZ DRUGINCH 1S/C15H11FO2/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-8,14H,9H2/t14-/m0/s1 D0I5CZ DRUGINKE SZNYRENOXQIQMR-AWEZNQCLSA-N D0I5CZ DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)F)C3=CC=CC=C3 D0I5CZ HIGHSTAT Investigative D0I5HZ DRUG__ID D0I5HZ D0I5HZ DRUGTYPE Small molecular drug D0I5HZ DRUGINCH 1S/C19H14N2O/c22-16-12-10-15(11-13-16)21-18-9-5-4-8-17(18)20-19(21)14-6-2-1-3-7-14/h1-13,22H D0I5HZ DRUGINKE MXMPRHRVFXJSFN-UHFFFAOYSA-N D0I5HZ DRUGSMIL C1=CC=C(C=C1)C2=NC3=CC=CC=C3N2C4=CC=C(C=C4)O D0I5HZ HIGHSTAT Investigative D0I5JP DRUG__ID D0I5JP D0I5JP DRUGTYPE Small molecular drug D0I5JP DRUGINCH 1S/C12H11Cl2NO5/c13-6-2-1-3-7(14)10(6)11(18)15-8(12(19)20)4-5-9(16)17/h1-3,8H,4-5H2,(H,15,18)(H,16,17)(H,19,20) D0I5JP DRUGINKE DGMFARLQEAXXKN-UHFFFAOYSA-N D0I5JP DRUGSMIL C1=CC(=C(C(=C1)Cl)C(=O)NC(CCC(=O)O)C(=O)O)Cl D0I5JP HIGHSTAT Investigative D0I5LV DRUG__ID D0I5LV D0I5LV DRUGTYPE Small molecular drug D0I5LV DRUGINCH 1S/C20H15NO3S/c1-23-14-7-6-8-15(13-14)24-20(22)21-16-9-2-4-11-18(16)25-19-12-5-3-10-17(19)21/h2-13H,1H3 D0I5LV DRUGINKE UVKJOYFYOPXYID-UHFFFAOYSA-N D0I5LV DRUGSMIL COC1=CC(=CC=C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0I5LV HIGHSTAT Investigative D0I5NW DRUG__ID D0I5NW D0I5NW DRUGTYPE Small molecular drug D0I5NW DRUGINCH 1S/C15H13N/c1-2-5-13-10-14(8-7-12(13)4-1)15-6-3-9-16-11-15/h1-6,9-11H,7-8H2 D0I5NW DRUGINKE AXLDMZNUHQOZFK-UHFFFAOYSA-N D0I5NW DRUGSMIL C1CC(=CC2=CC=CC=C21)C3=CN=CC=C3 D0I5NW HIGHSTAT Investigative D0I5PY DRUG__ID D0I5PY D0I5PY DRUGTYPE Small molecular drug D0I5PY DRUGINCH 1S/C15H13N3/c1-2-6-14(7-3-1)15-8-4-5-13(9-15)10-18-12-16-11-17-18/h1-9,11-12H,10H2 D0I5PY DRUGINKE OZOOKYPKFWRQMO-UHFFFAOYSA-N D0I5PY DRUGSMIL C1=CC=C(C=C1)C2=CC=CC(=C2)CN3C=NC=N3 D0I5PY HIGHSTAT Investigative D0I5PZ DRUG__ID D0I5PZ D0I5PZ DRUGTYPE Small molecular drug D0I5PZ DRUGINCH 1S/C14H24N3O7P/c1-9-13(18)11(10(6-17-9)8-24-25(21,22)23)7-16-5-3-2-4-12(15)14(19)20/h6,12,16,18H,2-5,7-8,15H2,1H3,(H,19,20)(H2,21,22,23)/t12-/m1/s1 D0I5PZ DRUGINKE FIXMYVJXXYQYGI-GFCCVEGCSA-N D0I5PZ DRUGSMIL CC1=NC=C(C(=C1O)CNCCCCC(C(=O)O)N)COP(=O)(O)O D0I5PZ HIGHSTAT Investigative D0I5TQ DRUG__ID D0I5TQ D0I5TQ DRUGTYPE Small molecular drug D0I5TQ DRUGINCH 1S/C14H12N2O2S/c1-10-5-7-11(8-6-10)19(17,18)14-4-2-3-13(16)12(14)9-15/h2-8H,16H2,1H3 D0I5TQ DRUGINKE RDGYQSLTDBICQU-UHFFFAOYSA-N D0I5TQ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=CC=CC(=C2C#N)N D0I5TQ HIGHSTAT Investigative D0I5TV DRUG__ID D0I5TV D0I5TV DRUGTYPE Small molecular drug D0I5TV DRUGINCH 1S/C10H16N5O11P3S/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(24-7)2-23-29(22,30)26-28(20,21)25-27(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,30)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+,29?/m0/s1 D0I5TV DRUGINKE CCPIKNHZOWQALM-DLQJRSQOSA-N D0I5TV DRUGSMIL C1C(C(OC1N2C=NC3=C(N=CN=C32)N)COP(=S)(O)OP(=O)(O)OP(=O)(O)O)O D0I5TV HIGHSTAT Investigative D0I5VJ DRUG__ID D0I5VJ D0I5VJ DRUGTYPE Small molecular drug D0I5VJ DRUGINCH 1S/C15H10O4S/c16-9-3-1-8(2-4-9)11-7-19-13-6-10(17)5-12(18)14(13)15(11)20/h1-7,16-18H D0I5VJ DRUGINKE RPDMOSIZAIBSRV-UHFFFAOYSA-N D0I5VJ DRUGSMIL C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=S)O)O)O D0I5VJ HIGHSTAT Investigative D0I5YK DRUG__ID D0I5YK D0I5YK DRUGTYPE Small molecular drug D0I5YK DRUGINCH 1S/C23H23N2.HI/c1-3-24-20(15-13-18-9-5-7-11-22(18)24)17-21-16-14-19-10-6-8-12-23(19)25(21)4-2;/h5-17H,3-4H2,1-2H3;1H/q+1;/p-1 D0I5YK DRUGINKE GMYRVMSXMHEDTL-UHFFFAOYSA-M D0I5YK DRUGSMIL CCN1C(=CC2=[N+](C3=CC=CC=C3C=C2)CC)C=CC4=CC=CC=C41.[I-] D0I5YK HIGHSTAT Investigative D0I5YQ DRUG__ID D0I5YQ D0I5YQ DRUGTYPE Small molecular drug D0I5YQ DRUGINCH 1S/C7H6F2N2O4S/c8-7(9,16(10,14)15)5-1-3-6(4-2-5)11(12)13/h1-4H,(H2,10,14,15) D0I5YQ DRUGINKE WUEDWPOZFNFODO-UHFFFAOYSA-N D0I5YQ DRUGSMIL C1=CC(=CC=C1C(F)(F)S(=O)(=O)N)[N+](=O)[O-] D0I5YQ HIGHSTAT Investigative D0I5YS DRUG__ID D0I5YS D0I5YS DRUGTYPE Small molecular drug D0I5YS DRUGINCH 1S/C19H16ClN/c20-18-14-8-7-13-17(18)19(21,15-9-3-1-4-10-15)16-11-5-2-6-12-16/h1-14H,21H2 D0I5YS DRUGINKE AXCRTHNDHLRNOA-UHFFFAOYSA-N D0I5YS DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N D0I5YS HIGHSTAT Investigative D0I5YT DRUG__ID D0I5YT D0I5YT DRUGTYPE Small molecular drug D0I5YT DRUGINCH 1S/C16H12O2S/c17-14-6-4-11(5-7-14)13-9-16(19-10-13)12-2-1-3-15(18)8-12/h1-10,17-18H D0I5YT DRUGINKE VPHQUMICJYAMAM-UHFFFAOYSA-N D0I5YT DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=CS2)C3=CC=C(C=C3)O D0I5YT HIGHSTAT Investigative D0I5YU DRUG__ID D0I5YU D0I5YU DRUGTYPE Small molecular drug D0I5YU DRUGINCH 1S/C11H10F3NS/c1-2-5-16-9-4-3-8(7-15)10(6-9)11(12,13)14/h3-4,6H,2,5H2,1H3 D0I5YU DRUGINKE CUMRETWHEPZEIN-UHFFFAOYSA-N D0I5YU DRUGSMIL CCCSC1=CC(=C(C=C1)C#N)C(F)(F)F D0I5YU HIGHSTAT Investigative D0I6AN DRUG__ID D0I6AN D0I6AN DRUGTYPE Small molecular drug D0I6AN DRUGINCH 1S/C90H141N33O18S2/c91-35-5-3-17-58-74(129)116-63(18-4-6-36-92)83(138)123-43-13-24-70(123)82(137)120-66(46-51-28-33-56(125)34-29-51)78(133)115-61(21-10-40-108-88(100)101)73(128)113-62(22-11-42-110-90(104)141)76(131)121-68(80(135)117-64(84(139)140)23-12-41-109-89(102)103)48-142-143-49-69(81(136)119-65(45-50-26-31-55(124)32-27-50)77(132)114-60(72(127)112-58)20-9-39-107-87(98)99)122-79(134)67(47-52-25-30-53-14-1-2-15-54(53)44-52)118-75(130)59(19-8-38-106-86(96)97)111-71(126)57(93)16-7-37-105-85(94)95/h1-2,14-15,25-34,44,57-70,124-125H,3-13,16-24,35-43,45-49,91-93H2,(H,111,126)(H,112,127)(H,113,128)(H,114,132)(H,115,133)(H,116,129)(H,117,135)(H,118,130)(H,119,136)(H,120,137)(H,121,131)(H,122,134)(H,139,140)(H4,94,95,105)(H4,96,97,106)(H4,98,99,107)(H4,100,101,108)(H4,102,103,109)(H3,104,110,141)/t57-,58-,59-,60-,61-,62-,63+,64-,65-,66-,67-,68-,69-,70-/m0/s1 D0I6AN DRUGINKE IMOHHNXUCDZLKM-ADZSTZGASA-N D0I6AN DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CCCCN)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N)C(=O)NC(CCCNC(=N)N)C(=O)O)CCCNC(=O)N)CCCNC(=N)N)CC6=CC=C(C=C6)O D0I6AN HIGHSTAT Investigative D0I6EH DRUG__ID D0I6EH D0I6EH DRUGTYPE Small molecular drug D0I6EH DRUGINCH 1S/C24H26O6/c1-7-24(4,5)20-17(29-6)10-14(25)19-22(28)18-13(9-8-12(2)3)21(27)15(26)11-16(18)30-23(19)20/h7-8,10-11,25-27H,1,9H2,2-6H3 D0I6EH DRUGINKE UIIGEZZURHDEDK-UHFFFAOYSA-N D0I6EH DRUGSMIL CC(=CCC1=C(C(=CC2=C1C(=O)C3=C(O2)C(=C(C=C3O)OC)C(C)(C)C=C)O)O)C D0I6EH HIGHSTAT Investigative D0I6EJ DRUG__ID D0I6EJ D0I6EJ DRUGTYPE Small molecular drug D0I6EJ DRUGINCH 1S/C22H16N2O/c25-20-8-4-7-18(13-20)22-15-19(16-5-2-1-3-6-16)14-21(24-22)17-9-11-23-12-10-17/h1-15,25H D0I6EJ DRUGINKE CBYVMWRLWYKHTF-UHFFFAOYSA-N D0I6EJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC(=CC=C3)O)C4=CC=NC=C4 D0I6EJ HIGHSTAT Investigative D0I6EU DRUG__ID D0I6EU D0I6EU DRUGTYPE Small molecular drug D0I6EU DRUGINCH 1S/C17H24N3O6P/c1-10(2)7-14(20-27(24,25)26)16(21)19-15(17(22)23)8-11-9-18-13-6-4-3-5-12(11)13/h3-6,9-10,14-15,18H,7-8H2,1-2H3,(H,19,21)(H,22,23)(H3,20,24,25,26)/p-3/t14-,15-/m0/s1 D0I6EU DRUGINKE GKNMEOYLZHYYGW-GJZGRUSLSA-K D0I6EU DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-])[O-] D0I6EU HIGHSTAT Investigative D0I6GH DRUG__ID D0I6GH D0I6GH DRUGTYPE Small molecular drug D0I6GH DRUGINCH 1S/C18H12N2O2/c21-18-15-9-5-4-8-14(15)17-16(18)10-12(19-20-17)11-22-13-6-2-1-3-7-13/h1-10H,11H2 D0I6GH DRUGINKE FYSBXMGLLLBKBR-UHFFFAOYSA-N D0I6GH DRUGSMIL C1=CC=C(C=C1)OCC2=CC3=C(C4=CC=CC=C4C3=O)N=N2 D0I6GH HIGHSTAT Investigative D0I6HV DRUG__ID D0I6HV D0I6HV DRUGTYPE Small molecular drug D0I6HV DRUGINCH 1S/C15H12N2O3S/c18-12-6-5-9(7-13(12)19)14(20)8-21-15-16-10-3-1-2-4-11(10)17-15/h1-7,18-19H,8H2,(H,16,17) D0I6HV DRUGINKE NVYSVDRYESXWBD-UHFFFAOYSA-N D0I6HV DRUGSMIL C1=CC=C2C(=C1)NC(=N2)SCC(=O)C3=CC(=C(C=C3)O)O D0I6HV HIGHSTAT Investigative D0I6II DRUG__ID D0I6II D0I6II DRUGTYPE Small molecular drug D0I6II DRUGINCH 1S/C8H9N3.BrH/c9-8-10-5-6-3-1-2-4-7(6)11-8;/h1-4H,5H2,(H3,9,10,11);1H D0I6II DRUGINKE RXCXYMVUYRKQAO-UHFFFAOYSA-N D0I6II DRUGSMIL C1C2=CC=CC=C2NC(=N1)N.Br D0I6II HIGHSTAT Investigative D0I6JQ DRUG__ID D0I6JQ D0I6JQ DRUGTYPE Small molecular drug D0I6JQ DRUGINCH 1S/C17H21ClN4O8S/c18-9-1-3-10(4-2-9)22(30)17(29)31-8-12(15(26)20-7-14(24)25)21-13(23)6-5-11(19)16(27)28/h1-4,11-12,30H,5-8,19H2,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t11-,12-/m0/s1 D0I6JQ DRUGINKE AJDQQFLYKZABLT-RYUDHWBXSA-N D0I6JQ DRUGSMIL C1=CC(=CC=C1N(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O)Cl D0I6JQ HIGHSTAT Investigative D0I6KF DRUG__ID D0I6KF D0I6KF DRUGTYPE Small molecular drug D0I6KF DRUGINCH 1S/C13H19NO3/c1-15-11-6-10-8(7-14)4-5-9(10)12(16-2)13(11)17-3/h6,8H,4-5,7,14H2,1-3H3/t8-/m1/s1 D0I6KF DRUGINKE AFTIZGHFDCOQFS-MRVPVSSYSA-N D0I6KF DRUGSMIL COC1=C(C(=C2CCC(C2=C1)CN)OC)OC D0I6KF HIGHSTAT Investigative D0I6KU DRUG__ID D0I6KU D0I6KU DRUGTYPE Small molecular drug D0I6KU DRUGINCH 1S/C13H10N2/c1-11-3-2-4-12(7-11)5-6-13-8-14-10-15-9-13/h2-4,7-10H,1H3 D0I6KU DRUGINKE WDWDORGIXVCIQC-UHFFFAOYSA-N D0I6KU DRUGSMIL CC1=CC(=CC=C1)C#CC2=CN=CN=C2 D0I6KU HIGHSTAT Investigative D0I6MA DRUG__ID D0I6MA D0I6MA DRUGTYPE Small molecular drug D0I6MA DRUGINCH 1S/C9H8Cl2N2O/c1-2-13-8-4-6(11)5(10)3-7(8)12-9(13)14/h3-4H,2H2,1H3,(H,12,14) D0I6MA DRUGINKE LKHRMULASXZCLG-UHFFFAOYSA-N D0I6MA DRUGSMIL CCN1C2=CC(=C(C=C2NC1=O)Cl)Cl D0I6MA HIGHSTAT Investigative D0I6MT DRUG__ID D0I6MT D0I6MT DRUGTYPE Small molecular drug D0I6MT DRUGINCH 1S/C24H20N6/c25-19-11-13-20(14-12-19)27-23-21-24(29-22(28-23)18-9-5-2-6-10-18)30(16-26-21)15-17-7-3-1-4-8-17/h1-14,16H,15,25H2,(H,27,28,29) D0I6MT DRUGINKE RVUVWWRSIWGIQQ-UHFFFAOYSA-N D0I6MT DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C(N=C(N=C32)C4=CC=CC=C4)NC5=CC=C(C=C5)N D0I6MT HIGHSTAT Investigative D0I6QE DRUG__ID D0I6QE D0I6QE DRUGTYPE Small molecular drug D0I6QE DRUGINCH 1S/C7H8ClO3PS/c8-6-3-1-5(2-4-6)7(13)12(9,10)11/h1-4,7,13H,(H2,9,10,11) D0I6QE DRUGINKE AVCBLMMQVNLVBY-UHFFFAOYSA-N D0I6QE DRUGSMIL C1=CC(=CC=C1C(P(=O)(O)O)S)Cl D0I6QE HIGHSTAT Investigative D0I6RE DRUG__ID D0I6RE D0I6RE DRUGTYPE Small molecular drug D0I6RE DRUGINCH 1S/C11H24O3/c12-8-3-1-5-11(7-10-14)6-2-4-9-13/h11-14H,1-10H2 D0I6RE DRUGINKE VICIXNZSEUYGFV-UHFFFAOYSA-N D0I6RE DRUGSMIL C(CCO)CC(CCCCO)CCO D0I6RE HIGHSTAT Investigative D0I6RL DRUG__ID D0I6RL D0I6RL DRUGTYPE Small molecular drug D0I6RL DRUGINCH 1S/C17H13NO4S/c19-17(20)16-14-9-5-4-6-12(14)10-11-15(16)18-23(21,22)13-7-2-1-3-8-13/h1-11,18H,(H,19,20) D0I6RL DRUGINKE CXPIFTCBANXJNX-UHFFFAOYSA-N D0I6RL DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=C(C3=CC=CC=C3C=C2)C(=O)O D0I6RL HIGHSTAT Investigative D0I6SI DRUG__ID D0I6SI D0I6SI DRUGTYPE Small molecular drug D0I6SI DRUGINCH 1S/C9H12O3/c1-2-6(10)9-7(11)4-3-5-8(9)12/h10H,2-5H2,1H3 D0I6SI DRUGINKE KIXYWPAKWURPPK-UHFFFAOYSA-N D0I6SI DRUGSMIL CCC(=C1C(=O)CCCC1=O)O D0I6SI HIGHSTAT Investigative D0I6UM DRUG__ID D0I6UM D0I6UM DRUGTYPE Small molecular drug D0I6UM DRUGINCH 1S/C14H6N2O2S/c17-13-7-3-1-2-4-8(7)14(18)11-9(13)5-6-10-12(11)16-19-15-10/h1-6H D0I6UM DRUGINKE SJPXIVLTCBBWKT-UHFFFAOYSA-N D0I6UM DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=NSN=C4C=C3 D0I6UM HIGHSTAT Investigative D0I6UV DRUG__ID D0I6UV D0I6UV DRUGTYPE Small molecular drug D0I6UV DRUGINCH 1S/C28H26N2O3/c1-22-21-30(27(32)29-26(22)31)19-11-12-20-33-28(23-13-5-2-6-14-23,24-15-7-3-8-16-24)25-17-9-4-10-18-25/h2-18,21H,19-20H2,1H3,(H,29,31,32)/b12-11- D0I6UV DRUGINKE BHMZJUVAVWRNLN-QXMHVHEDSA-N D0I6UV DRUGSMIL CC1=CN(C(=O)NC1=O)CC=CCOC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D0I6UV HIGHSTAT Investigative D0I6WA DRUG__ID D0I6WA D0I6WA DRUGTYPE Small molecular drug D0I6WA DRUGINCH 1S/C24H24F3N3O4/c1-14(2)21(31)17-8-9-19(20(22(17)32)24(25,26)27)34-12-16-6-4-15(5-7-16)10-28-23(33)18-11-30(3)13-29-18/h4-9,11,13-14,32H,10,12H2,1-3H3,(H,28,33) D0I6WA DRUGINKE RYINQFMHVVYWNS-UHFFFAOYSA-N D0I6WA DRUGSMIL CC(C)C(=O)C1=C(C(=C(C=C1)OCC2=CC=C(C=C2)CNC(=O)C3=CN(C=N3)C)C(F)(F)F)O D0I6WA HIGHSTAT Investigative D0I6YD DRUG__ID D0I6YD D0I6YD DRUGTYPE Small molecular drug D0I6YD DRUGINCH 1S/C10H24O7P2/c1-2-3-4-5-6-7-8-9-10(11,18(12,13)14)19(15,16)17/h11H,2-9H2,1H3,(H2,12,13,14)(H2,15,16,17) D0I6YD DRUGINKE NSCPCMXKWUFFNL-UHFFFAOYSA-N D0I6YD DRUGSMIL CCCCCCCCCC(O)(P(=O)(O)O)P(=O)(O)O D0I6YD HIGHSTAT Investigative D0I6YL DRUG__ID D0I6YL D0I6YL DRUGTYPE Small molecular drug D0I6YL DRUGINCH 1S/C37H50N2O10/c1-7-38-17-34(18-49-32(42)20-10-8-9-11-23(20)39-26(40)14-19(2)31(39)41)13-12-25(46-4)36-22-15-21-24(45-3)16-35(43,27(22)28(21)47-5)37(44,33(36)38)30(48-6)29(34)36/h8-11,19,21-22,24-25,27-30,33,43-44H,7,12-18H2,1-6H3/t19?,21?,22?,24?,25?,27?,28?,29?,30-,33?,34?,35+,36?,37-/m0/s1 D0I6YL DRUGINKE XLTANAWLDBYGFU-SCAXRLHISA-N D0I6YL DRUGSMIL CCN1CC2(CCC(C34C2C(C(C31)(C5(CC(C6CC4C5C6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N8C(=O)CC(C8=O)C D0I6YL HIGHSTAT Investigative D0I6ZS DRUG__ID D0I6ZS D0I6ZS DRUGTYPE Small molecular drug D0I6ZS DRUGINCH 1S/C20H26O4/c1-13(9-15-5-7-19(23-3)17(21)11-15)14(2)10-16-6-8-20(24-4)18(22)12-16/h5-8,11-14,21-22H,9-10H2,1-4H3/t13-,14+ D0I6ZS DRUGINKE FHAGEYRSWPQEQJ-OKILXGFUSA-N D0I6ZS DRUGSMIL CC(CC1=CC(=C(C=C1)OC)O)C(C)CC2=CC(=C(C=C2)OC)O D0I6ZS HIGHSTAT Investigative D0I7AL DRUG__ID D0I7AL D0I7AL DRUGTYPE Small molecular drug D0I7AL DRUGINCH 1S/C22H26N2O2S2/c1-14-9-12-27-20(14)16(21-15(2)10-13-28-21)6-5-11-24(3)17-7-4-8-18-19(17)22(25)23-26-18/h6,9-10,12-13,17H,4-5,7-8,11H2,1-3H3,(H,23,25)/t17-/m1/s1 D0I7AL DRUGINKE CUESOMOCKVRNIW-QGZVFWFLSA-N D0I7AL DRUGSMIL CC1=C(SC=C1)C(=CCCN(C)C2CCCC3=C2C(=O)NO3)C4=C(C=CS4)C D0I7AL HIGHSTAT Investigative D0I7BX DRUG__ID D0I7BX D0I7BX DRUGTYPE Small molecular drug D0I7BX DRUGINCH 1S/C23H15NO2S/c25-23(26-20-13-7-9-16-8-1-2-10-17(16)20)24-18-11-3-5-14-21(18)27-22-15-6-4-12-19(22)24/h1-15H D0I7BX DRUGINKE BJICBLMMTYZFKB-UHFFFAOYSA-N D0I7BX DRUGSMIL C1=CC=C2C(=C1)C=CC=C2OC(=O)N3C4=CC=CC=C4SC5=CC=CC=C53 D0I7BX HIGHSTAT Investigative D0I7DH DRUG__ID D0I7DH D0I7DH DRUGTYPE Small molecular drug D0I7DH DRUGINCH 1S/C17H24O/c1-3-5-6-7-8-10-15-11-13-16(14-12-15)17(18)9-4-2/h4,9,11-14H,3,5-8,10H2,1-2H3/b9-4+ D0I7DH DRUGINKE LCSOCUYXJADQCV-RUDMXATFSA-N D0I7DH DRUGSMIL CCCCCCCC1=CC=C(C=C1)C(=O)C=CC D0I7DH HIGHSTAT Investigative D0I7DN DRUG__ID D0I7DN D0I7DN DRUGTYPE Small molecular drug D0I7DN DRUGINCH 1S/C27H27NO6/c28-27(26(31)34-20-23-14-8-3-9-15-23,16-24(29)32-18-21-10-4-1-5-11-21)17-25(30)33-19-22-12-6-2-7-13-22/h1-15H,16-20,28H2 D0I7DN DRUGINKE LEIRLWNRJKDALU-UHFFFAOYSA-N D0I7DN DRUGSMIL C1=CC=C(C=C1)COC(=O)CC(CC(=O)OCC2=CC=CC=C2)(C(=O)OCC3=CC=CC=C3)N D0I7DN HIGHSTAT Investigative D0I7FF DRUG__ID D0I7FF D0I7FF DRUGTYPE Small molecular drug D0I7FF DRUGINCH 1S/C12H21F3O/c1-2-3-4-5-6-7-8-9-10-11(16)12(13,14)15/h2-10H2,1H3 D0I7FF DRUGINKE YXTBWTOMSMZIMA-UHFFFAOYSA-N D0I7FF DRUGSMIL CCCCCCCCCCC(=O)C(F)(F)F D0I7FF HIGHSTAT Investigative D0I7FI DRUG__ID D0I7FI D0I7FI DRUGTYPE Small molecular drug D0I7FI DRUGINCH 1S/C10H9NO3S/c11-10-3-1-2-7-6-8(15(12,13)14)4-5-9(7)10/h1-6H,11H2,(H,12,13,14) D0I7FI DRUGINKE UWPJYQYRSWYIGZ-UHFFFAOYSA-N D0I7FI DRUGSMIL C1=CC2=C(C=CC(=C2)S(=O)(=O)O)C(=C1)N D0I7FI HIGHSTAT Investigative D0I7FK DRUG__ID D0I7FK D0I7FK DRUGTYPE Small molecular drug D0I7FK DRUGINCH 1S/C16H20N2O/c1-11-4-2-6-13(10-11)19-14-7-3-5-12-8-9-15(17)18-16(12)14/h3,5,7-9,11,13H,2,4,6,10H2,1H3,(H2,17,18) D0I7FK DRUGINKE AZGLOGDXDJFQFK-UHFFFAOYSA-N D0I7FK DRUGSMIL CC1CCCC(C1)OC2=CC=CC3=C2N=C(C=C3)N D0I7FK HIGHSTAT Investigative D0I7GE DRUG__ID D0I7GE D0I7GE DRUGTYPE Small molecular drug D0I7GE DRUGINCH 1S/C19H12O2/c20-17-12-18(14-7-2-1-3-8-14)21-19-15-9-5-4-6-13(15)10-11-16(17)19/h1-12H D0I7GE DRUGINKE VFMMPHCGEFXGIP-UHFFFAOYSA-N D0I7GE DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0I7GE HIGHSTAT Investigative D0I7HL DRUG__ID D0I7HL D0I7HL DRUGTYPE Small molecular drug D0I7HL DRUGINCH 1S/C19H23N5O5/c20-16-13-17(24(10-21-13)18-15(27)14(26)12(9-25)29-18)23-19(22-16)28-8-4-7-11-5-2-1-3-6-11/h1-3,5-6,10,12,14-15,18,25-27H,4,7-9H2,(H2,20,22,23)/t12-,14-,15-,18-/m1/s1 D0I7HL DRUGINKE UDWLAWJOABGYPL-SCFUHWHPSA-N D0I7HL DRUGSMIL C1=CC=C(C=C1)CCCOC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D0I7HL HIGHSTAT Investigative D0I7HP DRUG__ID D0I7HP D0I7HP DRUGTYPE Small molecular drug D0I7HP DRUGINCH 1S/C12H12ClN3S2/c13-10-4-2-1-3-9(10)5-6-14-11(17)16-12-15-7-8-18-12/h1-4,7-8H,5-6H2,(H2,14,15,16,17) D0I7HP DRUGINKE KRROCUPDKUFLSH-UHFFFAOYSA-N D0I7HP DRUGSMIL C1=CC=C(C(=C1)CCNC(=S)NC2=NC=CS2)Cl D0I7HP HIGHSTAT Investigative D0I7IA DRUG__ID D0I7IA D0I7IA DRUGTYPE Small molecular drug D0I7IA DRUGINCH 1S/C12H18N5O3S.ClH/c1-21(2)3-6-8(18)9(19)12(20-6)17-5-16-7-10(13)14-4-15-11(7)17;/h4-6,8-9,12,18-19H,3H2,1-2H3,(H2,13,14,15);1H/q+1;/p-1/t6-,8-,9-,12-;/m1./s1 D0I7IA DRUGINKE UQRXECZPKCIHRJ-OUTCZKRVSA-M D0I7IA DRUGSMIL C[S+](C)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.[Cl-] D0I7IA HIGHSTAT Investigative D0I7IF DRUG__ID D0I7IF D0I7IF DRUGTYPE Small molecular drug D0I7IF DRUGINCH 1S/C10H7BrN2O2/c11-8-7(6-4-2-1-3-5-6)9(14)13-10(15)12-8/h1-5H,(H2,12,13,14,15) D0I7IF DRUGINKE XSEDFSJHHTXVPL-UHFFFAOYSA-N D0I7IF DRUGSMIL C1=CC=C(C=C1)C2=C(NC(=O)NC2=O)Br D0I7IF HIGHSTAT Investigative D0I7IH DRUG__ID D0I7IH D0I7IH DRUGTYPE Small molecular drug D0I7IH DRUGINCH 1S/C19H18O4S/c1-2-5-13-8-10-14(11-9-13)24(22,23)18-12-17(20)15-6-3-4-7-16(15)19(18)21/h3-4,6-12,20-21H,2,5H2,1H3 D0I7IH DRUGINKE BCECDLBGKYFWCS-UHFFFAOYSA-N D0I7IH DRUGSMIL CCCC1=CC=C(C=C1)S(=O)(=O)C2=C(C3=CC=CC=C3C(=C2)O)O D0I7IH HIGHSTAT Investigative D0I7MC DRUG__ID D0I7MC D0I7MC DRUGTYPE Small molecular drug D0I7MC DRUGINCH 1S/C17H20O3/c1-2-3-4-13-19-15-9-11-17(12-10-15)20-16-7-5-14(18)6-8-16/h5-12,18H,2-4,13H2,1H3 D0I7MC DRUGINKE JYQOLNAVBLFGQA-UHFFFAOYSA-N D0I7MC DRUGSMIL CCCCCOC1=CC=C(C=C1)OC2=CC=C(C=C2)O D0I7MC HIGHSTAT Investigative D0I7MW DRUG__ID D0I7MW D0I7MW DRUGTYPE Small molecular drug D0I7MW DRUGINCH 1S/C27H27NO/c1-3-4-7-17-28-19-23(18-26(28)22-15-13-20(2)14-16-22)27(29)25-12-8-10-21-9-5-6-11-24(21)25/h5-6,8-16,18-19H,3-4,7,17H2,1-2H3 D0I7MW DRUGINKE RZASCFFZBHYWDH-UHFFFAOYSA-N D0I7MW DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)C)C(=O)C3=CC=CC4=CC=CC=C43 D0I7MW HIGHSTAT Investigative D0I7OD DRUG__ID D0I7OD D0I7OD DRUGTYPE Small molecular drug D0I7OD DRUGINCH 1S/C17H16O8/c1-8-4-11(19)14(16(20)21)12(5-8)25-15-10(17(22)24-3)6-9(18)7-13(15)23-2/h4-7,18-19H,1-3H3,(H,20,21) D0I7OD DRUGINKE XOKVHFNTYHPEHN-UHFFFAOYSA-N D0I7OD DRUGSMIL CC1=CC(=C(C(=C1)OC2=C(C=C(C=C2OC)O)C(=O)OC)C(=O)O)O D0I7OD HIGHSTAT Investigative D0I7ON DRUG__ID D0I7ON D0I7ON DRUGTYPE Small molecular drug D0I7ON DRUGINCH 1S/C19H15N5O2S/c25-24(26)16-8-6-15(7-9-16)11-27-19-17-18(20-12-21-19)23(13-22-17)10-14-4-2-1-3-5-14/h1-9,12-13H,10-11H2 D0I7ON DRUGINKE VKPWNJKIHUERPQ-UHFFFAOYSA-N D0I7ON DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C2N=CN=C3SCC4=CC=C(C=C4)[N+](=O)[O-] D0I7ON HIGHSTAT Investigative D0I7PG DRUG__ID D0I7PG D0I7PG DRUGTYPE Small molecular drug D0I7PG DRUGINCH 1S/C11H17N2O7P/c1-6-10(14)9(4-13-7(2)11(15)16)8(3-12-6)5-20-21(17,18)19/h3,7,13-14H,4-5H2,1-2H3,(H,15,16)(H2,17,18,19)/t7-/m1/s1 D0I7PG DRUGINKE WACJCHFWJNNBPR-SSDOTTSWSA-N D0I7PG DRUGSMIL CC1=NC=C(C(=C1O)CNC(C)C(=O)O)COP(=O)(O)O D0I7PG HIGHSTAT Investigative D0I7QX DRUG__ID D0I7QX D0I7QX DRUGTYPE Small molecular drug D0I7QX DRUGINCH 1S/C17H11NO2/c19-17(14-9-11-5-1-3-7-13(11)18-14)16-10-12-6-2-4-8-15(12)20-16/h1-10,18H D0I7QX DRUGINKE NWBGABGOSKEFQJ-UHFFFAOYSA-N D0I7QX DRUGSMIL C1=CC=C2C(=C1)C=C(N2)C(=O)C3=CC4=CC=CC=C4O3 D0I7QX HIGHSTAT Investigative D0I7RA DRUG__ID D0I7RA D0I7RA DRUGTYPE Small molecular drug D0I7RA DRUGINCH 1S/C18H14BrN3O2/c1-23-16-6-12-15(7-17(16)24-2)21-9-22-18(12)13-8-20-14-4-3-10(19)5-11(13)14/h3-9,20H,1-2H3 D0I7RA DRUGINKE MWBJNWJINFGNLQ-UHFFFAOYSA-N D0I7RA DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)C3=CNC4=C3C=C(C=C4)Br)OC D0I7RA HIGHSTAT Investigative D0I7RF DRUG__ID D0I7RF D0I7RF DRUGTYPE Small molecular drug D0I7RF DRUGINCH 1S/C27H30O10/c1-12-19(29)35-17-16(28)25-15-10-14(23(2,3)4)24(25)18(33-11-13-8-6-5-7-9-13)20(30)36-22(24)37-27(25,21(31)34-15)26(12,17)32/h5-9,12,14-18,22,28,32H,10-11H2,1-4H3/t12?,14?,15?,16?,17-,18-,22?,24?,25?,26+,27-/m0/s1 D0I7RF DRUGINKE PHJOWQWLQBFEEM-ZTPSGWAGSA-N D0I7RF DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5)C(C)(C)C)C(C(=O)OC6O4)OCC7=CC=CC=C7)O D0I7RF HIGHSTAT Investigative D0I7TZ DRUG__ID D0I7TZ D0I7TZ DRUGTYPE Small molecular drug D0I7TZ DRUGINCH 1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/p-1 D0I7TZ DRUGINKE XVOYSCVBGLVSOL-UHFFFAOYSA-M D0I7TZ DRUGSMIL C(C(C(=O)[O-])N)S(=O)(=O)O D0I7TZ HIGHSTAT Investigative D0I7VD DRUG__ID D0I7VD D0I7VD DRUGTYPE Small molecular drug D0I7VD DRUGINCH 1S/C3H8N2S/c1-2-6-3(4)5/h2H2,1H3,(H3,4,5) D0I7VD DRUGINKE VFIZBHJTOHUOEK-UHFFFAOYSA-N D0I7VD DRUGSMIL CCSC(=N)N D0I7VD HIGHSTAT Investigative D0I7VY DRUG__ID D0I7VY D0I7VY DRUGTYPE Small molecular drug D0I7VY DRUGINCH 1S/C21H27N3O2/c1-14(2)20(25)23-17-11-12-19(24(4)5)18(13-17)21(26)22-15(3)16-9-7-6-8-10-16/h6-15H,1-5H3,(H,22,26)(H,23,25)/t15-/m1/s1 D0I7VY DRUGINKE LDXZFQWWXMRMAS-OAHLLOKOSA-N D0I7VY DRUGSMIL CC(C)C(=O)NC1=CC(=C(C=C1)N(C)C)C(=O)NC(C)C2=CC=CC=C2 D0I7VY HIGHSTAT Investigative D0I7YL DRUG__ID D0I7YL D0I7YL DRUGTYPE Small molecular drug D0I7YL DRUGINCH 1S/C235H341N57O67.C22H22N4O5/c1-20-120(13)194(290-218(342)155(69-83-184(246)303)258-198(322)122(15)254-201(325)149(63-77-178(240)297)263-211(335)157(71-85-187(307)308)270-221(345)166(97-117(7)8)280-222(346)164(95-115(3)4)277-199(323)124(17)256-235(359)196(125(18)294)292-234(358)195(121(14)21-2)291-217(341)148(58-38-42-94-239)261-205(329)150(64-78-179(241)298)265-212(336)158(72-86-188(309)310)272-227(351)172(104-131-111-251-142-52-32-27-47-137(131)142)284-215(339)159(73-87-189(311)312)267-208(332)153(67-81-182(244)301)269-226(350)170(257-126(19)295)102-129-109-249-140-50-30-25-45-135(129)140)233(357)275-154(68-82-183(245)302)209(333)264-151(65-79-180(242)299)207(331)266-156(70-84-186(305)306)210(334)260-146(56-36-40-92-237)204(328)287-175(107-185(247)304)230(354)274-161(75-89-191(315)316)214(338)282-169(101-128-59-61-134(296)62-60-128)225(349)271-160(74-88-190(313)314)213(337)279-165(96-116(5)6)220(344)268-152(66-80-181(243)300)206(330)259-145(55-35-39-91-236)202(326)278-167(98-118(9)10)224(348)288-176(108-193(319)320)231(355)262-147(57-37-41-93-238)203(327)283-171(103-130-110-250-141-51-31-26-46-136(130)141)219(343)255-123(16)200(324)289-177(114-293)232(356)281-168(99-119(11)12)223(347)286-173(105-132-112-252-143-53-33-28-48-138(132)143)228(352)273-162(76-90-192(317)318)216(340)285-174(106-133-113-253-144-54-34-29-49-139(133)144)229(353)276-163(197(248)321)100-127-43-23-22-24-44-127;1-30-16-13-24-20(31-2)18-17(16)15(12-23-18)19(27)22(29)26-10-8-25(9-11-26)21(28)14-6-4-3-5-7-14/h22-34,43-54,59-62,109-113,115-125,145-177,194-196,249-253,293-294,296H,20-21,35-42,55-58,63-108,114,236-239H2,1-19H3,(H2,240,297)(H2,241,298)(H2,242,299)(H2,243,300)(H2,244,301)(H2,245,302)(H2,246,303)(H2,247,304)(H2,248,321)(H,254,325)(H,255,343)(H,256,359)(H,257,295)(H,258,322)(H,259,330)(H,260,334)(H,261,329)(H,262,355)(H,263,335)(H,264,333)(H,265,336)(H,266,331)(H,267,332)(H,268,344)(H,269,350)(H,270,345)(H,271,349)(H,272,351)(H,273,352)(H,274,354)(H,275,357)(H,276,353)(H,277,323)(H,278,326)(H,279,337)(H,280,346)(H,281,356)(H,282,338)(H,283,327)(H,284,339)(H,285,340)(H,286,347)(H,287,328)(H,288,348)(H,289,324)(H,290,342)(H,291,341)(H,292,358)(H,305,306)(H,307,308)(H,309,310)(H,311,312)(H,313,314)(H,315,316)(H,317,318)(H,319,320);3-7,12-13,23H,8-11H2,1-2H3/t120-,121-,122-,123-,124-,125+,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,194-,195-,196-;/m0./s1 D0I7YL DRUGINKE HFYONINHPQMPNL-BENXRZQJSA-N D0I7YL DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCC(=O)O)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CC8=CC=CC=C8)C(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC9=CNC1=CC=CC=C19)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C.COC1=CN=C(C2=C1C(=CN2)C(=O)C(=O)N3CCN(CC3)C(=O)C4=CC=CC=C4)OC D0I7YL HIGHSTAT Investigative D0I8AF DRUG__ID D0I8AF D0I8AF DRUGTYPE Small molecular drug D0I8AF DRUGINCH 1S/C49H62N10O16S3/c1-76-18-16-34(55-47(69)37(58-44(66)32(50)23-41(61)62)21-28-12-14-30(15-13-28)75-78(72,73)74)45(67)53-26-40(60)54-38(22-29-25-52-33-11-7-6-10-31(29)33)48(70)56-35(17-19-77-2)46(68)59-39(24-42(63)64)49(71)57-36(43(51)65)20-27-8-4-3-5-9-27/h3-15,25,32,34-39,52H,16-24,26,50H2,1-2H3,(H2,51,65)(H,53,67)(H,54,60)(H,55,69)(H,56,70)(H,57,71)(H,58,66)(H,59,68)(H,61,62)(H,63,64)(H,72,73,74)/t32-,34-,35-,36-,37-,38-,39-/m0/s1 D0I8AF DRUGINKE IZTQOLKUZKXIRV-YRVFCXMDSA-N D0I8AF DRUGSMIL CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)N D0I8AF HIGHSTAT Investigative D0I8AT DRUG__ID D0I8AT D0I8AT DRUGTYPE Small molecular drug D0I8AT DRUGINCH 1S/C20H25N2O/c1-17(23)5-4-14-22-15-12-19(13-16-22)7-6-18-8-10-20(11-9-18)21(2)3/h6-13,15-16H,4-5,14H2,1-3H3/q+1 D0I8AT DRUGINKE FEDCZUMZENXUPU-UHFFFAOYSA-N D0I8AT DRUGSMIL CC(=O)CCC[N+]1=CC=C(C=C1)C=CC2=CC=C(C=C2)N(C)C D0I8AT HIGHSTAT Investigative D0I8BA DRUG__ID D0I8BA D0I8BA DRUGTYPE Small molecular drug D0I8BA DRUGINCH 1S/C19H17NO2/c21-18-12-7-13-20(19(22)16-10-5-2-6-11-16)17(18)14-15-8-3-1-4-9-15/h1-12,17H,13-14H2 D0I8BA DRUGINKE CKNOOIXBZFVOCF-UHFFFAOYSA-N D0I8BA DRUGSMIL C1C=CC(=O)C(N1C(=O)C2=CC=CC=C2)CC3=CC=CC=C3 D0I8BA HIGHSTAT Investigative D0I8BO DRUG__ID D0I8BO D0I8BO DRUGTYPE Small molecular drug D0I8BO DRUGINCH 1S/C25H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-22(27)25-26-21-24(29-25)23-19-17-20-28-23/h9-10,17,19-21H,2-8,11-16,18H2,1H3/b10-9- D0I8BO DRUGINKE RZGSPAWMLKONHZ-KTKRTIGZSA-N D0I8BO DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CO2 D0I8BO HIGHSTAT Investigative D0I8DW DRUG__ID D0I8DW D0I8DW DRUGTYPE Small molecular drug D0I8DW DRUGINCH 1S/C6H7N3O4S/c7-14(12,13)8-5-1-3-6(4-2-5)9(10)11/h1-4,8H,(H2,7,12,13) D0I8DW DRUGINKE RAXPQAODVUNKFW-UHFFFAOYSA-N D0I8DW DRUGSMIL C1=CC(=CC=C1NS(=O)(=O)N)[N+](=O)[O-] D0I8DW HIGHSTAT Investigative D0I8GD DRUG__ID D0I8GD D0I8GD DRUGTYPE Small molecular drug D0I8GD DRUGINCH 1S/C16H12ClN5O2/c1-2-13(23)19-16-18-11-6-5-9(17)8-10(11)15-20-14(21-22(15)16)12-4-3-7-24-12/h3-8H,2H2,1H3,(H,18,19,23) D0I8GD DRUGINKE SPZIDRYLSXDAEF-UHFFFAOYSA-N D0I8GD DRUGSMIL CCC(=O)NC1=NC2=C(C=C(C=C2)Cl)C3=NC(=NN31)C4=CC=CO4 D0I8GD HIGHSTAT Investigative D0I8HK DRUG__ID D0I8HK D0I8HK DRUGTYPE Small molecular drug D0I8HK DRUGINCH 1S/C11H9ClO/c1-2-10(13)8-7-9-5-3-4-6-11(9)12/h2-8H,1H2/b8-7+ D0I8HK DRUGINKE DIYSCNLXRVKMMK-BQYQJAHWSA-N D0I8HK DRUGSMIL C=CC(=O)C=CC1=CC=CC=C1Cl D0I8HK HIGHSTAT Investigative D0I8JJ DRUG__ID D0I8JJ D0I8JJ DRUGTYPE Small molecular drug D0I8JJ DRUGINCH 1S/C11H13N3O5/c15-2-5-8(16)9(17)10(19-5)4-1-12-7-6(4)13-3-14-11(7)18/h1,3,5,8-10,12,15-17H,2H2,(H,13,14,18)/t5-,8-,9-,10+/m1/s1 D0I8JJ DRUGINKE WKDMPDYUJKSXBW-KBHCAIDQSA-N D0I8JJ DRUGSMIL C1=C(C2=C(N1)C(=O)NC=N2)C3C(C(C(O3)CO)O)O D0I8JJ HIGHSTAT Investigative D0I8KC DRUG__ID D0I8KC D0I8KC DRUGTYPE Small molecular drug D0I8KC DRUGINCH 1S/C15H15N3/c16-15-3-1-2-13(18-15)7-5-11-4-6-12-8-9-17-14(12)10-11/h1-4,6,8-10,17H,5,7H2,(H2,16,18) D0I8KC DRUGINKE OSHSZKRWKLQZBV-UHFFFAOYSA-N D0I8KC DRUGSMIL C1=CC(=NC(=C1)N)CCC2=CC3=C(C=C2)C=CN3 D0I8KC HIGHSTAT Investigative D0I8LH DRUG__ID D0I8LH D0I8LH DRUGTYPE Small molecular drug D0I8LH DRUGINCH 1S/CH3NO/c2-1-3/h1H,(H2,2,3) D0I8LH DRUGINKE ZHNUHDYFZUAESO-UHFFFAOYSA-N D0I8LH DRUGSMIL C(=O)N D0I8LH HIGHSTAT Investigative D0I8MN DRUG__ID D0I8MN D0I8MN DRUGTYPE Small molecular drug D0I8MN DRUGINCH 1S/C13H15ClO3/c14-10-5-6-12(17-8-13(15)16)11(7-10)9-3-1-2-4-9/h5-7,9H,1-4,8H2,(H,15,16) D0I8MN DRUGINKE GOFMJZFPLZWDOU-UHFFFAOYSA-N D0I8MN DRUGSMIL C1CCC(C1)C2=C(C=CC(=C2)Cl)OCC(=O)O D0I8MN HIGHSTAT Investigative D0I8MP DRUG__ID D0I8MP D0I8MP DRUGTYPE Small molecular drug D0I8MP DRUGINCH 1S/C23H23BrN2O/c24-21-7-3-4-17(14-21)16-26-12-10-22(11-13-26)25-23(27)20-9-8-18-5-1-2-6-19(18)15-20/h1-9,14-15,22H,10-13,16H2,(H,25,27) D0I8MP DRUGINKE KMQWTBGTEFASGU-UHFFFAOYSA-N D0I8MP DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CC4=CC(=CC=C4)Br D0I8MP HIGHSTAT Investigative D0I8PQ DRUG__ID D0I8PQ D0I8PQ DRUGTYPE Small molecular drug D0I8PQ DRUGINCH 1S/C13H22N4O8S/c1-2-17(25)13(24)26-6-8(11(21)15-5-10(19)20)16-9(18)4-3-7(14)12(22)23/h7-8,25H,2-6,14H2,1H3,(H,15,21)(H,16,18)(H,19,20)(H,22,23)/t7-,8-/m0/s1 D0I8PQ DRUGINKE WQKIQOZTTDZDHN-YUMQZZPRSA-N D0I8PQ DRUGSMIL CCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D0I8PQ HIGHSTAT Investigative D0I8SK DRUG__ID D0I8SK D0I8SK DRUGTYPE Small molecular drug D0I8SK DRUGINCH 1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1 D0I8SK DRUGINKE AGPKZVBTJJNPAG-WHFBIAKZSA-N D0I8SK DRUGSMIL CCC(C)C(C(=O)O)N D0I8SK HIGHSTAT Investigative D0I8TR DRUG__ID D0I8TR D0I8TR DRUGTYPE Small molecular drug D0I8TR DRUGINCH 1S/C19H21NO4S/c1-14-12-19(21)17(15-8-4-2-5-9-15)13-18(14)20-24-25(22,23)16-10-6-3-7-11-16/h3,6-7,10-13,15H,2,4-5,8-9H2,1H3/b20-18- D0I8TR DRUGINKE RSMZOLWJZGIWOV-ZZEZOPTASA-N D0I8TR DRUGSMIL CC1=CC(=O)C(=CC1=NOS(=O)(=O)C2=CC=CC=C2)C3CCCCC3 D0I8TR HIGHSTAT Investigative D0I8WD DRUG__ID D0I8WD D0I8WD DRUGTYPE Small molecular drug D0I8WD DRUGINCH 1S/C10H13NO2/c1-13-10(12)9(11)7-8-5-3-2-4-6-8/h2-6,9H,7,11H2,1H3/t9-/m0/s1 D0I8WD DRUGINKE VSDUZFOSJDMAFZ-VIFPVBQESA-N D0I8WD DRUGSMIL COC(=O)C(CC1=CC=CC=C1)N D0I8WD HIGHSTAT Investigative D0I8WU DRUG__ID D0I8WU D0I8WU DRUGTYPE Small molecular drug D0I8WU DRUGINCH 1S/C34H44N4O8S/c1-21(39)35-30(29(23-13-7-3-8-14-23)24-15-9-4-10-16-24)33(44)36-25(17-18-28(40)41)31(42)37-26(19-22-11-5-2-6-12-22)32(43)38-27(20-47)34(45)46/h3-4,7-10,13-16,22,25-27,29-30,47H,2,5-6,11-12,17-20H2,1H3,(H,35,39)(H,36,44)(H,37,42)(H,38,43)(H,40,41)(H,45,46)/t25-,26-,27-,30-/m0/s1 D0I8WU DRUGINKE CJVPMARHOWZLLI-YRUYCOJQSA-N D0I8WU DRUGSMIL CC(=O)NC(C(C1=CC=CC=C1)C2=CC=CC=C2)C(=O)NC(CCC(=O)O)C(=O)NC(CC3CCCCC3)C(=O)NC(CS)C(=O)O D0I8WU HIGHSTAT Investigative D0I8WY DRUG__ID D0I8WY D0I8WY DRUGTYPE Small molecular drug D0I8WY DRUGINCH 1S/C25H29ClN4O2S/c26-23-3-1-22-18-25(4-2-21(22)17-23)33(31,32)30-15-13-28(14-16-30)19-20-7-11-29(12-8-20)24-5-9-27-10-6-24/h1-6,9-10,17-18,20H,7-8,11-16,19H2 D0I8WY DRUGINKE BFNYDPSXRNYUIS-UHFFFAOYSA-N D0I8WY DRUGSMIL C1CN(CCC1CN2CCN(CC2)S(=O)(=O)C3=CC4=C(C=C3)C=C(C=C4)Cl)C5=CC=NC=C5 D0I8WY HIGHSTAT Investigative D0I8XD DRUG__ID D0I8XD D0I8XD DRUGTYPE Small molecular drug D0I8XD DRUGINCH 1S/C15H15NO/c1-16-14-8-4-12(5-9-14)2-3-13-6-10-15(17)11-7-13/h2-11,16-17H,1H3/b3-2+ D0I8XD DRUGINKE ZWIARAQZLULYPG-NSCUHMNNSA-N D0I8XD DRUGSMIL CNC1=CC=C(C=C1)C=CC2=CC=C(C=C2)O D0I8XD HIGHSTAT Investigative D0I8YN DRUG__ID D0I8YN D0I8YN DRUGTYPE Small molecular drug D0I8YN DRUGINCH 1S/C14H12FNO2/c15-11-6-2-4-8-13(11)16-12-7-3-1-5-10(12)9-14(17)18/h1-8,16H,9H2,(H,17,18) D0I8YN DRUGINKE DWKOQWOOVUATNI-UHFFFAOYSA-N D0I8YN DRUGSMIL C1=CC=C(C(=C1)CC(=O)O)NC2=CC=CC=C2F D0I8YN HIGHSTAT Investigative D0I8ZZ DRUG__ID D0I8ZZ D0I8ZZ DRUGTYPE Small molecular drug D0I8ZZ DRUGINCH 1S/C28H27Cl2N3O7S/c1-39-23-12-10-17(15-24(23)40-2)41(37,38)33-21-11-9-16(29)14-19(21)28(36,18-6-3-4-7-20(18)30)25(33)27(35)32-13-5-8-22(32)26(31)34/h3-4,6-7,9-12,14-15,22,25,36H,5,8,13H2,1-2H3,(H2,31,34)/t22-,25-,28+/m0/s1 D0I8ZZ DRUGINKE CEBYCSRFKCEUSW-NAYZPBBASA-N D0I8ZZ DRUGSMIL COC1=C(C=C(C=C1)S(=O)(=O)N2C(C(C3=C2C=CC(=C3)Cl)(C4=CC=CC=C4Cl)O)C(=O)N5CCCC5C(=O)N)OC D0I8ZZ HIGHSTAT Investigative D0I9AA DRUG__ID D0I9AA D0I9AA DRUGTYPE Small molecular drug D0I9AA DRUGINCH 1S/C16H11FOS/c1-10-2-4-11(5-3-10)14-9-16(19)13-7-6-12(17)8-15(13)18-14/h2-9H,1H3 D0I9AA DRUGINKE SJJJFWHFSTWMGP-UHFFFAOYSA-N D0I9AA DRUGSMIL CC1=CC=C(C=C1)C2=CC(=S)C3=C(O2)C=C(C=C3)F D0I9AA HIGHSTAT Investigative D0I9AL DRUG__ID D0I9AL D0I9AL DRUGTYPE Small molecular drug D0I9AL DRUGINCH 1S/C19H21N7O2/c20-19(21)25-10-8-24(9-11-25)12-16(27)26-15-6-2-1-4-13(15)18(28)23-14-5-3-7-22-17(14)26/h1-7H,8-12H2,(H3,20,21)(H,23,28) D0I9AL DRUGINKE YGBQWISDDSXPRF-UHFFFAOYSA-N D0I9AL DRUGSMIL C1CN(CCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4)C(=N)N D0I9AL HIGHSTAT Investigative D0I9AT DRUG__ID D0I9AT D0I9AT DRUGTYPE Small molecular drug D0I9AT DRUGINCH 1S/C15H8N2O2/c18-13-10-6-2-4-8-12(10)17-14(13)16-11-7-3-1-5-9(11)15(17)19/h1-8H D0I9AT DRUGINKE VQQVWGVXDIPORV-UHFFFAOYSA-N D0I9AT DRUGSMIL C1=CC=C2C(=C1)C(=O)N3C4=CC=CC=C4C(=O)C3=N2 D0I9AT HIGHSTAT Investigative D0I9FI DRUG__ID D0I9FI D0I9FI DRUGTYPE Small molecular drug D0I9FI DRUGINCH 1S/C9H12BrN/c1-7(11)6-8-2-4-9(10)5-3-8/h2-5,7H,6,11H2,1H3 D0I9FI DRUGINKE SMNXUMMCCOZPPN-UHFFFAOYSA-N D0I9FI DRUGSMIL CC(CC1=CC=C(C=C1)Br)N D0I9FI HIGHSTAT Investigative D0I9IB DRUG__ID D0I9IB D0I9IB DRUGTYPE Small molecular drug D0I9IB DRUGINCH 1S/C22H24N2O2/c1-3-4-8-19-14-23-21(22(25)26)24(19)15-17-10-12-18(13-11-17)20-9-6-5-7-16(20)2/h5-7,9-14H,3-4,8,15H2,1-2H3,(H,25,26) D0I9IB DRUGINKE ZCAMCVJTCSXPMT-UHFFFAOYSA-N D0I9IB DRUGSMIL CCCCC1=CN=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C)C(=O)O D0I9IB HIGHSTAT Investigative D0I9IF DRUG__ID D0I9IF D0I9IF DRUGCOMP Avineuro Pharmaceuticals Inc D0I9IF DRUGINCH 1S/C17H21N5O2S/c1-11-14(21(4)5)12(2)22-17(19-11)15(16(18-3)20-22)25(23,24)13-9-7-6-8-10-13/h6-10H,1-5H3,(H,18,20) D0I9IF DRUGINKE SNPPEHMSSOEYDH-UHFFFAOYSA-N D0I9IF DRUGSMIL CC1=C(C(=NC2=C(C(=NN12)NC)S(=O)(=O)C3=CC=CC=C3)C)N(C)C D0I9IF HIGHSTAT Investigative D0I9KV DRUG__ID D0I9KV D0I9KV DRUGTYPE Small molecular drug D0I9KV DRUGINCH 1S/C15H20BrNO/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11H2,1H3 D0I9KV DRUGINKE RAHKQMUBMIJUFG-UHFFFAOYSA-N D0I9KV DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)Br)N2CCCC2 D0I9KV HIGHSTAT Investigative D0I9LU DRUG__ID D0I9LU D0I9LU DRUGTYPE Small molecular drug D0I9LU DRUGINCH 1S/C10H13NO2/c1-3-7-13-10(12)9-5-4-6-11(2)8-9/h1,5H,4,6-8H2,2H3 D0I9LU DRUGINKE SPHRJZBOFYIKMC-UHFFFAOYSA-N D0I9LU DRUGSMIL CN1CCC=C(C1)C(=O)OCC#C D0I9LU HIGHSTAT Investigative D0I9MF DRUG__ID D0I9MF D0I9MF DRUGTYPE Small molecular drug D0I9MF DRUGINCH 1S/C16H16N2O3/c1-2-20-15-10-8-14(9-11-15)18-16(19)21-17-12-13-6-4-3-5-7-13/h3-12H,2H2,1H3,(H,18,19)/b17-12+ D0I9MF DRUGINKE QJZVEQAWKFWLAR-SFQUDFHCSA-N D0I9MF DRUGSMIL CCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D0I9MF HIGHSTAT Investigative D0I9NE DRUG__ID D0I9NE D0I9NE DRUGTYPE Small molecular drug D0I9NE DRUGINCH 1S/C12H8FNS/c1-9-14-12(8-15-9)6-5-10-3-2-4-11(13)7-10/h2-4,7-8H,1H3 D0I9NE DRUGINKE SCVDCVQUJSBAAM-UHFFFAOYSA-N D0I9NE DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)F D0I9NE HIGHSTAT Investigative D0I9NH DRUG__ID D0I9NH D0I9NH DRUGTYPE Small molecular drug D0I9NH DRUGINCH 1S/C14H11NO2/c15-11-3-1-9(2-4-11)14-8-10-7-12(16)5-6-13(10)17-14/h1-8,16H,15H2 D0I9NH DRUGINKE JDGXRZSZWVUFMN-UHFFFAOYSA-N D0I9NH DRUGSMIL C1=CC(=CC=C1C2=CC3=C(O2)C=CC(=C3)O)N D0I9NH HIGHSTAT Investigative D0I9ON DRUG__ID D0I9ON D0I9ON DRUGTYPE Small molecular drug D0I9ON DRUGINCH 1S/C17H23NO2/c1-3-12-18-13-8-7-11-15(18)16(17(19)20-2)14-9-5-4-6-10-14/h3-6,9-10,15-16H,1,7-8,11-13H2,2H3/t15-,16-/m1/s1 D0I9ON DRUGINKE WMEIWLRYZFKRDU-HZPDHXFCSA-N D0I9ON DRUGSMIL COC(=O)C(C1CCCCN1CC=C)C2=CC=CC=C2 D0I9ON HIGHSTAT Investigative D0I9PA DRUG__ID D0I9PA D0I9PA DRUGTYPE Small molecular drug D0I9PA DRUGINCH 1S/C13H11NO2/c1-2-11(9-14-5-1)10-3-4-12-13(8-10)16-7-6-15-12/h1-5,8-9H,6-7H2 D0I9PA DRUGINKE WBKBSDQNOSGKCC-UHFFFAOYSA-N D0I9PA DRUGSMIL C1COC2=C(O1)C=CC(=C2)C3=CN=CC=C3 D0I9PA HIGHSTAT Investigative D0I9PF DRUG__ID D0I9PF D0I9PF DRUGTYPE Small molecular drug D0I9PF DRUGINCH 1S/C20H18FN3O4/c1-12-6-2-3-7-13(12)15(11-19(26)27)22-20(28)16-10-18(25)24(23-16)17-9-5-4-8-14(17)21/h2-10,15,23H,11H2,1H3,(H,22,28)(H,26,27)/t15-/m0/s1 D0I9PF DRUGINKE DGGLFHJMXJUSDG-HNNXBMFYSA-N D0I9PF DRUGSMIL CC1=CC=CC=C1C(CC(=O)O)NC(=O)C2=CC(=O)N(N2)C3=CC=CC=C3F D0I9PF HIGHSTAT Investigative D0I9PG DRUG__ID D0I9PG D0I9PG DRUGTYPE Small molecular drug D0I9PG DRUGINCH 1S/C8H15NO6/c1-3(11)9-8-7(14)6(13)5(12)4(2-10)15-8/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8-/m1/s1 D0I9PG DRUGINKE IBONACLSSOLHFU-JAJWTYFOSA-N D0I9PG DRUGSMIL CC(=O)NC1C(C(C(C(O1)CO)O)O)O D0I9PG HIGHSTAT Investigative D0I9RW DRUG__ID D0I9RW D0I9RW DRUGTYPE Small molecular drug D0I9RW DRUGINCH 1S/C10H12IN3O/c1-6(12)5-14-10-7(4-13-14)2-3-8(15)9(10)11/h2-4,6,15H,5,12H2,1H3/t6-/m0/s1 D0I9RW DRUGINKE NTWCUBZMEYKYQE-LURJTMIESA-N D0I9RW DRUGSMIL CC(CN1C2=C(C=CC(=C2I)O)C=N1)N D0I9RW HIGHSTAT Investigative D0I9RY DRUG__ID D0I9RY D0I9RY DRUGTYPE Small molecular drug D0I9RY DRUGINCH 1S/C14H13NO2/c1-10(14(16)15-17)8-11-6-7-12-4-2-3-5-13(12)9-11/h2-9,17H,1H3,(H,15,16)/b10-8+ D0I9RY DRUGINKE NPYWWIHEHONKOF-CSKARUKUSA-N D0I9RY DRUGSMIL CC(=CC1=CC2=CC=CC=C2C=C1)C(=O)NO D0I9RY HIGHSTAT Investigative D0I9SX DRUG__ID D0I9SX D0I9SX DRUGTYPE Small molecular drug D0I9SX DRUGINCH 1S/C22H27NO/c1-16-21-14-18-8-9-19(24)15-20(18)22(16,2)11-13-23(21)12-10-17-6-4-3-5-7-17/h3-9,15-16,21,24H,10-14H2,1-2H3 D0I9SX DRUGINKE ZQHYKVKNPWDQSL-UHFFFAOYSA-N D0I9SX DRUGSMIL CC1C2CC3=C(C1(CCN2CCC4=CC=CC=C4)C)C=C(C=C3)O D0I9SX HIGHSTAT Investigative D0I9TR DRUG__ID D0I9TR D0I9TR DRUGTYPE Small molecular drug D0I9TR DRUGINCH 1S/C26H26FNO3/c1-2-24-22(13-12-21-14-20(29)15-26(30)31-21)23(17-8-10-19(27)11-9-17)16-25(28-24)18-6-4-3-5-7-18/h3-11,16,20-21,29H,2,12-15H2,1H3/t20-,21?/m1/s1 D0I9TR DRUGINKE PNHBRYIAJCYNDA-VQCQRNETSA-N D0I9TR DRUGSMIL CCC1=C(C(=CC(=N1)C2=CC=CC=C2)C3=CC=C(C=C3)F)CCC4CC(CC(=O)O4)O D0I9TR HIGHSTAT Investigative D0I9VN DRUG__ID D0I9VN D0I9VN DRUGTYPE Small molecular drug D0I9VN DRUGINCH 1S/C13H18N4O/c14-11-6-10-12(16-8-15-10)13(17-11)18-7-9-4-2-1-3-5-9/h6,8-9H,1-5,7H2,(H2,14,17)(H,15,16) D0I9VN DRUGINKE VPUIDVRYMVIXGO-UHFFFAOYSA-N D0I9VN DRUGSMIL C1CCC(CC1)COC2=C3C(=CC(=N2)N)NC=N3 D0I9VN HIGHSTAT Investigative D0I9VY DRUG__ID D0I9VY D0I9VY DRUGTYPE Small molecular drug D0I9VY DRUGINCH 1S/C35H38N4O6.2ClH/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27;;/h4-16,23,32-33,36H,17-22H2,1-3H3;2*1H D0I9VY DRUGINKE JINNGBXKBDUGQT-UHFFFAOYSA-N D0I9VY DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl D0I9VY HIGHSTAT Investigative D0I9XR DRUG__ID D0I9XR D0I9XR DRUGTYPE Small molecular drug D0I9XR DRUGINCH 1S/C22H25NO2/c1-3-4-7-13-23-16-20(19-11-5-6-12-21(19)23)22(24)15-17-9-8-10-18(14-17)25-2/h5-6,8-12,14,16H,3-4,7,13,15H2,1-2H3 D0I9XR DRUGINKE XZVYWLVYUAQEIM-UHFFFAOYSA-N D0I9XR DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)OC D0I9XR HIGHSTAT Investigative D0I9YJ DRUG__ID D0I9YJ D0I9YJ DRUGTYPE Small molecular drug D0I9YJ DRUGINCH 1S/C35H48N8O11S/c1-15-27(47)38-22-10-20-19-7-5-6-8-21(19)41-33(20)55-13-24(34(53)43-12-18(46)9-25(43)31(51)37-15)40-32(52)26(17(3)45)42-28(48)16(2)36-30(50)23(39-29(22)49)11-35(4,54)14-44/h5-8,15-18,22-26,41,44-46,54H,9-14H2,1-4H3,(H,36,50)(H,37,51)(H,38,47)(H,39,49)(H,40,52)(H,42,48) D0I9YJ DRUGINKE KPKZJLCSROULON-UHFFFAOYSA-N D0I9YJ DRUGSMIL CC1C(=O)NC2CC3=C(NC4=CC=CC=C34)SCC(C(=O)N5CC(CC5C(=O)N1)O)NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CC(C)(CO)O)C)C(C)O D0I9YJ HIGHSTAT Investigative D0I9ZJ DRUG__ID D0I9ZJ D0I9ZJ DRUGTYPE Small molecular drug D0I9ZJ DRUGINCH 1S/C10H15N2O9P/c13-3-5-2-12(10(16)11-9(5)15)8-1-6(14)7(21-8)4-20-22(17,18)19/h2,6-8,13-14H,1,3-4H2,(H,11,15,16)(H2,17,18,19)/t6-,7+,8+/m0/s1 D0I9ZJ DRUGINKE WEBVWKFGRVLCNS-XLPZGREQSA-N D0I9ZJ DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)CO)COP(=O)(O)O)O D0I9ZJ HIGHSTAT Investigative D0IA3U DRUG__ID D0IA3U D0IA3U DRUGTYPE Small molecular drug D0IA3U DRUGINCH 1S/C15H14N4S/c16-9-11-5-7-12(8-6-11)14-10-20-15(17-14)19-18-13-3-1-2-4-13/h5-8,10H,1-4H2,(H,17,19) D0IA3U DRUGINKE XAEJIFARBQJLML-UHFFFAOYSA-N D0IA3U DRUGSMIL C1CCC(=NNC2=NC(=CS2)C3=CC=C(C=C3)C#N)C1 D0IA3U HIGHSTAT Investigative D0IA7R DRUG__ID D0IA7R D0IA7R DRUGTYPE Small molecular drug D0IA7R DRUGINCH 1S/C18H23NO2/c1-2-3-4-5-8-14-11-12-18(16(20)13-14)21-17-10-7-6-9-15(17)19/h6-7,9-13,20H,2-5,8,19H2,1H3 D0IA7R DRUGINKE UGZFBZMADDXZRA-UHFFFAOYSA-N D0IA7R DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC=C2N)O D0IA7R HIGHSTAT Investigative D0IB3K DRUG__ID D0IB3K D0IB3K DRUGTYPE Small molecular drug D0IB3K DRUGINCH 1S/C30H26O13/c31-16-6-1-14(2-7-16)3-10-22(35)40-13-21-24(36)26(38)27(39)30(42-21)43-29-25(37)23-19(34)11-18(33)12-20(23)41-28(29)15-4-8-17(32)9-5-15/h1-12,21,24,26-27,30-34,36,38-39H,13H2/b10-3+/t21-,24-,26+,27-,30+/m1/s1 D0IB3K DRUGINKE DVGGLGXQSFURLP-VWMSDXGPSA-N D0IB3K DRUGSMIL C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC=C(C=C5)O)O)O)O)O D0IB3K HIGHSTAT Investigative D0IB5L DRUG__ID D0IB5L D0IB5L DRUGTYPE Small molecular drug D0IB5L DRUGINCH 1S/C5H9NO4/c1-3(7)10-2-4(6)5(8)9/h4H,2,6H2,1H3,(H,8,9)/t4-/m0/s1 D0IB5L DRUGINKE VZXPDPZARILFQX-BYPYZUCNSA-N D0IB5L DRUGSMIL CC(=O)OCC(C(=O)O)N D0IB5L HIGHSTAT Investigative D0IB6Y DRUG__ID D0IB6Y D0IB6Y DRUGTYPE Small molecular drug D0IB6Y DRUGINCH 1S/C12H17NO2/c1-14-10-4-2-9(3-5-10)12-7-6-11(8-13)15-12/h2-5,11-12H,6-8,13H2,1H3 D0IB6Y DRUGINKE SUAFTJAVJHXARK-UHFFFAOYSA-N D0IB6Y DRUGSMIL COC1=CC=C(C=C1)C2CCC(O2)CN D0IB6Y HIGHSTAT Investigative D0IB8C DRUG__ID D0IB8C D0IB8C DRUGTYPE Small molecular drug D0IB8C DRUGINCH 1S/C11H10N2O3S/c1-8-2-4-9(5-3-8)17(15,16)11-7-6-10(14)12-13-11/h2-7H,1H3,(H,12,14) D0IB8C DRUGINKE SGMDNRFRSNYBCA-UHFFFAOYSA-N D0IB8C DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=NNC(=O)C=C2 D0IB8C HIGHSTAT Investigative D0IB8N DRUG__ID D0IB8N D0IB8N DRUGTYPE Small molecular drug D0IB8N DRUGINCH 1S/C8H9NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,10-11H,4,9H2 D0IB8N DRUGINKE CNFQARFTXUBHJY-UHFFFAOYSA-N D0IB8N DRUGSMIL C1=CC(=C(C=C1C(=O)CN)O)O D0IB8N HIGHSTAT Investigative D0IC1N DRUG__ID D0IC1N D0IC1N DRUGTYPE Small molecular drug D0IC1N DRUGINCH 1S/C6H8O8/c7-2(8)1-6(14,5(12)13)3(9)4(10)11/h3,9,14H,1H2,(H,7,8)(H,10,11)(H,12,13)/t3-,6+/m1/s1 D0IC1N DRUGINKE ZMJBYMUCKBYSCP-CVYQJGLWSA-N D0IC1N DRUGSMIL C(C(=O)O)C(C(C(=O)O)O)(C(=O)O)O D0IC1N HIGHSTAT Investigative D0IC4J DRUG__ID D0IC4J D0IC4J DRUGTYPE Small molecular drug D0IC4J DRUGINCH 1S/C17H18FNO/c18-14-4-3-5-15(12-14)20-17-7-2-1-6-16(17)13-8-10-19-11-9-13/h1-7,12-13,19H,8-11H2 D0IC4J DRUGINKE WLJMFBUPVRQPDQ-UHFFFAOYSA-N D0IC4J DRUGSMIL C1CNCCC1C2=CC=CC=C2OC3=CC(=CC=C3)F D0IC4J HIGHSTAT Investigative D0IC5F DRUG__ID D0IC5F D0IC5F DRUGTYPE Small molecular drug D0IC5F DRUGINCH 1S/C24H25NO7S/c1-25-12-11-24-16-8-10-19(32-33(27,28)29)22(24)31-21-18(9-7-15(20(21)24)13-17(16)25)30-23(26)14-5-3-2-4-6-14/h2-7,9,16-17,19,22H,8,10-13H2,1H3,(H,27,28,29)/t16-,17+,19-,22-,24-/m0/s1 D0IC5F DRUGINKE YEYZQNSVGVDYOU-MJFIPZRTSA-N D0IC5F DRUGSMIL C[NH+]1CCC23C4C1CC5=C2C(=C(C=C5)OC(=O)C6=CC=CC=C6)OC3C(CC4)OS(=O)(=O)[O-] D0IC5F HIGHSTAT Investigative D0IC5U DRUG__ID D0IC5U D0IC5U DRUGTYPE Small molecular drug D0IC5U DRUGINCH 1S/C14H16N2O7/c17-14(15-6-9-4-2-1-3-5-9)22-10-7-20-13-11(23-16(18)19)8-21-12(10)13/h1-5,10-13H,6-8H2,(H,15,17)/t10-,11+,12+,13+/m0/s1 D0IC5U DRUGINKE XCUJUZNXFHRMEC-UMSGYPCISA-N D0IC5U DRUGSMIL C1C(C2C(O1)C(CO2)O[N+](=O)[O-])OC(=O)NCC3=CC=CC=C3 D0IC5U HIGHSTAT Investigative D0IC7C DRUG__ID D0IC7C D0IC7C DRUGTYPE Small molecular drug D0IC7C DRUGINCH 1S/C7H10N2O2/c1-4(2)5-3-6(7(10)11)9-8-5/h3-4H,1-2H3,(H,8,9)(H,10,11) D0IC7C DRUGINKE CHWXKAHFWLSLOQ-UHFFFAOYSA-N D0IC7C DRUGSMIL CC(C)C1=CC(=NN1)C(=O)O D0IC7C HIGHSTAT Investigative D0IC8U DRUG__ID D0IC8U D0IC8U DRUGTYPE Small molecular drug D0IC8U DRUGINCH 1S/C19H33N3O/c1-2-5-22-6-3-17(4-7-22)20-18(23)21-19-11-14-8-15(12-19)10-16(9-14)13-19/h14-17H,2-13H2,1H3,(H2,20,21,23) D0IC8U DRUGINKE OYDLKUZQSIKGSE-UHFFFAOYSA-N D0IC8U DRUGSMIL CCCN1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D0IC8U HIGHSTAT Investigative D0ID3Y DRUG__ID D0ID3Y D0ID3Y DRUGTYPE Small molecular drug D0ID3Y DRUGINCH 1S/C11H13NO2S/c1-14-9-4-2-8(3-5-9)10-6-12-11(13)7-15-10/h2-5,10H,6-7H2,1H3,(H,12,13) D0ID3Y DRUGINKE KTKPTOSTWLGTNI-UHFFFAOYSA-N D0ID3Y DRUGSMIL COC1=CC=C(C=C1)C2CNC(=O)CS2 D0ID3Y HIGHSTAT Investigative D0ID6U DRUG__ID D0ID6U D0ID6U DRUGTYPE Small molecular drug D0ID6U DRUGINCH 1S/C26H38N8O7/c1-14(2)21-25(41)32-16(9-6-10-29-26(27)28)22(38)30-13-19(35)31-18(12-20(36)37)23(39)33-17(24(40)34-21)11-15-7-4-3-5-8-15/h3-5,7-8,14,16-18,21H,6,9-13H2,1-2H3,(H,30,38)(H,31,35)(H,32,41)(H,33,39)(H,34,40)(H,36,37)(H4,27,28,29)/t16-,17+,18-,21-/m0/s1 D0ID6U DRUGINKE YYQUWEHEBOMRPH-NYUBLWNDSA-N D0ID6U DRUGSMIL CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N D0ID6U HIGHSTAT Investigative D0IE6Z DRUG__ID D0IE6Z D0IE6Z DRUGTYPE Small molecular drug D0IE6Z DRUGINCH 1S/C71H126N16O17/c1-11-43(9)58(87-70(102)59(44(10)12-2)86-65(97)51(24-16-20-34-75)78-61(93)48(21-13-17-31-72)79-68(100)55(38-45-25-27-46(89)28-26-45)82-60(92)47(76)35-40(3)4)69(101)81-50(23-15-19-33-74)62(94)77-49(22-14-18-32-73)63(95)83-54(37-42(7)8)67(99)84-53(36-41(5)6)66(98)80-52(29-30-57(90)91)64(96)85-56(39-88)71(103)104/h25-28,40-44,47-56,58-59,88-89H,11-24,29-39,72-76H2,1-10H3,(H,77,94)(H,78,93)(H,79,100)(H,80,98)(H,81,101)(H,82,92)(H,83,95)(H,84,99)(H,85,96)(H,86,97)(H,87,102)(H,90,91)(H,103,104)/t43-,44-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,58-,59-/m0/s1 D0IE6Z DRUGINKE SVIMOXOHMCOIRM-UVKYVJJHSA-N D0IE6Z DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC(C)C)N D0IE6Z HIGHSTAT Investigative D0IF2H DRUG__ID D0IF2H D0IF2H DRUGTYPE Small molecular drug D0IF2H DRUGINCH 1S/C13H19NO3/c1-3-4-9-17-12-7-5-11(6-8-12)10-13(15)14(2)16/h5-8,16H,3-4,9-10H2,1-2H3 D0IF2H DRUGINKE JGCLGKCTJPLHOR-UHFFFAOYSA-N D0IF2H DRUGSMIL CCCCOC1=CC=C(C=C1)CC(=O)N(C)O D0IF2H HIGHSTAT Investigative D0IF3H DRUG__ID D0IF3H D0IF3H DRUGTYPE Small molecular drug D0IF3H DRUGINCH 1S/C9H12N2O5/c12-4-5-6(13)7(14)8(16-5)11-3-1-2-10-9(11)15/h1-3,5-8,12-14H,4H2/t5-,6-,7-,8-/m1/s1 D0IF3H DRUGINKE RPQZTTQVRYEKCR-WCTZXXKLSA-N D0IF3H DRUGSMIL C1=CN(C(=O)N=C1)C2C(C(C(O2)CO)O)O D0IF3H HIGHSTAT Investigative D0IF3N DRUG__ID D0IF3N D0IF3N DRUGTYPE Small molecular drug D0IF3N DRUGINCH 1S/C7H13N3/c1-10(2)4-3-7-5-8-6-9-7/h5-6H,3-4H2,1-2H3,(H,8,9) D0IF3N DRUGINKE ZJDIMSMQXMWMCF-UHFFFAOYSA-N D0IF3N DRUGSMIL CN(C)CCC1=CN=CN1 D0IF3N HIGHSTAT Investigative D0IF8Z DRUG__ID D0IF8Z D0IF8Z DRUGTYPE Small molecular drug D0IF8Z DRUGINCH 1S/C12H11NO3/c1-8-6-11(14)13(7-12(15)16)10-5-3-2-4-9(8)10/h2-6H,7H2,1H3,(H,15,16) D0IF8Z DRUGINKE VKKWCKNFSMMXJZ-UHFFFAOYSA-N D0IF8Z DRUGSMIL CC1=CC(=O)N(C2=CC=CC=C12)CC(=O)O D0IF8Z HIGHSTAT Investigative D0IG5E DRUG__ID D0IG5E D0IG5E DRUGTYPE Small molecular drug D0IG5E DRUGINCH 1S/C15H19Cl2N5O3/c16-5-8-10(23)11(24)14(25-8)22-6-18-9-12(19-7-3-1-2-4-7)20-15(17)21-13(9)22/h6-8,10-11,14,23-24H,1-5H2,(H,19,20,21)/t8-,10-,11-,14-/m1/s1 D0IG5E DRUGINKE GWUOJELSUSGGDU-IDTAVKCVSA-N D0IG5E DRUGSMIL C1CCC(C1)NC2=C3C(=NC(=N2)Cl)N(C=N3)C4C(C(C(O4)CCl)O)O D0IG5E HIGHSTAT Investigative D0IG7F DRUG__ID D0IG7F D0IG7F DRUGTYPE Small molecular drug D0IG7F DRUGINCH 1S/C20H32O4/c1-2-3-4-5-10-13-16-19(24-23)17-14-11-8-6-7-9-12-15-18-20(21)22/h7-11,13-14,17,19,23H,2-6,12,15-16,18H2,1H3,(H,21,22)/b9-7-,11-8-,13-10-,17-14+/t19-/m1/s1 D0IG7F DRUGINKE ZIOZYRSDNLNNNJ-ZYBDYUKJSA-N D0IG7F DRUGSMIL CCCCCC=CCC(C=CC=CCC=CCCCC(=O)O)OO D0IG7F HIGHSTAT Investigative D0IH6W DRUG__ID D0IH6W D0IH6W DRUGTYPE Small molecular drug D0IH6W DRUGINCH 1S/C19H18O/c20-19(16-15-18-11-5-2-6-12-18)14-8-7-13-17-9-3-1-4-10-17/h1-14H,15-16H2/b13-7+,14-8+ D0IH6W DRUGINKE OWMJDOUOHDOUFG-FNCQTZNRSA-N D0IH6W DRUGSMIL C1=CC=C(C=C1)CCC(=O)C=CC=CC2=CC=CC=C2 D0IH6W HIGHSTAT Investigative D0IJ2X DRUG__ID D0IJ2X D0IJ2X DRUGTYPE Small molecular drug D0IJ2X DRUGINCH 1S/C8H6N4O2/c1-2-3-12-7(13)5-6(10-4-9-5)11-8(12)14/h1,4H,3H2,(H,9,10)(H,11,14) D0IJ2X DRUGINKE HJYAFKKSAAYVHQ-UHFFFAOYSA-N D0IJ2X DRUGSMIL C#CCN1C(=O)C2=C(NC1=O)N=CN2 D0IJ2X HIGHSTAT Investigative D0IJ7H DRUG__ID D0IJ7H D0IJ7H DRUGTYPE Small molecular drug D0IJ7H DRUGINCH 1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10) D0IJ7H DRUGINKE NPOAOTPXWNWTSH-UHFFFAOYSA-N D0IJ7H DRUGSMIL CC(CC(=O)O)(CC(=O)O)O D0IJ7H HIGHSTAT Investigative D0IK2S DRUG__ID D0IK2S D0IK2S DRUGTYPE Small molecular drug D0IK2S DRUGINCH 1S/C15H11FO2/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-8,14H,9H2 D0IK2S DRUGINKE SZNYRENOXQIQMR-UHFFFAOYSA-N D0IK2S DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)F)C3=CC=CC=C3 D0IK2S HIGHSTAT Investigative D0IK4V DRUG__ID D0IK4V D0IK4V DRUGTYPE Small molecular drug D0IK4V DRUGINCH 1S/C17H20N2/c1-4-19-16-13-9-8-12-15(16)18(3)17(19,2)14-10-6-5-7-11-14/h5-13H,4H2,1-3H3 D0IK4V DRUGINKE QWPMTQMHWWDYRA-UHFFFAOYSA-N D0IK4V DRUGSMIL CCN1C2=CC=CC=C2N(C1(C)C3=CC=CC=C3)C D0IK4V HIGHSTAT Investigative D0IL0G DRUG__ID D0IL0G D0IL0G DRUGTYPE Small molecular drug D0IL0G DRUGINCH 1S/C15H15N3O2/c1-2-3-14(19)16-15-12-5-4-10(8-13(12)17-18-15)11-6-7-20-9-11/h4-9H,2-3H2,1H3,(H2,16,17,18,19) D0IL0G DRUGINKE ZGQZPFJWHPTRAH-UHFFFAOYSA-N D0IL0G DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=COC=C3 D0IL0G HIGHSTAT Investigative D0IL9H DRUG__ID D0IL9H D0IL9H DRUGTYPE Small molecular drug D0IL9H DRUGINCH 1S/C27H31NO/c1-2-9-22-14-16-25(17-15-22)27(29)18-20-28(21-19-27)26(23-10-5-3-6-11-23)24-12-7-4-8-13-24/h3-8,10-17,26,29H,2,9,18-21H2,1H3 D0IL9H DRUGINKE BVRSNRCGJVPHBA-UHFFFAOYSA-N D0IL9H DRUGSMIL CCCC1=CC=C(C=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D0IL9H HIGHSTAT Investigative D0IM1Q DRUG__ID D0IM1Q D0IM1Q DRUGTYPE Small molecular drug D0IM1Q DRUGINCH 1S/C19H14N2O/c1-2-6-14(7-3-1)15-10-12-16(13-11-15)20-19-17-8-4-5-9-18(17)22-21-19/h1-13H,(H,20,21) D0IM1Q DRUGINKE BKHHQJRHPIBTJZ-UHFFFAOYSA-N D0IM1Q DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)NC3=NOC4=CC=CC=C43 D0IM1Q HIGHSTAT Investigative D0IM4E DRUG__ID D0IM4E D0IM4E DRUGTYPE Small molecular drug D0IM4E DRUGINCH 1S/C16H13NO2/c1-10-5-6-15-13(7-10)14(18)9-16(19-15)11-3-2-4-12(17)8-11/h2-9H,17H2,1H3 D0IM4E DRUGINKE JDDRGOPANADJMA-UHFFFAOYSA-N D0IM4E DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC(=CC=C3)N D0IM4E HIGHSTAT Investigative D0IM5E DRUG__ID D0IM5E D0IM5E DRUGTYPE Small molecular drug D0IM5E DRUGINCH 1S/C18H18ClN3O/c1-2-20-11-12-3-5-14(10-18(12)23)22-16-7-8-21-17-9-13(19)4-6-15(16)17/h3-10,20,23H,2,11H2,1H3,(H,21,22) D0IM5E DRUGINKE XWBLHPDICBKAEX-UHFFFAOYSA-N D0IM5E DRUGSMIL CCNCC1=C(C=C(C=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O D0IM5E HIGHSTAT Investigative D0IM5H DRUG__ID D0IM5H D0IM5H DRUGTYPE Small molecular drug D0IM5H DRUGINCH 1S/C40H52N4O6S/c1-6-7-13-18-41-29-19-25(2)36(26(3)20-29)50-23-33(46)42-31(21-27-14-9-8-10-15-27)35(47)39(49)44-24-51-40(4,5)37(44)38(48)43-34-30-17-12-11-16-28(30)22-32(34)45/h8-12,14-17,19-20,31-32,34-35,37,41,45,47H,6-7,13,18,21-24H2,1-5H3,(H,42,46)(H,43,48)/t31-,32+,34-,35-,37+/m0/s1 D0IM5H DRUGINKE MLHPSGOBOHSFGF-IVJJLKHCSA-N D0IM5H DRUGSMIL CCCCCNC1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0IM5H HIGHSTAT Investigative D0IN0X DRUG__ID D0IN0X D0IN0X DRUGTYPE Small molecular drug D0IN0X DRUGINCH 1S/C17H19FN2O3/c18-14-3-1-2-13(8-14)11-23-15-6-4-12(5-7-15)9-20-16(10-21)17(19)22/h1-8,16,20-21H,9-11H2,(H2,19,22)/t16-/m0/s1 D0IN0X DRUGINKE UTIKAYGNKRMHTP-INIZCTEOSA-N D0IN0X DRUGSMIL C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CNC(CO)C(=O)N D0IN0X HIGHSTAT Investigative D0IN7A DRUG__ID D0IN7A D0IN7A DRUGTYPE Small molecular drug D0IN7A DRUGINCH 1S/C7H7Cl2O3PS/c8-4-1-2-5(6(9)3-4)7(14)13(10,11)12/h1-3,7,14H,(H2,10,11,12) D0IN7A DRUGINKE WJVBVZOYOCLGPI-UHFFFAOYSA-N D0IN7A DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C(P(=O)(O)O)S D0IN7A HIGHSTAT Investigative D0IO0I DRUG__ID D0IO0I D0IO0I DRUGTYPE Small molecular drug D0IO0I DRUGINCH 1S/C19H18O5/c1-23-18-11-13(5-9-16(18)21)3-7-15(20)8-4-14-6-10-17(22)19(12-14)24-2/h3-12,21-22H,1-2H3/b7-3+,8-4+ D0IO0I DRUGINKE ISIMGBQRFXXNON-FCXRPNKRSA-N D0IO0I DRUGSMIL COC1=C(C=CC(=C1)C=CC(=O)C=CC2=CC(=C(C=C2)O)OC)O D0IO0I HIGHSTAT Investigative D0IO8J DRUG__ID D0IO8J D0IO8J DRUGTYPE Small molecular drug D0IO8J DRUGINCH 1S/C14H11N/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13/h2-9H,1H3 D0IO8J DRUGINKE NEWKHUASLBMWRE-UHFFFAOYSA-N D0IO8J DRUGSMIL CC1=NC(=CC=C1)C#CC2=CC=CC=C2 D0IO8J HIGHSTAT Investigative D0IP7L DRUG__ID D0IP7L D0IP7L DRUGTYPE Small molecular drug D0IP7L DRUGINCH 1S/C16H21NO/c1-3-8-18-16-7-6-14-10-13(9-12(2)17)4-5-15(14)11-16/h4-7,10-12H,3,8-9,17H2,1-2H3 D0IP7L DRUGINKE CRXAYNAYXGFRGO-UHFFFAOYSA-N D0IP7L DRUGSMIL CCCOC1=CC2=C(C=C1)C=C(C=C2)CC(C)N D0IP7L HIGHSTAT Investigative D0IP9V DRUG__ID D0IP9V D0IP9V DRUGTYPE Small molecular drug D0IP9V DRUGINCH 1S/C15H17N3O2/c19-15(13-6-11-2-4-20-14(11)7-16-13)17-12-5-10-1-3-18(8-10)9-12/h2,4,6-7,10,12H,1,3,5,8-9H2,(H,17,19)/t10-,12-/m1/s1 D0IP9V DRUGINKE PTGWFYYEAUFEAS-ZYHUDNBSSA-N D0IP9V DRUGSMIL C1CN2CC1CC(C2)NC(=O)C3=NC=C4C(=C3)C=CO4 D0IP9V HIGHSTAT Investigative D0IQ0S DRUG__ID D0IQ0S D0IQ0S DRUGTYPE Small molecular drug D0IQ0S DRUGINCH 1S/C33H39N5O5/c1-22(30(40)35-21-25-11-6-3-7-12-25)36-31(41)28(20-23-9-4-2-5-10-23)37-32(42)29-13-8-18-38(29)33(43)27(34)19-24-14-16-26(39)17-15-24/h2-7,9-12,14-17,22,27-29,39H,8,13,18-21,34H2,1H3,(H,35,40)(H,36,41)(H,37,42)/t22-,27-,28-,29-/m0/s1 D0IQ0S DRUGINKE FFJZWXQQTXSXFM-OCDVNBFTSA-N D0IQ0S DRUGSMIL CC(C(=O)NCC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0IQ0S HIGHSTAT Investigative D0IQ4S DRUG__ID D0IQ4S D0IQ4S DRUGTYPE Small molecular drug D0IQ4S DRUGINCH 1S/C7H15BN2O3/c1-5(9)7(11)10-4-2-3-6(10)8(12)13/h5-6,12-13H,2-4,9H2,1H3/p+1/t5-,6-/m0/s1 D0IQ4S DRUGINKE WDFZXMUIFGGBQF-WDSKDSINSA-O D0IQ4S DRUGSMIL B(C1CCCN1C(=O)C(C)[NH3+])(O)O D0IQ4S HIGHSTAT Investigative D0IQ7Y DRUG__ID D0IQ7Y D0IQ7Y DRUGTYPE Small molecular drug D0IQ7Y DRUGINCH 1S/C14H11NOS/c1-10-6-8-11(9-7-10)15-14(16)12-4-2-3-5-13(12)17-15/h2-9H,1H3 D0IQ7Y DRUGINKE KRXMYBAZKJBJAB-UHFFFAOYSA-N D0IQ7Y DRUGSMIL CC1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3S2 D0IQ7Y HIGHSTAT Investigative D0IR0R DRUG__ID D0IR0R D0IR0R DRUGTYPE Small molecular drug D0IR0R DRUGINCH 1S/C15H22ClN/c1-2-5-14(15-6-3-4-11-17-15)12-7-9-13(16)10-8-12/h7-10,14-15,17H,2-6,11H2,1H3 D0IR0R DRUGINKE OICPVJMMZDEJMO-UHFFFAOYSA-N D0IR0R DRUGSMIL CCCC(C1CCCCN1)C2=CC=C(C=C2)Cl D0IR0R HIGHSTAT Investigative D0IR4Y DRUG__ID D0IR4Y D0IR4Y DRUGTYPE Small molecular drug D0IR4Y DRUGINCH 1S/C8H17N3/c9-6-5-7-3-1-2-4-8(10)11-7/h7H,1-6,9H2,(H2,10,11) D0IR4Y DRUGINKE KENFUNZIVHXJNM-UHFFFAOYSA-N D0IR4Y DRUGSMIL C1CCC(=NC(C1)CCN)N D0IR4Y HIGHSTAT Investigative D0IR5I DRUG__ID D0IR5I D0IR5I DRUGTYPE Small molecular drug D0IR5I DRUGINCH 1S/C14H10N2O2/c17-13-5-10-4-11(9-2-1-3-15-7-9)8-16-12(10)6-14(13)18/h1-8,17-18H D0IR5I DRUGINKE QQQXEUOUDIWAIJ-UHFFFAOYSA-N D0IR5I DRUGSMIL C1=CC(=CN=C1)C2=CN=C3C=C(C(=CC3=C2)O)O D0IR5I HIGHSTAT Investigative D0IR6U DRUG__ID D0IR6U D0IR6U DRUGTYPE Small molecular drug D0IR6U DRUGINCH 1S/C18H16FN3O/c1-18(2,3)17-21-14-10-5-4-9(19)8-12(10)13-11(15(14)22-17)6-7-20-16(13)23/h4-8H,1-3H3,(H,20,23)(H,21,22) D0IR6U DRUGINKE VNDWQCSOSCCWIP-UHFFFAOYSA-N D0IR6U DRUGSMIL CC(C)(C)C1=NC2=C(N1)C3=C(C=C(C=C3)F)C4=C2C=CNC4=O D0IR6U HIGHSTAT Investigative D0IR7E DRUG__ID D0IR7E D0IR7E DRUGTYPE Small molecular drug D0IR7E DRUGINCH 1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17,20H,2-16,19H2,1H3/t17-/m0/s1 D0IR7E DRUGINKE KBUNOSOGGAARKZ-KRWDZBQOSA-N D0IR7E DRUGSMIL CCCCCCCCCCCCCCCC(=O)C(CO)N D0IR7E HIGHSTAT Investigative D0IS6B DRUG__ID D0IS6B D0IS6B DRUGTYPE Small molecular drug D0IS6B DRUGINCH 1S/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3 D0IS6B DRUGINKE YNYAYWLBAHXHLL-UHFFFAOYSA-N D0IS6B DRUGSMIL COC1=C(C=CC(=C1)C(CN)O)O D0IS6B HIGHSTAT Investigative D0IT1M DRUG__ID D0IT1M D0IT1M DRUGTYPE Small molecular drug D0IT1M DRUGINCH 1S/C6H12O4/c1-3-2-4(7)5(8)6(9)10-3/h3-9H,2H2,1H3/t3-,4+,5-,6+/m1/s1 D0IT1M DRUGINKE BJBURJZEESAQPG-MOJAZDJTSA-N D0IT1M DRUGSMIL CC1CC(C(C(O1)O)O)O D0IT1M HIGHSTAT Investigative D0IT1P DRUG__ID D0IT1P D0IT1P DRUGTYPE Small molecular drug D0IT1P DRUGINCH 1S/C26H28N4O4/c31-23(15-29-9-1-2-10-29)27-17-5-7-19-21(13-17)26(34)22-14-18(6-8-20(22)25(19)33)28-24(32)16-30-11-3-4-12-30/h5-8,13-14H,1-4,9-12,15-16H2,(H,27,31)(H,28,32) D0IT1P DRUGINKE CJLKYQVGOOCWAC-UHFFFAOYSA-N D0IT1P DRUGSMIL C1CCN(C1)CC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CN5CCCC5 D0IT1P HIGHSTAT Investigative D0IT5D DRUG__ID D0IT5D D0IT5D DRUGTYPE Small molecular drug D0IT5D DRUGINCH 1S/C11H15NO3/c1-2-3-8(11(12)15)7-4-5-9(13)10(14)6-7/h4-6,8,13-14H,2-3H2,1H3,(H2,12,15) D0IT5D DRUGINKE GDXQWRJYXZXWMT-UHFFFAOYSA-N D0IT5D DRUGSMIL CCCC(C1=CC(=C(C=C1)O)O)C(=O)N D0IT5D HIGHSTAT Investigative D0IU2K DRUG__ID D0IU2K D0IU2K DRUGTYPE Small molecular drug D0IU2K DRUGINCH 1S/C20H29N5O5/c1-11(17(22)27)23-18(28)12(2)24-19(29)16-4-3-9-25(16)20(30)15(21)10-13-5-7-14(26)8-6-13/h5-8,11-12,15-16,26H,3-4,9-10,21H2,1-2H3,(H2,22,27)(H,23,28)(H,24,29)/t11-,12-,15-,16-/m0/s1 D0IU2K DRUGINKE UTONSZTXKQBYQC-APYUEPQZSA-N D0IU2K DRUGSMIL CC(C(=O)N)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)N D0IU2K HIGHSTAT Investigative D0IU3X DRUG__ID D0IU3X D0IU3X DRUGTYPE Small molecular drug D0IU3X DRUGINCH 1S/C7H6BrF2NO2S/c8-6-3-1-5(2-4-6)7(9,10)14(11,12)13/h1-4H,(H2,11,12,13) D0IU3X DRUGINKE LKSACQKQUJUBBP-UHFFFAOYSA-N D0IU3X DRUGSMIL C1=CC(=CC=C1C(F)(F)S(=O)(=O)N)Br D0IU3X HIGHSTAT Investigative D0IU5E DRUG__ID D0IU5E D0IU5E DRUGTYPE Small molecular drug D0IU5E DRUGINCH 1S/C17H13N3O2/c21-16(18-14-9-5-2-6-10-14)15-11-12-20(19-15)17(22)13-7-3-1-4-8-13/h1-12H,(H,18,21) D0IU5E DRUGINKE ZYYMCOZRPAHLRN-UHFFFAOYSA-N D0IU5E DRUGSMIL C1=CC=C(C=C1)C(=O)N2C=CC(=N2)C(=O)NC3=CC=CC=C3 D0IU5E HIGHSTAT Investigative D0IU6I DRUG__ID D0IU6I D0IU6I DRUGTYPE Small molecular drug D0IU6I DRUGINCH 1S/C33H40N4O5/c1-33(17-24-18-35-28-5-3-2-4-27(24)28,31(40)36-26(16-29(38)39)15-19-6-8-25(34)9-7-19)37-32(41)42-30-22-11-20-10-21(13-22)14-23(30)12-20/h2-9,18,20-23,26,30,35H,10-17,34H2,1H3,(H,36,40)(H,37,41)(H,38,39)/t20?,21?,22?,23?,26-,30?,33+/m0/s1/i8T,9T D0IU6I DRUGINKE ADYHBZJCWPIGJS-CXVPADNPSA-N D0IU6I DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=C(C=C3)N)CC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0IU6I HIGHSTAT Investigative D0IU8V DRUG__ID D0IU8V D0IU8V DRUGTYPE Small molecular drug D0IU8V DRUGINCH 1S/C17H18N2O2/c20-17-11-14-15(19-17)7-4-8-16(14)21-10-9-18-12-13-5-2-1-3-6-13/h1-8,18H,9-12H2,(H,19,20) D0IU8V DRUGINKE CVWQKEFTSSJDLS-UHFFFAOYSA-N D0IU8V DRUGSMIL C1C2=C(C=CC=C2OCCNCC3=CC=CC=C3)NC1=O D0IU8V HIGHSTAT Investigative D0IV2E DRUG__ID D0IV2E D0IV2E DRUGTYPE Small molecular drug D0IV2E DRUGINCH 1S/C30H52O7P2/c1-23(2)13-9-15-25(5)17-11-18-27(7)21-28-29(22-36-39(34,35)37-38(31,32)33)30(28,8)20-12-19-26(6)16-10-14-24(3)4/h13-14,17,19,21,28-29H,9-12,15-16,18,20,22H2,1-8H3,(H,34,35)(H2,31,32,33)/b25-17+,26-19+,27-21+/t28-,29-,30-/m0/s1 D0IV2E DRUGINKE ATZKAUGGNMSCCY-VYCBRMPGSA-N D0IV2E DRUGSMIL CC(=CCCC(=CCCC(=CC1C(C1(C)CCC=C(C)CCC=C(C)C)COP(=O)(O)OP(=O)(O)O)C)C)C D0IV2E HIGHSTAT Investigative D0IV5D DRUG__ID D0IV5D D0IV5D DRUGTYPE Small molecular drug D0IV5D DRUGINCH 1S/C11H13N3O/c12-7-10(14-11(15)8-13)6-9-4-2-1-3-5-9/h1-5,10H,6,8,13H2,(H,14,15) D0IV5D DRUGINKE QLVGHFBUSGYCCG-UHFFFAOYSA-N D0IV5D DRUGSMIL C1=CC=C(C=C1)CC(C#N)NC(=O)CN D0IV5D HIGHSTAT Investigative D0IV9K DRUG__ID D0IV9K D0IV9K DRUGTYPE Small molecular drug D0IV9K DRUGINCH 1S/C19H20F3NO3/c1-2-3-11-25-16-9-7-14(8-10-16)13-23-18(24)26-17-6-4-5-15(12-17)19(20,21)22/h4-10,12H,2-3,11,13H2,1H3,(H,23,24) D0IV9K DRUGINKE ULJSSIFMAROIAL-UHFFFAOYSA-N D0IV9K DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CC=CC(=C2)C(F)(F)F D0IV9K HIGHSTAT Investigative D0IW4Q DRUG__ID D0IW4Q D0IW4Q DRUGTYPE Small molecular drug D0IW4Q DRUGINCH 1S/C22H24BrNO/c1-3-4-9-14-24-16(2)22(18-11-6-8-13-20(18)24)21(25)15-17-10-5-7-12-19(17)23/h5-8,10-13H,3-4,9,14-15H2,1-2H3 D0IW4Q DRUGINKE VCQGIPSJKBCBFO-UHFFFAOYSA-N D0IW4Q DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3Br)C D0IW4Q HIGHSTAT Investigative D0IW5C DRUG__ID D0IW5C D0IW5C DRUGTYPE Small molecular drug D0IW5C DRUGINCH 1S/C12H9N5/c1-2-10(8-14-5-1)12-15-11(16-17-12)9-3-6-13-7-4-9/h1-8H,(H,15,16,17) D0IW5C DRUGINKE WIHUWTSKKGOEGI-UHFFFAOYSA-N D0IW5C DRUGSMIL C1=CC(=CN=C1)C2=NNC(=N2)C3=CC=NC=C3 D0IW5C HIGHSTAT Investigative D0IW8V DRUG__ID D0IW8V D0IW8V DRUGTYPE Small molecular drug D0IW8V DRUGINCH 1S/C15H18N4O4/c16-10(14(21)19-12(15(22)23)6-13(17)20)5-8-7-18-11-4-2-1-3-9(8)11/h1-4,7,10,12,18H,5-6,16H2,(H2,17,20)(H,19,21)(H,22,23)/t10-,12-/m0/s1 D0IW8V DRUGINKE GRQCSEWEPIHLBI-JQWIXIFHSA-N D0IW8V DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CC(=O)N)C(=O)O)N D0IW8V HIGHSTAT Investigative D0IX0N DRUG__ID D0IX0N D0IX0N DRUGTYPE Small molecular drug D0IX0N DRUGINCH 1S/C11H17N3O2/c1-9-4-5-11(14(15)16)10(8-9)13-7-3-2-6-12/h4-5,8,13H,2-3,6-7,12H2,1H3 D0IX0N DRUGINKE ANIBJVLRYPKMKX-UHFFFAOYSA-N D0IX0N DRUGSMIL CC1=CC(=C(C=C1)[N+](=O)[O-])NCCCCN D0IX0N HIGHSTAT Investigative D0IX1V DRUG__ID D0IX1V D0IX1V DRUGTYPE Small molecular drug D0IX1V DRUGINCH 1S/C17H16BrN/c1-11(19)10-16-12-6-2-4-8-14(12)17(18)15-9-5-3-7-13(15)16/h2-9,11H,10,19H2,1H3 D0IX1V DRUGINKE TUYLBDQSCRSJBH-UHFFFAOYSA-N D0IX1V DRUGSMIL CC(CC1=C2C=CC=CC2=C(C3=CC=CC=C31)Br)N D0IX1V HIGHSTAT Investigative D0IX3I DRUG__ID D0IX3I D0IX3I DRUGTYPE Small molecular drug D0IX3I DRUGINCH 1S/C14H11N3O/c15-14(18)12-8-4-5-10-9-17(16-13(10)12)11-6-2-1-3-7-11/h1-9H,(H2,15,18) D0IX3I DRUGINKE MWXFYWRQDSMARJ-UHFFFAOYSA-N D0IX3I DRUGSMIL C1=CC=C(C=C1)N2C=C3C=CC=C(C3=N2)C(=O)N D0IX3I HIGHSTAT Investigative D0IX7S DRUG__ID D0IX7S D0IX7S DRUGTYPE Small molecular drug D0IX7S DRUGINCH 1S/C5H10NO6P/c6-4(5(8)9)1-3(7)2-13(10,11)12/h4H,1-2,6H2,(H,8,9)(H2,10,11,12)/t4-/m1/s1 D0IX7S DRUGINKE OLCWOBHEVRCMLO-SCSAIBSYSA-N D0IX7S DRUGSMIL C(C(C(=O)O)N)C(=O)CP(=O)(O)O D0IX7S HIGHSTAT Investigative D0IX7Y DRUG__ID D0IX7Y D0IX7Y DRUGTYPE Small molecular drug D0IX7Y DRUGINCH 1S/C20H23BrN8O/c21-17-12-24-19(28-18(17)23-7-6-16-11-22-13-25-16)26-14-4-3-5-15(10-14)27-20(30)29-8-1-2-9-29/h3-5,10-13H,1-2,6-9H2,(H,22,25)(H,27,30)(H2,23,24,26,28) D0IX7Y DRUGINKE DMMILYKXNCVKOJ-UHFFFAOYSA-N D0IX7Y DRUGSMIL C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br D0IX7Y HIGHSTAT Investigative D0IY2V DRUG__ID D0IY2V D0IY2V DRUGTYPE Small molecular drug D0IY2V DRUGINCH 1S/C23H33N3O/c1-24-22(27)25-18-9-8-17-13-21-19-7-2-3-10-23(19,20(17)14-18)11-12-26(21)15-16-5-4-6-16/h8-9,14,16,19,21H,2-7,10-13,15H2,1H3,(H2,24,25,27)/t19-,21+,23+/m0/s1 D0IY2V DRUGINKE URMRSPJBIISGIL-XKCSPQBFSA-N D0IY2V DRUGSMIL CNC(=O)NC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CCC5)C=C1 D0IY2V HIGHSTAT Investigative D0IY3E DRUG__ID D0IY3E D0IY3E DRUGTYPE Small molecular drug D0IY3E DRUGINCH 1S/C33H41N5O4.ClH/c1-6-7-16-38-31-25(12-9-15-35-31)28(22-10-8-11-23(19-22)42-18-17-39)30(32(38)40)37-33(41)36-29-24(20(2)3)13-14-26(34)27(29)21(4)5;/h8-15,19-21,39H,6-7,16-18,34H2,1-5H3,(H2,36,37,41);1H D0IY3E DRUGINKE MXPCZHSTOIKVST-UHFFFAOYSA-N D0IY3E DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=CC(=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OCCO.Cl D0IY3E HIGHSTAT Investigative D0IY5Y DRUG__ID D0IY5Y D0IY5Y DRUGTYPE Small molecular drug D0IY5Y DRUGINCH 1S/C20H17N3O4S/c1-14(23(25)19(21)24)7-12-18-13-22-20(28-18)27-17-10-8-16(9-11-17)26-15-5-3-2-4-6-15/h2-6,8-11,13-14,25H,1H3,(H2,21,24) D0IY5Y DRUGINKE MCMUCDFOFIZPSA-UHFFFAOYSA-N D0IY5Y DRUGSMIL CC(C#CC1=CN=C(S1)OC2=CC=C(C=C2)OC3=CC=CC=C3)N(C(=O)N)O D0IY5Y HIGHSTAT Investigative D0IY9H DRUG__ID D0IY9H D0IY9H DRUGTYPE Small molecular drug D0IY9H DRUGINCH 1S/C25H35N3O3/c1-7-8-9-12-31-21-14-19-18(24(2,3)10-11-25(19,4)5)13-20(21)28(6)23-26-15-17(16-27-23)22(29)30/h13-16H,7-12H2,1-6H3,(H,29,30) D0IY9H DRUGINKE PMHLEYZHMPYVLJ-UHFFFAOYSA-N D0IY9H DRUGSMIL CCCCCOC1=C(C=C2C(=C1)C(CCC2(C)C)(C)C)N(C)C3=NC=C(C=N3)C(=O)O D0IY9H HIGHSTAT Investigative D0IZ1X DRUG__ID D0IZ1X D0IZ1X DRUGTYPE Small molecular drug D0IZ1X DRUGINCH 1S/C17H23NO/c1-4-8-18-9-7-17(3)12(2)16(18)10-13-5-6-14(19)11-15(13)17/h4-6,11-12,16,19H,1,7-10H2,2-3H3/t12-,16+,17+/m1/s1 D0IZ1X DRUGINKE LGQCVMYAEFTEFN-DQYPLSBCSA-N D0IZ1X DRUGSMIL CC1C2CC3=C(C1(CCN2CC=C)C)C=C(C=C3)O D0IZ1X HIGHSTAT Investigative D0IZ4Z DRUG__ID D0IZ4Z D0IZ4Z DRUGTYPE Small molecular drug D0IZ4Z DRUGINCH 1S/C15H11NO3/c17-12-6-4-10(5-7-12)14-9-19-15(16-14)11-2-1-3-13(18)8-11/h1-9,17-18H D0IZ4Z DRUGINKE NOWYSMIMXQPTPC-UHFFFAOYSA-N D0IZ4Z DRUGSMIL C1=CC(=CC(=C1)O)C2=NC(=CO2)C3=CC=C(C=C3)O D0IZ4Z HIGHSTAT Investigative D0IZ8M DRUG__ID D0IZ8M D0IZ8M DRUGTYPE Small molecular drug D0IZ8M DRUGINCH 1S/C25H27ClN8O/c1-25(2)14-27-7-8-34(25)24(35)18-6-5-17(9-19(18)26)31-22-23-28-12-21(16-10-29-30-11-16)33(23)13-20(32-22)15-3-4-15/h5-6,9-13,15,27H,3-4,7-8,14H2,1-2H3,(H,29,30)(H,31,32) D0IZ8M DRUGINKE MEQKJTZVPMNRIL-UHFFFAOYSA-N D0IZ8M DRUGSMIL CC1(CNCCN1C(=O)C2=C(C=C(C=C2)NC3=NC(=CN4C3=NC=C4C5=CNN=C5)C6CC6)Cl)C D0IZ8M HIGHSTAT Investigative D0IZ9O DRUG__ID D0IZ9O D0IZ9O DRUGTYPE Small molecular drug D0IZ9O DRUGINCH 1S/C28H24O3/c29-23-11-15-26-22(18-23)10-6-19-7-12-24(13-8-19)31-25-3-1-2-20(16-25)4-5-21-9-14-27(26)28(30)17-21/h1-3,7-9,11-18,29-30H,4-6,10H2 D0IZ9O DRUGINKE ZCEPVFMKRVLFDX-UHFFFAOYSA-N D0IZ9O DRUGSMIL C1CC2=C(C=CC(=C2)O)C3=C(C=C(CCC4=CC(=CC=C4)OC5=CC=C1C=C5)C=C3)O D0IZ9O HIGHSTAT Investigative D0J0AG DRUG__ID D0J0AG D0J0AG DRUGTYPE Small molecular drug D0J0AG DRUGINCH 1S/C15H10BrNO2/c16-15-11-5-6-12(9-1-3-10(18)4-2-9)17-13(11)7-8-14(15)19/h1-8,18-19H D0J0AG DRUGINKE BLXVDNNULRNBGB-UHFFFAOYSA-N D0J0AG DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C2)C(=C(C=C3)O)Br)O D0J0AG HIGHSTAT Investigative D0J0BV DRUG__ID D0J0BV D0J0BV DRUGTYPE Small molecular drug D0J0BV DRUGINCH 1S/C19H23N5O3/c1-5-12(2)13-6-8-14(9-7-13)21-15(25)10-24-11-20-17-16(24)18(26)23(4)19(27)22(17)3/h6-9,11-12H,5,10H2,1-4H3,(H,21,25) D0J0BV DRUGINKE ZUTUWJYMCADJHD-UHFFFAOYSA-N D0J0BV DRUGSMIL CCC(C)C1=CC=C(C=C1)NC(=O)CN2C=NC3=C2C(=O)N(C(=O)N3C)C D0J0BV HIGHSTAT Investigative D0J0BW DRUG__ID D0J0BW D0J0BW DRUGTYPE Small molecular drug D0J0BW DRUGINCH 1S/C19H15BN/c21-16-20(17-10-4-1-5-11-17,18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15H/q-1 D0J0BW DRUGINKE HYJITQQQMJSBOL-UHFFFAOYSA-N D0J0BW DRUGSMIL [B-](C#N)(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3 D0J0BW HIGHSTAT Investigative D0J0CA DRUG__ID D0J0CA D0J0CA DRUGTYPE Small molecular drug D0J0CA DRUGINCH 1S/C13H10N2O2/c1-17-13(16)11-6-9-8-4-2-3-5-10(8)15-12(9)7-14-11/h2-7,15H,1H3 D0J0CA DRUGINKE UKHFPVCOXBJPIN-UHFFFAOYSA-N D0J0CA DRUGSMIL COC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D0J0CA HIGHSTAT Investigative D0J0CB DRUG__ID D0J0CB D0J0CB DRUGTYPE Small molecular drug D0J0CB DRUGINCH 1S/C20H26N2O3/c1-22(16-6-3-2-4-7-16)20(24)8-5-13-25-17-10-11-18-15(14-17)9-12-19(23)21-18/h9-12,14,16H,2-8,13H2,1H3,(H,21,23) D0J0CB DRUGINKE UIAYVIIHMORPSJ-UHFFFAOYSA-N D0J0CB DRUGSMIL CN(C1CCCCC1)C(=O)CCCOC2=CC3=C(C=C2)NC(=O)C=C3 D0J0CB HIGHSTAT Investigative D0J0CU DRUG__ID D0J0CU D0J0CU DRUGTYPE Small molecular drug D0J0CU DRUGINCH 1S/C14H9N3O2S/c15-8-10-4-1-2-6-13(10)20(18,19)14-7-3-5-12(17)11(14)9-16/h1-7H,17H2 D0J0CU DRUGINKE QVEQBYNJIDMTHN-UHFFFAOYSA-N D0J0CU DRUGSMIL C1=CC=C(C(=C1)C#N)S(=O)(=O)C2=CC=CC(=C2C#N)N D0J0CU HIGHSTAT Investigative D0J0DK DRUG__ID D0J0DK D0J0DK DRUGTYPE Small molecular drug D0J0DK DRUGINCH 1S/C38H45N11O5/c1-22(50)46-33(18-27-20-42-21-45-27)37(54)49-32(16-23-12-13-24-7-2-3-8-25(24)15-23)36(53)47-30(11-6-14-43-38(40)41)35(52)48-31(34(39)51)17-26-19-44-29-10-5-4-9-28(26)29/h2-5,7-10,12-13,15,19-21,30-33,44H,6,11,14,16-18H2,1H3,(H2,39,51)(H,42,45)(H,46,50)(H,47,53)(H,48,52)(H,49,54)(H4,40,41,43)/t30-,31-,32-,33+/m0/s1 D0J0DK DRUGINKE OHBCPCNJWIQQPW-ZWDYZTTJSA-N D0J0DK DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)N D0J0DK HIGHSTAT Investigative D0J0ES DRUG__ID D0J0ES D0J0ES DRUGTYPE Small molecular drug D0J0ES DRUGINCH 1S/C19H21Cl2NO/c1-3-22(4-2)19-11-15(12-5-8-17(20)18(21)9-12)14-7-6-13(23)10-16(14)19/h5-10,15,19,23H,3-4,11H2,1-2H3 D0J0ES DRUGINKE NIIGXDSCJHJWSY-UHFFFAOYSA-N D0J0ES DRUGSMIL CCN(CC)C1CC(C2=C1C=C(C=C2)O)C3=CC(=C(C=C3)Cl)Cl D0J0ES HIGHSTAT Investigative D0J0GM DRUG__ID D0J0GM D0J0GM DRUGTYPE Small molecular drug D0J0GM DRUGINCH 1S/C13H11N3OS/c14-10-3-1-2-4-11(10)17-8-5-6-9-12(7-8)18-16-13(9)15/h1-7H,14H2,(H2,15,16) D0J0GM DRUGINKE HQCTTYOADNAJJR-UHFFFAOYSA-N D0J0GM DRUGSMIL C1=CC=C(C(=C1)N)OC2=CC3=C(C=C2)C(=NS3)N D0J0GM HIGHSTAT Investigative D0J0HK DRUG__ID D0J0HK D0J0HK DRUGTYPE Small molecular drug D0J0HK DRUGINCH 1S/C10H13N5O4/c11-10-13-7-6(8(18)14-10)12-3-15(7)9-5(17)1-4(2-16)19-9/h3-5,9,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,9+/m0/s1 D0J0HK DRUGINKE OROIAVZITJBGSM-OBXARNEKSA-N D0J0HK DRUGSMIL C1C(OC(C1O)N2C=NC3=C2N=C(NC3=O)N)CO D0J0HK HIGHSTAT Investigative D0J0IY DRUG__ID D0J0IY D0J0IY DRUGTYPE Small molecular drug D0J0IY DRUGINCH 1S/C22H14N2O2/c25-21-18-11-5-6-12-19(18)23-22(26)24(21)20-16-9-3-1-7-14(16)13-15-8-2-4-10-17(15)20/h1-13H,(H,23,26) D0J0IY DRUGINKE SISSLRJYACXIQF-UHFFFAOYSA-N D0J0IY DRUGSMIL C1=CC=C2C(=C1)C=C3C=CC=CC3=C2N4C(=O)C5=CC=CC=C5NC4=O D0J0IY HIGHSTAT Investigative D0J0JY DRUG__ID D0J0JY D0J0JY DRUGTYPE Small molecular drug D0J0JY DRUGINCH 1S/C14H30/c1-3-5-7-9-11-13-14-12-10-8-6-4-2/h3-14H2,1-2H3 D0J0JY DRUGINKE BGHCVCJVXZWKCC-UHFFFAOYSA-N D0J0JY DRUGSMIL CCCCCCCCCCCCCC D0J0JY HIGHSTAT Investigative D0J0KC DRUG__ID D0J0KC D0J0KC DRUGTYPE Small molecular drug D0J0KC DRUGINCH 1S/3Na.3H2O2.4O.V/c;;;3*1-2;;;;;/h;;;3*1-2H;;;;;/q3*+1;;;;;3*-1; D0J0KC DRUGINKE PZYFJWVGRGEWGO-UHFFFAOYSA-N D0J0KC DRUGSMIL OO.OO.OO.[O-][V](=O)([O-])[O-].[Na+].[Na+].[Na+] D0J0KC HIGHSTAT Investigative D0J0KG DRUG__ID D0J0KG D0J0KG DRUGTYPE Small molecular drug D0J0KG DRUGINCH 1S/C23H27Cl2N3O3/c24-22-19(6-7-20(29)23(22)25)28-12-10-27(11-13-28)9-1-2-14-31-17-5-3-16-4-8-21(30)26-18(16)15-17/h3,5-7,15,29H,1-2,4,8-14H2,(H,26,30) D0J0KG DRUGINKE YZIVLADPQQPFLO-UHFFFAOYSA-N D0J0KG DRUGSMIL C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=C(C=C4)O)Cl)Cl D0J0KG HIGHSTAT Investigative D0J0MD DRUG__ID D0J0MD D0J0MD DRUGTYPE Small molecular drug D0J0MD DRUGINCH 1S/C16H21NO3/c1-2-3-4-5-6-13-7-9-14(10-8-13)17-15(18)11-12-16(19)20/h7-12H,2-6H2,1H3,(H,17,18)(H,19,20)/b12-11- D0J0MD DRUGINKE OOWYMHDWBQTCOX-QXMHVHEDSA-N D0J0MD DRUGSMIL CCCCCCC1=CC=C(C=C1)NC(=O)C=CC(=O)O D0J0MD HIGHSTAT Investigative D0J0MX DRUG__ID D0J0MX D0J0MX DRUGTYPE Small molecular drug D0J0MX DRUGINCH 1S/C16H14/c1-3-9-15(10-4-1)13-7-8-14-16-11-5-2-6-12-16/h1-14H/b13-7+,14-8+ D0J0MX DRUGINKE JFLKFZNIIQFQBS-FNCQTZNRSA-N D0J0MX DRUGSMIL C1=CC=C(C=C1)C=CC=CC2=CC=CC=C2 D0J0MX HIGHSTAT Investigative D0J0NS DRUG__ID D0J0NS D0J0NS DRUGTYPE Small molecular drug D0J0NS DRUGINCH 1S/C51H67N9O14S/c1-5-8-18-37(52-4)46(65)57-41(28-45(63)64)47(66)56-39(25-31-15-11-10-12-16-31)49(68)60-50(69)40(27-33-29-53-36-19-14-13-17-35(33)36)58-51(70)42(61)30-54-43(20-9-6-2)59-48(67)38(55-44(62)7-3)26-32-21-23-34(24-22-32)74-75(71,72)73/h10-17,19,21-24,29,37-41,43,52-54H,5-9,18,20,25-28,30H2,1-4H3,(H,55,62)(H,56,66)(H,57,65)(H,58,70)(H,59,67)(H,63,64)(H,60,68,69)(H,71,72,73)/t37-,38-,39-,40-,41-,43-/m0/s1/i3T3,7T2 D0J0NS DRUGINKE VNNMDTHCFFZSSJ-LWSGDBLMSA-N D0J0NS DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(=O)CNC(CCCC)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)CC)NC D0J0NS HIGHSTAT Investigative D0J0OY DRUG__ID D0J0OY D0J0OY DRUGTYPE Small molecular drug D0J0OY DRUGINCH 1S/C16H14ClNO2S/c17-14-8-6-13(7-9-14)16-18(15(19)11-21-16)20-10-12-4-2-1-3-5-12/h1-9,16H,10-11H2 D0J0OY DRUGINKE HYDHJKJHWORBLX-UHFFFAOYSA-N D0J0OY DRUGSMIL C1C(=O)N(C(S1)C2=CC=C(C=C2)Cl)OCC3=CC=CC=C3 D0J0OY HIGHSTAT Investigative D0J0QW DRUG__ID D0J0QW D0J0QW DRUGTYPE Small molecular drug D0J0QW DRUGINCH 1S/C12H17NOS/c1-2-14-11-5-3-10(4-6-11)12-9-13-7-8-15-12/h3-6,12-13H,2,7-9H2,1H3 D0J0QW DRUGINKE GGYNYZIHJHLRIZ-UHFFFAOYSA-N D0J0QW DRUGSMIL CCOC1=CC=C(C=C1)C2CNCCS2 D0J0QW HIGHSTAT Investigative D0J0TP DRUG__ID D0J0TP D0J0TP DRUGTYPE Small molecular drug D0J0TP DRUGINCH 1S/C40H33F3N4O3/c1-46(25-26-11-5-3-6-12-26)39(50)36(28-13-7-4-8-14-28)45-38(49)35-24-29-23-31(21-22-34(29)47(35)2)44-37(48)33-16-10-9-15-32(33)27-17-19-30(20-18-27)40(41,42)43/h3-24,36H,25H2,1-2H3,(H,44,48)(H,45,49)/t36-/m0/s1 D0J0TP DRUGINKE TUOSYWCFRFNJBS-BHVANESWSA-N D0J0TP DRUGSMIL CN1C2=C(C=C(C=C2)NC(=O)C3=CC=CC=C3C4=CC=C(C=C4)C(F)(F)F)C=C1C(=O)NC(C5=CC=CC=C5)C(=O)N(C)CC6=CC=CC=C6 D0J0TP HIGHSTAT Investigative D0J0WJ DRUG__ID D0J0WJ D0J0WJ DRUGTYPE Small molecular drug D0J0WJ DRUGINCH 1S/C17H23N3O4/c1-2-3-11-18-16(22)12-14(17(23)20-24)19-15(21)10-9-13-7-5-4-6-8-13/h4-10,14,24H,2-3,11-12H2,1H3,(H,18,22)(H,19,21)(H,20,23)/b10-9+/t14-/m1/s1 D0J0WJ DRUGINKE INBRHSSIAXLSEI-ATWMFIQVSA-N D0J0WJ DRUGSMIL CCCCNC(=O)CC(C(=O)NO)NC(=O)C=CC1=CC=CC=C1 D0J0WJ HIGHSTAT Investigative D0J0WO DRUG__ID D0J0WO D0J0WO DRUGTYPE Small molecular drug D0J0WO DRUGINCH 1S/C12H8FNO/c13-11-3-1-9(2-4-11)12(15)10-5-7-14-8-6-10/h1-8H D0J0WO DRUGINKE WTRWBYGUMQEFFI-UHFFFAOYSA-N D0J0WO DRUGSMIL C1=CC(=CC=C1C(=O)C2=CC=NC=C2)F D0J0WO HIGHSTAT Investigative D0J0YB DRUG__ID D0J0YB D0J0YB DRUGTYPE Small molecular drug D0J0YB DRUGINCH 1S/C13H22N2O2/c16-2-1-14-12(17)15-13-6-9-3-10(7-13)5-11(4-9)8-13/h9-11,16H,1-8H2,(H2,14,15,17) D0J0YB DRUGINKE BBHYFNMMUBVBEX-UHFFFAOYSA-N D0J0YB DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCO D0J0YB HIGHSTAT Investigative D0J0ZF DRUG__ID D0J0ZF D0J0ZF DRUGTYPE Small molecular drug D0J0ZF DRUGINCH 1S/C19H24O6/c1-11(2)18(22)24-10-13-5-4-6-14(9-20)16(21)8-15-12(3)19(23)25-17(15)7-13/h6-7,11,15,17,20H,3-5,8-10H2,1-2H3/b13-7-,14-6+/t15-,17+/m0/s1 D0J0ZF DRUGINKE TXZUNEFLWSLHBF-UZBZFLIQSA-N D0J0ZF DRUGSMIL CC(C)C(=O)OCC1=CC2C(CC(=O)C(=CCC1)CO)C(=C)C(=O)O2 D0J0ZF HIGHSTAT Investigative D0J0ZK DRUG__ID D0J0ZK D0J0ZK DRUGTYPE Small molecular drug D0J0ZK DRUGINCH 1S/C43H51N3O8/c1-30(31-12-13-36(49-2)37(22-31)50-3)29-44(16-8-10-18-45-20-14-32-23-38(51-4)40(53-6)25-34(32)27-42(45)47)17-9-11-19-46-21-15-33-24-39(52-5)41(54-7)26-35(33)28-43(46)48/h8-15,20-26,30H,16-19,27-29H2,1-7H3/b10-8-,11-9-/t30-/m0/s1 D0J0ZK DRUGINKE WCJGGTAAPIAIJS-PSEQGZRXSA-N D0J0ZK DRUGSMIL CC(CN(CC=CCN1C=CC2=CC(=C(C=C2CC1=O)OC)OC)CC=CCN3C=CC4=CC(=C(C=C4CC3=O)OC)OC)C5=CC(=C(C=C5)OC)OC D0J0ZK HIGHSTAT Investigative D0J1AE DRUG__ID D0J1AE D0J1AE DRUGTYPE Small molecular drug D0J1AE DRUGINCH 1S/C18H23N/c1-3-9-17(10-4-1)13-7-8-15-19-16-14-18-11-5-2-6-12-18/h1-6,9-12,19H,7-8,13-16H2 D0J1AE DRUGINKE HMGFNEMDDFFJES-UHFFFAOYSA-N D0J1AE DRUGSMIL C1=CC=C(C=C1)CCCCNCCC2=CC=CC=C2 D0J1AE HIGHSTAT Investigative D0J1AW DRUG__ID D0J1AW D0J1AW DRUGTYPE Small molecular drug D0J1AW DRUGINCH 1S/C13H12N2O3S/c14-19(17,18)13-6-4-11(5-7-13)15-9-10-2-1-3-12(16)8-10/h1-9,16H,(H2,14,17,18) D0J1AW DRUGINKE FNUVWCBUDJAFOI-UHFFFAOYSA-N D0J1AW DRUGSMIL C1=CC(=CC(=C1)O)C=NC2=CC=C(C=C2)S(=O)(=O)N D0J1AW HIGHSTAT Investigative D0J1AY DRUG__ID D0J1AY D0J1AY DRUGTYPE Small molecular drug D0J1AY DRUGINCH 1S/C11H17N2O7P/c1-6-10(14)9(4-13-7(2)11(15)16)8(3-12-6)5-20-21(17,18)19/h3,7,13-14H,4-5H2,1-2H3,(H,15,16)(H2,17,18,19) D0J1AY DRUGINKE WACJCHFWJNNBPR-UHFFFAOYSA-N D0J1AY DRUGSMIL CC1=NC=C(C(=C1O)CNC(C)C(=O)O)COP(=O)(O)O D0J1AY HIGHSTAT Investigative D0J1BA DRUG__ID D0J1BA D0J1BA DRUGTYPE Small molecular drug D0J1BA DRUGINCH 1S/C31H27NO4/c1-3-35-30(33)27-22(2)32-29(25-17-11-6-12-18-25)28(26(27)20-19-23-13-7-4-8-14-23)31(34)36-21-24-15-9-5-10-16-24/h4-18,26,32H,3,21H2,1-2H3 D0J1BA DRUGINKE SNVFDPHQAOXWJZ-UHFFFAOYSA-N D0J1BA DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C#CC2=CC=CC=C2)C(=O)OCC3=CC=CC=C3)C4=CC=CC=C4)C D0J1BA HIGHSTAT Investigative D0J1CC DRUG__ID D0J1CC D0J1CC DRUGTYPE Small molecular drug D0J1CC DRUGINCH 1S/C20H15BrF2N4O2S3/c1-30-20-17(7-16(31-20)19(24)25)32(28,29)12-5-13(21)18-15(6-12)26-9-27(18)8-10-4-11(22)2-3-14(10)23/h2-7,9H,8H2,1H3,(H3,24,25) D0J1CC DRUGINKE HEZXZGJJNMPIJM-UHFFFAOYSA-N D0J1CC DRUGSMIL CSC1=C(C=C(S1)C(=N)N)S(=O)(=O)C2=CC3=C(C(=C2)Br)N(C=N3)CC4=C(C=CC(=C4)F)F D0J1CC HIGHSTAT Investigative D0J1DW DRUG__ID D0J1DW D0J1DW DRUGTYPE Small molecular drug D0J1DW DRUGINCH 1S/C30H51N/c1-25(2)13-9-16-28(5)19-10-17-26(3)14-7-8-15-27(4)18-11-20-29(6)21-12-24-31-30-22-23-30/h13-15,19-20,30-31H,7-12,16-18,21-24H2,1-6H3/b26-14+,27-15+,28-19+,29-20+ D0J1DW DRUGINKE AWTJYTFLSJBJTO-CQNOQWDGSA-N D0J1DW DRUGSMIL CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCCNC1CC1)C)C)C D0J1DW HIGHSTAT Investigative D0J1GM DRUG__ID D0J1GM D0J1GM DRUGTYPE Small molecular drug D0J1GM DRUGINCH 1S/C30H48O3/c1-18-10-13-27(5)16-17-30(25(32)33)20(24(27)19(18)2)8-9-22-28(6)14-12-23(31)26(3,4)21(28)11-15-29(22,30)7/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21?,22-,23+,24-,27-,28+,29-,30-/m1/s1 D0J1GM DRUGINKE RXVRYAUOTRSYDU-RKQWDYETSA-N D0J1GM DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C(=O)O)C D0J1GM HIGHSTAT Investigative D0J1HP DRUG__ID D0J1HP D0J1HP DRUGTYPE Small molecular drug D0J1HP DRUGINCH 1S/C17H19NO2/c19-15-8-6-14-7-9-16(20-17(14)10-15)12-18-11-13-4-2-1-3-5-13/h1-6,8,10,16,18-19H,7,9,11-12H2/t16-/m1/s1 D0J1HP DRUGINKE DWUAAOIZQFTYQP-MRXNPFEDSA-N D0J1HP DRUGSMIL C1CC2=C(C=C(C=C2)O)OC1CNCC3=CC=CC=C3 D0J1HP HIGHSTAT Investigative D0J1IE DRUG__ID D0J1IE D0J1IE DRUGTYPE Small molecular drug D0J1IE DRUGINCH 1S/C11H11NOS/c1-14-8-10-4-5-11(13-10)9-3-2-6-12-7-9/h2-7H,8H2,1H3 D0J1IE DRUGINKE QSLAHFFHHYZNQL-UHFFFAOYSA-N D0J1IE DRUGSMIL CSCC1=CC=C(O1)C2=CN=CC=C2 D0J1IE HIGHSTAT Investigative D0J1IX DRUG__ID D0J1IX D0J1IX DRUGTYPE Small molecular drug D0J1IX DRUGINCH 1S/C20H15NOS/c22-20(14-15-8-2-1-3-9-15)21-16-10-4-6-12-18(16)23-19-13-7-5-11-17(19)21/h1-13H,14H2 D0J1IX DRUGINKE ODRJXAKDUXFICI-UHFFFAOYSA-N D0J1IX DRUGSMIL C1=CC=C(C=C1)CC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0J1IX HIGHSTAT Investigative D0J1JB DRUG__ID D0J1JB D0J1JB DRUGTYPE Small molecular drug D0J1JB DRUGINCH 1S/C21H12N2O2S2/c24-21(25)13-6-5-12-10-15-16(11-14(12)9-13)23-20(18-4-2-8-27-18)19(22-15)17-3-1-7-26-17/h1-11H,(H,24,25) D0J1JB DRUGINKE GXGUVSXXUOACEX-UHFFFAOYSA-N D0J1JB DRUGSMIL C1=CSC(=C1)C2=NC3=C(C=C4C=C(C=CC4=C3)C(=O)O)N=C2C5=CC=CS5 D0J1JB HIGHSTAT Investigative D0J1KH DRUG__ID D0J1KH D0J1KH DRUGTYPE Small molecular drug D0J1KH DRUGINCH 1S/C14H14O4S2/c15-5-7-19-13-11(17)9-3-1-2-4-10(9)12(18)14(13)20-8-6-16/h1-4,15-16H,5-8H2 D0J1KH DRUGINKE MAASHDQFQDDECQ-UHFFFAOYSA-N D0J1KH DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=C(C2=O)SCCO)SCCO D0J1KH HIGHSTAT Investigative D0J1LO DRUG__ID D0J1LO D0J1LO DRUGTYPE Small molecular drug D0J1LO DRUGINCH 1S/C4H10N2S/c1-3(2)7-4(5)6/h3H,1-2H3,(H3,5,6) D0J1LO DRUGINKE XSSNABKEYXKKMK-UHFFFAOYSA-N D0J1LO DRUGSMIL CC(C)SC(=N)N D0J1LO HIGHSTAT Investigative D0J1LX DRUG__ID D0J1LX D0J1LX DRUGTYPE Small molecular drug D0J1LX DRUGINCH 1S/C19H24O5/c1-18(2)12-6-7-19(18,3)15(10-12)24-16(22)5-4-11-8-13(20)17(23)14(21)9-11/h4-5,8-9,12,15,20-21,23H,6-7,10H2,1-3H3/b5-4+/t12?,15?,19-/m1/s1 D0J1LX DRUGINKE IMMWANKYSKQCQN-UOAQAXRFSA-N D0J1LX DRUGSMIL CC1(C2CCC1(C(C2)OC(=O)C=CC3=CC(=C(C(=C3)O)O)O)C)C D0J1LX HIGHSTAT Investigative D0J1PG DRUG__ID D0J1PG D0J1PG DRUGTYPE Small molecular drug D0J1PG DRUGINCH 1S/C5H7N3O4/c6-2(5(10)11)1-3-4(9)8-12-7-3/h2H,1,6H2,(H,8,9)(H,10,11) D0J1PG DRUGINKE LSAPTLMISILBOS-UHFFFAOYSA-N D0J1PG DRUGSMIL C(C1=NONC1=O)C(C(=O)O)N D0J1PG HIGHSTAT Investigative D0J1PJ DRUG__ID D0J1PJ D0J1PJ DRUGTYPE Small molecular drug D0J1PJ DRUGINCH 1S/C19H26Cl2N2O.CH4O3S/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23;1-5(2,3)4/h8-9,12,17-18H,2-7,10-11,13H2,1H3;1H3,(H,2,3,4)/t17-,18-;/m1./s1 D0J1PJ DRUGINKE OJPHNZCUXUUVKU-JAXOOIEVSA-N D0J1PJ DRUGSMIL CN(C1CCCCC1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl.CS(=O)(=O)O D0J1PJ HIGHSTAT Investigative D0J1PL DRUG__ID D0J1PL D0J1PL DRUGTYPE Small molecular drug D0J1PL DRUGINCH 1S/C18H21NO4/c1-2-3-4-5-6-14-7-12-18(17(20)13-14)23-16-10-8-15(9-11-16)19(21)22/h7-13,20H,2-6H2,1H3 D0J1PL DRUGINKE NNNQXCYHIVPZRH-UHFFFAOYSA-N D0J1PL DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=C(C=C2)[N+](=O)[O-])O D0J1PL HIGHSTAT Investigative D0J1PZ DRUG__ID D0J1PZ D0J1PZ DRUGTYPE Small molecular drug D0J1PZ DRUGINCH 1S/C4H5N3OS2/c1-2(8)5-3-6-7-4(9)10-3/h1H3,(H,7,9)(H,5,6,8) D0J1PZ DRUGINKE DWSMAMSVZRCQMP-UHFFFAOYSA-N D0J1PZ DRUGSMIL CC(=O)NC1=NNC(=S)S1 D0J1PZ HIGHSTAT Investigative D0J1QT DRUG__ID D0J1QT D0J1QT DRUGTYPE Small molecular drug D0J1QT DRUGINCH 1S/C31H37N7O5/c1-20-16-22-17-23(10-12-26(22)43-20)33-31(35-28(40)21-9-11-24(32-18-21)29(41)36(2)3)34-25-8-4-5-15-38(30(25)42)19-27(39)37-13-6-7-14-37/h9-12,16-18,25H,4-8,13-15,19H2,1-3H3,(H2,33,34,35,40)/t25-/m0/s1 D0J1QT DRUGINKE YLSKCQOVDOZHTQ-VWLOTQADSA-N D0J1QT DRUGSMIL CC1=CC2=C(O1)C=CC(=C2)NC(=NC3CCCCN(C3=O)CC(=O)N4CCCC4)NC(=O)C5=CN=C(C=C5)C(=O)N(C)C D0J1QT HIGHSTAT Investigative D0J1SA DRUG__ID D0J1SA D0J1SA DRUGTYPE Small molecular drug D0J1SA DRUGINCH 1S/C22H30O7/c1-10-6-15-20(27,17(10)25)8-13(9-23)7-14-16-19(4,5)22(16,29-12(3)24)18(26)11(2)21(14,15)28/h6-7,11,14-16,18,23,26-28H,8-9H2,1-5H3/t11-,14+,15-,16-,18-,20-,21-,22-/m1/s1 D0J1SA DRUGINKE SDSVJYOOAPRSDA-RPCQODIISA-N D0J1SA DRUGSMIL CC1C(C2(C(C2(C)C)C3C1(C4C=C(C(=O)C4(CC(=C3)CO)O)C)O)OC(=O)C)O D0J1SA HIGHSTAT Investigative D0J1SX DRUG__ID D0J1SX D0J1SX DRUGTYPE Small molecular drug D0J1SX DRUGINCH 1S/C32H48O8/c1-7-9-11-13-24(34)39-28-20(4)31(38)22(16-21(18-33)17-30(37)23(31)15-19(3)27(30)36)26-29(5,6)32(26,28)40-25(35)14-12-10-8-2/h15-16,20,22-23,26,28,33,37-38H,7-14,17-18H2,1-6H3/t20-,22+,23-,26-,28-,30+,31-,32-/m1/s1 D0J1SX DRUGINKE XGPRSRGBAHBMAF-QYSBVNMQSA-N D0J1SX DRUGSMIL CCCCCC(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)CCCCC)O)C D0J1SX HIGHSTAT Investigative D0J1VB DRUG__ID D0J1VB D0J1VB DRUGTYPE Small molecular drug D0J1VB DRUGINCH 1S/C11H13N3S/c1-3-13-11(9-2-8-15-10(1)9)14-6-4-12-5-7-14/h1-3,8,12H,4-7H2 D0J1VB DRUGINKE RVGRTFBJOXMFAX-UHFFFAOYSA-N D0J1VB DRUGSMIL C1CN(CCN1)C2=NC=CC3=C2C=CS3 D0J1VB HIGHSTAT Investigative D0J1VS DRUG__ID D0J1VS D0J1VS DRUGTYPE Small molecular drug D0J1VS DRUGINCH 1S/C17H16N4O3/c22-21(23)12-3-4-15-13(10-12)14(16-2-1-9-24-16)11-17(19-15)20-7-5-18-6-8-20/h1-4,9-11,18H,5-8H2 D0J1VS DRUGINKE APJKUNDSNZQZPA-UHFFFAOYSA-N D0J1VS DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)C4=CC=CO4 D0J1VS HIGHSTAT Investigative D0J1XP DRUG__ID D0J1XP D0J1XP DRUGTYPE Small molecular drug D0J1XP DRUGINCH 1S/C13H11N3O4/c17-12-7-6-10(16(19)20)8-11(12)15-13(18)14-9-4-2-1-3-5-9/h1-8,17H,(H2,14,15,18) D0J1XP DRUGINKE MHNNUSRLYWTBJF-UHFFFAOYSA-N D0J1XP DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=C(C=CC(=C2)[N+](=O)[O-])O D0J1XP HIGHSTAT Investigative D0J1XZ DRUG__ID D0J1XZ D0J1XZ DRUGTYPE Small molecular drug D0J1XZ DRUGINCH 1S/C24H23NO9P2S/c26-24(35(27,28)29,36(30,31)32)16-17-5-3-8-19(13-17)20-9-4-10-22(14-20)25-37(33,34)23-12-11-18-6-1-2-7-21(18)15-23/h1-15,25-26H,16H2,(H2,27,28,29)(H2,30,31,32) D0J1XZ DRUGINKE MZVWVRVNMXTDAK-UHFFFAOYSA-N D0J1XZ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)NC3=CC=CC(=C3)C4=CC=CC(=C4)CC(O)(P(=O)(O)O)P(=O)(O)O D0J1XZ HIGHSTAT Investigative D0J2AE DRUG__ID D0J2AE D0J2AE DRUGTYPE Small molecular drug D0J2AE DRUGINCH 1S/C6H8N2O2S/c7-5-2-1-3-6(4-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10) D0J2AE DRUGINKE JPVKCHIPRSQDKL-UHFFFAOYSA-N D0J2AE DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)N)N D0J2AE HIGHSTAT Investigative D0J2CR DRUG__ID D0J2CR D0J2CR DRUGTYPE Small molecular drug D0J2CR DRUGINCH 1S/C23H25F3N4O5.CH4O3S/c1-30-12-20(23(24,25)26)29-22(30)14-2-4-16(5-3-14)35-13-15(31)11-28-8-9-34-17-6-7-19(32)18(10-17)21(27)33;1-5(2,3)4/h2-7,10,12,15,28,31-32H,8-9,11,13H2,1H3,(H2,27,33);1H3,(H,2,3,4) D0J2CR DRUGINKE VFPOVCXWKBYDNF-UHFFFAOYSA-N D0J2CR DRUGSMIL CN1C=C(N=C1C2=CC=C(C=C2)OCC(CNCCOC3=CC(=C(C=C3)O)C(=O)N)O)C(F)(F)F.CS(=O)(=O)O D0J2CR HIGHSTAT Investigative D0J2EE DRUG__ID D0J2EE D0J2EE DRUGTYPE Small molecular drug D0J2EE DRUGINCH 1S/C30H50O5/c1-3-5-7-9-11-13-15-17-19-21-24(31)28-26(33)23-27(34)29(30(28)35)25(32)22-20-18-16-14-12-10-8-6-4-2/h23,33-35H,3-22H2,1-2H3 D0J2EE DRUGINKE AIKYCZDMJFKXLS-UHFFFAOYSA-N D0J2EE DRUGSMIL CCCCCCCCCCCC(=O)C1=C(C(=C(C=C1O)O)C(=O)CCCCCCCCCCC)O D0J2EE HIGHSTAT Investigative D0J2FY DRUG__ID D0J2FY D0J2FY DRUGTYPE Small molecular drug D0J2FY DRUGINCH 1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/t10-,11-,13-,14-,15+,16+,20+,21+/m0/s1 D0J2FY DRUGINKE XJLXINKUBYWONI-XCSFTKGKSA-N D0J2FY DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=O)N D0J2FY HIGHSTAT Investigative D0J2ID DRUG__ID D0J2ID D0J2ID DRUGTYPE Small molecular drug D0J2ID DRUGINCH 1S/C14H12ClN3O/c15-11-4-3-10-5-7-18(13(10)8-11)14(19)17-12-2-1-6-16-9-12/h1-4,6,8-9H,5,7H2,(H,17,19) D0J2ID DRUGINKE LOMPSBWQXLVHJX-UHFFFAOYSA-N D0J2ID DRUGSMIL C1CN(C2=C1C=CC(=C2)Cl)C(=O)NC3=CN=CC=C3 D0J2ID HIGHSTAT Investigative D0J2IK DRUG__ID D0J2IK D0J2IK DRUGTYPE Small molecular drug D0J2IK DRUGINCH 1S/C51H60N8O7/c1-28-18-37(60)19-29(2)39(28)24-41(52)50(65)58-26-35-12-8-6-10-33(35)22-45(58)48(63)54-16-14-43-32(5)56-44(47(62)57-43)15-17-55-49(64)46-23-34-11-7-9-13-36(34)27-59(46)51(66)42(53)25-40-30(3)20-38(61)21-31(40)4/h6-13,18-21,41-42,45-46,60-61H,14-17,22-27,52-53H2,1-5H3,(H,54,63)(H,55,64)(H,57,62)/t41-,42-,45?,46?/m0/s1 D0J2IK DRUGINKE OOTASVYBVWGNJP-KJLUANBESA-N D0J2IK DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCC4=C(N=C(C(=O)N4)CCNC(=O)C5CC6=CC=CC=C6CN5C(=O)C(CC7=C(C=C(C=C7C)O)C)N)C)N)C)O D0J2IK HIGHSTAT Investigative D0J2JM DRUG__ID D0J2JM D0J2JM DRUGTYPE Small molecular drug D0J2JM DRUGINCH 1S/C8H15NO5/c10-3-1-5(12)9-2-4(11)8(14)6(9)7(3)13/h3-8,10-14H,1-2H2/t3-,4-,5-,6+,7-,8-/m1/s1 D0J2JM DRUGINKE HHLGVTQXFOVXKK-CVBHLRHXSA-N D0J2JM DRUGSMIL C1C(C(C2C(C(CN2C1O)O)O)O)O D0J2JM HIGHSTAT Investigative D0J2NG DRUG__ID D0J2NG D0J2NG DRUGTYPE Small molecular drug D0J2NG DRUGINCH 1S/C22H26O5/c1-2-3-4-5-6-7-16-17(24)12-18(25)21-19(26)13-20(27-22(16)21)14-8-10-15(23)11-9-14/h8-12,20,23-25H,2-7,13H2,1H3/t20-/m0/s1 D0J2NG DRUGINKE JDJYVQUSVHXJHY-FQEVSTJZSA-N D0J2NG DRUGSMIL CCCCCCCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D0J2NG HIGHSTAT Investigative D0J2NS DRUG__ID D0J2NS D0J2NS DRUGTYPE Small molecular drug D0J2NS DRUGINCH 1S/C6H13NO5.ClH/c7-3-5(10)4(9)2(1-8)12-6(3)11;/h2-6,8-11H,1,7H2;1H/t2-,3-,4-,5-,6-;/m1./s1 D0J2NS DRUGINKE QKPLRMLTKYXDST-OCOFDJSDSA-N D0J2NS DRUGSMIL C(C1C(C(C(C(O1)O)N)O)O)O.Cl D0J2NS HIGHSTAT Investigative D0J2PO DRUG__ID D0J2PO D0J2PO DRUGTYPE Small molecular drug D0J2PO DRUGINCH 1S/C25H22O7/c1-10(2)12-7-13-21(29)20-15(27)9-17-11(5-6-25(3,4)32-17)23(20)31-24(13)19-14(26)8-16(28)22(30)18(12)19/h5-6,8-9,12,26-28,30H,1,7H2,2-4H3/t12-/m1/s1 D0J2PO DRUGINKE ZIYAGIMFLYOZDS-GFCCVEGCSA-N D0J2PO DRUGSMIL CC(=C)C1CC2=C(C3=C1C(=C(C=C3O)O)O)OC4=C(C2=O)C(=CC5=C4C=CC(O5)(C)C)O D0J2PO HIGHSTAT Investigative D0J2PW DRUG__ID D0J2PW D0J2PW DRUGTYPE Small molecular drug D0J2PW DRUGINCH 1S/C9H8O4/c10-5-7-3-1-2-4-8(7)13-6-9(11)12/h1-5H,6H2,(H,11,12) D0J2PW DRUGINKE ANWMNLAAFDCKMT-UHFFFAOYSA-N D0J2PW DRUGSMIL C1=CC=C(C(=C1)C=O)OCC(=O)O D0J2PW HIGHSTAT Investigative D0J2RI DRUG__ID D0J2RI D0J2RI DRUGTYPE Small molecular drug D0J2RI DRUGINCH 1S/C7H14N2/c1-3-6-4-9-7(8)5(6)2/h5-6H,3-4H2,1-2H3,(H2,8,9) D0J2RI DRUGINKE BIWSZTWZJHYWGX-UHFFFAOYSA-N D0J2RI DRUGSMIL CCC1CN=C(C1C)N D0J2RI HIGHSTAT Investigative D0J2SM DRUG__ID D0J2SM D0J2SM DRUGTYPE Small molecular drug D0J2SM DRUGINCH 1S/C14H8INO2/c15-11-7-3-1-5-9(11)13-16-12-8-4-2-6-10(12)14(17)18-13/h1-8H D0J2SM DRUGINKE VEBIXPCJYGGBAF-UHFFFAOYSA-N D0J2SM DRUGSMIL C1=CC=C2C(=C1)C(=O)OC(=N2)C3=CC=CC=C3I D0J2SM HIGHSTAT Investigative D0J2UA DRUG__ID D0J2UA D0J2UA DRUGTYPE Small molecular drug D0J2UA DRUGINCH 1S/C14H13BrN4O/c1-18-12(13(20)19(2)14(18)16)5-8-7-17-11-6-9(15)3-4-10(8)11/h3-7,16,20H,1-2H3/b8-5+,16-14? D0J2UA DRUGINKE RZEXTWCYINCKES-JENRKBSESA-N D0J2UA DRUGSMIL CN1C(=C(N(C1=N)C)O)C=C2C=NC3=C2C=CC(=C3)Br D0J2UA HIGHSTAT Investigative D0J2UJ DRUG__ID D0J2UJ D0J2UJ DRUGTYPE Small molecular drug D0J2UJ DRUGINCH 1S/CCl3NO2/c2-1(3,4)5(6)7 D0J2UJ DRUGINKE LFHISGNCFUNFFM-UHFFFAOYSA-N D0J2UJ DRUGSMIL C([N+](=O)[O-])(Cl)(Cl)Cl D0J2UJ HIGHSTAT Investigative D0J2UW DRUG__ID D0J2UW D0J2UW DRUGTYPE Small molecular drug D0J2UW DRUGINCH 1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1 D0J2UW DRUGINKE PAOANWZGLPPROA-RQXXJAGISA-N D0J2UW DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)O)N)O)O D0J2UW HIGHSTAT Investigative D0J2VQ DRUG__ID D0J2VQ D0J2VQ DRUGTYPE Small molecular drug D0J2VQ DRUGINCH 1S/C38H67NO12/c1-14-26-38(11,44)31(41)21(5)29-19(3)17-37(10,51-29)33(50-35-28(40)25(39(12)15-2)16-20(4)46-35)22(6)30(23(7)34(43)48-26)49-27-18-36(9,45-13)32(42)24(8)47-27/h20-28,30-33,35,40-42,44H,14-18H2,1-13H3/t20-,21+,22+,23-,24+,25+,26-,27+,28-,30+,31-,32+,33-,35+,36-,37+,38-/m1/s1 D0J2VQ DRUGINKE UTTLXGDLSXWDJI-OTELOYJSSA-N D0J2VQ DRUGSMIL CCC1C(C(C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)CC)O)C)C)C)O)(C)O D0J2VQ HIGHSTAT Investigative D0J2WC DRUG__ID D0J2WC D0J2WC DRUGTYPE Small molecular drug D0J2WC DRUGINCH 1S/C30H35NO7/c1-18-26(36-2)12-22(13-27(18)37-3)29(34)24(11-19-9-20-7-5-6-8-21(20)10-19)16-31-15-23(14-28(32)33)25(17-31)30(35)38-4/h5-8,12-13,15,17,19,24,29,34H,9-11,14,16H2,1-4H3,(H,32,33)/t24-,29+/m0/s1 D0J2WC DRUGINKE PMPFDANPLYTSTM-PWUYWRBVSA-N D0J2WC DRUGSMIL CC1=C(C=C(C=C1OC)C(C(CC2CC3=CC=CC=C3C2)CN4C=C(C(=C4)C(=O)OC)CC(=O)O)O)OC D0J2WC HIGHSTAT Investigative D0J2WN DRUG__ID D0J2WN D0J2WN DRUGTYPE Small molecular drug D0J2WN DRUGINCH 1S/C12H13NO4/c13-10(12(16)17)8-7(9(8)11(14)15)6-4-2-1-3-5-6/h1-5,7-10H,13H2,(H,14,15)(H,16,17)/t7-,8+,9+,10+/m1/s1 D0J2WN DRUGINKE IFLWVSHRWAIVQF-KATARQTJSA-N D0J2WN DRUGSMIL C1=CC=C(C=C1)C2C(C2C(=O)O)C(C(=O)O)N D0J2WN HIGHSTAT Investigative D0J2WW DRUG__ID D0J2WW D0J2WW DRUGTYPE Small molecular drug D0J2WW DRUGINCH 1S/C16H15NO/c1-18-15-5-4-13-2-3-14(16(13)11-15)10-12-6-8-17-9-7-12/h4-11H,2-3H2,1H3/b14-10- D0J2WW DRUGINKE VFFWGGPPTWJBON-UVTDQMKNSA-N D0J2WW DRUGSMIL COC1=CC2=C(CCC2=CC3=CC=NC=C3)C=C1 D0J2WW HIGHSTAT Investigative D0J2XD DRUG__ID D0J2XD D0J2XD DRUGTYPE Small molecular drug D0J2XD DRUGINCH 1S/C16H11N3O/c17-10-12-5-4-8-14(9-12)19-16-18-11-15(20-16)13-6-2-1-3-7-13/h1-9,11H,(H,18,19) D0J2XD DRUGINKE VZMXZHOJAGFSNF-UHFFFAOYSA-N D0J2XD DRUGSMIL C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC(=C3)C#N D0J2XD HIGHSTAT Investigative D0J2YB DRUG__ID D0J2YB D0J2YB DRUGTYPE Small molecular drug D0J2YB DRUGINCH 1S/C24H28FN3O2/c1-16(2)27-12-4-5-18(14-27)15-28-17(3)26-23-11-10-21(13-22(23)24(28)29)30-20-8-6-19(25)7-9-20/h6-11,13,16,18H,4-5,12,14-15H2,1-3H3/t18-/m0/s1 D0J2YB DRUGINKE FRKXOBMDEXCHHD-SFHVURJKSA-N D0J2YB DRUGSMIL CC1=NC2=C(C=C(C=C2)OC3=CC=C(C=C3)F)C(=O)N1CC4CCCN(C4)C(C)C D0J2YB HIGHSTAT Investigative D0J2ZS DRUG__ID D0J2ZS D0J2ZS DRUGTYPE Small molecular drug D0J2ZS DRUGINCH 1S/C22H24N2O4/c1-28-19-8-9-21-20(13-19)16(14-24-21)10-11-23-22(27)12-18(26)7-4-15-2-5-17(25)6-3-15/h2-3,5-6,8-9,13-14,24-25H,4,7,10-12H2,1H3,(H,23,27) D0J2ZS DRUGINKE BPMOENJVOOOATO-UHFFFAOYSA-N D0J2ZS DRUGSMIL COC1=CC2=C(C=C1)NC=C2CCNC(=O)CC(=O)CCC3=CC=C(C=C3)O D0J2ZS HIGHSTAT Investigative D0J3AO DRUG__ID D0J3AO D0J3AO DRUGTYPE Small molecular drug D0J3AO DRUGINCH 1S/C29H41FN4O4/c1-21(2)25(22-14-8-7-9-15-22)38-28(37)34-29(3,20-23-16-10-11-17-24(23)30)26(35)32-18-12-5-4-6-13-19-33-27(31)36/h7-11,14-17,21,25H,4-6,12-13,18-20H2,1-3H3,(H,32,35)(H,34,37)(H3,31,33,36)/t25-,29+/m0/s1 D0J3AO DRUGINKE ZAYADERDILOEBG-ABYGYWHVSA-N D0J3AO DRUGSMIL CC(C)C(C1=CC=CC=C1)OC(=O)NC(C)(CC2=CC=CC=C2F)C(=O)NCCCCCCCNC(=O)N D0J3AO HIGHSTAT Investigative D0J3BT DRUG__ID D0J3BT D0J3BT DRUGTYPE Small molecular drug D0J3BT DRUGINCH 1S/C33H42N4O6/c1-2-18-36(32(39)43-23-25-12-14-30(15-13-25)37(41)42)29-16-19-34(20-17-29)21-28-22-35(31(38)26-8-6-7-9-26)24-33(28,40)27-10-4-3-5-11-27/h2-5,10-15,26,28-29,40H,1,6-9,16-24H2/t28-,33-/m0/s1 D0J3BT DRUGINKE JNSKQYZFEVKYDB-UVMMSNCQSA-N D0J3BT DRUGSMIL C=CCN(C1CCN(CC1)CC2CN(CC2(C3=CC=CC=C3)O)C(=O)C4CCCC4)C(=O)OCC5=CC=C(C=C5)[N+](=O)[O-] D0J3BT HIGHSTAT Investigative D0J3CJ DRUG__ID D0J3CJ D0J3CJ DRUGTYPE Small molecular drug D0J3CJ DRUGINCH 1S/C21H26FNO3/c1-2-3-4-5-6-9-16-25-18-14-12-17(13-15-18)23-21(24)26-20-11-8-7-10-19(20)22/h7-8,10-15H,2-6,9,16H2,1H3,(H,23,24) D0J3CJ DRUGINKE PHBVHSXINCCZDW-UHFFFAOYSA-N D0J3CJ DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D0J3CJ HIGHSTAT Investigative D0J3CY DRUG__ID D0J3CY D0J3CY DRUGTYPE Small molecular drug D0J3CY DRUGINCH 1S/C16H24N2O3/c1-2-13-8-7-9-14(12-13)17-15(19)10-5-3-4-6-11-16(20)18-21/h7-9,12,21H,2-6,10-11H2,1H3,(H,17,19)(H,18,20) D0J3CY DRUGINKE HABCYDNCOYWETL-UHFFFAOYSA-N D0J3CY DRUGSMIL CCC1=CC(=CC=C1)NC(=O)CCCCCCC(=O)NO D0J3CY HIGHSTAT Investigative D0J3DB DRUG__ID D0J3DB D0J3DB DRUGTYPE Small molecular drug D0J3DB DRUGINCH 1S/C21H16O4S/c1-13-6-8-16(9-7-13)26(24,25)20-12-19(22)17-10-14-4-2-3-5-15(14)11-18(17)21(20)23/h2-12,22-23H,1H3 D0J3DB DRUGINKE DKOISANXNBXJMG-UHFFFAOYSA-N D0J3DB DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C(C3=CC4=CC=CC=C4C=C3C(=C2)O)O D0J3DB HIGHSTAT Investigative D0J3DW DRUG__ID D0J3DW D0J3DW DRUGTYPE Small molecular drug D0J3DW DRUGINCH 1S/C16H26N2O/c19-16(18-4-2-1-3-5-18)17-15-13-7-11-6-12(9-13)10-14(15)8-11/h11-15H,1-10H2,(H,17,19) D0J3DW DRUGINKE RHMXRUDDABBEME-UHFFFAOYSA-N D0J3DW DRUGSMIL C1CCN(CC1)C(=O)NC2C3CC4CC(C3)CC2C4 D0J3DW HIGHSTAT Investigative D0J3EA DRUG__ID D0J3EA D0J3EA DRUGCOMP Hutchison Medipharma Enterprises Ltd D0J3EA DRUGINCH 1S/C25H26N6O2/c1-4-16-6-5-7-18(10-16)28-24-19-11-21(23(33-3)12-20(19)26-15-27-24)29-25(32)31-13-17-8-9-30(2)22(17)14-31/h1,5-7,10-12,15,17,22H,8-9,13-14H2,2-3H3,(H,29,32)(H,26,27,28)/t17-,22+/m1/s1 D0J3EA DRUGINKE FSXCKIBROURMFT-VGSWGCGISA-N D0J3EA DRUGSMIL CN1CCC2C1CN(C2)C(=O)NC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=CC(=C5)C#C)OC D0J3EA HIGHSTAT Investigative D0J3EJ DRUG__ID D0J3EJ D0J3EJ DRUGTYPE Small molecular drug D0J3EJ DRUGINCH 1S/C15H11N3O3S/c19-13-7-3-11(4-8-13)16-15-17-14(9-22-15)10-1-5-12(6-2-10)18(20)21/h1-9,19H,(H,16,17) D0J3EJ DRUGINKE PXYPXTOUOYAWOU-UHFFFAOYSA-N D0J3EJ DRUGSMIL C1=CC(=CC=C1C2=CSC(=N2)NC3=CC=C(C=C3)O)[N+](=O)[O-] D0J3EJ HIGHSTAT Investigative D0J3EZ DRUG__ID D0J3EZ D0J3EZ DRUGTYPE Small molecular drug D0J3EZ DRUGINCH 1S/C8H5N3O4/c12-7-8(13)10-6-3-4(11(14)15)1-2-5(6)9-7/h1-3H,(H,9,12)(H,10,13) D0J3EZ DRUGINKE RYMLSFWVYNAKAR-UHFFFAOYSA-N D0J3EZ DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])NC(=O)C(=O)N2 D0J3EZ HIGHSTAT Investigative D0J3FH DRUG__ID D0J3FH D0J3FH DRUGTYPE Small molecular drug D0J3FH DRUGINCH 1S/C38H35FN2O/c1-26(38(42)41(25-31-15-6-9-20-36(31)39)32-23-29-13-2-3-14-30(29)24-32)40-22-21-28-12-5-8-18-34(28)37(40)35-19-10-16-27-11-4-7-17-33(27)35/h2-20,26,32,37H,21-25H2,1H3/t26-,37+/m0/s1 D0J3FH DRUGINKE OEINKGYXWSIVKM-KJICVINHSA-N D0J3FH DRUGSMIL CC(C(=O)N(CC1=CC=CC=C1F)C2CC3=CC=CC=C3C2)N4CCC5=CC=CC=C5C4C6=CC=CC7=CC=CC=C76 D0J3FH HIGHSTAT Investigative D0J3HR DRUG__ID D0J3HR D0J3HR DRUGTYPE Small molecular drug D0J3HR DRUGINCH 1S/C12H12O/c1-9(13)11-8-4-6-10-5-2-3-7-12(10)11/h2-3,5,7-8H,4,6H2,1H3 D0J3HR DRUGINKE OUZPHFHCYBXKAY-UHFFFAOYSA-N D0J3HR DRUGSMIL CC(=O)C1=CCCC2=CC=CC=C21 D0J3HR HIGHSTAT Investigative D0J3IA DRUG__ID D0J3IA D0J3IA DRUGTYPE Small molecular drug D0J3IA DRUGINCH 1S/C12H15Cl2N3O2/c13-10-7-9(8-16-11(10)14)12(18)15-1-2-17-3-5-19-6-4-17/h7-8H,1-6H2,(H,15,18) D0J3IA DRUGINKE BNRXERZZOCTDMX-UHFFFAOYSA-N D0J3IA DRUGSMIL C1COCCN1CCNC(=O)C2=CC(=C(N=C2)Cl)Cl D0J3IA HIGHSTAT Investigative D0J3JI DRUG__ID D0J3JI D0J3JI DRUGTYPE Small molecular drug D0J3JI DRUGINCH 1S/C27H36N2O5/c1-5-26(30)29-11-12-33-27-22(17-29)13-21(20-8-9-23(31-3)24(14-20)32-4)15-25(27)34-18-19-7-6-10-28(2)16-19/h8-9,13-15,19H,5-7,10-12,16-18H2,1-4H3/t19-/m0/s1 D0J3JI DRUGINKE YKNAKDFZAWQEEO-IBGZPJMESA-N D0J3JI DRUGSMIL CCC(=O)N1CCOC2=C(C1)C=C(C=C2OCC3CCCN(C3)C)C4=CC(=C(C=C4)OC)OC D0J3JI HIGHSTAT Investigative D0J3NK DRUG__ID D0J3NK D0J3NK DRUGTYPE Small molecular drug D0J3NK DRUGINCH 1S/C23H32N2O2/c1-2-24-22(26)27-18-9-8-17-13-21-19-5-3-4-10-23(19,20(17)14-18)11-12-25(21)15-16-6-7-16/h8-9,14,16,19,21H,2-7,10-13,15H2,1H3,(H,24,26) D0J3NK DRUGINKE RVWFZRGYOXCUSN-UHFFFAOYSA-N D0J3NK DRUGSMIL CCNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3CC5CC5)C=C1 D0J3NK HIGHSTAT Investigative D0J3NS DRUG__ID D0J3NS D0J3NS DRUGTYPE Small molecular drug D0J3NS DRUGINCH 1S/C9H13NO2S/c10-5-8(4-9(11)12)3-7-1-2-13-6-7/h1-2,6,8H,3-5,10H2,(H,11,12) D0J3NS DRUGINKE DZFWQAKTRWBNFX-UHFFFAOYSA-N D0J3NS DRUGSMIL C1=CSC=C1CC(CC(=O)O)CN D0J3NS HIGHSTAT Investigative D0J3NX DRUG__ID D0J3NX D0J3NX DRUGTYPE Small molecular drug D0J3NX DRUGINCH 1S/C19H18N2O/c22-19(21-18-8-4-5-9-18)16-11-13-17(20-14-16)12-10-15-6-2-1-3-7-15/h1-3,6-7,11,13-14,18H,4-5,8-9H2,(H,21,22) D0J3NX DRUGINKE GKYRUZWYDPUSOV-UHFFFAOYSA-N D0J3NX DRUGSMIL C1CCC(C1)NC(=O)C2=CN=C(C=C2)C#CC3=CC=CC=C3 D0J3NX HIGHSTAT Investigative D0J3OZ DRUG__ID D0J3OZ D0J3OZ DRUGTYPE Small molecular drug D0J3OZ DRUGINCH 1S/C8H5N5S/c9-3-6-4-11-8(14-6)13-7-1-2-10-5-12-7/h1-2,4-5H,(H,10,11,12,13) D0J3OZ DRUGINKE SMNGUXOKYVUIRA-UHFFFAOYSA-N D0J3OZ DRUGSMIL C1=CN=CN=C1NC2=NC=C(S2)C#N D0J3OZ HIGHSTAT Investigative D0J3PJ DRUG__ID D0J3PJ D0J3PJ DRUGTYPE Small molecular drug D0J3PJ DRUGINCH 1S/C19H18F2N4O/c1-11-8-17(15-9-12(20)10-16(21)18(15)22-11)24-19(26)23-13-4-6-14(7-5-13)25(2)3/h4-10H,1-3H3,(H2,22,23,24,26) D0J3PJ DRUGINKE JTARFZSNUAGHRB-UHFFFAOYSA-N D0J3PJ DRUGSMIL CC1=CC(=C2C=C(C=C(C2=N1)F)F)NC(=O)NC3=CC=C(C=C3)N(C)C D0J3PJ HIGHSTAT Investigative D0J3PK DRUG__ID D0J3PK D0J3PK DRUGTYPE Small molecular drug D0J3PK DRUGINCH 1S/C18H16N2O2/c21-14-6-7-15-16(20-9-8-19-12-20)11-17(22-18(15)10-14)13-4-2-1-3-5-13/h1-10,12,16-17,21H,11H2 D0J3PK DRUGINKE ZVMPYRSCCMHXRC-UHFFFAOYSA-N D0J3PK DRUGSMIL C1C(C2=C(C=C(C=C2)O)OC1C3=CC=CC=C3)N4C=CN=C4 D0J3PK HIGHSTAT Investigative D0J3PM DRUG__ID D0J3PM D0J3PM DRUGTYPE Small molecular drug D0J3PM DRUGINCH 1S/C15H17NO3S/c1-12(2)16(13-6-4-3-5-7-13)20(18,19)15-10-8-14(17)9-11-15/h3-12,17H,1-2H3 D0J3PM DRUGINKE QYGYTGVIRJYHLA-UHFFFAOYSA-N D0J3PM DRUGSMIL CC(C)N(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O D0J3PM HIGHSTAT Investigative D0J3QC DRUG__ID D0J3QC D0J3QC DRUGTYPE Small molecular drug D0J3QC DRUGINCH 1S/C22H28Cl2O4/c1-2-3-10-22(15-7-4-5-8-15)13-14-12-16(28-11-6-9-17(25)26)19(23)20(24)18(14)21(22)27/h12,15H,2-11,13H2,1H3,(H,25,26) D0J3QC DRUGINKE KHKGTPJPBOQECW-UHFFFAOYSA-N D0J3QC DRUGSMIL CCCCC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCCCC(=O)O)C3CCCC3 D0J3QC HIGHSTAT Investigative D0J3RB DRUG__ID D0J3RB D0J3RB DRUGTYPE Small molecular drug D0J3RB DRUGINCH 1S/C19H16N2O2/c22-17-12-6-4-10-15(17)19(16-11-5-7-13-18(16)23)21-20-14-8-2-1-3-9-14/h1-13,20,22-23H D0J3RB DRUGINKE YZUKVOKQRHDWBG-UHFFFAOYSA-N D0J3RB DRUGSMIL C1=CC=C(C=C1)NN=C(C2=CC=CC=C2O)C3=CC=CC=C3O D0J3RB HIGHSTAT Investigative D0J3SN DRUG__ID D0J3SN D0J3SN DRUGTYPE Small molecular drug D0J3SN DRUGINCH 1S/C12H14N2O/c1-15-8-2-3-11-10(6-8)9-4-5-13-7-12(9)14-11/h2-3,6,13-14H,4-5,7H2,1H3 D0J3SN DRUGINKE QYMDEOQLJUUNOF-UHFFFAOYSA-N D0J3SN DRUGSMIL COC1=CC2=C(C=C1)NC3=C2CCNC3 D0J3SN HIGHSTAT Investigative D0J3SP DRUG__ID D0J3SP D0J3SP DRUGTYPE Small molecular drug D0J3SP DRUGINCH 1S/C16H11F5N2O3S/c17-11-10(12(18)14(20)15(21)13(11)19)16(24)23-8-3-6-1-2-9(27(22,25)26)5-7(6)4-8/h1-2,5,8H,3-4H2,(H,23,24)(H2,22,25,26) D0J3SP DRUGINKE DTWDCDSAKWSSGY-UHFFFAOYSA-N D0J3SP DRUGSMIL C1C(CC2=C1C=CC(=C2)S(=O)(=O)N)NC(=O)C3=C(C(=C(C(=C3F)F)F)F)F D0J3SP HIGHSTAT Investigative D0J3SW DRUG__ID D0J3SW D0J3SW DRUGTYPE Small molecular drug D0J3SW DRUGINCH 1S/C35H34N2O6/c1-4-42-30-8-6-5-7-27(30)21-29-32(38)37(33(29)43-28-19-17-26(18-20-28)34(39)40)35(41)36-31(24-13-9-22(2)10-14-24)25-15-11-23(3)12-16-25/h5-20,29,31,33H,4,21H2,1-3H3,(H,36,41)(H,39,40)/t29-,33+/m1/s1 D0J3SW DRUGINKE IGIOAZWNIRIBNB-CPBHLAHYSA-N D0J3SW DRUGSMIL CCOC1=CC=CC=C1CC2C(N(C2=O)C(=O)NC(C3=CC=C(C=C3)C)C4=CC=C(C=C4)C)OC5=CC=C(C=C5)C(=O)O D0J3SW HIGHSTAT Investigative D0J3TS DRUG__ID D0J3TS D0J3TS DRUGTYPE Small molecular drug D0J3TS DRUGINCH 1S/C9H6N2S2/c1-2-8(12-4-1)7-6-11-3-5-13-9(11)10-7/h1-6H D0J3TS DRUGINKE YKINBJCTANWRJC-UHFFFAOYSA-N D0J3TS DRUGSMIL C1=CSC(=C1)C2=CN3C=CSC3=N2 D0J3TS HIGHSTAT Investigative D0J3TY DRUG__ID D0J3TY D0J3TY DRUGTYPE Small molecular drug D0J3TY DRUGINCH 1S/C17H13N3O/c1-11-5-4-6-12(9-11)20-10-14-13-7-2-3-8-15(13)18-17(21)16(14)19-20/h2-10H,1H3,(H,18,21) D0J3TY DRUGINKE KHYUWCCULSYNJP-UHFFFAOYSA-N D0J3TY DRUGSMIL CC1=CC(=CC=C1)N2C=C3C4=CC=CC=C4NC(=O)C3=N2 D0J3TY HIGHSTAT Investigative D0J3UU DRUG__ID D0J3UU D0J3UU DRUGTYPE Small molecular drug D0J3UU DRUGINCH 1S/C15H13ClO3/c16-12-6-8-13(9-7-12)19-14(15(17)18)10-11-4-2-1-3-5-11/h1-9,14H,10H2,(H,17,18)/t14-/m0/s1 D0J3UU DRUGINKE CPBLTMSKPQDJPW-AWEZNQCLSA-N D0J3UU DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)OC2=CC=C(C=C2)Cl D0J3UU HIGHSTAT Investigative D0J3VX DRUG__ID D0J3VX D0J3VX DRUGTYPE Small molecular drug D0J3VX DRUGINCH 1S/C21H22N4O2/c26-21(24-20-3-1-2-17-15-22-9-8-19(17)20)23-14-16-4-6-18(7-5-16)25-10-12-27-13-11-25/h1-9,15H,10-14H2,(H2,23,24,26) D0J3VX DRUGINKE LAJBRLBYOVKUOY-UHFFFAOYSA-N D0J3VX DRUGSMIL C1COCCN1C2=CC=C(C=C2)CNC(=O)NC3=CC=CC4=C3C=CN=C4 D0J3VX HIGHSTAT Investigative D0J3XJ DRUG__ID D0J3XJ D0J3XJ DRUGTYPE Small molecular drug D0J3XJ DRUGINCH 1S/C23H22BrNO/c24-21-15-13-20(14-16-21)22(19-11-5-2-6-12-19)23(26)25-17-7-10-18-8-3-1-4-9-18/h1-6,8-9,11-16,22H,7,10,17H2,(H,25,26) D0J3XJ DRUGINKE ACZAPKHQBWGJHX-UHFFFAOYSA-N D0J3XJ DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Br D0J3XJ HIGHSTAT Investigative D0J3YD DRUG__ID D0J3YD D0J3YD DRUGTYPE Small molecular drug D0J3YD DRUGINCH 1S/C30H47NO3/c1-25(2)12-14-30(24(32)33)15-13-28(6)20(21(30)18-25)8-9-23-27(5)17-19(31-34)16-26(3,4)22(27)10-11-29(23,28)7/h8,19,21-23H,9-18H2,1-7H3,(H,32,33)/t19?,21-,22-,23+,27-,28+,29+,30-/m0/s1 D0J3YD DRUGINKE XTPUMPBRCGZOFP-VVLRTUPLSA-N D0J3YD DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)N=O)C)C)C2C1)C)C(=O)O)C D0J3YD HIGHSTAT Investigative D0J3ZK DRUG__ID D0J3ZK D0J3ZK DRUGTYPE Small molecular drug D0J3ZK DRUGINCH 1S/C18H21FN2O2/c1-12(9-19)20-10-13(22)11-23-17-8-4-7-16-18(17)14-5-2-3-6-15(14)21-16/h2-8,12-13,20-22H,9-11H2,1H3/t12?,13-/m1/s1 D0J3ZK DRUGINKE QHLGXPUIUKSADT-ZGTCLIOFSA-N D0J3ZK DRUGSMIL CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O D0J3ZK HIGHSTAT Investigative D0J4AT DRUG__ID D0J4AT D0J4AT DRUGTYPE Small molecular drug D0J4AT DRUGINCH 1S/C20H19NO2/c1-3-7-16(8-4-1)19-15-18(21-11-13-22-14-12-21)20(23-19)17-9-5-2-6-10-17/h1-10,15H,11-14H2 D0J4AT DRUGINKE UIZBMSXOYPJXSV-UHFFFAOYSA-N D0J4AT DRUGSMIL C1COCCN1C2=C(OC(=C2)C3=CC=CC=C3)C4=CC=CC=C4 D0J4AT HIGHSTAT Investigative D0J4BF DRUG__ID D0J4BF D0J4BF DRUGTYPE Small molecular drug D0J4BF DRUGINCH 1S/C29H41N9O10/c1-15(40)24(28(46)36-20(29(47)48)9-16-5-3-2-4-6-16)38-23(42)12-33-26(44)19(7-8-22(31)41)35-27(45)21(13-39)37-25(43)18(30)10-17-11-32-14-34-17/h2-6,11,14-15,18-21,24,39-40H,7-10,12-13,30H2,1H3,(H2,31,41)(H,32,34)(H,33,44)(H,35,45)(H,36,46)(H,37,43)(H,38,42)(H,47,48)/t15-,18+,19+,20+,21+,24+/m1/s1 D0J4BF DRUGINKE VDWWLJRQDNTHJB-MXAMYCJDSA-N D0J4BF DRUGSMIL CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC2=CN=CN2)N)O D0J4BF HIGHSTAT Investigative D0J4CB DRUG__ID D0J4CB D0J4CB DRUGTYPE Small molecular drug D0J4CB DRUGINCH 1S/C18H21NO/c1-20-13-17-11-18(17,8-9-19-12-17)16-7-6-14-4-2-3-5-15(14)10-16/h2-7,10,19H,8-9,11-13H2,1H3/t17-,18-/m1/s1 D0J4CB DRUGINKE KTJHVHZJTXJNIH-QZTJIDSGSA-N D0J4CB DRUGSMIL COCC12CC1(CCNC2)C3=CC4=CC=CC=C4C=C3 D0J4CB HIGHSTAT Investigative D0J4DJ DRUG__ID D0J4DJ D0J4DJ DRUGTYPE Small molecular drug D0J4DJ DRUGINCH 1S/C43H67N5O10/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-27-38(31(2)39(51)44-34-24-19-22-29-48(56)42(34)53)58-43(54)35(25-20-21-28-47(55)32(3)49)45-40(52)36-30-57-41(46-36)33-23-17-18-26-37(33)50/h17-18,23,26,30-31,34-35,38,50,55-56H,4-16,19-22,24-25,27-29H2,1-3H3,(H,44,51)(H,45,52) D0J4DJ DRUGINKE JJWFEHNQRVSVKR-UHFFFAOYSA-N D0J4DJ DRUGSMIL CCCCCCCCCCCCCCCC(C(C)C(=O)NC1CCCCN(C1=O)O)OC(=O)C(CCCCN(C(=O)C)O)NC(=O)C2=COC(=N2)C3=CC=CC=C3O D0J4DJ HIGHSTAT Investigative D0J4EF DRUG__ID D0J4EF D0J4EF DRUGTYPE Small molecular drug D0J4EF DRUGINCH 1S/C17H17N/c1-2-4-13(5-3-1)14-6-8-15(9-7-14)17-10-16(17)11-18-12-17/h1-9,16,18H,10-12H2 D0J4EF DRUGINKE FKKPHPHBDNQCCQ-UHFFFAOYSA-N D0J4EF DRUGSMIL C1C2C1(CNC2)C3=CC=C(C=C3)C4=CC=CC=C4 D0J4EF HIGHSTAT Investigative D0J4EZ DRUG__ID D0J4EZ D0J4EZ DRUGTYPE Small molecular drug D0J4EZ DRUGINCH 1S/C24H27N7O6/c1-4-10-30-21-19(22(33)31(11-5-2)24(30)36)26-20(27-21)16-12-18(28-29(16)3)37-13-17(32)25-15-8-6-14(7-9-15)23(34)35/h6-9,12H,4-5,10-11,13H2,1-3H3,(H,25,32)(H,26,27)(H,34,35) D0J4EZ DRUGINKE JTHIYDNBNYRAEL-UHFFFAOYSA-N D0J4EZ DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)NC4=CC=C(C=C4)C(=O)O D0J4EZ HIGHSTAT Investigative D0J4HH DRUG__ID D0J4HH D0J4HH DRUGTYPE Small molecular drug D0J4HH DRUGINCH 1S/C13H8N6/c14-9-10-4-3-5-11(8-10)19-17-13(16-18-19)12-6-1-2-7-15-12/h1-8H D0J4HH DRUGINKE OGIBYDWBTRKAOL-UHFFFAOYSA-N D0J4HH DRUGSMIL C1=CC=NC(=C1)C2=NN(N=N2)C3=CC=CC(=C3)C#N D0J4HH HIGHSTAT Investigative D0J4KJ DRUG__ID D0J4KJ D0J4KJ DRUGTYPE Small molecular drug D0J4KJ DRUGINCH 1S/C15H14N4S/c1-9-5-7-10(8-6-9)20-12-4-2-3-11-13(12)14(16)19-15(17)18-11/h2-8H,1H3,(H4,16,17,18,19) D0J4KJ DRUGINKE UOJFGEAPSYQDIP-UHFFFAOYSA-N D0J4KJ DRUGSMIL CC1=CC=C(C=C1)SC2=CC=CC3=C2C(=NC(=N3)N)N D0J4KJ HIGHSTAT Investigative D0J4LR DRUG__ID D0J4LR D0J4LR DRUGTYPE Small molecular drug D0J4LR DRUGINCH 1S/C29H50O3/c1-7-20(18(2)3)9-8-19(4)23-10-11-24-22-16-26(31)29(32)17-21(30)12-15-28(29,6)25(22)13-14-27(23,24)5/h16,18-21,23-26,30-32H,7-15,17H2,1-6H3/t19-,20?,21+,23-,24+,25+,26?,27-,28-,29?/m1/s1 D0J4LR DRUGINKE OZIAZQBXQMKSLA-XMWGPCPVSA-N D0J4LR DRUGSMIL CCC(CCC(C)C1CCC2C1(CCC3C2=CC(C4(C3(CCC(C4)O)C)O)O)C)C(C)C D0J4LR HIGHSTAT Investigative D0J4MU DRUG__ID D0J4MU D0J4MU DRUGTYPE Small molecular drug D0J4MU DRUGINCH 1S/C19H28N5O20P3/c1-38-22-10-2-4-23(18(30)20-10)16-14(28)12(26)8(41-16)6-39-45(32,33)43-47(36,37)44-46(34,35)40-7-9-13(27)15(29)17(42-9)24-5-3-11(25)21-19(24)31/h2-5,8-9,12-17,26-29H,6-7H2,1H3,(H,32,33)(H,34,35)(H,36,37)(H,20,22,30)(H,21,25,31)/t8-,9-,12+,13+,14+,15+,16-,17-/m1/s1 D0J4MU DRUGINKE SIKKMGJHOOQSAP-AOUMTEFLSA-N D0J4MU DRUGSMIL CONC1=NC(=O)N(C=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=CC(=O)NC4=O)O)O)O)O D0J4MU HIGHSTAT Investigative D0J4NI DRUG__ID D0J4NI D0J4NI DRUGTYPE Small molecular drug D0J4NI DRUGINCH 1S/C21H32O5/c1-5-9-18(7-3)25-20(23)16-11-15(14-22)12-17(13-16)21(24)26-19(8-4)10-6-2/h11-13,18-19,22H,5-10,14H2,1-4H3 D0J4NI DRUGINKE ONMFJTSDBZIFTK-UHFFFAOYSA-N D0J4NI DRUGSMIL CCCC(CC)OC(=O)C1=CC(=CC(=C1)CO)C(=O)OC(CC)CCC D0J4NI HIGHSTAT Investigative D0J4NN DRUG__ID D0J4NN D0J4NN DRUGTYPE Small molecular drug D0J4NN DRUGINCH 1S/C39H51N5O6S/c1-6-43(17-16-40)28-18-24(2)35(25(3)19-28)50-22-32(46)41-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(4,5)36(44)37(48)42-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,45,47H,6,16-17,20-23,40H2,1-5H3,(H,41,46)(H,42,48)/t30-,31+,33-,34-,36+/m0/s1 D0J4NN DRUGINKE QVEVEYWLPLMZQY-SQKWSBCUSA-N D0J4NN DRUGSMIL CCN(CCN)C1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0J4NN HIGHSTAT Investigative D0J4NQ DRUG__ID D0J4NQ D0J4NQ DRUGTYPE Small molecular drug D0J4NQ DRUGINCH 1S/C23H49N2O5P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(26)22(24)21-30-31(27,28)29-20-19-25(2,3)4/h17-18,22-23,26H,5-16,19-21,24H2,1-4H3/b18-17+/t22-,23+/m0/s1 D0J4NQ DRUGINKE JLVSPVFPBBFMBE-HXSWCURESA-N D0J4NQ DRUGSMIL CCCCCCCCCCCCCC=CC(C(COP(=O)([O-])OCC[N+](C)(C)C)N)O D0J4NQ HIGHSTAT Investigative D0J4ON DRUG__ID D0J4ON D0J4ON DRUGTYPE Small molecular drug D0J4ON DRUGINCH 1S/C23H22Cl2N4O3/c1-13(2)20-19-22(29(28-20)21-16(24)4-3-5-17(21)25)26-18(27-23(19)31)12-14-6-8-15(9-7-14)32-11-10-30/h3-9,13,30H,10-12H2,1-2H3,(H,26,27,31) D0J4ON DRUGINKE RSQPNXBTPUXMQN-UHFFFAOYSA-N D0J4ON DRUGSMIL CC(C)C1=NN(C2=C1C(=O)NC(=N2)CC3=CC=C(C=C3)OCCO)C4=C(C=CC=C4Cl)Cl D0J4ON HIGHSTAT Investigative D0J4QH DRUG__ID D0J4QH D0J4QH DRUGTYPE Small molecular drug D0J4QH DRUGINCH 1S/CH3O2P/c1-4(2)3/h1H3/p+1 D0J4QH DRUGINKE OFSFQGSFEXXHNH-UHFFFAOYSA-O D0J4QH DRUGSMIL C[P+](=O)O D0J4QH HIGHSTAT Investigative D0J4RI DRUG__ID D0J4RI D0J4RI DRUGTYPE Small molecular drug D0J4RI DRUGINCH 1S/C24H21ClF3N7O2/c25-18-4-2-1-3-15(18)13-35-21-19(32-33-35)22(36)31-20(30-21)14-9-11-34(12-10-14)23(37)29-17-7-5-16(6-8-17)24(26,27)28/h1-8,14H,9-13H2,(H,29,37)(H,30,31,36) D0J4RI DRUGINKE SKWHAHNDWJREJG-UHFFFAOYSA-N D0J4RI DRUGSMIL C1CN(CCC1C2=NC3=C(C(=O)N2)N=NN3CC4=CC=CC=C4Cl)C(=O)NC5=CC=C(C=C5)C(F)(F)F D0J4RI HIGHSTAT Investigative D0J4RY DRUG__ID D0J4RY D0J4RY DRUGTYPE Small molecular drug D0J4RY DRUGINCH 1S/C17H13Cl2N3OS/c18-12-7-8-13(14(19)10-12)16(23)20-17-22-21-15(24-17)9-6-11-4-2-1-3-5-11/h1-5,7-8,10H,6,9H2,(H,20,22,23) D0J4RY DRUGINKE BVZCHEPRCHHCRQ-UHFFFAOYSA-N D0J4RY DRUGSMIL C1=CC=C(C=C1)CCC2=NN=C(S2)NC(=O)C3=C(C=C(C=C3)Cl)Cl D0J4RY HIGHSTAT Investigative D0J4SW DRUG__ID D0J4SW D0J4SW DRUGTYPE Small molecular drug D0J4SW DRUGINCH 1S/C17H13N3O/c1-11-6-8-12(9-7-11)20-10-14-13-4-2-3-5-15(13)18-17(21)16(14)19-20/h2-10H,1H3,(H,18,21) D0J4SW DRUGINKE KTONIIHJBREXRC-UHFFFAOYSA-N D0J4SW DRUGSMIL CC1=CC=C(C=C1)N2C=C3C4=CC=CC=C4NC(=O)C3=N2 D0J4SW HIGHSTAT Investigative D0J4VA DRUG__ID D0J4VA D0J4VA DRUGTYPE Small molecular drug D0J4VA DRUGINCH 1S/C20H18FNO/c1-2-18(16-9-11-22-12-10-16)15-5-3-14(4-6-15)17-7-8-20(23)19(21)13-17/h3-13,18,23H,2H2,1H3 D0J4VA DRUGINKE MSZSUMNJIMRHDP-UHFFFAOYSA-N D0J4VA DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC(=C(C=C2)O)F)C3=CC=NC=C3 D0J4VA HIGHSTAT Investigative D0J4VR DRUG__ID D0J4VR D0J4VR DRUGTYPE Small molecular drug D0J4VR DRUGINCH 1S/C14H13NO2/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,16-17H,15H2/b2-1+ D0J4VR DRUGINKE MDUTXYLPODCITG-OWOJBTEDSA-N D0J4VR DRUGSMIL C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)N D0J4VR HIGHSTAT Investigative D0J4YA DRUG__ID D0J4YA D0J4YA DRUGTYPE Small molecular drug D0J4YA DRUGINCH 1S/C17H13N3O/c1-20-10-11(12-5-2-3-7-15(12)20)9-13-16-14(19-17(13)21)6-4-8-18-16/h2-10H,1H3,(H,19,21)/b13-9- D0J4YA DRUGINKE NXNQLECPAXXYTR-LCYFTJDESA-N D0J4YA DRUGSMIL CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC=N4)NC3=O D0J4YA HIGHSTAT Investigative D0J5AD DRUG__ID D0J5AD D0J5AD DRUGCOMP Humabs BioMed SA D0J5AD DRUGINCH 1S/C39H58N8O8/c1-5-24(4)33(39(54)55)47-35(50)28(18-12-13-19-40)43-37(52)30(22-31(42)48)44-36(51)29(21-26-16-10-7-11-17-26)45-38(53)32(23(2)3)46-34(49)27(41)20-25-14-8-6-9-15-25/h6-11,14-17,23-24,27-30,32-33H,5,12-13,18-22,40-41H2,1-4H3,(H2,42,48)(H,43,52)(H,44,51)(H,45,53)(H,46,49)(H,47,50)(H,54,55)/t24-,27-,28-,29-,30-,32-,33-/m0/s1 D0J5AD DRUGINKE NNORIMABIHWCBL-LMRDKNIASA-N D0J5AD DRUGSMIL CCC(C)C(C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N D0J5AD HIGHSTAT Investigative D0J5AR DRUG__ID D0J5AR D0J5AR DRUGTYPE Small molecular drug D0J5AR DRUGINCH 1S/C13H19NO/c14-9-8-12-6-7-13(15-12)10-11-4-2-1-3-5-11/h1-5,12-13H,6-10,14H2 D0J5AR DRUGINKE FZRYLYZNENTFJM-UHFFFAOYSA-N D0J5AR DRUGSMIL C1CC(OC1CCN)CC2=CC=CC=C2 D0J5AR HIGHSTAT Investigative D0J5AU DRUG__ID D0J5AU D0J5AU DRUGTYPE Small molecular drug D0J5AU DRUGINCH 1S/C9H14N2O7/c1-2-10-9(12)17-5-3-15-8-6(18-11(13)14)4-16-7(5)8/h5-8H,2-4H2,1H3,(H,10,12)/t5-,6+,7+,8+/m0/s1 D0J5AU DRUGINKE KSNZOFCCDYSKSB-LXGUWJNJSA-N D0J5AU DRUGSMIL CCNC(=O)OC1COC2C1OCC2O[N+](=O)[O-] D0J5AU HIGHSTAT Investigative D0J5DN DRUG__ID D0J5DN D0J5DN DRUGTYPE Small molecular drug D0J5DN DRUGINCH 1S/C15H10O5/c16-9-2-3-10-14(6-9)20-7-11(15(10)19)8-1-4-12(17)13(18)5-8/h1-7,16-18H D0J5DN DRUGINKE DDKGKOOLFLYZDL-UHFFFAOYSA-N D0J5DN DRUGSMIL C1=CC(=C(C=C1C2=COC3=C(C2=O)C=CC(=C3)O)O)O D0J5DN HIGHSTAT Investigative D0J5EF DRUG__ID D0J5EF D0J5EF DRUGTYPE Small molecular drug D0J5EF DRUGINCH 1S/C13H18FNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 D0J5EF DRUGINKE CCGVLNAUEKVICK-UHFFFAOYSA-N D0J5EF DRUGSMIL CC(C(=O)C1=CC(=CC=C1)F)NC(C)(C)C D0J5EF HIGHSTAT Investigative D0J5EZ DRUG__ID D0J5EZ D0J5EZ DRUGTYPE Small molecular drug D0J5EZ DRUGINCH 1S/C20H17NO3S/c1-13-11-17(25)18(22)19(24-13)20(23)21-12-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-11,22H,12H2,1H3,(H,21,23) D0J5EZ DRUGINKE ZOMMNLRHGAAUNM-UHFFFAOYSA-N D0J5EZ DRUGSMIL CC1=CC(=S)C(=C(O1)C(=O)NCC2=CC=C(C=C2)C3=CC=CC=C3)O D0J5EZ HIGHSTAT Investigative D0J5FK DRUG__ID D0J5FK D0J5FK DRUGTYPE Small molecular drug D0J5FK DRUGINCH 1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27) D0J5FK DRUGINKE XCFLWTZSJYBCPF-UHFFFAOYSA-N D0J5FK DRUGSMIL CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC D0J5FK HIGHSTAT Investigative D0J5IR DRUG__ID D0J5IR D0J5IR DRUGTYPE Small molecular drug D0J5IR DRUGINCH 1S/C35H43N5O5/c1-23(2)31(34(44)37-22-26-12-7-4-8-13-26)39-32(42)29(21-24-10-5-3-6-11-24)38-33(43)30-14-9-19-40(30)35(45)28(36)20-25-15-17-27(41)18-16-25/h3-8,10-13,15-18,23,28-31,41H,9,14,19-22,36H2,1-2H3,(H,37,44)(H,38,43)(H,39,42)/t28-,29-,30-,31+/m0/s1 D0J5IR DRUGINKE XAWPZZPZRCUIDR-XHPANXIASA-N D0J5IR DRUGSMIL CC(C)C(C(=O)NCC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0J5IR HIGHSTAT Investigative D0J5JO DRUG__ID D0J5JO D0J5JO DRUGTYPE Small molecular drug D0J5JO DRUGINCH 1S/C25H27NO/c1-20-9-8-14-23(19-20)25(27)15-17-26(18-16-25)24(21-10-4-2-5-11-21)22-12-6-3-7-13-22/h2-14,19,24,27H,15-18H2,1H3 D0J5JO DRUGINKE IFEJQGWUIGIJPD-UHFFFAOYSA-N D0J5JO DRUGSMIL CC1=CC(=CC=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D0J5JO HIGHSTAT Investigative D0J5KA DRUG__ID D0J5KA D0J5KA DRUGTYPE Small molecular drug D0J5KA DRUGINCH 1S/C32H55NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-32(34)33-27-26-29-24-25-30(35-2)28-31(29)36-3/h11-12,24-25,28H,4-10,13-23,26-27H2,1-3H3,(H,33,34)/b12-11- D0J5KA DRUGINKE VUAYHPSOKPDUPI-QXMHVHEDSA-N D0J5KA DRUGSMIL CCCCCCCCC=CCCCCCCCCCCCC(=O)NCCC1=C(C=C(C=C1)OC)OC D0J5KA HIGHSTAT Investigative D0J5KG DRUG__ID D0J5KG D0J5KG DRUGTYPE Small molecular drug D0J5KG DRUGINCH 1S/C30H48O3/c1-26(2)16-17-30(25(32)33-7)15-10-20-19(21(30)18-26)8-9-23-28(20,5)13-11-22-27(3,4)24(31)12-14-29(22,23)6/h8,20-24,31H,9-18H2,1-7H3/t20?,21-,22?,23-,24-,28-,29-,30+/m0/s1 D0J5KG DRUGINKE QQTTYKDXVIONSQ-HHKCSUCSSA-N D0J5KG DRUGSMIL CC1(CCC2(CCC3C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C(=O)OC)C D0J5KG HIGHSTAT Investigative D0J5KK DRUG__ID D0J5KK D0J5KK DRUGTYPE Small molecular drug D0J5KK DRUGINCH 1S/C16H27N3O/c20-15(18-14-1-3-17-4-2-14)19-16-8-11-5-12(9-16)7-13(6-11)10-16/h11-14,17H,1-10H2,(H2,18,19,20) D0J5KK DRUGINKE NWWZZPCDHOXVSZ-UHFFFAOYSA-N D0J5KK DRUGSMIL C1CNCCC1NC(=O)NC23CC4CC(C2)CC(C4)C3 D0J5KK HIGHSTAT Investigative D0J5OV DRUG__ID D0J5OV D0J5OV DRUGTYPE Small molecular drug D0J5OV DRUGINCH 1S/C41H30O27/c42-13-1-8(2-14(43)24(13)49)35(56)68-41-34-33-31(64-39(60)12(6-19(47)48)22-23-11(38(59)67-34)5-17(46)27(52)32(23)65-40(61)30(22)55)18(63-41)7-62-36(57)9-3-15(44)25(50)28(53)20(9)21-10(37(58)66-33)4-16(45)26(51)29(21)54/h1-5,12,18,22,30-31,33-34,41-46,49-55H,6-7H2,(H,47,48)/t12-,18+,22-,30-,31+,33-,34+,41-/m0/s1 D0J5OV DRUGINKE HGJXAVROWQLCTP-YABCKIEDSA-N D0J5OV DRUGSMIL C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C(C(C(=O)O3)CC(=O)O)C(C(=O)O6)O)O)O)OC(=O)C7=CC(=C(C(=C7C8=C(C(=C(C=C8C(=O)O1)O)O)O)O)O)O D0J5OV HIGHSTAT Investigative D0J5OX DRUG__ID D0J5OX D0J5OX DRUGTYPE Small molecular drug D0J5OX DRUGINCH 1S/C15H19ClO3/c16-12-6-7-14(19-9-8-15(17)18)13(10-12)11-4-2-1-3-5-11/h6-7,10-11H,1-5,8-9H2,(H,17,18) D0J5OX DRUGINKE ZHWIAECJQUFYPY-UHFFFAOYSA-N D0J5OX DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)Cl)OCCC(=O)O D0J5OX HIGHSTAT Investigative D0J5RG DRUG__ID D0J5RG D0J5RG DRUGTYPE Small molecular drug D0J5RG DRUGINCH 1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11) D0J5RG DRUGINKE FGSBNBBHOZHUBO-UHFFFAOYSA-N D0J5RG DRUGSMIL C(CC(=O)C(=O)O)CC(=O)O D0J5RG HIGHSTAT Investigative D0J5RQ DRUG__ID D0J5RQ D0J5RQ DRUGTYPE Small molecular drug D0J5RQ DRUGINCH 1S/C32H48O5/c1-18-9-14-32(27(35)36)16-15-30(7)21(25(32)19(18)2)17-22(34)26-29(6)12-11-24(37-20(3)33)28(4,5)23(29)10-13-31(26,30)8/h17-19,23-26H,9-16H2,1-8H3,(H,35,36)/t18-,19+,23+,24+,25+,26-,29+,30-,31-,32+/m1/s1 D0J5RQ DRUGINKE XDHCWTUZCOFKRH-CIKBGXLUSA-N D0J5RQ DRUGSMIL CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C)OC(=O)C)C)C)C2C1C)C)C(=O)O D0J5RQ HIGHSTAT Investigative D0J5SK DRUG__ID D0J5SK D0J5SK DRUGTYPE Small molecular drug D0J5SK DRUGINCH 1S/C14H9Cl2N3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19) D0J5SK DRUGINKE QKCFZLIUAVWYRM-UHFFFAOYSA-N D0J5SK DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)Cl D0J5SK HIGHSTAT Investigative D0J5TL DRUG__ID D0J5TL D0J5TL DRUGTYPE Small molecular drug D0J5TL DRUGINCH 1S/C10H16N2O2/c1-2-8-9(14-12-10(8)13)7-3-5-11-6-4-7/h7,11H,2-6H2,1H3,(H,12,13) D0J5TL DRUGINKE NKLHMQIBLBZVKZ-UHFFFAOYSA-N D0J5TL DRUGSMIL CCC1=C(ONC1=O)C2CCNCC2 D0J5TL HIGHSTAT Investigative D0J5VK DRUG__ID D0J5VK D0J5VK DRUGTYPE Small molecular drug D0J5VK DRUGINCH 1S/C15H12O6/c16-12-3-1-8(6-10(12)14(18)19)5-9-2-4-13(17)11(7-9)15(20)21/h1-4,6-7,16-17H,5H2,(H,18,19)(H,20,21) D0J5VK DRUGINKE JWQFKVGACKJIAV-UHFFFAOYSA-N D0J5VK DRUGSMIL C1=CC(=C(C=C1CC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O D0J5VK HIGHSTAT Investigative D0J6IE DRUG__ID D0J6IE D0J6IE DRUGTYPE Small molecular drug D0J6IE DRUGINCH 1S/C10H9ClN2OS/c1-6-9(14)13-10(15-6)12-8-5-3-2-4-7(8)11/h2-5,14H,1H3,(H,12,13) D0J6IE DRUGINKE JVRHHSAVCUJPIO-UHFFFAOYSA-N D0J6IE DRUGSMIL CC1=C(N=C(S1)NC2=CC=CC=C2Cl)O D0J6IE HIGHSTAT Investigative D0J6JT DRUG__ID D0J6JT D0J6JT DRUGTYPE Small molecular drug D0J6JT DRUGINCH 1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2 D0J6JT DRUGINKE VHFVKMTVMIZMIK-UHFFFAOYSA-N D0J6JT DRUGSMIL C1CN(CCN1)C2=CC(=CC=C2)Cl D0J6JT HIGHSTAT Investigative D0J6KJ DRUG__ID D0J6KJ D0J6KJ DRUGTYPE Small molecular drug D0J6KJ DRUGINCH 1S/C8H15NO7/c1-15-8(14)9-7-6(13)5(12)4(11)3(2-10)16-7/h3-7,10-13H,2H2,1H3,(H,9,14)/t3-,4-,5+,6-,7-/m1/s1 D0J6KJ DRUGINKE IZZJOGWXTFEDLL-XUUWZHRGSA-N D0J6KJ DRUGSMIL COC(=O)NC1C(C(C(C(O1)CO)O)O)O D0J6KJ HIGHSTAT Investigative D0J6KN DRUG__ID D0J6KN D0J6KN DRUGTYPE Small molecular drug D0J6KN DRUGINCH 1S/C17H18N2O/c1-3-11-19-17-12(2)5-4-6-15(17)16(18-19)13-7-9-14(20)10-8-13/h4-10,20H,3,11H2,1-2H3 D0J6KN DRUGINKE KGNRBLHSFFCQIN-UHFFFAOYSA-N D0J6KN DRUGSMIL CCCN1C2=C(C=CC=C2C(=N1)C3=CC=C(C=C3)O)C D0J6KN HIGHSTAT Investigative D0J6ME DRUG__ID D0J6ME D0J6ME DRUGTYPE Small molecular drug D0J6ME DRUGINCH 1S/C13H11N3S/c1-2-11-15-10-6-8-17-13(10)12(16-11)9-5-3-4-7-14-9/h3-8H,2H2,1H3 D0J6ME DRUGINKE RJLBQJZGTPMDPY-UHFFFAOYSA-N D0J6ME DRUGSMIL CCC1=NC2=C(C(=N1)C3=CC=CC=N3)SC=C2 D0J6ME HIGHSTAT Investigative D0J6NI DRUG__ID D0J6NI D0J6NI DRUGTYPE Small molecular drug D0J6NI DRUGINCH 1S/C15H19N3/c1-2-4-15(5-3-1)18-8-6-13(7-9-18)10-14-11-16-12-17-14/h1-5,11-13H,6-10H2,(H,16,17) D0J6NI DRUGINKE DKJLGZJEDGFKIC-UHFFFAOYSA-N D0J6NI DRUGSMIL C1CN(CCC1CC2=CN=CN2)C3=CC=CC=C3 D0J6NI HIGHSTAT Investigative D0J6PQ DRUG__ID D0J6PQ D0J6PQ DRUGTYPE Small molecular drug D0J6PQ DRUGINCH 1S/C15H11N5O/c16-15-18-12(11-7-4-8-21-11)13-14(19-15)20(9-17-13)10-5-2-1-3-6-10/h1-9H,(H2,16,18,19) D0J6PQ DRUGINKE VEZSQJIGMFDZRT-UHFFFAOYSA-N D0J6PQ DRUGSMIL C1=CC=C(C=C1)N2C=NC3=C(N=C(N=C32)N)C4=CC=CO4 D0J6PQ HIGHSTAT Investigative D0J6PV DRUG__ID D0J6PV D0J6PV DRUGTYPE Small molecular drug D0J6PV DRUGINCH 1S/C4H10F2NO2P/c5-4(6)10(8,9)3-1-2-7/h4H,1-3,7H2,(H,8,9) D0J6PV DRUGINKE TXAHGWWWANKBDA-UHFFFAOYSA-N D0J6PV DRUGSMIL C(CN)CP(=O)(C(F)F)O D0J6PV HIGHSTAT Investigative D0J6QC DRUG__ID D0J6QC D0J6QC DRUGTYPE Small molecular drug D0J6QC DRUGINCH 1S/C47H70N9O12P/c1-8-31(6)42(46(62)49-26-34-17-12-13-20-56(34)64)53-43(59)35(30(4)5)24-40(57)36(21-29(2)3)51-45(61)39(23-33-25-48-28-50-33)54(7)47(63)37(22-32-15-10-9-11-16-32)52-44(60)38-18-14-19-55(38)41(58)27-68-69(65,66)67/h9-13,15-17,20,25,28-31,35-40,42,57H,8,14,18-19,21-24,26-27H2,1-7H3,(H,48,50)(H,49,62)(H,51,61)(H,52,60)(H,53,59)(H2,65,66,67) D0J6QC DRUGINKE APMOVMFBSHFCLN-UHFFFAOYSA-N D0J6QC DRUGSMIL CCC(C)C(C(=O)NCC1=CC=CC=[N+]1[O-])NC(=O)C(CC(C(CC(C)C)NC(=O)C(CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)COP(=O)(O)O)O)C(C)C D0J6QC HIGHSTAT Investigative D0J6RQ DRUG__ID D0J6RQ D0J6RQ DRUGTYPE Small molecular drug D0J6RQ DRUGINCH 1S/C17H14O3/c18-15-7-1-13(2-8-15)5-11-17(20)12-6-14-3-9-16(19)10-4-14/h1-12,18-19H/b11-5+,12-6+ D0J6RQ DRUGINKE FTEGUKWEUQPKIS-YDWXAUTNSA-N D0J6RQ DRUGSMIL C1=CC(=CC=C1C=CC(=O)C=CC2=CC=C(C=C2)O)O D0J6RQ HIGHSTAT Investigative D0J6SP DRUG__ID D0J6SP D0J6SP DRUGTYPE Small molecular drug D0J6SP DRUGINCH 1S/C17H28N8O6/c18-17(19)20-3-1-2-9-14(29)22-7-12(26)24-11(5-13(27)28)16(31)23-8-4-10(21-6-8)15(30)25-9/h8-11,21H,1-7H2,(H,22,29)(H,23,31)(H,24,26)(H,25,30)(H,27,28)(H4,18,19,20)/t8-,9+,10-,11+/m1/s1 D0J6SP DRUGINKE RLABYQGJZRFBJA-YTWAJWBKSA-N D0J6SP DRUGSMIL C1C2CNC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D0J6SP HIGHSTAT Investigative D0J6SX DRUG__ID D0J6SX D0J6SX DRUGTYPE Small molecular drug D0J6SX DRUGINCH 1S/C18H21N3O2/c19-15(11-13-7-3-1-4-8-13)18(23)21-16(17(20)22)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H2,20,22)(H,21,23)/t15-,16+/m0/s1 D0J6SX DRUGINKE XXPXQEQOAZMUDD-JKSUJKDBSA-N D0J6SX DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)N D0J6SX HIGHSTAT Investigative D0J6TU DRUG__ID D0J6TU D0J6TU DRUGTYPE Small molecular drug D0J6TU DRUGINCH 1S/C16H12ClNOS/c1-19-14-8-4-11(5-9-14)15-10-18-20-16(15)12-2-6-13(17)7-3-12/h2-10H,1H3 D0J6TU DRUGINKE XGOLGQNTCHMSDA-UHFFFAOYSA-N D0J6TU DRUGSMIL COC1=CC=C(C=C1)C2=C(SN=C2)C3=CC=C(C=C3)Cl D0J6TU HIGHSTAT Investigative D0J6UH DRUG__ID D0J6UH D0J6UH DRUGTYPE Small molecular drug D0J6UH DRUGINCH 1S/C72H101N13O10S3.3C2HF3O2/c1-8-84(9-2)54-30-33-59-64(44-54)95-65-45-55(85(10-3)11-4)31-34-60(65)68(59)61-35-32-58(47-66(61)98(92,93)94)97(90,91)76-40-25-19-17-15-13-12-14-16-18-24-38-74-72(89)75-39-26-23-29-62(78-67(86)46-57-50-96-71(73)82(57)7)69(87)79-63(70(88)77-53-36-41-80(5)42-37-53)43-56-49-83(51-81(56)6)48-52-27-21-20-22-28-52;3*3-2(4,5)1(6)7/h20-22,27-28,30-35,44-45,47,49-51,53,62-63,73,76H,8-19,23-26,29,36-43,46,48H2,1-7H3,(H4-2,74,75,77,78,79,86,87,88,89,92,93,94);3*(H,6,7)/p+1 D0J6UH DRUGINKE SEZVZMIKECAWEG-UHFFFAOYSA-O D0J6UH DRUGSMIL CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)S(=O)(=O)NCCCCCCCCCCCCNC(=O)NCCCCC(C(=O)NC(CC5=C[N+](=CN5C)CC6=CC=CC=C6)C(=O)NC7CC[NH+](CC7)C)NC(=O)CC8=CSC(=N)[NH+]8C)S(=O)(=O)O.C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-] D0J6UH HIGHSTAT Investigative D0J6WG DRUG__ID D0J6WG D0J6WG DRUGTYPE Small molecular drug D0J6WG DRUGINCH 1S/C28H40N4O10/c1-13(2)25(37)19(41-18(34)15-7-6-10-31-15)26(38)21(4)12-24(36)22(25,5)28(26,39)27(42-24)17(14(3)8-9-23(21,27)35)40-16(33)11-32-20(29)30/h6-7,10,13-14,17,19,31,35-39H,8-9,11-12H2,1-5H3,(H4,29,30,32)/t14?,17-,19-,21+,22?,23?,24?,25?,26?,27?,28?/m1/s1 D0J6WG DRUGINKE JJIABRHLFSNGBC-BTZWEUFCSA-N D0J6WG DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CN=C(N)N)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O D0J6WG HIGHSTAT Investigative D0J6WM DRUG__ID D0J6WM D0J6WM DRUGTYPE Small molecular drug D0J6WM DRUGINCH 1S/C27H30O11/c1-11-19(30)35-17-15(29)25-16-13(28)14(23(2,3)4)24(25)18(34-10-12-8-6-5-7-9-12)20(31)37-22(24)38-27(25,21(32)36-16)26(11,17)33/h5-9,11,13-18,22,28-29,33H,10H2,1-4H3/t11?,13-,14?,15?,16?,17+,18+,22?,24?,25?,26-,27+/m1/s1 D0J6WM DRUGINKE YPOMAFCMSAKBRX-WULOTIIESA-N D0J6WM DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)OCC7=CC=CC=C7)O D0J6WM HIGHSTAT Investigative D0J6XI DRUG__ID D0J6XI D0J6XI DRUGTYPE Small molecular drug D0J6XI DRUGINCH 1S/C17H19N3O3S/c1-11-5-8-16(12(2)9-11)24(22,23)18-13-6-7-14-15(10-13)20(4)17(21)19(14)3/h5-10,18H,1-4H3 D0J6XI DRUGINKE HVGVNYJRZJHYBS-UHFFFAOYSA-N D0J6XI DRUGSMIL CC1=CC(=C(C=C1)S(=O)(=O)NC2=CC3=C(C=C2)N(C(=O)N3C)C)C D0J6XI HIGHSTAT Investigative D0J7AM DRUG__ID D0J7AM D0J7AM DRUGTYPE Small molecular drug D0J7AM DRUGINCH 1S/C7H6BrNO2/c8-6-3-1-5(2-4-6)7(10)9-11/h1-4,11H,(H,9,10) D0J7AM DRUGINKE VESPFSJNQMGUCQ-UHFFFAOYSA-N D0J7AM DRUGSMIL C1=CC(=CC=C1C(=O)NO)Br D0J7AM HIGHSTAT Investigative D0J7BH DRUG__ID D0J7BH D0J7BH DRUGTYPE Small molecular drug D0J7BH DRUGINCH 1S/C13H13NO3/c15-13-9-11(14-5-7-16-8-6-14)10-3-1-2-4-12(10)17-13/h1-4,9H,5-8H2 D0J7BH DRUGINKE YJXJQEJDZPLPTQ-UHFFFAOYSA-N D0J7BH DRUGSMIL C1COCCN1C2=CC(=O)OC3=CC=CC=C32 D0J7BH HIGHSTAT Investigative D0J7CR DRUG__ID D0J7CR D0J7CR DRUGTYPE Small molecular drug D0J7CR DRUGINCH 1S/C23H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)24-21-20-22(21)25/h6-7,9-10,12-13,15-16,21-22,25H,2-5,8,11,14,17-20H2,1H3,(H,24,26)/b7-6-,10-9-,13-12-,16-15-/t21-,22+/m1/s1 D0J7CR DRUGINKE LZHCSJBKBARIFQ-NFCFDWBMSA-N D0J7CR DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1CC1O D0J7CR HIGHSTAT Investigative D0J7EL DRUG__ID D0J7EL D0J7EL DRUGTYPE Small molecular drug D0J7EL DRUGINCH 1S/C6H6BNO4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4,9-10H D0J7EL DRUGINKE ZNRGSYUVFVNSAW-UHFFFAOYSA-N D0J7EL DRUGSMIL B(C1=CC(=CC=C1)[N+](=O)[O-])(O)O D0J7EL HIGHSTAT Investigative D0J7EM DRUG__ID D0J7EM D0J7EM DRUGTYPE Small molecular drug D0J7EM DRUGINCH 1S/C18H20N2S/c1-19(2)13-12-15-14-20(18-11-7-6-10-17(15)18)21-16-8-4-3-5-9-16/h3-11,14H,12-13H2,1-2H3 D0J7EM DRUGINKE APYJLIWKKMRCGM-UHFFFAOYSA-N D0J7EM DRUGSMIL CN(C)CCC1=CN(C2=CC=CC=C21)SC3=CC=CC=C3 D0J7EM HIGHSTAT Investigative D0J7EN DRUG__ID D0J7EN D0J7EN DRUGTYPE Small molecular drug D0J7EN DRUGINCH 1S/C31H29NO5/c1-31(2,3)37-27(33)18-36-20-14-12-19(13-15-20)16-24-28(25-17-32-26-11-7-6-8-21(25)26)22-9-4-5-10-23(22)29(34)30(24)35/h4-15,17,21,26,32H,16,18H2,1-3H3 D0J7EN DRUGINKE FUPVNXIRQSPKMZ-UHFFFAOYSA-N D0J7EN DRUGSMIL CC(C)(C)OC(=O)COC1=CC=C(C=C1)CC2=C(C3=CC=CC=C3C(=O)C2=O)C4=CNC5C4C=CC=C5 D0J7EN HIGHSTAT Investigative D0J7FD DRUG__ID D0J7FD D0J7FD DRUGTYPE Small molecular drug D0J7FD DRUGINCH 1S/C23H20N2O4S/c26-23(24-27)22(14-16-9-10-17-5-1-3-7-19(17)13-16)25-30(28,29)21-12-11-18-6-2-4-8-20(18)15-21/h1-13,15,22,25,27H,14H2,(H,24,26)/t22-/m1/s1 D0J7FD DRUGINKE MMOUXLMPQFMDRD-JOCHJYFZSA-N D0J7FD DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC(C(=O)NO)NS(=O)(=O)C3=CC4=CC=CC=C4C=C3 D0J7FD HIGHSTAT Investigative D0J7FJ DRUG__ID D0J7FJ D0J7FJ DRUGTYPE Small molecular drug D0J7FJ DRUGINCH 1S/C16H18FNO2/c17-15-12-18-16(20-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D0J7FJ DRUGINKE KUKHXFUDITXZRG-UHFFFAOYSA-N D0J7FJ DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=C(O2)F D0J7FJ HIGHSTAT Investigative D0J7FK DRUG__ID D0J7FK D0J7FK DRUGTYPE Small molecular drug D0J7FK DRUGINCH 1S/C14H26N2O3/c1-19-13(17)10-6-3-7-11-15-14(18)16-12-8-4-2-5-9-12/h12H,2-11H2,1H3,(H2,15,16,18) D0J7FK DRUGINKE WHXVJNIBTQCTJK-UHFFFAOYSA-N D0J7FK DRUGSMIL COC(=O)CCCCCNC(=O)NC1CCCCC1 D0J7FK HIGHSTAT Investigative D0J7GF DRUG__ID D0J7GF D0J7GF DRUGTYPE Small molecular drug D0J7GF DRUGINCH 1S/C21H17N3/c1-3-9-16(10-4-1)15-22-21-18-13-7-8-14-19(18)23-20(24-21)17-11-5-2-6-12-17/h1-14H,15H2,(H,22,23,24) D0J7GF DRUGINKE WXCHSHPXEPXKFN-UHFFFAOYSA-N D0J7GF DRUGSMIL C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4 D0J7GF HIGHSTAT Investigative D0J7GU DRUG__ID D0J7GU D0J7GU DRUGTYPE Small molecular drug D0J7GU DRUGINCH 1S/C6H8N2O2S2/c1-11-5-2-3-8-4-6(5)12(7,9)10/h2-4H,1H3,(H2,7,9,10) D0J7GU DRUGINKE PLOUCIVACOBALV-UHFFFAOYSA-N D0J7GU DRUGSMIL CSC1=C(C=NC=C1)S(=O)(=O)N D0J7GU HIGHSTAT Investigative D0J7KJ DRUG__ID D0J7KJ D0J7KJ DRUGTYPE Small molecular drug D0J7KJ DRUGINCH 1S/C14H14O4/c1-3-6-17-13-8-12-10(4-5-14(16)18-12)7-11(13)9(2)15/h4-5,7-8H,3,6H2,1-2H3 D0J7KJ DRUGINKE VIKCPCBUFQJHPC-UHFFFAOYSA-N D0J7KJ DRUGSMIL CCCOC1=C(C=C2C=CC(=O)OC2=C1)C(=O)C D0J7KJ HIGHSTAT Investigative D0J7LY DRUG__ID D0J7LY D0J7LY DRUGTYPE Small molecular drug D0J7LY DRUGINCH 1S/C11H10O4S/c1-6-3-7(5-16-6)11(2)9(12)4-8(15-11)10(13)14/h3-5H,1-2H3,(H,13,14) D0J7LY DRUGINKE NNWGOUJBCKZULC-UHFFFAOYSA-N D0J7LY DRUGSMIL CC1=CC(=CS1)C2(C(=O)C=C(O2)C(=O)O)C D0J7LY HIGHSTAT Investigative D0J7MD DRUG__ID D0J7MD D0J7MD DRUGTYPE Small molecular drug D0J7MD DRUGINCH 1S/C12H11NO4/c1-17-9-3-4-10-8(6-9)2-5-11(14)13(10)7-12(15)16/h2-6H,7H2,1H3,(H,15,16) D0J7MD DRUGINKE CHNXZDVEGNIZLG-UHFFFAOYSA-N D0J7MD DRUGSMIL COC1=CC2=C(C=C1)N(C(=O)C=C2)CC(=O)O D0J7MD HIGHSTAT Investigative D0J7MM DRUG__ID D0J7MM D0J7MM DRUGTYPE Small molecular drug D0J7MM DRUGINCH 1S/C22H24N4O3/c1-15-19-13-16(5-10-20(19)25-22(23-15)26-11-3-4-12-26)24-21(27)14-29-18-8-6-17(28-2)7-9-18/h5-10,13H,3-4,11-12,14H2,1-2H3,(H,24,27) D0J7MM DRUGINKE YXNSFDJSYOVION-UHFFFAOYSA-N D0J7MM DRUGSMIL CC1=C2C=C(C=CC2=NC(=N1)N3CCCC3)NC(=O)COC4=CC=C(C=C4)OC D0J7MM HIGHSTAT Investigative D0J7NR DRUG__ID D0J7NR D0J7NR DRUGTYPE Small molecular drug D0J7NR DRUGINCH 1S/C11H9N3O/c1-6-3-2-4-7-5-8-10(13-9(6)7)14-11(15)12-8/h2-5H,1H3,(H2,12,13,14,15) D0J7NR DRUGINKE YZNZOJPHYDBVIZ-UHFFFAOYSA-N D0J7NR DRUGSMIL CC1=C2C(=CC=C1)C=C3C(=N2)NC(=O)N3 D0J7NR HIGHSTAT Investigative D0J7NS DRUG__ID D0J7NS D0J7NS DRUGTYPE Small molecular drug D0J7NS DRUGINCH 1S/C5H10N2/c1-4-2-5(6)7-3-4/h4H,2-3H2,1H3,(H2,6,7) D0J7NS DRUGINKE IAGJRVCMUDBZSN-UHFFFAOYSA-N D0J7NS DRUGSMIL CC1CC(=NC1)N D0J7NS HIGHSTAT Investigative D0J7OM DRUG__ID D0J7OM D0J7OM DRUGTYPE Small molecular drug D0J7OM DRUGINCH 1S/C17H18N6/c1-2-3-9-23-12-20-15-16(21-14(10-18)22-17(15)23)19-11-13-7-5-4-6-8-13/h4-8,12H,2-3,9,11H2,1H3,(H,19,21,22) D0J7OM DRUGINKE OJVVVZACBFLFEJ-UHFFFAOYSA-N D0J7OM DRUGSMIL CCCCN1C=NC2=C(N=C(N=C21)C#N)NCC3=CC=CC=C3 D0J7OM HIGHSTAT Investigative D0J7VA DRUG__ID D0J7VA D0J7VA DRUGTYPE Small molecular drug D0J7VA DRUGINCH 1S/C22H22O11/c1-8-16(26)18(28)19(29)22(31-8)33-21-17(27)15-12(25)6-10(23)7-14(15)32-20(21)9-3-4-11(24)13(5-9)30-2/h3-8,16,18-19,22-26,28-29H,1-2H3/t8-,16-,18+,19+,22-/m0/s1 D0J7VA DRUGINKE UXXAEVMOIUAYQT-UFGFRKJLSA-N D0J7VA DRUGSMIL CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C=C4)O)OC)O)O)O D0J7VA HIGHSTAT Investigative D0J7VL DRUG__ID D0J7VL D0J7VL DRUGTYPE Small molecular drug D0J7VL DRUGINCH 1S/C30H39N5O8/c1-17(2)13-24(30(42)43)35-28(39)23(15-19-7-5-4-6-8-19)34-25(36)16-32-26(37)18(3)33-27(38)22(31)14-20-9-11-21(12-10-20)29(40)41/h4-12,17-18,22-24H,13-16,31H2,1-3H3,(H,32,37)(H,33,38)(H,34,36)(H,35,39)(H,40,41)(H,42,43)/t18-,22-,23-,24-/m0/s1 D0J7VL DRUGINKE YGSPIRVSMFDGND-IMNFJDCFSA-N D0J7VL DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)C(=O)O)N D0J7VL HIGHSTAT Investigative D0J7XB DRUG__ID D0J7XB D0J7XB DRUGTYPE Small molecular drug D0J7XB DRUGINCH 1S/C23H28O10/c1-10-14-16(31-21(27)23(5)11(2)32-23)15(29-12(3)24)13(20(26)28-6)8-7-9-22(4)18(33-22)17(14)30-19(10)25/h8,11,14-18H,1,7,9H2,2-6H3/b13-8+/t11-,14-,15+,16+,17+,18-,22-,23-/m1/s1 D0J7XB DRUGINKE VCBNPTWPJQLHQN-FQAPAZNFSA-N D0J7XB DRUGSMIL CC1C(O1)(C)C(=O)OC2C3C(C4C(O4)(CCC=C(C2OC(=O)C)C(=O)OC)C)OC(=O)C3=C D0J7XB HIGHSTAT Investigative D0J7XM DRUG__ID D0J7XM D0J7XM DRUGTYPE Small molecular drug D0J7XM DRUGINCH 1S/C38H54N8O10/c1-20(2)31(37(55)41-19-29(40)48)46-38(56)32(21(3)4)45-35(53)27(15-16-30(49)50)43-36(54)28(18-23-9-7-6-8-10-23)44-33(51)22(5)42-34(52)26(39)17-24-11-13-25(47)14-12-24/h6-14,20-22,26-28,31-32,47H,15-19,39H2,1-5H3,(H2,40,48)(H,41,55)(H,42,52)(H,43,54)(H,44,51)(H,45,53)(H,46,56)(H,49,50)/t22-,26+,27+,28+,31+,32?/m1/s1 D0J7XM DRUGINKE NUNBRHVOPFWRRG-MPNDMYOWSA-N D0J7XM DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)O)N D0J7XM HIGHSTAT Investigative D0J7XZ DRUG__ID D0J7XZ D0J7XZ DRUGTYPE Small molecular drug D0J7XZ DRUGINCH 1S/C24H26O2/c1-2-12-23(26)13-14-24(16-18-6-4-3-5-7-18)20(17-23)9-8-19-15-21(25)10-11-22(19)24/h3-7,10-11,15,20,25-26H,8-9,13-14,16-17H2,1H3/t20-,23-,24+/m1/s1 D0J7XZ DRUGINKE WDSPVCXWXOIFRA-HUVFLSCGSA-N D0J7XZ DRUGSMIL CC#CC1(CCC2(C(C1)CCC3=C2C=CC(=C3)O)CC4=CC=CC=C4)O D0J7XZ HIGHSTAT Investigative D0J7YE DRUG__ID D0J7YE D0J7YE DRUGTYPE Small molecular drug D0J7YE DRUGINCH 1S/C9H9N3O/c1-6(13)11-8-2-3-9-7(4-8)5-10-12-9/h2-5H,1H3,(H,10,12)(H,11,13) D0J7YE DRUGINKE XGVHKKOLBJMLLQ-UHFFFAOYSA-N D0J7YE DRUGSMIL CC(=O)NC1=CC2=C(C=C1)NN=C2 D0J7YE HIGHSTAT Investigative D0J7YU DRUG__ID D0J7YU D0J7YU DRUGTYPE Small molecular drug D0J7YU DRUGINCH 1S/C14H12N2O/c17-14-12-8-4-5-9-13(12)15-16(14)10-11-6-2-1-3-7-11/h1-9,15H,10H2 D0J7YU DRUGINKE IBMDKBAGSDBZIJ-UHFFFAOYSA-N D0J7YU DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C3=CC=CC=C3N2 D0J7YU HIGHSTAT Investigative D0J7YV DRUG__ID D0J7YV D0J7YV DRUGTYPE Small molecular drug D0J7YV DRUGINCH 1S/C24H24O6/c1-11(2)6-7-13-20-18(9-15(25)24(13)28-5)30-19-10-17-14(8-16(29-17)12(3)4)22(26)21(19)23(20)27/h6,9-10,16,25-26H,3,7-8H2,1-2,4-5H3 D0J7YV DRUGINKE AWFULCQUYOKYCM-UHFFFAOYSA-N D0J7YV DRUGSMIL CC(=CCC1=C(C(=CC2=C1C(=O)C3=C(C4=C(C=C3O2)OC(C4)C(=C)C)O)O)OC)C D0J7YV HIGHSTAT Investigative D0J7ZK DRUG__ID D0J7ZK D0J7ZK DRUGTYPE Small molecular drug D0J7ZK DRUGINCH 1S/C14H17N3/c1-2-6-11(7-3-1)17-14-12-8-4-5-9-13(12)15-10-16-14/h4-5,8-11H,1-3,6-7H2,(H,15,16,17) D0J7ZK DRUGINKE CIFOBGKTSPXVQX-UHFFFAOYSA-N D0J7ZK DRUGSMIL C1CCC(CC1)NC2=NC=NC3=CC=CC=C32 D0J7ZK HIGHSTAT Investigative D0J8BD DRUG__ID D0J8BD D0J8BD DRUGTYPE Small molecular drug D0J8BD DRUGINCH 1S/C13H16O4/c14-11(8-12(15)9-13(16)17)7-6-10-4-2-1-3-5-10/h1-5,12,15H,6-9H2,(H,16,17)/t12-/m1/s1 D0J8BD DRUGINKE AOBNEADIHQEJLV-GFCCVEGCSA-N D0J8BD DRUGSMIL C1=CC=C(C=C1)CCC(=O)CC(CC(=O)O)O D0J8BD HIGHSTAT Investigative D0J8BO DRUG__ID D0J8BO D0J8BO DRUGTYPE Small molecular drug D0J8BO DRUGINCH 1S/C22H41NO7/c1-2-3-4-5-6-7-8-9-10-11-12-13-20(26)30-22-17(14-19(25)23-28)16-29-18(15-24)21(22)27/h17-18,21-22,24,27-28H,2-16H2,1H3,(H,23,25)/t17-,18+,21+,22+/m0/s1 D0J8BO DRUGINKE INAPDIIIYSWKOC-XHIHJMKYSA-N D0J8BO DRUGSMIL CCCCCCCCCCCCCC(=O)OC1C(COC(C1O)CO)CC(=O)NO D0J8BO HIGHSTAT Investigative D0J8DC DRUG__ID D0J8DC D0J8DC DRUGTYPE Small molecular drug D0J8DC DRUGINCH 1S/C22H24N2/c1-2-8-19(9-3-1)22(24-15-13-23-14-16-24)17-20-11-6-10-18-7-4-5-12-21(18)20/h1-12,22-23H,13-17H2 D0J8DC DRUGINKE VWOWSEBOGHLBFX-UHFFFAOYSA-N D0J8DC DRUGSMIL C1CN(CCN1)C(CC2=CC=CC3=CC=CC=C32)C4=CC=CC=C4 D0J8DC HIGHSTAT Investigative D0J8FS DRUG__ID D0J8FS D0J8FS DRUGTYPE Small molecular drug D0J8FS DRUGINCH 1S/C14H10N2O4/c17-15(18)13-8-6-11(7-9-13)4-5-12-2-1-3-14(10-12)16(19)20/h1-10H/b5-4+ D0J8FS DRUGINKE WMOGPQFWQAXCTI-SNAWJCMRSA-N D0J8FS DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C=CC2=CC=C(C=C2)[N+](=O)[O-] D0J8FS HIGHSTAT Investigative D0J8KR DRUG__ID D0J8KR D0J8KR DRUGTYPE Small molecular drug D0J8KR DRUGINCH 1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h1,3-4H2,2H3,(H,9,10)(H2,6,7,8) D0J8KR DRUGINKE NUHSROFQTUXZQQ-UHFFFAOYSA-N D0J8KR DRUGSMIL CC(=C)CCOP(=O)(O)OP(=O)(O)O D0J8KR HIGHSTAT Investigative D0J8KW DRUG__ID D0J8KW D0J8KW DRUGTYPE Small molecular drug D0J8KW DRUGINCH 1S/C29H34ClN3O/c1-18-6-8-20(9-7-18)17-33-25(21-10-11-23(30)19(2)14-21)15-24(32-33)26(34)31-27-28(3,4)22-12-13-29(27,5)16-22/h6-11,14-15,22,27H,12-13,16-17H2,1-5H3,(H,31,34)/t22-,27-,29+/m1/s1 D0J8KW DRUGINKE SUGVYNSRNKFXQM-XRHWURSXSA-N D0J8KW DRUGSMIL CC1=CC=C(C=C1)CN2C(=CC(=N2)C(=O)NC3C(C4CCC3(C4)C)(C)C)C5=CC(=C(C=C5)Cl)C D0J8KW HIGHSTAT Investigative D0J8LQ DRUG__ID D0J8LQ D0J8LQ DRUGTYPE Small molecular drug D0J8LQ DRUGINCH 1S/C19H12BrNOS/c20-14-7-5-6-13(12-14)19(22)21-15-8-1-3-10-17(15)23-18-11-4-2-9-16(18)21/h1-12H D0J8LQ DRUGINKE XWGLMCFWNRNHDU-UHFFFAOYSA-N D0J8LQ DRUGSMIL C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)C4=CC(=CC=C4)Br D0J8LQ HIGHSTAT Investigative D0J8LU DRUG__ID D0J8LU D0J8LU DRUGTYPE Small molecular drug D0J8LU DRUGINCH 1S/C19H16O2/c1-13-11-17(9-10-19(13)21)15-7-5-14(6-8-15)16-3-2-4-18(20)12-16/h2-12,20-21H,1H3 D0J8LU DRUGINKE NXOBKCKXSAATAY-UHFFFAOYSA-N D0J8LU DRUGSMIL CC1=C(C=CC(=C1)C2=CC=C(C=C2)C3=CC(=CC=C3)O)O D0J8LU HIGHSTAT Investigative D0J8OW DRUG__ID D0J8OW D0J8OW DRUGTYPE Small molecular drug D0J8OW DRUGINCH 1S/C10H11NO4/c1-10(11,9(14)15)7-4-2-6(3-5-7)8(12)13/h2-5H,11H2,1H3,(H,12,13)(H,14,15)/t10-/m0/s1 D0J8OW DRUGINKE DNCAZYRLRMTVSF-JTQLQIEISA-N D0J8OW DRUGSMIL CC(C1=CC=C(C=C1)C(=O)O)(C(=O)O)N D0J8OW HIGHSTAT Investigative D0J8PY DRUG__ID D0J8PY D0J8PY DRUGTYPE Small molecular drug D0J8PY DRUGINCH 1S/C20H25NO/c1-3-7-18(8-4-1)17-19-11-13-21(14-12-19)15-16-22-20-9-5-2-6-10-20/h1-10,19H,11-17H2 D0J8PY DRUGINKE HRBKFQYSVXXYDE-UHFFFAOYSA-N D0J8PY DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)CCOC3=CC=CC=C3 D0J8PY HIGHSTAT Investigative D0J8QS DRUG__ID D0J8QS D0J8QS DRUGTYPE Small molecular drug D0J8QS DRUGINCH 1S/C9H11NO4/c10-9(7(13)14)3-1-4-5(9)8(4,2-3)6(11)12/h3-5H,1-2,10H2,(H,11,12)(H,13,14)/t3-,4-,5+,8+,9+/m0/s1 D0J8QS DRUGINKE KETJIAAJBCULKI-DPPUOXHASA-N D0J8QS DRUGSMIL C1C2CC3(C1C3C2(C(=O)O)N)C(=O)O D0J8QS HIGHSTAT Investigative D0J8RI DRUG__ID D0J8RI D0J8RI DRUGTYPE Small molecular drug D0J8RI DRUGINCH 1S/C11H13FN2/c1-8(13)7-14-5-4-9-6-10(12)2-3-11(9)14/h2-6,8H,7,13H2,1H3 D0J8RI DRUGINKE DUUXOYARAAZWLV-UHFFFAOYSA-N D0J8RI DRUGSMIL CC(CN1C=CC2=C1C=CC(=C2)F)N D0J8RI HIGHSTAT Investigative D0J8RP DRUG__ID D0J8RP D0J8RP DRUGTYPE Small molecular drug D0J8RP DRUGINCH 1S/C16H25N/c1-4-10-17-11-6-8-15(12-17)16-9-5-7-13(2)14(16)3/h5,7,9,15H,4,6,8,10-12H2,1-3H3 D0J8RP DRUGINKE AORDKZRSVBDZJZ-UHFFFAOYSA-N D0J8RP DRUGSMIL CCCN1CCCC(C1)C2=CC=CC(=C2C)C D0J8RP HIGHSTAT Investigative D0J8SU DRUG__ID D0J8SU D0J8SU DRUGTYPE Small molecular drug D0J8SU DRUGINCH 1S/C63H98N18O13S/c1-37(2)33-45(57(89)74-41(53(68)85)27-32-95-3)73-52(84)36-72-54(86)46(34-38-15-6-4-7-16-38)78-58(90)47(35-39-17-8-5-9-18-39)79-56(88)42(23-25-50(66)82)75-55(87)43(24-26-51(67)83)76-59(91)49-22-14-31-81(49)62(94)44(20-10-11-28-64)77-60(92)48-21-13-30-80(48)61(93)40(65)19-12-29-71-63(69)70/h4-9,15-18,37,40-49H,10-14,19-36,64-65H2,1-3H3,(H2,66,82)(H2,67,83)(H2,68,85)(H,72,86)(H,73,84)(H,74,89)(H,75,87)(H,76,91)(H,77,92)(H,78,90)(H,79,88)(H4,69,70,71)/t40-,41-,42-,43-,44-,45-,46-,47-,48-,49-/m0/s1 D0J8SU DRUGINKE ADNPLDHMAVUMIW-CUZNLEPHSA-N D0J8SU DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D0J8SU HIGHSTAT Investigative D0J8TY DRUG__ID D0J8TY D0J8TY DRUGTYPE Small molecular drug D0J8TY DRUGINCH 1S/C21H31F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(25)21(22,23)24/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3/b7-6-,10-9-,13-12-,16-15- D0J8TY DRUGINKE PLWROONZUDKYKG-DOFZRALJSA-N D0J8TY DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)C(F)(F)F D0J8TY HIGHSTAT Investigative D0J8VR DRUG__ID D0J8VR D0J8VR DRUGTYPE Small molecular drug D0J8VR DRUGINCH 1S/C16H16ClN5/c17-11-4-5-16-19-9-14(22(16)10-11)13-2-1-3-15(21-13)20-12-6-7-18-8-12/h1-5,9-10,12,18H,6-8H2,(H,20,21) D0J8VR DRUGINKE NAMQQRIYZTTYCJ-UHFFFAOYSA-N D0J8VR DRUGSMIL C1CNCC1NC2=CC=CC(=N2)C3=CN=C4N3C=C(C=C4)Cl D0J8VR HIGHSTAT Investigative D0J8VU DRUG__ID D0J8VU D0J8VU DRUGTYPE Small molecular drug D0J8VU DRUGINCH 1S/C15H19N3O2S/c1-2-3-4-5-10-16-15(19)20-13-8-6-12(7-9-13)14-11-21-18-17-14/h6-9,11H,2-5,10H2,1H3,(H,16,19) D0J8VU DRUGINKE KWDYSOZHSAWBCY-UHFFFAOYSA-N D0J8VU DRUGSMIL CCCCCCNC(=O)OC1=CC=C(C=C1)C2=CSN=N2 D0J8VU HIGHSTAT Investigative D0J8ZH DRUG__ID D0J8ZH D0J8ZH DRUGTYPE Small molecular drug D0J8ZH DRUGINCH 1S/C21H21NO7/c1-25-15-3-9(4-16(26-2)20(15)23)17-10-5-13-14(29-8-28-13)6-11(10)19(22)12-7-27-21(24)18(12)17/h3-6,12,17-19,23H,7-8,22H2,1-2H3/t12-,17+,18-,19+/m0/s1 D0J8ZH DRUGINKE WZTRSUUEQXXWCN-JHQYFNNDSA-N D0J8ZH DRUGSMIL COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)N D0J8ZH HIGHSTAT Investigative D0J9CR DRUG__ID D0J9CR D0J9CR DRUGTYPE Small molecular drug D0J9CR DRUGINCH 1S/C23H26N2O2S/c1-18-7-4-8-19(15-18)17-27-22-11-3-2-10-21(22)23(26)25(13-6-12-24)16-20-9-5-14-28-20/h2-5,7-11,14-15H,6,12-13,16-17,24H2,1H3 D0J9CR DRUGINKE LCQJRANJHOEQFG-UHFFFAOYSA-N D0J9CR DRUGSMIL CC1=CC(=CC=C1)COC2=CC=CC=C2C(=O)N(CCCN)CC3=CC=CS3 D0J9CR HIGHSTAT Investigative D0J9DD DRUG__ID D0J9DD D0J9DD DRUGTYPE Small molecular drug D0J9DD DRUGINCH 1S/C9H8N2/c1-2-4-8(5-3-1)9-6-10-7-11-9/h1-7H,(H,10,11) D0J9DD DRUGINKE XHLKOHSAWQPOFO-UHFFFAOYSA-N D0J9DD DRUGSMIL C1=CC=C(C=C1)C2=CN=CN2 D0J9DD HIGHSTAT Investigative D0J9DO DRUG__ID D0J9DO D0J9DO DRUGTYPE Small molecular drug D0J9DO DRUGINCH 1S/C48H57N7O8/c49-37(27-33-15-19-35(56)20-16-33)47(62)54-25-7-13-41(54)45(60)52-38(28-31-9-3-1-4-10-31)43(58)23-24-51-40(30-34-17-21-36(57)22-18-34)48(63)55-26-8-14-42(55)46(61)53-39(44(50)59)29-32-11-5-2-6-12-32/h1-6,9-12,15-22,37-42,51,56-57H,7-8,13-14,23-30,49H2,(H2,50,59)(H,52,60)(H,53,61)/t37-,38-,39-,40-,41-,42-/m0/s1 D0J9DO DRUGINKE SDEZJRFUZMVTCN-UJKKYYSESA-N D0J9DO DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)CCNC(CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CC6=CC=CC=C6)C(=O)N D0J9DO HIGHSTAT Investigative D0J9DY DRUG__ID D0J9DY D0J9DY DRUGTYPE Small molecular drug D0J9DY DRUGINCH 1S/C25H26F2N2O3/c1-15(2)24-22(12-11-21-13-20(30)14-23(31)32-21)25(16-3-5-17(26)6-4-16)29(28-24)19-9-7-18(27)8-10-19/h3-10,15,20-21,30H,11-14H2,1-2H3/t20-,21-/m0/s1 D0J9DY DRUGINKE CJOOCCJIHMSWOT-SFTDATJTSA-N D0J9DY DRUGSMIL CC(C)C1=NN(C(=C1CCC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0J9DY HIGHSTAT Investigative D0J9FK DRUG__ID D0J9FK D0J9FK DRUGTYPE Small molecular drug D0J9FK DRUGINCH 1S/C16H17N5O/c1-3-11-9-21-15(17-11)12-14(20(2)16(21)22)19-13(18-12)10-7-5-4-6-8-10/h4-8,11,17H,3,9H2,1-2H3 D0J9FK DRUGINKE XNWDEMWJNJVCBD-UHFFFAOYSA-N D0J9FK DRUGSMIL CCC1CN2C(=C3C(=NC(=N3)C4=CC=CC=C4)N(C2=O)C)N1 D0J9FK HIGHSTAT Investigative D0J9FT DRUG__ID D0J9FT D0J9FT DRUGTYPE Small molecular drug D0J9FT DRUGINCH 1S/C10H15NO/c1-8(11(2)3)9-5-4-6-10(12)7-9/h4-8,12H,1-3H3/t8-/m0/s1 D0J9FT DRUGINKE GQZXRLWUYONVCP-QMMMGPOBSA-N D0J9FT DRUGSMIL CC(C1=CC(=CC=C1)O)N(C)C D0J9FT HIGHSTAT Investigative D0J9JH DRUG__ID D0J9JH D0J9JH DRUGTYPE Small molecular drug D0J9JH DRUGINCH 1S/C20H20O5/c1-8-6-11-7-12-15(16(22)9(2)19(25)20(12,4)5)18(24)14(11)17(23)13(8)10(3)21/h6-7,22-24H,1-5H3 D0J9JH DRUGINKE WVQSFFSLBOWMAA-UHFFFAOYSA-N D0J9JH DRUGSMIL CC1=CC2=CC3=C(C(=C(C(=O)C3(C)C)C)O)C(=C2C(=C1C(=O)C)O)O D0J9JH HIGHSTAT Investigative D0J9MP DRUG__ID D0J9MP D0J9MP DRUGTYPE Small molecular drug D0J9MP DRUGINCH 1S/C15H18N2O2S/c16-11-5-7-13-6-4-8-14(12-13)17-20(18,19)15-9-2-1-3-10-15/h1-4,6,8-10,12,17H,5,7,11,16H2 D0J9MP DRUGINKE GTXNQXVWASTZFN-UHFFFAOYSA-N D0J9MP DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)CCCN D0J9MP HIGHSTAT Investigative D0J9OG DRUG__ID D0J9OG D0J9OG DRUGTYPE Small molecular drug D0J9OG DRUGINCH 1S/C17H19NO5/c1-20-12-5-6-15(16(10-12)23-4)18-17(19)11-7-13(21-2)9-14(8-11)22-3/h5-10H,1-4H3,(H,18,19) D0J9OG DRUGINKE MEYNLPQFSDKAAL-UHFFFAOYSA-N D0J9OG DRUGSMIL COC1=CC(=C(C=C1)NC(=O)C2=CC(=CC(=C2)OC)OC)OC D0J9OG HIGHSTAT Investigative D0J9OS DRUG__ID D0J9OS D0J9OS DRUGTYPE Small molecular drug D0J9OS DRUGINCH 1S/C13H11NO/c1-14-8-12(10-6-7-15-9-10)11-4-2-3-5-13(11)14/h2-9H,1H3 D0J9OS DRUGINKE UFMJKAKKDCGNEF-UHFFFAOYSA-N D0J9OS DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=COC=C3 D0J9OS HIGHSTAT Investigative D0J9PG DRUG__ID D0J9PG D0J9PG DRUGTYPE Small molecular drug D0J9PG DRUGINCH 1S/C17H14O5/c1-9(2)21-11-4-5-12-15(8-11)22-14-6-3-10(17(19)20)7-13(14)16(12)18/h3-9H,1-2H3,(H,19,20) D0J9PG DRUGINKE AQFFXPQJLZFABJ-UHFFFAOYSA-N D0J9PG DRUGSMIL CC(C)OC1=CC2=C(C=C1)C(=O)C3=C(O2)C=CC(=C3)C(=O)O D0J9PG HIGHSTAT Investigative D0J9PK DRUG__ID D0J9PK D0J9PK DRUGCOMP OSI Pharmaceuticals Inc D0J9PK DRUGINCH 1S/C21H20ClN5O2/c22-14-3-1-2-13-10-15(25-16(13)14)17-18-19(23)24-8-9-27(18)20(26-17)11-4-6-12(7-5-11)21(28)29/h1-3,8-12,25H,4-7H2,(H2,23,24)(H,28,29) D0J9PK DRUGINKE UXCAKZGNKOZXBM-UHFFFAOYSA-N D0J9PK DRUGSMIL C1CC(CCC1C2=NC(=C3N2C=CN=C3N)C4=CC5=C(N4)C(=CC=C5)Cl)C(=O)O D0J9PK HIGHSTAT Investigative D0J9QK DRUG__ID D0J9QK D0J9QK DRUGTYPE Small molecular drug D0J9QK DRUGINCH 1S/C17H26N2O2/c20-15-14(3-1-2-4-18-15)19-16(21)17-8-11-5-12(9-17)7-13(6-11)10-17/h11-14H,1-10H2,(H,18,20)(H,19,21)/t11?,12?,13?,14-,17?/m1/s1 D0J9QK DRUGINKE FRJOFURBYVCNEN-DLUQRMLASA-N D0J9QK DRUGSMIL C1CCNC(=O)C(C1)NC(=O)C23CC4CC(C2)CC(C4)C3 D0J9QK HIGHSTAT Investigative D0J9SO DRUG__ID D0J9SO D0J9SO DRUGTYPE Small molecular drug D0J9SO DRUGINCH 1S/C23H25NO/c1-24(2)16-15-23(25)21-10-6-4-8-18(21)12-14-19-13-11-17-7-3-5-9-20(17)22(19)23/h3-11,13,25H,12,14-16H2,1-2H3 D0J9SO DRUGINKE IUXDSDVOBHKNSE-UHFFFAOYSA-N D0J9SO DRUGSMIL CN(C)CCC1(C2=CC=CC=C2CCC3=C1C4=CC=CC=C4C=C3)O D0J9SO HIGHSTAT Investigative D0J9SS DRUG__ID D0J9SS D0J9SS DRUGTYPE Small molecular drug D0J9SS DRUGINCH 1S/C15H8N2O6/c18-13-8-15(9-2-1-3-10(6-9)16(19)20)23-14-5-4-11(17(21)22)7-12(13)14/h1-8H D0J9SS DRUGINKE CNVQMRWAJHEFGZ-UHFFFAOYSA-N D0J9SS DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC(=O)C3=C(O2)C=CC(=C3)[N+](=O)[O-] D0J9SS HIGHSTAT Investigative D0J9TD DRUG__ID D0J9TD D0J9TD DRUGTYPE Small molecular drug D0J9TD DRUGINCH 1S/C16H16N2O3/c19-15(10-16(20)18-21)17-11-12-5-4-8-14(9-12)13-6-2-1-3-7-13/h1-9,21H,10-11H2,(H,17,19)(H,18,20) D0J9TD DRUGINKE FKVBZDLUQPPZNE-UHFFFAOYSA-N D0J9TD DRUGSMIL C1=CC=C(C=C1)C2=CC=CC(=C2)CNC(=O)CC(=O)NO D0J9TD HIGHSTAT Investigative D0J9UC DRUG__ID D0J9UC D0J9UC DRUGTYPE Small molecular drug D0J9UC DRUGINCH 1S/C14H11F3N2O/c15-14(16,17)11-5-1-9(2-6-11)10-3-7-12(8-4-10)19-13(18)20/h1-8H,(H3,18,19,20) D0J9UC DRUGINKE SUCPPONDZMGXRQ-UHFFFAOYSA-N D0J9UC DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)NC(=O)N)C(F)(F)F D0J9UC HIGHSTAT Investigative D0J9VP DRUG__ID D0J9VP D0J9VP DRUGTYPE Small molecular drug D0J9VP DRUGINCH 1S/C10H18O2/c1-5-10(9(2,3)4)6-7-12-8(10)11/h5-7H2,1-4H3 D0J9VP DRUGINKE LHTNJLBXDQITGL-UHFFFAOYSA-N D0J9VP DRUGSMIL CCC1(CCOC1=O)C(C)(C)C D0J9VP HIGHSTAT Investigative D0J9ZA DRUG__ID D0J9ZA D0J9ZA DRUGTYPE Small molecular drug D0J9ZA DRUGINCH 1S/C17H21N3O5/c18-12(8-10-9-19-13-5-2-1-4-11(10)13)16(23)20-14(17(24)25)6-3-7-15(21)22/h1-2,4-5,9,12,14,19H,3,6-8,18H2,(H,20,23)(H,21,22)(H,24,25)/t12-,14-/m0/s1 D0J9ZA DRUGINKE LKKDYAZRMNSFJN-JSGCOSHPSA-N D0J9ZA DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCCC(=O)O)C(=O)O)N D0J9ZA HIGHSTAT Investigative D0J9ZF DRUG__ID D0J9ZF D0J9ZF DRUGTYPE Small molecular drug D0J9ZF DRUGINCH 1S/C16H14N2O/c1-18-16(19)14-10-6-5-9-13(14)15(17-18)11-12-7-3-2-4-8-12/h2-10H,11H2,1H3 D0J9ZF DRUGINKE KUTSOIMAOFABLX-UHFFFAOYSA-N D0J9ZF DRUGSMIL CN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=CC=C3 D0J9ZF HIGHSTAT Investigative D0JA5D DRUG__ID D0JA5D D0JA5D DRUGTYPE Small molecular drug D0JA5D DRUGINCH 1S/C27H30Cl2N4O3S/c1-35-24-6-4-19(12-25(24)36-2)20-14-32-27(33-15-20)37-16-26(34)30-8-7-21-10-18(13-31-21)9-17-3-5-22(28)23(29)11-17/h3-6,11-12,14-15,18,21,31H,7-10,13,16H2,1-2H3,(H,30,34)/t18-,21-/m1/s1 D0JA5D DRUGINKE OPLAETMHSJFRBS-WIYYLYMNSA-N D0JA5D DRUGSMIL COC1=C(C=C(C=C1)C2=CN=C(N=C2)SCC(=O)NCCC3CC(CN3)CC4=CC(=C(C=C4)Cl)Cl)OC D0JA5D HIGHSTAT Investigative D0JB4G DRUG__ID D0JB4G D0JB4G DRUGTYPE Small molecular drug D0JB4G DRUGINCH 1S/C10H8O8S2.2Na/c11-8-3-6(19(13,14)15)1-5-2-7(20(16,17)18)4-9(12)10(5)8;;/h1-4,11-12H,(H,13,14,15)(H,16,17,18);;/q;2*+1/p-2 D0JB4G DRUGINKE AFGPCIMUGMJQPD-UHFFFAOYSA-L D0JB4G DRUGSMIL C1=C2C=C(C=C(C2=C(C=C1S(=O)(=O)[O-])O)O)S(=O)(=O)[O-].[Na+].[Na+] D0JB4G HIGHSTAT Investigative D0JB6H DRUG__ID D0JB6H D0JB6H DRUGTYPE Small molecular drug D0JB6H DRUGINCH 1S/C14H15NO3/c1-10-2-3-13-11(8-10)12(9-14(16)18-13)15-4-6-17-7-5-15/h2-3,8-9H,4-7H2,1H3 D0JB6H DRUGINKE XWKCKOOKHALUIU-UHFFFAOYSA-N D0JB6H DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C=C2N3CCOCC3 D0JB6H HIGHSTAT Investigative D0JC4Q DRUG__ID D0JC4Q D0JC4Q DRUGTYPE Small molecular drug D0JC4Q DRUGINCH 1S/C18H15ClN2O/c1-2-11-21-18(22)16-6-4-3-5-15(16)17(20-21)12-13-7-9-14(19)10-8-13/h2-10H,1,11-12H2 D0JC4Q DRUGINKE OHEWOPKEAKDVRX-UHFFFAOYSA-N D0JC4Q DRUGSMIL C=CCN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl D0JC4Q HIGHSTAT Investigative D0JD1O DRUG__ID D0JD1O D0JD1O DRUGTYPE Small molecular drug D0JD1O DRUGINCH 1S/C22H29N7O13P2/c23-19-14-21(26-8-25-19)29(9-27-14)22-18(33)17(32)13(41-22)7-40-44(37,38)42-43(35,36)39-6-11-4-12(16(31)15(11)30)28-3-1-2-10(5-28)20(24)34/h1-3,5,8-9,11-13,15-18,22,30-33H,4,6-7H2,(H5-,23,24,25,26,34,35,36,37,38)/p+1/t11-,12-,13-,15-,16+,17-,18-,22-/m1/s1 D0JD1O DRUGINKE DGPLSUKWXXSBCU-VGXGLJSLSA-O D0JD1O DRUGSMIL C1C(C(C(C1[N+]2=CC=CC(=C2)C(=O)N)O)O)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O D0JD1O HIGHSTAT Investigative D0JD4C DRUG__ID D0JD4C D0JD4C DRUGTYPE Small molecular drug D0JD4C DRUGINCH 1S/C31H29N3O5S2/c1-20-33-30(39-34-20)28(22-11-13-26(14-12-22)40(4,35)36)17-21-8-6-9-23(16-21)27-19-25(31(2,3)41(5,37)38)18-24-10-7-15-32-29(24)27/h6-19H,1-5H3/b28-17+ D0JD4C DRUGINKE YYGZHVJDHMMABU-OGLMXYFKSA-N D0JD4C DRUGSMIL CC1=NOC(=N1)C(=CC2=CC(=CC=C2)C3=C4C(=CC(=C3)C(C)(C)S(=O)(=O)C)C=CC=N4)C5=CC=C(C=C5)S(=O)(=O)C D0JD4C HIGHSTAT Investigative D0JD9E DRUG__ID D0JD9E D0JD9E DRUGTYPE Small molecular drug D0JD9E DRUGINCH 1S/C7H15N3O2S/c8-7(9)10-3-1-2-5(4-13)6(11)12/h5,13H,1-4H2,(H,11,12)(H4,8,9,10) D0JD9E DRUGINKE JOVIPJZDTSYNNW-UHFFFAOYSA-N D0JD9E DRUGSMIL C(CC(CS)C(=O)O)CN=C(N)N D0JD9E HIGHSTAT Investigative D0JE1I DRUG__ID D0JE1I D0JE1I DRUGTYPE Small molecular drug D0JE1I DRUGINCH 1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2/t14-/m1/s1 D0JE1I DRUGINKE CLPFFLWZZBQMAO-CQSZACIVSA-N D0JE1I DRUGSMIL C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N D0JE1I HIGHSTAT Investigative D0JE3Z DRUG__ID D0JE3Z D0JE3Z DRUGTYPE Small molecular drug D0JE3Z DRUGINCH 1S/C41H51FN10O6/c1-24(2)19-33(49-35(53)23-48-38(56)34(20-25-9-4-3-5-10-25)52-37(55)26-14-16-28(42)17-15-26)40(58)50-31(13-8-18-46-41(44)45)39(57)51-32(36(43)54)21-27-22-47-30-12-7-6-11-29(27)30/h3-7,9-12,14-17,22,24,31-34,47H,8,13,18-21,23H2,1-2H3,(H2,43,54)(H,48,56)(H,49,53)(H,50,58)(H,51,57)(H,52,55)(H4,44,45,46)/t31-,32-,33-,34-/m0/s1 D0JE3Z DRUGINKE CSDUUNOZBMGMHZ-CUPIEXAXSA-N D0JE3Z DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N)NC(=O)CNC(=O)C(CC3=CC=CC=C3)NC(=O)C4=CC=C(C=C4)F D0JE3Z HIGHSTAT Investigative D0JF0W DRUG__ID D0JF0W D0JF0W DRUGTYPE Small molecular drug D0JF0W DRUGINCH 1S/C20H36O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-19,21-23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,18-,19+/m0/s1 D0JF0W DRUGINKE DZUXGQBLFALXCR-CDIPTNKSSA-N D0JF0W DRUGSMIL CCCCCC(C=CC1C(CC(C1CCCCCCC(=O)O)O)O)O D0JF0W HIGHSTAT Investigative D0JF8D DRUG__ID D0JF8D D0JF8D DRUGTYPE Small molecular drug D0JF8D DRUGINCH 1S/C16H21N3O4/c1-16(2,3)23-15(22)19-13(14(21)18-9-8-17)10-11-4-6-12(20)7-5-11/h4-7,13,20H,9-10H2,1-3H3,(H,18,21)(H,19,22)/t13-/m0/s1 D0JF8D DRUGINKE ZMDCVKGQECBOGN-ZDUSSCGKSA-N D0JF8D DRUGSMIL CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NCC#N D0JF8D HIGHSTAT Investigative D0JG2W DRUG__ID D0JG2W D0JG2W DRUGTYPE Small molecular drug D0JG2W DRUGINCH 1S/C15H10ClN3S/c16-11-4-6-12(7-5-11)20-14-8-10-18-15(19-14)13-3-1-2-9-17-13/h1-10H D0JG2W DRUGINKE GJICJCYMPFHBPO-UHFFFAOYSA-N D0JG2W DRUGSMIL C1=CC=NC(=C1)C2=NC=CC(=N2)SC3=CC=C(C=C3)Cl D0JG2W HIGHSTAT Investigative D0JH2D DRUG__ID D0JH2D D0JH2D DRUGTYPE Small molecular drug D0JH2D DRUGINCH 1S/C16H15N/c1-14-8-7-13-16(17-14)12-6-5-11-15-9-3-2-4-10-15/h2-4,7-10,13H,5,11H2,1H3 D0JH2D DRUGINKE YWQJYKCSHSTIRB-UHFFFAOYSA-N D0JH2D DRUGSMIL CC1=NC(=CC=C1)C#CCCC2=CC=CC=C2 D0JH2D HIGHSTAT Investigative D0JH4U DRUG__ID D0JH4U D0JH4U DRUGTYPE Small molecular drug D0JH4U DRUGINCH 1S/C20H30O4/c1-2-3-9-13-18(21)14-10-7-5-4-6-8-11-15-19(22)16-12-17-20(23)24/h5-8,10-11,14-15,18,21H,2-4,9,12-13,16-17H2,1H3,(H,23,24)/b7-5-,8-6-,14-10+,15-11+/t18-/m0/s1 D0JH4U DRUGINKE RIUDRKHGFDAKPO-WWWYWCMOSA-N D0JH4U DRUGSMIL CCCCCC(C=CC=CCC=CC=CC(=O)CCCC(=O)O)O D0JH4U HIGHSTAT Investigative D0JH5D DRUG__ID D0JH5D D0JH5D DRUGTYPE Small molecular drug D0JH5D DRUGINCH 1S/C24H24FNO/c25-22-14-8-7-13-21(22)24(27)15-17-26(18-16-24)23(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-14,23,27H,15-18H2 D0JH5D DRUGINKE RGFPDLNQIQLMPK-UHFFFAOYSA-N D0JH5D DRUGSMIL C1CN(CCC1(C2=CC=CC=C2F)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0JH5D HIGHSTAT Investigative D0JH7C DRUG__ID D0JH7C D0JH7C DRUGTYPE Small molecular drug D0JH7C DRUGINCH 1S/C12H6N2O2/c15-11-7-3-1-5-13-9(7)10-8(12(11)16)4-2-6-14-10/h1-6H D0JH7C DRUGINKE KCALAFIVPCAXJI-UHFFFAOYSA-N D0JH7C DRUGSMIL C1=CC2=C(C3=C(C=CC=N3)C(=O)C2=O)N=C1 D0JH7C HIGHSTAT Investigative D0JH9F DRUG__ID D0JH9F D0JH9F DRUGTYPE Small molecular drug D0JH9F DRUGINCH 1S/C12H14ClNO/c1-14-8-10(4-7-12(14)15)9-2-5-11(13)6-3-9/h2-3,5-6,10H,4,7-8H2,1H3 D0JH9F DRUGINKE QCCANQQHOCXGTL-UHFFFAOYSA-N D0JH9F DRUGSMIL CN1CC(CCC1=O)C2=CC=C(C=C2)Cl D0JH9F HIGHSTAT Investigative D0JH9J DRUG__ID D0JH9J D0JH9J DRUGTYPE Small molecular drug D0JH9J DRUGINCH 1S/C25H21NO3/c27-23-17-25(26-12-14-28-15-13-26)29-24-11-10-19(16-22(23)24)21-9-5-4-8-20(21)18-6-2-1-3-7-18/h1-11,16-17H,12-15H2 D0JH9J DRUGINKE RYQNUEMYQYWYOR-UHFFFAOYSA-N D0JH9J DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=CC=C4C5=CC=CC=C5 D0JH9J HIGHSTAT Investigative D0JI0H DRUG__ID D0JI0H D0JI0H DRUGTYPE Small molecular drug D0JI0H DRUGINCH 1S/C10H8BrNO2/c11-5-6-12-8-4-2-1-3-7(8)9(13)10(12)14/h1-4H,5-6H2 D0JI0H DRUGINKE SJALPCXFOSGNST-UHFFFAOYSA-N D0JI0H DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N2CCBr D0JI0H HIGHSTAT Investigative D0JI0Q DRUG__ID D0JI0Q D0JI0Q DRUGTYPE Small molecular drug D0JI0Q DRUGINCH 1S/C21H29NO3/c1-21-8-7-16-15-6-4-14(23)9-12(15)3-5-17(16)18(21)10-13(20(21)25)11-19(24)22-2/h4,6,9,13,16-18,20,23,25H,3,5,7-8,10-11H2,1-2H3,(H,22,24)/t13?,16?,17?,18?,20-,21-/m0/s1 D0JI0Q DRUGINKE LFTDXZXJMDAPQK-LCKYQJBKSA-N D0JI0Q DRUGSMIL CC12CCC3C(C1CC(C2O)CC(=O)NC)CCC4=C3C=CC(=C4)O D0JI0Q HIGHSTAT Investigative D0JI2X DRUG__ID D0JI2X D0JI2X DRUGTYPE Small molecular drug D0JI2X DRUGINCH 1S/C32H39N3O6/c1-4-5-18-33-29(37)21-27(36)26(19-22-12-8-6-9-13-22)34-32(39)30(23-14-10-7-11-15-23)35-31(38)25-17-16-24(40-2)20-28(25)41-3/h6-17,20,26-27,30,36H,4-5,18-19,21H2,1-3H3,(H,33,37)(H,34,39)(H,35,38)/t26?,27?,30-/m0/s1 D0JI2X DRUGINKE SXBWRHFAOQVOPG-VSBJFVJKSA-N D0JI2X DRUGSMIL CCCCNC(=O)CC(C(CC1=CC=CC=C1)NC(=O)C(C2=CC=CC=C2)NC(=O)C3=C(C=C(C=C3)OC)OC)O D0JI2X HIGHSTAT Investigative D0JI3S DRUG__ID D0JI3S D0JI3S DRUGTYPE Small molecular drug D0JI3S DRUGINCH 1S/C22H30N2/c1-2-3-10-20-17-24(16-15-21(20)23)22(18-11-6-4-7-12-18)19-13-8-5-9-14-19/h4-9,11-14,20-22H,2-3,10,15-17,23H2,1H3 D0JI3S DRUGINKE OJLIZWWFCLNTKT-UHFFFAOYSA-N D0JI3S DRUGSMIL CCCCC1CN(CCC1N)C(C2=CC=CC=C2)C3=CC=CC=C3 D0JI3S HIGHSTAT Investigative D0JI4G DRUG__ID D0JI4G D0JI4G DRUGTYPE Small molecular drug D0JI4G DRUGINCH 1S/C31H28O7/c1-16-10-23(20-7-5-18(32)13-26(20)35-2)30-24(11-16)22-12-17-4-9-29(34)37-25(17)15-28(22)38-31(30)21-8-6-19(33)14-27(21)36-3/h4-9,11-15,23-24,30-33H,10H2,1-3H3/t23-,24-,30-,31+/m0/s1 D0JI4G DRUGINKE BKCPZBIJQGQCCP-ODJQGHGISA-N D0JI4G DRUGSMIL CC1=CC2C(C(C1)C3=C(C=C(C=C3)O)OC)C(OC4=C2C=C5C=CC(=O)OC5=C4)C6=C(C=C(C=C6)O)OC D0JI4G HIGHSTAT Investigative D0JI8S DRUG__ID D0JI8S D0JI8S DRUGTYPE Small molecular drug D0JI8S DRUGINCH 1S/C14H9F2NO2/c15-12-7-6-10(8-13(12)16)9-17-19-14(18)11-4-2-1-3-5-11/h1-9H/b17-9+ D0JI8S DRUGINKE HOHACQRGFZUDCD-RQZCQDPDSA-N D0JI8S DRUGSMIL C1=CC=C(C=C1)C(=O)ON=CC2=CC(=C(C=C2)F)F D0JI8S HIGHSTAT Investigative D0JJ6T DRUG__ID D0JJ6T D0JJ6T DRUGTYPE Small molecular drug D0JJ6T DRUGINCH 1S/C17H23N5O4/c23-5-11-13(24)14(25)17(26-11)22-7-20-12-15(18-6-19-16(12)22)21-10-4-8-1-2-9(10)3-8/h6-11,13-14,17,23-25H,1-5H2,(H,18,19,21)/t8?,9?,10?,11-,13-,14-,17-/m1/s1 D0JJ6T DRUGINKE YKPCEENRZZBDMC-STHLEMNDSA-N D0JJ6T DRUGSMIL C1CC2CC1CC2NC3=C4C(=NC=N3)N(C=N4)C5C(C(C(O5)CO)O)O D0JJ6T HIGHSTAT Investigative D0JK0I DRUG__ID D0JK0I D0JK0I DRUGTYPE Small molecular drug D0JK0I DRUGINCH 1S/C12H19NO3/c1-9(2)13-7-11(15)8-16-12-5-3-10(14)4-6-12/h3-6,9,11,13-15H,7-8H2,1-2H3/t11-/m0/s1 D0JK0I DRUGINKE ADUKCCWBEDSMEB-NSHDSACASA-N D0JK0I DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)O)O D0JK0I HIGHSTAT Investigative D0JL2T DRUG__ID D0JL2T D0JL2T DRUGTYPE Small molecular drug D0JL2T DRUGINCH 1S/C15H10O4/c16-10-6-7-11-12(8-10)19-15(14(18)13(11)17)9-4-2-1-3-5-9/h1-8,16,18H D0JL2T DRUGINKE UWQJWDYDYIJWKY-UHFFFAOYSA-N D0JL2T DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O D0JL2T HIGHSTAT Investigative D0JL3O DRUG__ID D0JL3O D0JL3O DRUGTYPE Small molecular drug D0JL3O DRUGINCH 1S/C13H10N4O5.C6H8N2O/c18-13(14-9-1-5-11(6-2-9)16(19)20)15-10-3-7-12(8-4-10)17(21)22;1-4-3-5(2)8-6(9)7-4/h1-8H,(H2,14,15,18);3H,1-2H3,(H,7,8,9) D0JL3O DRUGINKE UKHWDRMMMYWSFL-UHFFFAOYSA-N D0JL3O DRUGSMIL CC1=CC(=NC(=O)N1)C.C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-] D0JL3O HIGHSTAT Investigative D0JL8I DRUG__ID D0JL8I D0JL8I DRUGTYPE Small molecular drug D0JL8I DRUGINCH 1S/C22H24O5/c1-13(2)5-7-15-18(24-3)10-9-17-20(15)27-21-16-8-6-14(23)11-19(16)26-12-22(17,21)25-4/h5-6,8-11,21,23H,7,12H2,1-4H3/t21-,22+/m0/s1 D0JL8I DRUGINKE IGSYALWDCAHJEF-FCHUYYIVSA-N D0JL8I DRUGSMIL CC(=CCC1=C(C=CC2=C1OC3C2(COC4=C3C=CC(=C4)O)OC)OC)C D0JL8I HIGHSTAT Investigative D0JM0Z DRUG__ID D0JM0Z D0JM0Z DRUGTYPE Small molecular drug D0JM0Z DRUGINCH 1S/C6H7N/c1-6-3-2-4-7-5-6/h2-5H,1H3 D0JM0Z DRUGINKE ITQTTZVARXURQS-UHFFFAOYSA-N D0JM0Z DRUGSMIL CC1=CN=CC=C1 D0JM0Z HIGHSTAT Investigative D0JN0N DRUG__ID D0JN0N D0JN0N DRUGTYPE Small molecular drug D0JN0N DRUGINCH 1S/C14H11F3N2OS/c15-14(16,17)21-12-7-3-10(4-8-12)9-1-5-11(6-2-9)19-13(18)20/h1-8H,(H3,18,19,20) D0JN0N DRUGINKE FHOBREWUJUOKGZ-UHFFFAOYSA-N D0JN0N DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)SC(F)(F)F)NC(=O)N D0JN0N HIGHSTAT Investigative D0JN8Q DRUG__ID D0JN8Q D0JN8Q DRUGTYPE Small molecular drug D0JN8Q DRUGINCH 1S/C18H17N3O2/c19-11-12-20-18(23)16(13-14-7-3-1-4-8-14)21-17(22)15-9-5-2-6-10-15/h1-10,16H,12-13H2,(H,20,23)(H,21,22)/t16-/m0/s1 D0JN8Q DRUGINKE WEIUVZVWLANUJJ-INIZCTEOSA-N D0JN8Q DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=CC=C2 D0JN8Q HIGHSTAT Investigative D0JN9R DRUG__ID D0JN9R D0JN9R DRUGTYPE Small molecular drug D0JN9R DRUGINCH 1S/C15H16N4O3/c1-17-11-12(18(2)15(21)19(3)13(11)20)16-14(17)22-9-10-7-5-4-6-8-10/h4-8H,9H2,1-3H3 D0JN9R DRUGINKE LSJWXGMOPMJCHP-UHFFFAOYSA-N D0JN9R DRUGSMIL CN1C2=C(N=C1OCC3=CC=CC=C3)N(C(=O)N(C2=O)C)C D0JN9R HIGHSTAT Investigative D0JO8Q DRUG__ID D0JO8Q D0JO8Q DRUGTYPE Small molecular drug D0JO8Q DRUGINCH 1S/C27H30FN5O3S/c1-4-33-25(23-7-5-6-8-24(23)30-27(33)32(2)3)17-26(34)29-18-19-9-13-21(14-10-19)31-37(35,36)22-15-11-20(28)12-16-22/h5-16,25,31H,4,17-18H2,1-3H3,(H,29,34) D0JO8Q DRUGINKE HWGHVXQPQONJBP-UHFFFAOYSA-N D0JO8Q DRUGSMIL CCN1C(C2=CC=CC=C2N=C1N(C)C)CC(=O)NCC3=CC=C(C=C3)NS(=O)(=O)C4=CC=C(C=C4)F D0JO8Q HIGHSTAT Investigative D0JP7S DRUG__ID D0JP7S D0JP7S DRUGTYPE Small molecular drug D0JP7S DRUGINCH 1S/C28H31F2N7O2/c1-4-38-19-14-22(29)21(23(30)15-19)17-37-24-7-5-6-20(24)26(35-37)28-32-16-25(39-13-12-36(2)3)27(34-28)33-18-8-10-31-11-9-18/h8-11,14-16H,4-7,12-13,17H2,1-3H3,(H,31,32,33,34) D0JP7S DRUGINKE HDLPONLLJOSAIM-UHFFFAOYSA-N D0JP7S DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C3=C(CCC3)C(=N2)C4=NC=C(C(=N4)NC5=CC=NC=C5)OCCN(C)C)F D0JP7S HIGHSTAT Investigative D0JQ1D DRUG__ID D0JQ1D D0JQ1D DRUGTYPE Small molecular drug D0JQ1D DRUGINCH 1S/C28H36O5S/c1-5-6-7-8-9-15-33-25-19-26-24(28(3,4)14-16-34(26,31)32)18-23(25)20(2)17-21-10-12-22(13-11-21)27(29)30/h10-13,17-19H,5-9,14-16H2,1-4H3,(H,29,30)/b20-17+ D0JQ1D DRUGINKE JEIWQRITHXYGIF-LVZFUZTISA-N D0JQ1D DRUGSMIL CCCCCCCOC1=CC2=C(C=C1C(=CC3=CC=C(C=C3)C(=O)O)C)C(CCS2(=O)=O)(C)C D0JQ1D HIGHSTAT Investigative D0JQ1T DRUG__ID D0JQ1T D0JQ1T DRUGTYPE Small molecular drug D0JQ1T DRUGINCH 1S/C17H15NO2/c1-11(17(19)20)12-2-4-13(5-3-12)14-6-7-16-15(10-14)8-9-18-16/h2-11,18H,1H3,(H,19,20) D0JQ1T DRUGINKE NSKFZVRZALCZND-UHFFFAOYSA-N D0JQ1T DRUGSMIL CC(C1=CC=C(C=C1)C2=CC3=C(C=C2)NC=C3)C(=O)O D0JQ1T HIGHSTAT Investigative D0JQ3X DRUG__ID D0JQ3X D0JQ3X DRUGTYPE Small molecular drug D0JQ3X DRUGINCH 1S/C13H12FNO2S/c1-18(16,17)13-8-6-12(7-9-13)15-11-4-2-10(14)3-5-11/h2-9,15H,1H3 D0JQ3X DRUGINKE QTRCGPBYCSHGJM-UHFFFAOYSA-N D0JQ3X DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)NC2=CC=C(C=C2)F D0JQ3X HIGHSTAT Investigative D0JQ7W DRUG__ID D0JQ7W D0JQ7W DRUGTYPE Small molecular drug D0JQ7W DRUGINCH 1S/C14H10BrNO4/c1-9-6-7-13(11(15)8-9)20-14(17)10-4-2-3-5-12(10)16(18)19/h2-8H,1H3 D0JQ7W DRUGINKE GWWHSLCVPYBDPI-UHFFFAOYSA-N D0JQ7W DRUGSMIL CC1=CC(=C(C=C1)OC(=O)C2=CC=CC=C2[N+](=O)[O-])Br D0JQ7W HIGHSTAT Investigative D0JR0W DRUG__ID D0JR0W D0JR0W DRUGTYPE Small molecular drug D0JR0W DRUGINCH 1S/C18H18FN5OS/c1-11(2)22-16-8-14(20-10-21-16)15-9-26-18(23-15)24(3)17(25)12-4-6-13(19)7-5-12/h4-11H,1-3H3,(H,20,21,22)/i19-1 D0JR0W DRUGINKE WIVGIKIKQHUFOD-AWDFDDCISA-N D0JR0W DRUGSMIL CC(C)NC1=NC=NC(=C1)C2=CSC(=N2)N(C)C(=O)C3=CC=C(C=C3)F D0JR0W HIGHSTAT Investigative D0JR3W DRUG__ID D0JR3W D0JR3W DRUGTYPE Small molecular drug D0JR3W DRUGINCH 1S/C29H27F3N6O/c1-20-3-4-22(15-21(20)6-8-25-17-33-18-27-34-9-10-38(25)27)28(39)35-24-7-5-23(26(16-24)29(30,31)32)19-37-13-11-36(2)12-14-37/h3-5,7,9-10,15-18H,11-14,19H2,1-2H3,(H,35,39) D0JR3W DRUGINKE VSJSIOZQNZPUAV-UHFFFAOYSA-N D0JR3W DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=CC5=NC=CN45 D0JR3W HIGHSTAT Investigative D0JR3Y DRUG__ID D0JR3Y D0JR3Y DRUGTYPE Small molecular drug D0JR3Y DRUGINCH 1S/C22H22N2O2/c1-2-3-4-5-6-11-18-23-17-13-12-16-19(20(17)24-18)22(26)15-10-8-7-9-14(15)21(16)25/h7-10,12-13H,2-6,11H2,1H3,(H,23,24) D0JR3Y DRUGINKE VJUQZYULXGTXCN-UHFFFAOYSA-N D0JR3Y DRUGSMIL CCCCCCCC1=NC2=C(N1)C=CC3=C2C(=O)C4=CC=CC=C4C3=O D0JR3Y HIGHSTAT Investigative D0JS4B DRUG__ID D0JS4B D0JS4B DRUGTYPE Small molecular drug D0JS4B DRUGINCH 1S/CH5N/c1-2/h2H2,1H3/i1+2 D0JS4B DRUGINKE BAVYZALUXZFZLV-NJFSPNSNSA-N D0JS4B DRUGSMIL CN D0JS4B HIGHSTAT Investigative D0JT2N DRUG__ID D0JT2N D0JT2N DRUGTYPE Small molecular drug D0JT2N DRUGINCH 1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/t1-,2-/m0/s1 D0JT2N DRUGINKE YYLQUHNPNCGKJQ-LWMBPPNESA-N D0JT2N DRUGSMIL C(C(C(=O)O)O)(C(=O)O)N D0JT2N HIGHSTAT Investigative D0JT3M DRUG__ID D0JT3M D0JT3M DRUGTYPE Small molecular drug D0JT3M DRUGINCH 1S/C19H22N2/c1-20(2)12-13-21-15-17(14-16-8-4-3-5-9-16)18-10-6-7-11-19(18)21/h3-11,15H,12-14H2,1-2H3 D0JT3M DRUGINKE OYHBRXFQPGMFDE-UHFFFAOYSA-N D0JT3M DRUGSMIL CN(C)CCN1C=C(C2=CC=CC=C21)CC3=CC=CC=C3 D0JT3M HIGHSTAT Investigative D0JT8Y DRUG__ID D0JT8Y D0JT8Y DRUGTYPE Small molecular drug D0JT8Y DRUGINCH 1S/C13H11N3O4S/c14-21(19,20)13-6-4-11(5-7-13)15-9-10-2-1-3-12(8-10)16(17)18/h1-9H,(H2,14,19,20) D0JT8Y DRUGINKE QDRKXDMYDRNCDI-UHFFFAOYSA-N D0JT8Y DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C=NC2=CC=C(C=C2)S(=O)(=O)N D0JT8Y HIGHSTAT Investigative D0JU4G DRUG__ID D0JU4G D0JU4G DRUGTYPE Small molecular drug D0JU4G DRUGINCH 1S/C20H24O10/c1-5-6-8(27-13(5)24)10(22)19-12-7(21)9(17(2,3)4)18(19)11(23)14(25)29-16(18)30-20(6,19)15(26)28-12/h5-12,16,21-23H,1-4H3 D0JU4G DRUGINKE KDKROYXEHCYLJQ-UHFFFAOYSA-N D0JU4G DRUGSMIL CC1C2C(C(C34C25C(=O)OC3C(C(C46C(C(=O)OC6O5)O)C(C)(C)C)O)O)OC1=O D0JU4G HIGHSTAT Investigative D0JU9N DRUG__ID D0JU9N D0JU9N DRUGTYPE Small molecular drug D0JU9N DRUGINCH 1S/C31H27F3N6O3/c32-31(33,34)28-24-12-14-39(30(42)27(24)40(36-28)21-9-10-26-25(15-21)29(35)37-43-26)20-7-5-18(6-8-20)23-4-2-1-3-19(23)16-38-13-11-22(41)17-38/h1-10,15,22,41H,11-14,16-17H2,(H2,35,37)/t22-/m1/s1 D0JU9N DRUGINKE DFRIQJHMGZBFOM-JOCHJYFZSA-N D0JU9N DRUGSMIL C1CN(CC1O)CC2=CC=CC=C2C3=CC=C(C=C3)N4CCC5=C(C4=O)N(N=C5C(F)(F)F)C6=CC7=C(C=C6)ON=C7N D0JU9N HIGHSTAT Investigative D0JV0F DRUG__ID D0JV0F D0JV0F DRUGTYPE Small molecular drug D0JV0F DRUGINCH 1S/C33H38N4O6S/c1-33(2)30(31(41)36-28-22-13-7-6-12-21(22)17-25(28)38)37(19-44-33)32(42)29(40)24(16-20-10-4-3-5-11-20)35-27(39)18-43-26-15-9-8-14-23(26)34/h3-15,24-25,28-30,38,40H,16-19,34H2,1-2H3,(H,35,39)(H,36,41)/t24-,25+,28-,29-,30+/m0/s1 D0JV0F DRUGINKE CTMJCAZSOKTPFA-VOULMWPJSA-N D0JV0F DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC=C3N)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0JV0F HIGHSTAT Investigative D0JV2P DRUG__ID D0JV2P D0JV2P DRUGTYPE Small molecular drug D0JV2P DRUGINCH 1S/C15H9F6N5OS/c1-7-12(28-25-23-7)13(27)22-8-2-4-9(5-3-8)26-11(15(19,20)21)6-10(24-26)14(16,17)18/h2-6H,1H3,(H,22,27) D0JV2P DRUGINKE XPRZIORDEVHURQ-UHFFFAOYSA-N D0JV2P DRUGSMIL CC1=C(SN=N1)C(=O)NC2=CC=C(C=C2)N3C(=CC(=N3)C(F)(F)F)C(F)(F)F D0JV2P HIGHSTAT Investigative D0JV2S DRUG__ID D0JV2S D0JV2S DRUGTYPE Small molecular drug D0JV2S DRUGINCH 1S/C15H10BrNO2/c16-11-7-5-10(6-8-11)9-17-13-4-2-1-3-12(13)14(18)15(17)19/h1-8H,9H2 D0JV2S DRUGINKE DELLOEULSHGYCG-UHFFFAOYSA-N D0JV2S DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N2CC3=CC=C(C=C3)Br D0JV2S HIGHSTAT Investigative D0JV5J DRUG__ID D0JV5J D0JV5J DRUGTYPE Small molecular drug D0JV5J DRUGINCH 1S/C5H5BO4S/c7-5(8)3-1-2-4(11-3)6(9)10/h1-2,9-10H,(H,7,8) D0JV5J DRUGINKE OQGIKNPOYTVNNF-UHFFFAOYSA-N D0JV5J DRUGSMIL B(C1=CC=C(S1)C(=O)O)(O)O D0JV5J HIGHSTAT Investigative D0JV5L DRUG__ID D0JV5L D0JV5L DRUGTYPE Small molecular drug D0JV5L DRUGINCH 1S/C9H14N2OS/c1-6-8(13-11-9(6)12)7-2-4-10-5-3-7/h7,10H,2-5H2,1H3,(H,11,12) D0JV5L DRUGINKE TVYLWJFICSYNFD-UHFFFAOYSA-N D0JV5L DRUGSMIL CC1=C(SNC1=O)C2CCNCC2 D0JV5L HIGHSTAT Investigative D0JW1C DRUG__ID D0JW1C D0JW1C DRUGTYPE Small molecular drug D0JW1C DRUGINCH 1S/C22H36O3/c1-16(2)22-13-12-18(4)9-7-8-17(3)10-11-20(24-19(5)23)21(6,25-22)14-15-22/h8,12,16,20H,7,9-11,13-15H2,1-6H3/b17-8+,18-12+/t20-,21+,22+/m0/s1 D0JW1C DRUGINKE HVBACKJYWZTKCA-XSLBTUIJSA-N D0JW1C DRUGSMIL CC1=CCCC(=CCC2(CCC(O2)(C(CC1)OC(=O)C)C)C(C)C)C D0JW1C HIGHSTAT Investigative D0JX2S DRUG__ID D0JX2S D0JX2S DRUGTYPE Small molecular drug D0JX2S DRUGINCH 1S/C13H17NO3S/c14-12(15)10(5-2-6-18)7-9-3-1-4-11(8-9)13(16)17/h1,3-4,8,10,18H,2,5-7H2,(H2,14,15)(H,16,17) D0JX2S DRUGINKE KSGSHIYQUPDDPN-UHFFFAOYSA-N D0JX2S DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CCCS)C(=O)N D0JX2S HIGHSTAT Investigative D0JX3P DRUG__ID D0JX3P D0JX3P DRUGTYPE Small molecular drug D0JX3P DRUGINCH 1S/C32H36N6O5/c1-19(36-31(42)25(33)15-21-11-13-23(39)14-12-21)30(41)38-28(17-22-18-35-26-10-6-5-9-24(22)26)32(43)37-27(29(34)40)16-20-7-3-2-4-8-20/h2-14,18-19,25,27-28,35,39H,15-17,33H2,1H3,(H2,34,40)(H,36,42)(H,37,43)(H,38,41)/t19-,25-,27-,28-/m0/s1 D0JX3P DRUGINKE AXMWRKQKSXEZPQ-VCJXGGRGSA-N D0JX3P DRUGSMIL CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D0JX3P HIGHSTAT Investigative D0JY6J DRUG__ID D0JY6J D0JY6J DRUGTYPE Small molecular drug D0JY6J DRUGINCH 1S/C12H14N4/c1-2-9-10(8-6-4-3-5-7-8)11(13)16-12(14)15-9/h3-7H,2H2,1H3,(H4,13,14,15,16) D0JY6J DRUGINKE XREDUPOVEQDQQS-UHFFFAOYSA-N D0JY6J DRUGSMIL CCC1=C(C(=NC(=N1)N)N)C2=CC=CC=C2 D0JY6J HIGHSTAT Investigative D0JY9B DRUG__ID D0JY9B D0JY9B DRUGTYPE Small molecular drug D0JY9B DRUGINCH 1S/C17H19ClN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m1/s1 D0JY9B DRUGINKE JFADNUHMEURSIM-GFCCVEGCSA-N D0JY9B DRUGSMIL CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)Cl D0JY9B HIGHSTAT Investigative D0JZ3S DRUG__ID D0JZ3S D0JZ3S DRUGTYPE Small molecular drug D0JZ3S DRUGINCH 1S/C8H16FN3O2/c1-5(10)12-3-2-6(9)4-7(11)8(13)14/h6-7H,2-4,11H2,1H3,(H2,10,12)(H,13,14)/t6-,7+/m1/s1 D0JZ3S DRUGINKE LTCJJIZTKXNFGK-RQJHMYQMSA-N D0JZ3S DRUGSMIL CC(=NCCC(CC(C(=O)O)N)F)N D0JZ3S HIGHSTAT Investigative D0JZ8P DRUG__ID D0JZ8P D0JZ8P DRUGTYPE Small molecular drug D0JZ8P DRUGINCH 1S/C16H15NOS/c1-2-11-17-13-8-4-6-10-15(13)19-14-9-5-3-7-12(14)16(17)18/h3-10H,2,11H2,1H3 D0JZ8P DRUGINKE ARJSKRFEYLKXQL-UHFFFAOYSA-N D0JZ8P DRUGSMIL CCCN1C2=CC=CC=C2SC3=CC=CC=C3C1=O D0JZ8P HIGHSTAT Investigative D0K0EW DRUG__ID D0K0EW D0K0EW DRUGTYPE Small molecular drug D0K0EW DRUGINCH 1S/C13H24N2O2S/c1-2-3-14-18(16,17)15-13-7-10-4-11(8-13)6-12(5-10)9-13/h10-12,14-15H,2-9H2,1H3 D0K0EW DRUGINKE LLVZKPBHOPZCRW-UHFFFAOYSA-N D0K0EW DRUGSMIL CCCNS(=O)(=O)NC12CC3CC(C1)CC(C3)C2 D0K0EW HIGHSTAT Investigative D0K0FI DRUG__ID D0K0FI D0K0FI DRUGTYPE Small molecular drug D0K0FI DRUGINCH 1S/C11H25NO3Si2/c1-16(2,3)17(4,5)7-6-12-11(13)15-9-10-8-14-10/h10H,6-9H2,1-5H3,(H,12,13) D0K0FI DRUGINKE RMYUPIFLALKWOD-UHFFFAOYSA-N D0K0FI DRUGSMIL C[Si](C)(C)[Si](C)(C)CCNC(=O)OCC1CO1 D0K0FI HIGHSTAT Investigative D0K0FZ DRUG__ID D0K0FZ D0K0FZ DRUGTYPE Small molecular drug D0K0FZ DRUGINCH 1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/t13-,16-,17-,18+,22-/m1/s1/i12+2 D0K0FZ DRUGINKE ZSLZBFCDCINBPY-YHBLMJDYSA-N D0K0FZ DRUGSMIL CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D0K0FZ HIGHSTAT Investigative D0K0GU DRUG__ID D0K0GU D0K0GU DRUGTYPE Small molecular drug D0K0GU DRUGINCH 1S/C23H18N2O/c24-23(25)19-9-8-18-12-17(7-6-16-4-2-1-3-5-16)13-21(22(18)14-19)20-10-11-26-15-20/h1-15H,(H3,24,25)/b7-6+ D0K0GU DRUGINKE VWKDMGIRFQHGHQ-VOTSOKGWSA-N D0K0GU DRUGSMIL C1=CC=C(C=C1)C=CC2=CC(=C3C=C(C=CC3=C2)C(=N)N)C4=COC=C4 D0K0GU HIGHSTAT Investigative D0K0HD DRUG__ID D0K0HD D0K0HD DRUGTYPE Small molecular drug D0K0HD DRUGINCH 1S/C20H37NO4/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-18(22)20(24)21-17-19(23)25-4-2/h3-17H2,1-2H3,(H,21,24) D0K0HD DRUGINKE OUAFHJCWFYXWSR-UHFFFAOYSA-N D0K0HD DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCC(=O)OCC D0K0HD HIGHSTAT Investigative D0K0HU DRUG__ID D0K0HU D0K0HU DRUGTYPE Small molecular drug D0K0HU DRUGINCH 1S/C17H21N/c1-14-7-4-5-10-17(14)16-9-6-8-15(13-16)11-12-18(2)3/h4-10,13H,11-12H2,1-3H3 D0K0HU DRUGINKE HOMNPSYKSQTOHK-UHFFFAOYSA-N D0K0HU DRUGSMIL CC1=CC=CC=C1C2=CC=CC(=C2)CCN(C)C D0K0HU HIGHSTAT Investigative D0K0IC DRUG__ID D0K0IC D0K0IC DRUGTYPE Small molecular drug D0K0IC DRUGINCH 1S/C20H15NO/c22-16-12-10-14(11-13-16)19-17-8-4-5-9-18(17)21-20(19)15-6-2-1-3-7-15/h1-13,21-22H D0K0IC DRUGINKE OITCYCYIUVYFKQ-UHFFFAOYSA-N D0K0IC DRUGSMIL C1=CC=C(C=C1)C2=C(C3=CC=CC=C3N2)C4=CC=C(C=C4)O D0K0IC HIGHSTAT Investigative D0K0JP DRUG__ID D0K0JP D0K0JP DRUGTYPE Small molecular drug D0K0JP DRUGINCH 1S/C21H27NO3/c1-2-3-4-5-6-10-17-24-19-15-13-18(14-16-19)22-21(23)25-20-11-8-7-9-12-20/h7-9,11-16H,2-6,10,17H2,1H3,(H,22,23) D0K0JP DRUGINKE IJCMIOMSKCNMQY-UHFFFAOYSA-N D0K0JP DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2 D0K0JP HIGHSTAT Investigative D0K0KR DRUG__ID D0K0KR D0K0KR DRUGTYPE Small molecular drug D0K0KR DRUGINCH 1S/C25H29BrF3N5O3S.ClH/c1-34(2)23-19-5-3-4-6-20(19)32-24(33-23)30-14-16-7-9-17(10-8-16)15-31-38(35,36)22-12-11-18(26)13-21(22)37-25(27,28)29;/h3-6,11-13,16-17,31H,7-10,14-15H2,1-2H3,(H,30,32,33);1H D0K0KR DRUGINKE SMEDDEAAKQVMQD-UHFFFAOYSA-N D0K0KR DRUGSMIL CN(C)C1=NC(=NC2=CC=CC=C21)NCC3CCC(CC3)CNS(=O)(=O)C4=C(C=C(C=C4)Br)OC(F)(F)F.Cl D0K0KR HIGHSTAT Investigative D0K0KT DRUG__ID D0K0KT D0K0KT DRUGTYPE Small molecular drug D0K0KT DRUGINCH 1S/C28H43N3O8S/c1-19(2)17-22(15-16-40(7,36)37)30-25(33)20(3)29-26(34)23(13-14-24(32)39-28(4,5)6)31-27(35)38-18-21-11-9-8-10-12-21/h8-12,15-16,19-20,22-23H,13-14,17-18H2,1-7H3,(H,29,34)(H,30,33)(H,31,35)/b16-15+/t20-,22+,23-/m0/s1 D0K0KT DRUGINKE LRSBIKVQDTUNIU-DSNMTOQLSA-N D0K0KT DRUGSMIL CC(C)CC(C=CS(=O)(=O)C)NC(=O)C(C)NC(=O)C(CCC(=O)OC(C)(C)C)NC(=O)OCC1=CC=CC=C1 D0K0KT HIGHSTAT Investigative D0K0OR DRUG__ID D0K0OR D0K0OR DRUGTYPE Small molecular drug D0K0OR DRUGINCH 1S/C16H20N2O2/c1-2-3-4-5-6-10-14(19)16-18-12-15(20-16)13-9-7-8-11-17-13/h7-9,11-12H,2-6,10H2,1H3 D0K0OR DRUGINKE VLJKBQYNIDBQEJ-UHFFFAOYSA-N D0K0OR DRUGSMIL CCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2 D0K0OR HIGHSTAT Investigative D0K0OT DRUG__ID D0K0OT D0K0OT DRUGTYPE Small molecular drug D0K0OT DRUGINCH 1S/C16H24N4O2/c1-3-9-19-14-12(15(21)20(10-4-2)16(19)22)17-13(18-14)11-7-5-6-8-11/h11H,3-10H2,1-2H3,(H,17,18) D0K0OT DRUGINKE FFBDFADSZUINTG-UHFFFAOYSA-N D0K0OT DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3CCCC3 D0K0OT HIGHSTAT Investigative D0K0PR DRUG__ID D0K0PR D0K0PR DRUGTYPE Small molecular drug D0K0PR DRUGINCH 1S/C30H46O5/c1-18-9-14-30(24(33)34)16-15-27(4)19(23(30)29(18,6)35)7-8-21-25(2)12-11-22(32)26(3,17-31)20(25)10-13-28(21,27)5/h7,18,20-21,23,31,35H,8-17H2,1-6H3,(H,33,34)/t18-,20-,21-,23-,25+,26-,27-,28-,29-,30+/m1/s1 D0K0PR DRUGINKE DICFMPCEXYENLE-OGHVSZAPSA-N D0K0PR DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)CO)C)C)C2C1(C)O)C)C(=O)O D0K0PR HIGHSTAT Investigative D0K0QU DRUG__ID D0K0QU D0K0QU DRUGTYPE Small molecular drug D0K0QU DRUGINCH 1S/C23H34O4/c1-21(2)9-7-10-22(3)18(21)8-11-23(4)20(22)19(26-6)14-12-17(25-5)15(24)13-16(14)27-23/h12-13,18-20,24H,7-11H2,1-6H3/t18-,19+,20+,22-,23-/m0/s1 D0K0QU DRUGINKE JAGJWSBNJZPDNL-FCSJJDFTSA-N D0K0QU DRUGSMIL CC1(CCCC2(C1CCC3(C2C(C4=CC(=C(C=C4O3)O)OC)OC)C)C)C D0K0QU HIGHSTAT Investigative D0K0SO DRUG__ID D0K0SO D0K0SO DRUGTYPE Small molecular drug D0K0SO DRUGINCH 1S/C37H49N11O6/c1-21-31(50)47-30(20-23-10-13-24-6-2-3-7-25(24)18-23)35(54)46-27(8-4-16-42-36(38)39)32(51)45-28(9-5-17-43-37(40)41)33(52)48-29(34(53)44-21)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,21,27-30,49H,4-5,8-9,16-17,19-20H2,1H3,(H,44,53)(H,45,51)(H,46,54)(H,47,50)(H,48,52)(H4,38,39,42)(H4,40,41,43)/t21-,27+,28-,29-,30+/m1/s1 D0K0SO DRUGINKE VWZBFEAQYFTPKH-UIMYGGOYSA-N D0K0SO DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D0K0SO HIGHSTAT Investigative D0K0TJ DRUG__ID D0K0TJ D0K0TJ DRUGTYPE Small molecular drug D0K0TJ DRUGINCH 1S/C23H27F3N4O3/c1-22(2)10-17-19(18(32)11-22)20(23(24,25)26)29-30(17)13-5-8-15(21(27)33)16(9-13)28-12-3-6-14(31)7-4-12/h5,8-9,12,14,28,31H,3-4,6-7,10-11H2,1-2H3,(H2,27,33) D0K0TJ DRUGINKE ZFVRYNYOPQZKDG-UHFFFAOYSA-N D0K0TJ DRUGSMIL CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C D0K0TJ HIGHSTAT Investigative D0K0TO DRUG__ID D0K0TO D0K0TO DRUGTYPE Small molecular drug D0K0TO DRUGINCH 1S/C13H12N2/c1-9-8-11-10-4-3-7-15(2)13(10)6-5-12(11)14-9/h3-8H,1-2H3/p+1 D0K0TO DRUGINKE SAKUMUAGJZFIGP-UHFFFAOYSA-O D0K0TO DRUGSMIL CC1=CC2=C(N1)C=CC3=C2C=CC=[N+]3C D0K0TO HIGHSTAT Investigative D0K0TR DRUG__ID D0K0TR D0K0TR DRUGTYPE Small molecular drug D0K0TR DRUGINCH 1S/C15H12O3/c16-13-4-1-10(2-5-13)12-7-11-3-6-14(17)8-15(11)18-9-12/h1-6,8-9,16-17H,7H2 D0K0TR DRUGINKE QCNUDDPWPNUALZ-UHFFFAOYSA-N D0K0TR DRUGSMIL C1C2=C(C=C(C=C2)O)OC=C1C3=CC=C(C=C3)O D0K0TR HIGHSTAT Investigative D0K0TY DRUG__ID D0K0TY D0K0TY DRUGTYPE Small molecular drug D0K0TY DRUGINCH 1S/C35H30N10.BrH.2Na/c1-2-3-12-33-32(21-24-13-17-26(18-14-24)28-8-4-6-10-30(28)34-37-41-42-38-34)36-23-45(33)22-25-15-19-27(20-16-25)29-9-5-7-11-31(29)35-39-43-44-40-35;;;/h4-11,13-20,23H,2-3,12,21-22H2,1H3;1H;;/q-2;;2*+1 D0K0TY DRUGINKE JJOQDSLKSULNDS-UHFFFAOYSA-N D0K0TY DRUGSMIL CCCCC1=C(NC=[N+]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[N-]N=N4)CC5=CC=C(C=C5)C6=CC=CC=C6C7=N[N-]N=N7.[Na+].[Na+].[Br-] D0K0TY HIGHSTAT Investigative D0K0UJ DRUG__ID D0K0UJ D0K0UJ DRUGTYPE Small molecular drug D0K0UJ DRUGINCH 1S/C21H28N4O5/c1-11-12(2)25(7-6-14(11)21(26)27)20-19(22)23-10-15(24-20)13-8-16(28-3)18(30-5)17(9-13)29-4/h8-12,14H,6-7H2,1-5H3,(H2,22,23)(H,26,27)/t11-,12+,14+/m0/s1 D0K0UJ DRUGINKE YPKLAWUGDWZBMV-OUCADQQQSA-N D0K0UJ DRUGSMIL CC1C(N(CCC1C(=O)O)C2=NC(=CN=C2N)C3=CC(=C(C(=C3)OC)OC)OC)C D0K0UJ HIGHSTAT Investigative D0K0UM DRUG__ID D0K0UM D0K0UM DRUGTYPE Small molecular drug D0K0UM DRUGINCH 1S/C25H27N5O2/c1-29-10-12-30(13-11-29)22-6-5-20(16-24(22)32-3)28-25-15-19(8-9-27-25)21-14-18(17-26)4-7-23(21)31-2/h4-9,14-16H,10-13H2,1-3H3,(H,27,28) D0K0UM DRUGINKE GOMSKBLQVUFHHS-UHFFFAOYSA-N D0K0UM DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC=CC(=C3)C4=C(C=CC(=C4)C#N)OC)OC D0K0UM HIGHSTAT Investigative D0K0WK DRUG__ID D0K0WK D0K0WK DRUGTYPE Small molecular drug D0K0WK DRUGINCH 1S/C20H15NO6/c1-21-18-10-5-15-16(27-8-26-15)6-11(10)19(22)17(18)9-4-13(24-2)14(25-3)7-12(9)20(21)23/h4-7H,8H2,1-3H3 D0K0WK DRUGINKE LWLNFIXOPOZENE-UHFFFAOYSA-N D0K0WK DRUGSMIL CN1C2=C(C3=CC(=C(C=C3C1=O)OC)OC)C(=O)C4=CC5=C(C=C42)OCO5 D0K0WK HIGHSTAT Investigative D0K0XT DRUG__ID D0K0XT D0K0XT DRUGTYPE Small molecular drug D0K0XT DRUGINCH 1S/C19H23NO2/c1-13-18-10-14-5-6-15(21)11-17(14)19(13,2)7-8-20(18)12-16-4-3-9-22-16/h3-6,9,11,13,18,21H,7-8,10,12H2,1-2H3/t13-,18+,19+/m0/s1 D0K0XT DRUGINKE ICHXZERPLTYYPM-MJXNMMHHSA-N D0K0XT DRUGSMIL CC1C2CC3=C(C1(CCN2CC4=CC=CO4)C)C=C(C=C3)O D0K0XT HIGHSTAT Investigative D0K0YF DRUG__ID D0K0YF D0K0YF DRUGTYPE Small molecular drug D0K0YF DRUGINCH 1S/C6H6BFO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4,9-10H D0K0YF DRUGINKE LBUNNMJLXWQQBY-UHFFFAOYSA-N D0K0YF DRUGSMIL B(C1=CC=C(C=C1)F)(O)O D0K0YF HIGHSTAT Investigative D0K0YX DRUG__ID D0K0YX D0K0YX DRUGTYPE Small molecular drug D0K0YX DRUGINCH 1S/C18H17NO3/c19-12-14-3-8-16(9-4-14)15-6-1-13(2-7-15)5-10-17(20)11-18(21)22/h1-4,6-9,17,20H,5,10-11H2,(H,21,22) D0K0YX DRUGINKE YDAZWMGCTBJQEO-UHFFFAOYSA-N D0K0YX DRUGSMIL C1=CC(=CC=C1CCC(CC(=O)O)O)C2=CC=C(C=C2)C#N D0K0YX HIGHSTAT Investigative D0K1AW DRUG__ID D0K1AW D0K1AW DRUGTYPE Small molecular drug D0K1AW DRUGINCH 1S/C9H10N2O5/c10-6(9(13)14)3-5-1-2-8(12)7(4-5)11(15)16/h1-2,4,6,12H,3,10H2,(H,13,14)/t6-/m0/s1 D0K1AW DRUGINKE FBTSQILOGYXGMD-LURJTMIESA-N D0K1AW DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)[N+](=O)[O-])O D0K1AW HIGHSTAT Investigative D0K1BV DRUG__ID D0K1BV D0K1BV DRUGTYPE Small molecular drug D0K1BV DRUGINCH 1S/C24H29N3O/c1-27-14-13-24-12-6-5-9-20(24)22(27)15-17-10-11-19(16-21(17)24)26-23(28)25-18-7-3-2-4-8-18/h2-4,7-8,10-11,16,20,22H,5-6,9,12-15H2,1H3,(H2,25,26,28)/t20-,22+,24+/m0/s1 D0K1BV DRUGINKE CVZRQQXQPKBKNJ-BGWNEDDSSA-N D0K1BV DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)NC(=O)NC5=CC=CC=C5 D0K1BV HIGHSTAT Investigative D0K1CM DRUG__ID D0K1CM D0K1CM DRUGTYPE Small molecular drug D0K1CM DRUGINCH 1S/C7H14N2/c8-7-5-3-1-2-4-6-9-7/h1-6H2,(H2,8,9) D0K1CM DRUGINKE AZNNPSMXKKWOPY-UHFFFAOYSA-N D0K1CM DRUGSMIL C1CCCN=C(CC1)N D0K1CM HIGHSTAT Investigative D0K1CU DRUG__ID D0K1CU D0K1CU DRUGTYPE Small molecular drug D0K1CU DRUGINCH 1S/C16H11ClO4S/c17-10-5-7-11(8-6-10)22(20,21)15-9-14(18)12-3-1-2-4-13(12)16(15)19/h1-9,18-19H D0K1CU DRUGINKE SXWUEZFUYNUEML-UHFFFAOYSA-N D0K1CU DRUGSMIL C1=CC=C2C(=C1)C(=CC(=C2O)S(=O)(=O)C3=CC=C(C=C3)Cl)O D0K1CU HIGHSTAT Investigative D0K1DR DRUG__ID D0K1DR D0K1DR DRUGTYPE Small molecular drug D0K1DR DRUGINCH 1S/C12H11N3O3/c1-15-11(16)8(14-12(15)13)4-7-2-3-9-10(5-7)18-6-17-9/h2-5H,6H2,1H3,(H2,13,14)/b8-4- D0K1DR DRUGINKE PKEDBIGNILOTHW-YWEYNIOJSA-N D0K1DR DRUGSMIL CN1C(=O)C(=CC2=CC3=C(C=C2)OCO3)N=C1N D0K1DR HIGHSTAT Investigative D0K1FE DRUG__ID D0K1FE D0K1FE DRUGTYPE Small molecular drug D0K1FE DRUGINCH 1S/C16H11BrO2/c1-10-7-12-9-13(11-5-3-2-4-6-11)16(18)19-15(12)14(17)8-10/h2-9H,1H3 D0K1FE DRUGINKE TYLXEMSZGAPZTD-UHFFFAOYSA-N D0K1FE DRUGSMIL CC1=CC2=C(C(=C1)Br)OC(=O)C(=C2)C3=CC=CC=C3 D0K1FE HIGHSTAT Investigative D0K1FG DRUG__ID D0K1FG D0K1FG DRUGTYPE Small molecular drug D0K1FG DRUGINCH 1S/C11H8O4/c1-6(12)10-8(13)4-2-7-3-5-9(14)15-11(7)10/h2-5,13H,1H3 D0K1FG DRUGINKE XWYMACPLPPQCHC-UHFFFAOYSA-N D0K1FG DRUGSMIL CC(=O)C1=C(C=CC2=C1OC(=O)C=C2)O D0K1FG HIGHSTAT Investigative D0K1HD DRUG__ID D0K1HD D0K1HD DRUGTYPE Small molecular drug D0K1HD DRUGINCH 1S/C12H18N2O2/c1-10(15)13-7-8-14(2)11-5-4-6-12(9-11)16-3/h4-6,9H,7-8H2,1-3H3,(H,13,15) D0K1HD DRUGINKE FAWOXVGCBAVSFR-UHFFFAOYSA-N D0K1HD DRUGSMIL CC(=O)NCCN(C)C1=CC(=CC=C1)OC D0K1HD HIGHSTAT Investigative D0K1MA DRUG__ID D0K1MA D0K1MA DRUGTYPE Small molecular drug D0K1MA DRUGINCH 1S/C27H26N5O3P/c33-36(34,35)26(18-20-12-15-22-8-4-5-9-24(22)16-20)28-25(27-29-31-32-30-27)17-19-10-13-23(14-11-19)21-6-2-1-3-7-21/h1-16,25-26,28H,17-18H2,(H2,33,34,35)(H,29,30,31,32)/t25-,26?/m0/s1 D0K1MA DRUGINKE PIBUIEXHVFJHNQ-PMCHYTPCSA-N D0K1MA DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CC(C3=NNN=N3)NC(CC4=CC5=CC=CC=C5C=C4)P(=O)(O)O D0K1MA HIGHSTAT Investigative D0K1MB DRUG__ID D0K1MB D0K1MB DRUGTYPE Small molecular drug D0K1MB DRUGINCH 1S/C31H50O6/c1-5-18(2)29(35)37-27-17-26-24(10-7-20-14-21(32)12-13-30(20,26)3)25-11-8-19(31(25,27)4)6-9-23-15-22(33)16-28(34)36-23/h18-27,32-33H,5-17H2,1-4H3/t18-,19?,20+,21+,22+,23+,24-,25-,26-,27-,30-,31+/m0/s1 D0K1MB DRUGINKE CFMOEGAYJQXZMT-UQTJVAAQSA-N D0K1MB DRUGSMIL CCC(C)C(=O)OC1CC2C(CCC3C2(CCC(C3)O)C)C4C1(C(CC4)CCC5CC(CC(=O)O5)O)C D0K1MB HIGHSTAT Investigative D0K1MS DRUG__ID D0K1MS D0K1MS DRUGTYPE Small molecular drug D0K1MS DRUGINCH 1S/C19H22O5/c1-21-15-8-6-11(9-14(15)20)13-7-5-12-10-16(22-2)18(23-3)19(24-4)17(12)13/h6,8-10,13,20H,5,7H2,1-4H3 D0K1MS DRUGINKE QYUAUFKQRRPTIK-UHFFFAOYSA-N D0K1MS DRUGSMIL COC1=C(C=C(C=C1)C2CCC3=CC(=C(C(=C23)OC)OC)OC)O D0K1MS HIGHSTAT Investigative D0K1NM DRUG__ID D0K1NM D0K1NM DRUGTYPE Small molecular drug D0K1NM DRUGINCH 1S/C15H20N2O/c18-14(9-17-2-1-16-10-17)15-6-11-3-12(7-15)5-13(4-11)8-15/h1-2,10-13H,3-9H2 D0K1NM DRUGINKE BBCQJSMDKDHVKG-UHFFFAOYSA-N D0K1NM DRUGSMIL C1C2CC3CC1CC(C2)(C3)C(=O)CN4C=CN=C4 D0K1NM HIGHSTAT Investigative D0K1PS DRUG__ID D0K1PS D0K1PS DRUGTYPE Small molecular drug D0K1PS DRUGINCH 1S/C7H13N3/c1-5(6(2)8)7-3-9-4-10-7/h3-6H,8H2,1-2H3,(H,9,10)/t5-,6+/m0/s1 D0K1PS DRUGINKE QQTWSOMOTYJIQP-NTSWFWBYSA-N D0K1PS DRUGSMIL CC(C1=CN=CN1)C(C)N D0K1PS HIGHSTAT Investigative D0K1QB DRUG__ID D0K1QB D0K1QB DRUGTYPE Small molecular drug D0K1QB DRUGINCH 1S/C20H15F2NO/c21-16-11-12-17(18(22)13-16)20(19(23)24,14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13H,(H2,23,24) D0K1QB DRUGINKE GASORINMDZETOC-UHFFFAOYSA-N D0K1QB DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=C(C=C(C=C3)F)F)C(=O)N D0K1QB HIGHSTAT Investigative D0K1QV DRUG__ID D0K1QV D0K1QV DRUGTYPE Small molecular drug D0K1QV DRUGINCH 1S/C15H17NO2S/c1-16-8-9-18-15(17,11-16)13-6-4-12(5-7-13)14-3-2-10-19-14/h2-7,10,17H,8-9,11H2,1H3 D0K1QV DRUGINKE KXFMAIULBLABNA-UHFFFAOYSA-N D0K1QV DRUGSMIL CN1CCOC(C1)(C2=CC=C(C=C2)C3=CC=CS3)O D0K1QV HIGHSTAT Investigative D0K1TQ DRUG__ID D0K1TQ D0K1TQ DRUGTYPE Small molecular drug D0K1TQ DRUGINCH 1S/C21H17F4NO3S2/c1-11-7-14(4-6-17(11)29-9-19(27)28)30-10-18-12(2)26-20(31-18)13-3-5-15(16(22)8-13)21(23,24)25/h3-8H,9-10H2,1-2H3,(H,27,28) D0K1TQ DRUGINKE HWVNEWGKWRGSRK-UHFFFAOYSA-N D0K1TQ DRUGSMIL CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC(=C(C=C3)C(F)(F)F)F)C)OCC(=O)O D0K1TQ HIGHSTAT Investigative D0K1TW DRUG__ID D0K1TW D0K1TW DRUGTYPE Small molecular drug D0K1TW DRUGINCH 1S/C13H8ClNO3/c14-9-5-7(1-3-11(9)17)13-15-10-6-8(16)2-4-12(10)18-13/h1-6,16-17H D0K1TW DRUGINKE XCJCSWQYKSCDIH-UHFFFAOYSA-N D0K1TW DRUGSMIL C1=CC(=C(C=C1C2=NC3=C(O2)C=CC(=C3)O)Cl)O D0K1TW HIGHSTAT Investigative D0K1UA DRUG__ID D0K1UA D0K1UA DRUGTYPE Small molecular drug D0K1UA DRUGINCH 1S/C10H12N4O2/c1-4-5-14-9(15)7-8(11-6-12(7)2)13(3)10(14)16/h4,6H,1,5H2,2-3H3 D0K1UA DRUGINKE BTFHIKZOEZREBX-UHFFFAOYSA-N D0K1UA DRUGSMIL CN1C=NC2=C1C(=O)N(C(=O)N2C)CC=C D0K1UA HIGHSTAT Investigative D0K1UI DRUG__ID D0K1UI D0K1UI DRUGTYPE Small molecular drug D0K1UI DRUGINCH 1S/C15H30O6/c1-2-3-4-5-6-7-8-9-20-15-14(19)13(18)12(17)11(10-16)21-15/h11-19H,2-10H2,1H3/t11-,12-,13+,14-,15-/m1/s1 D0K1UI DRUGINKE QFAPUKLCALRPLH-UXXRCYHCSA-N D0K1UI DRUGSMIL CCCCCCCCCOC1C(C(C(C(O1)CO)O)O)O D0K1UI HIGHSTAT Investigative D0K1UR DRUG__ID D0K1UR D0K1UR DRUGTYPE Small molecular drug D0K1UR DRUGINCH 1S/C22H26N2/c1-3-8-20(9-4-2)22-23-16-21(24-22)19-14-12-18(13-15-19)17-10-6-5-7-11-17/h5-7,10-16,20H,3-4,8-9H2,1-2H3,(H,23,24) D0K1UR DRUGINKE VAJCFLBVVHOAAW-UHFFFAOYSA-N D0K1UR DRUGSMIL CCCC(CCC)C1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3 D0K1UR HIGHSTAT Investigative D0K1YY DRUG__ID D0K1YY D0K1YY DRUGTYPE Small molecular drug D0K1YY DRUGINCH 1S/C17H18N4O4S/c22-6-11-13(23)14(24)17(25-11)21-9-20-12-15(21)18-8-19-16(12)26-7-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,22-24H,6-7H2 D0K1YY DRUGINKE OMJRXFOHHLLDFR-UHFFFAOYSA-N D0K1YY DRUGSMIL C1=CC=C(C=C1)CSC2=NC=NC3=C2N=CN3C4C(C(C(O4)CO)O)O D0K1YY HIGHSTAT Investigative D0K2AR DRUG__ID D0K2AR D0K2AR DRUGCOMP Commissariat a l`Energie Atomique D0K2AR DRUGINCH 1S/C15H10N2/c1-2-6-14-10(4-1)11-7-8-13-12(15(11)17-14)5-3-9-16-13/h1-9,17H D0K2AR DRUGINKE MALZYBOXBVXCSN-UHFFFAOYSA-N D0K2AR DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C4=C(C=C3)N=CC=C4 D0K2AR HIGHSTAT Investigative D0K2BZ DRUG__ID D0K2BZ D0K2BZ DRUGTYPE Small molecular drug D0K2BZ DRUGINCH 1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m0/s1 D0K2BZ DRUGINKE FEWJPZIEWOKRBE-LWMBPPNESA-N D0K2BZ DRUGSMIL C(C(C(=O)O)O)(C(=O)O)O D0K2BZ HIGHSTAT Investigative D0K2CZ DRUG__ID D0K2CZ D0K2CZ DRUGTYPE Small molecular drug D0K2CZ DRUGINCH 1S/C8H12O2/c1-7(2)5-8(7)3-4-10-6(8)9/h3-5H2,1-2H3 D0K2CZ DRUGINKE KTGHZHGRFYRANW-UHFFFAOYSA-N D0K2CZ DRUGSMIL CC1(CC12CCOC2=O)C D0K2CZ HIGHSTAT Investigative D0K2DR DRUG__ID D0K2DR D0K2DR DRUGTYPE Small molecular drug D0K2DR DRUGINCH 1S/C13H10N2O/c16-13-7-11-6-9(3-4-12(11)15-13)10-2-1-5-14-8-10/h1-6,8H,7H2,(H,15,16) D0K2DR DRUGINKE LRXSVYIRRDZVNQ-UHFFFAOYSA-N D0K2DR DRUGSMIL C1C2=C(C=CC(=C2)C3=CN=CC=C3)NC1=O D0K2DR HIGHSTAT Investigative D0K2EX DRUG__ID D0K2EX D0K2EX DRUGTYPE Small molecular drug D0K2EX DRUGINCH 1S/C23H29N3O4S2/c1-4-5-12-30-23(27)25-32(28,29)22-21(14-20(31-22)13-17(2)3)19-8-6-18(7-9-19)15-26-11-10-24-16-26/h6-11,14,16-17H,4-5,12-13,15H2,1-3H3,(H,25,27) D0K2EX DRUGINKE XTEOJPUYZWEXFI-UHFFFAOYSA-N D0K2EX DRUGSMIL CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C=CN=C3 D0K2EX HIGHSTAT Investigative D0K2FQ DRUG__ID D0K2FQ D0K2FQ DRUGTYPE Small molecular drug D0K2FQ DRUGINCH 1S/C40H34N2O8/c1-43-33-5-3-23-13-31-27-17-37-35(47-21-49-37)15-25(27)7-9-41(31)19-29(23)39(33)45-11-12-46-40-30-20-42-10-8-26-16-36-38(50-22-48-36)18-28(26)32(42)14-24(30)4-6-34(40)44-2/h3-6,13-20H,7-12,21-22H2,1-2H3/q+2 D0K2FQ DRUGINKE KHTZNQPZFCEMGU-UHFFFAOYSA-N D0K2FQ DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCOC6=C(C=CC7=CC8=[N+](CCC9=CC1=C(C=C98)OCO1)C=C76)OC D0K2FQ HIGHSTAT Investigative D0K2GB DRUG__ID D0K2GB D0K2GB DRUGTYPE Small molecular drug D0K2GB DRUGINCH 1S/C12H23N3O2/c1-3-7-14-11(16)10-6-5-8-15(10)12(17)9(13)4-2/h9-10H,3-8,13H2,1-2H3,(H,14,16)/t9-,10-/m0/s1 D0K2GB DRUGINKE PGTCIDPUBJUXTD-UWVGGRQHSA-N D0K2GB DRUGSMIL CCCNC(=O)C1CCCN1C(=O)C(CC)N D0K2GB HIGHSTAT Investigative D0K2NJ DRUG__ID D0K2NJ D0K2NJ DRUGTYPE Small molecular drug D0K2NJ DRUGINCH 1S/C23H22ClN3O3S/c1-13(25)23-21(30-14(2)15-7-5-6-8-16(15)24)11-22(31-23)27-12-26-17-9-19(28-3)20(29-4)10-18(17)27/h5-12,14H,1,25H2,2-4H3/t14-/m1/s1 D0K2NJ DRUGINKE AWMDAFUCNYEZNI-CQSZACIVSA-N D0K2NJ DRUGSMIL CC(C1=CC=CC=C1Cl)OC2=C(SC(=C2)N3C=NC4=CC(=C(C=C43)OC)OC)C(=C)N D0K2NJ HIGHSTAT Investigative D0K2NY DRUG__ID D0K2NY D0K2NY DRUGTYPE Small molecular drug D0K2NY DRUGINCH 1S/C47H76N14O8/c1-4-6-19-38(63)56-34(17-12-25-54-46(50)51)41(65)59-36(27-30-14-8-7-9-15-30)44(68)60-37(28-31-20-22-32(62)23-21-31)43(67)58-35(18-13-26-55-47(52)53)42(66)61-39(29(3)5-2)45(69)57-33(40(49)64)16-10-11-24-48/h7-9,14-15,20-23,29,33-37,39,62H,4-6,10-13,16-19,24-28,48H2,1-3H3,(H2,49,64)(H,56,63)(H,57,69)(H,58,67)(H,59,65)(H,60,68)(H,61,66)(H4,50,51,54)(H4,52,53,55)/t29-,33-,34-,35-,36-,37-,39-/m0/s1 D0K2NY DRUGINKE JKNVIONDDVKVIP-INYUMPDKSA-N D0K2NY DRUGSMIL CCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)N D0K2NY HIGHSTAT Investigative D0K2OK DRUG__ID D0K2OK D0K2OK DRUGTYPE Small molecular drug D0K2OK DRUGINCH 1S/C34H41N5O5/c1-21-8-6-9-22(2)26(21)20-29(32(42)37-28(31(36)41)19-23-10-4-3-5-11-23)38-33(43)30-12-7-17-39(30)34(44)27(35)18-24-13-15-25(40)16-14-24/h3-6,8-11,13-16,27-30,40H,7,12,17-20,35H2,1-2H3,(H2,36,41)(H,37,42)(H,38,43)/t27-,28-,29-,30-/m0/s1 D0K2OK DRUGINKE HJYUYBYISGYHKS-KRCBVYEFSA-N D0K2OK DRUGSMIL CC1=C(C(=CC=C1)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0K2OK HIGHSTAT Investigative D0K2PD DRUG__ID D0K2PD D0K2PD DRUGTYPE Small molecular drug D0K2PD DRUGINCH 1S/C7H8N2O/c8-6-3-1-2-5(4-6)7(9)10/h1-4H,8H2,(H2,9,10) D0K2PD DRUGINKE GSCPDZHWVNUUFI-UHFFFAOYSA-N D0K2PD DRUGSMIL C1=CC(=CC(=C1)N)C(=O)N D0K2PD HIGHSTAT Investigative D0K2PI DRUG__ID D0K2PI D0K2PI DRUGTYPE Small molecular drug D0K2PI DRUGINCH 1S/C25H47NO4/c1-4-6-8-9-10-11-12-13-14-15-16-17-19-23(27)25(29)26-22(18-7-5-2)20-21-24(28)30-3/h22H,4-21H2,1-3H3,(H,26,29)/t22-/m0/s1 D0K2PI DRUGINKE RFWRXBDBLIGDAF-QFIPXVFZSA-N D0K2PI DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NC(CCCC)CCC(=O)OC D0K2PI HIGHSTAT Investigative D0K2QF DRUG__ID D0K2QF D0K2QF DRUGTYPE Small molecular drug D0K2QF DRUGINCH 1S/C16H10Cl2N2OS/c17-12-7-6-11(8-13(12)18)15(21)20-16-19-14(9-22-16)10-4-2-1-3-5-10/h1-9H,(H,19,20,21) D0K2QF DRUGINKE AYVXSTQWLPUGKB-UHFFFAOYSA-N D0K2QF DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC(=C(C=C3)Cl)Cl D0K2QF HIGHSTAT Investigative D0K2SE DRUG__ID D0K2SE D0K2SE DRUGTYPE Small molecular drug D0K2SE DRUGINCH 1S/C12H13N3/c1-4-11-10(3-2-6-14-11)12(5-1)15-8-7-13-9-15/h2-3,6-9,12H,1,4-5H2 D0K2SE DRUGINKE QFNKKYLTOSVDJG-UHFFFAOYSA-N D0K2SE DRUGSMIL C1CC(C2=C(C1)N=CC=C2)N3C=CN=C3 D0K2SE HIGHSTAT Investigative D0K2UA DRUG__ID D0K2UA D0K2UA DRUGTYPE Small molecular drug D0K2UA DRUGINCH 1S/C16H22N2S/c1-11(2)12-8-6-7-9-13(12)17-15-18-14(10-19-15)16(3,4)5/h6-11H,1-5H3,(H,17,18) D0K2UA DRUGINKE XGRAMFLJGHKCSV-UHFFFAOYSA-N D0K2UA DRUGSMIL CC(C)C1=CC=CC=C1NC2=NC(=CS2)C(C)(C)C D0K2UA HIGHSTAT Investigative D0K2UP DRUG__ID D0K2UP D0K2UP DRUGTYPE Small molecular drug D0K2UP DRUGINCH 1S/C17H23N3O6S/c18-12(17(25)26)6-7-14(21)20-13(16(24)19-8-15(22)23)10-27-9-11-4-2-1-3-5-11/h1-5,12-13H,6-10,18H2,(H,19,24)(H,20,21)(H,22,23)(H,25,26)/t12-,13+/m0/s1 D0K2UP DRUGINKE XYJWEQWNNKNSFU-QWHCGFSZSA-N D0K2UP DRUGSMIL C1=CC=C(C=C1)CSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N D0K2UP HIGHSTAT Investigative D0K2VO DRUG__ID D0K2VO D0K2VO DRUGTYPE Small molecular drug D0K2VO DRUGINCH 1S/C20H18N2O2/c1-23-19-12-16-17(21-14-22-18(16)13-20(19)24-2)11-7-6-10-15-8-4-3-5-9-15/h3-5,8-9,12-14H,6,10H2,1-2H3 D0K2VO DRUGINKE UJTHKWFURJCQDD-UHFFFAOYSA-N D0K2VO DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)C#CCCC3=CC=CC=C3)OC D0K2VO HIGHSTAT Investigative D0K2XD DRUG__ID D0K2XD D0K2XD DRUGTYPE Small molecular drug D0K2XD DRUGINCH 1S/C17H19NO2/c1-4-16-18-17-14(19)8-12(9-15(17)20-16)13-6-5-10(2)7-11(13)3/h5-7,12H,4,8-9H2,1-3H3 D0K2XD DRUGINKE CPKZCQHJDFSOJT-UHFFFAOYSA-N D0K2XD DRUGSMIL CCC1=NC2=C(O1)CC(CC2=O)C3=C(C=C(C=C3)C)C D0K2XD HIGHSTAT Investigative D0K2XJ DRUG__ID D0K2XJ D0K2XJ DRUGTYPE Small molecular drug D0K2XJ DRUGINCH 1S/C41H30O26/c42-15-1-10(2-16(43)26(15)50)36(57)65-34-33-23(9-62-39(60)13-7-21(48)29(53)31(55)24(13)25-14(40(61)64-33)8-22(49)30(54)32(25)56)63-41(67-38(59)12-5-19(46)28(52)20(47)6-12)35(34)66-37(58)11-3-17(44)27(51)18(45)4-11/h1-8,23,33-35,41-56H,9H2/t23-,33-,34+,35-,41+/m1/s1 D0K2XJ DRUGINKE JCGHAEBIBSEQAD-UUUCSUBKSA-N D0K2XJ DRUGSMIL C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)O1)O)O)O)O)O)O D0K2XJ HIGHSTAT Investigative D0K2YG DRUG__ID D0K2YG D0K2YG DRUGTYPE Small molecular drug D0K2YG DRUGINCH 1S/C14H13N3O/c1-18-12-6-7-14-13(8-12)16-9-17(14)11-4-2-10(15)3-5-11/h2-9H,15H2,1H3 D0K2YG DRUGINKE KLJLVCKIKCKKEA-UHFFFAOYSA-N D0K2YG DRUGSMIL COC1=CC2=C(C=C1)N(C=N2)C3=CC=C(C=C3)N D0K2YG HIGHSTAT Investigative D0K2YY DRUG__ID D0K2YY D0K2YY DRUGTYPE Small molecular drug D0K2YY DRUGINCH 1S/C9H9NO4/c1-6(10(13)14)4-7-2-3-8(11)9(12)5-7/h2-5,11-12H,1H3 D0K2YY DRUGINKE CBBBJLQAIWVLBM-UHFFFAOYSA-N D0K2YY DRUGSMIL CC(=CC1=CC(=C(C=C1)O)O)[N+](=O)[O-] D0K2YY HIGHSTAT Investigative D0K3AO DRUG__ID D0K3AO D0K3AO DRUGTYPE Small molecular drug D0K3AO DRUGINCH 1S/C16H14O7/c1-21-15(19)9-3-5-11(17)13(7-9)23-14-8-10(16(20)22-2)4-6-12(14)18/h3-8,17-18H,1-2H3 D0K3AO DRUGINKE OEYSNLOOZVNLRA-UHFFFAOYSA-N D0K3AO DRUGSMIL COC(=O)C1=CC(=C(C=C1)O)OC2=C(C=CC(=C2)C(=O)OC)O D0K3AO HIGHSTAT Investigative D0K3BO DRUG__ID D0K3BO D0K3BO DRUGTYPE Small molecular drug D0K3BO DRUGINCH 1S/C8H10O3/c1-5(9)8-6(10)3-2-4-7(8)11/h8H,2-4H2,1H3 D0K3BO DRUGINKE CHNXDYRMRBQOEF-UHFFFAOYSA-N D0K3BO DRUGSMIL CC(=O)C1C(=O)CCCC1=O D0K3BO HIGHSTAT Investigative D0K3CE DRUG__ID D0K3CE D0K3CE DRUGTYPE Small molecular drug D0K3CE DRUGINCH 1S/C16H15NO/c1-18-15-5-4-13-2-3-14(16(13)11-15)10-12-6-8-17-9-7-12/h4-11H,2-3H2,1H3/b14-10+ D0K3CE DRUGINKE VFFWGGPPTWJBON-GXDHUFHOSA-N D0K3CE DRUGSMIL COC1=CC2=C(CCC2=CC3=CC=NC=C3)C=C1 D0K3CE HIGHSTAT Investigative D0K3CJ DRUG__ID D0K3CJ D0K3CJ DRUGTYPE Small molecular drug D0K3CJ DRUGINCH 1S/C17H15NO4/c1-20-16-9-13-14(10-17(16)21-2)18-7-6-15(13)22-12-5-3-4-11(19)8-12/h3-10,19H,1-2H3 D0K3CJ DRUGINKE CGIFTRWAYIWEGG-UHFFFAOYSA-N D0K3CJ DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=CC(=C3)O D0K3CJ HIGHSTAT Investigative D0K3ES DRUG__ID D0K3ES D0K3ES DRUGTYPE Small molecular drug D0K3ES DRUGINCH 1S/C21H18N4OS/c22-13-17(21(24)27-19-7-2-1-6-18(19)23)15-4-3-5-16(12-15)20(26)14-8-10-25-11-9-14/h1-12,20,26H,23-24H2/b21-17+ D0K3ES DRUGINKE NHBMKTBZZSJUGA-HEHNFIMWSA-N D0K3ES DRUGSMIL C1=CC=C(C(=C1)N)SC(=C(C#N)C2=CC=CC(=C2)C(C3=CC=NC=C3)O)N D0K3ES HIGHSTAT Investigative D0K3EW DRUG__ID D0K3EW D0K3EW DRUGTYPE Small molecular drug D0K3EW DRUGINCH 1S/C17H21Cl2NO/c1-3-4-15(21-2)17-10-16(17,7-8-20-11-17)12-5-6-13(18)14(19)9-12/h3,5-6,9,15,20H,1,4,7-8,10-11H2,2H3/t15?,16-,17+/m1/s1 D0K3EW DRUGINKE AOUKQWFJPNRGAH-FGJGXXMFSA-N D0K3EW DRUGSMIL COC(CC=C)C12CC1(CCNC2)C3=CC(=C(C=C3)Cl)Cl D0K3EW HIGHSTAT Investigative D0K3GQ DRUG__ID D0K3GQ D0K3GQ DRUGTYPE Small molecular drug D0K3GQ DRUGINCH 1S/C54H99O6PS/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-43-46-49-52(55)59-61(58,60-53(56)50-47-44-41-38-35-32-29-26-23-20-17-14-11-8-5-2)62-54(57)51-48-45-42-39-36-33-30-27-24-21-18-15-12-9-6-3/h25-30H,4-24,31-51H2,1-3H3/b28-25-,29-26-,30-27- D0K3GQ DRUGINKE VZTWVTAPKVGVJL-IUPFWZBJSA-N D0K3GQ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OP(=O)(OC(=O)CCCCCCCC=CCCCCCCCC)SC(=O)CCCCCCCC=CCCCCCCCC D0K3GQ HIGHSTAT Investigative D0K3HY DRUG__ID D0K3HY D0K3HY DRUGTYPE Small molecular drug D0K3HY DRUGINCH 1S/C18H19N3O2S/c1-10-8-11(2)21-18-14(10)15(19)16(24-18)17(22)20-9-12-4-6-13(23-3)7-5-12/h4-8H,9,19H2,1-3H3,(H,20,22) D0K3HY DRUGINKE MDNWGCQSCGNTKH-UHFFFAOYSA-N D0K3HY DRUGSMIL CC1=CC(=NC2=C1C(=C(S2)C(=O)NCC3=CC=C(C=C3)OC)N)C D0K3HY HIGHSTAT Investigative D0K3JC DRUG__ID D0K3JC D0K3JC DRUGTYPE Small molecular drug D0K3JC DRUGINCH 1S/C22H27N3O2/c1-16-7-5-10-18(13-16)15-24-21(26)20-11-6-12-25(20)22(27)19(23)14-17-8-3-2-4-9-17/h2-5,7-10,13,19-20H,6,11-12,14-15,23H2,1H3,(H,24,26)/t19-,20+/m1/s1 D0K3JC DRUGINKE CHKWABXWPATIIG-UXHICEINSA-N D0K3JC DRUGSMIL CC1=CC(=CC=C1)CNC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)N D0K3JC HIGHSTAT Investigative D0K3LN DRUG__ID D0K3LN D0K3LN DRUGTYPE Small molecular drug D0K3LN DRUGINCH 1S/C10H14N2O3S/c1-2-3-10(13)12-8-4-6-9(7-5-8)16(11,14)15/h4-7H,2-3H2,1H3,(H,12,13)(H2,11,14,15) D0K3LN DRUGINKE ZQNHPPBUHNMQIO-UHFFFAOYSA-N D0K3LN DRUGSMIL CCCC(=O)NC1=CC=C(C=C1)S(=O)(=O)N D0K3LN HIGHSTAT Investigative D0K3LQ DRUG__ID D0K3LQ D0K3LQ DRUGTYPE Small molecular drug D0K3LQ DRUGINCH 1S/C10H12N2O4/c1-2-5-11-8-4-3-7(10(13)14)6-9(8)12(15)16/h3-4,6,11H,2,5H2,1H3,(H,13,14) D0K3LQ DRUGINKE OVDGUTHABMXVMI-UHFFFAOYSA-N D0K3LQ DRUGSMIL CCCNC1=C(C=C(C=C1)C(=O)O)[N+](=O)[O-] D0K3LQ HIGHSTAT Investigative D0K3MR DRUG__ID D0K3MR D0K3MR DRUGTYPE Small molecular drug D0K3MR DRUGINCH 1S/C17H19NO2/c19-17(18-20)9-5-4-6-14-10-12-16(13-11-14)15-7-2-1-3-8-15/h1-3,7-8,10-13,20H,4-6,9H2,(H,18,19) D0K3MR DRUGINKE QQLOLMJSVXGPGC-UHFFFAOYSA-N D0K3MR DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCCCC(=O)NO D0K3MR HIGHSTAT Investigative D0K3QL DRUG__ID D0K3QL D0K3QL DRUGTYPE Small molecular drug D0K3QL DRUGINCH 1S/C30H39N3O4S/c1-37-26-12-11-25-8-5-15-30(34,28(25)20-26)22-31-21-23-13-17-33(18-14-23)19-16-32-38(35,36)29-10-4-7-24-6-2-3-9-27(24)29/h2-4,6-7,9-12,20,23,31-32,34H,5,8,13-19,21-22H2,1H3 D0K3QL DRUGINKE HROMPGSHGXAFBQ-UHFFFAOYSA-N D0K3QL DRUGSMIL COC1=CC2=C(CCCC2(CNCC3CCN(CC3)CCNS(=O)(=O)C4=CC=CC5=CC=CC=C54)O)C=C1 D0K3QL HIGHSTAT Investigative D0K3RC DRUG__ID D0K3RC D0K3RC DRUGTYPE Small molecular drug D0K3RC DRUGINCH 1S/C18H20O3S2/c19-23(20,18-8-4-7-16(22)13-18)17-11-9-15(10-12-17)21-14-5-2-1-3-6-14/h1-3,5-6,9-12,16,18,22H,4,7-8,13H2 D0K3RC DRUGINKE XOVSRAFNJNQNRK-UHFFFAOYSA-N D0K3RC DRUGSMIL C1CC(CC(C1)S(=O)(=O)C2=CC=C(C=C2)OC3=CC=CC=C3)S D0K3RC HIGHSTAT Investigative D0K3SI DRUG__ID D0K3SI D0K3SI DRUGTYPE Small molecular drug D0K3SI DRUGINCH 1S/C13H30N/c1-5-6-7-8-9-10-11-12-13-14(2,3)4/h5-13H2,1-4H3/q+1 D0K3SI DRUGINKE RKMJXTWHATWGNX-UHFFFAOYSA-N D0K3SI DRUGSMIL CCCCCCCCCC[N+](C)(C)C D0K3SI HIGHSTAT Investigative D0K3SZ DRUG__ID D0K3SZ D0K3SZ DRUGTYPE Small molecular drug D0K3SZ DRUGINCH 1S/C8H10S/c1-7-2-4-8(6-9)5-3-7/h2-5,9H,6H2,1H3 D0K3SZ DRUGINKE AGFYZLVFPSGUIX-UHFFFAOYSA-N D0K3SZ DRUGSMIL CC1=CC=C(C=C1)CS D0K3SZ HIGHSTAT Investigative D0K3TQ DRUG__ID D0K3TQ D0K3TQ DRUGTYPE Small molecular drug D0K3TQ DRUGINCH 1S/C29H50OS/c1-23(2)13-11-18-27(6)31-22-21-26(5)15-10-9-14-24(3)16-12-17-25(4)19-20-28-29(7,8)30-28/h13-15,17,27-28H,9-12,16,18-22H2,1-8H3/b24-14+,25-17+,26-15+ D0K3TQ DRUGINKE CRZHANPLXOIADK-YNWRIEOZSA-N D0K3TQ DRUGSMIL CC(CCC=C(C)C)SCCC(=CCCC=C(C)CCC=C(C)CCC1C(O1)(C)C)C D0K3TQ HIGHSTAT Investigative D0K3TS DRUG__ID D0K3TS D0K3TS DRUGTYPE Small molecular drug D0K3TS DRUGINCH 1S/C25H28O6/c1-13(2)5-7-15-9-18(17(8-6-14(3)4)25(30)24(15)29)21-12-20(28)23-19(27)10-16(26)11-22(23)31-21/h5-6,9-11,21,26-27,29-30H,7-8,12H2,1-4H3/t21-/m0/s1 D0K3TS DRUGINKE BVHLNRAYBCPKOY-NRFANRHFSA-N D0K3TS DRUGSMIL CC(=CCC1=CC(=C(C(=C1O)O)CC=C(C)C)C2CC(=O)C3=C(C=C(C=C3O2)O)O)C D0K3TS HIGHSTAT Investigative D0K3UL DRUG__ID D0K3UL D0K3UL DRUGTYPE Small molecular drug D0K3UL DRUGINCH 1S/C18H19FN4/c19-15-4-5-17-14(11-15)12-16(21-17)13-22-7-9-23(10-8-22)18-3-1-2-6-20-18/h1-6,11-12,21H,7-10,13H2 D0K3UL DRUGINKE PQOIDBZLMJMYCD-UHFFFAOYSA-N D0K3UL DRUGSMIL C1CN(CCN1CC2=CC3=C(N2)C=CC(=C3)F)C4=CC=CC=N4 D0K3UL HIGHSTAT Investigative D0K3VK DRUG__ID D0K3VK D0K3VK DRUGTYPE Small molecular drug D0K3VK DRUGINCH 1S/C16H14N2O3/c17-11-12-1-3-13(4-2-12)15-9-14(19)10-16(21-15)18-5-7-20-8-6-18/h1-4,9-10H,5-8H2 D0K3VK DRUGINKE GGAAWYRRMFPEHA-UHFFFAOYSA-N D0K3VK DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=C(C=C3)C#N D0K3VK HIGHSTAT Investigative D0K3VR DRUG__ID D0K3VR D0K3VR DRUGTYPE Small molecular drug D0K3VR DRUGINCH 1S/C20H32FNOSi/c21-18-10-12-20(13-11-18)24(23,19-8-3-1-4-9-19)17-7-16-22-14-5-2-6-15-22/h10-13,19,23H,1-9,14-17H2 D0K3VR DRUGINKE ZNSZQJHTFRQUPD-UHFFFAOYSA-N D0K3VR DRUGSMIL C1CCC(CC1)[Si](CCCN2CCCCC2)(C3=CC=C(C=C3)F)O D0K3VR HIGHSTAT Investigative D0K3YM DRUG__ID D0K3YM D0K3YM DRUGTYPE Small molecular drug D0K3YM DRUGINCH 1S/C16H16N2OS/c1-11(2)17-16(19)18-12-7-3-5-9-14(12)20-15-10-6-4-8-13(15)18/h3-11H,1-2H3,(H,17,19) D0K3YM DRUGINKE DIHZRSIYRBANNR-UHFFFAOYSA-N D0K3YM DRUGSMIL CC(C)NC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0K3YM HIGHSTAT Investigative D0K4AC DRUG__ID D0K4AC D0K4AC DRUGTYPE Small molecular drug D0K4AC DRUGINCH 1S/C44H62N10O10S2/c1-25(2)18-34(42(62)50-32(15-17-66-4)40(60)51-33(38(46)58)22-37(56)57)52-44(64)36(21-28-23-47-24-48-28)54-43(63)35(20-26-8-6-5-7-9-26)53-41(61)31(14-16-65-3)49-39(59)30(45)19-27-10-12-29(55)13-11-27/h5-13,23-25,30-36,55H,14-22,45H2,1-4H3,(H2,46,58)(H,47,48)(H,49,59)(H,50,62)(H,51,60)(H,52,64)(H,53,61)(H,54,63)(H,56,57)/t30-,31+,32-,33-,34-,35-,36-/m0/s1 D0K4AC DRUGINKE BHSURCCZOBVHJJ-NWOHMYAQSA-N D0K4AC DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCSC)NC(=O)C(CC3=CC=C(C=C3)O)N D0K4AC HIGHSTAT Investigative D0K4DP DRUG__ID D0K4DP D0K4DP DRUGTYPE Small molecular drug D0K4DP DRUGINCH 1S/C28H29N3O3/c32-21-22(16-18-31-19-17-26(33)30-27(31)34)20-29-28(23-10-4-1-5-11-23,24-12-6-2-7-13-24)25-14-8-3-9-15-25/h1-15,17,19,22,29,32H,16,18,20-21H2,(H,30,33,34) D0K4DP DRUGINKE AROLDFLIRWDCKX-UHFFFAOYSA-N D0K4DP DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCC(CCN4C=CC(=O)NC4=O)CO D0K4DP HIGHSTAT Investigative D0K4EM DRUG__ID D0K4EM D0K4EM DRUGTYPE Small molecular drug D0K4EM DRUGINCH 1S/C13H11N3/c14-10-1-2-11-12(8-16-13(11)7-10)9-3-5-15-6-4-9/h1-8,16H,14H2 D0K4EM DRUGINKE NUDVKMUJCFEKEL-UHFFFAOYSA-N D0K4EM DRUGSMIL C1=CC2=C(C=C1N)NC=C2C3=CC=NC=C3 D0K4EM HIGHSTAT Investigative D0K4GK DRUG__ID D0K4GK D0K4GK DRUGTYPE Small molecular drug D0K4GK DRUGINCH 1S/C27H46O2/c1-17(2)6-11-25(29)18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-25,28-29H,6,8-16H2,1-5H3/t18-,20-,21-,22+,23-,24-,25+,26-,27+/m0/s1 D0K4GK DRUGINKE RZPAXNJLEKLXNO-GFKLAVDKSA-N D0K4GK DRUGSMIL CC(C)CCC(C(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)O D0K4GK HIGHSTAT Investigative D0K4HG DRUG__ID D0K4HG D0K4HG DRUGTYPE Small molecular drug D0K4HG DRUGINCH 1S/C21H15N3O2/c25-24(26)19-5-1-3-17(14-19)20-13-16(11-15-6-9-22-10-7-15)12-18-4-2-8-23-21(18)20/h1-10,12-14H,11H2 D0K4HG DRUGINKE XRSKAWJXBDACRF-UHFFFAOYSA-N D0K4HG DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=C3C(=CC(=C2)CC4=CC=NC=C4)C=CC=N3 D0K4HG HIGHSTAT Investigative D0K4IH DRUG__ID D0K4IH D0K4IH DRUGTYPE Small molecular drug D0K4IH DRUGINCH 1S/C14H11NO2/c16-14(17)12-6-8-13(9-7-12)15-10-11-4-2-1-3-5-11/h1-10H,(H,16,17) D0K4IH DRUGINKE MREPJQZHXSDMKL-UHFFFAOYSA-N D0K4IH DRUGSMIL C1=CC=C(C=C1)C=NC2=CC=C(C=C2)C(=O)O D0K4IH HIGHSTAT Investigative D0K4LS DRUG__ID D0K4LS D0K4LS DRUGTYPE Small molecular drug D0K4LS DRUGINCH 1S/C21H22O7/c1-25-16-9-13(10-17(26-2)20(16)23)5-7-15(22)8-6-14-11-18(27-3)21(24)19(12-14)28-4/h5-12,23-24H,1-4H3/b7-5+,8-6+ D0K4LS DRUGINKE DDGVRFAFSCAHHH-KQQUZDAGSA-N D0K4LS DRUGSMIL COC1=CC(=CC(=C1O)OC)C=CC(=O)C=CC2=CC(=C(C(=C2)OC)O)OC D0K4LS HIGHSTAT Investigative D0K4MG DRUG__ID D0K4MG D0K4MG DRUGTYPE Small molecular drug D0K4MG DRUGINCH 1S/C23H26O7/c1-7-8-12-15-11(10-14(29-5)16(12)20(26)30-6)9-13-17(18(15)24)19(25)23(4,28)21(27)22(13,2)3/h9-10,24,28H,7-8H2,1-6H3 D0K4MG DRUGINKE PRAZMVBMBFPZFN-UHFFFAOYSA-N D0K4MG DRUGSMIL CCCC1=C(C(=CC2=CC3=C(C(=C21)O)C(=O)C(C(=O)C3(C)C)(C)O)OC)C(=O)OC D0K4MG HIGHSTAT Investigative D0K4PK DRUG__ID D0K4PK D0K4PK DRUGTYPE Small molecular drug D0K4PK DRUGINCH 1S/C10H11N5O2S/c11-10(12)15-9-8-5-7(18(13,16)17)2-1-6(8)3-4-14-9/h1-5H,(H2,13,16,17)(H4,11,12,14,15) D0K4PK DRUGINKE NRVVFOKWKSWIIV-UHFFFAOYSA-N D0K4PK DRUGSMIL C1=CC(=CC2=C1C=CN=C2N=C(N)N)S(=O)(=O)N D0K4PK HIGHSTAT Investigative D0K4PV DRUG__ID D0K4PV D0K4PV DRUGTYPE Small molecular drug D0K4PV DRUGINCH 1S/C26H26Cl3N3O2/c1-14(33)30-25(34)21-13-26(2,3)32(4)24-20(21)12-19(15-5-7-16(27)8-6-15)23(31-24)18-10-9-17(28)11-22(18)29/h5-12,14,21,33H,13H2,1-4H3,(H,30,34)/t14-,21?/m1/s1 D0K4PV DRUGINKE DIDXRIJBHXOGGD-CKAQCJTGSA-N D0K4PV DRUGSMIL CC(NC(=O)C1CC(N(C2=C1C=C(C(=N2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)C)(C)C)O D0K4PV HIGHSTAT Investigative D0K4PY DRUG__ID D0K4PY D0K4PY DRUGTYPE Small molecular drug D0K4PY DRUGINCH 1S/C15H12O4/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-7,14,16-17H,8H2/t14-/m0/s1 D0K4PY DRUGINKE FURUXTVZLHCCNA-AWEZNQCLSA-N D0K4PY DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O D0K4PY HIGHSTAT Investigative D0K4QW DRUG__ID D0K4QW D0K4QW DRUGTYPE Small molecular drug D0K4QW DRUGINCH 1S/C12H12N2O10/c1-8(15)23-11-5-3-2-4-10(11)12(16)24-9(6-21-13(17)18)7-22-14(19)20/h2-5,9H,6-7H2,1H3 D0K4QW DRUGINKE KDHWEMULLOVCEH-UHFFFAOYSA-N D0K4QW DRUGSMIL CC(=O)OC1=CC=CC=C1C(=O)OC(CO[N+](=O)[O-])CO[N+](=O)[O-] D0K4QW HIGHSTAT Investigative D0K4RN DRUG__ID D0K4RN D0K4RN DRUGTYPE Small molecular drug D0K4RN DRUGINCH 1S/C11H9NO4/c13-7-5-8(14)10(9(15)6-7)11(16)12-3-1-2-4-12/h1-6,13-15H D0K4RN DRUGINKE RYGSNHBTZDYVSS-UHFFFAOYSA-N D0K4RN DRUGSMIL C1=CN(C=C1)C(=O)C2=C(C=C(C=C2O)O)O D0K4RN HIGHSTAT Investigative D0K4SL DRUG__ID D0K4SL D0K4SL DRUGTYPE Small molecular drug D0K4SL DRUGINCH 1S/C13H24NO10P/c1-3-5-12(16)24-9(6-21-11(15)4-2)7-22-25(19,20)23-8-10(14)13(17)18/h9-10H,3-8,14H2,1-2H3,(H,17,18)(H,19,20)/t9-,10+/m1/s1 D0K4SL DRUGINKE UNJJBGNPUUVVFQ-ZJUUUORDSA-N D0K4SL DRUGSMIL CCCC(=O)OC(COC(=O)CC)COP(=O)(O)OCC(C(=O)O)N D0K4SL HIGHSTAT Investigative D0K4SV DRUG__ID D0K4SV D0K4SV DRUGTYPE Small molecular drug D0K4SV DRUGINCH 1S/C9H10N2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-4H,5-6H2,(H2,10,11) D0K4SV DRUGINKE RREBANHDFAXBEZ-UHFFFAOYSA-N D0K4SV DRUGSMIL C1CC(=NC2=CC=CC=C21)N D0K4SV HIGHSTAT Investigative D0K4TI DRUG__ID D0K4TI D0K4TI DRUGTYPE Small molecular drug D0K4TI DRUGINCH 1S/C16H20N2O3/c1-2-3-4-8-11-16(12-9-6-5-7-10-12)13(19)17-15(21)18-14(16)20/h5-7,9-10H,2-4,8,11H2,1H3,(H2,17,18,19,20,21) D0K4TI DRUGINKE LWBGXTORWSRDHX-UHFFFAOYSA-N D0K4TI DRUGSMIL CCCCCCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2 D0K4TI HIGHSTAT Investigative D0K4TV DRUG__ID D0K4TV D0K4TV DRUGTYPE Small molecular drug D0K4TV DRUGINCH 1S/C16H14N2O/c1-10-4-3-5-12(8-10)13-9-14(19)15-11(2)6-7-17-16(15)18-13/h3-9H,1-2H3,(H,17,18,19) D0K4TV DRUGINKE ZLZNSSZWWMBAMD-UHFFFAOYSA-N D0K4TV DRUGSMIL CC1=CC(=CC=C1)C2=CC(=O)C3=C(C=CN=C3N2)C D0K4TV HIGHSTAT Investigative D0K4WI DRUG__ID D0K4WI D0K4WI DRUGTYPE Small molecular drug D0K4WI DRUGINCH 1S/C15H12Cl2O4/c1-9(15(18)19)20-11-3-5-12(6-4-11)21-14-7-2-10(16)8-13(14)17/h2-9H,1H3,(H,18,19) D0K4WI DRUGINKE OOLBCHYXZDXLDS-UHFFFAOYSA-N D0K4WI DRUGSMIL CC(C(=O)O)OC1=CC=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl D0K4WI HIGHSTAT Investigative D0K4WS DRUG__ID D0K4WS D0K4WS DRUGTYPE Small molecular drug D0K4WS DRUGINCH 1S/C39H49N3O6S/c1-23(2)27-17-12-18-28(24(3)4)35(27)48-21-32(44)40-30(19-25-13-8-7-9-14-25)34(45)38(47)42-22-49-39(5,6)36(42)37(46)41-33-29-16-11-10-15-26(29)20-31(33)43/h7-18,23-24,30-31,33-34,36,43,45H,19-22H2,1-6H3,(H,40,44)(H,41,46)/t30-,31+,33-,34-,36+/m0/s1 D0K4WS DRUGINKE QPUVMQNOWWLTBU-SQKWSBCUSA-N D0K4WS DRUGSMIL CC(C)C1=C(C(=CC=C1)C(C)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D0K4WS HIGHSTAT Investigative D0K4XQ DRUG__ID D0K4XQ D0K4XQ DRUGTYPE Small molecular drug D0K4XQ DRUGINCH 1S/C20H28N2O2/c1-3-21-19(23)24-15-8-7-14-12-18-16-6-4-5-9-20(16,17(14)13-15)10-11-22(18)2/h7-8,13,16,18H,3-6,9-12H2,1-2H3,(H,21,23) D0K4XQ DRUGINKE ZNJDUQHDGFWNKK-UHFFFAOYSA-N D0K4XQ DRUGSMIL CCNC(=O)OC1=CC2=C(CC3C4C2(CCCC4)CCN3C)C=C1 D0K4XQ HIGHSTAT Investigative D0K4YP DRUG__ID D0K4YP D0K4YP DRUGTYPE Small molecular drug D0K4YP DRUGINCH 1S/C9H14N2O5/c1-4(13)9-10-2-5(11-9)7(15)8(16)6(14)3-12/h2,6-8,12,14-16H,3H2,1H3,(H,10,11)/t6-,7-,8-/m1/s1 D0K4YP DRUGINKE CQSIXFHVGKMLGQ-BWZBUEFSSA-N D0K4YP DRUGSMIL CC(=O)C1=NC=C(N1)C(C(C(CO)O)O)O D0K4YP HIGHSTAT Investigative D0K4YY DRUG__ID D0K4YY D0K4YY DRUGTYPE Small molecular drug D0K4YY DRUGINCH 1S/C9H16N2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h7-8H,1-6H2,(H2,10,11)/t7-,8+/m1/s1 D0K4YY DRUGINKE AEIXJVBMYJIICX-SFYZADRCSA-N D0K4YY DRUGSMIL C1CCC2C(C1)CCC(=N2)N D0K4YY HIGHSTAT Investigative D0K4ZP DRUG__ID D0K4ZP D0K4ZP DRUGTYPE Small molecular drug D0K4ZP DRUGINCH 1S/C17H17NO4S2/c1-10(2)16(17(19)20)18-24(21,22)11-7-8-13-12-5-3-4-6-14(12)23-15(13)9-11/h3-10,16,18H,1-2H3,(H,19,20)/t16-/m0/s1 D0K4ZP DRUGINKE RZWYSEXQXOXWKA-INIZCTEOSA-N D0K4ZP DRUGSMIL CC(C)C(C(=O)O)NS(=O)(=O)C1=CC2=C(C=C1)C3=CC=CC=C3S2 D0K4ZP HIGHSTAT Investigative D0K4ZR DRUG__ID D0K4ZR D0K4ZR DRUGTYPE Small molecular drug D0K4ZR DRUGINCH 1S/C17H20O5/c1-2-14(12-19)15(7-9-18)11-17(21)22-10-8-13-3-5-16(20)6-4-13/h2-6,9,12,15,20H,7-8,10-11H2,1H3/b14-2-/t15-/m0/s1 D0K4ZR DRUGINKE VPOVFCBNUOUZGG-VAKDEWRISA-N D0K4ZR DRUGSMIL CC=C(C=O)C(CC=O)CC(=O)OCCC1=CC=C(C=C1)O D0K4ZR HIGHSTAT Investigative D0K5CK DRUG__ID D0K5CK D0K5CK DRUGTYPE Small molecular drug D0K5CK DRUGINCH 1S/C17H16N2O/c1-10-5-4-6-13(7-10)14-9-15(20)16-11(2)8-12(3)18-17(16)19-14/h4-9H,1-3H3,(H,18,19,20) D0K5CK DRUGINKE RXJJJRMOQDHINF-UHFFFAOYSA-N D0K5CK DRUGSMIL CC1=CC(=CC=C1)C2=CC(=O)C3=C(N2)N=C(C=C3C)C D0K5CK HIGHSTAT Investigative D0K5DA DRUG__ID D0K5DA D0K5DA DRUGTYPE Small molecular drug D0K5DA DRUGINCH 1S/C26H43NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-26(28)27-23-24-19-21-25(29-2)22-20-24/h10-11,19-22H,3-9,12-18,23H2,1-2H3,(H,27,28)/b11-10- D0K5DA DRUGINKE AABDRJHZBVPFLI-KHPPLWFESA-N D0K5DA DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC=C(C=C1)OC D0K5DA HIGHSTAT Investigative D0K5EI DRUG__ID D0K5EI D0K5EI DRUGTYPE Small molecular drug D0K5EI DRUGINCH 1S/C17H19NO2/c19-17(18-15-8-2-1-3-9-15)20-16-11-10-13-6-4-5-7-14(13)12-16/h4-7,10-12,15H,1-3,8-9H2,(H,18,19) D0K5EI DRUGINKE ZYHUWMGJJOBBCF-UHFFFAOYSA-N D0K5EI DRUGSMIL C1CCC(CC1)NC(=O)OC2=CC3=CC=CC=C3C=C2 D0K5EI HIGHSTAT Investigative D0K5GG DRUG__ID D0K5GG D0K5GG DRUGTYPE Small molecular drug D0K5GG DRUGINCH 1S/C17H19NO3/c1-19-15-11-8-13(16(20-2)17(15)21-3)7-4-12-5-9-14(18)10-6-12/h4-11H,18H2,1-3H3/b7-4+ D0K5GG DRUGINKE YLCPSZLMRABQDV-QPJJXVBHSA-N D0K5GG DRUGSMIL COC1=C(C(=C(C=C1)C=CC2=CC=C(C=C2)N)OC)OC D0K5GG HIGHSTAT Investigative D0K5JA DRUG__ID D0K5JA D0K5JA DRUGTYPE Small molecular drug D0K5JA DRUGINCH 1S/C15H18N2O/c16-14-10-9-11-5-4-8-13(15(11)17-14)18-12-6-2-1-3-7-12/h4-5,8-10,12H,1-3,6-7H2,(H2,16,17) D0K5JA DRUGINKE MPHNEJNPZMBSBN-UHFFFAOYSA-N D0K5JA DRUGSMIL C1CCC(CC1)OC2=CC=CC3=C2N=C(C=C3)N D0K5JA HIGHSTAT Investigative D0K5JE DRUG__ID D0K5JE D0K5JE DRUGCOMP Handok Pharmaceuticals D0K5JE DRUGINCH 1S/C6H7BrO2/c7-6-4(8)2-1-3-5(6)9/h6H,1-3H2 D0K5JE DRUGINKE UBUJDMSDEQBNTG-UHFFFAOYSA-N D0K5JE DRUGSMIL C1CC(=O)C(C(=O)C1)Br D0K5JE HIGHSTAT Investigative D0K5JU DRUG__ID D0K5JU D0K5JU DRUGTYPE Small molecular drug D0K5JU DRUGINCH 1S/C17H11N3O4/c21-16-11-3-1-2-4-15(11)24-17-12(16)5-6-14(20(22)23)13(17)9-19-8-7-18-10-19/h1-8,10H,9H2 D0K5JU DRUGINKE SRBZAHSXFAWSRK-UHFFFAOYSA-N D0K5JU DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(O2)C(=C(C=C3)[N+](=O)[O-])CN4C=CN=C4 D0K5JU HIGHSTAT Investigative D0K5KG DRUG__ID D0K5KG D0K5KG DRUGTYPE Small molecular drug D0K5KG DRUGINCH 1S/C16H15N/c1-12-15-7-3-2-5-13(15)8-9-16(12)14-6-4-10-17-11-14/h2-7,10-11H,8-9H2,1H3 D0K5KG DRUGINKE WBEMJRFRGOAAJI-UHFFFAOYSA-N D0K5KG DRUGSMIL CC1=C(CCC2=CC=CC=C12)C3=CN=CC=C3 D0K5KG HIGHSTAT Investigative D0K5LJ DRUG__ID D0K5LJ D0K5LJ DRUGTYPE Small molecular drug D0K5LJ DRUGINCH 1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m0/s1 D0K5LJ DRUGINKE RUOKEQAAGRXIBM-LBPRGKRZSA-N D0K5LJ DRUGSMIL C#CCNC1CCC2=CC=CC=C12 D0K5LJ HIGHSTAT Investigative D0K5LX DRUG__ID D0K5LX D0K5LX DRUGTYPE Small molecular drug D0K5LX DRUGINCH 1S/C13H10N2O3/c16-7-1-3-9-11(5-7)14-15-13(9)10-4-2-8(17)6-12(10)18/h1-6,16-18H,(H,14,15) D0K5LX DRUGINKE WLDZDEMGKFWJNR-UHFFFAOYSA-N D0K5LX DRUGSMIL C1=CC2=C(C=C1O)NN=C2C3=C(C=C(C=C3)O)O D0K5LX HIGHSTAT Investigative D0K5ME DRUG__ID D0K5ME D0K5ME DRUGTYPE Small molecular drug D0K5ME DRUGINCH 1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)/t23-/m0/s1 D0K5ME DRUGINKE LQQIVYSCPWCSSD-QHCPKHFHSA-N D0K5ME DRUGSMIL C1CN(CCC1C2(CCC(=O)NC2=O)C3=CC=CC=C3)CC4=CC=CC=C4 D0K5ME HIGHSTAT Investigative D0K5NQ DRUG__ID D0K5NQ D0K5NQ DRUGTYPE Small molecular drug D0K5NQ DRUGINCH 1S/C7H7F3N2O2S/c8-7(9,10)5-1-3-6(4-2-5)12-15(11,13)14/h1-4,12H,(H2,11,13,14) D0K5NQ DRUGINKE LTJDGKNETMQCBO-UHFFFAOYSA-N D0K5NQ DRUGSMIL C1=CC(=CC=C1C(F)(F)F)NS(=O)(=O)N D0K5NQ HIGHSTAT Investigative D0K5NZ DRUG__ID D0K5NZ D0K5NZ DRUGTYPE Small molecular drug D0K5NZ DRUGINCH 1S/C18H26N4O2S/c1-20(2)25(23,24)19-13-9-15-14-6-5-7-16-18(14)12(10-21(16)3)8-17(15)22(4)11-13/h5-7,10,13,15,17,19H,8-9,11H2,1-4H3/t13-,15+,17+/m0/s1 D0K5NZ DRUGINKE JLVHTNZNKOSCNB-YSVLISHTSA-N D0K5NZ DRUGSMIL CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)NS(=O)(=O)N(C)C D0K5NZ HIGHSTAT Investigative D0K5OZ DRUG__ID D0K5OZ D0K5OZ DRUGTYPE Small molecular drug D0K5OZ DRUGINCH 1S/C25H22N6O/c1-15-9-20(10-16(2)22(15)32-3)25(23-21(24(26)31-25)29-7-8-30-23)19-6-4-5-17(11-19)18-12-27-14-28-13-18/h4-14H,1-3H3,(H2,26,31)/t25-/m0/s1 D0K5OZ DRUGINKE BICGYFRWDDPYEI-VWLOTQADSA-N D0K5OZ DRUGSMIL CC1=CC(=CC(=C1OC)C)C2(C3=NC=CN=C3C(=N2)N)C4=CC=CC(=C4)C5=CN=CN=C5 D0K5OZ HIGHSTAT Investigative D0K5QH DRUG__ID D0K5QH D0K5QH DRUGTYPE Small molecular drug D0K5QH DRUGINCH 1S/C27H46O2/c1-17(2)7-6-8-18(3)21-9-10-22-25-23(12-14-27(21,22)5)26(4)13-11-20(28)15-19(26)16-24(25)29/h16-18,20-25,28-29H,6-15H2,1-5H3/t18-,20+,21-,22+,23+,24-,25+,26+,27-/m1/s1 D0K5QH DRUGINKE OYXZMSRRJOYLLO-RVOWOUOISA-N D0K5QH DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C D0K5QH HIGHSTAT Investigative D0K5QJ DRUG__ID D0K5QJ D0K5QJ DRUGTYPE Small molecular drug D0K5QJ DRUGINCH 1S/C20H21F3N4O2/c1-12(2)24-19-26-16-9-6-14(10-17(16)27(19)3)25-18(28)11-29-15-7-4-13(5-8-15)20(21,22)23/h4-10,12H,11H2,1-3H3,(H,24,26)(H,25,28) D0K5QJ DRUGINKE YFLYQHULFMRTHA-UHFFFAOYSA-N D0K5QJ DRUGSMIL CC(C)NC1=NC2=C(N1C)C=C(C=C2)NC(=O)COC3=CC=C(C=C3)C(F)(F)F D0K5QJ HIGHSTAT Investigative D0K5QW DRUG__ID D0K5QW D0K5QW DRUGTYPE Small molecular drug D0K5QW DRUGINCH 1S/C12H8Br2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H D0K5QW DRUGINKE QBNABJXQGRVIRA-UHFFFAOYSA-N D0K5QW DRUGSMIL C1=CC(=CC=C1S(=O)(=O)C2=CC=C(C=C2)Br)Br D0K5QW HIGHSTAT Investigative D0K5RX DRUG__ID D0K5RX D0K5RX DRUGTYPE Small molecular drug D0K5RX DRUGINCH 1S/C34H37N5O/c35-22-10-3-11-23-36-34-38-31-17-9-8-16-30(31)32(24-33(40)37-25-26-12-4-1-5-13-26)39(34)29-20-18-28(19-21-29)27-14-6-2-7-15-27/h1-2,4-9,12-21,32H,3,10-11,22-25,35H2,(H,36,38)(H,37,40) D0K5RX DRUGINKE PHOBNPDRNIKURV-UHFFFAOYSA-N D0K5RX DRUGSMIL C1=CC=C(C=C1)CNC(=O)CC2C3=CC=CC=C3NC(=NCCCCCN)N2C4=CC=C(C=C4)C5=CC=CC=C5 D0K5RX HIGHSTAT Investigative D0K5UF DRUG__ID D0K5UF D0K5UF DRUGTYPE Small molecular drug D0K5UF DRUGINCH 1S/C22H23FN6O3S/c1-12-19(33-21(28-12)22(3,31)11-30)14-8-18(20(24)25-10-14)32-13(2)16-9-15(23)4-5-17(16)29-26-6-7-27-29/h4-10,13,30-31H,11H2,1-3H3,(H2,24,25)/t13-,22-/m1/s1 D0K5UF DRUGINKE DIXMBHMNEHPFCX-MCMMXHMISA-N D0K5UF DRUGSMIL CC1=C(SC(=N1)C(C)(CO)O)C2=CC(=C(N=C2)N)OC(C)C3=C(C=CC(=C3)F)N4N=CC=N4 D0K5UF HIGHSTAT Investigative D0K5UI DRUG__ID D0K5UI D0K5UI DRUGTYPE Small molecular drug D0K5UI DRUGINCH 1S/C14H15N3O6S/c1-7-4-16(6-9(15)12(19)20)14(23)17(11(7)18)5-8-2-3-24-10(8)13(21)22/h2-4,9H,5-6,15H2,1H3,(H,19,20)(H,21,22)/t9-/m0/s1 D0K5UI DRUGINKE ZTAZUCRXCRXNSU-VIFPVBQESA-N D0K5UI DRUGSMIL CC1=CN(C(=O)N(C1=O)CC2=C(SC=C2)C(=O)O)CC(C(=O)O)N D0K5UI HIGHSTAT Investigative D0K5UM DRUG__ID D0K5UM D0K5UM DRUGTYPE Small molecular drug D0K5UM DRUGINCH 1S/C15H15NO4S/c1-10-8-11(2)14(13(9-10)15(17)18)16-21(19,20)12-6-4-3-5-7-12/h3-9,16H,1-2H3,(H,17,18) D0K5UM DRUGINKE ORCGTMODRHXXRZ-UHFFFAOYSA-N D0K5UM DRUGSMIL CC1=CC(=C(C(=C1)C(=O)O)NS(=O)(=O)C2=CC=CC=C2)C D0K5UM HIGHSTAT Investigative D0K5VE DRUG__ID D0K5VE D0K5VE DRUGTYPE Small molecular drug D0K5VE DRUGINCH 1S/C15H14ClNO3/c16-12-3-1-11(2-4-12)14-9-13(10-15(18)20-14)17-5-7-19-8-6-17/h1-4,9-10H,5-8H2 D0K5VE DRUGINKE QAPAFHWHAZOAOB-UHFFFAOYSA-N D0K5VE DRUGSMIL C1COCCN1C2=CC(=O)OC(=C2)C3=CC=C(C=C3)Cl D0K5VE HIGHSTAT Investigative D0K5WC DRUG__ID D0K5WC D0K5WC DRUGTYPE Small molecular drug D0K5WC DRUGINCH 1S/C13H12N2O/c1-7-5-10-12(8(2)13(7)16)9-3-4-14-6-11(9)15-10/h3-6,15-16H,1-2H3 D0K5WC DRUGINKE RRUTVQQPPTZUTL-UHFFFAOYSA-N D0K5WC DRUGSMIL CC1=CC2=C(C(=C1O)C)C3=C(N2)C=NC=C3 D0K5WC HIGHSTAT Investigative D0K5XL DRUG__ID D0K5XL D0K5XL DRUGTYPE Small molecular drug D0K5XL DRUGINCH 1S/C21H21ClN4O2/c1-14-16-12-15(24-20(27)13-28-19-7-3-2-6-17(19)22)8-9-18(16)25-21(23-14)26-10-4-5-11-26/h2-3,6-9,12H,4-5,10-11,13H2,1H3,(H,24,27) D0K5XL DRUGINKE XIYWAMFWFFFEQL-UHFFFAOYSA-N D0K5XL DRUGSMIL CC1=C2C=C(C=CC2=NC(=N1)N3CCCC3)NC(=O)COC4=CC=CC=C4Cl D0K5XL HIGHSTAT Investigative D0K5ZY DRUG__ID D0K5ZY D0K5ZY DRUGTYPE Small molecular drug D0K5ZY DRUGINCH 1S/C17H23N3O2/c1-10(2)16-17(22)19-12(9-21)7-11-8-18-13-5-4-6-14(15(11)13)20(16)3/h4-6,8,10,12,16,18,21H,7,9H2,1-3H3,(H,19,22)/t12-,16-/m0/s1 D0K5ZY DRUGINKE LUZOFMGZMUZSSK-LRDDRELGSA-N D0K5ZY DRUGSMIL CC(C)C1C(=O)NC(CC2=CNC3=C2C(=CC=C3)N1C)CO D0K5ZY HIGHSTAT Investigative D0K6AF DRUG__ID D0K6AF D0K6AF DRUGTYPE Small molecular drug D0K6AF DRUGINCH 1S/C12H20N2O7/c1-14-8-6(15)4-20-7-3-12(11(18)19,21-9(7)8)2-5(13)10(16)17/h5-9,14-15H,2-4,13H2,1H3,(H,16,17)(H,18,19)/t5-,6+,7+,8+,9-,12+/m0/s1 D0K6AF DRUGINKE YUSZFKPLFIQTGF-FDNSHYBFSA-N D0K6AF DRUGSMIL CNC1C(COC2C1OC(C2)(CC(C(=O)O)N)C(=O)O)O D0K6AF HIGHSTAT Investigative D0K6BI DRUG__ID D0K6BI D0K6BI DRUGTYPE Small molecular drug D0K6BI DRUGINCH 1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20) D0K6BI DRUGINKE PHAOTASRLQMKBE-UHFFFAOYSA-N D0K6BI DRUGSMIL CN(C)C1=NC2=C(N1CC(=O)O)C(=C(C(=C2Br)Br)Br)Br D0K6BI HIGHSTAT Investigative D0K6EG DRUG__ID D0K6EG D0K6EG DRUGTYPE Small molecular drug D0K6EG DRUGINCH 1S/C23H21FO3/c1-16-2-7-18(8-3-16)22-12-9-20(24)14-19(22)15-27-21-10-4-17(5-11-21)6-13-23(25)26/h2-5,7-12,14H,6,13,15H2,1H3,(H,25,26) D0K6EG DRUGINKE LPGBXHWIQNZEJB-UHFFFAOYSA-N D0K6EG DRUGSMIL CC1=CC=C(C=C1)C2=C(C=C(C=C2)F)COC3=CC=C(C=C3)CCC(=O)O D0K6EG HIGHSTAT Investigative D0K6FM DRUG__ID D0K6FM D0K6FM DRUGTYPE Small molecular drug D0K6FM DRUGINCH 1S/C23H24O6/c1-12(2)5-4-6-13(3)7-8-14-17(26)11-18-20(21(14)27)22(28)19-15(24)9-10-16(25)23(19)29-18/h5,7,9-11,24-27H,4,6,8H2,1-3H3/b13-7+ D0K6FM DRUGINKE TWEXJIOSYZXWGT-NTUHNPAUSA-N D0K6FM DRUGSMIL CC(=CCCC(=CCC1=C(C2=C(C=C1O)OC3=C(C=CC(=C3C2=O)O)O)O)C)C D0K6FM HIGHSTAT Investigative D0K6GX DRUG__ID D0K6GX D0K6GX DRUGTYPE Small molecular drug D0K6GX DRUGINCH 1S/C16H23NO/c18-16(17-15-11-5-2-6-12-15)13-7-10-14-8-3-1-4-9-14/h1,3-4,8-9,15H,2,5-7,10-13H2,(H,17,18) D0K6GX DRUGINKE NWKPABISVRIQLP-UHFFFAOYSA-N D0K6GX DRUGSMIL C1CCC(CC1)NC(=O)CCCC2=CC=CC=C2 D0K6GX HIGHSTAT Investigative D0K6GY DRUG__ID D0K6GY D0K6GY DRUGTYPE Small molecular drug D0K6GY DRUGINCH 1S/C11H24FO2P/c1-4-5-6-7-8-9-10-15(12,13)14-11(2)3/h11H,4-10H2,1-3H3 D0K6GY DRUGINKE GLHLEAFTUHVDCD-UHFFFAOYSA-N D0K6GY DRUGSMIL CCCCCCCCP(=O)(OC(C)C)F D0K6GY HIGHSTAT Investigative D0K6HL DRUG__ID D0K6HL D0K6HL DRUGTYPE Small molecular drug D0K6HL DRUGINCH 1S/C20H20N2O3/c1-9(23)14-18(24)17-16-11-8-21-13-6-4-5-10(15(11)13)7-12(16)20(2,3)22(17)19(14)25/h4-6,8,12,16-17,21,24H,7H2,1-3H3/t12-,16+,17+/m1/s1 D0K6HL DRUGINKE SZINUGQCTHLQAZ-DQYPLSBCSA-N D0K6HL DRUGSMIL CC(=O)C1=C(C2C3C(CC4=C5C3=CNC5=CC=C4)C(N2C1=O)(C)C)O D0K6HL HIGHSTAT Investigative D0K6IW DRUG__ID D0K6IW D0K6IW DRUGTYPE Small molecular drug D0K6IW DRUGINCH 1S/C21H18F2N2O/c22-18-7-3-15(4-8-18)20(16-5-9-19(23)10-6-16)11-13-25-21(26)17-2-1-12-24-14-17/h1-10,12,14,20H,11,13H2,(H,25,26) D0K6IW DRUGINKE PGLSPMQRWMIFOQ-UHFFFAOYSA-N D0K6IW DRUGSMIL C1=CC(=CN=C1)C(=O)NCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D0K6IW HIGHSTAT Investigative D0K6MH DRUG__ID D0K6MH D0K6MH DRUGTYPE Small molecular drug D0K6MH DRUGINCH 1S/C17H18N2O2/c18-12-15-13-21-17(19-15)16(20)11-7-2-1-4-8-14-9-5-3-6-10-14/h3,5-6,9-10,13H,1-2,4,7-8,11H2 D0K6MH DRUGINKE IGDLMZPDBOKHRJ-UHFFFAOYSA-N D0K6MH DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)C#N D0K6MH HIGHSTAT Investigative D0K6MI DRUG__ID D0K6MI D0K6MI DRUGTYPE Small molecular drug D0K6MI DRUGINCH 1S/C15H18IN3O2/c1-9(2)18-7-10(20)8-21-13-5-3-4-11-14(13)15(16)12(6-17)19-11/h3-5,9-10,18-20H,7-8H2,1-2H3/i16-2 D0K6MI DRUGINKE WGSPBWSPJOBKNT-RFLHHMENSA-N D0K6MI DRUGSMIL CC(C)NCC(COC1=CC=CC2=C1C(=C(N2)C#N)I)O D0K6MI HIGHSTAT Investigative D0K6MM DRUG__ID D0K6MM D0K6MM DRUGTYPE Small molecular drug D0K6MM DRUGINCH 1S/C24H29NO4/c1-24-9-8-18-17-7-5-15(26)11-14(17)4-6-19(18)21(24)12-20(22(24)27)23(28)25-13-16-3-2-10-29-16/h2-3,5,7,10-11,18-22,26-27H,4,6,8-9,12-13H2,1H3,(H,25,28)/t18?,19?,20?,21?,22-,24-/m0/s1 D0K6MM DRUGINKE JKEJHEHCKBFOBU-OOBULCBASA-N D0K6MM DRUGSMIL CC12CCC3C(C1CC(C2O)C(=O)NCC4=CC=CO4)CCC5=C3C=CC(=C5)O D0K6MM HIGHSTAT Investigative D0K6OL DRUG__ID D0K6OL D0K6OL DRUGTYPE Small molecular drug D0K6OL DRUGINCH 1S/C15H21NO2/c1-18-14-9-7-13(8-10-14)16-15(17)11-12-5-3-2-4-6-12/h7-10,12H,2-6,11H2,1H3,(H,16,17) D0K6OL DRUGINKE SCFJMQSXUCFKPS-UHFFFAOYSA-N D0K6OL DRUGSMIL COC1=CC=C(C=C1)NC(=O)CC2CCCCC2 D0K6OL HIGHSTAT Investigative D0K6OM DRUG__ID D0K6OM D0K6OM DRUGTYPE Small molecular drug D0K6OM DRUGINCH 1S/C14H6F4O2/c15-9-3-1-7(5-11(9)17)13(19)14(20)8-2-4-10(16)12(18)6-8/h1-6H D0K6OM DRUGINKE IBDJXLAQEHPROM-UHFFFAOYSA-N D0K6OM DRUGSMIL C1=CC(=C(C=C1C(=O)C(=O)C2=CC(=C(C=C2)F)F)F)F D0K6OM HIGHSTAT Investigative D0K6PO DRUG__ID D0K6PO D0K6PO DRUGTYPE Small molecular drug D0K6PO DRUGINCH 1S/C16H8O2/c17-15-12-7-3-5-10-8-9-4-1-2-6-11(9)14(13(10)12)16(15)18/h1-8H D0K6PO DRUGINKE YAIBDWAANBTYIA-UHFFFAOYSA-N D0K6PO DRUGSMIL C1=CC=C2C(=C1)C=C3C=CC=C4C3=C2C(=O)C4=O D0K6PO HIGHSTAT Investigative D0K6QS DRUG__ID D0K6QS D0K6QS DRUGTYPE Small molecular drug D0K6QS DRUGINCH 1S/C9H11ClN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 D0K6QS DRUGINKE NJCXGFKPQSFZIB-RRKCRQDMSA-N D0K6QS DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)Cl)CO)O D0K6QS HIGHSTAT Investigative D0K6QX DRUG__ID D0K6QX D0K6QX DRUGTYPE Small molecular drug D0K6QX DRUGINCH 1S/C16H25N/c1-4-10-17-11-6-9-15(12-17)16-13(2)7-5-8-14(16)3/h5,7-8,15H,4,6,9-12H2,1-3H3 D0K6QX DRUGINKE HBTLGWNZDLWXQJ-UHFFFAOYSA-N D0K6QX DRUGSMIL CCCN1CCCC(C1)C2=C(C=CC=C2C)C D0K6QX HIGHSTAT Investigative D0K6RA DRUG__ID D0K6RA D0K6RA DRUGTYPE Small molecular drug D0K6RA DRUGINCH 1S/C16H20ClN3/c1-19(2)11-12-20(16-5-3-4-10-18-16)13-14-6-8-15(17)9-7-14/h3-10H,11-13H2,1-2H3 D0K6RA DRUGINKE ICKFFNBDFNZJSX-UHFFFAOYSA-N D0K6RA DRUGSMIL CN(C)CCN(CC1=CC=C(C=C1)Cl)C2=CC=CC=N2 D0K6RA HIGHSTAT Investigative D0K6RG DRUG__ID D0K6RG D0K6RG DRUGTYPE Small molecular drug D0K6RG DRUGINCH 1S/C7H7Br/c8-6-7-4-2-1-3-5-7/h1-5H,6H2 D0K6RG DRUGINKE AGEZXYOZHKGVCM-UHFFFAOYSA-N D0K6RG DRUGSMIL C1=CC=C(C=C1)CBr D0K6RG HIGHSTAT Investigative D0K6SD DRUG__ID D0K6SD D0K6SD DRUGTYPE Small molecular drug D0K6SD DRUGINCH 1S/C32H39N5O3.ClH/c1-7-8-17-37-30-24(13-10-16-34-30)27(21-11-9-12-22(18-21)40-6)29(31(37)38)36-32(39)35-28-23(19(2)3)14-15-25(33)26(28)20(4)5;/h9-16,18-20H,7-8,17,33H2,1-6H3,(H2,35,36,39);1H D0K6SD DRUGINKE HALGUFCFUQNPBN-UHFFFAOYSA-N D0K6SD DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=CC(=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OC.Cl D0K6SD HIGHSTAT Investigative D0K6SV DRUG__ID D0K6SV D0K6SV DRUGTYPE Small molecular drug D0K6SV DRUGINCH 1S/C15H24N4O7/c1-8(21)19-6-2-3-11(19)14(24)18-10(7-20)13(23)17-9(15(25)26)4-5-12(16)22/h9-11,20H,2-7H2,1H3,(H2,16,22)(H,17,23)(H,18,24)(H,25,26)/t9-,10-,11-/m0/s1 D0K6SV DRUGINKE HPQBUPGLRXIKEL-DCAQKATOSA-N D0K6SV DRUGSMIL CC(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)O D0K6SV HIGHSTAT Investigative D0K6TE DRUG__ID D0K6TE D0K6TE DRUGTYPE Small molecular drug D0K6TE DRUGINCH 1S/C16H11ClO2/c17-15-9-13(4-6-16(15)19)10-1-2-12-8-14(18)5-3-11(12)7-10/h1-9,18-19H D0K6TE DRUGINKE UVRXGDFVCKYIGU-UHFFFAOYSA-N D0K6TE DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C=C3)O)Cl D0K6TE HIGHSTAT Investigative D0K6TI DRUG__ID D0K6TI D0K6TI DRUGTYPE Small molecular drug D0K6TI DRUGINCH 1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-13-16-19(21)17-14-11-12-15-18-20(22)23/h6-7,9-11,13-14,16,19,21H,2-5,8,12,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,14-11-,16-13+/t19-/m1/s1 D0K6TI DRUGINKE NLUNAYAEIJYXRB-VYOQERLCSA-N D0K6TI DRUGSMIL CCCCCC=CCC=CC=CC(CC=CCCCC(=O)O)O D0K6TI HIGHSTAT Investigative D0K6UK DRUG__ID D0K6UK D0K6UK DRUGTYPE Small molecular drug D0K6UK DRUGINCH 1S/C29H30N4O8/c1-11-23(35)14-8-17-22-21-15(24(36)12(2)28(41-6)26(21)38)7-16(32(22)4)18(9-30)33(17)19(10-31-29(39)13(3)34)20(14)25(37)27(11)40-5/h16-19,22H,7-8,10H2,1-6H3,(H,31,39)/t16-,17-,18-,19-,22-/m0/s1 D0K6UK DRUGINKE JNEGMBHBUAJRSX-SHUHUVMISA-N D0K6UK DRUGSMIL CC1=C(C(=O)C2=C(C1=O)CC3C4C5=C(CC(N4C)C(N3C2CNC(=O)C(=O)C)C#N)C(=O)C(=C(C5=O)OC)C)OC D0K6UK HIGHSTAT Investigative D0K6VR DRUG__ID D0K6VR D0K6VR DRUGTYPE Small molecular drug D0K6VR DRUGINCH 1S/C11H11ClN2/c12-10-3-1-2-8-6-9-7-13-4-5-14(9)11(8)10/h1-3,6,13H,4-5,7H2 D0K6VR DRUGINKE AWEHDQNNOZXHOU-UHFFFAOYSA-N D0K6VR DRUGSMIL C1CN2C(=CC3=C2C(=CC=C3)Cl)CN1 D0K6VR HIGHSTAT Investigative D0K6WD DRUG__ID D0K6WD D0K6WD DRUGTYPE Small molecular drug D0K6WD DRUGINCH 1S/C13H13N3/c1-2-14-13-7-10-9-5-3-4-6-11(9)16-12(10)8-15-13/h3-8,16H,2H2,1H3,(H,14,15) D0K6WD DRUGINKE AANHPEPPBKKLLX-UHFFFAOYSA-N D0K6WD DRUGSMIL CCNC1=NC=C2C(=C1)C3=CC=CC=C3N2 D0K6WD HIGHSTAT Investigative D0K6WI DRUG__ID D0K6WI D0K6WI DRUGTYPE Small molecular drug D0K6WI DRUGINCH 1S/C3H10N2O.ClH/c4-2-1-3-6-5;/h1-5H2;1H D0K6WI DRUGINKE KJXCRFUWQRHVMV-UHFFFAOYSA-N D0K6WI DRUGSMIL C(CN)CON.Cl D0K6WI HIGHSTAT Investigative D0K6XD DRUG__ID D0K6XD D0K6XD DRUGTYPE Small molecular drug D0K6XD DRUGINCH 1S/C15H22N2O2/c1-11(2)17-10-12(18)7-9-19-15-5-3-4-14-13(15)6-8-16-14/h3-6,8,11-12,16-18H,7,9-10H2,1-2H3 D0K6XD DRUGINKE DJWOTJGQRBWXIN-UHFFFAOYSA-N D0K6XD DRUGSMIL CC(C)NCC(CCOC1=CC=CC2=C1C=CN2)O D0K6XD HIGHSTAT Investigative D0K6YK DRUG__ID D0K6YK D0K6YK DRUGTYPE Small molecular drug D0K6YK DRUGINCH 1S/C25H20N6O/c1-15-4-2-7-20(29-15)24-23(17-8-9-19-21(14-17)28-11-10-27-19)30-22(31-24)13-16-5-3-6-18(12-16)25(26)32/h2-12,14H,13H2,1H3,(H2,26,32)(H,30,31) D0K6YK DRUGINKE RYKSGWSKILPDDY-UHFFFAOYSA-N D0K6YK DRUGSMIL CC1=NC(=CC=C1)C2=C(N=C(N2)CC3=CC(=CC=C3)C(=O)N)C4=CC5=NC=CN=C5C=C4 D0K6YK HIGHSTAT Investigative D0K6ZA DRUG__ID D0K6ZA D0K6ZA DRUGTYPE Small molecular drug D0K6ZA DRUGINCH 1S/C30H35N7O2/c1-22(38)31-14-15-32-28-25-21-26(33-29(25)35-27(34-28)24-12-6-3-7-13-24)30(39)37-19-17-36(18-20-37)16-8-11-23-9-4-2-5-10-23/h2-7,9-10,12-13,21H,8,11,14-20H2,1H3,(H,31,38)(H2,32,33,34,35) D0K6ZA DRUGINKE MIUCZFWBCFZKEU-UHFFFAOYSA-N D0K6ZA DRUGSMIL CC(=O)NCCNC1=NC(=NC2=C1C=C(N2)C(=O)N3CCN(CC3)CCCC4=CC=CC=C4)C5=CC=CC=C5 D0K6ZA HIGHSTAT Investigative D0K6ZT DRUG__ID D0K6ZT D0K6ZT DRUGTYPE Small molecular drug D0K6ZT DRUGINCH 1S/C16H17FN2O/c17-14-5-1-2-6-15(14)20-16-13(4-3-9-19-16)12-7-10-18-11-8-12/h1-6,9,12,18H,7-8,10-11H2 D0K6ZT DRUGINKE OTTUCFBNHXCUBH-UHFFFAOYSA-N D0K6ZT DRUGSMIL C1CNCCC1C2=C(N=CC=C2)OC3=CC=CC=C3F D0K6ZT HIGHSTAT Investigative D0K7CR DRUG__ID D0K7CR D0K7CR DRUGTYPE Small molecular drug D0K7CR DRUGINCH 1S/C20H25N3O10S/c24-16(25)8-7-14(20(30)31)22-18(28)12-3-5-13(6-4-12)34(32,33)23-11-1-2-15(23)19(29)21-10-9-17(26)27/h3-6,14-15H,1-2,7-11H2,(H,21,29)(H,22,28)(H,24,25)(H,26,27)(H,30,31)/t14-,15+/m0/s1 D0K7CR DRUGINKE SRAHBOKVSSZEHQ-LSDHHAIUSA-N D0K7CR DRUGSMIL C1CC(N(C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)NCCC(=O)O D0K7CR HIGHSTAT Investigative D0K7CV DRUG__ID D0K7CV D0K7CV DRUGTYPE Small molecular drug D0K7CV DRUGINCH 1S/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9) D0K7CV DRUGINKE QYPPJABKJHAVHS-UHFFFAOYSA-N D0K7CV DRUGSMIL C(CCN=C(N)N)CN D0K7CV HIGHSTAT Investigative D0K7CX DRUG__ID D0K7CX D0K7CX DRUGTYPE Small molecular drug D0K7CX DRUGINCH 1S/C8H4N2O4S/c11-8-14-7(9-15-8)5-2-1-3-6(4-5)10(12)13/h1-4H D0K7CX DRUGINKE QBAZATRGWRVUFN-UHFFFAOYSA-N D0K7CX DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=NSC(=O)O2 D0K7CX HIGHSTAT Investigative D0K7DW DRUG__ID D0K7DW D0K7DW DRUGTYPE Small molecular drug D0K7DW DRUGINCH 1S/C43H67N13O10.C2H4O2/c1-7-24(4)35(40(63)53-31(19-27-20-47-22-49-27)41(64)56-17-9-11-32(56)38(61)50-25(5)42(65)66)55-37(60)30(18-26-12-14-28(57)15-13-26)52-39(62)34(23(2)3)54-36(59)29(51-33(58)21-46-6)10-8-16-48-43(44)45;1-2(3)4/h12-15,20,22-25,29-32,34-35,46,57H,7-11,16-19,21H2,1-6H3,(H,47,49)(H,50,61)(H,51,58)(H,52,62)(H,53,63)(H,54,59)(H,55,60)(H,65,66)(H4,44,45,48);1H3,(H,3,4) D0K7DW DRUGINKE RWZZWAGPSKCDPN-UHFFFAOYSA-N D0K7DW DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(C)C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC.CC(=O)O D0K7DW HIGHSTAT Investigative D0K7EC DRUG__ID D0K7EC D0K7EC DRUGTYPE Small molecular drug D0K7EC DRUGINCH 1S/C17H18N2OS/c1-3-18(4-2)17(20)19-13-9-5-7-11-15(13)21-16-12-8-6-10-14(16)19/h5-12H,3-4H2,1-2H3 D0K7EC DRUGINKE VZWXJPGNJLOWRM-UHFFFAOYSA-N D0K7EC DRUGSMIL CCN(CC)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0K7EC HIGHSTAT Investigative D0K7EZ DRUG__ID D0K7EZ D0K7EZ DRUGTYPE Small molecular drug D0K7EZ DRUGINCH 1S/C17H18N2O/c1-20-16-10-6-5-9-15(16)13-19-17(18)12-11-14-7-3-2-4-8-14/h2-12H,13H2,1H3,(H2,18,19)/b12-11+ D0K7EZ DRUGINKE YYJKWRHOJBQQMG-VAWYXSNFSA-N D0K7EZ DRUGSMIL COC1=CC=CC=C1CN=C(C=CC2=CC=CC=C2)N D0K7EZ HIGHSTAT Investigative D0K7FA DRUG__ID D0K7FA D0K7FA DRUGTYPE Small molecular drug D0K7FA DRUGINCH 1S/C44H59N9O15/c1-22(2)18-31-43(67)52-30(14-17-37(60)61)41(65)50-28(38(45)62)12-15-34(56)48-32(19-24-4-8-26(54)9-5-24)44(68)53-33(20-25-6-10-27(55)11-7-25)42(66)47-23(3)39(63)51-29(13-16-36(58)59)40(64)46-21-35(57)49-31/h4-11,22-23,28-33,54-55H,12-21H2,1-3H3,(H2,45,62)(H,46,64)(H,47,66)(H,48,56)(H,49,57)(H,50,65)(H,51,63)(H,52,67)(H,53,68)(H,58,59)(H,60,61)/t23-,28-,29-,30-,31-,32-,33-/m0/s1 D0K7FA DRUGINKE WSKHBZRJCGPPOH-RKNQSKIKSA-N D0K7FA DRUGSMIL CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CC3=CC=C(C=C3)O)C(=O)N)CCC(=O)O)CC(C)C)CCC(=O)O D0K7FA HIGHSTAT Investigative D0K7GD DRUG__ID D0K7GD D0K7GD DRUGTYPE Small molecular drug D0K7GD DRUGINCH 1S/C14H11BrN4/c15-9-2-1-3-11(6-9)19-14-12-5-4-10(16)7-13(12)17-8-18-14/h1-8H,16H2,(H,17,18,19) D0K7GD DRUGINKE GHVBIROTJQDRQB-UHFFFAOYSA-N D0K7GD DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=CC(=C3)N D0K7GD HIGHSTAT Investigative D0K7GL DRUG__ID D0K7GL D0K7GL DRUGTYPE Small molecular drug D0K7GL DRUGINCH 1S/C18H27NO3/c1-5-8-15-13-16(22-18(20)6-2)9-10-17(15)21-12-7-11-19-14(3)4/h5,9-10,13-14,19H,1,6-8,11-12H2,2-4H3 D0K7GL DRUGINKE TYOWLIKQVJJCEX-UHFFFAOYSA-N D0K7GL DRUGSMIL CCC(=O)OC1=CC(=C(C=C1)OCCCNC(C)C)CC=C D0K7GL HIGHSTAT Investigative D0K7HT DRUG__ID D0K7HT D0K7HT DRUGTYPE Small molecular drug D0K7HT DRUGINCH 1S/C10H14N5O5P/c1-5-6(20-21(16,17)18)2-7(19-5)15-4-14-8-9(11)12-3-13-10(8)15/h3-7H,2H2,1H3,(H2,11,12,13)(H2,16,17,18)/t5-,6+,7-/m1/s1 D0K7HT DRUGINKE NFGZMOICZSFFLB-DSYKOEDSSA-N D0K7HT DRUGSMIL CC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)OP(=O)(O)O D0K7HT HIGHSTAT Investigative D0K7HV DRUG__ID D0K7HV D0K7HV DRUGTYPE Small molecular drug D0K7HV DRUGINCH 1S/C17H20N2O/c1-17(2,3)14-8-4-12(5-9-14)13-6-10-15(11-7-13)19-16(18)20/h4-11H,1-3H3,(H3,18,19,20) D0K7HV DRUGINKE CQQWFWURFCAFPP-UHFFFAOYSA-N D0K7HV DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)N D0K7HV HIGHSTAT Investigative D0K7JT DRUG__ID D0K7JT D0K7JT DRUGTYPE Small molecular drug D0K7JT DRUGINCH 1S/C12H10N2O/c1-2-8-6-9-4-3-5-10(12(13)15)11(9)14-7-8/h2-7H,1H2,(H2,13,15) D0K7JT DRUGINKE CODIVOZOEAWHDX-UHFFFAOYSA-N D0K7JT DRUGSMIL C=CC1=CN=C2C(=C1)C=CC=C2C(=O)N D0K7JT HIGHSTAT Investigative D0K7KM DRUG__ID D0K7KM D0K7KM DRUGTYPE Small molecular drug D0K7KM DRUGINCH 1S/C18H13NS/c1-14-19-18(13-20-14)11-10-15-6-5-9-17(12-15)16-7-3-2-4-8-16/h2-9,12-13H,1H3 D0K7KM DRUGINKE JWWDWRFQBGXCEK-UHFFFAOYSA-N D0K7KM DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)C3=CC=CC=C3 D0K7KM HIGHSTAT Investigative D0K7LF DRUG__ID D0K7LF D0K7LF DRUGTYPE Small molecular drug D0K7LF DRUGINCH 1S/C16H36N/c1-5-9-13-17(14-10-6-2,15-11-7-3)16-12-8-4/h5-16H2,1-4H3/q+1 D0K7LF DRUGINKE DZLFLBLQUQXARW-UHFFFAOYSA-N D0K7LF DRUGSMIL CCCC[N+](CCCC)(CCCC)CCCC D0K7LF HIGHSTAT Investigative D0K7LZ DRUG__ID D0K7LZ D0K7LZ DRUGTYPE Small molecular drug D0K7LZ DRUGINCH 1S/C25H19NO4/c27-21-15-23(26-11-13-28-14-12-26)30-25-19(8-4-9-20(21)25)18-7-3-6-17-16-5-1-2-10-22(16)29-24(17)18/h1-10,15H,11-14H2 D0K7LZ DRUGINKE LEWYWLXLBNVBFP-UHFFFAOYSA-N D0K7LZ DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4OC6=CC=CC=C56 D0K7LZ HIGHSTAT Investigative D0K7PS DRUG__ID D0K7PS D0K7PS DRUGTYPE Small molecular drug D0K7PS DRUGINCH 1S/C13H9BrClNO4S/c14-8-1-6-12(11(7-8)13(17)18)16-21(19,20)10-4-2-9(15)3-5-10/h1-7,16H,(H,17,18) D0K7PS DRUGINKE JDVLYAYDIMUAAC-UHFFFAOYSA-N D0K7PS DRUGSMIL C1=CC(=CC=C1S(=O)(=O)NC2=C(C=C(C=C2)Br)C(=O)O)Cl D0K7PS HIGHSTAT Investigative D0K7QP DRUG__ID D0K7QP D0K7QP DRUGTYPE Small molecular drug D0K7QP DRUGINCH 1S/C19H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)20-17-16-18(17)21/h17-18,21H,2-16H2,1H3,(H,20,22)/t17-,18-/m0/s1 D0K7QP DRUGINKE LIBNBUULGCFJNR-ROUUACIJSA-N D0K7QP DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC1CC1O D0K7QP HIGHSTAT Investigative D0K7QR DRUG__ID D0K7QR D0K7QR DRUGTYPE Small molecular drug D0K7QR DRUGINCH 1S/C23H23N5O6/c29-23(26-30)5-3-1-2-4-16(19-12-24-21-8-6-14(27(31)32)10-17(19)21)20-13-25-22-9-7-15(28(33)34)11-18(20)22/h6-13,16,24-25,30H,1-5H2,(H,26,29) D0K7QR DRUGINKE VSVDNXSUROYWOP-UHFFFAOYSA-N D0K7QR DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C(=CN2)C(CCCCCC(=O)NO)C3=CNC4=C3C=C(C=C4)[N+](=O)[O-] D0K7QR HIGHSTAT Investigative D0K7RO DRUG__ID D0K7RO D0K7RO DRUGTYPE Small molecular drug D0K7RO DRUGINCH 1S/C22H31N3O2/c1-2-3-4-5-10-21(25-13-15-27-16-14-25)22(26,19-8-6-11-23-17-19)20-9-7-12-24-18-20/h6-9,11-12,17-18,21,26H,2-5,10,13-16H2,1H3 D0K7RO DRUGINKE PUFFDHPIZWKLSX-UHFFFAOYSA-N D0K7RO DRUGSMIL CCCCCCC(C(C1=CN=CC=C1)(C2=CN=CC=C2)O)N3CCOCC3 D0K7RO HIGHSTAT Investigative D0K7SU DRUG__ID D0K7SU D0K7SU DRUGTYPE Small molecular drug D0K7SU DRUGINCH 1S/C23H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24-22(2)23(25)26/h7-8,10-11,13-14,16-17,22,24H,3-6,9,12,15,18-21H2,1-2H3,(H,25,26)/b8-7-,11-10-,14-13-,17-16-/t22-/m1/s1 D0K7SU DRUGINKE ZMBYGVKXTACGHR-FQPARAGTSA-N D0K7SU DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCNC(C)C(=O)O D0K7SU HIGHSTAT Investigative D0K7UL DRUG__ID D0K7UL D0K7UL DRUGCOMP Shinogi & Co Ltd D0K7UL DRUGINCH 1S/C4H4O2/c1-2-3-4(5)6/h1H3,(H,5,6) D0K7UL DRUGINKE LUEHNHVFDCZTGL-UHFFFAOYSA-N D0K7UL DRUGSMIL CC#CC(=O)O D0K7UL HIGHSTAT Investigative D0K7WW DRUG__ID D0K7WW D0K7WW DRUGTYPE Small molecular drug D0K7WW DRUGINCH 1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8+,9-,10+,11-,12-,13-,14-/m1/s1 D0K7WW DRUGINKE HSCJRCZFDFQWRP-ABVWGUQPSA-N D0K7WW DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O D0K7WW HIGHSTAT Investigative D0K7XM DRUG__ID D0K7XM D0K7XM DRUGTYPE Small molecular drug D0K7XM DRUGINCH 1S/C15H24Br2N2O/c1-18(2)7-5-9-20-15-13(16)10-12(11-14(15)17)6-8-19(3)4/h10-11H,5-9H2,1-4H3 D0K7XM DRUGINKE LWENJEAGCYZOBC-UHFFFAOYSA-N D0K7XM DRUGSMIL CN(C)CCCOC1=C(C=C(C=C1Br)CCN(C)C)Br D0K7XM HIGHSTAT Investigative D0K7XQ DRUG__ID D0K7XQ D0K7XQ DRUGTYPE Small molecular drug D0K7XQ DRUGINCH 1S/C13H20N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)15(17)13(14)16/h4-7,9-10,17H,8H2,1-3H3,(H2,14,16) D0K7XQ DRUGINKE FBLDKAJQWYMCKR-UHFFFAOYSA-N D0K7XQ DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)N(C(=O)N)O D0K7XQ HIGHSTAT Investigative D0K7XU DRUG__ID D0K7XU D0K7XU DRUGTYPE Small molecular drug D0K7XU DRUGINCH 1S/C17H13NO2/c19-17(18-20)14-8-5-13(6-9-14)16-10-7-12-3-1-2-4-15(12)11-16/h1-11,20H,(H,18,19) D0K7XU DRUGINKE CYVBBSVZKCLSIR-UHFFFAOYSA-N D0K7XU DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC=C(C=C3)C(=O)NO D0K7XU HIGHSTAT Investigative D0K7YL DRUG__ID D0K7YL D0K7YL DRUGTYPE Small molecular drug D0K7YL DRUGINCH 1S/C21H17N3O/c22-21(23)14-9-10-18-15(11-14)12-19(24-18)17-8-4-7-16(20(17)25)13-5-2-1-3-6-13/h1-12,24-25H,(H3,22,23) D0K7YL DRUGINKE GAVRMVQHHVMXFD-UHFFFAOYSA-N D0K7YL DRUGSMIL C1=CC=C(C=C1)C2=C(C(=CC=C2)C3=CC4=C(N3)C=CC(=C4)C(=N)N)O D0K7YL HIGHSTAT Investigative D0K8AU DRUG__ID D0K8AU D0K8AU DRUGTYPE Small molecular drug D0K8AU DRUGINCH 1S/C16H20N4O/c1-2-4-14(5-3-1)6-8-17-15-7-9-18-16(19-15)20-10-12-21-13-11-20/h1-5,7,9H,6,8,10-13H2,(H,17,18,19) D0K8AU DRUGINKE QCZVHPUPIBZBLH-UHFFFAOYSA-N D0K8AU DRUGSMIL C1COCCN1C2=NC=CC(=N2)NCCC3=CC=CC=C3 D0K8AU HIGHSTAT Investigative D0K8BT DRUG__ID D0K8BT D0K8BT DRUGTYPE Small molecular drug D0K8BT DRUGINCH 1S/C15H17NO6/c1-16-15(18)22-11-8-20-12-10(7-19-13(11)12)21-14(17)9-5-3-2-4-6-9/h2-6,10-13H,7-8H2,1H3,(H,16,18)/t10-,11+,12-,13-/m1/s1 D0K8BT DRUGINKE XVQSZSYQBPAKTI-YVECIDJPSA-N D0K8BT DRUGSMIL CNC(=O)OC1COC2C1OCC2OC(=O)C3=CC=CC=C3 D0K8BT HIGHSTAT Investigative D0K8BZ DRUG__ID D0K8BZ D0K8BZ DRUGTYPE Small molecular drug D0K8BZ DRUGINCH 1S/C23H18N2O3S/c26-23(17-9-3-1-4-10-17)24-21-15-16-22(20-14-8-7-13-19(20)21)29(27,28)25-18-11-5-2-6-12-18/h1-16,25H,(H,24,26) D0K8BZ DRUGINKE WLKYPFNFQJMVGH-UHFFFAOYSA-N D0K8BZ DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=C(C3=CC=CC=C32)S(=O)(=O)NC4=CC=CC=C4 D0K8BZ HIGHSTAT Investigative D0K8DH DRUG__ID D0K8DH D0K8DH DRUGTYPE Small molecular drug D0K8DH DRUGINCH 1S/C21H24N2/c1-2-3-4-8-11-21-22-16-20(23-21)19-14-12-18(13-15-19)17-9-6-5-7-10-17/h5-7,9-10,12-16H,2-4,8,11H2,1H3,(H,22,23) D0K8DH DRUGINKE LLLKBKRUIUYVOU-UHFFFAOYSA-N D0K8DH DRUGSMIL CCCCCCC1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3 D0K8DH HIGHSTAT Investigative D0K8DY DRUG__ID D0K8DY D0K8DY DRUGTYPE Small molecular drug D0K8DY DRUGINCH 1S/C22H21N/c1-2-8-17(9-3-1)15-23-16-22-20-12-6-4-10-18(20)14-19-11-5-7-13-21(19)22/h1-13,22-23H,14-16H2 D0K8DY DRUGINKE PJLWLZAKVLPHRL-UHFFFAOYSA-N D0K8DY DRUGSMIL C1C2=CC=CC=C2C(C3=CC=CC=C31)CNCC4=CC=CC=C4 D0K8DY HIGHSTAT Investigative D0K8DZ DRUG__ID D0K8DZ D0K8DZ DRUGTYPE Small molecular drug D0K8DZ DRUGINCH 1S/C10H19N3/c1-13(2)7-5-3-4-6-10-8-11-9-12-10/h8-9H,3-7H2,1-2H3,(H,11,12) D0K8DZ DRUGINKE MVHBNHUOEFGIBK-UHFFFAOYSA-N D0K8DZ DRUGSMIL CN(C)CCCCCC1=CN=CN1 D0K8DZ HIGHSTAT Investigative D0K8ED DRUG__ID D0K8ED D0K8ED DRUGTYPE Small molecular drug D0K8ED DRUGINCH 1S/C15H17NO5/c17-13(18)9-16(10-5-1-2-6-10)14(19)11-7-3-4-8-12(11)15(20)21/h3-4,7-8,10H,1-2,5-6,9H2,(H,17,18)(H,20,21) D0K8ED DRUGINKE KOAQPWKIMYZORZ-UHFFFAOYSA-N D0K8ED DRUGSMIL C1CCC(C1)N(CC(=O)O)C(=O)C2=CC=CC=C2C(=O)O D0K8ED HIGHSTAT Investigative D0K8EE DRUG__ID D0K8EE D0K8EE DRUGTYPE Small molecular drug D0K8EE DRUGINCH 1S/C15H9FO2/c16-11-6-7-12-13(17)9-14(18-15(12)8-11)10-4-2-1-3-5-10/h1-9H D0K8EE DRUGINKE ZEYRNYUCQATYPC-UHFFFAOYSA-N D0K8EE DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)F D0K8EE HIGHSTAT Investigative D0K8EZ DRUG__ID D0K8EZ D0K8EZ DRUGTYPE Small molecular drug D0K8EZ DRUGINCH 1S/C13H9FN2S/c14-9-3-1-4-10(7-9)17-13-6-2-5-12(16)11(13)8-15/h1-7H,16H2 D0K8EZ DRUGINKE ZJXCBXBCZFLMTP-UHFFFAOYSA-N D0K8EZ DRUGSMIL C1=CC(=CC(=C1)SC2=CC=CC(=C2C#N)N)F D0K8EZ HIGHSTAT Investigative D0K8LN DRUG__ID D0K8LN D0K8LN DRUGTYPE Small molecular drug D0K8LN DRUGINCH 1S/C18H19ClO2S/c19-16-9-11-17(12-10-16)22(20,21)18(13-5-2-6-14-18)15-7-3-1-4-8-15/h1,3-4,7-12H,2,5-6,13-14H2 D0K8LN DRUGINKE XMYNJSLMUBGZIQ-UHFFFAOYSA-N D0K8LN DRUGSMIL C1CCC(CC1)(C2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)Cl D0K8LN HIGHSTAT Investigative D0K8MF DRUG__ID D0K8MF D0K8MF DRUGTYPE Small molecular drug D0K8MF DRUGINCH 1S/C14H19NO4/c1-19-12-9-7-11(8-10-12)13(16)5-3-2-4-6-14(17)15-18/h7-10,18H,2-6H2,1H3,(H,15,17) D0K8MF DRUGINKE NIGGAQZXTHMKPL-UHFFFAOYSA-N D0K8MF DRUGSMIL COC1=CC=C(C=C1)C(=O)CCCCCC(=O)NO D0K8MF HIGHSTAT Investigative D0K8MN DRUG__ID D0K8MN D0K8MN DRUGTYPE Small molecular drug D0K8MN DRUGINCH 1S/C18H20N4/c1-14(2)13-22-20-18(19-21-22)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14H,12-13H2,1-2H3 D0K8MN DRUGINKE PPXBPBABGOMYLY-UHFFFAOYSA-N D0K8MN DRUGSMIL CC(C)CN1N=C(N=N1)CC2=CC=C(C=C2)C3=CC=CC=C3 D0K8MN HIGHSTAT Investigative D0K8NO DRUG__ID D0K8NO D0K8NO DRUGTYPE Small molecular drug D0K8NO DRUGINCH 1S/C16H14ClFN2O4/c17-10-2-4-12(14(5-10)24-8-15(21)22)16(23)20-7-9-1-3-11(19)6-13(9)18/h1-6H,7-8,19H2,(H,20,23)(H,21,22) D0K8NO DRUGINKE GFJYPJDGRCZNDI-UHFFFAOYSA-N D0K8NO DRUGSMIL C1=CC(=C(C=C1N)F)CNC(=O)C2=C(C=C(C=C2)Cl)OCC(=O)O D0K8NO HIGHSTAT Investigative D0K8PH DRUG__ID D0K8PH D0K8PH DRUGCOMP Suven Life Sciences Ltd D0K8PH DRUGINCH 1S/C18H18BrFN2O3S/c1-21(2)9-10-25-18-12-22(17-8-3-13(19)11-16(17)18)26(23,24)15-6-4-14(20)5-7-15/h3-8,11-12H,9-10H2,1-2H3 D0K8PH DRUGINKE GTFCQLBBMSYCFM-UHFFFAOYSA-N D0K8PH DRUGSMIL CN(C)CCOC1=CN(C2=C1C=C(C=C2)Br)S(=O)(=O)C3=CC=C(C=C3)F D0K8PH HIGHSTAT Investigative D0K8QD DRUG__ID D0K8QD D0K8QD DRUGTYPE Small molecular drug D0K8QD DRUGINCH 1S/C22H20O2/c1-2-21(16-6-4-3-5-7-16)22(17-8-12-19(23)13-9-17)18-10-14-20(24)15-11-18/h3-15,23-24H,2H2,1H3 D0K8QD DRUGINKE BPKSDMHGDYTXLI-UHFFFAOYSA-N D0K8QD DRUGSMIL CCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=CC=C3 D0K8QD HIGHSTAT Investigative D0K8RK DRUG__ID D0K8RK D0K8RK DRUGCOMP Novartis pharmaceuticals D0K8RK THERCLAS Antiviral Agents D0K8RK DRUGTYPE Protein/peptide drug D0K8RK DRUGSMIL CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C D0K8RK HIGHSTAT Investigative D0K8SK DRUG__ID D0K8SK D0K8SK DRUGTYPE Small molecular drug D0K8SK DRUGINCH 1S/C10H12N2O/c1-13-9-4-2-8(3-5-9)10-11-6-7-12-10/h2-5H,6-7H2,1H3,(H,11,12) D0K8SK DRUGINKE LPRQSQCAHSRGRZ-UHFFFAOYSA-N D0K8SK DRUGSMIL COC1=CC=C(C=C1)C2=NCCN2 D0K8SK HIGHSTAT Investigative D0K8VA DRUG__ID D0K8VA D0K8VA DRUGTYPE Small molecular drug D0K8VA DRUGINCH 1S/C32H54O4/c1-22-25(20-26(33)21-29(22)34)14-13-24-12-9-19-32(6)27(15-16-28(24)32)23(10-7-17-30(2,3)35)11-8-18-31(4,5)36/h13-14,23,26-29,33-36H,1,7-12,15-21H2,2-6H3/b24-13+,25-14-/t26-,27-,28+,29+,32-/m1/s1 D0K8VA DRUGINKE WTQXZYVWLNPNEX-LKUPKUSPSA-N D0K8VA DRUGSMIL CC12CCCC(=CC=C3CC(CC(C3=C)O)O)C1CCC2C(CCCC(C)(C)O)CCCC(C)(C)O D0K8VA HIGHSTAT Investigative D0K8VL DRUG__ID D0K8VL D0K8VL DRUGTYPE Small molecular drug D0K8VL DRUGINCH 1S/C25H29NO4/c1-25-9-8-20-19-7-5-17(27)11-15(19)4-6-21(20)22(25)12-16(24(25)29)13-23(28)26-14-18-3-2-10-30-18/h2-3,5,7,10-11,16,20-22,27H,4,6,8-9,12-14H2,1H3,(H,26,28)/t16?,20?,21?,22?,25-/m0/s1 D0K8VL DRUGINKE NSHKXWHQUTUXRS-HIUOCNRYSA-N D0K8VL DRUGSMIL CC12CCC3C(C1CC(C2=O)CC(=O)NCC4=CC=CO4)CCC5=C3C=CC(=C5)O D0K8VL HIGHSTAT Investigative D0K8VR DRUG__ID D0K8VR D0K8VR DRUGTYPE Small molecular drug D0K8VR DRUGINCH 1S/C25H40O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h14-15,17,19-20,26-27H,6-13,16H2,1-5H3/t17-,19-,20-/m1/s1/i10T,17T/t10?,17-,19-,20- D0K8VR DRUGINKE MVEVPDCVOXJVBD-AENGYHINSA-N D0K8VR DRUGSMIL CCCCCCC(C)(C)C1=CC(=C2C3CC(CCC3C(OC2=C1)(C)C)CO)O D0K8VR HIGHSTAT Investigative D0K8XC DRUG__ID D0K8XC D0K8XC DRUGTYPE Small molecular drug D0K8XC DRUGINCH 1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11-,12+/m1/s1 D0K8XC DRUGINKE GUBGYTABKSRVRQ-DCSYEGIMSA-N D0K8XC DRUGSMIL C(C1C(C(C(C(O1)OC2C(OC(C(C2O)O)O)CO)O)O)O)O D0K8XC HIGHSTAT Investigative D0K8YD DRUG__ID D0K8YD D0K8YD DRUGTYPE Small molecular drug D0K8YD DRUGINCH 1S/C27H19F4N5O/c28-23-8-7-18(27(29,30)31)12-24(23)36-26(37)35-20-6-2-4-16(10-20)22-14-34-25-21(22)11-17(13-33-25)15-3-1-5-19(32)9-15/h1-14H,32H2,(H,33,34)(H2,35,36,37) D0K8YD DRUGINKE QQTPMHCXBYRWFQ-UHFFFAOYSA-N D0K8YD DRUGSMIL C1=CC(=CC(=C1)N)C2=CC3=C(NC=C3C4=CC(=CC=C4)NC(=O)NC5=C(C=CC(=C5)C(F)(F)F)F)N=C2 D0K8YD HIGHSTAT Investigative D0K8ZW DRUG__ID D0K8ZW D0K8ZW DRUGTYPE Small molecular drug D0K8ZW DRUGINCH 1S/C10H12N4O2/c15-9-7-8(12-5-11-7)13-10(16)14(9)6-3-1-2-4-6/h5-6H,1-4H2,(H,11,12)(H,13,16) D0K8ZW DRUGINKE IBCDFVYWAHQNAA-UHFFFAOYSA-N D0K8ZW DRUGSMIL C1CCC(C1)N2C(=O)C3=C(NC2=O)N=CN3 D0K8ZW HIGHSTAT Investigative D0K8ZZ DRUG__ID D0K8ZZ D0K8ZZ DRUGTYPE Small molecular drug D0K8ZZ DRUGINCH 1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1 D0K8ZZ DRUGINKE JADDQZYHOWSFJD-FLNNQWSLSA-N D0K8ZZ DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0K8ZZ HIGHSTAT Investigative D0K9BF DRUG__ID D0K9BF D0K9BF DRUGTYPE Small molecular drug D0K9BF DRUGINCH 1S/C43H56N6O14S/c1-24(50)44-31(22-35(55)56)41(60)45-29(18-20-34(53)54)39(58)49-37(36(26-13-7-3-8-14-26)27-15-9-4-10-16-27)42(61)46-28(17-19-33(51)52)38(57)47-30(21-25-11-5-2-6-12-25)40(59)48-32(23-64)43(62)63/h3-4,7-10,13-16,25,28-32,36-37,64H,2,5-6,11-12,17-23H2,1H3,(H,44,50)(H,45,60)(H,46,61)(H,47,57)(H,48,59)(H,49,58)(H,51,52)(H,53,54)(H,55,56)(H,62,63)/t28-,29-,30-,31-,32-,37-/m0/s1 D0K9BF DRUGINKE UJAUCRPOZPWCGV-XJJOYFJPSA-N D0K9BF DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C1=CC=CC=C1)C2=CC=CC=C2)C(=O)NC(CCC(=O)O)C(=O)NC(CC3CCCCC3)C(=O)NC(CS)C(=O)O D0K9BF HIGHSTAT Investigative D0K9GC DRUG__ID D0K9GC D0K9GC DRUGTYPE Small molecular drug D0K9GC DRUGINCH 1S/C19H14N2O4/c22-18(21-17-7-2-1-6-16(17)19(23)24)13-4-3-5-15(12-13)25-14-8-10-20-11-9-14/h1-12H,(H,21,22)(H,23,24) D0K9GC DRUGINKE YATZGUOENCNURV-UHFFFAOYSA-N D0K9GC DRUGSMIL C1=CC=C(C(=C1)C(=O)O)NC(=O)C2=CC(=CC=C2)OC3=CC=NC=C3 D0K9GC HIGHSTAT Investigative D0K9GG DRUG__ID D0K9GG D0K9GG DRUGTYPE Small molecular drug D0K9GG DRUGINCH 1S/C27H29IN2/c28-24-14-8-7-13-23(24)19-29-26-22-15-17-30(18-16-22)27(26)25(20-9-3-1-4-10-20)21-11-5-2-6-12-21/h1-14,22,25-27,29H,15-19H2/t26-,27-/m1/s1 D0K9GG DRUGINKE WSLTYZVXORBNLB-KAYWLYCHSA-N D0K9GG DRUGSMIL C1CN2CCC1C(C2C(C3=CC=CC=C3)C4=CC=CC=C4)NCC5=CC=CC=C5I D0K9GG HIGHSTAT Investigative D0K9HE DRUG__ID D0K9HE D0K9HE DRUGTYPE Small molecular drug D0K9HE DRUGINCH 1S/C40H43N3O6.2ClH/c44-25-7-5-21-13-27-39(46)15-23-24-16-40(47)28-14-22-6-8-26(45)34-30(22)38(40,10-12-43(28)18-20-3-4-20)36(49-34)32(24)41-31(23)35-37(39,29(21)33(25)48-35)9-11-42(27)17-19-1-2-19;;/h5-8,19-20,27-28,35-36,41,44-47H,1-4,9-18H2;2*1H/t27-,28-,35+,36+,37+,38+,39-,40-;;/m1../s1 D0K9HE DRUGINKE JOJPJLHRMGPDPV-LZQROVCBSA-N D0K9HE DRUGSMIL C1CC1CN2CCC34C5C6=C(CC3(C2CC7=C4C(=C(C=C7)O)O5)O)C8=C(N6)C9C12CCN(C(C1(C8)O)CC1=C2C(=C(C=C1)O)O9)CC1CC1.Cl.Cl D0K9HE HIGHSTAT Investigative D0K9HO DRUG__ID D0K9HO D0K9HO DRUGTYPE Small molecular drug D0K9HO DRUGINCH 1S/C24H35NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22-25-23(26)20-21-24(25)27/h6-7,9-10,12-13,15-16,20-21H,2-5,8,11,14,17-19,22H2,1H3/b7-6-,10-9-,13-12-,16-15- D0K9HO DRUGINKE GZNZRHSGGQUYAP-DOFZRALJSA-N D0K9HO DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCN1C(=O)C=CC1=O D0K9HO HIGHSTAT Investigative D0K9KJ DRUG__ID D0K9KJ D0K9KJ DRUGTYPE Small molecular drug D0K9KJ DRUGINCH 1S/C21H25ClN6/c22-17-8-6-16(7-9-17)19(20-5-1-2-11-25-20)10-13-27-21(23)26-12-3-4-18-14-24-15-28-18/h1-2,5-9,11,14-15,19H,3-4,10,12-13H2,(H,24,28)(H3,23,26,27) D0K9KJ DRUGINKE ZOROCGHIPADEFK-UHFFFAOYSA-N D0K9KJ DRUGSMIL C1=CC=NC(=C1)C(CCNC(=NCCCC2=CN=CN2)N)C3=CC=C(C=C3)Cl D0K9KJ HIGHSTAT Investigative D0K9KQ DRUG__ID D0K9KQ D0K9KQ DRUGTYPE Small molecular drug D0K9KQ DRUGINCH 1S/C30H43N11O5/c1-17-25(43)37-16-24(42)39-23(15-18-10-11-19-6-2-3-7-20(19)14-18)28(46)41-22(9-5-13-36-30(33)34)27(45)40-21(26(44)38-17)8-4-12-35-29(31)32/h2-3,6-7,10-11,14,17,21-23H,4-5,8-9,12-13,15-16H2,1H3,(H,37,43)(H,38,44)(H,39,42)(H,40,45)(H,41,46)(H4,31,32,35)(H4,33,34,36)/t17-,21-,22+,23+/m1/s1 D0K9KQ DRUGINKE SSVKJORMBVSSPN-DZWOVHDNSA-N D0K9KQ DRUGSMIL CC1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2 D0K9KQ HIGHSTAT Investigative D0K9KZ DRUG__ID D0K9KZ D0K9KZ DRUGTYPE Small molecular drug D0K9KZ DRUGINCH 1S/C20H24Cl2O4/c1-2-3-8-20(13-6-4-5-7-13)10-12-9-14(26-11-15(23)24)17(21)18(22)16(12)19(20)25/h9,13H,2-8,10-11H2,1H3,(H,23,24) D0K9KZ DRUGINKE YAWWQIFONIPBKT-UHFFFAOYSA-N D0K9KZ DRUGSMIL CCCCC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3CCCC3 D0K9KZ HIGHSTAT Investigative D0K9LT DRUG__ID D0K9LT D0K9LT DRUGTYPE Small molecular drug D0K9LT DRUGINCH 1S/C16H20N2O2/c1-2-3-4-5-6-13-7-8-15(14(19)11-13)20-16-12-17-9-10-18-16/h7-12,19H,2-6H2,1H3 D0K9LT DRUGINKE DIBZNKWLKFDWAC-UHFFFAOYSA-N D0K9LT DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=NC=CN=C2)O D0K9LT HIGHSTAT Investigative D0K9LV DRUG__ID D0K9LV D0K9LV DRUGTYPE Small molecular drug D0K9LV DRUGINCH 1S/C16H20N2O2/c1-2-3-4-5-7-13-8-9-15(14(19)12-13)20-16-17-10-6-11-18-16/h6,8-12,19H,2-5,7H2,1H3 D0K9LV DRUGINKE CWDKJRBSXCNZHS-UHFFFAOYSA-N D0K9LV DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=NC=CC=N2)O D0K9LV HIGHSTAT Investigative D0K9MT DRUG__ID D0K9MT D0K9MT DRUGTYPE Small molecular drug D0K9MT DRUGINCH 1S/C17H24N2/c1-13(2)14-5-6-17-16(11-14)15(12-18-17)7-10-19-8-3-4-9-19/h5-6,11-13,18H,3-4,7-10H2,1-2H3 D0K9MT DRUGINKE BCHGFZYQLYUXBO-UHFFFAOYSA-N D0K9MT DRUGSMIL CC(C)C1=CC2=C(C=C1)NC=C2CCN3CCCC3 D0K9MT HIGHSTAT Investigative D0K9NK DRUG__ID D0K9NK D0K9NK DRUGTYPE Small molecular drug D0K9NK DRUGINCH 1S/C26H31ClN4O3/c1-2-21-6-3-4-14-30(21)15-5-13-28-24(32)19-9-12-22-23(16-19)29-26(34)31(25(22)33)17-18-7-10-20(27)11-8-18/h7-12,16,21H,2-6,13-15,17H2,1H3,(H,28,32)(H,29,34) D0K9NK DRUGINKE PRICKWSOIKQPFF-UHFFFAOYSA-N D0K9NK DRUGSMIL CCC1CCCCN1CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl D0K9NK HIGHSTAT Investigative D0K9NW DRUG__ID D0K9NW D0K9NW DRUGTYPE Small molecular drug D0K9NW DRUGINCH 1S/C18H16N2/c1-2-6-15-13-20(12-10-14(15)5-1)18-9-11-19-17-8-4-3-7-16(17)18/h1-9,11H,10,12-13H2 D0K9NW DRUGINKE HRDFYQVITWAQGZ-UHFFFAOYSA-N D0K9NW DRUGSMIL C1CN(CC2=CC=CC=C21)C3=CC=NC4=CC=CC=C43 D0K9NW HIGHSTAT Investigative D0K9OK DRUG__ID D0K9OK D0K9OK DRUGTYPE Small molecular drug D0K9OK DRUGINCH 1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15-/m0/s1 D0K9OK DRUGINKE ZPUCINDJVBIVPJ-XGUBFFRZSA-N D0K9OK DRUGSMIL CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC D0K9OK HIGHSTAT Investigative D0K9ON DRUG__ID D0K9ON D0K9ON DRUGTYPE Small molecular drug D0K9ON DRUGINCH 1S/C19H25NO2/c1-21-18-11-16-10-15(9-8-14-6-4-3-5-7-14)13-20-17(16)12-19(18)22-2/h10-14H,3-9H2,1-2H3 D0K9ON DRUGINKE HLKSYKUFDFBKPC-UHFFFAOYSA-N D0K9ON DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)CCC3CCCCC3 D0K9ON HIGHSTAT Investigative D0K9UN DRUG__ID D0K9UN D0K9UN DRUGTYPE Small molecular drug D0K9UN DRUGINCH 1S/C15H12N2O/c18-15(16-12-7-2-1-3-8-12)14-10-11-6-4-5-9-13(11)17-14/h1-10,17H,(H,16,18) D0K9UN DRUGINKE ARBMSJKZZZWLOE-UHFFFAOYSA-N D0K9UN DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3N2 D0K9UN HIGHSTAT Investigative D0K9VE DRUG__ID D0K9VE D0K9VE DRUGTYPE Small molecular drug D0K9VE DRUGINCH 1S/C14H10N2O2/c17-11-6-13-12(14(18)7-11)5-10(8-16-13)9-1-3-15-4-2-9/h1-8,17-18H D0K9VE DRUGINKE QYWQBBCHWNMFSG-UHFFFAOYSA-N D0K9VE DRUGSMIL C1=CN=CC=C1C2=CC3=C(C=C(C=C3O)O)N=C2 D0K9VE HIGHSTAT Investigative D0K9WJ DRUG__ID D0K9WJ D0K9WJ DRUGTYPE Small molecular drug D0K9WJ DRUGINCH 1S/C16H19N3/c1-2-4-15-13(3-1)5-8-16(17-15)19-11-9-18(10-12-19)14-6-7-14/h1-5,8,14H,6-7,9-12H2 D0K9WJ DRUGINKE HOMYCGKCEABFJF-UHFFFAOYSA-N D0K9WJ DRUGSMIL C1CC1N2CCN(CC2)C3=NC4=CC=CC=C4C=C3 D0K9WJ HIGHSTAT Investigative D0K9XV DRUG__ID D0K9XV D0K9XV DRUGTYPE Small molecular drug D0K9XV DRUGINCH 1S/C17H17FN2O3/c18-14-8-6-13(7-9-14)11-19-16(21)15(17(22)20-23)10-12-4-2-1-3-5-12/h1-9,15,23H,10-11H2,(H,19,21)(H,20,22) D0K9XV DRUGINKE HPODXRZHNDBMJC-UHFFFAOYSA-N D0K9XV DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC2=CC=C(C=C2)F)C(=O)NO D0K9XV HIGHSTAT Investigative D0K9YS DRUG__ID D0K9YS D0K9YS DRUGTYPE Small molecular drug D0K9YS DRUGINCH 1S/C28H37NO4/c1-26(2)11-12-28(33-25(26)30)10-8-23-21-6-5-18-16-24(32-14-13-31-4)19(17-29)15-22(18)20(21)7-9-27(23,28)3/h15-16,20-21,23H,5-14H2,1-4H3/t20-,21+,23-,27-,28+/m0/s1 D0K9YS DRUGINKE DBERIEFIHOJVNL-NOPJHZOQSA-N D0K9YS DRUGSMIL CC1(CCC2(CCC3C2(CCC4C3CCC5=CC(=C(C=C45)C#N)OCCOC)C)OC1=O)C D0K9YS HIGHSTAT Investigative D0KA4R DRUG__ID D0KA4R D0KA4R DRUGCOMP Neuren Pharmaceuticals Ltd D0KA4R DRUGINCH 1S/C10H14N2O2/c1-2-4-10-5-3-6-12(10)8(13)7-11-9(10)14/h2H,1,3-7H2,(H,11,14)/t10-/m0/s1 D0KA4R DRUGINKE WVKCGUOWPZAROG-JTQLQIEISA-N D0KA4R DRUGSMIL C=CCC12CCCN1C(=O)CNC2=O D0KA4R HIGHSTAT Investigative D0KB2R DRUG__ID D0KB2R D0KB2R DRUGTYPE Small molecular drug D0KB2R DRUGINCH 1S/C16H16N2/c1-18-15(11-13-7-5-6-10-16(13)18)12-17-14-8-3-2-4-9-14/h2-11,17H,12H2,1H3 D0KB2R DRUGINKE HTRZQOWAQJHGBR-UHFFFAOYSA-N D0KB2R DRUGSMIL CN1C2=CC=CC=C2C=C1CNC3=CC=CC=C3 D0KB2R HIGHSTAT Investigative D0KB6Q DRUG__ID D0KB6Q D0KB6Q DRUGTYPE Small molecular drug D0KB6Q DRUGINCH 1S/C12H11NO2/c14-12(13-15)8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7,15H,8H2,(H,13,14) D0KB6Q DRUGINKE IYXUERDUKOVYLR-UHFFFAOYSA-N D0KB6Q DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC(=O)NO D0KB6Q HIGHSTAT Investigative D0KB6T DRUG__ID D0KB6T D0KB6T DRUGTYPE Small molecular drug D0KB6T DRUGINCH 1S/C13H12N2O3S/c14-19(17,18)12-8-6-11(7-9-12)15-13(16)10-4-2-1-3-5-10/h1-9H,(H,15,16)(H2,14,17,18) D0KB6T DRUGINKE VGYAUYNBRQPION-UHFFFAOYSA-N D0KB6T DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)N D0KB6T HIGHSTAT Investigative D0KB8D DRUG__ID D0KB8D D0KB8D DRUGTYPE Small molecular drug D0KB8D DRUGINCH 1S/C15H17N3O3/c1-3-10(2)21-15-16-9-8-13(18-15)17-12-7-5-4-6-11(12)14(19)20/h4-10H,3H2,1-2H3,(H,19,20)(H,16,17,18) D0KB8D DRUGINKE XCPPZXZCQFKXQJ-UHFFFAOYSA-N D0KB8D DRUGSMIL CCC(C)OC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O D0KB8D HIGHSTAT Investigative D0KC2Z DRUG__ID D0KC2Z D0KC2Z DRUGTYPE Small molecular drug D0KC2Z DRUGINCH 1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/t7-,8-,10-,11-,12-,13-,14-,15-,16-/m1/s1 D0KC2Z DRUGINKE LFTYTUAZOPRMMI-CFRASDGPSA-N D0KC2Z DRUGSMIL CC(=O)NC1C(C(C(OC1OP(=O)(O)OP(=O)(O)OCC2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)CO)O)O D0KC2Z HIGHSTAT Investigative D0KC9E DRUG__ID D0KC9E D0KC9E DRUGTYPE Small molecular drug D0KC9E DRUGINCH 1S/C18H23N5O/c1-12-6-3-4-7-14(12)8-5-9-15(13(2)24)23-11-22-16-17(19)20-10-21-18(16)23/h3-4,6-7,10-11,13,15,24H,5,8-9H2,1-2H3,(H2,19,20,21)/t13-,15+/m0/s1 D0KC9E DRUGINKE GLTLCSYYROAISP-DZGCQCFKSA-N D0KC9E DRUGSMIL CC1=CC=CC=C1CCCC(C(C)O)N2C=NC3=C(N=CN=C32)N D0KC9E HIGHSTAT Investigative D0KD6O DRUG__ID D0KD6O D0KD6O DRUGTYPE Small molecular drug D0KD6O DRUGINCH 1S/C11H14N2O4/c12-7(11(15)16)5-6-3-1-2-4-8-9(6)10(14)13-17-8/h3,7H,1-2,4-5,12H2,(H,13,14)(H,15,16)/t7-/m0/s1 D0KD6O DRUGINKE HJEPOXZLPHUVFE-ZETCQYMHSA-N D0KD6O DRUGSMIL C1CC=C(C2=C(C1)ONC2=O)CC(C(=O)O)N D0KD6O HIGHSTAT Investigative D0KD6S DRUG__ID D0KD6S D0KD6S DRUGTYPE Small molecular drug D0KD6S DRUGINCH 1S/C31H35N5O/c1-34-29(37)26-28(36-21-31(33-30(34)36)18-8-9-19-31)32-27(35(26)20-22-10-4-2-5-11-22)25-16-14-24(15-17-25)23-12-6-3-7-13-23/h2,4-5,10-11,14-17,23H,3,6-9,12-13,18-21H2,1H3 D0KD6S DRUGINKE COWBACSJPXQWNS-UHFFFAOYSA-N D0KD6S DRUGSMIL CN1C(=O)C2=C(N=C(N2CC3=CC=CC=C3)C4=CC=C(C=C4)C5CCCCC5)N6C1=NC7(C6)CCCC7 D0KD6S HIGHSTAT Investigative D0KD8D DRUG__ID D0KD8D D0KD8D DRUGTYPE Small molecular drug D0KD8D DRUGINCH 1S/C19H23N2/c1-20(2)12-13-21-15-17(14-16-8-4-3-5-9-16)18-10-6-7-11-19(18)21/h3-11,15,17H,12-14H2,1-2H3/q+1 D0KD8D DRUGINKE CEOWUNUFGJBATQ-UHFFFAOYSA-N D0KD8D DRUGSMIL CN(C)CC[N+]1=CC(C2=CC=CC=C21)CC3=CC=CC=C3 D0KD8D HIGHSTAT Investigative D0KD9M DRUG__ID D0KD9M D0KD9M DRUGTYPE Small molecular drug D0KD9M DRUGINCH 1S/C16H16N2O/c17-9-12-1-2-15-8-16(4-3-14(15)7-12)19-11-13-5-6-18-10-13/h1-4,7-8,13,18H,5-6,10-11H2/t13-/m0/s1 D0KD9M DRUGINKE PYEILVKGQDUINV-ZDUSSCGKSA-N D0KD9M DRUGSMIL C1CNCC1COC2=CC3=C(C=C2)C=C(C=C3)C#N D0KD9M HIGHSTAT Investigative D0KE3I DRUG__ID D0KE3I D0KE3I DRUGTYPE Small molecular drug D0KE3I DRUGINCH 1S/C23H23NO2/c25-22(23-24-17-18-26-23)12-8-3-1-2-5-9-19-13-15-21(16-14-19)20-10-6-4-7-11-20/h4-7,9-11,13-18H,1-3,8,12H2/b9-5+ D0KE3I DRUGINKE AHIZRRNUFLYTPT-WEVVVXLNSA-N D0KE3I DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C=CCCCCCC(=O)C3=NC=CO3 D0KE3I HIGHSTAT Investigative D0KE3S DRUG__ID D0KE3S D0KE3S DRUGTYPE Small molecular drug D0KE3S DRUGINCH 1S/C21H41N5O12/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34)/t6-,7+,8-,9+,10+,11+,12-,13+,14+,15+,16+,17+,18+,20+,21-/m0/s1 D0KE3S DRUGINKE XEQLFNPSYWZPOW-HBYCGHPUSA-N D0KE3S DRUGSMIL C1C(C(C(C(C1NC(=O)C(CCN)O)O)OC2C(C(C(O2)CO)O)O)OC3C(C(C(C(O3)CN)O)O)N)N D0KE3S HIGHSTAT Investigative D0KE8R DRUG__ID D0KE8R D0KE8R DRUGTYPE Small molecular drug D0KE8R DRUGINCH 1S/C8H15NO5/c10-3-1-9-2-4(11)7(13)8(14)5(9)6(3)12/h3-8,10-14H,1-2H2/t3-,4+,5-,6-,7-,8-/m1/s1 D0KE8R DRUGINKE KSWHMQGAWBUNLD-XAZAIFFQSA-N D0KE8R DRUGSMIL C1C(C(C2N1CC(C(C2O)O)O)O)O D0KE8R HIGHSTAT Investigative D0KF0N DRUG__ID D0KF0N D0KF0N DRUGTYPE Small molecular drug D0KF0N DRUGINCH 1S/C12H9NO4S/c14-13(15)11-8-4-5-9-12(11)18(16,17)10-6-2-1-3-7-10/h1-9H D0KF0N DRUGINKE GKNMUCPEXSCGKC-UHFFFAOYSA-N D0KF0N DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CC=CC=C2[N+](=O)[O-] D0KF0N HIGHSTAT Investigative D0KF2P DRUG__ID D0KF2P D0KF2P DRUGTYPE Small molecular drug D0KF2P DRUGINCH 1S/C29H37N5O9/c1-3-41-27(39)29(13-8-14-29)43-23-19-22(31-34(23)20-9-6-5-7-10-20)25(37)30-21(11-12-24(35)36)26(38)32-15-17-33(18-16-32)28(40)42-4-2/h5-7,9-10,19,21H,3-4,8,11-18H2,1-2H3,(H,30,37)(H,35,36)/t21-/m0/s1 D0KF2P DRUGINKE HPSHQEAEJMOGDO-NRFANRHFSA-N D0KF2P DRUGSMIL CCOC(=O)C1(CCC1)OC2=CC(=NN2C3=CC=CC=C3)C(=O)NC(CCC(=O)O)C(=O)N4CCN(CC4)C(=O)OCC D0KF2P HIGHSTAT Investigative D0KF3N DRUG__ID D0KF3N D0KF3N DRUGTYPE Small molecular drug D0KF3N DRUGINCH 1S/C16H17NO2/c1-18-15-8-12-7-13(11-5-3-4-6-11)10-17-14(12)9-16(15)19-2/h5,7-10H,3-4,6H2,1-2H3 D0KF3N DRUGINKE DVMMSUYWABLYCR-UHFFFAOYSA-N D0KF3N DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CCCC3 D0KF3N HIGHSTAT Investigative D0KG0Z DRUG__ID D0KG0Z D0KG0Z DRUGTYPE Small molecular drug D0KG0Z DRUGINCH 1S/C19H11FO2/c20-14-6-3-5-13(10-14)18-11-17(21)16-9-8-12-4-1-2-7-15(12)19(16)22-18/h1-11H D0KG0Z DRUGINKE PJCRQJRMDLDKLR-UHFFFAOYSA-N D0KG0Z DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2OC(=CC3=O)C4=CC(=CC=C4)F D0KG0Z HIGHSTAT Investigative D0KG1D DRUG__ID D0KG1D D0KG1D DRUGTYPE Small molecular drug D0KG1D DRUGINCH 1S/C15H11NO2/c17-12-3-1-2-10(8-12)14-6-4-11-9-13(18)5-7-15(11)16-14/h1-9,17-18H D0KG1D DRUGINKE KVSLALXAPWSPAG-UHFFFAOYSA-N D0KG1D DRUGSMIL C1=CC(=CC(=C1)O)C2=NC3=C(C=C2)C=C(C=C3)O D0KG1D HIGHSTAT Investigative D0KG3M DRUG__ID D0KG3M D0KG3M DRUGTYPE Small molecular drug D0KG3M DRUGINCH 1S/C18H20ClNO3S/c19-16-7-9-17(10-8-16)24(22,23)20-13-4-11-18(21,12-14-20)15-5-2-1-3-6-15/h1-3,5-10,21H,4,11-14H2 D0KG3M DRUGINKE RVUCFBVJACHZFJ-UHFFFAOYSA-N D0KG3M DRUGSMIL C1CC(CCN(C1)S(=O)(=O)C2=CC=C(C=C2)Cl)(C3=CC=CC=C3)O D0KG3M HIGHSTAT Investigative D0KH1D DRUG__ID D0KH1D D0KH1D DRUGTYPE Small molecular drug D0KH1D DRUGINCH 1S/C15H11FN2O/c16-12-3-7-14(8-4-12)19-13-5-1-11(2-6-13)15-9-10-17-18-15/h1-10H,(H,17,18) D0KH1D DRUGINKE CGMPMLHCCFCLQL-UHFFFAOYSA-N D0KH1D DRUGSMIL C1=CC(=CC=C1C2=CC=NN2)OC3=CC=C(C=C3)F D0KH1D HIGHSTAT Investigative D0KH3M DRUG__ID D0KH3M D0KH3M DRUGTYPE Small molecular drug D0KH3M DRUGINCH 1S/C14H9Cl2NO5/c1-21-14(18)10-7-9(3-4-12(10)17(19)20)22-13-5-2-8(15)6-11(13)16/h2-7H,1H3 D0KH3M DRUGINKE SUSRORUBZHMPCO-UHFFFAOYSA-N D0KH3M DRUGSMIL COC(=O)C1=C(C=CC(=C1)OC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-] D0KH3M HIGHSTAT Investigative D0KH5R DRUG__ID D0KH5R D0KH5R DRUGTYPE Small molecular drug D0KH5R DRUGINCH 1S/C19H16ClN3O/c1-12-10-13-7-9-23(18(13)11-15(12)20)19(24)22-17-6-2-5-16-14(17)4-3-8-21-16/h2-6,8,10-11H,7,9H2,1H3,(H,22,24) D0KH5R DRUGINKE HOVMHIRTZYQSKM-UHFFFAOYSA-N D0KH5R DRUGSMIL CC1=CC2=C(C=C1Cl)N(CC2)C(=O)NC3=CC=CC4=C3C=CC=N4 D0KH5R HIGHSTAT Investigative D0KH5T DRUG__ID D0KH5T D0KH5T DRUGTYPE Small molecular drug D0KH5T DRUGINCH 1S/C16H15N3O3/c1-21-14-7-12-13(8-15(14)22-2)17-9-18-16(12)19-10-4-3-5-11(20)6-10/h3-9,20H,1-2H3,(H,17,18,19) D0KH5T DRUGINKE BNDYIYYKEIXHNK-UHFFFAOYSA-N D0KH5T DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)O)OC D0KH5T HIGHSTAT Investigative D0KH8S DRUG__ID D0KH8S D0KH8S DRUGTYPE Small molecular drug D0KH8S DRUGINCH 1S/C16H15NO5/c18-13-9-14(11-2-1-3-12(8-11)16(19)20)22-15(10-13)17-4-6-21-7-5-17/h1-3,8-10H,4-7H2,(H,19,20) D0KH8S DRUGINKE DIBMCWVULMJJDM-UHFFFAOYSA-N D0KH8S DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC(=CC=C3)C(=O)O D0KH8S HIGHSTAT Investigative D0KH9W DRUG__ID D0KH9W D0KH9W DRUGTYPE Small molecular drug D0KH9W DRUGINCH 1S/C20H32O4/c1-2-3-13-16-19(24-23)17-14-11-9-7-5-4-6-8-10-12-15-18-20(21)22/h4-5,8-11,14,17,19,23H,2-3,6-7,12-13,15-16,18H2,1H3,(H,21,22)/b5-4-,10-8-,11-9-,17-14+/t19-/m0/s1 D0KH9W DRUGINKE BFWYTORDSFIVKP-VAEKSGALSA-N D0KH9W DRUGSMIL CCCCCC(C=CC=CCC=CCC=CCCCC(=O)O)OO D0KH9W HIGHSTAT Investigative D0KI3F DRUG__ID D0KI3F D0KI3F DRUGTYPE Small molecular drug D0KI3F DRUGINCH 1S/C16H18BrNO2/c17-15-12-20-16(18-15)14(19)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D0KI3F DRUGINKE PCSNCSLGTDBRDM-UHFFFAOYSA-N D0KI3F DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)Br D0KI3F HIGHSTAT Investigative D0KI5P DRUG__ID D0KI5P D0KI5P DRUGTYPE Small molecular drug D0KI5P DRUGINCH 1S/C25H24N4O3S/c1-17(24(30)26-18-9-5-4-6-10-18)33-25-28-27-23(21-11-7-8-12-22(21)32-3)29(25)19-13-15-20(31-2)16-14-19/h4-17H,1-3H3,(H,26,30) D0KI5P DRUGINKE KGGHSILNBGUJEN-UHFFFAOYSA-N D0KI5P DRUGSMIL CC(C(=O)NC1=CC=CC=C1)SC2=NN=C(N2C3=CC=C(C=C3)OC)C4=CC=CC=C4OC D0KI5P HIGHSTAT Investigative D0KJ3H DRUG__ID D0KJ3H D0KJ3H DRUGTYPE Small molecular drug D0KJ3H DRUGINCH 1S/C20H22N6O5/c21-17-14-18(26(9-22-14)19-16(29)15(28)13(8-27)31-19)25-20(24-17)30-6-5-11-7-10-3-1-2-4-12(10)23-11/h1-4,7,9,13,15-16,19,23,27-29H,5-6,8H2,(H2,21,24,25)/t13-,15-,16-,19-/m1/s1 D0KJ3H DRUGINKE VWETWISDPZSJHC-NVQRDWNXSA-N D0KJ3H DRUGSMIL C1=CC=C2C(=C1)C=C(N2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0KJ3H HIGHSTAT Investigative D0KJ4Q DRUG__ID D0KJ4Q D0KJ4Q DRUGTYPE Small molecular drug D0KJ4Q DRUGINCH 1S/C24H26FN5O2/c1-32-22-6-3-2-5-21(22)29-16-13-28(14-17-29)15-18-30(24-26-11-4-12-27-24)23(31)19-7-9-20(25)10-8-19/h2-12H,13-18H2,1H3/i25-1 D0KJ4Q DRUGINKE ADELHWYAKAZUCR-FNNGWQQSSA-N D0KJ4Q DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=NC=CC=N3)C(=O)C4=CC=C(C=C4)F D0KJ4Q HIGHSTAT Investigative D0KJ7C DRUG__ID D0KJ7C D0KJ7C DRUGTYPE Small molecular drug D0KJ7C DRUGINCH 1S/C15H30O6P2/c1-13(2)9-8-11-14(3)10-6-4-5-7-12-15(22(16,17)18)23(19,20)21/h9-10,15H,4-8,11-12H2,1-3H3,(H2,16,17,18)(H2,19,20,21)/b14-10+ D0KJ7C DRUGINKE YCVCYJHGGKYDRH-GXDHUFHOSA-N D0KJ7C DRUGSMIL CC(=CCCC(=CCCCCCC(P(=O)(O)O)P(=O)(O)O)C)C D0KJ7C HIGHSTAT Investigative D0KK4C DRUG__ID D0KK4C D0KK4C DRUGTYPE Small molecular drug D0KK4C DRUGINCH 1S/C8H13N3/c9-2-1-6-3-7(6)8-4-10-5-11-8/h4-7H,1-3,9H2,(H,10,11)/t6-,7+/m1/s1 D0KK4C DRUGINKE OTBYLNCJHFPRTL-RQJHMYQMSA-N D0KK4C DRUGSMIL C1C(C1C2=CN=CN2)CCN D0KK4C HIGHSTAT Investigative D0KK4F DRUG__ID D0KK4F D0KK4F DRUGTYPE Small molecular drug D0KK4F DRUGINCH 1S/C4H6N2/c1-4-2-5-3-6-4/h2-3H,1H3,(H,5,6) D0KK4F DRUGINKE XLSZMDLNRCVEIJ-UHFFFAOYSA-N D0KK4F DRUGSMIL CC1=CN=CN1 D0KK4F HIGHSTAT Investigative D0KK6A DRUG__ID D0KK6A D0KK6A DRUGTYPE Small molecular drug D0KK6A DRUGINCH 1S/C34H53F2N5O7S/c1-4-12-27(38-32(44)29(22-26-15-10-7-11-16-26)40-49(46,47)41-17-19-48-20-18-41)31(43)39-28(21-25-13-8-6-9-14-25)30(42)34(35,36)33(45)37-23-24(3)5-2/h4,7,10-11,15-16,24-25,27-30,40,42H,1,5-6,8-9,12-14,17-23H2,2-3H3,(H,37,45)(H,38,44)(H,39,43)/t24-,27-,28-,29-,30+/m0/s1 D0KK6A DRUGINKE SXQPECMJHHMDFO-DUGYJJFCSA-N D0KK6A DRUGSMIL CCC(C)CNC(=O)C(C(C(CC1CCCCC1)NC(=O)C(CC=C)NC(=O)C(CC2=CC=CC=C2)NS(=O)(=O)N3CCOCC3)O)(F)F D0KK6A HIGHSTAT Investigative D0KL1I DRUG__ID D0KL1I D0KL1I DRUGTYPE Small molecular drug D0KL1I DRUGINCH 1S/C6H10O8S/c7-3-1-4(6(8)9)13-2-5(3)14-15(10,11)12/h3-5,7H,1-2H2,(H,8,9)(H,10,11,12)/t3-,4-,5-/m1/s1 D0KL1I DRUGINKE IRTONBQROPNEJZ-UOWFLXDJSA-N D0KL1I DRUGSMIL C1C(C(COC1C(=O)O)OS(=O)(=O)O)O D0KL1I HIGHSTAT Investigative D0KL1P DRUG__ID D0KL1P D0KL1P DRUGTYPE Small molecular drug D0KL1P DRUGINCH 1S/C24H38N2O/c1-27-24-14-6-12-22-20(8-5-13-23(22)24)9-7-15-25-16-18-26(19-17-25)21-10-3-2-4-11-21/h6,12,14,20-21H,2-5,7-11,13,15-19H2,1H3 D0KL1P DRUGINKE PHRCDWVPTULQMT-UHFFFAOYSA-N D0KL1P DRUGSMIL COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4 D0KL1P HIGHSTAT Investigative D0KL4K DRUG__ID D0KL4K D0KL4K DRUGTYPE Small molecular drug D0KL4K DRUGINCH 1S/C13H18NO8P/c14-10(12(17)18)5-6-23(20,21)13(19)8-1-3-9(4-2-8)22-7-11(15)16/h1-4,10,13,19H,5-7,14H2,(H,15,16)(H,17,18)(H,20,21)/t10-,13?/m0/s1 D0KL4K DRUGINKE BGOFVWMHMQISHB-NKUHCKNESA-N D0KL4K DRUGSMIL C1=CC(=CC=C1C(O)P(=O)(CCC(C(=O)O)N)O)OCC(=O)O D0KL4K HIGHSTAT Investigative D0KL5N DRUG__ID D0KL5N D0KL5N DRUGTYPE Small molecular drug D0KL5N DRUGINCH 1S/C37H47N5O5/c1-21-14-22(2)29(23(3)15-21)20-32(35(45)40-31(34(39)44)18-26-10-7-6-8-11-26)41-36(46)33-12-9-13-42(33)37(47)30(38)19-28-24(4)16-27(43)17-25(28)5/h6-8,10-11,14-17,30-33,43H,9,12-13,18-20,38H2,1-5H3,(H2,39,44)(H,40,45)(H,41,46)/t30-,31-,32-,33-/m0/s1 D0KL5N DRUGINKE NHSNBLRALWOIIA-YRCZKMHPSA-N D0KL5N DRUGSMIL CC1=CC(=C(C(=C1)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N)C D0KL5N HIGHSTAT Investigative D0KM0Y DRUG__ID D0KM0Y D0KM0Y DRUGTYPE Small molecular drug D0KM0Y DRUGINCH 1S/C16H11N3S/c17-10-13-12(11-5-2-1-3-6-11)9-14(19-16(13)18)15-7-4-8-20-15/h1-9H,(H2,18,19) D0KM0Y DRUGINKE CMOAUWPKTBSUQT-UHFFFAOYSA-N D0KM0Y DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2C#N)N)C3=CC=CS3 D0KM0Y HIGHSTAT Investigative D0KM1H DRUG__ID D0KM1H D0KM1H DRUGTYPE Small molecular drug D0KM1H DRUGINCH 1S/C8H10N4O2/c1-10-4-9-5-6(10)11(2)8(14)12(3)7(5)13/h4H,1-3H3 D0KM1H DRUGINKE LPHGQDQBBGAPDZ-UHFFFAOYSA-N D0KM1H DRUGSMIL CN1C=NC2=C1N(C(=O)N(C2=O)C)C D0KM1H HIGHSTAT Investigative D0KM7H DRUG__ID D0KM7H D0KM7H DRUGTYPE Small molecular drug D0KM7H DRUGINCH 1S/C15H21NO4/c1-20-14-10-7-6-8-12(14)13(17)9-4-2-3-5-11-15(18)16-19/h6-8,10,19H,2-5,9,11H2,1H3,(H,16,18) D0KM7H DRUGINKE MFYBAPSRZVMJKO-UHFFFAOYSA-N D0KM7H DRUGSMIL COC1=CC=CC=C1C(=O)CCCCCCC(=O)NO D0KM7H HIGHSTAT Investigative D0KN0K DRUG__ID D0KN0K D0KN0K DRUGTYPE Small molecular drug D0KN0K DRUGINCH 1S/C11H10IN3O2/c12-8-9(14-11(17)15-10(8)16)13-6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,13,14,15,16,17) D0KN0K DRUGINKE XDTXBEGCSPNEIV-UHFFFAOYSA-N D0KN0K DRUGSMIL C1=CC=C(C=C1)CNC2=C(C(=O)NC(=O)N2)I D0KN0K HIGHSTAT Investigative D0KN1L DRUG__ID D0KN1L D0KN1L DRUGTYPE Small molecular drug D0KN1L DRUGINCH 1S/C12H14ClNO3/c1-9(11(15)7-13)14-12(16)17-8-10-5-3-2-4-6-10/h2-6,9H,7-8H2,1H3,(H,14,16)/t9-/m0/s1 D0KN1L DRUGINKE ASDQMJAOUJQRCM-VIFPVBQESA-N D0KN1L DRUGSMIL CC(C(=O)CCl)NC(=O)OCC1=CC=CC=C1 D0KN1L HIGHSTAT Investigative D0KN6Q DRUG__ID D0KN6Q D0KN6Q DRUGTYPE Small molecular drug D0KN6Q DRUGINCH 1S/C20H18ClNO6/c1-10-7-12-14(21)9-13(17(23)16(12)20(27)28-10)18(24)22-15(19(25)26)8-11-5-3-2-4-6-11/h2-6,9-10,15,23H,7-8H2,1H3,(H,22,24)(H,25,26)/t10-,15+/m1/s1 D0KN6Q DRUGINKE RWQKHEORZBHNRI-BMIGLBTASA-N D0KN6Q DRUGSMIL CC1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)NC(CC3=CC=CC=C3)C(=O)O)Cl D0KN6Q HIGHSTAT Investigative D0KO6Y DRUG__ID D0KO6Y D0KO6Y DRUGTYPE Small molecular drug D0KO6Y DRUGINCH 1S/C7H14NO5P/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8H,1-4H2,(H,9,10)(H2,11,12,13) D0KO6Y DRUGINKE LPMRCCNDNGONCD-UHFFFAOYSA-N D0KO6Y DRUGSMIL C1CNC(CC1CP(=O)(O)O)C(=O)O D0KO6Y HIGHSTAT Investigative D0KO9R DRUG__ID D0KO9R D0KO9R DRUGTYPE Small molecular drug D0KO9R DRUGINCH 1S/C21H14Br4O5S/c1-9-12(7-14(22)19(26)17(9)24)21(13-8-15(23)20(27)18(25)10(13)2)11-5-3-4-6-16(11)31(28,29)30-21/h3-8,26-27H,1-2H3 D0KO9R DRUGINKE FRPHFZCDPYBUAU-UHFFFAOYSA-N D0KO9R DRUGSMIL CC1=C(C(=C(C=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=CC(=C(C(=C4C)Br)O)Br)Br)O)Br D0KO9R HIGHSTAT Investigative D0KP3K DRUG__ID D0KP3K D0KP3K DRUGTYPE Small molecular drug D0KP3K DRUGINCH 1S/C18H16F2N4O/c1-24(2)12-5-3-11(4-6-12)22-18(25)23-15-9-10-21-17-14(20)8-7-13(19)16(15)17/h3-10H,1-2H3,(H2,21,22,23,25) D0KP3K DRUGINKE AZFKSWSBVCFBCG-UHFFFAOYSA-N D0KP3K DRUGSMIL CN(C)C1=CC=C(C=C1)NC(=O)NC2=CC=NC3=C(C=CC(=C23)F)F D0KP3K HIGHSTAT Investigative D0KQ6L DRUG__ID D0KQ6L D0KQ6L DRUGTYPE Small molecular drug D0KQ6L DRUGINCH 1S/C25H35NO3/c1-2-3-4-5-6-7-8-9-10-14-21-28-23-19-17-22(18-20-23)26-25(27)29-24-15-12-11-13-16-24/h11-13,15-20H,2-10,14,21H2,1H3,(H,26,27) D0KQ6L DRUGINKE DFYYHKJFWVSJHM-UHFFFAOYSA-N D0KQ6L DRUGSMIL CCCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2 D0KQ6L HIGHSTAT Investigative D0KQ6U DRUG__ID D0KQ6U D0KQ6U DRUGTYPE Small molecular drug D0KQ6U DRUGINCH 1S/C32H26N2O4/c35-29(17-11-21-7-3-1-4-8-21)33-23-13-15-25-27(19-23)32(38)28-20-24(14-16-26(28)31(25)37)34-30(36)18-12-22-9-5-2-6-10-22/h1-10,13-16,19-20H,11-12,17-18H2,(H,33,35)(H,34,36) D0KQ6U DRUGINKE SZRGPNHLVDLPHX-UHFFFAOYSA-N D0KQ6U DRUGSMIL C1=CC=C(C=C1)CCC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CCC5=CC=CC=C5 D0KQ6U HIGHSTAT Investigative D0KQ8A DRUG__ID D0KQ8A D0KQ8A DRUGTYPE Small molecular drug D0KQ8A DRUGINCH 1S/C37H44N6O5/c1-23(2)33(36(47)40-21-25-9-4-3-5-10-25)42-34(45)31(20-26-22-39-30-12-7-6-11-28(26)30)41-35(46)32-13-8-18-43(32)37(48)29(38)19-24-14-16-27(44)17-15-24/h3-7,9-12,14-17,22-23,29,31-33,39,44H,8,13,18-21,38H2,1-2H3,(H,40,47)(H,41,46)(H,42,45)/t29-,31-,32-,33+/m0/s1 D0KQ8A DRUGINKE FBLJJMPPZKDLDJ-DMBLRCPMSA-N D0KQ8A DRUGSMIL CC(C)C(C(=O)NCC1=CC=CC=C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N D0KQ8A HIGHSTAT Investigative D0KQ9H DRUG__ID D0KQ9H D0KQ9H DRUGTYPE Small molecular drug D0KQ9H DRUGINCH 1S/C16H19N5/c1-2-7-20(6-1)8-5-13-10-17-16-4-3-14(9-15(13)16)21-11-18-19-12-21/h3-4,9-12,17H,1-2,5-8H2 D0KQ9H DRUGINKE WYXPLVWYFDBFBS-UHFFFAOYSA-N D0KQ9H DRUGSMIL C1CCN(C1)CCC2=CNC3=C2C=C(C=C3)N4C=NN=C4 D0KQ9H HIGHSTAT Investigative D0KS0I DRUG__ID D0KS0I D0KS0I DRUGTYPE Small molecular drug D0KS0I DRUGINCH 1S/C20H29F3N2O2.2ClH/c1-24-10-12-25(13-11-24)15-18(19(26)8-3-2-4-9-19)16-6-5-7-17(14-16)27-20(21,22)23;;/h5-7,14,18,26H,2-4,8-13,15H2,1H3;2*1H/t18-;;/m1../s1 D0KS0I DRUGINKE DJVJRXDBDBMWFD-JPKZNVRTSA-N D0KS0I DRUGSMIL CN1CCN(CC1)CC(C2=CC(=CC=C2)OC(F)(F)F)C3(CCCCC3)O.Cl.Cl D0KS0I HIGHSTAT Investigative D0KS1Z DRUG__ID D0KS1Z D0KS1Z DRUGTYPE Small molecular drug D0KS1Z DRUGINCH 1S/C40H53N5O3.2ClH/c1-6-7-21-45-38-32(19-12-20-42-38)35(29-17-11-18-31(23-29)48-22-13-16-28-14-9-8-10-15-28)37(39(45)46)44-40(47)43-36-33(26(2)3)24-30(41)25-34(36)27(4)5;;/h11-12,17-20,23-28H,6-10,13-16,21-22,41H2,1-5H3,(H2,43,44,47);2*1H D0KS1Z DRUGINKE ZFNNBIMQDHBELV-UHFFFAOYSA-N D0KS1Z DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OCCCC5CCCCC5.Cl.Cl D0KS1Z HIGHSTAT Investigative D0KS2T DRUG__ID D0KS2T D0KS2T DRUGTYPE Small molecular drug D0KS2T DRUGINCH 1S/C30H34N3O7P/c1-21(34)31-28(19-22-12-16-26(17-13-22)40-41(37,38)39)29(35)32-27-9-5-6-18-33(30(27)36)20-23-10-14-25(15-11-23)24-7-3-2-4-8-24/h2-4,7-8,10-17,27-28H,5-6,9,18-20H2,1H3,(H,31,34)(H,32,35)(H2,37,38,39)/t27-,28-/m0/s1 D0KS2T DRUGINKE GGPXNASQNUOIPB-NSOVKSMOSA-N D0KS2T DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D0KS2T HIGHSTAT Investigative D0KS2X DRUG__ID D0KS2X D0KS2X DRUGTYPE Small molecular drug D0KS2X DRUGINCH 1S/C17H13N3O2/c1-22-12-8-6-11(7-9-12)20-17(21)14-10-18-15-5-3-2-4-13(15)16(14)19-20/h2-10,19H,1H3 D0KS2X DRUGINKE FTHGIXILGYJOBQ-UHFFFAOYSA-N D0KS2X DRUGSMIL COC1=CC=C(C=C1)N2C(=O)C3=C(N2)C4=CC=CC=C4N=C3 D0KS2X HIGHSTAT Investigative D0KS3X DRUG__ID D0KS3X D0KS3X DRUGTYPE Small molecular drug D0KS3X DRUGINCH 1S/C18H15N5O2/c24-14-8-7-13-16-15(17-20-18(25-21-17)10-5-6-10)19-9-22(16)11-3-1-2-4-12(11)23(13)14/h1-4,9-10,13H,5-8H2 D0KS3X DRUGINKE KIGZWNHARYMTNM-UHFFFAOYSA-N D0KS3X DRUGSMIL C1CC1C2=NC(=NO2)C3=C4C5CCC(=O)N5C6=CC=CC=C6N4C=N3 D0KS3X HIGHSTAT Investigative D0KS6A DRUG__ID D0KS6A D0KS6A DRUGTYPE Small molecular drug D0KS6A DRUGINCH 1S/C30H48O3/c1-18-10-13-30(25(32)33)15-14-28(6)21(24(30)19(18)2)8-9-23-27(5)17-20(31)16-26(3,4)22(27)11-12-29(23,28)7/h8,18-20,22-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,20+,22+,23-,24+,27+,28-,29-,30+/m1/s1 D0KS6A DRUGINKE DDHYEJNMSYDDTH-ZWHPGZRZSA-N D0KS6A DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)O)C)C)C2C1C)C)C(=O)O D0KS6A HIGHSTAT Investigative D0KT2M DRUG__ID D0KT2M D0KT2M DRUGTYPE Small molecular drug D0KT2M DRUGINCH 1S/C17H20N2O2/c1-20-15-6-2-3-7-16(15)21-17-14(5-4-10-19-17)13-8-11-18-12-9-13/h2-7,10,13,18H,8-9,11-12H2,1H3 D0KT2M DRUGINKE GZJLFOYGSNAXDK-UHFFFAOYSA-N D0KT2M DRUGSMIL COC1=CC=CC=C1OC2=C(C=CC=N2)C3CCNCC3 D0KT2M HIGHSTAT Investigative D0KT3L DRUG__ID D0KT3L D0KT3L DRUGTYPE Small molecular drug D0KT3L DRUGINCH 1S/C19H18FN5O5/c1-29-24-17-14-18(23-13(22-17)7-4-10-2-5-11(20)6-3-10)25(9-21-14)19-16(28)15(27)12(8-26)30-19/h2-3,5-6,9,12,15-16,19,26-28H,8H2,1H3,(H,22,23,24)/t12-,15-,16-,19-/m1/s1 D0KT3L DRUGINKE IEVVENMHWBPFQV-BGIGGGFGSA-N D0KT3L DRUGSMIL CONC1=C2C(=NC(=N1)C#CC3=CC=C(C=C3)F)N(C=N2)C4C(C(C(O4)CO)O)O D0KT3L HIGHSTAT Investigative D0KT3P DRUG__ID D0KT3P D0KT3P DRUGCOMP Kyorin Pharmaceutical Co Ltd D0KT3P DRUGINCH 1S/C22H26N4O3.C4H4O4/c1-5-14-11-16(28-4)12-18-19(14)22(27)29-21(24-18)17-7-6-9-23-20(17)26-10-8-15(13-26)25(2)3;5-3(6)1-2-4(7)8/h6-7,9,11-12,15H,5,8,10,13H2,1-4H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D0KT3P DRUGINKE YLFBWXUNSRKFNI-BTJKTKAUSA-N D0KT3P DRUGSMIL CCC1=C2C(=CC(=C1)OC)N=C(OC2=O)C3=C(N=CC=C3)N4CCC(C4)N(C)C.C(=CC(=O)O)C(=O)O D0KT3P HIGHSTAT Investigative D0KT4N DRUG__ID D0KT4N D0KT4N DRUGTYPE Small molecular drug D0KT4N DRUGINCH 1S/C4H9O7P/c5-1-3(6)4(7)2-11-12(8,9)10/h1,3-4,6-7H,2H2,(H2,8,9,10)/t3-,4+/m0/s1 D0KT4N DRUGINKE NGHMDNPXVRFFGS-IUYQGCFVSA-N D0KT4N DRUGSMIL C(C(C(C=O)O)O)OP(=O)(O)O D0KT4N HIGHSTAT Investigative D0KT5E DRUG__ID D0KT5E D0KT5E DRUGTYPE Small molecular drug D0KT5E DRUGINCH 1S/C10H22NO7P/c1-9(12)16-7-10(13)8-18-19(14,15)17-6-5-11(2,3)4/h10,13H,5-8H2,1-4H3/t10-/m1/s1 D0KT5E DRUGINKE RYCNUMLMNKHWPZ-SNVBAGLBSA-N D0KT5E DRUGSMIL CC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O D0KT5E HIGHSTAT Investigative D0KU2D DRUG__ID D0KU2D D0KU2D DRUGTYPE Small molecular drug D0KU2D DRUGINCH 1S/C11H10N2O/c14-11(10-7-4-8-12-10)13-9-5-2-1-3-6-9/h1-8,12H,(H,13,14) D0KU2D DRUGINKE MZPAQCAPWLAKSD-UHFFFAOYSA-N D0KU2D DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC=CN2 D0KU2D HIGHSTAT Investigative D0KU5D DRUG__ID D0KU5D D0KU5D DRUGTYPE Small molecular drug D0KU5D DRUGINCH 1S/C38H30F2N4O3/c39-38(40)21-23-44(34-16-7-6-15-32(34)33(38)24-35(45)42-25-29-12-8-9-22-41-29)37(47)27-17-19-28(20-18-27)43-36(46)31-14-5-4-13-30(31)26-10-2-1-3-11-26/h1-20,22,24H,21,23,25H2,(H,42,45)(H,43,46)/b33-24- D0KU5D DRUGINKE OPEZXZINWZCBQD-GIBOGKFOSA-N D0KU5D DRUGSMIL C1CN(C2=CC=CC=C2C(=CC(=O)NCC3=CC=CC=N3)C1(F)F)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6 D0KU5D HIGHSTAT Investigative D0KU6D DRUG__ID D0KU6D D0KU6D DRUGTYPE Small molecular drug D0KU6D DRUGINCH 1S/C11H13FN2/c1-8(13)7-14-5-4-9-2-3-10(12)6-11(9)14/h2-6,8H,7,13H2,1H3 D0KU6D DRUGINKE WZMZEXSQEAPONX-UHFFFAOYSA-N D0KU6D DRUGSMIL CC(CN1C=CC2=C1C=C(C=C2)F)N D0KU6D HIGHSTAT Investigative D0KV4G DRUG__ID D0KV4G D0KV4G DRUGTYPE Small molecular drug D0KV4G DRUGINCH 1S/C13H15N3/c1-2-4-12-11(3-1)5-6-15-13(12)16-9-7-14-8-10-16/h1-6,14H,7-10H2 D0KV4G DRUGINKE IDFYLSABDUMICK-UHFFFAOYSA-N D0KV4G DRUGSMIL C1CN(CCN1)C2=NC=CC3=CC=CC=C32 D0KV4G HIGHSTAT Investigative D0KW4Y DRUG__ID D0KW4Y D0KW4Y DRUGTYPE Small molecular drug D0KW4Y DRUGINCH 1S/C38H52N8O10/c1-19(2)31(36(54)41-17-29(40)48)45-37(55)32(20(3)4)44-34(52)27(16-30(49)50)43-35(53)28-15-23-8-6-7-9-24(23)18-46(28)38(56)21(5)42-33(51)26(39)14-22-10-12-25(47)13-11-22/h6-13,19-21,26-28,31-32,47H,14-18,39H2,1-5H3,(H2,40,48)(H,41,54)(H,42,51)(H,43,53)(H,44,52)(H,45,55)(H,49,50)/t21-,26+,27+,28+,31+,32+/m1/s1 D0KW4Y DRUGINKE JOXXADDFFWZHEE-JMZWVCJUSA-N D0KW4Y DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C1CC2=CC=CC=C2CN1C(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N D0KW4Y HIGHSTAT Investigative D0KW6V DRUG__ID D0KW6V D0KW6V DRUGTYPE Small molecular drug D0KW6V DRUGINCH 1S/C21H24N4O/c1-2-6-17(7-3-1)16-20-21(22-10-11-25-12-14-26-15-13-25)24-19-9-5-4-8-18(19)23-20/h1-9H,10-16H2,(H,22,24) D0KW6V DRUGINKE JEKWAIMSNCODJF-UHFFFAOYSA-N D0KW6V DRUGSMIL C1COCCN1CCNC2=NC3=CC=CC=C3N=C2CC4=CC=CC=C4 D0KW6V HIGHSTAT Investigative D0KX3C DRUG__ID D0KX3C D0KX3C DRUGTYPE Small molecular drug D0KX3C DRUGINCH 1S/C27H34Cl2N4O2/c1-31(26(34)20-6-3-2-4-7-20)19-22(21-8-9-24(28)25(29)18-21)10-15-32-16-11-23(12-17-32)33-14-5-13-30-27(33)35/h2-4,6-9,18,22-23H,5,10-17,19H2,1H3,(H,30,35)/t22-/m1/s1 D0KX3C DRUGINKE SCMPVSAUZONHCN-JOCHJYFZSA-N D0KX3C DRUGSMIL CN(CC(CCN1CCC(CC1)N2CCCNC2=O)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC=CC=C4 D0KX3C HIGHSTAT Investigative D0KX3X DRUG__ID D0KX3X D0KX3X DRUGTYPE Small molecular drug D0KX3X DRUGINCH 1S/C23H27NO3/c1-4-5-9-21(25)27-20-8-6-7-15-13-19-22-16(10-11-24(19)2)12-17(26-3)14-18(22)23(15)20/h6-8,12,14,19H,4-5,9-11,13H2,1-3H3/t19-/m1/s1 D0KX3X DRUGINKE NMUGDOOOAXACRK-LJQANCHMSA-N D0KX3X DRUGSMIL CCCCC(=O)OC1=CC=CC2=C1C3=CC(=CC4=C3C(C2)N(CC4)C)OC D0KX3X HIGHSTAT Investigative D0KX6D DRUG__ID D0KX6D D0KX6D DRUGTYPE Small molecular drug D0KX6D DRUGINCH 1S/C29H32O3/c1-4-14-29(32)15-13-26-24-11-9-21-16-22(31)10-12-23(21)27(24)25(17-28(26,29)3)20-7-5-19(6-8-20)18(2)30/h5-8,16,24-26,32H,9-13,15,17H2,1-3H3/t24-,25+,26-,28-,29-/m0/s1 D0KX6D DRUGINKE OPKMKRUFBKTTRF-GCNJZUOMSA-N D0KX6D DRUGSMIL CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)C(=O)C)C)O D0KX6D HIGHSTAT Investigative D0KY9B DRUG__ID D0KY9B D0KY9B DRUGTYPE Small molecular drug D0KY9B DRUGINCH 1S/C8H8ClN5O2/c10-3-1-2-4-5(6(3)9(15)16)7(11)14-8(12)13-4/h1-2H,10H2,(H4,11,12,13,14) D0KY9B DRUGINKE AOIWFGJNGXKHGL-UHFFFAOYSA-N D0KY9B DRUGSMIL C1=CC2=C(C(=C1N)Cl(=O)=O)C(=NC(=N2)N)N D0KY9B HIGHSTAT Investigative D0KZ2D DRUG__ID D0KZ2D D0KZ2D DRUGTYPE Small molecular drug D0KZ2D DRUGINCH 1S/C17H26N2O3S/c1-3-5-12(6-4-2)17(20)19-16-10-7-13-11-14(23(18,21)22)8-9-15(13)16/h8-9,11-12,16H,3-7,10H2,1-2H3,(H,19,20)(H2,18,21,22) D0KZ2D DRUGINKE FCGKZIRRZCVIGR-UHFFFAOYSA-N D0KZ2D DRUGSMIL CCCC(CCC)C(=O)NC1CCC2=C1C=CC(=C2)S(=O)(=O)N D0KZ2D HIGHSTAT Investigative D0KZ7A DRUG__ID D0KZ7A D0KZ7A DRUGTYPE Small molecular drug D0KZ7A DRUGINCH 1S/C9H13NO3/c10-6-7(5-9(11)12)4-8-2-1-3-13-8/h1-3,7H,4-6,10H2,(H,11,12) D0KZ7A DRUGINKE JASKMEUWYOXVFB-UHFFFAOYSA-N D0KZ7A DRUGSMIL C1=COC(=C1)CC(CC(=O)O)CN D0KZ7A HIGHSTAT Investigative D0L0AY DRUG__ID D0L0AY D0L0AY DRUGTYPE Small molecular drug D0L0AY DRUGINCH 1S/C13H19NO/c14-10-13-9-8-12(15-13)7-6-11-4-2-1-3-5-11/h1-5,12-13H,6-10,14H2 D0L0AY DRUGINKE LKTJWDXCFJJUGY-UHFFFAOYSA-N D0L0AY DRUGSMIL C1CC(OC1CCC2=CC=CC=C2)CN D0L0AY HIGHSTAT Investigative D0L0AZ DRUG__ID D0L0AZ D0L0AZ DRUGTYPE Small molecular drug D0L0AZ DRUGINCH 1S/C16H16Cl2O2/c1-10(2)7-11-3-5-16(14(19)8-11)20-15-6-4-12(17)9-13(15)18/h3-6,8-10,19H,7H2,1-2H3 D0L0AZ DRUGINKE ZPZSZEVICIKUBD-UHFFFAOYSA-N D0L0AZ DRUGSMIL CC(C)CC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D0L0AZ HIGHSTAT Investigative D0L0DC DRUG__ID D0L0DC D0L0DC DRUGTYPE Small molecular drug D0L0DC DRUGINCH 1S/C15H20BrN5O5S/c16-6-3-21(13-9(6)12(18)19-5-20-13)14-11(23)10(22)8(26-14)4-27-2-1-7(17)15(24)25/h3,5,7-8,10-11,14,22-23H,1-2,4,17H2,(H,24,25)(H2,18,19,20)/t7-,8+,10+,11+,14+/m0/s1 D0L0DC DRUGINKE DIULHULFPSIBAK-TWBCTODHSA-N D0L0DC DRUGSMIL C1=C(C2=C(N=CN=C2N1C3C(C(C(O3)CSCCC(C(=O)O)N)O)O)N)Br D0L0DC HIGHSTAT Investigative D0L0FC DRUG__ID D0L0FC D0L0FC DRUGTYPE Small molecular drug D0L0FC DRUGINCH 1S/C22H26N2/c1-2-3-4-10-16-23-21-15-17-24(18-19-11-6-5-7-12-19)22-14-9-8-13-20(21)22/h5-9,11-15,17H,2-4,10,16,18H2,1H3 D0L0FC DRUGINKE GRLRXFAGAKMYSQ-UHFFFAOYSA-N D0L0FC DRUGSMIL CCCCCCN=C1C=CN(C2=CC=CC=C12)CC3=CC=CC=C3 D0L0FC HIGHSTAT Investigative D0L0HG DRUG__ID D0L0HG D0L0HG DRUGTYPE Small molecular drug D0L0HG DRUGINCH 1S/C20H16N2OS/c21-12-17-15-9-3-4-11-18(15)24-20(17)22-19(23)16-10-5-7-13-6-1-2-8-14(13)16/h1-2,5-8,10H,3-4,9,11H2,(H,22,23) D0L0HG DRUGINKE WQGDQGAFSDMBLA-UHFFFAOYSA-N D0L0HG DRUGSMIL C1CCC2=C(C1)C(=C(S2)NC(=O)C3=CC=CC4=CC=CC=C43)C#N D0L0HG HIGHSTAT Investigative D0L0KO DRUG__ID D0L0KO D0L0KO DRUGTYPE Small molecular drug D0L0KO DRUGINCH 1S/C15H12BrN3/c1-10-3-2-4-12(7-10)19-15-13-8-11(16)5-6-14(13)17-9-18-15/h2-9H,1H3,(H,17,18,19) D0L0KO DRUGINKE CGCSONSXFOSORP-UHFFFAOYSA-N D0L0KO DRUGSMIL CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C(C=C3)Br D0L0KO HIGHSTAT Investigative D0L0MJ DRUG__ID D0L0MJ D0L0MJ DRUGTYPE Small molecular drug D0L0MJ DRUGINCH 1S/C13H10N2/c1-2-4-13-11(3-1)12(9-15-13)10-5-7-14-8-6-10/h1-9,15H D0L0MJ DRUGINKE LLJRXVHJOJRCSM-UHFFFAOYSA-N D0L0MJ DRUGSMIL C1=CC=C2C(=C1)C(=CN2)C3=CC=NC=C3 D0L0MJ HIGHSTAT Investigative D0L0MU DRUG__ID D0L0MU D0L0MU DRUGTYPE Small molecular drug D0L0MU DRUGINCH 1S/C16H15N/c17-11-16-14-7-3-1-5-12(14)9-10-13-6-2-4-8-15(13)16/h1-10,16H,11,17H2 D0L0MU DRUGINKE BKZVRYQHIBSITO-UHFFFAOYSA-N D0L0MU DRUGSMIL C1=CC=C2C(C3=CC=CC=C3C=CC2=C1)CN D0L0MU HIGHSTAT Investigative D0L0MZ DRUG__ID D0L0MZ D0L0MZ DRUGTYPE Small molecular drug D0L0MZ DRUGINCH 1S/C21H14O7/c1-11(22)25-15-3-5-17-13(7-15)9-19(27-17)21(24)20-10-14-8-16(26-12(2)23)4-6-18(14)28-20/h3-10H,1-2H3 D0L0MZ DRUGINKE UACDZFCKAGJOFV-UHFFFAOYSA-N D0L0MZ DRUGSMIL CC(=O)OC1=CC2=C(C=C1)OC(=C2)C(=O)C3=CC4=C(O3)C=CC(=C4)OC(=O)C D0L0MZ HIGHSTAT Investigative D0L0NI DRUG__ID D0L0NI D0L0NI DRUGTYPE Small molecular drug D0L0NI DRUGINCH 1S/C28H34N6O8S2/c1-15-9-19(35)10-16(2)20(15)7-8-24(36)32-23-14-44-43-13-22(26(29)38)33-28(40)21(31-25(37)12-30-27(23)39)11-17-3-5-18(6-4-17)34(41)42/h3-6,9-10,21-23,35H,7-8,11-14H2,1-2H3,(H2,29,38)(H,30,39)(H,31,37)(H,32,36)(H,33,40)/t21-,22-,23-/m0/s1 D0L0NI DRUGINKE UHOUPDXHBXXBLE-VABKMULXSA-N D0L0NI DRUGSMIL CC1=CC(=CC(=C1CCC(=O)NC2CSSCC(NC(=O)C(NC(=O)CNC2=O)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)N)C)O D0L0NI HIGHSTAT Investigative D0L0NY DRUG__ID D0L0NY D0L0NY DRUGTYPE Small molecular drug D0L0NY DRUGINCH 1S/C19H15N3/c1-2-5-16(6-3-1)18-12-15(13-22-10-9-20-14-22)11-17-7-4-8-21-19(17)18/h1-12,14H,13H2 D0L0NY DRUGINKE PBPLGORPOONLEQ-UHFFFAOYSA-N D0L0NY DRUGSMIL C1=CC=C(C=C1)C2=C3C(=CC(=C2)CN4C=CN=C4)C=CC=N3 D0L0NY HIGHSTAT Investigative D0L0OU DRUG__ID D0L0OU D0L0OU DRUGCOMP Charlesson LLC D0L0OU DRUGINCH 1S/C16H10O4/c1-8(17)9-4-2-5-10-13(9)15(19)11-6-3-7-12(18)14(11)16(10)20/h2-7,18H,1H3 D0L0OU DRUGINKE RROLKYCVTJGMND-UHFFFAOYSA-N D0L0OU DRUGSMIL CC(=O)C1=CC=CC2=C1C(=O)C3=C(C2=O)C(=CC=C3)O D0L0OU HIGHSTAT Investigative D0L0QR DRUG__ID D0L0QR D0L0QR DRUGTYPE Small molecular drug D0L0QR DRUGINCH 1S/C31H41N7O6/c1-19(2)15-24(27(40)34-22(18-39)16-20-9-5-3-6-10-20)35-28(41)26(23-13-14-33-30(32)36-23)38-31(44)37-25(29(42)43)17-21-11-7-4-8-12-21/h3-12,18-19,22-26H,13-17H2,1-2H3,(H,34,40)(H,35,41)(H,42,43)(H3,32,33,36)(H2,37,38,44)/t22-,23?,24-,25-,26-/m0/s1 D0L0QR DRUGINKE MRXDGVXSWIXTQL-HYHFHBMOSA-N D0L0QR DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)C(C2CCN=C(N2)N)NC(=O)NC(CC3=CC=CC=C3)C(=O)O D0L0QR HIGHSTAT Investigative D0L0RK DRUG__ID D0L0RK D0L0RK DRUGTYPE Small molecular drug D0L0RK DRUGINCH 1S/C15H17NO3S/c1-2-12-16(13-6-4-3-5-7-13)20(18,19)15-10-8-14(17)9-11-15/h3-11,17H,2,12H2,1H3 D0L0RK DRUGINKE VUUWGEGTDFUSTR-UHFFFAOYSA-N D0L0RK DRUGSMIL CCCN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O D0L0RK HIGHSTAT Investigative D0L0SD DRUG__ID D0L0SD D0L0SD DRUGTYPE Small molecular drug D0L0SD DRUGINCH 1S/C31H46N2O2/c1-3-30(26-12-9-14-28(34)22-26)16-5-7-18-32(24-30)20-11-21-33-19-8-6-17-31(4-2,25-33)27-13-10-15-29(35)23-27/h9-10,12-15,22-23,34-35H,3-8,11,16-21,24-25H2,1-2H3/t30-,31-/m1/s1 D0L0SD DRUGINKE SKYWWOFBHWQWFU-FIRIVFDPSA-N D0L0SD DRUGSMIL CCC1(CCCCN(C1)CCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0L0SD HIGHSTAT Investigative D0L0SF DRUG__ID D0L0SF D0L0SF DRUGTYPE Small molecular drug D0L0SF DRUGINCH 1S/C21H26N4O3/c1-3-5-17-15(8-11-18(20(17)27)19(26)4-2)13-28-16-9-6-14(7-10-16)12-24-25-21(22)23/h6-12,27H,3-5,13H2,1-2H3,(H4,22,23,25)/b24-12- D0L0SF DRUGINKE TUJFUBGJRSXFHG-MSXFZWOLSA-N D0L0SF DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)CC)COC2=CC=C(C=C2)C=NN=C(N)N D0L0SF HIGHSTAT Investigative D0L0SP DRUG__ID D0L0SP D0L0SP DRUGTYPE Small molecular drug D0L0SP DRUGINCH 1S/C3H5NO/c1-2-3(4)5/h2H,1H2,(H2,4,5) D0L0SP DRUGINKE HRPVXLWXLXDGHG-UHFFFAOYSA-N D0L0SP DRUGSMIL C=CC(=O)N D0L0SP HIGHSTAT Investigative D0L0UY DRUG__ID D0L0UY D0L0UY DRUGTYPE Small molecular drug D0L0UY DRUGINCH 1S/C29H36O16/c30-11-19-22(36)24(38)25(39)29(43-19)45-27-23(37)20(12-42-21(35)6-3-13-1-4-15(31)17(33)9-13)44-28(26(27)40)41-8-7-14-2-5-16(32)18(34)10-14/h1-6,9-10,19-20,22-34,36-40H,7-8,11-12H2/b6-3+/t19-,20-,22-,23-,24+,25-,26-,27+,28-,29+/m1/s1 D0L0UY DRUGINKE CBZYUWGJNYOKHT-ZKDZFUIGSA-N D0L0UY DRUGSMIL C1=CC(=C(C=C1CCOC2C(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O)O D0L0UY HIGHSTAT Investigative D0L0VU DRUG__ID D0L0VU D0L0VU DRUGTYPE Small molecular drug D0L0VU DRUGINCH 1S/C24H27N7O6/c1-4-8-30-22-20(23(33)31(9-5-2)24(30)34)26-21(27-22)15-11-19(28-29(15)3)35-12-18(32)25-14-6-7-16-17(10-14)37-13-36-16/h6-7,10-11H,4-5,8-9,12-13H2,1-3H3,(H,25,32)(H,26,27) D0L0VU DRUGINKE DBWQRFKXNBVPGA-UHFFFAOYSA-N D0L0VU DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)NC4=CC5=C(C=C4)OCO5 D0L0VU HIGHSTAT Investigative D0L0VV DRUG__ID D0L0VV D0L0VV DRUGCOMP Nippon Shinyaku Co Ltd D0L0VV DRUGINCH 1S/C23H26O5/c1-7-9-14-12-16(24)27-22-17(14)21-15(10-11-23(4,5)28-21)20(26-6)18(22)19(25)13(3)8-2/h8,10-12H,7,9H2,1-6H3/b13-8+ D0L0VV DRUGINKE RMUWCAYGHBNRQJ-MDWZMJQESA-N D0L0VV DRUGSMIL CCCC1=CC(=O)OC2=C1C3=C(C=CC(O3)(C)C)C(=C2C(=O)C(=CC)C)OC D0L0VV HIGHSTAT Investigative D0L0YF DRUG__ID D0L0YF D0L0YF DRUGTYPE Small molecular drug D0L0YF DRUGINCH 1S/C8H12N2O4/c1-4-5(7(11)10-14-4)2-3-6(9)8(12)13/h6H,2-3,9H2,1H3,(H,10,11)(H,12,13) D0L0YF DRUGINKE NZDIZJGEDFARSV-UHFFFAOYSA-N D0L0YF DRUGSMIL CC1=C(C(=O)NO1)CCC(C(=O)O)N D0L0YF HIGHSTAT Investigative D0L0ZH DRUG__ID D0L0ZH D0L0ZH DRUGTYPE Small molecular drug D0L0ZH DRUGINCH 1S/C20H19NO6/c1-21(2)8-7-10-9-13(25-4)18-16-14(10)20(23)27-17-12(24-3)6-5-11(15(16)17)19(22)26-18/h5-6,9H,7-8H2,1-4H3 D0L0ZH DRUGINKE MTAWKURMWOXCEO-UHFFFAOYSA-N D0L0ZH DRUGSMIL CN(C)CCC1=CC(=C2C3=C1C(=O)OC4=C(C=CC(=C34)C(=O)O2)OC)OC D0L0ZH HIGHSTAT Investigative D0L0ZP DRUG__ID D0L0ZP D0L0ZP DRUGTYPE Small molecular drug D0L0ZP DRUGINCH 1S/C10H10N2O2/c1-13-9-4-7(11)2-3-8(9)10-5-12-6-14-10/h2-6H,11H2,1H3 D0L0ZP DRUGINKE KYCMMXMEXWSPCV-UHFFFAOYSA-N D0L0ZP DRUGSMIL COC1=C(C=CC(=C1)N)C2=CN=CO2 D0L0ZP HIGHSTAT Investigative D0L1AV DRUG__ID D0L1AV D0L1AV DRUGTYPE Small molecular drug D0L1AV DRUGINCH 1S/C8H15NO4/c10-7-5-3-1-2-4-6-8(7)13-9(11)12/h7-8,10H,1-6H2/t7-,8-/m0/s1 D0L1AV DRUGINKE IWKAONCFSJZOOC-YUMQZZPRSA-N D0L1AV DRUGSMIL C1CCCC(C(CC1)O)O[N+](=O)[O-] D0L1AV HIGHSTAT Investigative D0L1BW DRUG__ID D0L1BW D0L1BW DRUGTYPE Small molecular drug D0L1BW DRUGINCH 1S/C15H17N3O3/c1-21-12-6-4-11(5-7-12)13-8-9-14(16)18(17-13)10-2-3-15(19)20/h4-9,16H,2-3,10H2,1H3,(H,19,20) D0L1BW DRUGINKE ACVGNKYJVGNLIL-UHFFFAOYSA-N D0L1BW DRUGSMIL COC1=CC=C(C=C1)C2=NN(C(=N)C=C2)CCCC(=O)O D0L1BW HIGHSTAT Investigative D0L1CX DRUG__ID D0L1CX D0L1CX DRUGTYPE Small molecular drug D0L1CX DRUGINCH 1S/C22H17NO3/c24-18-5-3-4-16(14-18)9-8-15-10-12-17(13-11-15)23-21(25)19-6-1-2-7-20(19)22(23)26/h1-7,10-14,24H,8-9H2 D0L1CX DRUGINKE TUMZBTITCWKZAT-UHFFFAOYSA-N D0L1CX DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=C(C=C3)CCC4=CC(=CC=C4)O D0L1CX HIGHSTAT Investigative D0L1EI DRUG__ID D0L1EI D0L1EI DRUGTYPE Small molecular drug D0L1EI DRUGINCH 1S/C23H29NO3/c25-23(21-11-5-2-6-12-21)26-18-8-7-15-24-16-13-22(14-17-24)27-19-20-9-3-1-4-10-20/h1-6,9-12,22H,7-8,13-19H2 D0L1EI DRUGINKE PIHTVJYRMYAPDJ-UHFFFAOYSA-N D0L1EI DRUGSMIL C1CN(CCC1OCC2=CC=CC=C2)CCCCOC(=O)C3=CC=CC=C3 D0L1EI HIGHSTAT Investigative D0L1GF DRUG__ID D0L1GF D0L1GF DRUGTYPE Small molecular drug D0L1GF DRUGINCH 1S/C16H10BrN3O2/c17-10-6-3-5-9-12(16(21)19-13(9)10)15-14(20-22)8-4-1-2-7-11(8)18-15/h1-7,12,18H,(H,19,21) D0L1GF DRUGINKE GMRAFJUVKHMGPN-UHFFFAOYSA-N D0L1GF DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3C4=C(C(=CC=C4)Br)NC3=O)N=O D0L1GF HIGHSTAT Investigative D0L1IB DRUG__ID D0L1IB D0L1IB DRUGTYPE Small molecular drug D0L1IB DRUGINCH 1S/C9H11FN2O/c10-9-8(2-1-4-12-9)13-6-7-3-5-11-7/h1-2,4,7,11H,3,5-6H2/t7-/m0/s1 D0L1IB DRUGINKE GVOOYVOZPRROMP-ZETCQYMHSA-N D0L1IB DRUGSMIL C1CNC1COC2=C(N=CC=C2)F D0L1IB HIGHSTAT Investigative D0L1IS DRUG__ID D0L1IS D0L1IS DRUGTYPE Small molecular drug D0L1IS DRUGINCH 1S/C18H21NO3/c1-21-14-5-3-12(4-6-14)9-16-15-11-18(22-2)17(20)10-13(15)7-8-19-16/h3-6,10-11,16,19-20H,7-9H2,1-2H3/t16-/m1/s1 D0L1IS DRUGINKE HIMHLENXDBHLCU-MRXNPFEDSA-N D0L1IS DRUGSMIL COC1=CC=C(C=C1)CC2C3=CC(=C(C=C3CCN2)O)OC D0L1IS HIGHSTAT Investigative D0L1JF DRUG__ID D0L1JF D0L1JF DRUGTYPE Small molecular drug D0L1JF DRUGINCH 1S/C15H12FN/c16-15-5-1-4-13-12(6-7-14(13)15)9-11-3-2-8-17-10-11/h1-5,8-10H,6-7H2/b12-9- D0L1JF DRUGINKE JKDSUQNXZNYUED-XFXZXTDPSA-N D0L1JF DRUGSMIL C1CC2=C(C1=CC3=CN=CC=C3)C=CC=C2F D0L1JF HIGHSTAT Investigative D0L1ME DRUG__ID D0L1ME D0L1ME DRUGTYPE Small molecular drug D0L1ME DRUGINCH 1S/C9H12N2O/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H2,11,12)/t8-/m0/s1 D0L1ME DRUGINKE OBSIQMZKFXFYLV-QMMMGPOBSA-N D0L1ME DRUGSMIL C1=CC=C(C=C1)CC(C(=O)N)N D0L1ME HIGHSTAT Investigative D0L1MJ DRUG__ID D0L1MJ D0L1MJ DRUGTYPE Small molecular drug D0L1MJ DRUGINCH 1S/C47H63N11O7/c1-3-5-15-35-42(61)55-36(16-6-4-2)43(62)57-38(25-28-19-20-29-12-7-8-13-30(29)24-28)45(64)56-37(18-11-23-51-47(49)50)44(63)58-39(26-31-27-52-33-17-10-9-14-32(31)33)46(65)54-34(41(48)60)21-22-40(59)53-35/h7-10,12-14,17,19-20,24,27,34-39,52H,3-6,11,15-16,18,21-23,25-26H2,1-2H3,(H2,48,60)(H,53,59)(H,54,65)(H,55,61)(H,56,64)(H,57,62)(H,58,63)(H4,49,50,51)/t34-,35-,36-,37-,38+,39-/m0/s1 D0L1MJ DRUGINKE TYFFXNLNRYRUAU-LFSOJSGESA-N D0L1MJ DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4)CCCC D0L1MJ HIGHSTAT Investigative D0L1ND DRUG__ID D0L1ND D0L1ND DRUGTYPE Small molecular drug D0L1ND DRUGINCH 1S/C19H21NO/c21-19(14-20-12-10-18(19)11-13-20)17-8-6-16(7-9-17)15-4-2-1-3-5-15/h1-9,18,21H,10-14H2 D0L1ND DRUGINKE WPCQYFUQHBLGAX-UHFFFAOYSA-N D0L1ND DRUGSMIL C1CN2CCC1C(C2)(C3=CC=C(C=C3)C4=CC=CC=C4)O D0L1ND HIGHSTAT Investigative D0L1NQ DRUG__ID D0L1NQ D0L1NQ DRUGTYPE Small molecular drug D0L1NQ DRUGINCH 1S/C16H12N2O/c17-16(19)14-8-4-7-12-9-13(10-18-15(12)14)11-5-2-1-3-6-11/h1-10H,(H2,17,19) D0L1NQ DRUGINKE DFGJDJRADWQKAW-UHFFFAOYSA-N D0L1NQ DRUGSMIL C1=CC=C(C=C1)C2=CN=C3C(=C2)C=CC=C3C(=O)N D0L1NQ HIGHSTAT Investigative D0L1NS DRUG__ID D0L1NS D0L1NS DRUGTYPE Small molecular drug D0L1NS DRUGINCH 1S/C18H19N3S/c1-2-6-15(7-3-1)14-20-10-12-21(13-11-20)18-19-16-8-4-5-9-17(16)22-18/h1-9H,10-14H2 D0L1NS DRUGINKE SNRZSONRAFJJSB-UHFFFAOYSA-N D0L1NS DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=NC4=CC=CC=C4S3 D0L1NS HIGHSTAT Investigative D0L1PQ DRUG__ID D0L1PQ D0L1PQ DRUGTYPE Small molecular drug D0L1PQ DRUGINCH 1S/C16H11N3/c17-11-13-4-3-5-15(10-13)19-9-7-14(12-19)16-6-1-2-8-18-16/h1-10,12H D0L1PQ DRUGINKE VWIHRRSEESXDSS-UHFFFAOYSA-N D0L1PQ DRUGSMIL C1=CC=NC(=C1)C2=CN(C=C2)C3=CC=CC(=C3)C#N D0L1PQ HIGHSTAT Investigative D0L1PW DRUG__ID D0L1PW D0L1PW DRUGCOMP Rigel Pharmaceuticals D0L1PW DRUGINCH 1S/C16H13FN4O2/c17-14-9-18-16(20-11-4-2-6-13(23)8-11)21-15(14)19-10-3-1-5-12(22)7-10/h1-9,22-23H,(H2,18,19,20,21) D0L1PW DRUGINKE TVKGTSHBQZEFEE-UHFFFAOYSA-N D0L1PW DRUGSMIL C1=CC(=CC(=C1)O)NC2=NC(=NC=C2F)NC3=CC(=CC=C3)O D0L1PW HIGHSTAT Investigative D0L1RM DRUG__ID D0L1RM D0L1RM DRUGTYPE Small molecular drug D0L1RM DRUGINCH 1S/C5H15NO6P2/c1-2-3-6-4-5(13(7,8)9)14(10,11)12/h5-6H,2-4H2,1H3,(H2,7,8,9)(H2,10,11,12) D0L1RM DRUGINKE YFFJUBPLIKXHAO-UHFFFAOYSA-N D0L1RM DRUGSMIL CCCNCC(P(=O)(O)O)P(=O)(O)O D0L1RM HIGHSTAT Investigative D0L1RZ DRUG__ID D0L1RZ D0L1RZ DRUGTYPE Small molecular drug D0L1RZ DRUGINCH 1S/C16H13N3O2/c1-21-11-7-5-10(6-8-11)14-9-18-13-4-2-3-12(16(17)20)15(13)19-14/h2-9H,1H3,(H2,17,20) D0L1RZ DRUGINKE XLKSSLKAULIQEE-UHFFFAOYSA-N D0L1RZ DRUGSMIL COC1=CC=C(C=C1)C2=NC3=C(C=CC=C3N=C2)C(=O)N D0L1RZ HIGHSTAT Investigative D0L1ST DRUG__ID D0L1ST D0L1ST DRUGTYPE Small molecular drug D0L1ST DRUGINCH 1S/C15H11ClO2/c1-10-2-4-11(5-3-10)14(17)15(18)12-6-8-13(16)9-7-12/h2-9H,1H3 D0L1ST DRUGINKE FKOYORNUXJRIQT-UHFFFAOYSA-N D0L1ST DRUGSMIL CC1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)Cl D0L1ST HIGHSTAT Investigative D0L1UA DRUG__ID D0L1UA D0L1UA DRUGTYPE Small molecular drug D0L1UA DRUGINCH 1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27(30)28-24-25-20-22-26(29)23-21-25/h6-7,9-10,12-13,15-16,20-23,29H,2-5,8,11,14,17-19,24H2,1H3,(H,28,30)/b7-6-,10-9-,13-12-,16-15- D0L1UA DRUGINKE YSOGPKZWDUJRGP-DOFZRALJSA-N D0L1UA DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCC1=CC=C(C=C1)O D0L1UA HIGHSTAT Investigative D0L1UK DRUG__ID D0L1UK D0L1UK DRUGTYPE Small molecular drug D0L1UK DRUGINCH 1S/C14H17N3O3S/c18-14-12-3-1-4-13(11(12)5-7-16-14)21(19,20)17-9-2-6-15-8-10-17/h1,3-5,7,15H,2,6,8-10H2,(H,16,18) D0L1UK DRUGINKE ZAVGJDAFCZAWSZ-UHFFFAOYSA-N D0L1UK DRUGSMIL C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O D0L1UK HIGHSTAT Investigative D0L1VT DRUG__ID D0L1VT D0L1VT DRUGTYPE Small molecular drug D0L1VT DRUGINCH 1S/C62H90N13O14P.C5H9NO3S.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-3(7)6-4(2-10)5(8)9;/h20-21,23,28,31,34-37,41,52-53,56-57,71,76,84H,12-19,22,24-27H2,1-11H3,(H2,63,77)(H2,64,78)(H2,65,79)(H2,66,80)(H2,67,81)(H2,68,82)(H,69,83)(H,85,86);4,10H,2H2,1H3,(H,6,7)(H,8,9);/q;;+2/p-2/b38-23-,50-32-,55-33-;;/t31-,34+,35+,36+,37-,41+,52+,53+,56+,57-,59+,60-,61-,62-;4-;/m00./s1 D0L1VT DRUGINKE BZLYFDSDKLBOFC-SFSIFEIQSA-L D0L1VT DRUGSMIL CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)N7)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.CC(=O)NC(CS)C(=O)[O-].[Co+2] D0L1VT HIGHSTAT Investigative D0L1XR DRUG__ID D0L1XR D0L1XR DRUGTYPE Small molecular drug D0L1XR DRUGINCH 1S/C12H18N2O/c15-12-6-5-11-14(12)10-4-3-9-13-7-1-2-8-13/h1-2,5-11H2 D0L1XR DRUGINKE RSDOPYMFZBJHRL-UHFFFAOYSA-N D0L1XR DRUGSMIL C1CCN(C1)CC#CCN2CCCC2=O D0L1XR HIGHSTAT Investigative D0L1YA DRUG__ID D0L1YA D0L1YA DRUGTYPE Small molecular drug D0L1YA DRUGINCH 1S/C16H13NO7/c1-5(18)10-7(20)4-9-16(2,14(10)22)12-8(21)3-6(19)11(15(17)23)13(12)24-9/h3-4,19-21H,1-2H3,(H2,17,23)/t16-/m1/s1 D0L1YA DRUGINKE GEWLYFZWVLXQME-MRXNPFEDSA-N D0L1YA DRUGSMIL CC(=O)C1=C(C=C2C(C1=O)(C3=C(C=C(C(=C3O2)C(=O)N)O)O)C)O D0L1YA HIGHSTAT Investigative D0L1YC DRUG__ID D0L1YC D0L1YC DRUGTYPE Small molecular drug D0L1YC DRUGINCH 1S/C12H26O/c1-2-3-4-5-6-7-8-9-10-11-12-13/h13H,2-12H2,1H3 D0L1YC DRUGINKE LQZZUXJYWNFBMV-UHFFFAOYSA-N D0L1YC DRUGSMIL CCCCCCCCCCCCO D0L1YC HIGHSTAT Investigative D0L2AO DRUG__ID D0L2AO D0L2AO DRUGTYPE Small molecular drug D0L2AO DRUGINCH 1S/C21H24O5/c1-13(2)4-10-16-18(24)12-19(26-3)20(21(16)25)17(23)11-7-14-5-8-15(22)9-6-14/h4-6,8-9,12,22,24-25H,7,10-11H2,1-3H3 D0L2AO DRUGINKE SVTCZHIDEDUTBH-UHFFFAOYSA-N D0L2AO DRUGSMIL CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)CCC2=CC=C(C=C2)O)O)C D0L2AO HIGHSTAT Investigative D0L2AW DRUG__ID D0L2AW D0L2AW DRUGTYPE Small molecular drug D0L2AW DRUGINCH 1S/C7H13NO4/c1-4(2)3-5(7(10)11)6(9)8-12/h4-5,12H,3H2,1-2H3,(H,8,9)(H,10,11)/t5-/m1/s1 D0L2AW DRUGINKE CINIOMOBGSHXRK-RXMQYKEDSA-N D0L2AW DRUGSMIL CC(C)CC(C(=O)NO)C(=O)O D0L2AW HIGHSTAT Investigative D0L2CG DRUG__ID D0L2CG D0L2CG DRUGTYPE Small molecular drug D0L2CG DRUGINCH 1S/C11H11N3S2/c15-10(14-11-12-6-7-16-11)13-8-9-4-2-1-3-5-9/h1-7H,8H2,(H2,12,13,14,15) D0L2CG DRUGINKE PDHMEDMWKUZUAB-UHFFFAOYSA-N D0L2CG DRUGSMIL C1=CC=C(C=C1)CNC(=S)NC2=NC=CS2 D0L2CG HIGHSTAT Investigative D0L2HK DRUG__ID D0L2HK D0L2HK DRUGTYPE Small molecular drug D0L2HK DRUGINCH 1S/C23H25N3O5/c1-3-7-19(22(28)29)26(20(27)4-2)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)21-24-23(30)31-25-21/h5-6,8-13,19H,3-4,7,14H2,1-2H3,(H,28,29)(H,24,25,30)/t19-/m0/s1 D0L2HK DRUGINKE FXELTRKWYHPHAE-IBGZPJMESA-N D0L2HK DRUGSMIL CCCC(C(=O)O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NOC(=O)N3)C(=O)CC D0L2HK HIGHSTAT Investigative D0L2JS DRUG__ID D0L2JS D0L2JS DRUGTYPE Small molecular drug D0L2JS DRUGINCH 1S/C19H23NO3/c1-22-19(21)18(15-8-3-2-4-9-15)17-11-5-6-12-20(17)14-16-10-7-13-23-16/h2-4,7-10,13,17-18H,5-6,11-12,14H2,1H3/t17-,18-/m1/s1 D0L2JS DRUGINKE PKLJJOYWJBBUAO-QZTJIDSGSA-N D0L2JS DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=CO2)C3=CC=CC=C3 D0L2JS HIGHSTAT Investigative D0L2KB DRUG__ID D0L2KB D0L2KB DRUGTYPE Small molecular drug D0L2KB DRUGINCH 1S/C17H17N3O3/c1-2-23-17(22)14-15-13-8-5-9-19(13)16(21)11-6-3-4-7-12(11)20(15)10-18-14/h3-4,6-7,10,13H,2,5,8-9H2,1H3/t13-/m0/s1 D0L2KB DRUGINKE VUSVWZBQTTWZGJ-ZDUSSCGKSA-N D0L2KB DRUGSMIL CCOC(=O)C1=C2C3CCCN3C(=O)C4=CC=CC=C4N2C=N1 D0L2KB HIGHSTAT Investigative D0L2KN DRUG__ID D0L2KN D0L2KN DRUGTYPE Small molecular drug D0L2KN DRUGINCH 1S/C10H7NS2/c1-8-11-10(7-13-8)3-2-9-4-5-12-6-9/h4-7H,1H3 D0L2KN DRUGINKE DWHLLFJNQYENJN-UHFFFAOYSA-N D0L2KN DRUGSMIL CC1=NC(=CS1)C#CC2=CSC=C2 D0L2KN HIGHSTAT Investigative D0L2LQ DRUG__ID D0L2LQ D0L2LQ DRUGTYPE Small molecular drug D0L2LQ DRUGINCH 1S/C16H15NO2/c1-2-11-17-16(18)19-15-10-6-9-14(12-15)13-7-4-3-5-8-13/h2-10,12H,1,11H2,(H,17,18) D0L2LQ DRUGINKE IVZVLOUIEAWCIN-UHFFFAOYSA-N D0L2LQ DRUGSMIL C=CCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2 D0L2LQ HIGHSTAT Investigative D0L2MN DRUG__ID D0L2MN D0L2MN DRUGTYPE Small molecular drug D0L2MN DRUGINCH 1S/C17H11ClN4/c18-13-8-6-12(7-9-13)16-21-14(11-4-2-1-3-5-11)15-17(22-16)20-10-19-15/h1-10H,(H,19,20,21,22) D0L2MN DRUGINKE FPWZFVSRIINTRB-UHFFFAOYSA-N D0L2MN DRUGSMIL C1=CC=C(C=C1)C2=C3C(=NC(=N2)C4=CC=C(C=C4)Cl)N=CN3 D0L2MN HIGHSTAT Investigative D0L2MU DRUG__ID D0L2MU D0L2MU DRUGTYPE Small molecular drug D0L2MU DRUGINCH 1S/C14H9BrO3/c15-12-7-11(17)5-9-6-13(18-14(9)12)8-1-3-10(16)4-2-8/h1-7,16-17H D0L2MU DRUGINKE UBYHIUUMRHTEFF-UHFFFAOYSA-N D0L2MU DRUGSMIL C1=CC(=CC=C1C2=CC3=CC(=CC(=C3O2)Br)O)O D0L2MU HIGHSTAT Investigative D0L2QD DRUG__ID D0L2QD D0L2QD DRUGTYPE Small molecular drug D0L2QD DRUGINCH 1S/C11H8BrN3/c12-11-6-14-8-15(11)7-10-3-1-9(5-13)2-4-10/h1-4,6,8H,7H2 D0L2QD DRUGINKE MHDGKGCOBILXLM-UHFFFAOYSA-N D0L2QD DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2Br)C#N D0L2QD HIGHSTAT Investigative D0L2VI DRUG__ID D0L2VI D0L2VI DRUGTYPE Small molecular drug D0L2VI DRUGINCH 1S/C11H13Cl2NO2S/c12-8-3-7(4-9(13)5-8)6-17-2-1-10(14)11(15)16/h3-5,10H,1-2,6,14H2,(H,15,16) D0L2VI DRUGINKE CLPWTUZDSOPCKQ-UHFFFAOYSA-N D0L2VI DRUGSMIL C1=C(C=C(C=C1Cl)Cl)CSCCC(C(=O)O)N D0L2VI HIGHSTAT Investigative D0L2WP DRUG__ID D0L2WP D0L2WP DRUGTYPE Small molecular drug D0L2WP DRUGINCH 1S/C28H25N5O2/c1-17-24-11-18(6-7-27(24)33-32-17)25-12-22(14-31-28(25)19-8-9-34-15-19)35-16-21(29)10-20-13-30-26-5-3-2-4-23(20)26/h2-9,11-15,21,30H,10,16,29H2,1H3,(H,32,33)/t21-/m0/s1 D0L2WP DRUGINKE XONRTPBYDAFIRW-NRFANRHFSA-N D0L2WP DRUGSMIL CC1=C2C=C(C=CC2=NN1)C3=C(N=CC(=C3)OCC(CC4=CNC5=CC=CC=C54)N)C6=COC=C6 D0L2WP HIGHSTAT Investigative D0L3AJ DRUG__ID D0L3AJ D0L3AJ DRUGTYPE Small molecular drug D0L3AJ DRUGINCH 1S/C12H13NO2/c1-8-7-11(14)13(2)12-9(8)5-4-6-10(12)15-3/h4-7H,1-3H3 D0L3AJ DRUGINKE NCNFIHNRVBJRPR-UHFFFAOYSA-N D0L3AJ DRUGSMIL CC1=CC(=O)N(C2=C1C=CC=C2OC)C D0L3AJ HIGHSTAT Investigative D0L3AP DRUG__ID D0L3AP D0L3AP DRUGTYPE Small molecular drug D0L3AP DRUGINCH 1S/C47H59N9O8/c1-26(2)18-36(42(49)59)52-44(61)37(19-27(3)4)54-47(64)40(22-30-25-51-35-17-11-9-15-32(30)35)56-45(62)38(20-28-12-6-5-7-13-28)55-46(63)39(53-43(60)33(48)23-41(57)58)21-29-24-50-34-16-10-8-14-31(29)34/h5-17,24-27,33,36-40,50-51H,18-23,48H2,1-4H3,(H2,49,59)(H,52,61)(H,53,60)(H,54,64)(H,55,63)(H,56,62)(H,57,58)/t33-,36-,37-,38-,39+,40+/m0/s1 D0L3AP DRUGINKE AYYVHEGPWNZVTO-YAQHVWCZSA-N D0L3AP DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CC(=O)O)N D0L3AP HIGHSTAT Investigative D0L3AX DRUG__ID D0L3AX D0L3AX DRUGTYPE Small molecular drug D0L3AX DRUGINCH 1S/C16H12O/c17-16-9-7-13(8-10-16)15-6-5-12-3-1-2-4-14(12)11-15/h1-11,17H D0L3AX DRUGINKE NIRHUNSXEDESLN-UHFFFAOYSA-N D0L3AX DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CC=C(C=C3)O D0L3AX HIGHSTAT Investigative D0L3BI DRUG__ID D0L3BI D0L3BI DRUGTYPE Small molecular drug D0L3BI DRUGINCH 1S/C22H18O4/c1-2-11-25-22-17-10-12-24-19(17)14-20-21(22)18(23)13-16(26-20)9-8-15-6-4-3-5-7-15/h3-10,12-14H,2,11H2,1H3/b9-8+ D0L3BI DRUGINKE RCPBGBWHKGZPFO-CMDGGOBGSA-N D0L3BI DRUGSMIL CCCOC1=C2C=COC2=CC3=C1C(=O)C=C(O3)C=CC4=CC=CC=C4 D0L3BI HIGHSTAT Investigative D0L3BQ DRUG__ID D0L3BQ D0L3BQ DRUGTYPE Small molecular drug D0L3BQ DRUGINCH 1S/C11H15NO2/c1-8(2)7-9-3-5-10(6-4-9)11(13)12-14/h3-6,8,14H,7H2,1-2H3,(H,12,13) D0L3BQ DRUGINKE ACMIPAPWWYGZNO-UHFFFAOYSA-N D0L3BQ DRUGSMIL CC(C)CC1=CC=C(C=C1)C(=O)NO D0L3BQ HIGHSTAT Investigative D0L3DF DRUG__ID D0L3DF D0L3DF DRUGTYPE Small molecular drug D0L3DF DRUGINCH 1S/C18H13FN4S/c19-14-8-6-13(7-9-14)10-23-12-22-16-17(23)20-11-21-18(16)24-15-4-2-1-3-5-15/h1-9,11-12H,10H2 D0L3DF DRUGINKE IHJWHIRJWNFCOO-UHFFFAOYSA-N D0L3DF DRUGSMIL C1=CC=C(C=C1)SC2=NC=NC3=C2N=CN3CC4=CC=C(C=C4)F D0L3DF HIGHSTAT Investigative D0L3DM DRUG__ID D0L3DM D0L3DM DRUGTYPE Small molecular drug D0L3DM DRUGINCH 1S/C28H35N5O5/c29-21(16-19-10-12-20(34)13-11-19)27(37)33-15-5-9-24(33)26(36)31-22(17-18-6-2-1-3-7-18)28(38)32-14-4-8-23(32)25(30)35/h1-3,6-7,10-13,21-24,34H,4-5,8-9,14-17,29H2,(H2,30,35)(H,31,36)/t21?,22-,23-,24?/m1/s1 D0L3DM DRUGINKE LSQXZIUREIDSHZ-BIELFDCTSA-N D0L3DM DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D0L3DM HIGHSTAT Investigative D0L3EE DRUG__ID D0L3EE D0L3EE DRUGTYPE Small molecular drug D0L3EE DRUGINCH 1S/C19H13NOS/c21-19(14-8-2-1-3-9-14)20-15-10-4-6-12-17(15)22-18-13-7-5-11-16(18)20/h1-13H D0L3EE DRUGINKE RVBAUHGQSLEOSR-UHFFFAOYSA-N D0L3EE DRUGSMIL C1=CC=C(C=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0L3EE HIGHSTAT Investigative D0L3EP DRUG__ID D0L3EP D0L3EP DRUGTYPE Small molecular drug D0L3EP DRUGINCH 1S/C22H23F6N5O/c23-21(24,25)15-9-16(22(26,27)28)11-17(10-15)30-31-20(34)19(14-3-1-5-29-12-14)33-8-7-32-6-2-4-18(32)13-33/h1,3,5,9-12,18-19,30H,2,4,6-8,13H2,(H,31,34)/t18-,19-/m1/s1 D0L3EP DRUGINKE QNOSCJDGJKVFJR-RTBURBONSA-N D0L3EP DRUGSMIL C1CC2CN(CCN2C1)C(C3=CN=CC=C3)C(=O)NNC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D0L3EP HIGHSTAT Investigative D0L3FK DRUG__ID D0L3FK D0L3FK DRUGTYPE Small molecular drug D0L3FK DRUGINCH 1S/C13H11N3O2/c1-18-9-2-3-12-10(5-9)11(13(17)16-12)4-8-6-14-7-15-8/h2-7H,1H3,(H,14,15)(H,16,17)/b11-4- D0L3FK DRUGINKE QNUKRWAIZMBVCU-WCIBSUBMSA-N D0L3FK DRUGSMIL COC1=CC2=C(C=C1)NC(=O)C2=CC3=CN=CN3 D0L3FK HIGHSTAT Investigative D0L3GT DRUG__ID D0L3GT D0L3GT DRUGTYPE Small molecular drug D0L3GT DRUGINCH 1S/C34H37N3O4S/c38-34(35-31-17-20-41-33-21-25(13-16-30(31)33)24-37-18-7-2-8-19-37)23-32(27-10-3-1-4-11-27)36-42(39,40)29-15-14-26-9-5-6-12-28(26)22-29/h1,3-6,9-16,21-22,31-32,36H,2,7-8,17-20,23-24H2,(H,35,38)/t31-,32-/m1/s1 D0L3GT DRUGINKE IQPWKAIEQBOLPJ-ROJLCIKYSA-N D0L3GT DRUGSMIL C1CCN(CC1)CC2=CC3=C(C=C2)C(CCO3)NC(=O)CC(C4=CC=CC=C4)NS(=O)(=O)C5=CC6=CC=CC=C6C=C5 D0L3GT HIGHSTAT Investigative D0L3HO DRUG__ID D0L3HO D0L3HO DRUGTYPE Small molecular drug D0L3HO DRUGINCH 1S/C6H9NO4/c8-5(9)3-1-4(6(10)11)7-2-3/h3-4,7H,1-2H2,(H,8,9)(H,10,11)/p-1/t3-,4+/m1/s1 D0L3HO DRUGINKE NRSBQSJHFYZIPH-DMTCNVIQSA-M D0L3HO DRUGSMIL C1C(C[NH2+]C1C(=O)[O-])C(=O)[O-] D0L3HO HIGHSTAT Investigative D0L3IQ DRUG__ID D0L3IQ D0L3IQ DRUGTYPE Small molecular drug D0L3IQ DRUGINCH 1S/C25H28O5/c1-14(2)5-7-16-9-18(10-17(25(16)29)8-6-15(3)4)22-13-21(28)24-20(27)11-19(26)12-23(24)30-22/h5-6,9-12,22,26-27,29H,7-8,13H2,1-4H3/t22-/m0/s1 D0L3IQ DRUGINKE LQHKFMYWTKORCE-QFIPXVFZSA-N D0L3IQ DRUGSMIL CC(=CCC1=CC(=CC(=C1O)CC=C(C)C)C2CC(=O)C3=C(C=C(C=C3O2)O)O)C D0L3IQ HIGHSTAT Investigative D0L3IS DRUG__ID D0L3IS D0L3IS DRUGTYPE Small molecular drug D0L3IS DRUGINCH 1S/C8H18O3/c1-3-9-5-7-11-8-6-10-4-2/h3-8H2,1-2H3 D0L3IS DRUGINKE RRQYJINTUHWNHW-UHFFFAOYSA-N D0L3IS DRUGSMIL CCOCCOCCOCC D0L3IS HIGHSTAT Investigative D0L3KR DRUG__ID D0L3KR D0L3KR DRUGTYPE Small molecular drug D0L3KR DRUGINCH 1S/C16H14O6/c1-22-15-8-11(18)7-14(21)16(15)12(19)5-3-9-2-4-10(17)6-13(9)20/h2-8,17-18,20-21H,1H3/b5-3+ D0L3KR DRUGINKE NNOIQNQJIKZQCN-HWKANZROSA-N D0L3KR DRUGSMIL COC1=CC(=CC(=C1C(=O)C=CC2=C(C=C(C=C2)O)O)O)O D0L3KR HIGHSTAT Investigative D0L3MJ DRUG__ID D0L3MJ D0L3MJ DRUGTYPE Small molecular drug D0L3MJ DRUGINCH 1S/C18H20ClNO2/c1-11-4-3-5-12(8-11)15-10-20(2)7-6-13-14(15)9-16(21)18(22)17(13)19/h3-5,8-9,15,21-22H,6-7,10H2,1-2H3 D0L3MJ DRUGINKE JXMYTVOBSFOHAF-UHFFFAOYSA-N D0L3MJ DRUGSMIL CC1=CC(=CC=C1)C2CN(CCC3=C(C(=C(C=C23)O)O)Cl)C D0L3MJ HIGHSTAT Investigative D0L3PO DRUG__ID D0L3PO D0L3PO DRUGTYPE Small molecular drug D0L3PO DRUGINCH 1S/C16H10FNO3/c17-11-7-5-10(6-8-11)9-18-15(20)13-4-2-1-3-12(13)14(19)16(18)21/h1-8H,9H2 D0L3PO DRUGINKE XFTAXSAPJPVWNZ-UHFFFAOYSA-N D0L3PO DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N(C2=O)CC3=CC=C(C=C3)F D0L3PO HIGHSTAT Investigative D0L3PY DRUG__ID D0L3PY D0L3PY DRUGTYPE Small molecular drug D0L3PY DRUGINCH 1S/C40H54N8O8/c1-5-24(4)34(47-35(50)29(44-37(52)33(41)23(2)3)18-26-13-15-28(49)16-14-26)38(53)45-30(20-27-21-42-22-43-27)39(54)48-17-9-12-32(48)36(51)46-31(40(55)56)19-25-10-7-6-8-11-25/h6-8,10-11,13-16,21-24,29-34,49H,5,9,12,17-20,41H2,1-4H3,(H,42,43)(H,44,52)(H,45,53)(H,46,51)(H,47,50)(H,55,56)/t24-,29-,30-,31-,32-,33-,34-/m0/s1 D0L3PY DRUGINKE QSBGWDDCOJYQGY-KOQODJNWSA-N D0L3PY DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)N D0L3PY HIGHSTAT Investigative D0L3RY DRUG__ID D0L3RY D0L3RY DRUGTYPE Small molecular drug D0L3RY DRUGINCH 1S/C12H12N2O2S/c1-8-7-17-12(13-8)14-11(15)9-4-3-5-10(6-9)16-2/h3-7H,1-2H3,(H,13,14,15) D0L3RY DRUGINKE PAGPVSQZNPBQLP-UHFFFAOYSA-N D0L3RY DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC(=CC=C2)OC D0L3RY HIGHSTAT Investigative D0L3SA DRUG__ID D0L3SA D0L3SA DRUGTYPE Small molecular drug D0L3SA DRUGINCH 1S/C26H26FN3O/c1-31-25-12-10-20(22-11-9-18(16-28)14-23(22)27)15-21(25)17-30-24-8-5-13-29-26(24)19-6-3-2-4-7-19/h2-4,6-7,9-12,14-15,24,26,29-30H,5,8,13,17H2,1H3/t24-,26-/m0/s1 D0L3SA DRUGINKE BJOOHYLOKXAENV-AHWVRZQESA-N D0L3SA DRUGSMIL COC1=C(C=C(C=C1)C2=C(C=C(C=C2)C#N)F)CNC3CCCNC3C4=CC=CC=C4 D0L3SA HIGHSTAT Investigative D0L3SN DRUG__ID D0L3SN D0L3SN DRUGTYPE Small molecular drug D0L3SN DRUGINCH 1S/C8H7NO4/c10-7-2-1-6(5-8(7)11)3-4-9(12)13/h1-5,10-11H/b4-3+ D0L3SN DRUGINKE LLJASJHXECDHOM-ONEGZZNKSA-N D0L3SN DRUGSMIL C1=CC(=C(C=C1C=C[N+](=O)[O-])O)O D0L3SN HIGHSTAT Investigative D0L3TX DRUG__ID D0L3TX D0L3TX DRUGTYPE Small molecular drug D0L3TX DRUGINCH 1S/C14H15NO2/c16-14-10-12(15-8-4-1-5-9-15)11-6-2-3-7-13(11)17-14/h2-3,6-7,10H,1,4-5,8-9H2 D0L3TX DRUGINKE AZAXRUNIGYYEKS-UHFFFAOYSA-N D0L3TX DRUGSMIL C1CCN(CC1)C2=CC(=O)OC3=CC=CC=C32 D0L3TX HIGHSTAT Investigative D0L3VV DRUG__ID D0L3VV D0L3VV DRUGTYPE Small molecular drug D0L3VV DRUGINCH 1S/C21H22N2O5/c24-16-12-15(22-6-3-7-23-8-10-28-11-9-23)21(27)18-17(16)19(25)13-4-1-2-5-14(13)20(18)26/h1-2,4-5,12,22,24,27H,3,6-11H2 D0L3VV DRUGINKE RKTZEDQWXDOHSW-UHFFFAOYSA-N D0L3VV DRUGSMIL C1COCCN1CCCNC2=CC(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O D0L3VV HIGHSTAT Investigative D0L4AR DRUG__ID D0L4AR D0L4AR DRUGTYPE Small molecular drug D0L4AR DRUGINCH 1S/C16H13NO2/c1-10-2-7-15-13(8-10)14(18)9-16(19-15)11-3-5-12(17)6-4-11/h2-9H,17H2,1H3 D0L4AR DRUGINKE BCMMIAHCWHQZDZ-UHFFFAOYSA-N D0L4AR DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=C(C=C3)N D0L4AR HIGHSTAT Investigative D0L4CB DRUG__ID D0L4CB D0L4CB DRUGTYPE Small molecular drug D0L4CB DRUGINCH 1S/C26H36IN2O7P/c1-18(20-6-5-7-21(15-20)26(33)34)29-16-22(30)17-37(35,36)13-4-2-3-12-28-25(32)11-9-19-8-10-24(31)23(27)14-19/h5-8,10,14-15,18,22,29-31H,2-4,9,11-13,16-17H2,1H3,(H,28,32)(H,33,34)(H,35,36)/t18-,22+/m1/s1 D0L4CB DRUGINKE RLYLJDJFHZHCTR-GCJKJVERSA-N D0L4CB DRUGSMIL CC(C1=CC(=CC=C1)C(=O)O)NCC(CP(=O)(CCCCCNC(=O)CCC2=CC(=C(C=C2)O)I)O)O D0L4CB HIGHSTAT Investigative D0L4CI DRUG__ID D0L4CI D0L4CI DRUGTYPE Small molecular drug D0L4CI DRUGINCH 1S/C18H21ClN2/c1-20-11-4-12-21-17-6-3-2-5-14(17)7-8-15-9-10-16(19)13-18(15)21/h2-3,5-6,9-10,13,20H,4,7-8,11-12H2,1H3 D0L4CI DRUGINKE VPIXQGUBUKFLRF-UHFFFAOYSA-N D0L4CI DRUGSMIL CNCCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl D0L4CI HIGHSTAT Investigative D0L4DW DRUG__ID D0L4DW D0L4DW DRUGTYPE Small molecular drug D0L4DW DRUGINCH 1S/C14H27N3O2/c1-3-5-6-9-16-13(18)12-8-7-10-17(12)14(19)11(15)4-2/h11-12H,3-10,15H2,1-2H3,(H,16,18)/t11-,12-/m0/s1 D0L4DW DRUGINKE DFWCJPNYAWVSTR-RYUDHWBXSA-N D0L4DW DRUGSMIL CCCCCNC(=O)C1CCCN1C(=O)C(CC)N D0L4DW HIGHSTAT Investigative D0L4EO DRUG__ID D0L4EO D0L4EO DRUGTYPE Small molecular drug D0L4EO DRUGINCH 1S/C20H18O3/c1-2-17(14-19(21)22)20(23)18-12-10-16(11-13-18)9-8-15-6-4-3-5-7-15/h3-7,10-13,17H,2,14H2,1H3,(H,21,22) D0L4EO DRUGINKE OQWWYXZJKRAMIK-UHFFFAOYSA-N D0L4EO DRUGSMIL CCC(CC(=O)O)C(=O)C1=CC=C(C=C1)C#CC2=CC=CC=C2 D0L4EO HIGHSTAT Investigative D0L4FJ DRUG__ID D0L4FJ D0L4FJ DRUGTYPE Small molecular drug D0L4FJ DRUGINCH 1S/C23H29N3/c1-2-6-21(7-3-1)22-11-9-20(10-12-22)13-15-25-16-18-26(19-17-25)23-8-4-5-14-24-23/h1-8,11,14,20H,9-10,12-13,15-19H2 D0L4FJ DRUGINKE MQHGACGPMGUHSJ-UHFFFAOYSA-N D0L4FJ DRUGSMIL C1CC(=CCC1CCN2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=C4 D0L4FJ HIGHSTAT Investigative D0L4FM DRUG__ID D0L4FM D0L4FM DRUGTYPE Small molecular drug D0L4FM DRUGINCH 1S/C6H7NO3S/c7-11(8,9)10-6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) D0L4FM DRUGINKE XOIYZMDJFLKIEI-UHFFFAOYSA-N D0L4FM DRUGSMIL C1=CC=C(C=C1)OS(=O)(=O)N D0L4FM HIGHSTAT Investigative D0L4HJ DRUG__ID D0L4HJ D0L4HJ DRUGTYPE Small molecular drug D0L4HJ DRUGINCH 1S/C19H21N3O5/c1-23-14-8-12-13(9-15(14)24-2)20-10-21-19(12)22-11-6-16(25-3)18(27-5)17(7-11)26-4/h6-10H,1-5H3,(H,20,21,22) D0L4HJ DRUGINKE RNCVPFCGSMNPPO-UHFFFAOYSA-N D0L4HJ DRUGSMIL COC1=CC(=CC(=C1OC)OC)NC2=NC=NC3=CC(=C(C=C32)OC)OC D0L4HJ HIGHSTAT Investigative D0L4HU DRUG__ID D0L4HU D0L4HU DRUGTYPE Small molecular drug D0L4HU DRUGINCH 1S/C14H15Cl2N/c15-13-7-6-11(8-14(13)16)12(9-17)10-4-2-1-3-5-10/h6-8,10,12H,1-5H2 D0L4HU DRUGINKE HAXWFRNRCIQCDM-UHFFFAOYSA-N D0L4HU DRUGSMIL C1CCC(CC1)C(C#N)C2=CC(=C(C=C2)Cl)Cl D0L4HU HIGHSTAT Investigative D0L4IV DRUG__ID D0L4IV D0L4IV DRUGTYPE Small molecular drug D0L4IV DRUGINCH 1S/C21H27ClO6/c22-15-6-5-7-17(12-15)27-13-16(23)10-11-20-18(19(24)14-28-20)8-3-1-2-4-9-21(25)26/h1-2,5-7,10-12,16,18-20,23-24H,3-4,8-9,13-14H2,(H,25,26)/b2-1-,11-10+/t16-,18+,19+,20-/m1/s1 D0L4IV DRUGINKE GLYAVTUPQOQHAD-MOBTWWNESA-N D0L4IV DRUGSMIL C1C(C(C(O1)C=CC(COC2=CC(=CC=C2)Cl)O)CCC=CCCC(=O)O)O D0L4IV HIGHSTAT Investigative D0L4KE DRUG__ID D0L4KE D0L4KE DRUGTYPE Small molecular drug D0L4KE DRUGINCH 1S/C9H10N2O4S4/c10-18(12,13)8-3-4-9(17-8)19(14,15)11-6-7-2-1-5-16-7/h1-5,11H,6H2,(H2,10,12,13) D0L4KE DRUGINKE STOTVDLYLKWVJB-UHFFFAOYSA-N D0L4KE DRUGSMIL C1=CSC(=C1)CNS(=O)(=O)C2=CC=C(S2)S(=O)(=O)N D0L4KE HIGHSTAT Investigative D0L4MF DRUG__ID D0L4MF D0L4MF DRUGTYPE Small molecular drug D0L4MF DRUGINCH 1S/C14H8F4O2/c15-9-1-7(2-10(16)5-9)13(19)14(20)8-3-11(17)6-12(18)4-8/h1-6,13,19H D0L4MF DRUGINKE RDAYGBPKZORYGI-UHFFFAOYSA-N D0L4MF DRUGSMIL C1=C(C=C(C=C1F)F)C(C(=O)C2=CC(=CC(=C2)F)F)O D0L4MF HIGHSTAT Investigative D0L4ML DRUG__ID D0L4ML D0L4ML DRUGTYPE Small molecular drug D0L4ML DRUGINCH 1S/C12H15NO3/c14-11(10-6-2-1-3-7-10)8-4-5-9-12(15)13-16/h1-3,6-7,16H,4-5,8-9H2,(H,13,15) D0L4ML DRUGINKE XCXZDISEAMNYJL-UHFFFAOYSA-N D0L4ML DRUGSMIL C1=CC=C(C=C1)C(=O)CCCCC(=O)NO D0L4ML HIGHSTAT Investigative D0L4NF DRUG__ID D0L4NF D0L4NF DRUGTYPE Small molecular drug D0L4NF DRUGINCH 1S/C13H25N3O2/c1-4-5-8-15-11(17)10-7-6-9-16(10)12(18)13(2,3)14/h10H,4-9,14H2,1-3H3,(H,15,17)/t10-/m0/s1 D0L4NF DRUGINKE XPMXVLRTYROPLL-JTQLQIEISA-N D0L4NF DRUGSMIL CCCCNC(=O)C1CCCN1C(=O)C(C)(C)N D0L4NF HIGHSTAT Investigative D0L4NG DRUG__ID D0L4NG D0L4NG DRUGTYPE Small molecular drug D0L4NG DRUGINCH 1S/C17H17N/c1-2-13-10-16(15-7-5-9-18-12-15)11-14-6-3-4-8-17(13)14/h3-9,11-13H,2,10H2,1H3 D0L4NG DRUGINKE FTBOKBNMIAPUAJ-UHFFFAOYSA-N D0L4NG DRUGSMIL CCC1CC(=CC2=CC=CC=C12)C3=CN=CC=C3 D0L4NG HIGHSTAT Investigative D0L4NP DRUG__ID D0L4NP D0L4NP DRUGTYPE Small molecular drug D0L4NP DRUGINCH 1S/C31H34N3O8P/c1-21(36)32-28(18-23-12-15-29(26(17-23)20-35)42-43(39,40)41)30(37)33-27-9-5-6-16-34(31(27)38)19-22-10-13-25(14-11-22)24-7-3-2-4-8-24/h2-4,7-8,10-15,17,20,27-28H,5-6,9,16,18-19H2,1H3,(H,32,36)(H,33,37)(H2,39,40,41)/t27-,28-/m0/s1 D0L4NP DRUGINKE SAFPHFWYRLLBFO-NSOVKSMOSA-N D0L4NP DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)OP(=O)(O)O)C=O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D0L4NP HIGHSTAT Investigative D0L4OW DRUG__ID D0L4OW D0L4OW DRUGTYPE Small molecular drug D0L4OW DRUGINCH 1S/C22H27N3O3/c1-5-15-8-6-7-9-18(15)23-21(26)27-16-10-11-19-17(14-16)22(2)12-13-24(3)28-20(22)25(19)4/h6-11,14,20H,5,12-13H2,1-4H3,(H,23,26)/t20-,22-/m0/s1 D0L4OW DRUGINKE ZOBDWFRKFSPCRB-UNMCSNQZSA-N D0L4OW DRUGSMIL CCC1=CC=CC=C1NC(=O)OC2=CC3=C(C=C2)N(C4C3(CCN(O4)C)C)C D0L4OW HIGHSTAT Investigative D0L4PT DRUG__ID D0L4PT D0L4PT DRUGTYPE Small molecular drug D0L4PT DRUGINCH 1S/C15H11ClN2O2S/c16-15-14(17-12-8-4-5-9-13(12)18-15)10-21(19,20)11-6-2-1-3-7-11/h1-9H,10H2 D0L4PT DRUGINKE AMNQYONRCBZMGT-UHFFFAOYSA-N D0L4PT DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CC2=NC3=CC=CC=C3N=C2Cl D0L4PT HIGHSTAT Investigative D0L4QC DRUG__ID D0L4QC D0L4QC DRUGTYPE Small molecular drug D0L4QC DRUGINCH 1S/C11H9NO3/c1-6-3-2-4-7-10(6)8(13)5-9(14)11(15)12-7/h2-5,13H,1H3,(H,12,14,15) D0L4QC DRUGINKE SFRUZUUPMLUZHX-UHFFFAOYSA-N D0L4QC DRUGSMIL CC1=C2C(=CC=C1)NC(=O)C(=O)C=C2O D0L4QC HIGHSTAT Investigative D0L4RU DRUG__ID D0L4RU D0L4RU DRUGTYPE Small molecular drug D0L4RU DRUGINCH 1S/C9H16N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h1,7H,3-6,10H2,(H,14,15)(H3,11,12,13)/t7-/m0/s1 D0L4RU DRUGINKE IAYULXZCALADJD-ZETCQYMHSA-N D0L4RU DRUGSMIL C#CCNC(=NCCCC(C(=O)O)N)N D0L4RU HIGHSTAT Investigative D0L4RX DRUG__ID D0L4RX D0L4RX DRUGTYPE Small molecular drug D0L4RX DRUGINCH 1S/C26H31N7O3S/c1-26(2,3)30-25(34)17-33(37(35,36)23-7-9-28-10-8-23)21-12-20-11-19(13-27)5-6-24(20)32(15-21)16-22-14-29-18-31(22)4/h5-11,14,18,21H,12,15-17H2,1-4H3,(H,30,34) D0L4RX DRUGINKE VXYRLLDULVRHBY-UHFFFAOYSA-N D0L4RX DRUGSMIL CC(C)(C)NC(=O)CN(C1CC2=C(C=CC(=C2)C#N)N(C1)CC3=CN=CN3C)S(=O)(=O)C4=CC=NC=C4 D0L4RX HIGHSTAT Investigative D0L4TM DRUG__ID D0L4TM D0L4TM DRUGTYPE Small molecular drug D0L4TM DRUGINCH 1S/C16H16N2O/c19-16-14-10-4-5-11-15(14)17-18(16)12-6-9-13-7-2-1-3-8-13/h1-5,7-8,10-11,17H,6,9,12H2 D0L4TM DRUGINKE ZTUNGCGUHQENHO-UHFFFAOYSA-N D0L4TM DRUGSMIL C1=CC=C(C=C1)CCCN2C(=O)C3=CC=CC=C3N2 D0L4TM HIGHSTAT Investigative D0L4TY DRUG__ID D0L4TY D0L4TY DRUGTYPE Small molecular drug D0L4TY DRUGINCH 1S/C21H21N3O/c1-15(2)13-20(25)24-21-22-18(16-9-5-3-6-10-16)14-19(23-21)17-11-7-4-8-12-17/h3-12,14-15H,13H2,1-2H3,(H,22,23,24,25) D0L4TY DRUGINKE RLCNDGHLHOXEDS-UHFFFAOYSA-N D0L4TY DRUGSMIL CC(C)CC(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D0L4TY HIGHSTAT Investigative D0L4UV DRUG__ID D0L4UV D0L4UV DRUGTYPE Small molecular drug D0L4UV DRUGINCH 1S/C19H17ClF3NO3/c20-15-3-1-2-13(8-15)10-17(25)24-16(11-18(26)27)9-12-4-6-14(7-5-12)19(21,22)23/h1-8,16H,9-11H2,(H,24,25)(H,26,27)/t16-/m0/s1 D0L4UV DRUGINKE QOSIJVVNNGXEKE-INIZCTEOSA-N D0L4UV DRUGSMIL C1=CC(=CC(=C1)Cl)CC(=O)NC(CC2=CC=C(C=C2)C(F)(F)F)CC(=O)O D0L4UV HIGHSTAT Investigative D0L4VR DRUG__ID D0L4VR D0L4VR DRUGTYPE Small molecular drug D0L4VR DRUGINCH 1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1 D0L4VR DRUGINKE OBZHEBDUNPOCJG-WBXJDKIVSA-N D0L4VR DRUGSMIL CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C D0L4VR HIGHSTAT Investigative D0L4WB DRUG__ID D0L4WB D0L4WB DRUGTYPE Small molecular drug D0L4WB DRUGINCH 1S/C16H20N2O/c1-11-5-8-13(9-6-11)19-14-4-2-3-12-7-10-15(17)18-16(12)14/h2-4,7,10-11,13H,5-6,8-9H2,1H3,(H2,17,18) D0L4WB DRUGINKE OQURIDUAVDCPLT-UHFFFAOYSA-N D0L4WB DRUGSMIL CC1CCC(CC1)OC2=CC=CC3=C2N=C(C=C3)N D0L4WB HIGHSTAT Investigative D0L4WN DRUG__ID D0L4WN D0L4WN DRUGTYPE Small molecular drug D0L4WN DRUGINCH 1S/C14H10N2O2/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6H,15-16H2 D0L4WN DRUGINKE FBMQNRKSAWNXBT-UHFFFAOYSA-N D0L4WN DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)N)N D0L4WN HIGHSTAT Investigative D0L4YF DRUG__ID D0L4YF D0L4YF DRUGTYPE Small molecular drug D0L4YF DRUGINCH 1S/C12H9N3/c1-2-6-10-9(5-1)14-12(15-10)11-7-3-4-8-13-11/h1-8H,(H,14,15) D0L4YF DRUGINKE YNFBMDWHEHETJW-UHFFFAOYSA-N D0L4YF DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=CC=CC=N3 D0L4YF HIGHSTAT Investigative D0L5AB DRUG__ID D0L5AB D0L5AB DRUGTYPE Small molecular drug D0L5AB DRUGINCH 1S/C15H14N4O2/c1-8(11-3-2-6-17-11)13-10-7-9(18-15(16)21)4-5-12(10)19-14(13)20/h2-7,17H,1H3,(H,19,20)(H3,16,18,21)/b13-8- D0L5AB DRUGINKE DFURSNCTQGJRRX-JYRVWZFOSA-N D0L5AB DRUGSMIL CC(=C1C2=C(C=CC(=C2)NC(=O)N)NC1=O)C3=CC=CN3 D0L5AB HIGHSTAT Investigative D0L5AG DRUG__ID D0L5AG D0L5AG DRUGTYPE Small molecular drug D0L5AG DRUGINCH 1S/C21H21N3O3/c1-2-27-17-10-8-16(9-11-17)22-14-21(26)24-23-13-19-18-6-4-3-5-15(18)7-12-20(19)25/h3-13,22,25H,2,14H2,1H3,(H,24,26)/b23-13+ D0L5AG DRUGINKE JWRJGCUSLSJMMD-YDZHTSKRSA-N D0L5AG DRUGSMIL CCOC1=CC=C(C=C1)NCC(=O)NN=CC2=C(C=CC3=CC=CC=C32)O D0L5AG HIGHSTAT Investigative D0L5BW DRUG__ID D0L5BW D0L5BW DRUGTYPE Small molecular drug D0L5BW DRUGINCH 1S/C25H24Cl2N2O/c1-3-22-16(2)24(28-20-9-5-4-6-10-20)21-11-7-8-12-23(21)29(22)25(30)17-13-18(26)15-19(27)14-17/h4-16,22,24,28H,3H2,1-2H3/t16-,22-,24+/m1/s1 D0L5BW DRUGINKE DKLLTFTXYHJXHK-OAEOJWKDSA-N D0L5BW DRUGSMIL CCC1C(C(C2=CC=CC=C2N1C(=O)C3=CC(=CC(=C3)Cl)Cl)NC4=CC=CC=C4)C D0L5BW HIGHSTAT Investigative D0L5DN DRUG__ID D0L5DN D0L5DN DRUGTYPE Small molecular drug D0L5DN DRUGINCH 1S/C20H28N2/c21-16-7-6-15-11-19-17-3-1-2-8-20(17,18(15)12-16)9-10-22(19)13-14-4-5-14/h6-7,12,14,17,19H,1-5,8-11,13,21H2/t17-,19+,20+/m0/s1 D0L5DN DRUGINKE JUWFFFGTHLQORF-DFQSSKMNSA-N D0L5DN DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)N)CC5CC5 D0L5DN HIGHSTAT Investigative D0L5EW DRUG__ID D0L5EW D0L5EW DRUGTYPE Small molecular drug D0L5EW DRUGINCH 1S/C15H19NO/c1-3-17-15-7-6-13-9-12(8-11(2)16)4-5-14(13)10-15/h4-7,9-11H,3,8,16H2,1-2H3 D0L5EW DRUGINKE RIBPBDJODPIITD-UHFFFAOYSA-N D0L5EW DRUGSMIL CCOC1=CC2=C(C=C1)C=C(C=C2)CC(C)N D0L5EW HIGHSTAT Investigative D0L5FW DRUG__ID D0L5FW D0L5FW DRUGTYPE Small molecular drug D0L5FW DRUGINCH 1S/C13H10N2O/c1-16-13-8-11(9-14-10-13)5-6-12-4-2-3-7-15-12/h2-4,7-10H,1H3/i1T3 D0L5FW DRUGINKE VRTFKUFTEWQHDD-RLXJOQACSA-N D0L5FW DRUGSMIL COC1=CN=CC(=C1)C#CC2=CC=CC=N2 D0L5FW HIGHSTAT Investigative D0L5GS DRUG__ID D0L5GS D0L5GS DRUGTYPE Small molecular drug D0L5GS DRUGINCH 1S/C20H16N4/c1-14-6-8-15(9-7-14)23-20-22-13-11-19(24-20)17-10-12-21-18-5-3-2-4-16(17)18/h2-13H,1H3,(H,22,23,24) D0L5GS DRUGINKE HFJKLAQBWSUMDJ-UHFFFAOYSA-N D0L5GS DRUGSMIL CC1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC=NC4=CC=CC=C34 D0L5GS HIGHSTAT Investigative D0L5IC DRUG__ID D0L5IC D0L5IC DRUGTYPE Small molecular drug D0L5IC DRUGINCH 1S/C23H23ClO2/c24-13-12-22(26)10-11-23(15-17-4-2-1-3-5-17)19(16-22)7-6-18-14-20(25)8-9-21(18)23/h1-5,8-9,14,19,25-26H,6-7,10-11,15-16H2/t19-,22+,23+/m1/s1 D0L5IC DRUGINKE CNOAOQSZNOTZLQ-OIBXWCBGSA-N D0L5IC DRUGSMIL C1CC2=C(C=CC(=C2)O)C3(C1CC(CC3)(C#CCl)O)CC4=CC=CC=C4 D0L5IC HIGHSTAT Investigative D0L5IM DRUG__ID D0L5IM D0L5IM DRUGTYPE Small molecular drug D0L5IM DRUGINCH 1S/C23H27NO2/c1-4-5-10-15-24-17(2)23(19-12-7-8-13-20(19)24)21(25)16-18-11-6-9-14-22(18)26-3/h6-9,11-14H,4-5,10,15-16H2,1-3H3 D0L5IM DRUGINKE HGGHYEFHTTXEIQ-UHFFFAOYSA-N D0L5IM DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3OC)C D0L5IM HIGHSTAT Investigative D0L5IN DRUG__ID D0L5IN D0L5IN DRUGTYPE Small molecular drug D0L5IN DRUGINCH 1S/C6H13NO2/c1-2-5(7)3-4-6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 D0L5IN DRUGINKE ROFNJLCLYMMXCT-YFKPBYRVSA-N D0L5IN DRUGSMIL CCC(CCC(=O)O)N D0L5IN HIGHSTAT Investigative D0L5JL DRUG__ID D0L5JL D0L5JL DRUGTYPE Small molecular drug D0L5JL DRUGINCH 1S/C12H16N4O2/c1-15-10-8(11(17)16(2)12(15)18)13-9(14-10)7-5-3-4-6-7/h7H,3-6H2,1-2H3,(H,13,14) D0L5JL DRUGINKE SCVHFRLUNIOSGI-UHFFFAOYSA-N D0L5JL DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3CCCC3 D0L5JL HIGHSTAT Investigative D0L5KP DRUG__ID D0L5KP D0L5KP DRUGTYPE Small molecular drug D0L5KP DRUGINCH 1S/C16H24N2O3/c1-12-9-10-14(11-13(12)2)17-15(19)7-5-3-4-6-8-16(20)18-21/h9-11,21H,3-8H2,1-2H3,(H,17,19)(H,18,20) D0L5KP DRUGINKE NJRGPRXJOLGSNN-UHFFFAOYSA-N D0L5KP DRUGSMIL CC1=C(C=C(C=C1)NC(=O)CCCCCCC(=O)NO)C D0L5KP HIGHSTAT Investigative D0L5KQ DRUG__ID D0L5KQ D0L5KQ DRUGTYPE Small molecular drug D0L5KQ DRUGINCH 1S/C14H18N2O2/c1-3-14(4-2)12(17)16-13(18-14)15-10-11-8-6-5-7-9-11/h5-9H,3-4,10H2,1-2H3,(H,15,16,17) D0L5KQ DRUGINKE UYIBORRFWIVHQJ-UHFFFAOYSA-N D0L5KQ DRUGSMIL CCC1(C(=O)NC(=NCC2=CC=CC=C2)O1)CC D0L5KQ HIGHSTAT Investigative D0L5KY DRUG__ID D0L5KY D0L5KY DRUGTYPE Small molecular drug D0L5KY DRUGINCH 1S/C9H17N3O2/c1-2-4-8(11)12-6-3-5-7(10)9(13)14/h2,4,7H,3,5-6,10H2,1H3,(H2,11,12)(H,13,14)/b4-2+/t7-/m0/s1 D0L5KY DRUGINKE RIIDRLUFTKIGSQ-XBBYQOBLSA-N D0L5KY DRUGSMIL CC=CC(=NCCCC(C(=O)O)N)N D0L5KY HIGHSTAT Investigative D0L5LN DRUG__ID D0L5LN D0L5LN DRUGTYPE Small molecular drug D0L5LN DRUGINCH 1S/C14H8O2/c15-13-9-5-1-2-6-10(9)14(16)12-8-4-3-7-11(12)13/h1-8H D0L5LN DRUGINKE RZVHIXYEVGDQDX-UHFFFAOYSA-N D0L5LN DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O D0L5LN HIGHSTAT Investigative D0L5OU DRUG__ID D0L5OU D0L5OU DRUGTYPE Small molecular drug D0L5OU DRUGINCH 1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3/i2-1 D0L5OU DRUGINKE JOLJIIDDOBNFHW-JVVVGQRLSA-N D0L5OU DRUGSMIL CCCCCCOC1=NSN=C1C2=CCCN(C2)C D0L5OU HIGHSTAT Investigative D0L5QJ DRUG__ID D0L5QJ D0L5QJ DRUGTYPE Small molecular drug D0L5QJ DRUGINCH 1S/C19H28N2.2BrH/c1(2-4-8-14-20-16-10-6-11-17-20)3-5-9-15-21-18-12-7-13-19-21;;/h6-7,10-13,16-19H,1-5,8-9,14-15H2;2*1H/q+2;;/p-2 D0L5QJ DRUGINKE UOOOOWOODBZUKX-UHFFFAOYSA-L D0L5QJ DRUGSMIL C1=CC=[N+](C=C1)CCCCCCCCC[N+]2=CC=CC=C2.[Br-].[Br-] D0L5QJ HIGHSTAT Investigative D0L5RI DRUG__ID D0L5RI D0L5RI DRUGTYPE Small molecular drug D0L5RI DRUGINCH 1S/C6H12N2S2/c1-5(7)6(9)8-2-3-10-4-8/h5H,2-4,7H2,1H3/t5-/m0/s1 D0L5RI DRUGINKE NRUOPZCNSMPDPG-YFKPBYRVSA-N D0L5RI DRUGSMIL CC(C(=S)N1CCSC1)N D0L5RI HIGHSTAT Investigative D0L5RY DRUG__ID D0L5RY D0L5RY DRUGTYPE Small molecular drug D0L5RY DRUGINCH 1S/C161H269N49O42/c1-23-27-41-96(189-145(239)107(52-59-123(217)218)199-152(246)114(71-84(13)14)207-157(251)126(85(15)16)208-147(241)108(53-60-124(219)220)197-140(234)102(47-38-66-179-161(172)173)193-151(245)112(69-82(9)10)204-153(247)113(70-83(11)12)205-155(249)116(74-94-77-175-79-181-94)201-134(228)95(163)72-92-39-30-29-31-40-92)135(229)182-88(19)130(224)186-100(45-36-64-177-159(168)169)136(230)183-89(20)131(225)188-106(51-58-122(215)216)144(238)195-104(49-56-119(165)212)146(240)202-110(67-80(5)6)149(243)185-90(21)132(226)187-103(48-55-118(164)211)143(237)196-105-50-57-121(214)176-63-35-33-44-99(192-154(248)115(73-93-76-174-78-180-93)200-133(227)91(22)184-137(105)231)142(236)206-117(75-120(166)213)156(250)194-101(46-37-65-178-160(170)171)139(233)190-98(43-32-34-62-162)141(235)203-111(68-81(7)8)150(244)191-97(42-28-24-2)138(232)198-109(54-61-125(221)222)148(242)210-128(87(18)26-4)158(252)209-127(129(167)223)86(17)25-3/h29-31,39-40,76-91,95-117,126-128H,23-28,32-38,41-75,162-163H2,1-22H3,(H2,164,211)(H2,165,212)(H2,166,213)(H2,167,223)(H,174,180)(H,175,181)(H,176,214)(H,182,229)(H,183,230)(H,184,231)(H,185,243)(H,186,224)(H,187,226)(H,188,225)(H,189,239)(H,190,233)(H,191,244)(H,192,248)(H,193,245)(H,194,250)(H,195,238)(H,196,237)(H,197,234)(H,198,232)(H,199,246)(H,200,227)(H,201,228)(H,202,240)(H,203,235)(H,204,247)(H,205,249)(H,206,236)(H,207,251)(H,208,241)(H,209,252)(H,210,242)(H,215,216)(H,217,218)(H,219,220)(H,221,222)(H4,168,169,177)(H4,170,171,178)(H4,172,173,179)/t86-,87-,88-,89-,90-,91-,95+,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,126-,127-,128-/m0/s1 D0L5RY DRUGINKE HPYIIXJJVYSMCV-MGDXKYBTSA-N D0L5RY DRUGSMIL CCCCC(C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC1CCC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC1=O)C)CC2=CNC=N2)C(=O)NC(CC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCC)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(C(C)CC)C(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC3=CNC=N3)NC(=O)C(CC4=CC=CC=C4)N D0L5RY HIGHSTAT Investigative D0L5TZ DRUG__ID D0L5TZ D0L5TZ DRUGTYPE Small molecular drug D0L5TZ DRUGINCH 1S/C10H8O3/c11-6-7-1-3-9-8(5-7)2-4-10(12)13-9/h1-5,11H,6H2 D0L5TZ DRUGINKE BPTGMUVORRVIEP-UHFFFAOYSA-N D0L5TZ DRUGSMIL C1=CC2=C(C=CC(=O)O2)C=C1CO D0L5TZ HIGHSTAT Investigative D0L5UC DRUG__ID D0L5UC D0L5UC DRUGTYPE Small molecular drug D0L5UC DRUGINCH 1S/C12H13NO3/c1-3-12(9-7-5-4-6-8-9)10(14)13(2)11(15)16-12/h4-8H,3H2,1-2H3 D0L5UC DRUGINKE BWNMMRKYEBCJHN-UHFFFAOYSA-N D0L5UC DRUGSMIL CCC1(C(=O)N(C(=O)O1)C)C2=CC=CC=C2 D0L5UC HIGHSTAT Investigative D0L5WI DRUG__ID D0L5WI D0L5WI DRUGTYPE Small molecular drug D0L5WI DRUGINCH 1S/C18H23NO2/c20-18(19-21)11-5-3-1-2-4-8-15-12-13-16-9-6-7-10-17(16)14-15/h6-7,9-10,12-14,21H,1-5,8,11H2,(H,19,20) D0L5WI DRUGINKE KWFDCRKEDDNSLQ-UHFFFAOYSA-N D0L5WI DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CCCCCCCC(=O)NO D0L5WI HIGHSTAT Investigative D0L5WS DRUG__ID D0L5WS D0L5WS DRUGTYPE Small molecular drug D0L5WS DRUGINCH 1S/C18H29N5O4/c1-12(13(2)24)22-16(25)15(9-6-10-21-17(19)20)23-18(26)27-11-14-7-4-3-5-8-14/h3-5,7-8,12,15,17,21H,6,9-11,19-20H2,1-2H3,(H,22,25)(H,23,26)/t12-,15-/m0/s1 D0L5WS DRUGINKE SLLMMFWUJVANSC-WFASDCNBSA-N D0L5WS DRUGSMIL CC(C(=O)C)NC(=O)C(CCCNC(N)N)NC(=O)OCC1=CC=CC=C1 D0L5WS HIGHSTAT Investigative D0L5XK DRUG__ID D0L5XK D0L5XK DRUGTYPE Small molecular drug D0L5XK DRUGINCH 1S/C10H9NO2/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5H,11H2,1H3 D0L5XK DRUGINKE GLNDAGDHSLMOKX-UHFFFAOYSA-N D0L5XK DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2)N D0L5XK HIGHSTAT Investigative D0L5XY DRUG__ID D0L5XY D0L5XY DRUGTYPE Small molecular drug D0L5XY DRUGINCH 1S/C14H17N3O2/c15-14(19)13-8-17(10-16-13)12(9-18)7-6-11-4-2-1-3-5-11/h1-5,8,10,12,18H,6-7,9H2,(H2,15,19)/t12-/m1/s1 D0L5XY DRUGINKE ZUYUIKKHHBEVHL-GFCCVEGCSA-N D0L5XY DRUGSMIL C1=CC=C(C=C1)CCC(CO)N2C=C(N=C2)C(=O)N D0L5XY HIGHSTAT Investigative D0L5YC DRUG__ID D0L5YC D0L5YC DRUGTYPE Small molecular drug D0L5YC DRUGINCH 1S/C11H15NO/c1-13-11-4-2-3-8-5-6-9(12)7-10(8)11/h2-4,9H,5-7,12H2,1H3 D0L5YC DRUGINKE RVKOHSCTEHZRRT-UHFFFAOYSA-N D0L5YC DRUGSMIL COC1=CC=CC2=C1CC(CC2)N D0L5YC HIGHSTAT Investigative D0L6CN DRUG__ID D0L6CN D0L6CN DRUGTYPE Small molecular drug D0L6CN DRUGINCH 1S/C6H10NO8P/c8-4(2-16(13,14)15)7-3(6(11)12)1-5(9)10/h3H,1-2H2,(H,7,8)(H,9,10)(H,11,12)(H2,13,14,15)/p-3/t3-/m0/s1 D0L6CN DRUGINKE ZZKNRXZVGOYGJT-VKHMYHEASA-K D0L6CN DRUGSMIL C(C(C(=O)[O-])NC(=O)CP(=O)(O)[O-])C(=O)[O-] D0L6CN HIGHSTAT Investigative D0L6GV DRUG__ID D0L6GV D0L6GV DRUGTYPE Small molecular drug D0L6GV DRUGINCH 1S/C30H18O4/c31-25-17-29(33-27-7-3-1-5-23(25)27)21-13-9-19(10-14-21)20-11-15-22(16-12-20)30-18-26(32)24-6-2-4-8-28(24)34-30/h1-18H D0L6GV DRUGINKE HTPYEYLGDZAIRX-UHFFFAOYSA-N D0L6GV DRUGSMIL C1=CC=C2C(=C1)C(=O)C=C(O2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CC(=O)C6=CC=CC=C6O5 D0L6GV HIGHSTAT Investigative D0L6HE DRUG__ID D0L6HE D0L6HE DRUGTYPE Small molecular drug D0L6HE DRUGINCH 1S/C15H10F2O2/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-7,14H,8H2/t14-/m0/s1 D0L6HE DRUGINKE YKJLGNVYFBPKJK-AWEZNQCLSA-N D0L6HE DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)F)C3=CC=C(C=C3)F D0L6HE HIGHSTAT Investigative D0L6HX DRUG__ID D0L6HX D0L6HX DRUGTYPE Small molecular drug D0L6HX DRUGINCH 1S/C29H36FN3O5/c1-18(2)27-25(15-14-23(34)16-24(35)17-26(36)37)33(22-12-10-21(30)11-13-22)31-28(27)29(38)32(4)19(3)20-8-6-5-7-9-20/h5-13,18-19,23-24,34-35H,14-17H2,1-4H3,(H,36,37)/p-1/t19-,23-,24-/m1/s1 D0L6HX DRUGINKE MPDDTAJMJCESGV-CTUHWIOQSA-M D0L6HX DRUGSMIL CC(C)C1=C(N(N=C1C(=O)N(C)C(C)C2=CC=CC=C2)C3=CC=C(C=C3)F)CCC(CC(CC(=O)[O-])O)O D0L6HX HIGHSTAT Investigative D0L6HY DRUG__ID D0L6HY D0L6HY DRUGTYPE Small molecular drug D0L6HY DRUGINCH 1S/C28H22N2/c1-3-7-22(8-4-1)24-11-15-26(16-12-24)28(30-20-19-29-21-30)27-17-13-25(14-18-27)23-9-5-2-6-10-23/h1-21,28H D0L6HY DRUGINKE CKRNCVRILASGRW-UHFFFAOYSA-N D0L6HY DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=C(C=C3)C4=CC=CC=C4)N5C=CN=C5 D0L6HY HIGHSTAT Investigative D0L6IQ DRUG__ID D0L6IQ D0L6IQ DRUGTYPE Small molecular drug D0L6IQ DRUGINCH 1S/C16H13NO3/c1-20-16-9-15(10-2-4-11(18)5-3-10)17-14-7-6-12(19)8-13(14)16/h2-9,18-19H,1H3 D0L6IQ DRUGINKE IOTUBGYZUXLZPC-UHFFFAOYSA-N D0L6IQ DRUGSMIL COC1=CC(=NC2=C1C=C(C=C2)O)C3=CC=C(C=C3)O D0L6IQ HIGHSTAT Investigative D0L6JS DRUG__ID D0L6JS D0L6JS DRUGTYPE Small molecular drug D0L6JS DRUGINCH 1S/C12H17N5/c1-8-9(17-12-15-6-7-16-12)2-3-10-11(8)14-5-4-13-10/h2-3,13-14H,4-7H2,1H3,(H2,15,16,17) D0L6JS DRUGINKE PGOVKWAJCVAZNG-UHFFFAOYSA-N D0L6JS DRUGSMIL CC1=C(C=CC2=C1NCCN2)NC3=NCCN3 D0L6JS HIGHSTAT Investigative D0L6LO DRUG__ID D0L6LO D0L6LO DRUGTYPE Small molecular drug D0L6LO DRUGINCH 1S/C14H18N2/c1-2-12(7-15-3-1)14-13-5-10-4-11(6-13)9-16(14)8-10/h1-3,7,10-11,13-14H,4-6,8-9H2/t10-,11+,13?,14-/m0/s1 D0L6LO DRUGINKE INDYXBQOPZTSTJ-OWZDMKDPSA-N D0L6LO DRUGSMIL C1C2CC3CC1CN(C2)C3C4=CN=CC=C4 D0L6LO HIGHSTAT Investigative D0L6ND DRUG__ID D0L6ND D0L6ND DRUGTYPE Small molecular drug D0L6ND DRUGINCH 1S/C10H7Br2N5/c11-4-3-6(15-9(4)12)7-8-5(1-2-14-7)16-10(13)17-8/h1-3,15H,(H3,13,16,17) D0L6ND DRUGINKE QAKGJAQGTQLMFN-UHFFFAOYSA-N D0L6ND DRUGSMIL C1=CN=C(C2=C1NC(=N2)N)C3=CC(=C(N3)Br)Br D0L6ND HIGHSTAT Investigative D0L6PL DRUG__ID D0L6PL D0L6PL DRUGTYPE Small molecular drug D0L6PL DRUGINCH 1S/C18H13N3/c1-14-13-19-21-18(20-14)12-9-15-7-10-17(11-8-15)16-5-3-2-4-6-16/h2-8,10-11,13H,1H3 D0L6PL DRUGINKE OXVAGVMMJCNKRK-UHFFFAOYSA-N D0L6PL DRUGSMIL CC1=CN=NC(=N1)C#CC2=CC=C(C=C2)C3=CC=CC=C3 D0L6PL HIGHSTAT Investigative D0L6QN DRUG__ID D0L6QN D0L6QN DRUGTYPE Small molecular drug D0L6QN DRUGINCH 1S/C25H32N2O3/c1-4-23(28)27(22-13-9-6-10-14-22)25(24(29)30-3)16-18-26(19-20(25)2)17-15-21-11-7-5-8-12-21/h5-14,20H,4,15-19H2,1-3H3/t20-,25+/m1/s1 D0L6QN DRUGINKE IMYHGORQCPYVBZ-NLFFAJNJSA-N D0L6QN DRUGSMIL CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2C)CCC3=CC=CC=C3)C(=O)OC D0L6QN HIGHSTAT Investigative D0L6RT DRUG__ID D0L6RT D0L6RT DRUGTYPE Small molecular drug D0L6RT DRUGINCH 1S/C23H26N2O3/c1-17-22(23(26)18-7-9-19(27-2)10-8-18)20-5-3-4-6-21(20)25(17)12-11-24-13-15-28-16-14-24/h3-10H,11-16H2,1-2H3 D0L6RT DRUGINKE MEUQWHZOUDZXHH-UHFFFAOYSA-N D0L6RT DRUGSMIL CC1=C(C2=CC=CC=C2N1CCN3CCOCC3)C(=O)C4=CC=C(C=C4)OC D0L6RT HIGHSTAT Investigative D0L6RV DRUG__ID D0L6RV D0L6RV DRUGTYPE Small molecular drug D0L6RV DRUGINCH 1S/C12H6Br4O2/c13-6-1-2-11(8(15)3-6)18-12-9(16)4-7(14)5-10(12)17/h1-5,17H D0L6RV DRUGINKE SNCQITRZEBFIRW-UHFFFAOYSA-N D0L6RV DRUGSMIL C1=CC(=C(C=C1Br)Br)OC2=C(C=C(C=C2Br)Br)O D0L6RV HIGHSTAT Investigative D0L6RY DRUG__ID D0L6RY D0L6RY DRUGTYPE Small molecular drug D0L6RY DRUGINCH 1S/C15H20FNO/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11H2,1H3 D0L6RY DRUGINKE BQLSUBYYRRZHRK-UHFFFAOYSA-N D0L6RY DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)F)N2CCCC2 D0L6RY HIGHSTAT Investigative D0L6TP DRUG__ID D0L6TP D0L6TP DRUGTYPE Small molecular drug D0L6TP DRUGINCH 1S/C14H16N2O3S/c1-2-10-20(17,18)16-13-8-9-15-11-14(13)19-12-6-4-3-5-7-12/h3-9,11H,2,10H2,1H3,(H,15,16) D0L6TP DRUGINKE LHXILNAQPGRTDA-UHFFFAOYSA-N D0L6TP DRUGSMIL CCCS(=O)(=O)NC1=C(C=NC=C1)OC2=CC=CC=C2 D0L6TP HIGHSTAT Investigative D0L6TQ DRUG__ID D0L6TQ D0L6TQ DRUGTYPE Small molecular drug D0L6TQ DRUGINCH 1S/C27H29N3O3/c28-24-17-23(24)21-12-7-13-22(16-21)33-15-14-25(30-26(31)20-10-5-2-6-11-20)27(32)29-18-19-8-3-1-4-9-19/h1-13,16,23-25H,14-15,17-18,28H2,(H,29,32)(H,30,31)/t23-,24+,25+/m0/s1 D0L6TQ DRUGINKE DTPSXFMGMQOVTG-ISJGIBHGSA-N D0L6TQ DRUGSMIL C1C(C1N)C2=CC(=CC=C2)OCCC(C(=O)NCC3=CC=CC=C3)NC(=O)C4=CC=CC=C4 D0L6TQ HIGHSTAT Investigative D0L6VM DRUG__ID D0L6VM D0L6VM DRUGTYPE Small molecular drug D0L6VM DRUGINCH 1S/C25H34FNO3/c1-2-3-4-5-6-7-8-9-10-13-20-29-22-18-16-21(17-19-22)27-25(28)30-24-15-12-11-14-23(24)26/h11-12,14-19H,2-10,13,20H2,1H3,(H,27,28) D0L6VM DRUGINKE WEDCHEHVZVVAIL-UHFFFAOYSA-N D0L6VM DRUGSMIL CCCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F D0L6VM HIGHSTAT Investigative D0L6YF DRUG__ID D0L6YF D0L6YF DRUGTYPE Small molecular drug D0L6YF DRUGINCH 1S/C13H18N2O4/c1-19-11-8-6-10(7-9-11)14-12(16)4-2-3-5-13(17)15-18/h6-9,18H,2-5H2,1H3,(H,14,16)(H,15,17) D0L6YF DRUGINKE QYJANBGLOGFJLV-UHFFFAOYSA-N D0L6YF DRUGSMIL COC1=CC=C(C=C1)NC(=O)CCCCC(=O)NO D0L6YF HIGHSTAT Investigative D0L6YI DRUG__ID D0L6YI D0L6YI DRUGTYPE Small molecular drug D0L6YI DRUGINCH 1S/C20H21BrN6O5/c21-10-1-2-12-11(5-10)9(6-23-12)3-4-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)13(7-28)32-19/h1-2,5-6,8,13,15-16,19,23,28-30H,3-4,7H2,(H2,22,25,26)/t13-,15-,16-,19-/m1/s1 D0L6YI DRUGINKE ZUYSJPWNKBPSJB-NVQRDWNXSA-N D0L6YI DRUGSMIL C1=CC2=C(C=C1Br)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0L6YI HIGHSTAT Investigative D0L6ZY DRUG__ID D0L6ZY D0L6ZY DRUGTYPE Small molecular drug D0L6ZY DRUGINCH 1S/C12H10N4/c13-8-4-5-9-11(7-8)16-12(15-9)10-3-1-2-6-14-10/h1-7H,13H2,(H,15,16) D0L6ZY DRUGINKE ITFXYBZUPPBWEC-UHFFFAOYSA-N D0L6ZY DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(N2)C=C(C=C3)N D0L6ZY HIGHSTAT Investigative D0L7AO DRUG__ID D0L7AO D0L7AO DRUGTYPE Small molecular drug D0L7AO DRUGINCH 1S/C8H15NO2/c9-6-8(5-7(10)11)3-1-2-4-8/h1-6,9H2,(H,10,11) D0L7AO DRUGINKE MKGSCDBHUPQQMX-UHFFFAOYSA-N D0L7AO DRUGSMIL C1CCC(C1)(CC(=O)O)CN D0L7AO HIGHSTAT Investigative D0L7AT DRUG__ID D0L7AT D0L7AT DRUGTYPE Small molecular drug D0L7AT DRUGINCH 1S/C24H16O12/c25-9-1-10(26)3-12(2-9)34-22-17(31)8-18(32)23-24(22)36-21-16(30)6-13(7-19(21)35-23)33-20-14(28)4-11(27)5-15(20)29/h1-8,25-32H D0L7AT DRUGINKE JLEVVQRBEATTCM-UHFFFAOYSA-N D0L7AT DRUGSMIL C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C=C4O3)OC5=C(C=C(C=C5O)O)O)O)O)O)O D0L7AT HIGHSTAT Investigative D0L7AW DRUG__ID D0L7AW D0L7AW DRUGTYPE Small molecular drug D0L7AW DRUGINCH 1S/C24H32N2O3/c1-2-3-4-5-6-7-8-12-19-28-23-17-15-22(16-18-23)26-24(27)29-25-20-21-13-10-9-11-14-21/h9-11,13-18,20H,2-8,12,19H2,1H3,(H,26,27)/b25-20+ D0L7AW DRUGINKE LFWYEOAFEYYRNZ-LKUDQCMESA-N D0L7AW DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D0L7AW HIGHSTAT Investigative D0L7AY DRUG__ID D0L7AY D0L7AY DRUGTYPE Small molecular drug D0L7AY DRUGINCH 1S/C20H31N4O5P/c1-5-13(3)18(24-30(27,28)29-6-2)20(26)23-17(19(25)21-4)11-14-12-22-16-10-8-7-9-15(14)16/h7-10,12-13,17-18,22H,5-6,11H2,1-4H3,(H,21,25)(H,23,26)(H2,24,27,28)/p-1/t13-,17?,18-/m0/s1 D0L7AY DRUGINKE IHAZHCJWGLQJQS-VCMPKCBFSA-M D0L7AY DRUGSMIL CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC)NP(=O)([O-])OCC D0L7AY HIGHSTAT Investigative D0L7BK DRUG__ID D0L7BK D0L7BK DRUGTYPE Small molecular drug D0L7BK DRUGINCH 1S/C20H26N2/c1-3-7-18(8-4-1)11-12-20(22-15-13-21-14-16-22)17-19-9-5-2-6-10-19/h1-10,20-21H,11-17H2 D0L7BK DRUGINKE OGFNNMZMCOBWPR-UHFFFAOYSA-N D0L7BK DRUGSMIL C1CN(CCN1)C(CCC2=CC=CC=C2)CC3=CC=CC=C3 D0L7BK HIGHSTAT Investigative D0L7DB DRUG__ID D0L7DB D0L7DB DRUGTYPE Small molecular drug D0L7DB DRUGINCH 1S/C19H16O5/c1-3-5-13(20)11-8-12-10-6-4-7-14(21)15(10)18(23)19(24)16(12)17(22)9(11)2/h4,6-8,21-22H,3,5H2,1-2H3 D0L7DB DRUGINKE YJQYHFMKGAVKDP-UHFFFAOYSA-N D0L7DB DRUGSMIL CCCC(=O)C1=C(C(=C2C(=C1)C3=C(C(=CC=C3)O)C(=O)C2=O)O)C D0L7DB HIGHSTAT Investigative D0L7DL DRUG__ID D0L7DL D0L7DL DRUGTYPE Small molecular drug D0L7DL DRUGINCH 1S/C24H24N4/c1-16-12-14-17(15-13-16)20-21-24(27-22(25-20)18-8-4-2-5-9-18)28-23(26-21)19-10-6-3-7-11-19/h2,4-5,8-9,12-15,19H,3,6-7,10-11H2,1H3,(H,25,26,27,28) D0L7DL DRUGINKE JOTMQRFWDYAWIE-UHFFFAOYSA-N D0L7DL DRUGSMIL CC1=CC=C(C=C1)C2=C3C(=NC(=N2)C4=CC=CC=C4)N=C(N3)C5CCCCC5 D0L7DL HIGHSTAT Investigative D0L7GI DRUG__ID D0L7GI D0L7GI DRUGTYPE Small molecular drug D0L7GI DRUGINCH 1S/C19H14ClN3O/c20-15-6-4-5-14(13-15)19(24)21-16-9-11-18(12-10-16)23-22-17-7-2-1-3-8-17/h1-13H,(H,21,24) D0L7GI DRUGINKE BVHXJXQDOFAUQY-UHFFFAOYSA-N D0L7GI DRUGSMIL C1=CC=C(C=C1)N=NC2=CC=C(C=C2)NC(=O)C3=CC(=CC=C3)Cl D0L7GI HIGHSTAT Investigative D0L7HD DRUG__ID D0L7HD D0L7HD DRUGTYPE Small molecular drug D0L7HD DRUGINCH 1S/C19H14Cl2O2/c20-15-7-9-18(16(21)12-15)23-19-8-6-14(11-17(19)22)10-13-4-2-1-3-5-13/h1-9,11-12,22H,10H2 D0L7HD DRUGINKE LUMKUDPYQGEIPU-UHFFFAOYSA-N D0L7HD DRUGSMIL C1=CC=C(C=C1)CC2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D0L7HD HIGHSTAT Investigative D0L7HP DRUG__ID D0L7HP D0L7HP DRUGTYPE Small molecular drug D0L7HP DRUGINCH 1S/C41H42N2O7S/c44-26-28-17-19-29(20-18-28)35-25-34(27-51-41-43-38(30-11-5-3-6-12-30)39(50-41)31-13-7-4-8-14-31)48-40(49-35)32-21-23-33(24-22-32)42-36(45)15-9-1-2-10-16-37(46)47/h3-8,11-14,17-24,34-35,40,44H,1-2,9-10,15-16,25-27H2,(H,42,45)(H,46,47)/t34-,35+,40+/m1/s1 D0L7HP DRUGINKE WLLKRNCIQXOQHG-YXQOSMAKSA-N D0L7HP DRUGSMIL C1C(OC(OC1C2=CC=C(C=C2)CO)C3=CC=C(C=C3)NC(=O)CCCCCCC(=O)O)CSC4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6 D0L7HP HIGHSTAT Investigative D0L7IZ DRUG__ID D0L7IZ D0L7IZ DRUGTYPE Small molecular drug D0L7IZ DRUGINCH 1S/C24H24N4/c1-27-14-16-28(17-15-27)19-12-10-18(11-13-19)25-24-20-6-2-4-8-22(20)26-23-9-5-3-7-21(23)24/h2-13H,14-17H2,1H3,(H,25,26) D0L7IZ DRUGINKE QZKGUNQLVFEEBA-UHFFFAOYSA-N D0L7IZ DRUGSMIL CN1CCN(CC1)C2=CC=C(C=C2)NC3=C4C=CC=CC4=NC5=CC=CC=C53 D0L7IZ HIGHSTAT Investigative D0L7MD DRUG__ID D0L7MD D0L7MD DRUGTYPE Small molecular drug D0L7MD DRUGINCH 1S/C16H11IO3/c1-19-12-5-2-10(3-6-12)16-9-14(18)13-8-11(17)4-7-15(13)20-16/h2-9H,1H3 D0L7MD DRUGINKE BYDBCAPACOXVEH-UHFFFAOYSA-N D0L7MD DRUGSMIL COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)I D0L7MD HIGHSTAT Investigative D0L7MI DRUG__ID D0L7MI D0L7MI DRUGTYPE Small molecular drug D0L7MI DRUGINCH 1S/C15H9NO5/c17-12-7-14(9-4-2-1-3-5-9)21-15-8-13(18)11(16(19)20)6-10(12)15/h1-8,18H D0L7MI DRUGINKE KJSLXXZBGFZOAH-UHFFFAOYSA-N D0L7MI DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=CC(=C(C=C3O2)O)[N+](=O)[O-] D0L7MI HIGHSTAT Investigative D0L7MM DRUG__ID D0L7MM D0L7MM DRUGTYPE Small molecular drug D0L7MM DRUGINCH 1S/C17H15NO2/c19-16-8-5-12(9-17(16)20)11-18-15-7-6-13-3-1-2-4-14(13)10-15/h1-10,18-20H,11H2 D0L7MM DRUGINKE QYMHAOZLKJHVDJ-UHFFFAOYSA-N D0L7MM DRUGSMIL C1=CC=C2C=C(C=CC2=C1)NCC3=CC(=C(C=C3)O)O D0L7MM HIGHSTAT Investigative D0L7OC DRUG__ID D0L7OC D0L7OC DRUGTYPE Small molecular drug D0L7OC DRUGINCH 1S/C12H12F3NS/c1-2-3-6-17-10-5-4-9(8-16)11(7-10)12(13,14)15/h4-5,7H,2-3,6H2,1H3 D0L7OC DRUGINKE FQVZVSZPULBOJM-UHFFFAOYSA-N D0L7OC DRUGSMIL CCCCSC1=CC(=C(C=C1)C#N)C(F)(F)F D0L7OC HIGHSTAT Investigative D0L7OM DRUG__ID D0L7OM D0L7OM DRUGTYPE Small molecular drug D0L7OM DRUGINCH 1S/C19H21NO4/c1-23-18-8-12-5-6-20-10-14-11(3-4-16(21)19(14)24-2)7-15(20)13(12)9-17(18)22/h3-4,8-9,15,21-22H,5-7,10H2,1-2H3/t15-/m0/s1 D0L7OM DRUGINKE JKPISQIIWUONPB-HNNXBMFYSA-N D0L7OM DRUGSMIL COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C(=C(C=C4)O)OC)O D0L7OM HIGHSTAT Investigative D0L7PA DRUG__ID D0L7PA D0L7PA DRUGTYPE Small molecular drug D0L7PA DRUGINCH 1S/C18H22IN3O3S/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16/h3-8,13,20H,9-12H2,1-2H3 D0L7PA DRUGINKE BDHMSYNBSBZCAF-UHFFFAOYSA-N D0L7PA DRUGSMIL CN1CCN(CC1)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)I)OC D0L7PA HIGHSTAT Investigative D0L7PI DRUG__ID D0L7PI D0L7PI DRUGTYPE Small molecular drug D0L7PI DRUGINCH 1S/C27H46O3/c1-17(7-6-12-25(2,3)30)20-8-9-21-24-22(11-14-27(20,21)5)26(4)13-10-19(28)15-18(26)16-23(24)29/h16-17,19-24,28-30H,6-15H2,1-5H3/t17-,19+,20-,21+,22+,23+,24+,26+,27-/m1/s1 D0L7PI DRUGINKE BQMSKLCEWBSPPY-CGSQRZAOSA-N D0L7PI DRUGSMIL CC(CCCC(C)(C)O)C1CCC2C1(CCC3C2C(C=C4C3(CCC(C4)O)C)O)C D0L7PI HIGHSTAT Investigative D0L7PQ DRUG__ID D0L7PQ D0L7PQ DRUGTYPE Small molecular drug D0L7PQ DRUGINCH 1S/C35H48N4O6S/c1-4-22(2)30(33(42)37-27(20-24-14-8-5-9-15-24)32(41)38-28(21-46)35(44)45)39-34(43)31(36-23(3)40)29(25-16-10-6-11-17-25)26-18-12-7-13-19-26/h6-7,10-13,16-19,22,24,27-31,46H,4-5,8-9,14-15,20-21H2,1-3H3,(H,36,40)(H,37,42)(H,38,41)(H,39,43)(H,44,45)/t22-,27+,28-,30-,31+/m1/s1 D0L7PQ DRUGINKE IIYOAVWUFJFCOP-SHQUAMPASA-N D0L7PQ DRUGSMIL CCC(C)C(C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(C(C2=CC=CC=C2)C3=CC=CC=C3)NC(=O)C D0L7PQ HIGHSTAT Investigative D0L7RB DRUG__ID D0L7RB D0L7RB DRUGTYPE Small molecular drug D0L7RB DRUGINCH 1S/C9H8O2/c1-2-9(11)7-3-5-8(10)6-4-7/h2-6,10H,1H2 D0L7RB DRUGINKE NKPPNPJUBLEKAD-UHFFFAOYSA-N D0L7RB DRUGSMIL C=CC(=O)C1=CC=C(C=C1)O D0L7RB HIGHSTAT Investigative D0L7RJ DRUG__ID D0L7RJ D0L7RJ DRUGCOMP D-Pharm Ltd D0L7RJ DRUGINCH 1S/C62H104N2O12/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-37-43-71-45-47-75-61(69)53-63(51-59(65)66)55-39-33-35-41-57(55)73-49-50-74-58-42-36-34-40-56(58)64(52-60(67)68)54-62(70)76-48-46-72-44-38-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h33-36,39-42H,3-32,37-38,43-54H2,1-2H3,(H,65,66)(H,67,68) D0L7RJ DRUGINKE CVNMKRSQOUAXTO-UHFFFAOYSA-N D0L7RJ DRUGSMIL CCCCCCCCCCCCCCCCCCOCCOC(=O)CN(CC(=O)O)C1=CC=CC=C1OCCOC2=CC=CC=C2N(CC(=O)O)CC(=O)OCCOCCCCCCCCCCCCCCCCCC D0L7RJ HIGHSTAT Investigative D0L7RU DRUG__ID D0L7RU D0L7RU DRUGTYPE Small molecular drug D0L7RU DRUGINCH 1S/C15H9Cl2NO2/c16-9-6-10(17)13-11(7-9)18-15(20)12(14(13)19)8-4-2-1-3-5-8/h1-7H,(H2,18,19,20) D0L7RU DRUGINKE ZIMBGBQTQUNKLP-UHFFFAOYSA-N D0L7RU DRUGSMIL C1=CC=C(C=C1)C2=C(C3=C(C=C(C=C3Cl)Cl)NC2=O)O D0L7RU HIGHSTAT Investigative D0L7TW DRUG__ID D0L7TW D0L7TW DRUGTYPE Small molecular drug D0L7TW DRUGINCH 1S/C20H25NO3/c1-2-3-4-5-9-16-23-18-14-12-17(13-15-18)21-20(22)24-19-10-7-6-8-11-19/h6-8,10-15H,2-5,9,16H2,1H3,(H,21,22) D0L7TW DRUGINKE JPIYDITTWBUFSY-UHFFFAOYSA-N D0L7TW DRUGSMIL CCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2 D0L7TW HIGHSTAT Investigative D0L7UB DRUG__ID D0L7UB D0L7UB DRUGTYPE Small molecular drug D0L7UB DRUGINCH 1S/C7H14O2/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H,8,9)/p-1 D0L7UB DRUGINKE MNWFXJYAOYHMED-UHFFFAOYSA-M D0L7UB DRUGSMIL CCCCCCC(=O)[O-] D0L7UB HIGHSTAT Investigative D0L7ZD DRUG__ID D0L7ZD D0L7ZD DRUGTYPE Small molecular drug D0L7ZD DRUGINCH 1S/C23H28Cl2N4O2/c24-18-5-3-6-19(22(18)25)29-13-4-12-28(14-15-29)11-1-2-16-31-21-10-8-17-7-9-20(30)26-23(17)27-21/h3,5-6,8,10H,1-2,4,7,9,11-16H2,(H,26,27,30) D0L7ZD DRUGINKE JQSRFMXTGAVHIR-UHFFFAOYSA-N D0L7ZD DRUGSMIL C1CN(CCN(C1)C2=C(C(=CC=C2)Cl)Cl)CCCCOC3=NC4=C(CCC(=O)N4)C=C3 D0L7ZD HIGHSTAT Investigative D0L8BN DRUG__ID D0L8BN D0L8BN DRUGTYPE Small molecular drug D0L8BN DRUGINCH 1S/C36H58N4O11S/c1-8-9-10-11-12-13-22(2)14-15-23(3)16-18-29(41)24(4)17-19-30-26(6)34(44)39-27(7)35(45)38-21-25(5)33(43)40-28(36(46)50-30)20-31(32(37)42)51-52(47,48)49/h15-16,18,22,24-26,28,30-31H,7-14,17,19-21H2,1-6H3,(H2,37,42)(H,38,45)(H,39,44)(H,40,43)(H,47,48,49)/b18-16+,23-15+/t22?,24?,25-,26?,28-,30?,31?/m0/s1 D0L8BN DRUGINKE XLDIAUNLPWGNHO-NUPNHORYSA-N D0L8BN DRUGSMIL CCCCCCCC(C)CC=C(C)C=CC(=O)C(C)CCC1C(C(=O)NC(=C)C(=O)NCC(C(=O)NC(C(=O)O1)CC(C(=O)N)OS(=O)(=O)O)C)C D0L8BN HIGHSTAT Investigative D0L8CF DRUG__ID D0L8CF D0L8CF DRUGTYPE Small molecular drug D0L8CF DRUGINCH 1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12) D0L8CF DRUGINKE GJAWHXHKYYXBSV-UHFFFAOYSA-N D0L8CF DRUGSMIL C1=CC(=C(N=C1)C(=O)O)C(=O)O D0L8CF HIGHSTAT Investigative D0L8CK DRUG__ID D0L8CK D0L8CK DRUGTYPE Small molecular drug D0L8CK DRUGINCH 1S/C23H26O11/c24-11-18-22(34-19(29)6-3-12-1-4-14(25)16(27)9-12)20(30)21(31)23(33-18)32-8-7-13-2-5-15(26)17(28)10-13/h1-6,9-10,18,20-28,30-31H,7-8,11H2/b6-3+/t18-,20-,21-,22-,23-/m1/s1 D0L8CK DRUGINKE UHIGZYLCYRQESL-VJWFJHQPSA-N D0L8CK DRUGSMIL C1=CC(=C(C=C1CCOC2C(C(C(C(O2)CO)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O)O)O D0L8CK HIGHSTAT Investigative D0L8CX DRUG__ID D0L8CX D0L8CX DRUGTYPE Small molecular drug D0L8CX DRUGINCH 1S/C12H17BrO/c1-7(2)10-5-9(13)6-11(8(3)4)12(10)14/h5-8,14H,1-4H3 D0L8CX DRUGINKE QNJVELOLCDKQBN-UHFFFAOYSA-N D0L8CX DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)Br D0L8CX HIGHSTAT Investigative D0L8DL DRUG__ID D0L8DL D0L8DL DRUGTYPE Small molecular drug D0L8DL DRUGINCH 1S/C19H19N5O4S2/c1-12(2)15-9-14(28-3)10-16-17(15)18(25)23(30(16,26)27)11-29-19-20-21-22-24(19)13-7-5-4-6-8-13/h4-10,12H,11H2,1-3H3 D0L8DL DRUGINKE LZCQHGLOTYILCS-UHFFFAOYSA-N D0L8DL DRUGSMIL CC(C)C1=C2C(=CC(=C1)OC)S(=O)(=O)N(C2=O)CSC3=NN=NN3C4=CC=CC=C4 D0L8DL HIGHSTAT Investigative D0L8DV DRUG__ID D0L8DV D0L8DV DRUGTYPE Small molecular drug D0L8DV DRUGINCH 1S/C25H36O5/c1-25(29,17-15-19-10-7-8-11-19)16-9-13-21-20(22(26)18-23(21)27)12-5-3-4-6-14-24(28)30-2/h3-4,9-10,13,15,17,20-21,23,27,29H,5-8,11-12,14,16,18H2,1-2H3/b4-3-,13-9+,17-15+/t20-,21-,23-,25-/m1/s1 D0L8DV DRUGINKE ZZVPHCPLTZTOBC-ZNJGPPGCSA-N D0L8DV DRUGSMIL CC(CC=CC1C(CC(=O)C1CCC=CCCC(=O)OC)O)(C=CC2=CCCC2)O D0L8DV HIGHSTAT Investigative D0L8DZ DRUG__ID D0L8DZ D0L8DZ DRUGTYPE Small molecular drug D0L8DZ DRUGINCH 1S/C11H8N4O2/c16-10-7-9(14-11(17)15-10)13-8(12-7)6-4-2-1-3-5-6/h1-5H,(H3,12,13,14,15,16,17) D0L8DZ DRUGINKE ACCCXSZCOGNLFL-UHFFFAOYSA-N D0L8DZ DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N2)C(=O)NC(=O)N3 D0L8DZ HIGHSTAT Investigative D0L8EN DRUG__ID D0L8EN D0L8EN DRUGTYPE Small molecular drug D0L8EN DRUGINCH 1S/C15H12N2O2S/c18-12-6-4-10(5-7-12)14-9-20-15(17-14)16-11-2-1-3-13(19)8-11/h1-9,18-19H,(H,16,17) D0L8EN DRUGINKE SAFZMMTWTRFRQE-UHFFFAOYSA-N D0L8EN DRUGSMIL C1=CC(=CC(=C1)O)NC2=NC(=CS2)C3=CC=C(C=C3)O D0L8EN HIGHSTAT Investigative D0L8FW DRUG__ID D0L8FW D0L8FW DRUGTYPE Small molecular drug D0L8FW DRUGINCH 1S/C14H14O3/c1-9-5-2-3-6-10(9)14(17)13-11(15)7-4-8-12(13)16/h2-3,5-6,13H,4,7-8H2,1H3 D0L8FW DRUGINKE ZGPNNJNODAAWSM-UHFFFAOYSA-N D0L8FW DRUGSMIL CC1=CC=CC=C1C(=O)C2C(=O)CCCC2=O D0L8FW HIGHSTAT Investigative D0L8HO DRUG__ID D0L8HO D0L8HO DRUGTYPE Small molecular drug D0L8HO DRUGINCH 1S/C20H13N3O2/c24-19-17(13-9-21-15-7-3-1-5-11(13)15)18(20(25)23-19)14-10-22-16-8-4-2-6-12(14)16/h1-10,21-22H,(H,23,24,25) D0L8HO DRUGINKE DQYBRTASHMYDJG-UHFFFAOYSA-N D0L8HO DRUGSMIL C1=CC=C2C(=C1)C(=CN2)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54 D0L8HO HIGHSTAT Investigative D0L8KL DRUG__ID D0L8KL D0L8KL DRUGTYPE Small molecular drug D0L8KL DRUGINCH 1S/C13H9NO/c1-2-4-11-7-12(6-5-10(11)3-1)13-8-14-9-15-13/h1-9H D0L8KL DRUGINKE UQGCSVOKHFBQIP-UHFFFAOYSA-N D0L8KL DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C3=CN=CO3 D0L8KL HIGHSTAT Investigative D0L8LX DRUG__ID D0L8LX D0L8LX DRUGTYPE Small molecular drug D0L8LX DRUGINCH 1S/C27H36N6O6S/c1-40-12-11-21(25(29)37)33-27(39)22(14-17-5-3-2-4-6-17)32-24(36)16-30-23(35)15-31-26(38)20(28)13-18-7-9-19(34)10-8-18/h2-10,20-22,34H,11-16,28H2,1H3,(H2,29,37)(H,30,35)(H,31,38)(H,32,36)(H,33,39)/t20-,21-,22-/m0/s1 D0L8LX DRUGINKE HBDDEVHKKBWEQT-FKBYEOEOSA-N D0L8LX DRUGSMIL CSCCC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N D0L8LX HIGHSTAT Investigative D0L8MR DRUG__ID D0L8MR D0L8MR DRUGTYPE Small molecular drug D0L8MR DRUGINCH 1S/C11H17NO3/c1-13-9-6-8(4-5-12)7-10(14-2)11(9)15-3/h6-7H,4-5,12H2,1-3H3 D0L8MR DRUGINKE RHCSKNNOAZULRK-UHFFFAOYSA-N D0L8MR DRUGSMIL COC1=CC(=CC(=C1OC)OC)CCN D0L8MR HIGHSTAT Investigative D0L8ND DRUG__ID D0L8ND D0L8ND DRUGTYPE Small molecular drug D0L8ND DRUGINCH 1S/C11H11BrN2/c12-8-2-1-3-9-11(8)7-4-5-13-6-10(7)14-9/h1-3,13-14H,4-6H2 D0L8ND DRUGINKE AOMJWOGZKNQVBI-UHFFFAOYSA-N D0L8ND DRUGSMIL C1CNCC2=C1C3=C(N2)C=CC=C3Br D0L8ND HIGHSTAT Investigative D0L8NF DRUG__ID D0L8NF D0L8NF DRUGTYPE Small molecular drug D0L8NF DRUGINCH 1S/C18H40NO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(20)18(21)16(19)15-25-26(22,23)24/h16-18,20-21H,2-15,19H2,1H3,(H2,22,23,24)/t16-,17+,18-/m0/s1 D0L8NF DRUGINKE AYGOSKULTISFCW-KSZLIROESA-N D0L8NF DRUGSMIL CCCCCCCCCCCCCCC(C(C(COP(=O)(O)O)N)O)O D0L8NF HIGHSTAT Investigative D0L8NG DRUG__ID D0L8NG D0L8NG DRUGTYPE Small molecular drug D0L8NG DRUGINCH 1S/C16H25NO2/c1-4-9-17(10-5-2)13-11-14-15(18-3)7-6-8-16(14)19-12-13/h6-8,13H,4-5,9-12H2,1-3H3 D0L8NG DRUGINKE GOWYIQOIWRLZLO-UHFFFAOYSA-N D0L8NG DRUGSMIL CCCN(CCC)C1CC2=C(C=CC=C2OC)OC1 D0L8NG HIGHSTAT Investigative D0L8OJ DRUG__ID D0L8OJ D0L8OJ DRUGTYPE Small molecular drug D0L8OJ DRUGINCH 1S/C33H38N2O9/c1-8-18-16-35-26-14-21(18)31(30(37)42-7,17-43-29(36)19-11-24(39-4)28(41-6)25(12-19)40-5)32-15-27(35)44-33(26,32)34(2)23-10-9-20(38-3)13-22(23)32/h8-13,21,26-27H,14-17H2,1-7H3/b18-8-/t21-,26-,27-,31-,32-,33-/m0/s1 D0L8OJ DRUGINKE JIGZBLWURVFVNC-MPYFAWNJSA-N D0L8OJ DRUGSMIL CC=C1CN2C3CC1C(C45C3(N(C6=C4C=C(C=C6)OC)C)OC2C5)(COC(=O)C7=CC(=C(C(=C7)OC)OC)OC)C(=O)OC D0L8OJ HIGHSTAT Investigative D0L8ON DRUG__ID D0L8ON D0L8ON DRUGCOMP RxBio Inc D0L8ON DRUGINCH 1S/C26H35Cl2N5O3/c1-5-32(6-2)9-11-35-23-15-19-17(13-21(23)27)18-14-22(28)24(36-12-10-33(7-3)8-4)16-20(18)25(19)30-31-26(29)34/h13-16H,5-12H2,1-4H3,(H3,29,31,34) D0L8ON DRUGINKE FTRKHDRTUUJAGN-UHFFFAOYSA-N D0L8ON DRUGSMIL CCN(CC)CCOC1=C(C=C2C(=C1)C(=NNC(=O)N)C3=CC(=C(C=C32)Cl)OCCN(CC)CC)Cl D0L8ON HIGHSTAT Investigative D0L8PI DRUG__ID D0L8PI D0L8PI DRUGTYPE Small molecular drug D0L8PI DRUGINCH 1S/C17H18ClNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3 D0L8PI DRUGINKE GOTMKOSCLKVOGG-UHFFFAOYSA-N D0L8PI DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)O)Cl D0L8PI HIGHSTAT Investigative D0L8QX DRUG__ID D0L8QX D0L8QX DRUGTYPE Small molecular drug D0L8QX DRUGINCH 1S/C8H13NO7P2/c10-8(17(11,12)13,18(14,15)16)4-3-7-2-1-5-9-6-7/h1-2,5-6,10H,3-4H2,(H2,11,12,13)(H2,14,15,16) D0L8QX DRUGINKE ILROXFQHACCDLA-UHFFFAOYSA-N D0L8QX DRUGSMIL C1=CC(=CN=C1)CCC(O)(P(=O)(O)O)P(=O)(O)O D0L8QX HIGHSTAT Investigative D0L8SN DRUG__ID D0L8SN D0L8SN DRUGTYPE Small molecular drug D0L8SN DRUGINCH 1S/C9H12IN/c1-7(11)6-8-2-4-9(10)5-3-8/h2-5,7H,6,11H2,1H3 D0L8SN DRUGINKE VZPKOWYCGWOYRF-UHFFFAOYSA-N D0L8SN DRUGSMIL CC(CC1=CC=C(C=C1)I)N D0L8SN HIGHSTAT Investigative D0L8UL DRUG__ID D0L8UL D0L8UL DRUGTYPE Small molecular drug D0L8UL DRUGINCH 1S/C21H22NO4.C2HF3O2/c1-23-18-8-13-5-6-22-12-15-10-20(25-3)19(24-2)9-14(15)7-17(22)16(13)11-21(18)26-4;3-2(4,5)1(6)7/h7-12H,5-6H2,1-4H3;(H,6,7)/q+1;/p-1 D0L8UL DRUGINKE KUZKREKOXDJDIQ-UHFFFAOYSA-M D0L8UL DRUGSMIL COC1=C(C=C2C(=C1)CC[N+]3=CC4=CC(=C(C=C4C=C23)OC)OC)OC.C(=O)(C(F)(F)F)[O-] D0L8UL HIGHSTAT Investigative D0L8ZG DRUG__ID D0L8ZG D0L8ZG DRUGTYPE Small molecular drug D0L8ZG DRUGINCH 1S/C7H9BO2/c1-6-2-4-7(5-3-6)8(9)10/h2-5,9-10H,1H3 D0L8ZG DRUGINKE BIWQNIMLAISTBV-UHFFFAOYSA-N D0L8ZG DRUGSMIL B(C1=CC=C(C=C1)C)(O)O D0L8ZG HIGHSTAT Investigative D0L9AX DRUG__ID D0L9AX D0L9AX DRUGTYPE Small molecular drug D0L9AX DRUGINCH 1S/C20H30N4O11/c1-9(2)17(20(35)22-11(8-25)6-15(29)30)24-18(33)12(4-5-14(27)28)23-19(34)13(7-16(31)32)21-10(3)26/h8-9,11-13,17H,4-7H2,1-3H3,(H,21,26)(H,22,35)(H,23,34)(H,24,33)(H,27,28)(H,29,30)(H,31,32)/t11-,12-,13-,17-/m0/s1 D0L9AX DRUGINKE UMBVAPCONCILTL-MRHIQRDNSA-N D0L9AX DRUGSMIL CC(C)C(C(=O)NC(CC(=O)O)C=O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0L9AX HIGHSTAT Investigative D0L9BT DRUG__ID D0L9BT D0L9BT DRUGTYPE Small molecular drug D0L9BT DRUGINCH 1S/C12H9N3O2/c16-11-3-4-17-12-5-9(1-2-10(11)12)6-15-7-13-14-8-15/h1-5,7-8H,6H2 D0L9BT DRUGINKE QNCWBRMMGXVBEU-UHFFFAOYSA-N D0L9BT DRUGSMIL C1=CC2=C(C=C1CN3C=NN=C3)OC=CC2=O D0L9BT HIGHSTAT Investigative D0L9DR DRUG__ID D0L9DR D0L9DR DRUGTYPE Small molecular drug D0L9DR DRUGINCH 1S/C21H16FN3OS/c1-12-17(8-9-18(23-12)14-3-5-15(22)6-4-14)21(26)25-16-7-10-20-19(11-16)24-13(2)27-20/h3-11H,1-2H3,(H,25,26) D0L9DR DRUGINKE QBATWTOFDFHEDZ-UHFFFAOYSA-N D0L9DR DRUGSMIL CC1=C(C=CC(=N1)C2=CC=C(C=C2)F)C(=O)NC3=CC4=C(C=C3)SC(=N4)C D0L9DR HIGHSTAT Investigative D0L9EF DRUG__ID D0L9EF D0L9EF DRUGTYPE Small molecular drug D0L9EF DRUGINCH 1S/C16H12O7/c1-22-16-14(21)13-11(20)5-8(17)6-12(13)23-15(16)7-2-3-9(18)10(19)4-7/h2-6,17-20H,1H3 D0L9EF DRUGINKE WEPBGSIAWZTEJR-UHFFFAOYSA-N D0L9EF DRUGSMIL COC1=C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC(=C(C=C3)O)O D0L9EF HIGHSTAT Investigative D0L9FD DRUG__ID D0L9FD D0L9FD DRUGTYPE Small molecular drug D0L9FD DRUGINCH 1S/C15H16N2O2/c1-17-7-8-18-14-9-12(10-16-15(14)17)11-19-13-5-3-2-4-6-13/h2-6,9-10H,7-8,11H2,1H3 D0L9FD DRUGINKE XAGOQHLVLYAAMO-UHFFFAOYSA-N D0L9FD DRUGSMIL CN1CCOC2=C1N=CC(=C2)COC3=CC=CC=C3 D0L9FD HIGHSTAT Investigative D0L9JE DRUG__ID D0L9JE D0L9JE DRUGTYPE Small molecular drug D0L9JE DRUGINCH 1S/C17H24N2O2S/c1-11(2)9-14(17(21)18-7-8-20)22-15-10-19-13-6-4-5-12(3)16(13)15/h4-6,10-11,14,19-20H,7-9H2,1-3H3,(H,18,21) D0L9JE DRUGINKE FTNIWEHRMFLJKE-UHFFFAOYSA-N D0L9JE DRUGSMIL CC1=C2C(=CC=C1)NC=C2SC(CC(C)C)C(=O)NCCO D0L9JE HIGHSTAT Investigative D0L9KK DRUG__ID D0L9KK D0L9KK DRUGTYPE Small molecular drug D0L9KK DRUGINCH 1S/C17H22Cl2N2O3S/c18-12-3-4-15(14(19)10-12)24-11-17(23)21-7-5-13(6-8-21)20-16(22)2-1-9-25/h3-4,10,13,25H,1-2,5-9,11H2,(H,20,22) D0L9KK DRUGINKE ZPXCEHMKUTXHRZ-UHFFFAOYSA-N D0L9KK DRUGSMIL C1CN(CCC1NC(=O)CCCS)C(=O)COC2=C(C=C(C=C2)Cl)Cl D0L9KK HIGHSTAT Investigative D0L9LH DRUG__ID D0L9LH D0L9LH DRUGTYPE Small molecular drug D0L9LH DRUGINCH 1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/b15-14+/t17-,18+/m0/s1/i25+1 D0L9LH DRUGINKE DUYSYHSSBDVJSM-CRGHQYIOSA-N D0L9LH DRUGSMIL CCCCCCCCCCCCCC=CC(C(COP(=O)(O)O)N)O D0L9LH HIGHSTAT Investigative D0L9NB DRUG__ID D0L9NB D0L9NB DRUGTYPE Small molecular drug D0L9NB DRUGINCH 1S/C31H33N5O3/c1-19-12-24(37)13-20(2)25(19)15-26(32)31(39)36-18-23-11-7-6-10-22(23)14-28(36)30(38)34-17-29-33-16-27(35-29)21-8-4-3-5-9-21/h3-13,16,26,28,37H,14-15,17-18,32H2,1-2H3,(H,33,35)(H,34,38)/t26-,28-/m0/s1 D0L9NB DRUGINKE LKMAEHUMCHTBER-XCZPVHLTSA-N D0L9NB DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=NC=C(N4)C5=CC=CC=C5)N)C)O D0L9NB HIGHSTAT Investigative D0L9OS DRUG__ID D0L9OS D0L9OS DRUGTYPE Small molecular drug D0L9OS DRUGINCH 1S/C18H17ClN4O3S2/c19-12-1-2-14-13(9-12)23(18(26)28-14)10-15(24)22-6-3-11(4-7-22)16(25)21-17-20-5-8-27-17/h1-2,5,8-9,11H,3-4,6-7,10H2,(H,20,21,25) D0L9OS DRUGINKE MYSZTUDXDIGAGW-UHFFFAOYSA-N D0L9OS DRUGSMIL C1CN(CCC1C(=O)NC2=NC=CS2)C(=O)CN3C4=C(C=CC(=C4)Cl)SC3=O D0L9OS HIGHSTAT Investigative D0L9OU DRUG__ID D0L9OU D0L9OU DRUGTYPE Small molecular drug D0L9OU DRUGINCH 1S/C36H44N4O6/c1-36(19-27-20-37-30-10-6-5-9-29(27)30,40-35(45)46-33-25-14-23-13-24(16-25)17-26(33)15-23)34(44)39-28(18-22-7-3-2-4-8-22)21-38-31(41)11-12-32(42)43/h2-10,20,23-26,28,33,37H,11-19,21H2,1H3,(H,38,41)(H,39,44)(H,40,45)(H,42,43)/t23?,24?,25?,26?,28-,33?,36-/m1/s1 D0L9OU DRUGINKE HAQJDPAHYIINDW-YUUWEXFGSA-N D0L9OU DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CNC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0L9OU HIGHSTAT Investigative D0L9PX DRUG__ID D0L9PX D0L9PX DRUGCOMP Harvard Medical School D0L9PX DRUGINCH 1S/CCl4/c2-1(3,4)5 D0L9PX DRUGINKE VZGDMQKNWNREIO-UHFFFAOYSA-N D0L9PX DRUGSMIL C(Cl)(Cl)(Cl)Cl D0L9PX HIGHSTAT Investigative D0L9RP DRUG__ID D0L9RP D0L9RP DRUGTYPE Small molecular drug D0L9RP DRUGINCH 1S/C51H67N9O14S/c1-5-8-18-37(52-4)46(65)57-41(28-45(63)64)47(66)56-39(25-31-15-11-10-12-16-31)49(68)60-50(69)40(27-33-29-53-36-19-14-13-17-35(33)36)58-51(70)42(61)30-54-43(20-9-6-2)59-48(67)38(55-44(62)7-3)26-32-21-23-34(24-22-32)74-75(71,72)73/h10-17,19,21-24,29,37-41,43,52-54H,5-9,18,20,25-28,30H2,1-4H3,(H,55,62)(H,56,66)(H,57,65)(H,58,70)(H,59,67)(H,63,64)(H,60,68,69)(H,71,72,73)/t37-,38-,39-,40-,41-,43-/m0/s1 D0L9RP DRUGINKE VNNMDTHCFFZSSJ-HWQWZYBXSA-N D0L9RP DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(=O)CNC(CCCC)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)CC)NC D0L9RP HIGHSTAT Investigative D0L9SL DRUG__ID D0L9SL D0L9SL DRUGTYPE Small molecular drug D0L9SL DRUGINCH 1S/C9H18N2O/c1-2-3-4-8-7-12-6-5-9(10)11-8/h8H,2-7H2,1H3,(H2,10,11) D0L9SL DRUGINKE YXURWRQCUHZROM-UHFFFAOYSA-N D0L9SL DRUGSMIL CCCCC1COCCC(=N1)N D0L9SL HIGHSTAT Investigative D0L9VP DRUG__ID D0L9VP D0L9VP DRUGTYPE Small molecular drug D0L9VP DRUGINCH 1S/C28H37N3O5S/c1-22(2)21-26(30-28(33)31-16-18-36-19-17-31)27(32)29-24(14-13-23-9-5-3-6-10-23)15-20-37(34,35)25-11-7-4-8-12-25/h3-12,15,20,22,24,26H,13-14,16-19,21H2,1-2H3,(H,29,32)(H,30,33)/b20-15+/t24-,26-/m0/s1 D0L9VP DRUGINKE YUMYYTORLYHUFW-MSKIIMLESA-N D0L9VP DRUGSMIL CC(C)CC(C(=O)NC(CCC1=CC=CC=C1)C=CS(=O)(=O)C2=CC=CC=C2)NC(=O)N3CCOCC3 D0L9VP HIGHSTAT Investigative D0L9WG DRUG__ID D0L9WG D0L9WG DRUGTYPE Small molecular drug D0L9WG DRUGINCH 1S/C11H13N5O4/c1-5-7(18)8(19)11(2-17,20-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-4,7-8,17-19H,1-2H2,(H2,12,13,14)/t7-,8-,11-/m1/s1 D0L9WG DRUGINKE UZSSGAOAYPICBZ-SOCHQFKDSA-N D0L9WG DRUGSMIL C=C1C(C(C(O1)(CO)N2C=NC3=C(N=CN=C32)N)O)O D0L9WG HIGHSTAT Investigative D0L9WN DRUG__ID D0L9WN D0L9WN DRUGTYPE Small molecular drug D0L9WN DRUGINCH 1S/C13H14N2/c1-9-3-2-4-11-10(9)5-6-12(11)13-7-14-8-15-13/h2-4,7-8,12H,5-6H2,1H3,(H,14,15) D0L9WN DRUGINKE XXQLSAWUSXSJTK-UHFFFAOYSA-N D0L9WN DRUGSMIL CC1=C2CCC(C2=CC=C1)C3=CN=CN3 D0L9WN HIGHSTAT Investigative D0L9XR DRUG__ID D0L9XR D0L9XR DRUGTYPE Small molecular drug D0L9XR DRUGINCH 1S/C9H18N2O/c1-7(2)8(10)9(12)11-5-3-4-6-11/h7-8H,3-6,10H2,1-2H3/t8-/m0/s1 D0L9XR DRUGINKE IHBAVXVTGLANPI-QMMMGPOBSA-N D0L9XR DRUGSMIL CC(C)C(C(=O)N1CCCC1)N D0L9XR HIGHSTAT Investigative D0L9YA DRUG__ID D0L9YA D0L9YA DRUGTYPE Small molecular drug D0L9YA DRUGINCH 1S/C12H14N2O2/c1-9(15)13-7-3-5-10-4-2-6-11-12(10)16-8-14-11/h2,4,6,8H,3,5,7H2,1H3,(H,13,15) D0L9YA DRUGINKE UVCQHPPYUDDOEQ-UHFFFAOYSA-N D0L9YA DRUGSMIL CC(=O)NCCCC1=C2C(=CC=C1)N=CO2 D0L9YA HIGHSTAT Investigative D0L9YJ DRUG__ID D0L9YJ D0L9YJ DRUGTYPE Small molecular drug D0L9YJ DRUGINCH 1S/C24H23NO3/c1-25(17-18-8-3-2-4-9-18)14-7-15-27-19-12-13-21-23(16-19)28-22-11-6-5-10-20(22)24(21)26/h2-6,8-13,16H,7,14-15,17H2,1H3 D0L9YJ DRUGINKE OTLLABLRJBVBHD-UHFFFAOYSA-N D0L9YJ DRUGSMIL CN(CCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D0L9YJ HIGHSTAT Investigative D0L9YP DRUG__ID D0L9YP D0L9YP DRUGTYPE Small molecular drug D0L9YP DRUGINCH 1S/C20H20N2O2/c21-19(23)15-7-5-14(6-8-15)17-13-20(9-11-22-12-10-20)24-18-4-2-1-3-16(17)18/h1-8,13,22H,9-12H2,(H2,21,23) D0L9YP DRUGINKE QQXCPIPMLCDOFK-UHFFFAOYSA-N D0L9YP DRUGSMIL C1CNCCC12C=C(C3=CC=CC=C3O2)C4=CC=C(C=C4)C(=O)N D0L9YP HIGHSTAT Investigative D0L9ZQ DRUG__ID D0L9ZQ D0L9ZQ DRUGTYPE Small molecular drug D0L9ZQ DRUGINCH 1S/C16H16N2O2/c1-18-8-10(16(19)20)5-12-11-3-2-4-13-15(11)9(7-17-13)6-14(12)18/h2-5,7,10,14,17H,6,8H2,1H3,(H,19,20)/t10-,14-/m1/s1 D0L9ZQ DRUGINKE ZAGRKAFMISFKIO-QMTHXVAHSA-N D0L9ZQ DRUGSMIL CN1CC(C=C2C1CC3=CNC4=CC=CC2=C34)C(=O)O D0L9ZQ HIGHSTAT Investigative D0LA0P DRUG__ID D0LA0P D0LA0P DRUGTYPE Small molecular drug D0LA0P DRUGINCH 1S/C25H23N3O3/c1-31-24(30)20-14-15-22-21(17-20)26-25(27-23(29)19-12-6-3-7-13-19)28(22)16-8-11-18-9-4-2-5-10-18/h2-7,9-10,12-15,17H,8,11,16H2,1H3,(H,26,27,29) D0LA0P DRUGINKE UCGWYCMPZXDHNR-UHFFFAOYSA-N D0LA0P DRUGSMIL COC(=O)C1=CC2=C(C=C1)N(C(=N2)NC(=O)C3=CC=CC=C3)CCCC4=CC=CC=C4 D0LA0P HIGHSTAT Investigative D0LA4I DRUG__ID D0LA4I D0LA4I DRUGTYPE Small molecular drug D0LA4I DRUGINCH 1S/C15H15NO2S/c16-12-6-8-13(9-7-12)19(17,18)15-10-5-11-3-1-2-4-14(11)15/h1-4,6-9,15H,5,10,16H2 D0LA4I DRUGINKE AJRGJBUDLAAWNT-UHFFFAOYSA-N D0LA4I DRUGSMIL C1CC2=CC=CC=C2C1S(=O)(=O)C3=CC=C(C=C3)N D0LA4I HIGHSTAT Investigative D0LA6S DRUG__ID D0LA6S D0LA6S DRUGTYPE Small molecular drug D0LA6S DRUGINCH 1S/C35H38F6N4O2/c1-23-7-6-8-24(2)32(23)42-31(46)22-43-13-15-44(16-14-43)29-11-12-45(30(21-29)17-25-9-4-3-5-10-25)33(47)26-18-27(34(36,37)38)20-28(19-26)35(39,40)41/h3-10,18-20,29-30H,11-17,21-22H2,1-2H3,(H,42,46)/t29-,30+/m0/s1 D0LA6S DRUGINKE KHOXGPDKCIQOOR-XZWHSSHBSA-N D0LA6S DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)C3CCN(C(C3)CC4=CC=CC=C4)C(=O)C5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F D0LA6S HIGHSTAT Investigative D0LB0N DRUG__ID D0LB0N D0LB0N DRUGTYPE Small molecular drug D0LB0N DRUGINCH 1S/C17H16O3/c18-16(12-17(19)20)11-8-13-6-9-15(10-7-13)14-4-2-1-3-5-14/h1-7,9-10H,8,11-12H2,(H,19,20) D0LB0N DRUGINKE HDXADAWBGFXTBW-UHFFFAOYSA-N D0LB0N DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)CC(=O)O D0LB0N HIGHSTAT Investigative D0LB4A DRUG__ID D0LB4A D0LB4A DRUGTYPE Small molecular drug D0LB4A DRUGINCH 1S/C7H6O4/c8-6-3-4-5(11-6)1-2-10-7(4)9/h1,3,7,9H,2H2 D0LB4A DRUGINKE ZRWPUFFVAOMMNM-UHFFFAOYSA-N D0LB4A DRUGSMIL C1C=C2C(=CC(=O)O2)C(O1)O D0LB4A HIGHSTAT Investigative D0LB6L DRUG__ID D0LB6L D0LB6L DRUGTYPE Small molecular drug D0LB6L DRUGINCH 1S/C17H16O4/c1-20-16-9-5-6-12(17(16)21-2)10-11-15(19)13-7-3-4-8-14(13)18/h3-11,18H,1-2H3/b11-10+ D0LB6L DRUGINKE HKKXNGSRSNONCJ-ZHACJKMWSA-N D0LB6L DRUGSMIL COC1=CC=CC(=C1OC)C=CC(=O)C2=CC=CC=C2O D0LB6L HIGHSTAT Investigative D0LB9U DRUG__ID D0LB9U D0LB9U DRUGTYPE Small molecular drug D0LB9U DRUGINCH 1S/C7H13N3O3/c8-7-2-4-13-5-6(9-7)1-3-10(11)12/h6H,1-5H2,(H2,8,9) D0LB9U DRUGINKE BWBBVEBIAZILKQ-UHFFFAOYSA-N D0LB9U DRUGSMIL C1COCC(N=C1N)CC[N+](=O)[O-] D0LB9U HIGHSTAT Investigative D0LC0F DRUG__ID D0LC0F D0LC0F DRUGTYPE Small molecular drug D0LC0F DRUGINCH 1S/C9H11NO2S/c10-13(11,12)9-5-4-7-2-1-3-8(7)6-9/h4-6H,1-3H2,(H2,10,11,12) D0LC0F DRUGINKE XVQJTFMKKZBBSX-UHFFFAOYSA-N D0LC0F DRUGSMIL C1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D0LC0F HIGHSTAT Investigative D0LC5C DRUG__ID D0LC5C D0LC5C DRUGTYPE Small molecular drug D0LC5C DRUGINCH 1S/C15H15ClN2O2/c16-12-3-1-11(2-4-12)14-9-13(19)10-15(17-14)18-5-7-20-8-6-18/h1-4,9-10H,5-8H2,(H,17,19) D0LC5C DRUGINKE PETWHCAMQFMDRM-UHFFFAOYSA-N D0LC5C DRUGSMIL C1COCCN1C2=CC(=O)C=C(N2)C3=CC=C(C=C3)Cl D0LC5C HIGHSTAT Investigative D0LC5O DRUG__ID D0LC5O D0LC5O DRUGTYPE Small molecular drug D0LC5O DRUGINCH 1S/C10H9NO6/c11-7(10(16)17)4-1-2-5(8(12)13)6(3-4)9(14)15/h1-3,7H,11H2,(H,12,13)(H,14,15)(H,16,17)/t7-/m0/s1 D0LC5O DRUGINKE IJVMOGKBEVRBPP-ZETCQYMHSA-N D0LC5O DRUGSMIL C1=CC(=C(C=C1C(C(=O)O)N)C(=O)O)C(=O)O D0LC5O HIGHSTAT Investigative D0LC7K DRUG__ID D0LC7K D0LC7K DRUGTYPE Small molecular drug D0LC7K DRUGINCH 1S/C30H48O5/c1-17-9-12-30(25(34)35)14-13-28(5)19(23(30)18(17)2)7-8-22-26(3)15-20(32)24(33)27(4,16-31)21(26)10-11-29(22,28)6/h7,17-18,20-24,31-33H,8-16H2,1-6H3,(H,34,35)/t17-,18+,20-,21-,22-,23+,24+,26+,27+,28-,29-,30+/m1/s1 D0LC7K DRUGINKE JXSVIVRDWWRQRT-UYDOISQJSA-N D0LC7K DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)O D0LC7K HIGHSTAT Investigative D0LC7Z DRUG__ID D0LC7Z D0LC7Z DRUGTYPE Small molecular drug D0LC7Z DRUGINCH 1S/C21H15NO/c23-21-7-6-19-13-18(4-5-20(19)14-21)17-3-1-2-16(12-17)15-8-10-22-11-9-15/h1-14,23H D0LC7Z DRUGINKE JKPUOZDSUARXRX-UHFFFAOYSA-N D0LC7Z DRUGSMIL C1=CC(=CC(=C1)C2=CC3=C(C=C2)C=C(C=C3)O)C4=CC=NC=C4 D0LC7Z HIGHSTAT Investigative D0LC8Z DRUG__ID D0LC8Z D0LC8Z DRUGTYPE Small molecular drug D0LC8Z DRUGINCH 1S/C22H30INO4S/c1-22(2)15-13-19(22)18(7-5-3-4-6-8-21(25)26)20(14-15)24-29(27,28)17-11-9-16(23)10-12-17/h3,5,9-12,15,18-20,24H,4,6-8,13-14H2,1-2H3,(H,25,26)/b5-3-/t15-,18-,19+,20-/m0/s1/i23-2 D0LC8Z DRUGINKE SZNMERGTFJHNSM-NTVCQXSRSA-N D0LC8Z DRUGSMIL CC1(C2CC1C(C(C2)NS(=O)(=O)C3=CC=C(C=C3)I)CC=CCCCC(=O)O)C D0LC8Z HIGHSTAT Investigative D0LD0X DRUG__ID D0LD0X D0LD0X DRUGTYPE Small molecular drug D0LD0X DRUGINCH 1S/C8H10N4O2/c1-2-3-12-7(13)5-6(10-4-9-5)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,14) D0LD0X DRUGINKE IWBONKMODGBEOX-UHFFFAOYSA-N D0LD0X DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=CN2 D0LD0X HIGHSTAT Investigative D0LD1X DRUG__ID D0LD1X D0LD1X DRUGTYPE Small molecular drug D0LD1X DRUGINCH 1S/C29H33FN2O/c30-25-13-11-22(12-14-25)28(33)17-18-31-19-20-32-21-26(31)15-16-27(32)29(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,26-29,33H,15-21H2/t26-,27-,28-/m0/s1 D0LD1X DRUGINKE GAKAYJNKCDLKCE-KCHLEUMXSA-N D0LD1X DRUGSMIL C1CC(N2CCN(C1C2)CCC(C3=CC=C(C=C3)F)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D0LD1X HIGHSTAT Investigative D0LE0E DRUG__ID D0LE0E D0LE0E DRUGTYPE Small molecular drug D0LE0E DRUGINCH 1S/C10H6FNO3/c11-5-1-2-6-7(3-5)12-10(15)9(14)4-8(6)13/h1-4,13H,(H,12,14,15) D0LE0E DRUGINKE ZAZQJJXYILGMQL-UHFFFAOYSA-N D0LE0E DRUGSMIL C1=CC2=C(C=C1F)NC(=O)C(=O)C=C2O D0LE0E HIGHSTAT Investigative D0LE1F DRUG__ID D0LE1F D0LE1F DRUGTYPE Small molecular drug D0LE1F DRUGINCH 1S/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3 D0LE1F DRUGINKE YKYOQIXTECBVBB-UHFFFAOYSA-N D0LE1F DRUGSMIL CCOC(=O)C1=C2C3CCCN3C(=O)C4=C(N2C=N1)C=CC(=C4)OC D0LE1F HIGHSTAT Investigative D0LE6N DRUG__ID D0LE6N D0LE6N DRUGTYPE Small molecular drug D0LE6N DRUGINCH 1S/C7H12N2/c8-7-6-3-1-2-5(6)4-9-7/h5-6H,1-4H2,(H2,8,9) D0LE6N DRUGINKE QRVPYEUERURUGX-UHFFFAOYSA-N D0LE6N DRUGSMIL C1CC2CN=C(C2C1)N D0LE6N HIGHSTAT Investigative D0LE7J DRUG__ID D0LE7J D0LE7J DRUGTYPE Small molecular drug D0LE7J DRUGINCH 1S/C20H22N4O3/c1-20(2,25)7-6-13-4-5-16-14(10-13)15(11-22-16)18-17(27-9-8-26-3)12-23-19(21)24-18/h4-5,10-12,22,25H,8-9H2,1-3H3,(H2,21,23,24) D0LE7J DRUGINKE ZZIZLABGKZWVAW-UHFFFAOYSA-N D0LE7J DRUGSMIL CC(C)(C#CC1=CC2=C(C=C1)NC=C2C3=NC(=NC=C3OCCOC)N)O D0LE7J HIGHSTAT Investigative D0LF7W DRUG__ID D0LF7W D0LF7W DRUGTYPE Small molecular drug D0LF7W DRUGINCH 1S/C18H29N7O8/c19-18(20)21-3-1-2-8-16(32)22-6-11(26)23-10(5-12(27)28)17(33)25-9-4-7(15(31)24-8)13(29)14(9)30/h7-10,13-14,29-30H,1-6H2,(H,22,32)(H,23,26)(H,24,31)(H,25,33)(H,27,28)(H4,19,20,21)/t7-,8-,9+,10-,13-,14-/m0/s1 D0LF7W DRUGINKE VNLGSUKLIVHSOW-NDCHHBOESA-N D0LF7W DRUGSMIL C1C2C(C(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O)O D0LF7W HIGHSTAT Investigative D0LG8A DRUG__ID D0LG8A D0LG8A DRUGTYPE Small molecular drug D0LG8A DRUGINCH 1S/C9H12F5NS/c1-7(15)5-8-3-2-4-9(6-8)16(10,11,12,13)14/h2-4,6-7H,5,15H2,1H3 D0LG8A DRUGINKE YGBSUVPUXAMOTQ-UHFFFAOYSA-N D0LG8A DRUGSMIL CC(CC1=CC(=CC=C1)S(F)(F)(F)(F)F)N D0LG8A HIGHSTAT Investigative D0LH1A DRUG__ID D0LH1A D0LH1A DRUGTYPE Small molecular drug D0LH1A DRUGINCH 1S/C15H18F4N2O.ClH/c16-13-9-11(8-12(10-13)15(17,18)19)14(22)20-4-7-21-5-2-1-3-6-21;/h8-10H,1-7H2,(H,20,22);1H D0LH1A DRUGINKE FEMIHMMAZDXYBI-UHFFFAOYSA-N D0LH1A DRUGSMIL C1CCN(CC1)CCNC(=O)C2=CC(=CC(=C2)F)C(F)(F)F.Cl D0LH1A HIGHSTAT Investigative D0LH3S DRUG__ID D0LH3S D0LH3S DRUGTYPE Small molecular drug D0LH3S DRUGINCH 1S/C18H20O4/c1-19-15-9-7-13(8-10-15)5-6-14-11-16(20-2)18(22-4)17(12-14)21-3/h5-12H,1-4H3/b6-5- D0LH3S DRUGINKE GGFQQRXTLIJXNY-WAYWQWQTSA-N D0LH3S DRUGSMIL COC1=CC=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC D0LH3S HIGHSTAT Investigative D0LH4L DRUG__ID D0LH4L D0LH4L DRUGTYPE Small molecular drug D0LH4L DRUGINCH 1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3/t13-/m0/s1 D0LH4L DRUGINKE LZJRNLRASBVRRX-ZDUSSCGKSA-N D0LH4L DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)O)OC)O D0LH4L HIGHSTAT Investigative D0LH5P DRUG__ID D0LH5P D0LH5P DRUGTYPE Small molecular drug D0LH5P DRUGINCH 1S/C20H21N7O5/c21-16-15-17(27-20(22)26-16)23-9-12(24-15)6-3-10-1-4-11(5-2-10)18(30)25-13(19(31)32)7-8-14(28)29/h1-2,4-5,9,13H,3,6-8H2,(H,25,30)(H,28,29)(H,31,32)(H4,21,22,23,26,27)/t13-/m0/s1 D0LH5P DRUGINKE LGFLRHWJJKLPCC-ZDUSSCGKSA-N D0LH5P DRUGSMIL C1=CC(=CC=C1CCC2=CN=C3C(=N2)C(=NC(=N3)N)N)C(=O)NC(CCC(=O)O)C(=O)O D0LH5P HIGHSTAT Investigative D0LH9A DRUG__ID D0LH9A D0LH9A DRUGTYPE Small molecular drug D0LH9A DRUGINCH 1S/C19H20O7/c1-8(2)17(22)24-12-7-19(5)13(20)6-11(26-19)9(3)15(21)16-14(12)10(4)18(23)25-16/h6,12,14-16,21H,1,3-4,7H2,2,5H3/t12-,14+,15+,16-,19+/m0/s1 D0LH9A DRUGINKE QOLGSSCWXRXSJG-FTLZPGDLSA-N D0LH9A DRUGSMIL CC(=C)C(=O)OC1CC2(C(=O)C=C(O2)C(=C)C(C3C1C(=C)C(=O)O3)O)C D0LH9A HIGHSTAT Investigative D0LI0M DRUG__ID D0LI0M D0LI0M DRUGTYPE Small molecular drug D0LI0M DRUGINCH 1S/C20H22O5/c1-2-3-4-5-14-15(22)10-16(23)19-17(24)11-18(25-20(14)19)12-6-8-13(21)9-7-12/h6-10,18,21-23H,2-5,11H2,1H3/t18-/m0/s1 D0LI0M DRUGINKE NKWHELZNPRCJAS-SFHVURJKSA-N D0LI0M DRUGSMIL CCCCCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D0LI0M HIGHSTAT Investigative D0LI3J DRUG__ID D0LI3J D0LI3J DRUGTYPE Small molecular drug D0LI3J DRUGINCH 1S/C11H10N2O/c1-2-4-9-8(3-1)7-10(14-9)11-12-5-6-13-11/h1-4,7H,5-6H2,(H,12,13) D0LI3J DRUGINKE YTJOHEUHUVBKSB-UHFFFAOYSA-N D0LI3J DRUGSMIL C1CN=C(N1)C2=CC3=CC=CC=C3O2 D0LI3J HIGHSTAT Investigative D0LJ2F DRUG__ID D0LJ2F D0LJ2F DRUGTYPE Small molecular drug D0LJ2F DRUGINCH 1S/C14H22O2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h11-12H,1-10H2 D0LJ2F DRUGINKE ZWDFMOMBVDVEHE-UHFFFAOYSA-N D0LJ2F DRUGSMIL C1CCC(CC1)C(=O)C(=O)C2CCCCC2 D0LJ2F HIGHSTAT Investigative D0LJ4Q DRUG__ID D0LJ4Q D0LJ4Q DRUGTYPE Small molecular drug D0LJ4Q DRUGINCH 1S/C12H14N2O/c1-2-8-15-10-5-3-4-9-6-7-11(13)14-12(9)10/h3-7H,2,8H2,1H3,(H2,13,14) D0LJ4Q DRUGINKE SZBXIIUHFFFWME-UHFFFAOYSA-N D0LJ4Q DRUGSMIL CCCOC1=CC=CC2=C1N=C(C=C2)N D0LJ4Q HIGHSTAT Investigative D0LJ5P DRUG__ID D0LJ5P D0LJ5P DRUGTYPE Small molecular drug D0LJ5P DRUGINCH 1S/C8H7NO2S/c1-2-7-3-5-8(6-4-7)12(9,10)11/h1,3-6H,(H2,9,10,11) D0LJ5P DRUGINKE OQPUCENNUFNCQO-UHFFFAOYSA-N D0LJ5P DRUGSMIL C#CC1=CC=C(C=C1)S(=O)(=O)N D0LJ5P HIGHSTAT Investigative D0LJ9D DRUG__ID D0LJ9D D0LJ9D DRUGTYPE Small molecular drug D0LJ9D DRUGINCH 1S/C16H13NS/c1-2-16(18-11-1)15-5-3-13(4-6-15)12-14-7-9-17-10-8-14/h1-11H,12H2 D0LJ9D DRUGINKE ORQOALYZYXEWJV-UHFFFAOYSA-N D0LJ9D DRUGSMIL C1=CSC(=C1)C2=CC=C(C=C2)CC3=CC=NC=C3 D0LJ9D HIGHSTAT Investigative D0LK4J DRUG__ID D0LK4J D0LK4J DRUGTYPE Small molecular drug D0LK4J DRUGINCH 1S/C44H58N8O12S/c1-4-25(2)38(51-42(59)37(24-65)46-26(3)53)43(60)49-35(22-29-12-18-32(55)19-13-29)40(57)47-33(7-5-6-20-45)39(56)48-34(21-28-10-16-31(54)17-11-28)41(58)50-36(44(61)62)23-27-8-14-30(15-9-27)52(63)64/h8-19,25,33-38,54-55,65H,4-7,20-24,45H2,1-3H3,(H,46,53)(H,47,57)(H,48,56)(H,49,60)(H,50,58)(H,51,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D0LK4J DRUGINKE FNBOPWDKOOFHTM-LBNFHWTGSA-N D0LK4J DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)O)NC(=O)C(CS)NC(=O)C D0LK4J HIGHSTAT Investigative D0LK5P DRUG__ID D0LK5P D0LK5P DRUGTYPE Small molecular drug D0LK5P DRUGINCH 1S/C25H39NO6S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22(21(27)15-14-17-24(29)30)33-19-18-23(28)26-20-25(31)32/h6-7,9-13,16,21-22,27H,2-5,8,14-15,17-20H2,1H3,(H,26,28)(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t21-,22+/m0/s1 D0LK5P DRUGINKE SEOZZZSLGDJWJL-FSKXFZJASA-N D0LK5P DRUGSMIL CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCCC(=O)NCC(=O)O D0LK5P HIGHSTAT Investigative D0LK8U DRUG__ID D0LK8U D0LK8U DRUGTYPE Small molecular drug D0LK8U DRUGINCH 1S/C13H13NO2/c15-13(14-16)11-7-2-1-4-8-12-9-5-3-6-10-12/h1-11,16H,(H,14,15)/b2-1+,8-4+,11-7+ D0LK8U DRUGINKE DBBYYRWVNDQECM-CDWOPPGASA-N D0LK8U DRUGSMIL C1=CC=C(C=C1)C=CC=CC=CC(=O)NO D0LK8U HIGHSTAT Investigative D0LL1F DRUG__ID D0LL1F D0LL1F DRUGTYPE Small molecular drug D0LL1F DRUGINCH 1S/C15H15N3S/c16-15(19)18-17-14(13-9-5-2-6-10-13)11-12-7-3-1-4-8-12/h1-10H,11H2,(H3,16,18,19)/b17-14+ D0LL1F DRUGINKE WHRFFXUXTGIZOH-SAPNQHFASA-N D0LL1F DRUGSMIL C1=CC=C(C=C1)CC(=NNC(=S)N)C2=CC=CC=C2 D0LL1F HIGHSTAT Investigative D0LL3D DRUG__ID D0LL3D D0LL3D DRUGTYPE Small molecular drug D0LL3D DRUGINCH 1S/C7H5BrN2/c8-6-3-1-2-5-4-9-10-7(5)6/h1-4H,(H,9,10) D0LL3D DRUGINKE KMHHWCPTROQUFM-UHFFFAOYSA-N D0LL3D DRUGSMIL C1=CC2=C(C(=C1)Br)NN=C2 D0LL3D HIGHSTAT Investigative D0LL4C DRUG__ID D0LL4C D0LL4C DRUGTYPE Small molecular drug D0LL4C DRUGINCH 1S/O/q-2 D0LL4C DRUGINKE AHKZTVQIVOEVFO-UHFFFAOYSA-N D0LL4C DRUGSMIL [O-2] D0LL4C HIGHSTAT Investigative D0LL5V DRUG__ID D0LL5V D0LL5V DRUGTYPE Small molecular drug D0LL5V DRUGINCH 1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1 D0LL5V DRUGINKE KZSNJWFQEVHDMF-BYPYZUCNSA-N D0LL5V DRUGSMIL CC(C)C(C(=O)O)N D0LL5V HIGHSTAT Investigative D0LL7N DRUG__ID D0LL7N D0LL7N DRUGTYPE Small molecular drug D0LL7N DRUGINCH 1S/C37H33Cl2N5O5/c1-23-19-32(48-21-26-7-4-5-18-41-26)27-8-6-9-31(36(27)43-23)49-22-28-29(38)15-16-30(35(28)39)44(3)34(46)20-42-33(45)17-12-24-10-13-25(14-11-24)37(47)40-2/h4-19H,20-22H2,1-3H3,(H,40,47)(H,42,45)/b17-12+ D0LL7N DRUGINKE YFMDLMSUZMRKKH-SFQUDFHCSA-N D0LL7N DRUGSMIL CC1=CC(=C2C=CC=C(C2=N1)OCC3=C(C=CC(=C3Cl)N(C)C(=O)CNC(=O)C=CC4=CC=C(C=C4)C(=O)NC)Cl)OCC5=CC=CC=N5 D0LL7N HIGHSTAT Investigative D0LL8H DRUG__ID D0LL8H D0LL8H DRUGTYPE Small molecular drug D0LL8H DRUGINCH 1S/C21H21NO6/c23-20(15-9-5-2-6-10-15)27-16-12-25-19-17(13-26-18(16)19)28-21(24)22-11-14-7-3-1-4-8-14/h1-10,16-19H,11-13H2,(H,22,24)/t16-,17+,18-,19-/m1/s1 D0LL8H DRUGINKE NIWDLVRLOCHGOV-FCGDIQPGSA-N D0LL8H DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NCC3=CC=CC=C3)OC(=O)C4=CC=CC=C4 D0LL8H HIGHSTAT Investigative D0LL8I DRUG__ID D0LL8I D0LL8I DRUGTYPE Small molecular drug D0LL8I DRUGINCH 1S/C33H31N3O7S/c1-22-18-23(2)31(28(19-22)32(37)35-39)36(21-24-8-4-3-5-9-24)44(40,41)27-14-12-26(13-15-27)42-17-16-34-33(38)30-20-25-10-6-7-11-29(25)43-30/h3-15,18-20,39H,16-17,21H2,1-2H3,(H,34,38)(H,35,37) D0LL8I DRUGINKE FARMEEAGJWMFSZ-UHFFFAOYSA-N D0LL8I DRUGSMIL CC1=CC(=C(C(=C1)C(=O)NO)N(CC2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)OCCNC(=O)C4=CC5=CC=CC=C5O4)C D0LL8I HIGHSTAT Investigative D0LL9E DRUG__ID D0LL9E D0LL9E DRUGTYPE Small molecular drug D0LL9E DRUGINCH 1S/C14H14N2O3S/c1-20(18,19)13-9-7-12(8-10-13)16-14(17)15-11-5-3-2-4-6-11/h2-10H,1H3,(H2,15,16,17) D0LL9E DRUGINKE BNCVKEKVEUVIPN-UHFFFAOYSA-N D0LL9E DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)NC(=O)NC2=CC=CC=C2 D0LL9E HIGHSTAT Investigative D0LM1Q DRUG__ID D0LM1Q D0LM1Q DRUGTYPE Small molecular drug D0LM1Q DRUGINCH 1S/C19H16N4O2/c24-18-16-17(21-13-20-16)22(11-14-7-3-1-4-8-14)19(25)23(18)12-15-9-5-2-6-10-15/h1-10,13H,11-12H2,(H,20,21) D0LM1Q DRUGINKE NHCLZKKZQJJXER-UHFFFAOYSA-N D0LM1Q DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C(=O)N(C2=O)CC4=CC=CC=C4)NC=N3 D0LM1Q HIGHSTAT Investigative D0LM2K DRUG__ID D0LM2K D0LM2K DRUGTYPE Small molecular drug D0LM2K DRUGINCH 1S/C16H16O4S/c17-16(18)12-21(19,20)11-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9H,10-12H2,(H,17,18) D0LM2K DRUGINKE PPYPHJNYICUMPA-UHFFFAOYSA-N D0LM2K DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)CCS(=O)(=O)CC(=O)O D0LM2K HIGHSTAT Investigative D0LM5H DRUG__ID D0LM5H D0LM5H DRUGTYPE Small molecular drug D0LM5H DRUGINCH 1S/C28H25F3N2O4/c1-37-20-5-6-25-22(15-20)21(8-10-32-25)26(34)7-4-17-9-12-33(16-23(17)28(35)36)11-2-3-18-13-19(29)14-24(30)27(18)31/h5-6,8,10,13-15,17,23H,4,7,9,11-12,16H2,1H3,(H,35,36)/t17-,23+/m1/s1 D0LM5H DRUGINKE VWNMWKSURFWKAL-HXOBKFHXSA-N D0LM5H DRUGSMIL COC1=CC2=C(C=CN=C2C=C1)C(=O)CCC3CCN(CC3C(=O)O)CC#CC4=C(C(=CC(=C4)F)F)F D0LM5H HIGHSTAT Investigative D0LM6A DRUG__ID D0LM6A D0LM6A DRUGTYPE Small molecular drug D0LM6A DRUGINCH 1S/C12H17N5O3S/c1-2-21-3-6-8(18)9(19)12(20-6)17-5-16-7-10(13)14-4-15-11(7)17/h4-6,8-9,12,18-19H,2-3H2,1H3,(H2,13,14,15)/t6-,8-,9-,12-/m1/s1 D0LM6A DRUGINKE HMXHURAGFHWODC-WOUKDFQISA-N D0LM6A DRUGSMIL CCSCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0LM6A HIGHSTAT Investigative D0LM8L DRUG__ID D0LM8L D0LM8L DRUGTYPE Small molecular drug D0LM8L DRUGINCH 1S/C9H9BrN2O2S2/c10-7-2-1-3-8-9(7)6(5-15-8)4-12-16(11,13)14/h1-3,5,12H,4H2,(H2,11,13,14) D0LM8L DRUGINKE FBZAPOBZDNKPQH-UHFFFAOYSA-N D0LM8L DRUGSMIL C1=CC2=C(C(=C1)Br)C(=CS2)CNS(=O)(=O)N D0LM8L HIGHSTAT Investigative D0LN2D DRUG__ID D0LN2D D0LN2D DRUGTYPE Small molecular drug D0LN2D DRUGINCH 1S/C6H13NO2S/c1-2-10-4-3-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1 D0LN2D DRUGINKE GGLZPLKKBSSKCX-YFKPBYRVSA-N D0LN2D DRUGSMIL CCSCCC(C(=O)O)N D0LN2D HIGHSTAT Investigative D0LN9P DRUG__ID D0LN9P D0LN9P DRUGTYPE Small molecular drug D0LN9P DRUGINCH 1S/C28H38N2O6.ClH/c1-9-34-26(32)23-18(3)29-21(17-30(7)8)25(27(33)35-10-2)24(23)20-14-12-11-13-19(20)15-16-22(31)36-28(4,5)6;/h11-16,24,29H,9-10,17H2,1-8H3;1H/b16-15+; D0LN9P DRUGINKE VMZCXIGDNRMWGI-GEEYTBSJSA-N D0LN9P DRUGSMIL CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)CN(C)C)C.Cl D0LN9P HIGHSTAT Investigative D0LO4T DRUG__ID D0LO4T D0LO4T DRUGTYPE Small molecular drug D0LO4T DRUGINCH 1S/C20H34NO3P/c1-2-3-4-5-6-7-8-9-18-10-12-19(13-11-18)16-21-15-14-20(17-21)25(22,23)24/h10-13,20H,2-9,14-17H2,1H3,(H2,22,23,24) D0LO4T DRUGINKE PRUUCTGBHIGGOH-UHFFFAOYSA-N D0LO4T DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)CN2CCC(C2)P(=O)(O)O D0LO4T HIGHSTAT Investigative D0LO5B DRUG__ID D0LO5B D0LO5B DRUGTYPE Small molecular drug D0LO5B DRUGINCH 1S/C31H28ClN7O2/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38)/b11-6+ D0LO5B DRUGINKE OBJNFLYHUXWUPF-IZZDOVSWSA-N D0LO5B DRUGSMIL CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl D0LO5B HIGHSTAT Investigative D0LO8S DRUG__ID D0LO8S D0LO8S DRUGTYPE Small molecular drug D0LO8S DRUGINCH 1S/C16H11N3O/c1-20-14-6-11(9-17)5-13(7-14)16-8-15-12(10-19-16)3-2-4-18-15/h2-8,10H,1H3 D0LO8S DRUGINKE YBYSMAYSUKEUHM-UHFFFAOYSA-N D0LO8S DRUGSMIL COC1=CC(=CC(=C1)C2=NC=C3C=CC=NC3=C2)C#N D0LO8S HIGHSTAT Investigative D0LP2H DRUG__ID D0LP2H D0LP2H DRUGTYPE Small molecular drug D0LP2H DRUGINCH 1S/C2H3NO3/c3-1(4)2(5)6/h(H2,3,4)(H,5,6) D0LP2H DRUGINKE SOWBFZRMHSNYGE-UHFFFAOYSA-N D0LP2H DRUGSMIL C(=O)(C(=O)O)N D0LP2H HIGHSTAT Investigative D0LP2K DRUG__ID D0LP2K D0LP2K DRUGTYPE Small molecular drug D0LP2K DRUGINCH 1S/C27H34N2O9S/c1-12(31)28-16-7-5-13-9-17(29-27-24(35)23(34)22(33)19(11-30)38-27)25(36-2)26(37-3)21(13)14-6-8-20(39-4)18(32)10-15(14)16/h6,8-10,16,19,22-24,27,29-30,33-35H,5,7,11H2,1-4H3,(H,28,31)/t16-,19+,22+,23-,24-,27+/m0/s1 D0LP2K DRUGINKE FPOIHQLRIKBTGP-LMOMQKJLSA-N D0LP2K DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)NC4C(C(C(C(O4)CO)O)O)O D0LP2K HIGHSTAT Investigative D0LP2M DRUG__ID D0LP2M D0LP2M DRUGTYPE Small molecular drug D0LP2M DRUGINCH 1S/C23H18N2O3/c26-22-20(23(27)25(24-22)19-12-5-2-6-13-19)15-18-11-7-8-14-21(18)28-16-17-9-3-1-4-10-17/h1-15H,16H2,(H,24,26)/b20-15- D0LP2M DRUGINKE NDWMSBYUWXNXGT-HKWRFOASSA-N D0LP2M DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC=C2C=C3C(=O)NN(C3=O)C4=CC=CC=C4 D0LP2M HIGHSTAT Investigative D0LP5G DRUG__ID D0LP5G D0LP5G DRUGTYPE Small molecular drug D0LP5G DRUGINCH 1S/C16H12N4/c17-15-14-13(11-8-4-5-9-12(11)18-15)19-16(20-14)10-6-2-1-3-7-10/h1-9H,(H2,17,18)(H,19,20) D0LP5G DRUGINKE IBRIUJBAFMFSDF-UHFFFAOYSA-N D0LP5G DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)N D0LP5G HIGHSTAT Investigative D0LP5V DRUG__ID D0LP5V D0LP5V DRUGTYPE Small molecular drug D0LP5V DRUGINCH 1S/C20H18N4/c1-13(2)18-22-17-16(14-9-5-3-6-10-14)21-19(24-20(17)23-18)15-11-7-4-8-12-15/h3-13H,1-2H3,(H,21,22,23,24) D0LP5V DRUGINKE WOKKQPCDRVUEPM-UHFFFAOYSA-N D0LP5V DRUGSMIL CC(C)C1=NC2=NC(=NC(=C2N1)C3=CC=CC=C3)C4=CC=CC=C4 D0LP5V HIGHSTAT Investigative D0LR8X DRUG__ID D0LR8X D0LR8X DRUGTYPE Small molecular drug D0LR8X DRUGINCH 1S/C17H18BrNO/c1-19-8-7-13-9-16(18)17(20)10-14(13)15(11-19)12-5-3-2-4-6-12/h2-6,9-10,15,20H,7-8,11H2,1H3 D0LR8X DRUGINKE XFTVOHWWEQGXLS-UHFFFAOYSA-N D0LR8X DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)O)Br D0LR8X HIGHSTAT Investigative D0LS2U DRUG__ID D0LS2U D0LS2U DRUGTYPE Small molecular drug D0LS2U DRUGINCH 1S/C17H16O6/c1-8-3-10(6-12(14(8)18)16(20)21)5-11-4-9(2)15(19)13(7-11)17(22)23/h3-4,6-7,18-19H,5H2,1-2H3,(H,20,21)(H,22,23) D0LS2U DRUGINKE UPLNCYRSCVJILM-UHFFFAOYSA-N D0LS2U DRUGSMIL CC1=CC(=CC(=C1O)C(=O)O)CC2=CC(=C(C(=C2)C)O)C(=O)O D0LS2U HIGHSTAT Investigative D0LT0T DRUG__ID D0LT0T D0LT0T DRUGTYPE Small molecular drug D0LT0T DRUGINCH 1S/C24H23N5O2/c30-21(14-28-10-3-4-11-28)25-15-7-8-20-18(13-15)24(31)29-12-9-17-16-5-1-2-6-19(16)26-22(17)23(29)27-20/h1-2,5-8,13,26H,3-4,9-12,14H2,(H,25,30) D0LT0T DRUGINKE WZTWUTJMQXWCQN-UHFFFAOYSA-N D0LT0T DRUGSMIL C1CCN(C1)CC(=O)NC2=CC3=C(C=C2)N=C4C5=C(CCN4C3=O)C6=CC=CC=C6N5 D0LT0T HIGHSTAT Investigative D0LT5D DRUG__ID D0LT5D D0LT5D DRUGTYPE Small molecular drug D0LT5D DRUGINCH 1S/C21H27NO/c1-3-13-22(14-4-2)19-15-18-11-8-12-20(21(18)23-16-19)17-9-6-5-7-10-17/h5-12,19H,3-4,13-16H2,1-2H3/t19-/m1/s1 D0LT5D DRUGINKE OYEKUFKQGCYWCG-LJQANCHMSA-N D0LT5D DRUGSMIL CCCN(CCC)C1CC2=C(C(=CC=C2)C3=CC=CC=C3)OC1 D0LT5D HIGHSTAT Investigative D0LT7Y DRUG__ID D0LT7Y D0LT7Y DRUGTYPE Small molecular drug D0LT7Y DRUGINCH 1S/C15H23NO4/c1-4-19-15(18)12-5-7-14(8-6-12)20-10-13(17)9-16-11(2)3/h5-8,11,13,16-17H,4,9-10H2,1-3H3 D0LT7Y DRUGINKE SLTRHTRCERUIHA-UHFFFAOYSA-N D0LT7Y DRUGSMIL CCOC(=O)C1=CC=C(C=C1)OCC(CNC(C)C)O D0LT7Y HIGHSTAT Investigative D0LU2F DRUG__ID D0LU2F D0LU2F DRUGTYPE Small molecular drug D0LU2F DRUGINCH 1S/C22H39BF2N2O2/c1-18-13-14-20-17-21-16-15-19(27(21)23(24,25)26(18)20)11-9-7-5-3-2-4-6-8-10-12-22(28)29/h17-20,26H,2-16H2,1H3,(H,28,29) D0LU2F DRUGINKE IRNYSPHCPBXXQD-UHFFFAOYSA-N D0LU2F DRUGSMIL [B-]1([NH+]2C(CCC2C=C3N1C(CC3)CCCCCCCCCCCC(=O)O)C)(F)F D0LU2F HIGHSTAT Investigative D0LU2N DRUG__ID D0LU2N D0LU2N DRUGTYPE Small molecular drug D0LU2N DRUGINCH 1S/C14H12Cl2O2/c1-2-9-3-5-14(12(17)7-9)18-13-6-4-10(15)8-11(13)16/h3-8,17H,2H2,1H3 D0LU2N DRUGINKE UUSUFMSMUYHSBH-UHFFFAOYSA-N D0LU2N DRUGSMIL CCC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D0LU2N HIGHSTAT Investigative D0LU4S DRUG__ID D0LU4S D0LU4S DRUGTYPE Small molecular drug D0LU4S DRUGINCH 1S/C13H14O3/c1-2-3-8-15-11-6-4-10-5-7-13(14)16-12(10)9-11/h4-7,9H,2-3,8H2,1H3 D0LU4S DRUGINKE BDOGTORASJEUBW-UHFFFAOYSA-N D0LU4S DRUGSMIL CCCCOC1=CC2=C(C=C1)C=CC(=O)O2 D0LU4S HIGHSTAT Investigative D0LV6B DRUG__ID D0LV6B D0LV6B DRUGTYPE Small molecular drug D0LV6B DRUGINCH 1S/C28H49N11O11/c29-8-2-1-5-16(27(49)50)37-25(47)19-7-4-10-39(19)26(48)18(14-40)38-24(46)17(11-22(43)44)36-21(42)13-34-23(45)15(35-20(41)12-30)6-3-9-33-28(31)32/h15-19,40H,1-14,29-30H2,(H,34,45)(H,35,41)(H,36,42)(H,37,47)(H,38,46)(H,43,44)(H,49,50)(H4,31,32,33)/t15-,16-,17-,18-,19-/m0/s1 D0LV6B DRUGINKE ZRVZOBGMZWVJOS-VMXHOPILSA-N D0LV6B DRUGSMIL C1CC(N(C1)C(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)CN)C(=O)NC(CCCCN)C(=O)O D0LV6B HIGHSTAT Investigative D0LV7S DRUG__ID D0LV7S D0LV7S DRUGTYPE Small molecular drug D0LV7S DRUGINCH 1S/CH2O3.2H3N/c2-1(3)4;;/h(H2,2,3,4);2*1H3 D0LV7S DRUGINKE PRKQVKDSMLBJBJ-UHFFFAOYSA-N D0LV7S DRUGSMIL C(=O)([O-])[O-].[NH4+].[NH4+] D0LV7S HIGHSTAT Investigative D0LV7U DRUG__ID D0LV7U D0LV7U DRUGTYPE Small molecular drug D0LV7U DRUGINCH 1S/C23H29N3O2/c1-28-22-11-5-4-10-21(22)25-16-14-24(15-17-25)12-6-7-13-26-20-9-3-2-8-19(20)18-23(26)27/h2-5,8-11H,6-7,12-18H2,1H3 D0LV7U DRUGINKE VJMHUOSOEAGNQW-UHFFFAOYSA-N D0LV7U DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC4=CC=CC=C43 D0LV7U HIGHSTAT Investigative D0LX0D DRUG__ID D0LX0D D0LX0D DRUGTYPE Small molecular drug D0LX0D DRUGINCH 1S/C22H18N2OS/c23-22(24)21-13-18-11-17(9-10-20(18)26-21)16-7-4-8-19(12-16)25-14-15-5-2-1-3-6-15/h1-13H,14H2,(H3,23,24) D0LX0D DRUGINKE HCMFEDPYXOWDMW-UHFFFAOYSA-N D0LX0D DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC(=C2)C3=CC4=C(C=C3)SC(=C4)C(=N)N D0LX0D HIGHSTAT Investigative D0LX4U DRUG__ID D0LX4U D0LX4U DRUGTYPE Small molecular drug D0LX4U DRUGINCH 1S/C20H16Br2N2S/c21-16-10-6-14(7-11-16)19(15-8-12-17(22)13-9-15)24-20(25)23-18-4-2-1-3-5-18/h1-13,19H,(H2,23,24,25) D0LX4U DRUGINKE JQWBRSQRBYVWFQ-UHFFFAOYSA-N D0LX4U DRUGSMIL C1=CC=C(C=C1)NC(=S)NC(C2=CC=C(C=C2)Br)C3=CC=C(C=C3)Br D0LX4U HIGHSTAT Investigative D0LX6R DRUG__ID D0LX6R D0LX6R DRUGTYPE Small molecular drug D0LX6R DRUGINCH 1S/C27H45NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-27(31)28-25(23-29)22-24-18-20-26(30)21-19-24/h9-10,18-21,25,29-30H,2-8,11-17,22-23H2,1H3,(H,28,31)/b10-9-/t25-/m0/s1 D0LX6R DRUGINKE ICDMLAQPOAVWNH-JRUKXMRZSA-N D0LX6R DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC(CC1=CC=C(C=C1)O)CO D0LX6R HIGHSTAT Investigative D0LY5S DRUG__ID D0LY5S D0LY5S DRUGTYPE Small molecular drug D0LY5S DRUGINCH 1S/C15H10N4O/c16-9-10-4-3-5-11(8-10)14(20)19-15-17-12-6-1-2-7-13(12)18-15/h1-8H,(H2,17,18,19,20) D0LY5S DRUGINKE JSWLIGOCNPPDTR-UHFFFAOYSA-N D0LY5S DRUGSMIL C1=CC=C2C(=C1)NC(=N2)NC(=O)C3=CC=CC(=C3)C#N D0LY5S HIGHSTAT Investigative D0LZ3O DRUG__ID D0LZ3O D0LZ3O DRUGTYPE Small molecular drug D0LZ3O DRUGINCH 1S/C17H18N2O4/c18-15(10-16(20)21)17(22)19-13-6-8-14(9-7-13)23-11-12-4-2-1-3-5-12/h1-9,15H,10-11,18H2,(H,19,22)(H,20,21)/t15-/m0/s1 D0LZ3O DRUGINKE VTMSXGVEMJOFRJ-HNNXBMFYSA-N D0LZ3O DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)C(CC(=O)O)N D0LZ3O HIGHSTAT Investigative D0LZ5R DRUG__ID D0LZ5R D0LZ5R DRUGTYPE Small molecular drug D0LZ5R DRUGINCH 1S/C31H29N5O7/c1-18-13-19(7-11-32-18)16-36-27(31(38)42-5)25(20-14-22(39-2)28(41-4)23(15-20)40-3)21-8-12-35-29(26(21)30(36)37)43-17-24-33-9-6-10-34-24/h6-15H,16-17H2,1-5H3 D0LZ5R DRUGINKE JEMJAABFSYOLAP-UHFFFAOYSA-N D0LZ5R DRUGSMIL CC1=NC=CC(=C1)CN2C(=C(C3=C(C2=O)C(=NC=C3)OCC4=NC=CC=N4)C5=CC(=C(C(=C5)OC)OC)OC)C(=O)OC D0LZ5R HIGHSTAT Investigative D0M0BM DRUG__ID D0M0BM D0M0BM DRUGTYPE Small molecular drug D0M0BM DRUGINCH 1S/C13H13ClN2/c14-8-5-6-10-12(7-8)16-11-4-2-1-3-9(11)13(10)15/h5-7H,1-4H2,(H2,15,16) D0M0BM DRUGINKE GQZMDBQRGRRPMS-UHFFFAOYSA-N D0M0BM DRUGSMIL C1CCC2=NC3=C(C=CC(=C3)Cl)C(=C2C1)N D0M0BM HIGHSTAT Investigative D0M0BN DRUG__ID D0M0BN D0M0BN DRUGTYPE Small molecular drug D0M0BN DRUGINCH 1S/C31H37F3N8O7/c32-31(33,34)30(16-19-10-5-2-6-11-19)28(49)41-20(12-7-13-37-29(35)36)25(46)38-17-23(43)39-22(15-24(44)45)26(47)40-21(27(48)42-30)14-18-8-3-1-4-9-18/h1-6,8-11,20-22H,7,12-17H2,(H,38,46)(H,39,43)(H,40,47)(H,41,49)(H,42,48)(H,44,45)(H4,35,36,37)/t20-,21+,22-,30+/m0/s1 D0M0BN DRUGINKE QAYABLFYSHKUBR-ULBBTDGDSA-N D0M0BN DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)(CC2=CC=CC=C2)C(F)(F)F)CC3=CC=CC=C3)CC(=O)O D0M0BN HIGHSTAT Investigative D0M0CF DRUG__ID D0M0CF D0M0CF DRUGTYPE Small molecular drug D0M0CF DRUGINCH 1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11+ D0M0CF DRUGINKE CRDAMVZIKSXKFV-YFVJMOTDSA-N D0M0CF DRUGSMIL CC(=CCCC(=CCCC(=CCO)C)C)C D0M0CF HIGHSTAT Investigative D0M0EE DRUG__ID D0M0EE D0M0EE DRUGTYPE Small molecular drug D0M0EE DRUGINCH 1S/C20H25NO3/c1-3-4-5-6-9-16-12-13-20(18(23)14-16)24-19-11-8-7-10-17(19)21-15(2)22/h7-8,10-14,23H,3-6,9H2,1-2H3,(H,21,22) D0M0EE DRUGINKE UNZWUCCAARAPNJ-UHFFFAOYSA-N D0M0EE DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC=C2NC(=O)C)O D0M0EE HIGHSTAT Investigative D0M0FE DRUG__ID D0M0FE D0M0FE DRUGTYPE Small molecular drug D0M0FE DRUGINCH 1S/C11H11N3O2/c15-14(16)11-3-1-10(2-4-11)5-7-13-8-6-12-9-13/h1-4,6,8-9H,5,7H2 D0M0FE DRUGINKE HCPMKJOVCNZGSD-UHFFFAOYSA-N D0M0FE DRUGSMIL C1=CC(=CC=C1CCN2C=CN=C2)[N+](=O)[O-] D0M0FE HIGHSTAT Investigative D0M0GV DRUG__ID D0M0GV D0M0GV DRUGTYPE Small molecular drug D0M0GV DRUGINCH 1S/C13H18IN5O8P2/c1-15-10-9-11(18-12(14)17-10)19(5-16-9)7-2-8(27-29(23,24)25)13(3-6(7)13)4-26-28(20,21)22/h5-8H,2-4H2,1H3,(H,15,17,18)(H2,20,21,22)(H2,23,24,25)/t6-,7+,8+,13+/m1/s1/i28+1 D0M0GV DRUGINKE NMVWLEUONAKGCD-PNGSNQAVSA-N D0M0GV DRUGSMIL CNC1=C2C(=NC(=N1)I)N(C=N2)C3CC(C4(C3C4)COP(=O)(O)O)OP(=O)(O)O D0M0GV HIGHSTAT Investigative D0M0HE DRUG__ID D0M0HE D0M0HE DRUGTYPE Small molecular drug D0M0HE DRUGINCH 1S/C25H26N2O/c1-2-9-22-24(28-17-8-16-26-18-19-10-4-3-5-11-19)15-14-21-20-12-6-7-13-23(20)27-25(21)22/h2-7,10-15,26-27H,1,8-9,16-18H2 D0M0HE DRUGINKE UPGXTVJBIFAVHT-UHFFFAOYSA-N D0M0HE DRUGSMIL C=CCC1=C(C=CC2=C1NC3=CC=CC=C23)OCCCNCC4=CC=CC=C4 D0M0HE HIGHSTAT Investigative D0M0HM DRUG__ID D0M0HM D0M0HM DRUGTYPE Small molecular drug D0M0HM DRUGINCH 1S/C21H23NO/c1-16(22-15-17-6-4-3-5-7-17)12-18-8-9-20-14-21(23-2)11-10-19(20)13-18/h3-11,13-14,16,22H,12,15H2,1-2H3 D0M0HM DRUGINKE KYXRSMFSOLANEF-UHFFFAOYSA-N D0M0HM DRUGSMIL CC(CC1=CC2=C(C=C1)C=C(C=C2)OC)NCC3=CC=CC=C3 D0M0HM HIGHSTAT Investigative D0M0IQ DRUG__ID D0M0IQ D0M0IQ DRUGTYPE Small molecular drug D0M0IQ DRUGINCH 1S/C20H17N3S2/c1-3-15(11-21-9-1)19-7-5-17(24-19)13-23-14-18-6-8-20(25-18)16-4-2-10-22-12-16/h1-12,23H,13-14H2 D0M0IQ DRUGINKE CKCZUAVVHJHNJY-UHFFFAOYSA-N D0M0IQ DRUGSMIL C1=CC(=CN=C1)C2=CC=C(S2)CNCC3=CC=C(S3)C4=CN=CC=C4 D0M0IQ HIGHSTAT Investigative D0M0KA DRUG__ID D0M0KA D0M0KA DRUGTYPE Small molecular drug D0M0KA DRUGINCH 1S/C20H36N2O2/c1-2-3-8-24-9-6-4-5-7-21-19(23)22-20-13-16-10-17(14-20)12-18(11-16)15-20/h16-18H,2-15H2,1H3,(H2,21,22,23) D0M0KA DRUGINKE KBTVUXWBRNQXPI-UHFFFAOYSA-N D0M0KA DRUGSMIL CCCCOCCCCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D0M0KA HIGHSTAT Investigative D0M0KX DRUG__ID D0M0KX D0M0KX DRUGTYPE Small molecular drug D0M0KX DRUGINCH 1S/C16H11FO2S/c17-13-9-11(4-5-14(13)19)16-7-6-15(20-16)10-2-1-3-12(18)8-10/h1-9,18-19H D0M0KX DRUGINKE NRSWHXCLBQLBRC-UHFFFAOYSA-N D0M0KX DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC(=C(C=C3)O)F D0M0KX HIGHSTAT Investigative D0M0LC DRUG__ID D0M0LC D0M0LC DRUGTYPE Small molecular drug D0M0LC DRUGINCH 1S/C13H9FN2/c1-10-6-11(4-5-13(10)14)2-3-12-7-15-9-16-8-12/h4-9H,1H3 D0M0LC DRUGINKE DCUICHQOGTUMNS-UHFFFAOYSA-N D0M0LC DRUGSMIL CC1=C(C=CC(=C1)C#CC2=CN=CN=C2)F D0M0LC HIGHSTAT Investigative D0M0QJ DRUG__ID D0M0QJ D0M0QJ DRUGTYPE Small molecular drug D0M0QJ DRUGINCH 1S/C18H18N4O4S/c23-18(21-24)17-4-3-16(27-17)13-5-7-22(20-13)8-6-19-10-12-1-2-14-15(9-12)26-11-25-14/h1-5,7,9,19,24H,6,8,10-11H2,(H,21,23) D0M0QJ DRUGINKE CCCCPSHFLXQUBH-UHFFFAOYSA-N D0M0QJ DRUGSMIL C1OC2=C(O1)C=C(C=C2)CNCCN3C=CC(=N3)C4=CC=C(S4)C(=O)NO D0M0QJ HIGHSTAT Investigative D0M0QQ DRUG__ID D0M0QQ D0M0QQ DRUGTYPE Small molecular drug D0M0QQ DRUGINCH 1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29) D0M0QQ DRUGINKE QAPAJIZPZGWAND-UHFFFAOYSA-N D0M0QQ DRUGSMIL CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C D0M0QQ HIGHSTAT Investigative D0M0RS DRUG__ID D0M0RS D0M0RS DRUGTYPE Small molecular drug D0M0RS DRUGINCH 1S/C14H9F9N2O/c15-12(16,17)5-25(6-13(18,19)20)7-1-2-10-8(3-7)9(14(21,22)23)4-11(26)24-10/h1-4H,5-6H2,(H,24,26) D0M0RS DRUGINKE ULBPQWIGZUGPHU-UHFFFAOYSA-N D0M0RS DRUGSMIL C1=CC2=C(C=C1N(CC(F)(F)F)CC(F)(F)F)C(=CC(=O)N2)C(F)(F)F D0M0RS HIGHSTAT Investigative D0M0TM DRUG__ID D0M0TM D0M0TM DRUGTYPE Small molecular drug D0M0TM DRUGINCH 1S/C10H14O5/c1-9(7(11)12)5-3-4-6(15-5)10(9,2)8(13)14/h5-6H,3-4H2,1-2H3,(H,11,12)(H,13,14) D0M0TM DRUGINKE NMTNUQBORQILRK-UHFFFAOYSA-N D0M0TM DRUGSMIL CC1(C2CCC(C1(C)C(=O)O)O2)C(=O)O D0M0TM HIGHSTAT Investigative D0M0TS DRUG__ID D0M0TS D0M0TS DRUGTYPE Small molecular drug D0M0TS DRUGINCH 1S/C13H25N3O2/c1-4-9(3)15-12(17)11-7-6-8-16(11)13(18)10(14)5-2/h9-11H,4-8,14H2,1-3H3,(H,15,17)/t9-,10+,11+/m1/s1 D0M0TS DRUGINKE VEBCSYAWQCGSMV-VWYCJHECSA-N D0M0TS DRUGSMIL CCC(C)NC(=O)C1CCCN1C(=O)C(CC)N D0M0TS HIGHSTAT Investigative D0M0VI DRUG__ID D0M0VI D0M0VI DRUGTYPE Small molecular drug D0M0VI DRUGINCH 1S/C40H43BF2N8O3S/c42-41(43)51-30(14-15-31(51)27-29-13-17-33(46-29)36-12-8-26-55-36)16-18-37(52)44-19-5-1-2-6-21-48-22-24-49(25-23-48)28-38(53)50-35-11-4-3-9-32(35)40(54)47-34-10-7-20-45-39(34)50/h3-4,7-15,17,20,26-27H,1-2,5-6,16,18-19,21-25,28H2,(H,44,52)(H,47,54)/b29-27+ D0M0VI DRUGINKE QGXCAYBSIKPOHP-ORIPQNMZSA-N D0M0VI DRUGSMIL B(N1C(=CC=C1C=C2C=CC(=N2)C3=CC=CS3)CCC(=O)NCCCCCCN4CCN(CC4)CC(=O)N5C6=CC=CC=C6C(=O)NC7=C5N=CC=C7)(F)F D0M0VI HIGHSTAT Investigative D0M0WT DRUG__ID D0M0WT D0M0WT DRUGTYPE Small molecular drug D0M0WT DRUGINCH 1S/C26H16S/c1-4-10-21-17(7-1)13-14-20-15-18-8-2-5-11-22(18)26(25(20)21)24-16-19-9-3-6-12-23(19)27-24/h1-16H D0M0WT DRUGINKE SJVMNTJUTHEADO-UHFFFAOYSA-N D0M0WT DRUGSMIL C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C(=C32)C5=CC6=CC=CC=C6S5 D0M0WT HIGHSTAT Investigative D0M0WX DRUG__ID D0M0WX D0M0WX DRUGTYPE Small molecular drug D0M0WX DRUGINCH 1S/C22H16N2O/c25-20-8-4-7-18(13-20)19-14-21(16-5-2-1-3-6-16)24-22(15-19)17-9-11-23-12-10-17/h1-15,25H D0M0WX DRUGINKE DFVGOMXQSFFZEA-UHFFFAOYSA-N D0M0WX DRUGSMIL C1=CC=C(C=C1)C2=NC(=CC(=C2)C3=CC(=CC=C3)O)C4=CC=NC=C4 D0M0WX HIGHSTAT Investigative D0M0XC DRUG__ID D0M0XC D0M0XC DRUGTYPE Small molecular drug D0M0XC DRUGINCH 1S/C19H14Cl2N6O/c20-14-7-5-8-15(18(14)21)27-19(24-25-26-27)23-12-13-6-1-2-9-16(13)28-17-10-3-4-11-22-17/h1-11H,12H2,(H,23,24,26) D0M0XC DRUGINKE GMVNBKZQJFRFAR-UHFFFAOYSA-N D0M0XC DRUGSMIL C1=CC=C(C(=C1)CNC2=NN=NN2C3=C(C(=CC=C3)Cl)Cl)OC4=CC=CC=N4 D0M0XC HIGHSTAT Investigative D0M0XL DRUG__ID D0M0XL D0M0XL DRUGTYPE Small molecular drug D0M0XL DRUGINCH 1S/C17H14O3/c1-20-17-15-8-4-12(10-13(15)5-9-16(17)19)11-2-6-14(18)7-3-11/h2-10,18-19H,1H3 D0M0XL DRUGINKE DSBWWPDVDPKMHN-UHFFFAOYSA-N D0M0XL DRUGSMIL COC1=C(C=CC2=C1C=CC(=C2)C3=CC=C(C=C3)O)O D0M0XL HIGHSTAT Investigative D0M0XR DRUG__ID D0M0XR D0M0XR DRUGTYPE Small molecular drug D0M0XR DRUGINCH 1S/C15H18F3NO5/c1-22-9-12-8-19(14(21)24-12)10-2-4-11(5-3-10)23-7-6-13(20)15(16,17)18/h2-5,12-13,20H,6-9H2,1H3/t12-,13-/m0/s1 D0M0XR DRUGINKE IALVDLPLCLFBCF-STQMWFEESA-N D0M0XR DRUGSMIL COCC1CN(C(=O)O1)C2=CC=C(C=C2)OCCC(C(F)(F)F)O D0M0XR HIGHSTAT Investigative D0M0XS DRUG__ID D0M0XS D0M0XS DRUGTYPE Small molecular drug D0M0XS DRUGINCH 1S/C32H50O4/c1-20(33)36-25-12-13-30(7)23(28(25,4)5)11-14-31(8)24(30)10-9-21-22-19-27(2,3)15-16-29(22,6)17-18-32(21,31)26(34)35/h9,22-25H,10-19H2,1-8H3,(H,34,35)/t22-,23?,24+,25-,29+,30-,31+,32+/m0/s1 D0M0XS DRUGINKE IQYUEJTVDLHZDJ-PVLVPSCMSA-N D0M0XS DRUGSMIL CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CC=C4C3(CCC5(C4CC(CC5)(C)C)C)C(=O)O)C)C D0M0XS HIGHSTAT Investigative D0M0YH DRUG__ID D0M0YH D0M0YH DRUGTYPE Small molecular drug D0M0YH DRUGINCH 1S/C21H31N3O5S/c1-14(2)11-17(23-19(26)16(22-13-25)9-10-30-3)20(27)24-18(21(28)29)12-15-7-5-4-6-8-15/h4-8,13-14,16-18H,9-12H2,1-3H3,(H,22,25)(H,23,26)(H,24,27)(H,28,29)/t16-,17-,18-/m0/s1 D0M0YH DRUGINKE PRQROPMIIGLWRP-BZSNNMDCSA-N D0M0YH DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C(CCSC)NC=O D0M0YH HIGHSTAT Investigative D0M0YO DRUG__ID D0M0YO D0M0YO DRUGTYPE Small molecular drug D0M0YO DRUGINCH 1S/C11H17NO2S/c1-11(2,5-4-10(13)15-3)12-6-8-14-9-7-12/h6-9H2,1-3H3 D0M0YO DRUGINKE XEVZURDMZKIWMB-UHFFFAOYSA-N D0M0YO DRUGSMIL CC(C)(C#CC(=O)SC)N1CCOCC1 D0M0YO HIGHSTAT Investigative D0M0ZB DRUG__ID D0M0ZB D0M0ZB DRUGTYPE Small molecular drug D0M0ZB DRUGINCH 1S/C26H33N5O4/c1-17(27)26(35)31-14-8-13-22(31)25(34)30-21(16-19-11-6-3-7-12-19)24(33)29-20(23(28)32)15-18-9-4-2-5-10-18/h2-7,9-12,17,20-22H,8,13-16,27H2,1H3,(H2,28,32)(H,29,33)(H,30,34)/t17-,20+,21+,22+/m1/s1 D0M0ZB DRUGINKE PYBNVPBCTAEKPN-MNAPGUCWSA-N D0M0ZB DRUGSMIL CC(C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC3=CC=CC=C3)C(=O)N)N D0M0ZB HIGHSTAT Investigative D0M0ZX DRUG__ID D0M0ZX D0M0ZX DRUGTYPE Small molecular drug D0M0ZX DRUGINCH 1S/C18H23NO3/c1-4-12(5-2)11-22-18(21)15-10-19-16-8-7-13(6-3)9-14(16)17(15)20/h7-10,12H,4-6,11H2,1-3H3,(H,19,20) D0M0ZX DRUGINKE ANYBYQLGVQJDTI-UHFFFAOYSA-N D0M0ZX DRUGSMIL CCC1=CC2=C(C=C1)NC=C(C2=O)C(=O)OCC(CC)CC D0M0ZX HIGHSTAT Investigative D0M1AC DRUG__ID D0M1AC D0M1AC DRUGTYPE Small molecular drug D0M1AC DRUGINCH 1S/C41H62N10O9/c1-6-23(3)20-33(54)46-25(5)36(56)49-30-22-45-32(53)17-14-27(21-26-12-15-28(52)16-13-26)47-38(58)34(24(4)7-2)50-39(59)35(55)29(10-8-18-44-41(42)43)48-37(57)31-11-9-19-51(31)40(30)60/h12-17,23-25,27,29-31,34,52H,6-11,18-22H2,1-5H3,(H,45,53)(H,46,54)(H,47,58)(H,48,57)(H,49,56)(H,50,59)(H4,42,43,44)/b17-14+/t23?,24-,25+,27-,29+,30+,31+,34+/m1/s1 D0M1AC DRUGINKE SJGLOQSIMVYUEK-BJQFAPFESA-N D0M1AC DRUGSMIL CCC(C)CC(=O)NC(C)C(=O)NC1CNC(=O)C=CC(NC(=O)C(NC(=O)C(=O)C(NC(=O)C2CCCN2C1=O)CCCN=C(N)N)C(C)CC)CC3=CC=C(C=C3)O D0M1AC HIGHSTAT Investigative D0M1AE DRUG__ID D0M1AE D0M1AE DRUGTYPE Small molecular drug D0M1AE DRUGINCH 1S/C24H20N2O3S/c27-24(19-11-5-2-6-12-19)26-22-15-16-23(21-14-8-7-13-20(21)22)30(28,29)25-17-18-9-3-1-4-10-18/h1-16,25H,17H2,(H,26,27) D0M1AE DRUGINKE QPJKMKVTEJYYGG-UHFFFAOYSA-N D0M1AE DRUGSMIL C1=CC=C(C=C1)CNS(=O)(=O)C2=CC=C(C3=CC=CC=C32)NC(=O)C4=CC=CC=C4 D0M1AE HIGHSTAT Investigative D0M1BF DRUG__ID D0M1BF D0M1BF DRUGTYPE Small molecular drug D0M1BF DRUGINCH 1S/C29H26N4O/c1-19-7-4-14-26-25(19)16-27(33(26)18-20-8-5-11-22(15-20)28(30)31)29(34)32-17-23-12-6-10-21-9-2-3-13-24(21)23/h2-16H,17-18H2,1H3,(H3,30,31)(H,32,34) D0M1BF DRUGINKE IDKGPACCMPKKQB-UHFFFAOYSA-N D0M1BF DRUGSMIL CC1=C2C=C(N(C2=CC=C1)CC3=CC(=CC=C3)C(=N)N)C(=O)NCC4=CC=CC5=CC=CC=C54 D0M1BF HIGHSTAT Investigative D0M1BJ DRUG__ID D0M1BJ D0M1BJ DRUGTYPE Small molecular drug D0M1BJ DRUGINCH 1S/C25H19Cl2N3O2/c1-30-21-10-6-5-9-19(21)23(17-7-3-2-4-8-17)29-24(25(30)32)28-22(31)14-12-16-11-13-18(26)15-20(16)27/h2-15,24H,1H3,(H,28,31)/b14-12+/t24-/m1/s1 D0M1BJ DRUGINKE BYULDQRRUINTAA-SWDTZWKESA-N D0M1BJ DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)C=CC3=C(C=C(C=C3)Cl)Cl)C4=CC=CC=C4 D0M1BJ HIGHSTAT Investigative D0M1CG DRUG__ID D0M1CG D0M1CG DRUGTYPE Small molecular drug D0M1CG DRUGINCH 1S/C6H14N/c1-5-6-7(2,3)4/h5H,1,6H2,2-4H3/q+1 D0M1CG DRUGINKE KGVWWFCEYXERAE-UHFFFAOYSA-N D0M1CG DRUGSMIL C[N+](C)(C)CC=C D0M1CG HIGHSTAT Investigative D0M1EI DRUG__ID D0M1EI D0M1EI DRUGTYPE Small molecular drug D0M1EI DRUGINCH 1S/C23H16N2/c1-16-7-8-18-9-10-20(14-23(18)25-16)19-11-12-22(21(13-19)15-24)17-5-3-2-4-6-17/h2-14H,1H3 D0M1EI DRUGINKE AGKCPUQJKJZENU-UHFFFAOYSA-N D0M1EI DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=C(C=C3)C4=CC=CC=C4)C#N D0M1EI HIGHSTAT Investigative D0M1JT DRUG__ID D0M1JT D0M1JT DRUGTYPE Small molecular drug D0M1JT DRUGINCH 1S/C19H15NOS/c1-21-18-16-11-7-13-20(16)15-10-5-6-12-17(15)22-19(18)14-8-3-2-4-9-14/h2-13H,1H3 D0M1JT DRUGINKE AWMKYXNZIQHXIW-UHFFFAOYSA-N D0M1JT DRUGSMIL COC1=C(SC2=CC=CC=C2N3C1=CC=C3)C4=CC=CC=C4 D0M1JT HIGHSTAT Investigative D0M1KX DRUG__ID D0M1KX D0M1KX DRUGTYPE Small molecular drug D0M1KX DRUGINCH 1S/Co.6H3N/h;6*1H3/q+3;;;;;; D0M1KX DRUGINKE DYLMFCCYOUSRTK-UHFFFAOYSA-N D0M1KX DRUGSMIL N.N.N.N.N.N.[Co+3] D0M1KX HIGHSTAT Investigative D0M1LO DRUG__ID D0M1LO D0M1LO DRUGTYPE Small molecular drug D0M1LO DRUGINCH 1S/C6H13N3/c7-6(8)9-4-2-1-3-5-9/h1-5H2,(H3,7,8) D0M1LO DRUGINKE QUUYRYYUKNNNNS-UHFFFAOYSA-N D0M1LO DRUGSMIL C1CCN(CC1)C(=N)N D0M1LO HIGHSTAT Investigative D0M1MQ DRUG__ID D0M1MQ D0M1MQ DRUGTYPE Small molecular drug D0M1MQ DRUGINCH 1S/C21H22ClNO/c1-2-3-8-13-23-15-18(17-10-5-7-12-20(17)23)21(24)14-16-9-4-6-11-19(16)22/h4-7,9-12,15H,2-3,8,13-14H2,1H3 D0M1MQ DRUGINKE YDINKDBAZJOSLV-UHFFFAOYSA-N D0M1MQ DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3Cl D0M1MQ HIGHSTAT Investigative D0M1OE DRUG__ID D0M1OE D0M1OE DRUGTYPE Small molecular drug D0M1OE DRUGINCH 1S/C17H15NO3/c19-11-1-2-12-10(5-11)6-13-15-9(3-4-18-13)7-14-17(16(12)15)21-8-20-14/h1-2,5,7,13,18-19H,3-4,6,8H2/t13-/m1/s1 D0M1OE DRUGINKE LTSPCGWFQLHECP-CYBMUJFWSA-N D0M1OE DRUGSMIL C1CNC2CC3=C(C=CC(=C3)O)C4=C2C1=CC5=C4OCO5 D0M1OE HIGHSTAT Investigative D0M1QJ DRUG__ID D0M1QJ D0M1QJ DRUGTYPE Small molecular drug D0M1QJ DRUGINCH 1S/C21H22N2O2S/c24-21(14-23-12-4-3-5-17(23)13-25-21)16-10-8-15(9-11-16)20-22-18-6-1-2-7-19(18)26-20/h1-2,6-11,17,24H,3-5,12-14H2 D0M1QJ DRUGINKE ZTONOAATDZXAON-UHFFFAOYSA-N D0M1QJ DRUGSMIL C1CCN2CC(OCC2C1)(C3=CC=C(C=C3)C4=NC5=CC=CC=C5S4)O D0M1QJ HIGHSTAT Investigative D0M1TF DRUG__ID D0M1TF D0M1TF DRUGTYPE Small molecular drug D0M1TF DRUGINCH 1S/C24H26N2O.ClH/c1-3-26(4-2)23-16-14-22(15-17-23)25-21-12-10-19(11-13-21)18-24(27)20-8-6-5-7-9-20;/h5-17,25H,3-4,18H2,1-2H3;1H D0M1TF DRUGINKE ACVBBILJICBIFG-UHFFFAOYSA-N D0M1TF DRUGSMIL CCN(CC)C1=CC=C(C=C1)NC2=CC=C(C=C2)CC(=O)C3=CC=CC=C3.Cl D0M1TF HIGHSTAT Investigative D0M1UA DRUG__ID D0M1UA D0M1UA DRUGTYPE Small molecular drug D0M1UA DRUGINCH 1S/C11H21O12P/c1-4(12)21-2-5(13)3-22-24(19,20)23-11-9(17)7(15)6(14)8(16)10(11)18/h5-11,13-18H,2-3H2,1H3,(H,19,20)/t5-,6?,7-,8+,9+,10+,11?/m0/s1 D0M1UA DRUGINKE FBDBXJJQMHPGMP-FNFFQOHASA-N D0M1UA DRUGSMIL CC(=O)OCC(COP(=O)(O)OC1C(C(C(C(C1O)O)O)O)O)O D0M1UA HIGHSTAT Investigative D0M1VF DRUG__ID D0M1VF D0M1VF DRUGTYPE Small molecular drug D0M1VF DRUGINCH 1S/C34H32N4O4.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);/q-4;+4/b25-13-,26-13?,27-14?,28-15-,29-14-,30-15?,31-16?,32-16?; D0M1VF DRUGINKE VWEYNEFKXXWVHZ-IBPJAKCHSA-N D0M1VF DRUGSMIL CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=CC5=C(C(=C([N-]5)C=C1[N-]2)C=C)C)[N-]4)C=C)C)C)CCC(=O)O)CCC(=O)O.[Sn+4] D0M1VF HIGHSTAT Investigative D0M1YU DRUG__ID D0M1YU D0M1YU DRUGTYPE Small molecular drug D0M1YU DRUGINCH 1S/C14H15N3/c1-10(15)9-17-8-6-11-4-5-13-12(14(11)17)3-2-7-16-13/h2-8,10H,9,15H2,1H3/t10-/m0/s1 D0M1YU DRUGINKE SDEXYLCQNBTWLI-JTQLQIEISA-N D0M1YU DRUGSMIL CC(CN1C=CC2=C1C3=C(C=C2)N=CC=C3)N D0M1YU HIGHSTAT Investigative D0M1YV DRUG__ID D0M1YV D0M1YV DRUGTYPE Small molecular drug D0M1YV DRUGINCH 1S/C16H19NO2/c1-11-5-2-8-14(18)15(11)16(19)12-6-3-9-17-10-4-7-13(12)17/h2,5-6,8,13,18H,3-4,7,9-10H2,1H3/t13-/m1/s1 D0M1YV DRUGINKE KNSLYJICIDVPEX-CYBMUJFWSA-N D0M1YV DRUGSMIL CC1=C(C(=CC=C1)O)C(=O)C2=CCCN3C2CCC3 D0M1YV HIGHSTAT Investigative D0M1ZC DRUG__ID D0M1ZC D0M1ZC DRUGTYPE Small molecular drug D0M1ZC DRUGINCH 1S/C20H32O2/c1-4-20(2,3)17-10-7-16(8-11-17)19-14-18(22)12-9-15(19)6-5-13-21/h7-8,10-11,15,18-19,21-22H,4-6,9,12-14H2,1-3H3/t15-,18-,19-/m1/s1 D0M1ZC DRUGINKE FDSWUKCGXVVOCA-ATZDWAIDSA-N D0M1ZC DRUGSMIL CCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D0M1ZC HIGHSTAT Investigative D0M1ZI DRUG__ID D0M1ZI D0M1ZI DRUGTYPE Small molecular drug D0M1ZI DRUGINCH 1S/C27H39N5O6/c1-15(2)23-27(38)29-17(4)25(36)31-21(14-18-10-12-19(33)13-11-18)26(37)30-20(16(3)24(35)32-23)8-6-5-7-9-22(28)34/h5-6,10-13,15-17,20-21,23,33H,7-9,14H2,1-4H3,(H2,28,34)(H,29,38)(H,30,37)(H,31,36)(H,32,35)/b6-5-/t16-,17+,20+,21+,23+/m0/s1 D0M1ZI DRUGINKE RFGAANHNJBCQAS-LFUPQXEOSA-N D0M1ZI DRUGSMIL CC1C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C)CC2=CC=C(C=C2)O)CC=CCCC(=O)N D0M1ZI HIGHSTAT Investigative D0M2AY DRUG__ID D0M2AY D0M2AY DRUGTYPE Small molecular drug D0M2AY DRUGINCH 1S/C15H18N2O2/c1-3-7-16-15(19)12-9-17-13-6-5-10(4-2)8-11(13)14(12)18/h5-6,8-9H,3-4,7H2,1-2H3,(H,16,19)(H,17,18) D0M2AY DRUGINKE YTLATZVRJZTHRQ-UHFFFAOYSA-N D0M2AY DRUGSMIL CCCNC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC D0M2AY HIGHSTAT Investigative D0M2BB DRUG__ID D0M2BB D0M2BB DRUGTYPE Small molecular drug D0M2BB DRUGINCH 1S/C20H22N4/c1-2-5-19(6-3-1)23-15-13-22(14-16-23)17-18-7-9-20(10-8-18)24-12-4-11-21-24/h1-12H,13-17H2 D0M2BB DRUGINKE PKQSDHHTBMYENT-UHFFFAOYSA-N D0M2BB DRUGSMIL C1CN(CCN1CC2=CC=C(C=C2)N3C=CC=N3)C4=CC=CC=C4 D0M2BB HIGHSTAT Investigative D0M2CT DRUG__ID D0M2CT D0M2CT DRUGTYPE Small molecular drug D0M2CT DRUGINCH 1S/C16H15N3O2/c1-20-12-5-3-11(4-6-12)19-16-14-9-13(21-2)7-8-15(14)17-10-18-16/h3-10H,1-2H3,(H,17,18,19) D0M2CT DRUGINKE XPJOMFBGKIABQW-UHFFFAOYSA-N D0M2CT DRUGSMIL COC1=CC=C(C=C1)NC2=NC=NC3=C2C=C(C=C3)OC D0M2CT HIGHSTAT Investigative D0M2CY DRUG__ID D0M2CY D0M2CY DRUGTYPE Small molecular drug D0M2CY DRUGINCH 1S/C17H21N3O2/c18-12-13(19)6-11-17(21)20-14-7-9-16(10-8-14)22-15-4-2-1-3-5-15/h1-5,7-10,13H,6,11-12,18-19H2,(H,20,21)/t13-/m0/s1 D0M2CY DRUGINKE YUSYHJFOQGXULG-ZDUSSCGKSA-N D0M2CY DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)CCC(CN)N D0M2CY HIGHSTAT Investigative D0M2DJ DRUG__ID D0M2DJ D0M2DJ DRUGTYPE Small molecular drug D0M2DJ DRUGINCH 1S/C10H9BrO4/c1-6(12)8-4-7(11)2-3-9(8)15-5-10(13)14/h2-4H,5H2,1H3,(H,13,14) D0M2DJ DRUGINKE ZPKLKLLENLTZEX-UHFFFAOYSA-N D0M2DJ DRUGSMIL CC(=O)C1=C(C=CC(=C1)Br)OCC(=O)O D0M2DJ HIGHSTAT Investigative D0M2EM DRUG__ID D0M2EM D0M2EM DRUGTYPE Small molecular drug D0M2EM DRUGINCH 1S/C6H4O2/c7-5-1-2-6(8)4-3-5/h1-4H D0M2EM DRUGINKE AZQWKYJCGOJGHM-UHFFFAOYSA-N D0M2EM DRUGSMIL C1=CC(=O)C=CC1=O D0M2EM HIGHSTAT Investigative D0M2EN DRUG__ID D0M2EN D0M2EN DRUGTYPE Small molecular drug D0M2EN DRUGINCH 1S/C10H14O2/c1-2-3-4-8-5-6-9(11)7-10(8)12/h5-7,11-12H,2-4H2,1H3 D0M2EN DRUGINKE CSHZYWUPJWVTMQ-UHFFFAOYSA-N D0M2EN DRUGSMIL CCCCC1=C(C=C(C=C1)O)O D0M2EN HIGHSTAT Investigative D0M2HC DRUG__ID D0M2HC D0M2HC DRUGTYPE Small molecular drug D0M2HC DRUGINCH 1S/C12H15N3/c1-10-2-4-11(5-3-10)14-7-6-12-8-13-9-15-12/h2-5,8-9,14H,6-7H2,1H3,(H,13,15) D0M2HC DRUGINKE OOTAMYWJHGNDAH-UHFFFAOYSA-N D0M2HC DRUGSMIL CC1=CC=C(C=C1)NCCC2=CN=CN2 D0M2HC HIGHSTAT Investigative D0M2IB DRUG__ID D0M2IB D0M2IB DRUGTYPE Small molecular drug D0M2IB DRUGINCH 1S/C21H26O2/c1-3-10-21-12-8-15(22)13-14(21)4-5-16-17-6-7-19(23)20(17,2)11-9-18(16)21/h1,13,16-18H,4-12H2,2H3/t16-,17-,18-,20-,21-/m0/s1 D0M2IB DRUGINKE JKPDEYAOCSQBSZ-OEUJLIAZSA-N D0M2IB DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=CC(=O)CCC34CC#C D0M2IB HIGHSTAT Investigative D0M2KQ DRUG__ID D0M2KQ D0M2KQ DRUGTYPE Small molecular drug D0M2KQ DRUGINCH 1S/C26H43NO4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-25(30)27-19-18-22-20-23(28)26(31)24(29)21-22/h9-10,20-21,28-29,31H,2-8,11-19H2,1H3,(H,27,30)/b10-9- D0M2KQ DRUGINKE MGJONYQVBJKXRL-KTKRTIGZSA-N D0M2KQ DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCC1=CC(=C(C(=C1)O)O)O D0M2KQ HIGHSTAT Investigative D0M2LV DRUG__ID D0M2LV D0M2LV DRUGTYPE Small molecular drug D0M2LV DRUGINCH 1S/C14H18O3/c1-16-13-9-5-8-12(15)14(13)17-10-11-6-3-2-4-7-11/h2-4,6-7,13-14H,5,8-10H2,1H3/t13-,14-/m1/s1 D0M2LV DRUGINKE KUAHCCGAHBFAKU-ZIAGYGMSSA-N D0M2LV DRUGSMIL COC1CCCC(=O)C1OCC2=CC=CC=C2 D0M2LV HIGHSTAT Investigative D0M2OL DRUG__ID D0M2OL D0M2OL DRUGTYPE Small molecular drug D0M2OL DRUGINCH 1S/C24H20IN7O/c25-20-7-5-18(6-8-20)24(33)28-11-2-14-32-16-29-22(23(32)17-9-12-27-13-10-17)19-3-1-4-21(15-19)30-31-26/h1,3-10,12-13,15-16H,2,11,14H2,(H,28,33) D0M2OL DRUGINKE LUMGXWHASLYPJW-UHFFFAOYSA-N D0M2OL DRUGSMIL C1=CC(=CC(=C1)N=[N+]=[N-])C2=C(N(C=N2)CCCNC(=O)C3=CC=C(C=C3)I)C4=CC=NC=C4 D0M2OL HIGHSTAT Investigative D0M2PE DRUG__ID D0M2PE D0M2PE DRUGTYPE Small molecular drug D0M2PE DRUGINCH 1S/C16H15N3/c17-16(18)14-6-7-15-13(10-14)8-9-19(15)11-12-4-2-1-3-5-12/h1-10H,11H2,(H3,17,18) D0M2PE DRUGINKE LHXHNJWJHADGSJ-UHFFFAOYSA-N D0M2PE DRUGSMIL C1=CC=C(C=C1)CN2C=CC3=C2C=CC(=C3)C(=N)N D0M2PE HIGHSTAT Investigative D0M2PP DRUG__ID D0M2PP D0M2PP DRUGTYPE Small molecular drug D0M2PP DRUGINCH 1S/C16H14N4OS2/c1-11-9-23-16(17-11)18-14(21)10-22-15-8-7-13(19-20-15)12-5-3-2-4-6-12/h2-9H,10H2,1H3,(H,17,18,21) D0M2PP DRUGINKE WJRWSLORVIHRNX-UHFFFAOYSA-N D0M2PP DRUGSMIL CC1=CSC(=N1)NC(=O)CSC2=NN=C(C=C2)C3=CC=CC=C3 D0M2PP HIGHSTAT Investigative D0M2QA DRUG__ID D0M2QA D0M2QA DRUGTYPE Small molecular drug D0M2QA DRUGINCH 1S/C13H9BrClNO3S/c14-10-3-1-2-9(8-10)13(17)16-20(18,19)12-6-4-11(15)5-7-12/h1-8H,(H,16,17) D0M2QA DRUGINKE PCSRHSZMCDEYGU-UHFFFAOYSA-N D0M2QA DRUGSMIL C1=CC(=CC(=C1)Br)C(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl D0M2QA HIGHSTAT Investigative D0M2QK DRUG__ID D0M2QK D0M2QK DRUGTYPE Small molecular drug D0M2QK DRUGINCH 1S/C39H51N11O5/c40-39(41)44-18-10-15-30-36(53)50-32(20-26-22-45-29-14-8-7-13-28(26)29)35(52)43-17-9-2-1-6-16-34(51)47-33(21-27-23-42-24-46-27)38(55)49-31(37(54)48-30)19-25-11-4-3-5-12-25/h3-5,7-8,11-14,22-24,30-33,45H,1-2,6,9-10,15-21H2,(H,42,46)(H,43,52)(H,47,51)(H,48,54)(H,49,55)(H,50,53)(H4,40,41,44)/t30-,31+,32+,33+/m0/s1 D0M2QK DRUGINKE YQBUXOUSHPXETO-LDLFXXLYSA-N D0M2QK DRUGSMIL C1CCCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CC1)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54 D0M2QK HIGHSTAT Investigative D0M2RC DRUG__ID D0M2RC D0M2RC DRUGTYPE Small molecular drug D0M2RC DRUGINCH 1S/C10H13NO5S/c1-7(10(12)13)11-17(14,15)9-5-3-8(16-2)4-6-9/h3-7,11H,1-2H3,(H,12,13)/t7-/m1/s1 D0M2RC DRUGINKE XTCIPBHRVYICGT-SSDOTTSWSA-N D0M2RC DRUGSMIL CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)OC D0M2RC HIGHSTAT Investigative D0M2RI DRUG__ID D0M2RI D0M2RI DRUGTYPE Small molecular drug D0M2RI DRUGINCH 1S/C36H58N6O14S/c1-6-18(4)28(33(51)39-23(13-20-10-8-7-9-11-20)30(48)40-25(16-57)36(55)56)41-31(49)22(12-17(2)3)38-34(52)29(21(35(53)54)14-26(44)45)42-32(50)24(15-27(46)47)37-19(5)43/h17-18,20-25,28-29,57H,6-16H2,1-5H3,(H,37,43)(H,38,52)(H,39,51)(H,40,48)(H,41,49)(H,42,50)(H,44,45)(H,46,47)(H,53,54)(H,55,56)/t18?,21?,22-,23-,24-,25-,28-,29+/m0/s1 D0M2RI DRUGINKE SBWANKMZZMQXKQ-JHOOERKCSA-N D0M2RI DRUGSMIL CCC(C)C(C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(CC(=O)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0M2RI HIGHSTAT Investigative D0M2TY DRUG__ID D0M2TY D0M2TY DRUGTYPE Small molecular drug D0M2TY DRUGINCH 1S/C15H8O6/c16-9-3-1-2-7-11(9)14(19)12-8(13(7)18)4-6(15(20)21)5-10(12)17/h1-5,16-17H,(H,20,21) D0M2TY DRUGINKE FCDLCPWAQCPTKC-UHFFFAOYSA-N D0M2TY DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)C(=O)O D0M2TY HIGHSTAT Investigative D0M2WG DRUG__ID D0M2WG D0M2WG DRUGTYPE Small molecular drug D0M2WG DRUGINCH 1S/C13H11NO5S/c14-20(17,18)19-10-7-5-9(6-8-10)13(16)11-3-1-2-4-12(11)15/h1-8,15H,(H2,14,17,18) D0M2WG DRUGINKE LJZUGMLIVIPULP-UHFFFAOYSA-N D0M2WG DRUGSMIL C1=CC=C(C(=C1)C(=O)C2=CC=C(C=C2)OS(=O)(=O)N)O D0M2WG HIGHSTAT Investigative D0M2YL DRUG__ID D0M2YL D0M2YL DRUGTYPE Small molecular drug D0M2YL DRUGINCH 1S/C34H45N5O6/c1-22(2)18-27(37-34(45)39-16-8-4-5-9-17-39)31(41)35-28(20-24-21-38(3)30-11-7-6-10-26(24)30)32(42)36-29(33(43)44)19-23-12-14-25(40)15-13-23/h6-7,10-15,21-22,27-29,40H,4-5,8-9,16-20H2,1-3H3,(H,35,41)(H,36,42)(H,37,45)(H,43,44)/t27-,28+,29+/m0/s1 D0M2YL DRUGINKE JVILFANCFWZBFU-ZGIBFIJWSA-N D0M2YL DRUGSMIL CC(C)CC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)N4CCCCCC4 D0M2YL HIGHSTAT Investigative D0M2YQ DRUG__ID D0M2YQ D0M2YQ DRUGTYPE Small molecular drug D0M2YQ DRUGINCH 1S/C17H11FN6O/c18-12-8-13(10-15(9-12)25-14-4-3-6-19-11-14)24-22-17(21-23-24)16-5-1-2-7-20-16/h1-11H D0M2YQ DRUGINKE IQSMPFFGKFZZMI-UHFFFAOYSA-N D0M2YQ DRUGSMIL C1=CC=NC(=C1)C2=NN(N=N2)C3=CC(=CC(=C3)F)OC4=CN=CC=C4 D0M2YQ HIGHSTAT Investigative D0M2ZD DRUG__ID D0M2ZD D0M2ZD DRUGTYPE Small molecular drug D0M2ZD DRUGINCH 1S/C14H8F4O2/c15-9-5-1-3-7(11(9)17)13(19)14(20)8-4-2-6-10(16)12(8)18/h1-6,13,19H D0M2ZD DRUGINKE PYTAIIXDDDIUHU-UHFFFAOYSA-N D0M2ZD DRUGSMIL C1=CC(=C(C(=C1)F)F)C(C(=O)C2=C(C(=CC=C2)F)F)O D0M2ZD HIGHSTAT Investigative D0M2ZE DRUG__ID D0M2ZE D0M2ZE DRUGTYPE Small molecular drug D0M2ZE DRUGINCH 1S/C18H29NO/c1-5-12-19(13-6-2)17-11-10-16-15(14(17)3)8-7-9-18(16)20-4/h7-9,14,17H,5-6,10-13H2,1-4H3/t14-,17+/m0/s1 D0M2ZE DRUGINKE BTOJYCTUJJHANF-WMLDXEAASA-N D0M2ZE DRUGSMIL CCCN(CCC)C1CCC2=C(C1C)C=CC=C2OC D0M2ZE HIGHSTAT Investigative D0M3AP DRUG__ID D0M3AP D0M3AP DRUGTYPE Small molecular drug D0M3AP DRUGINCH 1S/C14H11F2N3S/c15-11-5-1-3-9(7-11)13(18-19-14(17)20)10-4-2-6-12(16)8-10/h1-8H,(H3,17,19,20) D0M3AP DRUGINKE OBIMSARJMGBMKZ-UHFFFAOYSA-N D0M3AP DRUGSMIL C1=CC(=CC(=C1)F)C(=NNC(=S)N)C2=CC(=CC=C2)F D0M3AP HIGHSTAT Investigative D0M3CG DRUG__ID D0M3CG D0M3CG DRUGTYPE Small molecular drug D0M3CG DRUGINCH 1S/C19H23N5O4/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-16(27)15(26)13(8-25)28-19/h2-6,9-11,13,15-16,19,25-27H,7-8H2,1H3,(H,20,21,23)/t11-,13-,15-,16-,19-/m1/s1 D0M3CG DRUGINKE RIRGCFBBHQEQQH-SSFGXONLSA-N D0M3CG DRUGSMIL CC(CC1=CC=CC=C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O D0M3CG HIGHSTAT Investigative D0M3CT DRUG__ID D0M3CT D0M3CT DRUGTYPE Small molecular drug D0M3CT DRUGINCH 1S/C12H9N3S/c1-2-4-9(5-3-1)16-12-10-6-7-13-11(10)14-8-15-12/h1-8H,(H,13,14,15) D0M3CT DRUGINKE TUBUPSQEQADRHY-UHFFFAOYSA-N D0M3CT DRUGSMIL C1=CC=C(C=C1)SC2=NC=NC3=C2C=CN3 D0M3CT HIGHSTAT Investigative D0M3FH DRUG__ID D0M3FH D0M3FH DRUGTYPE Small molecular drug D0M3FH DRUGINCH 1S/C2H3Cl3/c1-2(3,4)5/h1H3 D0M3FH DRUGINKE UOCLXMDMGBRAIB-UHFFFAOYSA-N D0M3FH DRUGSMIL CC(Cl)(Cl)Cl D0M3FH HIGHSTAT Investigative D0M3GW DRUG__ID D0M3GW D0M3GW DRUGCOMP Eisai Co Ltd D0M3GW DRUGINCH 1S/C21H18N4O2/c22-21-18(4-3-11-24-21)19-13-17(25-27-19)12-15-6-8-16(9-7-15)14-26-20-5-1-2-10-23-20/h1-11,13H,12,14H2,(H2,22,24) D0M3GW DRUGINKE WSEKTEUGRLFBSE-UHFFFAOYSA-N D0M3GW DRUGSMIL C1=CC=NC(=C1)OCC2=CC=C(C=C2)CC3=NOC(=C3)C4=C(N=CC=C4)N D0M3GW HIGHSTAT Investigative D0M3HZ DRUG__ID D0M3HZ D0M3HZ DRUGTYPE Small molecular drug D0M3HZ DRUGINCH 1S/C19H23N3OS/c1-14-10-19(22-18-5-4-16(23-2)11-17(14)18)21-8-3-7-20-12-15-6-9-24-13-15/h4-6,9-11,13,20H,3,7-8,12H2,1-2H3,(H,21,22) D0M3HZ DRUGINKE ZDKZIFSAJUTJSK-UHFFFAOYSA-N D0M3HZ DRUGSMIL CC1=CC(=NC2=C1C=C(C=C2)OC)NCCCNCC3=CSC=C3 D0M3HZ HIGHSTAT Investigative D0M3LK DRUG__ID D0M3LK D0M3LK DRUGTYPE Small molecular drug D0M3LK DRUGINCH 1S/C23H26FNO4/c1-22(2)9-10-23(3,4)16-11-13(5-7-15(16)22)19(26)20(27)25-18-8-6-14(21(28)29)12-17(18)24/h5-8,11-12,19,26H,9-10H2,1-4H3,(H,25,27)(H,28,29)/t19-/m1/s1 D0M3LK DRUGINKE AANFHDFOMFRLLR-LJQANCHMSA-N D0M3LK DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(C(=O)NC3=C(C=C(C=C3)C(=O)O)F)O)(C)C)C D0M3LK HIGHSTAT Investigative D0M3PG DRUG__ID D0M3PG D0M3PG DRUGTYPE Small molecular drug D0M3PG DRUGINCH 1S/C10H9NO5/c12-6-3-1-2-5-4-7(13)10(14)9(8(5)6)11(15)16/h4,13-14H,1-3H2 D0M3PG DRUGINKE CXOQHHVPOJWTNP-UHFFFAOYSA-N D0M3PG DRUGSMIL C1CC2=CC(=C(C(=C2C(=O)C1)[N+](=O)[O-])O)O D0M3PG HIGHSTAT Investigative D0M3PO DRUG__ID D0M3PO D0M3PO DRUGTYPE Small molecular drug D0M3PO DRUGINCH 1S/C7H8F3N3O4S2/c8-7(9,10)3-1-4(11)6(19(13,16)17)2-5(3)18(12,14)15/h1-2H,11H2,(H2,12,14,15)(H2,13,16,17) D0M3PO DRUGINKE KRVABEGPNKGLOT-UHFFFAOYSA-N D0M3PO DRUGSMIL C1=C(C(=CC(=C1N)S(=O)(=O)N)S(=O)(=O)N)C(F)(F)F D0M3PO HIGHSTAT Investigative D0M3PV DRUG__ID D0M3PV D0M3PV DRUGTYPE Small molecular drug D0M3PV DRUGINCH 1S/C20H21ClN2O/c21-17-7-5-16(6-8-17)20(24)9-11-23(12-10-20)14-15-13-22-19-4-2-1-3-18(15)19/h1-8,13,22,24H,9-12,14H2 D0M3PV DRUGINKE LLBLNMUONVVVPG-UHFFFAOYSA-N D0M3PV DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CC3=CNC4=CC=CC=C43 D0M3PV HIGHSTAT Investigative D0M3RQ DRUG__ID D0M3RQ D0M3RQ DRUGTYPE Small molecular drug D0M3RQ DRUGINCH 1S/C15H11NO2/c17-14-4-3-10-5-11(1-2-12(10)6-14)13-7-15(18)9-16-8-13/h1-9,17-18H D0M3RQ DRUGINKE RTRRNSMMHNFJIV-UHFFFAOYSA-N D0M3RQ DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=CN=C3)O D0M3RQ HIGHSTAT Investigative D0M3RY DRUG__ID D0M3RY D0M3RY DRUGTYPE Small molecular drug D0M3RY DRUGINCH 1S/C15H15NO3/c17-15-11-13(16-6-8-18-9-7-16)10-14(19-15)12-4-2-1-3-5-12/h1-5,10-11H,6-9H2 D0M3RY DRUGINKE VKOGCIIARBRLEC-UHFFFAOYSA-N D0M3RY DRUGSMIL C1COCCN1C2=CC(=O)OC(=C2)C3=CC=CC=C3 D0M3RY HIGHSTAT Investigative D0M3SC DRUG__ID D0M3SC D0M3SC DRUGTYPE Small molecular drug D0M3SC DRUGINCH 1S/C18H18ClN3O/c1-3-4-17(23)20-18-14-9-13(12-7-5-11(2)6-8-12)15(19)10-16(14)21-22-18/h5-10H,3-4H2,1-2H3,(H2,20,21,22,23) D0M3SC DRUGINKE REESNWQQNIKZJK-UHFFFAOYSA-N D0M3SC DRUGSMIL CCCC(=O)NC1=NNC2=CC(=C(C=C21)C3=CC=C(C=C3)C)Cl D0M3SC HIGHSTAT Investigative D0M3TK DRUG__ID D0M3TK D0M3TK DRUGTYPE Small molecular drug D0M3TK DRUGINCH 1S/C16H17FN2O/c17-13-5-7-14(8-6-13)20-16-4-2-1-3-15(16)19-11-9-18-10-12-19/h1-8,18H,9-12H2 D0M3TK DRUGINKE VWVYZCFGGWGOMP-UHFFFAOYSA-N D0M3TK DRUGSMIL C1CN(CCN1)C2=CC=CC=C2OC3=CC=C(C=C3)F D0M3TK HIGHSTAT Investigative D0M3UR DRUG__ID D0M3UR D0M3UR DRUGTYPE Small molecular drug D0M3UR DRUGINCH 1S/C36H36O10/c1-19(2)34-28(42-25(38)16-15-22-11-7-5-8-12-22)21(4)35-24-17-20(3)27(39)33(24,41)31(40)32(18-37)29(43-32)26(35)30(34)44-36(45-34,46-35)23-13-9-6-10-14-23/h5-17,21,24,26,28-31,37,40-41H,1,18H2,2-4H3/b16-15+/t21-,24-,26-,28-,29+,30-,31-,32+,33-,34+,35-,36-/m1/s1 D0M3UR DRUGINKE OTTFLYUONKAFGT-KSFWXGPWSA-N D0M3UR DRUGSMIL CC1C(C2(C3C4C1(C5C=C(C(=O)C5(C(C6(C4O6)CO)O)O)C)OC(O3)(O2)C7=CC=CC=C7)C(=C)C)OC(=O)C=CC8=CC=CC=C8 D0M3UR HIGHSTAT Investigative D0M3VA DRUG__ID D0M3VA D0M3VA DRUGTYPE Small molecular drug D0M3VA DRUGINCH 1S/C30H32ClFN4O2/c1-19(2)27(35(15-7-14-33)29(37)22-11-10-20(3)25(32)16-22)28-34-26-17-23(31)12-13-24(26)30(38)36(28)18-21-8-5-4-6-9-21/h4-6,8-13,16-17,19,27H,7,14-15,18,33H2,1-3H3/t27-/m1/s1 D0M3VA DRUGINKE FSWMJRIVQDJZRP-HHHXNRCGSA-N D0M3VA DRUGSMIL CC1=C(C=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C)F D0M3VA HIGHSTAT Investigative D0M3XF DRUG__ID D0M3XF D0M3XF DRUGTYPE Small molecular drug D0M3XF DRUGINCH 1S/C17H27NO3S/c1-17(2,3)14-7-9-16(10-8-14)22(19,20)18-12-5-6-15(21-4)11-13-18/h7-10,15H,5-6,11-13H2,1-4H3 D0M3XF DRUGINKE XPMSNNNCHQEDRB-UHFFFAOYSA-N D0M3XF DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)N2CCCC(CC2)OC D0M3XF HIGHSTAT Investigative D0M3YA DRUG__ID D0M3YA D0M3YA DRUGTYPE Small molecular drug D0M3YA DRUGINCH 1S/C19H23NO2S/c1-22-19(21)18(15-8-3-2-4-9-15)17-11-5-6-12-20(17)14-16-10-7-13-23-16/h2-4,7-10,13,17-18H,5-6,11-12,14H2,1H3/t17-,18-/m1/s1 D0M3YA DRUGINKE XGTZBGNNSZZVLK-QZTJIDSGSA-N D0M3YA DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=CS2)C3=CC=CC=C3 D0M3YA HIGHSTAT Investigative D0M3ZV DRUG__ID D0M3ZV D0M3ZV DRUGTYPE Small molecular drug D0M3ZV DRUGINCH 1S/C13H9NO/c15-8-9-5-6-13-11(7-9)10-3-1-2-4-12(10)14-13/h1-8,14H D0M3ZV DRUGINKE WRBOHOGDAJPJOQ-UHFFFAOYSA-N D0M3ZV DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=CC(=C3)C=O D0M3ZV HIGHSTAT Investigative D0M4AQ DRUG__ID D0M4AQ D0M4AQ DRUGTYPE Small molecular drug D0M4AQ DRUGINCH 1S/C17H18INO2/c18-14-8-4-5-9-15(14)21-17(13-6-2-1-3-7-13)16-12-19-10-11-20-16/h1-9,16-17,19H,10-12H2 D0M4AQ DRUGINKE BHMLFPOTZYRDKA-UHFFFAOYSA-N D0M4AQ DRUGSMIL C1COC(CN1)C(C2=CC=CC=C2)OC3=CC=CC=C3I D0M4AQ HIGHSTAT Investigative D0M4BM DRUG__ID D0M4BM D0M4BM DRUGTYPE Small molecular drug D0M4BM DRUGINCH 1S/C4H8N2O/c5-4-6-2-1-3-7-4/h1-3H2,(H2,5,6) D0M4BM DRUGINKE VPVZSRIIAONGMU-UHFFFAOYSA-N D0M4BM DRUGSMIL C1CN=C(OC1)N D0M4BM HIGHSTAT Investigative D0M4BZ DRUG__ID D0M4BZ D0M4BZ DRUGTYPE Small molecular drug D0M4BZ DRUGINCH 1S/C20H17NO3/c22-19(21-18-8-4-3-7-17(18)20(23)24)12-10-14-9-11-15-5-1-2-6-16(15)13-14/h1-9,11,13H,10,12H2,(H,21,22)(H,23,24) D0M4BZ DRUGINKE TUCHRHOVXUFQLY-UHFFFAOYSA-N D0M4BZ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CCC(=O)NC3=CC=CC=C3C(=O)O D0M4BZ HIGHSTAT Investigative D0M4CP DRUG__ID D0M4CP D0M4CP DRUGTYPE Small molecular drug D0M4CP DRUGINCH 1S/C15H14N6O3/c1-3-24-15(23)13-12-7-20(2)14(22)10-6-9(18-19-16)4-5-11(10)21(12)8-17-13/h4-6,8H,3,7H2,1-2H3 D0M4CP DRUGINKE CFSOJZTUTOQNIA-UHFFFAOYSA-N D0M4CP DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)N=[N+]=[N-])C D0M4CP HIGHSTAT Investigative D0M4CX DRUG__ID D0M4CX D0M4CX DRUGTYPE Small molecular drug D0M4CX DRUGINCH 1S/C20H13ClN4O3/c1-11-12(10-22)8-17-19(23-11)16-9-15(25(26)27)6-7-18(16)28-20(17)24-14-4-2-13(21)3-5-14/h2-9,20,24H,1H3 D0M4CX DRUGINKE DAHDDFCIAFXETP-UHFFFAOYSA-N D0M4CX DRUGSMIL CC1=NC2=C(C=C1C#N)C(OC3=C2C=C(C=C3)[N+](=O)[O-])NC4=CC=C(C=C4)Cl D0M4CX HIGHSTAT Investigative D0M4DI DRUG__ID D0M4DI D0M4DI DRUGTYPE Small molecular drug D0M4DI DRUGINCH 1S/C21H27NO2/c1-3-18-20-11-16-5-6-17(23)12-19(16)21(18,4-2)8-9-22(20)13-15-7-10-24-14-15/h5-7,10,12,14,18,20,23H,3-4,8-9,11,13H2,1-2H3/t18-,20+,21+/m0/s1 D0M4DI DRUGINKE HEYXXBUDMDVUNQ-CEWLAPEOSA-N D0M4DI DRUGSMIL CCC1C2CC3=C(C1(CCN2CC4=COC=C4)CC)C=C(C=C3)O D0M4DI HIGHSTAT Investigative D0M4EF DRUG__ID D0M4EF D0M4EF DRUGTYPE Small molecular drug D0M4EF DRUGINCH 1S/C42H59N11O7/c1-4-5-15-30-38(57)53-35(24(2)3)41(60)52-32(21-25-12-7-6-8-13-25)39(58)50-31(17-11-20-46-42(44)45)37(56)51-33(22-26-23-47-28-16-10-9-14-27(26)28)40(59)49-29(36(43)55)18-19-34(54)48-30/h6-10,12-14,16,23-24,29-33,35,47H,4-5,11,15,17-22H2,1-3H3,(H2,43,55)(H,48,54)(H,49,59)(H,50,58)(H,51,56)(H,52,60)(H,53,57)(H4,44,45,46)/t29-,30-,31-,32+,33-,35-/m0/s1 D0M4EF DRUGINKE STHTUYXXUBUJIE-NMIKHESWSA-N D0M4EF DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)C(C)C D0M4EF HIGHSTAT Investigative D0M4EV DRUG__ID D0M4EV D0M4EV DRUGTYPE Small molecular drug D0M4EV DRUGINCH 1S/C7H7N3O2S/c8-5-6-1-3-7(4-2-6)10-13(9,11)12/h1-4,10H,(H2,9,11,12) D0M4EV DRUGINKE XFOYAXPHCAOZCA-UHFFFAOYSA-N D0M4EV DRUGSMIL C1=CC(=CC=C1C#N)NS(=O)(=O)N D0M4EV HIGHSTAT Investigative D0M4FW DRUG__ID D0M4FW D0M4FW DRUGTYPE Small molecular drug D0M4FW DRUGINCH 1S/C6H8N2O2/c9-6-4-3-7-2-1-5(4)10-8-6/h7H,1-3H2,(H,8,9) D0M4FW DRUGINKE SXXLKZCNJHJYFL-UHFFFAOYSA-N D0M4FW DRUGSMIL C1CNCC2=C1ONC2=O D0M4FW HIGHSTAT Investigative D0M4GR DRUG__ID D0M4GR D0M4GR DRUGTYPE Small molecular drug D0M4GR DRUGINCH 1S/C14H19NO2S/c1-2-3-8-17-12-6-4-11(5-7-12)13-9-15-14(16)10-18-13/h4-7,13H,2-3,8-10H2,1H3,(H,15,16) D0M4GR DRUGINKE ATDGSQDDAVNPIE-UHFFFAOYSA-N D0M4GR DRUGSMIL CCCCOC1=CC=C(C=C1)C2CNC(=O)CS2 D0M4GR HIGHSTAT Investigative D0M4IE DRUG__ID D0M4IE D0M4IE DRUGTYPE Small molecular drug D0M4IE DRUGINCH 1S/C33H40N4/c1(2-12-22-34-32-24-14-4-8-18-28(24)36-29-19-9-5-15-25(29)32)3-13-23-35-33-26-16-6-10-20-30(26)37-31-21-11-7-17-27(31)33/h4,6,8,10,14,16,18,20H,1-3,5,7,9,11-13,15,17,19,21-23H2,(H,34,36)(H,35,37) D0M4IE DRUGINKE ITZOKHKOFJOBFS-UHFFFAOYSA-N D0M4IE DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCCNC4=C5CCCCC5=NC6=CC=CC=C64 D0M4IE HIGHSTAT Investigative D0M4IF DRUG__ID D0M4IF D0M4IF DRUGTYPE Small molecular drug D0M4IF DRUGINCH 1S/C26H43NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-26(30)27-21-20-23-18-19-24(28)25(29)22-23/h9-10,18-19,22,28-29H,2-8,11-17,20-21H2,1H3,(H,27,30)/b10-9- D0M4IF DRUGINKE QQBPLXNESPTPNU-KTKRTIGZSA-N D0M4IF DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCC1=CC(=C(C=C1)O)O D0M4IF HIGHSTAT Investigative D0M4IR DRUG__ID D0M4IR D0M4IR DRUGTYPE Small molecular drug D0M4IR DRUGINCH 1S/C39H49N7O10/c1-20(2)13-30(35(50)44-29(14-22-9-6-5-7-10-22)32(47)37(52)43-27-12-8-11-23(18-27)38(53)54)45-36(51)31(21(3)4)46-34(49)28(41)19-42-33(48)24-15-25(39(55)56)17-26(40)16-24/h5-12,15-18,20-21,28-32,47H,13-14,19,40-41H2,1-4H3,(H,42,48)(H,43,52)(H,44,50)(H,45,51)(H,46,49)(H,53,54)(H,55,56)/t28-,29-,30-,31-,32+/m0/s1 D0M4IR DRUGINKE HJXHSIMUTPLJNT-QEUNAIBPSA-N D0M4IR DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(C(=O)NC2=CC=CC(=C2)C(=O)O)O)NC(=O)C(C(C)C)NC(=O)C(CNC(=O)C3=CC(=CC(=C3)N)C(=O)O)N D0M4IR HIGHSTAT Investigative D0M4JP DRUG__ID D0M4JP D0M4JP DRUGTYPE Small molecular drug D0M4JP DRUGINCH 1S/C43H59N5O6S/c1-8-46(9-2)20-21-47(10-3)32-22-28(4)39(29(5)23-32)54-26-36(50)44-34(24-30-16-12-11-13-17-30)38(51)42(53)48-27-55-43(6,7)40(48)41(52)45-37-33-19-15-14-18-31(33)25-35(37)49/h11-19,22-23,34-35,37-38,40,49,51H,8-10,20-21,24-27H2,1-7H3,(H,44,50)(H,45,52)/t34-,35+,37-,38-,40+/m0/s1 D0M4JP DRUGINKE FEJYRCRZYXAOJX-MQKWNYJDSA-N D0M4JP DRUGSMIL CCN(CC)CCN(CC)C1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0M4JP HIGHSTAT Investigative D0M4KN DRUG__ID D0M4KN D0M4KN DRUGTYPE Small molecular drug D0M4KN DRUGINCH 1S/C22H29NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,20-22,24H,8,13-17H2,1H3/t20-,21+,22+/m1/s1 D0M4KN DRUGINKE MUSFCRGEWKAWEE-FSSWDIPSSA-N D0M4KN DRUGSMIL CN1C(CCCC1CC(C2=CC=CC=C2)O)CCC3=CC=CC=C3 D0M4KN HIGHSTAT Investigative D0M4LQ DRUG__ID D0M4LQ D0M4LQ DRUGTYPE Small molecular drug D0M4LQ DRUGINCH 1S/C16H19NO3S/c1-2-3-13-17(14-7-5-4-6-8-14)21(19,20)16-11-9-15(18)10-12-16/h4-12,18H,2-3,13H2,1H3 D0M4LQ DRUGINKE PPNFXEDTKPJHLX-UHFFFAOYSA-N D0M4LQ DRUGSMIL CCCCN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)O D0M4LQ HIGHSTAT Investigative D0M4MA DRUG__ID D0M4MA D0M4MA DRUGTYPE Small molecular drug D0M4MA DRUGINCH 1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1 D0M4MA DRUGINKE WOVKYSAHUYNSMH-RRKCRQDMSA-N D0M4MA DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)Br)CO)O D0M4MA HIGHSTAT Investigative D0M4ND DRUG__ID D0M4ND D0M4ND DRUGTYPE Small molecular drug D0M4ND DRUGINCH 1S/C10H15NO/c1-2-9-7-8(5-6-11)3-4-10(9)12/h3-4,7,12H,2,5-6,11H2,1H3 D0M4ND DRUGINKE LDAFQVRTSOETPE-UHFFFAOYSA-N D0M4ND DRUGSMIL CCC1=C(C=CC(=C1)CCN)O D0M4ND HIGHSTAT Investigative D0M4PP DRUG__ID D0M4PP D0M4PP DRUGTYPE Small molecular drug D0M4PP DRUGINCH 1S/C15H14O4S/c1-19-13-9-7-12(8-10-13)15(16)11-20(17,18)14-5-3-2-4-6-14/h2-10H,11H2,1H3 D0M4PP DRUGINKE ZVVAUSXHYOKZSR-UHFFFAOYSA-N D0M4PP DRUGSMIL COC1=CC=C(C=C1)C(=O)CS(=O)(=O)C2=CC=CC=C2 D0M4PP HIGHSTAT Investigative D0M4QA DRUG__ID D0M4QA D0M4QA DRUGCOMP Simcere Pharmaceutical Group D0M4QA DRUGINCH 1S/C24H29FN4O2/c1-4-29(5-2)12-11-26-23(30)20-14(3)27-22-16(20)7-6-8-17(22)21-18-13-15(25)9-10-19(18)28-24(21)31/h9-10,13,27H,4-8,11-12H2,1-3H3,(H,26,30)(H,28,31)/b21-17- D0M4QA DRUGINKE KGSRYTUWXUESJK-FXBPSFAMSA-N D0M4QA DRUGSMIL CCN(CC)CCNC(=O)C1=C(NC2=C1CCCC2=C3C4=C(C=CC(=C4)F)NC3=O)C D0M4QA HIGHSTAT Investigative D0M4QM DRUG__ID D0M4QM D0M4QM DRUGTYPE Small molecular drug D0M4QM DRUGINCH 1S/C52H74N14O12S2/c1-78-32-16-14-31(15-17-32)25-35-46(73)63-36(24-30-10-4-2-5-11-30)47(74)61-34(18-19-40(53)67)45(72)64-37(26-41(54)68)48(75)65-38(29-79-80-52(27-43(70)60-35)20-6-3-7-21-52)50(77)66-23-9-13-39(66)49(76)62-33(12-8-22-58-51(56)57)44(71)59-28-42(55)69/h2,4-5,10-11,14-17,33-39H,3,6-9,12-13,18-29H2,1H3,(H2,53,67)(H2,54,68)(H2,55,69)(H,59,71)(H,60,70)(H,61,74)(H,62,76)(H,63,73)(H,64,72)(H,65,75)(H4,56,57,58)/t33-,34-,35+,36-,37-,38-,39+/m0/s1 D0M4QM DRUGINKE QVQOGNOOAMQKCE-OVSZNHMYSA-N D0M4QM DRUGSMIL COC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSC3(CCCCC3)CC(=O)N2)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC5=CC=CC=C5 D0M4QM HIGHSTAT Investigative D0M4RW DRUG__ID D0M4RW D0M4RW DRUGTYPE Small molecular drug D0M4RW DRUGINCH 1S/C23H25F3N2OS/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29/h1-2,4-8,16,29H,3,9-15H2/b18-5+ D0M4RW DRUGINKE NJMYODHXAKYRHW-BLLMUTORSA-N D0M4RW DRUGSMIL C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO D0M4RW HIGHSTAT Investigative D0M4SL DRUG__ID D0M4SL D0M4SL DRUGTYPE Small molecular drug D0M4SL DRUGINCH 1S/C23H31NO3/c1-13(2)24-21(26)12-15-11-20-19-6-4-14-10-16(25)5-7-17(14)18(19)8-9-23(20,3)22(15)27/h5,7,10,13,15,18-20,25H,4,6,8-9,11-12H2,1-3H3,(H,24,26)/t15?,18?,19?,20?,23-/m0/s1 D0M4SL DRUGINKE OHQDRZHZEKGJSZ-OOGUNDJRSA-N D0M4SL DRUGSMIL CC(C)NC(=O)CC1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D0M4SL HIGHSTAT Investigative D0M4SY DRUG__ID D0M4SY D0M4SY DRUGTYPE Small molecular drug D0M4SY DRUGINCH 1S/C25H26ClN5O3/c1-15-11-18(31-7-9-34-10-8-31)13-20-23(15)30-24(29-20)22-19(5-6-27-25(22)33)28-14-21(32)16-3-2-4-17(26)12-16/h2-6,11-13,21,32H,7-10,14H2,1H3,(H,29,30)(H2,27,28,33)/t21-/m1/s1 D0M4SY DRUGINKE ZWVZORIKUNOTCS-OAQYLSRUSA-N D0M4SY DRUGSMIL CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCC(C4=CC(=CC=C4)Cl)O)N5CCOCC5 D0M4SY HIGHSTAT Investigative D0M4UK DRUG__ID D0M4UK D0M4UK DRUGTYPE Small molecular drug D0M4UK DRUGINCH 1S/C26H23Cl2N5O3/c27-20-9-10-23(22(28)16-20)33-25(19-7-5-18(6-8-19)4-2-1-3-11-29)21(17-34)24(30-33)26(35)31-32-12-14-36-15-13-32/h5-10,16,34H,1,3,12-15,17H2,(H,31,35) D0M4UK DRUGINKE VQXIVPLXEIZJTH-UHFFFAOYSA-N D0M4UK DRUGSMIL C1COCCN1NC(=O)C2=NN(C(=C2CO)C3=CC=C(C=C3)C#CCCC#N)C4=C(C=C(C=C4)Cl)Cl D0M4UK HIGHSTAT Investigative D0M4VZ DRUG__ID D0M4VZ D0M4VZ DRUGTYPE Small molecular drug D0M4VZ DRUGINCH 1S/C21H31ClN6O3/c22-13-18(29)15(8-4-11-26-21(23)24)27-20(31)17(12-14-6-2-1-3-7-14)28-19(30)16-9-5-10-25-16/h1-3,6-7,15-17,25H,4-5,8-13H2,(H,27,31)(H,28,30)(H4,23,24,26)/t15-,16+,17-/m0/s1 D0M4VZ DRUGINKE HCCRRLVJBLDSLL-BBWFWOEESA-N D0M4VZ DRUGSMIL C1CC(NC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)CCl D0M4VZ HIGHSTAT Investigative D0M4XH DRUG__ID D0M4XH D0M4XH DRUGTYPE Small molecular drug D0M4XH DRUGINCH 1S/C3H7N3S/c1-2-5-6-3(4)7/h2H,1H3,(H3,4,6,7)/b5-2- D0M4XH DRUGINKE OOPAKHKIEGNKDU-DJWKRKHSSA-N D0M4XH DRUGSMIL CC=NNC(=S)N D0M4XH HIGHSTAT Investigative D0M4YT DRUG__ID D0M4YT D0M4YT DRUGTYPE Small molecular drug D0M4YT DRUGINCH 1S/C28H31FNO6P/c1-17(2)27-24(15-36-37(34,35)16-21(31)14-25(32)33)26(19-10-12-20(29)13-11-19)23-9-5-7-18-6-3-4-8-22(18)28(23)30-27/h3-4,6,8,10-13,17,21,31H,5,7,9,14-16H2,1-2H3,(H,32,33)(H,34,35)/p-2/t21-/m1/s1 D0M4YT DRUGINKE MZCZXPHMOGJQBJ-OAQYLSRUSA-L D0M4YT DRUGSMIL CC(C)C1=C(C(=C2CCCC3=CC=CC=C3C2=N1)C4=CC=C(C=C4)F)COP(=O)(CC(CC(=O)[O-])O)[O-] D0M4YT HIGHSTAT Investigative D0M4ZK DRUG__ID D0M4ZK D0M4ZK DRUGTYPE Small molecular drug D0M4ZK DRUGINCH 1S/C21H26O11/c1-6-13(24)29-11-10(23)19-7-8(22)9(17(2,3)4)18(19)12(28-5)15(26)30-16(18)32-21(19,20(6,11)27)31-14(7)25/h6-12,16,22-23,27H,1-5H3/t6-,7+,8+,9+,10+,11+,12+,16+,18+,19+,20-,21+/m1/s1 D0M4ZK DRUGINKE RYOIKJMKJWXJLR-XWGAEZTCSA-N D0M4ZK DRUGSMIL CC1C(=O)OC2C1(C34C5(C2O)C(C(C(C56C(C(=O)OC6O3)OC)C(C)(C)C)O)C(=O)O4)O D0M4ZK HIGHSTAT Investigative D0M4ZQ DRUG__ID D0M4ZQ D0M4ZQ DRUGTYPE Small molecular drug D0M4ZQ DRUGINCH 1S/C14H9ClN2O/c15-10-4-1-3-9(7-10)12-8-13(18)11-5-2-6-16-14(11)17-12/h1-8H,(H,16,17,18) D0M4ZQ DRUGINKE HZSAAZXBYZMFJN-UHFFFAOYSA-N D0M4ZQ DRUGSMIL C1=CC(=CC(=C1)Cl)C2=CC(=O)C3=C(N2)N=CC=C3 D0M4ZQ HIGHSTAT Investigative D0M5DB DRUG__ID D0M5DB D0M5DB DRUGTYPE Small molecular drug D0M5DB DRUGINCH 1S/C17H14ClN5/c1-11-19-20-17-22(2)21-16(12-6-4-3-5-7-12)14-10-13(18)8-9-15(14)23(11)17/h3-10H,1-2H3 D0M5DB DRUGINKE UYIVCPRWMLOCSB-UHFFFAOYSA-N D0M5DB DRUGSMIL CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NN2C)C4=CC=CC=C4 D0M5DB HIGHSTAT Investigative D0M5DR DRUG__ID D0M5DR D0M5DR DRUGTYPE Small molecular drug D0M5DR DRUGINCH 1S/C7H12N2O3S/c1-3-9-6(10)8(4-5-12-2)7(11)13-9/h3-5H2,1-2H3 D0M5DR DRUGINKE NCTIMJFWDQCLDW-UHFFFAOYSA-N D0M5DR DRUGSMIL CCN1C(=O)N(C(=O)S1)CCOC D0M5DR HIGHSTAT Investigative D0M5ES DRUG__ID D0M5ES D0M5ES DRUGTYPE Small molecular drug D0M5ES DRUGINCH 1S/C9H11Cl3NO3PS/c1-3-14-17(18,15-4-2)16-9-7(11)5-6(10)8(12)13-9/h5H,3-4H2,1-2H3 D0M5ES DRUGINKE SBPBAQFWLVIOKP-UHFFFAOYSA-N D0M5ES DRUGSMIL CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl D0M5ES HIGHSTAT Investigative D0M5EU DRUG__ID D0M5EU D0M5EU DRUGTYPE Small molecular drug D0M5EU DRUGINCH 1S/C20H23NO/c1-16-6-5-9-19(14-16)20(22)21-12-10-18(11-13-21)15-17-7-3-2-4-8-17/h2-9,14,18H,10-13,15H2,1H3 D0M5EU DRUGINKE POFAJEKTXKRKHK-UHFFFAOYSA-N D0M5EU DRUGSMIL CC1=CC(=CC=C1)C(=O)N2CCC(CC2)CC3=CC=CC=C3 D0M5EU HIGHSTAT Investigative D0M5EW DRUG__ID D0M5EW D0M5EW DRUGTYPE Small molecular drug D0M5EW DRUGINCH 1S/C13H10N2O2/c16-13-7-10(8-15-6-5-14-9-15)11-3-1-2-4-12(11)17-13/h1-7,9H,8H2 D0M5EW DRUGINKE SOWQJCOJWDYZNR-UHFFFAOYSA-N D0M5EW DRUGSMIL C1=CC=C2C(=C1)C(=CC(=O)O2)CN3C=CN=C3 D0M5EW HIGHSTAT Investigative D0M5FF DRUG__ID D0M5FF D0M5FF DRUGTYPE Small molecular drug D0M5FF DRUGINCH 1S/C25H23N5O2S/c1-29-13-17(15-7-2-4-9-19(15)29)21-22(24(32)28-23(21)31)18-14-30(11-6-12-33-25(26)27)20-10-5-3-8-16(18)20/h2-5,7-10,13-14H,6,11-12H2,1H3,(H3,26,27)(H,28,31,32) D0M5FF DRUGINKE DSXXEELGXBCYNQ-UHFFFAOYSA-N D0M5FF DRUGSMIL CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N D0M5FF HIGHSTAT Investigative D0M5KC DRUG__ID D0M5KC D0M5KC DRUGTYPE Small molecular drug D0M5KC DRUGINCH 1S/C23H29NO/c1-21(2)18-9-12-23(4)19(22(18,3)11-10-20(21)25)14-16-13-15-7-5-6-8-17(15)24(16)23/h5-8,13,18-19H,9-12,14H2,1-4H3/t18-,19-,22-,23+/m0/s1 D0M5KC DRUGINKE NEPLKJAINOWIJL-DHNNRRLOSA-N D0M5KC DRUGSMIL CC1(C2CCC3(C(C2(CCC1=O)C)CC4=CC5=CC=CC=C5N43)C)C D0M5KC HIGHSTAT Investigative D0M5LA DRUG__ID D0M5LA D0M5LA DRUGTYPE Small molecular drug D0M5LA DRUGINCH 1S/C45H57N9O9S2/c1-26(55)38-44(61)53-37(45(62)63)25-65-64-24-31(47)39(56)50-34(20-27-12-4-2-5-13-27)41(58)51-35(21-28-14-6-3-7-15-28)42(59)52-36(22-29-23-48-32-17-9-8-16-30(29)32)43(60)49-33(40(57)54-38)18-10-11-19-46/h2-9,12-17,23,26,31,33-38,48,55H,10-11,18-22,24-25,46-47H2,1H3,(H,49,60)(H,50,56)(H,51,58)(H,52,59)(H,53,61)(H,54,57)(H,62,63)/t26-,31-,33+,34-,35+,36+,37+,38-/m1/s1 D0M5LA DRUGINKE SEXJHXQMYWDZHJ-CNNVYZKHSA-N D0M5LA DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)N)C(=O)O)O D0M5LA HIGHSTAT Investigative D0M5LP DRUG__ID D0M5LP D0M5LP DRUGTYPE Small molecular drug D0M5LP DRUGINCH 1S/C14H22O2/c1-13(2,3)9-7-12(16)10(8-11(9)15)14(4,5)6/h7-8,15-16H,1-6H3 D0M5LP DRUGINKE JZODKRWQWUWGCD-UHFFFAOYSA-N D0M5LP DRUGSMIL CC(C)(C)C1=CC(=C(C=C1O)C(C)(C)C)O D0M5LP HIGHSTAT Investigative D0M5MI DRUG__ID D0M5MI D0M5MI DRUGTYPE Small molecular drug D0M5MI DRUGINCH 1S/C17H12ClF3N2O/c1-24-14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3 D0M5MI DRUGINKE PQUGCKBLVKJMNT-UHFFFAOYSA-N D0M5MI DRUGSMIL COC1=CC=C(C=C1)N2C(=CC(=N2)C(F)(F)F)C3=CC=C(C=C3)Cl D0M5MI HIGHSTAT Investigative D0M5NR DRUG__ID D0M5NR D0M5NR DRUGTYPE Small molecular drug D0M5NR DRUGINCH 1S/C12H11NO3/c1-2-5-10(14)13-9-7-4-3-6-8(9)11(15)12(13)16/h3-4,6-7H,2,5H2,1H3 D0M5NR DRUGINKE LYWOFWNKZLWLPZ-UHFFFAOYSA-N D0M5NR DRUGSMIL CCCC(=O)N1C2=CC=CC=C2C(=O)C1=O D0M5NR HIGHSTAT Investigative D0M5NU DRUG__ID D0M5NU D0M5NU DRUGTYPE Small molecular drug D0M5NU DRUGINCH 1S/C17H18N5O6P/c23-13-14-11(7-26-29(24,25)28-14)27-17(13)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23H,6-7H2,(H,24,25)(H,18,19,20)/t11-,13-,14-,17-/m1/s1 D0M5NU DRUGINKE GDDBIAMRTVTOBL-LSCFUAHRSA-N D0M5NU DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)NCC5=CC=CC=C5)O)OP(=O)(O1)O D0M5NU HIGHSTAT Investigative D0M5PB DRUG__ID D0M5PB D0M5PB DRUGTYPE Small molecular drug D0M5PB DRUGINCH 1S/C21H27N3O3S2/c1-29-10-9-19(21(26)27)24-20(25)17-8-7-16(23-12-15(22)13-28)11-18(17)14-5-3-2-4-6-14/h2-8,11,15,19,23,28H,9-10,12-13,22H2,1H3,(H,24,25)(H,26,27)/t15-,19+/m1/s1 D0M5PB DRUGINKE ZIXDDEATQSBHHL-BEFAXECRSA-N D0M5PB DRUGSMIL CSCCC(C(=O)O)NC(=O)C1=C(C=C(C=C1)NCC(CS)N)C2=CC=CC=C2 D0M5PB HIGHSTAT Investigative D0M5PI DRUG__ID D0M5PI D0M5PI DRUGTYPE Small molecular drug D0M5PI DRUGINCH 1S/C15H17N5/c1-11(2)20-10-19-13-14(17-9-18-15(13)20)16-8-12-6-4-3-5-7-12/h3-7,9-11H,8H2,1-2H3,(H,16,17,18) D0M5PI DRUGINKE JBLZWJCKPDQCNX-UHFFFAOYSA-N D0M5PI DRUGSMIL CC(C)N1C=NC2=C(N=CN=C21)NCC3=CC=CC=C3 D0M5PI HIGHSTAT Investigative D0M5RA DRUG__ID D0M5RA D0M5RA DRUGTYPE Small molecular drug D0M5RA DRUGINCH 1S/C7H10O6P2/c8-14(9,10)7(15(11,12)13)6-4-2-1-3-5-6/h1-5,7H,(H2,8,9,10)(H2,11,12,13) D0M5RA DRUGINKE FRLTXWJJMCIUNT-UHFFFAOYSA-N D0M5RA DRUGSMIL C1=CC=C(C=C1)C(P(=O)(O)O)P(=O)(O)O D0M5RA HIGHSTAT Investigative D0M5TM DRUG__ID D0M5TM D0M5TM DRUGTYPE Small molecular drug D0M5TM DRUGINCH 1S/C12H10FN5/c1-18-11(7-3-2-4-8(13)5-7)17-9-10(14)15-6-16-12(9)18/h2-6H,1H3,(H2,14,15,16) D0M5TM DRUGINKE JXJYLIUAIVDUNX-UHFFFAOYSA-N D0M5TM DRUGSMIL CN1C(=NC2=C(N=CN=C21)N)C3=CC(=CC=C3)F D0M5TM HIGHSTAT Investigative D0M5VF DRUG__ID D0M5VF D0M5VF DRUGTYPE Small molecular drug D0M5VF DRUGINCH 1S/C15H12N2O/c1-2-4-13(5-3-1)18-14-8-6-12(7-9-14)15-10-11-16-17-15/h1-11H,(H,16,17) D0M5VF DRUGINKE SGQSMRQYEPPNIA-UHFFFAOYSA-N D0M5VF DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C3=CC=NN3 D0M5VF HIGHSTAT Investigative D0M5WG DRUG__ID D0M5WG D0M5WG DRUGTYPE Small molecular drug D0M5WG DRUGINCH 1S/C18H37N5O10/c19-2-6-11(26)12(27)9(23)17(30-6)32-15-4(20)1-5(21)16(14(15)29)33-18-13(28)8(22)10(25)7(3-24)31-18/h4-18,24-29H,1-3,19-23H2/t4-,5+,6+,7+,8-,9+,10+,11+,12+,13+,14-,15+,16-,17+,18+/m0/s1 D0M5WG DRUGINKE SKKLOUVUUNMCJE-FQSMHNGLSA-N D0M5WG DRUGSMIL C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)N)N D0M5WG HIGHSTAT Investigative D0M5WP DRUG__ID D0M5WP D0M5WP DRUGTYPE Small molecular drug D0M5WP DRUGINCH 1S/C13H22N3O13P/c17-5-16(24)6(10(20)21)2-1-3-15-11(22)13(14-12(15)23)9(19)8(18)7(29-13)4-28-30(25,26)27/h6-9,17-19,24H,1-5H2,(H,14,23)(H,20,21)(H2,25,26,27)/t6-,7+,8+,9+,13-/m0/s1 D0M5WP DRUGINKE MAXSFYCTFIBEAR-FUIMDIGMSA-N D0M5WP DRUGSMIL C(CC(C(=O)O)N(CO)O)CN1C(=O)C2(C(C(C(O2)COP(=O)(O)O)O)O)NC1=O D0M5WP HIGHSTAT Investigative D0M5XV DRUG__ID D0M5XV D0M5XV DRUGTYPE Small molecular drug D0M5XV DRUGINCH 1S/C22H31Cl2N5S/c1-2-8-28(16-6-7-18-20(15-16)30-22(25)26-18)12-9-27-10-13-29(14-11-27)19-5-3-4-17(23)21(19)24/h3-5,16H,2,6-15H2,1H3,(H2,25,26) D0M5XV DRUGINKE MTSRJJUOIYINNP-UHFFFAOYSA-N D0M5XV DRUGSMIL CCCN(CCN1CCN(CC1)C2=C(C(=CC=C2)Cl)Cl)C3CCC4=C(C3)SC(=N4)N D0M5XV HIGHSTAT Investigative D0M5ZE DRUG__ID D0M5ZE D0M5ZE DRUGTYPE Small molecular drug D0M5ZE DRUGINCH 1S/C27H35ClN2O5/c1-32-23-8-6-19(16-24(23)33-2)4-3-11-30-12-9-18(10-13-30)5-7-22(31)20-17-21(28)25(29)27-26(20)34-14-15-35-27/h6,8,16-18H,3-5,7,9-15,29H2,1-2H3 D0M5ZE DRUGINKE UVOCSZKGWJOKNN-UHFFFAOYSA-N D0M5ZE DRUGSMIL COC1=C(C=C(C=C1)CCCN2CCC(CC2)CCC(=O)C3=CC(=C(C4=C3OCCO4)N)Cl)OC D0M5ZE HIGHSTAT Investigative D0M6BL DRUG__ID D0M6BL D0M6BL DRUGTYPE Small molecular drug D0M6BL DRUGINCH 1S/C55H63N9O9/c1-62(2)39-22-21-37-31-41-42(32-38(37)30-39)54(72)64(53(41)71)33-46(49(57)67)59-48(66)18-10-5-11-25-58-50(68)44(28-34-13-6-3-7-14-34)60-51(69)45(29-35-15-8-4-9-16-35)61-52(70)47-17-12-26-63(47)55(73)43(56)27-36-19-23-40(65)24-20-36/h3-4,6-9,13-16,19-24,30-32,43-47,65H,5,10-12,17-18,25-29,33,56H2,1-2H3,(H2,57,67)(H,58,68)(H,59,66)(H,60,69)(H,61,70)/t43-,44-,45-,46?,47-/m0/s1 D0M6BL DRUGINKE FATMKOSWYXDNJL-FCTRPSMQSA-N D0M6BL DRUGSMIL CN(C)C1=CC2=CC3=C(C=C2C=C1)C(=O)N(C3=O)CC(C(=O)N)NC(=O)CCCCCNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCCN6C(=O)C(CC7=CC=C(C=C7)O)N D0M6BL HIGHSTAT Investigative D0M6CB DRUG__ID D0M6CB D0M6CB DRUGTYPE Small molecular drug D0M6CB DRUGINCH 1S/C10H8O6S2/c11-17(12,13)9-3-1-7-5-10(18(14,15)16)4-2-8(7)6-9/h1-6H,(H,11,12,13)(H,14,15,16) D0M6CB DRUGINKE FITZJYAVATZPMJ-UHFFFAOYSA-N D0M6CB DRUGSMIL C1=CC2=C(C=CC(=C2)S(=O)(=O)O)C=C1S(=O)(=O)O D0M6CB HIGHSTAT Investigative D0M6CC DRUG__ID D0M6CC D0M6CC DRUGTYPE Small molecular drug D0M6CC DRUGINCH 1S/C103H147N27O37S5/c1-10-46(6)80(100(163)123-67(103(166)167)30-50-37-109-54-19-15-14-18-52(50)54)128-99(162)79(45(4)5)127-95(158)66(36-78(144)145)120-85(148)55(20-23-71(105)133)112-90(153)61(31-51-38-108-43-110-51)117-97(160)69-40-170-169-39-53(104)83(146)129-81(47(7)131)102(165)126-70-42-172-171-41-68(96(159)115-59(28-44(2)3)88(151)118-62(32-72(106)134)91(154)116-60(89(152)125-69)29-49-16-12-11-13-17-49)124-86(149)57(22-25-75(138)139)111-84(147)56(21-24-74(136)137)113-94(157)65(35-77(142)143)122-101(164)82(48(8)132)130-87(150)58(26-27-168-9)114-93(156)64(34-76(140)141)121-92(155)63(33-73(107)135)119-98(70)161/h11-19,37-38,43-48,53,55-70,79-82,109,131-132H,10,20-36,39-42,104H2,1-9H3,(H2,105,133)(H2,106,134)(H2,107,135)(H,108,110)(H,111,147)(H,112,153)(H,113,157)(H,114,156)(H,115,159)(H,116,154)(H,117,160)(H,118,151)(H,119,161)(H,120,148)(H,121,155)(H,122,164)(H,123,163)(H,124,149)(H,125,152)(H,126,165)(H,127,158)(H,128,162)(H,129,146)(H,130,150)(H,136,137)(H,138,139)(H,140,141)(H,142,143)(H,144,145)(H,166,167) D0M6CC DRUGINKE LXPHPKVWHQLBBA-UHFFFAOYSA-N D0M6CC DRUGSMIL CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC6=CC=CC=C6)CC(=O)N)CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CC(=O)N)CC(=O)O)CCSC)C(C)O)CC(=O)O)CCC(=O)O)CCC(=O)O)C(C)O)N D0M6CC HIGHSTAT Investigative D0M6CZ DRUG__ID D0M6CZ D0M6CZ DRUGTYPE Small molecular drug D0M6CZ DRUGINCH 1S/C39H42N4O6/c1-24-17-30(44)18-25(2)31(24)22-32(40)38(47)43-23-29-16-10-9-15-28(29)21-35(43)37(46)41-33(19-26-11-5-3-6-12-26)36(45)42-34(39(48)49)20-27-13-7-4-8-14-27/h3-18,32-35,44H,19-23,40H2,1-2H3,(H,41,46)(H,42,45)(H,48,49)/t32-,33-,34-,35-/m0/s1 D0M6CZ DRUGINKE SZIMPGYQGJRODH-BBACVFHCSA-N D0M6CZ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)N)C)O D0M6CZ HIGHSTAT Investigative D0M6DV DRUG__ID D0M6DV D0M6DV DRUGTYPE Small molecular drug D0M6DV DRUGINCH 1S/C20H24O6/c1-6-11(3)19(23)25-15-8-10(2)7-14(21)9-12(4)17(22)18-16(15)13(5)20(24)26-18/h6-7,9,15-18,22H,5,8H2,1-4H3/b10-7+,11-6+,12-9-/t15-,16+,17-,18-/m0/s1 D0M6DV DRUGINKE VUURQISRHJCAJY-CXRMMEALSA-N D0M6DV DRUGSMIL CC=C(C)C(=O)OC1CC(=CC(=O)C=C(C(C2C1C(=C)C(=O)O2)O)C)C D0M6DV HIGHSTAT Investigative D0M6GY DRUG__ID D0M6GY D0M6GY DRUGTYPE Small molecular drug D0M6GY DRUGINCH 1S/C21H11BrN2O2/c22-12-7-5-11(6-8-12)21-23-16-10-9-15-17(18(16)24-21)20(26)14-4-2-1-3-13(14)19(15)25/h1-10H,(H,23,24) D0M6GY DRUGINKE YFGTZSZLHQMMGA-UHFFFAOYSA-N D0M6GY DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=C(C=C3)NC(=N4)C5=CC=C(C=C5)Br D0M6GY HIGHSTAT Investigative D0M6IJ DRUG__ID D0M6IJ D0M6IJ DRUGTYPE Small molecular drug D0M6IJ DRUGINCH 1S/C23H15NOS/c25-23(18-14-13-16-7-1-2-8-17(16)15-18)24-19-9-3-5-11-21(19)26-22-12-6-4-10-20(22)24/h1-15H D0M6IJ DRUGINKE VEKGHAIWOIIXFF-UHFFFAOYSA-N D0M6IJ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)C(=O)N3C4=CC=CC=C4SC5=CC=CC=C53 D0M6IJ HIGHSTAT Investigative D0M6KC DRUG__ID D0M6KC D0M6KC DRUGTYPE Small molecular drug D0M6KC DRUGINCH 1S/C21H20O6/c1-21(2)5-4-11-6-12(7-18(25-3)20(11)27-21)16-10-15(24)19-14(23)8-13(22)9-17(19)26-16/h4-9,16,22-23H,10H2,1-3H3/t16-/m0/s1 D0M6KC DRUGINKE SDUMAACMVUGGAC-INIZCTEOSA-N D0M6KC DRUGSMIL CC1(C=CC2=C(O1)C(=CC(=C2)C3CC(=O)C4=C(C=C(C=C4O3)O)O)OC)C D0M6KC HIGHSTAT Investigative D0M6KL DRUG__ID D0M6KL D0M6KL DRUGTYPE Small molecular drug D0M6KL DRUGINCH 1S/C12H13Br2N5O/c1-17-10-12(16-11(17)15)3-2-4-18(12)9(20)7-5-6(13)8(14)19(7)10/h5,10H,2-4H2,1H3,(H2,15,16)/t10-,12+/m0/s1 D0M6KL DRUGINKE YPAFHZXYEACLQB-CMPLNLGQSA-N D0M6KL DRUGSMIL CN1C2C3(CCCN3C(=O)C4=CC(=C(N24)Br)Br)N=C1N D0M6KL HIGHSTAT Investigative D0M6NQ DRUG__ID D0M6NQ D0M6NQ DRUGTYPE Small molecular drug D0M6NQ DRUGINCH 1S/C32H39F3N8O7/c1-43-28(49)23(15-19-9-4-2-5-10-19)41-27(48)22(16-25(45)46)40-24(44)18-39-26(47)21(13-8-14-38-30(36)37)42-29(50)31(43,32(33,34)35)17-20-11-6-3-7-12-20/h2-7,9-12,21-23H,8,13-18H2,1H3,(H,39,47)(H,40,44)(H,41,48)(H,42,50)(H,45,46)(H4,36,37,38)/t21-,22-,23+,31-/m0/s1 D0M6NQ DRUGINKE IKBMFRHCMUKOBA-KAFAUTGVSA-N D0M6NQ DRUGSMIL CN1C(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C1(CC2=CC=CC=C2)C(F)(F)F)CCCN=C(N)N)CC(=O)O)CC3=CC=CC=C3 D0M6NQ HIGHSTAT Investigative D0M6OL DRUG__ID D0M6OL D0M6OL DRUGTYPE Small molecular drug D0M6OL DRUGINCH 1S/C6H13NO7S/c8-1-2-3(9)4(10)5(11)6(7-2)15(12,13)14/h2-11H,1H2,(H,12,13,14)/t2-,3-,4+,5-,6+/m1/s1 D0M6OL DRUGINKE PLICPKOWHZITQE-DVKNGEFBSA-N D0M6OL DRUGSMIL C(C1C(C(C(C(N1)S(=O)(=O)O)O)O)O)O D0M6OL HIGHSTAT Investigative D0M6OV DRUG__ID D0M6OV D0M6OV DRUGTYPE Small molecular drug D0M6OV DRUGINCH 1S/C37H65NO11/c1-14-26-37(10,42)31(40)22(5)29-19(2)16-36(9,49-29)32(48-34-28(39)25(38(11)12)15-20(3)45-34)23(6)30(24(7)33(41)46-26)47-27-18-35(8,43-13)17-21(4)44-27/h20-28,30-32,34,39-40,42H,14-18H2,1-13H3/t20-,21+,22+,23+,24-,25+,26-,27+,28-,30+,31-,32-,34+,35+,36-,37-/m1/s1 D0M6OV DRUGINKE UJUXMUPAZCCNTJ-ANUGEFLXSA-N D0M6OV DRUGSMIL CCC1C(C(C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(CC(O3)C)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)C)C)C)O)(C)O D0M6OV HIGHSTAT Investigative D0M6RM DRUG__ID D0M6RM D0M6RM DRUGTYPE Small molecular drug D0M6RM DRUGINCH 1S/C6H7AsO3/c8-7(9,10)6-4-2-1-3-5-6/h1-5H,(H2,8,9,10) D0M6RM DRUGINKE LVKZSFMYNWRPJX-UHFFFAOYSA-N D0M6RM DRUGSMIL C1=CC=C(C=C1)[As](=O)(O)O D0M6RM HIGHSTAT Investigative D0M6RQ DRUG__ID D0M6RQ D0M6RQ DRUGTYPE Small molecular drug D0M6RQ DRUGINCH 1S/C33H40N8O6/c1-19-29(44)41-26(16-20-9-12-24(42)13-10-20)30(45)37-18-28(43)39-27(17-21-8-11-22-5-2-3-6-23(22)15-21)32(47)40-25(31(46)38-19)7-4-14-36-33(34)35/h2-3,5-6,8-13,15,19,25-27,42H,4,7,14,16-18H2,1H3,(H,37,45)(H,38,46)(H,39,43)(H,40,47)(H,41,44)(H4,34,35,36)/t19-,25-,26+,27-/m0/s1 D0M6RQ DRUGINKE KSQLRHSLMODJAS-OQVMAISDSA-N D0M6RQ DRUGSMIL CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O D0M6RQ HIGHSTAT Investigative D0M6TB DRUG__ID D0M6TB D0M6TB DRUGTYPE Small molecular drug D0M6TB DRUGINCH 1S/C49H34F2N6O23S6/c50-33-9-7-25(47(60)54-35-11-13-39(83(69,70)71)31-19-29(81(63,64)65)21-41(43(31)35)85(75,76)77)17-37(33)56-45(58)23-3-1-5-27(15-23)52-49(62)53-28-6-2-4-24(16-28)46(59)57-38-18-26(8-10-34(38)51)48(61)55-36-12-14-40(84(72,73)74)32-20-30(82(66,67)68)22-42(44(32)36)86(78,79)80/h1-22H,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80) D0M6TB DRUGINKE UDVIAMRWOLIUAE-UHFFFAOYSA-N D0M6TB DRUGSMIL C1=CC(=CC(=C1)NC(=O)NC2=CC=CC(=C2)C(=O)NC3=C(C=CC(=C3)C(=O)NC4=C5C(=CC(=CC5=C(C=C4)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)F)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)F D0M6TB HIGHSTAT Investigative D0M6UK DRUG__ID D0M6UK D0M6UK DRUGTYPE Small molecular drug D0M6UK DRUGINCH 1S/C23H21ClN4O/c24-19-4-1-3-18(13-19)16-5-7-17(8-6-16)22(29)28-20-9-10-21(28)15-27(14-20)23-25-11-2-12-26-23/h1-8,11-13,20-21H,9-10,14-15H2 D0M6UK DRUGINKE FNHAFYQTHUKPIU-UHFFFAOYSA-N D0M6UK DRUGSMIL C1CC2CN(CC1N2C(=O)C3=CC=C(C=C3)C4=CC(=CC=C4)Cl)C5=NC=CC=N5 D0M6UK HIGHSTAT Investigative D0M6UM DRUG__ID D0M6UM D0M6UM DRUGTYPE Small molecular drug D0M6UM DRUGINCH 1S/C16H17NO3/c1-13(18)17(19)11-14-7-9-16(10-8-14)20-12-15-5-3-2-4-6-15/h2-10,19H,11-12H2,1H3 D0M6UM DRUGINKE LWIAYVCOMRXMSJ-UHFFFAOYSA-N D0M6UM DRUGSMIL CC(=O)N(CC1=CC=C(C=C1)OCC2=CC=CC=C2)O D0M6UM HIGHSTAT Investigative D0M6UZ DRUG__ID D0M6UZ D0M6UZ DRUGTYPE Small molecular drug D0M6UZ DRUGINCH 1S/C19H16O4/c1-3-4-12-7-14-10-16(23-19(14)18(8-12)20-2)13-5-6-15-17(9-13)22-11-21-15/h3,5-10H,1,4,11H2,2H3 D0M6UZ DRUGINKE QHQQIGTXXBIMFB-UHFFFAOYSA-N D0M6UZ DRUGSMIL COC1=CC(=CC2=C1OC(=C2)C3=CC4=C(C=C3)OCO4)CC=C D0M6UZ HIGHSTAT Investigative D0M6VZ DRUG__ID D0M6VZ D0M6VZ DRUGTYPE Small molecular drug D0M6VZ DRUGINCH 1S/C26H34O6/c1-16(2)26-14-20(30-22(29)15-27)25(4,32-26)19-12-10-17(3)23(19)24(26)31-21(28)13-11-18-8-6-5-7-9-18/h5-9,11,13,16-17,19-20,23-24,27H,10,12,14-15H2,1-4H3/b13-11+/t17-,19-,20-,23-,24+,25+,26-/m1/s1 D0M6VZ DRUGINKE GACOFEKSDCOVMV-RRYXBOBMSA-N D0M6VZ DRUGSMIL CC1CCC2C1C(C3(CC(C2(O3)C)OC(=O)CO)C(C)C)OC(=O)C=CC4=CC=CC=C4 D0M6VZ HIGHSTAT Investigative D0M6WJ DRUG__ID D0M6WJ D0M6WJ DRUGTYPE Small molecular drug D0M6WJ DRUGINCH 1S/C12H8N2O/c15-12-9-5-2-1-4-8(9)11-10(14-12)6-3-7-13-11/h1-7H,(H,14,15) D0M6WJ DRUGINKE NGHUYPCHBUPCNK-UHFFFAOYSA-N D0M6WJ DRUGSMIL C1=CC=C2C(=C1)C3=C(C=CC=N3)NC2=O D0M6WJ HIGHSTAT Investigative D0M6YZ DRUG__ID D0M6YZ D0M6YZ DRUGTYPE Small molecular drug D0M6YZ DRUGINCH 1S/C39H52O6/c1-23(2)12-15-27-21-38-22-28(16-13-24(3)4)37(9,10)45-34(38)31(32(41)26-14-17-30(44-11)29(40)20-26)33(42)39(35(38)43,36(27,7)8)19-18-25(5)6/h12-14,17-18,20,27-28,40H,15-16,19,21-22H2,1-11H3/t27-,28+,38+,39+/m1/s1 D0M6YZ DRUGINKE GEMUMPJYCDKSDU-OAKZDBKWSA-N D0M6YZ DRUGSMIL CC(=CCC1CC23CC(C(OC2=C(C(=O)C(C3=O)(C1(C)C)CC=C(C)C)C(=O)C4=CC(=C(C=C4)OC)O)(C)C)CC=C(C)C)C D0M6YZ HIGHSTAT Investigative D0M7AT DRUG__ID D0M7AT D0M7AT DRUGTYPE Small molecular drug D0M7AT DRUGINCH 1S/C17H24N6O3/c18-12(8-10-9-22-13-5-2-1-4-11(10)13)15(24)23-14(16(25)26)6-3-7-21-17(19)20/h1-2,4-5,9,12,14,22H,3,6-8,18H2,(H,23,24)(H,25,26)(H4,19,20,21)/t12-,14-/m0/s1 D0M7AT DRUGINKE LCPVBXOHXMBLFW-JSGCOSHPSA-N D0M7AT DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(C(=O)NC(CCCN=C(N)N)C(=O)O)N D0M7AT HIGHSTAT Investigative D0M7AU DRUG__ID D0M7AU D0M7AU DRUGTYPE Small molecular drug D0M7AU DRUGINCH 1S/C24H29NO3.C4H4O4/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;5-3(6)1-2-4(7)8/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1-2H,(H,5,6)(H,7,8)/p-2/b;2-1+ D0M7AU DRUGINKE APUVNJQYQMJLQQ-WLHGVMLRSA-L D0M7AU DRUGSMIL COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.C(=CC(=O)[O-])C(=O)[O-] D0M7AU HIGHSTAT Investigative D0M7AX DRUG__ID D0M7AX D0M7AX DRUGTYPE Small molecular drug D0M7AX DRUGINCH 1S/C9H12N4O2/c1-5(2)13-7-6(10-4-11-7)8(14)12(3)9(13)15/h4-5H,1-3H3,(H,10,11) D0M7AX DRUGINKE ZBQTVZYXBOKEMJ-UHFFFAOYSA-N D0M7AX DRUGSMIL CC(C)N1C2=C(C(=O)N(C1=O)C)NC=N2 D0M7AX HIGHSTAT Investigative D0M7BR DRUG__ID D0M7BR D0M7BR DRUGTYPE Small molecular drug D0M7BR DRUGINCH 1S/C16H12O4/c1-19-12-5-2-10(3-6-12)14-9-20-15-8-11(17)4-7-13(15)16(14)18/h2-9,17H,1H3 D0M7BR DRUGINKE HKQYGTCOTHHOMP-UHFFFAOYSA-N D0M7BR DRUGSMIL COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O D0M7BR HIGHSTAT Investigative D0M7DC DRUG__ID D0M7DC D0M7DC DRUGTYPE Small molecular drug D0M7DC DRUGINCH 1S/C4H4N2O2/c7-4(8)3-1-2-5-6-3/h1-2H,(H,5,6)(H,7,8) D0M7DC DRUGINKE KOPFEFZSAMLEHK-UHFFFAOYSA-N D0M7DC DRUGSMIL C1=C(NN=C1)C(=O)O D0M7DC HIGHSTAT Investigative D0M7DE DRUG__ID D0M7DE D0M7DE DRUGTYPE Small molecular drug D0M7DE DRUGINCH 1S/C9H10N2O3S/c10-15(12,13)11-5-7-6-14-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H2,10,12,13) D0M7DE DRUGINKE XOBOZYKTCAJRGO-UHFFFAOYSA-N D0M7DE DRUGSMIL C1=CC=C2C(=C1)C(=CO2)CNS(=O)(=O)N D0M7DE HIGHSTAT Investigative D0M7DG DRUG__ID D0M7DG D0M7DG DRUGTYPE Small molecular drug D0M7DG DRUGINCH 1S/C29H50OS/c1-19(2)31-17-12-20(3)21-10-13-27(7)23-9-8-22-25(4,5)24(30)11-14-28(22)18-29(23,28)16-15-26(21,27)6/h19-24,30H,8-18H2,1-7H3/t20-,21-,22+,23+,24+,26-,27+,28?,29?/m1/s1 D0M7DG DRUGINKE RCCUSRZZXQUAQP-VMZLNZKESA-N D0M7DG DRUGSMIL CC(C)SCCC(C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C D0M7DG HIGHSTAT Investigative D0M7EI DRUG__ID D0M7EI D0M7EI DRUGTYPE Small molecular drug D0M7EI DRUGINCH 1S/C13H18O2S/c1-3-4-7-10-16-13-9-6-5-8-12(13)15-11(2)14/h5-6,8-9H,3-4,7,10H2,1-2H3 D0M7EI DRUGINKE QCBPAZOETZPVCH-UHFFFAOYSA-N D0M7EI DRUGSMIL CCCCCSC1=CC=CC=C1OC(=O)C D0M7EI HIGHSTAT Investigative D0M7FS DRUG__ID D0M7FS D0M7FS DRUGTYPE Small molecular drug D0M7FS DRUGINCH 1S/C15H12FN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8- D0M7FS DRUGINKE WLUDJBASYYHRDC-WQLSENKSSA-N D0M7FS DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)F D0M7FS HIGHSTAT Investigative D0M7HH DRUG__ID D0M7HH D0M7HH DRUGTYPE Small molecular drug D0M7HH DRUGINCH 1S/C14H22Cl2N5O12P3S/c1-2-3-37-13-19-10(17)7-11(20-13)21(5-18-7)12-9(23)8(22)6(32-12)4-31-36(29,30)33-35(27,28)14(15,16)34(24,25)26/h5-6,8-9,12,22-23H,2-4H2,1H3,(H,27,28)(H,29,30)(H2,17,19,20)(H2,24,25,26)/t6-,8-,9-,12-/m1/s1/i1T3,2T2 D0M7HH DRUGINKE ZLIAJZQKKBOFJR-WNJXVAICSA-N D0M7HH DRUGSMIL CCCSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)N D0M7HH HIGHSTAT Investigative D0M7HQ DRUG__ID D0M7HQ D0M7HQ DRUGTYPE Small molecular drug D0M7HQ DRUGINCH 1S/C16H16N2S/c1-11(2)15-10-19-16(18-15)17-14-9-5-7-12-6-3-4-8-13(12)14/h3-11H,1-2H3,(H,17,18) D0M7HQ DRUGINKE UZYASSJTIRFKFN-UHFFFAOYSA-N D0M7HQ DRUGSMIL CC(C)C1=CSC(=N1)NC2=CC=CC3=CC=CC=C32 D0M7HQ HIGHSTAT Investigative D0M7IA DRUG__ID D0M7IA D0M7IA DRUGTYPE Small molecular drug D0M7IA DRUGINCH 1S/C40H36O12/c1-18(2)10-11-39-27-9-6-22(43)16-31(27)52-40(39,50)38(49)35-32(51-39)17-30(46)34(37(35)48)26-13-19(3)12-25(23-7-4-20(41)14-28(23)44)33(26)36(47)24-8-5-21(42)15-29(24)45/h4-10,13-17,25-26,33,41-46,48,50H,11-12H2,1-3H3/t25-,26+,33-,39?,40?/m1/s1 D0M7IA DRUGINKE XETHJOZXBVWLLM-QAHMVTMMSA-N D0M7IA DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C5=C(C=C4O)OC6(C7=C(C=C(C=C7)O)OC6(C5=O)O)CC=C(C)C)O D0M7IA HIGHSTAT Investigative D0M7KD DRUG__ID D0M7KD D0M7KD DRUGTYPE Small molecular drug D0M7KD DRUGINCH 1S/C17H17NO2/c19-17(18-15-9-5-10-15)20-16-11-4-8-14(12-16)13-6-2-1-3-7-13/h1-4,6-8,11-12,15H,5,9-10H2,(H,18,19) D0M7KD DRUGINKE CACLVJBQOQELCV-UHFFFAOYSA-N D0M7KD DRUGSMIL C1CC(C1)NC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3 D0M7KD HIGHSTAT Investigative D0M7KF DRUG__ID D0M7KF D0M7KF DRUGTYPE Small molecular drug D0M7KF DRUGINCH 1S/C15H13NO/c1-9-3-5-12-13-8-11(10(2)17)4-6-14(13)16-15(12)7-9/h3-8,16H,1-2H3 D0M7KF DRUGINKE YNKFXJJSPLSRRJ-UHFFFAOYSA-N D0M7KF DRUGSMIL CC1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)C(=O)C D0M7KF HIGHSTAT Investigative D0M7LA DRUG__ID D0M7LA D0M7LA DRUGTYPE Small molecular drug D0M7LA DRUGINCH 1S/C18H14ClF3O4/c1-8-5-10-7-26-17(24)15(10)14(13(8)16(23)25-2)9-3-4-12(19)11(6-9)18(20,21)22/h3-4,6,14H,5,7H2,1-2H3 D0M7LA DRUGINKE WMQUFXJLJGXXJD-UHFFFAOYSA-N D0M7LA DRUGSMIL CC1=C(C(C2=C(C1)COC2=O)C3=CC(=C(C=C3)Cl)C(F)(F)F)C(=O)OC D0M7LA HIGHSTAT Investigative D0M7LC DRUG__ID D0M7LC D0M7LC DRUGTYPE Small molecular drug D0M7LC DRUGINCH 1S/C16H12O3/c17-13-4-3-10-7-12(2-1-11(10)8-13)15-6-5-14(18)9-16(15)19/h1-9,17-19H D0M7LC DRUGINKE BXZJBSHLEZAMOP-UHFFFAOYSA-N D0M7LC DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=C(C=C(C=C3)O)O D0M7LC HIGHSTAT Investigative D0M7OP DRUG__ID D0M7OP D0M7OP DRUGTYPE Small molecular drug D0M7OP DRUGINCH 1S/C15H18ClNO/c1-15-8-7-14(18)17(2)13(15)6-3-10-9-11(16)4-5-12(10)15/h4-5,9,13H,3,6-8H2,1-2H3/t13-,15-/m1/s1 D0M7OP DRUGINKE KTBSRSVHEOTHLD-UKRRQHHQSA-N D0M7OP DRUGSMIL CC12CCC(=O)N(C1CCC3=C2C=CC(=C3)Cl)C D0M7OP HIGHSTAT Investigative D0M7QA DRUG__ID D0M7QA D0M7QA DRUGTYPE Small molecular drug D0M7QA DRUGINCH 1S/C10H14N2O3S/c1-8(13)12-7-6-9-2-4-10(5-3-9)16(11,14)15/h2-5H,6-7H2,1H3,(H,12,13)(H2,11,14,15) D0M7QA DRUGINKE IIMGUEXQORZTID-UHFFFAOYSA-N D0M7QA DRUGSMIL CC(=O)NCCC1=CC=C(C=C1)S(=O)(=O)N D0M7QA HIGHSTAT Investigative D0M7QR DRUG__ID D0M7QR D0M7QR DRUGTYPE Small molecular drug D0M7QR DRUGINCH 1S/C13H20N2/c1-2-12-5-6-13(14-11-12)7-10-15-8-3-4-9-15/h5-6,11H,2-4,7-10H2,1H3 D0M7QR DRUGINKE LTRFAPGENZNRNS-UHFFFAOYSA-N D0M7QR DRUGSMIL CCC1=CN=C(C=C1)CCN2CCCC2 D0M7QR HIGHSTAT Investigative D0M7RM DRUG__ID D0M7RM D0M7RM DRUGTYPE Small molecular drug D0M7RM DRUGINCH 1S/C28H21N3OS/c1-20-27(26(32)18-17-21-11-5-2-6-12-21)33-28(29-20)31-25(23-15-9-4-10-16-23)19-24(30-31)22-13-7-3-8-14-22/h2-19H,1H3/b18-17+ D0M7RM DRUGINKE DDJHJUVZEFZWQV-ISLYRVAYSA-N D0M7RM DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC=CC=C5 D0M7RM HIGHSTAT Investigative D0M7SQ DRUG__ID D0M7SQ D0M7SQ DRUGTYPE Small molecular drug D0M7SQ DRUGINCH 1S/C15H19F3O/c16-15(17,18)14(19)12-8-3-1-2-5-9-13-10-6-4-7-11-13/h4,6-7,10-11H,1-3,5,8-9,12H2 D0M7SQ DRUGINKE BAGRIDDIIFOCBK-UHFFFAOYSA-N D0M7SQ DRUGSMIL C1=CC=C(C=C1)CCCCCCCC(=O)C(F)(F)F D0M7SQ HIGHSTAT Investigative D0M7SY DRUG__ID D0M7SY D0M7SY DRUGTYPE Small molecular drug D0M7SY DRUGINCH 1S/C27H30N4O/c28-17-20-5-8-21-12-14-31(18-23(21)15-20)13-11-19-6-9-24(10-7-19)29-27(32)26-16-22-3-1-2-4-25(22)30-26/h1-5,8,15-16,19,24,30H,6-7,9-14,18H2,(H,29,32) D0M7SY DRUGINKE JGLGOAQPUQITLD-UHFFFAOYSA-N D0M7SY DRUGSMIL C1CC(CCC1CCN2CCC3=C(C2)C=C(C=C3)C#N)NC(=O)C4=CC5=CC=CC=C5N4 D0M7SY HIGHSTAT Investigative D0M7TC DRUG__ID D0M7TC D0M7TC DRUGTYPE Small molecular drug D0M7TC DRUGINCH 1S/C26H47N7O2/c27-11-5-14-28-12-3-4-13-29-15-6-16-30-17-7-19-33(35)20-8-18-31-26(34)21-23-22-32-25-10-2-1-9-24(23)25/h1-2,9-10,22,28-30,32,35H,3-8,11-21,27H2,(H,31,34) D0M7TC DRUGINKE LIURIBSBVUMOJS-UHFFFAOYSA-N D0M7TC DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CC(=O)NCCCN(CCCNCCCNCCCCNCCCN)O D0M7TC HIGHSTAT Investigative D0M7TP DRUG__ID D0M7TP D0M7TP DRUGTYPE Small molecular drug D0M7TP DRUGINCH 1S/C47H76N14O8/c1-6-28(2)37(43(68)56-32(38(49)63)16-10-11-23-48)61-40(65)33(17-12-24-54-45(50)51)57-41(66)36(27-30-19-21-31(62)22-20-30)59-42(67)35(26-29-14-8-7-9-15-29)58-39(64)34(18-13-25-55-46(52)53)60-44(69)47(3,4)5/h7-9,14-15,19-22,28,32-37,62H,6,10-13,16-18,23-27,48H2,1-5H3,(H2,49,63)(H,56,68)(H,57,66)(H,58,64)(H,59,67)(H,60,69)(H,61,65)(H4,50,51,54)(H4,52,53,55)/t28-,32-,33-,34-,35-,36-,37-/m0/s1 D0M7TP DRUGINKE KUMVVDGHDQEFOK-KHLMYIKTSA-N D0M7TP DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)(C)C D0M7TP HIGHSTAT Investigative D0M7VB DRUG__ID D0M7VB D0M7VB DRUGCOMP Avigen Inc D0M7VB DRUGINCH 1S/C13H17N3O/c1-8(2)12-11(13(17)9(3)14)10-6-4-5-7-16(10)15-12/h4-9H,14H2,1-3H3 D0M7VB DRUGINKE JLKPIOQFGACSJO-UHFFFAOYSA-N D0M7VB DRUGSMIL CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)N D0M7VB HIGHSTAT Investigative D0M7VN DRUG__ID D0M7VN D0M7VN DRUGTYPE Small molecular drug D0M7VN DRUGINCH 1S/C7H11N3O2S/c1-10(8)6-2-4-7(5-3-6)13(9,11)12/h2-5H,8H2,1H3,(H2,9,11,12) D0M7VN DRUGINKE XGAFGUJHKUYKIM-UHFFFAOYSA-N D0M7VN DRUGSMIL CN(C1=CC=C(C=C1)S(=O)(=O)N)N D0M7VN HIGHSTAT Investigative D0M7VY DRUG__ID D0M7VY D0M7VY DRUGTYPE Small molecular drug D0M7VY DRUGINCH 1S/C21H12N2O2/c24-19-13-8-4-5-9-14(13)20(25)17-15(19)10-11-16-18(17)23-21(22-16)12-6-2-1-3-7-12/h1-11H,(H,22,23) D0M7VY DRUGINKE DONDWNNDTIOAET-UHFFFAOYSA-N D0M7VY DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N2)C=CC4=C3C(=O)C5=CC=CC=C5C4=O D0M7VY HIGHSTAT Investigative D0M7WE DRUG__ID D0M7WE D0M7WE DRUGTYPE Small molecular drug D0M7WE DRUGINCH 1S/C11H12N2/c1-2-4-10-8(3-1)9-7-12-6-5-11(9)13-10/h1-4,12-13H,5-7H2 D0M7WE DRUGINKE RPROHCOBMVQVIV-UHFFFAOYSA-N D0M7WE DRUGSMIL C1CNCC2=C1NC3=CC=CC=C23 D0M7WE HIGHSTAT Investigative D0M7YB DRUG__ID D0M7YB D0M7YB DRUGTYPE Small molecular drug D0M7YB DRUGINCH 1S/C15H26O/c1-14(2)7-4-8-15(3)11-6-5-10(13(11)14)12(15)9-16/h10-13,16H,4-9H2,1-3H3/t10-,11-,12+,13+,15+/m1/s1 D0M7YB DRUGINKE VZJHQHUOVIDRCF-BIGJJFBESA-N D0M7YB DRUGSMIL CC1(CCCC2(C3C1C(C2CO)CC3)C)C D0M7YB HIGHSTAT Investigative D0M7ZZ DRUG__ID D0M7ZZ D0M7ZZ DRUGTYPE Small molecular drug D0M7ZZ DRUGINCH 1S/C25H26O5/c1-14(2)5-6-15-11-17-21(12-19(15)26)28-13-25(27)18-7-8-20-16(22(18)29-23(17)25)9-10-24(3,4)30-20/h5,7-12,23,26-27H,6,13H2,1-4H3/t23-,25+/m0/s1 D0M7ZZ DRUGINKE CMHGFGMNRHHGSN-UKILVPOCSA-N D0M7ZZ DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OCC3(C2OC4=C3C=CC5=C4C=CC(O5)(C)C)O)C D0M7ZZ HIGHSTAT Investigative D0M8AR DRUG__ID D0M8AR D0M8AR DRUGTYPE Small molecular drug D0M8AR DRUGINCH 1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(29)27-28-23-26(30-27)24-20-17-16-18-21-24/h9-10,16-18,20-21,23H,2-8,11-15,19,22H2,1H3/b10-9- D0M8AR DRUGINKE JBJNKCWDUQMEEA-KTKRTIGZSA-N D0M8AR DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=C2 D0M8AR HIGHSTAT Investigative D0M8CJ DRUG__ID D0M8CJ D0M8CJ DRUGTYPE Small molecular drug D0M8CJ DRUGINCH 1S/C21H21F3N2O2/c22-21(23,24)16-7-5-15(6-8-16)9-12-26-13-10-20(11-14-26)17-3-1-2-4-18(17)25-19(27)28-20/h1-8H,9-14H2,(H,25,27) D0M8CJ DRUGINKE HIDWEYPGMLIQSN-UHFFFAOYSA-N D0M8CJ DRUGSMIL C1CN(CCC12C3=CC=CC=C3NC(=O)O2)CCC4=CC=C(C=C4)C(F)(F)F D0M8CJ HIGHSTAT Investigative D0M8CO DRUG__ID D0M8CO D0M8CO DRUGTYPE Small molecular drug D0M8CO DRUGINCH 1S/C16H13N3O2/c20-12-8-7-11-4-3-5-14(13(11)10-12)18-16(21)19-15-6-1-2-9-17-15/h1-10,20H,(H2,17,18,19,21) D0M8CO DRUGINKE PLKPAJOIRNQZMG-UHFFFAOYSA-N D0M8CO DRUGSMIL C1=CC=NC(=C1)NC(=O)NC2=CC=CC3=C2C=C(C=C3)O D0M8CO HIGHSTAT Investigative D0M8DU DRUG__ID D0M8DU D0M8DU DRUGTYPE Small molecular drug D0M8DU DRUGINCH 1S/C11H17N2O14P3/c14-6-1-2-13(10(17)12-6)7-5-3-11(5,9(16)8(7)15)4-25-29(21,22)27-30(23,24)26-28(18,19)20/h1-2,5,7-9,15-16H,3-4H2,(H,21,22)(H,23,24)(H,12,14,17)(H2,18,19,20) D0M8DU DRUGINKE XWFVJTIKQWQNID-UHFFFAOYSA-N D0M8DU DRUGSMIL C1C2C1(C(C(C2N3C=CC(=O)NC3=O)O)O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O D0M8DU HIGHSTAT Investigative D0M8EH DRUG__ID D0M8EH D0M8EH DRUGTYPE Small molecular drug D0M8EH DRUGINCH 1S/C22H25ClO7/c1-2-28-15-5-3-12(4-6-15)7-13-8-16-14(9-17(13)23)11-29-22(16)21(27)20(26)19(25)18(10-24)30-22/h3-6,8-9,18-21,24-27H,2,7,10-11H2,1H3/t18-,19-,20+,21-,22+/m1/s1 D0M8EH DRUGINKE WUEOKKVPVLUFPP-BDHVOXNPSA-N D0M8EH DRUGSMIL CCOC1=CC=C(C=C1)CC2=C(C=C3COC4(C3=C2)C(C(C(C(O4)CO)O)O)O)Cl D0M8EH HIGHSTAT Investigative D0M8FL DRUG__ID D0M8FL D0M8FL DRUGTYPE Small molecular drug D0M8FL DRUGINCH 1S/C9H11NO/c1-2-4-9-8(3-1)7-10-5-6-11-9/h1-4,10H,5-7H2 D0M8FL DRUGINKE HDVHFHONOKCUHQ-UHFFFAOYSA-N D0M8FL DRUGSMIL C1COC2=CC=CC=C2CN1 D0M8FL HIGHSTAT Investigative D0M8HC DRUG__ID D0M8HC D0M8HC DRUGTYPE Small molecular drug D0M8HC DRUGINCH 1S/C12H14N2O5S3/c1-19-10-4-2-9(3-5-10)8-14-22(17,18)12-7-6-11(20-12)21(13,15)16/h2-7,14H,8H2,1H3,(H2,13,15,16) D0M8HC DRUGINKE LRRAIRJIZOLGPR-UHFFFAOYSA-N D0M8HC DRUGSMIL COC1=CC=C(C=C1)CNS(=O)(=O)C2=CC=C(S2)S(=O)(=O)N D0M8HC HIGHSTAT Investigative D0M8HU DRUG__ID D0M8HU D0M8HU DRUGTYPE Small molecular drug D0M8HU DRUGINCH 1S/C43H60N8O10/c1-22(2)18-30(44)38(55)46-24(5)37(54)49-35(23(3)4)41(58)48-33(19-26-13-15-28(53)16-14-26)42(59)51-17-9-12-34(51)40(57)47-32(39(56)50-36(25(6)52)43(60)61)20-27-21-45-31-11-8-7-10-29(27)31/h7-8,10-11,13-16,21-25,30,32-36,45,52-53H,9,12,17-20,44H2,1-6H3,(H,46,55)(H,47,57)(H,48,58)(H,49,54)(H,50,56)(H,60,61)/t24-,25+,30-,32-,33-,34-,35-,36-/m0/s1 D0M8HU DRUGINKE HOZWDBPFSGBJBM-DTSDQQARSA-N D0M8HU DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(C(C)O)C(=O)O)N D0M8HU HIGHSTAT Investigative D0M8IT DRUG__ID D0M8IT D0M8IT DRUGTYPE Small molecular drug D0M8IT DRUGINCH 1S/C24H48NO9P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(27)32-18-21(26)19-33-35(30,31)34-20-22(25)24(28)29/h21-22,26H,2-20,25H2,1H3,(H,28,29)(H,30,31)/t21-,22+/m1/s1 D0M8IT DRUGINKE ZPDQFUYPBVXUKS-YADHBBJMSA-N D0M8IT DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(C(=O)O)N)O D0M8IT HIGHSTAT Investigative D0M8JE DRUG__ID D0M8JE D0M8JE DRUGTYPE Small molecular drug D0M8JE DRUGINCH 1S/C23H20N2/c1-3-7-19(8-4-1)17-23(25-16-15-24-18-25)22-13-11-21(12-14-22)20-9-5-2-6-10-20/h1-16,18,23H,17H2 D0M8JE DRUGINKE TVOGKVRUROHUOE-UHFFFAOYSA-N D0M8JE DRUGSMIL C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=CC=C3)N4C=CN=C4 D0M8JE HIGHSTAT Investigative D0M8JZ DRUG__ID D0M8JZ D0M8JZ DRUGTYPE Small molecular drug D0M8JZ DRUGINCH 1S/C40H46N4O2/c1-43-15-13-39-31-7-3-5-9-33(31)41-22-30-28-20-36-40(14-16-44(36,2)24-26(28)12-18-46)32-8-4-6-10-34(32)42(38(30)40)21-29(37(39)41)27(19-35(39)43)25(23-43)11-17-45/h3-12,21-22,27-28,35-38,45-46H,13-20,23-24H2,1-2H3/q+2/b25-11-,26-12-,29-21-,30-22-/t27-,28-,35-,36-,37-,38-,39+,40+,43-,44-/m0/s1 D0M8JZ DRUGINKE IIYHWTVUYIYKKG-QQRSFBQTSA-N D0M8JZ DRUGSMIL C[N+]12CCC34C1CC(C(=CCO)C2)C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CC[N+]1(CC9=CCO)C)C1=CC=CC=C16 D0M8JZ HIGHSTAT Investigative D0M8LN DRUG__ID D0M8LN D0M8LN DRUGTYPE Small molecular drug D0M8LN DRUGINCH 1S/C22H31F3N6O2/c1-15-14-31(20(33)28-18(15)32)8-6-5-7-29-9-11-30(12-10-29)17-13-16(22(23,24)25)26-19(27-17)21(2,3)4/h13-14H,5-12H2,1-4H3,(H,28,32,33) D0M8LN DRUGINKE LRAYIUHUAWSEDX-UHFFFAOYSA-N D0M8LN DRUGSMIL CC1=CN(C(=O)NC1=O)CCCCN2CCN(CC2)C3=NC(=NC(=C3)C(F)(F)F)C(C)(C)C D0M8LN HIGHSTAT Investigative D0M8NW DRUG__ID D0M8NW D0M8NW DRUGTYPE Small molecular drug D0M8NW DRUGINCH 1S/C20H16N4OS/c1-11(25)21-8-7-14-17-16-13(12-4-2-3-5-15(12)24-17)6-9-22-18(16)19-20(14)26-10-23-19/h2-6,9-10,24H,7-8H2,1H3,(H,21,25) D0M8NW DRUGINKE GUSIRVISUKPQFL-UHFFFAOYSA-N D0M8NW DRUGSMIL CC(=O)NCCC1=C2C3=C(C=CN=C3C4=C1SC=N4)C5=CC=CC=C5N2 D0M8NW HIGHSTAT Investigative D0M8RB DRUG__ID D0M8RB D0M8RB DRUGTYPE Small molecular drug D0M8RB DRUGINCH 1S/C31H27N4S/c1-3-34-28-22-23(31-32-26-16-10-11-17-29(26)36-31)18-19-27(28)35(25-14-8-5-9-15-25)30(34)20-21-33(2)24-12-6-4-7-13-24/h4-22H,3H2,1-2H3/q+1 D0M8RB DRUGINKE OTHITMYLBRCVIT-UHFFFAOYSA-N D0M8RB DRUGSMIL CC[N+]1=C(N(C2=C1C=C(C=C2)C3=NC4=CC=CC=C4S3)C5=CC=CC=C5)C=CN(C)C6=CC=CC=C6 D0M8RB HIGHSTAT Investigative D0M8RO DRUG__ID D0M8RO D0M8RO DRUGTYPE Small molecular drug D0M8RO DRUGINCH 1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1 D0M8RO DRUGINKE AEMFNILZOJDQLW-QAGGRKNESA-N D0M8RO DRUGSMIL CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4=O)C D0M8RO HIGHSTAT Investigative D0M8SY DRUG__ID D0M8SY D0M8SY DRUGTYPE Small molecular drug D0M8SY DRUGINCH 1S/C35H45N5O3.ClH/c1-9-10-17-40-33-27(15-12-16-36-33)30(25-13-11-14-26(20-25)43-8)32(34(40)41)38-35(42)37-31-28(22(2)3)18-24(21-39(6)7)19-29(31)23(4)5;/h11-16,18-20,22-23H,9-10,17,21H2,1-8H3,(H2,37,38,42);1H D0M8SY DRUGINKE YCGQPIRMLGEWMW-UHFFFAOYSA-N D0M8SY DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)CN(C)C)C(C)C)C4=CC(=CC=C4)OC.Cl D0M8SY HIGHSTAT Investigative D0M8UY DRUG__ID D0M8UY D0M8UY DRUGTYPE Small molecular drug D0M8UY DRUGINCH 1S/C7H4O3S/c8-4-1-2-6-5(3-4)10-7(9)11-6/h1-3,8H D0M8UY DRUGINKE SLYPOVJCSQHITR-UHFFFAOYSA-N D0M8UY DRUGSMIL C1=CC2=C(C=C1O)OC(=O)S2 D0M8UY HIGHSTAT Investigative D0M8VN DRUG__ID D0M8VN D0M8VN DRUGTYPE Small molecular drug D0M8VN DRUGINCH 1S/C20H18N2O5S/c23-18-17(28-20(25)21-18)11-13-5-7-14(8-6-13)26-10-9-22-12-27-16-4-2-1-3-15(16)19(22)24/h1-8,17H,9-12H2,(H,21,23,25) D0M8VN DRUGINKE RFMNEXVCPAPDRA-UHFFFAOYSA-N D0M8VN DRUGSMIL C1N(C(=O)C2=CC=CC=C2O1)CCOC3=CC=C(C=C3)CC4C(=O)NC(=O)S4 D0M8VN HIGHSTAT Investigative D0M8VV DRUG__ID D0M8VV D0M8VV DRUGTYPE Small molecular drug D0M8VV DRUGINCH 1S/C19H20O3/c20-16-4-2-1-3-15-8-12-18(21)19(13-15)22-17-10-6-14(5-9-16)7-11-17/h6-8,10-13,21H,1-5,9H2 D0M8VV DRUGINKE DMCJCKWHLCLVNV-UHFFFAOYSA-N D0M8VV DRUGSMIL C1CCC2=CC(=C(C=C2)O)OC3=CC=C(CCC(=O)C1)C=C3 D0M8VV HIGHSTAT Investigative D0M8WX DRUG__ID D0M8WX D0M8WX DRUGTYPE Small molecular drug D0M8WX DRUGINCH 1S/C14H11F3O2/c15-11-6-5-10(13(16)14(11)17)9-3-1-2-4-12(9)19-8-7-18/h1-6,18H,7-8H2 D0M8WX DRUGINKE AGXPXFPIOHNDAN-UHFFFAOYSA-N D0M8WX DRUGSMIL C1=CC=C(C(=C1)C2=C(C(=C(C=C2)F)F)F)OCCO D0M8WX HIGHSTAT Investigative D0M8YB DRUG__ID D0M8YB D0M8YB DRUGTYPE Small molecular drug D0M8YB DRUGINCH 1S/C22H34N2O3/c1-3-4-5-12-21(27)23-13-8-15-24-14-7-10-18(24)16-20(26)22-17(2)9-6-11-19(22)25/h6,9,11,18,25H,3-5,7-8,10,12-16H2,1-2H3,(H,23,27) D0M8YB DRUGINKE LZFMYZNYVOKFEE-UHFFFAOYSA-N D0M8YB DRUGSMIL CCCCCC(=O)NCCCN1CCCC1CC(=O)C2=C(C=CC=C2O)C D0M8YB HIGHSTAT Investigative D0M9BA DRUG__ID D0M9BA D0M9BA DRUGTYPE Small molecular drug D0M9BA DRUGINCH 1S/C9H14N4O3/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6/h4-5,7H,1-3,10H2,(H,11,12)(H,13,14)(H,15,16)/t7-/m0/s1 D0M9BA DRUGINKE CQOVPNPJLQNMDC-ZETCQYMHSA-N D0M9BA DRUGSMIL C1=C(NC=N1)CC(C(=O)O)NC(=O)CCN D0M9BA HIGHSTAT Investigative D0M9BZ DRUG__ID D0M9BZ D0M9BZ DRUGTYPE Small molecular drug D0M9BZ DRUGINCH 1S/C24H26FNO5/c1-14(2)22-19-5-3-4-6-20(19)26-23(15-7-9-16(25)10-8-15)24(22)31-13-18(28)11-17(27)12-21(29)30/h3-10,14,17-18,27-28H,11-13H2,1-2H3,(H,29,30)/p-1/t17-,18?/m1/s1 D0M9BZ DRUGINKE WFJBUGLKYOMEIA-QNSVNVJESA-M D0M9BZ DRUGSMIL CC(C)C1=C(C(=NC2=CC=CC=C21)C3=CC=C(C=C3)F)OCC(CC(CC(=O)[O-])O)O D0M9BZ HIGHSTAT Investigative D0M9DD DRUG__ID D0M9DD D0M9DD DRUGTYPE Small molecular drug D0M9DD DRUGINCH 1S/C51H67N15O8/c52-42(67)29-38(44(53)69)64-45(70)36(15-7-23-59-50(54)55)62-48(73)41-17-9-25-66(41)49(74)37(16-8-24-60-51(56)57)63-47(72)40(27-31-10-2-1-3-11-31)65-46(71)39(61-43(68)21-19-32-12-6-22-58-30-32)28-33-18-20-34-13-4-5-14-35(34)26-33/h1-6,10-14,18,20,22,26,30,36-41H,7-9,15-17,19,21,23-25,27-29H2,(H2,52,67)(H2,53,69)(H,61,68)(H,62,73)(H,63,72)(H,64,70)(H,65,71)(H4,54,55,59)(H4,56,57,60)/t36-,37-,38-,39-,40-,41-/m0/s1 D0M9DD DRUGINKE HPJGEESDHAUUQR-SKGSPYGFSA-N D0M9DD DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC4=CC=CC=C4C=C3)NC(=O)CCC5=CN=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)N D0M9DD HIGHSTAT Investigative D0M9DT DRUG__ID D0M9DT D0M9DT DRUGTYPE Small molecular drug D0M9DT DRUGINCH 1S/C20H41NO2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)19(18-22)21(2)3/h16-17,19-20,22-23H,4-15,18H2,1-3H3/b17-16+/t19-,20+/m0/s1 D0M9DT DRUGINKE YRXOQXUDKDCXME-YIVRLKKSSA-N D0M9DT DRUGSMIL CCCCCCCCCCCCCC=CC(C(CO)N(C)C)O D0M9DT HIGHSTAT Investigative D0M9FC DRUG__ID D0M9FC D0M9FC DRUGTYPE Small molecular drug D0M9FC DRUGINCH 1S/C22H21NO3/c1-15-5-4-6-16(11-15)12-20(14-21(24)25)23-22(26)19-10-9-17-7-2-3-8-18(17)13-19/h2-11,13,20H,12,14H2,1H3,(H,23,26)(H,24,25)/t20-/m1/s1 D0M9FC DRUGINKE LDUFWTJAUGDLSR-HXUWFJFHSA-N D0M9FC DRUGSMIL CC1=CC(=CC=C1)CC(CC(=O)O)NC(=O)C2=CC3=CC=CC=C3C=C2 D0M9FC HIGHSTAT Investigative D0M9GO DRUG__ID D0M9GO D0M9GO DRUGTYPE Small molecular drug D0M9GO DRUGINCH 1S/C22H20FN3OS/c1-26-16(13-25-22(27)15-10-11-28-14-15)12-24-21(17-6-2-4-8-19(17)23)18-7-3-5-9-20(18)26/h2-11,14,16H,12-13H2,1H3,(H,25,27) D0M9GO DRUGINKE NPGABYHTDVGGJK-UHFFFAOYSA-N D0M9GO DRUGSMIL CN1C(CN=C(C2=CC=CC=C21)C3=CC=CC=C3F)CNC(=O)C4=CSC=C4 D0M9GO HIGHSTAT Investigative D0M9IC DRUG__ID D0M9IC D0M9IC DRUGTYPE Small molecular drug D0M9IC DRUGINCH 1S/C24H40N2/c1-16-20-8-9-22-19-7-6-17-14-18(25(3)4)10-12-23(17,2)21(19)11-13-24(20,22)15-26(16)5/h6,16,18-22H,7-15H2,1-5H3/t16-,18-,19+,20+,21-,22-,23-,24-/m0/s1 D0M9IC DRUGINKE GPLGAQQQNWMVMM-MYAJQUOBSA-N D0M9IC DRUGSMIL CC1C2CCC3C2(CCC4C3CC=C5C4(CCC(C5)N(C)C)C)CN1C D0M9IC HIGHSTAT Investigative D0M9IQ DRUG__ID D0M9IQ D0M9IQ DRUGTYPE Small molecular drug D0M9IQ DRUGINCH 1S/C8H11NO3S.Na/c1-9(7-13(10,11)12)8-5-3-2-4-6-8;/h2-6H,7H2,1H3,(H,10,11,12);/q;+1/p-1 D0M9IQ DRUGINKE XIDHWXUDYZMZID-UHFFFAOYSA-M D0M9IQ DRUGSMIL CN(CS(=O)(=O)[O-])C1=CC=CC=C1.[Na+] D0M9IQ HIGHSTAT Investigative D0M9JF DRUG__ID D0M9JF D0M9JF DRUGTYPE Small molecular drug D0M9JF DRUGINCH 1S/C21H17BrN3O2.ClH/c1-24-7-6-12-14(9-24)21(27)20-18-17(16(26)10-25(20,2)3)13-5-4-11(22)8-15(13)23-19(12)18;/h4-9H,10H2,1-3H3;1H/q+1;/p-1 D0M9JF DRUGINKE YWXZSQALRCVSLY-UHFFFAOYSA-M D0M9JF DRUGSMIL CN1C=CC2=C3C4=C(C(=O)C2=C1)[N+](CC(=O)C4=C5C=CC(=CC5=N3)Br)(C)C.[Cl-] D0M9JF HIGHSTAT Investigative D0M9JU DRUG__ID D0M9JU D0M9JU DRUGTYPE Small molecular drug D0M9JU DRUGINCH 1S/C14H11N3O2/c18-13-8-12(16-14(19)17-13)15-11-6-5-9-3-1-2-4-10(9)7-11/h1-8H,(H3,15,16,17,18,19) D0M9JU DRUGINKE KADGSGKDRXSVOE-UHFFFAOYSA-N D0M9JU DRUGSMIL C1=CC=C2C=C(C=CC2=C1)NC3=CC(=O)NC(=O)N3 D0M9JU HIGHSTAT Investigative D0M9LJ DRUG__ID D0M9LJ D0M9LJ DRUGTYPE Small molecular drug D0M9LJ DRUGINCH 1S/C18H15N3O/c19-16-9-8-14(13-5-2-1-3-6-13)11-17(16)21-18(22)15-7-4-10-20-12-15/h1-12H,19H2,(H,21,22) D0M9LJ DRUGINKE RAJXTGVDLBIWMD-UHFFFAOYSA-N D0M9LJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CN=CC=C3 D0M9LJ HIGHSTAT Investigative D0M9LL DRUG__ID D0M9LL D0M9LL DRUGTYPE Small molecular drug D0M9LL DRUGINCH 1S/C18H33NO4/c1-2-3-4-11-14-17(19(22)23)15-12-9-7-5-6-8-10-13-16-18(20)21/h14H,2-13,15-16H2,1H3,(H,20,21)/b17-14+ D0M9LL DRUGINKE LCOAELZDXRYQHF-SAPNQHFASA-N D0M9LL DRUGSMIL CCCCCC=C(CCCCCCCCCCC(=O)O)[N+](=O)[O-] D0M9LL HIGHSTAT Investigative D0M9OF DRUG__ID D0M9OF D0M9OF DRUGTYPE Small molecular drug D0M9OF DRUGINCH 1S/C17H12N2O/c20-17-13(9-11-5-1-4-8-15(11)19-17)16-10-12-6-2-3-7-14(12)18-16/h1-10,18H,(H,19,20) D0M9OF DRUGINKE OSFGHYZLBDAJTP-UHFFFAOYSA-N D0M9OF DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)N2)C3=CC4=CC=CC=C4N3 D0M9OF HIGHSTAT Investigative D0M9OW DRUG__ID D0M9OW D0M9OW DRUGTYPE Small molecular drug D0M9OW DRUGINCH 1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/t13-,17-,18-,19+,23-/m1/s1 D0M9OW DRUGINKE QAQREVBBADEHPA-IEXPHMLFSA-N D0M9OW DRUGSMIL CCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D0M9OW HIGHSTAT Investigative D0M9QJ DRUG__ID D0M9QJ D0M9QJ DRUGTYPE Small molecular drug D0M9QJ DRUGINCH 1S/C20H31N3O2S2/c1-2-3-4-5-6-7-8-9-10-11-12-18-13-15-19(16-14-18)27(24,25)23-20-22-21-17-26-20/h13-17H,2-12H2,1H3,(H,22,23) D0M9QJ DRUGINKE BYWWNRBKPCPJMG-UHFFFAOYSA-N D0M9QJ DRUGSMIL CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)NC2=NN=CS2 D0M9QJ HIGHSTAT Investigative D0M9QM DRUG__ID D0M9QM D0M9QM DRUGTYPE Small molecular drug D0M9QM DRUGINCH 1S/C17H13N5/c18-16-14-15(12-7-3-1-4-8-12)21-22(17(14)20-11-19-16)13-9-5-2-6-10-13/h1-11H,(H2,18,19,20) D0M9QM DRUGINKE CGWOMXNQGSNOHL-UHFFFAOYSA-N D0M9QM DRUGSMIL C1=CC=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C4=CC=CC=C4 D0M9QM HIGHSTAT Investigative D0M9RF DRUG__ID D0M9RF D0M9RF DRUGTYPE Small molecular drug D0M9RF DRUGINCH 1S/C22H20N2O4/c1-5-14-10-15-19(11-18(14)28-13(3)25)27-12(2)20(21(15)26)22-23-16-8-6-7-9-17(16)24(22)4/h6-11H,5H2,1-4H3 D0M9RF DRUGINKE HTTVYKXJCQENKW-UHFFFAOYSA-N D0M9RF DRUGSMIL CCC1=CC2=C(C=C1OC(=O)C)OC(=C(C2=O)C3=NC4=CC=CC=C4N3C)C D0M9RF HIGHSTAT Investigative D0M9RL DRUG__ID D0M9RL D0M9RL DRUGTYPE Small molecular drug D0M9RL DRUGINCH 1S/C18H18O2/c1-3-5-14-6-4-7-17(12-14)16-10-8-15(9-11-16)13(2)18(19)20/h3-4,6-13H,1,5H2,2H3,(H,19,20) D0M9RL DRUGINKE NOUUHOHFFJKTMS-UHFFFAOYSA-N D0M9RL DRUGSMIL CC(C1=CC=C(C=C1)C2=CC=CC(=C2)CC=C)C(=O)O D0M9RL HIGHSTAT Investigative D0M9RM DRUG__ID D0M9RM D0M9RM DRUGTYPE Small molecular drug D0M9RM DRUGINCH 1S/C16H11N3O/c20-16-13-10-17-14-9-5-4-8-12(14)15(13)18-19(16)11-6-2-1-3-7-11/h1-10,18H D0M9RM DRUGINKE XTYGFVVANLMBHE-UHFFFAOYSA-N D0M9RM DRUGSMIL C1=CC=C(C=C1)N2C(=O)C3=C(N2)C4=CC=CC=C4N=C3 D0M9RM HIGHSTAT Investigative D0M9TM DRUG__ID D0M9TM D0M9TM DRUGTYPE Small molecular drug D0M9TM DRUGINCH 1S/C16H25N/c1-4-7-17-8-5-6-15(12-17)16-10-13(2)9-14(3)11-16/h9-11,15H,4-8,12H2,1-3H3 D0M9TM DRUGINKE AMPXVBOIQBSQML-UHFFFAOYSA-N D0M9TM DRUGSMIL CCCN1CCCC(C1)C2=CC(=CC(=C2)C)C D0M9TM HIGHSTAT Investigative D0M9TW DRUG__ID D0M9TW D0M9TW DRUGTYPE Small molecular drug D0M9TW DRUGINCH 1S/C16H10N4O/c17-8-10-4-6-11(7-5-10)14-9-19-13-3-1-2-12(16(18)21)15(13)20-14/h1-7,9H,(H2,18,21) D0M9TW DRUGINKE WCZAODKSIJSHQD-UHFFFAOYSA-N D0M9TW DRUGSMIL C1=CC(=C2C(=C1)N=CC(=N2)C3=CC=C(C=C3)C#N)C(=O)N D0M9TW HIGHSTAT Investigative D0M9UG DRUG__ID D0M9UG D0M9UG DRUGTYPE Small molecular drug D0M9UG DRUGINCH 1S/C37H45N5O6S2/c1-37(2)33(35(47)41-31-26-15-8-7-13-24(26)19-29(31)43)42(21-50-37)36(48)32(45)27(17-22-10-5-4-6-11-22)40-34(46)28(20-49-3)39-30(44)18-23-12-9-14-25(38)16-23/h4-16,27-29,31-33,43,45H,17-21,38H2,1-3H3,(H,39,44)(H,40,46)(H,41,47)/t27-,28-,29+,31-,32-,33+/m0/s1 D0M9UG DRUGINKE OSOTUWUUAVSXOF-ACUZRORGSA-N D0M9UG DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC(=CC=C3)N)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0M9UG HIGHSTAT Investigative D0M9VK DRUG__ID D0M9VK D0M9VK DRUGTYPE Small molecular drug D0M9VK DRUGINCH 1S/C14H12N2O/c1-17-14-5-3-11-8-13(4-2-12(11)9-14)16-7-6-15-10-16/h2-10H,1H3 D0M9VK DRUGINKE IARFMQDFBJWHDO-UHFFFAOYSA-N D0M9VK DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)N3C=CN=C3 D0M9VK HIGHSTAT Investigative D0M9VP DRUG__ID D0M9VP D0M9VP DRUGTYPE Small molecular drug D0M9VP DRUGINCH 1S/C3H8O3S/c4-1-3(5)2-7-6/h3-6H,1-2H2/t3-/m1/s1 D0M9VP DRUGINKE DLQCXFUWHQZWJQ-GSVOUGTGSA-N D0M9VP DRUGSMIL C(C(CSO)O)O D0M9VP HIGHSTAT Investigative D0M9VY DRUG__ID D0M9VY D0M9VY DRUGTYPE Small molecular drug D0M9VY DRUGINCH 1S/C31H48O6S.Na/c1-21(11-13-24-19-25(32)14-15-27(24)33)9-7-10-23(3)28(37-38(34,35)36)20-26-22(2)12-16-29-30(4,5)17-8-18-31(26,29)6;/h11-12,14-15,19,23,26,28-29,32-33H,7-10,13,16-18,20H2,1-6H3,(H,34,35,36);/q;+1/p-1/b21-11+;/t23-,26+,28-,29+,31-;/m1./s1 D0M9VY DRUGINKE MWESFEYZPAHLCJ-NHDYRKAGSA-M D0M9VY DRUGSMIL CC1=CCC2C(CCCC2(C1CC(C(C)CCCC(=CCC3=C(C=CC(=C3)O)O)C)OS(=O)(=O)[O-])C)(C)C.[Na+] D0M9VY HIGHSTAT Investigative D0M9YH DRUG__ID D0M9YH D0M9YH DRUGTYPE Small molecular drug D0M9YH DRUGINCH 1S/C9H9NO5/c10-5(9(14)15)1-4-2-7(12)8(13)3-6(4)11/h2-3,5,11H,1,10H2,(H,14,15)/t5-/m0/s1 D0M9YH DRUGINKE YWRFBISQAMHSIX-YFKPBYRVSA-N D0M9YH DRUGSMIL C1=C(C(=CC(=O)C1=O)O)CC(C(=O)O)N D0M9YH HIGHSTAT Investigative D0M9ZX DRUG__ID D0M9ZX D0M9ZX DRUGTYPE Small molecular drug D0M9ZX DRUGINCH 1S/C24H25ClN2O/c1-27(2)17-16-23(20-12-14-22(25)15-13-20)26-24(28)21-10-8-19(9-11-21)18-6-4-3-5-7-18/h3-15,23H,16-17H2,1-2H3,(H,26,28) D0M9ZX DRUGINKE JXJCJZNVWYQHIF-UHFFFAOYSA-N D0M9ZX DRUGSMIL CN(C)CCC(C1=CC=C(C=C1)Cl)NC(=O)C2=CC=C(C=C2)C3=CC=CC=C3 D0M9ZX HIGHSTAT Investigative D0MA3M DRUG__ID D0MA3M D0MA3M DRUGTYPE Small molecular drug D0MA3M DRUGINCH 1S/C23H22O6/c1-10(2)5-6-12-14(24)8-18-20(21(12)26)22(27)19-13-7-16(11(3)4)29-23(13)15(25)9-17(19)28-18/h5,8-9,16,24-26H,3,6-7H2,1-2,4H3 D0MA3M DRUGINKE SEGCUVJLNASWOR-UHFFFAOYSA-N D0MA3M DRUGSMIL CC(=CCC1=C(C2=C(C=C1O)OC3=C(C2=O)C4=C(C(=C3)O)OC(C4)C(=C)C)O)C D0MA3M HIGHSTAT Investigative D0MA8C DRUG__ID D0MA8C D0MA8C DRUGTYPE Small molecular drug D0MA8C DRUGINCH 1S/C25H28N4O2/c1-18-16-20(4-6-22(18)19-8-10-26-11-9-19)25(30)27-21-5-7-24(31-3)23(17-21)29-14-12-28(2)13-15-29/h4-11,16-17H,12-15H2,1-3H3,(H,27,30) D0MA8C DRUGINKE GNOXPYACARZYMW-UHFFFAOYSA-N D0MA8C DRUGSMIL CC1=C(C=CC(=C1)C(=O)NC2=CC(=C(C=C2)OC)N3CCN(CC3)C)C4=CC=NC=C4 D0MA8C HIGHSTAT Investigative D0MA8Q DRUG__ID D0MA8Q D0MA8Q DRUGTYPE Small molecular drug D0MA8Q DRUGINCH 1S/C21H25N/c1-2-4-18(5-3-1)19-9-6-17(7-10-19)8-11-21-16-22-14-12-20(21)13-15-22/h1-7,9-10,20-21H,8,11-16H2 D0MA8Q DRUGINKE DZTCLALNSKOSGM-UHFFFAOYSA-N D0MA8Q DRUGSMIL C1CN2CCC1C(C2)CCC3=CC=C(C=C3)C4=CC=CC=C4 D0MA8Q HIGHSTAT Investigative D0MA9G DRUG__ID D0MA9G D0MA9G DRUGTYPE Small molecular drug D0MA9G DRUGINCH 1S/C17H17N/c1-2-15-16-8-4-3-6-13(16)9-10-17(15)14-7-5-11-18-12-14/h3-8,11-12H,2,9-10H2,1H3 D0MA9G DRUGINKE ZKPVULIWDZEZIT-UHFFFAOYSA-N D0MA9G DRUGSMIL CCC1=C(CCC2=CC=CC=C21)C3=CN=CC=C3 D0MA9G HIGHSTAT Investigative D0MB3S DRUG__ID D0MB3S D0MB3S DRUGTYPE Small molecular drug D0MB3S DRUGINCH 1S/C13H13ClN2/c14-8-5-6-12-10(7-8)13(15)9-3-1-2-4-11(9)16-12/h5-7H,1-4H2,(H2,15,16) D0MB3S DRUGINKE PUKKYURTEBJMKJ-UHFFFAOYSA-N D0MB3S DRUGSMIL C1CCC2=NC3=C(C=C(C=C3)Cl)C(=C2C1)N D0MB3S HIGHSTAT Investigative D0MC2R DRUG__ID D0MC2R D0MC2R DRUGTYPE Small molecular drug D0MC2R DRUGINCH 1S/C27H25F3N2O/c28-19-5-3-18(4-6-19)27(33)2-1-14-31-15-13-26-24(17-31)23-16-21(30)9-12-25(23)32(26)22-10-7-20(29)8-11-22/h3-12,16,27,33H,1-2,13-15,17H2 D0MC2R DRUGINKE OYGDOCFZQVGFIP-UHFFFAOYSA-N D0MC2R DRUGSMIL C1CN(CC2=C1N(C3=C2C=C(C=C3)F)C4=CC=C(C=C4)F)CCCC(C5=CC=C(C=C5)F)O D0MC2R HIGHSTAT Investigative D0MC3K DRUG__ID D0MC3K D0MC3K DRUGTYPE Small molecular drug D0MC3K DRUGINCH 1S/C12H11NO3/c14-7-3-4-10-9(6-7)8-2-1-5-13-12(15)11(8)16-10/h3-4,6,14H,1-2,5H2,(H,13,15) D0MC3K DRUGINKE AACFPJSJOWQNBN-UHFFFAOYSA-N D0MC3K DRUGSMIL C1CC2=C(C(=O)NC1)OC3=C2C=C(C=C3)O D0MC3K HIGHSTAT Investigative D0MC3U DRUG__ID D0MC3U D0MC3U DRUGTYPE Small molecular drug D0MC3U DRUGINCH 1S/C38H60N2O2/c1-3-37(33-19-17-21-35(41)29-33)23-11-15-27-39(31-37)25-13-9-7-5-6-8-10-14-26-40-28-16-12-24-38(4-2,32-40)34-20-18-22-36(42)30-34/h17-22,29-30,41-42H,3-16,23-28,31-32H2,1-2H3/t37-,38-/m1/s1 D0MC3U DRUGINKE PCOSLLZEMYSIRZ-XPSQVAKYSA-N D0MC3U DRUGSMIL CCC1(CCCCN(C1)CCCCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0MC3U HIGHSTAT Investigative D0MC4U DRUG__ID D0MC4U D0MC4U DRUGTYPE Small molecular drug D0MC4U DRUGINCH 1S/C25H25N5O6/c1-28-23(34)25(29(2)24(28)35)18-17(21(33)19-15(20(18)32)11(5-7-26)10-27-19)16-12-6-8-30(3,4)13(12)9-14(31)22(16)36-25/h9-10H,5-8,26H2,1-4H3,(H-,27,31,32,33)/p+1/t25-/m1/s1 D0MC4U DRUGINKE UEKKREMMIOJMRO-RUZDIDTESA-O D0MC4U DRUGSMIL CN1C(=O)C2(C3=C(C4=C5CC[N+](C5=CC(=C4O2)O)(C)C)C(=O)C6=C(C3=O)C(=CN6)CCN)N(C1=O)C D0MC4U HIGHSTAT Investigative D0MC5H DRUG__ID D0MC5H D0MC5H DRUGTYPE Small molecular drug D0MC5H DRUGINCH 1S/C12H11ClO/c13-11-6-4-9(5-7-11)8-10-2-1-3-12(10)14/h4-8H,1-3H2/b10-8+ D0MC5H DRUGINKE WUMOJUUCPXEEQL-CSKARUKUSA-N D0MC5H DRUGSMIL C1CC(=CC2=CC=C(C=C2)Cl)C(=O)C1 D0MC5H HIGHSTAT Investigative D0MC5J DRUG__ID D0MC5J D0MC5J DRUGTYPE Small molecular drug D0MC5J DRUGINCH 1S/C142H224N40O39S/c1-16-75(10)113(179-108(191)66-156-120(201)102(63-109(192)193)173-135(216)104(67-183)176-119(200)88(146)62-84-65-153-70-157-84)139(220)174-101(58-80-28-18-17-19-29-80)133(214)182-114(79(14)186)140(221)175-103(64-110(194)195)132(213)178-106(69-185)136(217)172-100(61-83-39-45-87(189)46-40-83)131(212)177-105(68-184)134(215)164-93(34-27-54-155-142(151)152)126(207)170-98(59-81-35-41-85(187)42-36-81)129(210)163-92(33-26-53-154-141(149)150)124(205)161-89(30-20-23-50-143)122(203)165-94(47-48-107(147)190)127(208)166-95(49-55-222-15)121(202)159-78(13)118(199)180-111(73(6)7)137(218)167-91(32-22-25-52-145)123(204)162-90(31-21-24-51-144)125(206)171-99(60-82-37-43-86(188)44-38-82)130(211)169-97(57-72(4)5)128(209)160-76(11)116(197)158-77(12)117(198)181-112(74(8)9)138(219)168-96(115(148)196)56-71(2)3/h17-19,28-29,35-46,65,70-79,88-106,111-114,183-189H,16,20-27,30-34,47-64,66-69,143-146H2,1-15H3,(H2,147,190)(H2,148,196)(H,153,157)(H,156,201)(H,158,197)(H,159,202)(H,160,209)(H,161,205)(H,162,204)(H,163,210)(H,164,215)(H,165,203)(H,166,208)(H,167,218)(H,168,219)(H,169,211)(H,170,207)(H,171,206)(H,172,217)(H,173,216)(H,174,220)(H,175,221)(H,176,200)(H,177,212)(H,178,213)(H,179,191)(H,180,199)(H,181,198)(H,182,214)(H,192,193)(H,194,195)(H4,149,150,154)(H4,151,152,155) D0MC5J DRUGINKE RZGBUJXSKLDAFE-UHFFFAOYSA-N D0MC5J DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)N)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC5=CN=CN5)N D0MC5J HIGHSTAT Investigative D0MC9C DRUG__ID D0MC9C D0MC9C DRUGTYPE Small molecular drug D0MC9C DRUGINCH 1S/C18H33N3O5/c1-18(2,3)26-17(24)20-14(11-5-4-6-12-15(22)21-25)16(23)19-13-9-7-8-10-13/h13-14,25H,4-12H2,1-3H3,(H,19,23)(H,20,24)(H,21,22)/t14-/m0/s1 D0MC9C DRUGINKE YKINZQJOQFMNPU-AWEZNQCLSA-N D0MC9C DRUGSMIL CC(C)(C)OC(=O)NC(CCCCCC(=O)NO)C(=O)NC1CCCC1 D0MC9C HIGHSTAT Investigative D0MD4U DRUG__ID D0MD4U D0MD4U DRUGTYPE Small molecular drug D0MD4U DRUGINCH 1S/C10H20N2O4/c11-4-3-7(5-10(15)16)8(6-12)1-2-9(13)14/h7-8H,1-6,11-12H2,(H,13,14)(H,15,16)/t7-,8-/m1/s1 D0MD4U DRUGINKE QMRGRIXXWLVLTR-HTQZYQBOSA-N D0MD4U DRUGSMIL C(CC(=O)O)C(CN)C(CCN)CC(=O)O D0MD4U HIGHSTAT Investigative D0MD6D DRUG__ID D0MD6D D0MD6D DRUGTYPE Small molecular drug D0MD6D DRUGINCH 1S/C20H16N6/c21-11-17-24-19(22-12-15-7-3-1-4-8-15)18-20(25-17)26(14-23-18)13-16-9-5-2-6-10-16/h1-10,14H,12-13H2,(H,22,24,25) D0MD6D DRUGINKE VVLPZPSTQWLQHU-UHFFFAOYSA-N D0MD6D DRUGSMIL C1=CC=C(C=C1)CNC2=C3C(=NC(=N2)C#N)N(C=N3)CC4=CC=CC=C4 D0MD6D HIGHSTAT Investigative D0MD7H DRUG__ID D0MD7H D0MD7H DRUGTYPE Small molecular drug D0MD7H DRUGINCH 1S/C19H16N2O/c20-17-12-11-16(14-7-3-1-4-8-14)13-18(17)21-19(22)15-9-5-2-6-10-15/h1-13H,20H2,(H,21,22) D0MD7H DRUGINKE ZWLFHHHQRUYIBT-UHFFFAOYSA-N D0MD7H DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D0MD7H HIGHSTAT Investigative D0ME6Y DRUG__ID D0ME6Y D0ME6Y DRUGTYPE Small molecular drug D0ME6Y DRUGINCH 1S/C14H20N2O4/c1-20-12-8-6-11(7-9-12)14(18)15-10-4-2-3-5-13(17)16-19/h6-9,19H,2-5,10H2,1H3,(H,15,18)(H,16,17) D0ME6Y DRUGINKE ZSXRABTZDFXDGV-UHFFFAOYSA-N D0ME6Y DRUGSMIL COC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NO D0ME6Y HIGHSTAT Investigative D0ME8Z DRUG__ID D0ME8Z D0ME8Z DRUGTYPE Small molecular drug D0ME8Z DRUGINCH 1S/C15H13FN4O/c16-10-5-2-1-4-9(10)8-21-12-7-3-6-11-13(12)14(17)20-15(18)19-11/h1-7H,8H2,(H4,17,18,19,20) D0ME8Z DRUGINKE SFJOSBAEWKPKPY-UHFFFAOYSA-N D0ME8Z DRUGSMIL C1=CC=C(C(=C1)COC2=CC=CC3=C2C(=NC(=N3)N)N)F D0ME8Z HIGHSTAT Investigative D0ME9B DRUG__ID D0ME9B D0ME9B DRUGTYPE Small molecular drug D0ME9B DRUGINCH 1S/C21H26N8OS/c1-12-9-29-18(16-6-23-24-7-16)8-22-21(29)20(25-12)26-19-5-17(27-31-19)15(4)28-10-13(2)30-14(3)11-28/h5-9,13-15H,10-11H2,1-4H3,(H,23,24)(H,25,26)/t13-,14+,15-/m1/s1 D0ME9B DRUGINKE QBWKPGNFQQJGFY-QLFBSQMISA-N D0ME9B DRUGSMIL CC1CN(CC(O1)C)C(C)C2=NSC(=C2)NC3=NC(=CN4C3=NC=C4C5=CNN=C5)C D0ME9B HIGHSTAT Investigative D0MF1G DRUG__ID D0MF1G D0MF1G DRUGTYPE Small molecular drug D0MF1G DRUGINCH 1S/C20H14O4S/c21-18-12-19(20(22)17-8-4-3-7-16(17)18)25(23,24)15-10-9-13-5-1-2-6-14(13)11-15/h1-12,21-22H D0MF1G DRUGINKE NEXUTBMTXKQNMP-UHFFFAOYSA-N D0MF1G DRUGSMIL C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)C3=C(C4=CC=CC=C4C(=C3)O)O D0MF1G HIGHSTAT Investigative D0MF5Y DRUG__ID D0MF5Y D0MF5Y DRUGTYPE Small molecular drug D0MF5Y DRUGINCH 1S/C15H10O6/c16-8-2-3-9-12(6-8)21-15(14(20)13(9)19)7-1-4-10(17)11(18)5-7/h1-6,16-18,20H D0MF5Y DRUGINKE XHEFDIBZLJXQHF-UHFFFAOYSA-N D0MF5Y DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O D0MF5Y HIGHSTAT Investigative D0MG3U DRUG__ID D0MG3U D0MG3U DRUGTYPE Small molecular drug D0MG3U DRUGINCH 1S/C18H17FN4O2/c1-21-14(10-5-4-7-12-8-6-9-13(19)11-12)20-16-15(21)17(24)23(3)18(25)22(16)2/h4-11H,1-3H3/b7-4+,10-5+ D0MG3U DRUGINKE PAJAMQUTBUEFEH-HOZCHFDZSA-N D0MG3U DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC=CC3=CC(=CC=C3)F D0MG3U HIGHSTAT Investigative D0MG5N DRUG__ID D0MG5N D0MG5N DRUGTYPE Small molecular drug D0MG5N DRUGINCH 1S/C32H48O6/c1-10-11-22(17-25(34)35)27-29-32(15-14-20(4)5,18-23(31(27,8)9)13-12-19(2)3)28(36)26(30(37)38-29)24(33)16-21(6)7/h12,14,21-23,36H,10-11,13,15-18H2,1-9H3,(H,34,35) D0MG5N DRUGINKE MEQHOADCAUKYIE-UHFFFAOYSA-N D0MG5N DRUGSMIL CCCC(CC(=O)O)C1=C2C(CC(C1(C)C)CC=C(C)C)(C(=C(C(=O)O2)C(=O)CC(C)C)O)CC=C(C)C D0MG5N HIGHSTAT Investigative D0MG9O DRUG__ID D0MG9O D0MG9O DRUGTYPE Small molecular drug D0MG9O DRUGINCH 1S/C33H20O13/c34-21-6-2-14(7-22(21)35)1-4-16-9-27(40)29(32(42)44-16)18-11-24(37)23(36)8-15(18)3-5-17-10-28-30(33(43)45-17)19-12-25(38)26(39)13-20(19)31(41)46-28/h1-13,34-40H/b4-1+,5-3+ D0MG9O DRUGINKE ZNLSHKJBXWCRKW-CLLRDSTBSA-N D0MG9O DRUGSMIL C1=CC(=C(C=C1C=CC2=CC(=C(C(=O)O2)C3=CC(=C(C=C3C=CC4=CC5=C(C6=CC(=C(C=C6C(=O)O5)O)O)C(=O)O4)O)O)O)O)O D0MG9O HIGHSTAT Investigative D0MH0S DRUG__ID D0MH0S D0MH0S DRUGTYPE Small molecular drug D0MH0S DRUGINCH 1S/C10H14FN3/c1-13-5-7-14(8-6-13)10-9(11)3-2-4-12-10/h2-4H,5-8H2,1H3 D0MH0S DRUGINKE KZNJAAWCEFRAPW-UHFFFAOYSA-N D0MH0S DRUGSMIL CN1CCN(CC1)C2=C(C=CC=N2)F D0MH0S HIGHSTAT Investigative D0MH1K DRUG__ID D0MH1K D0MH1K DRUGTYPE Small molecular drug D0MH1K DRUGINCH 1S/C28H35N7O/c1-4-5-11-22-18-35(26-19(2)9-8-10-20(26)3)28(36)34(22)17-21-14-15-25(29-16-21)23-12-6-7-13-24(23)27-30-32-33-31-27/h6-7,12-16,18-20,26H,4-5,8-11,17H2,1-3H3,(H,30,31,32,33)/t19-,20+,26? D0MH1K DRUGINKE GBXQWPCVQAHRBS-NJEHHLDASA-N D0MH1K DRUGSMIL CCCCC1=CN(C(=O)N1CC2=CN=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C5C(CCCC5C)C D0MH1K HIGHSTAT Investigative D0MH1X DRUG__ID D0MH1X D0MH1X DRUGTYPE Small molecular drug D0MH1X DRUGINCH 1S/C17H19ClFN7O/c1-9(2)27-15-6-14(25-26-15)23-16-12(18)8-21-17(24-16)22-10(3)13-5-4-11(19)7-20-13/h4-10H,1-3H3,(H3,21,22,23,24,25,26) D0MH1X DRUGINKE LBVKEEFIPBQIMD-UHFFFAOYSA-N D0MH1X DRUGSMIL CC(C)OC1=NNC(=C1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=C3)F D0MH1X HIGHSTAT Investigative D0MH4R DRUG__ID D0MH4R D0MH4R DRUGTYPE Small molecular drug D0MH4R DRUGINCH 1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-8(3-4-16-10)13(12)15-2/h3-6H,1-2H3 D0MH4R DRUGINKE NZVQLVGOZRELTG-UHFFFAOYSA-N D0MH4R DRUGSMIL CC1=CC(=O)C2=C(O1)C=C3C(=C2OC)C=CO3 D0MH4R HIGHSTAT Investigative D0MH9X DRUG__ID D0MH9X D0MH9X DRUGTYPE Small molecular drug D0MH9X DRUGINCH 1S/C6H16O18P4/c7-1-3(21-25(9,10)11)2(8)5(23-27(15,16)17)6(24-28(18,19)20)4(1)22-26(12,13)14/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/t1-,2-,3?,4-,5+,6?/m0/s1 D0MH9X DRUGINKE CIPFCGZLFXVXBG-FTSGZOCFSA-N D0MH9X DRUGSMIL C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O)OP(=O)(O)O)O D0MH9X HIGHSTAT Investigative D0MI2W DRUG__ID D0MI2W D0MI2W DRUGTYPE Small molecular drug D0MI2W DRUGINCH 1S/C42H55N7O9S/c1-3-24(2)36-42(58)47-34(22-27-11-17-30(52)18-12-27)38(54)44-31(6-4-5-19-43)37(53)45-32(20-25-7-13-28(50)14-8-25)39(55)46-33(21-26-9-15-29(51)16-10-26)40(56)48-35(23-59)41(57)49-36/h7-18,24,31-36,50-52,59H,3-6,19-23,43H2,1-2H3,(H,44,54)(H,45,53)(H,46,55)(H,47,58)(H,48,56)(H,49,57)/t24-,31-,32-,33-,34-,35-,36-/m0/s1 D0MI2W DRUGINKE FFQZQESXYOBYDZ-AAWCNGQVSA-N D0MI2W DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CS)CC2=CC=C(C=C2)O)CC3=CC=C(C=C3)O)CCCCN)CC4=CC=C(C=C4)O D0MI2W HIGHSTAT Investigative D0MI5C DRUG__ID D0MI5C D0MI5C DRUGTYPE Small molecular drug D0MI5C DRUGINCH 1S/C23H17NO2/c25-20-10-4-8-17(12-20)22-14-19(16-6-2-1-3-7-16)15-23(24-22)18-9-5-11-21(26)13-18/h1-15,25-26H D0MI5C DRUGINKE DLUFNTXHXJNUFJ-UHFFFAOYSA-N D0MI5C DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0MI5C HIGHSTAT Investigative D0MJ1L DRUG__ID D0MJ1L D0MJ1L DRUGTYPE Small molecular drug D0MJ1L DRUGINCH 1S/C19H17NO3/c21-17-13-19(20-8-10-22-11-9-20)23-18-12-15(6-7-16(17)18)14-4-2-1-3-5-14/h1-7,12-13H,8-11H2 D0MJ1L DRUGINKE RWIGISKNQAMRJZ-UHFFFAOYSA-N D0MJ1L DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=C(C=C3)C4=CC=CC=C4 D0MJ1L HIGHSTAT Investigative D0MK6D DRUG__ID D0MK6D D0MK6D DRUGTYPE Small molecular drug D0MK6D DRUGINCH 1S/C13H13N3O/c17-13(10-4-2-1-3-5-10)14-12-8-11(15-16-12)9-6-7-9/h1-5,8-9H,6-7H2,(H2,14,15,16,17) D0MK6D DRUGINKE LUCORKWTQSQFFU-UHFFFAOYSA-N D0MK6D DRUGSMIL C1CC1C2=CC(=NN2)NC(=O)C3=CC=CC=C3 D0MK6D HIGHSTAT Investigative D0ML3S DRUG__ID D0ML3S D0ML3S DRUGTYPE Small molecular drug D0ML3S DRUGINCH 1S/C50H92N2O5S.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-49(53)51-46-43-44-48(58(55,56)57)47(45-46)52-50(54)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h43-45H,3-42H2,1-2H3,(H,51,53)(H,52,54)(H,55,56,57);/q;+1/p-1 D0ML3S DRUGINKE IXCBRSKAYDVLLF-UHFFFAOYSA-M D0ML3S DRUGSMIL CCCCCCCCCCCCCCCCCCCCCC(=O)NC1=CC(=C(C=C1)S(=O)(=O)[O-])NC(=O)CCCCCCCCCCCCCCCCCCCCC.[Na+] D0ML3S HIGHSTAT Investigative D0MM5G DRUG__ID D0MM5G D0MM5G DRUGTYPE Small molecular drug D0MM5G DRUGINCH 1S/C14H28O6P2/c1-12(2)8-7-10-13(3)9-5-4-6-11-14(21(15,16)17)22(18,19)20/h8-9,14H,4-7,10-11H2,1-3H3,(H2,15,16,17)(H2,18,19,20)/b13-9+ D0MM5G DRUGINKE JCYZSGYSCXRCHX-UKTHLTGXSA-N D0MM5G DRUGSMIL CC(=CCCC(=CCCCCC(P(=O)(O)O)P(=O)(O)O)C)C D0MM5G HIGHSTAT Investigative D0MM6L DRUG__ID D0MM6L D0MM6L DRUGTYPE Small molecular drug D0MM6L DRUGINCH 1S/C7H13NO4/c1-4(2)3-5(7(10)11)6(9)8-12/h4-5,12H,3H2,1-2H3,(H,8,9)(H,10,11) D0MM6L DRUGINKE CINIOMOBGSHXRK-UHFFFAOYSA-N D0MM6L DRUGSMIL CC(C)CC(C(=O)NO)C(=O)O D0MM6L HIGHSTAT Investigative D0MM7G DRUG__ID D0MM7G D0MM7G DRUGTYPE Small molecular drug D0MM7G DRUGINCH 1S/C17H14N2/c1-2-4-16-14(3-1)10-15-9-13(5-6-17(15)16)11-19-8-7-18-12-19/h1-9,12H,10-11H2 D0MM7G DRUGINKE OLHTVPMFDRPUTG-UHFFFAOYSA-N D0MM7G DRUGSMIL C1C2=CC=CC=C2C3=C1C=C(C=C3)CN4C=CN=C4 D0MM7G HIGHSTAT Investigative D0MM9P DRUG__ID D0MM9P D0MM9P DRUGTYPE Small molecular drug D0MM9P DRUGINCH 1S/C20H30O2/c1-3-12-11-18-17-6-4-13-10-14(21)5-7-15(13)16(17)8-9-20(18,2)19(12)22/h10,12,15-19,22H,3-9,11H2,1-2H3/t12-,15-,16+,17+,18-,19-,20-/m0/s1 D0MM9P DRUGINKE FCKLFGKATYPJPG-SSTBVEFVSA-N D0MM9P DRUGSMIL CCC1CC2C3CCC4=CC(=O)CCC4C3CCC2(C1O)C D0MM9P HIGHSTAT Investigative D0MN3X DRUG__ID D0MN3X D0MN3X DRUGTYPE Small molecular drug D0MN3X DRUGINCH 1S/C3H9O6P/c4-1-3(2-5)9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8) D0MN3X DRUGINKE DHCLVCXQIBBOPH-UHFFFAOYSA-N D0MN3X DRUGSMIL C(C(CO)OP(=O)(O)O)O D0MN3X HIGHSTAT Investigative D0MO1O DRUG__ID D0MO1O D0MO1O DRUGTYPE Small molecular drug D0MO1O DRUGINCH 1S/C13H16N2/c1-15(11-13-8-5-9-14-13)10-12-6-3-2-4-7-12/h2-9,14H,10-11H2,1H3 D0MO1O DRUGINKE XQZWJHDHWFGAPS-UHFFFAOYSA-N D0MO1O DRUGSMIL CN(CC1=CC=CC=C1)CC2=CC=CN2 D0MO1O HIGHSTAT Investigative D0MP7N DRUG__ID D0MP7N D0MP7N DRUGTYPE Small molecular drug D0MP7N DRUGINCH 1S/C16H15NO5/c18-10(4-8-15(21)22)3-6-13(19)11-5-7-14(20)16-12(11)2-1-9-17-16/h1-2,5,7,9,20H,3-4,6,8H2,(H,21,22) D0MP7N DRUGINKE SDIIGLWXEVMFDA-UHFFFAOYSA-N D0MP7N DRUGSMIL C1=CC2=C(C=CC(=C2N=C1)O)C(=O)CCC(=O)CCC(=O)O D0MP7N HIGHSTAT Investigative D0MP8E DRUG__ID D0MP8E D0MP8E DRUGTYPE Small molecular drug D0MP8E DRUGINCH 1S/C4H11N5S/c5-3(6)9-1-2-10-4(7)8/h1-2H2,(H3,7,8)(H4,5,6,9) D0MP8E DRUGINKE GSYGTVNTZHFQQH-UHFFFAOYSA-N D0MP8E DRUGSMIL C(CSC(=N)N)N=C(N)N D0MP8E HIGHSTAT Investigative D0MQ6K DRUG__ID D0MQ6K D0MQ6K DRUGTYPE Small molecular drug D0MQ6K DRUGINCH 1S/C22H22N4O3S/c23-21(24)18-7-3-4-15(12-18)14-26-11-10-20(22(26)27)25-30(28,29)19-9-8-16-5-1-2-6-17(16)13-19/h1-9,12-13,20,25H,10-11,14H2,(H3,23,24)/t20-/m0/s1 D0MQ6K DRUGINKE NTFWSCPFRKNWEI-FQEVSTJZSA-N D0MQ6K DRUGSMIL C1CN(C(=O)C1NS(=O)(=O)C2=CC3=CC=CC=C3C=C2)CC4=CC(=CC=C4)C(=N)N D0MQ6K HIGHSTAT Investigative D0MQ8A DRUG__ID D0MQ8A D0MQ8A DRUGTYPE Small molecular drug D0MQ8A DRUGINCH 1S/C15H19NO2/c1-3-5-11-15(4-2)13(17)16(14(15)18)12-9-7-6-8-10-12/h6-10H,3-5,11H2,1-2H3 D0MQ8A DRUGINKE OMJBWYRKWVXDDX-UHFFFAOYSA-N D0MQ8A DRUGSMIL CCCCC1(C(=O)N(C1=O)C2=CC=CC=C2)CC D0MQ8A HIGHSTAT Investigative D0MR0Z DRUG__ID D0MR0Z D0MR0Z DRUGTYPE Small molecular drug D0MR0Z DRUGINCH 1S/C14H21NO/c1-12-4-3-10-15(12)11-9-13-5-7-14(16-2)8-6-13/h5-8,12H,3-4,9-11H2,1-2H3/t12-/m1/s1 D0MR0Z DRUGINKE NPUSLESRSBDEHN-GFCCVEGCSA-N D0MR0Z DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)OC D0MR0Z HIGHSTAT Investigative D0MR1B DRUG__ID D0MR1B D0MR1B DRUGTYPE Small molecular drug D0MR1B DRUGINCH 1S/C28H25N3O3S2/c32-27(30-26(23-11-5-2-6-12-23)25-13-7-8-18-29-25)28-31(19-20-35-28)36(33,34)24-16-14-22(15-17-24)21-9-3-1-4-10-21/h1-18,26,28H,19-20H2,(H,30,32)/t26-,28+/m1/s1 D0MR1B DRUGINKE LSSZZFZFFKZTCL-IAPPQJPRSA-N D0MR1B DRUGSMIL C1CSC(N1S(=O)(=O)C2=CC=C(C=C2)C3=CC=CC=C3)C(=O)NC(C4=CC=CC=C4)C5=CC=CC=N5 D0MR1B HIGHSTAT Investigative D0MR1K DRUG__ID D0MR1K D0MR1K DRUGTYPE Small molecular drug D0MR1K DRUGINCH 1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1-,2+,3+,4-,5-,6-/m1/s1 D0MR1K DRUGINKE MMWCIQZXVOZEGG-XJTPDSDZSA-N D0MR1K DRUGSMIL C1(C(C(C(C(C1OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O)O)O D0MR1K HIGHSTAT Investigative D0MR1Z DRUG__ID D0MR1Z D0MR1Z DRUGTYPE Small molecular drug D0MR1Z DRUGINCH 1S/C18H20N2O3/c1-2-3-13-22-17-11-9-16(10-12-17)20-18(21)23-19-14-15-7-5-4-6-8-15/h4-12,14H,2-3,13H2,1H3,(H,20,21)/b19-14+ D0MR1Z DRUGINKE BRPRTDQSLVFYMR-XMHGGMMESA-N D0MR1Z DRUGSMIL CCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D0MR1Z HIGHSTAT Investigative D0MR4N DRUG__ID D0MR4N D0MR4N DRUGTYPE Small molecular drug D0MR4N DRUGINCH 1S/C16H21N3S2/c1-2-3-9-14-12-21-16(18-14)19-15(20)17-11-10-13-7-5-4-6-8-13/h4-8,12H,2-3,9-11H2,1H3,(H2,17,18,19,20) D0MR4N DRUGINKE SXKJLZJKVYKNHV-UHFFFAOYSA-N D0MR4N DRUGSMIL CCCCC1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2 D0MR4N HIGHSTAT Investigative D0MS3D DRUG__ID D0MS3D D0MS3D DRUGTYPE Small molecular drug D0MS3D DRUGINCH 1S/C20H30O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,12,14-17,21H,2-3,5-6,8-11,13H2,1H3,(H,23,24)/b7-4-,18-14+/t16-,17-/m0/s1 D0MS3D DRUGINKE TUXFWOHFPFBNEJ-GJGHEGAFSA-N D0MS3D DRUGSMIL CCCCCC(CC=C1C(C=CC1=O)CC=CCCCC(=O)O)O D0MS3D HIGHSTAT Investigative D0MS3V DRUG__ID D0MS3V D0MS3V DRUGTYPE Small molecular drug D0MS3V DRUGINCH 1S/C16H19NS/c1-17(2)11-12-18-16-10-6-9-15(13-16)14-7-4-3-5-8-14/h3-10,13H,11-12H2,1-2H3 D0MS3V DRUGINKE NDJKJLMJAGRKRK-UHFFFAOYSA-N D0MS3V DRUGSMIL CN(C)CCSC1=CC=CC(=C1)C2=CC=CC=C2 D0MS3V HIGHSTAT Investigative D0MS4Z DRUG__ID D0MS4Z D0MS4Z DRUGTYPE Small molecular drug D0MS4Z DRUGINCH 1S/C19H31NO2/c1-5-6-7-8-15-22-17-11-9-16(10-12-17)18(21)20-14-13-19(2,3)4/h9-12H,5-8,13-15H2,1-4H3,(H,20,21) D0MS4Z DRUGINKE JPQPUSQXWSSOFH-UHFFFAOYSA-N D0MS4Z DRUGSMIL CCCCCCOC1=CC=C(C=C1)C(=O)NCCC(C)(C)C D0MS4Z HIGHSTAT Investigative D0MS8T DRUG__ID D0MS8T D0MS8T DRUGTYPE Small molecular drug D0MS8T DRUGINCH 1S/C21H20N2O3/c24-20(17-11-16(17)13-6-2-1-3-7-13)23-19(21(25)26)10-14-12-22-18-9-5-4-8-15(14)18/h1-9,12,16-17,19,22H,10-11H2,(H,23,24)(H,25,26)/t16?,17?,19-/m0/s1 D0MS8T DRUGINKE DRPGADQFIJJWNZ-TVPLGVNVSA-N D0MS8T DRUGSMIL C1C(C1C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)O)C4=CC=CC=C4 D0MS8T HIGHSTAT Investigative D0MT1N DRUG__ID D0MT1N D0MT1N DRUGTYPE Small molecular drug D0MT1N DRUGINCH 1S/C19H21NO2/c1-3-20-7-6-13-8-11(2)9-14-17(13)15(20)10-12-4-5-16(21)19(22)18(12)14/h4-5,8-9,15,21-22H,3,6-7,10H2,1-2H3/t15-/m1/s1 D0MT1N DRUGINKE VNGYREUWVHTKAV-OAHLLOKOSA-N D0MT1N DRUGSMIL CCN1CCC2=C3C1CC4=C(C3=CC(=C2)C)C(=C(C=C4)O)O D0MT1N HIGHSTAT Investigative D0MT5K DRUG__ID D0MT5K D0MT5K DRUGTYPE Small molecular drug D0MT5K DRUGINCH 1S/C29H40N2O8/c1-18(2)8-13-22-28(3,39-22)26-25(36-4)21(14-15-29(26)17-37-29)38-27(35)30-16-19-9-11-20(12-10-19)31-23(32)6-5-7-24(33)34/h8-12,21-22,25-26H,5-7,13-17H2,1-4H3,(H,30,35)(H,31,32)(H,33,34)/t21-,22-,25-,26-,28+,29+/m1/s1 D0MT5K DRUGINKE HRLDHINFRLTOEQ-UZHVHHFFSA-N D0MT5K DRUGSMIL CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)NCC4=CC=C(C=C4)NC(=O)CCCC(=O)O)OC)C D0MT5K HIGHSTAT Investigative D0MU1V DRUG__ID D0MU1V D0MU1V DRUGTYPE Small molecular drug D0MU1V DRUGINCH 1S/C16H17ClN2O2/c1-21-15-8-2-12(3-9-15)10-11-18-16(20)19-14-6-4-13(17)5-7-14/h2-9H,10-11H2,1H3,(H2,18,19,20) D0MU1V DRUGINKE OVFMMJNKICPJJH-UHFFFAOYSA-N D0MU1V DRUGSMIL COC1=CC=C(C=C1)CCNC(=O)NC2=CC=C(C=C2)Cl D0MU1V HIGHSTAT Investigative D0MU4A DRUG__ID D0MU4A D0MU4A DRUGTYPE Small molecular drug D0MU4A DRUGINCH 1S/C22H25N3O3/c26-21-22(25(16-23-21)17-6-2-1-3-7-17)10-12-24(13-11-22)14-18-15-27-19-8-4-5-9-20(19)28-18/h1-9,18H,10-16H2,(H,23,26) D0MU4A DRUGINKE JVGBTTIJPBFLTE-UHFFFAOYSA-N D0MU4A DRUGSMIL C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CC4COC5=CC=CC=C5O4 D0MU4A HIGHSTAT Investigative D0MU7C DRUG__ID D0MU7C D0MU7C DRUGTYPE Small molecular drug D0MU7C DRUGINCH 1S/C22H28FO6P/c1-13(2)18-7-14(3)8-19(16-5-6-21(23)15(4)9-16)20(18)11-29-30(27,28)12-17(24)10-22(25)26/h5-9,13,17,24H,10-12H2,1-4H3,(H,25,26)(H,27,28)/t17-/m0/s1 D0MU7C DRUGINKE WHQUHTXULUACFD-KRWDZBQOSA-N D0MU7C DRUGSMIL CC1=CC(=C(C(=C1)C(C)C)COP(=O)(CC(CC(=O)O)O)O)C2=CC(=C(C=C2)F)C D0MU7C HIGHSTAT Investigative D0MV0T DRUG__ID D0MV0T D0MV0T DRUGTYPE Small molecular drug D0MV0T DRUGINCH 1S/C11H11N3/c12-11-8-4-1-2-5-9(8)13-10-6-3-7-14(10)11/h1-2,4-5,12H,3,6-7H2 D0MV0T DRUGINKE AOSPPBURKIEYRC-UHFFFAOYSA-N D0MV0T DRUGSMIL C1CC2=NC3=CC=CC=C3C(=N)N2C1 D0MV0T HIGHSTAT Investigative D0MV0W DRUG__ID D0MV0W D0MV0W DRUGTYPE Small molecular drug D0MV0W DRUGINCH 1S/C16H11ClN2O4S/c1-22-13-4-2-8(6-11(13)17)12-5-3-9(23-12)7-10-14(20)18-16(24)19-15(10)21/h2-7H,1H3,(H2,18,19,20,21,24) D0MV0W DRUGINKE PKLIDAWVQNGMRD-UHFFFAOYSA-N D0MV0W DRUGSMIL COC1=C(C=C(C=C1)C2=CC=C(O2)C=C3C(=O)NC(=S)NC3=O)Cl D0MV0W HIGHSTAT Investigative D0MW5Z DRUG__ID D0MW5Z D0MW5Z DRUGTYPE Small molecular drug D0MW5Z DRUGINCH 1S/C14H10F3N/c1-8-2-4-10-11-7-9(14(15,16)17)3-5-12(11)18-13(10)6-8/h2-7,18H,1H3 D0MW5Z DRUGINKE QYXUJSGMFDAAAV-UHFFFAOYSA-N D0MW5Z DRUGSMIL CC1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)C(F)(F)F D0MW5Z HIGHSTAT Investigative D0MW7H DRUG__ID D0MW7H D0MW7H DRUGTYPE Small molecular drug D0MW7H DRUGINCH 1S/C8H12N4O/c9-8-11-7(13-12-8)5-3-4-1-2-6(5)10-4/h4-6,10H,1-3H2,(H2,9,12)/t4-,5-,6+/m1/s1 D0MW7H DRUGINKE XODBGPCGVOHHEP-PBXRRBTRSA-N D0MW7H DRUGSMIL C1CC2C(CC1N2)C3=NC(=NO3)N D0MW7H HIGHSTAT Investigative D0MX0Z DRUG__ID D0MX0Z D0MX0Z DRUGTYPE Small molecular drug D0MX0Z DRUGINCH 1S/C13H19NO/c1-11-5-4-9-14(11)10-8-12-6-2-3-7-13(12)15/h2-3,6-7,11,15H,4-5,8-10H2,1H3/t11-/m1/s1 D0MX0Z DRUGINKE XLLMSPMZEFQVLD-LLVKDONJSA-N D0MX0Z DRUGSMIL CC1CCCN1CCC2=CC=CC=C2O D0MX0Z HIGHSTAT Investigative D0MX1T DRUG__ID D0MX1T D0MX1T DRUGTYPE Small molecular drug D0MX1T DRUGINCH 1S/C11H15N/c1-12-11-8-4-6-9-5-2-3-7-10(9)11/h2-3,5,7,11-12H,4,6,8H2,1H3 D0MX1T DRUGINKE JQEUPNKUYMHYPW-UHFFFAOYSA-N D0MX1T DRUGSMIL CNC1CCCC2=CC=CC=C12 D0MX1T HIGHSTAT Investigative D0MY0E DRUG__ID D0MY0E D0MY0E DRUGTYPE Small molecular drug D0MY0E DRUGINCH 1S/C123H212N44O35S/c1-18-63(12)96(164-114(196)80(46-62(10)11)163-119(201)97(67(16)170)165-102(184)69(124)35-41-203-17)118(200)143-50-91(175)146-64(13)99(181)147-65(14)101(183)157-81(47-68-49-136-57-145-68)113(195)162-82(48-90(128)174)105(187)141-52-93(177)150-83(55-168)115(197)148-66(15)100(182)153-74(30-33-88(126)172)108(190)160-79(45-61(8)9)112(194)161-78(44-60(6)7)111(193)155-72(26-21-38-139-123(134)135)106(188)156-75(31-34-89(127)173)109(191)159-77(43-59(4)5)110(192)154-71(25-20-37-138-122(132)133)103(185)140-51-92(176)149-73(29-32-87(125)171)107(189)158-76(42-58(2)3)104(186)144-54-95(179)166-39-23-28-86(166)120(202)167-40-22-27-85(167)117(199)142-53-94(178)151-84(56-169)116(198)152-70(98(129)180)24-19-36-137-121(130)131/h49,57-67,69-86,96-97,168-170H,18-48,50-56,124H2,1-17H3,(H2,125,171)(H2,126,172)(H2,127,173)(H2,128,174)(H2,129,180)(H,136,145)(H,140,185)(H,141,187)(H,142,199)(H,143,200)(H,144,186)(H,146,175)(H,147,181)(H,148,197)(H,149,176)(H,150,177)(H,151,178)(H,152,198)(H,153,182)(H,154,192)(H,155,193)(H,156,188)(H,157,183)(H,158,189)(H,159,191)(H,160,190)(H,161,194)(H,162,195)(H,163,201)(H,164,196)(H,165,184)(H4,130,131,137)(H4,132,133,138)(H4,134,135,139)/t63-,64-,65-,66-,67+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,96-,97-/m0/s1 D0MY0E DRUGINKE OHOWSYIKESXDMN-WMQZXSDYSA-N D0MY0E DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C)C(=O)NC(C)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)N2CCCC2C(=O)N3CCCC3C(=O)NCC(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CCSC)N D0MY0E HIGHSTAT Investigative D0MY0M DRUG__ID D0MY0M D0MY0M DRUGTYPE Small molecular drug D0MY0M DRUGINCH 1S/C20H22O6/c1-6-10(2)18(22)25-15-9-20(5)16(21)8-13(26-20)11(3)7-14-17(15)12(4)19(23)24-14/h6-8,14-15,17H,4,9H2,1-3,5H3/b10-6-,11-7-/t14-,15-,17+,20-/m1/s1 D0MY0M DRUGINKE QATUWZPYBIHFFR-JWHLFBEVSA-N D0MY0M DRUGSMIL CC=C(C)C(=O)OC1CC2(C(=O)C=C(O2)C(=CC3C1C(=C)C(=O)O3)C)C D0MY0M HIGHSTAT Investigative D0MY0R DRUG__ID D0MY0R D0MY0R DRUGTYPE Small molecular drug D0MY0R DRUGINCH 1S/C7H9ClN4O6P2/c8-6-5-7(10-2-9-6)12(3-11-5)1-4(19(13,14)15)20(16,17)18/h2-4H,1H2,(H2,13,14,15)(H2,16,17,18) D0MY0R DRUGINKE SCQIYVIHMOWGRK-UHFFFAOYSA-N D0MY0R DRUGSMIL C1=NC2=C(C(=N1)Cl)N=CN2CC(P(=O)(O)O)P(=O)(O)O D0MY0R HIGHSTAT Investigative D0MY1A DRUG__ID D0MY1A D0MY1A DRUGTYPE Small molecular drug D0MY1A DRUGINCH 1S/C6H5.Hg/c1-2-4-6-5-3-1;/h1-5H; D0MY1A DRUGINKE DCNLOVYDMCVNRZ-UHFFFAOYSA-N D0MY1A DRUGSMIL C1=CC=C(C=C1)[Hg] D0MY1A HIGHSTAT Investigative D0MY2Y DRUG__ID D0MY2Y D0MY2Y DRUGTYPE Small molecular drug D0MY2Y DRUGINCH 1S/C28H50N2O2/c1-3-7-15-25-17-21-30-20-10-14-24(28(30)31-25)12-6-2-4-8-16-26-18-22-29-19-9-13-23(11-5-1)27(29)32-26/h23-28H,1-22H2/t23-,24+,25-,26-,27+,28+/m0/s1 D0MY2Y DRUGINKE PQYOPBRFUUEHRC-MUJQFDPKSA-N D0MY2Y DRUGSMIL C1CCCC2CCN3CCCC(C3O2)CCCCCCC4CCN5CCCC(C5O4)CC1 D0MY2Y HIGHSTAT Investigative D0MY8V DRUG__ID D0MY8V D0MY8V DRUGTYPE Small molecular drug D0MY8V DRUGINCH 1S/C16H10F2O2/c17-14-7-12(8-15(18)16(14)20)10-1-2-11-6-13(19)4-3-9(11)5-10/h1-8,19-20H D0MY8V DRUGINKE DZGRIHNLLUZLTL-UHFFFAOYSA-N D0MY8V DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C(=C3)F)O)F D0MY8V HIGHSTAT Investigative D0MZ2A DRUG__ID D0MZ2A D0MZ2A DRUGTYPE Small molecular drug D0MZ2A DRUGINCH 1S/C50H67N11O11S2/c1-26(62)39(42(53)65)59-49(72)41-50(3,4)74-73-25-38(58-43(66)33(52)21-28-11-6-5-7-12-28)47(70)56-36(22-29-16-18-31(64)19-17-29)45(68)57-37(23-30-24-54-34-14-9-8-13-32(30)34)46(69)55-35(15-10-20-51)44(67)60-40(27(2)63)48(71)61-41/h5-9,11-14,16-19,24,26-27,33,35-41,54,62-64H,10,15,20-23,25,51-52H2,1-4H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,68)(H,58,66)(H,59,72)(H,60,67)(H,61,71) D0MZ2A DRUGINKE PZWWYAHWHHNCHO-UHFFFAOYSA-N D0MZ2A DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0MZ2A HIGHSTAT Investigative D0MZ7C DRUG__ID D0MZ7C D0MZ7C DRUGTYPE Small molecular drug D0MZ7C DRUGINCH 1S/C15H20O2/c1-13(2)5-10-4-11(7-16)15(9-17)8-14(15,3)12(10)6-13/h4,7,9-10,12H,5-6,8H2,1-3H3/t10-,12+,14-,15-/m1/s1 D0MZ7C DRUGINKE PJAAESPGJOSQGZ-DZGBDDFRSA-N D0MZ7C DRUGSMIL CC1(CC2C=C(C3(CC3(C2C1)C)C=O)C=O)C D0MZ7C HIGHSTAT Investigative D0MZ9D DRUG__ID D0MZ9D D0MZ9D DRUGTYPE Small molecular drug D0MZ9D DRUGINCH 1S/C9H12O3/c1-2-6(10)9-7(11)4-3-5-8(9)12/h9H,2-5H2,1H3 D0MZ9D DRUGINKE DVLHCJHTXAHANV-UHFFFAOYSA-N D0MZ9D DRUGSMIL CCC(=O)C1C(=O)CCCC1=O D0MZ9D HIGHSTAT Investigative D0MZ9Q DRUG__ID D0MZ9Q D0MZ9Q DRUGTYPE Small molecular drug D0MZ9Q DRUGINCH 1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13?,14-,15+,16?,17?,18?,19+,20-,22?,23?,24?/m0/s1 D0MZ9Q DRUGINKE BHQCQFFYRZLCQQ-UMZBRFQRSA-N D0MZ9Q DRUGSMIL CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C D0MZ9Q HIGHSTAT Investigative D0N0BN DRUG__ID D0N0BN D0N0BN DRUGTYPE Small molecular drug D0N0BN DRUGINCH 1S/C19H40NO3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-20-18-14-15-19(17-18)24(21,22)23/h18-20H,2-17H2,1H3,(H2,21,22,23) D0N0BN DRUGINKE MVIUMKOQNNKAJB-UHFFFAOYSA-N D0N0BN DRUGSMIL CCCCCCCCCCCCCCNC1CCC(C1)P(=O)(O)O D0N0BN HIGHSTAT Investigative D0N0ED DRUG__ID D0N0ED D0N0ED DRUGTYPE Small molecular drug D0N0ED DRUGINCH 1S/C44H54FN5O4/c1-54-44(53)48-29-35(26-32-25-34-15-8-9-17-40(34)47-28-32)37-27-31(20-23-38(37)45)12-5-2-4-11-30-18-21-36(22-19-30)49-42(51)41(33-13-6-3-7-14-33)50-24-10-16-39(46)43(50)52/h8-9,15,17-23,25,27-28,33,35,39,41H,2-7,10-14,16,24,26,29,46H2,1H3,(H,48,53)(H,49,51)/t35-,39+,41+/m1/s1 D0N0ED DRUGINKE SDVPSGCYRLUZSS-WXSHXSFMSA-N D0N0ED DRUGSMIL COC(=O)NCC(CC1=CC2=CC=CC=C2N=C1)C3=C(C=CC(=C3)CCCCCC4=CC=C(C=C4)NC(=O)C(C5CCCCC5)N6CCCC(C6=O)N)F D0N0ED HIGHSTAT Investigative D0N0FX DRUG__ID D0N0FX D0N0FX DRUGTYPE Small molecular drug D0N0FX DRUGINCH 1S/C13H18O3S2/c1-16-10-5-7-12(8-6-10)18(14,15)13-4-2-3-11(17)9-13/h5-8,11,13,17H,2-4,9H2,1H3 D0N0FX DRUGINKE CTONTIQKTODDRQ-UHFFFAOYSA-N D0N0FX DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)C2CCCC(C2)S D0N0FX HIGHSTAT Investigative D0N0GE DRUG__ID D0N0GE D0N0GE DRUGTYPE Small molecular drug D0N0GE DRUGINCH 1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1 D0N0GE DRUGINKE AYFVYJQAPQTCCC-GBXIJSLDSA-N D0N0GE DRUGSMIL CC(C(C(=O)O)N)O D0N0GE HIGHSTAT Investigative D0N0GJ DRUG__ID D0N0GJ D0N0GJ DRUGTYPE Small molecular drug D0N0GJ DRUGINCH 1S/C12H8I.ClH/c1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11;/h1-8H;1H/q+1;/p-1 D0N0GJ DRUGINKE FCFZKAVCDNTYID-UHFFFAOYSA-M D0N0GJ DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3[I+]2.[Cl-] D0N0GJ HIGHSTAT Investigative D0N0GT DRUG__ID D0N0GT D0N0GT DRUGTYPE Small molecular drug D0N0GT DRUGINCH 1S/C18H21NO/c1-3-8-15(9-4-1)14-20-17-12-7-13-19-18(17)16-10-5-2-6-11-16/h1-6,8-11,17-19H,7,12-14H2/t17-,18-/m0/s1 D0N0GT DRUGINKE VPMJRXBIGDTSRT-ROUUACIJSA-N D0N0GT DRUGSMIL C1CC(C(NC1)C2=CC=CC=C2)OCC3=CC=CC=C3 D0N0GT HIGHSTAT Investigative D0N0GX DRUG__ID D0N0GX D0N0GX DRUGTYPE Small molecular drug D0N0GX DRUGINCH 1S/C12H11NO2S2/c13-17(14,15)12-5-3-10(4-6-12)1-2-11-7-8-16-9-11/h1-9H,(H2,13,14,15)/b2-1+ D0N0GX DRUGINKE JQHQATMSMAURMY-OWOJBTEDSA-N D0N0GX DRUGSMIL C1=CC(=CC=C1C=CC2=CSC=C2)S(=O)(=O)N D0N0GX HIGHSTAT Investigative D0N0HK DRUG__ID D0N0HK D0N0HK DRUGTYPE Small molecular drug D0N0HK DRUGINCH 1S/C6Cl4O2/c7-1-2(8)4(10)6(12)5(11)3(1)9 D0N0HK DRUGINKE VRGCYEIGVVTZCC-UHFFFAOYSA-N D0N0HK DRUGSMIL C1(=C(C(=O)C(=O)C(=C1Cl)Cl)Cl)Cl D0N0HK HIGHSTAT Investigative D0N0IC DRUG__ID D0N0IC D0N0IC DRUGTYPE Small molecular drug D0N0IC DRUGINCH 1S/C14H10Cl2N2O4/c1-22-13-3-2-8(4-12(13)18(20)21)14(19)17-11-6-9(15)5-10(16)7-11/h2-7H,1H3,(H,17,19) D0N0IC DRUGINKE BDZYJQMEFCDSIR-UHFFFAOYSA-N D0N0IC DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)[N+](=O)[O-] D0N0IC HIGHSTAT Investigative D0N0IV DRUG__ID D0N0IV D0N0IV DRUGTYPE Small molecular drug D0N0IV DRUGINCH 1S/C22H28O5/c1-13-14(2)22(16-8-10-18(24-4)20(12-16)26-6)27-21(13)15-7-9-17(23-3)19(11-15)25-5/h7-14,21-22H,1-6H3/t13-,14-,21-,22+/m0/s1 D0N0IV DRUGINKE JLJAVUZBHSLLJL-GKHNXXNSSA-N D0N0IV DRUGSMIL CC1C(C(OC1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C D0N0IV HIGHSTAT Investigative D0N0JC DRUG__ID D0N0JC D0N0JC DRUGTYPE Small molecular drug D0N0JC DRUGINCH 1S/C22H26ClNO/c1-17-16-24(13-6-8-18-7-3-4-11-21(18)23)14-12-22(17,2)19-9-5-10-20(25)15-19/h3-11,15,17,25H,12-14,16H2,1-2H3/b8-6+/t17-,22+/m0/s1 D0N0JC DRUGINKE RRGWRLNJBLFYOG-KISUKSLOSA-N D0N0JC DRUGSMIL CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC=CC3=CC=CC=C3Cl D0N0JC HIGHSTAT Investigative D0N0JL DRUG__ID D0N0JL D0N0JL DRUGTYPE Small molecular drug D0N0JL DRUGINCH 1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6) D0N0JL DRUGINKE XPPKVPWEQAFLFU-UHFFFAOYSA-N D0N0JL DRUGSMIL OP(=O)(O)OP(=O)(O)O D0N0JL HIGHSTAT Investigative D0N0LN DRUG__ID D0N0LN D0N0LN DRUGTYPE Small molecular drug D0N0LN DRUGINCH 1S/C35H35FN6O3/c1-39-12-14-41(15-13-39)26-8-9-32(37-19-26)38-30-18-25(20-40(2)34(30)44)27-4-3-5-31(28(27)21-43)42-11-10-23-16-24(22-6-7-22)17-29(36)33(23)35(42)45/h3-5,8-11,16-20,22,43H,6-7,12-15,21H2,1-2H3,(H,37,38) D0N0LN DRUGINKE ZTUJNJAKTLHBEX-UHFFFAOYSA-N D0N0LN DRUGSMIL CN1CCN(CC1)C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=CC=C4)N5C=CC6=CC(=CC(=C6C5=O)F)C7CC7)CO D0N0LN HIGHSTAT Investigative D0N0LZ DRUG__ID D0N0LZ D0N0LZ DRUGTYPE Small molecular drug D0N0LZ DRUGINCH 1S/C14H15N/c1-2-6-13-11(4-1)5-3-7-14(13)12-8-9-15-10-12/h1-7,12,15H,8-10H2 D0N0LZ DRUGINKE KTMCVZGLGDBGJZ-UHFFFAOYSA-N D0N0LZ DRUGSMIL C1CNCC1C2=CC=CC3=CC=CC=C32 D0N0LZ HIGHSTAT Investigative D0N0ME DRUG__ID D0N0ME D0N0ME DRUGTYPE Small molecular drug D0N0ME DRUGINCH 1S/C22H29N3O/c1-2-3-14-23-22(26)25-17-15-24(16-18-25)21(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21H,2-3,14-18H2,1H3,(H,23,26) D0N0ME DRUGINKE QRGYLEAVFDZUPV-UHFFFAOYSA-N D0N0ME DRUGSMIL CCCCNC(=O)N1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3 D0N0ME HIGHSTAT Investigative D0N0NJ DRUG__ID D0N0NJ D0N0NJ DRUGTYPE Small molecular drug D0N0NJ DRUGINCH 1S/C13H16N2O4/c14-13(12(18)19)6-10(11(16)17)15(8-13)7-9-4-2-1-3-5-9/h1-5,10H,6-8,14H2,(H,16,17)(H,18,19)/t10-,13-/m1/s1 D0N0NJ DRUGINKE LYCSUAGKQMUTBR-ZWNOBZJWSA-N D0N0NJ DRUGSMIL C1C(N(CC1(C(=O)O)N)CC2=CC=CC=C2)C(=O)O D0N0NJ HIGHSTAT Investigative D0N0OE DRUG__ID D0N0OE D0N0OE DRUGTYPE Small molecular drug D0N0OE DRUGINCH 1S/C26H44N4O6/c1-4-5-6-7-8-9-10-11-12-14-33-16-18-35-20-21-36-19-17-34-15-13-30-22-27-24-23(30)25(31)29(3)26(32)28(24)2/h4,22H,1,5-21H2,2-3H3 D0N0OE DRUGINKE VWEZUVSKUQSAQQ-UHFFFAOYSA-N D0N0OE DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCOCCOCCOCCOCCCCCCCCCC=C D0N0OE HIGHSTAT Investigative D0N0OY DRUG__ID D0N0OY D0N0OY DRUGTYPE Small molecular drug D0N0OY DRUGINCH 1S/C13H9NO3/c15-9-3-1-8(2-4-9)13-14-11-7-10(16)5-6-12(11)17-13/h1-7,15-16H D0N0OY DRUGINKE DPAMLAKLEWYMGF-UHFFFAOYSA-N D0N0OY DRUGSMIL C1=CC(=CC=C1C2=NC3=C(O2)C=CC(=C3)O)O D0N0OY HIGHSTAT Investigative D0N0PI DRUG__ID D0N0PI D0N0PI DRUGTYPE Small molecular drug D0N0PI DRUGINCH 1S/C10H8O3S/c11-14(12,13)10-6-5-8-3-1-2-4-9(8)7-10/h1-7H,(H,11,12,13) D0N0PI DRUGINKE KVBGVZZKJNLNJU-UHFFFAOYSA-N D0N0PI DRUGSMIL C1=CC=C2C=C(C=CC2=C1)S(=O)(=O)O D0N0PI HIGHSTAT Investigative D0N0SN DRUG__ID D0N0SN D0N0SN DRUGTYPE Small molecular drug D0N0SN DRUGINCH 1S/C24H35N3O5/c1-4-31-24(30)21-9-10-23(29)27(21)17-19(28)11-12-25-13-15-26(16-14-25)20-7-5-6-8-22(20)32-18(2)3/h5-8,18,21H,4,9-17H2,1-3H3 D0N0SN DRUGINKE WOLMQTMNCPQASG-UHFFFAOYSA-N D0N0SN DRUGSMIL CCOC(=O)C1CCC(=O)N1CC(=O)CCN2CCN(CC2)C3=CC=CC=C3OC(C)C D0N0SN HIGHSTAT Investigative D0N0TQ DRUG__ID D0N0TQ D0N0TQ DRUGTYPE Small molecular drug D0N0TQ DRUGINCH 1S/C11H15NO/c12-8-10-6-7-11(13-10)9-4-2-1-3-5-9/h1-5,10-11H,6-8,12H2 D0N0TQ DRUGINKE IAIACGGIZWXQIK-UHFFFAOYSA-N D0N0TQ DRUGSMIL C1CC(OC1CN)C2=CC=CC=C2 D0N0TQ HIGHSTAT Investigative D0N0TS DRUG__ID D0N0TS D0N0TS DRUGTYPE Small molecular drug D0N0TS DRUGINCH 1S/C22H24Br2N4O6S2/c23-15-9-13(1-3-19(15)29)11-17(27-33)21(31)25-5-7-35-36-8-6-26-22(32)18(28-34)12-14-2-4-20(30)16(24)10-14/h1-4,9-10,29-30,33-34H,5-8,11-12H2,(H,25,31)(H,26,32)/b27-17+,28-18+ D0N0TS DRUGINKE LMAFSGDNHVBIHU-XUIWWLCJSA-N D0N0TS DRUGSMIL C1=CC(=C(C=C1CC(=NO)C(=O)NCCSSCCNC(=O)C(=NO)CC2=CC(=C(C=C2)O)Br)Br)O D0N0TS HIGHSTAT Investigative D0N0UC DRUG__ID D0N0UC D0N0UC DRUGTYPE Small molecular drug D0N0UC DRUGINCH 1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14) D0N0UC DRUGINKE POULHZVOKOAJMA-UHFFFAOYSA-N D0N0UC DRUGSMIL CCCCCCCCCCCC(=O)O D0N0UC HIGHSTAT Investigative D0N0YS DRUG__ID D0N0YS D0N0YS DRUGTYPE Small molecular drug D0N0YS DRUGINCH 1S/C15H12O4/c16-15(17)8-10-5-6-12-11(7-10)9-18-13-3-1-2-4-14(13)19-12/h1-7H,8-9H2,(H,16,17) D0N0YS DRUGINKE UCLQILVHNXYKJH-UHFFFAOYSA-N D0N0YS DRUGSMIL C1C2=C(C=CC(=C2)CC(=O)O)OC3=CC=CC=C3O1 D0N0YS HIGHSTAT Investigative D0N0YX DRUG__ID D0N0YX D0N0YX DRUGTYPE Small molecular drug D0N0YX DRUGINCH 1S/C13H13NO2/c14-12(13(15)16)8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7,12H,8,14H2,(H,15,16)/t12-/m0/s1 D0N0YX DRUGINKE JPZXHKDZASGCLU-LBPRGKRZSA-N D0N0YX DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC(C(=O)O)N D0N0YX HIGHSTAT Investigative D0N0ZK DRUG__ID D0N0ZK D0N0ZK DRUGTYPE Small molecular drug D0N0ZK DRUGINCH 1S/C5H11NO2/c1-4(6)2-3-5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 D0N0ZK DRUGINKE ABSTXSZPGHDTAF-BYPYZUCNSA-N D0N0ZK DRUGSMIL CC(CCC(=O)O)N D0N0ZK HIGHSTAT Investigative D0N1AO DRUG__ID D0N1AO D0N1AO DRUGTYPE Small molecular drug D0N1AO DRUGINCH 1S/C31H35N3O3/c1-19-11-26(35)12-20(2)27(19)16-28(32)31(37)34-18-25-10-6-5-9-24(25)15-29(34)30(36)33-17-21-13-22-7-3-4-8-23(22)14-21/h3-12,21,28-29,35H,13-18,32H2,1-2H3,(H,33,36)/t28-,29-/m0/s1 D0N1AO DRUGINKE DDWRUPXWANOFLU-VMPREFPWSA-N D0N1AO DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4CC5=CC=CC=C5C4)N)C)O D0N1AO HIGHSTAT Investigative D0N1AW DRUG__ID D0N1AW D0N1AW DRUGTYPE Small molecular drug D0N1AW DRUGINCH 1S/C10H9NO2/c11-6-7-1-3-9-8(5-7)2-4-10(12)13-9/h1-5H,6,11H2 D0N1AW DRUGINKE MXXNUQUOHJMQEU-UHFFFAOYSA-N D0N1AW DRUGSMIL C1=CC2=C(C=CC(=O)O2)C=C1CN D0N1AW HIGHSTAT Investigative D0N1AZ DRUG__ID D0N1AZ D0N1AZ DRUGTYPE Small molecular drug D0N1AZ DRUGINCH 1S/C14H18N2/c1-12-3-5-13(6-4-12)14(11-15)7-9-16(2)10-8-14/h3-6H,7-10H2,1-2H3 D0N1AZ DRUGINKE UWFQWENRHDTJQQ-UHFFFAOYSA-N D0N1AZ DRUGSMIL CC1=CC=C(C=C1)C2(CCN(CC2)C)C#N D0N1AZ HIGHSTAT Investigative D0N1CL DRUG__ID D0N1CL D0N1CL DRUGTYPE Small molecular drug D0N1CL DRUGINCH 1S/C14H10BrClN2O3/c15-8-2-1-3-10(6-8)17-14(21)18-12-7-9(16)4-5-11(12)13(19)20/h1-7H,(H,19,20)(H2,17,18,21) D0N1CL DRUGINKE QRRARWFCZGWJJY-UHFFFAOYSA-N D0N1CL DRUGSMIL C1=CC(=CC(=C1)Br)NC(=O)NC2=C(C=CC(=C2)Cl)C(=O)O D0N1CL HIGHSTAT Investigative D0N1FU DRUG__ID D0N1FU D0N1FU DRUGTYPE Small molecular drug D0N1FU DRUGINCH 1S/C9H18N2OS/c1-3-7(2)8(10)9(12)11-4-5-13-6-11/h7-8H,3-6,10H2,1-2H3/t7-,8-/m0/s1 D0N1FU DRUGINKE WCRLBFHWFPELKW-YUMQZZPRSA-N D0N1FU DRUGSMIL CCC(C)C(C(=O)N1CCSC1)N D0N1FU HIGHSTAT Investigative D0N1GH DRUG__ID D0N1GH D0N1GH DRUGTYPE Small molecular drug D0N1GH DRUGINCH 1S/C16H10N2/c17-10-12-3-4-14-9-15(6-5-13(14)8-12)16-2-1-7-18-11-16/h1-9,11H D0N1GH DRUGINKE BRNSTMOAGOETDI-UHFFFAOYSA-N D0N1GH DRUGSMIL C1=CC(=CN=C1)C2=CC3=C(C=C2)C=C(C=C3)C#N D0N1GH HIGHSTAT Investigative D0N1HE DRUG__ID D0N1HE D0N1HE DRUGTYPE Small molecular drug D0N1HE DRUGINCH 1S/C28H32N4/c1-7-17-29-25-15-21-31(27-13-5-3-11-23(25)27)19-9-2-10-20-32-22-16-26(30-18-8-1)24-12-4-6-14-28(24)32/h3-6,11-16,21-22H,1-2,7-10,17-20H2/p+2 D0N1HE DRUGINKE IOXVWOJJNCBJBX-UHFFFAOYSA-P D0N1HE DRUGSMIL C1CCNC2=CC=[N+](CCCCC[N+]3=CC=C(C4=CC=CC=C43)NCC1)C5=CC=CC=C25 D0N1HE HIGHSTAT Investigative D0N1HV DRUG__ID D0N1HV D0N1HV DRUGTYPE Small molecular drug D0N1HV DRUGINCH 1S/C11H18N2O2/c12-9(3-6-11(13)15)7-8-1-4-10(14)5-2-8/h1-2,4-5,9,11,14-15H,3,6-7,12-13H2/t9-,11+/m1/s1 D0N1HV DRUGINKE VTBBVHAOBBELOH-KOLCDFICSA-N D0N1HV DRUGSMIL C1=CC(=CC=C1CC(CCC(N)O)N)O D0N1HV HIGHSTAT Investigative D0N1LT DRUG__ID D0N1LT D0N1LT DRUGTYPE Small molecular drug D0N1LT DRUGINCH 1S/C24H29NO2/c1-24-9-8-20-19-7-5-18(26)12-16(19)4-6-21(20)22(24)13-17(23(24)27)11-15-3-2-10-25-14-15/h2-3,5,7,10,12,14,17,20-23,26-27H,4,6,8-9,11,13H2,1H3/t17-,20?,21?,22?,23-,24-/m0/s1 D0N1LT DRUGINKE QLYAKILKANOLBC-ZCTINNFXSA-N D0N1LT DRUGSMIL CC12CCC3C(C1CC(C2O)CC4=CN=CC=C4)CCC5=C3C=CC(=C5)O D0N1LT HIGHSTAT Investigative D0N1MY DRUG__ID D0N1MY D0N1MY DRUGTYPE Small molecular drug D0N1MY DRUGINCH 1S/C15H26O/c1-11-6-5-8-15(4)9-7-12(10-13(11)15)14(2,3)16/h6,12-13,16H,5,7-10H2,1-4H3/t12-,13+,15-/m1/s1 D0N1MY DRUGINKE FCSRUSQUAVXUKK-VNHYZAJKSA-N D0N1MY DRUGSMIL CC1=CCCC2(C1CC(CC2)C(C)(C)O)C D0N1MY HIGHSTAT Investigative D0N1PH DRUG__ID D0N1PH D0N1PH DRUGTYPE Small molecular drug D0N1PH DRUGINCH 1S/C36H45Cl2N2O2/c1-27(2)42-32-12-7-9-28(23-32)24-35(41)39-19-8-17-36(26-39,31-13-14-33(37)34(38)25-31)18-22-40(3)20-15-30(16-21-40)29-10-5-4-6-11-29/h4-7,9-14,23,25,27,30H,8,15-22,24,26H2,1-3H3/q+1 D0N1PH DRUGINKE QRSSYNAUQYYMPH-UHFFFAOYSA-N D0N1PH DRUGSMIL CC(C)OC1=CC=CC(=C1)CC(=O)N2CCCC(C2)(CC[N+]3(CCC(CC3)C4=CC=CC=C4)C)C5=CC(=C(C=C5)Cl)Cl D0N1PH HIGHSTAT Investigative D0N1PQ DRUG__ID D0N1PQ D0N1PQ DRUGTYPE Small molecular drug D0N1PQ DRUGINCH 1S/C16H13NO/c1-18-16-7-6-12-9-13(4-5-14(12)10-16)15-3-2-8-17-11-15/h2-11H,1H3 D0N1PQ DRUGINKE DCVWYSMRLGKIJB-UHFFFAOYSA-N D0N1PQ DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CN=CC=C3 D0N1PQ HIGHSTAT Investigative D0N1PS DRUG__ID D0N1PS D0N1PS DRUGTYPE Small molecular drug D0N1PS DRUGINCH 1S/C15H21N5/c1-2-6-11(5-1)19-14-13-15(17-9-16-14)20(10-18-13)12-7-3-4-8-12/h9-12H,1-8H2,(H,16,17,19) D0N1PS DRUGINKE TYMGLHAHNFQONV-UHFFFAOYSA-N D0N1PS DRUGSMIL C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4CCCC4 D0N1PS HIGHSTAT Investigative D0N1PT DRUG__ID D0N1PT D0N1PT DRUGTYPE Small molecular drug D0N1PT DRUGINCH 1S/C15H9ClN4/c16-9-4-3-7-12-14(9)20-15(19-12)13-8-17-10-5-1-2-6-11(10)18-13/h1-8H,(H,19,20) D0N1PT DRUGINKE KBVMQLRZERGALQ-UHFFFAOYSA-N D0N1PT DRUGSMIL C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=CC=C4Cl D0N1PT HIGHSTAT Investigative D0N1PW DRUG__ID D0N1PW D0N1PW DRUGTYPE Small molecular drug D0N1PW DRUGINCH 1S/C16H15N3/c17-16(18)14-7-5-12(6-8-14)11-19-10-9-13-3-1-2-4-15(13)19/h1-10H,11H2,(H3,17,18) D0N1PW DRUGINKE VKEKMIKRPJWXHO-UHFFFAOYSA-N D0N1PW DRUGSMIL C1=CC=C2C(=C1)C=CN2CC3=CC=C(C=C3)C(=N)N D0N1PW HIGHSTAT Investigative D0N1QO DRUG__ID D0N1QO D0N1QO DRUGTYPE Small molecular drug D0N1QO DRUGINCH 1S/C20H21N5O6/c1-29-12-6-3-11(4-7-12)5-8-14-22-18(24-30-2)15-19(23-14)25(10-21-15)20-17(28)16(27)13(9-26)31-20/h3-4,6-7,10,13,16-17,20,26-28H,9H2,1-2H3,(H,22,23,24)/t13-,16-,17-,20-/m1/s1 D0N1QO DRUGINKE MZYNTNQYNANXII-AEVYOOLXSA-N D0N1QO DRUGSMIL COC1=CC=C(C=C1)C#CC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)NOC D0N1QO HIGHSTAT Investigative D0N1QP DRUG__ID D0N1QP D0N1QP DRUGTYPE Small molecular drug D0N1QP DRUGINCH 1S/C18H13N3/c1-3-7-13(8-4-1)15-11-16(14-9-5-2-6-10-14)21-18-17(15)19-12-20-18/h1-12H,(H,19,20,21) D0N1QP DRUGINKE JRQCVLBKLGJDMI-UHFFFAOYSA-N D0N1QP DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC3=C2NC=N3)C4=CC=CC=C4 D0N1QP HIGHSTAT Investigative D0N1QQ DRUG__ID D0N1QQ D0N1QQ DRUGTYPE Small molecular drug D0N1QQ DRUGINCH 1S/C17H31N3O4/c1-5-10(3)13(18)16(22)20-9-7-8-12(20)15(21)19-14(17(23)24)11(4)6-2/h10-14H,5-9,18H2,1-4H3,(H,19,21)(H,23,24)/t10-,11-,12-,13-,14-/m0/s1 D0N1QQ DRUGINKE JNTMAZFVYNDPLB-PEDHHIEDSA-N D0N1QQ DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(C(C)CC)C(=O)O)N D0N1QQ HIGHSTAT Investigative D0N1QW DRUG__ID D0N1QW D0N1QW DRUGTYPE Small molecular drug D0N1QW DRUGINCH 1S/C15H16N4O2S/c16-13(20)12-10-17-15(22-12)19-8-6-18(7-9-19)14(21)11-4-2-1-3-5-11/h1-5,10H,6-9H2,(H2,16,20) D0N1QW DRUGINKE NYHCFTYRFCRXPO-UHFFFAOYSA-N D0N1QW DRUGSMIL C1CN(CCN1C2=NC=C(S2)C(=O)N)C(=O)C3=CC=CC=C3 D0N1QW HIGHSTAT Investigative D0N1RQ DRUG__ID D0N1RQ D0N1RQ DRUGTYPE Small molecular drug D0N1RQ DRUGINCH 1S/C15H16ClNO/c1-15(2,18)13-9-11(6-7-14(13)17)10-4-3-5-12(16)8-10/h3-9,18H,17H2,1-2H3 D0N1RQ DRUGINKE ITEDDYPYHIHWHC-UHFFFAOYSA-N D0N1RQ DRUGSMIL CC(C)(C1=C(C=CC(=C1)C2=CC(=CC=C2)Cl)N)O D0N1RQ HIGHSTAT Investigative D0N1SE DRUG__ID D0N1SE D0N1SE DRUGTYPE Small molecular drug D0N1SE DRUGINCH 1S/C16H23N3O2/c1-3-15(20)19-9-7-13(8-10-19)17-16(21)18-14-6-4-5-12(2)11-14/h4-6,11,13H,3,7-10H2,1-2H3,(H2,17,18,21) D0N1SE DRUGINKE CWZWLJHZFNKFSC-UHFFFAOYSA-N D0N1SE DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2=CC=CC(=C2)C D0N1SE HIGHSTAT Investigative D0N1TQ DRUG__ID D0N1TQ D0N1TQ DRUGTYPE Small molecular drug D0N1TQ DRUGINCH 1S/C30H39N3O3/c1-7-33-29(34)32-19-24-16-25(35-5)17-26(36-6)28(24)22(4)15-27(32)30(33)8-10-31(11-9-30)18-23-13-20(2)12-21(3)14-23/h12-17,22H,7-11,18-19H2,1-6H3/t22-/m0/s1 D0N1TQ DRUGINKE ANKFBAJRCGOKJJ-QFIPXVFZSA-N D0N1TQ DRUGSMIL CCN1C(=O)N2CC3=C(C(C=C2C14CCN(CC4)CC5=CC(=CC(=C5)C)C)C)C(=CC(=C3)OC)OC D0N1TQ HIGHSTAT Investigative D0N1UB DRUG__ID D0N1UB D0N1UB DRUGTYPE Small molecular drug D0N1UB DRUGINCH 1S/C10H9N3O/c11-9-7(10(12)14)5-6-3-1-2-4-8(6)13-9/h1-5H,(H2,11,13)(H2,12,14) D0N1UB DRUGINKE GXZOXGRLLFZVGF-UHFFFAOYSA-N D0N1UB DRUGSMIL C1=CC=C2C(=C1)C=C(C(=N2)N)C(=O)N D0N1UB HIGHSTAT Investigative D0N1UU DRUG__ID D0N1UU D0N1UU DRUGTYPE Small molecular drug D0N1UU DRUGINCH 1S/C20H17Cl2N3O2/c21-13-3-1-11(2-4-13)15-9-23-10-16(15)20(27)25-18-7-12-5-6-24-19(26)14(12)8-17(18)22/h1-8,15-16,23H,9-10H2,(H,24,26)(H,25,27)/t15-,16+/m0/s1 D0N1UU DRUGINKE XBFAFSAUQFDEOK-JKSUJKDBSA-N D0N1UU DRUGSMIL C1C(C(CN1)C(=O)NC2=C(C=C3C(=C2)C=CNC3=O)Cl)C4=CC=C(C=C4)Cl D0N1UU HIGHSTAT Investigative D0N1XQ DRUG__ID D0N1XQ D0N1XQ DRUGTYPE Small molecular drug D0N1XQ DRUGINCH 1S/C48H64N12O11/c1-27(2)20-37(47(69)59-71)57-46(68)39(22-31-24-50-26-52-31)55-42(64)25-60-19-7-6-10-36(48(60)70)56-43(65)28(3)53-45(67)38(21-30-23-51-34-9-5-4-8-33(30)34)58-44(66)35(16-17-40(49)62)54-41(63)18-13-29-11-14-32(61)15-12-29/h4-5,8-9,11-12,14-15,23-24,26-28,35-39,51,61,71H,6-7,10,13,16-22,25H2,1-3H3,(H2,49,62)(H,50,52)(H,53,67)(H,54,63)(H,55,64)(H,56,65)(H,57,68)(H,58,66)(H,59,69)/t28?,35?,36?,37-,38?,39?/m1/s1 D0N1XQ DRUGINKE SVDHLNPEHKDLER-PGRJMBAQSA-N D0N1XQ DRUGSMIL CC(C)CC(C(=O)NO)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)CCC5=CC=C(C=C5)O D0N1XQ HIGHSTAT Investigative D0N1YW DRUG__ID D0N1YW D0N1YW DRUGTYPE Small molecular drug D0N1YW DRUGINCH 1S/C26H26N4O3/c1-3-29-10-12-30(13-11-29)25-14-17(2)20-15-18(8-9-21(20)28-25)27-26(32)24-16-22(31)19-6-4-5-7-23(19)33-24/h4-9,14-16H,3,10-13H2,1-2H3,(H,27,32) D0N1YW DRUGINKE GDOKGIIKPLGRMR-UHFFFAOYSA-N D0N1YW DRUGSMIL CCN1CCN(CC1)C2=NC3=C(C=C(C=C3)NC(=O)C4=CC(=O)C5=CC=CC=C5O4)C(=C2)C D0N1YW HIGHSTAT Investigative D0N1ZJ DRUG__ID D0N1ZJ D0N1ZJ DRUGTYPE Small molecular drug D0N1ZJ DRUGINCH 1S/C14H17NO/c1-14(2,3)15-12-8-9-13(16)11-7-5-4-6-10(11)12/h4-9,15-16H,1-3H3 D0N1ZJ DRUGINKE YZPHFECVIINFFI-UHFFFAOYSA-N D0N1ZJ DRUGSMIL CC(C)(C)NC1=CC=C(C2=CC=CC=C21)O D0N1ZJ HIGHSTAT Investigative D0N2BP DRUG__ID D0N2BP D0N2BP DRUGTYPE Small molecular drug D0N2BP DRUGINCH 1S/C20H15F2NO/c21-17-10-4-8-15(12-17)20(19(23)24,14-6-2-1-3-7-14)16-9-5-11-18(22)13-16/h1-13H,(H2,23,24) D0N2BP DRUGINKE WBCHZEIUTRPOCM-UHFFFAOYSA-N D0N2BP DRUGSMIL C1=CC=C(C=C1)C(C2=CC(=CC=C2)F)(C3=CC(=CC=C3)F)C(=O)N D0N2BP HIGHSTAT Investigative D0N2DN DRUG__ID D0N2DN D0N2DN DRUGTYPE Small molecular drug D0N2DN DRUGINCH 1S/C19H19NO/c1-2-6-15(7-3-1)17-14-19(10-12-20-13-11-19)21-18-9-5-4-8-16(17)18/h1-9,14,20H,10-13H2 D0N2DN DRUGINKE AWYPHZMWGAOGIC-UHFFFAOYSA-N D0N2DN DRUGSMIL C1CNCCC12C=C(C3=CC=CC=C3O2)C4=CC=CC=C4 D0N2DN HIGHSTAT Investigative D0N2DP DRUG__ID D0N2DP D0N2DP DRUGTYPE Small molecular drug D0N2DP DRUGINCH 1S/C19H24N6/c1-2-5-9-14(10-6-3-1)22-18-16-17(21-13-20-16)24-19(25-18)23-15-11-7-4-8-12-15/h4,7-8,11-14H,1-3,5-6,9-10H2,(H3,20,21,22,23,24,25) D0N2DP DRUGINKE MSEVQUIRSAPIPS-UHFFFAOYSA-N D0N2DP DRUGSMIL C1CCCC(CCC1)NC2=NC(=NC3=C2NC=N3)NC4=CC=CC=C4 D0N2DP HIGHSTAT Investigative D0N2GM DRUG__ID D0N2GM D0N2GM DRUGTYPE Small molecular drug D0N2GM DRUGINCH 1S/C45H65N15O12S2/c46-26(8-3-13-51-44(47)48)37(66)55-27(9-4-14-52-45(49)50)41(70)58-15-5-11-32(58)43(72)59-20-24(62)17-33(59)40(69)53-19-35(63)54-28(18-25-7-6-16-73-25)38(67)56-29(22-61)39(68)57-30-23-74-34-12-2-1-10-31(34)60(42(30)71)21-36(64)65/h1-2,6-7,10,12,16,24,26-30,32-33,61-62H,3-5,8-9,11,13-15,17-23,46H2,(H,53,69)(H,54,63)(H,55,66)(H,56,67)(H,57,68)(H,64,65)(H4,47,48,51)(H4,49,50,52)/t24?,26?,27-,28?,29+,30-,32+,33+/m1/s1 D0N2GM DRUGINKE YMROZBYZFLPAPA-RONNJKQASA-N D0N2GM DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC(CO)C(=O)NC4CSC5=CC=CC=C5N(C4=O)CC(=O)O)O D0N2GM HIGHSTAT Investigative D0N2GO DRUG__ID D0N2GO D0N2GO DRUGTYPE Small molecular drug D0N2GO DRUGINCH 1S/C15H20O3/c1-10-5-4-6-11(2)9-13-15(17,8-7-10)12(3)14(16)18-13/h5,9,13,17H,3-4,6-8H2,1-2H3/b10-5+,11-9+/t13-,15-/m1/s1 D0N2GO DRUGINKE AZKRCCHLNBJNOK-HZAIZTQPSA-N D0N2GO DRUGSMIL CC1=CCCC(=CC2C(CC1)(C(=C)C(=O)O2)O)C D0N2GO HIGHSTAT Investigative D0N2KP DRUG__ID D0N2KP D0N2KP DRUGTYPE Small molecular drug D0N2KP DRUGINCH 1S/C28H32O5/c1-29-25-13-11-19(17-27(25)31-21-7-3-4-8-21)23-15-16-24(33-23)20-12-14-26(30-2)28(18-20)32-22-9-5-6-10-22/h11-18,21-22H,3-10H2,1-2H3 D0N2KP DRUGINKE VJENKFARFHFXFG-UHFFFAOYSA-N D0N2KP DRUGSMIL COC1=C(C=C(C=C1)C2=CC=C(O2)C3=CC(=C(C=C3)OC)OC4CCCC4)OC5CCCC5 D0N2KP HIGHSTAT Investigative D0N2KU DRUG__ID D0N2KU D0N2KU DRUGTYPE Small molecular drug D0N2KU DRUGINCH 1S/C17H21F3N2O/c18-17(19,20)15-7-2-1-6-14(15)16(23)22(11-12-4-3-5-12)13-8-9-21-10-13/h1-2,6-7,12-13,21H,3-5,8-11H2/t13-/m0/s1 D0N2KU DRUGINKE SWADTMSKMJUFBO-ZDUSSCGKSA-N D0N2KU DRUGSMIL C1CC(C1)CN(C2CCNC2)C(=O)C3=CC=CC=C3C(F)(F)F D0N2KU HIGHSTAT Investigative D0N2LE DRUG__ID D0N2LE D0N2LE DRUGTYPE Small molecular drug D0N2LE DRUGINCH 1S/C11H14N5O8P/c12-10-14-7-4(8(18)15-10)13-2-16(7)9-6-5(3(1-17)22-9)23-11(24-6)25(19,20)21/h2-3,5-6,9,11,17H,1H2,(H2,19,20,21)(H3,12,14,15,18)/t3-,5-,6-,9-,11+/m1/s1 D0N2LE DRUGINKE GKAPYWCOOQBBHV-KXSYMAMXSA-N D0N2LE DRUGSMIL C1=NC2=C(N1C3C4C(C(O3)CO)OC(O4)P(=O)(O)O)N=C(NC2=O)N D0N2LE HIGHSTAT Investigative D0N2LW DRUG__ID D0N2LW D0N2LW DRUGTYPE Small molecular drug D0N2LW DRUGINCH 1S/C19H17NO2S/c21-17-13-18(20-9-11-23-12-10-20)22-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2 D0N2LW DRUGINKE BJZCLUNKKGYDPF-UHFFFAOYSA-N D0N2LW DRUGSMIL C1CSCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4 D0N2LW HIGHSTAT Investigative D0N2QH DRUG__ID D0N2QH D0N2QH DRUGTYPE Small molecular drug D0N2QH DRUGINCH 1S/C37H39IO9/c1-20(2)35-16-22(4)37-26(33(35)45-36(46-35,47-37)18-23-9-7-6-8-10-23)12-25(17-34(42)29(37)11-21(3)32(34)41)19-44-30(39)15-24-13-27(38)31(40)28(14-24)43-5/h6-14,22,26,29,33,40,42H,1,15-19H2,2-5H3/t22-,26+,29-,33-,34-,35-,36-,37-/m1/s1 D0N2QH DRUGINKE TZUJORCXGLGWDV-DZBJMWFRSA-N D0N2QH DRUGSMIL CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C(=C6)I)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C D0N2QH HIGHSTAT Investigative D0N2QX DRUG__ID D0N2QX D0N2QX DRUGTYPE Small molecular drug D0N2QX DRUGINCH 1S/C9H8F3N3S/c10-9(11,12)7-3-1-2-6(4-7)5-14-15-8(13)16/h1-5H,(H3,13,15,16)/b14-5+ D0N2QX DRUGINKE GDIMOASDCOFPTD-LHHJGKSTSA-N D0N2QX DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C=NNC(=S)N D0N2QX HIGHSTAT Investigative D0N2RJ DRUG__ID D0N2RJ D0N2RJ DRUGTYPE Small molecular drug D0N2RJ DRUGINCH 1S/C16H17FN2O/c17-13-4-3-5-14(12-13)20-16-7-2-1-6-15(16)19-10-8-18-9-11-19/h1-7,12,18H,8-11H2 D0N2RJ DRUGINKE ZTEDPRVVBLHAKJ-UHFFFAOYSA-N D0N2RJ DRUGSMIL C1CN(CCN1)C2=CC=CC=C2OC3=CC(=CC=C3)F D0N2RJ HIGHSTAT Investigative D0N2SM DRUG__ID D0N2SM D0N2SM DRUGTYPE Small molecular drug D0N2SM DRUGINCH 1S/C30H48O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20-,21-,22+,23+,27-,28+,29+,30-/m0/s1 D0N2SM DRUGINKE MDZKJHQSJHYOHJ-SXISEVPCSA-N D0N2SM DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C D0N2SM HIGHSTAT Investigative D0N2TF DRUG__ID D0N2TF D0N2TF DRUGTYPE Small molecular drug D0N2TF DRUGINCH 1S/C20H17NO2/c22-19(11-14-5-2-1-3-6-14)15-8-9-18-17(12-15)13-16-7-4-10-23-20(16)21-18/h1-3,5-6,8-9,12-13H,4,7,10-11H2 D0N2TF DRUGINKE HXUSRWUBSYSWII-UHFFFAOYSA-N D0N2TF DRUGSMIL C1CC2=C(N=C3C=CC(=CC3=C2)C(=O)CC4=CC=CC=C4)OC1 D0N2TF HIGHSTAT Investigative D0N2TP DRUG__ID D0N2TP D0N2TP DRUGTYPE Small molecular drug D0N2TP DRUGINCH 1S/C13H10N2/c1-11-4-2-5-12(10-11)6-7-13-14-8-3-9-15-13/h2-5,8-10H,1H3 D0N2TP DRUGINKE GHGMWMJKRGZKMW-UHFFFAOYSA-N D0N2TP DRUGSMIL CC1=CC(=CC=C1)C#CC2=NC=CC=N2 D0N2TP HIGHSTAT Investigative D0N2UF DRUG__ID D0N2UF D0N2UF DRUGTYPE Small molecular drug D0N2UF DRUGINCH 1S/C15H22BN3O4/c1-10(2)13(18-14(20)11-5-7-17-8-6-11)15(21)19-9-3-4-12(19)16(22)23/h5-8,10,12-13,22-23H,3-4,9H2,1-2H3,(H,18,20)/t12-,13-/m1/s1 D0N2UF DRUGINKE MXZNUGFCDVAXLG-CHWSQXEVSA-N D0N2UF DRUGSMIL B(C1CCCN1C(=O)C(C(C)C)NC(=O)C2=CC=NC=C2)(O)O D0N2UF HIGHSTAT Investigative D0N2VN DRUG__ID D0N2VN D0N2VN DRUGTYPE Small molecular drug D0N2VN DRUGINCH 1S/C17H16ClN3OS/c1-9-7-10(2)21-17-13(9)14(19)15(23-17)16(22)20-8-11-3-5-12(18)6-4-11/h3-7H,8,19H2,1-2H3,(H,20,22) D0N2VN DRUGINKE FPRULFHDSFKYBV-UHFFFAOYSA-N D0N2VN DRUGSMIL CC1=CC(=NC2=C1C(=C(S2)C(=O)NCC3=CC=C(C=C3)Cl)N)C D0N2VN HIGHSTAT Investigative D0N2VO DRUG__ID D0N2VO D0N2VO DRUGTYPE Small molecular drug D0N2VO DRUGINCH 1S/C18H13N3/c19-12-16-15(13-7-3-1-4-8-13)11-17(21-18(16)20)14-9-5-2-6-10-14/h1-11H,(H2,20,21) D0N2VO DRUGINKE YFQVSTNNJZZYLY-UHFFFAOYSA-N D0N2VO DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2C#N)N)C3=CC=CC=C3 D0N2VO HIGHSTAT Investigative D0N2WK DRUG__ID D0N2WK D0N2WK DRUGTYPE Small molecular drug D0N2WK DRUGINCH 1S/C28H53N2O7PS/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-29-28(31)35-24-27(34-2)25-37-38(32,33)36-22-20-30-21-23-39-26-30/h21,23,26-27H,3-20,22,24-25H2,1-2H3,(H-,29,31,32,33) D0N2WK DRUGINKE NMHKTASGTFXJPL-UHFFFAOYSA-N D0N2WK DRUGSMIL CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(=O)([O-])OCC[N+]1=CSC=C1)OC D0N2WK HIGHSTAT Investigative D0N2XO DRUG__ID D0N2XO D0N2XO DRUGTYPE Small molecular drug D0N2XO DRUGINCH 1S/C16H17NO4/c1-19-14-4-2-3-12(9-14)15-10-13(18)11-16(21-15)17-5-7-20-8-6-17/h2-4,9-11H,5-8H2,1H3 D0N2XO DRUGINKE OLIONIBTYZDPMY-UHFFFAOYSA-N D0N2XO DRUGSMIL COC1=CC=CC(=C1)C2=CC(=O)C=C(O2)N3CCOCC3 D0N2XO HIGHSTAT Investigative D0N3CC DRUG__ID D0N3CC D0N3CC DRUGTYPE Small molecular drug D0N3CC DRUGINCH 1S/C36H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-25(44)21-64-19-18-38-27(45)16-17-39-34(48)31(47)36(2,3)22-57-63(54,55)60-62(52,53)56-20-26-30(59-61(49,50)51)29(46)35(58-26)43-24-42-28-32(37)40-23-41-33(28)43/h23-24,26,29-31,35,46-47H,4-22H2,1-3H3,(H,38,45)(H,39,48)(H,52,53)(H,54,55)(H2,37,40,41)(H2,49,50,51)/t26-,29-,30-,31?,35-/m1/s1 D0N3CC DRUGINKE JKWHUJMJVNMKEF-DJEJIMQCSA-N D0N3CC DRUGSMIL CCCCCCCCCCCCCC(=O)CSCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D0N3CC HIGHSTAT Investigative D0N3CZ DRUG__ID D0N3CZ D0N3CZ DRUGTYPE Small molecular drug D0N3CZ DRUGINCH 1S/C12H11NO2/c1-8(14)7-10-9-5-3-4-6-11(9)13(2)12(10)15/h3-7H,1-2H3/b10-7+ D0N3CZ DRUGINKE CZKBLHCEDVWPRN-JXMROGBWSA-N D0N3CZ DRUGSMIL CC(=O)C=C1C2=CC=CC=C2N(C1=O)C D0N3CZ HIGHSTAT Investigative D0N3DD DRUG__ID D0N3DD D0N3DD DRUGTYPE Small molecular drug D0N3DD DRUGINCH 1S/C16H20FNO2/c1-18-12-7-8-14(18)15(16(19)20-2)13(9-12)10-3-5-11(17)6-4-10/h3-6,12-15H,7-9H2,1-2H3/t12-,13+,14+,15-/m0/s1 D0N3DD DRUGINKE QUSLQENMLDRCTO-YJNKXOJESA-N D0N3DD DRUGSMIL CN1C2CCC1C(C(C2)C3=CC=C(C=C3)F)C(=O)OC D0N3DD HIGHSTAT Investigative D0N3DW DRUG__ID D0N3DW D0N3DW DRUGTYPE Small molecular drug D0N3DW DRUGINCH 1S/C8H6N2S2/c11-8-10-9-7(12-8)6-4-2-1-3-5-6/h1-5H,(H,10,11) D0N3DW DRUGINKE ZTLMHGOWADYAHM-UHFFFAOYSA-N D0N3DW DRUGSMIL C1=CC=C(C=C1)C2=NNC(=S)S2 D0N3DW HIGHSTAT Investigative D0N3FL DRUG__ID D0N3FL D0N3FL DRUGTYPE Small molecular drug D0N3FL DRUGINCH 1S/C27H19N3O7S.Na/c28-24-18(27(33)34)13-20(22-23(24)26(32)17-9-5-4-8-16(17)25(22)31)30-15-10-11-19(21(12-15)38(35,36)37)29-14-6-2-1-3-7-14;/h1-13,29-30H,28H2,(H,33,34)(H,35,36,37);/q;+1/p-1 D0N3FL DRUGINKE PZRXTTYJQMKSRF-UHFFFAOYSA-M D0N3FL DRUGSMIL C1=CC=C(C=C1)NC2=C(C=C(C=C2)NC3=C4C(=C(C(=C3)C(=O)O)N)C(=O)C5=CC=CC=C5C4=O)S(=O)(=O)[O-].[Na+] D0N3FL HIGHSTAT Investigative D0N3GU DRUG__ID D0N3GU D0N3GU DRUGTYPE Small molecular drug D0N3GU DRUGINCH 1S/C28H34N6O5/c1-16(25(30)36)32-26(37)23(14-18-15-31-22-6-3-2-5-20(18)22)33-27(38)24-7-4-12-34(24)28(39)21(29)13-17-8-10-19(35)11-9-17/h2-3,5-6,8-11,15-16,21,23-24,31,35H,4,7,12-14,29H2,1H3,(H2,30,36)(H,32,37)(H,33,38)/t16-,21-,23-,24-/m0/s1 D0N3GU DRUGINKE FMYKJNQXBIJPPV-DFQATESRSA-N D0N3GU DRUGSMIL CC(C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0N3GU HIGHSTAT Investigative D0N3HU DRUG__ID D0N3HU D0N3HU DRUGTYPE Small molecular drug D0N3HU DRUGINCH 1S/C5H10N2S/c6-5-1-3-8-4-2-7-5/h1-4H2,(H2,6,7) D0N3HU DRUGINKE VXILVSMPTBRDEC-UHFFFAOYSA-N D0N3HU DRUGSMIL C1CSCCN=C1N D0N3HU HIGHSTAT Investigative D0N3JX DRUG__ID D0N3JX D0N3JX DRUGTYPE Small molecular drug D0N3JX DRUGINCH 1S/C28H25N3O3S/c1-18-15-24(35(4,32)33)9-10-25(18)28-30-26(19-11-13-29-14-12-19)27(31(28)2)22-6-5-21-17-23(34-3)8-7-20(21)16-22/h5-17H,1-4H3 D0N3JX DRUGINKE ZDSNJSQTPLXCSG-UHFFFAOYSA-N D0N3JX DRUGSMIL CC1=C(C=CC(=C1)S(=O)(=O)C)C2=NC(=C(N2C)C3=CC4=C(C=C3)C=C(C=C4)OC)C5=CC=NC=C5 D0N3JX HIGHSTAT Investigative D0N3LC DRUG__ID D0N3LC D0N3LC DRUGTYPE Small molecular drug D0N3LC DRUGINCH 1S/C15H12ClN5O2S/c1-23-7-2-3-8(9(16)6-7)11-12(13(17)22)24-14(21-11)10-4-5-19-15(18)20-10/h2-6H,1H3,(H2,17,22)(H2,18,19,20) D0N3LC DRUGINKE VCUXVXLUOHDHKK-UHFFFAOYSA-N D0N3LC DRUGSMIL COC1=CC(=C(C=C1)C2=C(SC(=N2)C3=NC(=NC=C3)N)C(=O)N)Cl D0N3LC HIGHSTAT Investigative D0N3RM DRUG__ID D0N3RM D0N3RM DRUGTYPE Small molecular drug D0N3RM DRUGINCH 1S/C29H29F6N3O2/c1-18-7-5-6-8-22(18)23-16-25(38-9-11-40-12-10-38)36-17-24(23)37(4)26(39)27(2,3)19-13-20(28(30,31)32)15-21(14-19)29(33,34)35/h5-8,13-17H,9-12H2,1-4H3 D0N3RM DRUGINKE ZGNPLCMMVKCTHM-UHFFFAOYSA-N D0N3RM DRUGSMIL CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCOCC4 D0N3RM HIGHSTAT Investigative D0N3UO DRUG__ID D0N3UO D0N3UO DRUGTYPE Small molecular drug D0N3UO DRUGINCH 1S/C5H12NO2P/c1-4(2)3-5(6)9(7)8/h4,6-8H,3H2,1-2H3 D0N3UO DRUGINKE UMMREILHNONHFP-UHFFFAOYSA-N D0N3UO DRUGSMIL CC(C)CC(=N)P(O)O D0N3UO HIGHSTAT Investigative D0N3XP DRUG__ID D0N3XP D0N3XP DRUGTYPE Small molecular drug D0N3XP DRUGINCH 1S/C25H25BrN6O2/c1-32-13-11-17(12-14-32)29-25-30-22-20(26)15-27-24(33)21(22)23(31-25)28-16-7-9-19(10-8-16)34-18-5-3-2-4-6-18/h2-10,15,17H,11-14H2,1H3,(H,27,33)(H2,28,29,30,31) D0N3XP DRUGINKE SXWMIXPJPNCXQQ-UHFFFAOYSA-N D0N3XP DRUGSMIL CN1CCC(CC1)NC2=NC3=C(C(=O)NC=C3Br)C(=N2)NC4=CC=C(C=C4)OC5=CC=CC=C5 D0N3XP HIGHSTAT Investigative D0N3YN DRUG__ID D0N3YN D0N3YN DRUGTYPE Small molecular drug D0N3YN DRUGINCH 1S/C31H34O7/c1-19-26(35-2)16-22(17-27(19)36-3)29(32)28(38-25-14-20-6-4-5-7-21(20)15-25)18-37-24-10-8-23(9-11-24)31(12-13-31)30(33)34/h4-11,16-17,25,28-29,32H,12-15,18H2,1-3H3,(H,33,34)/t28-,29+/m0/s1 D0N3YN DRUGINKE FVESDCZDESZGHA-URLMMPGGSA-N D0N3YN DRUGSMIL CC1=C(C=C(C=C1OC)C(C(COC2=CC=C(C=C2)C3(CC3)C(=O)O)OC4CC5=CC=CC=C5C4)O)OC D0N3YN HIGHSTAT Investigative D0N4AG DRUG__ID D0N4AG D0N4AG DRUGTYPE Small molecular drug D0N4AG DRUGINCH 1S/C14H29O3PS/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17-18(15,16)19/h5-6H,2-4,7-14H2,1H3,(H2,15,16,19)/b6-5+ D0N4AG DRUGINKE JIUMNBPJJCCLAG-AATRIKPKSA-N D0N4AG DRUGSMIL CCCCC=CCCCCCCCCOP(=S)(O)O D0N4AG HIGHSTAT Investigative D0N4AH DRUG__ID D0N4AH D0N4AH DRUGTYPE Small molecular drug D0N4AH DRUGINCH 1S/C20H20O7P2/c21-20(28(22,23)24,29(25,26)27)14-15-6-4-9-17(12-15)19-11-5-10-18(13-19)16-7-2-1-3-8-16/h1-13,21H,14H2,(H2,22,23,24)(H2,25,26,27) D0N4AH DRUGINKE YXQQNSYZOQHKHD-UHFFFAOYSA-N D0N4AH DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)C3=CC=CC(=C3)CC(O)(P(=O)(O)O)P(=O)(O)O D0N4AH HIGHSTAT Investigative D0N4BQ DRUG__ID D0N4BQ D0N4BQ DRUGTYPE Small molecular drug D0N4BQ DRUGINCH 1S/C19H21N/c1-2-4-15(5-3-1)16-6-8-17(9-7-16)19-14-20-12-10-18(19)11-13-20/h1-9,18-19H,10-14H2 D0N4BQ DRUGINKE ONKAPNPOBBUQAF-UHFFFAOYSA-N D0N4BQ DRUGSMIL C1CN2CCC1C(C2)C3=CC=C(C=C3)C4=CC=CC=C4 D0N4BQ HIGHSTAT Investigative D0N4DR DRUG__ID D0N4DR D0N4DR DRUGTYPE Small molecular drug D0N4DR DRUGINCH 1S/C16H14O2/c1-11-7-8-13-14(17)10-15(18-16(13)9-11)12-5-3-2-4-6-12/h2-9,15H,10H2,1H3/t15-/m0/s1 D0N4DR DRUGINKE FNOKOVWLKVWYRY-HNNXBMFYSA-N D0N4DR DRUGSMIL CC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=CC=C3 D0N4DR HIGHSTAT Investigative D0N4EZ DRUG__ID D0N4EZ D0N4EZ DRUGTYPE Small molecular drug D0N4EZ DRUGINCH 1S/C3H9NO2S/c4-2-1-3-7(5)6/h1-4H2,(H,5,6) D0N4EZ DRUGINKE NPGXQDBNBFXJKB-UHFFFAOYSA-N D0N4EZ DRUGSMIL C(CN)CS(=O)O D0N4EZ HIGHSTAT Investigative D0N4FS DRUG__ID D0N4FS D0N4FS DRUGTYPE Small molecular drug D0N4FS DRUGINCH 1S/C11H11O4P/c12-11(16(13,14)15)10-7-3-5-8-4-1-2-6-9(8)10/h1-7,11-12H,(H2,13,14,15)/t11-/m0/s1 D0N4FS DRUGINKE AXIBZLYWMBUYRV-NSHDSACASA-N D0N4FS DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C(O)P(=O)(O)O D0N4FS HIGHSTAT Investigative D0N4IT DRUG__ID D0N4IT D0N4IT DRUGTYPE Small molecular drug D0N4IT DRUGINCH 1S/C13H8Cl2N2O3/c14-8-5-6-11(10(15)7-8)16-13(18)9-3-1-2-4-12(9)17(19)20/h1-7H,(H,16,18) D0N4IT DRUGINKE YDNSNBQUGLSJRG-UHFFFAOYSA-N D0N4IT DRUGSMIL C1=CC=C(C(=C1)C(=O)NC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-] D0N4IT HIGHSTAT Investigative D0N4LR DRUG__ID D0N4LR D0N4LR DRUGTYPE Small molecular drug D0N4LR DRUGINCH 1S/C24H20F3N5O/c1-31-12-18(21-22(28)29-13-30-23(21)31)15-5-6-19-16(11-15)7-8-32(19)20(33)10-14-3-2-4-17(9-14)24(25,26)27/h2-6,9,11-13H,7-8,10H2,1H3,(H2,28,29,30) D0N4LR DRUGINKE SIXVRXARNAVBTC-UHFFFAOYSA-N D0N4LR DRUGSMIL CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F D0N4LR HIGHSTAT Investigative D0N4QQ DRUG__ID D0N4QQ D0N4QQ DRUGTYPE Small molecular drug D0N4QQ DRUGINCH 1S/C30H48N2O3/c1-18(2)17-27(34)31-26-14-16-30(6)24-13-15-29(5)22(19(3)32(7)8)11-12-23(29)21(24)9-10-25(30)28(26)35-20(4)33/h11,17,19,21,23-26,28H,9-10,12-16H2,1-8H3,(H,31,34)/t19-,21-,23-,24-,25-,26-,28+,29+,30+/m0/s1 D0N4QQ DRUGINKE SYWAOYCXRQDRLP-ULERWODGSA-N D0N4QQ DRUGSMIL CC(C1=CCC2C1(CCC3C2CCC4C3(CCC(C4OC(=O)C)NC(=O)C=C(C)C)C)C)N(C)C D0N4QQ HIGHSTAT Investigative D0N4QT DRUG__ID D0N4QT D0N4QT DRUGTYPE Small molecular drug D0N4QT DRUGINCH 1S/C24H28N4O2/c1-16-9-8-12-18(15-16)25-24(30)27-22-23(29)28(2)20-14-7-6-13-19(20)21(26-22)17-10-4-3-5-11-17/h6-9,12-15,17,22H,3-5,10-11H2,1-2H3,(H2,25,27,30)/t22-/m0/s1 D0N4QT DRUGINKE MYNLMIGJXBPKMR-QFIPXVFZSA-N D0N4QT DRUGSMIL CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4CCCCC4)C D0N4QT HIGHSTAT Investigative D0N4RO DRUG__ID D0N4RO D0N4RO DRUGTYPE Small molecular drug D0N4RO DRUGINCH 1S/C24H23NO3S/c26-23(22(29)16-17-7-3-1-4-8-17)25-21(24(27)28)15-18-11-13-20(14-12-18)19-9-5-2-6-10-19/h1-14,21-22,29H,15-16H2,(H,25,26)(H,27,28)/t21-,22+/m0/s1 D0N4RO DRUGINKE BNECOBGISSOLPT-FCHUYYIVSA-N D0N4RO DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)C3=CC=CC=C3)C(=O)O)S D0N4RO HIGHSTAT Investigative D0N4VI DRUG__ID D0N4VI D0N4VI DRUGTYPE Small molecular drug D0N4VI DRUGINCH 1S/C13H12N2/c1-2-4-12-9-13(6-5-11(12)3-1)15-8-7-14-10-15/h1-4,7-10H,5-6H2 D0N4VI DRUGINKE DHUCLDOIXQGVDQ-UHFFFAOYSA-N D0N4VI DRUGSMIL C1CC(=CC2=CC=CC=C21)N3C=CN=C3 D0N4VI HIGHSTAT Investigative D0N4VR DRUG__ID D0N4VR D0N4VR DRUGTYPE Small molecular drug D0N4VR DRUGINCH 1S/C13H8FNS/c14-12-2-1-3-13-11(12)6-10(7-15-13)9-4-5-16-8-9/h1-8H D0N4VR DRUGINKE BEVNNTNJJJWQAK-UHFFFAOYSA-N D0N4VR DRUGSMIL C1=CC2=C(C=C(C=N2)C3=CSC=C3)C(=C1)F D0N4VR HIGHSTAT Investigative D0N4WB DRUG__ID D0N4WB D0N4WB DRUGTYPE Small molecular drug D0N4WB DRUGINCH 1S/C16H10ClN3O5/c17-10-7-8(5-6-12(10)21)18-14-13(15(22)19-16(14)23)9-3-1-2-4-11(9)20(24)25/h1-7,21H,(H2,18,19,22,23) D0N4WB DRUGINKE PQCXVIPXISBFPN-UHFFFAOYSA-N D0N4WB DRUGSMIL C1=CC=C(C(=C1)C2=C(C(=O)NC2=O)NC3=CC(=C(C=C3)O)Cl)[N+](=O)[O-] D0N4WB HIGHSTAT Investigative D0N4WZ DRUG__ID D0N4WZ D0N4WZ DRUGTYPE Small molecular drug D0N4WZ DRUGINCH 1S/C5H14NO2P/c1-2-9(7,8)5-3-4-6/h2-6H2,1H3,(H,7,8) D0N4WZ DRUGINKE RWCIPYZWXPUGRM-UHFFFAOYSA-N D0N4WZ DRUGSMIL CCP(=O)(CCCN)O D0N4WZ HIGHSTAT Investigative D0N4XG DRUG__ID D0N4XG D0N4XG DRUGTYPE Small molecular drug D0N4XG DRUGINCH 1S/3H2O.O.V/h3*1H2;;/q;;;;+3/p-3 D0N4XG DRUGINKE WQEVDHBJGNOKKO-UHFFFAOYSA-K D0N4XG DRUGSMIL O[V](=O)(O)O D0N4XG HIGHSTAT Investigative D0N4YP DRUG__ID D0N4YP D0N4YP DRUGTYPE Small molecular drug D0N4YP DRUGINCH 1S/C14H14N2/c1-2-10-6-11(3-4-13(10)16-5-1)14-7-12(14)8-15-9-14/h1-6,12,15H,7-9H2 D0N4YP DRUGINKE RJVNCNHNNCNEMX-UHFFFAOYSA-N D0N4YP DRUGSMIL C1C2C1(CNC2)C3=CC4=C(C=C3)N=CC=C4 D0N4YP HIGHSTAT Investigative D0N4YR DRUG__ID D0N4YR D0N4YR DRUGTYPE Small molecular drug D0N4YR DRUGINCH 1S/C21H20O5/c1-21(2)11-10-15-18(26-21)9-6-14(20(15)24)16(22)7-4-13-5-8-17(23)19(12-13)25-3/h4-12,23-24H,1-3H3/b7-4+ D0N4YR DRUGINKE WNUBZQVPFKTBOZ-QPJJXVBHSA-N D0N4YR DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2O)C(=O)C=CC3=CC(=C(C=C3)O)OC)C D0N4YR HIGHSTAT Investigative D0N5BA DRUG__ID D0N5BA D0N5BA DRUGTYPE Small molecular drug D0N5BA DRUGINCH 1S/C6H5N3O/c10-6-5-4(1-2-7-5)8-3-9-6/h1-3,7H,(H,8,9,10) D0N5BA DRUGINKE UWMXUDUWVFWJPX-UHFFFAOYSA-N D0N5BA DRUGSMIL C1=CNC2=C1N=CNC2=O D0N5BA HIGHSTAT Investigative D0N5BI DRUG__ID D0N5BI D0N5BI DRUGTYPE Small molecular drug D0N5BI DRUGINCH 1S/C22H22F3N3O3S2/c1-2-28-12-17(13-4-3-5-14(10-13)22(23,24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30,31)9-7-15/h3-5,10-12,15H,2,6-9H2,1H3,(H2,26,27) D0N5BI DRUGINKE WRUWGLUCNBMGPS-UHFFFAOYSA-N D0N5BI DRUGSMIL CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F D0N5BI HIGHSTAT Investigative D0N5CH DRUG__ID D0N5CH D0N5CH DRUGTYPE Small molecular drug D0N5CH DRUGINCH 1S/C12H7ClF2N2O/c13-11-4-2-8(6-16-11)17-12(18)7-1-3-9(14)10(15)5-7/h1-6H,(H,17,18) D0N5CH DRUGINKE GDGUOCFTHNGPBK-UHFFFAOYSA-N D0N5CH DRUGSMIL C1=CC(=C(C=C1C(=O)NC2=CN=C(C=C2)Cl)F)F D0N5CH HIGHSTAT Investigative D0N5CI DRUG__ID D0N5CI D0N5CI DRUGTYPE Small molecular drug D0N5CI DRUGINCH 1S/C14H13N3/c15-8-12-11(10-4-2-1-3-5-10)6-7-13-14(12)17-9-16-13/h1-7,9H,8,15H2,(H,16,17) D0N5CI DRUGINKE IYXQHXUCPDCZDQ-UHFFFAOYSA-N D0N5CI DRUGSMIL C1=CC=C(C=C1)C2=C(C3=C(C=C2)NC=N3)CN D0N5CI HIGHSTAT Investigative D0N5GZ DRUG__ID D0N5GZ D0N5GZ DRUGTYPE Small molecular drug D0N5GZ DRUGINCH 1S/C11H12N2/c1-10-2-4-11(5-3-10)8-13-7-6-12-9-13/h2-7,9H,8H2,1H3 D0N5GZ DRUGINKE DQXGQHAFADWCKG-UHFFFAOYSA-N D0N5GZ DRUGSMIL CC1=CC=C(C=C1)CN2C=CN=C2 D0N5GZ HIGHSTAT Investigative D0N5IE DRUG__ID D0N5IE D0N5IE DRUGTYPE Small molecular drug D0N5IE DRUGINCH 1S/C15H12N4OS/c20-14(17-11-6-2-1-3-7-11)19-15-18-13(10-21-15)12-8-4-5-9-16-12/h1-10H,(H2,17,18,19,20) D0N5IE DRUGINKE SDGJJDKFCDDMKK-UHFFFAOYSA-N D0N5IE DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=NC(=CS2)C3=CC=CC=N3 D0N5IE HIGHSTAT Investigative D0N5KX DRUG__ID D0N5KX D0N5KX DRUGTYPE Small molecular drug D0N5KX DRUGINCH 1S/C8H12N2O6S2/c9-17(11,12)15-5-7-1-2-8(4-3-7)6-16-18(10,13)14/h1-4H,5-6H2,(H2,9,11,12)(H2,10,13,14) D0N5KX DRUGINKE YOXOVPXRAUISQE-UHFFFAOYSA-N D0N5KX DRUGSMIL C1=CC(=CC=C1COS(=O)(=O)N)COS(=O)(=O)N D0N5KX HIGHSTAT Investigative D0N5LD DRUG__ID D0N5LD D0N5LD DRUGTYPE Small molecular drug D0N5LD DRUGINCH 1S/C8H7N5O2/c9-8(10)12-4-5-2-1-3-6(13(14)15)7(5)11-12/h1-4H,(H3,9,10) D0N5LD DRUGINKE GFYAZUABYOOPCN-UHFFFAOYSA-N D0N5LD DRUGSMIL C1=CC2=CN(N=C2C(=C1)[N+](=O)[O-])C(=N)N D0N5LD HIGHSTAT Investigative D0N5LF DRUG__ID D0N5LF D0N5LF DRUGTYPE Small molecular drug D0N5LF DRUGINCH 1S/C15H9N3/c16-9-11-3-1-4-12(7-11)13-8-15-14(18-10-13)5-2-6-17-15/h1-8,10H D0N5LF DRUGINKE GOWMBIHHRVFADP-UHFFFAOYSA-N D0N5LF DRUGSMIL C1=CC(=CC(=C1)C2=CC3=C(C=CC=N3)N=C2)C#N D0N5LF HIGHSTAT Investigative D0N5MU DRUG__ID D0N5MU D0N5MU DRUGTYPE Small molecular drug D0N5MU DRUGINCH 1S/C12H12N2O4S/c15-11-9-7-8(3-4-10(9)13-12(11)16)19(17,18)14-5-1-2-6-14/h3-4,7H,1-2,5-6H2,(H,13,15,16) D0N5MU DRUGINKE QKCWUYHXHMXOLG-UHFFFAOYSA-N D0N5MU DRUGSMIL C1CCN(C1)S(=O)(=O)C2=CC3=C(C=C2)NC(=O)C3=O D0N5MU HIGHSTAT Investigative D0N5OD DRUG__ID D0N5OD D0N5OD DRUGTYPE Small molecular drug D0N5OD DRUGINCH 1S/C13H9F3/c14-13(15,16)12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9H D0N5OD DRUGINKE OUMKBAHMPRLISR-UHFFFAOYSA-N D0N5OD DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F D0N5OD HIGHSTAT Investigative D0N5QC DRUG__ID D0N5QC D0N5QC DRUGTYPE Small molecular drug D0N5QC DRUGINCH 1S/C19H23NO3/c1-3-22-15-7-4-11-10-13-12-5-6-14(21)18-19(12,8-9-20(13)2)16(11)17(15)23-18/h4-7,12-14,18,21H,3,8-10H2,1-2H3/t12-,13+,14-,18-,19-/m0/s1 D0N5QC DRUGINKE OGDVEMNWJVYAJL-LEPYJNQMSA-N D0N5QC DRUGSMIL CCOC1=C2C3=C(CC4C5C3(CCN4C)C(O2)C(C=C5)O)C=C1 D0N5QC HIGHSTAT Investigative D0N5RV DRUG__ID D0N5RV D0N5RV DRUGTYPE Small molecular drug D0N5RV DRUGINCH 1S/C29H39N5O3S2/c1-20-18-34-19-22-12-7-6-11-21(22)17-24(34)27(36)32-23(26(35)33-29(2,3)28(37)31-20)13-5-4-10-16-38-39-25-14-8-9-15-30-25/h6-9,11-12,14-15,20,23-24H,4-5,10,13,16-19H2,1-3H3,(H,31,37)(H,32,36)(H,33,35)/t20-,23-,24+/m0/s1 D0N5RV DRUGINKE ALYDIERJMKHYLO-NKKJXINNSA-N D0N5RV DRUGSMIL CC1CN2CC3=CC=CC=C3CC2C(=O)NC(C(=O)NC(C(=O)N1)(C)C)CCCCCSSC4=CC=CC=N4 D0N5RV HIGHSTAT Investigative D0N5TL DRUG__ID D0N5TL D0N5TL DRUGTYPE Small molecular drug D0N5TL DRUGINCH 1S/C38H43N5O5/c1-23-17-29(44)18-24(2)30(23)22-31(39)38(48)43-16-8-13-34(43)37(47)42-33(20-25-9-4-3-5-10-25)36(46)41-32(35(40)45)21-26-14-15-27-11-6-7-12-28(27)19-26/h3-7,9-12,14-15,17-19,31-34,44H,8,13,16,20-22,39H2,1-2H3,(H2,40,45)(H,41,46)(H,42,47)/t31-,32+,33-,34+/m0/s1 D0N5TL DRUGINKE XQWLHPWPDQSALN-GJZXTFMBSA-N D0N5TL DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC5=CC=CC=C5C=C4)C(=O)N)N)C)O D0N5TL HIGHSTAT Investigative D0N5VO DRUG__ID D0N5VO D0N5VO DRUGTYPE Small molecular drug D0N5VO DRUGINCH 1S/C20H32O/c1-4-5-6-14-20(2,3)18-12-10-16(11-13-18)17-8-7-9-19(21)15-17/h10-13,17,19,21H,4-9,14-15H2,1-3H3/t17-,19+/m0/s1 D0N5VO DRUGINKE RGRMJFXCHLLHAS-PKOBYXMFSA-N D0N5VO DRUGSMIL CCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0N5VO HIGHSTAT Investigative D0N5WV DRUG__ID D0N5WV D0N5WV DRUGTYPE Small molecular drug D0N5WV DRUGINCH 1S/C8H9NO4S/c1-14(12,13)9-7-4-2-6(3-5-7)8(10)11/h2-5,9H,1H3,(H,10,11) D0N5WV DRUGINKE SROHFTOYGFCJAF-UHFFFAOYSA-N D0N5WV DRUGSMIL CS(=O)(=O)NC1=CC=C(C=C1)C(=O)O D0N5WV HIGHSTAT Investigative D0N5XG DRUG__ID D0N5XG D0N5XG DRUGTYPE Small molecular drug D0N5XG DRUGINCH 1S/C14H12N2/c1-2-5-12(6-3-1)11-16-10-8-13-14(16)7-4-9-15-13/h1-10H,11H2 D0N5XG DRUGINKE LOGFFHFLSCMKJF-UHFFFAOYSA-N D0N5XG DRUGSMIL C1=CC=C(C=C1)CN2C=CC3=C2C=CC=N3 D0N5XG HIGHSTAT Investigative D0N6AM DRUG__ID D0N6AM D0N6AM DRUGTYPE Small molecular drug D0N6AM DRUGINCH 1S/C29H30BrClFN3O2/c30-22-5-1-19(2-6-22)26-18-24(35-13-15-37-16-14-35)9-10-25(26)29(36)34-28(20-3-7-23(31)8-4-20)21-11-12-33-27(32)17-21/h1-8,11-12,17,24-26,28H,9-10,13-16,18H2,(H,34,36)/t24-,25-,26+,28?/m1/s1 D0N6AM DRUGINKE ABJSOROVZZKJGI-OCYUSGCXSA-N D0N6AM DRUGSMIL C1CC(C(CC1N2CCOCC2)C3=CC=C(C=C3)Br)C(=O)NC(C4=CC=C(C=C4)Cl)C5=CC(=NC=C5)F D0N6AM HIGHSTAT Investigative D0N6AS DRUG__ID D0N6AS D0N6AS DRUGTYPE Small molecular drug D0N6AS DRUGINCH 1S/C49H64N12O9/c1-3-4-16-36(55-29(2)62)44(65)58-39-25-42(63)52-20-11-10-18-35(43(50)64)56-45(66)37(23-31-26-53-34-17-9-8-15-33(31)34)59-48(69)41-19-12-21-61(41)49(70)40(22-30-13-6-5-7-14-30)60-46(67)38(57-47(39)68)24-32-27-51-28-54-32/h5-9,13-15,17,26-28,35-41,53H,3-4,10-12,16,18-25H2,1-2H3,(H2,50,64)(H,51,54)(H,52,63)(H,55,62)(H,56,66)(H,57,68)(H,58,65)(H,59,69)(H,60,67)/t35-,36-,37-,38-,39-,40+,41-/m0/s1 D0N6AS DRUGINKE ZHWWUNQUSCAJKE-CQPWUTEUSA-N D0N6AS DRUGSMIL CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC1=O)CC3=CN=CN3)CC4=CC=CC=C4)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C D0N6AS HIGHSTAT Investigative D0N6AY DRUG__ID D0N6AY D0N6AY DRUGTYPE Small molecular drug D0N6AY DRUGINCH 1S/C10H12F3N/c1-7(14)5-8-3-2-4-9(6-8)10(11,12)13/h2-4,6-7H,5,14H2,1H3 D0N6AY DRUGINKE MLBHFBKZUPLWBD-UHFFFAOYSA-N D0N6AY DRUGSMIL CC(CC1=CC(=CC=C1)C(F)(F)F)N D0N6AY HIGHSTAT Investigative D0N6BC DRUG__ID D0N6BC D0N6BC DRUGTYPE Small molecular drug D0N6BC DRUGINCH 1S/C15H10N2O4S/c16-10-8-6-9(15(20)21)13(19)17-14(8)22-12(10)11(18)7-4-2-1-3-5-7/h1-6H,16H2,(H,17,19)(H,20,21) D0N6BC DRUGINKE OJHMDRZMENMQFP-UHFFFAOYSA-N D0N6BC DRUGSMIL C1=CC=C(C=C1)C(=O)C2=C(C3=C(S2)NC(=O)C(=C3)C(=O)O)N D0N6BC HIGHSTAT Investigative D0N6BY DRUG__ID D0N6BY D0N6BY DRUGTYPE Small molecular drug D0N6BY DRUGINCH 1S/C39H54N10O14S/c1-4-16(2)31-36(60)42-11-29(55)43-25-15-64(63)38-21(20-6-5-18(51)7-22(20)46-38)9-23(33(57)41-12-30(56)47-31)44-37(61)32(17(3)27(53)14-50)48-35(59)26-8-19(52)13-49(26)39(62)24(10-28(40)54)45-34(25)58/h5-7,16-17,19,23-27,31-32,46,50-53H,4,8-15H2,1-3H3,(H2,40,54)(H,41,57)(H,42,60)(H,43,55)(H,44,61)(H,45,58)(H,47,56)(H,48,59) D0N6BY DRUGINKE CIORWBWIBBPXCG-UHFFFAOYSA-N D0N6BY DRUGSMIL CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)C(CO)O)C5=C(N3)C=C(C=C5)O D0N6BY HIGHSTAT Investigative D0N6CB DRUG__ID D0N6CB D0N6CB DRUGTYPE Small molecular drug D0N6CB DRUGINCH 1S/C22H38N4OS/c1-3-10-24(11-4-1)14-7-15-26-17-9-20-21(19-26)28-22(23-20)27-18-8-16-25-12-5-2-6-13-25/h1-19H2 D0N6CB DRUGINKE SYMZYURRALQTPH-UHFFFAOYSA-N D0N6CB DRUGSMIL C1CCN(CC1)CCCN2CCC3=C(C2)SC(=N3)OCCCN4CCCCC4 D0N6CB HIGHSTAT Investigative D0N6CD DRUG__ID D0N6CD D0N6CD DRUGTYPE Small molecular drug D0N6CD DRUGINCH 1S/C13H25NO4S/c1-2-3-7-12(10-13(15)14-16)19(17,18)11-8-5-4-6-9-11/h11-12,16H,2-10H2,1H3,(H,14,15) D0N6CD DRUGINKE LUHJAOVICRNTRC-UHFFFAOYSA-N D0N6CD DRUGSMIL CCCCC(CC(=O)NO)S(=O)(=O)C1CCCCC1 D0N6CD HIGHSTAT Investigative D0N6CN DRUG__ID D0N6CN D0N6CN DRUGTYPE Small molecular drug D0N6CN DRUGINCH 1S/C13H19NO4/c1-3-4-9-17-11-5-7-12(8-6-11)18-10(2)13(15)14-16/h5-8,10,16H,3-4,9H2,1-2H3,(H,14,15) D0N6CN DRUGINKE PBEZWGMLOHXFDA-UHFFFAOYSA-N D0N6CN DRUGSMIL CCCCOC1=CC=C(C=C1)OC(C)C(=O)NO D0N6CN HIGHSTAT Investigative D0N6ES DRUG__ID D0N6ES D0N6ES DRUGTYPE Small molecular drug D0N6ES DRUGINCH 1S/C38H35N5O6S2/c1-41(50(45,46)36-11-5-7-29-26-39-19-17-33(29)36)35(38(44)43-23-21-42(22-24-43)31-9-3-2-4-10-31)25-28-13-15-32(16-14-28)49-51(47,48)37-12-6-8-30-27-40-20-18-34(30)37/h2-20,26-27,35H,21-25H2,1H3/t35-/m0/s1 D0N6ES DRUGINKE RJVLFQBBRSMWHX-DHUJRADRSA-N D0N6ES DRUGSMIL CN(C(CC1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C(=O)N4CCN(CC4)C5=CC=CC=C5)S(=O)(=O)C6=CC=CC7=C6C=CN=C7 D0N6ES HIGHSTAT Investigative D0N6FJ DRUG__ID D0N6FJ D0N6FJ DRUGTYPE Small molecular drug D0N6FJ DRUGINCH 1S/C12H6F2N2/c13-11-3-9(4-12(14)5-11)1-2-10-6-15-8-16-7-10/h3-8H D0N6FJ DRUGINKE AFBRTODAYUUWDJ-UHFFFAOYSA-N D0N6FJ DRUGSMIL C1=C(C=C(C=C1F)F)C#CC2=CN=CN=C2 D0N6FJ HIGHSTAT Investigative D0N6FL DRUG__ID D0N6FL D0N6FL DRUGTYPE Small molecular drug D0N6FL DRUGINCH 1S/C27H56/c1-25(2)21-17-13-10-8-6-7-9-11-15-19-23-27(5)24-20-16-12-14-18-22-26(3)4/h25-27H,6-24H2,1-5H3/t27-/m1/s1 D0N6FL DRUGINKE ZADHKSJXSZBQFB-HHHXNRCGSA-N D0N6FL DRUGSMIL CC(C)CCCCCCCCCCCCC(C)CCCCCCCC(C)C D0N6FL HIGHSTAT Investigative D0N6HL DRUG__ID D0N6HL D0N6HL DRUGTYPE Small molecular drug D0N6HL DRUGINCH 1S/C27H32ClN3O3S/c1-34-23-7-5-19-3-2-4-22(13-20(19)14-23)29-16-18-9-11-30(12-10-18)26(32)17-31-24-15-21(28)6-8-25(24)35-27(31)33/h5-8,14-15,18,22,29H,2-4,9-13,16-17H2,1H3 D0N6HL DRUGINKE RYHPEQQPQCIMIB-UHFFFAOYSA-N D0N6HL DRUGSMIL COC1=CC2=C(CCCC(C2)NCC3CCN(CC3)C(=O)CN4C5=C(C=CC(=C5)Cl)SC4=O)C=C1 D0N6HL HIGHSTAT Investigative D0N6HV DRUG__ID D0N6HV D0N6HV DRUGTYPE Small molecular drug D0N6HV DRUGINCH 1S/C21H10F6N4O3S/c22-20(23,24)15-5-3-13(4-6-15)17-8-18(21(25,26)27)31-19(30-17)14(10-29-31)2-1-12-7-16(11-28-9-12)35(32,33)34/h3-11H,(H,32,33,34) D0N6HV DRUGINKE VAQSOLIIQORHSP-UHFFFAOYSA-N D0N6HV DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=NN3C(=C2)C(F)(F)F)C#CC4=CC(=CN=C4)S(=O)(=O)O)C(F)(F)F D0N6HV HIGHSTAT Investigative D0N6IL DRUG__ID D0N6IL D0N6IL DRUGTYPE Small molecular drug D0N6IL DRUGINCH 1S/C22H26N2O/c1-2-3-4-10-15-23-21(25)16-19-18-13-8-9-14-20(18)24-22(19)17-11-6-5-7-12-17/h5-9,11-14,24H,2-4,10,15-16H2,1H3,(H,23,25) D0N6IL DRUGINKE SVHWOYODYBUWLL-UHFFFAOYSA-N D0N6IL DRUGSMIL CCCCCCNC(=O)CC1=C(NC2=CC=CC=C21)C3=CC=CC=C3 D0N6IL HIGHSTAT Investigative D0N6MR DRUG__ID D0N6MR D0N6MR DRUGTYPE Small molecular drug D0N6MR DRUGINCH 1S/C10H7N3O/c14-10-12-8-5-6-3-1-2-4-7(6)11-9(8)13-10/h1-5H,(H2,11,12,13,14) D0N6MR DRUGINKE BINWKEIURMBREF-UHFFFAOYSA-N D0N6MR DRUGSMIL C1=CC=C2C(=C1)C=C3C(=N2)NC(=O)N3 D0N6MR HIGHSTAT Investigative D0N6OH DRUG__ID D0N6OH D0N6OH DRUGTYPE Small molecular drug D0N6OH DRUGINCH 1S/C17H21NO2/c1-3-12-18-13-8-7-11-15(18)16(17(19)20-2)14-9-5-4-6-10-14/h1,4-6,9-10,15-16H,7-8,11-13H2,2H3/t15-,16-/m1/s1 D0N6OH DRUGINKE JZWSHRDYZHBSBM-HZPDHXFCSA-N D0N6OH DRUGSMIL COC(=O)C(C1CCCCN1CC#C)C2=CC=CC=C2 D0N6OH HIGHSTAT Investigative D0N6OL DRUG__ID D0N6OL D0N6OL DRUGTYPE Small molecular drug D0N6OL DRUGINCH 1S/C21H21ClN4O2/c1-14-18-12-16(24-20(27)13-28-17-7-4-15(22)5-8-17)6-9-19(18)25-21(23-14)26-10-2-3-11-26/h4-9,12H,2-3,10-11,13H2,1H3,(H,24,27) D0N6OL DRUGINKE MXDQNCXNQJMIEH-UHFFFAOYSA-N D0N6OL DRUGSMIL CC1=C2C=C(C=CC2=NC(=N1)N3CCCC3)NC(=O)COC4=CC=C(C=C4)Cl D0N6OL HIGHSTAT Investigative D0N6QM DRUG__ID D0N6QM D0N6QM DRUGTYPE Small molecular drug D0N6QM DRUGINCH 1S/C17H17NO3/c19-12-16(11-14-7-3-1-4-8-14)18-17(20)21-13-15-9-5-2-6-10-15/h1-10,12,16H,11,13H2,(H,18,20)/t16-/m0/s1 D0N6QM DRUGINKE HZDPJHOWPIVWMR-INIZCTEOSA-N D0N6QM DRUGSMIL C1=CC=C(C=C1)CC(C=O)NC(=O)OCC2=CC=CC=C2 D0N6QM HIGHSTAT Investigative D0N6QU DRUG__ID D0N6QU D0N6QU DRUGTYPE Small molecular drug D0N6QU DRUGINCH 1S/C20H20O6/c1-6-9-8(2)14(21)10-7-11-13(16(23)12(10)15(9)22)17(24)20(5,26)18(25)19(11,3)4/h7,23,26H,6H2,1-5H3 D0N6QU DRUGINKE MEDXQZJJCUKMBX-UHFFFAOYSA-N D0N6QU DRUGSMIL CCC1=C(C(=O)C2=CC3=C(C(=C2C1=O)O)C(=O)C(C(=O)C3(C)C)(C)O)C D0N6QU HIGHSTAT Investigative D0N6QW DRUG__ID D0N6QW D0N6QW DRUGTYPE Small molecular drug D0N6QW DRUGINCH 1S/C11H14BrNO2S/c12-9-3-1-2-8(6-9)7-16-5-4-10(13)11(14)15/h1-3,6,10H,4-5,7,13H2,(H,14,15) D0N6QW DRUGINKE NFPJCMSYLUNWCI-UHFFFAOYSA-N D0N6QW DRUGSMIL C1=CC(=CC(=C1)Br)CSCCC(C(=O)O)N D0N6QW HIGHSTAT Investigative D0N6TC DRUG__ID D0N6TC D0N6TC DRUGTYPE Small molecular drug D0N6TC DRUGINCH 1S/C19H22N2O4/c20-17(19(23)24)10-11-18(22)21-15-6-8-16(9-7-15)25-13-12-14-4-2-1-3-5-14/h1-9,17H,10-13,20H2,(H,21,22)(H,23,24)/t17-/m0/s1 D0N6TC DRUGINKE LXNLZSBSUTWVJA-KRWDZBQOSA-N D0N6TC DRUGSMIL C1=CC=C(C=C1)CCOC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D0N6TC HIGHSTAT Investigative D0N6XS DRUG__ID D0N6XS D0N6XS DRUGTYPE Small molecular drug D0N6XS DRUGINCH 1S/C22H19NOS/c1-2-17(16-10-4-3-5-11-16)22(24)23-18-12-6-8-14-20(18)25-21-15-9-7-13-19(21)23/h3-15,17H,2H2,1H3 D0N6XS DRUGINKE LASZSIUHSRRUPB-UHFFFAOYSA-N D0N6XS DRUGSMIL CCC(C1=CC=CC=C1)C(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0N6XS HIGHSTAT Investigative D0N6ZK DRUG__ID D0N6ZK D0N6ZK DRUGTYPE Small molecular drug D0N6ZK DRUGINCH 1S/C16H20N2O3S3/c1-16(2,3)14-17-10-7-11(21-4)9(8-12(10)24-14)18-15(22)23-6-5-13(19)20/h7-8H,5-6H2,1-4H3,(H,18,22)(H,19,20) D0N6ZK DRUGINKE SGSGNVTYYAWSKN-UHFFFAOYSA-N D0N6ZK DRUGSMIL CC(C)(C)C1=NC2=CC(=C(C=C2S1)NC(=S)SCCC(=O)O)OC D0N6ZK HIGHSTAT Investigative D0N6ZO DRUG__ID D0N6ZO D0N6ZO DRUGTYPE Small molecular drug D0N6ZO DRUGINCH 1S/C30H35NO9/c1-31-13-12-28-15-23(39-24(33)11-7-17-6-9-20(35-2)19(32)14-17)27(37-4)30(38-5)29(28,31)16-22(40-30)18-8-10-21(36-3)26(34)25(18)28/h6-11,14,22-23,27,32,34H,12-13,15-16H2,1-5H3/b11-7+/t22-,23-,27-,28-,29-,30+/m0/s1 D0N6ZO DRUGINKE CDTWAPXUQYEAIP-YYRBTORNSA-N D0N6ZO DRUGSMIL CN1CCC23C14CC(C5=C2C(=C(C=C5)OC)O)OC4(C(C(C3)OC(=O)C=CC6=CC(=C(C=C6)OC)O)OC)OC D0N6ZO HIGHSTAT Investigative D0N7AJ DRUG__ID D0N7AJ D0N7AJ DRUGTYPE Small molecular drug D0N7AJ DRUGINCH 1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37) D0N7AJ DRUGINKE ODPGGGTTYSGTGO-UHFFFAOYSA-N D0N7AJ DRUGSMIL CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC=NC(=C4)NC)C(F)(F)F D0N7AJ HIGHSTAT Investigative D0N7BP DRUG__ID D0N7BP D0N7BP DRUGTYPE Small molecular drug D0N7BP DRUGINCH 1S/C34H57N11O8/c1-18(2)16-24(40-28(47)23(14-11-15-38-32(36)37)41-34(52)53-17-22-12-9-8-10-13-22)29(48)42-26(20(5)6)31(50)44-45-33(51)43-25(19(3)4)30(49)39-21(7)27(35)46/h8-10,12-13,18-21,23-26H,11,14-17H2,1-7H3,(H2,35,46)(H,39,49)(H,40,47)(H,41,52)(H,42,48)(H,44,50)(H4,36,37,38)(H2,43,45,51) D0N7BP DRUGINKE OILQRSUIXCAKPE-UHFFFAOYSA-N D0N7BP DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(C(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1 D0N7BP HIGHSTAT Investigative D0N7CQ DRUG__ID D0N7CQ D0N7CQ DRUGTYPE Small molecular drug D0N7CQ DRUGINCH 1S/C18H18N2O2/c1-2-16(20-10-9-19-12-20)14-5-3-13(4-6-14)15-7-8-17(21)18(22)11-15/h3-12,16,21-22H,2H2,1H3 D0N7CQ DRUGINKE AJXMMNNBZYGUFM-UHFFFAOYSA-N D0N7CQ DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC(=C(C=C2)O)O)N3C=CN=C3 D0N7CQ HIGHSTAT Investigative D0N7HS DRUG__ID D0N7HS D0N7HS DRUGCOMP Astellas Pharma Inc D0N7HS DRUGINCH 1S/C20H19ClN2O3/c1-3-23-19-15(8-7-12(2)22-19)18(13-5-4-6-14(21)11-13)16(20(23)26)9-10-17(24)25/h4-8,11H,3,9-10H2,1-2H3,(H,24,25) D0N7HS DRUGINKE XYFVLSWIYKWKTC-UHFFFAOYSA-N D0N7HS DRUGSMIL CCN1C2=C(C=CC(=N2)C)C(=C(C1=O)CCC(=O)O)C3=CC(=CC=C3)Cl D0N7HS HIGHSTAT Investigative D0N7HY DRUG__ID D0N7HY D0N7HY DRUGTYPE Small molecular drug D0N7HY DRUGINCH 1S/C10H11ClF3N3/c11-9-7(10(12,13)14)1-2-8(16-9)17-5-3-15-4-6-17/h1-2,15H,3-6H2 D0N7HY DRUGINKE QZYYPQAYSFBKPW-UHFFFAOYSA-N D0N7HY DRUGSMIL C1CN(CCN1)C2=NC(=C(C=C2)C(F)(F)F)Cl D0N7HY HIGHSTAT Investigative D0N7IH DRUG__ID D0N7IH D0N7IH DRUGTYPE Small molecular drug D0N7IH DRUGINCH 1S/C11H12N4O2/c12-5-6-13-11-4-1-8-7-9(15(16)17)2-3-10(8)14-11/h1-4,7H,5-6,12H2,(H,13,14) D0N7IH DRUGINKE ULJORSRDDXAXJZ-UHFFFAOYSA-N D0N7IH DRUGSMIL C1=CC2=C(C=CC(=N2)NCCN)C=C1[N+](=O)[O-] D0N7IH HIGHSTAT Investigative D0N7KK DRUG__ID D0N7KK D0N7KK DRUGTYPE Small molecular drug D0N7KK DRUGINCH 1S/C15H20N2O/c1-18-14-4-5-15-12(11-14)10-13(16-15)6-9-17-7-2-3-8-17/h4-5,10-11,16H,2-3,6-9H2,1H3 D0N7KK DRUGINKE UXDACHZONACAIV-UHFFFAOYSA-N D0N7KK DRUGSMIL COC1=CC2=C(C=C1)NC(=C2)CCN3CCCC3 D0N7KK HIGHSTAT Investigative D0N7MS DRUG__ID D0N7MS D0N7MS DRUGTYPE Small molecular drug D0N7MS DRUGINCH 1S/C21H23NO3/c1-2-3-4-7-16-10-12-17(13-11-16)14-15-20(23)22-19-9-6-5-8-18(19)21(24)25/h5-6,8-15H,2-4,7H2,1H3,(H,22,23)(H,24,25)/b15-14+ D0N7MS DRUGINKE GAMRBCZMOOMBSQ-CCEZHUSRSA-N D0N7MS DRUGSMIL CCCCCC1=CC=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O D0N7MS HIGHSTAT Investigative D0N7NB DRUG__ID D0N7NB D0N7NB DRUGTYPE Small molecular drug D0N7NB DRUGINCH 1S/C18H25NO3S/c1-2-3-4-5-6-7-8-9-10-11-13-15(20)14-18(23-12-19-14)17(22)16(13)21/h12,20H,2-11H2,1H3 D0N7NB DRUGINKE VSIBLXWNANVQDH-UHFFFAOYSA-N D0N7NB DRUGSMIL CCCCCCCCCCCC1=C(C2=C(C(=O)C1=O)SC=N2)O D0N7NB HIGHSTAT Investigative D0N7NK DRUG__ID D0N7NK D0N7NK DRUGTYPE Small molecular drug D0N7NK DRUGINCH 1S/C17H18ClN5O2S2/c1-22(2)6-5-11-10-19-14-4-3-12(9-13(11)14)21-27(24,25)16-15(18)20-17-23(16)7-8-26-17/h3-4,7-10,19,21H,5-6H2,1-2H3 D0N7NK DRUGINKE RZAXUKVIIWUIOM-UHFFFAOYSA-N D0N7NK DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)NS(=O)(=O)C3=C(N=C4N3C=CS4)Cl D0N7NK HIGHSTAT Investigative D0N7OP DRUG__ID D0N7OP D0N7OP DRUGTYPE Small molecular drug D0N7OP DRUGINCH 1S/C16H14O/c1-17-16-9-5-4-8-15(16)14-10-12-6-2-3-7-13(12)11-14/h2-10H,11H2,1H3 D0N7OP DRUGINKE APOFCYAJMPJCJI-UHFFFAOYSA-N D0N7OP DRUGSMIL COC1=CC=CC=C1C2=CC3=CC=CC=C3C2 D0N7OP HIGHSTAT Investigative D0N7OV DRUG__ID D0N7OV D0N7OV DRUGTYPE Small molecular drug D0N7OV DRUGINCH 1S/C21H21ClN2O/c22-15-10-8-14(9-11-15)20-13-17(16-5-1-2-6-18(16)24-20)21(25)19-7-3-4-12-23-19/h1-2,5-6,8-11,13,19,21,23,25H,3-4,7,12H2 D0N7OV DRUGINKE VKLJPGAHSLIQKH-UHFFFAOYSA-N D0N7OV DRUGSMIL C1CCNC(C1)C(C2=CC(=NC3=CC=CC=C32)C4=CC=C(C=C4)Cl)O D0N7OV HIGHSTAT Investigative D0N7QV DRUG__ID D0N7QV D0N7QV DRUGTYPE Small molecular drug D0N7QV DRUGINCH 1S/C12H9N3/c1-10(15-7-6-14-9-15)12-4-2-11(8-13)3-5-12/h2-7,9H,1H2 D0N7QV DRUGINKE FUFISTOVGRWOOB-UHFFFAOYSA-N D0N7QV DRUGSMIL C=C(C1=CC=C(C=C1)C#N)N2C=CN=C2 D0N7QV HIGHSTAT Investigative D0N7RK DRUG__ID D0N7RK D0N7RK DRUGTYPE Small molecular drug D0N7RK DRUGINCH 1S/C30H33FO4/c1-3-30(4-2,23-8-6-5-7-9-23)24-14-10-21(13-17-26(32)19-27(33)20-29(34)35)28(18-24)22-11-15-25(31)16-12-22/h5-18,26-27,32-33H,3-4,19-20H2,1-2H3,(H,34,35)/p-1/b17-13+/t26-,27-/m1/s1 D0N7RK DRUGINKE VICOOSNNZUPVHM-IGPZRPDBSA-M D0N7RK DRUGSMIL CCC(CC)(C1=CC=CC=C1)C2=CC(=C(C=C2)C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F D0N7RK HIGHSTAT Investigative D0N7RW DRUG__ID D0N7RW D0N7RW DRUGTYPE Small molecular drug D0N7RW DRUGINCH 1S/C10H12FNO2/c1-6(2)12-10(14)8-5-7(11)3-4-9(8)13/h3-6,13H,1-2H3,(H,12,14) D0N7RW DRUGINKE OQHZTWFYOJLOMH-UHFFFAOYSA-N D0N7RW DRUGSMIL CC(C)NC(=O)C1=C(C=CC(=C1)F)O D0N7RW HIGHSTAT Investigative D0N7UE DRUG__ID D0N7UE D0N7UE DRUGTYPE Small molecular drug D0N7UE DRUGINCH 1S/C11H11N5/c1-2-9-10(13-4-3-12-9)7-8(1)16-11-14-5-6-15-11/h1-4,7H,5-6H2,(H2,14,15,16) D0N7UE DRUGINKE PVKUNRLEOHFACD-UHFFFAOYSA-N D0N7UE DRUGSMIL C1CN=C(N1)NC2=CC3=NC=CN=C3C=C2 D0N7UE HIGHSTAT Investigative D0N7VL DRUG__ID D0N7VL D0N7VL DRUGTYPE Small molecular drug D0N7VL DRUGINCH 1S/C20H29BrN3O9P/c1-10(2)7-15(20(29)30)24-19(28)14(23-18(27)13(22)9-16(25)26)8-11-3-5-12(6-4-11)17(21)34(31,32)33/h3-6,10,13-15,17H,7-9,22H2,1-2H3,(H,23,27)(H,24,28)(H,25,26)(H,29,30)(H2,31,32,33)/t13-,14-,15-,17?/m0/s1 D0N7VL DRUGINKE VZSILTSENHCLNI-CKSGOKGCSA-N D0N7VL DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=C(C=C1)C(P(=O)(O)O)Br)NC(=O)C(CC(=O)O)N D0N7VL HIGHSTAT Investigative D0N7WP DRUG__ID D0N7WP D0N7WP DRUGTYPE Small molecular drug D0N7WP DRUGINCH 1S/C13H13N3O3S/c14-20(18,19)12-6-4-10(5-7-12)16-13(17)9-11-3-1-2-8-15-11/h1-8H,9H2,(H,16,17)(H2,14,18,19) D0N7WP DRUGINKE AVVKIKWNABJSCP-UHFFFAOYSA-N D0N7WP DRUGSMIL C1=CC=NC(=C1)CC(=O)NC2=CC=C(C=C2)S(=O)(=O)N D0N7WP HIGHSTAT Investigative D0N7XM DRUG__ID D0N7XM D0N7XM DRUGTYPE Small molecular drug D0N7XM DRUGINCH 1S/C18H18O6/c19-13-3-1-9(5-15(13)21)17-11-7-24-18(12(11)8-23-17)10-2-4-14(20)16(22)6-10/h1-6,11-12,17-22H,7-8H2/t11-,12-,17+,18+/m1/s1 D0N7XM DRUGINKE OQSOTSIYXPYTRE-VVDPLQPHSA-N D0N7XM DRUGSMIL C1C2C(COC2C3=CC(=C(C=C3)O)O)C(O1)C4=CC(=C(C=C4)O)O D0N7XM HIGHSTAT Investigative D0N7YT DRUG__ID D0N7YT D0N7YT DRUGTYPE Small molecular drug D0N7YT DRUGINCH 1S/C20H19NO2/c1-12(2)17-18(21-14-10-8-13(3)9-11-14)15-6-4-5-7-16(15)19(22)20(17)23/h4-12,21H,1-3H3 D0N7YT DRUGINKE JFLZSYUNGPXQEX-UHFFFAOYSA-N D0N7YT DRUGSMIL CC1=CC=C(C=C1)NC2=C(C(=O)C(=O)C3=CC=CC=C32)C(C)C D0N7YT HIGHSTAT Investigative D0N8AO DRUG__ID D0N8AO D0N8AO DRUGTYPE Small molecular drug D0N8AO DRUGINCH 1S/C16H19N3O2S/c20-22(21,16-4-2-1-3-5-16)18-14-6-8-15(9-7-14)19-12-10-17-11-13-19/h1-9,17-18H,10-13H2 D0N8AO DRUGINKE LHOHHFFMBNKDDU-UHFFFAOYSA-N D0N8AO DRUGSMIL C1CN(CCN1)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=CC=C3 D0N8AO HIGHSTAT Investigative D0N8BJ DRUG__ID D0N8BJ D0N8BJ DRUGTYPE Small molecular drug D0N8BJ DRUGINCH 1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2/i3T,4T D0N8BJ DRUGINKE QZAYGJVTTNCVMB-PZFLKRBQSA-N D0N8BJ DRUGSMIL C1=CC2=C(C=C1O)C(=CN2)CCN D0N8BJ HIGHSTAT Investigative D0N8CN DRUG__ID D0N8CN D0N8CN DRUGCOMP Novartis AG D0N8CN DRUGINCH 1S/C29H33F2N7O/c1-19-16-37(17-20(2)33-19)23-5-3-22(4-6-23)34-29-32-15-21-7-8-38(28(21)35-29)24-13-26(30)25(27(31)14-24)18-36-9-11-39-12-10-36/h3-8,13-15,19-20,33H,9-12,16-18H2,1-2H3,(H,32,34,35)/t19-,20+ D0N8CN DRUGINKE VIIPVCPPCBLRRL-BGYRXZFFSA-N D0N8CN DRUGSMIL CC1CN(CC(N1)C)C2=CC=C(C=C2)NC3=NC=C4C=CN(C4=N3)C5=CC(=C(C(=C5)F)CN6CCOCC6)F D0N8CN HIGHSTAT Investigative D0N8EC DRUG__ID D0N8EC D0N8EC DRUGTYPE Small molecular drug D0N8EC DRUGINCH 1S/C40H52N6O4/c1-25-17-27-19-33-31(9-11-35(47)41-33)39(21-25)29(27)7-5-13-45(39)37(49)23-43(3)15-16-44(4)24-38(50)46-14-6-8-30-28-18-26(2)22-40(30,46)32-10-12-36(48)42-34(32)20-28/h9-12,17-18,27-30H,5-8,13-16,19-24H2,1-4H3,(H,41,47)(H,42,48)/t27?,28?,29-,30-,39-,40-/m1/s1 D0N8EC DRUGINKE CTEOPWRYKGOSFE-KUNPEOQISA-N D0N8EC DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4C(=O)CN(C)CCN(C)CC(=O)N5CCCC6C57CC(=CC6CC8=C7C=CC(=O)N8)C D0N8EC HIGHSTAT Investigative D0N8EI DRUG__ID D0N8EI D0N8EI DRUGTYPE Small molecular drug D0N8EI DRUGINCH 1S/C21H23N3O/c1-3-4-13-24(2)19-11-9-16(10-12-19)21(25)23-18-14-17-7-5-6-8-20(17)22-15-18/h5-12,14-15H,3-4,13H2,1-2H3,(H,23,25) D0N8EI DRUGINKE UYXXRZNAVMFMMG-UHFFFAOYSA-N D0N8EI DRUGSMIL CCCCN(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D0N8EI HIGHSTAT Investigative D0N8EL DRUG__ID D0N8EL D0N8EL DRUGTYPE Small molecular drug D0N8EL DRUGINCH 1S/C19H27ClN2O4.ClH/c1-2-3-6-22-7-4-13(5-8-22)12-26-19(23)14-11-15(20)16(21)18-17(14)24-9-10-25-18;/h11,13H,2-10,12,21H2,1H3;1H D0N8EL DRUGINKE YEQGKAOSYSXEPU-UHFFFAOYSA-N D0N8EL DRUGSMIL CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)N)Cl.Cl D0N8EL HIGHSTAT Investigative D0N8EU DRUG__ID D0N8EU D0N8EU DRUGTYPE Small molecular drug D0N8EU DRUGINCH 1S/C7H16N4O2/c1-11(7(9)10)4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H3,9,10)(H,12,13)/t5-/m0/s1 D0N8EU DRUGINKE XKCWNEVAXQCMGP-YFKPBYRVSA-N D0N8EU DRUGSMIL CN(CCCC(C(=O)O)N)C(=N)N D0N8EU HIGHSTAT Investigative D0N8FU DRUG__ID D0N8FU D0N8FU DRUGTYPE Small molecular drug D0N8FU DRUGINCH 1S/C16H17NO/c1-16(2,3)18-11-8-9-13-12-6-4-5-7-14(12)17-15(13)10-11/h4-10,17H,1-3H3 D0N8FU DRUGINKE VSDPUTYQQKWFAG-UHFFFAOYSA-N D0N8FU DRUGSMIL CC(C)(C)OC1=CC2=C(C=C1)C3=CC=CC=C3N2 D0N8FU HIGHSTAT Investigative D0N8KZ DRUG__ID D0N8KZ D0N8KZ DRUGTYPE Small molecular drug D0N8KZ DRUGINCH 1S/C12H8N2O6S/c15-13(16)9-5-1-3-7-11(9)21(19,20)12-8-4-2-6-10(12)14(17)18/h1-8H D0N8KZ DRUGINKE IHZVFZOUXUNSPQ-UHFFFAOYSA-N D0N8KZ DRUGSMIL C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)C2=CC=CC=C2[N+](=O)[O-] D0N8KZ HIGHSTAT Investigative D0N8LP DRUG__ID D0N8LP D0N8LP DRUGTYPE Small molecular drug D0N8LP DRUGINCH 1S/C158H251N39O46S/c1-17-84(9)126(153(237)182-102(44-29-34-65-163)137(221)186-112(74-118(166)206)142(226)171-86(11)131(215)183-110(73-94-48-52-96(204)53-49-94)146(230)177-99(41-26-31-62-160)135(219)175-98(40-25-30-61-159)134(218)170-78-122(210)173-106(158(242)243)56-59-124(213)214)193-154(238)127(85(10)18-2)192-132(216)87(12)172-143(227)113(75-119(167)207)185-136(220)100(42-27-32-63-161)178-147(231)111(72-92-38-23-20-24-39-92)184-144(228)107(68-81(3)4)188-155(239)129(89(14)201)195-152(236)125(83(7)8)191-148(232)108(69-82(5)6)187-151(235)116-45-35-66-197(116)157(241)130(90(15)202)196-140(224)103(54-57-117(165)205)179-149(233)114(79-198)189-138(222)101(43-28-33-64-162)176-139(223)104(55-58-123(211)212)180-150(234)115(80-199)190-156(240)128(88(13)200)194-141(225)105(60-67-244-16)181-145(229)109(71-91-36-21-19-22-37-91)174-121(209)77-168-120(208)76-169-133(217)97(164)70-93-46-50-95(203)51-47-93/h19-24,36-39,46-53,81-90,97-116,125-130,198-204H,17-18,25-35,40-45,54-80,159-164H2,1-16H3,(H2,165,205)(H2,166,206)(H2,167,207)(H,168,208)(H,169,217)(H,170,218)(H,171,226)(H,172,227)(H,173,210)(H,174,209)(H,175,219)(H,176,223)(H,177,230)(H,178,231)(H,179,233)(H,180,234)(H,181,229)(H,182,237)(H,183,215)(H,184,228)(H,185,220)(H,186,221)(H,187,235)(H,188,239)(H,189,222)(H,190,240)(H,191,232)(H,192,216)(H,193,238)(H,194,225)(H,195,236)(H,196,224)(H,211,212)(H,213,214)(H,242,243)/t84-,85-,86-,87-,88+,89+,90+,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,125-,126-,127-,128-,129-,130-/m0/s1 D0N8LP DRUGINKE JMHFFDIMOUKDCZ-NTXHZHDSSA-N D0N8LP DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C3CCCN3C(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CCSC)NC(=O)C(CC4=CC=CC=C4)NC(=O)CNC(=O)CNC(=O)C(CC5=CC=C(C=C5)O)N D0N8LP HIGHSTAT Investigative D0N8LR DRUG__ID D0N8LR D0N8LR DRUGTYPE Small molecular drug D0N8LR DRUGINCH 1S/C9H12N2O3S/c1-2-9(12)11-7-3-5-8(6-4-7)15(10,13)14/h3-6H,2H2,1H3,(H,11,12)(H2,10,13,14) D0N8LR DRUGINKE KEFCIQSZJXXOLO-UHFFFAOYSA-N D0N8LR DRUGSMIL CCC(=O)NC1=CC=C(C=C1)S(=O)(=O)N D0N8LR HIGHSTAT Investigative D0N8MN DRUG__ID D0N8MN D0N8MN DRUGTYPE Small molecular drug D0N8MN DRUGINCH 1S/C22H24N2O3/c1-16(2)20-19(13-17-9-5-3-6-10-17)24(22(26)23-21(20)25)15-27-14-18-11-7-4-8-12-18/h3-12,16H,13-15H2,1-2H3,(H,23,25,26) D0N8MN DRUGINKE KSAAUHMSLCPIEX-UHFFFAOYSA-N D0N8MN DRUGSMIL CC(C)C1=C(N(C(=O)NC1=O)COCC2=CC=CC=C2)CC3=CC=CC=C3 D0N8MN HIGHSTAT Investigative D0N8OO DRUG__ID D0N8OO D0N8OO DRUGTYPE Small molecular drug D0N8OO DRUGINCH 1S/C25H26O6/c1-13(2)5-6-16-17(9-14-7-8-25(3,4)31-24(14)23(16)29)20-12-19(28)22-18(27)10-15(26)11-21(22)30-20/h5,7-11,20,26-27,29H,6,12H2,1-4H3/t20-/m1/s1 D0N8OO DRUGINKE WPVMLODCRMLWMB-HXUWFJFHSA-N D0N8OO DRUGSMIL CC(=CCC1=C(C=C2C=CC(OC2=C1O)(C)C)C3CC(=O)C4=C(C=C(C=C4O3)O)O)C D0N8OO HIGHSTAT Investigative D0N8PI DRUG__ID D0N8PI D0N8PI DRUGTYPE Small molecular drug D0N8PI DRUGINCH 1S/C13H9ClN2S/c14-9-3-1-4-10(7-9)17-13-6-2-5-12(16)11(13)8-15/h1-7H,16H2 D0N8PI DRUGINKE IQGAOZOACGWEAI-UHFFFAOYSA-N D0N8PI DRUGSMIL C1=CC(=CC(=C1)Cl)SC2=CC=CC(=C2C#N)N D0N8PI HIGHSTAT Investigative D0N8QD DRUG__ID D0N8QD D0N8QD DRUGTYPE Small molecular drug D0N8QD DRUGINCH 1S/C11H12N2O/c14-8-11-3-1-10(2-4-11)7-13-6-5-12-9-13/h1-6,9,14H,7-8H2 D0N8QD DRUGINKE FSLVBXCLXDGFRE-UHFFFAOYSA-N D0N8QD DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)CO D0N8QD HIGHSTAT Investigative D0N8RD DRUG__ID D0N8RD D0N8RD DRUGTYPE Small molecular drug D0N8RD DRUGINCH 1S/C19H21N3O3S/c1-2-13(15-5-8-18-16(11-15)9-10-21-18)12-22-19(23)14-3-6-17(7-4-14)26(20,24)25/h3-11,13,21H,2,12H2,1H3,(H,22,23)(H2,20,24,25)/t13-/m1/s1 D0N8RD DRUGINKE FSRPBGBMEKDSIJ-CYBMUJFWSA-N D0N8RD DRUGSMIL CCC(CNC(=O)C1=CC=C(C=C1)S(=O)(=O)N)C2=CC3=C(C=C2)NC=C3 D0N8RD HIGHSTAT Investigative D0N8RM DRUG__ID D0N8RM D0N8RM DRUGTYPE Small molecular drug D0N8RM DRUGINCH 1S/C7H9N5O/c8-6-5-7(10-3-9-6)12(1-2-13)4-11-5/h3-4,13H,1-2H2,(H2,8,9,10) D0N8RM DRUGINKE VAQOTZQDXZDBJK-UHFFFAOYSA-N D0N8RM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)CCO)N D0N8RM HIGHSTAT Investigative D0N8RT DRUG__ID D0N8RT D0N8RT DRUGTYPE Small molecular drug D0N8RT DRUGINCH 1S/C14H14N2O2/c17-13(10-5-1-2-6-10)14-16-9-12(18-14)11-7-3-4-8-15-11/h3-4,7-10H,1-2,5-6H2 D0N8RT DRUGINKE CZXHLRXAHDZQJF-UHFFFAOYSA-N D0N8RT DRUGSMIL C1CCC(C1)C(=O)C2=NC=C(O2)C3=CC=CC=N3 D0N8RT HIGHSTAT Investigative D0N8TA DRUG__ID D0N8TA D0N8TA DRUGTYPE Small molecular drug D0N8TA DRUGINCH 1S/C21H34N4O10/c1-5-10(2)17(22-12(4)28)20(34)24-14(6-7-15(29)30)19(33)25-18(11(3)27)21(35)23-13(9-26)8-16(31)32/h9-11,13-14,17-18,27H,5-8H2,1-4H3,(H,22,28)(H,23,35)(H,24,34)(H,25,33)(H,29,30)(H,31,32)/t10-,11+,13-,14-,17-,18-/m0/s1 D0N8TA DRUGINKE AXTKTZHLZLOIIO-PBEPODTISA-N D0N8TA DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C=O)NC(=O)C D0N8TA HIGHSTAT Investigative D0N8TQ DRUG__ID D0N8TQ D0N8TQ DRUGTYPE Small molecular drug D0N8TQ DRUGINCH 1S/C17H14N4O/c1-2-16(22)20-13-8-9-15-14(10-13)17(19-11-18-15)21-12-6-4-3-5-7-12/h2-11H,1H2,(H,20,22)(H,18,19,21) D0N8TQ DRUGINKE JGWHILNNHLDARR-UHFFFAOYSA-N D0N8TQ DRUGSMIL C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC=CC=C3 D0N8TQ HIGHSTAT Investigative D0N8UD DRUG__ID D0N8UD D0N8UD DRUGTYPE Small molecular drug D0N8UD DRUGINCH 1S/C21H13F5N2O/c22-16-4-1-14(2-5-16)20(29,21(24,25)26)15-3-10-19-13(11-15)12-27-28(19)18-8-6-17(23)7-9-18/h1-12,29H D0N8UD DRUGINKE KMBFENZTPAWDBF-UHFFFAOYSA-N D0N8UD DRUGSMIL C1=CC(=CC=C1C(C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)(C(F)(F)F)O)F D0N8UD HIGHSTAT Investigative D0N8UE DRUG__ID D0N8UE D0N8UE DRUGTYPE Small molecular drug D0N8UE DRUGINCH 1S/C13H16N2/c1-2-5-12(6-3-1)8-10-14-11-13-7-4-9-15-13/h1-7,9,14-15H,8,10-11H2 D0N8UE DRUGINKE HKFLTDDIRURSLM-UHFFFAOYSA-N D0N8UE DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC=CN2 D0N8UE HIGHSTAT Investigative D0N8VZ DRUG__ID D0N8VZ D0N8VZ DRUGTYPE Small molecular drug D0N8VZ DRUGINCH 1S/C20H30N2O6S2/c1-3-12-10-16-13(11-18(12)27-29(21,23)24)4-5-15-14(16)8-9-20(2)17(15)6-7-19(20)28-30(22,25)26/h10-11,14-15,17,19H,3-9H2,1-2H3,(H2,21,23,24)(H2,22,25,26)/t14-,15+,17-,19-,20-/m0/s1 D0N8VZ DRUGINKE LDOGEZTUWBORPG-SSGANFLRSA-N D0N8VZ DRUGSMIL CCC1=C(C=C2CCC3C(C2=C1)CCC4(C3CCC4OS(=O)(=O)N)C)OS(=O)(=O)N D0N8VZ HIGHSTAT Investigative D0N8WR DRUG__ID D0N8WR D0N8WR DRUGTYPE Small molecular drug D0N8WR DRUGINCH 1S/C23H29IN2O/c24-21-8-4-5-18(15-21)16-25-12-11-23(27)22(17-25)26-13-9-20(10-14-26)19-6-2-1-3-7-19/h1-8,15,20,22-23,27H,9-14,16-17H2/t22-,23-/m1/s1 D0N8WR DRUGINKE UBVKSFDICLMPLH-DHIUTWEWSA-N D0N8WR DRUGSMIL C1CN(CCC1C2=CC=CC=C2)C3CN(CCC3O)CC4=CC(=CC=C4)I D0N8WR HIGHSTAT Investigative D0N8YA DRUG__ID D0N8YA D0N8YA DRUGTYPE Small molecular drug D0N8YA DRUGINCH 1S/C16H31N3O4/c1-7-8-9-12(10-19(23)11-20)14(21)17-13(16(2,3)4)15(22)18(5)6/h11-13,23H,7-10H2,1-6H3,(H,17,21)/t12-,13-/m1/s1 D0N8YA DRUGINKE AVDLWYHBABSSHC-CHWSQXEVSA-N D0N8YA DRUGSMIL CCCCC(CN(C=O)O)C(=O)NC(C(=O)N(C)C)C(C)(C)C D0N8YA HIGHSTAT Investigative D0N8YG DRUG__ID D0N8YG D0N8YG DRUGTYPE Small molecular drug D0N8YG DRUGINCH 1S/C11H15N3O/c1-7(12)6-14-11-8(2)10(15)4-3-9(11)5-13-14/h3-5,7,15H,6,12H2,1-2H3/t7-/m0/s1 D0N8YG DRUGINKE UFWMKRXWOOOKPI-ZETCQYMHSA-N D0N8YG DRUGSMIL CC1=C(C=CC2=C1N(N=C2)CC(C)N)O D0N8YG HIGHSTAT Investigative D0N8YZ DRUG__ID D0N8YZ D0N8YZ DRUGTYPE Small molecular drug D0N8YZ DRUGINCH 1S/C16H14O2/c1-11-8-9-14(10-12(11)2)16(18)15(17)13-6-4-3-5-7-13/h3-10H,1-2H3 D0N8YZ DRUGINKE UJARQLWFLLIFBN-UHFFFAOYSA-N D0N8YZ DRUGSMIL CC1=C(C=C(C=C1)C(=O)C(=O)C2=CC=CC=C2)C D0N8YZ HIGHSTAT Investigative D0N8ZS DRUG__ID D0N8ZS D0N8ZS DRUGTYPE Small molecular drug D0N8ZS DRUGINCH 1S/C15H16N2O3/c18-15(19)14-3-1-11-9-12(2-4-13(11)14)20-8-7-17-6-5-16-10-17/h2,4-6,9-10,14H,1,3,7-8H2,(H,18,19) D0N8ZS DRUGINKE IRWWXLHSNMVHNY-UHFFFAOYSA-N D0N8ZS DRUGSMIL C1CC2=C(C1C(=O)O)C=CC(=C2)OCCN3C=CN=C3 D0N8ZS HIGHSTAT Investigative D0N9AK DRUG__ID D0N9AK D0N9AK DRUGTYPE Small molecular drug D0N9AK DRUGINCH 1S/C17H11F5N2O3/c18-13-11(14(19)16(21)17(22)15(13)20)8-27-23-7-10-3-1-9(2-4-10)5-6-12(25)24-26/h1-7,26H,8H2,(H,24,25)/b6-5+,23-7+ D0N9AK DRUGINKE ATRIOAVZXXVRHX-UDVGQSQZSA-N D0N9AK DRUGSMIL C1=CC(=CC=C1C=CC(=O)NO)C=NOCC2=C(C(=C(C(=C2F)F)F)F)F D0N9AK HIGHSTAT Investigative D0N9DB DRUG__ID D0N9DB D0N9DB DRUGTYPE Small molecular drug D0N9DB DRUGINCH 1S/C16H10N2O/c17-10-4-5-11-13(8-10)16(19)12-3-1-2-9-6-7-18-15(11)14(9)12/h1-8H,17H2 D0N9DB DRUGINKE SWTAISDIUOZWOE-UHFFFAOYSA-N D0N9DB DRUGSMIL C1=CC2=C3C(=C1)C(=O)C4=C(C3=NC=C2)C=CC(=C4)N D0N9DB HIGHSTAT Investigative D0N9DG DRUG__ID D0N9DG D0N9DG DRUGTYPE Small molecular drug D0N9DG DRUGINCH 1S/C14H14N2O/c1-9(2)17-14-7-11-10-5-3-4-6-12(10)16-13(11)8-15-14/h3-9,16H,1-2H3 D0N9DG DRUGINKE AKHQVIZELNFWSQ-UHFFFAOYSA-N D0N9DG DRUGSMIL CC(C)OC1=NC=C2C(=C1)C3=CC=CC=C3N2 D0N9DG HIGHSTAT Investigative D0N9DP DRUG__ID D0N9DP D0N9DP DRUGTYPE Small molecular drug D0N9DP DRUGINCH 1S/C22H36O4/c1-3-5-7-9-11-13-15-18-17-20(24)21(22(25)26-18)19(23)16-14-12-10-8-6-4-2/h17,24H,3-16H2,1-2H3 D0N9DP DRUGINKE NLATVPVYSKNDRM-UHFFFAOYSA-N D0N9DP DRUGSMIL CCCCCCCCC1=CC(=C(C(=O)O1)C(=O)CCCCCCCC)O D0N9DP HIGHSTAT Investigative D0N9DY DRUG__ID D0N9DY D0N9DY DRUGTYPE Small molecular drug D0N9DY DRUGINCH 1S/C19H20INO4/c1-21-5-4-10-15-12(21)6-9-7-13(22)14(24-2)8-11(9)16(15)19(25-3)18(23)17(10)20/h7-8,12,22-23H,4-6H2,1-3H3/t12-/m0/s1 D0N9DY DRUGINKE YCBIBKGMUXWRRT-LBPRGKRZSA-N D0N9DY DRUGSMIL CN1CCC2=C3C1CC4=CC(=C(C=C4C3=C(C(=C2I)O)OC)OC)O D0N9DY HIGHSTAT Investigative D0N9FH DRUG__ID D0N9FH D0N9FH DRUGTYPE Small molecular drug D0N9FH DRUGINCH 1S/C10H12N2O/c1-2-4-9(5-3-1)13-8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12) D0N9FH DRUGINKE GRMJZZBFHKTYDJ-UHFFFAOYSA-N D0N9FH DRUGSMIL C1CN=C(N1)COC2=CC=CC=C2 D0N9FH HIGHSTAT Investigative D0N9HG DRUG__ID D0N9HG D0N9HG DRUGTYPE Small molecular drug D0N9HG DRUGINCH 1S/C20H32O3/c1-2-19(21)17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-18-20(22)23/h4-7,10-13,19,21H,2-3,8-9,14-18H2,1H3,(H,22,23)/b6-4-,7-5-,12-10-,13-11- D0N9HG DRUGINKE PPCHNRUZQWLEMF-XBOCNYGYSA-N D0N9HG DRUGSMIL CCC(CCC=CCC=CCC=CCC=CCCCC(=O)O)O D0N9HG HIGHSTAT Investigative D0N9HX DRUG__ID D0N9HX D0N9HX DRUGTYPE Small molecular drug D0N9HX DRUGINCH 1S/C21H16F3NO3/c22-21(23,24)28-19-8-4-5-15(13-19)14-25-20(26)16-9-11-18(12-10-16)27-17-6-2-1-3-7-17/h1-13H,14H2,(H,25,26) D0N9HX DRUGINKE CPWFANWMCRGXMG-UHFFFAOYSA-N D0N9HX DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC3=CC(=CC=C3)OC(F)(F)F D0N9HX HIGHSTAT Investigative D0N9IX DRUG__ID D0N9IX D0N9IX DRUGTYPE Small molecular drug D0N9IX DRUGINCH 1S/C22H39NO5/c24-13-18-20(26)21(27)19(25)12-23(18)4-2-1-3-5-28-14-22-9-15-6-16(10-22)8-17(7-15)11-22/h15-21,24-27H,1-14H2/t15?,16?,17?,18-,19+,20-,21-,22?/m1/s1 D0N9IX DRUGINKE XVYLNHVEAOOEGI-FAIWKWDXSA-N D0N9IX DRUGSMIL C1C2CC3CC1CC(C2)(C3)COCCCCCN4CC(C(C(C4CO)O)O)O D0N9IX HIGHSTAT Investigative D0N9MH DRUG__ID D0N9MH D0N9MH DRUGTYPE Small molecular drug D0N9MH DRUGINCH 1S/C49H65N11O11/c1-28(2)21-40(49(70)71-4)59-47(68)39(23-32-25-51-27-53-32)56-43(64)26-60-20-8-7-11-37(48(60)69)57-44(65)29(3)54-46(67)38(22-31-24-52-35-10-6-5-9-34(31)35)58-45(66)36(17-18-41(50)62)55-42(63)19-14-30-12-15-33(61)16-13-30/h5-6,9-10,12-13,15-16,24-25,27-29,36-40,52,61H,7-8,11,14,17-23,26H2,1-4H3,(H2,50,62)(H,51,53)(H,54,67)(H,55,63)(H,56,64)(H,57,65)(H,58,66)(H,59,68) D0N9MH DRUGINKE SVPHNBMMYLAPKY-UHFFFAOYSA-N D0N9MH DRUGSMIL CC(C)CC(C(=O)OC)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)CCC5=CC=C(C=C5)O D0N9MH HIGHSTAT Investigative D0N9NS DRUG__ID D0N9NS D0N9NS DRUGTYPE Small molecular drug D0N9NS DRUGINCH 1S/C21H19NO3/c1-14-5-4-6-15(11-14)12-19(21(24)25)22-20(23)18-10-9-16-7-2-3-8-17(16)13-18/h2-11,13,19H,12H2,1H3,(H,22,23)(H,24,25)/t19-/m1/s1 D0N9NS DRUGINKE ZDRUGIXKFVQOIJ-LJQANCHMSA-N D0N9NS DRUGSMIL CC1=CC(=CC=C1)CC(C(=O)O)NC(=O)C2=CC3=CC=CC=C3C=C2 D0N9NS HIGHSTAT Investigative D0N9ON DRUG__ID D0N9ON D0N9ON DRUGTYPE Small molecular drug D0N9ON DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(41)36-29-23-14-8-7-13-22(23)18-25(29)38)37(20-45-34)33(42)30(40)24(17-21-11-5-4-6-12-21)35-28(39)19-44-27-16-10-9-15-26(27)43-3/h4-16,24-25,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t24-,25+,29-,30-,31+/m0/s1 D0N9ON DRUGINKE JFCIKXOPSCFWBJ-ZNIFFWLPSA-N D0N9ON DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC=C3OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0N9ON HIGHSTAT Investigative D0N9PY DRUG__ID D0N9PY D0N9PY DRUGTYPE Small molecular drug D0N9PY DRUGINCH 1S/C17H17NO/c1-2-19-16-7-8-17-14(5-6-15(17)11-16)10-13-4-3-9-18-12-13/h3-4,7-12H,2,5-6H2,1H3/b14-10+ D0N9PY DRUGINKE PXXLKRIIKURDBT-GXDHUFHOSA-N D0N9PY DRUGSMIL CCOC1=CC2=C(C=C1)C(=CC3=CN=CC=C3)CC2 D0N9PY HIGHSTAT Investigative D0N9SV DRUG__ID D0N9SV D0N9SV DRUGTYPE Small molecular drug D0N9SV DRUGINCH 1S/C23H24N2O3/c26-23(27)11-6-7-19-12-14-21(15-13-19)28-18-17-25(20-8-2-1-3-9-20)22-10-4-5-16-24-22/h1-5,8-10,12-16H,6-7,11,17-18H2,(H,26,27) D0N9SV DRUGINKE WQXHZCYCKCQFQP-UHFFFAOYSA-N D0N9SV DRUGSMIL C1=CC=C(C=C1)N(CCOC2=CC=C(C=C2)CCCC(=O)O)C3=CC=CC=N3 D0N9SV HIGHSTAT Investigative D0N9UZ DRUG__ID D0N9UZ D0N9UZ DRUGTYPE Small molecular drug D0N9UZ DRUGINCH 1S/C20H19NO5/c21-20(19(24)25,15-9-13(15)18(22)23)10-14-11-5-1-3-7-16(11)26-17-8-4-2-6-12(14)17/h1-8,13-15H,9-10,21H2,(H,22,23)(H,24,25)/t13-,15-,20-/m0/s1 D0N9UZ DRUGINKE VLZBRVJVCCNPRJ-KPHUOKFYSA-N D0N9UZ DRUGSMIL C1C(C1C(CC2C3=CC=CC=C3OC4=CC=CC=C24)(C(=O)O)N)C(=O)O D0N9UZ HIGHSTAT Investigative D0N9WG DRUG__ID D0N9WG D0N9WG DRUGTYPE Small molecular drug D0N9WG DRUGINCH 1S/C23H16ClN3O/c24-19-13-7-12-18(14-19)22(28)27-23-25-20(16-8-3-1-4-9-16)15-21(26-23)17-10-5-2-6-11-17/h1-15H,(H,25,26,27,28) D0N9WG DRUGINKE BYALFPUQWRIWML-UHFFFAOYSA-N D0N9WG DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=N2)NC(=O)C3=CC(=CC=C3)Cl)C4=CC=CC=C4 D0N9WG HIGHSTAT Investigative D0N9XD DRUG__ID D0N9XD D0N9XD DRUGTYPE Small molecular drug D0N9XD DRUGINCH 1S/C21H24BrN7O3/c1-32-17-8-4-15(5-9-17)12-28-19(26-11-10-25-18(23)24)27-20(30)29(21(28)31)13-14-2-6-16(22)7-3-14/h2-9H,10-13H2,1H3,(H4,23,24,25)(H,26,27,30) D0N9XD DRUGINKE IRCKZEUJNJUYCC-UHFFFAOYSA-N D0N9XD DRUGSMIL COC1=CC=C(C=C1)CN2C(=NC(=O)N(C2=O)CC3=CC=C(C=C3)Br)NCCN=C(N)N D0N9XD HIGHSTAT Investigative D0N9YP DRUG__ID D0N9YP D0N9YP DRUGTYPE Small molecular drug D0N9YP DRUGINCH 1S/C44H55N5O5/c1-53-44(52)47-30-36(28-32-27-35-14-7-8-16-40(35)46-29-32)33-19-23-38(24-20-33)54-26-9-3-4-11-31-17-21-37(22-18-31)48-42(50)41(34-12-5-2-6-13-34)49-25-10-15-39(45)43(49)51/h7-8,14,16-24,27,29,34,36,39,41H,2-6,9-13,15,25-26,28,30,45H2,1H3,(H,47,52)(H,48,50)/t36-,39+,41+/m1/s1 D0N9YP DRUGINKE IGRIVAWLJUPVMM-UDEWTJCRSA-N D0N9YP DRUGSMIL COC(=O)NCC(CC1=CC2=CC=CC=C2N=C1)C3=CC=C(C=C3)OCCCCCC4=CC=C(C=C4)NC(=O)C(C5CCCCC5)N6CCCC(C6=O)N D0N9YP HIGHSTAT Investigative D0N9ZR DRUG__ID D0N9ZR D0N9ZR DRUGTYPE Small molecular drug D0N9ZR DRUGINCH 1S/C9H6BrNO2/c1-4-2-5-7(3-6(4)10)11-9(13)8(5)12/h2-3H,1H3,(H,11,12,13) D0N9ZR DRUGINKE DQZFCBOXZKQQPM-UHFFFAOYSA-N D0N9ZR DRUGSMIL CC1=CC2=C(C=C1Br)NC(=O)C2=O D0N9ZR HIGHSTAT Investigative D0NA2T DRUG__ID D0NA2T D0NA2T DRUGTYPE Small molecular drug D0NA2T DRUGINCH 1S/C20H23NO2/c1-3-8-21-9-7-14-10-15(23-2)12-16-19(14)17(21)11-13-5-4-6-18(22)20(13)16/h4-6,10,12,17,22H,3,7-9,11H2,1-2H3/t17-/m1/s1 D0NA2T DRUGINKE PGKMOUOGPCFQTK-QGZVFWFLSA-N D0NA2T DRUGSMIL CCCN1CCC2=C3C1CC4=C(C3=CC(=C2)OC)C(=CC=C4)O D0NA2T HIGHSTAT Investigative D0NA5S DRUG__ID D0NA5S D0NA5S DRUGTYPE Small molecular drug D0NA5S DRUGINCH 1S/C43H55NO9/c1-38(2)19-20-42(37(51)52)21-22-43(25-53-36(50)14-7-26-23-27(45)8-10-30(26)44-34(47)12-13-35(48)49)28(29(42)24-38)9-11-32-40(5)17-16-33(46)39(3,4)31(40)15-18-41(32,43)6/h7-10,12-14,23,29,31-32,45H,11,15-22,24-25H2,1-6H3,(H,44,47)(H,48,49)(H,51,52)/p-2/b13-12+,14-7+/t29-,31?,32?,40-,41+,42-,43-/m0/s1 D0NA5S DRUGINKE NZCHLXQRTYIWRL-VDJOMVRUSA-L D0NA5S DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1)COC(=O)C=CC6=C(C=CC(=C6)[O-])NC(=O)C=CC(=O)O)C(=O)[O-])C D0NA5S HIGHSTAT Investigative D0NA7G DRUG__ID D0NA7G D0NA7G DRUGTYPE Small molecular drug D0NA7G DRUGINCH 1S/C24H29N3O5/c1-14-9-18(28)10-15(2)19(14)12-20(25)24(32)27-13-17-6-4-3-5-16(17)11-21(27)23(31)26-8-7-22(29)30/h3-6,9-10,20-21,28H,7-8,11-13,25H2,1-2H3,(H,26,31)(H,29,30)/t20-,21-/m0/s1 D0NA7G DRUGINKE FEJBKZCTAXWTTN-SFTDATJTSA-N D0NA7G DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCC(=O)O)N)C)O D0NA7G HIGHSTAT Investigative D0NB0I DRUG__ID D0NB0I D0NB0I DRUGTYPE Small molecular drug D0NB0I DRUGINCH 1S/C20H26O2/c1-5-7-15-9-11-20(22-4)18(13-15)16-10-12-19(21-3)17(14-16)8-6-2/h9-14H,5-8H2,1-4H3 D0NB0I DRUGINKE GLDMMYBVNSMLGE-UHFFFAOYSA-N D0NB0I DRUGSMIL CCCC1=CC(=C(C=C1)OC)C2=CC(=C(C=C2)OC)CCC D0NB0I HIGHSTAT Investigative D0NB2G DRUG__ID D0NB2G D0NB2G DRUGTYPE Small molecular drug D0NB2G DRUGINCH 1S/C13H10ClN3O/c1-9-4-10(2-3-16-9)8-18-13-6-11(7-15)5-12(14)17-13/h2-6H,8H2,1H3 D0NB2G DRUGINKE MWMMUKIHNXXNGW-UHFFFAOYSA-N D0NB2G DRUGSMIL CC1=NC=CC(=C1)COC2=NC(=CC(=C2)C#N)Cl D0NB2G HIGHSTAT Investigative D0NB4Q DRUG__ID D0NB4Q D0NB4Q DRUGTYPE Small molecular drug D0NB4Q DRUGINCH 1S/C27H29FO10/c1-11-19(30)35-17-15(29)25-16-13(28)14(23(2,3)4)24(25)18(34-10-12-8-6-5-7-9-12)20(31)37-22(24)38-27(25,21(32)36-16)26(11,17)33/h5-9,11,13-18,22,29,33H,10H2,1-4H3/t11?,13-,14?,15?,16?,17-,18-,22?,24?,25?,26+,27-/m0/s1 D0NB4Q DRUGINKE LFVHCLPCEWRXME-CLNXZACASA-N D0NB4Q DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5F)C(C)(C)C)C(C(=O)OC6O4)OCC7=CC=CC=C7)O D0NB4Q HIGHSTAT Investigative D0NB7S DRUG__ID D0NB7S D0NB7S DRUGTYPE Small molecular drug D0NB7S DRUGINCH 1S/C36H44N4O6/c1-36(2,3)46-35(45)30(23-25-13-8-5-9-14-25)39-32(42)29(22-24-11-6-4-7-12-24)38-33(43)31-15-10-20-40(31)34(44)28(37)21-26-16-18-27(41)19-17-26/h4-9,11-14,16-19,28-31,41H,10,15,20-23,37H2,1-3H3,(H,38,43)(H,39,42)/t28-,29-,30-,31-/m0/s1 D0NB7S DRUGINKE MUCJBMLSOAIPBH-ORYMTKCHSA-N D0NB7S DRUGSMIL CC(C)(C)OC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0NB7S HIGHSTAT Investigative D0NB8V DRUG__ID D0NB8V D0NB8V DRUGTYPE Small molecular drug D0NB8V DRUGINCH 1S/C17H19NO3/c1-19-15-10-13(11-16(20-2)17(15)21-3)8-7-12-5-4-6-14(18)9-12/h4-11H,18H2,1-3H3/b8-7+ D0NB8V DRUGINKE KHIQMXWOBUJQMV-BQYQJAHWSA-N D0NB8V DRUGSMIL COC1=CC(=CC(=C1OC)OC)C=CC2=CC(=CC=C2)N D0NB8V HIGHSTAT Investigative D0NC3P DRUG__ID D0NC3P D0NC3P DRUGTYPE Small molecular drug D0NC3P DRUGINCH 1S/C20H20O6/c21-20-15(6-13-2-4-17-19(8-13)26-11-24-17)14(9-22-20)5-12-1-3-16-18(7-12)25-10-23-16/h1-4,7-8,14-15,20-21H,5-6,9-11H2/t14-,15+,20-/m0/s1 D0NC3P DRUGINKE DIYWRNLYKJKHAM-MDOVXXIYSA-N D0NC3P DRUGSMIL C1C(C(C(O1)O)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 D0NC3P HIGHSTAT Investigative D0NC8V DRUG__ID D0NC8V D0NC8V DRUGTYPE Small molecular drug D0NC8V DRUGINCH 1S/C28H33F2N3O3/c1-15(2)11-23-26(34)32-24(19-12-17-7-5-6-8-18(17)13-19)28(36)33(23)25(27(35)31-16(3)4)21-10-9-20(29)14-22(21)30/h5-10,14-16,19,23-25H,11-13H2,1-4H3,(H,31,35)(H,32,34)/t23-,24-,25-/m1/s1 D0NC8V DRUGINKE QGSYCKKZFPLTMQ-UBFVSLLYSA-N D0NC8V DRUGSMIL CC(C)CC1C(=O)NC(C(=O)N1C(C2=C(C=C(C=C2)F)F)C(=O)NC(C)C)C3CC4=CC=CC=C4C3 D0NC8V HIGHSTAT Investigative D0ND0M DRUG__ID D0ND0M D0ND0M DRUGTYPE Small molecular drug D0ND0M DRUGINCH 1S/C17H21NO2S/c19-17(18-20)9-3-1-2-6-12-21-16-11-10-14-7-4-5-8-15(14)13-16/h4-5,7-8,10-11,13,20H,1-3,6,9,12H2,(H,18,19) D0ND0M DRUGINKE KPNNXHVGOKRBEF-UHFFFAOYSA-N D0ND0M DRUGSMIL C1=CC=C2C=C(C=CC2=C1)SCCCCCCC(=O)NO D0ND0M HIGHSTAT Investigative D0ND1C DRUG__ID D0ND1C D0ND1C DRUGTYPE Small molecular drug D0ND1C DRUGINCH 1S/C12H14O5S/c13-11(14)8-3-1-4-9(7-8)17-10(12(15)16)5-2-6-18/h1,3-4,7,10,18H,2,5-6H2,(H,13,14)(H,15,16) D0ND1C DRUGINKE KUHQPVJMGPHXPD-UHFFFAOYSA-N D0ND1C DRUGSMIL C1=CC(=CC(=C1)OC(CCCS)C(=O)O)C(=O)O D0ND1C HIGHSTAT Investigative D0ND2Y DRUG__ID D0ND2Y D0ND2Y DRUGTYPE Small molecular drug D0ND2Y DRUGINCH 1S/C10H13N3O2/c14-13(15)10-3-1-2-9(8-10)12-6-4-11-5-7-12/h1-3,8,11H,4-7H2 D0ND2Y DRUGINKE LHHZRIYUOZPKSG-UHFFFAOYSA-N D0ND2Y DRUGSMIL C1CN(CCN1)C2=CC(=CC=C2)[N+](=O)[O-] D0ND2Y HIGHSTAT Investigative D0ND4N DRUG__ID D0ND4N D0ND4N DRUGTYPE Small molecular drug D0ND4N DRUGINCH 1S/C23H41NO4/c1-3-5-6-7-8-9-10-11-12-13-14-15-17-21(25)23(27)24-19-16-18-22(26)28-20-4-2/h4H,2-3,5-20H2,1H3,(H,24,27) D0ND4N DRUGINKE NCGQJUXYFOTZRW-UHFFFAOYSA-N D0ND4N DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NCCCC(=O)OCC=C D0ND4N HIGHSTAT Investigative D0ND5D DRUG__ID D0ND5D D0ND5D DRUGTYPE Small molecular drug D0ND5D DRUGINCH 1S/C20H22N2/c1-22-14-8-7-13-18(22)19-16-11-5-6-12-17(16)21-20(19)15-9-3-2-4-10-15/h2-6,9-12,18,21H,7-8,13-14H2,1H3 D0ND5D DRUGINKE YKKPUIDGSXNPRO-UHFFFAOYSA-N D0ND5D DRUGSMIL CN1CCCCC1C2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D0ND5D HIGHSTAT Investigative D0ND8J DRUG__ID D0ND8J D0ND8J DRUGTYPE Small molecular drug D0ND8J DRUGINCH 1S/C39H46N2O6.ClH/c1-40-16-14-27-21-35(43-4)37(45-6)23-30(27)32(40)18-25-8-11-29(12-9-25)47-39-20-26(10-13-34(39)42-3)19-33-31-24-38(46-7)36(44-5)22-28(31)15-17-41(33)2;/h8-13,20-24,32-33H,14-19H2,1-7H3;1H/t32-,33+;/m1./s1 D0ND8J DRUGINKE OEBMBMKSAQUFSL-VMXYRSAXSA-N D0ND8J DRUGSMIL CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)OC)OC)OC.Cl D0ND8J HIGHSTAT Investigative D0NE3U DRUG__ID D0NE3U D0NE3U DRUGTYPE Small molecular drug D0NE3U DRUGINCH 1S/C40H50N8O10/c1-23(44-37(55)29(41)18-25-9-13-27(50)14-10-25)36(54)46-30(19-24-6-3-2-4-7-24)38(56)43-21-34(52)45-31(20-26-11-15-28(51)16-12-26)40(58)48-17-5-8-33(48)39(57)47-32(22-49)35(42)53/h2-4,6-7,9-16,23,29-33,49-51H,5,8,17-22,41H2,1H3,(H2,42,53)(H,43,56)(H,44,55)(H,45,52)(H,46,54)(H,47,57)/t23-,29+,30+,31+,32+,33+/m1/s1 D0NE3U DRUGINKE FHZPGIUBXYVUOY-VWGYHWLBSA-N D0NE3U DRUGSMIL CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NCC(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CO)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D0NE3U HIGHSTAT Investigative D0NF3E DRUG__ID D0NF3E D0NF3E DRUGTYPE Small molecular drug D0NF3E DRUGINCH 1S/C15H9N5O2/c21-20(22)13-7-3-6-11-14(13)19-15(18-11)12-8-16-9-4-1-2-5-10(9)17-12/h1-8H,(H,18,19) D0NF3E DRUGINKE RDSFCGCNTCJZOD-UHFFFAOYSA-N D0NF3E DRUGSMIL C1=CC=C2C(=C1)N=CC(=N2)C3=NC4=C(N3)C=CC=C4[N+](=O)[O-] D0NF3E HIGHSTAT Investigative D0NF6F DRUG__ID D0NF6F D0NF6F DRUGTYPE Small molecular drug D0NF6F DRUGINCH 1S/C17H22N2O3/c1-12(5-10-16(20)18-22)11-13(2)17(21)14-6-8-15(9-7-14)19(3)4/h5-11,13,22H,1-4H3,(H,18,20)/b10-5+,12-11+/t13-/m1/s1 D0NF6F DRUGINKE RTKIYFITIVXBLE-QEQCGCAPSA-N D0NF6F DRUGSMIL CC(C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C D0NF6F HIGHSTAT Investigative D0NH1Y DRUG__ID D0NH1Y D0NH1Y DRUGTYPE Small molecular drug D0NH1Y DRUGINCH 1S/C10H13N5O4/c11-10-6-4(12-2-13-10)5(14-15-6)9-8(18)7(17)3(1-16)19-9/h2-3,7-9,16-18H,1H2,(H,14,15)(H2,11,12,13)/t3-,7-,8-,9+/m1/s1 D0NH1Y DRUGINKE KBHMEHLJSZMEMI-KSYZLYKTSA-N D0NH1Y DRUGSMIL C1=NC2=C(NN=C2C(=N1)N)C3C(C(C(O3)CO)O)O D0NH1Y HIGHSTAT Investigative D0NH5X DRUG__ID D0NH5X D0NH5X DRUGTYPE Small molecular drug D0NH5X DRUGINCH 1S/C12H17N5O/c18-6-5-17-8-15-10-11(13-7-14-12(10)17)16-9-3-1-2-4-9/h7-9,18H,1-6H2,(H,13,14,16) D0NH5X DRUGINKE XVKHXAUTWLZBQD-UHFFFAOYSA-N D0NH5X DRUGSMIL C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)CCO D0NH5X HIGHSTAT Investigative D0NH6Q DRUG__ID D0NH6Q D0NH6Q DRUGTYPE Small molecular drug D0NH6Q DRUGINCH 1S/C13H19N5O9P2S.3Na/c1-30-12-16-10(14)6-11(17-12)18(4-15-6)7-5-2-13(5,9(20)8(7)19)3-26-29(24,25)27-28(21,22)23;;;/h4-5,7-9,19-20H,2-3H2,1H3,(H,24,25)(H2,14,16,17)(H2,21,22,23);;;/q;3*+1/p-3/t5-,7?,8+,9+,13+;;;/m1.../s1 D0NH6Q DRUGINKE ZYPJOXVKTCEBCA-PVMCGCOJSA-K D0NH6Q DRUGSMIL CSC1=NC(=C2C(=N1)N(C=N2)C3C4CC4(C(C3O)O)COP(=O)([O-])OP(=O)([O-])[O-])N.[Na+].[Na+].[Na+] D0NH6Q HIGHSTAT Investigative D0NH6T DRUG__ID D0NH6T D0NH6T DRUGTYPE Small molecular drug D0NH6T DRUGINCH 1S/C20H20O5/c1-11(2)3-4-12-7-13(5-6-15(12)22)18-10-17(24)20-16(23)8-14(21)9-19(20)25-18/h3,5-9,18,21-23H,4,10H2,1-2H3 D0NH6T DRUGINKE CGKWSLSAYABZTL-UHFFFAOYSA-N D0NH6T DRUGSMIL CC(=CCC1=C(C=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)O)C D0NH6T HIGHSTAT Investigative D0NH7M DRUG__ID D0NH7M D0NH7M DRUGTYPE Small molecular drug D0NH7M DRUGINCH 1S/C16H11NO5/c17-8-11(5-9-1-3-12(18)14(20)6-9)16(22)10-2-4-13(19)15(21)7-10/h1-7,18-21H/b11-5+ D0NH7M DRUGINKE CANOJKGQDCJDOX-VZUCSPMQSA-N D0NH7M DRUGSMIL C1=CC(=C(C=C1C=C(C#N)C(=O)C2=CC(=C(C=C2)O)O)O)O D0NH7M HIGHSTAT Investigative D0NI4Z DRUG__ID D0NI4Z D0NI4Z DRUGTYPE Small molecular drug D0NI4Z DRUGINCH 1S/C10H6ClN3O/c11-6-1-2-7-5(3-6)4-8-9(12-7)14-10(15)13-8/h1-4H,(H2,12,13,14,15) D0NI4Z DRUGINKE OSBMKBWTTUTUMA-UHFFFAOYSA-N D0NI4Z DRUGSMIL C1=CC2=NC3=C(C=C2C=C1Cl)NC(=O)N3 D0NI4Z HIGHSTAT Investigative D0NI5C DRUG__ID D0NI5C D0NI5C DRUGTYPE Small molecular drug D0NI5C DRUGINCH 1S/C5H5NS/c7-5-3-1-2-4-6-5/h1-4H,(H,6,7) D0NI5C DRUGINKE WHMDPDGBKYUEMW-UHFFFAOYSA-N D0NI5C DRUGSMIL C1=CC(=S)NC=C1 D0NI5C HIGHSTAT Investigative D0NI8W DRUG__ID D0NI8W D0NI8W DRUGTYPE Small molecular drug D0NI8W DRUGINCH 1S/C9H8N2O/c12-9-4-2-1-3-7(9)8-5-10-6-11-8/h1-6,12H,(H,10,11) D0NI8W DRUGINKE BYAAMOMNSVKNMA-UHFFFAOYSA-N D0NI8W DRUGSMIL C1=CC=C(C(=C1)C2=CN=CN2)O D0NI8W HIGHSTAT Investigative D0NJ4G DRUG__ID D0NJ4G D0NJ4G DRUGTYPE Small molecular drug D0NJ4G DRUGINCH 1S/C8H3Cl2NO2/c9-3-1-4-6(5(10)2-3)11-8(13)7(4)12/h1-2H,(H,11,12,13) D0NJ4G DRUGINKE AYGGQJHJRFZDFH-UHFFFAOYSA-N D0NJ4G DRUGSMIL C1=C(C=C(C2=C1C(=O)C(=O)N2)Cl)Cl D0NJ4G HIGHSTAT Investigative D0NJ4H DRUG__ID D0NJ4H D0NJ4H DRUGTYPE Small molecular drug D0NJ4H DRUGINCH 1S/C15H10O7/c16-6-1-2-8(9(18)3-6)15-14(21)13(20)12-10(19)4-7(17)5-11(12)22-15/h1-5,16-19,21H D0NJ4H DRUGINKE YXOLAZRVSSWPPT-UHFFFAOYSA-N D0NJ4H DRUGSMIL C1=CC(=C(C=C1O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O D0NJ4H HIGHSTAT Investigative D0NJ5U DRUG__ID D0NJ5U D0NJ5U DRUGTYPE Small molecular drug D0NJ5U DRUGINCH 1S/C25H27FN2O4/c1-16(2)24-22(13-12-20(29)14-21(30)15-23(31)32)28(19-10-8-18(26)9-11-19)25(27-24)17-6-4-3-5-7-17/h3-13,16,20-21,29-30H,14-15H2,1-2H3,(H,31,32)/p-1/b13-12+/t20-,21-/m1/s1 D0NJ5U DRUGINKE ZYZCALPXKGUGJI-DDVDASKDSA-M D0NJ5U DRUGSMIL CC(C)C1=C(N(C(=N1)C2=CC=CC=C2)C3=CC=C(C=C3)F)C=CC(CC(CC(=O)[O-])O)O D0NJ5U HIGHSTAT Investigative D0NJ5W DRUG__ID D0NJ5W D0NJ5W DRUGTYPE Small molecular drug D0NJ5W DRUGINCH 1S/C40H66N4O4/c1-41(33-35-23-15-17-25-37(35)47-5)29-19-11-13-27-39(45)43(3)31-21-9-7-8-10-22-32-44(4)40(46)28-14-12-20-30-42(2)34-36-24-16-18-26-38(36)48-6/h15-18,23-26H,7-14,19-22,27-34H2,1-6H3 D0NJ5W DRUGINKE HDAQKLAKMZNBQB-UHFFFAOYSA-N D0NJ5W DRUGSMIL CN(CCCCCC(=O)N(C)CCCCCCCCN(C)C(=O)CCCCCN(C)CC1=CC=CC=C1OC)CC2=CC=CC=C2OC D0NJ5W HIGHSTAT Investigative D0NJ7Y DRUG__ID D0NJ7Y D0NJ7Y DRUGTYPE Small molecular drug D0NJ7Y DRUGINCH 1S/C29H32N2O2/c1-4-5-6-10-21-15-17-23(18-16-21)30-29(32)31-26-14-9-11-22-19-27(33-28(22)26)25-13-8-7-12-24(25)20(2)3/h7-9,11-20H,4-6,10H2,1-3H3,(H2,30,31,32) D0NJ7Y DRUGINKE ASCJIAKBYVUVNZ-UHFFFAOYSA-N D0NJ7Y DRUGSMIL CCCCCC1=CC=C(C=C1)NC(=O)NC2=CC=CC3=C2OC(=C3)C4=CC=CC=C4C(C)C D0NJ7Y HIGHSTAT Investigative D0NJ8L DRUG__ID D0NJ8L D0NJ8L DRUGTYPE Small molecular drug D0NJ8L DRUGINCH 1S/C13H9BrF2N2O/c14-9-3-1-7(5-10(9)15)8-2-4-12(11(16)6-8)18-13(17)19/h1-6H,(H3,17,18,19) D0NJ8L DRUGINKE SKBUTANQYXWCNX-UHFFFAOYSA-N D0NJ8L DRUGSMIL C1=CC(=C(C=C1C2=CC(=C(C=C2)Br)F)F)NC(=O)N D0NJ8L HIGHSTAT Investigative D0NL1F DRUG__ID D0NL1F D0NL1F DRUGTYPE Small molecular drug D0NL1F DRUGINCH 1S/C36H42N4/c1-2-5-11-20-39-22-18-31-30(33-34-29(17-19-37-33)28-15-9-10-16-32(28)38-34)23-26(13-7-3-1)35-36(31,25-39)24-27-14-8-4-6-12-21-40(27)35/h1,3,8-10,13-17,19,23,27,31,35,38H,2,4-7,11-12,18,20-22,24-25H2/b3-1-,14-8-,26-13-/t27-,31?,35-,36-/m0/s1 D0NL1F DRUGINKE XJPQQKQCGFEXKO-SGYLFFKUSA-N D0NL1F DRUGSMIL C1CCN2CCC3C(=CC(=CCC=CC1)C4C3(C2)CC5N4CCCCC=C5)C6=NC=CC7=C6NC8=CC=CC=C78 D0NL1F HIGHSTAT Investigative D0NL2L DRUG__ID D0NL2L D0NL2L DRUGTYPE Small molecular drug D0NL2L DRUGINCH 1S/C18H19NO/c1-20-17-5-4-14-10-16(3-2-15(14)11-17)18-12-19-8-6-13(18)7-9-19/h2-5,10-13H,6-9H2,1H3 D0NL2L DRUGINKE KZWBNNXTWZPPPP-UHFFFAOYSA-N D0NL2L DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CN4CCC3CC4 D0NL2L HIGHSTAT Investigative D0NL4R DRUG__ID D0NL4R D0NL4R DRUGTYPE Small molecular drug D0NL4R DRUGINCH 1S/C43H55N5O5/c1-29(2)39-24-44-40(50)41(51)48(39)27-35-13-8-20-45(35)26-36(23-32-14-17-33-11-6-7-12-34(33)21-32)47-28-37(22-30-15-18-38(49)19-16-30)46(42(52)43(47)53)25-31-9-4-3-5-10-31/h6-7,11-12,14-19,21,29,31,35-37,39,49H,3-5,8-10,13,20,22-28H2,1-2H3,(H,44,50)/t35-,36+,37+,39+/m0/s1 D0NL4R DRUGINKE RWNPDBWKKCTTOI-WIQNKZILSA-N D0NL4R DRUGSMIL CC(C)C1CNC(=O)C(=O)N1CC2CCCN2CC(CC3=CC4=CC=CC=C4C=C3)N5CC(N(C(=O)C5=O)CC6CCCCC6)CC7=CC=C(C=C7)O D0NL4R HIGHSTAT Investigative D0NL4Z DRUG__ID D0NL4Z D0NL4Z DRUGTYPE Small molecular drug D0NL4Z DRUGINCH 1S/C3H7O3P/c1-3(2)6-7(4)5/h3H,1-2H3/p+1 D0NL4Z DRUGINKE XZSFYYSNTQXWBM-UHFFFAOYSA-O D0NL4Z DRUGSMIL CC(C)O[P+](=O)O D0NL4Z HIGHSTAT Investigative D0NL5K DRUG__ID D0NL5K D0NL5K DRUGTYPE Small molecular drug D0NL5K DRUGINCH 1S/C20H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h22H,2-19H2,1H3,(H,21,23) D0NL5K DRUGINKE OTGQIQQTPXJQRG-UHFFFAOYSA-N D0NL5K DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)NCCO D0NL5K HIGHSTAT Investigative D0NL6C DRUG__ID D0NL6C D0NL6C DRUGTYPE Small molecular drug D0NL6C DRUGINCH 1S/C20H21F3O2/c21-20(22,23)19(24)13-6-1-2-7-14-25-18-12-8-11-17(15-18)16-9-4-3-5-10-16/h3-5,8-12,15H,1-2,6-7,13-14H2 D0NL6C DRUGINKE OFSLRFDWUPANFG-UHFFFAOYSA-N D0NL6C DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)OCCCCCCC(=O)C(F)(F)F D0NL6C HIGHSTAT Investigative D0NL7J DRUG__ID D0NL7J D0NL7J DRUGTYPE Small molecular drug D0NL7J DRUGINCH 1S/C10H12ClN3O3/c11-7-3-1-6(2-4-7)5-13-9(15)8(12)10(16)14-17/h1-4,8,17H,5,12H2,(H,13,15)(H,14,16) D0NL7J DRUGINKE OGTJYIPAKYEFNR-UHFFFAOYSA-N D0NL7J DRUGSMIL C1=CC(=CC=C1CNC(=O)C(C(=O)NO)N)Cl D0NL7J HIGHSTAT Investigative D0NM0G DRUG__ID D0NM0G D0NM0G DRUGTYPE Small molecular drug D0NM0G DRUGINCH 1S/C15H12ClF3N2O3S/c16-12-4-1-10(2-5-12)14(22)20-7-8-25(23,24)13-6-3-11(9-21-13)15(17,18)19/h1-6,9H,7-8H2,(H,20,22) D0NM0G DRUGINKE JFUIMTGOQCQTPF-UHFFFAOYSA-N D0NM0G DRUGSMIL C1=CC(=CC=C1C(=O)NCCS(=O)(=O)C2=NC=C(C=C2)C(F)(F)F)Cl D0NM0G HIGHSTAT Investigative D0NM0P DRUG__ID D0NM0P D0NM0P DRUGTYPE Small molecular drug D0NM0P DRUGINCH 1S/C16H12O2S/c17-14-6-4-11(5-7-14)16-9-13(10-19-16)12-2-1-3-15(18)8-12/h1-10,17-18H D0NM0P DRUGINKE JECPEAXUEYTRPA-UHFFFAOYSA-N D0NM0P DRUGSMIL C1=CC(=CC(=C1)O)C2=CSC(=C2)C3=CC=C(C=C3)O D0NM0P HIGHSTAT Investigative D0NM1F DRUG__ID D0NM1F D0NM1F DRUGTYPE Small molecular drug D0NM1F DRUGINCH 1S/C18H22N2O/c1-13(2)20(17-9-10-19-12-17)18(21)16-8-7-14-5-3-4-6-15(14)11-16/h3-8,11,13,17,19H,9-10,12H2,1-2H3/t17-/m1/s1 D0NM1F DRUGINKE ZQHFQDYTXXQENI-QGZVFWFLSA-N D0NM1F DRUGSMIL CC(C)N(C1CCNC1)C(=O)C2=CC3=CC=CC=C3C=C2 D0NM1F HIGHSTAT Investigative D0NM6R DRUG__ID D0NM6R D0NM6R DRUGTYPE Small molecular drug D0NM6R DRUGINCH 1S/C16H18N4O/c1-4-17-16-19(2)14(15(21)20(16)3)9-11-10-18-13-8-6-5-7-12(11)13/h5-10,21H,4H2,1-3H3/b11-9+,17-16? D0NM6R DRUGINKE UIFLDXAMSCVLFF-BKFIXLGBSA-N D0NM6R DRUGSMIL CCN=C1N(C(=C(N1C)O)C=C2C=NC3=CC=CC=C32)C D0NM6R HIGHSTAT Investigative D0NM7S DRUG__ID D0NM7S D0NM7S DRUGTYPE Small molecular drug D0NM7S DRUGINCH 1S/C18H19F3N2O2/c19-18(20,21)16-10-15(22-23-16)14-7-5-13(6-8-14)12-3-1-11(2-4-12)9-17(24)25/h5-8,10-12H,1-4,9H2,(H,22,23)(H,24,25) D0NM7S DRUGINKE YPHFQSYEKIEMNC-UHFFFAOYSA-N D0NM7S DRUGSMIL C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NNC(=C3)C(F)(F)F D0NM7S HIGHSTAT Investigative D0NN0V DRUG__ID D0NN0V D0NN0V DRUGTYPE Small molecular drug D0NN0V DRUGINCH 1S/C17H14O5/c1-8-14(19)9(2)17-13(15(8)20)16(21)12(7-22-17)10-3-5-11(18)6-4-10/h3-7,18-20H,1-2H3 D0NN0V DRUGINKE VSEIMGCATUFLSE-UHFFFAOYSA-N D0NN0V DRUGSMIL CC1=C(C(=C2C(=C1O)C(=O)C(=CO2)C3=CC=C(C=C3)O)C)O D0NN0V HIGHSTAT Investigative D0NN3G DRUG__ID D0NN3G D0NN3G DRUGTYPE Small molecular drug D0NN3G DRUGINCH 1S/C14H17NO3/c16-13-8-6-11(7-9-13)10-15-18-14(17)12-4-2-1-3-5-12/h6-10,12,16H,1-5H2/b15-10- D0NN3G DRUGINKE YWZBYSBZDQWXGQ-GDNBJRDFSA-N D0NN3G DRUGSMIL C1CCC(CC1)C(=O)ON=CC2=CC=C(C=C2)O D0NN3G HIGHSTAT Investigative D0NN3Q DRUG__ID D0NN3Q D0NN3Q DRUGTYPE Small molecular drug D0NN3Q DRUGINCH 1S/C6H9N3O2S/c7-9-5-1-3-6(4-2-5)12(8,10)11/h1-4,9H,7H2,(H2,8,10,11) D0NN3Q DRUGINKE NBJSNAGTUCWQRO-UHFFFAOYSA-N D0NN3Q DRUGSMIL C1=CC(=CC=C1NN)S(=O)(=O)N D0NN3Q HIGHSTAT Investigative D0NO5E DRUG__ID D0NO5E D0NO5E DRUGTYPE Small molecular drug D0NO5E DRUGINCH 1S/C19H16N2O3S/c1-2-24-19(23)21-18-20-15(13-9-5-3-6-10-13)17(25-18)16(22)14-11-7-4-8-12-14/h3-12H,2H2,1H3,(H,20,21,23) D0NO5E DRUGINKE VMTZCTQCFMWSEO-UHFFFAOYSA-N D0NO5E DRUGSMIL CCOC(=O)NC1=NC(=C(S1)C(=O)C2=CC=CC=C2)C3=CC=CC=C3 D0NO5E HIGHSTAT Investigative D0NP8A DRUG__ID D0NP8A D0NP8A DRUGTYPE Small molecular drug D0NP8A DRUGINCH 1S/C34H43N3O4/c1-23-21-25(19-20-29(23)27-16-10-7-11-17-27)13-12-18-28(22-30(38)37-41)32(39)36-31(34(3,4)5)33(40)35-24(2)26-14-8-6-9-15-26/h6-11,14-17,19-21,24,28,31,41H,12-13,18,22H2,1-5H3,(H,35,40)(H,36,39)(H,37,38)/t24-,28-,31-/m1/s1 D0NP8A DRUGINKE JJHRUUKMPWUYIB-HVOSOHGQSA-N D0NP8A DRUGSMIL CC1=C(C=CC(=C1)CCCC(CC(=O)NO)C(=O)NC(C(=O)NC(C)C2=CC=CC=C2)C(C)(C)C)C3=CC=CC=C3 D0NP8A HIGHSTAT Investigative D0NQ0B DRUG__ID D0NQ0B D0NQ0B DRUGTYPE Small molecular drug D0NQ0B DRUGINCH 1S/C25H26N2O6S/c1-16-4-8-19(9-5-16)34(30,31)33-18-7-11-22-20(14-18)24(29)23-21(26-12-13-27(2)3)10-6-17(15-28)25(23)32-22/h4-11,14,26,28H,12-13,15H2,1-3H3 D0NQ0B DRUGINKE SEVKFSGZVZFIMA-UHFFFAOYSA-N D0NQ0B DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)OC2=CC3=C(C=C2)OC4=C(C=CC(=C4C3=O)NCCN(C)C)CO D0NQ0B HIGHSTAT Investigative D0NQ7I DRUG__ID D0NQ7I D0NQ7I DRUGTYPE Small molecular drug D0NQ7I DRUGINCH 1S/C12H4Br4O3/c13-4-1-6(15)10-8(2-4)18-11-7(17)3-5(14)9(16)12(11)19-10/h1-3,17H D0NQ7I DRUGINKE SSCRQJOLSHUSSG-UHFFFAOYSA-N D0NQ7I DRUGSMIL C1=C(C=C(C2=C1OC3=C(O2)C(=C(C=C3O)Br)Br)Br)Br D0NQ7I HIGHSTAT Investigative D0NS0E DRUG__ID D0NS0E D0NS0E DRUGTYPE Small molecular drug D0NS0E DRUGINCH 1S/C8H6N2O3/c11-7-5-3-1-2-4-6(5)9-8(12)10(7)13/h1-4,13H,(H,9,12) D0NS0E DRUGINKE TZZSQUATPYDROZ-UHFFFAOYSA-N D0NS0E DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C(=O)N2)O D0NS0E HIGHSTAT Investigative D0NS1S DRUG__ID D0NS1S D0NS1S DRUGTYPE Small molecular drug D0NS1S DRUGINCH 1S/C16H12O5/c1-20-11-4-2-9(3-5-11)14-8-13(19)16-12(18)6-10(17)7-15(16)21-14/h2-8,17-18H,1H3 D0NS1S DRUGINKE DANYIYRPLHHOCZ-UHFFFAOYSA-N D0NS1S DRUGSMIL COC1=CC=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)O)O D0NS1S HIGHSTAT Investigative D0NS2U DRUG__ID D0NS2U D0NS2U DRUGCOMP Ohio State University D0NS2U DRUGINCH 1S/C14H9NO5S/c15-21(19,20)10-6-2-4-8-12(10)14(18)7-3-1-5-9(16)11(7)13(8)17/h1-6,16H,(H2,15,19,20) D0NS2U DRUGINKE CQBHSRLUQDYPBU-UHFFFAOYSA-N D0NS2U DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)N D0NS2U HIGHSTAT Investigative D0NS9H DRUG__ID D0NS9H D0NS9H DRUGTYPE Small molecular drug D0NS9H DRUGINCH 1S/C17H17N/c1-14(16-10-4-3-5-11-16)8-6-12-17-13-7-9-15(2)18-17/h3-5,7,9-11,13-14H,8H2,1-2H3 D0NS9H DRUGINKE QVXDBDKPSMNGHQ-UHFFFAOYSA-N D0NS9H DRUGSMIL CC1=NC(=CC=C1)C#CCC(C)C2=CC=CC=C2 D0NS9H HIGHSTAT Investigative D0NS9X DRUG__ID D0NS9X D0NS9X DRUGTYPE Small molecular drug D0NS9X DRUGINCH 1S/C13H18ClN3O2/c14-12-11(3-1-4-15-12)13(18)16-5-2-6-17-7-9-19-10-8-17/h1,3-4H,2,5-10H2,(H,16,18) D0NS9X DRUGINKE YLZONZBOTGMALV-UHFFFAOYSA-N D0NS9X DRUGSMIL C1COCCN1CCCNC(=O)C2=C(N=CC=C2)Cl D0NS9X HIGHSTAT Investigative D0NU1W DRUG__ID D0NU1W D0NU1W DRUGTYPE Small molecular drug D0NU1W DRUGINCH 1S/C12H5Br3O3/c13-5-1-7(15)11-9(3-5)18-12-8(16)2-6(14)4-10(12)17-11/h1-4,16H D0NU1W DRUGINKE XZPITRJUKODSMI-UHFFFAOYSA-N D0NU1W DRUGSMIL C1=C(C=C2C(=C1O)OC3=C(O2)C(=CC(=C3)Br)Br)Br D0NU1W HIGHSTAT Investigative D0NU3J DRUG__ID D0NU3J D0NU3J DRUGTYPE Small molecular drug D0NU3J DRUGINCH 1S/C12H9ClN2/c1-15-5-4-9-10-6-8(13)2-3-11(10)14-12(9)7-15/h2-7H,1H3/p+1 D0NU3J DRUGINKE RGQUDRQSJYJYAQ-UHFFFAOYSA-O D0NU3J DRUGSMIL C[N+]1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl D0NU3J HIGHSTAT Investigative D0NU5Z DRUG__ID D0NU5Z D0NU5Z DRUGTYPE Small molecular drug D0NU5Z DRUGINCH 1S/C13H10N2O2/c16-12-9-6-2-1-3-7(6)11-8(4-5-14-11)10(9)13(17)15-12/h4-5,14H,1-3H2,(H,15,16,17) D0NU5Z DRUGINKE NMFHMHLMLQVGMW-UHFFFAOYSA-N D0NU5Z DRUGSMIL C1CC2=C3C(=C4C=CNC4=C2C1)C(=O)NC3=O D0NU5Z HIGHSTAT Investigative D0NU6K DRUG__ID D0NU6K D0NU6K DRUGTYPE Small molecular drug D0NU6K DRUGINCH 1S/C18H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h13-14H,2-8,15-17H2,1H3,(H,19,20)/b14-13- D0NU6K DRUGINKE IGVKWAAPMVVTFX-YPKPFQOOSA-N D0NU6K DRUGSMIL CCCCCCCCC#CC#CC=CCCCC(=O)O D0NU6K HIGHSTAT Investigative D0NV2V DRUG__ID D0NV2V D0NV2V DRUGTYPE Small molecular drug D0NV2V DRUGINCH 1S/C5H7FO3/c6-3-4(7)1-2-5(8)9/h1-3H2,(H,8,9) D0NV2V DRUGINKE MBVLGMJBSFUHKW-UHFFFAOYSA-N D0NV2V DRUGSMIL C(CC(=O)O)C(=O)CF D0NV2V HIGHSTAT Investigative D0NV5N DRUG__ID D0NV5N D0NV5N DRUGTYPE Small molecular drug D0NV5N DRUGINCH 1S/C16H17NO3/c18-11-3-1-8-7-10-9-2-4-12(19)15-16(9,5-6-17-10)13(8)14(11)20-15/h1-4,9-10,12,15,17-19H,5-7H2/t9-,10+,12-,15-,16-/m0/s1 D0NV5N DRUGINKE ONBWJWYUHXVEJS-ZTYRTETDSA-N D0NV5N DRUGSMIL C1CNC2CC3=C4C15C2C=CC(C5OC4=C(C=C3)O)O D0NV5N HIGHSTAT Investigative D0NV7W DRUG__ID D0NV7W D0NV7W DRUGTYPE Small molecular drug D0NV7W DRUGINCH 1S/C17H12FN3/c18-16-4-2-1-3-15(16)17-10-20-12-21(17)11-14-7-5-13(9-19)6-8-14/h1-8,10,12H,11H2 D0NV7W DRUGINKE HPGUXAXJZVHMRJ-UHFFFAOYSA-N D0NV7W DRUGSMIL C1=CC=C(C(=C1)C2=CN=CN2CC3=CC=C(C=C3)C#N)F D0NV7W HIGHSTAT Investigative D0NV9C DRUG__ID D0NV9C D0NV9C DRUGTYPE Small molecular drug D0NV9C DRUGINCH 1S/C8H9BrN2O4S/c9-6-1-3-7(4-2-6)16(14,15)10-5-8(12)11-13/h1-4,10,13H,5H2,(H,11,12) D0NV9C DRUGINKE AKOBMMAQXVKOJR-UHFFFAOYSA-N D0NV9C DRUGSMIL C1=CC(=CC=C1S(=O)(=O)NCC(=O)NO)Br D0NV9C HIGHSTAT Investigative D0NW3Z DRUG__ID D0NW3Z D0NW3Z DRUGTYPE Small molecular drug D0NW3Z DRUGINCH 1S/C17H21NO4.ClH/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11;/h3-7,12-15H,8-10H2,1-2H3;1H/t12-,13-,14+,15-;/m1./s1 D0NW3Z DRUGINKE PIQVDUKEQYOJNR-RWXTUVLLSA-N D0NW3Z DRUGSMIL CN1C2CCC1C(C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC.Cl D0NW3Z HIGHSTAT Investigative D0NW6E DRUG__ID D0NW6E D0NW6E DRUGTYPE Small molecular drug D0NW6E DRUGINCH 1S/C13H26O5S/c1-2-3-4-5-6-7-19-13-12(17)11(16)10(15)9(8-14)18-13/h9-17H,2-8H2,1H3/t9-,10-,11+,12-,13+/m1/s1 D0NW6E DRUGINKE HPEGNLMTTNTJSP-LBELIVKGSA-N D0NW6E DRUGSMIL CCCCCCCSC1C(C(C(C(O1)CO)O)O)O D0NW6E HIGHSTAT Investigative D0NW7F DRUG__ID D0NW7F D0NW7F DRUGTYPE Small molecular drug D0NW7F DRUGINCH 1S/C16H11BrO2/c1-10-5-6-15-13(7-10)14(18)9-16(19-15)11-3-2-4-12(17)8-11/h2-9H,1H3 D0NW7F DRUGINKE NGKYRJKVRCEDNG-UHFFFAOYSA-N D0NW7F DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC(=CC=C3)Br D0NW7F HIGHSTAT Investigative D0NW9G DRUG__ID D0NW9G D0NW9G DRUGTYPE Small molecular drug D0NW9G DRUGINCH 1S/C20H17N3O/c21-14-9-13(12-24)10-15(11-14)22-20-16-5-1-3-7-18(16)23-19-8-4-2-6-17(19)20/h1-11,24H,12,21H2,(H,22,23) D0NW9G DRUGINKE GZHHMAFXYHPHBO-UHFFFAOYSA-N D0NW9G DRUGSMIL C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC(=CC(=C4)N)CO D0NW9G HIGHSTAT Investigative D0NX0M DRUG__ID D0NX0M D0NX0M DRUGTYPE Small molecular drug D0NX0M DRUGINCH 1S/C16H15NO/c1-18-16-7-6-12-9-13(4-5-14(12)10-16)15-3-2-8-17-11-15/h2-3,6-11H,4-5H2,1H3 D0NX0M DRUGINKE WUTGTMFGCHNUET-UHFFFAOYSA-N D0NX0M DRUGSMIL COC1=CC2=C(C=C1)C=C(CC2)C3=CN=CC=C3 D0NX0M HIGHSTAT Investigative D0NX2G DRUG__ID D0NX2G D0NX2G DRUGTYPE Small molecular drug D0NX2G DRUGINCH 1S/C22H17N5/c1-2-6-16(7-3-1)14-27-21-11-10-18(12-17(21)13-25-27)26-22-19-8-4-5-9-20(19)23-15-24-22/h1-13,15H,14H2,(H,23,24,26) D0NX2G DRUGINKE FIBNGENIDQNCFP-UHFFFAOYSA-N D0NX2G DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)NC4=NC=NC5=CC=CC=C54)C=N2 D0NX2G HIGHSTAT Investigative D0NY1J DRUG__ID D0NY1J D0NY1J DRUGTYPE Small molecular drug D0NY1J DRUGINCH 1S/C24H31N3O/c1-4-26(5-2)22-13-11-20(12-14-22)18-24(28)25-15-8-16-27-19(3)17-21-9-6-7-10-23(21)27/h6-7,9-14,17H,4-5,8,15-16,18H2,1-3H3,(H,25,28) D0NY1J DRUGINKE NBHMEDLJHJCMEZ-UHFFFAOYSA-N D0NY1J DRUGSMIL CCN(CC)C1=CC=C(C=C1)CC(=O)NCCCN2C(=CC3=CC=CC=C32)C D0NY1J HIGHSTAT Investigative D0NY1V DRUG__ID D0NY1V D0NY1V DRUGTYPE Small molecular drug D0NY1V DRUGINCH 1S/C45H67N4OP.ClH/c1-4-7-30-51(31-8-5-2,32-9-6-3)35-36-25-28-42(29-26-36)46-44(50)43(34-37-24-27-38-18-16-17-19-39(38)33-37)49-45(47-40-20-12-10-13-21-40)48-41-22-14-11-15-23-41;/h16-19,24-29,33,40-41,43H,4-15,20-23,30-32,34-35H2,1-3H3,(H2-,46,47,48,49,50);1H/t43-;/m0./s1 D0NY1V DRUGINKE MJWYKJXHACNJCD-SXWPEPABSA-N D0NY1V DRUGSMIL CCCC[P+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=NC4CCCCC4)NC5CCCCC5.[Cl-] D0NY1V HIGHSTAT Investigative D0NY4W DRUG__ID D0NY4W D0NY4W DRUGTYPE Small molecular drug D0NY4W DRUGINCH 1S/C15H20INO/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11H2,1H3 D0NY4W DRUGINKE QXBWECFEEZMKTN-UHFFFAOYSA-N D0NY4W DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)I)N2CCCC2 D0NY4W HIGHSTAT Investigative D0NY6P DRUG__ID D0NY6P D0NY6P DRUGTYPE Small molecular drug D0NY6P DRUGINCH 1S/C6H12N3OP/c10-11(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2 D0NY6P DRUGINKE FYAMXEPQQLNQDM-UHFFFAOYSA-N D0NY6P DRUGSMIL C1CN1P(=O)(N2CC2)N3CC3 D0NY6P HIGHSTAT Investigative D0NY6U DRUG__ID D0NY6U D0NY6U DRUGTYPE Small molecular drug D0NY6U DRUGINCH 1S/C13H9FN4/c14-9-3-1-2-8(6-9)10-4-5-11-12(18-10)13(15)17-7-16-11/h1-7H,(H2,15,16,17) D0NY6U DRUGINKE TWTLUQDFSDYZKO-UHFFFAOYSA-N D0NY6U DRUGSMIL C1=CC(=CC(=C1)F)C2=NC3=C(C=C2)N=CN=C3N D0NY6U HIGHSTAT Investigative D0NY7A DRUG__ID D0NY7A D0NY7A DRUGCOMP Servier D0NY7A DRUGINCH 1S/C38H49N5O/c44-38(41-36-27-42-24-22-31(36)23-25-42)43(37(39-32-12-3-1-4-13-32)40-33-14-5-2-6-15-33)26-28-18-20-30(21-19-28)35-17-9-11-29-10-7-8-16-34(29)35/h7-11,16-21,31-33,36H,1-6,12-15,22-27H2,(H,39,40)(H,41,44) D0NY7A DRUGINKE PNYOQUZLCMAUQE-UHFFFAOYSA-N D0NY7A DRUGSMIL C1CCC(CC1)NC(=NC2CCCCC2)N(CC3=CC=C(C=C3)C4=CC=CC5=CC=CC=C54)C(=O)NC6CN7CCC6CC7 D0NY7A HIGHSTAT Investigative D0O0AI DRUG__ID D0O0AI D0O0AI DRUGTYPE Small molecular drug D0O0AI DRUGINCH 1S/C6H6N2O4/c9-4-1-3(2-5(10)11)7-6(12)8-4/h1H,2H2,(H,10,11)(H2,7,8,9,12) D0O0AI DRUGINKE NQAUNZZEYKWTHM-UHFFFAOYSA-N D0O0AI DRUGSMIL C1=C(NC(=O)NC1=O)CC(=O)O D0O0AI HIGHSTAT Investigative D0O0BL DRUG__ID D0O0BL D0O0BL DRUGTYPE Small molecular drug D0O0BL DRUGINCH 1S/C17H15N3O2/c21-13-6-7-14-15(20-11-18-10-19-20)9-16(22-17(14)8-13)12-4-2-1-3-5-12/h1-8,10-11,15-16,21H,9H2 D0O0BL DRUGINKE FDEHVWXURCBTAP-UHFFFAOYSA-N D0O0BL DRUGSMIL C1C(C2=C(C=C(C=C2)O)OC1C3=CC=CC=C3)N4C=NC=N4 D0O0BL HIGHSTAT Investigative D0O0EA DRUG__ID D0O0EA D0O0EA DRUGTYPE Small molecular drug D0O0EA DRUGINCH 1S/C33H38N4O6S/c1-33(2)30(31(41)36-28-24-14-7-6-11-21(24)16-26(28)38)37(19-44-33)32(42)29(40)25(15-20-9-4-3-5-10-20)35-27(39)18-43-23-13-8-12-22(34)17-23/h3-14,17,25-26,28-30,38,40H,15-16,18-19,34H2,1-2H3,(H,35,39)(H,36,41)/t25-,26+,28-,29-,30+/m0/s1 D0O0EA DRUGINKE LQEMUNLLUUKMPD-DOWNBTJOSA-N D0O0EA DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC(=C3)N)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0O0EA HIGHSTAT Investigative D0O0FA DRUG__ID D0O0FA D0O0FA DRUGTYPE Small molecular drug D0O0FA DRUGINCH 1S/C25H28O5/c1-14(2)9-10-16(15(3)4)11-18-20(27)12-21(28)24-22(29)13-23(30-25(18)24)17-7-5-6-8-19(17)26/h5-9,12,16,23,26-28H,3,10-11,13H2,1-2,4H3/t16-,23+/m1/s1 D0O0FA DRUGINKE OGBMVWVBHWHRGD-MWTRTKDXSA-N D0O0FA DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=CC=C3O)C(=C)C)C D0O0FA HIGHSTAT Investigative D0O0FP DRUG__ID D0O0FP D0O0FP DRUGTYPE Small molecular drug D0O0FP DRUGINCH 1S/C12H16N8/c1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h6-7H,3-5H2,1-2H3,(H2,13,16,17) D0O0FP DRUGINKE CYYQMAWUIRPCNW-UHFFFAOYSA-N D0O0FP DRUGSMIL CCCCC1=NC(=C2C(=N1)N(C(=N2)N3N=CC=N3)C)N D0O0FP HIGHSTAT Investigative D0O0GA DRUG__ID D0O0GA D0O0GA DRUGTYPE Small molecular drug D0O0GA DRUGINCH 1S/C16H10FNO/c17-10-6-5-9-7-14-11-3-1-2-4-12(11)16(19)18-15(14)13(9)8-10/h1-6,8H,7H2,(H,18,19) D0O0GA DRUGINKE JDHAGQFOPJNKLS-UHFFFAOYSA-N D0O0GA DRUGSMIL C1C2=C(C=C(C=C2)F)C3=C1C4=CC=CC=C4C(=O)N3 D0O0GA HIGHSTAT Investigative D0O0GT DRUG__ID D0O0GT D0O0GT DRUGTYPE Small molecular drug D0O0GT DRUGINCH 1S/C20H25FN6O6S/c21-14-6-2-1-5-13(14)12-34(32,33)26-15-8-4-10-27(18(15)29)11-17(28)25-16(19(30)31)7-3-9-24-20(22)23/h1-2,4-6,8,10,16,26H,3,7,9,11-12H2,(H,25,28)(H,30,31)(H4,22,23,24)/t16-/m1/s1 D0O0GT DRUGINKE OFDAQIKHAJYTBV-MRXNPFEDSA-N D0O0GT DRUGSMIL C1=CC=C(C(=C1)CS(=O)(=O)NC2=CC=CN(C2=O)CC(=O)NC(CCCN=C(N)N)C(=O)O)F D0O0GT HIGHSTAT Investigative D0O0GW DRUG__ID D0O0GW D0O0GW DRUGTYPE Small molecular drug D0O0GW DRUGINCH 1S/C18H16ClFN4OS/c19-11-1-4-15(22-9-11)16(25)23-12-2-3-14(20)13(7-12)18-8-10(18)5-6-26-17(21)24-18/h1-4,7,9-10H,5-6,8H2,(H2,21,24)(H,23,25)/t10-,18+/m1/s1 D0O0GW DRUGINKE COCAUCFPFHUGAA-MGNBDDOMSA-N D0O0GW DRUGSMIL C1CSC(=NC2(C1C2)C3=C(C=CC(=C3)NC(=O)C4=NC=C(C=C4)Cl)F)N D0O0GW HIGHSTAT Investigative D0O0HR DRUG__ID D0O0HR D0O0HR DRUGTYPE Small molecular drug D0O0HR DRUGINCH 1S/C20H26N4O4/c1-6-10-23-18-16(19(25)24(11-7-2)20(23)26)22(3)17(21-18)13-8-9-14(27-4)15(12-13)28-5/h8-9,12H,6-7,10-11H2,1-5H3 D0O0HR DRUGINKE FSUNYKAEJIVAHY-UHFFFAOYSA-N D0O0HR DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)N(C(=N2)C3=CC(=C(C=C3)OC)OC)C D0O0HR HIGHSTAT Investigative D0O0HT DRUG__ID D0O0HT D0O0HT DRUGTYPE Small molecular drug D0O0HT DRUGINCH 1S/C11H17N3O3S/c12-7-1-2-8-14-11(15)9-3-5-10(6-4-9)18(13,16)17/h3-6H,1-2,7-8,12H2,(H,14,15)(H2,13,16,17) D0O0HT DRUGINKE ZDYFRIZTYRFPJC-UHFFFAOYSA-N D0O0HT DRUGSMIL C1=CC(=CC=C1C(=O)NCCCCN)S(=O)(=O)N D0O0HT HIGHSTAT Investigative D0O0IZ DRUG__ID D0O0IZ D0O0IZ DRUGTYPE Small molecular drug D0O0IZ DRUGINCH 1S/C36H44N4O6/c1-36(19-27-20-37-30-10-6-5-9-29(27)30,40-35(45)46-33-25-14-23-13-24(16-25)17-26(33)15-23)34(44)39-28(18-22-7-3-2-4-8-22)21-38-31(41)11-12-32(42)43/h2-10,20,23-26,28,33,37H,11-19,21H2,1H3,(H,38,41)(H,39,44)(H,40,45)(H,42,43)/t23?,24?,25?,26?,28-,33?,36+/m0/s1 D0O0IZ DRUGINKE HAQJDPAHYIINDW-JWZQQOIUSA-N D0O0IZ DRUGSMIL CC(CC1=CNC2=CC=CC=C21)(C(=O)NC(CC3=CC=CC=C3)CNC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6 D0O0IZ HIGHSTAT Investigative D0O0JO DRUG__ID D0O0JO D0O0JO DRUGTYPE Small molecular drug D0O0JO DRUGINCH 1S/C19H14Cl2N2O/c20-17-7-5-13(6-8-17)15-9-16(11-22-10-15)19(24)23-12-14-3-1-2-4-18(14)21/h1-11H,12H2,(H,23,24) D0O0JO DRUGINKE CKNIOMWTEPBNFF-UHFFFAOYSA-N D0O0JO DRUGSMIL C1=CC=C(C(=C1)CNC(=O)C2=CN=CC(=C2)C3=CC=C(C=C3)Cl)Cl D0O0JO HIGHSTAT Investigative D0O0LU DRUG__ID D0O0LU D0O0LU DRUGTYPE Small molecular drug D0O0LU DRUGINCH 1S/C15H11NO2/c17-14-12-8-4-5-9-13(12)16(15(14)18)10-11-6-2-1-3-7-11/h1-9H,10H2 D0O0LU DRUGINKE SIISFRLGYDVIRG-UHFFFAOYSA-N D0O0LU DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=O)C2=O D0O0LU HIGHSTAT Investigative D0O0MY DRUG__ID D0O0MY D0O0MY DRUGTYPE Small molecular drug D0O0MY DRUGINCH 1S/C17H16O3/c1-11-3-8-14-15(18)10-16(20-17(14)9-11)12-4-6-13(19-2)7-5-12/h3-9,16H,10H2,1-2H3 D0O0MY DRUGINKE OVTRXNFXZXVKKU-UHFFFAOYSA-N D0O0MY DRUGSMIL CC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)OC D0O0MY HIGHSTAT Investigative D0O0OP DRUG__ID D0O0OP D0O0OP DRUGTYPE Small molecular drug D0O0OP DRUGINCH 1S/C22H24FNO3/c23-14-16-6-8-19(9-7-16)22(26,18-4-2-1-3-5-18)21(25)27-20-15-24-12-10-17(20)11-13-24/h1-9,17,20,26H,10-15H2/t20-,22+/m0/s1/i23-1 D0O0OP DRUGINKE WYNSCFORRAXQPA-IFWCHYDGSA-N D0O0OP DRUGSMIL C1CN2CCC1C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=C(C=C4)CF)O D0O0OP HIGHSTAT Investigative D0O0QN DRUG__ID D0O0QN D0O0QN DRUGTYPE Small molecular drug D0O0QN DRUGINCH 1S/C14H12N2O4/c1-7-6-19-12-4-11-8(2-9(7)12)3-10(14(18)20-11)16-13(17)5-15/h2-4,6H,5,15H2,1H3,(H,16,17) D0O0QN DRUGINKE MNKUYMIFZBIEPU-UHFFFAOYSA-N D0O0QN DRUGSMIL CC1=COC2=C1C=C3C=C(C(=O)OC3=C2)NC(=O)CN D0O0QN HIGHSTAT Investigative D0O0SH DRUG__ID D0O0SH D0O0SH DRUGTYPE Small molecular drug D0O0SH DRUGINCH 1S/C24H29N7O/c1-3-5-9-19-17-30(14-6-4-2)24(32)31(19)16-18-12-13-22(25-15-18)20-10-7-8-11-21(20)23-26-28-29-27-23/h7-8,10-13,15,17H,3-6,9,14,16H2,1-2H3,(H,26,27,28,29) D0O0SH DRUGINKE MIKRUZGZQMVMAG-UHFFFAOYSA-N D0O0SH DRUGSMIL CCCCC1=CN(C(=O)N1CC2=CN=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CCCC D0O0SH HIGHSTAT Investigative D0O0UE DRUG__ID D0O0UE D0O0UE DRUGTYPE Small molecular drug D0O0UE DRUGINCH 1S/C14H14N2O3S/c15-20(18,19)13-8-6-12(7-9-13)16-14(17)10-11-4-2-1-3-5-11/h1-9H,10H2,(H,16,17)(H2,15,18,19) D0O0UE DRUGINKE JWDLYKTZCRIGNW-UHFFFAOYSA-N D0O0UE DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=CC=C(C=C2)S(=O)(=O)N D0O0UE HIGHSTAT Investigative D0O0VP DRUG__ID D0O0VP D0O0VP DRUGTYPE Small molecular drug D0O0VP DRUGINCH 1S/C18H16N6O2/c1-25-16-6-5-12(10-17(16)26-2)22-18-19-9-7-14(23-18)13-11-21-24-15(13)4-3-8-20-24/h3-11H,1-2H3,(H,19,22,23) D0O0VP DRUGINKE AGAYQQLAAVQQLA-UHFFFAOYSA-N D0O0VP DRUGSMIL COC1=C(C=C(C=C1)NC2=NC=CC(=N2)C3=C4C=CC=NN4N=C3)OC D0O0VP HIGHSTAT Investigative D0O0VZ DRUG__ID D0O0VZ D0O0VZ DRUGTYPE Small molecular drug D0O0VZ DRUGINCH 1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H/b2-1+ D0O0VZ DRUGINKE CDRPUGZCRXZLFL-OWOJBTEDSA-N D0O0VZ DRUGSMIL C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O D0O0VZ HIGHSTAT Investigative D0O0XX DRUG__ID D0O0XX D0O0XX DRUGTYPE Small molecular drug D0O0XX DRUGINCH 1S/C12H20N2O4/c1-2-3-4-5-6-8-10(18-14-11(8)15)7-9(13)12(16)17/h9H,2-7,13H2,1H3,(H,14,15)(H,16,17)/t9-/m0/s1 D0O0XX DRUGINKE OKJBLHIYOWSQDJ-VIFPVBQESA-N D0O0XX DRUGSMIL CCCCCCC1=C(ONC1=O)CC(C(=O)O)N D0O0XX HIGHSTAT Investigative D0O0ZC DRUG__ID D0O0ZC D0O0ZC DRUGTYPE Small molecular drug D0O0ZC DRUGINCH 1S/C15H12O3/c16-11-6-7-14-12(8-11)13(17)9-15(18-14)10-4-2-1-3-5-10/h1-8,15-16H,9H2 D0O0ZC DRUGINKE XYHWPQUEOOBIOW-UHFFFAOYSA-N D0O0ZC DRUGSMIL C1C(OC2=C(C1=O)C=C(C=C2)O)C3=CC=CC=C3 D0O0ZC HIGHSTAT Investigative D0O0ZU DRUG__ID D0O0ZU D0O0ZU DRUGTYPE Small molecular drug D0O0ZU DRUGINCH 1S/C6H14O2/c7-5-3-1-2-4-6-8/h7-8H,1-6H2 D0O0ZU DRUGINKE XXMIOPMDWAUFGU-UHFFFAOYSA-N D0O0ZU DRUGSMIL C(CCCO)CCO D0O0ZU HIGHSTAT Investigative D0O1AK DRUG__ID D0O1AK D0O1AK DRUGTYPE Small molecular drug D0O1AK DRUGINCH 1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m1/s1 D0O1AK DRUGINKE WHUUTDBJXJRKMK-GSVOUGTGSA-N D0O1AK DRUGSMIL C(CC(=O)O)C(C(=O)O)N D0O1AK HIGHSTAT Investigative D0O1BJ DRUG__ID D0O1BJ D0O1BJ DRUGTYPE Small molecular drug D0O1BJ DRUGINCH 1S/C49H74N10O12/c1-26(2)23-37-46(66)58-40(48(69)70)30(6)42(62)55-35(17-14-22-52-49(50)51)45(65)54-34(19-18-27(3)24-28(4)38(71-10)25-33-15-12-11-13-16-33)29(5)41(61)56-36(47(67)68)20-21-39(60)59(9)32(8)44(64)53-31(7)43(63)57-37/h11-13,15-16,18-19,24,26,28-31,34-38,40H,8,14,17,20-23,25H2,1-7,9-10H3,(H,53,64)(H,54,65)(H,55,62)(H,56,61)(H,57,63)(H,58,66)(H,67,68)(H,69,70)(H4,50,51,52)/b19-18+,27-24+/t28-,29-,30-,31+,34-,35-,36+,37-,38-,40+/m0/s1 D0O1BJ DRUGINKE ZYZCGGRZINLQBL-GWRQVWKTSA-N D0O1BJ DRUGSMIL CC1C(NC(=O)C(NC(=O)C(C(NC(=O)C(NC(=O)C(NC(=O)C(=C)N(C(=O)CCC(NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)C)CCCN=C(N)N)C=CC(=CC(C)C(CC2=CC=CC=C2)OC)C D0O1BJ HIGHSTAT Investigative D0O1BN DRUG__ID D0O1BN D0O1BN DRUGTYPE Small molecular drug D0O1BN DRUGINCH 1S/C8H13O2S/c1-10-8(9)7-4-3-5-11(2)6-7/h4H,3,5-6H2,1-2H3/q+1 D0O1BN DRUGINKE RPAWRCUXEGWRMJ-UHFFFAOYSA-N D0O1BN DRUGSMIL COC(=O)C1=CCC[S+](C1)C D0O1BN HIGHSTAT Investigative D0O1BT DRUG__ID D0O1BT D0O1BT DRUGTYPE Small molecular drug D0O1BT DRUGINCH 1S/C17H22N2O2/c1-3-4-5-6-8-14-9-10-15(16(13-14)20-2)21-17-18-11-7-12-19-17/h7,9-13H,3-6,8H2,1-2H3 D0O1BT DRUGINKE UIFANQCPIJLKBV-UHFFFAOYSA-N D0O1BT DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=NC=CC=N2)OC D0O1BT HIGHSTAT Investigative D0O1CW DRUG__ID D0O1CW D0O1CW DRUGTYPE Small molecular drug D0O1CW DRUGINCH 1S/C12H15N5O/c1-3-18-9-6-4-5-8-7(2)15-12(16-10(8)9)17-11(13)14/h4-6H,3H2,1-2H3,(H4,13,14,15,16,17) D0O1CW DRUGINKE NNFBJZLFJMBVGQ-UHFFFAOYSA-N D0O1CW DRUGSMIL CCOC1=CC=CC2=C(N=C(N=C21)N=C(N)N)C D0O1CW HIGHSTAT Investigative D0O1DU DRUG__ID D0O1DU D0O1DU DRUGTYPE Small molecular drug D0O1DU DRUGINCH 1S/C21H24ClN3O2/c22-17-9-4-8-16(12-17)14-24-20(26)19-10-5-11-25(19)21(27)18(23)13-15-6-2-1-3-7-15/h1-4,6-9,12,18-19H,5,10-11,13-14,23H2,(H,24,26)/t18-,19+/m1/s1 D0O1DU DRUGINKE CJHLRGCXPGIPCB-MOPGFXCFSA-N D0O1DU DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)N)C(=O)NCC3=CC(=CC=C3)Cl D0O1DU HIGHSTAT Investigative D0O1EY DRUG__ID D0O1EY D0O1EY DRUGTYPE Small molecular drug D0O1EY DRUGINCH 1S/C14H13NO3/c15-6-11-9-3-4-12(17)14(18)13(9)8-2-1-7(16)5-10(8)11/h1-5,11,16-18H,6,15H2 D0O1EY DRUGINKE KQVZVMZWAHAQGC-UHFFFAOYSA-N D0O1EY DRUGSMIL C1=CC2=C(C=C1O)C(C3=C2C(=C(C=C3)O)O)CN D0O1EY HIGHSTAT Investigative D0O1FU DRUG__ID D0O1FU D0O1FU DRUGTYPE Small molecular drug D0O1FU DRUGINCH 1S/C22H18N2O4/c1-22(16-12-14-19(15-13-16)27-18-10-6-3-7-11-18)20(25)24(21(26)28-22)23-17-8-4-2-5-9-17/h2-15,23H,1H3 D0O1FU DRUGINKE PCCSBWNGDMYFCW-UHFFFAOYSA-N D0O1FU DRUGSMIL CC1(C(=O)N(C(=O)O1)NC2=CC=CC=C2)C3=CC=C(C=C3)OC4=CC=CC=C4 D0O1FU HIGHSTAT Investigative D0O1GE DRUG__ID D0O1GE D0O1GE DRUGTYPE Small molecular drug D0O1GE DRUGINCH 1S/C17H14O3/c1-11-6-7-16-13(8-11)10-15(17(18)20-16)12-4-3-5-14(9-12)19-2/h3-10H,1-2H3 D0O1GE DRUGINKE FXKIDMXANLWDBM-UHFFFAOYSA-N D0O1GE DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C(=C2)C3=CC(=CC=C3)OC D0O1GE HIGHSTAT Investigative D0O1HH DRUG__ID D0O1HH D0O1HH DRUGTYPE Small molecular drug D0O1HH DRUGINCH 1S/C8H8N2/c9-5-1-3-8-4-2-6-10-7-8/h2,4,6-7H,5,9H2 D0O1HH DRUGINKE BGKUWZFWNZFRMO-UHFFFAOYSA-N D0O1HH DRUGSMIL C1=CC(=CN=C1)C#CCN D0O1HH HIGHSTAT Investigative D0O1JC DRUG__ID D0O1JC D0O1JC DRUGTYPE Small molecular drug D0O1JC DRUGINCH 1S/C19H37N/c1-3-5-7-9-10-11-13-15-19-17-16-18(20-19)14-12-8-6-4-2/h4,18-20H,2-3,5-17H2,1H3 D0O1JC DRUGINKE VJYHAIYEEJOCLT-UHFFFAOYSA-N D0O1JC DRUGSMIL CCCCCCCCCC1CCC(N1)CCCCC=C D0O1JC HIGHSTAT Investigative D0O1JD DRUG__ID D0O1JD D0O1JD DRUGTYPE Small molecular drug D0O1JD DRUGINCH 1S/C21H21N3O2/c22-21(25)18-8-11-20(24-15-18)26-19-9-6-16(7-10-19)12-13-23-14-17-4-2-1-3-5-17/h1-11,15,23H,12-14H2,(H2,22,25) D0O1JD DRUGINKE FCDWJNPFPYAKET-UHFFFAOYSA-N D0O1JD DRUGSMIL C1=CC=C(C=C1)CNCCC2=CC=C(C=C2)OC3=NC=C(C=C3)C(=O)N D0O1JD HIGHSTAT Investigative D0O1JH DRUG__ID D0O1JH D0O1JH DRUGTYPE Small molecular drug D0O1JH DRUGINCH 1S/C30H41N3O5S/c1-19-12-11-13-20(2)25(19)38-17-23(34)31-22(16-21-14-9-8-10-15-21)24(35)28(37)33-18-39-30(6,7)26(33)27(36)32-29(3,4)5/h8-15,22,24,26,35H,16-18H2,1-7H3,(H,31,34)(H,32,36)/t22-,24-,26+/m0/s1 D0O1JH DRUGINKE CSWRAOHDICNMPU-LLZJGCNPSA-N D0O1JH DRUGSMIL CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC(C)(C)C)(C)C)O D0O1JH HIGHSTAT Investigative D0O1KA DRUG__ID D0O1KA D0O1KA DRUGTYPE Small molecular drug D0O1KA DRUGINCH 1S/C42H66N12O12S2/c1-7-21(4)33-40(65)48-25(12-13-30(44)56)36(61)50-28(16-31(45)57)37(62)51-29(39(64)54-42(5,6)41(66)52-26(14-20(2)3)35(60)47-17-32(46)58)19-68-67-18-24(43)34(59)49-27(38(63)53-33)15-22-8-10-23(55)11-9-22/h8-11,20-21,24-29,33,55H,7,12-19,43H2,1-6H3,(H2,44,56)(H2,45,57)(H2,46,58)(H,47,60)(H,48,65)(H,49,59)(H,50,61)(H,51,62)(H,52,66)(H,53,63)(H,54,64)/t21-,24-,25-,26-,27-,28-,29-,33-/m0/s1 D0O1KA DRUGINKE VQOHKFLFXMHMBH-LQGOSMBMSA-N D0O1KA DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0O1KA HIGHSTAT Investigative D0O1LW DRUG__ID D0O1LW D0O1LW DRUGTYPE Small molecular drug D0O1LW DRUGINCH 1S/C6H16NO8P/c7-3(1-8)5(10)6(11)4(9)2-15-16(12,13)14/h3-6,8-11H,1-2,7H2,(H2,12,13,14)/t3-,4+,5+,6+/m0/s1 D0O1LW DRUGINKE LBNVXZROMBUNNQ-SLPGGIOYSA-N D0O1LW DRUGSMIL C(C(C(C(C(COP(=O)(O)O)O)O)O)N)O D0O1LW HIGHSTAT Investigative D0O1OC DRUG__ID D0O1OC D0O1OC DRUGTYPE Small molecular drug D0O1OC DRUGINCH 1S/C25H30FNO3/c1-15(2)24-20(11-10-19-12-18(28)13-23(29)30-19)21(14-22(27-24)25(3,4)5)16-6-8-17(26)9-7-16/h6-11,14-15,18-19,28H,12-13H2,1-5H3/b11-10+/t18-,19?/m1/s1 D0O1OC DRUGINKE VPMIAOSOTOODMY-KJAPKAAFSA-N D0O1OC DRUGSMIL CC(C)C1=C(C(=CC(=N1)C(C)(C)C)C2=CC=C(C=C2)F)C=CC3CC(CC(=O)O3)O D0O1OC HIGHSTAT Investigative D0O1OL DRUG__ID D0O1OL D0O1OL DRUGCOMP Northern Antibiotics Ltd D0O1OL DRUGINCH 1S/C48H82N16O14/c1-24(2)22-34-44(73)57-28(10-16-49)38(67)56-31(13-19-52)42(71)63-36(25(3)65)46(75)54-21-15-33(41(70)55-29(11-17-50)40(69)61-35(45(74)60-34)23-27-8-6-5-7-9-27)58-39(68)30(12-18-51)59-47(76)37(26(4)66)64-43(72)32(14-20-53)62-48(77)78/h5-9,24-26,28-37,62,65-66H,10-23,49-53H2,1-4H3,(H,54,75)(H,55,70)(H,56,67)(H,57,73)(H,58,68)(H,59,76)(H,60,74)(H,61,69)(H,63,71)(H,64,72)(H,77,78)/t25-,26-,28+,29+,30+,31+,32+,33+,34+,35-,36+,37+/m1/s1 D0O1OL DRUGINKE WGRSQPZAOZIPGC-VVYZPAMCSA-N D0O1OL DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCN)NC(=O)C(CCN)NC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)O)C(C)O)CCN)CCN D0O1OL HIGHSTAT Investigative D0O1OZ DRUG__ID D0O1OZ D0O1OZ DRUGTYPE Small molecular drug D0O1OZ DRUGINCH 1S/C17H17N3O/c1-9-7-8-11-14(16(9)21)15(18)13-10-5-3-4-6-12(10)20(2)17(13)19-11/h3-6,9H,7-8H2,1-2H3,(H2,18,19) D0O1OZ DRUGINKE NWCDOCLEZPSZBM-UHFFFAOYSA-N D0O1OZ DRUGSMIL CC1CCC2=C(C1=O)C(=C3C4=CC=CC=C4N(C3=N2)C)N D0O1OZ HIGHSTAT Investigative D0O1QB DRUG__ID D0O1QB D0O1QB DRUGTYPE Small molecular drug D0O1QB DRUGINCH 1S/C27H38N2O/c1-7-21-28(3,4)25-15-9-23(10-16-25)13-19-27(30)20-14-24-11-17-26(18-12-24)29(5,6)22-8-2/h7-12,15-18H,1-2,13-14,19-22H2,3-6H3/q+2 D0O1QB DRUGINKE ZAEXMNKDGJNLTA-UHFFFAOYSA-N D0O1QB DRUGSMIL C[N+](C)(CC=C)C1=CC=C(C=C1)CCC(=O)CCC2=CC=C(C=C2)[N+](C)(C)CC=C D0O1QB HIGHSTAT Investigative D0O1QK DRUG__ID D0O1QK D0O1QK DRUGTYPE Small molecular drug D0O1QK DRUGINCH 1S/C5H11NO2/c1-5(2,6-3)4(7)8/h6H,1-3H3,(H,7,8) D0O1QK DRUGINKE DLAMVQGYEVKIRE-UHFFFAOYSA-N D0O1QK DRUGSMIL CC(C)(C(=O)O)NC D0O1QK HIGHSTAT Investigative D0O1QT DRUG__ID D0O1QT D0O1QT DRUGTYPE Small molecular drug D0O1QT DRUGINCH 1S/C7H7N3O2S2/c8-4-1-2-5-6(3-4)13-7(10-5)14(9,11)12/h1-3H,8H2,(H2,9,11,12) D0O1QT DRUGINKE OFSGGVHHSMAUEI-UHFFFAOYSA-N D0O1QT DRUGSMIL C1=CC2=C(C=C1N)SC(=N2)S(=O)(=O)N D0O1QT HIGHSTAT Investigative D0O1UQ DRUG__ID D0O1UQ D0O1UQ DRUGTYPE Small molecular drug D0O1UQ DRUGINCH 1S/C7H6BF3O2/c9-7(10,11)5-1-3-6(4-2-5)8(12)13/h1-4,12-13H D0O1UQ DRUGINKE ALMFIOZYDASRRC-UHFFFAOYSA-N D0O1UQ DRUGSMIL B(C1=CC=C(C=C1)C(F)(F)F)(O)O D0O1UQ HIGHSTAT Investigative D0O1WV DRUG__ID D0O1WV D0O1WV DRUGTYPE Small molecular drug D0O1WV DRUGINCH 1S/C13H19NO/c15-10-12(11-6-2-1-3-7-11)13-8-4-5-9-14-13/h1-3,6-7,12-15H,4-5,8-10H2/t12-,13-/m1/s1 D0O1WV DRUGINKE IKNCLLOBJQVKNP-CHWSQXEVSA-N D0O1WV DRUGSMIL C1CCNC(C1)C(CO)C2=CC=CC=C2 D0O1WV HIGHSTAT Investigative D0O1YH DRUG__ID D0O1YH D0O1YH DRUGTYPE Small molecular drug D0O1YH DRUGINCH 1S/C6HBr4N3/c7-1-2(8)4(10)6-5(3(1)9)11-13-12-6/h(H,11,12,13) D0O1YH DRUGINKE OMZYUVOATZSGJY-UHFFFAOYSA-N D0O1YH DRUGSMIL C1(=C(C2=NNN=C2C(=C1Br)Br)Br)Br D0O1YH HIGHSTAT Investigative D0O1ZM DRUG__ID D0O1ZM D0O1ZM DRUGTYPE Small molecular drug D0O1ZM DRUGINCH 1S/C17H24N2O2/c1-2-3-4-5-11-17(12-10-15(20)19-16(17)21)13-6-8-14(18)9-7-13/h6-9H,2-5,10-12,18H2,1H3,(H,19,20,21) D0O1ZM DRUGINKE VWJXCBZWAWHJLE-UHFFFAOYSA-N D0O1ZM DRUGSMIL CCCCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N D0O1ZM HIGHSTAT Investigative D0O2AV DRUG__ID D0O2AV D0O2AV DRUGTYPE Small molecular drug D0O2AV DRUGINCH 1S/C22H27NO3S/c1-5-12-17-18(22(25)27-8-4)16(6-2)19(21(24)26-7-3)20(23-17)15-13-10-9-11-14-15/h9-11,13-14H,5-8,12H2,1-4H3 D0O2AV DRUGINKE GSMBGLUYORHXJR-UHFFFAOYSA-N D0O2AV DRUGSMIL CCCC1=NC(=C(C(=C1C(=O)SCC)CC)C(=O)OCC)C2=CC=CC=C2 D0O2AV HIGHSTAT Investigative D0O2CH DRUG__ID D0O2CH D0O2CH DRUGTYPE Small molecular drug D0O2CH DRUGINCH 1S/C10H8BrN3O/c11-6-7(12)10(15)9-5-4(3-14-9)1-2-13-8(5)6/h3,15H,1-2,12H2 D0O2CH DRUGINKE UMVGTIHJQQYCQI-UHFFFAOYSA-N D0O2CH DRUGSMIL C1CN=C2C3=C1C=NC3=C(C(=C2Br)N)O D0O2CH HIGHSTAT Investigative D0O2CM DRUG__ID D0O2CM D0O2CM DRUGTYPE Small molecular drug D0O2CM DRUGINCH 1S/C11H12FN5O3/c12-5-4(1-18)8(19)9(20)7(5)17-3-16-6-10(13)14-2-15-11(6)17/h2-3,7-9,18-20H,1H2,(H2,13,14,15)/t7-,8-,9+/m1/s1 D0O2CM DRUGINKE RWUXFWACUXDNKY-HLTSFMKQSA-N D0O2CM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(=C3F)CO)O)O)N D0O2CM HIGHSTAT Investigative D0O2DN DRUG__ID D0O2DN D0O2DN DRUGTYPE Small molecular drug D0O2DN DRUGINCH 1S/C38H49N5O2/c1-29(19-22-39)27-38(2,3)28-41-36(44)35(26-32-16-11-15-31-14-7-8-18-34(31)32)42-37(45)43(24-20-30-12-5-4-6-13-30)25-21-33-17-9-10-23-40-33/h4-18,23,29,35H,19-22,24-28,39H2,1-3H3,(H,41,44)(H,42,45)/t29?,35-/m1/s1 D0O2DN DRUGINKE MZKKCMXXGCRPGX-LMZJGDDPSA-N D0O2DN DRUGSMIL CC(CCN)CC(C)(C)CNC(=O)C(CC1=CC=CC2=CC=CC=C21)NC(=O)N(CCC3=CC=CC=C3)CCC4=CC=CC=N4 D0O2DN HIGHSTAT Investigative D0O2DQ DRUG__ID D0O2DQ D0O2DQ DRUGTYPE Small molecular drug D0O2DQ DRUGINCH 1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26) D0O2DQ DRUGINKE GPKJTRJOBQGKQK-UHFFFAOYSA-N D0O2DQ DRUGSMIL CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC D0O2DQ HIGHSTAT Investigative D0O2FD DRUG__ID D0O2FD D0O2FD DRUGTYPE Small molecular drug D0O2FD DRUGINCH 1S/C24H31FO5/c1-14(2)17-9-21(15(3)4)24(22(10-17)16-5-7-18(25)8-6-16)30-13-20(27)11-19(26)12-23(28)29/h5-10,14-15,19-20,26-27H,11-13H2,1-4H3,(H,28,29)/p-1/t19-,20?/m1/s1 D0O2FD DRUGINKE GWJDCGLHTDEKGT-FIWHBWSRSA-M D0O2FD DRUGSMIL CC(C)C1=CC(=C(C(=C1)C(C)C)OCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F D0O2FD HIGHSTAT Investigative D0O2GK DRUG__ID D0O2GK D0O2GK DRUGTYPE Small molecular drug D0O2GK DRUGINCH 1S/C13H15NO3/c1-9(15)14-6-5-10-8-17-13-4-3-11(16-2)7-12(10)13/h3-4,7-8H,5-6H2,1-2H3,(H,14,15) D0O2GK DRUGINKE BTVRPXLAXZPZPV-UHFFFAOYSA-N D0O2GK DRUGSMIL CC(=O)NCCC1=COC2=C1C=C(C=C2)OC D0O2GK HIGHSTAT Investigative D0O2HL DRUG__ID D0O2HL D0O2HL DRUGTYPE Small molecular drug D0O2HL DRUGINCH 1S/C19H32N2O5.C6H14N4O2/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24;7-4(5(11)12)2-1-3-10-6(8)9/h12-16,20H,4-11H2,1-3H3,(H,23,24);4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p-1/t12-,13-,14-,15-,16-;4-/m00/s1 D0O2HL DRUGINKE RYCSJJXKEWBUTI-YDYAIEMNSA-M D0O2HL DRUGSMIL CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.C(CC(C(=O)[O-])N)CN=C(N)N D0O2HL HIGHSTAT Investigative D0O2KO DRUG__ID D0O2KO D0O2KO DRUGTYPE Small molecular drug D0O2KO DRUGINCH 1S/C9H20N4O2/c1-2-5-12-9(11)13-6-3-4-7(10)8(14)15/h7H,2-6,10H2,1H3,(H,14,15)(H3,11,12,13)/t7-/m0/s1 D0O2KO DRUGINKE AOMXURITGZJPKB-ZETCQYMHSA-N D0O2KO DRUGSMIL CCCN=C(N)NCCCC(C(=O)O)N D0O2KO HIGHSTAT Investigative D0O2KP DRUG__ID D0O2KP D0O2KP DRUGTYPE Small molecular drug D0O2KP DRUGINCH 1S/C23H18O/c24-20-11-10-18-14-23(15-19(18)12-20)21-9-5-4-8-17(21)13-22(23)16-6-2-1-3-7-16/h1-13,24H,14-15H2 D0O2KP DRUGINKE SGBUUCIHANKAQI-UHFFFAOYSA-N D0O2KP DRUGSMIL C1C2=C(CC13C4=CC=CC=C4C=C3C5=CC=CC=C5)C=C(C=C2)O D0O2KP HIGHSTAT Investigative D0O2LC DRUG__ID D0O2LC D0O2LC DRUGTYPE Small molecular drug D0O2LC DRUGINCH 1S/C14H18ClNO/c1-10(16-13-7-2-3-8-13)14(17)11-5-4-6-12(15)9-11/h4-6,9-10,13,16H,2-3,7-8H2,1H3 D0O2LC DRUGINKE RPHSTODYKZLNFU-UHFFFAOYSA-N D0O2LC DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)NC2CCCC2 D0O2LC HIGHSTAT Investigative D0O2LD DRUG__ID D0O2LD D0O2LD DRUGTYPE Small molecular drug D0O2LD DRUGINCH 1S/C19H21NO3/c1-20-9-8-19-12-5-7-15(22-3)18(19)23-17-14(21-2)6-4-11(16(17)19)10-13(12)20/h4-7,13,18H,8-10H2,1-3H3/t13-,18+,19+/m1/s1 D0O2LD DRUGINKE FQXXSQDCDRQNQE-VMDGZTHMSA-N D0O2LD DRUGSMIL CN1CCC23C4C(=CC=C2C1CC5=C3C(=C(C=C5)OC)O4)OC D0O2LD HIGHSTAT Investigative D0O2OH DRUG__ID D0O2OH D0O2OH DRUGTYPE Small molecular drug D0O2OH DRUGINCH 1S/C23H29N3O2/c1-15(2)16-6-8-17(9-7-16)24-22(27)28-18-10-11-20-19(14-18)23(3)12-13-25(4)21(23)26(20)5/h6-11,14-15,21H,12-13H2,1-5H3,(H,24,27)/t21-,23+/m1/s1 D0O2OH DRUGINKE NKJRRVBTMYRXRB-GGAORHGYSA-N D0O2OH DRUGSMIL CC(C)C1=CC=C(C=C1)NC(=O)OC2=CC3=C(C=C2)N(C4C3(CCN4C)C)C D0O2OH HIGHSTAT Investigative D0O2RN DRUG__ID D0O2RN D0O2RN DRUGTYPE Small molecular drug D0O2RN DRUGINCH 1S/C17H19N3O/c1-13-7-9-15(10-8-13)16(21)20-17(18)19-12-11-14-5-3-2-4-6-14/h2-10H,11-12H2,1H3,(H3,18,19,20,21) D0O2RN DRUGINKE ZVURELUSYUBEQF-UHFFFAOYSA-N D0O2RN DRUGSMIL CC1=CC=C(C=C1)C(=O)NC(=NCCC2=CC=CC=C2)N D0O2RN HIGHSTAT Investigative D0O2RX DRUG__ID D0O2RX D0O2RX DRUGTYPE Small molecular drug D0O2RX DRUGINCH 1S/C20H19NO4/c1-12-19(13(2)25-21-12)16-9-17(11-18(10-16)24-14(3)22)20(23)15-7-5-4-6-8-15/h4-11,20,23H,1-3H3 D0O2RX DRUGINKE BLNKHZBHJDYSGF-UHFFFAOYSA-N D0O2RX DRUGSMIL CC1=C(C(=NO1)C)C2=CC(=CC(=C2)OC(=O)C)C(C3=CC=CC=C3)O D0O2RX HIGHSTAT Investigative D0O2TC DRUG__ID D0O2TC D0O2TC DRUGTYPE Small molecular drug D0O2TC DRUGINCH 1S/C179H274N50O55S7/c1-87(2)65-111-155(261)208-112(66-93-33-15-13-16-34-93)146(252)195-77-133(239)225-139(88(3)4)172(278)213-117(71-136(244)245)158(264)199-100(44-31-62-190-178(186)187)144(250)193-75-131(237)198-102(40-22-27-58-181)148(254)219-124(167(273)205-109(56-64-285-12)145(251)194-76-132(238)197-101(39-21-26-57-180)147(253)200-105(43-25-30-61-184)151(257)220-123-81-286-288-83-125(221-152(258)106(203-166(123)272)45-32-63-191-179(188)189)169(275)210-113(68-95-46-48-97(234)49-47-95)156(262)206-110(177(283)284)50-53-129(185)235)82-287-291-86-128(168(274)202-104(42-24-29-60-183)150(256)212-116(70-135(242)243)159(265)207-111)224-175(281)142(91(9)10)228-164(270)121(79-231)216-157(263)115(69-96-74-192-99-38-20-19-37-98(96)99)211-170(276)126-84-289-290-85-127(171(277)217-122(80-232)165(271)227-141(90(7)8)174(280)218-120(78-230)163(269)201-103(41-23-28-59-182)149(255)204-108(154(260)222-126)52-55-134(240)241)223-160(266)118(72-137(246)247)214-173(279)140(89(5)6)226-162(268)119(73-138(248)249)215-176(282)143(92(11)233)229-161(267)114(67-94-35-17-14-18-36-94)209-153(259)107-51-54-130(236)196-107/h13-20,33-38,46-49,74,87-92,100-128,139-143,192,230-234H,21-32,39-45,50-73,75-86,180-184H2,1-12H3,(H2,185,235)(H,193,250)(H,194,251)(H,195,252)(H,196,236)(H,197,238)(H,198,237)(H,199,264)(H,200,253)(H,201,269)(H,202,274)(H,203,272)(H,204,255)(H,205,273)(H,206,262)(H,207,265)(H,208,261)(H,209,259)(H,210,275)(H,211,276)(H,212,256)(H,213,278)(H,214,279)(H,215,282)(H,216,263)(H,217,277)(H,218,280)(H,219,254)(H,220,257)(H,221,258)(H,222,260)(H,223,266)(H,224,281)(H,225,239)(H,226,268)(H,227,271)(H,228,270)(H,229,267)(H,240,241)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,283,284)(H4,186,187,190)(H4,188,189,191) D0O2TC DRUGINKE VDNVVLOBNHIMQA-UHFFFAOYSA-N D0O2TC DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)O)CCCCN)NC(=O)C(C(C)C)NC(=O)C(CO)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CCC(=O)O)CCCCN)CO)C(C)C)CO)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCC(=O)N6)C(=O)NC(CCSC)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC7CSSCC(NC(=O)C(NC7=O)CCCNC(=N)N)C(=O)NC(CC8=CC=C(C=C8)O)C(=O)NC(CCC(=O)N)C(=O)O)CCCCN)CCCNC(=N)N)CC(=O)O)C(C)C)CC9=CC=CC=C9 D0O2TC HIGHSTAT Investigative D0O2UK DRUG__ID D0O2UK D0O2UK DRUGTYPE Small molecular drug D0O2UK DRUGINCH 1S/C12H14N2/c1-2-5-11(6-3-1)9-13-10-12-7-4-8-14-12/h1-8,13-14H,9-10H2 D0O2UK DRUGINKE YOGRUDYQEJQNLR-UHFFFAOYSA-N D0O2UK DRUGSMIL C1=CC=C(C=C1)CNCC2=CC=CN2 D0O2UK HIGHSTAT Investigative D0O2US DRUG__ID D0O2US D0O2US DRUGTYPE Small molecular drug D0O2US DRUGINCH 1S/C29H28N2O6/c1-19-24(31-27(37-19)21-8-4-3-5-9-21)16-17-36-22-14-12-20(13-15-22)18-26(28(32)33)30-25-11-7-6-10-23(25)29(34)35-2/h3-15,26,30H,16-18H2,1-2H3,(H,32,33)/t26-/m0/s1 D0O2US DRUGINKE KEGOAFNIGUBYHZ-SANMLTNESA-N D0O2US DRUGSMIL CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CC(C(=O)O)NC4=CC=CC=C4C(=O)OC D0O2US HIGHSTAT Investigative D0O2WX DRUG__ID D0O2WX D0O2WX DRUGTYPE Small molecular drug D0O2WX DRUGINCH 1S/C20H30F2O5/c1-2-3-4-7-13(23)10-11-14-15(24)12-16-19(14)20(21,22)17(27-16)8-5-6-9-18(25)26/h8,10-11,13-16,19,23-24H,2-7,9,12H2,1H3,(H,25,26)/b11-10+,17-8-/t13-,14-,15+,16-,19+/m0/s1 D0O2WX DRUGINKE ILUYAOVLMOPQAI-BFOOZVJSSA-N D0O2WX DRUGSMIL CCCCCC(C=CC1C(CC2C1C(C(=CCCCC(=O)O)O2)(F)F)O)O D0O2WX HIGHSTAT Investigative D0O2YF DRUG__ID D0O2YF D0O2YF DRUGTYPE Small molecular drug D0O2YF DRUGINCH 1S/C38H46N4O7S2/c1-38(2)34(36(47)41-32-27-13-9-8-12-25(27)20-30(32)43)42(22-51-38)37(48)33(45)28(18-23-10-6-5-7-11-23)40-35(46)29(21-50-4)39-31(44)19-24-14-16-26(49-3)17-15-24/h5-17,28-30,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t28-,29-,30+,32-,33-,34+/m0/s1 D0O2YF DRUGINKE GJESXLGDWNCUSK-DYCNJNKSSA-N D0O2YF DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC=C(C=C3)OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0O2YF HIGHSTAT Investigative D0O3BL DRUG__ID D0O3BL D0O3BL DRUGTYPE Small molecular drug D0O3BL DRUGINCH 1S/C19H13ClN4O/c20-15-4-1-3-14(11-15)17-18-16(5-2-8-22-18)19(25)24(23-17)12-13-6-9-21-10-7-13/h1-11H,12H2 D0O3BL DRUGINKE COLQUUDNEIJASV-UHFFFAOYSA-N D0O3BL DRUGSMIL C1=CC(=CC(=C1)Cl)C2=NN(C(=O)C3=C2N=CC=C3)CC4=CC=NC=C4 D0O3BL HIGHSTAT Investigative D0O3DI DRUG__ID D0O3DI D0O3DI DRUGTYPE Small molecular drug D0O3DI DRUGINCH 1S/C15H10O5.ClH/c16-9-3-1-8(2-4-9)15-13(19)7-11-12(18)5-10(17)6-14(11)20-15;/h1-7H,(H3-,16,17,18,19);1H D0O3DI DRUGINKE YPVZJXMTXCOTJN-UHFFFAOYSA-N D0O3DI DRUGSMIL C1=CC(=CC=C1C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O.[Cl-] D0O3DI HIGHSTAT Investigative D0O3FC DRUG__ID D0O3FC D0O3FC DRUGTYPE Small molecular drug D0O3FC DRUGINCH 1S/C16H13Cl4NO2S/c1-23-12-6-2-10(3-7-12)14(22)21-15(16(18,19)20)24-13-8-4-11(17)5-9-13/h2-9,15H,1H3,(H,21,22) D0O3FC DRUGINKE MRIRDTYIRGDISF-UHFFFAOYSA-N D0O3FC DRUGSMIL COC1=CC=C(C=C1)C(=O)NC(C(Cl)(Cl)Cl)SC2=CC=C(C=C2)Cl D0O3FC HIGHSTAT Investigative D0O3GF DRUG__ID D0O3GF D0O3GF DRUGTYPE Small molecular drug D0O3GF DRUGINCH 1S/C16H25NO/c1-3-10-17(11-4-2)14-9-8-13-6-5-7-16(18)15(13)12-14/h5-7,14,18H,3-4,8-12H2,1-2H3 D0O3GF DRUGINKE ASXGJMSKWNBENU-UHFFFAOYSA-N D0O3GF DRUGSMIL CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O D0O3GF HIGHSTAT Investigative D0O3GQ DRUG__ID D0O3GQ D0O3GQ DRUGTYPE Small molecular drug D0O3GQ DRUGINCH 1S/C14H15NS/c15-10-9-12-5-4-8-14(11-12)16-13-6-2-1-3-7-13/h1-8,11H,9-10,15H2 D0O3GQ DRUGINKE FJLQSSVQBNJTEU-UHFFFAOYSA-N D0O3GQ DRUGSMIL C1=CC=C(C=C1)SC2=CC=CC(=C2)CCN D0O3GQ HIGHSTAT Investigative D0O3GR DRUG__ID D0O3GR D0O3GR DRUGTYPE Small molecular drug D0O3GR DRUGINCH 1S/C13H16N2O2/c1-16-12-4-6-13(7-5-12)17-8-2-3-11-9-14-10-15-11/h4-7,9-10H,2-3,8H2,1H3,(H,14,15) D0O3GR DRUGINKE DEZXFTGWFMDRDA-UHFFFAOYSA-N D0O3GR DRUGSMIL COC1=CC=C(C=C1)OCCCC2=CN=CN2 D0O3GR HIGHSTAT Investigative D0O3IE DRUG__ID D0O3IE D0O3IE DRUGTYPE Small molecular drug D0O3IE DRUGINCH 1S/C8H7N3/c1-2-4-7(5-3-1)8-6-9-11-10-8/h1-6H,(H,9,10,11) D0O3IE DRUGINKE LUEYUHCBBXWTQT-UHFFFAOYSA-N D0O3IE DRUGSMIL C1=CC=C(C=C1)C2=NNN=C2 D0O3IE HIGHSTAT Investigative D0O3NG DRUG__ID D0O3NG D0O3NG DRUGTYPE Small molecular drug D0O3NG DRUGINCH 1S/C6H15N3S/c1-9(2)4-3-5-10-6(7)8/h3-5H2,1-2H3,(H3,7,8) D0O3NG DRUGINKE OLHQOJYVQUNWPL-UHFFFAOYSA-N D0O3NG DRUGSMIL CN(C)CCCSC(=N)N D0O3NG HIGHSTAT Investigative D0O3NY DRUG__ID D0O3NY D0O3NY DRUGTYPE Small molecular drug D0O3NY DRUGINCH 1S/C22H22IN3O3/c1-24-11-5-4-6-16(24)13-25-14-19(17-7-2-3-8-21(17)25)22(27)18-12-15(26(28)29)9-10-20(18)23/h2-3,7-10,12,14,16H,4-6,11,13H2,1H3 D0O3NY DRUGINKE ZUHIXXCLLBMBDW-UHFFFAOYSA-N D0O3NY DRUGSMIL CN1CCCCC1CN2C=C(C3=CC=CC=C32)C(=O)C4=C(C=CC(=C4)[N+](=O)[O-])I D0O3NY HIGHSTAT Investigative D0O3PE DRUG__ID D0O3PE D0O3PE DRUGTYPE Small molecular drug D0O3PE DRUGINCH 1S/C19H28N2O3/c1-2-3-9-21-10-7-15(8-11-21)14-20-19(22)16-5-4-6-17-18(16)24-13-12-23-17/h4-6,15H,2-3,7-14H2,1H3,(H,20,22) D0O3PE DRUGINKE VBFBEYXWJLASJA-UHFFFAOYSA-N D0O3PE DRUGSMIL CCCCN1CCC(CC1)CNC(=O)C2=C3C(=CC=C2)OCCO3 D0O3PE HIGHSTAT Investigative D0O3QI DRUG__ID D0O3QI D0O3QI DRUGTYPE Small molecular drug D0O3QI DRUGINCH 1S/C16H13N3O2/c1-2-4-13-12(3-1)16(19-9-18-13)17-8-11-5-6-14-15(7-11)21-10-20-14/h1-7,9H,8,10H2,(H,17,18,19) D0O3QI DRUGINKE MLVNLAHRZDXSAM-UHFFFAOYSA-N D0O3QI DRUGSMIL C1OC2=C(O1)C=C(C=C2)CNC3=NC=NC4=CC=CC=C43 D0O3QI HIGHSTAT Investigative D0O3QJ DRUG__ID D0O3QJ D0O3QJ DRUGTYPE Small molecular drug D0O3QJ DRUGINCH 1S/C14H17N3O3/c15-6-7-20-13(14(18)19)8-11-9-17(10-16-11)12-4-2-1-3-5-12/h1-5,9-10,13H,6-8,15H2,(H,18,19)/t13-/m0/s1 D0O3QJ DRUGINKE LVCATUGNENEDGZ-ZDUSSCGKSA-N D0O3QJ DRUGSMIL C1=CC=C(C=C1)N2C=C(N=C2)CC(C(=O)O)OCCN D0O3QJ HIGHSTAT Investigative D0O3TT DRUG__ID D0O3TT D0O3TT DRUGTYPE Small molecular drug D0O3TT DRUGINCH 1S/C16H15F3N4O2S/c17-16(18,19)11-4-2-1-3-10(11)14(25)22-5-7-23(8-6-22)15-21-9-12(26-15)13(20)24/h1-4,9H,5-8H2,(H2,20,24) D0O3TT DRUGINKE XCYAUDKMHBMJSP-UHFFFAOYSA-N D0O3TT DRUGSMIL C1CN(CCN1C2=NC=C(S2)C(=O)N)C(=O)C3=CC=CC=C3C(F)(F)F D0O3TT HIGHSTAT Investigative D0O3VF DRUG__ID D0O3VF D0O3VF DRUGTYPE Small molecular drug D0O3VF DRUGINCH 1S/C17H15NO3S/c19-14-11-16(18-6-8-20-9-7-18)21-17-12(14)3-1-4-13(17)15-5-2-10-22-15/h1-5,10-11H,6-9H2 D0O3VF DRUGINKE FEOKXELSWFEHJU-UHFFFAOYSA-N D0O3VF DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CS4 D0O3VF HIGHSTAT Investigative D0O3XZ DRUG__ID D0O3XZ D0O3XZ DRUGTYPE Small molecular drug D0O3XZ DRUGINCH 1S/C6H8N2/c1-5-2-3-8-6(7)4-5/h2-4H,1H3,(H2,7,8) D0O3XZ DRUGINKE ORLGLBZRQYOWNA-UHFFFAOYSA-N D0O3XZ DRUGSMIL CC1=CC(=NC=C1)N D0O3XZ HIGHSTAT Investigative D0O4BC DRUG__ID D0O4BC D0O4BC DRUGTYPE Small molecular drug D0O4BC DRUGINCH 1S/C15H17NO2/c17-14-7-4-8-15(11-14)18-10-9-16-12-13-5-2-1-3-6-13/h1-8,11,16-17H,9-10,12H2 D0O4BC DRUGINKE VBTFJGYCISLKEQ-UHFFFAOYSA-N D0O4BC DRUGSMIL C1=CC=C(C=C1)CNCCOC2=CC=CC(=C2)O D0O4BC HIGHSTAT Investigative D0O4BU DRUG__ID D0O4BU D0O4BU DRUGTYPE Small molecular drug D0O4BU DRUGINCH 1S/C12H13NO3S/c1-2-3-8-15-12(14)17-11-13-9-6-4-5-7-10(9)16-11/h4-7H,2-3,8H2,1H3 D0O4BU DRUGINKE MJTKQBGLMBYWSU-UHFFFAOYSA-N D0O4BU DRUGSMIL CCCCOC(=O)SC1=NC2=CC=CC=C2O1 D0O4BU HIGHSTAT Investigative D0O4IM DRUG__ID D0O4IM D0O4IM DRUGTYPE Small molecular drug D0O4IM DRUGINCH 1S/C5H11NO2/c1-4(2-3-6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1 D0O4IM DRUGINKE AEBRINKRALSWNY-SCSAIBSYSA-N D0O4IM DRUGSMIL CC(CCN)C(=O)O D0O4IM HIGHSTAT Investigative D0O4IO DRUG__ID D0O4IO D0O4IO DRUGTYPE Small molecular drug D0O4IO DRUGINCH 1S/C12H8ClFN2O/c13-11-6-5-10(7-15-11)16-12(17)8-1-3-9(14)4-2-8/h1-7H,(H,16,17) D0O4IO DRUGINKE URPKVELJRWKNQS-UHFFFAOYSA-N D0O4IO DRUGSMIL C1=CC(=CC=C1C(=O)NC2=CN=C(C=C2)Cl)F D0O4IO HIGHSTAT Investigative D0O4IV DRUG__ID D0O4IV D0O4IV DRUGTYPE Small molecular drug D0O4IV DRUGINCH 1S/C20H14FNO4/c21-16-10-5-11-17(18(16)20(24)25)22-19(23)13-6-4-9-15(12-13)26-14-7-2-1-3-8-14/h1-12H,(H,22,23)(H,24,25) D0O4IV DRUGINKE MUCVEZAGZUMXAG-UHFFFAOYSA-N D0O4IV DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)C(=O)NC3=C(C(=CC=C3)F)C(=O)O D0O4IV HIGHSTAT Investigative D0O4JU DRUG__ID D0O4JU D0O4JU DRUGTYPE Small molecular drug D0O4JU DRUGINCH 1S/C19H34NO5P/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-25-26(22,23)24/h9-12,21H,2-8,13-16,20H2,1H3,(H2,22,23,24)/t19-/m0/s1 D0O4JU DRUGINKE LRFKWQGGENFBFO-IBGZPJMESA-N D0O4JU DRUGSMIL CCCCCCCCC1=CC=C(C=C1)CCC(CO)(COP(=O)(O)O)N D0O4JU HIGHSTAT Investigative D0O4KC DRUG__ID D0O4KC D0O4KC DRUGTYPE Small molecular drug D0O4KC DRUGINCH 1S/C14H15NO4/c1-17-10-2-3-11-12(15-4-6-18-7-5-15)9-14(16)19-13(11)8-10/h2-3,8-9H,4-7H2,1H3 D0O4KC DRUGINKE DRJQJIYPCHBMLO-UHFFFAOYSA-N D0O4KC DRUGSMIL COC1=CC2=C(C=C1)C(=CC(=O)O2)N3CCOCC3 D0O4KC HIGHSTAT Investigative D0O4KI DRUG__ID D0O4KI D0O4KI DRUGTYPE Small molecular drug D0O4KI DRUGINCH 1S/C11H9N3S2/c1-2-8-13-7-3-5-15-10(7)9(14-8)11-12-4-6-16-11/h3-6H,2H2,1H3 D0O4KI DRUGINKE YNBYJWXOQPYWEM-UHFFFAOYSA-N D0O4KI DRUGSMIL CCC1=NC2=C(C(=N1)C3=NC=CS3)SC=C2 D0O4KI HIGHSTAT Investigative D0O4KL DRUG__ID D0O4KL D0O4KL DRUGTYPE Small molecular drug D0O4KL DRUGINCH 1S/C16H11F5N2O3S/c17-11-10(12(18)14(20)15(21)13(11)19)16(24)23-9-4-1-6-5-7(27(22,25)26)2-3-8(6)9/h2-3,5,9H,1,4H2,(H,23,24)(H2,22,25,26) D0O4KL DRUGINKE GSDOCCQCQXIOCL-UHFFFAOYSA-N D0O4KL DRUGSMIL C1CC2=C(C1NC(=O)C3=C(C(=C(C(=C3F)F)F)F)F)C=CC(=C2)S(=O)(=O)N D0O4KL HIGHSTAT Investigative D0O4KY DRUG__ID D0O4KY D0O4KY DRUGTYPE Small molecular drug D0O4KY DRUGINCH 1S/C33H38N4O6/c1-43-33(42)28(21-23-11-6-3-7-12-23)36-30(39)27(20-22-9-4-2-5-10-22)35-31(40)29-13-8-18-37(29)32(41)26(34)19-24-14-16-25(38)17-15-24/h2-7,9-12,14-17,26-29,38H,8,13,18-21,34H2,1H3,(H,35,40)(H,36,39)/t26-,27-,28-,29-/m0/s1 D0O4KY DRUGINKE YYNCXEIEPLRPCR-DZUOILHNSA-N D0O4KY DRUGSMIL COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0O4KY HIGHSTAT Investigative D0O4LO DRUG__ID D0O4LO D0O4LO DRUGTYPE Small molecular drug D0O4LO DRUGINCH 1S/C22H21Cl3N4O2S/c1-32(31)22-19(21(30)27-28-11-3-2-4-12-28)26-20(17-10-7-15(24)13-18(17)25)29(22)16-8-5-14(23)6-9-16/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) D0O4LO DRUGINKE XQPOHFLWEFPJAR-UHFFFAOYSA-N D0O4LO DRUGSMIL CS(=O)C1=C(N=C(N1C2=CC=C(C=C2)Cl)C3=C(C=C(C=C3)Cl)Cl)C(=O)NN4CCCCC4 D0O4LO HIGHSTAT Investigative D0O4MK DRUG__ID D0O4MK D0O4MK DRUGTYPE Small molecular drug D0O4MK DRUGINCH 1S/C11H7ClN2/c12-11-5-8-7-3-1-2-4-9(7)14-10(8)6-13-11/h1-6,14H D0O4MK DRUGINKE JDYLMOJCIKYTGV-UHFFFAOYSA-N D0O4MK DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NC=C3N2)Cl D0O4MK HIGHSTAT Investigative D0O4QX DRUG__ID D0O4QX D0O4QX DRUGTYPE Small molecular drug D0O4QX DRUGINCH 1S/C15H14N2O/c1-3-18-15-16-10-14(11-17-15)8-7-13-6-4-5-12(2)9-13/h4-6,9-11H,3H2,1-2H3 D0O4QX DRUGINKE LZJPKUYOMGXTBK-UHFFFAOYSA-N D0O4QX DRUGSMIL CCOC1=NC=C(C=N1)C#CC2=CC=CC(=C2)C D0O4QX HIGHSTAT Investigative D0O4TL DRUG__ID D0O4TL D0O4TL DRUGTYPE Small molecular drug D0O4TL DRUGINCH 1S/C16H21N3O8S/c1-7(20)27-5-8-6-28-14-11(13(22)19(14)12(8)16(25)26)18-10(21)4-2-3-9(17)15(23)24/h9,11,14H,2-6,17H2,1H3,(H,18,21)(H,23,24)(H,25,26)/t9-,11-,14-/m1/s1 D0O4TL DRUGINKE HOKIDJSKDBPKTQ-GLXFQSAKSA-N D0O4TL DRUGSMIL CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)CCCC(C(=O)O)N)SC1)C(=O)O D0O4TL HIGHSTAT Investigative D0O4UQ DRUG__ID D0O4UQ D0O4UQ DRUGTYPE Small molecular drug D0O4UQ DRUGINCH 1S/C70H96N10O8/c1-47(71-3)63(81)75-59(53-37-21-11-22-38-53)69(87)79-45-27-41-55(79)65(83)77-61(57(49-29-13-7-14-30-49)50-31-15-8-16-32-50)67(85)73-43-25-5-6-26-44-74-68(86)62(58(51-33-17-9-18-34-51)52-35-19-10-20-36-52)78-66(84)56-42-28-46-80(56)70(88)60(54-39-23-12-24-40-54)76-64(82)48(2)72-4/h7-10,13-20,29-36,47-48,53-62,71-72H,5-6,11-12,21-28,37-46H2,1-4H3,(H,73,85)(H,74,86)(H,75,81)(H,76,82)(H,77,83)(H,78,84)/t47-,48-,55-,56-,59-,60-,61-,62-/m0/s1 D0O4UQ DRUGINKE DPXJXGNXKOVBJV-YLOPQIBLSA-N D0O4UQ DRUGSMIL CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C(=O)NC(C(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)NCCCCCCNC(=O)C(C(C5=CC=CC=C5)C6=CC=CC=C6)NC(=O)C7CCCN7C(=O)C(C8CCCCC8)NC(=O)C(C)NC)NC D0O4UQ HIGHSTAT Investigative D0O4XF DRUG__ID D0O4XF D0O4XF DRUGTYPE Small molecular drug D0O4XF DRUGINCH 1S/C15H14N4/c16-19-15-14(10-11-6-2-1-3-7-11)17-12-8-4-5-9-13(12)18-15/h1-9H,10,16H2,(H,18,19) D0O4XF DRUGINKE VVXTVQMXZGMAAH-UHFFFAOYSA-N D0O4XF DRUGSMIL C1=CC=C(C=C1)CC2=NC3=CC=CC=C3N=C2NN D0O4XF HIGHSTAT Investigative D0O4YS DRUG__ID D0O4YS D0O4YS DRUGTYPE Small molecular drug D0O4YS DRUGINCH 1S/C11H9NO3/c1-6-4-9(13)12-10-7(6)2-3-8-11(10)15-5-14-8/h2-4H,5H2,1H3,(H,12,13) D0O4YS DRUGINKE XCKXJOHJSMHNFE-UHFFFAOYSA-N D0O4YS DRUGSMIL CC1=CC(=O)NC2=C1C=CC3=C2OCO3 D0O4YS HIGHSTAT Investigative D0O5BC DRUG__ID D0O5BC D0O5BC DRUGTYPE Small molecular drug D0O5BC DRUGINCH 1S/C17H15NO4/c19-13-10-16(15-9-12-3-1-2-4-14(12)21-15)22-17(11-13)18-5-7-20-8-6-18/h1-4,9-11H,5-8H2 D0O5BC DRUGINKE FFDIMOCTDZWGJB-UHFFFAOYSA-N D0O5BC DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC4=CC=CC=C4O3 D0O5BC HIGHSTAT Investigative D0O5CR DRUG__ID D0O5CR D0O5CR DRUGTYPE Small molecular drug D0O5CR DRUGINCH 1S/C17H20N2O2/c1-19-11-6-7-12(19)9-13(8-11)21-17(20)15-10-18-16-5-3-2-4-14(15)16/h2-5,10-13,18H,6-9H2,1H3 D0O5CR DRUGINKE ZNRGQMMCGHDTEI-UHFFFAOYSA-N D0O5CR DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43 D0O5CR HIGHSTAT Investigative D0O5EZ DRUG__ID D0O5EZ D0O5EZ DRUGTYPE Small molecular drug D0O5EZ DRUGINCH 1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2/t8-,9+,10+/m0/s1 D0O5EZ DRUGINKE NLPRAJRHRHZCQQ-IVZWLZJFSA-N D0O5EZ DRUGSMIL C1CC2C(CC1N2)C3=CN=C(C=C3)Cl D0O5EZ HIGHSTAT Investigative D0O5FK DRUG__ID D0O5FK D0O5FK DRUGTYPE Small molecular drug D0O5FK DRUGINCH 1S/C14H12N2OS/c1-15-10-4-2-9(3-5-10)14-16-12-7-6-11(17)8-13(12)18-14/h2-8,15,17H,1H3 D0O5FK DRUGINKE ZQAQXZBSGZUUNL-UHFFFAOYSA-N D0O5FK DRUGSMIL CNC1=CC=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O D0O5FK HIGHSTAT Investigative D0O5HF DRUG__ID D0O5HF D0O5HF DRUGTYPE Small molecular drug D0O5HF DRUGINCH 1S/C20H26O5/c1-6-10(2)18(22)25-17-16-12(4)19(23)24-14(16)9-11(3)13-7-8-15(21)20(13,17)5/h7-8,10-11,13-14,16-17H,4,6,9H2,1-3,5H3/t10?,11-,13+,14-,16-,17-,20+/m1/s1 D0O5HF DRUGINKE IFEHNUQNAATZSJ-MXCJSKHRSA-N D0O5HF DRUGSMIL CCC(C)C(=O)OC1C2C(CC(C3C1(C(=O)C=C3)C)C)OC(=O)C2=C D0O5HF HIGHSTAT Investigative D0O5KG DRUG__ID D0O5KG D0O5KG DRUGTYPE Small molecular drug D0O5KG DRUGINCH 1S/C20H15NO4/c22-19(21-18-12-5-4-11-17(18)20(23)24)14-7-6-10-16(13-14)25-15-8-2-1-3-9-15/h1-13H,(H,21,22)(H,23,24) D0O5KG DRUGINKE MIKJQLWATXBRIP-UHFFFAOYSA-N D0O5KG DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)C(=O)NC3=CC=CC=C3C(=O)O D0O5KG HIGHSTAT Investigative D0O5KK DRUG__ID D0O5KK D0O5KK DRUGTYPE Small molecular drug D0O5KK DRUGINCH 1S/C12H13NO/c1-2-10-5-8-14-12(10)11-4-7-13-6-3-9(1)11/h1-2,5,8,13H,3-4,6-7H2 D0O5KK DRUGINKE QDAAIWYKQLAISZ-UHFFFAOYSA-N D0O5KK DRUGSMIL C1CNCCC2=C1C=CC3=C2OC=C3 D0O5KK HIGHSTAT Investigative D0O5KR DRUG__ID D0O5KR D0O5KR DRUGTYPE Small molecular drug D0O5KR DRUGINCH 1S/C16H16O3/c1-8-13(17)6-4-11-12-5-7-14(18)9(2)16(12)19-10(3)15(8)11/h4-7,10,17-18H,1-3H3 D0O5KR DRUGINKE SKULOBHFUJYXEB-UHFFFAOYSA-N D0O5KR DRUGSMIL CC1C2=C(C=CC(=C2C)O)C3=C(O1)C(=C(C=C3)O)C D0O5KR HIGHSTAT Investigative D0O5OM DRUG__ID D0O5OM D0O5OM DRUGTYPE Small molecular drug D0O5OM DRUGINCH 1S/C26H23N5O4/c27-24(28)16-9-10-20-18(11-16)13-22(30-20)26(35)29-19-8-4-7-17(12-19)25(34)31-21(14-23(32)33)15-5-2-1-3-6-15/h1-13,21,30H,14H2,(H3,27,28)(H,29,35)(H,31,34)(H,32,33) D0O5OM DRUGINKE RVWSCZNGPOUASU-UHFFFAOYSA-N D0O5OM DRUGSMIL C1=CC=C(C=C1)C(CC(=O)O)NC(=O)C2=CC(=CC=C2)NC(=O)C3=CC4=C(N3)C=CC(=C4)C(=N)N D0O5OM HIGHSTAT Investigative D0O5PQ DRUG__ID D0O5PQ D0O5PQ DRUGTYPE Small molecular drug D0O5PQ DRUGINCH 1S/C17H17N3O/c1-20-9-13(12-4-2-3-5-16(12)20)17(21)11-6-7-14-15(8-11)19-10-18-14/h2-5,9-11H,6-8H2,1H3,(H,18,19)/t11-/m1/s1/i1T3 D0O5PQ DRUGINKE NTHPAPBPFQJABD-WENCKANPSA-N D0O5PQ DRUGSMIL CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4 D0O5PQ HIGHSTAT Investigative D0O5RK DRUG__ID D0O5RK D0O5RK DRUGTYPE Small molecular drug D0O5RK DRUGINCH 1S/C33H64NO10P/c1-5-6-7-8-9-10-11-12-13-14-15-18-21-24-32(37)41-28-30(29-43-45(39,40)42-27-26-34(2,3)4)44-33(38)25-22-19-16-17-20-23-31(35)36/h30H,5-29H2,1-4H3,(H-,35,36,39,40)/t30-/m1/s1 D0O5RK DRUGINKE GHQQYDSARXURNG-SSEXGKCCSA-N D0O5RK DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O D0O5RK HIGHSTAT Investigative D0O5SA DRUG__ID D0O5SA D0O5SA DRUGTYPE Small molecular drug D0O5SA DRUGINCH 1S/C36H54O9S2.2Na/c1-31(2)15-8-16-36(7)25(31)11-18-34(5)27-12-17-33(4)26(32(27,3)20-14-29(34)43-36)13-19-35(6)28(33)21-22-23(44-46(37,38)39)9-10-24(30(22)35)45-47(40,41)42;;/h9-10,25-29H,8,11-21H2,1-7H3,(H,37,38,39)(H,40,41,42);;/q;2*+1/p-2/t25-,26+,27+,28-,29-,32+,33+,34-,35-,36-;;/m0../s1 D0O5SA DRUGINKE LLFWGACFIWPWDA-TZYHAVDYSA-L D0O5SA DRUGSMIL CC1(CCCC2(C1CCC3(C4CCC5(C(C4(CCC3O2)C)CCC6(C5CC7=C(C=CC(=C76)OS(=O)(=O)[O-])OS(=O)(=O)[O-])C)C)C)C)C.[Na+].[Na+] D0O5SA HIGHSTAT Investigative D0O5SC DRUG__ID D0O5SC D0O5SC DRUGTYPE Small molecular drug D0O5SC DRUGINCH 1S/C35H48N2O10/c1-20(2)25-10-8-21(3)26-15-29(46-30(40)11-9-24-16-37(6)19-36-24)34(5)12-13-35(42-7,47-34)23(14-27(25)26)17-43-33-32(45-22(4)38)31(41)28(39)18-44-33/h8-9,11-14,16,19-20,25-29,31-33,39,41H,10,15,17-18H2,1-7H3/b11-9+,23-14-/t25-,26+,27-,28-,29+,31-,32+,33-,34+,35-/m1/s1 D0O5SC DRUGINKE XOPYFXBZMVTEJF-PDACKIITSA-N D0O5SC DRUGSMIL CC1=CCC(C2C1CC(C3(C=CC(O3)(C(=C2)COC4C(C(C(CO4)O)O)OC(=O)C)OC)C)OC(=O)C=CC5=CN(C=N5)C)C(C)C D0O5SC HIGHSTAT Investigative D0O5TA DRUG__ID D0O5TA D0O5TA DRUGTYPE Small molecular drug D0O5TA DRUGINCH 1S/C15H9Cl2NO2/c16-10-3-1-9(2-4-10)8-18-13-6-5-11(17)7-12(13)14(19)15(18)20/h1-7H,8H2 D0O5TA DRUGINKE NWUYWKYKVCEBTP-UHFFFAOYSA-N D0O5TA DRUGSMIL C1=CC(=CC=C1CN2C3=C(C=C(C=C3)Cl)C(=O)C2=O)Cl D0O5TA HIGHSTAT Investigative D0O5TK DRUG__ID D0O5TK D0O5TK DRUGTYPE Small molecular drug D0O5TK DRUGINCH 1S/C44H61N11O11S2/c1-24(2)17-28-39(61)52-31(20-35(46)57)42(64)54-33(44(66)55-15-6-9-34(55)43(65)53-32(21-45)38(60)48-22-36(47)58)23-68-67-16-14-37(59)49-29(19-26-10-12-27(56)13-11-26)40(62)51-30(41(63)50-28)18-25-7-4-3-5-8-25/h3-5,7-8,10-13,24,28-34,56H,6,9,14-23,45H2,1-2H3,(H2,46,57)(H2,47,58)(H,48,60)(H,49,59)(H,50,63)(H,51,62)(H,52,61)(H,53,65)(H,54,64)/t28-,29-,30-,31-,32-,33-,34-/m0/s1 D0O5TK DRUGINKE ZAOGZAMKKBQERK-NXBWRCJVSA-N D0O5TK DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CN)C(=O)NCC(=O)N)CC(=O)N D0O5TK HIGHSTAT Investigative D0O5VI DRUG__ID D0O5VI D0O5VI DRUGTYPE Small molecular drug D0O5VI DRUGINCH 1S/C14H24N2O10/c17-11(18)7-15(8-12(19)20)1-3-25-5-6-26-4-2-16(9-13(21)22)10-14(23)24/h1-10H2,(H,17,18)(H,19,20)(H,21,22)(H,23,24) D0O5VI DRUGINKE DEFVIWRASFVYLL-UHFFFAOYSA-N D0O5VI DRUGSMIL C(COCCOCCN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O D0O5VI HIGHSTAT Investigative D0O5YE DRUG__ID D0O5YE D0O5YE DRUGTYPE Small molecular drug D0O5YE DRUGINCH 1S/C13H18O2/c1-9(2)7-11-5-4-6-12(8-11)10(3)13(14)15/h4-6,8-10H,7H2,1-3H3,(H,14,15) D0O5YE DRUGINKE SFVKLYXPBKITCE-UHFFFAOYSA-N D0O5YE DRUGSMIL CC(C)CC1=CC(=CC=C1)C(C)C(=O)O D0O5YE HIGHSTAT Investigative D0O5ZG DRUG__ID D0O5ZG D0O5ZG DRUGTYPE Small molecular drug D0O5ZG DRUGINCH 1S/C20H16O2/c1-21-17-12-7-13-18-19(17)15-10-5-6-11-16(15)20(22-18)14-8-3-2-4-9-14/h2-13,20H,1H3 D0O5ZG DRUGINKE SZYXTCHBPGBQPM-UHFFFAOYSA-N D0O5ZG DRUGSMIL COC1=CC=CC2=C1C3=CC=CC=C3C(O2)C4=CC=CC=C4 D0O5ZG HIGHSTAT Investigative D0O5ZY DRUG__ID D0O5ZY D0O5ZY DRUGTYPE Small molecular drug D0O5ZY DRUGINCH 1S/C11H17N5O9P2/c1-12-10-9-11(14-4-13-10)16(5-15-9)8-2-6(25-27(20,21)22)7(24-8)3-23-26(17,18)19/h4-8H,2-3H2,1H3,(H,12,13,14)(H2,17,18,19)(H2,20,21,22)/p-2/t6-,7+,8+/m0/s1 D0O5ZY DRUGINKE CCPLITQNIFLYQB-XLPZGREQSA-L D0O5ZY DRUGSMIL CNC1=C2C(=NC=N1)N(C=N2)C3CC(C(O3)COP(=O)(O)[O-])OP(=O)(O)[O-] D0O5ZY HIGHSTAT Investigative D0O6BD DRUG__ID D0O6BD D0O6BD DRUGTYPE Small molecular drug D0O6BD DRUGINCH 1S/C19H21N3O7/c1-10-16(18(23)29-11-5-3-4-6-11)17(20-19(24)21(10)2)12-7-14-15(28-9-27-14)8-13(12)22(25)26/h7-8,11,17H,3-6,9H2,1-2H3,(H,20,24) D0O6BD DRUGINKE GUFKDOZSNUQIAS-UHFFFAOYSA-N D0O6BD DRUGSMIL CC1=C(C(NC(=O)N1C)C2=CC3=C(C=C2[N+](=O)[O-])OCO3)C(=O)OC4CCCC4 D0O6BD HIGHSTAT Investigative D0O6DN DRUG__ID D0O6DN D0O6DN DRUGTYPE Small molecular drug D0O6DN DRUGINCH 1S/C18H29N7O7/c19-18(20)21-3-1-2-9-16(31)22-7-13(27)23-11(6-14(28)29)17(32)25-10-4-8(5-12(10)26)15(30)24-9/h8-12,26H,1-7H2,(H,22,31)(H,23,27)(H,24,30)(H,25,32)(H,28,29)(H4,19,20,21)/t8-,9-,10-,11-,12-/m0/s1 D0O6DN DRUGINKE CFCPTSHVAOVLJR-HTFCKZLJSA-N D0O6DN DRUGSMIL C1C2CC(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O D0O6DN HIGHSTAT Investigative D0O6FX DRUG__ID D0O6FX D0O6FX DRUGTYPE Small molecular drug D0O6FX DRUGINCH 1S/C17H18O3/c1-8-7-14(19)9(2)16-11(4)20-17-10(3)13(18)6-5-12(17)15(8)16/h5-7,11,18-19H,1-4H3 D0O6FX DRUGINKE NXVCUJCNTBPNSZ-UHFFFAOYSA-N D0O6FX DRUGSMIL CC1C2=C(C(=CC(=C2C)O)C)C3=C(O1)C(=C(C=C3)O)C D0O6FX HIGHSTAT Investigative D0O6GL DRUG__ID D0O6GL D0O6GL DRUGTYPE Small molecular drug D0O6GL DRUGINCH 1S/C14H23N/c1-13(15-2)8-14(13)11-4-9-3-10(6-11)7-12(14)5-9/h9-12,15H,3-8H2,1-2H3 D0O6GL DRUGINKE LMLBGVHUFCZMCI-UHFFFAOYSA-N D0O6GL DRUGSMIL CC1(CC12C3CC4CC(C3)CC2C4)NC D0O6GL HIGHSTAT Investigative D0O6HW DRUG__ID D0O6HW D0O6HW DRUGTYPE Small molecular drug D0O6HW DRUGINCH 1S/C11H14BrNO2S/c12-9-3-1-8(2-4-9)7-16-6-5-10(13)11(14)15/h1-4,10H,5-7,13H2,(H,14,15) D0O6HW DRUGINKE XUFONRLUGMPMHQ-UHFFFAOYSA-N D0O6HW DRUGSMIL C1=CC(=CC=C1CSCCC(C(=O)O)N)Br D0O6HW HIGHSTAT Investigative D0O6JB DRUG__ID D0O6JB D0O6JB DRUGTYPE Small molecular drug D0O6JB DRUGINCH 1S/C12H12BrN3S2/c13-9-3-4-11(15-8-9)16-12(17)14-6-5-10-2-1-7-18-10/h1-4,7-8H,5-6H2,(H2,14,15,16,17) D0O6JB DRUGINKE GAIBJCKASOWHGH-UHFFFAOYSA-N D0O6JB DRUGSMIL C1=CSC(=C1)CCNC(=S)NC2=NC=C(C=C2)Br D0O6JB HIGHSTAT Investigative D0O6JQ DRUG__ID D0O6JQ D0O6JQ DRUGTYPE Small molecular drug D0O6JQ DRUGINCH 1S/C21H21ClN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3/t14-/m1/s1 D0O6JQ DRUGINKE RAVIZVQZGXBOQO-CQSZACIVSA-N D0O6JQ DRUGSMIL CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl D0O6JQ HIGHSTAT Investigative D0O6KR DRUG__ID D0O6KR D0O6KR DRUGTYPE Small molecular drug D0O6KR DRUGINCH 1S/C15H10O2/c16-15(17)14-12-7-3-1-5-10(12)9-11-6-2-4-8-13(11)14/h1-9H,(H,16,17) D0O6KR DRUGINKE XGWFJBFNAQHLEF-UHFFFAOYSA-N D0O6KR DRUGSMIL C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)O D0O6KR HIGHSTAT Investigative D0O6MG DRUG__ID D0O6MG D0O6MG DRUGTYPE Small molecular drug D0O6MG DRUGINCH 1S/C20H25F3N4O3/c1-15-13-24-19(29)27(18(15)28)8-4-7-25-9-11-26(12-10-25)16-5-2-3-6-17(16)30-14-20(21,22)23/h2-3,5-6,13H,4,7-12,14H2,1H3,(H,24,29) D0O6MG DRUGINKE RCOBWVAGWYRNHZ-UHFFFAOYSA-N D0O6MG DRUGSMIL CC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F D0O6MG HIGHSTAT Investigative D0O6NS DRUG__ID D0O6NS D0O6NS DRUGTYPE Small molecular drug D0O6NS DRUGINCH 1S/C5H4BrN5/c6-5-10-2-3(7)8-1-9-4(2)11-5/h1H,(H3,7,8,9,10,11) D0O6NS DRUGINKE FVXHPCVBOXMRJP-UHFFFAOYSA-N D0O6NS DRUGSMIL C1=NC(=C2C(=N1)N=C(N2)Br)N D0O6NS HIGHSTAT Investigative D0O6NU DRUG__ID D0O6NU D0O6NU DRUGTYPE Small molecular drug D0O6NU DRUGINCH 1S/C21H24N4O2/c1-4-24(5-2)11-10-22-16-7-8-17-20-19(16)21(27)15-12-14(26)6-9-18(15)25(20)13(3)23-17/h6-9,12,22,26H,4-5,10-11H2,1-3H3 D0O6NU DRUGINKE CAHBHXJBZIGLGG-UHFFFAOYSA-N D0O6NU DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=C(N3C4=C(C2=O)C=C(C=C4)O)C D0O6NU HIGHSTAT Investigative D0O6OH DRUG__ID D0O6OH D0O6OH DRUGTYPE Small molecular drug D0O6OH DRUGINCH 1S/C22H26Cl2N6O/c1-13-8-20(31-29-13)19-12-25-22(27-17-10-14(23)9-15(24)11-17)28-21(19)26-16-4-6-18(7-5-16)30(2)3/h8-12,16,18H,4-7H2,1-3H3,(H2,25,26,27,28) D0O6OH DRUGINKE ZTSOUDMNSOYCTG-UHFFFAOYSA-N D0O6OH DRUGSMIL CC1=NOC(=C1)C2=CN=C(N=C2NC3CCC(CC3)N(C)C)NC4=CC(=CC(=C4)Cl)Cl D0O6OH HIGHSTAT Investigative D0O6OI DRUG__ID D0O6OI D0O6OI DRUGTYPE Small molecular drug D0O6OI DRUGINCH 1S/C22H19NO5S/c1-15-2-10-19(11-3-15)29(27,28)23-18-8-6-17(7-9-18)20(24)12-4-16-5-13-21(25)22(26)14-16/h2-14,23,25-26H,1H3/b12-4+ D0O6OI DRUGINKE XCEAUELSIXURQB-UUILKARUSA-N D0O6OI DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C(=O)C=CC3=CC(=C(C=C3)O)O D0O6OI HIGHSTAT Investigative D0O6OJ DRUG__ID D0O6OJ D0O6OJ DRUGTYPE Small molecular drug D0O6OJ DRUGINCH 1S/C18H15NO2/c1-19(21)18(20)11-10-14-12-13-6-2-3-7-15(13)17-9-5-4-8-16(14)17/h2-12,21H,1H3/b11-10+ D0O6OJ DRUGINKE NKRFCIWHWNMHCB-ZHACJKMWSA-N D0O6OJ DRUGSMIL CN(C(=O)C=CC1=CC2=CC=CC=C2C3=CC=CC=C31)O D0O6OJ HIGHSTAT Investigative D0O6QU DRUG__ID D0O6QU D0O6QU DRUGTYPE Small molecular drug D0O6QU DRUGINCH 1S/C26H26O3/c1-25(2)11-12-26(3,4)22-15-19(9-10-21(22)25)23(27)18-7-5-17-14-20(24(28)29)8-6-16(17)13-18/h5-10,13-15H,11-12H2,1-4H3,(H,28,29) D0O6QU DRUGINKE RWYREGSYPCNZTL-UHFFFAOYSA-N D0O6QU DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(=O)C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)(C)C)C D0O6QU HIGHSTAT Investigative D0O6SB DRUG__ID D0O6SB D0O6SB DRUGTYPE Small molecular drug D0O6SB DRUGINCH 1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1 D0O6SB DRUGINKE OIJXLIIMXHRJJH-KNLIIKEYSA-N D0O6SB DRUGSMIL CC(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O D0O6SB HIGHSTAT Investigative D0O6SI DRUG__ID D0O6SI D0O6SI DRUGTYPE Small molecular drug D0O6SI DRUGINCH 1S/C4H10O2/c5-3-1-2-4-6/h5-6H,1-4H2 D0O6SI DRUGINKE WERYXYBDKMZEQL-UHFFFAOYSA-N D0O6SI DRUGSMIL C(CCO)CO D0O6SI HIGHSTAT Investigative D0O6WF DRUG__ID D0O6WF D0O6WF DRUGTYPE Small molecular drug D0O6WF DRUGINCH 1S/C35H42F3N11O5/c1-19(50)46-29(15-23-17-42-18-45-23)33(54)49-28(13-20-8-10-22(11-9-20)35(36,37)38)32(53)47-26(7-4-12-43-34(40)41)31(52)48-27(30(39)51)14-21-16-44-25-6-3-2-5-24(21)25/h2-3,5-6,8-11,16-18,26-29,44H,4,7,12-15H2,1H3,(H2,39,51)(H,42,45)(H,46,50)(H,47,53)(H,48,52)(H,49,54)(H4,40,41,43)/t26-,27-,28+,29-/m0/s1 D0O6WF DRUGINKE OBZQTNACJLTWOC-FKWFRFQNSA-N D0O6WF DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=C(C=C2)C(F)(F)F)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)N D0O6WF HIGHSTAT Investigative D0O6WW DRUG__ID D0O6WW D0O6WW DRUGTYPE Small molecular drug D0O6WW DRUGINCH 1S/C14H10N2O2/c17-11-8-4-7-10-12(11)15-13(16-14(10)18)9-5-2-1-3-6-9/h1-8,17H,(H,15,16,18) D0O6WW DRUGINKE JRDFYUFZPYBDNH-UHFFFAOYSA-N D0O6WW DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C=CC=C3O)C(=O)N2 D0O6WW HIGHSTAT Investigative D0O6XT DRUG__ID D0O6XT D0O6XT DRUGTYPE Small molecular drug D0O6XT DRUGINCH 1S/C19H17N3O4S/c1-12-8-14-10-15(5-6-16(14)22(2)19(12)23)21-27(24,25)18-7-4-13(11-20)9-17(18)26-3/h4-10,21H,1-3H3 D0O6XT DRUGINKE UEMQPCYDWCSVCU-UHFFFAOYSA-N D0O6XT DRUGSMIL CC1=CC2=C(C=CC(=C2)NS(=O)(=O)C3=C(C=C(C=C3)C#N)OC)N(C1=O)C D0O6XT HIGHSTAT Investigative D0O6ZD DRUG__ID D0O6ZD D0O6ZD DRUGTYPE Small molecular drug D0O6ZD DRUGINCH 1S/C18H14O4/c1-12(19)17-15(21-11-13-5-3-2-4-6-13)9-7-14-8-10-16(20)22-18(14)17/h2-10H,11H2,1H3 D0O6ZD DRUGINKE QMLSJCDSHGYBMT-UHFFFAOYSA-N D0O6ZD DRUGSMIL CC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OCC3=CC=CC=C3 D0O6ZD HIGHSTAT Investigative D0O6ZM DRUG__ID D0O6ZM D0O6ZM DRUGTYPE Small molecular drug D0O6ZM DRUGINCH 1S/C16H19NO2/c1-18-15-10-7-13(11-16(15)19-2)4-3-12-5-8-14(17)9-6-12/h5-11H,3-4,17H2,1-2H3 D0O6ZM DRUGINKE MEJNYOQOZUXCOG-UHFFFAOYSA-N D0O6ZM DRUGSMIL COC1=C(C=C(C=C1)CCC2=CC=C(C=C2)N)OC D0O6ZM HIGHSTAT Investigative D0O6ZN DRUG__ID D0O6ZN D0O6ZN DRUGTYPE Small molecular drug D0O6ZN DRUGINCH 1S/C30H37N3O/c1-4-8-22-10-12-23(13-11-22)24-14-16-25(17-15-24)33(20-28(31)21(3)5-2)30(34)27-19-26(27)29-9-6-7-18-32-29/h6-7,9-18,21,26-28H,4-5,8,19-20,31H2,1-3H3/t21-,26+,27+,28+/m0/s1 D0O6ZN DRUGINKE OBGKRTYDTRUMGO-RFNYNIMXSA-N D0O6ZN DRUGSMIL CCCC1=CC=C(C=C1)C2=CC=C(C=C2)N(CC(C(C)CC)N)C(=O)C3CC3C4=CC=CC=N4 D0O6ZN HIGHSTAT Investigative D0O7AS DRUG__ID D0O7AS D0O7AS DRUGTYPE Small molecular drug D0O7AS DRUGINCH 1S/C34H37F2N3O7S/c1-20(2)32-34(47(45,46)38-26-5-3-4-21(16-26)17-29(37)42)31(22-6-10-24(35)11-7-22)33(23-8-12-25(36)13-9-23)39(32)15-14-27(40)18-28(41)19-30(43)44/h3-13,16,20,27-28,38,40-41H,14-15,17-19H2,1-2H3,(H2,37,42)(H,43,44)/t27-,28-/m1/s1 D0O7AS DRUGINKE ZXGVFUKWWWNTTQ-VSGBNLITSA-N D0O7AS DRUGSMIL CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)S(=O)(=O)NC4=CC=CC(=C4)CC(=O)N D0O7AS HIGHSTAT Investigative D0O7CX DRUG__ID D0O7CX D0O7CX DRUGTYPE Small molecular drug D0O7CX DRUGINCH 1S/C15H13NO2/c16-13-6-4-12(5-7-13)15(18)10-3-11-1-8-14(17)9-2-11/h1-10,17H,16H2 D0O7CX DRUGINKE GJKSOGFGWQZGRL-UHFFFAOYSA-N D0O7CX DRUGSMIL C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)N)O D0O7CX HIGHSTAT Investigative D0O7DA DRUG__ID D0O7DA D0O7DA DRUGTYPE Small molecular drug D0O7DA DRUGINCH 1S/C25H31NO/c1-24(2,3)25(27)13-14-26-16-21-19-9-5-4-7-17(19)11-12-18-8-6-10-20(23(18)21)22(26)15-25/h4-10,21-22,27H,11-16H2,1-3H3/t21-,22-,25-/m0/s1 D0O7DA DRUGINKE ZZJYIKPMDIWRSN-HWBMXIPRSA-N D0O7DA DRUGSMIL CC(C)(C)C1(CCN2CC3C4=CC=CC=C4CCC5=C3C(=CC=C5)C2C1)O D0O7DA HIGHSTAT Investigative D0O7DP DRUG__ID D0O7DP D0O7DP DRUGTYPE Small molecular drug D0O7DP DRUGINCH 1S/C21H21F3N4O3/c1-13-20(31)28(8-7-25-19(30)12-29)18-10-16(5-6-17(18)27-13)26-11-14-3-2-4-15(9-14)21(22,23)24/h2-6,9-10,26,29H,7-8,11-12H2,1H3,(H,25,30) D0O7DP DRUGINKE HRAQDVZJYIAWOV-UHFFFAOYSA-N D0O7DP DRUGSMIL CC1=NC2=C(C=C(C=C2)NCC3=CC(=CC=C3)C(F)(F)F)N(C1=O)CCNC(=O)CO D0O7DP HIGHSTAT Investigative D0O7GD DRUG__ID D0O7GD D0O7GD DRUGTYPE Small molecular drug D0O7GD DRUGINCH 1S/C12H15N5O4/c1-7-5-16(12(20)14-11(7)19)10-4-8(9(6-18)21-10)17-3-2-13-15-17/h2-3,5,8-10,18H,4,6H2,1H3,(H,14,19,20)/t8-,9+,10+/m0/s1 D0O7GD DRUGINKE CPWUCLYZTKEZPT-IVZWLZJFSA-N D0O7GD DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N3C=CN=N3 D0O7GD HIGHSTAT Investigative D0O7HF DRUG__ID D0O7HF D0O7HF DRUGTYPE Small molecular drug D0O7HF DRUGINCH 1S/C21H26FN3O5/c1-11(2)18(20(29)23-14(9-17(27)28)16(26)10-22)24-21(30)19-12(3)13-7-5-6-8-15(13)25(19)4/h5-8,11,14,18H,9-10H2,1-4H3,(H,23,29)(H,24,30)(H,27,28)/t14?,18-/m0/s1 D0O7HF DRUGINKE GONUYDANRODTCF-IBYPIGCZSA-N D0O7HF DRUGSMIL CC1=C(N(C2=CC=CC=C12)C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)CF D0O7HF HIGHSTAT Investigative D0O7IS DRUG__ID D0O7IS D0O7IS DRUGTYPE Small molecular drug D0O7IS DRUGINCH 1S/C19H19FN2O/c20-17-3-1-2-13(9-17)15-8-14-10-19(23-18(14)21-11-15)12-22-6-4-16(19)5-7-22/h1-3,8-9,11,16H,4-7,10,12H2/t19-/m0/s1 D0O7IS DRUGINKE MRVNNESNVNUKCV-IBGZPJMESA-N D0O7IS DRUGSMIL C1CN2CCC1C3(C2)CC4=C(O3)N=CC(=C4)C5=CC(=CC=C5)F D0O7IS HIGHSTAT Investigative D0O7JV DRUG__ID D0O7JV D0O7JV DRUGTYPE Small molecular drug D0O7JV DRUGINCH 1S/C23H31NO/c1-2-3-6-15-22(20-11-7-4-8-12-20)24-18-16-23(25,17-19-24)21-13-9-5-10-14-21/h4-5,7-14,22,25H,2-3,6,15-19H2,1H3 D0O7JV DRUGINKE AHZUGQDNSYDLNN-UHFFFAOYSA-N D0O7JV DRUGSMIL CCCCCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D0O7JV HIGHSTAT Investigative D0O7LU DRUG__ID D0O7LU D0O7LU DRUGTYPE Small molecular drug D0O7LU DRUGINCH 1S/C24H25ClN6O/c1-32-22-12-16(31-10-8-15(26)9-11-31)6-7-21(22)29-24-28-14-19(25)23(30-24)18-13-27-20-5-3-2-4-17(18)20/h2-7,12-15,27H,8-11,26H2,1H3,(H,28,29,30) D0O7LU DRUGINKE GCYIGMXOIWJGBU-UHFFFAOYSA-N D0O7LU DRUGSMIL COC1=C(C=CC(=C1)N2CCC(CC2)N)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl D0O7LU HIGHSTAT Investigative D0O7MW DRUG__ID D0O7MW D0O7MW DRUGTYPE Small molecular drug D0O7MW DRUGINCH 1S/C10H12N2O/c1-13-8-2-3-10-9(4-8)7(5-11)6-12-10/h2-4,6,12H,5,11H2,1H3 D0O7MW DRUGINKE CAHOMULUOHSWPI-UHFFFAOYSA-N D0O7MW DRUGSMIL COC1=CC2=C(C=C1)NC=C2CN D0O7MW HIGHSTAT Investigative D0O7NC DRUG__ID D0O7NC D0O7NC DRUGTYPE Small molecular drug D0O7NC DRUGINCH 1S/C33H40N6O3/c1-20-15-24(40)16-21(2)25(20)18-26(35)33(42)39-19-23-10-4-3-9-22(23)17-30(39)32(41)38-29(13-7-8-14-34)31-36-27-11-5-6-12-28(27)37-31/h3-6,9-12,15-16,26,29-30,40H,7-8,13-14,17-19,34-35H2,1-2H3,(H,36,37)(H,38,41) D0O7NC DRUGINKE GDHJQGJCKHJHHZ-UHFFFAOYSA-N D0O7NC DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCN)C4=NC5=CC=CC=C5N4)N)C)O D0O7NC HIGHSTAT Investigative D0O7OE DRUG__ID D0O7OE D0O7OE DRUGTYPE Small molecular drug D0O7OE DRUGINCH 1S/C29H52N10O6/c30-22(7-4-15-38-29(32)33)27(44)36-16-6-13-35-12-5-11-34-10-2-1-3-14-37-28(45)23(19-25(31)42)39-26(43)17-20-8-9-21(40)18-24(20)41/h8-9,18,22-23,34-35,40-41H,1-7,10-17,19,30H2,(H2,31,42)(H,36,44)(H,37,45)(H,39,43)(H4,32,33,38)/t22-,23-/m0/s1 D0O7OE DRUGINKE FTNICLJXPYLDAH-GOTSBHOMSA-N D0O7OE DRUGSMIL C1=CC(=C(C=C1O)O)CC(=O)NC(CC(=O)N)C(=O)NCCCCCNCCCNCCCNC(=O)C(CCCN=C(N)N)N D0O7OE HIGHSTAT Investigative D0O7PT DRUG__ID D0O7PT D0O7PT DRUGTYPE Small molecular drug D0O7PT DRUGINCH 1S/C21H30Cl2N2O5/c1-3-4-5-11-25(12-6-13-30-2)21(29)18(9-10-19(26)27)24-20(28)15-7-8-16(22)17(23)14-15/h7-8,14,18H,3-6,9-13H2,1-2H3,(H,24,28)(H,26,27) D0O7PT DRUGINKE QNQZBKQEIFTHFZ-UHFFFAOYSA-N D0O7PT DRUGSMIL CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl D0O7PT HIGHSTAT Investigative D0O7QV DRUG__ID D0O7QV D0O7QV DRUGTYPE Small molecular drug D0O7QV DRUGINCH 1S/C62H92O28/c1-12-22(2)47-36(85-43-18-37(53(70)26(6)80-43)86-41-16-34(65)51(68)24(4)78-41)15-32-13-31-14-33(61(77-11)59(76)50(67)23(3)63)62(58(75)49(31)57(74)48(32)56(47)73)90-46-20-39(55(72)28(8)82-46)88-45-21-40(60(29(9)83-45)84-30(10)64)89-44-19-38(54(71)27(7)81-44)87-42-17-35(66)52(69)25(5)79-42/h13,15,22-29,33-35,37-46,50-55,60-63,65-74H,12,14,16-21H2,1-11H3/t22?,23?,24-,25-,26-,27-,28-,29-,33?,34-,35-,37-,38-,39-,40-,41+,42+,43+,44+,45+,46+,50?,51-,52-,53-,54-,55-,60+,61?,62?/m1/s1 D0O7QV DRUGINKE GKQPKEYSNFSHDQ-XQGPSDOPSA-N D0O7QV DRUGSMIL CCC(C)C1=C(C2=C(C3=C(CC(C(C3=O)OC4CC(C(C(O4)C)O)OC5CC(C(C(O5)C)OC(=O)C)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)O)C(C(=O)C(C(C)O)O)OC)C=C2C=C1OC8CC(C(C(O8)C)O)OC9CC(C(C(O9)C)O)O)O)O D0O7QV HIGHSTAT Investigative D0O7RK DRUG__ID D0O7RK D0O7RK DRUGTYPE Small molecular drug D0O7RK DRUGINCH 1S/C25H34O9/c1-24-7-5-16-23(28)34-19(15-6-8-31-13-15)12-25(16,2)21(24)20(26)18(11-17(24)22(27)30-4)33-14-32-10-9-29-3/h6,8,13,16-19,21H,5,7,9-12,14H2,1-4H3/t16-,17-,18-,19-,21-,24-,25-/m0/s1 D0O7RK DRUGINKE PIISJSXOJJEJHX-BYDLNXCSSA-N D0O7RK DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OCOCCOC)C)C4=COC=C4 D0O7RK HIGHSTAT Investigative D0O7SM DRUG__ID D0O7SM D0O7SM DRUGTYPE Small molecular drug D0O7SM DRUGINCH 1S/C17H24O3/c1-10-7-6-8-11(2)15(19)16(20-12(3)18)14-13(10)9-17(14,4)5/h8,13-14,16H,1,6-7,9H2,2-5H3/b11-8+/t13-,14+,16-/m1/s1 D0O7SM DRUGINKE SXWKLEULMBLXJM-PCRFWOPQSA-N D0O7SM DRUGSMIL CC1=CCCC(=C)C2CC(C2C(C1=O)OC(=O)C)(C)C D0O7SM HIGHSTAT Investigative D0O7TC DRUG__ID D0O7TC D0O7TC DRUGTYPE Small molecular drug D0O7TC DRUGINCH 1S/C13H10N2OS/c16-13-8-17-12-6-9(3-4-11(12)15-13)10-2-1-5-14-7-10/h1-7H,8H2,(H,15,16) D0O7TC DRUGINKE QVFBOIKMDDLOQP-UHFFFAOYSA-N D0O7TC DRUGSMIL C1C(=O)NC2=C(S1)C=C(C=C2)C3=CN=CC=C3 D0O7TC HIGHSTAT Investigative D0O7UF DRUG__ID D0O7UF D0O7UF DRUGTYPE Small molecular drug D0O7UF DRUGINCH 1S/C15H21NO4/c1-20-13-10-8-12(9-11-13)14(17)6-4-2-3-5-7-15(18)16-19/h8-11,19H,2-7H2,1H3,(H,16,18) D0O7UF DRUGINKE LIOTZVIDBXLBAC-UHFFFAOYSA-N D0O7UF DRUGSMIL COC1=CC=C(C=C1)C(=O)CCCCCCC(=O)NO D0O7UF HIGHSTAT Investigative D0O7UT DRUG__ID D0O7UT D0O7UT DRUGTYPE Small molecular drug D0O7UT DRUGINCH 1S/C22H20FNO2/c23-21-6-2-1-5-20(21)17-10-8-16(9-11-17)4-3-7-22(26)24-18-12-14-19(25)15-13-18/h1-2,5-6,8-15,25H,3-4,7H2,(H,24,26) D0O7UT DRUGINKE ODYAQBDIXCVKAE-UHFFFAOYSA-N D0O7UT DRUGSMIL C1=CC=C(C(=C1)C2=CC=C(C=C2)CCCC(=O)NC3=CC=C(C=C3)O)F D0O7UT HIGHSTAT Investigative D0O7WT DRUG__ID D0O7WT D0O7WT DRUGTYPE Small molecular drug D0O7WT DRUGINCH 1S/C11H17N4O5P/c1-2-8(5-21(17,18)19)20-4-3-15-7-14-9-10(15)12-6-13-11(9)16/h6-8H,2-5H2,1H3,(H,12,13,16)(H2,17,18,19) D0O7WT DRUGINKE WLWRLYCRISPQDH-UHFFFAOYSA-N D0O7WT DRUGSMIL CCC(CP(=O)(O)O)OCCN1C=NC2=C1N=CNC2=O D0O7WT HIGHSTAT Investigative D0O7ZE DRUG__ID D0O7ZE D0O7ZE DRUGTYPE Small molecular drug D0O7ZE DRUGINCH 1S/C50H81N4O15P/c1-29(20-22-51)16-14-17-30(2)32(4)24-33(5)42(57)35(7)38(55)25-41(65-13)45-46(69-70(61,62)63)49(8,9)50(68-45)26-39(56)34(6)40(67-50)19-15-18-36-27-66-48(53-36)31(3)21-23-52-47(60)44(59)43(58)37(28-64-12)54(10)11/h14-18,20,24,27,31,33-35,37-46,55-59H,19,21,23,25-26,28H2,1-13H3,(H,52,60)(H2,61,62,63)/b16-14+,18-15+,29-20-,30-17+,32-24+/t31-,33+,34-,35-,37-,38-,39+,40-,41-,42+,43-,44-,45+,46-,50+/m0/s1 D0O7ZE DRUGINKE FKAWLXNLHHIHLA-YCBIHMBMSA-N D0O7ZE DRUGSMIL CC1C(CC2(C(C(C(O2)C(CC(C(C)C(C(C)C=C(C)C(=CC=CC(=CC#N)C)C)O)O)OC)OP(=O)(O)O)(C)C)OC1CC=CC3=COC(=N3)C(C)CCNC(=O)C(C(C(COC)N(C)C)O)O)O D0O7ZE HIGHSTAT Investigative D0O7ZJ DRUG__ID D0O7ZJ D0O7ZJ DRUGTYPE Small molecular drug D0O7ZJ DRUGINCH 1S/C23H21NO/c1-3-14-24-15-21(19-10-6-7-11-22(19)24)23(25)20-13-12-16(2)17-8-4-5-9-18(17)20/h4-13,15H,3,14H2,1-2H3 D0O7ZJ DRUGINKE DUBUGSKBMMXSOU-UHFFFAOYSA-N D0O7ZJ DRUGSMIL CCCN1C=C(C2=CC=CC=C21)C(=O)C3=CC=C(C4=CC=CC=C43)C D0O7ZJ HIGHSTAT Investigative D0O7ZL DRUG__ID D0O7ZL D0O7ZL DRUGTYPE Small molecular drug D0O7ZL DRUGINCH 1S/C30H48O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20-,21-,22+,23-,27-,28+,29+,30-/m0/s1 D0O7ZL DRUGINKE MDZKJHQSJHYOHJ-KRGADYIYSA-N D0O7ZL DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C D0O7ZL HIGHSTAT Investigative D0O8AK DRUG__ID D0O8AK D0O8AK DRUGTYPE Small molecular drug D0O8AK DRUGINCH 1S/C4H10NO6P/c1-4(5,3(6)7)2-11-12(8,9)10/h2,5H2,1H3,(H,6,7)(H2,8,9,10) D0O8AK DRUGINKE GSFCOAGADOGIGE-UHFFFAOYSA-N D0O8AK DRUGSMIL CC(COP(=O)(O)O)(C(=O)O)N D0O8AK HIGHSTAT Investigative D0O8AN DRUG__ID D0O8AN D0O8AN DRUGTYPE Small molecular drug D0O8AN DRUGINCH 1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1 D0O8AN DRUGINKE HDYANYHVCAPMJV-LXQIFKJMSA-N D0O8AN DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)C(=O)O)O)O)O)O)O D0O8AN HIGHSTAT Investigative D0O8AQ DRUG__ID D0O8AQ D0O8AQ DRUGTYPE Small molecular drug D0O8AQ DRUGINCH 1S/C12H20N2O6/c1-3-13-11(15)19-7-5-17-10-8(6-18-9(7)10)20-12(16)14-4-2/h7-10H,3-6H2,1-2H3,(H,13,15)(H,14,16)/t7-,8+,9-,10-/m1/s1 D0O8AQ DRUGINKE IMAKVWCOCNQBSI-UTINFBMNSA-N D0O8AQ DRUGSMIL CCNC(=O)OC1COC2C1OCC2OC(=O)NCC D0O8AQ HIGHSTAT Investigative D0O8BX DRUG__ID D0O8BX D0O8BX DRUGTYPE Small molecular drug D0O8BX DRUGINCH 1S/C45H58N8O10S/c1-4-26(2)39(53-43(60)38(25-64)48-27(3)54)44(61)51-36(22-29-12-16-32(55)17-13-29)41(58)49-34(7-5-6-20-46)40(57)50-35(21-28-8-10-31(24-47)11-9-28)42(59)52-37(45(62)63)23-30-14-18-33(56)19-15-30/h8-19,26,34-39,55-56,64H,4-7,20-23,25,46H2,1-3H3,(H,48,54)(H,49,58)(H,50,57)(H,51,61)(H,52,59)(H,53,60)(H,62,63)/t26?,34-,35-,36-,37-,38-,39-/m0/s1 D0O8BX DRUGINKE HMZZZPUDXBITDY-QCGUVPLXSA-N D0O8BX DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)C#N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D0O8BX HIGHSTAT Investigative D0O8DZ DRUG__ID D0O8DZ D0O8DZ DRUGTYPE Small molecular drug D0O8DZ DRUGINCH 1S/C27H29NO3/c1-28(20-21-11-5-4-6-12-21)17-9-2-3-10-18-30-22-15-16-24-26(19-22)31-25-14-8-7-13-23(25)27(24)29/h4-8,11-16,19H,2-3,9-10,17-18,20H2,1H3 D0O8DZ DRUGINKE NKJXMWCNCBVIAA-UHFFFAOYSA-N D0O8DZ DRUGSMIL CN(CCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D0O8DZ HIGHSTAT Investigative D0O8EB DRUG__ID D0O8EB D0O8EB DRUGTYPE Small molecular drug D0O8EB DRUGINCH 1S/C23H24O6/c1-11(2)5-7-13-19(26)14(8-6-12(3)4)22-18(20(13)27)21(28)17-15(24)9-10-16(25)23(17)29-22/h5-6,9-10,24-27H,7-8H2,1-4H3 D0O8EB DRUGINKE OJXQLGQIDIPMTE-UHFFFAOYSA-N D0O8EB DRUGSMIL CC(=CCC1=C(C(=C2C(=C1O)C(=O)C3=C(C=CC(=C3O2)O)O)CC=C(C)C)O)C D0O8EB HIGHSTAT Investigative D0O8HW DRUG__ID D0O8HW D0O8HW DRUGTYPE Small molecular drug D0O8HW DRUGINCH 1S/C33H34FN5O3/c1-21-7-6-8-24(17-21)35-33(42)37-31-32(41)39(20-29(40)38-18-22-13-14-23(19-38)16-15-22)28-12-5-3-10-26(28)30(36-31)25-9-2-4-11-27(25)34/h2-12,17,22-23,31H,13-16,18-20H2,1H3,(H2,35,37,42) D0O8HW DRUGINKE GWKWFUNKYXSZQP-UHFFFAOYSA-N D0O8HW DRUGSMIL CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4F)CC(=O)N5CC6CCC(C5)CC6 D0O8HW HIGHSTAT Investigative D0O8IC DRUG__ID D0O8IC D0O8IC DRUGTYPE Small molecular drug D0O8IC DRUGINCH 1S/C30H27NO/c1-2-3-8-19-31-21-24(30(32)28-18-10-14-23-12-5-7-16-26(23)28)20-29(31)27-17-9-13-22-11-4-6-15-25(22)27/h4-7,9-18,20-21H,2-3,8,19H2,1H3 D0O8IC DRUGINKE WVISOUYKTUUDFW-UHFFFAOYSA-N D0O8IC DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC3=CC=CC=C32)C(=O)C4=CC=CC5=CC=CC=C54 D0O8IC HIGHSTAT Investigative D0O8IE DRUG__ID D0O8IE D0O8IE DRUGTYPE Small molecular drug D0O8IE DRUGINCH 1S/C6H12O5/c1-3(8)5(10)6(11)4(9)2-7/h2-6,8-11H,1H3/t3-,4+,5+,6-/m1/s1 D0O8IE DRUGINKE PNNNRSAQSRJVSB-DPYQTVNSSA-N D0O8IE DRUGSMIL CC(C(C(C(C=O)O)O)O)O D0O8IE HIGHSTAT Investigative D0O8JQ DRUG__ID D0O8JQ D0O8JQ DRUGTYPE Small molecular drug D0O8JQ DRUGINCH 1S/C33H36N4O8S/c1-33(2)30(31(41)35-28-24-11-7-6-10-21(24)17-26(28)38)36(19-46-33)32(42)29(40)25(16-20-8-4-3-5-9-20)34-27(39)18-45-23-14-12-22(13-15-23)37(43)44/h3-15,25-26,28-30,38,40H,16-19H2,1-2H3,(H,34,39)(H,35,41)/t25-,26+,28-,29-,30+/m0/s1 D0O8JQ DRUGINKE PABVKNPJQYYVNK-DOWNBTJOSA-N D0O8JQ DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=C(C=C3)[N+](=O)[O-])O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0O8JQ HIGHSTAT Investigative D0O8LK DRUG__ID D0O8LK D0O8LK DRUGTYPE Small molecular drug D0O8LK DRUGINCH 1S/C33H41NO3/c1-34(26-27-17-11-10-12-18-27)23-15-8-6-4-2-3-5-7-9-16-24-36-28-21-22-30-32(25-28)37-31-20-14-13-19-29(31)33(30)35/h10-14,17-22,25H,2-9,15-16,23-24,26H2,1H3 D0O8LK DRUGINKE JLVUWPGHBWDHKA-UHFFFAOYSA-N D0O8LK DRUGSMIL CN(CCCCCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4 D0O8LK HIGHSTAT Investigative D0O8LR DRUG__ID D0O8LR D0O8LR DRUGTYPE Small molecular drug D0O8LR DRUGINCH 1S/C23H30N2O/c1-17-11-10-12-18(2)20(17)22(26)24-21(19-13-6-5-7-14-19)23(25(3)4)15-8-9-16-23/h5-7,10-14,21H,8-9,15-16H2,1-4H3,(H,24,26)/t21-/m0/s1/i3T3 D0O8LR DRUGINKE BMXRRRIDMAIEKX-IUNCQSRSSA-N D0O8LR DRUGSMIL CC1=C(C(=CC=C1)C)C(=O)NC(C2=CC=CC=C2)C3(CCCC3)N(C)C D0O8LR HIGHSTAT Investigative D0O8MA DRUG__ID D0O8MA D0O8MA DRUGTYPE Small molecular drug D0O8MA DRUGINCH 1S/C20H24N2O2/c1-24-20(23)19(17-9-3-2-4-10-17)18-11-5-6-13-22(18)15-16-8-7-12-21-14-16/h2-4,7-10,12,14,18-19H,5-6,11,13,15H2,1H3/t18-,19-/m1/s1 D0O8MA DRUGINKE NCMGDVQEMNIZAB-RTBURBONSA-N D0O8MA DRUGSMIL COC(=O)C(C1CCCCN1CC2=CN=CC=C2)C3=CC=CC=C3 D0O8MA HIGHSTAT Investigative D0O8MU DRUG__ID D0O8MU D0O8MU DRUGTYPE Small molecular drug D0O8MU DRUGINCH 1S/C13H16O2/c14-12-3-1-2-10(13(12)15)11-7-8-4-5-9(11)6-8/h1-3,8-9,11,14-15H,4-7H2 D0O8MU DRUGINKE DWWJNUSFHLSDSW-UHFFFAOYSA-N D0O8MU DRUGSMIL C1CC2CC1CC2C3=C(C(=CC=C3)O)O D0O8MU HIGHSTAT Investigative D0O8PM DRUG__ID D0O8PM D0O8PM DRUGTYPE Small molecular drug D0O8PM DRUGINCH 1S/C13H13N3O3/c1-18-11-4-3-10(9-12(11)19-2)13(17)16(7-5-14)8-6-15/h3-4,9H,7-8H2,1-2H3 D0O8PM DRUGINKE GZUJYYKDHAQDKU-UHFFFAOYSA-N D0O8PM DRUGSMIL COC1=C(C=C(C=C1)C(=O)N(CC#N)CC#N)OC D0O8PM HIGHSTAT Investigative D0O8PQ DRUG__ID D0O8PQ D0O8PQ DRUGTYPE Small molecular drug D0O8PQ DRUGINCH 1S/C9H10N2O3/c10-5-6-1-3-7(4-2-6)11-8(12)9(13)14/h1-4H,5,10H2,(H,11,12)(H,13,14) D0O8PQ DRUGINKE RKILOCCSAVHHJT-UHFFFAOYSA-N D0O8PQ DRUGSMIL C1=CC(=CC=C1CN)NC(=O)C(=O)O D0O8PQ HIGHSTAT Investigative D0O8QJ DRUG__ID D0O8QJ D0O8QJ DRUGTYPE Small molecular drug D0O8QJ DRUGINCH 1S/C18H21FN2O2/c1-12(9-19)20-10-13(22)11-23-17-8-4-7-16-18(17)14-5-2-3-6-15(14)21-16/h2-8,12-13,20-22H,9-11H2,1H3/t12?,13-/m0/s1 D0O8QJ DRUGINKE QHLGXPUIUKSADT-ABLWVSNPSA-N D0O8QJ DRUGSMIL CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O D0O8QJ HIGHSTAT Investigative D0O8QM DRUG__ID D0O8QM D0O8QM DRUGTYPE Small molecular drug D0O8QM DRUGINCH 1S/C13H19NS/c1-4-9-14-11(2)10-12-5-7-13(15-3)8-6-12/h4-8,11,14H,1,9-10H2,2-3H3 D0O8QM DRUGINKE QEAUILQRYNKCJK-UHFFFAOYSA-N D0O8QM DRUGSMIL CC(CC1=CC=C(C=C1)SC)NCC=C D0O8QM HIGHSTAT Investigative D0O8QS DRUG__ID D0O8QS D0O8QS DRUGTYPE Small molecular drug D0O8QS DRUGINCH 1S/C23H18N2O2/c1-27-19-13-11-17(12-14-19)23(26)25-22-20-10-6-5-9-18(20)15-21(24-22)16-7-3-2-4-8-16/h2-15H,1H3,(H,24,25,26) D0O8QS DRUGINKE MJZBWCOZBVDNSM-UHFFFAOYSA-N D0O8QS DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NC(=CC3=CC=CC=C32)C4=CC=CC=C4 D0O8QS HIGHSTAT Investigative D0O8RG DRUG__ID D0O8RG D0O8RG DRUGTYPE Small molecular drug D0O8RG DRUGINCH 1S/C24H20N2O/c1-17(18-10-4-2-5-11-18)25-24(27)21-16-23(19-12-6-3-7-13-19)26-22-15-9-8-14-20(21)22/h2-17H,1H3,(H,25,27) D0O8RG DRUGINKE IEDWYQQEMKCMSQ-UHFFFAOYSA-N D0O8RG DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC(=NC3=CC=CC=C32)C4=CC=CC=C4 D0O8RG HIGHSTAT Investigative D0O8WT DRUG__ID D0O8WT D0O8WT DRUGTYPE Small molecular drug D0O8WT DRUGINCH 1S/C18H11F3N2O3/c19-18(20,21)14-9-25-17(22-14)23-16(24)15-10-5-1-3-7-12(10)26-13-8-4-2-6-11(13)15/h1-9,15H,(H,22,23,24) D0O8WT DRUGINKE GSGDLBUOSWGZER-UHFFFAOYSA-N D0O8WT DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C3O2)C(=O)NC4=NC(=CO4)C(F)(F)F D0O8WT HIGHSTAT Investigative D0O8WV DRUG__ID D0O8WV D0O8WV DRUGTYPE Small molecular drug D0O8WV DRUGINCH 1S/C13H18N2O3S/c1-2-3-13(16)15-11-6-9-4-5-12(19(14,17)18)8-10(9)7-11/h4-5,8,11H,2-3,6-7H2,1H3,(H,15,16)(H2,14,17,18) D0O8WV DRUGINKE ZTRWXFFYFBYLJU-UHFFFAOYSA-N D0O8WV DRUGSMIL CCCC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D0O8WV HIGHSTAT Investigative D0O8XG DRUG__ID D0O8XG D0O8XG DRUGTYPE Small molecular drug D0O8XG DRUGINCH 1S/C15H18O2S/c1-3-4-5-6-9-12-18-15-11-8-7-10-14(15)17-13(2)16/h7-8,10-11H,3-4,9,12H2,1-2H3 D0O8XG DRUGINKE DWPABKWGLDPTEB-UHFFFAOYSA-N D0O8XG DRUGSMIL CCCC#CCCSC1=CC=CC=C1OC(=O)C D0O8XG HIGHSTAT Investigative D0O8XW DRUG__ID D0O8XW D0O8XW DRUGTYPE Small molecular drug D0O8XW DRUGINCH 1S/C29H33FN2O7/c1-3-32-24(13-12-22(33)14-23(34)15-25(35)36)26(19-8-10-21(30)11-9-19)17(2)27(32)28(37)31-16-18-4-6-20(7-5-18)29(38)39/h4-11,22-23,33-34H,3,12-16H2,1-2H3,(H,31,37)(H,35,36)(H,38,39)/p-2/t22-,23-/m1/s1 D0O8XW DRUGINKE MFLMXRSHJVIMRF-DHIUTWEWSA-L D0O8XW DRUGSMIL CCN1C(=C(C(=C1C(=O)NCC2=CC=C(C=C2)C(=O)[O-])C)C3=CC=C(C=C3)F)CCC(CC(CC(=O)[O-])O)O D0O8XW HIGHSTAT Investigative D0O8YZ DRUG__ID D0O8YZ D0O8YZ DRUGTYPE Small molecular drug D0O8YZ DRUGINCH 1S/C12H10O5/c13-7-1-6(2-8(14)3-7)12-10(16)4-9(15)5-11(12)17/h1-5,13-17H D0O8YZ DRUGINKE KICYRZIVKKYRFS-UHFFFAOYSA-N D0O8YZ DRUGSMIL C1=C(C=C(C=C1O)O)C2=C(C=C(C=C2O)O)O D0O8YZ HIGHSTAT Investigative D0O8ZV DRUG__ID D0O8ZV D0O8ZV DRUGTYPE Small molecular drug D0O8ZV DRUGINCH 1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14- D0O8ZV DRUGINKE BPYKTIZUTYGOLE-IFADSCNNSA-N D0O8ZV DRUGSMIL CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)C=C3C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)C=C4C(=C(C(=O)N4)C=C)C D0O8ZV HIGHSTAT Investigative D0O9BL DRUG__ID D0O9BL D0O9BL DRUGTYPE Small molecular drug D0O9BL DRUGINCH 1S/C15H20INO/c1-2-6-14(17-9-3-4-10-17)15(18)12-7-5-8-13(16)11-12/h5,7-8,11,14H,2-4,6,9-10H2,1H3 D0O9BL DRUGINKE NYDUTEZMPZHSRY-UHFFFAOYSA-N D0O9BL DRUGSMIL CCCC(C(=O)C1=CC(=CC=C1)I)N2CCCC2 D0O9BL HIGHSTAT Investigative D0O9BS DRUG__ID D0O9BS D0O9BS DRUGTYPE Small molecular drug D0O9BS DRUGINCH 1S/C10H12N2O2S/c1-7-4-2-3-5-8(7)12-9(13)6-15-10(11)14/h2-5H,6H2,1H3,(H2,11,14)(H,12,13) D0O9BS DRUGINKE AGIYBDIJVLUNFI-UHFFFAOYSA-N D0O9BS DRUGSMIL CC1=CC=CC=C1NC(=O)CSC(=O)N D0O9BS HIGHSTAT Investigative D0O9BZ DRUG__ID D0O9BZ D0O9BZ DRUGTYPE Small molecular drug D0O9BZ DRUGINCH 1S/C19H21N3/c1-2-5-16(6-3-1)15-21-11-13-22(14-12-21)19-8-4-7-18-17(19)9-10-20-18/h1-10,20H,11-15H2 D0O9BZ DRUGINKE JLZIBIQTDGMAFZ-UHFFFAOYSA-N D0O9BZ DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=CC=CC4=C3C=CN4 D0O9BZ HIGHSTAT Investigative D0O9CZ DRUG__ID D0O9CZ D0O9CZ DRUGTYPE Small molecular drug D0O9CZ DRUGINCH 1S/C20H17FN6/c21-16-6-2-1-4-13(16)11-27-20-14(5-3-9-23-20)17(26-27)19-24-10-15(12-7-8-12)18(22)25-19/h1-6,9-10,12H,7-8,11H2,(H2,22,24,25) D0O9CZ DRUGINKE ATOAHNRJAXSBOR-UHFFFAOYSA-N D0O9CZ DRUGSMIL C1CC1C2=CN=C(N=C2N)C3=NN(C4=C3C=CC=N4)CC5=CC=CC=C5F D0O9CZ HIGHSTAT Investigative D0O9DH DRUG__ID D0O9DH D0O9DH DRUGTYPE Small molecular drug D0O9DH DRUGINCH 1S/C24H28N2O7/c1-4-9-19-23(32-19)22(29)18(12-7-14-25-20(28)13-8-15-26-31-3)33-24(30)21-16(5-2)10-6-11-17(21)27/h4-11,13-15,18-19,22-23,27,29H,2,12H2,1,3H3,(H,25,28)/b9-4-,13-8-,14-7-,26-15+ D0O9DH DRUGINKE HFJXCVFNVNHCKF-XTLNGFDXSA-N D0O9DH DRUGSMIL CC=CC1C(O1)C(C(CC=CNC(=O)C=CC=NOC)OC(=O)C2=C(C=CC=C2O)C=C)O D0O9DH HIGHSTAT Investigative D0O9EB DRUG__ID D0O9EB D0O9EB DRUGTYPE Small molecular drug D0O9EB DRUGINCH 1S/C7H11F3O2S/c1-2-3-4-13(12)5-6(11)7(8,9)10/h2-5H2,1H3 D0O9EB DRUGINKE MFTBLUCHUFLEGX-UHFFFAOYSA-N D0O9EB DRUGSMIL CCCCS(=O)CC(=O)C(F)(F)F D0O9EB HIGHSTAT Investigative D0O9ES DRUG__ID D0O9ES D0O9ES DRUGTYPE Small molecular drug D0O9ES DRUGINCH 1S/C22H29ClO6/c23-15-6-5-7-17(12-15)29-14-16(24)10-11-19-18(20(25)13-21(19)26)8-3-1-2-4-9-22(27)28/h1,3,5-7,10-12,16,18-21,24-26H,2,4,8-9,13-14H2,(H,27,28)/b3-1-,11-10+/t16-,18-,19-,20+,21-/m1/s1 D0O9ES DRUGINKE VJGGHXVGBSZVMZ-QIZQQNKQSA-N D0O9ES DRUGSMIL C1C(C(C(C1O)C=CC(COC2=CC(=CC=C2)Cl)O)CC=CCCCC(=O)O)O D0O9ES HIGHSTAT Investigative D0O9FL DRUG__ID D0O9FL D0O9FL DRUGTYPE Small molecular drug D0O9FL DRUGINCH 1S/C24H42N8O6/c1-2-3-4-5-6-10-32-14-15-11-18(32)23(38)31-16(8-7-9-27-24(25)26)21(36)28-13-19(33)30-17(12-20(34)35)22(37)29-15/h15-18H,2-14H2,1H3,(H,28,36)(H,29,37)(H,30,33)(H,31,38)(H,34,35)(H4,25,26,27)/t15-,16-,17-,18-/m0/s1 D0O9FL DRUGINKE JNEZPOFKGHMQAC-XSLAGTTESA-N D0O9FL DRUGSMIL CCCCCCCN1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D0O9FL HIGHSTAT Investigative D0O9GJ DRUG__ID D0O9GJ D0O9GJ DRUGTYPE Small molecular drug D0O9GJ DRUGINCH 1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1 D0O9GJ DRUGINKE OLCWZBFDIYXLAA-IOSLPCCCSA-N D0O9GJ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(CP(=O)(O)O)O)O)O)N D0O9GJ HIGHSTAT Investigative D0O9HS DRUG__ID D0O9HS D0O9HS DRUGTYPE Small molecular drug D0O9HS DRUGINCH 1S/C10H13ClN2/c11-9-3-1-2-4-10(9)13-7-5-12-6-8-13/h1-4,12H,5-8H2 D0O9HS DRUGINKE PWZDJIUQHUGFRJ-UHFFFAOYSA-N D0O9HS DRUGSMIL C1CN(CCN1)C2=CC=CC=C2Cl D0O9HS HIGHSTAT Investigative D0O9II DRUG__ID D0O9II D0O9II DRUGTYPE Small molecular drug D0O9II DRUGINCH 1S/C4H8N2S/c5-4-6-2-1-3-7-4/h1-3H2,(H2,5,6) D0O9II DRUGINKE PQXQEOIFIUJLIE-UHFFFAOYSA-N D0O9II DRUGSMIL C1CN=C(SC1)N D0O9II HIGHSTAT Investigative D0O9KA DRUG__ID D0O9KA D0O9KA DRUGTYPE Small molecular drug D0O9KA DRUGINCH 1S/C32H44N4O4/c1-35(2,23-13-19-33-29(37)25-15-7-8-16-26(25)30(33)38)21-11-5-6-12-22-36(3,4)24-14-20-34-31(39)27-17-9-10-18-28(27)32(34)40/h7-10,15-18H,5-6,11-14,19-24H2,1-4H3/q+2 D0O9KA DRUGINKE WDAXQFXYXWPELC-UHFFFAOYSA-N D0O9KA DRUGSMIL C[N+](C)(CCCCCC[N+](C)(C)CCCN1C(=O)C2=CC=CC=C2C1=O)CCCN3C(=O)C4=CC=CC=C4C3=O D0O9KA HIGHSTAT Investigative D0O9KV DRUG__ID D0O9KV D0O9KV DRUGTYPE Small molecular drug D0O9KV DRUGINCH 1S/C10H7BrN2O3S/c11-7-3-1-2-4-8(7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D0O9KV DRUGINKE MLFKNCYUUMLHTD-UHFFFAOYSA-N D0O9KV DRUGSMIL C1=CC=C(C(=C1)S(=O)(=O)C2=NNC(=O)C=C2)Br D0O9KV HIGHSTAT Investigative D0O9LR DRUG__ID D0O9LR D0O9LR DRUGTYPE Small molecular drug D0O9LR DRUGINCH 1S/C16H22N2O/c1-2-3-5-14-7-9-16(10-8-14)19-11-4-6-15-12-17-13-18-15/h7-10,12-13H,2-6,11H2,1H3,(H,17,18) D0O9LR DRUGINKE NKIFZJYIQSBUEI-UHFFFAOYSA-N D0O9LR DRUGSMIL CCCCC1=CC=C(C=C1)OCCCC2=CN=CN2 D0O9LR HIGHSTAT Investigative D0O9MG DRUG__ID D0O9MG D0O9MG DRUGTYPE Small molecular drug D0O9MG DRUGINCH 1S/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3/t14-/m0/s1 D0O9MG DRUGINKE YKYOQIXTECBVBB-AWEZNQCLSA-N D0O9MG DRUGSMIL CCOC(=O)C1=C2C3CCCN3C(=O)C4=C(N2C=N1)C=CC(=C4)OC D0O9MG HIGHSTAT Investigative D0O9NE DRUG__ID D0O9NE D0O9NE DRUGTYPE Small molecular drug D0O9NE DRUGINCH 1S/C17H18O3/c1-18-15-8-6-13(7-9-15)4-5-14-10-16(19-2)12-17(11-14)20-3/h4-12H,1-3H3/b5-4+ D0O9NE DRUGINKE GDHNBPHYVRHYCC-SNAWJCMRSA-N D0O9NE DRUGSMIL COC1=CC=C(C=C1)C=CC2=CC(=CC(=C2)OC)OC D0O9NE HIGHSTAT Investigative D0O9OB DRUG__ID D0O9OB D0O9OB DRUGTYPE Small molecular drug D0O9OB DRUGINCH 1S/C16H19NO4/c1-2-7-20-12-3-4-13-14(18)11-16(21-15(13)10-12)17-5-8-19-9-6-17/h3-4,10-11H,2,5-9H2,1H3 D0O9OB DRUGINKE RXAXOVGTCLFYCQ-UHFFFAOYSA-N D0O9OB DRUGSMIL CCCOC1=CC2=C(C=C1)C(=O)C=C(O2)N3CCOCC3 D0O9OB HIGHSTAT Investigative D0O9OW DRUG__ID D0O9OW D0O9OW DRUGTYPE Small molecular drug D0O9OW DRUGINCH 1S/C23H27NO4/c1-13(2)11-24-8-7-15-16-6-5-14-9-19(25)20(27-3)10-17(14)21(16)23(28-4)22(26)18(15)12-24/h5-6,9-10,13,25-26H,7-8,11-12H2,1-4H3 D0O9OW DRUGINKE WKTMDLQZTZEUIG-UHFFFAOYSA-N D0O9OW DRUGSMIL CC(C)CN1CCC2=C3C=CC4=CC(=C(C=C4C3=C(C(=C2C1)O)OC)OC)O D0O9OW HIGHSTAT Investigative D0O9QG DRUG__ID D0O9QG D0O9QG DRUGTYPE Small molecular drug D0O9QG DRUGINCH 1S/C8H9ClN2S.ClH/c9-7-3-1-6(2-4-7)5-12-8(10)11;/h1-4H,5H2,(H3,10,11);1H D0O9QG DRUGINKE QAVHMIYSTFZJAU-UHFFFAOYSA-N D0O9QG DRUGSMIL C1=CC(=CC=C1CSC(=N)N)Cl.Cl D0O9QG HIGHSTAT Investigative D0O9RD DRUG__ID D0O9RD D0O9RD DRUGTYPE Small molecular drug D0O9RD DRUGINCH 1S/C11H20N2O/c12-10(9-5-2-1-3-6-9)11(14)13-7-4-8-13/h9-10H,1-8,12H2/t10-/m0/s1 D0O9RD DRUGINKE ZFOKLNMBWVCMDT-JTQLQIEISA-N D0O9RD DRUGSMIL C1CCC(CC1)C(C(=O)N2CCC2)N D0O9RD HIGHSTAT Investigative D0O9SG DRUG__ID D0O9SG D0O9SG DRUGTYPE Small molecular drug D0O9SG DRUGINCH 1S/C15H10ClNO2/c16-12-6-8-13(9-7-12)17-15(18)10-14(19-17)11-4-2-1-3-5-11/h1-10H D0O9SG DRUGINKE DWRJXWOCTFGHCE-UHFFFAOYSA-N D0O9SG DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)N(O2)C3=CC=C(C=C3)Cl D0O9SG HIGHSTAT Investigative D0O9TT DRUG__ID D0O9TT D0O9TT DRUGTYPE Small molecular drug D0O9TT DRUGINCH 1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26) D0O9TT DRUGINKE GKWHICIUSVVNGX-UHFFFAOYSA-N D0O9TT DRUGSMIL CN(C)C1CCC2=C(C1)C3=C(N2)C=CC(=C3)NC(=O)C4=CC=C(C=C4)F D0O9TT HIGHSTAT Investigative D0O9UH DRUG__ID D0O9UH D0O9UH DRUGTYPE Small molecular drug D0O9UH DRUGINCH 1S/C4H7NO2/c5-3-1-2-4(6)7/h1-2H,3,5H2,(H,6,7)/b2-1- D0O9UH DRUGINKE FMKJUUQOYOHLTF-UPHRSURJSA-N D0O9UH DRUGSMIL C(C=CC(=O)O)N D0O9UH HIGHSTAT Investigative D0O9UI DRUG__ID D0O9UI D0O9UI DRUGTYPE Small molecular drug D0O9UI DRUGINCH 1S/C13H10Cl2O2/c1-8-2-4-13(11(16)6-8)17-12-5-3-9(14)7-10(12)15/h2-7,16H,1H3 D0O9UI DRUGINKE FHTKTADYDYDEMS-UHFFFAOYSA-N D0O9UI DRUGSMIL CC1=CC(=C(C=C1)OC2=C(C=C(C=C2)Cl)Cl)O D0O9UI HIGHSTAT Investigative D0O9UR DRUG__ID D0O9UR D0O9UR DRUGTYPE Small molecular drug D0O9UR DRUGINCH 1S/C9H9NO4/c1-14-9-6-7(2-3-8(9)11)4-5-10(12)13/h2-6,11H,1H3/b5-4+ D0O9UR DRUGINKE XVXCSPJSXIUNQJ-SNAWJCMRSA-N D0O9UR DRUGSMIL COC1=C(C=CC(=C1)C=C[N+](=O)[O-])O D0O9UR HIGHSTAT Investigative D0O9UY DRUG__ID D0O9UY D0O9UY DRUGTYPE Small molecular drug D0O9UY DRUGINCH 1S/C18H16O4/c1-11(2)22-14-7-8-15-17(9-14)21-10-16(18(15)20)12-3-5-13(19)6-4-12/h3-11,19H,1-2H3 D0O9UY DRUGINKE DEQMUPGWSXUDKV-UHFFFAOYSA-N D0O9UY DRUGSMIL CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=C(C=C3)O D0O9UY HIGHSTAT Investigative D0O9VU DRUG__ID D0O9VU D0O9VU DRUGTYPE Small molecular drug D0O9VU DRUGINCH 1S/C14H13FN2O3S/c15-12-9-11(21(16,19)20)6-7-13(12)17-14(18)8-10-4-2-1-3-5-10/h1-7,9H,8H2,(H,17,18)(H2,16,19,20) D0O9VU DRUGINKE NPXJDOTWYYSLEJ-UHFFFAOYSA-N D0O9VU DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=C(C=C(C=C2)S(=O)(=O)N)F D0O9VU HIGHSTAT Investigative D0O9YG DRUG__ID D0O9YG D0O9YG DRUGTYPE Small molecular drug D0O9YG DRUGINCH 1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16) D0O9YG DRUGINKE QMNFFXRFOJIOKZ-UHFFFAOYSA-N D0O9YG DRUGSMIL CC1(N=C(N=C(N1C2=CC=C(C=C2)Cl)N)N)C D0O9YG HIGHSTAT Investigative D0O9YL DRUG__ID D0O9YL D0O9YL DRUGTYPE Small molecular drug D0O9YL DRUGINCH 1S/C14H21NO/c1-12-6-5-10-15(12)11-9-13-7-3-4-8-14(13)16-2/h3-4,7-8,12H,5-6,9-11H2,1-2H3/t12-/m1/s1 D0O9YL DRUGINKE KDVUGYDZNTZESD-GFCCVEGCSA-N D0O9YL DRUGSMIL CC1CCCN1CCC2=CC=CC=C2OC D0O9YL HIGHSTAT Investigative D0O9YQ DRUG__ID D0O9YQ D0O9YQ DRUGTYPE Small molecular drug D0O9YQ DRUGINCH 1S/C20H28N2O/c1-3-4-5-8-13-21-20-16-9-6-7-10-18(16)22-19-12-11-15(23-2)14-17(19)20/h11-12,14H,3-10,13H2,1-2H3,(H,21,22) D0O9YQ DRUGINKE FHJNAXWWTVBTEP-UHFFFAOYSA-N D0O9YQ DRUGSMIL CCCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D0O9YQ HIGHSTAT Investigative D0O9ZY DRUG__ID D0O9ZY D0O9ZY DRUGTYPE Small molecular drug D0O9ZY DRUGINCH 1S/C12H17N3O/c1-2-15(11-6-4-3-5-7-11)8-10-9-16-12(13)14-10/h3-7,10H,2,8-9H2,1H3,(H2,13,14)/t10-/m0/s1 D0O9ZY DRUGINKE PPONHQQJLWPUPH-JTQLQIEISA-N D0O9ZY DRUGSMIL CCN(CC1COC(=N1)N)C2=CC=CC=C2 D0O9ZY HIGHSTAT Investigative D0OA3L DRUG__ID D0OA3L D0OA3L DRUGTYPE Small molecular drug D0OA3L DRUGINCH 1S/C23H30N4O/c1-15-14-26(21-4-3-5-25-20(21)13-24)6-7-27(15)22(28)23-10-17-8-18(11-23)16(2)19(9-17)12-23/h3-5,15-19H,6-12,14H2,1-2H3/t15-,16?,17?,18?,19?,23?/m1/s1 D0OA3L DRUGINKE HPOKCTFUFZGTGF-ABYMYHKNSA-N D0OA3L DRUGSMIL CC1CN(CCN1C(=O)C23CC4CC(C2)C(C(C4)C3)C)C5=C(N=CC=C5)C#N D0OA3L HIGHSTAT Investigative D0OA8M DRUG__ID D0OA8M D0OA8M DRUGTYPE Small molecular drug D0OA8M DRUGINCH 1S/C16H14ClN3O3/c1-10(21)18-19-16(22)20-9-11-4-2-3-5-14(11)23-15-7-6-12(17)8-13(15)20/h2-8H,9H2,1H3,(H,18,21)(H,19,22) D0OA8M DRUGINKE KNURFLJTOUGOOQ-UHFFFAOYSA-N D0OA8M DRUGSMIL CC(=O)NNC(=O)N1CC2=CC=CC=C2OC3=C1C=C(C=C3)Cl D0OA8M HIGHSTAT Investigative D0OB0M DRUG__ID D0OB0M D0OB0M DRUGTYPE Small molecular drug D0OB0M DRUGINCH 1S/C46H60N8O11S/c1-3-26(2)40-45(63)52-35(23-29-11-17-32(56)18-12-29)42(60)50-33(6-4-5-21-47)41(59)51-34(22-28-9-15-31(55)16-10-28)43(61)53-36(46(64)65)24-27-7-13-30(14-8-27)48-38(57)19-20-39(58)49-37(25-66)44(62)54-40/h7-18,26,33-37,40,55-56,66H,3-6,19-25,47H2,1-2H3,(H,48,57)(H,49,58)(H,50,60)(H,51,59)(H,52,63)(H,53,61)(H,54,62)(H,64,65)/t26-,33-,34-,35-,36-,37-,40?/m0/s1 D0OB0M DRUGINKE QMRXULYAQQEMJC-FYDLKOHDSA-N D0OB0M DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CC2=CC=C(C=C2)NC(=O)CCC(=O)NC(C(=O)N1)CS)C(=O)O)CC3=CC=C(C=C3)O)CCCCN)CC4=CC=C(C=C4)O D0OB0M HIGHSTAT Investigative D0OB1F DRUG__ID D0OB1F D0OB1F DRUGTYPE Small molecular drug D0OB1F DRUGINCH 1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/t1?,2-,3+,4-,5-,6?/m0/s1 D0OB1F DRUGINKE INAPMGSXUVUWAF-LXOASSSBSA-N D0OB1F DRUGSMIL C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O D0OB1F HIGHSTAT Investigative D0OB7B DRUG__ID D0OB7B D0OB7B DRUGTYPE Small molecular drug D0OB7B DRUGINCH 1S/C16H22N4S/c1-2-9-19(10-3-1)13-6-11-20(12-7-13)16-18-15-14(21-16)5-4-8-17-15/h4-5,8,13H,1-3,6-7,9-12H2 D0OB7B DRUGINKE LHPSMXXBNXLHOD-UHFFFAOYSA-N D0OB7B DRUGSMIL C1CCN(CC1)C2CCN(CC2)C3=NC4=C(S3)C=CC=N4 D0OB7B HIGHSTAT Investigative D0OC1W DRUG__ID D0OC1W D0OC1W DRUGTYPE Small molecular drug D0OC1W DRUGINCH 1S/C110H159N27O34S5/c1-9-55(6)88(108(168)130-77(110(170)171)40-59-45-116-64-22-14-13-21-62(59)64)136-107(167)87(54(4)5)135-102(162)76(44-86(148)149)128-93(153)67(29-31-82(114)141)121-99(159)73(41-60-46-115-52-117-60)126-106(166)81-49-174-173-48-63(113)90(150)131-78(47-138)103(163)134-79-50-175-176-51-80(105(165)123-70(37-53(2)3)96(156)124-72(39-58-25-27-61(140)28-26-58)97(157)125-71(98(158)133-81)38-57-19-11-10-12-20-57)132-94(154)68(30-32-83(142)143)120-91(151)65(23-15-17-34-111)118-101(161)75(43-85(146)147)129-109(169)89(56(7)139)137-95(155)69(33-36-172-8)122-100(160)74(42-84(144)145)127-92(152)66(119-104(79)164)24-16-18-35-112/h10-14,19-22,25-28,45-46,52-56,63,65-81,87-89,116,138-140H,9,15-18,23-24,29-44,47-51,111-113H2,1-8H3,(H2,114,141)(H,115,117)(H,118,161)(H,119,164)(H,120,151)(H,121,159)(H,122,160)(H,123,165)(H,124,156)(H,125,157)(H,126,166)(H,127,152)(H,128,153)(H,129,169)(H,130,168)(H,131,150)(H,132,154)(H,133,158)(H,134,163)(H,135,162)(H,136,167)(H,137,155)(H,142,143)(H,144,145)(H,146,147)(H,148,149)(H,170,171) D0OC1W DRUGINKE ZHRYDGYRZIWZPS-UHFFFAOYSA-N D0OC1W DRUGSMIL CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CNC=N3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC5CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC6=CC=CC=C6)CC7=CC=C(C=C7)O)CC(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC5=O)CCCCN)CC(=O)O)CCSC)C(C)O)CC(=O)O)CCCCN)CCC(=O)O)CO)N D0OC1W HIGHSTAT Investigative D0OC4B DRUG__ID D0OC4B D0OC4B DRUGTYPE Small molecular drug D0OC4B DRUGINCH 1S/C15H10O3/c16-11-6-7-12-13(10-4-2-1-3-5-10)9-15(17)18-14(12)8-11/h1-9,16H D0OC4B DRUGINKE IVJMJRRORVMRJJ-UHFFFAOYSA-N D0OC4B DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)OC3=C2C=CC(=C3)O D0OC4B HIGHSTAT Investigative D0OD3U DRUG__ID D0OD3U D0OD3U DRUGTYPE Small molecular drug D0OD3U DRUGINCH 1S/C7H6BF3O2/c9-7(10,11)5-2-1-3-6(4-5)8(12)13/h1-4,12-13H D0OD3U DRUGINKE WOAORAPRPVIATR-UHFFFAOYSA-N D0OD3U DRUGSMIL B(C1=CC(=CC=C1)C(F)(F)F)(O)O D0OD3U HIGHSTAT Investigative D0OD8N DRUG__ID D0OD8N D0OD8N DRUGTYPE Small molecular drug D0OD8N DRUGINCH 1S/C8H18O4/c1-9-3-5-11-7-8-12-6-4-10-2/h3-8H2,1-2H3 D0OD8N DRUGINKE YFNKIDBQEZZDLK-UHFFFAOYSA-N D0OD8N DRUGSMIL COCCOCCOCCOC D0OD8N HIGHSTAT Investigative D0OE0K DRUG__ID D0OE0K D0OE0K DRUGTYPE Small molecular drug D0OE0K DRUGINCH 1S/C8H13N5/c1-3-12-4-2-7(1)8(5-12)13-10-6-9-11-13/h6-8H,1-5H2 D0OE0K DRUGINKE AMJXIOSRIOJUEM-UHFFFAOYSA-N D0OE0K DRUGSMIL C1CN2CCC1C(C2)N3N=CN=N3 D0OE0K HIGHSTAT Investigative D0OE1R DRUG__ID D0OE1R D0OE1R DRUGTYPE Small molecular drug D0OE1R DRUGINCH 1S/C13H9NO5/c15-10-7-6-9(11(13(10)17)14(18)19)12(16)8-4-2-1-3-5-8/h1-7,15,17H D0OE1R DRUGINKE ICLKAUQIPVFHOI-UHFFFAOYSA-N D0OE1R DRUGSMIL C1=CC=C(C=C1)C(=O)C2=C(C(=C(C=C2)O)O)[N+](=O)[O-] D0OE1R HIGHSTAT Investigative D0OE2Z DRUG__ID D0OE2Z D0OE2Z DRUGTYPE Small molecular drug D0OE2Z DRUGINCH 1S/C30H46BrNO4S/c1-2-3-4-5-6-7-8-12-21-36-30(33)14-11-9-10-13-28-24-15-16-25(22-24)29(28)23-32-37(34,35)27-19-17-26(31)18-20-27/h10,13,17-20,24-25,28-29,32H,2-9,11-12,14-16,21-23H2,1H3/b13-10-/t24-,25+,28-,29+/m0/s1 D0OE2Z DRUGINKE KLMMNRLRCVRTDN-WHFHORQSSA-N D0OE2Z DRUGSMIL CCCCCCCCCCOC(=O)CCCC=CC1C2CCC(C2)C1CNS(=O)(=O)C3=CC=C(C=C3)Br D0OE2Z HIGHSTAT Investigative D0OE5N DRUG__ID D0OE5N D0OE5N DRUGTYPE Small molecular drug D0OE5N DRUGINCH 1S/C21H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-16-20(22)18-21(23)17-19/h7-8,16-18,22-23H,2-6,9-15H2,1H3/b8-7- D0OE5N DRUGINKE TUGAUFMQYWZJAB-FPLPWBNLSA-N D0OE5N DRUGSMIL CCCCCCC=CCCCCCCCC1=CC(=CC(=C1)O)O D0OE5N HIGHSTAT Investigative D0OF1I DRUG__ID D0OF1I D0OF1I DRUGTYPE Small molecular drug D0OF1I DRUGINCH 1S/C15H11N3O4/c1-22-12-4-2-3-11-13(12)16-14(17-15(11)19)9-5-7-10(8-6-9)18(20)21/h2-8H,1H3,(H,16,17,19) D0OF1I DRUGINKE PGAMJHQYVDYIQX-UHFFFAOYSA-N D0OF1I DRUGSMIL COC1=CC=CC2=C1N=C(NC2=O)C3=CC=C(C=C3)[N+](=O)[O-] D0OF1I HIGHSTAT Investigative D0OF1X DRUG__ID D0OF1X D0OF1X DRUGTYPE Small molecular drug D0OF1X DRUGINCH 1S/C21H23N/c1-2-4-18(5-3-1)19-9-6-17(7-10-19)8-11-21-16-22-14-12-20(21)13-15-22/h1-11,20-21H,12-16H2/b11-8+ D0OF1X DRUGINKE OBORHRVWTIDYCG-DHZHZOJOSA-N D0OF1X DRUGSMIL C1CN2CCC1C(C2)C=CC3=CC=C(C=C3)C4=CC=CC=C4 D0OF1X HIGHSTAT Investigative D0OF2J DRUG__ID D0OF2J D0OF2J DRUGTYPE Small molecular drug D0OF2J DRUGINCH 1S/C20H40BrO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(23)27-17-18(22)16-19(21)28(24,25)26/h18-19,22H,2-17H2,1H3,(H2,24,25,26)/t18-,19+/m0/s1 D0OF2J DRUGINKE HLVKVWDSLLFMSX-RBUKOAKNSA-N D0OF2J DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(CC(P(=O)(O)O)Br)O D0OF2J HIGHSTAT Investigative D0OF3B DRUG__ID D0OF3B D0OF3B DRUGTYPE Small molecular drug D0OF3B DRUGINCH 1S/C139H224N38O32S/c1-15-79(10)111(132(203)169-103(137(208)209)64-77(6)7)173-126(197)101(67-85-69-152-89-41-23-22-40-87(85)89)167-130(201)107-49-34-59-176(107)135(206)96(47-33-58-151-139(147)148)163-117(188)91(43-25-29-54-141)159-129(200)106-48-35-60-177(106)136(207)102(68-86-70-149-74-154-86)168-124(195)100(66-84-38-20-17-21-39-84)166-128(199)105(73-179)171-122(193)97(62-75(2)3)156-108(182)71-153-116(187)90(42-24-28-53-140)160-131(202)110(78(8)9)172-120(191)94(46-32-57-150-138(145)146)157-114(185)80(11)155-127(198)104(72-178)170-119(190)93(45-27-31-56-143)162-133(204)112(81(12)180)174-121(192)95(50-51-109(183)184)158-123(194)99(65-83-36-18-16-19-37-83)165-118(189)92(44-26-30-55-142)161-134(205)113(82(13)181)175-125(196)98(63-76(4)5)164-115(186)88(144)52-61-210-14/h16-23,36-41,69-70,74-82,88,90-107,110-113,152,178-181H,15,24-35,42-68,71-73,140-144H2,1-14H3,(H,149,154)(H,153,187)(H,155,198)(H,156,182)(H,157,185)(H,158,194)(H,159,200)(H,160,202)(H,161,205)(H,162,204)(H,163,188)(H,164,186)(H,165,189)(H,166,199)(H,167,201)(H,168,195)(H,169,203)(H,170,190)(H,171,193)(H,172,191)(H,173,197)(H,174,192)(H,175,196)(H,183,184)(H,208,209)(H4,145,146,150)(H4,147,148,151)/t79-,80-,81+,82+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,110-,111-,112-,113-/m0/s1 D0OF3B DRUGINKE IDHVLSACPFUBDY-QCDLPZBNSA-N D0OF3B DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C3CCCN3C(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)NC(=O)C(CCSC)N D0OF3B HIGHSTAT Investigative D0OF6C DRUG__ID D0OF6C D0OF6C DRUGTYPE Small molecular drug D0OF6C DRUGINCH 1S/C13H8F3N/c14-13(15,16)8-5-6-10-9-3-1-2-4-11(9)17-12(10)7-8/h1-7,17H D0OF6C DRUGINKE HWUDQSLQFQHKSV-UHFFFAOYSA-N D0OF6C DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)C(F)(F)F D0OF6C HIGHSTAT Investigative D0OG0R DRUG__ID D0OG0R D0OG0R DRUGTYPE Small molecular drug D0OG0R DRUGINCH 1S/C17H18FN3O2S/c1-20(2)9-10-21-12-16(15-7-4-8-19-17(15)21)24(22,23)14-6-3-5-13(18)11-14/h3-8,11-12H,9-10H2,1-2H3 D0OG0R DRUGINKE SFSFIDVAEMDPIP-UHFFFAOYSA-N D0OG0R DRUGSMIL CN(C)CCN1C=C(C2=C1N=CC=C2)S(=O)(=O)C3=CC=CC(=C3)F D0OG0R HIGHSTAT Investigative D0OG1Q DRUG__ID D0OG1Q D0OG1Q DRUGTYPE Small molecular drug D0OG1Q DRUGINCH 1S/C18H12ClN3/c19-17-16-15(13-7-3-1-4-8-13)11-22(18(16)21-12-20-17)14-9-5-2-6-10-14/h1-12H D0OG1Q DRUGINKE INLZGZMAUAHURP-UHFFFAOYSA-N D0OG1Q DRUGSMIL C1=CC=C(C=C1)C2=CN(C3=C2C(=NC=N3)Cl)C4=CC=CC=C4 D0OG1Q HIGHSTAT Investigative D0OG4X DRUG__ID D0OG4X D0OG4X DRUGTYPE Small molecular drug D0OG4X DRUGINCH 1S/C9H10FN3S/c1-6(12-13-9(11)14)7-2-4-8(10)5-3-7/h2-5H,1H3,(H3,11,13,14)/b12-6- D0OG4X DRUGINKE JBOMIBNEKCISGH-SDQBBNPISA-N D0OG4X DRUGSMIL CC(=NNC(=S)N)C1=CC=C(C=C1)F D0OG4X HIGHSTAT Investigative D0OH2P DRUG__ID D0OH2P D0OH2P DRUGTYPE Small molecular drug D0OH2P DRUGINCH 1S/C8H11NO4/c9-4(5(10)11)7-1-8(2-7,3-7)6(12)13/h4H,1-3,9H2,(H,10,11)(H,12,13)/t4-,7?,8?/m1/s1 D0OH2P DRUGINKE KNSHLWJBSDBBRH-XOJFDHPMSA-N D0OH2P DRUGSMIL C1C2(CC1(C2)C(=O)O)C(C(=O)O)N D0OH2P HIGHSTAT Investigative D0OH3J DRUG__ID D0OH3J D0OH3J DRUGTYPE Small molecular drug D0OH3J DRUGINCH 1S/C26H25Cl2N5O3/c1-4-33(16(2)34)12-13-36-19-10-8-18(9-11-19)30-26-29-15-17-14-20(25(35)32(3)24(17)31-26)23-21(27)6-5-7-22(23)28/h5-11,14-15H,4,12-13H2,1-3H3,(H,29,30,31) D0OH3J DRUGINKE ZPDSBOKGPBKXNQ-UHFFFAOYSA-N D0OH3J DRUGSMIL CCN(CCOC1=CC=C(C=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl)C(=O)C D0OH3J HIGHSTAT Investigative D0OH7D DRUG__ID D0OH7D D0OH7D DRUGTYPE Small molecular drug D0OH7D DRUGINCH 1S/C27H27NO4/c29-20-9-8-18-13-21-27(31)14-19(12-16-4-2-1-3-5-16)23(30)25-26(27,22(18)24(20)32-25)10-11-28(21)15-17-6-7-17/h1-5,8-9,12,17,21,25,29,31H,6-7,10-11,13-15H2/b19-12+/t21-,25+,26+,27-/m1/s1 D0OH7D DRUGINKE WXOUFNFMPVMGFZ-BDQAUFNLSA-N D0OH7D DRUGSMIL C1CC1CN2CCC34C5C(=O)C(=CC6=CC=CC=C6)CC3(C2CC7=C4C(=C(C=C7)O)O5)O D0OH7D HIGHSTAT Investigative D0OH9B DRUG__ID D0OH9B D0OH9B DRUGCOMP Institute of Materia Medica Chinese Academy of Medical Science D0OH9B DRUGINCH 1S/C22H23N5O8/c1-11(28)32-8-16-18(33-12(2)29)19(34-13(3)30)22(35-16)27-10-25-17-20(23-9-24-21(17)27)26-14-5-4-6-15(31)7-14/h4-7,9-10,16,18-19,22,31H,8H2,1-3H3,(H,23,24,26)/t16-,18-,19-,22-/m1/s1 D0OH9B DRUGINKE IUDLPZTURGVXEA-WGQQHEPDSA-N D0OH9B DRUGSMIL CC(=O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)NC4=CC(=CC=C4)O)OC(=O)C)OC(=O)C D0OH9B HIGHSTAT Investigative D0OI1H DRUG__ID D0OI1H D0OI1H DRUGTYPE Small molecular drug D0OI1H DRUGINCH 1S/C6H8N2O2S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H2,8,9,10) D0OI1H DRUGINKE YAZSBRQTAHVVGE-UHFFFAOYSA-N D0OI1H DRUGSMIL C1=CC=C(C(=C1)N)S(=O)(=O)N D0OI1H HIGHSTAT Investigative D0OI4E DRUG__ID D0OI4E D0OI4E DRUGTYPE Small molecular drug D0OI4E DRUGINCH 1S/C39H54O13/c1-4-5-6-7-8-9-10-11-12-13-17-23-29(40)50-32-31(42)37(51-33(34(43)44)38(49,35(45)46)39(32,52-37)36(47)48)25-24-27(3)30(41)26(2)19-18-22-28-20-15-14-16-21-28/h4-5,10-11,14-16,18,20-22,26-27,30-33,41-42,49H,6-9,12-13,17,19,23-25H2,1-3H3,(H,43,44)(H,45,46)(H,47,48)/b5-4+,11-10+,22-18+/t26?,27?,30?,31-,32-,33-,37+,38-,39+/m1/s1 D0OI4E DRUGINKE VFZAKIFLDMCTJV-NZHUAJKLSA-N D0OI4E DRUGSMIL CC=CCCCCC=CCCCCC(=O)OC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCC(C)C(C(C)CC=CC3=CC=CC=C3)O)O D0OI4E HIGHSTAT Investigative D0OI6B DRUG__ID D0OI6B D0OI6B DRUGTYPE Small molecular drug D0OI6B DRUGINCH 1S/C12H17NO3S/c1-16-11-5-3-2-4-9(11)8-17-7-6-10(13)12(14)15/h2-5,10H,6-8,13H2,1H3,(H,14,15) D0OI6B DRUGINKE OCNLPBAJIIKAGX-UHFFFAOYSA-N D0OI6B DRUGSMIL COC1=CC=CC=C1CSCCC(C(=O)O)N D0OI6B HIGHSTAT Investigative D0OJ1V DRUG__ID D0OJ1V D0OJ1V DRUGTYPE Small molecular drug D0OJ1V DRUGINCH 1S/C25H40O4/c1-16(2)12-21(26)29-15-18-14-25-11-8-19-23(3,20(25)7-6-17(18)13-25)9-5-10-24(19,4)22(27)28/h16-20H,5-15H2,1-4H3,(H,27,28)/t17-,18-,19?,20?,23-,24-,25+/m1/s1 D0OJ1V DRUGINKE ZOILZTWSQHWPGH-SLLFEXPVSA-N D0OJ1V DRUGSMIL CC(C)CC(=O)OCC1CC23CCC4C(C2CCC1C3)(CCCC4(C)C(=O)O)C D0OJ1V HIGHSTAT Investigative D0OJ5M DRUG__ID D0OJ5M D0OJ5M DRUGTYPE Small molecular drug D0OJ5M DRUGINCH 1S/C5H15NO7P2.Na/c1-6(2)4-3-5(7,14(8,9)10)15(11,12)13;/h7H,3-4H2,1-2H3,(H2,8,9,10)(H2,11,12,13);/q;+1/p-1 D0OJ5M DRUGINKE DXTIBTHCHBZFJG-UHFFFAOYSA-M D0OJ5M DRUGSMIL CN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+] D0OJ5M HIGHSTAT Investigative D0OJ7E DRUG__ID D0OJ7E D0OJ7E DRUGTYPE Small molecular drug D0OJ7E DRUGINCH 1S/C26H28N2O3/c27-25(29)23-15-8-13-21(18-23)22-14-9-16-24(19-22)31-26(30)28-17-7-2-1-4-10-20-11-5-3-6-12-20/h3,5-6,8-9,11-16,18-19H,1-2,4,7,10,17H2,(H2,27,29)(H,28,30) D0OJ7E DRUGINKE JMLPLSJWSHVJLP-UHFFFAOYSA-N D0OJ7E DRUGSMIL C1=CC=C(C=C1)CCCCCCNC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N D0OJ7E HIGHSTAT Investigative D0OJ7S DRUG__ID D0OJ7S D0OJ7S DRUGTYPE Small molecular drug D0OJ7S DRUGINCH 1S/C39H51N5O6/c1-23(2)29-21-26(37(46)43(5)15-9-14-42(3)4)12-13-31(29)44-32(35-33(49-6)10-8-11-34(35)50-7)22-30(41-44)36(45)40-39(38(47)48)27-17-24-16-25(19-27)20-28(39)18-24/h8,10-13,21-25,27-28H,9,14-20H2,1-7H3,(H,40,45)(H,47,48) D0OJ7S DRUGINKE LWULHXVBLMWCHO-UHFFFAOYSA-N D0OJ7S DRUGSMIL CC(C)C1=C(C=CC(=C1)C(=O)N(C)CCCN(C)C)N2C(=CC(=N2)C(=O)NC3(C4CC5CC(C4)CC3C5)C(=O)O)C6=C(C=CC=C6OC)OC D0OJ7S HIGHSTAT Investigative D0OJ9P DRUG__ID D0OJ9P D0OJ9P DRUGTYPE Small molecular drug D0OJ9P DRUGINCH 1S/C13H12N2O2/c1-15-9-5-8-12(10-15)17-13(16)14-11-6-3-2-4-7-11/h2-10H,1H3/p+1 D0OJ9P DRUGINKE HFCGFRPAGMNQAZ-UHFFFAOYSA-O D0OJ9P DRUGSMIL C[N+]1=CC=CC(=C1)OC(=O)NC2=CC=CC=C2 D0OJ9P HIGHSTAT Investigative D0OK8N DRUG__ID D0OK8N D0OK8N DRUGTYPE Small molecular drug D0OK8N DRUGINCH 1S/C10H11N3O3S/c1-13-10(12-17(14,15)16)7-9(11-13)8-5-3-2-4-6-8/h2-7,12H,1H3,(H,14,15,16) D0OK8N DRUGINKE OTZLVSGSRPNRFT-UHFFFAOYSA-N D0OK8N DRUGSMIL CN1C(=CC(=N1)C2=CC=CC=C2)NS(=O)(=O)O D0OK8N HIGHSTAT Investigative D0OL2D DRUG__ID D0OL2D D0OL2D DRUGTYPE Small molecular drug D0OL2D DRUGINCH 1S/C16H12O4S/c17-14-10-15(16(18)13-9-5-4-8-12(13)14)21(19,20)11-6-2-1-3-7-11/h1-10,17-18H D0OL2D DRUGINKE YEDZIHZPRGSAMI-UHFFFAOYSA-N D0OL2D DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=C(C3=CC=CC=C3C(=C2)O)O D0OL2D HIGHSTAT Investigative D0OL3X DRUG__ID D0OL3X D0OL3X DRUGTYPE Small molecular drug D0OL3X DRUGINCH 1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3/t11-,17-/m1/s1 D0OL3X DRUGINKE LSLYOANBFKQKPT-PIGZYNQJSA-N D0OL3X DRUGSMIL CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O D0OL3X HIGHSTAT Investigative D0OM2S DRUG__ID D0OM2S D0OM2S DRUGTYPE Small molecular drug D0OM2S DRUGINCH 1S/C26H28O3/c1-25(2)11-12-26(3,4)22-15-19(9-10-21(22)25)23(27)18-7-5-17-14-20(24(28)29)8-6-16(17)13-18/h5-10,13-15,23,27H,11-12H2,1-4H3,(H,28,29)/t23-/m0/s1 D0OM2S DRUGINKE AYAJZQYENGWICE-QHCPKHFHSA-N D0OM2S DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(C3=CC4=C(C=C3)C=C(C=C4)C(=O)O)O)(C)C)C D0OM2S HIGHSTAT Investigative D0OM9G DRUG__ID D0OM9G D0OM9G DRUGTYPE Small molecular drug D0OM9G DRUGINCH 1S/C9H15N3/c1-3-10-4-2-8(1)5-9-6-11-7-12-9/h6-8,10H,1-5H2,(H,11,12) D0OM9G DRUGINKE MCNGUYXRBCIGOV-UHFFFAOYSA-N D0OM9G DRUGSMIL C1CNCCC1CC2=CN=CN2 D0OM9G HIGHSTAT Investigative D0ON2A DRUG__ID D0ON2A D0ON2A DRUGTYPE Small molecular drug D0ON2A DRUGINCH 1S/C16H11N3/c1-11-2-3-13-4-5-14(7-16(13)19-11)15-6-12(8-17)9-18-10-15/h2-7,9-10H,1H3 D0ON2A DRUGINKE AYJCNPHACWMDIG-UHFFFAOYSA-N D0ON2A DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CN=CC(=C3)C#N D0ON2A HIGHSTAT Investigative D0ON2Z DRUG__ID D0ON2Z D0ON2Z DRUGTYPE Small molecular drug D0ON2Z DRUGINCH 1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37) D0ON2Z DRUGINKE OFJRNBWSFXEHSA-UHFFFAOYSA-N D0ON2Z DRUGSMIL CN(C)CC1=NC=CN1C2=CC(=C(C=C2)NC(=O)C3=CC(=NN3C4=CC5=C(C=C4)ON=C5N)C(F)(F)F)F D0ON2Z HIGHSTAT Investigative D0OO4P DRUG__ID D0OO4P D0OO4P DRUGTYPE Small molecular drug D0OO4P DRUGINCH 1S/C26H24N6O2/c1-2-3-11-23-27-22-10-6-9-21(26(33)34)24(22)32(23)16-17-12-14-18(15-13-17)19-7-4-5-8-20(19)25-28-30-31-29-25/h4-10,12-15H,2-3,11,16H2,1H3,(H,33,34)(H,28,29,30,31) D0OO4P DRUGINKE FLOKGHWIQFCIJW-UHFFFAOYSA-N D0OO4P DRUGSMIL CCCCC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O D0OO4P HIGHSTAT Investigative D0OP3D DRUG__ID D0OP3D D0OP3D DRUGTYPE Small molecular drug D0OP3D DRUGINCH 1S/C18H16F2N6/c1-10-7-16(26-25-10)23-18-15(20)8-13(9-21)17(24-18)22-11(2)12-3-5-14(19)6-4-12/h3-8,11H,1-2H3,(H3,22,23,24,25,26)/t11-/m0/s1 D0OP3D DRUGINKE SUNXHXDJOIXABJ-NSHDSACASA-N D0OP3D DRUGSMIL CC1=CC(=NN1)NC2=C(C=C(C(=N2)NC(C)C3=CC=C(C=C3)F)C#N)F D0OP3D HIGHSTAT Investigative D0OP3Y DRUG__ID D0OP3Y D0OP3Y DRUGTYPE Small molecular drug D0OP3Y DRUGINCH 1S/C11H14NO9P/c13-8-7(5-20-22(17,18)19)21-10(9(8)14)12-3-1-2-6(4-12)11(15)16/h1-4,7-10,13-14H,5H2,(H2-,15,16,17,18,19)/t7-,8-,9-,10-/m1/s1 D0OP3Y DRUGINKE JOUIQRNQJGXQDC-ZYUZMQFOSA-N D0OP3Y DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)[O-])O)O)C(=O)O D0OP3Y HIGHSTAT Investigative D0OQ1I DRUG__ID D0OQ1I D0OQ1I DRUGTYPE Small molecular drug D0OQ1I DRUGINCH 1S/C14H13NO7/c16-6-1-5-4-2-7-13(22-3-21-7)11(18)8(4)14(20)15-9(5)12(19)10(6)17/h1-2,6,9-10,12,16-19H,3H2,(H,15,20)/t6-,9+,10+,12-/m0/s1 D0OQ1I DRUGINKE LZAZURSABQIKGB-AEKGRLRDSA-N D0OQ1I DRUGSMIL C1OC2=C(O1)C(=C3C(=C2)C4=CC(C(C(C4NC3=O)O)O)O)O D0OQ1I HIGHSTAT Investigative D0OQ5H DRUG__ID D0OQ5H D0OQ5H DRUGTYPE Small molecular drug D0OQ5H DRUGINCH 1S/C25H24Cl3N3O2/c1-25(2)12-20(24(33)29-13-32)19-11-18(14-4-6-15(26)7-5-14)22(30-23(19)31(25)3)17-9-8-16(27)10-21(17)28/h4-11,20,32H,12-13H2,1-3H3,(H,29,33) D0OQ5H DRUGINKE URTQOVWDFKPXTI-UHFFFAOYSA-N D0OQ5H DRUGSMIL CC1(CC(C2=C(N1C)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C(=O)NCO)C D0OQ5H HIGHSTAT Investigative D0OR5S DRUG__ID D0OR5S D0OR5S DRUGTYPE Small molecular drug D0OR5S DRUGINCH 1S/C19H18N4O/c1-14(24)22-17-9-5-8-16(10-17)18-12-20-13-19(23-18)21-11-15-6-3-2-4-7-15/h2-10,12-13H,11H2,1H3,(H,21,23)(H,22,24) D0OR5S DRUGINKE APNYMHFAZCCZRG-UHFFFAOYSA-N D0OR5S DRUGSMIL CC(=O)NC1=CC=CC(=C1)C2=CN=CC(=N2)NCC3=CC=CC=C3 D0OR5S HIGHSTAT Investigative D0OR5V DRUG__ID D0OR5V D0OR5V DRUGTYPE Small molecular drug D0OR5V DRUGINCH 1S/C8H9N5/c9-7-6-8(11-3-10-7)13(4-12-6)5-1-2-5/h3-5H,1-2H2,(H2,9,10,11) D0OR5V DRUGINKE QKMZACGKMJHVSI-UHFFFAOYSA-N D0OR5V DRUGSMIL C1CC1N2C=NC3=C(N=CN=C32)N D0OR5V HIGHSTAT Investigative D0OR6C DRUG__ID D0OR6C D0OR6C DRUGTYPE Small molecular drug D0OR6C DRUGINCH 1S/C37H30N4O15S4.4Na/c1-19-3-5-23(35(42)38-33-17-27(59(51,52)53)11-21-7-9-25(15-29(21)33)57(45,46)47)13-31(19)40-37(44)41-32-14-24(6-4-20(32)2)36(43)39-34-18-28(60(54,55)56)12-22-8-10-26(16-30(22)34)58(48,49)50;;;;/h3-18H,1-2H3,(H,38,42)(H,39,43)(H2,40,41,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56);;;;/q;4*+1/p-4 D0OR6C DRUGINKE SJMHXBFWMZYDBY-UHFFFAOYSA-J D0OR6C DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=C3C=C(C=CC3=CC(=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)NC4=C(C=CC(=C4)C(=O)NC5=C6C=C(C=CC6=CC(=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+].[Na+] D0OR6C HIGHSTAT Investigative D0OR6O DRUG__ID D0OR6O D0OR6O DRUGTYPE Small molecular drug D0OR6O DRUGINCH 1S/C24H29N3O6S/c1-25-21(28)17-2-4-18(5-3-17)33-19-6-8-20(9-7-19)34(31,32)24(22(29)27-30)11-10-23(16-24)12-14-26-15-13-23/h2-9,26,30H,10-16H2,1H3,(H,25,28)(H,27,29)/t24-/m1/s1 D0OR6O DRUGINKE ZUZGJCNWNOCKEB-XMMPIXPASA-N D0OR6O DRUGSMIL CNC(=O)C1=CC=C(C=C1)OC2=CC=C(C=C2)S(=O)(=O)C3(CCC4(C3)CCNCC4)C(=O)NO D0OR6O HIGHSTAT Investigative D0OS3L DRUG__ID D0OS3L D0OS3L DRUGTYPE Small molecular drug D0OS3L DRUGINCH 1S/C13H8F3N/c14-13(15,16)10-6-3-5-9-8-4-1-2-7-11(8)17-12(9)10/h1-7,17H D0OS3L DRUGINKE RDMKBOMNZUKIDD-UHFFFAOYSA-N D0OS3L DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C(=CC=C3)C(F)(F)F D0OS3L HIGHSTAT Investigative D0OS7U DRUG__ID D0OS7U D0OS7U DRUGTYPE Small molecular drug D0OS7U DRUGINCH 1S/C20H41NO2/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)19(18-22)21(2)3/h16-17,19-20,22-23H,4-15,18H2,1-3H3/b17-16+/t19-,20+/m1/s1 D0OS7U DRUGINKE YRXOQXUDKDCXME-QWKHPXNBSA-N D0OS7U DRUGSMIL CCCCCCCCCCCCCC=CC(C(CO)N(C)C)O D0OS7U HIGHSTAT Investigative D0OS8Y DRUG__ID D0OS8Y D0OS8Y DRUGTYPE Small molecular drug D0OS8Y DRUGINCH 1S/C20H18F2N4O/c1-11(2)25-10-14-8-13(4-6-16(14)20(25)27)19-12(3)26(24-23-19)18-7-5-15(21)9-17(18)22/h4-9,11H,10H2,1-3H3 D0OS8Y DRUGINKE KKZVYGIANGOHBS-UHFFFAOYSA-N D0OS8Y DRUGSMIL CC1=C(N=NN1C2=C(C=C(C=C2)F)F)C3=CC4=C(C=C3)C(=O)N(C4)C(C)C D0OS8Y HIGHSTAT Investigative D0OT1Z DRUG__ID D0OT1Z D0OT1Z DRUGTYPE Small molecular drug D0OT1Z DRUGINCH 1S/C21H18N4O/c22-21(23)17-9-11-18(12-10-17)24-25-19-14-16(8-13-20(19)26)7-6-15-4-2-1-3-5-15/h1-14,26H,(H3,22,23)/b7-6+,25-24? D0OT1Z DRUGINKE HKRFQXBNVMEPED-RAKVFIQRSA-N D0OT1Z DRUGSMIL C1=CC=C(C=C1)C=CC2=CC(=C(C=C2)O)N=NC3=CC=C(C=C3)C(=N)N D0OT1Z HIGHSTAT Investigative D0OT2H DRUG__ID D0OT2H D0OT2H DRUGTYPE Small molecular drug D0OT2H DRUGINCH 1S/C2H3N3/c1-3-2-5-4-1/h1-2H,(H,3,4,5) D0OT2H DRUGINKE NSPMIYGKQJPBQR-UHFFFAOYSA-N D0OT2H DRUGSMIL C1=NC=NN1 D0OT2H HIGHSTAT Investigative D0OT3H DRUG__ID D0OT3H D0OT3H DRUGTYPE Small molecular drug D0OT3H DRUGINCH 1S/C34H59N2O5.ClH/c1-4-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22-25-39-33-26-31(28-40-33)29-41-34(38)36(30(3)37)27-32-23-20-21-24-35(32)5-2;/h20-21,23-24,31,33H,4-19,22,25-29H2,1-3H3;1H/q+1;/p-1 D0OT3H DRUGINKE KFNNWINXWGVOQN-UHFFFAOYSA-M D0OT3H DRUGSMIL CCCCCCCCCCCCCCCCCCOC1CC(CO1)COC(=O)N(CC2=CC=CC=[N+]2CC)C(=O)C.[Cl-] D0OT3H HIGHSTAT Investigative D0OT5L DRUG__ID D0OT5L D0OT5L DRUGTYPE Small molecular drug D0OT5L DRUGINCH 1S/C12H12O3/c1-2-7-14-10-5-3-9-4-6-12(13)15-11(9)8-10/h3-6,8H,2,7H2,1H3 D0OT5L DRUGINKE FCCCOTWGEKNZMI-UHFFFAOYSA-N D0OT5L DRUGSMIL CCCOC1=CC2=C(C=C1)C=CC(=O)O2 D0OT5L HIGHSTAT Investigative D0OT9B DRUG__ID D0OT9B D0OT9B DRUGTYPE Small molecular drug D0OT9B DRUGINCH 1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1 D0OT9B DRUGINKE CKLJMWTZIZZHCS-REOHCLBHSA-N D0OT9B DRUGSMIL C(C(C(=O)O)N)C(=O)O D0OT9B HIGHSTAT Investigative D0OT9G DRUG__ID D0OT9G D0OT9G DRUGTYPE Small molecular drug D0OT9G DRUGINCH 1S/C39H66N12O8/c1-6-23(4)31(36(57)50(5)30(37(58)59)20-22(2)3)49-33(54)28(21-24-13-15-25(52)16-14-24)48-34(55)29-12-9-19-51(29)35(56)27(11-8-18-46-39(43)44)47-32(53)26(40)10-7-17-45-38(41)42/h13-16,22-23,26-31,52H,6-12,17-21,40H2,1-5H3,(H,47,53)(H,48,55)(H,49,54)(H,58,59)(H4,41,42,45)(H4,43,44,46)/t23-,26-,27-,28-,29-,30-,31-/m0/s1 D0OT9G DRUGINKE DUYQEARXOLBXOJ-VGPFALITSA-N D0OT9G DRUGSMIL CCC(C)C(C(=O)N(C)C(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N D0OT9G HIGHSTAT Investigative D0OV0I DRUG__ID D0OV0I D0OV0I DRUGTYPE Small molecular drug D0OV0I DRUGINCH 1S/C14H12N2S/c1-10-4-2-5-11(8-10)17-14-7-3-6-13(16)12(14)9-15/h2-8H,16H2,1H3 D0OV0I DRUGINKE VGPLRZAJQWYFDD-UHFFFAOYSA-N D0OV0I DRUGSMIL CC1=CC(=CC=C1)SC2=CC=CC(=C2C#N)N D0OV0I HIGHSTAT Investigative D0OV2V DRUG__ID D0OV2V D0OV2V DRUGTYPE Small molecular drug D0OV2V DRUGINCH 1S/C21H25NO4/c22-19(21(25)26)14-17(20(23)24)12-7-13-18(15-8-3-1-4-9-15)16-10-5-2-6-11-16/h1-6,8-11,17-19H,7,12-14,22H2,(H,23,24)(H,25,26)/t17-,19-/m0/s1 D0OV2V DRUGINKE DWLOVDOPFJPWNE-HKUYNNGSSA-N D0OV2V DRUGSMIL C1=CC=C(C=C1)C(CCCC(CC(C(=O)O)N)C(=O)O)C2=CC=CC=C2 D0OV2V HIGHSTAT Investigative D0OV3S DRUG__ID D0OV3S D0OV3S DRUGTYPE Small molecular drug D0OV3S DRUGINCH 1S/C23H22O2/c1-2-6-22(17-7-4-3-5-8-17)23(18-9-13-20(24)14-10-18)19-11-15-21(25)16-12-19/h3-5,7-16,24-25H,2,6H2,1H3 D0OV3S DRUGINKE UTLLHWVRVATSPI-UHFFFAOYSA-N D0OV3S DRUGSMIL CCCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=CC=C3 D0OV3S HIGHSTAT Investigative D0OW4W DRUG__ID D0OW4W D0OW4W DRUGTYPE Small molecular drug D0OW4W DRUGINCH 1S/C16H12ClNS/c1-11-2-4-13(5-3-11)16-15(10-18-19-16)12-6-8-14(17)9-7-12/h2-10H,1H3 D0OW4W DRUGINKE YLLFNDIXMCYHET-UHFFFAOYSA-N D0OW4W DRUGSMIL CC1=CC=C(C=C1)C2=C(C=NS2)C3=CC=C(C=C3)Cl D0OW4W HIGHSTAT Investigative D0OW6Q DRUG__ID D0OW6Q D0OW6Q DRUGTYPE Small molecular drug D0OW6Q DRUGINCH 1S/C18H22N2O4/c1-21-14-8-6-11(9-13(14)19)5-7-12-10-15(22-2)17(23-3)18(24-4)16(12)20/h5-10H,19-20H2,1-4H3/b7-5- D0OW6Q DRUGINKE ONFPNROXTUMLBU-ALCCZGGFSA-N D0OW6Q DRUGSMIL COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2N)OC)OC)OC)N D0OW6Q HIGHSTAT Investigative D0OW8M DRUG__ID D0OW8M D0OW8M DRUGTYPE Small molecular drug D0OW8M DRUGINCH 1S/C19H20N4O2/c1-25-17-6-9-21-18(12-17)22-16-7-10-23(11-8-16)19(24)15-4-2-14(13-20)3-5-15/h2-6,9,12,16H,7-8,10-11H2,1H3,(H,21,22) D0OW8M DRUGINKE SZUVGMCKKLJAFX-UHFFFAOYSA-N D0OW8M DRUGSMIL COC1=CC(=NC=C1)NC2CCN(CC2)C(=O)C3=CC=C(C=C3)C#N D0OW8M HIGHSTAT Investigative D0OX0B DRUG__ID D0OX0B D0OX0B DRUGTYPE Small molecular drug D0OX0B DRUGINCH 1S/C19H20O3/c1-20-17-11-10-16(18(21-2)19(17)22-3)15-9-8-13-6-4-5-7-14(13)12-15/h4-7,10-12H,8-9H2,1-3H3 D0OX0B DRUGINKE WOSGVZBVAWUJJN-UHFFFAOYSA-N D0OX0B DRUGSMIL COC1=C(C(=C(C=C1)C2=CC3=CC=CC=C3CC2)OC)OC D0OX0B HIGHSTAT Investigative D0OX0V DRUG__ID D0OX0V D0OX0V DRUGTYPE Small molecular drug D0OX0V DRUGINCH 1S/C17H14N4S/c1-2-22-15-9-5-8-13-16(15)21-17(20-13)14-10-18-11-6-3-4-7-12(11)19-14/h3-10H,2H2,1H3,(H,20,21) D0OX0V DRUGINKE IHVQPVYBIZVMSJ-UHFFFAOYSA-N D0OX0V DRUGSMIL CCSC1=CC=CC2=C1N=C(N2)C3=NC4=CC=CC=C4N=C3 D0OX0V HIGHSTAT Investigative D0OX1T DRUG__ID D0OX1T D0OX1T DRUGTYPE Small molecular drug D0OX1T DRUGINCH 1S/C24H23N5O/c1-15-22-10-16(6-7-24(22)29-28-15)17-9-20(13-26-11-17)30-14-19(25)8-18-12-27-23-5-3-2-4-21(18)23/h2-7,9-13,19,27H,8,14,25H2,1H3,(H,28,29)/t19-/m0/s1 D0OX1T DRUGINKE YWTBGJGMTBHQTM-IBGZPJMESA-N D0OX1T DRUGSMIL CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N D0OX1T HIGHSTAT Investigative D0OY0X DRUG__ID D0OY0X D0OY0X DRUGTYPE Small molecular drug D0OY0X DRUGINCH 1S/C13H23N5O3/c1-18(2,3)10(12(15)19)4-5-11-16-7-8(17-11)6-9(14)13(20)21/h7,9-10H,4-6,14H2,1-3H3,(H3-,15,16,17,19,20,21) D0OY0X DRUGINKE FOOBQHKMWYGHCE-UHFFFAOYSA-N D0OY0X DRUGSMIL C[N+](C)(C)C(CCC1=NC=C(N1)CC(C(=O)[O-])N)C(=O)N D0OY0X HIGHSTAT Investigative D0OY1J DRUG__ID D0OY1J D0OY1J DRUGTYPE Small molecular drug D0OY1J DRUGINCH 1S/C13H10N2O2/c16-13-4-3-11-2-1-10(7-12(11)17-13)8-15-6-5-14-9-15/h1-7,9H,8H2 D0OY1J DRUGINKE HXFIMHPPOABVMO-UHFFFAOYSA-N D0OY1J DRUGSMIL C1=CC(=CC2=C1C=CC(=O)O2)CN3C=CN=C3 D0OY1J HIGHSTAT Investigative D0OY1R DRUG__ID D0OY1R D0OY1R DRUGTYPE Small molecular drug D0OY1R DRUGINCH 1S/C6H9N3O/c10-6-4-1-2-7-3-5(4)8-9-6/h7H,1-3H2,(H2,8,9,10) D0OY1R DRUGINKE UPMMUUFLHUEUKP-UHFFFAOYSA-N D0OY1R DRUGSMIL C1CNCC2=C1C(=O)NN2 D0OY1R HIGHSTAT Investigative D0OY2V DRUG__ID D0OY2V D0OY2V DRUGTYPE Small molecular drug D0OY2V DRUGINCH 1S/C20H20O4/c1-11(2)3-5-14-17(22)8-7-15-19(14)23-10-16-13-6-4-12(21)9-18(13)24-20(15)16/h3-4,6-9,16,20-22H,5,10H2,1-2H3/t16-,20-/m0/s1 D0OY2V DRUGINKE QKYUTKLCEVEMIE-JXFKEZNVSA-N D0OY2V DRUGSMIL CC(=CCC1=C(C=CC2=C1OCC3C2OC4=C3C=CC(=C4)O)O)C D0OY2V HIGHSTAT Investigative D0OY8Y DRUG__ID D0OY8Y D0OY8Y DRUGTYPE Small molecular drug D0OY8Y DRUGINCH 1S/C19H21NO2/c1-13(21)20-12-17-10-15-6-4-3-5-14(15)9-16-7-8-18(22-2)11-19(16)17/h3-8,11,17H,9-10,12H2,1-2H3,(H,20,21) D0OY8Y DRUGINKE PQZZGTZTKGECDT-UHFFFAOYSA-N D0OY8Y DRUGSMIL CC(=O)NCC1CC2=CC=CC=C2CC3=C1C=C(C=C3)OC D0OY8Y HIGHSTAT Investigative D0OZ2F DRUG__ID D0OZ2F D0OZ2F DRUGTYPE Small molecular drug D0OZ2F DRUGINCH 1S/C7H16NO5P/c8-6(7(9)10)4-2-1-3-5-14(11,12)13/h6H,1-5,8H2,(H,9,10)(H2,11,12,13) D0OZ2F DRUGINKE MYDMWESTDPJANS-UHFFFAOYSA-N D0OZ2F DRUGSMIL C(CCC(C(=O)O)N)CCP(=O)(O)O D0OZ2F HIGHSTAT Investigative D0OZ2S DRUG__ID D0OZ2S D0OZ2S DRUGTYPE Small molecular drug D0OZ2S DRUGINCH 1S/C31H30N8O/c1-20-7-6-8-21(2)27(20)39-29(40)24-19-32-30(35-28(24)38-26-10-5-4-9-25(26)34-31(38)39)33-22-11-13-23(14-12-22)37-17-15-36(3)16-18-37/h4-14,19H,15-18H2,1-3H3,(H,32,33,35) D0OZ2S DRUGINKE BHJJWVDKNXABFS-UHFFFAOYSA-N D0OZ2S DRUGSMIL CC1=C(C(=CC=C1)C)N2C(=O)C3=CN=C(N=C3N4C2=NC5=CC=CC=C54)NC6=CC=C(C=C6)N7CCN(CC7)C D0OZ2S HIGHSTAT Investigative D0OZ4C DRUG__ID D0OZ4C D0OZ4C DRUGTYPE Small molecular drug D0OZ4C DRUGINCH 1S/C10H8N2O3S/c13-9-6-7-10(12-11-9)16(14,15)8-4-2-1-3-5-8/h1-7H,(H,11,13) D0OZ4C DRUGINKE ZICCKDUVBPQRQT-UHFFFAOYSA-N D0OZ4C DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=NNC(=O)C=C2 D0OZ4C HIGHSTAT Investigative D0P0BV DRUG__ID D0P0BV D0P0BV DRUGTYPE Small molecular drug D0P0BV DRUGINCH 1S/C20H22N6O6/c21-17-14-18(26(8-23-14)19-16(30)15(29)13(7-27)32-19)25-20(24-17)31-4-3-9-6-22-12-2-1-10(28)5-11(9)12/h1-2,5-6,8,13,15-16,19,22,27-30H,3-4,7H2,(H2,21,24,25)/t13-,15-,16-,19-/m1/s1 D0P0BV DRUGINKE CPKNPTKTLVLFFU-NVQRDWNXSA-N D0P0BV DRUGSMIL C1=CC2=C(C=C1O)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0P0BV HIGHSTAT Investigative D0P0CB DRUG__ID D0P0CB D0P0CB DRUGTYPE Small molecular drug D0P0CB DRUGINCH 1S/C17H14INO2/c1-19(2)13-6-3-11(4-7-13)17-10-15(20)14-9-12(18)5-8-16(14)21-17/h3-10H,1-2H3 D0P0CB DRUGINKE MVKVWWKDDYBNOJ-UHFFFAOYSA-N D0P0CB DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)I D0P0CB HIGHSTAT Investigative D0P0CM DRUG__ID D0P0CM D0P0CM DRUGTYPE Small molecular drug D0P0CM DRUGINCH 1S/C8H9N5O2/c1-4-9-5-6(13(3)11-4)10-8(15)12(2)7(5)14/h1-3H3 D0P0CM DRUGINKE CPXHNWKHOFNPDO-UHFFFAOYSA-N D0P0CM DRUGSMIL CC1=NN(C2=NC(=O)N(C(=O)C2=N1)C)C D0P0CM HIGHSTAT Investigative D0P0CX DRUG__ID D0P0CX D0P0CX DRUGTYPE Small molecular drug D0P0CX DRUGINCH 1S/C14H12N2O2S/c1-10-4-2-5-11(8-10)19(17,18)14-7-3-6-13(16)12(14)9-15/h2-8H,16H2,1H3 D0P0CX DRUGINKE KWHGWXMLBAGGOE-UHFFFAOYSA-N D0P0CX DRUGSMIL CC1=CC(=CC=C1)S(=O)(=O)C2=CC=CC(=C2C#N)N D0P0CX HIGHSTAT Investigative D0P0EP DRUG__ID D0P0EP D0P0EP DRUGTYPE Small molecular drug D0P0EP DRUGINCH 1S/C9H13N2O10P/c12-4-1-5(13)11(9(16)10-4)8-7(15)6(14)3(21-8)2-20-22(17,18)19/h1,3,6-8,13-15H,2H2,(H,10,12,16)(H2,17,18,19)/t3-,6-,7-,8-/m1/s1 D0P0EP DRUGINKE UDOBICLZEKUKCV-YXZULKJRSA-N D0P0EP DRUGSMIL C1=C(N(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O)O D0P0EP HIGHSTAT Investigative D0P0FN DRUG__ID D0P0FN D0P0FN DRUGTYPE Small molecular drug D0P0FN DRUGINCH 1S/C30H43NO4S/c1-3-4-12-21-36(34,35)22-13-10-8-6-5-7-9-11-20-31-29-19-18-27(33)23-28(29)24(2)30(31)25-14-16-26(32)17-15-25/h14-19,23,32-33H,3-13,20-22H2,1-2H3 D0P0FN DRUGINKE LYJSJVYJLZOMCD-UHFFFAOYSA-N D0P0FN DRUGSMIL CCCCCS(=O)(=O)CCCCCCCCCCN1C2=C(C=C(C=C2)O)C(=C1C3=CC=C(C=C3)O)C D0P0FN HIGHSTAT Investigative D0P0GT DRUG__ID D0P0GT D0P0GT DRUGTYPE Small molecular drug D0P0GT DRUGINCH 1S/C6H11NO2/c7-6(5(8)9)3-1-2-4-6/h1-4,7H2,(H,8,9) D0P0GT DRUGINKE NILQLFBWTXNUOE-UHFFFAOYSA-N D0P0GT DRUGSMIL C1CCC(C1)(C(=O)O)N D0P0GT HIGHSTAT Investigative D0P0IE DRUG__ID D0P0IE D0P0IE DRUGTYPE Small molecular drug D0P0IE DRUGINCH 1S/C11H8O3/c1-6-5-9(13)10-7(11(6)14)3-2-4-8(10)12/h2-5,12H,1H3 D0P0IE DRUGINKE VCMMXZQDRFWYSE-UHFFFAOYSA-N D0P0IE DRUGSMIL CC1=CC(=O)C2=C(C1=O)C=CC=C2O D0P0IE HIGHSTAT Investigative D0P0IX DRUG__ID D0P0IX D0P0IX DRUGTYPE Small molecular drug D0P0IX DRUGINCH 1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-12-13(19)6-7-15(14)20-16-4-2-3-5-17(16)21-18/h2-7,12,20H,8-11H2,1H3 D0P0IX DRUGINKE APOMSSAGEAOUGO-UHFFFAOYSA-N D0P0IX DRUGSMIL CN1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(C=C4)Cl D0P0IX HIGHSTAT Investigative D0P0KG DRUG__ID D0P0KG D0P0KG DRUGTYPE Small molecular drug D0P0KG DRUGINCH 1S/C22H32O5/c1-2-3-9-14-19(23)15-10-6-4-5-7-11-16-20(24)21(25)17-12-8-13-18-22(26)27/h3-12,15-16,19-21,23-25H,2,13-14,17-18H2,1H3,(H,26,27)/b6-4-,7-5+,9-3-,12-8-,15-10+,16-11+/t19-,20-,21-/m0/s1 D0P0KG DRUGINKE OIWTWACQMDFHJG-LDOXQWQISA-N D0P0KG DRUGSMIL CCC=CCC(C=CC=CC=CC=CC(C(CC=CCCC(=O)O)O)O)O D0P0KG HIGHSTAT Investigative D0P0MN DRUG__ID D0P0MN D0P0MN DRUGTYPE Small molecular drug D0P0MN DRUGINCH 1S/C27H45NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21-28-27(30)23-24-19-20-25(29)26(22-24)31-2/h10-11,19-20,22,29H,3-9,12-18,21,23H2,1-2H3,(H,28,30)/b11-10- D0P0MN DRUGINKE PCZMUTQYZKAXBW-KHPPLWFESA-N D0P0MN DRUGSMIL CCCCCCCCC=CCCCCCCCCNC(=O)CC1=CC(=C(C=C1)O)OC D0P0MN HIGHSTAT Investigative D0P0MP DRUG__ID D0P0MP D0P0MP DRUGTYPE Small molecular drug D0P0MP DRUGINCH 1S/C22H33N2O6P/c1-15(2)12-19(23-16(3)25)21(26)24-11-7-10-20(24)31(29,30)14-18(22(27)28)13-17-8-5-4-6-9-17/h4-6,8-9,15,18-20H,7,10-14H2,1-3H3,(H,23,25)(H,27,28)(H,29,30)/t18-,19+,20+/m1/s1 D0P0MP DRUGINKE DGMLSHVZZKUDPN-AABGKKOBSA-N D0P0MP DRUGSMIL CC(C)CC(C(=O)N1CCCC1P(=O)(CC(CC2=CC=CC=C2)C(=O)O)O)NC(=O)C D0P0MP HIGHSTAT Investigative D0P0NH DRUG__ID D0P0NH D0P0NH DRUGCOMP China Pharmaceutical University D0P0NH DRUGINCH 1S/C30H42N4O4/c1-6-7-8-9-10-11-15-32-30(33-21-31)34-16-14-23-19-28(37-4)29(38-5)20-24(23)25(34)17-22-12-13-26(35-2)27(18-22)36-3/h12-13,18-20,25H,6-11,14-17H2,1-5H3,(H,32,33) D0P0NH DRUGINKE HLFJXQXFECJCAJ-UHFFFAOYSA-N D0P0NH DRUGSMIL CCCCCCCCN=C(NC#N)N1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC D0P0NH HIGHSTAT Investigative D0P0PP DRUG__ID D0P0PP D0P0PP DRUGTYPE Small molecular drug D0P0PP DRUGINCH 1S/C20H24N2O5/c1-12(2)11-26-16-7-15(8-17(9-16)27-13(3)4)19(23)22-18-6-5-14(10-21-18)20(24)25/h5-10,12-13H,11H2,1-4H3,(H,24,25)(H,21,22,23) D0P0PP DRUGINKE RTMFZNZPHCZAFG-UHFFFAOYSA-N D0P0PP DRUGSMIL CC(C)COC1=CC(=CC(=C1)C(=O)NC2=NC=C(C=C2)C(=O)O)OC(C)C D0P0PP HIGHSTAT Investigative D0P0QI DRUG__ID D0P0QI D0P0QI DRUGTYPE Small molecular drug D0P0QI DRUGINCH 1S/C14H7FN4O/c15-11-6-9(8-16)5-10(7-11)14-18-13(19-20-14)12-3-1-2-4-17-12/h1-7H D0P0QI DRUGINKE GELAFISMURFRCA-UHFFFAOYSA-N D0P0QI DRUGSMIL C1=CC=NC(=C1)C2=NOC(=N2)C3=CC(=CC(=C3)C#N)F D0P0QI HIGHSTAT Investigative D0P0RB DRUG__ID D0P0RB D0P0RB DRUGTYPE Small molecular drug D0P0RB DRUGINCH 1S/C53H65N9O8/c1-33(2)26-43(50(67)60-45(29-38-30-55-42-19-12-11-18-40(38)42)52(69)61(4)32-37-16-9-6-10-17-37)59-51(68)46-20-13-25-62(46)53(70)44(28-35-14-7-5-8-15-35)58-47(64)31-56-48(65)34(3)57-49(66)41(54)27-36-21-23-39(63)24-22-36/h5-12,14-19,21-24,30,33-34,41,43-46,55,63H,13,20,25-29,31-32,54H2,1-4H3,(H,56,65)(H,57,66)(H,58,64)(H,59,68)(H,60,67)/t34-,41+,43+,44+,45+,46+/m1/s1 D0P0RB DRUGINKE GYOWORZEZSLHIN-NATPVWCTSA-N D0P0RB DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N(C)CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D0P0RB HIGHSTAT Investigative D0P0RD DRUG__ID D0P0RD D0P0RD DRUGTYPE Small molecular drug D0P0RD DRUGINCH 1S/C17H13Cl2NO2/c1-21-16-7-11-5-12(9-20-15(11)8-17(16)22-2)10-3-4-13(18)14(19)6-10/h3-9H,1-2H3 D0P0RD DRUGINKE PSUROKVLDMNXCQ-UHFFFAOYSA-N D0P0RD DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC(=C(C=C3)Cl)Cl D0P0RD HIGHSTAT Investigative D0P0RY DRUG__ID D0P0RY D0P0RY DRUGTYPE Small molecular drug D0P0RY DRUGINCH 1S/C13H8N2S/c1-10-15-13(9-16-10)6-5-11-3-2-4-12(7-11)8-14/h2-4,7,9H,1H3 D0P0RY DRUGINKE GRUPMMBRLDBTDD-UHFFFAOYSA-N D0P0RY DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)C#N D0P0RY HIGHSTAT Investigative D0P0TI DRUG__ID D0P0TI D0P0TI DRUGTYPE Small molecular drug D0P0TI DRUGINCH 1S/C8H15O3PS/c1-7(2,3)8-4-9-12(13,10-5-8)11-6-8/h4-6H2,1-3H3 D0P0TI DRUGINKE VTBHBNXGFPTBJL-UHFFFAOYSA-N D0P0TI DRUGSMIL CC(C)(C)C12COP(=S)(OC1)OC2 D0P0TI HIGHSTAT Investigative D0P0US DRUG__ID D0P0US D0P0US DRUGTYPE Small molecular drug D0P0US DRUGINCH 1S/C13H13ClN4O2/c14-11-8-13(17-5-3-15-4-6-17)16-12-2-1-9(18(19)20)7-10(11)12/h1-2,7-8,15H,3-6H2 D0P0US DRUGINKE HADJVDJPSUSVPZ-UHFFFAOYSA-N D0P0US DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)Cl D0P0US HIGHSTAT Investigative D0P0UV DRUG__ID D0P0UV D0P0UV DRUGTYPE Small molecular drug D0P0UV DRUGINCH 1S/C9H8ClN3O/c1-6(10)9(14)13-8-3-2-7(4-11)12-5-8/h2-3,5-6H,1H3,(H,13,14) D0P0UV DRUGINKE VFOLQYOVUCHHET-UHFFFAOYSA-N D0P0UV DRUGSMIL CC(C(=O)NC1=CN=C(C=C1)C#N)Cl D0P0UV HIGHSTAT Investigative D0P0WG DRUG__ID D0P0WG D0P0WG DRUGTYPE Small molecular drug D0P0WG DRUGINCH 1S/C21H19N3/c1-2-24-20-13-16(23)9-11-18(20)17-10-8-15(22)12-19(17)21(24)14-6-4-3-5-7-14/h3-13,23H,2,22H2,1H3/p+1 D0P0WG DRUGINKE QTANTQQOYSUMLC-UHFFFAOYSA-O D0P0WG DRUGSMIL CC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N D0P0WG HIGHSTAT Investigative D0P0WT DRUG__ID D0P0WT D0P0WT DRUGTYPE Small molecular drug D0P0WT DRUGINCH 1S/C16H14N2O2/c1-19-13-8-15-14(16(9-13)20-2)7-12(10-18-15)11-3-5-17-6-4-11/h3-10H,1-2H3 D0P0WT DRUGINKE HBXDLZBPKJEWHZ-UHFFFAOYSA-N D0P0WT DRUGSMIL COC1=CC2=C(C=C(C=N2)C3=CC=NC=C3)C(=C1)OC D0P0WT HIGHSTAT Investigative D0P0XA DRUG__ID D0P0XA D0P0XA DRUGTYPE Small molecular drug D0P0XA DRUGINCH 1S/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13+,17+,20+/m1/s1 D0P0XA DRUGINKE HSIBGVUMFOSJPD-CFDPKNGZSA-N D0P0XA DRUGSMIL CCC1CC2CC3C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC D0P0XA HIGHSTAT Investigative D0P0XF DRUG__ID D0P0XF D0P0XF DRUGTYPE Small molecular drug D0P0XF DRUGINCH 1S/C20H30N4O11/c1-9(2)17(20(35)22-11(8-25)6-15(29)30)24-18(33)12(4-5-14(27)28)23-19(34)13(7-16(31)32)21-10(3)26/h8-9,11-13,17H,4-7H2,1-3H3,(H,21,26)(H,22,35)(H,23,34)(H,24,33)(H,27,28)(H,29,30)(H,31,32) D0P0XF DRUGINKE UMBVAPCONCILTL-UHFFFAOYSA-N D0P0XF DRUGSMIL CC(C)C(C(=O)NC(CC(=O)O)C=O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0P0XF HIGHSTAT Investigative D0P0XO DRUG__ID D0P0XO D0P0XO DRUGTYPE Small molecular drug D0P0XO DRUGINCH 1S/C9H8N2OS/c1-11-8(12)6-4-2-3-5-7(6)10-9(11)13/h2-5H,1H3,(H,10,13) D0P0XO DRUGINKE NVINMHFLRZHVKS-UHFFFAOYSA-N D0P0XO DRUGSMIL CN1C(=O)C2=CC=CC=C2NC1=S D0P0XO HIGHSTAT Investigative D0P0ZB DRUG__ID D0P0ZB D0P0ZB DRUGTYPE Small molecular drug D0P0ZB DRUGINCH 1S/C4H4ClF3/c5-3(6)1-2-4(3,7)8/h1-2H2 D0P0ZB DRUGINKE ZZQYDYODFHABLC-UHFFFAOYSA-N D0P0ZB DRUGSMIL C1CC(C1(F)F)(F)Cl D0P0ZB HIGHSTAT Investigative D0P0ZQ DRUG__ID D0P0ZQ D0P0ZQ DRUGTYPE Small molecular drug D0P0ZQ DRUGINCH 1S/C11H10F3NS/c1-7(2)16-9-4-3-8(6-15)10(5-9)11(12,13)14/h3-5,7H,1-2H3 D0P0ZQ DRUGINKE QPFAGTVKCMQHRW-UHFFFAOYSA-N D0P0ZQ DRUGSMIL CC(C)SC1=CC(=C(C=C1)C#N)C(F)(F)F D0P0ZQ HIGHSTAT Investigative D0P1BK DRUG__ID D0P1BK D0P1BK DRUGTYPE Small molecular drug D0P1BK DRUGINCH 1S/C18H36N2O/c1-19(2)14-16-12-10-8-6-5-7-9-11-13-17(18(16)21)15-20(3)4/h16-17H,5-15H2,1-4H3 D0P1BK DRUGINKE HRQRILLGGNNYSD-UHFFFAOYSA-N D0P1BK DRUGSMIL CN(C)CC1CCCCCCCCCC(C1=O)CN(C)C D0P1BK HIGHSTAT Investigative D0P1CO DRUG__ID D0P1CO D0P1CO DRUGTYPE Small molecular drug D0P1CO DRUGINCH 1S/C8H8Cl2N2S.ClH/c9-6-2-1-5(3-7(6)10)4-13-8(11)12;/h1-3H,4H2,(H3,11,12);1H D0P1CO DRUGINKE VBJNMXMOMSWRDV-UHFFFAOYSA-N D0P1CO DRUGSMIL C1=CC(=C(C=C1CSC(=N)N)Cl)Cl.Cl D0P1CO HIGHSTAT Investigative D0P1CP DRUG__ID D0P1CP D0P1CP DRUGTYPE Small molecular drug D0P1CP DRUGINCH 1S/C40H51N5O5/c1-24-18-31(46)19-25(2)32(24)22-33(41)40(50)45-23-30-17-11-10-16-29(30)21-35(45)38(48)44-36(26(3)28-14-8-5-9-15-28)39(49)43-34(37(42)47)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,46H,5,8-9,14-15,20-23,41H2,1-3H3,(H2,42,47)(H,43,49)(H,44,48)/t26-,33-,34-,35?,36-/m0/s1 D0P1CP DRUGINKE KIHHZGQBWZPIMS-VERNRBRGSA-N D0P1CP DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)N)N)C)O D0P1CP HIGHSTAT Investigative D0P1FJ DRUG__ID D0P1FJ D0P1FJ DRUGTYPE Small molecular drug D0P1FJ DRUGINCH 1S/C21H27NO2/c1-4-22(5-2)16-17-24-20(23)21(3,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15H,4-5,16-17H2,1-3H3 D0P1FJ DRUGINKE DIDYGLSKVUKRRP-UHFFFAOYSA-N D0P1FJ DRUGSMIL CCN(CC)CCOC(=O)C(C)(C1=CC=CC=C1)C2=CC=CC=C2 D0P1FJ HIGHSTAT Investigative D0P1HA DRUG__ID D0P1HA D0P1HA DRUGTYPE Small molecular drug D0P1HA DRUGINCH 1S/C38H42N2O6/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)18-24-9-12-31(41-3)33(19-24)45-27-10-7-23(8-11-27)17-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30+/m1/s1 D0P1HA DRUGINKE FBCXFKWMGIWMJQ-IHLOFXLRSA-N D0P1HA DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=CC(=C(C=C7CCN6C)OC)O3)OC)OC)OC D0P1HA HIGHSTAT Investigative D0P1HC DRUG__ID D0P1HC D0P1HC DRUGTYPE Small molecular drug D0P1HC DRUGINCH 1S/C28H36N6O5/c1-17(35)32-25(15-19-16-31-22-7-3-2-6-21(19)22)28(39)33-23(8-4-5-13-29)27(38)34-24(26(30)37)14-18-9-11-20(36)12-10-18/h2-3,6-7,9-12,16,23-25,31,36H,4-5,8,13-15,29H2,1H3,(H2,30,37)(H,32,35)(H,33,39)(H,34,38)/t23-,24-,25-/m0/s1 D0P1HC DRUGINKE NIAKXWGYSYBRJH-SDHOMARFSA-N D0P1HC DRUGSMIL CC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N D0P1HC HIGHSTAT Investigative D0P1HZ DRUG__ID D0P1HZ D0P1HZ DRUGTYPE Small molecular drug D0P1HZ DRUGINCH 1S/C31H39N5O6/c37-27(35-42)17-9-3-8-15-23-28(38)33-24(19-21-11-4-1-5-12-21)29(39)34-25(20-22-13-6-2-7-14-22)31(41)36-18-10-16-26(36)30(40)32-23/h1-2,4-7,11-14,23-26,42H,3,8-10,15-20H2,(H,32,40)(H,33,38)(H,34,39)(H,35,37)/t23-,24-,25-,26+/m0/s1 D0P1HZ DRUGINKE FQWUNUXAOHTLLG-ASDGIDEWSA-N D0P1HZ DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4=CC=CC=C4)CCCCCC(=O)NO D0P1HZ HIGHSTAT Investigative D0P1IK DRUG__ID D0P1IK D0P1IK DRUGTYPE Small molecular drug D0P1IK DRUGINCH 1S/C14H4F6O2/c15-7-3-1-5(9(17)11(7)19)13(21)14(22)6-2-4-8(16)12(20)10(6)18/h1-4H D0P1IK DRUGINKE PWUSEBWVFQBDEQ-UHFFFAOYSA-N D0P1IK DRUGSMIL C1=CC(=C(C(=C1C(=O)C(=O)C2=C(C(=C(C=C2)F)F)F)F)F)F D0P1IK HIGHSTAT Investigative D0P1JJ DRUG__ID D0P1JJ D0P1JJ DRUGTYPE Small molecular drug D0P1JJ DRUGINCH 1S/C21H24N6O4/c1-2-14-16(28)17(29)20(31-14)27-10-24-15-18(22)25-21(26-19(15)27)30-8-7-11-9-23-13-6-4-3-5-12(11)13/h3-6,9-10,14,16-17,20,23,28-29H,2,7-8H2,1H3,(H2,22,25,26)/t14-,16-,17-,20-/m1/s1 D0P1JJ DRUGINKE USRXNKLXHDLOMQ-WVSUBDOOSA-N D0P1JJ DRUGSMIL CCC1C(C(C(O1)N2C=NC3=C(N=C(N=C32)OCCC4=CNC5=CC=CC=C54)N)O)O D0P1JJ HIGHSTAT Investigative D0P1JQ DRUG__ID D0P1JQ D0P1JQ DRUGTYPE Small molecular drug D0P1JQ DRUGINCH 1S/C18H26ClN3O2/c1-12(2)9-15(20)18(24)22-8-4-7-16(22)17(23)21-11-13-5-3-6-14(19)10-13/h3,5-6,10,12,15-16H,4,7-9,11,20H2,1-2H3,(H,21,23)/t15-,16+/m1/s1 D0P1JQ DRUGINKE FHVBVJXZKNCSLP-CVEARBPZSA-N D0P1JQ DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)NCC2=CC(=CC=C2)Cl)N D0P1JQ HIGHSTAT Investigative D0P1LP DRUG__ID D0P1LP D0P1LP DRUGTYPE Small molecular drug D0P1LP DRUGINCH 1S/C9H10N2O/c12-9-6-7-11(10-9)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,10,12) D0P1LP DRUGINKE CMCWWLVWPDLCRM-UHFFFAOYSA-N D0P1LP DRUGSMIL C1CN(NC1=O)C2=CC=CC=C2 D0P1LP HIGHSTAT Investigative D0P1MT DRUG__ID D0P1MT D0P1MT DRUGTYPE Small molecular drug D0P1MT DRUGINCH 1S/C40H53N5O6S/c1-25-19-29(44(7)18-17-43(5)6)20-26(2)36(25)51-23-33(47)41-31(21-27-13-9-8-10-14-27)35(48)39(50)45-24-52-40(3,4)37(45)38(49)42-34-30-16-12-11-15-28(30)22-32(34)46/h8-16,19-20,31-32,34-35,37,46,48H,17-18,21-24H2,1-7H3,(H,41,47)(H,42,49)/t31-,32+,34-,35-,37+/m0/s1 D0P1MT DRUGINKE IZETWNQXMIHLNU-IVJJLKHCSA-N D0P1MT DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)N(C)CCN(C)C D0P1MT HIGHSTAT Investigative D0P1RQ DRUG__ID D0P1RQ D0P1RQ DRUGTYPE Small molecular drug D0P1RQ DRUGINCH 1S/C23H22N2O2/c24-20-6-2-3-7-21(20)25-23(26)18-11-9-16(10-12-18)13-17-14-19-5-1-4-8-22(19)27-15-17/h1-12,17H,13-15,24H2,(H,25,26) D0P1RQ DRUGINKE COJSUOYKFQWDMR-UHFFFAOYSA-N D0P1RQ DRUGSMIL C1C(COC2=CC=CC=C21)CC3=CC=C(C=C3)C(=O)NC4=CC=CC=C4N D0P1RQ HIGHSTAT Investigative D0P1TY DRUG__ID D0P1TY D0P1TY DRUGTYPE Small molecular drug D0P1TY DRUGINCH 1S/C17H38NO3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-16-14-17-22(19,20)21/h18H,2-17H2,1H3,(H2,19,20,21) D0P1TY DRUGINKE ROTPOJPBVJTWLI-UHFFFAOYSA-N D0P1TY DRUGSMIL CCCCCCCCCCCCCCNCCCP(=O)(O)O D0P1TY HIGHSTAT Investigative D0P1UC DRUG__ID D0P1UC D0P1UC DRUGTYPE Small molecular drug D0P1UC DRUGINCH 1S/C13H12N2O/c1-2-4-10(5-3-1)11-6-7-12(16-11)13-14-8-9-15-13/h1-7H,8-9H2,(H,14,15) D0P1UC DRUGINKE HNPLGLAMYJQFOS-UHFFFAOYSA-N D0P1UC DRUGSMIL C1CN=C(N1)C2=CC=C(O2)C3=CC=CC=C3 D0P1UC HIGHSTAT Investigative D0P1UO DRUG__ID D0P1UO D0P1UO DRUGTYPE Small molecular drug D0P1UO DRUGINCH 1S/C17H12FN3/c18-16-7-5-15(6-8-16)17-10-20-12-21(17)11-14-3-1-13(9-19)2-4-14/h1-8,10,12H,11H2 D0P1UO DRUGINKE KZBKCANQPHILBI-UHFFFAOYSA-N D0P1UO DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2C3=CC=C(C=C3)F)C#N D0P1UO HIGHSTAT Investigative D0P1US DRUG__ID D0P1US D0P1US DRUGTYPE Small molecular drug D0P1US DRUGINCH 1S/C21H23IN2O5/c1-3-27-19(20(25)26)13-14-8-9-17(15(22)12-14)28-11-10-24(2)21-23-16-6-4-5-7-18(16)29-21/h4-9,12,19H,3,10-11,13H2,1-2H3,(H,25,26)/t19-/m0/s1/i22-2 D0P1US DRUGINKE VMBRNDMISRCGGM-DYZOOXQFSA-N D0P1US DRUGSMIL CCOC(CC1=CC(=C(C=C1)OCCN(C)C2=NC3=CC=CC=C3O2)I)C(=O)O D0P1US HIGHSTAT Investigative D0P1UW DRUG__ID D0P1UW D0P1UW DRUGTYPE Small molecular drug D0P1UW DRUGINCH 1S/C17H24N3O6P/c1-3-10(2)15(20-27(24,25)26)16(21)19-14(17(22)23)8-11-9-18-13-7-5-4-6-12(11)13/h4-7,9-10,14-15,18H,3,8H2,1-2H3,(H,19,21)(H,22,23)(H3,20,24,25,26)/p-3/t10-,14+,15+/m1/s1 D0P1UW DRUGINKE OTHKGUJBHLOAHC-ONERCXAPSA-K D0P1UW DRUGSMIL CCC(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-])[O-] D0P1UW HIGHSTAT Investigative D0P1XH DRUG__ID D0P1XH D0P1XH DRUGTYPE Small molecular drug D0P1XH DRUGINCH 1S/C10H14N2O7/c13-3-4-6(15)7(16)8(17)9(19-4)12-2-1-5(14)11-10(12)18/h1-2,4,6-9,13,15-17H,3H2,(H,11,14,18)/t4-,6-,7+,8-,9-/m1/s1 D0P1XH DRUGINKE PBGBADORVLQASN-DDIGBBAMSA-N D0P1XH DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(C(O2)CO)O)O)O D0P1XH HIGHSTAT Investigative D0P1XM DRUG__ID D0P1XM D0P1XM DRUGTYPE Small molecular drug D0P1XM DRUGINCH 1S/C22H22F6N2O2/c23-21(24,25)16-9-14(10-17(11-16)22(26,27)28)13-32-18-7-4-8-30(12-19(29)31)20(18)15-5-2-1-3-6-15/h1-3,5-6,9-11,18,20H,4,7-8,12-13H2,(H2,29,31)/t18-,20-/m0/s1 D0P1XM DRUGINKE SUZSWSSXVHSRLT-ICSRJNTNSA-N D0P1XM DRUGSMIL C1CC(C(N(C1)CC(=O)N)C2=CC=CC=C2)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D0P1XM HIGHSTAT Investigative D0P1YC DRUG__ID D0P1YC D0P1YC DRUGTYPE Small molecular drug D0P1YC DRUGINCH 1S/C17H16O2/c1-11-3-6-13(7-4-11)16-10-15(18)14-8-5-12(2)9-17(14)19-16/h3-9,16H,10H2,1-2H3/t16-/m1/s1 D0P1YC DRUGINKE MIEPNGHJBCGJAW-MRXNPFEDSA-N D0P1YC DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)C D0P1YC HIGHSTAT Investigative D0P1YK DRUG__ID D0P1YK D0P1YK DRUGTYPE Small molecular drug D0P1YK DRUGINCH 1S/C20H15N3O3/c24-23(25)15-8-11-18-19(13-15)22-20(21-18)12-14-6-9-17(10-7-14)26-16-4-2-1-3-5-16/h1-11,13H,12H2,(H,21,22) D0P1YK DRUGINKE VRLHOPLBQZRORF-UHFFFAOYSA-N D0P1YK DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=C(N3)C=C(C=C4)[N+](=O)[O-] D0P1YK HIGHSTAT Investigative D0P1ZM DRUG__ID D0P1ZM D0P1ZM DRUGTYPE Small molecular drug D0P1ZM DRUGINCH 1S/C14H10N2O3S/c17-13-8-9-14(16-15-13)20(18,19)12-7-3-5-10-4-1-2-6-11(10)12/h1-9H,(H,15,17) D0P1ZM DRUGINKE HJXKXDILPXEWJY-UHFFFAOYSA-N D0P1ZM DRUGSMIL C1=CC=C2C(=C1)C=CC=C2S(=O)(=O)C3=NNC(=O)C=C3 D0P1ZM HIGHSTAT Investigative D0P2AC DRUG__ID D0P2AC D0P2AC DRUGCOMP Chugai Pharmaceutical Co Ltd D0P2AC DRUGINCH 1S/C20H15F3N2O4/c21-20(22,23)16-4-2-1-3-14(16)17-7-11-5-6-12(8-15(11)18(27)24-17)25-9-13(10-26)29-19(25)28/h1-8,13,26H,9-10H2,(H,24,27)/t13-/m0/s1 D0P2AC DRUGINKE FBZDYLQFPLNXOA-ZDUSSCGKSA-N D0P2AC DRUGSMIL C1C(OC(=O)N1C2=CC3=C(C=C2)C=C(NC3=O)C4=CC=CC=C4C(F)(F)F)CO D0P2AC HIGHSTAT Investigative D0P2AZ DRUG__ID D0P2AZ D0P2AZ DRUGTYPE Small molecular drug D0P2AZ DRUGINCH 1S/C20H31NO2/c1-2-3-4-5-6-7-8-9-17-10-12-18(13-11-17)14-21-15-19(16-21)20(22)23/h10-13,19H,2-9,14-16H2,1H3,(H,22,23) D0P2AZ DRUGINKE OVHZTRSKNATTNM-UHFFFAOYSA-N D0P2AZ DRUGSMIL CCCCCCCCCC1=CC=C(C=C1)CN2CC(C2)C(=O)O D0P2AZ HIGHSTAT Investigative D0P2BY DRUG__ID D0P2BY D0P2BY DRUGTYPE Small molecular drug D0P2BY DRUGINCH 1S/C9H12N2O6P2/c12-18(13,14)9(19(15,16)17)5-11-6-10-7-3-1-2-4-8(7)11/h1-4,6,9H,5H2,(H2,12,13,14)(H2,15,16,17) D0P2BY DRUGINKE ISSICOMKRRPVPD-UHFFFAOYSA-N D0P2BY DRUGSMIL C1=CC=C2C(=C1)N=CN2CC(P(=O)(O)O)P(=O)(O)O D0P2BY HIGHSTAT Investigative D0P2DB DRUG__ID D0P2DB D0P2DB DRUGTYPE Small molecular drug D0P2DB DRUGINCH 1S/C17H11N3/c1-3-7-12-10(5-1)15-14(19-12)9-18-16-11-6-2-4-8-13(11)20-17(15)16/h1-9,19-20H D0P2DB DRUGINKE UFTKNTUWDMJOIX-UHFFFAOYSA-N D0P2DB DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=NC=C3N2)C5=CC=CC=C5N4 D0P2DB HIGHSTAT Investigative D0P2DF DRUG__ID D0P2DF D0P2DF DRUGTYPE Small molecular drug D0P2DF DRUGINCH 1S/C30H40N6O7/c1-18(2)13-23(28(31)41)36-30(43)25(14-20-7-5-4-6-8-20)35-27(40)17-32-26(39)16-33-29(42)24(34-19(3)37)15-21-9-11-22(38)12-10-21/h4-12,18,23-25,38H,13-17H2,1-3H3,(H2,31,41)(H,32,39)(H,33,42)(H,34,37)(H,35,40)(H,36,43)/t23-,24-,25-/m0/s1 D0P2DF DRUGINKE GFXHMPKMESGSMX-SDHOMARFSA-N D0P2DF DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C D0P2DF HIGHSTAT Investigative D0P2DU DRUG__ID D0P2DU D0P2DU DRUGTYPE Small molecular drug D0P2DU DRUGINCH 1S/C20H25N/c1-17(2)21-15-13-20(14-16-21,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17H,13-16H2,1-2H3 D0P2DU DRUGINKE CFOOTBBXHJHHMT-UHFFFAOYSA-N D0P2DU DRUGSMIL CC(C)N1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3 D0P2DU HIGHSTAT Investigative D0P2DV DRUG__ID D0P2DV D0P2DV DRUGTYPE Small molecular drug D0P2DV DRUGINCH 1S/C12H8FNS/c1-9-14-12(8-15-9)7-4-10-2-5-11(13)6-3-10/h2-3,5-6,8H,1H3 D0P2DV DRUGINKE UUKQDEMVLZEXPO-UHFFFAOYSA-N D0P2DV DRUGSMIL CC1=NC(=CS1)C#CC2=CC=C(C=C2)F D0P2DV HIGHSTAT Investigative D0P2ET DRUG__ID D0P2ET D0P2ET DRUGTYPE Small molecular drug D0P2ET DRUGINCH 1S/C20H20O5/c1-6-10-8(2)15(21)11-7-12-14(18(24)13(11)17(10)23)16(22)9(3)19(25)20(12,4)5/h7,22,24H,6H2,1-5H3 D0P2ET DRUGINKE XUTUGWZITVPISM-UHFFFAOYSA-N D0P2ET DRUGSMIL CCC1=C(C(=O)C2=CC3=C(C(=C(C(=O)C3(C)C)C)O)C(=C2C1=O)O)C D0P2ET HIGHSTAT Investigative D0P2GB DRUG__ID D0P2GB D0P2GB DRUGTYPE Small molecular drug D0P2GB DRUGINCH 1S/C19H25NO3/c1-12-17-9-13-3-4-14(21)10-16(13)19(12,2)7-8-20(17)11-15-5-6-18(22)23-15/h3-4,10,12,15,17,21H,5-9,11H2,1-2H3/t12-,15+,17+,19-/m0/s1 D0P2GB DRUGINKE HHASRPPPJAXSNL-IQRRUJBNSA-N D0P2GB DRUGSMIL CC1C2CC3=C(C1(CCN2CC4CCC(=O)O4)C)C=C(C=C3)O D0P2GB HIGHSTAT Investigative D0P2GE DRUG__ID D0P2GE D0P2GE DRUGTYPE Small molecular drug D0P2GE DRUGINCH 1S/C18H14N2O2/c1-21-17-10-14-15(9-8-13-6-4-3-5-7-13)19-12-20-16(14)11-18(17)22-2/h3-7,10-12H,1-2H3 D0P2GE DRUGINKE ASHKAXPHUUQQTC-UHFFFAOYSA-N D0P2GE DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)C#CC3=CC=CC=C3)OC D0P2GE HIGHSTAT Investigative D0P2HR DRUG__ID D0P2HR D0P2HR DRUGTYPE Small molecular drug D0P2HR DRUGINCH 1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23) D0P2HR DRUGINKE MFWNKCLOYSRHCJ-UHFFFAOYSA-N D0P2HR DRUGSMIL CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C D0P2HR HIGHSTAT Investigative D0P2HX DRUG__ID D0P2HX D0P2HX DRUGTYPE Small molecular drug D0P2HX DRUGINCH 1S/C19H13N5O4/c25-18-16-5-2-8-21-17(16)23(14-3-1-4-15(11-14)24(27)28)19(26)22(18)12-13-6-9-20-10-7-13/h1-11H,12H2 D0P2HX DRUGINKE YLHRMVRLIOIWTO-UHFFFAOYSA-N D0P2HX DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])N2C3=C(C=CC=N3)C(=O)N(C2=O)CC4=CC=NC=C4 D0P2HX HIGHSTAT Investigative D0P2IJ DRUG__ID D0P2IJ D0P2IJ DRUGTYPE Small molecular drug D0P2IJ DRUGINCH 1S/C18H19ClFN3O2/c19-16-11-15(20)1-2-17(16)22-7-9-23(10-8-22)18(24)13-25-12-14-3-5-21-6-4-14/h1-6,11H,7-10,12-13H2 D0P2IJ DRUGINKE XNOMHUDLVRWWLV-UHFFFAOYSA-N D0P2IJ DRUGSMIL C1CN(CCN1C2=C(C=C(C=C2)F)Cl)C(=O)COCC3=CC=NC=C3 D0P2IJ HIGHSTAT Investigative D0P2IN DRUG__ID D0P2IN D0P2IN DRUGTYPE Small molecular drug D0P2IN DRUGINCH 1S/C10H15N3O4/c1-5-4-13(10(16)12-9(5)15)8-2-6(14)7(3-11)17-8/h4,6-8,14H,2-3,11H2,1H3,(H,12,15,16)/t6-,7+,8-/m0/s1 D0P2IN DRUGINKE PYWLBQPICCQJFF-RNJXMRFFSA-N D0P2IN DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)CN)O D0P2IN HIGHSTAT Investigative D0P2KV DRUG__ID D0P2KV D0P2KV DRUGTYPE Small molecular drug D0P2KV DRUGINCH 1S/C32H36N4O6/c1-19-13-24(37)14-20(2)25(19)16-26(33)31(41)36-18-22-10-8-7-9-21(22)15-28(36)30(40)34-27(17-29(38)39)32(42)35(3)23-11-5-4-6-12-23/h4-14,26-28,37H,15-18,33H2,1-3H3,(H,34,40)(H,38,39)/t26-,27-,28-/m0/s1 D0P2KV DRUGINKE HEKBLCZSNQVJKZ-KCHLEUMXSA-N D0P2KV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)N(C)C4=CC=CC=C4)N)C)O D0P2KV HIGHSTAT Investigative D0P2LE DRUG__ID D0P2LE D0P2LE DRUGTYPE Small molecular drug D0P2LE DRUGINCH 1S/C18H17N3O/c1-13-11-17(15-9-5-6-10-16(15)20-13)19-12-18(22)21-14-7-3-2-4-8-14/h2-11H,12H2,1H3,(H,19,20)(H,21,22) D0P2LE DRUGINKE HRXVDSHQRNNGBO-UHFFFAOYSA-N D0P2LE DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)NCC(=O)NC3=CC=CC=C3 D0P2LE HIGHSTAT Investigative D0P2NN DRUG__ID D0P2NN D0P2NN DRUGTYPE Small molecular drug D0P2NN DRUGINCH 1S/C12H21N.ClH/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12;/h8-11H,2-7,13H2,1H3;1H D0P2NN DRUGINKE OZBDFBJXRJWNAV-UHFFFAOYSA-N D0P2NN DRUGSMIL CC(C12CC3CC(C1)CC(C3)C2)N.Cl D0P2NN HIGHSTAT Investigative D0P2OA DRUG__ID D0P2OA D0P2OA DRUGTYPE Small molecular drug D0P2OA DRUGINCH 1S/C10H12N2O4/c1-16-8-4-2-7(3-5-8)10(14)11-6-9(13)12-15/h2-5,15H,6H2,1H3,(H,11,14)(H,12,13) D0P2OA DRUGINKE ZJTICILORBZVBV-UHFFFAOYSA-N D0P2OA DRUGSMIL COC1=CC=C(C=C1)C(=O)NCC(=O)NO D0P2OA HIGHSTAT Investigative D0P2OZ DRUG__ID D0P2OZ D0P2OZ DRUGTYPE Small molecular drug D0P2OZ DRUGINCH 1S/C16H18N3S.ClH.Zn/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;;/h5-10H,1-4H3;1H;/q+1;;+2/p-1 D0P2OZ DRUGINKE LXXWTKZXINWUFR-UHFFFAOYSA-M D0P2OZ DRUGSMIL CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-].[Zn+2] D0P2OZ HIGHSTAT Investigative D0P2QG DRUG__ID D0P2QG D0P2QG DRUGTYPE Small molecular drug D0P2QG DRUGINCH 1S/C20H20IN3O3/c1-3-23(4-2)16-8-5-13(18(25)12-16)11-17-19(26)22-24(20(17)27)15-9-6-14(21)7-10-15/h5-12,25H,3-4H2,1-2H3,(H,22,26)/b17-11- D0P2QG DRUGINKE QOVNZWROVBIKQY-BOPFTXTBSA-N D0P2QG DRUGSMIL CCN(CC)C1=CC(=C(C=C1)C=C2C(=O)NN(C2=O)C3=CC=C(C=C3)I)O D0P2QG HIGHSTAT Investigative D0P2QV DRUG__ID D0P2QV D0P2QV DRUGTYPE Small molecular drug D0P2QV DRUGINCH 1S/C33H37N5O5/c34-27(17-23-11-13-26(39)14-12-23)31(42)38-16-6-15-33(38)19-24-9-4-5-10-25(24)20-37(32(33)43)21-29(40)36-28(30(35)41)18-22-7-2-1-3-8-22/h1-5,7-14,27-28,39H,6,15-21,34H2,(H2,35,41)(H,36,40)/t27-,28-,33+/m0/s1 D0P2QV DRUGINKE XXSVWIUHNDWFND-NTBNWUQQSA-N D0P2QV DRUGSMIL C1CC2(CC3=CC=CC=C3CN(C2=O)CC(=O)NC(CC4=CC=CC=C4)C(=O)N)N(C1)C(=O)C(CC5=CC=C(C=C5)O)N D0P2QV HIGHSTAT Investigative D0P2TS DRUG__ID D0P2TS D0P2TS DRUGTYPE Small molecular drug D0P2TS DRUGINCH 1S/C15H24N4O4/c16-13(21)14-17-15(23-19-14)11(9-12(20)18-22)8-4-7-10-5-2-1-3-6-10/h10-11,22H,1-9H2,(H2,16,21)(H,18,20)/t11-/m1/s1 D0P2TS DRUGINKE ARJCBSRIPGJMAD-LLVKDONJSA-N D0P2TS DRUGSMIL C1CCC(CC1)CCCC(CC(=O)NO)C2=NC(=NO2)C(=O)N D0P2TS HIGHSTAT Investigative D0P2TT DRUG__ID D0P2TT D0P2TT DRUGTYPE Small molecular drug D0P2TT DRUGINCH 1S/C31H40N6O7S2/c1-30(2)23(36-26(40)20(32)14-18-10-12-19(13-11-18)25(33)39)28(42)34-16-22(38)35-21(15-17-8-6-5-7-9-17)27(41)37-24(29(43)44)31(3,4)46-45-30/h5-13,20-21,23-24H,14-16,32H2,1-4H3,(H2,33,39)(H,34,42)(H,35,38)(H,36,40)(H,37,41)(H,43,44)/t20-,21-,23-,24-/m0/s1 D0P2TT DRUGINKE KFLVOLBPEGAIIK-WMIMKTLMSA-N D0P2TT DRUGSMIL CC1(C(C(=O)NCC(=O)NC(C(=O)NC(C(SS1)(C)C)C(=O)O)CC2=CC=CC=C2)NC(=O)C(CC3=CC=C(C=C3)C(=O)N)N)C D0P2TT HIGHSTAT Investigative D0P2UM DRUG__ID D0P2UM D0P2UM DRUGTYPE Small molecular drug D0P2UM DRUGINCH 1S/C12H11NO4/c1-2-17-12(16)10-6-8-5-7(11(14)15)3-4-9(8)13-10/h3-6,13H,2H2,1H3,(H,14,15) D0P2UM DRUGINKE CAVYPAYXEMVXMS-UHFFFAOYSA-N D0P2UM DRUGSMIL CCOC(=O)C1=CC2=C(N1)C=CC(=C2)C(=O)O D0P2UM HIGHSTAT Investigative D0P2VL DRUG__ID D0P2VL D0P2VL DRUGTYPE Small molecular drug D0P2VL DRUGINCH 1S/C29H27N2O7/c1-34-26-9-4-19-14-25-23-16-28-27(37-18-38-28)15-20(23)10-11-30(25)17-24(19)29(26)36-13-3-2-12-35-22-7-5-21(6-8-22)31(32)33/h4-9,14-17H,2-3,10-13,18H2,1H3/q+1 D0P2VL DRUGINKE APBFBLUUWLQIQX-UHFFFAOYSA-N D0P2VL DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=CC=C(C=C6)[N+](=O)[O-] D0P2VL HIGHSTAT Investigative D0P2VP DRUG__ID D0P2VP D0P2VP DRUGTYPE Small molecular drug D0P2VP DRUGINCH 1S/C5H10NO5P/c6-4(5(7)8)2-1-3(2)12(9,10)11/h2-4H,1,6H2,(H,7,8)(H2,9,10,11)/t2-,3-,4?/m0/s1 D0P2VP DRUGINKE KZOMBNQLBSHMFV-LPGMDIISSA-N D0P2VP DRUGSMIL C1C(C1P(=O)(O)O)C(C(=O)O)N D0P2VP HIGHSTAT Investigative D0P2WA DRUG__ID D0P2WA D0P2WA DRUGTYPE Small molecular drug D0P2WA DRUGINCH 1S/C20H28N6O3/c1-14(2)26-13-22-17-18(21-12-15-4-6-16(29-3)7-5-15)23-20(24-19(17)26)25(8-10-27)9-11-28/h4-7,13-14,27-28H,8-12H2,1-3H3,(H,21,23,24) D0P2WA DRUGINKE NQVIIUBWMBHLOZ-UHFFFAOYSA-N D0P2WA DRUGSMIL CC(C)N1C=NC2=C(N=C(N=C21)N(CCO)CCO)NCC3=CC=C(C=C3)OC D0P2WA HIGHSTAT Investigative D0P2YV DRUG__ID D0P2YV D0P2YV DRUGTYPE Small molecular drug D0P2YV DRUGINCH 1S/C19H23NO2/c1-20-10-9-15-11-18(21-2)19(22-3)12-16(15)17(13-20)14-7-5-4-6-8-14/h4-8,11-12,17H,9-10,13H2,1-3H3 D0P2YV DRUGINKE ICPHJSKVAZMKIV-UHFFFAOYSA-N D0P2YV DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)OC)OC D0P2YV HIGHSTAT Investigative D0P3AU DRUG__ID D0P3AU D0P3AU DRUGTYPE Small molecular drug D0P3AU DRUGINCH 1S/C11H10N2O4S/c1-17-8-2-4-9(5-3-8)18(15,16)11-7-6-10(14)12-13-11/h2-7H,1H3,(H,12,14) D0P3AU DRUGINKE KLWAIVHFGCYFDO-UHFFFAOYSA-N D0P3AU DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)C2=NNC(=O)C=C2 D0P3AU HIGHSTAT Investigative D0P3BL DRUG__ID D0P3BL D0P3BL DRUGTYPE Small molecular drug D0P3BL DRUGINCH 1S/C14H23F3N4O4/c1-4-20(7(2)3)13(25)21-6-8(11(22)23)10(18)9(21)5-19-12(24)14(15,16)17/h7-10H,4-6,18H2,1-3H3,(H,19,24)(H,22,23)/t8-,9+,10-/m1/s1 D0P3BL DRUGINKE KRSIVMHLZOHCGR-KXUCPTDWSA-N D0P3BL DRUGSMIL CCN(C(C)C)C(=O)N1CC(C(C1CNC(=O)C(F)(F)F)N)C(=O)O D0P3BL HIGHSTAT Investigative D0P3BU DRUG__ID D0P3BU D0P3BU DRUGTYPE Small molecular drug D0P3BU DRUGINCH 1S/C17H16N2O/c1-2-3-4-7-10-20-17-11-14-13-8-5-6-9-15(13)19-16(14)12-18-17/h3-12,19H,2H2,1H3/b4-3+,10-7+ D0P3BU DRUGINKE PUUXLLSHSWLAML-YZQQHVNFSA-N D0P3BU DRUGSMIL CCC=CC=COC1=NC=C2C(=C1)C3=CC=CC=C3N2 D0P3BU HIGHSTAT Investigative D0P3CX DRUG__ID D0P3CX D0P3CX DRUGTYPE Small molecular drug D0P3CX DRUGINCH 1S/C16H12O2/c1-11-7-8-15-13(9-11)14(17)10-16(18-15)12-5-3-2-4-6-12/h2-10H,1H3 D0P3CX DRUGINKE NOQJBXPAMJLUSS-UHFFFAOYSA-N D0P3CX DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3 D0P3CX HIGHSTAT Investigative D0P3DV DRUG__ID D0P3DV D0P3DV DRUGTYPE Small molecular drug D0P3DV DRUGINCH 1S/C15H18N2O/c18-15(14-10-6-12-16-14)17-11-5-4-9-13-7-2-1-3-8-13/h1-3,6-8,10,12,16H,4-5,9,11H2,(H,17,18) D0P3DV DRUGINKE KBYBNLUYYDZWAT-UHFFFAOYSA-N D0P3DV DRUGSMIL C1=CC=C(C=C1)CCCCNC(=O)C2=CC=CN2 D0P3DV HIGHSTAT Investigative D0P3FP DRUG__ID D0P3FP D0P3FP DRUGTYPE Small molecular drug D0P3FP DRUGINCH 1S/C22H29NO/c1-2-3-14-21(19-10-6-4-7-11-19)23-17-15-22(24,16-18-23)20-12-8-5-9-13-20/h4-13,21,24H,2-3,14-18H2,1H3 D0P3FP DRUGINKE WQECIXIOLXNRTH-UHFFFAOYSA-N D0P3FP DRUGSMIL CCCCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D0P3FP HIGHSTAT Investigative D0P3FZ DRUG__ID D0P3FZ D0P3FZ DRUGTYPE Small molecular drug D0P3FZ DRUGINCH 1S/C8H12N2OS/c11-8-5-7(12-10-8)6-1-3-9-4-2-6/h5-6,9H,1-4H2,(H,10,11) D0P3FZ DRUGINKE WUINUICOEAZPLK-UHFFFAOYSA-N D0P3FZ DRUGSMIL C1CNCCC1C2=CC(=O)NS2 D0P3FZ HIGHSTAT Investigative D0P3HG DRUG__ID D0P3HG D0P3HG DRUGTYPE Small molecular drug D0P3HG DRUGINCH 1S/C23H37NO4/c1-23(2)16-13-18(23)17(11-5-3-4-6-12-20(25)26)19(14-16)24-22(28)21(27)15-9-7-8-10-15/h3,5,15-19,21,27H,4,6-14H2,1-2H3,(H,24,28)(H,25,26)/b5-3-/t16-,17+,18+,19+,21-/m1/s1 D0P3HG DRUGINKE SXHUZJPIRVLMHY-AZPSIHDESA-N D0P3HG DRUGSMIL CC1(C2CC1C(C(C2)NC(=O)C(C3CCCC3)O)CC=CCCCC(=O)O)C D0P3HG HIGHSTAT Investigative D0P3HP DRUG__ID D0P3HP D0P3HP DRUGTYPE Small molecular drug D0P3HP DRUGINCH 1S/C13H17N/c1-2-5-11-9-13-12(6-3-7-14-13)8-10(11)4-1/h1-2,4-5,12-14H,3,6-9H2 D0P3HP DRUGINKE PXDWMPVOPNRION-UHFFFAOYSA-N D0P3HP DRUGSMIL C1CC2CC3=CC=CC=C3CC2NC1 D0P3HP HIGHSTAT Investigative D0P3JW DRUG__ID D0P3JW D0P3JW DRUGTYPE Small molecular drug D0P3JW DRUGINCH 1S/C21H16Cl2N4O2/c1-27-19-13(9-15(20(27)29)18-16(22)6-3-7-17(18)23)10-24-21(26-19)25-14-5-2-4-12(8-14)11-28/h2-10,28H,11H2,1H3,(H,24,25,26) D0P3JW DRUGINKE ZIQFYVPVJZEOFS-UHFFFAOYSA-N D0P3JW DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC=CC(=C4)CO D0P3JW HIGHSTAT Investigative D0P3KI DRUG__ID D0P3KI D0P3KI DRUGTYPE Small molecular drug D0P3KI DRUGINCH 1S/C27H30N2O2/c1-31-26-14-7-4-11-23(26)27(30)15-19-28(20-16-27)17-8-18-29-24-12-5-2-9-21(24)22-10-3-6-13-25(22)29/h2-7,9-14,30H,8,15-20H2,1H3 D0P3KI DRUGINKE XZZYCJOGZYEPPW-UHFFFAOYSA-N D0P3KI DRUGSMIL COC1=CC=CC=C1C2(CCN(CC2)CCCN3C4=CC=CC=C4C5=CC=CC=C53)O D0P3KI HIGHSTAT Investigative D0P3MF DRUG__ID D0P3MF D0P3MF DRUGTYPE Small molecular drug D0P3MF DRUGINCH 1S/C12H19N3O7/c13-4-9(17)15-5-6(16)3-8(15)11(20)14-7(12(21)22)1-2-10(18)19/h6-8,16H,1-5,13H2,(H,14,20)(H,18,19)(H,21,22)/t6-,7+,8+/m1/s1 D0P3MF DRUGINKE MPZCPLJCORMPJI-CSMHCCOUSA-N D0P3MF DRUGSMIL C1C(CN(C1C(=O)NC(CCC(=O)O)C(=O)O)C(=O)CN)O D0P3MF HIGHSTAT Investigative D0P3ND DRUG__ID D0P3ND D0P3ND DRUGTYPE Small molecular drug D0P3ND DRUGINCH 1S/C14H11FN2/c15-14-4-3-12-2-1-11(7-13(12)8-14)9-17-6-5-16-10-17/h1-8,10H,9H2 D0P3ND DRUGINKE SFBANCVOUQRQEX-UHFFFAOYSA-N D0P3ND DRUGSMIL C1=CC(=CC2=C1C=CC(=C2)F)CN3C=CN=C3 D0P3ND HIGHSTAT Investigative D0P3OH DRUG__ID D0P3OH D0P3OH DRUGTYPE Small molecular drug D0P3OH DRUGINCH 1S/C16H9ClO4/c17-11-5-3-6-12(9-11)20-15(18)13-8-10-4-1-2-7-14(10)21-16(13)19/h1-9H D0P3OH DRUGINKE HDIMJBWUBWTFNJ-UHFFFAOYSA-N D0P3OH DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)O2)C(=O)OC3=CC(=CC=C3)Cl D0P3OH HIGHSTAT Investigative D0P3SU DRUG__ID D0P3SU D0P3SU DRUGTYPE Small molecular drug D0P3SU DRUGINCH 1S/C13H11NO3/c15-13(14-16)10-5-4-8-12(9-10)17-11-6-2-1-3-7-11/h1-9,16H,(H,14,15) D0P3SU DRUGINKE WFZFBIHVPMBSOS-UHFFFAOYSA-N D0P3SU DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)C(=O)NO D0P3SU HIGHSTAT Investigative D0P3VH DRUG__ID D0P3VH D0P3VH DRUGTYPE Small molecular drug D0P3VH DRUGINCH 1S/C21H17NOS/c23-21(15-14-16-8-2-1-3-9-16)22-17-10-4-6-12-19(17)24-20-13-7-5-11-18(20)22/h1-13H,14-15H2 D0P3VH DRUGINKE UFAZLVHMPFPAHH-UHFFFAOYSA-N D0P3VH DRUGSMIL C1=CC=C(C=C1)CCC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0P3VH HIGHSTAT Investigative D0P3WB DRUG__ID D0P3WB D0P3WB DRUGTYPE Small molecular drug D0P3WB DRUGINCH 1S/C21H21N3O/c22-20-12-11-18(15-24-20)21(25)23-14-13-19(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-12,15,19H,13-14H2,(H2,22,24)(H,23,25) D0P3WB DRUGINKE DZGHCDWBFODWBC-UHFFFAOYSA-N D0P3WB DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)C2=CN=C(C=C2)N)C3=CC=CC=C3 D0P3WB HIGHSTAT Investigative D0P3WF DRUG__ID D0P3WF D0P3WF DRUGTYPE Small molecular drug D0P3WF DRUGINCH 1S/C73H99N15O18/c1-41(90)61-71(103)85-55(36-45-28-30-47(92)31-29-45)69(101)88-62(42(2)91)72(104)86-58(40-89)70(102)80-52(73(105)106)26-10-5-11-27-60(94)78-50(24-14-16-32-74)63(95)84-57(38-59(76)93)68(100)82-53(34-43-18-6-3-7-19-43)65(97)81-54(35-44-20-8-4-9-21-44)66(98)83-56(37-46-39-77-49-23-13-12-22-48(46)49)67(99)79-51(64(96)87-61)25-15-17-33-75/h3-4,6-9,12-13,18-23,28-31,39,41-42,50-58,61-62,77,89-92H,5,10-11,14-17,24-27,32-38,40,74-75H2,1-2H3,(H2,76,93)(H,78,94)(H,79,99)(H,80,102)(H,81,97)(H,82,100)(H,83,98)(H,84,95)(H,85,103)(H,86,104)(H,87,96)(H,88,101)(H,105,106)/t41-,42-,50+,51+,52+,53+,54+,55+,56+,57?,58+,61?,62?/m1/s1 D0P3WF DRUGINKE HTEPNQQGQXAYEW-YQENAMKYSA-N D0P3WF DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCCCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)C(=O)O)CO)C(C)O)CC6=CC=C(C=C6)O)O D0P3WF HIGHSTAT Investigative D0P3XJ DRUG__ID D0P3XJ D0P3XJ DRUGTYPE Small molecular drug D0P3XJ DRUGINCH 1S/C29H36N4O9/c1-17(2)25(28(40)30-18(3)26(38)31-21(15-34)14-24(36)37)33-27(39)23(13-19-9-11-22(35)12-10-19)32-29(41)42-16-20-7-5-4-6-8-20/h4-12,15,17-18,21,23,25,35H,13-14,16H2,1-3H3,(H,30,40)(H,31,38)(H,32,41)(H,33,39)(H,36,37)/t18-,21-,23-,25-/m0/s1 D0P3XJ DRUGINKE NEIVVNHQVHXDKP-RCGJGYDGSA-N D0P3XJ DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C=O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)OCC2=CC=CC=C2 D0P3XJ HIGHSTAT Investigative D0P3XO DRUG__ID D0P3XO D0P3XO DRUGTYPE Small molecular drug D0P3XO DRUGINCH 1S/C9H9NO4/c10-7(9(13)14)5-1-3-6(4-2-5)8(11)12/h1-4,7H,10H2,(H,11,12)(H,13,14)/t7-/m0/s1 D0P3XO DRUGINKE VTMJKPGFERYGJF-ZETCQYMHSA-N D0P3XO DRUGSMIL C1=CC(=CC=C1C(C(=O)O)N)C(=O)O D0P3XO HIGHSTAT Investigative D0P3XW DRUG__ID D0P3XW D0P3XW DRUGTYPE Small molecular drug D0P3XW DRUGINCH 1S/C7H7ClS/c8-7-4-2-1-3-6(7)5-9/h1-4,9H,5H2 D0P3XW DRUGINKE WWFIIZLHSNBNTC-UHFFFAOYSA-N D0P3XW DRUGSMIL C1=CC=C(C(=C1)CS)Cl D0P3XW HIGHSTAT Investigative D0P3ZK DRUG__ID D0P3ZK D0P3ZK DRUGTYPE Small molecular drug D0P3ZK DRUGINCH 1S/C18H10F3NO3S2/c19-18(20,21)12-2-1-3-13(9-12)22-15(23)14(27-17(22)26)8-10-4-6-11(7-5-10)16(24)25/h1-9H,(H,24,25) D0P3ZK DRUGINKE JIMHYXZZCWVCMI-UHFFFAOYSA-N D0P3ZK DRUGSMIL C1=CC(=CC(=C1)N2C(=O)C(=CC3=CC=C(C=C3)C(=O)O)SC2=S)C(F)(F)F D0P3ZK HIGHSTAT Investigative D0P4BY DRUG__ID D0P4BY D0P4BY DRUGTYPE Small molecular drug D0P4BY DRUGINCH 1S/C16H16ClNO.BrH/c17-15-8-12-6-7-18-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11;/h1-5,8-9,14,18-19H,6-7,10H2;1H D0P4BY DRUGINKE XSWVQBLZJAURQF-UHFFFAOYSA-N D0P4BY DRUGSMIL C1CNCC(C2=CC(=C(C=C21)Cl)O)C3=CC=CC=C3.Br D0P4BY HIGHSTAT Investigative D0P4CQ DRUG__ID D0P4CQ D0P4CQ DRUGTYPE Small molecular drug D0P4CQ DRUGINCH 1S/C16H22N2O/c1-4-12(5-2)11(3)19-14-8-6-7-13-9-10-15(17)18-16(13)14/h6-12H,4-5H2,1-3H3,(H2,17,18) D0P4CQ DRUGINKE UMDWRYRCTHHCNV-UHFFFAOYSA-N D0P4CQ DRUGSMIL CCC(CC)C(C)OC1=CC=CC2=C1N=C(C=C2)N D0P4CQ HIGHSTAT Investigative D0P4GF DRUG__ID D0P4GF D0P4GF DRUGTYPE Small molecular drug D0P4GF DRUGINCH 1S/C17H13BrO3/c1-10(18)9-20-15-8-7-13-12-5-3-4-6-14(12)17(19)21-16(13)11(15)2/h3-8H,1,9H2,2H3 D0P4GF DRUGINKE GGTNLZBSSNHXRY-UHFFFAOYSA-N D0P4GF DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=CC=CC=C23)OCC(=C)Br D0P4GF HIGHSTAT Investigative D0P4GI DRUG__ID D0P4GI D0P4GI DRUGTYPE Small molecular drug D0P4GI DRUGINCH 1S/C46H59N11O7/c1-2-3-13-35-45(64)57-22-9-16-38(57)44(63)56-36(24-27-17-18-28-10-4-5-11-29(28)23-27)42(61)54-34(15-8-21-50-46(48)49)41(60)55-37(25-30-26-51-32-14-7-6-12-31(30)32)43(62)53-33(40(47)59)19-20-39(58)52-35/h4-7,10-12,14,17-18,23,26,33-38,51H,2-3,8-9,13,15-16,19-22,24-25H2,1H3,(H2,47,59)(H,52,58)(H,53,62)(H,54,61)(H,55,60)(H,56,63)(H4,48,49,50)/t33-,34-,35-,36+,37-,38-/m0/s1 D0P4GI DRUGINKE QQCJWXXVYXUARZ-ZPRVLUMXSA-N D0P4GI DRUGSMIL CCCCC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC6=CC=CC=C6C=C5 D0P4GI HIGHSTAT Investigative D0P4GP DRUG__ID D0P4GP D0P4GP DRUGTYPE Small molecular drug D0P4GP DRUGINCH 1S/C10H15F2N2O13P3S/c11-10(12,28(18,19)20)29(21,22)27-30(23,24)25-3-4-6(15)7(16)8(26-4)14-2-1-5(31)13-9(14)17/h1-2,4,6-8,15-16H,3H2,(H,21,22)(H,23,24)(H,13,17,31)(H2,18,19,20)/t4-,6-,7-,8-/m1/s1 D0P4GP DRUGINKE DFGBPSGNGNHNQM-XVFCMESISA-N D0P4GP DRUGSMIL C1=CN(C(=O)NC1=S)C2C(C(C(O2)COP(=O)(O)OP(=O)(C(F)(F)P(=O)(O)O)O)O)O D0P4GP HIGHSTAT Investigative D0P4IP DRUG__ID D0P4IP D0P4IP DRUGTYPE Small molecular drug D0P4IP DRUGINCH 1S/C27H47N9O10S2/c28-16(26(43)44)4-6-20(37)35-18-14-47-48-15-19(36-21(38)7-5-17(29)27(45)46)25(42)34-13-23(40)32-11-3-9-30-8-1-2-10-31-22(39)12-33-24(18)41/h16-19,30H,1-15,28-29H2,(H,31,39)(H,32,40)(H,33,41)(H,34,42)(H,35,37)(H,36,38)(H,43,44)(H,45,46)/t16-,17-,18-,19-/m0/s1 D0P4IP DRUGINKE LZMSXDHGHZKXJD-VJANTYMQSA-N D0P4IP DRUGSMIL C1CCNC(=O)CNC(=O)C(CSSCC(C(=O)NCC(=O)NCCCNC1)NC(=O)CCC(C(=O)O)N)NC(=O)CCC(C(=O)O)N D0P4IP HIGHSTAT Investigative D0P4JO DRUG__ID D0P4JO D0P4JO DRUGTYPE Small molecular drug D0P4JO DRUGINCH 1S/C29H36O15/c1-13-22(35)23(36)25(38)29(42-13)41-12-20-27(44-21(34)7-4-14-2-5-16(30)18(32)10-14)24(37)26(39)28(43-20)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+/t13-,20+,22-,23+,24+,25+,26+,27+,28+,29+/m0/s1 D0P4JO DRUGINKE DTOUWTJYUCZJQD-UJERWXFOSA-N D0P4JO DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OCCC3=CC(=C(C=C3)O)O)O)O)OC(=O)C=CC4=CC(=C(C=C4)O)O)O)O)O D0P4JO HIGHSTAT Investigative D0P4KF DRUG__ID D0P4KF D0P4KF DRUGTYPE Small molecular drug D0P4KF DRUGINCH 1S/C13H18N2/c1-13(2,3)11-6-4-10(5-7-11)12-14-8-9-15-12/h4-7H,8-9H2,1-3H3,(H,14,15) D0P4KF DRUGINKE JRUYKUSXUFPDNO-UHFFFAOYSA-N D0P4KF DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C2=NCCN2 D0P4KF HIGHSTAT Investigative D0P4KL DRUG__ID D0P4KL D0P4KL DRUGTYPE Small molecular drug D0P4KL DRUGINCH 1S/C17H13NO/c19-17-8-4-2-6-14(17)10-12-15-11-9-13-5-1-3-7-16(13)18-15/h1-12,19H/b12-10+ D0P4KL DRUGINKE NXNDEWNGCMCWMA-ZRDIBKRKSA-N D0P4KL DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)C=CC3=CC=CC=C3O D0P4KL HIGHSTAT Investigative D0P4MU DRUG__ID D0P4MU D0P4MU DRUGTYPE Small molecular drug D0P4MU DRUGINCH 1S/C17H21NO5/c1-2-20-9-10-22-13-3-4-14-15(19)12-17(23-16(14)11-13)18-5-7-21-8-6-18/h3-4,11-12H,2,5-10H2,1H3 D0P4MU DRUGINKE ICGVDPFEKFHPNV-UHFFFAOYSA-N D0P4MU DRUGSMIL CCOCCOC1=CC2=C(C=C1)C(=O)C=C(O2)N3CCOCC3 D0P4MU HIGHSTAT Investigative D0P4PM DRUG__ID D0P4PM D0P4PM DRUGTYPE Small molecular drug D0P4PM DRUGINCH 1S/C40H51N5O5/c1-24-18-31(46)19-25(2)32(24)22-33(41)40(50)45-23-30-17-11-10-16-29(30)21-35(45)38(48)44-36(26(3)28-14-8-5-9-15-28)39(49)43-34(37(42)47)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,46H,5,8-9,14-15,20-23,41H2,1-3H3,(H2,42,47)(H,43,49)(H,44,48)/t26-,33+,34+,35?,36-/m1/s1 D0P4PM DRUGINKE KIHHZGQBWZPIMS-RUXLTPPNSA-N D0P4PM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)N)N)C)O D0P4PM HIGHSTAT Investigative D0P4PQ DRUG__ID D0P4PQ D0P4PQ DRUGTYPE Small molecular drug D0P4PQ DRUGINCH 1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1 D0P4PQ DRUGINKE CAHGCLMLTWQZNJ-BQNIITSRSA-N D0P4PQ DRUGSMIL CC(CCC=C(C)C)C1CCC2(C1(CCC3=C2CCC4C3(CCC(C4(C)C)O)C)C)C D0P4PQ HIGHSTAT Investigative D0P4QS DRUG__ID D0P4QS D0P4QS DRUGTYPE Small molecular drug D0P4QS DRUGINCH 1S/C16H15NO3S/c1-20-13-5-8-15-12(9-13)10-16(17-15)11-3-6-14(7-4-11)21(2,18)19/h3-10,17H,1-2H3 D0P4QS DRUGINKE RQIQNXKCKAJTPF-UHFFFAOYSA-N D0P4QS DRUGSMIL COC1=CC2=C(C=C1)NC(=C2)C3=CC=C(C=C3)S(=O)(=O)C D0P4QS HIGHSTAT Investigative D0P4RL DRUG__ID D0P4RL D0P4RL DRUGTYPE Small molecular drug D0P4RL DRUGINCH 1S/C8H4N4O6/c13-7-8(14)10-6-4(9-7)1-3(11(15)16)2-5(6)12(17)18/h1-2H,(H,9,13)(H,10,14) D0P4RL DRUGINKE YUVRBZPHIDJESL-UHFFFAOYSA-N D0P4RL DRUGSMIL C1=C(C=C(C2=C1NC(=O)C(=O)N2)[N+](=O)[O-])[N+](=O)[O-] D0P4RL HIGHSTAT Investigative D0P4SR DRUG__ID D0P4SR D0P4SR DRUGTYPE Small molecular drug D0P4SR DRUGINCH 1S/C22H18O2/c1-14-2-4-16(5-3-14)22-20-11-10-19(24)12-17(20)13-21(22)15-6-8-18(23)9-7-15/h2-12,23-24H,13H2,1H3 D0P4SR DRUGINKE YIFNILRPNDYIBP-UHFFFAOYSA-N D0P4SR DRUGSMIL CC1=CC=C(C=C1)C2=C(CC3=C2C=CC(=C3)O)C4=CC=C(C=C4)O D0P4SR HIGHSTAT Investigative D0P4TX DRUG__ID D0P4TX D0P4TX DRUGTYPE Small molecular drug D0P4TX DRUGINCH 1S/C11H8N2S/c1-9-13-11(8-14-9)5-4-10-3-2-6-12-7-10/h2-3,6-8H,1H3/i11+2 D0P4TX DRUGINKE NRBNGHCYDWUVLC-OZUIXNLOSA-N D0P4TX DRUGSMIL CC1=NC(=CS1)C#CC2=CN=CC=C2 D0P4TX HIGHSTAT Investigative D0P4WT DRUG__ID D0P4WT D0P4WT DRUGTYPE Small molecular drug D0P4WT DRUGINCH 1S/C28H30F3N7O3/c1-18(39)34-25-15-26(33-17-32-25)41-22-5-6-24-19(13-22)7-8-38(24)27(40)35-21-4-3-20(23(14-21)28(29,30)31)16-37-11-9-36(2)10-12-37/h3-6,13-15,17H,7-12,16H2,1-2H3,(H,35,40)(H,32,33,34,39) D0P4WT DRUGINKE VQLNKQZLPGLOSI-UHFFFAOYSA-N D0P4WT DRUGSMIL CC(=O)NC1=CC(=NC=N1)OC2=CC3=C(C=C2)N(CC3)C(=O)NC4=CC(=C(C=C4)CN5CCN(CC5)C)C(F)(F)F D0P4WT HIGHSTAT Investigative D0P4YY DRUG__ID D0P4YY D0P4YY DRUGTYPE Small molecular drug D0P4YY DRUGINCH 1S/C29H30F2N6O4/c1-2-40-19-10-22(30)21(23(31)11-19)13-37-24-5-3-4-20(24)26(36-37)28-33-12-25(41-17-29(14-38)15-39-16-29)27(35-28)34-18-6-8-32-9-7-18/h6-12,38H,2-5,13-17H2,1H3,(H,32,33,34,35) D0P4YY DRUGINKE WIVMUEFNJYZIOY-UHFFFAOYSA-N D0P4YY DRUGSMIL CCOC1=CC(=C(C(=C1)F)CN2C3=C(CCC3)C(=N2)C4=NC=C(C(=N4)NC5=CC=NC=C5)OCC6(COC6)CO)F D0P4YY HIGHSTAT Investigative D0P5BT DRUG__ID D0P5BT D0P5BT DRUGTYPE Small molecular drug D0P5BT DRUGINCH 1S/C41H36N2O8/c1-44-34-6-4-24-14-32-28-18-38-36(48-22-50-38)16-26(28)8-10-42(32)20-30(24)40(34)46-12-3-13-47-41-31-21-43-11-9-27-17-37-39(51-23-49-37)19-29(27)33(43)15-25(31)5-7-35(41)45-2/h4-7,14-21H,3,8-13,22-23H2,1-2H3/q+2 D0P5BT DRUGINKE AOMDJTYUICYNJP-UHFFFAOYSA-N D0P5BT DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCOC6=C(C=CC7=CC8=[N+](CCC9=CC1=C(C=C98)OCO1)C=C76)OC D0P5BT HIGHSTAT Investigative D0P5BY DRUG__ID D0P5BY D0P5BY DRUGTYPE Small molecular drug D0P5BY DRUGINCH 1S/C9H12N2O/c10-6-7-11-9(12)8-4-2-1-3-5-8/h4H,1-3,5,7H2,(H,11,12) D0P5BY DRUGINKE ZVHMBSSCZBPAIY-UHFFFAOYSA-N D0P5BY DRUGSMIL C1CCC(=CC1)C(=O)NCC#N D0P5BY HIGHSTAT Investigative D0P5CT DRUG__ID D0P5CT D0P5CT DRUGTYPE Small molecular drug D0P5CT DRUGINCH 1S/C19H16N2O/c20-19(22)18-7-5-17(6-8-18)16-3-1-14(2-4-16)13-15-9-11-21-12-10-15/h1-12H,13H2,(H2,20,22) D0P5CT DRUGINKE IYXGEVQAAIDJAA-UHFFFAOYSA-N D0P5CT DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC=C(C=C3)C(=O)N D0P5CT HIGHSTAT Investigative D0P5CV DRUG__ID D0P5CV D0P5CV DRUGTYPE Small molecular drug D0P5CV DRUGINCH 1S/C48H68N6O4/c1-33-27-35-29-41-39(15-17-43(55)49-41)47(31-33)37(35)13-11-23-53(47)45(57)19-25-51(3)21-9-7-5-6-8-10-22-52(4)26-20-46(58)54-24-12-14-38-36-28-34(2)32-48(38,54)40-16-18-44(56)50-42(40)30-36/h15-18,27-28,35-38H,5-14,19-26,29-32H2,1-4H3,(H,49,55)(H,50,56)/t35?,36?,37-,38-,47-,48-/m1/s1 D0P5CV DRUGINKE XCDQISLHKSKFLH-AZGNAIHRSA-N D0P5CV DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4C(=O)CCN(C)CCCCCCCCN(C)CCC(=O)N5CCCC6C57CC(=CC6CC8=C7C=CC(=O)N8)C D0P5CV HIGHSTAT Investigative D0P5EI DRUG__ID D0P5EI D0P5EI DRUGTYPE Small molecular drug D0P5EI DRUGINCH 1S/C31H43N5O6/c1-19-14-23(37)15-20(2)24(19)17-25(33)31(42)36-18-22-9-5-4-8-21(22)16-27(36)30(41)35-26(10-11-28(38)39)29(40)34-13-7-3-6-12-32/h4-5,8-9,14-15,25-27,37H,3,6-7,10-13,16-18,32-33H2,1-2H3,(H,34,40)(H,35,41)(H,38,39)/t25-,26-,27?/m0/s1 D0P5EI DRUGINKE JKBJCPFUZMWEMK-TXIPYEPDSA-N D0P5EI DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCC(=O)O)C(=O)NCCCCCN)N)C)O D0P5EI HIGHSTAT Investigative D0P5IH DRUG__ID D0P5IH D0P5IH DRUGTYPE Small molecular drug D0P5IH DRUGINCH 1S/C35H37N5O5/c1-45-25-15-13-23(14-16-25)19-30-35(44)40-17-7-12-31(40)34(43)38-28(18-22-8-3-2-4-9-22)32(41)37-29(33(42)39-30)20-24-21-36-27-11-6-5-10-26(24)27/h2-6,8-11,13-16,21,28-31,36H,7,12,17-20H2,1H3,(H,37,41)(H,38,43)(H,39,42)/t28-,29+,30-,31+/m0/s1 D0P5IH DRUGINKE OGVYQAXJPKYKOQ-XFBWMNOSSA-N D0P5IH DRUGSMIL COC1=CC=C(C=C1)CC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)N2)CC4=CNC5=CC=CC=C54)CC6=CC=CC=C6 D0P5IH HIGHSTAT Investigative D0P5MJ DRUG__ID D0P5MJ D0P5MJ DRUGTYPE Small molecular drug D0P5MJ DRUGINCH 1S/C26H30O5/c1-15(2)6-8-17-12-19-23(13-21(17)27)30-14-26(28)20-10-11-22(29-5)18(9-7-16(3)4)24(20)31-25(19)26/h6-7,10-13,25,27-28H,8-9,14H2,1-5H3/t25-,26+/m0/s1 D0P5MJ DRUGINKE OOAXWUFECWLVEQ-IZZNHLLZSA-N D0P5MJ DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OCC3(C2OC4=C3C=CC(=C4CC=C(C)C)OC)O)C D0P5MJ HIGHSTAT Investigative D0P5OE DRUG__ID D0P5OE D0P5OE DRUGTYPE Small molecular drug D0P5OE DRUGINCH 1S/C14H16N2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13-14H,15-16H2/t13-,14-/m1/s1 D0P5OE DRUGINKE PONXTPCRRASWKW-ZIAGYGMSSA-N D0P5OE DRUGSMIL C1=CC=C(C=C1)C(C(C2=CC=CC=C2)N)N D0P5OE HIGHSTAT Investigative D0P5OF DRUG__ID D0P5OF D0P5OF DRUGTYPE Small molecular drug D0P5OF DRUGINCH 1S/C8H8N2O/c1-11-7-4-2-3-6-5-9-10-8(6)7/h2-5H,1H3,(H,9,10) D0P5OF DRUGINKE QCBANHQTMCETBI-UHFFFAOYSA-N D0P5OF DRUGSMIL COC1=CC=CC2=C1NN=C2 D0P5OF HIGHSTAT Investigative D0P5PW DRUG__ID D0P5PW D0P5PW DRUGTYPE Small molecular drug D0P5PW DRUGINCH 1S/C15H14N2/c1-11(15-9-16-10-17-15)13-8-4-6-12-5-2-3-7-14(12)13/h2-11H,1H3,(H,16,17) D0P5PW DRUGINKE DZSQSLQSMKNVBV-UHFFFAOYSA-N D0P5PW DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)C3=CN=CN3 D0P5PW HIGHSTAT Investigative D0P5QI DRUG__ID D0P5QI D0P5QI DRUGTYPE Small molecular drug D0P5QI DRUGINCH 1S/C18H25NO2/c1-19-7-6-18-5-3-2-4-14(18)16(19)9-12-8-13(11-20)17(21)10-15(12)18/h8,10,14,16,20-21H,2-7,9,11H2,1H3/t14-,16+,18+/m0/s1 D0P5QI DRUGINKE BPBSRBFSNMZXSP-YXJHDRRASA-N D0P5QI DRUGSMIL CN1CCC23CCCCC2C1CC4=CC(=C(C=C34)O)CO D0P5QI HIGHSTAT Investigative D0P5QM DRUG__ID D0P5QM D0P5QM DRUGTYPE Small molecular drug D0P5QM DRUGINCH 1S/C18H33NO4/c1-2-3-11-14-17(19(22)23)15-12-9-7-5-4-6-8-10-13-16-18(20)21/h15H,2-14,16H2,1H3,(H,20,21)/b17-15+ D0P5QM DRUGINKE PQAOIUQONUIELV-BMRADRMJSA-N D0P5QM DRUGSMIL CCCCCC(=CCCCCCCCCCCC(=O)O)[N+](=O)[O-] D0P5QM HIGHSTAT Investigative D0P5QU DRUG__ID D0P5QU D0P5QU DRUGTYPE Small molecular drug D0P5QU DRUGINCH 1S/C20H17N3O3/c24-19(16-7-2-1-3-8-16)23-18(12-17-9-5-11-26-17)20(25)22-14-15-6-4-10-21-13-15/h1-13H,14H2,(H,22,25)(H,23,24)/b18-12- D0P5QU DRUGINKE ANTQNDKESCDJPE-PDGQHHTCSA-N D0P5QU DRUGSMIL C1=CC=C(C=C1)C(=O)NC(=CC2=CC=CO2)C(=O)NCC3=CN=CC=C3 D0P5QU HIGHSTAT Investigative D0P5QW DRUG__ID D0P5QW D0P5QW DRUGTYPE Small molecular drug D0P5QW DRUGINCH 1S/C27H31N3O2/c1-18-25(29-27(31)21-7-10-24(11-8-21)32-17-20-5-6-20)12-9-22-15-23(16-28-26(18)22)19(2)30-13-3-4-14-30/h7-12,15-16,19-20H,3-6,13-14,17H2,1-2H3,(H,29,31)/t19-/m1/s1 D0P5QW DRUGINKE DFWKNBVJNXPUBW-LJQANCHMSA-N D0P5QW DRUGSMIL CC1=C(C=CC2=CC(=CN=C12)C(C)N3CCCC3)NC(=O)C4=CC=C(C=C4)OCC5CC5 D0P5QW HIGHSTAT Investigative D0P5ST DRUG__ID D0P5ST D0P5ST DRUGTYPE Small molecular drug D0P5ST DRUGINCH 1S/C13H10N4O/c14-13-15-11-5-4-9(7-12(11)16-17-13)8-2-1-3-10(18)6-8/h1-7,18H,(H2,14,15,17) D0P5ST DRUGINKE WCBDDBSMIBIXTG-UHFFFAOYSA-N D0P5ST DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)N=C(N=N3)N D0P5ST HIGHSTAT Investigative D0P5TI DRUG__ID D0P5TI D0P5TI DRUGCOMP Avila Therapeutics Inc D0P5TI DRUGINCH 1S/C30H35N7O3S/c1-20(2)16-21(38)6-7-27(39)36-10-8-35(9-11-36)19-22-17-26-28(41-22)30(37-12-14-40-15-13-37)33-29(32-26)23-4-3-5-25-24(23)18-31-34-25/h3-5,16-18H,6-15,19H2,1-2H3,(H,31,34) D0P5TI DRUGINKE DLNUPKDFXMWRFP-UHFFFAOYSA-N D0P5TI DRUGSMIL CC(=CC(=O)CCC(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6)C D0P5TI HIGHSTAT Investigative D0P5UW DRUG__ID D0P5UW D0P5UW DRUGTYPE Small molecular drug D0P5UW DRUGINCH 1S/C39H33Cl3N2O5S/c40-30-14-18-36-33(24-30)32(20-22-49-31-15-12-29(13-16-31)39(45)46)37(19-21-43-50(47,48)25-26-11-17-34(41)35(42)23-26)44(36)38(27-7-3-1-4-8-27)28-9-5-2-6-10-28/h1-18,23-24,38,43H,19-22,25H2,(H,45,46) D0P5UW DRUGINKE FMMCHWHNSUBYAV-UHFFFAOYSA-N D0P5UW DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)N3C4=C(C=C(C=C4)Cl)C(=C3CCNS(=O)(=O)CC5=CC(=C(C=C5)Cl)Cl)CCOC6=CC=C(C=C6)C(=O)O D0P5UW HIGHSTAT Investigative D0P5VJ DRUG__ID D0P5VJ D0P5VJ DRUGTYPE Small molecular drug D0P5VJ DRUGINCH 1S/C25H30O2/c1-16-11-12-20-19(13-16)23-21(26)14-18(15-22(23)27-25(20,4)5)24(2,3)17-9-7-6-8-10-17/h6-11,14-15,19-20,26H,12-13H2,1-5H3/t19-,20-/m1/s1 D0P5VJ DRUGINKE GZYXCXRHVALIJD-WOJBJXKFSA-N D0P5VJ DRUGSMIL CC1=CCC2C(C1)C3=C(C=C(C=C3OC2(C)C)C(C)(C)C4=CC=CC=C4)O D0P5VJ HIGHSTAT Investigative D0P5YR DRUG__ID D0P5YR D0P5YR DRUGTYPE Small molecular drug D0P5YR DRUGINCH 1S/C13H21N7O4/c1-19(2-3-23-15)4-7-9(21)10(22)13(24-7)20-6-18-8-11(14)16-5-17-12(8)20/h5-7,9-10,13,21-22H,2-4,15H2,1H3,(H2,14,16,17)/t7-,9-,10-,13-/m1/s1 D0P5YR DRUGINKE PPIPUCUVJJZYEK-QYVSTXNMSA-N D0P5YR DRUGSMIL CN(CCON)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0P5YR HIGHSTAT Investigative D0P5YS DRUG__ID D0P5YS D0P5YS DRUGTYPE Small molecular drug D0P5YS DRUGINCH 1S/C29H34O9/c1-25(2)9-8-22(30)27(4)28(25,32)11-10-26(3)29(27,33)15-17-19(38-26)14-18(37-24(17)31)16-12-20(34-5)23(36-7)21(13-16)35-6/h8-9,12-14,32-33H,10-11,15H2,1-7H3/t26-,27+,28-,29-/m1/s1 D0P5YS DRUGINKE PBXNNDFKPQPJBB-VJLHXPKFSA-N D0P5YS DRUGSMIL CC1(C=CC(=O)C2(C1(CCC3(C2(CC4=C(O3)C=C(OC4=O)C5=CC(=C(C(=C5)OC)OC)OC)O)C)O)C)C D0P5YS HIGHSTAT Investigative D0P5ZE DRUG__ID D0P5ZE D0P5ZE DRUGTYPE Small molecular drug D0P5ZE DRUGINCH 1S/C17H19N5O/c1-3-7-12(8-4-1)20-16-14-15(19-11-18-14)21-17(22-16)23-13-9-5-2-6-10-13/h2,5-6,9-12H,1,3-4,7-8H2,(H2,18,19,20,21,22) D0P5ZE DRUGINKE OGCQBCHLFMBCCE-UHFFFAOYSA-N D0P5ZE DRUGSMIL C1CCC(CC1)NC2=NC(=NC3=C2NC=N3)OC4=CC=CC=C4 D0P5ZE HIGHSTAT Investigative D0P5ZV DRUG__ID D0P5ZV D0P5ZV DRUGTYPE Small molecular drug D0P5ZV DRUGINCH 1S/C19H26O3/c1-11-15-10-12(20)6-9-19(3,22-15)14-7-8-18(2)13(17(11)14)4-5-16(18)21/h10-11,13-14,17H,4-9H2,1-3H3/t11-,13-,14-,17-,18-,19?/m0/s1 D0P5ZV DRUGINKE PCQJXIDDNRAKDR-HXWRFABVSA-N D0P5ZV DRUGSMIL CC1C2C3CCC(=O)C3(CCC2C4(CCC(=O)C=C1O4)C)C D0P5ZV HIGHSTAT Investigative D0P6AR DRUG__ID D0P6AR D0P6AR DRUGTYPE Small molecular drug D0P6AR DRUGINCH 1S/C29H37N5O5/c1-32(25(18-19-7-3-2-4-8-19)29(39)33-15-5-9-23(33)26(31)36)28(38)24-10-6-16-34(24)27(37)22(30)17-20-11-13-21(35)14-12-20/h2-4,7-8,11-14,22-25,35H,5-6,9-10,15-18,30H2,1H3,(H2,31,36)/t22?,23-,24?,25+/m1/s1 D0P6AR DRUGINKE JAKBYSTWCHUQOK-DZIFKCOOSA-N D0P6AR DRUGSMIL CN(C(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)N)C(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0P6AR HIGHSTAT Investigative D0P6FF DRUG__ID D0P6FF D0P6FF DRUGTYPE Small molecular drug D0P6FF DRUGINCH 1S/C28H36N2/c1-2-7-21(8-3-1)19-29-24-13-12-23-17-27-25-11-4-5-14-28(25,26(23)18-24)15-16-30(27)20-22-9-6-10-22/h1-3,7-8,12-13,18,22,25,27,29H,4-6,9-11,14-17,19-20H2/t25-,27+,28+/m0/s1 D0P6FF DRUGINKE WFGYABIAABXTFI-KJYTXNCISA-N D0P6FF DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NCC5=CC=CC=C5)CC6CCC6 D0P6FF HIGHSTAT Investigative D0P6FN DRUG__ID D0P6FN D0P6FN DRUGTYPE Small molecular drug D0P6FN DRUGINCH 1S/C17H14O3/c1-20-17-10-15(19)6-7-16(17)13-3-2-12-9-14(18)5-4-11(12)8-13/h2-10,18-19H,1H3 D0P6FN DRUGINKE TWSSGPRRAGPVKD-UHFFFAOYSA-N D0P6FN DRUGSMIL COC1=C(C=CC(=C1)O)C2=CC3=C(C=C2)C=C(C=C3)O D0P6FN HIGHSTAT Investigative D0P6GH DRUG__ID D0P6GH D0P6GH DRUGTYPE Small molecular drug D0P6GH DRUGINCH 1S/C16H29FO10P2/c1-12(2)6-5-7-13(3)8-10-25-28(21,22)27-29(23,24)26-11-9-16(4,20)14(17)15(18)19/h6,8,14,20H,5,7,9-11H2,1-4H3,(H,18,19)(H,21,22)(H,23,24)/b13-8+ D0P6GH DRUGINKE ACYPMTKDKJZHBJ-MDWZMJQESA-N D0P6GH DRUGSMIL CC(=CCCC(=CCOP(=O)(O)OP(=O)(O)OCCC(C)(C(C(=O)O)F)O)C)C D0P6GH HIGHSTAT Investigative D0P6HX DRUG__ID D0P6HX D0P6HX DRUGTYPE Small molecular drug D0P6HX DRUGINCH 1S/C17H12FN5/c1-11-16(13-6-7-14-12(10-13)4-2-8-19-14)21-22-23(11)15-5-3-9-20-17(15)18/h2-10H,1H3 D0P6HX DRUGINKE RTUBNVSZHGWRCV-UHFFFAOYSA-N D0P6HX DRUGSMIL CC1=C(N=NN1C2=C(N=CC=C2)F)C3=CC4=C(C=C3)N=CC=C4 D0P6HX HIGHSTAT Investigative D0P6IA DRUG__ID D0P6IA D0P6IA DRUGTYPE Small molecular drug D0P6IA DRUGINCH 1S/C79H114N22O26/c1-36(2)26-50(98-78(127)64(39(6)104)101-77(126)63(83)37(3)4)70(119)95-51(27-40-13-17-43(105)18-14-40)71(120)91-49(22-24-59(81)108)69(118)99-57(35-103)76(125)96-53(29-42-32-87-46-11-8-7-10-45(42)46)73(122)90-47(12-9-25-86-79(84)85)68(117)94-52(28-41-15-19-44(106)20-16-41)72(121)100-56(34-102)75(124)92-48(21-23-58(80)107)67(116)89-38(5)65(114)93-55(31-61(110)111)74(123)97-54(30-60(82)109)66(115)88-33-62(112)113/h7-8,10-11,13-20,32,36-39,47-57,63-64,87,102-106H,9,12,21-31,33-35,83H2,1-6H3,(H2,80,107)(H2,81,108)(H2,82,109)(H,88,115)(H,89,116)(H,90,122)(H,91,120)(H,92,124)(H,93,114)(H,94,117)(H,95,119)(H,96,125)(H,97,123)(H,98,127)(H,99,118)(H,100,121)(H,101,126)(H,110,111)(H,112,113)(H4,84,85,86)/t38-,39+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-,64-/m0/s1 D0P6IA DRUGINKE QFVHHVFVZLFPHM-UCEBDAAVSA-N D0P6IA DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(CC(=O)N)C(=O)NCC(=O)O)NC(=O)C(C(C)O)NC(=O)C(C(C)C)N D0P6IA HIGHSTAT Investigative D0P6IL DRUG__ID D0P6IL D0P6IL DRUGTYPE Small molecular drug D0P6IL DRUGINCH 1S/C8H9N5O3/c9-7-11-5-4(6(14)12-7)13-3(1-10-5)2-16-8(13)15/h3H,1-2H2,(H4,9,10,11,12,14)/t3-/m1/s1 D0P6IL DRUGINKE XAZOBOCYEGBXHD-GSVOUGTGSA-N D0P6IL DRUGSMIL C1C2COC(=O)N2C3=C(N1)N=C(NC3=O)N D0P6IL HIGHSTAT Investigative D0P6IO DRUG__ID D0P6IO D0P6IO DRUGTYPE Small molecular drug D0P6IO DRUGINCH 1S/C11H15NO5S/c1-2-3-8-16-11(13)9-4-6-10(7-5-9)17-18(12,14)15/h4-7H,2-3,8H2,1H3,(H2,12,14,15) D0P6IO DRUGINKE DTGVRFABWYOAMJ-UHFFFAOYSA-N D0P6IO DRUGSMIL CCCCOC(=O)C1=CC=C(C=C1)OS(=O)(=O)N D0P6IO HIGHSTAT Investigative D0P6IV DRUG__ID D0P6IV D0P6IV DRUGTYPE Small molecular drug D0P6IV DRUGINCH 1S/C26H30N4O4/c1-18-3-8-21(30-11-9-28(2)10-12-30)25-24(18)22(31)17-23(34-25)26(32)27-19-4-6-20(7-5-19)29-13-15-33-16-14-29/h3-8,17H,9-16H2,1-2H3,(H,27,32)/i2-1 D0P6IV DRUGINKE JKPWOPNZKYPRPZ-JVVVGQRLSA-N D0P6IV DRUGSMIL CC1=C2C(=O)C=C(OC2=C(C=C1)N3CCN(CC3)C)C(=O)NC4=CC=C(C=C4)N5CCOCC5 D0P6IV HIGHSTAT Investigative D0P6IZ DRUG__ID D0P6IZ D0P6IZ DRUGTYPE Small molecular drug D0P6IZ DRUGINCH 1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m1/s1 D0P6IZ DRUGINKE PYMYPHUHKUWMLA-WISUUJSJSA-N D0P6IZ DRUGSMIL C(C(C(C(C=O)O)O)O)O D0P6IZ HIGHSTAT Investigative D0P6JE DRUG__ID D0P6JE D0P6JE DRUGTYPE Small molecular drug D0P6JE DRUGINCH 1S/C17H14O2S/c1-11-8-16(12-4-2-6-14(18)9-12)20-17(11)13-5-3-7-15(19)10-13/h2-10,18-19H,1H3 D0P6JE DRUGINKE LRHCSXOEZSEMIF-UHFFFAOYSA-N D0P6JE DRUGSMIL CC1=C(SC(=C1)C2=CC(=CC=C2)O)C3=CC(=CC=C3)O D0P6JE HIGHSTAT Investigative D0P6JS DRUG__ID D0P6JS D0P6JS DRUGTYPE Small molecular drug D0P6JS DRUGINCH 1S/C19H21FN6O/c1-11(2)26-12(3)23-10-17(26)16-7-8-22-19(25-16)24-13-5-6-14(15(20)9-13)18(27)21-4/h5-11H,1-4H3,(H,21,27)(H,22,24,25) D0P6JS DRUGINKE OCUYCOQPRGFQEV-UHFFFAOYSA-N D0P6JS DRUGSMIL CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC(=C(C=C3)C(=O)NC)F D0P6JS HIGHSTAT Investigative D0P6KN DRUG__ID D0P6KN D0P6KN DRUGTYPE Small molecular drug D0P6KN DRUGINCH 1S/C26H31N4O20P3/c31-16-6-8-29(25(35)27-16)23-20(34)19(33)14(45-23)11-43-51(37,38)49-53(41,42)50-52(39,40)44-12-15-21-22(24(46-15)30-9-7-17(32)28-26(30)36)48-18(47-21)10-13-4-2-1-3-5-13/h1-9,14-15,18-24,33-34H,10-12H2,(H,37,38)(H,39,40)(H,41,42)(H,27,31,35)(H,28,32,36)/t14-,15+,18?,19-,20-,21+,22+,23-,24+/m0/s1 D0P6KN DRUGINKE FIZCPSOYGRAJHH-LAJHJGSGSA-N D0P6KN DRUGSMIL C1=CC=C(C=C1)CC2OC3C(OC(C3O2)N4C=CC(=O)NC4=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)OCC5C(C(C(O5)N6C=CC(=O)NC6=O)O)O D0P6KN HIGHSTAT Investigative D0P6LN DRUG__ID D0P6LN D0P6LN DRUGTYPE Small molecular drug D0P6LN DRUGINCH 1S/C14H21NO/c1-2-3-9-15-10-7-12-5-4-6-14(16)13(12)8-11-15/h4-6,16H,2-3,7-11H2,1H3 D0P6LN DRUGINKE LLOMAHVTVGHSNN-UHFFFAOYSA-N D0P6LN DRUGSMIL CCCCN1CCC2=C(CC1)C(=CC=C2)O D0P6LN HIGHSTAT Investigative D0P6NA DRUG__ID D0P6NA D0P6NA DRUGTYPE Small molecular drug D0P6NA DRUGINCH 1S/C23H27NO2/c1-4-5-8-15-24-17(2)23(20-9-6-7-10-21(20)24)22(25)16-18-11-13-19(26-3)14-12-18/h6-7,9-14H,4-5,8,15-16H2,1-3H3 D0P6NA DRUGINKE RNQWQIZOTKYEKJ-UHFFFAOYSA-N D0P6NA DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)OC)C D0P6NA HIGHSTAT Investigative D0P6PQ DRUG__ID D0P6PQ D0P6PQ DRUGTYPE Small molecular drug D0P6PQ DRUGINCH 1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10) D0P6PQ DRUGINKE AGBQKNBQESQNJD-UHFFFAOYSA-N D0P6PQ DRUGSMIL C1CSSC1CCCCC(=O)O D0P6PQ HIGHSTAT Investigative D0P6RT DRUG__ID D0P6RT D0P6RT DRUGTYPE Small molecular drug D0P6RT DRUGINCH 1S/C35H52F2N6O8S/c1-2-9-28(39-33(46)30(25-27-12-7-4-8-13-27)41-52(48,49)43-18-22-51-23-19-43)32(45)40-29(24-26-10-5-3-6-11-26)31(44)35(36,37)34(47)38-14-15-42-16-20-50-21-17-42/h2,4,7-8,12-13,26,28-30,41H,1,3,5-6,9-11,14-25H2,(H,38,47)(H,39,46)(H,40,45)/t28-,29-,30-/m0/s1 D0P6RT DRUGINKE MQDDTALXSBQTQP-DTXPUJKBSA-N D0P6RT DRUGSMIL C=CCC(C(=O)NC(CC1CCCCC1)C(=O)C(C(=O)NCCN2CCOCC2)(F)F)NC(=O)C(CC3=CC=CC=C3)NS(=O)(=O)N4CCOCC4 D0P6RT HIGHSTAT Investigative D0P6SY DRUG__ID D0P6SY D0P6SY DRUGTYPE Small molecular drug D0P6SY DRUGINCH 1S/C18H18F3NO/c1-22-11-13-10-12-4-2-3-5-16(12)17(13)23-15-8-6-14(7-9-15)18(19,20)21/h2-9,13,17,22H,10-11H2,1H3/t13-,17+/m0/s1 D0P6SY DRUGINKE BDCMARKCSKLIKU-SUMWQHHRSA-N D0P6SY DRUGSMIL CNCC1CC2=CC=CC=C2C1OC3=CC=C(C=C3)C(F)(F)F D0P6SY HIGHSTAT Investigative D0P6TX DRUG__ID D0P6TX D0P6TX DRUGTYPE Small molecular drug D0P6TX DRUGINCH 1S/C19H17N3O2/c23-19(21-16-10-5-2-6-11-16)22-18-17(12-7-13-20-18)24-14-15-8-3-1-4-9-15/h1-13H,14H2,(H2,20,21,22,23) D0P6TX DRUGINKE PFMMAQSZJDBKOE-UHFFFAOYSA-N D0P6TX DRUGSMIL C1=CC=C(C=C1)COC2=C(N=CC=C2)NC(=O)NC3=CC=CC=C3 D0P6TX HIGHSTAT Investigative D0P6ZZ DRUG__ID D0P6ZZ D0P6ZZ DRUGTYPE Small molecular drug D0P6ZZ DRUGINCH 1S/C36H48N8O8S2/c1-20(45)30-35(50)43-29(36(51)52)19-54-53-18-24(38)31(46)41-27(15-21-9-3-2-4-10-21)33(48)42-28(16-22-17-39-25-12-6-5-11-23(22)25)34(49)40-26(32(47)44-30)13-7-8-14-37/h2-6,9-12,17,20,24,26-30,39,45H,7-8,13-16,18-19,37-38H2,1H3,(H,40,49)(H,41,46)(H,42,48)(H,43,50)(H,44,47)(H,51,52)/t20-,24+,26+,27+,28-,29+,30+/m1/s1 D0P6ZZ DRUGINKE XNCLQDHGWMNJRY-XJVQTVDVSA-N D0P6ZZ DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)N)C(=O)O)O D0P6ZZ HIGHSTAT Investigative D0P7AS DRUG__ID D0P7AS D0P7AS DRUGTYPE Small molecular drug D0P7AS DRUGINCH 1S/C11H16FN2O9P/c1-2-4-6(12)9(17)13-11(18)14(4)10-8(16)7(15)5(23-10)3-22-24(19,20)21/h5,7-8,10,15-16H,2-3H2,1H3,(H,13,17,18)(H2,19,20,21)/t5-,7-,8-,10-/m1/s1 D0P7AS DRUGINKE JBBLQWFDKGRNST-VPCXQMTMSA-N D0P7AS DRUGSMIL CCC1=C(C(=O)NC(=O)N1C2C(C(C(O2)COP(=O)(O)O)O)O)F D0P7AS HIGHSTAT Investigative D0P7CD DRUG__ID D0P7CD D0P7CD DRUGTYPE Small molecular drug D0P7CD DRUGINCH 1S/C13H12N4S2/c14-8-11-9-19-13(16-11)17-12(18)15-7-6-10-4-2-1-3-5-10/h1-5,9H,6-7H2,(H2,15,16,17,18) D0P7CD DRUGINKE BZAWZCHHJAFXDY-UHFFFAOYSA-N D0P7CD DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NC(=CS2)C#N D0P7CD HIGHSTAT Investigative D0P7CS DRUG__ID D0P7CS D0P7CS DRUGTYPE Small molecular drug D0P7CS DRUGINCH 1S/C16H13N3O2S/c1-21-13-9-7-12(8-10-13)15(20)18-16-17-14(19-22-16)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18,19,20) D0P7CS DRUGINKE RGVXOHBJCGPTQH-UHFFFAOYSA-N D0P7CS DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=NC(=NS2)C3=CC=CC=C3 D0P7CS HIGHSTAT Investigative D0P7DF DRUG__ID D0P7DF D0P7DF DRUGTYPE Small molecular drug D0P7DF DRUGINCH 1S/C16H17IN2O/c17-13-1-5-15(6-2-13)20-16-7-3-14(4-8-16)19-11-9-18-10-12-19/h1-8,18H,9-12H2 D0P7DF DRUGINKE AFIBQMXKOKSOEJ-UHFFFAOYSA-N D0P7DF DRUGSMIL C1CN(CCN1)C2=CC=C(C=C2)OC3=CC=C(C=C3)I D0P7DF HIGHSTAT Investigative D0P7FK DRUG__ID D0P7FK D0P7FK DRUGTYPE Small molecular drug D0P7FK DRUGINCH 1S/C16H11N3O/c17-10-13-12(15-7-4-8-20-15)9-14(19-16(13)18)11-5-2-1-3-6-11/h1-9H,(H2,18,19) D0P7FK DRUGINKE UPNSGUUFOFSFEZ-UHFFFAOYSA-N D0P7FK DRUGSMIL C1=CC=C(C=C1)C2=NC(=C(C(=C2)C3=CC=CO3)C#N)N D0P7FK HIGHSTAT Investigative D0P7GR DRUG__ID D0P7GR D0P7GR DRUGTYPE Small molecular drug D0P7GR DRUGINCH 1S/C14H31O3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18(15,16)17/h2-14H2,1H3,(H2,15,16,17) D0P7GR DRUGINKE BVQJQTMSTANITJ-UHFFFAOYSA-N D0P7GR DRUGSMIL CCCCCCCCCCCCCCP(=O)(O)O D0P7GR HIGHSTAT Investigative D0P7JE DRUG__ID D0P7JE D0P7JE DRUGTYPE Small molecular drug D0P7JE DRUGINCH 1S/C5H11NO3S2/c6-4(5(8)9)3-11-10-2-1-7/h4,7H,1-3,6H2,(H,8,9)/t4-/m0/s1 D0P7JE DRUGINKE YPUBRSXDQSFQBA-BYPYZUCNSA-N D0P7JE DRUGSMIL C(CSSCC(C(=O)O)N)O D0P7JE HIGHSTAT Investigative D0P7KL DRUG__ID D0P7KL D0P7KL DRUGTYPE Small molecular drug D0P7KL DRUGINCH 1S/C17H12N2O2/c1-2-13-18-12-8-7-11-14(15(12)19-13)17(21)10-6-4-3-5-9(10)16(11)20/h3-8H,2H2,1H3,(H,18,19) D0P7KL DRUGINKE ADOUNJBEKVZHQH-UHFFFAOYSA-N D0P7KL DRUGSMIL CCC1=NC2=C(N1)C=CC3=C2C(=O)C4=CC=CC=C4C3=O D0P7KL HIGHSTAT Investigative D0P7KP DRUG__ID D0P7KP D0P7KP DRUGTYPE Small molecular drug D0P7KP DRUGINCH 1S/C15H34N/c1-5-6-7-8-9-10-11-12-13-14-15-16(2,3)4/h5-15H2,1-4H3/q+1 D0P7KP DRUGINKE VICYBMUVWHJEFT-UHFFFAOYSA-N D0P7KP DRUGSMIL CCCCCCCCCCCC[N+](C)(C)C D0P7KP HIGHSTAT Investigative D0P7MU DRUG__ID D0P7MU D0P7MU DRUGTYPE Small molecular drug D0P7MU DRUGINCH 1S/C15H11N3OS/c19-14(11-6-2-1-3-7-11)18-15-17-13(10-20-15)12-8-4-5-9-16-12/h1-10H,(H,17,18,19) D0P7MU DRUGINKE NNBHDRDMPNNEKO-UHFFFAOYSA-N D0P7MU DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NC(=CS2)C3=CC=CC=N3 D0P7MU HIGHSTAT Investigative D0P7NP DRUG__ID D0P7NP D0P7NP DRUGTYPE Small molecular drug D0P7NP DRUGINCH 1S/C30H44N2O5/c1-21(2)18-25(33)29(34)24(19-22-10-5-4-6-11-22)32-30(35)28-26(36-3)14-7-15-27(28)37-17-9-13-23-12-8-16-31-20-23/h7-8,12,14-16,20-22,24-25,29,33-34H,4-6,9-11,13,17-19H2,1-3H3,(H,32,35)/t24-,25-,29+/m0/s1 D0P7NP DRUGINKE PJZBKGNAKHKHSH-IALVYGIMSA-N D0P7NP DRUGSMIL CC(C)CC(C(C(CC1CCCCC1)NC(=O)C2=C(C=CC=C2OCCCC3=CN=CC=C3)OC)O)O D0P7NP HIGHSTAT Investigative D0P7NW DRUG__ID D0P7NW D0P7NW DRUGTYPE Small molecular drug D0P7NW DRUGINCH 1S/C21H24ClNO2/c1-25-21(24)20(17-10-7-11-18(22)14-17)19-12-5-6-13-23(19)15-16-8-3-2-4-9-16/h2-4,7-11,14,19-20H,5-6,12-13,15H2,1H3/t19-,20-/m1/s1 D0P7NW DRUGINKE QUIVXFJDADACBW-WOJBJXKFSA-N D0P7NW DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=CC=C2)C3=CC(=CC=C3)Cl D0P7NW HIGHSTAT Investigative D0P7NY DRUG__ID D0P7NY D0P7NY DRUGTYPE Small molecular drug D0P7NY DRUGINCH 1S/C25H35N3O2/c1-4-27(5-2)19-20-10-12-22(13-11-20)25(29)28(23-14-16-26-18-23)17-15-21-8-6-7-9-24(21)30-3/h6-13,23,26H,4-5,14-19H2,1-3H3/t23-/m1/s1 D0P7NY DRUGINKE XKPJTOHUPQWSOJ-HSZRJFAPSA-N D0P7NY DRUGSMIL CCN(CC)CC1=CC=C(C=C1)C(=O)N(CCC2=CC=CC=C2OC)C3CCNC3 D0P7NY HIGHSTAT Investigative D0P7OB DRUG__ID D0P7OB D0P7OB DRUGTYPE Small molecular drug D0P7OB DRUGINCH 1S/C22H27N3O/c1-16-7-8-18(15-17(16)2)25-13-11-24(12-14-25)10-9-21-19-5-3-4-6-20(19)22(26)23-21/h3-8,15,21H,9-14H2,1-2H3,(H,23,26)/t21-/m0/s1 D0P7OB DRUGINKE WQEPZBNLBWDIRZ-NRFANRHFSA-N D0P7OB DRUGSMIL CC1=C(C=C(C=C1)N2CCN(CC2)CCC3C4=CC=CC=C4C(=O)N3)C D0P7OB HIGHSTAT Investigative D0P7OY DRUG__ID D0P7OY D0P7OY DRUGTYPE Small molecular drug D0P7OY DRUGINCH 1S/C6H13N/c1-7-5-3-2-4-6-7/h2-6H2,1H3 D0P7OY DRUGINKE PAMIQIKDUOTOBW-UHFFFAOYSA-N D0P7OY DRUGSMIL CN1CCCCC1 D0P7OY HIGHSTAT Investigative D0P7PK DRUG__ID D0P7PK D0P7PK DRUGTYPE Small molecular drug D0P7PK DRUGINCH 1S/C20H15N/c1-3-9-15(10-4-1)19-17-13-7-8-14-18(17)21-20(19)16-11-5-2-6-12-16/h1-14,21H D0P7PK DRUGINKE GYGKJNGSQQORRG-UHFFFAOYSA-N D0P7PK DRUGSMIL C1=CC=C(C=C1)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D0P7PK HIGHSTAT Investigative D0P7RI DRUG__ID D0P7RI D0P7RI DRUGTYPE Small molecular drug D0P7RI DRUGINCH 1S/C9H14BrN2O15P3/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(25-8)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h1,4-6,8,13-14H,2H2,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1 D0P7RI DRUGINKE IWFHOSULCAJGRM-UAKXSSHOSA-N D0P7RI DRUGSMIL C1=C(C(=O)NC(=O)N1C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)Br D0P7RI HIGHSTAT Investigative D0P7RN DRUG__ID D0P7RN D0P7RN DRUGTYPE Small molecular drug D0P7RN DRUGINCH 1S/C14H11FO3S/c15-12-8-6-11(7-9-12)14(16)10-19(17,18)13-4-2-1-3-5-13/h1-9H,10H2 D0P7RN DRUGINKE FCXNRTNBPQUTBL-UHFFFAOYSA-N D0P7RN DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CC(=O)C2=CC=C(C=C2)F D0P7RN HIGHSTAT Investigative D0P7RO DRUG__ID D0P7RO D0P7RO DRUGTYPE Small molecular drug D0P7RO DRUGINCH 1S/C4H3N5/c1-3-4(6-2-5-1)8-9-7-3/h1-2H,(H,5,6,7,8,9) D0P7RO DRUGINKE GIIGHSIIKVOWKZ-UHFFFAOYSA-N D0P7RO DRUGSMIL C1=NC=NC2=NNN=C21 D0P7RO HIGHSTAT Investigative D0P7SY DRUG__ID D0P7SY D0P7SY DRUGTYPE Small molecular drug D0P7SY DRUGINCH 1S/C16H12O2S/c1-17-12-8-6-11(7-9-12)15-10-16(19)13-4-2-3-5-14(13)18-15/h2-10H,1H3 D0P7SY DRUGINKE VNYCDMLKRQOQKQ-UHFFFAOYSA-N D0P7SY DRUGSMIL COC1=CC=C(C=C1)C2=CC(=S)C3=CC=CC=C3O2 D0P7SY HIGHSTAT Investigative D0P7TN DRUG__ID D0P7TN D0P7TN DRUGTYPE Small molecular drug D0P7TN DRUGINCH 1S/C18H19N2O7P/c1-11-3-5-15-13(7-11)9-24-28(23,27-15)25-10-14-4-6-16(26-14)20-8-12(2)17(21)19-18(20)22/h3-8,14,16H,9-10H2,1-2H3,(H,19,21,22)/t14-,16+,28?/m0/s1 D0P7TN DRUGINKE XCQZHNHBKUHUEJ-NIGMZYBYSA-N D0P7TN DRUGSMIL CC1=CC2=C(C=C1)OP(=O)(OC2)OCC3C=CC(O3)N4C=C(C(=O)NC4=O)C D0P7TN HIGHSTAT Investigative D0P7UV DRUG__ID D0P7UV D0P7UV DRUGTYPE Small molecular drug D0P7UV DRUGINCH 1S/C37H49N11O6/c38-36(39)43-16-3-7-27-33(52)46-28(8-4-17-44-37(40)41)34(53)48-29(20-22-10-13-26(49)14-11-22)32(51)42-18-15-31(50)45-30(35(54)47-27)21-23-9-12-24-5-1-2-6-25(24)19-23/h1-2,5-6,9-14,19,27-30,49H,3-4,7-8,15-18,20-21H2,(H,42,51)(H,45,50)(H,46,52)(H,47,54)(H,48,53)(H4,38,39,43)(H4,40,41,44)/t27-,28-,29+,30-/m0/s1 D0P7UV DRUGINKE LMVXXKJNXQKPHR-ZXYZSCNASA-N D0P7UV DRUGSMIL C1CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CC3=CC=CC=C3C=C2)CCCN=C(N)N)CCCN=C(N)N)CC4=CC=C(C=C4)O D0P7UV HIGHSTAT Investigative D0P8AW DRUG__ID D0P8AW D0P8AW DRUGTYPE Small molecular drug D0P8AW DRUGINCH 1S/C18H19NO2/c1-19-10-11-4-2-3-5-12(11)17-13-7-9-16(20)18(21)14(13)6-8-15(17)19/h2-5,7,9,15,17,20-21H,6,8,10H2,1H3/t15-,17-/m1/s1 D0P8AW DRUGINKE GFOJCADGVHYVJC-NVXWUHKLSA-N D0P8AW DRUGSMIL CN1CC2=CC=CC=C2C3C1CCC4=C3C=CC(=C4O)O D0P8AW HIGHSTAT Investigative D0P8BE DRUG__ID D0P8BE D0P8BE DRUGTYPE Small molecular drug D0P8BE DRUGINCH 1S/C17H19N3/c1-3-12-19(15-8-10-18-11-9-15)20-13-14(2)16-6-4-5-7-17(16)20/h4-11,13H,3,12H2,1-2H3 D0P8BE DRUGINKE JFXXREWKFGYUCE-UHFFFAOYSA-N D0P8BE DRUGSMIL CCCN(C1=CC=NC=C1)N2C=C(C3=CC=CC=C32)C D0P8BE HIGHSTAT Investigative D0P8DW DRUG__ID D0P8DW D0P8DW DRUGTYPE Small molecular drug D0P8DW DRUGINCH 1S/C17H21N5/c18-12-8-9-22(10-12)16-14-7-3-5-11-4-1-2-6-13(11)15(14)20-17(19)21-16/h1-2,4,6,12H,3,5,7-10,18H2,(H2,19,20,21)/t12-/m1/s1 D0P8DW DRUGINKE SDTRYHWIXVHTLM-GFCCVEGCSA-N D0P8DW DRUGSMIL C1CC2=CC=CC=C2C3=C(C1)C(=NC(=N3)N)N4CCC(C4)N D0P8DW HIGHSTAT Investigative D0P8EY DRUG__ID D0P8EY D0P8EY DRUGTYPE Small molecular drug D0P8EY DRUGINCH 1S/C19H20N8O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(28)27-33/h1-4,8,12,21,33H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1 D0P8EY DRUGINKE TZBJIYPNYFAUQG-LBPRGKRZSA-N D0P8EY DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)NO)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N D0P8EY HIGHSTAT Investigative D0P8IK DRUG__ID D0P8IK D0P8IK DRUGTYPE Small molecular drug D0P8IK DRUGINCH 1S/C9H15NO3/c1-2-13-9(12)8(11)10-6-4-3-5-7-10/h2-7H2,1H3 D0P8IK DRUGINKE ASBDXHCMVYVJQQ-UHFFFAOYSA-N D0P8IK DRUGSMIL CCOC(=O)C(=O)N1CCCCC1 D0P8IK HIGHSTAT Investigative D0P8IX DRUG__ID D0P8IX D0P8IX DRUGTYPE Small molecular drug D0P8IX DRUGINCH 1S/C14H10O2/c15-12-7-3-5-10-8-9-4-1-2-6-11(9)14(16)13(10)12/h1-7,15H,8H2 D0P8IX DRUGINKE AXHRXVXCOMMNLG-UHFFFAOYSA-N D0P8IX DRUGSMIL C1C2=C(C(=CC=C2)O)C(=O)C3=CC=CC=C31 D0P8IX HIGHSTAT Investigative D0P8JA DRUG__ID D0P8JA D0P8JA DRUGTYPE Small molecular drug D0P8JA DRUGINCH 1S/C12H16N6O2S/c1-14-10-7-11(17-12(15-2)16-10)18-21(19,20)9-5-3-8(13)4-6-9/h3-7H,13H2,1-2H3,(H3,14,15,16,17,18) D0P8JA DRUGINKE JELFWSXQTXRMAJ-UHFFFAOYSA-N D0P8JA DRUGSMIL CNC1=CC(=NC(=N1)NC)NS(=O)(=O)C2=CC=C(C=C2)N D0P8JA HIGHSTAT Investigative D0P8JC DRUG__ID D0P8JC D0P8JC DRUGCOMP AngioChem Inc D0P8JC DRUGINCH 1S/C197H242N32O70/c1-88(231)160(228-136(242)55-60-144(252)293-87-131(237)197(287)77-105-153(128(80-197)299-147-72-108(200)164(255)92(5)296-147)176(267)159-156(170(105)261)167(258)102-35-24-42-125(290-8)150(102)173(159)264)190(281)226-118(67-95-31-16-11-17-32-95)186(277)222-117(66-94-29-14-10-15-30-94)185(276)221-115(68-96-43-47-98(233)48-44-96)178(269)212-81-137(243)211-82-138(244)215-122(84-230)189(280)216-109(38-25-63-209-193(203)204)177(268)213-83-139(245)214-110(36-18-20-61-207-134(240)53-58-142(250)291-85-129(235)195(285)75-103-151(126(78-195)297-145-70-106(198)162(253)90(3)294-145)174(265)157-154(168(103)259)165(256)100-33-22-40-123(288-6)148(100)171(157)262)179(270)217-112(39-26-64-210-194(205)206)180(271)224-119(73-132(201)238)188(279)225-120(74-133(202)239)187(278)223-116(65-93-27-12-9-13-28-93)184(275)218-111(183(274)229-161(89(2)232)191(282)220-114(52-57-141(248)249)181(272)219-113(51-56-140(246)247)182(273)227-121(192(283)284)69-97-45-49-99(234)50-46-97)37-19-21-62-208-135(241)54-59-143(251)292-86-130(236)196(286)76-104-152(127(79-196)298-146-71-107(199)163(254)91(4)295-146)175(266)158-155(169(104)260)166(257)101-34-23-41-124(289-7)149(101)172(158)263/h9-17,22-24,27-35,40-50,88-92,106-122,126-128,145-147,160-164,230-234,253-255,259-261,265-267,285-287H,18-21,25-26,36-39,51-87,198-200H2,1-8H3,(H2,201,238)(H2,202,239)(H,207,240)(H,208,241)(H,211,243)(H,212,269)(H,213,268)(H,214,245)(H,215,244)(H,216,280)(H,217,270)(H,218,275)(H,219,272)(H,220,282)(H,221,276)(H,222,277)(H,223,278)(H,224,271)(H,225,279)(H,226,281)(H,227,273)(H,228,242)(H,229,274)(H,246,247)(H,248,249)(H,283,284)(H4,203,204,209)(H4,205,206,210)/t88?,89-,90+,91+,92+,106+,107+,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118+,119+,120+,121+,122+,126+,127+,128+,145+,146+,147+,160+,161+,162-,163-,164-,195+,196+,197+/m1/s1 D0P8JC DRUGINKE NNYUKHCUMZKJBM-DGMYVURFSA-N D0P8JC DRUGSMIL CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)COC(=O)CCC(=O)NCCCCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CCCCNC(=O)CCC(=O)OCC(=O)C7(CC(C8=C(C7)C(=C9C(=C8O)C(=O)C1=C(C9=O)C=CC=C1OC)O)OC1CC(C(C(O1)C)O)N)O)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)CNC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C1C(=C2O)C(=O)C2=C(C1=O)C=CC=C2OC)O)OC1CC(C(C(O1)C)O)N)O)O)N)O D0P8JC HIGHSTAT Investigative D0P8MK DRUG__ID D0P8MK D0P8MK DRUGTYPE Small molecular drug D0P8MK DRUGINCH 1S/C7H8BrN5O/c8-7-12-4-5(9)10-3-11-6(4)13(7)1-2-14/h3,14H,1-2H2,(H2,9,10,11) D0P8MK DRUGINKE HPCQLQBYCLLETI-UHFFFAOYSA-N D0P8MK DRUGSMIL C1=NC(=C2C(=N1)N(C(=N2)Br)CCO)N D0P8MK HIGHSTAT Investigative D0P8MM DRUG__ID D0P8MM D0P8MM DRUGTYPE Small molecular drug D0P8MM DRUGINCH 1S/C16H23N3O2/c1-3-15(20)19-10-8-13(9-11-19)17-16(21)18-14-7-5-4-6-12(14)2/h4-7,13H,3,8-11H2,1-2H3,(H2,17,18,21) D0P8MM DRUGINKE CBKNSQNPJUKLHL-UHFFFAOYSA-N D0P8MM DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2=CC=CC=C2C D0P8MM HIGHSTAT Investigative D0P8NZ DRUG__ID D0P8NZ D0P8NZ DRUGTYPE Small molecular drug D0P8NZ DRUGINCH 1S/C30H32N4O3/c1-18-11-24(35)12-19(2)25(18)15-26(31)30(37)34-17-22-9-4-3-7-20(22)14-28(34)29(36)32-16-23-13-21-8-5-6-10-27(21)33-23/h3-13,26,28,33,35H,14-17,31H2,1-2H3,(H,32,36)/t26-,28-/m0/s1 D0P8NZ DRUGINKE WOVWFYGUXKNNEL-XCZPVHLTSA-N D0P8NZ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=CC5=CC=CC=C5N4)N)C)O D0P8NZ HIGHSTAT Investigative D0P8PG DRUG__ID D0P8PG D0P8PG DRUGTYPE Small molecular drug D0P8PG DRUGINCH 1S/C11H11BrN2/c12-11-3-1-10(2-4-11)5-7-14-8-6-13-9-14/h1-4,6,8-9H,5,7H2 D0P8PG DRUGINKE PAYXPBIBNFYADE-UHFFFAOYSA-N D0P8PG DRUGSMIL C1=CC(=CC=C1CCN2C=CN=C2)Br D0P8PG HIGHSTAT Investigative D0P8PH DRUG__ID D0P8PH D0P8PH DRUGTYPE Small molecular drug D0P8PH DRUGINCH 1S/C26H20N2O/c29-25-21-5-1-3-7-23(21)26(17-19-9-13-27-14-10-19,18-20-11-15-28-16-12-20)24-8-4-2-6-22(24)25/h1-16H,17-18H2 D0P8PH DRUGINKE KHJFBUUFMUBONL-UHFFFAOYSA-N D0P8PH DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2(CC4=CC=NC=C4)CC5=CC=NC=C5 D0P8PH HIGHSTAT Investigative D0P8RH DRUG__ID D0P8RH D0P8RH DRUGTYPE Small molecular drug D0P8RH DRUGINCH 1S/C10H18O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7-8,11H,4-6H2,1-3H3 D0P8RH DRUGINKE DTGKSKDOIYIVQL-UHFFFAOYSA-N D0P8RH DRUGSMIL CC1(C2CCC1(C(C2)O)C)C D0P8RH HIGHSTAT Investigative D0P8SU DRUG__ID D0P8SU D0P8SU DRUGTYPE Small molecular drug D0P8SU DRUGINCH 1S/C13H18N2O2/c1-11-3-2-9-14(11)10-8-12-4-6-13(7-5-12)15(16)17/h4-7,11H,2-3,8-10H2,1H3/t11-/m1/s1 D0P8SU DRUGINKE PFZYNGPCNCRLFU-LLVKDONJSA-N D0P8SU DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)[N+](=O)[O-] D0P8SU HIGHSTAT Investigative D0P8TI DRUG__ID D0P8TI D0P8TI DRUGTYPE Small molecular drug D0P8TI DRUGINCH 1S/C25H36O12/c1-11(26)35-14-9-13(19(29)32-4)23(2)8-7-12-20(30)36-15(10-24(12,3)17(23)16(14)27)25(31)18(28)21(33-5)37-22(25)34-6/h12-15,17-18,21-22,28,31H,7-10H2,1-6H3/t12-,13-,14-,15-,17-,18+,21-,22+,23-,24-,25+/m0/s1 D0P8TI DRUGINKE QEBAQEQKIKWXTO-QYGCUGILSA-N D0P8TI DRUGSMIL CC(=O)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4(C(C(OC4OC)OC)O)O)C)C(=O)OC D0P8TI HIGHSTAT Investigative D0P8TJ DRUG__ID D0P8TJ D0P8TJ DRUGTYPE Small molecular drug D0P8TJ DRUGINCH 1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1 D0P8TJ DRUGINKE YBJHBAHKTGYVGT-ZKWXMUAHSA-N D0P8TJ DRUGSMIL C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2 D0P8TJ HIGHSTAT Investigative D0P8TL DRUG__ID D0P8TL D0P8TL DRUGTYPE Small molecular drug D0P8TL DRUGINCH 1S/C10H17N7O4/c11-6-15-5-4(3-21-8(13)18)14-7(12)17-2-1-9(19,20)10(5,17)16-6/h4-5,19-20H,1-3H2,(H2,12,14)(H2,13,18)(H3,11,15,16)/t4-,5-,10-/m0/s1 D0P8TL DRUGINKE RPQXVSUAYFXFJA-HGRQIUPRSA-N D0P8TL DRUGSMIL C1CN2C(=NC(C3C2(C1(O)O)NC(=N3)N)COC(=O)N)N D0P8TL HIGHSTAT Investigative D0P8UI DRUG__ID D0P8UI D0P8UI DRUGTYPE Small molecular drug D0P8UI DRUGINCH 1S/C14H21N/c1-12-5-7-14(8-6-12)9-11-15-10-3-4-13(15)2/h5-8,13H,3-4,9-11H2,1-2H3/t13-/m0/s1 D0P8UI DRUGINKE BFMXEUSPYLVDSY-ZDUSSCGKSA-N D0P8UI DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)C D0P8UI HIGHSTAT Investigative D0P8XE DRUG__ID D0P8XE D0P8XE DRUGTYPE Small molecular drug D0P8XE DRUGINCH 1S/C23H16N4O2S2/c28-22(19-3-1-11-30-19)24-15-7-5-14(6-8-15)21-26-17-10-9-16(13-18(17)27-21)25-23(29)20-4-2-12-31-20/h1-13H,(H,24,28)(H,25,29)(H,26,27) D0P8XE DRUGINKE ALZVAGBHXQHAIA-UHFFFAOYSA-N D0P8XE DRUGSMIL C1=CSC(=C1)C(=O)NC2=CC=C(C=C2)C3=NC4=C(N3)C=C(C=C4)NC(=O)C5=CC=CS5 D0P8XE HIGHSTAT Investigative D0P8YV DRUG__ID D0P8YV D0P8YV DRUGTYPE Small molecular drug D0P8YV DRUGINCH 1S/C7H12O5/c8-2-3-1-4(9)6(11)7(12)5(3)10/h1,4-12H,2H2/t4-,5+,6-,7-/m0/s1 D0P8YV DRUGINKE PJPGMULJEYSZBS-VZFHVOOUSA-N D0P8YV DRUGSMIL C1=C(C(C(C(C1O)O)O)O)CO D0P8YV HIGHSTAT Investigative D0P9AP DRUG__ID D0P9AP D0P9AP DRUGTYPE Small molecular drug D0P9AP DRUGINCH 1S/C17H21NO2/c1-2-3-4-5-6-14-7-8-17(16(19)13-14)20-15-9-11-18-12-10-15/h7-13,19H,2-6H2,1H3 D0P9AP DRUGINKE YVUSUCCKZBSLJS-UHFFFAOYSA-N D0P9AP DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=NC=C2)O D0P9AP HIGHSTAT Investigative D0P9BG DRUG__ID D0P9BG D0P9BG DRUGTYPE Small molecular drug D0P9BG DRUGINCH 1S/C23H20O4/c1-26-22-14-12-17(11-13-21(25)19-9-5-6-10-20(19)24)15-23(22)27-16-18-7-3-2-4-8-18/h2-15,24H,16H2,1H3/b13-11+ D0P9BG DRUGINKE QYADGBNDKLLFIV-ACCUITESSA-N D0P9BG DRUGSMIL COC1=C(C=C(C=C1)C=CC(=O)C2=CC=CC=C2O)OCC3=CC=CC=C3 D0P9BG HIGHSTAT Investigative D0P9BM DRUG__ID D0P9BM D0P9BM DRUGTYPE Small molecular drug D0P9BM DRUGINCH 1S/C7H10N2O/c8-9-5-6-2-1-3-7(10)4-6/h1-4,9-10H,5,8H2 D0P9BM DRUGINKE OFKWWALNMPEOSZ-UHFFFAOYSA-N D0P9BM DRUGSMIL C1=CC(=CC(=C1)O)CNN D0P9BM HIGHSTAT Investigative D0P9CN DRUG__ID D0P9CN D0P9CN DRUGTYPE Small molecular drug D0P9CN DRUGINCH 1S/C14H12F8O/c15-10(8-4-7-9-5-2-1-3-6-9)11(23)12(16,17)13(18,19)14(20,21)22/h1-3,5-6,10H,4,7-8H2 D0P9CN DRUGINKE MSCLPOMDBKAOHB-UHFFFAOYSA-N D0P9CN DRUGSMIL C1=CC=C(C=C1)CCCC(C(=O)C(C(C(F)(F)F)(F)F)(F)F)F D0P9CN HIGHSTAT Investigative D0P9DD DRUG__ID D0P9DD D0P9DD DRUGTYPE Small molecular drug D0P9DD DRUGINCH 1S/C7H15O7P/c1-5(7(9)10)6(8)3-2-4-14-15(11,12)13/h5-6,8H,2-4H2,1H3,(H,9,10)(H2,11,12,13)/t5-,6+/m1/s1 D0P9DD DRUGINKE MQRCYOMQUQMVCH-RITPCOANSA-N D0P9DD DRUGSMIL CC(C(CCCOP(=O)(O)O)O)C(=O)O D0P9DD HIGHSTAT Investigative D0P9ED DRUG__ID D0P9ED D0P9ED DRUGTYPE Small molecular drug D0P9ED DRUGINCH 1S/C12H15ClN2/c1-15-9-3-4-11(15)10(6-9)8-2-5-12(13)14-7-8/h2,5,7,9-11H,3-4,6H2,1H3 D0P9ED DRUGINKE HLNPMOXPJPCMLY-UHFFFAOYSA-N D0P9ED DRUGSMIL CN1C2CCC1C(C2)C3=CN=C(C=C3)Cl D0P9ED HIGHSTAT Investigative D0P9EO DRUG__ID D0P9EO D0P9EO DRUGTYPE Small molecular drug D0P9EO DRUGINCH 1S/C15H21NO/c1-11-6-5-7-13(10-11)15(17)12(2)16-14-8-3-4-9-14/h5-7,10,12,14,16H,3-4,8-9H2,1-2H3 D0P9EO DRUGINKE VLLKJTHFWNJPCE-UHFFFAOYSA-N D0P9EO DRUGSMIL CC1=CC(=CC=C1)C(=O)C(C)NC2CCCC2 D0P9EO HIGHSTAT Investigative D0P9IA DRUG__ID D0P9IA D0P9IA DRUGTYPE Small molecular drug D0P9IA DRUGINCH 1S/C15H29O4P/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-19-20(16,17)18/h7,9,15H,5-6,8,10-12H2,1-4H3,(H2,16,17,18)/b14-9+ D0P9IA DRUGINKE DZHSRPJGCZHWOM-NTEUORMPSA-N D0P9IA DRUGSMIL CC(CCC=C(C)CCC=C(C)C)CCOP(=O)(O)O D0P9IA HIGHSTAT Investigative D0P9II DRUG__ID D0P9II D0P9II DRUGTYPE Small molecular drug D0P9II DRUGINCH 1S/C13H25N3O2/c1-4-10(14)13(18)16-7-5-6-11(16)12(17)15-8-9(2)3/h9-11H,4-8,14H2,1-3H3,(H,15,17)/t10-,11-/m0/s1 D0P9II DRUGINKE IJQXRRHHARNIBV-QWRGUYRKSA-N D0P9II DRUGSMIL CCC(C(=O)N1CCCC1C(=O)NCC(C)C)N D0P9II HIGHSTAT Investigative D0P9JF DRUG__ID D0P9JF D0P9JF DRUGTYPE Small molecular drug D0P9JF DRUGINCH 1S/C15H18N2O/c1-15(2,13-7-5-9-17-11-13)14(18-3)12-6-4-8-16-10-12/h4-11,14H,1-3H3 D0P9JF DRUGINKE NIZJKWCUCWIETQ-UHFFFAOYSA-N D0P9JF DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CN=CC=C2)OC D0P9JF HIGHSTAT Investigative D0P9KU DRUG__ID D0P9KU D0P9KU DRUGTYPE Small molecular drug D0P9KU DRUGINCH 1S/C23H27NO/c1-4-5-10-15-24-18(3)23(20-13-8-9-14-21(20)24)22(25)16-19-12-7-6-11-17(19)2/h6-9,11-14H,4-5,10,15-16H2,1-3H3 D0P9KU DRUGINKE NHQVWPJMCINXPI-UHFFFAOYSA-N D0P9KU DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3C)C D0P9KU HIGHSTAT Investigative D0P9MQ DRUG__ID D0P9MQ D0P9MQ DRUGTYPE Small molecular drug D0P9MQ DRUGINCH 1S/C21H24N2O4/c1-27-21(24)20(17-7-3-2-4-8-17)19-9-5-6-14-22(19)15-16-10-12-18(13-11-16)23(25)26/h2-4,7-8,10-13,19-20H,5-6,9,14-15H2,1H3/t19-,20-/m1/s1 D0P9MQ DRUGINKE WXZFAWFIMBPTEP-WOJBJXKFSA-N D0P9MQ DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=C(C=C2)[N+](=O)[O-])C3=CC=CC=C3 D0P9MQ HIGHSTAT Investigative D0P9RP DRUG__ID D0P9RP D0P9RP DRUGTYPE Small molecular drug D0P9RP DRUGINCH 1S/C12H22O35S8/c13-48(14,15)37-1-4-6(43-51(22,23)24)8(45-53(28,29)30)9(46-54(31,32)33)11(40-4)42-12(3-39-50(19,20)21)10(47-55(34,35)36)7(44-52(25,26)27)5(41-12)2-38-49(16,17)18/h4-11H,1-3H2,(H,13,14,15)(H,16,17,18)(H,19,20,21)(H,22,23,24)(H,25,26,27)(H,28,29,30)(H,31,32,33)(H,34,35,36)/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1 D0P9RP DRUGINKE WEPNHBQBLCNOBB-UGDNZRGBSA-N D0P9RP DRUGSMIL C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O D0P9RP HIGHSTAT Investigative D0P9SW DRUG__ID D0P9SW D0P9SW DRUGTYPE Small molecular drug D0P9SW DRUGINCH 1S/C25H26O4/c1-14(2)5-7-17-20(26)10-9-18-22(17)27-13-19-16-8-6-15-11-12-25(3,4)29-21(15)24(16)28-23(18)19/h5-6,8-12,19,23,26H,7,13H2,1-4H3/t19-,23-/m0/s1 D0P9SW DRUGINKE YODBFZQPDZJGJG-CVDCTZTESA-N D0P9SW DRUGSMIL CC(=CCC1=C(C=CC2=C1OCC3C2OC4=C3C=CC5=C4OC(C=C5)(C)C)O)C D0P9SW HIGHSTAT Investigative D0P9YU DRUG__ID D0P9YU D0P9YU DRUGTYPE Small molecular drug D0P9YU DRUGINCH 1S/C8H10NO2P/c9-8(12(10)11)6-7-4-2-1-3-5-7/h1-5,9-11H,6H2 D0P9YU DRUGINKE SBTPFRFIHZOOQM-UHFFFAOYSA-N D0P9YU DRUGSMIL C1=CC=C(C=C1)CC(=N)P(O)O D0P9YU HIGHSTAT Investigative D0P9YV DRUG__ID D0P9YV D0P9YV DRUGTYPE Small molecular drug D0P9YV DRUGINCH 1S/C16H16ClNOS/c1-2-6-16(19)18-14-11-12(17)9-10-15(14)20-13-7-4-3-5-8-13/h3-5,7-11H,2,6H2,1H3,(H,18,19) D0P9YV DRUGINKE XBVVQFDKYKYIDI-UHFFFAOYSA-N D0P9YV DRUGSMIL CCCC(=O)NC1=C(C=CC(=C1)Cl)SC2=CC=CC=C2 D0P9YV HIGHSTAT Investigative D0P9ZN DRUG__ID D0P9ZN D0P9ZN DRUGTYPE Small molecular drug D0P9ZN DRUGINCH 1S/C14H10F3N/c1-8-2-4-12-10(6-8)11-7-9(14(15,16)17)3-5-13(11)18-12/h2-7,18H,1H3 D0P9ZN DRUGINKE KIKCAVCUKRAGJM-UHFFFAOYSA-N D0P9ZN DRUGSMIL CC1=CC2=C(C=C1)NC3=C2C=C(C=C3)C(F)(F)F D0P9ZN HIGHSTAT Investigative D0P9ZV DRUG__ID D0P9ZV D0P9ZV DRUGTYPE Small molecular drug D0P9ZV DRUGINCH 1S/C13H17NO5S/c14-20(16,17)19-12-8-6-10(7-9-12)13(15)18-11-4-2-1-3-5-11/h6-9,11H,1-5H2,(H2,14,16,17) D0P9ZV DRUGINKE VMBLTTIYVBQGQH-UHFFFAOYSA-N D0P9ZV DRUGSMIL C1CCC(CC1)OC(=O)C2=CC=C(C=C2)OS(=O)(=O)N D0P9ZV HIGHSTAT Investigative D0P9ZZ DRUG__ID D0P9ZZ D0P9ZZ DRUGTYPE Small molecular drug D0P9ZZ DRUGINCH 1S/C24H33NO3/c1-2-3-4-5-6-7-8-9-13-20-27-22-18-16-21(17-19-22)25-24(26)28-23-14-11-10-12-15-23/h10-12,14-19H,2-9,13,20H2,1H3,(H,25,26) D0P9ZZ DRUGINKE QJLORVSDABTRCS-UHFFFAOYSA-N D0P9ZZ DRUGSMIL CCCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2 D0P9ZZ HIGHSTAT Investigative D0PA1G DRUG__ID D0PA1G D0PA1G DRUGTYPE Small molecular drug D0PA1G DRUGINCH 1S/C7H8O2S/c8-10(9)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,8,9) D0PA1G DRUGINKE NVSONFIVLCXXDH-UHFFFAOYSA-N D0PA1G DRUGSMIL C1=CC=C(C=C1)CS(=O)O D0PA1G HIGHSTAT Investigative D0PA5L DRUG__ID D0PA5L D0PA5L DRUGTYPE Small molecular drug D0PA5L DRUGINCH 1S/C6H3F5N2O2S/c7-1-2(8)4(10)6(5(11)3(1)9)13-16(12,14)15/h13H,(H2,12,14,15) D0PA5L DRUGINKE UPYNRFQXRYOBBD-UHFFFAOYSA-N D0PA5L DRUGSMIL C1(=C(C(=C(C(=C1F)F)F)F)F)NS(=O)(=O)N D0PA5L HIGHSTAT Investigative D0PB2M DRUG__ID D0PB2M D0PB2M DRUGTYPE Small molecular drug D0PB2M DRUGINCH 1S/C14H16IN3O/c15-11-5-3-10(4-6-11)8-13(17)14(19)18-7-1-2-12(18)9-16/h3-6,12-13H,1-2,7-8,17H2/t12-,13-/m0/s1 D0PB2M DRUGINKE PQFUJTFHVDWNOF-STQMWFEESA-N D0PB2M DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)I)N)C#N D0PB2M HIGHSTAT Investigative D0PB2W DRUG__ID D0PB2W D0PB2W DRUGTYPE Small molecular drug D0PB2W DRUGINCH 1S/C9H12N4O3/c1-11-7-6(8(15)12(2)9(11)16)13(3-4-14)5-10-7/h5,14H,3-4H2,1-2H3 D0PB2W DRUGINKE NWPRCRWQMGIBOT-UHFFFAOYSA-N D0PB2W DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCO D0PB2W HIGHSTAT Investigative D0PB5Q DRUG__ID D0PB5Q D0PB5Q DRUGTYPE Small molecular drug D0PB5Q DRUGINCH 1S/C12H15NO3S/c14-11(15)7-13-12(16)10(8-17)6-9-4-2-1-3-5-9/h1-5,10,17H,6-8H2,(H,13,16)(H,14,15) D0PB5Q DRUGINKE LJJKNPQAGWVLDQ-UHFFFAOYSA-N D0PB5Q DRUGSMIL C1=CC=C(C=C1)CC(CS)C(=O)NCC(=O)O D0PB5Q HIGHSTAT Investigative D0PB6B DRUG__ID D0PB6B D0PB6B DRUGTYPE Small molecular drug D0PB6B DRUGINCH 1S/C22H27N3/c1-25(2)16-15-20-17-23-22(24-20)14-13-21(18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17,21H,13-16H2,1-2H3,(H,23,24) D0PB6B DRUGINKE GNBOIGBQIBQOIA-UHFFFAOYSA-N D0PB6B DRUGSMIL CN(C)CCC1=CN=C(N1)CCC(C2=CC=CC=C2)C3=CC=CC=C3 D0PB6B HIGHSTAT Investigative D0PC1Z DRUG__ID D0PC1Z D0PC1Z DRUGTYPE Small molecular drug D0PC1Z DRUGINCH 1S/C19H30O/c1-4-5-13-19(2,3)17-11-9-15(10-12-17)16-7-6-8-18(20)14-16/h9-12,16,18,20H,4-8,13-14H2,1-3H3/t16-,18+/m0/s1 D0PC1Z DRUGINKE WMICXNJEJDOUPN-FUHWJXTLSA-N D0PC1Z DRUGSMIL CCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0PC1Z HIGHSTAT Investigative D0PC2C DRUG__ID D0PC2C D0PC2C DRUGTYPE Small molecular drug D0PC2C DRUGINCH 1S/C12H17NO/c1-2-13-8-6-10-4-3-5-12(14)11(10)7-9-13/h3-5,14H,2,6-9H2,1H3 D0PC2C DRUGINKE HTCXSPINZBVTNI-UHFFFAOYSA-N D0PC2C DRUGSMIL CCN1CCC2=C(CC1)C(=CC=C2)O D0PC2C HIGHSTAT Investigative D0PC2Y DRUG__ID D0PC2Y D0PC2Y DRUGTYPE Small molecular drug D0PC2Y DRUGINCH 1S/C11H14BrN2O8P/c12-2-1-6-4-14(11(17)13-10(6)16)9-3-7(15)8(22-9)5-21-23(18,19)20/h1-2,4,7-9,15H,3,5H2,(H,13,16,17)(H2,18,19,20)/b2-1+/t7-,8+,9-/m1/s1 D0PC2Y DRUGINKE LKWCVKAHHUJPQO-UDGIAEMFSA-N D0PC2Y DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)C=CBr)COP(=O)(O)O)O D0PC2Y HIGHSTAT Investigative D0PC5A DRUG__ID D0PC5A D0PC5A DRUGTYPE Small molecular drug D0PC5A DRUGINCH 1S/C21H23Cl2N3O2/c22-16-8-6-15(7-9-16)19(18-5-4-10-24-20(18)23)28-17-13-26(14-17)21(27)25-11-2-1-3-12-25/h4-10,17,19H,1-3,11-14H2/t19-/m0/s1 D0PC5A DRUGINKE QEKKZTBXSULKCC-IBGZPJMESA-N D0PC5A DRUGSMIL C1CCN(CC1)C(=O)N2CC(C2)OC(C3=CC=C(C=C3)Cl)C4=C(N=CC=C4)Cl D0PC5A HIGHSTAT Investigative D0PC5N DRUG__ID D0PC5N D0PC5N DRUGTYPE Small molecular drug D0PC5N DRUGINCH 1S/C21H26FN3O4/c1-11(23-2)12-6-7-24(9-12)18-16(22)8-14-17(20(18)29-3)25(13-4-5-13)10-15(19(14)26)21(27)28/h8,10-13,23H,4-7,9H2,1-3H3,(H,27,28)/t11-,12+/m0/s1 D0PC5N DRUGINKE SUQUWONDIBHQOZ-NWDGAFQWSA-N D0PC5N DRUGSMIL CC(C1CCN(C1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F)NC D0PC5N HIGHSTAT Investigative D0PC7A DRUG__ID D0PC7A D0PC7A DRUGTYPE Small molecular drug D0PC7A DRUGINCH 1S/C18H21N/c1-19(2)16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,12-13H2,1-2H3/t16-,18-/m1/s1 D0PC7A DRUGINKE DXJUCAUQIHNOAF-SJLPKXTDSA-N D0PC7A DRUGSMIL CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3 D0PC7A HIGHSTAT Investigative D0PD7X DRUG__ID D0PD7X D0PD7X DRUGTYPE Small molecular drug D0PD7X DRUGINCH 1S/C13H10N2O4/c16-13(14-17)10-7-5-9(6-8-10)11-3-1-2-4-12(11)15(18)19/h1-8,17H,(H,14,16) D0PD7X DRUGINKE MDYLSZYFKUGXHL-UHFFFAOYSA-N D0PD7X DRUGSMIL C1=CC=C(C(=C1)C2=CC=C(C=C2)C(=O)NO)[N+](=O)[O-] D0PD7X HIGHSTAT Investigative D0PE0V DRUG__ID D0PE0V D0PE0V DRUGTYPE Small molecular drug D0PE0V DRUGINCH 1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m1/s1 D0PE0V DRUGINKE XUJNEKJLAYXESH-UWTATZPHSA-N D0PE0V DRUGSMIL C(C(C(=O)O)N)S D0PE0V HIGHSTAT Investigative D0PE5T DRUG__ID D0PE5T D0PE5T DRUGTYPE Small molecular drug D0PE5T DRUGINCH 1S/C15H28N4O3/c1-4-9(5-2)13(18-8(3)20)11-6-10(14(21)22)7-12(11)19-15(16)17/h9-13H,4-7H2,1-3H3,(H,18,20)(H,21,22)(H4,16,17,19)/t10-,11-,12-,13+/m1/s1 D0PE5T DRUGINKE FOCBRFMNUQOMCY-LPWJVIDDSA-N D0PE5T DRUGSMIL CCC(CC)C(C1CC(CC1N=C(N)N)C(=O)O)NC(=O)C D0PE5T HIGHSTAT Investigative D0PE8U DRUG__ID D0PE8U D0PE8U DRUGTYPE Small molecular drug D0PE8U DRUGINCH 1S/C27H37N3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-27(31)29-25-20-21-26-24(22-25)23-28-30-26/h6-7,9-10,12-13,15-16,20-23H,2-5,8,11,14,17-19H2,1H3,(H,28,30)(H,29,31)/b7-6-,10-9-,13-12-,16-15- D0PE8U DRUGINKE UYWJHPBUSXDXOJ-DOFZRALJSA-N D0PE8U DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1=CC2=C(C=C1)NN=C2 D0PE8U HIGHSTAT Investigative D0PF3Z DRUG__ID D0PF3Z D0PF3Z DRUGTYPE Small molecular drug D0PF3Z DRUGINCH 1S/C23H27NO4.HI/c1-5-9-24(2)10-8-15-16-7-6-14-11-19(25)20(27-3)12-17(14)21(16)23(28-4)22(26)18(15)13-24;/h6-7,11-12H,5,8-10,13H2,1-4H3,(H-,25,26);1H D0PF3Z DRUGINKE ATOFDXKLKQOFOQ-UHFFFAOYSA-N D0PF3Z DRUGSMIL CCC[N+]1(CCC2=C3C=CC4=CC(=C(C=C4C3=C(C(=C2C1)O)OC)OC)O)C.[I-] D0PF3Z HIGHSTAT Investigative D0PF7F DRUG__ID D0PF7F D0PF7F DRUGTYPE Small molecular drug D0PF7F DRUGINCH 1S/C21H25N3O2/c1-14-7-5-6-8-17(14)22-20(25)26-15-9-10-18-16(13-15)21(2)11-12-23(3)19(21)24(18)4/h5-10,13,19H,11-12H2,1-4H3,(H,22,25)/t19-,21+/m1/s1 D0PF7F DRUGINKE JGAGHIIOCADQOV-CTNGQTDRSA-N D0PF7F DRUGSMIL CC1=CC=CC=C1NC(=O)OC2=CC3=C(C=C2)N(C4C3(CCN4C)C)C D0PF7F HIGHSTAT Investigative D0PF9Q DRUG__ID D0PF9Q D0PF9Q DRUGTYPE Small molecular drug D0PF9Q DRUGINCH 1S/C19H20N2OS/c1-4-12-21(13-5-1)14-15-8-10-16(11-9-15)22-19-20-17-6-2-3-7-18(17)23-19/h2-3,6-11H,1,4-5,12-14H2 D0PF9Q DRUGINKE JNKRNJIZLGLIJG-UHFFFAOYSA-N D0PF9Q DRUGSMIL C1CCN(CC1)CC2=CC=C(C=C2)OC3=NC4=CC=CC=C4S3 D0PF9Q HIGHSTAT Investigative D0PG5D DRUG__ID D0PG5D D0PG5D DRUGTYPE Small molecular drug D0PG5D DRUGINCH 1S/C24H23N5O6/c1-2-11-29(13-14-3-8-18-17(12-14)22(33)28-24(25)27-18)16-6-4-15(5-7-16)21(32)26-19(23(34)35)9-10-20(30)31/h1,3-8,12,19H,9-11,13H2,(H,26,32)(H,30,31)(H,34,35)(H3,25,27,28,33)/t19-/m0/s1 D0PG5D DRUGINKE LTKHPMDRMUCUEB-IBGZPJMESA-N D0PG5D DRUGSMIL C#CCN(CC1=CC2=C(C=C1)N=C(NC2=O)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0PG5D HIGHSTAT Investigative D0PG8L DRUG__ID D0PG8L D0PG8L DRUGTYPE Small molecular drug D0PG8L DRUGINCH 1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m1/s1 D0PG8L DRUGINKE HNDVDQJCIGZPNO-RXMQYKEDSA-N D0PG8L DRUGSMIL C1=C(NC=N1)CC(C(=O)O)N D0PG8L HIGHSTAT Investigative D0PG8M DRUG__ID D0PG8M D0PG8M DRUGTYPE Small molecular drug D0PG8M DRUGINCH 1S/C15H12O3/c16-13-6-1-11(2-7-13)3-10-15(18)12-4-8-14(17)9-5-12/h1-10,16-17H/b10-3+ D0PG8M DRUGINKE FZQLEXXZAVVCCA-XCVCLJGOSA-N D0PG8M DRUGSMIL C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)O)O D0PG8M HIGHSTAT Investigative D0PH1G DRUG__ID D0PH1G D0PH1G DRUGTYPE Small molecular drug D0PH1G DRUGINCH 1S/C14H15N3O/c15-8-12-3-5-13(6-4-12)10-17-11-16-9-14(17)2-1-7-18/h3-6,9,11,18H,1-2,7,10H2 D0PH1G DRUGINKE ACOYOVQVLSTOMH-UHFFFAOYSA-N D0PH1G DRUGSMIL C1=CC(=CC=C1CN2C=NC=C2CCCO)C#N D0PH1G HIGHSTAT Investigative D0PI0R DRUG__ID D0PI0R D0PI0R DRUGTYPE Small molecular drug D0PI0R DRUGINCH 1S/C20H18O3/c1-22-17-11-15(12-18(13-17)23-2)20-6-4-3-5-19(20)14-7-9-16(21)10-8-14/h3-13,21H,1-2H3 D0PI0R DRUGINKE WBVVLROKTBXXTP-UHFFFAOYSA-N D0PI0R DRUGSMIL COC1=CC(=CC(=C1)C2=CC=CC=C2C3=CC=C(C=C3)O)OC D0PI0R HIGHSTAT Investigative D0PI1C DRUG__ID D0PI1C D0PI1C DRUGTYPE Small molecular drug D0PI1C DRUGINCH 1S/C22H27N5O/c1-3-8-18(9-4-1)22(19-10-5-2-6-11-19)28-20-13-16-27(17-14-20)15-7-12-21-23-25-26-24-21/h1-6,8-11,20,22H,7,12-17H2,(H,23,24,25,26) D0PI1C DRUGINKE TZQGXAHOROZEKN-UHFFFAOYSA-N D0PI1C DRUGSMIL C1CN(CCC1OC(C2=CC=CC=C2)C3=CC=CC=C3)CCCC4=NNN=N4 D0PI1C HIGHSTAT Investigative D0PI4H DRUG__ID D0PI4H D0PI4H DRUGTYPE Small molecular drug D0PI4H DRUGINCH 1S/C34H52NO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-34(36)35-32(29-41-42(37,38)39)27-30-23-25-33(26-24-30)40-28-31-20-17-16-18-21-31/h9-10,16-18,20-21,23-26,32H,2-8,11-15,19,22,27-29H2,1H3,(H,35,36)(H2,37,38,39)/b10-9-/t32-/m1/s1 D0PI4H DRUGINKE NJLPYJKKKSBCSK-MJPIYRIWSA-N D0PI4H DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)COP(=O)(O)O D0PI4H HIGHSTAT Investigative D0PI5D DRUG__ID D0PI5D D0PI5D DRUGTYPE Small molecular drug D0PI5D DRUGINCH 1S/C15H13N3/c1-10-4-3-5-12(8-10)14-16-9-13-7-6-11(2)17-15(13)18-14/h3-9H,1-2H3 D0PI5D DRUGINKE AHSIQPYQWYRYSS-UHFFFAOYSA-N D0PI5D DRUGSMIL CC1=CC(=CC=C1)C2=NC=C3C=CC(=NC3=N2)C D0PI5D HIGHSTAT Investigative D0PJ3M DRUG__ID D0PJ3M D0PJ3M DRUGTYPE Small molecular drug D0PJ3M DRUGINCH 1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+ D0PJ3M DRUGINKE KJPRLNWUNMBNBZ-QPJJXVBHSA-N D0PJ3M DRUGSMIL C1=CC=C(C=C1)C=CC=O D0PJ3M HIGHSTAT Investigative D0PJ3R DRUG__ID D0PJ3R D0PJ3R DRUGTYPE Small molecular drug D0PJ3R DRUGINCH 1S/C22H37NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(2)21(24)22-23-18-19-25-22/h10-11,18-20H,3-9,12-17H2,1-2H3/b11-10- D0PJ3R DRUGINKE VNDQKKVLWCFNIJ-KHPPLWFESA-N D0PJ3R DRUGSMIL CCCCCCCCC=CCCCCCCC(C)C(=O)C1=NC=CO1 D0PJ3R HIGHSTAT Investigative D0PJ9J DRUG__ID D0PJ9J D0PJ9J DRUGTYPE Small molecular drug D0PJ9J DRUGINCH 1S/C12H13N3OS2/c17-11(15-12-14-7-9-18-12)13-6-8-16-10-4-2-1-3-5-10/h1-5,7,9H,6,8H2,(H2,13,14,15,17) D0PJ9J DRUGINKE MJPUUVIJLSCJEY-UHFFFAOYSA-N D0PJ9J DRUGSMIL C1=CC=C(C=C1)OCCNC(=S)NC2=NC=CS2 D0PJ9J HIGHSTAT Investigative D0PK8Y DRUG__ID D0PK8Y D0PK8Y DRUGTYPE Small molecular drug D0PK8Y DRUGINCH 1S/C25H24N6O2S2/c1-29-18-27-13-23(29)16-30-15-22(11-21-10-19(12-26)5-6-24(21)30)31(14-20-7-9-34-17-20)35(32,33)25-4-2-3-8-28-25/h2-10,13,17-18,22H,11,14-16H2,1H3 D0PK8Y DRUGINKE FPEPZFNRGIPRRN-UHFFFAOYSA-N D0PK8Y DRUGSMIL CN1C=NC=C1CN2CC(CC3=C2C=CC(=C3)C#N)N(CC4=CSC=C4)S(=O)(=O)C5=CC=CC=N5 D0PK8Y HIGHSTAT Investigative D0PK9V DRUG__ID D0PK9V D0PK9V DRUGTYPE Small molecular drug D0PK9V DRUGINCH 1S/C14H11Cl2NO2/c15-11-5-1-9(2-6-11)13(14(18)17-19)10-3-7-12(16)8-4-10/h1-8,13,19H,(H,17,18) D0PK9V DRUGINKE MITRLTIJDHOUFN-UHFFFAOYSA-N D0PK9V DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(=O)NO)Cl D0PK9V HIGHSTAT Investigative D0PL0Y DRUG__ID D0PL0Y D0PL0Y DRUGTYPE Small molecular drug D0PL0Y DRUGINCH 1S/C8H14NO/c1-9(2,3)7-8-5-4-6-10-8/h4-6H,7H2,1-3H3/q+1 D0PL0Y DRUGINKE HEDXEAAVEOJUCR-UHFFFAOYSA-N D0PL0Y DRUGSMIL C[N+](C)(C)CC1=CC=CO1 D0PL0Y HIGHSTAT Investigative D0PL4F DRUG__ID D0PL4F D0PL4F DRUGTYPE Small molecular drug D0PL4F DRUGINCH 1S/C33H31ClF3NO3/c34-32-27(15-8-17-30(32)33(35,36)37)22-38(18-9-19-41-28-16-7-10-24(20-28)21-31(39)40)23-29(25-11-3-1-4-12-25)26-13-5-2-6-14-26/h1-8,10-17,20,29H,9,18-19,21-23H2,(H,39,40) D0PL4F DRUGINKE NAXSRXHZFIBFMI-UHFFFAOYSA-N D0PL4F DRUGSMIL C1=CC=C(C=C1)C(CN(CCCOC2=CC=CC(=C2)CC(=O)O)CC3=C(C(=CC=C3)C(F)(F)F)Cl)C4=CC=CC=C4 D0PL4F HIGHSTAT Investigative D0PM5R DRUG__ID D0PM5R D0PM5R DRUGTYPE Small molecular drug D0PM5R DRUGINCH 1S/C18H21N7O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-2-4-10(19)5-3-9/h2-5,7-8,12-14,18,26-27H,6,19H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1 D0PM5R DRUGINKE LDYMCRRFCMRFKB-MOROJQBDSA-N D0PM5R DRUGSMIL CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)NCC4=CC=C(C=C4)N)O)O D0PM5R HIGHSTAT Investigative D0PN1A DRUG__ID D0PN1A D0PN1A DRUGTYPE Small molecular drug D0PN1A DRUGINCH 1S/C31H34N4O6/c1-18-12-23(36)13-19(2)24(18)15-25(32)31(41)35-17-21-9-7-6-8-20(21)14-27(35)30(40)34-26(16-28(37)38)29(39)33-22-10-4-3-5-11-22/h3-13,25-27,36H,14-17,32H2,1-2H3,(H,33,39)(H,34,40)(H,37,38)/t25-,26-,27-/m0/s1 D0PN1A DRUGINKE ISUHYDNNFIRLMN-QKDODKLFSA-N D0PN1A DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C(=O)NC4=CC=CC=C4)N)C)O D0PN1A HIGHSTAT Investigative D0PN2C DRUG__ID D0PN2C D0PN2C DRUGTYPE Small molecular drug D0PN2C DRUGINCH 1S/C46H74N14O8/c1-5-28(4)37(44(68)55-32(38(48)62)15-9-10-22-47)60-41(65)34(17-12-24-54-46(51)52)57-42(66)36(26-30-18-20-31(61)21-19-30)59-43(67)35(25-29-13-7-6-8-14-29)58-40(64)33(56-39(63)27(2)3)16-11-23-53-45(49)50/h6-8,13-14,18-21,27-28,32-37,61H,5,9-12,15-17,22-26,47H2,1-4H3,(H2,48,62)(H,55,68)(H,56,63)(H,57,66)(H,58,64)(H,59,67)(H,60,65)(H4,49,50,53)(H4,51,52,54)/t28-,32-,33-,34-,35-,36-,37-/m0/s1 D0PN2C DRUGINKE WWFAEBUHIGIWNK-KHLMYIKTSA-N D0PN2C DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)C D0PN2C HIGHSTAT Investigative D0PN3P DRUG__ID D0PN3P D0PN3P DRUGTYPE Small molecular drug D0PN3P DRUGINCH 1S/C30H39N7O6S/c1-16(2)11-23(29(42)43)36-28(41)22(13-18-7-5-4-6-8-18)35-25(38)15-33-26(39)17(3)34-27(40)20(31)12-19-9-10-21-24(14-19)44-30(32)37-21/h4-10,14,16-17,20,22-23H,11-13,15,31H2,1-3H3,(H2,32,37)(H,33,39)(H,34,40)(H,35,38)(H,36,41)(H,42,43)/t17-,20-,22-,23-/m0/s1 D0PN3P DRUGINKE VLIQMZUUPDOVAM-NWZJSZKRSA-N D0PN3P DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(C)NC(=O)C(CC2=CC3=C(C=C2)N=C(S3)N)N D0PN3P HIGHSTAT Investigative D0PN6Z DRUG__ID D0PN6Z D0PN6Z DRUGTYPE Small molecular drug D0PN6Z DRUGINCH 1S/C4H10NO5P/c5-3(4(6)7)1-2-11(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/t3-/m0/s1 D0PN6Z DRUGINKE DDOQBQRIEWHWBT-VKHMYHEASA-N D0PN6Z DRUGSMIL C(CP(=O)(O)O)C(C(=O)O)N D0PN6Z HIGHSTAT Investigative D0PN8D DRUG__ID D0PN8D D0PN8D DRUGTYPE Small molecular drug D0PN8D DRUGINCH 1S/C15H18N2O/c1-18-15-5-3-12-2-4-14(10-13(12)11-15)17-8-6-16-7-9-17/h2-5,10-11,16H,6-9H2,1H3 D0PN8D DRUGINKE FRTFBUOBLXTGSL-UHFFFAOYSA-N D0PN8D DRUGSMIL COC1=CC2=C(C=CC(=C2)N3CCNCC3)C=C1 D0PN8D HIGHSTAT Investigative D0PN9R DRUG__ID D0PN9R D0PN9R DRUGTYPE Small molecular drug D0PN9R DRUGINCH 1S/C27H32FN3O4/c1-18(12-19-4-6-20(28)7-5-19)15-30-8-10-31(11-9-30)16-26-22-17-34-23-14-25(33-3)24(32-2)13-21(23)27(22)29-35-26/h4-7,12-14,22,26H,8-11,15-17H2,1-3H3/b18-12+/t22-,26-/m0/s1 D0PN9R DRUGINKE UCNOTTVNPRSTFW-XSFNXXSESA-N D0PN9R DRUGSMIL CC(=CC1=CC=C(C=C1)F)CN2CCN(CC2)CC3C4COC5=CC(=C(C=C5C4=NO3)OC)OC D0PN9R HIGHSTAT Investigative D0PN9S DRUG__ID D0PN9S D0PN9S DRUGTYPE Small molecular drug D0PN9S DRUGINCH 1S/C22H23NO2/c24-21(16-10-2-1-5-11-18-12-6-3-7-13-18)22-23-20(17-25-22)19-14-8-4-9-15-19/h3-4,6-9,12-15,17H,1-2,5,10-11,16H2 D0PN9S DRUGINKE XOLGPHAVLXMSGU-UHFFFAOYSA-N D0PN9S DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)C3=CC=CC=C3 D0PN9S HIGHSTAT Investigative D0PO8E DRUG__ID D0PO8E D0PO8E DRUGTYPE Small molecular drug D0PO8E DRUGINCH 1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 D0PO8E DRUGINKE FFEARJCKVFRZRR-BYPYZUCNSA-N D0PO8E DRUGSMIL CSCCC(C(=O)O)N D0PO8E HIGHSTAT Investigative D0PO9X DRUG__ID D0PO9X D0PO9X DRUGTYPE Small molecular drug D0PO9X DRUGINCH 1S/C19H17NO3/c21-15-12-18(23-19(13-15)20-8-10-22-11-9-20)17-7-3-5-14-4-1-2-6-16(14)17/h1-7,12-13H,8-11H2 D0PO9X DRUGINKE VSXKSTFHVOSHSV-UHFFFAOYSA-N D0PO9X DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC4=CC=CC=C43 D0PO9X HIGHSTAT Investigative D0PP3Q DRUG__ID D0PP3Q D0PP3Q DRUGTYPE Small molecular drug D0PP3Q DRUGINCH 1S/C9H7NO2S2/c11-9(10-12)8-4-3-7(14-8)6-2-1-5-13-6/h1-5,12H,(H,10,11) D0PP3Q DRUGINKE PSYPMKKEKUDELT-UHFFFAOYSA-N D0PP3Q DRUGSMIL C1=CSC(=C1)C2=CC=C(S2)C(=O)NO D0PP3Q HIGHSTAT Investigative D0PP6Y DRUG__ID D0PP6Y D0PP6Y DRUGTYPE Small molecular drug D0PP6Y DRUGINCH 1S/C19H18N6O/c1-3-17(24-5-7-26-8-6-24)4-2-14(1)16-9-20-19-18(12-23-25(19)13-16)15-10-21-22-11-15/h1-4,9-13H,5-8H2,(H,21,22) D0PP6Y DRUGINKE WCDLCPLAAKUJNY-UHFFFAOYSA-N D0PP6Y DRUGSMIL C1COCCN1C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CNN=C5)N=C3 D0PP6Y HIGHSTAT Investigative D0PP7U DRUG__ID D0PP7U D0PP7U DRUGTYPE Small molecular drug D0PP7U DRUGINCH 1S/C29H30N4O3/c1-20(32-28(35)22-12-6-3-7-13-22)27(34)33-26(18-23-19-31-25-15-9-8-14-24(23)25)29(36)30-17-16-21-10-4-2-5-11-21/h2-15,19-20,26,31H,16-18H2,1H3,(H,30,36)(H,32,35)(H,33,34) D0PP7U DRUGINKE OXMOOJYZUSQLNA-UHFFFAOYSA-N D0PP7U DRUGSMIL CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NCCC3=CC=CC=C3)NC(=O)C4=CC=CC=C4 D0PP7U HIGHSTAT Investigative D0PP8T DRUG__ID D0PP8T D0PP8T DRUGTYPE Small molecular drug D0PP8T DRUGINCH 1S/C17H23NO4/c1-22-16(20)13-18-17(21)15(19)12-8-3-2-5-9-14-10-6-4-7-11-14/h4,6-7,10-11H,2-3,5,8-9,12-13H2,1H3,(H,18,21) D0PP8T DRUGINKE MUJNYULVHMASQZ-UHFFFAOYSA-N D0PP8T DRUGSMIL COC(=O)CNC(=O)C(=O)CCCCCCC1=CC=CC=C1 D0PP8T HIGHSTAT Investigative D0PQ1U DRUG__ID D0PQ1U D0PQ1U DRUGTYPE Small molecular drug D0PQ1U DRUGINCH 1S/C20H23N/c1-21(2)13-12-17-15-18(14-16-8-4-3-5-9-16)20-11-7-6-10-19(17)20/h3-11,15,18H,12-14H2,1-2H3 D0PQ1U DRUGINKE CKYIFJXFLBXUQQ-UHFFFAOYSA-N D0PQ1U DRUGSMIL CN(C)CCC1=CC(C2=CC=CC=C21)CC3=CC=CC=C3 D0PQ1U HIGHSTAT Investigative D0PQ3Q DRUG__ID D0PQ3Q D0PQ3Q DRUGTYPE Small molecular drug D0PQ3Q DRUGINCH 1S/C16H12ClNOS/c1-19-14-8-4-12(5-9-14)16-15(10-18-20-16)11-2-6-13(17)7-3-11/h2-10H,1H3 D0PQ3Q DRUGINKE OORIOMOWZWWCHX-UHFFFAOYSA-N D0PQ3Q DRUGSMIL COC1=CC=C(C=C1)C2=C(C=NS2)C3=CC=C(C=C3)Cl D0PQ3Q HIGHSTAT Investigative D0PQ5R DRUG__ID D0PQ5R D0PQ5R DRUGTYPE Small molecular drug D0PQ5R DRUGINCH 1S/C20H15NO2S/c1-14-10-12-15(13-11-14)23-20(22)21-16-6-2-4-8-18(16)24-19-9-5-3-7-17(19)21/h2-13H,1H3 D0PQ5R DRUGINKE HXQRAZTUUZVKLB-UHFFFAOYSA-N D0PQ5R DRUGSMIL CC1=CC=C(C=C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0PQ5R HIGHSTAT Investigative D0PQ5T DRUG__ID D0PQ5T D0PQ5T DRUGTYPE Small molecular drug D0PQ5T DRUGINCH 1S/C9H18N2O4/c12-8(10-14)6-4-2-1-3-5-7-9(13)11-15/h14-15H,1-7H2,(H,10,12)(H,11,13) D0PQ5T DRUGINKE VBJZDMOTYJEHEP-UHFFFAOYSA-N D0PQ5T DRUGSMIL C(CCCC(=O)NO)CCCC(=O)NO D0PQ5T HIGHSTAT Investigative D0PQ8B DRUG__ID D0PQ8B D0PQ8B DRUGTYPE Small molecular drug D0PQ8B DRUGINCH 1S/C24H40O4/c1-3-5-7-9-11-13-15-17-20-19-22(26)23(24(27)28-20)21(25)18-16-14-12-10-8-6-4-2/h19,26H,3-18H2,1-2H3 D0PQ8B DRUGINKE FFXYZCMDXPBYIG-UHFFFAOYSA-N D0PQ8B DRUGSMIL CCCCCCCCCC1=CC(=C(C(=O)O1)C(=O)CCCCCCCCC)O D0PQ8B HIGHSTAT Investigative D0PR2Q DRUG__ID D0PR2Q D0PR2Q DRUGTYPE Small molecular drug D0PR2Q DRUGINCH 1S/C45H72N14O8/c1-4-27(3)37(43(67)55-31(38(47)62)15-9-10-22-46)59-40(64)33(17-12-24-53-45(50)51)56-41(65)35(26-29-18-20-30(60)21-19-29)58-42(66)34(25-28-13-7-6-8-14-28)57-39(63)32(54-36(61)5-2)16-11-23-52-44(48)49/h6-8,13-14,18-21,27,31-35,37,60H,4-5,9-12,15-17,22-26,46H2,1-3H3,(H2,47,62)(H,54,61)(H,55,67)(H,56,65)(H,57,63)(H,58,66)(H,59,64)(H4,48,49,52)(H4,50,51,53)/t27-,31-,32-,33-,34-,35-,37-/m0/s1 D0PR2Q DRUGINKE DWZCXYUZSXSRCU-OQYWAUBWSA-N D0PR2Q DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)CC D0PR2Q HIGHSTAT Investigative D0PR2T DRUG__ID D0PR2T D0PR2T DRUGTYPE Small molecular drug D0PR2T DRUGINCH 1S/C22H28O4/c1-13-14(2)22(16-8-10-18(24-4)20(12-16)26-6)21(13)15-7-9-17(23-3)19(11-15)25-5/h7-14,21-22H,1-6H3/t13-,14-,21-,22-/m0/s1 D0PR2T DRUGINKE IOTXFXWARGNLEJ-WJWAULOUSA-N D0PR2T DRUGSMIL CC1C(C(C1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C D0PR2T HIGHSTAT Investigative D0PR7L DRUG__ID D0PR7L D0PR7L DRUGTYPE Small molecular drug D0PR7L DRUGINCH 1S/C7H7FS/c8-7-3-1-6(5-9)2-4-7/h1-4,9H,5H2 D0PR7L DRUGINKE RKTRHMNWVZRZJQ-UHFFFAOYSA-N D0PR7L DRUGSMIL C1=CC(=CC=C1CS)F D0PR7L HIGHSTAT Investigative D0PR9E DRUG__ID D0PR9E D0PR9E DRUGTYPE Small molecular drug D0PR9E DRUGINCH 1S/C34H45N7O9/c1-18(2)15-25(38-32(47)27(19(3)4)39-30(45)23(35)13-14-26(42)43)31(46)37-24(16-20-9-6-5-7-10-20)28(44)33(48)36-22-12-8-11-21(17-22)29-40-34(49)50-41-29/h5-12,17-19,23-25,27-28,44H,13-16,35H2,1-4H3,(H,36,48)(H,37,46)(H,38,47)(H,39,45)(H,42,43)(H,40,41,49)/t23-,24-,25-,27-,28+/m0/s1 D0PR9E DRUGINKE WXPDDAQNFBWSRN-WZFFGLSISA-N D0PR9E DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(C(=O)NC2=CC=CC(=C2)C3=NOC(=O)N3)O)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)N D0PR9E HIGHSTAT Investigative D0PS7U DRUG__ID D0PS7U D0PS7U DRUGTYPE Small molecular drug D0PS7U DRUGINCH 1S/C156H212N34O52S8/c1-85(169-88(4)195)135(212)165-76-126(202)171-111(80-192)145(222)184-114-83-245-244-82-113(183-144(221)109(69-92-72-162-100-31-17-16-30-97(92)100)179-148(225)112-81-243-246-84-115(182-143(220)108(178-147(114)224)68-91-41-45-94(197)46-42-91)149(226)180-110(79-191)137(214)168-78-128(204)189-62-27-35-119(189)153(230)190-63-26-34-118(190)150(227)174-102(33-25-59-161-154(158)159)138(215)176-106(66-89-28-11-8-12-29-89)141(218)172-104(139(216)181-112)50-55-130(207)208)146(223)177-107(67-90-39-43-93(196)44-40-90)142(219)173-105(51-56-131(209)210)140(217)186-133(87(3)194)152(229)175-103(49-54-129(205)206)136(213)166-77-127(203)185-132(86(2)193)151(228)167-74-124(200)163-73-123(199)164-75-125(201)170-101(134(157)211)32-18-20-58-160-122(198)38-15-10-21-60-187-116-52-47-95(249(237,238)239)70-98(116)155(5,6)120(187)36-13-9-14-37-121-156(7,57-19-23-64-247(231,232)233)99-71-96(250(240,241)242)48-53-117(99)188(121)61-22-24-65-248(234,235)236/h8-9,11-14,16-17,28-31,36-37,39-48,52-53,70-72,85-87,101-115,118-119,132-133,162,191-194H,10,15,18-27,32-35,38,49-51,54-69,73-84H2,1-7H3,(H39-,157,158,159,160,161,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,195,196,197,198,199,200,201,202,203,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,231,232,233,234,235,236,237,238,239,240,241,242)/t85-,86+,87+,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,118-,119-,132-,133-,156?/m0/s1 D0PS7U DRUGINKE UQYUYHHXESUXGH-ABPLELQPSA-N D0PS7U DRUGSMIL CC(C(C(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CCCCCN1C2=C(C=C(C=C2)S(=O)(=O)O)C(C1=CC=CC=CC3=[N+](C4=C(C3(C)CCCCS(=O)(=O)O)C=C(C=C4)S(=O)(=O)[O-])CCCCS(=O)(=O)O)(C)C)C(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C6CSSCC(C(=O)NC(C(=O)NC7CSSCC(C(=O)NC(C(=O)N6)CC8=CNC9=CC=CC=C98)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)CNC(=O)C(NC7=O)CO)CCCNC(=N)N)CC1=CC=CC=C1)CCC(=O)O)CC1=CC=C(C=C1)O)NC(=O)C(CO)NC(=O)CNC(=O)C(C)NC(=O)C)O D0PS7U HIGHSTAT Investigative D0PT1K DRUG__ID D0PT1K D0PT1K DRUGTYPE Small molecular drug D0PT1K DRUGINCH 1S/C14H10ClN3O/c15-10-4-6-11(7-5-10)18-8-9-2-1-3-12(14(16)19)13(9)17-18/h1-8H,(H2,16,19) D0PT1K DRUGINKE ZUUTWXXAMVQOFT-UHFFFAOYSA-N D0PT1K DRUGSMIL C1=CC2=CN(N=C2C(=C1)C(=O)N)C3=CC=C(C=C3)Cl D0PT1K HIGHSTAT Investigative D0PT2D DRUG__ID D0PT2D D0PT2D DRUGTYPE Small molecular drug D0PT2D DRUGINCH 1S/C16H11NO3S/c1-20-13-5-4-9(7-12(13)18)10-8-21-16-14(10)17-6-2-3-11(17)15(16)19/h2-8,18H,1H3 D0PT2D DRUGINKE IXGRUAKWRHZSAP-UHFFFAOYSA-N D0PT2D DRUGSMIL COC1=C(C=C(C=C1)C2=CSC3=C2N4C=CC=C4C3=O)O D0PT2D HIGHSTAT Investigative D0PT8O DRUG__ID D0PT8O D0PT8O DRUGTYPE Small molecular drug D0PT8O DRUGINCH 1S/C44H61N7O12S/c1-26(52)46-33(24-36(55)56)42(60)47-31(20-21-35(53)54)40(58)51-38(37(28-15-7-3-8-16-28)29-17-9-4-10-18-29)43(61)48-30(19-11-12-22-45)39(57)49-32(23-27-13-5-2-6-14-27)41(59)50-34(25-64)44(62)63/h3-4,7-10,15-18,27,30-34,37-38,64H,2,5-6,11-14,19-25,45H2,1H3,(H,46,52)(H,47,60)(H,48,61)(H,49,57)(H,50,59)(H,51,58)(H,53,54)(H,55,56)(H,62,63)/t30-,31-,32-,33-,34-,38-/m0/s1 D0PT8O DRUGINKE MMHRSDHCRGNWNY-PHPRXEDMSA-N D0PT8O DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C1=CC=CC=C1)C2=CC=CC=C2)C(=O)NC(CCCCN)C(=O)NC(CC3CCCCC3)C(=O)NC(CS)C(=O)O D0PT8O HIGHSTAT Investigative D0PU1J DRUG__ID D0PU1J D0PU1J DRUGTYPE Small molecular drug D0PU1J DRUGINCH 1S/C18H19NO3/c1-14(19(21)15(2)20)11-12-16-7-6-10-18(13-16)22-17-8-4-3-5-9-17/h3-14,21H,1-2H3/b12-11+ D0PU1J DRUGINKE ZLIVOFMPDUIULQ-VAWYXSNFSA-N D0PU1J DRUGSMIL CC(C=CC1=CC(=CC=C1)OC2=CC=CC=C2)N(C(=O)C)O D0PU1J HIGHSTAT Investigative D0PU1R DRUG__ID D0PU1R D0PU1R DRUGTYPE Small molecular drug D0PU1R DRUGINCH 1S/C15H12N2/c1-11-7-8-13-9-10-14(17-15(13)16-11)12-5-3-2-4-6-12/h2-10H,1H3 D0PU1R DRUGINKE BGLSJWRWFABGNC-UHFFFAOYSA-N D0PU1R DRUGSMIL CC1=NC2=C(C=C1)C=CC(=N2)C3=CC=CC=C3 D0PU1R HIGHSTAT Investigative D0PU5V DRUG__ID D0PU5V D0PU5V DRUGTYPE Small molecular drug D0PU5V DRUGINCH 1S/C13H11N3/c1-2-12-3-4-14-8-13(12)7-11(1)9-16-6-5-15-10-16/h1-8,10H,9H2 D0PU5V DRUGINKE SIZZGSWTNCSETD-UHFFFAOYSA-N D0PU5V DRUGSMIL C1=CC(=CC2=C1C=CN=C2)CN3C=CN=C3 D0PU5V HIGHSTAT Investigative D0PU6F DRUG__ID D0PU6F D0PU6F DRUGTYPE Small molecular drug D0PU6F DRUGINCH 1S/C15H10N4/c1-2-6-11-10(5-1)16-9-14(17-11)15-18-12-7-3-4-8-13(12)19-15/h1-9H,(H,18,19) D0PU6F DRUGINKE AYFBMQMYJRNGIM-UHFFFAOYSA-N D0PU6F DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=NC4=CC=CC=C4N=C3 D0PU6F HIGHSTAT Investigative D0PV6G DRUG__ID D0PV6G D0PV6G DRUGTYPE Small molecular drug D0PV6G DRUGINCH 1S/C18H27NO/c1-3-8-19(9-4-2)17-6-5-14-11-15-7-10-20-18(15)13-16(14)12-17/h11,13,17H,3-10,12H2,1-2H3 D0PV6G DRUGINKE IJICKINLCUKIHY-UHFFFAOYSA-N D0PV6G DRUGSMIL CCCN(CCC)C1CCC2=CC3=C(C=C2C1)OCC3 D0PV6G HIGHSTAT Investigative D0PW4M DRUG__ID D0PW4M D0PW4M DRUGTYPE Small molecular drug D0PW4M DRUGINCH 1S/C39H51N5O6S/c1-6-40-16-17-41-28-18-24(2)35(25(3)19-28)50-22-32(46)42-30(20-26-12-8-7-9-13-26)34(47)38(49)44-23-51-39(4,5)36(44)37(48)43-33-29-15-11-10-14-27(29)21-31(33)45/h7-15,18-19,30-31,33-34,36,40-41,45,47H,6,16-17,20-23H2,1-5H3,(H,42,46)(H,43,48)/t30-,31+,33-,34-,36+/m0/s1 D0PW4M DRUGINKE QWIMGFUQWCHOOH-SQKWSBCUSA-N D0PW4M DRUGSMIL CCNCCNC1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0PW4M HIGHSTAT Investigative D0PW7B DRUG__ID D0PW7B D0PW7B DRUGTYPE Small molecular drug D0PW7B DRUGINCH 1S/C16H10N2O6S4/c19-27(20,21)15-7-13(17-9-25)5-3-11(15)1-2-12-4-6-14(18-10-26)8-16(12)28(22,23)24/h1-8H,(H,19,20,21)(H,22,23,24)/b2-1+ D0PW7B DRUGINKE YSCNMFDFYJUPEF-OWOJBTEDSA-N D0PW7B DRUGSMIL C1=CC(=C(C=C1N=C=S)S(=O)(=O)O)C=CC2=C(C=C(C=C2)N=C=S)S(=O)(=O)O D0PW7B HIGHSTAT Investigative D0PX3G DRUG__ID D0PX3G D0PX3G DRUGTYPE Small molecular drug D0PX3G DRUGINCH 1S/C32H39F2N5O6/c1-4-27(40)36-23-8-5-7-21(17-23)20-11-15-38(16-12-20)14-6-13-35-31(42)39-29(22-9-10-24(33)25(34)18-22)28(30(41)45-3)26(19-44-2)37-32(39)43/h5,7-10,17-18,20,29H,4,6,11-16,19H2,1-3H3,(H,35,42)(H,36,40)(H,37,43)/t29-/m0/s1 D0PX3G DRUGINKE PTSDBXLVMLZQHY-LJAQVGFWSA-N D0PX3G DRUGSMIL CCC(=O)NC1=CC=CC(=C1)C2CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)COC)C(=O)OC)C4=CC(=C(C=C4)F)F D0PX3G HIGHSTAT Investigative D0Q0BK DRUG__ID D0Q0BK D0Q0BK DRUGTYPE Small molecular drug D0Q0BK DRUGINCH 1S/C18H14FNO/c19-17-12-16(5-6-18(17)21)15-3-1-13(2-4-15)11-14-7-9-20-10-8-14/h1-10,12,21H,11H2 D0Q0BK DRUGINKE SFFLHOMUFWFHRI-UHFFFAOYSA-N D0Q0BK DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)O)F D0Q0BK HIGHSTAT Investigative D0Q0BV DRUG__ID D0Q0BV D0Q0BV DRUGTYPE Small molecular drug D0Q0BV DRUGINCH 1S/C23H15NO2S/c25-23(26-18-14-13-16-7-1-2-8-17(16)15-18)24-19-9-3-5-11-21(19)27-22-12-6-4-10-20(22)24/h1-15H D0Q0BV DRUGINKE DFCQYZLDLAWXGY-UHFFFAOYSA-N D0Q0BV DRUGSMIL C1=CC=C2C=C(C=CC2=C1)OC(=O)N3C4=CC=CC=C4SC5=CC=CC=C53 D0Q0BV HIGHSTAT Investigative D0Q0EB DRUG__ID D0Q0EB D0Q0EB DRUGTYPE Small molecular drug D0Q0EB DRUGINCH 1S/C25H24N4O6/c1-3-12-29(14-16-4-9-20-19(13-16)24(33)27-15(2)26-20)18-7-5-17(6-8-18)23(32)28-21(25(34)35)10-11-22(30)31/h1,4-9,13,21H,10-12,14H2,2H3,(H,28,32)(H,30,31)(H,34,35)(H,26,27,33)/t21-/m0/s1 D0Q0EB DRUGINKE PMTUUSDTAKQWQJ-NRFANRHFSA-N D0Q0EB DRUGSMIL CC1=NC2=C(C=C(C=C2)CN(CC#C)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1 D0Q0EB HIGHSTAT Investigative D0Q0EK DRUG__ID D0Q0EK D0Q0EK DRUGTYPE Small molecular drug D0Q0EK DRUGINCH 1S/C7H9N3O3S/c8-10-7(11)5-1-3-6(4-2-5)14(9,12)13/h1-4H,8H2,(H,10,11)(H2,9,12,13) D0Q0EK DRUGINKE JIDAHYHCQJXNTD-UHFFFAOYSA-N D0Q0EK DRUGSMIL C1=CC(=CC=C1C(=O)NN)S(=O)(=O)N D0Q0EK HIGHSTAT Investigative D0Q0EY DRUG__ID D0Q0EY D0Q0EY DRUGTYPE Small molecular drug D0Q0EY DRUGINCH 1S/C6H15NS/c1-5(2)3-6(7)4-8/h5-6,8H,3-4,7H2,1-2H3/t6-/m0/s1 D0Q0EY DRUGINKE GXEDNWSUKCJLLB-LURJTMIESA-N D0Q0EY DRUGSMIL CC(C)CC(CS)N D0Q0EY HIGHSTAT Investigative D0Q0IE DRUG__ID D0Q0IE D0Q0IE DRUGTYPE Small molecular drug D0Q0IE DRUGINCH 1S/C15H11ClF2N4S/c16-10-2-4-13(21-8-10)22-15(23)20-6-5-11-12(17)3-1-9(7-19)14(11)18/h1-4,8H,5-6H2,(H2,20,21,22,23) D0Q0IE DRUGINKE OZXHOQRXBCCXFI-UHFFFAOYSA-N D0Q0IE DRUGSMIL C1=CC(=NC=C1Cl)NC(=S)NCCC2=C(C=CC(=C2F)C#N)F D0Q0IE HIGHSTAT Investigative D0Q0IR DRUG__ID D0Q0IR D0Q0IR DRUGTYPE Small molecular drug D0Q0IR DRUGINCH 1S/C28H24O2/c1-19-4-11-22(12-5-19)24-16-17-28(2,3)26-15-10-21(18-25(24)26)7-6-20-8-13-23(14-9-20)27(29)30/h4-5,8-16,18H,17H2,1-3H3,(H,29,30) D0Q0IR DRUGINKE NCEQLLNVRRTCKJ-UHFFFAOYSA-N D0Q0IR DRUGSMIL CC1=CC=C(C=C1)C2=CCC(C3=C2C=C(C=C3)C#CC4=CC=C(C=C4)C(=O)O)(C)C D0Q0IR HIGHSTAT Investigative D0Q0LD DRUG__ID D0Q0LD D0Q0LD DRUGTYPE Small molecular drug D0Q0LD DRUGINCH 1S/C17H23Cl6N3O2S/c1-9(16(18,19)20)7-12(25-13(27)8-10(2)17(21,22)23)15(28)26(4)11(3)14-24-5-6-29-14/h5-6,9-12H,7-8H2,1-4H3,(H,25,27)/t9-,10-,11+,12-/m0/s1 D0Q0LD DRUGINKE MBVQTLXBQHZLRO-YFKTTZPYSA-N D0Q0LD DRUGSMIL CC(CC(C(=O)N(C)C(C)C1=NC=CS1)NC(=O)CC(C)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl D0Q0LD HIGHSTAT Investigative D0Q0LH DRUG__ID D0Q0LH D0Q0LH DRUGTYPE Small molecular drug D0Q0LH DRUGINCH 1S/C21H23NO4/c1-14(23)22-10-9-18-19-13-17(25-3)7-8-20(19)26-21(18)12-15-5-4-6-16(11-15)24-2/h4-8,11,13H,9-10,12H2,1-3H3,(H,22,23) D0Q0LH DRUGINKE GNWDMICUDNQPEK-UHFFFAOYSA-N D0Q0LH DRUGSMIL CC(=O)NCCC1=C(OC2=C1C=C(C=C2)OC)CC3=CC(=CC=C3)OC D0Q0LH HIGHSTAT Investigative D0Q0MN DRUG__ID D0Q0MN D0Q0MN DRUGTYPE Small molecular drug D0Q0MN DRUGINCH 1S/C13H17Cl2NO/c14-11-5-4-9(7-12(11)15)10(8-17)13-3-1-2-6-16-13/h4-5,7,10,13,16-17H,1-3,6,8H2/t10-,13-/m1/s1 D0Q0MN DRUGINKE VBLILHAGVIRWHD-ZWNOBZJWSA-N D0Q0MN DRUGSMIL C1CCNC(C1)C(CO)C2=CC(=C(C=C2)Cl)Cl D0Q0MN HIGHSTAT Investigative D0Q0OH DRUG__ID D0Q0OH D0Q0OH DRUGTYPE Small molecular drug D0Q0OH DRUGINCH 1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5+,6+/m1/s1 D0Q0OH DRUGINKE NBSCHQHZLSJFNQ-PQMKYFCFSA-N D0Q0OH DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)OP(=O)(O)O D0Q0OH HIGHSTAT Investigative D0Q0OR DRUG__ID D0Q0OR D0Q0OR DRUGTYPE Small molecular drug D0Q0OR DRUGINCH 1S/C33H31Cl2N3O4/c1-5-37(19-21-7-6-14-36-18-21)31(39)22-9-12-28(35)26(15-22)33(2)27-16-24(34)10-13-29(27)38(32(33)40)20-23-8-11-25(41-3)17-30(23)42-4/h6-18H,5,19-20H2,1-4H3/t33-/m0/s1 D0Q0OR DRUGINKE UENRBNCNIZQNTR-XIFFEERXSA-N D0Q0OR DRUGSMIL CCN(CC1=CN=CC=C1)C(=O)C2=CC(=C(C=C2)Cl)C3(C4=C(C=CC(=C4)Cl)N(C3=O)CC5=C(C=C(C=C5)OC)OC)C D0Q0OR HIGHSTAT Investigative D0Q0PN DRUG__ID D0Q0PN D0Q0PN DRUGTYPE Small molecular drug D0Q0PN DRUGINCH 1S/C21H19N3O4/c25-15-7-9-18-13(11-15)5-8-19-14(12-22-24(18)19)6-10-20(26)23-17-4-2-1-3-16(17)21(27)28/h1-4,7,9,11-12,25H,5-6,8,10H2,(H,23,26)(H,27,28) D0Q0PN DRUGINKE PCUNTWOSLIUDRR-UHFFFAOYSA-N D0Q0PN DRUGSMIL C1CC2=C(C=NN2C3=C1C=C(C=C3)O)CCC(=O)NC4=CC=CC=C4C(=O)O D0Q0PN HIGHSTAT Investigative D0Q0XE DRUG__ID D0Q0XE D0Q0XE DRUGTYPE Small molecular drug D0Q0XE DRUGINCH 1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2/t2-,5+/m0/s1 D0Q0XE DRUGINKE SBJKKFFYIZUCET-JLAZNSOCSA-N D0Q0XE DRUGSMIL C(C(C1C(=O)C(=O)C(=O)O1)O)O D0Q0XE HIGHSTAT Investigative D0Q0XO DRUG__ID D0Q0XO D0Q0XO DRUGTYPE Small molecular drug D0Q0XO DRUGINCH 1S/C11H16N2O3S/c1-2-3-4-11(14)13-9-5-7-10(8-6-9)17(12,15)16/h5-8H,2-4H2,1H3,(H,13,14)(H2,12,15,16) D0Q0XO DRUGINKE YLGGQMUYDSKQIG-UHFFFAOYSA-N D0Q0XO DRUGSMIL CCCCC(=O)NC1=CC=C(C=C1)S(=O)(=O)N D0Q0XO HIGHSTAT Investigative D0Q0XV DRUG__ID D0Q0XV D0Q0XV DRUGTYPE Small molecular drug D0Q0XV DRUGINCH 1S/C19H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19(22)20-17-16-18(17)21/h17-18,21H,2-16H2,1H3,(H,20,22)/t17-,18+/m0/s1 D0Q0XV DRUGINKE LIBNBUULGCFJNR-ZWKOTPCHSA-N D0Q0XV DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC1CC1O D0Q0XV HIGHSTAT Investigative D0Q0YC DRUG__ID D0Q0YC D0Q0YC DRUGTYPE Small molecular drug D0Q0YC DRUGINCH 1S/C15H19N3/c1-2-17-9-11-18(12-10-17)15-8-7-13-5-3-4-6-14(13)16-15/h3-8H,2,9-12H2,1H3 D0Q0YC DRUGINKE HEWVIFVVKWCRML-UHFFFAOYSA-N D0Q0YC DRUGSMIL CCN1CCN(CC1)C2=NC3=CC=CC=C3C=C2 D0Q0YC HIGHSTAT Investigative D0Q0YS DRUG__ID D0Q0YS D0Q0YS DRUGTYPE Small molecular drug D0Q0YS DRUGINCH 1S/C15H12I3NO4/c16-9-3-7(4-12(19)15(21)22)1-2-13(9)23-8-5-10(17)14(20)11(18)6-8/h1-3,5-6,12,20H,4,19H2,(H,21,22)/t12-/m0/s1 D0Q0YS DRUGINKE HZCBWYNLGPIQRK-LBPRGKRZSA-N D0Q0YS DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)I)OC2=CC(=C(C(=C2)I)O)I D0Q0YS HIGHSTAT Investigative D0Q0YV DRUG__ID D0Q0YV D0Q0YV DRUGTYPE Small molecular drug D0Q0YV DRUGINCH 1S/C21H21N5O/c1-21(2,3)16-6-4-15(5-7-16)20(27)24-18-13-26-12-17(8-9-19(26)23-18)25-11-10-22-14-25/h4-14H,1-3H3,(H,24,27) D0Q0YV DRUGINKE SMJAMOAYGIVKRI-UHFFFAOYSA-N D0Q0YV DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C(=O)NC2=CN3C=C(C=CC3=N2)N4C=CN=C4 D0Q0YV HIGHSTAT Investigative D0Q1AC DRUG__ID D0Q1AC D0Q1AC DRUGTYPE Small molecular drug D0Q1AC DRUGINCH 1S/C12H10FN5/c1-18-7-16-10-11(14-6-15-12(10)18)17-9-4-2-8(13)3-5-9/h2-7H,1H3,(H,14,15,17) D0Q1AC DRUGINKE JDDWQQHPEXJAKO-UHFFFAOYSA-N D0Q1AC DRUGSMIL CN1C=NC2=C(N=CN=C21)NC3=CC=C(C=C3)F D0Q1AC HIGHSTAT Investigative D0Q1BD DRUG__ID D0Q1BD D0Q1BD DRUGTYPE Small molecular drug D0Q1BD DRUGINCH 1S/C20H27N8O24P5/c29-11-7(47-19(13(11)31)27-5-25-9-15(27)21-3-23-17(9)33)1-45-57(44,52-56(42,43)51-55(40,41)50-54(38,39)49-53(35,36)37)46-2-8-12(30)14(32)20(48-8)28-6-26-10-16(28)22-4-24-18(10)34/h3-8,11-14,19-20,29-32H,1-2H2,(H,38,39)(H,40,41)(H,42,43)(H,21,23,33)(H,22,24,34)(H2,35,36,37)/p-5/t7-,8-,11?,12?,13?,14?,19-,20-,57?/m1/s1 D0Q1BD DRUGINKE GFFAYTMBCSSULP-ICIWVTHHSA-I D0Q1BD DRUGSMIL C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(OCC4C(C(C(O4)N5C=NC6=C5N=CNC6=O)O)O)OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O D0Q1BD HIGHSTAT Investigative D0Q1EI DRUG__ID D0Q1EI D0Q1EI DRUGTYPE Small molecular drug D0Q1EI DRUGINCH 1S/C6H6Br2N2O2S/c7-4-1-3(13(10,11)12)2-5(8)6(4)9/h1-2H,9H2,(H2,10,11,12) D0Q1EI DRUGINKE DLXJPWSYRLLYSV-UHFFFAOYSA-N D0Q1EI DRUGSMIL C1=C(C=C(C(=C1Br)N)Br)S(=O)(=O)N D0Q1EI HIGHSTAT Investigative D0Q1FX DRUG__ID D0Q1FX D0Q1FX DRUGTYPE Small molecular drug D0Q1FX DRUGINCH 1S/C18H18N2O/c1-2-18(20-11-10-19-13-20)15-8-6-14(7-9-15)16-4-3-5-17(21)12-16/h3-13,18,21H,2H2,1H3 D0Q1FX DRUGINKE QPIBEGYAAIVGIH-UHFFFAOYSA-N D0Q1FX DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC(=CC=C2)O)N3C=CN=C3 D0Q1FX HIGHSTAT Investigative D0Q1HE DRUG__ID D0Q1HE D0Q1HE DRUGTYPE Small molecular drug D0Q1HE DRUGINCH 1S/C9H16N3O13P3S/c10-6-7(14)4(23-8(6)12-2-1-5(13)11-9(12)29)3-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,4,6-8,14H,3,10H2,(H,18,19)(H,20,21)(H,11,13,29)(H2,15,16,17)/t4-,6-,7-,8-/m1/s1 D0Q1HE DRUGINKE UWTUUIWWVPWHAA-XVFCMESISA-N D0Q1HE DRUGSMIL C1=CN(C(=S)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)N D0Q1HE HIGHSTAT Investigative D0Q1HF DRUG__ID D0Q1HF D0Q1HF DRUGTYPE Small molecular drug D0Q1HF DRUGINCH 1S/C20H25ClN2O/c1-3-22(4-2)13-7-8-14-23-17-9-5-6-10-19(17)24-20-12-11-16(21)15-18(20)23/h5-6,9-12,15H,3-4,7-8,13-14H2,1-2H3 D0Q1HF DRUGINKE GYBXAGDWMCJZJK-UHFFFAOYSA-N D0Q1HF DRUGSMIL CCN(CC)CCCCN1C2=CC=CC=C2OC3=C1C=C(C=C3)Cl D0Q1HF HIGHSTAT Investigative D0Q1HK DRUG__ID D0Q1HK D0Q1HK DRUGTYPE Small molecular drug D0Q1HK DRUGINCH 1S/C20H27NO/c1-3-11-21(12-4-2)17-10-9-16-13-15-7-5-6-8-18(15)20(22)19(16)14-17/h5-8,13,17,22H,3-4,9-12,14H2,1-2H3 D0Q1HK DRUGINKE TXKDLYBWCJNMHU-UHFFFAOYSA-N D0Q1HK DRUGSMIL CCCN(CCC)C1CCC2=CC3=CC=CC=C3C(=C2C1)O D0Q1HK HIGHSTAT Investigative D0Q1HN DRUG__ID D0Q1HN D0Q1HN DRUGTYPE Small molecular drug D0Q1HN DRUGINCH 1S/C7H4Cl2N4O/c8-5-2-1-4(3-6(5)9)13-11-7(10)14-12-13/h1-3,10H D0Q1HN DRUGINKE VXGYFEOSZYEJBK-UHFFFAOYSA-N D0Q1HN DRUGSMIL C1=CC(=C(C=C1[N+]2=NOC(=N)[N-]2)Cl)Cl D0Q1HN HIGHSTAT Investigative D0Q1IP DRUG__ID D0Q1IP D0Q1IP DRUGTYPE Small molecular drug D0Q1IP DRUGINCH 1S/C16H19N3S/c1-2-7-11-14(10-6-1)18-19-16-17-15(12-20-16)13-8-4-3-5-9-13/h3-5,8-9,12H,1-2,6-7,10-11H2,(H,17,19) D0Q1IP DRUGINKE HFWROKPXAPGNOY-UHFFFAOYSA-N D0Q1IP DRUGSMIL C1CCCC(=NNC2=NC(=CS2)C3=CC=CC=C3)CC1 D0Q1IP HIGHSTAT Investigative D0Q1KL DRUG__ID D0Q1KL D0Q1KL DRUGTYPE Small molecular drug D0Q1KL DRUGINCH 1S/C7H15NO5/c9-1-3-5(11)7(13)6(12)4(2-10)8-3/h3-13H,1-2H2/t3?,4?,5-,6?,7?/m1/s1 D0Q1KL DRUGINKE CLVUFWXGNIFGNC-BQHSNLCNSA-N D0Q1KL DRUGSMIL C(C1C(C(C(C(N1)CO)O)O)O)O D0Q1KL HIGHSTAT Investigative D0Q1LD DRUG__ID D0Q1LD D0Q1LD DRUGTYPE Small molecular drug D0Q1LD DRUGINCH 1S/C25H39NO4/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-23(27)24(28)26-22-19-17-21(18-20-22)25(29)30-4-2/h17-20H,3-16H2,1-2H3,(H,26,28) D0Q1LD DRUGINKE HUIFVZXXYFVZMD-UHFFFAOYSA-N D0Q1LD DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NC1=CC=C(C=C1)C(=O)OCC D0Q1LD HIGHSTAT Investigative D0Q1LG DRUG__ID D0Q1LG D0Q1LG DRUGTYPE Small molecular drug D0Q1LG DRUGINCH 1S/C20H22N2/c1-2-3-9-20(22-15-14-21-16-22)19-12-10-18(11-13-19)17-7-5-4-6-8-17/h4-8,10-16,20H,2-3,9H2,1H3 D0Q1LG DRUGINKE LJLOALSYDDARJF-UHFFFAOYSA-N D0Q1LG DRUGSMIL CCCCC(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D0Q1LG HIGHSTAT Investigative D0Q1PO DRUG__ID D0Q1PO D0Q1PO DRUGTYPE Small molecular drug D0Q1PO DRUGINCH 1S/C19H17N5/c1-14(15-7-3-2-4-8-15)23-19(22-13-20)24-18-11-5-10-17-16(18)9-6-12-21-17/h2-12,14H,1H3,(H2,22,23,24)/t14-/m0/s1 D0Q1PO DRUGINKE PQYCRDPLPKGSME-AWEZNQCLSA-N D0Q1PO DRUGSMIL CC(C1=CC=CC=C1)N=C(NC#N)NC2=CC=CC3=C2C=CC=N3 D0Q1PO HIGHSTAT Investigative D0Q1RD DRUG__ID D0Q1RD D0Q1RD DRUGTYPE Small molecular drug D0Q1RD DRUGINCH 1S/C20H21ClN6O5/c21-10-1-2-12-11(5-10)9(6-23-12)3-4-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)13(7-28)32-19/h1-2,5-6,8,13,15-16,19,23,28-30H,3-4,7H2,(H2,22,25,26)/t13-,15-,16-,19-/m1/s1 D0Q1RD DRUGINKE RBLGZQGAVZQMSY-NVQRDWNXSA-N D0Q1RD DRUGSMIL C1=CC2=C(C=C1Cl)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0Q1RD HIGHSTAT Investigative D0Q1XK DRUG__ID D0Q1XK D0Q1XK DRUGTYPE Small molecular drug D0Q1XK DRUGINCH 1S/C19H22BrNO2S/c1-21-12-19(22,23-16-5-3-2-4-15(16)21)14-8-6-13(7-9-14)17-10-11-18(20)24-17/h6-11,15-16,22H,2-5,12H2,1H3 D0Q1XK DRUGINKE GFRMFVSDSQREBC-UHFFFAOYSA-N D0Q1XK DRUGSMIL CN1CC(OC2C1CCCC2)(C3=CC=C(C=C3)C4=CC=C(S4)Br)O D0Q1XK HIGHSTAT Investigative D0Q1ZC DRUG__ID D0Q1ZC D0Q1ZC DRUGTYPE Small molecular drug D0Q1ZC DRUGINCH 1S/C20H22N2/c1-22-13-11-15(12-14-22)19-17-9-5-6-10-18(17)21-20(19)16-7-3-2-4-8-16/h2-10,15,21H,11-14H2,1H3 D0Q1ZC DRUGINKE UBCVYEFSXHCFPK-UHFFFAOYSA-N D0Q1ZC DRUGSMIL CN1CCC(CC1)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D0Q1ZC HIGHSTAT Investigative D0Q1ZT DRUG__ID D0Q1ZT D0Q1ZT DRUGTYPE Small molecular drug D0Q1ZT DRUGINCH 1S/C23H16F3N3O/c1-23(2,30)18-7-8-29-20(12-28-22(29)21(18)26)13-3-6-19(25)17(10-13)16-5-4-15(24)9-14(16)11-27/h3-10,12,30H,1-2H3 D0Q1ZT DRUGINKE SJMMDWXJSSJHOQ-UHFFFAOYSA-N D0Q1ZT DRUGSMIL CC(C)(C1=C(C2=NC=C(N2C=C1)C3=CC(=C(C=C3)F)C4=C(C=C(C=C4)F)C#N)F)O D0Q1ZT HIGHSTAT Investigative D0Q2CC DRUG__ID D0Q2CC D0Q2CC DRUGTYPE Small molecular drug D0Q2CC DRUGINCH 1S/C13H18N2O3/c1-10-6-2-3-7-11(10)14-12(16)8-4-5-9-13(17)15-18/h2-3,6-7,18H,4-5,8-9H2,1H3,(H,14,16)(H,15,17) D0Q2CC DRUGINKE BUBGRWCYPBJWRL-UHFFFAOYSA-N D0Q2CC DRUGSMIL CC1=CC=CC=C1NC(=O)CCCCC(=O)NO D0Q2CC HIGHSTAT Investigative D0Q2CR DRUG__ID D0Q2CR D0Q2CR DRUGTYPE Small molecular drug D0Q2CR DRUGINCH 1S/C15H18N2O2/c18-14(15-17-16-12-19-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D0Q2CR DRUGINKE SRGOKBDAYNCSOV-UHFFFAOYSA-N D0Q2CR DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NN=CO2 D0Q2CR HIGHSTAT Investigative D0Q2DE DRUG__ID D0Q2DE D0Q2DE DRUGTYPE Small molecular drug D0Q2DE DRUGINCH 1S/C5H14NO.HI/c1-6(2,3)4-5-7;/h7H,4-5H2,1-3H3;1H/q+1;/p-1 D0Q2DE DRUGINKE FNPBHXSBDADRBT-UHFFFAOYSA-M D0Q2DE DRUGSMIL C[N+](C)(C)CCO.[I-] D0Q2DE HIGHSTAT Investigative D0Q2EH DRUG__ID D0Q2EH D0Q2EH DRUGCOMP Biopharm Technology Corp D0Q2EH DRUGINCH 1S/C34H42O18/c1-13-26(41)28(43)30(45)33(49-13)52-32-29(44)27(42)22(12-48-24(40)11-34(2,46)10-23(38)39)51-31(32)15-7-17(36)25-18(37)9-20(50-21(25)8-15)14-4-5-19(47-3)16(35)6-14/h4-8,13,20,22,26-33,35-36,41-46H,9-12H2,1-3H3,(H,38,39)/t13-,20?,22+,26-,27+,28+,29-,30+,31-,32+,33-,34?/m0/s1 D0Q2EH DRUGINKE YZURXYIFQZWQHI-RODJDRFJSA-N D0Q2EH DRUGSMIL CC1C(C(C(C(O1)OC2C(C(C(OC2C3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)COC(=O)CC(C)(CC(=O)O)O)O)O)O)O)O D0Q2EH HIGHSTAT Investigative D0Q2GK DRUG__ID D0Q2GK D0Q2GK DRUGTYPE Small molecular drug D0Q2GK DRUGINCH 1S/C23H20N4O3/c1-12-19(13(2)30-27-12)16-10-17-21(26-23(16)29-3)20-15(9-14-7-5-4-6-8-14)22(28)25-18(20)11-24-17/h4-8,10-11,15H,9H2,1-3H3,(H,25,28) D0Q2GK DRUGINKE ZULXIHDLPPWDPC-UHFFFAOYSA-N D0Q2GK DRUGSMIL CC1=C(C(=NO1)C)C2=CC3=NC=C4C(=C3N=C2OC)C(C(=O)N4)CC5=CC=CC=C5 D0Q2GK HIGHSTAT Investigative D0Q2GM DRUG__ID D0Q2GM D0Q2GM DRUGTYPE Small molecular drug D0Q2GM DRUGINCH 1S/C16H13N3OS/c17-13-6-5-11(15-4-2-8-21-15)9-14(13)19-16(20)12-3-1-7-18-10-12/h1-10H,17H2,(H,19,20) D0Q2GM DRUGINKE VHWNADCYYRKHOX-UHFFFAOYSA-N D0Q2GM DRUGSMIL C1=CC(=CN=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=CS3)N D0Q2GM HIGHSTAT Investigative D0Q2GP DRUG__ID D0Q2GP D0Q2GP DRUGTYPE Small molecular drug D0Q2GP DRUGINCH 1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-4-2-3-5-16(14)23-17-7-6-13(19)12-15(17)20-18/h2-7,12H,8-11H2,1H3 D0Q2GP DRUGINKE AWHNHDGHHNGACT-UHFFFAOYSA-N D0Q2GP DRUGSMIL CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)OC4=CC=CC=C42 D0Q2GP HIGHSTAT Investigative D0Q2HZ DRUG__ID D0Q2HZ D0Q2HZ DRUGTYPE Small molecular drug D0Q2HZ DRUGINCH 1S/C32H35N5O5/c1-18-12-22(38)13-19(2)23(18)15-24(33)32(42)37-17-21-9-5-4-8-20(21)14-28(37)31(41)35-26(16-29(39)40)30-34-25-10-6-7-11-27(25)36(30)3/h4-13,24,26,28,38H,14-17,33H2,1-3H3,(H,35,41)(H,39,40)/t24-,26+,28-/m0/s1 D0Q2HZ DRUGINKE XFKPEXYNTQLONY-YIOBJHAYSA-N D0Q2HZ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CC(=O)O)C4=NC5=CC=CC=C5N4C)N)C)O D0Q2HZ HIGHSTAT Investigative D0Q2KK DRUG__ID D0Q2KK D0Q2KK DRUGTYPE Small molecular drug D0Q2KK DRUGINCH 1S/C15H10N2O2S/c18-20(19)13-6-2-1-5-11(13)12-8-7-10-4-3-9-16-14(10)15(12)17-20/h1-9,17H D0Q2KK DRUGINKE CYSOFAOLQAYKGU-UHFFFAOYSA-N D0Q2KK DRUGSMIL C1=CC=C2C(=C1)C3=C(C4=C(C=CC=N4)C=C3)NS2(=O)=O D0Q2KK HIGHSTAT Investigative D0Q2LG DRUG__ID D0Q2LG D0Q2LG DRUGTYPE Small molecular drug D0Q2LG DRUGINCH 1S/C20H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(24-23)17-15-18-20(21)22/h6-7,9-10,12-14,16,19,23H,2-5,8,11,15,17-18H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-14+/t19-/m1/s1 D0Q2LG DRUGINKE JNUUNUQHXIOFDA-JGKLHWIESA-N D0Q2LG DRUGSMIL CCCCCC=CCC=CCC=CC=CC(CCCC(=O)O)OO D0Q2LG HIGHSTAT Investigative D0Q2MI DRUG__ID D0Q2MI D0Q2MI DRUGTYPE Small molecular drug D0Q2MI DRUGINCH 1S/C16H16O3S/c1-12-8-9-15(13(2)10-12)16(17)11-20(18,19)14-6-4-3-5-7-14/h3-10H,11H2,1-2H3 D0Q2MI DRUGINKE MYSKHEDYGIVTKV-UHFFFAOYSA-N D0Q2MI DRUGSMIL CC1=CC(=C(C=C1)C(=O)CS(=O)(=O)C2=CC=CC=C2)C D0Q2MI HIGHSTAT Investigative D0Q2MX DRUG__ID D0Q2MX D0Q2MX DRUGTYPE Small molecular drug D0Q2MX DRUGINCH 1S/C21H22Cl2N2OS/c22-18-4-1-3-17(21(18)23)15-7-10-25(11-8-15)9-2-12-26-16-5-6-20-19(13-16)24-14-27-20/h1,3-6,13-15H,2,7-12H2 D0Q2MX DRUGINKE URYZTMIOHYGTNJ-UHFFFAOYSA-N D0Q2MX DRUGSMIL C1CN(CCC1C2=C(C(=CC=C2)Cl)Cl)CCCOC3=CC4=C(C=C3)SC=N4 D0Q2MX HIGHSTAT Investigative D0Q2OH DRUG__ID D0Q2OH D0Q2OH DRUGTYPE Small molecular drug D0Q2OH DRUGINCH 1S/C9H16O4S/c1-14-6-2-3-7(9(12)13)4-5-8(10)11/h7H,2-6H2,1H3,(H,10,11)(H,12,13) D0Q2OH DRUGINKE AXRGKFNGKGNVEI-UHFFFAOYSA-N D0Q2OH DRUGSMIL CSCCCC(CCC(=O)O)C(=O)O D0Q2OH HIGHSTAT Investigative D0Q2OK DRUG__ID D0Q2OK D0Q2OK DRUGTYPE Small molecular drug D0Q2OK DRUGINCH 1S/C9H13IN2O12P2/c10-4-1-5(13)11-9(16)12(4)8-7(15)6(14)3(23-8)2-22-26(20,21)24-25(17,18)19/h1,3,6-8,14-15H,2H2,(H,20,21)(H,11,13,16)(H2,17,18,19)/t3-,6-,7-,8-/m1/s1 D0Q2OK DRUGINKE ZPKIYZBENSTKTC-YXZULKJRSA-N D0Q2OK DRUGSMIL C1=C(N(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)O)O)O)I D0Q2OK HIGHSTAT Investigative D0Q2QA DRUG__ID D0Q2QA D0Q2QA DRUGTYPE Small molecular drug D0Q2QA DRUGINCH 1S/C10H15NS/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3/t8-/m0/s1 D0Q2QA DRUGINKE OLEWMKVPSUCNLG-QMMMGPOBSA-N D0Q2QA DRUGSMIL CC(CC1=CC=C(C=C1)SC)N D0Q2QA HIGHSTAT Investigative D0Q2RP DRUG__ID D0Q2RP D0Q2RP DRUGTYPE Small molecular drug D0Q2RP DRUGINCH 1S/C27H44O2/c1-17(6-11-24-25(2,3)29-24)21-9-10-22-20-8-7-18-16-19(28)12-14-26(18,4)23(20)13-15-27(21,22)5/h7,17,19-24,28H,6,8-16H2,1-5H3/t17-,19+,20+,21-,22+,23+,24+,26+,27-/m1/s1 D0Q2RP DRUGINKE OSENKJZWYQXHBN-XVYZBDJZSA-N D0Q2RP DRUGSMIL CC(CCC1C(O1)(C)C)C2CCC3C2(CCC4C3CC=C5C4(CCC(C5)O)C)C D0Q2RP HIGHSTAT Investigative D0Q2SI DRUG__ID D0Q2SI D0Q2SI DRUGTYPE Small molecular drug D0Q2SI DRUGINCH 1S/C15H11ClN2O/c16-11-7-5-10(6-8-11)9-14-12-3-1-2-4-13(12)15(19)18-17-14/h1-8H,9H2,(H,18,19) D0Q2SI DRUGINKE NLXGCQIEVZYDRS-UHFFFAOYSA-N D0Q2SI DRUGSMIL C1=CC=C2C(=C1)C(=NNC2=O)CC3=CC=C(C=C3)Cl D0Q2SI HIGHSTAT Investigative D0Q2TF DRUG__ID D0Q2TF D0Q2TF DRUGTYPE Small molecular drug D0Q2TF DRUGINCH 1S/C16H25NO3S/c1-16(2,3)13-6-8-15(9-7-13)21(19,20)17-11-4-5-14(18)10-12-17/h6-9,14,18H,4-5,10-12H2,1-3H3 D0Q2TF DRUGINKE GHPTYGKGUJYMFW-UHFFFAOYSA-N D0Q2TF DRUGSMIL CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)N2CCCC(CC2)O D0Q2TF HIGHSTAT Investigative D0Q2VN DRUG__ID D0Q2VN D0Q2VN DRUGTYPE Small molecular drug D0Q2VN DRUGINCH 1S/C20H23NO3/c1-21-14-12-18(13-15-21)24-19(22)20(23,16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18,23H,12-15H2,1H3 D0Q2VN DRUGINKE UGYPGJCVNPPUPE-UHFFFAOYSA-N D0Q2VN DRUGSMIL CN1CCC(CC1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O D0Q2VN HIGHSTAT Investigative D0Q2XB DRUG__ID D0Q2XB D0Q2XB DRUGTYPE Small molecular drug D0Q2XB DRUGINCH 1S/C6H4F2O/c7-4-1-5(8)3-6(9)2-4/h1-3,9H D0Q2XB DRUGINKE HJSSBIMVTMYKPD-UHFFFAOYSA-N D0Q2XB DRUGSMIL C1=C(C=C(C=C1F)F)O D0Q2XB HIGHSTAT Investigative D0Q2YH DRUG__ID D0Q2YH D0Q2YH DRUGTYPE Small molecular drug D0Q2YH DRUGINCH 1S/C13H21N3O5S/c1-7(11(18)15-9(6-22)13(20)21)14-12(19)10-4-3-5-16(10)8(2)17/h7,9-10,22H,3-6H2,1-2H3,(H,14,19)(H,15,18)(H,20,21)/t7-,9-,10-/m0/s1 D0Q2YH DRUGINKE YFMHBFVZXDWWRU-HGNGGELXSA-N D0Q2YH DRUGSMIL CC(C(=O)NC(CS)C(=O)O)NC(=O)C1CCCN1C(=O)C D0Q2YH HIGHSTAT Investigative D0Q2YJ DRUG__ID D0Q2YJ D0Q2YJ DRUGTYPE Small molecular drug D0Q2YJ DRUGINCH 1S/C14H8O2/c15-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)14(13)16/h1-8H D0Q2YJ DRUGINKE YYVYAPXYZVYDHN-UHFFFAOYSA-N D0Q2YJ DRUGSMIL C1=CC=C2C(=C1)C3=CC=CC=C3C(=O)C2=O D0Q2YJ HIGHSTAT Investigative D0Q2ZO DRUG__ID D0Q2ZO D0Q2ZO DRUGTYPE Small molecular drug D0Q2ZO DRUGINCH 1S/C20H26N2O/c1-2-3-4-5-6-7-9-17-11-13-18(14-12-17)20(23)22-19-10-8-15-21-16-19/h8,10-16H,2-7,9H2,1H3,(H,22,23) D0Q2ZO DRUGINKE ONPWXUJVJZCKSY-UHFFFAOYSA-N D0Q2ZO DRUGSMIL CCCCCCCCC1=CC=C(C=C1)C(=O)NC2=CN=CC=C2 D0Q2ZO HIGHSTAT Investigative D0Q3AN DRUG__ID D0Q3AN D0Q3AN DRUGTYPE Small molecular drug D0Q3AN DRUGINCH 1S/C16H11FO2S/c17-14-7-10(4-5-15(14)19)12-8-16(20-9-12)11-2-1-3-13(18)6-11/h1-9,18-19H D0Q3AN DRUGINKE MOBQDOLSPUFHFF-UHFFFAOYSA-N D0Q3AN DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=CS2)C3=CC(=C(C=C3)O)F D0Q3AN HIGHSTAT Investigative D0Q3CD DRUG__ID D0Q3CD D0Q3CD DRUGTYPE Small molecular drug D0Q3CD DRUGINCH 1S/C25H34O8/c1-23(2,30-6)33-17-11-16(21(27)29-5)24(3)9-7-15-22(28)32-18(14-8-10-31-13-14)12-25(15,4)20(24)19(17)26/h8,10,13,15-18,20H,7,9,11-12H2,1-6H3/t15-,16-,17-,18-,20-,24-,25-/m0/s1 D0Q3CD DRUGINKE CRCQUPUJAMIWQE-AZKXBNKQSA-N D0Q3CD DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OC(C)(C)OC)C)C4=COC=C4 D0Q3CD HIGHSTAT Investigative D0Q3CX DRUG__ID D0Q3CX D0Q3CX DRUGTYPE Small molecular drug D0Q3CX DRUGINCH 1S/C17H12N2/c1-12-6-7-19-11-17(12)16-5-4-14-8-13(10-18)2-3-15(14)9-16/h2-9,11H,1H3 D0Q3CX DRUGINKE BVEDDOVOLJETRX-UHFFFAOYSA-N D0Q3CX DRUGSMIL CC1=C(C=NC=C1)C2=CC3=C(C=C2)C=C(C=C3)C#N D0Q3CX HIGHSTAT Investigative D0Q3DI DRUG__ID D0Q3DI D0Q3DI DRUGTYPE Small molecular drug D0Q3DI DRUGINCH 1S/C16H11N3O/c1-20-14-6-11(9-17)5-12(7-14)13-8-16-15(19-10-13)3-2-4-18-16/h2-8,10H,1H3 D0Q3DI DRUGINKE KPRNNBVYUUWBLA-UHFFFAOYSA-N D0Q3DI DRUGSMIL COC1=CC(=CC(=C1)C2=CC3=C(C=CC=N3)N=C2)C#N D0Q3DI HIGHSTAT Investigative D0Q3DS DRUG__ID D0Q3DS D0Q3DS DRUGTYPE Small molecular drug D0Q3DS DRUGINCH 1S/C14H10N2/c1-2-4-14-12(3-1)9-13(10-16-14)11-5-7-15-8-6-11/h1-10H D0Q3DS DRUGINKE QYCONSXONLLGHQ-UHFFFAOYSA-N D0Q3DS DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)C3=CC=NC=C3 D0Q3DS HIGHSTAT Investigative D0Q3DY DRUG__ID D0Q3DY D0Q3DY DRUGTYPE Small molecular drug D0Q3DY DRUGINCH 1S/C27H33ClN2O8/c1-27(2,15-31)14-30-19-9-8-16(28)12-18(19)24(17-6-5-7-20(36-3)25(17)37-4)38-21(26(30)35)13-22(32)29-11-10-23(33)34/h5-9,12,21,24,31H,10-11,13-15H2,1-4H3,(H,29,32)(H,33,34)/t21-,24-/m1/s1 D0Q3DY DRUGINKE PILXQRRCKWZQCO-ZJSXRUAMSA-N D0Q3DY DRUGSMIL CC(C)(CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)NCCC(=O)O)C3=C(C(=CC=C3)OC)OC)CO D0Q3DY HIGHSTAT Investigative D0Q3EJ DRUG__ID D0Q3EJ D0Q3EJ DRUGTYPE Small molecular drug D0Q3EJ DRUGINCH 1S/C12H19NOS/c1-3-11(13-14)9-10-5-7-12(8-6-10)15-4-2/h5-8,11,13-14H,3-4,9H2,1-2H3 D0Q3EJ DRUGINKE HZILCAQYLMPMJC-UHFFFAOYSA-N D0Q3EJ DRUGSMIL CCC(CC1=CC=C(C=C1)SCC)NO D0Q3EJ HIGHSTAT Investigative D0Q3EV DRUG__ID D0Q3EV D0Q3EV DRUGTYPE Small molecular drug D0Q3EV DRUGINCH 1S/C22H32N2O/c1-3-4-5-6-7-10-15-23-22-18-11-8-9-12-20(18)24-21-14-13-17(25-2)16-19(21)22/h13-14,16H,3-12,15H2,1-2H3,(H,23,24) D0Q3EV DRUGINKE IFHMPKOJBNGXHV-UHFFFAOYSA-N D0Q3EV DRUGSMIL CCCCCCCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC D0Q3EV HIGHSTAT Investigative D0Q3EW DRUG__ID D0Q3EW D0Q3EW DRUGTYPE Small molecular drug D0Q3EW DRUGINCH 1S/C21H18F3N5O/c22-21(23,24)14-3-1-4-15(11-14)26-18-9-10-25-20(29-18)28-17-6-2-5-16(12-17)27-19(30)13-7-8-13/h1-6,9-13H,7-8H2,(H,27,30)(H2,25,26,28,29) D0Q3EW DRUGINKE RDTDWGQDFJPTPD-UHFFFAOYSA-N D0Q3EW DRUGSMIL C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=CC(=N3)NC4=CC=CC(=C4)C(F)(F)F D0Q3EW HIGHSTAT Investigative D0Q3FY DRUG__ID D0Q3FY D0Q3FY DRUGTYPE Small molecular drug D0Q3FY DRUGINCH 1S/C24H32N4O2/c1-16-14-18(17-8-11-28(12-9-17)13-10-25-2)15-19-23(16)27-24(26-19)22-20(29-3)6-5-7-21(22)30-4/h5-7,14-15,17,25H,8-13H2,1-4H3,(H,26,27) D0Q3FY DRUGINKE PFOQIHIIOLBCEQ-UHFFFAOYSA-N D0Q3FY DRUGSMIL CC1=CC(=CC2=C1N=C(N2)C3=C(C=CC=C3OC)OC)C4CCN(CC4)CCNC D0Q3FY HIGHSTAT Investigative D0Q3GG DRUG__ID D0Q3GG D0Q3GG DRUGTYPE Small molecular drug D0Q3GG DRUGINCH 1S/C10H8N2O2S/c11-5-7(10(12)15)3-6-1-2-8(13)9(14)4-6/h1-4,13-14H,(H2,12,15)/b7-3+ D0Q3GG DRUGINKE ZGHQGWOETPXKLY-XVNBXDOJSA-N D0Q3GG DRUGSMIL C1=CC(=C(C=C1C=C(C#N)C(=S)N)O)O D0Q3GG HIGHSTAT Investigative D0Q3GH DRUG__ID D0Q3GH D0Q3GH DRUGTYPE Small molecular drug D0Q3GH DRUGINCH 1S/C11H19F3OS/c1-2-3-4-5-6-7-8-16-9-10(15)11(12,13)14/h2-9H2,1H3 D0Q3GH DRUGINKE WMQHRXUKAYSPPK-UHFFFAOYSA-N D0Q3GH DRUGSMIL CCCCCCCCSCC(=O)C(F)(F)F D0Q3GH HIGHSTAT Investigative D0Q3GQ DRUG__ID D0Q3GQ D0Q3GQ DRUGTYPE Small molecular drug D0Q3GQ DRUGINCH 1S/C20H22O2/c21-18-11-7-16(8-12-18)20(15-5-3-1-2-4-6-15)17-9-13-19(22)14-10-17/h7-14,21-22H,1-6H2 D0Q3GQ DRUGINKE XVTAYJKFHUKWSR-UHFFFAOYSA-N D0Q3GQ DRUGSMIL C1CCCC(=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)CC1 D0Q3GQ HIGHSTAT Investigative D0Q3JZ DRUG__ID D0Q3JZ D0Q3JZ DRUGTYPE Small molecular drug D0Q3JZ DRUGINCH 1S/C17H17NO/c1-2-19-16-7-8-17-14(5-6-15(17)11-16)10-13-4-3-9-18-12-13/h3-4,7-12H,2,5-6H2,1H3/b14-10- D0Q3JZ DRUGINKE PXXLKRIIKURDBT-UVTDQMKNSA-N D0Q3JZ DRUGSMIL CCOC1=CC2=C(C=C1)C(=CC3=CN=CC=C3)CC2 D0Q3JZ HIGHSTAT Investigative D0Q3KD DRUG__ID D0Q3KD D0Q3KD DRUGTYPE Small molecular drug D0Q3KD DRUGINCH 1S/C10H18O4S/c11-9(12)6-5-8(10(13)14)4-2-1-3-7-15/h8,15H,1-7H2,(H,11,12)(H,13,14) D0Q3KD DRUGINKE RHHNRXAIWMGSRF-UHFFFAOYSA-N D0Q3KD DRUGSMIL C(CCC(CCC(=O)O)C(=O)O)CCS D0Q3KD HIGHSTAT Investigative D0Q3KF DRUG__ID D0Q3KF D0Q3KF DRUGTYPE Small molecular drug D0Q3KF DRUGINCH 1S/C25H24O2/c1-2-3-7-25-23(22-6-4-5-8-24(22)27-25)17-18-9-11-19(12-10-18)20-13-15-21(26)16-14-20/h4-6,8-16,26H,2-3,7,17H2,1H3 D0Q3KF DRUGINKE AESGURZHBVMCOS-UHFFFAOYSA-N D0Q3KF DRUGSMIL CCCCC1=C(C2=CC=CC=C2O1)CC3=CC=C(C=C3)C4=CC=C(C=C4)O D0Q3KF HIGHSTAT Investigative D0Q3KS DRUG__ID D0Q3KS D0Q3KS DRUGTYPE Small molecular drug D0Q3KS DRUGINCH 1S/C20H17Cl2N9O2/c21-11-1-2-12(14(22)9-11)17-13(19-25-6-7-26-19)10-28-20(30-17)27-8-5-24-16-4-3-15(31(32)33)18(23)29-16/h1-4,6-7,9-10H,5,8H2,(H,25,26)(H3,23,24,29)(H,27,28,30) D0Q3KS DRUGINKE NDFXSHIIGXVOKT-UHFFFAOYSA-N D0Q3KS DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C2=NC(=NC=C2C3=NC=CN3)NCCNC4=NC(=C(C=C4)[N+](=O)[O-])N D0Q3KS HIGHSTAT Investigative D0Q3KV DRUG__ID D0Q3KV D0Q3KV DRUGTYPE Small molecular drug D0Q3KV DRUGINCH 1S/C8H7F2NO2/c9-5-3-1-2-4(6(5)10)7(11)8(12)13/h1-3,7H,11H2,(H,12,13) D0Q3KV DRUGINKE DNWOZEQWCCXGRU-UHFFFAOYSA-N D0Q3KV DRUGSMIL C1=CC(=C(C(=C1)F)F)C(C(=O)O)N D0Q3KV HIGHSTAT Investigative D0Q3LM DRUG__ID D0Q3LM D0Q3LM DRUGTYPE Small molecular drug D0Q3LM DRUGINCH 1S/C16H23N5O5Si/c1-25-20-14-11-15(19-10(18-14)5-6-27(2,3)4)21(8-17-11)16-13(24)12(23)9(7-22)26-16/h8-9,12-13,16,22-24H,7H2,1-4H3,(H,18,19,20)/t9-,12-,13-,16-/m1/s1 D0Q3LM DRUGINKE UOJJCTHGWLSJEL-RVXWVPLUSA-N D0Q3LM DRUGSMIL CONC1=C2C(=NC(=N1)C#C[Si](C)(C)C)N(C=N2)C3C(C(C(O3)CO)O)O D0Q3LM HIGHSTAT Investigative D0Q3MM DRUG__ID D0Q3MM D0Q3MM DRUGTYPE Small molecular drug D0Q3MM DRUGINCH 1S/C36H47N11O6/c37-35(38)41-15-3-7-26-32(51)45-27(8-4-16-42-36(39)40)33(52)47-28(18-21-10-13-25(48)14-11-21)31(50)43-20-30(49)44-29(34(53)46-26)19-22-9-12-23-5-1-2-6-24(23)17-22/h1-2,5-6,9-14,17,26-29,48H,3-4,7-8,15-16,18-20H2,(H,43,50)(H,44,49)(H,45,51)(H,46,53)(H,47,52)(H4,37,38,41)(H4,39,40,42)/t26-,27-,28+,29-/m0/s1 D0Q3MM DRUGINKE YASYVKCWJGCXLS-FKWFRFQNSA-N D0Q3MM DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D0Q3MM HIGHSTAT Investigative D0Q3NG DRUG__ID D0Q3NG D0Q3NG DRUGTYPE Small molecular drug D0Q3NG DRUGINCH 1S/C10H12N4O2/c1-3-16-10-7(5-11)8(12)4-9(14-10)13-6(2)15/h4H,3H2,1-2H3,(H3,12,13,14,15) D0Q3NG DRUGINKE DXAJWOOLPAIVJG-UHFFFAOYSA-N D0Q3NG DRUGSMIL CCOC1=C(C(=CC(=N1)NC(=O)C)N)C#N D0Q3NG HIGHSTAT Investigative D0Q3OK DRUG__ID D0Q3OK D0Q3OK DRUGTYPE Small molecular drug D0Q3OK DRUGINCH 1S/C11H13ClN2/c1-8(13)7-14-5-4-9-6-10(12)2-3-11(9)14/h2-6,8H,7,13H2,1H3 D0Q3OK DRUGINKE XXCLNSYNUQMDML-UHFFFAOYSA-N D0Q3OK DRUGSMIL CC(CN1C=CC2=C1C=CC(=C2)Cl)N D0Q3OK HIGHSTAT Investigative D0Q3QI DRUG__ID D0Q3QI D0Q3QI DRUGTYPE Small molecular drug D0Q3QI DRUGINCH 1S/C8H16O3/c1-2-3-4-5-6-7(9)8(10)11/h7,9H,2-6H2,1H3,(H,10,11) D0Q3QI DRUGINKE JKRDADVRIYVCCY-UHFFFAOYSA-N D0Q3QI DRUGSMIL CCCCCCC(C(=O)O)O D0Q3QI HIGHSTAT Investigative D0Q3RF DRUG__ID D0Q3RF D0Q3RF DRUGTYPE Small molecular drug D0Q3RF DRUGINCH 1S/C14H10N2O3/c17-14(9-6-12-3-1-2-10-15-12)11-4-7-13(8-5-11)16(18)19/h1-10H/b9-6+ D0Q3RF DRUGINKE DYGZKSFWHRDUCX-RMKNXTFCSA-N D0Q3RF DRUGSMIL C1=CC=NC(=C1)C=CC(=O)C2=CC=C(C=C2)[N+](=O)[O-] D0Q3RF HIGHSTAT Investigative D0Q3VI DRUG__ID D0Q3VI D0Q3VI DRUGTYPE Small molecular drug D0Q3VI DRUGINCH 1S/C12H14N2O/c1-15-11-4-2-3-9-8-5-6-13-7-10(8)14-12(9)11/h2-4,13-14H,5-7H2,1H3 D0Q3VI DRUGINKE KKTKOWJABJYACN-UHFFFAOYSA-N D0Q3VI DRUGSMIL COC1=CC=CC2=C1NC3=C2CCNC3 D0Q3VI HIGHSTAT Investigative D0Q3VS DRUG__ID D0Q3VS D0Q3VS DRUGTYPE Small molecular drug D0Q3VS DRUGINCH 1S/C9H8Cl2N2/c10-6-1-2-7(8(11)5-6)9-12-3-4-13-9/h1-2,5H,3-4H2,(H,12,13) D0Q3VS DRUGINKE DSQMJENLNWSEMO-UHFFFAOYSA-N D0Q3VS DRUGSMIL C1CN=C(N1)C2=C(C=C(C=C2)Cl)Cl D0Q3VS HIGHSTAT Investigative D0Q3VU DRUG__ID D0Q3VU D0Q3VU DRUGTYPE Small molecular drug D0Q3VU DRUGINCH 1S/C5H10N2O3/c1-7(3-5(9)10)4(8)2-6/h2-3,6H2,1H3,(H,9,10) D0Q3VU DRUGINKE VYAMLSCELQQRAE-UHFFFAOYSA-N D0Q3VU DRUGSMIL CN(CC(=O)O)C(=O)CN D0Q3VU HIGHSTAT Investigative D0Q3WC DRUG__ID D0Q3WC D0Q3WC DRUGTYPE Small molecular drug D0Q3WC DRUGINCH 1S/C15H14N4O2/c1-21-19-15(20)18-11-2-3-12-13(9-17-14(12)8-11)10-4-6-16-7-5-10/h2-9,17H,1H3,(H2,18,19,20) D0Q3WC DRUGINKE XYNMCCVGHHUPIU-UHFFFAOYSA-N D0Q3WC DRUGSMIL CONC(=O)NC1=CC2=C(C=C1)C(=CN2)C3=CC=NC=C3 D0Q3WC HIGHSTAT Investigative D0Q3WV DRUG__ID D0Q3WV D0Q3WV DRUGTYPE Small molecular drug D0Q3WV DRUGINCH 1S/C23H29IO6/c1-23(2,3)30-22(25)12-15-10-19(27-5)18(26-4)9-14(15)8-16-11-20(28-6)21(29-7)13-17(16)24/h9-11,13H,8,12H2,1-7H3/i24-2 D0Q3WV DRUGINKE UIYQREMVBQNPNM-XXFZXMJFSA-N D0Q3WV DRUGSMIL CC(C)(C)OC(=O)CC1=CC(=C(C=C1CC2=CC(=C(C=C2I)OC)OC)OC)OC D0Q3WV HIGHSTAT Investigative D0Q3XB DRUG__ID D0Q3XB D0Q3XB DRUGTYPE Small molecular drug D0Q3XB DRUGINCH 1S/C41H30O26/c42-15-1-10(2-16(43)26(15)50)36(57)64-33-23-9-62-39(60)13-7-21(48)29(53)31(55)24(13)25-14(8-22(49)30(54)32(25)56)40(61)65-34(33)35(66-37(58)11-3-17(44)27(51)18(45)4-11)41(63-23)67-38(59)12-5-19(46)28(52)20(47)6-12/h1-8,23,33-35,41-56H,9H2/t23-,33-,34+,35-,41+/m1/s1 D0Q3XB DRUGINKE DPBVYZVSXAZMAY-UUUCSUBKSA-N D0Q3XB DRUGSMIL C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O1)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O D0Q3XB HIGHSTAT Investigative D0Q3XK DRUG__ID D0Q3XK D0Q3XK DRUGTYPE Small molecular drug D0Q3XK DRUGINCH 1S/C19H25NO6/c1-20-7-6-17-8-11(21)16(25-3)19(23)18(17,20)9-13(26-19)10-4-5-12(24-2)15(22)14(10)17/h4-5,11,13,16,21-23H,6-9H2,1-3H3/t11-,13-,16-,17-,18-,19+/m0/s1 D0Q3XK DRUGINKE UHRGPVJRLXHZFG-OOXWPESWSA-N D0Q3XK DRUGSMIL CN1CCC23C14CC(C5=C2C(=C(C=C5)OC)O)OC4(C(C(C3)O)OC)O D0Q3XK HIGHSTAT Investigative D0Q4AQ DRUG__ID D0Q4AQ D0Q4AQ DRUGTYPE Small molecular drug D0Q4AQ DRUGINCH 1S/C10H12BrN5/c11-8-7-16-6-3-13-9(16)10(14-8)15-4-1-12-2-5-15/h3,6-7,12H,1-2,4-5H2 D0Q4AQ DRUGINKE XNILOZDQMHSDIZ-UHFFFAOYSA-N D0Q4AQ DRUGSMIL C1CN(CCN1)C2=NC(=CN3C2=NC=C3)Br D0Q4AQ HIGHSTAT Investigative D0Q4AV DRUG__ID D0Q4AV D0Q4AV DRUGTYPE Small molecular drug D0Q4AV DRUGINCH 1S/C15H20N4O3S/c16-23(21,22)18-10-3-1-2-6-15(20)19-13-7-8-14-12(11-13)5-4-9-17-14/h4-5,7-9,11,18H,1-3,6,10H2,(H,19,20)(H2,16,21,22) D0Q4AV DRUGINKE CGIYOYXFUHZSMD-UHFFFAOYSA-N D0Q4AV DRUGSMIL C1=CC2=C(C=CC(=C2)NC(=O)CCCCCNS(=O)(=O)N)N=C1 D0Q4AV HIGHSTAT Investigative D0Q4BK DRUG__ID D0Q4BK D0Q4BK DRUGTYPE Small molecular drug D0Q4BK DRUGINCH 1S/C20H24N4/c1-3-11-21-19(5-1)17-7-9-18(10-8-17)23-13-15-24(16-14-23)20-6-2-4-12-22-20/h1-7,11-12,18H,8-10,13-16H2 D0Q4BK DRUGINKE MCTSZRVXVCAAHY-UHFFFAOYSA-N D0Q4BK DRUGSMIL C1CC(=CCC1N2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=N4 D0Q4BK HIGHSTAT Investigative D0Q4CT DRUG__ID D0Q4CT D0Q4CT DRUGTYPE Small molecular drug D0Q4CT DRUGINCH 1S/C18H18O5/c1-21-16-10-12(11-17(22-2)18(16)23-3)8-9-15(20)13-6-4-5-7-14(13)19/h4-11,19H,1-3H3/b9-8+ D0Q4CT DRUGINKE SRSBUHVXNLHWHU-CMDGGOBGSA-N D0Q4CT DRUGSMIL COC1=CC(=CC(=C1OC)OC)C=CC(=O)C2=CC=CC=C2O D0Q4CT HIGHSTAT Investigative D0Q4DB DRUG__ID D0Q4DB D0Q4DB DRUGTYPE Small molecular drug D0Q4DB DRUGINCH 1S/C24H41NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-24(27)25-22-23-26/h6-7,9-10,12-13,15-16,26H,2-5,8,11,14,17-23H2,1H3,(H,25,27)/b7-6-,10-9-,13-12-,16-15- D0Q4DB DRUGINKE FMVHVRYFQIXOAF-DOFZRALJSA-N D0Q4DB DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCCC(=O)NCCO D0Q4DB HIGHSTAT Investigative D0Q4DP DRUG__ID D0Q4DP D0Q4DP DRUGTYPE Small molecular drug D0Q4DP DRUGINCH 1S/C18H19IN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21) D0Q4DP DRUGINKE OOEUHRGMLFVKQO-UHFFFAOYSA-N D0Q4DP DRUGSMIL C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)I D0Q4DP HIGHSTAT Investigative D0Q4EG DRUG__ID D0Q4EG D0Q4EG DRUGTYPE Small molecular drug D0Q4EG DRUGINCH 1S/C17H11NO3/c19-15-10-14(16(20)13-9-5-4-8-12(13)15)18-17(21)11-6-2-1-3-7-11/h1-10H,(H,18,21) D0Q4EG DRUGINKE BIVQBWSIGJFXLF-UHFFFAOYSA-N D0Q4EG DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC(=O)C3=CC=CC=C3C2=O D0Q4EG HIGHSTAT Investigative D0Q4EU DRUG__ID D0Q4EU D0Q4EU DRUGTYPE Small molecular drug D0Q4EU DRUGINCH 1S/C21H24O4/c1-21(2,15-3-7-17(8-4-15)22-11-19-13-24-19)16-5-9-18(10-6-16)23-12-20-14-25-20/h3-10,19-20H,11-14H2,1-2H3 D0Q4EU DRUGINKE LCFVJGUPQDGYKZ-UHFFFAOYSA-N D0Q4EU DRUGSMIL CC(C)(C1=CC=C(C=C1)OCC2CO2)C3=CC=C(C=C3)OCC4CO4 D0Q4EU HIGHSTAT Investigative D0Q4FH DRUG__ID D0Q4FH D0Q4FH DRUGTYPE Small molecular drug D0Q4FH DRUGINCH 1S/C19H14Cl3NO4/c1-9-12(8-17(24)25)13-7-11(27-2)3-4-16(13)23(9)19(26)18-14(21)5-10(20)6-15(18)22/h3-7H,8H2,1-2H3,(H,24,25) D0Q4FH DRUGINKE WUJUBERMAKRECF-UHFFFAOYSA-N D0Q4FH DRUGSMIL CC1=C(C2=C(N1C(=O)C3=C(C=C(C=C3Cl)Cl)Cl)C=CC(=C2)OC)CC(=O)O D0Q4FH HIGHSTAT Investigative D0Q4GB DRUG__ID D0Q4GB D0Q4GB DRUGTYPE Small molecular drug D0Q4GB DRUGINCH 1S/C10H18O/c1-9(2)5-4-6-10(3)7-8-11/h5,7,11H,4,6,8H2,1-3H3/b10-7+ D0Q4GB DRUGINKE GLZPCOQZEFWAFX-JXMROGBWSA-N D0Q4GB DRUGSMIL CC(=CCCC(=CCO)C)C D0Q4GB HIGHSTAT Investigative D0Q4GH DRUG__ID D0Q4GH D0Q4GH DRUGTYPE Small molecular drug D0Q4GH DRUGINCH 1S/C22H16O4/c23-21(24)15-8-16-6-9-17(10-7-16)22(25)18-11-13-20(14-12-18)26-19-4-2-1-3-5-19/h1-15H,(H,23,24)/b15-8+ D0Q4GH DRUGINKE UXUCKEBTHPCTFJ-OVCLIPMQSA-N D0Q4GH DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C=CC(=O)O D0Q4GH HIGHSTAT Investigative D0Q4GJ DRUG__ID D0Q4GJ D0Q4GJ DRUGTYPE Small molecular drug D0Q4GJ DRUGINCH 1S/C18H11NO2/c20-16-10-17(13-5-3-9-19-11-13)21-18-14-6-2-1-4-12(14)7-8-15(16)18/h1-11H D0Q4GJ DRUGINKE RURRJHXFMININK-UHFFFAOYSA-N D0Q4GJ DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2OC(=CC3=O)C4=CN=CC=C4 D0Q4GJ HIGHSTAT Investigative D0Q4IM DRUG__ID D0Q4IM D0Q4IM DRUGTYPE Small molecular drug D0Q4IM DRUGINCH 1S/C21H22ClNO/c1-2-3-6-12-23-15-19(18-10-4-5-11-20(18)23)21(24)14-16-8-7-9-17(22)13-16/h4-5,7-11,13,15H,2-3,6,12,14H2,1H3 D0Q4IM DRUGINKE KURUPMPUIIQATM-UHFFFAOYSA-N D0Q4IM DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)Cl D0Q4IM HIGHSTAT Investigative D0Q4JF DRUG__ID D0Q4JF D0Q4JF DRUGTYPE Small molecular drug D0Q4JF DRUGINCH 1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p+1 D0Q4JF DRUGINKE YHHSONZFOIEMCP-UHFFFAOYSA-O D0Q4JF DRUGSMIL C[N+](C)(C)CCOP(=O)(O)O D0Q4JF HIGHSTAT Investigative D0Q4LI DRUG__ID D0Q4LI D0Q4LI DRUGTYPE Small molecular drug D0Q4LI DRUGINCH 1S/C12H10O4S/c1-17(14,15)11-4-2-9(3-5-11)12(13)10-6-7-16-8-10/h2-8H,1H3 D0Q4LI DRUGINKE ULFFSZMVURLRPK-UHFFFAOYSA-N D0Q4LI DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C(=O)C2=COC=C2 D0Q4LI HIGHSTAT Investigative D0Q4LX DRUG__ID D0Q4LX D0Q4LX DRUGTYPE Small molecular drug D0Q4LX DRUGINCH 1S/C21H16N2O2/c22-17-11-10-16(20-13-15-8-4-5-9-19(15)25-20)12-18(17)23-21(24)14-6-2-1-3-7-14/h1-13H,22H2,(H,23,24) D0Q4LX DRUGINKE ABLQYLIPCDUOQX-UHFFFAOYSA-N D0Q4LX DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC4=CC=CC=C4O3)N D0Q4LX HIGHSTAT Investigative D0Q4PB DRUG__ID D0Q4PB D0Q4PB DRUGTYPE Small molecular drug D0Q4PB DRUGINCH 1S/C44H48N8O4/c1-30-50(29-36-8-4-7-34-6-2-3-9-38(34)36)44(56)52-40(43(55)48-28-33-13-11-32(27-45)12-14-33)20-19-39(51(30)52)35-21-24-49(25-22-35)42(54)10-5-23-47-41(53)26-31-15-17-37(46)18-16-31/h2-4,6-9,11-20,35H,1,5,10,21-29,45-46H2,(H,47,53)(H,48,55) D0Q4PB DRUGINKE VVCVJEWENXURHU-UHFFFAOYSA-N D0Q4PB DRUGSMIL C=C1N(C(=O)N2N1C(=CC=C2C(=O)NCC3=CC=C(C=C3)CN)C4CCN(CC4)C(=O)CCCNC(=O)CC5=CC=C(C=C5)N)CC6=CC=CC7=CC=CC=C76 D0Q4PB HIGHSTAT Investigative D0Q4PQ DRUG__ID D0Q4PQ D0Q4PQ DRUGTYPE Small molecular drug D0Q4PQ DRUGINCH 1S/C15H11NO3/c17-15(10-9-12-5-2-1-3-6-12)13-7-4-8-14(11-13)16(18)19/h1-11H/b10-9+ D0Q4PQ DRUGINKE MJXRQBATDWPDNF-MDZDMXLPSA-N D0Q4PQ DRUGSMIL C1=CC=C(C=C1)C=CC(=O)C2=CC(=CC=C2)[N+](=O)[O-] D0Q4PQ HIGHSTAT Investigative D0Q4PY DRUG__ID D0Q4PY D0Q4PY DRUGTYPE Small molecular drug D0Q4PY DRUGINCH 1S/C23H36N4O3/c1-19(2)30-21-9-6-5-8-20(21)26-16-14-25(15-17-26)13-11-24-22(28)18-27-12-7-3-4-10-23(27)29/h5-6,8-9,19H,3-4,7,10-18H2,1-2H3,(H,24,28) D0Q4PY DRUGINKE XHBOWUOETHUEOP-UHFFFAOYSA-N D0Q4PY DRUGSMIL CC(C)OC1=CC=CC=C1N2CCN(CC2)CCNC(=O)CN3CCCCCC3=O D0Q4PY HIGHSTAT Investigative D0Q4QF DRUG__ID D0Q4QF D0Q4QF DRUGTYPE Small molecular drug D0Q4QF DRUGINCH 1S/C36H44N4O/c41-36-18-10-4-1-2-5-11-20-39-22-17-30(35(25-39)23-26-13-7-3-6-12-21-40(26)34(35)36)29(24-36)32-33-28(16-19-37-32)27-14-8-9-15-31(27)38-33/h1,4,7-9,13-16,19,24,26,30,34,38,41H,2-3,5-6,10-12,17-18,20-23,25H2/b4-1-,13-7-/t26-,30-,34+,35-,36-/m0/s1 D0Q4QF DRUGINKE FUCSLKWLLSEMDQ-MKYGIPPKSA-N D0Q4QF DRUGSMIL C1CCN2CCC3C(=CC(CCC=CC1)(C4C3(C2)CC5N4CCCCC=C5)O)C6=NC=CC7=C6NC8=CC=CC=C78 D0Q4QF HIGHSTAT Investigative D0Q4TA DRUG__ID D0Q4TA D0Q4TA DRUGTYPE Small molecular drug D0Q4TA DRUGINCH 1S/C17H20N2O5S/c1-13(2)24-19(12-17(20)18-21)25(22,23)16-10-8-15(9-11-16)14-6-4-3-5-7-14/h3-11,13,21H,12H2,1-2H3,(H,18,20) D0Q4TA DRUGINKE PHGLPDURIUEELR-UHFFFAOYSA-N D0Q4TA DRUGSMIL CC(C)ON(CC(=O)NO)S(=O)(=O)C1=CC=C(C=C1)C2=CC=CC=C2 D0Q4TA HIGHSTAT Investigative D0Q4UA DRUG__ID D0Q4UA D0Q4UA DRUGTYPE Small molecular drug D0Q4UA DRUGINCH 1S/C38H64N10O9/c1-10-24(8)30(33(51)45-29(23(6)7)35(53)56-9)46-37(54)48-47-34(52)28(22(4)5)44-32(50)27(19-21(2)3)42-31(49)26(17-14-18-41-36(39)40)43-38(55)57-20-25-15-12-11-13-16-25/h11-13,15-16,21-24,26-30H,10,14,17-20H2,1-9H3,(H,42,49)(H,43,55)(H,44,50)(H,45,51)(H,47,52)(H4,39,40,41)(H2,46,48,54)/t24-,26-,27-,28-,29-,30-/m0/s1 D0Q4UA DRUGINKE ZLXFGUGFOLETFJ-POPCVQDUSA-N D0Q4UA DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1 D0Q4UA HIGHSTAT Investigative D0Q4UD DRUG__ID D0Q4UD D0Q4UD DRUGTYPE Small molecular drug D0Q4UD DRUGINCH 1S/C18H33NO4/c1-2-3-4-5-6-7-8-9-10-11-12-14-17(19(22)23)15-13-16-18(20)21/h14H,2-13,15-16H2,1H3,(H,20,21)/b17-14+ D0Q4UD DRUGINKE UWYMGOJUTJPTOD-SAPNQHFASA-N D0Q4UD DRUGSMIL CCCCCCCCCCCCC=C(CCCC(=O)O)[N+](=O)[O-] D0Q4UD HIGHSTAT Investigative D0Q4VE DRUG__ID D0Q4VE D0Q4VE DRUGTYPE Small molecular drug D0Q4VE DRUGINCH 1S/C24H32O4/c1-16-5-4-7-17(11-16)13-20(25)9-10-21-22-14-18(6-2-3-8-24(27)28)12-19(22)15-23(21)26/h4-5,7,9-12,19-23,25-26H,2-3,6,8,13-15H2,1H3,(H,27,28)/b10-9+/t19-,20-,21+,22-,23+/m0/s1 D0Q4VE DRUGINKE WECZQLFTKNIXDD-RNJUVHPUSA-N D0Q4VE DRUGSMIL CC1=CC(=CC=C1)CC(C=CC2C(CC3C2CC(=C3)CCCCC(=O)O)O)O D0Q4VE HIGHSTAT Investigative D0Q4VG DRUG__ID D0Q4VG D0Q4VG DRUGTYPE Small molecular drug D0Q4VG DRUGINCH 1S/C17H17ClN2O/c1-2-3-11-20-17-14(5-4-6-15(17)18)16(19-20)12-7-9-13(21)10-8-12/h4-10,21H,2-3,11H2,1H3 D0Q4VG DRUGINKE NPAAZPFDWTWFDL-UHFFFAOYSA-N D0Q4VG DRUGSMIL CCCCN1C2=C(C=CC=C2Cl)C(=N1)C3=CC=C(C=C3)O D0Q4VG HIGHSTAT Investigative D0Q4VO DRUG__ID D0Q4VO D0Q4VO DRUGTYPE Small molecular drug D0Q4VO DRUGINCH 1S/2Na.H3O4P/c;;1-5(2,3)4/h;;(H3,1,2,3,4)/q2*+1;/p-2 D0Q4VO DRUGINKE BNIILDVGGAEEIG-UHFFFAOYSA-L D0Q4VO DRUGSMIL OP(=O)([O-])[O-].[Na+].[Na+] D0Q4VO HIGHSTAT Investigative D0Q4YR DRUG__ID D0Q4YR D0Q4YR DRUGTYPE Small molecular drug D0Q4YR DRUGINCH 1S/C18H28O/c1-4-12-18(2,3)16-10-8-14(9-11-16)15-6-5-7-17(19)13-15/h8-11,15,17,19H,4-7,12-13H2,1-3H3/t15-,17+/m0/s1 D0Q4YR DRUGINKE IWAZRTQOOAVKDN-DOTOQJQBSA-N D0Q4YR DRUGSMIL CCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0Q4YR HIGHSTAT Investigative D0Q4YY DRUG__ID D0Q4YY D0Q4YY DRUGTYPE Small molecular drug D0Q4YY DRUGINCH 1S/C38H64N10O9/c1-10-24(8)30(33(51)45-29(23(6)7)35(53)56-9)46-37(54)48-47-34(52)28(22(4)5)44-32(50)27(19-21(2)3)42-31(49)26(17-14-18-41-36(39)40)43-38(55)57-20-25-15-12-11-13-16-25/h11-13,15-16,21-24,26-30H,10,14,17-20H2,1-9H3,(H,42,49)(H,43,55)(H,44,50)(H,45,51)(H,47,52)(H4,39,40,41)(H2,46,48,54) D0Q4YY DRUGINKE ZLXFGUGFOLETFJ-UHFFFAOYSA-N D0Q4YY DRUGSMIL CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1 D0Q4YY HIGHSTAT Investigative D0Q5AD DRUG__ID D0Q5AD D0Q5AD DRUGTYPE Small molecular drug D0Q5AD DRUGINCH 1S/C23H33NO7/c1-11-10-17(30-22(11)27)14-7-8-15-18(16(25)6-5-9-24(14)15)12(2)19(26)21-20(29-4)13(3)23(28)31-21/h11-12,14-18,25,28H,5-10H2,1-4H3/t11-,12-,14-,15-,16-,17-,18+/m0/s1 D0Q5AD DRUGINKE JQDHOVUUTIBLDW-YFIQHYBRSA-N D0Q5AD DRUGSMIL CC1CC(OC1=O)C2CCC3N2CCCC(C3C(C)C(=O)C4=C(C(=C(O4)O)C)OC)O D0Q5AD HIGHSTAT Investigative D0Q5AJ DRUG__ID D0Q5AJ D0Q5AJ DRUGTYPE Small molecular drug D0Q5AJ DRUGINCH 1S/C52H76N2O2/c1(3-5-11-31-55-43-23-21-41-33-49-45-19-7-9-25-51(45,47(41)35-43)27-29-53(49)37-39-15-13-16-39)2-4-6-12-32-56-44-24-22-42-34-50-46-20-8-10-26-52(46,48(42)36-44)28-30-54(50)38-40-17-14-18-40/h21-24,35-36,39-40,45-46,49-50H,1-20,25-34,37-38H2/t45-,46-,49+,50+,51+,52+/m0/s1 D0Q5AJ DRUGINKE NDMWWBDABLNMKI-YMWIEQFASA-N D0Q5AJ DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OCCCCCCCCCCOC5=CC6=C(CC7C8C6(CCCC8)CCN7CC9CCC9)C=C5)CC1CCC1 D0Q5AJ HIGHSTAT Investigative D0Q5CS DRUG__ID D0Q5CS D0Q5CS DRUGTYPE Small molecular drug D0Q5CS DRUGINCH 1S/C20H22N8O4/c21-16(22)15-13(29)14(30)19(32-15)28-8-25-12-17(23)26-20(27-18(12)28)31-6-5-9-7-24-11-4-2-1-3-10(9)11/h1-4,7-8,13-15,19,24,29-30H,5-6H2,(H3,21,22)(H2,23,26,27)/t13-,14+,15-,19+/m0/s1 D0Q5CS DRUGINKE AWBHOELFSQMGIY-QCUYGVNKSA-N D0Q5CS DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)C(=N)N)O)O)N D0Q5CS HIGHSTAT Investigative D0Q5DI DRUG__ID D0Q5DI D0Q5DI DRUGTYPE Small molecular drug D0Q5DI DRUGINCH 1S/C19H23N3O3/c1-2-3-13-22(19(24)20-17-7-5-4-6-8-17)14-15-9-11-16(12-10-15)18(23)21-25/h4-12,25H,2-3,13-14H2,1H3,(H,20,24)(H,21,23) D0Q5DI DRUGINKE JZWXMCPARMXZQV-UHFFFAOYSA-N D0Q5DI DRUGSMIL CCCCN(CC1=CC=C(C=C1)C(=O)NO)C(=O)NC2=CC=CC=C2 D0Q5DI HIGHSTAT Investigative D0Q5FJ DRUG__ID D0Q5FJ D0Q5FJ DRUGTYPE Small molecular drug D0Q5FJ DRUGINCH 1S/C20H19NO2/c22-18-14-19(21-12-5-2-6-13-21)23-20-16(10-7-11-17(18)20)15-8-3-1-4-9-15/h1,3-4,7-11,14H,2,5-6,12-13H2 D0Q5FJ DRUGINKE OSJZAQVQDRSBPT-UHFFFAOYSA-N D0Q5FJ DRUGSMIL C1CCN(CC1)C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4 D0Q5FJ HIGHSTAT Investigative D0Q5FV DRUG__ID D0Q5FV D0Q5FV DRUGTYPE Small molecular drug D0Q5FV DRUGINCH 1S/C2H6OS/c3-1-2-4/h3-4H,1-2H2 D0Q5FV DRUGINKE DGVVWUTYPXICAM-UHFFFAOYSA-N D0Q5FV DRUGSMIL C(CS)O D0Q5FV HIGHSTAT Investigative D0Q5HW DRUG__ID D0Q5HW D0Q5HW DRUGTYPE Small molecular drug D0Q5HW DRUGINCH 1S/C20H21N5O5/c1-11-3-5-12(6-4-11)7-8-14-22-18(24-29-2)15-19(23-14)25(10-21-15)20-17(28)16(27)13(9-26)30-20/h3-6,10,13,16-17,20,26-28H,9H2,1-2H3,(H,22,23,24)/t13-,16-,17-,20-/m1/s1 D0Q5HW DRUGINKE QEUCNKIJAMGFSL-AEVYOOLXSA-N D0Q5HW DRUGSMIL CC1=CC=C(C=C1)C#CC2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)NOC D0Q5HW HIGHSTAT Investigative D0Q5IP DRUG__ID D0Q5IP D0Q5IP DRUGTYPE Small molecular drug D0Q5IP DRUGINCH 1S/C20H22N2/c1-2-6-16(7-3-1)17-10-12-22(13-11-17)15-18-14-21-20-9-5-4-8-19(18)20/h1-9,14,17,21H,10-13,15H2 D0Q5IP DRUGINKE XNXQFTTXHFQTRX-UHFFFAOYSA-N D0Q5IP DRUGSMIL C1CN(CCC1C2=CC=CC=C2)CC3=CNC4=CC=CC=C43 D0Q5IP HIGHSTAT Investigative D0Q5PC DRUG__ID D0Q5PC D0Q5PC DRUGTYPE Small molecular drug D0Q5PC DRUGINCH 1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2 D0Q5PC DRUGINKE JTJMJGYZQZDUJJ-UHFFFAOYSA-N D0Q5PC DRUGSMIL C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3 D0Q5PC HIGHSTAT Investigative D0Q5PQ DRUG__ID D0Q5PQ D0Q5PQ DRUGTYPE Small molecular drug D0Q5PQ DRUGINCH 1S/C25H26O4/c1-14(2)5-6-15-11-18-22(12-20(15)26)27-13-19-16-7-8-21-17(23(16)28-24(18)19)9-10-25(3,4)29-21/h5,7-12,19,24,26H,6,13H2,1-4H3/t19-,24-/m0/s1 D0Q5PQ DRUGINKE XERSCIKBWOLVNC-CYFREDJKSA-N D0Q5PQ DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OCC3C2OC4=C3C=CC5=C4C=CC(O5)(C)C)C D0Q5PQ HIGHSTAT Investigative D0Q5RG DRUG__ID D0Q5RG D0Q5RG DRUGTYPE Small molecular drug D0Q5RG DRUGINCH 1S/C7H9N3S2/c1-5(9-10-7(8)11)6-3-2-4-12-6/h2-4H,1H3,(H3,8,10,11)/b9-5- D0Q5RG DRUGINKE PJVHAJJEMJNPHN-UITAMQMPSA-N D0Q5RG DRUGSMIL CC(=NNC(=S)N)C1=CC=CS1 D0Q5RG HIGHSTAT Investigative D0Q5SL DRUG__ID D0Q5SL D0Q5SL DRUGTYPE Small molecular drug D0Q5SL DRUGINCH 1S/C14H18N2O/c1-16-6-4-10(5-7-16)13-9-15-14-3-2-11(17)8-12(13)14/h2-3,8-10,15,17H,4-7H2,1H3 D0Q5SL DRUGINKE WKNFADCGOAHBPG-UHFFFAOYSA-N D0Q5SL DRUGSMIL CN1CCC(CC1)C2=CNC3=C2C=C(C=C3)O D0Q5SL HIGHSTAT Investigative D0Q5SV DRUG__ID D0Q5SV D0Q5SV DRUGTYPE Small molecular drug D0Q5SV DRUGINCH 1S/C12H20N2O8P2S/c1-7-8(2)11(14-4-3-10(15)13-12(14)25)22-9(7)5-21-24(19,20)6-23(16,17)18/h3-4,7-9,11H,5-6H2,1-2H3,(H,19,20)(H,13,15,25)(H2,16,17,18)/t7-,8+,9+,11+/m0/s1 D0Q5SV DRUGINKE HGGLEWIKYOGGHB-YSSBGUOXSA-N D0Q5SV DRUGSMIL CC1C(C(OC1COP(=O)(CP(=O)(O)O)O)N2C=CC(=O)NC2=S)C D0Q5SV HIGHSTAT Investigative D0Q5UH DRUG__ID D0Q5UH D0Q5UH DRUGTYPE Small molecular drug D0Q5UH DRUGINCH 1S/C20H21N3O2/c1-12-6-5-7-14(21-12)18-17(22-19(23-18)20(2,3)4)13-8-9-15-16(10-13)25-11-24-15/h5-10H,11H2,1-4H3,(H,22,23) D0Q5UH DRUGINKE WGZOTBUYUFBEPZ-UHFFFAOYSA-N D0Q5UH DRUGSMIL CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4 D0Q5UH HIGHSTAT Investigative D0Q5VB DRUG__ID D0Q5VB D0Q5VB DRUGTYPE Small molecular drug D0Q5VB DRUGINCH 1S/C6H10N4O2S/c1-8-10-5-2-3-9-4-6(5)13(7,11)12/h2-4,8H,1H3,(H,9,10)(H2,7,11,12) D0Q5VB DRUGINKE CKTSHDQZQGLANI-UHFFFAOYSA-N D0Q5VB DRUGSMIL CNNC1=C(C=NC=C1)S(=O)(=O)N D0Q5VB HIGHSTAT Investigative D0Q5WB DRUG__ID D0Q5WB D0Q5WB DRUGTYPE Small molecular drug D0Q5WB DRUGINCH 1S/C29H33ClN4OS/c1-32(2)17-18-35-27-9-5-3-8-23(27)21-31-34-15-13-33(14-16-34)26-19-22-7-4-6-10-28(22)36-29-12-11-24(30)20-25(26)29/h3-12,20-21,26H,13-19H2,1-2H3/b31-21- D0Q5WB DRUGINKE OKSZYIOFSXRHJB-YQYKVWLJSA-N D0Q5WB DRUGSMIL CN(C)CCOC1=CC=CC=C1C=NN2CCN(CC2)C3CC4=CC=CC=C4SC5=C3C=C(C=C5)Cl D0Q5WB HIGHSTAT Investigative D0Q5XD DRUG__ID D0Q5XD D0Q5XD DRUGTYPE Small molecular drug D0Q5XD DRUGINCH 1S/C10H16N5O13P3S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(26-9)1-25-29(19,20)27-30(21,22)28-31(23,24)32/h2-3,5-6,9,16-17H,1H2,(H,19,20)(H,21,22)(H2,23,24,32)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1 D0Q5XD DRUGINKE XOFLBQFBSOEHOG-UUOKFMHZSA-N D0Q5XD DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N=C(NC2=O)N D0Q5XD HIGHSTAT Investigative D0Q5YP DRUG__ID D0Q5YP D0Q5YP DRUGTYPE Small molecular drug D0Q5YP DRUGINCH 1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12-,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1 D0Q5YP DRUGINKE QFJCIRLUMZQUOT-KADBNGAOSA-N D0Q5YP DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC D0Q5YP HIGHSTAT Investigative D0Q5ZZ DRUG__ID D0Q5ZZ D0Q5ZZ DRUGTYPE Small molecular drug D0Q5ZZ DRUGINCH 1S/C23H19NO/c1-25-22-10-9-18-15-23(19-8-5-11-24-16-19)21(13-20(18)14-22)12-17-6-3-2-4-7-17/h2-11,13-16H,12H2,1H3 D0Q5ZZ DRUGINKE OXCXOWFIXPOTGG-UHFFFAOYSA-N D0Q5ZZ DRUGSMIL COC1=CC2=CC(=C(C=C2C=C1)C3=CN=CC=C3)CC4=CC=CC=C4 D0Q5ZZ HIGHSTAT Investigative D0Q6AD DRUG__ID D0Q6AD D0Q6AD DRUGTYPE Small molecular drug D0Q6AD DRUGINCH 1S/C16H11ClOS/c17-16-9-8-15(19-16)12-6-4-11(5-7-12)13-2-1-3-14(18)10-13/h1-10,18H D0Q6AD DRUGINKE ABAQWDXYFZGNGR-UHFFFAOYSA-N D0Q6AD DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(C=C2)C3=CC=C(S3)Cl D0Q6AD HIGHSTAT Investigative D0Q6BJ DRUG__ID D0Q6BJ D0Q6BJ DRUGTYPE Small molecular drug D0Q6BJ DRUGINCH 1S/C22H17NO/c1-24-22-10-9-17-11-18(7-8-19(17)13-22)21-12-20(14-23-15-21)16-5-3-2-4-6-16/h2-15H,1H3 D0Q6BJ DRUGINKE SQTORKYTOSOTPB-UHFFFAOYSA-N D0Q6BJ DRUGSMIL COC1=CC2=C(C=C1)C=C(C=C2)C3=CN=CC(=C3)C4=CC=CC=C4 D0Q6BJ HIGHSTAT Investigative D0Q6CF DRUG__ID D0Q6CF D0Q6CF DRUGTYPE Small molecular drug D0Q6CF DRUGINCH 1S/C34H35N5O5/c40-24-14-12-22(13-15-24)18-29-34(44)39-16-6-11-30(39)33(43)37-27(17-21-7-2-1-3-8-21)31(41)36-28(32(42)38-29)19-23-20-35-26-10-5-4-9-25(23)26/h1-5,7-10,12-15,20,27-30,35,40H,6,11,16-19H2,(H,36,41)(H,37,43)(H,38,42)/t27-,28+,29-,30+/m0/s1 D0Q6CF DRUGINKE YTXYSUHLDDXFGK-RRGQHJHPSA-N D0Q6CF DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=C(C=C3)O)CC4=CNC5=CC=CC=C54)CC6=CC=CC=C6 D0Q6CF HIGHSTAT Investigative D0Q6CJ DRUG__ID D0Q6CJ D0Q6CJ DRUGTYPE Small molecular drug D0Q6CJ DRUGINCH 1S/C15H8BrNO4/c16-10-3-1-2-9(6-10)15-8-13(18)12-7-11(17(19)20)4-5-14(12)21-15/h1-8H D0Q6CJ DRUGINKE IOYFMBZXVIRMNX-UHFFFAOYSA-N D0Q6CJ DRUGSMIL C1=CC(=CC(=C1)Br)C2=CC(=O)C3=C(O2)C=CC(=C3)[N+](=O)[O-] D0Q6CJ HIGHSTAT Investigative D0Q6EE DRUG__ID D0Q6EE D0Q6EE DRUGTYPE Small molecular drug D0Q6EE DRUGINCH 1S/C17H12N2/c1-12-5-6-14-7-8-16(10-17(14)19-12)15-4-2-3-13(9-15)11-18/h2-10H,1H3 D0Q6EE DRUGINKE RPEUOKKTGONULE-UHFFFAOYSA-N D0Q6EE DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC(=C3)C#N D0Q6EE HIGHSTAT Investigative D0Q6EK DRUG__ID D0Q6EK D0Q6EK DRUGTYPE Small molecular drug D0Q6EK DRUGINCH 1S/C22H29NO10/c1-6-23-8-9(18(3,4)5)19-11(25)15(27)32-17(19)33-22-16(28)31-12(8)20(19,22)10(24)13-21(22,29)7(2)14(26)30-13/h7-13,17,23-25,29H,6H2,1-5H3/t7?,8-,9?,10?,11-,12?,13-,17?,19?,20?,21+,22-/m0/s1 D0Q6EK DRUGINKE UIERCQIWSNGSNJ-YUTHRBKVSA-N D0Q6EK DRUGSMIL CCNC1C(C23C(C(=O)OC2OC45C3(C1OC4=O)C(C6C5(C(C(=O)O6)C)O)O)O)C(C)(C)C D0Q6EK HIGHSTAT Investigative D0Q6FF DRUG__ID D0Q6FF D0Q6FF DRUGTYPE Small molecular drug D0Q6FF DRUGINCH 1S/C21H22BrNO/c1-2-3-8-13-23-15-18(17-10-5-7-12-20(17)23)21(24)14-16-9-4-6-11-19(16)22/h4-7,9-12,15H,2-3,8,13-14H2,1H3 D0Q6FF DRUGINKE CGQRVOHECAULLB-UHFFFAOYSA-N D0Q6FF DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3Br D0Q6FF HIGHSTAT Investigative D0Q6HT DRUG__ID D0Q6HT D0Q6HT DRUGTYPE Small molecular drug D0Q6HT DRUGINCH 1S/C15H20N2O2/c1-10(18)17-9-15(2,3)13-8-16-14-6-5-11(19-4)7-12(13)14/h5-8,16H,9H2,1-4H3,(H,17,18) D0Q6HT DRUGINKE OMYMGFDKAPBSGB-UHFFFAOYSA-N D0Q6HT DRUGSMIL CC(=O)NCC(C)(C)C1=CNC2=C1C=C(C=C2)OC D0Q6HT HIGHSTAT Investigative D0Q6KO DRUG__ID D0Q6KO D0Q6KO DRUGTYPE Small molecular drug D0Q6KO DRUGINCH 1S/C8H11N5O/c1-5(14)2-13-4-12-6-7(9)10-3-11-8(6)13/h3-5,14H,2H2,1H3,(H2,9,10,11) D0Q6KO DRUGINKE MJZYTEBKXLVLMY-UHFFFAOYSA-N D0Q6KO DRUGSMIL CC(CN1C=NC2=C(N=CN=C21)N)O D0Q6KO HIGHSTAT Investigative D0Q6MS DRUG__ID D0Q6MS D0Q6MS DRUGTYPE Small molecular drug D0Q6MS DRUGINCH 1S/C21H18O2/c1-15(16-5-3-2-4-6-16)21(17-7-11-19(22)12-8-17)18-9-13-20(23)14-10-18/h2-14,22-23H,1H3 D0Q6MS DRUGINKE VGWVLJXJHQENDY-UHFFFAOYSA-N D0Q6MS DRUGSMIL CC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=CC=C3 D0Q6MS HIGHSTAT Investigative D0Q6PI DRUG__ID D0Q6PI D0Q6PI DRUGTYPE Small molecular drug D0Q6PI DRUGINCH 1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2 D0Q6PI DRUGINKE BHHGXPLMPWCGHP-UHFFFAOYSA-N D0Q6PI DRUGSMIL C1=CC=C(C=C1)CCN D0Q6PI HIGHSTAT Investigative D0Q6RH DRUG__ID D0Q6RH D0Q6RH DRUGTYPE Small molecular drug D0Q6RH DRUGINCH 1S/C20H16N2O4/c23-22(24)16-7-11-20(21-13-16)25-17-8-10-19-15(12-17)6-9-18(26-19)14-4-2-1-3-5-14/h1-5,7-8,10-13,18H,6,9H2 D0Q6RH DRUGINKE GZONLGPIHCCJOI-UHFFFAOYSA-N D0Q6RH DRUGSMIL C1CC2=C(C=CC(=C2)OC3=NC=C(C=C3)[N+](=O)[O-])OC1C4=CC=CC=C4 D0Q6RH HIGHSTAT Investigative D0Q6SH DRUG__ID D0Q6SH D0Q6SH DRUGTYPE Small molecular drug D0Q6SH DRUGINCH 1S/C18H20FNO/c1-13-5-6-17(14-7-9-20-10-8-14)18(11-13)21-16-4-2-3-15(19)12-16/h2-6,11-12,14,20H,7-10H2,1H3 D0Q6SH DRUGINKE BBYFZRZFESDGLZ-UHFFFAOYSA-N D0Q6SH DRUGSMIL CC1=CC(=C(C=C1)C2CCNCC2)OC3=CC(=CC=C3)F D0Q6SH HIGHSTAT Investigative D0Q6TU DRUG__ID D0Q6TU D0Q6TU DRUGTYPE Small molecular drug D0Q6TU DRUGINCH 1S/C14H21N3O2/c18-14(19-8-10-4-2-1-3-5-10)17-12-6-11(12)13-7-15-9-16-13/h7,9-12H,1-6,8H2,(H,15,16)(H,17,18)/t11-,12-/m1/s1 D0Q6TU DRUGINKE SLQAVEDMASVHTL-VXGBXAGGSA-N D0Q6TU DRUGSMIL C1CCC(CC1)COC(=O)NC2CC2C3=CN=CN3 D0Q6TU HIGHSTAT Investigative D0Q6UT DRUG__ID D0Q6UT D0Q6UT DRUGTYPE Small molecular drug D0Q6UT DRUGINCH 1S/C8H12N2OS/c12-8-10-9-7(11-8)6-4-2-1-3-5-6/h6H,1-5H2,(H,10,12) D0Q6UT DRUGINKE ONBUSMDUKULCRC-UHFFFAOYSA-N D0Q6UT DRUGSMIL C1CCC(CC1)C2=NNC(=S)O2 D0Q6UT HIGHSTAT Investigative D0Q6VH DRUG__ID D0Q6VH D0Q6VH DRUGTYPE Small molecular drug D0Q6VH DRUGINCH 1S/C14H13N/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13/h2-11H,1H3/b11-10+ D0Q6VH DRUGINKE SISOFUCTXZKSOQ-ZHACJKMWSA-N D0Q6VH DRUGSMIL CC1=NC(=CC=C1)C=CC2=CC=CC=C2 D0Q6VH HIGHSTAT Investigative D0Q6VK DRUG__ID D0Q6VK D0Q6VK DRUGTYPE Small molecular drug D0Q6VK DRUGINCH 1S/C32H38Cl2N10O4.ClH/c1-41-18-22(14-25(41)30(46)37-11-8-28(35)36)39-32(48)27-16-23(19-43(27)3)40-31(47)26-15-21(17-42(26)2)38-29(45)20-4-6-24(7-5-20)44(12-9-33)13-10-34;/h4-7,14-19H,8-13H2,1-3H3,(H3,35,36)(H,37,46)(H,38,45)(H,39,48)(H,40,47);1H D0Q6VK DRUGINKE BLSOATWWAGIRGE-UHFFFAOYSA-N D0Q6VK DRUGSMIL CN1C=C(C=C1C(=O)NC2=CN(C(=C2)C(=O)NC3=CN(C(=C3)C(=O)NCCC(=N)N)C)C)NC(=O)C4=CC=C(C=C4)N(CCCl)CCCl.Cl D0Q6VK HIGHSTAT Investigative D0Q6WP DRUG__ID D0Q6WP D0Q6WP DRUGTYPE Small molecular drug D0Q6WP DRUGINCH 1S/C26H27F2NO4/c1-16(2)24-15-23(17-3-7-19(27)8-4-17)26(18-5-9-20(28)10-6-18)29(24)12-11-21(30)13-22(31)14-25(32)33/h3-12,15-16,21-22,30-31H,13-14H2,1-2H3,(H,32,33)/b12-11+/t21-,22-/m1/s1 D0Q6WP DRUGINKE NRLBNECCSXRCMS-CXYUPCIPSA-N D0Q6WP DRUGSMIL CC(C)C1=CC(=C(N1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)F D0Q6WP HIGHSTAT Investigative D0Q6WX DRUG__ID D0Q6WX D0Q6WX DRUGTYPE Small molecular drug D0Q6WX DRUGINCH 1S/C13H8ClN5O/c14-7-3-4-9-8(6-7)12-17-11(10-2-1-5-20-10)18-19(12)13(15)16-9/h1-6H,(H2,15,16) D0Q6WX DRUGINKE MSJODEOZODDVGW-UHFFFAOYSA-N D0Q6WX DRUGSMIL C1=COC(=C1)C2=NN3C(=N2)C4=C(C=CC(=C4)Cl)N=C3N D0Q6WX HIGHSTAT Investigative D0Q6XB DRUG__ID D0Q6XB D0Q6XB DRUGTYPE Small molecular drug D0Q6XB DRUGINCH 1S/C14H14N2/c15-13-8-6-11(7-9-13)4-5-12-2-1-3-14(16)10-12/h1-10H,15-16H2/b5-4+ D0Q6XB DRUGINKE IXGDBTKLQUHIAX-SNAWJCMRSA-N D0Q6XB DRUGSMIL C1=CC(=CC(=C1)N)C=CC2=CC=C(C=C2)N D0Q6XB HIGHSTAT Investigative D0Q7AF DRUG__ID D0Q7AF D0Q7AF DRUGTYPE Small molecular drug D0Q7AF DRUGINCH 1S/C22H22ClN3O2S/c1-26(2)11-10-16-14-24-22-9-6-17(13-20(16)22)25-29(27,28)18-7-8-19-15(12-18)4-3-5-21(19)23/h3-9,12-14,24-25H,10-11H2,1-2H3 D0Q7AF DRUGINKE OOIQBABUMXSCPC-UHFFFAOYSA-N D0Q7AF DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)NS(=O)(=O)C3=CC4=C(C=C3)C(=CC=C4)Cl D0Q7AF HIGHSTAT Investigative D0Q7BG DRUG__ID D0Q7BG D0Q7BG DRUGTYPE Small molecular drug D0Q7BG DRUGINCH 1S/C26H21F3O3/c1-2-4-21(16-25(30)31)20-9-13-24(14-10-20)32-17-18-5-3-6-22(15-18)19-7-11-23(12-8-19)26(27,28)29/h3,5-15,21H,16-17H2,1H3,(H,30,31)/t21-/m0/s1 D0Q7BG DRUGINKE ZOPNBMMVVZRSGH-NRFANRHFSA-N D0Q7BG DRUGSMIL CC#CC(CC(=O)O)C1=CC=C(C=C1)OCC2=CC(=CC=C2)C3=CC=C(C=C3)C(F)(F)F D0Q7BG HIGHSTAT Investigative D0Q7DJ DRUG__ID D0Q7DJ D0Q7DJ DRUGTYPE Small molecular drug D0Q7DJ DRUGINCH 1S/C9H10O5/c1-13-6-3-5(9(11)12)4-7(14-2)8(6)10/h3-4,10H,1-2H3,(H,11,12) D0Q7DJ DRUGINKE JMSVCTWVEWCHDZ-UHFFFAOYSA-N D0Q7DJ DRUGSMIL COC1=CC(=CC(=C1O)OC)C(=O)O D0Q7DJ HIGHSTAT Investigative D0Q7FM DRUG__ID D0Q7FM D0Q7FM DRUGTYPE Small molecular drug D0Q7FM DRUGINCH 1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2 D0Q7FM DRUGINKE XTKDAFGWCDAMPY-UHFFFAOYSA-N D0Q7FM DRUGSMIL C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3 D0Q7FM HIGHSTAT Investigative D0Q7GZ DRUG__ID D0Q7GZ D0Q7GZ DRUGTYPE Small molecular drug D0Q7GZ DRUGINCH 1S/C18H26N2O2/c1-2-3-4-5-6-7-11-14-18(15-12-9-8-10-13-15)16(21)19-17(22)20-18/h8-10,12-13H,2-7,11,14H2,1H3,(H2,19,20,21,22) D0Q7GZ DRUGINKE YDNZJQWFOGASIE-UHFFFAOYSA-N D0Q7GZ DRUGSMIL CCCCCCCCCC1(C(=O)NC(=O)N1)C2=CC=CC=C2 D0Q7GZ HIGHSTAT Investigative D0Q7HG DRUG__ID D0Q7HG D0Q7HG DRUGTYPE Small molecular drug D0Q7HG DRUGINCH 1S/C52H63N9O8/c1-32(2)25-42(50(67)59-43(49(66)55-29-36-15-8-5-9-16-36)28-37-30-54-41-18-11-10-17-39(37)41)60-51(68)45-19-12-24-61(45)52(69)44(27-34-13-6-4-7-14-34)58-46(63)31-56-47(64)33(3)57-48(65)40(53)26-35-20-22-38(62)23-21-35/h4-11,13-18,20-23,30,32-33,40,42-45,54,62H,12,19,24-29,31,53H2,1-3H3,(H,55,66)(H,56,64)(H,57,65)(H,58,63)(H,59,67)(H,60,68)/t33-,40+,42+,43+,44+,45+/m1/s1 D0Q7HG DRUGINKE VXHMITAKWYIILS-FDXPNMITSA-N D0Q7HG DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NCC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D0Q7HG HIGHSTAT Investigative D0Q7IU DRUG__ID D0Q7IU D0Q7IU DRUGTYPE Small molecular drug D0Q7IU DRUGINCH 1S/C21H24N4O3/c1-23-17-12-15(22-20(26)14-8-4-5-9-19(14)28-3)16(25-10-6-7-11-25)13-18(17)24(2)21(23)27/h4-5,8-9,12-13H,6-7,10-11H2,1-3H3,(H,22,26) D0Q7IU DRUGINKE QCIJLRJBZDBVDB-UHFFFAOYSA-N D0Q7IU DRUGSMIL CN1C2=C(C=C(C(=C2)NC(=O)C3=CC=CC=C3OC)N4CCCC4)N(C1=O)C D0Q7IU HIGHSTAT Investigative D0Q7LD DRUG__ID D0Q7LD D0Q7LD DRUGTYPE Small molecular drug D0Q7LD DRUGINCH 1S/C4H10O/c1-4(2,3)5/h5H,1-3H3 D0Q7LD DRUGINKE DKGAVHZHDRPRBM-UHFFFAOYSA-N D0Q7LD DRUGSMIL CC(C)(C)O D0Q7LD HIGHSTAT Investigative D0Q7NZ DRUG__ID D0Q7NZ D0Q7NZ DRUGTYPE Small molecular drug D0Q7NZ DRUGINCH 1S/C15H16N2.BrH/c1-12(16)17-15(13-8-4-2-5-9-13)14-10-6-3-7-11-14;/h2-11,15H,1H3,(H2,16,17);1H D0Q7NZ DRUGINKE SCBRUNBFSUXITM-UHFFFAOYSA-N D0Q7NZ DRUGSMIL CC(=NC(C1=CC=CC=C1)C2=CC=CC=C2)N.Br D0Q7NZ HIGHSTAT Investigative D0Q7OY DRUG__ID D0Q7OY D0Q7OY DRUGTYPE Small molecular drug D0Q7OY DRUGINCH 1S/C10H12O3/c11-7-2-1-3-8(12)9(7)10(13)6-4-5-6/h6,9H,1-5H2 D0Q7OY DRUGINKE DYVQTUZCXQZYGL-UHFFFAOYSA-N D0Q7OY DRUGSMIL C1CC(=O)C(C(=O)C1)C(=O)C2CC2 D0Q7OY HIGHSTAT Investigative D0Q7QU DRUG__ID D0Q7QU D0Q7QU DRUGTYPE Small molecular drug D0Q7QU DRUGINCH 1S/C18H13ClFN3O/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)22-9-12-8-21-17(10-24)23(12)16/h1-8,24H,9-10H2 D0Q7QU DRUGINKE QHSMEGADRFZVNE-UHFFFAOYSA-N D0Q7QU DRUGSMIL C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO D0Q7QU HIGHSTAT Investigative D0Q7SF DRUG__ID D0Q7SF D0Q7SF DRUGTYPE Small molecular drug D0Q7SF DRUGINCH 1S/C26H30N2O7/c1-2-14-35-20-10-8-18(9-11-20)23(31)17-4-6-19(7-5-17)26(34)27-12-3-13-28-15-22(30)25(33)24(32)21(28)16-29/h1,4-11,21-22,24-25,29-30,32-33H,3,12-16H2,(H,27,34)/t21-,22+,24-,25-/m1/s1 D0Q7SF DRUGINKE ISWDTKRAKJESLP-PEISPCAHSA-N D0Q7SF DRUGSMIL C#CCOC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)C(=O)NCCCN3CC(C(C(C3CO)O)O)O D0Q7SF HIGHSTAT Investigative D0Q7SP DRUG__ID D0Q7SP D0Q7SP DRUGTYPE Small molecular drug D0Q7SP DRUGINCH 1S/C35H52O4/c1-22(2)13-12-19-33(11)27(16-14-23(3)4)21-34(20-18-25(7)8)30(37)28(17-15-24(5)6)31(38)35(33,32(34)39)29(36)26(9)10/h13-15,18,26-27,37H,12,16-17,19-21H2,1-11H3 D0Q7SP DRUGINKE KGSZHKRKHXOAMG-UHFFFAOYSA-N D0Q7SP DRUGSMIL CC(C)C(=O)C12C(=O)C(=C(C(C1=O)(CC(C2(C)CCC=C(C)C)CC=C(C)C)CC=C(C)C)O)CC=C(C)C D0Q7SP HIGHSTAT Investigative D0Q7SS DRUG__ID D0Q7SS D0Q7SS DRUGTYPE Small molecular drug D0Q7SS DRUGINCH 1S/C30H33N5O5/c31-24(14-20-10-12-23(36)13-11-20)29(39)34-26-16-21-8-4-5-9-22(21)17-35(30(26)40)18-27(37)33-25(28(32)38)15-19-6-2-1-3-7-19/h1-13,24-26,36H,14-18,31H2,(H2,32,38)(H,33,37)(H,34,39)/t24-,25-,26-/m0/s1 D0Q7SS DRUGINKE XIRBKSHTAOQLGM-GSDHBNRESA-N D0Q7SS DRUGSMIL C1C(C(=O)N(CC2=CC=CC=C21)CC(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D0Q7SS HIGHSTAT Investigative D0Q7ST DRUG__ID D0Q7ST D0Q7ST DRUGTYPE Small molecular drug D0Q7ST DRUGINCH 1S/C43H64BFN6O11/c1-22(2)35(49-38(57)28(15-17-33(52)53)47-37(56)27(46)21-34(54)55)40(59)50-36(23(3)4)41(60)51-18-8-9-29(51)39(58)48-32(16-12-24-10-13-26(45)14-11-24)44-61-31-20-25-19-30(42(25,5)6)43(31,7)62-44/h10-11,13-14,22-23,25,27-32,35-36H,8-9,12,15-21,46H2,1-7H3,(H,47,56)(H,48,58)(H,49,57)(H,50,59)(H,52,53)(H,54,55)/t25-,27-,28-,29+,30-,31+,32-,35-,36-,43-/m0/s1 D0Q7ST DRUGINKE JAXFJECJQZDFJS-XHEPKHHKSA-N D0Q7ST DRUGSMIL B1(OC2CC3CC(C3(C)C)C2(O1)C)C(CCC4=CC=C(C=C4)F)NC(=O)C5CCCN5C(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)N D0Q7ST HIGHSTAT Investigative D0Q7SY DRUG__ID D0Q7SY D0Q7SY DRUGTYPE Small molecular drug D0Q7SY DRUGINCH 1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7) D0Q7SY DRUGINKE HHDDCCUIIUWNGJ-UHFFFAOYSA-N D0Q7SY DRUGSMIL C(C(=O)C(=O)O)O D0Q7SY HIGHSTAT Investigative D0Q7TL DRUG__ID D0Q7TL D0Q7TL DRUGTYPE Small molecular drug D0Q7TL DRUGINCH 1S/C28H36N4O3/c1-19(29-2)26(33)30-23-16-10-9-15-22-17-18-24(32(22)28(23)35)27(34)31-25(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,19,22-25,29H,9-10,15-18H2,1-2H3,(H,30,33)(H,31,34)/t19-,22-,23-,24-/m0/s1 D0Q7TL DRUGINKE XBTLZUHJBOBKRG-HCUBDLJJSA-N D0Q7TL DRUGSMIL CC(C(=O)NC1CCCCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)NC D0Q7TL HIGHSTAT Investigative D0Q7TO DRUG__ID D0Q7TO D0Q7TO DRUGTYPE Small molecular drug D0Q7TO DRUGINCH 1S/C18H15N5/c1-12-11-16(23-22-12)20-18-14-9-5-6-10-15(14)19-17(21-18)13-7-3-2-4-8-13/h2-11H,1H3,(H2,19,20,21,22,23) D0Q7TO DRUGINKE JYCUVOXSZBECAY-UHFFFAOYSA-N D0Q7TO DRUGSMIL CC1=CC(=NN1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4 D0Q7TO HIGHSTAT Investigative D0Q7VU DRUG__ID D0Q7VU D0Q7VU DRUGTYPE Small molecular drug D0Q7VU DRUGINCH 1S/C5H13N3O/c1-2-3-4-7-5(6)8-9/h9H,2-4H2,1H3,(H3,6,7,8) D0Q7VU DRUGINKE ULDDTFAPYWLDGF-UHFFFAOYSA-N D0Q7VU DRUGSMIL CCCCN=C(N)NO D0Q7VU HIGHSTAT Investigative D0Q7WP DRUG__ID D0Q7WP D0Q7WP DRUGTYPE Small molecular drug D0Q7WP DRUGINCH 1S/C11H18N5O5P/c1-2-7(5-22(18,19)20)21-4-3-16-6-13-8-9(16)14-11(12)15-10(8)17/h6-7H,2-5H2,1H3,(H2,18,19,20)(H3,12,14,15,17) D0Q7WP DRUGINKE RGMQGNHVNYSQHV-UHFFFAOYSA-N D0Q7WP DRUGSMIL CCC(CP(=O)(O)O)OCCN1C=NC2=C1N=C(NC2=O)N D0Q7WP HIGHSTAT Investigative D0Q7ZR DRUG__ID D0Q7ZR D0Q7ZR DRUGTYPE Small molecular drug D0Q7ZR DRUGINCH 1S/C25H26N4O3S/c1-32-21-10-6-5-9-20(21)28-14-11-27(12-15-28)13-16-29-24(30)22-19(18-7-3-2-4-8-18)17-33-23(22)26-25(29)31/h2-10,17H,11-16H2,1H3,(H,26,31) D0Q7ZR DRUGINKE HLVQBOYEHQRWHG-UHFFFAOYSA-N D0Q7ZR DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(NC3=O)SC=C4C5=CC=CC=C5 D0Q7ZR HIGHSTAT Investigative D0Q8AT DRUG__ID D0Q8AT D0Q8AT DRUGTYPE Small molecular drug D0Q8AT DRUGINCH 1S/C30H48O4/c1-25(2)12-14-30(24(33)34)15-13-28(6)18(19(30)16-25)8-9-22-27(5)17-20(31)23(32)26(3,4)21(27)10-11-29(22,28)7/h8,19-23,31-32H,9-17H2,1-7H3,(H,33,34)/t19-,20+,21-,22+,23+,27-,28+,29+,30-/m0/s1 D0Q8AT DRUGINKE MDZKJHQSJHYOHJ-HFYZCPLSSA-N D0Q8AT DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C D0Q8AT HIGHSTAT Investigative D0Q8BK DRUG__ID D0Q8BK D0Q8BK DRUGTYPE Small molecular drug D0Q8BK DRUGINCH 1S/C20H17F3N4O3/c21-20(22,23)30-16-6-4-15(5-7-16)27-18-11-17(25-12-26-18)13-2-1-3-14(10-13)19(29)24-8-9-28/h1-7,10-12,28H,8-9H2,(H,24,29)(H,25,26,27) D0Q8BK DRUGINKE IIQUYGWWHIHOCF-UHFFFAOYSA-N D0Q8BK DRUGSMIL C1=CC(=CC(=C1)C(=O)NCCO)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F D0Q8BK HIGHSTAT Investigative D0Q8BS DRUG__ID D0Q8BS D0Q8BS DRUGTYPE Small molecular drug D0Q8BS DRUGINCH 1S/C6H11N3/c1-5(7)2-6-3-8-4-9-6/h3-5H,2,7H2,1H3,(H,8,9)/t5-/m0/s1 D0Q8BS DRUGINKE XNQIOISZPFVUFG-YFKPBYRVSA-N D0Q8BS DRUGSMIL CC(CC1=CN=CN1)N D0Q8BS HIGHSTAT Investigative D0Q8CE DRUG__ID D0Q8CE D0Q8CE DRUGTYPE Small molecular drug D0Q8CE DRUGINCH 1S/C15H21N3/c1-15(2,3)12-5-4-6-13(9-12)17-8-7-14-10-16-11-18-14/h4-6,9-11,17H,7-8H2,1-3H3,(H,16,18) D0Q8CE DRUGINKE LRIVTYQQFCXAFC-UHFFFAOYSA-N D0Q8CE DRUGSMIL CC(C)(C)C1=CC(=CC=C1)NCCC2=CN=CN2 D0Q8CE HIGHSTAT Investigative D0Q8EX DRUG__ID D0Q8EX D0Q8EX DRUGTYPE Small molecular drug D0Q8EX DRUGINCH 1S/C4H11N3O/c1-3(2)6-4(5)7-8/h3,8H,1-2H3,(H3,5,6,7) D0Q8EX DRUGINKE OITVEDMMUMUWTL-UHFFFAOYSA-N D0Q8EX DRUGSMIL CC(C)N=C(N)NO D0Q8EX HIGHSTAT Investigative D0Q8HM DRUG__ID D0Q8HM D0Q8HM DRUGTYPE Small molecular drug D0Q8HM DRUGINCH 1S/C11H7FN4S/c12-7-1-3-8(4-2-7)17-11-9-10(14-5-13-9)15-6-16-11/h1-6H,(H,13,14,15,16) D0Q8HM DRUGINKE MTSKQGGVBOTGLP-UHFFFAOYSA-N D0Q8HM DRUGSMIL C1=CC(=CC=C1F)SC2=NC=NC3=C2NC=N3 D0Q8HM HIGHSTAT Investigative D0Q8HV DRUG__ID D0Q8HV D0Q8HV DRUGTYPE Small molecular drug D0Q8HV DRUGINCH 1S/C9H8N2O6/c1-4(12)10-8-6(11(16)17)2-5(9(14)15)3-7(8)13/h2-3,13H,1H3,(H,10,12)(H,14,15) D0Q8HV DRUGINKE JIDRTCHFBHJIDG-UHFFFAOYSA-N D0Q8HV DRUGSMIL CC(=O)NC1=C(C=C(C=C1O)C(=O)O)[N+](=O)[O-] D0Q8HV HIGHSTAT Investigative D0Q8IQ DRUG__ID D0Q8IQ D0Q8IQ DRUGTYPE Small molecular drug D0Q8IQ DRUGINCH 1S/C11H14ClNO/c1-8(13(2)3)11(14)9-5-4-6-10(12)7-9/h4-8H,1-3H3 D0Q8IQ DRUGINKE UYZAXUWVJGHEFL-UHFFFAOYSA-N D0Q8IQ DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)N(C)C D0Q8IQ HIGHSTAT Investigative D0Q8JE DRUG__ID D0Q8JE D0Q8JE DRUGTYPE Small molecular drug D0Q8JE DRUGINCH 1S/C22H26N4O2/c1-5-25(6-2)12-11-23-17-8-9-18-21-20(17)22(27)16-13-15(28-4)7-10-19(16)26(21)14(3)24-18/h7-10,13,23H,5-6,11-12H2,1-4H3 D0Q8JE DRUGINKE URGOPTXSJQVCSA-UHFFFAOYSA-N D0Q8JE DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=C(N3C4=C(C2=O)C=C(C=C4)OC)C D0Q8JE HIGHSTAT Investigative D0Q8KM DRUG__ID D0Q8KM D0Q8KM DRUGTYPE Small molecular drug D0Q8KM DRUGINCH 1S/C17H13N3/c18-10-14-6-8-15(9-7-14)12-20-13-19-11-17(20)16-4-2-1-3-5-16/h1-9,11,13H,12H2 D0Q8KM DRUGINKE HPKNNFRLCPHIRD-UHFFFAOYSA-N D0Q8KM DRUGSMIL C1=CC=C(C=C1)C2=CN=CN2CC3=CC=C(C=C3)C#N D0Q8KM HIGHSTAT Investigative D0Q8LS DRUG__ID D0Q8LS D0Q8LS DRUGTYPE Small molecular drug D0Q8LS DRUGINCH 1S/C20H22N2OS/c1-4-13-22(14-5-1)15-12-16-8-10-17(11-9-16)23-20-21-18-6-2-3-7-19(18)24-20/h2-3,6-11H,1,4-5,12-15H2 D0Q8LS DRUGINKE DHHMVJVCMLXZBO-UHFFFAOYSA-N D0Q8LS DRUGSMIL C1CCN(CC1)CCC2=CC=C(C=C2)OC3=NC4=CC=CC=C4S3 D0Q8LS HIGHSTAT Investigative D0Q8LU DRUG__ID D0Q8LU D0Q8LU DRUGTYPE Small molecular drug D0Q8LU DRUGINCH 1S/C16H22N4S/c1-2-8-19(9-3-1)13-5-10-20(11-6-13)16-18-14-12-17-7-4-15(14)21-16/h4,7,12-13H,1-3,5-6,8-11H2 D0Q8LU DRUGINKE CYASDRJNADLAFT-UHFFFAOYSA-N D0Q8LU DRUGSMIL C1CCN(CC1)C2CCN(CC2)C3=NC4=C(S3)C=CN=C4 D0Q8LU HIGHSTAT Investigative D0Q8NE DRUG__ID D0Q8NE D0Q8NE DRUGTYPE Small molecular drug D0Q8NE DRUGINCH 1S/C17H22N2O2/c20-15-3-1-14(2-4-15)18-16(21)19-17-8-11-5-12(9-17)7-13(6-11)10-17/h1-4,11-13,20H,5-10H2,(H2,18,19,21) D0Q8NE DRUGINKE NGFXIFJXNYMTPD-UHFFFAOYSA-N D0Q8NE DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=C(C=C4)O D0Q8NE HIGHSTAT Investigative D0Q8NO DRUG__ID D0Q8NO D0Q8NO DRUGTYPE Small molecular drug D0Q8NO DRUGINCH 1S/C7H12N4S/c8-7(9)12-3-1-2-6-4-10-5-11-6/h4-5H,1-3H2,(H3,8,9)(H,10,11) D0Q8NO DRUGINKE QJUVWGBVEFRHCN-UHFFFAOYSA-N D0Q8NO DRUGSMIL C1=C(NC=N1)CCCSC(=N)N D0Q8NO HIGHSTAT Investigative D0Q8NW DRUG__ID D0Q8NW D0Q8NW DRUGTYPE Small molecular drug D0Q8NW DRUGINCH 1S/C13H9NO2S/c15-11-9-6-7-17-13(9)14-12(16)10(11)8-4-2-1-3-5-8/h1-7H,(H2,14,15,16) D0Q8NW DRUGINKE LLZJLIULTBEDHM-UHFFFAOYSA-N D0Q8NW DRUGSMIL C1=CC=C(C=C1)C2=C(C3=C(NC2=O)SC=C3)O D0Q8NW HIGHSTAT Investigative D0Q8PE DRUG__ID D0Q8PE D0Q8PE DRUGTYPE Small molecular drug D0Q8PE DRUGINCH 1S/C19H23NO2/c21-18-6-8-19(9-7-18)22-15-14-20-12-10-17(11-13-20)16-4-2-1-3-5-16/h1-9,17,21H,10-15H2 D0Q8PE DRUGINKE JRNIKKDZNLWUQY-UHFFFAOYSA-N D0Q8PE DRUGSMIL C1CN(CCC1C2=CC=CC=C2)CCOC3=CC=C(C=C3)O D0Q8PE HIGHSTAT Investigative D0Q8QA DRUG__ID D0Q8QA D0Q8QA DRUGTYPE Small molecular drug D0Q8QA DRUGINCH 1S/C10H8F3N3O2S/c1-16-5(4-8(14-16)10(11,12)13)6-2-3-7(19-6)9(17)15-18/h2-4,18H,1H3,(H,15,17) D0Q8QA DRUGINKE CBAUPWKIZUBNOQ-UHFFFAOYSA-N D0Q8QA DRUGSMIL CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(S2)C(=O)NO D0Q8QA HIGHSTAT Investigative D0Q8QH DRUG__ID D0Q8QH D0Q8QH DRUGTYPE Small molecular drug D0Q8QH DRUGINCH 1S/C20H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21(24)18-19-22/h9-10,22,24H,2-8,11-19H2,1H3/b10-9- D0Q8QH DRUGINKE QINGXEUKNRODNT-KTKRTIGZSA-N D0Q8QH DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)N(CCO)O D0Q8QH HIGHSTAT Investigative D0Q8SO DRUG__ID D0Q8SO D0Q8SO DRUGTYPE Small molecular drug D0Q8SO DRUGINCH 1S/C22H25NO/c1-3-4-7-14-23-16-20(19-8-5-6-9-21(19)23)22(24)15-18-12-10-17(2)11-13-18/h5-6,8-13,16H,3-4,7,14-15H2,1-2H3 D0Q8SO DRUGINKE GSVYYNBRAJBCQS-UHFFFAOYSA-N D0Q8SO DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)C D0Q8SO HIGHSTAT Investigative D0Q8SP DRUG__ID D0Q8SP D0Q8SP DRUGTYPE Small molecular drug D0Q8SP DRUGINCH 1S/C22H14N2O4/c1-28-17-10-11(6-9-16(17)25)22-23-15-8-7-14-18(19(15)24-22)21(27)13-5-3-2-4-12(13)20(14)26/h2-10,25H,1H3,(H,23,24) D0Q8SP DRUGINKE FJEOIDUPEMASKE-UHFFFAOYSA-N D0Q8SP DRUGSMIL COC1=C(C=CC(=C1)C2=NC3=C(N2)C=CC4=C3C(=O)C5=CC=CC=C5C4=O)O D0Q8SP HIGHSTAT Investigative D0Q8TD DRUG__ID D0Q8TD D0Q8TD DRUGTYPE Small molecular drug D0Q8TD DRUGINCH 1S/C13H11BrN2O3/c14-9-3-1-2-4-10(9)15-13(19)16-11-6-5-8(17)7-12(11)18/h1-7,17-18H,(H2,15,16,19) D0Q8TD DRUGINKE UUVQJGFAYHMNII-UHFFFAOYSA-N D0Q8TD DRUGSMIL C1=CC=C(C(=C1)NC(=O)NC2=C(C=C(C=C2)O)O)Br D0Q8TD HIGHSTAT Investigative D0Q8TJ DRUG__ID D0Q8TJ D0Q8TJ DRUGTYPE Small molecular drug D0Q8TJ DRUGINCH 1S/C23H20N2O5/c1-27-21-11-17(7-9-19(21)28-14-16-5-3-2-4-6-16)13-24-25-23(26)18-8-10-20-22(12-18)30-15-29-20/h2-13H,14-15H2,1H3,(H,25,26)/b24-13- D0Q8TJ DRUGINKE ULOKADSYVZOTTL-CFRMEGHHSA-N D0Q8TJ DRUGSMIL COC1=C(C=CC(=C1)C=NNC(=O)C2=CC3=C(C=C2)OCO3)OCC4=CC=CC=C4 D0Q8TJ HIGHSTAT Investigative D0Q8TK DRUG__ID D0Q8TK D0Q8TK DRUGTYPE Small molecular drug D0Q8TK DRUGINCH 1S/C13H10N2O2S/c14-18(16,17)13-5-3-11(4-6-13)1-2-12-7-9-15-10-8-12/h3-10H,(H2,14,16,17) D0Q8TK DRUGINKE WAURLAKEIUZSMJ-UHFFFAOYSA-N D0Q8TK DRUGSMIL C1=CC(=CC=C1C#CC2=CC=NC=C2)S(=O)(=O)N D0Q8TK HIGHSTAT Investigative D0Q8UV DRUG__ID D0Q8UV D0Q8UV DRUGTYPE Small molecular drug D0Q8UV DRUGINCH 1S/C17H16ClN3O3/c1-2-24-17(23)14-15-13-4-3-7-20(13)16(22)11-8-10(18)5-6-12(11)21(15)9-19-14/h5-6,8-9,13H,2-4,7H2,1H3 D0Q8UV DRUGINKE GXXNSEYTZVNYNW-UHFFFAOYSA-N D0Q8UV DRUGSMIL CCOC(=O)C1=C2C3CCCN3C(=O)C4=C(N2C=N1)C=CC(=C4)Cl D0Q8UV HIGHSTAT Investigative D0Q8UZ DRUG__ID D0Q8UZ D0Q8UZ DRUGTYPE Small molecular drug D0Q8UZ DRUGINCH 1S/C16H17NO2/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11H,17H2,1-2H3/b4-3+ D0Q8UZ DRUGINKE LGVZJSLFOMGJOS-ONEGZZNKSA-N D0Q8UZ DRUGSMIL COC1=CC(=CC(=C1)C=CC2=CC=C(C=C2)N)OC D0Q8UZ HIGHSTAT Investigative D0Q8WL DRUG__ID D0Q8WL D0Q8WL DRUGTYPE Small molecular drug D0Q8WL DRUGINCH 1S/C34H28N6O14S4.4Na/c1-15-11-17(3-7-21(15)37-39-23-9-5-19-25(55(43,44)45)13-27(57(49,50)51)31(35)29(19)33(23)41)18-4-8-22(16(2)12-18)38-40-24-10-6-20-26(56(46,47)48)14-28(58(52,53)54)32(36)30(20)34(24)42;;;;/h3-14,37-38H,35-36H2,1-2H3,(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54);;;;/q;4*+1/p-4/b39-23-,40-24-;;;; D0Q8WL DRUGINKE KBNIFDASRCWYGC-KJPFXMIPSA-J D0Q8WL DRUGSMIL CC1=C(C=CC(=C1)C2=CC(=C(C=C2)NN=C3C=CC4=C(C3=O)C(=C(C=C4S(=O)(=O)[O-])S(=O)(=O)[O-])N)C)NN=C5C=CC6=C(C5=O)C(=C(C=C6S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+].[Na+].[Na+] D0Q8WL HIGHSTAT Investigative D0Q8WN DRUG__ID D0Q8WN D0Q8WN DRUGTYPE Small molecular drug D0Q8WN DRUGINCH 1S/C6H10N2O5/c7-4(9)1-8(2-5(10)11)3-6(12)13/h1-3H2,(H2,7,9)(H,10,11)(H,12,13) D0Q8WN DRUGINKE QZTKDVCDBIDYMD-UHFFFAOYSA-N D0Q8WN DRUGSMIL C(C(=O)N)N(CC(=O)O)CC(=O)O D0Q8WN HIGHSTAT Investigative D0Q8YO DRUG__ID D0Q8YO D0Q8YO DRUGTYPE Small molecular drug D0Q8YO DRUGINCH 1S/C20H23F2N3O3/c1-2-23-8-11-5-6-24(9-11)18-15(21)7-13-17(16(18)22)25(12-3-4-12)10-14(19(13)26)20(27)28/h7,10-12,23H,2-6,8-9H2,1H3,(H,27,28) D0Q8YO DRUGINKE WDBGUJBLPRXPIX-UHFFFAOYSA-N D0Q8YO DRUGSMIL CCNCC1CCN(C1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)F D0Q8YO HIGHSTAT Investigative D0Q8ZV DRUG__ID D0Q8ZV D0Q8ZV DRUGTYPE Small molecular drug D0Q8ZV DRUGINCH 1S/C14H11ClO3/c15-11-6-2-4-8-13(11)18-12-7-3-1-5-10(12)9-14(16)17/h1-8H,9H2,(H,16,17) D0Q8ZV DRUGINKE SYANOAWCBFRXNL-UHFFFAOYSA-N D0Q8ZV DRUGSMIL C1=CC=C(C(=C1)CC(=O)O)OC2=CC=CC=C2Cl D0Q8ZV HIGHSTAT Investigative D0Q9CI DRUG__ID D0Q9CI D0Q9CI DRUGTYPE Small molecular drug D0Q9CI DRUGINCH 1S/C23H31NO4/c1-23-8-7-18-17-6-4-16(25)11-14(17)3-5-19(18)20(23)12-15(22(23)27)13-21(26)24-9-10-28-2/h4,6,11,15,18-20,25H,3,5,7-10,12-13H2,1-2H3,(H,24,26)/t15?,18?,19?,20?,23-/m0/s1 D0Q9CI DRUGINKE LQHCZQAKWAQLJZ-OOGUNDJRSA-N D0Q9CI DRUGSMIL CC12CCC3C(C1CC(C2=O)CC(=O)NCCOC)CCC4=C3C=CC(=C4)O D0Q9CI HIGHSTAT Investigative D0Q9CM DRUG__ID D0Q9CM D0Q9CM DRUGTYPE Small molecular drug D0Q9CM DRUGINCH 1S/C14H8BrClN2O/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H D0Q9CM DRUGINKE WAILHPROBXVCQL-UHFFFAOYSA-N D0Q9CM DRUGSMIL C1=CC(=CC(=C1)Br)OC2=NC=NC3=C2C=C(C=C3)Cl D0Q9CM HIGHSTAT Investigative D0Q9EB DRUG__ID D0Q9EB D0Q9EB DRUGTYPE Small molecular drug D0Q9EB DRUGINCH 1S/C35H45N5O6S2/c1-34(2,3)39-32(44)30-35(4,5)48-21-40(30)33(45)29(42)25(17-22-11-8-7-9-12-22)38-31(43)26(20-47-6)37-28(41)19-46-27-14-10-13-23-18-36-16-15-24(23)27/h7-16,18,25-26,29-30,42H,17,19-21H2,1-6H3,(H,37,41)(H,38,43)(H,39,44)/t25-,26-,29-,30+/m0/s1 D0Q9EB DRUGINKE AHWCYDXQIXZVRK-RPQLRNILSA-N D0Q9EB DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)COC3=CC=CC4=C3C=CN=C4)O)C(=O)NC(C)(C)C)C D0Q9EB HIGHSTAT Investigative D0Q9FB DRUG__ID D0Q9FB D0Q9FB DRUGTYPE Small molecular drug D0Q9FB DRUGINCH 1S/C26H24FNO/c1-2-3-6-16-28-18-21(17-25(28)20-12-14-22(27)15-13-20)26(29)24-11-7-9-19-8-4-5-10-23(19)24/h4-5,7-15,17-18H,2-3,6,16H2,1H3 D0Q9FB DRUGINKE PJNACIYIFHTDCK-UHFFFAOYSA-N D0Q9FB DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)F)C(=O)C3=CC=CC4=CC=CC=C43 D0Q9FB HIGHSTAT Investigative D0Q9FU DRUG__ID D0Q9FU D0Q9FU DRUGTYPE Small molecular drug D0Q9FU DRUGINCH 1S/C11H12F2N2/c1-7(14)6-15-3-2-8-4-9(12)10(13)5-11(8)15/h2-5,7H,6,14H2,1H3/t7-/m0/s1 D0Q9FU DRUGINKE MYZDBEVPJGKIQS-ZETCQYMHSA-N D0Q9FU DRUGSMIL CC(CN1C=CC2=CC(=C(C=C21)F)F)N D0Q9FU HIGHSTAT Investigative D0Q9FZ DRUG__ID D0Q9FZ D0Q9FZ DRUGTYPE Small molecular drug D0Q9FZ DRUGINCH 1S/C26H36O3/c1-8-14-29-23-17-22-21(25(4,5)12-13-26(22,6)7)16-20(23)19(3)11-9-10-18(2)15-24(27)28/h9-11,15-17H,8,12-14H2,1-7H3,(H,27,28)/b10-9+,18-15+,19-11- D0Q9FZ DRUGINKE HNODNXQAYXJFMQ-LQUSFLDPSA-N D0Q9FZ DRUGSMIL CCCOC1=CC2=C(C=C1C(=CC=CC(=CC(=O)O)C)C)C(CCC2(C)C)(C)C D0Q9FZ HIGHSTAT Investigative D0Q9GL DRUG__ID D0Q9GL D0Q9GL DRUGTYPE Small molecular drug D0Q9GL DRUGINCH 1S/C27H34N8O4/c1-4-11-34-25-23(26(37)35(12-5-2)27(34)38)28-24(29-25)20-17-21(30-31(20)3)39-18-22(36)33-15-13-32(14-16-33)19-9-7-6-8-10-19/h6-10,17H,4-5,11-16,18H2,1-3H3,(H,28,29) D0Q9GL DRUGINKE BVHLYIIHYJFKSI-UHFFFAOYSA-N D0Q9GL DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)N4CCN(CC4)C5=CC=CC=C5 D0Q9GL HIGHSTAT Investigative D0Q9GU DRUG__ID D0Q9GU D0Q9GU DRUGTYPE Small molecular drug D0Q9GU DRUGINCH 1S/C24H23N3O4S2/c1-27(20-9-4-3-5-10-20)33(29,30)21-15-13-19(14-16-21)25-24(32)26-23(28)17-12-18-8-6-7-11-22(18)31-2/h3-17H,1-2H3,(H2,25,26,28,32)/b17-12+ D0Q9GU DRUGINKE XOMQERYBMDFBAG-SFQUDFHCSA-N D0Q9GU DRUGSMIL CN(C1=CC=CC=C1)S(=O)(=O)C2=CC=C(C=C2)NC(=S)NC(=O)C=CC3=CC=CC=C3OC D0Q9GU HIGHSTAT Investigative D0Q9IU DRUG__ID D0Q9IU D0Q9IU DRUGTYPE Small molecular drug D0Q9IU DRUGINCH 1S/C121H190N34O35/c1-10-65(8)98(153-115(185)87-32-23-53-155(87)118(188)97(64(6)7)152-100(170)71(124)56-67-24-13-11-14-25-67)116(186)151-85(57-68-26-15-12-16-27-68)114(184)154-99(66(9)156)117(187)150-84(58-69-33-35-70(157)36-34-69)102(172)136-60-92(162)137-76(40-46-94(164)165)106(176)148-83(55-63(4)5)112(182)145-77(37-43-88(125)158)107(177)141-74(30-21-51-133-120(129)130)104(174)147-82(54-62(2)3)111(181)146-78(38-44-89(126)159)108(178)144-80(42-48-96(168)169)109(179)140-73(29-18-20-50-123)103(173)143-79(41-47-95(166)167)110(180)142-75(31-22-52-134-121(131)132)105(175)149-86(59-91(128)161)113(183)139-72(28-17-19-49-122)101(171)135-61-93(163)138-81(119(189)190)39-45-90(127)160/h11-16,24-27,33-36,62-66,71-87,97-99,156-157H,10,17-23,28-32,37-61,122-124H2,1-9H3,(H2,125,158)(H2,126,159)(H2,127,160)(H2,128,161)(H,135,171)(H,136,172)(H,137,162)(H,138,163)(H,139,183)(H,140,179)(H,141,177)(H,142,180)(H,143,173)(H,144,178)(H,145,182)(H,146,181)(H,147,174)(H,148,176)(H,149,175)(H,150,187)(H,151,186)(H,152,170)(H,153,185)(H,154,184)(H,164,165)(H,166,167)(H,168,169)(H,189,190)(H4,129,130,133)(H4,131,132,134)/t65-,66+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,97-,98-,99-/m0/s1 D0Q9IU DRUGINKE GFOZQXMKARUPQI-HYOAWBISSA-N D0Q9IU DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C3CCCN3C(=O)C(C(C)C)NC(=O)C(CC4=CC=CC=C4)N D0Q9IU HIGHSTAT Investigative D0Q9JG DRUG__ID D0Q9JG D0Q9JG DRUGTYPE Small molecular drug D0Q9JG DRUGINCH 1S/C9H12N2OS.ClH/c1-12-8-4-2-7(3-5-8)6-13-9(10)11;/h2-5H,6H2,1H3,(H3,10,11);1H D0Q9JG DRUGINKE QGNMUFKTLKVUHM-UHFFFAOYSA-N D0Q9JG DRUGSMIL COC1=CC=C(C=C1)CSC(=N)N.Cl D0Q9JG HIGHSTAT Investigative D0Q9JN DRUG__ID D0Q9JN D0Q9JN DRUGTYPE Small molecular drug D0Q9JN DRUGINCH 1S/C17H21NO2/c1-14-13-18-17(20-14)16(19)12-8-3-2-5-9-15-10-6-4-7-11-15/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D0Q9JN DRUGINKE PBGYMEUYJWSKDY-UHFFFAOYSA-N D0Q9JN DRUGSMIL CC1=CN=C(O1)C(=O)CCCCCCC2=CC=CC=C2 D0Q9JN HIGHSTAT Investigative D0Q9KP DRUG__ID D0Q9KP D0Q9KP DRUGTYPE Small molecular drug D0Q9KP DRUGINCH 1S/C10H12FN3/c1-7(12)6-14-10-3-2-9(11)4-8(10)5-13-14/h2-5,7H,6,12H2,1H3/t7-/m0/s1 D0Q9KP DRUGINKE ILPBKZWYZJHZAZ-ZETCQYMHSA-N D0Q9KP DRUGSMIL CC(CN1C2=C(C=C(C=C2)F)C=N1)N D0Q9KP HIGHSTAT Investigative D0Q9LC DRUG__ID D0Q9LC D0Q9LC DRUGTYPE Small molecular drug D0Q9LC DRUGINCH 1S/C22H24N2O3/c1-2-3-4-8-15-22(19(25)23-21(27)24-20(22)26)18-13-11-17(12-14-18)16-9-6-5-7-10-16/h5-7,9-14H,2-4,8,15H2,1H3,(H2,23,24,25,26,27) D0Q9LC DRUGINKE KYTLMUVGULFASG-UHFFFAOYSA-N D0Q9LC DRUGSMIL CCCCCCC1(C(=O)NC(=O)NC1=O)C2=CC=C(C=C2)C3=CC=CC=C3 D0Q9LC HIGHSTAT Investigative D0Q9MA DRUG__ID D0Q9MA D0Q9MA DRUGTYPE Small molecular drug D0Q9MA DRUGINCH 1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,10+/m0/s1 D0Q9MA DRUGINKE OFEZSBMBBKLLBJ-BAJZRUMYSA-N D0Q9MA DRUGSMIL C1C(OC(C1O)N2C=NC3=C(N=CN=C32)N)CO D0Q9MA HIGHSTAT Investigative D0Q9NC DRUG__ID D0Q9NC D0Q9NC DRUGTYPE Small molecular drug D0Q9NC DRUGINCH 1S/C17H12N2/c1-2-6-12(7-3-1)17-18-11-15-14-9-5-4-8-13(14)10-16(15)19-17/h1-11H,(H,18,19) D0Q9NC DRUGINKE INQKEQXZMUIZGI-UHFFFAOYSA-N D0Q9NC DRUGSMIL C1=CC=C(C=C1)C2=NC=C3C4=CC=CC=C4C=C3N2 D0Q9NC HIGHSTAT Investigative D0Q9NW DRUG__ID D0Q9NW D0Q9NW DRUGTYPE Small molecular drug D0Q9NW DRUGINCH 1S/C14H21NO/c1-16-11-13(12-7-3-2-4-8-12)14-9-5-6-10-15-14/h2-4,7-8,13-15H,5-6,9-11H2,1H3/t13-,14-/m1/s1 D0Q9NW DRUGINKE DNWCZLGJLQABLG-ZIAGYGMSSA-N D0Q9NW DRUGSMIL COCC(C1CCCCN1)C2=CC=CC=C2 D0Q9NW HIGHSTAT Investigative D0Q9PO DRUG__ID D0Q9PO D0Q9PO DRUGTYPE Small molecular drug D0Q9PO DRUGINCH 1S/C27H38N4O7/c1-15(2)23-27(38)28-17(4)25(36)30-21(14-18-10-12-19(32)13-11-18)26(37)29-20(16(3)24(35)31-23)8-6-5-7-9-22(33)34/h5-6,10-13,15-17,20-21,23,32H,7-9,14H2,1-4H3,(H,28,38)(H,29,37)(H,30,36)(H,31,35)(H,33,34)/b6-5-/t16-,17+,20+,21+,23+/m0/s1 D0Q9PO DRUGINKE QKNOLJBQLJGNKI-LFUPQXEOSA-N D0Q9PO DRUGSMIL CC1C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C)CC2=CC=C(C=C2)O)CC=CCCC(=O)O D0Q9PO HIGHSTAT Investigative D0Q9RA DRUG__ID D0Q9RA D0Q9RA DRUGTYPE Small molecular drug D0Q9RA DRUGINCH 1S/C13H15ClO/c1-15-13-4-2-3-11(13)9-10-5-7-12(14)8-6-10/h5-9,13H,2-4H2,1H3/b11-9+ D0Q9RA DRUGINKE HTHFNFRVDYWDQC-PKNBQFBNSA-N D0Q9RA DRUGSMIL COC1CCCC1=CC2=CC=C(C=C2)Cl D0Q9RA HIGHSTAT Investigative D0Q9SC DRUG__ID D0Q9SC D0Q9SC DRUGTYPE Small molecular drug D0Q9SC DRUGINCH 1S/C21H32F2O4/c1-2-3-6-9-16(24)13-12-15-14-18-21(22,23)20(27-18)17(15)10-7-4-5-8-11-19(25)26/h4,7,12-13,15-18,20,24H,2-3,5-6,8-11,14H2,1H3,(H,25,26)/b7-4-,13-12+/t15-,16-,17+,18-,20+/m0/s1 D0Q9SC DRUGINKE CIYZUODQUHAGKZ-SCVXEUJASA-N D0Q9SC DRUGSMIL CCCCCC(C=CC1CC2C(C(C1CC=CCCCC(=O)O)O2)(F)F)O D0Q9SC HIGHSTAT Investigative D0Q9TL DRUG__ID D0Q9TL D0Q9TL DRUGTYPE Small molecular drug D0Q9TL DRUGINCH 1S/C28H23NO5/c29-14-19-8-21-11-23(4-5-25(21)26(10-19)20-6-7-31-16-20)32-15-18-2-1-3-22(9-18)28(30)12-24-17-33-27(13-28)34-24/h1-11,16,24,27,30H,12-13,15,17H2 D0Q9TL DRUGINKE CHLJRXIFRPILDX-UHFFFAOYSA-N D0Q9TL DRUGSMIL C1C2COC(O2)CC1(C3=CC=CC(=C3)COC4=CC5=C(C=C4)C(=CC(=C5)C#N)C6=COC=C6)O D0Q9TL HIGHSTAT Investigative D0Q9TQ DRUG__ID D0Q9TQ D0Q9TQ DRUGTYPE Small molecular drug D0Q9TQ DRUGINCH 1S/C25H27NO/c1-27-25(23-15-9-4-10-16-23)17-19-26(20-18-25)24(21-11-5-2-6-12-21)22-13-7-3-8-14-22/h2-16,24H,17-20H2,1H3 D0Q9TQ DRUGINKE ULOWZIQCEGBTDH-UHFFFAOYSA-N D0Q9TQ DRUGSMIL COC1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4 D0Q9TQ HIGHSTAT Investigative D0Q9UZ DRUG__ID D0Q9UZ D0Q9UZ DRUGTYPE Small molecular drug D0Q9UZ DRUGINCH 1S/C18H20INO2/c1-13-5-2-3-8-16(13)22-18(17-12-20-9-10-21-17)14-6-4-7-15(19)11-14/h2-8,11,17-18,20H,9-10,12H2,1H3 D0Q9UZ DRUGINKE GUJGIDDFMFZKIV-UHFFFAOYSA-N D0Q9UZ DRUGSMIL CC1=CC=CC=C1OC(C2CNCCO2)C3=CC(=CC=C3)I D0Q9UZ HIGHSTAT Investigative D0Q9VD DRUG__ID D0Q9VD D0Q9VD DRUGTYPE Small molecular drug D0Q9VD DRUGINCH 1S/C22H27F2N5O2/c1-2-29-9-3-4-19(29)22(31)28-18(11-14-5-7-16(23)17(24)10-14)21(30)27-13-15-6-8-20(25)26-12-15/h5-8,10,12,18-19H,2-4,9,11,13H2,1H3,(H2,25,26)(H,27,30)(H,28,31)/t18-,19+/m0/s1 D0Q9VD DRUGINKE ALLYUHIQZKTLFG-RBUKOAKNSA-N D0Q9VD DRUGSMIL CCN1CCCC1C(=O)NC(CC2=CC(=C(C=C2)F)F)C(=O)NCC3=CN=C(C=C3)N D0Q9VD HIGHSTAT Investigative D0Q9XX DRUG__ID D0Q9XX D0Q9XX DRUGTYPE Small molecular drug D0Q9XX DRUGINCH 1S/C9H6N2O4/c1-10-7-3-2-5(11(14)15)4-6(7)8(12)9(10)13/h2-4H,1H3 D0Q9XX DRUGINKE JPTDPTOWOMFBRY-UHFFFAOYSA-N D0Q9XX DRUGSMIL CN1C2=C(C=C(C=C2)[N+](=O)[O-])C(=O)C1=O D0Q9XX HIGHSTAT Investigative D0Q9YG DRUG__ID D0Q9YG D0Q9YG DRUGTYPE Small molecular drug D0Q9YG DRUGINCH 1S/C22H17NO3/c24-21(19-14-13-17-10-4-5-11-18(17)15-19)23-20(22(25)26)12-6-9-16-7-2-1-3-8-16/h1-5,7-8,10-11,13-15,20H,12H2,(H,23,24)(H,25,26)/t20-/m1/s1 D0Q9YG DRUGINKE IIZVJSCXCNYCFJ-HXUWFJFHSA-N D0Q9YG DRUGSMIL C1=CC=C(C=C1)C#CCC(C(=O)O)NC(=O)C2=CC3=CC=CC=C3C=C2 D0Q9YG HIGHSTAT Investigative D0Q9ZN DRUG__ID D0Q9ZN D0Q9ZN DRUGTYPE Small molecular drug D0Q9ZN DRUGINCH 1S/C16H14Br2O3/c17-13-8-12(6-7-15(19)20)9-14(18)16(13)21-10-11-4-2-1-3-5-11/h1-5,8-9H,6-7,10H2,(H,19,20) D0Q9ZN DRUGINKE ZCVQDNGOBFARHQ-UHFFFAOYSA-N D0Q9ZN DRUGSMIL C1=CC=C(C=C1)COC2=C(C=C(C=C2Br)CCC(=O)O)Br D0Q9ZN HIGHSTAT Investigative D0QA3I DRUG__ID D0QA3I D0QA3I DRUGTYPE Small molecular drug D0QA3I DRUGINCH 1S/C4H6O2/c5-4-2-1-3-6-4/h1-3H2 D0QA3I DRUGINKE YEJRWHAVMIAJKC-UHFFFAOYSA-N D0QA3I DRUGSMIL C1CC(=O)OC1 D0QA3I HIGHSTAT Investigative D0QA5U DRUG__ID D0QA5U D0QA5U DRUGTYPE Small molecular drug D0QA5U DRUGINCH 1S/C13H16O4S/c14-12(15)10(5-3-7-18)8-9-4-1-2-6-11(9)13(16)17/h1-2,4,6,10,18H,3,5,7-8H2,(H,14,15)(H,16,17) D0QA5U DRUGINKE AJRYUIBEXXWDCQ-UHFFFAOYSA-N D0QA5U DRUGSMIL C1=CC=C(C(=C1)CC(CCCS)C(=O)O)C(=O)O D0QA5U HIGHSTAT Investigative D0QB9L DRUG__ID D0QB9L D0QB9L DRUGTYPE Small molecular drug D0QB9L DRUGINCH 1S/C19H17NO3/c21-17-12-18(23-19(13-17)20-7-9-22-10-8-20)16-6-5-14-3-1-2-4-15(14)11-16/h1-6,11-13H,7-10H2 D0QB9L DRUGINKE FNMVAZNGFWLDOQ-UHFFFAOYSA-N D0QB9L DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC4=CC=CC=C4C=C3 D0QB9L HIGHSTAT Investigative D0QC0W DRUG__ID D0QC0W D0QC0W DRUGTYPE Small molecular drug D0QC0W DRUGINCH 1S/C29H31N5O4/c1-36-26-18-24-25(19-27(26)38-15-5-12-34-13-16-37-17-14-34)30-20-31-28(24)32-22-8-10-23(11-9-22)33-29(35)21-6-3-2-4-7-21/h2-4,6-11,18-20H,5,12-17H2,1H3,(H,33,35)(H,30,31,32) D0QC0W DRUGINKE OGNYUTNQZVRGMN-UHFFFAOYSA-N D0QC0W DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5 D0QC0W HIGHSTAT Investigative D0QC9F DRUG__ID D0QC9F D0QC9F DRUGTYPE Small molecular drug D0QC9F DRUGINCH 1S/C20H17N3O2S/c1-25-14-6-4-13(5-7-14)23-11-9-15-17-16(22-12-2-3-12)8-10-21-19(17)26-18(15)20(23)24/h4-12H,2-3H2,1H3,(H,21,22) D0QC9F DRUGINKE ZUUBRGCTXRXCLV-UHFFFAOYSA-N D0QC9F DRUGSMIL COC1=CC=C(C=C1)N2C=CC3=C(C2=O)SC4=NC=CC(=C34)NC5CC5 D0QC9F HIGHSTAT Investigative D0QD3O DRUG__ID D0QD3O D0QD3O DRUGTYPE Small molecular drug D0QD3O DRUGINCH 1S/C16H13N3/c17-16-18-14(12-7-3-1-4-8-12)11-15(19-16)13-9-5-2-6-10-13/h1-11H,(H2,17,18,19) D0QD3O DRUGINKE KZUCBEYDRUCBCS-UHFFFAOYSA-N D0QD3O DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=N2)N)C3=CC=CC=C3 D0QD3O HIGHSTAT Investigative D0QD8P DRUG__ID D0QD8P D0QD8P DRUGTYPE Small molecular drug D0QD8P DRUGINCH 1S/C35H62N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h22-24,28-30,34,45-46H,4-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/t24-,28-,29-,30+,34-/m1/s1 D0QD8P DRUGINKE DUAFKXOFBZQTQE-QSGBVPJFSA-N D0QD8P DRUGSMIL CCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O D0QD8P HIGHSTAT Investigative D0QE0D DRUG__ID D0QE0D D0QE0D DRUGTYPE Small molecular drug D0QE0D DRUGINCH 1S/C14H9N3/c1-11-3-2-4-14(17-11)6-5-12-7-13(8-15)10-16-9-12/h2-4,7,9-10H,1H3 D0QE0D DRUGINKE ZWOWJRDKGWIZDL-UHFFFAOYSA-N D0QE0D DRUGSMIL CC1=NC(=CC=C1)C#CC2=CC(=CN=C2)C#N D0QE0D HIGHSTAT Investigative D0QE3C DRUG__ID D0QE3C D0QE3C DRUGTYPE Small molecular drug D0QE3C DRUGINCH 1S/C17H13NO/c19-17-8-4-7-16-15(17)12-11-14(18-16)10-9-13-5-2-1-3-6-13/h1-3,5-6,11-12H,4,7-8H2 D0QE3C DRUGINKE XOUDFZJCSDKXLG-UHFFFAOYSA-N D0QE3C DRUGSMIL C1CC2=C(C=CC(=N2)C#CC3=CC=CC=C3)C(=O)C1 D0QE3C HIGHSTAT Investigative D0QE3V DRUG__ID D0QE3V D0QE3V DRUGTYPE Small molecular drug D0QE3V DRUGINCH 1S/C19H15ClFNO2S/c20-12-1-4-14(5-2-12)25-19-15-6-3-13(21)10-16(15)22-8-7-11(18(19)22)9-17(23)24/h1-6,10-11H,7-9H2,(H,23,24)/t11-/m0/s1 D0QE3V DRUGINKE GSBAVONRPNJJOH-NSHDSACASA-N D0QE3V DRUGSMIL C1CN2C3=C(C=CC(=C3)F)C(=C2C1CC(=O)O)SC4=CC=C(C=C4)Cl D0QE3V HIGHSTAT Investigative D0QE7J DRUG__ID D0QE7J D0QE7J DRUGTYPE Small molecular drug D0QE7J DRUGINCH 1S/C11H16N2O/c14-11-3-1-2-8-13(11)9-10-4-6-12-7-5-10/h1-3,8,10,12H,4-7,9H2 D0QE7J DRUGINKE WLPUWPRHPIZJQK-UHFFFAOYSA-N D0QE7J DRUGSMIL C1CNCCC1CN2C=CC=CC2=O D0QE7J HIGHSTAT Investigative D0QG6G DRUG__ID D0QG6G D0QG6G DRUGTYPE Small molecular drug D0QG6G DRUGINCH 1S/C20H18O3/c1-22-19-11-17(12-20(13-19)23-2)16-5-3-4-15(10-16)14-6-8-18(21)9-7-14/h3-13,21H,1-2H3 D0QG6G DRUGINKE MWVCWBDXUJZBEC-UHFFFAOYSA-N D0QG6G DRUGSMIL COC1=CC(=CC(=C1)C2=CC=CC(=C2)C3=CC=C(C=C3)O)OC D0QG6G HIGHSTAT Investigative D0QH0X DRUG__ID D0QH0X D0QH0X DRUGTYPE Small molecular drug D0QH0X DRUGINCH 1S/C10H13N/c1-2-5-10-8-11-7-3-6-9(10)4-1/h1-2,4-5,11H,3,6-8H2 D0QH0X DRUGINKE SIQBPWRTJNBBER-UHFFFAOYSA-N D0QH0X DRUGSMIL C1CC2=CC=CC=C2CNC1 D0QH0X HIGHSTAT Investigative D0QH4A DRUG__ID D0QH4A D0QH4A DRUGTYPE Small molecular drug D0QH4A DRUGINCH 1S/C24H24FNO/c25-22-13-11-21(12-14-22)24(27)15-17-26(18-16-24)23(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-14,23,27H,15-18H2 D0QH4A DRUGINKE WBNMPDBWSUFASE-UHFFFAOYSA-N D0QH4A DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)F)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0QH4A HIGHSTAT Investigative D0QH5C DRUG__ID D0QH5C D0QH5C DRUGTYPE Small molecular drug D0QH5C DRUGINCH 1S/C14H17ClO3/c15-11-6-7-13(18-9-14(16)17)12(8-11)10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17) D0QH5C DRUGINKE OGVODSDQXYUSDP-UHFFFAOYSA-N D0QH5C DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)Cl)OCC(=O)O D0QH5C HIGHSTAT Investigative D0QH5P DRUG__ID D0QH5P D0QH5P DRUGTYPE Small molecular drug D0QH5P DRUGINCH 1S/C10H8IN3O2/c11-6-2-1-3-7(4-6)12-8-5-9(15)14-10(16)13-8/h1-5H,(H3,12,13,14,15,16) D0QH5P DRUGINKE NUGFPABWAOETRO-UHFFFAOYSA-N D0QH5P DRUGSMIL C1=CC(=CC(=C1)I)NC2=CC(=O)NC(=O)N2 D0QH5P HIGHSTAT Investigative D0QH6F DRUG__ID D0QH6F D0QH6F DRUGTYPE Small molecular drug D0QH6F DRUGINCH 1S/C12H13NO3/c1-13-7-8-5-12(14)16-11-6-9(15-2)3-4-10(8)11/h3-6,13H,7H2,1-2H3 D0QH6F DRUGINKE GWMGUFTYUOYYQV-UHFFFAOYSA-N D0QH6F DRUGSMIL CNCC1=CC(=O)OC2=C1C=CC(=C2)OC D0QH6F HIGHSTAT Investigative D0QI7H DRUG__ID D0QI7H D0QI7H DRUGTYPE Small molecular drug D0QI7H DRUGINCH 1S/C18H21N5O/c1-3-7-13(8-4-1)11-24-17-15-16(20-12-19-15)22-18(23-17)21-14-9-5-2-6-10-14/h2,5-6,9-10,12-13H,1,3-4,7-8,11H2,(H2,19,20,21,22,23) D0QI7H DRUGINKE XWWRLKIBRPJQJX-UHFFFAOYSA-N D0QI7H DRUGSMIL C1CCC(CC1)COC2=NC(=NC3=C2NC=N3)NC4=CC=CC=C4 D0QI7H HIGHSTAT Investigative D0QK2E DRUG__ID D0QK2E D0QK2E DRUGTYPE Small molecular drug D0QK2E DRUGINCH 1S/C27H28F3NO2/c1-16-25-23(22-8-3-2-5-18(22)14-24(25)26(32)33-16)12-11-21-10-9-19(15-31-21)17-6-4-7-20(13-17)27(28,29)30/h4,6-7,9-13,15-16,18,22-25H,2-3,5,8,14H2,1H3/b12-11+/t16-,18+,22-,23+,24-,25+/m1/s1 D0QK2E DRUGINKE PQLBJVPZXNPVOS-HLBWOJLBSA-N D0QK2E DRUGSMIL CC1C2C(CC3CCCCC3C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)C(F)(F)F)C(=O)O1 D0QK2E HIGHSTAT Investigative D0QL1V DRUG__ID D0QL1V D0QL1V DRUGTYPE Small molecular drug D0QL1V DRUGINCH 1S/C23H21N3/c1-3-7-20(8-4-1)17-26(25-16-15-24-19-25)18-21-11-13-23(14-12-21)22-9-5-2-6-10-22/h1-16,19H,17-18H2 D0QL1V DRUGINKE PHOWNTQCWGWFEX-UHFFFAOYSA-N D0QL1V DRUGSMIL C1=CC=C(C=C1)CN(CC2=CC=C(C=C2)C3=CC=CC=C3)N4C=CN=C4 D0QL1V HIGHSTAT Investigative D0QL1X DRUG__ID D0QL1X D0QL1X DRUGTYPE Small molecular drug D0QL1X DRUGINCH 1S/C10H17NO/c1-9(10(2)12)7-5-6-8-11(3)4/h9H,7-8H2,1-4H3 D0QL1X DRUGINKE PDSSGGXKHZHTIQ-UHFFFAOYSA-N D0QL1X DRUGSMIL CC(CC#CCN(C)C)C(=O)C D0QL1X HIGHSTAT Investigative D0QL5M DRUG__ID D0QL5M D0QL5M DRUGTYPE Small molecular drug D0QL5M DRUGINCH 1S/C10H16ClN7O/c1-3-4-18(2)8-6(11)15-5(7(12)16-8)9(19)17-10(13)14/h3-4H2,1-2H3,(H2,12,16)(H4,13,14,17,19) D0QL5M DRUGINKE HDJJAWCPAZTZIG-UHFFFAOYSA-N D0QL5M DRUGSMIL CCCN(C)C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N D0QL5M HIGHSTAT Investigative D0QM3E DRUG__ID D0QM3E D0QM3E DRUGTYPE Small molecular drug D0QM3E DRUGINCH 1S/C29H28ClN5O/c1-33-14-16-34(17-15-33)28-19-27-21(18-25(28)30)10-13-35(27)29(36)32-26-7-6-22(20-8-11-31-12-9-20)23-4-2-3-5-24(23)26/h2-9,11-12,18-19H,10,13-17H2,1H3,(H,32,36) D0QM3E DRUGINKE DAPBIPAGJXKFCI-UHFFFAOYSA-N D0QM3E DRUGSMIL CN1CCN(CC1)C2=C(C=C3CCN(C3=C2)C(=O)NC4=CC=C(C5=CC=CC=C54)C6=CC=NC=C6)Cl D0QM3E HIGHSTAT Investigative D0QM9Y DRUG__ID D0QM9Y D0QM9Y DRUGTYPE Small molecular drug D0QM9Y DRUGINCH 1S/C24H27ClN4O3/c25-19-8-5-17(6-9-19)16-29-23(31)20-10-7-18(15-21(20)27-24(29)32)22(30)26-11-4-14-28-12-2-1-3-13-28/h5-10,15H,1-4,11-14,16H2,(H,26,30)(H,27,32) D0QM9Y DRUGINKE IWAHUQRZIUVMSG-UHFFFAOYSA-N D0QM9Y DRUGSMIL C1CCN(CC1)CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl D0QM9Y HIGHSTAT Investigative D0QN4U DRUG__ID D0QN4U D0QN4U DRUGTYPE Small molecular drug D0QN4U DRUGINCH 1S/C20H21BrN6O5/c21-11-3-1-2-10-9(6-23-13(10)11)4-5-31-20-25-17(22)14-18(26-20)27(8-24-14)19-16(30)15(29)12(7-28)32-19/h1-3,6,8,12,15-16,19,23,28-30H,4-5,7H2,(H2,22,25,26)/t12-,15-,16-,19-/m1/s1 D0QN4U DRUGINKE DKKUXTZYGGOBFU-BGIGGGFGSA-N D0QN4U DRUGSMIL C1=CC2=C(C(=C1)Br)NC=C2CCOC3=NC(=C4C(=N3)N(C=N4)C5C(C(C(O5)CO)O)O)N D0QN4U HIGHSTAT Investigative D0QN5E DRUG__ID D0QN5E D0QN5E DRUGTYPE Small molecular drug D0QN5E DRUGINCH 1S/C20H22N2O/c23-19(18-6-5-16-3-1-2-4-17(16)21-18)22-20-10-13-7-14(11-20)9-15(8-13)12-20/h1-6,13-15H,7-12H2,(H,22,23) D0QN5E DRUGINKE JRSHTOGGDUKFMC-UHFFFAOYSA-N D0QN5E DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)C4=NC5=CC=CC=C5C=C4 D0QN5E HIGHSTAT Investigative D0QN5I DRUG__ID D0QN5I D0QN5I DRUGTYPE Small molecular drug D0QN5I DRUGINCH 1S/C10H7N3OS/c11-10-12-6-3-5-15-9(6)8(13-10)7-2-1-4-14-7/h1-5H,(H2,11,12,13) D0QN5I DRUGINKE ARPSUXKIHNZLQL-UHFFFAOYSA-N D0QN5I DRUGSMIL C1=COC(=C1)C2=NC(=NC3=C2SC=C3)N D0QN5I HIGHSTAT Investigative D0QN6H DRUG__ID D0QN6H D0QN6H DRUGTYPE Small molecular drug D0QN6H DRUGINCH 1S/C48H32O32/c49-15-1-9(2-16(50)27(15)55)41(65)79-46-39-38-36(76-45(69)13-7-22(54)48(72)47(70,71)26(13)25-11(43(67)78-39)4-19(53)30(58)37(25)80-48)21(75-46)8-73-42(66)10-3-17(51)28(56)32(60)23(10)24-12(44(68)77-38)6-20(31(59)33(24)61)74-35-14(40(63)64)5-18(52)29(57)34(35)62/h1-7,21,26,36,38-39,46,49-53,55-62,70-72H,8H2,(H,63,64) D0QN6H DRUGINKE MWPRJJBXNINUTQ-UHFFFAOYSA-N D0QN6H DRUGSMIL C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7C(=CC(=O)C(C7(O)O)(O6)O)C(=O)O3)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)OC1=C(C(=C(C=C1C(=O)O)O)O)O D0QN6H HIGHSTAT Investigative D0QN6U DRUG__ID D0QN6U D0QN6U DRUGTYPE Small molecular drug D0QN6U DRUGINCH 1S/C29H30F3N5/c1-19(20-7-4-3-5-8-20)35-25-18-23(13-16-34-25)27-26(22-9-6-10-24(17-22)29(30,31)32)36-28(37(27)2)21-11-14-33-15-12-21/h3-10,13,16-19,21,33H,11-12,14-15H2,1-2H3,(H,34,35)/t19-/m0/s1 D0QN6U DRUGINKE ZLQKJFNLHHGAQF-IBGZPJMESA-N D0QN6U DRUGSMIL CC(C1=CC=CC=C1)NC2=NC=CC(=C2)C3=C(N=C(N3C)C4CCNCC4)C5=CC(=CC=C5)C(F)(F)F D0QN6U HIGHSTAT Investigative D0QO0L DRUG__ID D0QO0L D0QO0L DRUGTYPE Small molecular drug D0QO0L DRUGINCH 1S/C17H18N2O3/c1-2-15(12-6-4-3-5-7-12)17(21)18-14-10-8-13(9-11-14)16(20)19-22/h3-11,15,22H,2H2,1H3,(H,18,21)(H,19,20)/t15-/m0/s1 D0QO0L DRUGINKE SPLALNOEMVSHPJ-HNNXBMFYSA-N D0QO0L DRUGSMIL CCC(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO D0QO0L HIGHSTAT Investigative D0QO8X DRUG__ID D0QO8X D0QO8X DRUGTYPE Small molecular drug D0QO8X DRUGINCH 1S/C9H11NO/c11-9-2-1-7-3-4-10-6-8(7)5-9/h1-2,5,10-11H,3-4,6H2 D0QO8X DRUGINKE RADQTHXRZJGDQI-UHFFFAOYSA-N D0QO8X DRUGSMIL C1CNCC2=C1C=CC(=C2)O D0QO8X HIGHSTAT Investigative D0QP3A DRUG__ID D0QP3A D0QP3A DRUGTYPE Small molecular drug D0QP3A DRUGINCH 1S/C19H23NO/c1-2-6-18(7-3-1)16-21-19-10-8-17(9-11-19)12-15-20-13-4-5-14-20/h1-3,6-11H,4-5,12-16H2 D0QP3A DRUGINKE VREWPTOWOFJSKF-UHFFFAOYSA-N D0QP3A DRUGSMIL C1CCN(C1)CCC2=CC=C(C=C2)OCC3=CC=CC=C3 D0QP3A HIGHSTAT Investigative D0QP5D DRUG__ID D0QP5D D0QP5D DRUGTYPE Small molecular drug D0QP5D DRUGINCH 1S/C20H20N2O2/c1-24-16-6-4-5-14(11-16)19-13-20(23)17-12-15(7-8-18(17)21-19)22-9-2-3-10-22/h4-8,11-13H,2-3,9-10H2,1H3,(H,21,23) D0QP5D DRUGINKE GVMDHCGKOFHSHB-UHFFFAOYSA-N D0QP5D DRUGSMIL COC1=CC=CC(=C1)C2=CC(=O)C3=C(N2)C=CC(=C3)N4CCCC4 D0QP5D HIGHSTAT Investigative D0QP7C DRUG__ID D0QP7C D0QP7C DRUGTYPE Small molecular drug D0QP7C DRUGINCH 1S/C15H10N2O4/c18-14-11-8-10(17(20)21)6-7-12(11)16-15(19)13(14)9-4-2-1-3-5-9/h1-8H,(H2,16,18,19) D0QP7C DRUGINKE FHJYCGCXAYLWFD-UHFFFAOYSA-N D0QP7C DRUGSMIL C1=CC=C(C=C1)C2=C(C3=C(C=CC(=C3)[N+](=O)[O-])NC2=O)O D0QP7C HIGHSTAT Investigative D0QP9D DRUG__ID D0QP9D D0QP9D DRUGTYPE Small molecular drug D0QP9D DRUGINCH 1S/C16H12O3/c17-12-6-7-14-15(18)10-13(19-16(14)9-12)8-11-4-2-1-3-5-11/h1-7,9-10,17H,8H2 D0QP9D DRUGINKE BQFDTKDYOCJBGZ-UHFFFAOYSA-N D0QP9D DRUGSMIL C1=CC=C(C=C1)CC2=CC(=O)C3=C(O2)C=C(C=C3)O D0QP9D HIGHSTAT Investigative D0QQ4Z DRUG__ID D0QQ4Z D0QQ4Z DRUGTYPE Small molecular drug D0QQ4Z DRUGINCH 1S/C28H32N6O4S.C2HF3O2/c29-26(30)22-13-11-19(12-14-22)17-32-27(35)23-15-16-34(18-23)28(36)25(33-39(31,37)38)24(20-7-3-1-4-8-20)21-9-5-2-6-10-21;3-2(4,5)1(6)7/h1-14,23-25,33H,15-18H2,(H3,29,30)(H,32,35)(H2,31,37,38);(H,6,7)/t23-,25-;/m1./s1 D0QQ4Z DRUGINKE RNDLEWFHHMPODL-ZHEQYFEDSA-N D0QQ4Z DRUGSMIL C1CN(CC1C(=O)NCC2=CC=C(C=C2)C(=N)N)C(=O)C(C(C3=CC=CC=C3)C4=CC=CC=C4)NS(=O)(=O)N.C(=O)(C(F)(F)F)O D0QQ4Z HIGHSTAT Investigative D0QQ7A DRUG__ID D0QQ7A D0QQ7A DRUGTYPE Small molecular drug D0QQ7A DRUGINCH 1S/C26H30O4/c1-17(2)6-9-20-14-19(15-21(26(20)30-5)10-7-18(3)4)8-13-24(28)23-12-11-22(27)16-25(23)29/h6-8,11-16,27,29H,9-10H2,1-5H3/b13-8+ D0QQ7A DRUGINKE AHQPCANDOCWXDN-MDWZMJQESA-N D0QQ7A DRUGSMIL CC(=CCC1=CC(=CC(=C1OC)CC=C(C)C)C=CC(=O)C2=C(C=C(C=C2)O)O)C D0QQ7A HIGHSTAT Investigative D0QS2N DRUG__ID D0QS2N D0QS2N DRUGTYPE Small molecular drug D0QS2N DRUGINCH 1S/C8H10N2O2/c1-10(8(11)9-12)7-5-3-2-4-6-7/h2-6,12H,1H3,(H,9,11) D0QS2N DRUGINKE UDJKPENTLREIMW-UHFFFAOYSA-N D0QS2N DRUGSMIL CN(C1=CC=CC=C1)C(=O)NO D0QS2N HIGHSTAT Investigative D0QS9T DRUG__ID D0QS9T D0QS9T DRUGTYPE Small molecular drug D0QS9T DRUGINCH 1S/C19H16N2O2/c22-19(21-14-16-6-4-5-13-20-16)15-9-11-18(12-10-15)23-17-7-2-1-3-8-17/h1-13H,14H2,(H,21,22) D0QS9T DRUGINKE HVLSCZSVTCNAQX-UHFFFAOYSA-N D0QS9T DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)NCC3=CC=CC=N3 D0QS9T HIGHSTAT Investigative D0QT2F DRUG__ID D0QT2F D0QT2F DRUGTYPE Small molecular drug D0QT2F DRUGINCH 1S/C10H14N6/c1-15-2-4-16(5-3-15)10-8-9(12-6-11-8)13-7-14-10/h6-7H,2-5H2,1H3,(H,11,12,13,14) D0QT2F DRUGINKE AXPCNBLIEMWMMG-UHFFFAOYSA-N D0QT2F DRUGSMIL CN1CCN(CC1)C2=NC=NC3=C2NC=N3 D0QT2F HIGHSTAT Investigative D0QT4X DRUG__ID D0QT4X D0QT4X DRUGTYPE Small molecular drug D0QT4X DRUGINCH 1S/C13H7F2NS/c14-11-4-9-3-10(8-1-2-17-7-8)6-16-13(9)5-12(11)15/h1-7H D0QT4X DRUGINKE RAEOQRGQVOSWAJ-UHFFFAOYSA-N D0QT4X DRUGSMIL C1=CSC=C1C2=CN=C3C=C(C(=CC3=C2)F)F D0QT4X HIGHSTAT Investigative D0QU1E DRUG__ID D0QU1E D0QU1E DRUGTYPE Small molecular drug D0QU1E DRUGINCH 1S/C13H15N3OS2/c1-17-11-5-3-2-4-10(11)6-7-14-12(18)16-13-15-8-9-19-13/h2-5,8-9H,6-7H2,1H3,(H2,14,15,16,18) D0QU1E DRUGINKE MRSDMFHPBHPUME-UHFFFAOYSA-N D0QU1E DRUGSMIL COC1=CC=CC=C1CCNC(=S)NC2=NC=CS2 D0QU1E HIGHSTAT Investigative D0QV3O DRUG__ID D0QV3O D0QV3O DRUGCOMP Orchid Research Laboratories Ltd D0QV3O DRUGINCH 1S/C25H22FN3O2/c26-19-11-9-17(10-12-19)21(25(31)28-20-13-14-20)15-16-5-7-18(8-6-16)24(30)29-23-4-2-1-3-22(23)27/h1-12,15,20H,13-14,27H2,(H,28,31)(H,29,30)/b21-15+ D0QV3O DRUGINKE PSMVQVNDYRGHCI-RCCKNPSSSA-N D0QV3O DRUGSMIL C1CC1NC(=O)C(=CC2=CC=C(C=C2)C(=O)NC3=CC=CC=C3N)C4=CC=C(C=C4)F D0QV3O HIGHSTAT Investigative D0QV6M DRUG__ID D0QV6M D0QV6M DRUGTYPE Small molecular drug D0QV6M DRUGINCH 1S/C27H25ClN2O3/c1-18-23(17-26(31)29-15-14-19-6-4-3-5-7-19)24-16-22(33-2)12-13-25(24)30(18)27(32)20-8-10-21(28)11-9-20/h3-13,16H,14-15,17H2,1-2H3,(H,29,31) D0QV6M DRUGINKE VYDBTNADENXYSN-UHFFFAOYSA-N D0QV6M DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NCCC4=CC=CC=C4 D0QV6M HIGHSTAT Investigative D0QV8V DRUG__ID D0QV8V D0QV8V DRUGTYPE Small molecular drug D0QV8V DRUGINCH 1S/C21H18Cl2O2/c22-17-10-12-20(18(23)14-17)25-21-11-9-16(13-19(21)24)8-4-7-15-5-2-1-3-6-15/h1-3,5-6,9-14,24H,4,7-8H2 D0QV8V DRUGINKE MJRPBNSOVIMDHN-UHFFFAOYSA-N D0QV8V DRUGSMIL C1=CC=C(C=C1)CCCC2=CC(=C(C=C2)OC3=C(C=C(C=C3)Cl)Cl)O D0QV8V HIGHSTAT Investigative D0QW4A DRUG__ID D0QW4A D0QW4A DRUGTYPE Small molecular drug D0QW4A DRUGINCH 1S/C45H55N11O7/c46-38(57)33-18-8-9-21-49-39(58)30-15-4-5-16-31(30)44(63)56-23-11-20-37(56)43(62)55-35(24-27-12-2-1-3-13-27)41(60)53-34(19-10-22-50-45(47)48)40(59)54-36(42(61)52-33)25-28-26-51-32-17-7-6-14-29(28)32/h1-7,12-17,26,33-37,51H,8-11,18-25H2,(H2,46,57)(H,49,58)(H,52,61)(H,53,60)(H,54,59)(H,55,62)(H4,47,48,50)/t33-,34-,35+,36-,37-/m0/s1 D0QW4A DRUGINKE CLUDKTYPSAGGGT-GJOOVXBSSA-N D0QW4A DRUGSMIL C1CCNC(=O)C2=CC=CC=C2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC4=CNC5=CC=CC=C54)CCCN=C(N)N)CC6=CC=CC=C6 D0QW4A HIGHSTAT Investigative D0QW5N DRUG__ID D0QW5N D0QW5N DRUGTYPE Small molecular drug D0QW5N DRUGINCH 1S/C18H21N/c1-19(2)16-12-15-10-6-7-11-17(15)18(13-16)14-8-4-3-5-9-14/h3-11,16,18H,12-13H2,1-2H3/t16-,18+/m0/s1 D0QW5N DRUGINKE DXJUCAUQIHNOAF-FUHWJXTLSA-N D0QW5N DRUGSMIL CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3 D0QW5N HIGHSTAT Investigative D0QW6X DRUG__ID D0QW6X D0QW6X DRUGTYPE Small molecular drug D0QW6X DRUGINCH 1S/C19H20N2O2.C10H14N2/c1-22-17-8-7-14(18(12-17)23-2)11-15-5-4-10-21-19(15)16-6-3-9-20-13-16;1-11-7-3-2-5-10-6-4-8-12-9-10/h3,6-9,11-13H,4-5,10H2,1-2H3;2,4-6,8-9,11H,3,7H2,1H3/b15-11+;5-2+ D0QW6X DRUGINKE MILFUDCXGDJQOI-ZSPSLKEUSA-N D0QW6X DRUGSMIL CNCCC=CC1=CN=CC=C1.COC1=CC(=C(C=C1)C=C2CCCN=C2C3=CN=CC=C3)OC D0QW6X HIGHSTAT Investigative D0QW7W DRUG__ID D0QW7W D0QW7W DRUGTYPE Small molecular drug D0QW7W DRUGINCH 1S/C10H10N2O/c13-10-3-1-9(2-4-10)7-12-6-5-11-8-12/h1-6,8,13H,7H2 D0QW7W DRUGINKE ZEFROCQEWXHIEP-UHFFFAOYSA-N D0QW7W DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)O D0QW7W HIGHSTAT Investigative D0QX4B DRUG__ID D0QX4B D0QX4B DRUGTYPE Small molecular drug D0QX4B DRUGINCH 1S/C19H15NO4/c20-13-16(11-15-8-9-17(21)18(22)12-15)19(23)24-10-4-7-14-5-2-1-3-6-14/h1-9,11-12,21-22H,10H2/b7-4+,16-11+ D0QX4B DRUGINKE XGHYFEJMJXGPGN-UYHGDYIZSA-N D0QX4B DRUGSMIL C1=CC=C(C=C1)C=CCOC(=O)C(=CC2=CC(=C(C=C2)O)O)C#N D0QX4B HIGHSTAT Investigative D0QX5D DRUG__ID D0QX5D D0QX5D DRUGTYPE Small molecular drug D0QX5D DRUGINCH 1S/C15H10ClNOS/c16-15-5-4-14(19-15)13-9-11(6-7-17-13)10-2-1-3-12(18)8-10/h1-9,18H D0QX5D DRUGINKE IJRUJPYMZCIXQJ-UHFFFAOYSA-N D0QX5D DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=NC=C2)C3=CC=C(S3)Cl D0QX5D HIGHSTAT Investigative D0QX6B DRUG__ID D0QX6B D0QX6B DRUGTYPE Small molecular drug D0QX6B DRUGINCH 1S/C20H36O7P2/c1-17(2)9-6-10-18(3)11-7-12-19(4)13-8-14-20(5)15-16-26-29(24,25)27-28(21,22)23/h9,11,13,15H,6-8,10,12,14,16H2,1-5H3,(H,24,25)(H2,21,22,23)/b18-11+,19-13+,20-15+ D0QX6B DRUGINKE OINNEUNVOZHBOX-QIRCYJPOSA-N D0QX6B DRUGSMIL CC(=CCCC(=CCCC(=CCCC(=CCOP(=O)(O)OP(=O)(O)O)C)C)C)C D0QX6B HIGHSTAT Investigative D0QX6R DRUG__ID D0QX6R D0QX6R DRUGTYPE Small molecular drug D0QX6R DRUGINCH 1S/C13H17NO3/c15-12(11-7-3-1-4-8-11)9-5-2-6-10-13(16)14-17/h1,3-4,7-8,17H,2,5-6,9-10H2,(H,14,16) D0QX6R DRUGINKE IHUNPXAEVKBAPH-UHFFFAOYSA-N D0QX6R DRUGSMIL C1=CC=C(C=C1)C(=O)CCCCCC(=O)NO D0QX6R HIGHSTAT Investigative D0QY3R DRUG__ID D0QY3R D0QY3R DRUGTYPE Small molecular drug D0QY3R DRUGINCH 1S/C35H56N4O9S/c1-10-24(4)30(39-34(44)47-22-26-15-12-11-13-16-26)33(43)38-28(17-14-18-29(40)48-35(6,7)8)32(42)36-25(5)31(41)37-27(21-23(2)3)19-20-49(9,45)46/h11-13,15-16,19-20,23-25,27-28,30H,10,14,17-18,21-22H2,1-9H3,(H,36,42)(H,37,41)(H,38,43)(H,39,44)/b20-19+/t24-,25-,27+,28-,30-/m0/s1 D0QY3R DRUGINKE JWIOGOVPAFUFAB-OKNAZKIESA-N D0QY3R DRUGSMIL CCC(C)C(C(=O)NC(CCCC(=O)OC(C)(C)C)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC1=CC=CC=C1 D0QY3R HIGHSTAT Investigative D0R0AX DRUG__ID D0R0AX D0R0AX DRUGTYPE Small molecular drug D0R0AX DRUGINCH 1S/C20H20N2O2S/c1-14-7-9-16(10-8-14)18-17(11-12-23)19(24)22-20(21-18)25-13-15-5-3-2-4-6-15/h2-10,23H,11-13H2,1H3,(H,21,22,24) D0R0AX DRUGINKE MMKBRXXCKNYUMD-UHFFFAOYSA-N D0R0AX DRUGSMIL CC1=CC=C(C=C1)C2=C(C(=O)NC(=N2)SCC3=CC=CC=C3)CCO D0R0AX HIGHSTAT Investigative D0R0EI DRUG__ID D0R0EI D0R0EI DRUGTYPE Small molecular drug D0R0EI DRUGINCH 1S/C8H11N5O/c1-5(14)2-13-4-12-6-7(9)10-3-11-8(6)13/h3-5,14H,2H2,1H3,(H2,9,10,11)/t5-/m0/s1 D0R0EI DRUGINKE MJZYTEBKXLVLMY-YFKPBYRVSA-N D0R0EI DRUGSMIL CC(CN1C=NC2=C(N=CN=C21)N)O D0R0EI HIGHSTAT Investigative D0R0IB DRUG__ID D0R0IB D0R0IB DRUGTYPE Small molecular drug D0R0IB DRUGINCH 1S/C22H23NO3/c1-26-21-12-8-18(9-13-21)5-4-17-6-10-20(11-7-17)22(25)23-14-2-3-19(15-23)16-24/h6-13,19,24H,2-3,14-16H2,1H3/t19-/m1/s1 D0R0IB DRUGINKE VSLWUPHHCFQTDB-LJQANCHMSA-N D0R0IB DRUGSMIL COC1=CC=C(C=C1)C#CC2=CC=C(C=C2)C(=O)N3CCCC(C3)CO D0R0IB HIGHSTAT Investigative D0R0JE DRUG__ID D0R0JE D0R0JE DRUGTYPE Small molecular drug D0R0JE DRUGINCH 1S/C12H8BrN3/c1-9-8-14-16-12(15-9)6-5-10-3-2-4-11(13)7-10/h2-4,7-8H,1H3 D0R0JE DRUGINKE ZFPUZPDBHDTJCE-UHFFFAOYSA-N D0R0JE DRUGSMIL CC1=CN=NC(=N1)C#CC2=CC(=CC=C2)Br D0R0JE HIGHSTAT Investigative D0R0LQ DRUG__ID D0R0LQ D0R0LQ DRUGTYPE Small molecular drug D0R0LQ DRUGINCH 1S/C17H17NO2/c1-18(2)14-6-4-12(5-7-14)17-11-13-10-15(19-3)8-9-16(13)20-17/h4-11H,1-3H3 D0R0LQ DRUGINKE KKKKLHNEZMGUPC-UHFFFAOYSA-N D0R0LQ DRUGSMIL CN(C)C1=CC=C(C=C1)C2=CC3=C(O2)C=CC(=C3)OC D0R0LQ HIGHSTAT Investigative D0R0OZ DRUG__ID D0R0OZ D0R0OZ DRUGTYPE Small molecular drug D0R0OZ DRUGINCH 1S/C28H35N5O5/c29-21(16-19-10-12-20(34)13-11-19)27(37)33-15-5-9-24(33)26(36)31-22(17-18-6-2-1-3-7-18)28(38)32-14-4-8-23(32)25(30)35/h1-3,6-7,10-13,21-24,34H,4-5,8-9,14-17,29H2,(H2,30,35)(H,31,36)/t21-,22-,23-,24-/m0/s1 D0R0OZ DRUGINKE LSQXZIUREIDSHZ-ZJZGAYNASA-N D0R0OZ DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D0R0OZ HIGHSTAT Investigative D0R0PU DRUG__ID D0R0PU D0R0PU DRUGTYPE Small molecular drug D0R0PU DRUGINCH 1S/C15H11FN2/c1-10-5-12(7-13(16)6-10)15-8-14-11(9-18-15)3-2-4-17-14/h2-9H,1H3 D0R0PU DRUGINKE ZJIGDEYNCCHRKX-UHFFFAOYSA-N D0R0PU DRUGSMIL CC1=CC(=CC(=C1)F)C2=NC=C3C=CC=NC3=C2 D0R0PU HIGHSTAT Investigative D0R0TE DRUG__ID D0R0TE D0R0TE DRUGTYPE Small molecular drug D0R0TE DRUGINCH 1S/C17H15NO/c1-2-19-17-8-7-13-10-14(5-6-15(13)11-17)16-4-3-9-18-12-16/h3-12H,2H2,1H3 D0R0TE DRUGINKE CQLHDOYGDGBDQA-UHFFFAOYSA-N D0R0TE DRUGSMIL CCOC1=CC2=C(C=C1)C=C(C=C2)C3=CN=CC=C3 D0R0TE HIGHSTAT Investigative D0R0TW DRUG__ID D0R0TW D0R0TW DRUGTYPE Small molecular drug D0R0TW DRUGINCH 1S/C33H34N4O4S/c1-2-35-12-14-36(15-13-35)21-29(39)34-26-11-10-23(33-31(26)25-6-3-4-9-28(25)42-33)22-7-5-8-24-27(38)20-30(41-32(22)24)37-16-18-40-19-17-37/h3-11,20H,2,12-19,21H2,1H3,(H,34,39) D0R0TW DRUGINKE AATCBLYHOUOCTO-UHFFFAOYSA-N D0R0TW DRUGSMIL CCN1CCN(CC1)CC(=O)NC2=C3C4=CC=CC=C4SC3=C(C=C2)C5=CC=CC6=C5OC(=CC6=O)N7CCOCC7 D0R0TW HIGHSTAT Investigative D0R0UV DRUG__ID D0R0UV D0R0UV DRUGTYPE Small molecular drug D0R0UV DRUGINCH 1S/C13H30O6P2S/c1-3-4-5-6-7-8-9-10-11-22(2)12-13(20(14,15)16)21(17,18)19/h13H,3-12H2,1-2H3,(H3-,14,15,16,17,18,19) D0R0UV DRUGINKE RKGOJPTZXHKAKX-UHFFFAOYSA-N D0R0UV DRUGSMIL CCCCCCCCCC[S+](C)CC(P(=O)(O)O)P(=O)(O)[O-] D0R0UV HIGHSTAT Investigative D0R0UZ DRUG__ID D0R0UZ D0R0UZ DRUGTYPE Small molecular drug D0R0UZ DRUGINCH 1S/C15H8FN3/c16-13-5-10(8-17)4-12(6-13)15-7-14-11(9-19-15)2-1-3-18-14/h1-7,9H D0R0UZ DRUGINKE PSQNPPVCWZBHDY-UHFFFAOYSA-N D0R0UZ DRUGSMIL C1=CC2=CN=C(C=C2N=C1)C3=CC(=CC(=C3)C#N)F D0R0UZ HIGHSTAT Investigative D0R0XE DRUG__ID D0R0XE D0R0XE DRUGTYPE Small molecular drug D0R0XE DRUGINCH 1S/C8H10O3/c1-5(9)8-6(10)3-2-4-7(8)11/h10H,2-4H2,1H3 D0R0XE DRUGINKE YKOOMGHHVDVJAY-UHFFFAOYSA-N D0R0XE DRUGSMIL CC(=O)C1=C(CCCC1=O)O D0R0XE HIGHSTAT Investigative D0R0XY DRUG__ID D0R0XY D0R0XY DRUGTYPE Small molecular drug D0R0XY DRUGINCH 1S/C45H59N9O17/c1-22(2)17-30-42(68)52-29(13-16-37(61)62)41(67)50-27(39(46)65)11-14-34(57)48-31(18-23-3-7-25(55)8-4-23)43(69)53-32(19-24-5-9-26(56)10-6-24)44(70)54-33(20-38(63)64)45(71)51-28(12-15-36(59)60)40(66)47-21-35(58)49-30/h3-10,22,27-33,55-56H,11-21H2,1-2H3,(H2,46,65)(H,47,66)(H,48,57)(H,49,58)(H,50,67)(H,51,71)(H,52,68)(H,53,69)(H,54,70)(H,59,60)(H,61,62)(H,63,64)/t27-,28-,29-,30-,31-,32-,33-/m0/s1 D0R0XY DRUGINKE FRCBDVBWQMWQOW-MRNVWEPHSA-N D0R0XY DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CCC(=O)O)CC(=O)O)CC2=CC=C(C=C2)O)CC3=CC=C(C=C3)O)C(=O)N)CCC(=O)O D0R0XY HIGHSTAT Investigative D0R0ZC DRUG__ID D0R0ZC D0R0ZC DRUGTYPE Small molecular drug D0R0ZC DRUGINCH 1S/C39H50N4O6S/c1-6-7-17-40-28-18-24(2)35(25(3)19-28)49-22-32(45)41-30(20-26-13-9-8-10-14-26)34(46)38(48)43-23-50-39(4,5)36(43)37(47)42-33-29-16-12-11-15-27(29)21-31(33)44/h8-16,18-19,30-31,33-34,36,40,44,46H,6-7,17,20-23H2,1-5H3,(H,41,45)(H,42,47)/t30-,31+,33-,34-,36+/m0/s1 D0R0ZC DRUGINKE YFOGAJAJKAWILS-SQKWSBCUSA-N D0R0ZC DRUGSMIL CCCCNC1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0R0ZC HIGHSTAT Investigative D0R1AB DRUG__ID D0R1AB D0R1AB DRUGTYPE Small molecular drug D0R1AB DRUGINCH 1S/C28H35N5O7/c29-20(14-18-10-12-19(34)13-11-18)25(36)32-21-8-4-5-9-22(28(39)40)33-27(38)23(15-17-6-2-1-3-7-17)31-24(35)16-30-26(21)37/h1-3,6-7,10-13,20-23,34H,4-5,8-9,14-16,29H2,(H,30,37)(H,31,35)(H,32,36)(H,33,38)(H,39,40)/t20-,21+,22+,23-/m0/s1 D0R1AB DRUGINKE GDFBPHMKQXUQTN-AFXVXQJMSA-N D0R1AB DRUGSMIL C1CCC(NC(=O)C(NC(=O)CNC(=O)C(C1)NC(=O)C(CC2=CC=C(C=C2)O)N)CC3=CC=CC=C3)C(=O)O D0R1AB HIGHSTAT Investigative D0R1AE DRUG__ID D0R1AE D0R1AE DRUGTYPE Small molecular drug D0R1AE DRUGINCH 1S/C18H14O2/c1-20-18(19)17-9-5-4-8-16(17)15-11-10-13-6-2-3-7-14(13)12-15/h2-12H,1H3 D0R1AE DRUGINKE SKSUKRWKVAZHJI-UHFFFAOYSA-N D0R1AE DRUGSMIL COC(=O)C1=CC=CC=C1C2=CC3=CC=CC=C3C=C2 D0R1AE HIGHSTAT Investigative D0R1BG DRUG__ID D0R1BG D0R1BG DRUGTYPE Small molecular drug D0R1BG DRUGINCH 1S/C14H15NO4/c1-17-12-4-2-3-10-11(16)9-13(19-14(10)12)15-5-7-18-8-6-15/h2-4,9H,5-8H2,1H3 D0R1BG DRUGINKE USIRKXHEGVTPLO-UHFFFAOYSA-N D0R1BG DRUGSMIL COC1=CC=CC2=C1OC(=CC2=O)N3CCOCC3 D0R1BG HIGHSTAT Investigative D0R1DY DRUG__ID D0R1DY D0R1DY DRUGTYPE Small molecular drug D0R1DY DRUGINCH 1S/C34H43N5O4/c1-22-16-27(40)17-23(2)28(22)19-29(36)34(43)39-21-26-13-7-6-12-25(26)18-31(39)33(42)38-30(14-8-9-15-35)32(41)37-20-24-10-4-3-5-11-24/h3-7,10-13,16-17,29-31,40H,8-9,14-15,18-21,35-36H2,1-2H3,(H,37,41)(H,38,42) D0R1DY DRUGINKE RMSWGJUPLHHSPI-UHFFFAOYSA-N D0R1DY DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCN)C(=O)NCC4=CC=CC=C4)N)C)O D0R1DY HIGHSTAT Investigative D0R1EO DRUG__ID D0R1EO D0R1EO DRUGTYPE Small molecular drug D0R1EO DRUGINCH 1S/C17H21NO/c1-18(2)13-6-14-19-17-11-9-16(10-12-17)15-7-4-3-5-8-15/h3-5,7-12H,6,13-14H2,1-2H3 D0R1EO DRUGINKE ITTYRYJIHNHJBL-UHFFFAOYSA-N D0R1EO DRUGSMIL CN(C)CCCOC1=CC=C(C=C1)C2=CC=CC=C2 D0R1EO HIGHSTAT Investigative D0R1ER DRUG__ID D0R1ER D0R1ER DRUGTYPE Small molecular drug D0R1ER DRUGINCH 1S/C16H13N3O/c20-16-13-6-2-4-8-15(13)18-19(16)10-11-9-17-14-7-3-1-5-12(11)14/h1-9,17-18H,10H2 D0R1ER DRUGINKE IAJFPXRONWWXNK-UHFFFAOYSA-N D0R1ER DRUGSMIL C1=CC=C2C(=C1)C(=CN2)CN3C(=O)C4=CC=CC=C4N3 D0R1ER HIGHSTAT Investigative D0R1FP DRUG__ID D0R1FP D0R1FP DRUGTYPE Small molecular drug D0R1FP DRUGINCH 1S/C24H24FNO4/c1-16-22(12-11-20(27)13-21(28)14-24(29)30)23(17-7-9-18(25)10-8-17)15-26(16)19-5-3-2-4-6-19/h2-12,15,20-21,27-28H,13-14H2,1H3,(H,29,30)/p-1/b12-11+/t20-,21-/m1/s1 D0R1FP DRUGINKE FQMQFMROIGKGDU-LKWCPCFXSA-M D0R1FP DRUGSMIL CC1=C(C(=CN1C2=CC=CC=C2)C3=CC=C(C=C3)F)C=CC(CC(CC(=O)[O-])O)O D0R1FP HIGHSTAT Investigative D0R1FR DRUG__ID D0R1FR D0R1FR DRUGTYPE Small molecular drug D0R1FR DRUGINCH 1S/C14H16N2/c1-9-6-7-11-13(8-9)16-12-5-3-2-4-10(12)14(11)15/h2-5,9H,6-8H2,1H3,(H2,15,16)/t9-/m1/s1 D0R1FR DRUGINKE WVQOYPIATZDPLZ-SECBINFHSA-N D0R1FR DRUGSMIL CC1CCC2=C(C3=CC=CC=C3N=C2C1)N D0R1FR HIGHSTAT Investigative D0R1FT DRUG__ID D0R1FT D0R1FT DRUGTYPE Small molecular drug D0R1FT DRUGINCH 1S/C12H17N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h7-8H,1-6H2,(H3,13,14,15,16,17) D0R1FT DRUGINKE MWGXGTJJAOZBNW-UHFFFAOYSA-N D0R1FT DRUGSMIL C1CCC(CC1)COC2=NC(=NC3=C2NC=N3)N D0R1FT HIGHSTAT Investigative D0R1FZ DRUG__ID D0R1FZ D0R1FZ DRUGTYPE Small molecular drug D0R1FZ DRUGINCH 1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1 D0R1FZ DRUGINKE IXAQOQZEOGMIQS-SSQFXEBMSA-N D0R1FZ DRUGSMIL CCCCCC(C=CC=CC=CC=CC(C(CCCC(=O)O)O)O)O D0R1FZ HIGHSTAT Investigative D0R1GF DRUG__ID D0R1GF D0R1GF DRUGTYPE Small molecular drug D0R1GF DRUGINCH 1S/C20H15NO3/c22-19(21-18-9-5-4-8-17(18)20(23)24)16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13H,(H,21,22)(H,23,24) D0R1GF DRUGINKE WXLRBDMDGLLZRS-UHFFFAOYSA-N D0R1GF DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)NC3=CC=CC=C3C(=O)O D0R1GF HIGHSTAT Investigative D0R1IL DRUG__ID D0R1IL D0R1IL DRUGTYPE Small molecular drug D0R1IL DRUGINCH 1S/C18H18N2O2/c21-18-16(17(22-20-18)13-7-9-19-10-8-13)15-6-5-12-3-1-2-4-14(12)11-15/h1-6,11,13,19H,7-10H2,(H,20,21) D0R1IL DRUGINKE PWDALQSYHZMANN-UHFFFAOYSA-N D0R1IL DRUGSMIL C1CNCCC1C2=C(C(=O)NO2)C3=CC4=CC=CC=C4C=C3 D0R1IL HIGHSTAT Investigative D0R1KE DRUG__ID D0R1KE D0R1KE DRUGTYPE Small molecular drug D0R1KE DRUGINCH 1S/C9H9BrO4/c10-7-1-2-8(6(3-7)4-11)14-5-9(12)13/h1-3,11H,4-5H2,(H,12,13) D0R1KE DRUGINKE QMNTWAAGYOSTJK-UHFFFAOYSA-N D0R1KE DRUGSMIL C1=CC(=C(C=C1Br)CO)OCC(=O)O D0R1KE HIGHSTAT Investigative D0R1MB DRUG__ID D0R1MB D0R1MB DRUGTYPE Small molecular drug D0R1MB DRUGINCH 1S/C22H28N2O4/c1-4-14-12-24-10-9-21-17-11-15(26)5-6-18(17)23(2)22(21,24)8-7-16(14)20(21,13-25)19(27)28-3/h4-6,11,16,25-26H,7-10,12-13H2,1-3H3/b14-4-/t16-,20+,21+,22+/m1/s1 D0R1MB DRUGINKE SJFXTBHAODZALL-PEZZAXBTSA-N D0R1MB DRUGSMIL CC=C1CN2CCC34C2(CCC1C3(CO)C(=O)OC)N(C5=C4C=C(C=C5)O)C D0R1MB HIGHSTAT Investigative D0R1MM DRUG__ID D0R1MM D0R1MM DRUGTYPE Small molecular drug D0R1MM DRUGINCH 1S/C12H21N3O2/c1-2-3-4-5-6-7-8-13-10-9-11(16)15-12(17)14-10/h9H,2-8H2,1H3,(H3,13,14,15,16,17) D0R1MM DRUGINKE PFSWASUQURIOOR-UHFFFAOYSA-N D0R1MM DRUGSMIL CCCCCCCCNC1=CC(=O)NC(=O)N1 D0R1MM HIGHSTAT Investigative D0R1NR DRUG__ID D0R1NR D0R1NR DRUGTYPE Small molecular drug D0R1NR DRUGINCH 1S/C30H33NO/c1-3-5-9-20-31-22-26(21-29(31)25-18-16-23(17-19-25)11-6-4-2)30(32)28-15-10-13-24-12-7-8-14-27(24)28/h7-8,10,12-19,21-22H,3-6,9,11,20H2,1-2H3 D0R1NR DRUGINKE PKNGYYSGLHBRGC-UHFFFAOYSA-N D0R1NR DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)CCCC)C(=O)C3=CC=CC4=CC=CC=C43 D0R1NR HIGHSTAT Investigative D0R1PD DRUG__ID D0R1PD D0R1PD DRUGTYPE Small molecular drug D0R1PD DRUGINCH 1S/C30H35N3O9P2/c1-20(34)31-26(17-22-12-15-27(43(37,38)39)28(18-22)44(40,41)42)29(35)32-25-9-5-6-16-33(30(25)36)19-21-10-13-24(14-11-21)23-7-3-2-4-8-23/h2-4,7-8,10-15,18,25-26H,5-6,9,16-17,19H2,1H3,(H,31,34)(H,32,35)(H2,37,38,39)(H2,40,41,42)/t25-,26-/m0/s1 D0R1PD DRUGINKE WCMLXBUNHNAMNH-UIOOFZCWSA-N D0R1PD DRUGSMIL CC(=O)NC(CC1=CC(=C(C=C1)P(=O)(O)O)P(=O)(O)O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D0R1PD HIGHSTAT Investigative D0R1QW DRUG__ID D0R1QW D0R1QW DRUGTYPE Small molecular drug D0R1QW DRUGINCH 1S/C9H13NO3/c10-6-7(5-9(11)12)4-8-2-1-3-13-8/h1-3,7H,4-6,10H2,(H,11,12)/t7-/m1/s1 D0R1QW DRUGINKE JASKMEUWYOXVFB-SSDOTTSWSA-N D0R1QW DRUGSMIL C1=COC(=C1)CC(CC(=O)O)CN D0R1QW HIGHSTAT Investigative D0R1UA DRUG__ID D0R1UA D0R1UA DRUGTYPE Small molecular drug D0R1UA DRUGINCH 1S/C21H31NO2/c1-5-6-7-8-9-15-12-18(23)20-16-10-11-22(4)14-17(16)21(2,3)24-19(20)13-15/h12-13,23H,5-11,14H2,1-4H3 D0R1UA DRUGINKE CXLQUCPRQKBNSP-UHFFFAOYSA-N D0R1UA DRUGSMIL CCCCCCC1=CC(=C2C3=C(CN(CC3)C)C(OC2=C1)(C)C)O D0R1UA HIGHSTAT Investigative D0R1UO DRUG__ID D0R1UO D0R1UO DRUGTYPE Small molecular drug D0R1UO DRUGINCH 1S/C10H12O4/c1-5(2)10(14)9-7(12)3-6(11)4-8(9)13/h3-5,11-13H,1-2H3 D0R1UO DRUGINKE BNEBXEZRBLYBCZ-UHFFFAOYSA-N D0R1UO DRUGSMIL CC(C)C(=O)C1=C(C=C(C=C1O)O)O D0R1UO HIGHSTAT Investigative D0R1XT DRUG__ID D0R1XT D0R1XT DRUGTYPE Small molecular drug D0R1XT DRUGINCH 1S/C14H13N3/c1-16(13-6-9-15-10-7-13)17-11-8-12-4-2-3-5-14(12)17/h2-11H,1H3 D0R1XT DRUGINKE DZLHSFJMKLMKMN-UHFFFAOYSA-N D0R1XT DRUGSMIL CN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32 D0R1XT HIGHSTAT Investigative D0R1XY DRUG__ID D0R1XY D0R1XY DRUGTYPE Small molecular drug D0R1XY DRUGINCH 1S/C15H20ClN5O4/c16-15-19-12(18-7-3-1-2-4-7)9-13(20-15)21(6-17-9)14-11(24)10(23)8(5-22)25-14/h6-8,10-11,14,22-24H,1-5H2,(H,18,19,20)/t8-,10-,11-,14-/m1/s1 D0R1XY DRUGINKE XSMYYYQVWPZWIZ-IDTAVKCVSA-N D0R1XY DRUGSMIL C1CCC(C1)NC2=C3C(=NC(=N2)Cl)N(C=N3)C4C(C(C(O4)CO)O)O D0R1XY HIGHSTAT Investigative D0R1YP DRUG__ID D0R1YP D0R1YP DRUGTYPE Small molecular drug D0R1YP DRUGINCH 1S/C13H24N2O3/c16-11-5-1-9(2-6-11)14-13(18)15-10-3-7-12(17)8-4-10/h9-12,16-17H,1-8H2,(H2,14,15,18) D0R1YP DRUGINKE CHWFTRBAEVNHFK-UHFFFAOYSA-N D0R1YP DRUGSMIL C1CC(CCC1NC(=O)NC2CCC(CC2)O)O D0R1YP HIGHSTAT Investigative D0R1YT DRUG__ID D0R1YT D0R1YT DRUGTYPE Small molecular drug D0R1YT DRUGINCH 1S/C19H18FN5O/c1-3-9-24-11-14-10-13(6-7-15(14)19(24)26)17-12(2)25(23-22-17)16-5-4-8-21-18(16)20/h4-8,10H,3,9,11H2,1-2H3/i20-1 D0R1YT DRUGINKE NYDVTBHNZHBCKX-LRFGSCOBSA-N D0R1YT DRUGSMIL CCCN1CC2=C(C1=O)C=CC(=C2)C3=C(N(N=N3)C4=C(N=CC=C4)F)C D0R1YT HIGHSTAT Investigative D0R1ZD DRUG__ID D0R1ZD D0R1ZD DRUGTYPE Small molecular drug D0R1ZD DRUGINCH 1S/C24H23F2N3O3S/c1-33(31,32)19-7-8-20(16-2-4-17(25)5-3-16)21(15-19)24(30)29-12-10-28(11-13-29)23-9-6-18(27)14-22(23)26/h2-9,14-15H,10-13,27H2,1H3 D0R1ZD DRUGINKE DAPKZHQMEQRNPY-UHFFFAOYSA-N D0R1ZD DRUGSMIL CS(=O)(=O)C1=CC(=C(C=C1)C2=CC=C(C=C2)F)C(=O)N3CCN(CC3)C4=C(C=C(C=C4)N)F D0R1ZD HIGHSTAT Investigative D0R2AT DRUG__ID D0R2AT D0R2AT DRUGTYPE Small molecular drug D0R2AT DRUGINCH 1S/C16H18N2O2S/c1-9(2)14-13(16(19)20)18-15(21-14)12-7-10-5-3-4-6-11(10)8-17-12/h3-6,9,12,17H,7-8H2,1-2H3,(H,19,20)/t12-/m0/s1 D0R2AT DRUGINKE HCUGCUQZFBURHR-LBPRGKRZSA-N D0R2AT DRUGSMIL CC(C)C1=C(N=C(S1)C2CC3=CC=CC=C3CN2)C(=O)O D0R2AT HIGHSTAT Investigative D0R2BA DRUG__ID D0R2BA D0R2BA DRUGTYPE Small molecular drug D0R2BA DRUGINCH 1S/C6H12N2O5/c9-1-2-3(10)4(11)5(12)6(7-2)8-13/h2-5,9-13H,1H2,(H,7,8)/t2-,3-,4+,5-/m1/s1 D0R2BA DRUGINKE VBXHGXTYZGYTQG-SQOUGZDYSA-N D0R2BA DRUGSMIL C(C1C(C(C(C(=N1)NO)O)O)O)O D0R2BA HIGHSTAT Investigative D0R2BM DRUG__ID D0R2BM D0R2BM DRUGTYPE Small molecular drug D0R2BM DRUGINCH 1S/C15H22N2O/c1-2-5-14(17-10-3-4-11-17)15(18)12-6-8-13(16)9-7-12/h6-9,14H,2-5,10-11,16H2,1H3 D0R2BM DRUGINKE DUNXFOYJTLLKNQ-UHFFFAOYSA-N D0R2BM DRUGSMIL CCCC(C(=O)C1=CC=C(C=C1)N)N2CCCC2 D0R2BM HIGHSTAT Investigative D0R2BO DRUG__ID D0R2BO D0R2BO DRUGTYPE Small molecular drug D0R2BO DRUGINCH 1S/C18H27N3O4/c1-12(2)9-14(11-16(22)21-25)17(23)20-15(18(24)19-3)10-13-7-5-4-6-8-13/h4-8,12,14-15,25H,9-11H2,1-3H3,(H,19,24)(H,20,23)(H,21,22)/t14-,15+/m1/s1 D0R2BO DRUGINKE MOPRTFSMCQNUCT-CABCVRRESA-N D0R2BO DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC D0R2BO HIGHSTAT Investigative D0R2CF DRUG__ID D0R2CF D0R2CF DRUGTYPE Small molecular drug D0R2CF DRUGINCH 1S/C16H14N2O2/c1-19-13-6-12(7-14(8-13)20-2)16-9-15-11(10-18-16)4-3-5-17-15/h3-10H,1-2H3 D0R2CF DRUGINKE HVIBISIIVPOREN-UHFFFAOYSA-N D0R2CF DRUGSMIL COC1=CC(=CC(=C1)C2=NC=C3C=CC=NC3=C2)OC D0R2CF HIGHSTAT Investigative D0R2DP DRUG__ID D0R2DP D0R2DP DRUGTYPE Small molecular drug D0R2DP DRUGINCH 1S/C15H9IO4/c16-9-1-4-11(5-2-9)20-14-8-19-13-7-10(17)3-6-12(13)15(14)18/h1-8,17H D0R2DP DRUGINKE XXZKJJYWINSUMJ-UHFFFAOYSA-N D0R2DP DRUGSMIL C1=CC(=CC=C1OC2=COC3=C(C2=O)C=CC(=C3)O)I D0R2DP HIGHSTAT Investigative D0R2GR DRUG__ID D0R2GR D0R2GR DRUGTYPE Small molecular drug D0R2GR DRUGINCH 1S/C18H20N2OS/c1-18(2,3)12-19-17(21)20-13-8-4-6-10-15(13)22-16-11-7-5-9-14(16)20/h4-11H,12H2,1-3H3,(H,19,21) D0R2GR DRUGINKE IOIGXILMSZNTOC-UHFFFAOYSA-N D0R2GR DRUGSMIL CC(C)(C)CNC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0R2GR HIGHSTAT Investigative D0R2HF DRUG__ID D0R2HF D0R2HF DRUGTYPE Small molecular drug D0R2HF DRUGINCH 1S/C14H20N2O2S/c17-13(16-12-7-3-1-4-8-12)9-5-2-6-10-15-14(18)11-19/h1,3-4,7-8,19H,2,5-6,9-11H2,(H,15,18)(H,16,17) D0R2HF DRUGINKE ICMLRCZXRBTKLJ-UHFFFAOYSA-N D0R2HF DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCNC(=O)CS D0R2HF HIGHSTAT Investigative D0R2HJ DRUG__ID D0R2HJ D0R2HJ DRUGTYPE Small molecular drug D0R2HJ DRUGINCH 1S/C11H9NO2/c1-14-11(13)10-6-8-4-2-3-5-9(8)7-12-10/h2-7H,1H3 D0R2HJ DRUGINKE ZBCGBIZQNMVMPC-UHFFFAOYSA-N D0R2HJ DRUGSMIL COC(=O)C1=CC2=CC=CC=C2C=N1 D0R2HJ HIGHSTAT Investigative D0R2HZ DRUG__ID D0R2HZ D0R2HZ DRUGTYPE Small molecular drug D0R2HZ DRUGINCH 1S/C13H16N2O3/c1-2-17-13(12-14-7-8-15-12)9-16-10-5-3-4-6-11(10)18-13/h3-6H,2,7-9H2,1H3,(H,14,15) D0R2HZ DRUGINKE PXTLRBYNGGDZBN-UHFFFAOYSA-N D0R2HZ DRUGSMIL CCOC1(COC2=CC=CC=C2O1)C3=NCCN3 D0R2HZ HIGHSTAT Investigative D0R2JA DRUG__ID D0R2JA D0R2JA DRUGTYPE Small molecular drug D0R2JA DRUGINCH 1S/C30H36F3N3O6S/c1-43(39,40)35-16-12-24(13-17-35)42-25-8-6-22(27(19-25)41-20-30(31,32)33)18-29(38)34-14-10-23(11-15-34)36-26-5-3-2-4-21(26)7-9-28(36)37/h2-6,8,19,23-24H,7,9-18,20H2,1H3/i43+3 D0R2JA DRUGINKE WGABGZOBUZZBRA-FFSUGBGASA-N D0R2JA DRUGSMIL CS(=O)(=O)N1CCC(CC1)OC2=CC(=C(C=C2)CC(=O)N3CCC(CC3)N4C(=O)CCC5=CC=CC=C54)OCC(F)(F)F D0R2JA HIGHSTAT Investigative D0R2JE DRUG__ID D0R2JE D0R2JE DRUGTYPE Small molecular drug D0R2JE DRUGINCH 1S/C9H15ClN2O/c1-13-11-9(10)8-6-12-4-2-7(8)3-5-12/h7-8H,2-6H2,1H3/b11-9- D0R2JE DRUGINKE NJVYTBKHLPNMEV-LUAWRHEFSA-N D0R2JE DRUGSMIL CON=C(C1CN2CCC1CC2)Cl D0R2JE HIGHSTAT Investigative D0R2JT DRUG__ID D0R2JT D0R2JT DRUGTYPE Small molecular drug D0R2JT DRUGINCH 1S/C15H18IN3O2/c1-9(2)18-7-10(20)8-21-13-5-3-4-11-14(13)15(16)12(6-17)19-11/h3-5,9-10,18-20H,7-8H2,1-2H3 D0R2JT DRUGINKE WGSPBWSPJOBKNT-UHFFFAOYSA-N D0R2JT DRUGSMIL CC(C)NCC(COC1=CC=CC2=C1C(=C(N2)C#N)I)O D0R2JT HIGHSTAT Investigative D0R2KL DRUG__ID D0R2KL D0R2KL DRUGTYPE Small molecular drug D0R2KL DRUGINCH 1S/C21H31NO4S/c1-2-3-4-7-18(23)13-14-22-19(24)15-27-20(22)8-5-6-16-9-11-17(12-10-16)21(25)26/h9-12,18,20,23H,2-8,13-15H2,1H3,(H,25,26) D0R2KL DRUGINKE NDAXAJCKSWCWQI-UHFFFAOYSA-N D0R2KL DRUGSMIL CCCCCC(CCN1C(SCC1=O)CCCC2=CC=C(C=C2)C(=O)O)O D0R2KL HIGHSTAT Investigative D0R2MO DRUG__ID D0R2MO D0R2MO DRUGTYPE Small molecular drug D0R2MO DRUGINCH 1S/C15H16O3/c1-7-4-14-12(9(3)15(17)18-14)5-11-8(2)13(16)6-10(7)11/h6-7,11-12,14H,2-5H2,1H3/t7-,11-,12+,14+/m0/s1 D0R2MO DRUGINKE RVBPAMCSEVHKLO-LWZBDFBTSA-N D0R2MO DRUGSMIL CC1CC2C(CC3C1=CC(=O)C3=C)C(=C)C(=O)O2 D0R2MO HIGHSTAT Investigative D0R2OX DRUG__ID D0R2OX D0R2OX DRUGTYPE Small molecular drug D0R2OX DRUGINCH 1S/C14H11N/c1-12-7-9-14(15-11-12)10-8-13-5-3-2-4-6-13/h2-7,9,11H,1H3 D0R2OX DRUGINKE HESJPHOOGDBABM-UHFFFAOYSA-N D0R2OX DRUGSMIL CC1=CN=C(C=C1)C#CC2=CC=CC=C2 D0R2OX HIGHSTAT Investigative D0R2PW DRUG__ID D0R2PW D0R2PW DRUGTYPE Small molecular drug D0R2PW DRUGINCH 1S/C9H11NO2S/c10-7-3-1-2-6(4-7)8(5-13)9(11)12/h1-4,8,13H,5,10H2,(H,11,12) D0R2PW DRUGINKE WOYCAJIRNXWVLG-UHFFFAOYSA-N D0R2PW DRUGSMIL C1=CC(=CC(=C1)N)C(CS)C(=O)O D0R2PW HIGHSTAT Investigative D0R2QC DRUG__ID D0R2QC D0R2QC DRUGTYPE Small molecular drug D0R2QC DRUGINCH 1S/C29H33NO3/c31-29(26-16-8-3-9-17-26)32-23-11-10-20-30-21-18-27(19-22-30)33-28(24-12-4-1-5-13-24)25-14-6-2-7-15-25/h1-9,12-17,27-28H,10-11,18-23H2 D0R2QC DRUGINKE SUQKPOGAPWZPRM-UHFFFAOYSA-N D0R2QC DRUGSMIL C1CN(CCC1OC(C2=CC=CC=C2)C3=CC=CC=C3)CCCCOC(=O)C4=CC=CC=C4 D0R2QC HIGHSTAT Investigative D0R2QS DRUG__ID D0R2QS D0R2QS DRUGTYPE Small molecular drug D0R2QS DRUGINCH 1S/C11H13N5O3/c12-10-7-11(14-3-13-10)16(4-15-7)6-1-5(2-17)8(18)9(6)19/h1,3-4,6,8-9,17-19H,2H2,(H2,12,13,14)/t6-,8-,9+/m1/s1 D0R2QS DRUGINKE XUGWUUDOWNZAGW-VDAHYXPESA-N D0R2QS DRUGSMIL C1=C(C(C(C1N2C=NC3=C(N=CN=C32)N)O)O)CO D0R2QS HIGHSTAT Investigative D0R2TU DRUG__ID D0R2TU D0R2TU DRUGTYPE Small molecular drug D0R2TU DRUGINCH 1S/C12H14N2O/c1-2-6-12(7-3-1)15-8-4-5-11-9-13-10-14-11/h1-3,6-7,9-10H,4-5,8H2,(H,13,14) D0R2TU DRUGINKE DOOCQHQHBHNOGX-UHFFFAOYSA-N D0R2TU DRUGSMIL C1=CC=C(C=C1)OCCCC2=CN=CN2 D0R2TU HIGHSTAT Investigative D0R2TW DRUG__ID D0R2TW D0R2TW DRUGTYPE Small molecular drug D0R2TW DRUGINCH 1S/C24H18ClF2NO3/c25-15-8-10-23(31-13-14-7-9-16(26)12-20(14)27)19(11-15)17-3-1-4-18(17)21-5-2-6-22(28-21)24(29)30/h2,5-12H,1,3-4,13H2,(H,29,30) D0R2TW DRUGINKE PFODPHDNBFSMOX-UHFFFAOYSA-N D0R2TW DRUGSMIL C1CC(=C(C1)C2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)F)F)C4=NC(=CC=C4)C(=O)O D0R2TW HIGHSTAT Investigative D0R2UG DRUG__ID D0R2UG D0R2UG DRUGTYPE Small molecular drug D0R2UG DRUGINCH 1S/C21H18N4O4S/c1-2-29-21(26)19-13-23-20-9-8-15(14-25(19)20)16-10-17(12-22-11-16)24-30(27,28)18-6-4-3-5-7-18/h3-14,24H,2H2,1H3 D0R2UG DRUGINKE SEKOTFCHZNXZMM-UHFFFAOYSA-N D0R2UG DRUGSMIL CCOC(=O)C1=CN=C2N1C=C(C=C2)C3=CC(=CN=C3)NS(=O)(=O)C4=CC=CC=C4 D0R2UG HIGHSTAT Investigative D0R2UZ DRUG__ID D0R2UZ D0R2UZ DRUGTYPE Small molecular drug D0R2UZ DRUGINCH 1S/C22H29N4O10P/c1-3-34-37(33,35-4-2)12-13-5-7-14(8-6-13)24-16(28)11-23-20(31)19-17(29)18(30)21(36-19)26-10-9-15(27)25-22(26)32/h5-10,17-19,21,29-30H,3-4,11-12H2,1-2H3,(H,23,31)(H,24,28)(H,25,27,32)/t17-,18+,19-,21+/m0/s1 D0R2UZ DRUGINKE AEVBPXDFDKBGLT-YOUFYPILSA-N D0R2UZ DRUGSMIL CCOP(=O)(CC1=CC=C(C=C1)NC(=O)CNC(=O)C2C(C(C(O2)N3C=CC(=O)NC3=O)O)O)OCC D0R2UZ HIGHSTAT Investigative D0R2VH DRUG__ID D0R2VH D0R2VH DRUGTYPE Small molecular drug D0R2VH DRUGINCH 1S/C21H41O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)28-20(18-22)19-27-29(24,25)26/h9-10,20,22H,2-8,11-19H2,1H3,(H2,24,25,26)/b10-9- D0R2VH DRUGINKE ZOOLJLSXNRZLDH-KTKRTIGZSA-N D0R2VH DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OC(CO)COP(=O)(O)O D0R2VH HIGHSTAT Investigative D0R2VL DRUG__ID D0R2VL D0R2VL DRUGTYPE Small molecular drug D0R2VL DRUGINCH 1S/C21H19N3O2/c22-21(25)16-7-9-20(23-11-16)26-19-8-6-17-13-24(14-18(17)10-19)12-15-4-2-1-3-5-15/h1-11H,12-14H2,(H2,22,25) D0R2VL DRUGINKE GGVSFVBTUMOASO-UHFFFAOYSA-N D0R2VL DRUGSMIL C1C2=C(CN1CC3=CC=CC=C3)C=C(C=C2)OC4=NC=C(C=C4)C(=O)N D0R2VL HIGHSTAT Investigative D0R2WK DRUG__ID D0R2WK D0R2WK DRUGTYPE Small molecular drug D0R2WK DRUGINCH 1S/C30H40ClN7O3S/c1-21(2)42(39,40)28-8-6-5-7-26(28)33-29-24(31)20-32-30(35-29)34-25-10-9-23(19-27(25)41-4)37-13-11-22(12-14-37)38-17-15-36(3)16-18-38/h5-10,19-22H,11-18H2,1-4H3,(H2,32,33,34,35) D0R2WK DRUGINKE QQWUGDVOUVUTOY-UHFFFAOYSA-N D0R2WK DRUGSMIL CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC D0R2WK HIGHSTAT Investigative D0R2XE DRUG__ID D0R2XE D0R2XE DRUGTYPE Small molecular drug D0R2XE DRUGINCH 1S/C19H32O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17-22-18-15-16-19(20)21/h9-10,12-14,17H,2-8,11,15-16,18H2,1H3,(H,20,21)/b10-9-,13-12-,17-14+ D0R2XE DRUGINKE YRBDHTFMZHCRCL-MPAZIYIRSA-N D0R2XE DRUGSMIL CCCCCCCCC=CCC=CC=CSCCCC(=O)O D0R2XE HIGHSTAT Investigative D0R2YM DRUG__ID D0R2YM D0R2YM DRUGTYPE Small molecular drug D0R2YM DRUGINCH 1S/C10H12BrN5/c11-8-7-14-9(10-13-3-6-16(8)10)15-4-1-12-2-5-15/h3,6-7,12H,1-2,4-5H2 D0R2YM DRUGINKE SOIWQJOBNCOQPP-UHFFFAOYSA-N D0R2YM DRUGSMIL C1CN(CCN1)C2=NC=C(N3C2=NC=C3)Br D0R2YM HIGHSTAT Investigative D0R2YN DRUG__ID D0R2YN D0R2YN DRUGTYPE Small molecular drug D0R2YN DRUGINCH 1S/C18H20O3S/c1-4-15(16(5-2)17-10-11-18(20)22-17)13-6-8-14(9-7-13)21-12(3)19/h6-11,15H,4-5H2,1-3H3/b17-16- D0R2YN DRUGINKE CYZIBHGLFHMMJY-MSUUIHNZSA-N D0R2YN DRUGSMIL CCC(C1=CC=C(C=C1)OC(=O)C)C(=C2C=CC(=O)S2)CC D0R2YN HIGHSTAT Investigative D0R2ZN DRUG__ID D0R2ZN D0R2ZN DRUGTYPE Small molecular drug D0R2ZN DRUGINCH 1S/C20H14N2O4S2/c23-14-9-7-13(8-10-14)21-18-12-17(15-4-1-2-5-16(15)20(18)24)22-28(25,26)19-6-3-11-27-19/h1-12,21,23H D0R2ZN DRUGINKE YXKCWSSSTBYFQS-UHFFFAOYSA-N D0R2ZN DRUGSMIL C1=CC=C2C(=C1)C(=NS(=O)(=O)C3=CC=CS3)C=C(C2=O)NC4=CC=C(C=C4)O D0R2ZN HIGHSTAT Investigative D0R3AA DRUG__ID D0R3AA D0R3AA DRUGTYPE Small molecular drug D0R3AA DRUGINCH 1S/C17H31F3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(21)17(18,19)20/h2-15H2,1H3 D0R3AA DRUGINKE MAHYXYTYTLCTQD-UHFFFAOYSA-N D0R3AA DRUGSMIL CCCCCCCCCCCCCCCC(=O)C(F)(F)F D0R3AA HIGHSTAT Investigative D0R3CY DRUG__ID D0R3CY D0R3CY DRUGTYPE Small molecular drug D0R3CY DRUGINCH 1S/C25H26N2O3/c28-25(29)17-21-14-18-9-10-22(16-20(18)15-19-6-1-2-7-23(19)21)30-13-5-12-27-24-8-3-4-11-26-24/h1-4,6-11,16,21H,5,12-15,17H2,(H,26,27)(H,28,29)/t21-/m0/s1 D0R3CY DRUGINKE HODBWQCCKYDYPY-NRFANRHFSA-N D0R3CY DRUGSMIL C1C(C2=CC=CC=C2CC3=C1C=CC(=C3)OCCCNC4=CC=CC=N4)CC(=O)O D0R3CY HIGHSTAT Investigative D0R3DP DRUG__ID D0R3DP D0R3DP DRUGTYPE Small molecular drug D0R3DP DRUGINCH 1S/C16H31N3O2/c1-4-5-6-7-10-18-15(20)13-9-8-11-19(13)16(21)14(17)12(2)3/h12-14H,4-11,17H2,1-3H3,(H,18,20)/t13-,14-/m0/s1 D0R3DP DRUGINKE BWJSLNXXZBEGLH-KBPBESRZSA-N D0R3DP DRUGSMIL CCCCCCNC(=O)C1CCCN1C(=O)C(C(C)C)N D0R3DP HIGHSTAT Investigative D0R3FS DRUG__ID D0R3FS D0R3FS DRUGTYPE Small molecular drug D0R3FS DRUGINCH 1S/C9H5N3O2/c13-9-12-7-4-2-1-3-6(7)10-5-8(12)11-14-9/h1-5H D0R3FS DRUGINKE LZMHWZHOZLVYDL-UHFFFAOYSA-N D0R3FS DRUGSMIL C1=CC=C2C(=C1)N=CC3=NOC(=O)N23 D0R3FS HIGHSTAT Investigative D0R3GD DRUG__ID D0R3GD D0R3GD DRUGTYPE Small molecular drug D0R3GD DRUGINCH 1S/C41H46N6O5/c1-26-20-31(48)21-27(2)32(26)23-33(42)40(50)47-24-30-15-7-6-14-29(30)22-37(47)39(49)46-36(38-44-34-16-8-9-17-35(34)45-38)18-10-11-19-43-41(51)52-25-28-12-4-3-5-13-28/h3-9,12-17,20-21,33,36-37,48H,10-11,18-19,22-25,42H2,1-2H3,(H,43,51)(H,44,45)(H,46,49)/t33?,36-,37?/m1/s1 D0R3GD DRUGINKE ZHRKDWCBKIOLKI-QNUATKLTSA-N D0R3GD DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)OCC4=CC=CC=C4)C5=NC6=CC=CC=C6N5)N)C)O D0R3GD HIGHSTAT Investigative D0R3GN DRUG__ID D0R3GN D0R3GN DRUGTYPE Small molecular drug D0R3GN DRUGINCH 1S/C30H33NO/c1-3-5-11-20-31-22-25(21-29(31)27-18-10-8-15-24(27)13-6-4-2)30(32)28-19-12-16-23-14-7-9-17-26(23)28/h7-10,12,14-19,21-22H,3-6,11,13,20H2,1-2H3 D0R3GN DRUGINKE LDGBUSJKRUNXPK-UHFFFAOYSA-N D0R3GN DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2CCCC)C(=O)C3=CC=CC4=CC=CC=C43 D0R3GN HIGHSTAT Investigative D0R3GW DRUG__ID D0R3GW D0R3GW DRUGTYPE Small molecular drug D0R3GW DRUGINCH 1S/C26H29N3O3/c1-18-5-7-21-22(27-18)3-2-4-24(21)31-14-13-29-11-9-19(10-12-29)15-20-6-8-25-23(16-20)28-26(30)17-32-25/h2-8,16,19H,9-15,17H2,1H3,(H,28,30) D0R3GW DRUGINKE PJSUYRBCBFPCQW-UHFFFAOYSA-N D0R3GW DRUGSMIL CC1=NC2=C(C=C1)C(=CC=C2)OCCN3CCC(CC3)CC4=CC5=C(C=C4)OCC(=O)N5 D0R3GW HIGHSTAT Investigative D0R3HP DRUG__ID D0R3HP D0R3HP DRUGTYPE Small molecular drug D0R3HP DRUGINCH 1S/C14H10N4O2/c19-11-5-1-3-9(7-11)13-15-17-14(18-16-13)10-4-2-6-12(20)8-10/h1-8,19-20H D0R3HP DRUGINKE YDADTNARCJIMQM-UHFFFAOYSA-N D0R3HP DRUGSMIL C1=CC(=CC(=C1)O)C2=NN=C(N=N2)C3=CC(=CC=C3)O D0R3HP HIGHSTAT Investigative D0R3IN DRUG__ID D0R3IN D0R3IN DRUGTYPE Small molecular drug D0R3IN DRUGINCH 1S/C17H22BrN3O6S/c18-11-3-1-10(2-4-11)8-28-9-13(16(25)20-7-15(23)24)21-14(22)6-5-12(19)17(26)27/h1-4,12-13H,5-9,19H2,(H,20,25)(H,21,22)(H,23,24)(H,26,27)/t12-,13-/m0/s1 D0R3IN DRUGINKE HMNYAPVDRLKBJH-STQMWFEESA-N D0R3IN DRUGSMIL C1=CC(=CC=C1CSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)Br D0R3IN HIGHSTAT Investigative D0R3LP DRUG__ID D0R3LP D0R3LP DRUGTYPE Small molecular drug D0R3LP DRUGINCH 1S/C16H14O2/c1-11-6-8-12(9-7-11)16-10-14(17)13-4-2-3-5-15(13)18-16/h2-9,16H,10H2,1H3 D0R3LP DRUGINKE HITISLKGAFZTFZ-UHFFFAOYSA-N D0R3LP DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=CC=CC=C3O2 D0R3LP HIGHSTAT Investigative D0R3MB DRUG__ID D0R3MB D0R3MB DRUGTYPE Small molecular drug D0R3MB DRUGINCH 1S/C12H8N2O4S/c15-10-5-6-11(14-13-10)19(16,17)12-7-8-3-1-2-4-9(8)18-12/h1-7H,(H,13,15) D0R3MB DRUGINKE RBZSSTPBYFHRSR-UHFFFAOYSA-N D0R3MB DRUGSMIL C1=CC=C2C(=C1)C=C(O2)S(=O)(=O)C3=NNC(=O)C=C3 D0R3MB HIGHSTAT Investigative D0R3MO DRUG__ID D0R3MO D0R3MO DRUGTYPE Small molecular drug D0R3MO DRUGINCH 1S/C27H33N5O3/c1-32-9-7-18(8-10-32)17-35-26-13-19(22-15-29-30-16-22)4-6-24(26)31-27(33)25-12-21-11-23(34-2)5-3-20(21)14-28-25/h3-6,11,13,15-16,18,25,28H,7-10,12,14,17H2,1-2H3,(H,29,30)(H,31,33)/t25-/m1/s1 D0R3MO DRUGINKE GFWDPXHTWJXOEI-RUZDIDTESA-N D0R3MO DRUGSMIL CN1CCC(CC1)COC2=C(C=CC(=C2)C3=CNN=C3)NC(=O)C4CC5=C(CN4)C=CC(=C5)OC D0R3MO HIGHSTAT Investigative D0R3PD DRUG__ID D0R3PD D0R3PD DRUGTYPE Small molecular drug D0R3PD DRUGINCH 1S/C30H50O4/c1-18(9-12-24(32)27(4,5)34)19-13-15-30(8)21-10-11-23-26(2,3)25(33)22(31)17-28(23,6)20(21)14-16-29(19,30)7/h18-19,22-24,31-32,34H,9-17H2,1-8H3/t18-,19-,22-,23+,24?,28-,29-,30+/m1/s1 D0R3PD DRUGINKE TZXHHXSEUPQHDR-ITLZUSRVSA-N D0R3PD DRUGSMIL CC(CCC(C(C)(C)O)O)C1CCC2(C1(CCC3=C2CCC4C3(CC(C(=O)C4(C)C)O)C)C)C D0R3PD HIGHSTAT Investigative D0R3TA DRUG__ID D0R3TA D0R3TA DRUGTYPE Small molecular drug D0R3TA DRUGINCH 1S/C18H20FNO/c19-16-7-5-14(6-8-16)13-21-18-4-2-1-3-17(18)15-9-11-20-12-10-15/h1-8,15,20H,9-13H2 D0R3TA DRUGINKE QJRQNVRAJVCSDH-UHFFFAOYSA-N D0R3TA DRUGSMIL C1CNCCC1C2=CC=CC=C2OCC3=CC=C(C=C3)F D0R3TA HIGHSTAT Investigative D0R3TU DRUG__ID D0R3TU D0R3TU DRUGTYPE Small molecular drug D0R3TU DRUGINCH 1S/C28H42N4O6/c33-23-9-5-21(19-25(23)35)7-11-27(37)31-17-3-15-29-13-1-2-14-30-16-4-18-32-28(38)12-8-22-6-10-24(34)26(36)20-22/h5-6,9-10,19-20,29-30,33-36H,1-4,7-8,11-18H2,(H,31,37)(H,32,38) D0R3TU DRUGINKE IOLDDENZPBFBHV-UHFFFAOYSA-N D0R3TU DRUGSMIL C1=CC(=C(C=C1CCC(=O)NCCCNCCCCNCCCNC(=O)CCC2=CC(=C(C=C2)O)O)O)O D0R3TU HIGHSTAT Investigative D0R3VQ DRUG__ID D0R3VQ D0R3VQ DRUGCOMP Basilea Pharmaceutica International Ltd D0R3VQ DRUGINCH 1S/C20H17N7O2/c21-10-3-11-23-19-18(25-29-26-19)20-24-15-4-1-2-5-16(15)27(20)12-17(28)13-6-8-14(22)9-7-13/h1-2,4-9H,3,11-12,22H2,(H,23,26) D0R3VQ DRUGINKE LSFOZQQVTWFMNS-UHFFFAOYSA-N D0R3VQ DRUGSMIL C1=CC=C2C(=C1)N=C(N2CC(=O)C3=CC=C(C=C3)N)C4=NON=C4NCCC#N D0R3VQ HIGHSTAT Investigative D0R3XC DRUG__ID D0R3XC D0R3XC DRUGTYPE Small molecular drug D0R3XC DRUGINCH 1S/C24H36N6/c1(7-13-27-15-19-29(20-16-27)23-9-3-5-11-25-23)2-8-14-28-17-21-30(22-18-28)24-10-4-6-12-26-24/h3-6,9-12H,1-2,7-8,13-22H2 D0R3XC DRUGINKE OSEVIYJKDQCRJK-UHFFFAOYSA-N D0R3XC DRUGSMIL C1CN(CCN1CCCCCCN2CCN(CC2)C3=CC=CC=N3)C4=CC=CC=N4 D0R3XC HIGHSTAT Investigative D0R3XO DRUG__ID D0R3XO D0R3XO DRUGTYPE Small molecular drug D0R3XO DRUGINCH 1S/C24H35N5O4S2/c1-16-22(32)29-14-9-11-18(29)21(31)27-17(20(30)28-24(2,3)23(33)26-16)10-5-4-8-15-34-35-19-12-6-7-13-25-19/h6-7,12-13,16-18H,4-5,8-11,14-15H2,1-3H3,(H,26,33)(H,27,31)(H,28,30)/t16-,17-,18+/m0/s1 D0R3XO DRUGINKE SNOZDSAKXKVXTD-OKZBNKHCSA-N D0R3XO DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)(C)C)CCCCCSSC3=CC=CC=N3 D0R3XO HIGHSTAT Investigative D0R4AV DRUG__ID D0R4AV D0R4AV DRUGTYPE Small molecular drug D0R4AV DRUGINCH 1S/C21H33BN4O5/c1-15(27)24-17(14-16-8-3-2-4-9-16)21(29)26-13-7-10-18(26)20(28)25-19(22(30)31)11-5-6-12-23/h2-4,8-9,17-19,30-31H,5-7,10-14,23H2,1H3,(H,24,27)(H,25,28)/t17-,18+,19+/m1/s1 D0R4AV DRUGINKE UCQIHCRMWNRFNP-QYZOEREBSA-N D0R4AV DRUGSMIL B(C(CCCCN)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)C)(O)O D0R4AV HIGHSTAT Investigative D0R4BT DRUG__ID D0R4BT D0R4BT DRUGTYPE Small molecular drug D0R4BT DRUGINCH 1S/C19H21BrN2O3/c1-19(2)24-12-16(17(25-19)13-8-4-3-5-9-13)22-18(23)21-15-11-7-6-10-14(15)20/h3-11,16-17H,12H2,1-2H3,(H2,21,22,23)/t16-,17-/m0/s1 D0R4BT DRUGINKE ZVELNGXIEZFZIB-IRXDYDNUSA-N D0R4BT DRUGSMIL CC1(OCC(C(O1)C2=CC=CC=C2)NC(=O)NC3=CC=CC=C3Br)C D0R4BT HIGHSTAT Investigative D0R4DK DRUG__ID D0R4DK D0R4DK DRUGTYPE Small molecular drug D0R4DK DRUGINCH 1S/C11H11N3OS/c1-9(15)8-16-11-7-12-13-14(11)10-5-3-2-4-6-10/h2-7H,8H2,1H3 D0R4DK DRUGINKE ZEWXXPJFFAXSFB-UHFFFAOYSA-N D0R4DK DRUGSMIL CC(=O)CSC1=CN=NN1C2=CC=CC=C2 D0R4DK HIGHSTAT Investigative D0R4ER DRUG__ID D0R4ER D0R4ER DRUGTYPE Small molecular drug D0R4ER DRUGINCH 1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m1/s1 D0R4ER DRUGINKE KDXKERNSBIXSRK-RXMQYKEDSA-N D0R4ER DRUGSMIL C(CCN)CC(C(=O)O)N D0R4ER HIGHSTAT Investigative D0R4EY DRUG__ID D0R4EY D0R4EY DRUGTYPE Small molecular drug D0R4EY DRUGINCH 1S/C18H12Cl2N2O/c19-13-9-7-12(8-10-13)14-4-1-2-6-16(14)22-18(23)15-5-3-11-21-17(15)20/h1-11H,(H,22,23) D0R4EY DRUGINKE WYEMLYFITZORAB-UHFFFAOYSA-N D0R4EY DRUGSMIL C1=CC=C(C(=C1)C2=CC=C(C=C2)Cl)NC(=O)C3=C(N=CC=C3)Cl D0R4EY HIGHSTAT Investigative D0R4FM DRUG__ID D0R4FM D0R4FM DRUGTYPE Small molecular drug D0R4FM DRUGINCH 1S/C15H12O6/c16-8-3-1-7(2-4-8)15-14(20)13(19)12-10(18)5-9(17)6-11(12)21-15/h1-6,14-18,20H/t14-,15+/m0/s1 D0R4FM DRUGINKE PADQINQHPQKXNL-LSDHHAIUSA-N D0R4FM DRUGSMIL C1=CC(=CC=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O D0R4FM HIGHSTAT Investigative D0R4GD DRUG__ID D0R4GD D0R4GD DRUGTYPE Small molecular drug D0R4GD DRUGINCH 1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13- D0R4GD DRUGINKE FPIPGXGPPPQFEQ-HWCYFHEPSA-N D0R4GD DRUGSMIL CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C D0R4GD HIGHSTAT Investigative D0R4GI DRUG__ID D0R4GI D0R4GI DRUGTYPE Small molecular drug D0R4GI DRUGINCH 1S/C45H57N9O10/c1-4-5-15-37(44(63)53-35(23-39(57)58)43(62)52-34(40(47)59)21-27-11-7-6-8-12-27)54(3)45(64)36(22-29-24-48-33-14-10-9-13-31(29)33)51-38(56)25-49-41(60)26(2)50-42(61)32(46)20-28-16-18-30(55)19-17-28/h6-14,16-19,24,26,32,34-37,48,55H,4-5,15,20-23,25,46H2,1-3H3,(H2,47,59)(H,49,60)(H,50,61)(H,51,56)(H,52,62)(H,53,63)(H,57,58)/t26-,32+,34+,35+,36+,37+/m1/s1 D0R4GI DRUGINKE LFIFGNCFEBAIHA-XSAWFYHVSA-N D0R4GI DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N D0R4GI HIGHSTAT Investigative D0R4GX DRUG__ID D0R4GX D0R4GX DRUGTYPE Small molecular drug D0R4GX DRUGINCH 1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m1/s1 D0R4GX DRUGINKE WHBMMWSBFZVSSR-GSVOUGTGSA-N D0R4GX DRUGSMIL CC(CC(=O)O)O D0R4GX HIGHSTAT Investigative D0R4JZ DRUG__ID D0R4JZ D0R4JZ DRUGTYPE Small molecular drug D0R4JZ DRUGINCH 1S/C11H23NO3/c1-2-3-4-5-6-8-10(14)11(15)9(13)7-12-8/h8-15H,2-7H2,1H3/t8-,9-,10+,11+/m1/s1 D0R4JZ DRUGINKE JVCIUBNETYXXOR-ZNSHCXBVSA-N D0R4JZ DRUGSMIL CCCCCCC1C(C(C(CN1)O)O)O D0R4JZ HIGHSTAT Investigative D0R4KE DRUG__ID D0R4KE D0R4KE DRUGTYPE Small molecular drug D0R4KE DRUGINCH 1S/C17H12FNO4S/c18-12-6-8-13(9-7-12)24(22,23)19-15-10-5-11-3-1-2-4-14(11)16(15)17(20)21/h1-10,19H,(H,20,21) D0R4KE DRUGINKE KIYWIXCUCALPGQ-UHFFFAOYSA-N D0R4KE DRUGSMIL C1=CC=C2C(=C1)C=CC(=C2C(=O)O)NS(=O)(=O)C3=CC=C(C=C3)F D0R4KE HIGHSTAT Investigative D0R4KJ DRUG__ID D0R4KJ D0R4KJ DRUGTYPE Small molecular drug D0R4KJ DRUGINCH 1S/C40H50N4O6/c1-24-18-31(45)19-25(2)32(24)22-33(41)39(48)44-23-30-17-11-10-16-29(30)21-35(44)37(46)43-36(26(3)28-14-8-5-9-15-28)38(47)42-34(40(49)50)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,45H,5,8-9,14-15,20-23,41H2,1-3H3,(H,42,47)(H,43,46)(H,49,50)/t26-,33+,34+,35?,36+/m1/s1 D0R4KJ DRUGINKE GWHRSTGESQKJIQ-IAEIRYAQSA-N D0R4KJ DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)N)C)O D0R4KJ HIGHSTAT Investigative D0R4KQ DRUG__ID D0R4KQ D0R4KQ DRUGTYPE Small molecular drug D0R4KQ DRUGINCH 1S/C9H12N4O2S/c1-7-2-5-12-13(7)8-3-4-11-6-9(8)16(10,14)15/h3-7H,2H2,1H3,(H2,10,14,15) D0R4KQ DRUGINKE LMKCKKHGIIIBOX-UHFFFAOYSA-N D0R4KQ DRUGSMIL CC1CC=NN1C2=C(C=NC=C2)S(=O)(=O)N D0R4KQ HIGHSTAT Investigative D0R4LZ DRUG__ID D0R4LZ D0R4LZ DRUGTYPE Small molecular drug D0R4LZ DRUGINCH 1S/C18H14N4O/c1-23-14-9-7-13(8-10-14)17-21-15(12-5-3-2-4-6-12)16-18(22-17)20-11-19-16/h2-11H,1H3,(H,19,20,21,22) D0R4LZ DRUGINKE COPIEKYOHOQDKK-UHFFFAOYSA-N D0R4LZ DRUGSMIL COC1=CC=C(C=C1)C2=NC(=C3C(=N2)N=CN3)C4=CC=CC=C4 D0R4LZ HIGHSTAT Investigative D0R4MH DRUG__ID D0R4MH D0R4MH DRUGTYPE Small molecular drug D0R4MH DRUGINCH 1S/C25H23N5O2/c26-25(27-19-9-2-1-3-10-19)30-15-13-29(14-16-30)17-22-24(31)32-23(28-22)21-12-6-8-18-7-4-5-11-20(18)21/h1-12,17H,13-16H2,(H2,26,27)/b22-17+ D0R4MH DRUGINKE ADANDPMLNDAKNZ-OQKWZONESA-N D0R4MH DRUGSMIL C1CN(CCN1C=C2C(=O)OC(=N2)C3=CC=CC4=CC=CC=C43)C(=NC5=CC=CC=C5)N D0R4MH HIGHSTAT Investigative D0R4PI DRUG__ID D0R4PI D0R4PI DRUGTYPE Small molecular drug D0R4PI DRUGINCH 1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-4 D0R4PI DRUGINKE XPPKVPWEQAFLFU-UHFFFAOYSA-J D0R4PI DRUGSMIL [O-]P(=O)([O-])OP(=O)([O-])[O-] D0R4PI HIGHSTAT Investigative D0R4PR DRUG__ID D0R4PR D0R4PR DRUGTYPE Small molecular drug D0R4PR DRUGINCH 1S/C15H15NO6/c1-8(17)7-21-12-5-4-10-6-11(16-9(2)18)15(19)22-13(10)14(12)20-3/h4-6H,7H2,1-3H3,(H,16,18) D0R4PR DRUGINKE BPSQKFACFYVPBO-UHFFFAOYSA-N D0R4PR DRUGSMIL CC(=O)COC1=C(C2=C(C=C1)C=C(C(=O)O2)NC(=O)C)OC D0R4PR HIGHSTAT Investigative D0R4PS DRUG__ID D0R4PS D0R4PS DRUGTYPE Small molecular drug D0R4PS DRUGINCH 1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1 D0R4PS DRUGINKE VVIAGPKUTFNRDU-ABLWVSNPSA-N D0R4PS DRUGSMIL C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0R4PS HIGHSTAT Investigative D0R4QF DRUG__ID D0R4QF D0R4QF DRUGTYPE Small molecular drug D0R4QF DRUGINCH 1S/C28H30O8/c1-27-11-9-18-26(32)36-21(17-10-12-34-15-17)14-28(18,2)23(27)22(29)20(13-19(27)25(31)33-3)35-24(30)16-7-5-4-6-8-16/h4-8,10,12,15,18-21,23H,9,11,13-14H2,1-3H3/t18-,19-,20-,21-,23-,27-,28-/m0/s1 D0R4QF DRUGINKE PYDQMXRFUVDCHC-XAGHGKQISA-N D0R4QF DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)OC(=O)C4=CC=CC=C4)C)C5=COC=C5 D0R4QF HIGHSTAT Investigative D0R4RN DRUG__ID D0R4RN D0R4RN DRUGTYPE Small molecular drug D0R4RN DRUGINCH 1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2 D0R4RN DRUGINKE NLPRAJRHRHZCQQ-UHFFFAOYSA-N D0R4RN DRUGSMIL C1CC2C(CC1N2)C3=CN=C(C=C3)Cl D0R4RN HIGHSTAT Investigative D0R4TA DRUG__ID D0R4TA D0R4TA DRUGTYPE Small molecular drug D0R4TA DRUGINCH 1S/C31H38O8S/c1-17-10-8-9-13-21(32)12-7-5-4-6-11-20-14-18(2)19(3)15-31(20)28(35)24(30(38)39-31)25(33)22-16-40-27(23(17)22)26(34)29(36)37/h4-9,14,17,19-23,27,32,35H,10-13,15-16H2,1-3H3,(H,36,37)/b6-4+,7-5+,9-8+ D0R4TA DRUGINKE WWHAZVYADWRKPA-SFYXYOTASA-N D0R4TA DRUGSMIL CC1CC=CCC(CC=CC=CCC2C=C(C(CC23C(=C(C(=O)C4C1C(SC4)C(=O)C(=O)O)C(=O)O3)O)C)C)O D0R4TA HIGHSTAT Investigative D0R4TI DRUG__ID D0R4TI D0R4TI DRUGTYPE Small molecular drug D0R4TI DRUGINCH 1S/C14H17NS/c1-10(15)7-11-3-4-13-9-14(16-2)6-5-12(13)8-11/h3-6,8-10H,7,15H2,1-2H3 D0R4TI DRUGINKE YTLQCSVRMANEOQ-UHFFFAOYSA-N D0R4TI DRUGSMIL CC(CC1=CC2=C(C=C1)C=C(C=C2)SC)N D0R4TI HIGHSTAT Investigative D0R4WJ DRUG__ID D0R4WJ D0R4WJ DRUGTYPE Small molecular drug D0R4WJ DRUGINCH 1S/C76H52O46/c77-32-1-22(2-33(78)53(32)92)67(103)113-47-16-27(11-42(87)58(47)97)66(102)112-21-52-63(119-72(108)28-12-43(88)59(98)48(17-28)114-68(104)23-3-34(79)54(93)35(80)4-23)64(120-73(109)29-13-44(89)60(99)49(18-29)115-69(105)24-5-36(81)55(94)37(82)6-24)65(121-74(110)30-14-45(90)61(100)50(19-30)116-70(106)25-7-38(83)56(95)39(84)8-25)76(118-52)122-75(111)31-15-46(91)62(101)51(20-31)117-71(107)26-9-40(85)57(96)41(86)10-26/h1-20,52,63-65,76-101H,21H2/t52-,63-,64+,65-,76+/m1/s1 D0R4WJ DRUGINKE LRBQNJMCXXYXIU-PPKXGCFTSA-N D0R4WJ DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OCC3C(C(C(C(O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O D0R4WJ HIGHSTAT Investigative D0R4WW DRUG__ID D0R4WW D0R4WW DRUGTYPE Small molecular drug D0R4WW DRUGINCH 1S/C21H15NO/c23-21-18-9-5-4-8-17(18)20(16-6-2-1-3-7-16)19(21)14-15-10-12-22-13-11-15/h1-14,20H/b19-14- D0R4WW DRUGINKE ALLOQIRZHVQYIA-RGEXLXHISA-N D0R4WW DRUGSMIL C1=CC=C(C=C1)C2C3=CC=CC=C3C(=O)C2=CC4=CC=NC=C4 D0R4WW HIGHSTAT Investigative D0R4YD DRUG__ID D0R4YD D0R4YD DRUGTYPE Small molecular drug D0R4YD DRUGINCH 1S/C40H50N4O6/c1-24-18-31(45)19-25(2)32(24)22-33(41)39(48)44-23-30-17-11-10-16-29(30)21-35(44)37(46)43-36(26(3)28-14-8-5-9-15-28)38(47)42-34(40(49)50)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,45H,5,8-9,14-15,20-23,41H2,1-3H3,(H,42,47)(H,43,46)(H,49,50)/t26-,33-,34-,35?,36+/m0/s1 D0R4YD DRUGINKE GWHRSTGESQKJIQ-FVTMYMNWSA-N D0R4YD DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)N)C)O D0R4YD HIGHSTAT Investigative D0R5AD DRUG__ID D0R5AD D0R5AD DRUGTYPE Small molecular drug D0R5AD DRUGINCH 1S/C13H18ClNO/c1-4-15(5-2)10(3)13(16)11-7-6-8-12(14)9-11/h6-10H,4-5H2,1-3H3 D0R5AD DRUGINKE TZRAZPTWNAPWGU-UHFFFAOYSA-N D0R5AD DRUGSMIL CCN(CC)C(C)C(=O)C1=CC(=CC=C1)Cl D0R5AD HIGHSTAT Investigative D0R5AJ DRUG__ID D0R5AJ D0R5AJ DRUGTYPE Small molecular drug D0R5AJ DRUGINCH 1S/C4H7/c1-2-4-3-1/h1H,2-4H2 D0R5AJ DRUGINKE ZAEBLFKQMDEPDM-UHFFFAOYSA-N D0R5AJ DRUGSMIL C1C[CH]C1 D0R5AJ HIGHSTAT Investigative D0R5EF DRUG__ID D0R5EF D0R5EF DRUGTYPE Small molecular drug D0R5EF DRUGINCH 1S/C16H16N4O/c1-2-4-15(21)18-16-13-7-6-11(9-14(13)19-20-16)12-5-3-8-17-10-12/h3,5-10H,2,4H2,1H3,(H2,18,19,20,21) D0R5EF DRUGINKE CZTAWAQITKVBNQ-UHFFFAOYSA-N D0R5EF DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CN=CC=C3 D0R5EF HIGHSTAT Investigative D0R5EW DRUG__ID D0R5EW D0R5EW DRUGTYPE Small molecular drug D0R5EW DRUGINCH 1S/C12H16ClN3O2/c13-11-10(2-1-3-14-11)12(17)15-4-5-16-6-8-18-9-7-16/h1-3H,4-9H2,(H,15,17) D0R5EW DRUGINKE DSNJJTFFMQNNPE-UHFFFAOYSA-N D0R5EW DRUGSMIL C1COCCN1CCNC(=O)C2=C(N=CC=C2)Cl D0R5EW HIGHSTAT Investigative D0R5FE DRUG__ID D0R5FE D0R5FE DRUGTYPE Small molecular drug D0R5FE DRUGINCH 1S/C9H9INO3P/c10-8-3-1-7(2-4-8)5-9(12)11-6-15(13)14/h1-4H,5-6H2,(H-,11,12,13,14)/p+1 D0R5FE DRUGINKE HVYODBROOQYJGM-UHFFFAOYSA-O D0R5FE DRUGSMIL C1=CC(=CC=C1CC(=O)NC[P+](=O)O)I D0R5FE HIGHSTAT Investigative D0R5FH DRUG__ID D0R5FH D0R5FH DRUGTYPE Small molecular drug D0R5FH DRUGINCH 1S/C9H7N5/c10-8-7-9(14-13-8)12-6-4-2-1-3-5(6)11-7/h1-4H,(H3,10,12,13,14) D0R5FH DRUGINKE DWHVZCLBMTZRQM-UHFFFAOYSA-N D0R5FH DRUGSMIL C1=CC2=NC3=C(NN=C3N=C2C=C1)N D0R5FH HIGHSTAT Investigative D0R5FO DRUG__ID D0R5FO D0R5FO DRUGTYPE Small molecular drug D0R5FO DRUGINCH 1S/C32H33N5O3S/c1-23-13-19-27(20-14-23)41(39,40)35-25-17-15-24(16-18-25)22-33-31(38)21-30-28-11-7-8-12-29(28)34-32(36(2)3)37(30)26-9-5-4-6-10-26/h4-20,30,35H,21-22H2,1-3H3,(H,33,38) D0R5FO DRUGINKE BUARRUHMMCHOQJ-UHFFFAOYSA-N D0R5FO DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CNC(=O)CC3C4=CC=CC=C4N=C(N3C5=CC=CC=C5)N(C)C D0R5FO HIGHSTAT Investigative D0R5HK DRUG__ID D0R5HK D0R5HK DRUGTYPE Small molecular drug D0R5HK DRUGINCH 1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1 D0R5HK DRUGINKE AEQFSUDEHCCHBT-UHFFFAOYSA-M D0R5HK DRUGSMIL CCCC(CCC)C(=O)[O-].[Na+] D0R5HK HIGHSTAT Investigative D0R5HV DRUG__ID D0R5HV D0R5HV DRUGTYPE Small molecular drug D0R5HV DRUGINCH 1S/C6H13NO4/c8-1-3-5(10)6(11)4(2-9)7-3/h3-11H,1-2H2/t3-,4-,5-,6-/m1/s1 D0R5HV DRUGINKE PFYHYHZGDNWFIF-KVTDHHQDSA-N D0R5HV DRUGSMIL C(C1C(C(C(N1)CO)O)O)O D0R5HV HIGHSTAT Investigative D0R5JD DRUG__ID D0R5JD D0R5JD DRUGTYPE Small molecular drug D0R5JD DRUGINCH 1S/C31H34N2O4/c1-22(34)32-16-14-26-8-3-6-24-10-12-28(20-30(24)26)36-18-5-19-37-29-13-11-25-7-4-9-27(31(25)21-29)15-17-33-23(2)35/h3-4,6-13,20-21H,5,14-19H2,1-2H3,(H,32,34)(H,33,35) D0R5JD DRUGINKE NSXBZYDTTKLTOH-UHFFFAOYSA-N D0R5JD DRUGSMIL CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OCCCOC3=CC4=C(C=CC=C4CCNC(=O)C)C=C3 D0R5JD HIGHSTAT Investigative D0R5KO DRUG__ID D0R5KO D0R5KO DRUGTYPE Small molecular drug D0R5KO DRUGINCH 1S/C38H49N11O5/c39-38(40)43-17-9-14-29-35(52)49-31(19-25-21-44-28-13-7-6-12-27(25)28)34(51)42-16-8-2-5-15-33(50)46-32(20-26-22-41-23-45-26)37(54)48-30(36(53)47-29)18-24-10-3-1-4-11-24/h1,3-4,6-7,10-13,21-23,29-32,44H,2,5,8-9,14-20H2,(H,41,45)(H,42,51)(H,46,50)(H,47,53)(H,48,54)(H,49,52)(H4,39,40,43)/t29-,30+,31-,32+/m0/s1 D0R5KO DRUGINKE NKDXCOMNRCSRHU-MLMSKLGMSA-N D0R5KO DRUGSMIL C1CCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC1)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5 D0R5KO HIGHSTAT Investigative D0R5KV DRUG__ID D0R5KV D0R5KV DRUGTYPE Small molecular drug D0R5KV DRUGINCH 1S/C25H24F2N6O5/c1-32-9-8-30-23(32)14-4-3-5-15(10-14)37-24-19(26)21(33(2)12-18(35)36)20(27)25(31-24)38-17-11-13(22(28)29)6-7-16(17)34/h3-7,10-11,34H,8-9,12H2,1-2H3,(H3,28,29)(H,35,36) D0R5KV DRUGINKE NPNSVNGQJGRSNR-UHFFFAOYSA-N D0R5KV DRUGSMIL CN1CCN=C1C2=CC(=CC=C2)OC3=NC(=C(C(=C3F)N(C)CC(=O)O)F)OC4=C(C=CC(=C4)C(=N)N)O D0R5KV HIGHSTAT Investigative D0R5MR DRUG__ID D0R5MR D0R5MR DRUGTYPE Small molecular drug D0R5MR DRUGINCH 1S/C20H18N4O2/c25-19(21-12-15-7-3-1-4-8-15)17-11-18(24-14-23-17)20(26)22-13-16-9-5-2-6-10-16/h1-11,14H,12-13H2,(H,21,25)(H,22,26) D0R5MR DRUGINKE WIUCYEOLRGUYEH-UHFFFAOYSA-N D0R5MR DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC(=NC=N2)C(=O)NCC3=CC=CC=C3 D0R5MR HIGHSTAT Investigative D0R5NA DRUG__ID D0R5NA D0R5NA DRUGTYPE Small molecular drug D0R5NA DRUGINCH 1S/C23H21N3O3/c1-29-20-11-9-17(10-12-20)14-21(26-22(27)19-7-3-2-4-8-19)23(28)25-16-18-6-5-13-24-15-18/h2-15H,16H2,1H3,(H,25,28)(H,26,27)/b21-14- D0R5NA DRUGINKE KKDANILRTKQMGA-STZFKDTASA-N D0R5NA DRUGSMIL COC1=CC=C(C=C1)C=C(C(=O)NCC2=CN=CC=C2)NC(=O)C3=CC=CC=C3 D0R5NA HIGHSTAT Investigative D0R5OE DRUG__ID D0R5OE D0R5OE DRUGTYPE Small molecular drug D0R5OE DRUGINCH 1S/C8H14N2OS/c11-8(7-2-1-3-9-7)10-4-5-12-6-10/h7,9H,1-6H2/t7-/m0/s1 D0R5OE DRUGINKE GTTPYCGIEGLJPF-ZETCQYMHSA-N D0R5OE DRUGSMIL C1CC(NC1)C(=O)N2CCSC2 D0R5OE HIGHSTAT Investigative D0R5OF DRUG__ID D0R5OF D0R5OF DRUGTYPE Small molecular drug D0R5OF DRUGINCH 1S/C21H27NO2/c1-17(2)20(22-13-15-24-16-14-22)21(23,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17,20,23H,13-16H2,1-2H3 D0R5OF DRUGINKE DKXSPARARMBTSS-UHFFFAOYSA-N D0R5OF DRUGSMIL CC(C)C(C(C1=CC=CC=C1)(C2=CC=CC=C2)O)N3CCOCC3 D0R5OF HIGHSTAT Investigative D0R5OU DRUG__ID D0R5OU D0R5OU DRUGTYPE Small molecular drug D0R5OU DRUGINCH 1S/C18H14N2O/c1-2-6-13(7-3-1)12-21-18-10-15-14-8-4-5-9-16(14)20-17(15)11-19-18/h1-11,20H,12H2 D0R5OU DRUGINKE ZROLETFFKMIVMZ-UHFFFAOYSA-N D0R5OU DRUGSMIL C1=CC=C(C=C1)COC2=NC=C3C(=C2)C4=CC=CC=C4N3 D0R5OU HIGHSTAT Investigative D0R5QF DRUG__ID D0R5QF D0R5QF DRUGTYPE Small molecular drug D0R5QF DRUGINCH 1S/C21H24FN7O5S/c1-12(2)18-26-21(34-27-18)13-6-8-28(9-7-13)20-17(29(30)31)19(23-11-24-20)25-16-5-4-14(10-15(16)22)35(3,32)33/h4-5,10-13H,6-9H2,1-3H3,(H,23,24,25) D0R5QF DRUGINKE DGBKNTVAKIFYNU-UHFFFAOYSA-N D0R5QF DRUGSMIL CC(C)C1=NOC(=N1)C2CCN(CC2)C3=NC=NC(=C3[N+](=O)[O-])NC4=C(C=C(C=C4)S(=O)(=O)C)F D0R5QF HIGHSTAT Investigative D0R5QM DRUG__ID D0R5QM D0R5QM DRUGTYPE Small molecular drug D0R5QM DRUGINCH 1S/C15H24N2O/c1-3-4-9-16-10-12-17(13-11-16)14-7-5-6-8-15(14)18-2/h5-8H,3-4,9-13H2,1-2H3 D0R5QM DRUGINKE DCFYVNHQUVKFKK-UHFFFAOYSA-N D0R5QM DRUGSMIL CCCCN1CCN(CC1)C2=CC=CC=C2OC D0R5QM HIGHSTAT Investigative D0R5RE DRUG__ID D0R5RE D0R5RE DRUGTYPE Small molecular drug D0R5RE DRUGINCH 1S/C7H15NO5/c9-1-3-6(12)7(13)5(8-3)4(11)2-10/h3-13H,1-2H2/t3-,4?,5-,6-,7-/m1/s1 D0R5RE DRUGINKE ZJRUOSSQTZGFJV-UHEPRFFZSA-N D0R5RE DRUGSMIL C(C1C(C(C(N1)C(CO)O)O)O)O D0R5RE HIGHSTAT Investigative D0R5RF DRUG__ID D0R5RF D0R5RF DRUGTYPE Small molecular drug D0R5RF DRUGINCH 1S/C17H18N4O3S/c22-15-11(7-25-9-4-2-1-3-5-9)21-13(16(15)23)10-6-18-14-12(10)19-8-20-17(14)24/h1-6,8,11,13,15-16,18,21-23H,7H2,(H,19,20,24)/t11-,13+,15-,16+/m1/s1 D0R5RF DRUGINKE RILVLBFFRDXSEY-JMGFVUJMSA-N D0R5RF DRUGSMIL C1=CC=C(C=C1)SCC2C(C(C(N2)C3=CNC4=C3N=CNC4=O)O)O D0R5RF HIGHSTAT Investigative D0R5RW DRUG__ID D0R5RW D0R5RW DRUGTYPE Small molecular drug D0R5RW DRUGINCH 1S/C18H19N3O4/c22-18(25-17-8-6-16(7-9-17)21(23)24)20-12-10-19(11-13-20)14-15-4-2-1-3-5-15/h1-9H,10-14H2 D0R5RW DRUGINKE HNIDATBYDXCKRE-UHFFFAOYSA-N D0R5RW DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-] D0R5RW HIGHSTAT Investigative D0R5TA DRUG__ID D0R5TA D0R5TA DRUGTYPE Small molecular drug D0R5TA DRUGINCH 1S/C34H38N6O5/c35-26(17-22-12-14-24(41)15-13-22)34(45)40-16-6-11-30(40)33(44)39-29(19-23-20-37-27-10-5-4-9-25(23)27)32(43)38-28(31(36)42)18-21-7-2-1-3-8-21/h1-5,7-10,12-15,20,26,28-30,37,41H,6,11,16-19,35H2,(H2,36,42)(H,38,43)(H,39,44)/t26-,28-,29-,30-/m0/s1 D0R5TA DRUGINKE ZEXLJFNSKAHNFH-SYKYGTKKSA-N D0R5TA DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CC=CC=C5)C(=O)N D0R5TA HIGHSTAT Investigative D0R5VG DRUG__ID D0R5VG D0R5VG DRUGTYPE Small molecular drug D0R5VG DRUGINCH 1S/C18H20N2O3/c21-17(9-5-4-8-14-6-2-1-3-7-14)19-16-12-10-15(11-13-16)18(22)20-23/h1-3,6-7,10-13,23H,4-5,8-9H2,(H,19,21)(H,20,22) D0R5VG DRUGINKE ZCTKPFZOLLIQQR-UHFFFAOYSA-N D0R5VG DRUGSMIL C1=CC=C(C=C1)CCCCC(=O)NC2=CC=C(C=C2)C(=O)NO D0R5VG HIGHSTAT Investigative D0R5VO DRUG__ID D0R5VO D0R5VO DRUGCOMP Qwell Pharmaceuticals Inc D0R5VO DRUGINCH 1S/C98H155NO46/c1-16-93(11,127)26-18-20-45(34-101)81(125)139-75-41(4)132-87(73(122)69(75)118)145-94(12,17-2)27-19-21-44(33-100)80(124)137-57-32-98(90(126)144-89-79(68(117)62(111)50(36-103)135-89)143-86-74(123)77(141-85-72(121)66(115)61(110)49(35-102)133-85)76(42(5)131-86)140-84-71(120)63(112)51(37-104)134-84)47(30-91(57,7)8)46-22-23-54-95(13)28-25-56(92(9,10)53(95)24-29-96(54,14)97(46,15)31-55(98)107)138-82-58(99-43(6)105)65(114)64(113)52(136-82)39-129-88-78(67(116)59(108)40(3)130-88)142-83-70(119)60(109)48(106)38-128-83/h16-17,20-22,40-42,47-79,82-89,100-104,106-123,127H,1-2,18-19,23-39H2,3-15H3,(H,99,105)/b44-21+,45-20+/t40-,41-,42+,47+,48-,49-,50-,51+,52-,53+,54-,55-,56+,57+,58-,59+,60+,61-,62-,63+,64-,65-,66+,67+,68+,69-,70-,71-,72-,73-,74-,75-,76+,77+,78-,79-,82+,83+,84+,85+,86+,87+,88-,89+,93+,94+,95+,96-,97-,98-/m1/s1 D0R5VO DRUGINKE HKEDBKXRDHFCFB-LUAQNYIXSA-N D0R5VO DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3CCC4(C(C3(C)C)CCC5(C4CC=C6C5(CC(C7(C6CC(C(C7)OC(=O)C(=CCCC(C)(C=C)OC8C(C(C(C(O8)C)OC(=O)C(=CCCC(C)(C=C)O)CO)O)O)CO)(C)C)C(=O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(C(O1)C)OC1C(C(C(O1)CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)C)C)NC(=O)C)O)O)OC1C(C(C(CO1)O)O)O)O)O D0R5VO HIGHSTAT Investigative D0R5WB DRUG__ID D0R5WB D0R5WB DRUGTYPE Small molecular drug D0R5WB DRUGINCH 1S/C21H24N2/c1-3-9-17(10-4-1)21-19(13-16-23-14-7-2-8-15-23)18-11-5-6-12-20(18)22-21/h1,3-6,9-12,22H,2,7-8,13-16H2 D0R5WB DRUGINKE FKIIRAHSARSGPF-UHFFFAOYSA-N D0R5WB DRUGSMIL C1CCN(CC1)CCC2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D0R5WB HIGHSTAT Investigative D0R5WV DRUG__ID D0R5WV D0R5WV DRUGTYPE Small molecular drug D0R5WV DRUGINCH 1S/C14H10N2O2S/c17-11-5-1-3-9(7-11)13-15-16-14(19-13)10-4-2-6-12(18)8-10/h1-8,17-18H D0R5WV DRUGINKE KZZBPNSRBQBVII-UHFFFAOYSA-N D0R5WV DRUGSMIL C1=CC(=CC(=C1)O)C2=NN=C(S2)C3=CC(=CC=C3)O D0R5WV HIGHSTAT Investigative D0R5WX DRUG__ID D0R5WX D0R5WX DRUGTYPE Small molecular drug D0R5WX DRUGINCH 1S/C22H27NO/c1-2-6-18(7-3-1)16-19-12-14-23(15-13-19)17-21-11-10-20-8-4-5-9-22(20)24-21/h1-9,19,21H,10-17H2 D0R5WX DRUGINKE XIEPNNMDKPLLAY-UHFFFAOYSA-N D0R5WX DRUGSMIL C1CC2=CC=CC=C2OC1CN3CCC(CC3)CC4=CC=CC=C4 D0R5WX HIGHSTAT Investigative D0R5ZH DRUG__ID D0R5ZH D0R5ZH DRUGTYPE Small molecular drug D0R5ZH DRUGINCH 1S/C10H13BrN5O7P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-6(18)5(17)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,17-18H,1H2,(H2,12,13,14)(H2,19,20,21)/t3-,5-,6-,9-/m1/s1 D0R5ZH DRUGINKE DNPIJKNXFSPNNY-UUOKFMHZSA-N D0R5ZH DRUGSMIL C1=NC(=C2C(=N1)N(C(=N2)Br)C3C(C(C(O3)COP(=O)(O)O)O)O)N D0R5ZH HIGHSTAT Investigative D0R5ZL DRUG__ID D0R5ZL D0R5ZL DRUGTYPE Small molecular drug D0R5ZL DRUGINCH 1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(22-2)6-7-14(13)23(16,20)21/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21) D0R5ZL DRUGINKE KRSITCLIUSFUOQ-UHFFFAOYSA-N D0R5ZL DRUGSMIL CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)OC)S(=O)(=O)N D0R5ZL HIGHSTAT Investigative D0R6CW DRUG__ID D0R6CW D0R6CW DRUGTYPE Small molecular drug D0R6CW DRUGINCH 1S/C15H21N3O2/c1-2-14(19)18-10-8-13(9-11-18)17-15(20)16-12-6-4-3-5-7-12/h3-7,13H,2,8-11H2,1H3,(H2,16,17,20) D0R6CW DRUGINKE XOEKGIBLQVJFBB-UHFFFAOYSA-N D0R6CW DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC2=CC=CC=C2 D0R6CW HIGHSTAT Investigative D0R6DA DRUG__ID D0R6DA D0R6DA DRUGTYPE Small molecular drug D0R6DA DRUGINCH 1S/C10H15NO5/c1-3-15-9(13)6-5-7(12)11-8(6)10(14)16-4-2/h6,8H,3-5H2,1-2H3,(H,11,12) D0R6DA DRUGINKE OUZUMLMSKXXOLI-UHFFFAOYSA-N D0R6DA DRUGSMIL CCOC(=O)C1CC(=O)NC1C(=O)OCC D0R6DA HIGHSTAT Investigative D0R6DT DRUG__ID D0R6DT D0R6DT DRUGTYPE Small molecular drug D0R6DT DRUGINCH 1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1 D0R6DT DRUGINKE WKRLQDKEXYKHJB-HFTRVMKXSA-N D0R6DT DRUGSMIL CC12CCC3C(=CCC4=C3C=CC(=C4)O)C1CCC2=O D0R6DT HIGHSTAT Investigative D0R6FJ DRUG__ID D0R6FJ D0R6FJ DRUGTYPE Small molecular drug D0R6FJ DRUGINCH 1S/C11H8N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-7,13H D0R6FJ DRUGINKE AIFRHYZBTHREPW-UHFFFAOYSA-N D0R6FJ DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=NC=C3 D0R6FJ HIGHSTAT Investigative D0R6GQ DRUG__ID D0R6GQ D0R6GQ DRUGTYPE Small molecular drug D0R6GQ DRUGINCH 1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13) D0R6GQ DRUGINKE ODBLHEXUDAPZAU-UHFFFAOYSA-N D0R6GQ DRUGSMIL C(C(C(C(=O)O)O)C(=O)O)C(=O)O D0R6GQ HIGHSTAT Investigative D0R6JE DRUG__ID D0R6JE D0R6JE DRUGTYPE Small molecular drug D0R6JE DRUGINCH 1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1 D0R6JE DRUGINKE BAWFJGJZGIEFAR-NNYOXOHSSA-N D0R6JE DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)([O-])OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N D0R6JE HIGHSTAT Investigative D0R6JG DRUG__ID D0R6JG D0R6JG DRUGTYPE Small molecular drug D0R6JG DRUGINCH 1S/C25H24N4O2/c1-29(2)15-16-7-6-10-19(13-16)27-23(17-8-4-3-5-9-17)22-20-12-11-18(24(26)30)14-21(20)28-25(22)31/h3-14,28,31H,15H2,1-2H3,(H2,26,30) D0R6JG DRUGINKE WGPXKFOFEXJMBD-UHFFFAOYSA-N D0R6JG DRUGSMIL CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N)O D0R6JG HIGHSTAT Investigative D0R6JK DRUG__ID D0R6JK D0R6JK DRUGTYPE Small molecular drug D0R6JK DRUGINCH 1S/C14H11NO3/c16-13-7-1-10(2-8-13)9-15-12-5-3-11(4-6-12)14(17)18/h1-9,16H,(H,17,18) D0R6JK DRUGINKE HRLVVRLMLAPCBI-UHFFFAOYSA-N D0R6JK DRUGSMIL C1=CC(=CC=C1C=NC2=CC=C(C=C2)C(=O)O)O D0R6JK HIGHSTAT Investigative D0R6KV DRUG__ID D0R6KV D0R6KV DRUGTYPE Small molecular drug D0R6KV DRUGINCH 1S/C25H30N2O7/c1-15(26-19(24(29)30)10-9-16-7-5-4-6-8-16)23(28)27-14-18-13-22(34-3)21(33-2)12-17(18)11-20(27)25(31)32/h4-8,12-13,15,19-20,26H,9-11,14H2,1-3H3,(H,29,30)(H,31,32)/t15-,19-,20-/m0/s1 D0R6KV DRUGINKE CMPAGYDKASJORH-YSSFQJQWSA-N D0R6KV DRUGSMIL CC(C(=O)N1CC2=CC(=C(C=C2CC1C(=O)O)OC)OC)NC(CCC3=CC=CC=C3)C(=O)O D0R6KV HIGHSTAT Investigative D0R6MB DRUG__ID D0R6MB D0R6MB DRUGTYPE Small molecular drug D0R6MB DRUGINCH 1S/C23H19Cl3N2O2/c1-23(2)11-18(21(27)29)17-10-16(12-3-5-13(24)6-4-12)20(28-22(17)30-23)15-8-7-14(25)9-19(15)26/h3-10,18H,11H2,1-2H3,(H2,27,29) D0R6MB DRUGINKE YYFWEVOTTPIJNN-UHFFFAOYSA-N D0R6MB DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C(=O)N)C D0R6MB HIGHSTAT Investigative D0R6MT DRUG__ID D0R6MT D0R6MT DRUGTYPE Small molecular drug D0R6MT DRUGINCH 1S/C10H14N4O2/c1-6(2)4-14-8-7(11-5-12-8)9(15)13(3)10(14)16/h5-6H,4H2,1-3H3,(H,11,12) D0R6MT DRUGINKE APIXJSLKIYYUKG-UHFFFAOYSA-N D0R6MT DRUGSMIL CC(C)CN1C2=C(C(=O)N(C1=O)C)NC=N2 D0R6MT HIGHSTAT Investigative D0R6NP DRUG__ID D0R6NP D0R6NP DRUGTYPE Small molecular drug D0R6NP DRUGINCH 1S/C23H18F3N5O2/c1-13-3-4-14(21(32)30-16-7-8-27-20(11-16)23(24,25)26)9-19(13)29-15-5-6-18-17(10-15)22(33)31(2)12-28-18/h3-12,29H,1-2H3,(H,27,30,32) D0R6NP DRUGINKE QOTCLGLPFWDADD-UHFFFAOYSA-N D0R6NP DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=CC(=NC=C2)C(F)(F)F)NC3=CC4=C(C=C3)N=CN(C4=O)C D0R6NP HIGHSTAT Investigative D0R6OM DRUG__ID D0R6OM D0R6OM DRUGCOMP Bayer AG D0R6OM DRUGINCH 1S/C27H26F5N7O3/c1-41-13-17-22(12-38-6-8-42-9-7-38)39-24(25(33)34-14-35-39)23(17)15-2-5-20(19(29)10-15)36-26(40)37-21-11-16(27(30,31)32)3-4-18(21)28/h2-5,10-11,14H,6-9,12-13H2,1H3,(H2,33,34,35)(H2,36,37,40) D0R6OM DRUGINKE GZPJCJKUZPUFAL-UHFFFAOYSA-N D0R6OM DRUGSMIL COCC1=C(N2C(=C1C3=CC(=C(C=C3)NC(=O)NC4=C(C=CC(=C4)C(F)(F)F)F)F)C(=NC=N2)N)CN5CCOCC5 D0R6OM HIGHSTAT Investigative D0R6PF DRUG__ID D0R6PF D0R6PF DRUGTYPE Small molecular drug D0R6PF DRUGINCH 1S/C21H24N8O2/c1-14(2)19-26-21(27-31-19)28-6-7-29(15(3)12-28)20-24-10-18(11-25-20)30-13-16-4-5-23-9-17(16)8-22/h4-5,9-11,14-15H,6-7,12-13H2,1-3H3/t15-/m0/s1 D0R6PF DRUGINKE UNGZTVLHLKAKQE-HNNXBMFYSA-N D0R6PF DRUGSMIL CC1CN(CCN1C2=NC=C(C=N2)OCC3=C(C=NC=C3)C#N)C4=NOC(=N4)C(C)C D0R6PF HIGHSTAT Investigative D0R6PX DRUG__ID D0R6PX D0R6PX DRUGTYPE Small molecular drug D0R6PX DRUGINCH 1S/C34H38N3O7P/c1-24-30(33(38)42-19-18-36(28-15-9-6-10-16-28)21-26-12-7-5-8-13-26)31(27-14-11-17-29(20-27)37(39)40)32(25(2)35-24)45(41)43-22-34(3,4)23-44-45/h5-17,20,31,35H,18-19,21-23H2,1-4H3/t31-/m1/s1 D0R6PX DRUGINKE NSVFSAJIGAJDMR-WJOKGBTCSA-N D0R6PX DRUGSMIL CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5 D0R6PX HIGHSTAT Investigative D0R6TL DRUG__ID D0R6TL D0R6TL DRUGTYPE Small molecular drug D0R6TL DRUGINCH 1S/C11H12ClN3O/c1-2-3-10(16)13-11-8-5-4-7(12)6-9(8)14-15-11/h4-6H,2-3H2,1H3,(H2,13,14,15,16) D0R6TL DRUGINKE VHQZZDZWVQELLJ-UHFFFAOYSA-N D0R6TL DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)Cl D0R6TL HIGHSTAT Investigative D0R6UA DRUG__ID D0R6UA D0R6UA DRUGTYPE Small molecular drug D0R6UA DRUGINCH 1S/C5H6N6O/c6-4-8-1-2(9-4)10-5(7)11-3(1)12/h(H6,6,7,8,9,10,11,12) D0R6UA DRUGINKE WYDKPTZGVLTYPG-UHFFFAOYSA-N D0R6UA DRUGSMIL C12=C(N=C(N1)N)N=C(NC2=O)N D0R6UA HIGHSTAT Investigative D0R6UI DRUG__ID D0R6UI D0R6UI DRUGTYPE Small molecular drug D0R6UI DRUGINCH 1S/C19H27IN2O4/c1-2-3-6-22-7-4-13(5-8-22)12-26-19(23)14-11-15(20)16(21)18-17(14)24-9-10-25-18/h11,13H,2-10,12,21H2,1H3/i20-4 D0R6UI DRUGINKE FCKKCDRMGKXQDK-BMILMZPDSA-N D0R6UI DRUGSMIL CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)N)I D0R6UI HIGHSTAT Investigative D0R6VF DRUG__ID D0R6VF D0R6VF DRUGTYPE Small molecular drug D0R6VF DRUGINCH 1S/C29H29ClN2O4/c30-20-7-3-17(4-8-20)5-10-24(35)31-29-12-11-22(34)27-28(29)13-14-32(16-18-1-2-18)23(29)15-19-6-9-21(33)26(36-27)25(19)28/h3-10,18,23,27,33H,1-2,11-16H2,(H,31,35)/b10-5+/t23-,27+,28+,29-/m1/s1 D0R6VF DRUGINKE RAURUSFBVQLAPW-DNIKMYEQSA-N D0R6VF DRUGSMIL C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)NC(=O)C=CC7=CC=C(C=C7)Cl D0R6VF HIGHSTAT Investigative D0R6VX DRUG__ID D0R6VX D0R6VX DRUGTYPE Small molecular drug D0R6VX DRUGINCH 1S/C34H38N6O5/c35-27(17-22-12-14-25(41)15-13-22)34(45)40-16-6-11-30(40)33(44)39-29(18-24-20-36-28-10-5-4-9-26(24)28)32(43)38-21-31(42)37-19-23-7-2-1-3-8-23/h1-5,7-10,12-15,20,27,29-30,36,41H,6,11,16-19,21,35H2,(H,37,42)(H,38,43)(H,39,44)/t27-,29-,30-/m0/s1 D0R6VX DRUGINKE BDVRZLFOEXKBFR-BKHJTQGXSA-N D0R6VX DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NCC5=CC=CC=C5 D0R6VX HIGHSTAT Investigative D0R6YB DRUG__ID D0R6YB D0R6YB DRUGTYPE Small molecular drug D0R6YB DRUGINCH 1S/C11H14N2/c1-2-8(7-12-5-1)10-6-9-3-4-11(10)13-9/h1-2,5,7,9-11,13H,3-4,6H2 D0R6YB DRUGINKE GYACOUGJSVTBRX-UHFFFAOYSA-N D0R6YB DRUGSMIL C1CC2C(CC1N2)C3=CN=CC=C3 D0R6YB HIGHSTAT Investigative D0R6ZC DRUG__ID D0R6ZC D0R6ZC DRUGTYPE Small molecular drug D0R6ZC DRUGINCH 1S/C18H22O2/c1-3-5-13-7-9-18(20)16(11-13)14-8-10-17(19)15(12-14)6-4-2/h7-12,19-20H,3-6H2,1-2H3 D0R6ZC DRUGINKE PJBHWFHBOPMXAM-UHFFFAOYSA-N D0R6ZC DRUGSMIL CCCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CCC D0R6ZC HIGHSTAT Investigative D0R6ZS DRUG__ID D0R6ZS D0R6ZS DRUGTYPE Small molecular drug D0R6ZS DRUGINCH 1S/C14H9BrClN3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19) D0R6ZS DRUGINKE NBEFPXHBLZGXNK-UHFFFAOYSA-N D0R6ZS DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)Cl D0R6ZS HIGHSTAT Investigative D0R7AG DRUG__ID D0R7AG D0R7AG DRUGTYPE Small molecular drug D0R7AG DRUGINCH 1S/C13H9NO4/c15-7-2-4-12-10(5-7)14-13(18-12)9-3-1-8(16)6-11(9)17/h1-6,15-17H D0R7AG DRUGINKE RGXSSCFRVTXICH-UHFFFAOYSA-N D0R7AG DRUGSMIL C1=CC(=C(C=C1O)O)C2=NC3=C(O2)C=CC(=C3)O D0R7AG HIGHSTAT Investigative D0R7BT DRUG__ID D0R7BT D0R7BT DRUGTYPE Small molecular drug D0R7BT DRUGINCH 1S/C9H9NS2/c10-6-7-3-4-9(12-7)8-2-1-5-11-8/h1-5H,6,10H2 D0R7BT DRUGINKE FHYTVXBZSXZMGD-UHFFFAOYSA-N D0R7BT DRUGSMIL C1=CSC(=C1)C2=CC=C(S2)CN D0R7BT HIGHSTAT Investigative D0R7BX DRUG__ID D0R7BX D0R7BX DRUGTYPE Small molecular drug D0R7BX DRUGINCH 1S/C9H8O4/c10-8(11)7(9(12)13)6-4-2-1-3-5-6/h1-5,7H,(H,10,11)(H,12,13) D0R7BX DRUGINKE WWYDYZMNFQIYPT-UHFFFAOYSA-N D0R7BX DRUGSMIL C1=CC=C(C=C1)C(C(=O)O)C(=O)O D0R7BX HIGHSTAT Investigative D0R7FI DRUG__ID D0R7FI D0R7FI DRUGTYPE Small molecular drug D0R7FI DRUGINCH 1S/C20H25NO/c1-17(16-18-8-4-2-5-9-18)21-14-12-20(22,13-15-21)19-10-6-3-7-11-19/h2-11,17,22H,12-16H2,1H3 D0R7FI DRUGINKE DBTIAPBSTRWDLH-UHFFFAOYSA-N D0R7FI DRUGSMIL CC(CC1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D0R7FI HIGHSTAT Investigative D0R7HM DRUG__ID D0R7HM D0R7HM DRUGTYPE Small molecular drug D0R7HM DRUGINCH 1S/C15H15NO3/c17-13-10-14(12-4-2-1-3-5-12)19-15(11-13)16-6-8-18-9-7-16/h1-5,10-11H,6-9H2 D0R7HM DRUGINKE QQHMBGBSWORRAG-UHFFFAOYSA-N D0R7HM DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC=C3 D0R7HM HIGHSTAT Investigative D0R7HU DRUG__ID D0R7HU D0R7HU DRUGTYPE Small molecular drug D0R7HU DRUGINCH 1S/C14H8N2O2/c17-13-8-5-6-10-11(12(8)14(18)16-13)7-3-1-2-4-9(7)15-10/h1-6,15H,(H,16,17,18) D0R7HU DRUGINKE AGFYXNWRDSDSRA-UHFFFAOYSA-N D0R7HU DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=CC4=C3C(=O)NC4=O D0R7HU HIGHSTAT Investigative D0R7IJ DRUG__ID D0R7IJ D0R7IJ DRUGTYPE Small molecular drug D0R7IJ DRUGINCH 1S/C10H7ClN2O3S/c11-7-2-1-3-8(6-7)17(15,16)10-5-4-9(14)12-13-10/h1-6H,(H,12,14) D0R7IJ DRUGINKE JORLLGPOJPMFRS-UHFFFAOYSA-N D0R7IJ DRUGSMIL C1=CC(=CC(=C1)Cl)S(=O)(=O)C2=NNC(=O)C=C2 D0R7IJ HIGHSTAT Investigative D0R7IM DRUG__ID D0R7IM D0R7IM DRUGTYPE Small molecular drug D0R7IM DRUGINCH 1S/C73H124N28O17/c1-42(91-57(106)40-90-70(118)59(44(3)103)101-68(116)53(35-45-19-6-4-7-20-45)93-58(107)39-89-56(105)38-88-55(104)37-84-36-46-21-8-5-9-22-46)61(109)95-50(26-16-32-85-71(78)79)65(113)98-49(25-12-15-31-76)67(115)100-54(41-102)69(117)92-43(2)62(110)96-51(27-17-33-86-72(80)81)66(114)97-48(24-11-14-30-75)64(112)99-52(28-18-34-87-73(82)83)63(111)94-47(60(77)108)23-10-13-29-74/h4-9,19-22,42-44,47-54,59,84,102-103H,10-18,23-41,74-76H2,1-3H3,(H2,77,108)(H,88,104)(H,89,105)(H,90,118)(H,91,106)(H,92,117)(H,93,107)(H,94,111)(H,95,109)(H,96,110)(H,97,114)(H,98,113)(H,99,112)(H,100,115)(H,101,116)(H4,78,79,85)(H4,80,81,86)(H4,82,83,87)/t42-,43-,44+,47-,48-,49-,50-,51-,52-,53-,54-,59-/m0/s1 D0R7IM DRUGINKE JEXLNFNIIVBCHM-OSMJMQRHSA-N D0R7IM DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)CNCC2=CC=CC=C2)O D0R7IM HIGHSTAT Investigative D0R7JA DRUG__ID D0R7JA D0R7JA DRUGTYPE Small molecular drug D0R7JA DRUGINCH 1S/C25H21F3N4O3S/c26-25(27,28)22-31-20(32-35-22)17-7-4-8-18(13-17)21(33)29-15-24(9-11-34-12-10-24)23-30-19(14-36-23)16-5-2-1-3-6-16/h1-8,13-14H,9-12,15H2,(H,29,33) D0R7JA DRUGINKE HORXBWNTEDOVKN-UHFFFAOYSA-N D0R7JA DRUGSMIL C1COCCC1(CNC(=O)C2=CC=CC(=C2)C3=NOC(=N3)C(F)(F)F)C4=NC(=CS4)C5=CC=CC=C5 D0R7JA HIGHSTAT Investigative D0R7LQ DRUG__ID D0R7LQ D0R7LQ DRUGTYPE Small molecular drug D0R7LQ DRUGINCH 1S/C20H25N5O6/c21-16-13(18(29)25-20(22)24-16)4-2-1-3-11-5-7-12(8-6-11)17(28)23-14(19(30)31)9-10-15(26)27/h5-8,14H,1-4,9-10H2,(H,23,28)(H,26,27)(H,30,31)(H5,21,22,24,25,29)/t14-/m0/s1 D0R7LQ DRUGINKE LNUHUIPUTGDPDG-AWEZNQCLSA-N D0R7LQ DRUGSMIL C1=CC(=CC=C1CCCCC2=C(N=C(NC2=O)N)N)C(=O)NC(CCC(=O)O)C(=O)O D0R7LQ HIGHSTAT Investigative D0R7LY DRUG__ID D0R7LY D0R7LY DRUGTYPE Small molecular drug D0R7LY DRUGINCH 1S/C28H33N5O7/c29-20(14-18-10-12-19(34)13-11-18)25(36)32-21-8-4-5-9-22(28(39)40)33-27(38)23(15-17-6-2-1-3-7-17)31-24(35)16-30-26(21)37/h1-7,10-13,20-23,34H,8-9,14-16,29H2,(H,30,37)(H,31,35)(H,32,36)(H,33,38)(H,39,40)/b5-4-/t20-,21+,22+,23-/m0/s1 D0R7LY DRUGINKE VNZCTJLIVONUDE-HOJIFOFPSA-N D0R7LY DRUGSMIL C1C=CCC(NC(=O)C(NC(=O)CNC(=O)C1NC(=O)C(CC2=CC=C(C=C2)O)N)CC3=CC=CC=C3)C(=O)O D0R7LY HIGHSTAT Investigative D0R7OD DRUG__ID D0R7OD D0R7OD DRUGTYPE Small molecular drug D0R7OD DRUGINCH 1S/C63H88N16O16S2/c1-34(66)53(84)69-30-51(83)70-48-32-96-97-33-49(63(94)95)78-60(91)47(31-80)77-62(93)52(35(2)81)79-55(86)42(22-12-14-24-65)71-58(89)45(27-38-29-68-40-20-10-9-19-39(38)40)75-57(88)44(26-37-17-7-4-8-18-37)73-56(87)43(25-36-15-5-3-6-16-36)74-59(90)46(28-50(67)82)76-54(85)41(72-61(48)92)21-11-13-23-64/h3-10,15-20,29,34-35,41-49,52,68,80-81H,11-14,21-28,30-33,64-66H2,1-2H3,(H2,67,82)(H,69,84)(H,70,83)(H,71,89)(H,72,92)(H,73,87)(H,74,90)(H,75,88)(H,76,85)(H,77,93)(H,78,91)(H,79,86)(H,94,95)/t34-,35+,41+,42-,43+,44-,45+,46-,47-,48+,49-,52+/m0/s1 D0R7OD DRUGINKE VVEJUSYNERNRME-XGFVQVCISA-N D0R7OD DRUGSMIL CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)O D0R7OD HIGHSTAT Investigative D0R7OE DRUG__ID D0R7OE D0R7OE DRUGTYPE Small molecular drug D0R7OE DRUGINCH 1S/C25H34O8/c1-14(2)31-13-32-18-10-17(22(27)29-5)24(3)8-6-16-23(28)33-19(15-7-9-30-12-15)11-25(16,4)21(24)20(18)26/h7,9,12,14,16-19,21H,6,8,10-11,13H2,1-5H3/t16-,17-,18-,19-,21-,24-,25-/m0/s1 D0R7OE DRUGINKE FRUCKVROBALDJE-BYDLNXCSSA-N D0R7OE DRUGSMIL CC(C)OCOC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D0R7OE HIGHSTAT Investigative D0R7PE DRUG__ID D0R7PE D0R7PE DRUGTYPE Small molecular drug D0R7PE DRUGINCH 1S/C6H13NO2S/c7-3-1-2-5(4-10)6(8)9/h5,10H,1-4,7H2,(H,8,9) D0R7PE DRUGINKE IKYCTNVIQZAWIB-UHFFFAOYSA-N D0R7PE DRUGSMIL C(CC(CS)C(=O)O)CN D0R7PE HIGHSTAT Investigative D0R7QF DRUG__ID D0R7QF D0R7QF DRUGTYPE Small molecular drug D0R7QF DRUGINCH 1S/C23H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-23(26)24-21-20-22(21)25/h6-7,9-10,12-13,15-16,21-22,25H,2-5,8,11,14,17-20H2,1H3,(H,24,26)/b7-6-,10-9-,13-12-,16-15-/t21-,22+/m0/s1 D0R7QF DRUGINKE LZHCSJBKBARIFQ-MTVZMXCXSA-N D0R7QF DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NC1CC1O D0R7QF HIGHSTAT Investigative D0R7QL DRUG__ID D0R7QL D0R7QL DRUGTYPE Small molecular drug D0R7QL DRUGINCH 1S/C40H52N4O2/c1-3-43-36-30(17-15-18-34(36)46-4-2)31-19-22-41-35(37(31)43)32-27-40(45)21-12-8-5-6-9-13-23-42-25-20-33(32)39(28-42)26-29-16-11-7-10-14-24-44(29)38(39)40/h5,8,11,15-19,22,27,29,33,38,45H,3-4,6-7,9-10,12-14,20-21,23-26,28H2,1-2H3/b8-5-,16-11-/t29-,33?,38+,39-,40-/m0/s1 D0R7QL DRUGINKE ZOZMQOQRAXCUJA-OGIDAHSQSA-N D0R7QL DRUGSMIL CCN1C2=C(C=CC=C2OCC)C3=C1C(=NC=C3)C4=CC5(CCC=CCCCCN6CCC4C7(C6)C5N8CCCCC=CC8C7)O D0R7QL HIGHSTAT Investigative D0R7QY DRUG__ID D0R7QY D0R7QY DRUGTYPE Small molecular drug D0R7QY DRUGINCH 1S/C18H23NO4S/c1-18-9-8-14-13-5-3-12(23-24(19,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16H,2,4,6-9H2,1H3,(H2,19,21,22)/t14-,15-,16+,18+/m1/s1 D0R7QY DRUGINKE RVKFQAJIXCZXQY-CBZIJGRNSA-N D0R7QY DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)N D0R7QY HIGHSTAT Investigative D0R7QZ DRUG__ID D0R7QZ D0R7QZ DRUGTYPE Small molecular drug D0R7QZ DRUGINCH 1S/C16H12O3/c1-10-6-7-15-12(8-10)14(18)9-16(19-15)11-4-2-3-5-13(11)17/h2-9,17H,1H3 D0R7QZ DRUGINKE JWTNDTDENSEMQI-UHFFFAOYSA-N D0R7QZ DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3O D0R7QZ HIGHSTAT Investigative D0R7RB DRUG__ID D0R7RB D0R7RB DRUGTYPE Small molecular drug D0R7RB DRUGINCH 1S/C10H12N4O4/c15-2-6-7(16)8(17)10(18-6)14-4-13-5-1-11-3-12-9(5)14/h1,3-4,6-8,10,15-17H,2H2/t6-,7-,8-,10-/m1/s1 D0R7RB DRUGINKE MRWXACSTFXYYMV-FDDDBJFASA-N D0R7RB DRUGSMIL C1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O D0R7RB HIGHSTAT Investigative D0R7SM DRUG__ID D0R7SM D0R7SM DRUGTYPE Small molecular drug D0R7SM DRUGINCH 1S/C21H23ClN2O2/c22-20-9-4-10-21(19(20)13-23)26-15-18(25)14-24-11-5-8-17(24)12-16-6-2-1-3-7-16/h1-4,6-7,9-10,17-18,25H,5,8,11-12,14-15H2/t17-,18+/m0/s1 D0R7SM DRUGINKE HSTMYWDURDPUMY-ZWKOTPCHSA-N D0R7SM DRUGSMIL C1CC(N(C1)CC(COC2=C(C(=CC=C2)Cl)C#N)O)CC3=CC=CC=C3 D0R7SM HIGHSTAT Investigative D0R7UO DRUG__ID D0R7UO D0R7UO DRUGTYPE Small molecular drug D0R7UO DRUGINCH 1S/C8H11N3O2/c9-5-7-6-11(8(12)13-7)10-3-1-2-4-10/h1-4,7H,5-6,9H2/t7-/m0/s1 D0R7UO DRUGINKE OZSRSVNLPCHFKO-ZETCQYMHSA-N D0R7UO DRUGSMIL C1C(OC(=O)N1N2C=CC=C2)CN D0R7UO HIGHSTAT Investigative D0R7VT DRUG__ID D0R7VT D0R7VT DRUGTYPE Small molecular drug D0R7VT DRUGINCH 1S/C14H12N2O2S/c15-12-5-7-13(8-6-12)19(17,18)16-10-9-11-3-1-2-4-14(11)16/h1-10H,15H2 D0R7VT DRUGINKE FLNRELDLHZADER-UHFFFAOYSA-N D0R7VT DRUGSMIL C1=CC=C2C(=C1)C=CN2S(=O)(=O)C3=CC=C(C=C3)N D0R7VT HIGHSTAT Investigative D0R7VW DRUG__ID D0R7VW D0R7VW DRUGTYPE Small molecular drug D0R7VW DRUGINCH 1S/C15H10ClN3S/c16-11-4-3-5-12(10-11)20-14-7-9-18-15(19-14)13-6-1-2-8-17-13/h1-10H D0R7VW DRUGINKE UISOVRMNRPVABO-UHFFFAOYSA-N D0R7VW DRUGSMIL C1=CC=NC(=C1)C2=NC=CC(=N2)SC3=CC(=CC=C3)Cl D0R7VW HIGHSTAT Investigative D0R7ZC DRUG__ID D0R7ZC D0R7ZC DRUGTYPE Small molecular drug D0R7ZC DRUGINCH 1S/C10H15NO/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3 D0R7ZC DRUGINKE NEGYEDYHPHMHGK-UHFFFAOYSA-N D0R7ZC DRUGSMIL CC(CC1=CC=C(C=C1)OC)N D0R7ZC HIGHSTAT Investigative D0R8BC DRUG__ID D0R8BC D0R8BC DRUGTYPE Small molecular drug D0R8BC DRUGINCH 1S/C18H17NO4/c1-20-12-4-6-13(7-5-12)23-16-8-9-19-15-11-18(22-3)17(21-2)10-14(15)16/h4-11H,1-3H3 D0R8BC DRUGINKE GBYWCVLXEHHOFE-UHFFFAOYSA-N D0R8BC DRUGSMIL COC1=CC=C(C=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC D0R8BC HIGHSTAT Investigative D0R8DO DRUG__ID D0R8DO D0R8DO DRUGTYPE Small molecular drug D0R8DO DRUGINCH 1S/C25H24N4/c1-3-9-20(10-4-1)19-24-22-13-7-8-14-23(22)25(27-26-24)29-17-15-28(16-18-29)21-11-5-2-6-12-21/h1-14H,15-19H2 D0R8DO DRUGINKE PMNLMFUHSIYHHB-UHFFFAOYSA-N D0R8DO DRUGSMIL C1CN(CCN1C2=CC=CC=C2)C3=NN=C(C4=CC=CC=C43)CC5=CC=CC=C5 D0R8DO HIGHSTAT Investigative D0R8EU DRUG__ID D0R8EU D0R8EU DRUGTYPE Small molecular drug D0R8EU DRUGINCH 1S/C18H23FN6O/c1-12(2)23(4)18(26)24-10-7-14(8-11-24)16-13(3)25(22-21-16)15-6-5-9-20-17(15)19/h5-7,9,12H,8,10-11H2,1-4H3 D0R8EU DRUGINKE CJTLKLBSIFQKNT-UHFFFAOYSA-N D0R8EU DRUGSMIL CC1=C(N=NN1C2=C(N=CC=C2)F)C3=CCN(CC3)C(=O)N(C)C(C)C D0R8EU HIGHSTAT Investigative D0R8EV DRUG__ID D0R8EV D0R8EV DRUGTYPE Small molecular drug D0R8EV DRUGINCH 1S/C14H20ClNO/c1-5-12(16-14(2,3)4)13(17)10-7-6-8-11(15)9-10/h6-9,12,16H,5H2,1-4H3 D0R8EV DRUGINKE PGTPXIBBHIHMQS-UHFFFAOYSA-N D0R8EV DRUGSMIL CCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D0R8EV HIGHSTAT Investigative D0R8FS DRUG__ID D0R8FS D0R8FS DRUGTYPE Small molecular drug D0R8FS DRUGINCH 1S/C9H15NO/c1-9(11)7-5-4-6-8-10(2)3/h5,7-8H2,1-3H3 D0R8FS DRUGINKE UYTLBASHEWACKP-UHFFFAOYSA-N D0R8FS DRUGSMIL CC(=O)CCC#CCN(C)C D0R8FS HIGHSTAT Investigative D0R8GW DRUG__ID D0R8GW D0R8GW DRUGTYPE Small molecular drug D0R8GW DRUGINCH 1S/C19H20ClNO2/c1-21(2)12-11-19(15-7-9-16(20)10-8-15)13-14-5-3-4-6-17(14)18(22)23-19/h3-10H,11-13H2,1-2H3 D0R8GW DRUGINKE HIVBATDUVFEJFZ-UHFFFAOYSA-N D0R8GW DRUGSMIL CN(C)CCC1(CC2=CC=CC=C2C(=O)O1)C3=CC=C(C=C3)Cl D0R8GW HIGHSTAT Investigative D0R8IQ DRUG__ID D0R8IQ D0R8IQ DRUGTYPE Small molecular drug D0R8IQ DRUGINCH 1S/C18H15NO3/c20-18(21)11-13-4-3-6-16(10-13)22-12-15-9-8-14-5-1-2-7-17(14)19-15/h1-10H,11-12H2,(H,20,21) D0R8IQ DRUGINKE VTTJDSVAGYOMKY-UHFFFAOYSA-N D0R8IQ DRUGSMIL C1=CC=C2C(=C1)C=CC(=N2)COC3=CC=CC(=C3)CC(=O)O D0R8IQ HIGHSTAT Investigative D0R8JK DRUG__ID D0R8JK D0R8JK DRUGTYPE Small molecular drug D0R8JK DRUGINCH 1S/C12H19N3O3S/c13-19(17,18)14-10-6-2-5-9-12(16)15-11-7-3-1-4-8-11/h1,3-4,7-8,14H,2,5-6,9-10H2,(H,15,16)(H2,13,17,18) D0R8JK DRUGINKE GJBBLVDVDAQQMI-UHFFFAOYSA-N D0R8JK DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCNS(=O)(=O)N D0R8JK HIGHSTAT Investigative D0R8JR DRUG__ID D0R8JR D0R8JR DRUGTYPE Small molecular drug D0R8JR DRUGINCH 1S/C14H20N2O3/c1-4-5-10-18-13-8-6-12(7-9-13)15-14(17)19-16-11(2)3/h6-9H,4-5,10H2,1-3H3,(H,15,17) D0R8JR DRUGINKE DFYKIRMDPFHHCI-UHFFFAOYSA-N D0R8JR DRUGSMIL CCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D0R8JR HIGHSTAT Investigative D0R8KA DRUG__ID D0R8KA D0R8KA DRUGTYPE Small molecular drug D0R8KA DRUGINCH 1S/C23H23N5O/c1-2-6-18(7-3-1)16-28-15-11-20-22(28)25-17-26-23(20)29-19-9-13-27(14-10-19)21-8-4-5-12-24-21/h1-8,11-12,15,17,19H,9-10,13-14,16H2 D0R8KA DRUGINKE ZMRCFNOIVYNNGH-UHFFFAOYSA-N D0R8KA DRUGSMIL C1CN(CCC1OC2=NC=NC3=C2C=CN3CC4=CC=CC=C4)C5=CC=CC=N5 D0R8KA HIGHSTAT Investigative D0R8LB DRUG__ID D0R8LB D0R8LB DRUGTYPE Small molecular drug D0R8LB DRUGINCH 1S/C20H40NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(22)21-18-19-26-27(23,24)25/h9-10H,2-8,11-19H2,1H3,(H,21,22)(H2,23,24,25)/b10-9- D0R8LB DRUGINKE BCSUWOZFWWBYSX-KTKRTIGZSA-N D0R8LB DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCOP(=O)(O)O D0R8LB HIGHSTAT Investigative D0R8LN DRUG__ID D0R8LN D0R8LN DRUGTYPE Small molecular drug D0R8LN DRUGINCH 1S/C23H19NO3/c1-27-19-6-4-5-17(15-19)10-9-16-11-13-18(14-12-16)24-22(25)20-7-2-3-8-21(20)23(24)26/h2-8,11-15H,9-10H2,1H3 D0R8LN DRUGINKE CNZNMDJWLSHLJZ-UHFFFAOYSA-N D0R8LN DRUGSMIL COC1=CC=CC(=C1)CCC2=CC=C(C=C2)N3C(=O)C4=CC=CC=C4C3=O D0R8LN HIGHSTAT Investigative D0R8NC DRUG__ID D0R8NC D0R8NC DRUGTYPE Small molecular drug D0R8NC DRUGINCH 1S/C19H31NO2/c1-5-7-13-21-18-10-11-19(17(15-18)9-6-2)22-14-8-12-20-16(3)4/h6,10-11,15-16,20H,2,5,7-9,12-14H2,1,3-4H3 D0R8NC DRUGINKE BLGFFZRIKMFSOM-UHFFFAOYSA-N D0R8NC DRUGSMIL CCCCOC1=CC(=C(C=C1)OCCCNC(C)C)CC=C D0R8NC HIGHSTAT Investigative D0R8NE DRUG__ID D0R8NE D0R8NE DRUGTYPE Small molecular drug D0R8NE DRUGINCH 1S/C11H12N2O/c1-2-4-11(5-3-1)14-9-8-13-7-6-12-10-13/h1-7,10H,8-9H2 D0R8NE DRUGINKE INUSBZKZIYQSRM-UHFFFAOYSA-N D0R8NE DRUGSMIL C1=CC=C(C=C1)OCCN2C=CN=C2 D0R8NE HIGHSTAT Investigative D0R8OK DRUG__ID D0R8OK D0R8OK DRUGTYPE Small molecular drug D0R8OK DRUGINCH 1S/C6H6BrN5/c1-12-5-3(11-6(12)7)4(8)9-2-10-5/h2H,1H3,(H2,8,9,10) D0R8OK DRUGINKE ICJDGKILGBQWGF-UHFFFAOYSA-N D0R8OK DRUGSMIL CN1C2=NC=NC(=C2N=C1Br)N D0R8OK HIGHSTAT Investigative D0R8PL DRUG__ID D0R8PL D0R8PL DRUGTYPE Small molecular drug D0R8PL DRUGINCH 1S/C25H31NO2/c1-3-5-6-13-23(27)28-22-12-8-10-19-17-21-24-18(14-16-26(21)15-4-2)9-7-11-20(24)25(19)22/h7-12,21H,3-6,13-17H2,1-2H3/t21-/m1/s1 D0R8PL DRUGINKE IHDFATFMTYOPPY-OAQYLSRUSA-N D0R8PL DRUGSMIL CCCCCC(=O)OC1=CC=CC2=C1C3=CC=CC4=C3C(C2)N(CC4)CCC D0R8PL HIGHSTAT Investigative D0R8TH DRUG__ID D0R8TH D0R8TH DRUGTYPE Small molecular drug D0R8TH DRUGINCH 1S/C14H20ClN/c1-2-13(14-5-3-4-10-16-14)11-6-8-12(15)9-7-11/h6-9,13-14,16H,2-5,10H2,1H3 D0R8TH DRUGINKE CJUVIUZOUUBMJB-UHFFFAOYSA-N D0R8TH DRUGSMIL CCC(C1CCCCN1)C2=CC=C(C=C2)Cl D0R8TH HIGHSTAT Investigative D0R8TL DRUG__ID D0R8TL D0R8TL DRUGTYPE Small molecular drug D0R8TL DRUGINCH 1S/C18H12ClN3OS/c19-13-8-6-12(7-9-13)18(23)21-17-16(14-4-3-11-24-14)20-15-5-1-2-10-22(15)17/h1-11H,(H,21,23) D0R8TL DRUGINKE AZKMWHRDICVYEI-UHFFFAOYSA-N D0R8TL DRUGSMIL C1=CC2=NC(=C(N2C=C1)NC(=O)C3=CC=C(C=C3)Cl)C4=CC=CS4 D0R8TL HIGHSTAT Investigative D0R8TR DRUG__ID D0R8TR D0R8TR DRUGTYPE Small molecular drug D0R8TR DRUGINCH 1S/C5H11NO3/c7-3-1-6-2-4(8)5(3)9/h3-9H,1-2H2/t3-,4+,5? D0R8TR DRUGINKE RMCNETIHECSPMZ-NGQZWQHPSA-N D0R8TR DRUGSMIL C1C(C(C(CN1)O)O)O D0R8TR HIGHSTAT Investigative D0R8UU DRUG__ID D0R8UU D0R8UU DRUGTYPE Small molecular drug D0R8UU DRUGINCH 1S/C20H25NO/c1-3-9-18(10-4-1)17-19-11-5-6-12-20(19)22-16-15-21-13-7-2-8-14-21/h1,3-6,9-12H,2,7-8,13-17H2 D0R8UU DRUGINKE QKRCVHKKBOUVNT-UHFFFAOYSA-N D0R8UU DRUGSMIL C1CCN(CC1)CCOC2=CC=CC=C2CC3=CC=CC=C3 D0R8UU HIGHSTAT Investigative D0R8VT DRUG__ID D0R8VT D0R8VT DRUGTYPE Small molecular drug D0R8VT DRUGINCH 1S/C13H18N2O/c1-14(2)8-7-10-9-15(3)11-5-4-6-12(16)13(10)11/h4-6,9,16H,7-8H2,1-3H3 D0R8VT DRUGINKE MZZRFEIDRWKTKJ-UHFFFAOYSA-N D0R8VT DRUGSMIL CN1C=C(C2=C1C=CC=C2O)CCN(C)C D0R8VT HIGHSTAT Investigative D0R8XV DRUG__ID D0R8XV D0R8XV DRUGTYPE Small molecular drug D0R8XV DRUGINCH 1S/C12H19NS/c1-4-14-12-7-5-11(6-8-12)9-10(2)13-3/h5-8,10,13H,4,9H2,1-3H3 D0R8XV DRUGINKE LCGABASJFJNHGF-UHFFFAOYSA-N D0R8XV DRUGSMIL CCSC1=CC=C(C=C1)CC(C)NC D0R8XV HIGHSTAT Investigative D0R8XX DRUG__ID D0R8XX D0R8XX DRUGTYPE Small molecular drug D0R8XX DRUGINCH 1S/C22H34N2O2/c1-2-3-4-5-6-7-8-9-10-11-22(26)23-15-14-18-17-24-21-13-12-19(25)16-20(18)21/h12-13,16-17,24-25H,2-11,14-15H2,1H3,(H,23,26) D0R8XX DRUGINKE MOQBGJJXYJJJFQ-UHFFFAOYSA-N D0R8XX DRUGSMIL CCCCCCCCCCCC(=O)NCCC1=CNC2=C1C=C(C=C2)O D0R8XX HIGHSTAT Investigative D0R8YJ DRUG__ID D0R8YJ D0R8YJ DRUGTYPE Small molecular drug D0R8YJ DRUGINCH 1S/C12H16N2/c1-3-14(2)10-5-4-7-12-8-6-9-13-11-12/h6,8-9,11H,3,5,10H2,1-2H3 D0R8YJ DRUGINKE DGPGTYZUJIIMAU-UHFFFAOYSA-N D0R8YJ DRUGSMIL CCN(C)CCC#CC1=CN=CC=C1 D0R8YJ HIGHSTAT Investigative D0R8YV DRUG__ID D0R8YV D0R8YV DRUGTYPE Small molecular drug D0R8YV DRUGINCH 1S/C25H32FNO4/c1-15(2)24-20(11-10-18(28)12-19(29)13-23(30)31)21(14-22(27-24)25(3,4)5)16-6-8-17(26)9-7-16/h6-11,14-15,18-19,28-29H,12-13H2,1-5H3,(H,30,31)/p-1/b11-10+/t18?,19-/m1/s1 D0R8YV DRUGINKE SRKGZXIJDGWVAI-GVAVTCRGSA-M D0R8YV DRUGSMIL CC(C)C1=C(C(=CC(=N1)C(C)(C)C)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)[O-])O)O D0R8YV HIGHSTAT Investigative D0R9AA DRUG__ID D0R9AA D0R9AA DRUGTYPE Small molecular drug D0R9AA DRUGINCH 1S/C3H9NS/c1-3(4)2-5/h3,5H,2,4H2,1H3/t3-/m0/s1 D0R9AA DRUGINKE DJJIBYYAHJOUMY-VKHMYHEASA-N D0R9AA DRUGSMIL CC(CS)N D0R9AA HIGHSTAT Investigative D0R9AD DRUG__ID D0R9AD D0R9AD DRUGTYPE Small molecular drug D0R9AD DRUGINCH 1S/C8H9Cl2N5/c9-4-1-5(10)3-6(2-4)14-8(13)15-7(11)12/h1-3H,(H6,11,12,13,14,15) D0R9AD DRUGINKE BUXACHZAYWAZJL-UHFFFAOYSA-N D0R9AD DRUGSMIL C1=C(C=C(C=C1Cl)Cl)N=C(N)N=C(N)N D0R9AD HIGHSTAT Investigative D0R9AP DRUG__ID D0R9AP D0R9AP DRUGTYPE Small molecular drug D0R9AP DRUGINCH 1S/C29H40N6O6/c1-17(2)13-24(29(40)41)35-28(39)23(15-19-7-5-4-6-8-19)34-25(36)16-32-26(37)18(3)33-27(38)22(31)14-20-9-11-21(30)12-10-20/h4-12,17-18,22-24H,13-16,30-31H2,1-3H3,(H,32,37)(H,33,38)(H,34,36)(H,35,39)(H,40,41)/t18-,22-,23-,24-/m0/s1 D0R9AP DRUGINKE DFYAWCYXKNEWBW-IMNFJDCFSA-N D0R9AP DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)N)N D0R9AP HIGHSTAT Investigative D0R9CC DRUG__ID D0R9CC D0R9CC DRUGTYPE Small molecular drug D0R9CC DRUGINCH 1S/C19H32N2O5/c22-16(14-8-4-3-5-9-14)12-13-21-15(18(25)20-19(21)26)10-6-1-2-7-11-17(23)24/h14-16,22H,1-13H2,(H,23,24)(H,20,25,26) D0R9CC DRUGINKE ZIDQIOZJEJFMOH-UHFFFAOYSA-N D0R9CC DRUGSMIL C1CCC(CC1)C(CCN2C(C(=O)NC2=O)CCCCCCC(=O)O)O D0R9CC HIGHSTAT Investigative D0R9CF DRUG__ID D0R9CF D0R9CF DRUGTYPE Small molecular drug D0R9CF DRUGINCH 1S/C21H18O5/c22-20-9-8-16-19(26-20)14-18-17(10-13-24-18)21(16)25-12-5-4-11-23-15-6-2-1-3-7-15/h1-3,6-10,13-14H,4-5,11-12H2 D0R9CF DRUGINKE KINMYBBFQRSVLL-UHFFFAOYSA-N D0R9CF DRUGSMIL C1=CC=C(C=C1)OCCCCOC2=C3C=CC(=O)OC3=CC4=C2C=CO4 D0R9CF HIGHSTAT Investigative D0R9CH DRUG__ID D0R9CH D0R9CH DRUGTYPE Small molecular drug D0R9CH DRUGINCH 1S/C23H20Cl3N5O4S/c1-31(23-27-5-6-35-23)10-12-11-36-20(18(12)26)22(33)30-19-15(7-14(25)8-16(19)34-2)21(32)29-17-4-3-13(24)9-28-17/h3-4,7-9,11H,5-6,10H2,1-2H3,(H,30,33)(H,28,29,32) D0R9CH DRUGINKE FBXIHZSULWMHJY-UHFFFAOYSA-N D0R9CH DRUGSMIL CN(CC1=CSC(=C1Cl)C(=O)NC2=C(C=C(C=C2OC)Cl)C(=O)NC3=NC=C(C=C3)Cl)C4=NCCO4 D0R9CH HIGHSTAT Investigative D0R9DX DRUG__ID D0R9DX D0R9DX DRUGCOMP Rose Pharmaceuticals LLC D0R9DX DRUGINCH 1S/C185H273N49O45S6/c1-98(2)72-121-160(255)203-114(54-27-33-65-188)156(251)229-141-96-284-283-95-140-178(273)225-134(84-147(195)239)184(279)234-71-39-60-144(234)182(277)224-131(83-146(194)238)170(265)222-133(86-151(245)246)172(267)223-132(85-150(243)244)171(266)206-116(56-29-35-67-190)158(253)230-142(97-285-282-94-139(177(272)221-130(82-145(193)237)169(264)218-127(79-105-46-19-12-20-47-105)166(261)226-136(91-236)174(269)211-120(152(196)247)76-102-40-13-9-14-41-102)231-163(258)124(75-101(7)8)214-153(248)112(52-25-31-63-186)204-164(259)125(77-103-42-15-10-16-43-103)217-162(257)123(74-100(5)6)213-154(249)113(53-26-32-64-187)207-173(268)135(90-235)227-179(141)274)180(275)232-138(176(271)210-119(58-37-69-199-185(197)198)183(278)233-70-38-59-143(233)181(276)209-117(155(250)212-121)57-30-36-68-191)93-281-280-92-137(202-148(240)87-192)175(270)215-122(73-99(3)4)161(256)208-118(61-62-149(241)242)159(254)216-126(78-104-44-17-11-18-45-104)165(260)219-129(81-107-89-201-111-51-24-22-49-109(107)111)168(263)220-128(80-106-88-200-110-50-23-21-48-108(106)110)167(262)205-115(157(252)228-140)55-28-34-66-189/h9-24,40-51,88-89,98-101,112-144,200-201,235-236H,25-39,52-87,90-97,186-192H2,1-8H3,(H2,193,237)(H2,194,238)(H2,195,239)(H2,196,247)(H,202,240)(H,203,255)(H,204,259)(H,205,262)(H,206,266)(H,207,268)(H,208,256)(H,209,276)(H,210,271)(H,211,269)(H,212,250)(H,213,249)(H,214,248)(H,215,270)(H,216,254)(H,217,257)(H,218,264)(H,219,260)(H,220,263)(H,221,272)(H,222,265)(H,223,267)(H,224,277)(H,225,273)(H,226,261)(H,227,274)(H,228,252)(H,229,251)(H,230,253)(H,231,258)(H,232,275)(H,241,242)(H,243,244)(H,245,246)(H4,197,198,199) D0R9DX DRUGINKE WVDNTWXIIKNMHY-UHFFFAOYSA-N D0R9DX DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)CN)C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CCCCN)CC(C)C)CCCCN)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C5CCCN5C(=O)C(NC2=O)CC(=O)N)CC(=O)N)CC(=O)O)CC(=O)O)CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CO)C(=O)NC(CC7=CC=CC=C7)C(=O)N)CC(C)C)CCCCN)CC8=CC=CC=C8)CC(C)C)CCCCN)CO)CCCCN)CC9=CNC1=CC=CC=C19)CC1=CNC2=CC=CC=C21)CC1=CC=CC=C1)CCC(=O)O D0R9DX HIGHSTAT Investigative D0R9ED DRUG__ID D0R9ED D0R9ED DRUGTYPE Small molecular drug D0R9ED DRUGINCH 1S/C29H37NO7/c1-4-6-20-23(12-9-19-10-13-25(29(32)33)37-26(19)20)35-15-5-16-36-24-14-11-21(28(31)30-2)27(34-3)22(24)17-18-7-8-18/h9,11-12,14,18,25H,4-8,10,13,15-17H2,1-3H3,(H,30,31)(H,32,33) D0R9ED DRUGINKE SSLKTPMFZMERSJ-UHFFFAOYSA-N D0R9ED DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)NC)OC)CC4CC4 D0R9ED HIGHSTAT Investigative D0R9GW DRUG__ID D0R9GW D0R9GW DRUGTYPE Small molecular drug D0R9GW DRUGINCH 1S/C18H29N7O8/c19-18(20)21-3-1-2-8-16(32)22-6-11(26)23-10(5-12(27)28)17(33)25-9-4-7(15(31)24-8)13(29)14(9)30/h7-10,13-14,29-30H,1-6H2,(H,22,32)(H,23,26)(H,24,31)(H,25,33)(H,27,28)(H4,19,20,21)/t7-,8+,9+,10+,13+,14-/m1/s1 D0R9GW DRUGINKE VNLGSUKLIVHSOW-BDDFMHDSSA-N D0R9GW DRUGSMIL C1C2C(C(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O)O D0R9GW HIGHSTAT Investigative D0R9KF DRUG__ID D0R9KF D0R9KF DRUGTYPE Small molecular drug D0R9KF DRUGINCH 1S/C14H8Cl2N2O/c15-9-5-3-7-11(12(9)16)17-13-8-4-1-2-6-10(8)18-14(13)19/h1-7H,(H,17,18,19) D0R9KF DRUGINKE AUBZCTXOLGPERG-UHFFFAOYSA-N D0R9KF DRUGSMIL C1=CC=C2C(=C1)C(=NC3=C(C(=CC=C3)Cl)Cl)C(=O)N2 D0R9KF HIGHSTAT Investigative D0R9KV DRUG__ID D0R9KV D0R9KV DRUGTYPE Small molecular drug D0R9KV DRUGINCH 1S/C16H25N/c1-4-9-17-10-5-6-15(12-17)16-11-13(2)7-8-14(16)3/h7-8,11,15H,4-6,9-10,12H2,1-3H3 D0R9KV DRUGINKE SSDVDUAQCIGPNR-UHFFFAOYSA-N D0R9KV DRUGSMIL CCCN1CCCC(C1)C2=C(C=CC(=C2)C)C D0R9KV HIGHSTAT Investigative D0R9KX DRUG__ID D0R9KX D0R9KX DRUGTYPE Small molecular drug D0R9KX DRUGINCH 1S/C9H16N2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h7-8H,1-6H2,(H2,10,11)/t7-,8-/m0/s1 D0R9KX DRUGINKE AEIXJVBMYJIICX-YUMQZZPRSA-N D0R9KX DRUGSMIL C1CCC2C(C1)CCC(=N2)N D0R9KX HIGHSTAT Investigative D0R9LV DRUG__ID D0R9LV D0R9LV DRUGTYPE Small molecular drug D0R9LV DRUGINCH 1S/C52H68N6O6/c1-33-23-41(59)24-34(2)43(33)29-47(55(5)6)51(63)57-31-39-19-13-11-17-37(39)27-45(57)49(61)53-21-15-9-10-16-22-54-50(62)46-28-38-18-12-14-20-40(38)32-58(46)52(64)48(56(7)8)30-44-35(3)25-42(60)26-36(44)4/h11-14,17-20,23-26,45-48,59-60H,9-10,15-16,21-22,27-32H2,1-8H3,(H,53,61)(H,54,62)/t45?,46?,47-,48-/m0/s1 D0R9LV DRUGINKE WQLMNYRHCQXDKA-QYXCYUBVSA-N D0R9LV DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCCCNC(=O)C4CC5=CC=CC=C5CN4C(=O)C(CC6=C(C=C(C=C6C)O)C)N(C)C)N(C)C)C)O D0R9LV HIGHSTAT Investigative D0R9SJ DRUG__ID D0R9SJ D0R9SJ DRUGTYPE Small molecular drug D0R9SJ DRUGINCH 1S/C21H33N7O6/c22-21(23)24-8-2-5-12-18(32)15-7-6-11-3-1-4-13(20(34)28(11)15)26-14(9-17(30)31)19(33)25-10-16(29)27-12/h11-15,26H,1-10H2,(H,25,33)(H,27,29)(H,30,31)(H4,22,23,24)/t11-,12-,13-,14+,15+/m0/s1 D0R9SJ DRUGINKE MYSBVCKSODARFZ-BTFPBAQTSA-N D0R9SJ DRUGSMIL C1CC2CCC3N2C(=O)C(C1)NC(C(=O)NCC(=O)NC(C3=O)CCCN=C(N)N)CC(=O)O D0R9SJ HIGHSTAT Investigative D0R9TX DRUG__ID D0R9TX D0R9TX DRUGTYPE Small molecular drug D0R9TX DRUGINCH 1S/C17H14O3/c1-11-3-8-16-13(9-11)10-15(17(18)20-16)12-4-6-14(19-2)7-5-12/h3-10H,1-2H3 D0R9TX DRUGINKE IXPFLPLQVXPBGF-UHFFFAOYSA-N D0R9TX DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C(=C2)C3=CC=C(C=C3)OC D0R9TX HIGHSTAT Investigative D0R9VV DRUG__ID D0R9VV D0R9VV DRUGTYPE Small molecular drug D0R9VV DRUGINCH 1S/C26H21ClO10/c1-9-5-11-6-14(29)19-20(17(11)25(35-3)21(9)27)22(31)12-7-13(26(34)36-4)16(10(2)37-15(30)8-28)23(32)18(12)24(19)33/h5-7,10,28-29,32H,8H2,1-4H3 D0R9VV DRUGINKE LMNHPKWXMIGBEL-UHFFFAOYSA-N D0R9VV DRUGSMIL CC1=CC2=CC(=C3C(=C2C(=C1Cl)OC)C(=O)C4=CC(=C(C(=C4C3=O)O)C(C)OC(=O)CO)C(=O)OC)O D0R9VV HIGHSTAT Investigative D0R9VY DRUG__ID D0R9VY D0R9VY DRUGTYPE Small molecular drug D0R9VY DRUGINCH 1S/C27H27Cl3N2O3/c1-26(2,14-33)32-24(34)21-13-27(3,4)35-25-20(21)12-19(15-5-7-16(28)8-6-15)23(31-25)18-10-9-17(29)11-22(18)30/h5-12,21,33H,13-14H2,1-4H3,(H,32,34) D0R9VY DRUGINKE JUNWVTKDXNTEJW-UHFFFAOYSA-N D0R9VY DRUGSMIL CC1(CC(C2=C(O1)N=C(C(=C2)C3=CC=C(C=C3)Cl)C4=C(C=C(C=C4)Cl)Cl)C(=O)NC(C)(C)CO)C D0R9VY HIGHSTAT Investigative D0R9XD DRUG__ID D0R9XD D0R9XD DRUGTYPE Small molecular drug D0R9XD DRUGINCH 1S/C42H49N5O6/c1-28-21-34(48)22-29(2)35(28)24-36(43)41(51)47-26-33-18-10-9-17-32(33)23-38(47)40(50)46-37(39(49)45-25-30-13-5-3-6-14-30)19-11-12-20-44-42(52)53-27-31-15-7-4-8-16-31/h3-10,13-18,21-22,36-38,48H,11-12,19-20,23-27,43H2,1-2H3,(H,44,52)(H,45,49)(H,46,50) D0R9XD DRUGINKE MVEIALIQEDSFAK-UHFFFAOYSA-N D0R9XD DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)OCC4=CC=CC=C4)C(=O)NCC5=CC=CC=C5)N)C)O D0R9XD HIGHSTAT Investigative D0R9ZS DRUG__ID D0R9ZS D0R9ZS DRUGTYPE Small molecular drug D0R9ZS DRUGINCH 1S/C21H24ClNO2/c1-25-21(24)20(16-9-3-2-4-10-16)19-13-7-8-14-23(19)15-17-11-5-6-12-18(17)22/h2-6,9-12,19-20H,7-8,13-15H2,1H3/t19-,20-/m1/s1 D0R9ZS DRUGINKE AQQXLSKTANRVGK-WOJBJXKFSA-N D0R9ZS DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=CC=C2Cl)C3=CC=CC=C3 D0R9ZS HIGHSTAT Investigative D0R9ZY DRUG__ID D0R9ZY D0R9ZY DRUGTYPE Small molecular drug D0R9ZY DRUGINCH 1S/C19H37NO7P2/c1-17(2)9-6-10-18(3)11-7-12-19(4)13-8-14-20(5)15-16-26-29(24,25)27-28(21,22)23/h9,11,13H,6-8,10,12,14-16H2,1-5H3,(H,24,25)(H2,21,22,23)/b18-11+,19-13+ D0R9ZY DRUGINKE OEMBPHBKZPOPBN-NWLVNBMCSA-N D0R9ZY DRUGSMIL CC(=CCCC(=CCCC(=CCCN(C)CCOP(=O)(O)OP(=O)(O)O)C)C)C D0R9ZY HIGHSTAT Investigative D0RA0P DRUG__ID D0RA0P D0RA0P DRUGTYPE Small molecular drug D0RA0P DRUGINCH 1S/C6H7NO2S/c7-5(6(8)9)4-2-1-3-10-4/h1-3,5H,7H2,(H,8,9) D0RA0P DRUGINKE XLMSKXASROPJNG-UHFFFAOYSA-N D0RA0P DRUGSMIL C1=CSC(=C1)C(C(=O)O)N D0RA0P HIGHSTAT Investigative D0RA5T DRUG__ID D0RA5T D0RA5T DRUGTYPE Small molecular drug D0RA5T DRUGINCH 1S/C20H19NO4.C2HF3O2/c1-23-18-7-12-4-5-21-11-14-9-20(25-3)19(24-2)8-13(14)6-16(21)15(12)10-17(18)22;3-2(4,5)1(6)7/h6-11H,4-5H2,1-3H3;(H,6,7) D0RA5T DRUGINKE NJSNVNFFIBGGAE-UHFFFAOYSA-N D0RA5T DRUGSMIL COC1=C(C=C2C(=C1)CC[N+]3=CC4=CC(=C(C=C4C=C23)OC)OC)O.C(=O)(C(F)(F)F)[O-] D0RA5T HIGHSTAT Investigative D0RA6H DRUG__ID D0RA6H D0RA6H DRUGTYPE Small molecular drug D0RA6H DRUGINCH 1S/C30H50O/c1-19(2)20-11-14-27(5)17-18-29(7)21(25(20)27)9-10-23-28(6)15-13-24(31)26(3,4)22(28)12-16-30(23,29)8/h20-25,31H,1,9-18H2,2-8H3/t20-,21+,22-,23+,24-,25+,27+,28-,29+,30+/m0/s1 D0RA6H DRUGINKE MQYXUWHLBZFQQO-QGTGJCAVSA-N D0RA6H DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C D0RA6H HIGHSTAT Investigative D0RA8F DRUG__ID D0RA8F D0RA8F DRUGTYPE Small molecular drug D0RA8F DRUGINCH 1S/C26H28FNO4/c1-17(2)26-23(13-12-21(29)14-22(30)15-25(31)32)24(18-8-10-19(27)11-9-18)16-28(26)20-6-4-3-5-7-20/h3-13,16-17,21-22,29-30H,14-15H2,1-2H3,(H,31,32)/b13-12+/t21-,22-/m1/s1 D0RA8F DRUGINKE VAVHMEQFYYBAPR-ITWZMISCSA-N D0RA8F DRUGSMIL CC(C)C1=C(C(=CN1C2=CC=CC=C2)C3=CC=C(C=C3)F)C=CC(CC(CC(=O)O)O)O D0RA8F HIGHSTAT Investigative D0RB0D DRUG__ID D0RB0D D0RB0D DRUGTYPE Small molecular drug D0RB0D DRUGINCH 1S/C11H8O5/c1-15-6-2-3-7-8(11(13)14)5-10(12)16-9(7)4-6/h2-5H,1H3,(H,13,14) D0RB0D DRUGINKE IHHLDCASADSHEG-UHFFFAOYSA-N D0RB0D DRUGSMIL COC1=CC2=C(C=C1)C(=CC(=O)O2)C(=O)O D0RB0D HIGHSTAT Investigative D0RB1V DRUG__ID D0RB1V D0RB1V DRUGTYPE Small molecular drug D0RB1V DRUGINCH 1S/C22H18O10/c23-11-6-14(25)12-8-19(32-22(30)10-4-16(27)20(29)17(28)5-10)21(31-18(12)7-11)9-1-2-13(24)15(26)3-9/h1-7,19,21,23-29H,8H2/t19-,21+/m1/s1 D0RB1V DRUGINKE LSHVYAFMTMFKBA-CTNGQTDRSA-N D0RB1V DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O D0RB1V HIGHSTAT Investigative D0RC4F DRUG__ID D0RC4F D0RC4F DRUGTYPE Small molecular drug D0RC4F DRUGINCH 1S/C18H16N2O6/c1-2-3-4-8-5-9-12(21)6-10(17(23)24)20-16(9)14-13(22)7-11(18(25)26)19-15(8)14/h5-7H,2-4H2,1H3,(H,19,22)(H,20,21)(H,23,24)(H,25,26) D0RC4F DRUGINKE BQVIONBNDNFCCP-UHFFFAOYSA-N D0RC4F DRUGSMIL CCCCC1=CC2=C(C3=C1NC(=CC3=O)C(=O)O)NC(=CC2=O)C(=O)O D0RC4F HIGHSTAT Investigative D0RC5X DRUG__ID D0RC5X D0RC5X DRUGTYPE Small molecular drug D0RC5X DRUGINCH 1S/C9H11NO2/c1-6-2-4-7(5-3-6)8(10)9(11)12/h2-5,8H,10H2,1H3,(H,11,12)/t8-/m0/s1 D0RC5X DRUGINKE RZRRCPHBUKHOEY-QMMMGPOBSA-N D0RC5X DRUGSMIL CC1=CC=C(C=C1)C(C(=O)O)N D0RC5X HIGHSTAT Investigative D0RC9T DRUG__ID D0RC9T D0RC9T DRUGTYPE Small molecular drug D0RC9T DRUGINCH 1S/C19H20N2/c1-2-7-14(8-3-1)19-18(15-9-6-12-20-13-15)16-10-4-5-11-17(16)21-19/h1-5,7-8,10-11,15,20-21H,6,9,12-13H2 D0RC9T DRUGINKE FYHCOUIJWCQUMZ-UHFFFAOYSA-N D0RC9T DRUGSMIL C1CC(CNC1)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4 D0RC9T HIGHSTAT Investigative D0RD0R DRUG__ID D0RD0R D0RD0R DRUGTYPE Small molecular drug D0RD0R DRUGINCH 1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-15(7-10-17(18)21)19(24)23-16-8-5-14(6-9-16)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26) D0RD0R DRUGINKE SZWKGOZKRMMLAJ-UHFFFAOYSA-N D0RD0R DRUGSMIL CC1(CCC(C2=C1C=CC(=C2)C(=O)NC3=CC=C(C=C3)C(=O)O)(C)C)C D0RD0R HIGHSTAT Investigative D0RD3C DRUG__ID D0RD3C D0RD3C DRUGTYPE Small molecular drug D0RD3C DRUGINCH 1S/C20H22N2/c1-16(2)14-20(22-13-12-21-15-22)19-10-8-18(9-11-19)17-6-4-3-5-7-17/h3-13,15-16,20H,14H2,1-2H3 D0RD3C DRUGINKE WLSWBXVWEUOVLV-UHFFFAOYSA-N D0RD3C DRUGSMIL CC(C)CC(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D0RD3C HIGHSTAT Investigative D0RD5S DRUG__ID D0RD5S D0RD5S DRUGTYPE Small molecular drug D0RD5S DRUGINCH 1S/C15H13NO2S/c1-17-12-6-14-13(15(7-12)18-2)5-11(8-16-14)10-3-4-19-9-10/h3-9H,1-2H3 D0RD5S DRUGINKE OOSYGDRIWJDGFV-UHFFFAOYSA-N D0RD5S DRUGSMIL COC1=CC2=C(C=C(C=N2)C3=CSC=C3)C(=C1)OC D0RD5S HIGHSTAT Investigative D0RD5U DRUG__ID D0RD5U D0RD5U DRUGTYPE Small molecular drug D0RD5U DRUGINCH 1S/C16H17ClF2N4S/c1-23(2)11-7-13(18)12(14(19)8-11)5-6-20-16(24)22-15-4-3-10(17)9-21-15/h3-4,7-9H,5-6H2,1-2H3,(H2,20,21,22,24) D0RD5U DRUGINKE CTKOUWBTBJGZKA-UHFFFAOYSA-N D0RD5U DRUGSMIL CN(C)C1=CC(=C(C(=C1)F)CCNC(=S)NC2=NC=C(C=C2)Cl)F D0RD5U HIGHSTAT Investigative D0RD6G DRUG__ID D0RD6G D0RD6G DRUGTYPE Small molecular drug D0RD6G DRUGINCH 1S/C18H11NO3/c1-2-12-14-7-10(20)4-6-16(14)19-18-13-5-3-11(21)8-17(13)22-9-15(12)18/h1,3-8,20-21H,9H2 D0RD6G DRUGINKE NFDYBNVVFHAKIV-UHFFFAOYSA-N D0RD6G DRUGSMIL C#CC1=C2COC3=C(C2=NC4=C1C=C(C=C4)O)C=CC(=C3)O D0RD6G HIGHSTAT Investigative D0RE7T DRUG__ID D0RE7T D0RE7T DRUGTYPE Small molecular drug D0RE7T DRUGINCH 1S/C27H21N3/c1-4-12-20(13-5-1)25(21-14-6-2-7-15-21)29-27-23-18-10-11-19-24(23)28-26(30-27)22-16-8-3-9-17-22/h1-19,25H,(H,28,29,30) D0RE7T DRUGINKE LJIQXEUCYVPWRY-UHFFFAOYSA-N D0RE7T DRUGSMIL C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=N2)NC(C4=CC=CC=C4)C5=CC=CC=C5 D0RE7T HIGHSTAT Investigative D0RE9X DRUG__ID D0RE9X D0RE9X DRUGTYPE Small molecular drug D0RE9X DRUGINCH 1S/C8H11ClN2O2/c1-2-3-4-5-6(9)10-8(13)11-7(5)12/h2-4H2,1H3,(H2,10,11,12,13) D0RE9X DRUGINKE CYNWJDGCUODOPW-UHFFFAOYSA-N D0RE9X DRUGSMIL CCCCC1=C(NC(=O)NC1=O)Cl D0RE9X HIGHSTAT Investigative D0RF2M DRUG__ID D0RF2M D0RF2M DRUGTYPE Small molecular drug D0RF2M DRUGINCH 1S/C6H11NO2/c8-6(9)5-2-1-3-7-4-5/h5,7H,1-4H2,(H,8,9) D0RF2M DRUGINKE XJLSEXAGTJCILF-UHFFFAOYSA-N D0RF2M DRUGSMIL C1CC(CNC1)C(=O)O D0RF2M HIGHSTAT Investigative D0RF4L DRUG__ID D0RF4L D0RF4L DRUGTYPE Small molecular drug D0RF4L DRUGINCH 1S/C20H22N2O2/c1-14(23)21-11-10-17-18-13-16(24-2)8-9-19(18)22-20(17)12-15-6-4-3-5-7-15/h3-9,13,22H,10-12H2,1-2H3,(H,21,23) D0RF4L DRUGINKE MUQOTEHRXIKHKR-UHFFFAOYSA-N D0RF4L DRUGSMIL CC(=O)NCCC1=C(NC2=C1C=C(C=C2)OC)CC3=CC=CC=C3 D0RF4L HIGHSTAT Investigative D0RF6M DRUG__ID D0RF6M D0RF6M DRUGTYPE Small molecular drug D0RF6M DRUGINCH 1S/C32H35N5O5/c1-42-26-15-9-23(10-16-26)32(17-5-2-6-18-32)21-34-30(38)29(19-22-20-33-28-8-4-3-7-27(22)28)36-31(39)35-24-11-13-25(14-12-24)37(40)41/h3-4,7-16,20,29,33H,2,5-6,17-19,21H2,1H3,(H,34,38)(H2,35,36,39)/t29-/m0/s1 D0RF6M DRUGINKE JOKVJNCYOSFDGC-LJAQVGFWSA-N D0RF6M DRUGSMIL COC1=CC=C(C=C1)C2(CCCCC2)CNC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)NC5=CC=C(C=C5)[N+](=O)[O-] D0RF6M HIGHSTAT Investigative D0RF7O DRUG__ID D0RF7O D0RF7O DRUGTYPE Small molecular drug D0RF7O DRUGINCH 1S/C22H16N4O/c1-27-17-9-7-15(8-10-17)16-12-24-22-20(13-25-26(22)14-16)18-4-2-6-21-19(18)5-3-11-23-21/h2-14H,1H3 D0RF7O DRUGINKE FVRYPYDPKSZGNS-UHFFFAOYSA-N D0RF7O DRUGSMIL COC1=CC=C(C=C1)C2=CN3C(=C(C=N3)C4=C5C=CC=NC5=CC=C4)N=C2 D0RF7O HIGHSTAT Investigative D0RG0Z DRUG__ID D0RG0Z D0RG0Z DRUGTYPE Small molecular drug D0RG0Z DRUGINCH 1S/C23H26IN7O2S/c24-18-15-27-22(30-20(18)25-9-5-10-26-21(32)19-8-4-13-34-19)28-16-6-3-7-17(14-16)29-23(33)31-11-1-2-12-31/h3-4,6-8,13-15H,1-2,5,9-12H2,(H,26,32)(H,29,33)(H2,25,27,28,30) D0RG0Z DRUGINKE VAVXGGRQQJZYBL-UHFFFAOYSA-N D0RG0Z DRUGSMIL C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I D0RG0Z HIGHSTAT Investigative D0RG1F DRUG__ID D0RG1F D0RG1F DRUGTYPE Small molecular drug D0RG1F DRUGINCH 1S/C38H50N6O3.2ClH/c1-6-7-20-44-36-30(15-11-16-40-36)33(27-13-10-14-29(22-27)47-21-12-19-43-17-8-9-18-43)35(37(44)45)42-38(46)41-34-31(25(2)3)23-28(39)24-32(34)26(4)5;;/h10-11,13-16,22-26H,6-9,12,17-21,39H2,1-5H3,(H2,41,42,46);2*1H D0RG1F DRUGINKE YRTFLDFDKPFNCJ-UHFFFAOYSA-N D0RG1F DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OCCCN5CCCC5.Cl.Cl D0RG1F HIGHSTAT Investigative D0RG8O DRUG__ID D0RG8O D0RG8O DRUGTYPE Small molecular drug D0RG8O DRUGINCH 1S/C20H23N3/c21-14-13-18-15-22-20(23-18)12-11-19(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-10,15,19H,11-14,21H2,(H,22,23) D0RG8O DRUGINKE BPZGZNLONLANFE-UHFFFAOYSA-N D0RG8O DRUGSMIL C1=CC=C(C=C1)C(CCC2=NC=C(N2)CCN)C3=CC=CC=C3 D0RG8O HIGHSTAT Investigative D0RH4S DRUG__ID D0RH4S D0RH4S DRUGTYPE Small molecular drug D0RH4S DRUGINCH 1S/C11H18NO3P/c1-2-3-9-11(12)16(13,14)15-10-7-5-4-6-8-10/h4-8,11H,2-3,9,12H2,1H3,(H,13,14) D0RH4S DRUGINKE WRTBDONQGQRUNP-UHFFFAOYSA-N D0RH4S DRUGSMIL CCCCC(N)P(=O)(O)OC1=CC=CC=C1 D0RH4S HIGHSTAT Investigative D0RI3H DRUG__ID D0RI3H D0RI3H DRUGTYPE Small molecular drug D0RI3H DRUGINCH 1S/C22H30INO4S/c1-22(2)15-13-19(22)18(7-5-3-4-6-8-21(25)26)20(14-15)24-29(27,28)17-11-9-16(23)10-12-17/h3,5,9-12,15,18-20,24H,4,6-8,13-14H2,1-2H3,(H,25,26)/b5-3-/t15-,18+,19+,20+/m1/s1 D0RI3H DRUGINKE SZNMERGTFJHNSM-JAWYFFTGSA-N D0RI3H DRUGSMIL CC1(C2CC1C(C(C2)NS(=O)(=O)C3=CC=C(C=C3)I)CC=CCCCC(=O)O)C D0RI3H HIGHSTAT Investigative D0RI4S DRUG__ID D0RI4S D0RI4S DRUGTYPE Small molecular drug D0RI4S DRUGINCH 1S/C17H13N3O/c21-17-16-14(13-8-4-5-9-15(13)18-17)11-20(19-16)10-12-6-2-1-3-7-12/h1-9,11H,10H2,(H,18,21) D0RI4S DRUGINKE XJRYZVBNFXKWFF-UHFFFAOYSA-N D0RI4S DRUGSMIL C1=CC=C(C=C1)CN2C=C3C4=CC=CC=C4NC(=O)C3=N2 D0RI4S HIGHSTAT Investigative D0RI6U DRUG__ID D0RI6U D0RI6U DRUGTYPE Small molecular drug D0RI6U DRUGINCH 1S/C22H16N4O3/c27-22(17-10-7-13-19(14-17)26(28)29)23-21-15-20(16-8-3-1-4-9-16)24-25(21)18-11-5-2-6-12-18/h1-15H,(H,23,27) D0RI6U DRUGINKE NTGZFLVYBRAVEA-UHFFFAOYSA-N D0RI6U DRUGSMIL C1=CC=C(C=C1)C2=NN(C(=C2)NC(=O)C3=CC(=CC=C3)[N+](=O)[O-])C4=CC=CC=C4 D0RI6U HIGHSTAT Investigative D0RI7T DRUG__ID D0RI7T D0RI7T DRUGTYPE Small molecular drug D0RI7T DRUGINCH 1S/C18H16N2/c1-2-18(20-13-12-19-14-20)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h2-14,18H,1H2 D0RI7T DRUGINKE VEPBIHWDSCDYJS-UHFFFAOYSA-N D0RI7T DRUGSMIL C=CC(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D0RI7T HIGHSTAT Investigative D0RI8G DRUG__ID D0RI8G D0RI8G DRUGTYPE Small molecular drug D0RI8G DRUGINCH 1S/C21H22FNO/c1-2-3-6-12-23-15-19(18-10-4-5-11-20(18)23)21(24)14-16-8-7-9-17(22)13-16/h4-5,7-11,13,15H,2-3,6,12,14H2,1H3 D0RI8G DRUGINKE ZOBARDBQXUOIQF-UHFFFAOYSA-N D0RI8G DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC(=CC=C3)F D0RI8G HIGHSTAT Investigative D0RJ5B DRUG__ID D0RJ5B D0RJ5B DRUGTYPE Small molecular drug D0RJ5B DRUGINCH 1S/C15H10BrN3S/c16-11-4-3-5-12(10-11)20-14-7-9-18-15(19-14)13-6-1-2-8-17-13/h1-10H D0RJ5B DRUGINKE GOUWEKQNTSGAGA-UHFFFAOYSA-N D0RJ5B DRUGSMIL C1=CC=NC(=C1)C2=NC=CC(=N2)SC3=CC(=CC=C3)Br D0RJ5B HIGHSTAT Investigative D0RJ6S DRUG__ID D0RJ6S D0RJ6S DRUGTYPE Small molecular drug D0RJ6S DRUGINCH 1S/C15H10BrN/c16-15-6-5-11-8-12(3-4-13(11)9-15)14-2-1-7-17-10-14/h1-10H D0RJ6S DRUGINKE MAIJPIYXFRLIEK-UHFFFAOYSA-N D0RJ6S DRUGSMIL C1=CC(=CN=C1)C2=CC3=C(C=C2)C=C(C=C3)Br D0RJ6S HIGHSTAT Investigative D0RJ8J DRUG__ID D0RJ8J D0RJ8J DRUGTYPE Small molecular drug D0RJ8J DRUGINCH 1S/C14H9Cl2N5OS/c15-6-1-2-7(8(16)5-6)10-11(12(17)22)23-13(21-10)9-3-4-19-14(18)20-9/h1-5H,(H2,17,22)(H2,18,19,20) D0RJ8J DRUGINKE CQNCHLJHIGRPDA-UHFFFAOYSA-N D0RJ8J DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C2=C(SC(=N2)C3=NC(=NC=C3)N)C(=O)N D0RJ8J HIGHSTAT Investigative D0RK2I DRUG__ID D0RK2I D0RK2I DRUGTYPE Small molecular drug D0RK2I DRUGINCH 1S/C4H9O6P/c1-2-3(4(5)6)10-11(7,8)9/h3H,2H2,1H3,(H,5,6)(H2,7,8,9)/t3-/m1/s1 D0RK2I DRUGINKE OETAGSCBSKODFW-GSVOUGTGSA-N D0RK2I DRUGSMIL CCC(C(=O)O)OP(=O)(O)O D0RK2I HIGHSTAT Investigative D0RK4K DRUG__ID D0RK4K D0RK4K DRUGTYPE Small molecular drug D0RK4K DRUGINCH 1S/C18H22N2O3/c21-16(22)14-2-1-3-15(7-14)19-17(23)20-18-8-11-4-12(9-18)6-13(5-11)10-18/h1-3,7,11-13H,4-6,8-10H2,(H,21,22)(H2,19,20,23) D0RK4K DRUGINKE IPTYXUOUPSNRTP-UHFFFAOYSA-N D0RK4K DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=CC(=C4)C(=O)O D0RK4K HIGHSTAT Investigative D0RK7J DRUG__ID D0RK7J D0RK7J DRUGTYPE Small molecular drug D0RK7J DRUGINCH 1S/C8H7F3N2O3S/c9-8(10,11)7(14)13-5-1-3-6(4-2-5)17(12,15)16/h1-4H,(H,13,14)(H2,12,15,16) D0RK7J DRUGINKE KYCGMLPXHVMDAN-UHFFFAOYSA-N D0RK7J DRUGSMIL C1=CC(=CC=C1NC(=O)C(F)(F)F)S(=O)(=O)N D0RK7J HIGHSTAT Investigative D0RL0F DRUG__ID D0RL0F D0RL0F DRUGTYPE Small molecular drug D0RL0F DRUGINCH 1S/C9H11BrN2S/c1-12(2)9(13)11-8-5-3-7(10)4-6-8/h3-6H,1-2H3,(H,11,13) D0RL0F DRUGINKE YZPBPTSRPUXFGV-UHFFFAOYSA-N D0RL0F DRUGSMIL CN(C)C(=S)NC1=CC=C(C=C1)Br D0RL0F HIGHSTAT Investigative D0RL4S DRUG__ID D0RL4S D0RL4S DRUGTYPE Small molecular drug D0RL4S DRUGINCH 1S/C35H50N4O7S/c1-7-25(4)31(39-35(43)46-23-28-16-12-9-13-17-28)34(42)38-30(19-18-27-14-10-8-11-15-27)33(41)36-26(5)32(40)37-29(22-24(2)3)20-21-47(6,44)45/h8-17,20-21,24-26,29-31H,7,18-19,22-23H2,1-6H3,(H,36,41)(H,37,40)(H,38,42)(H,39,43)/b21-20+/t25-,26-,29+,30-,31-/m0/s1 D0RL4S DRUGINKE BZKLWACICJITOJ-QBZCPKQRSA-N D0RL4S DRUGSMIL CCC(C)C(C(=O)NC(CCC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC(C)C)C=CS(=O)(=O)C)NC(=O)OCC2=CC=CC=C2 D0RL4S HIGHSTAT Investigative D0RL8P DRUG__ID D0RL8P D0RL8P DRUGTYPE Small molecular drug D0RL8P DRUGINCH 1S/C26H21ClO9/c1-9-6-12-7-15(29)19-20(17(12)25(34-4)21(9)27)22(30)13-8-14(26(33)35-5)16(10(2)36-11(3)28)23(31)18(13)24(19)32/h6-8,10,29,31H,1-5H3 D0RL8P DRUGINKE MFLXCCWOEBQIHW-UHFFFAOYSA-N D0RL8P DRUGSMIL CC1=CC2=CC(=C3C(=C2C(=C1Cl)OC)C(=O)C4=CC(=C(C(=C4C3=O)O)C(C)OC(=O)C)C(=O)OC)O D0RL8P HIGHSTAT Investigative D0RL8X DRUG__ID D0RL8X D0RL8X DRUGTYPE Small molecular drug D0RL8X DRUGINCH 1S/C26H26N4O4/c1-3-5-6-10-29-14-27-18-8-7-9-19-21(18)23(29)15-12-30-20(22(15)28-19)11-17-16(24(30)31)13-34-25(32)26(17,33)4-2/h7-9,11,14,33H,3-6,10,12-13H2,1-2H3/t26-/m0/s1 D0RL8X DRUGINKE NPAAFPODGAKMTC-SANMLTNESA-N D0RL8X DRUGSMIL CCCCCN1C=NC2=CC=CC3=C2C1=C4CN5C(=CC6=C(C5=O)COC(=O)C6(CC)O)C4=N3 D0RL8X HIGHSTAT Investigative D0RM7D DRUG__ID D0RM7D D0RM7D DRUGTYPE Small molecular drug D0RM7D DRUGINCH 1S/C3H3IN2/c4-3-1-5-6-2-3/h1-2H,(H,5,6) D0RM7D DRUGINKE LLNQWPTUJJYTTE-UHFFFAOYSA-N D0RM7D DRUGSMIL C1=C(C=NN1)I D0RM7D HIGHSTAT Investigative D0RM7J DRUG__ID D0RM7J D0RM7J DRUGTYPE Small molecular drug D0RM7J DRUGINCH 1S/C23H26F3N3O2/c1-15-6-7-18(16(2)10-15)13-29-9-8-20(14-29)28-21(30)12-27-22(31)17-4-3-5-19(11-17)23(24,25)26/h3-7,10-11,20H,8-9,12-14H2,1-2H3,(H,27,31)(H,28,30)/t20-/m1/s1 D0RM7J DRUGINKE MRRGKBBDXLJMCV-HXUWFJFHSA-N D0RM7J DRUGSMIL CC1=CC(=C(C=C1)CN2CCC(C2)NC(=O)CNC(=O)C3=CC(=CC=C3)C(F)(F)F)C D0RM7J HIGHSTAT Investigative D0RN8T DRUG__ID D0RN8T D0RN8T DRUGTYPE Small molecular drug D0RN8T DRUGINCH 1S/C13H18N2O11P2S/c16-13(27(17,18)19,28(20,21)22)8-4-5-9-25-11-12(15-26-14-11)29(23,24)10-6-2-1-3-7-10/h1-3,6-7,16H,4-5,8-9H2,(H2,17,18,19)(H2,20,21,22) D0RN8T DRUGINKE PSWFNEHHRVMWEJ-UHFFFAOYSA-N D0RN8T DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=NON=C2OCCCCC(O)(P(=O)(O)O)P(=O)(O)O D0RN8T HIGHSTAT Investigative D0RO6K DRUG__ID D0RO6K D0RO6K DRUGTYPE Small molecular drug D0RO6K DRUGINCH 1S/C2H6NO6P/c4-2(3-5)1-9-10(6,7)8/h5H,1H2,(H,3,4)(H2,6,7,8) D0RO6K DRUGINKE BAXHHWZKQZIJID-UHFFFAOYSA-N D0RO6K DRUGSMIL C(C(=O)NO)OP(=O)(O)O D0RO6K HIGHSTAT Investigative D0RO7K DRUG__ID D0RO7K D0RO7K DRUGTYPE Small molecular drug D0RO7K DRUGINCH 1S/C13H11N/c1-9-6-7-11-10-4-2-3-5-12(10)14-13(11)8-9/h2-8,14H,1H3 D0RO7K DRUGINKE PWJYOTPKLOICJK-UHFFFAOYSA-N D0RO7K DRUGSMIL CC1=CC2=C(C=C1)C3=CC=CC=C3N2 D0RO7K HIGHSTAT Investigative D0RO8V DRUG__ID D0RO8V D0RO8V DRUGTYPE Small molecular drug D0RO8V DRUGINCH 1S/C20H19IN2/c21-15-7-5-6-14(12-15)13-22-20-16-8-1-3-10-18(16)23-19-11-4-2-9-17(19)20/h1,3,5-8,10,12H,2,4,9,11,13H2,(H,22,23) D0RO8V DRUGINKE ZUCWQTWGZGIYPV-UHFFFAOYSA-N D0RO8V DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCC4=CC(=CC=C4)I D0RO8V HIGHSTAT Investigative D0RO9R DRUG__ID D0RO9R D0RO9R DRUGTYPE Small molecular drug D0RO9R DRUGINCH 1S/C26H28ClFN6O2/c1-5-34-20-13-15(9-10-17(20)26(2,3)12-11-21(34)35)31-25-30-14-18(27)23(33-25)32-22-16(24(36)29-4)7-6-8-19(22)28/h6-10,13-14H,5,11-12H2,1-4H3,(H,29,36)(H2,30,31,32,33) D0RO9R DRUGINKE KHBUKOVUBUJCGM-UHFFFAOYSA-N D0RO9R DRUGSMIL CCN1C(=O)CCC(C2=C1C=C(C=C2)NC3=NC=C(C(=N3)NC4=C(C=CC=C4F)C(=O)NC)Cl)(C)C D0RO9R HIGHSTAT Investigative D0RO9T DRUG__ID D0RO9T D0RO9T DRUGTYPE Small molecular drug D0RO9T DRUGINCH 1S/C24H21N3O3/c28-22(18-11-5-2-6-12-18)26-24-25-20-16-19(23(29)30)13-14-21(20)27(24)15-7-10-17-8-3-1-4-9-17/h1-6,8-9,11-14,16H,7,10,15H2,(H,29,30)(H,25,26,28) D0RO9T DRUGINKE WPXMEOBILYVKBC-UHFFFAOYSA-N D0RO9T DRUGSMIL C1=CC=C(C=C1)CCCN2C3=C(C=C(C=C3)C(=O)O)N=C2NC(=O)C4=CC=CC=C4 D0RO9T HIGHSTAT Investigative D0RP8X DRUG__ID D0RP8X D0RP8X DRUGTYPE Small molecular drug D0RP8X DRUGINCH 1S/C15H22N2O3/c18-17(19)14-6-8-15(9-7-14)20-13-5-1-2-10-16-11-3-4-12-16/h6-9H,1-5,10-13H2 D0RP8X DRUGINKE ITOJPDNONZGUKB-UHFFFAOYSA-N D0RP8X DRUGSMIL C1CCN(C1)CCCCCOC2=CC=C(C=C2)[N+](=O)[O-] D0RP8X HIGHSTAT Investigative D0RQ2T DRUG__ID D0RQ2T D0RQ2T DRUGTYPE Small molecular drug D0RQ2T DRUGINCH 1S/C36H45N9O8/c37-36(38)39-16-4-8-26-31(49)34(52)44-27(19-22-6-2-1-3-7-22)32(50)42-24(18-23-10-13-25(47)14-11-23)12-15-30(48)40-20-28(41-21-46)35(53)45-17-5-9-29(45)33(51)43-26/h1-3,6-7,10-15,21,24,26-29,47H,4-5,8-9,16-20H2,(H,40,48)(H,41,46)(H,42,50)(H,43,51)(H,44,52)(H4,37,38,39)/b15-12-/t24-,26+,27-,28+,29+/m0/s1 D0RQ2T DRUGINKE CDWXSPKJKIUEQF-SMUYMMTFSA-N D0RQ2T DRUGSMIL C1CC2C(=O)NC(C(=O)C(=O)NC(C(=O)NC(C=CC(=O)NCC(C(=O)N2C1)NC=O)CC3=CC=C(C=C3)O)CC4=CC=CC=C4)CCCN=C(N)N D0RQ2T HIGHSTAT Investigative D0RQ8R DRUG__ID D0RQ8R D0RQ8R DRUGTYPE Small molecular drug D0RQ8R DRUGINCH 1S/C20H19NO/c1-2-8-17(9-3-1)13-14-18-10-4-5-12-20(18)22-16-19-11-6-7-15-21-19/h1-12,15H,13-14,16H2 D0RQ8R DRUGINKE XVQTWFFAIBVICX-UHFFFAOYSA-N D0RQ8R DRUGSMIL C1=CC=C(C=C1)CCC2=CC=CC=C2OCC3=CC=CC=N3 D0RQ8R HIGHSTAT Investigative D0RR7X DRUG__ID D0RR7X D0RR7X DRUGTYPE Small molecular drug D0RR7X DRUGINCH 1S/C49H61N9O8/c1-5-29(2)41(42(50)59)56-47(64)39-22-14-24-57(39)49(66)40-23-15-25-58(40)48(65)38(26-32-16-8-6-9-17-32)55-46(63)37(27-34-28-51-36-21-13-12-20-35(34)36)54-44(61)31(4)52-43(60)30(3)53-45(62)33-18-10-7-11-19-33/h6-13,16-21,28-31,37-41,51H,5,14-15,22-27H2,1-4H3,(H2,50,59)(H,52,60)(H,53,62)(H,54,61)(H,55,63)(H,56,64)/t29-,30-,31-,37+,38-,39-,40+,41-/m0/s1 D0RR7X DRUGINKE KIPTYYXCLIQOHM-KKMBCTKYSA-N D0RR7X DRUGSMIL CCC(C)C(C(=O)N)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(C)NC(=O)C(C)NC(=O)C6=CC=CC=C6 D0RR7X HIGHSTAT Investigative D0RS1Q DRUG__ID D0RS1Q D0RS1Q DRUGCOMP ProCor Pharmaceuticals D0RS1Q DRUGINCH 1S/C13H17BN2O4/c1-12(2)13(3,4)20-14(19-12)7-5-10-9-11(16(17)18)6-8-15-10/h5-9H,1-4H3/b7-5+ D0RS1Q DRUGINKE SYGPLVJRKODTDL-FNORWQNLSA-N D0RS1Q DRUGSMIL B1(OC(C(O1)(C)C)(C)C)C=CC2=NC=CC(=C2)[N+](=O)[O-] D0RS1Q HIGHSTAT Investigative D0RS3R DRUG__ID D0RS3R D0RS3R DRUGTYPE Small molecular drug D0RS3R DRUGINCH 1S/C10H19NO2/c1-2-8-3-4-10(5-8,7-11)6-9(12)13/h8H,2-7,11H2,1H3,(H,12,13) D0RS3R DRUGINKE JUNVYYPZXPVIAH-UHFFFAOYSA-N D0RS3R DRUGSMIL CCC1CCC(C1)(CC(=O)O)CN D0RS3R HIGHSTAT Investigative D0RT9B DRUG__ID D0RT9B D0RT9B DRUGTYPE Small molecular drug D0RT9B DRUGINCH 1S/C11H14ClNO/c12-9-3-1-8(2-4-9)11-6-5-10(7-13)14-11/h1-4,10-11H,5-7,13H2 D0RT9B DRUGINKE KHKLNHSDQIKVSU-UHFFFAOYSA-N D0RT9B DRUGSMIL C1CC(OC1CN)C2=CC=C(C=C2)Cl D0RT9B HIGHSTAT Investigative D0RU1X DRUG__ID D0RU1X D0RU1X DRUGTYPE Small molecular drug D0RU1X DRUGINCH 1S/C14H18O3/c15-13(12-8-4-3-5-9-12)10-6-1-2-7-11-14(16)17/h3-5,8-9H,1-2,6-7,10-11H2,(H,16,17) D0RU1X DRUGINKE UMCSRRHQLAVYRS-UHFFFAOYSA-N D0RU1X DRUGSMIL C1=CC=C(C=C1)C(=O)CCCCCCC(=O)O D0RU1X HIGHSTAT Investigative D0RU5N DRUG__ID D0RU5N D0RU5N DRUGTYPE Small molecular drug D0RU5N DRUGINCH 1S/C11H21NO3/c1-3-4-5-8-7(2)10(14)11(15)9(6-13)12-8/h3,7-15H,1,4-6H2,2H3/t7-,8-,9+,10+,11-/m0/s1 D0RU5N DRUGINKE DJRPURFURDDUBK-DAWVFNFOSA-N D0RU5N DRUGSMIL CC1C(NC(C(C1O)O)CO)CCC=C D0RU5N HIGHSTAT Investigative D0RV7M DRUG__ID D0RV7M D0RV7M DRUGTYPE Small molecular drug D0RV7M DRUGINCH 1S/C9H14N2O11P2/c12-5-3-8(11-2-1-7(13)10-9(11)14)21-6(5)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1 D0RV7M DRUGINKE QHWZTVCCBMIIKE-SHYZEUOFSA-N D0RV7M DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(O)OP(=O)(O)O)O D0RV7M HIGHSTAT Investigative D0RW1Y DRUG__ID D0RW1Y D0RW1Y DRUGTYPE Small molecular drug D0RW1Y DRUGINCH 1S/C20H20N2/c1-2-8-15(9-3-1)14-21-20-16-10-4-6-12-18(16)22-19-13-7-5-11-17(19)20/h1-4,6,8-10,12H,5,7,11,13-14H2,(H,21,22) D0RW1Y DRUGINKE JYJAEHAURXXPSD-UHFFFAOYSA-N D0RW1Y DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCC4=CC=CC=C4 D0RW1Y HIGHSTAT Investigative D0RX6I DRUG__ID D0RX6I D0RX6I DRUGTYPE Small molecular drug D0RX6I DRUGINCH 1S/C16H14N2/c1-2-13(16-10-17-11-18-16)15-9-5-7-12-6-3-4-8-14(12)15/h2-11H,1H3,(H,17,18)/b13-2+ D0RX6I DRUGINKE VDVBKYMIYSQNPM-XNJYKOPJSA-N D0RX6I DRUGSMIL CC=C(C1=CC=CC2=CC=CC=C21)C3=CN=CN3 D0RX6I HIGHSTAT Investigative D0RX9W DRUG__ID D0RX9W D0RX9W DRUGTYPE Small molecular drug D0RX9W DRUGINCH 1S/C13H24N2O/c16-13(14-11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h11-12H,1-10H2,(H2,14,15,16) D0RX9W DRUGINKE ADFXKUOMJKEIND-UHFFFAOYSA-N D0RX9W DRUGSMIL C1CCC(CC1)NC(=O)NC2CCCCC2 D0RX9W HIGHSTAT Investigative D0RZ1H DRUG__ID D0RZ1H D0RZ1H DRUGTYPE Small molecular drug D0RZ1H DRUGINCH 1S/C9H8O5/c1-3-6-4(9(13)14-3)2-5(10)7(11)8(6)12/h2-3,10-12H,1H3 D0RZ1H DRUGINKE AGUVVAYMPQDJDX-UHFFFAOYSA-N D0RZ1H DRUGSMIL CC1C2=C(C(=C(C=C2C(=O)O1)O)O)O D0RZ1H HIGHSTAT Investigative D0RZ2M DRUG__ID D0RZ2M D0RZ2M DRUGTYPE Small molecular drug D0RZ2M DRUGINCH 1S/C17H12N4/c1-3-7-12(8-4-1)14-15-17(19-11-18-15)21-16(20-14)13-9-5-2-6-10-13/h1-11H,(H,18,19,20,21) D0RZ2M DRUGINKE WNVFFQZYOFELQA-UHFFFAOYSA-N D0RZ2M DRUGSMIL C1=CC=C(C=C1)C2=C3C(=NC(=N2)C4=CC=CC=C4)N=CN3 D0RZ2M HIGHSTAT Investigative D0RZ5U DRUG__ID D0RZ5U D0RZ5U DRUGTYPE Small molecular drug D0RZ5U DRUGINCH 1S/C10H12N4O2/c1-4-5-14-6-11-8-7(14)9(15)13(3)10(16)12(8)2/h4,6H,1,5H2,2-3H3 D0RZ5U DRUGINKE ZGIBYCLLIMGXEZ-UHFFFAOYSA-N D0RZ5U DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC=C D0RZ5U HIGHSTAT Investigative D0S0AN DRUG__ID D0S0AN D0S0AN DRUGTYPE Small molecular drug D0S0AN DRUGINCH 1S/C23H23ClFN3O3/c24-16-3-6-19-15(12-16)13-20(26-19)22(30)27-21(11-14-1-4-17(25)5-2-14)23(31)28-9-7-18(29)8-10-28/h1-6,12-13,18,21,26,29H,7-11H2,(H,27,30)/t21-/m0/s1 D0S0AN DRUGINKE YDCGVASFVACWKF-NRFANRHFSA-N D0S0AN DRUGSMIL C1CN(CCC1O)C(=O)C(CC2=CC=C(C=C2)F)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl D0S0AN HIGHSTAT Investigative D0S0BK DRUG__ID D0S0BK D0S0BK DRUGTYPE Small molecular drug D0S0BK DRUGINCH 1S/C15H20O3/c1-11-7-8-14(18-10-15(16)17)13(9-11)12-5-3-2-4-6-12/h7-9,12H,2-6,10H2,1H3,(H,16,17) D0S0BK DRUGINKE QMGSFVNEZAIRGD-UHFFFAOYSA-N D0S0BK DRUGSMIL CC1=CC(=C(C=C1)OCC(=O)O)C2CCCCC2 D0S0BK HIGHSTAT Investigative D0S0BN DRUG__ID D0S0BN D0S0BN DRUGTYPE Small molecular drug D0S0BN DRUGINCH 1S/C30H18O14/c31-10-1-11(32)4-14(3-10)40-24-17(36)7-16(35)22-23-21(42-28(22)24)9-20(39)25-29(23)43-27-19(38)8-18(37)26(30(27)44-25)41-15-5-12(33)2-13(34)6-15/h1-9,31-39H D0S0BN DRUGINKE SLWPBUMYPRVYIJ-UHFFFAOYSA-N D0S0BN DRUGSMIL C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C3C5=C(C(=C4)O)OC6=C(O5)C(=CC(=C6OC7=CC(=CC(=C7)O)O)O)O)O)O)O D0S0BN HIGHSTAT Investigative D0S0DT DRUG__ID D0S0DT D0S0DT DRUGTYPE Small molecular drug D0S0DT DRUGINCH 1S/C25H25NO3/c1-2-3-13-24(27)26(21-9-5-4-6-10-21)18-19-14-16-20(17-15-19)22-11-7-8-12-23(22)25(28)29/h4-12,14-17H,2-3,13,18H2,1H3,(H,28,29) D0S0DT DRUGINKE IUJTVDNJFPZYBL-UHFFFAOYSA-N D0S0DT DRUGSMIL CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C(=O)O)C3=CC=CC=C3 D0S0DT HIGHSTAT Investigative D0S0EE DRUG__ID D0S0EE D0S0EE DRUGTYPE Small molecular drug D0S0EE DRUGINCH 1S/C20H23NO/c1-3-7-16(8-4-1)15-22-20(17-9-5-2-6-10-17)13-18-11-12-19(14-20)21-18/h1-10,18-19,21H,11-15H2 D0S0EE DRUGINKE DFUGHSKLQQMYID-UHFFFAOYSA-N D0S0EE DRUGSMIL C1CC2CC(CC1N2)(C3=CC=CC=C3)OCC4=CC=CC=C4 D0S0EE HIGHSTAT Investigative D0S0EP DRUG__ID D0S0EP D0S0EP DRUGTYPE Small molecular drug D0S0EP DRUGINCH 1S/C10H9N3O2/c14-13(15)10-3-1-9(2-4-10)7-12-6-5-11-8-12/h1-6,8H,7H2 D0S0EP DRUGINKE FLYGQJXMRPZYHQ-UHFFFAOYSA-N D0S0EP DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)[N+](=O)[O-] D0S0EP HIGHSTAT Investigative D0S0GT DRUG__ID D0S0GT D0S0GT DRUGTYPE Small molecular drug D0S0GT DRUGINCH 1S/C13H10N2O2S/c16-18(17,10-5-2-1-3-6-10)12-9-15-13-11(12)7-4-8-14-13/h1-9H,(H,14,15) D0S0GT DRUGINKE XIVJYIWQYBHEBJ-UHFFFAOYSA-N D0S0GT DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CNC3=C2C=CC=N3 D0S0GT HIGHSTAT Investigative D0S0GV DRUG__ID D0S0GV D0S0GV DRUGTYPE Small molecular drug D0S0GV DRUGINCH 1S/C37H49N11O6/c1-48-30(20-22-11-14-26(49)15-12-22)34(53)44-21-31(50)45-29(19-23-10-13-24-6-2-3-7-25(24)18-23)33(52)46-27(8-4-16-42-36(38)39)32(51)47-28(35(48)54)9-5-17-43-37(40)41/h2-3,6-7,10-15,18,27-30,49H,4-5,8-9,16-17,19-21H2,1H3,(H,44,53)(H,45,50)(H,46,52)(H,47,51)(H4,38,39,42)(H4,40,41,43)/t27-,28-,29-,30+/m0/s1 D0S0GV DRUGINKE KKHZUKILPGNUFR-GCXHJFECSA-N D0S0GV DRUGSMIL CN1C(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C1=O)CCCN=C(N)N)CCCN=C(N)N)CC2=CC3=CC=CC=C3C=C2)CC4=CC=C(C=C4)O D0S0GV HIGHSTAT Investigative D0S0HT DRUG__ID D0S0HT D0S0HT DRUGTYPE Small molecular drug D0S0HT DRUGINCH 1S/C9H9N3/c1-2-8(5-10-3-1)4-9-6-11-7-12-9/h1-3,5-7H,4H2,(H,11,12) D0S0HT DRUGINKE IQMRECYOUIKYGG-UHFFFAOYSA-N D0S0HT DRUGSMIL C1=CC(=CN=C1)CC2=CN=CN2 D0S0HT HIGHSTAT Investigative D0S0JH DRUG__ID D0S0JH D0S0JH DRUGTYPE Small molecular drug D0S0JH DRUGINCH 1S/C12H9NO4/c1-15-11-9-6(2-3-16-9)4-7-5-8(13)12(14)17-10(7)11/h2-5H,13H2,1H3 D0S0JH DRUGINKE YFAQAXXPQHHTHA-UHFFFAOYSA-N D0S0JH DRUGSMIL COC1=C2C(=CC3=C1OC(=O)C(=C3)N)C=CO2 D0S0JH HIGHSTAT Investigative D0S0JL DRUG__ID D0S0JL D0S0JL DRUGTYPE Small molecular drug D0S0JL DRUGINCH 1S/C10H13NO2S/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1 D0S0JL DRUGINKE GHBAYRBVXCRIHT-VIFPVBQESA-N D0S0JL DRUGSMIL C1=CC=C(C=C1)CSCC(C(=O)O)N D0S0JL HIGHSTAT Investigative D0S0NB DRUG__ID D0S0NB D0S0NB DRUGTYPE Small molecular drug D0S0NB DRUGINCH 1S/C14H8ClF3N2O/c15-9-2-1-3-10(7-9)20-12-5-4-8(14(16,17)18)6-11(12)19-13(20)21/h1-7H,(H,19,21) D0S0NB DRUGINKE NMPJFFWYEIIGFW-UHFFFAOYSA-N D0S0NB DRUGSMIL C1=CC(=CC(=C1)Cl)N2C3=C(C=C(C=C3)C(F)(F)F)NC2=O D0S0NB HIGHSTAT Investigative D0S0OE DRUG__ID D0S0OE D0S0OE DRUGTYPE Small molecular drug D0S0OE DRUGINCH 1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-19(23-18)16-14-17-20(21)22/h6-7,9-13,15,18-19H,2-5,8,14,16-17H2,1H3,(H,21,22)/b7-6-,10-9-,12-11+,15-13+/t18-,19-/m0/s1 D0S0OE DRUGINKE UFPQIRYSPUYQHK-WAQVJNLQSA-N D0S0OE DRUGSMIL CCCCCC=CCC=CC=CC=CC1C(O1)CCCC(=O)O D0S0OE HIGHSTAT Investigative D0S0OV DRUG__ID D0S0OV D0S0OV DRUGTYPE Small molecular drug D0S0OV DRUGINCH 1S/C19H18N2O2/c1-22-15-7-8-16-17(21-10-9-20-13-21)12-18(23-19(16)11-15)14-5-3-2-4-6-14/h2-11,13,17-18H,12H2,1H3 D0S0OV DRUGINKE JEQHTTKNYWNYDK-UHFFFAOYSA-N D0S0OV DRUGSMIL COC1=CC2=C(C=C1)C(CC(O2)C3=CC=CC=C3)N4C=CN=C4 D0S0OV HIGHSTAT Investigative D0S0PA DRUG__ID D0S0PA D0S0PA DRUGTYPE Small molecular drug D0S0PA DRUGINCH 1S/C14H13NO/c15-9-12-10-5-1-3-7-13(10)16-14-8-4-2-6-11(12)14/h1-8,12H,9,15H2 D0S0PA DRUGINKE VYDDHEPARBFMGU-UHFFFAOYSA-N D0S0PA DRUGSMIL C1=CC=C2C(=C1)C(C3=CC=CC=C3O2)CN D0S0PA HIGHSTAT Investigative D0S0PB DRUG__ID D0S0PB D0S0PB DRUGTYPE Small molecular drug D0S0PB DRUGINCH 1S/C13H10N2O/c16-13-11-8-4-5-9-12(11)14-15(13)10-6-2-1-3-7-10/h1-9,14H D0S0PB DRUGINKE CFNJFZDGHGYAMU-UHFFFAOYSA-N D0S0PB DRUGSMIL C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3N2 D0S0PB HIGHSTAT Investigative D0S0PI DRUG__ID D0S0PI D0S0PI DRUGTYPE Small molecular drug D0S0PI DRUGINCH 1S/C17H17N5O6S/c23-5-11-13(24)14(25)17(28-11)21-8-20-12-15(21)18-7-19-16(12)29-6-9-1-3-10(4-2-9)22(26)27/h1-4,7-8,11,13-14,17,23-25H,5-6H2 D0S0PI DRUGINKE DYCJFJRCWPVDHY-UHFFFAOYSA-N D0S0PI DRUGSMIL C1=CC(=CC=C1CSC2=NC=NC3=C2N=CN3C4C(C(C(O4)CO)O)O)[N+](=O)[O-] D0S0PI HIGHSTAT Investigative D0S0PU DRUG__ID D0S0PU D0S0PU DRUGTYPE Small molecular drug D0S0PU DRUGINCH 1S/C37H49N11O6/c1-21-31(50)47-30(20-23-10-13-24-6-2-3-7-25(24)18-23)35(54)46-27(8-4-16-42-36(38)39)32(51)45-28(9-5-17-43-37(40)41)33(52)48-29(34(53)44-21)19-22-11-14-26(49)15-12-22/h2-3,6-7,10-15,18,21,27-30,49H,4-5,8-9,16-17,19-20H2,1H3,(H,44,53)(H,45,51)(H,46,54)(H,47,50)(H,48,52)(H4,38,39,42)(H4,40,41,43)/t21-,27+,28+,29-,30+/m1/s1 D0S0PU DRUGINKE VWZBFEAQYFTPKH-CSHHCLTFSA-N D0S0PU DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D0S0PU HIGHSTAT Investigative D0S0QN DRUG__ID D0S0QN D0S0QN DRUGTYPE Small molecular drug D0S0QN DRUGINCH 1S/C19H16O3/c20-17-7-1-13(2-8-17)11-15-5-6-16(19(15)22)12-14-3-9-18(21)10-4-14/h1-4,7-12,20-21H,5-6H2/b15-11+,16-12+ D0S0QN DRUGINKE YSEMBYWAAKOCKW-JOBJLJCHSA-N D0S0QN DRUGSMIL C1CC(=CC2=CC=C(C=C2)O)C(=O)C1=CC3=CC=C(C=C3)O D0S0QN HIGHSTAT Investigative D0S0QY DRUG__ID D0S0QY D0S0QY DRUGTYPE Small molecular drug D0S0QY DRUGINCH 1S/C19H14FNO2/c20-18-13-14(6-8-17(18)9-10-19(22)23)5-7-15-3-1-2-4-16(15)11-12-21/h1-4,6,8,13H,9-11H2,(H,22,23) D0S0QY DRUGINKE KIZUBVPJNPVIIN-UHFFFAOYSA-N D0S0QY DRUGSMIL C1=CC=C(C(=C1)CC#N)C#CC2=CC(=C(C=C2)CCC(=O)O)F D0S0QY HIGHSTAT Investigative D0S0RK DRUG__ID D0S0RK D0S0RK DRUGTYPE Small molecular drug D0S0RK DRUGINCH 1S/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H D0S0RK DRUGINKE VHBFFQKBGNRLFZ-UHFFFAOYSA-N D0S0RK DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=CC=CC=C3O2 D0S0RK HIGHSTAT Investigative D0S0SH DRUG__ID D0S0SH D0S0SH DRUGTYPE Small molecular drug D0S0SH DRUGINCH 1S/C23H40N2O3/c26-21(27)10-8-6-4-2-1-3-5-7-9-11-24-22(28)25-23-15-18-12-19(16-23)14-20(13-18)17-23/h18-20H,1-17H2,(H,26,27)(H2,24,25,28) D0S0SH DRUGINKE XLGSEOAVLVTJDH-UHFFFAOYSA-N D0S0SH DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCCCCCCCCCCC(=O)O D0S0SH HIGHSTAT Investigative D0S0SZ DRUG__ID D0S0SZ D0S0SZ DRUGTYPE Small molecular drug D0S0SZ DRUGINCH 1S/C15H9NO3/c1-2-9-7-12(18)8-13-14(9)19-15(16-13)10-3-5-11(17)6-4-10/h1,3-8,17-18H D0S0SZ DRUGINKE UASSHNIRIMIZTA-UHFFFAOYSA-N D0S0SZ DRUGSMIL C#CC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D0S0SZ HIGHSTAT Investigative D0S0TY DRUG__ID D0S0TY D0S0TY DRUGTYPE Small molecular drug D0S0TY DRUGINCH 1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/t1?,2-,3-,4-,5+,6?/m0/s1 D0S0TY DRUGINKE INAPMGSXUVUWAF-GFWFORPUSA-N D0S0TY DRUGSMIL C1(C(C(C(C(C1O)O)OP(=O)(O)O)O)O)O D0S0TY HIGHSTAT Investigative D0S0WK DRUG__ID D0S0WK D0S0WK DRUGTYPE Small molecular drug D0S0WK DRUGINCH 1S/C14H19NO3/c16-13(12-8-4-3-5-9-12)10-6-1-2-7-11-14(17)15-18/h3-5,8-9,18H,1-2,6-7,10-11H2,(H,15,17) D0S0WK DRUGINKE DPHGSTLAQCKOFV-UHFFFAOYSA-N D0S0WK DRUGSMIL C1=CC=C(C=C1)C(=O)CCCCCCC(=O)NO D0S0WK HIGHSTAT Investigative D0S0WU DRUG__ID D0S0WU D0S0WU DRUGTYPE Small molecular drug D0S0WU DRUGINCH 1S/C11H13Cl2NO2S/c12-8-3-1-2-7(10(8)13)6-17-5-4-9(14)11(15)16/h1-3,9H,4-6,14H2,(H,15,16) D0S0WU DRUGINKE IHFPLLZGLBOAJJ-UHFFFAOYSA-N D0S0WU DRUGSMIL C1=CC(=C(C(=C1)Cl)Cl)CSCCC(C(=O)O)N D0S0WU HIGHSTAT Investigative D0S0WX DRUG__ID D0S0WX D0S0WX DRUGTYPE Small molecular drug D0S0WX DRUGINCH 1S/C17H19N/c18-11-5-10-17-15-8-3-1-6-13(15)12-14-7-2-4-9-16(14)17/h1-4,6-9,17H,5,10-12,18H2 D0S0WX DRUGINKE AUTKMGMMFJXIDV-UHFFFAOYSA-N D0S0WX DRUGSMIL C1C2=CC=CC=C2C(C3=CC=CC=C31)CCCN D0S0WX HIGHSTAT Investigative D0S0XD DRUG__ID D0S0XD D0S0XD DRUGTYPE Small molecular drug D0S0XD DRUGINCH 1S/C20H14Cl2N6O2S/c1-10(29)26-20-25-9-17(31-20)14-7-15(18-12(21)5-11(30-2)6-13(18)22)28-19(27-14)16-8-23-3-4-24-16/h3-9H,1-2H3,(H,25,26,29) D0S0XD DRUGINKE XACSASLXEAYEEO-UHFFFAOYSA-N D0S0XD DRUGSMIL CC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4Cl)OC)Cl D0S0XD HIGHSTAT Investigative D0S0YQ DRUG__ID D0S0YQ D0S0YQ DRUGTYPE Small molecular drug D0S0YQ DRUGINCH 1S/C12H10ClN3S/c13-9-5-1-2-6-10(9)15-12(17)16-11-7-3-4-8-14-11/h1-8H,(H2,14,15,16,17) D0S0YQ DRUGINKE ZRDDWFAJQXEXAI-UHFFFAOYSA-N D0S0YQ DRUGSMIL C1=CC=C(C(=C1)NC(=S)NC2=CC=CC=N2)Cl D0S0YQ HIGHSTAT Investigative D0S1AY DRUG__ID D0S1AY D0S1AY DRUGTYPE Small molecular drug D0S1AY DRUGINCH 1S/C12H13NO3/c1-7-6-10(14)13-12-9(16-3)5-4-8(15-2)11(7)12/h4-6H,1-3H3,(H,13,14) D0S1AY DRUGINKE BUHDAIGNGIXQJO-UHFFFAOYSA-N D0S1AY DRUGSMIL CC1=CC(=O)NC2=C(C=CC(=C12)OC)OC D0S1AY HIGHSTAT Investigative D0S1CS DRUG__ID D0S1CS D0S1CS DRUGTYPE Small molecular drug D0S1CS DRUGINCH 1S/C17H11FN2/c1-11-2-3-13-4-5-14(9-17(13)20-11)15-6-12(10-19)7-16(18)8-15/h2-9H,1H3 D0S1CS DRUGINKE SDOLISUYGVMVBK-UHFFFAOYSA-N D0S1CS DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC(=C3)C#N)F D0S1CS HIGHSTAT Investigative D0S1DD DRUG__ID D0S1DD D0S1DD DRUGTYPE Small molecular drug D0S1DD DRUGINCH 1S/C13H11ClN2O/c1-9-4-2-7-12(15-9)16-13(17)10-5-3-6-11(14)8-10/h2-8H,1H3,(H,15,16,17) D0S1DD DRUGINKE HNLLGNJHYQMYEI-UHFFFAOYSA-N D0S1DD DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CC(=CC=C2)Cl D0S1DD HIGHSTAT Investigative D0S1ER DRUG__ID D0S1ER D0S1ER DRUGTYPE Small molecular drug D0S1ER DRUGINCH 1S/C24H26FN3O4/c1-15(2)24-27-22(17-4-3-10-26-14-17)23(16-5-7-18(25)8-6-16)28(24)11-9-19(29)12-20(30)13-21(31)32/h3-11,14-15,19-20,29-30H,12-13H2,1-2H3,(H,31,32)/p-1/b11-9+/t19-,20-/m1/s1 D0S1ER DRUGINKE ALLUALRNIBGJAM-MBUYQLGJSA-M D0S1ER DRUGSMIL CC(C)C1=NC(=C(N1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CN=CC=C3 D0S1ER HIGHSTAT Investigative D0S1FF DRUG__ID D0S1FF D0S1FF DRUGTYPE Small molecular drug D0S1FF DRUGINCH 1S/C13H15NO/c1-9(2)14-12-7-8-13(15)11-6-4-3-5-10(11)12/h3-9,14-15H,1-2H3 D0S1FF DRUGINKE TWBKFLLEYLZFHH-UHFFFAOYSA-N D0S1FF DRUGSMIL CC(C)NC1=CC=C(C2=CC=CC=C21)O D0S1FF HIGHSTAT Investigative D0S1FM DRUG__ID D0S1FM D0S1FM DRUGCOMP Genta D0S1FM THERCLAS Antisense D0S1FM DRUGTYPE Combination drug (Antisense drug) D0S1FM DRUGSMIL failed D0S1FM HIGHSTAT Investigative D0S1FV DRUG__ID D0S1FV D0S1FV DRUGTYPE Small molecular drug D0S1FV DRUGINCH 1S/C19H15Br2N3O3/c20-15-8-13(18(26)17(21)19(15)27)9-23-24-16(25)10-22-14-6-5-11-3-1-2-4-12(11)7-14/h1-9,22,26-27H,10H2,(H,24,25)/b23-9+ D0S1FV DRUGINKE RMBDLOATEPYBSI-NUGSKGIGSA-N D0S1FV DRUGSMIL C1=CC=C2C=C(C=CC2=C1)NCC(=O)NN=CC3=CC(=C(C(=C3O)Br)O)Br D0S1FV HIGHSTAT Investigative D0S1GB DRUG__ID D0S1GB D0S1GB DRUGTYPE Small molecular drug D0S1GB DRUGINCH 1S/C13H19N/c1-10-5-6-12(8-11(10)2)13-4-3-7-14-9-13/h5-6,8,13-14H,3-4,7,9H2,1-2H3 D0S1GB DRUGINKE NDGKSXYKTXZIQO-UHFFFAOYSA-N D0S1GB DRUGSMIL CC1=C(C=C(C=C1)C2CCCNC2)C D0S1GB HIGHSTAT Investigative D0S1GH DRUG__ID D0S1GH D0S1GH DRUGTYPE Small molecular drug D0S1GH DRUGINCH 1S/C10H13NO3/c12-8-2-1-7(5-9(8)13)10-6-11-3-4-14-10/h1-2,5,10-13H,3-4,6H2 D0S1GH DRUGINKE GYJRRQRGZZEHEB-UHFFFAOYSA-N D0S1GH DRUGSMIL C1COC(CN1)C2=CC(=C(C=C2)O)O D0S1GH HIGHSTAT Investigative D0S1HI DRUG__ID D0S1HI D0S1HI DRUGCOMP Drugs for Neglected Diseases initiative D0S1HI DRUGINCH 1S/C14H8FN3O3/c15-11-6-4-9(5-7-11)14-16-13(17-21-14)10-2-1-3-12(8-10)18(19)20/h1-8H D0S1HI DRUGINKE PHSKMUVSVYQIRN-UHFFFAOYSA-N D0S1HI DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=NOC(=N2)C3=CC=C(C=C3)F D0S1HI HIGHSTAT Investigative D0S1II DRUG__ID D0S1II D0S1II DRUGTYPE Small molecular drug D0S1II DRUGINCH 1S/C15H13N3O2/c19-18(20)14-5-2-1-4-12(14)7-10-17-11-8-13-15(17)6-3-9-16-13/h1-6,8-9,11H,7,10H2 D0S1II DRUGINKE CEHGVNIFTRLUOI-UHFFFAOYSA-N D0S1II DRUGSMIL C1=CC=C(C(=C1)CCN2C=CC3=C2C=CC=N3)[N+](=O)[O-] D0S1II HIGHSTAT Investigative D0S1KJ DRUG__ID D0S1KJ D0S1KJ DRUGTYPE Small molecular drug D0S1KJ DRUGINCH 1S/C24H21Cl2N5O2/c1-30-22-15(13-18(23(30)32)21-19(25)3-2-4-20(21)26)14-27-24(29-22)28-16-5-7-17(8-6-16)31-9-11-33-12-10-31/h2-8,13-14H,9-12H2,1H3,(H,27,28,29) D0S1KJ DRUGINKE XZEJMVDCQZRHLN-UHFFFAOYSA-N D0S1KJ DRUGSMIL CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC=C(C=C4)N5CCOCC5 D0S1KJ HIGHSTAT Investigative D0S1LA DRUG__ID D0S1LA D0S1LA DRUGTYPE Small molecular drug D0S1LA DRUGINCH 1S/C24H34N6O8/c1-14(31)21(23(37)27-12-19(33)26-13-20(34)35)29-22(36)17-8-5-9-30(17)24(38)16(28-18(32)11-25)10-15-6-3-2-4-7-15/h2-4,6-7,14,16-17,21,31H,5,8-13,25H2,1H3,(H,26,33)(H,27,37)(H,28,32)(H,29,36)(H,34,35)/t14-,16+,17+,21+/m1/s1 D0S1LA DRUGINKE JWBSOWVZSDHJSP-IOFRSVQKSA-N D0S1LA DRUGSMIL CC(C(C(=O)NCC(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C(CC2=CC=CC=C2)NC(=O)CN)O D0S1LA HIGHSTAT Investigative D0S1MA DRUG__ID D0S1MA D0S1MA DRUGTYPE Small molecular drug D0S1MA DRUGINCH 1S/C19H22O4/c1-13(2)10-16(20)11-14(3)8-9-22-17-6-4-15-5-7-19(21)23-18(15)12-17/h4-8,10,12,16,20H,9,11H2,1-3H3/b14-8+ D0S1MA DRUGINKE VNADFOGBKXRWGC-RIYZIHGNSA-N D0S1MA DRUGSMIL CC(=CC(CC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C)O)C D0S1MA HIGHSTAT Investigative D0S1MC DRUG__ID D0S1MC D0S1MC DRUGTYPE Small molecular drug D0S1MC DRUGINCH 1S/C27H27NO4/c1-4-28(17-19-8-6-5-7-9-19)18-20-10-12-21(13-11-20)23-14-22-15-25(30-2)26(31-3)16-24(22)32-27(23)29/h5-16H,4,17-18H2,1-3H3 D0S1MC DRUGINKE PNZIOQNBQOTGPK-UHFFFAOYSA-N D0S1MC DRUGSMIL CCN(CC1=CC=CC=C1)CC2=CC=C(C=C2)C3=CC4=CC(=C(C=C4OC3=O)OC)OC D0S1MC HIGHSTAT Investigative D0S1MI DRUG__ID D0S1MI D0S1MI DRUGTYPE Small molecular drug D0S1MI DRUGINCH 1S/C19H22O3/c20-16-4-2-1-3-14-6-10-17(11-7-14)22-19-13-15(5-9-16)8-12-18(19)21/h6-8,10-13,16,20-21H,1-5,9H2/t16-/m0/s1 D0S1MI DRUGINKE BDTAPCJUUZRFKY-INIZCTEOSA-N D0S1MI DRUGSMIL C1CCC2=CC=C(C=C2)OC3=C(C=CC(=C3)CCC(C1)O)O D0S1MI HIGHSTAT Investigative D0S1OY DRUG__ID D0S1OY D0S1OY DRUGTYPE Small molecular drug D0S1OY DRUGINCH 1S/C15H24N2O3S/c1-3-5-13(6-4-2)15(18)17-11-12-7-9-14(10-8-12)21(16,19)20/h7-10,13H,3-6,11H2,1-2H3,(H,17,18)(H2,16,19,20) D0S1OY DRUGINKE VQEFALSVKDRQBJ-UHFFFAOYSA-N D0S1OY DRUGSMIL CCCC(CCC)C(=O)NCC1=CC=C(C=C1)S(=O)(=O)N D0S1OY HIGHSTAT Investigative D0S1VJ DRUG__ID D0S1VJ D0S1VJ DRUGTYPE Small molecular drug D0S1VJ DRUGINCH 1S/C13H14N6O2/c1-20-7-3-6(4-8(5-7)21-2)11-16-9-10(14)17-13(15)19-12(9)18-11/h3-5H,1-2H3,(H5,14,15,16,17,18,19) D0S1VJ DRUGINKE CFTYJGDHKCKXBN-UHFFFAOYSA-N D0S1VJ DRUGSMIL COC1=CC(=CC(=C1)C2=NC3=NC(=NC(=C3N2)N)N)OC D0S1VJ HIGHSTAT Investigative D0S1VT DRUG__ID D0S1VT D0S1VT DRUGTYPE Small molecular drug D0S1VT DRUGINCH 1S/C14H17N5O5/c15-12-9-13(17-5-16-12)19(6-18-9)14-11(23)10(22)7(24-14)3-1-2-4-8(20)21/h1,3,5-7,10-11,14,22-23H,2,4H2,(H,20,21)(H2,15,16,17)/b3-1-/t7-,10-,11-,14-/m1/s1 D0S1VT DRUGINKE ZZPNPWVYLOIHPM-RSPDOVAOSA-N D0S1VT DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C=CCCC(=O)O)O)O)N D0S1VT HIGHSTAT Investigative D0S1XC DRUG__ID D0S1XC D0S1XC DRUGTYPE Small molecular drug D0S1XC DRUGINCH 1S/C16H22N2/c1-2-3-7-16(8-10-17-12-16)14-4-5-15-13(11-14)6-9-18-15/h4-6,9,11,17-18H,2-3,7-8,10,12H2,1H3 D0S1XC DRUGINKE FIIZGBLPZZYXCS-UHFFFAOYSA-N D0S1XC DRUGSMIL CCCCC1(CCNC1)C2=CC3=C(C=C2)NC=C3 D0S1XC HIGHSTAT Investigative D0S1XN DRUG__ID D0S1XN D0S1XN DRUGTYPE Small molecular drug D0S1XN DRUGINCH 1S/C19H20BrN3/c20-17-6-7-18(16-8-9-21-19(16)17)23-12-10-22(11-13-23)14-15-4-2-1-3-5-15/h1-9,21H,10-14H2 D0S1XN DRUGINKE RBUDKKJLRVBPDA-UHFFFAOYSA-N D0S1XN DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=C4C=CNC4=C(C=C3)Br D0S1XN HIGHSTAT Investigative D0S2BB DRUG__ID D0S2BB D0S2BB DRUGTYPE Small molecular drug D0S2BB DRUGINCH 1S/C14H18N2O.C4H4O4/c1-16-6-4-10(5-7-16)13-9-15-14-3-2-11(17)8-12(13)14;5-3(6)1-2-4(7)8/h2-3,8-10,15,17H,4-7H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1- D0S2BB DRUGINKE INGCLXPSKXSYND-BTJKTKAUSA-N D0S2BB DRUGSMIL CN1CCC(CC1)C2=CNC3=C2C=C(C=C3)O.C(=CC(=O)O)C(=O)O D0S2BB HIGHSTAT Investigative D0S2BW DRUG__ID D0S2BW D0S2BW DRUGTYPE Small molecular drug D0S2BW DRUGINCH 1S/C20H26O4/c1-20-8-7-14-13-6-4-12(21)9-11(13)3-5-15(14)17(20)10-16(18(20)22)19(23)24-2/h4,6,9,14-18,21-22H,3,5,7-8,10H2,1-2H3/t14?,15?,16-,17?,18-,20-/m0/s1 D0S2BW DRUGINKE ATXQVYDXJMHPHM-ASCAHHBESA-N D0S2BW DRUGSMIL CC12CCC3C(C1CC(C2O)C(=O)OC)CCC4=C3C=CC(=C4)O D0S2BW HIGHSTAT Investigative D0S2DW DRUG__ID D0S2DW D0S2DW DRUGTYPE Small molecular drug D0S2DW DRUGINCH 1S/C26H25NO4/c1-27(16-18-7-5-4-6-8-18)17-19-9-11-20(12-10-19)22-13-21-14-24(29-2)25(30-3)15-23(21)31-26(22)28/h4-15H,16-17H2,1-3H3 D0S2DW DRUGINKE KXMCSAUVAHKCOR-UHFFFAOYSA-N D0S2DW DRUGSMIL CN(CC1=CC=CC=C1)CC2=CC=C(C=C2)C3=CC4=CC(=C(C=C4OC3=O)OC)OC D0S2DW HIGHSTAT Investigative D0S2FW DRUG__ID D0S2FW D0S2FW DRUGTYPE Small molecular drug D0S2FW DRUGINCH 1S/C11H13IN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11?/m1/s1 D0S2FW DRUGINKE WHSIXKUPQCKWBY-YNJARDAQSA-N D0S2FW DRUGSMIL C1=C(C2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N)I D0S2FW HIGHSTAT Investigative D0S2GF DRUG__ID D0S2GF D0S2GF DRUGTYPE Small molecular drug D0S2GF DRUGINCH 1S/C10H5ClN2/c11-10-4-2-1-3-9(10)5-8(6-12)7-13/h1-5H D0S2GF DRUGINKE JJNZXLAFIPKXIG-UHFFFAOYSA-N D0S2GF DRUGSMIL C1=CC=C(C(=C1)C=C(C#N)C#N)Cl D0S2GF HIGHSTAT Investigative D0S2HQ DRUG__ID D0S2HQ D0S2HQ DRUGTYPE Small molecular drug D0S2HQ DRUGINCH 1S/C15H13ClO3/c16-12-6-8-13(9-7-12)19-14(15(17)18)10-11-4-2-1-3-5-11/h1-9,14H,10H2,(H,17,18) D0S2HQ DRUGINKE CPBLTMSKPQDJPW-UHFFFAOYSA-N D0S2HQ DRUGSMIL C1=CC=C(C=C1)CC(C(=O)O)OC2=CC=C(C=C2)Cl D0S2HQ HIGHSTAT Investigative D0S2II DRUG__ID D0S2II D0S2II DRUGTYPE Small molecular drug D0S2II DRUGINCH 1S/C13H12N2O2S/c14-18(16,17)13-8-6-12(7-9-13)15-10-11-4-2-1-3-5-11/h1-10H,(H2,14,16,17) D0S2II DRUGINKE OPUFYXLEFFRGSQ-UHFFFAOYSA-N D0S2II DRUGSMIL C1=CC=C(C=C1)C=NC2=CC=C(C=C2)S(=O)(=O)N D0S2II HIGHSTAT Investigative D0S2IS DRUG__ID D0S2IS D0S2IS DRUGTYPE Small molecular drug D0S2IS DRUGINCH 1S/C10H12BrN3S/c1-2-9(13-14-10(12)15)7-4-3-5-8(11)6-7/h3-6H,2H2,1H3,(H3,12,14,15)/b13-9+ D0S2IS DRUGINKE WBIKZQWGHHXZTG-UKTHLTGXSA-N D0S2IS DRUGSMIL CCC(=NNC(=S)N)C1=CC(=CC=C1)Br D0S2IS HIGHSTAT Investigative D0S2LO DRUG__ID D0S2LO D0S2LO DRUGTYPE Small molecular drug D0S2LO DRUGINCH 1S/C21H29N5O2/c27-19(16-17-8-4-3-5-9-17)13-11-18-12-14-21(28)26(18)15-7-2-1-6-10-20-22-24-25-23-20/h3-5,8-9,11,13,18-19,27H,1-2,6-7,10,12,14-16H2,(H,22,23,24,25)/b13-11+/t18-,19+/m0/s1 D0S2LO DRUGINKE JWYPJSNXPZTEHL-VJKINUSGSA-N D0S2LO DRUGSMIL C1CC(=O)N(C1C=CC(CC2=CC=CC=C2)O)CCCCCCC3=NNN=N3 D0S2LO HIGHSTAT Investigative D0S2MO DRUG__ID D0S2MO D0S2MO DRUGTYPE Small molecular drug D0S2MO DRUGINCH 1S/C23H23N5O/c1-26-15-12-18(13-16-26)28-21(29)11-10-19(24-28)22-20-9-5-6-14-27(20)25-23(22)17-7-3-2-4-8-17/h2-11,14,18H,12-13,15-16H2,1H3 D0S2MO DRUGINKE YHDRUTMZCJZJAL-UHFFFAOYSA-N D0S2MO DRUGSMIL CN1CCC(CC1)N2C(=O)C=CC(=N2)C3=C4C=CC=CN4N=C3C5=CC=CC=C5 D0S2MO HIGHSTAT Investigative D0S2NU DRUG__ID D0S2NU D0S2NU DRUGTYPE Small molecular drug D0S2NU DRUGINCH 1S/C8H7Cl2N3S/c9-6-1-5(2-7(10)3-6)4-12-13-8(11)14/h1-4H,(H3,11,13,14)/b12-4+ D0S2NU DRUGINKE OTKIBPHYGDDNDE-UUILKARUSA-N D0S2NU DRUGSMIL C1=C(C=C(C=C1Cl)Cl)C=NNC(=S)N D0S2NU HIGHSTAT Investigative D0S2OA DRUG__ID D0S2OA D0S2OA DRUGTYPE Small molecular drug D0S2OA DRUGINCH 1S/C31H31NO/c1-5-13-26(14-6-1)25-33-31(29-19-11-4-12-20-29)21-23-32(24-22-31)30(27-15-7-2-8-16-27)28-17-9-3-10-18-28/h1-20,30H,21-25H2 D0S2OA DRUGINKE KSNUQMXXRSKFOM-UHFFFAOYSA-N D0S2OA DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)OCC3=CC=CC=C3)C(C4=CC=CC=C4)C5=CC=CC=C5 D0S2OA HIGHSTAT Investigative D0S2QZ DRUG__ID D0S2QZ D0S2QZ DRUGTYPE Small molecular drug D0S2QZ DRUGINCH 1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 D0S2QZ DRUGINKE IERHLVCPSMICTF-XVFCMESISA-N D0S2QZ DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O D0S2QZ HIGHSTAT Investigative D0S2TI DRUG__ID D0S2TI D0S2TI DRUGTYPE Small molecular drug D0S2TI DRUGINCH 1S/C22H21N3O2/c1-22(2)12-13-9-19(26-3)20(27-4)10-14(13)18-11-17-21(25(18)22)24-16-8-6-5-7-15(16)23-17/h5-11H,12H2,1-4H3 D0S2TI DRUGINKE HIXSPVQXXDULHS-UHFFFAOYSA-N D0S2TI DRUGSMIL CC1(CC2=CC(=C(C=C2C3=CC4=NC5=CC=CC=C5N=C4N31)OC)OC)C D0S2TI HIGHSTAT Investigative D0S2TZ DRUG__ID D0S2TZ D0S2TZ DRUGTYPE Small molecular drug D0S2TZ DRUGINCH 1S/C19H22O6/c1-8-5-14(24-18(22)9(2)7-20)16-11(4)19(23)25-17(16)15-10(3)13(21)6-12(8)15/h12-17,20-21H,1-7H2/t12-,13-,14-,15-,16+,17+/m0/s1 D0S2TZ DRUGINKE KHSCYOFDKADJDJ-NQLMQOPMSA-N D0S2TZ DRUGSMIL C=C1CC(C2C(C3C1CC(C3=C)O)OC(=O)C2=C)OC(=O)C(=C)CO D0S2TZ HIGHSTAT Investigative D0S2UZ DRUG__ID D0S2UZ D0S2UZ DRUGTYPE Small molecular drug D0S2UZ DRUGINCH 1S/C21H27NO3/c23-21(22-14-8-5-9-15-22)11-7-4-2-1-3-6-10-18-12-13-19-20(16-18)25-17-24-19/h6-7,10-13,16H,1-5,8-9,14-15,17H2/b10-6+,11-7+ D0S2UZ DRUGINKE PKLGRWSJBLGIBF-JMQWPVDRSA-N D0S2UZ DRUGSMIL C1CCN(CC1)C(=O)C=CCCCCC=CC2=CC3=C(C=C2)OCO3 D0S2UZ HIGHSTAT Investigative D0S2XF DRUG__ID D0S2XF D0S2XF DRUGTYPE Small molecular drug D0S2XF DRUGINCH 1S/C20H32O6/c1-2-3-6-9-15(21)12-13-18-16(17(22)14-20(25)26-18)10-7-4-5-8-11-19(23)24/h4,7,12-13,15-18,21-22H,2-3,5-6,8-11,14H2,1H3,(H,23,24)/b7-4-,13-12+/t15-,16-,17-,18+/m0/s1 D0S2XF DRUGINKE KJYIVXDPWBUJBQ-UHHGALCXSA-N D0S2XF DRUGSMIL CCCCCC(C=CC1C(C(CC(=O)O1)O)CC=CCCCC(=O)O)O D0S2XF HIGHSTAT Investigative D0S2ZJ DRUG__ID D0S2ZJ D0S2ZJ DRUGTYPE Small molecular drug D0S2ZJ DRUGINCH 1S/C13H9NO4/c15-7-4-5-9-11(6-7)18-13(14-9)8-2-1-3-10(16)12(8)17/h1-6,15-17H D0S2ZJ DRUGINKE MRXLNZKXLFWEGB-UHFFFAOYSA-N D0S2ZJ DRUGSMIL C1=CC(=C(C(=C1)O)O)C2=NC3=C(O2)C=C(C=C3)O D0S2ZJ HIGHSTAT Investigative D0S2ZR DRUG__ID D0S2ZR D0S2ZR DRUGTYPE Small molecular drug D0S2ZR DRUGINCH 1S/C27H27NO/c1-2-3-4-10-18-28-20-23(19-26(28)22-13-6-5-7-14-22)27(29)25-17-11-15-21-12-8-9-16-24(21)25/h5-9,11-17,19-20H,2-4,10,18H2,1H3 D0S2ZR DRUGINKE FRMYAMAGHYHNKF-UHFFFAOYSA-N D0S2ZR DRUGSMIL CCCCCCN1C=C(C=C1C2=CC=CC=C2)C(=O)C3=CC=CC4=CC=CC=C43 D0S2ZR HIGHSTAT Investigative D0S3BO DRUG__ID D0S3BO D0S3BO DRUGTYPE Small molecular drug D0S3BO DRUGINCH 1S/C35H41N3O6S/c1-21-11-10-12-22(2)31(21)44-19-28(40)36-26(17-23-13-6-5-7-14-23)30(41)34(43)38-20-45-35(3,4)32(38)33(42)37-29-25-16-9-8-15-24(25)18-27(29)39/h5-16,26-27,29-30,32,39,41H,17-20H2,1-4H3,(H,36,40)(H,37,42)/t26-,27+,29-,30-,32+/m0/s1 D0S3BO DRUGINKE KKTYZYHUPKXLPL-RIQJEONASA-N D0S3BO DRUGSMIL CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D0S3BO HIGHSTAT Investigative D0S3DD DRUG__ID D0S3DD D0S3DD DRUGTYPE Small molecular drug D0S3DD DRUGINCH 1S/C22H23N5O2/c28-21(29)8-12-24-19-15-20(26-22(25-19)18-7-3-4-11-23-18)27-13-9-16-5-1-2-6-17(16)10-14-27/h1-7,11,15H,8-10,12-14H2,(H,28,29)(H,24,25,26) D0S3DD DRUGINKE AVZCPICCWKMZDT-UHFFFAOYSA-N D0S3DD DRUGSMIL C1CN(CCC2=CC=CC=C21)C3=NC(=NC(=C3)NCCC(=O)O)C4=CC=CC=N4 D0S3DD HIGHSTAT Investigative D0S3FW DRUG__ID D0S3FW D0S3FW DRUGTYPE Small molecular drug D0S3FW DRUGINCH 1S/C18H14N4/c1-3-7-14(8-4-1)16-12-20-18(17-11-19-13-22(16)17)21-15-9-5-2-6-10-15/h1-13H,(H,20,21) D0S3FW DRUGINKE BJCBFPYPEDWTTE-UHFFFAOYSA-N D0S3FW DRUGSMIL C1=CC=C(C=C1)C2=CN=C(C3=CN=CN32)NC4=CC=CC=C4 D0S3FW HIGHSTAT Investigative D0S3IX DRUG__ID D0S3IX D0S3IX DRUGTYPE Small molecular drug D0S3IX DRUGINCH 1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8) D0S3IX DRUGINKE AWUCVROLDVIAJX-UHFFFAOYSA-N D0S3IX DRUGSMIL C(C(COP(=O)(O)O)O)O D0S3IX HIGHSTAT Investigative D0S3KS DRUG__ID D0S3KS D0S3KS DRUGTYPE Small molecular drug D0S3KS DRUGINCH 1S/C15H21NO2/c1-18-14-9-7-12(8-10-14)11-15(17)16-13-5-3-2-4-6-13/h7-10,13H,2-6,11H2,1H3,(H,16,17) D0S3KS DRUGINKE OUQSDJMKYLLVED-UHFFFAOYSA-N D0S3KS DRUGSMIL COC1=CC=C(C=C1)CC(=O)NC2CCCCC2 D0S3KS HIGHSTAT Investigative D0S3LK DRUG__ID D0S3LK D0S3LK DRUGTYPE Small molecular drug D0S3LK DRUGINCH 1S/C48H60N6O6/c1-29-19-37(55)20-30(2)39(29)25-41(49)47(59)53-27-35-15-9-7-13-33(35)23-43(53)45(57)51-17-11-5-6-12-18-52-46(58)44-24-34-14-8-10-16-36(34)28-54(44)48(60)42(50)26-40-31(3)21-38(56)22-32(40)4/h7-10,13-16,19-22,41-44,55-56H,5-6,11-12,17-18,23-28,49-50H2,1-4H3,(H,51,57)(H,52,58)/t41-,42-,43?,44?/m0/s1 D0S3LK DRUGINKE VJIXEMXKNBJTQB-GCGBLBKRSA-N D0S3LK DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCCCNC(=O)C4CC5=CC=CC=C5CN4C(=O)C(CC6=C(C=C(C=C6C)O)C)N)N)C)O D0S3LK HIGHSTAT Investigative D0S3NS DRUG__ID D0S3NS D0S3NS DRUGTYPE Small molecular drug D0S3NS DRUGINCH 1S/C22H25N3O2/c1-15(26)23-11-9-18-19-13-17(27-2)7-8-20(19)24-21(18)14-25-12-10-16-5-3-4-6-22(16)25/h3-8,13,24H,9-12,14H2,1-2H3,(H,23,26) D0S3NS DRUGINKE WPMBIMXWTHXWHN-UHFFFAOYSA-N D0S3NS DRUGSMIL CC(=O)NCCC1=C(NC2=C1C=C(C=C2)OC)CN3CCC4=CC=CC=C43 D0S3NS HIGHSTAT Investigative D0S3QN DRUG__ID D0S3QN D0S3QN DRUGTYPE Small molecular drug D0S3QN DRUGINCH 1S/C18H15NO4/c19-17(20)8-13-9-18(21)23-16-10-14(6-7-15(13)16)22-11-12-4-2-1-3-5-12/h1-7,9-10H,8,11H2,(H2,19,20) D0S3QN DRUGINKE XAUATGLGKLEUAX-UHFFFAOYSA-N D0S3QN DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)C(=CC(=O)O3)CC(=O)N D0S3QN HIGHSTAT Investigative D0S3RP DRUG__ID D0S3RP D0S3RP DRUGTYPE Small molecular drug D0S3RP DRUGINCH 1S/C17H17N3O2/c1-2-3-16(22)18-17-14-9-6-12(10-15(14)19-20-17)11-4-7-13(21)8-5-11/h4-10,21H,2-3H2,1H3,(H2,18,19,20,22) D0S3RP DRUGINKE VCIZMGNKKFEEHA-UHFFFAOYSA-N D0S3RP DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=C(C=C3)O D0S3RP HIGHSTAT Investigative D0S3RZ DRUG__ID D0S3RZ D0S3RZ DRUGTYPE Small molecular drug D0S3RZ DRUGINCH 1S/C18H26N2O6S2/c1-18-9-8-14-13-5-3-12(25-27(19,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)26-28(20,23)24/h3,5,10,14-17H,2,4,6-9H2,1H3,(H2,19,21,22)(H2,20,23,24)/t14-,15-,16+,17+,18+/m1/s1 D0S3RZ DRUGINKE ZVSCPWTWOPVEDW-ZBRFXRBCSA-N D0S3RZ DRUGSMIL CC12CCC3C(C1CCC2OS(=O)(=O)N)CCC4=C3C=CC(=C4)OS(=O)(=O)N D0S3RZ HIGHSTAT Investigative D0S3TJ DRUG__ID D0S3TJ D0S3TJ DRUGTYPE Small molecular drug D0S3TJ DRUGINCH 1S/C9H11N5O/c1-3-15-4-2-14(1)9-7-8(11-5-10-7)12-6-13-9/h5-6H,1-4H2,(H,10,11,12,13) D0S3TJ DRUGINKE MEOMXKNIFWDDGZ-UHFFFAOYSA-N D0S3TJ DRUGSMIL C1COCCN1C2=NC=NC3=C2NC=N3 D0S3TJ HIGHSTAT Investigative D0S3TY DRUG__ID D0S3TY D0S3TY DRUGTYPE Small molecular drug D0S3TY DRUGINCH 1S/C21H29N3/c1-3-5-7-17-9-13-19(14-10-17)23-21(22)24-20-15-11-18(12-16-20)8-6-4-2/h9-16H,3-8H2,1-2H3,(H3,22,23,24) D0S3TY DRUGINKE XDEXLYGQRYSUON-UHFFFAOYSA-N D0S3TY DRUGSMIL CCCCC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)CCCC)N D0S3TY HIGHSTAT Investigative D0S3TZ DRUG__ID D0S3TZ D0S3TZ DRUGTYPE Small molecular drug D0S3TZ DRUGINCH 1S/C22H29NO3/c1-25-18-5-3-4-16-12-19-22(26-2)9-8-17(24)13-21(22,20(16)18)10-11-23(19)14-15-6-7-15/h3-5,15,19H,6-14H2,1-2H3/t19-,21-,22-/m1/s1 D0S3TZ DRUGINKE INUCRGMCKDQKNA-CEMLEFRQSA-N D0S3TZ DRUGSMIL COC1=CC=CC2=C1C34CCN(C(C2)C3(CCC(=O)C4)OC)CC5CC5 D0S3TZ HIGHSTAT Investigative D0S3UA DRUG__ID D0S3UA D0S3UA DRUGTYPE Small molecular drug D0S3UA DRUGINCH 1S/C26H25NO/c1-2-3-9-17-27-19-22(18-25(27)21-12-5-4-6-13-21)26(28)24-16-10-14-20-11-7-8-15-23(20)24/h4-8,10-16,18-19H,2-3,9,17H2,1H3 D0S3UA DRUGINKE JLXYYSHMURZHKI-UHFFFAOYSA-N D0S3UA DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2)C(=O)C3=CC=CC4=CC=CC=C43 D0S3UA HIGHSTAT Investigative D0S3UM DRUG__ID D0S3UM D0S3UM DRUGTYPE Small molecular drug D0S3UM DRUGINCH 1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1 D0S3UM DRUGINKE YWEZXUNAYVCODW-RBUKOAKNSA-N D0S3UM DRUGSMIL CCCCCC1=C(C(=CC(=C1)O)O)C2C=C(CCC2C(=C)C)C D0S3UM HIGHSTAT Investigative D0S3UR DRUG__ID D0S3UR D0S3UR DRUGTYPE Small molecular drug D0S3UR DRUGINCH 1S/C12H24O22P4/c1-4(13)29-6(30-5(2)14)3-28-38(26,27)34-9-7(15)10(31-35(17,18)19)12(33-37(23,24)25)11(8(9)16)32-36(20,21)22/h6-12,15-16H,3H2,1-2H3,(H,26,27)(H2,17,18,19)(H2,20,21,22)(H2,23,24,25)/t7-,8-,9?,10-,11+,12?/m0/s1 D0S3UR DRUGINKE RQQIRMLGKSPXSE-WIPMOJCBSA-N D0S3UR DRUGSMIL CC(=O)OC(COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O)OC(=O)C D0S3UR HIGHSTAT Investigative D0S3VV DRUG__ID D0S3VV D0S3VV DRUGTYPE Small molecular drug D0S3VV DRUGINCH 1S/C8H9NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h1-4H,5,9H2,(H,10,11) D0S3VV DRUGINKE QCTBMLYLENLHLA-UHFFFAOYSA-N D0S3VV DRUGSMIL C1=CC(=CC=C1CN)C(=O)O D0S3VV HIGHSTAT Investigative D0S3WF DRUG__ID D0S3WF D0S3WF DRUGTYPE Small molecular drug D0S3WF DRUGINCH 1S/C23H28ClNO3/c24-21-10-6-9-20(17-21)23(26)27-16-5-4-13-25-14-11-22(12-15-25)28-18-19-7-2-1-3-8-19/h1-3,6-10,17,22H,4-5,11-16,18H2 D0S3WF DRUGINKE NDGPQNPYSUGIAY-UHFFFAOYSA-N D0S3WF DRUGSMIL C1CN(CCC1OCC2=CC=CC=C2)CCCCOC(=O)C3=CC(=CC=C3)Cl D0S3WF HIGHSTAT Investigative D0S3WN DRUG__ID D0S3WN D0S3WN DRUGTYPE Small molecular drug D0S3WN DRUGINCH 1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-28(18,19)26-29(20,21)27-30(22,23)31/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H,20,21)(H2,11,12,13)(H2,22,23,31)/p-4/t4-,6-,7-,10-/m1/s1 D0S3WN DRUGINKE NLTUCYMLOPLUHL-KQYNXXCUSA-J D0S3WN DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=S)([O-])[O-])O)O)N D0S3WN HIGHSTAT Investigative D0S3WR DRUG__ID D0S3WR D0S3WR DRUGTYPE Small molecular drug D0S3WR DRUGINCH 1S/C18H23N/c1-19(2)15-9-14-18(16-10-5-3-6-11-16)17-12-7-4-8-13-17/h3-8,10-13,18H,9,14-15H2,1-2H3 D0S3WR DRUGINKE BDSUMBDGCUOHGR-UHFFFAOYSA-N D0S3WR DRUGSMIL CN(C)CCCC(C1=CC=CC=C1)C2=CC=CC=C2 D0S3WR HIGHSTAT Investigative D0S3XI DRUG__ID D0S3XI D0S3XI DRUGTYPE Small molecular drug D0S3XI DRUGINCH 1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/p-1/b3-2+ D0S3XI DRUGINKE NKHAVTQWNUWKEO-NSCUHMNNSA-M D0S3XI DRUGSMIL COC(=O)C=CC(=O)[O-] D0S3XI HIGHSTAT Investigative D0S3XL DRUG__ID D0S3XL D0S3XL DRUGTYPE Small molecular drug D0S3XL DRUGINCH 1S/C52H73N15O12S/c1-27(2)17-36(64-51(78)40(21-41(54)69)61-42(70)22-53)48(75)66-38(19-31-23-57-34-14-10-9-13-33(31)34)47(74)60-28(3)46(73)67-44(29(4)68)52(79)58-25-43(71)62-39(20-32-24-56-26-59-32)50(77)65-37(18-30-11-7-6-8-12-30)49(76)63-35(45(55)72)15-16-80-5/h6-14,23-24,26-29,35-40,44,57,68H,15-22,25,53H2,1-5H3,(H2,54,69)(H2,55,72)(H,56,59)(H,58,79)(H,60,74)(H,61,70)(H,62,71)(H,63,76)(H,64,78)(H,65,77)(H,66,75)(H,67,73) D0S3XL DRUGINKE YPFNACALNKVZNK-UHFFFAOYSA-N D0S3XL DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CC3=CN=CN3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC(=O)N)NC(=O)CN D0S3XL HIGHSTAT Investigative D0S3YP DRUG__ID D0S3YP D0S3YP DRUGTYPE Small molecular drug D0S3YP DRUGINCH 1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3/t16-/m0/s1 D0S3YP DRUGINKE HMJIYCCIJYRONP-INIZCTEOSA-N D0S3YP DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC D0S3YP HIGHSTAT Investigative D0S4BK DRUG__ID D0S4BK D0S4BK DRUGTYPE Small molecular drug D0S4BK DRUGINCH 1S/C19H25N7O14P2S/c20-15-9-17(23-4-22-15)26(5-24-9)19-13(30)11(28)8(39-19)2-37-42(34,35)40-41(32,33)36-1-7-10(27)12(29)14(38-7)18-25-6(3-43-18)16(21)31/h3-5,7-8,10-14,19,27-30H,1-2H2,(H2,21,31)(H,32,33)(H,34,35)(H2,20,22,23)/t7-,8-,10-,11-,12-,13-,14-,19-/m1/s1 D0S4BK DRUGINKE INQLNSVYIFCUML-QZTLEVGFSA-N D0S4BK DRUGSMIL C1=C(N=C(S1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N D0S4BK HIGHSTAT Investigative D0S4BV DRUG__ID D0S4BV D0S4BV DRUGTYPE Small molecular drug D0S4BV DRUGINCH 1S/C37H44N4O3/c1-3-4-5-6-28-7-17-33(18-8-28)37(43)41(34-19-23-40(24-20-34)27-35-38-21-22-39-35)26-30-11-15-32(16-12-30)31-13-9-29(10-14-31)25-36(42)44-2/h7-18,21-22,34H,3-6,19-20,23-27H2,1-2H3,(H,38,39) D0S4BV DRUGINKE JJVQUUYZGJWBPW-UHFFFAOYSA-N D0S4BV DRUGSMIL CCCCCC1=CC=C(C=C1)C(=O)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)CC(=O)OC)C4CCN(CC4)CC5=NC=CN5 D0S4BV HIGHSTAT Investigative D0S4CE DRUG__ID D0S4CE D0S4CE DRUGTYPE Small molecular drug D0S4CE DRUGINCH 1S/C38H25N3O3/c42-34-21-20-28-27(19-16-24-14-17-26(18-15-24)25-8-2-1-3-9-25)22-35-39-32-12-6-7-13-33(32)41(35)36(28)31(34)23-40-37(43)29-10-4-5-11-30(29)38(40)44/h1-22,42H,23H2/b19-16+ D0S4CE DRUGINKE XCVOBDZXSDXTNL-KNTRCKAVSA-N D0S4CE DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)C=CC3=CC4=NC5=CC=CC=C5N4C6=C3C=CC(=C6CN7C(=O)C8=CC=CC=C8C7=O)O D0S4CE HIGHSTAT Investigative D0S4DT DRUG__ID D0S4DT D0S4DT DRUGTYPE Small molecular drug D0S4DT DRUGINCH 1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1 D0S4DT DRUGINKE WYJAPUKIYAZSEM-MOPGFXCFSA-N D0S4DT DRUGSMIL CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=O)C2 D0S4DT HIGHSTAT Investigative D0S4DV DRUG__ID D0S4DV D0S4DV DRUGTYPE Small molecular drug D0S4DV DRUGINCH 1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6+,7-/m1/s1 D0S4DV DRUGINKE FXFBVZOJVHCEDO-IBISWUOJSA-N D0S4DV DRUGSMIL C1CC2(C(C(C(C1N2)O)O)O)O D0S4DV HIGHSTAT Investigative D0S4EI DRUG__ID D0S4EI D0S4EI DRUGTYPE Small molecular drug D0S4EI DRUGINCH 1S/C14H14OS2/c15-17(12-14-9-5-2-6-10-14)16-11-13-7-3-1-4-8-13/h1-10H,11-12H2 D0S4EI DRUGINKE VUJONJHZKSZFSA-UHFFFAOYSA-N D0S4EI DRUGSMIL C1=CC=C(C=C1)CSS(=O)CC2=CC=CC=C2 D0S4EI HIGHSTAT Investigative D0S4FV DRUG__ID D0S4FV D0S4FV DRUGTYPE Small molecular drug D0S4FV DRUGINCH 1S/C27H45NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-27(31)28-25(23-29)22-24-18-20-26(30)21-19-24/h9-10,18-21,25,29-30H,2-8,11-17,22-23H2,1H3,(H,28,31)/b10-9+/t25-/m1/s1 D0S4FV DRUGINKE ICDMLAQPOAVWNH-YHZGQTRVSA-N D0S4FV DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC(CC1=CC=C(C=C1)O)CO D0S4FV HIGHSTAT Investigative D0S4GK DRUG__ID D0S4GK D0S4GK DRUGTYPE Small molecular drug D0S4GK DRUGINCH 1S/C42H75N3O15/c1-22(26-9-10-27-25-8-7-23-18-24(48)12-13-41(23,2)28(25)19-31(51)42(26,27)3)6-11-32(52)45(16-4-14-43-39(59)37(57)35(55)33(53)29(49)20-46)17-5-15-44-40(60)38(58)36(56)34(54)30(50)21-47/h22-31,33-38,46-51,53-58H,4-21H2,1-3H3,(H,43,59)(H,44,60)/t22-,23-,24-,25+,26-,27+,28+,29-,30-,31+,33-,34-,35+,36+,37-,38-,41+,42-/m1/s1 D0S4GK DRUGINKE OJSUWTDDXLCUFR-HGZMBBKESA-N D0S4GK DRUGSMIL CC(CCC(=O)N(CCCNC(=O)C(C(C(C(CO)O)O)O)O)CCCNC(=O)C(C(C(C(CO)O)O)O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C D0S4GK HIGHSTAT Investigative D0S4JI DRUG__ID D0S4JI D0S4JI DRUGTYPE Small molecular drug D0S4JI DRUGINCH 1S/C12H11N5/c13-11-10-12(15-7-14-11)17(8-16-10)6-9-4-2-1-3-5-9/h1-5,7-8H,6H2,(H2,13,14,15) D0S4JI DRUGINKE MRHCSNNEUHXNIC-UHFFFAOYSA-N D0S4JI DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C(N=CN=C32)N D0S4JI HIGHSTAT Investigative D0S4JT DRUG__ID D0S4JT D0S4JT DRUGTYPE Small molecular drug D0S4JT DRUGINCH 1S/C17H20N2O/c1-2-7-16(8-3-1)20-14-15-6-4-5-9-17(15)19-12-10-18-11-13-19/h1-9,18H,10-14H2 D0S4JT DRUGINKE WLIGTTARDYGFBV-UHFFFAOYSA-N D0S4JT DRUGSMIL C1CN(CCN1)C2=CC=CC=C2COC3=CC=CC=C3 D0S4JT HIGHSTAT Investigative D0S4KP DRUG__ID D0S4KP D0S4KP DRUGTYPE Small molecular drug D0S4KP DRUGINCH 1S/C21H17NO/c1-14-9-17-10-18(23-2)8-7-15(17)11-20(14)21-13-22-12-16-5-3-4-6-19(16)21/h3-13H,1-2H3 D0S4KP DRUGINKE PVTDLLYLEPRYDL-UHFFFAOYSA-N D0S4KP DRUGSMIL CC1=CC2=C(C=CC(=C2)OC)C=C1C3=CN=CC4=CC=CC=C43 D0S4KP HIGHSTAT Investigative D0S4LW DRUG__ID D0S4LW D0S4LW DRUGTYPE Small molecular drug D0S4LW DRUGINCH 1S/C42H46N2O8/c1-27(2)23-43(25-29-15-19-33(20-16-29)51-31-11-7-5-8-12-31)39(45)35-36(38(42(49)50)37(35)41(47)48)40(46)44(24-28(3)4)26-30-17-21-34(22-18-30)52-32-13-9-6-10-14-32/h5-22,27-28,35-38H,23-26H2,1-4H3,(H,47,48)(H,49,50)/t35-,36-,37-,38-/m0/s1 D0S4LW DRUGINKE ZXCUOCHXNYWBBG-ZQWQDMLBSA-N D0S4LW DRUGSMIL CC(C)CN(CC1=CC=C(C=C1)OC2=CC=CC=C2)C(=O)C3C(C(C3C(=O)O)C(=O)O)C(=O)N(CC4=CC=C(C=C4)OC5=CC=CC=C5)CC(C)C D0S4LW HIGHSTAT Investigative D0S4MN DRUG__ID D0S4MN D0S4MN DRUGTYPE Small molecular drug D0S4MN DRUGINCH 1S/C36H51NO11/c1-19-6-11-26-31(3,40)35(43)25(17-37(26)16-19)33(42)18-34-24(32(33,41)15-27(35)38)10-9-23-30(34,2)13-12-28(36(23,44)48-34)47-29(39)20-7-8-21(45-4)22(14-20)46-5/h7-8,14,19,23-28,38,40-44H,6,9-13,15-18H2,1-5H3/t19-,23-,24-,25-,26-,27-,28-,30-,31+,32+,33+,34+,35-,36-/m0/s1 D0S4MN DRUGINKE FVECELJHCSPHKY-YFUMOZOISA-N D0S4MN DRUGSMIL CC1CCC2C(C3(C(CC4(C5CCC6C7(C5(CC4(C3CN2C1)O)OC6(C(CC7)OC(=O)C8=CC(=C(C=C8)OC)OC)O)C)O)O)O)(C)O D0S4MN HIGHSTAT Investigative D0S4MQ DRUG__ID D0S4MQ D0S4MQ DRUGTYPE Small molecular drug D0S4MQ DRUGINCH 1S/C19H15BrN2/c20-18-11-14(7-6-13-4-2-1-3-5-13)10-15-8-9-16(19(21)22)12-17(15)18/h1-12H,(H3,21,22)/b7-6+ D0S4MQ DRUGINKE QHYGSRQJBXWIGI-VOTSOKGWSA-N D0S4MQ DRUGSMIL C1=CC=C(C=C1)C=CC2=CC(=C3C=C(C=CC3=C2)C(=N)N)Br D0S4MQ HIGHSTAT Investigative D0S4NO DRUG__ID D0S4NO D0S4NO DRUGTYPE Small molecular drug D0S4NO DRUGINCH 1S/C4H8N4O2S2/c1-2-3-6-7-4(11-3)8-12(5,9)10/h2H2,1H3,(H,7,8)(H2,5,9,10) D0S4NO DRUGINKE HVRGNGCSIVHKLU-UHFFFAOYSA-N D0S4NO DRUGSMIL CCC1=NN=C(S1)NS(=O)(=O)N D0S4NO HIGHSTAT Investigative D0S4RQ DRUG__ID D0S4RQ D0S4RQ DRUGTYPE Small molecular drug D0S4RQ DRUGINCH 1S/C15H16N2O/c1-3-10(2)18-15-8-12-11-6-4-5-7-13(11)17-14(12)9-16-15/h4-10,17H,3H2,1-2H3 D0S4RQ DRUGINKE JKWXAXMOLXCXJS-UHFFFAOYSA-N D0S4RQ DRUGSMIL CCC(C)OC1=NC=C2C(=C1)C3=CC=CC=C3N2 D0S4RQ HIGHSTAT Investigative D0S4UA DRUG__ID D0S4UA D0S4UA DRUGTYPE Small molecular drug D0S4UA DRUGINCH 1S/C22H25NO3/c1-4-8-16-18(25-14-7-13-23-15(2)3)11-12-20-21(16)22(24)17-9-5-6-10-19(17)26-20/h4-6,9-12,15,23H,1,7-8,13-14H2,2-3H3 D0S4UA DRUGINKE NZEPLPVSYIYMMM-UHFFFAOYSA-N D0S4UA DRUGSMIL CC(C)NCCCOC1=C(C2=C(C=C1)OC3=CC=CC=C3C2=O)CC=C D0S4UA HIGHSTAT Investigative D0S4VR DRUG__ID D0S4VR D0S4VR DRUGTYPE Small molecular drug D0S4VR DRUGINCH 1S/C10H9N5/c1-2-8-9(14-6-13-8)5-7(1)15-10-11-3-4-12-10/h1-6H,(H,13,14)(H2,11,12,15) D0S4VR DRUGINKE NFSIDEIKDWWMOX-UHFFFAOYSA-N D0S4VR DRUGSMIL C1=CC2=C(C=C1NC3=NC=CN3)NC=N2 D0S4VR HIGHSTAT Investigative D0S4VW DRUG__ID D0S4VW D0S4VW DRUGTYPE Small molecular drug D0S4VW DRUGINCH 1S/2C2H4O2.Pb/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2 D0S4VW DRUGINKE GUWSLQUAAYEZAF-UHFFFAOYSA-L D0S4VW DRUGSMIL CC(=O)[O-].CC(=O)[O-].[Pb+2] D0S4VW HIGHSTAT Investigative D0S4WQ DRUG__ID D0S4WQ D0S4WQ DRUGTYPE Small molecular drug D0S4WQ DRUGINCH 1S/C10H9ClN2/c11-10-3-1-2-9(6-10)7-13-5-4-12-8-13/h1-6,8H,7H2 D0S4WQ DRUGINKE DARGVYVMURXBSO-UHFFFAOYSA-N D0S4WQ DRUGSMIL C1=CC(=CC(=C1)Cl)CN2C=CN=C2 D0S4WQ HIGHSTAT Investigative D0S4XR DRUG__ID D0S4XR D0S4XR DRUGTYPE Small molecular drug D0S4XR DRUGINCH 1S/C18H22N2O/c1-15-17(20-12-10-19-11-13-20)8-5-9-18(15)21-14-16-6-3-2-4-7-16/h2-9,19H,10-14H2,1H3 D0S4XR DRUGINKE LLKMJMQVKKJDAT-UHFFFAOYSA-N D0S4XR DRUGSMIL CC1=C(C=CC=C1OCC2=CC=CC=C2)N3CCNCC3 D0S4XR HIGHSTAT Investigative D0S4YV DRUG__ID D0S4YV D0S4YV DRUGTYPE Small molecular drug D0S4YV DRUGINCH 1S/C6H13FO10P2/c1-6(10,4(7)5(8)9)2-3-16-19(14,15)17-18(11,12)13/h4,10H,2-3H2,1H3,(H,8,9)(H,14,15)(H2,11,12,13) D0S4YV DRUGINKE WPXHWHACORBSDS-UHFFFAOYSA-N D0S4YV DRUGSMIL CC(CCOP(=O)(O)OP(=O)(O)O)(C(C(=O)O)F)O D0S4YV HIGHSTAT Investigative D0S4ZT DRUG__ID D0S4ZT D0S4ZT DRUGTYPE Small molecular drug D0S4ZT DRUGINCH 1S/C18H17N3OS/c1-2-10-23-18-20-16-9-8-14(19)11-15(16)17(22)21(18)12-13-6-4-3-5-7-13/h2-9,11H,1,10,12,19H2 D0S4ZT DRUGINKE FKQLYAVUAISVGO-UHFFFAOYSA-N D0S4ZT DRUGSMIL C=CCSC1=NC2=C(C=C(C=C2)N)C(=O)N1CC3=CC=CC=C3 D0S4ZT HIGHSTAT Investigative D0S5BA DRUG__ID D0S5BA D0S5BA DRUGTYPE Small molecular drug D0S5BA DRUGINCH 1S/C13H11NO5S/c14-20(17,18)19-12-3-1-2-10(8-12)13(16)9-4-6-11(15)7-5-9/h1-8,15H,(H2,14,17,18) D0S5BA DRUGINKE VGINQGIMAOLOBO-UHFFFAOYSA-N D0S5BA DRUGSMIL C1=CC(=CC(=C1)OS(=O)(=O)N)C(=O)C2=CC=C(C=C2)O D0S5BA HIGHSTAT Investigative D0S5BG DRUG__ID D0S5BG D0S5BG DRUGTYPE Small molecular drug D0S5BG DRUGINCH 1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5) D0S5BG DRUGINKE XBDQKXXYIPTUBI-UHFFFAOYSA-N D0S5BG DRUGSMIL CCC(=O)O D0S5BG HIGHSTAT Investigative D0S5BJ DRUG__ID D0S5BJ D0S5BJ DRUGTYPE Small molecular drug D0S5BJ DRUGINCH 1S/C17H17NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,16,19H,6-8H2,1H3/t10-,11+,16-,17-/m0/s1 D0S5BJ DRUGINKE PFBSOANQDDTNGJ-YNHQPCIGSA-N D0S5BJ DRUGSMIL CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)C=C4 D0S5BJ HIGHSTAT Investigative D0S5DB DRUG__ID D0S5DB D0S5DB DRUGTYPE Small molecular drug D0S5DB DRUGINCH 1S/C14H13NO2/c1-9(16)15-12-7-3-2-5-10(12)11-6-4-8-13(17)14(11)15/h2-3,5,7H,4,6,8H2,1H3 D0S5DB DRUGINKE MIGJEXKBUJPKJF-UHFFFAOYSA-N D0S5DB DRUGSMIL CC(=O)N1C2=CC=CC=C2C3=C1C(=O)CCC3 D0S5DB HIGHSTAT Investigative D0S5DR DRUG__ID D0S5DR D0S5DR DRUGTYPE Small molecular drug D0S5DR DRUGINCH 1S/C4H11N/c1-4-5(2)3/h4H2,1-3H3 D0S5DR DRUGINKE DAZXVJBJRMWXJP-UHFFFAOYSA-N D0S5DR DRUGSMIL CCN(C)C D0S5DR HIGHSTAT Investigative D0S5FN DRUG__ID D0S5FN D0S5FN DRUGTYPE Small molecular drug D0S5FN DRUGINCH 1S/C32H44N6O7/c1-17(2)11-26(32(44)45)38-31(43)25(14-21-9-7-6-8-10-21)37-27(39)16-35-29(41)20(5)36-30(42)24(33)15-23-18(3)12-22(28(34)40)13-19(23)4/h6-10,12-13,17,20,24-26H,11,14-16,33H2,1-5H3,(H2,34,40)(H,35,41)(H,36,42)(H,37,39)(H,38,43)(H,44,45)/t20-,24-,25-,26-/m0/s1 D0S5FN DRUGINKE MNNRFUWQCDJULI-CGIBELHQSA-N D0S5FN DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(C)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)O)N)C)C(=O)N D0S5FN HIGHSTAT Investigative D0S5GM DRUG__ID D0S5GM D0S5GM DRUGTYPE Small molecular drug D0S5GM DRUGINCH 1S/C15H15NO4S/c1-2-11-8-9-14(13(10-11)15(17)18)16-21(19,20)12-6-4-3-5-7-12/h3-10,16H,2H2,1H3,(H,17,18) D0S5GM DRUGINKE BUWBVEJQFXVJCT-UHFFFAOYSA-N D0S5GM DRUGSMIL CCC1=CC(=C(C=C1)NS(=O)(=O)C2=CC=CC=C2)C(=O)O D0S5GM HIGHSTAT Investigative D0S5GU DRUG__ID D0S5GU D0S5GU DRUGTYPE Small molecular drug D0S5GU DRUGINCH 1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1 D0S5GU DRUGINKE QCICUPZZLIQAPA-XPWFQUROSA-N D0S5GU DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)N D0S5GU HIGHSTAT Investigative D0S5HO DRUG__ID D0S5HO D0S5HO DRUGTYPE Small molecular drug D0S5HO DRUGINCH 1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31)/t12?,13-/m1/s1 D0S5HO DRUGINKE ZNOVTXRBGFNYRX-ZGTCLIOFSA-N D0S5HO DRUGSMIL CN1C(CNC2=C1C(=O)NC(=N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O D0S5HO HIGHSTAT Investigative D0S5LS DRUG__ID D0S5LS D0S5LS DRUGTYPE Small molecular drug D0S5LS DRUGINCH 1S/C14H12F2N2O3S/c15-12-2-1-3-13(16)11(12)8-18-14(19)9-4-6-10(7-5-9)22(17,20)21/h1-7H,8H2,(H,18,19)(H2,17,20,21) D0S5LS DRUGINKE ZFNCKGXGCCDDFN-UHFFFAOYSA-N D0S5LS DRUGSMIL C1=CC(=C(C(=C1)F)CNC(=O)C2=CC=C(C=C2)S(=O)(=O)N)F D0S5LS HIGHSTAT Investigative D0S5ON DRUG__ID D0S5ON D0S5ON DRUGTYPE Small molecular drug D0S5ON DRUGINCH 1S/C12H16N2O2/c15-14(16)12-5-3-11(4-6-12)7-10-13-8-1-2-9-13/h3-6H,1-2,7-10H2 D0S5ON DRUGINKE YFOCDNYNVHXLJE-UHFFFAOYSA-N D0S5ON DRUGSMIL C1CCN(C1)CCC2=CC=C(C=C2)[N+](=O)[O-] D0S5ON HIGHSTAT Investigative D0S5OQ DRUG__ID D0S5OQ D0S5OQ DRUGTYPE Small molecular drug D0S5OQ DRUGINCH 1S/C13H21N3O6/c1-7(14)12(20)16-6-2-3-9(16)11(19)15-8(13(21)22)4-5-10(17)18/h7-9H,2-6,14H2,1H3,(H,15,19)(H,17,18)(H,21,22)/t7-,8+,9+/m1/s1 D0S5OQ DRUGINKE IORKCNUBHNIMKY-VGMNWLOBSA-N D0S5OQ DRUGSMIL CC(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)O)N D0S5OQ HIGHSTAT Investigative D0S5OR DRUG__ID D0S5OR D0S5OR DRUGTYPE Small molecular drug D0S5OR DRUGINCH 1S/C11H12O3/c1-11(13-2)6-5-8-7-9(12)3-4-10(8)14-11/h3-7,12H,1-2H3 D0S5OR DRUGINKE DLZKKUHAZDHCSL-UHFFFAOYSA-N D0S5OR DRUGSMIL CC1(C=CC2=C(O1)C=CC(=C2)O)OC D0S5OR HIGHSTAT Investigative D0S5OU DRUG__ID D0S5OU D0S5OU DRUGTYPE Small molecular drug D0S5OU DRUGINCH 1S/C26H23ClN6/c1-18-17-32(11-12-33(18)25-10-7-20(15-28)16-29-25)26-23-14-21(27)8-9-22(23)24(30-31-26)13-19-5-3-2-4-6-19/h2-10,14,16,18H,11-13,17H2,1H3/t18-/m1/s1 D0S5OU DRUGINKE XUZUIICAPXZZDU-GOSISDBHSA-N D0S5OU DRUGSMIL CC1CN(CCN1C2=NC=C(C=C2)C#N)C3=NN=C(C4=C3C=C(C=C4)Cl)CC5=CC=CC=C5 D0S5OU HIGHSTAT Investigative D0S5PS DRUG__ID D0S5PS D0S5PS DRUGTYPE Small molecular drug D0S5PS DRUGINCH 1S/C5H8N2O2/c1-3(6)4-2-5(8)7-9-4/h2-3H,6H2,1H3,(H,7,8)/t3-/m0/s1 D0S5PS DRUGINKE ICRYUJPBYIPXQF-VKHMYHEASA-N D0S5PS DRUGSMIL CC(C1=CC(=O)NO1)N D0S5PS HIGHSTAT Investigative D0S5QB DRUG__ID D0S5QB D0S5QB DRUGTYPE Small molecular drug D0S5QB DRUGINCH 1S/C28H31N5O/c29-22-15-13-21(14-16-22)20-30-27(34)19-26-24-11-5-6-12-25(24)31-28(32-17-7-2-8-18-32)33(26)23-9-3-1-4-10-23/h1,3-6,9-16,26H,2,7-8,17-20,29H2,(H,30,34) D0S5QB DRUGINKE NEMYASVJMUEWED-UHFFFAOYSA-N D0S5QB DRUGSMIL C1CCN(CC1)C2=NC3=CC=CC=C3C(N2C4=CC=CC=C4)CC(=O)NCC5=CC=C(C=C5)N D0S5QB HIGHSTAT Investigative D0S5RI DRUG__ID D0S5RI D0S5RI DRUGTYPE Small molecular drug D0S5RI DRUGINCH 1S/C30H38NO.BrH/c1-5-7-22-31(3,4)23-24-32-28-20-18-27(19-21-28)30(26-16-12-9-13-17-26)29(6-2)25-14-10-8-11-15-25;/h8-21H,5-7,22-24H2,1-4H3;1H/q+1;/p-1/b30-29-; D0S5RI DRUGINKE XHYMZYZWHWNTMN-DHKWPOFJSA-M D0S5RI DRUGSMIL CCCC[N+](C)(C)CCOC1=CC=C(C=C1)C(=C(CC)C2=CC=CC=C2)C3=CC=CC=C3.[Br-] D0S5RI HIGHSTAT Investigative D0S5RV DRUG__ID D0S5RV D0S5RV DRUGTYPE Small molecular drug D0S5RV DRUGINCH 1S/C10H7NO3/c12-8-5-9(13)10(14)11-7-4-2-1-3-6(7)8/h1-5,12H,(H,11,13,14) D0S5RV DRUGINKE LRWDJVXXZACNEV-UHFFFAOYSA-N D0S5RV DRUGSMIL C1=CC=C2C(=C1)C(=CC(=O)C(=O)N2)O D0S5RV HIGHSTAT Investigative D0S5RY DRUG__ID D0S5RY D0S5RY DRUGTYPE Small molecular drug D0S5RY DRUGINCH 1S/C7H7FO2S/c8-11(9,10)6-7-4-2-1-3-5-7/h1-5H,6H2 D0S5RY DRUGINKE YBYRMVIVWMBXKQ-UHFFFAOYSA-N D0S5RY DRUGSMIL C1=CC=C(C=C1)CS(=O)(=O)F D0S5RY HIGHSTAT Investigative D0S5SG DRUG__ID D0S5SG D0S5SG DRUGTYPE Small molecular drug D0S5SG DRUGINCH 1S/C13H13NO3S/c15-11-7-12(10-1-6-18-9-10)17-13(8-11)14-2-4-16-5-3-14/h1,6-9H,2-5H2 D0S5SG DRUGINKE LICYALMZYZNUAP-UHFFFAOYSA-N D0S5SG DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CSC=C3 D0S5SG HIGHSTAT Investigative D0S5VI DRUG__ID D0S5VI D0S5VI DRUGTYPE Small molecular drug D0S5VI DRUGINCH 1S/C17H25N3O/c21-17(18-14-15-6-2-1-3-7-15)20-12-10-19(11-13-20)16-8-4-5-9-16/h1-3,6-7,16H,4-5,8-14H2,(H,18,21) D0S5VI DRUGINKE HVJJGTXESXSGPU-UHFFFAOYSA-N D0S5VI DRUGSMIL C1CCC(C1)N2CCN(CC2)C(=O)NCC3=CC=CC=C3 D0S5VI HIGHSTAT Investigative D0S5WE DRUG__ID D0S5WE D0S5WE DRUGTYPE Small molecular drug D0S5WE DRUGINCH 1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6-/m1/s1 D0S5WE DRUGINKE HXXFSFRBOHSIMQ-VFUOTHLCSA-N D0S5WE DRUGSMIL C(C1C(C(C(C(O1)OP(=O)(O)O)O)O)O)O D0S5WE HIGHSTAT Investigative D0S5XP DRUG__ID D0S5XP D0S5XP DRUGTYPE Small molecular drug D0S5XP DRUGINCH 1S/C8H8BrN5/c1-2-3-14-7-5(13-8(14)9)6(10)11-4-12-7/h2,4H,1,3H2,(H2,10,11,12) D0S5XP DRUGINKE RSFSQISQTSQYRO-UHFFFAOYSA-N D0S5XP DRUGSMIL C=CCN1C2=NC=NC(=C2N=C1Br)N D0S5XP HIGHSTAT Investigative D0S5YH DRUG__ID D0S5YH D0S5YH DRUGTYPE Small molecular drug D0S5YH DRUGINCH 1S/C9H12ClNO3S/c10-9-3-1-7(2-4-9)8(5-11)6-15(12,13)14/h1-4,8H,5-6,11H2,(H,12,13,14) D0S5YH DRUGINKE JYLNVJYYQQXNEK-UHFFFAOYSA-N D0S5YH DRUGSMIL C1=CC(=CC=C1C(CN)CS(=O)(=O)O)Cl D0S5YH HIGHSTAT Investigative D0S5YV DRUG__ID D0S5YV D0S5YV DRUGTYPE Small molecular drug D0S5YV DRUGINCH 1S/C14H16ClN3O4S2/c1-8-13(23-14(17-8)18-9(2)20)10-3-4-11(15)12(7-10)24(21,22)16-5-6-19/h3-4,7,16,19H,5-6H2,1-2H3,(H,17,18,20) D0S5YV DRUGINKE JFVNFXCESCXMBC-UHFFFAOYSA-N D0S5YV DRUGSMIL CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO D0S5YV HIGHSTAT Investigative D0S5ZE DRUG__ID D0S5ZE D0S5ZE DRUGTYPE Small molecular drug D0S5ZE DRUGINCH 1S/C22H32N4O/c1-2-10-25(21-8-9-22-19(17-21)18-27-23-22)14-11-24-12-15-26(16-13-24)20-6-4-3-5-7-20/h3-7,18,21H,2,8-17H2,1H3 D0S5ZE DRUGINKE FVLVETKUEQQGET-UHFFFAOYSA-N D0S5ZE DRUGSMIL CCCN(CCN1CCN(CC1)C2=CC=CC=C2)C3CCC4=NOC=C4C3 D0S5ZE HIGHSTAT Investigative D0S5ZY DRUG__ID D0S5ZY D0S5ZY DRUGTYPE Small molecular drug D0S5ZY DRUGINCH 1S/C17H21N/c1-2-11-18-12-10-15(13-18)17-9-5-7-14-6-3-4-8-16(14)17/h3-9,15H,2,10-13H2,1H3 D0S5ZY DRUGINKE JPGGRFYDEHKZFB-UHFFFAOYSA-N D0S5ZY DRUGSMIL CCCN1CCC(C1)C2=CC=CC3=CC=CC=C32 D0S5ZY HIGHSTAT Investigative D0S6BX DRUG__ID D0S6BX D0S6BX DRUGTYPE Small molecular drug D0S6BX DRUGINCH 1S/C29H37N5O5/c1-32(25(18-19-7-3-2-4-8-19)29(39)33-15-5-9-23(33)26(31)36)28(38)24-10-6-16-34(24)27(37)22(30)17-20-11-13-21(35)14-12-20/h2-4,7-8,11-14,22-25,35H,5-6,9-10,15-18,30H2,1H3,(H2,31,36)/t22-,23+,24-,25-/m0/s1 D0S6BX DRUGINKE JAKBYSTWCHUQOK-NDBXHCKUSA-N D0S6BX DRUGSMIL CN(C(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)N)C(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N D0S6BX HIGHSTAT Investigative D0S6CO DRUG__ID D0S6CO D0S6CO DRUGTYPE Small molecular drug D0S6CO DRUGINCH 1S/C7H5Cl2NO4S/c8-4-2-5(9)6(15(10,13)14)1-3(4)7(11)12/h1-2H,(H,11,12)(H2,10,13,14) D0S6CO DRUGINKE ZSHHRBYVHTVRFK-UHFFFAOYSA-N D0S6CO DRUGSMIL C1=C(C(=CC(=C1S(=O)(=O)N)Cl)Cl)C(=O)O D0S6CO HIGHSTAT Investigative D0S6CT DRUG__ID D0S6CT D0S6CT DRUGTYPE Small molecular drug D0S6CT DRUGINCH 1S/C25H33NO2/c1-28-25(27)24(22-16-8-3-9-17-22)23-18-10-12-20-26(23)19-11-4-7-15-21-13-5-2-6-14-21/h2-3,5-6,8-9,13-14,16-17,23-24H,4,7,10-12,15,18-20H2,1H3/t23-,24-/m1/s1 D0S6CT DRUGINKE CYCPZJLWKPRDTM-DNQXCXABSA-N D0S6CT DRUGSMIL COC(=O)C(C1CCCCN1CCCCCC2=CC=CC=C2)C3=CC=CC=C3 D0S6CT HIGHSTAT Investigative D0S6CW DRUG__ID D0S6CW D0S6CW DRUGTYPE Small molecular drug D0S6CW DRUGINCH 1S/C33H51N2O6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-33(36)35-31(28-41-42(37,38)39)25-29-20-22-32(23-21-29)40-27-30-18-17-24-34-26-30/h9-10,17-18,20-24,26,31H,2-8,11-16,19,25,27-28H2,1H3,(H,35,36)(H2,37,38,39)/b10-9-/t31-/m1/s1 D0S6CW DRUGINKE KMTDWYLEJRZIJN-HWNQJZBBSA-N D0S6CW DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC(CC1=CC=C(C=C1)OCC2=CN=CC=C2)COP(=O)(O)O D0S6CW HIGHSTAT Investigative D0S6DK DRUG__ID D0S6DK D0S6DK DRUGTYPE Small molecular drug D0S6DK DRUGINCH 1S/C9H9NO5/c10-7(9(14)15)4-1-2-5(8(12)13)6(11)3-4/h1-3,7,11H,10H2,(H,12,13)(H,14,15)/t7-/m0/s1 D0S6DK DRUGINKE GXZSAQLJWLCLOX-ZETCQYMHSA-N D0S6DK DRUGSMIL C1=CC(=C(C=C1C(C(=O)O)N)O)C(=O)O D0S6DK HIGHSTAT Investigative D0S6FE DRUG__ID D0S6FE D0S6FE DRUGCOMP University of Minnesota D0S6FE DRUGINCH 1S/C52H72N8O8/c1-57(2)25-21-53-45(61)33-65-49-37-13-9-14-38(49)30-40-16-11-18-42(51(40)67-35-47(63)55-23-27-59(5)6)32-44-20-12-19-43(52(44)68-36-48(64)56-24-28-60(7)8)31-41-17-10-15-39(29-37)50(41)66-34-46(62)54-22-26-58(3)4/h9-20H,21-36H2,1-8H3,(H,53,61)(H,54,62)(H,55,63)(H,56,64) D0S6FE DRUGINKE CQVAQQNDZCZBSU-UHFFFAOYSA-N D0S6FE DRUGSMIL CN(C)CCNC(=O)COC1=C2CC3=C(C(=CC=C3)CC4=C(C(=CC=C4)CC5=CC=CC(=C5OCC(=O)NCCN(C)C)CC1=CC=C2)OCC(=O)NCCN(C)C)OCC(=O)NCCN(C)C D0S6FE HIGHSTAT Investigative D0S6FJ DRUG__ID D0S6FJ D0S6FJ DRUGTYPE Small molecular drug D0S6FJ DRUGINCH 1S/C20H24N2O3/c1-2-3-4-8-15-24-19-13-11-18(12-14-19)22-20(23)25-21-16-17-9-6-5-7-10-17/h5-7,9-14,16H,2-4,8,15H2,1H3,(H,22,23)/b21-16+ D0S6FJ DRUGINKE HNESYIHKTKWBMV-LTGZKZEYSA-N D0S6FJ DRUGSMIL CCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D0S6FJ HIGHSTAT Investigative D0S6FK DRUG__ID D0S6FK D0S6FK DRUGTYPE Small molecular drug D0S6FK DRUGINCH 1S/C28H43N5O12S/c1-6-28(4)23(26(41)31-10-19(36)37)33-24(39)20(12(2)3)32-25(40)21(30-5)22(38)14-8-17(45-28)16(35)9-18(14)46(44)11-13(34)7-15(29)27(42)43/h8-9,12-13,15,20-23,30,34-35,38H,6-7,10-11,29H2,1-5H3,(H,31,41)(H,32,40)(H,33,39)(H,36,37)(H,42,43)/t13-,15-,20-,21-,22+,23+,28+,46?/m0/s1 D0S6FK DRUGINKE QRLBQXQEGMBXFM-MWFNQMQISA-N D0S6FK DRUGSMIL CCC1(C(NC(=O)C(NC(=O)C(C(C2=CC(=C(C=C2S(=O)CC(CC(C(=O)O)N)O)O)O1)O)NC)C(C)C)C(=O)NCC(=O)O)C D0S6FK HIGHSTAT Investigative D0S6GE DRUG__ID D0S6GE D0S6GE DRUGTYPE Small molecular drug D0S6GE DRUGINCH 1S/C19H18FN3O4/c20-13-4-6-14(7-5-13)23-19(21)17(9-22-23)18(26)12-2-1-3-16(8-12)27-11-15(25)10-24/h1-9,15,24-25H,10-11,21H2/t15-/m0/s1 D0S6GE DRUGINKE IJDQETGUEUJVTB-HNNXBMFYSA-N D0S6GE DRUGSMIL C1=CC(=CC(=C1)OCC(CO)O)C(=O)C2=C(N(N=C2)C3=CC=C(C=C3)F)N D0S6GE HIGHSTAT Investigative D0S6GK DRUG__ID D0S6GK D0S6GK DRUGTYPE Small molecular drug D0S6GK DRUGINCH 1S/C6H5F2NO2S/c7-4-1-5(8)3-6(2-4)12(9,10)11/h1-3H,(H2,9,10,11) D0S6GK DRUGINKE MKQPOVUFDWKPNO-UHFFFAOYSA-N D0S6GK DRUGSMIL C1=C(C=C(C=C1F)S(=O)(=O)N)F D0S6GK HIGHSTAT Investigative D0S6GS DRUG__ID D0S6GS D0S6GS DRUGTYPE Small molecular drug D0S6GS DRUGINCH 1S/C15H9BrO2/c16-11-6-7-14-12(8-11)13(17)9-15(18-14)10-4-2-1-3-5-10/h1-9H D0S6GS DRUGINKE LPOZDKMXSPAATL-UHFFFAOYSA-N D0S6GS DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)Br D0S6GS HIGHSTAT Investigative D0S6HI DRUG__ID D0S6HI D0S6HI DRUGTYPE Small molecular drug D0S6HI DRUGINCH 1S/C6H16N6/c7-5(8)11-3-1-2-4-12-6(9)10/h1-4H2,(H4,7,8,11)(H4,9,10,12) D0S6HI DRUGINKE HGMDNMBBCKDWTQ-UHFFFAOYSA-N D0S6HI DRUGSMIL C(CCN=C(N)N)CN=C(N)N D0S6HI HIGHSTAT Investigative D0S6JQ DRUG__ID D0S6JQ D0S6JQ DRUGTYPE Small molecular drug D0S6JQ DRUGINCH 1S/C28H18N2O4/c31-25-21-13-11-19(29-27(33)17-7-3-1-4-8-17)15-23(21)26(32)24-16-20(12-14-22(24)25)30-28(34)18-9-5-2-6-10-18/h1-16H,(H,29,33)(H,30,34) D0S6JQ DRUGINKE IJKYLKHKCJTQGH-UHFFFAOYSA-N D0S6JQ DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)C5=CC=CC=C5 D0S6JQ HIGHSTAT Investigative D0S6KD DRUG__ID D0S6KD D0S6KD DRUGTYPE Small molecular drug D0S6KD DRUGINCH 1S/C28H40N2O10/c1-14(2)25(35)20(39-19(32)16-7-6-12-30-16)26(36)21(4)13-24(34)22(25,5)28(26,37)27(40-24)18(38-17(31)9-11-29)15(3)8-10-23(21,27)33/h6-7,12,14-15,18,20,30,33-37H,8-11,13,29H2,1-5H3/t15?,18-,20-,21+,22?,23?,24?,25?,26?,27?,28?/m1/s1 D0S6KD DRUGINKE RNYNXNCQNFQWFI-UHHIQCFMSA-N D0S6KD DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CCN)O4)O)O)OC(=O)C6=CC=CN6)(C(C)C)O)C)O)C)O D0S6KD HIGHSTAT Investigative D0S6KY DRUG__ID D0S6KY D0S6KY DRUGTYPE Small molecular drug D0S6KY DRUGINCH 1S/C2H5NO/c1-2(3)4/h1H3,(H2,3,4) D0S6KY DRUGINKE DLFVBJFMPXGRIB-UHFFFAOYSA-N D0S6KY DRUGSMIL CC(=O)N D0S6KY HIGHSTAT Investigative D0S6ME DRUG__ID D0S6ME D0S6ME DRUGTYPE Small molecular drug D0S6ME DRUGINCH 1S/C20H19NO3/c1-2-10-24-20(23)17-13-21-18-9-8-15(12-16(18)19(17)22)11-14-6-4-3-5-7-14/h3-9,12-13H,2,10-11H2,1H3,(H,21,22) D0S6ME DRUGINKE JIOMLDXNFGNQFW-UHFFFAOYSA-N D0S6ME DRUGSMIL CCCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC3=CC=CC=C3 D0S6ME HIGHSTAT Investigative D0S6NE DRUG__ID D0S6NE D0S6NE DRUGTYPE Small molecular drug D0S6NE DRUGINCH 1S/C24H17ClF3NO3S/c25-18-6-7-21(32-14-15-4-2-1-3-5-15)20(11-18)19-8-9-33-22(19)16-10-17(13-29-12-16)23(30,31)24(26,27)28/h1-13,30-31H,14H2 D0S6NE DRUGINKE JCCQFQOPADDTRS-UHFFFAOYSA-N D0S6NE DRUGSMIL C1=CC=C(C=C1)COC2=C(C=C(C=C2)Cl)C3=C(SC=C3)C4=CC(=CN=C4)C(C(F)(F)F)(O)O D0S6NE HIGHSTAT Investigative D0S6NP DRUG__ID D0S6NP D0S6NP DRUGTYPE Small molecular drug D0S6NP DRUGINCH 1S/C16H12O6/c1-21-16-14(20)13-11(19)6-10(18)7-12(13)22-15(16)8-2-4-9(17)5-3-8/h2-7,17-19H,1H3 D0S6NP DRUGINKE VJJZJBUCDWKPLC-UHFFFAOYSA-N D0S6NP DRUGSMIL COC1=C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O D0S6NP HIGHSTAT Investigative D0S6NV DRUG__ID D0S6NV D0S6NV DRUGTYPE Small molecular drug D0S6NV DRUGINCH 1S/C16H11BrO2/c17-16-14-7-3-11(9-12(14)4-8-15(16)19)10-1-5-13(18)6-2-10/h1-9,18-19H D0S6NV DRUGINKE IPBYYNRPJBGKET-UHFFFAOYSA-N D0S6NV DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C=C2)C(=C(C=C3)O)Br)O D0S6NV HIGHSTAT Investigative D0S6QA DRUG__ID D0S6QA D0S6QA DRUGTYPE Small molecular drug D0S6QA DRUGINCH 1S/C9H12BrN5/c1-2-3-4-15-8-6(14-9(15)10)7(11)12-5-13-8/h5H,2-4H2,1H3,(H2,11,12,13) D0S6QA DRUGINKE FKNNQOCJLMQVAV-UHFFFAOYSA-N D0S6QA DRUGSMIL CCCCN1C2=NC=NC(=C2N=C1Br)N D0S6QA HIGHSTAT Investigative D0S6RD DRUG__ID D0S6RD D0S6RD DRUGTYPE Small molecular drug D0S6RD DRUGINCH 1S/C20H37N3O13/c1-23-7-2-5(21)9(26)15(10(7)27)33-19-17-16(11(28)8(4-25)32-19)35-20(36-17)18(31)13(30)12(29)14(34-20)6(22)3-24/h5-19,23-31H,2-4,21-22H2,1H3/t5-,6+,7+,8-,9+,10-,11+,12-,13+,14-,15-,16+,17+,18-,19+,20?/m1/s1 D0S6RD DRUGINKE GRRNUXAQVGOGFE-HUCHGKBZSA-N D0S6RD DRUGSMIL CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N D0S6RD HIGHSTAT Investigative D0S6RL DRUG__ID D0S6RL D0S6RL DRUGTYPE Small molecular drug D0S6RL DRUGINCH 1S/C22H14S/c1-3-7-19-15(5-1)9-10-17-13-16-6-2-4-8-20(16)22(21(17)19)18-11-12-23-14-18/h1-14H D0S6RL DRUGINKE FJWVAKJBVCNSHF-UHFFFAOYSA-N D0S6RL DRUGSMIL C1=CC=C2C(=C1)C=CC3=CC4=CC=CC=C4C(=C32)C5=CSC=C5 D0S6RL HIGHSTAT Investigative D0S6SN DRUG__ID D0S6SN D0S6SN DRUGTYPE Small molecular drug D0S6SN DRUGINCH 1S/C13H16N2O3/c1-8(16)14-4-3-9-7-15-11-6-12(17)13(18-2)5-10(9)11/h5-7,15,17H,3-4H2,1-2H3,(H,14,16) D0S6SN DRUGINKE OMYMRCXOJJZYKE-UHFFFAOYSA-N D0S6SN DRUGSMIL CC(=O)NCCC1=CNC2=CC(=C(C=C21)OC)O D0S6SN HIGHSTAT Investigative D0S6TW DRUG__ID D0S6TW D0S6TW DRUGTYPE Small molecular drug D0S6TW DRUGINCH 1S/C8H4Cl2N2O2/c9-3-1-5-6(2-4(3)10)12-8(14)7(13)11-5/h1-2H,(H,11,13)(H,12,14) D0S6TW DRUGINKE AVBSIKMUAFYZAV-UHFFFAOYSA-N D0S6TW DRUGSMIL C1=C2C(=CC(=C1Cl)Cl)NC(=O)C(=O)N2 D0S6TW HIGHSTAT Investigative D0S6XY DRUG__ID D0S6XY D0S6XY DRUGTYPE Small molecular drug D0S6XY DRUGINCH 1S/C14H10O3/c15-12-5-1-3-8-10(12)7-11-9(14(8)17)4-2-6-13(11)16/h1-6,15-16H,7H2 D0S6XY DRUGINKE BGECJMUUSSERAU-UHFFFAOYSA-N D0S6XY DRUGSMIL C1C2=C(C=CC=C2O)C(=O)C3=C1C(=CC=C3)O D0S6XY HIGHSTAT Investigative D0S7AY DRUG__ID D0S7AY D0S7AY DRUGTYPE Small molecular drug D0S7AY DRUGINCH 1S/C18H12N2O2S2/c21-13-5-1-3-11-7-9-15(19-17(11)13)23-24-16-10-8-12-4-2-6-14(22)18(12)20-16/h1-10,21-22H D0S7AY DRUGINKE XHJJWLOYIZUQTP-UHFFFAOYSA-N D0S7AY DRUGSMIL C1=CC2=C(C(=C1)O)N=C(C=C2)SSC3=NC4=C(C=CC=C4O)C=C3 D0S7AY HIGHSTAT Investigative D0S7BE DRUG__ID D0S7BE D0S7BE DRUGTYPE Small molecular drug D0S7BE DRUGINCH 1S/C33H43N3O6/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40)/t28?,29-/m1/s1 D0S7BE DRUGINKE GWNOTCOIYUNTQP-YPJJGMIRSA-N D0S7BE DRUGSMIL CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)C(C5CCCCC5)O D0S7BE HIGHSTAT Investigative D0S7BK DRUG__ID D0S7BK D0S7BK DRUGTYPE Small molecular drug D0S7BK DRUGINCH 1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11) D0S7BK DRUGINKE PXQPEWDEAKTCGB-UHFFFAOYSA-N D0S7BK DRUGSMIL C1=C(NC(=O)NC1=O)C(=O)O D0S7BK HIGHSTAT Investigative D0S7HC DRUG__ID D0S7HC D0S7HC DRUGTYPE Small molecular drug D0S7HC DRUGINCH 1S/C20H18N2O3/c23-19(17-14-15-6-4-5-9-18(15)25-20(17)24)22-12-10-21(11-13-22)16-7-2-1-3-8-16/h1-9,14H,10-13H2 D0S7HC DRUGINKE PEIQALYIIRRQAZ-UHFFFAOYSA-N D0S7HC DRUGSMIL C1CN(CCN1C2=CC=CC=C2)C(=O)C3=CC4=CC=CC=C4OC3=O D0S7HC HIGHSTAT Investigative D0S7IE DRUG__ID D0S7IE D0S7IE DRUGTYPE Small molecular drug D0S7IE DRUGINCH 1S/C14H12N4O/c1-9(19)17-13-7-12(16)11(8-15)14(18-13)10-5-3-2-4-6-10/h2-7H,1H3,(H3,16,17,18,19) D0S7IE DRUGINKE GTMGQYXCPKUZAD-UHFFFAOYSA-N D0S7IE DRUGSMIL CC(=O)NC1=NC(=C(C(=C1)N)C#N)C2=CC=CC=C2 D0S7IE HIGHSTAT Investigative D0S7IJ DRUG__ID D0S7IJ D0S7IJ DRUGTYPE Small molecular drug D0S7IJ DRUGINCH 1S/C15H18N2O/c1-10-5-7-12(9-10)18-13-4-2-3-11-6-8-14(16)17-15(11)13/h2-4,6,8,10,12H,5,7,9H2,1H3,(H2,16,17) D0S7IJ DRUGINKE XSBYTVRYECCAPQ-UHFFFAOYSA-N D0S7IJ DRUGSMIL CC1CCC(C1)OC2=CC=CC3=C2N=C(C=C3)N D0S7IJ HIGHSTAT Investigative D0S7LD DRUG__ID D0S7LD D0S7LD DRUGTYPE Small molecular drug D0S7LD DRUGINCH 1S/C15H12O6/c1-19-12-5-7-11(6-9(12)17)21-10-4-3-8(16)15(20-2)13(10)14(7)18/h3-6,16-17H,1-2H3 D0S7LD DRUGINKE SROSPGQNFCAFNO-UHFFFAOYSA-N D0S7LD DRUGSMIL COC1=C(C=C2C(=C1)C(=O)C3=C(O2)C=CC(=C3OC)O)O D0S7LD HIGHSTAT Investigative D0S7MJ DRUG__ID D0S7MJ D0S7MJ DRUGTYPE Small molecular drug D0S7MJ DRUGINCH 1S/C10H14N2.BrH/c1-8(12-9(2)11)10-6-4-3-5-7-10;/h3-8H,1-2H3,(H2,11,12);1H/t8-;/m0./s1 D0S7MJ DRUGINKE SXSWEEJYFGUAON-QRPNPIFTSA-N D0S7MJ DRUGSMIL CC(C1=CC=CC=C1)N=C(C)N.Br D0S7MJ HIGHSTAT Investigative D0S7NH DRUG__ID D0S7NH D0S7NH DRUGTYPE Small molecular drug D0S7NH DRUGINCH 1S/C12H14N2O2S/c1-14(2)11-7-3-6-10-9(11)5-4-8-12(10)17(13,15)16/h3-8H,1-2H3,(H2,13,15,16) D0S7NH DRUGINKE TYNBFJJKZPTRKS-UHFFFAOYSA-N D0S7NH DRUGSMIL CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)N D0S7NH HIGHSTAT Investigative D0S7NM DRUG__ID D0S7NM D0S7NM DRUGTYPE Small molecular drug D0S7NM DRUGINCH 1S/C19H17NO4/c21-14-6-4-13(5-7-14)15-2-1-3-16-17(22)12-18(24-19(15)16)20-8-10-23-11-9-20/h1-7,12,21H,8-11H2 D0S7NM DRUGINKE WSNZUFRPSRSILZ-UHFFFAOYSA-N D0S7NM DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=C(C=C4)O D0S7NM HIGHSTAT Investigative D0S7SE DRUG__ID D0S7SE D0S7SE DRUGTYPE Small molecular drug D0S7SE DRUGINCH 1S/C13H12N2OS/c1-10-15-13(9-17-10)4-3-11-5-12(8-16-2)7-14-6-11/h5-7,9H,8H2,1-2H3 D0S7SE DRUGINKE AWDRAHDWMICWJM-UHFFFAOYSA-N D0S7SE DRUGSMIL CC1=NC(=CS1)C#CC2=CN=CC(=C2)COC D0S7SE HIGHSTAT Investigative D0S7TM DRUG__ID D0S7TM D0S7TM DRUGTYPE Small molecular drug D0S7TM DRUGINCH 1S/C4H2N4S4/c9-3-7-5-1(11-3)2-6-8-4(10)12-2/h(H,7,9)(H,8,10) D0S7TM DRUGINKE DAHNZAVSTBXUBS-UHFFFAOYSA-N D0S7TM DRUGSMIL C1(=NNC(=S)S1)C2=NNC(=S)S2 D0S7TM HIGHSTAT Investigative D0S7UD DRUG__ID D0S7UD D0S7UD DRUGTYPE Small molecular drug D0S7UD DRUGINCH 1S/C22H15N3O/c23-13-19-15-24-14-18(7-6-16-4-2-1-3-5-16)22(19)26-20-8-9-21-17(12-20)10-11-25-21/h1-12,14-15,25H/b7-6+ D0S7UD DRUGINKE IMMBFBPNPIRCBR-VOTSOKGWSA-N D0S7UD DRUGSMIL C1=CC=C(C=C1)C=CC2=CN=CC(=C2OC3=CC4=C(C=C3)NC=C4)C#N D0S7UD HIGHSTAT Investigative D0S7VY DRUG__ID D0S7VY D0S7VY DRUGTYPE Small molecular drug D0S7VY DRUGINCH 1S/C18H17NO4/c1-12(20)22-17-9-15(10-18(11-17)23-13(2)21)4-3-14-5-7-16(19)8-6-14/h3-11H,19H2,1-2H3/b4-3+ D0S7VY DRUGINKE QERWBDJMMUMFOT-ONEGZZNKSA-N D0S7VY DRUGSMIL CC(=O)OC1=CC(=CC(=C1)C=CC2=CC=C(C=C2)N)OC(=O)C D0S7VY HIGHSTAT Investigative D0S7WQ DRUG__ID D0S7WQ D0S7WQ DRUGTYPE Small molecular drug D0S7WQ DRUGINCH 1S/C17H18N2O3/c20-16(8-4-7-13-5-2-1-3-6-13)18-15-11-9-14(10-12-15)17(21)19-22/h1-3,5-6,9-12,22H,4,7-8H2,(H,18,20)(H,19,21) D0S7WQ DRUGINKE VZROKPBSFBHVTL-UHFFFAOYSA-N D0S7WQ DRUGSMIL C1=CC=C(C=C1)CCCC(=O)NC2=CC=C(C=C2)C(=O)NO D0S7WQ HIGHSTAT Investigative D0S7WZ DRUG__ID D0S7WZ D0S7WZ DRUGTYPE Small molecular drug D0S7WZ DRUGINCH 1S/C15H20N2/c1-2-8-17-9-4-7-15(12-17)14-6-3-5-13(10-14)11-16/h3,5-6,10,15H,2,4,7-9,12H2,1H3 D0S7WZ DRUGINKE GQRIAOUUYRIMLH-UHFFFAOYSA-N D0S7WZ DRUGSMIL CCCN1CCCC(C1)C2=CC=CC(=C2)C#N D0S7WZ HIGHSTAT Investigative D0S7YD DRUG__ID D0S7YD D0S7YD DRUGTYPE Small molecular drug D0S7YD DRUGINCH 1S/C7H16N2O6P2/c1-5-3-2-4-8-6(5)9-7(16(10,11)12)17(13,14)15/h5,7H,2-4H2,1H3,(H,8,9)(H2,10,11,12)(H2,13,14,15) D0S7YD DRUGINKE XUCBNFJYKWKAMN-UHFFFAOYSA-N D0S7YD DRUGSMIL CC1CCCN=C1NC(P(=O)(O)O)P(=O)(O)O D0S7YD HIGHSTAT Investigative D0S7ZQ DRUG__ID D0S7ZQ D0S7ZQ DRUGTYPE Small molecular drug D0S7ZQ DRUGINCH 1S/C19H24O2/c1-4-6-14-8-10-18(20)17(12-14)15-9-11-19(21-3)16(13-15)7-5-2/h8-13,20H,4-7H2,1-3H3 D0S7ZQ DRUGINKE HFEJJSAHPYKAPW-UHFFFAOYSA-N D0S7ZQ DRUGSMIL CCCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)OC)CCC D0S7ZQ HIGHSTAT Investigative D0S7ZU DRUG__ID D0S7ZU D0S7ZU DRUGTYPE Small molecular drug D0S7ZU DRUGINCH 1S/C16H14N2/c1-12-17-11-16(18-12)15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-11H,1H3,(H,17,18) D0S7ZU DRUGINKE MBBDOQNKURHTFH-UHFFFAOYSA-N D0S7ZU DRUGSMIL CC1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3 D0S7ZU HIGHSTAT Investigative D0S7ZZ DRUG__ID D0S7ZZ D0S7ZZ DRUGTYPE Small molecular drug D0S7ZZ DRUGINCH 1S/C22H23NO5S2.C16H18N2O3/c1-15(14-30(28)22(27)16-8-4-2-5-9-16)20(24)23-13-18(12-19(23)21(25)26)29-17-10-6-3-7-11-17;1-16(2)15(20)14(18-7-3-4-13(18)19)11-8-10(9-17)5-6-12(11)21-16/h2-11,15,18-19H,12-14H2,1H3,(H,25,26);5-6,8,14-15,20H,3-4,7H2,1-2H3/t15-,18-,19-,30?;14-,15+/m01/s1 D0S7ZZ DRUGINKE CPIFLUAOCGEKJE-QTQBKYSQSA-N D0S7ZZ DRUGSMIL CC(CS(=O)C(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)O)SC3=CC=CC=C3.CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N3CCCC3=O)O)C D0S7ZZ HIGHSTAT Investigative D0S8AC DRUG__ID D0S8AC D0S8AC DRUGTYPE Small molecular drug D0S8AC DRUGINCH 1S/C21H31NO2/c1-2-3-4-5-6-7-8-9-10-11-14-18-17-21(23)19-15-12-13-16-20(19)22(18)24/h12-13,15-17,24H,2-11,14H2,1H3 D0S8AC DRUGINKE SBALADRDZPFHLM-UHFFFAOYSA-N D0S8AC DRUGSMIL CCCCCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1O D0S8AC HIGHSTAT Investigative D0S8AN DRUG__ID D0S8AN D0S8AN DRUGTYPE Small molecular drug D0S8AN DRUGINCH 1S/C6H11NO4/c1-3(5(8)9)2-4(7)6(10)11/h3-4H,2,7H2,1H3,(H,8,9)(H,10,11)/p-2/t3-,4+/m1/s1 D0S8AN DRUGINKE KRKRAOXTGDJWNI-DMTCNVIQSA-L D0S8AN DRUGSMIL CC(CC(C(=O)[O-])N)C(=O)[O-] D0S8AN HIGHSTAT Investigative D0S8AS DRUG__ID D0S8AS D0S8AS DRUGTYPE Small molecular drug D0S8AS DRUGINCH 1S/C17H17NO2S/c1-17(2,3)20-16(19)18-12-8-4-6-10-14(12)21-15-11-7-5-9-13(15)18/h4-11H,1-3H3 D0S8AS DRUGINKE ZJCHCPTZZNZOLM-UHFFFAOYSA-N D0S8AS DRUGSMIL CC(C)(C)OC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0S8AS HIGHSTAT Investigative D0S8AV DRUG__ID D0S8AV D0S8AV DRUGTYPE Small molecular drug D0S8AV DRUGINCH 1S/C20H20O5/c1-11(2)3-8-14-15(22)9-16(23)19-17(24)10-18(25-20(14)19)12-4-6-13(21)7-5-12/h3-7,9,18,21-23H,8,10H2,1-2H3 D0S8AV DRUGINKE LPEPZZAVFJPLNZ-UHFFFAOYSA-N D0S8AV DRUGSMIL CC(=CCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O)C D0S8AV HIGHSTAT Investigative D0S8CE DRUG__ID D0S8CE D0S8CE DRUGTYPE Small molecular drug D0S8CE DRUGINCH 1S/C34H30N4O2/c39-33(28-21-26-8-3-5-11-31(26)35-22-28)37-32-12-6-4-10-30(32)34(40)36-29-15-13-24(14-16-29)17-19-38-20-18-25-7-1-2-9-27(25)23-38/h1-16,21-22H,17-20,23H2,(H,36,40)(H,37,39) D0S8CE DRUGINKE JCKRZMGEVAGHHV-UHFFFAOYSA-N D0S8CE DRUGSMIL C1CN(CC2=CC=CC=C21)CCC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4NC(=O)C5=CC6=CC=CC=C6N=C5 D0S8CE HIGHSTAT Investigative D0S8CL DRUG__ID D0S8CL D0S8CL DRUGTYPE Small molecular drug D0S8CL DRUGINCH 1S/C22H25ClNO.BrH/c1-2-3-4-8-15-25-22-13-14-24(17-18-9-6-5-7-10-18)21-16-19(23)11-12-20(21)22;/h5-7,9-14,16H,2-4,8,15,17H2,1H3;1H/q+1;/p-1 D0S8CL DRUGINKE RZJKFYPDZZJFFA-UHFFFAOYSA-M D0S8CL DRUGSMIL CCCCCCOC1=C2C=CC(=CC2=[N+](C=C1)CC3=CC=CC=C3)Cl.[Br-] D0S8CL HIGHSTAT Investigative D0S8DT DRUG__ID D0S8DT D0S8DT DRUGTYPE Small molecular drug D0S8DT DRUGINCH 1S/C24H29N5O6S/c30-22(27-14-21(24(32)33)28-36(34,35)19-2-1-8-26-13-19)17-3-4-18-15-29(23(31)20(18)12-17)11-7-16-5-9-25-10-6-16/h1-4,8,12-13,16,21,25,28H,5-7,9-11,14-15H2,(H,27,30)(H,32,33)/t21-/m0/s1 D0S8DT DRUGINKE FVGFTYFYGPWTIR-NRFANRHFSA-N D0S8DT DRUGSMIL C1CNCCC1CCN2CC3=C(C2=O)C=C(C=C3)C(=O)NCC(C(=O)O)NS(=O)(=O)C4=CN=CC=C4 D0S8DT HIGHSTAT Investigative D0S8EB DRUG__ID D0S8EB D0S8EB DRUGTYPE Small molecular drug D0S8EB DRUGINCH 1S/C16H16O3/c1-8-6-11(17)7-13-10(3)19-16-9(2)14(18)5-4-12(16)15(8)13/h4-7,10,17-18H,1-3H3 D0S8EB DRUGINKE ACLQWAFSCNOYRE-UHFFFAOYSA-N D0S8EB DRUGSMIL CC1C2=C(C(=CC(=C2)O)C)C3=C(O1)C(=C(C=C3)O)C D0S8EB HIGHSTAT Investigative D0S8FV DRUG__ID D0S8FV D0S8FV DRUGTYPE Small molecular drug D0S8FV DRUGINCH 1S/C17H15NO/c1-12-8-15-9-16(19-2)6-5-13(15)10-17(12)14-4-3-7-18-11-14/h3-11H,1-2H3 D0S8FV DRUGINKE YGFDDQOJFLQBKT-UHFFFAOYSA-N D0S8FV DRUGSMIL CC1=CC2=C(C=CC(=C2)OC)C=C1C3=CN=CC=C3 D0S8FV HIGHSTAT Investigative D0S8HE DRUG__ID D0S8HE D0S8HE DRUGTYPE Small molecular drug D0S8HE DRUGINCH 1S/C10H14NO6P/c1-10(11,9(12)13)7-16-18(14,15)17-8-5-3-2-4-6-8/h2-6H,7,11H2,1H3,(H,12,13)(H,14,15) D0S8HE DRUGINKE GBCGDIQJCHNFKA-UHFFFAOYSA-N D0S8HE DRUGSMIL CC(COP(=O)(O)OC1=CC=CC=C1)(C(=O)O)N D0S8HE HIGHSTAT Investigative D0S8HZ DRUG__ID D0S8HZ D0S8HZ DRUGTYPE Small molecular drug D0S8HZ DRUGINCH 1S/C11H10N2O/c1-7-5-6-8-3-2-4-9(11(12)14)10(8)13-7/h2-6H,1H3,(H2,12,14) D0S8HZ DRUGINKE FKDAECIKJPVBCN-UHFFFAOYSA-N D0S8HZ DRUGSMIL CC1=NC2=C(C=CC=C2C(=O)N)C=C1 D0S8HZ HIGHSTAT Investigative D0S8MJ DRUG__ID D0S8MJ D0S8MJ DRUGTYPE Small molecular drug D0S8MJ DRUGINCH 1S/C19H15N5O2/c25-24(26)15-4-5-18-17(13-15)22-19(16-3-1-2-9-21-16)23(18)12-8-14-6-10-20-11-7-14/h1-7,9-11,13H,8,12H2 D0S8MJ DRUGINKE DPWNICJBRRYQIR-UHFFFAOYSA-N D0S8MJ DRUGSMIL C1=CC=NC(=C1)C2=NC3=C(N2CCC4=CC=NC=C4)C=CC(=C3)[N+](=O)[O-] D0S8MJ HIGHSTAT Investigative D0S8MS DRUG__ID D0S8MS D0S8MS DRUGTYPE Small molecular drug D0S8MS DRUGINCH 1S/C32H37NO8/c1-19(34)30-27(39-2)14-24(15-28(30)40-3)31(37)25(13-20-11-21-7-5-6-8-22(21)12-20)17-33-16-23(9-10-29(35)36)26(18-33)32(38)41-4/h5-8,14-16,18,20,25,31,37H,9-13,17H2,1-4H3,(H,35,36)/t25-,31+/m0/s1 D0S8MS DRUGINKE URHZQBASTULQKJ-VVFBEHOQSA-N D0S8MS DRUGSMIL CC(=O)C1=C(C=C(C=C1OC)C(C(CC2CC3=CC=CC=C3C2)CN4C=C(C(=C4)C(=O)OC)CCC(=O)O)O)OC D0S8MS HIGHSTAT Investigative D0S8NM DRUG__ID D0S8NM D0S8NM DRUGTYPE Small molecular drug D0S8NM DRUGINCH 1S/C22H28N4O4/c23-22(24)25-13-7-12-19(21(28)29)26-20(27)15-30-14-18(16-8-3-1-4-9-16)17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,26,27)(H,28,29)(H4,23,24,25)/t19-/m0/s1 D0S8NM DRUGINKE RRKKJYBCPXAJAO-IBGZPJMESA-N D0S8NM DRUGSMIL C1=CC=C(C=C1)C(COCC(=O)NC(CCCN=C(N)N)C(=O)O)C2=CC=CC=C2 D0S8NM HIGHSTAT Investigative D0S8QZ DRUG__ID D0S8QZ D0S8QZ DRUGTYPE Small molecular drug D0S8QZ DRUGINCH 1S/C36H48N4O3/c37-23-27-12-9-19-40(25-27)36(42)28-15-16-33-31(22-28)34(30-13-7-8-14-32(30)43-33)35(41)38-29-17-20-39(21-18-29)24-26-10-5-3-1-2-4-6-11-26/h7-8,10,13-16,22,27,29,34H,1-6,9,11-12,17-21,23-25,37H2,(H,38,41)/t27-,34?/m0/s1 D0S8QZ DRUGINKE AAPRNHKWNGDTOT-DVRVPOOOSA-N D0S8QZ DRUGSMIL C1CCCC=C(CCC1)CN2CCC(CC2)NC(=O)C3C4=CC=CC=C4OC5=C3C=C(C=C5)C(=O)N6CCCC(C6)CN D0S8QZ HIGHSTAT Investigative D0S8RD DRUG__ID D0S8RD D0S8RD DRUGTYPE Small molecular drug D0S8RD DRUGINCH 1S/C27H29NO/c1-20(27(29)23-12-4-3-5-13-23)28(2)19-18-26-24-14-8-6-10-21(24)16-17-22-11-7-9-15-25(22)26/h3-15,18,20,27,29H,16-17,19H2,1-2H3 D0S8RD DRUGINKE BHVGOYREXHCFOE-UHFFFAOYSA-N D0S8RD DRUGSMIL CC(C(C1=CC=CC=C1)O)N(C)CC=C2C3=CC=CC=C3CCC4=CC=CC=C42 D0S8RD HIGHSTAT Investigative D0S8UN DRUG__ID D0S8UN D0S8UN DRUGTYPE Small molecular drug D0S8UN DRUGINCH 1S/C40H40N4O4.Fe/c1-7-26-24(6)39-38(25-12-10-9-11-13-25)40-27(8-2)21(3)32(43-40)18-30-22(4)28(14-16-36(45)46)34(41-30)20-35-29(15-17-37(47)48)23(5)31(42-35)19-33(26)44-39;/h7-13,18-20,24,26H,1-2,14-17H2,3-6H3,(H4,41,42,43,44,45,46,47,48);/q;+2/p-2 D0S8UN DRUGINKE ODMHOWCUYFSODS-UHFFFAOYSA-L D0S8UN DRUGSMIL CC1C(C2=NC1=C(C3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=C2)[N-]5)C)CCC(=O)O)CCC(=O)O)C)C)C=C)C6=CC=CC=C6)C=C.[Fe+2] D0S8UN HIGHSTAT Investigative D0S8UP DRUG__ID D0S8UP D0S8UP DRUGTYPE Small molecular drug D0S8UP DRUGINCH 1S/C14H10O3/c15-12-6-5-10-11(14(12)17)7-8-3-1-2-4-9(8)13(10)16/h1-6,15,17H,7H2 D0S8UP DRUGINKE KBOKOYAHHLPGSJ-UHFFFAOYSA-N D0S8UP DRUGSMIL C1C2=CC=CC=C2C(=O)C3=C1C(=C(C=C3)O)O D0S8UP HIGHSTAT Investigative D0S8VE DRUG__ID D0S8VE D0S8VE DRUGTYPE Small molecular drug D0S8VE DRUGINCH 1S/C12H11N5O/c1-18-9-3-5-14-11-10(9)7(6-16-11)8-2-4-15-12(13)17-8/h2-6H,1H3,(H,14,16)(H2,13,15,17) D0S8VE DRUGINKE GGEWEQJWGGJUHO-UHFFFAOYSA-N D0S8VE DRUGSMIL COC1=C2C(=CNC2=NC=C1)C3=NC(=NC=C3)N D0S8VE HIGHSTAT Investigative D0S8YD DRUG__ID D0S8YD D0S8YD DRUGTYPE Small molecular drug D0S8YD DRUGINCH 1S/C12H27NO/c1-4-5-6-7-8-9-10-11-12-13(2,3)14/h4-12H2,1-3H3 D0S8YD DRUGINKE ZRKZFNZPJKEWPC-UHFFFAOYSA-N D0S8YD DRUGSMIL CCCCCCCCCC[N+](C)(C)[O-] D0S8YD HIGHSTAT Investigative D0S8ZJ DRUG__ID D0S8ZJ D0S8ZJ DRUGTYPE Small molecular drug D0S8ZJ DRUGINCH 1S/C18H22N2O2/c1-19-13-7-8-14(19)11-15(10-13)22-18(21)17-9-12-5-3-4-6-16(12)20(17)2/h3-6,9,13-15H,7-8,10-11H2,1-2H3/t13-,14-/m1/s1 D0S8ZJ DRUGINKE WGAYVVNWRFPKMG-ZIAGYGMSSA-N D0S8ZJ DRUGSMIL CN1C2CCC1CC(C2)OC(=O)C3=CC4=CC=CC=C4N3C D0S8ZJ HIGHSTAT Investigative D0S9AT DRUG__ID D0S9AT D0S9AT DRUGTYPE Small molecular drug D0S9AT DRUGINCH 1S/C22H23N3O3/c1-15-18-9-8-17(25(27)28)14-19(18)21(16-6-4-3-5-7-16)20(15)22(26)24-12-10-23(2)11-13-24/h3-9,14-15H,10-13H2,1-2H3 D0S9AT DRUGINKE BBPOBHFPZPRPGB-UHFFFAOYSA-N D0S9AT DRUGSMIL CC1C2=C(C=C(C=C2)[N+](=O)[O-])C(=C1C(=O)N3CCN(CC3)C)C4=CC=CC=C4 D0S9AT HIGHSTAT Investigative D0S9AY DRUG__ID D0S9AY D0S9AY DRUGTYPE Small molecular drug D0S9AY DRUGINCH 1S/C16H19FN2/c17-16-4-3-14-11-13(1-2-15(14)12-16)5-8-19-9-6-18-7-10-19/h1-4,11-12,18H,5-10H2 D0S9AY DRUGINKE AVSJNVNTDDYDEP-UHFFFAOYSA-N D0S9AY DRUGSMIL C1CN(CCN1)CCC2=CC3=C(C=C2)C=C(C=C3)F D0S9AY HIGHSTAT Investigative D0S9CI DRUG__ID D0S9CI D0S9CI DRUGTYPE Small molecular drug D0S9CI DRUGINCH 1S/C33H36FN5O3/c1-33(2,3)38-20-18-37(19-21-38)22-26-28(31(40)36-39(32(41)42-4)24-14-9-6-10-15-24)25-16-11-17-27(34)30(25)35-29(26)23-12-7-5-8-13-23/h5-17H,18-22H2,1-4H3,(H,36,40) D0S9CI DRUGINKE KQNYTTDHCMFOME-UHFFFAOYSA-N D0S9CI DRUGSMIL CC(C)(C)N1CCN(CC1)CC2=C(N=C3C(=C2C(=O)NN(C4=CC=CC=C4)C(=O)OC)C=CC=C3F)C5=CC=CC=C5 D0S9CI HIGHSTAT Investigative D0S9GU DRUG__ID D0S9GU D0S9GU DRUGTYPE Small molecular drug D0S9GU DRUGINCH 1S/C25H28O6/c1-13(2)5-6-15-7-16(8-17(25(15)30)9-19(27)14(3)4)22-12-21(29)24-20(28)10-18(26)11-23(24)31-22/h5,7-8,10-11,19,22,26-28,30H,3,6,9,12H2,1-2,4H3/t19?,22-/m0/s1 D0S9GU DRUGINKE FZUJHUDJFJCWMT-BPARTEKVSA-N D0S9GU DRUGSMIL CC(=CCC1=C(C(=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)O)O)CC(C(=C)C)O)O)C D0S9GU HIGHSTAT Investigative D0S9IO DRUG__ID D0S9IO D0S9IO DRUGTYPE Small molecular drug D0S9IO DRUGINCH 1S/C19H25N3O2/c1-3-22(4-2)18(23)19(15-8-6-5-7-9-15)12-16(19)13-20-14-17-21-10-11-24-17/h5-11,16,20H,3-4,12-14H2,1-2H3 D0S9IO DRUGINKE NCRFMJNGTNNKEE-UHFFFAOYSA-N D0S9IO DRUGSMIL CCN(CC)C(=O)C1(CC1CNCC2=NC=CO2)C3=CC=CC=C3 D0S9IO HIGHSTAT Investigative D0S9JC DRUG__ID D0S9JC D0S9JC DRUGTYPE Small molecular drug D0S9JC DRUGINCH 1S/C12H16ClN3O2/c13-11-1-2-14-9-10(11)12(17)15-3-4-16-5-7-18-8-6-16/h1-2,9H,3-8H2,(H,15,17) D0S9JC DRUGINKE FJZDMBYDDXBLAU-UHFFFAOYSA-N D0S9JC DRUGSMIL C1COCCN1CCNC(=O)C2=C(C=CN=C2)Cl D0S9JC HIGHSTAT Investigative D0S9JF DRUG__ID D0S9JF D0S9JF DRUGTYPE Small molecular drug D0S9JF DRUGINCH 1S/C12H17NO2S/c14-12(13-15)9-5-2-6-10-16-11-7-3-1-4-8-11/h1,3-4,7-8,15H,2,5-6,9-10H2,(H,13,14) D0S9JF DRUGINKE RFQHGQGHSXXDPZ-UHFFFAOYSA-N D0S9JF DRUGSMIL C1=CC=C(C=C1)SCCCCCC(=O)NO D0S9JF HIGHSTAT Investigative D0S9JG DRUG__ID D0S9JG D0S9JG DRUGTYPE Small molecular drug D0S9JG DRUGINCH 1S/C25H25N3O2S/c29-22(18-4-2-1-3-5-18)28-24-27-20-7-6-19(11-21(20)31-24)26-23(30)25-12-15-8-16(13-25)10-17(9-15)14-25/h1-7,11,15-17H,8-10,12-14H2,(H,26,30)(H,27,28,29) D0S9JG DRUGINKE MVSSJPGNLQPWSW-UHFFFAOYSA-N D0S9JG DRUGSMIL C1C2CC3CC1CC(C2)(C3)C(=O)NC4=CC5=C(C=C4)N=C(S5)NC(=O)C6=CC=CC=C6 D0S9JG HIGHSTAT Investigative D0S9KH DRUG__ID D0S9KH D0S9KH DRUGTYPE Small molecular drug D0S9KH DRUGINCH 1S/C21H28FNO4/c1-11-8-15-14-5-4-12-9-13(24)6-7-18(12,2)20(14,22)16(25)10-19(15,3)21(11,27)17(23)26/h6-7,9,11,14-16,25,27H,4-5,8,10H2,1-3H3,(H2,23,26)/t11-,14+,15+,16+,18+,19+,20+,21+/m1/s1 D0S9KH DRUGINKE PILCISDJZUQFIS-AFKBWYBQSA-N D0S9KH DRUGSMIL CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)N)O)C)O)F)C D0S9KH HIGHSTAT Investigative D0S9LT DRUG__ID D0S9LT D0S9LT DRUGTYPE Small molecular drug D0S9LT DRUGINCH 1S/C6H7O4P/c7-11(8,9)10-6-4-2-1-3-5-6/h1-5H,(H2,7,8,9) D0S9LT DRUGINKE CMPQUABWPXYYSH-UHFFFAOYSA-N D0S9LT DRUGSMIL C1=CC=C(C=C1)OP(=O)(O)O D0S9LT HIGHSTAT Investigative D0S9OL DRUG__ID D0S9OL D0S9OL DRUGTYPE Small molecular drug D0S9OL DRUGINCH 1S/C19H15NO5S/c21-19(20-22)17-8-4-5-9-18(17)26(23,24)16-12-10-15(11-13-16)25-14-6-2-1-3-7-14/h1-13,22H,(H,20,21) D0S9OL DRUGINKE MYZHQACPXTZCJY-UHFFFAOYSA-N D0S9OL DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)S(=O)(=O)C3=CC=CC=C3C(=O)NO D0S9OL HIGHSTAT Investigative D0S9PC DRUG__ID D0S9PC D0S9PC DRUGTYPE Small molecular drug D0S9PC DRUGINCH 1S/C39H66N12O8/c1-6-23(4)31(34(55)48-28(37(58)59)20-22(2)3)49-32(53)27(21-24-13-15-25(52)16-14-24)47-33(54)29-12-9-19-51(29)36(57)30(11-8-18-46-39(43)44)50(5)35(56)26(40)10-7-17-45-38(41)42/h13-16,22-23,26-31,52H,6-12,17-21,40H2,1-5H3,(H,47,54)(H,48,55)(H,49,53)(H,58,59)(H4,41,42,45)(H4,43,44,46)/t23-,26-,27-,28-,29-,30-,31-/m0/s1 D0S9PC DRUGINKE FMWPNVFPKCUWHA-VGPFALITSA-N D0S9PC DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N(C)C(=O)C(CCCN=C(N)N)N D0S9PC HIGHSTAT Investigative D0S9QP DRUG__ID D0S9QP D0S9QP DRUGTYPE Small molecular drug D0S9QP DRUGINCH 1S/C24H18N2O2/c1-27-23-14-20-21(25-16-26-22(20)15-24(23)28-2)13-12-18-10-6-7-11-19(18)17-8-4-3-5-9-17/h3-11,14-16H,1-2H3 D0S9QP DRUGINKE ZUBUFJOEYHKFCQ-UHFFFAOYSA-N D0S9QP DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)C#CC3=CC=CC=C3C4=CC=CC=C4)OC D0S9QP HIGHSTAT Investigative D0S9SJ DRUG__ID D0S9SJ D0S9SJ DRUGTYPE Small molecular drug D0S9SJ DRUGINCH 1S/C28H40BrN7O4/c1-16(2)35(12-6-11-31-27(39)34-18-9-7-17(8-10-18)28(3,4)5)14-20-22(37)23(38)26(40-20)36-13-19(29)21-24(30)32-15-33-25(21)36/h7-10,13,15-16,20,22-23,26,37-38H,6,11-12,14H2,1-5H3,(H2,30,32,33)(H2,31,34,39)/t20-,22-,23-,26-/m1/s1 D0S9SJ DRUGINKE IQCKJUKAQJINMK-HUBRGWSESA-N D0S9SJ DRUGSMIL CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O D0S9SJ HIGHSTAT Investigative D0S9SX DRUG__ID D0S9SX D0S9SX DRUGTYPE Small molecular drug D0S9SX DRUGINCH 1S/C17H16N2S/c1-3-15-19-16(14-6-4-5-12(2)11-14)17(20-15)13-7-9-18-10-8-13/h4-11H,3H2,1-2H3 D0S9SX DRUGINKE QUKIIQWKXMTFAE-UHFFFAOYSA-N D0S9SX DRUGSMIL CCC1=NC(=C(S1)C2=CC=NC=C2)C3=CC=CC(=C3)C D0S9SX HIGHSTAT Investigative D0S9TZ DRUG__ID D0S9TZ D0S9TZ DRUGTYPE Small molecular drug D0S9TZ DRUGINCH 1S/C18H22N4OS/c1-11-16(17(23)21(2)13-6-4-3-5-7-13)24-18-20-14-9-8-12(19)10-15(14)22(11)18/h8-10,13H,3-7,19H2,1-2H3 D0S9TZ DRUGINKE KCBXOMYXOBVLED-UHFFFAOYSA-N D0S9TZ DRUGSMIL CC1=C(SC2=NC3=C(N12)C=C(C=C3)N)C(=O)N(C)C4CCCCC4 D0S9TZ HIGHSTAT Investigative D0S9UK DRUG__ID D0S9UK D0S9UK DRUGTYPE Small molecular drug D0S9UK DRUGINCH 1S/C21H15N/c22-16-20(17-10-4-1-5-11-17)21(18-12-6-2-7-13-18)19-14-8-3-9-15-19/h1-15H D0S9UK DRUGINKE OPACMJHTQWVSKW-UHFFFAOYSA-N D0S9UK DRUGSMIL C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=CC=C3)C#N D0S9UK HIGHSTAT Investigative D0S9UQ DRUG__ID D0S9UQ D0S9UQ DRUGTYPE Small molecular drug D0S9UQ DRUGINCH 1S/C10H11N5/c1-6-7-4-2-3-5-8(7)14-10(13-6)15-9(11)12/h2-5H,1H3,(H4,11,12,13,14,15) D0S9UQ DRUGINKE ONQKSKDLYYDFLL-UHFFFAOYSA-N D0S9UQ DRUGSMIL CC1=NC(=NC2=CC=CC=C12)N=C(N)N D0S9UQ HIGHSTAT Investigative D0S9WV DRUG__ID D0S9WV D0S9WV DRUGTYPE Small molecular drug D0S9WV DRUGINCH 1S/C15H19N3O/c19-14(13-9-16-1-2-17-13)18-15-6-10-3-11(7-15)5-12(4-10)8-15/h1-2,9-12H,3-8H2,(H,18,19) D0S9WV DRUGINKE RURVWNUUUXCYRB-UHFFFAOYSA-N D0S9WV DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)C4=NC=CN=C4 D0S9WV HIGHSTAT Investigative D0S9XO DRUG__ID D0S9XO D0S9XO DRUGTYPE Small molecular drug D0S9XO DRUGINCH 1S/C11H8BrNO2S/c12-7-1-2-9-8(4-7)6(5-13-9)3-10(16)11(14)15/h1-5,13,16H,(H,14,15)/b10-3- D0S9XO DRUGINKE RLEKFRNXGFHPHZ-KMKOMSMNSA-N D0S9XO DRUGSMIL C1=CC2=C(C=C1Br)C(=CN2)C=C(C(=O)O)S D0S9XO HIGHSTAT Investigative D0S9YA DRUG__ID D0S9YA D0S9YA DRUGTYPE Small molecular drug D0S9YA DRUGINCH 1S/C15H12O2/c16-14-9-5-4-8-13(14)15(17)11-10-12-6-2-1-3-7-12/h1-11,16H/b11-10+ D0S9YA DRUGINKE AETKQQBRKSELEL-ZHACJKMWSA-N D0S9YA DRUGSMIL C1=CC=C(C=C1)C=CC(=O)C2=CC=CC=C2O D0S9YA HIGHSTAT Investigative D0S9YE DRUG__ID D0S9YE D0S9YE DRUGTYPE Small molecular drug D0S9YE DRUGINCH 1S/C12H8N2O2/c15-12(16)10-5-8-7-3-1-2-4-9(7)14-11(8)6-13-10/h1-6,14H,(H,15,16) D0S9YE DRUGINKE ARLVFKCLBYUINL-UHFFFAOYSA-N D0S9YE DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NC=C3N2)C(=O)O D0S9YE HIGHSTAT Investigative D0S9YX DRUG__ID D0S9YX D0S9YX DRUGTYPE Small molecular drug D0S9YX DRUGINCH 1S/C16H12O5/c1-20-11-4-2-9(3-5-11)12-8-21-14-7-10(17)6-13(18)15(14)16(12)19/h2-8,17-18H,1H3 D0S9YX DRUGINKE WUADCCWRTIWANL-UHFFFAOYSA-N D0S9YX DRUGSMIL COC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3C2=O)O)O D0S9YX HIGHSTAT Investigative D0SA1G DRUG__ID D0SA1G D0SA1G DRUGTYPE Small molecular drug D0SA1G DRUGINCH 1S/C12H19NS/c1-4-13-10(2)9-11-5-7-12(14-3)8-6-11/h5-8,10,13H,4,9H2,1-3H3 D0SA1G DRUGINKE LAWDOCPCCFOXQO-UHFFFAOYSA-N D0SA1G DRUGSMIL CCNC(C)CC1=CC=C(C=C1)SC D0SA1G HIGHSTAT Investigative D0SA4A DRUG__ID D0SA4A D0SA4A DRUGTYPE Small molecular drug D0SA4A DRUGINCH 1S/C8H10ClN5/c9-5-2-1-3-6(4-5)13-8(12)14-7(10)11/h1-4H,(H6,10,11,12,13,14) D0SA4A DRUGINKE DIHXJZHAIHGSAW-UHFFFAOYSA-N D0SA4A DRUGSMIL C1=CC(=CC(=C1)Cl)N=C(N)N=C(N)N D0SA4A HIGHSTAT Investigative D0SB0W DRUG__ID D0SB0W D0SB0W DRUGTYPE Small molecular drug D0SB0W DRUGINCH 1S/C13H14N6O2/c1-20-6-3-4-7(8(5-6)21-2)11-16-9-10(14)17-13(15)19-12(9)18-11/h3-5H,1-2H3,(H5,14,15,16,17,18,19) D0SB0W DRUGINKE GCFWRZGRJQMBPE-UHFFFAOYSA-N D0SB0W DRUGSMIL COC1=CC(=C(C=C1)C2=NC3=NC(=NC(=C3N2)N)N)OC D0SB0W HIGHSTAT Investigative D0SB5H DRUG__ID D0SB5H D0SB5H DRUGTYPE Small molecular drug D0SB5H DRUGINCH 1S/C6H12N2S/c1-5-4-8-6(7)2-3-9-5/h5H,2-4H2,1H3,(H2,7,8) D0SB5H DRUGINKE FACIWFABQIDLEA-UHFFFAOYSA-N D0SB5H DRUGSMIL CC1CN=C(CCS1)N D0SB5H HIGHSTAT Investigative D0SB6Y DRUG__ID D0SB6Y D0SB6Y DRUGTYPE Small molecular drug D0SB6Y DRUGINCH 1S/C29H33FN2O/c30-25-13-11-22(12-14-25)28(33)17-18-31-19-20-32-21-26(31)15-16-27(32)29(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,26-29,33H,15-21H2/t26-,27-,28+/m0/s1 D0SB6Y DRUGINKE GAKAYJNKCDLKCE-HZFUHODCSA-N D0SB6Y DRUGSMIL C1CC(N2CCN(C1C2)CCC(C3=CC=C(C=C3)F)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D0SB6Y HIGHSTAT Investigative D0SB7U DRUG__ID D0SB7U D0SB7U DRUGTYPE Small molecular drug D0SB7U DRUGINCH 1S/C18H15N5O2S/c1-25-12-6-4-11(5-7-12)23-9-21-14-13-16(22-10-2-3-10)19-8-20-17(13)26-15(14)18(23)24/h4-10H,2-3H2,1H3,(H,19,20,22) D0SB7U DRUGINKE DBUMITZHDMTTNX-UHFFFAOYSA-N D0SB7U DRUGSMIL COC1=CC=C(C=C1)N2C=NC3=C(C2=O)SC4=NC=NC(=C34)NC5CC5 D0SB7U HIGHSTAT Investigative D0SB9H DRUG__ID D0SB9H D0SB9H DRUGTYPE Small molecular drug D0SB9H DRUGINCH 1S/C27H47N7O6/c28-10-6-13-30-11-4-5-12-31-16-9-25(38)32-14-2-1-3-15-33-27(40)22(19-24(29)37)34-26(39)17-20-7-8-21(35)18-23(20)36/h7-8,18,22,30-31,35-36H,1-6,9-17,19,28H2,(H2,29,37)(H,32,38)(H,33,40)(H,34,39)/t22-/m0/s1 D0SB9H DRUGINKE SJLRBGDPTALRDM-QFIPXVFZSA-N D0SB9H DRUGSMIL C1=CC(=C(C=C1O)O)CC(=O)NC(CC(=O)N)C(=O)NCCCCCNC(=O)CCNCCCCNCCCN D0SB9H HIGHSTAT Investigative D0SC3W DRUG__ID D0SC3W D0SC3W DRUGTYPE Small molecular drug D0SC3W DRUGINCH 1S/C48H60N2O4/c1-3-27-49-29-25-47-23-13-11-15-39(47)43(49)31-35-19-21-37(33-41(35)47)53-45(51)17-9-7-5-6-8-10-18-46(52)54-38-22-20-36-32-44-40-16-12-14-24-48(40,42(36)34-38)26-30-50(44)28-4-2/h1-2,19-22,33-34,39-40,43-44H,5-18,23-32H2/t39?,40?,43-,44-,47-,48-/m1/s1 D0SC3W DRUGINKE CMJNSGDVJLNRPB-TXEWOLIYSA-N D0SC3W DRUGSMIL C#CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC(=O)CCCCCCCCC(=O)OC5=CC6=C(CC7C8C6(CCCC8)CCN7CC#C)C=C5 D0SC3W HIGHSTAT Investigative D0SC4X DRUG__ID D0SC4X D0SC4X DRUGTYPE Small molecular drug D0SC4X DRUGINCH 1S/C36H50O14/c1-4-5-6-7-8-9-13-21-27(38)48-29-28(39)34(49-30(31(40)41)35(46,32(42)43)36(29,50-34)33(44)45)22-15-20-26(47-24(3)37)23(2)16-14-19-25-17-11-10-12-18-25/h10-12,14,17-19,23,26,28-30,39,46H,4-9,13,15-16,20-22H2,1-3H3,(H,40,41)(H,42,43)(H,44,45)/b19-14+/t23?,26?,28-,29-,30-,34+,35-,36+/m1/s1 D0SC4X DRUGINKE WDLYATMIWWDJQY-FYSMYQDTSA-N D0SC4X DRUGSMIL CCCCCCCCCC(=O)OC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCCC(C(C)CC=CC3=CC=CC=C3)OC(=O)C)O D0SC4X HIGHSTAT Investigative D0SC5V DRUG__ID D0SC5V D0SC5V DRUGTYPE Small molecular drug D0SC5V DRUGINCH 1S/C10H11NO2/c11-10(9(12)13)5-7-3-1-2-4-8(7)6-10/h1-4H,5-6,11H2,(H,12,13) D0SC5V DRUGINKE UHQFXIWMAQOCAN-UHFFFAOYSA-N D0SC5V DRUGSMIL C1C2=CC=CC=C2CC1(C(=O)O)N D0SC5V HIGHSTAT Investigative D0SC7C DRUG__ID D0SC7C D0SC7C DRUGTYPE Small molecular drug D0SC7C DRUGINCH 1S/C10H15N2O7P/c1-6-4-12(10(14)11-9(6)13)8-3-2-7(19-8)5-18-20(15,16)17/h4,7-8H,2-3,5H2,1H3,(H,11,13,14)(H2,15,16,17)/t7-,8+/m0/s1 D0SC7C DRUGINKE WVNRRNJFRREKAR-JGVFFNPUSA-N D0SC7C DRUGSMIL CC1=CN(C(=O)NC1=O)C2CCC(O2)COP(=O)(O)O D0SC7C HIGHSTAT Investigative D0SD3Q DRUG__ID D0SD3Q D0SD3Q DRUGTYPE Small molecular drug D0SD3Q DRUGINCH 1S/C17H15BrN4O2/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)20-9-16(24)22(14)10-15(23)21-19/h1-8H,9-10,19H2,(H,21,23) D0SD3Q DRUGINKE XLGCMZLSEXRBSG-UHFFFAOYSA-N D0SD3Q DRUGSMIL C1C(=O)N(C2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3)CC(=O)NN D0SD3Q HIGHSTAT Investigative D0SD4O DRUG__ID D0SD4O D0SD4O DRUGTYPE Small molecular drug D0SD4O DRUGINCH 1S/C11H17NS/c1-9(12-2)8-10-4-6-11(13-3)7-5-10/h4-7,9,12H,8H2,1-3H3 D0SD4O DRUGINKE WWHIYWVWPXXBTC-UHFFFAOYSA-N D0SD4O DRUGSMIL CC(CC1=CC=C(C=C1)SC)NC D0SD4O HIGHSTAT Investigative D0SD8Q DRUG__ID D0SD8Q D0SD8Q DRUGTYPE Small molecular drug D0SD8Q DRUGINCH 1S/C33H42N4O6/c1-21-28(31(38)42-4)30(29(22(2)35-21)32(39)43-5)25-10-6-11-26(19-25)36-33(40)34-15-8-16-37-17-13-23(14-18-37)24-9-7-12-27(20-24)41-3/h6-7,9-12,19-20,23,30,35H,8,13-18H2,1-5H3,(H2,34,36,40) D0SD8Q DRUGINKE WMYSXJSJXZFODY-UHFFFAOYSA-N D0SD8Q DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)NC(=O)NCCCN3CCC(CC3)C4=CC(=CC=C4)OC)C(=O)OC D0SD8Q HIGHSTAT Investigative D0SD9H DRUG__ID D0SD9H D0SD9H DRUGTYPE Small molecular drug D0SD9H DRUGINCH 1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6-/m1/s1 D0SD9H DRUGINKE WQZGKKKJIJFFOK-RWOPYEJCSA-N D0SD9H DRUGSMIL C(C1C(C(C(C(O1)O)O)O)O)O D0SD9H HIGHSTAT Investigative D0SE1R DRUG__ID D0SE1R D0SE1R DRUGTYPE Small molecular drug D0SE1R DRUGINCH 1S/C22H19NO4S/c1-16-2-13-21(14-3-16)28(26,27)23-19-9-7-18(8-10-19)22(25)15-6-17-4-11-20(24)12-5-17/h2-15,23-24H,1H3/b15-6+ D0SE1R DRUGINKE KDODYFOOJCIHGK-GIDUJCDVSA-N D0SE1R DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C(=O)C=CC3=CC=C(C=C3)O D0SE1R HIGHSTAT Investigative D0SE2D DRUG__ID D0SE2D D0SE2D DRUGTYPE Small molecular drug D0SE2D DRUGINCH 1S/C16H18ClN3O/c1-3-20(4-2)16(21)12-5-10-15(18-11-12)19-14-8-6-13(17)7-9-14/h5-11H,3-4H2,1-2H3,(H,18,19) D0SE2D DRUGINKE UEKPAIMMZMCKSL-UHFFFAOYSA-N D0SE2D DRUGSMIL CCN(CC)C(=O)C1=CN=C(C=C1)NC2=CC=C(C=C2)Cl D0SE2D HIGHSTAT Investigative D0SE3C DRUG__ID D0SE3C D0SE3C DRUGTYPE Small molecular drug D0SE3C DRUGINCH 1S/C26H27N/c1-18(16-19-8-3-2-4-9-19)27-25-17-24-22-12-6-5-10-20(22)14-15-21-11-7-13-23(25)26(21)24/h2-13,18,24-25,27H,14-17H2,1H3 D0SE3C DRUGINKE DNSDIYWJKBRJKP-UHFFFAOYSA-N D0SE3C DRUGSMIL CC(CC1=CC=CC=C1)NC2CC3C4=CC=CC=C4CCC5=C3C2=CC=C5 D0SE3C HIGHSTAT Investigative D0SE9M DRUG__ID D0SE9M D0SE9M DRUGTYPE Small molecular drug D0SE9M DRUGINCH 1S/C16H14ClN5O/c1-10-14(15(23)20-13-8-9-18-16(17)21-13)19-11(2)22(10)12-6-4-3-5-7-12/h3-9H,1-2H3,(H,18,20,21,23) D0SE9M DRUGINKE YCJZWBZJSYLMPB-UHFFFAOYSA-N D0SE9M DRUGSMIL CC1=C(N=C(N1C2=CC=CC=C2)C)C(=O)NC3=NC(=NC=C3)Cl D0SE9M HIGHSTAT Investigative D0SF3B DRUG__ID D0SF3B D0SF3B DRUGTYPE Small molecular drug D0SF3B DRUGINCH 1S/C14H20N2O3S/c1-2-3-4-14(17)16-12-7-10-5-6-13(20(15,18)19)9-11(10)8-12/h5-6,9,12H,2-4,7-8H2,1H3,(H,16,17)(H2,15,18,19) D0SF3B DRUGINKE VPKYLHQTQYEJLJ-UHFFFAOYSA-N D0SF3B DRUGSMIL CCCCC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N D0SF3B HIGHSTAT Investigative D0SF9Z DRUG__ID D0SF9Z D0SF9Z DRUGTYPE Small molecular drug D0SF9Z DRUGINCH 1S/C19H17N3O2S/c1-21(2)15-8-10-20-18-16(15)14-9-11-22(19(23)17(14)25-18)12-4-6-13(24-3)7-5-12/h4-11H,1-3H3 D0SF9Z DRUGINKE KBKYZXCTHJUCOC-UHFFFAOYSA-N D0SF9Z DRUGSMIL CN(C)C1=C2C3=C(C(=O)N(C=C3)C4=CC=C(C=C4)OC)SC2=NC=C1 D0SF9Z HIGHSTAT Investigative D0SG0G DRUG__ID D0SG0G D0SG0G DRUGTYPE Small molecular drug D0SG0G DRUGINCH 1S/C17H16N2O3/c1-20-15-9-14-13(16(21-2)17(15)22-3)8-12(10-19-14)11-4-6-18-7-5-11/h4-10H,1-3H3 D0SG0G DRUGINKE FQVDOOFEQQAHPX-UHFFFAOYSA-N D0SG0G DRUGSMIL COC1=C(C(=C2C=C(C=NC2=C1)C3=CC=NC=C3)OC)OC D0SG0G HIGHSTAT Investigative D0SG6A DRUG__ID D0SG6A D0SG6A DRUGTYPE Small molecular drug D0SG6A DRUGINCH 1S/C10H16N2O3S/c1-11-7-10(13)8-4-3-5-9(6-8)12-16(2,14)15/h3-6,10-13H,7H2,1-2H3 D0SG6A DRUGINKE ZHOWHMXTJFZXRB-UHFFFAOYSA-N D0SG6A DRUGSMIL CNCC(C1=CC(=CC=C1)NS(=O)(=O)C)O D0SG6A HIGHSTAT Investigative D0SG6Q DRUG__ID D0SG6Q D0SG6Q DRUGTYPE Small molecular drug D0SG6Q DRUGINCH 1S/C18H11ClN4OS/c1-2-8-20-13-7-9-21-17-14(13)15-16(25-17)18(24)23(10-22-15)12-5-3-11(19)4-6-12/h1,3-7,9-10H,8H2,(H,20,21) D0SG6Q DRUGINKE MAYHTEHJUHRFSA-UHFFFAOYSA-N D0SG6Q DRUGSMIL C#CCNC1=C2C3=C(C(=O)N(C=N3)C4=CC=C(C=C4)Cl)SC2=NC=C1 D0SG6Q HIGHSTAT Investigative D0SH0M DRUG__ID D0SH0M D0SH0M DRUGTYPE Small molecular drug D0SH0M DRUGINCH 1S/C16H11NO5/c1-9-2-4-10(5-3-9)22-11-6-7-12-13(8-11)15(19)17(14(12)18)16(20)21/h2-8H,1H3,(H,20,21) D0SH0M DRUGINKE QSPCKQSNISDWOH-UHFFFAOYSA-N D0SH0M DRUGSMIL CC1=CC=C(C=C1)OC2=CC3=C(C=C2)C(=O)N(C3=O)C(=O)O D0SH0M HIGHSTAT Investigative D0SH1L DRUG__ID D0SH1L D0SH1L DRUGTYPE Small molecular drug D0SH1L DRUGINCH 1S/C23H19N3O/c27-23(25-21-13-7-12-19-16-24-15-14-20(19)21)26-22(17-8-3-1-4-9-17)18-10-5-2-6-11-18/h1-16,22H,(H2,25,26,27) D0SH1L DRUGINKE ZBZSZXCYOYRLKL-UHFFFAOYSA-N D0SH1L DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)NC(=O)NC3=CC=CC4=C3C=CN=C4 D0SH1L HIGHSTAT Investigative D0SI7S DRUG__ID D0SI7S D0SI7S DRUGTYPE Small molecular drug D0SI7S DRUGINCH 1S/C14H12O2/c15-13-5-6-14(16)12-8-10-4-2-1-3-9(10)7-11(12)13/h5-8H,1-4H2 D0SI7S DRUGINKE DWXLNXHEUIUNRF-UHFFFAOYSA-N D0SI7S DRUGSMIL C1CCC2=CC3=C(C=C2C1)C(=O)C=CC3=O D0SI7S HIGHSTAT Investigative D0SJ2Q DRUG__ID D0SJ2Q D0SJ2Q DRUGTYPE Small molecular drug D0SJ2Q DRUGINCH 1S/C30H48O3/c1-25(2)14-16-30(24(32)33)17-15-28(6)19(20(30)18-25)8-9-22-27(5)12-11-23(31)26(3,4)21(27)10-13-29(22,28)7/h8,20-23,31H,9-18H2,1-7H3,(H,32,33)/t20-,21-,22+,23-,27-,28+,29+,30-/m0/s1 D0SJ2Q DRUGINKE MIJYXULNPSFWEK-GTOFXWBISA-N D0SJ2Q DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)O)C D0SJ2Q HIGHSTAT Investigative D0SJ3W DRUG__ID D0SJ3W D0SJ3W DRUGTYPE Small molecular drug D0SJ3W DRUGINCH 1S/C12H10N2O2/c15-12-10-5-1-2-6-11(10)13-14(12)8-9-4-3-7-16-9/h1-7,13H,8H2 D0SJ3W DRUGINKE FFYKZUMLEJLSIN-UHFFFAOYSA-N D0SJ3W DRUGSMIL C1=CC=C2C(=C1)C(=O)N(N2)CC3=CC=CO3 D0SJ3W HIGHSTAT Investigative D0SJ6E DRUG__ID D0SJ6E D0SJ6E DRUGTYPE Small molecular drug D0SJ6E DRUGINCH 1S/C19H22N2O2S/c1-15-8-10-17(11-9-15)24(22,23)21-14-16(12-13-20(2)3)18-6-4-5-7-19(18)21/h4-11,14H,12-13H2,1-3H3 D0SJ6E DRUGINKE RJGTUGOGNODPPC-UHFFFAOYSA-N D0SJ6E DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C=C(C3=CC=CC=C32)CCN(C)C D0SJ6E HIGHSTAT Investigative D0SK3A DRUG__ID D0SK3A D0SK3A DRUGTYPE Small molecular drug D0SK3A DRUGINCH 1S/C30H30N2O3/c1-30(2,24-8-12-26(33)13-9-24)25-10-16-28(17-11-25)35-20-22-5-3-4-21(18-22)19-34-27-14-6-23(7-15-27)29(31)32/h3-18,33H,19-20H2,1-2H3,(H3,31,32) D0SK3A DRUGINKE MBLJFKQACMILLC-UHFFFAOYSA-N D0SK3A DRUGSMIL CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)OCC3=CC=CC(=C3)COC4=CC=C(C=C4)C(=N)N D0SK3A HIGHSTAT Investigative D0SK8U DRUG__ID D0SK8U D0SK8U DRUGTYPE Small molecular drug D0SK8U DRUGINCH 1S/C21H35N7O13P2S/c1-21(2,16(32)19(33)24-4-3-12(29)23-5-6-44)8-39-43(36,37)41-42(34,35)38-7-11-14(30)15(31)20(40-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-32,44H,3-8H2,1-2H3,(H,23,29)(H,24,33)(H,34,35)(H,36,37)(H2,22,25,26)/t11-,14-,15-,16+,20-/m1/s1 D0SK8U DRUGINKE KDTSHFARGAKYJN-IBOSZNHHSA-N D0SK8U DRUGSMIL CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O)C(C(=O)NCCC(=O)NCCS)O D0SK8U HIGHSTAT Investigative D0SL4Q DRUG__ID D0SL4Q D0SL4Q DRUGTYPE Small molecular drug D0SL4Q DRUGINCH 1S/C17H19ClN6/c1-22-15-5-3-2-4-14(15)21-16(22)12-23-6-8-24(9-7-23)17-19-10-13(18)11-20-17/h2-5,10-11H,6-9,12H2,1H3 D0SL4Q DRUGINKE IXXZGBOSQDVMTC-UHFFFAOYSA-N D0SL4Q DRUGSMIL CN1C2=CC=CC=C2N=C1CN3CCN(CC3)C4=NC=C(C=N4)Cl D0SL4Q HIGHSTAT Investigative D0SM3V DRUG__ID D0SM3V D0SM3V DRUGTYPE Small molecular drug D0SM3V DRUGINCH 1S/C17H28O3/c1-2-3-10-13-16(18)14-11-8-6-4-5-7-9-12-15-17(19)20/h5-8,11,14,16,18H,2-4,9-10,12-13,15H2,1H3,(H,19,20)/b7-5-,8-6+,14-11+/t16-/m0/s1 D0SM3V DRUGINKE KUKJHGXXZWHSBG-WBGSEQOASA-N D0SM3V DRUGSMIL CCCCCC(C=CC=CCC=CCCCC(=O)O)O D0SM3V HIGHSTAT Investigative D0SM4F DRUG__ID D0SM4F D0SM4F DRUGTYPE Small molecular drug D0SM4F DRUGINCH 1S/C18H18N2O/c1-2-18(20-12-11-19-13-20)16-5-3-14(4-6-16)15-7-9-17(21)10-8-15/h3-13,18,21H,2H2,1H3 D0SM4F DRUGINKE LYYLXDSSMORBEQ-UHFFFAOYSA-N D0SM4F DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC=C(C=C2)O)N3C=CN=C3 D0SM4F HIGHSTAT Investigative D0SN3L DRUG__ID D0SN3L D0SN3L DRUGTYPE Small molecular drug D0SN3L DRUGINCH 1S/C13H14N2O/c16-13(12-7-4-9-14-12)15-10-8-11-5-2-1-3-6-11/h1-7,9,14H,8,10H2,(H,15,16) D0SN3L DRUGINKE JSHPCVXIXZUURL-UHFFFAOYSA-N D0SN3L DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C2=CC=CN2 D0SN3L HIGHSTAT Investigative D0SN6R DRUG__ID D0SN6R D0SN6R DRUGTYPE Small molecular drug D0SN6R DRUGINCH 1S/C15H17NO/c1-2-4-14-9-15(6-5-13(14)3-1)17-11-12-7-8-16-10-12/h1-6,9,12,16H,7-8,10-11H2 D0SN6R DRUGINKE FXQBHPKGRGPIKE-UHFFFAOYSA-N D0SN6R DRUGSMIL C1CNCC1COC2=CC3=CC=CC=C3C=C2 D0SN6R HIGHSTAT Investigative D0SN6V DRUG__ID D0SN6V D0SN6V DRUGTYPE Small molecular drug D0SN6V DRUGINCH 1S/C48H78N14O8/c1-6-29(2)39(45(70)58-33(40(50)65)16-10-11-23-49)62-42(67)35(18-13-25-56-47(53)54)59-43(68)37(27-31-19-21-32(63)22-20-31)61-44(69)36(26-30-14-8-7-9-15-30)60-41(66)34(17-12-24-55-46(51)52)57-38(64)28-48(3,4)5/h7-9,14-15,19-22,29,33-37,39,63H,6,10-13,16-18,23-28,49H2,1-5H3,(H2,50,65)(H,57,64)(H,58,70)(H,59,68)(H,60,66)(H,61,69)(H,62,67)(H4,51,52,55)(H4,53,54,56)/t29-,33-,34-,35-,36-,37-,39-/m0/s1 D0SN6V DRUGINKE MBLODLLZWHUJED-INYUMPDKSA-N D0SN6V DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)CC(C)(C)C D0SN6V HIGHSTAT Investigative D0SO2D DRUG__ID D0SO2D D0SO2D DRUGTYPE Small molecular drug D0SO2D DRUGINCH 1S/C6H12O4/c1-6(10,2-3-7)4-5(8)9/h7,10H,2-4H2,1H3,(H,8,9) D0SO2D DRUGINKE KJTLQQUUPVSXIM-UHFFFAOYSA-N D0SO2D DRUGSMIL CC(CCO)(CC(=O)O)O D0SO2D HIGHSTAT Investigative D0SO5A DRUG__ID D0SO5A D0SO5A DRUGTYPE Small molecular drug D0SO5A DRUGINCH 1S/C21H29N3O2S2/c1-15(17-8-12-19(13-9-17)24-28(5,25)26)23-20(27)22-14-16-6-10-18(11-7-16)21(2,3)4/h6-13,15,24H,14H2,1-5H3,(H2,22,23,27)/t15-/m1/s1 D0SO5A DRUGINKE MRGDOZGZFFCDRJ-OAHLLOKOSA-N D0SO5A DRUGSMIL CC(C1=CC=C(C=C1)NS(=O)(=O)C)NC(=S)NCC2=CC=C(C=C2)C(C)(C)C D0SO5A HIGHSTAT Investigative D0SO9Q DRUG__ID D0SO9Q D0SO9Q DRUGTYPE Small molecular drug D0SO9Q DRUGINCH 1S/C37H46N2O4S/c1-2-3-4-5-12-20-35-39(25-14-13-15-29-21-23-32(24-22-29)37(42)43)36(41)33(44-35)26-34(40)38(27-30-16-8-6-9-17-30)28-31-18-10-7-11-19-31/h6-11,16-19,21-24,33,35H,2-5,12-15,20,25-28H2,1H3,(H,42,43)/t33-,35-/m0/s1 D0SO9Q DRUGINKE GHJJBEKMPCOSRH-LRHLLKFHSA-N D0SO9Q DRUGSMIL CCCCCCCC1N(C(=O)C(S1)CC(=O)N(CC2=CC=CC=C2)CC3=CC=CC=C3)CCCCC4=CC=C(C=C4)C(=O)O D0SO9Q HIGHSTAT Investigative D0SP2I DRUG__ID D0SP2I D0SP2I DRUGTYPE Small molecular drug D0SP2I DRUGINCH 1S/C28H35N7O3S/c29-26(30)23-7-3-4-20(16-23)17-25(27(36)35-14-11-19(12-15-35)10-13-33-28(31)32)34-39(37,38)24-9-8-21-5-1-2-6-22(21)18-24/h1-9,16,18-19,25,34H,10-15,17H2,(H3,29,30)(H4,31,32,33)/t25-/m0/s1 D0SP2I DRUGINKE BKOKSJAQZJNVPN-VWLOTQADSA-N D0SP2I DRUGSMIL C1CN(CCC1CCN=C(N)N)C(=O)C(CC2=CC(=CC=C2)C(=N)N)NS(=O)(=O)C3=CC4=CC=CC=C4C=C3 D0SP2I HIGHSTAT Investigative D0SP2J DRUG__ID D0SP2J D0SP2J DRUGTYPE Small molecular drug D0SP2J DRUGINCH 1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3 D0SP2J DRUGINKE VTTONGPRPXSUTJ-UHFFFAOYSA-N D0SP2J DRUGSMIL CN(C)CCC1=CNC2=C1C=C(C=C2)O D0SP2J HIGHSTAT Investigative D0SP2O DRUG__ID D0SP2O D0SP2O DRUGTYPE Small molecular drug D0SP2O DRUGINCH 1S/C8H5NO2/c10-7-5-3-1-2-4-6(5)9-8(7)11/h1-4H,(H,9,10,11) D0SP2O DRUGINKE JXDYKVIHCLTXOP-UHFFFAOYSA-N D0SP2O DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)N2 D0SP2O HIGHSTAT Investigative D0SP7S DRUG__ID D0SP7S D0SP7S DRUGTYPE Small molecular drug D0SP7S DRUGINCH 1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1 D0SP7S DRUGINKE PDMMFKSKQVNJMI-BLQWBTBKSA-N D0SP7S DRUGSMIL CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C D0SP7S HIGHSTAT Investigative D0SQ0T DRUG__ID D0SQ0T D0SQ0T DRUGTYPE Small molecular drug D0SQ0T DRUGINCH 1S/C7H11N3/c8-2-5-1-6(5)7-3-9-4-10-7/h3-6H,1-2,8H2,(H,9,10)/t5-,6+/m1/s1 D0SQ0T DRUGINKE LMFNLINKCDGRTE-RITPCOANSA-N D0SQ0T DRUGSMIL C1C(C1C2=CN=CN2)CN D0SQ0T HIGHSTAT Investigative D0SQ1F DRUG__ID D0SQ1F D0SQ1F DRUGTYPE Small molecular drug D0SQ1F DRUGINCH 1S/C16H24N2O3/c1-12-8-7-9-13(2)16(12)17-14(19)10-5-3-4-6-11-15(20)18-21/h7-9,21H,3-6,10-11H2,1-2H3,(H,17,19)(H,18,20) D0SQ1F DRUGINKE ZFUIPWQRONDTNH-UHFFFAOYSA-N D0SQ1F DRUGSMIL CC1=C(C(=CC=C1)C)NC(=O)CCCCCCC(=O)NO D0SQ1F HIGHSTAT Investigative D0SQ1T DRUG__ID D0SQ1T D0SQ1T DRUGTYPE Small molecular drug D0SQ1T DRUGINCH 1S/C6H13NO4/c8-1-3-5(10)6(11)4(2-9)7-3/h3-11H,1-2H2/t3-,4-,5-,6+/m1/s1 D0SQ1T DRUGINKE PFYHYHZGDNWFIF-KAZBKCHUSA-N D0SQ1T DRUGSMIL C(C1C(C(C(N1)CO)O)O)O D0SQ1T HIGHSTAT Investigative D0SR8Q DRUG__ID D0SR8Q D0SR8Q DRUGTYPE Small molecular drug D0SR8Q DRUGINCH 1S/C16H12O/c17-16-9-8-13-6-7-14(10-15(13)11-16)12-4-2-1-3-5-12/h1-11,17H D0SR8Q DRUGINKE MLFRZWHPLMDWES-UHFFFAOYSA-N D0SR8Q DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(C=C2)C=CC(=C3)O D0SR8Q HIGHSTAT Investigative D0SS4S DRUG__ID D0SS4S D0SS4S DRUGTYPE Small molecular drug D0SS4S DRUGINCH 1S/C16H18N2O2/c1-4-10-18(11-5-2)15-14(16(19)20-3)12-8-6-7-9-13(12)17-15/h4-9,17H,1-2,10-11H2,3H3 D0SS4S DRUGINKE VOAOXYYRHVDNNJ-UHFFFAOYSA-N D0SS4S DRUGSMIL COC(=O)C1=C(NC2=CC=CC=C21)N(CC=C)CC=C D0SS4S HIGHSTAT Investigative D0SS5D DRUG__ID D0SS5D D0SS5D DRUGTYPE Small molecular drug D0SS5D DRUGINCH 1S/C26H56NO6P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22-31-24-26(28)25-33-34(29,30)32-23-21-27(2,3)4/h26,28H,5-25H2,1-4H3/p+1/t26-/m1/s1 D0SS5D DRUGINKE XKBJVQHMEXMFDZ-AREMUKBSSA-O D0SS5D DRUGSMIL CCCCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)O D0SS5D HIGHSTAT Investigative D0SS8M DRUG__ID D0SS8M D0SS8M DRUGTYPE Small molecular drug D0SS8M DRUGINCH 1S/C12H24N2O/c13-11-9-7-5-3-1-2-4-6-8-10-14-12(11)15/h11H,1-10,13H2,(H,14,15)/t11-/m0/s1 D0SS8M DRUGINKE CQZLEYBEPASILI-NSHDSACASA-N D0SS8M DRUGSMIL C1CCCCCNC(=O)C(CCCC1)N D0SS8M HIGHSTAT Investigative D0ST0H DRUG__ID D0ST0H D0ST0H DRUGTYPE Small molecular drug D0ST0H DRUGINCH 1S/C10H13N4O9P.Na/c15-5-3(1-22-24(19,20)21)23-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17;/h2-3,5-6,9,15-16H,1H2,(H2,19,20,21)(H2,12,13,17,18);/q;+1/p-1/t3-,5-,6-,9-;/m1./s1 D0ST0H DRUGINKE FVWNNNBCIYRTSW-GWTDSMLYSA-M D0ST0H DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)[O-])O)O)NC(=O)NC2=O.[Na+] D0ST0H HIGHSTAT Investigative D0ST1M DRUG__ID D0ST1M D0ST1M DRUGTYPE Small molecular drug D0ST1M DRUGINCH 1S/C17H19NO4S/c1-2-21-17(20)14-11-7-4-3-5-9-13(11)23-16(14)18-15(19)12-8-6-10-22-12/h6,8,10H,2-5,7,9H2,1H3,(H,18,19) D0ST1M DRUGINKE SCIMXCMXGZZKTB-UHFFFAOYSA-N D0ST1M DRUGSMIL CCOC(=O)C1=C(SC2=C1CCCCC2)NC(=O)C3=CC=CO3 D0ST1M HIGHSTAT Investigative D0ST1U DRUG__ID D0ST1U D0ST1U DRUGTYPE Small molecular drug D0ST1U DRUGINCH 1S/C40H53N11O6/c41-39(42)45-18-5-9-29-34(53)47-30(10-6-19-46-40(43)44)35(54)50-32(22-24-13-16-28(52)17-14-24)38(57)51-20-4-3-11-33(51)37(56)49-31(36(55)48-29)23-25-12-15-26-7-1-2-8-27(26)21-25/h1-2,7-8,12-17,21,29-33,52H,3-6,9-11,18-20,22-23H2,(H,47,53)(H,48,55)(H,49,56)(H,50,54)(H4,41,42,45)(H4,43,44,46)/t29-,30+,31-,32+,33-/m0/s1 D0ST1U DRUGINKE OGLLNRFCXLYAMK-AUURQCAXSA-N D0ST1U DRUGSMIL C1CCN2C(C1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=C(C=C3)O)CCCN=C(N)N)CCCN=C(N)N)CC4=CC5=CC=CC=C5C=C4 D0ST1U HIGHSTAT Investigative D0ST3S DRUG__ID D0ST3S D0ST3S DRUGTYPE Small molecular drug D0ST3S DRUGINCH 1S/C11H7FN2S/c12-9-3-1-2-8(6-9)4-5-10-7-15-11(13)14-10/h1-3,6-7H,(H2,13,14) D0ST3S DRUGINKE XTUCFPVDIBJRML-UHFFFAOYSA-N D0ST3S DRUGSMIL C1=CC(=CC(=C1)F)C#CC2=CSC(=N2)N D0ST3S HIGHSTAT Investigative D0ST4P DRUG__ID D0ST4P D0ST4P DRUGTYPE Small molecular drug D0ST4P DRUGINCH 1S/C22H15ClF2N4O2/c23-22(24,25)31-16-11-9-15(10-12-16)27-21-18-4-2-1-3-17(18)19(28-29-21)13-5-7-14(8-6-13)20(26)30/h1-12H,(H2,26,30)(H,27,29) D0ST4P DRUGINKE GUSAPNPQBHFHSX-UHFFFAOYSA-N D0ST4P DRUGSMIL C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=C(C=C4)C(=O)N D0ST4P HIGHSTAT Investigative D0ST5A DRUG__ID D0ST5A D0ST5A DRUGTYPE Small molecular drug D0ST5A DRUGINCH 1S/C13H13BrN2O5S/c14-10-2-1-9(22-10)6-4-16(13(20)15-12(6)19)11-3-7(18)8(5-17)21-11/h1-2,4,7-8,11,17-18H,3,5H2,(H,15,19,20)/t7-,8+,11+/m0/s1 D0ST5A DRUGINKE IGUZFFOBAZCVRK-VAOFZXAKSA-N D0ST5A DRUGSMIL C1C(C(OC1N2C=C(C(=O)NC2=O)C3=CC=C(S3)Br)CO)O D0ST5A HIGHSTAT Investigative D0ST5U DRUG__ID D0ST5U D0ST5U DRUGTYPE Small molecular drug D0ST5U DRUGINCH 1S/C32H37N2O5/c1-38-26-13-12-22-21-33(19-16-32-15-14-23(35)20-27(32)39-29(26)28(22)32)17-8-4-2-3-5-9-18-34-30(36)24-10-6-7-11-25(24)31(34)37/h6-7,10-15,21,23,27,35H,2-5,8-9,16-20H2,1H3/q+1/t23-,27-,32-/m0/s1 D0ST5U DRUGINKE VLGAHTYYCHWLNI-BHRZLAGCSA-N D0ST5U DRUGSMIL COC1=C2C3=C(C=C1)C=[N+](CCC34C=CC(CC4O2)O)CCCCCCCCN5C(=O)C6=CC=CC=C6C5=O D0ST5U HIGHSTAT Investigative D0SU0Y DRUG__ID D0SU0Y D0SU0Y DRUGTYPE Small molecular drug D0SU0Y DRUGINCH 1S/C19H20N2/c1-2-6-19(21-14-13-20-15-21)18-11-9-17(10-12-18)16-7-4-3-5-8-16/h3-5,7-15,19H,2,6H2,1H3 D0SU0Y DRUGINKE SLKWPFBZPUBKHY-UHFFFAOYSA-N D0SU0Y DRUGSMIL CCCC(C1=CC=C(C=C1)C2=CC=CC=C2)N3C=CN=C3 D0SU0Y HIGHSTAT Investigative D0SU5M DRUG__ID D0SU5M D0SU5M DRUGTYPE Small molecular drug D0SU5M DRUGINCH 1S/C25H44N4O8/c1-14(2)20(25(36)37)28-22(33)15(3)27-24(35)21(16(4)30)29-23(34)18(10-11-19(31)32)26-13-12-17-8-6-5-7-9-17/h14-18,20-21,26,30H,5-13H2,1-4H3,(H,27,35)(H,28,33)(H,29,34)(H,31,32)(H,36,37)/t15-,16?,18-,20-,21-/m0/s1 D0SU5M DRUGINKE APPLGLBBZPGQBX-GDEPEFMTSA-N D0SU5M DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCC1CCCCC1 D0SU5M HIGHSTAT Investigative D0SU7B DRUG__ID D0SU7B D0SU7B DRUGTYPE Small molecular drug D0SU7B DRUGINCH 1S/C27H44N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-26(30)28-23-22-24-18-20-25(21-19-24)27(31)29-32/h9-10,18-21,32H,2-8,11-17,22-23H2,1H3,(H,28,30)(H,29,31)/b10-9- D0SU7B DRUGINKE NGQCNQPGVUJPCK-KTKRTIGZSA-N D0SU7B DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NCCC1=CC=C(C=C1)C(=O)NO D0SU7B HIGHSTAT Investigative D0SV1F DRUG__ID D0SV1F D0SV1F DRUGTYPE Small molecular drug D0SV1F DRUGINCH 1S/C16H19N3O3/c1-2-3-6-11-22-16-17-10-9-14(19-16)18-13-8-5-4-7-12(13)15(20)21/h4-5,7-10H,2-3,6,11H2,1H3,(H,20,21)(H,17,18,19) D0SV1F DRUGINKE QOFCYNIGWDGPEN-UHFFFAOYSA-N D0SV1F DRUGSMIL CCCCCOC1=NC=CC(=N1)NC2=CC=CC=C2C(=O)O D0SV1F HIGHSTAT Investigative D0SV6C DRUG__ID D0SV6C D0SV6C DRUGTYPE Small molecular drug D0SV6C DRUGINCH 1S/C18H16N4O10S3/c1-9(23)20-14-8-13-10(6-15(14)34(27,28)29)7-16(35(30,31)32)17(18(13)24)22-21-11-2-4-12(5-3-11)33(19,25)26/h2-8,24H,1H3,(H,20,23)(H2,19,25,26)(H,27,28,29)(H,30,31,32) D0SV6C DRUGINKE RALNLQYPLYWQRT-UHFFFAOYSA-N D0SV6C DRUGSMIL CC(=O)NC1=C(C=C2C=C(C(=C(C2=C1)O)N=NC3=CC=C(C=C3)S(=O)(=O)N)S(=O)(=O)O)S(=O)(=O)O D0SV6C HIGHSTAT Investigative D0SY2M DRUG__ID D0SY2M D0SY2M DRUGTYPE Small molecular drug D0SY2M DRUGINCH 1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H D0SY2M DRUGINKE ZQSIJRDFPHDXIC-UHFFFAOYSA-N D0SY2M DRUGSMIL C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O D0SY2M HIGHSTAT Investigative D0SY6C DRUG__ID D0SY6C D0SY6C DRUGTYPE Small molecular drug D0SY6C DRUGINCH 1S/C15H10O4/c16-10-3-1-9(2-4-10)14-8-13(18)12-6-5-11(17)7-15(12)19-14/h1-8,16-17H D0SY6C DRUGINKE LCAWNFIFMLXZPQ-UHFFFAOYSA-N D0SY6C DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C=C3)O)O D0SY6C HIGHSTAT Investigative D0SY6T DRUG__ID D0SY6T D0SY6T DRUGTYPE Small molecular drug D0SY6T DRUGINCH 1S/C23H22N2O/c1-18-9-8-14-21(17-18)25-23(26)24-16-15-22(19-10-4-2-5-11-19)20-12-6-3-7-13-20/h2-15,17H,16H2,1H3,(H2,24,25,26) D0SY6T DRUGINKE AQCRRYHNTDGOLK-UHFFFAOYSA-N D0SY6T DRUGSMIL CC1=CC(=CC=C1)NC(=O)NCC=C(C2=CC=CC=C2)C3=CC=CC=C3 D0SY6T HIGHSTAT Investigative D0SZ4T DRUG__ID D0SZ4T D0SZ4T DRUGTYPE Small molecular drug D0SZ4T DRUGINCH 1S/C18H32O3/c1-2-3-4-5-6-8-11-14-17(19)15-12-9-7-10-13-16-18(20)21/h6,8,11,14,17,19H,2-5,7,9-10,12-13,15-16H2,1H3,(H,20,21)/b8-6-,14-11+/t17-/m1/s1 D0SZ4T DRUGINKE NPDSHTNEKLQQIJ-UINYOVNOSA-N D0SZ4T DRUGSMIL CCCCCC=CC=CC(CCCCCCCC(=O)O)O D0SZ4T HIGHSTAT Investigative D0SZ9E DRUG__ID D0SZ9E D0SZ9E DRUGTYPE Small molecular drug D0SZ9E DRUGINCH 1S/C10H19NO3/c1-7(10(13)14)5-3-4-6-9(12)8(2)11/h7-8H,3-6,11H2,1-2H3,(H,13,14)/t7-,8+/m1/s1 D0SZ9E DRUGINKE YBWPFLPQZXWNNM-SFYZADRCSA-N D0SZ9E DRUGSMIL CC(CCCCC(=O)C(C)N)C(=O)O D0SZ9E HIGHSTAT Investigative D0SZ9F DRUG__ID D0SZ9F D0SZ9F DRUGTYPE Small molecular drug D0SZ9F DRUGINCH 1S/C7H6Cl2S/c8-6-2-1-5(4-10)7(9)3-6/h1-3,10H,4H2 D0SZ9F DRUGINKE ZSPXTTVUJDSRNJ-UHFFFAOYSA-N D0SZ9F DRUGSMIL C1=CC(=C(C=C1Cl)Cl)CS D0SZ9F HIGHSTAT Investigative D0T0AG DRUG__ID D0T0AG D0T0AG DRUGTYPE Small molecular drug D0T0AG DRUGINCH 1S/C9H10N2O/c1-2-11-8-6-4-3-5-7(8)10-9(11)12/h3-6H,2H2,1H3,(H,10,12) D0T0AG DRUGINKE CXUCKELNYMZTRT-UHFFFAOYSA-N D0T0AG DRUGSMIL CCN1C2=CC=CC=C2NC1=O D0T0AG HIGHSTAT Investigative D0T0BE DRUG__ID D0T0BE D0T0BE DRUGTYPE Small molecular drug D0T0BE DRUGINCH 1S/C15H21N3O4/c19-13(18-22)10-6-1-2-7-11-16-15(21)17-14(20)12-8-4-3-5-9-12/h3-5,8-9,22H,1-2,6-7,10-11H2,(H,18,19)(H2,16,17,20,21) D0T0BE DRUGINKE XEBCJLKRZJZBNT-UHFFFAOYSA-N D0T0BE DRUGSMIL C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCCC(=O)NO D0T0BE HIGHSTAT Investigative D0T0BY DRUG__ID D0T0BY D0T0BY DRUGTYPE Small molecular drug D0T0BY DRUGINCH 1S/C16H15N3O2/c20-15-11-14(18-7-9-21-10-8-18)17-16-13-4-2-1-3-12(13)5-6-19(15)16/h1-6,11H,7-10H2 D0T0BY DRUGINKE BVRDQVRQVGRNHG-UHFFFAOYSA-N D0T0BY DRUGSMIL C1COCCN1C2=CC(=O)N3C=CC4=CC=CC=C4C3=N2 D0T0BY HIGHSTAT Investigative D0T0CG DRUG__ID D0T0CG D0T0CG DRUGTYPE Small molecular drug D0T0CG DRUGINCH 1S/C16H15ClN5O6PS2/c17-6-1-3-7(4-2-6)31-16-19-9-12(20-15(18)21-13(9)24)22(16)14-10(23)11-8(27-14)5-26-29(25,30)28-11/h1-4,8,10-11,14,23,25,30H,5H2,(H2-,18,20,21,24)/p+1/t8-,10+,11?,14?,29?/m1/s1 D0T0CG DRUGINKE OUBFBEIDDZMLBN-MXSLEPDVSA-O D0T0CG DRUGSMIL C1C2C(C(C(O2)N3C4=C(C(=O)NC(=N4)N)N=C3SC5=CC=C(C=C5)Cl)O)O[P+](O1)(O)S D0T0CG HIGHSTAT Investigative D0T0CK DRUG__ID D0T0CK D0T0CK DRUGTYPE Small molecular drug D0T0CK DRUGINCH 1S/C16H17NO2/c1-18-15-10-7-13(11-16(15)19-2)4-3-12-5-8-14(17)9-6-12/h3-11H,17H2,1-2H3/b4-3+ D0T0CK DRUGINKE JZZHXIPQAWDZPC-ONEGZZNKSA-N D0T0CK DRUGSMIL COC1=C(C=C(C=C1)C=CC2=CC=C(C=C2)N)OC D0T0CK HIGHSTAT Investigative D0T0CY DRUG__ID D0T0CY D0T0CY DRUGTYPE Small molecular drug D0T0CY DRUGINCH 1S/C13H19NO4/c1-3-4-9-17-11-5-7-12(8-6-11)18-10-13(15)14(2)16/h5-8,16H,3-4,9-10H2,1-2H3 D0T0CY DRUGINKE QJXRKNPTYVKBQZ-UHFFFAOYSA-N D0T0CY DRUGSMIL CCCCOC1=CC=C(C=C1)OCC(=O)N(C)O D0T0CY HIGHSTAT Investigative D0T0EJ DRUG__ID D0T0EJ D0T0EJ DRUGTYPE Small molecular drug D0T0EJ DRUGINCH 1S/C10H20N2O2/c13-9-6-12-8(10(9)14)5-11-7-3-1-2-4-7/h7-14H,1-6H2 D0T0EJ DRUGINKE CAYLVMUUXWDLQS-UHFFFAOYSA-N D0T0EJ DRUGSMIL C1CCC(C1)NCC2C(C(CN2)O)O D0T0EJ HIGHSTAT Investigative D0T0GA DRUG__ID D0T0GA D0T0GA DRUGTYPE Small molecular drug D0T0GA DRUGINCH 1S/C20H16N2O2/c23-18-8-4-7-17-20(18)22-19(21-17)13-14-9-11-16(12-10-14)24-15-5-2-1-3-6-15/h1-12,23H,13H2,(H,21,22) D0T0GA DRUGINKE MRBKMMZUVLPGTA-UHFFFAOYSA-N D0T0GA DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CC3=NC4=C(N3)C=CC=C4O D0T0GA HIGHSTAT Investigative D0T0GL DRUG__ID D0T0GL D0T0GL DRUGTYPE Small molecular drug D0T0GL DRUGINCH 1S/C43H68N14O8/c1-3-26(2)35(41(65)53-30(36(45)60)13-7-8-20-44)57-38(62)32(15-10-22-51-43(48)49)54-39(63)34(24-28-16-18-29(59)19-17-28)56-40(64)33(23-27-11-5-4-6-12-27)55-37(61)31(52-25-58)14-9-21-50-42(46)47/h4-6,11-12,16-19,25-26,30-35,59H,3,7-10,13-15,20-24,44H2,1-2H3,(H2,45,60)(H,52,58)(H,53,65)(H,54,63)(H,55,61)(H,56,64)(H,57,62)(H4,46,47,50)(H4,48,49,51)/t26-,30-,31-,32-,33-,34-,35-/m0/s1 D0T0GL DRUGINKE ZABHXVCIKRRWGE-OLPQHFNPSA-N D0T0GL DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC=O D0T0GL HIGHSTAT Investigative D0T0HH DRUG__ID D0T0HH D0T0HH DRUGTYPE Small molecular drug D0T0HH DRUGINCH 1S/C7H8/c1-7-5-3-2-4-6-7/h2-6H,1H3 D0T0HH DRUGINKE YXFVVABEGXRONW-UHFFFAOYSA-N D0T0HH DRUGSMIL CC1=CC=CC=C1 D0T0HH HIGHSTAT Investigative D0T0HS DRUG__ID D0T0HS D0T0HS DRUGTYPE Small molecular drug D0T0HS DRUGINCH 1S/C23H17N3OS3/c1-28-23-25-17-13-12-16-19(20(17)30-23)29-22(24-16)26-21(27)18(14-8-4-2-5-9-14)15-10-6-3-7-11-15/h2-13,18H,1H3,(H,24,26,27) D0T0HS DRUGINKE UFOBDFMYJABXGK-UHFFFAOYSA-N D0T0HS DRUGSMIL CSC1=NC2=C(S1)C3=C(C=C2)N=C(S3)NC(=O)C(C4=CC=CC=C4)C5=CC=CC=C5 D0T0HS HIGHSTAT Investigative D0T0IR DRUG__ID D0T0IR D0T0IR DRUGTYPE Small molecular drug D0T0IR DRUGINCH 1S/C10H22OS2/c1-9(2)5-7-12-13(11)8-6-10(3)4/h9-10H,5-8H2,1-4H3 D0T0IR DRUGINKE PPSCLEFHDJTMFD-UHFFFAOYSA-N D0T0IR DRUGSMIL CC(C)CCSS(=O)CCC(C)C D0T0IR HIGHSTAT Investigative D0T0IX DRUG__ID D0T0IX D0T0IX DRUGTYPE Small molecular drug D0T0IX DRUGINCH 1S/C19H28N2O5/c1-13(2)10-11-20-18(25)15(9-8-14-6-4-3-5-7-14)21-19(26)16(22)12-17(23)24/h3-7,13,15-16,22H,8-12H2,1-2H3,(H,20,25)(H,21,26)(H,23,24)/t15-,16-/m0/s1 D0T0IX DRUGINKE KVZMXOVSHIMGNA-HOTGVXAUSA-N D0T0IX DRUGSMIL CC(C)CCNC(=O)C(CCC1=CC=CC=C1)NC(=O)C(CC(=O)O)O D0T0IX HIGHSTAT Investigative D0T0JU DRUG__ID D0T0JU D0T0JU DRUGTYPE Small molecular drug D0T0JU DRUGINCH 1S/C26H36O7/c1-16-8-7-9-18(3)25-22(12-10-16)23(15-31-26(25)33-21(6)29)24(32-20(5)28)13-11-17(2)14-30-19(4)27/h8,11,15,22,24-26H,3,7,9-10,12-14H2,1-2,4-6H3/b16-8?,17-11+/t22-,24+,25+,26-/m1/s1 D0T0JU DRUGINKE DCZJIZRGTZFSQY-VWQHOESYSA-N D0T0JU DRUGSMIL CC1=CCCC(=C)C2C(CC1)C(=COC2OC(=O)C)C(CC=C(C)COC(=O)C)OC(=O)C D0T0JU HIGHSTAT Investigative D0T0OW DRUG__ID D0T0OW D0T0OW DRUGTYPE Small molecular drug D0T0OW DRUGINCH 1S/C11H16N4O5/c16-2-6-8(18)9(19)11(20-6)15-4-14-7-5(17)1-12-3-13-10(7)15/h3-6,8-9,11,16-19H,1-2H2,(H,12,13)/t5-,6-,8-,9-,11-/m1/s1 D0T0OW DRUGINKE YOOVTUPUBVHMPG-LODYRLCVSA-N D0T0OW DRUGSMIL C1C(C2=C(NC=N1)N(C=N2)C3C(C(C(O3)CO)O)O)O D0T0OW HIGHSTAT Investigative D0T0RI DRUG__ID D0T0RI D0T0RI DRUGTYPE Small molecular drug D0T0RI DRUGINCH 1S/C29H31N3O4/c1-20(22-8-5-4-6-9-22)30-14-16-31(17-15-30)24-11-7-10-23-27(24)29(34)32(28(23)33)19-21-12-13-25(35-2)26(18-21)36-3/h4-13,18,20H,14-17,19H2,1-3H3/t20-/m1/s1 D0T0RI DRUGINKE XVYISGJLURJDNX-HXUWFJFHSA-N D0T0RI DRUGSMIL CC(C1=CC=CC=C1)N2CCN(CC2)C3=CC=CC4=C3C(=O)N(C4=O)CC5=CC(=C(C=C5)OC)OC D0T0RI HIGHSTAT Investigative D0T0SK DRUG__ID D0T0SK D0T0SK DRUGTYPE Small molecular drug D0T0SK DRUGINCH 1S/C17H15N3O5/c21-17(19-22)10-7-13-1-3-14(4-2-13)11-18-25-12-15-5-8-16(9-6-15)20(23)24/h1-11,22H,12H2,(H,19,21)/b10-7+,18-11+ D0T0SK DRUGINKE IWWFFHDXUHSRDM-PFMZDYLOSA-N D0T0SK DRUGSMIL C1=CC(=CC=C1CON=CC2=CC=C(C=C2)C=CC(=O)NO)[N+](=O)[O-] D0T0SK HIGHSTAT Investigative D0T0UH DRUG__ID D0T0UH D0T0UH DRUGTYPE Small molecular drug D0T0UH DRUGINCH 1S/C21H15NO2/c22-14-20(15-4-2-1-3-5-15)21(16-6-10-18(23)11-7-16)17-8-12-19(24)13-9-17/h1-13,23-24H D0T0UH DRUGINKE PMKMHLVHNOXPOY-UHFFFAOYSA-N D0T0UH DRUGSMIL C1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C#N D0T0UH HIGHSTAT Investigative D0T0VC DRUG__ID D0T0VC D0T0VC DRUGTYPE Small molecular drug D0T0VC DRUGINCH 1S/C10H7N3OS/c11-6-8-9(14)13-15-10(8)12-7-4-2-1-3-5-7/h1-5,12H,(H,13,14) D0T0VC DRUGINKE GHXPCAXQBVCFNU-UHFFFAOYSA-N D0T0VC DRUGSMIL C1=CC=C(C=C1)NC2=C(C(=O)NS2)C#N D0T0VC HIGHSTAT Investigative D0T0XY DRUG__ID D0T0XY D0T0XY DRUGTYPE Small molecular drug D0T0XY DRUGINCH 1S/C44H34O22/c45-15-5-21(47)17-11-31(65-43(61)13-1-23(49)35(55)24(50)2-13)41(63-29(17)7-15)19-9-27(53)37(57)39(59)33(19)34-20(10-28(54)38(58)40(34)60)42-32(12-18-22(48)6-16(46)8-30(18)64-42)66-44(62)14-3-25(51)36(56)26(52)4-14/h1-10,31-32,41-42,45-60H,11-12H2/t31-,32-,41-,42-/m1/s1 D0T0XY DRUGINKE YUULFXAQUWEYNP-GXAWFILRSA-N D0T0XY DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3C4=C(C(=C(C=C4C5C(CC6=C(C=C(C=C6O5)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O D0T0XY HIGHSTAT Investigative D0T0YI DRUG__ID D0T0YI D0T0YI DRUGTYPE Small molecular drug D0T0YI DRUGINCH 1S/C6H6NO6P/c8-7(9)5-1-3-6(4-2-5)13-14(10,11)12/h1-4H,(H2,10,11,12) D0T0YI DRUGINKE XZKIHKMTEMTJQX-UHFFFAOYSA-N D0T0YI DRUGSMIL C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)O D0T0YI HIGHSTAT Investigative D0T1BU DRUG__ID D0T1BU D0T1BU DRUGTYPE Small molecular drug D0T1BU DRUGINCH 1S/C86H117N17O27/c1-11-44(7)71(84(127)100-63(86(129)130)35-50-39-88-54-21-17-16-20-53(50)54)103-85(128)72(45(8)12-2)102-82(125)62(38-69(114)115)98-78(121)57(32-42(3)4)96-80(123)60(36-51-40-87-41-89-51)95-73(116)46(9)91-77(120)58(33-48-18-14-13-15-19-48)97-79(122)59(34-49-22-24-52(104)25-23-49)99-83(126)70(43(5)6)101-74(117)47(10)90-75(118)55(26-29-65(106)107)93-76(119)56(27-30-66(108)109)94-81(124)61(37-68(112)113)92-64(105)28-31-67(110)111/h13-25,39-47,55-63,70-72,88,104H,11-12,26-38H2,1-10H3,(H,87,89)(H,90,118)(H,91,120)(H,92,105)(H,93,119)(H,94,124)(H,95,116)(H,96,123)(H,97,122)(H,98,121)(H,99,126)(H,100,127)(H,101,117)(H,102,125)(H,103,128)(H,106,107)(H,108,109)(H,110,111)(H,112,113)(H,114,115)(H,129,130)/t44-,45-,46-,47-,55-,56-,57-,58-,59-,60-,61-,62-,63-,70-,71-,72-/m0/s1 D0T1BU DRUGINKE DXPHNGAMYPPTBJ-TZMIJSMNSA-N D0T1BU DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CN=CN3)NC(=O)C(C)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)CCC(=O)O D0T1BU HIGHSTAT Investigative D0T1CE DRUG__ID D0T1CE D0T1CE DRUGTYPE Small molecular drug D0T1CE DRUGINCH 1S/C15H15N3OS/c1-2-3-14(19)16-15-12-5-4-10(8-13(12)17-18-15)11-6-7-20-9-11/h4-9H,2-3H2,1H3,(H2,16,17,18,19) D0T1CE DRUGINKE KEXXQGBZRBKVRC-UHFFFAOYSA-N D0T1CE DRUGSMIL CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CSC=C3 D0T1CE HIGHSTAT Investigative D0T1CH DRUG__ID D0T1CH D0T1CH DRUGTYPE Small molecular drug D0T1CH DRUGINCH 1S/C21H21NO/c1-3-21(19-12-14-22-15-13-19)18-6-4-16(5-7-18)17-8-10-20(23-2)11-9-17/h4-15,21H,3H2,1-2H3 D0T1CH DRUGINKE DURIQWOMVBEIPW-UHFFFAOYSA-N D0T1CH DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC=C(C=C2)OC)C3=CC=NC=C3 D0T1CH HIGHSTAT Investigative D0T1FJ DRUG__ID D0T1FJ D0T1FJ DRUGTYPE Small molecular drug D0T1FJ DRUGINCH 1S/C17H15NO3/c18-10-13-8-17(19)21-16-9-14(6-7-15(13)16)20-11-12-4-2-1-3-5-12/h1-9H,10-11,18H2 D0T1FJ DRUGINKE XCWHFSADYQMGEA-UHFFFAOYSA-N D0T1FJ DRUGSMIL C1=CC=C(C=C1)COC2=CC3=C(C=C2)C(=CC(=O)O3)CN D0T1FJ HIGHSTAT Investigative D0T1FR DRUG__ID D0T1FR D0T1FR DRUGTYPE Small molecular drug D0T1FR DRUGINCH 1S/C7H15N2O4P/c8-5-3-1-2-4-6(5)9-7(10)14(11,12)13/h5-6H,1-4,8H2,(H,9,10)(H2,11,12,13)/t5-,6+/m0/s1 D0T1FR DRUGINKE XHCXISPZIHYKQD-NTSWFWBYSA-N D0T1FR DRUGSMIL C1CCC(C(C1)N)NC(=O)P(=O)(O)O D0T1FR HIGHSTAT Investigative D0T1GP DRUG__ID D0T1GP D0T1GP DRUGTYPE Small molecular drug D0T1GP DRUGINCH 1S/C16H14O2/c1-11-7-8-13-14(17)10-15(18-16(13)9-11)12-5-3-2-4-6-12/h2-9,15H,10H2,1H3 D0T1GP DRUGINKE FNOKOVWLKVWYRY-UHFFFAOYSA-N D0T1GP DRUGSMIL CC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=CC=C3 D0T1GP HIGHSTAT Investigative D0T1GZ DRUG__ID D0T1GZ D0T1GZ DRUGTYPE Small molecular drug D0T1GZ DRUGINCH 1S/C17H21N/c1-3-8-16(9-4-1)12-7-14-18-15-13-17-10-5-2-6-11-17/h1-6,8-11,18H,7,12-15H2 D0T1GZ DRUGINKE MCXHGJLRTJKZGT-UHFFFAOYSA-N D0T1GZ DRUGSMIL C1=CC=C(C=C1)CCCNCCC2=CC=CC=C2 D0T1GZ HIGHSTAT Investigative D0T1HY DRUG__ID D0T1HY D0T1HY DRUGTYPE Small molecular drug D0T1HY DRUGINCH 1S/C19H15NO2/c21-19(20(22)18-8-2-1-3-9-18)13-11-15-10-12-16-6-4-5-7-17(16)14-15/h1-14,22H/b13-11+ D0T1HY DRUGINKE OSTLUPOHWIAJIK-ACCUITESSA-N D0T1HY DRUGSMIL C1=CC=C(C=C1)N(C(=O)C=CC2=CC3=CC=CC=C3C=C2)O D0T1HY HIGHSTAT Investigative D0T1JA DRUG__ID D0T1JA D0T1JA DRUGTYPE Small molecular drug D0T1JA DRUGINCH 1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/t4-/m1/s1 D0T1JA DRUGINKE AHLPHDHHMVZTML-SCSAIBSYSA-N D0T1JA DRUGSMIL C(CC(C(=O)O)N)CN D0T1JA HIGHSTAT Investigative D0T1MK DRUG__ID D0T1MK D0T1MK DRUGTYPE Small molecular drug D0T1MK DRUGINCH 1S/C18H23NO4/c20-17(21)13-4-1-11(2-5-13)7-12-3-6-14-10-19-16(18(22)23)9-15(14)8-12/h1-2,4-5,12,14-16,19H,3,6-10H2,(H,20,21)(H,22,23)/t12-,14+,15-,16+/m1/s1 D0T1MK DRUGINKE YVMADKYPKNLVGU-BVUBDWEXSA-N D0T1MK DRUGSMIL C1CC2CNC(CC2CC1CC3=CC=C(C=C3)C(=O)O)C(=O)O D0T1MK HIGHSTAT Investigative D0T1OG DRUG__ID D0T1OG D0T1OG DRUGTYPE Small molecular drug D0T1OG DRUGINCH 1S/C10H13N3O3S/c1-6-3-4-7(17(2,15)16)5-8(6)9(14)13-10(11)12/h3-5H,1-2H3,(H4,11,12,13,14) D0T1OG DRUGINKE SSLQVRLYNHXNIS-UHFFFAOYSA-N D0T1OG DRUGSMIL CC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N=C(N)N D0T1OG HIGHSTAT Investigative D0T1PA DRUG__ID D0T1PA D0T1PA DRUGTYPE Small molecular drug D0T1PA DRUGINCH 1S/C46H74O15/c1-20-9-14-46(55-19-20)22(3)32-29(61-46)17-28-26-8-7-24-16-25(10-12-44(24,5)27(26)11-13-45(28,32)6)57-43-41(58-30-15-21(2)33(48)37(52)35(30)50)40(36(51)31(18-47)59-43)60-42-39(54)38(53)34(49)23(4)56-42/h7,20-23,25-43,47-54H,8-19H2,1-6H3/t20-,21-,22-,23-,25-,26+,27-,28-,29-,30-,31+,32-,33+,34-,35-,36+,37+,38+,39+,40-,41+,42-,43+,44-,45-,46+/m0/s1 D0T1PA DRUGINKE SRFKCMVQTOGLCC-NSNPDTTGSA-N D0T1PA DRUGSMIL CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)OC8C(C(C(C(O8)C)O)O)O)OC9CC(C(C(C9O)O)O)C)C)C)C)OC1 D0T1PA HIGHSTAT Investigative D0T1SP DRUG__ID D0T1SP D0T1SP DRUGTYPE Small molecular drug D0T1SP DRUGINCH 1S/C18H17N3/c1-2-6-15(7-3-1)21-13-14(12-20-21)16-10-11-19-18-9-5-4-8-17(16)18/h1-11,14,20H,12-13H2 D0T1SP DRUGINKE KQNXOSZPTJGHDO-UHFFFAOYSA-N D0T1SP DRUGSMIL C1C(CN(N1)C2=CC=CC=C2)C3=CC=NC4=CC=CC=C34 D0T1SP HIGHSTAT Investigative D0T1TU DRUG__ID D0T1TU D0T1TU DRUGTYPE Small molecular drug D0T1TU DRUGINCH 1S/C19H25NO/c1-3-20(4-2)14-15-21-19-13-9-8-12-18(19)16-17-10-6-5-7-11-17/h5-13H,3-4,14-16H2,1-2H3 D0T1TU DRUGINKE BPXIOWINQPQVOY-UHFFFAOYSA-N D0T1TU DRUGSMIL CCN(CC)CCOC1=CC=CC=C1CC2=CC=CC=C2 D0T1TU HIGHSTAT Investigative D0T1XE DRUG__ID D0T1XE D0T1XE DRUGTYPE Small molecular drug D0T1XE DRUGINCH 1S/C23H25NO4/c1-26-13-6-7-14-15(9-13)16-10-20(27-2)21(28-3)11-17(16)18-12-24-8-4-5-19(24)23(25)22(14)18/h6-7,9-11,19,23,25H,4-5,8,12H2,1-3H3/t19-,23-/m0/s1 D0T1XE DRUGINKE LAWAARLALKUFQQ-CVDCTZTESA-N D0T1XE DRUGSMIL COC1=CC2=C(C=C1)C3=C(CN4CCCC4C3O)C5=CC(=C(C=C52)OC)OC D0T1XE HIGHSTAT Investigative D0T1YO DRUG__ID D0T1YO D0T1YO DRUGTYPE Small molecular drug D0T1YO DRUGINCH 1S/C17H10N2O/c20-17-13-9-5-4-8-12(13)16-14(17)10-15(18-19-16)11-6-2-1-3-7-11/h1-10H D0T1YO DRUGINKE ORLUBUYLVCUFDE-UHFFFAOYSA-N D0T1YO DRUGSMIL C1=CC=C(C=C1)C2=NN=C3C4=CC=CC=C4C(=O)C3=C2 D0T1YO HIGHSTAT Investigative D0T1YY DRUG__ID D0T1YY D0T1YY DRUGTYPE Small molecular drug D0T1YY DRUGINCH 1S/C11H13NO/c1-9(10(2)12-13)8-11-6-4-3-5-7-11/h3-8,10H,1-2H3/b9-8+ D0T1YY DRUGINKE LZZIRBNCATZAGX-CMDGGOBGSA-N D0T1YY DRUGSMIL CC(C(=CC1=CC=CC=C1)C)N=O D0T1YY HIGHSTAT Investigative D0T1ZM DRUG__ID D0T1ZM D0T1ZM DRUGTYPE Small molecular drug D0T1ZM DRUGINCH 1S/C22H11N3O2/c23-11-12-5-7-13(8-6-12)22-24-17-10-9-16-18(19(17)25-22)21(27)15-4-2-1-3-14(15)20(16)26/h1-10H,(H,24,25) D0T1ZM DRUGINKE KHYKISCIUUOMQS-UHFFFAOYSA-N D0T1ZM DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=C(C=C3)NC(=N4)C5=CC=C(C=C5)C#N D0T1ZM HIGHSTAT Investigative D0T2CG DRUG__ID D0T2CG D0T2CG DRUGTYPE Small molecular drug D0T2CG DRUGINCH 1S/C12H24O3/c1-2-3-4-5-6-7-8-9-11(13)10-12(14)15/h11,13H,2-10H2,1H3,(H,14,15) D0T2CG DRUGINKE MUCMKTPAZLSKTL-UHFFFAOYSA-N D0T2CG DRUGSMIL CCCCCCCCCC(CC(=O)O)O D0T2CG HIGHSTAT Investigative D0T2DC DRUG__ID D0T2DC D0T2DC DRUGTYPE Small molecular drug D0T2DC DRUGINCH 1S/C16H13FN2O/c1-2-11-4-3-5-15(8-11)19-16(20)13-6-12(10-18)7-14(17)9-13/h3-9H,2H2,1H3,(H,19,20) D0T2DC DRUGINKE FGYATISUHIGFJB-UHFFFAOYSA-N D0T2DC DRUGSMIL CCC1=CC(=CC=C1)NC(=O)C2=CC(=CC(=C2)C#N)F D0T2DC HIGHSTAT Investigative D0T2DP DRUG__ID D0T2DP D0T2DP DRUGTYPE Small molecular drug D0T2DP DRUGINCH 1S/C21H32N2/c1-18(2)8-5-9-19(3)10-6-11-20(4)13-15-23-17-21-12-7-14-22-16-21/h7-8,10,12-14,16,23H,5-6,9,11,15,17H2,1-4H3/b19-10+,20-13+ D0T2DP DRUGINKE LOBKJLMNXXPMNQ-OPBVARBZSA-N D0T2DP DRUGSMIL CC(=CCCC(=CCCC(=CCNCC1=CN=CC=C1)C)C)C D0T2DP HIGHSTAT Investigative D0T2EW DRUG__ID D0T2EW D0T2EW DRUGTYPE Small molecular drug D0T2EW DRUGINCH 1S/C13H21N3O/c14-9-11-7-4-8-16(11)13(17)12(15)10-5-2-1-3-6-10/h10-12H,1-8,15H2/t11-,12-/m0/s1 D0T2EW DRUGINKE SXNUNNAPZNTPQV-RYUDHWBXSA-N D0T2EW DRUGSMIL C1CCC(CC1)C(C(=O)N2CCCC2C#N)N D0T2EW HIGHSTAT Investigative D0T2GA DRUG__ID D0T2GA D0T2GA DRUGTYPE Small molecular drug D0T2GA DRUGINCH 1S/C25H24F3NO6S/c1-17(2)15-29(36(32,33)24-4-3-13-34-24)21-11-10-20(25(26,27)28)14-22(21)35-16-19-7-5-18(6-8-19)9-12-23(30)31/h3-14,17H,15-16H2,1-2H3,(H,30,31)/b12-9+ D0T2GA DRUGINKE LOQMSUDLLHPPHQ-FMIVXFBMSA-N D0T2GA DRUGSMIL CC(C)CN(C1=C(C=C(C=C1)C(F)(F)F)OCC2=CC=C(C=C2)C=CC(=O)O)S(=O)(=O)C3=CC=CO3 D0T2GA HIGHSTAT Investigative D0T2HN DRUG__ID D0T2HN D0T2HN DRUGTYPE Small molecular drug D0T2HN DRUGINCH 1S/C29H40N4O8/c1-16(2)24(29(40)41)32-26(37)17(3)31-28(39)25(18(4)34)33-27(38)22(11-12-23(35)36)30-14-13-19-9-10-20-7-5-6-8-21(20)15-19/h5-10,15-18,22,24-25,30,34H,11-14H2,1-4H3,(H,31,39)(H,32,37)(H,33,38)(H,35,36)(H,40,41)/t17-,18?,22-,24-,25-/m0/s1 D0T2HN DRUGINKE BVNXVJDQOOZPCM-FZDDQCGTSA-N D0T2HN DRUGSMIL CC(C)C(C(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)O)NCCC1=CC2=CC=CC=C2C=C1 D0T2HN HIGHSTAT Investigative D0T2JN DRUG__ID D0T2JN D0T2JN DRUGTYPE Small molecular drug D0T2JN DRUGINCH 1S/C26H26N2O4/c29-23-19-11-9-17(27-25(31)15-5-1-2-6-15)13-21(19)24(30)22-14-18(10-12-20(22)23)28-26(32)16-7-3-4-8-16/h9-16H,1-8H2,(H,27,31)(H,28,32) D0T2JN DRUGINKE IYTIDEOSIOFBPE-UHFFFAOYSA-N D0T2JN DRUGSMIL C1CCC(C1)C(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)C5CCCC5 D0T2JN HIGHSTAT Investigative D0T2KY DRUG__ID D0T2KY D0T2KY DRUGTYPE Small molecular drug D0T2KY DRUGINCH 1S/C14H13N3O2S2/c18-14(19)12-5-13(16-15-12)17(6-10-1-3-20-8-10)7-11-2-4-21-9-11/h1-5,8-9H,6-7H2,(H,15,16)(H,18,19) D0T2KY DRUGINKE SQUDZZYXGWLQLZ-UHFFFAOYSA-N D0T2KY DRUGSMIL C1=CSC=C1CN(CC2=CSC=C2)C3=NNC(=C3)C(=O)O D0T2KY HIGHSTAT Investigative D0T2NE DRUG__ID D0T2NE D0T2NE DRUGTYPE Small molecular drug D0T2NE DRUGINCH 1S/C20H20N6O2S/c1-26(7-5-21)20-23-10-17-18(25-20)13(11-29-17)19(27)24-15-8-12-4-3-6-22-14(12)9-16(15)28-2/h3-4,6,8-11H,5,7,21H2,1-2H3,(H,24,27) D0T2NE DRUGINKE BUJSZRICYLPWCM-UHFFFAOYSA-N D0T2NE DRUGSMIL CN(CCN)C1=NC=C2C(=N1)C(=CS2)C(=O)NC3=C(C=C4C(=C3)C=CC=N4)OC D0T2NE HIGHSTAT Investigative D0T2QL DRUG__ID D0T2QL D0T2QL DRUGTYPE Small molecular drug D0T2QL DRUGINCH 1S/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11)/b7-6+ D0T2QL DRUGINKE WBYWAXJHAXSJNI-VOTSOKGWSA-N D0T2QL DRUGSMIL C1=CC=C(C=C1)C=CC(=O)O D0T2QL HIGHSTAT Investigative D0T2RY DRUG__ID D0T2RY D0T2RY DRUGTYPE Small molecular drug D0T2RY DRUGINCH 1S/C20H31NO/c1-3-4-9-18-12-15-21(16-13-18)14-7-11-20(22)19-10-6-5-8-17(19)2/h5-6,8,10,18H,3-4,7,9,11-16H2,1-2H3 D0T2RY DRUGINKE ANTKBACNWQHQJE-UHFFFAOYSA-N D0T2RY DRUGSMIL CCCCC1CCN(CC1)CCCC(=O)C2=CC=CC=C2C D0T2RY HIGHSTAT Investigative D0T2SD DRUG__ID D0T2SD D0T2SD DRUGTYPE Small molecular drug D0T2SD DRUGINCH 1S/C14H14N2O2S/c1-11-2-6-13(7-3-11)16-10-12-4-8-14(9-5-12)19(15,17)18/h2-10H,1H3,(H2,15,17,18) D0T2SD DRUGINKE GFCNORPCMFOXDQ-UHFFFAOYSA-N D0T2SD DRUGSMIL CC1=CC=C(C=C1)N=CC2=CC=C(C=C2)S(=O)(=O)N D0T2SD HIGHSTAT Investigative D0T2SJ DRUG__ID D0T2SJ D0T2SJ DRUGTYPE Small molecular drug D0T2SJ DRUGINCH 1S/C30H22N4O/c1-34-20-33-18-29(34)30(35-19-22-11-9-21(16-31)10-12-22)24-13-14-25(17-32)28(15-24)27-8-4-6-23-5-2-3-7-26(23)27/h2-15,18,20,30H,19H2,1H3 D0T2SJ DRUGINKE ZBRVJLSHNVWEKS-UHFFFAOYSA-N D0T2SJ DRUGSMIL CN1C=NC=C1C(C2=CC(=C(C=C2)C#N)C3=CC=CC4=CC=CC=C43)OCC5=CC=C(C=C5)C#N D0T2SJ HIGHSTAT Investigative D0T2TW DRUG__ID D0T2TW D0T2TW DRUGTYPE Small molecular drug D0T2TW DRUGINCH 1S/C13H11NO4S/c15-13(16)7-5-11-4-6-12(19-11)9-2-1-3-10(8-9)14(17)18/h1-4,6,8H,5,7H2,(H,15,16) D0T2TW DRUGINKE IHKCOKRMJRDWAL-UHFFFAOYSA-N D0T2TW DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC=C(S2)CCC(=O)O D0T2TW HIGHSTAT Investigative D0T2VG DRUG__ID D0T2VG D0T2VG DRUGTYPE Small molecular drug D0T2VG DRUGINCH 1S/C15H12N4O/c20-15(19-14-8-1-2-9-17-14)18-13-7-3-6-12-11(13)5-4-10-16-12/h1-10H,(H2,17,18,19,20) D0T2VG DRUGINKE XJYQTPJBOGSWBE-UHFFFAOYSA-N D0T2VG DRUGSMIL C1=CC=NC(=C1)NC(=O)NC2=CC=CC3=C2C=CC=N3 D0T2VG HIGHSTAT Investigative D0T2VH DRUG__ID D0T2VH D0T2VH DRUGTYPE Small molecular drug D0T2VH DRUGINCH 1S/C6H12N4O2S2/c1-6(2,3)4-8-9-5(13-4)10-14(7,11)12/h1-3H3,(H,9,10)(H2,7,11,12) D0T2VH DRUGINKE JJBJNTIFYMQMKH-UHFFFAOYSA-N D0T2VH DRUGSMIL CC(C)(C)C1=NN=C(S1)NS(=O)(=O)N D0T2VH HIGHSTAT Investigative D0T2VK DRUG__ID D0T2VK D0T2VK DRUGTYPE Small molecular drug D0T2VK DRUGINCH 1S/C9H13NO3/c10-5-8(4-9(11)12)3-7-1-2-13-6-7/h1-2,6,8H,3-5,10H2,(H,11,12) D0T2VK DRUGINKE CZUZSIQSURACNQ-UHFFFAOYSA-N D0T2VK DRUGSMIL C1=COC=C1CC(CC(=O)O)CN D0T2VK HIGHSTAT Investigative D0T2WM DRUG__ID D0T2WM D0T2WM DRUGTYPE Small molecular drug D0T2WM DRUGINCH 1S/C14H13NO5/c16-10-3-1-9(12(18)6-10)7-15-14(20)8-2-4-11(17)13(19)5-8/h1-6,16-19H,7H2,(H,15,20) D0T2WM DRUGINKE QWXDIFRZEIADFB-UHFFFAOYSA-N D0T2WM DRUGSMIL C1=CC(=C(C=C1C(=O)NCC2=C(C=C(C=C2)O)O)O)O D0T2WM HIGHSTAT Investigative D0T2YP DRUG__ID D0T2YP D0T2YP DRUGTYPE Small molecular drug D0T2YP DRUGINCH 1S/C23H30N2O4/c1-28-10-7-16-12-15-13-23(22(27)29-11-9-26)20-18(6-8-25(14-15)21(16)23)17-4-2-3-5-19(17)24-20/h2-5,15-16,21,24,26H,6-14H2,1H3/t15?,16-,21-,23+/m0/s1 D0T2YP DRUGINKE VOCSICAFSPBNRT-NVVKDKPXSA-N D0T2YP DRUGSMIL COCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OCCO D0T2YP HIGHSTAT Investigative D0T2YZ DRUG__ID D0T2YZ D0T2YZ DRUGTYPE Small molecular drug D0T2YZ DRUGINCH 1S/C10H14N2O3S/c1-7(2)10(13)12-8-3-5-9(6-4-8)16(11,14)15/h3-7H,1-2H3,(H,12,13)(H2,11,14,15) D0T2YZ DRUGINKE VVHPZBGPXIXCQI-UHFFFAOYSA-N D0T2YZ DRUGSMIL CC(C)C(=O)NC1=CC=C(C=C1)S(=O)(=O)N D0T2YZ HIGHSTAT Investigative D0T3AE DRUG__ID D0T3AE D0T3AE DRUGTYPE Small molecular drug D0T3AE DRUGINCH 1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8) D0T3AE DRUGINKE DTBNBXWJWCWCIK-UHFFFAOYSA-N D0T3AE DRUGSMIL C=C(C(=O)O)OP(=O)(O)O D0T3AE HIGHSTAT Investigative D0T3AT DRUG__ID D0T3AT D0T3AT DRUGTYPE Small molecular drug D0T3AT DRUGINCH 1S/C17H16N4S2/c1-20-14-8-4-5-9-15(14)21(17(20)22)10-11-23-16-18-12-6-2-3-7-13(12)19-16/h2-9H,10-11H2,1H3,(H,18,19) D0T3AT DRUGINKE KDPSGIFCBZTBEZ-UHFFFAOYSA-N D0T3AT DRUGSMIL CN1C2=CC=CC=C2N(C1=S)CCSC3=NC4=CC=CC=C4N3 D0T3AT HIGHSTAT Investigative D0T3BL DRUG__ID D0T3BL D0T3BL DRUGTYPE Small molecular drug D0T3BL DRUGINCH 1S/C11H11ClN2/c12-11-3-1-10(2-4-11)5-7-14-8-6-13-9-14/h1-4,6,8-9H,5,7H2 D0T3BL DRUGINKE MOYFWXULYXUBOS-UHFFFAOYSA-N D0T3BL DRUGSMIL C1=CC(=CC=C1CCN2C=CN=C2)Cl D0T3BL HIGHSTAT Investigative D0T3CM DRUG__ID D0T3CM D0T3CM DRUGTYPE Small molecular drug D0T3CM DRUGINCH 1S/C22H30O4/c1-13-7-6-8-16-14(2)21(3,9-10-22(13,16)4)12-15-19(24)17(23)11-18(26-5)20(15)25/h7,11,14,16,24H,6,8-10,12H2,1-5H3/t14-,16+,21-,22-/m1/s1 D0T3CM DRUGINKE PYUXUMSQSVWNDS-NSAJDELNSA-N D0T3CM DRUGSMIL CC1C2CCC=C(C2(CCC1(C)CC3=C(C(=O)C=C(C3=O)OC)O)C)C D0T3CM HIGHSTAT Investigative D0T3CP DRUG__ID D0T3CP D0T3CP DRUGTYPE Small molecular drug D0T3CP DRUGINCH 1S/C20H39NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-24-19-18-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9- D0T3CP DRUGINKE NPPFEZUZEVDUDA-KTKRTIGZSA-N D0T3CP DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NOCCO D0T3CP HIGHSTAT Investigative D0T3ED DRUG__ID D0T3ED D0T3ED DRUGTYPE Small molecular drug D0T3ED DRUGINCH 1S/C18H16ClN5/c1-13-14(4-7-23-8-5-20-11-23)10-15-17(22-13)3-2-16(19)18(15)24-9-6-21-12-24/h2-3,5-6,8-12H,4,7H2,1H3 D0T3ED DRUGINKE IYLACPJLCQDSFP-UHFFFAOYSA-N D0T3ED DRUGSMIL CC1=NC2=C(C=C1CCN3C=CN=C3)C(=C(C=C2)Cl)N4C=CN=C4 D0T3ED HIGHSTAT Investigative D0T3FW DRUG__ID D0T3FW D0T3FW DRUGTYPE Small molecular drug D0T3FW DRUGINCH 1S/C21H27NO/c23-21-17(9-14-4-2-1-3-5-14)6-7-22(21)20-18-10-15-8-16(12-18)13-19(20)11-15/h1-5,15-20H,6-13H2 D0T3FW DRUGINKE HAAVSDQVLBVURQ-UHFFFAOYSA-N D0T3FW DRUGSMIL C1CN(C(=O)C1CC2=CC=CC=C2)C3C4CC5CC(C4)CC3C5 D0T3FW HIGHSTAT Investigative D0T3HK DRUG__ID D0T3HK D0T3HK DRUGTYPE Small molecular drug D0T3HK DRUGINCH 1S/C9H13N3/c1-3-10-4-2-9(1)12-7-5-11-6-8-12/h1-4,11H,5-8H2 D0T3HK DRUGINKE OQZBAQXTXNIPRA-UHFFFAOYSA-N D0T3HK DRUGSMIL C1CN(CCN1)C2=CC=NC=C2 D0T3HK HIGHSTAT Investigative D0T3IH DRUG__ID D0T3IH D0T3IH DRUGTYPE Small molecular drug D0T3IH DRUGINCH 1S/C24H28FN3O2/c1-26-18-28(21-6-3-2-4-7-21)24(23(26)30)13-16-27(17-14-24)15-5-8-22(29)19-9-11-20(25)12-10-19/h2-4,6-7,9-12H,5,8,13-18H2,1H3 D0T3IH DRUGINKE QHJLPOSPWKZACG-UHFFFAOYSA-N D0T3IH DRUGSMIL CN1CN(C2(C1=O)CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4 D0T3IH HIGHSTAT Investigative D0T3KK DRUG__ID D0T3KK D0T3KK DRUGTYPE Small molecular drug D0T3KK DRUGINCH 1S/C34H39N3O7S/c1-34(2)31(32(41)36-29-25-15-8-7-12-22(25)17-27(29)38)37(20-45-34)33(42)30(40)26(16-21-10-5-4-6-11-21)35-28(39)19-44-24-14-9-13-23(18-24)43-3/h4-15,18,26-27,29-31,38,40H,16-17,19-20H2,1-3H3,(H,35,39)(H,36,41)/t26-,27+,29-,30-,31+/m0/s1 D0T3KK DRUGINKE JUVIZUPSXSIJMO-VFCPCCRCSA-N D0T3KK DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC(=C3)OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0T3KK HIGHSTAT Investigative D0T3KZ DRUG__ID D0T3KZ D0T3KZ DRUGTYPE Small molecular drug D0T3KZ DRUGINCH 1S/C12H8O4S/c13-11(14)8-4-1-2-5-9(8)16-12(15)10-6-3-7-17-10/h1-7H,(H,13,14) D0T3KZ DRUGINKE JCUTZUSPPNNLDC-UHFFFAOYSA-N D0T3KZ DRUGSMIL C1=CC=C(C(=C1)C(=O)O)OC(=O)C2=CC=CS2 D0T3KZ HIGHSTAT Investigative D0T3NP DRUG__ID D0T3NP D0T3NP DRUGTYPE Small molecular drug D0T3NP DRUGINCH 1S/C8H8O3/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5,9H,1H3 D0T3NP DRUGINKE LXCFILQKKLGQFO-UHFFFAOYSA-N D0T3NP DRUGSMIL COC(=O)C1=CC=C(C=C1)O D0T3NP HIGHSTAT Investigative D0T3PV DRUG__ID D0T3PV D0T3PV DRUGTYPE Small molecular drug D0T3PV DRUGINCH 1S/C3H2N2O3S/c6-2-1(3(7)8)4-9-5-2/h(H,5,6)(H,7,8) D0T3PV DRUGINKE FVZITYNLUYJDOE-UHFFFAOYSA-N D0T3PV DRUGSMIL C1(=NSNC1=O)C(=O)O D0T3PV HIGHSTAT Investigative D0T3PW DRUG__ID D0T3PW D0T3PW DRUGTYPE Small molecular drug D0T3PW DRUGINCH 1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H D0T3PW DRUGINKE IKMDFBPHZNJCSN-UHFFFAOYSA-N D0T3PW DRUGSMIL C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O D0T3PW HIGHSTAT Investigative D0T3QN DRUG__ID D0T3QN D0T3QN DRUGTYPE Small molecular drug D0T3QN DRUGINCH 1S/C8H17N3O2/c9-4-2-1-3-7(8(12)13)11-6-5-10/h5,7,10-11H,1-4,6,9H2,(H,12,13)/t7-/m0/s1 D0T3QN DRUGINKE NNRMAICNBIUGOW-ZETCQYMHSA-N D0T3QN DRUGSMIL C(CCN)CC(C(=O)O)NCC=N D0T3QN HIGHSTAT Investigative D0T3QZ DRUG__ID D0T3QZ D0T3QZ DRUGTYPE Small molecular drug D0T3QZ DRUGINCH 1S/C16H17N3O/c1-11-14(18-10-17-11)7-8-16(20)13-9-19(2)15-6-4-3-5-12(13)15/h3-6,9-10H,7-8H2,1-2H3,(H,17,18) D0T3QZ DRUGINKE QZNZJWLUNDXZQA-UHFFFAOYSA-N D0T3QZ DRUGSMIL CC1=C(N=CN1)CCC(=O)C2=CN(C3=CC=CC=C32)C D0T3QZ HIGHSTAT Investigative D0T3SY DRUG__ID D0T3SY D0T3SY DRUGTYPE Small molecular drug D0T3SY DRUGINCH 1S/C10H10N2O2/c1-6-11-9-7(10(13)12-6)4-3-5-8(9)14-2/h3-5H,1-2H3,(H,11,12,13) D0T3SY DRUGINKE ZWCBMSNYXIFTCM-UHFFFAOYSA-N D0T3SY DRUGSMIL CC1=NC2=C(C=CC=C2OC)C(=O)N1 D0T3SY HIGHSTAT Investigative D0T3UP DRUG__ID D0T3UP D0T3UP DRUGTYPE Small molecular drug D0T3UP DRUGINCH 1S/C11H8N2O/c14-11-12-9-5-7-3-1-2-4-8(7)6-10(9)13-11/h1-6H,(H2,12,13,14) D0T3UP DRUGINKE HUOPXZLFTBYAML-UHFFFAOYSA-N D0T3UP DRUGSMIL C1=CC=C2C=C3C(=CC2=C1)NC(=O)N3 D0T3UP HIGHSTAT Investigative D0T3VP DRUG__ID D0T3VP D0T3VP DRUGTYPE Small molecular drug D0T3VP DRUGINCH 1S/C13H9FO2/c14-12-7-5-10(6-8-12)9-1-3-11(4-2-9)13(15)16/h1-8H,(H,15,16) D0T3VP DRUGINKE LXWNTLBMNCXRQN-UHFFFAOYSA-N D0T3VP DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)F)C(=O)O D0T3VP HIGHSTAT Investigative D0T3WL DRUG__ID D0T3WL D0T3WL DRUGTYPE Small molecular drug D0T3WL DRUGINCH 1S/C20H21NO4S/c1-4-11-25-15-9-10-21-18(14(2)22)13-17(19(21)12-15)16-7-5-6-8-20(16)26(3,23)24/h5-10,12-13H,4,11H2,1-3H3 D0T3WL DRUGINKE KHWCPNJRJCNVRI-UHFFFAOYSA-N D0T3WL DRUGSMIL CCCOC1=CC2=C(C=C(N2C=C1)C(=O)C)C3=CC=CC=C3S(=O)(=O)C D0T3WL HIGHSTAT Investigative D0T3XC DRUG__ID D0T3XC D0T3XC DRUGTYPE Small molecular drug D0T3XC DRUGINCH 1S/C14H21NOS/c1-2-3-9-16-13-6-4-12(5-7-13)14-11-15-8-10-17-14/h4-7,14-15H,2-3,8-11H2,1H3 D0T3XC DRUGINKE SHHIIRIFRIVAFS-UHFFFAOYSA-N D0T3XC DRUGSMIL CCCCOC1=CC=C(C=C1)C2CNCCS2 D0T3XC HIGHSTAT Investigative D0T3YS DRUG__ID D0T3YS D0T3YS DRUGTYPE Small molecular drug D0T3YS DRUGINCH 1S/C26H21FN4O2/c1-17-8-10-20(27)13-22(17)25(32)29-24-11-9-18(14-28-24)26(33)31-16-21-6-4-12-30(21)15-19-5-2-3-7-23(19)31/h2-14H,15-16H2,1H3,(H,28,29,32) D0T3YS DRUGINKE XJZRYHGTQLKUDO-UHFFFAOYSA-N D0T3YS DRUGSMIL CC1=C(C=C(C=C1)F)C(=O)NC2=NC=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53 D0T3YS HIGHSTAT Investigative D0T3YY DRUG__ID D0T3YY D0T3YY DRUGTYPE Small molecular drug D0T3YY DRUGINCH 1S/C20H19ClN4O2S/c1-10-11(2)28-20-17(10)18(13-5-7-14(21)8-6-13)22-15(9-16(26)27-4)19-24-23-12(3)25(19)20/h5-8,15H,9H2,1-4H3/t15-/m0/s1 D0T3YY DRUGINKE GGRCIHACOIMRKY-HNNXBMFYSA-N D0T3YY DRUGSMIL CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)OC)C4=CC=C(C=C4)Cl)C D0T3YY HIGHSTAT Investigative D0T3ZS DRUG__ID D0T3ZS D0T3ZS DRUGTYPE Small molecular drug D0T3ZS DRUGINCH 1S/C17H17NO2S/c19-17-12-21-16(10-18-17)14-6-8-15(9-7-14)20-11-13-4-2-1-3-5-13/h1-9,16H,10-12H2,(H,18,19) D0T3ZS DRUGINKE WREDZZPMENXHRK-UHFFFAOYSA-N D0T3ZS DRUGSMIL C1C(SCC(=O)N1)C2=CC=C(C=C2)OCC3=CC=CC=C3 D0T3ZS HIGHSTAT Investigative D0T4AC DRUG__ID D0T4AC D0T4AC DRUGTYPE Small molecular drug D0T4AC DRUGINCH 1S/C23H28O8/c1-25-17-8-14(9-18(26-2)21(17)28-4)6-16-15(11-29-23(16)24)5-13-7-19(27-3)22-20(10-13)30-12-31-22/h7-10,15-16,23-24H,5-6,11-12H2,1-4H3/t15-,16+,23-/m0/s1 D0T4AC DRUGINKE ADGULOHTKSMBCP-PXAQALGRSA-N D0T4AC DRUGSMIL COC1=CC(=CC2=C1OCO2)CC3COC(C3CC4=CC(=C(C(=C4)OC)OC)OC)O D0T4AC HIGHSTAT Investigative D0T4AN DRUG__ID D0T4AN D0T4AN DRUGTYPE Small molecular drug D0T4AN DRUGINCH 1S/C14H19NO4/c1-2-3-10-19-12-6-4-11(5-7-12)13(16)8-9-14(17)15-18/h4-7,18H,2-3,8-10H2,1H3,(H,15,17) D0T4AN DRUGINKE SFIUVAFWSBUQJK-UHFFFAOYSA-N D0T4AN DRUGSMIL CCCCOC1=CC=C(C=C1)C(=O)CCC(=O)NO D0T4AN HIGHSTAT Investigative D0T4BP DRUG__ID D0T4BP D0T4BP DRUGTYPE Small molecular drug D0T4BP DRUGINCH 1S/C12H24O3/c1-2-3-4-5-6-7-8-9-10-11(13)12(14)15/h11,13H,2-10H2,1H3,(H,14,15) D0T4BP DRUGINKE YDZIJQXINJLRLL-UHFFFAOYSA-N D0T4BP DRUGSMIL CCCCCCCCCCC(C(=O)O)O D0T4BP HIGHSTAT Investigative D0T4DJ DRUG__ID D0T4DJ D0T4DJ DRUGTYPE Small molecular drug D0T4DJ DRUGINCH 1S/C6H8N2O4/c9-5-3-2(12-8-5)1-7-4(3)6(10)11/h2-4,7H,1H2,(H,8,9)(H,10,11)/t2-,3-,4-/m0/s1 D0T4DJ DRUGINKE XJSXFNHFIBCTDU-HZLVTQRSSA-N D0T4DJ DRUGSMIL C1C2C(C(N1)C(=O)O)C(=O)NO2 D0T4DJ HIGHSTAT Investigative D0T4FT DRUG__ID D0T4FT D0T4FT DRUGTYPE Small molecular drug D0T4FT DRUGINCH 1S/C32H38N8O5/c1-21(2)16-25(39-32(44)45-18-23-12-7-4-8-13-23)30(42)38-24(17-22-10-5-3-6-11-22)27(41)31(43)34-14-9-15-40-20-37-26-28(33)35-19-36-29(26)40/h3-8,10-13,19-21,24-25H,9,14-18H2,1-2H3,(H,34,43)(H,38,42)(H,39,44)(H2,33,35,36)/t24?,25-/m0/s1 D0T4FT DRUGINKE OVLNPOAZKHQAAD-BBMPLOMVSA-N D0T4FT DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)C(=O)NCCCN2C=NC3=C(N=CN=C32)N)NC(=O)OCC4=CC=CC=C4 D0T4FT HIGHSTAT Investigative D0T4HB DRUG__ID D0T4HB D0T4HB DRUGTYPE Small molecular drug D0T4HB DRUGINCH 1S/C21H44FO2P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25(22,23)24-2/h3-21H2,1-2H3 D0T4HB DRUGINKE IRQAGEYFWAZZPI-UHFFFAOYSA-N D0T4HB DRUGSMIL CCCCCCCCCCCCCCCCCCCCP(=O)(OC)F D0T4HB HIGHSTAT Investigative D0T4IY DRUG__ID D0T4IY D0T4IY DRUGTYPE Small molecular drug D0T4IY DRUGINCH 1S/C16H20N2OS/c19-16(9-3-1-2-6-10-20)18-14-11-13-7-4-5-8-15(13)17-12-14/h4-5,7-8,11-12,20H,1-3,6,9-10H2,(H,18,19) D0T4IY DRUGINKE XAFIWTHVBLRJFM-UHFFFAOYSA-N D0T4IY DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)NC(=O)CCCCCCS D0T4IY HIGHSTAT Investigative D0T4JD DRUG__ID D0T4JD D0T4JD DRUGTYPE Small molecular drug D0T4JD DRUGINCH 1S/C23H21N5O6S2/c1-15-14-18(8-13-21(15)35(30,31)27-17-6-4-3-5-7-17)24-25-22-16(2)26-28(23(22)29)19-9-11-20(12-10-19)36(32,33)34/h3-14,22,27H,1-2H3,(H,32,33,34) D0T4JD DRUGINKE SFQBOTBDUOOSJB-UHFFFAOYSA-N D0T4JD DRUGSMIL CC1=C(C=CC(=C1)N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)O)C)S(=O)(=O)NC4=CC=CC=C4 D0T4JD HIGHSTAT Investigative D0T4JO DRUG__ID D0T4JO D0T4JO DRUGTYPE Small molecular drug D0T4JO DRUGINCH 1S/C27H21F6N3O2/c1-15-6-8-17(9-7-15)21-20-5-4-10-34-22(20)24(37)36(3)23(21)25(38)35(2)14-16-11-18(26(28,29)30)13-19(12-16)27(31,32)33/h4-13H,14H2,1-3H3 D0T4JO DRUGINKE GIAQQXUCTFYCHO-UHFFFAOYSA-N D0T4JO DRUGSMIL CC1=CC=C(C=C1)C2=C(N(C(=O)C3=C2C=CC=N3)C)C(=O)N(C)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D0T4JO HIGHSTAT Investigative D0T4JQ DRUG__ID D0T4JQ D0T4JQ DRUGTYPE Small molecular drug D0T4JQ DRUGINCH 1S/C4H8O2/c1-2-3-4(5)6/h2-3H2,1H3,(H,5,6) D0T4JQ DRUGINKE FERIUCNNQQJTOY-UHFFFAOYSA-N D0T4JQ DRUGSMIL CCCC(=O)O D0T4JQ HIGHSTAT Investigative D0T4KC DRUG__ID D0T4KC D0T4KC DRUGTYPE Small molecular drug D0T4KC DRUGINCH 1S/C14H11N3O2/c15-9-10-5-4-8-12(13(10)18)17-14(19)16-11-6-2-1-3-7-11/h1-8,18H,(H2,16,17,19) D0T4KC DRUGINKE JFGPRCHQZYGZRH-UHFFFAOYSA-N D0T4KC DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=CC=CC(=C2O)C#N D0T4KC HIGHSTAT Investigative D0T4MJ DRUG__ID D0T4MJ D0T4MJ DRUGTYPE Small molecular drug D0T4MJ DRUGINCH 1S/C14H15F3N6O/c15-14(16,17)8-2-1-3-9(6-8)22-12-10(11(19)24)7-21-13(23-12)20-5-4-18/h1-3,6-7H,4-5,18H2,(H2,19,24)(H2,20,21,22,23) D0T4MJ DRUGINKE FQNFLNSVHWCZML-UHFFFAOYSA-N D0T4MJ DRUGSMIL C1=CC(=CC(=C1)NC2=NC(=NC=C2C(=O)N)NCCN)C(F)(F)F D0T4MJ HIGHSTAT Investigative D0T4ML DRUG__ID D0T4ML D0T4ML DRUGTYPE Small molecular drug D0T4ML DRUGINCH 1S/C33H38N4O6/c1-23-24(7-5-15-36(23)40)21-34-16-13-27(14-17-34)43-28-9-10-29(31(20-28)41-2)32(38)35-18-11-26(12-19-35)37-30-8-4-3-6-25(30)22-42-33(37)39/h3-10,15,20,26-27H,11-14,16-19,21-22H2,1-2H3 D0T4ML DRUGINKE SKWSXDUHUVMPBT-UHFFFAOYSA-N D0T4ML DRUGSMIL CC1=C(C=CC=[N+]1[O-])CN2CCC(CC2)OC3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5C6=CC=CC=C6COC5=O)OC D0T4ML HIGHSTAT Investigative D0T4MS DRUG__ID D0T4MS D0T4MS DRUGTYPE Small molecular drug D0T4MS DRUGINCH 1S/C19H18ClN3O4/c1-3-21-19(26)18-16(10-4-6-11(27-2)7-5-10)17(22-23-18)12-8-13(20)15(25)9-14(12)24/h4-9,24-25H,3H2,1-2H3,(H,21,26)(H,22,23) D0T4MS DRUGINKE HUNAOTXNHVALTN-UHFFFAOYSA-N D0T4MS DRUGSMIL CCNC(=O)C1=C(C(=NN1)C2=CC(=C(C=C2O)O)Cl)C3=CC=C(C=C3)OC D0T4MS HIGHSTAT Investigative D0T4PL DRUG__ID D0T4PL D0T4PL DRUGTYPE Small molecular drug D0T4PL DRUGINCH 1S/C27H28F2O5S/c1-16(2)24-13-23(35-22-9-7-19(29)8-10-22)14-25(17-3-5-18(28)6-4-17)27(24)34-15-21(31)11-20(30)12-26(32)33/h3-10,13-14,16,20-21,30-31H,11-12,15H2,1-2H3,(H,32,33)/p-1/t20-,21?/m1/s1 D0T4PL DRUGINKE UFSXOKMGOHBXIH-VQCQRNETSA-M D0T4PL DRUGSMIL CC(C)C1=CC(=CC(=C1OCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)SC3=CC=C(C=C3)F D0T4PL HIGHSTAT Investigative D0T4PS DRUG__ID D0T4PS D0T4PS DRUGTYPE Small molecular drug D0T4PS DRUGINCH 1S/C19H22F3N3/c20-19(21,22)16-2-1-3-18(14-16)25-12-10-24(11-13-25)9-8-15-4-6-17(23)7-5-15/h1-7,14H,8-13,23H2 D0T4PS DRUGINKE GAAKALASJNGQKD-UHFFFAOYSA-N D0T4PS DRUGSMIL C1CN(CCN1CCC2=CC=C(C=C2)N)C3=CC=CC(=C3)C(F)(F)F D0T4PS HIGHSTAT Investigative D0T4RW DRUG__ID D0T4RW D0T4RW DRUGTYPE Small molecular drug D0T4RW DRUGINCH 1S/C17H17N5O2/c1-21(2)8-7-18-12-4-5-13-16-15(12)17(24)11-9-10(23)3-6-14(11)22(16)20-19-13/h3-6,9,18,23H,7-8H2,1-2H3 D0T4RW DRUGINKE OMSFZBMJHQNEQZ-UHFFFAOYSA-N D0T4RW DRUGSMIL CN(C)CCNC1=C2C3=C(C=C1)N=NN3C4=C(C2=O)C=C(C=C4)O D0T4RW HIGHSTAT Investigative D0T4SE DRUG__ID D0T4SE D0T4SE DRUGTYPE Small molecular drug D0T4SE DRUGINCH 1S/C20H31NO2/c1-3-4-5-6-7-8-9-10-11-20(22)21-17-16-18-12-14-19(23-2)15-13-18/h10-15H,3-9,16-17H2,1-2H3,(H,21,22)/b11-10+ D0T4SE DRUGINKE WHWQEVQBWRYYLL-ZHACJKMWSA-N D0T4SE DRUGSMIL CCCCCCCCC=CC(=O)NCCC1=CC=C(C=C1)OC D0T4SE HIGHSTAT Investigative D0T4SL DRUG__ID D0T4SL D0T4SL DRUGTYPE Small molecular drug D0T4SL DRUGINCH 1S/C18H16N2O/c1-10-15-9-19-7-6-13(15)11(2)18-17(10)14-8-12(21-3)4-5-16(14)20-18/h4-9,20H,1-3H3 D0T4SL DRUGINKE BKRMCDAOAQWNTG-UHFFFAOYSA-N D0T4SL DRUGSMIL CC1=C2C=CN=CC2=C(C3=C1NC4=C3C=C(C=C4)OC)C D0T4SL HIGHSTAT Investigative D0T4UE DRUG__ID D0T4UE D0T4UE DRUGTYPE Small molecular drug D0T4UE DRUGINCH 1S/C13H18N2O8S2/c1-7-9-5-23-13(17)10(9)11(16)8(12(7)22-2)3-4-15-25(20,21)6-24(14,18)19/h15-16H,3-6H2,1-2H3,(H2,14,18,19) D0T4UE DRUGINKE IVAOVFUEHDFBPQ-UHFFFAOYSA-N D0T4UE DRUGSMIL CC1=C2COC(=O)C2=C(C(=C1OC)CCNS(=O)(=O)CS(=O)(=O)N)O D0T4UE HIGHSTAT Investigative D0T4UO DRUG__ID D0T4UO D0T4UO DRUGTYPE Small molecular drug D0T4UO DRUGINCH 1S/C32H44N4O/c37-31-21-20-24-27(18-13-19-28(24)36-31)33-22-11-5-3-1-2-4-6-12-23-34-32-25-14-7-9-16-29(25)35-30-17-10-8-15-26(30)32/h7,9,14,16,20-21,27,33H,1-6,8,10-13,15,17-19,22-23H2,(H,34,35)(H,36,37)/t27-/m0/s1 D0T4UO DRUGINKE ROTFGKJJMRTWBD-MHZLTWQESA-N D0T4UO DRUGSMIL C1CCC2=NC3=CC=CC=C3C(=C2C1)NCCCCCCCCCCNC4CCCC5=C4C=CC(=O)N5 D0T4UO HIGHSTAT Investigative D0T4VL DRUG__ID D0T4VL D0T4VL DRUGTYPE Small molecular drug D0T4VL DRUGINCH 1S/C17H14F3N3O3S/c18-17(19,20)16-9-15(12-3-1-11(10-24)2-4-12)23(22-16)13-5-7-14(8-6-13)27(21,25)26/h1-9,24H,10H2,(H2,21,25,26) D0T4VL DRUGINKE ICRSYPPLGADZKA-UHFFFAOYSA-N D0T4VL DRUGSMIL C1=CC(=CC=C1CO)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F D0T4VL HIGHSTAT Investigative D0T4WF DRUG__ID D0T4WF D0T4WF DRUGTYPE Small molecular drug D0T4WF DRUGINCH 1S/C17H20N2O13P2/c20-11(10-4-2-1-3-5-10)8-19-13(21)6-7-18(17(19)24)16-15(23)14(22)12(31-16)9-30-34(28,29)32-33(25,26)27/h1-7,12,14-16,22-23H,8-9H2,(H,28,29)(H2,25,26,27)/t12-,14-,15-,16-/m1/s1 D0T4WF DRUGINKE SEUHNFHNNANEAJ-DTZQCDIJSA-N D0T4WF DRUGSMIL C1=CC=C(C=C1)C(=O)CN2C(=O)C=CN(C2=O)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O D0T4WF HIGHSTAT Investigative D0T4WL DRUG__ID D0T4WL D0T4WL DRUGTYPE Small molecular drug D0T4WL DRUGINCH 1S/C7H8N2O2/c10-7(9-11)8-6-4-2-1-3-5-6/h1-5,11H,(H2,8,9,10) D0T4WL DRUGINKE AAVSQBMWOCNSDL-UHFFFAOYSA-N D0T4WL DRUGSMIL C1=CC=C(C=C1)NC(=O)NO D0T4WL HIGHSTAT Investigative D0T4YQ DRUG__ID D0T4YQ D0T4YQ DRUGTYPE Small molecular drug D0T4YQ DRUGINCH 1S/C20H19NO2/c22-19-12-14-21(15-13-19)20(23)18-10-8-17(9-11-18)7-6-16-4-2-1-3-5-16/h1-5,8-11,19,22H,12-15H2 D0T4YQ DRUGINKE FPDBSDNGFNDSSK-UHFFFAOYSA-N D0T4YQ DRUGSMIL C1CN(CCC1O)C(=O)C2=CC=C(C=C2)C#CC3=CC=CC=C3 D0T4YQ HIGHSTAT Investigative D0T4ZI DRUG__ID D0T4ZI D0T4ZI DRUGTYPE Small molecular drug D0T4ZI DRUGINCH 1S/C15H8ClNO4/c16-10-4-5-14-12(7-10)13(18)8-15(21-14)9-2-1-3-11(6-9)17(19)20/h1-8H D0T4ZI DRUGINKE DKCAUMRZSZVJCP-UHFFFAOYSA-N D0T4ZI DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC(=O)C3=C(O2)C=CC(=C3)Cl D0T4ZI HIGHSTAT Investigative D0T4ZY DRUG__ID D0T4ZY D0T4ZY DRUGTYPE Small molecular drug D0T4ZY DRUGINCH 1S/C21H27NO2/c1-2-24-17-20(18-9-5-3-6-10-18)22-15-13-21(23,14-16-22)19-11-7-4-8-12-19/h3-12,20,23H,2,13-17H2,1H3 D0T4ZY DRUGINKE ZZEVNYNMIVJANK-UHFFFAOYSA-N D0T4ZY DRUGSMIL CCOCC(C1=CC=CC=C1)N2CCC(CC2)(C3=CC=CC=C3)O D0T4ZY HIGHSTAT Investigative D0T5DO DRUG__ID D0T5DO D0T5DO DRUGTYPE Small molecular drug D0T5DO DRUGINCH 1S/C14H11IO3S/c1-8(14(17)18)9-2-4-10(5-3-9)13(16)11-6-7-12(15)19-11/h2-8H,1H3,(H,17,18) D0T5DO DRUGINKE UIZPHGUBGPJBAR-UHFFFAOYSA-N D0T5DO DRUGSMIL CC(C1=CC=C(C=C1)C(=O)C2=CC=C(S2)I)C(=O)O D0T5DO HIGHSTAT Investigative D0T5EI DRUG__ID D0T5EI D0T5EI DRUGTYPE Small molecular drug D0T5EI DRUGINCH 1S/C19H25NO2/c1-3-19-8-9-20(11-13-4-5-13)17(12(19)2)18(22)15-7-6-14(21)10-16(15)19/h6-7,10,12-13,17,21H,3-5,8-9,11H2,1-2H3/t12?,17-,19+/m0/s1 D0T5EI DRUGINKE SEJUQQOPVAUETF-SCTOPSOGSA-N D0T5EI DRUGSMIL CCC12CCN(C(C1C)C(=O)C3=C2C=C(C=C3)O)CC4CC4 D0T5EI HIGHSTAT Investigative D0T5FY DRUG__ID D0T5FY D0T5FY DRUGTYPE Small molecular drug D0T5FY DRUGINCH 1S/C16H10Cl2N2OS/c17-11-6-7-12(13(18)8-11)15(21)20-16-19-14(9-22-16)10-4-2-1-3-5-10/h1-9H,(H,19,20,21) D0T5FY DRUGINKE MWSDOEQEOIKHRL-UHFFFAOYSA-N D0T5FY DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=C(C=C(C=C3)Cl)Cl D0T5FY HIGHSTAT Investigative D0T5GV DRUG__ID D0T5GV D0T5GV DRUGTYPE Small molecular drug D0T5GV DRUGINCH 1S/C8H8Cl3NO/c9-8(10,11)7(13)5-6-1-3-12-4-2-6/h1-4,7,13H,5H2 D0T5GV DRUGINKE NGTDJJKTGRNNAU-UHFFFAOYSA-N D0T5GV DRUGSMIL C1=CN=CC=C1CC(C(Cl)(Cl)Cl)O D0T5GV HIGHSTAT Investigative D0T5IP DRUG__ID D0T5IP D0T5IP DRUGTYPE Small molecular drug D0T5IP DRUGINCH 1S/C22H19NO/c1-4-10-18(11-5-1)22(21-23-16-17-24-21,19-12-6-2-7-13-19)20-14-8-3-9-15-20/h1-15H,16-17H2 D0T5IP DRUGINKE PHFOYYZFWZIUBU-UHFFFAOYSA-N D0T5IP DRUGSMIL C1COC(=N1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D0T5IP HIGHSTAT Investigative D0T5KC DRUG__ID D0T5KC D0T5KC DRUGTYPE Small molecular drug D0T5KC DRUGINCH 1S/C13H19NO/c1-11-5-4-9-14(11)10-8-12-6-2-3-7-13(12)15/h2-3,6-7,11,15H,4-5,8-10H2,1H3/t11-/m0/s1 D0T5KC DRUGINKE XLLMSPMZEFQVLD-NSHDSACASA-N D0T5KC DRUGSMIL CC1CCCN1CCC2=CC=CC=C2O D0T5KC HIGHSTAT Investigative D0T5KJ DRUG__ID D0T5KJ D0T5KJ DRUGTYPE Small molecular drug D0T5KJ DRUGINCH 1S/C11H15NO3/c13-9-3-2-8(6-10(9)14)11(15)4-1-5-12-7-11/h2-3,6,12-15H,1,4-5,7H2 D0T5KJ DRUGINKE REBGJGKBMBFBHE-UHFFFAOYSA-N D0T5KJ DRUGSMIL C1CC(CNC1)(C2=CC(=C(C=C2)O)O)O D0T5KJ HIGHSTAT Investigative D0T5MD DRUG__ID D0T5MD D0T5MD DRUGTYPE Small molecular drug D0T5MD DRUGINCH 1S/C18H21NO6/c20-17(12-6-7-12)24-13-9-22-16-14(10-23-15(13)16)25-18(21)19-8-11-4-2-1-3-5-11/h1-5,12-16H,6-10H2,(H,19,21)/t13-,14+,15-,16-/m1/s1 D0T5MD DRUGINKE FEYSXVBUKKSWGH-QKPAOTATSA-N D0T5MD DRUGSMIL C1CC1C(=O)OC2COC3C2OCC3OC(=O)NCC4=CC=CC=C4 D0T5MD HIGHSTAT Investigative D0T5MO DRUG__ID D0T5MO D0T5MO DRUGTYPE Small molecular drug D0T5MO DRUGINCH 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-16H,3-11H2,1-2H3/t12-,14-,15-,16-,18-,19-/m0/s1 D0T5MO DRUGINKE RAJWOBJTTGJROA-WZNAKSSCSA-N D0T5MO DRUGSMIL CC12CCC(=O)CC1CCC3C2CCC4(C3CCC4=O)C D0T5MO HIGHSTAT Investigative D0T5NO DRUG__ID D0T5NO D0T5NO DRUGTYPE Small molecular drug D0T5NO DRUGINCH 1S/C14H17NO4/c1-8-6-11(16)15(2)13-9(17-3)7-10(18-4)14(19-5)12(8)13/h6-7H,1-5H3 D0T5NO DRUGINKE PJUNWPXRLZUYPB-UHFFFAOYSA-N D0T5NO DRUGSMIL CC1=CC(=O)N(C2=C1C(=C(C=C2OC)OC)OC)C D0T5NO HIGHSTAT Investigative D0T5OD DRUG__ID D0T5OD D0T5OD DRUGTYPE Small molecular drug D0T5OD DRUGINCH 1S/C15H21NO5S/c16-22(18,19)21-14-10-8-12(9-11-14)15(17)20-13-6-4-2-1-3-5-7-13/h8-11,13H,1-7H2,(H2,16,18,19) D0T5OD DRUGINKE AGVIMIWKQHZOFR-UHFFFAOYSA-N D0T5OD DRUGSMIL C1CCCC(CCC1)OC(=O)C2=CC=C(C=C2)OS(=O)(=O)N D0T5OD HIGHSTAT Investigative D0T5OS DRUG__ID D0T5OS D0T5OS DRUGTYPE Small molecular drug D0T5OS DRUGINCH 1S/C9H12NO6P/c10-8(9(11)12)5-6-1-3-7(4-2-6)16-17(13,14)15/h1-4,8H,5,10H2,(H,11,12)(H2,13,14,15)/t8-/m0/s1 D0T5OS DRUGINKE DCWXELXMIBXGTH-QMMMGPOBSA-N D0T5OS DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)N)OP(=O)(O)O D0T5OS HIGHSTAT Investigative D0T5OW DRUG__ID D0T5OW D0T5OW DRUGTYPE Small molecular drug D0T5OW DRUGINCH 1S/C15H12N2O2S/c18-11-7-5-10(6-8-11)13-9-20-15(17-13)16-12-3-1-2-4-14(12)19/h1-9,18-19H,(H,16,17) D0T5OW DRUGINKE HXSHJTRADFDFMA-UHFFFAOYSA-N D0T5OW DRUGSMIL C1=CC=C(C(=C1)NC2=NC(=CS2)C3=CC=C(C=C3)O)O D0T5OW HIGHSTAT Investigative D0T5PO DRUG__ID D0T5PO D0T5PO DRUGTYPE Small molecular drug D0T5PO DRUGINCH 1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) D0T5PO DRUGINKE HJORMJIFDVBMOB-UHFFFAOYSA-N D0T5PO DRUGSMIL COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 D0T5PO HIGHSTAT Investigative D0T5SU DRUG__ID D0T5SU D0T5SU DRUGTYPE Small molecular drug D0T5SU DRUGINCH 1S/C7H10N2O4/c1-3-4(6(10)9-13-3)2-5(8)7(11)12/h5H,2,8H2,1H3,(H,9,10)(H,11,12)/t5-/m0/s1 D0T5SU DRUGINKE UUDAMDVQRQNNHZ-YFKPBYRVSA-N D0T5SU DRUGSMIL CC1=C(C(=O)NO1)CC(C(=O)O)N D0T5SU HIGHSTAT Investigative D0T5TT DRUG__ID D0T5TT D0T5TT DRUGTYPE Small molecular drug D0T5TT DRUGINCH 1S/C13H10N2O/c1-2-4-9-7-10-5-3-6-11(13(14)16)12(10)15-8-9/h3,5-8H,1H3,(H2,14,16) D0T5TT DRUGINKE IUUKYHUSWYCGAA-UHFFFAOYSA-N D0T5TT DRUGSMIL CC#CC1=CN=C2C(=C1)C=CC=C2C(=O)N D0T5TT HIGHSTAT Investigative D0T5VB DRUG__ID D0T5VB D0T5VB DRUGTYPE Small molecular drug D0T5VB DRUGINCH 1S/C20H24N8O2/c1-4-27-10-9-17(25-27)22-19-21-13-16-18(23-19)24-26-28(16)15-7-5-14(6-8-15)20(2,3)30-12-11-29/h5-10,13,29H,4,11-12H2,1-3H3,(H,21,22,23,25) D0T5VB DRUGINKE XNAMZBCMLZQBIC-UHFFFAOYSA-N D0T5VB DRUGSMIL CCN1C=CC(=N1)NC2=NC=C3C(=N2)N=NN3C4=CC=C(C=C4)C(C)(C)OCCO D0T5VB HIGHSTAT Investigative D0T5VG DRUG__ID D0T5VG D0T5VG DRUGTYPE Small molecular drug D0T5VG DRUGINCH 1S/C17H21NO/c18-12-16-11-10-15(19-16)9-8-14-6-3-5-13-4-1-2-7-17(13)14/h1-7,15-16H,8-12,18H2 D0T5VG DRUGINKE QLXIMJBRAWACSR-UHFFFAOYSA-N D0T5VG DRUGSMIL C1CC(OC1CCC2=CC=CC3=CC=CC=C32)CN D0T5VG HIGHSTAT Investigative D0T5WY DRUG__ID D0T5WY D0T5WY DRUGTYPE Small molecular drug D0T5WY DRUGINCH 1S/C26H24N2O3/c1-2-3-6-15-27-18-21(17-25(27)20-11-7-12-22(16-20)28(30)31)26(29)24-14-8-10-19-9-4-5-13-23(19)24/h4-5,7-14,16-18H,2-3,6,15H2,1H3 D0T5WY DRUGINKE FQGNQKRWZNTBLM-UHFFFAOYSA-N D0T5WY DRUGSMIL CCCCCN1C=C(C=C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)C3=CC=CC4=CC=CC=C43 D0T5WY HIGHSTAT Investigative D0T5XC DRUG__ID D0T5XC D0T5XC DRUGTYPE Small molecular drug D0T5XC DRUGINCH 1S/C15H12O3/c1-18-13-9-7-12(8-10-13)15(17)14(16)11-5-3-2-4-6-11/h2-10H,1H3 D0T5XC DRUGINKE NTINAJCDYRYMML-UHFFFAOYSA-N D0T5XC DRUGSMIL COC1=CC=C(C=C1)C(=O)C(=O)C2=CC=CC=C2 D0T5XC HIGHSTAT Investigative D0T6DR DRUG__ID D0T6DR D0T6DR DRUGTYPE Small molecular drug D0T6DR DRUGINCH 1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11) D0T6DR DRUGINKE AYXYPKUFHZROOJ-UHFFFAOYSA-N D0T6DR DRUGSMIL CC(C)CC(CC(=O)O)CN D0T6DR HIGHSTAT Investigative D0T6DU DRUG__ID D0T6DU D0T6DU DRUGTYPE Small molecular drug D0T6DU DRUGINCH 1S/C23H42O5/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(26)27-20-22(19-24)28-21(2)25/h10-11,22,24H,3-9,12-20H2,1-2H3/b11-10+ D0T6DU DRUGINKE PWTCCMJTPHCGMS-ZHACJKMWSA-N D0T6DU DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)OC(=O)C D0T6DU HIGHSTAT Investigative D0T6ED DRUG__ID D0T6ED D0T6ED DRUGTYPE Small molecular drug D0T6ED DRUGINCH 1S/C24H33NO6/c1-6-7-10-16(2)12-13-18(4)22(27)21-19(26)15-20(31-23(21)28)17(3)11-8-9-14-25-24(29)30-5/h9,12-15,17,26H,6-8,10-11H2,1-5H3,(H,25,29)/b14-9+,16-12+,18-13+/t17-/m1/s1 D0T6ED DRUGINKE SPQDIDVJAZFBRL-WXFBSNOUSA-N D0T6ED DRUGSMIL CCCCC(=CC=C(C)C(=O)C1=C(C=C(OC1=O)C(C)CCC=CNC(=O)OC)O)C D0T6ED HIGHSTAT Investigative D0T6GM DRUG__ID D0T6GM D0T6GM DRUGTYPE Small molecular drug D0T6GM DRUGINCH 1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1 D0T6GM DRUGINKE MTCFGRXMJLQNBG-REOHCLBHSA-N D0T6GM DRUGSMIL C(C(C(=O)O)N)O D0T6GM HIGHSTAT Investigative D0T6ID DRUG__ID D0T6ID D0T6ID DRUGTYPE Small molecular drug D0T6ID DRUGINCH 1S/C13H21N3S2/c1-3-4-5-9-17-13-12(14-18-15-13)11-7-6-8-16(2)10-11/h7H,3-6,8-10H2,1-2H3 D0T6ID DRUGINKE LRTWCQHCJKYNPS-UHFFFAOYSA-N D0T6ID DRUGSMIL CCCCCSC1=NSN=C1C2=CCCN(C2)C D0T6ID HIGHSTAT Investigative D0T6MF DRUG__ID D0T6MF D0T6MF DRUGTYPE Small molecular drug D0T6MF DRUGINCH 1S/C17H17NO2/c1-17(2,3)11-5-6-12-13-8-10(16(19)20)4-7-14(13)18-15(12)9-11/h4-9,18H,1-3H3,(H,19,20) D0T6MF DRUGINKE DIDFDNKTXWWCAJ-UHFFFAOYSA-N D0T6MF DRUGSMIL CC(C)(C)C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)C(=O)O D0T6MF HIGHSTAT Investigative D0T6NJ DRUG__ID D0T6NJ D0T6NJ DRUGTYPE Small molecular drug D0T6NJ DRUGINCH 1S/C20H22N2O/c1-3-22(4-2)19(23)14-17-16-12-8-9-13-18(16)21-20(17)15-10-6-5-7-11-15/h5-13,21H,3-4,14H2,1-2H3 D0T6NJ DRUGINKE JAQRBHPLECRUHQ-UHFFFAOYSA-N D0T6NJ DRUGSMIL CCN(CC)C(=O)CC1=C(NC2=CC=CC=C21)C3=CC=CC=C3 D0T6NJ HIGHSTAT Investigative D0T6OQ DRUG__ID D0T6OQ D0T6OQ DRUGTYPE Small molecular drug D0T6OQ DRUGINCH 1S/C21H24N2O4/c22-19(25)13-4-3-12-9-15-21(26)6-5-14(24)18-20(21,16(12)17(13)27-18)7-8-23(15)10-11-1-2-11/h3-4,11,15,18,26H,1-2,5-10H2,(H2,22,25)/t15-,18+,20+,21-/m1/s1 D0T6OQ DRUGINKE QAICPHMNUHNDMC-WUHBCXKYSA-N D0T6OQ DRUGSMIL C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)C(=O)N)O5)O D0T6OQ HIGHSTAT Investigative D0T6SC DRUG__ID D0T6SC D0T6SC DRUGTYPE Small molecular drug D0T6SC DRUGINCH 1S/C6H11N3.2ClH/c1-7-3-2-6-4-8-5-9-6;;/h4-5,7H,2-3H2,1H3,(H,8,9);2*1H D0T6SC DRUGINKE AYUQICXJAMPXPF-UHFFFAOYSA-N D0T6SC DRUGSMIL CNCCC1=CN=CN1.Cl.Cl D0T6SC HIGHSTAT Investigative D0T6VA DRUG__ID D0T6VA D0T6VA DRUGTYPE Small molecular drug D0T6VA DRUGINCH 1S/C9H8N2OS2/c10-6-3-7(5-1-2-13-4-5)14-8(6)9(11)12/h1-4H,10H2,(H2,11,12) D0T6VA DRUGINKE BMUACLADCKCNKZ-UHFFFAOYSA-N D0T6VA DRUGSMIL C1=CSC=C1C2=CC(=C(S2)C(=O)N)N D0T6VA HIGHSTAT Investigative D0T6VB DRUG__ID D0T6VB D0T6VB DRUGTYPE Small molecular drug D0T6VB DRUGINCH 1S/CHNO/c1-2-3/h1H D0T6VB DRUGINKE UXKUODQYLDZXDL-UHFFFAOYSA-N D0T6VB DRUGSMIL C#[N+][O-] D0T6VB HIGHSTAT Investigative D0T6WL DRUG__ID D0T6WL D0T6WL DRUGTYPE Small molecular drug D0T6WL DRUGINCH 1S/C15H11NO2S/c17-12-5-1-3-10(7-12)14-9-19-15(16-14)11-4-2-6-13(18)8-11/h1-9,17-18H D0T6WL DRUGINKE WSUUHCNQLBCNOV-UHFFFAOYSA-N D0T6WL DRUGSMIL C1=CC(=CC(=C1)O)C2=CSC(=N2)C3=CC(=CC=C3)O D0T6WL HIGHSTAT Investigative D0T6WV DRUG__ID D0T6WV D0T6WV DRUGTYPE Small molecular drug D0T6WV DRUGINCH 1S/C18H20N2O/c1-2-3-8-18-19-16-6-4-5-7-17(16)20(18)13-14-9-11-15(21)12-10-14/h4-7,9-12,21H,2-3,8,13H2,1H3 D0T6WV DRUGINKE SSRIUMAFZMGUFE-UHFFFAOYSA-N D0T6WV DRUGSMIL CCCCC1=NC2=CC=CC=C2N1CC3=CC=C(C=C3)O D0T6WV HIGHSTAT Investigative D0T6XB DRUG__ID D0T6XB D0T6XB DRUGTYPE Small molecular drug D0T6XB DRUGINCH 1S/C13H25NO/c1-5-14-13(15)12-8-10(4)6-7-11(12)9(2)3/h9-12H,5-8H2,1-4H3,(H,14,15) D0T6XB DRUGINKE VUNOFAIHSALQQH-UHFFFAOYSA-N D0T6XB DRUGSMIL CCNC(=O)C1CC(CCC1C(C)C)C D0T6XB HIGHSTAT Investigative D0T6XC DRUG__ID D0T6XC D0T6XC DRUGTYPE Small molecular drug D0T6XC DRUGINCH 1S/C16H18N2O2/c17-16(19)11-18-10-13-6-8-15(9-7-13)20-12-14-4-2-1-3-5-14/h1-9,18H,10-12H2,(H2,17,19) D0T6XC DRUGINKE QPCKNQVICWJWJF-UHFFFAOYSA-N D0T6XC DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)CNCC(=O)N D0T6XC HIGHSTAT Investigative D0T6XD DRUG__ID D0T6XD D0T6XD DRUGTYPE Small molecular drug D0T6XD DRUGINCH 1S/C22H27NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,15-16,20-22,24H,8,13-14,17H2,1H3/b16-15+/t20-,21+,22+/m1/s1 D0T6XD DRUGINKE IKYXUFYHDWVXST-XIGZGLEXSA-N D0T6XD DRUGSMIL CN1C(CCCC1C=CC2=CC=CC=C2)CC(C3=CC=CC=C3)O D0T6XD HIGHSTAT Investigative D0T6XM DRUG__ID D0T6XM D0T6XM DRUGTYPE Small molecular drug D0T6XM DRUGINCH 1S/C13H20N4O2/c1-8(2)5-16-11-10(14-7-15-11)12(18)17(13(16)19)6-9(3)4/h7-9H,5-6H2,1-4H3,(H,14,15) D0T6XM DRUGINKE IPUAJXHKDUKOCH-UHFFFAOYSA-N D0T6XM DRUGSMIL CC(C)CN1C2=C(C(=O)N(C1=O)CC(C)C)NC=N2 D0T6XM HIGHSTAT Investigative D0T6XN DRUG__ID D0T6XN D0T6XN DRUGTYPE Small molecular drug D0T6XN DRUGINCH 1S/C10H14N4O11P2/c15-6-4(1-23-26(17,18)19)24-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)25-27(20,21)22/h2-4,6-7,10,15-16H,1H2,(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1 D0T6XN DRUGINKE RXRZOKQPANIEDW-KQYNXXCUSA-N D0T6XN DRUGSMIL C1=NC2=C(C(=N1)OP(=O)(O)O)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O D0T6XN HIGHSTAT Investigative D0T6YJ DRUG__ID D0T6YJ D0T6YJ DRUGTYPE Small molecular drug D0T6YJ DRUGINCH 1S/C11H14ClNO2S/c12-9-3-1-2-8(6-9)7-16-5-4-10(13)11(14)15/h1-3,6,10H,4-5,7,13H2,(H,14,15) D0T6YJ DRUGINKE CHLGWHKXVGUGBH-UHFFFAOYSA-N D0T6YJ DRUGSMIL C1=CC(=CC(=C1)Cl)CSCCC(C(=O)O)N D0T6YJ HIGHSTAT Investigative D0T6ZX DRUG__ID D0T6ZX D0T6ZX DRUGTYPE Small molecular drug D0T6ZX DRUGINCH 1S/H2S/h1H2/p-1 D0T6ZX DRUGINKE RWSOTUBLDIXVET-UHFFFAOYSA-M D0T6ZX DRUGSMIL [SH-] D0T6ZX HIGHSTAT Investigative D0T7AR DRUG__ID D0T7AR D0T7AR DRUGTYPE Small molecular drug D0T7AR DRUGINCH 1S/C11H12ClN3/c12-9-3-1-2-8(6-9)11-14-7-10(15-11)4-5-13/h1-3,6-7H,4-5,13H2,(H,14,15) D0T7AR DRUGINKE DHGUFKPZDMQBED-UHFFFAOYSA-N D0T7AR DRUGSMIL C1=CC(=CC(=C1)Cl)C2=NC=C(N2)CCN D0T7AR HIGHSTAT Investigative D0T7BP DRUG__ID D0T7BP D0T7BP DRUGTYPE Small molecular drug D0T7BP DRUGINCH 1S/C15H16N2O3S/c1-11-3-5-12(6-4-11)16-15(18)17-13-7-9-14(10-8-13)21(2,19)20/h3-10H,1-2H3,(H2,16,17,18) D0T7BP DRUGINKE ZWDYDUJTBVZZLR-UHFFFAOYSA-N D0T7BP DRUGSMIL CC1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)S(=O)(=O)C D0T7BP HIGHSTAT Investigative D0T7BZ DRUG__ID D0T7BZ D0T7BZ DRUGTYPE Small molecular drug D0T7BZ DRUGINCH 1S/C18H17NO/c1-13-6-7-15-8-9-17(11-18(15)19-13)16-5-3-4-14(10-16)12-20-2/h3-11H,12H2,1-2H3 D0T7BZ DRUGINKE JADKCVGREWVUKV-UHFFFAOYSA-N D0T7BZ DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC(=C3)COC D0T7BZ HIGHSTAT Investigative D0T7CB DRUG__ID D0T7CB D0T7CB DRUGTYPE Small molecular drug D0T7CB DRUGINCH 1S/C10H18N3O12P3/c11-8-1-2-13(10(15)12-8)9-3-6(14)7(24-9)4-23-26(16,17)5-27(18,19)25-28(20,21)22/h1-2,6-7,9,14H,3-5H2,(H,16,17)(H,18,19)(H2,11,12,15)(H2,20,21,22)/t6-,7+,9+/m0/s1 D0T7CB DRUGINKE YSCOIIOUWFAHFY-LKEWCRSYSA-N D0T7CB DRUGSMIL C1C(C(OC1N2C=CC(=NC2=O)N)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O D0T7CB HIGHSTAT Investigative D0T7DV DRUG__ID D0T7DV D0T7DV DRUGTYPE Small molecular drug D0T7DV DRUGINCH 1S/C14H23N3O3S2.Na.Zn/c18-13(4-2-1-3-11(22)5-6-21)17-12(14(19)20)7-10-8-15-9-16-10;;/h8-9,11-12,21-22H,1-7H2,(H,15,16)(H,17,18)(H,19,20);;/q;+1;+2/p-3 D0T7DV DRUGINKE GLGKCICLFLDJDO-UHFFFAOYSA-K D0T7DV DRUGSMIL C1=C(NC=N1)CC(C(=O)[O-])NC(=O)CCCCC(CC[S-])[S-].[Na+].[Zn+2] D0T7DV HIGHSTAT Investigative D0T7EJ DRUG__ID D0T7EJ D0T7EJ DRUGTYPE Small molecular drug D0T7EJ DRUGINCH 1S/C16H17ClN2O2/c17-14-3-1-2-13(8-14)11-21-15-6-4-12(5-7-15)9-19-10-16(18)20/h1-8,19H,9-11H2,(H2,18,20) D0T7EJ DRUGINKE ZBEJIFHLSRYHPP-UHFFFAOYSA-N D0T7EJ DRUGSMIL C1=CC(=CC(=C1)Cl)COC2=CC=C(C=C2)CNCC(=O)N D0T7EJ HIGHSTAT Investigative D0T7GC DRUG__ID D0T7GC D0T7GC DRUGTYPE Small molecular drug D0T7GC DRUGINCH 1S/C16H11Cl3F3N3O3/c1-2-28-15(27)10-7-23-25(12(10)16(20,21)22)9-5-3-8(4-6-9)24-14(26)11(17)13(18)19/h3-7H,2H2,1H3,(H,24,26) D0T7GC DRUGINKE RZHGONNSASQOAY-UHFFFAOYSA-N D0T7GC DRUGSMIL CCOC(=O)C1=C(N(N=C1)C2=CC=C(C=C2)NC(=O)C(=C(Cl)Cl)Cl)C(F)(F)F D0T7GC HIGHSTAT Investigative D0T7GG DRUG__ID D0T7GG D0T7GG DRUGTYPE Small molecular drug D0T7GG DRUGINCH 1S/C23H21N3/c1-3-9-16(10-4-1)19-15-20(17-11-5-2-6-12-17)24-23-21(19)25-22(26-23)18-13-7-8-14-18/h1-6,9-12,15,18H,7-8,13-14H2,(H,24,25,26) D0T7GG DRUGINKE LEUPSQCQJOFTFI-UHFFFAOYSA-N D0T7GG DRUGSMIL C1CCC(C1)C2=NC3=C(N2)C(=CC(=N3)C4=CC=CC=C4)C5=CC=CC=C5 D0T7GG HIGHSTAT Investigative D0T7GQ DRUG__ID D0T7GQ D0T7GQ THERCLAS Analgesics D0T7GQ DRUGINCH 1S/C196H280N54O61S6/c1-12-94(4)152-186(303)230-125(71-107-48-56-112(263)57-49-107)169(286)229-126(72-108-77-209-114-34-20-19-33-113(108)114)170(287)228-122(67-103-31-17-14-18-32-103)167(284)227-123(69-105-44-52-110(261)53-45-105)165(282)223-118(38-25-61-208-196(204)205)190(307)248-62-26-40-141(248)183(300)235-133(86-254)177(294)241-139-92-317-316-91-138(181(298)247-157(101(11)259)192(309)250-64-28-39-140(250)182(299)215-95(5)158(275)232-129(193(310)311)75-151(273)274)239-180(297)137-90-315-313-88-135(236-159(276)96(6)216-187(304)154(98(8)256)242-144(265)76-198)179(296)234-132(85-253)176(293)237-134(163(280)213-79-146(267)218-127(73-143(199)264)171(288)233-131(84-252)175(292)221-115(35-21-22-58-197)160(277)211-81-148(269)243-152)87-312-314-89-136(178(295)222-117(37-24-60-207-195(202)203)164(281)225-124(70-106-46-54-111(262)55-47-106)168(285)226-121(66-102-29-15-13-16-30-102)166(283)224-119(65-93(2)3)162(279)212-82-149(270)244-155(99(9)257)188(305)240-137)238-174(291)130(83-251)219-147(268)80-214-185(302)153(97(7)255)245-173(290)120(68-104-42-50-109(260)51-43-104)217-145(266)78-210-161(278)116(36-23-59-206-194(200)201)220-172(289)128(74-150(271)272)231-189(306)156(100(10)258)246-184(301)142-41-27-63-249(142)191(139)308/h13-20,29-34,42-57,77,93-101,115-142,152-157,209,251-263H,12,21-28,35-41,58-76,78-92,197-198H2,1-11H3,(H2,199,264)(H,210,278)(H,211,277)(H,212,279)(H,213,280)(H,214,302)(H,215,299)(H,216,304)(H,217,266)(H,218,267)(H,219,268)(H,220,289)(H,221,292)(H,222,295)(H,223,282)(H,224,283)(H,225,281)(H,226,285)(H,227,284)(H,228,287)(H,229,286)(H,230,303)(H,231,306)(H,232,275)(H,233,288)(H,234,296)(H,235,300)(H,236,276)(H,237,293)(H,238,291)(H,239,297)(H,240,305)(H,241,294)(H,242,265)(H,243,269)(H,244,270)(H,245,290)(H,246,301)(H,247,298)(H,271,272)(H,273,274)(H,310,311)(H4,200,201,206)(H4,202,203,207)(H4,204,205,208) D0T7GQ DRUGINKE HEHYILNFEUDIQC-UHFFFAOYSA-N D0T7GQ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC3CSSCC(NC(=O)C4CSSCC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N4)C(C)O)CC(C)C)CC5=CC=CC=C5)CC6=CC=C(C=C6)O)CCCNC(=N)N)NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C7CCCN7C3=O)C(C)O)CC(=O)O)CCCNC(=N)N)CC8=CC=C(C=C8)O)C(C)O)CO)C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CCCCN)CO)CC(=O)N)CO)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)CN)C(=O)NC(C(C)O)C(=O)N9CCCC9C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)O)CO)CCCNC(=N)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CC1=CC=C(C=C1)O D0T7GQ HIGHSTAT Investigative D0T7IG DRUG__ID D0T7IG D0T7IG DRUGTYPE Small molecular drug D0T7IG DRUGINCH 1S/C14H13ClN4O/c1-3-19-12-9(5-4-8-16-12)14(20)18(2)10-6-7-11(15)17-13(10)19/h4-8H,3H2,1-2H3 D0T7IG DRUGINKE YSEMEGXOKULCML-UHFFFAOYSA-N D0T7IG DRUGSMIL CCN1C2=C(C=CC=N2)C(=O)N(C3=C1N=C(C=C3)Cl)C D0T7IG HIGHSTAT Investigative D0T7LR DRUG__ID D0T7LR D0T7LR DRUGTYPE Small molecular drug D0T7LR DRUGINCH 1S/C15H13NO2/c1-11-3-6-13(7-4-11)18-14-8-5-12(10-16)15(9-14)17-2/h3-9H,1-2H3 D0T7LR DRUGINKE UIOZKPIEPDRGOC-UHFFFAOYSA-N D0T7LR DRUGSMIL CC1=CC=C(C=C1)OC2=CC(=C(C=C2)C#N)OC D0T7LR HIGHSTAT Investigative D0T7QF DRUG__ID D0T7QF D0T7QF DRUGTYPE Small molecular drug D0T7QF DRUGINCH 1S/C11H21NO3/c1-5-6-7-9(8-13)12-10(14)15-11(2,3)4/h8-9H,5-7H2,1-4H3,(H,12,14)/t9-/m0/s1 D0T7QF DRUGINKE OBMGXPJNZKYOQY-VIFPVBQESA-N D0T7QF DRUGSMIL CCCCC(C=O)NC(=O)OC(C)(C)C D0T7QF HIGHSTAT Investigative D0T7QT DRUG__ID D0T7QT D0T7QT DRUGTYPE Small molecular drug D0T7QT DRUGINCH 1S/C10H11N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,7,10,16,18H,1H2,(H2,11,12,13)/t4-,7-,10-/m1/s1 D0T7QT DRUGINKE MIAZJCOESMXYNJ-XMRAEQSQSA-N D0T7QT DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(=O)C(O3)CO)O)N D0T7QT HIGHSTAT Investigative D0T7RY DRUG__ID D0T7RY D0T7RY DRUGTYPE Small molecular drug D0T7RY DRUGINCH 1S/C10H11Cl2N/c11-9-2-1-7-3-5-13-6-4-8(7)10(9)12/h1-2,13H,3-6H2 D0T7RY DRUGINKE WMCWIMZEYWNBOQ-UHFFFAOYSA-N D0T7RY DRUGSMIL C1CNCCC2=C1C=CC(=C2Cl)Cl D0T7RY HIGHSTAT Investigative D0T7SA DRUG__ID D0T7SA D0T7SA DRUGTYPE Small molecular drug D0T7SA DRUGINCH 1S/C18H13NS/c1-14-19-17(13-20-14)12-11-16-9-5-6-10-18(16)15-7-3-2-4-8-15/h2-10,13H,1H3 D0T7SA DRUGINKE BXIUXCNGUNCOFW-UHFFFAOYSA-N D0T7SA DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CC=C2C3=CC=CC=C3 D0T7SA HIGHSTAT Investigative D0T7TB DRUG__ID D0T7TB D0T7TB DRUGTYPE Small molecular drug D0T7TB DRUGINCH 1S/C12H20N4O6/c13-4-9(17)16-5-6(14)3-8(16)11(20)15-7(12(21)22)1-2-10(18)19/h6-8H,1-5,13-14H2,(H,15,20)(H,18,19)(H,21,22)/t6-,7-,8-/m0/s1 D0T7TB DRUGINKE FVOTXFYXMKNJIH-FXQIFTODSA-N D0T7TB DRUGSMIL C1C(CN(C1C(=O)NC(CCC(=O)O)C(=O)O)C(=O)CN)N D0T7TB HIGHSTAT Investigative D0T7UG DRUG__ID D0T7UG D0T7UG DRUGTYPE Small molecular drug D0T7UG DRUGINCH 1S/C18H16N2/c1-2-7-15-12-16(11-14(15)6-1)20-18-17-8-4-3-5-13(17)9-10-19-18/h1-10,16H,11-12H2,(H,19,20) D0T7UG DRUGINKE LJNDWVYBQFLXJV-UHFFFAOYSA-N D0T7UG DRUGSMIL C1C(CC2=CC=CC=C21)NC3=NC=CC4=CC=CC=C43 D0T7UG HIGHSTAT Investigative D0T7UP DRUG__ID D0T7UP D0T7UP DRUGTYPE Small molecular drug D0T7UP DRUGINCH 1S/C4H6FNO2/c1-2(5)3(6)4(7)8/h3H,1,6H2,(H,7,8) D0T7UP DRUGINKE HMOXWHQSNHKKFM-UHFFFAOYSA-N D0T7UP DRUGSMIL C=C(C(C(=O)O)N)F D0T7UP HIGHSTAT Investigative D0T7VA DRUG__ID D0T7VA D0T7VA DRUGTYPE Small molecular drug D0T7VA DRUGINCH 1S/C16H14O3/c1-18-12-8-6-11(7-9-12)16-10-14(17)13-4-2-3-5-15(13)19-16/h2-9,16H,10H2,1H3 D0T7VA DRUGINKE QIUYUYOXCGBABP-UHFFFAOYSA-N D0T7VA DRUGSMIL COC1=CC=C(C=C1)C2CC(=O)C3=CC=CC=C3O2 D0T7VA HIGHSTAT Investigative D0T7VU DRUG__ID D0T7VU D0T7VU DRUGTYPE Small molecular drug D0T7VU DRUGINCH 1S/C14H23NS/c1-5-13(15-11(2)3)10-12-6-8-14(16-4)9-7-12/h6-9,11,13,15H,5,10H2,1-4H3 D0T7VU DRUGINKE JPJSEWJNHDIYAS-UHFFFAOYSA-N D0T7VU DRUGSMIL CCC(CC1=CC=C(C=C1)SC)NC(C)C D0T7VU HIGHSTAT Investigative D0T7VZ DRUG__ID D0T7VZ D0T7VZ DRUGTYPE Small molecular drug D0T7VZ DRUGINCH 1S/C19H22N2/c1-20(2)13-12-17-15-21(14-16-8-4-3-5-9-16)19-11-7-6-10-18(17)19/h3-11,15H,12-14H2,1-2H3 D0T7VZ DRUGINKE QBWKAYAFIXQNCU-UHFFFAOYSA-N D0T7VZ DRUGSMIL CN(C)CCC1=CN(C2=CC=CC=C21)CC3=CC=CC=C3 D0T7VZ HIGHSTAT Investigative D0T7YM DRUG__ID D0T7YM D0T7YM DRUGTYPE Small molecular drug D0T7YM DRUGINCH 1S/C24H39NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-24(26)25-23-20-17-16-18-21-23/h9-10,16-18,20-21H,2-8,11-15,19,22H2,1H3,(H,25,26)/b10-9- D0T7YM DRUGINKE YPUOCYKJOLQYQS-KTKRTIGZSA-N D0T7YM DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC1=CC=CC=C1 D0T7YM HIGHSTAT Investigative D0T8AD DRUG__ID D0T8AD D0T8AD DRUGTYPE Small molecular drug D0T8AD DRUGINCH 1S/C17H19ClN2O3/c18-14-5-1-13(2-6-14)11-23-15-7-3-12(4-8-15)9-20-16(10-21)17(19)22/h1-8,16,20-21H,9-11H2,(H2,19,22)/t16-/m0/s1 D0T8AD DRUGINKE NKJUZCSUSIWWQG-INIZCTEOSA-N D0T8AD DRUGSMIL C1=CC(=CC=C1CNC(CO)C(=O)N)OCC2=CC=C(C=C2)Cl D0T8AD HIGHSTAT Investigative D0T8AJ DRUG__ID D0T8AJ D0T8AJ DRUGTYPE Small molecular drug D0T8AJ DRUGINCH 1S/C18H23N3O3S/c19-25(23,24)20-13-6-2-5-12-18(22)21-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,20H,2,5-6,12-13H2,(H,21,22)(H2,19,23,24) D0T8AJ DRUGINKE XZBFBJMQHOJIMB-UHFFFAOYSA-N D0T8AJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)CCCCCNS(=O)(=O)N D0T8AJ HIGHSTAT Investigative D0T8BU DRUG__ID D0T8BU D0T8BU DRUGTYPE Small molecular drug D0T8BU DRUGINCH 1S/C18H22N2O/c21-17-8-4-5-15(13-17)14-18(16-6-2-1-3-7-16)20-11-9-19-10-12-20/h1-8,13,18-19,21H,9-12,14H2 D0T8BU DRUGINKE VPNYIGJUQBPBMU-UHFFFAOYSA-N D0T8BU DRUGSMIL C1CN(CCN1)C(CC2=CC(=CC=C2)O)C3=CC=CC=C3 D0T8BU HIGHSTAT Investigative D0T8DR DRUG__ID D0T8DR D0T8DR DRUGTYPE Small molecular drug D0T8DR DRUGINCH 1S/C22H24N2O/c1-2-3-4-5-8-17-11-13-18(14-12-17)22(25)24-20-15-19-9-6-7-10-21(19)23-16-20/h6-7,9-16H,2-5,8H2,1H3,(H,24,25) D0T8DR DRUGINKE RTKCLHOLWGNTOT-UHFFFAOYSA-N D0T8DR DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D0T8DR HIGHSTAT Investigative D0T8IK DRUG__ID D0T8IK D0T8IK DRUGTYPE Small molecular drug D0T8IK DRUGINCH 1S/C11H19N2O7P/c1-11(2,3)8-6(4-7(12)10(14)15)9(13-20-8)19-5-21(16,17)18/h7H,4-5,12H2,1-3H3,(H,14,15)(H2,16,17,18)/t7-/m0/s1 D0T8IK DRUGINKE AGSOOCUNMTYPSE-ZETCQYMHSA-N D0T8IK DRUGSMIL CC(C)(C)C1=C(C(=NO1)OCP(=O)(O)O)CC(C(=O)O)N D0T8IK HIGHSTAT Investigative D0T8IS DRUG__ID D0T8IS D0T8IS DRUGTYPE Small molecular drug D0T8IS DRUGINCH 1S/C19H15ClN4O2/c1-10-11(4-3-6-22-10)19(25)24-17-16-13(8-14(20)18(17)26-2)12-5-7-21-9-15(12)23-16/h3-9,23H,1-2H3,(H,24,25) D0T8IS DRUGINKE ZNOLRTPMNMPLHY-UHFFFAOYSA-N D0T8IS DRUGSMIL CC1=C(C=CC=N1)C(=O)NC2=C3C(=CC(=C2OC)Cl)C4=C(N3)C=NC=C4 D0T8IS HIGHSTAT Investigative D0T8JM DRUG__ID D0T8JM D0T8JM DRUGTYPE Small molecular drug D0T8JM DRUGINCH 1S/C27H36F2N2O4/c1-4-6-7-8-9-17-31(26(34)30-24-15-12-21(28)19-23(24)29)18-16-20-10-13-22(14-11-20)35-27(3,5-2)25(32)33/h10-15,19H,4-9,16-18H2,1-3H3,(H,30,34)(H,32,33)/i15T D0T8JM DRUGINKE VGSJXSLGVQINOL-BBSCNJGJSA-N D0T8JM DRUGSMIL CCCCCCCN(CCC1=CC=C(C=C1)OC(C)(CC)C(=O)O)C(=O)NC2=C(C=C(C=C2)F)F D0T8JM HIGHSTAT Investigative D0T8JU DRUG__ID D0T8JU D0T8JU DRUGTYPE Small molecular drug D0T8JU DRUGINCH 1S/C17H16N2O/c1-20-16-9-7-14(8-10-16)12-19-13-18-11-17(19)15-5-3-2-4-6-15/h2-11,13H,12H2,1H3 D0T8JU DRUGINKE AZQFSYIIRUWICT-UHFFFAOYSA-N D0T8JU DRUGSMIL COC1=CC=C(C=C1)CN2C=NC=C2C3=CC=CC=C3 D0T8JU HIGHSTAT Investigative D0T8KR DRUG__ID D0T8KR D0T8KR DRUGTYPE Small molecular drug D0T8KR DRUGINCH 1S/C18H14N4O2/c19-12-4-1-3-11(7-12)16-9-15-17(22-16)20-10-21-18(15)24-14-6-2-5-13(23)8-14/h1-10,23H,19H2,(H,20,21,22) D0T8KR DRUGINKE VPVLEBIVXZSOMQ-UHFFFAOYSA-N D0T8KR DRUGSMIL C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O D0T8KR HIGHSTAT Investigative D0T8LP DRUG__ID D0T8LP D0T8LP DRUGTYPE Small molecular drug D0T8LP DRUGINCH 1S/C9H12N3O7P/c10-5-1-2-12(9(14)11-5)8-6(13)7-4(18-8)3-17-20(15,16)19-7/h1-2,4,6-8,13H,3H2,(H,15,16)(H2,10,11,14)/t4-,6-,7-,8-/m1/s1 D0T8LP DRUGINKE WCPTXJJVVDAEMW-XVFCMESISA-N D0T8LP DRUGSMIL C1C2C(C(C(O2)N3C=CC(=NC3=O)N)O)OP(=O)(O1)O D0T8LP HIGHSTAT Investigative D0T8MM DRUG__ID D0T8MM D0T8MM DRUGTYPE Small molecular drug D0T8MM DRUGINCH 1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-28(18,19)26-29(20,21)27-30(22,23)31/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H,20,21)(H2,11,12,13)(H2,22,23,31)/p-4/t4-,6-,7-,10-/m1/s1/i31+3 D0T8MM DRUGINKE NLTUCYMLOPLUHL-RZDQATCLSA-J D0T8MM DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=S)([O-])[O-])O)O)N D0T8MM HIGHSTAT Investigative D0T8MV DRUG__ID D0T8MV D0T8MV DRUGTYPE Small molecular drug D0T8MV DRUGINCH 1S/C14H21NO/c1-12-4-3-10-15(12)11-9-13-5-7-14(16-2)8-6-13/h5-8,12H,3-4,9-11H2,1-2H3/t12-/m0/s1 D0T8MV DRUGINKE NPUSLESRSBDEHN-LBPRGKRZSA-N D0T8MV DRUGSMIL CC1CCCN1CCC2=CC=C(C=C2)OC D0T8MV HIGHSTAT Investigative D0T8NU DRUG__ID D0T8NU D0T8NU DRUGTYPE Small molecular drug D0T8NU DRUGINCH 1S/C13H14FN5O/c14-3-1-7-6-17-12(20)8-5-10(18-11(7)8)9-2-4-16-13(15)19-9/h2,4-5,7,18H,1,3,6H2,(H,17,20)(H2,15,16,19)/t7-/m0/s1 D0T8NU DRUGINKE LCBAQTCTQXHTJG-ZETCQYMHSA-N D0T8NU DRUGSMIL C1C(C2=C(C=C(N2)C3=NC(=NC=C3)N)C(=O)N1)CCF D0T8NU HIGHSTAT Investigative D0T8OD DRUG__ID D0T8OD D0T8OD DRUGTYPE Small molecular drug D0T8OD DRUGINCH 1S/C14H17ClN4S/c15-12-5-3-11(4-6-12)8-18-14(16)20-7-1-2-13-9-17-10-19-13/h3-6,9-10H,1-2,7-8H2,(H2,16,18)(H,17,19) D0T8OD DRUGINKE UCAIEVHKDLMIFL-UHFFFAOYSA-N D0T8OD DRUGSMIL C1=CC(=CC=C1CN=C(N)SCCCC2=CN=CN2)Cl D0T8OD HIGHSTAT Investigative D0T8RL DRUG__ID D0T8RL D0T8RL DRUGTYPE Small molecular drug D0T8RL DRUGINCH 1S/C14H11FO3/c15-11-6-2-4-8-13(11)18-12-7-3-1-5-10(12)9-14(16)17/h1-8H,9H2,(H,16,17) D0T8RL DRUGINKE LAVKHAMQQVBXLL-UHFFFAOYSA-N D0T8RL DRUGSMIL C1=CC=C(C(=C1)CC(=O)O)OC2=CC=CC=C2F D0T8RL HIGHSTAT Investigative D0T8SD DRUG__ID D0T8SD D0T8SD DRUGTYPE Small molecular drug D0T8SD DRUGINCH 1S/C9H12ClNO4S/c10-8-3-1-7(2-4-8)9(12,5-11)6-16(13,14)15/h1-4,12H,5-6,11H2,(H,13,14,15) D0T8SD DRUGINKE WBSMZVIMANOCNX-UHFFFAOYSA-N D0T8SD DRUGSMIL C1=CC(=CC=C1C(CN)(CS(=O)(=O)O)O)Cl D0T8SD HIGHSTAT Investigative D0T8SN DRUG__ID D0T8SN D0T8SN DRUGTYPE Small molecular drug D0T8SN DRUGINCH 1S/C7H10N2O3S/c1-12-7-4-2-6(3-5-7)9-13(8,10)11/h2-5,9H,1H3,(H2,8,10,11) D0T8SN DRUGINKE ICWBFSCBEZAOCT-UHFFFAOYSA-N D0T8SN DRUGSMIL COC1=CC=C(C=C1)NS(=O)(=O)N D0T8SN HIGHSTAT Investigative D0T8TS DRUG__ID D0T8TS D0T8TS DRUGTYPE Small molecular drug D0T8TS DRUGINCH 1S/C21H21NO2S/c1-2-3-6-15-18(23)24-20-19(16-11-7-4-8-12-16)25-21(22-20)17-13-9-5-10-14-17/h4-5,7-14H,2-3,6,15H2,1H3 D0T8TS DRUGINKE HQKAVFKKTZEFLJ-UHFFFAOYSA-N D0T8TS DRUGSMIL CCCCCC(=O)OC1=C(SC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D0T8TS HIGHSTAT Investigative D0T8UR DRUG__ID D0T8UR D0T8UR DRUGTYPE Small molecular drug D0T8UR DRUGINCH 1S/C12H16N2O/c1-13(2)7-9-8-14(3)10-5-4-6-11(15)12(9)10/h4-6,8,15H,7H2,1-3H3 D0T8UR DRUGINKE QOWUCENJFGRMQC-UHFFFAOYSA-N D0T8UR DRUGSMIL CN1C=C(C2=C1C=CC=C2O)CN(C)C D0T8UR HIGHSTAT Investigative D0T8ZL DRUG__ID D0T8ZL D0T8ZL DRUGTYPE Small molecular drug D0T8ZL DRUGINCH 1S/C11H12O4S/c12-10(13)8-3-1-2-7(4-8)5-9(6-16)11(14)15/h1-4,9,16H,5-6H2,(H,12,13)(H,14,15) D0T8ZL DRUGINKE LQVBVNPZOILYPX-UHFFFAOYSA-N D0T8ZL DRUGSMIL C1=CC(=CC(=C1)C(=O)O)CC(CS)C(=O)O D0T8ZL HIGHSTAT Investigative D0T9BB DRUG__ID D0T9BB D0T9BB DRUGTYPE Small molecular drug D0T9BB DRUGINCH 1S/C13H12O4/c1-3-9(14)12-10(16-2)6-4-8-5-7-11(15)17-13(8)12/h4-7H,3H2,1-2H3 D0T9BB DRUGINKE XQJPTVQKFUWDCL-UHFFFAOYSA-N D0T9BB DRUGSMIL CCC(=O)C1=C(C=CC2=C1OC(=O)C=C2)OC D0T9BB HIGHSTAT Investigative D0T9CW DRUG__ID D0T9CW D0T9CW DRUGTYPE Small molecular drug D0T9CW DRUGINCH 1S/C7H15O9P/c1-7(16-17(12,13)14)6(11)5(10)4(9)3(2-8)15-7/h3-6,8-11H,2H2,1H3,(H2,12,13,14)/t3-,4-,5+,6-,7-/m1/s1 D0T9CW DRUGINKE QZBAZODTRUGOQS-XUUWZHRGSA-N D0T9CW DRUGSMIL CC1(C(C(C(C(O1)CO)O)O)O)OP(=O)(O)O D0T9CW HIGHSTAT Investigative D0T9DI DRUG__ID D0T9DI D0T9DI DRUGTYPE Small molecular drug D0T9DI DRUGINCH 1S/C18H11NO2/c20-16-11-17(13-7-9-19-10-8-13)21-18-14-4-2-1-3-12(14)5-6-15(16)18/h1-11H D0T9DI DRUGINKE LZCOBWKVDSSOBB-UHFFFAOYSA-N D0T9DI DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2OC(=CC3=O)C4=CC=NC=C4 D0T9DI HIGHSTAT Investigative D0T9DS DRUG__ID D0T9DS D0T9DS DRUGTYPE Small molecular drug D0T9DS DRUGINCH 1S/C8H15O3PS/c1-7(2,3)8-4-9-12(13,10-5-8)11-6-8/h4-6H2,1-3H3/i13+3 D0T9DS DRUGINKE VTBHBNXGFPTBJL-DLSVHHIMSA-N D0T9DS DRUGSMIL CC(C)(C)C12COP(=S)(OC1)OC2 D0T9DS HIGHSTAT Investigative D0T9FE DRUG__ID D0T9FE D0T9FE DRUGTYPE Small molecular drug D0T9FE DRUGINCH 1S/C16H10FN3O2/c17-8-5-6-12-10(7-8)13(16(21)19-12)15-14(20-22)9-3-1-2-4-11(9)18-15/h1-7,18-19,21H D0T9FE DRUGINKE LAPHNLUPQPQSKF-UHFFFAOYSA-N D0T9FE DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C(NC4=C3C=C(C=C4)F)O)N=O D0T9FE HIGHSTAT Investigative D0T9FQ DRUG__ID D0T9FQ D0T9FQ DRUGTYPE Small molecular drug D0T9FQ DRUGINCH 1S/C16H14N2O2/c1-19-15-8-12-7-13(11-3-5-17-6-4-11)10-18-14(12)9-16(15)20-2/h3-10H,1-2H3 D0T9FQ DRUGINKE GDUOSVIOUNAARR-UHFFFAOYSA-N D0T9FQ DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CC=NC=C3 D0T9FQ HIGHSTAT Investigative D0T9IK DRUG__ID D0T9IK D0T9IK DRUGTYPE Small molecular drug D0T9IK DRUGINCH 1S/C15H15NO2/c1-17-14-9-13(10-15(11-14)18-2)4-3-12-5-7-16-8-6-12/h3-11H,1-2H3/b4-3+ D0T9IK DRUGINKE HXJQPOSPRKZPGS-ONEGZZNKSA-N D0T9IK DRUGSMIL COC1=CC(=CC(=C1)C=CC2=CC=NC=C2)OC D0T9IK HIGHSTAT Investigative D0T9KE DRUG__ID D0T9KE D0T9KE DRUGTYPE Small molecular drug D0T9KE DRUGINCH 1S/C25H27NO2/c1-28-23-15-9-8-14-22(23)25(27)16-18-26(19-17-25)24(20-10-4-2-5-11-20)21-12-6-3-7-13-21/h2-15,24,27H,16-19H2,1H3 D0T9KE DRUGINKE MMHFMRZIXGSYBY-UHFFFAOYSA-N D0T9KE DRUGSMIL COC1=CC=CC=C1C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D0T9KE HIGHSTAT Investigative D0T9NX DRUG__ID D0T9NX D0T9NX DRUGTYPE Small molecular drug D0T9NX DRUGINCH 1S/C17H21N3O2S/c1-14-5-7-16(8-6-14)23(21,22)20-12-10-19(11-13-20)17-15(2)4-3-9-18-17/h3-9H,10-13H2,1-2H3 D0T9NX DRUGINKE VJVLLYXNCKJIIY-UHFFFAOYSA-N D0T9NX DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=C(C=CC=N3)C D0T9NX HIGHSTAT Investigative D0T9NZ DRUG__ID D0T9NZ D0T9NZ DRUGTYPE Small molecular drug D0T9NZ DRUGINCH 1S/C34H66N12O10S2/c35-11-1-3-13-39-15-5-17-41-29(49)19-43-31(51)25(45-27(47)9-7-23(37)33(53)54)21-57-58-22-26(46-28(48)10-8-24(38)34(55)56)32(52)44-20-30(50)42-18-6-16-40-14-4-2-12-36/h23-26,39-40H,1-22,35-38H2,(H,41,49)(H,42,50)(H,43,51)(H,44,52)(H,45,47)(H,46,48)(H,53,54)(H,55,56)/t23-,24-,25+,26+/m1/s1 D0T9NZ DRUGINKE HCMZDPYSWPSKSP-XPGKHFPBSA-N D0T9NZ DRUGSMIL C(CCNCCCNC(=O)CNC(=O)C(CSSCC(C(=O)NCC(=O)NCCCNCCCCN)NC(=O)CCC(C(=O)O)N)NC(=O)CCC(C(=O)O)N)CN D0T9NZ HIGHSTAT Investigative D0T9PE DRUG__ID D0T9PE D0T9PE DRUGTYPE Small molecular drug D0T9PE DRUGINCH 1S/C12H13N3OS2/c16-10-4-2-1-3-9(10)5-6-13-11(17)15-12-14-7-8-18-12/h1-4,7-8,16H,5-6H2,(H2,13,14,15,17) D0T9PE DRUGINKE PRHAOTURKTZAEQ-UHFFFAOYSA-N D0T9PE DRUGSMIL C1=CC=C(C(=C1)CCNC(=S)NC2=NC=CS2)O D0T9PE HIGHSTAT Investigative D0T9QW DRUG__ID D0T9QW D0T9QW DRUGTYPE Small molecular drug D0T9QW DRUGINCH 1S/C19H17ClN2O4/c1-11-15(10-18(23)21-25)16-9-14(26-2)7-8-17(16)22(11)19(24)12-3-5-13(20)6-4-12/h3-9,25H,10H2,1-2H3,(H,21,23) D0T9QW DRUGINKE AJRNYCDWNITGHF-UHFFFAOYSA-N D0T9QW DRUGSMIL CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)NO D0T9QW HIGHSTAT Investigative D0T9RD DRUG__ID D0T9RD D0T9RD DRUGTYPE Small molecular drug D0T9RD DRUGINCH 1S/C30H51NO/c1-6-7-8-9-10-11-12-13-14-16-20-27(25(2)3)21-19-24-29(26(4)5)30(32)31-28-22-17-15-18-23-28/h13-15,17-18,22-23,25-27,29H,6-12,16,19-21,24H2,1-5H3,(H,31,32)/b14-13- D0T9RD DRUGINKE HUQXXTSZFWLRDE-YPKPFQOOSA-N D0T9RD DRUGSMIL CCCCCCCCC=CCCC(CCCC(C(C)C)C(=O)NC1=CC=CC=C1)C(C)C D0T9RD HIGHSTAT Investigative D0T9SK DRUG__ID D0T9SK D0T9SK DRUGTYPE Small molecular drug D0T9SK DRUGINCH 1S/C4H12N/c1-5(2,3)4/h1-4H3/q+1 D0T9SK DRUGINKE QEMXHQIAXOOASZ-UHFFFAOYSA-N D0T9SK DRUGSMIL C[N+](C)(C)C D0T9SK HIGHSTAT Investigative D0T9TC DRUG__ID D0T9TC D0T9TC DRUGTYPE Small molecular drug D0T9TC DRUGINCH 1S/C19H18N2O2/c1-12-9-16-15(14-7-8-20-19(22)18(14)21-16)10-17(12)23-11-13-5-3-2-4-6-13/h2-6,9-10,21H,7-8,11H2,1H3,(H,20,22) D0T9TC DRUGINKE DYTMNPUOZGPWQA-UHFFFAOYSA-N D0T9TC DRUGSMIL CC1=CC2=C(C=C1OCC3=CC=CC=C3)C4=C(N2)C(=O)NCC4 D0T9TC HIGHSTAT Investigative D0T9VC DRUG__ID D0T9VC D0T9VC DRUGTYPE Small molecular drug D0T9VC DRUGINCH 1S/C25H26F3N3O2S/c1-15-6-12-20-22(16(15)2)31(14-17-7-13-21(25(26,27)28)30-23(17)29-20)34(32,33)19-10-8-18(9-11-19)24(3,4)5/h6-13H,14H2,1-5H3,(H,29,30) D0T9VC DRUGINKE OAIVSBLLDFJYMS-UHFFFAOYSA-N D0T9VC DRUGSMIL CC1=C(C2=C(C=C1)NC3=C(CN2S(=O)(=O)C4=CC=C(C=C4)C(C)(C)C)C=CC(=N3)C(F)(F)F)C D0T9VC HIGHSTAT Investigative D0T9WZ DRUG__ID D0T9WZ D0T9WZ DRUGTYPE Small molecular drug D0T9WZ DRUGINCH 1S/C23H15ClN2/c24-16-10-11-22-19(12-16)18(15-6-2-1-3-7-15)13-23(26-22)20-14-25-21-9-5-4-8-17(20)21/h1-14,25H D0T9WZ DRUGINKE LTUZPODERZUPRD-UHFFFAOYSA-N D0T9WZ DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC3=C2C=C(C=C3)Cl)C4=CNC5=CC=CC=C54 D0T9WZ HIGHSTAT Investigative D0T9ZL DRUG__ID D0T9ZL D0T9ZL DRUGTYPE Small molecular drug D0T9ZL DRUGINCH 1S/C21H18NO4/c1-22-10-16-13(6-7-17(23-2)21(16)24-3)14-5-4-12-8-18-19(26-11-25-18)9-15(12)20(14)22/h4-10H,11H2,1-3H3/q+1 D0T9ZL DRUGINKE LLEJIEBFSOEYIV-UHFFFAOYSA-N D0T9ZL DRUGSMIL C[N+]1=C2C(=C3C=CC(=C(C3=C1)OC)OC)C=CC4=CC5=C(C=C42)OCO5 D0T9ZL HIGHSTAT Investigative D0T9ZN DRUG__ID D0T9ZN D0T9ZN DRUGTYPE Small molecular drug D0T9ZN DRUGINCH 1S/C21H38N2O2/c1-2-3-4-5-7-19(24)8-6-9-22-20(25)23-21-13-16-10-17(14-21)12-18(11-16)15-21/h16-19,24H,2-15H2,1H3,(H2,22,23,25) D0T9ZN DRUGINKE BQABXUIGNYSGOR-UHFFFAOYSA-N D0T9ZN DRUGSMIL CCCCCCC(CCCNC(=O)NC12CC3CC(C1)CC(C3)C2)O D0T9ZN HIGHSTAT Investigative D0T9ZQ DRUG__ID D0T9ZQ D0T9ZQ DRUGTYPE Small molecular drug D0T9ZQ DRUGINCH 1S/C7H5ClN2/c8-6-1-2-7-5(3-6)4-9-10-7/h1-4H,(H,9,10) D0T9ZQ DRUGINKE FVNCILPDWNBPLK-UHFFFAOYSA-N D0T9ZQ DRUGSMIL C1=CC2=C(C=C1Cl)C=NN2 D0T9ZQ HIGHSTAT Investigative D0TA0J DRUG__ID D0TA0J D0TA0J DRUGTYPE Small molecular drug D0TA0J DRUGINCH 1S/C16H12O2S/c17-13-5-1-3-11(9-13)15-7-8-16(19-15)12-4-2-6-14(18)10-12/h1-10,17-18H D0TA0J DRUGINKE SVBBCXVMACPXGW-UHFFFAOYSA-N D0TA0J DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC(=CC=C3)O D0TA0J HIGHSTAT Investigative D0TA0L DRUG__ID D0TA0L D0TA0L DRUGTYPE Small molecular drug D0TA0L DRUGINCH 1S/C30H27NO4.Na/c32-27(33)20-34-25-16-9-10-21(19-25)18-24-15-7-8-17-26(24)30-31-28(22-11-3-1-4-12-22)29(35-30)23-13-5-2-6-14-23;/h1-6,9-14,16-17,19,24H,7-8,15,18,20H2,(H,32,33);/q;+1/p-1/t24-;/m0./s1 D0TA0L DRUGINKE DPECFBBZFTXROT-JIDHJSLPSA-M D0TA0L DRUGSMIL C1CC=C(C(C1)CC2=CC(=CC=C2)OCC(=O)[O-])C3=NC(=C(O3)C4=CC=CC=C4)C5=CC=CC=C5.[Na+] D0TA0L HIGHSTAT Investigative D0TA8F DRUG__ID D0TA8F D0TA8F DRUGTYPE Small molecular drug D0TA8F DRUGINCH 1S/C37H38N2O7/c1-38-12-11-22-18-32(45-5)36(42)37-33(22)27(38)15-20-6-9-29(43-3)26(14-20)25-16-23(7-8-28(25)40)35(41)34-24-19-31(46-37)30(44-4)17-21(24)10-13-39(34)2/h6-9,14,16-19,27,34,40,42H,10-13,15H2,1-5H3/t27-,34-/m0/s1 D0TA8F DRUGINKE XCZPVAXCZZECDL-FOPBOCKXSA-N D0TA8F DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C4)OC)C5=C(C=CC(=C5)C(=O)C6C7=CC(=C(C=C7CCN6C)OC)O3)O)O)OC D0TA8F HIGHSTAT Investigative D0TB1E DRUG__ID D0TB1E D0TB1E DRUGTYPE Small molecular drug D0TB1E DRUGINCH 1S/C17H16O2/c1-11-3-6-13(7-4-11)16-10-15(18)14-8-5-12(2)9-17(14)19-16/h3-9,16H,10H2,1-2H3/t16-/m0/s1 D0TB1E DRUGINKE MIEPNGHJBCGJAW-INIZCTEOSA-N D0TB1E DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)C D0TB1E HIGHSTAT Investigative D0TB4A DRUG__ID D0TB4A D0TB4A DRUGTYPE Small molecular drug D0TB4A DRUGINCH 1S/C37H47N5O5/c1-5-26-14-9-11-22(2)29(26)21-32(35(45)40-31(34(39)44)19-25-12-7-6-8-13-25)41-36(46)33-15-10-16-42(33)37(47)30(38)20-28-23(3)17-27(43)18-24(28)4/h6-9,11-14,17-18,30-33,43H,5,10,15-16,19-21,38H2,1-4H3,(H2,39,44)(H,40,45)(H,41,46)/t30-,31-,32-,33-/m0/s1 D0TB4A DRUGINKE FZEQHIVEBCRYJC-YRCZKMHPSA-N D0TB4A DRUGSMIL CCC1=CC=CC(=C1CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N)C D0TB4A HIGHSTAT Investigative D0TC1E DRUG__ID D0TC1E D0TC1E DRUGTYPE Small molecular drug D0TC1E DRUGINCH 1S/C31H34F2N3O6P/c1-21(37)34-28(19-22-12-16-26(17-13-22)31(32,33)43(40,41)42)29(38)35-27-9-5-6-18-36(30(27)39)20-23-10-14-25(15-11-23)24-7-3-2-4-8-24/h2-4,7-8,10-17,27-28H,5-6,9,18-20H2,1H3,(H,34,37)(H,35,38)(H2,40,41,42)/t27-,28-/m0/s1 D0TC1E DRUGINKE LVZDQVATAQEMCX-NSOVKSMOSA-N D0TC1E DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)C(F)(F)P(=O)(O)O)C(=O)NC2CCCCN(C2=O)CC3=CC=C(C=C3)C4=CC=CC=C4 D0TC1E HIGHSTAT Investigative D0TC4I DRUG__ID D0TC4I D0TC4I DRUGTYPE Small molecular drug D0TC4I DRUGINCH 1S/C18H30N2O2/c1-2-3-4-5-6-7-8-15-9-11-16(12-10-15)20-18(22)17(19)13-14-21/h9-12,17,21H,2-8,13-14,19H2,1H3,(H,20,22)/t17-/m0/s1 D0TC4I DRUGINKE QJTVTVAQRCRXSM-KRWDZBQOSA-N D0TC4I DRUGSMIL CCCCCCCCC1=CC=C(C=C1)NC(=O)C(CCO)N D0TC4I HIGHSTAT Investigative D0TC4Z DRUG__ID D0TC4Z D0TC4Z DRUGTYPE Small molecular drug D0TC4Z DRUGINCH 1S/C15H27O4P/c1-12(2)7-5-8-13(3)9-6-10-14(4)11-15(16)20(17,18)19/h7,9,11,15-16H,5-6,8,10H2,1-4H3,(H2,17,18,19)/b13-9+,14-11+ D0TC4Z DRUGINKE MONZTFSZTWQCKH-IJFRVEDASA-N D0TC4Z DRUGSMIL CC(=CCCC(=CCCC(=CC(O)P(=O)(O)O)C)C)C D0TC4Z HIGHSTAT Investigative D0TC5E DRUG__ID D0TC5E D0TC5E DRUGTYPE Small molecular drug D0TC5E DRUGINCH 1S/C6H11N3/c1-5-8-4-6(9-5)2-3-7/h4H,2-3,7H2,1H3,(H,8,9) D0TC5E DRUGINKE XDKYTXBAVJELDQ-UHFFFAOYSA-N D0TC5E DRUGSMIL CC1=NC=C(N1)CCN D0TC5E HIGHSTAT Investigative D0TC5H DRUG__ID D0TC5H D0TC5H DRUGTYPE Small molecular drug D0TC5H DRUGINCH 1S/C15H15N5O2/c21-11-3-1-2-10(8-11)13-18-14-12(16-9-17-14)15(19-13)20-4-6-22-7-5-20/h1-3,8-9,21H,4-7H2,(H,16,17,18,19) D0TC5H DRUGINKE FUDQNOGEMXSUSQ-UHFFFAOYSA-N D0TC5H DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC(=CC=C4)O D0TC5H HIGHSTAT Investigative D0TC7N DRUG__ID D0TC7N D0TC7N DRUGTYPE Small molecular drug D0TC7N DRUGINCH 1S/C20H20N6O4/c1-2-22-19(29)16-14(27)15(28)20(30-16)26-10-23-13-17(21)24-12(25-18(13)26)9-8-11-6-4-3-5-7-11/h3-7,10,14-16,20,27-28H,2H2,1H3,(H,22,29)(H2,21,24,25)/t14-,15+,16-,20+/m0/s1 D0TC7N DRUGINKE SWXXHYTUMIMRFO-KSVNGYGVSA-N D0TC7N DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)C#CC4=CC=CC=C4)N)O)O D0TC7N HIGHSTAT Investigative D0TD2F DRUG__ID D0TD2F D0TD2F DRUGTYPE Small molecular drug D0TD2F DRUGINCH 1S/C42H58N6O7S/c49-38(27-39(50)43-13-14-47-15-19-54-20-16-47)36(23-30-7-2-1-3-8-30)45-42(53)37(26-34-28-56-29-44-34)46-41(52)33(25-40(51)48-17-21-55-22-18-48)24-32-11-6-10-31-9-4-5-12-35(31)32/h4-6,9-12,28-30,33,36-38,49H,1-3,7-8,13-27H2,(H,43,50)(H,45,53)(H,46,52)/t33-,36+,37+,38+/m1/s1 D0TD2F DRUGINKE UACWUNAXAAUHDZ-MVPOBJIPSA-N D0TD2F DRUGSMIL C1CCC(CC1)CC(C(CC(=O)NCCN2CCOCC2)O)NC(=O)C(CC3=CSC=N3)NC(=O)C(CC4=CC=CC5=CC=CC=C54)CC(=O)N6CCOCC6 D0TD2F HIGHSTAT Investigative D0TE5Q DRUG__ID D0TE5Q D0TE5Q DRUGTYPE Small molecular drug D0TE5Q DRUGINCH 1S/C15H21N/c1-2-7-13(8-3-1)14-9-6-12-16-11-5-4-10-15(14)16/h1-3,7-8,14-15H,4-6,9-12H2/t14-,15-/m1/s1 D0TE5Q DRUGINKE OUZYKKYJPBLWGM-HUUCEWRRSA-N D0TE5Q DRUGSMIL C1CCN2CCCC(C2C1)C3=CC=CC=C3 D0TE5Q HIGHSTAT Investigative D0TE9B DRUG__ID D0TE9B D0TE9B DRUGTYPE Small molecular drug D0TE9B DRUGINCH 1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m1/s1 D0TE9B DRUGINKE ONIBWKKTOPOVIA-SCSAIBSYSA-N D0TE9B DRUGSMIL C1CC(NC1)C(=O)O D0TE9B HIGHSTAT Investigative D0TF0V DRUG__ID D0TF0V D0TF0V DRUGTYPE Small molecular drug D0TF0V DRUGINCH 1S/C8H8N2O2/c11-6-2-4-10-8(12)7-5(6)1-3-9-7/h1,3,9H,2,4H2,(H,10,12) D0TF0V DRUGINKE AAPGLCCSVSGLFH-UHFFFAOYSA-N D0TF0V DRUGSMIL C1CNC(=O)C2=C(C1=O)C=CN2 D0TF0V HIGHSTAT Investigative D0TF9P DRUG__ID D0TF9P D0TF9P DRUGTYPE Small molecular drug D0TF9P DRUGINCH 1S/C14H9BrN2OS/c15-7-1-2-10-8(5-7)9-6-12(18)16-11-3-4-19-14(11)13(9)17-10/h1-5,17H,6H2,(H,16,18) D0TF9P DRUGINKE XLKHCIUFNPNLIE-UHFFFAOYSA-N D0TF9P DRUGSMIL C1C2=C(C3=C(C=CS3)NC1=O)NC4=C2C=C(C=C4)Br D0TF9P HIGHSTAT Investigative D0TF9R DRUG__ID D0TF9R D0TF9R DRUGTYPE Small molecular drug D0TF9R DRUGINCH 1S/C13H16N2OS/c1-8(2)11-12(16)15-13(17-11)14-10-7-5-4-6-9(10)3/h4-8,16H,1-3H3,(H,14,15) D0TF9R DRUGINKE CSOPFNOFIZHDML-UHFFFAOYSA-N D0TF9R DRUGSMIL CC1=CC=CC=C1NC2=NC(=C(S2)C(C)C)O D0TF9R HIGHSTAT Investigative D0TG0I DRUG__ID D0TG0I D0TG0I DRUGTYPE Small molecular drug D0TG0I DRUGINCH 1S/C18H19N3O2S/c22-24(23,15-5-2-1-3-6-15)21-12-9-16-17(7-4-8-18(16)21)20-13-10-19-11-14-20/h1-9,12,19H,10-11,13-14H2 D0TG0I DRUGINKE OPAMDWUUNKYGOR-UHFFFAOYSA-N D0TG0I DRUGSMIL C1CN(CCN1)C2=CC=CC3=C2C=CN3S(=O)(=O)C4=CC=CC=C4 D0TG0I HIGHSTAT Investigative D0TH6L DRUG__ID D0TH6L D0TH6L DRUGTYPE Small molecular drug D0TH6L DRUGINCH 1S/C17H17N3S/c1-3-7-15-13(5-1)17(20-11-9-18-10-12-20)19-14-6-2-4-8-16(14)21-15/h1-8,18H,9-12H2 D0TH6L DRUGINKE JLOAJISUHPIQOX-UHFFFAOYSA-N D0TH6L DRUGSMIL C1CN(CCN1)C2=NC3=CC=CC=C3SC4=CC=CC=C42 D0TH6L HIGHSTAT Investigative D0TH7L DRUG__ID D0TH7L D0TH7L DRUGTYPE Small molecular drug D0TH7L DRUGINCH 1S/C18H21NO4/c1-2-3-4-5-8-14-11-12-18(16(20)13-14)23-17-10-7-6-9-15(17)19(21)22/h6-7,9-13,20H,2-5,8H2,1H3 D0TH7L DRUGINKE ASCHWJRXPZBPHV-UHFFFAOYSA-N D0TH7L DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC=C2[N+](=O)[O-])O D0TH7L HIGHSTAT Investigative D0TH7S DRUG__ID D0TH7S D0TH7S DRUGTYPE Small molecular drug D0TH7S DRUGINCH 1S/C14H10ClN3O/c15-11-6-1-2-7-12(11)18-8-9-4-3-5-10(14(16)19)13(9)17-18/h1-8H,(H2,16,19) D0TH7S DRUGINKE CYJGVBUKZAGGCY-UHFFFAOYSA-N D0TH7S DRUGSMIL C1=CC=C(C(=C1)N2C=C3C=CC=C(C3=N2)C(=O)N)Cl D0TH7S HIGHSTAT Investigative D0TH8D DRUG__ID D0TH8D D0TH8D DRUGTYPE Small molecular drug D0TH8D DRUGINCH 1S/C14H17N3O/c1-18-12-4-2-3-11-5-6-13(16-14(11)12)17-9-7-15-8-10-17/h2-6,15H,7-10H2,1H3 D0TH8D DRUGINKE CUULVNAZRYFNIT-UHFFFAOYSA-N D0TH8D DRUGSMIL COC1=CC=CC2=C1N=C(C=C2)N3CCNCC3 D0TH8D HIGHSTAT Investigative D0TH8E DRUG__ID D0TH8E D0TH8E DRUGTYPE Small molecular drug D0TH8E DRUGINCH 1S/C22H27NO7S/c1-21(2,3)20(24)28-15-7-5-12-11-14-13-6-8-16(30-31(25,26)27)19-22(13,9-10-23(14)4)17(12)18(15)29-19/h5-8,13-14,16,19H,9-11H2,1-4H3,(H,25,26,27)/t13-,14+,16-,19-,22-/m0/s1 D0TH8E DRUGINKE NEUKRIIKAHFBFQ-JYSMHPMOSA-N D0TH8E DRUGSMIL CC(C)(C)C(=O)OC1=C2C3=C(CC4C5C3(CC[NH+]4C)C(O2)C(C=C5)OS(=O)(=O)[O-])C=C1 D0TH8E HIGHSTAT Investigative D0TJ2L DRUG__ID D0TJ2L D0TJ2L DRUGTYPE Small molecular drug D0TJ2L DRUGINCH 1S/C15H15N3O3/c1-3-21-15(20)13-12-8-17(2)14(19)10-6-4-5-7-11(10)18(12)9-16-13/h4-7,9H,3,8H2,1-2H3 D0TJ2L DRUGINKE HNGRWUCKESPKRC-UHFFFAOYSA-N D0TJ2L DRUGSMIL CCOC(=O)C1=C2CN(C(=O)C3=CC=CC=C3N2C=N1)C D0TJ2L HIGHSTAT Investigative D0TJ6Z DRUG__ID D0TJ6Z D0TJ6Z DRUGTYPE Small molecular drug D0TJ6Z DRUGINCH 1S/C13H11N3S/c1-2-4-10(5-3-1)12-8-17-13(16-12)6-11-7-14-9-15-11/h1-5,7-9H,6H2,(H,14,15) D0TJ6Z DRUGINKE TVRYIDIUBFYXFE-UHFFFAOYSA-N D0TJ6Z DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)CC3=CN=CN3 D0TJ6Z HIGHSTAT Investigative D0TJ7R DRUG__ID D0TJ7R D0TJ7R DRUGTYPE Small molecular drug D0TJ7R DRUGINCH 1S/C18H21NO/c20-18(17-9-5-2-6-10-17)11-13-19(14-12-18)15-16-7-3-1-4-8-16/h1-10,20H,11-15H2 D0TJ7R DRUGINKE FCLMXEAPEVBCKQ-UHFFFAOYSA-N D0TJ7R DRUGSMIL C1CN(CCC1(C2=CC=CC=C2)O)CC3=CC=CC=C3 D0TJ7R HIGHSTAT Investigative D0TK4X DRUG__ID D0TK4X D0TK4X DRUGTYPE Small molecular drug D0TK4X DRUGINCH 1S/C15H14Cl4O6P2/c16-11-3-1-9(13(18)5-11)7-15(26(20,21)22,27(23,24)25)8-10-2-4-12(17)6-14(10)19/h1-6H,7-8H2,(H2,20,21,22)(H2,23,24,25) D0TK4X DRUGINKE HOUGVWVFZPBNCB-UHFFFAOYSA-N D0TK4X DRUGSMIL C1=CC(=C(C=C1Cl)Cl)CC(CC2=C(C=C(C=C2)Cl)Cl)(P(=O)(O)O)P(=O)(O)O D0TK4X HIGHSTAT Investigative D0TL0V DRUG__ID D0TL0V D0TL0V DRUGTYPE Small molecular drug D0TL0V DRUGINCH 1S/C30H47NO3/c1-25(2)21-10-13-30(7)22(28(21,5)12-11-23(25)31-34)9-8-19-20-18-27(4,24(32)33)15-14-26(20,3)16-17-29(19,30)6/h8,20-23H,9-18H2,1-7H3,(H,32,33)/t20-,21-,22+,23?,26+,27+,28-,29+,30+/m0/s1 D0TL0V DRUGINKE WINMXRJYKUPMJI-DEXHSINNSA-N D0TL0V DRUGSMIL CC1(C2CCC3(C(C2(CCC1N=O)C)CC=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C D0TL0V HIGHSTAT Investigative D0TL3N DRUG__ID D0TL3N D0TL3N DRUGTYPE Small molecular drug D0TL3N DRUGINCH 1S/C18H20O3/c1-21-17(13-18(19)20)12-9-14-7-10-16(11-8-14)15-5-3-2-4-6-15/h2-8,10-11,17H,9,12-13H2,1H3,(H,19,20) D0TL3N DRUGINKE KYPWLTXIHUQMGA-UHFFFAOYSA-N D0TL3N DRUGSMIL COC(CCC1=CC=C(C=C1)C2=CC=CC=C2)CC(=O)O D0TL3N HIGHSTAT Investigative D0TL3S DRUG__ID D0TL3S D0TL3S DRUGTYPE Small molecular drug D0TL3S DRUGINCH 1S/C17H14O5/c1-10(18)9-21-14-8-7-12-11-5-3-4-6-13(11)17(19)22-15(12)16(14)20-2/h3-8H,9H2,1-2H3 D0TL3S DRUGINKE KXJLOTAAVRETIT-UHFFFAOYSA-N D0TL3S DRUGSMIL CC(=O)COC1=C(C2=C(C=C1)C3=CC=CC=C3C(=O)O2)OC D0TL3S HIGHSTAT Investigative D0TL4O DRUG__ID D0TL4O D0TL4O DRUGTYPE Small molecular drug D0TL4O DRUGINCH 1S/C28H23F6N3O2/c1-15-7-9-17(10-8-15)22-21-6-5-11-35-23(21)25(38)37(4)24(22)26(39)36(3)16(2)18-12-19(27(29,30)31)14-20(13-18)28(32,33)34/h5-14,16H,1-4H3/t16-/m0/s1 D0TL4O DRUGINKE TTZWDLZPHOQUAU-INIZCTEOSA-N D0TL4O DRUGSMIL CC1=CC=C(C=C1)C2=C(N(C(=O)C3=C2C=CC=N3)C)C(=O)N(C)C(C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D0TL4O HIGHSTAT Investigative D0TL6C DRUG__ID D0TL6C D0TL6C DRUGTYPE Small molecular drug D0TL6C DRUGINCH 1S/C109H164N38O22S4/c110-40-6-3-17-72-90(155)131-54-87(152)132-78(48-59-24-32-64(148)33-25-59)96(161)146-85-57-172-171-56-84(102(167)140-79(97(162)135-72)49-60-26-34-65(149)35-27-60)145-95(160)74(19-5-8-42-112)137-92(157)77(23-13-47-129-109(123)124)139-99(164)81(51-62-30-38-67(151)39-31-62)142-104(169)86(147-100(165)82(52-63-53-130-70-16-2-1-14-68(63)70)143-93(158)75(21-11-45-127-107(119)120)134-89(154)69(113)15-9-43-125-105(115)116)58-173-170-55-83(101(166)133-71(88(114)153)20-10-44-126-106(117)118)144-94(159)73(18-4-7-41-111)136-91(156)76(22-12-46-128-108(121)122)138-98(163)80(141-103(85)168)50-61-28-36-66(150)37-29-61/h1-2,14,16,24-39,53,69,71-86,130,148-151H,3-13,15,17-23,40-52,54-58,110-113H2,(H2,114,153)(H,131,155)(H,132,152)(H,133,166)(H,134,154)(H,135,162)(H,136,156)(H,137,157)(H,138,163)(H,139,164)(H,140,167)(H,141,168)(H,142,169)(H,143,158)(H,144,159)(H,145,160)(H,146,161)(H,147,165)(H4,115,116,125)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)(H4,123,124,129)/t69-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-/m0/s1 D0TL6C DRUGINKE MJULKHZUJYASFR-FQPMSUGVSA-N D0TL6C DRUGSMIL C1C2C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSS1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CCCCN)CCCNC(=N)N)CC3=CC=C(C=C3)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N)C(=O)NC(CCCNC(=N)N)C(=O)N)CCCCN)CCCNC(=N)N)CC6=CC=C(C=C6)O)CC7=CC=C(C=C7)O)CCCCN)CC8=CC=C(C=C8)O D0TL6C HIGHSTAT Investigative D0TM0N DRUG__ID D0TM0N D0TM0N DRUGTYPE Small molecular drug D0TM0N DRUGINCH 1S/C17H20N2O2/c1-14(20)18-12-13-19(15-6-4-3-5-7-15)16-8-10-17(21-2)11-9-16/h3-11H,12-13H2,1-2H3,(H,18,20) D0TM0N DRUGINKE PWTCGLHUMIIRML-UHFFFAOYSA-N D0TM0N DRUGSMIL CC(=O)NCCN(C1=CC=CC=C1)C2=CC=C(C=C2)OC D0TM0N HIGHSTAT Investigative D0TM0Z DRUG__ID D0TM0Z D0TM0Z DRUGTYPE Small molecular drug D0TM0Z DRUGINCH 1S/C8H5NO2/c10-6-1-2-7(11)8-5(6)3-4-9-8/h1-4,9H D0TM0Z DRUGINKE QMRIWYCCTCNABA-UHFFFAOYSA-N D0TM0Z DRUGSMIL C1=CC(=O)C2=C(C1=O)C=CN2 D0TM0Z HIGHSTAT Investigative D0TM1Z DRUG__ID D0TM1Z D0TM1Z DRUGTYPE Small molecular drug D0TM1Z DRUGINCH 1S/C14H15NO2/c1-11-6-7-13(16-2)14(9-11)17-10-12-5-3-4-8-15-12/h3-9H,10H2,1-2H3 D0TM1Z DRUGINKE AVXQTLSOXWQOHO-UHFFFAOYSA-N D0TM1Z DRUGSMIL CC1=CC(=C(C=C1)OC)OCC2=CC=CC=N2 D0TM1Z HIGHSTAT Investigative D0TM4K DRUG__ID D0TM4K D0TM4K DRUGTYPE Small molecular drug D0TM4K DRUGINCH 1S/C16H15N/c1-12-9-14(10-13-5-4-8-17-11-13)16-7-3-2-6-15(12)16/h2-8,10-12H,9H2,1H3/b14-10+ D0TM4K DRUGINKE KMRIBBKLCIMDTB-GXDHUFHOSA-N D0TM4K DRUGSMIL CC1CC(=CC2=CN=CC=C2)C3=CC=CC=C13 D0TM4K HIGHSTAT Investigative D0TN0A DRUG__ID D0TN0A D0TN0A DRUGTYPE Small molecular drug D0TN0A DRUGINCH 1S/C18H18N2O2/c21-15(18-20-17-16(22-18)12-7-13-19-17)11-6-2-5-10-14-8-3-1-4-9-14/h1,3-4,7-9,12-13H,2,5-6,10-11H2 D0TN0A DRUGINKE VPZHQLPAKFVGKX-UHFFFAOYSA-N D0TN0A DRUGSMIL C1=CC=C(C=C1)CCCCCC(=O)C2=NC3=C(O2)C=CC=N3 D0TN0A HIGHSTAT Investigative D0TN0D DRUG__ID D0TN0D D0TN0D DRUGTYPE Small molecular drug D0TN0D DRUGINCH 1S/C15H21NO/c1-10-14-8-11-4-5-12(17)9-13(11)15(10,2)6-7-16(14)3/h4-5,9-10,14,17H,6-8H2,1-3H3 D0TN0D DRUGINKE YGSVZRIZCHZUHB-UHFFFAOYSA-N D0TN0D DRUGSMIL CC1C2CC3=C(C1(CCN2C)C)C=C(C=C3)O D0TN0D HIGHSTAT Investigative D0TN1F DRUG__ID D0TN1F D0TN1F DRUGTYPE Small molecular drug D0TN1F DRUGINCH 1S/C13H10F3N/c14-13(15,16)11-5-1-9(2-6-11)10-3-7-12(17)8-4-10/h1-8H,17H2 D0TN1F DRUGINKE PDKIAMYXBRKPBW-UHFFFAOYSA-N D0TN1F DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)N)C(F)(F)F D0TN1F HIGHSTAT Investigative D0TN1L DRUG__ID D0TN1L D0TN1L DRUGTYPE Small molecular drug D0TN1L DRUGINCH 1S/C28H29NO/c1-2-3-4-5-11-19-29-21-24(20-27(29)23-14-7-6-8-15-23)28(30)26-18-12-16-22-13-9-10-17-25(22)26/h6-10,12-18,20-21H,2-5,11,19H2,1H3 D0TN1L DRUGINKE JDBFNFBWXVCTSA-UHFFFAOYSA-N D0TN1L DRUGSMIL CCCCCCCN1C=C(C=C1C2=CC=CC=C2)C(=O)C3=CC=CC4=CC=CC=C43 D0TN1L HIGHSTAT Investigative D0TN2R DRUG__ID D0TN2R D0TN2R DRUGTYPE Small molecular drug D0TN2R DRUGINCH 1S/C11H15NO/c1-13-8-11-6-9-4-2-3-5-10(9)7-12-11/h2-5,11-12H,6-8H2,1H3 D0TN2R DRUGINKE IDSUOIGUQHWCCU-UHFFFAOYSA-N D0TN2R DRUGSMIL COCC1CC2=CC=CC=C2CN1 D0TN2R HIGHSTAT Investigative D0TN4X DRUG__ID D0TN4X D0TN4X DRUGTYPE Small molecular drug D0TN4X DRUGINCH 1S/C18H25NO2S/c1-17(2,3)12-7-11(9-14-16(21)19-10-22-14)8-13(15(12)20)18(4,5)6/h7-9,20H,10H2,1-6H3,(H,19,21)/b14-9- D0TN4X DRUGINKE BUDGLLLMROWLOB-ZROIWOOFSA-N D0TN4X DRUGSMIL CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C2C(=O)NCS2 D0TN4X HIGHSTAT Investigative D0TO0E DRUG__ID D0TO0E D0TO0E DRUGTYPE Small molecular drug D0TO0E DRUGINCH 1S/C24H24N2O/c1-26-9-8-24-14-22-17(10-16-4-2-3-5-21(16)25-22)11-20(24)23(26)12-15-6-7-18(27)13-19(15)24/h2-7,10,13,20,23,27H,8-9,11-12,14H2,1H3/t20-,23+,24+/m0/s1 D0TO0E DRUGINKE HDRKKGULQPRYBL-TUACAJSNSA-N D0TO0E DRUGSMIL CN1CCC23CC4=NC5=CC=CC=C5C=C4CC2C1CC6=C3C=C(C=C6)O D0TO0E HIGHSTAT Investigative D0TO4N DRUG__ID D0TO4N D0TO4N DRUGTYPE Small molecular drug D0TO4N DRUGINCH 1S/C9H11NS/c1-2-8(11-3-1)9-4-7(9)5-10-6-9/h1-3,7,10H,4-6H2 D0TO4N DRUGINKE DMILNTFRFSJCOO-UHFFFAOYSA-N D0TO4N DRUGSMIL C1C2C1(CNC2)C3=CC=CS3 D0TO4N HIGHSTAT Investigative D0TO6S DRUG__ID D0TO6S D0TO6S DRUGTYPE Small molecular drug D0TO6S DRUGINCH 1S/C25H24N4O2/c1-28(2)12-7-13-29-15-19(17-9-4-6-11-21(17)29)23-22(24(30)27-25(23)31)18-14-26-20-10-5-3-8-16(18)20/h3-6,8-11,14-15,26H,7,12-13H2,1-2H3,(H,27,30,31) D0TO6S DRUGINKE QMGUOJYZJKLOLH-UHFFFAOYSA-N D0TO6S DRUGSMIL CN(C)CCCN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54 D0TO6S HIGHSTAT Investigative D0TP1H DRUG__ID D0TP1H D0TP1H DRUGTYPE Small molecular drug D0TP1H DRUGINCH 1S/C17H19NO4/c19-15(16-18-14(12-22-16)17(20)21)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2,(H,20,21) D0TP1H DRUGINKE UJGLCAJZAMDFHN-UHFFFAOYSA-N D0TP1H DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)C(=O)O D0TP1H HIGHSTAT Investigative D0TP8S DRUG__ID D0TP8S D0TP8S DRUGTYPE Small molecular drug D0TP8S DRUGINCH 1S/C26H25N3O4/c30-24(31)15-23(18-5-2-1-3-6-18)29-26(33)20-8-4-7-19(13-20)25(32)28-22-10-9-17-11-12-27-16-21(17)14-22/h1-10,13-14,23,27H,11-12,15-16H2,(H,28,32)(H,29,33)(H,30,31) D0TP8S DRUGINKE OCNALRIBAIFGLP-UHFFFAOYSA-N D0TP8S DRUGSMIL C1CNCC2=C1C=CC(=C2)NC(=O)C3=CC(=CC=C3)C(=O)NC(CC(=O)O)C4=CC=CC=C4 D0TP8S HIGHSTAT Investigative D0TR0R DRUG__ID D0TR0R D0TR0R DRUGTYPE Small molecular drug D0TR0R DRUGINCH 1S/C13H9NO/c15-8-9-5-6-11-10-3-1-2-4-12(10)14-13(11)7-9/h1-8,14H D0TR0R DRUGINKE LCENSQOWDHIKAN-UHFFFAOYSA-N D0TR0R DRUGSMIL C1=CC=C2C(=C1)C3=C(N2)C=C(C=C3)C=O D0TR0R HIGHSTAT Investigative D0TR0U DRUG__ID D0TR0U D0TR0U DRUGTYPE Small molecular drug D0TR0U DRUGINCH 1S/C51H61N9O10/c1-3-4-19-43(50(69)59-41(28-45(63)64)49(68)57-39(46(53)65)25-31-13-7-5-8-14-31)60(2)51(70)42(27-34-29-54-38-18-12-11-17-36(34)38)56-44(62)30-55-48(67)40(26-32-15-9-6-10-16-32)58-47(66)37(52)24-33-20-22-35(61)23-21-33/h5-18,20-23,29,37,39-43,54,61H,3-4,19,24-28,30,52H2,1-2H3,(H2,53,65)(H,55,67)(H,56,62)(H,57,68)(H,58,66)(H,59,69)(H,63,64)/t37-,39-,40+,41-,42+,43-/m0/s1 D0TR0U DRUGINKE KKPFQTRKARZYLE-YKEIYGJZSA-N D0TR0U DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CC=C(C=C5)O)N D0TR0U HIGHSTAT Investigative D0TR4N DRUG__ID D0TR4N D0TR4N DRUGTYPE Small molecular drug D0TR4N DRUGINCH 1S/C39H60N8O9/c1-19(2)16-26(40)33(49)44-31(21(5)6)37(53)45-30(20(3)4)36(52)42-22(7)38(54)47-15-11-14-29(47)35(51)43-28(34(50)46-32(23(8)48)39(55)56)17-24-18-41-27-13-10-9-12-25(24)27/h9-10,12-13,18-23,26,28-32,41,48H,11,14-17,40H2,1-8H3,(H,42,52)(H,43,51)(H,44,49)(H,45,53)(H,46,50)(H,55,56)/t22-,23+,26-,28-,29-,30-,31-,32-/m0/s1 D0TR4N DRUGINKE AHEGGNDTVLEUNO-YIHGEGNXSA-N D0TR4N DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(C(C)O)C(=O)O)N D0TR4N HIGHSTAT Investigative D0TS5I DRUG__ID D0TS5I D0TS5I DRUGTYPE Small molecular drug D0TS5I DRUGINCH 1S/C26H24ClNO/c1-2-3-6-16-28-18-21(17-25(28)20-12-14-22(27)15-13-20)26(29)24-11-7-9-19-8-4-5-10-23(19)24/h4-5,7-15,17-18H,2-3,6,16H2,1H3 D0TS5I DRUGINKE GBQKSTSSOVRZFN-UHFFFAOYSA-N D0TS5I DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)Cl)C(=O)C3=CC=CC4=CC=CC=C43 D0TS5I HIGHSTAT Investigative D0TS7G DRUG__ID D0TS7G D0TS7G DRUGTYPE Small molecular drug D0TS7G DRUGINCH 1S/C11H20N2O3/c14-10(15)7-4-8-12-11(16)13-9-5-2-1-3-6-9/h9H,1-8H2,(H,14,15)(H2,12,13,16) D0TS7G DRUGINKE WSVFRGGLURJIMG-UHFFFAOYSA-N D0TS7G DRUGSMIL C1CCC(CC1)NC(=O)NCCCC(=O)O D0TS7G HIGHSTAT Investigative D0TS8S DRUG__ID D0TS8S D0TS8S DRUGTYPE Small molecular drug D0TS8S DRUGINCH 1S/C6H11N3S/c7-6(10)9-8-5-3-1-2-4-5/h1-4H2,(H3,7,9,10) D0TS8S DRUGINKE PKHFATUAFMXAKP-UHFFFAOYSA-N D0TS8S DRUGSMIL C1CCC(=NNC(=S)N)C1 D0TS8S HIGHSTAT Investigative D0TT3K DRUG__ID D0TT3K D0TT3K DRUGTYPE Small molecular drug D0TT3K DRUGINCH 1S/C20H22N4O2/c1-3-23(4-2)10-9-21-15-7-8-16-19-18(15)20(26)14-6-5-13(25)11-17(14)24(19)12-22-16/h5-8,11-12,21,26H,3-4,9-10H2,1-2H3 D0TT3K DRUGINKE VCSROMHSGSVBHE-UHFFFAOYSA-N D0TT3K DRUGSMIL CCN(CC)CCNC1=C2C3=C(C=C1)N=CN3C4=CC(=O)C=CC4=C2O D0TT3K HIGHSTAT Investigative D0TT5V DRUG__ID D0TT5V D0TT5V DRUGTYPE Small molecular drug D0TT5V DRUGINCH 1S/C25H25NO7S/c1-26(2)13-12-25-17-9-11-20(33-34(28,29)30)23(25)32-22-19(10-8-16(21(22)25)14-18(17)26)31-24(27)15-6-4-3-5-7-15/h3-11,17-18,20,23H,12-14H2,1-2H3/t17-,18+,20-,23-,25-/m0/s1 D0TT5V DRUGINKE RMPWVEGPFQZBPZ-SDSLYQAOSA-N D0TT5V DRUGSMIL C[N+]1(CCC23C4C1CC5=C2C(=C(C=C5)OC(=O)C6=CC=CC=C6)OC3C(C=C4)OS(=O)(=O)[O-])C D0TT5V HIGHSTAT Investigative D0TT9H DRUG__ID D0TT9H D0TT9H DRUGTYPE Small molecular drug D0TT9H DRUGINCH 1S/C22H16N2O6/c25-19(13-7-3-1-4-8-13)23-17-12-18(16(22(29)30)11-15(17)21(27)28)24-20(26)14-9-5-2-6-10-14/h1-12H,(H,23,25)(H,24,26)(H,27,28)(H,29,30) D0TT9H DRUGINKE UUDYZUDTQPLDDP-UHFFFAOYSA-N D0TT9H DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC(=C(C=C2C(=O)O)C(=O)O)NC(=O)C3=CC=CC=C3 D0TT9H HIGHSTAT Investigative D0TU2Z DRUG__ID D0TU2Z D0TU2Z DRUGTYPE Small molecular drug D0TU2Z DRUGINCH 1S/C13H12O4S/c1-9-2-5-11(6-3-9)18(16,17)13-8-10(14)4-7-12(13)15/h2-8,14-15H,1H3 D0TU2Z DRUGINKE JDVLOEPBUIGUKP-UHFFFAOYSA-N D0TU2Z DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C(C=CC(=C2)O)O D0TU2Z HIGHSTAT Investigative D0TU5W DRUG__ID D0TU5W D0TU5W DRUGTYPE Small molecular drug D0TU5W DRUGINCH 1S/C19H20ClN3/c20-17-6-7-18-16(8-9-21-18)19(17)23-12-10-22(11-13-23)14-15-4-2-1-3-5-15/h1-9,21H,10-14H2 D0TU5W DRUGINKE IRFLVVGRMBDQSJ-UHFFFAOYSA-N D0TU5W DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=C(C=CC4=C3C=CN4)Cl D0TU5W HIGHSTAT Investigative D0TU7I DRUG__ID D0TU7I D0TU7I DRUGTYPE Small molecular drug D0TU7I DRUGINCH 1S/C16H15ClN4O2/c1-19-12(8-7-10-5-4-6-11(17)9-10)18-14-13(19)15(22)21(3)16(23)20(14)2/h4-9H,1-3H3/b8-7+ D0TU7I DRUGINKE WBWFIUAVMCNYPG-BQYQJAHWSA-N D0TU7I DRUGSMIL CN1C(=NC2=C1C(=O)N(C(=O)N2C)C)C=CC3=CC(=CC=C3)Cl D0TU7I HIGHSTAT Investigative D0TV0V DRUG__ID D0TV0V D0TV0V DRUGTYPE Small molecular drug D0TV0V DRUGINCH 1S/C10H16O/c1-6(2)10-4-8(10)7(3)9(11)5-10/h6-8H,4-5H2,1-3H3/t7-,8-,10+/m1/s1 D0TV0V DRUGINKE USMNOWBWPHYOEA-MRTMQBJTSA-N D0TV0V DRUGSMIL CC1C2CC2(CC1=O)C(C)C D0TV0V HIGHSTAT Investigative D0TV1R DRUG__ID D0TV1R D0TV1R DRUGTYPE Small molecular drug D0TV1R DRUGINCH 1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)/p-1 D0TV1R DRUGINKE LPEPZBJOKDYZAD-UHFFFAOYSA-M D0TV1R DRUGSMIL C1=CC=C(C(=C1)C(=O)[O-])NC2=CC=CC(=C2)C(F)(F)F D0TV1R HIGHSTAT Investigative D0TV9X DRUG__ID D0TV9X D0TV9X DRUGTYPE Small molecular drug D0TV9X DRUGINCH 1S/C18H28N2O3/c1-4-5-6-7-8-9-14-22-17-12-10-16(11-13-17)19-18(21)23-20-15(2)3/h10-13H,4-9,14H2,1-3H3,(H,19,21) D0TV9X DRUGINKE CZUCVARHDLBFBC-UHFFFAOYSA-N D0TV9X DRUGSMIL CCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D0TV9X HIGHSTAT Investigative D0TW0I DRUG__ID D0TW0I D0TW0I DRUGTYPE Small molecular drug D0TW0I DRUGINCH 1S/C11H10N2S/c1-9-13-11(8-14-9)5-4-10-3-2-6-12-7-10/h2-8H,1H3/b5-4+ D0TW0I DRUGINKE HHLKCNHXNVMBFW-SNAWJCMRSA-N D0TW0I DRUGSMIL CC1=NC(=CS1)C=CC2=CN=CC=C2 D0TW0I HIGHSTAT Investigative D0TW9N DRUG__ID D0TW9N D0TW9N DRUGTYPE Small molecular drug D0TW9N DRUGINCH 1S/C16H25NO3/c1-4-18-15-7-5-6-8-16(15)20-12-14-11-17(13(2)3)9-10-19-14/h5-8,13-14H,4,9-12H2,1-3H3 D0TW9N DRUGINKE YIUUQQVMBNHWQV-UHFFFAOYSA-N D0TW9N DRUGSMIL CCOC1=CC=CC=C1OCC2CN(CCO2)C(C)C D0TW9N HIGHSTAT Investigative D0TX8L DRUG__ID D0TX8L D0TX8L DRUGTYPE Small molecular drug D0TX8L DRUGINCH 1S/C28H41N3O3/c1-4-28(2,14-15-30-16-18-34-19-17-30)31(27(33)22-10-6-5-7-11-22)21-24-20-23-12-8-9-13-25(23)29(3)26(24)32/h8-9,12-13,20,22H,4-7,10-11,14-19,21H2,1-3H3 D0TX8L DRUGINKE FWHNGUFKFXDMER-UHFFFAOYSA-N D0TX8L DRUGSMIL CCC(C)(CCN1CCOCC1)N(CC2=CC3=CC=CC=C3N(C2=O)C)C(=O)C4CCCCC4 D0TX8L HIGHSTAT Investigative D0TX8W DRUG__ID D0TX8W D0TX8W DRUGTYPE Small molecular drug D0TX8W DRUGINCH 1S/C12H15N3/c1-2-11-10(4-5-14-11)12(3-1)15-8-6-13-7-9-15/h1-5,13-14H,6-9H2 D0TX8W DRUGINKE YZKSXUIOKWQABW-UHFFFAOYSA-N D0TX8W DRUGSMIL C1CN(CCN1)C2=CC=CC3=C2C=CN3 D0TX8W HIGHSTAT Investigative D0TX9P DRUG__ID D0TX9P D0TX9P DRUGTYPE Small molecular drug D0TX9P DRUGINCH 1S/C10H8N2O2/c13-10(14)8-3-1-2-7(6-8)9-4-5-11-12-9/h1-6H,(H,11,12)(H,13,14) D0TX9P DRUGINKE RXZRBZWATRFHCS-UHFFFAOYSA-N D0TX9P DRUGSMIL C1=CC(=CC(=C1)C(=O)O)C2=CC=NN2 D0TX9P HIGHSTAT Investigative D0TY8X DRUG__ID D0TY8X D0TY8X DRUGTYPE Small molecular drug D0TY8X DRUGINCH 1S/C10H11N5O2S/c11-10-13-6-5-9(15-10)14-7-1-3-8(4-2-7)18(12,16)17/h1-6H,(H2,12,16,17)(H3,11,13,14,15) D0TY8X DRUGINKE QOAXQANKSMHFKJ-UHFFFAOYSA-N D0TY8X DRUGSMIL C1=CC(=CC=C1NC2=NC(=NC=C2)N)S(=O)(=O)N D0TY8X HIGHSTAT Investigative D0TZ5V DRUG__ID D0TZ5V D0TZ5V DRUGTYPE Small molecular drug D0TZ5V DRUGINCH 1S/C9H8N4OS/c10-9(15)13-12-7-5-3-1-2-4-6(5)11-8(7)14/h1-4,11,14H,(H2,10,15) D0TZ5V DRUGINKE PEYNLAQGUNUQLY-UHFFFAOYSA-N D0TZ5V DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)O)N=NC(=S)N D0TZ5V HIGHSTAT Investigative D0TZ8C DRUG__ID D0TZ8C D0TZ8C DRUGTYPE Small molecular drug D0TZ8C DRUGINCH 1S/C14H11N3O/c18-14-4-2-12-9-11(1-3-13(12)16-14)5-7-17-8-6-15-10-17/h1-10H,(H,16,18)/b7-5+ D0TZ8C DRUGINKE ULTZJAJIZBBKSG-FNORWQNLSA-N D0TZ8C DRUGSMIL C1=CC2=C(C=CC(=O)N2)C=C1C=CN3C=CN=C3 D0TZ8C HIGHSTAT Investigative D0U0BV DRUG__ID D0U0BV D0U0BV DRUGTYPE Small molecular drug D0U0BV DRUGINCH 1S/C14H8F4O2/c15-9-3-1-7(5-11(9)17)13(19)14(20)8-2-4-10(16)12(18)6-8/h1-6,13,19H D0U0BV DRUGINKE VPCIITRKAXBIRA-UHFFFAOYSA-N D0U0BV DRUGSMIL C1=CC(=C(C=C1C(C(=O)C2=CC(=C(C=C2)F)F)O)F)F D0U0BV HIGHSTAT Investigative D0U0CV DRUG__ID D0U0CV D0U0CV DRUGTYPE Small molecular drug D0U0CV DRUGINCH 1S/C12H25FO2S/c1-2-3-4-5-6-7-8-9-10-11-12-16(13,14)15/h2-12H2,1H3 D0U0CV DRUGINKE UVLRFDMRDPQRSM-UHFFFAOYSA-N D0U0CV DRUGSMIL CCCCCCCCCCCCS(=O)(=O)F D0U0CV HIGHSTAT Investigative D0U0EZ DRUG__ID D0U0EZ D0U0EZ DRUGTYPE Small molecular drug D0U0EZ DRUGINCH 1S/C24H35N5O5S2/c1-24(2)23(34)27-17(15-30)22(33)29-13-8-10-18(29)21(32)26-16(20(31)28-24)9-4-3-7-14-35-36-19-11-5-6-12-25-19/h5-6,11-12,16-18,30H,3-4,7-10,13-15H2,1-2H3,(H,26,32)(H,27,34)(H,28,31)/t16-,17-,18+/m0/s1 D0U0EZ DRUGINKE HNLHPMBNXUOXHG-OKZBNKHCSA-N D0U0EZ DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CO)C D0U0EZ HIGHSTAT Investigative D0U0GE DRUG__ID D0U0GE D0U0GE DRUGTYPE Small molecular drug D0U0GE DRUGINCH 1S/C9H10N4S/c1-5-8(14-6(2)12-5)7-3-4-11-9(10)13-7/h3-4H,1-2H3,(H2,10,11,13) D0U0GE DRUGINKE CTFDMGIBHFQWKB-UHFFFAOYSA-N D0U0GE DRUGSMIL CC1=C(SC(=N1)C)C2=NC(=NC=C2)N D0U0GE HIGHSTAT Investigative D0U0GY DRUG__ID D0U0GY D0U0GY DRUGTYPE Small molecular drug D0U0GY DRUGINCH 1S/C16H22O/c1-3-5-6-7-8-9-14-10-12-15(13-11-14)16(17)4-2/h4,10-13H,2-3,5-9H2,1H3 D0U0GY DRUGINKE WZQJNZZJSOSTIH-UHFFFAOYSA-N D0U0GY DRUGSMIL CCCCCCCC1=CC=C(C=C1)C(=O)C=C D0U0GY HIGHSTAT Investigative D0U0KJ DRUG__ID D0U0KJ D0U0KJ DRUGTYPE Small molecular drug D0U0KJ DRUGINCH 1S/C15H13ClN3O8P/c1-7-13(21)10(5-20)11(6-27-28(24,25)26)14(17-7)19-18-8-2-3-9(15(22)23)12(16)4-8/h2-5,21H,6H2,1H3,(H,22,23)(H2,24,25,26) D0U0KJ DRUGINKE KMRWDYZPXRUNAQ-UHFFFAOYSA-N D0U0KJ DRUGSMIL CC1=C(C(=C(C(=N1)N=NC2=CC(=C(C=C2)C(=O)O)Cl)COP(=O)(O)O)C=O)O D0U0KJ HIGHSTAT Investigative D0U0KS DRUG__ID D0U0KS D0U0KS DRUGTYPE Small molecular drug D0U0KS DRUGINCH 1S/C25H43NO3/c1-7-29-22-14-24(3)16(12-21(22)28)8-9-17-19-11-10-18(15(2)27)25(19,4)13-20(23(17)24)26(5)6/h16-23,28H,7-14H2,1-6H3/t16-,17-,18+,19-,20+,21-,22-,23+,24-,25+/m0/s1 D0U0KS DRUGINKE NCGLTZSBTFVVAW-KNXRZYMVSA-N D0U0KS DRUGSMIL CCOC1CC2(C(CCC3C2C(CC4(C3CCC4C(=O)C)C)N(C)C)CC1O)C D0U0KS HIGHSTAT Investigative D0U0KY DRUG__ID D0U0KY D0U0KY DRUGTYPE Small molecular drug D0U0KY DRUGINCH 1S/C11H8Cl2N6/c12-4-2-1-3-5(13)6(4)9-16-7-8(14)17-11(15)19-10(7)18-9/h1-3H,(H5,14,15,16,17,18,19) D0U0KY DRUGINKE ZBIYAIOEBKNMQY-UHFFFAOYSA-N D0U0KY DRUGSMIL C1=CC(=C(C(=C1)Cl)C2=NC3=NC(=NC(=C3N2)N)N)Cl D0U0KY HIGHSTAT Investigative D0U0LH DRUG__ID D0U0LH D0U0LH DRUGTYPE Small molecular drug D0U0LH DRUGINCH 1S/C23H31N3O2/c1-25(2)10-8-16-12-15-13-23(22(27)28-3)20-18(9-11-26(14-15)21(16)23)17-6-4-5-7-19(17)24-20/h4-7,15-16,21,24H,8-14H2,1-3H3/t15?,16-,21-,23+/m0/s1 D0U0LH DRUGINKE WUYGHHRQOSQDIC-NVVKDKPXSA-N D0U0LH DRUGSMIL CN(C)CCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)OC D0U0LH HIGHSTAT Investigative D0U0LL DRUG__ID D0U0LL D0U0LL DRUGTYPE Small molecular drug D0U0LL DRUGINCH 1S/C15H19N3S2/c1-2-6-13-11-20-15(17-13)18-14(19)16-10-9-12-7-4-3-5-8-12/h3-5,7-8,11H,2,6,9-10H2,1H3,(H2,16,17,18,19) D0U0LL DRUGINKE YVTPTTMDIAAXHM-UHFFFAOYSA-N D0U0LL DRUGSMIL CCCC1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2 D0U0LL HIGHSTAT Investigative D0U0NT DRUG__ID D0U0NT D0U0NT DRUGTYPE Small molecular drug D0U0NT DRUGINCH 1S/C25H30N2O3/c1-29-16-5-17-30-24-9-8-21(23(26-24)18-20-6-3-2-4-7-20)10-13-25(28)19-27-14-11-22(25)12-15-27/h2-4,6-9,22,28H,5,11-12,14-19H2,1H3/t25-/m1/s1 D0U0NT DRUGINKE HVIKCINYHLGLMN-RUZDIDTESA-N D0U0NT DRUGSMIL COCCCOC1=NC(=C(C=C1)C#CC2(CN3CCC2CC3)O)CC4=CC=CC=C4 D0U0NT HIGHSTAT Investigative D0U0QW DRUG__ID D0U0QW D0U0QW DRUGTYPE Small molecular drug D0U0QW DRUGINCH 1S/C9H12N2O2S/c10-14(12,13)7-6-11-8-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,10,12,13) D0U0QW DRUGINKE TZIDZFKPPIWVBP-UHFFFAOYSA-N D0U0QW DRUGSMIL C1=CC=C(C=C1)C=NCCS(=O)(=O)N D0U0QW HIGHSTAT Investigative D0U0ST DRUG__ID D0U0ST D0U0ST DRUGTYPE Small molecular drug D0U0ST DRUGINCH 1S/C16H18F3IN4/c1-2-24-7-3-4-11(9-24)21-14-12-8-10(20)5-6-13(12)22-15(23-14)16(17,18)19/h5-6,8,11H,2-4,7,9H2,1H3,(H,21,22,23) D0U0ST DRUGINKE IRWWFCJIOHCTMV-UHFFFAOYSA-N D0U0ST DRUGSMIL CCN1CCCC(C1)NC2=NC(=NC3=C2C=C(C=C3)I)C(F)(F)F D0U0ST HIGHSTAT Investigative D0U0TS DRUG__ID D0U0TS D0U0TS DRUGTYPE Small molecular drug D0U0TS DRUGINCH 1S/C23H31N3O3/c1-23(2,3)21(25-14-16-6-9-24-10-7-16)22(27)26-11-8-17-12-19(28-4)20(29-5)13-18(17)15-26/h6-7,9-10,12-13,21,25H,8,11,14-15H2,1-5H3/t21-/m1/s1 D0U0TS DRUGINKE COFVZFLCAOUMJT-OAQYLSRUSA-N D0U0TS DRUGSMIL CC(C)(C)C(C(=O)N1CCC2=CC(=C(C=C2C1)OC)OC)NCC3=CC=NC=C3 D0U0TS HIGHSTAT Investigative D0U0UB DRUG__ID D0U0UB D0U0UB DRUGTYPE Small molecular drug D0U0UB DRUGINCH 1S/C13H11NS/c1-10-5-3-4-6-12(10)7-8-13-9-15-11(2)14-13/h3-6,9H,1-2H3 D0U0UB DRUGINKE XDQBEOSJZSBVGG-UHFFFAOYSA-N D0U0UB DRUGSMIL CC1=CC=CC=C1C#CC2=CSC(=N2)C D0U0UB HIGHSTAT Investigative D0U0VF DRUG__ID D0U0VF D0U0VF DRUGTYPE Small molecular drug D0U0VF DRUGINCH 1S/C17H28N8O6/c18-9-5-12(26)23-8-4-11(21-6-8)15(29)25-17(19)20-3-1-2-10(16(30)31)24-13(27)7-22-14(9)28/h8-11,21H,1-7,18H2,(H,22,28)(H,23,26)(H,24,27)(H,30,31)(H3,19,20,25,29)/t8-,9?,10-,11+/m0/s1 D0U0VF DRUGINKE HWQCIVMCAIEOPT-OFLUOSHYSA-N D0U0VF DRUGSMIL C1CC(NC(=O)CNC(=O)C(CC(=O)NC2CC(C(=O)NC(=NC1)N)NC2)N)C(=O)O D0U0VF HIGHSTAT Investigative D0U0VH DRUG__ID D0U0VH D0U0VH DRUGTYPE Small molecular drug D0U0VH DRUGINCH 1S/C19H25N3/c1-3-9-22(10-4-2)16-7-5-14-6-8-19-18(17(14)12-16)11-15(13-20)21-19/h6,8,11,16,21H,3-5,7,9-10,12H2,1-2H3/t16-/m1/s1 D0U0VH DRUGINKE WDDZPZKGLZNGEH-MRXNPFEDSA-N D0U0VH DRUGSMIL CCCN(CCC)C1CCC2=C(C1)C3=C(C=C2)NC(=C3)C#N D0U0VH HIGHSTAT Investigative D0U0VO DRUG__ID D0U0VO D0U0VO DRUGTYPE Small molecular drug D0U0VO DRUGINCH 1S/C14H20N2O3S2/c1-11-4-6-12(7-5-11)21(18,19)16-9-2-3-13(16)14(17)15-8-10-20/h4-7,13,20H,2-3,8-10H2,1H3,(H,15,17)/t13-/m1/s1 D0U0VO DRUGINKE NWUYDTGYTUQMDG-CYBMUJFWSA-N D0U0VO DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCCC2C(=O)NCCS D0U0VO HIGHSTAT Investigative D0U0WU DRUG__ID D0U0WU D0U0WU DRUGTYPE Small molecular drug D0U0WU DRUGINCH 1S/C19H36N2O3/c1-2-3-13-16-20-19(24)21-17-14-11-9-7-5-4-6-8-10-12-15-18(22)23/h5,7H,2-4,6,8-17H2,1H3,(H,22,23)(H2,20,21,24)/b7-5- D0U0WU DRUGINKE CVIWLKCFJOISPD-ALCCZGGFSA-N D0U0WU DRUGSMIL CCCCCNC(=O)NCCCCC=CCCCCCCC(=O)O D0U0WU HIGHSTAT Investigative D0U0XG DRUG__ID D0U0XG D0U0XG DRUGTYPE Small molecular drug D0U0XG DRUGINCH 1S/C12H21N3O3S/c1-12(2,3)18-11(17)15-9(5-8-19-4)10(16)14-7-6-13/h9H,5,7-8H2,1-4H3,(H,14,16)(H,15,17)/t9-/m0/s1 D0U0XG DRUGINKE PDUKBZKBRGAZFC-VIFPVBQESA-N D0U0XG DRUGSMIL CC(C)(C)OC(=O)NC(CCSC)C(=O)NCC#N D0U0XG HIGHSTAT Investigative D0U0YE DRUG__ID D0U0YE D0U0YE DRUGTYPE Small molecular drug D0U0YE DRUGINCH 1S/C16H17NO2/c1-11-6-5-7-12(2)16(11)17-14-9-4-3-8-13(14)10-15(18)19/h3-9,17H,10H2,1-2H3,(H,18,19) D0U0YE DRUGINKE ICJTVRXTYOYEOT-UHFFFAOYSA-N D0U0YE DRUGSMIL CC1=C(C(=CC=C1)C)NC2=CC=CC=C2CC(=O)O D0U0YE HIGHSTAT Investigative D0U0ZE DRUG__ID D0U0ZE D0U0ZE DRUGTYPE Small molecular drug D0U0ZE DRUGINCH 1S/C15H12O3/c1-8-5-9(2)14-11-4-3-10(16)7-13(11)18-15(17)12(14)6-8/h3-7,16H,1-2H3 D0U0ZE DRUGINKE LTZNXKCOWADUFT-UHFFFAOYSA-N D0U0ZE DRUGSMIL CC1=CC(=C2C3=C(C=C(C=C3)O)OC(=O)C2=C1)C D0U0ZE HIGHSTAT Investigative D0U1AN DRUG__ID D0U1AN D0U1AN DRUGTYPE Small molecular drug D0U1AN DRUGINCH 1S/C7H6N2O2S2/c8-13(10,11)7-3-1-6(2-4-7)9-5-12/h1-4H,(H2,8,10,11) D0U1AN DRUGINKE IMDUFDNFSJWYQT-UHFFFAOYSA-N D0U1AN DRUGSMIL C1=CC(=CC=C1N=C=S)S(=O)(=O)N D0U1AN HIGHSTAT Investigative D0U1BA DRUG__ID D0U1BA D0U1BA DRUGTYPE Small molecular drug D0U1BA DRUGINCH 1S/C44H57N9O13S/c1-4-25(2)38(51-42(59)37(24-67)46-26(3)54)43(60)49-35(21-27-8-14-30(15-9-27)52(63)64)40(57)47-33(7-5-6-20-45)39(56)48-34(22-29-12-18-32(55)19-13-29)41(58)50-36(44(61)62)23-28-10-16-31(17-11-28)53(65)66/h8-19,25,33-38,55,67H,4-7,20-24,45H2,1-3H3,(H,46,54)(H,47,57)(H,48,56)(H,49,60)(H,50,58)(H,51,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D0U1BA DRUGINKE YSCBRLXTMTYHMK-LBNFHWTGSA-N D0U1BA DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)[N+](=O)[O-])C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)O)NC(=O)C(CS)NC(=O)C D0U1BA HIGHSTAT Investigative D0U1CN DRUG__ID D0U1CN D0U1CN DRUGTYPE Small molecular drug D0U1CN DRUGINCH 1S/C22H27NO5/c1-22(2,3)17-11-15(16-6-8-19-20(12-16)28-14-27-19)5-7-18(17)26-10-9-23(4)13-21(24)25/h5-8,11-12H,9-10,13-14H2,1-4H3,(H,24,25) D0U1CN DRUGINKE FKPLJWGRBCQLTL-UHFFFAOYSA-N D0U1CN DRUGSMIL CC(C)(C)C1=C(C=CC(=C1)C2=CC3=C(C=C2)OCO3)OCCN(C)CC(=O)O D0U1CN HIGHSTAT Investigative D0U1DR DRUG__ID D0U1DR D0U1DR DRUGTYPE Small molecular drug D0U1DR DRUGINCH 1S/C14H25N3/c1-3-7-13(8-4-1)16-10-6-2-5-9-14-11-15-12-17-14/h11-13,16H,1-10H2,(H,15,17) D0U1DR DRUGINKE XFSHNAXXKOSENG-UHFFFAOYSA-N D0U1DR DRUGSMIL C1CCC(CC1)NCCCCCC2=CN=CN2 D0U1DR HIGHSTAT Investigative D0U1DU DRUG__ID D0U1DU D0U1DU DRUGCOMP University of Southern California D0U1DU DRUGINCH 1S/C36H59NO6/c1-22(2)24-11-16-36(30(41)42-21-35(37,19-38)20-39)18-17-33(7)25(29(24)36)9-10-27-32(6)14-13-28(43-23(3)40)31(4,5)26(32)12-15-34(27,33)8/h24-29,38-39H,1,9-21,37H2,2-8H3/t24-,25+,26-,27+,28-,29+,32-,33+,34+,36-/m0/s1 D0U1DU DRUGINKE KQZVSTAVTJCKDG-DRSBITMPSA-N D0U1DU DRUGSMIL CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)C(=O)OCC(CO)(CO)N D0U1DU HIGHSTAT Investigative D0U1EV DRUG__ID D0U1EV D0U1EV DRUGTYPE Small molecular drug D0U1EV DRUGINCH 1S/C18H20N2O4/c19-16(18(22)23)10-11-17(21)20-14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16H,10-12,19H2,(H,20,21)(H,22,23)/t16-/m1/s1 D0U1EV DRUGINKE BYSBXIPCDJNEBG-MRXNPFEDSA-N D0U1EV DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D0U1EV HIGHSTAT Investigative D0U1IJ DRUG__ID D0U1IJ D0U1IJ DRUGTYPE Small molecular drug D0U1IJ DRUGINCH 1S/C30H18O5/c31-25-17-29(20-9-5-2-6-10-20)35-30-16-22(11-13-23(25)30)33-21-12-14-27-24(15-21)26(32)18-28(34-27)19-7-3-1-4-8-19/h1-18H D0U1IJ DRUGINKE IGRXBHDMCKHQQC-UHFFFAOYSA-N D0U1IJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OC4=CC5=C(C=C4)C(=O)C=C(O5)C6=CC=CC=C6 D0U1IJ HIGHSTAT Investigative D0U1MF DRUG__ID D0U1MF D0U1MF DRUGTYPE Small molecular drug D0U1MF DRUGINCH 1S/C9H11NO3/c1-2-13-10-6-7-3-4-8(11)9(12)5-7/h3-6,11-12H,2H2,1H3/b10-6- D0U1MF DRUGINKE XMXAPNDTHZRELH-POHAHGRESA-N D0U1MF DRUGSMIL CCON=CC1=CC(=C(C=C1)O)O D0U1MF HIGHSTAT Investigative D0U1MN DRUG__ID D0U1MN D0U1MN DRUGTYPE Small molecular drug D0U1MN DRUGINCH 1S/C13H20N2O/c1-3-14-8-10-15(11-9-14)12-6-4-5-7-13(12)16-2/h4-7H,3,8-11H2,1-2H3 D0U1MN DRUGINKE VLKJSRWSKNCNBI-UHFFFAOYSA-N D0U1MN DRUGSMIL CCN1CCN(CC1)C2=CC=CC=C2OC D0U1MN HIGHSTAT Investigative D0U1OJ DRUG__ID D0U1OJ D0U1OJ DRUGTYPE Small molecular drug D0U1OJ DRUGINCH 1S/C11H18N5O13P3S/c1-33-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H,24,25)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1 D0U1OJ DRUGINKE XNOBOKJVOTYSJV-KQYNXXCUSA-N D0U1OJ DRUGSMIL CSC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N D0U1OJ HIGHSTAT Investigative D0U1OX DRUG__ID D0U1OX D0U1OX DRUGTYPE Small molecular drug D0U1OX DRUGINCH 1S/C15H20N2O/c1-15(2,3)9-10-18-12-6-4-5-11-7-8-13(16)17-14(11)12/h4-8H,9-10H2,1-3H3,(H2,16,17) D0U1OX DRUGINKE GUJKDUVYIJMAPL-UHFFFAOYSA-N D0U1OX DRUGSMIL CC(C)(C)CCOC1=CC=CC2=C1N=C(C=C2)N D0U1OX HIGHSTAT Investigative D0U1PE DRUG__ID D0U1PE D0U1PE DRUGTYPE Small molecular drug D0U1PE DRUGINCH 1S/C18H16O2/c1-12(2)14-8-9-17-15(10-14)16(19)11-18(20-17)13-6-4-3-5-7-13/h3-12H,1-2H3 D0U1PE DRUGINKE APJYDAHXYGPDII-UHFFFAOYSA-N D0U1PE DRUGSMIL CC(C)C1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3 D0U1PE HIGHSTAT Investigative D0U1SE DRUG__ID D0U1SE D0U1SE DRUGTYPE Small molecular drug D0U1SE DRUGINCH 1S/C9H22N/c1-5-6-7-8-9-10(2,3)4/h5-9H2,1-4H3/q+1 D0U1SE DRUGINKE XTPRURKTXNFVQT-UHFFFAOYSA-N D0U1SE DRUGSMIL CCCCCC[N+](C)(C)C D0U1SE HIGHSTAT Investigative D0U1SF DRUG__ID D0U1SF D0U1SF DRUGTYPE Small molecular drug D0U1SF DRUGINCH 1S/C26H18N2O5/c29-21(30)15-31-20-13-7-12-19(14-20)24-23(27-16-32-24)26-28-22(17-8-3-1-4-9-17)25(33-26)18-10-5-2-6-11-18/h1-14,16H,15H2,(H,29,30) D0U1SF DRUGINKE DSRSEEYZGWTODH-UHFFFAOYSA-N D0U1SF DRUGSMIL C1=CC=C(C=C1)C2=C(OC(=N2)C3=C(OC=N3)C4=CC(=CC=C4)OCC(=O)O)C5=CC=CC=C5 D0U1SF HIGHSTAT Investigative D0U1UP DRUG__ID D0U1UP D0U1UP DRUGTYPE Small molecular drug D0U1UP DRUGINCH 1S/C29H24O4/c30-26-14-8-7-13-25(26)27(31)17-15-22-16-18-28(32-20-23-9-3-1-4-10-23)29(19-22)33-21-24-11-5-2-6-12-24/h1-19,30H,20-21H2/b17-15+ D0U1UP DRUGINKE LHMDXKJKKAITQJ-BMRADRMJSA-N D0U1UP DRUGSMIL C1=CC=C(C=C1)COC2=C(C=C(C=C2)C=CC(=O)C3=CC=CC=C3O)OCC4=CC=CC=C4 D0U1UP HIGHSTAT Investigative D0U1UV DRUG__ID D0U1UV D0U1UV DRUGTYPE Small molecular drug D0U1UV DRUGINCH 1S/C17H18N2O4/c18-15(10-16(20)21)17(22)19-13-6-8-14(9-7-13)23-11-12-4-2-1-3-5-12/h1-9,15H,10-11,18H2,(H,19,22)(H,20,21)/t15-/m1/s1 D0U1UV DRUGINKE VTMSXGVEMJOFRJ-OAHLLOKOSA-N D0U1UV DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)C(CC(=O)O)N D0U1UV HIGHSTAT Investigative D0U1UZ DRUG__ID D0U1UZ D0U1UZ DRUGTYPE Small molecular drug D0U1UZ DRUGINCH 1S/C36H45N11O5/c37-36(38)41-15-6-12-27-33(50)47-29(17-23-19-42-26-11-5-4-10-25(23)26)32(49)40-14-7-13-31(48)44-30(18-24-20-39-21-43-24)35(52)46-28(34(51)45-27)16-22-8-2-1-3-9-22/h1-5,8-11,19-21,27-30,42H,6-7,12-18H2,(H,39,43)(H,40,49)(H,44,48)(H,45,51)(H,46,52)(H,47,50)(H4,37,38,41)/t27-,28+,29-,30+/m0/s1 D0U1UZ DRUGINKE IYMUEULNOLBKRK-RRGQHJHPSA-N D0U1UZ DRUGSMIL C1CC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC1)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5 D0U1UZ HIGHSTAT Investigative D0U1WH DRUG__ID D0U1WH D0U1WH DRUGTYPE Small molecular drug D0U1WH DRUGINCH 1S/C17H19NO2/c1-2-3-12-18-17(19)20-16-11-7-10-15(13-16)14-8-5-4-6-9-14/h4-11,13H,2-3,12H2,1H3,(H,18,19) D0U1WH DRUGINKE KILLQYKNNVPEJL-UHFFFAOYSA-N D0U1WH DRUGSMIL CCCCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2 D0U1WH HIGHSTAT Investigative D0U1WL DRUG__ID D0U1WL D0U1WL DRUGTYPE Small molecular drug D0U1WL DRUGINCH 1S/C11H9N5O/c12-11-14-3-1-7(16-11)6-5-15-10-9(6)8(17)2-4-13-10/h1-5H,(H2,12,14,16)(H2,13,15,17) D0U1WL DRUGINKE JYGNOLIKBUTZNC-UHFFFAOYSA-N D0U1WL DRUGSMIL C1=CNC2=C(C1=O)C(=CN2)C3=NC(=NC=C3)N D0U1WL HIGHSTAT Investigative D0U1XJ DRUG__ID D0U1XJ D0U1XJ DRUGTYPE Small molecular drug D0U1XJ DRUGINCH 1S/C18H20ClN3O5S/c1-20-18(24)22-28(25,26)14-6-3-12(4-7-14)9-10-21-17(23)15-11-13(19)5-8-16(15)27-2/h3-8,11H,9-10H2,1-2H3,(H,21,23)(H2,20,22,24) D0U1XJ DRUGINKE RXOBKRPNVDTZQF-UHFFFAOYSA-N D0U1XJ DRUGSMIL CNC(=O)NS(=O)(=O)C1=CC=C(C=C1)CCNC(=O)C2=C(C=CC(=C2)Cl)OC D0U1XJ HIGHSTAT Investigative D0U1YU DRUG__ID D0U1YU D0U1YU DRUGTYPE Small molecular drug D0U1YU DRUGINCH 1S/C25H47NO4/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-22(27)24(29)26-21(2)19-20-23(28)30-25(3,4)5/h21H,6-20H2,1-5H3,(H,26,29)/t21-/m0/s1 D0U1YU DRUGINKE MWODQGJPDWEORS-NRFANRHFSA-N D0U1YU DRUGSMIL CCCCCCCCCCCCCCC(=O)C(=O)NC(C)CCC(=O)OC(C)(C)C D0U1YU HIGHSTAT Investigative D0U2AM DRUG__ID D0U2AM D0U2AM DRUGTYPE Small molecular drug D0U2AM DRUGINCH 1S/C18H21N3O2/c19-16(18(20)23)10-11-17(22)21-15-8-6-14(7-9-15)12-13-4-2-1-3-5-13/h1-9,16H,10-12,19H2,(H2,20,23)(H,21,22)/t16-/m0/s1 D0U2AM DRUGINKE RYHUMGNBCPJDFD-INIZCTEOSA-N D0U2AM DRUGSMIL C1=CC=C(C=C1)CC2=CC=C(C=C2)NC(=O)CCC(C(=O)N)N D0U2AM HIGHSTAT Investigative D0U2CJ DRUG__ID D0U2CJ D0U2CJ DRUGTYPE Small molecular drug D0U2CJ DRUGINCH 1S/C21H29ClN10O16P4S2/c22-21(49(37,38)47-51(41,53)43-1-7-11(33)13(35)19(45-7)31-5-29-9-15(23)25-3-27-17(9)31)50(39,40)48-52(42,54)44-2-8-12(34)14(36)20(46-8)32-6-30-10-16(24)26-4-28-18(10)32/h3-8,11-14,19-21,33-36H,1-2H2,(H,37,38)(H,39,40)(H,41,53)(H,42,54)(H2,23,25,27)(H2,24,26,28)/t7-,8?,11+,12+,13?,14+,19-,20-,21?,51?,52?/m1/s1 D0U2CJ DRUGINKE SQXLFBVOQBYLCG-BUWSHSPFSA-N D0U2CJ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=S)(O)OP(=O)(C(P(=O)(O)OP(=O)(OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)S)Cl)O)O)O)N D0U2CJ HIGHSTAT Investigative D0U2GG DRUG__ID D0U2GG D0U2GG DRUGTYPE Small molecular drug D0U2GG DRUGINCH 1S/C12H8ClN3/c1-9-8-14-16-12(15-9)6-5-10-3-2-4-11(13)7-10/h2-4,7-8H,1H3 D0U2GG DRUGINKE KPQLYWIRBOHKMO-UHFFFAOYSA-N D0U2GG DRUGSMIL CC1=CN=NC(=N1)C#CC2=CC(=CC=C2)Cl D0U2GG HIGHSTAT Investigative D0U2GX DRUG__ID D0U2GX D0U2GX DRUGTYPE Small molecular drug D0U2GX DRUGINCH 1S/C20H29F3O2/c1-2-3-4-5-6-7-8-9-16-25-18-13-10-17(11-14-18)12-15-19(24)20(21,22)23/h10-11,13-14H,2-9,12,15-16H2,1H3 D0U2GX DRUGINKE DJDSHOVBFZKIEK-UHFFFAOYSA-N D0U2GX DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)CCC(=O)C(F)(F)F D0U2GX HIGHSTAT Investigative D0U2HZ DRUG__ID D0U2HZ D0U2HZ DRUGTYPE Small molecular drug D0U2HZ DRUGINCH 1S/C12H15ClN2/c1-7-9(3-5-12(13)14-7)10-6-8-2-4-11(10)15-8/h3,5,8,10-11,15H,2,4,6H2,1H3 D0U2HZ DRUGINKE CEIOZCMVGWULLM-UHFFFAOYSA-N D0U2HZ DRUGSMIL CC1=C(C=CC(=N1)Cl)C2CC3CCC2N3 D0U2HZ HIGHSTAT Investigative D0U2IL DRUG__ID D0U2IL D0U2IL DRUGTYPE Small molecular drug D0U2IL DRUGINCH 1S/C11H18N2O/c1-11(10-12-14)6-2-3-7-13-8-4-5-9-13/h11H,4-10H2,1H3 D0U2IL DRUGINKE GMFWCDSZRLSMRO-UHFFFAOYSA-N D0U2IL DRUGSMIL CC(CC#CCN1CCCC1)CN=O D0U2IL HIGHSTAT Investigative D0U2KT DRUG__ID D0U2KT D0U2KT DRUGTYPE Small molecular drug D0U2KT DRUGINCH 1S/C10H14N2O4/c1-5-4-12(10(15)11-9(5)14)8-3-7(13)6(2)16-8/h4,6-8,13H,3H2,1-2H3,(H,11,14,15)/t6-,7+,8-/m1/s1 D0U2KT DRUGINKE UGUILUGCFSCUKR-GJMOJQLCSA-N D0U2KT DRUGSMIL CC1C(CC(O1)N2C=C(C(=O)NC2=O)C)O D0U2KT HIGHSTAT Investigative D0U2NV DRUG__ID D0U2NV D0U2NV DRUGTYPE Small molecular drug D0U2NV DRUGINCH 1S/C31H37F3N8O7/c32-31(33,34)30(16-19-10-5-2-6-11-19)28(49)41-21(14-18-8-3-1-4-9-18)26(47)40-20(12-7-13-37-29(35)36)25(46)38-17-23(43)39-22(15-24(44)45)27(48)42-30/h1-6,8-11,20-22H,7,12-17H2,(H,38,46)(H,39,43)(H,40,47)(H,41,49)(H,42,48)(H,44,45)(H4,35,36,37)/t20-,21-,22-,30+/m0/s1 D0U2NV DRUGINKE UVOUWFPJSKSTMI-YNJMIAMQSA-N D0U2NV DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CC=CC=C2)(CC3=CC=CC=C3)C(F)(F)F)CC(=O)O D0U2NV HIGHSTAT Investigative D0U2QP DRUG__ID D0U2QP D0U2QP DRUGTYPE Small molecular drug D0U2QP DRUGINCH 1S/C19H25N3O3S/c1-2-3-4-8-15-20-19(23)21-16-11-13-18(14-12-16)26(24,25)22-17-9-6-5-7-10-17/h5-7,9-14,22H,2-4,8,15H2,1H3,(H2,20,21,23) D0U2QP DRUGINKE ADKICSRVDIFTQJ-UHFFFAOYSA-N D0U2QP DRUGSMIL CCCCCCNC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2 D0U2QP HIGHSTAT Investigative D0U2QT DRUG__ID D0U2QT D0U2QT DRUGTYPE Small molecular drug D0U2QT DRUGINCH 1S/C22H19N3O3/c1-26-20-12-18-19(13-21(20)27-2)23-14-24-22(18)25-15-8-10-17(11-9-15)28-16-6-4-3-5-7-16/h3-14H,1-2H3,(H,23,24,25) D0U2QT DRUGINKE DMWVGXGXHPOEPT-UHFFFAOYSA-N D0U2QT DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OC4=CC=CC=C4)OC D0U2QT HIGHSTAT Investigative D0U2QY DRUG__ID D0U2QY D0U2QY DRUGTYPE Small molecular drug D0U2QY DRUGINCH 1S/C14H15F5O/c15-13(16,14(17,18)19)12(20)10-6-2-5-9-11-7-3-1-4-8-11/h1,3-4,7-8H,2,5-6,9-10H2 D0U2QY DRUGINKE SZHLULFEEMJIQU-UHFFFAOYSA-N D0U2QY DRUGSMIL C1=CC=C(C=C1)CCCCCC(=O)C(C(F)(F)F)(F)F D0U2QY HIGHSTAT Investigative D0U2UJ DRUG__ID D0U2UJ D0U2UJ DRUGTYPE Small molecular drug D0U2UJ DRUGINCH 1S/C13H11N3O4/c17-12-8-10(16(19)20)6-7-11(12)15-13(18)14-9-4-2-1-3-5-9/h1-8,17H,(H2,14,15,18) D0U2UJ DRUGINKE SAUHQYBXEGARCC-UHFFFAOYSA-N D0U2UJ DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])O D0U2UJ HIGHSTAT Investigative D0U2VA DRUG__ID D0U2VA D0U2VA DRUGTYPE Small molecular drug D0U2VA DRUGINCH 1S/C17H11NO3/c19-10-7-8-14-16(9-10)21-17(18-14)13-5-1-4-12-11(13)3-2-6-15(12)20/h1-9,19-20H D0U2VA DRUGINKE JHOZVRGNIYFYHE-UHFFFAOYSA-N D0U2VA DRUGSMIL C1=CC2=C(C=CC=C2O)C(=C1)C3=NC4=C(O3)C=C(C=C4)O D0U2VA HIGHSTAT Investigative D0U2WU DRUG__ID D0U2WU D0U2WU DRUGTYPE Small molecular drug D0U2WU DRUGINCH 1S/C7H5IO4/c9-7(10)5-2-1-3-6(4-5)8(11)12/h1-4H,(H,9,10) D0U2WU DRUGINKE PXGYMLKSIXWMJW-UHFFFAOYSA-N D0U2WU DRUGSMIL C1=CC(=CC(=C1)I(=O)=O)C(=O)O D0U2WU HIGHSTAT Investigative D0U2XR DRUG__ID D0U2XR D0U2XR DRUGTYPE Small molecular drug D0U2XR DRUGINCH 1S/C13H18O2/c1-8(2)11-5-10(7-14)6-12(9(3)4)13(11)15/h5-9,15H,1-4H3 D0U2XR DRUGINKE WVGDLTQPAQUBMO-UHFFFAOYSA-N D0U2XR DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)C=O D0U2XR HIGHSTAT Investigative D0U2YL DRUG__ID D0U2YL D0U2YL DRUGTYPE Small molecular drug D0U2YL DRUGINCH 1S/C17H16N2O4/c18-17(20)19(21)10-12-8-13-9-15(6-7-16(13)22-11-12)23-14-4-2-1-3-5-14/h1-9,21H,10-11H2,(H2,18,20) D0U2YL DRUGINKE FPOBKZCHKXONBB-UHFFFAOYSA-N D0U2YL DRUGSMIL C1C(=CC2=C(O1)C=CC(=C2)OC3=CC=CC=C3)CN(C(=O)N)O D0U2YL HIGHSTAT Investigative D0U3DW DRUG__ID D0U3DW D0U3DW DRUGTYPE Small molecular drug D0U3DW DRUGINCH 1S/C25H33NO9/c1-12(2)22(31)17(34-16(28)14-7-6-10-26-14)23(32)18(4)11-21(30)19(22,5)25(23,33)24(35-21)15(27)13(3)8-9-20(18,24)29/h6-7,10,12,15,17,26-27,29-33H,3,8-9,11H2,1-2,4-5H3/t15-,17-,18+,19?,20?,21?,22?,23?,24?,25?/m1/s1 D0U3DW DRUGINKE BPFNBBLVUYSFRK-MKKQGFNNSA-N D0U3DW DRUGSMIL CC(C)C1(C(C2(C3(CC4(C1(C2(C5(C3(CCC(=C)C5O)O)O4)O)C)O)C)O)OC(=O)C6=CC=CN6)O D0U3DW HIGHSTAT Investigative D0U3GH DRUG__ID D0U3GH D0U3GH DRUGTYPE Small molecular drug D0U3GH DRUGINCH 1S/C14H12N2S/c1-10-5-7-11(8-6-10)17-14-4-2-3-13(16)12(14)9-15/h2-8H,16H2,1H3 D0U3GH DRUGINKE NLGYCJNCIXKPHK-UHFFFAOYSA-N D0U3GH DRUGSMIL CC1=CC=C(C=C1)SC2=CC=CC(=C2C#N)N D0U3GH HIGHSTAT Investigative D0U3GZ DRUG__ID D0U3GZ D0U3GZ DRUGTYPE Small molecular drug D0U3GZ DRUGINCH 1S/C10H14BrNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3 D0U3GZ DRUGINKE YMHOBZXQZVXHBM-UHFFFAOYSA-N D0U3GZ DRUGSMIL COC1=CC(=C(C=C1CCN)OC)Br D0U3GZ HIGHSTAT Investigative D0U3JD DRUG__ID D0U3JD D0U3JD DRUGTYPE Small molecular drug D0U3JD DRUGINCH 1S/C9H7NO2/c1-10-7-5-3-2-4-6(7)8(11)9(10)12/h2-5H,1H3 D0U3JD DRUGINKE VCYBVWFTGAZHGH-UHFFFAOYSA-N D0U3JD DRUGSMIL CN1C2=CC=CC=C2C(=O)C1=O D0U3JD HIGHSTAT Investigative D0U3LA DRUG__ID D0U3LA D0U3LA DRUGTYPE Small molecular drug D0U3LA DRUGINCH 1S/C15H11BrO4/c16-11-6-7-13(20-9-14(17)18)12(8-11)15(19)10-4-2-1-3-5-10/h1-8H,9H2,(H,17,18) D0U3LA DRUGINKE QCXHRPLPQPZWKP-UHFFFAOYSA-N D0U3LA DRUGSMIL C1=CC=C(C=C1)C(=O)C2=C(C=CC(=C2)Br)OCC(=O)O D0U3LA HIGHSTAT Investigative D0U3MB DRUG__ID D0U3MB D0U3MB DRUGTYPE Small molecular drug D0U3MB DRUGINCH 1S/C24H21N3O4/c28-21(27-31)15-14-17-8-7-9-18(16-17)22(23(29)25-19-10-3-1-4-11-19)24(30)26-20-12-5-2-6-13-20/h1-16,22,31H,(H,25,29)(H,26,30)(H,27,28)/b15-14+ D0U3MB DRUGINKE SQGNVWSNUGLNRK-CCEZHUSRSA-N D0U3MB DRUGSMIL C1=CC=C(C=C1)NC(=O)C(C2=CC=CC(=C2)C=CC(=O)NO)C(=O)NC3=CC=CC=C3 D0U3MB HIGHSTAT Investigative D0U3ME DRUG__ID D0U3ME D0U3ME DRUGTYPE Small molecular drug D0U3ME DRUGINCH 1S/C23H32/c1-6-7-8-9-14-23(4,5)22-12-10-20(11-13-22)21-16-18(2)15-19(3)17-21/h10-13,15-17H,6-9,14H2,1-5H3 D0U3ME DRUGINKE KOXFWOOFJAOOQK-UHFFFAOYSA-N D0U3ME DRUGSMIL CCCCCCC(C)(C)C1=CC=C(C=C1)C2=CC(=CC(=C2)C)C D0U3ME HIGHSTAT Investigative D0U3NI DRUG__ID D0U3NI D0U3NI DRUGTYPE Small molecular drug D0U3NI DRUGINCH 1S/C26H30N6O2/c1-17-11-12-27-25(34)23-15-18-9-10-19(16-22(18)32(17)23)24(33)29-26-28-20-7-4-5-8-21(20)31(26)14-6-13-30(2)3/h4-5,7-10,15-17H,6,11-14H2,1-3H3,(H,27,34)(H,28,29,33)/t17-/m1/s1 D0U3NI DRUGINKE ZHMXXVNQAFCXKK-QGZVFWFLSA-N D0U3NI DRUGSMIL CC1CCNC(=O)C2=CC3=C(N12)C=C(C=C3)C(=O)NC4=NC5=CC=CC=C5N4CCCN(C)C D0U3NI HIGHSTAT Investigative D0U3PC DRUG__ID D0U3PC D0U3PC DRUGTYPE Small molecular drug D0U3PC DRUGINCH 1S/C15H19NS/c16-15(9-5-1-2-6-10-15)14-11-12-7-3-4-8-13(12)17-14/h3-4,7-8,11H,1-2,5-6,9-10,16H2 D0U3PC DRUGINKE BCBMINBNEZGMJJ-UHFFFAOYSA-N D0U3PC DRUGSMIL C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N D0U3PC HIGHSTAT Investigative D0U3SB DRUG__ID D0U3SB D0U3SB DRUGTYPE Small molecular drug D0U3SB DRUGINCH 1S/C14H18BrNO/c1-11(16-8-3-2-4-9-16)14(17)12-6-5-7-13(15)10-12/h5-7,10-11H,2-4,8-9H2,1H3 D0U3SB DRUGINKE DNVMLFGJFSQQDE-UHFFFAOYSA-N D0U3SB DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Br)N2CCCCC2 D0U3SB HIGHSTAT Investigative D0U3UM DRUG__ID D0U3UM D0U3UM DRUGTYPE Small molecular drug D0U3UM DRUGINCH 1S/C22H28N4O3/c1-4-24(5-2)13-14-25-21-12-9-18(26(27)28)16-20(21)23-22(25)15-17-7-10-19(11-8-17)29-6-3/h7-12,16H,4-6,13-15H2,1-3H3 D0U3UM DRUGINKE PXDBZSCGSQSKST-UHFFFAOYSA-N D0U3UM DRUGSMIL CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCC D0U3UM HIGHSTAT Investigative D0U3WK DRUG__ID D0U3WK D0U3WK DRUGTYPE Small molecular drug D0U3WK DRUGINCH 1S/C18H22BrN3O/c1-3-22(15-8-6-7-14(2)13-15)12-11-20-18(23)21-17-10-5-4-9-16(17)19/h4-10,13H,3,11-12H2,1-2H3,(H2,20,21,23) D0U3WK DRUGINKE IFJYEGJUQIBBQV-UHFFFAOYSA-N D0U3WK DRUGSMIL CCN(CCNC(=O)NC1=CC=CC=C1Br)C2=CC=CC(=C2)C D0U3WK HIGHSTAT Investigative D0U3WQ DRUG__ID D0U3WQ D0U3WQ DRUGTYPE Small molecular drug D0U3WQ DRUGINCH 1S/C15H12N4S/c1-9-17-12-6-11-10(7-14(12)19(9)2)16-8-13(18-11)15-4-3-5-20-15/h3-8H,1-2H3 D0U3WQ DRUGINKE ZGDACLBJJXLKJY-UHFFFAOYSA-N D0U3WQ DRUGSMIL CC1=NC2=C(N1C)C=C3C(=C2)N=C(C=N3)C4=CC=CS4 D0U3WQ HIGHSTAT Investigative D0U3WW DRUG__ID D0U3WW D0U3WW DRUGTYPE Small molecular drug D0U3WW DRUGINCH 1S/C34H36N4O3S/c1-6-31-36-32-23(4)19-24(5)35-33(32)38(31)21-25-12-15-27(16-13-25)29-20-26(18-22(2)3)14-17-30(29)42(40,41)37-34(39)28-10-8-7-9-11-28/h7-17,19-20,22H,6,18,21H2,1-5H3,(H,37,39) D0U3WW DRUGINKE BRUYKNQQCIYYNP-UHFFFAOYSA-N D0U3WW DRUGSMIL CCC1=NC2=C(N1CC3=CC=C(C=C3)C4=C(C=CC(=C4)CC(C)C)S(=O)(=O)NC(=O)C5=CC=CC=C5)N=C(C=C2C)C D0U3WW HIGHSTAT Investigative D0U3YC DRUG__ID D0U3YC D0U3YC DRUGTYPE Small molecular drug D0U3YC DRUGINCH 1S/C12H12IN9O2/c1-21(2)12(24)22-10(17-19-20-22)6-15-11(23)7-3-4-9(16-18-14)8(13)5-7/h3-5H,6H2,1-2H3,(H,15,23) D0U3YC DRUGINKE QJNXEOBTVAWQME-UHFFFAOYSA-N D0U3YC DRUGSMIL CN(C)C(=O)N1C(=NN=N1)CNC(=O)C2=CC(=C(C=C2)N=[N+]=[N-])I D0U3YC HIGHSTAT Investigative D0U3YQ DRUG__ID D0U3YQ D0U3YQ DRUGTYPE Small molecular drug D0U3YQ DRUGINCH 1S/C9H5BrN2O3/c10-5-1-2-7-6(3-5)12-8(4-14-7)11-15-9(12)13/h1-3H,4H2 D0U3YQ DRUGINKE MUDRLQRJCGJJTB-UHFFFAOYSA-N D0U3YQ DRUGSMIL C1C2=NOC(=O)N2C3=C(O1)C=CC(=C3)Br D0U3YQ HIGHSTAT Investigative D0U3ZL DRUG__ID D0U3ZL D0U3ZL DRUGTYPE Small molecular drug D0U3ZL DRUGINCH 1S/C23H28N2O3/c26-22(11-12-23(27)28)25(20-9-5-2-6-10-20)21-14-17-24(18-15-21)16-13-19-7-3-1-4-8-19/h1-10,21H,11-18H2,(H,27,28) D0U3ZL DRUGINKE MEVFKTVEGJUHHI-UHFFFAOYSA-N D0U3ZL DRUGSMIL C1CN(CCC1N(C2=CC=CC=C2)C(=O)CCC(=O)O)CCC3=CC=CC=C3 D0U3ZL HIGHSTAT Investigative D0U3ZP DRUG__ID D0U3ZP D0U3ZP DRUGTYPE Small molecular drug D0U3ZP DRUGINCH 1S/C20H16N2O/c1-23-18-10-7-15(8-11-18)16-9-12-20-19(13-16)21-14-22(20)17-5-3-2-4-6-17/h2-14H,1H3 D0U3ZP DRUGINKE OPGUZRRLMQSMAQ-UHFFFAOYSA-N D0U3ZP DRUGSMIL COC1=CC=C(C=C1)C2=CC3=C(C=C2)N(C=N3)C4=CC=CC=C4 D0U3ZP HIGHSTAT Investigative D0U4BB DRUG__ID D0U4BB D0U4BB DRUGTYPE Small molecular drug D0U4BB DRUGINCH 1S/C10H8O3/c1-12-8-4-2-7-3-5-10(11)13-9(7)6-8/h2-6H,1H3 D0U4BB DRUGINKE LIIALPBMIOVAHH-UHFFFAOYSA-N D0U4BB DRUGSMIL COC1=CC2=C(C=C1)C=CC(=O)O2 D0U4BB HIGHSTAT Investigative D0U4BQ DRUG__ID D0U4BQ D0U4BQ DRUGTYPE Small molecular drug D0U4BQ DRUGINCH 1S/C13H9ClN2O2S/c14-10-4-1-2-6-13(10)19(17,18)12-7-3-5-11(16)9(12)8-15/h1-7H,16H2 D0U4BQ DRUGINKE NXUSIYJXPBRFJT-UHFFFAOYSA-N D0U4BQ DRUGSMIL C1=CC=C(C(=C1)S(=O)(=O)C2=CC=CC(=C2C#N)N)Cl D0U4BQ HIGHSTAT Investigative D0U4HG DRUG__ID D0U4HG D0U4HG DRUGTYPE Small molecular drug D0U4HG DRUGINCH 1S/C33H34O7/c1-38-31-19-27(36)15-8-23(31)9-16-28(21-4-11-25(34)12-5-21)29-18-24(32(39-2)20-33(29)40-3)10-17-30(37)22-6-13-26(35)14-7-22/h4-8,11-15,18-20,28,34-36H,9-10,16-17H2,1-3H3 D0U4HG DRUGINKE QFWXEYRQNKRQDH-UHFFFAOYSA-N D0U4HG DRUGSMIL COC1=CC(=C(C=C1CCC(=O)C2=CC=C(C=C2)O)C(CCC3=C(C=C(C=C3)O)OC)C4=CC=C(C=C4)O)OC D0U4HG HIGHSTAT Investigative D0U4HM DRUG__ID D0U4HM D0U4HM DRUGTYPE Small molecular drug D0U4HM DRUGINCH 1S/C6H12NO2P/c1-10(8,9)6-2-4-7-5-3-6/h2,7H,3-5H2,1H3,(H,8,9) D0U4HM DRUGINKE MFUKVPOVVKKLRQ-UHFFFAOYSA-N D0U4HM DRUGSMIL CP(=O)(C1=CCNCC1)O D0U4HM HIGHSTAT Investigative D0U4JD DRUG__ID D0U4JD D0U4JD DRUGTYPE Small molecular drug D0U4JD DRUGINCH 1S/C17H20N2O3/c18-17(21)16(11-20)19-10-13-6-8-15(9-7-13)22-12-14-4-2-1-3-5-14/h1-9,16,19-20H,10-12H2,(H2,18,21)/t16-/m0/s1 D0U4JD DRUGINKE JMIJOQDPXHRPOI-INIZCTEOSA-N D0U4JD DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)CNC(CO)C(=O)N D0U4JD HIGHSTAT Investigative D0U4JI DRUG__ID D0U4JI D0U4JI DRUGTYPE Small molecular drug D0U4JI DRUGINCH 1S/C24H40O2/c1-4-5-6-7-16-24(2,3)21-13-10-20(11-14-21)23-18-22(26)15-12-19(23)9-8-17-25/h10-11,13-14,19,22-23,25-26H,4-9,12,15-18H2,1-3H3/t19-,22-,23-/m1/s1 D0U4JI DRUGINKE BTHPTUSWFPTQIG-UEVCKROQSA-N D0U4JI DRUGSMIL CCCCCCC(C)(C)C1=CC=C(C=C1)C2CC(CCC2CCCO)O D0U4JI HIGHSTAT Investigative D0U4JL DRUG__ID D0U4JL D0U4JL DRUGTYPE Small molecular drug D0U4JL DRUGINCH 1S/C19H17NO4/c21-15-4-1-13(2-5-15)14-3-6-18-16(11-14)17(22)12-19(24-18)20-7-9-23-10-8-20/h1-6,11-12,21H,7-10H2 D0U4JL DRUGINKE JERFBKBQDMCBEI-UHFFFAOYSA-N D0U4JL DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=C(C=C4)O D0U4JL HIGHSTAT Investigative D0U4JW DRUG__ID D0U4JW D0U4JW DRUGTYPE Small molecular drug D0U4JW DRUGINCH 1S/C13H10N2O2S/c16-18(17,11-5-2-1-3-6-11)15-10-8-12-13(15)7-4-9-14-12/h1-10H D0U4JW DRUGINKE HGOGRVVSSAWHTO-UHFFFAOYSA-N D0U4JW DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)N2C=CC3=C2C=CC=N3 D0U4JW HIGHSTAT Investigative D0U4KM DRUG__ID D0U4KM D0U4KM DRUGTYPE Small molecular drug D0U4KM DRUGINCH 1S/C19H31N3O2/c1-2-17(23)22-5-3-16(4-6-22)20-18(24)21-19-10-13-7-14(11-19)9-15(8-13)12-19/h13-16H,2-12H2,1H3,(H2,20,21,24) D0U4KM DRUGINKE LFQPHKTUDTUJEA-UHFFFAOYSA-N D0U4KM DRUGSMIL CCC(=O)N1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D0U4KM HIGHSTAT Investigative D0U4LU DRUG__ID D0U4LU D0U4LU DRUGTYPE Small molecular drug D0U4LU DRUGINCH 1S/C36H47N5O4/c1-24-18-29(42)19-25(2)30(24)22-32(38)36(45)41-23-28-15-9-8-14-27(28)21-33(41)35(44)40-17-11-4-3-10-16-39-34(43)31(37)20-26-12-6-5-7-13-26/h5-9,12-15,18-19,31-33,42H,3-4,10-11,16-17,20-23,37-38H2,1-2H3,(H,39,43)(H,40,44)/t31-,32-,33?/m0/s1 D0U4LU DRUGINKE VWEMLWZEBKVSHE-KOPQTXDBSA-N D0U4LU DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCCCNC(=O)C(CC4=CC=CC=C4)N)N)C)O D0U4LU HIGHSTAT Investigative D0U4LV DRUG__ID D0U4LV D0U4LV DRUGTYPE Small molecular drug D0U4LV DRUGINCH 1S/C26H28O10/c1-10(2)5-12-17(11(3)4)26(19-23(34)13(6-27)20(31)14(7-28)24(19)35)36-25-16(9-30)21(32)15(8-29)22(33)18(12)25/h6-12,17,26,31-35H,5H2,1-4H3/t12-,17-,26+/m0/s1 D0U4LV DRUGINKE PHQDMQGEKNBIPF-GKZOTJLQSA-N D0U4LV DRUGSMIL CC(C)CC1C(C(OC2=C(C(=C(C(=C12)O)C=O)O)C=O)C3=C(C(=C(C(=C3O)C=O)O)C=O)O)C(C)C D0U4LV HIGHSTAT Investigative D0U4SG DRUG__ID D0U4SG D0U4SG DRUGTYPE Small molecular drug D0U4SG DRUGINCH 1S/C34H41N7O2/c1-2-19-41-30-13-7-6-12-29(30)31(25-9-4-3-5-10-25)37-32(33(41)42)38-34(43)36-26-14-16-27(17-15-26)39-20-22-40(23-21-39)28-11-8-18-35-24-28/h6-8,11-18,24-25,32H,2-5,9-10,19-23H2,1H3,(H2,36,38,43) D0U4SG DRUGINKE AIHOVEHIRAAXQV-UHFFFAOYSA-N D0U4SG DRUGSMIL CCCN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC=C(C=C3)N4CCN(CC4)C5=CN=CC=C5)C6CCCCC6 D0U4SG HIGHSTAT Investigative D0U4SS DRUG__ID D0U4SS D0U4SS DRUGCOMP Curacyte AG D0U4SS DRUGINCH 1S/C21H22N6O/c1-2-28-20-19-18(25-21(26-20)27-11-9-23-10-12-27)16-4-3-15(13-17(16)24-19)14-5-7-22-8-6-14/h3-8,13,23-24H,2,9-12H2,1H3 D0U4SS DRUGINKE HFGHRUCCKVYFKL-UHFFFAOYSA-N D0U4SS DRUGSMIL CCOC1=NC(=NC2=C1NC3=C2C=CC(=C3)C4=CC=NC=C4)N5CCNCC5 D0U4SS HIGHSTAT Investigative D0U4TA DRUG__ID D0U4TA D0U4TA DRUGTYPE Small molecular drug D0U4TA DRUGINCH 1S/C11H13N3O/c12-7-10(14-11(15)8-13)6-9-4-2-1-3-5-9/h1-5,10H,6,8,13H2,(H,14,15)/t10-/m0/s1 D0U4TA DRUGINKE QLVGHFBUSGYCCG-JTQLQIEISA-N D0U4TA DRUGSMIL C1=CC=C(C=C1)CC(C#N)NC(=O)CN D0U4TA HIGHSTAT Investigative D0U4TN DRUG__ID D0U4TN D0U4TN DRUGTYPE Small molecular drug D0U4TN DRUGINCH 1S/C20H21NO2/c1-2-3-4-5-10-15-11-6-9-14-18(15)21-19(22)16-12-7-8-13-17(16)20(21)23/h6-9,11-14H,2-5,10H2,1H3 D0U4TN DRUGINKE USXHUJLIZBGCGH-UHFFFAOYSA-N D0U4TN DRUGSMIL CCCCCCC1=CC=CC=C1N2C(=O)C3=CC=CC=C3C2=O D0U4TN HIGHSTAT Investigative D0U4TY DRUG__ID D0U4TY D0U4TY DRUGTYPE Small molecular drug D0U4TY DRUGINCH 1S/C15H21N3/c1-2-7-13-10-14(18-15(11-16)17-13)12-8-5-3-4-6-9-12/h10,12H,2-9H2,1H3 D0U4TY DRUGINKE UOAUUFFKQMFGTJ-UHFFFAOYSA-N D0U4TY DRUGSMIL CCCC1=CC(=NC(=N1)C#N)C2CCCCCC2 D0U4TY HIGHSTAT Investigative D0U4VL DRUG__ID D0U4VL D0U4VL DRUGTYPE Small molecular drug D0U4VL DRUGINCH 1S/C19H24O3/c1-13(2)5-8-16-11-15(7-10-18(20)21)12-17(19(16)22)9-6-14(3)4/h5-7,10-12,22H,8-9H2,1-4H3,(H,20,21)/b10-7+ D0U4VL DRUGINKE KABCFARPAMSXCC-JXMROGBWSA-N D0U4VL DRUGSMIL CC(=CCC1=CC(=CC(=C1O)CC=C(C)C)C=CC(=O)O)C D0U4VL HIGHSTAT Investigative D0U4VW DRUG__ID D0U4VW D0U4VW DRUGTYPE Small molecular drug D0U4VW DRUGINCH 1S/C27H34N4O9/c1-5-39-26(38)31-12-10-30(11-13-31)24(35)18(8-9-22(32)33)29-23(34)20-15-21(40-27(3,4)25(36)37)17-7-6-16(2)14-19(17)28-20/h6-7,14-15,18H,5,8-13H2,1-4H3,(H,29,34)(H,32,33)(H,36,37) D0U4VW DRUGINKE MCBLPJPMVOVJCO-UHFFFAOYSA-N D0U4VW DRUGSMIL CCOC(=O)N1CCN(CC1)C(=O)C(CCC(=O)O)NC(=O)C2=NC3=C(C=CC(=C3)C)C(=C2)OC(C)(C)C(=O)O D0U4VW HIGHSTAT Investigative D0U4WP DRUG__ID D0U4WP D0U4WP DRUGTYPE Small molecular drug D0U4WP DRUGINCH 1S/C31H32Cl2FN3O2/c1-36(30(39)21-6-9-25(34)10-7-21)20-24(22-8-11-27(32)28(33)18-22)12-15-37-16-13-31(14-17-37)26-5-3-2-4-23(26)19-29(38)35-31/h2-11,18,24H,12-17,19-20H2,1H3,(H,35,38) D0U4WP DRUGINKE MIXOPBNZLJBQJH-UHFFFAOYSA-N D0U4WP DRUGSMIL CN(CC(CCN1CCC2(CC1)C3=CC=CC=C3CC(=O)N2)C4=CC(=C(C=C4)Cl)Cl)C(=O)C5=CC=C(C=C5)F D0U4WP HIGHSTAT Investigative D0U4ZS DRUG__ID D0U4ZS D0U4ZS DRUGTYPE Small molecular drug D0U4ZS DRUGINCH 1S/C24H28N2O2/c1-4-24(2,3)15-19-16-25-22(26-19)14-11-17-9-12-18(13-10-17)20-7-5-6-8-21(20)23(27)28/h5-10,12-13,16H,4,11,14-15H2,1-3H3,(H,25,26)(H,27,28) D0U4ZS DRUGINKE AXHVEQQLKVIZLO-UHFFFAOYSA-N D0U4ZS DRUGSMIL CCC(C)(C)CC1=CN=C(N1)CCC2=CC=C(C=C2)C3=CC=CC=C3C(=O)O D0U4ZS HIGHSTAT Investigative D0U4ZV DRUG__ID D0U4ZV D0U4ZV DRUGTYPE Small molecular drug D0U4ZV DRUGINCH 1S/C10H13BClN5O9P2/c11-27(20,26-28(21,22)23)24-1-3-5(18)6(19)9(25-3)17-2-14-4-7(13)15-10(12)16-8(4)17/h2-3,5-6,9,18-19H,1H2,(H2,13,15,16)(H2,21,22,23)/q-1/t3-,5-,6-,9-,27-/m1/s1 D0U4ZV DRUGINKE XLTJNJOUVKOQCW-MWZJDIDNSA-N D0U4ZV DRUGSMIL [B-]P(=O)(OCC1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)N)O)O)OP(=O)(O)O D0U4ZV HIGHSTAT Investigative D0U5DH DRUG__ID D0U5DH D0U5DH DRUGTYPE Small molecular drug D0U5DH DRUGINCH 1S/C21H24ClNO2/c1-25-21(24)20(17-7-3-2-4-8-17)19-9-5-6-14-23(19)15-16-10-12-18(22)13-11-16/h2-4,7-8,10-13,19-20H,5-6,9,14-15H2,1H3/t19-,20-/m1/s1 D0U5DH DRUGINKE SUYRDAUAEDYGHW-WOJBJXKFSA-N D0U5DH DRUGSMIL COC(=O)C(C1CCCCN1CC2=CC=C(C=C2)Cl)C3=CC=CC=C3 D0U5DH HIGHSTAT Investigative D0U5GF DRUG__ID D0U5GF D0U5GF DRUGTYPE Small molecular drug D0U5GF DRUGINCH 1S/C17H15N3/c1-12(20-9-8-18-11-20)13-6-7-15-14-4-2-3-5-16(14)19-17(15)10-13/h2-12,19H,1H3 D0U5GF DRUGINKE VCFYTQOGKYSBGI-UHFFFAOYSA-N D0U5GF DRUGSMIL CC(C1=CC2=C(C=C1)C3=CC=CC=C3N2)N4C=CN=C4 D0U5GF HIGHSTAT Investigative D0U5HC DRUG__ID D0U5HC D0U5HC DRUGTYPE Small molecular drug D0U5HC DRUGINCH 1S/C6H15NO/c1-5(2)3-6(7)4-8/h5-6,8H,3-4,7H2,1-2H3/t6-/m0/s1 D0U5HC DRUGINKE VPSSPAXIFBTOHY-LURJTMIESA-N D0U5HC DRUGSMIL CC(C)CC(CO)N D0U5HC HIGHSTAT Investigative D0U5HQ DRUG__ID D0U5HQ D0U5HQ DRUGTYPE Small molecular drug D0U5HQ DRUGINCH 1S/C13H18N2O/c1-14(2)8-9-15-7-6-11-4-5-12(16-3)10-13(11)15/h4-7,10H,8-9H2,1-3H3 D0U5HQ DRUGINKE VIEWFQAHIRFETA-UHFFFAOYSA-N D0U5HQ DRUGSMIL CN(C)CCN1C=CC2=C1C=C(C=C2)OC D0U5HQ HIGHSTAT Investigative D0U5HS DRUG__ID D0U5HS D0U5HS DRUGTYPE Small molecular drug D0U5HS DRUGINCH 1S/C23H27N3O6S2/c24-33(28,29)23-8-4-5-21(15-23)32-17-20(27)16-25-14-13-18-9-11-19(12-10-18)26-34(30,31)22-6-2-1-3-7-22/h1-12,15,20,25-27H,13-14,16-17H2,(H2,24,28,29)/t20-/m0/s1 D0U5HS DRUGINKE CVPJSQZQNBKALR-FQEVSTJZSA-N D0U5HS DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CCNCC(COC3=CC(=CC=C3)S(=O)(=O)N)O D0U5HS HIGHSTAT Investigative D0U5HX DRUG__ID D0U5HX D0U5HX DRUGTYPE Small molecular drug D0U5HX DRUGINCH 1S/C23H15ClO7/c1-7-4-9-5-12(25)16-17(14(9)22(30-3)18(7)24)19(26)10-6-11-13(8(2)31-23(11)29)20(27)15(10)21(16)28/h4-6,8,25,27H,1-3H3 D0U5HX DRUGINKE RSSUHOCYQSARQQ-UHFFFAOYSA-N D0U5HX DRUGSMIL CC1C2=C(C3=C(C=C2C(=O)O1)C(=O)C4=C5C(=CC(=C4C3=O)O)C=C(C(=C5OC)Cl)C)O D0U5HX HIGHSTAT Investigative D0U5KF DRUG__ID D0U5KF D0U5KF DRUGTYPE Small molecular drug D0U5KF DRUGINCH 1S/C9H12NO4P/c11-15(12,13)14-8-5-1-3-7-4-2-6-10-9(7)8/h1,3,5,10H,2,4,6H2,(H2,11,12,13) D0U5KF DRUGINKE NSJSAHCLJYVEDM-UHFFFAOYSA-N D0U5KF DRUGSMIL C1CC2=C(C(=CC=C2)OP(=O)(O)O)NC1 D0U5KF HIGHSTAT Investigative D0U5KM DRUG__ID D0U5KM D0U5KM DRUGTYPE Small molecular drug D0U5KM DRUGINCH 1S/C34H43N11O5/c1-20(46)42-29(16-23-18-38-19-41-23)33(50)45-28(14-21-8-3-2-4-9-21)32(49)43-26(12-7-13-39-34(36)37)31(48)44-27(30(35)47)15-22-17-40-25-11-6-5-10-24(22)25/h2-6,8-11,17-19,26-29,40H,7,12-16H2,1H3,(H2,35,47)(H,38,41)(H,42,46)(H,43,49)(H,44,48)(H,45,50)(H4,36,37,39)/t26-,27-,28+,29-/m0/s1 D0U5KM DRUGINKE DFCJPPDAOZROBS-FKWFRFQNSA-N D0U5KM DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)N D0U5KM HIGHSTAT Investigative D0U5LL DRUG__ID D0U5LL D0U5LL DRUGTYPE Small molecular drug D0U5LL DRUGINCH 1S/C21H26O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h9-13,22H,5-8H2,1-4H3 D0U5LL DRUGINKE VBGLYOIFKLUMQG-UHFFFAOYSA-N D0U5LL DRUGSMIL CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O D0U5LL HIGHSTAT Investigative D0U5ML DRUG__ID D0U5ML D0U5ML DRUGTYPE Small molecular drug D0U5ML DRUGINCH 1S/C26H30N6O3/c1-26(2,3)24(31-23(33)15-17-11-12-21(34-4)22(14-17)35-5)32-25(29-16-27)30-20-10-6-9-19-18(20)8-7-13-28-19/h6-14,24H,15H2,1-5H3,(H,31,33)(H2,29,30,32) D0U5ML DRUGINKE PUHSRMSFDASMAE-UHFFFAOYSA-N D0U5ML DRUGSMIL CC(C)(C)C(NC(=O)CC1=CC(=C(C=C1)OC)OC)N=C(NC#N)NC2=CC=CC3=C2C=CC=N3 D0U5ML HIGHSTAT Investigative D0U5NA DRUG__ID D0U5NA D0U5NA DRUGTYPE Small molecular drug D0U5NA DRUGINCH 1S/C26H26N4O5/c1-29(21-11-4-2-5-12-21)24(32)18-30(22-13-6-3-7-14-22)23(31)17-27-26(35)28-20-10-8-9-19(15-20)16-25(33)34/h2-15H,16-18H2,1H3,(H,33,34)(H2,27,28,35) D0U5NA DRUGINKE CRUWRCOXWORZBA-UHFFFAOYSA-N D0U5NA DRUGSMIL CN(C1=CC=CC=C1)C(=O)CN(C2=CC=CC=C2)C(=O)CNC(=O)NC3=CC=CC(=C3)CC(=O)O D0U5NA HIGHSTAT Investigative D0U5OP DRUG__ID D0U5OP D0U5OP DRUGTYPE Small molecular drug D0U5OP DRUGINCH 1S/C20H15N3O/c24-19-11-5-10-18(13-19)23-14-21-22-20(23)17-9-4-8-16(12-17)15-6-2-1-3-7-15/h1-14,24H D0U5OP DRUGINKE XGXZTGGFJHBJDN-UHFFFAOYSA-N D0U5OP DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)C3=NN=CN3C4=CC(=CC=C4)O D0U5OP HIGHSTAT Investigative D0U5PC DRUG__ID D0U5PC D0U5PC DRUGTYPE Small molecular drug D0U5PC DRUGINCH 1S/C16H21ClO3/c17-13-8-9-15(20-10-4-7-16(18)19)14(11-13)12-5-2-1-3-6-12/h8-9,11-12H,1-7,10H2,(H,18,19) D0U5PC DRUGINKE BDEUQTBTFVDWEA-UHFFFAOYSA-N D0U5PC DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)Cl)OCCCC(=O)O D0U5PC HIGHSTAT Investigative D0U5QL DRUG__ID D0U5QL D0U5QL DRUGTYPE Small molecular drug D0U5QL DRUGINCH 1S/C16H21NO2/c1-11-5-2-8-14(18)15(11)16(19)12-6-3-9-17-10-4-7-13(12)17/h2,6,8,11,13,15H,3-5,7,9-10H2,1H3/t11-,13-,15+/m0/s1 D0U5QL DRUGINKE FKYCJVGMJYUVIJ-CORIIIEPSA-N D0U5QL DRUGSMIL CC1CC=CC(=O)C1C(=O)C2=CCCN3C2CCC3 D0U5QL HIGHSTAT Investigative D0U5TK DRUG__ID D0U5TK D0U5TK DRUGTYPE Small molecular drug D0U5TK DRUGINCH 1S/C29H35N7O3/c30-28(31)33-17-7-12-24(26(37)34-18-20-13-15-21(16-14-20)19-35-29(32)39)36-27(38)25(22-8-3-1-4-9-22)23-10-5-2-6-11-23/h1-6,8-11,13-16,24-25H,7,12,17-19H2,(H,34,37)(H,36,38)(H4,30,31,33)(H3,32,35,39)/t24-/m1/s1 D0U5TK DRUGINKE TVMJSGGZULFVCZ-XMMPIXPASA-N D0U5TK DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NCC3=CC=C(C=C3)CNC(=O)N D0U5TK HIGHSTAT Investigative D0U5TP DRUG__ID D0U5TP D0U5TP DRUGTYPE Small molecular drug D0U5TP DRUGINCH 1S/C27H46O2/c1-17(2)7-6-8-18(3)22-11-12-23-21-10-9-19-15-20(28)16-25(29)27(19,5)24(21)13-14-26(22,23)4/h9,17-18,20-25,28-29H,6-8,10-16H2,1-5H3/t18-,20+,21-,22+,23-,24-,25?,26+,27-/m0/s1 D0U5TP DRUGINKE UXFVRWPSABSGRQ-GFHPJIRMSA-N D0U5TP DRUGSMIL CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(C(CC(C4)O)O)C)C D0U5TP HIGHSTAT Investigative D0U5US DRUG__ID D0U5US D0U5US DRUGTYPE Small molecular drug D0U5US DRUGINCH 1S/C12H27O3P/c1-2-3-4-5-6-7-8-9-10-11-12-16(13,14)15/h2-12H2,1H3,(H2,13,14,15) D0U5US DRUGINKE SVMUEEINWGBIPD-UHFFFAOYSA-N D0U5US DRUGSMIL CCCCCCCCCCCCP(=O)(O)O D0U5US HIGHSTAT Investigative D0U5WY DRUG__ID D0U5WY D0U5WY DRUGTYPE Small molecular drug D0U5WY DRUGINCH 1S/C16H21N3O/c20-16-13-7-2-3-8-14(13)17-15(18-16)9-6-12-19-10-4-1-5-11-19/h2-3,7-8H,1,4-6,9-12H2,(H,17,18,20) D0U5WY DRUGINKE HDVNQQSSIKDDKS-UHFFFAOYSA-N D0U5WY DRUGSMIL C1CCN(CC1)CCCC2=NC3=CC=CC=C3C(=O)N2 D0U5WY HIGHSTAT Investigative D0U5YT DRUG__ID D0U5YT D0U5YT DRUGTYPE Small molecular drug D0U5YT DRUGINCH 1S/C8H9NO3/c9-7(8(11)12)5-2-1-3-6(10)4-5/h1-4,7,10H,9H2,(H,11,12)/t7-/m0/s1 D0U5YT DRUGINKE DQLYTFPAEVJTFM-ZETCQYMHSA-N D0U5YT DRUGSMIL C1=CC(=CC(=C1)O)C(C(=O)O)N D0U5YT HIGHSTAT Investigative D0U6BT DRUG__ID D0U6BT D0U6BT DRUGTYPE Small molecular drug D0U6BT DRUGINCH 1S/C16H23N/c1-3-9-15(10-4-1)16(11-5-2-6-12-16)17-13-7-8-14-17/h1,3-4,9-10H,2,5-8,11-14H2 D0U6BT DRUGINKE FYOWWXMGDATDQY-UHFFFAOYSA-N D0U6BT DRUGSMIL C1CCC(CC1)(C2=CC=CC=C2)N3CCCC3 D0U6BT HIGHSTAT Investigative D0U6DZ DRUG__ID D0U6DZ D0U6DZ DRUGTYPE Small molecular drug D0U6DZ DRUGINCH 1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10)/p-1/t1-,2+/m0/s1 D0U6DZ DRUGINKE YYLQUHNPNCGKJQ-NHYDCYSISA-M D0U6DZ DRUGSMIL C(C(C(=O)[O-])O)(C(=O)[O-])[NH3+] D0U6DZ HIGHSTAT Investigative D0U6FH DRUG__ID D0U6FH D0U6FH DRUGTYPE Small molecular drug D0U6FH DRUGINCH 1S/C12H17ClO/c1-7(2)10-5-9(13)6-11(8(3)4)12(10)14/h5-8,14H,1-4H3 D0U6FH DRUGINKE ZRTAKZQCHCQFAB-UHFFFAOYSA-N D0U6FH DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)Cl D0U6FH HIGHSTAT Investigative D0U6FM DRUG__ID D0U6FM D0U6FM DRUGTYPE Small molecular drug D0U6FM DRUGINCH 1S/C48H78N14O8/c1-4-6-8-20-39(64)57-35(18-13-26-55-47(51)52)42(66)60-37(28-31-15-9-7-10-16-31)45(69)61-38(29-32-21-23-33(63)24-22-32)44(68)59-36(19-14-27-56-48(53)54)43(67)62-40(30(3)5-2)46(70)58-34(41(50)65)17-11-12-25-49/h7,9-10,15-16,21-24,30,34-38,40,63H,4-6,8,11-14,17-20,25-29,49H2,1-3H3,(H2,50,65)(H,57,64)(H,58,70)(H,59,68)(H,60,66)(H,61,69)(H,62,67)(H4,51,52,55)(H4,53,54,56)/t30-,34-,35-,36-,37-,38-,40-/m0/s1 D0U6FM DRUGINKE BULLVLNXUBKWQF-GCRPBELOSA-N D0U6FM DRUGSMIL CCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)N D0U6FM HIGHSTAT Investigative D0U6IL DRUG__ID D0U6IL D0U6IL DRUGTYPE Small molecular drug D0U6IL DRUGINCH 1S/C10H13NO3/c11-5-9-6-1-2-8(12)10(13)7(6)3-4-14-9/h1-2,9,12-13H,3-5,11H2 D0U6IL DRUGINKE JBSRTZUQAXYSQB-UHFFFAOYSA-N D0U6IL DRUGSMIL C1COC(C2=C1C(=C(C=C2)O)O)CN D0U6IL HIGHSTAT Investigative D0U6IT DRUG__ID D0U6IT D0U6IT DRUGTYPE Small molecular drug D0U6IT DRUGINCH 1S/C14H13NOS/c1-16-12-4-5-14-10(6-12)2-3-11(14)7-13-8-15-9-17-13/h4-9H,2-3H2,1H3/b11-7- D0U6IT DRUGINKE YBVSJXCRZPLUNH-XFFZJAGNSA-N D0U6IT DRUGSMIL COC1=CC2=C(C=C1)C(=CC3=CN=CS3)CC2 D0U6IT HIGHSTAT Investigative D0U6JI DRUG__ID D0U6JI D0U6JI DRUGTYPE Small molecular drug D0U6JI DRUGINCH 1S/C20H19NO/c1-2-20(17-10-12-21-13-11-17)16-8-6-15(7-9-16)18-4-3-5-19(22)14-18/h3-14,20,22H,2H2,1H3 D0U6JI DRUGINKE CANWOPWELBFZMH-UHFFFAOYSA-N D0U6JI DRUGSMIL CCC(C1=CC=C(C=C1)C2=CC(=CC=C2)O)C3=CC=NC=C3 D0U6JI HIGHSTAT Investigative D0U6KE DRUG__ID D0U6KE D0U6KE DRUGTYPE Small molecular drug D0U6KE DRUGINCH 1S/C18H18N2/c19-17-11-7-15(8-12-17)5-3-1-2-4-6-16-9-13-18(20)14-10-16/h1-14H,19-20H2/b2-1+,5-3+,6-4+ D0U6KE DRUGINKE IZOOKGZEMKOBQA-CRQXNEITSA-N D0U6KE DRUGSMIL C1=CC(=CC=C1C=CC=CC=CC2=CC=C(C=C2)N)N D0U6KE HIGHSTAT Investigative D0U6NJ DRUG__ID D0U6NJ D0U6NJ DRUGTYPE Small molecular drug D0U6NJ DRUGINCH 1S/C14H12N2O3/c17-14-9-13(11-3-1-2-4-12(11)19-14)18-8-7-16-6-5-15-10-16/h1-6,9-10H,7-8H2 D0U6NJ DRUGINKE MXJNKMWQNZHBOE-UHFFFAOYSA-N D0U6NJ DRUGSMIL C1=CC=C2C(=C1)C(=CC(=O)O2)OCCN3C=CN=C3 D0U6NJ HIGHSTAT Investigative D0U6NZ DRUG__ID D0U6NZ D0U6NZ DRUGTYPE Small molecular drug D0U6NZ DRUGINCH 1S/C18H22N6O4/c19-11-3-1-10(2-4-11)5-6-20-16-13-17(22-8-21-16)24(9-23-13)18-15(27)14(26)12(7-25)28-18/h1-4,8-9,12,14-15,18,25-27H,5-7,19H2,(H,20,21,22) D0U6NZ DRUGINKE XTPOZVLRZZIEBW-UHFFFAOYSA-N D0U6NZ DRUGSMIL C1=CC(=CC=C1CCNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N D0U6NZ HIGHSTAT Investigative D0U6OA DRUG__ID D0U6OA D0U6OA DRUGTYPE Small molecular drug D0U6OA DRUGINCH 1S/C44H55N9O10/c1-3-4-13-33(42(61)53-36(22-38(56)57)44(63)52-34(39(46)58)20-26-10-6-5-7-11-26)51-43(62)35(21-28-23-47-32-14-9-8-12-30(28)32)50-37(55)24-48-40(59)25(2)49-41(60)31(45)19-27-15-17-29(54)18-16-27/h5-12,14-18,23,25,31,33-36,47,54H,3-4,13,19-22,24,45H2,1-2H3,(H2,46,58)(H,48,59)(H,49,60)(H,50,55)(H,51,62)(H,52,63)(H,53,61)(H,56,57)/t25-,31+,33+,34+,35+,36+/m1/s1 D0U6OA DRUGINKE LTNSZIYAGMZDDY-QMXRFRSXSA-N D0U6OA DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N D0U6OA HIGHSTAT Investigative D0U6QM DRUG__ID D0U6QM D0U6QM DRUGTYPE Small molecular drug D0U6QM DRUGINCH 1S/C10H9IN2/c11-10-3-1-9(2-4-10)7-13-6-5-12-8-13/h1-6,8H,7H2 D0U6QM DRUGINKE WZKZRSOWLZKJCL-UHFFFAOYSA-N D0U6QM DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)I D0U6QM HIGHSTAT Investigative D0U6SQ DRUG__ID D0U6SQ D0U6SQ DRUGTYPE Small molecular drug D0U6SQ DRUGINCH 1S/C7H10N2O2/c1-2-3-5-4-6(7(10)11)9-8-5/h4H,2-3H2,1H3,(H,8,9)(H,10,11) D0U6SQ DRUGINKE QYPSYPPSHXDFLV-UHFFFAOYSA-N D0U6SQ DRUGSMIL CCCC1=CC(=NN1)C(=O)O D0U6SQ HIGHSTAT Investigative D0U6TM DRUG__ID D0U6TM D0U6TM DRUGTYPE Small molecular drug D0U6TM DRUGINCH 1S/C22H39NO/c1-2-3-4-5-6-7-8-9-10-23-21(24)17-22-14-18-11-19(15-22)13-20(12-18)16-22/h18-20H,2-17H2,1H3,(H,23,24) D0U6TM DRUGINKE CIOJRKYNUJJCLZ-UHFFFAOYSA-N D0U6TM DRUGSMIL CCCCCCCCCCNC(=O)CC12CC3CC(C1)CC(C3)C2 D0U6TM HIGHSTAT Investigative D0U6WB DRUG__ID D0U6WB D0U6WB DRUGTYPE Small molecular drug D0U6WB DRUGINCH 1S/C16H12BrN5/c1-22-9-20-14-6-12-13(7-15(14)22)18-8-19-16(12)21-11-4-2-3-10(17)5-11/h2-9H,1H3,(H,18,19,21) D0U6WB DRUGINKE YAMAGACQNDAKFB-UHFFFAOYSA-N D0U6WB DRUGSMIL CN1C=NC2=C1C=C3C(=C2)C(=NC=N3)NC4=CC(=CC=C4)Br D0U6WB HIGHSTAT Investigative D0U6ZD DRUG__ID D0U6ZD D0U6ZD DRUGTYPE Small molecular drug D0U6ZD DRUGINCH 1S/C4H9NO2S/c5-3(1-2-8)4(6)7/h3,8H,1-2,5H2,(H,6,7)/t3-/m0/s1 D0U6ZD DRUGINKE FFFHZYDWPBMWHY-VKHMYHEASA-N D0U6ZD DRUGSMIL C(CS)C(C(=O)O)N D0U6ZD HIGHSTAT Investigative D0U7BH DRUG__ID D0U7BH D0U7BH DRUGTYPE Small molecular drug D0U7BH DRUGINCH 1S/C10H12F3N/c1-7(14)5-8-3-2-4-9(6-8)10(11,12)13/h2-4,6-7H,5,14H2,1H3/t7-/m0/s1 D0U7BH DRUGINKE MLBHFBKZUPLWBD-ZETCQYMHSA-N D0U7BH DRUGSMIL CC(CC1=CC(=CC=C1)C(F)(F)F)N D0U7BH HIGHSTAT Investigative D0U7BI DRUG__ID D0U7BI D0U7BI DRUGTYPE Small molecular drug D0U7BI DRUGINCH 1S/C17H18N4O5/c1-8(2)25-17(22)13-9(3)18-10(4)16(21(23)24)14(13)11-6-5-7-12-15(11)20-26-19-12/h5-8,14,18H,1-4H3 D0U7BI DRUGINKE LYFZEFDZKPJBJK-UHFFFAOYSA-N D0U7BI DRUGSMIL CC1=C(C(C(=C(N1)C)[N+](=O)[O-])C2=CC=CC3=NON=C32)C(=O)OC(C)C D0U7BI HIGHSTAT Investigative D0U7BJ DRUG__ID D0U7BJ D0U7BJ DRUGTYPE Small molecular drug D0U7BJ DRUGINCH 1S/C17H17N3O/c1-2-10-19-15(4-1)5-3-13-21-17-8-6-16(7-9-17)20-12-11-18-14-20/h1-2,4,6-12,14H,3,5,13H2 D0U7BJ DRUGINKE UGLPVHLKYTWQRV-UHFFFAOYSA-N D0U7BJ DRUGSMIL C1=CC=NC(=C1)CCCOC2=CC=C(C=C2)N3C=CN=C3 D0U7BJ HIGHSTAT Investigative D0U7BQ DRUG__ID D0U7BQ D0U7BQ DRUGTYPE Small molecular drug D0U7BQ DRUGINCH 1S/C20H15NO2S/c1-14-8-2-5-11-17(14)23-20(22)21-15-9-3-6-12-18(15)24-19-13-7-4-10-16(19)21/h2-13H,1H3 D0U7BQ DRUGINKE GUKIJFIFHIRCFR-UHFFFAOYSA-N D0U7BQ DRUGSMIL CC1=CC=CC=C1OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0U7BQ HIGHSTAT Investigative D0U7BY DRUG__ID D0U7BY D0U7BY DRUGTYPE Small molecular drug D0U7BY DRUGINCH 1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6) D0U7BY DRUGINKE MUBZPKHOEPUJKR-UHFFFAOYSA-N D0U7BY DRUGSMIL C(=O)(C(=O)O)O D0U7BY HIGHSTAT Investigative D0U7CD DRUG__ID D0U7CD D0U7CD DRUGTYPE Small molecular drug D0U7CD DRUGINCH 1S/C27H24N4O5/c32-24-18-25(33)28-26(34)27(24,21-8-6-20(7-9-21)19-4-2-1-3-5-19)30-16-14-29(15-17-30)22-10-12-23(13-11-22)31(35)36/h1-13H,14-18H2,(H,28,33,34) D0U7CD DRUGINKE VWJFDSFQMZGQHZ-UHFFFAOYSA-N D0U7CD DRUGSMIL C1CN(CCN1C2=CC=C(C=C2)[N+](=O)[O-])C3(C(=O)CC(=O)NC3=O)C4=CC=C(C=C4)C5=CC=CC=C5 D0U7CD HIGHSTAT Investigative D0U7CJ DRUG__ID D0U7CJ D0U7CJ DRUGTYPE Small molecular drug D0U7CJ DRUGINCH 1S/C13H14N6O3/c1-21-6-3-5(4-7(22-2)9(6)20)11-16-8-10(14)17-13(15)19-12(8)18-11/h3-4,20H,1-2H3,(H5,14,15,16,17,18,19) D0U7CJ DRUGINKE TWOVCAQBEASXFN-UHFFFAOYSA-N D0U7CJ DRUGSMIL COC1=CC(=CC(=C1O)OC)C2=NC3=NC(=NC(=C3N2)N)N D0U7CJ HIGHSTAT Investigative D0U7DJ DRUG__ID D0U7DJ D0U7DJ DRUGTYPE Small molecular drug D0U7DJ DRUGINCH 1S/C26H27NO2/c1-26-11-10-22-21-9-7-20(28)13-18(21)6-8-23(22)24(26)14-19(25(26)29)12-16-2-4-17(15-27)5-3-16/h2-5,7,9,12-13,22-25,28-29H,6,8,10-11,14H2,1H3/b19-12+/t22?,23?,24?,25-,26-/m0/s1 D0U7DJ DRUGINKE RMEMBAHSFFEOKG-HNTYVEMZSA-N D0U7DJ DRUGSMIL CC12CCC3C(C1CC(=CC4=CC=C(C=C4)C#N)C2O)CCC5=C3C=CC(=C5)O D0U7DJ HIGHSTAT Investigative D0U7DO DRUG__ID D0U7DO D0U7DO DRUGTYPE Small molecular drug D0U7DO DRUGINCH 1S/C9H17NO6/c1-4(12)10-6-8(14)7(13)5(3-11)16-9(6)15-2/h5-9,11,13-14H,3H2,1-2H3,(H,10,12)/t5-,6-,7-,8-,9-/m1/s1 D0U7DO DRUGINKE ZEVOCXOZYFLVKN-JGKVKWKGSA-N D0U7DO DRUGSMIL CC(=O)NC1C(C(C(OC1OC)CO)O)O D0U7DO HIGHSTAT Investigative D0U7EG DRUG__ID D0U7EG D0U7EG DRUGTYPE Small molecular drug D0U7EG DRUGINCH 1S/C16H14N2O/c1-10-4-3-5-12(8-10)14-9-15(19)13-7-6-11(2)17-16(13)18-14/h3-9H,1-2H3,(H,17,18,19) D0U7EG DRUGINKE WHANICGPAJMUTA-UHFFFAOYSA-N D0U7EG DRUGSMIL CC1=CC(=CC=C1)C2=CC(=O)C3=C(N2)N=C(C=C3)C D0U7EG HIGHSTAT Investigative D0U7FE DRUG__ID D0U7FE D0U7FE DRUGTYPE Small molecular drug D0U7FE DRUGINCH 1S/C16H17N3S/c1-16(2,3)14-10-20-15(19-14)18-13-8-4-7-12-11(13)6-5-9-17-12/h4-10H,1-3H3,(H,18,19) D0U7FE DRUGINKE RGBQNFYMCAUMHK-UHFFFAOYSA-N D0U7FE DRUGSMIL CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=C2C=CC=N3 D0U7FE HIGHSTAT Investigative D0U7GL DRUG__ID D0U7GL D0U7GL DRUGTYPE Small molecular drug D0U7GL DRUGINCH 1S/C14H13FN2O3S/c15-13-4-2-1-3-11(13)9-17-14(18)10-5-7-12(8-6-10)21(16,19)20/h1-8H,9H2,(H,17,18)(H2,16,19,20) D0U7GL DRUGINKE ULYMHSXFSKOHGH-UHFFFAOYSA-N D0U7GL DRUGSMIL C1=CC=C(C(=C1)CNC(=O)C2=CC=C(C=C2)S(=O)(=O)N)F D0U7GL HIGHSTAT Investigative D0U7IO DRUG__ID D0U7IO D0U7IO DRUGTYPE Small molecular drug D0U7IO DRUGINCH 1S/C14H9ClFN3/c15-9-2-1-3-11(6-9)19-14-12-7-10(16)4-5-13(12)17-8-18-14/h1-8H,(H,17,18,19) D0U7IO DRUGINKE FKNWIVATYZCUKH-UHFFFAOYSA-N D0U7IO DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)F D0U7IO HIGHSTAT Investigative D0U7JS DRUG__ID D0U7JS D0U7JS DRUGTYPE Small molecular drug D0U7JS DRUGINCH 1S/C28H37N7O6S/c1-42-12-11-21(26(31)39)35-28(41)22(14-17-5-3-2-4-6-17)34-24(37)16-32-23(36)15-33-27(40)20(29)13-18-7-9-19(10-8-18)25(30)38/h2-10,20-22H,11-16,29H2,1H3,(H2,30,38)(H2,31,39)(H,32,36)(H,33,40)(H,34,37)(H,35,41)/t20-,21-,22-/m0/s1 D0U7JS DRUGINKE WVSXHGGHIPRNNC-FKBYEOEOSA-N D0U7JS DRUGSMIL CSCCC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)C(=O)N)N D0U7JS HIGHSTAT Investigative D0U7KV DRUG__ID D0U7KV D0U7KV DRUGTYPE Small molecular drug D0U7KV DRUGINCH 1S/C20H15NO2/c22-15-9-5-13(6-10-15)19-17-3-1-2-4-18(17)21-20(19)14-7-11-16(23)12-8-14/h1-12,21-23H D0U7KV DRUGINKE MGOARPQWMKCCSF-UHFFFAOYSA-N D0U7KV DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=CC=C(C=C3)O)C4=CC=C(C=C4)O D0U7KV HIGHSTAT Investigative D0U7MR DRUG__ID D0U7MR D0U7MR DRUGTYPE Small molecular drug D0U7MR DRUGINCH 1S/C13H7Cl2NO2/c14-9-2-4-12(10(15)6-9)18-13-3-1-8(7-16)5-11(13)17/h1-6,17H D0U7MR DRUGINKE QYLRCMQANMWAOJ-UHFFFAOYSA-N D0U7MR DRUGSMIL C1=CC(=C(C=C1C#N)O)OC2=C(C=C(C=C2)Cl)Cl D0U7MR HIGHSTAT Investigative D0U7OD DRUG__ID D0U7OD D0U7OD DRUGTYPE Small molecular drug D0U7OD DRUGINCH 1S/C20H26N2O/c1-2-23-20-11-7-6-10-18(20)16-19(17-8-4-3-5-9-17)22-14-12-21-13-15-22/h3-11,19,21H,2,12-16H2,1H3/t19-/m1/s1 D0U7OD DRUGINKE CVFBVSUFNWOPLD-LJQANCHMSA-N D0U7OD DRUGSMIL CCOC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D0U7OD HIGHSTAT Investigative D0U7OO DRUG__ID D0U7OO D0U7OO DRUGTYPE Small molecular drug D0U7OO DRUGINCH 1S/C7H15FO10P2/c1-7(11,3-6(9)10)2-5(4-8)17-20(15,16)18-19(12,13)14/h5,11H,2-4H2,1H3,(H,9,10)(H,15,16)(H2,12,13,14) D0U7OO DRUGINKE YGLNCOGHKIHKSA-UHFFFAOYSA-N D0U7OO DRUGSMIL CC(CC(CF)OP(=O)(O)OP(=O)(O)O)(CC(=O)O)O D0U7OO HIGHSTAT Investigative D0U7PV DRUG__ID D0U7PV D0U7PV DRUGTYPE Small molecular drug D0U7PV DRUGINCH 1S/C12H15NO5S/c13-19(15,16)18-11-7-5-9(6-8-11)12(14)17-10-3-1-2-4-10/h5-8,10H,1-4H2,(H2,13,15,16) D0U7PV DRUGINKE UOISMBVIIRRGNN-UHFFFAOYSA-N D0U7PV DRUGSMIL C1CCC(C1)OC(=O)C2=CC=C(C=C2)OS(=O)(=O)N D0U7PV HIGHSTAT Investigative D0U7QA DRUG__ID D0U7QA D0U7QA DRUGTYPE Small molecular drug D0U7QA DRUGINCH 1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1 D0U7QA DRUGINKE ODHCTXKNWHHXJC-VKHMYHEASA-N D0U7QA DRUGSMIL C1CC(=O)NC1C(=O)O D0U7QA HIGHSTAT Investigative D0U7RR DRUG__ID D0U7RR D0U7RR DRUGTYPE Small molecular drug D0U7RR DRUGINCH 1S/C15H12BrN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8- D0U7RR DRUGINKE QWAFSKBCSGIDRF-WQLSENKSSA-N D0U7RR DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)Br D0U7RR HIGHSTAT Investigative D0U7RS DRUG__ID D0U7RS D0U7RS DRUGTYPE Small molecular drug D0U7RS DRUGINCH 1S/C6H6BFO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4,9-10H D0U7RS DRUGINKE QCSLIRFWJPOENV-UHFFFAOYSA-N D0U7RS DRUGSMIL B(C1=CC=CC=C1F)(O)O D0U7RS HIGHSTAT Investigative D0U7TM DRUG__ID D0U7TM D0U7TM DRUGTYPE Small molecular drug D0U7TM DRUGINCH 1S/C14H16N2O5/c17-13(18)9-15(10-5-1-2-6-10)14(19)11-7-3-4-8-12(11)16(20)21/h3-4,7-8,10H,1-2,5-6,9H2,(H,17,18) D0U7TM DRUGINKE QLSOVPLMYSMOSO-UHFFFAOYSA-N D0U7TM DRUGSMIL C1CCC(C1)N(CC(=O)O)C(=O)C2=CC=CC=C2[N+](=O)[O-] D0U7TM HIGHSTAT Investigative D0U7TR DRUG__ID D0U7TR D0U7TR DRUGTYPE Small molecular drug D0U7TR DRUGINCH 1S/C16H14IN7O2/c17-10-8-9(3-4-11(10)25)5-6-19-15-21-14(18)24-16(22-15)20-13(23-24)12-2-1-7-26-12/h1-4,7-8,25H,5-6H2,(H3,18,19,20,21,22,23)/i17-2 D0U7TR DRUGINKE RVECQPQWOUQTSZ-QZIRHQCUSA-N D0U7TR DRUGSMIL C1=COC(=C1)C2=NN3C(=NC(=NC3=N2)NCCC4=CC(=C(C=C4)O)I)N D0U7TR HIGHSTAT Investigative D0U7UD DRUG__ID D0U7UD D0U7UD DRUGTYPE Small molecular drug D0U7UD DRUGINCH 1S/C14H12ClN3O/c15-11-3-4-13-10(8-11)5-7-18(13)14(19)17-12-2-1-6-16-9-12/h1-4,6,8-9H,5,7H2,(H,17,19) D0U7UD DRUGINKE BYXYRVSXGVLRKM-UHFFFAOYSA-N D0U7UD DRUGSMIL C1CN(C2=C1C=C(C=C2)Cl)C(=O)NC3=CN=CC=C3 D0U7UD HIGHSTAT Investigative D0U7WU DRUG__ID D0U7WU D0U7WU DRUGTYPE Small molecular drug D0U7WU DRUGINCH 1S/C17H15NO3/c19-15-11-17(18-5-7-20-8-6-18)21-16-10-13-4-2-1-3-12(13)9-14(15)16/h1-4,9-11H,5-8H2 D0U7WU DRUGINKE FKURMCWOGPDJSJ-UHFFFAOYSA-N D0U7WU DRUGSMIL C1COCCN1C2=CC(=O)C3=CC4=CC=CC=C4C=C3O2 D0U7WU HIGHSTAT Investigative D0U7XP DRUG__ID D0U7XP D0U7XP DRUGTYPE Small molecular drug D0U7XP DRUGINCH 1S/C11H18N5O12P3/c12-11-14-9-8(10(18)15-11)13-3-16(9)7-1-5(17)6(27-7)2-26-29(19,20)4-30(21,22)28-31(23,24)25/h3,5-7,17H,1-2,4H2,(H,19,20)(H,21,22)(H2,23,24,25)(H3,12,14,15,18)/t5-,6+,7+/m0/s1 D0U7XP DRUGINKE JTBKCZGNQPBEJY-RRKCRQDMSA-N D0U7XP DRUGSMIL C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(CP(=O)(O)OP(=O)(O)O)O)O D0U7XP HIGHSTAT Investigative D0U7YB DRUG__ID D0U7YB D0U7YB DRUGTYPE Small molecular drug D0U7YB DRUGINCH 1S/C9H18NO8P/c1-7(11)15-5-9(18-8(2)12)6-17-19(13,14)16-4-3-10/h9H,3-6,10H2,1-2H3,(H,13,14)/t9-/m1/s1 D0U7YB DRUGINKE CFWRDBDJAOHXSH-SECBINFHSA-N D0U7YB DRUGSMIL CC(=O)OCC(COP(=O)(O)OCCN)OC(=O)C D0U7YB HIGHSTAT Investigative D0U7YK DRUG__ID D0U7YK D0U7YK DRUGTYPE Small molecular drug D0U7YK DRUGINCH 1S/C23H25ClNO6PS/c24-22-14-21(10-9-17(22)11-12-23(25,15-26)16-30-32(27,28)29)33-20-8-4-7-19(13-20)31-18-5-2-1-3-6-18/h1-10,13-14,26H,11-12,15-16,25H2,(H2,27,28,29) D0U7YK DRUGINKE BZVUYJGCYLMFGX-UHFFFAOYSA-N D0U7YK DRUGSMIL C1=CC=C(C=C1)OC2=CC(=CC=C2)SC3=CC(=C(C=C3)CCC(CO)(COP(=O)(O)O)N)Cl D0U7YK HIGHSTAT Investigative D0U8AU DRUG__ID D0U8AU D0U8AU DRUGTYPE Small molecular drug D0U8AU DRUGINCH 1S/C23H22O6/c1-6-22(2,3)15-19-12(9-10-23(4,5)29-19)17(26)14-16(25)11-7-8-13(24)18(27)20(11)28-21(14)15/h6-10,24,26-27H,1H2,2-5H3 D0U8AU DRUGINKE XRVLGJCHUWXTDX-UHFFFAOYSA-N D0U8AU DRUGSMIL CC1(C=CC2=C(C3=C(C(=C2O1)C(C)(C)C=C)OC4=C(C3=O)C=CC(=C4O)O)O)C D0U8AU HIGHSTAT Investigative D0U8BM DRUG__ID D0U8BM D0U8BM DRUGTYPE Small molecular drug D0U8BM DRUGINCH 1S/C21H29N3/c1-5-15(3)17-7-11-19(12-8-17)23-21(22)24-20-13-9-18(10-14-20)16(4)6-2/h7-16H,5-6H2,1-4H3,(H3,22,23,24) D0U8BM DRUGINKE CSOJBDHYOONOPF-UHFFFAOYSA-N D0U8BM DRUGSMIL CCC(C)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(C)CC)N D0U8BM HIGHSTAT Investigative D0U8CM DRUG__ID D0U8CM D0U8CM DRUGTYPE Small molecular drug D0U8CM DRUGINCH 1S/C8H8N2O/c1-10-8(11)6-4-2-3-5-7(6)9-10/h2-5,9H,1H3 D0U8CM DRUGINKE FPNXGZRMUROVNY-UHFFFAOYSA-N D0U8CM DRUGSMIL CN1C(=O)C2=CC=CC=C2N1 D0U8CM HIGHSTAT Investigative D0U8DW DRUG__ID D0U8DW D0U8DW DRUGTYPE Small molecular drug D0U8DW DRUGINCH 1S/C15H16N4O2/c1-2-3-9-19-14(20)11-13(18-15(19)21)17-12(16-11)10-7-5-4-6-8-10/h4-8H,2-3,9H2,1H3,(H,16,17)(H,18,21) D0U8DW DRUGINKE UGAWDWCYTZJBPQ-UHFFFAOYSA-N D0U8DW DRUGSMIL CCCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=CC=C3 D0U8DW HIGHSTAT Investigative D0U8ET DRUG__ID D0U8ET D0U8ET DRUGTYPE Small molecular drug D0U8ET DRUGINCH 1S/C16H11BrO2/c1-10-6-7-15-11(8-10)9-13(16(18)19-15)12-4-2-3-5-14(12)17/h2-9H,1H3 D0U8ET DRUGINKE AEOXYENOHINSQF-UHFFFAOYSA-N D0U8ET DRUGSMIL CC1=CC2=C(C=C1)OC(=O)C(=C2)C3=CC=CC=C3Br D0U8ET HIGHSTAT Investigative D0U8FC DRUG__ID D0U8FC D0U8FC DRUGTYPE Small molecular drug D0U8FC DRUGINCH 1S/C13H12N2O/c14-11-8-4-5-9-12(11)15-13(16)10-6-2-1-3-7-10/h1-9H,14H2,(H,15,16) D0U8FC DRUGINKE RFDVMOUXHKTCDO-UHFFFAOYSA-N D0U8FC DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N D0U8FC HIGHSTAT Investigative D0U8GZ DRUG__ID D0U8GZ D0U8GZ DRUGTYPE Small molecular drug D0U8GZ DRUGINCH 1S/C22H22O15S/c1-33-12-3-2-8(4-10(12)24)20-21(36-22-19(29)18(28)16(26)14(7-23)35-22)17(27)15-11(25)5-9(6-13(15)34-20)37-38(30,31)32/h2-6,14,16,18-19,22-26,28-29H,7H2,1H3,(H,30,31,32)/t14-,16-,18?,19?,22+/m1/s1 D0U8GZ DRUGINKE HDCDAUMQECHFOE-VZIAGGLWSA-N D0U8GZ DRUGSMIL COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)OS(=O)(=O)O)O)OC4C(C(C(C(O4)CO)O)O)O)O D0U8GZ HIGHSTAT Investigative D0U8HD DRUG__ID D0U8HD D0U8HD DRUGTYPE Small molecular drug D0U8HD DRUGINCH 1S/C10H15ClN5O13P3/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(18)5(17)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,17-18H,1H2,(H,22,23)(H,24,25)(H2,12,14,15)(H2,19,20,21)/t3-,5-,6-,9-/m1/s1 D0U8HD DRUGINKE RNGCVFCOKZEZFL-UUOKFMHZSA-N D0U8HD DRUGSMIL C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)Cl)N D0U8HD HIGHSTAT Investigative D0U8JC DRUG__ID D0U8JC D0U8JC DRUGTYPE Small molecular drug D0U8JC DRUGINCH 1S/C20H20O5/c1-12(2)3-7-15-18(23)10-8-16(20(15)25)17(22)9-5-13-4-6-14(21)11-19(13)24/h3-6,8-11,21,23-25H,7H2,1-2H3/b9-5+ D0U8JC DRUGINKE NXBYIJSAISXPKJ-WEVVVXLNSA-N D0U8JC DRUGSMIL CC(=CCC1=C(C=CC(=C1O)C(=O)C=CC2=C(C=C(C=C2)O)O)O)C D0U8JC HIGHSTAT Investigative D0U8KW DRUG__ID D0U8KW D0U8KW DRUGTYPE Small molecular drug D0U8KW DRUGINCH 1S/C39H45Cl2N7O6S/c40-27-13-8-23(18-28(27)41)33(50)31-26-14-16-47(19-30(26)55-36(31)42)15-6-4-2-1-3-5-7-17-53-25-11-9-24(10-12-25)46-37-32-38(44-21-43-37)48(22-45-32)39-35(52)34(51)29(20-49)54-39/h8-13,18,21-22,29,34-35,39,49,51-52H,1-7,14-17,19-20,42H2,(H,43,44,46)/t29-,34-,35-,39-/m1/s1 D0U8KW DRUGINKE DERHYILBHUKLGL-VMPBLTEISA-N D0U8KW DRUGSMIL C1CN(CC2=C1C(=C(S2)N)C(=O)C3=CC(=C(C=C3)Cl)Cl)CCCCCCCCCOC4=CC=C(C=C4)NC5=C6C(=NC=N5)N(C=N6)C7C(C(C(O7)CO)O)O D0U8KW HIGHSTAT Investigative D0U8OA DRUG__ID D0U8OA D0U8OA DRUGTYPE Small molecular drug D0U8OA DRUGINCH 1S/C9H12N2/c1-3-4-8-5-7(2)6-9(10)11-8/h3-6H,1-2H3,(H2,10,11)/b4-3+ D0U8OA DRUGINKE QHUQCHMVBGZYHI-ONEGZZNKSA-N D0U8OA DRUGSMIL CC=CC1=NC(=CC(=C1)C)N D0U8OA HIGHSTAT Investigative D0U8OK DRUG__ID D0U8OK D0U8OK DRUGTYPE Small molecular drug D0U8OK DRUGINCH 1S/C19H27N3O2S/c1-20(2)25(23,24)12-13-8-16-15-6-5-7-17-19(15)14(11-22(17)4)9-18(16)21(3)10-13/h5-7,11,13,16,18H,8-10,12H2,1-4H3 D0U8OK DRUGINKE WYCMFCPHWDZHMR-UHFFFAOYSA-N D0U8OK DRUGSMIL CN1CC(CC2C1CC3=CN(C4=CC=CC2=C34)C)CS(=O)(=O)N(C)C D0U8OK HIGHSTAT Investigative D0U8OS DRUG__ID D0U8OS D0U8OS DRUGTYPE Small molecular drug D0U8OS DRUGINCH 1S/C12H17NO2/c1-10(14)13-8-4-6-11-5-3-7-12(9-11)15-2/h3,5,7,9H,4,6,8H2,1-2H3,(H,13,14) D0U8OS DRUGINKE LOVJFNACINEBJW-UHFFFAOYSA-N D0U8OS DRUGSMIL CC(=O)NCCCC1=CC(=CC=C1)OC D0U8OS HIGHSTAT Investigative D0U8RR DRUG__ID D0U8RR D0U8RR DRUGTYPE Small molecular drug D0U8RR DRUGINCH 1S/C6H13O8P/c7-3-1-5(8)14-4(6(3)9)2-13-15(10,11)12/h3-9H,1-2H2,(H2,10,11,12)/t3-,4-,5-,6+/m1/s1 D0U8RR DRUGINKE UQJFZAAGZAYVKZ-KAZBKCHUSA-N D0U8RR DRUGSMIL C1C(C(C(OC1O)COP(=O)(O)O)O)O D0U8RR HIGHSTAT Investigative D0U8RZ DRUG__ID D0U8RZ D0U8RZ DRUGTYPE Small molecular drug D0U8RZ DRUGINCH 1S/C12H13ClN2/c13-11-5-1-2-6-12(11)15-9-3-4-10(15)7-8-14/h1-6,9H,7-8,14H2 D0U8RZ DRUGINKE QDZRUXBRYDSOHU-UHFFFAOYSA-N D0U8RZ DRUGSMIL C1=CC=C(C(=C1)N2C=CC=C2CCN)Cl D0U8RZ HIGHSTAT Investigative D0U8TM DRUG__ID D0U8TM D0U8TM DRUGTYPE Small molecular drug D0U8TM DRUGINCH 1S/C13HF9N2/c14-3-1(4(15)7(18)9(20)6(3)17)12-2-5(16)8(19)10(21)11(22)13(2)24-23-12/h(H,23,24) D0U8TM DRUGINKE BLRLNVDCKOMIHM-UHFFFAOYSA-N D0U8TM DRUGSMIL C12=C(NN=C1C(=C(C(=C2F)F)F)F)C3=C(C(=C(C(=C3F)F)F)F)F D0U8TM HIGHSTAT Investigative D0U8UH DRUG__ID D0U8UH D0U8UH DRUGTYPE Small molecular drug D0U8UH DRUGINCH 1S/C10H7N2O4P/c11-6-8-5-4-7-2-1-3-9(10(7)12-8)16-17(13,14)15/h1-5H,(H2,13,14,15) D0U8UH DRUGINKE NQLPTOOPFMPCHQ-UHFFFAOYSA-N D0U8UH DRUGSMIL C1=CC2=C(C(=C1)OP(=O)(O)O)N=C(C=C2)C#N D0U8UH HIGHSTAT Investigative D0U8UK DRUG__ID D0U8UK D0U8UK DRUGTYPE Small molecular drug D0U8UK DRUGINCH 1S/C24H21F3N6O/c1-33-21(31-32-22(33)16-9-11-28-12-10-16)15-29-19-7-4-6-17(13-19)23(34)30-14-18-5-2-3-8-20(18)24(25,26)27/h2-13,29H,14-15H2,1H3,(H,30,34) D0U8UK DRUGINKE WFOVEDJTASPCIR-UHFFFAOYSA-N D0U8UK DRUGSMIL CN1C(=NN=C1C2=CC=NC=C2)CNC3=CC=CC(=C3)C(=O)NCC4=CC=CC=C4C(F)(F)F D0U8UK HIGHSTAT Investigative D0U8VY DRUG__ID D0U8VY D0U8VY DRUGTYPE Small molecular drug D0U8VY DRUGINCH 1S/C23H20N4O3/c1-29-20-12-18-19(13-21(20)30-2)24-14-25-22(18)26-16-8-10-17(11-9-16)27-23(28)15-6-4-3-5-7-15/h3-14H,1-2H3,(H,27,28)(H,24,25,26) D0U8VY DRUGINKE IMYVCWQAHSYYOO-UHFFFAOYSA-N D0U8VY DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OC D0U8VY HIGHSTAT Investigative D0U8YQ DRUG__ID D0U8YQ D0U8YQ DRUGTYPE Small molecular drug D0U8YQ DRUGINCH 1S/C20H16N4/c1-2-6-15(7-3-1)14-22-20-17-8-4-5-9-18(17)23-19(24-20)16-10-12-21-13-11-16/h1-13H,14H2,(H,22,23,24) D0U8YQ DRUGINKE NZWWYUMFUATSTK-UHFFFAOYSA-N D0U8YQ DRUGSMIL C1=CC=C(C=C1)CNC2=NC(=NC3=CC=CC=C32)C4=CC=NC=C4 D0U8YQ HIGHSTAT Investigative D0U8YU DRUG__ID D0U8YU D0U8YU DRUGTYPE Small molecular drug D0U8YU DRUGINCH 1S/C32H38N4O5/c33-27(19-24-13-15-26(38)16-14-24)32(41)36-17-7-12-29(36)31(40)35-28(20-23-10-5-2-6-11-23)30(39)34-25(21-37)18-22-8-3-1-4-9-22/h1-6,8-11,13-16,25,27-29,37-38H,7,12,17-21,33H2,(H,34,39)(H,35,40)/t25-,27-,28-,29-/m0/s1 D0U8YU DRUGINKE PZNSQIAIDOIARA-AMEOFWRWSA-N D0U8YU DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)CO D0U8YU HIGHSTAT Investigative D0U8YV DRUG__ID D0U8YV D0U8YV DRUGTYPE Small molecular drug D0U8YV DRUGINCH 1S/C15H18N2O2/c18-14(15-16-12-17-19-15)11-7-2-1-4-8-13-9-5-3-6-10-13/h3,5-6,9-10,12H,1-2,4,7-8,11H2 D0U8YV DRUGINKE ZZEHRRGWKDFITC-UHFFFAOYSA-N D0U8YV DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=NO2 D0U8YV HIGHSTAT Investigative D0U8ZQ DRUG__ID D0U8ZQ D0U8ZQ DRUGTYPE Small molecular drug D0U8ZQ DRUGINCH 1S/C15H25N3O2/c16-9-4-5-11-18(12-6-10-17)15(19)20-13-14-7-2-1-3-8-14/h1-3,7-8H,4-6,9-13,16-17H2 D0U8ZQ DRUGINKE ADDDUQKJZAGBIG-UHFFFAOYSA-N D0U8ZQ DRUGSMIL C1=CC=C(C=C1)COC(=O)N(CCCCN)CCCN D0U8ZQ HIGHSTAT Investigative D0U9AU DRUG__ID D0U9AU D0U9AU DRUGTYPE Small molecular drug D0U9AU DRUGINCH 1S/C30H35N3O2/c1-21(2)23-10-12-24(13-11-23)31-29(34)35-25-14-15-27-26(20-25)30(3)17-19-33(28(30)32(27)4)18-16-22-8-6-5-7-9-22/h5-15,20-21,28H,16-19H2,1-4H3,(H,31,34)/t28?,30-/m0/s1 D0U9AU DRUGINKE WKDFOVDLOVYRAJ-TXDWVUBVSA-N D0U9AU DRUGSMIL CC(C)C1=CC=C(C=C1)NC(=O)OC2=CC3=C(C=C2)N(C4C3(CCN4CCC5=CC=CC=C5)C)C D0U9AU HIGHSTAT Investigative D0U9DD DRUG__ID D0U9DD D0U9DD DRUGTYPE Small molecular drug D0U9DD DRUGINCH 1S/C18H19NO2S/c1-14-7-9-15(10-8-14)18-19(11-12-22-18)17(20)13-21-16-5-3-2-4-6-16/h2-10,18H,11-13H2,1H3 D0U9DD DRUGINKE MHEJSTGXKATLNP-UHFFFAOYSA-N D0U9DD DRUGSMIL CC1=CC=C(C=C1)C2N(CCS2)C(=O)COC3=CC=CC=C3 D0U9DD HIGHSTAT Investigative D0U9ET DRUG__ID D0U9ET D0U9ET DRUGTYPE Small molecular drug D0U9ET DRUGINCH 1S/C10H16O2/c1-9(2)4-3-5-10(9)6-7-12-8(10)11/h3-7H2,1-2H3 D0U9ET DRUGINKE FHWLTPUPKBUBCF-UHFFFAOYSA-N D0U9ET DRUGSMIL CC1(CCCC12CCOC2=O)C D0U9ET HIGHSTAT Investigative D0U9EW DRUG__ID D0U9EW D0U9EW DRUGTYPE Small molecular drug D0U9EW DRUGINCH 1S/C2H2O3/c3-1-2(4)5/h1H,(H,4,5) D0U9EW DRUGINKE HHLFWLYXYJOTON-UHFFFAOYSA-N D0U9EW DRUGSMIL C(=O)C(=O)O D0U9EW HIGHSTAT Investigative D0U9GN DRUG__ID D0U9GN D0U9GN DRUGTYPE Small molecular drug D0U9GN DRUGINCH 1S/C17H18BrNO2/c1-19-10-11-21-17(20,12-19)15-6-2-13(3-7-15)14-4-8-16(18)9-5-14/h2-9,20H,10-12H2,1H3 D0U9GN DRUGINKE NALOOEVGTGAOHW-UHFFFAOYSA-N D0U9GN DRUGSMIL CN1CCOC(C1)(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)O D0U9GN HIGHSTAT Investigative D0U9HE DRUG__ID D0U9HE D0U9HE DRUGTYPE Small molecular drug D0U9HE DRUGINCH 1S/C27H31F3N4O7S/c1-40-22-16-23(41-2)20(33-42(38,39)18-8-6-17(7-9-18)27(28,29)30)15-19(22)21(35)5-3-4-12-34-13-10-26(11-14-34)24(36)31-25(37)32-26/h6-9,15-16,33H,3-5,10-14H2,1-2H3,(H2,31,32,36,37) D0U9HE DRUGINKE HZZZZODVDSHQRG-UHFFFAOYSA-N D0U9HE DRUGSMIL COC1=CC(=C(C=C1C(=O)CCCCN2CCC3(CC2)C(=O)NC(=O)N3)NS(=O)(=O)C4=CC=C(C=C4)C(F)(F)F)OC D0U9HE HIGHSTAT Investigative D0U9HN DRUG__ID D0U9HN D0U9HN DRUGTYPE Small molecular drug D0U9HN DRUGINCH 1S/C23H33NO6S/c1-14-6-5-7-17-15(2)22(3,8-9-23(14,17)4)13-16-20(26)18(12-19(25)21(16)27)24-10-11-31(28,29)30/h6,12,15,17,24,26H,5,7-11,13H2,1-4H3,(H,28,29,30)/t15-,17+,22-,23-/m1/s1 D0U9HN DRUGINKE JUZCKAMLAZUOHD-CIVZFWGOSA-N D0U9HN DRUGSMIL CC1C2CCC=C(C2(CCC1(C)CC3=C(C(=CC(=O)C3=O)NCCS(=O)(=O)O)O)C)C D0U9HN HIGHSTAT Investigative D0U9IB DRUG__ID D0U9IB D0U9IB DRUGTYPE Small molecular drug D0U9IB DRUGINCH 1S/C54H85N13O15S/c1-7-30(4)44(53(81)57-27-42(70)60-36(24-29(2)3)49(77)61-33(45(56)73)20-23-83-6)66-50(78)37(25-32-14-9-8-10-15-32)63-46(74)31(5)58-48(76)38(26-43(71)72)64-47(75)34(16-11-12-21-55)62-51(79)39(28-68)65-52(80)40-17-13-22-67(40)54(82)35-18-19-41(69)59-35/h8-10,14-15,29-31,33-40,44,68H,7,11-13,16-28,55H2,1-6H3,(H2,56,73)(H,57,81)(H,58,76)(H,59,69)(H,60,70)(H,61,77)(H,62,79)(H,63,74)(H,64,75)(H,65,80)(H,66,78)(H,71,72)/t30-,31-,33-,34-,35-,36-,37-,38-,39-,40-,44-/m0/s1 D0U9IB DRUGINKE AYLPVIWBPZMVSH-FCKMLYJASA-N D0U9IB DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C2CCCN2C(=O)C3CCC(=O)N3 D0U9IB HIGHSTAT Investigative D0U9IJ DRUG__ID D0U9IJ D0U9IJ DRUGTYPE Small molecular drug D0U9IJ DRUGINCH 1S/C11H13N5/c1-16-7-8-9(3-2-4-10(8)15-16)14-11-12-5-6-13-11/h2-4,7H,5-6H2,1H3,(H2,12,13,14) D0U9IJ DRUGINKE PNHJTLDBYZVCGW-UHFFFAOYSA-N D0U9IJ DRUGSMIL CN1C=C2C(=N1)C=CC=C2NC3=NCCN3 D0U9IJ HIGHSTAT Investigative D0U9IR DRUG__ID D0U9IR D0U9IR DRUGTYPE Small molecular drug D0U9IR DRUGINCH 1S/C15H10F3NS/c1-10-4-2-3-5-14(10)20-12-7-6-11(9-19)13(8-12)15(16,17)18/h2-8H,1H3 D0U9IR DRUGINKE RAJQECAXWDTUGF-UHFFFAOYSA-N D0U9IR DRUGSMIL CC1=CC=CC=C1SC2=CC(=C(C=C2)C#N)C(F)(F)F D0U9IR HIGHSTAT Investigative D0U9JC DRUG__ID D0U9JC D0U9JC DRUGTYPE Small molecular drug D0U9JC DRUGINCH 1S/C17H24O/c1-3-5-6-7-8-9-10-15-11-13-16(14-12-15)17(18)4-2/h4,11-14H,2-3,5-10H2,1H3 D0U9JC DRUGINKE GXBVBDUWTMDYAH-UHFFFAOYSA-N D0U9JC DRUGSMIL CCCCCCCCC1=CC=C(C=C1)C(=O)C=C D0U9JC HIGHSTAT Investigative D0U9LD DRUG__ID D0U9LD D0U9LD DRUGTYPE Small molecular drug D0U9LD DRUGINCH 1S/C18H33NO7P2/c1-3-4-5-6-7-8-9-10-11-26-17-12-16(14-19(2)15-17)13-18(27(20,21)22)28(23,24)25/h12,14-15,18H,3-11,13H2,1-2H3,(H3-,20,21,22,23,24,25) D0U9LD DRUGINKE PUCSJEGLZHMUSS-UHFFFAOYSA-N D0U9LD DRUGSMIL CCCCCCCCCCOC1=C[N+](=CC(=C1)CC(P(=O)(O)O)P(=O)(O)[O-])C D0U9LD HIGHSTAT Investigative D0U9PX DRUG__ID D0U9PX D0U9PX DRUGTYPE Small molecular drug D0U9PX DRUGINCH 1S/C9H9Br2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 D0U9PX DRUGINKE COESHZUDRKCEPA-ZETCQYMHSA-N D0U9PX DRUGSMIL C1=C(C=C(C(=C1Br)O)Br)CC(C(=O)O)N D0U9PX HIGHSTAT Investigative D0U9QB DRUG__ID D0U9QB D0U9QB DRUGTYPE Small molecular drug D0U9QB DRUGINCH 1S/C15H16O3/c1-7-4-5-10-9(3)15(17)18-14(10)13-8(2)6-11(16)12(7)13/h6,10,13-14H,3-5H2,1-2H3/t10-,13-,14-/m0/s1 D0U9QB DRUGINKE SKNVIAFTENCNGB-BPNCWPANSA-N D0U9QB DRUGSMIL CC1=C2C(C3C(CC1)C(=C)C(=O)O3)C(=CC2=O)C D0U9QB HIGHSTAT Investigative D0U9QD DRUG__ID D0U9QD D0U9QD DRUGTYPE Small molecular drug D0U9QD DRUGINCH 1S/C11H11FN2O2/c12-7-1-2-8-6(3-9(13)11(15)16)5-14-10(8)4-7/h1-2,4-5,9,14H,3,13H2,(H,15,16) D0U9QD DRUGINKE YMEXGEAJNZRQEH-UHFFFAOYSA-N D0U9QD DRUGSMIL C1=CC2=C(C=C1F)NC=C2CC(C(=O)O)N D0U9QD HIGHSTAT Investigative D0U9QL DRUG__ID D0U9QL D0U9QL DRUGTYPE Small molecular drug D0U9QL DRUGINCH 1S/C18H19F2N3O.C3H8NO5P/c1-23-9-14(16(22-23)17(19)20)18(24)21-15-5-3-2-4-11(15)13-8-12(13)10-6-7-10;5-3(6)1-4-2-10(7,8)9/h2-5,9-10,12-13,17H,6-8H2,1H3,(H,21,24);4H,1-2H2,(H,5,6)(H2,7,8,9) D0U9QL DRUGINKE ZLEQCJLOZSQAHT-UHFFFAOYSA-N D0U9QL DRUGSMIL CN1C=C(C(=N1)C(F)F)C(=O)NC2=CC=CC=C2C3CC3C4CC4.C(C(=O)O)NCP(=O)(O)O D0U9QL HIGHSTAT Investigative D0U9UL DRUG__ID D0U9UL D0U9UL DRUGTYPE Small molecular drug D0U9UL DRUGINCH 1S/C15H13ClN2O/c1-2-10-3-6-12(7-4-10)17-15-18-13-9-11(16)5-8-14(13)19-15/h3-9H,2H2,1H3,(H,17,18) D0U9UL DRUGINKE CKVTZZTZMCGPHV-UHFFFAOYSA-N D0U9UL DRUGSMIL CCC1=CC=C(C=C1)NC2=NC3=C(O2)C=CC(=C3)Cl D0U9UL HIGHSTAT Investigative D0U9VX DRUG__ID D0U9VX D0U9VX DRUGTYPE Small molecular drug D0U9VX DRUGINCH 1S/C14H13NO4/c15-5-1-6-17-14-12-10(4-7-18-12)8-9-2-3-11(16)19-13(9)14/h2-4,7-8H,1,5-6,15H2 D0U9VX DRUGINKE ZTTJBZXILLQBLD-UHFFFAOYSA-N D0U9VX DRUGSMIL C1=CC(=O)OC2=C(C3=C(C=CO3)C=C21)OCCCN D0U9VX HIGHSTAT Investigative D0U9XC DRUG__ID D0U9XC D0U9XC DRUGTYPE Small molecular drug D0U9XC DRUGINCH 1S/C18H16NO3P/c19-15-8-7-13-18(14-15)23(20,21-16-9-3-1-4-10-16)22-17-11-5-2-6-12-17/h1-14H,19H2 D0U9XC DRUGINKE CJCPJYQCUVSSBA-UHFFFAOYSA-N D0U9XC DRUGSMIL C1=CC=C(C=C1)OP(=O)(C2=CC=CC(=C2)N)OC3=CC=CC=C3 D0U9XC HIGHSTAT Investigative D0U9YY DRUG__ID D0U9YY D0U9YY DRUGTYPE Small molecular drug D0U9YY DRUGINCH 1S/C22H16N4/c23-13-19-15-24-14-18(7-6-16-4-2-1-3-5-16)22(19)26-20-8-9-21-17(12-20)10-11-25-21/h1-12,14-15,25H,(H,24,26)/b7-6+ D0U9YY DRUGINKE GLBDOEWDGNREFF-VOTSOKGWSA-N D0U9YY DRUGSMIL C1=CC=C(C=C1)C=CC2=CN=CC(=C2NC3=CC4=C(C=C3)NC=C4)C#N D0U9YY HIGHSTAT Investigative D0U9ZW DRUG__ID D0U9ZW D0U9ZW DRUGTYPE Small molecular drug D0U9ZW DRUGINCH 1S/C14H15NO3/c1-10-3-2-4-11-12(9-13(16)18-14(10)11)15-5-7-17-8-6-15/h2-4,9H,5-8H2,1H3 D0U9ZW DRUGINKE HXUJEFDGGXBUQX-UHFFFAOYSA-N D0U9ZW DRUGSMIL CC1=C2C(=CC=C1)C(=CC(=O)O2)N3CCOCC3 D0U9ZW HIGHSTAT Investigative D0UA3E DRUG__ID D0UA3E D0UA3E DRUGTYPE Small molecular drug D0UA3E DRUGINCH 1S/C20H27NO6/c1-21-8-7-18-9-12(22)17(25-3)20(26-4)19(18,21)10-14(27-20)11-5-6-13(24-2)16(23)15(11)18/h5-6,12,14,17,22-23H,7-10H2,1-4H3/t12-,14-,17-,18-,19-,20+/m0/s1 D0UA3E DRUGINKE GAUBYMMEBUOLGW-HMOIBATMSA-N D0UA3E DRUGSMIL CN1CCC23C14CC(C5=C2C(=C(C=C5)OC)O)OC4(C(C(C3)O)OC)OC D0UA3E HIGHSTAT Investigative D0UB2J DRUG__ID D0UB2J D0UB2J DRUGTYPE Small molecular drug D0UB2J DRUGINCH 1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1 D0UB2J DRUGINKE IVOMOUWHDPKRLL-KQYNXXCUSA-N D0UB2J DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O D0UB2J HIGHSTAT Investigative D0UB3V DRUG__ID D0UB3V D0UB3V DRUGTYPE Small molecular drug D0UB3V DRUGINCH 1S/C28H19Cl2N3OS/c1-18-27(26(34)15-13-19-12-14-22(29)23(30)16-19)35-28(31-18)33-25(21-10-6-3-7-11-21)17-24(32-33)20-8-4-2-5-9-20/h2-17H,1H3/b15-13+ D0UB3V DRUGINKE GDGXJFJBRMKYDL-FYWRMAATSA-N D0UB3V DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC(=C(C=C5)Cl)Cl D0UB3V HIGHSTAT Investigative D0UB6O DRUG__ID D0UB6O D0UB6O DRUGTYPE Small molecular drug D0UB6O DRUGINCH 1S/C18H22IN3O3S/c1-21-9-11-22(12-10-21)17-13-15(5-8-18(17)25-2)20-26(23,24)16-6-3-14(19)4-7-16/h3-8,13,20H,9-12H2,1-2H3/i19-2 D0UB6O DRUGINKE BDHMSYNBSBZCAF-GBVACIEGSA-N D0UB6O DRUGSMIL CN1CCN(CC1)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)I)OC D0UB6O HIGHSTAT Investigative D0UC4G DRUG__ID D0UC4G D0UC4G DRUGTYPE Small molecular drug D0UC4G DRUGINCH 1S/C21H16N2O6S.Na/c1-29-15-9-5-4-8-13(15)23-14-10-16(30(26,27)28)19(22)18-17(14)20(24)11-6-2-3-7-12(11)21(18)25;/h2-10,23H,22H2,1H3,(H,26,27,28);/q;+1/p-1 D0UC4G DRUGINKE REACUBXXZFBLMO-UHFFFAOYSA-M D0UC4G DRUGSMIL COC1=CC=CC=C1NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+] D0UC4G HIGHSTAT Investigative D0UD1U DRUG__ID D0UD1U D0UD1U DRUGTYPE Small molecular drug D0UD1U DRUGINCH 1S/C25H28O5/c1-13(2)5-6-14-9-16-21(11-19(14)26)28-12-18-15-7-8-20-17(23(15)29-24(16)18)10-22(27)25(3,4)30-20/h5,7-9,11,18,22,24,26-27H,6,10,12H2,1-4H3/t18-,22?,24-/m0/s1 D0UD1U DRUGINKE UNODSKHATHZQGW-HRKCMRQESA-N D0UD1U DRUGSMIL CC(=CCC1=CC2=C(C=C1O)OCC3C2OC4=C3C=CC5=C4CC(C(O5)(C)C)O)C D0UD1U HIGHSTAT Investigative D0UD5X DRUG__ID D0UD5X D0UD5X DRUGTYPE Small molecular drug D0UD5X DRUGINCH 1S/C13H12O3S/c1-17(14,15)13-8-5-11(6-9-13)4-7-12-3-2-10-16-12/h2-10H,1H3/b7-4+ D0UD5X DRUGINKE WFCBWFJZEUDGIS-QPJJXVBHSA-N D0UD5X DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C=CC2=CC=CO2 D0UD5X HIGHSTAT Investigative D0UD7H DRUG__ID D0UD7H D0UD7H DRUGTYPE Small molecular drug D0UD7H DRUGINCH 1S/C8H12N2O2/c11-7-9-5-3-1-2-4-6-10-8-12/h1-6H2 D0UD7H DRUGINKE RRAMGCGOFNQTLD-UHFFFAOYSA-N D0UD7H DRUGSMIL C(CCCN=C=O)CCN=C=O D0UD7H HIGHSTAT Investigative D0UD9H DRUG__ID D0UD9H D0UD9H DRUGTYPE Small molecular drug D0UD9H DRUGINCH 1S/C21H19Cl2IN4O2/c1-13-19(21(29)26-27-8-10-30-11-9-27)25-28(18-7-4-15(22)12-17(18)23)20(13)14-2-5-16(24)6-3-14/h2-7,12H,8-11H2,1H3,(H,26,29) D0UD9H DRUGINKE AJFFBPZYXRNAIC-UHFFFAOYSA-N D0UD9H DRUGSMIL CC1=C(N(N=C1C(=O)NN2CCOCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I D0UD9H HIGHSTAT Investigative D0UE7H DRUG__ID D0UE7H D0UE7H DRUGTYPE Small molecular drug D0UE7H DRUGINCH 1S/C18H29N7O6/c19-18(20)21-5-1-2-11-16(30)22-8-13(26)24-12(7-14(27)28)17(31)23-10-4-3-9(6-10)15(29)25-11/h9-12H,1-8H2,(H,22,30)(H,23,31)(H,24,26)(H,25,29)(H,27,28)(H4,19,20,21)/t9-,10-,11-,12-/m0/s1 D0UE7H DRUGINKE SLTMEZLQPRTTBL-BJDJZHNGSA-N D0UE7H DRUGSMIL C1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D0UE7H HIGHSTAT Investigative D0UF0U DRUG__ID D0UF0U D0UF0U DRUGTYPE Small molecular drug D0UF0U DRUGINCH 1S/C12H12N2O/c1-2-8-6-9-4-3-5-10(12(13)15)11(9)14-7-8/h3-7H,2H2,1H3,(H2,13,15) D0UF0U DRUGINKE ACADFMJVXMCIFY-UHFFFAOYSA-N D0UF0U DRUGSMIL CCC1=CN=C2C(=C1)C=CC=C2C(=O)N D0UF0U HIGHSTAT Investigative D0UF1R DRUG__ID D0UF1R D0UF1R DRUGTYPE Small molecular drug D0UF1R DRUGINCH 1S/C10H13N/c11-10-7-3-5-8-4-1-2-6-9(8)10/h1-2,4,6,10H,3,5,7,11H2 D0UF1R DRUGINKE JRZGPXSSNPTNMA-UHFFFAOYSA-N D0UF1R DRUGSMIL C1CC(C2=CC=CC=C2C1)N D0UF1R HIGHSTAT Investigative D0UF2B DRUG__ID D0UF2B D0UF2B DRUGTYPE Small molecular drug D0UF2B DRUGINCH 1S/C20H15F2NO/c21-17-12-11-16(13-18(17)22)20(19(23)24,14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13H,(H2,23,24) D0UF2B DRUGINKE ADMJNOLCZZLSIA-UHFFFAOYSA-N D0UF2B DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC(=C(C=C3)F)F)C(=O)N D0UF2B HIGHSTAT Investigative D0UF9K DRUG__ID D0UF9K D0UF9K DRUGTYPE Small molecular drug D0UF9K DRUGINCH 1S/C41H54N6O4/c1-26-18-28-20-34-32(10-12-36(48)42-34)40(22-26)30(28)8-5-16-46(40)38(50)24-44(3)14-7-15-45(4)25-39(51)47-17-6-9-31-29-19-27(2)23-41(31,47)33-11-13-37(49)43-35(33)21-29/h10-13,18-19,28-31H,5-9,14-17,20-25H2,1-4H3,(H,42,48)(H,43,49)/t28?,29?,30-,31-,40-,41-/m1/s1 D0UF9K DRUGINKE KTFGBMXGPUIYSS-LMMAWDAISA-N D0UF9K DRUGSMIL CC1=CC2CC3=C(C=CC(=O)N3)C4(C1)C2CCCN4C(=O)CN(C)CCCN(C)CC(=O)N5CCCC6C57CC(=CC6CC8=C7C=CC(=O)N8)C D0UF9K HIGHSTAT Investigative D0UG1U DRUG__ID D0UG1U D0UG1U DRUGTYPE Small molecular drug D0UG1U DRUGINCH 1S/C22H23F2N5O/c23-17-7-3-15(4-8-17)20(16-5-9-18(24)10-6-16)12-21(30)29-22(25)27-11-1-2-19-13-26-14-28-19/h3-10,13-14,20H,1-2,11-12H2,(H,26,28)(H3,25,27,29,30) D0UG1U DRUGINKE BRPONMOKDIJLJF-UHFFFAOYSA-N D0UG1U DRUGSMIL C1=CC(=CC=C1C(CC(=O)NC(=NCCCC2=CN=CN2)N)C3=CC=C(C=C3)F)F D0UG1U HIGHSTAT Investigative D0UG4S DRUG__ID D0UG4S D0UG4S DRUGTYPE Small molecular drug D0UG4S DRUGINCH 1S/C11H18N5O12P3/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(27-11)1-26-31(24,25)28-30(22,23)4-29(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H,24,25)(H2,12,13,14)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1 D0UG4S DRUGINKE UFZTZBNSLXELAL-IOSLPCCCSA-N D0UG4S DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O)O)N D0UG4S HIGHSTAT Investigative D0UG5M DRUG__ID D0UG5M D0UG5M DRUGTYPE Small molecular drug D0UG5M DRUGINCH 1S/C28H39N3O3/c1-18(2)26(30-27(34)25-13-20-8-9-24(33)12-21(20)15-29-25)17-31-11-10-28(4,19(3)16-31)22-6-5-7-23(32)14-22/h5-9,12,14,18-19,25-26,29,32-33H,10-11,13,15-17H2,1-4H3,(H,30,34)/t19-,25+,26+,28+/m0/s1 D0UG5M DRUGINKE ZLVXBBHTMQJRSX-VMGNSXQWSA-N D0UG5M DRUGSMIL CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(C(C)C)NC(=O)C3CC4=C(CN3)C=C(C=C4)O D0UG5M HIGHSTAT Investigative D0UG6N DRUG__ID D0UG6N D0UG6N DRUGTYPE Small molecular drug D0UG6N DRUGINCH 1S/C28H23F6N3O2/c1-15-7-9-17(10-8-15)22-21-6-5-11-35-23(21)25(38)37(4)24(22)26(39)36(3)16(2)18-12-19(27(29,30)31)14-20(13-18)28(32,33)34/h5-14,16H,1-4H3/t16-/m1/s1 D0UG6N DRUGINKE TTZWDLZPHOQUAU-MRXNPFEDSA-N D0UG6N DRUGSMIL CC1=CC=C(C=C1)C2=C(N(C(=O)C3=C2C=CC=N3)C)C(=O)N(C)C(C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F D0UG6N HIGHSTAT Investigative D0UG8H DRUG__ID D0UG8H D0UG8H DRUGTYPE Small molecular drug D0UG8H DRUGINCH 1S/C27H28N2O/c30-21-8-7-18-13-26-23-12-20-11-19-3-1-2-4-24(19)28-25(20)15-27(23,22(18)14-21)9-10-29(26)16-17-5-6-17/h1-4,7-8,11,14,17,23,26,30H,5-6,9-10,12-13,15-16H2/t23-,26+,27+/m0/s1 D0UG8H DRUGINKE FTJYQAMRGYACMS-HUROMRQRSA-N D0UG8H DRUGSMIL C1CC1CN2CCC34CC5=NC6=CC=CC=C6C=C5CC3C2CC7=C4C=C(C=C7)O D0UG8H HIGHSTAT Investigative D0UH0Q DRUG__ID D0UH0Q D0UH0Q DRUGTYPE Small molecular drug D0UH0Q DRUGINCH 1S/C17H15NO3/c19-8-9-21-14-6-3-5-12(10-14)15-11-13-4-1-2-7-16(13)18-17(15)20/h1-7,10-11,19H,8-9H2,(H,18,20) D0UH0Q DRUGINKE CAPTUZLISRNFKN-UHFFFAOYSA-N D0UH0Q DRUGSMIL C1=CC=C2C(=C1)C=C(C(=O)N2)C3=CC(=CC=C3)OCCO D0UH0Q HIGHSTAT Investigative D0UH3D DRUG__ID D0UH3D D0UH3D DRUGTYPE Small molecular drug D0UH3D DRUGINCH 1S/C15H17FO3.Na/c1-9(15(18)19)12-6-5-10(8-13(12)16)7-11-3-2-4-14(11)17;/h5-6,8-9,11H,2-4,7H2,1H3,(H,18,19);/q;+1/p-1 D0UH3D DRUGINKE ISLFLEUBAXYHSW-UHFFFAOYSA-M D0UH3D DRUGSMIL CC(C1=C(C=C(C=C1)CC2CCCC2=O)F)C(=O)[O-].[Na+] D0UH3D HIGHSTAT Investigative D0UH3W DRUG__ID D0UH3W D0UH3W DRUGTYPE Small molecular drug D0UH3W DRUGINCH 1S/C18H14O5/c1-10-13-5-11(8-19)6-16(20-2)18(13)23-17(10)12-3-4-14-15(7-12)22-9-21-14/h3-8H,9H2,1-2H3 D0UH3W DRUGINKE HCCYBFOBGKSPJH-UHFFFAOYSA-N D0UH3W DRUGSMIL CC1=C(OC2=C1C=C(C=C2OC)C=O)C3=CC4=C(C=C3)OCO4 D0UH3W HIGHSTAT Investigative D0UH6R DRUG__ID D0UH6R D0UH6R DRUGTYPE Small molecular drug D0UH6R DRUGINCH 1S/C17H15NO4/c1-13(19)18(21)17(20)11-10-14-6-5-9-16(12-14)22-15-7-3-2-4-8-15/h2-12,21H,1H3/b11-10+ D0UH6R DRUGINKE REDOCAPSVCSQLX-ZHACJKMWSA-N D0UH6R DRUGSMIL CC(=O)N(C(=O)C=CC1=CC(=CC=C1)OC2=CC=CC=C2)O D0UH6R HIGHSTAT Investigative D0UH9E DRUG__ID D0UH9E D0UH9E DRUGTYPE Small molecular drug D0UH9E DRUGINCH 1S/C17H12ClF3N2O3S/c1-8-4-11(3-2-9(8)5-13-14(24)23-16(25)27-13)26-15-12(18)6-10(7-22-15)17(19,20)21/h2-4,6-7,13H,5H2,1H3,(H,23,24,25) D0UH9E DRUGINKE ZAMASFSDWVSMSY-UHFFFAOYSA-N D0UH9E DRUGSMIL CC1=C(C=CC(=C1)OC2=C(C=C(C=N2)C(F)(F)F)Cl)CC3C(=O)NC(=O)S3 D0UH9E HIGHSTAT Investigative D0UI1P DRUG__ID D0UI1P D0UI1P DRUGTYPE Small molecular drug D0UI1P DRUGINCH 1S/C19H27N3O4/c1-2-3-4-8-13-20-18(24)14-16(19(25)22-26)21-17(23)12-11-15-9-6-5-7-10-15/h5-7,9-12,16,26H,2-4,8,13-14H2,1H3,(H,20,24)(H,21,23)(H,22,25)/b12-11+/t16-/m1/s1 D0UI1P DRUGINKE AOIMNHYQILMKAB-LPQFERQCSA-N D0UI1P DRUGSMIL CCCCCCNC(=O)CC(C(=O)NO)NC(=O)C=CC1=CC=CC=C1 D0UI1P HIGHSTAT Investigative D0UI3L DRUG__ID D0UI3L D0UI3L DRUGTYPE Small molecular drug D0UI3L DRUGINCH 1S/C32H43N5O5/c1-17(2)12-25-29(39)36-11-7-10-26(36)32(41)37(25)30(40)31(42-32,18(3)4)34-28(38)20-13-22-21-8-6-9-23-27(21)19(15-33-23)14-24(22)35(5)16-20/h6,8-9,15,17-18,20,22,24-26,33,41H,7,10-14,16H2,1-5H3,(H,34,38)/t20-,22-,24-,25+,26+,31-,32+/m1/s1 D0UI3L DRUGINKE PBUNVLRHZGSROC-VTIMJTGVSA-N D0UI3L DRUGSMIL CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O D0UI3L HIGHSTAT Investigative D0UI7U DRUG__ID D0UI7U D0UI7U DRUGTYPE Small molecular drug D0UI7U DRUGINCH 1S/C18H13Cl2N3O2/c19-13-3-11(4-14(20)6-13)7-22-18-15(8-21-9-23-18)12-1-2-16-17(5-12)25-10-24-16/h1-6,8-9H,7,10H2,(H,21,22,23) D0UI7U DRUGINKE JQSJAVBMIMDUFO-UHFFFAOYSA-N D0UI7U DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=CN=CN=C3NCC4=CC(=CC(=C4)Cl)Cl D0UI7U HIGHSTAT Investigative D0UI8Q DRUG__ID D0UI8Q D0UI8Q DRUGTYPE Small molecular drug D0UI8Q DRUGINCH 1S/C13H9BrN2O2/c14-10-2-1-9(7-16-5-4-15-8-16)13-12(10)11(17)3-6-18-13/h1-6,8H,7H2 D0UI8Q DRUGINKE QYFIAVSWVXIKAW-UHFFFAOYSA-N D0UI8Q DRUGSMIL C1=CC(=C2C(=O)C=COC2=C1CN3C=CN=C3)Br D0UI8Q HIGHSTAT Investigative D0UJ2C DRUG__ID D0UJ2C D0UJ2C DRUGTYPE Small molecular drug D0UJ2C DRUGINCH 1S/C12H10O3S2/c13-12(10-6-7-16-8-10)9-17(14,15)11-4-2-1-3-5-11/h1-8H,9H2 D0UJ2C DRUGINKE CBJGWEVSYFKKBK-UHFFFAOYSA-N D0UJ2C DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)CC(=O)C2=CSC=C2 D0UJ2C HIGHSTAT Investigative D0UJ9V DRUG__ID D0UJ9V D0UJ9V DRUGTYPE Small molecular drug D0UJ9V DRUGINCH 1S/C16H28N2O2/c19-5-3-1-2-4-17-15(20)18-16-9-12-6-13(10-16)8-14(7-12)11-16/h12-14,19H,1-11H2,(H2,17,18,20) D0UJ9V DRUGINKE MMIRJMPACJKTFC-UHFFFAOYSA-N D0UJ9V DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCCCCO D0UJ9V HIGHSTAT Investigative D0UK0F DRUG__ID D0UK0F D0UK0F DRUGTYPE Small molecular drug D0UK0F DRUGINCH 1S/C9H16N6/c1-14-2-4-15(5-3-14)8-6-7(10)12-9(11)13-8/h6H,2-5H2,1H3,(H4,10,11,12,13) D0UK0F DRUGINKE RBHNSRTVBDSNLG-UHFFFAOYSA-N D0UK0F DRUGSMIL CN1CCN(CC1)C2=NC(=NC(=C2)N)N D0UK0F HIGHSTAT Investigative D0UK4O DRUG__ID D0UK4O D0UK4O DRUGTYPE Small molecular drug D0UK4O DRUGINCH 1S/C32H28O4/c33-26(18-16-23-10-4-1-5-11-23)20-28-21-29(25-14-8-3-9-15-25)31-30(35-28)22-27(36-32(31)34)19-17-24-12-6-2-7-13-24/h1-15,17,19,22,28-29H,16,18,20-21H2/b19-17+/t28-,29+/m1/s1 D0UK4O DRUGINKE IAIGBNIWSBFKNA-FIACUDKOSA-N D0UK4O DRUGSMIL C1C(OC2=C(C1C3=CC=CC=C3)C(=O)OC(=C2)C=CC4=CC=CC=C4)CC(=O)CCC5=CC=CC=C5 D0UK4O HIGHSTAT Investigative D0UK5A DRUG__ID D0UK5A D0UK5A DRUGTYPE Small molecular drug D0UK5A DRUGINCH 1S/C16H14O2/c1-11-3-7-13(8-4-11)15(17)16(18)14-9-5-12(2)6-10-14/h3-10H,1-2H3 D0UK5A DRUGINKE BCWCEHMHCDCJAD-UHFFFAOYSA-N D0UK5A DRUGSMIL CC1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)C D0UK5A HIGHSTAT Investigative D0UL6C DRUG__ID D0UL6C D0UL6C DRUGTYPE Small molecular drug D0UL6C DRUGINCH 1S/C8H7Cl2N3S/c9-6-2-1-5(3-7(6)10)4-12-13-8(11)14/h1-4H,(H3,11,13,14)/b12-4+ D0UL6C DRUGINKE OMVGKAWQTXZISA-UUILKARUSA-N D0UL6C DRUGSMIL C1=CC(=C(C=C1C=NNC(=S)N)Cl)Cl D0UL6C HIGHSTAT Investigative D0UL6I DRUG__ID D0UL6I D0UL6I DRUGTYPE Small molecular drug D0UL6I DRUGINCH 1S/C15H21NO/c17-13-6-3-5-12(11-13)14-7-4-10-16-9-2-1-8-15(14)16/h3,5-6,11,14-15,17H,1-2,4,7-10H2 D0UL6I DRUGINKE RUTLNJGVITWMQE-UHFFFAOYSA-N D0UL6I DRUGSMIL C1CCN2CCCC(C2C1)C3=CC(=CC=C3)O D0UL6I HIGHSTAT Investigative D0UL6Y DRUG__ID D0UL6Y D0UL6Y DRUGTYPE Small molecular drug D0UL6Y DRUGINCH 1S/C9H9F2N/c10-7-3-1-6(2-4-7)9(11)5-8(9)12/h1-4,8H,5,12H2/t8-,9+/m1/s1 D0UL6Y DRUGINKE JCUGJWBVZNWAIJ-BDAKNGLRSA-N D0UL6Y DRUGSMIL C1C(C1(C2=CC=C(C=C2)F)F)N D0UL6Y HIGHSTAT Investigative D0UL7N DRUG__ID D0UL7N D0UL7N DRUGTYPE Small molecular drug D0UL7N DRUGINCH 1S/C24H15NO6/c26-16-8-4-14(5-9-16)24(15-6-10-17(27)11-7-15)20-12-13-21(25(29)30)18-2-1-3-19(22(18)20)23(28)31-24/h1-13,26-27H D0UL7N DRUGINKE FLWABCQDXUKNQY-UHFFFAOYSA-N D0UL7N DRUGSMIL C1=CC2=C(C=CC3=C2C(=C1)C(=O)OC3(C4=CC=C(C=C4)O)C5=CC=C(C=C5)O)[N+](=O)[O-] D0UL7N HIGHSTAT Investigative D0UL7R DRUG__ID D0UL7R D0UL7R DRUGTYPE Small molecular drug D0UL7R DRUGINCH 1S/C11H8N2S/c12-11-13-10-8-4-2-1-3-7(8)5-6-9(10)14-11/h1-6H,(H2,12,13) D0UL7R DRUGINKE FECQXVPRUCCUIL-UHFFFAOYSA-N D0UL7R DRUGSMIL C1=CC=C2C(=C1)C=CC3=C2N=C(S3)N D0UL7R HIGHSTAT Investigative D0UM1I DRUG__ID D0UM1I D0UM1I DRUGTYPE Small molecular drug D0UM1I DRUGINCH 1S/C5H8N4O2S/c6-9-4-1-2-8-3-5(4)12(7,10)11/h1-3H,6H2,(H,8,9)(H2,7,10,11) D0UM1I DRUGINKE PTRSDYFZXIJRKG-UHFFFAOYSA-N D0UM1I DRUGSMIL C1=CN=CC(=C1NN)S(=O)(=O)N D0UM1I HIGHSTAT Investigative D0UM4R DRUG__ID D0UM4R D0UM4R DRUGTYPE Small molecular drug D0UM4R DRUGINCH 1S/C12H10ClN5/c1-18-7-14-9-10(16-12(13)17-11(9)18)15-8-5-3-2-4-6-8/h2-7H,1H3,(H,15,16,17) D0UM4R DRUGINKE DBTWDYPKBBODMU-UHFFFAOYSA-N D0UM4R DRUGSMIL CN1C=NC2=C(N=C(N=C21)Cl)NC3=CC=CC=C3 D0UM4R HIGHSTAT Investigative D0UM6O DRUG__ID D0UM6O D0UM6O DRUGTYPE Small molecular drug D0UM6O DRUGINCH 1S/C9H4ClN3S2/c10-9-12-5-1-3-14-7(5)6(13-9)8-11-2-4-15-8/h1-4H D0UM6O DRUGINKE GWBPGRWRSLAHEX-UHFFFAOYSA-N D0UM6O DRUGSMIL C1=CSC2=C1N=C(N=C2C3=NC=CS3)Cl D0UM6O HIGHSTAT Investigative D0UN0E DRUG__ID D0UN0E D0UN0E DRUGTYPE Small molecular drug D0UN0E DRUGINCH 1S/C7H7F2NO2S/c8-7(9,13(10,11)12)6-4-2-1-3-5-6/h1-5H,(H2,10,11,12) D0UN0E DRUGINKE MISDUXOMBAGVQG-UHFFFAOYSA-N D0UN0E DRUGSMIL C1=CC=C(C=C1)C(F)(F)S(=O)(=O)N D0UN0E HIGHSTAT Investigative D0UN0R DRUG__ID D0UN0R D0UN0R DRUGTYPE Small molecular drug D0UN0R DRUGINCH 1S/C25H32O4/c1-16(2)8-12-21-19(7-5-6-18-10-11-20(26)15-23(18)27)14-24(28)25(29)22(21)13-9-17(3)4/h8-11,14-15,26-29H,5-7,12-13H2,1-4H3 D0UN0R DRUGINKE PNQQDEFGJPUAGZ-UHFFFAOYSA-N D0UN0R DRUGSMIL CC(=CCC1=C(C(=C(C=C1CCCC2=C(C=C(C=C2)O)O)O)O)CC=C(C)C)C D0UN0R HIGHSTAT Investigative D0UN6P DRUG__ID D0UN6P D0UN6P DRUGTYPE Small molecular drug D0UN6P DRUGINCH 1S/C14H9ClN4O2/c15-9-2-1-3-10(6-9)18-14-12-7-11(19(20)21)4-5-13(12)16-8-17-14/h1-8H,(H,16,17,18) D0UN6P DRUGINKE USAMIYATKINXLP-UHFFFAOYSA-N D0UN6P DRUGSMIL C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)[N+](=O)[O-] D0UN6P HIGHSTAT Investigative D0UN9O DRUG__ID D0UN9O D0UN9O DRUGTYPE Small molecular drug D0UN9O DRUGINCH 1S/C15H10N2O/c1-2-6-10(7-3-1)13-15-14(17-16-13)11-8-4-5-9-12(11)18-15/h1-9H,(H,16,17) D0UN9O DRUGINKE DZQLVVLATXPWBK-UHFFFAOYSA-N D0UN9O DRUGSMIL C1=CC=C(C=C1)C2=NNC3=C2OC4=CC=CC=C43 D0UN9O HIGHSTAT Investigative D0UO1E DRUG__ID D0UO1E D0UO1E DRUGTYPE Small molecular drug D0UO1E DRUGINCH 1S/C26H22N2O2/c1-18(19-7-3-2-4-8-19)28-26(30)21-11-14-22(15-12-21)27-17-24-23-10-6-5-9-20(23)13-16-25(24)29/h2-18,29H,1H3,(H,28,30) D0UO1E DRUGINKE IJMMXTFONLLCMY-UHFFFAOYSA-N D0UO1E DRUGSMIL CC(C1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)N=CC3=C(C=CC4=CC=CC=C43)O D0UO1E HIGHSTAT Investigative D0UO2H DRUG__ID D0UO2H D0UO2H DRUGCOMP Nerviano Medical Sciences Srl D0UO2H DRUGINCH 1S/C35H39F3N8O3/c1-5-20-8-7-9-21(6-2)28(20)42-33(48)30-25-12-10-23-19-39-34(43-29(23)31(25)46(4)44-30)41-26-13-11-22(18-27(26)49-35(36,37)38)32(47)40-24-14-16-45(3)17-15-24/h7-9,11,13,18-19,24H,5-6,10,12,14-17H2,1-4H3,(H,40,47)(H,42,48)(H,39,41,43) D0UO2H DRUGINKE JFOAJUGFHDCBJJ-UHFFFAOYSA-N D0UO2H DRUGSMIL CCC1=C(C(=CC=C1)CC)NC(=O)C2=NN(C3=C2CCC4=CN=C(N=C43)NC5=C(C=C(C=C5)C(=O)NC6CCN(CC6)C)OC(F)(F)F)C D0UO2H HIGHSTAT Investigative D0UO2Q DRUG__ID D0UO2Q D0UO2Q DRUGTYPE Small molecular drug D0UO2Q DRUGINCH 1S/C25H27ClN2O/c1-17(21-10-6-8-18-7-2-3-9-22(18)21)27-23-11-4-5-12-24(23)28-25(29)19-13-15-20(26)16-14-19/h2-3,6-10,13-17,23-24,27H,4-5,11-12H2,1H3,(H,28,29)/t17-,23+,24+/m1/s1 D0UO2Q DRUGINKE YTFUQWWKTIWYEY-CQLNOVPUSA-N D0UO2Q DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)NC3CCCCC3NC(=O)C4=CC=C(C=C4)Cl D0UO2Q HIGHSTAT Investigative D0UO2Z DRUG__ID D0UO2Z D0UO2Z DRUGTYPE Small molecular drug D0UO2Z DRUGINCH 1S/C17H23N3/c1-2-4-14(5-3-1)15-6-8-16(9-7-15)19-11-10-17-12-18-13-20-17/h6-9,12-14,19H,1-5,10-11H2,(H,18,20) D0UO2Z DRUGINKE GEYDSVZUDGXVCV-UHFFFAOYSA-N D0UO2Z DRUGSMIL C1CCC(CC1)C2=CC=C(C=C2)NCCC3=CN=CN3 D0UO2Z HIGHSTAT Investigative D0UO3I DRUG__ID D0UO3I D0UO3I DRUGTYPE Small molecular drug D0UO3I DRUGINCH 1S/C14H16N2O4S/c1-10-12(18)15-14(19)16(9-20-8-7-17)13(10)21-11-5-3-2-4-6-11/h2-6,17H,7-9H2,1H3,(H,15,18,19) D0UO3I DRUGINKE HDMHBHNRWDNNCD-UHFFFAOYSA-N D0UO3I DRUGSMIL CC1=C(N(C(=O)NC1=O)COCCO)SC2=CC=CC=C2 D0UO3I HIGHSTAT Investigative D0UO6Q DRUG__ID D0UO6Q D0UO6Q DRUGTYPE Small molecular drug D0UO6Q DRUGINCH 1S/C16H13N/c1-12-7-8-14-9-10-15(11-16(14)17-12)13-5-3-2-4-6-13/h2-11H,1H3 D0UO6Q DRUGINKE FGRQGIBMKYGMEX-UHFFFAOYSA-N D0UO6Q DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC=CC=C3 D0UO6Q HIGHSTAT Investigative D0UP6G DRUG__ID D0UP6G D0UP6G DRUGTYPE Small molecular drug D0UP6G DRUGINCH 1S/C13H12N2O/c14-12-7-6-10(8-11(12)13(15)16)9-4-2-1-3-5-9/h1-8H,14H2,(H2,15,16) D0UP6G DRUGINKE KLDLPUIJJYDCEE-UHFFFAOYSA-N D0UP6G DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(C=C2)N)C(=O)N D0UP6G HIGHSTAT Investigative D0UP8X DRUG__ID D0UP8X D0UP8X DRUGTYPE Small molecular drug D0UP8X DRUGINCH 1S/C7H14N2O/c1-3-5-6(4-2)10-7(8)9-5/h5-6H,3-4H2,1-2H3,(H2,8,9)/t5-,6+/m0/s1 D0UP8X DRUGINKE KYKDCIRQVPPSOP-NTSWFWBYSA-N D0UP8X DRUGSMIL CCC1C(OC(=N1)N)CC D0UP8X HIGHSTAT Investigative D0UQ6A DRUG__ID D0UQ6A D0UQ6A DRUGTYPE Small molecular drug D0UQ6A DRUGINCH 1S/C23H25FNO5P/c1-15(2)23-19-5-3-4-6-20(19)25(17-9-7-16(24)8-10-17)21(23)11-12-31(29,30)14-18(26)13-22(27)28/h3-12,15,18,26H,13-14H2,1-2H3,(H,27,28)(H,29,30)/b12-11+/t18-/m0/s1 D0UQ6A DRUGINKE RTTUBUXMNUJHRR-DXRVJIQQSA-N D0UQ6A DRUGSMIL CC(C)C1=C(N(C2=CC=CC=C21)C3=CC=C(C=C3)F)C=CP(=O)(CC(CC(=O)O)O)O D0UQ6A HIGHSTAT Investigative D0UQ6J DRUG__ID D0UQ6J D0UQ6J DRUGTYPE Small molecular drug D0UQ6J DRUGINCH 1S/C15H17N3O3S/c1-15(2,3)21-14(20)11-10-7-17(4)13(19)12-9(5-6-22-12)18(10)8-16-11/h5-6,8H,7H2,1-4H3 D0UQ6J DRUGINKE ZIGMMUKDYCABPW-UHFFFAOYSA-N D0UQ6J DRUGSMIL CC(C)(C)OC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CS3)C D0UQ6J HIGHSTAT Investigative D0UQ6U DRUG__ID D0UQ6U D0UQ6U DRUGTYPE Small molecular drug D0UQ6U DRUGINCH 1S/C20H30O2/c1-13(2)14-6-8-16-15(12-14)7-9-17-19(16,3)10-5-11-20(17,4)18(21)22/h7,12-13,16-17H,5-6,8-11H2,1-4H3,(H,21,22)/t16-,17+,19+,20+/m0/s1 D0UQ6U DRUGINKE RSWGJHLUYNHPMX-ONCXSQPRSA-N D0UQ6U DRUGSMIL CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)O)C D0UQ6U HIGHSTAT Investigative D0UR3U DRUG__ID D0UR3U D0UR3U DRUGTYPE Small molecular drug D0UR3U DRUGINCH 1S/C19H26N2O4/c1-2-16-10-15(12-21-5-8-22-9-6-21)13-25-19(16)18(3-1)24-14-17-11-20-4-7-23-17/h1-3,10,17,20H,4-9,11-14H2 D0UR3U DRUGINKE RTKDBEOSPDFLGD-UHFFFAOYSA-N D0UR3U DRUGSMIL C1COC(CN1)COC2=CC=CC3=C2OCC(=C3)CN4CCOCC4 D0UR3U HIGHSTAT Investigative D0UR6C DRUG__ID D0UR6C D0UR6C DRUGTYPE Small molecular drug D0UR6C DRUGINCH 1S/C16H11FOS/c17-13-6-4-11(5-7-13)15-8-9-16(19-15)12-2-1-3-14(18)10-12/h1-10,18H D0UR6C DRUGINKE LBERAJGCBDGPHK-UHFFFAOYSA-N D0UR6C DRUGSMIL C1=CC(=CC(=C1)O)C2=CC=C(S2)C3=CC=C(C=C3)F D0UR6C HIGHSTAT Investigative D0UR7D DRUG__ID D0UR7D D0UR7D DRUGTYPE Small molecular drug D0UR7D DRUGINCH 1S/C54H60N2O8/c1-56-28-27-54-43(46(56)29-41-23-24-42(57)30-44(41)54)25-26-45(53(54)59-2)55-49(58)31-47-50(61-33-38-17-9-4-10-18-38)52(63-35-40-21-13-6-14-22-40)51(62-34-39-19-11-5-12-20-39)48(64-47)36-60-32-37-15-7-3-8-16-37/h3-26,30,43,45-48,50-53,57H,27-29,31-36H2,1-2H3,(H,55,58)/t43-,45+,46+,47?,48?,50?,51?,52?,53?,54-/m0/s1 D0UR7D DRUGINKE AKEFSYMTVVZMKO-GZNILVGYSA-N D0UR7D DRUGSMIL CN1CCC23C(C1CC4=C2C=C(C=C4)O)C=CC(C3OC)NC(=O)CC5C(C(C(C(O5)COCC6=CC=CC=C6)OCC7=CC=CC=C7)OCC8=CC=CC=C8)OCC9=CC=CC=C9 D0UR7D HIGHSTAT Investigative D0UR7U DRUG__ID D0UR7U D0UR7U DRUGTYPE Small molecular drug D0UR7U DRUGINCH 1S/C24H28O6/c1-7-24(4,5)20-17(29-6)10-14(25)19-22(28)18-13(9-8-12(2)3)21(27)15(26)11-16(18)30-23(19)20/h7-8,10-11,19,23,25-27H,1,9H2,2-6H3 D0UR7U DRUGINKE WIZSEOVKPIAUIS-UHFFFAOYSA-N D0UR7U DRUGSMIL CC(=CCC1=C(C(=CC2=C1C(=O)C3C(O2)C(=C(C=C3O)OC)C(C)(C)C=C)O)O)C D0UR7U HIGHSTAT Investigative D0UR9D DRUG__ID D0UR9D D0UR9D DRUGTYPE Small molecular drug D0UR9D DRUGINCH 1S/C15H11N3O3S/c19-14-12-8-11(18(20)21)6-7-13(12)16-15(22)17(14)9-10-4-2-1-3-5-10/h1-8H,9H2,(H,16,22) D0UR9D DRUGINKE CAFCJNRLHXPRGN-UHFFFAOYSA-N D0UR9D DRUGSMIL C1=CC=C(C=C1)CN2C(=O)C3=C(C=CC(=C3)[N+](=O)[O-])NC2=S D0UR9D HIGHSTAT Investigative D0US0J DRUG__ID D0US0J D0US0J DRUGTYPE Small molecular drug D0US0J DRUGINCH 1S/C20H20O3/c1-15(2)12-13-23-17-9-10-18(20(22)14-17)19(21)11-8-16-6-4-3-5-7-16/h3-12,14,22H,13H2,1-2H3/b11-8+ D0US0J DRUGINKE DGUGLZYULGVSIZ-DHZHZOJOSA-N D0US0J DRUGSMIL CC(=CCOC1=CC(=C(C=C1)C(=O)C=CC2=CC=CC=C2)O)C D0US0J HIGHSTAT Investigative D0US2X DRUG__ID D0US2X D0US2X DRUGTYPE Small molecular drug D0US2X DRUGINCH 1S/C13H14FN/c14-11-3-1-9(2-4-11)10-7-12-5-6-13(8-10)15-12/h1-4,7,12-13,15H,5-6,8H2 D0US2X DRUGINKE LKSXLNMBLGXHQS-UHFFFAOYSA-N D0US2X DRUGSMIL C1CC2C=C(CC1N2)C3=CC=C(C=C3)F D0US2X HIGHSTAT Investigative D0US4S DRUG__ID D0US4S D0US4S DRUGTYPE Small molecular drug D0US4S DRUGINCH 1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19(21)17-15-18-20(22)23/h6-7,9-10,12-14,16H,2-5,8,11,15,17-18H2,1H3,(H,22,23)/b7-6-,10-9-,13-12-,16-14+ D0US4S DRUGINKE MEASLHGILYBXFO-XTDASVJISA-N D0US4S DRUGSMIL CCCCCC=CCC=CCC=CC=CC(=O)CCCC(=O)O D0US4S HIGHSTAT Investigative D0US9O DRUG__ID D0US9O D0US9O DRUGTYPE Small molecular drug D0US9O DRUGINCH 1S/C16H16FN9/c1-9(13-19-5-10(17)6-20-13)22-16-24-14-11(3-4-18-14)15(25-16)23-12-7-26(2)8-21-12/h3-9H,1-2H3,(H3,18,22,23,24,25)/t9-/m0/s1 D0US9O DRUGINKE QHXBWJSQXSYAGG-VIFPVBQESA-N D0US9O DRUGSMIL CC(C1=NC=C(C=N1)F)NC2=NC3=C(C=CN3)C(=N2)NC4=CN(C=N4)C D0US9O HIGHSTAT Investigative D0UT1X DRUG__ID D0UT1X D0UT1X DRUGTYPE Small molecular drug D0UT1X DRUGINCH 1S/C14H8N2O6/c17-13(9-3-1-5-11(7-9)15(19)20)14(18)10-4-2-6-12(8-10)16(21)22/h1-8H D0UT1X DRUGINKE SGKVXDKTNJHBCA-UHFFFAOYSA-N D0UT1X DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)C(=O)C2=CC(=CC=C2)[N+](=O)[O-] D0UT1X HIGHSTAT Investigative D0UT2X DRUG__ID D0UT2X D0UT2X DRUGTYPE Small molecular drug D0UT2X DRUGINCH 1S/C9H9ClO2/c10-6-5-9(12)7-1-3-8(11)4-2-7/h1-4,11H,5-6H2 D0UT2X DRUGINKE QRXBKSZGQHXBDO-UHFFFAOYSA-N D0UT2X DRUGSMIL C1=CC(=CC=C1C(=O)CCCl)O D0UT2X HIGHSTAT Investigative D0UT7Y DRUG__ID D0UT7Y D0UT7Y DRUGTYPE Small molecular drug D0UT7Y DRUGINCH 1S/C16H16N2O4/c19-15(10-16(20)18-21)17-11-12-5-4-8-14(9-12)22-13-6-2-1-3-7-13/h1-9,21H,10-11H2,(H,17,19)(H,18,20) D0UT7Y DRUGINKE AKGLDBDNAJLOMB-UHFFFAOYSA-N D0UT7Y DRUGSMIL C1=CC=C(C=C1)OC2=CC=CC(=C2)CNC(=O)CC(=O)NO D0UT7Y HIGHSTAT Investigative D0UU1I DRUG__ID D0UU1I D0UU1I DRUGTYPE Small molecular drug D0UU1I DRUGINCH 1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-2 D0UU1I DRUGINKE KABFMIBPWCXCRK-UHFFFAOYSA-L D0UU1I DRUGSMIL CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)O)CCC(=O)O.[Fe+2] D0UU1I HIGHSTAT Investigative D0UV1C DRUG__ID D0UV1C D0UV1C DRUGTYPE Small molecular drug D0UV1C DRUGINCH 1S/C55H68N8O7/c1-32-22-41(64)23-33(2)43(32)28-45(56)54(69)62-30-39-16-8-6-14-37(39)26-49(62)52(67)58-20-12-10-18-47-36(5)60-48(51(66)61-47)19-11-13-21-59-53(68)50-27-38-15-7-9-17-40(38)31-63(50)55(70)46(57)29-44-34(3)24-42(65)25-35(44)4/h6-9,14-17,22-25,45-46,49-50,64-65H,10-13,18-21,26-31,56-57H2,1-5H3,(H,58,67)(H,59,68)(H,61,66)/t45-,46-,49?,50?/m0/s1 D0UV1C DRUGINKE HHTSJHJHPFGARW-RFLUKDKXSA-N D0UV1C DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCC4=C(N=C(C(=O)N4)CCCCNC(=O)C5CC6=CC=CC=C6CN5C(=O)C(CC7=C(C=C(C=C7C)O)C)N)C)N)C)O D0UV1C HIGHSTAT Investigative D0UV1S DRUG__ID D0UV1S D0UV1S DRUGTYPE Small molecular drug D0UV1S DRUGINCH 1S/C39H46N2O6/c1-40-16-14-27-21-35(43-4)37(45-6)23-30(27)32(40)18-25-8-11-29(12-9-25)47-39-20-26(10-13-34(39)42-3)19-33-31-24-38(46-7)36(44-5)22-28(31)15-17-41(33)2/h8-13,20-24,32-33H,14-19H2,1-7H3/t32-,33-/m1/s1 D0UV1S DRUGINKE UHYCXSGUNAWVBW-CZNDPXEESA-N D0UV1S DRUGSMIL CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)OC)OC)OC D0UV1S HIGHSTAT Investigative D0UV2N DRUG__ID D0UV2N D0UV2N DRUGTYPE Small molecular drug D0UV2N DRUGINCH 1S/C14H15F7O/c15-12(16,13(17,18)14(19,20)21)11(22)9-5-4-8-10-6-2-1-3-7-10/h1-3,6-7,11,22H,4-5,8-9H2 D0UV2N DRUGINKE JTXDZUWPNVVKQF-UHFFFAOYSA-N D0UV2N DRUGSMIL C1=CC=C(C=C1)CCCCC(C(C(C(F)(F)F)(F)F)(F)F)O D0UV2N HIGHSTAT Investigative D0UV6L DRUG__ID D0UV6L D0UV6L DRUGTYPE Small molecular drug D0UV6L DRUGINCH 1S/C15H20ClN3O2/c1-21-14-7-12(17)11(16)6-10(14)15(20)18-13-8-19-4-2-9(13)3-5-19/h6-7,9,13H,2-5,8,17H2,1H3,(H,18,20)/t13-/m1/s1/i1T3 D0UV6L DRUGINKE FEROPKNOYKURCJ-RYASAWMLSA-N D0UV6L DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CN3CCC2CC3)Cl)N D0UV6L HIGHSTAT Investigative D0UV8T DRUG__ID D0UV8T D0UV8T DRUGTYPE Small molecular drug D0UV8T DRUGINCH 1S/C7H6N4/c1-3-8-4-2-6(1)7-5-9-11-10-7/h1-5H,(H,9,10,11) D0UV8T DRUGINKE KEFBRERBEDJOQZ-UHFFFAOYSA-N D0UV8T DRUGSMIL C1=CN=CC=C1C2=NNN=C2 D0UV8T HIGHSTAT Investigative D0UV9G DRUG__ID D0UV9G D0UV9G DRUGTYPE Small molecular drug D0UV9G DRUGINCH 1S/C16H12O/c17-16-9-8-14-10-13(6-7-15(14)11-16)12-4-2-1-3-5-12/h1-11,17H D0UV9G DRUGINKE PZOXFBPKKGTQDZ-UHFFFAOYSA-N D0UV9G DRUGSMIL C1=CC=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)O D0UV9G HIGHSTAT Investigative D0UW9I DRUG__ID D0UW9I D0UW9I DRUGTYPE Small molecular drug D0UW9I DRUGINCH 1S/C14H21N/c1-12-5-3-7-14(11-12)8-10-15-9-4-6-13(15)2/h3,5,7,11,13H,4,6,8-10H2,1-2H3/t13-/m0/s1 D0UW9I DRUGINKE PXZKWHANTMQGIH-ZDUSSCGKSA-N D0UW9I DRUGSMIL CC1CCCN1CCC2=CC=CC(=C2)C D0UW9I HIGHSTAT Investigative D0UX3T DRUG__ID D0UX3T D0UX3T DRUGTYPE Small molecular drug D0UX3T DRUGINCH 1S/C17H12N2S/c1-2-4-17-15(3-1)16(10-19-17)14-7-13(8-18-9-14)12-5-6-20-11-12/h1-11,19H D0UX3T DRUGINKE GDLQJKCZVIUEDN-UHFFFAOYSA-N D0UX3T DRUGSMIL C1=CC=C2C(=C1)C(=CN2)C3=CN=CC(=C3)C4=CSC=C4 D0UX3T HIGHSTAT Investigative D0UX4A DRUG__ID D0UX4A D0UX4A DRUGCOMP Yissum Research Development Co D0UX4A DRUGINCH 1S/C27H42O3/c1-8-9-10-11-12-26(2,3)19-14-23(29-6)25(24(15-19)30-7)20-13-18(17-28)21-16-22(20)27(21,4)5/h13-15,20-22,28H,8-12,16-17H2,1-7H3/t20?,21-,22+/m0/s1 D0UX4A DRUGINKE CFMRIVODIXTERW-JTGIGXABSA-N D0UX4A DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C(=C1)OC)C2C=C(C3CC2C3(C)C)CO)OC D0UX4A HIGHSTAT Investigative D0UX4C DRUG__ID D0UX4C D0UX4C DRUGTYPE Small molecular drug D0UX4C DRUGINCH 1S/C38H46N4O7S2/c1-38(2)34(36(47)41-32-27-16-9-8-14-25(27)20-30(32)43)42(22-51-38)37(48)33(45)28(18-23-11-6-5-7-12-23)40-35(46)29(21-50-4)39-31(44)19-24-13-10-15-26(17-24)49-3/h5-17,28-30,32-34,43,45H,18-22H2,1-4H3,(H,39,44)(H,40,46)(H,41,47)/t28-,29-,30+,32-,33-,34+/m0/s1 D0UX4C DRUGINKE CLMDKZSFODILEW-DYCNJNKSSA-N D0UX4C DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC(=CC=C3)OC)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0UX4C HIGHSTAT Investigative D0UX5M DRUG__ID D0UX5M D0UX5M DRUGTYPE Small molecular drug D0UX5M DRUGINCH 1S/C8H12N2/c1-10(2)7-8-4-3-5-9-6-8/h3-6H,7H2,1-2H3 D0UX5M DRUGINKE SLZCOYDOFRTTHF-UHFFFAOYSA-N D0UX5M DRUGSMIL CN(C)CC1=CN=CC=C1 D0UX5M HIGHSTAT Investigative D0UZ4J DRUG__ID D0UZ4J D0UZ4J DRUGTYPE Small molecular drug D0UZ4J DRUGINCH 1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23) D0UZ4J DRUGINKE AKMNUCBQGHFICM-UHFFFAOYSA-N D0UZ4J DRUGSMIL CC1=NC2=C(O1)C=C(C=C2)NC(=O)NC3=C4C(=NC=C3)C=CC=N4 D0UZ4J HIGHSTAT Investigative D0UZ5N DRUG__ID D0UZ5N D0UZ5N DRUGTYPE Small molecular drug D0UZ5N DRUGINCH 1S/C22H28N4O5S2/c1-23-33(29,30)21-11-12-22-17(15-21)5-6-19(24-22)16-26(2)13-4-14-31-20-9-7-18(8-10-20)25-32(3,27)28/h5-12,15,23,25H,4,13-14,16H2,1-3H3 D0UZ5N DRUGINKE YENONGAXQMSIAO-UHFFFAOYSA-N D0UZ5N DRUGSMIL CNS(=O)(=O)C1=CC2=C(C=C1)N=C(C=C2)CN(C)CCCOC3=CC=C(C=C3)NS(=O)(=O)C D0UZ5N HIGHSTAT Investigative D0UZ5W DRUG__ID D0UZ5W D0UZ5W DRUGTYPE Small molecular drug D0UZ5W DRUGINCH 1S/C13H9Cl2NO3S/c14-9-5-7-10(8-6-9)20(18,19)16-13(17)11-3-1-2-4-12(11)15/h1-8H,(H,16,17) D0UZ5W DRUGINKE XWHYBUXHQMUOJE-UHFFFAOYSA-N D0UZ5W DRUGSMIL C1=CC=C(C(=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl)Cl D0UZ5W HIGHSTAT Investigative D0UZ8R DRUG__ID D0UZ8R D0UZ8R DRUGTYPE Small molecular drug D0UZ8R DRUGINCH 1S/C16H14O4/c1-19-13-7-3-11(4-8-13)15(17)16(18)12-5-9-14(20-2)10-6-12/h3-10H,1-2H3 D0UZ8R DRUGINKE YNANGXWUZWWFKX-UHFFFAOYSA-N D0UZ8R DRUGSMIL COC1=CC=C(C=C1)C(=O)C(=O)C2=CC=C(C=C2)OC D0UZ8R HIGHSTAT Investigative D0V0AI DRUG__ID D0V0AI D0V0AI DRUGTYPE Small molecular drug D0V0AI DRUGINCH 1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9) D0V0AI DRUGINKE KHPXUQMNIQBQEV-UHFFFAOYSA-N D0V0AI DRUGSMIL C(C(=O)C(=O)O)C(=O)O D0V0AI HIGHSTAT Investigative D0V0AW DRUG__ID D0V0AW D0V0AW DRUGTYPE Small molecular drug D0V0AW DRUGINCH 1S/C12H18N2O/c1-3-15-12-8-11(9-14-10-12)6-4-5-7-13-2/h4,6,8-10,13H,3,5,7H2,1-2H3/b6-4+ D0V0AW DRUGINKE HFZDMKMXPGRKCK-GQCTYLIASA-N D0V0AW DRUGSMIL CCOC1=CN=CC(=C1)C=CCCNC D0V0AW HIGHSTAT Investigative D0V0DB DRUG__ID D0V0DB D0V0DB DRUGTYPE Small molecular drug D0V0DB DRUGINCH 1S/C19H12O3/c20-15-8-4-7-13-9-10-14-16(21)11-17(22-19(14)18(13)15)12-5-2-1-3-6-12/h1-11,20H D0V0DB DRUGINKE UQEKEVFKEDHKOB-UHFFFAOYSA-N D0V0DB DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=C(C=CC=C4O)C=C3 D0V0DB HIGHSTAT Investigative D0V0FG DRUG__ID D0V0FG D0V0FG DRUGTYPE Small molecular drug D0V0FG DRUGINCH 1S/C10H16O3/c11-9(6-7-10(12)13)8-4-2-1-3-5-8/h6-9,11H,1-5H2,(H,12,13)/b7-6+ D0V0FG DRUGINKE CGIACWYLNZMXMN-VOTSOKGWSA-N D0V0FG DRUGSMIL C1CCC(CC1)C(C=CC(=O)O)O D0V0FG HIGHSTAT Investigative D0V0FY DRUG__ID D0V0FY D0V0FY DRUGTYPE Small molecular drug D0V0FY DRUGINCH 1S/C15H16O4/c1-3-9-18-12-7-5-10-6-8-13(17)19-15(10)14(12)11(16)4-2/h5-8H,3-4,9H2,1-2H3 D0V0FY DRUGINKE CVYSNMWNCSOWAN-UHFFFAOYSA-N D0V0FY DRUGSMIL CCCOC1=C(C2=C(C=C1)C=CC(=O)O2)C(=O)CC D0V0FY HIGHSTAT Investigative D0V0HH DRUG__ID D0V0HH D0V0HH DRUGTYPE Small molecular drug D0V0HH DRUGINCH 1S/C33H66NO9P/c1-5-6-7-8-9-10-11-12-13-14-15-16-20-23-27-40-29-31(30-42-44(38,39)41-28-26-34(2,3)4)43-33(37)25-22-19-17-18-21-24-32(35)36/h31H,5-30H2,1-4H3,(H-,35,36,38,39)/t31-/m1/s1 D0V0HH DRUGINKE ZDFOCDTXDPKJKA-WJOKGBTCSA-N D0V0HH DRUGSMIL CCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC(=O)O D0V0HH HIGHSTAT Investigative D0V0HJ DRUG__ID D0V0HJ D0V0HJ DRUGTYPE Small molecular drug D0V0HJ DRUGINCH 1S/C7H9N5O2/c1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h1-2H3,(H3,8,9,10) D0V0HJ DRUGINKE ZZESAIGPDOBLKZ-UHFFFAOYSA-N D0V0HJ DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC(=N2)N D0V0HJ HIGHSTAT Investigative D0V0JC DRUG__ID D0V0JC D0V0JC DRUGTYPE Small molecular drug D0V0JC DRUGINCH 1S/C27H37F3N8O7/c1-14(2)20-23(44)36-16(9-6-10-33-25(31)32)21(42)34-13-18(39)35-17(11-19(40)41)22(43)38-26(24(45)37-20,27(28,29)30)12-15-7-4-3-5-8-15/h3-5,7-8,14,16-17,20H,6,9-13H2,1-2H3,(H,34,42)(H,35,39)(H,36,44)(H,37,45)(H,38,43)(H,40,41)(H4,31,32,33)/t16-,17-,20-,26-/m0/s1 D0V0JC DRUGINKE IIJWLNNXJHIKND-CVJKZBOTSA-N D0V0JC DRUGSMIL CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)(CC2=CC=CC=C2)C(F)(F)F)CC(=O)O)CCCN=C(N)N D0V0JC HIGHSTAT Investigative D0V0KA DRUG__ID D0V0KA D0V0KA DRUGTYPE Small molecular drug D0V0KA DRUGINCH 1S/C20H18ClN3O2/c21-16-11-15-13(8-9-22-19(15)25)10-17(16)24-20(26)18(23-14-6-7-14)12-4-2-1-3-5-12/h1-5,8-11,14,18,23H,6-7H2,(H,22,25)(H,24,26) D0V0KA DRUGINKE SKYALJGMRAGHEN-UHFFFAOYSA-N D0V0KA DRUGSMIL C1CC1NC(C2=CC=CC=C2)C(=O)NC3=C(C=C4C(=C3)C=CNC4=O)Cl D0V0KA HIGHSTAT Investigative D0V0LA DRUG__ID D0V0LA D0V0LA DRUGTYPE Small molecular drug D0V0LA DRUGINCH 1S/C5H14NO2P/c1-5(3-4-6)9(2,7)8/h5H,3-4,6H2,1-2H3,(H,7,8) D0V0LA DRUGINKE CCFBFTKQKRGULP-UHFFFAOYSA-N D0V0LA DRUGSMIL CC(CCN)P(=O)(C)O D0V0LA HIGHSTAT Investigative D0V0LU DRUG__ID D0V0LU D0V0LU DRUGTYPE Small molecular drug D0V0LU DRUGINCH 1S/C24H18O5/c1-28-18-10-16(27)21-15(26)9-13-11-5-2-3-8-17(11)29-24-12-6-4-7-14(25)19(12)22(18)23(21)20(13)24/h2-8,10,13,20,24-25,27H,9H2,1H3/t13-,20+,24+/m1/s1 D0V0LU DRUGINKE ZVFNSNHXUYAPTP-VVTWNTARSA-N D0V0LU DRUGSMIL COC1=C2C3=C(C(=O)CC4C3C(C5=C2C(=CC=C5)O)OC6=CC=CC=C46)C(=C1)O D0V0LU HIGHSTAT Investigative D0V0LY DRUG__ID D0V0LY D0V0LY DRUGTYPE Small molecular drug D0V0LY DRUGINCH 1S/C47H75N13O11/c1-28(2)24-33(46(70)71)56-42(66)36-17-10-21-58(36)44(68)34(27-61)57-40(64)32(25-29-12-4-3-5-13-29)54-38(62)26-53-41(65)35-16-9-22-59(35)45(69)37-18-11-23-60(37)43(67)31(15-8-20-52-47(50)51)55-39(63)30(49)14-6-7-19-48/h3-5,12-13,28,30-37,61H,6-11,14-27,48-49H2,1-2H3,(H,53,65)(H,54,62)(H,55,63)(H,56,66)(H,57,64)(H,70,71)(H4,50,51,52)/t30-,31-,32-,33-,34-,35-,36-,37-/m0/s1 D0V0LY DRUGINKE AGTPZUQKOYEAOH-MDKUUQCZSA-N D0V0LY DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C1CCCN1C(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)N D0V0LY HIGHSTAT Investigative D0V0MH DRUG__ID D0V0MH D0V0MH DRUGTYPE Small molecular drug D0V0MH DRUGINCH 1S/C16H18N2O/c1-2-4-15(5-3-1)19-16-8-6-14(7-9-16)18-12-10-17-11-13-18/h1-9,17H,10-13H2 D0V0MH DRUGINKE CEDIEUVYUSGIDQ-UHFFFAOYSA-N D0V0MH DRUGSMIL C1CN(CCN1)C2=CC=C(C=C2)OC3=CC=CC=C3 D0V0MH HIGHSTAT Investigative D0V0NJ DRUG__ID D0V0NJ D0V0NJ DRUGTYPE Small molecular drug D0V0NJ DRUGINCH 1S/C9H12N2/c1-2-4-9-8(3-1)7-10-5-6-11-9/h1-4,10-11H,5-7H2 D0V0NJ DRUGINKE MLXBHOCKBUILHN-UHFFFAOYSA-N D0V0NJ DRUGSMIL C1CNC2=CC=CC=C2CN1 D0V0NJ HIGHSTAT Investigative D0V0NM DRUG__ID D0V0NM D0V0NM DRUGTYPE Small molecular drug D0V0NM DRUGINCH 1S/C20H19NO4/c1-23-18-5-4-12-8-16-14-10-19(24-2)17(22)9-13(14)6-7-21(16)11-15(12)20(18)25-3/h4-5,8-11H,6-7H2,1-3H3/p+1 D0V0NM DRUGINKE MXTLAHSTUOXGQF-UHFFFAOYSA-O D0V0NM DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)O)OC)OC D0V0NM HIGHSTAT Investigative D0V0NO DRUG__ID D0V0NO D0V0NO DRUGTYPE Small molecular drug D0V0NO DRUGINCH 1S/C19H23NO2S/c1-22-19(21)18(16-7-3-2-4-8-16)17-9-5-6-11-20(17)13-15-10-12-23-14-15/h2-4,7-8,10,12,14,17-18H,5-6,9,11,13H2,1H3/t17-,18-/m1/s1 D0V0NO DRUGINKE LNROKOGUORZBBV-QZTJIDSGSA-N D0V0NO DRUGSMIL COC(=O)C(C1CCCCN1CC2=CSC=C2)C3=CC=CC=C3 D0V0NO HIGHSTAT Investigative D0V0OM DRUG__ID D0V0OM D0V0OM DRUGTYPE Small molecular drug D0V0OM DRUGINCH 1S/C11H16FN3S2/c1-15-6-2-4-9(8-15)10-11(14-17-13-10)16-7-3-5-12/h4H,2-3,5-8H2,1H3/i12-1 D0V0OM DRUGINKE NQKPPQNBFQLLIZ-DWSYCVKZSA-N D0V0OM DRUGSMIL CN1CCC=C(C1)C2=NSN=C2SCCCF D0V0OM HIGHSTAT Investigative D0V0PR DRUG__ID D0V0PR D0V0PR DRUGTYPE Small molecular drug D0V0PR DRUGINCH 1S/C18H21NO/c1-2-7-17(8-3-1)20-14-16-6-4-5-9-18(16)15-10-12-19-13-11-15/h1-9,15,19H,10-14H2 D0V0PR DRUGINKE SYLMRMITUMFBTA-UHFFFAOYSA-N D0V0PR DRUGSMIL C1CNCCC1C2=CC=CC=C2COC3=CC=CC=C3 D0V0PR HIGHSTAT Investigative D0V0PS DRUG__ID D0V0PS D0V0PS DRUGTYPE Small molecular drug D0V0PS DRUGINCH 1S/C13H14N2O2/c14-13-8-6-7(16)4-5-9(8)15-10-2-1-3-11(17)12(10)13/h4-6,11,16-17H,1-3H2,(H2,14,15) D0V0PS DRUGINKE RIGISKTXVJDQAZ-UHFFFAOYSA-N D0V0PS DRUGSMIL C1CC(C2=C(C3=C(C=CC(=C3)O)N=C2C1)N)O D0V0PS HIGHSTAT Investigative D0V0QJ DRUG__ID D0V0QJ D0V0QJ DRUGTYPE Small molecular drug D0V0QJ DRUGINCH 1S/C14H8ClNO4/c15-11-12(16-9(17)5-6-10(16)18)14(20)8-4-2-1-3-7(8)13(11)19/h1-4H,5-6H2 D0V0QJ DRUGINKE GYQSWJNGTWVFOL-UHFFFAOYSA-N D0V0QJ DRUGSMIL C1CC(=O)N(C1=O)C2=C(C(=O)C3=CC=CC=C3C2=O)Cl D0V0QJ HIGHSTAT Investigative D0V0RB DRUG__ID D0V0RB D0V0RB DRUGTYPE Small molecular drug D0V0RB DRUGINCH 1S/C47H61N9O10/c1-3-5-15-35(53-43(62)33(48)22-29-18-20-31(57)21-19-29)44(63)51-27-40(58)52-38(24-30-26-50-34-17-11-10-14-32(30)34)46(65)54-36(16-6-4-2)45(64)56-39(25-41(59)60)47(66)55-37(42(49)61)23-28-12-8-7-9-13-28/h7-14,17-21,26,33,35-39,50,57H,3-6,15-16,22-25,27,48H2,1-2H3,(H2,49,61)(H,51,63)(H,52,58)(H,53,62)(H,54,65)(H,55,66)(H,56,64)(H,59,60)/t33-,35+,36-,37-,38+,39-/m0/s1 D0V0RB DRUGINKE YVOYRMXNVINXII-PREDZLEHSA-N D0V0RB DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)O)N D0V0RB HIGHSTAT Investigative D0V0RS DRUG__ID D0V0RS D0V0RS DRUGTYPE Small molecular drug D0V0RS DRUGINCH 1S/C20H23NO4/c1-21(2)10-9-13-6-8-16(22)20-15(13)7-5-14-11-18(23-3)19(24-4)12-17(14)25-20/h5-8,11-12,22H,9-10H2,1-4H3 D0V0RS DRUGINKE DBGGUODEECPLSS-UHFFFAOYSA-N D0V0RS DRUGSMIL CN(C)CCC1=C2C=CC3=CC(=C(C=C3OC2=C(C=C1)O)OC)OC D0V0RS HIGHSTAT Investigative D0V0SD DRUG__ID D0V0SD D0V0SD DRUGTYPE Small molecular drug D0V0SD DRUGINCH 1S/C12H13N3O2/c16-12-9-11(14-5-7-17-8-6-14)13-10-3-1-2-4-15(10)12/h1-4,9H,5-8H2 D0V0SD DRUGINKE VDMRPNTZWKDYBB-UHFFFAOYSA-N D0V0SD DRUGSMIL C1COCCN1C2=CC(=O)N3C=CC=CC3=N2 D0V0SD HIGHSTAT Investigative D0V0TN DRUG__ID D0V0TN D0V0TN DRUGTYPE Small molecular drug D0V0TN DRUGINCH 1S/C17H16N2O/c1-19(12-13-7-3-2-4-8-13)17(20)16-11-14-9-5-6-10-15(14)18-16/h2-11,18H,12H2,1H3 D0V0TN DRUGINKE DIVKZMHOMDSMBZ-UHFFFAOYSA-N D0V0TN DRUGSMIL CN(CC1=CC=CC=C1)C(=O)C2=CC3=CC=CC=C3N2 D0V0TN HIGHSTAT Investigative D0V0WB DRUG__ID D0V0WB D0V0WB DRUGTYPE Small molecular drug D0V0WB DRUGINCH 1S/C8H17NO3/c1-2-5-3-7(11)8(12)6(4-10)9-5/h5-12H,2-4H2,1H3/t5-,6-,7+,8+/m1/s1 D0V0WB DRUGINKE QWEWPBRDYZVGBR-NGJRWZKOSA-N D0V0WB DRUGSMIL CCC1CC(C(C(N1)CO)O)O D0V0WB HIGHSTAT Investigative D0V0YP DRUG__ID D0V0YP D0V0YP DRUGTYPE Small molecular drug D0V0YP DRUGINCH 1S/C12H10N2S/c13-9-1-2-10-11(6-14-12(10)5-9)8-3-4-15-7-8/h1-7,14H,13H2 D0V0YP DRUGINKE QEKXSCXVUJXAFF-UHFFFAOYSA-N D0V0YP DRUGSMIL C1=CC2=C(C=C1N)NC=C2C3=CSC=C3 D0V0YP HIGHSTAT Investigative D0V1CL DRUG__ID D0V1CL D0V1CL DRUGTYPE Small molecular drug D0V1CL DRUGINCH 1S/C15H22N4O2/c1-4-7-8-16-13-11-10-18-19(5-2)14(11)17-9-12(13)15(20)21-6-3/h9-10H,4-8H2,1-3H3,(H,16,17) D0V1CL DRUGINKE IQNQAOGGWGCROX-UHFFFAOYSA-N D0V1CL DRUGSMIL CCCCNC1=C2C=NN(C2=NC=C1C(=O)OCC)CC D0V1CL HIGHSTAT Investigative D0V1CP DRUG__ID D0V1CP D0V1CP DRUGTYPE Small molecular drug D0V1CP DRUGINCH 1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1 D0V1CP DRUGINKE LEVWYRKDKASIDU-IMJSIDKUSA-N D0V1CP DRUGSMIL C(C(C(=O)O)N)SSCC(C(=O)O)N D0V1CP HIGHSTAT Investigative D0V1DW DRUG__ID D0V1DW D0V1DW DRUGTYPE Small molecular drug D0V1DW DRUGINCH 1S/C12H5Br5O2/c13-5-1-2-9(6(14)3-5)19-12-8(18)4-7(15)10(16)11(12)17/h1-4,18H D0V1DW DRUGINKE LNZHBUPVHNJGJG-UHFFFAOYSA-N D0V1DW DRUGSMIL C1=CC(=C(C=C1Br)Br)OC2=C(C(=C(C=C2O)Br)Br)Br D0V1DW HIGHSTAT Investigative D0V1EJ DRUG__ID D0V1EJ D0V1EJ DRUGTYPE Small molecular drug D0V1EJ DRUGINCH 1S/C20H27NO3/c1-3-12-21(13-4-2)14-11-16-7-10-18(23)20(24)19(16)15-5-8-17(22)9-6-15/h5-10,22-24H,3-4,11-14H2,1-2H3 D0V1EJ DRUGINKE NTNWFRQRDDNMJY-UHFFFAOYSA-N D0V1EJ DRUGSMIL CCCN(CCC)CCC1=C(C(=C(C=C1)O)O)C2=CC=C(C=C2)O D0V1EJ HIGHSTAT Investigative D0V1EK DRUG__ID D0V1EK D0V1EK DRUGTYPE Small molecular drug D0V1EK DRUGINCH 1S/C12H12N2OS/c1-8-11(9(2)15)16-12(13-8)14-10-6-4-3-5-7-10/h3-7H,1-2H3,(H,13,14) D0V1EK DRUGINKE UIIUOFPGDKBCEZ-UHFFFAOYSA-N D0V1EK DRUGSMIL CC1=C(SC(=N1)NC2=CC=CC=C2)C(=O)C D0V1EK HIGHSTAT Investigative D0V1HA DRUG__ID D0V1HA D0V1HA DRUGTYPE Small molecular drug D0V1HA DRUGINCH 1S/C13H11NO2/c15-13(14-16)9-8-11-6-3-5-10-4-1-2-7-12(10)11/h1-9,16H,(H,14,15)/b9-8+ D0V1HA DRUGINKE AOXOYUCWJCCUDO-CMDGGOBGSA-N D0V1HA DRUGSMIL C1=CC=C2C(=C1)C=CC=C2C=CC(=O)NO D0V1HA HIGHSTAT Investigative D0V1IM DRUG__ID D0V1IM D0V1IM DRUGTYPE Small molecular drug D0V1IM DRUGINCH 1S/C24H17F10NO4/c25-20(26)38-18-6-3-15(12-19(18)39-21(27)28)17(11-13-7-9-35(37)10-8-13)14-1-4-16(5-2-14)22(36,23(29,30)31)24(32,33)34/h1-10,12,17,20-21,36H,11H2 D0V1IM DRUGINKE VIOWRSXFEPSZFI-UHFFFAOYSA-N D0V1IM DRUGSMIL C1=CC(=CC=C1C(CC2=CC=[N+](C=C2)[O-])C3=CC(=C(C=C3)OC(F)F)OC(F)F)C(C(F)(F)F)(C(F)(F)F)O D0V1IM HIGHSTAT Investigative D0V1JT DRUG__ID D0V1JT D0V1JT DRUGTYPE Small molecular drug D0V1JT DRUGINCH 1S/C34H42IN11O5/c1-19(47)43-29(15-23-17-39-18-42-23)33(51)46-28(13-20-8-10-22(35)11-9-20)32(50)44-26(7-4-12-40-34(37)38)31(49)45-27(30(36)48)14-21-16-41-25-6-3-2-5-24(21)25/h2-3,5-6,8-11,16-18,26-29,41H,4,7,12-15H2,1H3,(H2,36,48)(H,39,42)(H,43,47)(H,44,50)(H,45,49)(H,46,51)(H4,37,38,40)/t26-,27-,28+,29-/m0/s1 D0V1JT DRUGINKE OBADRSUMIBIHEX-FKWFRFQNSA-N D0V1JT DRUGSMIL CC(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=C(C=C2)I)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)N D0V1JT HIGHSTAT Investigative D0V1KP DRUG__ID D0V1KP D0V1KP DRUGCOMP Memorial Sloan-Kettering Cancer Center D0V1KP DRUGINCH 1S/C28H28N4O3/c1-6-27(4,5)28-15-22-23-29-20-13-9-7-11-18(20)25(35)30(23)16(2)24(34)32(22)26(28)31(17(3)33)21-14-10-8-12-19(21)28/h6-14,16,22,26H,1,15H2,2-5H3/t16-,22+,26+,28-/m1/s1 D0V1KP DRUGINKE XTLQWSBGQKPGCF-YWDSKPHESA-N D0V1KP DRUGSMIL CC1C(=O)N2C(CC3(C2N(C4=CC=CC=C43)C(=O)C)C(C)(C)C=C)C5=NC6=CC=CC=C6C(=O)N15 D0V1KP HIGHSTAT Investigative D0V1PD DRUG__ID D0V1PD D0V1PD DRUGTYPE Small molecular drug D0V1PD DRUGINCH 1S/C13H26O3/c1-9(2)12-5-4-10(3)6-13(12)16-8-11(15)7-14/h9-15H,4-8H2,1-3H3 D0V1PD DRUGINKE MDVYIGJINBYKOM-UHFFFAOYSA-N D0V1PD DRUGSMIL CC1CCC(C(C1)OCC(CO)O)C(C)C D0V1PD HIGHSTAT Investigative D0V1PE DRUG__ID D0V1PE D0V1PE DRUGTYPE Small molecular drug D0V1PE DRUGINCH 1S/C10H6ClNO3/c11-5-1-2-6-7(3-5)12-10(15)9(14)4-8(6)13/h1-4,13H,(H,12,14,15) D0V1PE DRUGINKE CPGVEVDFZYFBBP-UHFFFAOYSA-N D0V1PE DRUGSMIL C1=CC2=C(C=C1Cl)NC(=O)C(=O)C=C2O D0V1PE HIGHSTAT Investigative D0V1TS DRUG__ID D0V1TS D0V1TS DRUGTYPE Small molecular drug D0V1TS DRUGINCH 1S/C16H12N4O2/c21-15-13-14(17-12-8-4-5-9-19(12)13)20(16(22)18-15)10-11-6-2-1-3-7-11/h1-9H,10H2,(H,18,21,22) D0V1TS DRUGINKE JHTRSVKUCQEETB-UHFFFAOYSA-N D0V1TS DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C(=O)NC2=O)N4C=CC=CC4=N3 D0V1TS HIGHSTAT Investigative D0V1UL DRUG__ID D0V1UL D0V1UL DRUGTYPE Small molecular drug D0V1UL DRUGINCH 1S/C14H14N6S/c15-12-11-13(20-14(16)19-12)17-8-9(18-11)6-7-21-10-4-2-1-3-5-10/h1-5,8H,6-7H2,(H4,15,16,17,19,20) D0V1UL DRUGINKE OVPXUMDQGFGLQK-UHFFFAOYSA-N D0V1UL DRUGSMIL C1=CC=C(C=C1)SCCC2=CN=C3C(=N2)C(=NC(=N3)N)N D0V1UL HIGHSTAT Investigative D0V1UY DRUG__ID D0V1UY D0V1UY DRUGTYPE Small molecular drug D0V1UY DRUGINCH 1S/C18H12N4/c19-11-14-1-5-16(6-2-14)18(22-10-9-21-13-22)17-7-3-15(12-20)4-8-17/h1-10,13,18H D0V1UY DRUGINKE NRXVWQIGPASRKU-UHFFFAOYSA-N D0V1UY DRUGSMIL C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=CN=C3 D0V1UY HIGHSTAT Investigative D0V2DT DRUG__ID D0V2DT D0V2DT DRUGTYPE Small molecular drug D0V2DT DRUGINCH 1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m1/s1 D0V2DT DRUGINKE RHGKLRLOHDJJDR-SCSAIBSYSA-N D0V2DT DRUGSMIL C(CC(C(=O)O)N)CNC(=O)N D0V2DT HIGHSTAT Investigative D0V2ER DRUG__ID D0V2ER D0V2ER DRUGTYPE Small molecular drug D0V2ER DRUGINCH 1S/C34H39N3O6S/c1-21-10-9-14-24(16-21)43-19-28(39)35-26(17-22-11-5-4-6-12-22)30(40)33(42)37-20-44-34(2,3)31(37)32(41)36-29-25-15-8-7-13-23(25)18-27(29)38/h4-16,26-27,29-31,38,40H,17-20H2,1-3H3,(H,35,39)(H,36,41)/t26-,27+,29-,30-,31+/m0/s1 D0V2ER DRUGINKE LAVCSYCCYHZRBK-VFCPCCRCSA-N D0V2ER DRUGSMIL CC1=CC(=CC=C1)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O D0V2ER HIGHSTAT Investigative D0V2IR DRUG__ID D0V2IR D0V2IR DRUGTYPE Small molecular drug D0V2IR DRUGINCH 1S/C14H18N2O/c1-3-11(4-2)17-12-7-5-6-10-8-9-13(15)16-14(10)12/h5-9,11H,3-4H2,1-2H3,(H2,15,16) D0V2IR DRUGINKE ZYSOQSQXCCTFTO-UHFFFAOYSA-N D0V2IR DRUGSMIL CCC(CC)OC1=CC=CC2=C1N=C(C=C2)N D0V2IR HIGHSTAT Investigative D0V2KB DRUG__ID D0V2KB D0V2KB DRUGTYPE Small molecular drug D0V2KB DRUGINCH 1S/C21H25NO4.HI/c1-22(2)7-6-12-9-16(23)21(26-5)20-14-11-18(25-4)17(24-3)10-13(14)8-15(22)19(12)20;/h9-11,15H,6-8H2,1-5H3;1H/t15-;/m0./s1 D0V2KB DRUGINKE FAVKNAGZQSEXNM-RSAXXLAASA-N D0V2KB DRUGSMIL C[N+]1(CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)OC)O)C.[I-] D0V2KB HIGHSTAT Investigative D0V2KV DRUG__ID D0V2KV D0V2KV DRUGTYPE Small molecular drug D0V2KV DRUGINCH 1S/C21H15NOS/c23-19-8-4-7-16(11-19)18-12-20(15-5-2-1-3-6-15)22-21(13-18)17-9-10-24-14-17/h1-14,23H D0V2KV DRUGINKE GWFRFJZJQITLHW-UHFFFAOYSA-N D0V2KV DRUGSMIL C1=CC=C(C=C1)C2=NC(=CC(=C2)C3=CC(=CC=C3)O)C4=CSC=C4 D0V2KV HIGHSTAT Investigative D0V2LK DRUG__ID D0V2LK D0V2LK DRUGTYPE Small molecular drug D0V2LK DRUGINCH 1S/C15H8N2O6/c18-13-8-15(9-1-3-10(4-2-9)16(19)20)23-14-6-5-11(17(21)22)7-12(13)14/h1-8H D0V2LK DRUGINKE FPLQIUAPEQSTCP-UHFFFAOYSA-N D0V2LK DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=CC(=C3)[N+](=O)[O-])[N+](=O)[O-] D0V2LK HIGHSTAT Investigative D0V2MR DRUG__ID D0V2MR D0V2MR DRUGTYPE Small molecular drug D0V2MR DRUGINCH 1S/C6H13NO4/c8-3-1-7(2-4-9)5-6(10)11/h8-9H,1-5H2,(H,10,11) D0V2MR DRUGINKE FSVCELGFZIQNCK-UHFFFAOYSA-N D0V2MR DRUGSMIL C(CO)N(CCO)CC(=O)O D0V2MR HIGHSTAT Investigative D0V2NH DRUG__ID D0V2NH D0V2NH DRUGTYPE Small molecular drug D0V2NH DRUGINCH 1S/C13H12N4O2/c18-12-10-11(15-8-14-10)16-13(19)17(12)7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H,14,15)(H,16,19) D0V2NH DRUGINKE WZIAGOQSFXTMAJ-UHFFFAOYSA-N D0V2NH DRUGSMIL C1=CC=C(C=C1)CCN2C(=O)C3=C(NC2=O)N=CN3 D0V2NH HIGHSTAT Investigative D0V2NQ DRUG__ID D0V2NQ D0V2NQ DRUGTYPE Small molecular drug D0V2NQ DRUGINCH 1S/C23H23NO/c25-23(24-18-10-13-19-11-4-1-5-12-19)22(20-14-6-2-7-15-20)21-16-8-3-9-17-21/h1-9,11-12,14-17,22H,10,13,18H2,(H,24,25) D0V2NQ DRUGINKE GGASESVHBWYDKY-UHFFFAOYSA-N D0V2NQ DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3 D0V2NQ HIGHSTAT Investigative D0V2PB DRUG__ID D0V2PB D0V2PB DRUGTYPE Small molecular drug D0V2PB DRUGINCH 1S/C13H17N5O2S/c1-15-12-7-10(8-13(16-2)17-12)18-21(19,20)11-5-3-9(14)4-6-11/h3-8H,14H2,1-2H3,(H3,15,16,17,18) D0V2PB DRUGINKE PTFNKZLSFWJYFJ-UHFFFAOYSA-N D0V2PB DRUGSMIL CNC1=CC(=CC(=N1)NC)NS(=O)(=O)C2=CC=C(C=C2)N D0V2PB HIGHSTAT Investigative D0V2PM DRUG__ID D0V2PM D0V2PM DRUGTYPE Small molecular drug D0V2PM DRUGINCH 1S/C25H29N5O3/c1-15-9-19(31)10-16(2)20(15)12-21(26)25(33)30-14-18-6-4-3-5-17(18)11-22(30)24(32)29-13-23-27-7-8-28-23/h3-10,21-22,31H,11-14,26H2,1-2H3,(H,27,28)(H,29,32)/t21-,22-/m0/s1 D0V2PM DRUGINKE PFUVPVAVWLKTQT-VXKWHMMOSA-N D0V2PM DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=NC=CN4)N)C)O D0V2PM HIGHSTAT Investigative D0V2QF DRUG__ID D0V2QF D0V2QF DRUGTYPE Small molecular drug D0V2QF DRUGINCH 1S/C14H24N8O3/c1-21(4-2-3-20-16)5-8-10(23)11(24)14(25-8)22-7-19-9-12(15)17-6-18-13(9)22/h6-8,10-11,14,20,23-24H,2-5,16H2,1H3,(H2,15,17,18)/t8-,10-,11-,14-/m1/s1 D0V2QF DRUGINKE MYNRDUPGBPOWQT-IDTAVKCVSA-N D0V2QF DRUGSMIL CN(CCCNN)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0V2QF HIGHSTAT Investigative D0V2QH DRUG__ID D0V2QH D0V2QH DRUGTYPE Small molecular drug D0V2QH DRUGINCH 1S/C22H16O2/c23-19-8-4-7-16(14-19)17-9-11-20-18(13-17)10-12-21(24)22(20)15-5-2-1-3-6-15/h1-14,23-24H D0V2QH DRUGINKE ZYOIQICRHUXCRL-UHFFFAOYSA-N D0V2QH DRUGSMIL C1=CC=C(C=C1)C2=C(C=CC3=C2C=CC(=C3)C4=CC(=CC=C4)O)O D0V2QH HIGHSTAT Investigative D0V2QP DRUG__ID D0V2QP D0V2QP DRUGTYPE Small molecular drug D0V2QP DRUGINCH 1S/C22H17NO2S/c1-26(24,25)19-13-11-17(12-14-19)22-20(16-7-3-2-4-8-16)15-18-9-5-6-10-21(18)23-22/h2-15H,1H3 D0V2QP DRUGINKE OPLJPOZQZWTQDV-UHFFFAOYSA-N D0V2QP DRUGSMIL CS(=O)(=O)C1=CC=C(C=C1)C2=NC3=CC=CC=C3C=C2C4=CC=CC=C4 D0V2QP HIGHSTAT Investigative D0V2VU DRUG__ID D0V2VU D0V2VU DRUGTYPE Small molecular drug D0V2VU DRUGINCH 1S/C19H17NO2S/c1-2-22-19(21)16-15(13-9-5-3-6-10-13)17(23-18(16)20)14-11-7-4-8-12-14/h3-12H,2,20H2,1H3 D0V2VU DRUGINKE KZDXAPZNXDJJMB-UHFFFAOYSA-N D0V2VU DRUGSMIL CCOC(=O)C1=C(SC(=C1C2=CC=CC=C2)C3=CC=CC=C3)N D0V2VU HIGHSTAT Investigative D0V2YR DRUG__ID D0V2YR D0V2YR DRUGTYPE Small molecular drug D0V2YR DRUGINCH 1S/C15H25N7O7S2/c1-30-3-2-7(16)14(25)21-31(26,27)28-4-8-10(23)11(24)15(29-8)22-6-20-9-12(17)18-5-19-13(9)22/h5-8,10-11,13,15,23-24H,2-4,16-17H2,1H3,(H,18,19)(H,21,25)/t7-,8+,10+,11-,13+,15-/m1/s1 D0V2YR DRUGINKE SQDXXTAOGLOMRP-JJWYTCDVSA-N D0V2YR DRUGSMIL CSCCC(C(=O)NS(=O)(=O)OCC1C(C(C(O1)N2C=NC3=C(NC=NC32)N)O)O)N D0V2YR HIGHSTAT Investigative D0V2ZB DRUG__ID D0V2ZB D0V2ZB DRUGTYPE Small molecular drug D0V2ZB DRUGINCH 1S/C12H23NO2/c1-2-3-4-10-5-6-12(7-10,9-13)8-11(14)15/h10H,2-9,13H2,1H3,(H,14,15) D0V2ZB DRUGINKE USZXKKPNEFLRDV-UHFFFAOYSA-N D0V2ZB DRUGSMIL CCCCC1CCC(C1)(CC(=O)O)CN D0V2ZB HIGHSTAT Investigative D0V2ZO DRUG__ID D0V2ZO D0V2ZO DRUGTYPE Small molecular drug D0V2ZO DRUGINCH 1S/C11H14ClNO2/c12-10-7-5-9(6-8-10)3-1-2-4-11(14)13-15/h5-8,15H,1-4H2,(H,13,14) D0V2ZO DRUGINKE PRMXJXDYJXBBPT-UHFFFAOYSA-N D0V2ZO DRUGSMIL C1=CC(=CC=C1CCCCC(=O)NO)Cl D0V2ZO HIGHSTAT Investigative D0V3DO DRUG__ID D0V3DO D0V3DO DRUGTYPE Small molecular drug D0V3DO DRUGINCH 1S/C36H36N2O6/c1-37-9-7-21-13-23(17-25-31(21)27(37)15-19-3-5-29(39)35(41)33(19)25)43-11-12-44-24-14-22-8-10-38(2)28-16-20-4-6-30(40)36(42)34(20)26(18-24)32(22)28/h3-6,13-14,17-18,27-28,39-42H,7-12,15-16H2,1-2H3/t27-,28-/m1/s1 D0V3DO DRUGINKE KWKONXOZQQYOJW-VSGBNLITSA-N D0V3DO DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OCCOC5=CC6=C7C(CC8=C(C7=C5)C(=C(C=C8)O)O)N(CC6)C)C(=C(C=C4)O)O D0V3DO HIGHSTAT Investigative D0V3GN DRUG__ID D0V3GN D0V3GN DRUGTYPE Small molecular drug D0V3GN DRUGINCH 1S/C32H38N6O5/c33-25(18-23-13-15-24(39)16-14-23)32(43)38-17-7-12-28(38)31(42)36-26(19-21-8-3-1-4-9-21)29(40)35-27(30(41)37-34)20-22-10-5-2-6-11-22/h1-6,8-11,13-16,25-28,39H,7,12,17-20,33-34H2,(H,35,40)(H,36,42)(H,37,41)/t25-,26-,27-,28-/m0/s1 D0V3GN DRUGINKE JZSLBNUKUIAYPN-LJWNLINESA-N D0V3GN DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NN D0V3GN HIGHSTAT Investigative D0V3IT DRUG__ID D0V3IT D0V3IT DRUGTYPE Small molecular drug D0V3IT DRUGINCH 1S/C35H39N5O4/c1-24-30(33(36)41)32(26-14-16-29(17-15-26)40(43)44)31(25(2)38-24)34(42)37-20-9-21-39-22-18-35(19-23-39,27-10-5-3-6-11-27)28-12-7-4-8-13-28/h3-8,10-17,32,38H,9,18-23H2,1-2H3,(H2,36,41)(H,37,42) D0V3IT DRUGINKE OZQHHXAYNRRVBN-UHFFFAOYSA-N D0V3IT DRUGSMIL CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N D0V3IT HIGHSTAT Investigative D0V3LC DRUG__ID D0V3LC D0V3LC DRUGTYPE Small molecular drug D0V3LC DRUGINCH 1S/C29H50O2/c1-7-21(19(2)3)9-8-20(4)24-10-11-25-23-13-17-29(31)18-22(30)12-16-28(29,6)26(23)14-15-27(24,25)5/h13,17,19-26,30-31H,7-12,14-16,18H2,1-6H3/t20-,21?,22+,23+,24-,25+,26+,27-,28-,29?/m1/s1 D0V3LC DRUGINKE CIZGZRCBMJRIFK-VRGDKWBFSA-N D0V3LC DRUGSMIL CCC(CCC(C)C1CCC2C1(CCC3C2C=CC4(C3(CCC(C4)O)C)O)C)C(C)C D0V3LC HIGHSTAT Investigative D0V3LR DRUG__ID D0V3LR D0V3LR DRUGTYPE Small molecular drug D0V3LR DRUGINCH 1S/C29H34N2O/c32-27(20-23-10-4-1-5-11-23)22-30-18-19-31-21-26(30)16-17-28(31)29(24-12-6-2-7-13-24)25-14-8-3-9-15-25/h1-15,26-29,32H,16-22H2/t26-,27+,28-/m0/s1 D0V3LR DRUGINKE WRZZCPUVRXRVCC-IARZGTGTSA-N D0V3LR DRUGSMIL C1CC(N2CCN(C1C2)CC(CC3=CC=CC=C3)O)C(C4=CC=CC=C4)C5=CC=CC=C5 D0V3LR HIGHSTAT Investigative D0V3MV DRUG__ID D0V3MV D0V3MV DRUGTYPE Small molecular drug D0V3MV DRUGINCH 1S/C16H13N3O3/c20-19(21)14-7-6-13(11-18-9-8-17-12-18)16(10-14)22-15-4-2-1-3-5-15/h1-10,12H,11H2 D0V3MV DRUGINKE JIPGEBKJKOMJSL-UHFFFAOYSA-N D0V3MV DRUGSMIL C1=CC=C(C=C1)OC2=C(C=CC(=C2)[N+](=O)[O-])CN3C=CN=C3 D0V3MV HIGHSTAT Investigative D0V3NI DRUG__ID D0V3NI D0V3NI DRUGTYPE Small molecular drug D0V3NI DRUGINCH 1S/C24H30N4O/c1-2-28-22(17-23(29)25-18-19-11-5-3-6-12-19)20-13-7-8-14-21(20)26-24(28)27-15-9-4-10-16-27/h3,5-8,11-14,22H,2,4,9-10,15-18H2,1H3,(H,25,29) D0V3NI DRUGINKE OTPISXIISBCQOC-UHFFFAOYSA-N D0V3NI DRUGSMIL CCN1C(C2=CC=CC=C2N=C1N3CCCCC3)CC(=O)NCC4=CC=CC=C4 D0V3NI HIGHSTAT Investigative D0V3NT DRUG__ID D0V3NT D0V3NT DRUGTYPE Small molecular drug D0V3NT DRUGINCH 1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3 D0V3NT DRUGINKE MXUNKHLAEDCYJL-UHFFFAOYSA-N D0V3NT DRUGSMIL CC1=CC(=CC=C1)N2CC(OC2=O)CO D0V3NT HIGHSTAT Investigative D0V3OJ DRUG__ID D0V3OJ D0V3OJ DRUGTYPE Small molecular drug D0V3OJ DRUGINCH 1S/C19H14N4/c1-2-6-14(7-3-1)18-22-17-9-5-4-8-16(17)19(23-18)21-15-10-12-20-13-11-15/h1-13H,(H,20,21,22,23) D0V3OJ DRUGINKE QGWNGFYEPGNYNY-UHFFFAOYSA-N D0V3OJ DRUGSMIL C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC=NC=C4 D0V3OJ HIGHSTAT Investigative D0V3OR DRUG__ID D0V3OR D0V3OR DRUGTYPE Small molecular drug D0V3OR DRUGINCH 1S/C15H10O4/c16-9-3-1-8(2-4-9)13-14(18)11-6-5-10(17)7-12(11)15(13)19/h1-7,13,16-17H D0V3OR DRUGINKE QKHHOGHOHPKHGS-UHFFFAOYSA-N D0V3OR DRUGSMIL C1=CC(=CC=C1C2C(=O)C3=C(C2=O)C=C(C=C3)O)O D0V3OR HIGHSTAT Investigative D0V3OY DRUG__ID D0V3OY D0V3OY DRUGTYPE Small molecular drug D0V3OY DRUGINCH 1S/C22H32N2O2/c1-23(21(25)16-18-8-3-2-4-9-18)19-10-12-22(11-7-15-26-22)17-20(19)24-13-5-6-14-24/h2-4,8-9,19-20H,5-7,10-17H2,1H3/t19-,20-,22-/m0/s1 D0V3OY DRUGINKE PGZRDDYTKFZSFR-ONTIZHBOSA-N D0V3OY DRUGSMIL CN(C1CCC2(CCCO2)CC1N3CCCC3)C(=O)CC4=CC=CC=C4 D0V3OY HIGHSTAT Investigative D0V3PG DRUG__ID D0V3PG D0V3PG DRUGTYPE Small molecular drug D0V3PG DRUGINCH 1S/C15H10O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-6H,(H4-,16,17,18,19,20)/p+1 D0V3PG DRUGINKE VEVZSMAEJFVWIL-UHFFFAOYSA-O D0V3PG DRUGSMIL C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2O)O)O)O)O D0V3PG HIGHSTAT Investigative D0V3TO DRUG__ID D0V3TO D0V3TO DRUGTYPE Small molecular drug D0V3TO DRUGINCH 1S/C27H24F3NO/c1-2-3-6-16-31-18-21(17-25(31)20-12-14-22(15-13-20)27(28,29)30)26(32)24-11-7-9-19-8-4-5-10-23(19)24/h4-5,7-15,17-18H,2-3,6,16H2,1H3 D0V3TO DRUGINKE KFMFBZYLXNTONN-UHFFFAOYSA-N D0V3TO DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)C(F)(F)F)C(=O)C3=CC=CC4=CC=CC=C43 D0V3TO HIGHSTAT Investigative D0V3UU DRUG__ID D0V3UU D0V3UU DRUGTYPE Small molecular drug D0V3UU DRUGINCH 1S/C21H19F5N4O/c1-12-11-30(20(31)28-19-6-4-15(22)7-18(19)23)13(2)10-29(12)16-5-3-14(9-27)17(8-16)21(24,25)26/h3-8,12-13H,10-11H2,1-2H3,(H,28,31)/t12-,13+/m0/s1 D0V3UU DRUGINKE WTZSNQXSDYHCRV-QWHCGFSZSA-N D0V3UU DRUGSMIL CC1CN(C(CN1C(=O)NC2=C(C=C(C=C2)F)F)C)C3=CC(=C(C=C3)C#N)C(F)(F)F D0V3UU HIGHSTAT Investigative D0V3WS DRUG__ID D0V3WS D0V3WS DRUGTYPE Small molecular drug D0V3WS DRUGINCH 1S/C37H40N2O6.ClH/c1-38-12-10-23-18-32(43-4)33-20-25(23)28(38)16-21-6-8-30(40)26(14-21)27-15-22(7-9-31(27)42-3)17-29-35-24(11-13-39(29)2)19-34(44-5)36(41)37(35)45-33;/h6-9,14-15,18-20,28-29,40-41H,10-13,16-17H2,1-5H3;1H/t28-,29+;/m1./s1 D0V3WS DRUGINKE XMYUKGNJCHUIHP-XZVFQGBBSA-N D0V3WS DRUGSMIL CN1CCC2=CC(=C3C=C2C1CC4=CC(=C(C=C4)O)C5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC.Cl D0V3WS HIGHSTAT Investigative D0V3XZ DRUG__ID D0V3XZ D0V3XZ DRUGTYPE Small molecular drug D0V3XZ DRUGINCH 1S/C19H16ClNO3/c20-14-6-4-13(5-7-14)15-2-1-3-16-17(22)12-18(24-19(15)16)21-8-10-23-11-9-21/h1-7,12H,8-11H2 D0V3XZ DRUGINKE HYBIQRLHJUFHFC-UHFFFAOYSA-N D0V3XZ DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=C(C=C4)Cl D0V3XZ HIGHSTAT Investigative D0V3YH DRUG__ID D0V3YH D0V3YH DRUGTYPE Small molecular drug D0V3YH DRUGINCH 1S/C15H12ClN/c16-15-5-1-4-13-12(6-7-14(13)15)9-11-3-2-8-17-10-11/h1-5,8-10H,6-7H2/b12-9+ D0V3YH DRUGINKE OAISOHCDZRMGCP-FMIVXFBMSA-N D0V3YH DRUGSMIL C1CC2=C(C1=CC3=CN=CC=C3)C=CC=C2Cl D0V3YH HIGHSTAT Investigative D0V3YX DRUG__ID D0V3YX D0V3YX DRUGTYPE Small molecular drug D0V3YX DRUGINCH 1S/C18H22N4OS/c1-21(2)13-9-10-19-17-14(13)15-16(24-17)18(23)22(11-20-15)12-7-5-3-4-6-8-12/h9-12H,3-8H2,1-2H3 D0V3YX DRUGINKE WOADNNTWYZOWNV-UHFFFAOYSA-N D0V3YX DRUGSMIL CN(C)C1=C2C3=C(C(=O)N(C=N3)C4CCCCCC4)SC2=NC=C1 D0V3YX HIGHSTAT Investigative D0V3ZG DRUG__ID D0V3ZG D0V3ZG DRUGTYPE Small molecular drug D0V3ZG DRUGINCH 1S/C36H38O8S/c37-35(38)10-6-17-42-32-9-5-8-25(31(32)12-14-36(39)40)7-3-1-2-4-16-41-30-20-28(19-29(21-30)27-15-18-45-23-27)26-11-13-33-34(22-26)44-24-43-33/h5,8-9,11,13,15,18-23H,1-4,6-7,10,12,14,16-17,24H2,(H,37,38)(H,39,40) D0V3ZG DRUGINKE SRPFDFNVILUDAI-UHFFFAOYSA-N D0V3ZG DRUGSMIL C1OC2=C(O1)C=C(C=C2)C3=CC(=CC(=C3)OCCCCCCC4=C(C(=CC=C4)OCCCC(=O)O)CCC(=O)O)C5=CSC=C5 D0V3ZG HIGHSTAT Investigative D0V4AR DRUG__ID D0V4AR D0V4AR DRUGTYPE Small molecular drug D0V4AR DRUGINCH 1S/C16H10ClN3/c17-11-7-5-10(6-8-11)16-19-14-9-18-13-4-2-1-3-12(13)15(14)20-16/h1-9H,(H,19,20) D0V4AR DRUGINKE CGBRMMMHBXSYHH-UHFFFAOYSA-N D0V4AR DRUGSMIL C1=CC=C2C(=C1)C3=C(C=N2)NC(=N3)C4=CC=C(C=C4)Cl D0V4AR HIGHSTAT Investigative D0V4AX DRUG__ID D0V4AX D0V4AX DRUGTYPE Small molecular drug D0V4AX DRUGINCH 1S/C11H13NO4/c1-11(12,10(15)16)6-9(14)7-3-2-4-8(13)5-7/h2-5,13H,6,12H2,1H3,(H,15,16) D0V4AX DRUGINKE DVMCGTUZEKNSGK-UHFFFAOYSA-N D0V4AX DRUGSMIL CC(CC(=O)C1=CC(=CC=C1)O)(C(=O)O)N D0V4AX HIGHSTAT Investigative D0V4BE DRUG__ID D0V4BE D0V4BE DRUGTYPE Small molecular drug D0V4BE DRUGINCH 1S/C22H29NO3/c1-3-23-20(25)12-14-11-19-18-6-4-13-10-15(24)5-7-16(13)17(18)8-9-22(19,2)21(14)26/h5,7,10,14,17-19,24H,3-4,6,8-9,11-12H2,1-2H3,(H,23,25)/t14?,17?,18?,19?,22-/m0/s1 D0V4BE DRUGINKE DGCNLEJTGGXFLE-SSBKPBJFSA-N D0V4BE DRUGSMIL CCNC(=O)CC1CC2C3CCC4=C(C3CCC2(C1=O)C)C=CC(=C4)O D0V4BE HIGHSTAT Investigative D0V4BR DRUG__ID D0V4BR D0V4BR DRUGTYPE Small molecular drug D0V4BR DRUGINCH 1S/C14H12ClNO3S/c1-10-4-2-3-5-13(10)14(17)16-20(18,19)12-8-6-11(15)7-9-12/h2-9H,1H3,(H,16,17) D0V4BR DRUGINKE JQSONZDJELNSLQ-UHFFFAOYSA-N D0V4BR DRUGSMIL CC1=CC=CC=C1C(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl D0V4BR HIGHSTAT Investigative D0V4EK DRUG__ID D0V4EK D0V4EK DRUGTYPE Small molecular drug D0V4EK DRUGINCH 1S/C5H12O/c1-5(2)3-4-6/h5-6H,3-4H2,1-2H3 D0V4EK DRUGINKE PHTQWCKDNZKARW-UHFFFAOYSA-N D0V4EK DRUGSMIL CC(C)CCO D0V4EK HIGHSTAT Investigative D0V4FC DRUG__ID D0V4FC D0V4FC DRUGTYPE Small molecular drug D0V4FC DRUGINCH 1S/C28H36N2OSi/c1-7-30(19-10-8-9-18-28(2,3)4)22-25-12-11-13-26(20-25)31-23-32(5,6)27-16-14-24(21-29)15-17-27/h8,10-17,20H,7,19,22-23H2,1-6H3/b10-8+ D0V4FC DRUGINKE LIDUGWDLSDKCLM-CSKARUKUSA-N D0V4FC DRUGSMIL CCN(CC=CC#CC(C)(C)C)CC1=CC(=CC=C1)OC[Si](C)(C)C2=CC=C(C=C2)C#N D0V4FC HIGHSTAT Investigative D0V4FT DRUG__ID D0V4FT D0V4FT DRUGTYPE Small molecular drug D0V4FT DRUGINCH 1S/C16H12N2S2/c19-11-17-15-7-3-13(4-8-15)1-2-14-5-9-16(10-6-14)18-12-20/h3-10H,1-2H2 D0V4FT DRUGINKE KGPFLJVFCCOOEO-UHFFFAOYSA-N D0V4FT DRUGSMIL C1=CC(=CC=C1CCC2=CC=C(C=C2)N=C=S)N=C=S D0V4FT HIGHSTAT Investigative D0V4FW DRUG__ID D0V4FW D0V4FW DRUGTYPE Small molecular drug D0V4FW DRUGINCH 1S/C16H16N2O2S/c17-10-9-12-5-4-8-14-16(12)15(11-18-14)21(19,20)13-6-2-1-3-7-13/h1-8,11,18H,9-10,17H2 D0V4FW DRUGINKE RSVUNKKDIROCQS-UHFFFAOYSA-N D0V4FW DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CNC3=CC=CC(=C32)CCN D0V4FW HIGHSTAT Investigative D0V4FZ DRUG__ID D0V4FZ D0V4FZ DRUGTYPE Small molecular drug D0V4FZ DRUGINCH 1S/C17H19NO2/c1-18-8-7-13-9-16(19)17(20)10-14(13)15(11-18)12-5-3-2-4-6-12/h2-6,9-10,15,19-20H,7-8,11H2,1H3 D0V4FZ DRUGINKE LIHCKGZEDBNUJG-UHFFFAOYSA-N D0V4FZ DRUGSMIL CN1CCC2=CC(=C(C=C2C(C1)C3=CC=CC=C3)O)O D0V4FZ HIGHSTAT Investigative D0V4GQ DRUG__ID D0V4GQ D0V4GQ DRUGTYPE Small molecular drug D0V4GQ DRUGINCH 1S/C10H15N5O9P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(23-10)1-22-25(18,19)24-26(20,21)27/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H2,20,21,27)/t4-,6-,7-,10-/m1/s1 D0V4GQ DRUGINKE HCIKUKNAJRJFOW-KQYNXXCUSA-N D0V4GQ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=S)(O)O)O)O)N D0V4GQ HIGHSTAT Investigative D0V4NU DRUG__ID D0V4NU D0V4NU DRUGTYPE Small molecular drug D0V4NU DRUGINCH 1S/C7H16NO/c1-8(2,3)6-4-5-7-9/h7H,4-6H2,1-3H3/q+1 D0V4NU DRUGINKE OITBLCDWXSXNCN-UHFFFAOYSA-N D0V4NU DRUGSMIL C[N+](C)(C)CCCC=O D0V4NU HIGHSTAT Investigative D0V4NV DRUG__ID D0V4NV D0V4NV DRUGTYPE Small molecular drug D0V4NV DRUGINCH 1S/C23H24O5/c1-7-11(3)15-9-17(24)13(5)20-19(15)23(26)28-21-14(6)18(25)10-16(12(4)8-2)22(21)27-20/h7-10,24-25H,1-6H3/b11-7-,12-8- D0V4NV DRUGINKE JJMKBGPTPXPMBH-OXAWKVHCSA-N D0V4NV DRUGSMIL CC=C(C)C1=CC(=C(C2=C1C(=O)OC3=C(O2)C(=CC(=C3C)O)C(=CC)C)C)O D0V4NV HIGHSTAT Investigative D0V4NW DRUG__ID D0V4NW D0V4NW DRUGTYPE Small molecular drug D0V4NW DRUGINCH 1S/C23H32N2O/c1-3-17-25(18-4-2)19-9-8-16-24-23(26)22-14-12-21(13-15-22)20-10-6-5-7-11-20/h5-7,10-15H,3-4,8-9,16-19H2,1-2H3,(H,24,26) D0V4NW DRUGINKE HXCWGVSINJYYSW-UHFFFAOYSA-N D0V4NW DRUGSMIL CCCN(CCC)CCCCNC(=O)C1=CC=C(C=C1)C2=CC=CC=C2 D0V4NW HIGHSTAT Investigative D0V4PB DRUG__ID D0V4PB D0V4PB DRUGTYPE Small molecular drug D0V4PB DRUGINCH 1S/C12H16FN/c13-12-3-1-10(2-4-12)9-11-5-7-14-8-6-11/h1-4,11,14H,5-9H2 D0V4PB DRUGINKE JLAKCHGEEBPDQI-UHFFFAOYSA-N D0V4PB DRUGSMIL C1CNCCC1CC2=CC=C(C=C2)F D0V4PB HIGHSTAT Investigative D0V4PJ DRUG__ID D0V4PJ D0V4PJ DRUGTYPE Small molecular drug D0V4PJ DRUGINCH 1S/C21H24O8/c1-10(2)20(25)29-19-15-12(4)21(26)28-18(15)16(24)11(3)7-6-8-14(9-22)17(19)27-13(5)23/h8-9,15-19,24H,1,3-4,6-7H2,2,5H3/b14-8-/t15-,16-,17-,18-,19-/m0/s1 D0V4PJ DRUGINKE QCTYKEDNIPKZDW-QHWUSFJTSA-N D0V4PJ DRUGSMIL CC(=C)C(=O)OC1C2C(C(C(=C)CCC=C(C1OC(=O)C)C=O)O)OC(=O)C2=C D0V4PJ HIGHSTAT Investigative D0V4PL DRUG__ID D0V4PL D0V4PL DRUGTYPE Small molecular drug D0V4PL DRUGINCH 1S/C17H14N2O/c1-17(2)14-9-13(6-7-15(14)19-16(17)20)12-5-3-4-11(8-12)10-18/h3-9H,1-2H3,(H,19,20) D0V4PL DRUGINKE WZZPSUKZMZKXTQ-UHFFFAOYSA-N D0V4PL DRUGSMIL CC1(C2=C(C=CC(=C2)C3=CC=CC(=C3)C#N)NC1=O)C D0V4PL HIGHSTAT Investigative D0V4PZ DRUG__ID D0V4PZ D0V4PZ DRUGTYPE Small molecular drug D0V4PZ DRUGINCH 1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h3-4,6-7,12-13,15-18,21-22H,2,5,8-11,14H2,1H3,(H,24,25)/b6-3-,7-4-,13-12+/t15-,16+,17+,18-/m0/s1 D0V4PZ DRUGINKE ANOICLBSJIMQTA-WXGBOJPQSA-N D0V4PZ DRUGSMIL CCC=CCC(C=CC1C(C(CC1=O)O)CC=CCCCC(=O)O)O D0V4PZ HIGHSTAT Investigative D0V4RD DRUG__ID D0V4RD D0V4RD DRUGTYPE Small molecular drug D0V4RD DRUGINCH 1S/C19H12N2O3S/c22-19(13-9-11-14(12-10-13)21(23)24)20-15-5-1-3-7-17(15)25-18-8-4-2-6-16(18)20/h1-12H D0V4RD DRUGINKE TUBVLHCMQWIBNP-UHFFFAOYSA-N D0V4RD DRUGSMIL C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)C4=CC=C(C=C4)[N+](=O)[O-] D0V4RD HIGHSTAT Investigative D0V4RO DRUG__ID D0V4RO D0V4RO DRUGTYPE Small molecular drug D0V4RO DRUGINCH 1S/C15H10N4/c16-11-12-4-3-5-13(10-12)19-9-7-15(18-19)14-6-1-2-8-17-14/h1-10H D0V4RO DRUGINKE FUXJRPCONXOULZ-UHFFFAOYSA-N D0V4RO DRUGSMIL C1=CC=NC(=C1)C2=NN(C=C2)C3=CC=CC(=C3)C#N D0V4RO HIGHSTAT Investigative D0V4RP DRUG__ID D0V4RP D0V4RP DRUGTYPE Small molecular drug D0V4RP DRUGINCH 1S/C11H16N2O/c1-14-11-5-3-2-4-10(11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3 D0V4RP DRUGINKE VNZLQLYBRIOLFZ-UHFFFAOYSA-N D0V4RP DRUGSMIL COC1=CC=CC=C1N2CCNCC2 D0V4RP HIGHSTAT Investigative D0V4RZ DRUG__ID D0V4RZ D0V4RZ DRUGTYPE Small molecular drug D0V4RZ DRUGINCH 1S/C21H13F5N2/c22-15-10-8-13(9-11-15)20-16-5-3-6-17(21(24,25)26)19(16)27-28(20)12-14-4-1-2-7-18(14)23/h1-11H,12H2 D0V4RZ DRUGINKE NHSFDMDEDPAKNH-UHFFFAOYSA-N D0V4RZ DRUGSMIL C1=CC=C(C(=C1)CN2C(=C3C=CC=C(C3=N2)C(F)(F)F)C4=CC=C(C=C4)F)F D0V4RZ HIGHSTAT Investigative D0V4SG DRUG__ID D0V4SG D0V4SG DRUGTYPE Small molecular drug D0V4SG DRUGINCH 1S/C15H13NO2/c1-11-7-8-14-13(9-11)16(15(17)18-14)10-12-5-3-2-4-6-12/h2-9H,10H2,1H3 D0V4SG DRUGINKE OHZOKKGTLRVETE-UHFFFAOYSA-N D0V4SG DRUGSMIL CC1=CC2=C(C=C1)OC(=O)N2CC3=CC=CC=C3 D0V4SG HIGHSTAT Investigative D0V4TK DRUG__ID D0V4TK D0V4TK DRUGTYPE Small molecular drug D0V4TK DRUGINCH 1S/C18H15N3O/c1-13-6-5-9-17(20-13)21-18(22)15-10-11-16(19-12-15)14-7-3-2-4-8-14/h2-12H,1H3,(H,20,21,22) D0V4TK DRUGINKE SJCQCBNYZNABCO-UHFFFAOYSA-N D0V4TK DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CN=C(C=C2)C3=CC=CC=C3 D0V4TK HIGHSTAT Investigative D0V4UU DRUG__ID D0V4UU D0V4UU DRUGTYPE Small molecular drug D0V4UU DRUGINCH 1S/C10H14N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2,4,6-7,10,13,15-17H,1,3H2,(H,11,12,18)/t4-,6-,7+,10+/m0/s1 D0V4UU DRUGINKE ZWTNXGIZBOQCAJ-FCIPNVEPSA-N D0V4UU DRUGSMIL C1NC2=C(N1C3C(C(C(O3)CO)O)O)N=CNC2=O D0V4UU HIGHSTAT Investigative D0V4WB DRUG__ID D0V4WB D0V4WB DRUGTYPE Small molecular drug D0V4WB DRUGINCH 1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m0/s1 D0V4WB DRUGINKE IOSAAWHGJUZBOG-WDEREUQCSA-N D0V4WB DRUGSMIL CCCCCCC(C(C)O)N1C=NC2=C(N=CN=C21)N D0V4WB HIGHSTAT Investigative D0V4WT DRUG__ID D0V4WT D0V4WT DRUGTYPE Small molecular drug D0V4WT DRUGINCH 1S/C27H33NO4/c1-24(2,30)23-20(29)14-18-21(32-23)10-11-25(3)26(4)15(9-12-27(18,25)31)13-17-16-7-5-6-8-19(16)28-22(17)26/h5-8,14-15,21,23,28,30-31H,9-13H2,1-4H3/t15-,21-,23-,25+,26+,27+/m0/s1 D0V4WT DRUGINKE ACNHBCIZLNNLRS-UBGQALKQSA-N D0V4WT DRUGSMIL CC12CCC3C(=CC(=O)C(O3)C(C)(C)O)C1(CCC4C2(C5=C(C4)C6=CC=CC=C6N5)C)O D0V4WT HIGHSTAT Investigative D0V4YQ DRUG__ID D0V4YQ D0V4YQ DRUGCOMP Vical Inc D0V4YQ DRUGINCH 1S/C45H90NO8P.C36H73N2O2.BrH/c1-35(2)17-11-19-37(5)21-13-23-39(7)25-15-27-41(9)31-44(47)51-33-43(34-53-55(49,50)52-30-29-46)54-45(48)32-42(10)28-16-26-40(8)24-14-22-38(6)20-12-18-36(3)4;1-5-7-9-11-13-15-17-19-21-23-25-27-32-39-35-36(34-38(3,4)31-29-30-37)40-33-28-26-24-22-20-18-16-14-12-10-8-6-2;/h35-43H,11-34,46H2,1-10H3,(H,49,50);11-14,36H,5-10,15-35,37H2,1-4H3;1H/q;+1;/p-1/b;13-11-,14-12-;/t37?,38?,39?,40?,41?,42?,43-;;/m1../s1 D0V4YQ DRUGINKE LTOCXIVQWDANEX-UXCYUTBZSA-M D0V4YQ DRUGSMIL CCCCC=CCCCCCCCCOCC(C[N+](C)(C)CCCN)OCCCCCCCCC=CCCCC.CC(C)CCCC(C)CCCC(C)CCCC(C)CC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CC(C)CCCC(C)CCCC(C)CCCC(C)C.[Br-] D0V4YQ HIGHSTAT Investigative D0V5AN DRUG__ID D0V5AN D0V5AN DRUGTYPE Small molecular drug D0V5AN DRUGINCH 1S/C19H20N2O2S/c1-14-6-8-15(9-7-14)24(22,23)21-18-5-3-2-4-16(18)17-10-12-20-13-11-19(17)21/h2-9,20H,10-13H2,1H3 D0V5AN DRUGINKE LXDIYGJJOWTGAR-UHFFFAOYSA-N D0V5AN DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2C3=C(CCNCC3)C4=CC=CC=C42 D0V5AN HIGHSTAT Investigative D0V5AQ DRUG__ID D0V5AQ D0V5AQ DRUGTYPE Small molecular drug D0V5AQ DRUGINCH 1S/C19H22O/c20-18-12-7-13-19(18,14-16-8-3-1-4-9-16)15-17-10-5-2-6-11-17/h1-6,8-11,18,20H,7,12-15H2 D0V5AQ DRUGINKE MSJGQZXPPBXPBA-UHFFFAOYSA-N D0V5AQ DRUGSMIL C1CC(C(C1)(CC2=CC=CC=C2)CC3=CC=CC=C3)O D0V5AQ HIGHSTAT Investigative D0V5BX DRUG__ID D0V5BX D0V5BX DRUGTYPE Small molecular drug D0V5BX DRUGINCH 1S/C16H13N3O4/c1-2-17-15(20)13-8-3-4-9-14(13)18(16(17)21)11-6-5-7-12(10-11)19(22)23/h3-10H,2H2,1H3 D0V5BX DRUGINKE GNWCRBFQZDJFTI-UHFFFAOYSA-N D0V5BX DRUGSMIL CCN1C(=O)C2=CC=CC=C2N(C1=O)C3=CC(=CC=C3)[N+](=O)[O-] D0V5BX HIGHSTAT Investigative D0V5GB DRUG__ID D0V5GB D0V5GB DRUGTYPE Small molecular drug D0V5GB DRUGINCH 1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2/t8-,11+/m0/s1 D0V5GB DRUGINKE BSMNRYCSBFHEMQ-GZMMTYOYSA-N D0V5GB DRUGSMIL C1C2C1(CNC2)C3=CC(=C(C=C3)Cl)Cl D0V5GB HIGHSTAT Investigative D0V5HF DRUG__ID D0V5HF D0V5HF DRUGTYPE Small molecular drug D0V5HF DRUGINCH 1S/C16H12O3/c1-18-13-8-5-9-14-16(13)12(17)10-15(19-14)11-6-3-2-4-7-11/h2-10H,1H3 D0V5HF DRUGINKE XRQSPUXANRGDAV-UHFFFAOYSA-N D0V5HF DRUGSMIL COC1=CC=CC2=C1C(=O)C=C(O2)C3=CC=CC=C3 D0V5HF HIGHSTAT Investigative D0V5HG DRUG__ID D0V5HG D0V5HG DRUGTYPE Small molecular drug D0V5HG DRUGINCH 1S/C10H5Cl2NO3/c11-6-2-1-4-8(7(6)12)13-3-5(9(4)14)10(15)16/h1-3H,(H,13,14)(H,15,16) D0V5HG DRUGINKE HVXHDYSWCHQWBD-UHFFFAOYSA-N D0V5HG DRUGSMIL C1=CC(=C(C2=C1C(=O)C(=CN2)C(=O)O)Cl)Cl D0V5HG HIGHSTAT Investigative D0V5HI DRUG__ID D0V5HI D0V5HI DRUGTYPE Small molecular drug D0V5HI DRUGINCH 1S/C9H19N3O/c1-7(13)9(11)5-3-4-6-12-8(2)10/h9H,3-6,11H2,1-2H3,(H2,10,12) D0V5HI DRUGINKE ADHBRNMPDLVKQT-UHFFFAOYSA-N D0V5HI DRUGSMIL CC(=O)C(CCCCN=C(C)N)N D0V5HI HIGHSTAT Investigative D0V5HV DRUG__ID D0V5HV D0V5HV DRUGTYPE Small molecular drug D0V5HV DRUGINCH 1S/C11H13F3N2/c12-11(13,14)9-2-1-3-10(8-9)16-6-4-15-5-7-16/h1-3,8,15H,4-7H2 D0V5HV DRUGINKE KKIMDKMETPPURN-UHFFFAOYSA-N D0V5HV DRUGSMIL C1CN(CCN1)C2=CC=CC(=C2)C(F)(F)F D0V5HV HIGHSTAT Investigative D0V5IZ DRUG__ID D0V5IZ D0V5IZ DRUGTYPE Small molecular drug D0V5IZ DRUGINCH 1S/C20H27NO/c1-2-21(17-15-19-11-13-20(22)14-12-19)16-7-6-10-18-8-4-3-5-9-18/h3-5,8-9,11-14,22H,2,6-7,10,15-17H2,1H3 D0V5IZ DRUGINKE CJODMSRSFMFSCO-UHFFFAOYSA-N D0V5IZ DRUGSMIL CCN(CCCCC1=CC=CC=C1)CCC2=CC=C(C=C2)O D0V5IZ HIGHSTAT Investigative D0V5JV DRUG__ID D0V5JV D0V5JV DRUGTYPE Small molecular drug D0V5JV DRUGINCH 1S/C22H31NO3/c1-3-23-20(25)12-14-11-19-18-6-4-13-10-15(24)5-7-16(13)17(18)8-9-22(19,2)21(14)26/h5,7,10,14,17-19,21,24,26H,3-4,6,8-9,11-12H2,1-2H3,(H,23,25)/t14?,17?,18?,19?,21-,22-/m0/s1 D0V5JV DRUGINKE ZQUXDOJBDFPTDM-LAULZOBPSA-N D0V5JV DRUGSMIL CCNC(=O)CC1CC2C3CCC4=C(C3CCC2(C1O)C)C=CC(=C4)O D0V5JV HIGHSTAT Investigative D0V5NZ DRUG__ID D0V5NZ D0V5NZ DRUGTYPE Small molecular drug D0V5NZ DRUGINCH 1S/C11H18ClN7O/c1-4-19(5(2)3)9-7(12)16-6(8(13)17-9)10(20)18-11(14)15/h5H,4H2,1-3H3,(H2,13,17)(H4,14,15,18,20) D0V5NZ DRUGINKE QDERNBXNXJCIQK-UHFFFAOYSA-N D0V5NZ DRUGSMIL CCN(C1=NC(=C(N=C1Cl)C(=O)N=C(N)N)N)C(C)C D0V5NZ HIGHSTAT Investigative D0V5OS DRUG__ID D0V5OS D0V5OS DRUGTYPE Small molecular drug D0V5OS DRUGINCH 1S/C15H25NO4/c1-12(2)16-10-13(17)11-20-15-6-4-14(5-7-15)19-9-8-18-3/h4-7,12-13,16-17H,8-11H2,1-3H3 D0V5OS DRUGINKE FGAPARDHTDKREN-UHFFFAOYSA-N D0V5OS DRUGSMIL CC(C)NCC(COC1=CC=C(C=C1)OCCOC)O D0V5OS HIGHSTAT Investigative D0V5OW DRUG__ID D0V5OW D0V5OW DRUGTYPE Small molecular drug D0V5OW DRUGINCH 1S/C7H9N3O3S2/c8-7(11)4-14-5-1-2-10-3-6(5)15(9,12)13/h1-3H,4H2,(H2,8,11)(H2,9,12,13) D0V5OW DRUGINKE GMEZLQXYYUCJAQ-UHFFFAOYSA-N D0V5OW DRUGSMIL C1=CN=CC(=C1SCC(=O)N)S(=O)(=O)N D0V5OW HIGHSTAT Investigative D0V5OY DRUG__ID D0V5OY D0V5OY DRUGTYPE Small molecular drug D0V5OY DRUGINCH 1S/C23H24N2O/c26-23(21-11-10-19-8-4-5-9-20(19)16-21)24-22-12-14-25(15-13-22)17-18-6-2-1-3-7-18/h1-11,16,22H,12-15,17H2,(H,24,26) D0V5OY DRUGINKE RQEOFDOXFRRFQL-UHFFFAOYSA-N D0V5OY DRUGSMIL C1CN(CCC1NC(=O)C2=CC3=CC=CC=C3C=C2)CC4=CC=CC=C4 D0V5OY HIGHSTAT Investigative D0V5SQ DRUG__ID D0V5SQ D0V5SQ DRUGTYPE Small molecular drug D0V5SQ DRUGINCH 1S/C22H26FN3O2/c23-18-7-9-20(10-8-18)28-16-4-13-25-14-11-22(12-15-25)21(27)24-17-26(22)19-5-2-1-3-6-19/h1-3,5-10H,4,11-17H2,(H,24,27) D0V5SQ DRUGINKE FJUKDAZEABGEIH-UHFFFAOYSA-N D0V5SQ DRUGSMIL C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCOC4=CC=C(C=C4)F D0V5SQ HIGHSTAT Investigative D0V5TC DRUG__ID D0V5TC D0V5TC DRUGTYPE Small molecular drug D0V5TC DRUGINCH 1S/C16H18N4O4S/c1-13-4-6-14(7-5-13)25(23,24)19-11-9-18(10-12-19)16-15(20(21)22)3-2-8-17-16/h2-8H,9-12H2,1H3 D0V5TC DRUGINKE JYSIWWVOXFISJK-UHFFFAOYSA-N D0V5TC DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C3=C(C=CC=N3)[N+](=O)[O-] D0V5TC HIGHSTAT Investigative D0V5YV DRUG__ID D0V5YV D0V5YV DRUGTYPE Small molecular drug D0V5YV DRUGINCH 1S/C40H53N11O5/c41-40(42)45-19-11-16-31-37(54)51-33(21-27-23-46-30-15-9-8-14-29(27)30)36(53)44-18-10-3-1-2-7-17-35(52)48-34(22-28-24-43-25-47-28)39(56)50-32(38(55)49-31)20-26-12-5-4-6-13-26/h4-6,8-9,12-15,23-25,31-34,46H,1-3,7,10-11,16-22H2,(H,43,47)(H,44,53)(H,48,52)(H,49,55)(H,50,56)(H,51,54)(H4,41,42,45)/t31-,32-,33-,34+/m0/s1 D0V5YV DRUGINKE KYHILABVVZODQF-GZXHTMMISA-N D0V5YV DRUGSMIL C1CCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCC1)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5 D0V5YV HIGHSTAT Investigative D0V5ZI DRUG__ID D0V5ZI D0V5ZI DRUGTYPE Small molecular drug D0V5ZI DRUGINCH 1S/C22H20O4/c1-24-20-13-11-18(21(25-2)22(20)26-3)19(23)12-9-15-8-10-16-6-4-5-7-17(16)14-15/h4-14H,1-3H3/b12-9+ D0V5ZI DRUGINKE RUDVXNBRAYSKEY-FMIVXFBMSA-N D0V5ZI DRUGSMIL COC1=C(C(=C(C=C1)C(=O)C=CC2=CC3=CC=CC=C3C=C2)OC)OC D0V5ZI HIGHSTAT Investigative D0V5ZP DRUG__ID D0V5ZP D0V5ZP DRUGTYPE Small molecular drug D0V5ZP DRUGINCH 1S/C25H29BrF3N5O/c1-34(2)23-20-5-3-4-6-21(20)32-24(33-23)31-19-11-9-18(10-12-19)30-14-13-16-7-8-17(26)15-22(16)35-25(27,28)29/h3-8,15,18-19,30H,9-14H2,1-2H3,(H,31,32,33) D0V5ZP DRUGINKE FWKVXHBRMCTKHZ-UHFFFAOYSA-N D0V5ZP DRUGSMIL CN(C)C1=NC(=NC2=CC=CC=C21)NC3CCC(CC3)NCCC4=C(C=C(C=C4)Br)OC(F)(F)F D0V5ZP HIGHSTAT Investigative D0V6CM DRUG__ID D0V6CM D0V6CM DRUGTYPE Small molecular drug D0V6CM DRUGINCH 1S/C16H15N/c1-2-6-12-11(5-1)9-10-14-13-7-3-4-8-15(13)17-16(12)14/h3-4,7-10,17H,1-2,5-6H2 D0V6CM DRUGINKE OOCBASGHISDDOY-UHFFFAOYSA-N D0V6CM DRUGSMIL C1CCC2=C(C1)C=CC3=C2NC4=CC=CC=C34 D0V6CM HIGHSTAT Investigative D0V6DE DRUG__ID D0V6DE D0V6DE DRUGTYPE Small molecular drug D0V6DE DRUGINCH 1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/b8-7- D0V6DE DRUGINKE UWHZIFQPPBDJPM-FPLPWBNLSA-N D0V6DE DRUGSMIL CCCCCCC=CCCCCCCCCCC(=O)O D0V6DE HIGHSTAT Investigative D0V6DF DRUG__ID D0V6DF D0V6DF DRUGCOMP La Jolla Pharmaceutical Co D0V6DF DRUGINCH 1S/C9H12N2/c1-8(7-11-10)9-5-3-2-4-6-9/h2-6,11H,1,7,10H2 D0V6DF DRUGINKE IHEVYQFGSZLVRV-UHFFFAOYSA-N D0V6DF DRUGSMIL C=C(CNN)C1=CC=CC=C1 D0V6DF HIGHSTAT Investigative D0V6DJ DRUG__ID D0V6DJ D0V6DJ DRUGTYPE Small molecular drug D0V6DJ DRUGINCH 1S/C21H31N5O3/c1-16-19(23(2)21(28)24(3)20(16)27)22-10-7-11-25-12-14-26(15-13-25)17-8-5-6-9-18(17)29-4/h5-6,8-9,22H,7,10-15H2,1-4H3 D0V6DJ DRUGINKE HIHZDNKKIUQQSC-UHFFFAOYSA-N D0V6DJ DRUGSMIL CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC D0V6DJ HIGHSTAT Investigative D0V6DX DRUG__ID D0V6DX D0V6DX DRUGTYPE Small molecular drug D0V6DX DRUGINCH 1S/C9H5NO3/c11-7-5-3-1-2-4-6(5)8(12)10-9(7)13/h1-4H,(H,10,12,13) D0V6DX DRUGINKE YIOFGHHAURBGSJ-UHFFFAOYSA-N D0V6DX DRUGSMIL C1=CC=C2C(=C1)C(=O)C(=O)NC2=O D0V6DX HIGHSTAT Investigative D0V6EH DRUG__ID D0V6EH D0V6EH DRUGTYPE Small molecular drug D0V6EH DRUGINCH 1S/C8H8Cl3N3O4S2/c9-7(8(10)11)3-1-4(12)6(20(14,17)18)2-5(3)19(13,15)16/h1-2H,12H2,(H2,13,15,16)(H2,14,17,18) D0V6EH DRUGINKE QOVTVIYTBRHADL-UHFFFAOYSA-N D0V6EH DRUGSMIL C1=C(C(=CC(=C1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl D0V6EH HIGHSTAT Investigative D0V6GX DRUG__ID D0V6GX D0V6GX DRUGTYPE Small molecular drug D0V6GX DRUGINCH 1S/C14H12N4O2/c15-14(20)17-9-3-4-12-10(7-9)11(13(19)18-12)6-8-2-1-5-16-8/h1-7,16H,(H,18,19)(H3,15,17,20)/b11-6- D0V6GX DRUGINKE SOVOJYOIAXOTIM-WDZFZDKYSA-N D0V6GX DRUGSMIL C1=CNC(=C1)C=C2C3=C(C=CC(=C3)NC(=O)N)NC2=O D0V6GX HIGHSTAT Investigative D0V6HG DRUG__ID D0V6HG D0V6HG DRUGTYPE Small molecular drug D0V6HG DRUGINCH 1S/C18H12N6/c19-10-12-5-4-6-13(9-12)16-23-15-17(20-11-21-18(15)24-16)22-14-7-2-1-3-8-14/h1-9,11H,(H2,20,21,22,23,24) D0V6HG DRUGINKE JMBXPIFLNLGLKP-UHFFFAOYSA-N D0V6HG DRUGSMIL C1=CC=C(C=C1)NC2=NC=NC3=C2NC(=N3)C4=CC=CC(=C4)C#N D0V6HG HIGHSTAT Investigative D0V6IE DRUG__ID D0V6IE D0V6IE DRUGTYPE Small molecular drug D0V6IE DRUGINCH 1S/C5H10O2/c1-2-3-4-5(6)7/h2-4H2,1H3,(H,6,7) D0V6IE DRUGINKE NQPDZGIKBAWPEJ-UHFFFAOYSA-N D0V6IE DRUGSMIL CCCCC(=O)O D0V6IE HIGHSTAT Investigative D0V6KJ DRUG__ID D0V6KJ D0V6KJ DRUGTYPE Small molecular drug D0V6KJ DRUGINCH 1S/C16H10F2O2/c17-14-7-13(20)8-15(18)16(14)11-2-1-10-6-12(19)4-3-9(10)5-11/h1-8,19-20H D0V6KJ DRUGINKE AUZLISXBMGKYGA-UHFFFAOYSA-N D0V6KJ DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=C(C=C(C=C3F)O)F D0V6KJ HIGHSTAT Investigative D0V6KN DRUG__ID D0V6KN D0V6KN DRUGTYPE Small molecular drug D0V6KN DRUGINCH 1S/C17H15Cl2N5/c1-20-17-23-15(14-4-2-3-7-21-14)9-16(24-17)22-10-11-5-6-12(18)8-13(11)19/h2-9H,10H2,1H3,(H2,20,22,23,24) D0V6KN DRUGINKE HOVRMCPKCWLHJS-UHFFFAOYSA-N D0V6KN DRUGSMIL CNC1=NC(=CC(=N1)NCC2=C(C=C(C=C2)Cl)Cl)C3=CC=CC=N3 D0V6KN HIGHSTAT Investigative D0V6LP DRUG__ID D0V6LP D0V6LP DRUGTYPE Small molecular drug D0V6LP DRUGINCH 1S/C17H13N3O2/c1-22-20-15-11-7-3-5-9-13(11)18-16(15)14-10-6-2-4-8-12(10)19-17(14)21/h2-9,19,21H,1H3/b20-15- D0V6LP DRUGINKE DLJNVUXERDSYFS-HKWRFOASSA-N D0V6LP DRUGSMIL CON=C1C2=CC=CC=C2N=C1C3=C(NC4=CC=CC=C43)O D0V6LP HIGHSTAT Investigative D0V6OH DRUG__ID D0V6OH D0V6OH DRUGTYPE Small molecular drug D0V6OH DRUGINCH 1S/C3H9NO2S2/c1-8(5,7)6-3-2-4/h2-4H2,1H3 D0V6OH DRUGINKE HKERMLQDWIEJQS-UHFFFAOYSA-N D0V6OH DRUGSMIL CS(=O)(=S)OCCN D0V6OH HIGHSTAT Investigative D0V6QA DRUG__ID D0V6QA D0V6QA DRUGTYPE Small molecular drug D0V6QA DRUGINCH 1S/C21H36FO3P/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-25-26(22,23)24-2/h7-8,10-11,13-14,16-17H,3-6,9,12,15,18-21H2,1-2H3/b8-7-,11-10-,14-13-,17-16- D0V6QA DRUGINKE HNVKMEOEBANRAT-ZKWNWVNESA-N D0V6QA DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCCOP(=O)(OC)F D0V6QA HIGHSTAT Investigative D0V6QN DRUG__ID D0V6QN D0V6QN DRUGTYPE Small molecular drug D0V6QN DRUGINCH 1S/C18H15N3/c1-14-2-8-17(9-3-14)18-11-20-13-21(18)12-16-6-4-15(10-19)5-7-16/h2-9,11,13H,12H2,1H3 D0V6QN DRUGINKE DWILASUQXSLXIX-UHFFFAOYSA-N D0V6QN DRUGSMIL CC1=CC=C(C=C1)C2=CN=CN2CC3=CC=C(C=C3)C#N D0V6QN HIGHSTAT Investigative D0V6QZ DRUG__ID D0V6QZ D0V6QZ DRUGTYPE Small molecular drug D0V6QZ DRUGINCH 1S/C15H11N3O4S/c19-18(20)13-8-1-2-9-14(13)23(21,22)17-12-7-3-5-11-6-4-10-16-15(11)12/h1-10,17H D0V6QZ DRUGINKE YCXUFEOBLVZNAP-UHFFFAOYSA-N D0V6QZ DRUGSMIL C1=CC=C(C(=C1)[N+](=O)[O-])S(=O)(=O)NC2=CC=CC3=C2N=CC=C3 D0V6QZ HIGHSTAT Investigative D0V6RT DRUG__ID D0V6RT D0V6RT DRUGTYPE Small molecular drug D0V6RT DRUGINCH 1S/C81H142O17P2.2Na/c1-5-9-13-17-21-25-29-33-37-41-45-49-53-57-61-65-78(83)91-71-76(97-80(85)67-63-59-55-51-47-43-39-35-31-27-23-19-15-11-7-3)73-95-99(87,88)93-69-75(82)70-94-100(89,90)96-74-77(98-81(86)68-64-60-56-52-48-44-40-36-32-28-24-20-16-12-8-4)72-92-79(84)66-62-58-54-50-46-42-38-34-30-26-22-18-14-10-6-2;;/h21-28,33-40,75-77,82H,5-20,29-32,41-74H2,1-4H3,(H,87,88)(H,89,90);;/q;2*+1/p-2 D0V6RT DRUGINKE ZGSPNIOCEDOHGS-UHFFFAOYSA-L D0V6RT DRUGSMIL CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC(COP(=O)([O-])OCC(COC(=O)CCCCCCCC=CCC=CCCCCC)OC(=O)CCCCCCCC=CCC=CCCCCC)O)OC(=O)CCCCCCCC=CCC=CCCCCC.[Na+].[Na+] D0V6RT HIGHSTAT Investigative D0V6SS DRUG__ID D0V6SS D0V6SS DRUGTYPE Small molecular drug D0V6SS DRUGINCH 1S/C8H8FNO2/c9-6-4-2-1-3-5(6)7(10)8(11)12/h1-4,7H,10H2,(H,11,12) D0V6SS DRUGINKE CGNMJIBUVDGMIY-UHFFFAOYSA-N D0V6SS DRUGSMIL C1=CC=C(C(=C1)C(C(=O)O)N)F D0V6SS HIGHSTAT Investigative D0V6TM DRUG__ID D0V6TM D0V6TM DRUGTYPE Small molecular drug D0V6TM DRUGINCH 1S/C19H16N2O2/c1-22-18-12-13(9-10-14(18)15-6-4-5-11-20-15)19-21-16-7-2-3-8-17(16)23-19/h2-12,19,21H,1H3 D0V6TM DRUGINKE DNFFCLRSKDXRKM-UHFFFAOYSA-N D0V6TM DRUGSMIL COC1=C(C=CC(=C1)C2NC3=CC=CC=C3O2)C4=CC=CC=N4 D0V6TM HIGHSTAT Investigative D0V6TX DRUG__ID D0V6TX D0V6TX DRUGTYPE Small molecular drug D0V6TX DRUGINCH 1S/C24H26N6O3/c25-23(32)21-14-30(16-27-21)20(15-31)9-11-29-10-8-18-6-7-19(12-22(18)29)28-24(33)26-13-17-4-2-1-3-5-17/h1-8,10,12,14,16,20,31H,9,11,13,15H2,(H2,25,32)(H2,26,28,33)/t20-/m1/s1 D0V6TX DRUGINKE KCCUBLLGAMGDJL-HXUWFJFHSA-N D0V6TX DRUGSMIL C1=CC=C(C=C1)CNC(=O)NC2=CC3=C(C=C2)C=CN3CCC(CO)N4C=C(N=C4)C(=O)N D0V6TX HIGHSTAT Investigative D0V6UC DRUG__ID D0V6UC D0V6UC DRUGTYPE Small molecular drug D0V6UC DRUGINCH 1S/C3H7NO3S/c4-2(1-8-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1 D0V6UC DRUGINKE FXIRVRPOOYSARH-REOHCLBHSA-N D0V6UC DRUGSMIL C(C(C(=O)O)N)SO D0V6UC HIGHSTAT Investigative D0V6XA DRUG__ID D0V6XA D0V6XA DRUGTYPE Small molecular drug D0V6XA DRUGINCH 1S/C12H12N2O/c1-15-11-4-2-3-9-12(11)8-5-6-13-7-10(8)14-9/h2-4,7,14H,5-6H2,1H3 D0V6XA DRUGINKE UXOCVYNVGBOVRY-UHFFFAOYSA-N D0V6XA DRUGSMIL COC1=CC=CC2=C1C3=C(N2)C=NCC3 D0V6XA HIGHSTAT Investigative D0V6YT DRUG__ID D0V6YT D0V6YT DRUGTYPE Small molecular drug D0V6YT DRUGINCH 1S/C32H40N2O5S.C2H2O4/c1-23(2)31-27-10-7-8-11-28(27)34(4)32(31)40(35,36)26-15-13-25(14-16-26)39-21-9-19-33(3)20-18-24-12-17-29(37-5)30(22-24)38-6;3-1(4)2(5)6/h7-8,10-17,22-23H,9,18-21H2,1-6H3;(H,3,4)(H,5,6) D0V6YT DRUGINKE MZWPPDAHWIKZID-UHFFFAOYSA-N D0V6YT DRUGSMIL CC(C)C1=C(N(C2=CC=CC=C21)C)S(=O)(=O)C3=CC=C(C=C3)OCCCN(C)CCC4=CC(=C(C=C4)OC)OC.C(=O)(C(=O)O)O D0V6YT HIGHSTAT Investigative D0V7AA DRUG__ID D0V7AA D0V7AA DRUGTYPE Small molecular drug D0V7AA DRUGINCH 1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s1 D0V7AA DRUGINKE PFTAWBLQPZVEMU-DZGCQCFKSA-N D0V7AA DRUGSMIL C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O D0V7AA HIGHSTAT Investigative D0V7EA DRUG__ID D0V7EA D0V7EA DRUGTYPE Small molecular drug D0V7EA DRUGINCH 1S/C21H18N2O4/c24-19(15-6-2-1-3-7-15)22-10-12-23(13-11-22)20(25)17-14-16-8-4-5-9-18(16)27-21(17)26/h1-9,14H,10-13H2 D0V7EA DRUGINKE YBJQFYCTDMHHMH-UHFFFAOYSA-N D0V7EA DRUGSMIL C1CN(CCN1C(=O)C2=CC=CC=C2)C(=O)C3=CC4=CC=CC=C4OC3=O D0V7EA HIGHSTAT Investigative D0V7EK DRUG__ID D0V7EK D0V7EK DRUGTYPE Small molecular drug D0V7EK DRUGINCH 1S/C19H13NO2S/c21-19(22-14-8-2-1-3-9-14)20-15-10-4-6-12-17(15)23-18-13-7-5-11-16(18)20/h1-13H D0V7EK DRUGINKE FGMRQVNHYGGLSF-UHFFFAOYSA-N D0V7EK DRUGSMIL C1=CC=C(C=C1)OC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0V7EK HIGHSTAT Investigative D0V7HJ DRUG__ID D0V7HJ D0V7HJ DRUGTYPE Small molecular drug D0V7HJ DRUGINCH 1S/C10H17N2O/c1-12(2,3)7-8-13-10-5-4-6-11-9-10/h4-6,9H,7-8H2,1-3H3/q+1 D0V7HJ DRUGINKE WBRKKKJHXQZXEM-UHFFFAOYSA-N D0V7HJ DRUGSMIL C[N+](C)(C)CCOC1=CN=CC=C1 D0V7HJ HIGHSTAT Investigative D0V7KU DRUG__ID D0V7KU D0V7KU DRUGTYPE Small molecular drug D0V7KU DRUGINCH 1S/C13H7Cl2N3/c14-10-4-9(5-11(15)6-10)13-17-7-8-2-1-3-16-12(8)18-13/h1-7H D0V7KU DRUGINKE UDWGFUUPZLVQFW-UHFFFAOYSA-N D0V7KU DRUGSMIL C1=CC2=CN=C(N=C2N=C1)C3=CC(=CC(=C3)Cl)Cl D0V7KU HIGHSTAT Investigative D0V7LZ DRUG__ID D0V7LZ D0V7LZ DRUGTYPE Small molecular drug D0V7LZ DRUGINCH 1S/C6H14OS2/c1-3-5-8-9(7)6-4-2/h3-6H2,1-2H3 D0V7LZ DRUGINKE XPRZAEWSYWTDSQ-UHFFFAOYSA-N D0V7LZ DRUGSMIL CCCSS(=O)CCC D0V7LZ HIGHSTAT Investigative D0V7MX DRUG__ID D0V7MX D0V7MX DRUGTYPE Small molecular drug D0V7MX DRUGINCH 1S/C12H17N5/c13-11-10-12(15-7-14-11)17(8-16-10)9-5-3-1-2-4-6-9/h7-9H,1-6H2,(H2,13,14,15) D0V7MX DRUGINKE FHZRSYFMJLJWBS-UHFFFAOYSA-N D0V7MX DRUGSMIL C1CCCC(CC1)N2C=NC3=C(N=CN=C32)N D0V7MX HIGHSTAT Investigative D0V7OK DRUG__ID D0V7OK D0V7OK DRUGTYPE Small molecular drug D0V7OK DRUGINCH 1S/C22H20O/c1-2-21(17-9-5-3-6-10-17)22(18-11-7-4-8-12-18)19-13-15-20(23)16-14-19/h3-16,23H,2H2,1H3/b22-21- D0V7OK DRUGINKE YJVFSITVRZYTHO-DQRAZIAOSA-N D0V7OK DRUGSMIL CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)O)C3=CC=CC=C3 D0V7OK HIGHSTAT Investigative D0V7OO DRUG__ID D0V7OO D0V7OO DRUGTYPE Small molecular drug D0V7OO DRUGINCH 1S/C24H28N6/c1-2-4-19(5-3-1)13-25-14-20-8-10-29(16-20)11-9-21-15-26-24-7-6-22(12-23(21)24)30-17-27-28-18-30/h1-7,12,15,17-18,20,25-26H,8-11,13-14,16H2/t20-/m0/s1 D0V7OO DRUGINKE JCFDYNJSFCXYRT-FQEVSTJZSA-N D0V7OO DRUGSMIL C1CN(CC1CNCC2=CC=CC=C2)CCC3=CNC4=C3C=C(C=C4)N5C=NN=C5 D0V7OO HIGHSTAT Investigative D0V7QA DRUG__ID D0V7QA D0V7QA DRUGTYPE Small molecular drug D0V7QA DRUGINCH 1S/C22H19Cl3N4O/c23-14-4-6-16-13(10-14)11-17-20(22(30)27-28-8-2-1-3-9-28)26-29(21(16)17)19-7-5-15(24)12-18(19)25/h4-7,10,12H,1-3,8-9,11H2,(H,27,30) D0V7QA DRUGINKE AOONPZHOPMGIMM-UHFFFAOYSA-N D0V7QA DRUGSMIL C1CCN(CC1)NC(=O)C2=NN(C3=C2CC4=C3C=CC(=C4)Cl)C5=C(C=C(C=C5)Cl)Cl D0V7QA HIGHSTAT Investigative D0V7QZ DRUG__ID D0V7QZ D0V7QZ DRUGTYPE Small molecular drug D0V7QZ DRUGINCH 1S/C13H8ClNO3/c14-10-5-7(16)1-3-9(10)13-15-11-6-8(17)2-4-12(11)18-13/h1-6,16-17H D0V7QZ DRUGINKE RDNJWPGDJWLTPJ-UHFFFAOYSA-N D0V7QZ DRUGSMIL C1=CC(=C(C=C1O)Cl)C2=NC3=C(O2)C=CC(=C3)O D0V7QZ HIGHSTAT Investigative D0V7RD DRUG__ID D0V7RD D0V7RD DRUGTYPE Small molecular drug D0V7RD DRUGINCH 1S/C26H44N6O10S/c1-14(2)8-17(30-24(36)22(41-3)13-42-43(38,39)40)25(37)32-18-11-21(34)20(33)10-16(18)9-19(32)23(35)29-6-4-15-5-7-31(12-15)26(27)28/h5,14,16-22,33-34H,4,6-13H2,1-3H3,(H6,27,28,29,30,35,36,38,39,40)/t16-,17-,18+,19+,20+,21+,22-/m1/s1 D0V7RD DRUGINKE FJKGWCOVORXKMM-FAWMDMTCSA-N D0V7RD DRUGSMIL CC(C)CC(C(=O)N1C2CC(C(CC2CC1C(=O)NCCC3=CC[N+](=C(N)N)C3)O)O)NC(=O)C(COS(=O)(=O)[O-])OC D0V7RD HIGHSTAT Investigative D0V7RG DRUG__ID D0V7RG D0V7RG DRUGTYPE Small molecular drug D0V7RG DRUGINCH 1S/C6H9NO2/c8-6(9)5-2-1-3-7-4-5/h2,7H,1,3-4H2,(H,8,9) D0V7RG DRUGINKE QTDZOWFRBNTPQR-UHFFFAOYSA-N D0V7RG DRUGSMIL C1CNCC(=C1)C(=O)O D0V7RG HIGHSTAT Investigative D0V7RI DRUG__ID D0V7RI D0V7RI DRUGTYPE Small molecular drug D0V7RI DRUGINCH 1S/C20H15F2NO/c21-17-12-6-4-10-15(17)20(19(23)24,14-8-2-1-3-9-14)16-11-5-7-13-18(16)22/h1-13H,(H2,23,24) D0V7RI DRUGINKE JYLGTXBPFRKVJO-UHFFFAOYSA-N D0V7RI DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2F)(C3=CC=CC=C3F)C(=O)N D0V7RI HIGHSTAT Investigative D0V7RM DRUG__ID D0V7RM D0V7RM DRUGTYPE Small molecular drug D0V7RM DRUGINCH 1S/C17H23NO/c1-3-4-9-19-17-8-7-15-11-14(10-13(2)18)5-6-16(15)12-17/h5-8,11-13H,3-4,9-10,18H2,1-2H3 D0V7RM DRUGINKE HQJXBGMWVQCDJS-UHFFFAOYSA-N D0V7RM DRUGSMIL CCCCOC1=CC2=C(C=C1)C=C(C=C2)CC(C)N D0V7RM HIGHSTAT Investigative D0V7TA DRUG__ID D0V7TA D0V7TA DRUGTYPE Small molecular drug D0V7TA DRUGINCH 1S/C11H8N4O/c16-11-10-9(12-7-13-11)6-15(14-10)8-4-2-1-3-5-8/h1-7H,(H,12,13,16) D0V7TA DRUGINKE OQHWVAQCLKFQMO-UHFFFAOYSA-N D0V7TA DRUGSMIL C1=CC=C(C=C1)N2C=C3C(=N2)C(=O)NC=N3 D0V7TA HIGHSTAT Investigative D0V7TC DRUG__ID D0V7TC D0V7TC DRUGTYPE Small molecular drug D0V7TC DRUGINCH 1S/C12H7ClN2/c13-12-3-1-2-10(6-12)4-5-11-7-14-9-15-8-11/h1-3,6-9H D0V7TC DRUGINKE BYUKCJHVLPJKLQ-UHFFFAOYSA-N D0V7TC DRUGSMIL C1=CC(=CC(=C1)Cl)C#CC2=CN=CN=C2 D0V7TC HIGHSTAT Investigative D0V7TH DRUG__ID D0V7TH D0V7TH DRUGTYPE Small molecular drug D0V7TH DRUGINCH 1S/C28H38N6O4/c29-22-12-8-19(9-13-22)15-24(27(37)33-16-20-6-10-21(11-7-20)26(30)31)34-28(38)23(32-17-25(35)36)14-18-4-2-1-3-5-18/h6-13,18,23-24,32H,1-5,14-17,29H2,(H3,30,31)(H,33,37)(H,34,38)(H,35,36)/t23-,24+/m1/s1 D0V7TH DRUGINKE CHAFCBBAYJKFNL-RPWUZVMVSA-N D0V7TH DRUGSMIL C1CCC(CC1)CC(C(=O)NC(CC2=CC=C(C=C2)N)C(=O)NCC3=CC=C(C=C3)C(=N)N)NCC(=O)O D0V7TH HIGHSTAT Investigative D0V7VF DRUG__ID D0V7VF D0V7VF DRUGTYPE Small molecular drug D0V7VF DRUGINCH 1S/C18H19NO2/c1-14(20)19-12-11-18(15-7-4-3-5-8-15)16-9-6-10-17(13-16)21-2/h3-11,13H,12H2,1-2H3,(H,19,20)/b18-11+ D0V7VF DRUGINKE SJNURYXTMIYOKB-WOJGMQOQSA-N D0V7VF DRUGSMIL CC(=O)NCC=C(C1=CC=CC=C1)C2=CC(=CC=C2)OC D0V7VF HIGHSTAT Investigative D0V7WD DRUG__ID D0V7WD D0V7WD DRUGTYPE Small molecular drug D0V7WD DRUGINCH 1S/C19H32O/c1-18-9-3-4-16(18)15-6-5-13-12-14(20)7-11-19(13,2)17(15)8-10-18/h13-17,20H,3-12H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1 D0V7WD DRUGINKE DJTOLSNIKJIDFF-LOVVWNRFSA-N D0V7WD DRUGSMIL CC12CCCC1C3CCC4CC(CCC4(C3CC2)C)O D0V7WD HIGHSTAT Investigative D0V7WT DRUG__ID D0V7WT D0V7WT DRUGTYPE Small molecular drug D0V7WT DRUGINCH 1S/C14H12ClN4O8P/c1-7-13(21)9(5-20)10(6-27-28(24,25)26)14(16-7)18-17-8-2-3-11(15)12(4-8)19(22)23/h2-5,21H,6H2,1H3,(H2,24,25,26) D0V7WT DRUGINKE AIYCSQYPGGJSRN-UHFFFAOYSA-N D0V7WT DRUGSMIL CC1=C(C(=C(C(=N1)N=NC2=CC(=C(C=C2)Cl)[N+](=O)[O-])COP(=O)(O)O)C=O)O D0V7WT HIGHSTAT Investigative D0V7YQ DRUG__ID D0V7YQ D0V7YQ DRUGTYPE Small molecular drug D0V7YQ DRUGINCH 1S/C16H29N3/c1-2-3-4-5-6-9-19-10-7-15(8-11-19)12-16-13-17-14-18-16/h13-15H,2-12H2,1H3,(H,17,18) D0V7YQ DRUGINKE PKTDABXMBJERIM-UHFFFAOYSA-N D0V7YQ DRUGSMIL CCCCCCCN1CCC(CC1)CC2=CN=CN2 D0V7YQ HIGHSTAT Investigative D0V7ZI DRUG__ID D0V7ZI D0V7ZI DRUGTYPE Small molecular drug D0V7ZI DRUGINCH 1S/C18H17ClN2O/c19-16-7-3-6-15-17(12-8-10-14(22)11-9-12)20-21(18(15)16)13-4-1-2-5-13/h3,6-11,13,22H,1-2,4-5H2 D0V7ZI DRUGINKE NDUBFDHNGRZGIL-UHFFFAOYSA-N D0V7ZI DRUGSMIL C1CCC(C1)N2C3=C(C=CC=C3Cl)C(=N2)C4=CC=C(C=C4)O D0V7ZI HIGHSTAT Investigative D0V8AC DRUG__ID D0V8AC D0V8AC DRUGTYPE Small molecular drug D0V8AC DRUGINCH 1S/C17H10ClFN6/c18-10-1-2-13(19)12(9-10)15-24-16-14(21-7-8-22-16)17(25-15)23-11-3-5-20-6-4-11/h1-9H,(H,20,22,23,24,25) D0V8AC DRUGINKE BERLXWPRSBJFHO-UHFFFAOYSA-N D0V8AC DRUGSMIL C1=CC(=C(C=C1Cl)C2=NC3=NC=CN=C3C(=N2)NC4=CC=NC=C4)F D0V8AC HIGHSTAT Investigative D0V8CR DRUG__ID D0V8CR D0V8CR DRUGTYPE Small molecular drug D0V8CR DRUGINCH 1S/C15H12FN/c16-14-5-6-15-12(3-4-13(15)9-14)8-11-2-1-7-17-10-11/h1-2,5-10H,3-4H2/b12-8+ D0V8CR DRUGINKE WLUDJBASYYHRDC-XYOKQWHBSA-N D0V8CR DRUGSMIL C1CC(=CC2=CN=CC=C2)C3=C1C=C(C=C3)F D0V8CR HIGHSTAT Investigative D0V8DB DRUG__ID D0V8DB D0V8DB DRUGTYPE Small molecular drug D0V8DB DRUGINCH 1S/C15H9IN4/c16-12-7-11-4-2-6-18-15(11)14(9-12)10-3-1-5-13(8-10)19-20-17/h1-9H D0V8DB DRUGINKE PBIQIEZSLAPKDM-UHFFFAOYSA-N D0V8DB DRUGSMIL C1=CC(=CC(=C1)N=[N+]=[N-])C2=C3C(=CC(=C2)I)C=CC=N3 D0V8DB HIGHSTAT Investigative D0V8DH DRUG__ID D0V8DH D0V8DH DRUGTYPE Small molecular drug D0V8DH DRUGINCH 1S/C26H38N6O2/c1-20(2)15-27-24-23(25(33)28-16-21-7-4-3-5-8-21)17-29-26(30-24)32-12-10-31(11-13-32)18-22-9-6-14-34-19-22/h3-5,7-8,17,20,22H,6,9-16,18-19H2,1-2H3,(H,28,33)(H,27,29,30) D0V8DH DRUGINKE PPANZCQXFYBGHN-UHFFFAOYSA-N D0V8DH DRUGSMIL CC(C)CNC1=NC(=NC=C1C(=O)NCC2=CC=CC=C2)N3CCN(CC3)CC4CCCOC4 D0V8DH HIGHSTAT Investigative D0V8DJ DRUG__ID D0V8DJ D0V8DJ DRUGTYPE Small molecular drug D0V8DJ DRUGINCH 1S/C20H17N5O2S/c26-25(27)17-8-6-16(7-9-17)12-28-20-18-19(21-13-22-20)24(14-23-18)11-10-15-4-2-1-3-5-15/h1-9,13-14H,10-12H2 D0V8DJ DRUGINKE RXUAVXPJZWEMTE-UHFFFAOYSA-N D0V8DJ DRUGSMIL C1=CC=C(C=C1)CCN2C=NC3=C2N=CN=C3SCC4=CC=C(C=C4)[N+](=O)[O-] D0V8DJ HIGHSTAT Investigative D0V8DQ DRUG__ID D0V8DQ D0V8DQ DRUGTYPE Small molecular drug D0V8DQ DRUGINCH 1S/C9H9Cl2N3S/c1-5(13-14-9(12)15)6-2-3-7(10)8(11)4-6/h2-4H,1H3,(H3,12,14,15)/b13-5+ D0V8DQ DRUGINKE WLYQLQVFJXFMJD-WLRTZDKTSA-N D0V8DQ DRUGSMIL CC(=NNC(=S)N)C1=CC(=C(C=C1)Cl)Cl D0V8DQ HIGHSTAT Investigative D0V8EH DRUG__ID D0V8EH D0V8EH DRUGTYPE Small molecular drug D0V8EH DRUGINCH 1S/C23H33NO2/c1-20(2)18-7-6-15-16(21(18,3)12-14-13-24-26-19(14)20)8-10-22(4)17(15)9-11-23(22,5)25/h7,13,15-17,25H,6,8-12H2,1-5H3/t15?,16-,17-,21?,22?,23-/m0/s1 D0V8EH DRUGINKE AXLOCHLTNQDFFS-BELXDXCXSA-N D0V8EH DRUGSMIL CC1(C2=CCC3C4CCC(C4(CCC3C2(CC5=C1ON=C5)C)C)(C)O)C D0V8EH HIGHSTAT Investigative D0V8EQ DRUG__ID D0V8EQ D0V8EQ DRUGTYPE Small molecular drug D0V8EQ DRUGINCH 1S/C18H24N2O2/c1-22-16-4-2-3-15(8-16)19-17(21)20-18-9-12-5-13(10-18)7-14(6-12)11-18/h2-4,8,12-14H,5-7,9-11H2,1H3,(H2,19,20,21) D0V8EQ DRUGINKE QPAGLMBLMPXYKJ-UHFFFAOYSA-N D0V8EQ DRUGSMIL COC1=CC=CC(=C1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D0V8EQ HIGHSTAT Investigative D0V8FG DRUG__ID D0V8FG D0V8FG DRUGTYPE Small molecular drug D0V8FG DRUGINCH 1S/C6H3N3O2S/c10-9(11)5-3-1-2-4-6(5)8-12-7-4/h1-3H D0V8FG DRUGINKE IWQKAMJGVIHECB-UHFFFAOYSA-N D0V8FG DRUGSMIL C1=CC2=NSN=C2C(=C1)[N+](=O)[O-] D0V8FG HIGHSTAT Investigative D0V8GX DRUG__ID D0V8GX D0V8GX DRUGTYPE Small molecular drug D0V8GX DRUGINCH 1S/C25H24N4O2/c1-17-12-18(2)23(13-22(17)24-14-29(3)16-27-24)28-25(30)19-7-9-21(10-8-19)31-15-20-6-4-5-11-26-20/h4-14,16H,15H2,1-3H3,(H,28,30) D0V8GX DRUGINKE SMQVBAGSZVHCJP-UHFFFAOYSA-N D0V8GX DRUGSMIL CC1=CC(=C(C=C1C2=CN(C=N2)C)NC(=O)C3=CC=C(C=C3)OCC4=CC=CC=N4)C D0V8GX HIGHSTAT Investigative D0V8IZ DRUG__ID D0V8IZ D0V8IZ DRUGTYPE Small molecular drug D0V8IZ DRUGINCH 1S/C16H24ClNO/c1-5-6-10-14(18-16(2,3)4)15(19)12-8-7-9-13(17)11-12/h7-9,11,14,18H,5-6,10H2,1-4H3 D0V8IZ DRUGINKE WSLDIWPVDFGUNH-UHFFFAOYSA-N D0V8IZ DRUGSMIL CCCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D0V8IZ HIGHSTAT Investigative D0V8JJ DRUG__ID D0V8JJ D0V8JJ DRUGTYPE Small molecular drug D0V8JJ DRUGINCH 1S/C21H18O3/c1-23-17-11-12-19(21(14-17)24-2)20(22)13-10-16-8-5-7-15-6-3-4-9-18(15)16/h3-14H,1-2H3/b13-10+ D0V8JJ DRUGINKE MLJPSPKBQRTVGK-JLHYYAGUSA-N D0V8JJ DRUGSMIL COC1=CC(=C(C=C1)C(=O)C=CC2=CC=CC3=CC=CC=C32)OC D0V8JJ HIGHSTAT Investigative D0V8KA DRUG__ID D0V8KA D0V8KA DRUGTYPE Small molecular drug D0V8KA DRUGINCH 1S/C11H9N5S/c1-2-4-12-10(3-1)16-11-15-9(7-17-11)8-5-13-14-6-8/h1-7H,(H,13,14)(H,12,15,16) D0V8KA DRUGINKE WIILZWDTWZFGNO-UHFFFAOYSA-N D0V8KA DRUGSMIL C1=CC=NC(=C1)NC2=NC(=CS2)C3=CNN=C3 D0V8KA HIGHSTAT Investigative D0V8MD DRUG__ID D0V8MD D0V8MD DRUGTYPE Small molecular drug D0V8MD DRUGINCH 1S/C13H12N4O2/c1-16-11-9(12(18)17(2)13(16)19)14-10(15-11)8-6-4-3-5-7-8/h3-7H,1-2H3,(H,14,15) D0V8MD DRUGINKE PJFMAVHETLRJHJ-UHFFFAOYSA-N D0V8MD DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CC=CC=C3 D0V8MD HIGHSTAT Investigative D0V8MJ DRUG__ID D0V8MJ D0V8MJ DRUGTYPE Small molecular drug D0V8MJ DRUGINCH 1S/C14H20N2/c1(3-7-13-8-5-6-9-13)2-4-10-14-11-15-12-16-14/h11-13H,3-10H2,(H,15,16) D0V8MJ DRUGINKE XFHACGZTJUJXHB-UHFFFAOYSA-N D0V8MJ DRUGSMIL C1CCC(C1)CCC#CCCC2=CN=CN2 D0V8MJ HIGHSTAT Investigative D0V8MX DRUG__ID D0V8MX D0V8MX DRUGTYPE Small molecular drug D0V8MX DRUGINCH 1S/C13H14N2O4S/c1-17-9-6-8(7-10(18-2)11(9)19-3)12(16)15-13-14-4-5-20-13/h4-7H,1-3H3,(H,14,15,16) D0V8MX DRUGINKE XSAYHNGEJLPKEX-UHFFFAOYSA-N D0V8MX DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(=O)NC2=NC=CS2 D0V8MX HIGHSTAT Investigative D0V8PE DRUG__ID D0V8PE D0V8PE DRUGTYPE Small molecular drug D0V8PE DRUGINCH 1S/C17H17NO2S/c1-2-3-12-20-17(19)18-13-8-4-6-10-15(13)21-16-11-7-5-9-14(16)18/h4-11H,2-3,12H2,1H3 D0V8PE DRUGINKE YNOVMVUUQJTZIS-UHFFFAOYSA-N D0V8PE DRUGSMIL CCCCOC(=O)N1C2=CC=CC=C2SC3=CC=CC=C31 D0V8PE HIGHSTAT Investigative D0V8QI DRUG__ID D0V8QI D0V8QI DRUGTYPE Small molecular drug D0V8QI DRUGINCH 1S/C14H11NOS/c1-16-13-3-2-10-6-12(8-15-14(10)7-13)11-4-5-17-9-11/h2-9H,1H3 D0V8QI DRUGINKE AOLUUEDZXBVWED-UHFFFAOYSA-N D0V8QI DRUGSMIL COC1=CC2=NC=C(C=C2C=C1)C3=CSC=C3 D0V8QI HIGHSTAT Investigative D0V8SM DRUG__ID D0V8SM D0V8SM DRUGTYPE Small molecular drug D0V8SM DRUGINCH 1S/C13H9N3O4/c17-11-3-6-20-13-9(7-15-5-4-14-8-15)1-2-10(12(11)13)16(18)19/h1-6,8H,7H2 D0V8SM DRUGINKE YKATXTHPSQAGQZ-UHFFFAOYSA-N D0V8SM DRUGSMIL C1=CC(=C2C(=O)C=COC2=C1CN3C=CN=C3)[N+](=O)[O-] D0V8SM HIGHSTAT Investigative D0V8UG DRUG__ID D0V8UG D0V8UG DRUGTYPE Small molecular drug D0V8UG DRUGINCH 1S/C29H30N4O4/c1-17-11-21(34)12-18(2)22(17)14-23(30)29(36)33-16-20-8-4-3-7-19(20)13-25(33)28(35)31-15-27-32-24-9-5-6-10-26(24)37-27/h3-12,23,25,34H,13-16,30H2,1-2H3,(H,31,35)/t23-,25-/m0/s1 D0V8UG DRUGINKE JBEVAWMNEBELDV-ZCYQVOJMSA-N D0V8UG DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCC4=NC5=CC=CC=C5O4)N)C)O D0V8UG HIGHSTAT Investigative D0V8UV DRUG__ID D0V8UV D0V8UV DRUGTYPE Small molecular drug D0V8UV DRUGINCH 1S/C14H13NO2/c1-15(17)14(16)10-9-12-7-4-6-11-5-2-3-8-13(11)12/h2-10,17H,1H3/b10-9+ D0V8UV DRUGINKE AQTNKWXWVAWKHS-MDZDMXLPSA-N D0V8UV DRUGSMIL CN(C(=O)C=CC1=CC=CC2=CC=CC=C21)O D0V8UV HIGHSTAT Investigative D0V8VY DRUG__ID D0V8VY D0V8VY DRUGTYPE Small molecular drug D0V8VY DRUGINCH 1S/C17H15NO2/c19-15-11-16(18-9-3-4-10-18)20-17-13-6-2-1-5-12(13)7-8-14(15)17/h1-2,5-8,11H,3-4,9-10H2 D0V8VY DRUGINKE CYNBNMZZLAYOIM-UHFFFAOYSA-N D0V8VY DRUGSMIL C1CCN(C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0V8VY HIGHSTAT Investigative D0V8WE DRUG__ID D0V8WE D0V8WE DRUGTYPE Small molecular drug D0V8WE DRUGINCH 1S/C14H18N2O2S/c1-2-3-8-16-14(17)18-12-6-4-11(5-7-12)13-15-9-10-19-13/h4-7H,2-3,8-10H2,1H3,(H,16,17) D0V8WE DRUGINKE OUBMDYCXTDANEM-UHFFFAOYSA-N D0V8WE DRUGSMIL CCCCNC(=O)OC1=CC=C(C=C1)C2=NCCS2 D0V8WE HIGHSTAT Investigative D0V8XD DRUG__ID D0V8XD D0V8XD DRUGTYPE Small molecular drug D0V8XD DRUGINCH 1S/C38H46N6O5/c1-2-31-34(36(40)45)33(27-14-16-30(17-15-27)44(47)48)35(32(42-31)26-49-25-20-39)37(46)41-21-9-22-43-23-18-38(19-24-43,28-10-5-3-6-11-28)29-12-7-4-8-13-29/h3-8,10-17,33,42H,2,9,18-26,39H2,1H3,(H2,40,45)(H,41,46)/t33-/m0/s1 D0V8XD DRUGINKE FLMJQBHJNDEDJH-XIFFEERXSA-N D0V8XD DRUGSMIL CCC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N D0V8XD HIGHSTAT Investigative D0V8YH DRUG__ID D0V8YH D0V8YH DRUGTYPE Small molecular drug D0V8YH DRUGINCH 1S/C23H34O5/c1-3-4-10-15-20(24)16-11-7-5-6-8-12-17-21(25)22(26)18-13-9-14-19-23(27)28-2/h4-13,16-17,20-22,24-26H,3,14-15,18-19H2,1-2H3/b7-5-,8-6+,10-4-,13-9-,16-11+,17-12+/t20-,21+,22-/m0/s1 D0V8YH DRUGINKE WUKVAFWBFGABJN-ZXQGQRHTSA-N D0V8YH DRUGSMIL CCC=CCC(C=CC=CC=CC=CC(C(CC=CCCC(=O)OC)O)O)O D0V8YH HIGHSTAT Investigative D0V8ZD DRUG__ID D0V8ZD D0V8ZD DRUGTYPE Small molecular drug D0V8ZD DRUGINCH 1S/C23H27F3N2O2/c1-15-18(16-8-10-17(30-4)11-9-16)14-19-20(23(24,25)26)6-5-7-21(19)28(22(15)29)13-12-27(2)3/h5-11,15,18H,12-14H2,1-4H3 D0V8ZD DRUGINKE ZBCRNIFALVNVKY-UHFFFAOYSA-N D0V8ZD DRUGSMIL CC1C(CC2=C(C=CC=C2N(C1=O)CCN(C)C)C(F)(F)F)C3=CC=C(C=C3)OC D0V8ZD HIGHSTAT Investigative D0V8ZU DRUG__ID D0V8ZU D0V8ZU DRUGTYPE Small molecular drug D0V8ZU DRUGINCH 1S/C20H34O4/c1-14(12-17(22)23)6-7-16-19(3)10-5-9-18(2,13-21)15(19)8-11-20(16,4)24/h12,15-16,21,24H,5-11,13H2,1-4H3,(H,22,23)/b14-12+/t15-,16+,18-,19-,20+/m0/s1 D0V8ZU DRUGINKE IYSBWLRXTOIYFZ-KBLZDMJYSA-N D0V8ZU DRUGSMIL CC(=CC(=O)O)CCC1C2(CCCC(C2CCC1(C)O)(C)CO)C D0V8ZU HIGHSTAT Investigative D0V9AJ DRUG__ID D0V9AJ D0V9AJ DRUGTYPE Small molecular drug D0V9AJ DRUGINCH 1S/C13H19NO/c1-15-13-7-3-2-6-12(13)8-11-14-9-4-5-10-14/h2-3,6-7H,4-5,8-11H2,1H3 D0V9AJ DRUGINKE YLUDJHIUYWQPKA-UHFFFAOYSA-N D0V9AJ DRUGSMIL COC1=CC=CC=C1CCN2CCCC2 D0V9AJ HIGHSTAT Investigative D0V9AU DRUG__ID D0V9AU D0V9AU DRUGTYPE Small molecular drug D0V9AU DRUGINCH 1S/C13H10N2O2S/c14-18(16,17)13-8-5-11(6-9-13)4-7-12-3-1-2-10-15-12/h1-3,5-6,8-10H,(H2,14,16,17) D0V9AU DRUGINKE GZRBQSAJFPOMOT-UHFFFAOYSA-N D0V9AU DRUGSMIL C1=CC=NC(=C1)C#CC2=CC=C(C=C2)S(=O)(=O)N D0V9AU HIGHSTAT Investigative D0V9CG DRUG__ID D0V9CG D0V9CG DRUGTYPE Small molecular drug D0V9CG DRUGINCH 1S/C22H23ClN4O3/c23-17-6-3-15(4-7-17)14-27-21(29)18-8-5-16(13-19(18)25-22(27)30)20(28)24-9-12-26-10-1-2-11-26/h3-8,13H,1-2,9-12,14H2,(H,24,28)(H,25,30) D0V9CG DRUGINKE VJRGAGPCQUZOLU-UHFFFAOYSA-N D0V9CG DRUGSMIL C1CCN(C1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl D0V9CG HIGHSTAT Investigative D0V9DQ DRUG__ID D0V9DQ D0V9DQ DRUGTYPE Small molecular drug D0V9DQ DRUGINCH 1S/C16H14N2O2/c19-11-12-5-4-8-14(9-12)18-16-17-10-15(20-16)13-6-2-1-3-7-13/h1-10,19H,11H2,(H,17,18) D0V9DQ DRUGINKE WTSNQZLKTLSHSD-UHFFFAOYSA-N D0V9DQ DRUGSMIL C1=CC=C(C=C1)C2=CN=C(O2)NC3=CC=CC(=C3)CO D0V9DQ HIGHSTAT Investigative D0V9EE DRUG__ID D0V9EE D0V9EE DRUGTYPE Small molecular drug D0V9EE DRUGINCH 1S/C16H11N3O/c17-10-13-12(11-5-2-1-3-6-11)9-14(19-16(13)18)15-7-4-8-20-15/h1-9H,(H2,18,19) D0V9EE DRUGINKE ABFMBAYHWWNULS-UHFFFAOYSA-N D0V9EE DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC(=C2C#N)N)C3=CC=CO3 D0V9EE HIGHSTAT Investigative D0V9EH DRUG__ID D0V9EH D0V9EH DRUGTYPE Small molecular drug D0V9EH DRUGINCH 1S/C15H19N3S2/c1-11(2)13-10-20-15(17-13)18-14(19)16-9-8-12-6-4-3-5-7-12/h3-7,10-11H,8-9H2,1-2H3,(H2,16,17,18,19) D0V9EH DRUGINKE WXIISNREJKBCAO-UHFFFAOYSA-N D0V9EH DRUGSMIL CC(C)C1=CSC(=N1)NC(=S)NCCC2=CC=CC=C2 D0V9EH HIGHSTAT Investigative D0V9FZ DRUG__ID D0V9FZ D0V9FZ DRUGTYPE Small molecular drug D0V9FZ DRUGINCH 1S/C5H12N4O3/c6-3(4(10)11)1-2-12-9-5(7)8/h3H,1-2,6H2,(H,10,11)(H4,7,8,9)/t3-/m0/s1 D0V9FZ DRUGINKE FSBIGDSBMBYOPN-VKHMYHEASA-N D0V9FZ DRUGSMIL C(CON=C(N)N)C(C(=O)O)N D0V9FZ HIGHSTAT Investigative D0V9GS DRUG__ID D0V9GS D0V9GS DRUGTYPE Small molecular drug D0V9GS DRUGINCH 1S/C16H23NO4/c1-2-3-4-5-10-21-13-8-6-12(7-9-13)14(16(17)20)11-15(18)19/h6-9,14H,2-5,10-11H2,1H3,(H2,17,20)(H,18,19) D0V9GS DRUGINKE RRXQHLQCQYPPMF-UHFFFAOYSA-N D0V9GS DRUGSMIL CCCCCCOC1=CC=C(C=C1)C(CC(=O)O)C(=O)N D0V9GS HIGHSTAT Investigative D0V9JS DRUG__ID D0V9JS D0V9JS DRUGTYPE Small molecular drug D0V9JS DRUGINCH 1S/C15H17N/c1-15(2,14-9-6-10-16-12-14)11-13-7-4-3-5-8-13/h3-10,12H,11H2,1-2H3 D0V9JS DRUGINKE MSUUKPGKCBHOAJ-UHFFFAOYSA-N D0V9JS DRUGSMIL CC(C)(CC1=CC=CC=C1)C2=CN=CC=C2 D0V9JS HIGHSTAT Investigative D0V9KF DRUG__ID D0V9KF D0V9KF DRUGTYPE Small molecular drug D0V9KF DRUGINCH 1S/C12H11F3N2O/c13-12(14,15)6-7-18-9-3-1-2-8-4-5-10(16)17-11(8)9/h1-5H,6-7H2,(H2,16,17) D0V9KF DRUGINKE ZGZSZXFSLMTFBX-UHFFFAOYSA-N D0V9KF DRUGSMIL C1=CC2=C(C(=C1)OCCC(F)(F)F)N=C(C=C2)N D0V9KF HIGHSTAT Investigative D0V9LR DRUG__ID D0V9LR D0V9LR DRUGTYPE Small molecular drug D0V9LR DRUGINCH 1S/C22H24Cl2N4O2/c1-14-17(22(29)25-9-10-30-16-5-3-2-4-6-16)12-26-21-18(13-27-28(14)21)15-7-8-19(23)20(24)11-15/h2-6,12-13,15,19-20H,7-11H2,1H3,(H,25,29) D0V9LR DRUGINKE BHDJYYFELGTSTL-UHFFFAOYSA-N D0V9LR DRUGSMIL CC1=C(C=NC2=C(C=NN12)C3CCC(C(C3)Cl)Cl)C(=O)NCCOC4=CC=CC=C4 D0V9LR HIGHSTAT Investigative D0V9MG DRUG__ID D0V9MG D0V9MG DRUGCOMP Kyoto Pharmaceutical Industries Ltd D0V9MG DRUGINCH 1S/C19H32N4O4S/c1-7-27-11-10-23-9-8-14-12(2)15(22-28(20,25)26)13(3)16(17(14)23)21-18(24)19(4,5)6/h22H,7-11H2,1-6H3,(H,21,24)(H2,20,25,26) D0V9MG DRUGINKE PXCNVWWWTVXCME-UHFFFAOYSA-N D0V9MG DRUGSMIL CCOCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)NS(=O)(=O)N)C D0V9MG HIGHSTAT Investigative D0V9MI DRUG__ID D0V9MI D0V9MI DRUGTYPE Small molecular drug D0V9MI DRUGINCH 1S/C27H32N4O4/c1-17-25-27(33)29-24(16-20-13-14-22(34-3)23(15-20)35-4)30-31(25)26(28-17)21(18(2)32)12-8-11-19-9-6-5-7-10-19/h5-7,9-10,13-15,18,21,32H,8,11-12,16H2,1-4H3,(H,29,30,33)/t18-,21+/m1/s1 D0V9MI DRUGINKE MYTWFJKBZGMYCS-NQIIRXRSSA-N D0V9MI DRUGSMIL CC1=C2C(=O)NC(=NN2C(=N1)C(CCCC3=CC=CC=C3)C(C)O)CC4=CC(=C(C=C4)OC)OC D0V9MI HIGHSTAT Investigative D0V9NE DRUG__ID D0V9NE D0V9NE DRUGTYPE Small molecular drug D0V9NE DRUGINCH 1S/C16H15N3OS/c1-16(2)12-8-10(4-6-13(12)18-15(21)20-16)14-7-5-11(9-17)19(14)3/h4-8H,1-3H3,(H,18,21) D0V9NE DRUGINKE PYVFWTPEBMRKSR-UHFFFAOYSA-N D0V9NE DRUGSMIL CC1(C2=C(C=CC(=C2)C3=CC=C(N3C)C#N)NC(=S)O1)C D0V9NE HIGHSTAT Investigative D0V9OO DRUG__ID D0V9OO D0V9OO DRUGTYPE Small molecular drug D0V9OO DRUGINCH 1S/C21H22N6O5/c1-2-23-20(31)17-15(29)16(30)21(32-17)27-10-24-14-18(22)25-13(26-19(14)27)9-8-12(28)11-6-4-3-5-7-11/h3-7,10,12,15-17,21,28-30H,2H2,1H3,(H,23,31)(H2,22,25,26)/t12?,15-,16+,17+,21-/m1/s1 D0V9OO DRUGINKE WOAZCBPWCCREDO-CERUIEQFSA-N D0V9OO DRUGSMIL CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)C#CC(C4=CC=CC=C4)O)N)O)O D0V9OO HIGHSTAT Investigative D0V9QT DRUG__ID D0V9QT D0V9QT DRUGTYPE Small molecular drug D0V9QT DRUGINCH 1S/C22H20ClN3O4S/c23-16-7-8-20-18(12-16)26(13-15-4-1-2-6-19(15)30-20)22(28)25-24-21(27)9-11-31-14-17-5-3-10-29-17/h1-8,10,12H,9,11,13-14H2,(H,24,27)(H,25,28) D0V9QT DRUGINKE CQBVTZDISUKDSX-UHFFFAOYSA-N D0V9QT DRUGSMIL C1C2=CC=CC=C2OC3=C(N1C(=O)NNC(=O)CCSCC4=CC=CO4)C=C(C=C3)Cl D0V9QT HIGHSTAT Investigative D0V9SV DRUG__ID D0V9SV D0V9SV DRUGTYPE Small molecular drug D0V9SV DRUGINCH 1S/C19H28O10/c20-6-11-14(22)15(23)13(9-26-11)29-19-17(25)18(16(24)12(7-21)28-19)27-8-10-4-2-1-3-5-10/h1-5,11-25H,6-9H2/t11-,12-,13+,14-,15-,16+,17-,18+,19-/m0/s1 D0V9SV DRUGINKE PBKBHCJPMCMBCZ-GDLYOHBGSA-N D0V9SV DRUGSMIL C1C(C(C(C(O1)CO)O)O)OC2C(C(C(C(O2)CO)O)OCC3=CC=CC=C3)O D0V9SV HIGHSTAT Investigative D0V9SW DRUG__ID D0V9SW D0V9SW DRUGTYPE Small molecular drug D0V9SW DRUGINCH 1S/C19H20O2/c20-17-10-6-15(7-11-17)19(14-4-2-1-3-5-14)16-8-12-18(21)13-9-16/h6-13,20-21H,1-5H2 D0V9SW DRUGINKE POEZOFHZEJTFHF-UHFFFAOYSA-N D0V9SW DRUGSMIL C1CCC(=C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)CC1 D0V9SW HIGHSTAT Investigative D0V9TZ DRUG__ID D0V9TZ D0V9TZ DRUGTYPE Small molecular drug D0V9TZ DRUGINCH 1S/C10H14F2N2O11P2/c11-10(12,26(19,20)21)27(22,23)24-3-4-6(16)7(17)8(25-4)14-2-1-5(15)13-9(14)18/h1-2,4,6-8,16-17H,3H2,(H,22,23)(H,13,15,18)(H2,19,20,21)/t4-,6+,7+,8-/m1/s1 D0V9TZ DRUGINKE JKJYHYKRGKKASI-YDKYIBAVSA-N D0V9TZ DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(C(F)(F)P(=O)(O)O)O)O)O D0V9TZ HIGHSTAT Investigative D0V9US DRUG__ID D0V9US D0V9US DRUGTYPE Small molecular drug D0V9US DRUGINCH 1S/C13H12N6S/c14-11-10-12(19-13(15)18-11)16-6-8(17-10)7-20-9-4-2-1-3-5-9/h1-6H,7H2,(H4,14,15,16,18,19) D0V9US DRUGINKE ZJOATKLQTCGUSP-UHFFFAOYSA-N D0V9US DRUGSMIL C1=CC=C(C=C1)SCC2=CN=C3C(=N2)C(=NC(=N3)N)N D0V9US HIGHSTAT Investigative D0V9VJ DRUG__ID D0V9VJ D0V9VJ DRUGTYPE Small molecular drug D0V9VJ DRUGINCH 1S/C7H8N2O/c1-9-5-3-2-4-7(9)6-8-10/h2-6H,1H3/p+1 D0V9VJ DRUGINKE JBKPUQTUERUYQE-UHFFFAOYSA-O D0V9VJ DRUGSMIL C[N+]1=CC=CC=C1C=NO D0V9VJ HIGHSTAT Investigative D0V9XE DRUG__ID D0V9XE D0V9XE DRUGTYPE Small molecular drug D0V9XE DRUGINCH 1S/C33H34N4O3/c1-4-36-15-12-33(13-16-36)20-39-30-18-25-11-14-37(29(25)19-28(30)33)32(38)24-7-5-23(6-8-24)27-10-9-26(17-21(27)2)31-35-34-22(3)40-31/h5-10,17-19H,4,11-16,20H2,1-3H3 D0V9XE DRUGINKE WXAKEEQOWUHGCI-UHFFFAOYSA-N D0V9XE DRUGSMIL CCN1CCC2(CC1)COC3=C2C=C4C(=C3)CCN4C(=O)C5=CC=C(C=C5)C6=C(C=C(C=C6)C7=NN=C(O7)C)C D0V9XE HIGHSTAT Investigative D0V9XF DRUG__ID D0V9XF D0V9XF DRUGTYPE Small molecular drug D0V9XF DRUGINCH 1S/C15H18O7/c1-12(2,18)6-7-10(16)20-8(6)9-13(3)14(7,19)4-5-15(13,22-5)11(17)21-9/h5-9,18-19H,4H2,1-3H3/t5-,6+,7-,8-,9-,13-,14-,15+/m1/s1 D0V9XF DRUGINKE RYEFFICCPKWYML-QCGISDTRSA-N D0V9XF DRUGSMIL CC12C3C4C(C(C1(CC5C2(O5)C(=O)O3)O)C(=O)O4)C(C)(C)O D0V9XF HIGHSTAT Investigative D0VA0J DRUG__ID D0VA0J D0VA0J DRUGTYPE Small molecular drug D0VA0J DRUGINCH 1S/C22H17Cl2NO/c23-20-12-11-18(15-21(20)24)22(26)25-14-13-19(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-13,15H,14H2,(H,25,26) D0VA0J DRUGINKE OYXWUVAZLKNOAB-UHFFFAOYSA-N D0VA0J DRUGSMIL C1=CC=C(C=C1)C(=CCNC(=O)C2=CC(=C(C=C2)Cl)Cl)C3=CC=CC=C3 D0VA0J HIGHSTAT Investigative D0VA2O DRUG__ID D0VA2O D0VA2O DRUGTYPE Small molecular drug D0VA2O DRUGINCH 1S/C11H13Cl2NO2S/c12-8-1-2-9(13)7(5-8)6-17-4-3-10(14)11(15)16/h1-2,5,10H,3-4,6,14H2,(H,15,16) D0VA2O DRUGINKE TYFOZYAERVGDAT-UHFFFAOYSA-N D0VA2O DRUGSMIL C1=CC(=C(C=C1Cl)CSCCC(C(=O)O)N)Cl D0VA2O HIGHSTAT Investigative D0VA5V DRUG__ID D0VA5V D0VA5V DRUGTYPE Small molecular drug D0VA5V DRUGINCH 1S/C23H31N3O3/c1-29-11-7-16-12-15-13-23(22(28)24-8-10-27)20-18(6-9-26(14-15)21(16)23)17-4-2-3-5-19(17)25-20/h2-5,15-16,21,25,27H,6-14H2,1H3,(H,24,28)/t15?,16-,21-,23+/m0/s1 D0VA5V DRUGINKE RPYHLEHPZWHJIE-NVVKDKPXSA-N D0VA5V DRUGSMIL COCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)NCCO D0VA5V HIGHSTAT Investigative D0VA7C DRUG__ID D0VA7C D0VA7C DRUGTYPE Small molecular drug D0VA7C DRUGINCH 1S/C20H31N3O2/c1-20(2,3)25-19(24)23-13-8-17(9-14-23)16-6-11-22(12-7-16)18-5-4-10-21-15-18/h4-5,10,15-17H,6-9,11-14H2,1-3H3 D0VA7C DRUGINKE CRZGKAWVJIDZPZ-UHFFFAOYSA-N D0VA7C DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)C2CCN(CC2)C3=CN=CC=C3 D0VA7C HIGHSTAT Investigative D0VA9F DRUG__ID D0VA9F D0VA9F DRUGTYPE Small molecular drug D0VA9F DRUGINCH 1S/C34H28O9/c1-16-8-24(22-6-4-19(35)13-26(22)38)32(34(42)23-7-5-20(36)14-27(23)39)25(9-16)33-28(40)10-18(11-29(33)41)30-12-17-2-3-21(37)15-31(17)43-30/h2-7,9-15,24-25,32,35-41H,8H2,1H3/t24-,25+,32-/m0/s1 D0VA9F DRUGINKE WTGKDESIYCVAOP-UNTHUGQZSA-N D0VA9F DRUGSMIL CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C=C(C=C4O)C5=CC6=C(O5)C=C(C=C6)O)O D0VA9F HIGHSTAT Investigative D0VB2W DRUG__ID D0VB2W D0VB2W DRUGTYPE Small molecular drug D0VB2W DRUGINCH 1S/C7H5N3O2/c11-10(12)6-1-2-7-5(3-6)4-8-9-7/h1-4H,(H,8,9) D0VB2W DRUGINKE WSGURAYTCUVDQL-UHFFFAOYSA-N D0VB2W DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])C=NN2 D0VB2W HIGHSTAT Investigative D0VB6X DRUG__ID D0VB6X D0VB6X DRUGTYPE Small molecular drug D0VB6X DRUGINCH 1S/C16H12N4/c1-2-6-11(7-3-1)19-16-15-14(17-10-18-15)12-8-4-5-9-13(12)20-16/h1-10H,(H,17,18)(H,19,20) D0VB6X DRUGINKE BWQWMNKFCIJEBY-UHFFFAOYSA-N D0VB6X DRUGSMIL C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C4=C2NC=N4 D0VB6X HIGHSTAT Investigative D0VB8K DRUG__ID D0VB8K D0VB8K DRUGTYPE Small molecular drug D0VB8K DRUGINCH 1S/C21H24N2O6/c24-10-8-23(9-11-25)7-3-6-22-15-12-16(26)17-18(21(15)29)20(28)14-5-2-1-4-13(14)19(17)27/h1-2,4-5,12,22,24-26,29H,3,6-11H2 D0VB8K DRUGINKE PYKCJLACRZVGNR-UHFFFAOYSA-N D0VB8K DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=C(C(=C3C2=O)O)NCCCN(CCO)CCO)O D0VB8K HIGHSTAT Investigative D0VC0I DRUG__ID D0VC0I D0VC0I DRUGTYPE Small molecular drug D0VC0I DRUGINCH 1S/C20H14FN3O/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(25)8-4-15/h1-12,25H,(H,23,24) D0VC0I DRUGINKE QHKYPYXTTXKZST-UHFFFAOYSA-N D0VC0I DRUGSMIL C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)O D0VC0I HIGHSTAT Investigative D0VC1K DRUG__ID D0VC1K D0VC1K DRUGTYPE Small molecular drug D0VC1K DRUGINCH 1S/C15H17NO/c1-16(2)12-13-8-6-7-11-15(13)17-14-9-4-3-5-10-14/h3-11H,12H2,1-2H3 D0VC1K DRUGINKE BBLALPDUHCRAKZ-UHFFFAOYSA-N D0VC1K DRUGSMIL CN(C)CC1=CC=CC=C1OC2=CC=CC=C2 D0VC1K HIGHSTAT Investigative D0VC2M DRUG__ID D0VC2M D0VC2M DRUGTYPE Small molecular drug D0VC2M DRUGINCH 1S/C15H23NO/c17-14(16-3-1-2-4-16)15-8-11-5-12(9-15)7-13(6-11)10-15/h11-13H,1-10H2 D0VC2M DRUGINKE RVXVNLMWQYKNHL-UHFFFAOYSA-N D0VC2M DRUGSMIL C1CCN(C1)C(=O)C23CC4CC(C2)CC(C4)C3 D0VC2M HIGHSTAT Investigative D0VD2C DRUG__ID D0VD2C D0VD2C DRUGTYPE Small molecular drug D0VD2C DRUGINCH 1S/C19H34O4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-17(19(22)23)16(2)18(20)21/h3-15H2,1-2H3,(H,20,21)(H,22,23)/b17-16- D0VD2C DRUGINKE ULSDRNDLXFVDED-MSUUIHNZSA-N D0VD2C DRUGSMIL CCCCCCCCCCCCCCC(=C(C)C(=O)O)C(=O)O D0VD2C HIGHSTAT Investigative D0VD3M DRUG__ID D0VD3M D0VD3M DRUGTYPE Small molecular drug D0VD3M DRUGINCH 1S/C19H20O6/c1-9(2)17(21)24-14-8-19(5)15(20)7-12(25-19)10(3)6-13-16(14)11(4)18(22)23-13/h6-7,13-14,16H,1,4,8H2,2-3,5H3/b10-6-/t13-,14-,16+,19-/m1/s1 D0VD3M DRUGINKE RYBHZNMPMHOBAR-IRNKKCRZSA-N D0VD3M DRUGSMIL CC1=CC2C(C(CC3(C(=O)C=C1O3)C)OC(=O)C(=C)C)C(=C)C(=O)O2 D0VD3M HIGHSTAT Investigative D0VD4L DRUG__ID D0VD4L D0VD4L DRUGTYPE Small molecular drug D0VD4L DRUGINCH 1S/C14H16N4O2/c19-18(20)12-3-4-13-11(10-12)2-5-14(16-13)17-8-1-6-15-7-9-17/h2-5,10,15H,1,6-9H2 D0VD4L DRUGINKE DKLQZCAIKFJPKG-UHFFFAOYSA-N D0VD4L DRUGSMIL C1CNCCN(C1)C2=NC3=C(C=C2)C=C(C=C3)[N+](=O)[O-] D0VD4L HIGHSTAT Investigative D0VD5N DRUG__ID D0VD5N D0VD5N DRUGTYPE Small molecular drug D0VD5N DRUGINCH 1S/C10H12ClN4O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,18,19,20)/p+1/t4-,6-,7-,10-/m1/s1 D0VD5N DRUGINKE ALOBOMYIOYNCBS-KQYNXXCUSA-O D0VD5N DRUGSMIL C1=[N+](C2=C(N1)C(=NC=N2)Cl)C3C(C(C(O3)COP(=O)(O)O)O)O D0VD5N HIGHSTAT Investigative D0VD5O DRUG__ID D0VD5O D0VD5O DRUGTYPE Small molecular drug D0VD5O DRUGINCH 1S/C10H8FNS/c1-7-4-5-13-10(7)8-2-3-9(11)12-6-8/h2-6H,1H3 D0VD5O DRUGINKE RYGQGRAICBWYPW-UHFFFAOYSA-N D0VD5O DRUGSMIL CC1=C(SC=C1)C2=CN=C(C=C2)F D0VD5O HIGHSTAT Investigative D0VD7R DRUG__ID D0VD7R D0VD7R DRUGTYPE Small molecular drug D0VD7R DRUGINCH 1S/C42H57N11O7/c1-2-3-14-31-41(60)53-21-10-17-34(53)40(59)52-32(22-25-11-5-4-6-12-25)38(57)50-30(16-9-20-46-42(44)45)37(56)51-33(23-26-24-47-28-15-8-7-13-27(26)28)39(58)49-29(36(43)55)18-19-35(54)48-31/h4-8,11-13,15,24,29-34,47H,2-3,9-10,14,16-23H2,1H3,(H2,43,55)(H,48,54)(H,49,58)(H,50,57)(H,51,56)(H,52,59)(H4,44,45,46)/t29-,30-,31-,32+,33-,34+/m0/s1 D0VD7R DRUGINKE AKNCBPIMUGVGES-IPLXUGDNSA-N D0VD7R DRUGSMIL CCCCC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC=CC=C5 D0VD7R HIGHSTAT Investigative D0VD8B DRUG__ID D0VD8B D0VD8B DRUGTYPE Small molecular drug D0VD8B DRUGINCH 1S/C15H13NO2S/c1-17-11-7-8-12(18-2)14-13(11)15(19)9-5-3-4-6-10(9)16-14/h3-8H,1-2H3,(H,16,19) D0VD8B DRUGINKE KFAKESMKRPNZTM-UHFFFAOYSA-N D0VD8B DRUGSMIL COC1=C2C(=C(C=C1)OC)NC3=CC=CC=C3C2=S D0VD8B HIGHSTAT Investigative D0VE0F DRUG__ID D0VE0F D0VE0F DRUGTYPE Small molecular drug D0VE0F DRUGINCH 1S/C19H27NO3/c1-2-3-11-17(15-21)20-18(22)23-19(12-7-8-13-19)14-16-9-5-4-6-10-16/h4-6,9-10,15,17H,2-3,7-8,11-14H2,1H3,(H,20,22)/t17-/m0/s1 D0VE0F DRUGINKE ONABDOMWRCXLPX-KRWDZBQOSA-N D0VE0F DRUGSMIL CCCCC(C=O)NC(=O)OC1(CCCC1)CC2=CC=CC=C2 D0VE0F HIGHSTAT Investigative D0VE0Q DRUG__ID D0VE0Q D0VE0Q DRUGTYPE Small molecular drug D0VE0Q DRUGINCH 1S/C25H28O6/c1-13(2)5-6-15(14(3)4)9-18-20(28)11-21(29)24-22(30)12-23(31-25(18)24)17-8-7-16(26)10-19(17)27/h5,7-8,10-11,15,23,26-29H,3,6,9,12H2,1-2,4H3/t15-,23+/m1/s1 D0VE0Q DRUGINKE XRYVAQQLDYTHCL-CMJOXMDJSA-N D0VE0Q DRUGSMIL CC(=CCC(CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=C(C=C(C=C3)O)O)C(=C)C)C D0VE0Q HIGHSTAT Investigative D0VE4Z DRUG__ID D0VE4Z D0VE4Z DRUGTYPE Small molecular drug D0VE4Z DRUGINCH 1S/C15H22N2OS/c1-3-9-17(10-4-2)11-8-12-6-5-7-13-14(12)19-15(18)16-13/h5-7H,3-4,8-11H2,1-2H3,(H,16,18) D0VE4Z DRUGINKE ZAHKGALZXMOXJH-UHFFFAOYSA-N D0VE4Z DRUGSMIL CCCN(CCC)CCC1=C2C(=CC=C1)NC(=O)S2 D0VE4Z HIGHSTAT Investigative D0VE6A DRUG__ID D0VE6A D0VE6A DRUGTYPE Small molecular drug D0VE6A DRUGINCH 1S/C13H14F3NS/c1-9(2)5-6-18-11-4-3-10(8-17)12(7-11)13(14,15)16/h3-4,7,9H,5-6H2,1-2H3 D0VE6A DRUGINKE JCLWLTZDKYNAQH-UHFFFAOYSA-N D0VE6A DRUGSMIL CC(C)CCSC1=CC(=C(C=C1)C#N)C(F)(F)F D0VE6A HIGHSTAT Investigative D0VE9G DRUG__ID D0VE9G D0VE9G DRUGTYPE Small molecular drug D0VE9G DRUGINCH 1S/C10H11N3O2/c1-6(2)13-9-4-3-7(10(14)15)5-8(9)11-12-13/h3-6H,1-2H3,(H,14,15) D0VE9G DRUGINKE RUTVRAJKELSHCC-UHFFFAOYSA-N D0VE9G DRUGSMIL CC(C)N1C2=C(C=C(C=C2)C(=O)O)N=N1 D0VE9G HIGHSTAT Investigative D0VF5V DRUG__ID D0VF5V D0VF5V DRUGTYPE Small molecular drug D0VF5V DRUGINCH 1S/C30H33Cl2N7O/c31-24-11-9-22(10-12-24)18-34-29(40)26(16-21-5-2-1-3-6-21)36-27-17-28(39-14-13-33-20-39)38-30(37-27)35-19-23-7-4-8-25(32)15-23/h4,7-15,17,20-21,26H,1-3,5-6,16,18-19H2,(H,34,40)(H2,35,36,37,38) D0VF5V DRUGINKE HIENPNTVAACRGD-UHFFFAOYSA-N D0VF5V DRUGSMIL C1CCC(CC1)CC(C(=O)NCC2=CC=C(C=C2)Cl)NC3=CC(=NC(=N3)NCC4=CC(=CC=C4)Cl)N5C=CN=C5 D0VF5V HIGHSTAT Investigative D0VF6E DRUG__ID D0VF6E D0VF6E DRUGTYPE Small molecular drug D0VF6E DRUGINCH 1S/C28H41N7O3/c1-8-35(9-2)13-11-10-12-29-26-30-18-20-16-23(19-14-21(37-6)17-22(15-19)38-7)25(31-24(20)32-26)33-27(36)34-28(3,4)5/h14-18H,8-13H2,1-7H3,(H3,29,30,31,32,33,34,36) D0VF6E DRUGINKE DXCUKNQANPLTEJ-UHFFFAOYSA-N D0VF6E DRUGSMIL CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C D0VF6E HIGHSTAT Investigative D0VF6F DRUG__ID D0VF6F D0VF6F DRUGTYPE Small molecular drug D0VF6F DRUGINCH 1S/C12H12N2O3S/c1-18(15,16)14-11-7-8-13-9-12(11)17-10-5-3-2-4-6-10/h2-9H,1H3,(H,13,14) D0VF6F DRUGINKE CQEDUEBRINEBGP-UHFFFAOYSA-N D0VF6F DRUGSMIL CS(=O)(=O)NC1=C(C=NC=C1)OC2=CC=CC=C2 D0VF6F HIGHSTAT Investigative D0VG6L DRUG__ID D0VG6L D0VG6L DRUGTYPE Small molecular drug D0VG6L DRUGINCH 1S/C10H16O5/c11-8(6-7-10(14)15)4-2-1-3-5-9(12)13/h1-7H2,(H,12,13)(H,14,15) D0VG6L DRUGINKE XTQIBFVBYWIHIP-UHFFFAOYSA-N D0VG6L DRUGSMIL C(CCC(=O)CCC(=O)O)CCC(=O)O D0VG6L HIGHSTAT Investigative D0VG9P DRUG__ID D0VG9P D0VG9P DRUGTYPE Small molecular drug D0VG9P DRUGINCH 1S/C14H23NO/c1-9(2)12-7-11(15(5)6)8-13(10(3)4)14(12)16/h7-10,16H,1-6H3 D0VG9P DRUGINKE BOEKREBRMTXRRJ-UHFFFAOYSA-N D0VG9P DRUGSMIL CC(C)C1=CC(=CC(=C1O)C(C)C)N(C)C D0VG9P HIGHSTAT Investigative D0VH8A DRUG__ID D0VH8A D0VH8A DRUGTYPE Small molecular drug D0VH8A DRUGINCH 1S/C16H14N2O2/c1-12(19)18-15-7-5-13(6-8-15)16(20)10-9-14-4-2-3-11-17-14/h2-11H,1H3,(H,18,19)/b10-9+ D0VH8A DRUGINKE LAXKVXCZXLEVKG-MDZDMXLPSA-N D0VH8A DRUGSMIL CC(=O)NC1=CC=C(C=C1)C(=O)C=CC2=CC=CC=N2 D0VH8A HIGHSTAT Investigative D0VH8M DRUG__ID D0VH8M D0VH8M DRUGTYPE Small molecular drug D0VH8M DRUGINCH 1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12) D0VH8M DRUGINKE XNGIFLGASWRNHJ-UHFFFAOYSA-N D0VH8M DRUGSMIL C1=CC=C(C(=C1)C(=O)O)C(=O)O D0VH8M HIGHSTAT Investigative D0VI0S DRUG__ID D0VI0S D0VI0S DRUGTYPE Small molecular drug D0VI0S DRUGINCH 1S/C18H20N4O2S/c1-13-5-7-14(8-6-13)25(23,24)18-17-15(20-21-18)3-2-4-16(17)22-11-9-19-10-12-22/h2-8,19H,9-12H2,1H3,(H,20,21) D0VI0S DRUGINKE SJAUEJQIVFASOP-UHFFFAOYSA-N D0VI0S DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=C3C(=NN2)C=CC=C3N4CCNCC4 D0VI0S HIGHSTAT Investigative D0VI1H DRUG__ID D0VI1H D0VI1H DRUGTYPE Small molecular drug D0VI1H DRUGINCH 1S/C18H21NO4/c1-21-15-8-10-4-7-14(19)13-9-11(20)5-6-12(13)16(10)18(23-3)17(15)22-2/h5-6,8-9,14,20H,4,7,19H2,1-3H3/t14-/m0/s1 D0VI1H DRUGINKE HSDSUBIABLFGDX-AWEZNQCLSA-N D0VI1H DRUGSMIL COC1=C(C(=C2C(=C1)CCC(C3=C2C=CC(=C3)O)N)OC)OC D0VI1H HIGHSTAT Investigative D0VI2A DRUG__ID D0VI2A D0VI2A DRUGTYPE Small molecular drug D0VI2A DRUGINCH 1S/C25H37N3O7S/c1-18-5-2-3-6-20(18)19-9-13-28(14-10-19)36(33,34)17-25(23(30)26-32)11-15-27(16-12-25)24(31)35-22-8-4-7-21(22)29/h2-3,5-6,19,21-22,29,32H,4,7-17H2,1H3,(H,26,30) D0VI2A DRUGINKE JRYQAIVHIZIBOQ-UHFFFAOYSA-N D0VI2A DRUGSMIL CC1=CC=CC=C1C2CCN(CC2)S(=O)(=O)CC3(CCN(CC3)C(=O)OC4CCCC4O)C(=O)NO D0VI2A HIGHSTAT Investigative D0VI6N DRUG__ID D0VI6N D0VI6N DRUGTYPE Small molecular drug D0VI6N DRUGINCH 1S/C22H23NO8S/c1-14-7-9-16(10-8-14)32(26,27)22(25)31-18-13-29-19-17(12-28-20(18)19)30-21(24)23-11-15-5-3-2-4-6-15/h2-10,17-20H,11-13H2,1H3,(H,23,24)/t17-,18+,19+,20+/m0/s1 D0VI6N DRUGINKE RGANIXDJVGCBKP-MTQWCTHYSA-N D0VI6N DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C(=O)OC2COC3C2OCC3OC(=O)NCC4=CC=CC=C4 D0VI6N HIGHSTAT Investigative D0VJ2S DRUG__ID D0VJ2S D0VJ2S DRUGTYPE Small molecular drug D0VJ2S DRUGINCH 1S/C29H29N7O2/c1-20-17-24(11-12-25(20)34-29-31-15-13-26(35-29)22-8-5-14-30-19-22)33-28(38)21-7-4-9-23(18-21)32-27(37)10-6-16-36(2)3/h4-15,17-19H,16H2,1-3H3,(H,32,37)(H,33,38)(H,31,34,35)/b10-6+ D0VJ2S DRUGINKE GJFCSAPFHAXMSF-UXBLZVDNSA-N D0VJ2S DRUGSMIL CC1=C(C=CC(=C1)NC(=O)C2=CC(=CC=C2)NC(=O)C=CCN(C)C)NC3=NC=CC(=N3)C4=CN=CC=C4 D0VJ2S HIGHSTAT Investigative D0VJ5W DRUG__ID D0VJ5W D0VJ5W DRUGTYPE Small molecular drug D0VJ5W DRUGINCH 1S/C18H17NO3/c1-12-5-4-6-13(9-12)22-16-7-8-19-15-11-18(21-3)17(20-2)10-14(15)16/h4-11H,1-3H3 D0VJ5W DRUGINKE DKQOYJJIXRSARC-UHFFFAOYSA-N D0VJ5W DRUGSMIL CC1=CC(=CC=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC D0VJ5W HIGHSTAT Investigative D0VJ7A DRUG__ID D0VJ7A D0VJ7A DRUGTYPE Small molecular drug D0VJ7A DRUGINCH 1S/C29H34O4/c1-18(31)19-4-6-20(7-5-19)25-17-28(2)26(12-14-29(28,33)13-3-15-30)24-10-8-21-16-22(32)9-11-23(21)27(24)25/h3-7,13,16,24-26,30,33H,8-12,14-15,17H2,1-2H3/b13-3-/t24-,25+,26-,28-,29-/m0/s1 D0VJ7A DRUGINKE QRFXQUJABMFXNM-VRQKHSNCSA-N D0VJ7A DRUGSMIL CC(=O)C1=CC=C(C=C1)C2CC3(C(CCC3(C=CCO)O)C4C2=C5CCC(=O)C=C5CC4)C D0VJ7A HIGHSTAT Investigative D0VK7M DRUG__ID D0VK7M D0VK7M DRUGTYPE Small molecular drug D0VK7M DRUGINCH 1S/C58H78N8O8/c1-37(59-3)53(67)61-49(39-21-9-7-10-22-39)57(71)65-31-19-29-45(65)55(69)63-51-43-27-15-13-25-41(43)35-47(51)73-33-17-5-6-18-34-74-48-36-42-26-14-16-28-44(42)52(48)64-56(70)46-30-20-32-66(46)58(72)50(40-23-11-8-12-24-40)62-54(68)38(2)60-4/h13-16,25-28,37-40,45-52,59-60H,7-12,19-24,29-36H2,1-4H3,(H,61,67)(H,62,68)(H,63,69)(H,64,70)/t37-,38-,45-,46-,47+,48+,49-,50-,51-,52-/m0/s1 D0VK7M DRUGINKE WLMCRYCCYXHPQF-ZVMUOSSASA-N D0VK7M DRUGSMIL CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C(=O)NC3C(CC4=CC=CC=C34)OCC#CC#CCOC5CC6=CC=CC=C6C5NC(=O)C7CCCN7C(=O)C(C8CCCCC8)NC(=O)C(C)NC)NC D0VK7M HIGHSTAT Investigative D0VK9Y DRUG__ID D0VK9Y D0VK9Y DRUGTYPE Small molecular drug D0VK9Y DRUGINCH 1S/C79H131N31O24S4/c1-35(2)26-49-70(127)107-51-31-136-135-30-41(81)63(120)105-50(28-57(84)114)71(128)108-53(73(130)99-42(12-7-8-22-80)64(121)96-38(5)77(134)110-25-11-15-54(110)75(132)102-47(18-21-58(115)116)69(126)109-59(39(6)111)76(133)95-37(4)62(119)104-49)33-138-137-32-52(106-66(123)44(14-10-24-92-79(88)89)98-65(122)43(13-9-23-91-78(86)87)97-61(118)36(3)94-72(51)129)74(131)101-45(16-19-55(82)112)67(124)100-46(17-20-56(83)113)68(125)103-48(60(85)117)27-40-29-90-34-93-40/h29,34-39,41-54,59,111H,7-28,30-33,80-81H2,1-6H3,(H2,82,112)(H2,83,113)(H2,84,114)(H2,85,117)(H,90,93)(H,94,129)(H,95,133)(H,96,121)(H,97,118)(H,98,122)(H,99,130)(H,100,124)(H,101,131)(H,102,132)(H,103,125)(H,104,119)(H,105,120)(H,106,123)(H,107,127)(H,108,128)(H,109,126)(H,115,116)(H4,86,87,91)(H4,88,89,92)/t36-,37-,38-,39+,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,59-/m0/s1 D0VK9Y DRUGINKE YVIIHEKJCKCXOB-STYWVVQQSA-N D0VK9Y DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N2)CC(=O)N)N)C(=O)N1)CC(C)C)C)C(C)O)CCC(=O)O)C)CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC4=CN=CN4)C(=O)N)CCCNC(=N)N)CCCNC(=N)N D0VK9Y HIGHSTAT Investigative D0VL3R DRUG__ID D0VL3R D0VL3R DRUGTYPE Small molecular drug D0VL3R DRUGINCH 1S/C15H15N/c1-2-5-13-10-14(8-7-12(13)4-1)15-6-3-9-16-11-15/h3,6-11H,1-2,4-5H2 D0VL3R DRUGINKE WGNJGUOGXBTDMP-UHFFFAOYSA-N D0VL3R DRUGSMIL C1CCC2=C(C1)C=CC(=C2)C3=CN=CC=C3 D0VL3R HIGHSTAT Investigative D0VM0N DRUG__ID D0VM0N D0VM0N DRUGTYPE Small molecular drug D0VM0N DRUGINCH 1S/C34H54N6O14S/c1-17(2)13-22(38-29(48)20(9-11-26(42)43)37-33(52)24(15-28(46)47)35-18(3)41)31(50)36-21(10-12-27(44)45)30(49)39-23(14-19-7-5-4-6-8-19)32(51)40-25(16-55)34(53)54/h17,19-25,55H,4-16H2,1-3H3,(H,35,41)(H,36,50)(H,37,52)(H,38,48)(H,39,49)(H,40,51)(H,42,43)(H,44,45)(H,46,47)(H,53,54)/t20-,21+,22+,23+,24+,25+/m1/s1 D0VM0N DRUGINKE SYHFABLPDKKGNQ-RFXJPFPRSA-N D0VM0N DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0VM0N HIGHSTAT Investigative D0VM5U DRUG__ID D0VM5U D0VM5U DRUGTYPE Small molecular drug D0VM5U DRUGINCH 1S/C20H27N3O2S2/c1-20(2,3)17-9-5-15(6-10-17)13-21-19(26)22-14-16-7-11-18(12-8-16)23-27(4,24)25/h5-12,23H,13-14H2,1-4H3,(H2,21,22,26) D0VM5U DRUGINKE LOMAEJPLJSUBML-UHFFFAOYSA-N D0VM5U DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CNC(=S)NCC2=CC=C(C=C2)NS(=O)(=O)C D0VM5U HIGHSTAT Investigative D0VN2R DRUG__ID D0VN2R D0VN2R DRUGTYPE Small molecular drug D0VN2R DRUGINCH 1S/C22H16O2/c23-19-10-6-15(7-11-19)17-8-12-20-18(14-17)9-13-21(24)22(20)16-4-2-1-3-5-16/h1-14,23-24H D0VN2R DRUGINKE INNGVLJQICTRAF-UHFFFAOYSA-N D0VN2R DRUGSMIL C1=CC=C(C=C1)C2=C(C=CC3=C2C=CC(=C3)C4=CC=C(C=C4)O)O D0VN2R HIGHSTAT Investigative D0VN4K DRUG__ID D0VN4K D0VN4K DRUGTYPE Small molecular drug D0VN4K DRUGINCH 1S/C21H21ClN2O/c1-4-14(2)24(3)21(25)19-13-15-9-5-6-10-16(15)20(23-19)17-11-7-8-12-18(17)22/h5-14H,4H2,1-3H3 D0VN4K DRUGINKE RAVIZVQZGXBOQO-UHFFFAOYSA-N D0VN4K DRUGSMIL CCC(C)N(C)C(=O)C1=CC2=CC=CC=C2C(=N1)C3=CC=CC=C3Cl D0VN4K HIGHSTAT Investigative D0VN5D DRUG__ID D0VN5D D0VN5D DRUGTYPE Small molecular drug D0VN5D DRUGINCH 1S/C18H16N4O2S/c1-24-12-4-2-11(3-5-12)22-9-21-15-13-14-10(6-7-19-14)8-20-17(13)25-16(15)18(22)23/h2-5,8-9,15-16,19H,6-7H2,1H3 D0VN5D DRUGINKE SIUQQICXQVLRLA-UHFFFAOYSA-N D0VN5D DRUGSMIL COC1=CC=C(C=C1)N2C=NC3C(C2=O)SC4=NC=C5CCNC5=C34 D0VN5D HIGHSTAT Investigative D0VN7G DRUG__ID D0VN7G D0VN7G DRUGTYPE Small molecular drug D0VN7G DRUGINCH 1S/C7H12N2/c8-7-4-3-6-2-1-5-9(6)7/h6,8H,1-5H2 D0VN7G DRUGINKE IGTGCXXJCCYMRS-UHFFFAOYSA-N D0VN7G DRUGSMIL C1CC2CCC(=N)N2C1 D0VN7G HIGHSTAT Investigative D0VN8V DRUG__ID D0VN8V D0VN8V DRUGTYPE Small molecular drug D0VN8V DRUGINCH 1S/C20H19NO/c1-2-4-18(5-3-1)16-19-6-8-20(9-7-19)22-15-12-17-10-13-21-14-11-17/h1-11,13-14H,12,15-16H2 D0VN8V DRUGINKE PHONRHOSBJCBIH-UHFFFAOYSA-N D0VN8V DRUGSMIL C1=CC=C(C=C1)CC2=CC=C(C=C2)OCCC3=CC=NC=C3 D0VN8V HIGHSTAT Investigative D0VN9U DRUG__ID D0VN9U D0VN9U DRUGTYPE Small molecular drug D0VN9U DRUGINCH 1S/C23H31NO3/c1-2-3-4-5-6-7-8-12-19-26-21-17-15-20(16-18-21)24-23(25)27-22-13-10-9-11-14-22/h9-11,13-18H,2-8,12,19H2,1H3,(H,24,25) D0VN9U DRUGINKE ZNJJGGVTHHJCRN-UHFFFAOYSA-N D0VN9U DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2 D0VN9U HIGHSTAT Investigative D0VP6M DRUG__ID D0VP6M D0VP6M DRUGTYPE Small molecular drug D0VP6M DRUGINCH 1S/C14H15NO3/c1-14(2,3)11(16)8-15-10-7-5-4-6-9(10)12(17)13(15)18/h4-7H,8H2,1-3H3 D0VP6M DRUGINKE GGQBSDZGSYIVQW-UHFFFAOYSA-N D0VP6M DRUGSMIL CC(C)(C)C(=O)CN1C2=CC=CC=C2C(=O)C1=O D0VP6M HIGHSTAT Investigative D0VQ3O DRUG__ID D0VQ3O D0VQ3O DRUGTYPE Small molecular drug D0VQ3O DRUGINCH 1S/C18H15NO3/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)22-15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2 D0VQ3O DRUGINKE LLQSCQSWBWHWLL-UHFFFAOYSA-N D0VQ3O DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)CCC(=O)C3=NC=CO3 D0VQ3O HIGHSTAT Investigative D0VQ4G DRUG__ID D0VQ4G D0VQ4G DRUGTYPE Small molecular drug D0VQ4G DRUGINCH 1S/C21H27N3/c1-3-24(4-2)16-10-9-15-22-21-17-11-5-7-13-19(17)23-20-14-8-6-12-18(20)21/h5-8,11-14H,3-4,9-10,15-16H2,1-2H3,(H,22,23) D0VQ4G DRUGINKE OALXTIRPFIITPC-UHFFFAOYSA-N D0VQ4G DRUGSMIL CCN(CC)CCCCNC1=C2C=CC=CC2=NC3=CC=CC=C31 D0VQ4G HIGHSTAT Investigative D0VR3K DRUG__ID D0VR3K D0VR3K DRUGTYPE Small molecular drug D0VR3K DRUGINCH 1S/C10H12FNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14) D0VR3K DRUGINKE QWHXHLDNSXLAPX-UHFFFAOYSA-N D0VR3K DRUGSMIL C1=CC(=CC=C1C(CC(=O)O)CN)F D0VR3K HIGHSTAT Investigative D0VR4A DRUG__ID D0VR4A D0VR4A DRUGTYPE Small molecular drug D0VR4A DRUGINCH 1S/C22H24N4O4/c1-25(2)11-19(27)23-13-5-7-15-17(9-13)22(30)18-10-14(6-8-16(18)21(15)29)24-20(28)12-26(3)4/h5-10H,11-12H2,1-4H3,(H,23,27)(H,24,28) D0VR4A DRUGINKE BQUQDCVNESTXAU-UHFFFAOYSA-N D0VR4A DRUGSMIL CN(C)CC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CN(C)C D0VR4A HIGHSTAT Investigative D0VR8J DRUG__ID D0VR8J D0VR8J DRUGTYPE Small molecular drug D0VR8J DRUGINCH 1S/C28H25NO4/c30-26(29-28(21-9-3-1-4-10-21)22-11-5-2-6-12-22)18-17-20-13-7-15-24-23(20)14-8-16-25(24)33-19-27(31)32/h1-16,28H,17-19H2,(H,29,30)(H,31,32) D0VR8J DRUGINKE YAPFKFDLARVWDB-UHFFFAOYSA-N D0VR8J DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)NC(=O)CCC3=C4C=CC=C(C4=CC=C3)OCC(=O)O D0VR8J HIGHSTAT Investigative D0VR9K DRUG__ID D0VR9K D0VR9K DRUGTYPE Small molecular drug D0VR9K DRUGINCH 1S/C62H89N17O14/c1-7-35(6)51(78-56(87)44(25-37-17-19-40(80)20-18-37)74-58(89)50(34(4)5)77-53(84)42(15-11-21-68-62(64)65)71-52(83)41(63)28-49(81)82)59(90)75-46(27-39-30-67-32-70-39)60(91)79-22-12-16-48(79)57(88)73-43(24-36-13-9-8-10-14-36)54(85)72-45(26-38-29-66-31-69-38)55(86)76-47(61(92)93)23-33(2)3/h8-10,13-14,17-20,29-35,41-48,50-51,80H,7,11-12,15-16,21-28,63H2,1-6H3,(H,66,69)(H,67,70)(H,71,83)(H,72,85)(H,73,88)(H,74,89)(H,75,90)(H,76,86)(H,77,84)(H,78,87)(H,81,82)(H,92,93)(H4,64,65,68)/t35-,41-,42-,43-,44-,45-,46-,47-,48-,50-,51-/m0/s1 D0VR9K DRUGINKE ORWYRWWVDCYOMK-HBZPZAIKSA-N D0VR9K DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CN=CN4)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N D0VR9K HIGHSTAT Investigative D0VR9L DRUG__ID D0VR9L D0VR9L DRUGTYPE Small molecular drug D0VR9L DRUGINCH 1S/C12H2F8N2O2/c13-1-5(17)11(23)6(18)2(14)9(1)21-22-10-3(15)7(19)12(24)8(20)4(10)16/h23-24H D0VR9L DRUGINKE OLAUREFYJFRAJD-UHFFFAOYSA-N D0VR9L DRUGSMIL C1(=C(C(=C(C(=C1F)F)O)F)F)N=NC2=C(C(=C(C(=C2F)F)O)F)F D0VR9L HIGHSTAT Investigative D0VS0Z DRUG__ID D0VS0Z D0VS0Z DRUGTYPE Small molecular drug D0VS0Z DRUGINCH 1S/C25H33Cl2N7O2/c26-18-8-4-7-17(22(18)27)20-13-19(32-33-20)15-9-11-34(12-10-15)21(35)14-30-24(36)23(31-25(28)29)16-5-2-1-3-6-16/h4,7-8,13,15-16,23H,1-3,5-6,9-12,14H2,(H,30,36)(H,32,33)(H4,28,29,31)/t23-/m1/s1 D0VS0Z DRUGINKE SSSXBBASYYVGCI-HSZRJFAPSA-N D0VS0Z DRUGSMIL C1CCC(CC1)C(C(=O)NCC(=O)N2CCC(CC2)C3=CC(=NN3)C4=C(C(=CC=C4)Cl)Cl)N=C(N)N D0VS0Z HIGHSTAT Investigative D0VS1V DRUG__ID D0VS1V D0VS1V DRUGTYPE Small molecular drug D0VS1V DRUGINCH 1S/C19H30O5/c1-2-3-4-5-6-7-8-9-10-11-12-24-19(23)15-13-16(20)18(22)17(21)14-15/h13-14,20-22H,2-12H2,1H3 D0VS1V DRUGINKE RPWFJAMTCNSJKK-UHFFFAOYSA-N D0VS1V DRUGSMIL CCCCCCCCCCCCOC(=O)C1=CC(=C(C(=C1)O)O)O D0VS1V HIGHSTAT Investigative D0VW5G DRUG__ID D0VW5G D0VW5G DRUGTYPE Small molecular drug D0VW5G DRUGINCH 1S/C7H11N2O9P/c10-3-2(1-17-19(14,15)16)18-7(4(3)11)5(12)8-6(13)9-7/h2-4,10-11H,1H2,(H2,14,15,16)(H2,8,9,12,13)/t2-,3-,4-,7+/m1/s1 D0VW5G DRUGINKE HVXIMXHBUJADCC-GTBMBKLPSA-N D0VW5G DRUGSMIL C(C1C(C(C2(O1)C(=O)NC(=O)N2)O)O)OP(=O)(O)O D0VW5G HIGHSTAT Investigative D0VW5M DRUG__ID D0VW5M D0VW5M DRUGTYPE Small molecular drug D0VW5M DRUGINCH 1S/C5H11NO3S/c7-10(8,9)5-1-3-6-4-2-5/h5-6H,1-4H2,(H,7,8,9) D0VW5M DRUGINKE UGBJGGRINDTHIH-UHFFFAOYSA-N D0VW5M DRUGSMIL C1CNCCC1S(=O)(=O)O D0VW5M HIGHSTAT Investigative D0VW6H DRUG__ID D0VW6H D0VW6H DRUGTYPE Small molecular drug D0VW6H DRUGINCH 1S/C4H4ClN3O2.ClH/c5-1-2(6)7-4(10)8-3(1)9;/h(H4,6,7,8,9,10);1H D0VW6H DRUGINKE LZWPDUHEHWOBPF-UHFFFAOYSA-N D0VW6H DRUGSMIL C1(=C(NC(=O)NC1=O)N)Cl.Cl D0VW6H HIGHSTAT Investigative D0VW6Y DRUG__ID D0VW6Y D0VW6Y DRUGTYPE Small molecular drug D0VW6Y DRUGINCH 1S/C20H36N2O2/c1-2-3-4-5-8-24-9-6-7-21-19(23)22-20-13-16-10-17(14-20)12-18(11-16)15-20/h16-18H,2-15H2,1H3,(H2,21,22,23) D0VW6Y DRUGINKE XMBHPHYTFZFYFH-UHFFFAOYSA-N D0VW6Y DRUGSMIL CCCCCCOCCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D0VW6Y HIGHSTAT Investigative D0VX1V DRUG__ID D0VX1V D0VX1V DRUGTYPE Small molecular drug D0VX1V DRUGINCH 1S/C11H17NOS/c1-9(12-13-2)8-10-4-6-11(14-3)7-5-10/h4-7,9,12H,8H2,1-3H3 D0VX1V DRUGINKE BWEGTFZAQIVRFB-UHFFFAOYSA-N D0VX1V DRUGSMIL CC(CC1=CC=C(C=C1)SC)NOC D0VX1V HIGHSTAT Investigative D0VX9R DRUG__ID D0VX9R D0VX9R DRUGTYPE Small molecular drug D0VX9R DRUGINCH 1S/C10H13NO3/c11-9(10(12)13)7-14-6-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1 D0VX9R DRUGINKE IDGQXGPQOGUGIX-VIFPVBQESA-N D0VX9R DRUGSMIL C1=CC=C(C=C1)COCC(C(=O)O)N D0VX9R HIGHSTAT Investigative D0VY2Z DRUG__ID D0VY2Z D0VY2Z DRUGTYPE Small molecular drug D0VY2Z DRUGINCH 1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1 D0VY2Z DRUGINKE WHTCPDAXWFLDIH-KQYNXXCUSA-N D0VY2Z DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)OP(=O)(O)O)O)N D0VY2Z HIGHSTAT Investigative D0VY9K DRUG__ID D0VY9K D0VY9K DRUGTYPE Small molecular drug D0VY9K DRUGINCH 1S/C14H18N2O3/c1-11(15-8-3-2-4-9-15)14(17)12-6-5-7-13(10-12)16(18)19/h5-7,10-11H,2-4,8-9H2,1H3 D0VY9K DRUGINKE LTLFRBMKBHQUTH-UHFFFAOYSA-N D0VY9K DRUGSMIL CC(C(=O)C1=CC(=CC=C1)[N+](=O)[O-])N2CCCCC2 D0VY9K HIGHSTAT Investigative D0W0BK DRUG__ID D0W0BK D0W0BK DRUGTYPE Small molecular drug D0W0BK DRUGINCH 1S/C7H13N3O2/c1-7(2,3)12-6(11)9-10(4)5-8/h1-4H3,(H,9,11) D0W0BK DRUGINKE SWELYBAPJHIOQT-UHFFFAOYSA-N D0W0BK DRUGSMIL CC(C)(C)OC(=O)NN(C)C#N D0W0BK HIGHSTAT Investigative D0W0BO DRUG__ID D0W0BO D0W0BO DRUGTYPE Small molecular drug D0W0BO DRUGINCH 1S/C17H32N4O4/c1-4-6-10(7-5-2)14(20-9(3)22)13-12(21-17(18)19)8-11(15(13)23)16(24)25/h10-15,23H,4-8H2,1-3H3,(H,20,22)(H,24,25)(H4,18,19,21)/t11?,12-,13-,14?,15?/m1/s1 D0W0BO DRUGINKE IIZTWIZWLKRAMW-YATPQJKZSA-N D0W0BO DRUGSMIL CCCC(CCC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C D0W0BO HIGHSTAT Investigative D0W0CO DRUG__ID D0W0CO D0W0CO DRUGTYPE Small molecular drug D0W0CO DRUGINCH 1S/C27H34N2/c1-2-9-22(10-3-1)28-23-13-12-21-17-26-24-11-4-5-14-27(24,25(21)18-23)15-16-29(26)19-20-7-6-8-20/h1-3,9-10,12-13,18,20,24,26,28H,4-8,11,14-17,19H2/t24-,26+,27+/m0/s1 D0W0CO DRUGINKE JXXVPNRGUCGAEU-WYMJOSIYSA-N D0W0CO DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)NC5=CC=CC=C5)CC6CCC6 D0W0CO HIGHSTAT Investigative D0W0FI DRUG__ID D0W0FI D0W0FI DRUGTYPE Small molecular drug D0W0FI DRUGINCH 1S/C16H13N3O3S/c20-16(13-8-9-15-12(11-13)5-4-10-17-15)18-19-23(21,22)14-6-2-1-3-7-14/h1-11,19H,(H,18,20) D0W0FI DRUGINKE YPRPLJAGGWUKMX-UHFFFAOYSA-N D0W0FI DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NNC(=O)C2=CC3=C(C=C2)N=CC=C3 D0W0FI HIGHSTAT Investigative D0W0FX DRUG__ID D0W0FX D0W0FX DRUGTYPE Small molecular drug D0W0FX DRUGINCH 1S/C7H12N2O6P2/c10-16(11,12)7(17(13,14)15)5-9-6-3-1-2-4-8-6/h1-4,7H,5H2,(H,8,9)(H2,10,11,12)(H2,13,14,15) D0W0FX DRUGINKE BHVCADPDEFLLGM-UHFFFAOYSA-N D0W0FX DRUGSMIL C1=CC=NC(=C1)NCC(P(=O)(O)O)P(=O)(O)O D0W0FX HIGHSTAT Investigative D0W0HN DRUG__ID D0W0HN D0W0HN DRUGTYPE Small molecular drug D0W0HN DRUGINCH 1S/C18H23NO/c20-18-11-9-17(10-12-18)13-15-19-14-5-4-8-16-6-2-1-3-7-16/h1-3,6-7,9-12,19-20H,4-5,8,13-15H2 D0W0HN DRUGINKE FNRAWMBUHCSCSX-UHFFFAOYSA-N D0W0HN DRUGSMIL C1=CC=C(C=C1)CCCCNCCC2=CC=C(C=C2)O D0W0HN HIGHSTAT Investigative D0W0IX DRUG__ID D0W0IX D0W0IX DRUGTYPE Small molecular drug D0W0IX DRUGINCH 1S/C17H12O4S/c1-11-6-8-12(9-7-11)22(20,21)16-10-15(18)13-4-2-3-5-14(13)17(16)19/h2-10H,1H3 D0W0IX DRUGINKE UCFUGRHGHVYUOA-UHFFFAOYSA-N D0W0IX DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)C2=CC(=O)C3=CC=CC=C3C2=O D0W0IX HIGHSTAT Investigative D0W0LG DRUG__ID D0W0LG D0W0LG DRUGTYPE Small molecular drug D0W0LG DRUGINCH 1S/C18H18O5/c1-2-3-12-13(20)8-14(21)17-15(22)9-16(23-18(12)17)10-4-6-11(19)7-5-10/h4-8,16,19-21H,2-3,9H2,1H3/t16-/m0/s1 D0W0LG DRUGINKE PFCDDRUHZAMKHP-INIZCTEOSA-N D0W0LG DRUGSMIL CCCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D0W0LG HIGHSTAT Investigative D0W0MD DRUG__ID D0W0MD D0W0MD DRUGCOMP Microbiotix Inc D0W0MD DRUGINCH 1S/C16H25NO.ClH/c1-2-15-9-5-6-10-16(15)18-14-13-17-11-7-3-4-8-12-17;/h5-6,9-10H,2-4,7-8,11-14H2,1H3;1H D0W0MD DRUGINKE JMIAUPZSIMYFEG-UHFFFAOYSA-N D0W0MD DRUGSMIL CCC1=CC=CC=C1OCCN2CCCCCC2.Cl D0W0MD HIGHSTAT Investigative D0W0NE DRUG__ID D0W0NE D0W0NE DRUGTYPE Small molecular drug D0W0NE DRUGINCH 1S/C7H9N5O2/c8-7-11-5-4(6(14)12-7)10-3(2-13)1-9-5/h13H,1-2H2,(H4,8,9,11,12,14) D0W0NE DRUGINKE CQQNNQTXUGLUEV-UHFFFAOYSA-N D0W0NE DRUGSMIL C1C(=NC2=C(N1)N=C(NC2=O)N)CO D0W0NE HIGHSTAT Investigative D0W0NJ DRUG__ID D0W0NJ D0W0NJ DRUGTYPE Small molecular drug D0W0NJ DRUGINCH 1S/C18H14ClN5O3S/c1-11-22-17-16(18(25)23(11)13-4-2-12(19)3-5-13)10-21-24(17)14-6-8-15(9-7-14)28(20,26)27/h2-10H,1H3,(H2,20,26,27) D0W0NJ DRUGINKE VRNFEVMRDQNBHD-UHFFFAOYSA-N D0W0NJ DRUGSMIL CC1=NC2=C(C=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(=O)N1C4=CC=C(C=C4)Cl D0W0NJ HIGHSTAT Investigative D0W0OJ DRUG__ID D0W0OJ D0W0OJ DRUGTYPE Small molecular drug D0W0OJ DRUGINCH 1S/C7H5ClN2/c8-6-2-1-5-4-9-10-7(5)3-6/h1-4H,(H,9,10) D0W0OJ DRUGINKE VUZQHUVRBPILAX-UHFFFAOYSA-N D0W0OJ DRUGSMIL C1=CC2=C(C=C1Cl)NN=C2 D0W0OJ HIGHSTAT Investigative D0W0PF DRUG__ID D0W0PF D0W0PF DRUGTYPE Small molecular drug D0W0PF DRUGINCH 1S/C4H4ClN3/c5-3-1-7-2-4(6)8-3/h1-2H,(H2,6,8) D0W0PF DRUGINKE JTPXVCKCLBROOJ-UHFFFAOYSA-N D0W0PF DRUGSMIL C1=C(N=C(C=N1)Cl)N D0W0PF HIGHSTAT Investigative D0W0PH DRUG__ID D0W0PH D0W0PH DRUGTYPE Small molecular drug D0W0PH DRUGINCH 1S/C26H27NO3/c1-29-22-15-11-20(12-16-22)25-24(10-6-9-19-7-4-3-5-8-19)26(28)27(25)21-13-17-23(30-2)18-14-21/h3-5,7-8,11-18,24-25H,6,9-10H2,1-2H3/t24-,25+/m0/s1 D0W0PH DRUGINKE IMNTVVOUWFPRSB-LOSJGSFVSA-N D0W0PH DRUGSMIL COC1=CC=C(C=C1)C2C(C(=O)N2C3=CC=C(C=C3)OC)CCCC4=CC=CC=C4 D0W0PH HIGHSTAT Investigative D0W0QF DRUG__ID D0W0QF D0W0QF DRUGTYPE Small molecular drug D0W0QF DRUGINCH 1S/C17H14N2OS/c1-12-7-9-14(10-8-12)16(20)19-17-18-15(11-21-17)13-5-3-2-4-6-13/h2-11H,1H3,(H,18,19,20) D0W0QF DRUGINKE NERONVMZIDSIRT-UHFFFAOYSA-N D0W0QF DRUGSMIL CC1=CC=C(C=C1)C(=O)NC2=NC(=CS2)C3=CC=CC=C3 D0W0QF HIGHSTAT Investigative D0W0SE DRUG__ID D0W0SE D0W0SE DRUGTYPE Small molecular drug D0W0SE DRUGINCH 1S/C22H23N3O/c26-22(24-20-7-2-1-3-8-20)25-12-10-17(11-13-25)14-18-15-19-6-4-5-9-21(19)23-16-18/h1-9,15-17H,10-14H2,(H,24,26) D0W0SE DRUGINKE BIODYGOZWZNCAG-UHFFFAOYSA-N D0W0SE DRUGSMIL C1CN(CCC1CC2=CC3=CC=CC=C3N=C2)C(=O)NC4=CC=CC=C4 D0W0SE HIGHSTAT Investigative D0W0VK DRUG__ID D0W0VK D0W0VK DRUGTYPE Small molecular drug D0W0VK DRUGINCH 1S/C15H11NO2/c17-14-11-8-4-5-9-12(11)16-15(18)13(14)10-6-2-1-3-7-10/h1-9H,(H2,16,17,18) D0W0VK DRUGINKE WNISVGSZMGXKHE-UHFFFAOYSA-N D0W0VK DRUGSMIL C1=CC=C(C=C1)C2=C(C3=CC=CC=C3NC2=O)O D0W0VK HIGHSTAT Investigative D0W0WL DRUG__ID D0W0WL D0W0WL DRUGTYPE Small molecular drug D0W0WL DRUGINCH 1S/C20H22N2/c1-21-19-13-9-17(10-14-19)7-5-3-4-6-8-18-11-15-20(22-2)16-12-18/h3-16,21-22H,1-2H3/b4-3+,7-5+,8-6+ D0W0WL DRUGINKE SWZSFUMMCHKHMM-OKWWDJPNSA-N D0W0WL DRUGSMIL CNC1=CC=C(C=C1)C=CC=CC=CC2=CC=C(C=C2)NC D0W0WL HIGHSTAT Investigative D0W0XK DRUG__ID D0W0XK D0W0XK DRUGTYPE Small molecular drug D0W0XK DRUGINCH 1S/C8H13NO/c1-2-3-4-5-7-6-9-8(7)10/h2,7H,1,3-6H2,(H,9,10) D0W0XK DRUGINKE ABPZGIHKPZCCMN-UHFFFAOYSA-N D0W0XK DRUGSMIL C=CCCCC1CNC1=O D0W0XK HIGHSTAT Investigative D0W1AW DRUG__ID D0W1AW D0W1AW DRUGTYPE Small molecular drug D0W1AW DRUGINCH 1S/C11H16OS2.K/c13-11(14)12-10-5-6-4-9(10)8-3-1-2-7(6)8;/h6-10H,1-5H2,(H,13,14);/q;+1/p-1 D0W1AW DRUGINKE IGULCCCBGBDZKQ-UHFFFAOYSA-M D0W1AW DRUGSMIL C1CC2C(C1)C3CC2CC3OC(=S)[S-].[K+] D0W1AW HIGHSTAT Investigative D0W1BE DRUG__ID D0W1BE D0W1BE DRUGTYPE Small molecular drug D0W1BE DRUGINCH 1S/C8H7NO3/c10-8-3-1-7(2-4-8)5-6-9(11)12/h1-6,10H/b6-5+ D0W1BE DRUGINKE CTJKRKMPTRJAIT-AATRIKPKSA-N D0W1BE DRUGSMIL C1=CC(=CC=C1C=C[N+](=O)[O-])O D0W1BE HIGHSTAT Investigative D0W1CC DRUG__ID D0W1CC D0W1CC DRUGTYPE Small molecular drug D0W1CC DRUGINCH 1S/C13H19NO3/c1-15-11-6-10-8(7-14)4-5-9(10)12(16-2)13(11)17-3/h6,8H,4-5,7,14H2,1-3H3/t8-/m0/s1 D0W1CC DRUGINKE AFTIZGHFDCOQFS-QMMMGPOBSA-N D0W1CC DRUGSMIL COC1=C(C(=C2CCC(C2=C1)CN)OC)OC D0W1CC HIGHSTAT Investigative D0W1FM DRUG__ID D0W1FM D0W1FM DRUGTYPE Small molecular drug D0W1FM DRUGINCH 1S/C22H16N4/c23-13-18-15-24-14-17(10-9-16-5-2-1-3-6-16)22(18)26-21-8-4-7-20-19(21)11-12-25-20/h1-12,14-15,25H,(H,24,26)/b10-9+ D0W1FM DRUGINKE HETWGNHMXYNQPB-MDZDMXLPSA-N D0W1FM DRUGSMIL C1=CC=C(C=C1)C=CC2=CN=CC(=C2NC3=CC=CC4=C3C=CN4)C#N D0W1FM HIGHSTAT Investigative D0W1GH DRUG__ID D0W1GH D0W1GH DRUGTYPE Small molecular drug D0W1GH DRUGINCH 1S/C6H16O18P4/c7-1-2(8)4(22-26(12,13)14)6(24-28(18,19)20)5(23-27(15,16)17)3(1)21-25(9,10)11/h1-8H,(H2,9,10,11)(H2,12,13,14)(H2,15,16,17)(H2,18,19,20)/t1-,2+,3-,4-,5+,6+/m0/s1 D0W1GH DRUGINKE MRVYFOANPDTYBY-UZAAGFTCSA-N D0W1GH DRUGSMIL C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O)O D0W1GH HIGHSTAT Investigative D0W1GR DRUG__ID D0W1GR D0W1GR DRUGTYPE Small molecular drug D0W1GR DRUGINCH 1S/C10H14N2/c1-2-3-4-5-6-7-10-8-11-9-12-10/h8-9H,2-3,6-7H2,1H3,(H,11,12) D0W1GR DRUGINKE UDXIRDIVFQGLKT-UHFFFAOYSA-N D0W1GR DRUGSMIL CCCC#CCCC1=CN=CN1 D0W1GR HIGHSTAT Investigative D0W1HM DRUG__ID D0W1HM D0W1HM DRUGTYPE Small molecular drug D0W1HM DRUGINCH 1S/C22H27N3O2/c1-3-4-11-25-12-7-8-17(25)15-24-22(26)20-13-16(14-23)18-9-5-6-10-19(18)21(20)27-2/h5-6,9-10,13,17H,3-4,7-8,11-12,15H2,1-2H3,(H,24,26) D0W1HM DRUGINKE IDZASIQMRGPBCQ-UHFFFAOYSA-N D0W1HM DRUGSMIL CCCCN1CCCC1CNC(=O)C2=C(C3=CC=CC=C3C(=C2)C#N)OC D0W1HM HIGHSTAT Investigative D0W1HZ DRUG__ID D0W1HZ D0W1HZ DRUGTYPE Small molecular drug D0W1HZ DRUGINCH 1S/C39H38INO11/c1-47-27-10-7-25(8-11-27)37(44)28(36(39(45)46)26-9-13-31-32(21-26)52-22-51-31)17-24-19-33(48-2)38(49-3)34(20-24)50-16-4-5-35(43)41-15-14-23-6-12-30(42)29(40)18-23/h6-13,18-21,42H,4-5,14-17,22H2,1-3H3,(H,41,43)(H,45,46)/b36-28- D0W1HZ DRUGINKE LKWYYULZSFFLFK-DKJXEYTPSA-N D0W1HZ DRUGSMIL COC1=CC=C(C=C1)C(=O)C(=C(C2=CC3=C(C=C2)OCO3)C(=O)O)CC4=CC(=C(C(=C4)OCCCC(=O)NCCC5=CC(=C(C=C5)O)I)OC)OC D0W1HZ HIGHSTAT Investigative D0W1JY DRUG__ID D0W1JY D0W1JY DRUGTYPE Small molecular drug D0W1JY DRUGINCH 1S/C8H7NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5H,1H3 D0W1JY DRUGINKE URNSECGXFRDEDC-UHFFFAOYSA-N D0W1JY DRUGSMIL CC(=O)N=C1C=CC(=O)C=C1 D0W1JY HIGHSTAT Investigative D0W1NH DRUG__ID D0W1NH D0W1NH DRUGTYPE Small molecular drug D0W1NH DRUGINCH 1S/C4H5NO2S2/c5-9(6,7)4-2-1-3-8-4/h1-3H,(H2,5,6,7) D0W1NH DRUGINKE KTFDYVNEGTXQCV-UHFFFAOYSA-N D0W1NH DRUGSMIL C1=CSC(=C1)S(=O)(=O)N D0W1NH HIGHSTAT Investigative D0W1OQ DRUG__ID D0W1OQ D0W1OQ DRUGTYPE Small molecular drug D0W1OQ DRUGINCH 1S/C30H46O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h8,18,21-24,31H,2,9-17H2,1,3-7H3,(H,32,33)/t18-,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1 D0W1OQ DRUGINKE VPMTUSRUIJFRMW-XCYSCKFXSA-N D0W1OQ DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1=C)C)C(=O)O D0W1OQ HIGHSTAT Investigative D0W1OR DRUG__ID D0W1OR D0W1OR DRUGTYPE Small molecular drug D0W1OR DRUGINCH 1S/C7H6O4/c8-5-1-4(7(10)11)2-6(9)3-5/h1-3,8-9H,(H,10,11) D0W1OR DRUGINKE UYEMGAFJOZZIFP-UHFFFAOYSA-N D0W1OR DRUGSMIL C1=C(C=C(C=C1O)O)C(=O)O D0W1OR HIGHSTAT Investigative D0W1OX DRUG__ID D0W1OX D0W1OX DRUGTYPE Small molecular drug D0W1OX DRUGINCH 1S/C19H21NO2/c21-19(22-18-12-5-2-6-13-18)20-17-11-7-10-16(14-17)15-8-3-1-4-9-15/h1,3-4,7-11,14,18H,2,5-6,12-13H2,(H,20,21) D0W1OX DRUGINKE HHVUFQYJOSFTEH-UHFFFAOYSA-N D0W1OX DRUGSMIL C1CCC(CC1)OC(=O)NC2=CC=CC(=C2)C3=CC=CC=C3 D0W1OX HIGHSTAT Investigative D0W1PF DRUG__ID D0W1PF D0W1PF DRUGTYPE Small molecular drug D0W1PF DRUGINCH 1S/C21H19N3/c1-14(2)20-23-19-17(15-9-5-3-6-10-15)13-18(22-21(19)24-20)16-11-7-4-8-12-16/h3-14H,1-2H3,(H,22,23,24) D0W1PF DRUGINKE REXYMDQLBZWOMA-UHFFFAOYSA-N D0W1PF DRUGSMIL CC(C)C1=NC2=C(N1)C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4 D0W1PF HIGHSTAT Investigative D0W1PV DRUG__ID D0W1PV D0W1PV DRUGTYPE Small molecular drug D0W1PV DRUGINCH 1S/C34H49N5O6/c1-5-22(3)30-34(44)38-19-13-12-18-29(38)33(43)35-26(16-9-7-8-14-24(40)6-2)31(41)36-27(32(42)37-30)20-23-21-39(45-4)28-17-11-10-15-25(23)28/h10-11,15,17,21-22,26-27,29-30H,5-9,12-14,16,18-20H2,1-4H3,(H,35,43)(H,36,41)(H,37,42)/t22-,26-,27-,29+,30-/m0/s1 D0W1PV DRUGINKE JWOGUUIOCYMBPV-GMFLJSBRSA-N D0W1PV DRUGSMIL CCC(C)C1C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)N1)CC3=CN(C4=CC=CC=C43)OC)CCCCCC(=O)CC D0W1PV HIGHSTAT Investigative D0W1SM DRUG__ID D0W1SM D0W1SM DRUGTYPE Small molecular drug D0W1SM DRUGINCH 1S/C42H58N12O8/c1-2-3-13-29-37(58)52-31(16-18-34(43)55)39(60)53-32(21-24-10-5-4-6-11-24)40(61)51-30(15-9-20-47-42(45)46)38(59)54-33(22-25-23-48-27-14-8-7-12-26(25)27)41(62)50-28(36(44)57)17-19-35(56)49-29/h4-8,10-12,14,23,28-33,48H,2-3,9,13,15-22H2,1H3,(H2,43,55)(H2,44,57)(H,49,56)(H,50,62)(H,51,61)(H,52,58)(H,53,60)(H,54,59)(H4,45,46,47)/t28-,29-,30-,31+,32+,33-/m0/s1 D0W1SM DRUGINKE RNMRQCPIALKVBK-HSPZZYPGSA-N D0W1SM DRUGSMIL CCCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCC(=O)N1)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CCC(=O)N D0W1SM HIGHSTAT Investigative D0W1SP DRUG__ID D0W1SP D0W1SP DRUGTYPE Small molecular drug D0W1SP DRUGINCH 1S/C20H27NO3/c1-2-3-4-5-6-7-8-11-14-21-18-13-10-9-12-16(18)17(20(21)24)15-19(22)23/h9-10,12-13,15H,2-8,11,14H2,1H3,(H,22,23)/b17-15- D0W1SP DRUGINKE LIUQXAWYSKFADK-ICFOKQHNSA-N D0W1SP DRUGSMIL CCCCCCCCCCN1C2=CC=CC=C2C(=CC(=O)O)C1=O D0W1SP HIGHSTAT Investigative D0W1ST DRUG__ID D0W1ST D0W1ST DRUGTYPE Small molecular drug D0W1ST DRUGINCH 1S/C17H15NO3/c19-15-11-16(18-7-9-20-10-8-18)21-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2 D0W1ST DRUGINKE KKTZALUTXUZPSN-UHFFFAOYSA-N D0W1ST DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0W1ST HIGHSTAT Investigative D0W1SX DRUG__ID D0W1SX D0W1SX DRUGTYPE Small molecular drug D0W1SX DRUGINCH 1S/C13H11BrN2O/c1-9-4-2-7-12(15-9)16-13(17)10-5-3-6-11(14)8-10/h2-8H,1H3,(H,15,16,17) D0W1SX DRUGINKE BOCBDQIZNZCOPX-UHFFFAOYSA-N D0W1SX DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=CC(=CC=C2)Br D0W1SX HIGHSTAT Investigative D0W1VL DRUG__ID D0W1VL D0W1VL DRUGTYPE Small molecular drug D0W1VL DRUGINCH 1S/C19H14N2S/c1-2-8-15(9-3-1)18-13-22-19(21-18)20-17-12-6-10-14-7-4-5-11-16(14)17/h1-13H,(H,20,21) D0W1VL DRUGINKE JWZVJRBKXQFLBH-UHFFFAOYSA-N D0W1VL DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC3=CC=CC4=CC=CC=C43 D0W1VL HIGHSTAT Investigative D0W1WE DRUG__ID D0W1WE D0W1WE DRUGTYPE Small molecular drug D0W1WE DRUGINCH 1S/C17H13NO3/c1-18(13-8-3-2-4-9-13)16(19)14-11-12-7-5-6-10-15(12)21-17(14)20/h2-11H,1H3 D0W1WE DRUGINKE JRUWEFVSUSZZHI-UHFFFAOYSA-N D0W1WE DRUGSMIL CN(C1=CC=CC=C1)C(=O)C2=CC3=CC=CC=C3OC2=O D0W1WE HIGHSTAT Investigative D0W1WF DRUG__ID D0W1WF D0W1WF DRUGTYPE Small molecular drug D0W1WF DRUGINCH 1S/C10H7IN2/c11-10-6-9(12-7-13-10)8-4-2-1-3-5-8/h1-7H D0W1WF DRUGINKE ZTCJXHNJVLUUMR-UHFFFAOYSA-N D0W1WF DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC=N2)I D0W1WF HIGHSTAT Investigative D0W1WQ DRUG__ID D0W1WQ D0W1WQ DRUGTYPE Small molecular drug D0W1WQ DRUGINCH 1S/C14H20O/c1-10(2)9-13-5-7-14(8-6-13)11(3)12(4)15/h5-8,10-11H,9H2,1-4H3/t11-/m0/s1 D0W1WQ DRUGINKE VOYZJYGIHFRNAG-NSHDSACASA-N D0W1WQ DRUGSMIL CC(C)CC1=CC=C(C=C1)C(C)C(=O)C D0W1WQ HIGHSTAT Investigative D0W1YD DRUG__ID D0W1YD D0W1YD DRUGTYPE Small molecular drug D0W1YD DRUGINCH 1S/C32H45N7O10/c1-18(2)13-23(31(46)38-27(19(3)41)32(47)48)36-30(45)24(15-20-7-5-4-6-8-20)35-26(42)16-34-29(44)25(17-40)37-28(43)22(33)14-21-9-11-39(49)12-10-21/h4-12,18-19,22-25,27,40-41H,13-17,33H2,1-3H3,(H,34,44)(H,35,42)(H,36,45)(H,37,43)(H,38,46)(H,47,48)/t19-,22+,23+,24+,25+,27+/m1/s1 D0W1YD DRUGINKE PDLKKPWJIQINFZ-GQHROEFJSA-N D0W1YD DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)C(CO)NC(=O)C(CC2=CC=[N+](C=C2)[O-])N D0W1YD HIGHSTAT Investigative D0W1YI DRUG__ID D0W1YI D0W1YI DRUGTYPE Small molecular drug D0W1YI DRUGINCH 1S/C16H16F3NO2S/c1-10-7-11(2)15(12(3)8-10)23(21,22)20-14-6-4-5-13(9-14)16(17,18)19/h4-9,20H,1-3H3 D0W1YI DRUGINKE ZIIUUSVHCHPIQD-UHFFFAOYSA-N D0W1YI DRUGSMIL CC1=CC(=C(C(=C1)C)S(=O)(=O)NC2=CC=CC(=C2)C(F)(F)F)C D0W1YI HIGHSTAT Investigative D0W1YT DRUG__ID D0W1YT D0W1YT DRUGTYPE Small molecular drug D0W1YT DRUGINCH 1S/C16H10ClNO3/c17-15-11-5-8(19)2-4-13(11)18-16-10-3-1-9(20)6-14(10)21-7-12(15)16/h1-6,19-20H,7H2 D0W1YT DRUGINKE RYBHKLZSHRZGQK-UHFFFAOYSA-N D0W1YT DRUGSMIL C1C2=C(C3=C(C=CC(=C3)O)N=C2C4=C(O1)C=C(C=C4)O)Cl D0W1YT HIGHSTAT Investigative D0W1ZW DRUG__ID D0W1ZW D0W1ZW DRUGTYPE Small molecular drug D0W1ZW DRUGINCH 1S/C19H32NO4P/c1-2-3-4-5-6-7-9-16-10-8-11-17(12-16)18-13-19(20,14-18)15-24-25(21,22)23/h8,10-12,18H,2-7,9,13-15,20H2,1H3,(H2,21,22,23) D0W1ZW DRUGINKE LNMFICMTNRORPU-UHFFFAOYSA-N D0W1ZW DRUGSMIL CCCCCCCCC1=CC(=CC=C1)C2CC(C2)(COP(=O)(O)O)N D0W1ZW HIGHSTAT Investigative D0W2BI DRUG__ID D0W2BI D0W2BI DRUGTYPE Small molecular drug D0W2BI DRUGINCH 1S/C20H18O7/c1-9(2)3-5-11-13(22)8-15(24)16-17(25)18(26)19(27-20(11)16)10-4-6-12(21)14(23)7-10/h3-4,6-8,21-24,26H,5H2,1-2H3 D0W2BI DRUGINKE ZHTTWVRMGWQEOH-UHFFFAOYSA-N D0W2BI DRUGSMIL CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC(=C(C=C3)O)O)O)C D0W2BI HIGHSTAT Investigative D0W2BP DRUG__ID D0W2BP D0W2BP DRUGTYPE Small molecular drug D0W2BP DRUGINCH 1S/C19H15ClN2O/c20-18-8-6-15(7-9-18)16-10-17(13-21-12-16)19(23)22-11-14-4-2-1-3-5-14/h1-10,12-13H,11H2,(H,22,23) D0W2BP DRUGINKE FWHXSLFSGPLDBM-UHFFFAOYSA-N D0W2BP DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CN=CC(=C2)C3=CC=C(C=C3)Cl D0W2BP HIGHSTAT Investigative D0W2DN DRUG__ID D0W2DN D0W2DN DRUGTYPE Small molecular drug D0W2DN DRUGINCH 1S/C28H34N2O2/c31-27(29-18-20-6-2-1-3-7-20)32-23-12-11-22-16-26-24-8-4-5-13-28(24,25(22)17-23)14-15-30(26)19-21-9-10-21/h1-3,6-7,11-12,17,21,24,26H,4-5,8-10,13-16,18-19H2,(H,29,31) D0W2DN DRUGINKE VSBFHNWLJXFFTK-UHFFFAOYSA-N D0W2DN DRUGSMIL C1CCC23CCN(C(C2C1)CC4=C3C=C(C=C4)OC(=O)NCC5=CC=CC=C5)CC6CC6 D0W2DN HIGHSTAT Investigative D0W2EX DRUG__ID D0W2EX D0W2EX DRUGTYPE Small molecular drug D0W2EX DRUGINCH 1S/C11H15NO2S/c12-10(11(13)14)6-7-15-8-9-4-2-1-3-5-9/h1-5,10H,6-8,12H2,(H,13,14)/t10-/m0/s1 D0W2EX DRUGINKE KIPDMPPOTUGMPW-JTQLQIEISA-N D0W2EX DRUGSMIL C1=CC=C(C=C1)CSCCC(C(=O)O)N D0W2EX HIGHSTAT Investigative D0W2FU DRUG__ID D0W2FU D0W2FU DRUGTYPE Small molecular drug D0W2FU DRUGINCH 1S/C23H25N3O4S2/c1-16-6-12-19(13-7-16)32(28,29)26-14-4-3-5-21(26)22(27)25-23-24-20(15-31-23)17-8-10-18(30-2)11-9-17/h6-13,15,21H,3-5,14H2,1-2H3,(H,24,25,27)/t21-/m1/s1 D0W2FU DRUGINKE OXQNLLVUVDAEHC-OAQYLSRUSA-N D0W2FU DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCCCC2C(=O)NC3=NC(=CS3)C4=CC=C(C=C4)OC D0W2FU HIGHSTAT Investigative D0W2GG DRUG__ID D0W2GG D0W2GG DRUGTYPE Small molecular drug D0W2GG DRUGINCH 1S/C18H13ClN4O2S/c1-9-6-20-14-12(25-9)7-21-17-13(14)15-16(26-17)18(24)23(8-22-15)11-4-2-10(19)3-5-11/h2-5,7-9,20H,6H2,1H3/t9-/m1/s1 D0W2GG DRUGINKE LFUPTQIEOBBAJE-SECBINFHSA-N D0W2GG DRUGSMIL CC1CNC2=C3C4=C(C(=O)N(C=N4)C5=CC=C(C=C5)Cl)SC3=NC=C2O1 D0W2GG HIGHSTAT Investigative D0W2HJ DRUG__ID D0W2HJ D0W2HJ DRUGTYPE Small molecular drug D0W2HJ DRUGINCH 1S/C13H19NO/c1-15-13-6-4-12(5-7-13)8-11-14-9-2-3-10-14/h4-7H,2-3,8-11H2,1H3 D0W2HJ DRUGINKE JMIPWGFKCQDIBK-UHFFFAOYSA-N D0W2HJ DRUGSMIL COC1=CC=C(C=C1)CCN2CCCC2 D0W2HJ HIGHSTAT Investigative D0W2HW DRUG__ID D0W2HW D0W2HW DRUGTYPE Small molecular drug D0W2HW DRUGINCH 1S/C14H20N2/c1-3-16(4-2)10-9-12-11-15-14-8-6-5-7-13(12)14/h5-8,11,15H,3-4,9-10H2,1-2H3 D0W2HW DRUGINKE LSSUMOWDTKZHHT-UHFFFAOYSA-N D0W2HW DRUGSMIL CCN(CC)CCC1=CNC2=CC=CC=C21 D0W2HW HIGHSTAT Investigative D0W2OP DRUG__ID D0W2OP D0W2OP DRUGTYPE Small molecular drug D0W2OP DRUGINCH 1S/C15H17NO/c16-10-11-17-15-8-6-14(7-9-15)12-13-4-2-1-3-5-13/h1-9H,10-12,16H2 D0W2OP DRUGINKE MJTXDDKAEQAMNA-UHFFFAOYSA-N D0W2OP DRUGSMIL C1=CC=C(C=C1)CC2=CC=C(C=C2)OCCN D0W2OP HIGHSTAT Investigative D0W2PQ DRUG__ID D0W2PQ D0W2PQ DRUGTYPE Small molecular drug D0W2PQ DRUGINCH 1S/C16H13BrN2O3/c1-2-15(21)18-12-6-7-13(14(20)9-12)16(22)19-11-5-3-4-10(17)8-11/h2-9,20H,1H2,(H,18,21)(H,19,22) D0W2PQ DRUGINKE RVPAGQILSYDDNT-UHFFFAOYSA-N D0W2PQ DRUGSMIL C=CC(=O)NC1=CC(=C(C=C1)C(=O)NC2=CC(=CC=C2)Br)O D0W2PQ HIGHSTAT Investigative D0W2PX DRUG__ID D0W2PX D0W2PX DRUGTYPE Small molecular drug D0W2PX DRUGINCH 1S/C20H18N2O2/c1-24-17-10-7-14(8-11-17)16-9-12-18(21)19(13-16)22-20(23)15-5-3-2-4-6-15/h2-13H,21H2,1H3,(H,22,23) D0W2PX DRUGINKE YOKIWEOZLFOUFK-UHFFFAOYSA-N D0W2PX DRUGSMIL COC1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CC=CC=C3 D0W2PX HIGHSTAT Investigative D0W2PZ DRUG__ID D0W2PZ D0W2PZ DRUGCOMP Korea Institute of Science and Technology D0W2PZ DRUGINCH 1S/C82H154N34O24/c1-43(2)63(115-74(134)50(21-8-13-31-85)107-60(122)38-99-59(121)37-101-69(129)55(27-28-58(89)120)110-72(132)49(20-7-12-30-84)106-62(124)40-102-68(128)48(24-16-34-96-80(90)91)105-61(123)39-100-67(127)47(88)19-6-11-29-83)77(137)111-53(25-17-35-97-81(92)93)71(131)104-44(3)65(125)108-51(22-9-14-32-86)70(130)103-45(4)66(126)109-52(23-10-15-33-87)75(135)116-64(46(5)119)78(138)112-54(26-18-36-98-82(94)95)73(133)113-56(41-117)76(136)114-57(42-118)79(139)140/h43-57,63-64,117-119H,6-42,83-88H2,1-5H3,(H2,89,120)(H,99,121)(H,100,127)(H,101,129)(H,102,128)(H,103,130)(H,104,131)(H,105,123)(H,106,124)(H,107,122)(H,108,125)(H,109,126)(H,110,132)(H,111,137)(H,112,138)(H,113,133)(H,114,136)(H,115,134)(H,116,135)(H,139,140)(H4,90,91,96)(H4,92,93,97)(H4,94,95,98)/t44-,45-,46+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-,64-/m0/s1 D0W2PZ DRUGINKE NFEQUGKCQWAGLY-UAAVROCESA-N D0W2PZ DRUGSMIL CC(C)C(C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NC(CO)C(=O)O)NC(=O)C(CCCCN)NC(=O)CNC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)CNC(=O)C(CCCCN)N D0W2PZ HIGHSTAT Investigative D0W2QN DRUG__ID D0W2QN D0W2QN DRUGTYPE Small molecular drug D0W2QN DRUGINCH 1S/C16H22N2O/c1-3-14-16(11-6-8-17-9-7-11)13-10-12(19-2)4-5-15(13)18-14/h4-5,10-11,17-18H,3,6-9H2,1-2H3 D0W2QN DRUGINKE UMTBQNCFQQORNJ-UHFFFAOYSA-N D0W2QN DRUGSMIL CCC1=C(C2=C(N1)C=CC(=C2)OC)C3CCNCC3 D0W2QN HIGHSTAT Investigative D0W2SV DRUG__ID D0W2SV D0W2SV DRUGTYPE Small molecular drug D0W2SV DRUGINCH 1S/C27H42N12O5S/c1-14(36-24(44)18(10-11-20(29)40)38-23(43)15(28)6-4-12-34-26(30)31)22(42)37-17(8-5-13-35-27(32)33)21(41)25-39-16-7-2-3-9-19(16)45-25/h2-3,7,9,14-15,17-18H,4-6,8,10-13,28H2,1H3,(H2,29,40)(H,36,44)(H,37,42)(H,38,43)(H4,30,31,34)(H4,32,33,35)/t14-,15-,17-,18-/m0/s1 D0W2SV DRUGINKE JRNGHBUUFQDBPT-LAQRGFTBSA-N D0W2SV DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)C1=NC2=CC=CC=C2S1)NC(=O)C(CCC(=O)N)NC(=O)C(CCCN=C(N)N)N D0W2SV HIGHSTAT Investigative D0W2TQ DRUG__ID D0W2TQ D0W2TQ DRUGTYPE Small molecular drug D0W2TQ DRUGINCH 1S/C14H24N3O8P/c1-9-13(18)11(10(6-16-9)8-25-26(21,22)23)7-17-12(14(19)20)2-4-24-5-3-15/h2,4,9,12,16-17H,3,5-8,15H2,1H3,(H,19,20)(H2,21,22,23)/b4-2+ D0W2TQ DRUGINKE YUVPJAIAVDYTLF-DUXPYHPUSA-N D0W2TQ DRUGSMIL CC1C(=O)C(=C(CN1)COP(=O)(O)O)CNC(C=COCCN)C(=O)O D0W2TQ HIGHSTAT Investigative D0W2UK DRUG__ID D0W2UK D0W2UK DRUGTYPE Small molecular drug D0W2UK DRUGINCH 1S/C25H27N3O4/c1-16-14-18(21-6-4-5-7-22(21)26-16)15-32-20-10-8-19(9-11-20)25(3)12-13-28(24(25)30)17(2)23(29)27-31/h4-11,14,17,31H,12-13,15H2,1-3H3,(H,27,29)/t17-,25+/m1/s1 D0W2UK DRUGINKE YDMIPBHQKFOFQW-NSYGIPOTSA-N D0W2UK DRUGSMIL CC1=NC2=CC=CC=C2C(=C1)COC3=CC=C(C=C3)C4(CCN(C4=O)C(C)C(=O)NO)C D0W2UK HIGHSTAT Investigative D0W2XO DRUG__ID D0W2XO D0W2XO DRUGTYPE Small molecular drug D0W2XO DRUGINCH 1S/C4H4O4.2Na/c5-3(6)1-2-4(7)8;;/h1-2H,(H,5,6)(H,7,8);;/q;2*+1/p-2/b2-1-;; D0W2XO DRUGINKE MSJMDZAOKORVFC-UAIGNFCESA-L D0W2XO DRUGSMIL C(=CC(=O)[O-])C(=O)[O-].[Na+].[Na+] D0W2XO HIGHSTAT Investigative D0W2YN DRUG__ID D0W2YN D0W2YN DRUGTYPE Small molecular drug D0W2YN DRUGINCH 1S/C14H16N2/c1-2-4-13-11-14(6-5-12(13)3-1)16-9-7-15-8-10-16/h1-6,11,15H,7-10H2 D0W2YN DRUGINKE LWLBVIFUVSUSAY-UHFFFAOYSA-N D0W2YN DRUGSMIL C1CN(CCN1)C2=CC3=CC=CC=C3C=C2 D0W2YN HIGHSTAT Investigative D0W2YR DRUG__ID D0W2YR D0W2YR DRUGTYPE Small molecular drug D0W2YR DRUGINCH 1S/C13H9NO4/c15-7-4-5-11-9(6-7)14-13(18-11)8-2-1-3-10(16)12(8)17/h1-6,15-17H D0W2YR DRUGINKE XVMUZRUUMXAORF-UHFFFAOYSA-N D0W2YR DRUGSMIL C1=CC(=C(C(=C1)O)O)C2=NC3=C(O2)C=CC(=C3)O D0W2YR HIGHSTAT Investigative D0W2ZM DRUG__ID D0W2ZM D0W2ZM DRUGTYPE Small molecular drug D0W2ZM DRUGINCH 1S/C15H12N2O/c1-11-17-14(12-5-3-2-4-6-12)15(18-11)13-7-9-16-10-8-13/h2-10H,1H3 D0W2ZM DRUGINKE BHWCZLOXTLWZAQ-UHFFFAOYSA-N D0W2ZM DRUGSMIL CC1=NC(=C(O1)C2=CC=NC=C2)C3=CC=CC=C3 D0W2ZM HIGHSTAT Investigative D0W3BX DRUG__ID D0W3BX D0W3BX DRUGTYPE Small molecular drug D0W3BX DRUGINCH 1S/C17H12N2/c1-2-6-12(7-3-1)17-18-11-14-10-13-8-4-5-9-15(13)16(14)19-17/h1-9,11H,10H2 D0W3BX DRUGINKE GOMPLLCNQNCUNU-UHFFFAOYSA-N D0W3BX DRUGSMIL C1C2=CC=CC=C2C3=NC(=NC=C31)C4=CC=CC=C4 D0W3BX HIGHSTAT Investigative D0W3FF DRUG__ID D0W3FF D0W3FF DRUGTYPE Small molecular drug D0W3FF DRUGINCH 1S/C17H11NO3/c19-10-5-7-14-16(9-10)21-17(18-14)13-6-8-15(20)12-4-2-1-3-11(12)13/h1-9,19-20H D0W3FF DRUGINKE JOCGYNKOMBFRII-UHFFFAOYSA-N D0W3FF DRUGSMIL C1=CC=C2C(=C1)C(=CC=C2O)C3=NC4=C(O3)C=C(C=C4)O D0W3FF HIGHSTAT Investigative D0W3FQ DRUG__ID D0W3FQ D0W3FQ DRUGTYPE Small molecular drug D0W3FQ DRUGINCH 1S/C15H9NO4/c17-13-9-15(10-4-2-1-3-5-10)20-14-7-6-11(16(18)19)8-12(13)14/h1-9H D0W3FQ DRUGINKE ZDFHPVOEUNRYMP-UHFFFAOYSA-N D0W3FQ DRUGSMIL C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)[N+](=O)[O-] D0W3FQ HIGHSTAT Investigative D0W3LG DRUG__ID D0W3LG D0W3LG DRUGTYPE Small molecular drug D0W3LG DRUGINCH 1S/C25H26O6/c1-13(2)5-7-15-11-16(8-10-18(15)26)24-23(30)22(29)21-20(28)12-19(27)17(25(21)31-24)9-6-14(3)4/h5-6,8,10-12,26-28,30H,7,9H2,1-4H3 D0W3LG DRUGINKE KNMMNUQOUANAJS-UHFFFAOYSA-N D0W3LG DRUGSMIL CC(=CCC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C(=C3O2)CC=C(C)C)O)O)O)O)C D0W3LG HIGHSTAT Investigative D0W3LM DRUG__ID D0W3LM D0W3LM DRUGTYPE Small molecular drug D0W3LM DRUGINCH 1S/C16H14O4/c1-19-12-6-7-13-14(18)9-15(20-16(13)8-12)10-2-4-11(17)5-3-10/h2-8,15,17H,9H2,1H3 D0W3LM DRUGINKE OJOSVTQXBSSCMQ-UHFFFAOYSA-N D0W3LM DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=C(C=C3)O D0W3LM HIGHSTAT Investigative D0W3ME DRUG__ID D0W3ME D0W3ME DRUGTYPE Small molecular drug D0W3ME DRUGINCH 1S/C13H10F5N5O2S2/c1-19-10(24)4(20-11(25)21-12-22-23-13(26)27-12)2-3-5(14)7(16)9(18)8(17)6(3)15/h4H,2H2,1H3,(H,19,24)(H,23,26)(H2,20,21,22,25)/t4-/m0/s1 D0W3ME DRUGINKE HZAXNPDJVFUGDS-BYPYZUCNSA-N D0W3ME DRUGSMIL CNC(=O)C(CC1=C(C(=C(C(=C1F)F)F)F)F)NC(=O)NC2=NNC(=S)S2 D0W3ME HIGHSTAT Investigative D0W3MT DRUG__ID D0W3MT D0W3MT DRUGTYPE Small molecular drug D0W3MT DRUGINCH 1S/C20H18N4/c1-2-9-16-21-18-17(14-10-5-3-6-11-14)23-19(24-20(18)22-16)15-12-7-4-8-13-15/h3-8,10-13H,2,9H2,1H3,(H,21,22,23,24) D0W3MT DRUGINKE LIJDFWULFIYULY-UHFFFAOYSA-N D0W3MT DRUGSMIL CCCC1=NC2=NC(=NC(=C2N1)C3=CC=CC=C3)C4=CC=CC=C4 D0W3MT HIGHSTAT Investigative D0W3NA DRUG__ID D0W3NA D0W3NA DRUGTYPE Small molecular drug D0W3NA DRUGINCH 1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/t11-,14-,15-,16+,20-/m1/s1 D0W3NA DRUGINKE RGJOEKWQDUBAIZ-IBOSZNHHSA-N D0W3NA DRUGSMIL CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O D0W3NA HIGHSTAT Investigative D0W3ON DRUG__ID D0W3ON D0W3ON DRUGTYPE Small molecular drug D0W3ON DRUGINCH 1S/C9H8N2O/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12H,10H2 D0W3ON DRUGINKE YDEUKNRKEYICTH-UHFFFAOYSA-N D0W3ON DRUGSMIL C1=CC2=C(C=CC(=C2N=C1)O)N D0W3ON HIGHSTAT Investigative D0W3OY DRUG__ID D0W3OY D0W3OY DRUGTYPE Small molecular drug D0W3OY DRUGINCH 1S/C8H9N3O2S.ClH/c9-8(10)14-5-6-1-3-7(4-2-6)11(12)13;/h1-4H,5H2,(H3,9,10);1H D0W3OY DRUGINKE XLXMUFLBCRDKMJ-UHFFFAOYSA-N D0W3OY DRUGSMIL C1=CC(=CC=C1CSC(=N)N)[N+](=O)[O-].Cl D0W3OY HIGHSTAT Investigative D0W3PR DRUG__ID D0W3PR D0W3PR DRUGTYPE Small molecular drug D0W3PR DRUGINCH 1S/C35H40N6O5/c1-22(32(43)38-20-24-8-3-2-4-9-24)39-33(44)30(19-25-21-37-29-11-6-5-10-27(25)29)40-34(45)31-12-7-17-41(31)35(46)28(36)18-23-13-15-26(42)16-14-23/h2-6,8-11,13-16,21-22,28,30-31,37,42H,7,12,17-20,36H2,1H3,(H,38,43)(H,39,44)(H,40,45)/t22-,28+,30+,31+/m1/s1 D0W3PR DRUGINKE IRQJYTHTLNHEDS-QVBNWNEOSA-N D0W3PR DRUGSMIL CC(C(=O)NCC1=CC=CC=C1)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)N D0W3PR HIGHSTAT Investigative D0W3PY DRUG__ID D0W3PY D0W3PY DRUGTYPE Small molecular drug D0W3PY DRUGINCH 1S/C8H11NO6/c9-8(7(14)15)1-3(5(10)11)4(2-8)6(12)13/h3-4H,1-2,9H2,(H,10,11)(H,12,13)(H,14,15)/t3-,4+,8? D0W3PY DRUGINKE FERIKTBTNCSGJS-OBLUMXEWSA-N D0W3PY DRUGSMIL C1C(C(CC1(C(=O)O)N)C(=O)O)C(=O)O D0W3PY HIGHSTAT Investigative D0W3QB DRUG__ID D0W3QB D0W3QB DRUGTYPE Small molecular drug D0W3QB DRUGINCH 1S/C17H15NO2S/c21-15-11-16(18-7-9-19-10-8-18)20-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2 D0W3QB DRUGINKE VNZKDSHSVFSENH-UHFFFAOYSA-N D0W3QB DRUGSMIL C1COCCN1C2=CC(=S)C3=C(O2)C4=CC=CC=C4C=C3 D0W3QB HIGHSTAT Investigative D0W3RE DRUG__ID D0W3RE D0W3RE DRUGTYPE Small molecular drug D0W3RE DRUGINCH 1S/C10H16N5O12P3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(25-10)1-24-30(23,31)27-29(21,22)26-28(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,31)(H2,11,12,13)(H2,18,19,20)/i31+3 D0W3RE DRUGINKE ROYJKVPBJVNHCQ-KUIAXLJASA-N D0W3RE DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=S)(O)OP(=O)(O)OP(=O)(O)O)O)O)N D0W3RE HIGHSTAT Investigative D0W3UL DRUG__ID D0W3UL D0W3UL DRUGTYPE Small molecular drug D0W3UL DRUGINCH 1S/C10H12O2S/c11-10(12)9(7-13)6-8-4-2-1-3-5-8/h1-5,9,13H,6-7H2,(H,11,12)/t9-/m1/s1 D0W3UL DRUGINKE ZUEBVBPVXLQMQR-SECBINFHSA-N D0W3UL DRUGSMIL C1=CC=C(C=C1)CC(CS)C(=O)O D0W3UL HIGHSTAT Investigative D0W3VM DRUG__ID D0W3VM D0W3VM DRUGTYPE Small molecular drug D0W3VM DRUGINCH 1S/C22H22N2O/c1-22(2,3)18-11-13-19(14-12-18)24-21(25)17-9-7-16(8-10-17)20-6-4-5-15-23-20/h4-15H,1-3H3,(H,24,25) D0W3VM DRUGINKE JWPYMHAYISNKIC-UHFFFAOYSA-N D0W3VM DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)C3=CC=CC=N3 D0W3VM HIGHSTAT Investigative D0W3VT DRUG__ID D0W3VT D0W3VT DRUGTYPE Small molecular drug D0W3VT DRUGINCH 1S/C24H24ClNO/c25-22-13-11-21(12-14-22)24(27)15-17-26(18-16-24)23(19-7-3-1-4-8-19)20-9-5-2-6-10-20/h1-14,23,27H,15-18H2 D0W3VT DRUGINKE LTTPWCPNNZPPLF-UHFFFAOYSA-N D0W3VT DRUGSMIL C1CN(CCC1(C2=CC=C(C=C2)Cl)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0W3VT HIGHSTAT Investigative D0W3WW DRUG__ID D0W3WW D0W3WW DRUGTYPE Small molecular drug D0W3WW DRUGINCH 1S/C37H49NO6/c1-6-23(3)37(42)44-34-16-22(2)15-27-9-7-24(4)30(36(27)34)13-11-28-18-29(40)19-35(41)38(28)20-25-8-12-31-26(17-25)10-14-33(43-5)32(31)21-39/h7-10,12,14-15,17,22-24,28-30,34,36,39-40H,6,11,13,16,18-21H2,1-5H3/t22-,23-,24-,28-,29+,30-,34-,36-/m0/s1 D0W3WW DRUGINKE WPVRNXUYVXQXPY-YFAYRSKXSA-N D0W3WW DRUGSMIL CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)N3CC4=CC5=C(C=C4)C(=C(C=C5)OC)CO)O)C D0W3WW HIGHSTAT Investigative D0W3XD DRUG__ID D0W3XD D0W3XD DRUGTYPE Small molecular drug D0W3XD DRUGINCH 1S/C25H21N3O4/c1-31-23-21(24(29)27-28(25(30)32-2)18-13-7-4-8-14-18)19-15-9-10-16-20(19)26-22(23)17-11-5-3-6-12-17/h3-16H,1-2H3,(H,27,29) D0W3XD DRUGINKE JLSTVOPSMZBZSR-UHFFFAOYSA-N D0W3XD DRUGSMIL COC1=C(C2=CC=CC=C2N=C1C3=CC=CC=C3)C(=O)NN(C4=CC=CC=C4)C(=O)OC D0W3XD HIGHSTAT Investigative D0W3XP DRUG__ID D0W3XP D0W3XP DRUGTYPE Small molecular drug D0W3XP DRUGINCH 1S/C22H24O5/c1-10-8-12-9-13-16(19(25)22(5,6)20(26)21(13,3)4)17(24)15(12)18(27-7)14(10)11(2)23/h8-9,24H,1-7H3 D0W3XP DRUGINKE BRECKZGJFRHNPM-UHFFFAOYSA-N D0W3XP DRUGSMIL CC1=CC2=CC3=C(C(=C2C(=C1C(=O)C)OC)O)C(=O)C(C(=O)C3(C)C)(C)C D0W3XP HIGHSTAT Investigative D0W3ZN DRUG__ID D0W3ZN D0W3ZN DRUGTYPE Small molecular drug D0W3ZN DRUGINCH 1S/C20H13FN4O2/c21-16-5-1-13(2-6-16)18-19(14-9-11-22-12-10-14)24-20(23-18)15-3-7-17(8-4-15)25(26)27/h1-12H,(H,23,24) D0W3ZN DRUGINKE BGIYKDUASORTBB-UHFFFAOYSA-N D0W3ZN DRUGSMIL C1=CC(=CC=C1C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)[N+](=O)[O-] D0W3ZN HIGHSTAT Investigative D0W3ZW DRUG__ID D0W3ZW D0W3ZW DRUGTYPE Small molecular drug D0W3ZW DRUGINCH 1S/C9H14N3O9P/c10-4-1-5(13)11-9(16)12(4)8-7(15)6(14)3(21-8)2-20-22(17,18)19/h1,3,6-8,14-15H,2,10H2,(H,11,13,16)(H2,17,18,19)/t3-,6-,7-,8-/m1/s1 D0W3ZW DRUGINKE DUFXRFNPGXQQOI-YXZULKJRSA-N D0W3ZW DRUGSMIL C1=C(N(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O)N D0W3ZW HIGHSTAT Investigative D0W4CN DRUG__ID D0W4CN D0W4CN DRUGTYPE Small molecular drug D0W4CN DRUGINCH 1S/C39H50N7O11P/c1-23(57-58(54,55)56)34(45-37(51)30(42-24(2)47)21-25-10-4-3-5-11-25)39(53)46-19-9-8-14-32(46)38(52)44-31(36(50)43-29(35(41)49)17-18-33(40)48)22-26-15-16-27-12-6-7-13-28(27)20-26/h3-7,10-13,15-16,20,23,29-32,34H,8-9,14,17-19,21-22H2,1-2H3,(H2,40,48)(H2,41,49)(H,42,47)(H,43,50)(H,44,52)(H,45,51)(H2,54,55,56)/t23-,29-,30-,31-,32+,34+/m0/s1 D0W4CN DRUGINKE KZSGJDBAWAUUMC-DHQPFQMDSA-N D0W4CN DRUGSMIL CC(C(C(=O)N1CCCCC1C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C)OP(=O)(O)O D0W4CN HIGHSTAT Investigative D0W4FF DRUG__ID D0W4FF D0W4FF DRUGTYPE Small molecular drug D0W4FF DRUGINCH 1S/C23H21FN4S/c1-15(16-6-4-3-5-7-16)26-20-14-18(12-13-25-20)22-21(27-23(28-22)29-2)17-8-10-19(24)11-9-17/h3-15H,1-2H3,(H,25,26)(H,27,28) D0W4FF DRUGINKE VXPWQNBKEIVYIS-UHFFFAOYSA-N D0W4FF DRUGSMIL CC(C1=CC=CC=C1)NC2=NC=CC(=C2)C3=C(NC(=N3)SC)C4=CC=C(C=C4)F D0W4FF HIGHSTAT Investigative D0W4GM DRUG__ID D0W4GM D0W4GM DRUGTYPE Small molecular drug D0W4GM DRUGINCH 1S/C12H17N/c13-10-12(8-4-5-9-12)11-6-2-1-3-7-11/h1-3,6-7H,4-5,8-10,13H2 D0W4GM DRUGINKE SJWOFBVBNFLWLP-UHFFFAOYSA-N D0W4GM DRUGSMIL C1CCC(C1)(CN)C2=CC=CC=C2 D0W4GM HIGHSTAT Investigative D0W4GQ DRUG__ID D0W4GQ D0W4GQ DRUGTYPE Small molecular drug D0W4GQ DRUGINCH 1S/2C18H16O2/c2*19-18(20)14-13-17-11-5-4-10-16(17)12-6-9-15-7-2-1-3-8-15/h1-8,10-14H,9H2,(H,19,20);1-11,13-14H,12H2,(H,19,20)/b12-6+,14-13+;9-6+,14-13+ D0W4GQ DRUGINKE QRLAGHDTOFFHIC-UMYPGWKJSA-N D0W4GQ DRUGSMIL C1=CC=C(C=C1)CC=CC2=CC=CC=C2C=CC(=O)O.C1=CC=C(C=C1)C=CCC2=CC=CC=C2C=CC(=O)O D0W4GQ HIGHSTAT Investigative D0W4GY DRUG__ID D0W4GY D0W4GY DRUGTYPE Small molecular drug D0W4GY DRUGINCH 1S/C13H9F3O/c14-13(15,16)11-5-1-9(2-6-11)10-3-7-12(17)8-4-10/h1-8,17H D0W4GY DRUGINKE AFPOYLCQXONCPX-UHFFFAOYSA-N D0W4GY DRUGSMIL C1=CC(=CC=C1C2=CC=C(C=C2)O)C(F)(F)F D0W4GY HIGHSTAT Investigative D0W4IB DRUG__ID D0W4IB D0W4IB DRUGTYPE Small molecular drug D0W4IB DRUGINCH 1S/C19H14N2O3/c1-23-14-7-8-15-16(11-14)24-19(21-10-9-20-12-21)17(18(15)22)13-5-3-2-4-6-13/h2-12H,1H3 D0W4IB DRUGINKE XDJIKPUCOXIQTJ-UHFFFAOYSA-N D0W4IB DRUGSMIL COC1=CC2=C(C=C1)C(=O)C(=C(O2)N3C=CN=C3)C4=CC=CC=C4 D0W4IB HIGHSTAT Investigative D0W4IK DRUG__ID D0W4IK D0W4IK DRUGTYPE Small molecular drug D0W4IK DRUGINCH 1S/C6H10OS2/c1-2-5-9(7)6-3-4-8/h2-4,8H,1,5-6H2/b4-3+/t9-/m1/s1 D0W4IK DRUGINKE HSVQDVSVQIMRSS-CDAZIORVSA-N D0W4IK DRUGSMIL C=CCS(=O)CC=CS D0W4IK HIGHSTAT Investigative D0W4IL DRUG__ID D0W4IL D0W4IL DRUGTYPE Small molecular drug D0W4IL DRUGINCH 1S/C8H8O4/c9-7-5-3-1-2-4(11-3)6(5)8(10)12-7/h3-6H,1-2H2 D0W4IL DRUGINKE JAABVEXCGCXWRR-UHFFFAOYSA-N D0W4IL DRUGSMIL C1CC2C3C(C1O2)C(=O)OC3=O D0W4IL HIGHSTAT Investigative D0W4JC DRUG__ID D0W4JC D0W4JC DRUGTYPE Small molecular drug D0W4JC DRUGINCH 1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)/i5T D0W4JC DRUGINKE PWTBZOIUWZOPFT-XHHURNKPSA-N D0W4JC DRUGSMIL C1=COC(=C1)C2=NN3C(=NC(=NC3=N2)NCCC4=CC=C(C=C4)O)N D0W4JC HIGHSTAT Investigative D0W4JS DRUG__ID D0W4JS D0W4JS DRUGTYPE Small molecular drug D0W4JS DRUGINCH 1S/C25H19F2NO5/c26-19-6-1-15(2-7-19)11-22(24(29)30)28-25(31)32-14-21-13-18-12-17(5-10-23(18)33-21)16-3-8-20(27)9-4-16/h1-10,12-13,22H,11,14H2,(H,28,31)(H,29,30) D0W4JS DRUGINKE IDONYPMIPXYFLY-UHFFFAOYSA-N D0W4JS DRUGSMIL C1=CC(=CC=C1CC(C(=O)O)NC(=O)OCC2=CC3=C(O2)C=CC(=C3)C4=CC=C(C=C4)F)F D0W4JS HIGHSTAT Investigative D0W4MZ DRUG__ID D0W4MZ D0W4MZ DRUGTYPE Small molecular drug D0W4MZ DRUGINCH 1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1 D0W4MZ DRUGINKE ROHFNLRQFUQHCH-YFKPBYRVSA-N D0W4MZ DRUGSMIL CC(C)CC(C(=O)O)N D0W4MZ HIGHSTAT Investigative D0W4OF DRUG__ID D0W4OF D0W4OF DRUGTYPE Small molecular drug D0W4OF DRUGINCH 1S/C13H21O3PS/c1-10(2)15-17(14,16-11(3)4)13(18)12-8-6-5-7-9-12/h5-11,13,18H,1-4H3 D0W4OF DRUGINKE NOPVXMUUBWYONO-UHFFFAOYSA-N D0W4OF DRUGSMIL CC(C)OP(=O)(C(C1=CC=CC=C1)S)OC(C)C D0W4OF HIGHSTAT Investigative D0W4TW DRUG__ID D0W4TW D0W4TW DRUGTYPE Small molecular drug D0W4TW DRUGINCH 1S/C11H9BrN2/c12-7-1-2-8-9-3-4-13-6-11(9)14-10(8)5-7/h1-2,5-6,14H,3-4H2 D0W4TW DRUGINKE NTZLLWPDAQVIOA-UHFFFAOYSA-N D0W4TW DRUGSMIL C1CN=CC2=C1C3=C(N2)C=C(C=C3)Br D0W4TW HIGHSTAT Investigative D0W4UQ DRUG__ID D0W4UQ D0W4UQ DRUGTYPE Small molecular drug D0W4UQ DRUGINCH 1S/C16H14N2O2/c1-20-12-5-2-10(3-6-12)8-14-13-9-11(17)4-7-15(13)18-16(14)19/h2-9H,17H2,1H3,(H,18,19)/b14-8- D0W4UQ DRUGINKE DYCBCUFDDRQCID-ZSOIEALJSA-N D0W4UQ DRUGSMIL COC1=CC=C(C=C1)C=C2C3=C(C=CC(=C3)N)NC2=O D0W4UQ HIGHSTAT Investigative D0W4UX DRUG__ID D0W4UX D0W4UX DRUGTYPE Small molecular drug D0W4UX DRUGINCH 1S/C21H25N3O3S/c1-13(2)11-16-9-10-17(19(22)12-16)18-7-5-6-8-20(18)28(25,26)24-21-14(3)15(4)23-27-21/h5-10,12-13,24H,11,22H2,1-4H3 D0W4UX DRUGINKE OZDIAVKCLFSBME-UHFFFAOYSA-N D0W4UX DRUGSMIL CC1=C(ON=C1C)NS(=O)(=O)C2=CC=CC=C2C3=C(C=C(C=C3)CC(C)C)N D0W4UX HIGHSTAT Investigative D0W4VM DRUG__ID D0W4VM D0W4VM DRUGTYPE Small molecular drug D0W4VM DRUGINCH 1S/C26H34O6/c1-2-3-4-5-6-7-8-9-18-30-23-14-16-25(17-15-23)32-20-22(27)19-31-24-12-10-21(11-13-24)26(28)29/h10-17H,2-9,18-20H2,1H3,(H,28,29) D0W4VM DRUGINKE BBWMRBSEGFTSQC-UHFFFAOYSA-N D0W4VM DRUGSMIL CCCCCCCCCCOC1=CC=C(C=C1)OCC(=O)COC2=CC=C(C=C2)C(=O)O D0W4VM HIGHSTAT Investigative D0W4WB DRUG__ID D0W4WB D0W4WB DRUGTYPE Small molecular drug D0W4WB DRUGINCH 1S/C14H17NO5/c16-10-7-18-13-11(8-19-12(10)13)20-14(17)15-6-9-4-2-1-3-5-9/h1-5,10-13,16H,6-8H2,(H,15,17)/t10-,11+,12-,13-/m1/s1 D0W4WB DRUGINKE LYJZFQNPWOVWIJ-YVECIDJPSA-N D0W4WB DRUGSMIL C1C(C2C(O1)C(CO2)OC(=O)NCC3=CC=CC=C3)O D0W4WB HIGHSTAT Investigative D0W4WF DRUG__ID D0W4WF D0W4WF DRUGTYPE Small molecular drug D0W4WF DRUGINCH 1S/C17H16O2/c1-3-11-8-13(18)9-12-4-5-14-10(2)16(19)7-6-15(14)17(11)12/h3,6-9,18-19H,1,4-5H2,2H3 D0W4WF DRUGINKE GEXAPRXWKRZPCK-UHFFFAOYSA-N D0W4WF DRUGSMIL CC1=C(C=CC2=C1CCC3=C2C(=CC(=C3)O)C=C)O D0W4WF HIGHSTAT Investigative D0W4ZU DRUG__ID D0W4ZU D0W4ZU DRUGTYPE Small molecular drug D0W4ZU DRUGINCH 1S/C26H32O7/c1-14(2)15(8-9-26(3,4)31)10-18-20(29)12-23(32-5)24-21(30)13-22(33-25(18)24)17-7-6-16(27)11-19(17)28/h6-7,11-12,15,22,27-29,31H,1,8-10,13H2,2-5H3/t15-,22+/m1/s1 D0W4ZU DRUGINKE XMUPAAIHKAIUSU-QRQCRPRQSA-N D0W4ZU DRUGSMIL CC(=C)C(CCC(C)(C)O)CC1=C2C(=C(C=C1O)OC)C(=O)CC(O2)C3=C(C=C(C=C3)O)O D0W4ZU HIGHSTAT Investigative D0W5CQ DRUG__ID D0W5CQ D0W5CQ DRUGTYPE Small molecular drug D0W5CQ DRUGINCH 1S/C6H5NO2/c8-6(9)5-1-3-7-4-2-5/h1-4H,(H,8,9) D0W5CQ DRUGINKE TWBYWOBDOCUKOW-UHFFFAOYSA-N D0W5CQ DRUGSMIL C1=CN=CC=C1C(=O)O D0W5CQ HIGHSTAT Investigative D0W5CR DRUG__ID D0W5CR D0W5CR DRUGTYPE Small molecular drug D0W5CR DRUGINCH 1S/C37H51N5O7/c1-37-15-14-25-24-13-11-23(43)16-21(24)10-12-26(25)27(37)17-22(33(37)47)8-6-4-2-3-5-7-9-29(44)48-18-28-31(45)32(46)36(49-28)42-20-41-30-34(38)39-19-40-35(30)42/h11,13,16,19-20,22,25-28,31-33,36,43,45-47H,2-10,12,14-15,17-18H2,1H3,(H2,38,39,40)/t22-,25+,26+,27-,28+,31+,32+,33-,36+,37-/m0/s1 D0W5CR DRUGINKE CKSDYJASHNGOOS-KTXOUVACSA-N D0W5CR DRUGSMIL CC12CCC3C(C1CC(C2O)CCCCCCCCC(=O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)CCC7=C3C=CC(=C7)O D0W5CR HIGHSTAT Investigative D0W5CZ DRUG__ID D0W5CZ D0W5CZ DRUGTYPE Small molecular drug D0W5CZ DRUGINCH 1S/C10H8N4O/c11-10-13-8(7-2-1-5-15-7)6-3-4-12-9(6)14-10/h1-5H,(H3,11,12,13,14) D0W5CZ DRUGINKE YOPVCNSOKMOXST-UHFFFAOYSA-N D0W5CZ DRUGSMIL C1=COC(=C1)C2=C3C=CNC3=NC(=N2)N D0W5CZ HIGHSTAT Investigative D0W5DZ DRUG__ID D0W5DZ D0W5DZ DRUGTYPE Small molecular drug D0W5DZ DRUGINCH 1S/C21H27ClO3/c1-19(2)7-5-8-20(3)15(19)6-9-21(4)16(20)10-12-14(25-21)11-13(23)18(24)17(12)22/h10-11,15-16,24H,5-9H2,1-4H3/t15-,16+,20-,21-/m0/s1 D0W5DZ DRUGINKE IVURSJNKOFPQMR-GQSCTRQFSA-N D0W5DZ DRUGSMIL CC1(CCCC2(C1CCC3(C2C=C4C(=CC(=O)C(=C4Cl)O)O3)C)C)C D0W5DZ HIGHSTAT Investigative D0W5ED DRUG__ID D0W5ED D0W5ED DRUGTYPE Small molecular drug D0W5ED DRUGINCH 1S/C7H9NOS2/c1-2-3-4-5-6(9)8-7(10)11-5/h3-4,9H,2H2,1H3,(H,8,10)/b4-3+ D0W5ED DRUGINKE KKMMHMVDVICNOR-ONEGZZNKSA-N D0W5ED DRUGSMIL CCC=CC1=C(NC(=S)S1)O D0W5ED HIGHSTAT Investigative D0W5EF DRUG__ID D0W5EF D0W5EF DRUGTYPE Small molecular drug D0W5EF DRUGINCH 1S/C48H66N8O13/c1-9-14-36(59)49-26(5)41(61)53-39(27(6)57)44(64)54-40-28(7)69-48(68)38(25(3)4)52-43(63)34(23-30-17-19-31(58)20-18-30)55(8)47(67)35(24-29-15-12-11-13-16-29)56-37(60)22-21-33(46(56)66)51-42(62)32(10-2)50-45(40)65/h10-13,15-20,25-28,33-35,37-40,57-58,60H,9,14,21-24H2,1-8H3,(H,49,59)(H,50,65)(H,51,62)(H,52,63)(H,53,61)(H,54,64)/b32-10-/t26-,27+,28+,33-,34-,35-,37+,38-,39-,40-/m0/s1 D0W5EF DRUGINKE KXSGCAPYMUMVSH-VFYPFKDGSA-N D0W5EF DRUGSMIL CCCC(=O)NC(C)C(=O)NC(C(C)O)C(=O)NC1C(OC(=O)C(NC(=O)C(N(C(=O)C(N2C(CCC(C2=O)NC(=O)C(=CC)NC1=O)O)CC3=CC=CC=C3)C)CC4=CC=C(C=C4)O)C(C)C)C D0W5EF HIGHSTAT Investigative D0W5FM DRUG__ID D0W5FM D0W5FM DRUGTYPE Small molecular drug D0W5FM DRUGINCH 1S/C23H36O6/c1-4-13(2)23(27)29-20-11-16(24)9-15-6-5-14(3)19(22(15)20)8-7-18-10-17(25)12-21(26)28-18/h5-6,13-20,22,24-25H,4,7-12H2,1-3H3/t13-,14-,15-,16+,17+,18?,19-,20-,22-/m0/s1 D0W5FM DRUGINKE LJOOWESTVASNOG-UFJKPHDISA-N D0W5FM DRUGSMIL CCC(C)C(=O)OC1CC(CC2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)O D0W5FM HIGHSTAT Investigative D0W5HL DRUG__ID D0W5HL D0W5HL DRUGTYPE Small molecular drug D0W5HL DRUGINCH 1S/C32H39N5O3.ClH/c1-7-8-15-37-30-24(13-10-14-34-30)27(21-11-9-12-23(16-21)40-6)29(31(37)38)36-32(39)35-28-25(19(2)3)17-22(33)18-26(28)20(4)5;/h9-14,16-20H,7-8,15,33H2,1-6H3,(H2,35,36,39);1H D0W5HL DRUGINKE NPAVKCDQHSYXFT-UHFFFAOYSA-N D0W5HL DRUGSMIL CCCCN1C2=C(C=CC=N2)C(=C(C1=O)NC(=O)NC3=C(C=C(C=C3C(C)C)N)C(C)C)C4=CC(=CC=C4)OC.Cl D0W5HL HIGHSTAT Investigative D0W5HT DRUG__ID D0W5HT D0W5HT DRUGTYPE Small molecular drug D0W5HT DRUGINCH 1S/C24H30O5/c1-2-3-4-5-6-7-8-9-18-19(26)14-20(27)23-21(28)15-22(29-24(18)23)16-10-12-17(25)13-11-16/h10-14,22,25-27H,2-9,15H2,1H3/t22-/m0/s1 D0W5HT DRUGINKE PGTXFXPDRFSQPT-QFIPXVFZSA-N D0W5HT DRUGSMIL CCCCCCCCCC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D0W5HT HIGHSTAT Investigative D0W5IN DRUG__ID D0W5IN D0W5IN DRUGTYPE Small molecular drug D0W5IN DRUGINCH 1S/C17H19N3/c1-3-12-19(16-8-10-18-11-9-16)20-14(2)13-15-6-4-5-7-17(15)20/h4-11,13H,3,12H2,1-2H3 D0W5IN DRUGINKE JCEBKNUYKMFQGZ-UHFFFAOYSA-N D0W5IN DRUGSMIL CCCN(C1=CC=NC=C1)N2C(=CC3=CC=CC=C32)C D0W5IN HIGHSTAT Investigative D0W5IP DRUG__ID D0W5IP D0W5IP DRUGTYPE Small molecular drug D0W5IP DRUGINCH 1S/C15H17NO3/c1-4-19-15(18)12-8-16-13-6-5-10(9(2)3)7-11(13)14(12)17/h5-9H,4H2,1-3H3,(H,16,17) D0W5IP DRUGINKE JBFFEVKDAYLOKF-UHFFFAOYSA-N D0W5IP DRUGSMIL CCOC(=O)C1=CNC2=C(C1=O)C=C(C=C2)C(C)C D0W5IP HIGHSTAT Investigative D0W5JE DRUG__ID D0W5JE D0W5JE DRUGTYPE Small molecular drug D0W5JE DRUGINCH 1S/C12H7F2NS/c1-8-15-12(7-16-8)3-2-9-4-10(13)6-11(14)5-9/h4-7H,1H3 D0W5JE DRUGINKE RIXDIVBFRYYMRM-UHFFFAOYSA-N D0W5JE DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC(=C2)F)F D0W5JE HIGHSTAT Investigative D0W5NB DRUG__ID D0W5NB D0W5NB DRUGTYPE Small molecular drug D0W5NB DRUGINCH 1S/C8H6N2O2/c11-8(12)7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H,9,10)(H,11,12) D0W5NB DRUGINKE RHXSYTACTOMVLJ-UHFFFAOYSA-N D0W5NB DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C(=O)O D0W5NB HIGHSTAT Investigative D0W5OM DRUG__ID D0W5OM D0W5OM DRUGTYPE Small molecular drug D0W5OM DRUGINCH 1S/C14H18N2S/c1-10-7-5-6-8-11(10)15-13-16-12(9-17-13)14(2,3)4/h5-9H,1-4H3,(H,15,16) D0W5OM DRUGINKE LGKMKCIPKKOAPX-UHFFFAOYSA-N D0W5OM DRUGSMIL CC1=CC=CC=C1NC2=NC(=CS2)C(C)(C)C D0W5OM HIGHSTAT Investigative D0W5QR DRUG__ID D0W5QR D0W5QR DRUGTYPE Small molecular drug D0W5QR DRUGINCH 1S/C26H25N3O2/c30-24-17-20-29(25(31)28-24)19-10-18-27-26(21-11-4-1-5-12-21,22-13-6-2-7-14-22)23-15-8-3-9-16-23/h1-9,11-17,20,27H,10,18-19H2,(H,28,30,31) D0W5QR DRUGINKE FFJOPHQHIVRWNN-UHFFFAOYSA-N D0W5QR DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCCCN4C=CC(=O)NC4=O D0W5QR HIGHSTAT Investigative D0W5RQ DRUG__ID D0W5RQ D0W5RQ DRUGTYPE Small molecular drug D0W5RQ DRUGINCH 1S/C18H21NO4/c1-20-14-8-7-13(15(19)11-14)6-5-12-9-16(21-2)18(23-4)17(10-12)22-3/h5-11H,19H2,1-4H3/b6-5- D0W5RQ DRUGINKE XMMNPPLYAJJFPL-WAYWQWQTSA-N D0W5RQ DRUGSMIL COC1=CC(=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)N D0W5RQ HIGHSTAT Investigative D0W5SZ DRUG__ID D0W5SZ D0W5SZ DRUGTYPE Small molecular drug D0W5SZ DRUGINCH 1S/C14H14N2O4S.ClH/c15-10-1-5-12(6-2-10)21(19,20)13-7-3-11(4-8-13)16-9-14(17)18;/h1-8,16H,9,15H2,(H,17,18);1H D0W5SZ DRUGINKE NNALULAMJZHAQK-UHFFFAOYSA-N D0W5SZ DRUGSMIL C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)NCC(=O)O.Cl D0W5SZ HIGHSTAT Investigative D0W5TY DRUG__ID D0W5TY D0W5TY DRUGTYPE Small molecular drug D0W5TY DRUGINCH 1S/C13H14N2O2/c16-13(17)12-9-11(14-15-12)8-4-7-10-5-2-1-3-6-10/h1-3,5-6,9H,4,7-8H2,(H,14,15)(H,16,17) D0W5TY DRUGINKE JDCXDGHZXKZHQL-UHFFFAOYSA-N D0W5TY DRUGSMIL C1=CC=C(C=C1)CCCC2=CC(=NN2)C(=O)O D0W5TY HIGHSTAT Investigative D0W5UJ DRUG__ID D0W5UJ D0W5UJ DRUGTYPE Small molecular drug D0W5UJ DRUGINCH 1S/C8H16N2O2/c1-2-10-6-4-3-5-7(9)8(11)12/h6-7H,2-5,9H2,1H3,(H,11,12)/t7-/m0/s1 D0W5UJ DRUGINKE SWSFWCQRQUCVNB-ZETCQYMHSA-N D0W5UJ DRUGSMIL CCN=CCCCC(C(=O)O)N D0W5UJ HIGHSTAT Investigative D0W5WG DRUG__ID D0W5WG D0W5WG DRUGTYPE Small molecular drug D0W5WG DRUGINCH 1S/C19H19N5OS/c25-18(20-16-9-5-2-6-10-16)23-11-13-24(14-12-23)19-21-17(22-26-19)15-7-3-1-4-8-15/h1-10H,11-14H2,(H,20,25) D0W5WG DRUGINKE BHBOSTKQCZEAJM-UHFFFAOYSA-N D0W5WG DRUGSMIL C1CN(CCN1C2=NC(=NS2)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4 D0W5WG HIGHSTAT Investigative D0W5XD DRUG__ID D0W5XD D0W5XD DRUGTYPE Small molecular drug D0W5XD DRUGINCH 1S/C29H40N2O5/c1-30(13-11-20-9-10-25(33-2)26(15-20)34-3)23-7-6-8-24(19-23)31-14-12-21-16-27(35-4)28(36-5)17-22(21)18-29(31)32/h9-10,15-17,23-24H,6-8,11-14,18-19H2,1-5H3 D0W5XD DRUGINKE IUAVZEYOWYFRAS-UHFFFAOYSA-N D0W5XD DRUGSMIL CN(CCC1=CC(=C(C=C1)OC)OC)C2CCCC(C2)N3CCC4=CC(=C(C=C4CC3=O)OC)OC D0W5XD HIGHSTAT Investigative D0W5ZK DRUG__ID D0W5ZK D0W5ZK DRUGTYPE Small molecular drug D0W5ZK DRUGINCH 1S/C20H24N4O4/c1-2-15(11-19(26)27)22-18(25)13-24-8-5-14-3-4-16(12-17(14)20(24)28)23-9-6-21-7-10-23/h1,3-4,12,15,21H,5-11,13H2,(H,22,25)(H,26,27)/t15-/m1/s1 D0W5ZK DRUGINKE QTVKUFZTCJLGEJ-OAHLLOKOSA-N D0W5ZK DRUGSMIL C#CC(CC(=O)O)NC(=O)CN1CCC2=C(C1=O)C=C(C=C2)N3CCNCC3 D0W5ZK HIGHSTAT Investigative D0W6AC DRUG__ID D0W6AC D0W6AC DRUGTYPE Small molecular drug D0W6AC DRUGINCH 1S/C16H19ClN2O2/c1-11(20)19-14-6-3-7-16(9-14)10-18-15(21-16)12-4-2-5-13(17)8-12/h2,4-5,8,14H,3,6-7,9-10H2,1H3,(H,19,20)/t14-,16+/m0/s1 D0W6AC DRUGINKE NFPUARSXIMWASK-GOEBONIOSA-N D0W6AC DRUGSMIL CC(=O)NC1CCCC2(C1)CN=C(O2)C3=CC(=CC=C3)Cl D0W6AC HIGHSTAT Investigative D0W6CE DRUG__ID D0W6CE D0W6CE DRUGTYPE Small molecular drug D0W6CE DRUGINCH 1S/C22H36O6/c1-8-13(2)16-20(5,15(23)9-10-28-7)17-14(3)11-19(4,25)12-22(17,27)18(24)21(16,6)26/h9-10,13-14,16-17,25-27H,8,11-12H2,1-7H3/b10-9+/t13?,14-,16-,17-,19-,20-,21+,22-/m1/s1 D0W6CE DRUGINKE ONZDNBGTAVEQQN-FJXLOMMUSA-N D0W6CE DRUGSMIL CCC(C)C1C(C2C(CC(CC2(C(=O)C1(C)O)O)(C)O)C)(C)C(=O)C=COC D0W6CE HIGHSTAT Investigative D0W6CJ DRUG__ID D0W6CJ D0W6CJ DRUGTYPE Small molecular drug D0W6CJ DRUGINCH 1S/C18H29N7O8/c19-18(20)21-3-1-2-8-16(32)22-6-11(26)23-10(5-12(27)28)17(33)25-9-4-7(15(31)24-8)13(29)14(9)30/h7-10,13-14,29-30H,1-6H2,(H,22,32)(H,23,26)(H,24,31)(H,25,33)(H,27,28)(H4,19,20,21)/t7-,8-,9+,10-,13+,14-/m0/s1 D0W6CJ DRUGINKE VNLGSUKLIVHSOW-RNSQFEBMSA-N D0W6CJ DRUGSMIL C1C2C(C(C1NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCCN=C(N)N)CC(=O)O)O)O D0W6CJ HIGHSTAT Investigative D0W6FC DRUG__ID D0W6FC D0W6FC DRUGTYPE Small molecular drug D0W6FC DRUGINCH 1S/C8H10BrN5O/c1-4(15)2-14-7-5(13-8(14)9)6(10)11-3-12-7/h3-4,15H,2H2,1H3,(H2,10,11,12) D0W6FC DRUGINKE MMKXSEBGGSBLDX-UHFFFAOYSA-N D0W6FC DRUGSMIL CC(CN1C2=NC=NC(=C2N=C1Br)N)O D0W6FC HIGHSTAT Investigative D0W6GB DRUG__ID D0W6GB D0W6GB DRUGTYPE Small molecular drug D0W6GB DRUGINCH 1S/C18H18ClNO5/c1-4-24-20-17(25-18(21)12-8-6-5-7-9-12)15-14(22-2)11-10-13(19)16(15)23-3/h5-11H,4H2,1-3H3/b20-17- D0W6GB DRUGINKE BZMIHNKNQJJVRO-JZJYNLBNSA-N D0W6GB DRUGSMIL CCON=C(C1=C(C=CC(=C1OC)Cl)OC)OC(=O)C2=CC=CC=C2 D0W6GB HIGHSTAT Investigative D0W6GE DRUG__ID D0W6GE D0W6GE DRUGTYPE Small molecular drug D0W6GE DRUGINCH 1S/C18H20N2S/c1-18(2,3)11-14-12-21-17(19-14)20-16-10-6-8-13-7-4-5-9-15(13)16/h4-10,12H,11H2,1-3H3,(H,19,20) D0W6GE DRUGINKE RIPVNQXJGQJLHV-UHFFFAOYSA-N D0W6GE DRUGSMIL CC(C)(C)CC1=CSC(=N1)NC2=CC=CC3=CC=CC=C32 D0W6GE HIGHSTAT Investigative D0W6HB DRUG__ID D0W6HB D0W6HB DRUGTYPE Small molecular drug D0W6HB DRUGINCH 1S/C20H14O4/c21-19(14-6-8-16(9-7-14)20(22)23)15-10-12-18(13-11-15)24-17-4-2-1-3-5-17/h1-13H,(H,22,23) D0W6HB DRUGINKE SQQFOBWKPOREAO-UHFFFAOYSA-N D0W6HB DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)C3=CC=C(C=C3)C(=O)O D0W6HB HIGHSTAT Investigative D0W6HI DRUG__ID D0W6HI D0W6HI DRUGTYPE Small molecular drug D0W6HI DRUGINCH 1S/C25H28N4O5/c1-2-33-21-6-3-5-19(13-21)18-10-8-17(9-11-18)16-34-25(32)29-12-4-7-22(29)24(31)28-20(15-26)14-23(27)30/h3,5-6,8-11,13,20,22H,2,4,7,12,14,16H2,1H3,(H2,27,30)(H,28,31)/t20-,22-/m0/s1 D0W6HI DRUGINKE BZVXYJWEOARYIS-UNMCSNQZSA-N D0W6HI DRUGSMIL CCOC1=CC=CC(=C1)C2=CC=C(C=C2)COC(=O)N3CCCC3C(=O)NC(CC(=O)N)C#N D0W6HI HIGHSTAT Investigative D0W6LJ DRUG__ID D0W6LJ D0W6LJ DRUGTYPE Small molecular drug D0W6LJ DRUGINCH 1S/C36H32N4O5/c41-31-29(22-44-36(26-15-7-2-8-16-26,27-17-9-3-10-18-27)28-19-11-4-12-20-28)45-35(32(31)42)40-24-37-30-33(40)38-23-39(34(30)43)21-25-13-5-1-6-14-25/h1-20,23-24,29,31-32,35,41-42H,21-22H2/t29-,31-,32-,35-/m1/s1 D0W6LJ DRUGINKE AUYLAWYEMLZGBM-QSYCCZFCSA-N D0W6LJ DRUGSMIL C1=CC=C(C=C1)CN2C=NC3=C(C2=O)N=CN3C4C(C(C(O4)COC(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)O)O D0W6LJ HIGHSTAT Investigative D0W6OP DRUG__ID D0W6OP D0W6OP DRUGTYPE Small molecular drug D0W6OP DRUGINCH 1S/C26H32N6O6S2/c27-18(10-16-6-8-17(33)9-7-16)24(36)32-21-14-40-39-13-20(23(28)35)31-26(38)19(11-15-4-2-1-3-5-15)30-22(34)12-29-25(21)37/h1-9,18-21,33H,10-14,27H2,(H2,28,35)(H,29,37)(H,30,34)(H,31,38)(H,32,36)/t18-,19-,20-,21-/m0/s1 D0W6OP DRUGINKE VUVASMYWPNXOGI-TUFLPTIASA-N D0W6OP DRUGSMIL C1C(C(=O)NCC(=O)NC(C(=O)NC(CSS1)C(=O)N)CC2=CC=CC=C2)NC(=O)C(CC3=CC=C(C=C3)O)N D0W6OP HIGHSTAT Investigative D0W6PP DRUG__ID D0W6PP D0W6PP DRUGTYPE Small molecular drug D0W6PP DRUGINCH 1S/C40H46N4O6/c1-25-21-37(45)50-36-23-27(18-19-28(25)36)42-38(46)34(17-9-10-20-41)43-39(47)35(22-26-11-3-2-4-12-26)44-40(48)49-24-33-31-15-7-5-13-29(31)30-14-6-8-16-32(30)33/h5-8,13-16,18-19,21,23,26,33-35H,2-4,9-12,17,20,22,24,41H2,1H3,(H,42,46)(H,43,47)(H,44,48)/t34-,35-/m0/s1 D0W6PP DRUGINKE IKNOZZKXIDSTRN-PXLJZGITSA-N D0W6PP DRUGSMIL CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CCCCN)NC(=O)C(CC3CCCCC3)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46 D0W6PP HIGHSTAT Investigative D0W6PT DRUG__ID D0W6PT D0W6PT DRUGTYPE Small molecular drug D0W6PT DRUGINCH 1S/C9H11Cl3NO4P/c1-3-15-18(14,16-4-2)17-9-7(11)5-6(10)8(12)13-9/h5H,3-4H2,1-2H3 D0W6PT DRUGINKE OTMOUPHCTWPNSL-UHFFFAOYSA-N D0W6PT DRUGSMIL CCOP(=O)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl D0W6PT HIGHSTAT Investigative D0W6RV DRUG__ID D0W6RV D0W6RV DRUGTYPE Small molecular drug D0W6RV DRUGINCH 1S/C14H18N2/c1-3-10-9-15-7-8-16-13-6-2-4-11(13)12(5-1)14(10)16/h1,3,5,11,13,15H,2,4,6-9H2/t11-,13-/m1/s1 D0W6RV DRUGINKE XOSKJKGKWRIMGV-DGCLKSJQSA-N D0W6RV DRUGSMIL C1CC2C(C1)N3CCNCC4=C3C2=CC=C4 D0W6RV HIGHSTAT Investigative D0W6TB DRUG__ID D0W6TB D0W6TB DRUGCOMP Merck Frosst Canada & Co D0W6TB DRUGINCH 1S/C32H27FN4O2/c1-32(2,38)15-19-5-7-24-26(11-19)27-14-23(39-10-9-18-3-4-18)6-8-25(27)30-29(24)36-31(37-30)28-20(16-34)12-22(33)13-21(28)17-35/h5-8,11-14,18,38H,3-4,9-10,15H2,1-2H3,(H,36,37) D0W6TB DRUGINKE PYRKKGOKRMZEIT-UHFFFAOYSA-N D0W6TB DRUGSMIL CC(C)(CC1=CC2=C(C=C1)C3=C(C4=C2C=C(C=C4)OCCC5CC5)N=C(N3)C6=C(C=C(C=C6C#N)F)C#N)O D0W6TB HIGHSTAT Investigative D0W6TG DRUG__ID D0W6TG D0W6TG DRUGTYPE Small molecular drug D0W6TG DRUGINCH 1S/C25H25F3N6O4S/c1-2-34-23(35)20-22(31-24(34)36)30-21(29-20)17-5-9-19(10-6-17)39(37,38)33-13-11-32(12-14-33)15-16-3-7-18(8-4-16)25(26,27)28/h3-10H,2,11-15H2,1H3,(H,29,30)(H,31,36) D0W6TG DRUGINKE PGUVAKMIEAFDEA-UHFFFAOYSA-N D0W6TG DRUGSMIL CCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)CC5=CC=C(C=C5)C(F)(F)F D0W6TG HIGHSTAT Investigative D0W6TX DRUG__ID D0W6TX D0W6TX DRUGTYPE Small molecular drug D0W6TX DRUGINCH 1S/C14H9F3INO2/c15-14(16,17)21-12-7-1-9(2-8-12)13(20)19-11-5-3-10(18)4-6-11/h1-8H,(H,19,20) D0W6TX DRUGINKE IUHUCVXLTXIWPU-UHFFFAOYSA-N D0W6TX DRUGSMIL C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)I)OC(F)(F)F D0W6TX HIGHSTAT Investigative D0W6VA DRUG__ID D0W6VA D0W6VA DRUGTYPE Small molecular drug D0W6VA DRUGINCH 1S/C9H8N2O/c12-9-3-1-8(2-4-9)11-6-5-10-7-11/h1-7,12H D0W6VA DRUGINKE CYKCUAPYWQDIKR-UHFFFAOYSA-N D0W6VA DRUGSMIL C1=CC(=CC=C1N2C=CN=C2)O D0W6VA HIGHSTAT Investigative D0W6WL DRUG__ID D0W6WL D0W6WL DRUGTYPE Small molecular drug D0W6WL DRUGINCH 1S/C19H24N2/c1-3-7-17(8-4-1)11-12-19(18-9-5-2-6-10-18)21-15-13-20-14-16-21/h1-10,19-20H,11-16H2 D0W6WL DRUGINKE QKYQOSPSZVKFEL-UHFFFAOYSA-N D0W6WL DRUGSMIL C1CN(CCN1)C(CCC2=CC=CC=C2)C3=CC=CC=C3 D0W6WL HIGHSTAT Investigative D0W6WU DRUG__ID D0W6WU D0W6WU DRUGTYPE Small molecular drug D0W6WU DRUGINCH 1S/C45H58N8O11S/c1-3-25(2)38-43(61)53-39(28-11-13-29(14-12-28)47-36(56)19-20-37(57)48-35(24-65)42(60)52-38)44(62)49-32(6-4-5-21-46)40(58)50-33(22-26-7-15-30(54)16-8-26)41(59)51-34(45(63)64)23-27-9-17-31(55)18-10-27/h7-18,25,32-35,38-39,54-55,65H,3-6,19-24,46H2,1-2H3,(H,47,56)(H,48,57)(H,49,62)(H,50,58)(H,51,59)(H,52,60)(H,53,61)(H,63,64)/t25?,32-,33-,34-,35+,38-,39-/m0/s1 D0W6WU DRUGINKE HFHVOHKEMBUZCY-GKLJNLTASA-N D0W6WU DRUGSMIL CCC(C)C1C(=O)NC(C2=CC=C(C=C2)NC(=O)CCC(=O)NC(C(=O)N1)CS)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O D0W6WU HIGHSTAT Investigative D0W6YE DRUG__ID D0W6YE D0W6YE DRUGTYPE Small molecular drug D0W6YE DRUGINCH 1S/C14H16IN3O3/c1-8(19)16-6-5-10-11-7-9(17-14(20)21-2)3-4-12(11)18-13(10)15/h3-4,7,18H,5-6H2,1-2H3,(H,16,19)(H,17,20)/i15-2 D0W6YE DRUGINKE BMRSKORHUNWKLU-VLPIPSKASA-N D0W6YE DRUGSMIL CC(=O)NCCC1=C(NC2=C1C=C(C=C2)NC(=O)OC)I D0W6YE HIGHSTAT Investigative D0W6YX DRUG__ID D0W6YX D0W6YX DRUGTYPE Small molecular drug D0W6YX DRUGINCH 1S/C21H18O2/c1-15-8-9-18(14-16(15)2)21(22)17-10-12-20(13-11-17)23-19-6-4-3-5-7-19/h3-14H,1-2H3 D0W6YX DRUGINKE WAJARHMGAQFYHB-UHFFFAOYSA-N D0W6YX DRUGSMIL CC1=C(C=C(C=C1)C(=O)C2=CC=C(C=C2)OC3=CC=CC=C3)C D0W6YX HIGHSTAT Investigative D0W7BI DRUG__ID D0W7BI D0W7BI DRUGTYPE Small molecular drug D0W7BI DRUGINCH 1S/C23H16O2/c24-22(18-12-6-2-7-13-18)20-16-21(17-10-4-1-5-11-17)25-23(20)19-14-8-3-9-15-19/h1-16H D0W7BI DRUGINKE QGPDONYUANCEMJ-UHFFFAOYSA-N D0W7BI DRUGSMIL C1=CC=C(C=C1)C2=CC(=C(O2)C3=CC=CC=C3)C(=O)C4=CC=CC=C4 D0W7BI HIGHSTAT Investigative D0W7CF DRUG__ID D0W7CF D0W7CF DRUGTYPE Small molecular drug D0W7CF DRUGINCH 1S/C44H70N14O9/c1-4-25(2)36(42(67)54-31(37(46)62)9-5-6-20-45)58-39(64)33(11-8-22-52-44(49)50)55-40(65)34(23-27-12-16-29(60)17-13-27)57-41(66)35(24-28-14-18-30(61)19-15-28)56-38(63)32(53-26(3)59)10-7-21-51-43(47)48/h12-19,25,31-36,60-61H,4-11,20-24,45H2,1-3H3,(H2,46,62)(H,53,59)(H,54,67)(H,55,65)(H,56,63)(H,57,66)(H,58,64)(H4,47,48,51)(H4,49,50,52)/t25-,31-,32-,33-,34-,35-,36-/m0/s1 D0W7CF DRUGINKE WBBBVZGQADABSU-RERZDIOCSA-N D0W7CF DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCN=C(N)N)NC(=O)C D0W7CF HIGHSTAT Investigative D0W7DM DRUG__ID D0W7DM D0W7DM DRUGTYPE Small molecular drug D0W7DM DRUGINCH 1S/C21H26O6S/c1-20-6-4-12-19(24)27-14(11-5-7-26-10-11)9-21(12,2)17(20)16(22)15(28)8-13(20)18(23)25-3/h5,7,10,12-15,17,28H,4,6,8-9H2,1-3H3/t12-,13-,14-,15-,17-,20-,21-/m0/s1 D0W7DM DRUGINKE NGNBKFTYZQINBO-CEFSSPBYSA-N D0W7DM DRUGSMIL CC12CCC3C(=O)OC(CC3(C1C(=O)C(CC2C(=O)OC)S)C)C4=COC=C4 D0W7DM HIGHSTAT Investigative D0W7GQ DRUG__ID D0W7GQ D0W7GQ DRUGTYPE Small molecular drug D0W7GQ DRUGINCH 1S/C18H22N4O2.2ClH/c1-14-11-18(22(23)24)17(12-16(14)19)21-9-7-20(8-10-21)13-15-5-3-2-4-6-15;;/h2-6,11-12H,7-10,13,19H2,1H3;2*1H D0W7GQ DRUGINKE AYRFPZMTRYDWGP-UHFFFAOYSA-N D0W7GQ DRUGSMIL CC1=CC(=C(C=C1N)N2CCN(CC2)CC3=CC=CC=C3)[N+](=O)[O-].Cl.Cl D0W7GQ HIGHSTAT Investigative D0W7GU DRUG__ID D0W7GU D0W7GU DRUGTYPE Small molecular drug D0W7GU DRUGINCH 1S/C16H17NO2/c1-18-15-9-10-16(19-2)13(11-15)6-3-12-4-7-14(17)8-5-12/h3-11H,17H2,1-2H3/b6-3+ D0W7GU DRUGINKE OZGXSMOLBWHIQA-ZZXKWVIFSA-N D0W7GU DRUGSMIL COC1=CC(=C(C=C1)OC)C=CC2=CC=C(C=C2)N D0W7GU HIGHSTAT Investigative D0W7IN DRUG__ID D0W7IN D0W7IN DRUGTYPE Small molecular drug D0W7IN DRUGINCH 1S/C14H11NOS/c1-16-13-2-3-14-11(7-13)6-12(8-15-14)10-4-5-17-9-10/h2-9H,1H3 D0W7IN DRUGINKE SQHKULNLQJHPDX-UHFFFAOYSA-N D0W7IN DRUGSMIL COC1=CC2=CC(=CN=C2C=C1)C3=CSC=C3 D0W7IN HIGHSTAT Investigative D0W7JA DRUG__ID D0W7JA D0W7JA DRUGTYPE Small molecular drug D0W7JA DRUGINCH 1S/C23H26O11/c24-14-4-1-12(9-16(14)26)3-6-19(28)33-11-18-20(29)21(30)22(31)23(34-18)32-8-7-13-2-5-15(25)17(27)10-13/h1-6,9-10,18,20-27,29-31H,7-8,11H2/b6-3+/t18-,20-,21+,22-,23-/m1/s1 D0W7JA DRUGINKE LFKQVVDFNHDYNK-FOXCETOMSA-N D0W7JA DRUGSMIL C1=CC(=C(C=C1CCOC2C(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)O)O)O)O)O)O D0W7JA HIGHSTAT Investigative D0W7JJ DRUG__ID D0W7JJ D0W7JJ DRUGTYPE Small molecular drug D0W7JJ DRUGINCH 1S/C11H10O4S/c1-16(14,15)10-6-9(12)7-4-2-3-5-8(7)11(10)13/h2-6,12-13H,1H3 D0W7JJ DRUGINKE LDKPKJBNGZYJSR-UHFFFAOYSA-N D0W7JJ DRUGSMIL CS(=O)(=O)C1=C(C2=CC=CC=C2C(=C1)O)O D0W7JJ HIGHSTAT Investigative D0W7LK DRUG__ID D0W7LK D0W7LK DRUGTYPE Small molecular drug D0W7LK DRUGINCH 1S/C3H8O/c1-3(2)4/h3-4H,1-2H3 D0W7LK DRUGINKE KFZMGEQAYNKOFK-UHFFFAOYSA-N D0W7LK DRUGSMIL CC(C)O D0W7LK HIGHSTAT Investigative D0W7ND DRUG__ID D0W7ND D0W7ND DRUGTYPE Small molecular drug D0W7ND DRUGINCH 1S/C16H11N3/c1-2-6-11(7-3-1)16-18-14-10-17-13-9-5-4-8-12(13)15(14)19-16/h1-10H,(H,18,19) D0W7ND DRUGINKE ZGICTZVKFFYIEA-UHFFFAOYSA-N D0W7ND DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(N2)C=NC4=CC=CC=C43 D0W7ND HIGHSTAT Investigative D0W7NY DRUG__ID D0W7NY D0W7NY DRUGTYPE Small molecular drug D0W7NY DRUGINCH 1S/C17H18N2O2/c18-12-15-13-19-17(21-15)16(20)11-7-2-1-4-8-14-9-5-3-6-10-14/h3,5-6,9-10,13H,1-2,4,7-8,11H2 D0W7NY DRUGINKE JOWNZAGZZQQDKI-UHFFFAOYSA-N D0W7NY DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C2=NC=C(O2)C#N D0W7NY HIGHSTAT Investigative D0W7OR DRUG__ID D0W7OR D0W7OR DRUGTYPE Small molecular drug D0W7OR DRUGINCH 1S/C9H9N3/c1-2-4-11-8(3-1)5-9-6-10-7-12-9/h1-4,6-7H,5H2,(H,10,12) D0W7OR DRUGINKE YSOIYRCVNZBHGT-UHFFFAOYSA-N D0W7OR DRUGSMIL C1=CC=NC(=C1)CC2=CN=CN2 D0W7OR HIGHSTAT Investigative D0W7RI DRUG__ID D0W7RI D0W7RI DRUGTYPE Small molecular drug D0W7RI DRUGINCH 1S/C21H34O4/c1-2-3-4-8-17(22)10-11-18-19-13-15(7-5-6-9-21(24)25)12-16(19)14-20(18)23/h7,10-11,16-20,22-23H,2-6,8-9,12-14H2,1H3,(H,24,25)/b11-10+,15-7-/t16-,17-,18+,19-,20+/m0/s1 D0W7RI DRUGINKE XZFRIPGNUQRGPI-WLPVIMDJSA-N D0W7RI DRUGSMIL CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O D0W7RI HIGHSTAT Investigative D0W7WV DRUG__ID D0W7WV D0W7WV DRUGTYPE Small molecular drug D0W7WV DRUGINCH 1S/C23H18F8N2O4S/c24-20(25)37-16-6-3-13(9-17(16)36-14-4-5-14)15(8-12-2-1-7-33(35)11-12)18-10-32-19(38-18)21(34,22(26,27)28)23(29,30)31/h1-3,6-7,9-11,14-15,20,34H,4-5,8H2/t15-/m0/s1 D0W7WV DRUGINKE YDLQPURWTSDWCC-HNNXBMFYSA-N D0W7WV DRUGSMIL C1CC1OC2=C(C=CC(=C2)C(CC3=C[N+](=CC=C3)[O-])C4=CN=C(S4)C(C(F)(F)F)(C(F)(F)F)O)OC(F)F D0W7WV HIGHSTAT Investigative D0W7XH DRUG__ID D0W7XH D0W7XH DRUGTYPE Small molecular drug D0W7XH DRUGINCH 1S/C8H10N2OS/c1-5-9-7-2-3-12-4-6(7)8(11)10-5/h2-4H2,1H3,(H,9,10,11) D0W7XH DRUGINKE HRYKZAKEAVZGJD-UHFFFAOYSA-N D0W7XH DRUGSMIL CC1=NC2=C(CSCC2)C(=O)N1 D0W7XH HIGHSTAT Investigative D0W7XK DRUG__ID D0W7XK D0W7XK DRUGTYPE Small molecular drug D0W7XK DRUGINCH 1S/C16H11FO3/c1-19-12-5-2-10(3-6-12)15-9-14(18)13-7-4-11(17)8-16(13)20-15/h2-9H,1H3 D0W7XK DRUGINKE STGBQHUMAHPOBT-UHFFFAOYSA-N D0W7XK DRUGSMIL COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)F D0W7XK HIGHSTAT Investigative D0W7XL DRUG__ID D0W7XL D0W7XL DRUGTYPE Small molecular drug D0W7XL DRUGINCH 1S/C28H26NO5/c1-30-25-9-8-19-14-24-22-16-27-26(33-18-34-27)15-20(22)10-11-29(24)17-23(19)28(25)32-13-5-12-31-21-6-3-2-4-7-21/h2-4,6-9,14-17H,5,10-13,18H2,1H3/q+1 D0W7XL DRUGINKE GGIRCXOFADOIHD-UHFFFAOYSA-N D0W7XL DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCOC6=CC=CC=C6 D0W7XL HIGHSTAT Investigative D0W7XR DRUG__ID D0W7XR D0W7XR DRUGTYPE Small molecular drug D0W7XR DRUGINCH 1S/C17H17N5O/c1-21(2)17(23)22-16(18-19-20-22)12-13-8-10-15(11-9-13)14-6-4-3-5-7-14/h3-11H,12H2,1-2H3 D0W7XR DRUGINKE GZNIYOXWFCDBBJ-UHFFFAOYSA-N D0W7XR DRUGSMIL CN(C)C(=O)N1C(=NN=N1)CC2=CC=C(C=C2)C3=CC=CC=C3 D0W7XR HIGHSTAT Investigative D0W7ZB DRUG__ID D0W7ZB D0W7ZB DRUGTYPE Small molecular drug D0W7ZB DRUGINCH 1S/C13H19NO3/c1-10(15)14-8-4-5-11-9-12(16-2)6-7-13(11)17-3/h6-7,9H,4-5,8H2,1-3H3,(H,14,15) D0W7ZB DRUGINKE JFAQPXCGWLODGO-UHFFFAOYSA-N D0W7ZB DRUGSMIL CC(=O)NCCCC1=C(C=CC(=C1)OC)OC D0W7ZB HIGHSTAT Investigative D0W7ZM DRUG__ID D0W7ZM D0W7ZM DRUGTYPE Small molecular drug D0W7ZM DRUGINCH 1S/C14H18N2O/c1-10(2)8-9-17-12-5-3-4-11-6-7-13(15)16-14(11)12/h3-7,10H,8-9H2,1-2H3,(H2,15,16) D0W7ZM DRUGINKE RGLJKEQVQXDAIT-UHFFFAOYSA-N D0W7ZM DRUGSMIL CC(C)CCOC1=CC=CC2=C1N=C(C=C2)N D0W7ZM HIGHSTAT Investigative D0W8AD DRUG__ID D0W8AD D0W8AD DRUGTYPE Small molecular drug D0W8AD DRUGINCH 1S/C31H34N2O3/c1-25-24-33(30(35)32-29(25)34)22-14-3-2-4-15-23-36-31(26-16-8-5-9-17-26,27-18-10-6-11-19-27)28-20-12-7-13-21-28/h5-13,16-21,24H,2-4,14-15,22-23H2,1H3,(H,32,34,35) D0W8AD DRUGINKE MYFJLJCVSVNEDV-UHFFFAOYSA-N D0W8AD DRUGSMIL CC1=CN(C(=O)NC1=O)CCCCCCCOC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4 D0W8AD HIGHSTAT Investigative D0W8BJ DRUG__ID D0W8BJ D0W8BJ DRUGTYPE Small molecular drug D0W8BJ DRUGINCH 1S/C16H17NO/c1-11-6-2-5-9-15(11)18-16-10-14(17)12-7-3-4-8-13(12)16/h2-9,14,16H,10,17H2,1H3/t14-,16-/m0/s1 D0W8BJ DRUGINKE VQMGCAXPAOTPQE-HOCLYGCPSA-N D0W8BJ DRUGSMIL CC1=CC=CC=C1OC2CC(C3=CC=CC=C23)N D0W8BJ HIGHSTAT Investigative D0W8CA DRUG__ID D0W8CA D0W8CA DRUGCOMP Genzyme Corp D0W8CA DRUGINCH 1S/C17H14F3N3O2S/c1-9-21-12-8-11(25-17(18,19)20)4-5-13(12)23(9)15-7-6-14(26-15)16(24)22-10-2-3-10/h4-8,10H,2-3H2,1H3,(H,22,24) D0W8CA DRUGINKE ACFOZQUWTKSSQQ-UHFFFAOYSA-N D0W8CA DRUGSMIL CC1=NC2=C(N1C3=CC=C(S3)C(=O)NC4CC4)C=CC(=C2)OC(F)(F)F D0W8CA HIGHSTAT Investigative D0W8EB DRUG__ID D0W8EB D0W8EB DRUGTYPE Small molecular drug D0W8EB DRUGINCH 1S/C13H18N2O/c1-15(2)8-4-5-10-9-14-11-6-3-7-12(16)13(10)11/h3,6-7,9,14,16H,4-5,8H2,1-2H3 D0W8EB DRUGINKE IBSZSSDQXMYZOZ-UHFFFAOYSA-N D0W8EB DRUGSMIL CN(C)CCCC1=CNC2=C1C(=CC=C2)O D0W8EB HIGHSTAT Investigative D0W8EP DRUG__ID D0W8EP D0W8EP DRUGTYPE Small molecular drug D0W8EP DRUGINCH 1S/C14H21ClN2O3/c1-4-17(5-2)6-7-20-14(18)10-8-11(15)12(16)9-13(10)19-3/h8-9H,4-7,16H2,1-3H3 D0W8EP DRUGINKE FFNWMBDISAYHDC-UHFFFAOYSA-N D0W8EP DRUGSMIL CCN(CC)CCOC(=O)C1=CC(=C(C=C1OC)N)Cl D0W8EP HIGHSTAT Investigative D0W8FQ DRUG__ID D0W8FQ D0W8FQ DRUGTYPE Small molecular drug D0W8FQ DRUGINCH 1S/C2H5NS/c3-1-2-4/h1-2,4H,3H2/b2-1+ D0W8FQ DRUGINKE JLZMZFJVTNYDOT-OWOJBTEDSA-N D0W8FQ DRUGSMIL C(=CS)N D0W8FQ HIGHSTAT Investigative D0W8GU DRUG__ID D0W8GU D0W8GU DRUGTYPE Small molecular drug D0W8GU DRUGINCH 1S/C12H25O9S.ClH/c13-1-5(15)10(19)12(21)11(20)7(17)4-22-3-6(16)9(18)8(22)2-14;/h5-21H,1-4H2;1H/q+1;/p-1/t5-,6+,7+,8+,9-,10+,11+,12+,22?;/m0./s1 D0W8GU DRUGINKE RCIVZPJZNIFSOZ-RDZATYDKSA-M D0W8GU DRUGSMIL C1C(C(C([S+]1CC(C(C(C(C(CO)O)O)O)O)O)CO)O)O.[Cl-] D0W8GU HIGHSTAT Investigative D0W8GY DRUG__ID D0W8GY D0W8GY DRUGTYPE Small molecular drug D0W8GY DRUGINCH 1S/C20H10Br4O10S2.2Na/c21-15-13-14(16(22)18(24)17(15)23)20(34-19(13)27,7-1-3-9(25)11(5-7)35(28,29)30)8-2-4-10(26)12(6-8)36(31,32)33;;/h1-6,25-26H,(H,28,29,30)(H,31,32,33);;/q;2*+1/p-2 D0W8GY DRUGINKE GHAFORRTMVIXHS-UHFFFAOYSA-L D0W8GY DRUGSMIL C1=CC(=C(C=C1C2(C3=C(C(=C(C(=C3Br)Br)Br)Br)C(=O)O2)C4=CC(=C(C=C4)O)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+] D0W8GY HIGHSTAT Investigative D0W8IZ DRUG__ID D0W8IZ D0W8IZ DRUGTYPE Small molecular drug D0W8IZ DRUGINCH 1S/C16H13ClN2/c17-15-8-6-13(7-9-15)11-19-12-18-10-16(19)14-4-2-1-3-5-14/h1-10,12H,11H2 D0W8IZ DRUGINKE ILEPDNSLDAJTII-UHFFFAOYSA-N D0W8IZ DRUGSMIL C1=CC=C(C=C1)C2=CN=CN2CC3=CC=C(C=C3)Cl D0W8IZ HIGHSTAT Investigative D0W8JP DRUG__ID D0W8JP D0W8JP DRUGTYPE Small molecular drug D0W8JP DRUGINCH 1S/C11H12N4S2/c16-10(14-11-15-13-8-17-11)12-7-6-9-4-2-1-3-5-9/h1-5,8H,6-7H2,(H2,12,14,15,16) D0W8JP DRUGINKE CKSSUWZTRWMHOY-UHFFFAOYSA-N D0W8JP DRUGSMIL C1=CC=C(C=C1)CCNC(=S)NC2=NN=CS2 D0W8JP HIGHSTAT Investigative D0W8MP DRUG__ID D0W8MP D0W8MP DRUGTYPE Small molecular drug D0W8MP DRUGINCH 1S/C26H32N4O6/c1-14-9-18(31)10-15(2)19(14)12-20(27)26(36)30-13-17-6-4-3-5-16(17)11-22(30)25(35)29-21(24(28)34)7-8-23(32)33/h3-6,9-10,20-22,31H,7-8,11-13,27H2,1-2H3,(H2,28,34)(H,29,35)(H,32,33)/t20-,21-,22-/m0/s1 D0W8MP DRUGINKE CXJVHAFXBCEOKB-FKBYEOEOSA-N D0W8MP DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCC(=O)O)C(=O)N)N)C)O D0W8MP HIGHSTAT Investigative D0W8MX DRUG__ID D0W8MX D0W8MX DRUGTYPE Small molecular drug D0W8MX DRUGINCH 1S/C39H50N7O11P/c1-23(57-58(54,55)56)34(45-37(51)30(42-24(2)47)21-25-10-4-3-5-11-25)39(53)46-19-9-8-14-32(46)38(52)44-31(36(50)43-29(35(41)49)17-18-33(40)48)22-26-15-16-27-12-6-7-13-28(27)20-26/h3-7,10-13,15-16,20,23,29-32,34H,8-9,14,17-19,21-22H2,1-2H3,(H2,40,48)(H2,41,49)(H,42,47)(H,43,50)(H,44,52)(H,45,51)(H2,54,55,56)/t23-,29-,30-,31-,32+,34-/m0/s1 D0W8MX DRUGINKE KZSGJDBAWAUUMC-UHZLREMTSA-N D0W8MX DRUGSMIL CC(C(C(=O)N1CCCCC1C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C)OP(=O)(O)O D0W8MX HIGHSTAT Investigative D0W8NK DRUG__ID D0W8NK D0W8NK DRUGTYPE Small molecular drug D0W8NK DRUGINCH 1S/C14H15N2/c1-3-16-13-7-5-4-6-11(13)12-8-9-15(2)10-14(12)16/h4-10H,3H2,1-2H3/q+1 D0W8NK DRUGINKE UYPDJRFFVNWZQV-UHFFFAOYSA-N D0W8NK DRUGSMIL CCN1C2=CC=CC=C2C3=C1C=[N+](C=C3)C D0W8NK HIGHSTAT Investigative D0W8RB DRUG__ID D0W8RB D0W8RB DRUGTYPE Small molecular drug D0W8RB DRUGINCH 1S/C9H10BrN5/c1-2-3-4-15-8-6(14-9(15)10)7(11)12-5-13-8/h2,5H,1,3-4H2,(H2,11,12,13) D0W8RB DRUGINKE PZPGDJLTSOBNOR-UHFFFAOYSA-N D0W8RB DRUGSMIL C=CCCN1C2=NC=NC(=C2N=C1Br)N D0W8RB HIGHSTAT Investigative D0W8RP DRUG__ID D0W8RP D0W8RP DRUGTYPE Small molecular drug D0W8RP DRUGINCH 1S/C6H14NO6P/c1-4(2)13-14(10,11)12-3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)(H,10,11)/t5-/m1/s1 D0W8RP DRUGINKE DALHHSOTZKMXMV-RXMQYKEDSA-N D0W8RP DRUGSMIL CC(C)OP(=O)(O)OCC(C(=O)O)N D0W8RP HIGHSTAT Investigative D0W8SX DRUG__ID D0W8SX D0W8SX DRUGTYPE Small molecular drug D0W8SX DRUGINCH 1S/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6) D0W8SX DRUGINKE UCMIRNVEIXFBKS-UHFFFAOYSA-N D0W8SX DRUGSMIL C(CN)C(=O)O D0W8SX HIGHSTAT Investigative D0W8UW DRUG__ID D0W8UW D0W8UW DRUGTYPE Small molecular drug D0W8UW DRUGINCH 1S/C25H25FN6O2S/c1-16(18-6-8-19(26)9-7-18)31-10-12-32(13-11-31)22-14-23(28-15-27-22)34-20-4-3-5-21-24(20)30-25(35-21)29-17(2)33/h3-9,14-16H,10-13H2,1-2H3,(H,29,30,33)/t16-/m1/s1 D0W8UW DRUGINKE QUHZTEMPQQZPNB-MRXNPFEDSA-N D0W8UW DRUGSMIL CC(C1=CC=C(C=C1)F)N2CCN(CC2)C3=CC(=NC=N3)OC4=C5C(=CC=C4)SC(=N5)NC(=O)C D0W8UW HIGHSTAT Investigative D0W8VX DRUG__ID D0W8VX D0W8VX DRUGTYPE Small molecular drug D0W8VX DRUGINCH 1S/C23H23NO6/c1-26-17-7-12-6-15(13-8-19(28-3)22(30-5)20(9-13)29-4)21-16(11-24-23(21)25)14(12)10-18(17)27-2/h6-10H,11H2,1-5H3,(H,24,25) D0W8VX DRUGINKE LXPGOZAAMPJFEA-UHFFFAOYSA-N D0W8VX DRUGSMIL COC1=CC2=CC(=C3C(=C2C=C1OC)CNC3=O)C4=CC(=C(C(=C4)OC)OC)OC D0W8VX HIGHSTAT Investigative D0W8WZ DRUG__ID D0W8WZ D0W8WZ DRUGTYPE Small molecular drug D0W8WZ DRUGINCH 1S/C31H34N4O2/c1-3-23-11-7-9-15-28(23)35-30(21-22(2)34-35)37-29-16-10-8-14-27(29)33-31(36)32-26-19-17-25(18-20-26)24-12-5-4-6-13-24/h7-11,14-21,24H,3-6,12-13H2,1-2H3,(H2,32,33,36) D0W8WZ DRUGINKE BLOWXIFVYOKSMX-UHFFFAOYSA-N D0W8WZ DRUGSMIL CCC1=CC=CC=C1N2C(=CC(=N2)C)OC3=CC=CC=C3NC(=O)NC4=CC=C(C=C4)C5CCCCC5 D0W8WZ HIGHSTAT Investigative D0W8XI DRUG__ID D0W8XI D0W8XI DRUGTYPE Small molecular drug D0W8XI DRUGINCH 1S/C21H33NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1,4-5,11-12,20,23H,2-3,6-10,13-18H2 D0W8XI DRUGINKE ILHSFCNKNNNPRN-UHFFFAOYSA-N D0W8XI DRUGSMIL C1CCC(CC1)C(CCCN2CCCCC2)(C3=CC=CC=C3)O D0W8XI HIGHSTAT Investigative D0W8YE DRUG__ID D0W8YE D0W8YE DRUGTYPE Small molecular drug D0W8YE DRUGINCH 1S/C19H24N2O3/c1-3-5-12-21-19(22)17-13-14(20)6-11-18(17)24-16-9-7-15(8-10-16)23-4-2/h6-11,13H,3-5,12,20H2,1-2H3,(H,21,22) D0W8YE DRUGINKE RDHPPQMUBJSJFR-UHFFFAOYSA-N D0W8YE DRUGSMIL CCCCNC(=O)C1=C(C=CC(=C1)N)OC2=CC=C(C=C2)OCC D0W8YE HIGHSTAT Investigative D0W8YO DRUG__ID D0W8YO D0W8YO DRUGTYPE Small molecular drug D0W8YO DRUGINCH 1S/C17H17F2NO/c18-13-4-1-2-6-15(13)21-16-7-3-5-14(19)17(16)12-8-10-20-11-9-12/h1-7,12,20H,8-11H2 D0W8YO DRUGINKE ZSIHFDAUAFSTIM-UHFFFAOYSA-N D0W8YO DRUGSMIL C1CNCCC1C2=C(C=CC=C2F)OC3=CC=CC=C3F D0W8YO HIGHSTAT Investigative D0W9BD DRUG__ID D0W9BD D0W9BD DRUGTYPE Small molecular drug D0W9BD DRUGINCH 1S/C22H24FNO/c1-3-4-9-14-24-16(2)22(18-11-6-8-13-20(18)24)21(25)15-17-10-5-7-12-19(17)23/h5-8,10-13H,3-4,9,14-15H2,1-2H3 D0W9BD DRUGINKE SMBDYSPMOWAQKQ-UHFFFAOYSA-N D0W9BD DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3F)C D0W9BD HIGHSTAT Investigative D0W9BF DRUG__ID D0W9BF D0W9BF DRUGTYPE Small molecular drug D0W9BF DRUGINCH 1S/C15H13NO2S/c1-17-14-6-11-5-12(10-3-4-19-9-10)8-16-13(11)7-15(14)18-2/h3-9H,1-2H3 D0W9BF DRUGINKE KGGRQYJJHXVWSI-UHFFFAOYSA-N D0W9BF DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C3=CSC=C3 D0W9BF HIGHSTAT Investigative D0W9BH DRUG__ID D0W9BH D0W9BH DRUGTYPE Small molecular drug D0W9BH DRUGINCH 1S/C16H12N2O2/c17-11-13-3-8-15(9-4-13)14-6-1-12(2-7-14)5-10-16(19)18-20/h1-10,20H,(H,18,19)/b10-5+ D0W9BH DRUGINKE NJUOLWKIAIFTKT-BJMVGYQFSA-N D0W9BH DRUGSMIL C1=CC(=CC=C1C=CC(=O)NO)C2=CC=C(C=C2)C#N D0W9BH HIGHSTAT Investigative D0W9II DRUG__ID D0W9II D0W9II DRUGTYPE Small molecular drug D0W9II DRUGINCH 1S/C43H71N11O7/c1-8-61-41(60)33(23-26(2)3)52-39(58)35(43(4,5)6)53-37(56)32(24-27-25-49-29-16-10-9-15-28(27)29)51-38(57)34-19-14-22-54(34)40(59)31(17-11-12-20-44)50-36(55)30(47-7)18-13-21-48-42(45)46/h9-10,15-16,25-26,30-35,47,49H,8,11-14,17-24,44H2,1-7H3,(H,50,55)(H,51,57)(H,52,58)(H,53,56)(H4,45,46,48)/t30-,31-,32-,33-,34-,35+/m0/s1 D0W9II DRUGINKE BLWANJSERJECRU-ULWXFTFZSA-N D0W9II DRUGSMIL CCOC(=O)C(CC(C)C)NC(=O)C(C(C)(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC D0W9II HIGHSTAT Investigative D0W9JC DRUG__ID D0W9JC D0W9JC DRUGTYPE Small molecular drug D0W9JC DRUGINCH 1S/C20H28N2O2/c1-2-3-4-5-6-7-8-9-10-14-18(23)20-22-16-19(24-20)17-13-11-12-15-21-17/h11-13,15-16H,2-10,14H2,1H3 D0W9JC DRUGINKE VESZWTBYTDWAEO-UHFFFAOYSA-N D0W9JC DRUGSMIL CCCCCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=N2 D0W9JC HIGHSTAT Investigative D0W9JK DRUG__ID D0W9JK D0W9JK DRUGTYPE Small molecular drug D0W9JK DRUGINCH 1S/C19H24N2O/c1-14(2)13-21(18-9-10-20-12-18)19(22)17-8-7-15-5-3-4-6-16(15)11-17/h3-8,11,14,18,20H,9-10,12-13H2,1-2H3/t18-/m0/s1 D0W9JK DRUGINKE CEUJKSVEPJAVKD-SFHVURJKSA-N D0W9JK DRUGSMIL CC(C)CN(C1CCNC1)C(=O)C2=CC3=CC=CC=C3C=C2 D0W9JK HIGHSTAT Investigative D0W9KO DRUG__ID D0W9KO D0W9KO DRUGTYPE Small molecular drug D0W9KO DRUGINCH 1S/C14H13N3O2/c18-13-4-1-9(5-14(13)19)7-15-11-3-2-10-8-16-17-12(10)6-11/h1-6,8,15,18-19H,7H2,(H,16,17) D0W9KO DRUGINKE FOCLURCEJLBSGE-UHFFFAOYSA-N D0W9KO DRUGSMIL C1=CC(=C(C=C1CNC2=CC3=C(C=C2)C=NN3)O)O D0W9KO HIGHSTAT Investigative D0W9LJ DRUG__ID D0W9LJ D0W9LJ DRUGTYPE Small molecular drug D0W9LJ DRUGINCH 1S/C9H16N4S2/c1-7-8(13-6-12-7)5-15-4-3-11-9(14)10-2/h6H,3-5H2,1-2H3,(H,12,13)(H2,10,11,14) D0W9LJ DRUGINKE FPBPLBWLMYGIQR-UHFFFAOYSA-N D0W9LJ DRUGSMIL CC1=C(N=CN1)CSCCNC(=S)NC D0W9LJ HIGHSTAT Investigative D0W9PF DRUG__ID D0W9PF D0W9PF DRUGTYPE Small molecular drug D0W9PF DRUGINCH 1S/C19H24O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,11,14-16H,3-6,8,10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1 D0W9PF DRUGINKE LUJVUUWNAPIQQI-QAGGRKNESA-N D0W9PF DRUGSMIL CC12CCC3C(C1CCC2=O)CCC4=CC(=O)C=CC34C D0W9PF HIGHSTAT Investigative D0W9RM DRUG__ID D0W9RM D0W9RM DRUGTYPE Small molecular drug D0W9RM DRUGINCH 1S/C11H11NO3/c1-7-2-3-8(11(14)15)6-9(7)12-5-4-10(12)13/h2-3,6H,4-5H2,1H3,(H,14,15) D0W9RM DRUGINKE XLQAIEGAEHIXRJ-UHFFFAOYSA-N D0W9RM DRUGSMIL CC1=C(C=C(C=C1)C(=O)O)N2CCC2=O D0W9RM HIGHSTAT Investigative D0W9RR DRUG__ID D0W9RR D0W9RR DRUGTYPE Small molecular drug D0W9RR DRUGINCH 1S/C32H43N5O2/c38-31(36-20-12-27(13-21-36)34-16-4-5-17-34)25-10-11-29(30(24-25)33-26-8-2-1-3-9-26)32(39)37-22-14-28(15-23-37)35-18-6-7-19-35/h1-3,8-11,24,27-28,33H,4-7,12-23H2 D0W9RR DRUGINKE PQOOIERVZAXHBP-UHFFFAOYSA-N D0W9RR DRUGSMIL C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6 D0W9RR HIGHSTAT Investigative D0W9TD DRUG__ID D0W9TD D0W9TD DRUGTYPE Small molecular drug D0W9TD DRUGINCH 1S/C8H8N2O4S/c11-8(10-12)6-9-15(13,14)7-4-2-1-3-5-7/h1-5,9H,6H2 D0W9TD DRUGINKE LBEMJFIVKDOIBO-UHFFFAOYSA-N D0W9TD DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NCC(=O)N=O D0W9TD HIGHSTAT Investigative D0W9UV DRUG__ID D0W9UV D0W9UV DRUGTYPE Small molecular drug D0W9UV DRUGINCH 1S/C7H10N2/c1-5-3-6(2)9-7(8)4-5/h3-4H,1-2H3,(H2,8,9) D0W9UV DRUGINKE BRBUBVKGJRPRRD-UHFFFAOYSA-N D0W9UV DRUGSMIL CC1=CC(=NC(=C1)N)C D0W9UV HIGHSTAT Investigative D0W9VA DRUG__ID D0W9VA D0W9VA DRUGTYPE Small molecular drug D0W9VA DRUGINCH 1S/C10H6O2/c11-9-6-5-7-3-1-2-4-8(7)10(9)12/h1-6H D0W9VA DRUGINKE KETQAJRQOHHATG-UHFFFAOYSA-N D0W9VA DRUGSMIL C1=CC=C2C(=C1)C=CC(=O)C2=O D0W9VA HIGHSTAT Investigative D0W9VC DRUG__ID D0W9VC D0W9VC DRUGTYPE Small molecular drug D0W9VC DRUGINCH 1S/C12H12N2O3S2/c13-19(16,17)11-5-3-9(4-6-11)14-12(15)8-10-2-1-7-18-10/h1-7H,8H2,(H,14,15)(H2,13,16,17) D0W9VC DRUGINKE ZQWXOBLMDBJRLY-UHFFFAOYSA-N D0W9VC DRUGSMIL C1=CSC(=C1)CC(=O)NC2=CC=C(C=C2)S(=O)(=O)N D0W9VC HIGHSTAT Investigative D0W9VN DRUG__ID D0W9VN D0W9VN DRUGTYPE Small molecular drug D0W9VN DRUGINCH 1S/C12H9ClN2O/c13-9-4-3-5-10(8-9)15-12(16)11-6-1-2-7-14-11/h1-8H,(H,15,16) D0W9VN DRUGINKE SUYUTNCKIOLMAJ-UHFFFAOYSA-N D0W9VN DRUGSMIL C1=CC=NC(=C1)C(=O)NC2=CC(=CC=C2)Cl D0W9VN HIGHSTAT Investigative D0W9WG DRUG__ID D0W9WG D0W9WG DRUGTYPE Small molecular drug D0W9WG DRUGINCH 1S/C15H20N2O2/c1-3-15(4-2)13(18)17-14(19-15)16-11-10-12-8-6-5-7-9-12/h5-9H,3-4,10-11H2,1-2H3,(H,16,17,18) D0W9WG DRUGINKE ARZSETSNEBJNMA-UHFFFAOYSA-N D0W9WG DRUGSMIL CCC1(C(=O)NC(=NCCC2=CC=CC=C2)O1)CC D0W9WG HIGHSTAT Investigative D0W9WU DRUG__ID D0W9WU D0W9WU DRUGTYPE Small molecular drug D0W9WU DRUGINCH 1S/C16H29NO4/c1-2-3-4-9-12-15(17(20)21)13-10-7-5-6-8-11-14-16(18)19/h13H,2-12,14H2,1H3,(H,18,19)/b15-13+ D0W9WU DRUGINKE WZWPBDQYCAJWSX-FYWRMAATSA-N D0W9WU DRUGSMIL CCCCCCC(=CCCCCCCCC(=O)O)[N+](=O)[O-] D0W9WU HIGHSTAT Investigative D0W9WW DRUG__ID D0W9WW D0W9WW DRUGTYPE Small molecular drug D0W9WW DRUGINCH 1S/C15H8FNO4/c16-10-4-5-14-12(7-10)13(18)8-15(21-14)9-2-1-3-11(6-9)17(19)20/h1-8H D0W9WW DRUGINKE QKZNNAUSAVZXNE-UHFFFAOYSA-N D0W9WW DRUGSMIL C1=CC(=CC(=C1)[N+](=O)[O-])C2=CC(=O)C3=C(O2)C=CC(=C3)F D0W9WW HIGHSTAT Investigative D0W9YC DRUG__ID D0W9YC D0W9YC DRUGTYPE Small molecular drug D0W9YC DRUGINCH 1S/C14H12N2OS/c1-17-12-6-2-3-7-14(12)18-13-8-4-5-11(16)10(13)9-15/h2-8H,16H2,1H3 D0W9YC DRUGINKE NZXQIIPHDSINPY-UHFFFAOYSA-N D0W9YC DRUGSMIL COC1=CC=CC=C1SC2=CC=CC(=C2C#N)N D0W9YC HIGHSTAT Investigative D0W9ZC DRUG__ID D0W9ZC D0W9ZC DRUGTYPE Small molecular drug D0W9ZC DRUGINCH 1S/C17H11N3O3S/c21-16-12-3-1-2-4-14(12)24-17-11(9-19-8-7-18-10-19)5-6-13(15(16)17)20(22)23/h1-8,10H,9H2 D0W9ZC DRUGINKE OCFFNJCKSSDREB-UHFFFAOYSA-N D0W9ZC DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3S2)CN4C=CN=C4)[N+](=O)[O-] D0W9ZC HIGHSTAT Investigative D0W9ZH DRUG__ID D0W9ZH D0W9ZH DRUGTYPE Small molecular drug D0W9ZH DRUGINCH 1S/C26H23N4O2.CHF3O3S/c1-27(2)20-11-9-18(10-12-20)15-22-23-16-21(30(31)32)13-14-24(23)29-26(22)17-25(28(29)3)19-7-5-4-6-8-19;2-1(3,4)8(5,6)7/h4-17H,1-3H3;(H,5,6,7)/q+1;/p-1 D0W9ZH DRUGINKE CKJNKVUCIFATCQ-UHFFFAOYSA-M D0W9ZH DRUGSMIL C[N+]1=C(C=C2N1C3=C(C2=CC4=CC=C(C=C4)N(C)C)C=C(C=C3)[N+](=O)[O-])C5=CC=CC=C5.C(F)(F)(F)S(=O)(=O)[O-] D0W9ZH HIGHSTAT Investigative D0W9ZV DRUG__ID D0W9ZV D0W9ZV DRUGTYPE Small molecular drug D0W9ZV DRUGINCH 1S/C14H10BrClN2O2S3/c1-8-17-12(7-21-8)13-4-5-14(22-13)23(19,20)18-11-3-2-9(15)6-10(11)16/h2-7,18H,1H3 D0W9ZV DRUGINKE AMNKYHFERGWVCB-UHFFFAOYSA-N D0W9ZV DRUGSMIL CC1=NC(=CS1)C2=CC=C(S2)S(=O)(=O)NC3=C(C=C(C=C3)Br)Cl D0W9ZV HIGHSTAT Investigative D0WA3E DRUG__ID D0WA3E D0WA3E DRUGTYPE Small molecular drug D0WA3E DRUGINCH 1S/C19H16N2O5/c22-15(23)10-20-18(25)16-17(24)13-8-4-5-9-14(13)21(19(16)26)11-12-6-2-1-3-7-12/h1-9,24H,10-11H2,(H,20,25)(H,22,23) D0WA3E DRUGINKE CAOSCCRYLYQBES-UHFFFAOYSA-N D0WA3E DRUGSMIL C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O D0WA3E HIGHSTAT Investigative D0WA9S DRUG__ID D0WA9S D0WA9S DRUGTYPE Small molecular drug D0WA9S DRUGINCH 1S/C18H10O9/c19-6-1-8(21)14-11(3-6)26-17-13(24-14)5-10(23)16-18(17)27-15-9(22)2-7(20)4-12(15)25-16/h1-5,19-23H D0WA9S DRUGINKE LBHQACSAGWCMAB-UHFFFAOYSA-N D0WA9S DRUGSMIL C1=C(C=C2C(=C1O)OC3=C(O2)C4=C(C(=C3)O)OC5=CC(=CC(=C5O4)O)O)O D0WA9S HIGHSTAT Investigative D0WB1D DRUG__ID D0WB1D D0WB1D DRUGTYPE Small molecular drug D0WB1D DRUGINCH 1S/C23H28FNO3/c24-21-10-8-20(9-11-21)23(26)27-17-5-4-14-25-15-12-22(13-16-25)28-18-19-6-2-1-3-7-19/h1-3,6-11,22H,4-5,12-18H2 D0WB1D DRUGINKE WNLQOEBYDOWFBU-UHFFFAOYSA-N D0WB1D DRUGSMIL C1CN(CCC1OCC2=CC=CC=C2)CCCCOC(=O)C3=CC=C(C=C3)F D0WB1D HIGHSTAT Investigative D0WB6P DRUG__ID D0WB6P D0WB6P DRUGTYPE Small molecular drug D0WB6P DRUGINCH 1S/C17H17NOS/c18-11-10-16(17-9-4-12-20-17)19-15-8-3-6-13-5-1-2-7-14(13)15/h1-9,12,16H,10-11,18H2/t16-/m1/s1 D0WB6P DRUGINKE ZMXLKLOJDLMZFC-MRXNPFEDSA-N D0WB6P DRUGSMIL C1=CC=C2C(=C1)C=CC=C2OC(CCN)C3=CC=CS3 D0WB6P HIGHSTAT Investigative D0WB8E DRUG__ID D0WB8E D0WB8E DRUGTYPE Small molecular drug D0WB8E DRUGINCH 1S/C20H21ClN4O2/c1-13(2)18-17(23-20(27)22-15-11-9-14(21)10-12-15)19(26)25(24(18)3)16-7-5-4-6-8-16/h4-13H,1-3H3,(H2,22,23,27) D0WB8E DRUGINKE PAEBEUZTAPIOIO-UHFFFAOYSA-N D0WB8E DRUGSMIL CC(C)C1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)NC3=CC=C(C=C3)Cl D0WB8E HIGHSTAT Investigative D0WC5L DRUG__ID D0WC5L D0WC5L DRUGTYPE Small molecular drug D0WC5L DRUGINCH 1S/C16H20N2O2/c1-3-5-8-17-16(20)13-10-18-14-7-6-11(4-2)9-12(14)15(13)19/h6-7,9-10H,3-5,8H2,1-2H3,(H,17,20)(H,18,19) D0WC5L DRUGINKE QHHMSXBSEWIFOB-UHFFFAOYSA-N D0WC5L DRUGSMIL CCCCNC(=O)C1=CNC2=C(C1=O)C=C(C=C2)CC D0WC5L HIGHSTAT Investigative D0WD1E DRUG__ID D0WD1E D0WD1E DRUGTYPE Small molecular drug D0WD1E DRUGINCH 1S/C29H44O8/c1-18-16-17-24(34-5)23(33-4)15-11-10-14-22(21-12-8-7-9-13-21)36-28(31)20(3)29(32)27(35-6)25(30)19(2)26(18)37-29/h7-9,12-13,16-20,22-27,30,32H,10-11,14-15H2,1-6H3/b17-16+/t18-,19-,20+,22-,23-,24+,25-,26-,27+,29+/m0/s1 D0WD1E DRUGINKE WPMGNXPRKGXGBO-OFQQMTDKSA-N D0WD1E DRUGSMIL CC1C=CC(C(CCCCC(OC(=O)C(C2(C(C(C(C1O2)C)O)OC)O)C)C3=CC=CC=C3)OC)OC D0WD1E HIGHSTAT Investigative D0WD1F DRUG__ID D0WD1F D0WD1F DRUGTYPE Small molecular drug D0WD1F DRUGINCH 1S/C22H25NO/c1-3-4-10-15-23-17(2)22(19-13-8-9-14-20(19)23)21(24)16-18-11-6-5-7-12-18/h5-9,11-14H,3-4,10,15-16H2,1-2H3 D0WD1F DRUGINKE BVRXLMVNOFBNCJ-UHFFFAOYSA-N D0WD1F DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=CC=C3)C D0WD1F HIGHSTAT Investigative D0WD6J DRUG__ID D0WD6J D0WD6J DRUGTYPE Small molecular drug D0WD6J DRUGINCH 1S/C19H21N3O/c1-2-5-16(6-3-1)14-21-11-8-17(9-12-21)22-10-4-7-18(22)19-13-20-15-23-19/h1-7,10,13,15,17H,8-9,11-12,14H2 D0WD6J DRUGINKE JTHXHSNJAJMWTQ-UHFFFAOYSA-N D0WD6J DRUGSMIL C1CN(CCC1N2C=CC=C2C3=CN=CO3)CC4=CC=CC=C4 D0WD6J HIGHSTAT Investigative D0WE4C DRUG__ID D0WE4C D0WE4C DRUGTYPE Small molecular drug D0WE4C DRUGINCH 1S/C24H28N2O2/c1-3-7-23(27)25-14-13-20-21-16-18(28-2)11-12-22(21)26-15-6-9-17-8-4-5-10-19(17)24(20)26/h4-5,8,10-12,16H,3,6-7,9,13-15H2,1-2H3,(H,25,27) D0WE4C DRUGINKE SPIFQXPRSJKRAO-UHFFFAOYSA-N D0WE4C DRUGSMIL CCCC(=O)NCCC1=C2C3=CC=CC=C3CCCN2C4=C1C=C(C=C4)OC D0WE4C HIGHSTAT Investigative D0WF7I DRUG__ID D0WF7I D0WF7I DRUGTYPE Small molecular drug D0WF7I DRUGINCH 1S/C22H18Cl2O5/c23-17-9-3-1-6-14(17)12-28-19-11-5-8-16(20(25)22(26)27)21(19)29-13-15-7-2-4-10-18(15)24/h1-11,20,25H,12-13H2,(H,26,27)/t20-/m0/s1 D0WF7I DRUGINKE NCWQPARYSYJFNI-FQEVSTJZSA-N D0WF7I DRUGSMIL C1=CC=C(C(=C1)COC2=CC=CC(=C2OCC3=CC=CC=C3Cl)C(C(=O)O)O)Cl D0WF7I HIGHSTAT Investigative D0WG0O DRUG__ID D0WG0O D0WG0O DRUGTYPE Small molecular drug D0WG0O DRUGINCH 1S/C45H57N9O9S2/c1-26(55)38-44(61)52-35(21-28-14-6-3-7-15-28)42(59)53-37(45(62)63)25-65-64-24-31(47)39(56)50-34(20-27-12-4-2-5-13-27)41(58)51-36(22-29-23-48-32-17-9-8-16-30(29)32)43(60)49-33(40(57)54-38)18-10-11-19-46/h2-9,12-17,23,26,31,33-38,48,55H,10-11,18-22,24-25,46-47H2,1H3,(H,49,60)(H,50,56)(H,51,58)(H,52,61)(H,53,59)(H,54,57)(H,62,63)/t26-,31-,33+,34+,35+,36+,37+,38-/m1/s1 D0WG0O DRUGINKE GGSHKARHPHVZOO-KLCDHWPJSA-N D0WG0O DRUGSMIL CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)N)C(=O)O)CC5=CC=CC=C5)O D0WG0O HIGHSTAT Investigative D0WG7H DRUG__ID D0WG7H D0WG7H DRUGTYPE Small molecular drug D0WG7H DRUGINCH 1S/C23H25O7PS/c24-31(25,26)23(32(27,28)29)15-7-11-19-10-6-13-21(17-19)30-22-14-5-4-12-20(22)16-18-8-2-1-3-9-18/h1-6,8-10,12-14,17,23H,7,11,15-16H2,(H2,24,25,26)(H,27,28,29)/p-3 D0WG7H DRUGINKE ZMOCESLEEQXYRI-UHFFFAOYSA-K D0WG7H DRUGSMIL C1=CC=C(C=C1)CC2=CC=CC=C2OC3=CC=CC(=C3)CCCC(P(=O)([O-])[O-])S(=O)(=O)[O-] D0WG7H HIGHSTAT Investigative D0WG9Y DRUG__ID D0WG9Y D0WG9Y DRUGTYPE Small molecular drug D0WG9Y DRUGINCH 1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(25-27(20,21)22)6(16)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1 D0WG9Y DRUGINKE AEOBEOJCBAYXBA-KQYNXXCUSA-N D0WG9Y DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)OP(=O)(O)O)N D0WG9Y HIGHSTAT Investigative D0WH4J DRUG__ID D0WH4J D0WH4J DRUGTYPE Small molecular drug D0WH4J DRUGINCH 1S/C10H16N2O7/c1-2-3-11-10(13)18-6-4-16-9-7(19-12(14)15)5-17-8(6)9/h6-9H,2-5H2,1H3,(H,11,13)/t6-,7+,8+,9+/m0/s1 D0WH4J DRUGINKE HZZGTUOWJWTZKT-JQCXWYLXSA-N D0WH4J DRUGSMIL CCCNC(=O)OC1COC2C1OCC2O[N+](=O)[O-] D0WH4J HIGHSTAT Investigative D0WI3V DRUG__ID D0WI3V D0WI3V DRUGTYPE Small molecular drug D0WI3V DRUGINCH 1S/C15H12Cl2N4/c16-10-7-12-13(8-11(10)17)20-15(21-18)14(19-12)6-9-4-2-1-3-5-9/h1-5,7-8H,6,18H2,(H,20,21) D0WI3V DRUGINKE UMCSOEDKYUEPEK-UHFFFAOYSA-N D0WI3V DRUGSMIL C1=CC=C(C=C1)CC2=NC3=CC(=C(C=C3N=C2NN)Cl)Cl D0WI3V HIGHSTAT Investigative D0WI3W DRUG__ID D0WI3W D0WI3W DRUGTYPE Small molecular drug D0WI3W DRUGINCH 1S/C4H12N2S2/c5-1-3-7-8-4-2-6/h1-6H2 D0WI3W DRUGINKE APQPRKLAWCIJEK-UHFFFAOYSA-N D0WI3W DRUGSMIL C(CSSCCN)N D0WI3W HIGHSTAT Investigative D0WI4D DRUG__ID D0WI4D D0WI4D DRUGTYPE Small molecular drug D0WI4D DRUGINCH 1S/C22H20N4/c1-3-9-15(10-4-1)18-19-22(26-21(24-19)17-13-7-8-14-17)25-20(23-18)16-11-5-2-6-12-16/h1-6,9-12,17H,7-8,13-14H2,(H,23,24,25,26) D0WI4D DRUGINKE NDJOQVVSPLVIDN-UHFFFAOYSA-N D0WI4D DRUGSMIL C1CCC(C1)C2=NC3=NC(=NC(=C3N2)C4=CC=CC=C4)C5=CC=CC=C5 D0WI4D HIGHSTAT Investigative D0WI8M DRUG__ID D0WI8M D0WI8M DRUGTYPE Small molecular drug D0WI8M DRUGINCH 1S/C46H61N11O7/c47-34-14-5-3-12-32(58)20-21-40(59)51-22-8-7-16-36(41(48)60)54-45(64)39(26-31-27-53-35-15-6-4-13-33(31)35)57-43(62)37(17-9-23-52-46(49)50)55-44(63)38(56-42(34)61)25-28-18-19-29-10-1-2-11-30(29)24-28/h1-2,4,6,10-11,13,15,18-19,24,27,34,36-39,53H,3,5,7-9,12,14,16-17,20-23,25-26,47H2,(H2,48,60)(H,51,59)(H,54,64)(H,55,63)(H,56,61)(H,57,62)(H4,49,50,52)/t34-,36-,37-,38+,39-/m0/s1 D0WI8M DRUGINKE KDTZLQMUHBEBMZ-OUBWENQOSA-N D0WI8M DRUGSMIL C1CCC(=O)CCC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C1)N)CC2=CC3=CC=CC=C3C=C2)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N D0WI8M HIGHSTAT Investigative D0WJ1N DRUG__ID D0WJ1N D0WJ1N DRUGTYPE Small molecular drug D0WJ1N DRUGINCH 1S/C38H63N2O7P/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21-28-39-36(41)44-32-37(2)26-27-38(3,47-37)33-46-48(42,43)45-31-30-40-29-22-24-34-23-19-20-25-35(34)40/h19-20,22-25,29H,4-18,21,26-28,30-33H2,1-3H3,(H-,39,41,42,43)/t37-,38+/m0/s1 D0WJ1N DRUGINKE JANHWNKOVXOFLY-QPPIDDCLSA-N D0WJ1N DRUGSMIL CCCCCCCCCCCCCCCCCCNC(=O)OCC1(CCC(O1)(C)COP(=O)([O-])OCC[N+]2=CC=CC3=CC=CC=C32)C D0WJ1N HIGHSTAT Investigative D0WJ5T DRUG__ID D0WJ5T D0WJ5T DRUGTYPE Small molecular drug D0WJ5T DRUGINCH 1S/C22H22N2O4/c1-3-5-19(25)23-13-7-9-15-17(11-13)22(28)18-12-14(24-20(26)6-4-2)8-10-16(18)21(15)27/h7-12H,3-6H2,1-2H3,(H,23,25)(H,24,26) D0WJ5T DRUGINKE WKZCLVUWGOTILL-UHFFFAOYSA-N D0WJ5T DRUGSMIL CCCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CCC D0WJ5T HIGHSTAT Investigative D0WJ8I DRUG__ID D0WJ8I D0WJ8I DRUGTYPE Small molecular drug D0WJ8I DRUGINCH 1S/C12H9NOS/c1-9-13-11(8-15-9)6-5-10-3-2-4-12(14)7-10/h2-4,7-8,14H,1H3 D0WJ8I DRUGINKE HMWLZOIKORRPSN-UHFFFAOYSA-N D0WJ8I DRUGSMIL CC1=NC(=CS1)C#CC2=CC(=CC=C2)O D0WJ8I HIGHSTAT Investigative D0WK2F DRUG__ID D0WK2F D0WK2F DRUGTYPE Small molecular drug D0WK2F DRUGINCH 1S/C31H38F2N8O7/c32-28(33)31(16-19-10-5-2-6-11-19)29(48)40-20(12-7-13-36-30(34)35)25(45)37-17-23(42)38-22(15-24(43)44)26(46)39-21(27(47)41-31)14-18-8-3-1-4-9-18/h1-6,8-11,20-22,28H,7,12-17H2,(H,37,45)(H,38,42)(H,39,46)(H,40,48)(H,41,47)(H,43,44)(H4,34,35,36)/t20-,21+,22-,31?/m0/s1 D0WK2F DRUGINKE DZUCEYPUEFNCRE-ZONASRJLSA-N D0WK2F DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)(CC2=CC=CC=C2)C(F)F)CC3=CC=CC=C3)CC(=O)O D0WK2F HIGHSTAT Investigative D0WK3N DRUG__ID D0WK3N D0WK3N DRUGTYPE Small molecular drug D0WK3N DRUGINCH 1S/C26H33N3O/c1-3-4-5-6-7-8-11-18-29(2)24-16-14-21(15-17-24)26(30)28-23-19-22-12-9-10-13-25(22)27-20-23/h9-10,12-17,19-20H,3-8,11,18H2,1-2H3,(H,28,30) D0WK3N DRUGINKE KGQMIDBMCJPWMX-UHFFFAOYSA-N D0WK3N DRUGSMIL CCCCCCCCCN(C)C1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D0WK3N HIGHSTAT Investigative D0WK9Q DRUG__ID D0WK9Q D0WK9Q DRUGTYPE Small molecular drug D0WK9Q DRUGINCH 1S/C16H19NO2/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h5-11H,3-4,17H2,1-2H3 D0WK9Q DRUGINKE LIBKKCPPEBZEHD-UHFFFAOYSA-N D0WK9Q DRUGSMIL COC1=CC(=CC(=C1)CCC2=CC=C(C=C2)N)OC D0WK9Q HIGHSTAT Investigative D0WK9R DRUG__ID D0WK9R D0WK9R DRUGTYPE Small molecular drug D0WK9R DRUGINCH 1S/C17H15N5O/c18-9-12-2-1-3-13(8-12)14-10-19-16-15(14)17(21-11-20-16)22-4-6-23-7-5-22/h1-3,8,10-11H,4-7H2,(H,19,20,21) D0WK9R DRUGINKE BHTWDJBVZQBRKP-UHFFFAOYSA-N D0WK9R DRUGSMIL C1COCCN1C2=NC=NC3=C2C(=CN3)C4=CC=CC(=C4)C#N D0WK9R HIGHSTAT Investigative D0WM4K DRUG__ID D0WM4K D0WM4K DRUGTYPE Small molecular drug D0WM4K DRUGINCH 1S/C24H29NO2/c1-24-10-9-20-19-8-6-18(26)13-15(19)5-7-21(20)22(24)14-16(23(24)27)12-17-4-2-3-11-25-17/h2-4,6,8,11,13,16,20-23,26-27H,5,7,9-10,12,14H2,1H3/t16-,20?,21?,22?,23-,24-/m0/s1 D0WM4K DRUGINKE SJHBYTOZADGQDY-CCXBEIMISA-N D0WM4K DRUGSMIL CC12CCC3C(C1CC(C2O)CC4=CC=CC=N4)CCC5=C3C=CC(=C5)O D0WM4K HIGHSTAT Investigative D0WN3O DRUG__ID D0WN3O D0WN3O DRUGTYPE Small molecular drug D0WN3O DRUGINCH 1S/C22H23N3O/c1-3-16(4-2)21(26)25-22-23-19(17-11-7-5-8-12-17)15-20(24-22)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3,(H,23,24,25,26) D0WN3O DRUGINKE YOARGGKKYZIYSU-UHFFFAOYSA-N D0WN3O DRUGSMIL CCC(CC)C(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D0WN3O HIGHSTAT Investigative D0WN7V DRUG__ID D0WN7V D0WN7V DRUGTYPE Small molecular drug D0WN7V DRUGINCH 1S/C16H14O5/c1-8-11(18)6-14-15(16(8)20)12(19)7-13(21-14)9-2-4-10(17)5-3-9/h2-6,13,17-18,20H,7H2,1H3 D0WN7V DRUGINKE SLFZBNOERHGNMI-UHFFFAOYSA-N D0WN7V DRUGSMIL CC1=C(C2=C(C=C1O)OC(CC2=O)C3=CC=C(C=C3)O)O D0WN7V HIGHSTAT Investigative D0WN9P DRUG__ID D0WN9P D0WN9P DRUGTYPE Small molecular drug D0WN9P DRUGINCH 1S/C18H16N2/c19-18-3-1-2-17(13-18)16-6-4-14(5-7-16)12-15-8-10-20-11-9-15/h1-11,13H,12,19H2 D0WN9P DRUGINKE MVDKLMQNQSJYHJ-UHFFFAOYSA-N D0WN9P DRUGSMIL C1=CC(=CC(=C1)N)C2=CC=C(C=C2)CC3=CC=NC=C3 D0WN9P HIGHSTAT Investigative D0WO3A DRUG__ID D0WO3A D0WO3A DRUGTYPE Small molecular drug D0WO3A DRUGINCH 1S/C9H16NO/c1-8-5-6-9(11-8)7-10(2,3)4/h5-6H,7H2,1-4H3/q+1 D0WO3A DRUGINKE KOWVJDFMEZKDDT-UHFFFAOYSA-N D0WO3A DRUGSMIL CC1=CC=C(O1)C[N+](C)(C)C D0WO3A HIGHSTAT Investigative D0WO3P DRUG__ID D0WO3P D0WO3P DRUGTYPE Small molecular drug D0WO3P DRUGINCH 1S/C15H11N5O2/c1-22-12-4-2-3-11-13(12)17-14(18-15(11)21)9-5-7-10(8-6-9)19-20-16/h2-8H,1H3,(H,17,18,21) D0WO3P DRUGINKE BLVUCZJFMHXSJA-UHFFFAOYSA-N D0WO3P DRUGSMIL COC1=CC=CC2=C1N=C(NC2=O)C3=CC=C(C=C3)N=[N+]=[N-] D0WO3P HIGHSTAT Investigative D0WO8A DRUG__ID D0WO8A D0WO8A DRUGTYPE Small molecular drug D0WO8A DRUGINCH 1S/C21H13Cl3N2O2/c22-14-3-1-13(2-4-14)19-20(27)26(18-11-7-16(24)8-12-18)21(28)25(19)17-9-5-15(23)6-10-17/h1-12,27H D0WO8A DRUGINKE FXRARDZLGGDTOS-UHFFFAOYSA-N D0WO8A DRUGSMIL C1=CC(=CC=C1C2=C(N(C(=O)N2C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl)O)Cl D0WO8A HIGHSTAT Investigative D0WP6A DRUG__ID D0WP6A D0WP6A DRUGTYPE Small molecular drug D0WP6A DRUGINCH 1S/C14H10O3/c1-8-12(15)7-6-10-9-4-2-3-5-11(9)14(16)17-13(8)10/h2-7,15H,1H3 D0WP6A DRUGINKE LAVHXGNOROFSCU-UHFFFAOYSA-N D0WP6A DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=CC=CC=C23)O D0WP6A HIGHSTAT Investigative D0WQ4G DRUG__ID D0WQ4G D0WQ4G DRUGTYPE Small molecular drug D0WQ4G DRUGINCH 1S/C18H10N2O4/c1-5-13-9-7(3-19-13)12-10-8(11(9)17(23)15(5)21)4-20-14(10)6(2)16(22)18(12)24/h3-4,19-20H,1-2H3 D0WQ4G DRUGINKE XUMBMVFBXHLACL-UHFFFAOYSA-N D0WQ4G DRUGSMIL CC1=C2C3=C(C4=CNC5=C(C(=O)C(=O)C(=C45)C3=CN2)C)C(=O)C1=O D0WQ4G HIGHSTAT Investigative D0WQ7U DRUG__ID D0WQ7U D0WQ7U DRUGTYPE Small molecular drug D0WQ7U DRUGINCH 1S/C3H7O7P/c4-2(3(5)6)1-10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/t2-/m1/s1 D0WQ7U DRUGINKE OSJPPGNTCRNQQC-UWTATZPHSA-N D0WQ7U DRUGSMIL C(C(C(=O)O)O)OP(=O)(O)O D0WQ7U HIGHSTAT Investigative D0WQ9A DRUG__ID D0WQ9A D0WQ9A DRUGTYPE Small molecular drug D0WQ9A DRUGINCH 1S/C24H33N3O3/c1-29-11-8-17-13-16-14-24(23(28)25-9-12-30-2)21-19(7-10-27(15-16)22(17)24)18-5-3-4-6-20(18)26-21/h3-6,16-17,22,26H,7-15H2,1-2H3,(H,25,28)/t16?,17-,22-,24+/m0/s1 D0WQ9A DRUGINKE OLGJSZRDLAADNK-SAJNPJMVSA-N D0WQ9A DRUGSMIL COCCC1CC2CC3(C1N(C2)CCC4=C3NC5=CC=CC=C45)C(=O)NCCOC D0WQ9A HIGHSTAT Investigative D0WS8K DRUG__ID D0WS8K D0WS8K DRUGCOMP Novartis AG D0WS8K DRUGINCH 1S/C61H86N10O20S2/c1-31(74)42(25-72)68-58(86)44-29-93-92-28-43(69-54(82)39(21-33-13-5-3-6-14-33)64-30-61(88)52(80)51(45(76)27-89-61)91-60-50(79)49(78)48(77)46(26-73)90-60)57(85)66-40(22-34-15-7-4-8-16-34)55(83)67-41(23-35-24-63-37-18-10-9-17-36(35)37)56(84)65-38(19-11-12-20-62)53(81)71-47(32(2)75)59(87)70-44/h3-10,13-18,24,31-32,38-52,60,63-64,72-80,88H,11-12,19-23,25-30,62H2,1-2H3,(H,65,84)(H,66,85)(H,67,83)(H,68,86)(H,69,82)(H,70,87)(H,71,81)/t31-,32-,38+,39-,40+,41-,42-,43+,44+,45-,46-,47+,48-,49+,50-,51-,52+,60-,61-/m1/s1 D0WS8K DRUGINKE FYSDQQZUTAKKQX-CULBQIHKSA-N D0WS8K DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NCC6(C(C(C(CO6)O)OC7C(C(C(C(O7)CO)O)O)O)O)O)C(=O)NC(CO)C(C)O)O D0WS8K HIGHSTAT Investigative D0WT2Z DRUG__ID D0WT2Z D0WT2Z DRUGTYPE Small molecular drug D0WT2Z DRUGINCH 1S/C36H46N2O12/c1-20(2)33(44)27(49-26(40)23-12-9-16-37-23)34(45)29(4)19-32(43)30(33,5)36(34,46)35(50-32)25(21(3)13-15-31(29,35)42)48-24(39)14-17-38-28(41)47-18-22-10-7-6-8-11-22/h6-12,16,20-21,25,27,37,42-46H,13-15,17-19H2,1-5H3,(H,38,41)/t21?,25-,27-,29+,30?,31?,32?,33?,34?,35?,36?/m1/s1 D0WT2Z DRUGINKE YNAMTGCWRIKJBG-IQCGZQJLSA-N D0WT2Z DRUGSMIL CC1CCC2(C3(CC4(C5(C(C(C3(C5(C2(C1OC(=O)CCNC(=O)OCC6=CC=CC=C6)O4)O)O)OC(=O)C7=CC=CN7)(C(C)C)O)C)O)C)O D0WT2Z HIGHSTAT Investigative D0WT5D DRUG__ID D0WT5D D0WT5D DRUGTYPE Small molecular drug D0WT5D DRUGINCH 1S/C22H26N2O2S2/c1-14-9-12-27-20(14)16(21-15(2)10-13-28-21)6-5-11-24(3)17-7-4-8-18-19(17)22(25)23-26-18/h6,9-10,12-13,17H,4-5,7-8,11H2,1-3H3,(H,23,25)/t17-/m0/s1 D0WT5D DRUGINKE CUESOMOCKVRNIW-KRWDZBQOSA-N D0WT5D DRUGSMIL CC1=C(SC=C1)C(=CCCN(C)C2CCCC3=C2C(=O)NO3)C4=C(C=CS4)C D0WT5D HIGHSTAT Investigative D0WT5M DRUG__ID D0WT5M D0WT5M DRUGTYPE Small molecular drug D0WT5M DRUGINCH 1S/C15H18N2O/c1-3-13-9-14(15(18)17-11(13)2)16-10-12-7-5-4-6-8-12/h4-9,16H,3,10H2,1-2H3,(H,17,18) D0WT5M DRUGINKE HEQCOEDABQUKBA-UHFFFAOYSA-N D0WT5M DRUGSMIL CCC1=C(NC(=O)C(=C1)NCC2=CC=CC=C2)C D0WT5M HIGHSTAT Investigative D0WT6A DRUG__ID D0WT6A D0WT6A DRUGTYPE Small molecular drug D0WT6A DRUGINCH 1S/C2H8N2/c3-1-2-4/h1-4H2 D0WT6A DRUGINKE PIICEJLVQHRZGT-UHFFFAOYSA-N D0WT6A DRUGSMIL C(CN)N D0WT6A HIGHSTAT Investigative D0WT7H DRUG__ID D0WT7H D0WT7H DRUGTYPE Small molecular drug D0WT7H DRUGINCH 1S/C25H30N2O6/c1-32-20(30)7-6-19(29)26-16-8-9-25(31)18-12-15-4-5-17(28)22-21(15)24(25,23(16)33-22)10-11-27(18)13-14-2-3-14/h4-7,14,16,18,23,28,31H,2-3,8-13H2,1H3,(H,26,29)/b7-6+/t16-,18-,23+,24+,25-/m1/s1 D0WT7H DRUGINKE PQKHESYTSKMWFP-WZJCLRDWSA-N D0WT7H DRUGSMIL COC(=O)C=CC(=O)NC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O D0WT7H HIGHSTAT Investigative D0WU1S DRUG__ID D0WU1S D0WU1S DRUGTYPE Small molecular drug D0WU1S DRUGINCH 1S/C23H21N5O3/c1-12-21(14(3)31-27-12)16-9-18-15(10-20(16)30-4)22-19(11-25-18)26-23(29)28(22)13(2)17-7-5-6-8-24-17/h5-11,13H,1-4H3,(H,26,29)/t13-/m1/s1 D0WU1S DRUGINKE VUVUVNZRUGEAHB-CYBMUJFWSA-N D0WU1S DRUGSMIL CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)C(C)C5=CC=CC=N5)OC D0WU1S HIGHSTAT Investigative D0WU9R DRUG__ID D0WU9R D0WU9R DRUGTYPE Small molecular drug D0WU9R DRUGINCH 1S/C23H25ClN2O/c1-17-22(25-27-23(17)20-7-9-21(24)10-8-20)19-12-15-26(16-13-19)14-11-18-5-3-2-4-6-18/h2-10,19H,11-16H2,1H3 D0WU9R DRUGINKE QDMAKDIDFJTXEL-UHFFFAOYSA-N D0WU9R DRUGSMIL CC1=C(ON=C1C2CCN(CC2)CCC3=CC=CC=C3)C4=CC=C(C=C4)Cl D0WU9R HIGHSTAT Investigative D0WV0Q DRUG__ID D0WV0Q D0WV0Q DRUGTYPE Small molecular drug D0WV0Q DRUGINCH 1S/C21H17BrFN3O4S/c1-13-8-20(25-30-13)24-21(27)12-31(28,29)19-11-26(18-5-3-2-4-16(18)19)10-14-9-15(22)6-7-17(14)23/h2-9,11H,10,12H2,1H3,(H,24,25,27) D0WV0Q DRUGINKE RUYRNYRGPSAXTK-UHFFFAOYSA-N D0WV0Q DRUGSMIL CC1=CC(=NO1)NC(=O)CS(=O)(=O)C2=CN(C3=CC=CC=C32)CC4=C(C=CC(=C4)Br)F D0WV0Q HIGHSTAT Investigative D0WV3D DRUG__ID D0WV3D D0WV3D DRUGTYPE Small molecular drug D0WV3D DRUGINCH 1S/C36H38O7/c37-25-16-14-24(15-17-25)32-21-28(27-19-18-26(38)20-33(27)43-32)34-30(40)22-31(41)35(36(34)42)29(39)13-9-4-2-1-3-6-10-23-11-7-5-8-12-23/h5,7-8,11-12,14-20,22,28,32,37-38,40-42H,1-4,6,9-10,13,21H2/t28-,32+/m1/s1 D0WV3D DRUGINKE NWJOIWGNEIDTTG-NSJVFKKDSA-N D0WV3D DRUGSMIL C1C(C2=C(C=C(C=C2)O)OC1C3=CC=C(C=C3)O)C4=C(C(=C(C=C4O)O)C(=O)CCCCCCCCC5=CC=CC=C5)O D0WV3D HIGHSTAT Investigative D0WV4Z DRUG__ID D0WV4Z D0WV4Z DRUGTYPE Small molecular drug D0WV4Z DRUGINCH 1S/C6H14O12P2/c7-1-2(8)5(17-19(11,12)13)4(10)6(3(1)9)18-20(14,15)16/h1-10H,(H2,11,12,13)(H2,14,15,16)/t1?,2-,3+,4?,5+,6- D0WV4Z DRUGINKE PUVHMWJJTITUGO-WJPCITMWSA-N D0WV4Z DRUGSMIL C1(C(C(C(C(C1O)OP(=O)(O)O)O)OP(=O)(O)O)O)O D0WV4Z HIGHSTAT Investigative D0WV5J DRUG__ID D0WV5J D0WV5J DRUGTYPE Small molecular drug D0WV5J DRUGINCH 1S/C19H15ClFNO2S/c20-12-1-4-14(5-2-12)25-19-15-6-3-13(21)10-16(15)22-8-7-11(18(19)22)9-17(23)24/h1-6,10-11H,7-9H2,(H,23,24) D0WV5J DRUGINKE GSBAVONRPNJJOH-UHFFFAOYSA-N D0WV5J DRUGSMIL C1CN2C3=C(C=CC(=C3)F)C(=C2C1CC(=O)O)SC4=CC=C(C=C4)Cl D0WV5J HIGHSTAT Investigative D0WV5R DRUG__ID D0WV5R D0WV5R DRUGTYPE Small molecular drug D0WV5R DRUGINCH 1S/CN/c1-2/q-1 D0WV5R DRUGINKE XFXPMWWXUTWYJX-UHFFFAOYSA-N D0WV5R DRUGSMIL [C-]#N D0WV5R HIGHSTAT Investigative D0WV8K DRUG__ID D0WV8K D0WV8K DRUGTYPE Small molecular drug D0WV8K DRUGINCH 1S/C5H9NO2/c6-2-3-1-4(3)5(7)8/h3-4H,1-2,6H2,(H,7,8) D0WV8K DRUGINKE QUFMERRXRMSAPZ-UHFFFAOYSA-N D0WV8K DRUGSMIL C1C(C1C(=O)O)CN D0WV8K HIGHSTAT Investigative D0WW1K DRUG__ID D0WW1K D0WW1K DRUGTYPE Small molecular drug D0WW1K DRUGINCH 1S/C15H12O5/c16-11-3-1-10(2-4-11)14(15(19)20)7-9-5-12(17)8-13(18)6-9/h1-8,16-18H,(H,19,20)/b14-7+ D0WW1K DRUGINKE LGVSCQYCQUYTOK-VGOFMYFVSA-N D0WW1K DRUGSMIL C1=CC(=CC=C1C(=CC2=CC(=CC(=C2)O)O)C(=O)O)O D0WW1K HIGHSTAT Investigative D0WW2D DRUG__ID D0WW2D D0WW2D DRUGTYPE Small molecular drug D0WW2D DRUGINCH 1S/C19H16N6O/c20-19(21)13-6-8-15(9-7-13)23-25-17-12-16(10-11-18(17)26)24-22-14-4-2-1-3-5-14/h1-12,26H,(H3,20,21) D0WW2D DRUGINKE NKLDVTYKPPGNGG-UHFFFAOYSA-N D0WW2D DRUGSMIL C1=CC=C(C=C1)N=NC2=CC(=C(C=C2)O)N=NC3=CC=C(C=C3)C(=N)N D0WW2D HIGHSTAT Investigative D0WW2X DRUG__ID D0WW2X D0WW2X DRUGTYPE Small molecular drug D0WW2X DRUGINCH 1S/C16H15ClN4O2/c1-16(2,3)14-8-12(21-23-14)15(22)13(9-18)20-19-11-6-4-5-10(17)7-11/h4-8,19H,1-3H3/b20-13- D0WW2X DRUGINKE DXEATJQGQHDURZ-MOSHPQCFSA-N D0WW2X DRUGSMIL CC(C)(C)C1=CC(=NO1)C(=O)C(=NNC2=CC(=CC=C2)Cl)C#N D0WW2X HIGHSTAT Investigative D0WW4F DRUG__ID D0WW4F D0WW4F DRUGTYPE Small molecular drug D0WW4F DRUGINCH 1S/C14H16N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10,13,17H,1-2H3 D0WW4F DRUGINKE DDFNHFXLQJLFSX-UHFFFAOYSA-N D0WW4F DRUGSMIL CC(C)(C1=CN=CC=C1)C(C2=CN=CC=C2)O D0WW4F HIGHSTAT Investigative D0WW5X DRUG__ID D0WW5X D0WW5X DRUGTYPE Small molecular drug D0WW5X DRUGINCH 1S/C21H27NO2/c1-2-3-4-5-6-10-16-22-21(23)24-20-15-11-14-19(17-20)18-12-8-7-9-13-18/h7-9,11-15,17H,2-6,10,16H2,1H3,(H,22,23) D0WW5X DRUGINKE ZVIQRVAPSQCQGM-UHFFFAOYSA-N D0WW5X DRUGSMIL CCCCCCCCNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2 D0WW5X HIGHSTAT Investigative D0WW7A DRUG__ID D0WW7A D0WW7A DRUGTYPE Small molecular drug D0WW7A DRUGINCH 1S/C29H27Cl2FN6O3S/c1-41-28-33-14-20(15-34-28)12-21-16-38(29(35-27(21)40)42-18-19-2-4-22(32)5-3-19)17-26(39)37-10-8-36(9-11-37)23-6-7-24(30)25(31)13-23/h2-7,13-16H,8-12,17-18H2,1H3 D0WW7A DRUGINKE ATFLNJHGWNOVTM-UHFFFAOYSA-N D0WW7A DRUGSMIL COC1=NC=C(C=N1)CC2=CN(C(=NC2=O)SCC3=CC=C(C=C3)F)CC(=O)N4CCN(CC4)C5=CC(=C(C=C5)Cl)Cl D0WW7A HIGHSTAT Investigative D0WW8M DRUG__ID D0WW8M D0WW8M DRUGTYPE Small molecular drug D0WW8M DRUGINCH 1S/C19H15NO2/c1-21-18-11-16-10-15(9-8-14-6-4-3-5-7-14)13-20-17(16)12-19(18)22-2/h3-7,10-13H,1-2H3 D0WW8M DRUGINKE FIWNVHIDDOMDBP-UHFFFAOYSA-N D0WW8M DRUGSMIL COC1=CC2=CC(=CN=C2C=C1OC)C#CC3=CC=CC=C3 D0WW8M HIGHSTAT Investigative D0WX6R DRUG__ID D0WX6R D0WX6R DRUGTYPE Small molecular drug D0WX6R DRUGINCH 1S/C12H4N2O6/c15-11-5-1-3-7(13(17)18)10-8(14(19)20)4-2-6(9(5)10)12(11)16/h1-4H D0WX6R DRUGINKE HKNXJYVCBQHLBT-UHFFFAOYSA-N D0WX6R DRUGSMIL C1=CC(=C2C(=CC=C3C2=C1C(=O)C3=O)[N+](=O)[O-])[N+](=O)[O-] D0WX6R HIGHSTAT Investigative D0WX7S DRUG__ID D0WX7S D0WX7S DRUGTYPE Small molecular drug D0WX7S DRUGINCH 1S/C26H28O10/c1-10(2)5-12-17(11(3)4)26(19-23(34)13(6-27)20(31)14(7-28)24(19)35)36-25-16(9-30)21(32)15(8-29)22(33)18(12)25/h6-12,17,26,31-35H,5H2,1-4H3/t12-,17+,26+/m0/s1 D0WX7S DRUGINKE PHQDMQGEKNBIPF-FLFOAQQMSA-N D0WX7S DRUGSMIL CC(C)CC1C(C(OC2=C(C(=C(C(=C12)O)C=O)O)C=O)C3=C(C(=C(C(=C3O)C=O)O)C=O)O)C(C)C D0WX7S HIGHSTAT Investigative D0WZ3T DRUG__ID D0WZ3T D0WZ3T DRUGTYPE Small molecular drug D0WZ3T DRUGINCH 1S/C11H12N4S2/c16-10(15-11-14-7-8-17-11)13-6-4-9-3-1-2-5-12-9/h1-3,5,7-8H,4,6H2,(H2,13,14,15,16) D0WZ3T DRUGINKE XNZLMIJCCHZKKA-UHFFFAOYSA-N D0WZ3T DRUGSMIL C1=CC=NC(=C1)CCNC(=S)NC2=NC=CS2 D0WZ3T HIGHSTAT Investigative D0WZ7J DRUG__ID D0WZ7J D0WZ7J DRUGTYPE Small molecular drug D0WZ7J DRUGINCH 1S/C19H21NO7S/c1-10(21)25-14-5-3-11-9-13-12-4-6-15(27-28(22,23)24)18-19(12,7-8-20(13)2)16(11)17(14)26-18/h3-6,12-13,15,18H,7-9H2,1-2H3,(H,22,23,24)/t12-,13+,15-,18-,19-/m0/s1 D0WZ7J DRUGINKE AVTOGXGTGWUJBM-SSTWWWIQSA-N D0WZ7J DRUGSMIL CC(=O)OC1=C2C3=C(CC4C5C3(CC[NH+]4C)C(O2)C(C=C5)OS(=O)(=O)[O-])C=C1 D0WZ7J HIGHSTAT Investigative D0WZ9T DRUG__ID D0WZ9T D0WZ9T DRUGTYPE Small molecular drug D0WZ9T DRUGINCH 1S/C4H12NO3P/c1-9(7,8)3-4(6)2-5/h4,6H,2-3,5H2,1H3,(H,7,8)/t4-/m1/s1 D0WZ9T DRUGINKE FUUPFUIGNBPCAY-SCSAIBSYSA-N D0WZ9T DRUGSMIL CP(=O)(CC(CN)O)O D0WZ9T HIGHSTAT Investigative D0X0AM DRUG__ID D0X0AM D0X0AM DRUGTYPE Small molecular drug D0X0AM DRUGINCH 1S/C32H48O5/c1-5-6-18-37-30(36)32(16-17-32)29(35)14-9-21(2)26-12-13-27-23(8-7-15-31(26,27)4)10-11-24-19-25(33)20-28(34)22(24)3/h9-11,14,21,25-29,33-35H,3,5-8,12-13,15-20H2,1-2,4H3/b14-9+,23-10+,24-11-/t21-,25-,26-,27+,28+,29-,31-/m1/s1 D0X0AM DRUGINKE SPARTCPUGRJFRS-PBDCIXLPSA-N D0X0AM DRUGSMIL CCCCOC(=O)C1(CC1)C(C=CC(C)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C)O D0X0AM HIGHSTAT Investigative D0X0CS DRUG__ID D0X0CS D0X0CS DRUGTYPE Small molecular drug D0X0CS DRUGINCH 1S/C16H17NO4/c1-9(2)11-8-12(14(19)15(20)13(11)18)16(21)17-10-6-4-3-5-7-10/h3-9,18-20H,1-2H3,(H,17,21) D0X0CS DRUGINKE HMVKMSUSFWLQLX-UHFFFAOYSA-N D0X0CS DRUGSMIL CC(C)C1=CC(=C(C(=C1O)O)O)C(=O)NC2=CC=CC=C2 D0X0CS HIGHSTAT Investigative D0X0ER DRUG__ID D0X0ER D0X0ER DRUGTYPE Small molecular drug D0X0ER DRUGINCH 1S/C8H4ClNO2/c9-5-3-1-2-4-6(5)10-8(12)7(4)11/h1-3H,(H,10,11,12) D0X0ER DRUGINKE MPLXQMMMGDYXIT-UHFFFAOYSA-N D0X0ER DRUGSMIL C1=CC2=C(C(=C1)Cl)NC(=O)C2=O D0X0ER HIGHSTAT Investigative D0X0FB DRUG__ID D0X0FB D0X0FB DRUGTYPE Small molecular drug D0X0FB DRUGINCH 1S/C21H22ClNO/c1-2-3-6-13-23-15-19(18-7-4-5-8-20(18)23)21(24)14-16-9-11-17(22)12-10-16/h4-5,7-12,15H,2-3,6,13-14H2,1H3 D0X0FB DRUGINKE GPMUZXUMSOFDBA-UHFFFAOYSA-N D0X0FB DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)Cl D0X0FB HIGHSTAT Investigative D0X0GG DRUG__ID D0X0GG D0X0GG DRUGTYPE Small molecular drug D0X0GG DRUGINCH 1S/C21H29ClO4/c1-13-8-14(2)21(25-12-17-10-16(23)11-19(24)26-17)18(9-13)20(22)15-6-4-3-5-7-15/h8-9,15-17,20,23H,3-7,10-12H2,1-2H3/t16-,17+,20?/m1/s1 D0X0GG DRUGINKE JEIUHLQCZMJKSE-LIHHCBPRSA-N D0X0GG DRUGSMIL CC1=CC(=C(C(=C1)C(C2CCCCC2)Cl)OCC3CC(CC(=O)O3)O)C D0X0GG HIGHSTAT Investigative D0X0GV DRUG__ID D0X0GV D0X0GV DRUGTYPE Small molecular drug D0X0GV DRUGINCH 1S/C21H34N6O9/c1-11(2)6-13(25-15(28)8-22)21(36)27-5-3-4-14(27)20(35)26-12(7-17(30)31)19(34)24-9-16(29)23-10-18(32)33/h11-14H,3-10,22H2,1-2H3,(H,23,29)(H,24,34)(H,25,28)(H,26,35)(H,30,31)(H,32,33)/t12-,13-,14-/m0/s1 D0X0GV DRUGINKE SKODABHETMRRBC-IHRRRGAJSA-N D0X0GV DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)NC(CC(=O)O)C(=O)NCC(=O)NCC(=O)O)NC(=O)CN D0X0GV HIGHSTAT Investigative D0X0IF DRUG__ID D0X0IF D0X0IF DRUGTYPE Small molecular drug D0X0IF DRUGINCH 1S/C32H32O6/c1-36-27-15-9-22(10-16-27)29(17-11-23-8-14-26(34)19-31(23)38-3)32-24(18-28(37-2)20-30(32)35)7-4-21-5-12-25(33)13-6-21/h4-10,12-16,18-20,29,33-35H,11,17H2,1-3H3/b7-4+ D0X0IF DRUGINKE XZVDYCHPJWUZFS-QPJJXVBHSA-N D0X0IF DRUGSMIL COC1=CC=C(C=C1)C(CCC2=C(C=C(C=C2)O)OC)C3=C(C=C(C=C3O)OC)C=CC4=CC=C(C=C4)O D0X0IF HIGHSTAT Investigative D0X0IH DRUG__ID D0X0IH D0X0IH DRUGTYPE Small molecular drug D0X0IH DRUGINCH 1S/C10H10N2/c1-2-4-10(5-3-1)8-12-7-6-11-9-12/h1-7,9H,8H2 D0X0IH DRUGINKE KKKDZZRICRFGSD-UHFFFAOYSA-N D0X0IH DRUGSMIL C1=CC=C(C=C1)CN2C=CN=C2 D0X0IH HIGHSTAT Investigative D0X0IT DRUG__ID D0X0IT D0X0IT DRUGTYPE Small molecular drug D0X0IT DRUGINCH 1S/C14H12O2/c15-14(16)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13H,(H,15,16) D0X0IT DRUGINKE PYHXGXCGESYPCW-UHFFFAOYSA-N D0X0IT DRUGSMIL C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)O D0X0IT HIGHSTAT Investigative D0X0KZ DRUG__ID D0X0KZ D0X0KZ DRUGTYPE Small molecular drug D0X0KZ DRUGINCH 1S/C12H12B2O4/c15-13(16)11-5-1-9(2-6-11)10-3-7-12(8-4-10)14(17)18/h1-8,15-18H D0X0KZ DRUGINKE SLHKDOGTVUCXKX-UHFFFAOYSA-N D0X0KZ DRUGSMIL B(C1=CC=C(C=C1)C2=CC=C(C=C2)B(O)O)(O)O D0X0KZ HIGHSTAT Investigative D0X0OP DRUG__ID D0X0OP D0X0OP DRUGTYPE Small molecular drug D0X0OP DRUGINCH 1S/C22H45O5PS/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-26-20-22(25-2)21-27-28(23,24)29/h10-11,22H,3-9,12-21H2,1-2H3,(H2,23,24,29)/b11-10-/t22-/m0/s1 D0X0OP DRUGINKE FEHMGBUAJYEJMW-YRBAHSOBSA-N D0X0OP DRUGSMIL CCCCCCCCC=CCCCCCCCCOCC(COP(=S)(O)O)OC D0X0OP HIGHSTAT Investigative D0X0PA DRUG__ID D0X0PA D0X0PA DRUGTYPE Small molecular drug D0X0PA DRUGINCH 1S/C11H17NO/c1-3-13-11-6-4-10(5-7-11)8-9(2)12/h4-7,9H,3,8,12H2,1-2H3 D0X0PA DRUGINKE CCAMEVFYMFXHEN-UHFFFAOYSA-N D0X0PA DRUGSMIL CCOC1=CC=C(C=C1)CC(C)N D0X0PA HIGHSTAT Investigative D0X0PF DRUG__ID D0X0PF D0X0PF DRUGTYPE Small molecular drug D0X0PF DRUGINCH 1S/C11H22O2/c1-2-3-4-5-6-7-8-9-10-11(12)13/h2-10H2,1H3,(H,12,13) D0X0PF DRUGINKE ZDPHROOEEOARMN-UHFFFAOYSA-N D0X0PF DRUGSMIL CCCCCCCCCCC(=O)O D0X0PF HIGHSTAT Investigative D0X0PO DRUG__ID D0X0PO D0X0PO DRUGTYPE Small molecular drug D0X0PO DRUGINCH 1S/C6H16N2O6S2/c7-15(9,10)13-5-3-1-2-4-6-14-16(8,11)12/h1-6H2,(H2,7,9,10)(H2,8,11,12) D0X0PO DRUGINKE AEARVEODHXFSKG-UHFFFAOYSA-N D0X0PO DRUGSMIL C(CCCOS(=O)(=O)N)CCOS(=O)(=O)N D0X0PO HIGHSTAT Investigative D0X0RE DRUG__ID D0X0RE D0X0RE DRUGTYPE Small molecular drug D0X0RE DRUGINCH 1S/C9H11BO2/c1-8-2-4-9(5-3-8)6-7-10(11)12/h2-7,11-12H,1H3/b7-6+ D0X0RE DRUGINKE JJOBVKVXRDHVRP-VOTSOKGWSA-N D0X0RE DRUGSMIL B(C=CC1=CC=C(C=C1)C)(O)O D0X0RE HIGHSTAT Investigative D0X0RJ DRUG__ID D0X0RJ D0X0RJ DRUGTYPE Small molecular drug D0X0RJ DRUGINCH 1S/C31H33NO5/c1-34-24-10-12-27-28(20-24)36-17-13-26-25-11-7-22(33)19-29(25)37-31(30(26)27)21-5-8-23(9-6-21)35-18-16-32-14-3-2-4-15-32/h5-12,19-20,31,33H,2-4,13-18H2,1H3/t31-/m1/s1 D0X0RJ DRUGINKE BHYFKQDXXVAJEL-WJOKGBTCSA-N D0X0RJ DRUGSMIL COC1=CC2=C(C=C1)C3=C(CCO2)C4=C(C=C(C=C4)O)OC3C5=CC=C(C=C5)OCCN6CCCCC6 D0X0RJ HIGHSTAT Investigative D0X0UR DRUG__ID D0X0UR D0X0UR DRUGTYPE Small molecular drug D0X0UR DRUGINCH 1S/C21H41O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(23)27-18-20(22)19-28-29(24,25)26/h9-10,20,22H,2-8,11-19H2,1H3,(H2,24,25,26)/b10-9- D0X0UR DRUGINKE WRGQSWVCFNIUNZ-KTKRTIGZSA-N D0X0UR DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)O)O D0X0UR HIGHSTAT Investigative D0X0XV DRUG__ID D0X0XV D0X0XV DRUGTYPE Small molecular drug D0X0XV DRUGINCH 1S/C36H45N5O5/c1-21-10-8-11-22(2)28(21)20-31(34(44)39-30(33(38)43)18-25-12-6-5-7-13-25)40-35(45)32-14-9-15-41(32)36(46)29(37)19-27-23(3)16-26(42)17-24(27)4/h5-8,10-13,16-17,29-32,42H,9,14-15,18-20,37H2,1-4H3,(H2,38,43)(H,39,44)(H,40,45)/t29-,30-,31-,32-/m0/s1 D0X0XV DRUGINKE KIPQYPCUMMQKJB-YDPTYEFTSA-N D0X0XV DRUGSMIL CC1=C(C(=CC=C1)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N D0X0XV HIGHSTAT Investigative D0X1BT DRUG__ID D0X1BT D0X1BT DRUGTYPE Small molecular drug D0X1BT DRUGINCH 1S/C9H13NO3/c10-6-7(5-9(11)12)4-8-2-1-3-13-8/h1-3,7H,4-6,10H2,(H,11,12)/t7-/m0/s1 D0X1BT DRUGINKE JASKMEUWYOXVFB-ZETCQYMHSA-N D0X1BT DRUGSMIL C1=COC(=C1)CC(CC(=O)O)CN D0X1BT HIGHSTAT Investigative D0X1CB DRUG__ID D0X1CB D0X1CB DRUGTYPE Small molecular drug D0X1CB DRUGINCH 1S/C33H40N4O6/c38-28(29-21-43-29)17-9-3-8-15-24-30(39)35-25(19-22-11-4-1-5-12-22)31(40)36-26(20-23-13-6-2-7-14-23)33(42)37-18-10-16-27(37)32(41)34-24/h1-2,4-7,11-14,24-27,29H,3,8-10,15-21H2,(H,34,41)(H,35,39)(H,36,40)/t24-,25-,26-,27+,29-/m0/s1 D0X1CB DRUGINKE LLOKIGWPNVSDGJ-AFBVCZJXSA-N D0X1CB DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4=CC=CC=C4)CCCCCC(=O)C5CO5 D0X1CB HIGHSTAT Investigative D0X1DO DRUG__ID D0X1DO D0X1DO DRUGTYPE Small molecular drug D0X1DO DRUGINCH 1S/C12H14O4S2/c13-11(14)8-3-1-4-9(7-8)18-10(12(15)16)5-2-6-17/h1,3-4,7,10,17H,2,5-6H2,(H,13,14)(H,15,16) D0X1DO DRUGINKE QIPLUMAHVZVCQB-UHFFFAOYSA-N D0X1DO DRUGSMIL C1=CC(=CC(=C1)SC(CCCS)C(=O)O)C(=O)O D0X1DO HIGHSTAT Investigative D0X1DV DRUG__ID D0X1DV D0X1DV DRUGTYPE Small molecular drug D0X1DV DRUGINCH 1S/C20H22N2/c1-3-16-5-7-17(8-6-16)18-9-11-19(12-10-18)20(4-2)22-14-13-21-15-22/h5-15,20H,3-4H2,1-2H3 D0X1DV DRUGINKE QQMBOZZNCNQCSN-UHFFFAOYSA-N D0X1DV DRUGSMIL CCC1=CC=C(C=C1)C2=CC=C(C=C2)C(CC)N3C=CN=C3 D0X1DV HIGHSTAT Investigative D0X1EC DRUG__ID D0X1EC D0X1EC DRUGTYPE Small molecular drug D0X1EC DRUGINCH 1S/C21H22BrNO/c1-2-3-6-13-23-15-19(18-7-4-5-8-20(18)23)21(24)14-16-9-11-17(22)12-10-16/h4-5,7-12,15H,2-3,6,13-14H2,1H3 D0X1EC DRUGINKE BMRAIRSNJUSFSM-UHFFFAOYSA-N D0X1EC DRUGSMIL CCCCCN1C=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)Br D0X1EC HIGHSTAT Investigative D0X1EG DRUG__ID D0X1EG D0X1EG DRUGTYPE Small molecular drug D0X1EG DRUGINCH 1S/C19H36N2O3/c1-2-3-13-16-20-19(24)21-17-14-11-9-7-5-4-6-8-10-12-15-18(22)23/h6,8H,2-5,7,9-17H2,1H3,(H,22,23)(H2,20,21,24)/b8-6- D0X1EG DRUGINKE YUYHEPLRNYDYLU-VURMDHGXSA-N D0X1EG DRUGSMIL CCCCCNC(=O)NCCCCCCCC=CCCCC(=O)O D0X1EG HIGHSTAT Investigative D0X1EY DRUG__ID D0X1EY D0X1EY DRUGTYPE Small molecular drug D0X1EY DRUGINCH 1S/C15H9IO3/c16-10-3-6-14-12(7-10)13(18)8-15(19-14)9-1-4-11(17)5-2-9/h1-8,17H D0X1EY DRUGINKE IFAJNNUYROKKPW-UHFFFAOYSA-N D0X1EY DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=CC(=C3)I)O D0X1EY HIGHSTAT Investigative D0X1FT DRUG__ID D0X1FT D0X1FT DRUGTYPE Small molecular drug D0X1FT DRUGINCH 1S/C17H31NO7P2/c1-2-3-4-5-6-7-8-9-13-25-16-11-10-12-18(14-16)15-17(26(19,20)21)27(22,23)24/h10-12,14,17H,2-9,13,15H2,1H3,(H3-,19,20,21,22,23,24) D0X1FT DRUGINKE QYJHUOZDBUEKQC-UHFFFAOYSA-N D0X1FT DRUGSMIL CCCCCCCCCCOC1=C[N+](=CC=C1)CC(P(=O)(O)O)P(=O)(O)[O-] D0X1FT HIGHSTAT Investigative D0X1FX DRUG__ID D0X1FX D0X1FX DRUGTYPE Small molecular drug D0X1FX DRUGINCH 1S/C22H36O2/c1-5-6-7-8-14-22(2,3)18-12-13-20(21(16-18)24-4)17-10-9-11-19(23)15-17/h12-13,16-17,19,23H,5-11,14-15H2,1-4H3/t17-,19+/m0/s1 D0X1FX DRUGINKE ZVQYLLPGZZZCSV-PKOBYXMFSA-N D0X1FX DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CCCC(C2)O)OC D0X1FX HIGHSTAT Investigative D0X1HX DRUG__ID D0X1HX D0X1HX DRUGTYPE Small molecular drug D0X1HX DRUGINCH 1S/C8H11N5O/c1-5(14)2-13-4-12-6-7(9)10-3-11-8(6)13/h3-5,14H,2H2,1H3,(H2,9,10,11)/t5-/m1/s1 D0X1HX DRUGINKE MJZYTEBKXLVLMY-RXMQYKEDSA-N D0X1HX DRUGSMIL CC(CN1C=NC2=C(N=CN=C21)N)O D0X1HX HIGHSTAT Investigative D0X1IU DRUG__ID D0X1IU D0X1IU DRUGTYPE Small molecular drug D0X1IU DRUGINCH 1S/C16H17N/c17-15-9-5-12(6-10-15)11-14-8-7-13-3-1-2-4-16(13)14/h1-6,9-10,14H,7-8,11,17H2 D0X1IU DRUGINKE IFNMCDJEFWXUCT-UHFFFAOYSA-N D0X1IU DRUGSMIL C1CC2=CC=CC=C2C1CC3=CC=C(C=C3)N D0X1IU HIGHSTAT Investigative D0X1JG DRUG__ID D0X1JG D0X1JG DRUGTYPE Small molecular drug D0X1JG DRUGINCH 1S/C13H13NO2/c1-9-6-7-10(2)14(9)12-5-3-4-11(8-12)13(15)16/h3-8H,1-2H3,(H,15,16) D0X1JG DRUGINKE NJPUZFUOUGTNOV-UHFFFAOYSA-N D0X1JG DRUGSMIL CC1=CC=C(N1C2=CC=CC(=C2)C(=O)O)C D0X1JG HIGHSTAT Investigative D0X1JO DRUG__ID D0X1JO D0X1JO DRUGTYPE Small molecular drug D0X1JO DRUGINCH 1S/C21H23N3OS/c1-2-6-17(7-3-1)20-16-22-21(26-20)23-18-8-10-19(11-9-18)25-15-14-24-12-4-5-13-24/h1-3,6-11,16H,4-5,12-15H2,(H,22,23) D0X1JO DRUGINKE FNZTULJDGIXMJJ-UHFFFAOYSA-N D0X1JO DRUGSMIL C1CCN(C1)CCOC2=CC=C(C=C2)NC3=NC=C(S3)C4=CC=CC=C4 D0X1JO HIGHSTAT Investigative D0X1MY DRUG__ID D0X1MY D0X1MY DRUGTYPE Small molecular drug D0X1MY DRUGINCH 1S/C2H3N3S2/c3-1-4-5-2(6)7-1/h(H2,3,4)(H,5,6) D0X1MY DRUGINKE GDGIVSREGUOIJZ-UHFFFAOYSA-N D0X1MY DRUGSMIL C1(=NNC(=S)S1)N D0X1MY HIGHSTAT Investigative D0X1NW DRUG__ID D0X1NW D0X1NW DRUGTYPE Small molecular drug D0X1NW DRUGINCH 1S/C19H13N3O2/c23-18-13-7-2-1-6-12(13)17-14(18)8-5-9-15(17)21-19(24)22-16-10-3-4-11-20-16/h1-11H,(H2,20,21,22,24) D0X1NW DRUGINKE XVVDNGPUSVDRAJ-UHFFFAOYSA-N D0X1NW DRUGSMIL C1=CC=C2C(=C1)C3=C(C2=O)C=CC=C3NC(=O)NC4=CC=CC=N4 D0X1NW HIGHSTAT Investigative D0X1OY DRUG__ID D0X1OY D0X1OY DRUGTYPE Small molecular drug D0X1OY DRUGINCH 1S/C10H6Cl2N2O/c11-8-3-2-7(6-9(8)12)10(15)14-5-1-4-13-14/h1-6H D0X1OY DRUGINKE PPOZMMBGUFTQOQ-UHFFFAOYSA-N D0X1OY DRUGSMIL C1=CN(N=C1)C(=O)C2=CC(=C(C=C2)Cl)Cl D0X1OY HIGHSTAT Investigative D0X1QS DRUG__ID D0X1QS D0X1QS DRUGTYPE Small molecular drug D0X1QS DRUGINCH 1S/C16H15N/c1-12-9-15(14-6-4-8-17-11-14)10-13-5-2-3-7-16(12)13/h2-8,10-12H,9H2,1H3 D0X1QS DRUGINKE HIOBIABFPPEMPT-UHFFFAOYSA-N D0X1QS DRUGSMIL CC1CC(=CC2=CC=CC=C12)C3=CN=CC=C3 D0X1QS HIGHSTAT Investigative D0X1QW DRUG__ID D0X1QW D0X1QW DRUGTYPE Small molecular drug D0X1QW DRUGINCH 1S/C15H23NO/c1-4-10-16-14-9-8-13-12(11(14)2)6-5-7-15(13)17-3/h5-7,11,14,16H,4,8-10H2,1-3H3/t11-,14+/m0/s1 D0X1QW DRUGINKE YGHLYBIUVOLKCV-SMDDNHRTSA-N D0X1QW DRUGSMIL CCCNC1CCC2=C(C1C)C=CC=C2OC D0X1QW HIGHSTAT Investigative D0X1RH DRUG__ID D0X1RH D0X1RH DRUGTYPE Small molecular drug D0X1RH DRUGINCH 1S/C26H27ClN4O3S/c1-16(19-5-3-4-6-20(19)27)33-23-14-24(35-25(23)26(28)32)31-15-29-21-8-7-18(13-22(21)31)34-17-9-11-30(2)12-10-17/h3-8,13-17H,9-12H2,1-2H3,(H2,28,32)/t16-/m1/s1 D0X1RH DRUGINKE GILNGUYOGYOZMP-MRXNPFEDSA-N D0X1RH DRUGSMIL CC(C1=CC=CC=C1Cl)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)OC5CCN(CC5)C)C(=O)N D0X1RH HIGHSTAT Investigative D0X1SN DRUG__ID D0X1SN D0X1SN DRUGTYPE Small molecular drug D0X1SN DRUGINCH 1S/C38H52N8O10/c1-19(2)30(35(54)41-18-28(40)48)45-36(55)31(20(3)4)44-34(53)27(15-29(49)50)43-37(56)38(16-23-8-6-7-9-24(23)17-38)46-32(51)21(5)42-33(52)26(39)14-22-10-12-25(47)13-11-22/h6-13,19-21,26-27,30-31,47H,14-18,39H2,1-5H3,(H2,40,48)(H,41,54)(H,42,52)(H,43,56)(H,44,53)(H,45,55)(H,46,51)(H,49,50)/t21-,26+,27+,30+,31+/m1/s1 D0X1SN DRUGINKE QZYUFPDOTMWDCQ-UZHHEQFGSA-N D0X1SN DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C1(CC2=CC=CC=C2C1)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N D0X1SN HIGHSTAT Investigative D0X1TN DRUG__ID D0X1TN D0X1TN DRUGTYPE Small molecular drug D0X1TN DRUGINCH 1S/C23H28O9/c1-3-29-23(27)30-13-18-19(24)20(25)21(26)22(32-18)31-17-7-5-4-6-15(17)12-14-8-10-16(28-2)11-9-14/h4-11,18-22,24-26H,3,12-13H2,1-2H3/t18-,19-,20+,21-,22-/m1/s1 D0X1TN DRUGINKE QLXKHBNJTPICNF-QMCAAQAGSA-N D0X1TN DRUGSMIL CCOC(=O)OCC1C(C(C(C(O1)OC2=CC=CC=C2CC3=CC=C(C=C3)OC)O)O)O D0X1TN HIGHSTAT Investigative D0X1VL DRUG__ID D0X1VL D0X1VL DRUGTYPE Small molecular drug D0X1VL DRUGINCH 1S/C22H31FN4O7/c1-11(2)18(27-20(31)15(24)10-13-4-6-14(23)7-5-13)21(32)25-12(3)19(30)26-16(22(33)34)8-9-17(28)29/h4-7,11-12,15-16,18H,8-10,24H2,1-3H3,(H,25,32)(H,26,30)(H,27,31)(H,28,29)(H,33,34)/t12-,15-,16-,18-/m0/s1 D0X1VL DRUGINKE HREKBPJJOGCVRC-RPZXMPESSA-N D0X1VL DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)F)N D0X1VL HIGHSTAT Investigative D0X1XM DRUG__ID D0X1XM D0X1XM DRUGTYPE Small molecular drug D0X1XM DRUGINCH 1S/C31H32N2O6/c1-21-19-22(2)33-30(32-21)39-28(29(34)35)31(24-11-7-5-8-12-24,25-13-9-6-10-14-25)38-18-17-23-15-16-26(36-3)27(20-23)37-4/h5-16,19-20,28H,17-18H2,1-4H3,(H,34,35)/t28-/m1/s1 D0X1XM DRUGINKE CLSJNXXMIVKULC-MUUNZHRXSA-N D0X1XM DRUGSMIL CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OCCC4=CC(=C(C=C4)OC)OC)C D0X1XM HIGHSTAT Investigative D0X1ZC DRUG__ID D0X1ZC D0X1ZC DRUGTYPE Small molecular drug D0X1ZC DRUGINCH 1S/C30H31N3O4/c1-19-13-20(2)15-22(14-19)29(35)33(3)27(16-21-9-5-4-6-10-21)28(34)32-26(30(36)37)17-23-18-31-25-12-8-7-11-24(23)25/h4-15,18,26-27,31H,16-17H2,1-3H3,(H,32,34)(H,36,37)/t26-,27+/m0/s1 D0X1ZC DRUGINKE JFNANCYIHVAEQV-RRPNLBNLSA-N D0X1ZC DRUGSMIL CC1=CC(=CC(=C1)C(=O)N(C)C(CC2=CC=CC=C2)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)O)C D0X1ZC HIGHSTAT Investigative D0X1ZP DRUG__ID D0X1ZP D0X1ZP DRUGTYPE Small molecular drug D0X1ZP DRUGINCH 1S/C9H11FN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6-,8-/m1/s1 D0X1ZP DRUGINKE FHIDNBAQOFJWCA-UAKXSSHOSA-N D0X1ZP DRUGSMIL C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)O)F D0X1ZP HIGHSTAT Investigative D0X2CC DRUG__ID D0X2CC D0X2CC DRUGTYPE Small molecular drug D0X2CC DRUGINCH 1S/C15H14N2O/c1-2-5-15(18)13-8-11-10-6-3-4-7-12(10)17-14(11)9-16-13/h3-4,6-9,17H,2,5H2,1H3 D0X2CC DRUGINKE QIZPCEVRKTWHIE-UHFFFAOYSA-N D0X2CC DRUGSMIL CCCC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D0X2CC HIGHSTAT Investigative D0X2CX DRUG__ID D0X2CX D0X2CX DRUGTYPE Small molecular drug D0X2CX DRUGINCH 1S/C39H42N4O8S2/c1-39(2)34(37(49)42-32-24-14-8-7-13-23(24)18-29(32)45)43(21-53-39)38(50)33(46)26(17-22-11-5-4-6-12-22)40-35(47)27(20-52-3)41-36(48)31-19-28(44)25-15-9-10-16-30(25)51-31/h4-16,19,26-27,29,32-34,45-46H,17-18,20-21H2,1-3H3,(H,40,47)(H,41,48)(H,42,49)/t26-,27-,29+,32-,33-,34+/m0/s1 D0X2CX DRUGINKE KMPZTBYBVXRNNV-CJFFKWHBSA-N D0X2CX DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)C3=CC(=O)C4=CC=CC=C4O3)O)C(=O)NC5C(CC6=CC=CC=C56)O)C D0X2CX HIGHSTAT Investigative D0X2DH DRUG__ID D0X2DH D0X2DH DRUGTYPE Small molecular drug D0X2DH DRUGINCH 1S/C18H13N3O2/c22-17-15(13-10-19-14-9-5-4-8-12(13)14)16(18(23)21-17)20-11-6-2-1-3-7-11/h1-10,19H,(H2,20,21,22,23) D0X2DH DRUGINKE WEKZVKNLORTLQV-UHFFFAOYSA-N D0X2DH DRUGSMIL C1=CC=C(C=C1)NC2=C(C(=O)NC2=O)C3=CNC4=CC=CC=C43 D0X2DH HIGHSTAT Investigative D0X2GF DRUG__ID D0X2GF D0X2GF DRUGTYPE Small molecular drug D0X2GF DRUGINCH 1S/C6H6N4O/c7-6-9-3-1-2-8-4(3)5(11)10-6/h1-2,8H,(H3,7,9,10,11) D0X2GF DRUGINKE FFYPRJYSJODFFD-UHFFFAOYSA-N D0X2GF DRUGSMIL C1=CNC2=C1N=C(NC2=O)N D0X2GF HIGHSTAT Investigative D0X2HA DRUG__ID D0X2HA D0X2HA DRUGTYPE Small molecular drug D0X2HA DRUGINCH 1S/C35H42N6O4/c1-21-16-26(43)17-22(2)27(21)19-28(36)35(45)41-20-25-11-5-4-10-24(25)18-32(41)34(44)40-31(14-8-9-15-37-23(3)42)33-38-29-12-6-7-13-30(29)39-33/h4-7,10-13,16-17,28,31-32,43H,8-9,14-15,18-20,36H2,1-3H3,(H,37,42)(H,38,39)(H,40,44) D0X2HA DRUGINKE IOSGXZKTOLVOTQ-UHFFFAOYSA-N D0X2HA DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(CCCCNC(=O)C)C4=NC5=CC=CC=C5N4)N)C)O D0X2HA HIGHSTAT Investigative D0X2HK DRUG__ID D0X2HK D0X2HK DRUGTYPE Small molecular drug D0X2HK DRUGINCH 1S/C22H17NO3/c24-18-13-9-16(10-14-18)6-5-15-7-11-17(12-8-15)23-21(25)19-3-1-2-4-20(19)22(23)26/h1-4,7-14,24H,5-6H2 D0X2HK DRUGINKE OFQPQJJVXCUPFR-UHFFFAOYSA-N D0X2HK DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=C(C=C3)CCC4=CC=C(C=C4)O D0X2HK HIGHSTAT Investigative D0X2HT DRUG__ID D0X2HT D0X2HT DRUGTYPE Small molecular drug D0X2HT DRUGINCH 1S/C21H25NO7S/c1-11(2)20(23)27-15-6-4-12-10-14-13-5-7-16(29-30(24,25)26)19-21(13,8-9-22(14)3)17(12)18(15)28-19/h4-7,11,13-14,16,19H,8-10H2,1-3H3,(H,24,25,26)/t13-,14+,16-,19-,21-/m0/s1 D0X2HT DRUGINKE GABBKMMVICEZHE-AYHJQLAQSA-N D0X2HT DRUGSMIL CC(C)C(=O)OC1=C2C3=C(CC4C5C3(CC[NH+]4C)C(O2)C(C=C5)OS(=O)(=O)[O-])C=C1 D0X2HT HIGHSTAT Investigative D0X2IG DRUG__ID D0X2IG D0X2IG DRUGTYPE Small molecular drug D0X2IG DRUGINCH 1S/C13H10N2O2S/c14-9-11-12(15)7-4-8-13(11)18(16,17)10-5-2-1-3-6-10/h1-8H,15H2 D0X2IG DRUGINKE HVMPJKPAYPLWJZ-UHFFFAOYSA-N D0X2IG DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CC=CC(=C2C#N)N D0X2IG HIGHSTAT Investigative D0X2JG DRUG__ID D0X2JG D0X2JG DRUGTYPE Small molecular drug D0X2JG DRUGINCH 1S/C13H12ClNO/c14-12-7-4-8-13(11(12)9-15)16-10-5-2-1-3-6-10/h1-8H,9,15H2 D0X2JG DRUGINKE SNTOZVXKDWQFEW-UHFFFAOYSA-N D0X2JG DRUGSMIL C1=CC=C(C=C1)OC2=C(C(=CC=C2)Cl)CN D0X2JG HIGHSTAT Investigative D0X2JU DRUG__ID D0X2JU D0X2JU DRUGTYPE Small molecular drug D0X2JU DRUGINCH 1S/C9H15FN2O/c1-13-11-9(10)8-6-12-4-2-7(8)3-5-12/h7-8H,2-6H2,1H3/b11-9- D0X2JU DRUGINKE DNYJYFSXGOMRNZ-LUAWRHEFSA-N D0X2JU DRUGSMIL CON=C(C1CN2CCC1CC2)F D0X2JU HIGHSTAT Investigative D0X2LN DRUG__ID D0X2LN D0X2LN DRUGTYPE Small molecular drug D0X2LN DRUGINCH 1S/C35H42F2N2O6/c1-42-30-22-27(23-31(43-2)32(30)44-3)35(36,37)34(41)39-21-8-7-19-29(39)33(40)45-28(17-9-14-25-12-5-4-6-13-25)18-10-15-26-16-11-20-38-24-26/h4-6,11-13,16,20,22-24,28-29H,7-10,14-15,17-19,21H2,1-3H3/t28-,29-/m0/s1 D0X2LN DRUGINKE NBYCDVVSYOMFMS-VMPREFPWSA-N D0X2LN DRUGSMIL COC1=CC(=CC(=C1OC)OC)C(C(=O)N2CCCCC2C(=O)OC(CCCC3=CC=CC=C3)CCCC4=CN=CC=C4)(F)F D0X2LN HIGHSTAT Investigative D0X2MQ DRUG__ID D0X2MQ D0X2MQ DRUGTYPE Small molecular drug D0X2MQ DRUGINCH 1S/C23H30O5/c24-18(13-12-17-8-4-3-5-9-17)14-15-20-19(21(25)16-22(20)26)10-6-1-2-7-11-23(27)28/h1,3-6,8-9,14-15,18-20,22,24,26H,2,7,10-13,16H2,(H,27,28)/b6-1-,15-14+/t18-,19+,20+,22+/m0/s1 D0X2MQ DRUGINKE FOBVMYJQWZOGGJ-XYRJXBATSA-N D0X2MQ DRUGSMIL C1C(C(C(C1=O)CC=CCCCC(=O)O)C=CC(CCC2=CC=CC=C2)O)O D0X2MQ HIGHSTAT Investigative D0X2NH DRUG__ID D0X2NH D0X2NH DRUGTYPE Small molecular drug D0X2NH DRUGINCH 1S/C34H52N2O2S/c1-23(2)8-7-9-25(4)30-16-17-31-29-15-12-26-22-27(18-20-33(26,5)32(29)19-21-34(30,31)6)35-36-39(37,38)28-13-10-24(3)11-14-28/h10-11,13-14,22-23,25,29-32,36H,7-9,12,15-21H2,1-6H3/b35-27+/t25-,29+,30-,31+,32+,33+,34-/m1/s1 D0X2NH DRUGINKE PDENTDVQTUHVQO-YEDBHZBASA-N D0X2NH DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NN=C2CCC3(C4CCC5(C(C4CCC3=C2)CCC5C(C)CCCC(C)C)C)C D0X2NH HIGHSTAT Investigative D0X2NO DRUG__ID D0X2NO D0X2NO DRUGTYPE Small molecular drug D0X2NO DRUGINCH 1S/C10H13NO2/c11-8-2-1-6-4-9(12)10(13)5-7(6)3-8/h4-5,8,12-13H,1-3,11H2 D0X2NO DRUGINKE ASXGAOFCKGHGMF-UHFFFAOYSA-N D0X2NO DRUGSMIL C1CC2=CC(=C(C=C2CC1N)O)O D0X2NO HIGHSTAT Investigative D0X2OD DRUG__ID D0X2OD D0X2OD DRUGTYPE Small molecular drug D0X2OD DRUGINCH 1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1 D0X2OD DRUGINKE MPDGHEJMBKOTSU-YKLVYJNSSA-N D0X2OD DRUGSMIL CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C D0X2OD HIGHSTAT Investigative D0X2VK DRUG__ID D0X2VK D0X2VK DRUGTYPE Small molecular drug D0X2VK DRUGINCH 1S/C23H18O2/c24-19-7-5-15(6-8-19)22-12-18-11-20(25)9-10-21(18)23(22)13-16-3-1-2-4-17(16)14-23/h1-12,24-25H,13-14H2 D0X2VK DRUGINKE NRJDKQAGGSKGKV-UHFFFAOYSA-N D0X2VK DRUGSMIL C1C2=CC=CC=C2CC13C4=C(C=C(C=C4)O)C=C3C5=CC=C(C=C5)O D0X2VK HIGHSTAT Investigative D0X2VN DRUG__ID D0X2VN D0X2VN DRUGTYPE Small molecular drug D0X2VN DRUGINCH 1S/C10H12N4O5/c15-1-3-7(16)8(17)9(19-3)5-4-6(14-13-5)10(18)12-2-11-4/h2-3,7-9,15-17H,1H2,(H,13,14)(H,11,12,18)/t3-,7-,8-,9+/m1/s1 D0X2VN DRUGINKE MTCJZZBQNCXKAP-KSYZLYKTSA-N D0X2VN DRUGSMIL C1=NC2=C(NN=C2C(=O)N1)C3C(C(C(O3)CO)O)O D0X2VN HIGHSTAT Investigative D0X2XQ DRUG__ID D0X2XQ D0X2XQ DRUGTYPE Small molecular drug D0X2XQ DRUGINCH 1S/C10H12N4S2/c1-2-15-9(11)13-6-3-4-7-8(5-6)16-10(12)14-7/h3-5H,2H2,1H3,(H2,11,13)(H2,12,14) D0X2XQ DRUGINKE ROUITZBECQQTSH-UHFFFAOYSA-N D0X2XQ DRUGSMIL CCSC(=NC1=CC2=C(C=C1)N=C(S2)N)N D0X2XQ HIGHSTAT Investigative D0X2ZM DRUG__ID D0X2ZM D0X2ZM DRUGTYPE Small molecular drug D0X2ZM DRUGINCH 1S/C56H53Cl2N7O5/c1-34-51(54(67)61-64-28-7-6-8-29-64)60-65(48-26-20-40(57)31-47(48)58)52(34)38-17-15-37(16-18-38)36-13-11-35(12-14-36)10-9-27-59-53(66)39-19-23-44-43(30-39)55(68)70-56(44)45-24-21-41(62(2)3)32-49(45)69-50-33-42(63(4)5)22-25-46(50)56/h11-26,30-33H,6-10,27-29H2,1-5H3,(H,59,66)(H,61,67) D0X2ZM DRUGINKE RNAPRXIZPJDYPH-UHFFFAOYSA-N D0X2ZM DRUGSMIL CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)C5=CC=C(C=C5)CCCNC(=O)C6=CC7=C(C=C6)C8(C9=C(C=C(C=C9)N(C)C)OC1=C8C=CC(=C1)N(C)C)OC7=O D0X2ZM HIGHSTAT Investigative D0X2ZW DRUG__ID D0X2ZW D0X2ZW DRUGTYPE Small molecular drug D0X2ZW DRUGINCH 1S/C18H26N2O3S/c1-5-7-10-20(24(21,22)6-2)16-12-18(3,4)23-17-9-8-14(13-19)11-15(16)17/h8-9,11,16H,5-7,10,12H2,1-4H3 D0X2ZW DRUGINKE VTICUGOJGKDYJD-UHFFFAOYSA-N D0X2ZW DRUGSMIL CCCCN(C1CC(OC2=C1C=C(C=C2)C#N)(C)C)S(=O)(=O)CC D0X2ZW HIGHSTAT Investigative D0X3AT DRUG__ID D0X3AT D0X3AT DRUGTYPE Small molecular drug D0X3AT DRUGINCH 1S/C22H43NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-23-22(24)21-18-15-14-16-19-21/h21H,2-20H2,1H3,(H,23,24) D0X3AT DRUGINKE VMFXYTSKMWPHQH-UHFFFAOYSA-N D0X3AT DRUGSMIL CCCCCCCCCCCCCCCNC(=O)C1CCCCC1 D0X3AT HIGHSTAT Investigative D0X3CF DRUG__ID D0X3CF D0X3CF DRUGTYPE Small molecular drug D0X3CF DRUGINCH 1S/C20H18O6/c21-20-15(6-13-2-4-17-19(8-13)26-11-24-17)14(9-22-20)5-12-1-3-16-18(7-12)25-10-23-16/h1-4,7-8,14-15H,5-6,9-11H2/t14-,15+/m0/s1 D0X3CF DRUGINKE DDWGQGZPYDSYEL-LSDHHAIUSA-N D0X3CF DRUGSMIL C1C(C(C(=O)O1)CC2=CC3=C(C=C2)OCO3)CC4=CC5=C(C=C4)OCO5 D0X3CF HIGHSTAT Investigative D0X3DK DRUG__ID D0X3DK D0X3DK DRUGTYPE Small molecular drug D0X3DK DRUGINCH 1S/C30H44F4O2/c1-6-29(36,7-2)30(33,34)16-14-19(3)25-12-13-26-21(9-8-15-28(25,26)5)10-11-22-17-23(35)18-24(20(22)4)27(31)32/h10-12,19,23-24,26-27,35-36H,4,6-9,13-18H2,1-3,5H3/b21-10+,22-11-/t19-,23-,24+,26+,28-/m1/s1 D0X3DK DRUGINKE CUKDGTJRZFQGCK-HBXJJCJFSA-N D0X3DK DRUGSMIL CCC(CC)(C(CCC(C)C1=CCC2C1(CCCC2=CC=C3CC(CC(C3=C)C(F)F)O)C)(F)F)O D0X3DK HIGHSTAT Investigative D0X3FF DRUG__ID D0X3FF D0X3FF DRUGTYPE Small molecular drug D0X3FF DRUGINCH 1S/C29H48O3/c1-7-19(17(2)3)14-26(31)18(4)23-10-11-24-22-9-8-20-15-21(30)16-27(32)29(20,6)25(22)12-13-28(23,24)5/h8-9,15,17-19,21-27,30-32H,7,10-14,16H2,1-6H3/t18-,19+,21+,22?,23+,24?,25?,26+,27-,28+,29-/m0/s1 D0X3FF DRUGINKE MVMHIMFXUANMIR-IWAMNEIESA-N D0X3FF DRUGSMIL CCC(CC(C(C)C1CCC2C1(CCC3C2C=CC4=CC(CC(C34C)O)O)C)O)C(C)C D0X3FF HIGHSTAT Investigative D0X3FT DRUG__ID D0X3FT D0X3FT DRUGTYPE Small molecular drug D0X3FT DRUGINCH 1S/C55H59N5O20/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66)/t38-,39-,42+,43+,44-,45-,52-,53-/m1/s1 D0X3FT DRUGINKE WTIJXIZOODAMJT-DHFGXMAYSA-N D0X3FT DRUGSMIL CC1=CC=C(N1)C(=O)OC2C(C(OC(C2OC)(C)C)OC3=C(C4=C(C=C3)C(=C(C(=O)O4)NC(=O)C5=CNC(=C5C)C(=O)NC6=C(C7=C(C(=C(C=C7)OC8C(C(C(C(O8)(C)C)OC)OC(=O)C9=CC=C(N9)C)O)C)OC6=O)O)O)C)O D0X3FT HIGHSTAT Investigative D0X3GG DRUG__ID D0X3GG D0X3GG DRUGTYPE Small molecular drug D0X3GG DRUGINCH 1S/C23H27BrFNO2/c1-3-14-26(2)15-6-4-5-7-16-28-20-12-13-21(22(25)17-20)23(27)18-8-10-19(24)11-9-18/h3,8-13,17H,1,4-7,14-16H2,2H3 D0X3GG DRUGINKE CMYCCJYVZIMDFU-UHFFFAOYSA-N D0X3GG DRUGSMIL CN(CCCCCCOC1=CC(=C(C=C1)C(=O)C2=CC=C(C=C2)Br)F)CC=C D0X3GG HIGHSTAT Investigative D0X3HB DRUG__ID D0X3HB D0X3HB DRUGTYPE Small molecular drug D0X3HB DRUGINCH 1S/C23H25FN4O3/c24-18-7-4-16(5-8-18)15-28-22(30)19-9-6-17(14-20(19)26-23(28)31)21(29)25-10-13-27-11-2-1-3-12-27/h4-9,14H,1-3,10-13,15H2,(H,25,29)(H,26,31) D0X3HB DRUGINKE PYCLIFABZLPONX-UHFFFAOYSA-N D0X3HB DRUGSMIL C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)F D0X3HB HIGHSTAT Investigative D0X3JB DRUG__ID D0X3JB D0X3JB DRUGTYPE Small molecular drug D0X3JB DRUGINCH 1S/C14H22N2O2S/c1-3-7-15-8-10-16(11-9-15)13-5-4-6-14(12-13)19(2,17)18/h4-6,12H,3,7-11H2,1-2H3 D0X3JB DRUGINKE IIFAQXPNYXJBMU-UHFFFAOYSA-N D0X3JB DRUGSMIL CCCN1CCN(CC1)C2=CC(=CC=C2)S(=O)(=O)C D0X3JB HIGHSTAT Investigative D0X3MK DRUG__ID D0X3MK D0X3MK DRUGTYPE Small molecular drug D0X3MK DRUGINCH 1S/C12H14N4O3/c13-12-9-7(1-2-14-12)16(5-15-9)8-3-6(4-17)10(18)11(8)19/h1-3,5,8,10-11,17-19H,4H2,(H2,13,14)/t8-,10-,11+/m1/s1 D0X3MK DRUGINKE OMKHWTRUYNAGFG-IEBDPFPHSA-N D0X3MK DRUGSMIL C1=CN=C(C2=C1N(C=N2)C3C=C(C(C3O)O)CO)N D0X3MK HIGHSTAT Investigative D0X3NW DRUG__ID D0X3NW D0X3NW DRUGTYPE Small molecular drug D0X3NW DRUGINCH 1S/C22H26FN5O4S2/c1-22(2,3)32-21(29)27-9-7-14(8-10-27)33-20-16-12-26-28(19(16)24-13-25-20)18-6-5-15(11-17(18)23)34(4,30)31/h5-6,11-14H,7-10H2,1-4H3 D0X3NW DRUGINKE KRCCTTRJUJRZKA-UHFFFAOYSA-N D0X3NW DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)SC2=NC=NC3=C2C=NN3C4=C(C=C(C=C4)S(=O)(=O)C)F D0X3NW HIGHSTAT Investigative D0X3PD DRUG__ID D0X3PD D0X3PD DRUGTYPE Small molecular drug D0X3PD DRUGINCH 1S/C23H22IN5O5/c1-2-9-28-22(32)19-21(29(23(28)33)11-13-3-8-17(25)16(24)10-13)27-20(26-19)14-4-6-15(7-5-14)34-12-18(30)31/h3-8,10H,2,9,11-12,25H2,1H3,(H,26,27)(H,30,31) D0X3PD DRUGINKE DKJMGIXWGPEEFF-UHFFFAOYSA-N D0X3PD DRUGSMIL CCCN1C(=O)C2=C(N=C(N2)C3=CC=C(C=C3)OCC(=O)O)N(C1=O)CC4=CC(=C(C=C4)N)I D0X3PD HIGHSTAT Investigative D0X3RZ DRUG__ID D0X3RZ D0X3RZ DRUGTYPE Small molecular drug D0X3RZ DRUGINCH 1S/C17H23N3O3/c1-10(2)7-15(17(22)23)20-16(21)13(18)8-11-9-19-14-6-4-3-5-12(11)14/h3-6,9-10,13,15,19H,7-8,18H2,1-2H3,(H,20,21)(H,22,23)/t13-,15-/m0/s1 D0X3RZ DRUGINKE LYMVXFSTACVOLP-ZFWWWQNUSA-N D0X3RZ DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)N D0X3RZ HIGHSTAT Investigative D0X3SO DRUG__ID D0X3SO D0X3SO DRUGTYPE Small molecular drug D0X3SO DRUGINCH 1S/C4H9N3S/c1-3(2)6-7-4(5)8/h1-2H3,(H3,5,7,8) D0X3SO DRUGINKE FQUDPIIGGVBZEQ-UHFFFAOYSA-N D0X3SO DRUGSMIL CC(=NNC(=S)N)C D0X3SO HIGHSTAT Investigative D0X3TF DRUG__ID D0X3TF D0X3TF DRUGTYPE Small molecular drug D0X3TF DRUGINCH 1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3 D0X3TF DRUGINKE YNZFFALZMRAPHQ-UHFFFAOYSA-N D0X3TF DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CC(CCC2CCCO)O)O D0X3TF HIGHSTAT Investigative D0X3TL DRUG__ID D0X3TL D0X3TL DRUGTYPE Small molecular drug D0X3TL DRUGINCH 1S/C20H22O8/c1-7-11-9(25-13(7)22)6-18-8-5-10(17(2,3)4)19(18)12(21)15(24)26-16(19)28-20(11,18)27-14(8)23/h8-10,12,16,21H,5-6H2,1-4H3/t8-,9-,10-,12-,16-,18-,19-,20+/m0/s1 D0X3TL DRUGINKE KQXWWKYPPREDFP-VETRYGRWSA-N D0X3TL DRUGSMIL CC1=C2C(CC34C25OC6C3(C(CC4C(=O)O5)C(C)(C)C)C(C(=O)O6)O)OC1=O D0X3TL HIGHSTAT Investigative D0X3TO DRUG__ID D0X3TO D0X3TO DRUGTYPE Small molecular drug D0X3TO DRUGINCH 1S/C12H8FN3OS/c1-7-6-18-12(15-7)16-11(17)9-2-8(5-14)3-10(13)4-9/h2-4,6H,1H3,(H,15,16,17) D0X3TO DRUGINKE KTQZJPKEGPXLRL-UHFFFAOYSA-N D0X3TO DRUGSMIL CC1=CSC(=N1)NC(=O)C2=CC(=CC(=C2)C#N)F D0X3TO HIGHSTAT Investigative D0X3VM DRUG__ID D0X3VM D0X3VM DRUGTYPE Small molecular drug D0X3VM DRUGINCH 1S/C14H15Cl2NO3/c15-8-5-9(16)7-10(6-8)17-13(18)11-3-1-2-4-12(11)14(19)20/h5-7,11-12H,1-4H2,(H,17,18)(H,19,20)/t11-,12+/m0/s1 D0X3VM DRUGINKE VSMUYYFJVFSVCA-NWDGAFQWSA-N D0X3VM DRUGSMIL C1CCC(C(C1)C(=O)NC2=CC(=CC(=C2)Cl)Cl)C(=O)O D0X3VM HIGHSTAT Investigative D0X3XE DRUG__ID D0X3XE D0X3XE DRUGTYPE Small molecular drug D0X3XE DRUGINCH 1S/C24H34ClN5O/c1-31-19-7-9-22-21(17-19)24(20-8-6-18(25)16-23(20)29-22)28-12-5-15-30(14-4-11-27)13-3-2-10-26/h6-9,16-17H,2-5,10-15,26-27H2,1H3,(H,28,29) D0X3XE DRUGINKE BIGAHIIWPDZJMX-UHFFFAOYSA-N D0X3XE DRUGSMIL COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCN(CCCCN)CCCN D0X3XE HIGHSTAT Investigative D0X4AL DRUG__ID D0X4AL D0X4AL DRUGTYPE Small molecular drug D0X4AL DRUGINCH 1S/C6H8O8S/c7-3-1-4(6(8)9)13-2-5(3)14-15(10,11)12/h1,3,5,7H,2H2,(H,8,9)(H,10,11,12)/t3-,5-/m1/s1 D0X4AL DRUGINKE SLBOXLMLDIGNGG-NQXXGFSBSA-N D0X4AL DRUGSMIL C1C(C(C=C(O1)C(=O)O)O)OS(=O)(=O)O D0X4AL HIGHSTAT Investigative D0X4BJ DRUG__ID D0X4BJ D0X4BJ DRUGTYPE Small molecular drug D0X4BJ DRUGINCH 1S/C12H9Cl2NO2/c13-7-1-3-12(10(16)5-7)17-11-4-2-8(15)6-9(11)14/h1-6,16H,15H2 D0X4BJ DRUGINKE MCYCMAVHVQGDNE-UHFFFAOYSA-N D0X4BJ DRUGSMIL C1=CC(=C(C=C1N)Cl)OC2=C(C=C(C=C2)Cl)O D0X4BJ HIGHSTAT Investigative D0X4BT DRUG__ID D0X4BT D0X4BT DRUGTYPE Small molecular drug D0X4BT DRUGINCH 1S/C26H14Cl8O4/c27-13-1-9(2-14(28)23(13)35)21(10-3-15(29)24(36)16(30)4-10)22(11-5-17(31)25(37)18(32)6-11)12-7-19(33)26(38)20(34)8-12/h1-8,21-22,35-38H D0X4BT DRUGINKE PGVJRDOIJQMGEF-UHFFFAOYSA-N D0X4BT DRUGSMIL C1=C(C=C(C(=C1Cl)O)Cl)C(C2=CC(=C(C(=C2)Cl)O)Cl)C(C3=CC(=C(C(=C3)Cl)O)Cl)C4=CC(=C(C(=C4)Cl)O)Cl D0X4BT HIGHSTAT Investigative D0X4CI DRUG__ID D0X4CI D0X4CI DRUGTYPE Small molecular drug D0X4CI DRUGINCH 1S/C12H4Br6O2/c13-4-1-2-6(5(14)3-4)20-12-10(18)8(16)7(15)9(17)11(12)19/h1-3,19H D0X4CI DRUGINKE LDMKXEGTHGJWLG-UHFFFAOYSA-N D0X4CI DRUGSMIL C1=CC(=C(C=C1Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)O D0X4CI HIGHSTAT Investigative D0X4CO DRUG__ID D0X4CO D0X4CO DRUGTYPE Small molecular drug D0X4CO DRUGINCH 1S/C20H16Cl2N8O2/c21-12-1-3-14(16(22)9-12)18-15(19-24-6-7-25-19)11-28-20(29-18)26-8-5-23-17-4-2-13(10-27-17)30(31)32/h1-4,6-7,9-11H,5,8H2,(H,23,27)(H,24,25)(H,26,28,29) D0X4CO DRUGINKE GUMBZKISKUIHJB-UHFFFAOYSA-N D0X4CO DRUGSMIL C1=CC(=C(C=C1Cl)Cl)C2=NC(=NC=C2C3=NC=CN3)NCCNC4=NC=C(C=C4)[N+](=O)[O-] D0X4CO HIGHSTAT Investigative D0X4DE DRUG__ID D0X4DE D0X4DE DRUGTYPE Small molecular drug D0X4DE DRUGINCH 1S/C25H26/c1-17-21-12-13-22(17)15-18(14-21)16-25-23-8-4-2-6-19(23)10-11-20-7-3-5-9-24(20)25/h2-9,14,16-17,21-22H,10-13,15H2,1H3 D0X4DE DRUGINKE RMNZMKPVCVYBDK-UHFFFAOYSA-N D0X4DE DRUGSMIL CC1C2CCC1C=C(C2)C=C3C4=CC=CC=C4CCC5=CC=CC=C53 D0X4DE HIGHSTAT Investigative D0X4DY DRUG__ID D0X4DY D0X4DY DRUGTYPE Small molecular drug D0X4DY DRUGINCH 1S/C18H25NO2/c1-2-3-4-5-6-7-8-11-15-14-18(20)16-12-9-10-13-17(16)19(15)21/h9-10,12-14,21H,2-8,11H2,1H3 D0X4DY DRUGINKE JYFNTDPGDPZMCM-UHFFFAOYSA-N D0X4DY DRUGSMIL CCCCCCCCCC1=CC(=O)C2=CC=CC=C2N1O D0X4DY HIGHSTAT Investigative D0X4EB DRUG__ID D0X4EB D0X4EB DRUGTYPE Small molecular drug D0X4EB DRUGINCH 1S/C6H11FO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1H2/t2-,3-,4-,5-,6-/m1/s1 D0X4EB DRUGINKE ZCXUVYAZINUVJD-QZABAPFNSA-N D0X4EB DRUGSMIL C(C1C(C(C(C(O1)O)F)O)O)O D0X4EB HIGHSTAT Investigative D0X4EE DRUG__ID D0X4EE D0X4EE DRUGTYPE Small molecular drug D0X4EE DRUGINCH 1S/C21H34N8O12/c1-9(31)26-11(5-15(33)34)18(38)28-10(3-2-4-24-21(22)23)17(37)25-7-14(32)27-12(6-16(35)36)19(39)29-13(8-30)20(40)41/h10-13,30H,2-8H2,1H3,(H,25,37)(H,26,31)(H,27,32)(H,28,38)(H,29,39)(H,33,34)(H,35,36)(H,40,41)(H4,22,23,24)/t10-,11-,12-,13-/m0/s1 D0X4EE DRUGINKE SSQXWSYTLDJJAP-CYDGBPFRSA-N D0X4EE DRUGSMIL CC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)O D0X4EE HIGHSTAT Investigative D0X4EV DRUG__ID D0X4EV D0X4EV DRUGTYPE Small molecular drug D0X4EV DRUGINCH 1S/C13H13ClN2/c14-9-5-3-7-11-12(9)13(15)8-4-1-2-6-10(8)16-11/h3,5,7H,1-2,4,6H2,(H2,15,16) D0X4EV DRUGINKE KVGMGGLTJLJDFE-UHFFFAOYSA-N D0X4EV DRUGSMIL C1CCC2=NC3=C(C(=CC=C3)Cl)C(=C2C1)N D0X4EV HIGHSTAT Investigative D0X4FO DRUG__ID D0X4FO D0X4FO DRUGTYPE Small molecular drug D0X4FO DRUGINCH 1S/C15H16N4O2/c1-2-11-9-15(18-7-5-16-6-8-18)17-14-4-3-12(19(20)21)10-13(11)14/h2-4,9-10,16H,1,5-8H2 D0X4FO DRUGINKE BFHGMHUBVIINKT-UHFFFAOYSA-N D0X4FO DRUGSMIL C=CC1=CC(=NC2=C1C=C(C=C2)[N+](=O)[O-])N3CCNCC3 D0X4FO HIGHSTAT Investigative D0X4HG DRUG__ID D0X4HG D0X4HG DRUGTYPE Small molecular drug D0X4HG DRUGINCH 1S/C26H26N2O5/c1-27-26(30)32-20-8-5-7-18(15-20)17-28(2)13-6-14-31-19-11-12-22-24(16-19)33-23-10-4-3-9-21(23)25(22)29/h3-5,7-12,15-16H,6,13-14,17H2,1-2H3,(H,27,30) D0X4HG DRUGINKE DNSUFPJFKSCBRT-UHFFFAOYSA-N D0X4HG DRUGSMIL CNC(=O)OC1=CC=CC(=C1)CN(C)CCCOC2=CC3=C(C=C2)C(=O)C4=CC=CC=C4O3 D0X4HG HIGHSTAT Investigative D0X4KR DRUG__ID D0X4KR D0X4KR DRUGTYPE Small molecular drug D0X4KR DRUGINCH 1S/C43H50N4O4S/c1-30-16-18-32(19-17-30)52(49,50)51-37-15-12-14-33-34-20-23-44-39(40(34)45-38(33)37)35-28-43(48)22-9-5-2-3-6-10-24-46-26-21-36(35)42(29-46)27-31-13-8-4-7-11-25-47(31)41(42)43/h2,5,8,12-20,23,28,31,36,41,45,48H,3-4,6-7,9-11,21-22,24-27,29H2,1H3/b5-2-,13-8-/t31-,36-,41+,42-,43-/m0/s1 D0X4KR DRUGINKE YYODILDWWWVNHZ-PPDYSKKASA-N D0X4KR DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=CC3=C2NC4=C3C=CN=C4C5=CC6(CCC=CCCCCN7CCC5C8(C7)C6N9CCCCC=CC9C8)O D0X4KR HIGHSTAT Investigative D0X4LI DRUG__ID D0X4LI D0X4LI DRUGTYPE Small molecular drug D0X4LI DRUGINCH 1S/C17H14O3S2/c1-19-13-7-3-11(4-8-13)15-16(21-22-17(15)18)12-5-9-14(20-2)10-6-12/h3-10H,1-2H3 D0X4LI DRUGINKE HXHFMMHFTDDRIF-UHFFFAOYSA-N D0X4LI DRUGSMIL COC1=CC=C(C=C1)C2=C(SSC2=O)C3=CC=C(C=C3)OC D0X4LI HIGHSTAT Investigative D0X4LQ DRUG__ID D0X4LQ D0X4LQ DRUGTYPE Small molecular drug D0X4LQ DRUGINCH 1S/C15H10Cl4O2S/c1-22(20,21)13-8-11(17)6-7-12(13)14(15(18)19)9-2-4-10(16)5-3-9/h2-8H,1H3 D0X4LQ DRUGINKE YQCQEXWXRQQMAR-UHFFFAOYSA-N D0X4LQ DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)Cl)C(=C(Cl)Cl)C2=CC=C(C=C2)Cl D0X4LQ HIGHSTAT Investigative D0X4NG DRUG__ID D0X4NG D0X4NG DRUGTYPE Small molecular drug D0X4NG DRUGINCH 1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-19,22-23H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17-,18+,19-/m1/s1 D0X4NG DRUGINKE VKTIONYPMSCHQI-XAGFEHLVSA-N D0X4NG DRUGSMIL CCCCCC(=O)CCC1C(CC(C1CC=CCCCC(=O)O)O)O D0X4NG HIGHSTAT Investigative D0X4NX DRUG__ID D0X4NX D0X4NX DRUGTYPE Small molecular drug D0X4NX DRUGINCH 1S/C18H12O4/c19-15-13(11-7-3-1-4-8-11)16(20)18(22)14(17(15)21)12-9-5-2-6-10-12/h1-10,19,22H D0X4NX DRUGINKE HZKFHDXTSAYOSN-UHFFFAOYSA-N D0X4NX DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C(=C(C2=O)O)C3=CC=CC=C3)O D0X4NX HIGHSTAT Investigative D0X4OP DRUG__ID D0X4OP D0X4OP DRUGTYPE Small molecular drug D0X4OP DRUGINCH 1S/C21H26N2O/c1-4-8-18-20(24-14-7-13-22-15(2)3)12-11-17-16-9-5-6-10-19(16)23-21(17)18/h4-6,9-12,15,22-23H,1,7-8,13-14H2,2-3H3 D0X4OP DRUGINKE UQDMMPHZGIOABI-UHFFFAOYSA-N D0X4OP DRUGSMIL CC(C)NCCCOC1=C(C2=C(C=C1)C3=CC=CC=C3N2)CC=C D0X4OP HIGHSTAT Investigative D0X4OU DRUG__ID D0X4OU D0X4OU DRUGTYPE Small molecular drug D0X4OU DRUGINCH 1S/C23H21N3O3/c1-27-21-12-19-20(13-22(21)28-2)24-15-25-23(19)26-17-8-10-18(11-9-17)29-14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,24,25,26) D0X4OU DRUGINKE DNOKYISWMVFYFA-UHFFFAOYSA-N D0X4OU DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OCC4=CC=CC=C4)OC D0X4OU HIGHSTAT Investigative D0X4OW DRUG__ID D0X4OW D0X4OW DRUGTYPE Small molecular drug D0X4OW DRUGINCH 1S/C8H12O2/c9-7-8(5-6-10-7)3-1-2-4-8/h1-6H2 D0X4OW DRUGINKE PBZONIMHAVOWHW-UHFFFAOYSA-N D0X4OW DRUGSMIL C1CCC2(C1)CCOC2=O D0X4OW HIGHSTAT Investigative D0X4PH DRUG__ID D0X4PH D0X4PH DRUGTYPE Small molecular drug D0X4PH DRUGINCH 1S/C27H37N3OS/c1-32-26-15-7-6-14-25(26)30-20-18-29(19-21-30)17-8-2-3-16-27(31)28-24-13-9-11-22-10-4-5-12-23(22)24/h4-7,10,12,14-15,24H,2-3,8-9,11,13,16-21H2,1H3,(H,28,31) D0X4PH DRUGINKE JNBBJUHCODFLEG-UHFFFAOYSA-N D0X4PH DRUGSMIL CSC1=CC=CC=C1N2CCN(CC2)CCCCCC(=O)NC3CCCC4=CC=CC=C34 D0X4PH HIGHSTAT Investigative D0X4QC DRUG__ID D0X4QC D0X4QC DRUGTYPE Small molecular drug D0X4QC DRUGINCH 1S/C31H41N5O4S2/c1-31(2)30(40)34-24(18-17-22-12-5-3-6-13-22)29(39)36-20-11-15-25(36)28(38)33-23(27(37)35-31)14-7-4-10-21-41-42-26-16-8-9-19-32-26/h3,5-6,8-9,12-13,16,19,23-25H,4,7,10-11,14-15,17-18,20-21H2,1-2H3,(H,33,38)(H,34,40)(H,35,37)/t23-,24-,25+/m0/s1 D0X4QC DRUGINKE VOORCQROXYSHCG-CCDWMCETSA-N D0X4QC DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CCC4=CC=CC=C4)C D0X4QC HIGHSTAT Investigative D0X4RC DRUG__ID D0X4RC D0X4RC DRUGTYPE Small molecular drug D0X4RC DRUGINCH 1S/C10H14N2/c1-2-4-10(5-3-1)12-8-6-11-7-9-12/h1-5,11H,6-9H2 D0X4RC DRUGINKE YZTJYBJCZXZGCT-UHFFFAOYSA-N D0X4RC DRUGSMIL C1CN(CCN1)C2=CC=CC=C2 D0X4RC HIGHSTAT Investigative D0X4RV DRUG__ID D0X4RV D0X4RV DRUGTYPE Small molecular drug D0X4RV DRUGINCH 1S/C26H27NO4/c1-19-8-10-21(11-9-19)26(30)22-12-14-23(15-13-22)31-24(20-6-4-3-5-7-20)16-17-27(2)18-25(28)29/h3-15,24H,16-18H2,1-2H3,(H,28,29) D0X4RV DRUGINKE HNBKNDFZJLEZLZ-UHFFFAOYSA-N D0X4RV DRUGSMIL CC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)OC(CCN(C)CC(=O)O)C3=CC=CC=C3 D0X4RV HIGHSTAT Investigative D0X4SF DRUG__ID D0X4SF D0X4SF DRUGTYPE Small molecular drug D0X4SF DRUGINCH 1S/C13H9BrN2O2S/c14-10-4-1-2-6-13(10)19(17,18)12-7-3-5-11(16)9(12)8-15/h1-7H,16H2 D0X4SF DRUGINKE WBNCALTXWWEQQV-UHFFFAOYSA-N D0X4SF DRUGSMIL C1=CC=C(C(=C1)S(=O)(=O)C2=CC=CC(=C2C#N)N)Br D0X4SF HIGHSTAT Investigative D0X4SX DRUG__ID D0X4SX D0X4SX DRUGTYPE Small molecular drug D0X4SX DRUGINCH 1S/C27H31NO/c1-2-22-29-27(25-16-10-5-11-17-25)18-20-28(21-19-27)26(23-12-6-3-7-13-23)24-14-8-4-9-15-24/h3-17,26H,2,18-22H2,1H3 D0X4SX DRUGINKE RCNHZINTASPDKK-UHFFFAOYSA-N D0X4SX DRUGSMIL CCCOC1(CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4 D0X4SX HIGHSTAT Investigative D0X4UE DRUG__ID D0X4UE D0X4UE DRUGTYPE Small molecular drug D0X4UE DRUGINCH 1S/C15H14N4/c1-10-3-2-4-12(7-10)19-15-13-8-11(16)5-6-14(13)17-9-18-15/h2-9H,16H2,1H3,(H,17,18,19) D0X4UE DRUGINKE NFBCSWGEYDCCDW-UHFFFAOYSA-N D0X4UE DRUGSMIL CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C(C=C3)N D0X4UE HIGHSTAT Investigative D0X4UN DRUG__ID D0X4UN D0X4UN DRUGTYPE Small molecular drug D0X4UN DRUGINCH 1S/C14H14N2O/c1-10-5-3-7-12(9-10)14(17)16-13-8-4-6-11(2)15-13/h3-9H,1-2H3,(H,15,16,17) D0X4UN DRUGINKE AKCGNQRHTCXVRF-UHFFFAOYSA-N D0X4UN DRUGSMIL CC1=CC(=CC=C1)C(=O)NC2=CC=CC(=N2)C D0X4UN HIGHSTAT Investigative D0X4VN DRUG__ID D0X4VN D0X4VN DRUGTYPE Small molecular drug D0X4VN DRUGINCH 1S/C16H11FO2/c17-15-9-13(4-6-16(15)19)10-1-2-12-8-14(18)5-3-11(12)7-10/h1-9,18-19H D0X4VN DRUGINKE QTDYCKGQBCKMGC-UHFFFAOYSA-N D0X4VN DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C=C3)O)F D0X4VN HIGHSTAT Investigative D0X4VO DRUG__ID D0X4VO D0X4VO DRUGTYPE Small molecular drug D0X4VO DRUGINCH 1S/C13H18N2O3/c16-11-15(18)10-6-2-5-9-14-13(17)12-7-3-1-4-8-12/h1,3-4,7-8,11,18H,2,5-6,9-10H2,(H,14,17) D0X4VO DRUGINKE XZVIJIAWKVHBTR-UHFFFAOYSA-N D0X4VO DRUGSMIL C1=CC=C(C=C1)C(=O)NCCCCCN(C=O)O D0X4VO HIGHSTAT Investigative D0X4XX DRUG__ID D0X4XX D0X4XX DRUGTYPE Small molecular drug D0X4XX DRUGINCH 1S/C10H8F2N2/c11-9-2-1-8(5-10(9)12)6-14-4-3-13-7-14/h1-5,7H,6H2 D0X4XX DRUGINKE YOWSCWVTVGDNPQ-UHFFFAOYSA-N D0X4XX DRUGSMIL C1=CC(=C(C=C1CN2C=CN=C2)F)F D0X4XX HIGHSTAT Investigative D0X4YC DRUG__ID D0X4YC D0X4YC DRUGTYPE Small molecular drug D0X4YC DRUGINCH 1S/C37H47N5O4/c1-24-17-30(43)18-25(2)31(24)21-32(38)37(46)42-23-29-14-8-6-12-27(29)20-34(42)36(45)40-16-10-4-3-9-15-39-35(44)33-19-26-11-5-7-13-28(26)22-41-33/h5-8,11-14,17-18,32-34,41,43H,3-4,9-10,15-16,19-23,38H2,1-2H3,(H,39,44)(H,40,45)/t32-,33?,34?/m0/s1 D0X4YC DRUGINKE SIUMEPYYYNRSSX-BGVJURHFSA-N D0X4YC DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NCCCCCCNC(=O)C4CC5=CC=CC=C5CN4)N)C)O D0X4YC HIGHSTAT Investigative D0X5AA DRUG__ID D0X5AA D0X5AA DRUGTYPE Small molecular drug D0X5AA DRUGINCH 1S/C12H20N2/c1-9-7-12(14(3)4)6-5-11(9)8-10(2)13/h5-7,10H,8,13H2,1-4H3/t10-/m0/s1 D0X5AA DRUGINKE HFQMYSHATTXRTC-JTQLQIEISA-N D0X5AA DRUGSMIL CC1=C(C=CC(=C1)N(C)C)CC(C)N D0X5AA HIGHSTAT Investigative D0X5AY DRUG__ID D0X5AY D0X5AY DRUGTYPE Small molecular drug D0X5AY DRUGINCH 1S/C12H13N3O2S/c1-8-7-13-12(18-8)15-11(16)14-9-3-5-10(17-2)6-4-9/h3-7H,1-2H3,(H2,13,14,15,16) D0X5AY DRUGINKE OHPUNXDCCJNSEH-UHFFFAOYSA-N D0X5AY DRUGSMIL CC1=CN=C(S1)NC(=O)NC2=CC=C(C=C2)OC D0X5AY HIGHSTAT Investigative D0X5CM DRUG__ID D0X5CM D0X5CM DRUGTYPE Small molecular drug D0X5CM DRUGINCH 1S/C18H15FN4O/c1-11(2)18-22-21-15-8-5-13(9-23(15)18)17-16(20-10-24-17)12-3-6-14(19)7-4-12/h3-11H,1-2H3 D0X5CM DRUGINKE OVCXRBARSPBVMC-UHFFFAOYSA-N D0X5CM DRUGSMIL CC(C)C1=NN=C2N1C=C(C=C2)C3=C(N=CO3)C4=CC=C(C=C4)F D0X5CM HIGHSTAT Investigative D0X5DB DRUG__ID D0X5DB D0X5DB DRUGTYPE Small molecular drug D0X5DB DRUGINCH 1S/C15H21N3/c1-15(2,3)12-4-6-13(7-5-12)17-9-8-14-10-16-11-18-14/h4-7,10-11,17H,8-9H2,1-3H3,(H,16,18) D0X5DB DRUGINKE CAUIWLDBMLQRJD-UHFFFAOYSA-N D0X5DB DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NCCC2=CN=CN2 D0X5DB HIGHSTAT Investigative D0X5DC DRUG__ID D0X5DC D0X5DC DRUGTYPE Small molecular drug D0X5DC DRUGINCH 1S/C10H18O/c1-5-10(4,11)8-6-7-9(2)3/h5,7,11H,1,6,8H2,2-4H3 D0X5DC DRUGINKE CDOSHBSSFJOMGT-UHFFFAOYSA-N D0X5DC DRUGSMIL CC(=CCCC(C)(C=C)O)C D0X5DC HIGHSTAT Investigative D0X5DT DRUG__ID D0X5DT D0X5DT DRUGTYPE Small molecular drug D0X5DT DRUGINCH 1S/C22H17NO2/c24-21-18-11-5-6-12-19(18)22(25)23(21)20-13-7-4-10-17(20)15-14-16-8-2-1-3-9-16/h1-13H,14-15H2 D0X5DT DRUGINKE XGSWAPNRKGOSKD-UHFFFAOYSA-N D0X5DT DRUGSMIL C1=CC=C(C=C1)CCC2=CC=CC=C2N3C(=O)C4=CC=CC=C4C3=O D0X5DT HIGHSTAT Investigative D0X5HL DRUG__ID D0X5HL D0X5HL DRUGTYPE Small molecular drug D0X5HL DRUGINCH 1S/C12H14N2/c13-8-9-14-12-7-3-5-10-4-1-2-6-11(10)12/h1-7,14H,8-9,13H2 D0X5HL DRUGINKE NULAJYZBOLVQPQ-UHFFFAOYSA-N D0X5HL DRUGSMIL C1=CC=C2C(=C1)C=CC=C2NCCN D0X5HL HIGHSTAT Investigative D0X5JR DRUG__ID D0X5JR D0X5JR DRUGTYPE Small molecular drug D0X5JR DRUGINCH 1S/C20H18N4O3/c21-18(25)15-8-10-16(11-9-15)23-20(26)24-19-17(7-4-12-22-19)27-13-14-5-2-1-3-6-14/h1-12H,13H2,(H2,21,25)(H2,22,23,24,26) D0X5JR DRUGINKE TWCYUPDQSZQMLM-UHFFFAOYSA-N D0X5JR DRUGSMIL C1=CC=C(C=C1)COC2=C(N=CC=C2)NC(=O)NC3=CC=C(C=C3)C(=O)N D0X5JR HIGHSTAT Investigative D0X5KQ DRUG__ID D0X5KQ D0X5KQ DRUGTYPE Small molecular drug D0X5KQ DRUGINCH 1S/C39H69N9O11S3/c1-20(2)16-26(42-29(50)17-41-33(52)24(11-14-61-7)43-32(51)23(40)18-49)38(57)48-13-9-10-28(48)35(54)45-27(19-60)34(53)46-31(22(5)6)37(56)47-30(21(3)4)36(55)44-25(39(58)59)12-15-62-8/h20-28,30-31,49,60H,9-19,40H2,1-8H3,(H,41,52)(H,42,50)(H,43,51)(H,44,55)(H,45,54)(H,46,53)(H,47,56)(H,58,59)/t23-,24-,25-,26-,27-,28-,30-,31-/m0/s1 D0X5KQ DRUGINKE XSTRKZMDUHFCKT-LFPOIMSVSA-N D0X5KQ DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)NC(CS)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCSC)C(=O)O)NC(=O)CNC(=O)C(CCSC)NC(=O)C(CO)N D0X5KQ HIGHSTAT Investigative D0X5LJ DRUG__ID D0X5LJ D0X5LJ DRUGTYPE Small molecular drug D0X5LJ DRUGINCH 1S/C14H21NO/c1-2-8-15-9-6-12(7-10-15)13-4-3-5-14(16)11-13/h3-5,11-12,16H,2,6-10H2,1H3 D0X5LJ DRUGINKE HPUYFCNUROWQBG-UHFFFAOYSA-N D0X5LJ DRUGSMIL CCCN1CCC(CC1)C2=CC(=CC=C2)O D0X5LJ HIGHSTAT Investigative D0X5LN DRUG__ID D0X5LN D0X5LN DRUGTYPE Small molecular drug D0X5LN DRUGINCH 1S/C15H10O6/c16-9-3-1-7(5-12(9)19)13-6-11(18)8-2-4-10(17)14(20)15(8)21-13/h1-6,16-17,19-20H D0X5LN DRUGINKE ARYCMKPCDNHQCL-UHFFFAOYSA-N D0X5LN DRUGSMIL C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3)O)O)O)O D0X5LN HIGHSTAT Investigative D0X5MA DRUG__ID D0X5MA D0X5MA DRUGTYPE Small molecular drug D0X5MA DRUGINCH 1S/C23H29IO5/c24-16-7-10-18(11-8-16)28-15-17(25)9-12-20-19(21-13-14-22(20)29-21)5-3-1-2-4-6-23(26)27/h1,3,7-12,17,19-22,25H,2,4-6,13-15H2,(H,26,27)/b3-1-,12-9+/t17-,19-,20-,21+,22-/m1/s1 D0X5MA DRUGINKE UYFMSCHBODMWON-HBHIRWTLSA-N D0X5MA DRUGSMIL C1CC2C(C(C1O2)CC=CCCCC(=O)O)C=CC(COC3=CC=C(C=C3)I)O D0X5MA HIGHSTAT Investigative D0X5OY DRUG__ID D0X5OY D0X5OY DRUGTYPE Small molecular drug D0X5OY DRUGINCH 1S/C14H23N6O3S/c1-24(4-2-3-15)5-8-10(21)11(22)14(23-8)20-7-19-9-12(16)17-6-18-13(9)20/h6-8,10-11,14,21-22H,2-5,15H2,1H3,(H2,16,17,18)/q+1/p+1/t8-,10-,11-,14-,24?/m1/s1 D0X5OY DRUGINKE ZUNBITIXDCPNSD-LSRJEVITSA-O D0X5OY DRUGSMIL C[S+](CCC[NH3+])CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0X5OY HIGHSTAT Investigative D0X5PJ DRUG__ID D0X5PJ D0X5PJ DRUGTYPE Small molecular drug D0X5PJ DRUGINCH 1S/C30H33N7O4/c1-4-15-36-28-26(29(39)37(16-5-2)30(36)40)32-27(33-28)23-18-24(34-35(23)3)31-25(38)17-20-11-13-22(14-12-20)41-19-21-9-7-6-8-10-21/h6-14,18H,4-5,15-17,19H2,1-3H3,(H,32,33)(H,31,34,38) D0X5PJ DRUGINKE YJWWRRYUAYGZCB-UHFFFAOYSA-N D0X5PJ DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)NC(=O)CC4=CC=C(C=C4)OCC5=CC=CC=C5 D0X5PJ HIGHSTAT Investigative D0X5QJ DRUG__ID D0X5QJ D0X5QJ DRUGTYPE Small molecular drug D0X5QJ DRUGINCH 1S/C7H4BrN3O2/c8-7-4-2-1-3-5(11(12)13)6(4)9-10-7/h1-3H,(H,9,10) D0X5QJ DRUGINKE NFSTZPMYAZRZPC-UHFFFAOYSA-N D0X5QJ DRUGSMIL C1=CC2=C(NN=C2C(=C1)[N+](=O)[O-])Br D0X5QJ HIGHSTAT Investigative D0X5RA DRUG__ID D0X5RA D0X5RA DRUGTYPE Small molecular drug D0X5RA DRUGINCH 1S/C4H4BrN3O2/c5-1-2(6)7-4(10)8-3(1)9/h(H4,6,7,8,9,10) D0X5RA DRUGINKE FSLBEEVCUZFKRL-UHFFFAOYSA-N D0X5RA DRUGSMIL C1(=C(NC(=O)NC1=O)N)Br D0X5RA HIGHSTAT Investigative D0X5RR DRUG__ID D0X5RR D0X5RR DRUGTYPE Small molecular drug D0X5RR DRUGINCH 1S/C15H12O4/c16-15(17)8-10-5-6-13-14(7-10)19-12-4-2-1-3-11(12)9-18-13/h1-7H,8-9H2,(H,16,17) D0X5RR DRUGINKE MREFHNNUMIAIHP-UHFFFAOYSA-N D0X5RR DRUGSMIL C1C2=CC=CC=C2OC3=C(O1)C=CC(=C3)CC(=O)O D0X5RR HIGHSTAT Investigative D0X5SZ DRUG__ID D0X5SZ D0X5SZ DRUGTYPE Small molecular drug D0X5SZ DRUGINCH 1S/C14H13N3O3/c1-8-4-2-7-11(15-8)16-13(18)9-5-3-6-10-12(9)17-14(19)20-10/h2-4,6-7,9H,5H2,1H3,(H,17,19)(H,15,16,18) D0X5SZ DRUGINKE ILTICRNSZLAODU-UHFFFAOYSA-N D0X5SZ DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2CC=CC3=C2NC(=O)O3 D0X5SZ HIGHSTAT Investigative D0X5TB DRUG__ID D0X5TB D0X5TB DRUGTYPE Small molecular drug D0X5TB DRUGINCH 1S/C36H51N7O10/c1-18(2)11-26(35(51)43-30(21(5)45)36(52)53)41-34(50)27(14-22-9-7-6-8-10-22)40-29(46)16-39-33(49)28(17-44)42-32(48)25(37)15-24-19(3)12-23(31(38)47)13-20(24)4/h6-10,12-13,18,21,25-28,30,44-45H,11,14-17,37H2,1-5H3,(H2,38,47)(H,39,49)(H,40,46)(H,41,50)(H,42,48)(H,43,51)(H,52,53)/t21-,25+,26+,27+,28+,30+/m1/s1 D0X5TB DRUGINKE OCIDAPABHMBEIS-VVPQYXBXSA-N D0X5TB DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC(CO)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)O)N)C)C(=O)N D0X5TB HIGHSTAT Investigative D0X5US DRUG__ID D0X5US D0X5US DRUGTYPE Small molecular drug D0X5US DRUGINCH 1S/C10H7NO3/c12-8-4-3-7(10(13)14)6-2-1-5-11-9(6)8/h1-5,12H,(H,13,14) D0X5US DRUGINKE JGRPKOGHYBAVMW-UHFFFAOYSA-N D0X5US DRUGSMIL C1=CC2=C(C=CC(=C2N=C1)O)C(=O)O D0X5US HIGHSTAT Investigative D0X5WD DRUG__ID D0X5WD D0X5WD DRUGTYPE Small molecular drug D0X5WD DRUGINCH 1S/C19H17NO2/c1-12(2)16-17(20-13-8-4-3-5-9-13)14-10-6-7-11-15(14)18(21)19(16)22/h3-12,20H,1-2H3 D0X5WD DRUGINKE HHIYZEJIOLXXOB-UHFFFAOYSA-N D0X5WD DRUGSMIL CC(C)C1=C(C2=CC=CC=C2C(=O)C1=O)NC3=CC=CC=C3 D0X5WD HIGHSTAT Investigative D0X5WP DRUG__ID D0X5WP D0X5WP DRUGTYPE Small molecular drug D0X5WP DRUGINCH 1S/C29H30N2O2/c1-28(2)14-15-29(3,4)22-17-25-23(16-21(22)28)30-26(18-10-12-19(13-11-18)27(32)33)20-8-6-7-9-24(20)31(25)5/h6-13,16-17H,14-15H2,1-5H3,(H,32,33) D0X5WP DRUGINKE YZZAIQOVMHVWBS-UHFFFAOYSA-N D0X5WP DRUGSMIL CC1(CCC(C2=CC3=C(C=C21)N=C(C4=CC=CC=C4N3C)C5=CC=C(C=C5)C(=O)O)(C)C)C D0X5WP HIGHSTAT Investigative D0X5YM DRUG__ID D0X5YM D0X5YM DRUGTYPE Small molecular drug D0X5YM DRUGINCH 1S/C30H48O3/c1-25(2)12-14-30(24(32)33)15-13-28(6)20(21(30)18-25)8-9-23-27(5)17-19(31)16-26(3,4)22(27)10-11-29(23,28)7/h8,19,21-23,31H,9-18H2,1-7H3,(H,32,33)/t19-,21-,22-,23+,27-,28+,29+,30-/m0/s1 D0X5YM DRUGINKE UODITNOILLXLOO-DBWGAYEVSA-N D0X5YM DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(CC5(C)C)O)C)C)C2C1)C)C(=O)O)C D0X5YM HIGHSTAT Investigative D0X5ZA DRUG__ID D0X5ZA D0X5ZA DRUGTYPE Small molecular drug D0X5ZA DRUGINCH 1S/C35H40N4O4/c1-8-22-18(3)28-17-33-23(9-2)21(6)32(39(33)7)16-27-20(5)25(11-13-35(42)43)31(38-27)15-30-24(10-12-34(40)41)19(4)26(36-30)14-29(22)37-28/h14-17,37H,8-13H2,1-7H3,(H,40,41)(H,42,43) D0X5ZA DRUGINKE ZIBXESYSFXNOJI-UHFFFAOYSA-N D0X5ZA DRUGSMIL CCC1=C(C2=CC3=C(C(=C(N3C)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1N2)C)CCC(=O)O)CCC(=O)O)C)C)CC)C D0X5ZA HIGHSTAT Investigative D0X5ZH DRUG__ID D0X5ZH D0X5ZH DRUGCOMP Alkermes D0X5ZH THERCLAS Anticancer Agents D0X5ZH DRUGTYPE Small molecular drug D0X5ZH DRUGSMIL C(C1C(C(C(O1)C2=C(C(=NN2)C(=O)N)O)O)O)O D0X5ZH HIGHSTAT Investigative D0X6BK DRUG__ID D0X6BK D0X6BK DRUGTYPE Small molecular drug D0X6BK DRUGINCH 1S/C7H15NO4/c9-2-1-4-6(11)7(12)5(3-10)8-4/h4-12H,1-3H2/t4-,5-,6-,7-/m1/s1 D0X6BK DRUGINKE AGFACLQFIYFFOI-DBRKOABJSA-N D0X6BK DRUGSMIL C(CO)C1C(C(C(N1)CO)O)O D0X6BK HIGHSTAT Investigative D0X6BT DRUG__ID D0X6BT D0X6BT DRUGTYPE Small molecular drug D0X6BT DRUGINCH 1S/C11H21N3O2/c1-7(2)6-8(12)11(16)14-5-3-4-9(14)10(13)15/h7-9H,3-6,12H2,1-2H3,(H2,13,15)/t8-,9-/m0/s1 D0X6BT DRUGINKE DZWHFXYOHKJJJA-IUCAKERBSA-N D0X6BT DRUGSMIL CC(C)CC(C(=O)N1CCCC1C(=O)N)N D0X6BT HIGHSTAT Investigative D0X6BU DRUG__ID D0X6BU D0X6BU DRUGTYPE Small molecular drug D0X6BU DRUGINCH 1S/C26H32N6O6S2/c27-18(10-16-6-8-17(33)9-7-16)24(36)32-21-14-40-39-13-20(23(28)35)31-26(38)19(11-15-4-2-1-3-5-15)30-22(34)12-29-25(21)37/h1-9,18-21,33H,10-14,27H2,(H2,28,35)(H,29,37)(H,30,34)(H,31,38)(H,32,36)/t18-,19-,20+,21-/m0/s1 D0X6BU DRUGINKE VUVASMYWPNXOGI-BURNTYAHSA-N D0X6BU DRUGSMIL C1C(C(=O)NCC(=O)NC(C(=O)NC(CSS1)C(=O)N)CC2=CC=CC=C2)NC(=O)C(CC3=CC=C(C=C3)O)N D0X6BU HIGHSTAT Investigative D0X6DO DRUG__ID D0X6DO D0X6DO DRUGTYPE Small molecular drug D0X6DO DRUGINCH 1S/C27H21BrClNO4S/c1-34-25-12-10-23(28)17-26(25)35(32,33)30-27(31)13-9-22-16-24(29)11-8-21(22)15-18-6-7-19-4-2-3-5-20(19)14-18/h2-14,16-17H,15H2,1H3,(H,30,31)/b13-9+ D0X6DO DRUGINKE DYXFUJYHEDGCLS-UKTHLTGXSA-N D0X6DO DRUGSMIL COC1=C(C=C(C=C1)Br)S(=O)(=O)NC(=O)C=CC2=C(C=CC(=C2)Cl)CC3=CC4=CC=CC=C4C=C3 D0X6DO HIGHSTAT Investigative D0X6EI DRUG__ID D0X6EI D0X6EI DRUGTYPE Small molecular drug D0X6EI DRUGINCH 1S/C17H16N2O2/c1-11-4-5-12-10-18-16(9-17(12)19-11)13-6-14(20-2)8-15(7-13)21-3/h4-10H,1-3H3 D0X6EI DRUGINKE AWGMVVADCJSVIO-UHFFFAOYSA-N D0X6EI DRUGSMIL CC1=NC2=CC(=NC=C2C=C1)C3=CC(=CC(=C3)OC)OC D0X6EI HIGHSTAT Investigative D0X6GP DRUG__ID D0X6GP D0X6GP DRUGCOMP Pfizer Inc D0X6GP DRUGINCH 1S/C26H37N7O3/c1-17-14-32(18(2)13-31(17)15-19-8-11-36-12-9-19)25(35)33-16-20-22(26(33,3)4)29-30-23(20)28-24(34)21-7-5-6-10-27-21/h5-7,10,17-19H,8-9,11-16H2,1-4H3,(H2,28,29,30,34)/t17-,18+/m1/s1 D0X6GP DRUGINKE WIUOWTNXQICTJG-MSOLQXFVSA-N D0X6GP DRUGSMIL CC1CN(C(CN1C(=O)N2CC3=C(C2(C)C)NN=C3NC(=O)C4=CC=CC=N4)C)CC5CCOCC5 D0X6GP HIGHSTAT Investigative D0X6IE DRUG__ID D0X6IE D0X6IE DRUGTYPE Small molecular drug D0X6IE DRUGINCH 1S/C13H15N3O4S2/c14-11-3-7-13(8-4-11)22(19,20)16-9-10-1-5-12(6-2-10)21(15,17)18/h1-8,16H,9,14H2,(H2,15,17,18) D0X6IE DRUGINKE HHCXOFYGBAPOJR-UHFFFAOYSA-N D0X6IE DRUGSMIL C1=CC(=CC=C1CNS(=O)(=O)C2=CC=C(C=C2)N)S(=O)(=O)N D0X6IE HIGHSTAT Investigative D0X6KS DRUG__ID D0X6KS D0X6KS DRUGTYPE Small molecular drug D0X6KS DRUGINCH 1S/C20H16N4O/c21-19-18-16(7-4-8-17(18)23-24-19)13-9-11-15(12-10-13)22-20(25)14-5-2-1-3-6-14/h1-12H,(H,22,25)(H3,21,23,24) D0X6KS DRUGINKE ZBWAOEUPXWDTQS-UHFFFAOYSA-N D0X6KS DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N D0X6KS HIGHSTAT Investigative D0X6LK DRUG__ID D0X6LK D0X6LK DRUGTYPE Small molecular drug D0X6LK DRUGINCH 1S/C14H9NO3/c16-10-6-7-11-12(8-10)14(18)15(13(11)17)9-4-2-1-3-5-9/h1-8,16H D0X6LK DRUGINKE HCUAWJNHCZEMJS-UHFFFAOYSA-N D0X6LK DRUGSMIL C1=CC=C(C=C1)N2C(=O)C3=C(C2=O)C=C(C=C3)O D0X6LK HIGHSTAT Investigative D0X6LS DRUG__ID D0X6LS D0X6LS DRUGTYPE Small molecular drug D0X6LS DRUGINCH 1S/C11H11N3O2/c1-7-2-4-8(5-3-7)12-9-6-10(15)14-11(16)13-9/h2-6H,1H3,(H3,12,13,14,15,16) D0X6LS DRUGINKE QKHUPPJBNXWLJB-UHFFFAOYSA-N D0X6LS DRUGSMIL CC1=CC=C(C=C1)NC2=CC(=O)NC(=O)N2 D0X6LS HIGHSTAT Investigative D0X6LZ DRUG__ID D0X6LZ D0X6LZ DRUGTYPE Small molecular drug D0X6LZ DRUGINCH 1S/C9H10ClNO3/c10-6-3-5(1-2-8(6)12)4-7(11)9(13)14/h1-3,7,12H,4,11H2,(H,13,14)/t7-/m0/s1 D0X6LZ DRUGINKE ACWBBAGYTKWBCD-ZETCQYMHSA-N D0X6LZ DRUGSMIL C1=CC(=C(C=C1CC(C(=O)O)N)Cl)O D0X6LZ HIGHSTAT Investigative D0X6MB DRUG__ID D0X6MB D0X6MB DRUGTYPE Small molecular drug D0X6MB DRUGINCH 1S/C5H10N2/c1-4-2-3-7-5(4)6/h4H,2-3H2,1H3,(H2,6,7) D0X6MB DRUGINKE IIZNRRGQKIIKRY-UHFFFAOYSA-N D0X6MB DRUGSMIL CC1CCN=C1N D0X6MB HIGHSTAT Investigative D0X6MT DRUG__ID D0X6MT D0X6MT DRUGTYPE Small molecular drug D0X6MT DRUGINCH 1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3 D0X6MT DRUGINKE RLJFTICUTYVZDG-UHFFFAOYSA-N D0X6MT DRUGSMIL CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)SC D0X6MT HIGHSTAT Investigative D0X6OV DRUG__ID D0X6OV D0X6OV DRUGTYPE Small molecular drug D0X6OV DRUGINCH 1S/C10H8Cl8/c1-4-7(2-11,3-12)9(16)6(14)5(13)8(4,15)10(9,17)18/h5-6H,1-3H2 D0X6OV DRUGINKE OEJNXTAZZBRGDN-UHFFFAOYSA-N D0X6OV DRUGSMIL C=C1C(C2(C(C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)(CCl)CCl D0X6OV HIGHSTAT Investigative D0X6PH DRUG__ID D0X6PH D0X6PH DRUGTYPE Small molecular drug D0X6PH DRUGINCH 1S/C16H12O4/c17-13-4-3-9-5-10(1-2-11(9)6-13)12-7-14(18)16(20)15(19)8-12/h1-8,17-20H D0X6PH DRUGINKE PBTSXIZGBMXUHW-UHFFFAOYSA-N D0X6PH DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C(=C3)O)O)O D0X6PH HIGHSTAT Investigative D0X6PY DRUG__ID D0X6PY D0X6PY DRUGTYPE Small molecular drug D0X6PY DRUGINCH 1S/C29H33NO3/c31-28(32)16-10-2-1-9-15-26-22-17-19-23(20-18-22)27(26)21-30-33-29(24-11-5-3-6-12-24)25-13-7-4-8-14-25/h1,3-9,11-14,17,19,21-23,26-27,29H,2,10,15-16,18,20H2,(H,31,32)/b9-1-,30-21-/t22-,23+,26+,27+/m0/s1 D0X6PY DRUGINKE NBBRUBRIVJNCKV-WXGDQWFLSA-N D0X6PY DRUGSMIL C1CC2C=CC1C(C2C=NOC(C3=CC=CC=C3)C4=CC=CC=C4)CC=CCCCC(=O)O D0X6PY HIGHSTAT Investigative D0X6QY DRUG__ID D0X6QY D0X6QY DRUGTYPE Small molecular drug D0X6QY DRUGINCH 1S/C7H14N2/c1-3-6-4-7(8)9-5(6)2/h5-6H,3-4H2,1-2H3,(H2,8,9) D0X6QY DRUGINKE NMCNOZCNKVOIET-UHFFFAOYSA-N D0X6QY DRUGSMIL CCC1CC(=NC1C)N D0X6QY HIGHSTAT Investigative D0X6RO DRUG__ID D0X6RO D0X6RO DRUGTYPE Small molecular drug D0X6RO DRUGINCH 1S/C13H11FN2O2S/c14-11-3-1-10(2-4-11)9-16-12-5-7-13(8-6-12)19(15,17)18/h1-9H,(H2,15,17,18) D0X6RO DRUGINKE BKZPDMSMFWCHPI-UHFFFAOYSA-N D0X6RO DRUGSMIL C1=CC(=CC=C1C=NC2=CC=C(C=C2)S(=O)(=O)N)F D0X6RO HIGHSTAT Investigative D0X6SA DRUG__ID D0X6SA D0X6SA DRUGTYPE Small molecular drug D0X6SA DRUGINCH 1S/C18H14N2O/c21-18-16-7-3-4-8-17(16)19-20(18)12-13-9-10-14-5-1-2-6-15(14)11-13/h1-11,19H,12H2 D0X6SA DRUGINKE UVPPFCAMTBSDRP-UHFFFAOYSA-N D0X6SA DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CN3C(=O)C4=CC=CC=C4N3 D0X6SA HIGHSTAT Investigative D0X6SR DRUG__ID D0X6SR D0X6SR DRUGTYPE Small molecular drug D0X6SR DRUGINCH 1S/C12H18N2/c1-11-3-2-9-14(11)10-6-12-4-7-13-8-5-12/h4-5,7-8,11H,2-3,6,9-10H2,1H3/t11-/m1/s1 D0X6SR DRUGINKE HTPLEJUDOQHUSX-LLVKDONJSA-N D0X6SR DRUGSMIL CC1CCCN1CCC2=CC=NC=C2 D0X6SR HIGHSTAT Investigative D0X6UV DRUG__ID D0X6UV D0X6UV DRUGTYPE Small molecular drug D0X6UV DRUGINCH 1S/C14H10FNO2/c15-13-8-6-11(7-9-13)10-16-18-14(17)12-4-2-1-3-5-12/h1-10H/b16-10+ D0X6UV DRUGINKE DIEBAKUPBFEXAP-MHWRWJLKSA-N D0X6UV DRUGSMIL C1=CC=C(C=C1)C(=O)ON=CC2=CC=C(C=C2)F D0X6UV HIGHSTAT Investigative D0X6WQ DRUG__ID D0X6WQ D0X6WQ DRUGTYPE Small molecular drug D0X6WQ DRUGINCH 1S/C21H24N2O5/c1-14(15(2)24)22-20(26)19(12-16-8-10-18(25)11-9-16)23-21(27)28-13-17-6-4-3-5-7-17/h3-11,14,19,25H,12-13H2,1-2H3,(H,22,26)(H,23,27)/t14-,19-/m0/s1 D0X6WQ DRUGINKE CLDDOKCDXBMMKZ-LIRRHRJNSA-N D0X6WQ DRUGSMIL CC(C(=O)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)OCC2=CC=CC=C2 D0X6WQ HIGHSTAT Investigative D0X6WV DRUG__ID D0X6WV D0X6WV DRUGTYPE Small molecular drug D0X6WV DRUGINCH 1S/C17H21NO2/c1-14-13-20-17(18-14)16(19)12-8-3-2-5-9-15-10-6-4-7-11-15/h4,6-7,10-11,13H,2-3,5,8-9,12H2,1H3 D0X6WV DRUGINKE UCOJBUIULZAIKB-UHFFFAOYSA-N D0X6WV DRUGSMIL CC1=COC(=N1)C(=O)CCCCCCC2=CC=CC=C2 D0X6WV HIGHSTAT Investigative D0X6YR DRUG__ID D0X6YR D0X6YR DRUGTYPE Small molecular drug D0X6YR DRUGINCH 1S/C13H9ClN2O3S/c14-9-6-7-12-11(8-9)15-13(19-12)16-20(17,18)10-4-2-1-3-5-10/h1-8H,(H,15,16) D0X6YR DRUGINKE AGIHDQSDUKQVDK-UHFFFAOYSA-N D0X6YR DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=NC3=C(O2)C=CC(=C3)Cl D0X6YR HIGHSTAT Investigative D0X6ZY DRUG__ID D0X6ZY D0X6ZY DRUGTYPE Small molecular drug D0X6ZY DRUGINCH 1S/C17H28N2O2/c20-15-3-1-14(2-4-15)18-16(21)19-17-8-11-5-12(9-17)7-13(6-11)10-17/h11-15,20H,1-10H2,(H2,18,19,21) D0X6ZY DRUGINKE YHZXOUHNBSOYQD-UHFFFAOYSA-N D0X6ZY DRUGSMIL C1CC(CCC1NC(=O)NC23CC4CC(C2)CC(C4)C3)O D0X6ZY HIGHSTAT Investigative D0X7AM DRUG__ID D0X7AM D0X7AM DRUGTYPE Small molecular drug D0X7AM DRUGINCH 1S/C20H26FN3O2S2/c1-20(2,3)16-8-5-14(6-9-16)12-22-19(27)23-13-15-7-10-18(17(21)11-15)24-28(4,25)26/h5-11,24H,12-13H2,1-4H3,(H2,22,23,27) D0X7AM DRUGINKE DUHBVFMCIJLUJX-UHFFFAOYSA-N D0X7AM DRUGSMIL CC(C)(C)C1=CC=C(C=C1)CNC(=S)NCC2=CC(=C(C=C2)NS(=O)(=O)C)F D0X7AM HIGHSTAT Investigative D0X7AZ DRUG__ID D0X7AZ D0X7AZ DRUGTYPE Small molecular drug D0X7AZ DRUGINCH 1S/C13H12N4O5S.H2O/c1-16-11-9(12(18)17(2)13(16)19)14-10(15-11)7-3-5-8(6-4-7)23(20,21)22;/h3-6H,1-2H3,(H,14,15)(H,20,21,22);1H2 D0X7AZ DRUGINKE AYQOEZBHENEBEJ-UHFFFAOYSA-N D0X7AZ DRUGSMIL CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CC=C(C=C3)S(=O)(=O)O.O D0X7AZ HIGHSTAT Investigative D0X7BG DRUG__ID D0X7BG D0X7BG DRUGTYPE Small molecular drug D0X7BG DRUGINCH 1S/C18H24ClNO3/c1-3-17(22-15-8-4-12(19)5-9-15)18(21)23-16-10-13-6-7-14(11-16)20(13)2/h4-5,8-9,13-14,16-17H,3,6-7,10-11H2,1-2H3 D0X7BG DRUGINKE WTPAXDRULIZRDJ-UHFFFAOYSA-N D0X7BG DRUGSMIL CCC(C(=O)OC1CC2CCC(C1)N2C)OC3=CC=C(C=C3)Cl D0X7BG HIGHSTAT Investigative D0X7BP DRUG__ID D0X7BP D0X7BP DRUGTYPE Small molecular drug D0X7BP DRUGINCH 1S/C10H7ClN2O3/c11-4-1-2-5-6(3-4)13-8(10(15)16)7(5)9(12)14/h1-3,13H,(H2,12,14)(H,15,16) D0X7BP DRUGINKE UVIJBMMICWJDAD-UHFFFAOYSA-N D0X7BP DRUGSMIL C1=CC2=C(C=C1Cl)NC(=C2C(=O)N)C(=O)O D0X7BP HIGHSTAT Investigative D0X7CW DRUG__ID D0X7CW D0X7CW DRUGTYPE Small molecular drug D0X7CW DRUGINCH 1S/C23H21N2O7P/c1-15-12-25(23(27)24-22(15)26)20-11-10-18(31-20)14-30-33(28)29-13-17-8-5-9-19(21(17)32-33)16-6-3-2-4-7-16/h2-12,18,20H,13-14H2,1H3,(H,24,26,27)/t18-,20+,33?/m0/s1 D0X7CW DRUGINKE OQMPUIYQXGGVDT-GQODUDPDSA-N D0X7CW DRUGSMIL CC1=CN(C(=O)NC1=O)C2C=CC(O2)COP3(=O)OCC4=C(O3)C(=CC=C4)C5=CC=CC=C5 D0X7CW HIGHSTAT Investigative D0X7CX DRUG__ID D0X7CX D0X7CX DRUGTYPE Small molecular drug D0X7CX DRUGINCH 1S/C16H21NO3/c1-19-13-3-2-12-5-7-17-6-4-11-10-20-15(18)8-14(11)16(12,17)9-13/h2,13H,3-10H2,1H3/t13-,16-/m0/s1 D0X7CX DRUGINKE ALSKYCOJJPXPFS-BBRMVZONSA-N D0X7CX DRUGSMIL COC1CC=C2CCN3C2(C1)C4=C(CC3)COC(=O)C4 D0X7CX HIGHSTAT Investigative D0X7DJ DRUG__ID D0X7DJ D0X7DJ DRUGTYPE Small molecular drug D0X7DJ DRUGINCH 1S/C16H10F2O2/c17-14-8-16(20)15(18)7-13(14)11-2-1-10-6-12(19)4-3-9(10)5-11/h1-8,19-20H D0X7DJ DRUGINKE VLJUOFGVEJAFFK-UHFFFAOYSA-N D0X7DJ DRUGSMIL C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=C(C=C3F)O)F D0X7DJ HIGHSTAT Investigative D0X7HD DRUG__ID D0X7HD D0X7HD DRUGTYPE Small molecular drug D0X7HD DRUGINCH 1S/C14H18N4O/c1-10-2-3-12-13(15-10)16-14(19-12)18-9-8-17-6-4-11(18)5-7-17/h2-3,11H,4-9H2,1H3 D0X7HD DRUGINKE BSNKYWSMUAGMDO-UHFFFAOYSA-N D0X7HD DRUGSMIL CC1=NC2=C(C=C1)OC(=N2)N3CCN4CCC3CC4 D0X7HD HIGHSTAT Investigative D0X7HP DRUG__ID D0X7HP D0X7HP DRUGTYPE Small molecular drug D0X7HP DRUGINCH 1S/C19H14FNO3/c20-17-8-4-5-9-18(17)24-19(22)21-14-10-12-16(13-11-14)23-15-6-2-1-3-7-15/h1-13H,(H,21,22) D0X7HP DRUGINKE KFKCZSDVVBTNPG-UHFFFAOYSA-N D0X7HP DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)OC3=CC=CC=C3F D0X7HP HIGHSTAT Investigative D0X7IC DRUG__ID D0X7IC D0X7IC DRUGTYPE Small molecular drug D0X7IC DRUGINCH 1S/C29H30F3N5O2/c1-3-36-12-14-37(15-13-36)18-21-6-7-22(17-24(21)29(30,31)32)35-28(38)20-5-4-19(2)26(16-20)39-25-9-11-34-27-23(25)8-10-33-27/h4-11,16-17H,3,12-15,18H2,1-2H3,(H,33,34)(H,35,38) D0X7IC DRUGINKE SMPGEBOIKULBCT-UHFFFAOYSA-N D0X7IC DRUGSMIL CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)OC4=C5C=CNC5=NC=C4)C(F)(F)F D0X7IC HIGHSTAT Investigative D0X7IM DRUG__ID D0X7IM D0X7IM DRUGTYPE Small molecular drug D0X7IM DRUGINCH 1S/C13H12N2O/c16-13(14-11-7-3-1-4-8-11)15-12-9-5-2-6-10-12/h1-10H,(H2,14,15,16) D0X7IM DRUGINKE GWEHVDNNLFDJLR-UHFFFAOYSA-N D0X7IM DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=CC=CC=C2 D0X7IM HIGHSTAT Investigative D0X7IZ DRUG__ID D0X7IZ D0X7IZ DRUGTYPE Small molecular drug D0X7IZ DRUGINCH 1S/C14H18N2O7/c17-6-8-9(18)10(19)11(20)13(23-8)16-14(22)15-12(21)7-4-2-1-3-5-7/h1-5,8-11,13,17-20H,6H2,(H2,15,16,21,22)/t8-,9-,10+,11-,13-/m1/s1 D0X7IZ DRUGINKE JSBCZGSPFATCOV-BZNQNGANSA-N D0X7IZ DRUGSMIL C1=CC=C(C=C1)C(=O)NC(=O)NC2C(C(C(C(O2)CO)O)O)O D0X7IZ HIGHSTAT Investigative D0X7JA DRUG__ID D0X7JA D0X7JA DRUGTYPE Small molecular drug D0X7JA DRUGINCH 1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9) D0X7JA DRUGINKE BKAJNAXTPSGJCU-UHFFFAOYSA-N D0X7JA DRUGSMIL CC(C)CC(=O)C(=O)O D0X7JA HIGHSTAT Investigative D0X7JK DRUG__ID D0X7JK D0X7JK DRUGTYPE Small molecular drug D0X7JK DRUGINCH 1S/C18H20N2O4S/c1-23-12-8-7-10(9-13(12)24-2)17(22)20-18-15(16(19)21)11-5-3-4-6-14(11)25-18/h7-9H,3-6H2,1-2H3,(H2,19,21)(H,20,22) D0X7JK DRUGINKE FSPQCTGGIANIJZ-UHFFFAOYSA-N D0X7JK DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2=C(C3=C(S2)CCCC3)C(=O)N)OC D0X7JK HIGHSTAT Investigative D0X7LC DRUG__ID D0X7LC D0X7LC DRUGTYPE Small molecular drug D0X7LC DRUGINCH 1S/C44H55N9O10/c1-3-4-14-36(43(62)52-34(22-39(57)58)42(61)51-33(40(46)59)20-26-10-6-5-7-11-26)53(2)44(63)35(21-28-23-47-32-13-9-8-12-30(28)32)50-38(56)25-48-37(55)24-49-41(60)31(45)19-27-15-17-29(54)18-16-27/h5-13,15-18,23,31,33-36,47,54H,3-4,14,19-22,24-25,45H2,1-2H3,(H2,46,59)(H,48,55)(H,49,60)(H,50,56)(H,51,61)(H,52,62)(H,57,58)/t31-,33-,34-,35-,36-/m0/s1 D0X7LC DRUGINKE KSAGKPZDJHLHBS-AWSJBNSNSA-N D0X7LC DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)N(C)C(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=C(C=C4)O)N D0X7LC HIGHSTAT Investigative D0X7MB DRUG__ID D0X7MB D0X7MB DRUGTYPE Small molecular drug D0X7MB DRUGINCH 1S/C20H40BrO6P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20(23)27-17-18(22)16-19(21)28(24,25)26/h18-19,22H,2-17H2,1H3,(H2,24,25,26)/t18-,19-/m0/s1 D0X7MB DRUGINKE HLVKVWDSLLFMSX-OALUTQOASA-N D0X7MB DRUGSMIL CCCCCCCCCCCCCCCC(=O)OCC(CC(P(=O)(O)O)Br)O D0X7MB HIGHSTAT Investigative D0X7OS DRUG__ID D0X7OS D0X7OS DRUGTYPE Small molecular drug D0X7OS DRUGINCH 1S/C18H24N4O10S/c19-12(17(27)28)5-6-14(23)21-13(16(26)20-7-15(24)25)9-33-18(29)32-8-10-1-3-11(4-2-10)22(30)31/h1-4,12-13,18,29H,5-9,19H2,(H,20,26)(H,21,23)(H,24,25)(H,27,28)/t12-,13+,18+/m0/s1 D0X7OS DRUGINKE QYFGPQQSJQOGEO-VEVIJQCQSA-N D0X7OS DRUGSMIL C1=CC(=CC=C1COC(O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)[N+](=O)[O-] D0X7OS HIGHSTAT Investigative D0X7SD DRUG__ID D0X7SD D0X7SD DRUGTYPE Small molecular drug D0X7SD DRUGINCH 1S/C16H19NO/c1-17(2)12-13-18-16-11-7-6-10-15(16)14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3 D0X7SD DRUGINKE HEGXUUYKFGNKJB-UHFFFAOYSA-N D0X7SD DRUGSMIL CN(C)CCOC1=CC=CC=C1C2=CC=CC=C2 D0X7SD HIGHSTAT Investigative D0X7SR DRUG__ID D0X7SR D0X7SR DRUGTYPE Small molecular drug D0X7SR DRUGINCH 1S/C20H18O5/c1-11(2)3-8-14-15(22)9-16(23)19-17(24)10-18(25-20(14)19)12-4-6-13(21)7-5-12/h3-7,9-10,21-23H,8H2,1-2H3 D0X7SR DRUGINKE MEHHCBRCXIDGKZ-UHFFFAOYSA-N D0X7SR DRUGSMIL CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C=C(O2)C3=CC=C(C=C3)O)C D0X7SR HIGHSTAT Investigative D0X7TB DRUG__ID D0X7TB D0X7TB DRUGTYPE Small molecular drug D0X7TB DRUGINCH 1S/C18H17NO3/c1-12-11-19(8-9-21-12)17-10-16(20)15-7-6-13-4-2-3-5-14(13)18(15)22-17/h2-7,10,12H,8-9,11H2,1H3 D0X7TB DRUGINKE RFWCIJWQGHFULK-UHFFFAOYSA-N D0X7TB DRUGSMIL CC1CN(CCO1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3 D0X7TB HIGHSTAT Investigative D0X7VM DRUG__ID D0X7VM D0X7VM DRUGTYPE Small molecular drug D0X7VM DRUGINCH 1S/C37H43N5O/c1-40(2)25-13-6-14-26-41(3)37-39-34-20-12-11-19-33(34)35(27-36(43)38-28-29-15-7-4-8-16-29)42(37)32-23-21-31(22-24-32)30-17-9-5-10-18-30/h4-5,7-12,15-24,35H,6,13-14,25-28H2,1-3H3,(H,38,43) D0X7VM DRUGINKE QVXCZTNUVKNCGU-UHFFFAOYSA-N D0X7VM DRUGSMIL CN(C)CCCCCN(C)C1=NC2=CC=CC=C2C(N1C3=CC=C(C=C3)C4=CC=CC=C4)CC(=O)NCC5=CC=CC=C5 D0X7VM HIGHSTAT Investigative D0X7ZC DRUG__ID D0X7ZC D0X7ZC DRUGTYPE Small molecular drug D0X7ZC DRUGINCH 1S/C14H13NO2/c15-7-11-8-3-1-2-4-9(8)13-10(11)5-6-12(16)14(13)17/h1-6,11,16-17H,7,15H2 D0X7ZC DRUGINKE YLOTUMWDVNOPBU-UHFFFAOYSA-N D0X7ZC DRUGSMIL C1=CC=C2C(=C1)C(C3=C2C(=C(C=C3)O)O)CN D0X7ZC HIGHSTAT Investigative D0X8BS DRUG__ID D0X8BS D0X8BS DRUGTYPE Small molecular drug D0X8BS DRUGINCH 1S/C12H17NO4/c1-2-3-8-16-10-4-6-11(7-5-10)17-9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14) D0X8BS DRUGINKE UJAGRYRJVJSNJC-UHFFFAOYSA-N D0X8BS DRUGSMIL CCCCOC1=CC=C(C=C1)OCC(=O)NO D0X8BS HIGHSTAT Investigative D0X8BU DRUG__ID D0X8BU D0X8BU DRUGTYPE Small molecular drug D0X8BU DRUGINCH 1S/C35H50N2O4/c1-21(8-13-32(39)37-31(33(40)41)18-22-20-36-30-7-5-4-6-25(22)30)27-11-12-28-26-10-9-23-19-24(38)14-16-34(23,2)29(26)15-17-35(27,28)3/h4-7,20-21,23-24,26-29,31,36,38H,8-19H2,1-3H3,(H,37,39)(H,40,41)/t21-,23-,24-,26+,27-,28+,29+,31+,34+,35-/m1/s1 D0X8BU DRUGINKE ITOFPJRDSCGOSA-KZLRUDJFSA-N D0X8BU DRUGSMIL CC(CCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)C3CCC4C3(CCC5C4CCC6C5(CCC(C6)O)C)C D0X8BU HIGHSTAT Investigative D0X8DF DRUG__ID D0X8DF D0X8DF DRUGTYPE Small molecular drug D0X8DF DRUGINCH 1S/C19H32N2O2/c1-4-7-8-9-16-23-18-12-10-17(11-13-18)19(22)20-14-15-21(5-2)6-3/h10-13H,4-9,14-16H2,1-3H3,(H,20,22) D0X8DF DRUGINKE ZVGROIFLIDCWLT-UHFFFAOYSA-N D0X8DF DRUGSMIL CCCCCCOC1=CC=C(C=C1)C(=O)NCCN(CC)CC D0X8DF HIGHSTAT Investigative D0X8DW DRUG__ID D0X8DW D0X8DW DRUGTYPE Small molecular drug D0X8DW DRUGINCH 1S/C19H18N4O2/c24-23(25)15-6-7-18-17(12-15)16(14-4-2-1-3-5-14)13-19(21-18)22-10-8-20-9-11-22/h1-7,12-13,20H,8-11H2 D0X8DW DRUGINKE VABDCPDEFUPFHF-UHFFFAOYSA-N D0X8DW DRUGSMIL C1CN(CCN1)C2=NC3=C(C=C(C=C3)[N+](=O)[O-])C(=C2)C4=CC=CC=C4 D0X8DW HIGHSTAT Investigative D0X8FV DRUG__ID D0X8FV D0X8FV DRUGTYPE Small molecular drug D0X8FV DRUGINCH 1S/C22H23N3O/c1-14(2)24-22(26)19-13-23-20(17-9-5-15(3)6-10-17)21(25-19)18-11-7-16(4)8-12-18/h5-14H,1-4H3,(H,24,26) D0X8FV DRUGINKE IZKDGGVGSMLFPW-UHFFFAOYSA-N D0X8FV DRUGSMIL CC1=CC=C(C=C1)C2=NC=C(N=C2C3=CC=C(C=C3)C)C(=O)NC(C)C D0X8FV HIGHSTAT Investigative D0X8GC DRUG__ID D0X8GC D0X8GC DRUGTYPE Small molecular drug D0X8GC DRUGINCH 1S/C20H24N2O/c23-20(17-9-8-15-4-1-2-5-16(15)14-17)22(18-6-3-7-18)19-10-12-21-13-11-19/h1-2,4-5,8-9,14,18-19,21H,3,6-7,10-13H2 D0X8GC DRUGINKE AZTPZTRJVCAAMX-UHFFFAOYSA-N D0X8GC DRUGSMIL C1CC(C1)N(C2CCNCC2)C(=O)C3=CC4=CC=CC=C4C=C3 D0X8GC HIGHSTAT Investigative D0X8HH DRUG__ID D0X8HH D0X8HH DRUGTYPE Small molecular drug D0X8HH DRUGINCH 1S/C16H10FNO2/c17-12-3-1-2-10(8-12)4-5-11-6-7-14-13(9-11)15(19)16(20)18-14/h1-9H,(H,18,19,20)/b5-4+ D0X8HH DRUGINKE UQOGXLMBLXKBJJ-SNAWJCMRSA-N D0X8HH DRUGSMIL C1=CC(=CC(=C1)F)C=CC2=CC3=C(C=C2)NC(=O)C3=O D0X8HH HIGHSTAT Investigative D0X8JE DRUG__ID D0X8JE D0X8JE DRUGTYPE Small molecular drug D0X8JE DRUGINCH 1S/C20H25NO3/c1-3-4-5-6-8-16-11-12-20(19(23)13-16)24-18-10-7-9-17(14-18)21-15(2)22/h7,9-14,23H,3-6,8H2,1-2H3,(H,21,22) D0X8JE DRUGINKE DCPQCSKZPKBKGX-UHFFFAOYSA-N D0X8JE DRUGSMIL CCCCCCC1=CC(=C(C=C1)OC2=CC=CC(=C2)NC(=O)C)O D0X8JE HIGHSTAT Investigative D0X8KC DRUG__ID D0X8KC D0X8KC DRUGTYPE Small molecular drug D0X8KC DRUGINCH 1S/AsHO2/c2-1-3/h(H,2,3) D0X8KC DRUGINKE XHTRYVMKFMUJLU-UHFFFAOYSA-N D0X8KC DRUGSMIL O[As]=O D0X8KC HIGHSTAT Investigative D0X8LG DRUG__ID D0X8LG D0X8LG DRUGTYPE Small molecular drug D0X8LG DRUGINCH 1S/C19H23NO/c1-2-7-18(20-12-5-6-13-20)19(21)17-11-10-15-8-3-4-9-16(15)14-17/h3-4,8-11,14,18H,2,5-7,12-13H2,1H3 D0X8LG DRUGINKE DTNUPBSOODGRKW-UHFFFAOYSA-N D0X8LG DRUGSMIL CCCC(C(=O)C1=CC2=CC=CC=C2C=C1)N3CCCC3 D0X8LG HIGHSTAT Investigative D0X8NK DRUG__ID D0X8NK D0X8NK DRUGCOMP Microbial Chemistry Research Foundation D0X8NK DRUGINCH 1S/C51H83N11O19/c1-26(2)14-9-7-5-4-6-8-10-15-28-24-34(66)57-35(27(3)64)47(75)61-22-13-18-32(61)46(74)60-21-12-17-31(60)42(70)55-29(16-11-20-54-51(52)53)41(69)58-36(39(67)48(76)77)43(71)56-30(25-63)45(73)62-23-19-33(65)38(62)44(72)59-37(50(80)81-28)40(68)49(78)79/h26-33,35-40,63-65,67-68H,4-25H2,1-3H3,(H,55,70)(H,56,71)(H,57,66)(H,58,69)(H,59,72)(H,76,77)(H,78,79)(H4,52,53,54) D0X8NK DRUGINKE ZRHHHIZQDIARCA-UHFFFAOYSA-N D0X8NK DRUGSMIL CC(C)CCCCCCCCCC1CC(=O)NC(C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCC(C4C(=O)NC(C(=O)O1)C(C(=O)O)O)O)CO)C(C(=O)O)O)CCCN=C(N)N)C(C)O D0X8NK HIGHSTAT Investigative D0X8OL DRUG__ID D0X8OL D0X8OL DRUGTYPE Small molecular drug D0X8OL DRUGINCH 1S/C13H10N2O2S2/c16-19(17,12-7-3-9-18-12)15-11-6-1-4-10-5-2-8-14-13(10)11/h1-9,15H D0X8OL DRUGINKE CPSRVVXBTZFZPM-UHFFFAOYSA-N D0X8OL DRUGSMIL C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=CS3)N=CC=C2 D0X8OL HIGHSTAT Investigative D0X8RN DRUG__ID D0X8RN D0X8RN DRUGTYPE Small molecular drug D0X8RN DRUGINCH 1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2/t8-,9-/m1/s1 D0X8RN DRUGINKE AELCINSCMGFISI-RKDXNWHRSA-N D0X8RN DRUGSMIL C1C(C1N)C2=CC=CC=C2 D0X8RN HIGHSTAT Investigative D0X8UK DRUG__ID D0X8UK D0X8UK DRUGTYPE Small molecular drug D0X8UK DRUGINCH 1S/C14H13N3/c1-3-12(6-9-17-10-8-15-11-17)13-4-2-7-16-14(13)5-1/h1-5,7-8,10-11H,6,9H2 D0X8UK DRUGINKE AVFNKJKCERQPJI-UHFFFAOYSA-N D0X8UK DRUGSMIL C1=CC(=C2C=CC=NC2=C1)CCN3C=CN=C3 D0X8UK HIGHSTAT Investigative D0X8VQ DRUG__ID D0X8VQ D0X8VQ DRUGTYPE Small molecular drug D0X8VQ DRUGINCH 1S/C16H11N3/c1-11-5-6-13-7-8-15(19-16(13)18-11)14-4-2-3-12(9-14)10-17/h2-9H,1H3 D0X8VQ DRUGINKE LAVFGKYBDJIZSF-UHFFFAOYSA-N D0X8VQ DRUGSMIL CC1=NC2=C(C=C1)C=CC(=N2)C3=CC=CC(=C3)C#N D0X8VQ HIGHSTAT Investigative D0X8XO DRUG__ID D0X8XO D0X8XO DRUGTYPE Small molecular drug D0X8XO DRUGINCH 1S/C20H27N3O7/c1-12(2)17(23-20(29)30-11-14-7-5-4-6-8-14)19(28)21-13(3)18(27)22-15(10-24)9-16(25)26/h4-8,10,12-13,15,17H,9,11H2,1-3H3,(H,21,28)(H,22,27)(H,23,29)(H,25,26)/t13-,15-,17-/m0/s1 D0X8XO DRUGINKE YYQWNJQKDSNAES-QRTARXTBSA-N D0X8XO DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)O)C=O)NC(=O)OCC1=CC=CC=C1 D0X8XO HIGHSTAT Investigative D0X8XU DRUG__ID D0X8XU D0X8XU DRUGTYPE Small molecular drug D0X8XU DRUGINCH 1S/C19H19N3O/c1-2-17(14-7-4-3-5-8-14)21-19(23)22-18-10-6-9-15-13-20-12-11-16(15)18/h3-13,17H,2H2,1H3,(H2,21,22,23) D0X8XU DRUGINKE MDUZRJXYUICAEF-UHFFFAOYSA-N D0X8XU DRUGSMIL CCC(C1=CC=CC=C1)NC(=O)NC2=CC=CC3=C2C=CN=C3 D0X8XU HIGHSTAT Investigative D0X8YK DRUG__ID D0X8YK D0X8YK DRUGTYPE Small molecular drug D0X8YK DRUGINCH 1S/C16H37O6P3/c1-4-5-6-7-8-9-10-11-12-13-14-23(2,3)15-16(24(17,18)19)25(20,21)22/h16H,4-15H2,1-3H3,(H3-,17,18,19,20,21,22) D0X8YK DRUGINKE QCMHKGWUOSRYCF-UHFFFAOYSA-N D0X8YK DRUGSMIL CCCCCCCCCCCC[P+](C)(C)CC(P(=O)(O)O)P(=O)(O)[O-] D0X8YK HIGHSTAT Investigative D0X8ZA DRUG__ID D0X8ZA D0X8ZA DRUGTYPE Small molecular drug D0X8ZA DRUGINCH 1S/C16H21N3O2/c1-16(2,3)18-9-12(20)10-21-15-6-4-5-14-13(15)7-11(8-17)19-14/h4-7,12,18-20H,9-10H2,1-3H3 D0X8ZA DRUGINKE QXIUMMLTJVHILT-UHFFFAOYSA-N D0X8ZA DRUGSMIL CC(C)(C)NCC(COC1=CC=CC2=C1C=C(N2)C#N)O D0X8ZA HIGHSTAT Investigative D0X8ZO DRUG__ID D0X8ZO D0X8ZO DRUGTYPE Small molecular drug D0X8ZO DRUGINCH 1S/C18H26N2O2/c1-2-3-4-5-6-7-8-9-10-12-15(21)18-20-17-16(22-18)13-11-14-19-17/h11,13-14H,2-10,12H2,1H3 D0X8ZO DRUGINKE XUWBDQAPIZBSRY-UHFFFAOYSA-N D0X8ZO DRUGSMIL CCCCCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2 D0X8ZO HIGHSTAT Investigative D0X8ZS DRUG__ID D0X8ZS D0X8ZS DRUGTYPE Small molecular drug D0X8ZS DRUGINCH 1S/C10H13NO2/c1-7-3-2-4-8(5-7)6-9(11)10(12)13/h2-5,9H,6,11H2,1H3,(H,12,13)/t9-/m0/s1 D0X8ZS DRUGINKE JZRBSTONIYRNRI-VIFPVBQESA-N D0X8ZS DRUGSMIL CC1=CC(=CC=C1)CC(C(=O)O)N D0X8ZS HIGHSTAT Investigative D0X9DP DRUG__ID D0X9DP D0X9DP DRUGTYPE Small molecular drug D0X9DP DRUGINCH 1S/C9H12O3S/c1-2-3-13-6-7-4-8(10)9(11)5-12-7/h4-5,11H,2-3,6H2,1H3 D0X9DP DRUGINKE DKYLUTJQQPXXLM-UHFFFAOYSA-N D0X9DP DRUGSMIL CCCSCC1=CC(=O)C(=CO1)O D0X9DP HIGHSTAT Investigative D0X9LJ DRUG__ID D0X9LJ D0X9LJ DRUGTYPE Small molecular drug D0X9LJ DRUGINCH 1S/C13H13FN2O4S2/c14-11-3-7-13(8-4-11)22(19,20)16-9-10-1-5-12(6-2-10)21(15,17)18/h1-8,16H,9H2,(H2,15,17,18) D0X9LJ DRUGINKE RXAAVLURIXEENO-UHFFFAOYSA-N D0X9LJ DRUGSMIL C1=CC(=CC=C1CNS(=O)(=O)C2=CC=C(C=C2)F)S(=O)(=O)N D0X9LJ HIGHSTAT Investigative D0X9MW DRUG__ID D0X9MW D0X9MW DRUGTYPE Small molecular drug D0X9MW DRUGINCH 1S/C25H23ClN3O2/c26-21-5-6-22-20(16-21)4-3-18-2-1-11-27-24(18)23(22)17-7-12-28(13-8-17)25(30)19-9-14-29(31)15-10-19/h1-2,5-6,9-11,14,16H,3-4,7-8,12-13,15H2/q-1 D0X9MW DRUGINKE IJTLWVCXERQDJL-UHFFFAOYSA-N D0X9MW DRUGSMIL C1CC2=C(C=CC(=C2)Cl)C(=C3CCN(CC3)C(=O)C4=CCN(C=C4)[O-])C5=C1C=CC=N5 D0X9MW HIGHSTAT Investigative D0X9OV DRUG__ID D0X9OV D0X9OV DRUGTYPE Small molecular drug D0X9OV DRUGINCH 1S/C17H19NO3/c1-19-14-8-5-12(6-9-14)4-7-13-10-15(20-2)11-16(21-3)17(13)18/h4-11H,18H2,1-3H3/b7-4- D0X9OV DRUGINKE WCORNZIRKFTEOF-DAXSKMNVSA-N D0X9OV DRUGSMIL COC1=CC=C(C=C1)C=CC2=C(C(=CC(=C2)OC)OC)N D0X9OV HIGHSTAT Investigative D0X9PI DRUG__ID D0X9PI D0X9PI DRUGTYPE Small molecular drug D0X9PI DRUGINCH 1S/C17H11BrFN5OS/c1-25-15(20)17-24-12-5-4-11-13(14(12)26-17)16(22-7-21-11)23-10-3-2-8(18)6-9(10)19/h2-7,20H,1H3,(H,21,22,23) D0X9PI DRUGINKE ZBELDPMWYXDLNY-UHFFFAOYSA-N D0X9PI DRUGSMIL COC(=N)C1=NC2=C(S1)C3=C(C=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F D0X9PI HIGHSTAT Investigative D0X9QV DRUG__ID D0X9QV D0X9QV DRUGTYPE Small molecular drug D0X9QV DRUGINCH 1S/C20H21N9O4/c21-20-24-16-15(18(31)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(30)23-13(19(32)33)7-8-14-26-28-29-27-14/h1-2,4-5,9,13H,3,6-8H2,(H,23,30)(H,32,33)(H,26,27,28,29)(H4,21,22,24,25,31)/t13-/m0/s1 D0X9QV DRUGINKE MXAFDBCLWLMXSI-ZDUSSCGKSA-N D0X9QV DRUGSMIL C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC4=NNN=N4)C(=O)O D0X9QV HIGHSTAT Investigative D0X9RL DRUG__ID D0X9RL D0X9RL DRUGTYPE Small molecular drug D0X9RL DRUGINCH 1S/C22H30N4O3S/c1-5-29-15-19(12-16(2)3)25-30(27,28)20-8-6-18(7-9-20)14-26-17(4)24-21-13-23-11-10-22(21)26/h6-11,13,16,19,25H,5,12,14-15H2,1-4H3/t19-/m0/s1 D0X9RL DRUGINKE BCRDOIMCNBBVGM-IBGZPJMESA-N D0X9RL DRUGSMIL CCOCC(CC(C)C)NS(=O)(=O)C1=CC=C(C=C1)CN2C(=NC3=C2C=CN=C3)C D0X9RL HIGHSTAT Investigative D0X9RM DRUG__ID D0X9RM D0X9RM DRUGTYPE Small molecular drug D0X9RM DRUGINCH 1S/C12H10N2OS/c15-12-10-5-1-2-6-11(10)13-14(12)8-9-4-3-7-16-9/h1-7,13H,8H2 D0X9RM DRUGINKE JGPURYLHMLRGGI-UHFFFAOYSA-N D0X9RM DRUGSMIL C1=CC=C2C(=C1)C(=O)N(N2)CC3=CC=CS3 D0X9RM HIGHSTAT Investigative D0X9TF DRUG__ID D0X9TF D0X9TF DRUGTYPE Small molecular drug D0X9TF DRUGINCH 1S/C30H44N2O2/c1-3-29(25-11-9-13-27(33)21-25)15-5-7-17-31(23-29)19-20-32-18-8-6-16-30(4-2,24-32)26-12-10-14-28(34)22-26/h9-14,21-22,33-34H,3-8,15-20,23-24H2,1-2H3/t29-,30-/m1/s1 D0X9TF DRUGINKE RMHAJXOOJPBLSR-LOYHVIPDSA-N D0X9TF DRUGSMIL CCC1(CCCCN(C1)CCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0X9TF HIGHSTAT Investigative D0X9TG DRUG__ID D0X9TG D0X9TG DRUGTYPE Small molecular drug D0X9TG DRUGINCH 1S/C6H12N4O2/c1-9(2)5(11)7-8-6(12)10(3)4/h1-4H3/b8-7+ D0X9TG DRUGINKE VLSDXINSOMDCBK-BQYQJAHWSA-N D0X9TG DRUGSMIL CN(C)C(=O)N=NC(=O)N(C)C D0X9TG HIGHSTAT Investigative D0X9TT DRUG__ID D0X9TT D0X9TT DRUGTYPE Small molecular drug D0X9TT DRUGINCH 1S/C33H37N5O5/c34-27(17-23-11-13-26(39)14-12-23)31(42)38-16-6-15-33(38)19-24-9-4-5-10-25(24)20-37(32(33)43)21-29(40)36-28(30(35)41)18-22-7-2-1-3-8-22/h1-5,7-14,27-28,39H,6,15-21,34H2,(H2,35,41)(H,36,40)/t27-,28-,33-/m0/s1 D0X9TT DRUGINKE XXSVWIUHNDWFND-DRVYDUGISA-N D0X9TT DRUGSMIL C1CC2(CC3=CC=CC=C3CN(C2=O)CC(=O)NC(CC4=CC=CC=C4)C(=O)N)N(C1)C(=O)C(CC5=CC=C(C=C5)O)N D0X9TT HIGHSTAT Investigative D0X9UJ DRUG__ID D0X9UJ D0X9UJ DRUGTYPE Small molecular drug D0X9UJ DRUGINCH 1S/C11H15N3O3S/c1-5-6-13-7-8(14(16)17)18-10(13)12-9(15)11(2,3)4/h5,7H,1,6H2,2-4H3 D0X9UJ DRUGINKE SPVZIILAYYBEDM-UHFFFAOYSA-N D0X9UJ DRUGSMIL CC(C)(C)C(=O)N=C1N(C=C(S1)[N+](=O)[O-])CC=C D0X9UJ HIGHSTAT Investigative D0X9VY DRUG__ID D0X9VY D0X9VY DRUGTYPE Small molecular drug D0X9VY DRUGINCH 1S/C15H22O2S/c1-3-4-5-6-9-12-18-15-11-8-7-10-14(15)17-13(2)16/h7-8,10-11H,3-6,9,12H2,1-2H3 D0X9VY DRUGINKE FBOXARNCZRHBOP-UHFFFAOYSA-N D0X9VY DRUGSMIL CCCCCCCSC1=CC=CC=C1OC(=O)C D0X9VY HIGHSTAT Investigative D0X9YD DRUG__ID D0X9YD D0X9YD DRUGTYPE Small molecular drug D0X9YD DRUGINCH 1S/C6H10OS2/c1-3-5-8-9(7)6-4-2/h3-4H,1-2,5-6H2 D0X9YD DRUGINKE JDLKFOPOAOFWQN-UHFFFAOYSA-N D0X9YD DRUGSMIL C=CCSS(=O)CC=C D0X9YD HIGHSTAT Investigative D0X9YS DRUG__ID D0X9YS D0X9YS DRUGTYPE Small molecular drug D0X9YS DRUGINCH 1S/C18H25N3/c1-12-18(13(2)21(5)19-12)17-8-6-7-14-11-15(20(3)4)9-10-16(14)17/h6-8,15H,9-11H2,1-5H3/t15-/m0/s1 D0X9YS DRUGINKE BTTOYOKCLDAHHO-HNNXBMFYSA-N D0X9YS DRUGSMIL CC1=C(C(=NN1C)C)C2=CC=CC3=C2CCC(C3)N(C)C D0X9YS HIGHSTAT Investigative D0XA0N DRUG__ID D0XA0N D0XA0N DRUGTYPE Small molecular drug D0XA0N DRUGINCH 1S/C7H15N3O2S2/c8-7(9)10-1-2-14-4-5(3-13)6(11)12/h5,13H,1-4H2,(H,11,12)(H4,8,9,10) D0XA0N DRUGINKE AKPKWZRKZOAAAZ-UHFFFAOYSA-N D0XA0N DRUGSMIL C(CSCC(CS)C(=O)O)N=C(N)N D0XA0N HIGHSTAT Investigative D0XB1H DRUG__ID D0XB1H D0XB1H DRUGTYPE Small molecular drug D0XB1H DRUGINCH 1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1 D0XB1H DRUGINKE BUFLLCUFNHESEH-UUOKFMHZSA-N D0XB1H DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)OP(=O)(O)OP(=O)(O)O)O)N=C(NC2=O)N D0XB1H HIGHSTAT Investigative D0XB2Z DRUG__ID D0XB2Z D0XB2Z DRUGTYPE Small molecular drug D0XB2Z DRUGINCH 1S/C17H17NO3S/c1-20-15-9-7-13(8-10-15)11-21-18-16(19)12-22-17(18)14-5-3-2-4-6-14/h2-10,17H,11-12H2,1H3 D0XB2Z DRUGINKE IUBPXBYZGYCTMU-UHFFFAOYSA-N D0XB2Z DRUGSMIL COC1=CC=C(C=C1)CON2C(SCC2=O)C3=CC=CC=C3 D0XB2Z HIGHSTAT Investigative D0XB3U DRUG__ID D0XB3U D0XB3U DRUGTYPE Small molecular drug D0XB3U DRUGINCH 1S/C18H22N4O5S/c1-12-5-7-13(8-6-12)19-15-10-9-14(22(24)25)11-16(15)28(26,27)21-17(23)20-18(2,3)4/h5-11,19H,1-4H3,(H2,20,21,23) D0XB3U DRUGINKE SILRUCMXYIKULW-UHFFFAOYSA-N D0XB3U DRUGSMIL CC1=CC=C(C=C1)NC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)NC(=O)NC(C)(C)C D0XB3U HIGHSTAT Investigative D0XB4P DRUG__ID D0XB4P D0XB4P DRUGTYPE Small molecular drug D0XB4P DRUGINCH 1S/C17H12N4/c1-2-6-15-13(5-1)12(8-10-19-15)14-11-20-21-17(14)16-7-3-4-9-18-16/h1-11H,(H,20,21) D0XB4P DRUGINKE IBCXZJCWDGCXQT-UHFFFAOYSA-N D0XB4P DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)C3=C(NN=C3)C4=CC=CC=N4 D0XB4P HIGHSTAT Investigative D0XB7H DRUG__ID D0XB7H D0XB7H DRUGTYPE Small molecular drug D0XB7H DRUGINCH 1S/C31H47N3O9/c1-5-6-10-15-32-27(37)23(18-21-13-14-25(42-19-26(35)36)22(16-21)29(39)40)33-28(38)24(17-20-11-8-7-9-12-20)34-30(41)43-31(2,3)4/h7-9,11-14,16,23-24,27-28,30,32-34,37-38,41H,5-6,10,15,17-19H2,1-4H3,(H,35,36)(H,39,40)/t23-,24-,27+,28-,30-/m0/s1 D0XB7H DRUGINKE WVFJFYADATXBBE-JIFQQKSFSA-N D0XB7H DRUGSMIL CCCCCNC(C(CC1=CC(=C(C=C1)OCC(=O)O)C(=O)O)NC(C(CC2=CC=CC=C2)NC(O)OC(C)(C)C)O)O D0XB7H HIGHSTAT Investigative D0XC3V DRUG__ID D0XC3V D0XC3V DRUGTYPE Small molecular drug D0XC3V DRUGINCH 1S/C24H24O2/c1-2-3-9-23(18-7-5-4-6-8-18)24(19-10-14-21(25)15-11-19)20-12-16-22(26)17-13-20/h4-8,10-17,25-26H,2-3,9H2,1H3 D0XC3V DRUGINKE LOSAKSLRALRQMY-UHFFFAOYSA-N D0XC3V DRUGSMIL CCCCC(=C(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O)C3=CC=CC=C3 D0XC3V HIGHSTAT Investigative D0XC6G DRUG__ID D0XC6G D0XC6G DRUGTYPE Small molecular drug D0XC6G DRUGINCH 1S/C14H10N4/c1-2-6-10-9(5-1)13(18-17-10)14-15-11-7-3-4-8-12(11)16-14/h1-8H,(H,15,16)(H,17,18) D0XC6G DRUGINKE JTKFRFMSUBOCIQ-UHFFFAOYSA-N D0XC6G DRUGSMIL C1=CC=C2C(=C1)C(=NN2)C3=NC4=CC=CC=C4N3 D0XC6G HIGHSTAT Investigative D0XC9U DRUG__ID D0XC9U D0XC9U DRUGTYPE Small molecular drug D0XC9U DRUGINCH 1S/C24H28O5/c1-4-12-26-18-15-19(27-13-5-2)21-20(16-18)29-23(17-10-8-7-9-11-17)24(22(21)25)28-14-6-3/h7-11,15-16H,4-6,12-14H2,1-3H3 D0XC9U DRUGINKE ABZJCSJCNNCZRY-UHFFFAOYSA-N D0XC9U DRUGSMIL CCCOC1=CC2=C(C(=C1)OCCC)C(=O)C(=C(O2)C3=CC=CC=C3)OCCC D0XC9U HIGHSTAT Investigative D0XD1Q DRUG__ID D0XD1Q D0XD1Q DRUGTYPE Small molecular drug D0XD1Q DRUGINCH 1S/C10H7FN2O3S/c11-7-1-3-8(4-2-7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D0XD1Q DRUGINKE OVAVDZRNJWQJPL-UHFFFAOYSA-N D0XD1Q DRUGSMIL C1=CC(=CC=C1F)S(=O)(=O)C2=NNC(=O)C=C2 D0XD1Q HIGHSTAT Investigative D0XE1I DRUG__ID D0XE1I D0XE1I DRUGTYPE Small molecular drug D0XE1I DRUGINCH 1S/C31H42FN3O5/c1-2-33-28(36)19-38-25-12-11-22(32)16-21(25)17-23-26-13-14-27(40-26)29(23)31-35-24(18-39-31)30(37)34-15-7-6-10-20-8-4-3-5-9-20/h11-12,16,18,20,23,26-27,29H,2-10,13-15,17,19H2,1H3,(H,33,36)(H,34,37)/t23-,26-,27+,29-/m0/s1 D0XE1I DRUGINKE FPMMMZJJCYYVIK-QIBGPLTASA-N D0XE1I DRUGSMIL CCNC(=O)COC1=C(C=C(C=C1)F)CC2C3CCC(C2C4=NC(=CO4)C(=O)NCCCCC5CCCCC5)O3 D0XE1I HIGHSTAT Investigative D0XE4B DRUG__ID D0XE4B D0XE4B DRUGTYPE Small molecular drug D0XE4B DRUGINCH 1S/C11H16O3S2/c1-9(15)7-8-16(12,13)11-5-3-10(14-2)4-6-11/h3-6,9,15H,7-8H2,1-2H3 D0XE4B DRUGINKE UXTQFUKVODXBBJ-UHFFFAOYSA-N D0XE4B DRUGSMIL CC(CCS(=O)(=O)C1=CC=C(C=C1)OC)S D0XE4B HIGHSTAT Investigative D0XE8T DRUG__ID D0XE8T D0XE8T DRUGTYPE Small molecular drug D0XE8T DRUGINCH 1S/C25H32O7/c1-7-22(28)32-21-9-8-13(2)10-20-17(15(4)24(29)31-20)12-18-14(3)11-19(27)23(25(18,21)6)30-16(5)26/h10-11,18,20-21,23H,7-9,12H2,1-6H3/b13-10-/t18-,20-,21+,23-,25-/m0/s1 D0XE8T DRUGINKE SOZYLLOAOCBQFQ-GUNDZKFLSA-N D0XE8T DRUGSMIL CCC(=O)OC1CCC(=CC2C(=C(C(=O)O2)C)CC3C1(C(C(=O)C=C3C)OC(=O)C)C)C D0XE8T HIGHSTAT Investigative D0XF5P DRUG__ID D0XF5P D0XF5P DRUGTYPE Small molecular drug D0XF5P DRUGINCH 1S/C15H17NO/c1-2-4-14-9-12(5-6-13(14)3-1)11-17-15-7-8-16-10-15/h1-6,9,15-16H,7-8,10-11H2/t15-/m1/s1 D0XF5P DRUGINKE IQZVBBALTJFFCB-OAHLLOKOSA-N D0XF5P DRUGSMIL C1CNCC1OCC2=CC3=CC=CC=C3C=C2 D0XF5P HIGHSTAT Investigative D0XF5X DRUG__ID D0XF5X D0XF5X DRUGTYPE Small molecular drug D0XF5X DRUGINCH 1S/C7H11NO6.ClH/c1-14-6(13)7(8,2-4(9)10)3-5(11)12;/h2-3,8H2,1H3,(H,9,10)(H,11,12);1H D0XF5X DRUGINKE SQNZWVALOOOEKW-UHFFFAOYSA-N D0XF5X DRUGSMIL COC(=O)C(CC(=O)O)(CC(=O)O)N.Cl D0XF5X HIGHSTAT Investigative D0XF6C DRUG__ID D0XF6C D0XF6C DRUGTYPE Small molecular drug D0XF6C DRUGINCH 1S/C10H8N2O2/c13-10(14)8-6-11-9(12-8)7-4-2-1-3-5-7/h1-6H,(H,11,12)(H,13,14) D0XF6C DRUGINKE XCAXKZJNJCKTQH-UHFFFAOYSA-N D0XF6C DRUGSMIL C1=CC=C(C=C1)C2=NC=C(N2)C(=O)O D0XF6C HIGHSTAT Investigative D0XF7N DRUG__ID D0XF7N D0XF7N DRUGTYPE Small molecular drug D0XF7N DRUGINCH 1S/C23H28N4O6S2/c1-23(2)19(27(15-34-23)35(32,33)17-11-7-4-8-12-17)20(28)26-18(21(29)30)14-25-22(31)24-13-16-9-5-3-6-10-16/h3-12,18-19H,13-15H2,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t18-,19-/m0/s1 D0XF7N DRUGINKE XKLHCUGVLCGKKX-OALUTQOASA-N D0XF7N DRUGSMIL CC1(C(N(CS1)S(=O)(=O)C2=CC=CC=C2)C(=O)NC(CNC(=O)NCC3=CC=CC=C3)C(=O)O)C D0XF7N HIGHSTAT Investigative D0XF9F DRUG__ID D0XF9F D0XF9F DRUGTYPE Small molecular drug D0XF9F DRUGINCH 1S/C29H31N3O3/c1-21-28(22-5-11-25(33)12-6-22)30-32(24-9-13-26(34)14-10-24)29(21)23-7-15-27(16-8-23)35-20-19-31-17-3-2-4-18-31/h5-16,33-34H,2-4,17-20H2,1H3 D0XF9F DRUGINKE TXLGPGWHIIHRHH-UHFFFAOYSA-N D0XF9F DRUGSMIL CC1=C(N(N=C1C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C4=CC=C(C=C4)OCCN5CCCCC5 D0XF9F HIGHSTAT Investigative D0XG0G DRUG__ID D0XG0G D0XG0G DRUGTYPE Small molecular drug D0XG0G DRUGINCH 1S/C21H38N2O/c1-2-3-4-5-6-7-8-9-10-22-20(24)23-21-14-17-11-18(15-21)13-19(12-17)16-21/h17-19H,2-16H2,1H3,(H2,22,23,24) D0XG0G DRUGINKE KDYRDODPBAFNHJ-UHFFFAOYSA-N D0XG0G DRUGSMIL CCCCCCCCCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D0XG0G HIGHSTAT Investigative D0XG6U DRUG__ID D0XG6U D0XG6U DRUGTYPE Small molecular drug D0XG6U DRUGINCH 1S/C12H17N2O9P/c1-23-9-5-6(4-8(10(9)15)14(19)20)12(18)24(21,22)3-2-7(13)11(16)17/h4-5,7,12,15,18H,2-3,13H2,1H3,(H,16,17)(H,21,22)/t7-,12?/m0/s1 D0XG6U DRUGINKE PEXVMHLARUAHNC-KAJCPDDVSA-N D0XG6U DRUGSMIL COC1=CC(=CC(=C1O)[N+](=O)[O-])C(O)P(=O)(CCC(C(=O)O)N)O D0XG6U HIGHSTAT Investigative D0XH1F DRUG__ID D0XH1F D0XH1F DRUGTYPE Small molecular drug D0XH1F DRUGINCH 1S/C18H20FNO3/c1-2-3-12-22-16-8-4-14(5-9-16)13-20-18(21)23-17-10-6-15(19)7-11-17/h4-11H,2-3,12-13H2,1H3,(H,20,21) D0XH1F DRUGINKE BVPXJSVMJYBIRX-UHFFFAOYSA-N D0XH1F DRUGSMIL CCCCOC1=CC=C(C=C1)CNC(=O)OC2=CC=C(C=C2)F D0XH1F HIGHSTAT Investigative D0XH1N DRUG__ID D0XH1N D0XH1N DRUGTYPE Small molecular drug D0XH1N DRUGINCH 1S/C19H14N2O4/c22-19(14-5-4-6-16(13-14)21(23)24)20-15-9-11-18(12-10-15)25-17-7-2-1-3-8-17/h1-13H,(H,20,22) D0XH1N DRUGINKE GDWKBKTVROCPNZ-UHFFFAOYSA-N D0XH1N DRUGSMIL C1=CC=C(C=C1)OC2=CC=C(C=C2)NC(=O)C3=CC(=CC=C3)[N+](=O)[O-] D0XH1N HIGHSTAT Investigative D0XH2N DRUG__ID D0XH2N D0XH2N DRUGCOMP Daiichi Sankyo Co Ltd D0XH2N DRUGINCH 1S/C23H25F3N4O/c1-3-30(4-2)11-12-31-19-9-6-16(7-10-19)22-28-15-21(26)23(29-22)27-14-17-5-8-18(24)13-20(17)25/h5-10,13,15H,3-4,11-12,14H2,1-2H3,(H,27,28,29) D0XH2N DRUGINKE QWIZBXCRZIVLRC-UHFFFAOYSA-N D0XH2N DRUGSMIL CCN(CC)CCOC1=CC=C(C=C1)C2=NC=C(C(=N2)NCC3=C(C=C(C=C3)F)F)F D0XH2N HIGHSTAT Investigative D0XI3W DRUG__ID D0XI3W D0XI3W DRUGTYPE Small molecular drug D0XI3W DRUGINCH 1S/C29H32F3N5O3/c1-35-7-9-37(10-8-35)26-6-5-22(21-4-2-3-20(15-21)19-36-11-13-40-14-12-36)16-25(26)34-28(39)23-18-33-27(38)17-24(23)29(30,31)32/h2-6,15-18H,7-14,19H2,1H3,(H,33,38)(H,34,39) D0XI3W DRUGINKE DJOVLOYCGXNVPI-UHFFFAOYSA-N D0XI3W DRUGSMIL CN1CCN(CC1)C2=C(C=C(C=C2)C3=CC=CC(=C3)CN4CCOCC4)NC(=O)C5=CNC(=O)C=C5C(F)(F)F D0XI3W HIGHSTAT Investigative D0XI4U DRUG__ID D0XI4U D0XI4U DRUGTYPE Small molecular drug D0XI4U DRUGINCH 1S/C13H12N2O/c1-15-6-5-10-11-7-9(16-2)3-4-12(11)14-13(10)8-15/h3-8H,1-2H3/p+1 D0XI4U DRUGINKE UXIBWQLCPYHBSH-UHFFFAOYSA-O D0XI4U DRUGSMIL C[N+]1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)OC D0XI4U HIGHSTAT Investigative D0XJ1C DRUG__ID D0XJ1C D0XJ1C DRUGTYPE Small molecular drug D0XJ1C DRUGINCH 1S/C7H14N2/c1-3-6-5(2)4-7(8)9-6/h5-6H,3-4H2,1-2H3,(H2,8,9) D0XJ1C DRUGINKE APKCAWUHKKJFRX-UHFFFAOYSA-N D0XJ1C DRUGSMIL CCC1C(CC(=N1)N)C D0XJ1C HIGHSTAT Investigative D0XJ6D DRUG__ID D0XJ6D D0XJ6D DRUGTYPE Small molecular drug D0XJ6D DRUGINCH 1S/C15H14N2O2S/c1-11-10-17(15-5-3-2-4-14(11)15)20(18,19)13-8-6-12(16)7-9-13/h2-10H,16H2,1H3 D0XJ6D DRUGINKE ZNRJXSHXWJKTGJ-UHFFFAOYSA-N D0XJ6D DRUGSMIL CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=C(C=C3)N D0XJ6D HIGHSTAT Investigative D0XJ7I DRUG__ID D0XJ7I D0XJ7I DRUGTYPE Small molecular drug D0XJ7I DRUGINCH 1S/C14H8O5/c15-8-5-9(16)14(19)11-10(8)12(17)6-3-1-2-4-7(6)13(11)18/h1-5,15-16,19H D0XJ7I DRUGINKE BBNQQADTFFCFGB-UHFFFAOYSA-N D0XJ7I DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O D0XJ7I HIGHSTAT Investigative D0XJ9P DRUG__ID D0XJ9P D0XJ9P DRUGTYPE Small molecular drug D0XJ9P DRUGINCH 1S/C12H27O4P/c1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h2-12H2,1H3,(H2,13,14,15) D0XJ9P DRUGINKE TVACALAUIQMRDF-UHFFFAOYSA-N D0XJ9P DRUGSMIL CCCCCCCCCCCCOP(=O)(O)O D0XJ9P HIGHSTAT Investigative D0XK0T DRUG__ID D0XK0T D0XK0T DRUGTYPE Small molecular drug D0XK0T DRUGINCH 1S/C24H33N3O2/c1-24(2,3)25-23(28)20(19-10-6-5-7-11-19)18-26-14-16-27(17-15-26)21-12-8-9-13-22(21)29-4/h5-13,20H,14-18H2,1-4H3,(H,25,28) D0XK0T DRUGINKE UMTDAKAAYOXIKU-UHFFFAOYSA-N D0XK0T DRUGSMIL CC(C)(C)NC(=O)C(CN1CCN(CC1)C2=CC=CC=C2OC)C3=CC=CC=C3 D0XK0T HIGHSTAT Investigative D0XK7G DRUG__ID D0XK7G D0XK7G DRUGTYPE Small molecular drug D0XK7G DRUGINCH 1S/C9H12N2O5S/c1-16-7-2-4-8(5-3-7)17(14,15)10-6-9(12)11-13/h2-5,10,13H,6H2,1H3,(H,11,12) D0XK7G DRUGINKE WLZISXXOYYGJNT-UHFFFAOYSA-N D0XK7G DRUGSMIL COC1=CC=C(C=C1)S(=O)(=O)NCC(=O)NO D0XK7G HIGHSTAT Investigative D0XL1R DRUG__ID D0XL1R D0XL1R DRUGTYPE Small molecular drug D0XL1R DRUGINCH 1S/C22H27N3O2/c1-5-15-8-6-7-9-18(15)23-21(26)27-16-10-11-19-17(14-16)22(2)12-13-24(3)20(22)25(19)4/h6-11,14,20H,5,12-13H2,1-4H3,(H,23,26)/t20-,22+/m1/s1 D0XL1R DRUGINKE NRKKZJALIFDZIJ-IRLDBZIGSA-N D0XL1R DRUGSMIL CCC1=CC=CC=C1NC(=O)OC2=CC3=C(C=C2)N(C4C3(CCN4C)C)C D0XL1R HIGHSTAT Investigative D0XL5D DRUG__ID D0XL5D D0XL5D DRUGTYPE Small molecular drug D0XL5D DRUGINCH 1S/C14H12N2O2/c1-17-11-7-8-13-12(9-11)16-14(18-13)15-10-5-3-2-4-6-10/h2-9H,1H3,(H,15,16) D0XL5D DRUGINKE PZJKFSCOZOTZRO-UHFFFAOYSA-N D0XL5D DRUGSMIL COC1=CC2=C(C=C1)OC(=N2)NC3=CC=CC=C3 D0XL5D HIGHSTAT Investigative D0XL5K DRUG__ID D0XL5K D0XL5K DRUGTYPE Small molecular drug D0XL5K DRUGINCH 1S/C7H6N2O2S2/c8-13(10,11)7-9-5-3-1-2-4-6(5)12-7/h1-4H,(H2,8,10,11) D0XL5K DRUGINKE SDYMYAFSQACTQP-UHFFFAOYSA-N D0XL5K DRUGSMIL C1=CC=C2C(=C1)N=C(S2)S(=O)(=O)N D0XL5K HIGHSTAT Investigative D0XL6P DRUG__ID D0XL6P D0XL6P DRUGTYPE Small molecular drug D0XL6P DRUGINCH 1S/C23H19NO3/c25-21-15-23(24-10-12-26-13-11-24)27-22-9-8-17(14-20(21)22)19-7-3-5-16-4-1-2-6-18(16)19/h1-9,14-15H,10-13H2 D0XL6P DRUGINKE ALYIMYTWUBXFRH-UHFFFAOYSA-N D0XL6P DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=CC5=CC=CC=C54 D0XL6P HIGHSTAT Investigative D0XL7C DRUG__ID D0XL7C D0XL7C DRUGTYPE Small molecular drug D0XL7C DRUGINCH 1S/C17H12N4S/c18-17-21-15(14-7-3-4-9-19-14)16(22-17)12-8-10-20-13-6-2-1-5-11(12)13/h1-10H,(H2,18,21) D0XL7C DRUGINKE UPYLCJSMNYCTLZ-UHFFFAOYSA-N D0XL7C DRUGSMIL C1=CC=C2C(=C1)C(=CC=N2)C3=C(N=C(S3)N)C4=CC=CC=N4 D0XL7C HIGHSTAT Investigative D0XL8C DRUG__ID D0XL8C D0XL8C DRUGTYPE Small molecular drug D0XL8C DRUGINCH 1S/C18H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-14-17(19)15-13-16-18(20)21/h10-12,14H,2-9,13,15-16H2,1H3,(H,20,21)/b11-10-,14-12+ D0XL8C DRUGINKE YVWMHFYOIJMUMN-HSINTONASA-N D0XL8C DRUGSMIL CCCCCCCCCC=CC=CC(=O)CCCC(=O)O D0XL8C HIGHSTAT Investigative D0XL8K DRUG__ID D0XL8K D0XL8K DRUGTYPE Small molecular drug D0XL8K DRUGINCH 1S/C15H29N3O4/c1-9(2)7-10(8-11(19)18-22)13(20)17-12(14(21)16-6)15(3,4)5/h9-10,12,22H,7-8H2,1-6H3,(H,16,21)(H,17,20)(H,18,19)/t10-,12+/m1/s1 D0XL8K DRUGINKE QRXOZHSEEGNRFC-PWSUYJOCSA-N D0XL8K DRUGSMIL CC(C)CC(CC(=O)NO)C(=O)NC(C(=O)NC)C(C)(C)C D0XL8K HIGHSTAT Investigative D0XL9J DRUG__ID D0XL9J D0XL9J DRUGTYPE Small molecular drug D0XL9J DRUGINCH 1S/C20H26F4N4O5/c1-19(32)16(29)25-18(31)28(17(19)30)6-2-5-26-7-9-27(10-8-26)14-4-3-13(21)11-15(14)33-12-20(22,23)24/h3-4,11,16,29,32H,2,5-10,12H2,1H3,(H,25,31)/t16-,19+/m1/s1 D0XL9J DRUGINKE CFECXSNWRXZHNR-APWZRJJASA-N D0XL9J DRUGSMIL CC1(C(NC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F)O)O D0XL9J HIGHSTAT Investigative D0XL9W DRUG__ID D0XL9W D0XL9W DRUGTYPE Small molecular drug D0XL9W DRUGINCH 1S/C20H17F3N2O4/c1-3-29-18(27)16-14-9-6-12(20(21,22)23)10-15(14)25(17(16)26)19(28)24-13-7-4-11(2)5-8-13/h4-10,26H,3H2,1-2H3,(H,24,28) D0XL9W DRUGINKE YMEXYIFTFLKKQK-UHFFFAOYSA-N D0XL9W DRUGSMIL CCOC(=O)C1=C(N(C2=C1C=CC(=C2)C(F)(F)F)C(=O)NC3=CC=C(C=C3)C)O D0XL9W HIGHSTAT Investigative D0XM1U DRUG__ID D0XM1U D0XM1U DRUGTYPE Small molecular drug D0XM1U DRUGINCH 1S/C22H28N6/c1-4-20-25-16(2)13-21(26-20)27-9-5-18(6-10-27)19-7-11-28(12-8-19)22-15-23-17(3)14-24-22/h1,13-15,18-19H,5-12H2,2-3H3 D0XM1U DRUGINKE GIKAEVLPYSTAGY-UHFFFAOYSA-N D0XM1U DRUGSMIL CC1=CC(=NC(=N1)C#C)N2CCC(CC2)C3CCN(CC3)C4=NC=C(N=C4)C D0XM1U HIGHSTAT Investigative D0XN1T DRUG__ID D0XN1T D0XN1T DRUGTYPE Small molecular drug D0XN1T DRUGINCH 1S/C21H21NO/c23-21(16-22-14-11-20(21)12-15-22)13-10-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-9,20,23H,11-12,14-16H2 D0XN1T DRUGINKE MWHQFRXYYJSIFR-UHFFFAOYSA-N D0XN1T DRUGSMIL C1CN2CCC1C(C2)(C#CC3=CC=C(C=C3)C4=CC=CC=C4)O D0XN1T HIGHSTAT Investigative D0XN4W DRUG__ID D0XN4W D0XN4W DRUGTYPE Small molecular drug D0XN4W DRUGINCH 1S/C16H14N2/c1-11-5-6-14(10-12(11)2)15-8-7-13-4-3-9-17-16(13)18-15/h3-10H,1-2H3 D0XN4W DRUGINKE HNJUUHIKQMSRFO-UHFFFAOYSA-N D0XN4W DRUGSMIL CC1=C(C=C(C=C1)C2=NC3=C(C=CC=N3)C=C2)C D0XN4W HIGHSTAT Investigative D0XN8A DRUG__ID D0XN8A D0XN8A DRUGTYPE Small molecular drug D0XN8A DRUGINCH 1S/C17H13N2O.ClH/c20-15-10-11-4-3-8-18-9-7-13-12-5-1-2-6-14(12)19(15)17(13)16(11)18;/h1-2,5-7,9-10H,3-4,8H2;1H/q+1;/p-1 D0XN8A DRUGINKE ANXYOVQDHIBQTM-UHFFFAOYSA-M D0XN8A DRUGSMIL C1CC2=CC(=O)N3C4=CC=CC=C4C5=C3C2=[N+](C1)C=C5.[Cl-] D0XN8A HIGHSTAT Investigative D0XO2E DRUG__ID D0XO2E D0XO2E DRUGTYPE Small molecular drug D0XO2E DRUGINCH 1S/C16H18BrN3O2S/c1-21-13-4-5-14(22-2)11(9-13)7-8-18-16(23)20-15-6-3-12(17)10-19-15/h3-6,9-10H,7-8H2,1-2H3,(H2,18,19,20,23) D0XO2E DRUGINKE GNLVRKKIIIVZHZ-UHFFFAOYSA-N D0XO2E DRUGSMIL COC1=CC(=C(C=C1)OC)CCNC(=S)NC2=NC=C(C=C2)Br D0XO2E HIGHSTAT Investigative D0XO2G DRUG__ID D0XO2G D0XO2G DRUGTYPE Small molecular drug D0XO2G DRUGINCH 1S/C21H23NO3/c1-21(2,3)16-7-4-15(5-8-16)6-11-20(23)22-17-9-10-18-19(14-17)25-13-12-24-18/h4-11,14H,12-13H2,1-3H3,(H,22,23)/b11-6+ D0XO2G DRUGINKE GZTFUVZVLYUPRG-IZZDOVSWSA-N D0XO2G DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C=CC(=O)NC2=CC3=C(C=C2)OCCO3 D0XO2G HIGHSTAT Investigative D0XO7J DRUG__ID D0XO7J D0XO7J DRUGTYPE Small molecular drug D0XO7J DRUGINCH 1S/C5H13N/c1-5(2)3-4-6/h5H,3-4,6H2,1-2H3 D0XO7J DRUGINKE BMFVGAAISNGQNM-UHFFFAOYSA-N D0XO7J DRUGSMIL CC(C)CCN D0XO7J HIGHSTAT Investigative D0XP0J DRUG__ID D0XP0J D0XP0J DRUGTYPE Small molecular drug D0XP0J DRUGINCH 1S/C10H12F3O4P/c1-15-18(14,16-2)17-9(10(11,12)13)8-6-4-3-5-7-8/h3-7,9H,1-2H3 D0XP0J DRUGINKE LEDQZLXLDMICCN-UHFFFAOYSA-N D0XP0J DRUGSMIL COP(=O)(OC)OC(C1=CC=CC=C1)C(F)(F)F D0XP0J HIGHSTAT Investigative D0XP5P DRUG__ID D0XP5P D0XP5P DRUGTYPE Small molecular drug D0XP5P DRUGINCH 1S/C12H11ClN4S/c13-10-7-6-9(18-10)11(16-17-12(14)15)8-4-2-1-3-5-8/h1-7H,(H4,14,15,17)/b16-11+ D0XP5P DRUGINKE LXZSGGMOFNDLPW-LFIBNONCSA-N D0XP5P DRUGSMIL C1=CC=C(C=C1)C(=NN=C(N)N)C2=CC=C(S2)Cl D0XP5P HIGHSTAT Investigative D0XQ5U DRUG__ID D0XQ5U D0XQ5U DRUGTYPE Small molecular drug D0XQ5U DRUGINCH 1S/C42H48N12O6/c43-36(55)30-12-5-6-16-48-40(59)34-35(47-19-18-46-34)41(60)54-32(21-24-14-15-25-8-1-2-9-26(25)20-24)38(57)52-31(13-7-17-49-42(44)45)37(56)53-33(39(58)51-30)22-27-23-50-29-11-4-3-10-28(27)29/h1-4,8-11,14-15,18-20,23,30-33,50H,5-7,12-13,16-17,21-22H2,(H2,43,55)(H,48,59)(H,51,58)(H,52,57)(H,53,56)(H,54,60)(H4,44,45,49)/t30-,31-,32+,33-/m0/s1 D0XQ5U DRUGINKE YIHQUVPRWHIYHB-SSNHPIBPSA-N D0XQ5U DRUGSMIL C1CCNC(=O)C2=NC=CN=C2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C1)C(=O)N)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC6=CC=CC=C6C=C5 D0XQ5U HIGHSTAT Investigative D0XQ6T DRUG__ID D0XQ6T D0XQ6T DRUGTYPE Small molecular drug D0XQ6T DRUGINCH 1S/C13H15NO3/c1-8-7-11(15)14(2)12-9(8)5-6-10(16-3)13(12)17-4/h5-7H,1-4H3 D0XQ6T DRUGINKE DHJBSOKLGMWDBA-UHFFFAOYSA-N D0XQ6T DRUGSMIL CC1=CC(=O)N(C2=C1C=CC(=C2OC)OC)C D0XQ6T HIGHSTAT Investigative D0XQ8P DRUG__ID D0XQ8P D0XQ8P DRUGTYPE Small molecular drug D0XQ8P DRUGINCH 1S/C11H9N3OS/c15-11-9-3-1-2-4-10(9)13-14(11)6-8-5-12-7-16-8/h1-5,7,13H,6H2 D0XQ8P DRUGINKE KPXSUQVYEHMEMW-UHFFFAOYSA-N D0XQ8P DRUGSMIL C1=CC=C2C(=C1)C(=O)N(N2)CC3=CN=CS3 D0XQ8P HIGHSTAT Investigative D0XR0L DRUG__ID D0XR0L D0XR0L DRUGTYPE Small molecular drug D0XR0L DRUGINCH 1S/C4H6O4S2/c5-9(6)1-2-10(7,8)4-3-9/h1-2H,3-4H2 D0XR0L DRUGINKE YNEKVCMDWXAQGQ-UHFFFAOYSA-N D0XR0L DRUGSMIL C1CS(=O)(=O)C=CS1(=O)=O D0XR0L HIGHSTAT Investigative D0XR2J DRUG__ID D0XR2J D0XR2J DRUGTYPE Small molecular drug D0XR2J DRUGINCH 1S/C3H10N2O2.ClH/c4-1-3(6)2-7-5;/h3,6H,1-2,4-5H2;1H D0XR2J DRUGINKE CDNYZQKHCXXBPH-UHFFFAOYSA-N D0XR2J DRUGSMIL C(C(CON)O)N.Cl D0XR2J HIGHSTAT Investigative D0XR4J DRUG__ID D0XR4J D0XR4J DRUGTYPE Small molecular drug D0XR4J DRUGINCH 1S/C18H21N3O2/c19-15(11-13-7-3-1-4-8-13)18(23)21-16(17(20)22)12-14-9-5-2-6-10-14/h1-10,15-16H,11-12,19H2,(H2,20,22)(H,21,23)/t15-,16-/m0/s1 D0XR4J DRUGINKE XXPXQEQOAZMUDD-HOTGVXAUSA-N D0XR4J DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)N D0XR4J HIGHSTAT Investigative D0XR6A DRUG__ID D0XR6A D0XR6A DRUGTYPE Small molecular drug D0XR6A DRUGINCH 1S/C49H66N10O6/c1-29(2)22-39(44(52)60)55-46(62)40(23-30(3)4)57-49(65)43(26-33-28-54-38-20-11-9-17-35(33)38)59-47(63)41(24-31-14-6-5-7-15-31)58-48(64)42(56-45(61)36(51)18-12-13-21-50)25-32-27-53-37-19-10-8-16-34(32)37/h5-11,14-17,19-20,27-30,36,39-43,53-54H,12-13,18,21-26,50-51H2,1-4H3,(H2,52,60)(H,55,62)(H,56,61)(H,57,65)(H,58,64)(H,59,63)/t36-,39-,40-,41-,42+,43+/m0/s1 D0XR6A DRUGINKE ZGQSDHNDIKTEJD-XLAQBFAFSA-N D0XR6A DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCCN)N D0XR6A HIGHSTAT Investigative D0XR8Q DRUG__ID D0XR8Q D0XR8Q DRUGTYPE Small molecular drug D0XR8Q DRUGINCH 1S/C28H28Cl3FN2O4/c1-28(2,26(35)36)38-19-13-11-18(12-14-19)6-5-16-34(17-15-20-21(29)7-3-9-23(20)32)27(37)33-24-10-4-8-22(30)25(24)31/h3-4,7-14H,5-6,15-17H2,1-2H3,(H,33,37)(H,35,36) D0XR8Q DRUGINKE YMWJDWJXIXITMD-UHFFFAOYSA-N D0XR8Q DRUGSMIL CC(C)(C(=O)O)OC1=CC=C(C=C1)CCCN(CCC2=C(C=CC=C2Cl)F)C(=O)NC3=C(C(=CC=C3)Cl)Cl D0XR8Q HIGHSTAT Investigative D0XR9Z DRUG__ID D0XR9Z D0XR9Z DRUGTYPE Small molecular drug D0XR9Z DRUGINCH 1S/C28H34NO6P/c30-23-10-14-25(15-11-23)34-20-24(31)19-29-28(16-4-5-17-28)18-22-8-12-26(13-9-22)35-21-36(32,33)27-6-2-1-3-7-27/h1-3,6-15,24,29-31H,4-5,16-21H2,(H,32,33)/t24-/m0/s1 D0XR9Z DRUGINKE MKEFUSOCGOBQMJ-DEOSSOPVSA-N D0XR9Z DRUGSMIL C1CCC(C1)(CC2=CC=C(C=C2)OCP(=O)(C3=CC=CC=C3)O)NCC(COC4=CC=C(C=C4)O)O D0XR9Z HIGHSTAT Investigative D0XS0R DRUG__ID D0XS0R D0XS0R DRUGTYPE Small molecular drug D0XS0R DRUGINCH 1S/C24H30O6/c1-22-7-4-13(25)10-12(22)11-14(21(27)28-3)17-15-5-8-24(9-6-16(26)30-24)23(15,2)20-19(29-20)18(17)22/h10,14-15,17-20H,4-9,11H2,1-3H3/t14-,15?,17?,18?,19+,20+,22+,23-,24-/m1/s1 D0XS0R DRUGINKE QBIRIYASLUPKQB-CBHLJOAQSA-N D0XS0R DRUGSMIL CC12CCC(=O)C=C1CC(C3C2C4C(O4)C5(C3CCC56CCC(=O)O6)C)C(=O)OC D0XS0R HIGHSTAT Investigative D0XS0X DRUG__ID D0XS0X D0XS0X DRUGTYPE Small molecular drug D0XS0X DRUGINCH 1S/C39H54O5/c1-34(2)19-21-39(33(42)43)22-20-37(6)26(27(39)23-34)14-15-30-36(5)24-28(40)32(35(3,4)29(36)17-18-38(30,37)7)44-31(41)16-13-25-11-9-8-10-12-25/h8-14,16,27-30,32,40H,15,17-24H2,1-7H3,(H,42,43)/b16-13+/t27-,28+,29-,30+,32-,36-,37+,38+,39-/m0/s1 D0XS0X DRUGINKE QYNZDAXHBDWWFS-BECYFJCGSA-N D0XS0X DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)OC(=O)C=CC6=CC=CC=C6)O)C)C)C2C1)C)C(=O)O)C D0XS0X HIGHSTAT Investigative D0XS3W DRUG__ID D0XS3W D0XS3W DRUGTYPE Small molecular drug D0XS3W DRUGINCH 1S/C18H31N3O/c1-2-21-5-3-16(4-6-21)19-17(22)20-18-10-13-7-14(11-18)9-15(8-13)12-18/h13-16H,2-12H2,1H3,(H2,19,20,22) D0XS3W DRUGINKE SMBXAXBAAIGIAK-UHFFFAOYSA-N D0XS3W DRUGSMIL CCN1CCC(CC1)NC(=O)NC23CC4CC(C2)CC(C4)C3 D0XS3W HIGHSTAT Investigative D0XS4G DRUG__ID D0XS4G D0XS4G DRUGTYPE Small molecular drug D0XS4G DRUGINCH 1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10) D0XS4G DRUGINKE WWZKQHOCKIZLMA-UHFFFAOYSA-N D0XS4G DRUGSMIL CCCCCCCC(=O)O D0XS4G HIGHSTAT Investigative D0XS6T DRUG__ID D0XS6T D0XS6T DRUGTYPE Small molecular drug D0XS6T DRUGINCH 1S/C11H11N3O/c12-10-3-1-9(2-4-10)11(15)7-14-6-5-13-8-14/h1-6,8H,7,12H2 D0XS6T DRUGINKE QRMNVYHFJCGDDI-UHFFFAOYSA-N D0XS6T DRUGSMIL C1=CC(=CC=C1C(=O)CN2C=CN=C2)N D0XS6T HIGHSTAT Investigative D0XS9E DRUG__ID D0XS9E D0XS9E DRUGTYPE Small molecular drug D0XS9E DRUGINCH 1S/C17H12N2O2/c20-12-5-6-14-11(7-12)9-16(19-14)17(21)15-8-10-3-1-2-4-13(10)18-15/h1-9,18-20H D0XS9E DRUGINKE AALNCHNFTKRFEL-UHFFFAOYSA-N D0XS9E DRUGSMIL C1=CC=C2C(=C1)C=C(N2)C(=O)C3=CC4=C(N3)C=CC(=C4)O D0XS9E HIGHSTAT Investigative D0XT0I DRUG__ID D0XT0I D0XT0I DRUGTYPE Small molecular drug D0XT0I DRUGINCH 1S/C20H20F3N3O5/c21-20(22,23)14-2-1-3-15(12-14)25-8-6-24(7-9-25)5-4-17(27)13-10-16(26(30)31)19(29)18(28)11-13/h1-3,10-12,28-29H,4-9H2 D0XT0I DRUGINKE KVIVJQWOYSWCCZ-UHFFFAOYSA-N D0XT0I DRUGSMIL C1CN(CCN1CCC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-])C3=CC=CC(=C3)C(F)(F)F D0XT0I HIGHSTAT Investigative D0XT2X DRUG__ID D0XT2X D0XT2X DRUGTYPE Small molecular drug D0XT2X DRUGINCH 1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1/i5+2 D0XT2X DRUGINKE HNDVDQJCIGZPNO-YDUYVQCESA-N D0XT2X DRUGSMIL C1=C(NC=N1)CC(C(=O)O)N D0XT2X HIGHSTAT Investigative D0XT3Z DRUG__ID D0XT3Z D0XT3Z DRUGTYPE Small molecular drug D0XT3Z DRUGINCH 1S/C26H29ClN2O4S/c1-28(17-5-6-21-9-11-23(27)12-10-21)20-22-7-3-4-8-26(22)29(18-19-30)34(31,32)25-15-13-24(33-2)14-16-25/h3-16,30H,17-20H2,1-2H3/b6-5+ D0XT3Z DRUGINKE LLLQTDSSHZREGW-AATRIKPKSA-N D0XT3Z DRUGSMIL CN(CC=CC1=CC=C(C=C1)Cl)CC2=CC=CC=C2N(CCO)S(=O)(=O)C3=CC=C(C=C3)OC D0XT3Z HIGHSTAT Investigative D0XT4J DRUG__ID D0XT4J D0XT4J DRUGTYPE Small molecular drug D0XT4J DRUGINCH 1S/C16H12ClN/c1-11-5-6-12-7-8-14(10-16(12)18-11)13-3-2-4-15(17)9-13/h2-10H,1H3 D0XT4J DRUGINKE HNAVWOSKROEPOM-UHFFFAOYSA-N D0XT4J DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=CC(=CC=C3)Cl D0XT4J HIGHSTAT Investigative D0XU0G DRUG__ID D0XU0G D0XU0G DRUGTYPE Small molecular drug D0XU0G DRUGINCH 1S/C15H20N4O3S/c16-23(21,22)18-9-5-1-2-8-15(20)19-13-10-12-6-3-4-7-14(12)17-11-13/h3-4,6-7,10-11,18H,1-2,5,8-9H2,(H,19,20)(H2,16,21,22) D0XU0G DRUGINKE HIRQWWZRMZTUFZ-UHFFFAOYSA-N D0XU0G DRUGSMIL C1=CC=C2C(=C1)C=C(C=N2)NC(=O)CCCCCNS(=O)(=O)N D0XU0G HIGHSTAT Investigative D0XU4Y DRUG__ID D0XU4Y D0XU4Y DRUGTYPE Small molecular drug D0XU4Y DRUGINCH 1S/C14H10O5/c1-6-7-2-9(15)11(17)4-13(7)19-14-5-12(18)10(16)3-8(6)14/h2-5,15-17H,1H3 D0XU4Y DRUGINKE TZVNNUHRZXQCHM-UHFFFAOYSA-N D0XU4Y DRUGSMIL CC1=C2C=C(C(=O)C=C2OC3=CC(=C(C=C13)O)O)O D0XU4Y HIGHSTAT Investigative D0XU6H DRUG__ID D0XU6H D0XU6H DRUGTYPE Small molecular drug D0XU6H DRUGINCH 1S/C37H45N5O6S2/c1-37(2)33(35(47)41-31-25-15-9-7-13-23(25)18-29(31)43)42(21-50-37)36(48)32(45)27(17-22-11-5-4-6-12-22)40-34(46)28(20-49-3)39-30(44)19-24-14-8-10-16-26(24)38/h4-16,27-29,31-33,43,45H,17-21,38H2,1-3H3,(H,39,44)(H,40,46)(H,41,47)/t27-,28-,29+,31-,32-,33+/m0/s1 D0XU6H DRUGINKE JXPOIFQLOPSPRM-ACUZRORGSA-N D0XU6H DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC=CC=C3N)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0XU6H HIGHSTAT Investigative D0XU7M DRUG__ID D0XU7M D0XU7M DRUGTYPE Small molecular drug D0XU7M DRUGINCH 1S/C15H16ClN3O3/c16-11-13(18-4-5-19-6-8-22-9-7-19)15(21)12-10(14(11)20)2-1-3-17-12/h1-3,18H,4-9H2 D0XU7M DRUGINKE BMKPVDQDJQWBPD-UHFFFAOYSA-N D0XU7M DRUGSMIL C1COCCN1CCNC2=C(C(=O)C3=C(C2=O)N=CC=C3)Cl D0XU7M HIGHSTAT Investigative D0XU7N DRUG__ID D0XU7N D0XU7N DRUGTYPE Small molecular drug D0XU7N DRUGINCH 1S/C22H30F3N5O8/c23-22(24,25)21(37,38)13(3-1-2-12-16(26)29-20(27)30-18(12)34)10-4-6-11(7-5-10)17(33)28-14(19(35)36)8-9-15(31)32/h4-7,12-14,16,20,29,37-38H,1-3,8-9,26-27H2,(H,28,33)(H,30,34)(H,31,32)(H,35,36)/t12-,13+,14-,16+,20-/m1/s1 D0XU7N DRUGINKE KOLDLUFBEMUZIM-WUAYEBGVSA-N D0XU7N DRUGSMIL C1=CC(=CC=C1C(CCCC2C(NC(NC2=O)N)N)C(C(F)(F)F)(O)O)C(=O)NC(CCC(=O)O)C(=O)O D0XU7N HIGHSTAT Investigative D0XV3B DRUG__ID D0XV3B D0XV3B DRUGTYPE Small molecular drug D0XV3B DRUGINCH 1S/C5H11NO3S/c1-10(9)3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8) D0XV3B DRUGINKE QEFRNWWLZKMPFJ-UHFFFAOYSA-N D0XV3B DRUGSMIL CS(=O)CCC(C(=O)O)N D0XV3B HIGHSTAT Investigative D0XW9U DRUG__ID D0XW9U D0XW9U DRUGTYPE Small molecular drug D0XW9U DRUGINCH 1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3 D0XW9U DRUGINKE UUQMNUMQCIQDMZ-UHFFFAOYSA-N D0XW9U DRUGSMIL CNCCC1=CC=CC=N1 D0XW9U HIGHSTAT Investigative D0XX1Y DRUG__ID D0XX1Y D0XX1Y DRUGTYPE Small molecular drug D0XX1Y DRUGINCH 1S/C25H27NO/c1-20-12-14-22(15-13-20)24(21-8-4-2-5-9-21)26-18-16-25(27,17-19-26)23-10-6-3-7-11-23/h2-15,24,27H,16-19H2,1H3 D0XX1Y DRUGINKE RKHFFYFBKRWGAL-UHFFFAOYSA-N D0XX1Y DRUGSMIL CC1=CC=C(C=C1)C(C2=CC=CC=C2)N3CCC(CC3)(C4=CC=CC=C4)O D0XX1Y HIGHSTAT Investigative D0XX2U DRUG__ID D0XX2U D0XX2U DRUGTYPE Small molecular drug D0XX2U DRUGINCH 1S/C10H13N3O/c1-6-7-4-3-5-8(14-2)9(7)13-10(11)12-6/h3-6H,1-2H3,(H3,11,12,13) D0XX2U DRUGINKE SCKPQZMXGISHHF-UHFFFAOYSA-N D0XX2U DRUGSMIL CC1C2=C(C(=CC=C2)OC)NC(=N1)N D0XX2U HIGHSTAT Investigative D0XX5S DRUG__ID D0XX5S D0XX5S DRUGTYPE Small molecular drug D0XX5S DRUGINCH 1S/C11H15Cl2NO/c1-7(2)14-6-11(15)8-3-4-9(12)10(13)5-8/h3-5,7,11,14-15H,6H2,1-2H3 D0XX5S DRUGINKE VKMGSWIFEHZQRS-UHFFFAOYSA-N D0XX5S DRUGSMIL CC(C)NCC(C1=CC(=C(C=C1)Cl)Cl)O D0XX5S HIGHSTAT Investigative D0XX7J DRUG__ID D0XX7J D0XX7J DRUGTYPE Small molecular drug D0XX7J DRUGINCH 1S/C12H13NO/c1-2-12-11(5-8-14-12)10-4-7-13-6-3-9(1)10/h1-2,5,8,13H,3-4,6-7H2 D0XX7J DRUGINKE BGHAWUGGSCZWBN-UHFFFAOYSA-N D0XX7J DRUGSMIL C1CNCCC2=C1C=CC3=C2C=CO3 D0XX7J HIGHSTAT Investigative D0XX9C DRUG__ID D0XX9C D0XX9C DRUGTYPE Small molecular drug D0XX9C DRUGINCH 1S/C14H17N3O5S3/c1-16-12-8-17(9-4-3-5-10(6-9)22-2)25(20,21)14-11(12)7-13(23-14)24(15,18)19/h3-7,12,16H,8H2,1-2H3,(H2,15,18,19)/t12-/m1/s1 D0XX9C DRUGINKE RMOXCYSVWCHXII-GFCCVEGCSA-N D0XX9C DRUGSMIL CNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C3=CC(=CC=C3)OC D0XX9C HIGHSTAT Investigative D0XX9G DRUG__ID D0XX9G D0XX9G DRUGTYPE Small molecular drug D0XX9G DRUGINCH 1S/C4H11NO3P/c5-2-1-3-9(7,8)4-6/h4,7-8H,1-3,5H2/q+1 D0XX9G DRUGINKE WKJVZSFFUHQPOM-UHFFFAOYSA-N D0XX9G DRUGSMIL C(CN)C[P+](C=O)(O)O D0XX9G HIGHSTAT Investigative D0XX9Y DRUG__ID D0XX9Y D0XX9Y DRUGTYPE Small molecular drug D0XX9Y DRUGINCH 1S/C22H26N2O/c1-2-3-13-22(25)23-15-14-19-18-11-7-8-12-20(18)24-21(19)16-17-9-5-4-6-10-17/h4-12,24H,2-3,13-16H2,1H3,(H,23,25) D0XX9Y DRUGINKE HDOIPCLEKCEANF-UHFFFAOYSA-N D0XX9Y DRUGSMIL CCCCC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 D0XX9Y HIGHSTAT Investigative D0XY0Z DRUG__ID D0XY0Z D0XY0Z DRUGTYPE Small molecular drug D0XY0Z DRUGINCH 1S/C12H25O3PS/c1-2-3-4-5-6-7-8-9-10-11-12-15-16(13,14)17/h3-4H,2,5-12H2,1H3,(H2,13,14,17)/b4-3+ D0XY0Z DRUGINKE WIHXFYRABDDREX-ONEGZZNKSA-N D0XY0Z DRUGSMIL CCC=CCCCCCCCCOP(=S)(O)O D0XY0Z HIGHSTAT Investigative D0XY2M DRUG__ID D0XY2M D0XY2M DRUGTYPE Small molecular drug D0XY2M DRUGINCH 1S/C17H23NO/c1-10-6-11(2)16(12(3)7-10)18-17(19)15-9-13-4-5-14(15)8-13/h6-7,13-15H,4-5,8-9H2,1-3H3,(H,18,19) D0XY2M DRUGINKE SIQGKPGBLYKQBB-UHFFFAOYSA-N D0XY2M DRUGSMIL CC1=CC(=C(C(=C1)C)NC(=O)C2CC3CCC2C3)C D0XY2M HIGHSTAT Investigative D0XY3G DRUG__ID D0XY3G D0XY3G DRUGTYPE Small molecular drug D0XY3G DRUGINCH 1S/C5H8N2S/c6-2-1-5-7-3-4-8-5/h3-4H,1-2,6H2 D0XY3G DRUGINKE TWZOYAWHWDRMEZ-UHFFFAOYSA-N D0XY3G DRUGSMIL C1=CSC(=N1)CCN D0XY3G HIGHSTAT Investigative D0XY9E DRUG__ID D0XY9E D0XY9E DRUGTYPE Small molecular drug D0XY9E DRUGINCH 1S/C15H22ClNO/c1-5-7-13(17-15(2,3)4)14(18)11-8-6-9-12(16)10-11/h6,8-10,13,17H,5,7H2,1-4H3 D0XY9E DRUGINKE PREYWAJYVTVVPE-UHFFFAOYSA-N D0XY9E DRUGSMIL CCCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C D0XY9E HIGHSTAT Investigative D0XZ2P DRUG__ID D0XZ2P D0XZ2P DRUGTYPE Small molecular drug D0XZ2P DRUGINCH 1S/C30H48F2O3/c1-6-30(34,7-2)16-9-17-35-21(4)26-13-14-27-22(10-8-15-29(26,27)5)11-12-23-18-24(33)19-25(20(23)3)28(31)32/h11-12,21,24-28,33-34H,3,6-10,13-19H2,1-2,4-5H3/b22-11+,23-12-/t21-,24-,25+,26-,27+,29-/m1/s1 D0XZ2P DRUGINKE JHEXIWJRXZGBMA-AFLZJIMUSA-N D0XZ2P DRUGSMIL CCC(CC)(CCCOC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)C(F)F)O)C)O D0XZ2P HIGHSTAT Investigative D0XZ5D DRUG__ID D0XZ5D D0XZ5D DRUGTYPE Small molecular drug D0XZ5D DRUGINCH 1S/C14H10ClN3O/c15-10-4-2-5-11(7-10)18-8-9-3-1-6-12(14(16)19)13(9)17-18/h1-8H,(H2,16,19) D0XZ5D DRUGINKE HWNODZACISEDHJ-UHFFFAOYSA-N D0XZ5D DRUGSMIL C1=CC(=CC(=C1)Cl)N2C=C3C=CC=C(C3=N2)C(=O)N D0XZ5D HIGHSTAT Investigative D0XZ9Q DRUG__ID D0XZ9Q D0XZ9Q DRUGTYPE Small molecular drug D0XZ9Q DRUGINCH 1S/C14H21NOS/c16-14(11-7-2-1-3-8-12-17)15-13-9-5-4-6-10-13/h4-6,9-10,17H,1-3,7-8,11-12H2,(H,15,16) D0XZ9Q DRUGINKE VTVJPXWTXILBGK-UHFFFAOYSA-N D0XZ9Q DRUGSMIL C1=CC=C(C=C1)NC(=O)CCCCCCCS D0XZ9Q HIGHSTAT Investigative D0Y0BB DRUG__ID D0Y0BB D0Y0BB DRUGTYPE Small molecular drug D0Y0BB DRUGINCH 1S/C13H14ClN/c14-11-3-1-9(2-4-11)10-7-12-5-6-13(8-10)15-12/h1-4,7,12-13,15H,5-6,8H2 D0Y0BB DRUGINKE QBSBBGLHCMPGNO-UHFFFAOYSA-N D0Y0BB DRUGSMIL C1CC2C=C(CC1N2)C3=CC=C(C=C3)Cl D0Y0BB HIGHSTAT Investigative D0Y0BK DRUG__ID D0Y0BK D0Y0BK DRUGTYPE Small molecular drug D0Y0BK DRUGINCH 1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2 D0Y0BK DRUGINKE XHBVYDAKJHETMP-UHFFFAOYSA-N D0Y0BK DRUGSMIL C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3 D0Y0BK HIGHSTAT Investigative D0Y0CA DRUG__ID D0Y0CA D0Y0CA DRUGTYPE Small molecular drug D0Y0CA DRUGINCH 1S/C15H16O3/c1-7-4-14-12(9(3)15(17)18-14)5-11-8(2)13(16)6-10(7)11/h6-7,11-12,14H,2-5H2,1H3/t7-,11-,12+,14-/m0/s1 D0Y0CA DRUGINKE RVBPAMCSEVHKLO-MZZAWFPRSA-N D0Y0CA DRUGSMIL CC1CC2C(CC3C1=CC(=O)C3=C)C(=C)C(=O)O2 D0Y0CA HIGHSTAT Investigative D0Y0CT DRUG__ID D0Y0CT D0Y0CT DRUGTYPE Small molecular drug D0Y0CT DRUGINCH 1S/C21H17N/c1-2-8-17(9-3-1)21-14-18(13-16-7-6-12-22-15-16)19-10-4-5-11-20(19)21/h1-13,15,21H,14H2/b18-13+ D0Y0CT DRUGINKE ADQBWRCDKUIPFI-QGOAFFKASA-N D0Y0CT DRUGSMIL C1C(C2=CC=CC=C2C1=CC3=CN=CC=C3)C4=CC=CC=C4 D0Y0CT HIGHSTAT Investigative D0Y0DG DRUG__ID D0Y0DG D0Y0DG DRUGTYPE Small molecular drug D0Y0DG DRUGINCH 1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8) D0Y0DG DRUGINKE ISAKRJDGNUQOIC-UHFFFAOYSA-N D0Y0DG DRUGSMIL C1=CNC(=O)NC1=O D0Y0DG HIGHSTAT Investigative D0Y0EK DRUG__ID D0Y0EK D0Y0EK DRUGTYPE Small molecular drug D0Y0EK DRUGINCH 1S/C15H12O4/c16-10-3-1-2-9(6-10)14-8-13(18)12-5-4-11(17)7-15(12)19-14/h1-7,14,16-17H,8H2 D0Y0EK DRUGINKE MXNJBOFUFMJXOB-UHFFFAOYSA-N D0Y0EK DRUGSMIL C1C(OC2=C(C1=O)C=CC(=C2)O)C3=CC(=CC=C3)O D0Y0EK HIGHSTAT Investigative D0Y0ES DRUG__ID D0Y0ES D0Y0ES DRUGTYPE Small molecular drug D0Y0ES DRUGINCH 1S/C16H11N3O2/c20-16-13(9-5-1-3-7-11(9)18-16)15-14(19-21)10-6-2-4-8-12(10)17-15/h1-8,17-18,20H D0Y0ES DRUGINKE FQCPPVRJPILDIK-UHFFFAOYSA-N D0Y0ES DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)O)C3=C(C4=CC=CC=C4N3)N=O D0Y0ES HIGHSTAT Investigative D0Y0FC DRUG__ID D0Y0FC D0Y0FC DRUGTYPE Small molecular drug D0Y0FC DRUGINCH 1S/C10H13NO5S/c11-9(10(12)13)6-16-17(14,15)7-8-4-2-1-3-5-8/h1-5,9H,6-7,11H2,(H,12,13)/t9-/m0/s1 D0Y0FC DRUGINKE GCZVEKLTOLTWLM-VIFPVBQESA-N D0Y0FC DRUGSMIL C1=CC=C(C=C1)CS(=O)(=O)OCC(C(=O)O)N D0Y0FC HIGHSTAT Investigative D0Y0FN DRUG__ID D0Y0FN D0Y0FN DRUGTYPE Small molecular drug D0Y0FN DRUGINCH 1S/C13H23F3O3S/c1-2-3-4-5-6-7-8-9-10-20(18,19)11-12(17)13(14,15)16/h2-11H2,1H3 D0Y0FN DRUGINKE QTDVUUSBCIIYIV-UHFFFAOYSA-N D0Y0FN DRUGSMIL CCCCCCCCCCS(=O)(=O)CC(=O)C(F)(F)F D0Y0FN HIGHSTAT Investigative D0Y0FS DRUG__ID D0Y0FS D0Y0FS DRUGTYPE Small molecular drug D0Y0FS DRUGINCH 1S/C7H5N3O2/c11-10(12)6-2-1-5-4-8-9-7(5)3-6/h1-4H,(H,8,9) D0Y0FS DRUGINKE ORZRMRUXSPNQQL-UHFFFAOYSA-N D0Y0FS DRUGSMIL C1=CC2=C(C=C1[N+](=O)[O-])NN=C2 D0Y0FS HIGHSTAT Investigative D0Y0JM DRUG__ID D0Y0JM D0Y0JM DRUGTYPE Small molecular drug D0Y0JM DRUGINCH 1S/C14H16N2/c1-12(14-9-6-10-15-14)16(2)11-13-7-4-3-5-8-13/h3-10,15H,1,11H2,2H3 D0Y0JM DRUGINKE UBPBOEOYYZRWQS-UHFFFAOYSA-N D0Y0JM DRUGSMIL CN(CC1=CC=CC=C1)C(=C)C2=CC=CN2 D0Y0JM HIGHSTAT Investigative D0Y0KF DRUG__ID D0Y0KF D0Y0KF DRUGTYPE Small molecular drug D0Y0KF DRUGINCH 1S/C14H10O3/c15-11-5-2-4-9-10(11)7-8-3-1-6-12(16)13(8)14(9)17/h1-6,15-16H,7H2 D0Y0KF DRUGINKE MYYRAEQRSBLQQO-UHFFFAOYSA-N D0Y0KF DRUGSMIL C1C2=C(C(=CC=C2)O)C(=O)C3=C1C(=CC=C3)O D0Y0KF HIGHSTAT Investigative D0Y0KU DRUG__ID D0Y0KU D0Y0KU DRUGTYPE Small molecular drug D0Y0KU DRUGINCH 1S/C16H13FO2/c1-10-2-4-11(5-3-10)15-9-14(18)13-7-6-12(17)8-16(13)19-15/h2-8,15H,9H2,1H3 D0Y0KU DRUGINKE QNQXLNDULBVXEX-UHFFFAOYSA-N D0Y0KU DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)F D0Y0KU HIGHSTAT Investigative D0Y0LD DRUG__ID D0Y0LD D0Y0LD DRUGTYPE Small molecular drug D0Y0LD DRUGINCH 1S/C4H8O2S2/c5-3-1-7-8-2-4(3)6/h3-6H,1-2H2/t3-,4-/m0/s1 D0Y0LD DRUGINKE YPGMOWHXEQDBBV-IMJSIDKUSA-N D0Y0LD DRUGSMIL C1C(C(CSS1)O)O D0Y0LD HIGHSTAT Investigative D0Y0LQ DRUG__ID D0Y0LQ D0Y0LQ DRUGTYPE Small molecular drug D0Y0LQ DRUGINCH 1S/C17H18N2/c1-2-6-14(7-3-1)10-11-18-13-16-12-15-8-4-5-9-17(15)19-16/h1-9,12,18-19H,10-11,13H2 D0Y0LQ DRUGINKE LMNUEZRZRYCQSM-UHFFFAOYSA-N D0Y0LQ DRUGSMIL C1=CC=C(C=C1)CCNCC2=CC3=CC=CC=C3N2 D0Y0LQ HIGHSTAT Investigative D0Y0MY DRUG__ID D0Y0MY D0Y0MY DRUGTYPE Small molecular drug D0Y0MY DRUGINCH 1S/C23H38O/c1-4-5-6-7-8-9-17-23(2,3)21-15-13-19(14-16-21)20-11-10-12-22(24)18-20/h13-16,20,22,24H,4-12,17-18H2,1-3H3/t20-,22-/m1/s1 D0Y0MY DRUGINKE DQKOXMDLNBLQTB-IFMALSPDSA-N D0Y0MY DRUGSMIL CCCCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0Y0MY HIGHSTAT Investigative D0Y0OA DRUG__ID D0Y0OA D0Y0OA DRUGTYPE Small molecular drug D0Y0OA DRUGINCH 1S/C30H18O10/c31-16-8-20(34)29-22(36)12-24(39-27(29)10-16)14-1-4-18(5-2-14)38-26-7-15(3-6-19(26)33)25-13-23(37)30-21(35)9-17(32)11-28(30)40-25/h1-13,31-35H D0Y0OA DRUGINKE NNPGECDACGBKDH-UHFFFAOYSA-N D0Y0OA DRUGSMIL C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)OC4=C(C=CC(=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O D0Y0OA HIGHSTAT Investigative D0Y0QI DRUG__ID D0Y0QI D0Y0QI DRUGTYPE Small molecular drug D0Y0QI DRUGINCH 1S/C13H13N3/c1-3-11(9-16-8-7-14-10-16)12-4-2-6-15-13(12)5-1/h2-4,6-8,10H,1,5,9H2 D0Y0QI DRUGINKE DVAOHPCQHIOCSM-UHFFFAOYSA-N D0Y0QI DRUGSMIL C1CC2=C(C=CC=N2)C(=C1)CN3C=CN=C3 D0Y0QI HIGHSTAT Investigative D0Y0SA DRUG__ID D0Y0SA D0Y0SA DRUGTYPE Small molecular drug D0Y0SA DRUGINCH 1S/C10H13N3O/c1-7(11)6-13-10-4-9(14)3-2-8(10)5-12-13/h2-5,7,14H,6,11H2,1H3/t7-/m1/s1 D0Y0SA DRUGINKE WBYHTZYHAFNBKW-SSDOTTSWSA-N D0Y0SA DRUGSMIL CC(CN1C2=C(C=CC(=C2)O)C=N1)N D0Y0SA HIGHSTAT Investigative D0Y0SO DRUG__ID D0Y0SO D0Y0SO DRUGTYPE Small molecular drug D0Y0SO DRUGINCH 1S/C46H65N13O11S2/c1-25(2)38-44(69)56-32(22-35(47)61)41(66)57-33(45(70)59-18-7-11-34(59)43(68)54-29(10-6-17-51-46(49)50)39(64)52-23-36(48)62)24-72-71-19-16-37(63)53-30(21-27-12-14-28(60)15-13-27)40(65)55-31(42(67)58-38)20-26-8-4-3-5-9-26/h3-5,8-9,12-15,25,29-34,38,60H,6-7,10-11,16-24H2,1-2H3,(H2,47,61)(H2,48,62)(H,52,64)(H,53,63)(H,54,68)(H,55,65)(H,56,69)(H,57,66)(H,58,67)(H4,49,50,51)/t29-,30+,31+,32+,33+,34+,38+/m1/s1 D0Y0SO DRUGINKE KEBRFHAVFOSSOX-WSFLLCRESA-N D0Y0SO DRUGSMIL CC(C)C1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N D0Y0SO HIGHSTAT Investigative D0Y0UV DRUG__ID D0Y0UV D0Y0UV DRUGTYPE Small molecular drug D0Y0UV DRUGINCH 1S/C20H16N2OS/c1-14-8-2-3-9-15(14)21-20(23)22-16-10-4-6-12-18(16)24-19-13-7-5-11-17(19)22/h2-13H,1H3,(H,21,23) D0Y0UV DRUGINKE ZYTFFKKLLJLEPW-UHFFFAOYSA-N D0Y0UV DRUGSMIL CC1=CC=CC=C1NC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0Y0UV HIGHSTAT Investigative D0Y0VQ DRUG__ID D0Y0VQ D0Y0VQ DRUGTYPE Small molecular drug D0Y0VQ DRUGINCH 1S/C36H56N2O2/c1-3-35(31-17-15-19-33(39)27-31)21-9-13-25-37(29-35)23-11-7-5-6-8-12-24-38-26-14-10-22-36(4-2,30-38)32-18-16-20-34(40)28-32/h15-20,27-28,39-40H,3-14,21-26,29-30H2,1-2H3/t35-,36-/m1/s1 D0Y0VQ DRUGINKE XFXBGPOUAKCCMC-LQFQNGICSA-N D0Y0VQ DRUGSMIL CCC1(CCCCN(C1)CCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0Y0VQ HIGHSTAT Investigative D0Y0XQ DRUG__ID D0Y0XQ D0Y0XQ DRUGTYPE Small molecular drug D0Y0XQ DRUGINCH 1S/C9H5NO4/c11-7-4-2-1-3-5(9(13)14)6(4)10-8(7)12/h1-3H,(H,13,14)(H,10,11,12) D0Y0XQ DRUGINKE ROODQCZSWXEDJL-UHFFFAOYSA-N D0Y0XQ DRUGSMIL C1=CC2=C(C(=C1)C(=O)O)NC(=O)C2=O D0Y0XQ HIGHSTAT Investigative D0Y1CJ DRUG__ID D0Y1CJ D0Y1CJ DRUGTYPE Small molecular drug D0Y1CJ DRUGINCH 1S/C19H19NO4/c1-4-23-13-6-5-7-14(10-13)24-17-8-9-20-16-12-19(22-3)18(21-2)11-15(16)17/h5-12H,4H2,1-3H3 D0Y1CJ DRUGINKE PKUBIFVLLLNKCO-UHFFFAOYSA-N D0Y1CJ DRUGSMIL CCOC1=CC(=CC=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC D0Y1CJ HIGHSTAT Investigative D0Y1DR DRUG__ID D0Y1DR D0Y1DR DRUGTYPE Small molecular drug D0Y1DR DRUGINCH 1S/C17H16N6O/c1-2-12(9-13-11(1)3-4-18-13)15-21-16-14(19-10-20-16)17(22-15)23-5-7-24-8-6-23/h1-4,9-10,18H,5-8H2,(H,19,20,21,22) D0Y1DR DRUGINKE LYJKHCYTQHFQLX-UHFFFAOYSA-N D0Y1DR DRUGSMIL C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC5=C(C=C4)C=CN5 D0Y1DR HIGHSTAT Investigative D0Y1EX DRUG__ID D0Y1EX D0Y1EX DRUGTYPE Small molecular drug D0Y1EX DRUGINCH 1S/C21H28N2S.ClH/c1-3-21-9-5-6-17-7-8-19(24-4-2)18(20(17)21)12-16(13-21)14-23-11-10-22-15-23;/h7-8,10-11,15-16H,3-6,9,12-14H2,1-2H3;1H/t16-,21-;/m1./s1 D0Y1EX DRUGINKE CQCWQGXXUFLLAL-KTWHHOSASA-N D0Y1EX DRUGSMIL CCC12CCCC3=C1C(=C(C=C3)SCC)CC(C2)CN4C=CN=C4.Cl D0Y1EX HIGHSTAT Investigative D0Y1GL DRUG__ID D0Y1GL D0Y1GL DRUGTYPE Small molecular drug D0Y1GL DRUGINCH 1S/C12H12N2O/c1-15-11-4-2-3-9-8-5-6-13-7-10(8)14-12(9)11/h2-4,7,14H,5-6H2,1H3 D0Y1GL DRUGINKE LIUNAKJFUYIJFE-UHFFFAOYSA-N D0Y1GL DRUGSMIL COC1=CC=CC2=C1NC3=C2CCN=C3 D0Y1GL HIGHSTAT Investigative D0Y1GW DRUG__ID D0Y1GW D0Y1GW DRUGTYPE Small molecular drug D0Y1GW DRUGINCH 1S/C15H16O6/c1-5(2)7-8-11(16)19-9(7)10-13(3)14(8,18)4-6-15(13,21-6)12(17)20-10/h6-10,18H,1,4H2,2-3H3/t6-,7+,8-,9-,10-,13-,14-,15+/m1/s1 D0Y1GW DRUGINKE PIMZUZSSNYHVCU-YKWPQBAZSA-N D0Y1GW DRUGSMIL CC(=C)C1C2C3C4(C(C1C(=O)O2)(CC5C4(O5)C(=O)O3)O)C D0Y1GW HIGHSTAT Investigative D0Y1HN DRUG__ID D0Y1HN D0Y1HN DRUGTYPE Small molecular drug D0Y1HN DRUGINCH 1S/C33H38N2O6/c1-4-16-39-25-13-10-23(11-14-25)32-30(33(37)38)26(24-12-15-27-28(17-24)41-20-40-27)18-35(32)19-29(36)34-31-21(5-2)8-7-9-22(31)6-3/h7-15,17,26,30,32H,4-6,16,18-20H2,1-3H3,(H,34,36)(H,37,38)/t26-,30-,32+/m1/s1 D0Y1HN DRUGINKE LQEHCKYYIXQEBM-FUKIBTTHSA-N D0Y1HN DRUGSMIL CCCOC1=CC=C(C=C1)C2C(C(CN2CC(=O)NC3=C(C=CC=C3CC)CC)C4=CC5=C(C=C4)OCO5)C(=O)O D0Y1HN HIGHSTAT Investigative D0Y1IF DRUG__ID D0Y1IF D0Y1IF DRUGTYPE Small molecular drug D0Y1IF DRUGINCH 1S/C31H30N2O4.Na/c34-28(35)20-36-27-18-8-14-23-24(27)15-7-16-25(23)33-19-9-17-26(33)31-32-29(21-10-3-1-4-11-21)30(37-31)22-12-5-2-6-13-22;/h1-6,8,10-14,18,25-26H,7,9,15-17,19-20H2,(H,34,35);/q;+1/p-1/t25-,26-;/m1./s1 D0Y1IF DRUGINKE NRXVVCOCESTRSY-JUJAXGASSA-M D0Y1IF DRUGSMIL C1CC(C2=C(C1)C(=CC=C2)OCC(=O)[O-])N3CCCC3C4=NC(=C(O4)C5=CC=CC=C5)C6=CC=CC=C6.[Na+] D0Y1IF HIGHSTAT Investigative D0Y1JB DRUG__ID D0Y1JB D0Y1JB DRUGTYPE Small molecular drug D0Y1JB DRUGINCH 1S/C10H14O4.2Li/c1-7(2)4-3-5-8(10(13)14)6-9(11)12;;/h6H,1,3-5H2,2H3,(H,11,12)(H,13,14);;/q;2*+1/p-2/b8-6+;; D0Y1JB DRUGINKE GPRQQRASSGZCNY-OVGXCEQFSA-L D0Y1JB DRUGSMIL [Li+].[Li+].CC(=C)CCCC(=CC(=O)[O-])C(=O)[O-] D0Y1JB HIGHSTAT Investigative D0Y1LJ DRUG__ID D0Y1LJ D0Y1LJ DRUGTYPE Small molecular drug D0Y1LJ DRUGINCH 1S/C16H16N2O2S/c17-10-11-18-12-16(14-8-4-5-9-15(14)18)21(19,20)13-6-2-1-3-7-13/h1-9,12H,10-11,17H2 D0Y1LJ DRUGINKE AIHYRVVMMSIZRM-UHFFFAOYSA-N D0Y1LJ DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)C2=CN(C3=CC=CC=C32)CCN D0Y1LJ HIGHSTAT Investigative D0Y1MH DRUG__ID D0Y1MH D0Y1MH DRUGTYPE Small molecular drug D0Y1MH DRUGINCH 1S/C15H12N2O2/c1-9-3-2-4-12-13(9)16-14(17-15(12)19)10-5-7-11(18)8-6-10/h2-8,18H,1H3,(H,16,17,19) D0Y1MH DRUGINKE NIPIEXNSQBQPML-UHFFFAOYSA-N D0Y1MH DRUGSMIL CC1=C2C(=CC=C1)C(=O)NC(=N2)C3=CC=C(C=C3)O D0Y1MH HIGHSTAT Investigative D0Y1MJ DRUG__ID D0Y1MJ D0Y1MJ DRUGTYPE Small molecular drug D0Y1MJ DRUGINCH 1S/C13H18ClN/c1-10(13-4-2-3-9-15-13)11-5-7-12(14)8-6-11/h5-8,10,13,15H,2-4,9H2,1H3 D0Y1MJ DRUGINKE BMRJUXFHOOHDBF-UHFFFAOYSA-N D0Y1MJ DRUGSMIL CC(C1CCCCN1)C2=CC=C(C=C2)Cl D0Y1MJ HIGHSTAT Investigative D0Y1MM DRUG__ID D0Y1MM D0Y1MM DRUGTYPE Small molecular drug D0Y1MM DRUGINCH 1S/C22H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)23-26-21-20-24/h6-7,9-10,12-13,15-16,24H,2-5,8,11,14,17-21H2,1H3,(H,23,25)/b7-6-,10-9-,13-12-,16-15- D0Y1MM DRUGINKE ANMKTCMIIFBOGG-DOFZRALJSA-N D0Y1MM DRUGSMIL CCCCCC=CCC=CCC=CCC=CCCCC(=O)NOCCO D0Y1MM HIGHSTAT Investigative D0Y1NM DRUG__ID D0Y1NM D0Y1NM DRUGTYPE Small molecular drug D0Y1NM DRUGINCH 1S/C15H15NO4S/c1-11(15(17)18)16-21(19,20)14-9-7-13(8-10-14)12-5-3-2-4-6-12/h2-11,16H,1H3,(H,17,18)/t11-/m1/s1 D0Y1NM DRUGINKE KXVXZFCETOKHTC-LLVKDONJSA-N D0Y1NM DRUGSMIL CC(C(=O)O)NS(=O)(=O)C1=CC=C(C=C1)C2=CC=CC=C2 D0Y1NM HIGHSTAT Investigative D0Y1RO DRUG__ID D0Y1RO D0Y1RO DRUGTYPE Small molecular drug D0Y1RO DRUGINCH 1S/C9H6INO5/c10-4-1-2-6(5(3-4)8(13)14)11-7(12)9(15)16/h1-3H,(H,11,12)(H,13,14)(H,15,16) D0Y1RO DRUGINKE SHSWHSQPJKMCPN-UHFFFAOYSA-N D0Y1RO DRUGSMIL C1=CC(=C(C=C1I)C(=O)O)NC(=O)C(=O)O D0Y1RO HIGHSTAT Investigative D0Y1SR DRUG__ID D0Y1SR D0Y1SR DRUGTYPE Small molecular drug D0Y1SR DRUGINCH 1S/C32H36N6O4/c1-22-7-6-8-23(2)30(22)42-32(39)38(27-14-13-26(40-4)21-28(27)41-5)29-15-16-33-31(35-29)34-24-9-11-25(12-10-24)37-19-17-36(3)18-20-37/h6-16,21H,17-20H2,1-5H3,(H,33,34,35) D0Y1SR DRUGINKE NBTNHSGBRGTFJS-UHFFFAOYSA-N D0Y1SR DRUGSMIL CC1=C(C(=CC=C1)C)OC(=O)N(C2=C(C=C(C=C2)OC)OC)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5CCN(CC5)C D0Y1SR HIGHSTAT Investigative D0Y1TA DRUG__ID D0Y1TA D0Y1TA DRUGTYPE Small molecular drug D0Y1TA DRUGINCH 1S/C22H22O4/c1-5-7-17-9-11-22(26-16(4)24)20(13-17)18-10-12-21(25-15(3)23)19(14-18)8-6-2/h5-6,9-14H,1-2,7-8H2,3-4H3 D0Y1TA DRUGINKE XNFZWGDLKCJOLJ-UHFFFAOYSA-N D0Y1TA DRUGSMIL CC(=O)OC1=C(C=C(C=C1)C2=C(C=CC(=C2)CC=C)OC(=O)C)CC=C D0Y1TA HIGHSTAT Investigative D0Y1UG DRUG__ID D0Y1UG D0Y1UG DRUGTYPE Small molecular drug D0Y1UG DRUGINCH 1S/C20H20O6/c1-11-14-6-12(10-21)7-15(22-2)19(14)26-18(11)13-8-16(23-3)20(25-5)17(9-13)24-4/h6-10H,1-5H3 D0Y1UG DRUGINKE ABGNFLATGXMICB-UHFFFAOYSA-N D0Y1UG DRUGSMIL CC1=C(OC2=C1C=C(C=C2OC)C=O)C3=CC(=C(C(=C3)OC)OC)OC D0Y1UG HIGHSTAT Investigative D0Y1UL DRUG__ID D0Y1UL D0Y1UL DRUGTYPE Small molecular drug D0Y1UL DRUGINCH 1S/C15H11NO2/c17-11-7-5-10(6-8-11)9-13-12-3-1-2-4-14(12)16-15(13)18/h1-9,17H,(H,16,18)/b13-9+ D0Y1UL DRUGINKE PLAOAGFXNCEZMZ-UKTHLTGXSA-N D0Y1UL DRUGSMIL C1=CC=C2C(=C1)C(=CC3=CC=C(C=C3)O)C(=O)N2 D0Y1UL HIGHSTAT Investigative D0Y1UV DRUG__ID D0Y1UV D0Y1UV DRUGTYPE Small molecular drug D0Y1UV DRUGINCH 1S/C12H19NO2/c1-8-5-11(14-3)10(7-9(2)13)12(6-8)15-4/h5-6,9H,7,13H2,1-4H3 D0Y1UV DRUGINKE CFFJUEYUTHKVMQ-UHFFFAOYSA-N D0Y1UV DRUGSMIL CC1=CC(=C(C(=C1)OC)CC(C)N)OC D0Y1UV HIGHSTAT Investigative D0Y1VB DRUG__ID D0Y1VB D0Y1VB DRUGTYPE Small molecular drug D0Y1VB DRUGINCH 1S/C18H17N3O3S/c1-9-5-10(2)21-18-14(9)15(19)16(25-18)17(22)20-7-11-3-4-12-13(6-11)24-8-23-12/h3-6H,7-8,19H2,1-2H3,(H,20,22) D0Y1VB DRUGINKE AZOGCTMOKNTHIU-UHFFFAOYSA-N D0Y1VB DRUGSMIL CC1=CC(=NC2=C1C(=C(S2)C(=O)NCC3=CC4=C(C=C3)OCO4)N)C D0Y1VB HIGHSTAT Investigative D0Y1VG DRUG__ID D0Y1VG D0Y1VG DRUGTYPE Small molecular drug D0Y1VG DRUGINCH 1S/C33H37N3O7S/c1-33(2)30(31(41)35-28-22-13-7-6-12-21(22)17-25(28)38)36(19-44-33)32(42)29(40)23(16-20-10-4-3-5-11-20)34-27(39)18-43-26-15-9-8-14-24(26)37/h3-15,23,25,28-30,37-38,40H,16-19H2,1-2H3,(H,34,39)(H,35,41)/t23-,25+,28-,29-,30+/m0/s1 D0Y1VG DRUGINKE ZHDZQXHOQVYYCG-OIRZSGMBSA-N D0Y1VG DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)COC3=CC=CC=C3O)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0Y1VG HIGHSTAT Investigative D0Y1WV DRUG__ID D0Y1WV D0Y1WV DRUGTYPE Small molecular drug D0Y1WV DRUGINCH 1S/C7H9NO6/c8-4(7(13)14)1-2(5(9)10)3(1)6(11)12/h1-4H,8H2,(H,9,10)(H,11,12)(H,13,14)/t2-,3-,4+/m1/s1 D0Y1WV DRUGINKE MATPZHBYOVDBLI-JJYYJPOSSA-N D0Y1WV DRUGSMIL C1(C(C1C(=O)O)C(=O)O)C(C(=O)O)N D0Y1WV HIGHSTAT Investigative D0Y1XM DRUG__ID D0Y1XM D0Y1XM DRUGTYPE Small molecular drug D0Y1XM DRUGINCH 1S/C13H20N2O3/c1-2-3-9-12(13(16)14-17)15-18-10-11-7-5-4-6-8-11/h4-8,12,15,17H,2-3,9-10H2,1H3,(H,14,16) D0Y1XM DRUGINKE MTXWGHZYBWXADO-UHFFFAOYSA-N D0Y1XM DRUGSMIL CCCCC(C(=O)NO)NOCC1=CC=CC=C1 D0Y1XM HIGHSTAT Investigative D0Y1XS DRUG__ID D0Y1XS D0Y1XS DRUGTYPE Small molecular drug D0Y1XS DRUGINCH 1S/C17H14O4/c1-10(18)9-20-15-8-7-13-12-5-3-4-6-14(12)17(19)21-16(13)11(15)2/h3-8H,9H2,1-2H3 D0Y1XS DRUGINKE VNVLPLZRLNYOQH-UHFFFAOYSA-N D0Y1XS DRUGSMIL CC1=C(C=CC2=C1OC(=O)C3=CC=CC=C23)OCC(=O)C D0Y1XS HIGHSTAT Investigative D0Y1YR DRUG__ID D0Y1YR D0Y1YR DRUGTYPE Small molecular drug D0Y1YR DRUGINCH 1S/C17H26O4/c1-3-4-5-6-14(18)12-15(19)9-7-13-8-10-16(20)17(11-13)21-2/h8,10-11,14,18,20H,3-7,9,12H2,1-2H3/t14-/m0/s1 D0Y1YR DRUGINKE NLDDIKRKFXEWBK-AWEZNQCLSA-N D0Y1YR DRUGSMIL CCCCCC(CC(=O)CCC1=CC(=C(C=C1)O)OC)O D0Y1YR HIGHSTAT Investigative D0Y1YZ DRUG__ID D0Y1YZ D0Y1YZ DRUGTYPE Small molecular drug D0Y1YZ DRUGINCH 1S/C12H13N3O2/c13-12(16)10-1-3-11(4-2-10)17-8-7-15-6-5-14-9-15/h1-6,9H,7-8H2,(H2,13,16) D0Y1YZ DRUGINKE DVALIYTWWUIPGC-UHFFFAOYSA-N D0Y1YZ DRUGSMIL C1=CC(=CC=C1C(=O)N)OCCN2C=CN=C2 D0Y1YZ HIGHSTAT Investigative D0Y2AK DRUG__ID D0Y2AK D0Y2AK DRUGTYPE Small molecular drug D0Y2AK DRUGINCH 1S/C14H13NO/c1-11(13-8-5-9-15-10-13)14(16)12-6-3-2-4-7-12/h2-11H,1H3 D0Y2AK DRUGINKE NFHIPZYAYZPXJE-UHFFFAOYSA-N D0Y2AK DRUGSMIL CC(C1=CN=CC=C1)C(=O)C2=CC=CC=C2 D0Y2AK HIGHSTAT Investigative D0Y2AM DRUG__ID D0Y2AM D0Y2AM DRUGTYPE Small molecular drug D0Y2AM DRUGINCH 1S/C14H9BrN4O2/c15-9-3-1-4-10(7-9)18-14-13-11(16-8-17-14)5-2-6-12(13)19(20)21/h1-8H,(H,16,17,18) D0Y2AM DRUGINKE CFLDNHCFXUEPKN-UHFFFAOYSA-N D0Y2AM DRUGSMIL C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C(=CC=C3)[N+](=O)[O-] D0Y2AM HIGHSTAT Investigative D0Y2AO DRUG__ID D0Y2AO D0Y2AO DRUGTYPE Small molecular drug D0Y2AO DRUGINCH 1S/C3H4N2S/c4-3-5-1-2-6-3/h1-2H,(H2,4,5) D0Y2AO DRUGINKE RAIPHJJURHTUIC-UHFFFAOYSA-N D0Y2AO DRUGSMIL C1=CSC(=N1)N D0Y2AO HIGHSTAT Investigative D0Y2BD DRUG__ID D0Y2BD D0Y2BD DRUGTYPE Small molecular drug D0Y2BD DRUGINCH 1S/C20H28N2O2/c1-2-3-4-5-6-7-8-18-9-11-20(12-10-18)24-16-19(23)15-22-14-13-21-17-22/h9-14,17H,2-8,15-16H2,1H3 D0Y2BD DRUGINKE CGVPWFIJGMBNPP-UHFFFAOYSA-N D0Y2BD DRUGSMIL CCCCCCCCC1=CC=C(C=C1)OCC(=O)CN2C=CN=C2 D0Y2BD HIGHSTAT Investigative D0Y2BL DRUG__ID D0Y2BL D0Y2BL DRUGTYPE Small molecular drug D0Y2BL DRUGINCH 1S/C9H10N2O2S/c10-4-3-5-1-2-6(12)7-8(5)14-9(13)11-7/h1-2,12H,3-4,10H2,(H,11,13) D0Y2BL DRUGINKE YPLJLRNXOFWVTL-UHFFFAOYSA-N D0Y2BL DRUGSMIL C1=CC(=C2C(=C1CCN)SC(=O)N2)O D0Y2BL HIGHSTAT Investigative D0Y2DW DRUG__ID D0Y2DW D0Y2DW DRUGTYPE Small molecular drug D0Y2DW DRUGINCH 1S/C29H45N5O7/c1-4-19(2)25(18-35)33-29(39)24(17-20-12-14-21(41-3)15-13-20)32-28(38)23(9-6-5-7-11-26(36)34-40)31-27(37)22-10-8-16-30-22/h12-15,18-19,22-25,30,40H,4-11,16-17H2,1-3H3,(H,31,37)(H,32,38)(H,33,39)(H,34,36)/t19-,22?,23+,24-,25-/m1/s1 D0Y2DW DRUGINKE NTGGUMOPMBIWTJ-UIKXIZPHSA-N D0Y2DW DRUGSMIL CCC(C)C(C=O)NC(=O)C(CC1=CC=C(C=C1)OC)NC(=O)C(CCCCCC(=O)NO)NC(=O)C2CCCN2 D0Y2DW HIGHSTAT Investigative D0Y2FF DRUG__ID D0Y2FF D0Y2FF DRUGTYPE Small molecular drug D0Y2FF DRUGINCH 1S/C13H15N3S2/c1-10-4-2-3-5-11(10)6-7-14-12(17)16-13-15-8-9-18-13/h2-5,8-9H,6-7H2,1H3,(H2,14,15,16,17) D0Y2FF DRUGINKE VTSYVNSWDAGAAS-UHFFFAOYSA-N D0Y2FF DRUGSMIL CC1=CC=CC=C1CCNC(=S)NC2=NC=CS2 D0Y2FF HIGHSTAT Investigative D0Y2GE DRUG__ID D0Y2GE D0Y2GE DRUGTYPE Small molecular drug D0Y2GE DRUGINCH 1S/C13H8FN3O/c14-11-6-9(8-15)5-10(7-11)13(18)17-12-3-1-2-4-16-12/h1-7H,(H,16,17,18) D0Y2GE DRUGINKE QSQNDNOCUDDTAZ-UHFFFAOYSA-N D0Y2GE DRUGSMIL C1=CC=NC(=C1)NC(=O)C2=CC(=CC(=C2)C#N)F D0Y2GE HIGHSTAT Investigative D0Y2HI DRUG__ID D0Y2HI D0Y2HI DRUGTYPE Small molecular drug D0Y2HI DRUGINCH 1S/C29H32N4O4/c1-18-12-23(34)13-19(2)24(18)15-25(30)28(36)32-26-14-20-8-6-7-9-21(20)16-33(29(26)37)17-27(35)31-22-10-4-3-5-11-22/h3-13,25-26,34H,14-17,30H2,1-2H3,(H,31,35)(H,32,36)/t25-,26-/m0/s1 D0Y2HI DRUGINKE JYNUREYKNAJNLW-UIOOFZCWSA-N D0Y2HI DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)NC2CC3=CC=CC=C3CN(C2=O)CC(=O)NC4=CC=CC=C4)N)C)O D0Y2HI HIGHSTAT Investigative D0Y2JI DRUG__ID D0Y2JI D0Y2JI DRUGTYPE Small molecular drug D0Y2JI DRUGINCH 1S/C12H16N2S/c1-9-5-3-6-10(2)11(9)14-12-13-7-4-8-15-12/h3,5-6H,4,7-8H2,1-2H3,(H,13,14) D0Y2JI DRUGINKE BPICBUSOMSTKRF-UHFFFAOYSA-N D0Y2JI DRUGSMIL CC1=C(C(=CC=C1)C)NC2=NCCCS2 D0Y2JI HIGHSTAT Investigative D0Y2JY DRUG__ID D0Y2JY D0Y2JY DRUGTYPE Small molecular drug D0Y2JY DRUGINCH 1S/C22H29NO2/c1-15(24)23-11-9-19-18(13-16-5-3-2-4-6-16)14-17-7-8-21-20(22(17)19)10-12-25-21/h7-8,16H,2-6,9-14H2,1H3,(H,23,24) D0Y2JY DRUGINKE MMMAALHYEKMNHU-UHFFFAOYSA-N D0Y2JY DRUGSMIL CC(=O)NCCC1=C(CC2=C1C3=C(C=C2)OCC3)CC4CCCCC4 D0Y2JY HIGHSTAT Investigative D0Y2LJ DRUG__ID D0Y2LJ D0Y2LJ DRUGTYPE Small molecular drug D0Y2LJ DRUGINCH 1S/C19H20O5/c1-10(2)7-13-14(21)8-15(22)18-16(23)9-17(24-19(13)18)11-3-5-12(20)6-4-11/h3-6,8,10,17,20-22H,7,9H2,1-2H3/t17-/m0/s1 D0Y2LJ DRUGINKE ZYVQEHNABDHJGN-KRWDZBQOSA-N D0Y2LJ DRUGSMIL CC(C)CC1=C2C(=C(C=C1O)O)C(=O)CC(O2)C3=CC=C(C=C3)O D0Y2LJ HIGHSTAT Investigative D0Y2OB DRUG__ID D0Y2OB D0Y2OB DRUGTYPE Small molecular drug D0Y2OB DRUGINCH 1S/C17H13NO2/c19-17(16-11-13-6-2-4-8-15(13)20-16)18-10-9-12-5-1-3-7-14(12)18/h1-8,11H,9-10H2 D0Y2OB DRUGINKE NWLAYUVGWMPNSG-UHFFFAOYSA-N D0Y2OB DRUGSMIL C1CN(C2=CC=CC=C21)C(=O)C3=CC4=CC=CC=C4O3 D0Y2OB HIGHSTAT Investigative D0Y2RL DRUG__ID D0Y2RL D0Y2RL DRUGTYPE Small molecular drug D0Y2RL DRUGINCH 1S/C17H14O2S/c1-11-9-13(5-6-15(11)19)17-8-7-16(20-17)12-3-2-4-14(18)10-12/h2-10,18-19H,1H3 D0Y2RL DRUGINKE ICDRVGLMFQWTDX-UHFFFAOYSA-N D0Y2RL DRUGSMIL CC1=C(C=CC(=C1)C2=CC=C(S2)C3=CC(=CC=C3)O)O D0Y2RL HIGHSTAT Investigative D0Y2RM DRUG__ID D0Y2RM D0Y2RM DRUGTYPE Small molecular drug D0Y2RM DRUGINCH 1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1 D0Y2RM DRUGINKE MIKUYHXYGGJMLM-UUOKFMHZSA-N D0Y2RM DRUGSMIL C1=NC2=C(NC(=O)N=C2N1C3C(C(C(O3)CO)O)O)N D0Y2RM HIGHSTAT Investigative D0Y2RR DRUG__ID D0Y2RR D0Y2RR DRUGTYPE Small molecular drug D0Y2RR DRUGINCH 1S/C15H12O5/c16-11(10-3-6-13(18)15(20)8-10)4-1-9-2-5-12(17)14(19)7-9/h1-8,17-20H/b4-1+ D0Y2RR DRUGINKE DOWSJIIZLUFMFM-DAFODLJHSA-N D0Y2RR DRUGSMIL C1=CC(=C(C=C1C=CC(=O)C2=CC(=C(C=C2)O)O)O)O D0Y2RR HIGHSTAT Investigative D0Y2TE DRUG__ID D0Y2TE D0Y2TE DRUGTYPE Small molecular drug D0Y2TE DRUGINCH 1S/C23H28N2O5/c26-23(20-8-10-21(11-9-20)25(27)28)29-17-5-4-14-24-15-12-22(13-16-24)30-18-19-6-2-1-3-7-19/h1-3,6-11,22H,4-5,12-18H2 D0Y2TE DRUGINKE CBYWQHUSTLWEBJ-UHFFFAOYSA-N D0Y2TE DRUGSMIL C1CN(CCC1OCC2=CC=CC=C2)CCCCOC(=O)C3=CC=C(C=C3)[N+](=O)[O-] D0Y2TE HIGHSTAT Investigative D0Y2UR DRUG__ID D0Y2UR D0Y2UR DRUGTYPE Small molecular drug D0Y2UR DRUGINCH 1S/C14H13NO2/c1-15-14(16)17-13-9-5-8-12(10-13)11-6-3-2-4-7-11/h2-10H,1H3,(H,15,16) D0Y2UR DRUGINKE NYOGSYRWQAQOKA-UHFFFAOYSA-N D0Y2UR DRUGSMIL CNC(=O)OC1=CC=CC(=C1)C2=CC=CC=C2 D0Y2UR HIGHSTAT Investigative D0Y2WP DRUG__ID D0Y2WP D0Y2WP DRUGTYPE Small molecular drug D0Y2WP DRUGINCH 1S/C23H24N2O2S/c1-13-11-18(26)19(16-7-5-15(6-8-16)14(2)12-25(3)4)20-17-9-10-28-22(17)23(27)24-21(13)20/h5-11,14,26H,12H2,1-4H3,(H,24,27)/t14-/m0/s1 D0Y2WP DRUGINKE XCFRUAOZMVFDPQ-AWEZNQCLSA-N D0Y2WP DRUGSMIL CC1=CC(=C(C2=C1NC(=O)C3=C2C=CS3)C4=CC=C(C=C4)C(C)CN(C)C)O D0Y2WP HIGHSTAT Investigative D0Y2XY DRUG__ID D0Y2XY D0Y2XY DRUGTYPE Small molecular drug D0Y2XY DRUGINCH 1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7-,11-8-,13-10-,17-14+/t19-/m1/s1 D0Y2XY DRUGINKE ZNHVWPKMFKADKW-ZYBDYUKJSA-N D0Y2XY DRUGSMIL CCCCCC=CCC(C=CC=CCC=CCCCC(=O)O)O D0Y2XY HIGHSTAT Investigative D0Y2YH DRUG__ID D0Y2YH D0Y2YH DRUGTYPE Small molecular drug D0Y2YH DRUGINCH 1S/C20H23Cl2NO/c21-18-10-9-16(12-19(18)22)17(14-24)20-8-4-5-11-23(20)13-15-6-2-1-3-7-15/h1-3,6-7,9-10,12,17,20,24H,4-5,8,11,13-14H2/t17-,20-/m1/s1 D0Y2YH DRUGINKE NRJOAYKSGZHTCR-YLJYHZDGSA-N D0Y2YH DRUGSMIL C1CCN(C(C1)C(CO)C2=CC(=C(C=C2)Cl)Cl)CC3=CC=CC=C3 D0Y2YH HIGHSTAT Investigative D0Y2ZC DRUG__ID D0Y2ZC D0Y2ZC DRUGTYPE Small molecular drug D0Y2ZC DRUGINCH 1S/C21H28N4O3S/c22-17(26)11-13-1-6-16-18(13)19-20(23-12-24-21(19)29-16)28-15-4-2-14(3-5-15)25-7-9-27-10-8-25/h12-15H,1-11H2,(H2,22,26)/t13-,14?,15?/m1/s1 D0Y2ZC DRUGINKE VZOLINZYKOLXAC-WLYUNCDWSA-N D0Y2ZC DRUGSMIL C1CC(CCC1N2CCOCC2)OC3=C4C5=C(CCC5CC(=O)N)SC4=NC=N3 D0Y2ZC HIGHSTAT Investigative D0Y3AV DRUG__ID D0Y3AV D0Y3AV DRUGTYPE Small molecular drug D0Y3AV DRUGINCH 1S/C18H17NO2/c1-3-21-18-10-16(11-19-12-18)14-4-5-15-9-17(20-2)7-6-13(15)8-14/h4-12H,3H2,1-2H3 D0Y3AV DRUGINKE YYDLHEYJRYMTMO-UHFFFAOYSA-N D0Y3AV DRUGSMIL CCOC1=CN=CC(=C1)C2=CC3=C(C=C2)C=C(C=C3)OC D0Y3AV HIGHSTAT Investigative D0Y3BI DRUG__ID D0Y3BI D0Y3BI DRUGTYPE Small molecular drug D0Y3BI DRUGINCH 1S/C15H17NO/c16-10-12-8-9-15(17-12)14-7-3-5-11-4-1-2-6-13(11)14/h1-7,12,15H,8-10,16H2 D0Y3BI DRUGINKE HDLNQDARKJUPIY-UHFFFAOYSA-N D0Y3BI DRUGSMIL C1CC(OC1CN)C2=CC=CC3=CC=CC=C32 D0Y3BI HIGHSTAT Investigative D0Y3DR DRUG__ID D0Y3DR D0Y3DR DRUGTYPE Small molecular drug D0Y3DR DRUGINCH 1S/C19H25NS/c1-2-8-14-20(13-7-1)19(11-5-6-12-19)18-15-16-9-3-4-10-17(16)21-18/h3-4,9-10,15H,1-2,5-8,11-14H2 D0Y3DR DRUGINKE XZXHOFZYYWGLCJ-UHFFFAOYSA-N D0Y3DR DRUGSMIL C1CCCN(CC1)C2(CCCC2)C3=CC4=CC=CC=C4S3 D0Y3DR HIGHSTAT Investigative D0Y3DW DRUG__ID D0Y3DW D0Y3DW DRUGTYPE Small molecular drug D0Y3DW DRUGINCH 1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1/i2T,3T D0Y3DW DRUGINKE ANJTVLIZGCUXLD-ZIAKYUPESA-N D0Y3DW DRUGSMIL C1C2CNCC1C3=CC=CC(=O)N3C2 D0Y3DW HIGHSTAT Investigative D0Y3EG DRUG__ID D0Y3EG D0Y3EG DRUGTYPE Small molecular drug D0Y3EG DRUGINCH 1S/C8H9NO4S/c1-3-2-4(7(10)11)14-6(3)5(9)8(12)13/h2,5H,9H2,1H3,(H,10,11)(H,12,13) D0Y3EG DRUGINKE KOMWRBFEDDEWEP-UHFFFAOYSA-N D0Y3EG DRUGSMIL CC1=C(SC(=C1)C(=O)O)C(C(=O)O)N D0Y3EG HIGHSTAT Investigative D0Y3LO DRUG__ID D0Y3LO D0Y3LO DRUGTYPE Small molecular drug D0Y3LO DRUGINCH 1S/C28H42N4O2/c33-27-17-15-21-23(11-9-13-25(21)31-27)29-19-7-5-3-1-2-4-6-8-20-30-24-12-10-14-26-22(24)16-18-28(34)32-26/h15-18,23-24,29-30H,1-14,19-20H2,(H,31,33)(H,32,34)/t23-,24-/m0/s1 D0Y3LO DRUGINKE CKFAWHBPSZAYLS-ZEQRLZLVSA-N D0Y3LO DRUGSMIL C1CC(C2=C(C1)NC(=O)C=C2)NCCCCCCCCCCNC3CCCC4=C3C=CC(=O)N4 D0Y3LO HIGHSTAT Investigative D0Y3OO DRUG__ID D0Y3OO D0Y3OO DRUGTYPE Small molecular drug D0Y3OO DRUGINCH 1S/C25H19NO3S/c27-21-15-23(26-11-13-28-14-12-26)29-24-17(6-3-9-20(21)24)19-8-4-7-18-16-5-1-2-10-22(16)30-25(18)19/h1-10,15H,11-14H2 D0Y3OO DRUGINKE JAMULYFATHSZJM-UHFFFAOYSA-N D0Y3OO DRUGSMIL C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56 D0Y3OO HIGHSTAT Investigative D0Y3PH DRUG__ID D0Y3PH D0Y3PH DRUGTYPE Small molecular drug D0Y3PH DRUGINCH 1S/C14H8N2O3/c17-6-1-3-9-8(5-6)11-10(15-9)4-2-7-12(11)14(19)16-13(7)18/h1-5,15,17H,(H,16,18,19) D0Y3PH DRUGINKE IJHAYZZOYYQESB-UHFFFAOYSA-N D0Y3PH DRUGSMIL C1=CC2=C(C=C1O)C3=C(N2)C=CC4=C3C(=O)NC4=O D0Y3PH HIGHSTAT Investigative D0Y3PV DRUG__ID D0Y3PV D0Y3PV DRUGTYPE Small molecular drug D0Y3PV DRUGINCH 1S/C17H15NO/c19-17-8-4-7-16-15(17)12-11-14(18-16)10-9-13-5-2-1-3-6-13/h1-3,5-6,11-12,17,19H,4,7-8H2 D0Y3PV DRUGINKE VUDNTKZUIAXLLZ-UHFFFAOYSA-N D0Y3PV DRUGSMIL C1CC(C2=C(C1)N=C(C=C2)C#CC3=CC=CC=C3)O D0Y3PV HIGHSTAT Investigative D0Y3TU DRUG__ID D0Y3TU D0Y3TU DRUGTYPE Small molecular drug D0Y3TU DRUGINCH 1S/C10H9N5/c11-9-8-5-3-4-13-6(5)1-2-7(8)14-10(12)15-9/h1-4H,11H2,(H3,12,14,15) D0Y3TU DRUGINKE TYJMBWNFQVCGFT-UHFFFAOYSA-N D0Y3TU DRUGSMIL C1=C2C(=C(N=C(N2)N)N)C3=CC=NC3=C1 D0Y3TU HIGHSTAT Investigative D0Y3TZ DRUG__ID D0Y3TZ D0Y3TZ DRUGTYPE Small molecular drug D0Y3TZ DRUGINCH 1S/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12) D0Y3TZ DRUGINKE LNTHITQWFMADLM-UHFFFAOYSA-N D0Y3TZ DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)O D0Y3TZ HIGHSTAT Investigative D0Y3UL DRUG__ID D0Y3UL D0Y3UL DRUGTYPE Small molecular drug D0Y3UL DRUGINCH 1S/C13H19N/c1-10-6-11(2)8-13(7-10)12-4-3-5-14-9-12/h6-8,12,14H,3-5,9H2,1-2H3 D0Y3UL DRUGINKE KCTMOZHTZAFYSJ-UHFFFAOYSA-N D0Y3UL DRUGSMIL CC1=CC(=CC(=C1)C2CCCNC2)C D0Y3UL HIGHSTAT Investigative D0Y3UT DRUG__ID D0Y3UT D0Y3UT DRUGTYPE Small molecular drug D0Y3UT DRUGINCH 1S/C18H15N3O/c1-13-6-5-9-17(20-13)21-18(22)16-11-10-15(12-19-16)14-7-3-2-4-8-14/h2-12H,1H3,(H,20,21,22) D0Y3UT DRUGINKE RDRCRZMPPOKVOV-UHFFFAOYSA-N D0Y3UT DRUGSMIL CC1=NC(=CC=C1)NC(=O)C2=NC=C(C=C2)C3=CC=CC=C3 D0Y3UT HIGHSTAT Investigative D0Y3VE DRUG__ID D0Y3VE D0Y3VE DRUGTYPE Small molecular drug D0Y3VE DRUGINCH 1S/C15H12N2/c1-11-4-2-5-12(8-11)13-9-15-14(17-10-13)6-3-7-16-15/h2-10H,1H3 D0Y3VE DRUGINKE OICHXALTVOUDOG-UHFFFAOYSA-N D0Y3VE DRUGSMIL CC1=CC(=CC=C1)C2=CC3=C(C=CC=N3)N=C2 D0Y3VE HIGHSTAT Investigative D0Y3WN DRUG__ID D0Y3WN D0Y3WN DRUGTYPE Small molecular drug D0Y3WN DRUGINCH 1S/C17H24N2O16P4/c1-11-12(2)16(19-9-8-15(20)18-17(19)21)31-14(11)10-30-36(22,23)33-38(26,27)35-39(28,29)34-37(24,25)32-13-6-4-3-5-7-13/h3-9,11-12,14,16H,10H2,1-2H3,(H,22,23)(H,24,25)(H,26,27)(H,28,29)(H,18,20,21)/t11-,12+,14+,16+/m0/s1 D0Y3WN DRUGINKE ACRDMMYBLHHSSD-KLZCAUPSSA-N D0Y3WN DRUGSMIL CC1C(C(OC1COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC2=CC=CC=C2)N3C=CC(=O)NC3=O)C D0Y3WN HIGHSTAT Investigative D0Y3XR DRUG__ID D0Y3XR D0Y3XR DRUGTYPE Small molecular drug D0Y3XR DRUGINCH 1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)4-6-2-1-3-8-5-6/h1-3,5,7H,4H2,(H2,9,10,11)(H2,12,13,14) D0Y3XR DRUGINKE KZMOFWIRXNQJET-UHFFFAOYSA-N D0Y3XR DRUGSMIL C1=CC(=CN=C1)CC(P(=O)(O)O)P(=O)(O)O D0Y3XR HIGHSTAT Investigative D0Y4AS DRUG__ID D0Y4AS D0Y4AS DRUGTYPE Small molecular drug D0Y4AS DRUGINCH 1S/C6H12N2/c1-2-8-5-3-7(1)4-6-8/h1-6H2 D0Y4AS DRUGINKE IMNIMPAHZVJRPE-UHFFFAOYSA-N D0Y4AS DRUGSMIL C1CN2CCN1CC2 D0Y4AS HIGHSTAT Investigative D0Y4BL DRUG__ID D0Y4BL D0Y4BL DRUGTYPE Small molecular drug D0Y4BL DRUGINCH 1S/C26H32N6O2/c1-31(2)17-24(33)32-12-10-18(11-13-32)20-8-9-23(22(14-20)19-6-4-3-5-7-19)30-26(34)25-28-16-21(15-27)29-25/h6,8-9,14,16,18H,3-5,7,10-13,17H2,1-2H3,(H,28,29)(H,30,34) D0Y4BL DRUGINKE GUBJNPWVIUFSTR-UHFFFAOYSA-N D0Y4BL DRUGSMIL CN(C)CC(=O)N1CCC(CC1)C2=CC(=C(C=C2)NC(=O)C3=NC=C(N3)C#N)C4=CCCCC4 D0Y4BL HIGHSTAT Investigative D0Y4CC DRUG__ID D0Y4CC D0Y4CC DRUGTYPE Small molecular drug D0Y4CC DRUGINCH 1S/C15H13N5O/c16-15(17)20-14(21)10-7-5-9(6-8-10)13-18-11-3-1-2-4-12(11)19-13/h1-8H,(H,18,19)(H4,16,17,20,21) D0Y4CC DRUGINKE RAYGWMJYTDFZDD-UHFFFAOYSA-N D0Y4CC DRUGSMIL C1=CC=C2C(=C1)NC(=N2)C3=CC=C(C=C3)C(=O)N=C(N)N D0Y4CC HIGHSTAT Investigative D0Y4EW DRUG__ID D0Y4EW D0Y4EW DRUGTYPE Small molecular drug D0Y4EW DRUGINCH 1S/C61H100N22O15/c1-34(75-47(87)32-74-59(98)49(36(3)85)83-57(96)44(29-38-18-8-5-9-19-38)77-48(88)31-72-46(86)30-73-53(92)39(64)28-37-16-6-4-7-17-37)51(90)79-43(23-15-27-71-61(68)69)55(94)81-41(21-11-13-25-63)56(95)82-45(33-84)58(97)76-35(2)52(91)80-42(22-14-26-70-60(66)67)54(93)78-40(50(65)89)20-10-12-24-62/h4-9,16-19,34-36,39-45,49,84-85H,10-15,20-33,62-64H2,1-3H3,(H2,65,89)(H,72,86)(H,73,92)(H,74,98)(H,75,87)(H,76,97)(H,77,88)(H,78,93)(H,79,90)(H,80,91)(H,81,94)(H,82,95)(H,83,96)(H4,66,67,70)(H4,68,69,71)/t34-,35-,36+,39-,40-,41-,42-,43-,44-,45-,49-/m0/s1 D0Y4EW DRUGINKE RHMALYOXPBRJBG-CGUXNFSNSA-N D0Y4EW DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0Y4EW HIGHSTAT Investigative D0Y4GL DRUG__ID D0Y4GL D0Y4GL DRUGTYPE Small molecular drug D0Y4GL DRUGINCH 1S/C19H20N2O4S/c1-20-17-8-7-15(9-16(17)13-26(20,23)24)18-11-21(19(22)12-25-18)10-14-5-3-2-4-6-14/h2-9,18H,10-13H2,1H3/t18-/m1/s1 D0Y4GL DRUGINKE CIUMOGWIMXNXSQ-GOSISDBHSA-N D0Y4GL DRUGSMIL CN1C2=C(CS1(=O)=O)C=C(C=C2)C3CN(C(=O)CO3)CC4=CC=CC=C4 D0Y4GL HIGHSTAT Investigative D0Y4HL DRUG__ID D0Y4HL D0Y4HL DRUGTYPE Small molecular drug D0Y4HL DRUGINCH 1S/C46H64N12O12S2/c1-24(2)17-30(40(64)51-21-38(50)62)56-45(69)35-9-6-16-58(35)46(70)34-23-72-71-22-28(47)39(63)53-31(19-26-10-12-27(59)13-11-26)43(67)54-32(18-25-7-4-3-5-8-25)42(66)52-29(14-15-36(48)60)41(65)55-33(20-37(49)61)44(68)57-34/h3-5,7-8,10-13,24,28-35,59H,6,9,14-23,47H2,1-2H3,(H2,48,60)(H2,49,61)(H2,50,62)(H,51,64)(H,52,66)(H,53,63)(H,54,67)(H,55,65)(H,56,69)(H,57,68)/t28-,29-,30-,31-,32-,33-,34-,35-/m0/s1 D0Y4HL DRUGINKE WTHKESHUHBGMGM-DZCXQCEKSA-N D0Y4HL DRUGSMIL CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N D0Y4HL HIGHSTAT Investigative D0Y4JQ DRUG__ID D0Y4JQ D0Y4JQ DRUGTYPE Small molecular drug D0Y4JQ DRUGINCH 1S/C14H16N2O/c17-14(13-9-5-10-15-13)16-11-4-8-12-6-2-1-3-7-12/h1-3,5-7,9-10,15H,4,8,11H2,(H,16,17) D0Y4JQ DRUGINKE FQRIYWSUESDLNK-UHFFFAOYSA-N D0Y4JQ DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C2=CC=CN2 D0Y4JQ HIGHSTAT Investigative D0Y4KJ DRUG__ID D0Y4KJ D0Y4KJ DRUGTYPE Small molecular drug D0Y4KJ DRUGINCH 1S/C22H18N2OS/c23-22(24)21-13-18-12-17(8-11-20(18)26-21)16-6-9-19(10-7-16)25-14-15-4-2-1-3-5-15/h1-13H,14H2,(H3,23,24) D0Y4KJ DRUGINKE VZVHZNRYOZAOJD-UHFFFAOYSA-N D0Y4KJ DRUGSMIL C1=CC=C(C=C1)COC2=CC=C(C=C2)C3=CC4=C(C=C3)SC(=C4)C(=N)N D0Y4KJ HIGHSTAT Investigative D0Y4MC DRUG__ID D0Y4MC D0Y4MC DRUGTYPE Small molecular drug D0Y4MC DRUGINCH 1S/C23H27FN4O3/c1-14-18(23(30)28-13-17(29)3-5-21(28)25-14)8-11-27-9-6-15(7-10-27)22-19-4-2-16(24)12-20(19)31-26-22/h2,4,12,15,17,29H,3,5-11,13H2,1H3 D0Y4MC DRUGINKE ABWPQNZPAOAQSG-UHFFFAOYSA-N D0Y4MC DRUGSMIL CC1=C(C(=O)N2CC(CCC2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F D0Y4MC HIGHSTAT Investigative D0Y4MD DRUG__ID D0Y4MD D0Y4MD DRUGTYPE Small molecular drug D0Y4MD DRUGINCH 1S/C11H16N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h4,7-9,14-15H,2-3,5H2,1H3,(H,12,16,17)/t7-,8+,9+/m0/s1 D0Y4MD DRUGINKE XACKNLSZYYIACO-DJLDLDEBSA-N D0Y4MD DRUGSMIL CCC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O D0Y4MD HIGHSTAT Investigative D0Y4NJ DRUG__ID D0Y4NJ D0Y4NJ DRUGTYPE Small molecular drug D0Y4NJ DRUGINCH 1S/C28H28N2O3S/c1-18(2)29-13-15-30(16-14-29)21-7-3-19(4-8-21)27(33)26-24-12-11-23(32)17-25(24)34-28(26)20-5-9-22(31)10-6-20/h3-12,17-18,31-32H,13-16H2,1-2H3 D0Y4NJ DRUGINKE LQEOPHGPHCWOAC-UHFFFAOYSA-N D0Y4NJ DRUGSMIL CC(C)N1CCN(CC1)C2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O D0Y4NJ HIGHSTAT Investigative D0Y4SD DRUG__ID D0Y4SD D0Y4SD DRUGTYPE Small molecular drug D0Y4SD DRUGINCH 1S/C16H13N3OS/c17-13-7-6-12(16-18-8-9-21-16)10-14(13)19-15(20)11-4-2-1-3-5-11/h1-10H,17H2,(H,19,20) D0Y4SD DRUGINKE FHTINQMYYLCTSM-UHFFFAOYSA-N D0Y4SD DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=NC=CS3)N D0Y4SD HIGHSTAT Investigative D0Y4SO DRUG__ID D0Y4SO D0Y4SO DRUGTYPE Small molecular drug D0Y4SO DRUGINCH 1S/C31H32N4/c1(2-4-10-20-34-28-14-8-6-12-24(28)26-16-18-32-22-30(26)34)3-5-11-21-35-29-15-9-7-13-25(29)27-17-19-33-23-31(27)35/h6-9,12-19,22-23H,1-5,10-11,20-21H2 D0Y4SO DRUGINKE JJAATQLWMKLMJU-UHFFFAOYSA-N D0Y4SO DRUGSMIL C1=CC=C2C(=C1)C3=C(N2CCCCCCCCCN4C5=CC=CC=C5C6=C4C=NC=C6)C=NC=C3 D0Y4SO HIGHSTAT Investigative D0Y4SP DRUG__ID D0Y4SP D0Y4SP DRUGTYPE Small molecular drug D0Y4SP DRUGINCH 1S/C34H46N4O6S/c1-5-17-38(18-6-2)29(21-26-12-14-27(39)15-13-26)32(41)36-23-31(40)35-16-19-45-30(22-25-10-8-7-9-11-25)33(42)37-28(34(43)44)20-24(3)4/h5-15,24,28-30,39H,1-2,16-23H2,3-4H3,(H,35,40)(H,36,41)(H,37,42)(H,43,44)/t28-,29-,30-/m0/s1 D0Y4SP DRUGINKE CZRZYRKTYLLLRL-DTXPUJKBSA-N D0Y4SP DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)SCCNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N(CC=C)CC=C D0Y4SP HIGHSTAT Investigative D0Y4SQ DRUG__ID D0Y4SQ D0Y4SQ DRUGTYPE Small molecular drug D0Y4SQ DRUGINCH 1S/C14H12N2O3/c17-12-7-3-1-5-10(12)9-15-16-14(19)11-6-2-4-8-13(11)18/h1-9,17-18H,(H,16,19)/b15-9+ D0Y4SQ DRUGINKE OMCYEZUIYGPHDJ-OQLLNIDSSA-N D0Y4SQ DRUGSMIL C1=CC=C(C(=C1)C=NNC(=O)C2=CC=CC=C2O)O D0Y4SQ HIGHSTAT Investigative D0Y4TE DRUG__ID D0Y4TE D0Y4TE DRUGTYPE Small molecular drug D0Y4TE DRUGINCH 1S/C18H16N2O4/c1-22-13-4-2-12(3-5-13)18(20-7-6-19-10-20)14-8-16-17(9-15(14)21)24-11-23-16/h2-10,18,21H,11H2,1H3 D0Y4TE DRUGINKE SLZWZNUKPMKGCR-UHFFFAOYSA-N D0Y4TE DRUGSMIL COC1=CC=C(C=C1)C(C2=CC3=C(C=C2O)OCO3)N4C=CN=C4 D0Y4TE HIGHSTAT Investigative D0Y4TF DRUG__ID D0Y4TF D0Y4TF DRUGTYPE Small molecular drug D0Y4TF DRUGINCH 1S/C5H10O3/c6-4-2-1-3-5(7)8/h6H,1-4H2,(H,7,8) D0Y4TF DRUGINKE PHOJOSOUIAQEDH-UHFFFAOYSA-N D0Y4TF DRUGSMIL C(CCO)CC(=O)O D0Y4TF HIGHSTAT Investigative D0Y4UG DRUG__ID D0Y4UG D0Y4UG DRUGTYPE Small molecular drug D0Y4UG DRUGINCH 1S/C14H17FO3/c15-11-6-7-13(18-9-14(16)17)12(8-11)10-4-2-1-3-5-10/h6-8,10H,1-5,9H2,(H,16,17) D0Y4UG DRUGINKE QBBFFBYIFRGECW-UHFFFAOYSA-N D0Y4UG DRUGSMIL C1CCC(CC1)C2=C(C=CC(=C2)F)OCC(=O)O D0Y4UG HIGHSTAT Investigative D0Y4WH DRUG__ID D0Y4WH D0Y4WH DRUGTYPE Small molecular drug D0Y4WH DRUGINCH 1S/C18H18N2O2S/c21-23(22,15-6-2-1-3-7-15)18-13-20(14-10-11-19-12-14)17-9-5-4-8-16(17)18/h1-9,13-14,19H,10-12H2 D0Y4WH DRUGINKE RLICEYAZXFQQMC-UHFFFAOYSA-N D0Y4WH DRUGSMIL C1CNCC1N2C=C(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4 D0Y4WH HIGHSTAT Investigative D0Y4WI DRUG__ID D0Y4WI D0Y4WI DRUGTYPE Small molecular drug D0Y4WI DRUGINCH 1S/C25H29ClN4O3/c1-2-20-5-3-4-13-29(20)14-12-27-23(31)18-8-11-21-22(15-18)28-25(33)30(24(21)32)16-17-6-9-19(26)10-7-17/h6-11,15,20H,2-5,12-14,16H2,1H3,(H,27,31)(H,28,33) D0Y4WI DRUGINKE FKCDNDBJVOQPJB-UHFFFAOYSA-N D0Y4WI DRUGSMIL CCC1CCCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl D0Y4WI HIGHSTAT Investigative D0Y4YV DRUG__ID D0Y4YV D0Y4YV DRUGTYPE Small molecular drug D0Y4YV DRUGINCH 1S/C24H32O6/c1-13-9-15-11-17(25-3)21(27-5)23(29-7)19(15)20-16(10-14(13)2)12-18(26-4)22(28-6)24(20)30-8/h11-14H,9-10H2,1-8H3/t13-,14+ D0Y4YV DRUGINKE JEJFTTRHGBKKEI-OKILXGFUSA-N D0Y4YV DRUGSMIL CC1CC2=CC(=C(C(=C2C3=C(C(=C(C=C3CC1C)OC)OC)OC)OC)OC)OC D0Y4YV HIGHSTAT Investigative D0Y5CG DRUG__ID D0Y5CG D0Y5CG DRUGTYPE Small molecular drug D0Y5CG DRUGINCH 1S/C17H19FN2O/c18-15-5-3-6-16(12-15)21-13-14-4-1-2-7-17(14)20-10-8-19-9-11-20/h1-7,12,19H,8-11,13H2 D0Y5CG DRUGINKE IGKKFJKUWPDJDR-UHFFFAOYSA-N D0Y5CG DRUGSMIL C1CN(CCN1)C2=CC=CC=C2COC3=CC(=CC=C3)F D0Y5CG HIGHSTAT Investigative D0Y5IQ DRUG__ID D0Y5IQ D0Y5IQ DRUGTYPE Small molecular drug D0Y5IQ DRUGINCH 1S/C58H95N9O16/c1-30(2)25-38(43(69)29-45(71)64-46(36(12)68)52(74)60-35(11)54(76)66(15)42(27-37-21-18-17-19-22-37)55(77)67-24-20-23-41(67)56(78)81-16)61-51(73)40(28-44(59)70)62-50(72)39(26-31(3)4)63-53(75)48(33(7)8)82-58(80)49(34(9)10)83-57(79)47(32(5)6)65(13)14/h17-19,21-22,30-36,38-43,46-49,68-69H,20,23-29H2,1-16H3,(H2,59,70)(H,60,74)(H,61,73)(H,62,72)(H,63,75)(H,64,71)/t35-,36+,38-,39-,40-,41-,42+,43-,46-,47-,48+,49-/m0/s1 D0Y5IQ DRUGINKE JZYWSTGTBRHGTL-BIXXXADNSA-N D0Y5IQ DRUGSMIL CC(C)CC(C(CC(=O)NC(C(C)O)C(=O)NC(C)C(=O)N(C)C(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)OC)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)OC(=O)C(C(C)C)OC(=O)C(C(C)C)N(C)C D0Y5IQ HIGHSTAT Investigative D0Y5IW DRUG__ID D0Y5IW D0Y5IW DRUGTYPE Small molecular drug D0Y5IW DRUGINCH 1S/C22H24N4O4/c1-3-23-11-19(27)25-13-5-7-15-17(9-13)22(30)18-10-14(6-8-16(18)21(15)29)26-20(28)12-24-4-2/h5-10,23-24H,3-4,11-12H2,1-2H3,(H,25,27)(H,26,28) D0Y5IW DRUGINKE DJJHCFWUEPEODX-UHFFFAOYSA-N D0Y5IW DRUGSMIL CCNCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CNCC D0Y5IW HIGHSTAT Investigative D0Y5JB DRUG__ID D0Y5JB D0Y5JB DRUGTYPE Small molecular drug D0Y5JB DRUGINCH 1S/C14H16N6O3/c1-21-7-5-4-6(9(22-2)10(7)23-3)12-17-8-11(15)18-14(16)20-13(8)19-12/h4-5H,1-3H3,(H5,15,16,17,18,19,20) D0Y5JB DRUGINKE PMHAERKHAISVTI-UHFFFAOYSA-N D0Y5JB DRUGSMIL COC1=C(C(=C(C=C1)C2=NC3=NC(=NC(=C3N2)N)N)OC)OC D0Y5JB HIGHSTAT Investigative D0Y5KJ DRUG__ID D0Y5KJ D0Y5KJ DRUGTYPE Small molecular drug D0Y5KJ DRUGINCH 1S/C15H11NO2/c1-10-4-5-14-12(7-10)13(17)8-15(18-14)11-3-2-6-16-9-11/h2-9H,1H3 D0Y5KJ DRUGINKE KPZRGUDQIYLPKX-UHFFFAOYSA-N D0Y5KJ DRUGSMIL CC1=CC2=C(C=C1)OC(=CC2=O)C3=CN=CC=C3 D0Y5KJ HIGHSTAT Investigative D0Y5KN DRUG__ID D0Y5KN D0Y5KN DRUGTYPE Small molecular drug D0Y5KN DRUGINCH 1S/C18H23NO6/c1-3-11(2)19-18(21)25-14-10-23-15-13(9-22-16(14)15)24-17(20)12-7-5-4-6-8-12/h4-8,11,13-16H,3,9-10H2,1-2H3,(H,19,21)/t11?,13-,14+,15-,16-/m1/s1 D0Y5KN DRUGINKE PEHJQBISUGKFJH-IXCHPVQKSA-N D0Y5KN DRUGSMIL CCC(C)NC(=O)OC1COC2C1OCC2OC(=O)C3=CC=CC=C3 D0Y5KN HIGHSTAT Investigative D0Y5KX DRUG__ID D0Y5KX D0Y5KX DRUGTYPE Small molecular drug D0Y5KX DRUGINCH 1S/C18H16N2/c19-18-7-5-17(6-8-18)16-3-1-14(2-4-16)13-15-9-11-20-12-10-15/h1-12H,13,19H2 D0Y5KX DRUGINKE DFRORZVGCQQRJH-UHFFFAOYSA-N D0Y5KX DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC=C(C=C3)N D0Y5KX HIGHSTAT Investigative D0Y5LJ DRUG__ID D0Y5LJ D0Y5LJ DRUGTYPE Small molecular drug D0Y5LJ DRUGINCH 1S/C22H23NO2/c24-22(20-12-7-17-25-20)13-15-23(16-14-22)21(18-8-3-1-4-9-18)19-10-5-2-6-11-19/h1-12,17,21,24H,13-16H2 D0Y5LJ DRUGINKE RANYWKODIKNHDB-UHFFFAOYSA-N D0Y5LJ DRUGSMIL C1CN(CCC1(C2=CC=CO2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0Y5LJ HIGHSTAT Investigative D0Y5LX DRUG__ID D0Y5LX D0Y5LX DRUGTYPE Small molecular drug D0Y5LX DRUGINCH 1S/C14H19N3/c1-2-6-12-9-13(17-14(10-15)16-12)11-7-4-3-5-8-11/h9,11H,2-8H2,1H3 D0Y5LX DRUGINKE WGTHPYHNMKDPLN-UHFFFAOYSA-N D0Y5LX DRUGSMIL CCCC1=CC(=NC(=N1)C#N)C2CCCCC2 D0Y5LX HIGHSTAT Investigative D0Y5MR DRUG__ID D0Y5MR D0Y5MR DRUGTYPE Small molecular drug D0Y5MR DRUGINCH 1S/C20H24FNO3/c1-3-5-14-24-16-12-10-15(11-13-16)18(4-2)22-20(23)25-19-9-7-6-8-17(19)21/h6-13,18H,3-5,14H2,1-2H3,(H,22,23) D0Y5MR DRUGINKE GDLJXVIFSNBWKP-UHFFFAOYSA-N D0Y5MR DRUGSMIL CCCCOC1=CC=C(C=C1)C(CC)NC(=O)OC2=CC=CC=C2F D0Y5MR HIGHSTAT Investigative D0Y5MS DRUG__ID D0Y5MS D0Y5MS DRUGTYPE Small molecular drug D0Y5MS DRUGINCH 1S/C15H17BrN4O3/c1-23-14-3-2-10(6-12(14)16)7-13(20-22)15(21)18-5-4-11-8-17-9-19-11/h2-3,6,8-9,22H,4-5,7H2,1H3,(H,17,19)(H,18,21)/b20-13+ D0Y5MS DRUGINKE MFMMJKGZEGTTSV-DEDYPNTBSA-N D0Y5MS DRUGSMIL COC1=C(C=C(C=C1)CC(=NO)C(=O)NCCC2=CN=CN2)Br D0Y5MS HIGHSTAT Investigative D0Y5OB DRUG__ID D0Y5OB D0Y5OB DRUGTYPE Small molecular drug D0Y5OB DRUGINCH 1S/C15H8F2OS/c16-10-3-1-9(2-4-10)13-8-15(19)12-6-5-11(17)7-14(12)18-13/h1-8H D0Y5OB DRUGINKE JDKXGUUVCBWLSB-UHFFFAOYSA-N D0Y5OB DRUGSMIL C1=CC(=CC=C1C2=CC(=S)C3=C(O2)C=C(C=C3)F)F D0Y5OB HIGHSTAT Investigative D0Y5QR DRUG__ID D0Y5QR D0Y5QR DRUGTYPE Small molecular drug D0Y5QR DRUGINCH 1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18-/m1/s1 D0Y5QR DRUGINKE BKRGVLQUQGGVSM-RDTXWAMCSA-N D0Y5QR DRUGSMIL CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C D0Y5QR HIGHSTAT Investigative D0Y5RO DRUG__ID D0Y5RO D0Y5RO DRUGTYPE Small molecular drug D0Y5RO DRUGINCH 1S/C18H22N6O3S/c19-28(25,26)14-8-6-13(7-9-14)22-18-23-16-15(20-11-21-16)17(24-18)27-10-12-4-2-1-3-5-12/h6-9,11-12H,1-5,10H2,(H2,19,25,26)(H2,20,21,22,23,24) D0Y5RO DRUGINKE OWXORKPNCHJYOF-UHFFFAOYSA-N D0Y5RO DRUGSMIL C1CCC(CC1)COC2=NC(=NC3=C2NC=N3)NC4=CC=C(C=C4)S(=O)(=O)N D0Y5RO HIGHSTAT Investigative D0Y5SB DRUG__ID D0Y5SB D0Y5SB DRUGTYPE Small molecular drug D0Y5SB DRUGINCH 1S/C9H7NO5/c11-7(9(14)15)10-6-4-2-1-3-5(6)8(12)13/h1-4H,(H,10,11)(H,12,13)(H,14,15) D0Y5SB DRUGINKE QBYNNSFEMMNINN-UHFFFAOYSA-N D0Y5SB DRUGSMIL C1=CC=C(C(=C1)C(=O)O)NC(=O)C(=O)O D0Y5SB HIGHSTAT Investigative D0Y5TF DRUG__ID D0Y5TF D0Y5TF DRUGTYPE Small molecular drug D0Y5TF DRUGINCH 1S/C35H43N5O5/c1-3-25-12-7-9-22(2)27(25)21-30(33(43)38-29(32(37)42)20-23-10-5-4-6-11-23)39-34(44)31-13-8-18-40(31)35(45)28(36)19-24-14-16-26(41)17-15-24/h4-7,9-12,14-17,28-31,41H,3,8,13,18-21,36H2,1-2H3,(H2,37,42)(H,38,43)(H,39,44)/t28-,29-,30-,31-/m0/s1 D0Y5TF DRUGINKE AAXFHBRSEVMRCW-ORYMTKCHSA-N D0Y5TF DRUGSMIL CCC1=CC=CC(=C1CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CCCN3C(=O)C(CC4=CC=C(C=C4)O)N)C D0Y5TF HIGHSTAT Investigative D0Y5TL DRUG__ID D0Y5TL D0Y5TL DRUGTYPE Small molecular drug D0Y5TL DRUGINCH 1S/C10H6N4O2/c15-9-7-8(13-10(16)14-9)12-6-4-2-1-3-5(6)11-7/h1-4H,(H2,12,13,14,15,16) D0Y5TL DRUGINKE HAUGRYOERYOXHX-UHFFFAOYSA-N D0Y5TL DRUGSMIL C1=CC=C2C(=C1)N=C3C(=N2)NC(=O)NC3=O D0Y5TL HIGHSTAT Investigative D0Y5TO DRUG__ID D0Y5TO D0Y5TO DRUGTYPE Small molecular drug D0Y5TO DRUGINCH 1S/C16H18N4O2/c1-12(13-6-4-3-5-7-13)20-11-17-10-14(20)15(21)22-9-8-16(2)18-19-16/h3-7,10-12H,8-9H2,1-2H3 D0Y5TO DRUGINKE DUOHNSBKYJHAMQ-UHFFFAOYSA-N D0Y5TO DRUGSMIL CC(C1=CC=CC=C1)N2C=NC=C2C(=O)OCCC3(N=N3)C D0Y5TO HIGHSTAT Investigative D0Y5UC DRUG__ID D0Y5UC D0Y5UC DRUGCOMP ProCell Therapeutics Inc D0Y5UC DRUGINCH 1S/C14H22N2O/c1-5-16(6-2)13(17)10-15-14-11(3)8-7-9-12(14)4/h7-9,15H,5-6,10H2,1-4H3 D0Y5UC DRUGINKE HQMQWFJSTXFCPH-UHFFFAOYSA-N D0Y5UC DRUGSMIL CCN(CC)C(=O)CNC1=C(C=CC=C1C)C D0Y5UC HIGHSTAT Investigative D0Y5UF DRUG__ID D0Y5UF D0Y5UF DRUGTYPE Small molecular drug D0Y5UF DRUGINCH 1S/C7H8BrN3O2.ClH/c8-4-5(9-3-1-2-3)10-7(13)11-6(4)12;/h3H,1-2H2,(H3,9,10,11,12,13);1H D0Y5UF DRUGINKE CUQFSKAHEOAMRH-UHFFFAOYSA-N D0Y5UF DRUGSMIL C1CC1NC2=C(C(=O)NC(=O)N2)Br.Cl D0Y5UF HIGHSTAT Investigative D0Y5UN DRUG__ID D0Y5UN D0Y5UN DRUGTYPE Small molecular drug D0Y5UN DRUGINCH 1S/C28H35N5O5/c29-21(16-19-10-12-20(34)13-11-19)27(37)33-15-5-9-24(33)26(36)31-22(17-18-6-2-1-3-7-18)28(38)32-14-4-8-23(32)25(30)35/h1-3,6-7,10-13,21-24,34H,4-5,8-9,14-17,29H2,(H2,30,35)(H,31,36)/t21?,22-,23+,24?/m0/s1 D0Y5UN DRUGINKE LSQXZIUREIDSHZ-JULQRDMDSA-N D0Y5UN DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)N4CCCC4C(=O)N D0Y5UN HIGHSTAT Investigative D0Y5WD DRUG__ID D0Y5WD D0Y5WD DRUGTYPE Small molecular drug D0Y5WD DRUGINCH 1S/C15H22FNO/c16-13-14-5-7-15(8-6-14)18-12-4-11-17-9-2-1-3-10-17/h5-8H,1-4,9-13H2 D0Y5WD DRUGINKE JRFMDYWVKRGBGL-UHFFFAOYSA-N D0Y5WD DRUGSMIL C1CCN(CC1)CCCOC2=CC=C(C=C2)CF D0Y5WD HIGHSTAT Investigative D0Y5WQ DRUG__ID D0Y5WQ D0Y5WQ DRUGTYPE Small molecular drug D0Y5WQ DRUGINCH 1S/C24H25ClN6O4S/c1-2-11-31-23(32)20-22(28-24(31)33)27-21(26-20)16-3-9-19(10-4-16)36(34,35)30-14-12-29(13-15-30)18-7-5-17(25)6-8-18/h3-10H,2,11-15H2,1H3,(H,26,27)(H,28,33) D0Y5WQ DRUGINKE OVHCTHHFOHMNFV-UHFFFAOYSA-N D0Y5WQ DRUGSMIL CCCN1C(=O)C2=C(NC1=O)N=C(N2)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)C5=CC=C(C=C5)Cl D0Y5WQ HIGHSTAT Investigative D0Y5ZP DRUG__ID D0Y5ZP D0Y5ZP DRUGTYPE Small molecular drug D0Y5ZP DRUGINCH 1S/C24H28IN3O/c1-28-13-12-24-11-3-2-4-20(24)22(28)14-16-5-8-19(15-21(16)24)27-23(29)26-18-9-6-17(25)7-10-18/h5-10,15,20,22H,2-4,11-14H2,1H3,(H2,26,27,29)/t20-,22+,24+/m0/s1 D0Y5ZP DRUGINKE PNKGWKXKIPIROR-BGWNEDDSSA-N D0Y5ZP DRUGSMIL CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)NC(=O)NC5=CC=C(C=C5)I D0Y5ZP HIGHSTAT Investigative D0Y6DJ DRUG__ID D0Y6DJ D0Y6DJ DRUGTYPE Small molecular drug D0Y6DJ DRUGINCH 1S/C29H24Br4O7/c1-40-12-17-11-23(33)29(39)27(37)19(17)6-14-4-16(25(35)21(31)8-14)9-15-10-22(32)28(38)26(36)18(15)5-13-2-3-24(34)20(30)7-13/h2-4,7-8,10-11,34-39H,5-6,9,12H2,1H3 D0Y6DJ DRUGINKE KCFBHVMAGOSSRA-UHFFFAOYSA-N D0Y6DJ DRUGSMIL COCC1=CC(=C(C(=C1CC2=CC(=C(C(=C2)Br)O)CC3=CC(=C(C(=C3CC4=CC(=C(C=C4)O)Br)O)O)Br)O)O)Br D0Y6DJ HIGHSTAT Investigative D0Y6DX DRUG__ID D0Y6DX D0Y6DX DRUGTYPE Small molecular drug D0Y6DX DRUGINCH 1S/C18H21N5O2/c24-14-8-6-13(7-9-14)21-18-22-16-15(19-11-20-16)17(23-18)25-10-12-4-2-1-3-5-12/h6-9,11-12,24H,1-5,10H2,(H2,19,20,21,22,23) D0Y6DX DRUGINKE RFSDQDHHBKYQOD-UHFFFAOYSA-N D0Y6DX DRUGSMIL C1CCC(CC1)COC2=NC(=NC3=C2NC=N3)NC4=CC=C(C=C4)O D0Y6DX HIGHSTAT Investigative D0Y6FA DRUG__ID D0Y6FA D0Y6FA DRUGTYPE Small molecular drug D0Y6FA DRUGINCH 1S/C23H26F3NO4S/c24-23(25,26)16-4-1-3-15(13-16)14-18(28)8-6-17-7-11-21(29)27(17)12-2-5-19-9-10-20(32-19)22(30)31/h1,3-4,9-10,13,17-18,28H,2,5-8,11-12,14H2,(H,30,31)/p-1/t17-,18+/m0/s1 D0Y6FA DRUGINKE JYZXGURJKNAFPT-ZWKOTPCHSA-M D0Y6FA DRUGSMIL C1CC(=O)N(C1CCC(CC2=CC(=CC=C2)C(F)(F)F)O)CCCC3=CC=C(S3)C(=O)[O-] D0Y6FA HIGHSTAT Investigative D0Y6GQ DRUG__ID D0Y6GQ D0Y6GQ DRUGTYPE Small molecular drug D0Y6GQ DRUGINCH 1S/C17H21N3/c1-2-6-15(7-3-1)17(20-12-10-18-11-13-20)14-16-8-4-5-9-19-16/h1-9,17-18H,10-14H2 D0Y6GQ DRUGINKE BAYDYCDSOWCJTI-UHFFFAOYSA-N D0Y6GQ DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=N2)C3=CC=CC=C3 D0Y6GQ HIGHSTAT Investigative D0Y6HD DRUG__ID D0Y6HD D0Y6HD DRUGTYPE Small molecular drug D0Y6HD DRUGINCH 1S/C17H23BN2O4/c1-12(2)11-15(18(23)24)19-16(21)8-10-20-9-7-13-5-3-4-6-14(13)17(20)22/h3-7,9,12,15,23-24H,8,10-11H2,1-2H3,(H,19,21)/t15-/m0/s1 D0Y6HD DRUGINKE QCKLWTRAVKQTPI-HNNXBMFYSA-N D0Y6HD DRUGSMIL B(C(CC(C)C)NC(=O)CCN1C=CC2=CC=CC=C2C1=O)(O)O D0Y6HD HIGHSTAT Investigative D0Y6HQ DRUG__ID D0Y6HQ D0Y6HQ DRUGTYPE Small molecular drug D0Y6HQ DRUGINCH 1S/C18H18N6O5/c1-28-23-16-13-17(22-12(21-16)5-4-10-3-2-6-19-7-10)24(9-20-13)18-15(27)14(26)11(8-25)29-18/h2-3,6-7,9,11,14-15,18,25-27H,8H2,1H3,(H,21,22,23)/t11-,14-,15-,18-/m1/s1 D0Y6HQ DRUGINKE XQAKVNKMDSEKNH-XKLVTHTNSA-N D0Y6HQ DRUGSMIL CONC1=C2C(=NC(=N1)C#CC3=CN=CC=C3)N(C=N2)C4C(C(C(O4)CO)O)O D0Y6HQ HIGHSTAT Investigative D0Y6IQ DRUG__ID D0Y6IQ D0Y6IQ DRUGTYPE Small molecular drug D0Y6IQ DRUGINCH 1S/C14H10F3N/c1-18-12-5-3-2-4-10(12)11-7-6-9(8-13(11)18)14(15,16)17/h2-8H,1H3 D0Y6IQ DRUGINKE XEEUWRNTJAAJOP-UHFFFAOYSA-N D0Y6IQ DRUGSMIL CN1C2=CC=CC=C2C3=C1C=C(C=C3)C(F)(F)F D0Y6IQ HIGHSTAT Investigative D0Y6IV DRUG__ID D0Y6IV D0Y6IV DRUGTYPE Small molecular drug D0Y6IV DRUGINCH 1S/C15H16O3/c1-2-11-17-13-7-9-15(10-8-13)18-14-5-3-12(16)4-6-14/h3-10,16H,2,11H2,1H3 D0Y6IV DRUGINKE FNAGBMSBTIDLJO-UHFFFAOYSA-N D0Y6IV DRUGSMIL CCCOC1=CC=C(C=C1)OC2=CC=C(C=C2)O D0Y6IV HIGHSTAT Investigative D0Y6LK DRUG__ID D0Y6LK D0Y6LK DRUGTYPE Small molecular drug D0Y6LK DRUGINCH 1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1 D0Y6LK DRUGINKE SENPVEZBRZQVST-HISDBWNOSA-O D0Y6LK DRUGSMIL C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)O D0Y6LK HIGHSTAT Investigative D0Y6LS DRUG__ID D0Y6LS D0Y6LS DRUGTYPE Small molecular drug D0Y6LS DRUGINCH 1S/C22H36O3/c1-2-3-6-9-20(23)13-12-18-14-17-15-19(16-17)21(18)10-7-4-5-8-11-22(24)25/h4,7,12-13,17-21,23H,2-3,5-6,8-11,14-16H2,1H3,(H,24,25)/b7-4-,13-12+/t17?,18-,19?,20-,21+/m0/s1 D0Y6LS DRUGINKE ZIWNJZLXPXFNGN-GXTQQWMXSA-N D0Y6LS DRUGSMIL CCCCCC(C=CC1CC2CC(C2)C1CC=CCCCC(=O)O)O D0Y6LS HIGHSTAT Investigative D0Y6MD DRUG__ID D0Y6MD D0Y6MD DRUGCOMP Natco Pharma Ltd D0Y6MD DRUGINCH 1S/C24H26N4O3/c1-3-18-6-4-7-19(14-18)27-24-20-15-23(22(29-2)16-21(20)25-17-26-24)31-11-5-8-28-9-12-30-13-10-28/h1,4,6-7,14-17H,5,8-13H2,2H3,(H,25,26,27) D0Y6MD DRUGINKE WBKHQQZRHCECKK-UHFFFAOYSA-N D0Y6MD DRUGSMIL COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4 D0Y6MD HIGHSTAT Investigative D0Y6MS DRUG__ID D0Y6MS D0Y6MS DRUGTYPE Small molecular drug D0Y6MS DRUGINCH 1S/C18H28O/c1-4-12-18(2,3)16-10-8-14(9-11-16)15-6-5-7-17(19)13-15/h8-11,15,17,19H,4-7,12-13H2,1-3H3/t15-,17-/m1/s1 D0Y6MS DRUGINKE IWAZRTQOOAVKDN-NVXWUHKLSA-N D0Y6MS DRUGSMIL CCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0Y6MS HIGHSTAT Investigative D0Y6MY DRUG__ID D0Y6MY D0Y6MY DRUGTYPE Small molecular drug D0Y6MY DRUGINCH 1S/C6H4N2O3S/c7-8-5-2-1-3-6(4-5)12(9,10)11/h1-4H D0Y6MY DRUGINKE MQAGWJGGLKPBSC-UHFFFAOYSA-N D0Y6MY DRUGSMIL C1=CC(=CC(=C1)S(=O)(=O)[O-])[N+]#N D0Y6MY HIGHSTAT Investigative D0Y6OK DRUG__ID D0Y6OK D0Y6OK DRUGTYPE Small molecular drug D0Y6OK DRUGINCH 1S/C14H8O4/c15-9-5-6-10(16)12-11(9)13(17)7-3-1-2-4-8(7)14(12)18/h1-6,15-16H D0Y6OK DRUGINKE GUEIZVNYDFNHJU-UHFFFAOYSA-N D0Y6OK DRUGSMIL C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)O D0Y6OK HIGHSTAT Investigative D0Y6OX DRUG__ID D0Y6OX D0Y6OX DRUGTYPE Small molecular drug D0Y6OX DRUGINCH 1S/C20H30O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,12-18,21H,2-3,5-6,8-11H2,1H3,(H,23,24)/b7-4-,14-13+/t16-,17-,18+/m0/s1 D0Y6OX DRUGINKE UQOQENZZLBSFKO-POPPZSFYSA-N D0Y6OX DRUGSMIL CCCCCC(C=CC1C(C=CC1=O)CC=CCCCC(=O)O)O D0Y6OX HIGHSTAT Investigative D0Y6RZ DRUG__ID D0Y6RZ D0Y6RZ DRUGTYPE Small molecular drug D0Y6RZ DRUGINCH 1S/C14H8F2O2/c15-11-5-1-3-9(7-11)13(17)14(18)10-4-2-6-12(16)8-10/h1-8H D0Y6RZ DRUGINKE NIOZEPOIIGVTTO-UHFFFAOYSA-N D0Y6RZ DRUGSMIL C1=CC(=CC(=C1)F)C(=O)C(=O)C2=CC(=CC=C2)F D0Y6RZ HIGHSTAT Investigative D0Y6ST DRUG__ID D0Y6ST D0Y6ST DRUGTYPE Small molecular drug D0Y6ST DRUGINCH 1S/C28H28ClN3OS/c1-30-22-9-11-23(12-10-22)32(28(33)27-26(29)24-7-2-3-8-25(24)34-27)18-19-5-4-6-21(17-19)20-13-15-31-16-14-20/h2-8,13-17,22-23,30H,9-12,18H2,1H3 D0Y6ST DRUGINKE VFSUUTYAEQOIMW-UHFFFAOYSA-N D0Y6ST DRUGSMIL CNC1CCC(CC1)N(CC2=CC(=CC=C2)C3=CC=NC=C3)C(=O)C4=C(C5=CC=CC=C5S4)Cl D0Y6ST HIGHSTAT Investigative D0Y6UB DRUG__ID D0Y6UB D0Y6UB DRUGTYPE Small molecular drug D0Y6UB DRUGINCH 1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) D0Y6UB DRUGINKE ISEYJGQFXSTPMQ-UHFFFAOYSA-N D0Y6UB DRUGSMIL C(CC(=O)O)C(CP(=O)(O)O)C(=O)O D0Y6UB HIGHSTAT Investigative D0Y6WJ DRUG__ID D0Y6WJ D0Y6WJ DRUGTYPE Small molecular drug D0Y6WJ DRUGINCH 1S/C31H34O5/c1-34-8-9-35-19-36-29-15-26-7-6-25(23-2-4-24(5-3-23)30(32)33)13-27(26)14-28(29)31-16-20-10-21(17-31)12-22(11-20)18-31/h2-7,13-15,20-22H,8-12,16-19H2,1H3,(H,32,33) D0Y6WJ DRUGINKE JBALRFFXKQPVLT-UHFFFAOYSA-N D0Y6WJ DRUGSMIL COCCOCOC1=C(C=C2C=C(C=CC2=C1)C3=CC=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5 D0Y6WJ HIGHSTAT Investigative D0Y7AN DRUG__ID D0Y7AN D0Y7AN DRUGTYPE Small molecular drug D0Y7AN DRUGINCH 1S/C8H14O4S/c9-7(10)4-3-6(8(11)12)2-1-5-13/h6,13H,1-5H2,(H,9,10)(H,11,12) D0Y7AN DRUGINKE FNLNSQHJKVQCBP-UHFFFAOYSA-N D0Y7AN DRUGSMIL C(CC(CCC(=O)O)C(=O)O)CS D0Y7AN HIGHSTAT Investigative D0Y7AV DRUG__ID D0Y7AV D0Y7AV DRUGTYPE Small molecular drug D0Y7AV DRUGINCH 1S/C12H10N2OS/c1-2-10-13-9-4-6-16-12(9)11(14-10)8-3-5-15-7-8/h3-7H,2H2,1H3 D0Y7AV DRUGINKE XVRNMWQROQLUBA-UHFFFAOYSA-N D0Y7AV DRUGSMIL CCC1=NC2=C(C(=N1)C3=COC=C3)SC=C2 D0Y7AV HIGHSTAT Investigative D0Y7CI DRUG__ID D0Y7CI D0Y7CI DRUGTYPE Small molecular drug D0Y7CI DRUGINCH 1S/C28H39N3O2/c1-7-17-30-19-22(5)31(20-21(30)4)27(25-11-10-12-26(18-25)33-6)23-13-15-24(16-14-23)28(32)29(8-2)9-3/h7,10-16,18,21-22,27H,1,8-9,17,19-20H2,2-6H3/t21-,22+,27-/m1/s1 D0Y7CI DRUGINKE KQWVAUSXZDRQPZ-UMTXDNHDSA-N D0Y7CI DRUGSMIL CCN(CC)C(=O)C1=CC=C(C=C1)C(C2=CC(=CC=C2)OC)N3CC(N(CC3C)CC=C)C D0Y7CI HIGHSTAT Investigative D0Y7CS DRUG__ID D0Y7CS D0Y7CS DRUGTYPE Small molecular drug D0Y7CS DRUGINCH 1S/C14H21NO/c1-10-7-6-8-12(9-10)13(16)11(2)15-14(3,4)5/h6-9,11,15H,1-5H3 D0Y7CS DRUGINKE YDGOUEKZXBLUDG-UHFFFAOYSA-N D0Y7CS DRUGSMIL CC1=CC(=CC=C1)C(=O)C(C)NC(C)(C)C D0Y7CS HIGHSTAT Investigative D0Y7FX DRUG__ID D0Y7FX D0Y7FX DRUGTYPE Small molecular drug D0Y7FX DRUGINCH 1S/C14H10O2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10H D0Y7FX DRUGINKE WURBFLDFSFBTLW-UHFFFAOYSA-N D0Y7FX DRUGSMIL C1=CC=C(C=C1)C(=O)C(=O)C2=CC=CC=C2 D0Y7FX HIGHSTAT Investigative D0Y7HC DRUG__ID D0Y7HC D0Y7HC DRUGTYPE Small molecular drug D0Y7HC DRUGINCH 1S/C34H38N6O8/c1-5-18(2)27(39(4)19(3)41)31(46)35-23-15-14-20-12-9-13-22-16-25(40(28(20)22)34(23)47)30(45)36-24(17-26(42)43)29(44)33-38-37-32(48-33)21-10-7-6-8-11-21/h6-13,18,23-25,27H,5,14-17H2,1-4H3,(H,35,46)(H,36,45)(H,42,43)/t18-,23-,24-,25-,27-/m0/s1 D0Y7HC DRUGINKE UCXMBOHIKJZNMQ-GIYJSHOWSA-N D0Y7HC DRUGSMIL CCC(C)C(C(=O)NC1CCC2=C3C(=CC=C2)CC(N3C1=O)C(=O)NC(CC(=O)O)C(=O)C4=NN=C(O4)C5=CC=CC=C5)N(C)C(=O)C D0Y7HC HIGHSTAT Investigative D0Y7HG DRUG__ID D0Y7HG D0Y7HG DRUGTYPE Small molecular drug D0Y7HG DRUGINCH 1S/C15H10O5/c16-9-6-10(17)12-11(7-9)20-15(14(19)13(12)18)8-4-2-1-3-5-8/h1-7,16-17,19H D0Y7HG DRUGINKE VCCRNZQBSJXYJD-UHFFFAOYSA-N D0Y7HG DRUGSMIL C1=CC=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O D0Y7HG HIGHSTAT Investigative D0Y7KE DRUG__ID D0Y7KE D0Y7KE DRUGTYPE Small molecular drug D0Y7KE DRUGINCH 1S/C26H29NO/c1-2-21-13-15-24(16-14-21)26(28)17-19-27(20-18-26)25(22-9-5-3-6-10-22)23-11-7-4-8-12-23/h3-16,25,28H,2,17-20H2,1H3 D0Y7KE DRUGINKE JHTQREMVHFRWEJ-UHFFFAOYSA-N D0Y7KE DRUGSMIL CCC1=CC=C(C=C1)C2(CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)O D0Y7KE HIGHSTAT Investigative D0Y7ND DRUG__ID D0Y7ND D0Y7ND DRUGTYPE Small molecular drug D0Y7ND DRUGINCH 1S/C12H11ClN2O2S/c13-11-3-1-2-4-12(11)15-18(16,17)10-7-5-9(14)6-8-10/h1-8,15H,14H2 D0Y7ND DRUGINKE XZQHDUUDKCHQIL-UHFFFAOYSA-N D0Y7ND DRUGSMIL C1=CC=C(C(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)Cl D0Y7ND HIGHSTAT Investigative D0Y7NV DRUG__ID D0Y7NV D0Y7NV DRUGTYPE Small molecular drug D0Y7NV DRUGINCH 1S/C18H16N2O3/c1-2-18(15(21)19-17(23)20-16(18)22)14-10-8-13(9-11-14)12-6-4-3-5-7-12/h3-11H,2H2,1H3,(H2,19,20,21,22,23) D0Y7NV DRUGINKE XWZIZWWEAJZAMO-UHFFFAOYSA-N D0Y7NV DRUGSMIL CCC1(C(=O)NC(=O)NC1=O)C2=CC=C(C=C2)C3=CC=CC=C3 D0Y7NV HIGHSTAT Investigative D0Y7PW DRUG__ID D0Y7PW D0Y7PW DRUGTYPE Small molecular drug D0Y7PW DRUGINCH 1S/C10H7BrN2O3S/c11-7-1-3-8(4-2-7)17(15,16)10-6-5-9(14)12-13-10/h1-6H,(H,12,14) D0Y7PW DRUGINKE MKFSHYSDCZFZEZ-UHFFFAOYSA-N D0Y7PW DRUGSMIL C1=CC(=CC=C1S(=O)(=O)C2=NNC(=O)C=C2)Br D0Y7PW HIGHSTAT Investigative D0Y7PY DRUG__ID D0Y7PY D0Y7PY DRUGTYPE Small molecular drug D0Y7PY DRUGINCH 1S/C41H50N7O11PS/c1-23(59-60(56,57)58)36(47-39(53)32(44-24(2)49)21-28-22-61-34-13-6-5-11-29(28)34)41(55)48-18-8-7-12-33(48)40(54)46-31(38(52)45-30(37(43)51)16-17-35(42)50)20-25-14-15-26-9-3-4-10-27(26)19-25/h3-6,9-11,13-15,19,22-23,30-33,36H,7-8,12,16-18,20-21H2,1-2H3,(H2,42,50)(H2,43,51)(H,44,49)(H,45,52)(H,46,54)(H,47,53)(H2,56,57,58)/t23-,30+,31+,32+,33-,36+/m1/s1 D0Y7PY DRUGINKE WPZGCIDLTHYADD-YIVWXNOFSA-N D0Y7PY DRUGSMIL CC(C(C(=O)N1CCCCC1C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CC4=CSC5=CC=CC=C54)NC(=O)C)OP(=O)(O)O D0Y7PY HIGHSTAT Investigative D0Y7QY DRUG__ID D0Y7QY D0Y7QY DRUGTYPE Small molecular drug D0Y7QY DRUGINCH 1S/C19H21NO/c1-19(2,3)16-12-9-15(10-13-16)11-14-18(21)20-17-7-5-4-6-8-17/h4-14H,1-3H3,(H,20,21)/b14-11+ D0Y7QY DRUGINKE AVMIAJAOFXDOSN-SDNWHVSQSA-N D0Y7QY DRUGSMIL CC(C)(C)C1=CC=C(C=C1)C=CC(=O)NC2=CC=CC=C2 D0Y7QY HIGHSTAT Investigative D0Y7QZ DRUG__ID D0Y7QZ D0Y7QZ DRUGTYPE Small molecular drug D0Y7QZ DRUGINCH 1S/C20H16N4/c1-14-6-8-17(9-7-14)23-20-21-11-10-19(24-20)16-12-15-4-2-3-5-18(15)22-13-16/h2-13H,1H3,(H,21,23,24) D0Y7QZ DRUGINKE DLSCDFDGOMZHSD-UHFFFAOYSA-N D0Y7QZ DRUGSMIL CC1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC4=CC=CC=C4N=C3 D0Y7QZ HIGHSTAT Investigative D0Y7RB DRUG__ID D0Y7RB D0Y7RB DRUGTYPE Small molecular drug D0Y7RB DRUGINCH 1S/C16H15N/c1-12-4-5-14-6-7-15(16(14)9-12)10-13-3-2-8-17-11-13/h2-5,8-11H,6-7H2,1H3/b15-10- D0Y7RB DRUGINKE INXZXCKRUCKCJE-GDNBJRDFSA-N D0Y7RB DRUGSMIL CC1=CC2=C(CCC2=CC3=CN=CC=C3)C=C1 D0Y7RB HIGHSTAT Investigative D0Y7RV DRUG__ID D0Y7RV D0Y7RV DRUGTYPE Small molecular drug D0Y7RV DRUGINCH 1S/C28H27N5O2/c1-32-16-20(15-31-32)24-11-10-18(14-29-24)12-19-13-23-27(22-7-3-2-6-21(19)22)30-17-33(28(23)35)25-8-4-5-9-26(25)34/h2-3,6-7,10-11,13-17,25-26,34H,4-5,8-9,12H2,1H3/t25-,26-/m0/s1 D0Y7RV DRUGINKE SXJQBWJPNSOKQV-UIOOFZCWSA-N D0Y7RV DRUGSMIL CN1C=C(C=N1)C2=NC=C(C=C2)CC3=CC4=C(C5=CC=CC=C53)N=CN(C4=O)C6CCCCC6O D0Y7RV HIGHSTAT Investigative D0Y7UG DRUG__ID D0Y7UG D0Y7UG DRUGTYPE Small molecular drug D0Y7UG DRUGINCH 1S/C34H52N2O2/c1-3-33(29-15-13-17-31(37)25-29)19-7-11-23-35(27-33)21-9-5-6-10-22-36-24-12-8-20-34(4-2,28-36)30-16-14-18-32(38)26-30/h13-18,25-26,37-38H,3-12,19-24,27-28H2,1-2H3/t33-,34-/m1/s1 D0Y7UG DRUGINKE YBOHCXLIWATJCJ-KKLWWLSJSA-N D0Y7UG DRUGSMIL CCC1(CCCCN(C1)CCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0Y7UG HIGHSTAT Investigative D0Y7UJ DRUG__ID D0Y7UJ D0Y7UJ DRUGTYPE Small molecular drug D0Y7UJ DRUGINCH 1S/C16H20N2/c1-2-4-16-13-14(5-6-15(16)3-1)7-10-18-11-8-17-9-12-18/h1-6,13,17H,7-12H2 D0Y7UJ DRUGINKE MXNHEKIHSVXJPG-UHFFFAOYSA-N D0Y7UJ DRUGSMIL C1CN(CCN1)CCC2=CC3=CC=CC=C3C=C2 D0Y7UJ HIGHSTAT Investigative D0Y7VM DRUG__ID D0Y7VM D0Y7VM DRUGTYPE Small molecular drug D0Y7VM DRUGINCH 1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1 D0Y7VM DRUGINKE OHCQJHSOBUTRHG-KGGHGJDLSA-N D0Y7VM DRUGSMIL CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O D0Y7VM HIGHSTAT Investigative D0Y7WJ DRUG__ID D0Y7WJ D0Y7WJ DRUGTYPE Small molecular drug D0Y7WJ DRUGINCH 1S/C12H26O3S/c1-2-3-4-5-6-7-8-9-10-11-12-16(13,14)15/h2-12H2,1H3,(H,13,14,15)/p-1 D0Y7WJ DRUGINKE LDMOEFOXLIZJOW-UHFFFAOYSA-M D0Y7WJ DRUGSMIL CCCCCCCCCCCCS(=O)(=O)[O-] D0Y7WJ HIGHSTAT Investigative D0Y7WU DRUG__ID D0Y7WU D0Y7WU DRUGTYPE Small molecular drug D0Y7WU DRUGINCH 1S/C16H17NO4/c1-19-14-4-2-12(3-5-14)15-10-13(11-16(18)21-15)17-6-8-20-9-7-17/h2-5,10-11H,6-9H2,1H3 D0Y7WU DRUGINKE PRPSUNXAZLZCBS-UHFFFAOYSA-N D0Y7WU DRUGSMIL COC1=CC=C(C=C1)C2=CC(=CC(=O)O2)N3CCOCC3 D0Y7WU HIGHSTAT Investigative D0Y7XK DRUG__ID D0Y7XK D0Y7XK DRUGTYPE Small molecular drug D0Y7XK DRUGINCH 1S/C16H13N3O2/c20-15-13-9-4-10-17-14(13)18-16(19-15)21-11-5-8-12-6-2-1-3-7-12/h1-10H,11H2,(H,17,18,19,20)/b8-5+ D0Y7XK DRUGINKE FROKBSNKSJMXTH-VMPITWQZSA-N D0Y7XK DRUGSMIL C1=CC=C(C=C1)C=CCOC2=NC3=C(C=CC=N3)C(=O)N2 D0Y7XK HIGHSTAT Investigative D0Y7XQ DRUG__ID D0Y7XQ D0Y7XQ DRUGTYPE Small molecular drug D0Y7XQ DRUGINCH 1S/C5H15NO6P2/c1-4(2)6-3-5(13(7,8)9)14(10,11)12/h4-6H,3H2,1-2H3,(H2,7,8,9)(H2,10,11,12) D0Y7XQ DRUGINKE XUKNZUJYUAFJQJ-UHFFFAOYSA-N D0Y7XQ DRUGSMIL CC(C)NCC(P(=O)(O)O)P(=O)(O)O D0Y7XQ HIGHSTAT Investigative D0Y7YL DRUG__ID D0Y7YL D0Y7YL DRUGTYPE Small molecular drug D0Y7YL DRUGINCH 1S/C15H23N7O3/c1-21(5-3-2-4-16)6-9-11(23)12(24)15(25-9)22-8-20-10-13(17)18-7-19-14(10)22/h2-3,7-9,11-12,15,23-24H,4-6,16H2,1H3,(H2,17,18,19)/b3-2- D0Y7YL DRUGINKE YWJCZGDVJQLZET-IHWYPQMZSA-N D0Y7YL DRUGSMIL CN(CC=CCN)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0Y7YL HIGHSTAT Investigative D0Y8AB DRUG__ID D0Y8AB D0Y8AB DRUGTYPE Small molecular drug D0Y8AB DRUGINCH 1S/C18H17N3O/c19-17(14-6-2-1-3-7-14)18(22,15-8-4-10-20-12-15)16-9-5-11-21-13-16/h1-13,17,22H,19H2 D0Y8AB DRUGINKE BBACDJSPZTWBIB-UHFFFAOYSA-N D0Y8AB DRUGSMIL C1=CC=C(C=C1)C(C(C2=CN=CC=C2)(C3=CN=CC=C3)O)N D0Y8AB HIGHSTAT Investigative D0Y8AN DRUG__ID D0Y8AN D0Y8AN DRUGTYPE Small molecular drug D0Y8AN DRUGINCH 1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3 D0Y8AN DRUGINKE MEZLKOACVSPNER-UHFFFAOYSA-N D0Y8AN DRUGSMIL CC(CC1=CC=CC=C1)N(C)CC#C D0Y8AN HIGHSTAT Investigative D0Y8CU DRUG__ID D0Y8CU D0Y8CU DRUGTYPE Small molecular drug D0Y8CU DRUGINCH 1S/C10H4Cl3NO3/c11-4-1-5(12)8-6(7(4)13)9(15)3(2-14-8)10(16)17/h1-2H,(H,14,15)(H,16,17) D0Y8CU DRUGINKE DIMMLVONVUPWHB-UHFFFAOYSA-N D0Y8CU DRUGSMIL C1=C(C2=C(C(=C1Cl)Cl)C(=O)C(=CN2)C(=O)O)Cl D0Y8CU HIGHSTAT Investigative D0Y8DJ DRUG__ID D0Y8DJ D0Y8DJ DRUGTYPE Small molecular drug D0Y8DJ DRUGINCH 1S/C10H13NO/c12-7-10-5-8-3-1-2-4-9(8)6-11-10/h1-4,10-12H,5-7H2 D0Y8DJ DRUGINKE ZSKDXMLMMQFHGW-UHFFFAOYSA-N D0Y8DJ DRUGSMIL C1C(NCC2=CC=CC=C21)CO D0Y8DJ HIGHSTAT Investigative D0Y8DT DRUG__ID D0Y8DT D0Y8DT DRUGTYPE Small molecular drug D0Y8DT DRUGINCH 1S/C18H24N4O3S/c1-13-10-20-11-15-5-3-6-16(18(13)15)26(24,25)22-8-4-7-21(12-14(22)2)17(23)9-19/h3,5-6,10-11,14H,4,7-9,12,19H2,1-2H3/t14-/m0/s1 D0Y8DT DRUGINKE CMKMGFAUKPAOMG-AWEZNQCLSA-N D0Y8DT DRUGSMIL CC1CN(CCCN1S(=O)(=O)C2=CC=CC3=C2C(=CN=C3)C)C(=O)CN D0Y8DT HIGHSTAT Investigative D0Y8DZ DRUG__ID D0Y8DZ D0Y8DZ DRUGTYPE Small molecular drug D0Y8DZ DRUGINCH 1S/C7H12N2/c1-2-6-3-4-9-7(8)5-6/h5H,2-4H2,1H3,(H2,8,9) D0Y8DZ DRUGINKE PZWTXXAVOPPTGW-UHFFFAOYSA-N D0Y8DZ DRUGSMIL CCC1=CC(=NCC1)N D0Y8DZ HIGHSTAT Investigative D0Y8EU DRUG__ID D0Y8EU D0Y8EU DRUGTYPE Small molecular drug D0Y8EU DRUGINCH 1S/C21H14ClN5O2/c22-14-8-9-16-15(12-14)20-25-19(17-7-4-10-29-17)26-27(20)21(23-16)24-18(28)11-13-5-2-1-3-6-13/h1-10,12H,11H2,(H,23,24,28) D0Y8EU DRUGINKE TWWFAXQOKNBUCR-UHFFFAOYSA-N D0Y8EU DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=NC3=C(C=C(C=C3)Cl)C4=NC(=NN42)C5=CC=CO5 D0Y8EU HIGHSTAT Investigative D0Y8JN DRUG__ID D0Y8JN D0Y8JN DRUGTYPE Small molecular drug D0Y8JN DRUGINCH 1S/C16H13NO4S/c1-11-10-17(14-8-4-2-6-12(11)14)22(20,21)15-9-5-3-7-13(15)16(18)19/h2-10H,1H3,(H,18,19) D0Y8JN DRUGINKE FBAOKNXTXGWCMO-UHFFFAOYSA-N D0Y8JN DRUGSMIL CC1=CN(C2=CC=CC=C12)S(=O)(=O)C3=CC=CC=C3C(=O)O D0Y8JN HIGHSTAT Investigative D0Y8KY DRUG__ID D0Y8KY D0Y8KY DRUGTYPE Small molecular drug D0Y8KY DRUGINCH 1S/C27H30N4O7S/c1-30(22-10-4-3-5-11-22)26(33)19-31(23-12-7-13-24(17-23)38-2)25(32)18-28-27(34)29-21-9-6-8-20(16-21)14-15-39(35,36)37/h3-13,16-17H,14-15,18-19H2,1-2H3,(H2,28,29,34)(H,35,36,37) D0Y8KY DRUGINKE NGZMTMPEGDUWJQ-UHFFFAOYSA-N D0Y8KY DRUGSMIL CN(C1=CC=CC=C1)C(=O)CN(C2=CC(=CC=C2)OC)C(=O)CNC(=O)NC3=CC=CC(=C3)CCS(=O)(=O)O D0Y8KY HIGHSTAT Investigative D0Y8LD DRUG__ID D0Y8LD D0Y8LD DRUGTYPE Small molecular drug D0Y8LD DRUGINCH 1S/C26H31N7O6/c1-5-12-32-23-21(24(35)33(13-6-2)26(32)37)28-22(29-23)18-14-20(30-31(18)4)39-15-19(34)27-17-10-8-16(9-11-17)25(36)38-7-3/h8-11,14H,5-7,12-13,15H2,1-4H3,(H,27,34)(H,28,29) D0Y8LD DRUGINKE BVABUBJIQWDRNZ-UHFFFAOYSA-N D0Y8LD DRUGSMIL CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)NC4=CC=C(C=C4)C(=O)OCC D0Y8LD HIGHSTAT Investigative D0Y8NO DRUG__ID D0Y8NO D0Y8NO DRUGTYPE Small molecular drug D0Y8NO DRUGINCH 1S/C23H29NO/c1-18-22-11-6-13-23(18,20-9-5-10-21(25)17-20)14-16-24(22)15-12-19-7-3-2-4-8-19/h2-5,7-10,17-18,22,25H,6,11-16H2,1H3/t18-,22?,23?/m0/s1 D0Y8NO DRUGINKE FJRARMQVERMSNJ-NWLLBJEDSA-N D0Y8NO DRUGSMIL CC1C2CCCC1(CCN2CCC3=CC=CC=C3)C4=CC(=CC=C4)O D0Y8NO HIGHSTAT Investigative D0Y8PY DRUG__ID D0Y8PY D0Y8PY DRUGTYPE Small molecular drug D0Y8PY DRUGINCH 1S/C6H14NO8P/c7-3-5(9)4(8)2(15-6(3)10)1-14-16(11,12)13/h2-6,8-10H,1,7H2,(H2,11,12,13)/t2-,3-,4-,5-,6+/m1/s1 D0Y8PY DRUGINKE XHMJOUIAFHJHBW-UKFBFLRUSA-N D0Y8PY DRUGSMIL C(C1C(C(C(C(O1)O)N)O)O)OP(=O)(O)O D0Y8PY HIGHSTAT Investigative D0Y8QU DRUG__ID D0Y8QU D0Y8QU DRUGTYPE Small molecular drug D0Y8QU DRUGINCH 1S/C20H30N6O5S/c21-20(22)26-11-5-8-15(19(26)29)23-17(27)12-25-10-4-9-16(18(25)28)24-32(30,31)13-14-6-2-1-3-7-14/h1-3,6-7,15-16,19,24,29H,4-5,8-13H2,(H3,21,22)(H,23,27)/t15-,16-,19?/m0/s1 D0Y8QU DRUGINKE SPUAEQJRVQHWKF-NRAVZPKASA-N D0Y8QU DRUGSMIL C1CC(C(N(C1)C(=N)N)O)NC(=O)CN2CCCC(C2=O)NS(=O)(=O)CC3=CC=CC=C3 D0Y8QU HIGHSTAT Investigative D0Y8RM DRUG__ID D0Y8RM D0Y8RM DRUGTYPE Small molecular drug D0Y8RM DRUGINCH 1S/C7H16O2P/c1-6(7(2,3)4)9-10(5)8/h6H,1-5H3/q+1/t6-/m1/s1 D0Y8RM DRUGINKE AYQIEWWYFGQKPK-ZCFIWIBFSA-N D0Y8RM DRUGSMIL CC(C(C)(C)C)O[P+](=O)C D0Y8RM HIGHSTAT Investigative D0Y8SB DRUG__ID D0Y8SB D0Y8SB DRUGTYPE Small molecular drug D0Y8SB DRUGINCH 1S/C18H16N4O2/c1-21-9-8-13-14(10-21)17-19-16(12-6-4-3-5-7-12)20-22(17)11-15(13)18(23)24-2/h3-10H,11H2,1-2H3 D0Y8SB DRUGINKE DBROFPXBIMMIMF-UHFFFAOYSA-N D0Y8SB DRUGSMIL CN1C=CC2=C(CN3C(=NC(=N3)C4=CC=CC=C4)C2=C1)C(=O)OC D0Y8SB HIGHSTAT Investigative D0Y8UC DRUG__ID D0Y8UC D0Y8UC DRUGTYPE Small molecular drug D0Y8UC DRUGINCH 1S/C21H23F2NO/c1-24-18-10-11-19(24)13-20(12-18)25-21(14-2-6-16(22)7-3-14)15-4-8-17(23)9-5-15/h2-9,18-21H,10-13H2,1H3 D0Y8UC DRUGINKE MHNSOBBJZCWUGS-UHFFFAOYSA-N D0Y8UC DRUGSMIL CN1C2CCC1CC(C2)OC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F D0Y8UC HIGHSTAT Investigative D0Y8UF DRUG__ID D0Y8UF D0Y8UF DRUGTYPE Small molecular drug D0Y8UF DRUGINCH 1S/C24H22N2O3/c1-2-3-22-23(16-4-10-19(27)11-5-16)25-26(18-8-14-21(29)15-9-18)24(22)17-6-12-20(28)13-7-17/h4-15,27-29H,2-3H2,1H3 D0Y8UF DRUGINKE IOTXSIGGFRQYKW-UHFFFAOYSA-N D0Y8UF DRUGSMIL CCCC1=C(N(N=C1C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C4=CC=C(C=C4)O D0Y8UF HIGHSTAT Investigative D0Y8UP DRUG__ID D0Y8UP D0Y8UP DRUGTYPE Small molecular drug D0Y8UP DRUGINCH 1S/C13H10N2O2/c1-8-4-5-9-11(16)7-10(15-13(9)14-8)12-3-2-6-17-12/h2-7H,1H3,(H,14,15,16) D0Y8UP DRUGINKE INGWEZCOABYORO-UHFFFAOYSA-N D0Y8UP DRUGSMIL CC1=NC2=C(C=C1)C(=O)C=C(N2)C3=CC=CO3 D0Y8UP HIGHSTAT Investigative D0Y8VQ DRUG__ID D0Y8VQ D0Y8VQ DRUGTYPE Small molecular drug D0Y8VQ DRUGINCH 1S/C27H32N2O9/c1-18-10-11-19-6-3-8-23(32)26(19)27(35)38-20(7-4-14-28-24(33)9-5-15-29-36-2)16-25(34)37-21(17-30)12-13-22(18)31/h3-6,8-10,12-15,20-22,30-32H,7,11,16-17H2,1-2H3,(H,28,33)/b9-5+,13-12+,14-4+,18-10-,29-15- D0Y8VQ DRUGINKE JIRIKJKTSMGHQG-CFMTYHAKSA-N D0Y8VQ DRUGSMIL CC1=CCC2=C(C(=CC=C2)O)C(=O)OC(CC(=O)OC(C=CC1O)CO)CC=CNC(=O)C=CC=NOC D0Y8VQ HIGHSTAT Investigative D0Y8XJ DRUG__ID D0Y8XJ D0Y8XJ DRUGTYPE Small molecular drug D0Y8XJ DRUGINCH 1S/C22H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15- D0Y8XJ DRUGINKE YUFFSWGQGVEMMI-JLNKQSITSA-N D0Y8XJ DRUGSMIL CCC=CCC=CCC=CCC=CCC=CCCCCCC(=O)O D0Y8XJ HIGHSTAT Investigative D0Y8YN DRUG__ID D0Y8YN D0Y8YN DRUGTYPE Small molecular drug D0Y8YN DRUGINCH 1S/C9H22NO2P/c1-2-3-4-5-8-13(11,12)9-6-7-10/h2-10H2,1H3,(H,11,12) D0Y8YN DRUGINKE QVUUPQCCYOPHFY-UHFFFAOYSA-N D0Y8YN DRUGSMIL CCCCCCP(=O)(CCCN)O D0Y8YN HIGHSTAT Investigative D0Y9AQ DRUG__ID D0Y9AQ D0Y9AQ DRUGTYPE Small molecular drug D0Y9AQ DRUGINCH 1S/C24H27NO5/c1-27-19-8-13-14-9-20(28-2)22(30-4)11-16(14)23-17(15(13)10-21(19)29-3)12-25-7-5-6-18(25)24(23)26/h8-11,18,24,26H,5-7,12H2,1-4H3/t18-,24+/m0/s1 D0Y9AQ DRUGINKE JWHWLMNMGLICQZ-MHECFPHRSA-N D0Y9AQ DRUGSMIL COC1=C(C=C2C(=C1)C3=C(C(C4CCCN4C3)O)C5=CC(=C(C=C25)OC)OC)OC D0Y9AQ HIGHSTAT Investigative D0Y9BO DRUG__ID D0Y9BO D0Y9BO DRUGTYPE Small molecular drug D0Y9BO DRUGINCH 1S/C17H13F3N2O2/c1-2-8-22-16-12(4-3-5-13(16)17(18,19)20)15(21-22)11-7-6-10(23)9-14(11)24/h2-7,9,23-24H,1,8H2 D0Y9BO DRUGINKE ZDUDMCQPFKPISO-UHFFFAOYSA-N D0Y9BO DRUGSMIL C=CCN1C2=C(C=CC=C2C(F)(F)F)C(=N1)C3=C(C=C(C=C3)O)O D0Y9BO HIGHSTAT Investigative D0Y9BU DRUG__ID D0Y9BU D0Y9BU DRUGTYPE Small molecular drug D0Y9BU DRUGINCH 1S/C21H17ClF6N2O2/c22-16-3-5-17(6-4-16)29-18(31)12-2-1-7-30(11-12)19(32)13-8-14(20(23,24)25)10-15(9-13)21(26,27)28/h3-6,8-10,12H,1-2,7,11H2,(H,29,31) D0Y9BU DRUGINKE MOQCFMZWVKQBAP-UHFFFAOYSA-N D0Y9BU DRUGSMIL C1CC(CN(C1)C(=O)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)C(=O)NC3=CC=C(C=C3)Cl D0Y9BU HIGHSTAT Investigative D0Y9EU DRUG__ID D0Y9EU D0Y9EU DRUGTYPE Small molecular drug D0Y9EU DRUGINCH 1S/C23H26N2O/c1-2-3-4-5-6-9-18-12-14-19(15-13-18)23(26)25-21-16-20-10-7-8-11-22(20)24-17-21/h7-8,10-17H,2-6,9H2,1H3,(H,25,26) D0Y9EU DRUGINKE VJFYODCLTPGLMR-UHFFFAOYSA-N D0Y9EU DRUGSMIL CCCCCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2 D0Y9EU HIGHSTAT Investigative D0Y9GK DRUG__ID D0Y9GK D0Y9GK DRUGTYPE Small molecular drug D0Y9GK DRUGINCH 1S/C13H12N4/c14-9-6-4-8(5-7-9)10-2-1-3-11-12(10)13(15)17-16-11/h1-7H,14H2,(H3,15,16,17) D0Y9GK DRUGINKE KHQLSBOHZQJRPC-UHFFFAOYSA-N D0Y9GK DRUGSMIL C1=CC(=C2C(=C1)NN=C2N)C3=CC=C(C=C3)N D0Y9GK HIGHSTAT Investigative D0Y9HD DRUG__ID D0Y9HD D0Y9HD DRUGTYPE Small molecular drug D0Y9HD DRUGINCH 1S/C20H16N4O3/c25-13-20-18(12-22-9-8-21-14-22)17-10-16(24(26)27)6-7-19(17)23(20)11-15-4-2-1-3-5-15/h1-10,13-14H,11-12H2 D0Y9HD DRUGINKE QEODFJMVDIPNKP-UHFFFAOYSA-N D0Y9HD DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C=C(C=C3)[N+](=O)[O-])C(=C2C=O)CN4C=CN=C4 D0Y9HD HIGHSTAT Investigative D0Y9HT DRUG__ID D0Y9HT D0Y9HT DRUGTYPE Small molecular drug D0Y9HT DRUGINCH 1S/C27H24F3NO/c1-2-3-6-15-31-18-21(17-25(31)20-11-7-12-22(16-20)27(28,29)30)26(32)24-14-8-10-19-9-4-5-13-23(19)24/h4-5,7-14,16-18H,2-3,6,15H2,1H3 D0Y9HT DRUGINKE GETLFVZYXNFVJS-UHFFFAOYSA-N D0Y9HT DRUGSMIL CCCCCN1C=C(C=C1C2=CC(=CC=C2)C(F)(F)F)C(=O)C3=CC=CC4=CC=CC=C43 D0Y9HT HIGHSTAT Investigative D0Y9IB DRUG__ID D0Y9IB D0Y9IB DRUGTYPE Small molecular drug D0Y9IB DRUGINCH 1S/C21H23N5O/c22-21(24-12-11-18-14-23-15-25-18)26-20(27)13-19(16-7-3-1-4-8-16)17-9-5-2-6-10-17/h1-10,14-15,19H,11-13H2,(H,23,25)(H3,22,24,26,27) D0Y9IB DRUGINKE BCIVIRNJAROBHW-UHFFFAOYSA-N D0Y9IB DRUGSMIL C1=CC=C(C=C1)C(CC(=O)NC(=NCCC2=CN=CN2)N)C3=CC=CC=C3 D0Y9IB HIGHSTAT Investigative D0Y9PH DRUG__ID D0Y9PH D0Y9PH DRUGTYPE Small molecular drug D0Y9PH DRUGINCH 1S/C33H50N12O4/c1-20(2)27(45-30(48)25(11-7-17-41-33(38)39)43-26(46)18-21-8-4-3-5-9-21)31(49)44-24(10-6-16-40-32(36)37)29(47)42-19-22-12-14-23(15-13-22)28(34)35/h3-5,8-9,12-15,20,24-25,27H,6-7,10-11,16-19H2,1-2H3,(H3,34,35)(H,42,47)(H,43,46)(H,44,49)(H,45,48)(H4,36,37,40)(H4,38,39,41)/t24-,25-,27-/m0/s1 D0Y9PH DRUGINKE YGMAIAXBJLVVLI-KLJDGLGGSA-N D0Y9PH DRUGSMIL CC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)NCC1=CC=C(C=C1)C(=N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CC2=CC=CC=C2 D0Y9PH HIGHSTAT Investigative D0Y9RY DRUG__ID D0Y9RY D0Y9RY DRUGTYPE Small molecular drug D0Y9RY DRUGINCH 1S/C6H13NO4/c1-2-3(7)4(8)5(9)6(10)11-2/h2-6,8-10H,7H2,1H3/t2-,3-,4+,5-,6+/m1/s1 D0Y9RY DRUGINKE RJKBJEZZABBYBA-DVKNGEFBSA-N D0Y9RY DRUGSMIL CC1C(C(C(C(O1)O)O)O)N D0Y9RY HIGHSTAT Investigative D0Y9SE DRUG__ID D0Y9SE D0Y9SE DRUGTYPE Small molecular drug D0Y9SE DRUGINCH 1S/C29H25N3O5/c1-28-29(36-4,27(34)35-3)13-20(37-28)31-18-11-7-5-9-15(18)22-23-17(14-30(2)26(23)33)21-16-10-6-8-12-19(16)32(28)25(21)24(22)31/h5-12,20H,13-14H2,1-4H3/t20-,28+,29+/m1/s1 D0Y9SE DRUGINKE QTYMDECKVKSGSM-YMUMJAELSA-N D0Y9SE DRUGSMIL CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CN(C6=O)C)(C(=O)OC)OC D0Y9SE HIGHSTAT Investigative D0Y9SI DRUG__ID D0Y9SI D0Y9SI DRUGTYPE Small molecular drug D0Y9SI DRUGINCH 1S/C15H21N3O2S/c1-2-3-4-5-9-16-15(21)18-17-11-12-7-6-8-13(10-12)14(19)20/h6-8,10-11H,2-5,9H2,1H3,(H,19,20)(H2,16,18,21)/b17-11+ D0Y9SI DRUGINKE WAIVPXALQIYLJU-GZTJUZNOSA-N D0Y9SI DRUGSMIL CCCCCCNC(=S)NN=CC1=CC(=CC=C1)C(=O)O D0Y9SI HIGHSTAT Investigative D0Y9TL DRUG__ID D0Y9TL D0Y9TL DRUGTYPE Small molecular drug D0Y9TL DRUGINCH 1S/C8H8ClN3/c9-6-2-1-3-7-5(6)4-11-8(10)12-7/h1-3H,4H2,(H3,10,11,12) D0Y9TL DRUGINKE UDUQYNVUNNDSEJ-UHFFFAOYSA-N D0Y9TL DRUGSMIL C1C2=C(C=CC=C2Cl)NC(=N1)N D0Y9TL HIGHSTAT Investigative D0Y9WZ DRUG__ID D0Y9WZ D0Y9WZ DRUGTYPE Small molecular drug D0Y9WZ DRUGINCH 1S/C20H24N4O5/c1-3-9-24-19(27)18-16(23(2)20(24)28)11-15(22-18)13-4-6-14(7-5-13)29-12-17(26)21-8-10-25/h4-7,11,22,25H,3,8-10,12H2,1-2H3,(H,21,26) D0Y9WZ DRUGINKE DLDXAAWYBLTTEM-UHFFFAOYSA-N D0Y9WZ DRUGSMIL CCCN1C(=O)C2=C(C=C(N2)C3=CC=C(C=C3)OCC(=O)NCCO)N(C1=O)C D0Y9WZ HIGHSTAT Investigative D0Y9XK DRUG__ID D0Y9XK D0Y9XK DRUGTYPE Small molecular drug D0Y9XK DRUGINCH 1S/C16H13N3O2/c20-15(13-7-3-1-4-8-13)12-21-16-11-17-18-19(16)14-9-5-2-6-10-14/h1-11H,12H2 D0Y9XK DRUGINKE NFBZAZXCZDAVSL-UHFFFAOYSA-N D0Y9XK DRUGSMIL C1=CC=C(C=C1)C(=O)COC2=CN=NN2C3=CC=CC=C3 D0Y9XK HIGHSTAT Investigative D0Y9ZO DRUG__ID D0Y9ZO D0Y9ZO DRUGTYPE Small molecular drug D0Y9ZO DRUGINCH 1S/C13H11FN2O2S/c14-11-3-5-12(6-4-11)16-9-10-1-7-13(8-2-10)19(15,17)18/h1-9H,(H2,15,17,18) D0Y9ZO DRUGINKE JAKLWQFGJXPTHN-UHFFFAOYSA-N D0Y9ZO DRUGSMIL C1=CC(=CC=C1C=NC2=CC=C(C=C2)F)S(=O)(=O)N D0Y9ZO HIGHSTAT Investigative D0YA7R DRUG__ID D0YA7R D0YA7R DRUGTYPE Small molecular drug D0YA7R DRUGINCH 1S/C17H24N6O4/c1-22-13(4-5-14(22)24)16(26)21-11(7-10-8-19-9-20-10)17(27)23-6-2-3-12(23)15(18)25/h8-9,11-13H,2-7H2,1H3,(H2,18,25)(H,19,20)(H,21,26)/t11-,12-,13-/m0/s1 D0YA7R DRUGINKE DJLHRAHTTSWYAW-AVGNSLFASA-N D0YA7R DRUGSMIL CN1C(CCC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N D0YA7R HIGHSTAT Investigative D0YA8C DRUG__ID D0YA8C D0YA8C DRUGTYPE Small molecular drug D0YA8C DRUGINCH 1S/C19H22N2O3/c22-18(20-13-7-12-15-8-3-1-4-9-15)17(19(23)21-24)14-16-10-5-2-6-11-16/h1-6,8-11,17,24H,7,12-14H2,(H,20,22)(H,21,23) D0YA8C DRUGINKE CQGGQNFRJIAPHA-UHFFFAOYSA-N D0YA8C DRUGSMIL C1=CC=C(C=C1)CCCNC(=O)C(CC2=CC=CC=C2)C(=O)NO D0YA8C HIGHSTAT Investigative D0YA8J DRUG__ID D0YA8J D0YA8J DRUGTYPE Small molecular drug D0YA8J DRUGINCH 1S/C20H34O6/c1-16(2)13(21)7-12-18(4,25)11-6-5-10-15(23)19(11,9-17(10,3)24)8-14(22)20(12,16)26/h10-15,21-26H,5-9H2,1-4H3/t10-,11+,12+,13+,14-,15-,17-,18-,19+,20+/m1/s1 D0YA8J DRUGINKE BWMFRQKICHXLSH-FIRPSQKQSA-N D0YA8J DRUGSMIL CC1(C(CC2C1(C(CC34CC(C(C3O)CCC4C2(C)O)(C)O)O)O)O)C D0YA8J HIGHSTAT Investigative D0YB0K DRUG__ID D0YB0K D0YB0K DRUGTYPE Small molecular drug D0YB0K DRUGINCH 1S/C16H22INO/c1-2-10-18(11-4-9-17)14-8-7-13-5-3-6-16(19)15(13)12-14/h3-6,9,14,19H,2,7-8,10-12H2,1H3/b9-4-/t14-/m1/s1 D0YB0K DRUGINKE QBXHUZJZYDSLRH-RXTQTKKPSA-N D0YB0K DRUGSMIL CCCN(CC=CI)C1CCC2=C(C1)C(=CC=C2)O D0YB0K HIGHSTAT Investigative D0YB3X DRUG__ID D0YB3X D0YB3X DRUGTYPE Small molecular drug D0YB3X DRUGINCH 1S/C16H11ClN2OS/c17-13-8-4-7-12(9-13)15(20)19-16-18-14(10-21-16)11-5-2-1-3-6-11/h1-10H,(H,18,19,20) D0YB3X DRUGINKE OHXHEHNTSIBWMV-UHFFFAOYSA-N D0YB3X DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC(=CC=C3)Cl D0YB3X HIGHSTAT Investigative D0YB7F DRUG__ID D0YB7F D0YB7F DRUGTYPE Small molecular drug D0YB7F DRUGINCH 1S/C50H69N15O9/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56)/t35-,36-,37-,38+,39-,40-,41-/m0/s1 D0YB7F DRUGINKE JDKLPDJLXHXHNV-MFVUMRCOSA-N D0YB7F DRUGSMIL CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N)NC(=O)C D0YB7F HIGHSTAT Investigative D0YD6H DRUG__ID D0YD6H D0YD6H DRUGTYPE Small molecular drug D0YD6H DRUGINCH 1S/C20H13N3O3/c24-10-1-3-16-14(8-10)15(9-22-16)20(26)19-18-12(5-6-21-19)13-7-11(25)2-4-17(13)23-18/h1-9,22-25H D0YD6H DRUGINKE OATSYJQLKPRTBO-UHFFFAOYSA-N D0YD6H DRUGSMIL C1=CC2=C(C=C1O)C(=CN2)C(=O)C3=NC=CC4=C3NC5=C4C=C(C=C5)O D0YD6H HIGHSTAT Investigative D0YD9F DRUG__ID D0YD9F D0YD9F DRUGTYPE Small molecular drug D0YD9F DRUGINCH 1S/C12H12N2O4S2/c13-19(15,16)11-8-6-10(7-9-11)14-20(17,18)12-4-2-1-3-5-12/h1-9,14H,(H2,13,15,16) D0YD9F DRUGINKE FOOYRJIJNYBGIF-UHFFFAOYSA-N D0YD9F DRUGSMIL C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)S(=O)(=O)N D0YD9F HIGHSTAT Investigative D0YD9J DRUG__ID D0YD9J D0YD9J DRUGTYPE Small molecular drug D0YD9J DRUGINCH 1S/C15H12ClN/c16-14-3-4-15-12(1-2-13(15)10-14)9-11-5-7-17-8-6-11/h3-10H,1-2H2/b12-9+ D0YD9J DRUGINKE NFCDNDMUSHGWSU-FMIVXFBMSA-N D0YD9J DRUGSMIL C1CC(=CC2=CC=NC=C2)C3=C1C=C(C=C3)Cl D0YD9J HIGHSTAT Investigative D0YD9W DRUG__ID D0YD9W D0YD9W DRUGTYPE Small molecular drug D0YD9W DRUGINCH 1S/C23H29NO2/c1-26-23(25)22(20-14-6-3-7-15-20)21-16-8-9-17-24(21)18-10-13-19-11-4-2-5-12-19/h2-7,11-12,14-15,21-22H,8-10,13,16-18H2,1H3/t21-,22-/m1/s1 D0YD9W DRUGINKE ALPWYQATULXWEM-FGZHOGPDSA-N D0YD9W DRUGSMIL COC(=O)C(C1CCCCN1CCCC2=CC=CC=C2)C3=CC=CC=C3 D0YD9W HIGHSTAT Investigative D0YE1X DRUG__ID D0YE1X D0YE1X DRUGTYPE Small molecular drug D0YE1X DRUGINCH 1S/C19H19NO5/c1-21-16-6-5-12(9-17(16)22-2)25-15-7-8-20-14-11-19(24-4)18(23-3)10-13(14)15/h5-11H,1-4H3 D0YE1X DRUGINKE ZQSHUGGLESWJFP-UHFFFAOYSA-N D0YE1X DRUGSMIL COC1=C(C=C(C=C1)OC2=C3C=C(C(=CC3=NC=C2)OC)OC)OC D0YE1X HIGHSTAT Investigative D0YE2Z DRUG__ID D0YE2Z D0YE2Z DRUGTYPE Small molecular drug D0YE2Z DRUGINCH 1S/C14H14N2O2S/c17-9-4-1-3-8(7-9)13-12-10(15-14(19)16-13)5-2-6-11(12)18/h1,3-4,7,13,17H,2,5-6H2,(H2,15,16,19)/t13-/m0/s1 D0YE2Z DRUGINKE BJTGVSGWTIUCSM-ZDUSSCGKSA-N D0YE2Z DRUGSMIL C1CC2=C(C(NC(=S)N2)C3=CC(=CC=C3)O)C(=O)C1 D0YE2Z HIGHSTAT Investigative D0YE4B DRUG__ID D0YE4B D0YE4B DRUGTYPE Small molecular drug D0YE4B DRUGINCH 1S/C15H12N4OS/c20-15(17-12-4-2-1-3-5-12)19-13-10-21-14(18-13)11-6-8-16-9-7-11/h1-10H,(H2,17,19,20) D0YE4B DRUGINKE AXDWPTZOIRLDDO-UHFFFAOYSA-N D0YE4B DRUGSMIL C1=CC=C(C=C1)NC(=O)NC2=CSC(=N2)C3=CC=NC=C3 D0YE4B HIGHSTAT Investigative D0YE5K DRUG__ID D0YE5K D0YE5K DRUGTYPE Small molecular drug D0YE5K DRUGINCH 1S/C15H11N3OS/c19-14(12-9-5-2-6-10-12)17-15-16-13(18-20-15)11-7-3-1-4-8-11/h1-10H,(H,16,17,18,19) D0YE5K DRUGINKE AYSLYXJUYHXKHV-UHFFFAOYSA-N D0YE5K DRUGSMIL C1=CC=C(C=C1)C2=NSC(=N2)NC(=O)C3=CC=CC=C3 D0YE5K HIGHSTAT Investigative D0YF6S DRUG__ID D0YF6S D0YF6S DRUGTYPE Small molecular drug D0YF6S DRUGINCH 1S/C14H17NO3S/c1-2-3-4-5-6-7-9-11(16)10-14(19-8-15-10)13(18)12(9)17/h8,16H,2-7H2,1H3 D0YF6S DRUGINKE PJALLUJRPFUWAF-UHFFFAOYSA-N D0YF6S DRUGSMIL CCCCCCCC1=C(C2=C(C(=O)C1=O)SC=N2)O D0YF6S HIGHSTAT Investigative D0YF9S DRUG__ID D0YF9S D0YF9S DRUGTYPE Small molecular drug D0YF9S DRUGINCH 1S/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6) D0YF9S DRUGINKE FSYKKLYZXJSNPZ-UHFFFAOYSA-N D0YF9S DRUGSMIL CNCC(=O)O D0YF9S HIGHSTAT Investigative D0YG0D DRUG__ID D0YG0D D0YG0D DRUGTYPE Small molecular drug D0YG0D DRUGINCH 1S/C20H21NO2S/c1-16-6-8-18(9-7-16)24(22,23)21-14-12-20(13-15-21)11-10-17-4-2-3-5-19(17)20/h2-11H,12-15H2,1H3 D0YG0D DRUGINKE VRVIZJNFYYAUKC-UHFFFAOYSA-N D0YG0D DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N2CCC3(CC2)C=CC4=CC=CC=C34 D0YG0D HIGHSTAT Investigative D0YG1E DRUG__ID D0YG1E D0YG1E DRUGTYPE Small molecular drug D0YG1E DRUGINCH 1S/C19H28N4O2S/c1-4-23(5-2)26(24,25)21-14-10-16-15-7-6-8-17-19(15)13(11-20-17)9-18(16)22(3)12-14/h6-8,11,14,16,18,20-21H,4-5,9-10,12H2,1-3H3/t14-,16+,18+/m0/s1 D0YG1E DRUGINKE YHEIHLVIKSTGJE-YXJHDRRASA-N D0YG1E DRUGSMIL CCN(CC)S(=O)(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C D0YG1E HIGHSTAT Investigative D0YH4T DRUG__ID D0YH4T D0YH4T DRUGTYPE Small molecular drug D0YH4T DRUGINCH 1S/C17H11NO3/c19-11-4-6-13-10(8-11)2-1-3-14(13)17-18-15-7-5-12(20)9-16(15)21-17/h1-9,19-20H D0YH4T DRUGINKE ZRGCERZQAHMXNC-UHFFFAOYSA-N D0YH4T DRUGSMIL C1=CC2=C(C=CC(=C2)O)C(=C1)C3=NC4=C(O3)C=C(C=C4)O D0YH4T HIGHSTAT Investigative D0YH7K DRUG__ID D0YH7K D0YH7K DRUGTYPE Small molecular drug D0YH7K DRUGINCH 1S/C17H20N2O5/c1-23-15(21)18-14(20)17(13-10-6-7-11-13,19(18)16(22)24-2)12-8-4-3-5-9-12/h3-5,8-9,13H,6-7,10-11H2,1-2H3/t17-/m0/s1 D0YH7K DRUGINKE ZRHWCAFAIHTQKD-KRWDZBQOSA-N D0YH7K DRUGSMIL COC(=O)N1C(=O)C(N1C(=O)OC)(C2CCCC2)C3=CC=CC=C3 D0YH7K HIGHSTAT Investigative D0YI1Z DRUG__ID D0YI1Z D0YI1Z DRUGTYPE Small molecular drug D0YI1Z DRUGINCH 1S/C23H27N9O2/c1-15-11-26-20-19(15)21(29-14-28-20)31-7-8-32(16(2)12-31)23(27-13-24)30-18-5-3-4-17(10-18)22(34)25-6-9-33/h3-5,10-11,14,16,33H,6-9,12H2,1-2H3,(H,25,34)(H,27,30)(H,26,28,29)/t16-/m0/s1 D0YI1Z DRUGINKE BCNLLDVODACBHT-INIZCTEOSA-N D0YI1Z DRUGSMIL CC1CN(CCN1C(=NC2=CC=CC(=C2)C(=O)NCCO)NC#N)C3=NC=NC4=C3C(=CN4)C D0YI1Z HIGHSTAT Investigative D0YI3V DRUG__ID D0YI3V D0YI3V DRUGTYPE Small molecular drug D0YI3V DRUGINCH 1S/C17H16O2/c1-3-13-5-4-6-16(11-13)15-9-7-14(8-10-15)12(2)17(18)19/h3-12H,1H2,2H3,(H,18,19) D0YI3V DRUGINKE VRFXYYPKWQXDFK-UHFFFAOYSA-N D0YI3V DRUGSMIL CC(C1=CC=C(C=C1)C2=CC=CC(=C2)C=C)C(=O)O D0YI3V HIGHSTAT Investigative D0YI4T DRUG__ID D0YI4T D0YI4T DRUGTYPE Small molecular drug D0YI4T DRUGINCH 1S/C11H14N2O/c1-3-11(13-14)9(2)7-10-5-4-6-12-8-10/h4-8,11H,3H2,1-2H3/b9-7+ D0YI4T DRUGINKE ZJNKUZQXZJOGMM-VQHVLOKHSA-N D0YI4T DRUGSMIL CCC(C(=CC1=CN=CC=C1)C)N=O D0YI4T HIGHSTAT Investigative D0YI5C DRUG__ID D0YI5C D0YI5C DRUGTYPE Small molecular drug D0YI5C DRUGINCH 1S/C17H30N4O8S/c1-2-3-4-5-8-21(29)17(28)30-10-12(15(25)19-9-14(23)24)20-13(22)7-6-11(18)16(26)27/h11-12,29H,2-10,18H2,1H3,(H,19,25)(H,20,22)(H,23,24)(H,26,27)/t11-,12-/m0/s1 D0YI5C DRUGINKE VKRQPFKVQRNOCI-RYUDHWBXSA-N D0YI5C DRUGSMIL CCCCCCN(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D0YI5C HIGHSTAT Investigative D0YJ3Q DRUG__ID D0YJ3Q D0YJ3Q DRUGTYPE Small molecular drug D0YJ3Q DRUGINCH 1S/C15H10O5/c16-9-2-3-10-12(18)7-14(20-15(10)6-9)8-1-4-11(17)13(19)5-8/h1-7,16-17,19H D0YJ3Q DRUGINKE PVFGJHYLIHMCQD-UHFFFAOYSA-N D0YJ3Q DRUGSMIL C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C=C(C=C3)O)O)O D0YJ3Q HIGHSTAT Investigative D0YJ5W DRUG__ID D0YJ5W D0YJ5W DRUGTYPE Small molecular drug D0YJ5W DRUGINCH 1S/C12H8F3N5O/c13-12(14,15)6-2-1-3-7(4-6)18-11-19-9-8(10(21)20-11)16-5-17-9/h1-5H,(H3,16,17,18,19,20,21) D0YJ5W DRUGINKE IOWPKEYIXBBDOQ-UHFFFAOYSA-N D0YJ5W DRUGSMIL C1=CC(=CC(=C1)NC2=NC3=C(C(=O)N2)NC=N3)C(F)(F)F D0YJ5W HIGHSTAT Investigative D0YK1E DRUG__ID D0YK1E D0YK1E DRUGTYPE Small molecular drug D0YK1E DRUGINCH 1S/C10H11ClO3/c1-2-9(10(12)13)14-8-5-3-7(11)4-6-8/h3-6,9H,2H2,1H3,(H,12,13) D0YK1E DRUGINKE CEJKAKCQVUWNNA-UHFFFAOYSA-N D0YK1E DRUGSMIL CCC(C(=O)O)OC1=CC=C(C=C1)Cl D0YK1E HIGHSTAT Investigative D0YK5E DRUG__ID D0YK5E D0YK5E DRUGTYPE Small molecular drug D0YK5E DRUGINCH 1S/C18H22N4O4.ClH/c1-22-7-6-17-13-9-2-3-11(23)14(13)26-15(17)10(20-21-16(19)24)4-5-18(17,25)12(22)8-9;/h2-3,12,15,23,25H,4-8H2,1H3,(H3,19,21,24);1H/b20-10-;/t12?,15-,17?,18+;/m0./s1 D0YK5E DRUGINKE QIYGMMZVSGQNFS-XVSNUZMHSA-N D0YK5E DRUGSMIL CN1CCC23C4C(=NNC(=O)N)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O.Cl D0YK5E HIGHSTAT Investigative D0YK5U DRUG__ID D0YK5U D0YK5U DRUGTYPE Small molecular drug D0YK5U DRUGINCH 1S/C14H10Cl2N2O3/c1-8-2-3-9(6-13(8)18(20)21)14(19)17-12-5-4-10(15)7-11(12)16/h2-7H,1H3,(H,17,19) D0YK5U DRUGINKE VNKILQNNNYOVJY-UHFFFAOYSA-N D0YK5U DRUGSMIL CC1=C(C=C(C=C1)C(=O)NC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-] D0YK5U HIGHSTAT Investigative D0YK9T DRUG__ID D0YK9T D0YK9T DRUGTYPE Small molecular drug D0YK9T DRUGINCH 1S/C22H26O7/c1-3-5-19-20(11-10-18(15(2)23)22(19)26)28-13-4-12-27-16-6-8-17(9-7-16)29-14-21(24)25/h6-11,26H,3-5,12-14H2,1-2H3,(H,24,25) D0YK9T DRUGINKE HBBVCKCCQCQCTJ-UHFFFAOYSA-N D0YK9T DRUGSMIL CCCC1=C(C=CC(=C1O)C(=O)C)OCCCOC2=CC=C(C=C2)OCC(=O)O D0YK9T HIGHSTAT Investigative D0YL0L DRUG__ID D0YL0L D0YL0L DRUGTYPE Small molecular drug D0YL0L DRUGINCH 1S/C14H14ClN5/c15-10-6-7-12(16)11(8-10)13(19-20-14(17)18)9-4-2-1-3-5-9/h1-8H,16H2,(H4,17,18,20)/b19-13+ D0YL0L DRUGINKE VOMKMECTFJLAPY-CPNJWEJPSA-N D0YL0L DRUGSMIL C1=CC=C(C=C1)C(=NN=C(N)N)C2=C(C=CC(=C2)Cl)N D0YL0L HIGHSTAT Investigative D0YL4X DRUG__ID D0YL4X D0YL4X DRUGTYPE Small molecular drug D0YL4X DRUGINCH 1S/C37H44N4O7S2/c1-37(2)33(35(47)40-31-25-15-9-7-13-23(25)18-29(31)43)41(21-50-37)36(48)32(45)26(17-22-11-5-4-6-12-22)39-34(46)27(20-49-3)38-30(44)19-24-14-8-10-16-28(24)42/h4-16,26-27,29,31-33,42-43,45H,17-21H2,1-3H3,(H,38,44)(H,39,46)(H,40,47)/t26-,27-,29+,31-,32-,33+/m0/s1 D0YL4X DRUGINKE BJANBLOVCAEXPY-CFLSISTJSA-N D0YL4X DRUGSMIL CC1(C(N(CS1)C(=O)C(C(CC2=CC=CC=C2)NC(=O)C(CSC)NC(=O)CC3=CC=CC=C3O)O)C(=O)NC4C(CC5=CC=CC=C45)O)C D0YL4X HIGHSTAT Investigative D0YL6T DRUG__ID D0YL6T D0YL6T DRUGTYPE Small molecular drug D0YL6T DRUGINCH 1S/C43H65N11O11S2/c1-7-23(4)35-41(64)48-26(12-13-31(44)55)37(60)49-28(18-32(45)56)38(61)50-29(39(62)53-43(5,6)42(65)51-27(16-22(2)3)36(59)47-19-33(46)57)21-67-66-15-14-34(58)54-20-25-11-9-8-10-24(25)17-30(54)40(63)52-35/h8-11,22-23,26-30,35H,7,12-21H2,1-6H3,(H2,44,55)(H2,45,56)(H2,46,57)(H,47,59)(H,48,64)(H,49,60)(H,50,61)(H,51,65)(H,52,63)(H,53,62)/t23-,26-,27-,28-,29-,30+,35-/m0/s1 D0YL6T DRUGINKE JBEGYQDVCITYKL-JEDRZNSQSA-N D0YL6T DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)N2CC3=CC=CC=C3CC2C(=O)N1)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0YL6T HIGHSTAT Investigative D0YL8Z DRUG__ID D0YL8Z D0YL8Z DRUGTYPE Small molecular drug D0YL8Z DRUGINCH 1S/C24H19N3O6/c1-13-10-20(21(27(31)32)11-14(13)2)22-9-8-18(33-22)12-19-15(3)25-26(23(19)28)17-6-4-16(5-7-17)24(29)30/h4-12H,1-3H3,(H,29,30)/b19-12+ D0YL8Z DRUGINKE HEKJYZZSCQBJGB-XDHOZWIPSA-N D0YL8Z DRUGSMIL CC1=CC(=C(C=C1C)[N+](=O)[O-])C2=CC=C(O2)C=C3C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C D0YL8Z HIGHSTAT Investigative D0YM4A DRUG__ID D0YM4A D0YM4A DRUGTYPE Small molecular drug D0YM4A DRUGINCH 1S/C17H16ClN3O/c1-2-6-16(22)19-17-13-9-12(11-7-4-3-5-8-11)14(18)10-15(13)20-21-17/h3-5,7-10H,2,6H2,1H3,(H2,19,20,21,22) D0YM4A DRUGINKE WGVVIVGNBSSANI-UHFFFAOYSA-N D0YM4A DRUGSMIL CCCC(=O)NC1=NNC2=CC(=C(C=C21)C3=CC=CC=C3)Cl D0YM4A HIGHSTAT Investigative D0YM6B DRUG__ID D0YM6B D0YM6B DRUGTYPE Small molecular drug D0YM6B DRUGINCH 1S/C13H20N6O3/c1-6-17-8-11(14)15-5-16-12(8)19(6)13-10(21)9(20)7(22-13)4-18(2)3/h5,7,9-10,13,20-21H,4H2,1-3H3,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1 D0YM6B DRUGINKE BDRUNDKEQQVJJG-QYVSTXNMSA-N D0YM6B DRUGSMIL CC1=NC2=C(N=CN=C2N1C3C(C(C(O3)CN(C)C)O)O)N D0YM6B HIGHSTAT Investigative D0YM8O DRUG__ID D0YM8O D0YM8O DRUGTYPE Small molecular drug D0YM8O DRUGINCH 1S/C23H27NO/c1-4-5-8-15-24-18(3)23(20-9-6-7-10-21(20)24)22(25)16-19-13-11-17(2)12-14-19/h6-7,9-14H,4-5,8,15-16H2,1-3H3 D0YM8O DRUGINKE RDYZLFKKWNGIJS-UHFFFAOYSA-N D0YM8O DRUGSMIL CCCCCN1C(=C(C2=CC=CC=C21)C(=O)CC3=CC=C(C=C3)C)C D0YM8O HIGHSTAT Investigative D0YN1A DRUG__ID D0YN1A D0YN1A DRUGTYPE Small molecular drug D0YN1A DRUGINCH 1S/C14H13NO4S/c16-14(17)10-15-20(18,19)13-8-6-12(7-9-13)11-4-2-1-3-5-11/h1-9,15H,10H2,(H,16,17) D0YN1A DRUGINKE ZIAFXLGSGMQYPL-UHFFFAOYSA-N D0YN1A DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)NCC(=O)O D0YN1A HIGHSTAT Investigative D0YN1E DRUG__ID D0YN1E D0YN1E DRUGTYPE Small molecular drug D0YN1E DRUGINCH 1S/C16H11N5/c1-5-17-6-2-12(1)14-9-19-16-15(10-20-21(16)11-14)13-3-7-18-8-4-13/h1-11H D0YN1E DRUGINKE ZLISHOMLHVNDJG-UHFFFAOYSA-N D0YN1E DRUGSMIL C1=CN=CC=C1C2=CN3C(=C(C=N3)C4=CC=NC=C4)N=C2 D0YN1E HIGHSTAT Investigative D0YN5P DRUG__ID D0YN5P D0YN5P DRUGTYPE Small molecular drug D0YN5P DRUGINCH 1S/C12H30N2/c1-13(2,3)11-9-7-8-10-12-14(4,5)6/h7-12H2,1-6H3/q+2 D0YN5P DRUGINKE VZJFGSRCJCXDSG-UHFFFAOYSA-N D0YN5P DRUGSMIL C[N+](C)(C)CCCCCC[N+](C)(C)C D0YN5P HIGHSTAT Investigative D0YN8Q DRUG__ID D0YN8Q D0YN8Q DRUGTYPE Small molecular drug D0YN8Q DRUGINCH 1S/C18H20N2O2/c1-22-16-7-6-14-8-12-4-2-3-5-13(12)9-15(17(14)10-16)11-20-18(19)21/h2-7,10,15H,8-9,11H2,1H3,(H3,19,20,21) D0YN8Q DRUGINKE DIXNMQKCFFPTKU-UHFFFAOYSA-N D0YN8Q DRUGSMIL COC1=CC2=C(CC3=CC=CC=C3CC2CNC(=O)N)C=C1 D0YN8Q HIGHSTAT Investigative D0YO0R DRUG__ID D0YO0R D0YO0R DRUGTYPE Small molecular drug D0YO0R DRUGINCH 1S/C20H24N2O3/c23-19(21-14-8-7-11-16-9-3-1-4-10-16)18(20(24)22-25)15-17-12-5-2-6-13-17/h1-6,9-10,12-13,18,25H,7-8,11,14-15H2,(H,21,23)(H,22,24) D0YO0R DRUGINKE WBIXUIDQAJRMSZ-UHFFFAOYSA-N D0YO0R DRUGSMIL C1=CC=C(C=C1)CCCCNC(=O)C(CC2=CC=CC=C2)C(=O)NO D0YO0R HIGHSTAT Investigative D0YO2D DRUG__ID D0YO2D D0YO2D DRUGTYPE Small molecular drug D0YO2D DRUGINCH 1S/C15H21N5O13P2/c16-12-7-13-18-4-19(12)14-10(23)8(21)5(31-14)1-29-34(25,26)33-35(27,28)30-2-6-9(22)11(24)15(32-6)20(13)3-17-7/h3-6,8-11,14-16,21-24H,1-2H2,(H,25,26)(H,27,28)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1 D0YO2D DRUGINKE BQOHYSXSASDCEA-KEOHHSTQSA-N D0YO2D DRUGSMIL C1C2C(C(C(O2)N3C=NC4=C3N=CN(C4=N)C5C(C(C(O5)COP(=O)(OP(=O)(O1)O)O)O)O)O)O D0YO2D HIGHSTAT Investigative D0YO2N DRUG__ID D0YO2N D0YO2N DRUGCOMP Molecular Partners AG D0YO2N DRUGINCH 1S/C3HBr2F3O/c4-2(5)1(9)3(6,7)8/h2H D0YO2N DRUGINKE HEPPAPZASXFWTB-UHFFFAOYSA-N D0YO2N DRUGSMIL C(C(=O)C(F)(F)F)(Br)Br D0YO2N HIGHSTAT Investigative D0YO6M DRUG__ID D0YO6M D0YO6M DRUGTYPE Small molecular drug D0YO6M DRUGINCH 1S/C14H14N2O2/c1-18-11-8-6-10(7-9-11)14(17)16-13-5-3-2-4-12(13)15/h2-9H,15H2,1H3,(H,16,17) D0YO6M DRUGINKE BDYVCYUXCNZYRW-UHFFFAOYSA-N D0YO6M DRUGSMIL COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N D0YO6M HIGHSTAT Investigative D0YO7C DRUG__ID D0YO7C D0YO7C DRUGTYPE Small molecular drug D0YO7C DRUGINCH 1S/C17H16N2O/c20-17(18-11-10-13-6-2-1-3-7-13)16-12-14-8-4-5-9-15(14)19-16/h1-9,12,19H,10-11H2,(H,18,20) D0YO7C DRUGINKE LANZFLJGXZCWQM-UHFFFAOYSA-N D0YO7C DRUGSMIL C1=CC=C(C=C1)CCNC(=O)C2=CC3=CC=CC=C3N2 D0YO7C HIGHSTAT Investigative D0YO8B DRUG__ID D0YO8B D0YO8B DRUGTYPE Small molecular drug D0YO8B DRUGINCH 1S/C7H11NO4/c1-7(8,6(11)12)4-2-3(4)5(9)10/h3-4H,2,8H2,1H3,(H,9,10)(H,11,12)/t3-,4-,7-/m0/s1 D0YO8B DRUGINKE KFACHLANPCGTFI-FVSJBQLASA-N D0YO8B DRUGSMIL CC(C1CC1C(=O)O)(C(=O)O)N D0YO8B HIGHSTAT Investigative D0YP0A DRUG__ID D0YP0A D0YP0A DRUGTYPE Small molecular drug D0YP0A DRUGINCH 1S/C14H19ClN4O2/c15-9-12(16)18-8-4-7-11(13(17)20)19-14(21)10-5-2-1-3-6-10/h1-3,5-6,11H,4,7-9H2,(H2,16,18)(H2,17,20)(H,19,21)/t11-/m0/s1 D0YP0A DRUGINKE BPWATVWOHQZVRP-NSHDSACASA-N D0YP0A DRUGSMIL C1=CC=C(C=C1)C(=O)NC(CCCN=C(CCl)N)C(=O)N D0YP0A HIGHSTAT Investigative D0YP0P DRUG__ID D0YP0P D0YP0P DRUGTYPE Small molecular drug D0YP0P DRUGINCH 1S/C13H9FN2O2S/c14-10-4-1-2-6-13(10)19(17,18)12-7-3-5-11(16)9(12)8-15/h1-7H,16H2 D0YP0P DRUGINKE MBHOZDSUDFTYGO-UHFFFAOYSA-N D0YP0P DRUGSMIL C1=CC=C(C(=C1)F)S(=O)(=O)C2=CC=CC(=C2C#N)N D0YP0P HIGHSTAT Investigative D0YP4A DRUG__ID D0YP4A D0YP4A DRUGTYPE Small molecular drug D0YP4A DRUGINCH 1S/C10H9NOS/c13-7-9-3-4-10(12-9)8-2-1-5-11-6-8/h1-6,13H,7H2 D0YP4A DRUGINKE GLMNDKCXHHOKIQ-UHFFFAOYSA-N D0YP4A DRUGSMIL C1=CC(=CN=C1)C2=CC=C(O2)CS D0YP4A HIGHSTAT Investigative D0YP4F DRUG__ID D0YP4F D0YP4F DRUGTYPE Small molecular drug D0YP4F DRUGINCH 1S/C17H21N3O3S/c21-15(10-6-1-2-7-11-16(22)20-23)19-17-18-14(12-24-17)13-8-4-3-5-9-13/h3-5,8-9,12,23H,1-2,6-7,10-11H2,(H,20,22)(H,18,19,21) D0YP4F DRUGINKE BDTAPZUZFJRPNM-UHFFFAOYSA-N D0YP4F DRUGSMIL C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)CCCCCCC(=O)NO D0YP4F HIGHSTAT Investigative D0YQ0G DRUG__ID D0YQ0G D0YQ0G DRUGTYPE Small molecular drug D0YQ0G DRUGINCH 1S/C6H3N3O9S.C5H9Cl2N3O2/c10-7(11)3-1-4(8(12)13)6(19(16,17)18)5(2-3)9(14)15;6-1-3-8-5(11)10(9-12)4-2-7/h1-2H,(H,16,17,18);1-4H2,(H,8,11) D0YQ0G DRUGINKE LMBKFJAIRIBNHB-UHFFFAOYSA-N D0YQ0G DRUGSMIL C1=C(C=C(C(=C1[N+](=O)[O-])S(=O)(=O)[O-])[N+](=O)[O-])[N+](=O)[O-].C(CCl)[NH2+]C(=O)N(CCCl)N=O D0YQ0G HIGHSTAT Investigative D0YQ2A DRUG__ID D0YQ2A D0YQ2A DRUGTYPE Small molecular drug D0YQ2A DRUGINCH 1S/C13H29NO/c1-4-5-6-7-8-9-10-11-12-13-14(2,3)15/h4-13H2,1-3H3 D0YQ2A DRUGINKE OZHBUVQCJMARBN-UHFFFAOYSA-N D0YQ2A DRUGSMIL CCCCCCCCCCC[N+](C)(C)[O-] D0YQ2A HIGHSTAT Investigative D0YQ8U DRUG__ID D0YQ8U D0YQ8U DRUGTYPE Small molecular drug D0YQ8U DRUGINCH 1S/C11H11NO/c12-8-10-6-7-11(13-10)9-4-2-1-3-5-9/h1-7H,8,12H2 D0YQ8U DRUGINKE HQHHWOJYOUTZHZ-UHFFFAOYSA-N D0YQ8U DRUGSMIL C1=CC=C(C=C1)C2=CC=C(O2)CN D0YQ8U HIGHSTAT Investigative D0YQ8V DRUG__ID D0YQ8V D0YQ8V DRUGTYPE Small molecular drug D0YQ8V DRUGINCH 1S/C24H21N3O3/c1-28-21-10-16(11-22(29-2)23(21)30-3)17-9-18-19(13-27-24(18)26-12-17)14-4-5-20-15(8-14)6-7-25-20/h4-13,25H,1-3H3,(H,26,27) D0YQ8V DRUGINKE UQHKXSZPEUNUDH-UHFFFAOYSA-N D0YQ8V DRUGSMIL COC1=CC(=CC(=C1OC)OC)C2=CC3=C(NC=C3C4=CC5=C(C=C4)NC=C5)N=C2 D0YQ8V HIGHSTAT Investigative D0YR1V DRUG__ID D0YR1V D0YR1V DRUGTYPE Small molecular drug D0YR1V DRUGINCH 1S/C16H16N6/c1-2-3-9-12-19-15-13(17-10-18-15)16-20-14(21-22(12)16)11-7-5-4-6-8-11/h4-8,10H,2-3,9H2,1H3,(H,17,18) D0YR1V DRUGINKE LTQQXOYFDPLYHI-UHFFFAOYSA-N D0YR1V DRUGSMIL CCCCC1=NC2=C(C3=NC(=NN13)C4=CC=CC=C4)NC=N2 D0YR1V HIGHSTAT Investigative D0YS1G DRUG__ID D0YS1G D0YS1G DRUGTYPE Small molecular drug D0YS1G DRUGINCH 1S/C20H36N2O2/c1-2-3-4-5-6-8-24-9-7-21-19(23)22-20-13-16-10-17(14-20)12-18(11-16)15-20/h16-18H,2-15H2,1H3,(H2,21,22,23) D0YS1G DRUGINKE ADHBJDWCKMOLCA-UHFFFAOYSA-N D0YS1G DRUGSMIL CCCCCCCOCCNC(=O)NC12CC3CC(C1)CC(C3)C2 D0YS1G HIGHSTAT Investigative D0YS2F DRUG__ID D0YS2F D0YS2F DRUGTYPE Small molecular drug D0YS2F DRUGINCH 1S/C16H15NO/c1-18-15-6-2-5-13-7-8-14(16(13)15)10-12-4-3-9-17-11-12/h2-6,9-11H,7-8H2,1H3/b14-10+ D0YS2F DRUGINKE VTCRFWNOJMKNRS-GXDHUFHOSA-N D0YS2F DRUGSMIL COC1=CC=CC2=C1C(=CC3=CN=CC=C3)CC2 D0YS2F HIGHSTAT Investigative D0YS9J DRUG__ID D0YS9J D0YS9J DRUGTYPE Small molecular drug D0YS9J DRUGINCH 1S/C177H281N47O50S7/c1-17-92(10)141(222-159(256)116(71-99-42-22-19-23-43-99)207-169(266)136(184)96(14)226)173(270)210-120(76-135(238)239)160(257)219-138(89(4)5)171(268)209-119(75-134(236)237)157(254)216-127(87-280)167(264)223-142(97(15)227)174(271)220-139(90(6)7)172(269)211-121(81-225)161(258)199-109(49-29-35-64-181)151(248)202-112(58-59-132(232)233)154(251)215-125(85-278)166(263)206-117(73-101-77-188-104-45-25-24-44-103(101)104)155(252)194-95(13)175(272)224-68-39-53-128(224)168(265)217-126(86-279)164(261)200-108(48-28-34-63-180)148(245)193-93(11)143(240)192-94(12)144(241)204-114(70-98-40-20-18-21-41-98)147(244)191-80-131(231)218-137(88(2)3)170(267)208-118(74-133(234)235)156(253)197-105(52-38-67-187-177(185)186)145(242)189-78-129(229)196-107(47-27-33-62-179)150(247)212-123(83-276)163(260)203-113(60-69-281-16)146(243)190-79-130(230)195-106(46-26-32-61-178)149(246)198-110(50-30-36-65-182)152(249)213-122(82-275)162(259)201-111(51-31-37-66-183)153(250)214-124(84-277)165(262)205-115(72-100-54-56-102(228)57-55-100)158(255)221-140(91(8)9)176(273)274/h18-25,40-45,54-57,77,88-97,105-128,136-142,188,225-228,275-280H,17,26-39,46-53,58-76,78-87,178-184H2,1-16H3,(H,189,242)(H,190,243)(H,191,244)(H,192,240)(H,193,245)(H,194,252)(H,195,230)(H,196,229)(H,197,253)(H,198,246)(H,199,258)(H,200,261)(H,201,259)(H,202,248)(H,203,260)(H,204,241)(H,205,262)(H,206,263)(H,207,266)(H,208,267)(H,209,268)(H,210,270)(H,211,269)(H,212,247)(H,213,249)(H,214,250)(H,215,251)(H,216,254)(H,217,265)(H,218,231)(H,219,257)(H,220,271)(H,221,255)(H,222,256)(H,223,264)(H,232,233)(H,234,235)(H,236,237)(H,238,239)(H,273,274)(H4,185,186,187)/t92-,93-,94-,95-,96+,97+,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,136-,137-,138-,139-,140-,141-,142-/m0/s1 D0YS9J DRUGINKE IYKSHBADGOZWIF-UTPLJIOFSA-N D0YS9J DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CS)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)N3CCCC3C(=O)NC(CS)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CCSC)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)N D0YS9J HIGHSTAT Investigative D0YT6O DRUG__ID D0YT6O D0YT6O DRUGTYPE Small molecular drug D0YT6O DRUGINCH 1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1 D0YT6O DRUGINKE WHBMMWSBFZVSSR-VKHMYHEASA-N D0YT6O DRUGSMIL CC(CC(=O)O)O D0YT6O HIGHSTAT Investigative D0YU4D DRUG__ID D0YU4D D0YU4D DRUGTYPE Small molecular drug D0YU4D DRUGINCH 1S/C15H22N2O3/c1-4-5-6-11-19-14-9-7-13(8-10-14)16-15(18)20-17-12(2)3/h7-10H,4-6,11H2,1-3H3,(H,16,18) D0YU4D DRUGINKE OBNDMPDDMGXHSO-UHFFFAOYSA-N D0YU4D DRUGSMIL CCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D0YU4D HIGHSTAT Investigative D0YU5H DRUG__ID D0YU5H D0YU5H DRUGTYPE Small molecular drug D0YU5H DRUGINCH 1S/C20H19N3O2/c21-20(24)17-8-11-19(23-14-17)25-18-9-6-16(7-10-18)13-22-12-15-4-2-1-3-5-15/h1-11,14,22H,12-13H2,(H2,21,24) D0YU5H DRUGINKE LUBVSQAMVPXMBJ-UHFFFAOYSA-N D0YU5H DRUGSMIL C1=CC=C(C=C1)CNCC2=CC=C(C=C2)OC3=NC=C(C=C3)C(=O)N D0YU5H HIGHSTAT Investigative D0YU8J DRUG__ID D0YU8J D0YU8J DRUGTYPE Small molecular drug D0YU8J DRUGINCH 1S/C6H7ClN2O2S/c7-5-3-4(12(9,10)11)1-2-6(5)8/h1-3H,8H2,(H2,9,10,11) D0YU8J DRUGINKE LFIOFZKZCDMGFG-UHFFFAOYSA-N D0YU8J DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)Cl)N D0YU8J HIGHSTAT Investigative D0YU9L DRUG__ID D0YU9L D0YU9L DRUGTYPE Small molecular drug D0YU9L DRUGINCH 1S/C3H5N5O/c4-2(5)1-3(6)8-9-7-1/h(H3,4,5)(H2,6,8) D0YU9L DRUGINKE YHIJOLKAHGHVML-UHFFFAOYSA-N D0YU9L DRUGSMIL C1(=NON=C1N)C(=N)N D0YU9L HIGHSTAT Investigative D0YU9Z DRUG__ID D0YU9Z D0YU9Z DRUGTYPE Small molecular drug D0YU9Z DRUGINCH 1S/C15H20O/c1-3-5-6-7-8-13-9-11-14(12-10-13)15(16)4-2/h4,9-12H,2-3,5-8H2,1H3 D0YU9Z DRUGINKE IINHTEWASPUCMH-UHFFFAOYSA-N D0YU9Z DRUGSMIL CCCCCCC1=CC=C(C=C1)C(=O)C=C D0YU9Z HIGHSTAT Investigative D0YV1R DRUG__ID D0YV1R D0YV1R DRUGTYPE Small molecular drug D0YV1R DRUGINCH 1S/C17H26N6O/c1-9(2)22(3)17-21-14-15(18-8-19-16(14)23(17)4)20-12-6-11-5-10(12)7-13(11)24/h8-13,24H,5-7H2,1-4H3,(H,18,19,20)/t10?,11?,12-,13?/m1/s1 D0YV1R DRUGINKE FTVZUYADPTUEKI-AYNROABZSA-N D0YV1R DRUGSMIL CC(C)N(C)C1=NC2=C(N=CN=C2N1C)NC3CC4CC3CC4O D0YV1R HIGHSTAT Investigative D0YW4C DRUG__ID D0YW4C D0YW4C DRUGTYPE Small molecular drug D0YW4C DRUGINCH 1S/C15H11NO3/c1-2-9-7-12(18)8-13-14(9)19-15(16-13)10-3-5-11(17)6-4-10/h2-8,17-18H,1H2 D0YW4C DRUGINKE DNOMWUYUDHLCAY-UHFFFAOYSA-N D0YW4C DRUGSMIL C=CC1=C2C(=CC(=C1)O)N=C(O2)C3=CC=C(C=C3)O D0YW4C HIGHSTAT Investigative D0YW9C DRUG__ID D0YW9C D0YW9C DRUGTYPE Small molecular drug D0YW9C DRUGINCH 1S/C18H17NO2/c1-12-13(2)19(11-14-7-4-3-5-8-14)17-15(12)9-6-10-16(17)18(20)21/h3-10H,11H2,1-2H3,(H,20,21) D0YW9C DRUGINKE NSKDMNCONIAVGH-UHFFFAOYSA-N D0YW9C DRUGSMIL CC1=C(N(C2=C1C=CC=C2C(=O)O)CC3=CC=CC=C3)C D0YW9C HIGHSTAT Investigative D0YX4U DRUG__ID D0YX4U D0YX4U DRUGTYPE Small molecular drug D0YX4U DRUGINCH 1S/C7H8N5O5P/c8-7-11-5-4(6(13)12-7)10-3(1-9-5)2-17-18(14,15)16/h1H,2H2,(H2,14,15,16)(H3,8,9,11,12,13) D0YX4U DRUGINKE AJXFJEHKGGCFNM-UHFFFAOYSA-N D0YX4U DRUGSMIL C1=C(N=C2C(=O)NC(=NC2=N1)N)COP(=O)(O)O D0YX4U HIGHSTAT Investigative D0YX4V DRUG__ID D0YX4V D0YX4V DRUGTYPE Small molecular drug D0YX4V DRUGINCH 1S/C31H39FN4O9/c1-18(2)27(30(42)33-19(3)28(40)34-23(25(38)16-32)15-26(39)44-4)36-29(41)24(14-20-10-12-22(37)13-11-20)35-31(43)45-17-21-8-6-5-7-9-21/h5-13,18-19,23-24,27,37H,14-17H2,1-4H3,(H,33,42)(H,34,40)(H,35,43)(H,36,41)/t19-,23-,24-,27-/m0/s1 D0YX4V DRUGINKE MVPQJUFFTWWKBT-LBDWYMBGSA-N D0YX4V DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)OCC2=CC=CC=C2 D0YX4V HIGHSTAT Investigative D0YX5U DRUG__ID D0YX5U D0YX5U DRUGTYPE Small molecular drug D0YX5U DRUGINCH 1S/C23H25NO/c1-18(2)24(17-19-8-4-3-5-9-19)15-14-23(25)22-13-12-20-10-6-7-11-21(20)16-22/h3-13,16,18H,14-15,17H2,1-2H3 D0YX5U DRUGINKE JSASWRWALCMOQP-UHFFFAOYSA-N D0YX5U DRUGSMIL CC(C)N(CCC(=O)C1=CC2=CC=CC=C2C=C1)CC3=CC=CC=C3 D0YX5U HIGHSTAT Investigative D0YX9D DRUG__ID D0YX9D D0YX9D DRUGTYPE Small molecular drug D0YX9D DRUGINCH 1S/C6H11NO4S/c1-12-3-2-4(5(8)9)7-6(10)11/h4,7H,2-3H2,1H3,(H,8,9)(H,10,11)/t4-/m0/s1 D0YX9D DRUGINKE LWQBAQJPCYBWJQ-BYPYZUCNSA-N D0YX9D DRUGSMIL CSCCC(C(=O)O)NC(=O)O D0YX9D HIGHSTAT Investigative D0YY2L DRUG__ID D0YY2L D0YY2L DRUGTYPE Small molecular drug D0YY2L DRUGINCH 1S/C9H21O3PS/c1-6-9(14)13(10,11-7(2)3)12-8(4)5/h7-9,14H,6H2,1-5H3 D0YY2L DRUGINKE SGAGKIQXGMCPPU-UHFFFAOYSA-N D0YY2L DRUGSMIL CCC(P(=O)(OC(C)C)OC(C)C)S D0YY2L HIGHSTAT Investigative D0YY2W DRUG__ID D0YY2W D0YY2W DRUGTYPE Small molecular drug D0YY2W DRUGINCH 1S/C9H8N4S2/c14-8(12-9-13-10-6-15-9)11-7-4-2-1-3-5-7/h1-6H,(H2,11,12,13,14) D0YY2W DRUGINKE CSUHGRXUQXQHRB-UHFFFAOYSA-N D0YY2W DRUGSMIL C1=CC=C(C=C1)NC(=S)NC2=NN=CS2 D0YY2W HIGHSTAT Investigative D0YY3T DRUG__ID D0YY3T D0YY3T DRUGTYPE Small molecular drug D0YY3T DRUGINCH 1S/C43H55N9O10/c1-25(55)47-37(24-54)43(62)50-33(19-26-9-3-2-4-10-26)40(59)51-35(21-28-22-46-31-12-6-5-11-30(28)31)42(61)48-32(13-7-8-18-44)39(58)49-34(20-27-14-16-29(56)17-15-27)41(60)52-36(23-53)38(45)57/h2-6,9-12,14-17,22,32-37,46,53-54,56H,7-8,13,18-21,23-24,44H2,1H3,(H2,45,57)(H,47,55)(H,48,61)(H,49,58)(H,50,62)(H,51,59)(H,52,60)/t32-,33-,34-,35-,36-,37-/m0/s1 D0YY3T DRUGINKE QNAVIRFMKUQHRS-DUGSHLAESA-N D0YY3T DRUGSMIL CC(=O)NC(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCCN)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CO)C(=O)N D0YY3T HIGHSTAT Investigative D0YY9M DRUG__ID D0YY9M D0YY9M DRUGTYPE Small molecular drug D0YY9M DRUGINCH 1S/C14H20N2O3/c17-13(16-19)10-6-1-2-7-11-15-14(18)12-8-4-3-5-9-12/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,18)(H,16,17) D0YY9M DRUGINKE ATWJTSVDLBPZQP-UHFFFAOYSA-N D0YY9M DRUGSMIL C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO D0YY9M HIGHSTAT Investigative D0YZ0L DRUG__ID D0YZ0L D0YZ0L DRUGTYPE Small molecular drug D0YZ0L DRUGINCH 1S/C17H22O2/c1-3-4-5-6-8-16-13-14(2)11-12-15(16)9-7-10-17(18)19/h6-9,11-13H,3-5,10H2,1-2H3,(H,18,19)/b8-6+,9-7+ D0YZ0L DRUGINKE BPISPUIKHXBPSU-CDJQDVQCSA-N D0YZ0L DRUGSMIL CCCCC=CC1=C(C=CC(=C1)C)C=CCC(=O)O D0YZ0L HIGHSTAT Investigative D0YZ3E DRUG__ID D0YZ3E D0YZ3E DRUGTYPE Small molecular drug D0YZ3E DRUGINCH 1S/C22H19NOS/c24-22(16-8-11-17-9-2-1-3-10-17)23-18-12-4-6-14-20(18)25-21-15-7-5-13-19(21)23/h1-7,9-10,12-15H,8,11,16H2 D0YZ3E DRUGINKE IDGMQHJPMVCZGQ-UHFFFAOYSA-N D0YZ3E DRUGSMIL C1=CC=C(C=C1)CCCC(=O)N2C3=CC=CC=C3SC4=CC=CC=C42 D0YZ3E HIGHSTAT Investigative D0YZ5G DRUG__ID D0YZ5G D0YZ5G DRUGTYPE Small molecular drug D0YZ5G DRUGINCH 1S/C9H6O4/c10-6-3-5-1-2-9(12)13-8(5)4-7(6)11/h1-4,10-11H D0YZ5G DRUGINKE ILEDWLMCKZNDJK-UHFFFAOYSA-N D0YZ5G DRUGSMIL C1=CC(=O)OC2=CC(=C(C=C21)O)O D0YZ5G HIGHSTAT Investigative D0YZ7H DRUG__ID D0YZ7H D0YZ7H DRUGTYPE Small molecular drug D0YZ7H DRUGINCH 1S/C18H16FN3O2/c1-23-15-7-10-6-14-17(13(10)9-16(15)24-2)21-22-18(14)20-12-5-3-4-11(19)8-12/h3-5,7-9H,6H2,1-2H3,(H2,20,21,22) D0YZ7H DRUGINKE ZDNURMVOKAERHZ-UHFFFAOYSA-N D0YZ7H DRUGSMIL COC1=C(C=C2C(=C1)CC3=C2NN=C3NC4=CC(=CC=C4)F)OC D0YZ7H HIGHSTAT Investigative D0YZ8G DRUG__ID D0YZ8G D0YZ8G DRUGTYPE Small molecular drug D0YZ8G DRUGINCH 1S/C17H11ClN2/c1-11-2-3-12-4-5-13(9-17(12)20-11)16-7-6-15(18)8-14(16)10-19/h2-9H,1H3 D0YZ8G DRUGINKE BYFVDRQULSVRKZ-UHFFFAOYSA-N D0YZ8G DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=C(C=C(C=C3)Cl)C#N D0YZ8G HIGHSTAT Investigative D0Z0AA DRUG__ID D0Z0AA D0Z0AA DRUGTYPE Small molecular drug D0Z0AA DRUGINCH 1S/C8H8O3/c1-11-8(10)6-4-2-3-5-7(6)9/h2-5,9H,1H3 D0Z0AA DRUGINKE OSWPMRLSEDHDFF-UHFFFAOYSA-N D0Z0AA DRUGSMIL COC(=O)C1=CC=CC=C1O D0Z0AA HIGHSTAT Investigative D0Z0AS DRUG__ID D0Z0AS D0Z0AS DRUGCOMP Central Drug Research Institute D0Z0AS DRUGINCH 1S/C17H24FN3O/c18-15-4-6-16(7-5-15)20-13-11-19(12-14-20)8-2-10-21-9-1-3-17(21)22/h4-7H,1-3,8-14H2 D0Z0AS DRUGINKE IXBOMVODGPKDJS-UHFFFAOYSA-N D0Z0AS DRUGSMIL C1CC(=O)N(C1)CCCN2CCN(CC2)C3=CC=C(C=C3)F D0Z0AS HIGHSTAT Investigative D0Z0BB DRUG__ID D0Z0BB D0Z0BB DRUGTYPE Small molecular drug D0Z0BB DRUGINCH 1S/C7H6Cl2S/c8-6-2-1-5(4-10)3-7(6)9/h1-3,10H,4H2 D0Z0BB DRUGINKE CEGBRSQPRQXALB-UHFFFAOYSA-N D0Z0BB DRUGSMIL C1=CC(=C(C=C1CS)Cl)Cl D0Z0BB HIGHSTAT Investigative D0Z0EF DRUG__ID D0Z0EF D0Z0EF DRUGTYPE Small molecular drug D0Z0EF DRUGINCH 1S/C9H9I2NO3/c10-5-1-4(2-6(11)8(5)13)3-7(12)9(14)15/h1-2,7,13H,3,12H2,(H,14,15)/t7-/m0/s1 D0Z0EF DRUGINKE NYPYHUZRZVSYKL-ZETCQYMHSA-N D0Z0EF DRUGSMIL C1=C(C=C(C(=C1I)O)I)CC(C(=O)O)N D0Z0EF HIGHSTAT Investigative D0Z0IR DRUG__ID D0Z0IR D0Z0IR DRUGTYPE Small molecular drug D0Z0IR DRUGINCH 1S/C12H14O2/c13-12(14)11-7-6-10(8-11)9-4-2-1-3-5-9/h1-5,10-11H,6-8H2,(H,13,14) D0Z0IR DRUGINKE IWOLSKRVZNXDNU-UHFFFAOYSA-N D0Z0IR DRUGSMIL C1CC(CC1C2=CC=CC=C2)C(=O)O D0Z0IR HIGHSTAT Investigative D0Z0JF DRUG__ID D0Z0JF D0Z0JF DRUGTYPE Small molecular drug D0Z0JF DRUGINCH 1S/C15H13NO/c1-12-6-8-14(16-11-12)9-7-13-4-3-5-15(10-13)17-2/h3-6,8,10-11H,1-2H3 D0Z0JF DRUGINKE CCQPQKFLWKYOMJ-UHFFFAOYSA-N D0Z0JF DRUGSMIL CC1=CN=C(C=C1)C#CC2=CC(=CC=C2)OC D0Z0JF HIGHSTAT Investigative D0Z0JU DRUG__ID D0Z0JU D0Z0JU DRUGTYPE Small molecular drug D0Z0JU DRUGINCH 1S/C12H13N3O/c1-2-16-10-6-5-9-14-12(10)15-11-7-3-4-8-13-11/h3-9H,2H2,1H3,(H,13,14,15) D0Z0JU DRUGINKE QXDACVHUAQTTKS-UHFFFAOYSA-N D0Z0JU DRUGSMIL CCOC1=C(N=CC=C1)NC2=CC=CC=N2 D0Z0JU HIGHSTAT Investigative D0Z0KH DRUG__ID D0Z0KH D0Z0KH DRUGTYPE Small molecular drug D0Z0KH DRUGINCH 1S/C4H5N/c1-2-4-5-3-1/h1-5H D0Z0KH DRUGINKE KAESVJOAVNADME-UHFFFAOYSA-N D0Z0KH DRUGSMIL C1=CNC=C1 D0Z0KH HIGHSTAT Investigative D0Z0KY DRUG__ID D0Z0KY D0Z0KY DRUGTYPE Small molecular drug D0Z0KY DRUGINCH 1S/C27H28F2N2O4S/c1-18(35-2)20-6-11-26(25(29)16-20)30-12-14-31(15-13-30)27(32)24-17-22(36(3,33)34)9-10-23(24)19-4-7-21(28)8-5-19/h4-11,16-18H,12-15H2,1-3H3 D0Z0KY DRUGINKE JQXZHDOSMUZLML-UHFFFAOYSA-N D0Z0KY DRUGSMIL CC(C1=CC(=C(C=C1)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)S(=O)(=O)C)C4=CC=C(C=C4)F)F)OC D0Z0KY HIGHSTAT Investigative D0Z0LP DRUG__ID D0Z0LP D0Z0LP DRUGTYPE Small molecular drug D0Z0LP DRUGINCH 1S/C22H29NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,20-22,24H,8,13-17H2,1H3/t20-,21+,22+/m0/s1 D0Z0LP DRUGINKE MUSFCRGEWKAWEE-BHDDXSALSA-N D0Z0LP DRUGSMIL CN1C(CCCC1CC(C2=CC=CC=C2)O)CCC3=CC=CC=C3 D0Z0LP HIGHSTAT Investigative D0Z0LV DRUG__ID D0Z0LV D0Z0LV DRUGTYPE Small molecular drug D0Z0LV DRUGINCH 1S/C18H15FN2O/c19-15-4-1-3-13(11-15)7-9-16-10-8-14(12-20-16)18(22)21-17-5-2-6-17/h1,3-4,8,10-12,17H,2,5-6H2,(H,21,22) D0Z0LV DRUGINKE NEMHWVUKNWAKTM-UHFFFAOYSA-N D0Z0LV DRUGSMIL C1CC(C1)NC(=O)C2=CN=C(C=C2)C#CC3=CC(=CC=C3)F D0Z0LV HIGHSTAT Investigative D0Z0LX DRUG__ID D0Z0LX D0Z0LX DRUGTYPE Small molecular drug D0Z0LX DRUGINCH 1S/C21H27NO4/c1-4-6-15-25-18-9-7-16(8-10-18)20(5-2)22-21(23)26-19-13-11-17(24-3)12-14-19/h7-14,20H,4-6,15H2,1-3H3,(H,22,23) D0Z0LX DRUGINKE SOBJGOKNEOSMPL-UHFFFAOYSA-N D0Z0LX DRUGSMIL CCCCOC1=CC=C(C=C1)C(CC)NC(=O)OC2=CC=C(C=C2)OC D0Z0LX HIGHSTAT Investigative D0Z0QC DRUG__ID D0Z0QC D0Z0QC DRUGTYPE Small molecular drug D0Z0QC DRUGINCH 1S/C12H16N2O3/c1-4-16-11-7-5-10(6-8-11)13-12(15)17-14-9(2)3/h5-8H,4H2,1-3H3,(H,13,15) D0Z0QC DRUGINKE HAJFSNBTGAUVST-UHFFFAOYSA-N D0Z0QC DRUGSMIL CCOC1=CC=C(C=C1)NC(=O)ON=C(C)C D0Z0QC HIGHSTAT Investigative D0Z0QD DRUG__ID D0Z0QD D0Z0QD DRUGTYPE Small molecular drug D0Z0QD DRUGINCH 1S/C45H64N8O10/c1-23(2)19-31(46)39(56)50-37(25(5)6)43(60)51-36(24(3)4)42(59)49-34(20-27-14-16-29(55)17-15-27)44(61)53-18-10-13-35(53)41(58)48-33(40(57)52-38(26(7)54)45(62)63)21-28-22-47-32-12-9-8-11-30(28)32/h8-9,11-12,14-17,22-26,31,33-38,47,54-55H,10,13,18-21,46H2,1-7H3,(H,48,58)(H,49,59)(H,50,56)(H,51,60)(H,52,57)(H,62,63)/t26-,31+,33+,34+,35+,36+,37+,38+/m1/s1 D0Z0QD DRUGINKE BXIFNVGZIMFBQB-DYDSHOKNSA-N D0Z0QD DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(C(C)O)C(=O)O)N D0Z0QD HIGHSTAT Investigative D0Z0UC DRUG__ID D0Z0UC D0Z0UC DRUGTYPE Small molecular drug D0Z0UC DRUGINCH 1S/C21H16O3/c22-16-5-1-13(2-6-16)20-12-15-11-18(24)9-10-19(15)21(20)14-3-7-17(23)8-4-14/h1-11,22-24H,12H2 D0Z0UC DRUGINKE PTZCIKOPLAEWTE-UHFFFAOYSA-N D0Z0UC DRUGSMIL C1C2=C(C=CC(=C2)O)C(=C1C3=CC=C(C=C3)O)C4=CC=C(C=C4)O D0Z0UC HIGHSTAT Investigative D0Z0UQ DRUG__ID D0Z0UQ D0Z0UQ DRUGTYPE Small molecular drug D0Z0UQ DRUGINCH 1S/C5H10O2S/c6-5(7)3-1-2-4-8/h8H,1-4H2,(H,6,7) D0Z0UQ DRUGINKE GCIZMJUHGHGRNW-UHFFFAOYSA-N D0Z0UQ DRUGSMIL C(CCS)CC(=O)O D0Z0UQ HIGHSTAT Investigative D0Z0VF DRUG__ID D0Z0VF D0Z0VF DRUGTYPE Small molecular drug D0Z0VF DRUGINCH 1S/C9H11NO2/c1-9(10,8(11)12)7-5-3-2-4-6-7/h2-6H,10H2,1H3,(H,11,12)/t9-/m0/s1 D0Z0VF DRUGINKE HTCSFFGLRQDZDE-VIFPVBQESA-N D0Z0VF DRUGSMIL CC(C1=CC=CC=C1)(C(=O)O)N D0Z0VF HIGHSTAT Investigative D0Z0VL DRUG__ID D0Z0VL D0Z0VL DRUGTYPE Small molecular drug D0Z0VL DRUGINCH 1S/C31H46O18S2/c1-14(2)9-21(33)47-24-23(49-51(42,43)44)22(48-50(39,40)41)18(13-32)46-26(24)45-17-11-29(4)19-6-5-16-10-30(19,25(34)15(16)3)8-7-20(29)31(12-17,27(35)36)28(37)38/h14,16-20,22-26,32,34H,3,5-13H2,1-2,4H3,(H,35,36)(H,37,38)(H,39,40,41)(H,42,43,44)/t16-,17+,18-,19+,20+,22-,23+,24-,25+,26-,29+,30-/m1/s1 D0Z0VL DRUGINKE AQFATIOBERWBDY-LNQSNDDKSA-N D0Z0VL DRUGSMIL CC(C)CC(=O)OC1C(C(C(OC1OC2CC3(C4CCC5CC4(CCC3C(C2)(C(=O)O)C(=O)O)C(C5=C)O)C)CO)OS(=O)(=O)O)OS(=O)(=O)O D0Z0VL HIGHSTAT Investigative D0Z0XL DRUG__ID D0Z0XL D0Z0XL DRUGTYPE Small molecular drug D0Z0XL DRUGINCH 1S/C17H12N2O/c1-2-6-13-11-14(10-9-12(13)5-1)18-17-15-7-3-4-8-16(15)20-19-17/h1-11H,(H,18,19) D0Z0XL DRUGINKE KQZPQVBDFIHPIN-UHFFFAOYSA-N D0Z0XL DRUGSMIL C1=CC=C2C=C(C=CC2=C1)NC3=NOC4=CC=CC=C43 D0Z0XL HIGHSTAT Investigative D0Z0YB DRUG__ID D0Z0YB D0Z0YB DRUGTYPE Small molecular drug D0Z0YB DRUGINCH 1S/C21H16N2O2/c24-20-16-8-4-5-9-18(16)23-19-12-15(10-11-17(19)20)21(25)22-13-14-6-2-1-3-7-14/h1-12H,13H2,(H,22,25)(H,23,24) D0Z0YB DRUGINKE YUICSGTVFUPFFC-UHFFFAOYSA-N D0Z0YB DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC3=C(C=C2)C(=O)C4=CC=CC=C4N3 D0Z0YB HIGHSTAT Investigative D0Z0ZM DRUG__ID D0Z0ZM D0Z0ZM DRUGTYPE Small molecular drug D0Z0ZM DRUGINCH 1S/C10H12N2O4/c1-15-6-2-3-7-8(12(14)10(11)13)5-16-9(7)4-6/h2-4,8,14H,5H2,1H3,(H2,11,13)/t8-/m1/s1 D0Z0ZM DRUGINKE KQTIJEDPTHQHRM-MRVPVSSYSA-N D0Z0ZM DRUGSMIL COC1=CC2=C(C=C1)C(CO2)N(C(=O)N)O D0Z0ZM HIGHSTAT Investigative D0Z0ZP DRUG__ID D0Z0ZP D0Z0ZP DRUGTYPE Small molecular drug D0Z0ZP DRUGINCH 1S/C14H12N2/c1-11-3-4-12(2)14(7-11)6-5-13-8-15-10-16-9-13/h3-4,7-10H,1-2H3 D0Z0ZP DRUGINKE XOIZHMAWDAZINA-UHFFFAOYSA-N D0Z0ZP DRUGSMIL CC1=CC(=C(C=C1)C)C#CC2=CN=CN=C2 D0Z0ZP HIGHSTAT Investigative D0Z0ZU DRUG__ID D0Z0ZU D0Z0ZU DRUGTYPE Small molecular drug D0Z0ZU DRUGINCH 1S/C13H21NS/c1-3-4-9-15-13-7-5-12(6-8-13)10-11(2)14/h5-8,11H,3-4,9-10,14H2,1-2H3/t11-/m0/s1 D0Z0ZU DRUGINKE RRHFSAVFMIWFCE-NSHDSACASA-N D0Z0ZU DRUGSMIL CCCCSC1=CC=C(C=C1)CC(C)N D0Z0ZU HIGHSTAT Investigative D0Z1AL DRUG__ID D0Z1AL D0Z1AL DRUGTYPE Small molecular drug D0Z1AL DRUGINCH 1S/C14H14O2S/c1-15-12-8-11(9-13(10-12)16-2)5-6-14-4-3-7-17-14/h3-10H,1-2H3/b6-5+ D0Z1AL DRUGINKE URRYDXXEGGXDQJ-AATRIKPKSA-N D0Z1AL DRUGSMIL COC1=CC(=CC(=C1)C=CC2=CC=CS2)OC D0Z1AL HIGHSTAT Investigative D0Z1AT DRUG__ID D0Z1AT D0Z1AT DRUGTYPE Small molecular drug D0Z1AT DRUGINCH 1S/C19H26O3/c1-19-7-6-15-14-5-3-13(21)8-11(14)2-4-16(15)17(19)9-12(10-20)18(19)22/h3,5,8,12,15-18,20-22H,2,4,6-7,9-10H2,1H3/t12-,15?,16?,17?,18+,19+/m1/s1 D0Z1AT DRUGINKE MWYASXMURYJSCR-CMYKETFCSA-N D0Z1AT DRUGSMIL CC12CCC3C(C1CC(C2O)CO)CCC4=C3C=CC(=C4)O D0Z1AT HIGHSTAT Investigative D0Z1CL DRUG__ID D0Z1CL D0Z1CL DRUGTYPE Small molecular drug D0Z1CL DRUGINCH 1S/C6H6BBrO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4,9-10H D0Z1CL DRUGINKE QBLFZIBJXUQVRF-UHFFFAOYSA-N D0Z1CL DRUGSMIL B(C1=CC=C(C=C1)Br)(O)O D0Z1CL HIGHSTAT Investigative D0Z1DQ DRUG__ID D0Z1DQ D0Z1DQ DRUGTYPE Small molecular drug D0Z1DQ DRUGINCH 1S/C33H27NO8/c35-30(25-17-27(32(38)39)28(33(40)41)18-26(25)31(36)37)34(29-15-7-10-21-9-4-5-14-24(21)29)19-20-8-6-13-23(16-20)42-22-11-2-1-3-12-22/h1-6,8-9,11-14,16-18,29H,7,10,15,19H2,(H,36,37)(H,38,39)(H,40,41)/t29-/m0/s1 D0Z1DQ DRUGINKE VQGBOYBIENNKMI-LJAQVGFWSA-N D0Z1DQ DRUGSMIL C1CC(C2=CC=CC=C2C1)N(CC3=CC(=CC=C3)OC4=CC=CC=C4)C(=O)C5=CC(=C(C=C5C(=O)O)C(=O)O)C(=O)O D0Z1DQ HIGHSTAT Investigative D0Z1HV DRUG__ID D0Z1HV D0Z1HV DRUGTYPE Small molecular drug D0Z1HV DRUGINCH 1S/C30H48O4/c1-18-10-15-30(24(32)33)17-16-27(5)19(23(30)29(18,7)34)8-9-21-26(4)13-12-22(31)25(2,3)20(26)11-14-28(21,27)6/h8,18,20-23,31,34H,9-17H2,1-7H3,(H,32,33)/t18-,20+,21-,22+,23-,26+,27-,28-,29-,30+/m1/s1 D0Z1HV DRUGINKE ZZTYPLSBNNGEIS-OPAXANQDSA-N D0Z1HV DRUGSMIL CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1(C)O)C)C(=O)O D0Z1HV HIGHSTAT Investigative D0Z1HY DRUG__ID D0Z1HY D0Z1HY DRUGTYPE Small molecular drug D0Z1HY DRUGINCH 1S/C6H8ClN3O4S2/c7-3-1-4(8)6(16(10,13)14)2-5(3)15(9,11)12/h1-2H,8H2,(H2,9,11,12)(H2,10,13,14) D0Z1HY DRUGINKE IHJCXVZDYSXXFT-UHFFFAOYSA-N D0Z1HY DRUGSMIL C1=C(C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N)N D0Z1HY HIGHSTAT Investigative D0Z1ID DRUG__ID D0Z1ID D0Z1ID DRUGTYPE Small molecular drug D0Z1ID DRUGINCH 1S/C18H15NO3/c20-18(19-13-17-10-5-11-21-17)22-16-9-4-8-15(12-16)14-6-2-1-3-7-14/h1-12H,13H2,(H,19,20) D0Z1ID DRUGINKE OLMUNVAXPITDSI-UHFFFAOYSA-N D0Z1ID DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)OC(=O)NCC3=CC=CO3 D0Z1ID HIGHSTAT Investigative D0Z1LY DRUG__ID D0Z1LY D0Z1LY DRUGTYPE Small molecular drug D0Z1LY DRUGINCH 1S/C25H27FN4O2/c1-32-23-7-3-2-6-22(23)29-17-14-28(15-18-29)16-19-30(24-8-4-5-13-27-24)25(31)20-9-11-21(26)12-10-20/h2-13H,14-19H2,1H3 D0Z1LY DRUGINKE YJZYDPRMWYWYCG-UHFFFAOYSA-N D0Z1LY DRUGSMIL COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4=CC=C(C=C4)F D0Z1LY HIGHSTAT Investigative D0Z1MJ DRUG__ID D0Z1MJ D0Z1MJ DRUGTYPE Small molecular drug D0Z1MJ DRUGINCH 1S/C22H16O3S/c23-17-7-1-4-14(10-17)20-13-21(15-5-2-8-18(24)11-15)26-22(20)16-6-3-9-19(25)12-16/h1-13,23-25H D0Z1MJ DRUGINKE ZBWIOPSLXQDYEV-UHFFFAOYSA-N D0Z1MJ DRUGSMIL C1=CC(=CC(=C1)O)C2=CC(=C(S2)C3=CC(=CC=C3)O)C4=CC(=CC=C4)O D0Z1MJ HIGHSTAT Investigative D0Z1NH DRUG__ID D0Z1NH D0Z1NH DRUGTYPE Small molecular drug D0Z1NH DRUGINCH 1S/C21H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)22-19-18-20(19)23/h9-10,19-20,23H,2-8,11-18H2,1H3,(H,22,24)/b10-9-/t19-,20+/m1/s1 D0Z1NH DRUGINKE VCMSNKIQHBVCSW-VSEBXTFHSA-N D0Z1NH DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)NC1CC1O D0Z1NH HIGHSTAT Investigative D0Z1OC DRUG__ID D0Z1OC D0Z1OC DRUGTYPE Small molecular drug D0Z1OC DRUGINCH 1S/C15H8FN3O/c16-13-5-11(9-18)4-12(7-13)15(20)19-14-3-1-2-10(6-14)8-17/h1-7H,(H,19,20) D0Z1OC DRUGINKE YKPYRZLWZZAYPC-UHFFFAOYSA-N D0Z1OC DRUGSMIL C1=CC(=CC(=C1)NC(=O)C2=CC(=CC(=C2)C#N)F)C#N D0Z1OC HIGHSTAT Investigative D0Z1OF DRUG__ID D0Z1OF D0Z1OF DRUGTYPE Small molecular drug D0Z1OF DRUGINCH 1S/C32H39N3O/c36-32(33-30-18-11-15-26-14-6-7-16-28(26)30)20-5-2-10-21-34-22-24-35(25-23-34)31-19-9-8-17-29(31)27-12-3-1-4-13-27/h1,3-4,6-9,12-14,16-17,19,30H,2,5,10-11,15,18,20-25H2,(H,33,36) D0Z1OF DRUGINKE NMZIDFFHGCRAJV-UHFFFAOYSA-N D0Z1OF DRUGSMIL C1CC(C2=CC=CC=C2C1)NC(=O)CCCCCN3CCN(CC3)C4=CC=CC=C4C5=CC=CC=C5 D0Z1OF HIGHSTAT Investigative D0Z1OI DRUG__ID D0Z1OI D0Z1OI DRUGTYPE Small molecular drug D0Z1OI DRUGINCH 1S/C12H14N2O2/c1-2-12(7-10(15)14-11(12)16)8-3-5-9(13)6-4-8/h3-6H,2,7,13H2,1H3,(H,14,15,16) D0Z1OI DRUGINKE QPJZAHJMZUCFMF-UHFFFAOYSA-N D0Z1OI DRUGSMIL CCC1(CC(=O)NC1=O)C2=CC=C(C=C2)N D0Z1OI HIGHSTAT Investigative D0Z1PY DRUG__ID D0Z1PY D0Z1PY DRUGTYPE Small molecular drug D0Z1PY DRUGINCH 1S/C12H8FNS/c1-9-14-11(8-15-9)7-6-10-4-2-3-5-12(10)13/h2-5,8H,1H3 D0Z1PY DRUGINKE IDJAGQSTASLJRW-UHFFFAOYSA-N D0Z1PY DRUGSMIL CC1=NC(=CS1)C#CC2=CC=CC=C2F D0Z1PY HIGHSTAT Investigative D0Z1QU DRUG__ID D0Z1QU D0Z1QU DRUGTYPE Small molecular drug D0Z1QU DRUGINCH 1S/C34H47FN4O/c1-27(2)38-22-24-39(25-23-38)33(29-11-14-30(35)15-12-29)26-37-20-18-36(19-21-37)17-7-6-10-32-31-9-5-4-8-28(31)13-16-34(32)40-3/h4-5,8-9,11-16,27,33H,6-7,10,17-26H2,1-3H3 D0Z1QU DRUGINKE SLGLZEJKMBCODK-UHFFFAOYSA-N D0Z1QU DRUGSMIL CC(C)N1CCN(CC1)C(CN2CCN(CC2)CCCCC3=C(C=CC4=CC=CC=C43)OC)C5=CC=C(C=C5)F D0Z1QU HIGHSTAT Investigative D0Z1RC DRUG__ID D0Z1RC D0Z1RC DRUGTYPE Small molecular drug D0Z1RC DRUGINCH 1S/C27H31N5O3.ClH/c1-30-25-20(11-18(13-24(25)35-2)27(34)31-10-9-23(33)19(28)15-31)29-26(30)22-12-17-5-3-4-6-21(17)32(22)14-16-7-8-16;/h3-6,11-13,16,19,23,33H,7-10,14-15,28H2,1-2H3;1H/t19-,23+;/m0./s1 D0Z1RC DRUGINKE MULKOGJHUZTANI-ADMBKAPUSA-N D0Z1RC DRUGSMIL CN1C2=C(C=C(C=C2OC)C(=O)N3CCC(C(C3)N)O)N=C1C4=CC5=CC=CC=C5N4CC6CC6.Cl D0Z1RC HIGHSTAT Investigative D0Z1WF DRUG__ID D0Z1WF D0Z1WF DRUGTYPE Small molecular drug D0Z1WF DRUGINCH 1S/C13H13N3O3S/c1-19-12-6-2-10(3-7-12)15-16-11-4-8-13(9-5-11)20(14,17)18/h2-9H,1H3,(H2,14,17,18) D0Z1WF DRUGINKE IPDZIIYOQAEWIC-UHFFFAOYSA-N D0Z1WF DRUGSMIL COC1=CC=C(C=C1)N=NC2=CC=C(C=C2)S(=O)(=O)N D0Z1WF HIGHSTAT Investigative D0Z1WQ DRUG__ID D0Z1WQ D0Z1WQ DRUGTYPE Small molecular drug D0Z1WQ DRUGINCH 1S/C14H20O2/c1-13(2,3)9-7-10(14(4,5)6)12(16)11(15)8-9/h7-8H,1-6H3 D0Z1WQ DRUGINKE NOUZOVBGCDDMSX-UHFFFAOYSA-N D0Z1WQ DRUGSMIL CC(C)(C)C1=CC(=O)C(=O)C(=C1)C(C)(C)C D0Z1WQ HIGHSTAT Investigative D0Z1WW DRUG__ID D0Z1WW D0Z1WW DRUGTYPE Small molecular drug D0Z1WW DRUGINCH 1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)/t21-/m0/s1 D0Z1WW DRUGINKE ZKLPARSLTMPFCP-NRFANRHFSA-N D0Z1WW DRUGSMIL C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl D0Z1WW HIGHSTAT Investigative D0Z1WY DRUG__ID D0Z1WY D0Z1WY DRUGTYPE Small molecular drug D0Z1WY DRUGINCH 1S/C15H20ClN5O5/c1-15(24)10(23)8(4-22)26-13(15)21-6-17-9-11(18-7-2-3-25-5-7)19-14(16)20-12(9)21/h6-8,10,13,22-24H,2-5H2,1H3,(H,18,19,20)/t7-,8-,10-,13-,15-/m1/s1 D0Z1WY DRUGINKE PKAKDOUFCOQHOJ-RAPCHXAISA-N D0Z1WY DRUGSMIL CC1(C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)NC4CCOC4)CO)O)O D0Z1WY HIGHSTAT Investigative D0Z1XE DRUG__ID D0Z1XE D0Z1XE DRUGTYPE Small molecular drug D0Z1XE DRUGINCH 1S/C21H34O/c1-4-5-6-7-15-21(2,3)19-13-11-17(12-14-19)18-9-8-10-20(22)16-18/h11-14,18,20,22H,4-10,15-16H2,1-3H3/t18-,20+/m0/s1 D0Z1XE DRUGINKE CICRJVLFNFCUOX-AZUAARDMSA-N D0Z1XE DRUGSMIL CCCCCCC(C)(C)C1=CC=C(C=C1)C2CCCC(C2)O D0Z1XE HIGHSTAT Investigative D0Z1XR DRUG__ID D0Z1XR D0Z1XR DRUGTYPE Small molecular drug D0Z1XR DRUGINCH 1S/C10H12O2/c1-7(2)8-3-5-9(11)10(12)6-4-8/h3-7H,1-2H3,(H,11,12) D0Z1XR DRUGINKE WKEWHSLZDDZONF-UHFFFAOYSA-N D0Z1XR DRUGSMIL CC(C)C1=CC=C(C(=O)C=C1)O D0Z1XR HIGHSTAT Investigative D0Z1YK DRUG__ID D0Z1YK D0Z1YK DRUGCOMP Kitasato University D0Z1YK DRUGINCH 1S/C36H63NO12/c1-13-24(38)36(10,42)31-19(4)27-17(2)15-35(9,49-27)30(48-33-26(39)23(37-11)14-18(3)44-33)20(5)28(21(6)32(41)47-31)46-25-16-34(8,43-12)29(40)22(7)45-25/h18-26,28-31,33,37-40,42H,13-16H2,1-12H3/t18-,19+,20+,21-,22+,23+,24-,25+,26-,28+,29+,30-,31+,33+,34-,35-,36-/m1/s1 D0Z1YK DRUGINKE XOBMIYSKMVYGLU-DWHVFYFZSA-N D0Z1YK DRUGSMIL CCC(C(C)(C1C(C2=C(CC(O2)(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)NC)O)C)C)C)O)O D0Z1YK HIGHSTAT Investigative D0Z1ZI DRUG__ID D0Z1ZI D0Z1ZI DRUGTYPE Small molecular drug D0Z1ZI DRUGINCH 1S/C3H5NO4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6) D0Z1ZI DRUGINKE WBLZUCOIBUDNBV-UHFFFAOYSA-N D0Z1ZI DRUGSMIL C(C[N+](=O)[O-])C(=O)O D0Z1ZI HIGHSTAT Investigative D0Z2CL DRUG__ID D0Z2CL D0Z2CL DRUGTYPE Small molecular drug D0Z2CL DRUGINCH 1S/C15H11BrN4O/c16-9-5-7-10(8-6-9)18-14(21)13-11-3-1-2-4-12(11)19-15(17)20-13/h1-8H,(H,18,21)(H2,17,19,20) D0Z2CL DRUGINKE DYTZVUGMYADHJM-UHFFFAOYSA-N D0Z2CL DRUGSMIL C1=CC=C2C(=C1)C(=NC(=N2)N)C(=O)NC3=CC=C(C=C3)Br D0Z2CL HIGHSTAT Investigative D0Z2CN DRUG__ID D0Z2CN D0Z2CN DRUGTYPE Small molecular drug D0Z2CN DRUGINCH 1S/C15H8N4O2/c20-14-11-9-5-16-6-19(9)13-10(12(11)15(21)18-14)7-3-1-2-4-8(7)17-13/h1-6,20H,(H,18,21) D0Z2CN DRUGINKE KUWAFJHRXZRHJH-UHFFFAOYSA-N D0Z2CN DRUGSMIL C1=CC=C2C(=C1)C3=C4C(=C(NC4=O)O)C5=CN=CN5C3=N2 D0Z2CN HIGHSTAT Investigative D0Z2CY DRUG__ID D0Z2CY D0Z2CY DRUGTYPE Small molecular drug D0Z2CY DRUGINCH 1S/C20H21NO3S/c1-2-14-3-5-15(6-4-14)11-12-24-17-9-7-16(8-10-17)13-18-19(22)21-20(23)25-18/h3-10,18H,2,11-13H2,1H3,(H,21,22,23) D0Z2CY DRUGINKE CZKMWGGUVIBIOI-UHFFFAOYSA-N D0Z2CY DRUGSMIL CCC1=CC=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3 D0Z2CY HIGHSTAT Investigative D0Z2FF DRUG__ID D0Z2FF D0Z2FF DRUGTYPE Small molecular drug D0Z2FF DRUGINCH 1S/C23H23ClF2N2O/c1-2-3-11-27-12-9-23(10-13-27)15-28(20-8-7-16(24)14-17(20)23)22(29)21-18(25)5-4-6-19(21)26/h2,4-8,14H,1,3,9-13,15H2 D0Z2FF DRUGINKE QKPSTNGNDWHYCH-UHFFFAOYSA-N D0Z2FF DRUGSMIL C=CCCN1CCC2(CC1)CN(C3=C2C=C(C=C3)Cl)C(=O)C4=C(C=CC=C4F)F D0Z2FF HIGHSTAT Investigative D0Z2GH DRUG__ID D0Z2GH D0Z2GH DRUGCOMP Astellas Pharma Inc D0Z2GH DRUGINCH 1S/C29H42N4O6/c1-4-29(3)28(39)31-22(18-20-12-7-5-8-13-20)27(38)33-17-11-15-23(33)26(37)30-21(25(36)32-29)14-9-6-10-16-24(35)19(2)34/h5,7-8,12-13,19,21-23,34H,4,6,9-11,14-18H2,1-3H3,(H,30,37)(H,31,39)(H,32,36)/t19-,21+,22+,23-,29+/m1/s1 D0Z2GH DRUGINKE XQURZRWZWZDDKH-XLSSLVJHSA-N D0Z2GH DRUGSMIL CCC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCC(=O)C(C)O)CC3=CC=CC=C3)C D0Z2GH HIGHSTAT Investigative D0Z2JN DRUG__ID D0Z2JN D0Z2JN DRUGTYPE Small molecular drug D0Z2JN DRUGINCH 1S/C17H18N2O3/c20-16(18-12-14-9-5-2-6-10-14)15(17(21)19-22)11-13-7-3-1-4-8-13/h1-10,15,22H,11-12H2,(H,18,20)(H,19,21) D0Z2JN DRUGINKE WKIMWNKNDQXNCK-UHFFFAOYSA-N D0Z2JN DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NCC2=CC=CC=C2)C(=O)NO D0Z2JN HIGHSTAT Investigative D0Z2KB DRUG__ID D0Z2KB D0Z2KB DRUGTYPE Small molecular drug D0Z2KB DRUGINCH 1S/C4H12NO3PS/c1-10-3-2-4(5)9(6,7)8/h4H,2-3,5H2,1H3,(H2,6,7,8)/t4-/m1/s1 D0Z2KB DRUGINKE XKCSXHUCPYVQIW-SCSAIBSYSA-N D0Z2KB DRUGSMIL CSCCC(N)P(=O)(O)O D0Z2KB HIGHSTAT Investigative D0Z2MJ DRUG__ID D0Z2MJ D0Z2MJ DRUGTYPE Small molecular drug D0Z2MJ DRUGINCH 1S/C13H9BrN2O2S/c14-9-3-1-4-10(7-9)19(17,18)13-6-2-5-12(16)11(13)8-15/h1-7H,16H2 D0Z2MJ DRUGINKE YZHGYTBCSXZBDO-UHFFFAOYSA-N D0Z2MJ DRUGSMIL C1=CC(=CC(=C1)Br)S(=O)(=O)C2=CC=CC(=C2C#N)N D0Z2MJ HIGHSTAT Investigative D0Z2PJ DRUG__ID D0Z2PJ D0Z2PJ DRUGTYPE Small molecular drug D0Z2PJ DRUGINCH 1S/C16H14N2OS/c17-16(18)15-9-12-13(7-4-8-14(12)20-15)19-10-11-5-2-1-3-6-11/h1-9H,10H2,(H3,17,18) D0Z2PJ DRUGINKE BMADCBRXHDOABZ-UHFFFAOYSA-N D0Z2PJ DRUGSMIL C1=CC=C(C=C1)COC2=C3C=C(SC3=CC=C2)C(=N)N D0Z2PJ HIGHSTAT Investigative D0Z2QM DRUG__ID D0Z2QM D0Z2QM DRUGTYPE Small molecular drug D0Z2QM DRUGINCH 1S/C8H11N5/c1-5(2)13-4-12-8-6(13)7(9)10-3-11-8/h3-5H,1-2H3,(H2,9,10,11) D0Z2QM DRUGINKE WAPXYHTXSGPYEX-UHFFFAOYSA-N D0Z2QM DRUGSMIL CC(C)N1C=NC2=NC=NC(=C21)N D0Z2QM HIGHSTAT Investigative D0Z2QV DRUG__ID D0Z2QV D0Z2QV DRUGTYPE Small molecular drug D0Z2QV DRUGINCH 1S/C10H23O3PS/c1-2-3-4-5-6-7-8-9-10-13-14(11,12)15/h2-10H2,1H3,(H2,11,12,15) D0Z2QV DRUGINKE ISIPUCJUDOMIDU-UHFFFAOYSA-N D0Z2QV DRUGSMIL CCCCCCCCCCOP(=S)(O)O D0Z2QV HIGHSTAT Investigative D0Z2RR DRUG__ID D0Z2RR D0Z2RR DRUGTYPE Small molecular drug D0Z2RR DRUGINCH 1S/C5H12N2O2/c6-1-3-5(9)4(8)2-7-3/h3-5,7-9H,1-2,6H2 D0Z2RR DRUGINKE PTUICKYMXFZVGV-UHFFFAOYSA-N D0Z2RR DRUGSMIL C1C(C(C(N1)CN)O)O D0Z2RR HIGHSTAT Investigative D0Z2SL DRUG__ID D0Z2SL D0Z2SL DRUGTYPE Small molecular drug D0Z2SL DRUGINCH 1S/C23H31NO4/c1-12-5-6-17-21(2,3)18(26)7-8-23(17)22(12,4)10-14-16(25)9-13-15(19(14)28-23)11-24-20(13)27/h9,12,17-18,25-26H,5-8,10-11H2,1-4H3,(H,24,27)/t12-,17-,18-,22+,23-/m0/s1 D0Z2SL DRUGINKE KUWCILGWLAWLGB-SFJHCMNLSA-N D0Z2SL DRUGSMIL CC1CCC2C(C(CCC23C1(CC4=C(C=C5C(=C4O3)CNC5=O)O)C)O)(C)C D0Z2SL HIGHSTAT Investigative D0Z2TG DRUG__ID D0Z2TG D0Z2TG DRUGTYPE Small molecular drug D0Z2TG DRUGINCH 1S/C34H24O22/c35-10-1-6-15(23(43)19(10)39)16-7(2-11(36)20(40)24(16)44)31(48)54-27-14(5-52-30(6)47)53-34(51)29-28(27)55-32(49)8-3-12(37)21(41)25(45)17(8)18-9(33(50)56-29)4-13(38)22(42)26(18)46/h1-4,14,27-29,34-46,51H,5H2/t14-,27-,28+,29-,34?/m1/s1 D0Z2TG DRUGINKE IYMHVUYNBVWXKH-ZITZVVOASA-N D0Z2TG DRUGSMIL C1C2C(C3C(C(O2)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O3)O)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6C7=C(C(=C(C=C7C(=O)O1)O)O)O)O)O)O D0Z2TG HIGHSTAT Investigative D0Z2TV DRUG__ID D0Z2TV D0Z2TV DRUGTYPE Small molecular drug D0Z2TV DRUGINCH 1S/C28H28FN5O4/c1-37-22-14-12-21(13-15-22)34(26(35)18-33-25-7-3-2-6-24(25)31-32-33)27(19-8-10-20(29)11-9-19)28(36)30-17-23-5-4-16-38-23/h2-3,6-15,23,27H,4-5,16-18H2,1H3,(H,30,36) D0Z2TV DRUGINKE HIWKGPKZDUQDKF-UHFFFAOYSA-N D0Z2TV DRUGSMIL COC1=CC=C(C=C1)N(C(C2=CC=C(C=C2)F)C(=O)NCC3CCCO3)C(=O)CN4C5=CC=CC=C5N=N4 D0Z2TV HIGHSTAT Investigative D0Z2VP DRUG__ID D0Z2VP D0Z2VP DRUGTYPE Small molecular drug D0Z2VP DRUGINCH 1S/C15H21NO3/c17-14(13-9-5-4-6-10-13)11-7-2-1-3-8-12-15(18)16-19/h4-6,9-10,19H,1-3,7-8,11-12H2,(H,16,18) D0Z2VP DRUGINKE ZCJNQRRQDXSGEO-UHFFFAOYSA-N D0Z2VP DRUGSMIL C1=CC=C(C=C1)C(=O)CCCCCCCC(=O)NO D0Z2VP HIGHSTAT Investigative D0Z2XR DRUG__ID D0Z2XR D0Z2XR DRUGTYPE Small molecular drug D0Z2XR DRUGINCH 1S/C17H16O2/c1-11-3-6-13(7-4-11)16-10-15(18)14-8-5-12(2)9-17(14)19-16/h3-9,16H,10H2,1-2H3 D0Z2XR DRUGINKE MIEPNGHJBCGJAW-UHFFFAOYSA-N D0Z2XR DRUGSMIL CC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)C D0Z2XR HIGHSTAT Investigative D0Z3BM DRUG__ID D0Z3BM D0Z3BM DRUGTYPE Small molecular drug D0Z3BM DRUGINCH 1S/C19H19F3O2/c20-19(21,22)18(23)9-5-2-6-14-24-17-12-10-16(11-13-17)15-7-3-1-4-8-15/h1,3-4,7-8,10-13H,2,5-6,9,14H2 D0Z3BM DRUGINKE JQEVPQYABGWLCL-UHFFFAOYSA-N D0Z3BM DRUGSMIL C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCC(=O)C(F)(F)F D0Z3BM HIGHSTAT Investigative D0Z3BT DRUG__ID D0Z3BT D0Z3BT DRUGTYPE Small molecular drug D0Z3BT DRUGINCH 1S/C22H23N3O/c1-22(2,3)15-20(26)24-19-14-18(16-10-6-4-7-11-16)23-21(25-19)17-12-8-5-9-13-17/h4-14H,15H2,1-3H3,(H,23,24,25,26) D0Z3BT DRUGINKE HRLXAMBTUIRRBL-UHFFFAOYSA-N D0Z3BT DRUGSMIL CC(C)(C)CC(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D0Z3BT HIGHSTAT Investigative D0Z3CC DRUG__ID D0Z3CC D0Z3CC DRUGTYPE Small molecular drug D0Z3CC DRUGINCH 1S/C18H16N2O3/c21-14-11-16(23-17(12-14)20-7-9-22-10-8-20)15-5-1-3-13-4-2-6-19-18(13)15/h1-6,11-12H,7-10H2 D0Z3CC DRUGINKE GJFZIARIYRYNDJ-UHFFFAOYSA-N D0Z3CC DRUGSMIL C1COCCN1C2=CC(=O)C=C(O2)C3=CC=CC4=C3N=CC=C4 D0Z3CC HIGHSTAT Investigative D0Z3CK DRUG__ID D0Z3CK D0Z3CK DRUGTYPE Small molecular drug D0Z3CK DRUGINCH 1S/C21H25BrN2O2S/c1-2-24(12-13-25)11-3-4-14-26-18-9-10-19-20(15-18)27-23-21(19)16-5-7-17(22)8-6-16/h5-10,15,25H,2-4,11-14H2,1H3 D0Z3CK DRUGINKE XHOKJNHLSGAYJL-UHFFFAOYSA-N D0Z3CK DRUGSMIL CCN(CCCCOC1=CC2=C(C=C1)C(=NS2)C3=CC=C(C=C3)Br)CCO D0Z3CK HIGHSTAT Investigative D0Z3CZ DRUG__ID D0Z3CZ D0Z3CZ DRUGTYPE Small molecular drug D0Z3CZ DRUGINCH 1S/C14H17N3O2S/c1-11-9-16-7-8-17(11)20(18,19)14-4-2-3-12-10-15-6-5-13(12)14/h2-6,10-11,16H,7-9H2,1H3 D0Z3CZ DRUGINKE BDVFVCGFMNCYPV-UHFFFAOYSA-N D0Z3CZ DRUGSMIL CC1CNCCN1S(=O)(=O)C2=CC=CC3=C2C=CN=C3 D0Z3CZ HIGHSTAT Investigative D0Z3DW DRUG__ID D0Z3DW D0Z3DW DRUGTYPE Small molecular drug D0Z3DW DRUGINCH 1S/C17H10O3/c18-17(15-9-11-5-1-3-7-13(11)19-15)16-10-12-6-2-4-8-14(12)20-16/h1-10H D0Z3DW DRUGINKE ZLYFWIZGRHGKMM-UHFFFAOYSA-N D0Z3DW DRUGSMIL C1=CC=C2C(=C1)C=C(O2)C(=O)C3=CC4=CC=CC=C4O3 D0Z3DW HIGHSTAT Investigative D0Z3EG DRUG__ID D0Z3EG D0Z3EG DRUGTYPE Small molecular drug D0Z3EG DRUGINCH 1S/C7H10N2O4/c1-3-5(13-9-6(3)10)2-4(8)7(11)12/h4H,2,8H2,1H3,(H,9,10)(H,11,12) D0Z3EG DRUGINKE QQKCZEULAPHDJP-UHFFFAOYSA-N D0Z3EG DRUGSMIL CC1=C(ONC1=O)CC(C(=O)O)N D0Z3EG HIGHSTAT Investigative D0Z3FP DRUG__ID D0Z3FP D0Z3FP DRUGTYPE Small molecular drug D0Z3FP DRUGINCH 1S/C16H16N2O2/c1-2-3-8-20-16(19)14-9-12-11-6-4-5-7-13(11)18-15(12)10-17-14/h4-7,9-10,18H,2-3,8H2,1H3 D0Z3FP DRUGINKE WGNGIELOOKACSB-UHFFFAOYSA-N D0Z3FP DRUGSMIL CCCCOC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2 D0Z3FP HIGHSTAT Investigative D0Z3FX DRUG__ID D0Z3FX D0Z3FX DRUGTYPE Small molecular drug D0Z3FX DRUGINCH 1S/C22H22O13/c1-32-20-10(26)5-11-13(15(20)28)16(29)21(19(33-11)7-2-3-8(24)9(25)4-7)35-22-18(31)17(30)14(27)12(6-23)34-22/h2-5,12,14,17-18,22-28,30-31H,6H2,1H3/t12-,14+,17+,18-,22+/m1/s1 D0Z3FX DRUGINKE AFBZFRQNKMLRPU-UFJVGALSSA-N D0Z3FX DRUGSMIL COC1=C(C2=C(C=C1O)OC(=C(C2=O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)O)O D0Z3FX HIGHSTAT Investigative D0Z3GC DRUG__ID D0Z3GC D0Z3GC DRUGTYPE Small molecular drug D0Z3GC DRUGINCH 1S/C41H55N5O6S/c1-7-45(8-2)19-18-42-30-20-26(3)37(27(4)21-30)52-24-34(48)43-32(22-28-14-10-9-11-15-28)36(49)40(51)46-25-53-41(5,6)38(46)39(50)44-35-31-17-13-12-16-29(31)23-33(35)47/h9-17,20-21,32-33,35-36,38,42,47,49H,7-8,18-19,22-25H2,1-6H3,(H,43,48)(H,44,50)/t32-,33+,35-,36-,38+/m0/s1 D0Z3GC DRUGINKE MOXFYRJTMGBJQV-CTRNRRKFSA-N D0Z3GC DRUGSMIL CCN(CC)CCNC1=CC(=C(C(=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C D0Z3GC HIGHSTAT Investigative D0Z3GX DRUG__ID D0Z3GX D0Z3GX DRUGTYPE Small molecular drug D0Z3GX DRUGINCH 1S/C16H13NS/c1-3-15(16-7-10-18-12-16)4-2-13(1)11-14-5-8-17-9-6-14/h1-10,12H,11H2 D0Z3GX DRUGINKE JZVKRZVTIHAZFG-UHFFFAOYSA-N D0Z3GX DRUGSMIL C1=CC(=CC=C1CC2=CC=NC=C2)C3=CSC=C3 D0Z3GX HIGHSTAT Investigative D0Z3IZ DRUG__ID D0Z3IZ D0Z3IZ DRUGTYPE Small molecular drug D0Z3IZ DRUGINCH 1S/C13H20N6/c1-2-14-13-18-11-10(15-8-16-11)12(19-13)17-9-6-4-3-5-7-9/h8-9H,2-7H2,1H3,(H3,14,15,16,17,18,19) D0Z3IZ DRUGINKE XHOVJLBZYXEITR-UHFFFAOYSA-N D0Z3IZ DRUGSMIL CCNC1=NC2=C(C(=N1)NC3CCCCC3)NC=N2 D0Z3IZ HIGHSTAT Investigative D0Z3JI DRUG__ID D0Z3JI D0Z3JI DRUGTYPE Small molecular drug D0Z3JI DRUGINCH 1S/C18H38N4S2/c1-23-17(19)21-15-13-11-9-7-5-3-4-6-8-10-12-14-16-22-18(20)24-2/h3-16H2,1-2H3,(H2,19,21)(H2,20,22) D0Z3JI DRUGINKE IOKDMHHZKWLWKO-UHFFFAOYSA-N D0Z3JI DRUGSMIL CSC(=NCCCCCCCCCCCCCCN=C(N)SC)N D0Z3JI HIGHSTAT Investigative D0Z3KA DRUG__ID D0Z3KA D0Z3KA DRUGTYPE Small molecular drug D0Z3KA DRUGINCH 1S/C22H25NO5S/c1-12(24)23-16-8-6-13-10-18(26-2)21(27-3)22(28-4)20(13)14-7-9-19(29-5)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1 D0Z3KA DRUGINKE CMEGANPVAXDBPL-INIZCTEOSA-N D0Z3KA DRUGSMIL CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)OC D0Z3KA HIGHSTAT Investigative D0Z3KV DRUG__ID D0Z3KV D0Z3KV DRUGTYPE Small molecular drug D0Z3KV DRUGINCH 1S/C21H8Cl12O5S/c22-11-13(24)18(28)9-7(16(11,26)20(18,30)31)3-1-5(15(34)35)6(39(36,37)38)2-4(3)8-10(9)19(29)14(25)12(23)17(8,27)21(19,32)33/h1-2,7-10H,(H,34,35)(H,36,37,38) D0Z3KV DRUGINKE QCIIYEDWVXHYTF-UHFFFAOYSA-N D0Z3KV DRUGSMIL C1=C2C3C(C4C(C2=CC(=C1C(=O)O)S(=O)(=O)O)C5(C(=C(C4(C5(Cl)Cl)Cl)Cl)Cl)Cl)C6(C(=C(C3(C6(Cl)Cl)Cl)Cl)Cl)Cl D0Z3KV HIGHSTAT Investigative D0Z3MT DRUG__ID D0Z3MT D0Z3MT DRUGTYPE Small molecular drug D0Z3MT DRUGINCH 1S/C22H28O3/c1-2-3-4-5-6-8-17-11-13-18(14-12-17)15-16-19-9-7-10-20(23)21(19)22(24)25/h7,9-14,23H,2-6,8,15-16H2,1H3,(H,24,25) D0Z3MT DRUGINKE WBHQYBZRTAEHRR-UHFFFAOYSA-N D0Z3MT DRUGSMIL CCCCCCCC1=CC=C(C=C1)CCC2=C(C(=CC=C2)O)C(=O)O D0Z3MT HIGHSTAT Investigative D0Z3NC DRUG__ID D0Z3NC D0Z3NC DRUGTYPE Small molecular drug D0Z3NC DRUGINCH 1S/C14H11Cl3O2/c15-14(16,17)13(9-1-5-11(18)6-2-9)10-3-7-12(19)8-4-10/h1-8,13,18-19H D0Z3NC DRUGINKE IUGDILGOLSSKNE-UHFFFAOYSA-N D0Z3NC DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)O)C(Cl)(Cl)Cl)O D0Z3NC HIGHSTAT Investigative D0Z3NE DRUG__ID D0Z3NE D0Z3NE DRUGTYPE Small molecular drug D0Z3NE DRUGINCH 1S/C15H7N3O4/c19-13-10-7-8(18(21)22)5-6-12(10)17-14(13)16-11-4-2-1-3-9(11)15(17)20/h1-7H D0Z3NE DRUGINKE UFMQJYHLIUACCG-UHFFFAOYSA-N D0Z3NE DRUGSMIL C1=CC=C2C(=C1)C(=O)N3C4=C(C=C(C=C4)[N+](=O)[O-])C(=O)C3=N2 D0Z3NE HIGHSTAT Investigative D0Z3OD DRUG__ID D0Z3OD D0Z3OD DRUGTYPE Small molecular drug D0Z3OD DRUGINCH 1S/C12H12N6O/c13-11-16-9-8(10(19)17-11)15-12(14)18(9)6-7-4-2-1-3-5-7/h1-5H,6H2,(H2,14,15)(H3,13,16,17,19) D0Z3OD DRUGINKE DPDYTYOWSIRPMB-UHFFFAOYSA-N D0Z3OD DRUGSMIL C1=CC=C(C=C1)CN2C3=C(C(=O)NC(=N3)N)N=C2N D0Z3OD HIGHSTAT Investigative D0Z3PB DRUG__ID D0Z3PB D0Z3PB DRUGTYPE Small molecular drug D0Z3PB DRUGINCH 1S/C12H12N2O/c1-2-9-7-6-8-4-3-5-10(12(13)15)11(8)14-9/h3-7H,2H2,1H3,(H2,13,15) D0Z3PB DRUGINKE DFEARBGMUARFKD-UHFFFAOYSA-N D0Z3PB DRUGSMIL CCC1=NC2=C(C=CC=C2C(=O)N)C=C1 D0Z3PB HIGHSTAT Investigative D0Z3PG DRUG__ID D0Z3PG D0Z3PG DRUGTYPE Small molecular drug D0Z3PG DRUGINCH 1S/C8H16O2S2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H,9,10) D0Z3PG DRUGINKE IZFHEQBZOYJLPK-UHFFFAOYSA-N D0Z3PG DRUGSMIL C(CCC(=O)O)CC(CCS)S D0Z3PG HIGHSTAT Investigative D0Z3TJ DRUG__ID D0Z3TJ D0Z3TJ DRUGTYPE Small molecular drug D0Z3TJ DRUGINCH 1S/C29H28F3NO5S2/c1-19-14-20(2)28(21(3)15-19)40(36,37)33(18-25-12-13-27(38-25)29(30,31)32)17-22-8-10-23(11-9-22)24-6-5-7-26(16-24)39(4,34)35/h5-16H,17-18H2,1-4H3 D0Z3TJ DRUGINKE PSOXOVKYGWBTPB-UHFFFAOYSA-N D0Z3TJ DRUGSMIL CC1=CC(=C(C(=C1)C)S(=O)(=O)N(CC2=CC=C(C=C2)C3=CC(=CC=C3)S(=O)(=O)C)CC4=CC=C(O4)C(F)(F)F)C D0Z3TJ HIGHSTAT Investigative D0Z3WA DRUG__ID D0Z3WA D0Z3WA DRUGTYPE Small molecular drug D0Z3WA DRUGINCH 1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h7,9,12,14-17,21H,3-6,8,10-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1 D0Z3WA DRUGINKE OKJCFMUGMSVJBG-ABEVXSGRSA-N D0Z3WA DRUGSMIL CC12CCC3C(C1CCC2O)CCC4C3(C=CC(=O)C4)C D0Z3WA HIGHSTAT Investigative D0Z3XC DRUG__ID D0Z3XC D0Z3XC DRUGTYPE Small molecular drug D0Z3XC DRUGINCH 1S/C18H15N3O/c1-13(22)19-17-12-16(14-8-4-2-5-9-14)20-18(21-17)15-10-6-3-7-11-15/h2-12H,1H3,(H,19,20,21,22) D0Z3XC DRUGINKE ZFBASLSZDCISGS-UHFFFAOYSA-N D0Z3XC DRUGSMIL CC(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D0Z3XC HIGHSTAT Investigative D0Z3XJ DRUG__ID D0Z3XJ D0Z3XJ DRUGTYPE Small molecular drug D0Z3XJ DRUGINCH 1S/C20H16O2/c21-20(22)12-11-17-6-2-4-8-19(17)14-15-9-10-16-5-1-3-7-18(16)13-15/h1-13H,14H2,(H,21,22)/b12-11+ D0Z3XJ DRUGINKE MOLQZQYMXCCLHS-VAWYXSNFSA-N D0Z3XJ DRUGSMIL C1=CC=C2C=C(C=CC2=C1)CC3=CC=CC=C3C=CC(=O)O D0Z3XJ HIGHSTAT Investigative D0Z3YY DRUG__ID D0Z3YY D0Z3YY DRUGTYPE Small molecular drug D0Z3YY DRUGINCH 1S/C20H19N3O/c1-2-9-19(24)23-20-21-17(15-10-5-3-6-11-15)14-18(22-20)16-12-7-4-8-13-16/h3-8,10-14H,2,9H2,1H3,(H,21,22,23,24) D0Z3YY DRUGINKE IGXLAZUQYPCBKI-UHFFFAOYSA-N D0Z3YY DRUGSMIL CCCC(=O)NC1=NC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3 D0Z3YY HIGHSTAT Investigative D0Z3ZZ DRUG__ID D0Z3ZZ D0Z3ZZ DRUGTYPE Small molecular drug D0Z3ZZ DRUGINCH 1S/C12H14N2/c1-10(12-6-4-3-5-7-12)14-9-8-13-11(14)2/h3-10H,1-2H3 D0Z3ZZ DRUGINKE CILDGVODBJAMGO-UHFFFAOYSA-N D0Z3ZZ DRUGSMIL CC1=NC=CN1C(C)C2=CC=CC=C2 D0Z3ZZ HIGHSTAT Investigative D0Z4AC DRUG__ID D0Z4AC D0Z4AC DRUGTYPE Small molecular drug D0Z4AC DRUGINCH 1S/C10H13N3O3/c11-8(10(15)13-16)9(14)12-6-7-4-2-1-3-5-7/h1-5,8,16H,6,11H2,(H,12,14)(H,13,15) D0Z4AC DRUGINKE HVTWOBIOCPYSGH-UHFFFAOYSA-N D0Z4AC DRUGSMIL C1=CC=C(C=C1)CNC(=O)C(C(=O)NO)N D0Z4AC HIGHSTAT Investigative D0Z4AU DRUG__ID D0Z4AU D0Z4AU DRUGTYPE Small molecular drug D0Z4AU DRUGINCH 1S/C10H16N5O13P3S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(26-9)1-25-29(19,20)27-30(21,22)28-31(23,24)32/h2-3,5-6,9,16-17H,1H2,(H,19,20)(H,21,22)(H2,23,24,32)(H3,11,13,14,18) D0Z4AU DRUGINKE XOFLBQFBSOEHOG-UHFFFAOYSA-N D0Z4AU DRUGSMIL C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OP(=S)(O)O)O)O)N=C(NC2=O)N D0Z4AU HIGHSTAT Investigative D0Z4GJ DRUG__ID D0Z4GJ D0Z4GJ DRUGTYPE Small molecular drug D0Z4GJ DRUGINCH 1S/C28H23N7O3S/c1-15-3-8-20-17(11-15)5-6-18-12-16(2)4-9-21(18)24(20)22-14-35(28(37)30-26(22)39)13-19-7-10-23(38-19)25(36)29-27-31-33-34-32-27/h3-12,14,24H,13H2,1-2H3,(H,30,37,39)(H2,29,31,32,33,34,36) D0Z4GJ DRUGINKE PVKNPGQAFNALOI-UHFFFAOYSA-N D0Z4GJ DRUGSMIL CC1=CC2=C(C=C1)C(C3=C(C=C2)C=C(C=C3)C)C4=CN(C(=O)NC4=S)CC5=CC=C(O5)C(=O)NC6=NNN=N6 D0Z4GJ HIGHSTAT Investigative D0Z4GR DRUG__ID D0Z4GR D0Z4GR DRUGTYPE Small molecular drug D0Z4GR DRUGINCH 1S/C19H15N/c1-3-7-17(8-4-1)19(18-9-5-2-6-10-18)15-16-11-13-20-14-12-16/h1-15H D0Z4GR DRUGINKE QSVVYMBWQOGDNI-UHFFFAOYSA-N D0Z4GR DRUGSMIL C1=CC=C(C=C1)C(=CC2=CC=NC=C2)C3=CC=CC=C3 D0Z4GR HIGHSTAT Investigative D0Z4HK DRUG__ID D0Z4HK D0Z4HK DRUGTYPE Small molecular drug D0Z4HK DRUGINCH 1S/C53H71N9O15S/c1-7-9-20-42(62(6)51(71)41(56-45(64)30-43(54)63)28-34-31-55-37-19-15-14-18-36(34)37)50(70)58-40(29-46(65)66)47(67)57-38(26-32-16-12-11-13-17-32)48(68)60-44(21-10-8-2)61-49(69)39(59-52(72)76-53(3,4)5)27-33-22-24-35(25-23-33)77-78(73,74)75/h11-19,22-25,31,38-42,44,55H,7-10,20-21,26-30H2,1-6H3,(H2,54,63)(H,56,64)(H,57,67)(H,58,70)(H,59,72)(H,60,68)(H,61,69)(H,65,66)(H,73,74,75)/t38-,39-,40-,41-,42-,44-/m0/s1 D0Z4HK DRUGINKE LEXXPLMUWFLNAN-OZUMUDGSSA-N D0Z4HK DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCC)NC(=O)C(CC2=CC=C(C=C2)OS(=O)(=O)O)NC(=O)OC(C)(C)C)N(C)C(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CC(=O)N D0Z4HK HIGHSTAT Investigative D0Z4HV DRUG__ID D0Z4HV D0Z4HV DRUGTYPE Small molecular drug D0Z4HV DRUGINCH 1S/C14H9ClN2/c15-13-2-1-11-7-12(9-17-14(11)8-13)10-3-5-16-6-4-10/h1-9H D0Z4HV DRUGINKE WMECTFBVYBAOOF-UHFFFAOYSA-N D0Z4HV DRUGSMIL C1=CC(=CC2=NC=C(C=C21)C3=CC=NC=C3)Cl D0Z4HV HIGHSTAT Investigative D0Z4IH DRUG__ID D0Z4IH D0Z4IH DRUGTYPE Small molecular drug D0Z4IH DRUGINCH 1S/C22H27NO/c1-23-20(16-15-18-9-4-2-5-10-18)13-8-14-21(23)17-22(24)19-11-6-3-7-12-19/h2-7,9-12,15-16,20-22,24H,8,13-14,17H2,1H3/b16-15+/t20-,21+,22-/m0/s1 D0Z4IH DRUGINKE IKYXUFYHDWVXST-HTNBDEJSSA-N D0Z4IH DRUGSMIL CN1C(CCCC1C=CC2=CC=CC=C2)CC(C3=CC=CC=C3)O D0Z4IH HIGHSTAT Investigative D0Z4JG DRUG__ID D0Z4JG D0Z4JG DRUGTYPE Small molecular drug D0Z4JG DRUGINCH 1S/C11H11NO/c1-13-11-7-6-10(12)8-4-2-3-5-9(8)11/h2-7H,12H2,1H3 D0Z4JG DRUGINKE JVMUPDOMGALPOW-UHFFFAOYSA-N D0Z4JG DRUGSMIL COC1=CC=C(C2=CC=CC=C21)N D0Z4JG HIGHSTAT Investigative D0Z4JL DRUG__ID D0Z4JL D0Z4JL DRUGTYPE Small molecular drug D0Z4JL DRUGINCH 1S/C23H25ClN4O3/c24-18-7-4-16(5-8-18)15-28-22(30)19-9-6-17(14-20(19)26-23(28)31)21(29)25-10-13-27-11-2-1-3-12-27/h4-9,14H,1-3,10-13,15H2,(H,25,29)(H,26,31) D0Z4JL DRUGINKE BKSKSEWIBBBRSQ-UHFFFAOYSA-N D0Z4JL DRUGSMIL C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl D0Z4JL HIGHSTAT Investigative D0Z4JT DRUG__ID D0Z4JT D0Z4JT DRUGTYPE Small molecular drug D0Z4JT DRUGINCH 1S/C18H17ClF2N4O2/c1-10-4-11(19)6-23-16(10)17(26)24-12-2-3-14(21)13(5-12)18(8-20)9-27-7-15(22)25-18/h2-6H,7-9H2,1H3,(H2,22,25)(H,24,26)/t18-/m0/s1 D0Z4JT DRUGINKE NQNLROFWOGGJGK-SFHVURJKSA-N D0Z4JT DRUGSMIL CC1=CC(=CN=C1C(=O)NC2=CC(=C(C=C2)F)C3(COCC(=N3)N)CF)Cl D0Z4JT HIGHSTAT Investigative D0Z4KU DRUG__ID D0Z4KU D0Z4KU DRUGTYPE Small molecular drug D0Z4KU DRUGINCH 1S/C16H15N3/c1-10-4-5-13-6-7-14(9-15(13)17-10)16-18-11(2)8-12(3)19-16/h4-9H,1-3H3 D0Z4KU DRUGINKE QOOQRVAAEYZPDS-UHFFFAOYSA-N D0Z4KU DRUGSMIL CC1=NC2=C(C=C1)C=CC(=C2)C3=NC(=CC(=N3)C)C D0Z4KU HIGHSTAT Investigative D0Z4LO DRUG__ID D0Z4LO D0Z4LO DRUGTYPE Small molecular drug D0Z4LO DRUGINCH 1S/C26H23N5O5/c32-23-26(24(33)28-25(34)27-23,20-8-6-19(7-9-20)18-4-2-1-3-5-18)30-16-14-29(15-17-30)21-10-12-22(13-11-21)31(35)36/h1-13H,14-17H2,(H2,27,28,32,33,34) D0Z4LO DRUGINKE NJKTYSXXGARILV-UHFFFAOYSA-N D0Z4LO DRUGSMIL C1CN(CCN1C2=CC=C(C=C2)[N+](=O)[O-])C3(C(=O)NC(=O)NC3=O)C4=CC=C(C=C4)C5=CC=CC=C5 D0Z4LO HIGHSTAT Investigative D0Z4NU DRUG__ID D0Z4NU D0Z4NU DRUGTYPE Small molecular drug D0Z4NU DRUGINCH 1S/C21H31N3O4/c1-2-3-4-5-6-10-15-22-20(26)16-18(21(27)24-28)23-19(25)14-13-17-11-8-7-9-12-17/h7-9,11-14,18,28H,2-6,10,15-16H2,1H3,(H,22,26)(H,23,25)(H,24,27)/b14-13+/t18-/m1/s1 D0Z4NU DRUGINKE TYVAVCSSCPJBHI-KAUXGEHWSA-N D0Z4NU DRUGSMIL CCCCCCCCNC(=O)CC(C(=O)NO)NC(=O)C=CC1=CC=CC=C1 D0Z4NU HIGHSTAT Investigative D0Z4NW DRUG__ID D0Z4NW D0Z4NW DRUGTYPE Small molecular drug D0Z4NW DRUGINCH 1S/C18H33NO4/c1-2-3-4-5-6-7-8-9-10-11-14-17(19(22)23)15-12-13-16-18(20)21/h15H,2-14,16H2,1H3,(H,20,21)/b17-15+ D0Z4NW DRUGINKE ZNCCLONFJQTFGL-BMRADRMJSA-N D0Z4NW DRUGSMIL CCCCCCCCCCCCC(=CCCCC(=O)O)[N+](=O)[O-] D0Z4NW HIGHSTAT Investigative D0Z4OS DRUG__ID D0Z4OS D0Z4OS DRUGTYPE Small molecular drug D0Z4OS DRUGINCH 1S/C15H18N4O/c1-2-4-13(5-3-1)12-17-14-6-7-16-15(18-14)19-8-10-20-11-9-19/h1-7H,8-12H2,(H,16,17,18) D0Z4OS DRUGINKE PKTXFNWLILBNOJ-UHFFFAOYSA-N D0Z4OS DRUGSMIL C1COCCN1C2=NC=CC(=N2)NCC3=CC=CC=C3 D0Z4OS HIGHSTAT Investigative D0Z4RZ DRUG__ID D0Z4RZ D0Z4RZ DRUGTYPE Small molecular drug D0Z4RZ DRUGINCH 1S/C23H25NO2/c25-22(24-23-13-16-9-17(14-23)11-18(10-16)15-23)26-21-8-4-7-20(12-21)19-5-2-1-3-6-19/h1-8,12,16-18H,9-11,13-15H2,(H,24,25) D0Z4RZ DRUGINKE STNJKWWAIGCDRW-UHFFFAOYSA-N D0Z4RZ DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)OC4=CC=CC(=C4)C5=CC=CC=C5 D0Z4RZ HIGHSTAT Investigative D0Z4SA DRUG__ID D0Z4SA D0Z4SA DRUGTYPE Small molecular drug D0Z4SA DRUGINCH 1S/C22H26N2O/c1-3-14-24(15-4-2)21(25)16-19-18-12-8-9-13-20(18)23-22(19)17-10-6-5-7-11-17/h5-13,23H,3-4,14-16H2,1-2H3 D0Z4SA DRUGINKE VEAFPKIMCGYMFZ-UHFFFAOYSA-N D0Z4SA DRUGSMIL CCCN(CCC)C(=O)CC1=C(NC2=CC=CC=C21)C3=CC=CC=C3 D0Z4SA HIGHSTAT Investigative D0Z4SS DRUG__ID D0Z4SS D0Z4SS DRUGTYPE Small molecular drug D0Z4SS DRUGINCH 1S/C23H19IN4O2/c1-28-19-13-6-5-12-18(19)20(15-8-3-2-4-9-15)26-21(22(28)29)27-23(30)25-17-11-7-10-16(24)14-17/h2-14,21H,1H3,(H2,25,27,30)/t21-/m0/s1/i24-2 D0Z4SS DRUGINKE VLKJKVMACAESPP-MRDSYVANSA-N D0Z4SS DRUGSMIL CN1C2=CC=CC=C2C(=NC(C1=O)NC(=O)NC3=CC(=CC=C3)I)C4=CC=CC=C4 D0Z4SS HIGHSTAT Investigative D0Z4UF DRUG__ID D0Z4UF D0Z4UF DRUGTYPE Small molecular drug D0Z4UF DRUGINCH 1S/C23H23ClN2S/c1-26-18-11-12-20(26)22(19(13-18)15-7-9-17(24)10-8-15)23-25-14-21(27-23)16-5-3-2-4-6-16/h2-10,14,18-20,22H,11-13H2,1H3/t18-,19+,20+,22-/m0/s1 D0Z4UF DRUGINKE WEUZYHQNGQDGAB-HIUFNZKISA-N D0Z4UF DRUGSMIL CN1C2CCC1C(C(C2)C3=CC=C(C=C3)Cl)C4=NC=C(S4)C5=CC=CC=C5 D0Z4UF HIGHSTAT Investigative D0Z4VD DRUG__ID D0Z4VD D0Z4VD DRUGTYPE Small molecular drug D0Z4VD DRUGINCH 1S/C16H25N/c1-4-9-17-10-5-6-15(12-17)16-8-7-13(2)11-14(16)3/h7-8,11,15H,4-6,9-10,12H2,1-3H3 D0Z4VD DRUGINKE XMWBOCKXCDCQOT-UHFFFAOYSA-N D0Z4VD DRUGSMIL CCCN1CCCC(C1)C2=C(C=C(C=C2)C)C D0Z4VD HIGHSTAT Investigative D0Z5AO DRUG__ID D0Z5AO D0Z5AO DRUGTYPE Small molecular drug D0Z5AO DRUGINCH 1S/C24H28N4O4/c1-3-9-25-13-21(29)27-15-5-7-17-19(11-15)24(32)20-12-16(6-8-18(20)23(17)31)28-22(30)14-26-10-4-2/h5-8,11-12,25-26H,3-4,9-10,13-14H2,1-2H3,(H,27,29)(H,28,30) D0Z5AO DRUGINKE OBGMWZLARFADCF-UHFFFAOYSA-N D0Z5AO DRUGSMIL CCCNCC(=O)NC1=CC2=C(C=C1)C(=O)C3=C(C2=O)C=C(C=C3)NC(=O)CNCCC D0Z5AO HIGHSTAT Investigative D0Z5BQ DRUG__ID D0Z5BQ D0Z5BQ DRUGTYPE Small molecular drug D0Z5BQ DRUGINCH 1S/C19H23NO3/c1-2-23-18(21)13-16-5-3-15(4-6-16)7-10-19(22)14-20-11-8-17(19)9-12-20/h3-6,17,22H,2,8-9,11-14H2,1H3 D0Z5BQ DRUGINKE YWKVMGDEOUPQGN-UHFFFAOYSA-N D0Z5BQ DRUGSMIL CCOC(=O)CC1=CC=C(C=C1)C#CC2(CN3CCC2CC3)O D0Z5BQ HIGHSTAT Investigative D0Z5BU DRUG__ID D0Z5BU D0Z5BU DRUGTYPE Small molecular drug D0Z5BU DRUGINCH 1S/C13H17NO2S/c1-2-7-16-11-5-3-10(4-6-11)12-8-14-13(15)9-17-12/h3-6,12H,2,7-9H2,1H3,(H,14,15) D0Z5BU DRUGINKE WOEGUBDEEHNIKD-UHFFFAOYSA-N D0Z5BU DRUGSMIL CCCOC1=CC=C(C=C1)C2CNC(=O)CS2 D0Z5BU HIGHSTAT Investigative D0Z5CX DRUG__ID D0Z5CX D0Z5CX DRUGTYPE Small molecular drug D0Z5CX DRUGINCH 1S/C29H27NO/c31-29(28(25-17-9-3-10-18-25)26-19-11-4-12-20-26)30-22-21-27(23-13-5-1-6-14-23)24-15-7-2-8-16-24/h1-20,27-28H,21-22H2,(H,30,31) D0Z5CX DRUGINKE LMRDWMVRJNJYIQ-UHFFFAOYSA-N D0Z5CX DRUGSMIL C1=CC=C(C=C1)C(CCNC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4 D0Z5CX HIGHSTAT Investigative D0Z5GE DRUG__ID D0Z5GE D0Z5GE DRUGTYPE Small molecular drug D0Z5GE DRUGINCH 1S/C14H13BrN2O3S/c15-12-9-11(21(16,19)20)6-7-13(12)17-14(18)8-10-4-2-1-3-5-10/h1-7,9H,8H2,(H,17,18)(H2,16,19,20) D0Z5GE DRUGINKE LBFJKAVSXZGFAX-UHFFFAOYSA-N D0Z5GE DRUGSMIL C1=CC=C(C=C1)CC(=O)NC2=C(C=C(C=C2)S(=O)(=O)N)Br D0Z5GE HIGHSTAT Investigative D0Z5GR DRUG__ID D0Z5GR D0Z5GR DRUGTYPE Small molecular drug D0Z5GR DRUGINCH 1S/C15H16ClN3O/c16-12-4-1-2-6-14(12)20-15-13(5-3-7-18-15)19-10-8-17-9-11-19/h1-7,17H,8-11H2 D0Z5GR DRUGINKE LVSZWRFDLAUNPF-UHFFFAOYSA-N D0Z5GR DRUGSMIL C1CN(CCN1)C2=C(N=CC=C2)OC3=CC=CC=C3Cl D0Z5GR HIGHSTAT Investigative D0Z5HX DRUG__ID D0Z5HX D0Z5HX DRUGTYPE Small molecular drug D0Z5HX DRUGINCH 1S/C25H30N2O3S/c1-18(22-11-7-9-19-8-3-4-10-23(19)22)26-24-12-5-6-13-25(24)27-31(28,29)21-16-14-20(30-2)15-17-21/h3-4,7-11,14-18,24-27H,5-6,12-13H2,1-2H3/t18?,24-,25-/m1/s1 D0Z5HX DRUGINKE AKPJKVQQBSNRID-XTEKXTAFSA-N D0Z5HX DRUGSMIL CC(C1=CC=CC2=CC=CC=C21)NC3CCCCC3NS(=O)(=O)C4=CC=C(C=C4)OC D0Z5HX HIGHSTAT Investigative D0Z5JD DRUG__ID D0Z5JD D0Z5JD DRUGTYPE Small molecular drug D0Z5JD DRUGINCH 1S/C28H38N6O6/c1-17(2)12-22(26(30)38)34-28(40)23(14-18-6-4-3-5-7-18)33-25(37)16-31-24(36)15-32-27(39)21(29)13-19-8-10-20(35)11-9-19/h3-11,17,21-23,35H,12-16,29H2,1-2H3,(H2,30,38)(H,31,36)(H,32,39)(H,33,37)(H,34,40)/t21-,22-,23-/m0/s1 D0Z5JD DRUGINKE YZXGODHVAJPXSG-VABKMULXSA-N D0Z5JD DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N D0Z5JD HIGHSTAT Investigative D0Z5JT DRUG__ID D0Z5JT D0Z5JT DRUGTYPE Small molecular drug D0Z5JT DRUGINCH 1S/C16H14N4O/c1-11-16(19-15-5-3-2-4-14(15)18-11)20-17-10-12-6-8-13(21)9-7-12/h2-10,21H,1H3,(H,19,20)/b17-10- D0Z5JT DRUGINKE WDPUHMPVZBSBGB-YVLHZVERSA-N D0Z5JT DRUGSMIL CC1=NC2=CC=CC=C2N=C1NN=CC3=CC=C(C=C3)O D0Z5JT HIGHSTAT Investigative D0Z5KQ DRUG__ID D0Z5KQ D0Z5KQ DRUGTYPE Small molecular drug D0Z5KQ DRUGINCH 1S/C14H12O2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13,15H D0Z5KQ DRUGINKE ISAOCJYIOMOJEB-UHFFFAOYSA-N D0Z5KQ DRUGSMIL C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)O D0Z5KQ HIGHSTAT Investigative D0Z5KX DRUG__ID D0Z5KX D0Z5KX DRUGTYPE Small molecular drug D0Z5KX DRUGINCH 1S/C14H18N2OS2/c17-13(9-3-1-2-6-10-18)16-14-15-11-7-4-5-8-12(11)19-14/h4-5,7-8,18H,1-3,6,9-10H2,(H,15,16,17) D0Z5KX DRUGINKE QMWKKGIVGMUWJC-UHFFFAOYSA-N D0Z5KX DRUGSMIL C1=CC=C2C(=C1)N=C(S2)NC(=O)CCCCCCS D0Z5KX HIGHSTAT Investigative D0Z5LU DRUG__ID D0Z5LU D0Z5LU DRUGTYPE Small molecular drug D0Z5LU DRUGINCH 1S/C22H18O7/c1-8-9-2-3-10(8)17(22(27)28)16(9)15-11-4-6-13(23)18(25)20(11)29-21-12(15)5-7-14(24)19(21)26/h2-10,16-17,23,25-26H,1H3,(H,27,28) D0Z5LU DRUGINKE BSAMRWOMXJWVCE-UHFFFAOYSA-N D0Z5LU DRUGSMIL CC1C2C=CC1C(C2C3=C4C=CC(=O)C(=C4OC5=C3C=CC(=C5O)O)O)C(=O)O D0Z5LU HIGHSTAT Investigative D0Z5MR DRUG__ID D0Z5MR D0Z5MR DRUGTYPE Small molecular drug D0Z5MR DRUGINCH 1S/C41H47N5O6S/c1-25-18-30(43-22-28-14-16-42-17-15-28)19-26(2)37(25)52-23-34(48)44-32(20-27-10-6-5-7-11-27)36(49)40(51)46-24-53-41(3,4)38(46)39(50)45-35-31-13-9-8-12-29(31)21-33(35)47/h5-19,32-33,35-36,38,43,47,49H,20-24H2,1-4H3,(H,44,48)(H,45,50)/t32-,33+,35-,36-,38+/m0/s1 D0Z5MR DRUGINKE LZKUFQZJJUVPHA-CTRNRRKFSA-N D0Z5MR DRUGSMIL CC1=CC(=CC(=C1OCC(=O)NC(CC2=CC=CC=C2)C(C(=O)N3CSC(C3C(=O)NC4C(CC5=CC=CC=C45)O)(C)C)O)C)NCC6=CC=NC=C6 D0Z5MR HIGHSTAT Investigative D0Z5QA DRUG__ID D0Z5QA D0Z5QA DRUGTYPE Small molecular drug D0Z5QA DRUGINCH 1S/C20H32O3/c1-2-3-4-5-10-13-16-19(21)17-14-11-8-6-7-9-12-15-18-20(22)23/h7-11,13-14,17,19,21H,2-6,12,15-16,18H2,1H3,(H,22,23)/b9-7-,11-8-,13-10-,17-14+/t19-/m0/s1 D0Z5QA DRUGINKE ZNHVWPKMFKADKW-LQWMCKPYSA-N D0Z5QA DRUGSMIL CCCCCC=CCC(C=CC=CCC=CCCCC(=O)O)O D0Z5QA HIGHSTAT Investigative D0Z5QM DRUG__ID D0Z5QM D0Z5QM DRUGTYPE Small molecular drug D0Z5QM DRUGINCH 1S/C17H18N2O3/c1-2-12-21-16-10-8-15(9-11-16)19-17(20)22-18-13-14-6-4-3-5-7-14/h3-11,13H,2,12H2,1H3,(H,19,20)/b18-13+ D0Z5QM DRUGINKE AIEVCSUZILYYSA-QGOAFFKASA-N D0Z5QM DRUGSMIL CCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2 D0Z5QM HIGHSTAT Investigative D0Z5RQ DRUG__ID D0Z5RQ D0Z5RQ DRUGTYPE Small molecular drug D0Z5RQ DRUGINCH 1S/C14H25NO3/c1-3-10(2)13(16)14(17)18-9-11-6-8-15-7-4-5-12(11)15/h10-13,16H,3-9H2,1-2H3/t10-,11-,12+,13-/m1/s1 D0Z5RQ DRUGINKE AVBKRVFZNFJQBK-FVCCEPFGSA-N D0Z5RQ DRUGSMIL CCC(C)C(C(=O)OCC1CCN2C1CCC2)O D0Z5RQ HIGHSTAT Investigative D0Z5SB DRUG__ID D0Z5SB D0Z5SB DRUGTYPE Small molecular drug D0Z5SB DRUGINCH 1S/C21H15N5/c22-26-25-19-5-1-3-17(14-19)20-13-16(11-15-6-9-23-10-7-15)12-18-4-2-8-24-21(18)20/h1-10,12-14H,11H2 D0Z5SB DRUGINKE SJSUBWZFLWXJFL-UHFFFAOYSA-N D0Z5SB DRUGSMIL C1=CC(=CC(=C1)N=[N+]=[N-])C2=C3C(=CC(=C2)CC4=CC=NC=C4)C=CC=N3 D0Z5SB HIGHSTAT Investigative D0Z5TQ DRUG__ID D0Z5TQ D0Z5TQ DRUGTYPE Small molecular drug D0Z5TQ DRUGINCH 1S/C15H8Br2INO2/c16-11-4-7(5-12(17)14(11)20)3-10-9-6-8(18)1-2-13(9)19-15(10)21/h1-6,20H,(H,19,21)/b10-3- D0Z5TQ DRUGINKE LMXYVLFTZRPNRV-KMKOMSMNSA-N D0Z5TQ DRUGSMIL C1=CC2=C(C=C1I)C(=CC3=CC(=C(C(=C3)Br)O)Br)C(=O)N2 D0Z5TQ HIGHSTAT Investigative D0Z5TV DRUG__ID D0Z5TV D0Z5TV DRUGTYPE Small molecular drug D0Z5TV DRUGINCH 1S/C18H32O3/c1-2-3-11-14-17(19)15-12-9-7-5-4-6-8-10-13-16-18(20)21/h7,9,12,15,17,19H,2-6,8,10-11,13-14,16H2,1H3,(H,20,21)/b9-7-,15-12+/t17-/m0/s1 D0Z5TV DRUGINKE HNICUWMFWZBIFP-IRQZEAMPSA-N D0Z5TV DRUGSMIL CCCCCC(C=CC=CCCCCCCCC(=O)O)O D0Z5TV HIGHSTAT Investigative D0Z5UG DRUG__ID D0Z5UG D0Z5UG DRUGTYPE Small molecular drug D0Z5UG DRUGINCH 1S/C37H44N4O6/c38-30(19-26-15-17-29(42)18-16-26)36(45)41-23-28-14-8-7-13-27(28)22-33(41)35(44)39-31(20-24-9-3-1-4-10-24)34(43)40-32(37(46)47)21-25-11-5-2-6-12-25/h2,5-8,11-18,24,30-33,42H,1,3-4,9-10,19-23,38H2,(H,39,44)(H,40,43)(H,46,47)/t30-,31-,32-,33?/m0/s1 D0Z5UG DRUGINKE AFTOYBSNHFSKRV-KSTJSZMBSA-N D0Z5UG DRUGSMIL C1CCC(CC1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)NC(=O)C3CC4=CC=CC=C4CN3C(=O)C(CC5=CC=C(C=C5)O)N D0Z5UG HIGHSTAT Investigative D0Z5VI DRUG__ID D0Z5VI D0Z5VI DRUGTYPE Small molecular drug D0Z5VI DRUGINCH 1S/C7H13O7P/c8-6(9)2-1-5(7(10)11)3-4-15(12,13)14/h5H,1-4H2,(H,8,9)(H,10,11)(H2,12,13,14) D0Z5VI DRUGINKE NKKKETAADLKALP-UHFFFAOYSA-N D0Z5VI DRUGSMIL C(CC(=O)O)C(CCP(=O)(O)O)C(=O)O D0Z5VI HIGHSTAT Investigative D0Z5WG DRUG__ID D0Z5WG D0Z5WG DRUGTYPE Small molecular drug D0Z5WG DRUGINCH 1S/C10H15N4O9P/c11-8(18)5-9(13-3-15)14(2-12-5)10-7(17)6(16)4(23-10)1-22-24(19,20)21/h2-4,6-7,10,16-17H,1H2,(H2,11,18)(H,13,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1 D0Z5WG DRUGINKE ABCOOORLYAOBOZ-KQYNXXCUSA-N D0Z5WG DRUGSMIL C1=NC(=C(N1C2C(C(C(O2)COP(=O)(O)O)O)O)NC=O)C(=O)N D0Z5WG HIGHSTAT Investigative D0Z5WP DRUG__ID D0Z5WP D0Z5WP DRUGTYPE Small molecular drug D0Z5WP DRUGINCH 1S/C28H35N3O6/c1-15-12-18-17(27(3,4)14-16(2)28(18,5)6)13-20(15)37-21-11-10-19(36-21)23(32)29-22-24(33-7)30-26(35-9)31-25(22)34-8/h10-13,16H,14H2,1-9H3,(H,29,32) D0Z5WP DRUGINKE JTFNDUMPCFHPFC-UHFFFAOYSA-N D0Z5WP DRUGSMIL CC1CC(C2=C(C1(C)C)C=C(C(=C2)OC3=CC=C(O3)C(=O)NC4=C(N=C(N=C4OC)OC)OC)C)(C)C D0Z5WP HIGHSTAT Investigative D0Z5XD DRUG__ID D0Z5XD D0Z5XD DRUGTYPE Small molecular drug D0Z5XD DRUGINCH 1S/C13H11N3O/c17-13-11-3-1-2-4-12(11)15-16(13)9-10-5-7-14-8-6-10/h1-8,15H,9H2 D0Z5XD DRUGINKE CCCUFFBZCPVPFV-UHFFFAOYSA-N D0Z5XD DRUGSMIL C1=CC=C2C(=C1)C(=O)N(N2)CC3=CC=NC=C3 D0Z5XD HIGHSTAT Investigative D0Z5YO DRUG__ID D0Z5YO D0Z5YO DRUGTYPE Small molecular drug D0Z5YO DRUGINCH 1S/C16H14N2O/c19-16(17-11-12-6-2-1-3-7-12)15-10-13-8-4-5-9-14(13)18-15/h1-10,18H,11H2,(H,17,19) D0Z5YO DRUGINKE AYMFXIQFBKQBGU-UHFFFAOYSA-N D0Z5YO DRUGSMIL C1=CC=C(C=C1)CNC(=O)C2=CC3=CC=CC=C3N2 D0Z5YO HIGHSTAT Investigative D0Z6AE DRUG__ID D0Z6AE D0Z6AE DRUGTYPE Small molecular drug D0Z6AE DRUGINCH 1S/C8H8O5/c9-5-2-1-4(3-6(5)10)7(11)8(12)13/h1-3,7,9-11H,(H,12,13) D0Z6AE DRUGINKE RGHMISIYKIHAJW-UHFFFAOYSA-N D0Z6AE DRUGSMIL C1=CC(=C(C=C1C(C(=O)O)O)O)O D0Z6AE HIGHSTAT Investigative D0Z6BO DRUG__ID D0Z6BO D0Z6BO DRUGTYPE Small molecular drug D0Z6BO DRUGINCH 1S/C27H30O11/c1-11-19(30)35-17-15(29)25-16-13(28)14(23(2,3)4)24(25)18(34-10-12-8-6-5-7-9-12)20(31)37-22(24)38-27(25,21(32)36-16)26(11,17)33/h5-9,11,13-18,22,28-29,33H,10H2,1-4H3/t11?,13-,14?,15?,16?,17-,18-,22?,24?,25?,26+,27-/m0/s1 D0Z6BO DRUGINKE YPOMAFCMSAKBRX-CLNXZACASA-N D0Z6BO DRUGSMIL CC1C(=O)OC2C1(C34C(=O)OC5C3(C2O)C6(C(C5O)C(C)(C)C)C(C(=O)OC6O4)OCC7=CC=CC=C7)O D0Z6BO HIGHSTAT Investigative D0Z6BT DRUG__ID D0Z6BT D0Z6BT DRUGTYPE Small molecular drug D0Z6BT DRUGINCH 1S/C21H16O4/c22-20(16-9-11-17(12-10-16)21(23)24)18-7-4-8-19(13-18)25-14-15-5-2-1-3-6-15/h1-13H,14H2,(H,23,24) D0Z6BT DRUGINKE UBSDFPUNDIGYKJ-UHFFFAOYSA-N D0Z6BT DRUGSMIL C1=CC=C(C=C1)COC2=CC=CC(=C2)C(=O)C3=CC=C(C=C3)C(=O)O D0Z6BT HIGHSTAT Investigative D0Z6BY DRUG__ID D0Z6BY D0Z6BY DRUGTYPE Small molecular drug D0Z6BY DRUGINCH 1S/C27H27NO2/c1-3-4-7-17-28-19-22(18-26(28)21-13-15-23(30-2)16-14-21)27(29)25-12-8-10-20-9-5-6-11-24(20)25/h5-6,8-16,18-19H,3-4,7,17H2,1-2H3 D0Z6BY DRUGINKE IQIAZANEJACDNJ-UHFFFAOYSA-N D0Z6BY DRUGSMIL CCCCCN1C=C(C=C1C2=CC=C(C=C2)OC)C(=O)C3=CC=CC4=CC=CC=C43 D0Z6BY HIGHSTAT Investigative D0Z6BZ DRUG__ID D0Z6BZ D0Z6BZ DRUGTYPE Small molecular drug D0Z6BZ DRUGINCH 1S/C25H19NO2/c27-25(26-23-15-7-13-21(17-23)19-9-3-1-4-10-19)28-24-16-8-14-22(18-24)20-11-5-2-6-12-20/h1-18H,(H,26,27) D0Z6BZ DRUGINKE GJGNAZXEUGJLTC-UHFFFAOYSA-N D0Z6BZ DRUGSMIL C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)OC3=CC=CC(=C3)C4=CC=CC=C4 D0Z6BZ HIGHSTAT Investigative D0Z6CZ DRUG__ID D0Z6CZ D0Z6CZ DRUGTYPE Small molecular drug D0Z6CZ DRUGINCH 1S/C8H3Cl2NO2/c9-3-1-2-4-5(6(3)10)7(12)8(13)11-4/h1-2H,(H,11,12,13) D0Z6CZ DRUGINKE WWSWHYAXEFLETD-UHFFFAOYSA-N D0Z6CZ DRUGSMIL C1=CC(=C(C2=C1NC(=O)C2=O)Cl)Cl D0Z6CZ HIGHSTAT Investigative D0Z6DB DRUG__ID D0Z6DB D0Z6DB DRUGTYPE Small molecular drug D0Z6DB DRUGINCH 1S/C5H13NO/c1-4(2)5(6)3-7/h4-5,7H,3,6H2,1-2H3/t5-/m1/s1 D0Z6DB DRUGINKE NWYYWIJOWOLJNR-RXMQYKEDSA-N D0Z6DB DRUGSMIL CC(C)C(CO)N D0Z6DB HIGHSTAT Investigative D0Z6DG DRUG__ID D0Z6DG D0Z6DG DRUGTYPE Small molecular drug D0Z6DG DRUGINCH 1S/C23H43O6PS.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-23(24)28-22-20-27-19-18-21(22)29-30(25,26)31;/h9-10,21-22H,2-8,11-20H2,1H3,(H2,25,26,31);/q;+1/p-1/b10-9-;/t21-,22+;/m0./s1 D0Z6DG DRUGINKE DFEVXZSENXLXQQ-LYOQJJATSA-M D0Z6DG DRUGSMIL CCCCCCCCC=CCCCCCCCC(=O)OC1COCCC1OP(=O)(O)[S-].[Na+] D0Z6DG HIGHSTAT Investigative D0Z6DK DRUG__ID D0Z6DK D0Z6DK DRUGTYPE Small molecular drug D0Z6DK DRUGINCH 1S/C16H19NO2/c1-10-4-2-6-12-14(10)16(18)15-11-5-3-8-17(11)9-7-13(15)19-12/h2,4,6,11,13,15H,3,5,7-9H2,1H3/t11-,13+,15-/m1/s1 D0Z6DK DRUGINKE DXTYYNIKCKARPP-OSAQELSMSA-N D0Z6DK DRUGSMIL CC1=C2C(=CC=C1)OC3CCN4CCCC4C3C2=O D0Z6DK HIGHSTAT Investigative D0Z6DL DRUG__ID D0Z6DL D0Z6DL DRUGTYPE Small molecular drug D0Z6DL DRUGINCH 1S/C17H19N3O3/c18-15(17(22)23)10-11-16(21)20-14-8-6-13(7-9-14)19-12-4-2-1-3-5-12/h1-9,15,19H,10-11,18H2,(H,20,21)(H,22,23)/t15-/m0/s1 D0Z6DL DRUGINKE CKEDBZVOBFKCJM-HNNXBMFYSA-N D0Z6DL DRUGSMIL C1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)CCC(C(=O)O)N D0Z6DL HIGHSTAT Investigative D0Z6GG DRUG__ID D0Z6GG D0Z6GG DRUGTYPE Small molecular drug D0Z6GG DRUGINCH 1S/C15H18N4/c1-2-6-13(7-3-1)12-17-14-8-9-16-15(18-14)19-10-4-5-11-19/h1-3,6-9H,4-5,10-12H2,(H,16,17,18) D0Z6GG DRUGINKE PGBNXXDXGXQQRQ-UHFFFAOYSA-N D0Z6GG DRUGSMIL C1CCN(C1)C2=NC=CC(=N2)NCC3=CC=CC=C3 D0Z6GG HIGHSTAT Investigative D0Z6HR DRUG__ID D0Z6HR D0Z6HR DRUGTYPE Small molecular drug D0Z6HR DRUGINCH 1S/C30H39N5O4S2/c1-21-28(38)35-18-11-15-24(35)27(37)33-23(14-7-4-10-19-40-41-25-16-8-9-17-31-25)26(36)34-30(2,29(39)32-21)20-22-12-5-3-6-13-22/h3,5-6,8-9,12-13,16-17,21,23-24H,4,7,10-11,14-15,18-20H2,1-2H3,(H,32,39)(H,33,37)(H,34,36)/t21-,23-,24+,30-/m0/s1 D0Z6HR DRUGINKE ITTWBEZYTYPCGB-GAOIQBMKSA-N D0Z6HR DRUGSMIL CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)(C)CC3=CC=CC=C3)CCCCCSSC4=CC=CC=N4 D0Z6HR HIGHSTAT Investigative D0Z6LR DRUG__ID D0Z6LR D0Z6LR DRUGTYPE Small molecular drug D0Z6LR DRUGINCH 1S/C10H7Cl2NO2S2/c11-9-6-8(10(12)16-9)17(14,15)13-7-4-2-1-3-5-7/h1-6,13H D0Z6LR DRUGINKE ILXABJHIVUDACG-UHFFFAOYSA-N D0Z6LR DRUGSMIL C1=CC=C(C=C1)NS(=O)(=O)C2=C(SC(=C2)Cl)Cl D0Z6LR HIGHSTAT Investigative D0Z6MI DRUG__ID D0Z6MI D0Z6MI DRUGTYPE Small molecular drug D0Z6MI DRUGINCH 1S/C30H39N5O4S2/c1-30(2)29(39)33-23(20-21-12-5-3-6-13-21)28(38)35-18-11-15-24(35)27(37)32-22(26(36)34-30)14-7-4-10-19-40-41-25-16-8-9-17-31-25/h3,5-6,8-9,12-13,16-17,22-24H,4,7,10-11,14-15,18-20H2,1-2H3,(H,32,37)(H,33,39)(H,34,36)/t22-,23-,24+/m0/s1 D0Z6MI DRUGINKE GNIYZHFLRFNYMZ-KMDXXIMOSA-N D0Z6MI DRUGSMIL CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CC4=CC=CC=C4)C D0Z6MI HIGHSTAT Investigative D0Z6OT DRUG__ID D0Z6OT D0Z6OT DRUGTYPE Small molecular drug D0Z6OT DRUGINCH 1S/C28H20O12/c29-11(9-19(34)35)7-8-15(30)12-3-1-5-16(31)20(12)27(38)24-22-14(10-18(33)23(24)28(39)40)25(36)13-4-2-6-17(32)21(13)26(22)37/h1-6,10-11,29,31-33H,7-9H2,(H,34,35)(H,39,40) D0Z6OT DRUGINKE XFESZXMDORIFAO-UHFFFAOYSA-N D0Z6OT DRUGSMIL C1=CC2=C(C(=C1)O)C(=O)C3=C(C(=C(C=C3C2=O)O)C(=O)O)C(=O)C4=C(C=CC=C4O)C(=O)CCC(CC(=O)O)O D0Z6OT HIGHSTAT Investigative D0Z6RT DRUG__ID D0Z6RT D0Z6RT DRUGTYPE Small molecular drug D0Z6RT DRUGINCH 1S/C29H50O/c1-7-21(19(2)3)9-8-20(4)25-12-13-26-24-11-10-22-18-23(30)14-16-28(22,5)27(24)15-17-29(25,26)6/h18-21,23-27,30H,7-17H2,1-6H3/t20-,21-,23+,24+,25-,26+,27+,28+,29-/m1/s1 D0Z6RT DRUGINKE BBTIMXAYZRWPNG-VJSFXXLFSA-N D0Z6RT DRUGSMIL CCC(CCC(C)C1CCC2C1(CCC3C2CCC4=CC(CCC34C)O)C)C(C)C D0Z6RT HIGHSTAT Investigative D0Z6SS DRUG__ID D0Z6SS D0Z6SS DRUGTYPE Small molecular drug D0Z6SS DRUGINCH 1S/C17H22N2O/c20-16(18-15-4-2-1-3-5-15)19-17-9-12-6-13(10-17)8-14(7-12)11-17/h1-5,12-14H,6-11H2,(H2,18,19,20) D0Z6SS DRUGINKE BOKJLWGPHOTBQZ-UHFFFAOYSA-N D0Z6SS DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NC4=CC=CC=C4 D0Z6SS HIGHSTAT Investigative D0Z6SY DRUG__ID D0Z6SY D0Z6SY DRUGTYPE Small molecular drug D0Z6SY DRUGINCH 1S/C20H30O4/c21-18-13-11-9-7-5-3-1-2-4-6-8-10-12-15-19(22)16-14-17-20(23)24/h2-5,8,10,12,15,21H,1,6-7,9,11,13-14,16-18H2,(H,23,24)/b4-2-,5-3-,10-8-,15-12+ D0Z6SY DRUGINKE DTSRZRUIWKDHMR-DHYYJNSCSA-N D0Z6SY DRUGSMIL C(CCC=CCC=CCC=CC=CC(=O)CCCC(=O)O)CCO D0Z6SY HIGHSTAT Investigative D0Z6TG DRUG__ID D0Z6TG D0Z6TG DRUGTYPE Small molecular drug D0Z6TG DRUGINCH 1S/C35H35Cl2N3O2S/c1-39(35(41)31-20-24(22-38)19-27-7-3-4-8-29(27)31)23-28(26-11-12-32(36)33(37)21-26)15-18-40-16-13-25(14-17-40)30-9-5-6-10-34(30)43(2)42/h3-12,19-21,25,28H,13-18,23H2,1-2H3/t28-,43+/m1/s1 D0Z6TG DRUGINKE SJHZTGDJTIZMSK-KPRDSAADSA-N D0Z6TG DRUGSMIL CN(CC(CCN1CCC(CC1)C2=CC=CC=C2S(=O)C)C3=CC(=C(C=C3)Cl)Cl)C(=O)C4=CC(=CC5=CC=CC=C54)C#N D0Z6TG HIGHSTAT Investigative D0Z6TM DRUG__ID D0Z6TM D0Z6TM DRUGTYPE Small molecular drug D0Z6TM DRUGINCH 1S/C6H6N4O2S/c7-10-9-5-1-3-6(4-2-5)13(8,11)12/h1-4H,(H2,8,11,12) D0Z6TM DRUGINKE UZEFHQIOSJWWSB-UHFFFAOYSA-N D0Z6TM DRUGSMIL C1=CC(=CC=C1N=[N+]=[N-])S(=O)(=O)N D0Z6TM HIGHSTAT Investigative D0Z6UE DRUG__ID D0Z6UE D0Z6UE DRUGTYPE Small molecular drug D0Z6UE DRUGINCH 1S/C42H58N8O10/c1-21(2)33(48-40(57)34(22(3)4)47-36(53)23(5)43)39(56)46-31(18-25-13-15-27(52)16-14-25)41(58)50-17-9-12-32(50)38(55)45-30(37(54)49-35(24(6)51)42(59)60)19-26-20-44-29-11-8-7-10-28(26)29/h7-8,10-11,13-16,20-24,30-35,44,51-52H,9,12,17-19,43H2,1-6H3,(H,45,55)(H,46,56)(H,47,53)(H,48,57)(H,49,54)(H,59,60)/t23-,24+,30-,31-,32-,33-,34-,35-/m0/s1 D0Z6UE DRUGINKE JZZWLFSCHMSJQR-XXWLAZNXSA-N D0Z6UE DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(C)N D0Z6UE HIGHSTAT Investigative D0Z6UK DRUG__ID D0Z6UK D0Z6UK DRUGTYPE Small molecular drug D0Z6UK DRUGINCH 1S/C20H17N3O4/c24-18(14-10-21-16-9-5-4-8-13(14)16)22-17-15(20(26)27)11-23(19(17)25)12-6-2-1-3-7-12/h1-10,15,17,21H,11H2,(H,22,24)(H,26,27) D0Z6UK DRUGINKE TUYVXFVSHUIIJR-UHFFFAOYSA-N D0Z6UK DRUGSMIL C1C(C(C(=O)N1C2=CC=CC=C2)NC(=O)C3=CNC4=CC=CC=C43)C(=O)O D0Z6UK HIGHSTAT Investigative D0Z6VR DRUG__ID D0Z6VR D0Z6VR DRUGTYPE Small molecular drug D0Z6VR DRUGINCH 1S/C8H18N2O3S/c1-2-3-5-14(10,13)6-4-7(9)8(11)12/h7,10H,2-6,9H2,1H3,(H,11,12) D0Z6VR DRUGINKE KJQFBVYMGADDTQ-UHFFFAOYSA-N D0Z6VR DRUGSMIL CCCCS(=N)(=O)CCC(C(=O)O)N D0Z6VR HIGHSTAT Investigative D0Z6VT DRUG__ID D0Z6VT D0Z6VT DRUGTYPE Small molecular drug D0Z6VT DRUGINCH 1S/C23H25F3N4O3S/c1-2-29(15-17-5-3-4-6-20(17)23(24,25)26)22(31)16-9-11-30(12-10-16)34(32,33)19-7-8-21-18(13-19)14-27-28-21/h3-8,13-14,16H,2,9-12,15H2,1H3,(H,27,28) D0Z6VT DRUGINKE FJPQEOQGIZSLES-UHFFFAOYSA-N D0Z6VT DRUGSMIL CCN(CC1=CC=CC=C1C(F)(F)F)C(=O)C2CCN(CC2)S(=O)(=O)C3=CC4=C(C=C3)NN=C4 D0Z6VT HIGHSTAT Investigative D0Z6WU DRUG__ID D0Z6WU D0Z6WU DRUGTYPE Small molecular drug D0Z6WU DRUGINCH 1S/C20H30N2.2BrH/c1(3-5-9-15-21-17-11-7-12-18-21)2-4-6-10-16-22-19-13-8-14-20-22;;/h7-8,11-14,17-20H,1-6,9-10,15-16H2;2*1H/q+2;;/p-2 D0Z6WU DRUGINKE XZZPVHYTBRRMNM-UHFFFAOYSA-L D0Z6WU DRUGSMIL C1=CC=[N+](C=C1)CCCCCCCCCC[N+]2=CC=CC=C2.[Br-].[Br-] D0Z6WU HIGHSTAT Investigative D0Z6WZ DRUG__ID D0Z6WZ D0Z6WZ DRUGTYPE Small molecular drug D0Z6WZ DRUGINCH 1S/C20H32N8O7/c1-2-15(30)28-9-10-6-13(28)19(35)27-11(4-3-5-23-20(21)22)17(33)24-8-14(29)26-12(7-16(31)32)18(34)25-10/h10-13H,2-9H2,1H3,(H,24,33)(H,25,34)(H,26,29)(H,27,35)(H,31,32)(H4,21,22,23)/t10-,11-,12-,13-/m0/s1 D0Z6WZ DRUGINKE BGIHRGIMRVRYKO-CYDGBPFRSA-N D0Z6WZ DRUGSMIL CCC(=O)N1CC2CC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)N2)CC(=O)O)CCCN=C(N)N D0Z6WZ HIGHSTAT Investigative D0Z6YA DRUG__ID D0Z6YA D0Z6YA DRUGTYPE Small molecular drug D0Z6YA DRUGINCH 1S/C20H26N2O/c1-2-23-20-11-7-6-10-18(20)16-19(17-8-4-3-5-9-17)22-14-12-21-13-15-22/h3-11,19,21H,2,12-16H2,1H3 D0Z6YA DRUGINKE CVFBVSUFNWOPLD-UHFFFAOYSA-N D0Z6YA DRUGSMIL CCOC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3 D0Z6YA HIGHSTAT Investigative D0Z7AF DRUG__ID D0Z7AF D0Z7AF DRUGTYPE Small molecular drug D0Z7AF DRUGINCH 1S/C32H40N4O4S/c1-7-9-16-40-32(37)35-41(38,39)28-15-12-25(17-21(3)4)19-27(28)26-13-10-24(11-14-26)20-36-29(8-2)34-30-22(5)18-23(6)33-31(30)36/h10-15,18-19,21H,7-9,16-17,20H2,1-6H3,(H,35,37) D0Z7AF DRUGINKE GABMQILPAPONQS-UHFFFAOYSA-N D0Z7AF DRUGSMIL CCCCOC(=O)NS(=O)(=O)C1=C(C=C(C=C1)CC(C)C)C2=CC=C(C=C2)CN3C(=NC4=C3N=C(C=C4C)C)CC D0Z7AF HIGHSTAT Investigative D0Z7BC DRUG__ID D0Z7BC D0Z7BC DRUGTYPE Small molecular drug D0Z7BC DRUGINCH 1S/C19H29N6O5/c1-18(2)5-10(19(3,4)25(18)29)6-20-15-12-16(22-8-21-15)24(9-23-12)17-14(28)13(27)11(7-26)30-17/h8-11,13-14,17,26-28H,5-7H2,1-4H3,(H,20,21,22)/t10?,11-,13-,14-,17-/m1/s1 D0Z7BC DRUGINKE QFFVFNDFHJHEHU-QIFOKDCASA-N D0Z7BC DRUGSMIL CC1(CC(C(N1[O])(C)C)CNC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O)C D0Z7BC HIGHSTAT Investigative D0Z7CZ DRUG__ID D0Z7CZ D0Z7CZ DRUGTYPE Small molecular drug D0Z7CZ DRUGINCH 1S/C6H9NO4/c7-4(6(10)11)2-1-3(2)5(8)9/h2-4H,1,7H2,(H,8,9)(H,10,11) D0Z7CZ DRUGINKE GZOVEPYOCJWRFC-UHFFFAOYSA-N D0Z7CZ DRUGSMIL C1C(C1C(=O)O)C(C(=O)O)N D0Z7CZ HIGHSTAT Investigative D0Z7EA DRUG__ID D0Z7EA D0Z7EA DRUGTYPE Small molecular drug D0Z7EA DRUGINCH 1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15+,17+,18+,19+/m1/s1 D0Z7EA DRUGINKE BLGXFZZNTVWLAY-DIRVCLHFSA-N D0Z7EA DRUGSMIL COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O D0Z7EA HIGHSTAT Investigative D0Z7EF DRUG__ID D0Z7EF D0Z7EF DRUGTYPE Small molecular drug D0Z7EF DRUGINCH 1S/C17H22N2O3/c20-17(16-13-14-5-1-2-6-15(14)22-16)18-7-3-4-8-19-9-11-21-12-10-19/h1-2,5-6,13H,3-4,7-12H2,(H,18,20) D0Z7EF DRUGINKE KUJQEQAVMNFFAO-UHFFFAOYSA-N D0Z7EF DRUGSMIL C1COCCN1CCCCNC(=O)C2=CC3=CC=CC=C3O2 D0Z7EF HIGHSTAT Investigative D0Z7EL DRUG__ID D0Z7EL D0Z7EL DRUGTYPE Small molecular drug D0Z7EL DRUGINCH 1S/C15H10O8/c16-6-2-1-5(3-7(6)17)14-13(22)12(21)10-8(18)4-9(19)11(20)15(10)23-14/h1-4,16-20,22H D0Z7EL DRUGINKE YRRAGUMVDQQZIY-UHFFFAOYSA-N D0Z7EL DRUGSMIL C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C(=C(C=C3O)O)O)O)O)O D0Z7EL HIGHSTAT Investigative D0Z7FF DRUG__ID D0Z7FF D0Z7FF DRUGTYPE Small molecular drug D0Z7FF DRUGINCH 1S/C26H24ClNO/c1-2-3-6-15-28-18-21(17-25(28)20-11-7-12-22(27)16-20)26(29)24-14-8-10-19-9-4-5-13-23(19)24/h4-5,7-14,16-18H,2-3,6,15H2,1H3 D0Z7FF DRUGINKE UVJANPIKZUBGAE-UHFFFAOYSA-N D0Z7FF DRUGSMIL CCCCCN1C=C(C=C1C2=CC(=CC=C2)Cl)C(=O)C3=CC=CC4=CC=CC=C43 D0Z7FF HIGHSTAT Investigative D0Z7FM DRUG__ID D0Z7FM D0Z7FM DRUGTYPE Small molecular drug D0Z7FM DRUGINCH 1S/C12H7Cl2NO4/c13-7-1-3-12(10(16)5-7)19-11-4-2-8(15(17)18)6-9(11)14/h1-6,16H D0Z7FM DRUGINKE DEDBMNCDHFNYKX-UHFFFAOYSA-N D0Z7FM DRUGSMIL C1=CC(=C(C=C1[N+](=O)[O-])Cl)OC2=C(C=C(C=C2)Cl)O D0Z7FM HIGHSTAT Investigative D0Z7GH DRUG__ID D0Z7GH D0Z7GH DRUGTYPE Small molecular drug D0Z7GH DRUGINCH 1S/C22H18Cl2N4O2/c1-3-30-15-9-7-14(8-10-15)26-22-25-12-13-11-16(21(29)28(2)20(13)27-22)19-17(23)5-4-6-18(19)24/h4-12H,3H2,1-2H3,(H,25,26,27) D0Z7GH DRUGINKE AFZKXALTXCNQAZ-UHFFFAOYSA-N D0Z7GH DRUGSMIL CCOC1=CC=C(C=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl D0Z7GH HIGHSTAT Investigative D0Z7GS DRUG__ID D0Z7GS D0Z7GS DRUGTYPE Small molecular drug D0Z7GS DRUGINCH 1S/C13H15FN2O2/c1-8(17)15-4-3-9-7-16-12-6-11(14)13(18-2)5-10(9)12/h5-7,16H,3-4H2,1-2H3,(H,15,17) D0Z7GS DRUGINKE BTTITVUHHXXLFM-UHFFFAOYSA-N D0Z7GS DRUGSMIL CC(=O)NCCC1=CNC2=CC(=C(C=C21)OC)F D0Z7GS HIGHSTAT Investigative D0Z7IJ DRUG__ID D0Z7IJ D0Z7IJ DRUGTYPE Small molecular drug D0Z7IJ DRUGINCH 1S/C12H21NO6/c1-4-17-9(14)7-12(13,11(16)19-6-3)8-10(15)18-5-2/h4-8,13H2,1-3H3 D0Z7IJ DRUGINKE OUTCCXFGNSXCFR-UHFFFAOYSA-N D0Z7IJ DRUGSMIL CCOC(=O)CC(CC(=O)OCC)(C(=O)OCC)N D0Z7IJ HIGHSTAT Investigative D0Z7KW DRUG__ID D0Z7KW D0Z7KW DRUGTYPE Small molecular drug D0Z7KW DRUGINCH 1S/C14H18ClN/c1-16-8-7-12-13(15)6-5-10-3-2-4-11(9-16)14(10)12/h5-6,11H,2-4,7-9H2,1H3 D0Z7KW DRUGINKE KELNXILYABMXFF-UHFFFAOYSA-N D0Z7KW DRUGSMIL CN1CCC2=C(C=CC3=C2C(C1)CCC3)Cl D0Z7KW HIGHSTAT Investigative D0Z7LS DRUG__ID D0Z7LS D0Z7LS DRUGTYPE Small molecular drug D0Z7LS DRUGINCH 1S/C14H17NO2/c1-4-14(5-2)12(16)15(13(14)17)11-9-7-6-8-10(11)3/h6-9H,4-5H2,1-3H3 D0Z7LS DRUGINKE QNAKQLGCEYBHNC-UHFFFAOYSA-N D0Z7LS DRUGSMIL CCC1(C(=O)N(C1=O)C2=CC=CC=C2C)CC D0Z7LS HIGHSTAT Investigative D0Z7NC DRUG__ID D0Z7NC D0Z7NC DRUGTYPE Small molecular drug D0Z7NC DRUGINCH 1S/C11H14N2/c1-2-4-10(5-3-1)6-7-11-12-8-9-13-11/h1-5H,6-9H2,(H,12,13) D0Z7NC DRUGINKE CPMMXSDLEOJRHI-UHFFFAOYSA-N D0Z7NC DRUGSMIL C1CN=C(N1)CCC2=CC=CC=C2 D0Z7NC HIGHSTAT Investigative D0Z7OB DRUG__ID D0Z7OB D0Z7OB DRUGTYPE Small molecular drug D0Z7OB DRUGINCH 1S/C21H33NO3/c1-4-5-6-7-8-9-10-11-12-21(23)22-14-13-18-15-19(24-2)17-20(16-18)25-3/h11-12,15-17H,4-10,13-14H2,1-3H3,(H,22,23)/b12-11+ D0Z7OB DRUGINKE RWXZZBVYJHEKRB-VAWYXSNFSA-N D0Z7OB DRUGSMIL CCCCCCCCC=CC(=O)NCCC1=CC(=CC(=C1)OC)OC D0Z7OB HIGHSTAT Investigative D0Z7OX DRUG__ID D0Z7OX D0Z7OX DRUGTYPE Small molecular drug D0Z7OX DRUGINCH 1S/C28H27NO5/c1-19-25(17-18-32-23-13-15-24(16-14-23)34-28(2,3)27(30)31)29-26(33-19)22-11-9-21(10-12-22)20-7-5-4-6-8-20/h4-16H,17-18H2,1-3H3,(H,30,31) D0Z7OX DRUGINKE JDJHTJNBMZSSLK-UHFFFAOYSA-N D0Z7OX DRUGSMIL CC1=C(N=C(O1)C2=CC=C(C=C2)C3=CC=CC=C3)CCOC4=CC=C(C=C4)OC(C)(C)C(=O)O D0Z7OX HIGHSTAT Investigative D0Z7QZ DRUG__ID D0Z7QZ D0Z7QZ DRUGTYPE Small molecular drug D0Z7QZ DRUGINCH 1S/C10H8N2OS/c13-9(8-4-2-1-3-5-8)12-10-11-6-7-14-10/h1-7H,(H,11,12,13) D0Z7QZ DRUGINKE SCQBDADQAVXTMZ-UHFFFAOYSA-N D0Z7QZ DRUGSMIL C1=CC=C(C=C1)C(=O)NC2=NC=CS2 D0Z7QZ HIGHSTAT Investigative D0Z7RB DRUG__ID D0Z7RB D0Z7RB DRUGTYPE Small molecular drug D0Z7RB DRUGINCH 1S/C28H28N6O2/c1-20(35)30-25(19-21-9-3-2-4-10-21)28(36)34-17-15-33(16-18-34)27-22-11-5-6-12-23(22)31-26(32-27)24-13-7-8-14-29-24/h2-14,25H,15-19H2,1H3,(H,30,35)/t25-/m0/s1 D0Z7RB DRUGINKE NHHPRDYQOKYIBK-VWLOTQADSA-N D0Z7RB DRUGSMIL CC(=O)NC(CC1=CC=CC=C1)C(=O)N2CCN(CC2)C3=NC(=NC4=CC=CC=C43)C5=CC=CC=N5 D0Z7RB HIGHSTAT Investigative D0Z7SL DRUG__ID D0Z7SL D0Z7SL DRUGTYPE Small molecular drug D0Z7SL DRUGINCH 1S/C22H22N4O2/c1-25-13-17(18-5-3-4-6-19(18)25)14-26(2)21(28)10-7-15-11-16-8-9-20(27)24-22(16)23-12-15/h3-7,10-13H,8-9,14H2,1-2H3,(H,23,24,27)/b10-7+ D0Z7SL DRUGINKE VAZMNDXVXVUKFY-JXMROGBWSA-N D0Z7SL DRUGSMIL CN1C=C(C2=CC=CC=C21)CN(C)C(=O)C=CC3=CC4=C(NC(=O)CC4)N=C3 D0Z7SL HIGHSTAT Investigative D0Z7TM DRUG__ID D0Z7TM D0Z7TM DRUGTYPE Small molecular drug D0Z7TM DRUGINCH 1S/C20H20N8O/c1-10(2)16-15(20-27-26-12(4)29-20)8-28-17(16)19(22-9-23-28)25-14-6-13-5-11(3)24-18(13)21-7-14/h5-10H,1-4H3,(H,21,24)(H,22,23,25) D0Z7TM DRUGINKE OOQXPATWSOGSAV-UHFFFAOYSA-N D0Z7TM DRUGSMIL CC1=CC2=CC(=CN=C2N1)NC3=NC=NN4C3=C(C(=C4)C5=NN=C(O5)C)C(C)C D0Z7TM HIGHSTAT Investigative D0Z7WK DRUG__ID D0Z7WK D0Z7WK DRUGTYPE Small molecular drug D0Z7WK DRUGINCH 1S/C9H15F3OS/c1-2-3-4-5-6-14-7-8(13)9(10,11)12/h2-7H2,1H3 D0Z7WK DRUGINKE JKYLDTTWQQEIHX-UHFFFAOYSA-N D0Z7WK DRUGSMIL CCCCCCSCC(=O)C(F)(F)F D0Z7WK HIGHSTAT Investigative D0Z7XI DRUG__ID D0Z7XI D0Z7XI DRUGTYPE Small molecular drug D0Z7XI DRUGINCH 1S/C10H13N/c1-8-6-9-4-2-3-5-10(9)7-11-8/h2-5,8,11H,6-7H2,1H3 D0Z7XI DRUGINKE UEKQPSAKUNXFHL-UHFFFAOYSA-N D0Z7XI DRUGSMIL CC1CC2=CC=CC=C2CN1 D0Z7XI HIGHSTAT Investigative D0Z7YI DRUG__ID D0Z7YI D0Z7YI DRUGTYPE Small molecular drug D0Z7YI DRUGINCH 1S/C12H13N3O/c1-2-11(16)10-5-7-3-4-8(12(13)14)6-9(7)15-10/h3-6,15H,2H2,1H3,(H3,13,14) D0Z7YI DRUGINKE MUIPXQPVWYRDNF-UHFFFAOYSA-N D0Z7YI DRUGSMIL CCC(=O)C1=CC2=C(N1)C=C(C=C2)C(=N)N D0Z7YI HIGHSTAT Investigative D0Z7YK DRUG__ID D0Z7YK D0Z7YK DRUGTYPE Small molecular drug D0Z7YK DRUGINCH 1S/C23H28O3/c1-5-8-23(26)10-7-17-16-11-14(2)18-12-15(24)6-9-21(18,3)20(16)19(25)13-22(17,23)4/h6,9,11-12,16-17,19-20,25-26H,7,10,13H2,1-4H3/t16-,17-,19-,20+,21-,22-,23-/m0/s1 D0Z7YK DRUGINKE UFZKDKHLKHEFGA-ZFTCBNFESA-N D0Z7YK DRUGSMIL CC#CC1(CCC2C1(CC(C3C2C=C(C4=CC(=O)C=CC34C)C)O)C)O D0Z7YK HIGHSTAT Investigative D0Z7YS DRUG__ID D0Z7YS D0Z7YS DRUGTYPE Small molecular drug D0Z7YS DRUGINCH 1S/C13H18N2O3/c1-2-3-4-12(16)14-9-10-5-7-11(8-6-10)13(17)15-18/h5-8,18H,2-4,9H2,1H3,(H,14,16)(H,15,17) D0Z7YS DRUGINKE ZOLDKKORXZQAQV-UHFFFAOYSA-N D0Z7YS DRUGSMIL CCCCC(=O)NCC1=CC=C(C=C1)C(=O)NO D0Z7YS HIGHSTAT Investigative D0Z7ZZ DRUG__ID D0Z7ZZ D0Z7ZZ DRUGTYPE Small molecular drug D0Z7ZZ DRUGINCH 1S/C7H15NO2/c1-8(2,3)6-4-5-7(9)10/h4-6H2,1-3H3/p+1 D0Z7ZZ DRUGINKE JHPNVNIEXXLNTR-UHFFFAOYSA-O D0Z7ZZ DRUGSMIL C[N+](C)(C)CCCC(=O)O D0Z7ZZ HIGHSTAT Investigative D0Z8CP DRUG__ID D0Z8CP D0Z8CP DRUGTYPE Small molecular drug D0Z8CP DRUGINCH 1S/C12H14O4S2/c1-10-3-5-11(6-4-10)12-9-17(13,14)7-2-8-18(12,15)16/h3-6,9H,2,7-8H2,1H3 D0Z8CP DRUGINKE KZYCUCAZAITGMW-UHFFFAOYSA-N D0Z8CP DRUGSMIL CC1=CC=C(C=C1)C2=CS(=O)(=O)CCCS2(=O)=O D0Z8CP HIGHSTAT Investigative D0Z8EI DRUG__ID D0Z8EI D0Z8EI DRUGTYPE Small molecular drug D0Z8EI DRUGINCH 1S/C8H9N5O/c1-2-3-14-7-5-6(11-4-10-5)12-8(9)13-7/h2,4H,1,3H2,(H3,9,10,11,12,13) D0Z8EI DRUGINKE HJMGFQNIHIHSCQ-UHFFFAOYSA-N D0Z8EI DRUGSMIL C=CCOC1=NC(=NC2=C1NC=N2)N D0Z8EI HIGHSTAT Investigative D0Z8EU DRUG__ID D0Z8EU D0Z8EU DRUGTYPE Small molecular drug D0Z8EU DRUGINCH 1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)5-6-3-1-2-4-8-6/h1-4,9H,5H2,(H2,10,11,12)(H2,13,14,15) D0Z8EU DRUGINKE XXNASZAYANFLID-UHFFFAOYSA-N D0Z8EU DRUGSMIL C1=CC=NC(=C1)CC(O)(P(=O)(O)O)P(=O)(O)O D0Z8EU HIGHSTAT Investigative D0Z8GS DRUG__ID D0Z8GS D0Z8GS DRUGTYPE Small molecular drug D0Z8GS DRUGINCH 1S/C25H27Cl2F3N4O7S2/c1-3-43(39,40)20-7-6-15(26)9-14(20)12-34-23(35)17-10-19(41-25(28,29)30)18(21(27)22(17)32-24(34)36)13-33-8-4-5-16(33)11-31-42(2,37)38/h6-7,9-10,16,31H,3-5,8,11-13H2,1-2H3,(H,32,36)/t16-/m0/s1 D0Z8GS DRUGINKE ADNJLXQZOZXZJU-INIZCTEOSA-N D0Z8GS DRUGSMIL CCS(=O)(=O)C1=C(C=C(C=C1)Cl)CN2C(=O)C3=CC(=C(C(=C3NC2=O)Cl)CN4CCCC4CNS(=O)(=O)C)OC(F)(F)F D0Z8GS HIGHSTAT Investigative D0Z8HX DRUG__ID D0Z8HX D0Z8HX DRUGTYPE Small molecular drug D0Z8HX DRUGINCH 1S/C8H3Cl2NO2/c9-4-2-1-3-6(5(4)10)11-8(13)7(3)12/h1-2H,(H,11,12,13) D0Z8HX DRUGINKE XTXIILHWOQZVAQ-UHFFFAOYSA-N D0Z8HX DRUGSMIL C1=CC(=C(C2=C1C(=O)C(=O)N2)Cl)Cl D0Z8HX HIGHSTAT Investigative D0Z8IJ DRUG__ID D0Z8IJ D0Z8IJ DRUGTYPE Small molecular drug D0Z8IJ DRUGINCH 1S/C4H6N2O2/c5-2-3-1-4(7)6-8-3/h1H,2,5H2,(H,6,7) D0Z8IJ DRUGINKE ZJQHPWUVQPJPQT-UHFFFAOYSA-N D0Z8IJ DRUGSMIL C1=C(ONC1=O)CN D0Z8IJ HIGHSTAT Investigative D0Z8JX DRUG__ID D0Z8JX D0Z8JX DRUGTYPE Small molecular drug D0Z8JX DRUGINCH 1S/C34H35N5O5/c40-24-11-6-10-22(16-24)18-27-31(41)36-28(19-23-20-35-26-13-5-4-12-25(23)26)32(42)38-29(17-21-8-2-1-3-9-21)34(44)39-15-7-14-30(39)33(43)37-27/h1-6,8-13,16,20,27-30,35,40H,7,14-15,17-19H2,(H,36,41)(H,37,43)(H,38,42)/t27-,28+,29-,30+/m0/s1 D0Z8JX DRUGINKE NXAWTNITTPJQAL-RRGQHJHPSA-N D0Z8JX DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CC=CC=C3)CC4=CNC5=CC=CC=C54)CC6=CC(=CC=C6)O D0Z8JX HIGHSTAT Investigative D0Z8LE DRUG__ID D0Z8LE D0Z8LE DRUGTYPE Small molecular drug D0Z8LE DRUGINCH 1S/C28H24O3/c29-26-16-11-21-6-5-20-10-15-25(27(30)17-20)24-4-2-1-3-22(24)12-7-19-8-13-23(14-9-19)31-28(26)18-21/h1-4,8-11,13-18,29-30H,5-7,12H2 D0Z8LE DRUGINKE OAEVJFPPXJHCKV-UHFFFAOYSA-N D0Z8LE DRUGSMIL C1CC2=CC=CC=C2C3=C(C=C(CCC4=CC(=C(C=C4)O)OC5=CC=C1C=C5)C=C3)O D0Z8LE HIGHSTAT Investigative D0Z8MX DRUG__ID D0Z8MX D0Z8MX DRUGTYPE Small molecular drug D0Z8MX DRUGINCH 1S/C9H8N2OS/c13-9-11-10-8(12-9)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,11,13) D0Z8MX DRUGINKE ARGIBMBTIISQNH-UHFFFAOYSA-N D0Z8MX DRUGSMIL C1=CC=C(C=C1)CC2=NNC(=S)O2 D0Z8MX HIGHSTAT Investigative D0Z8NC DRUG__ID D0Z8NC D0Z8NC DRUGTYPE Small molecular drug D0Z8NC DRUGINCH 1S/C24H23N3/c1-4-10-17(11-5-1)20-16-21(18-12-6-2-7-13-18)25-24-22(20)26-23(27-24)19-14-8-3-9-15-19/h1-2,4-7,10-13,16,19H,3,8-9,14-15H2,(H,25,26,27) D0Z8NC DRUGINKE DXBBMCIVYYJMJC-UHFFFAOYSA-N D0Z8NC DRUGSMIL C1CCC(CC1)C2=NC3=C(N2)C(=CC(=N3)C4=CC=CC=C4)C5=CC=CC=C5 D0Z8NC HIGHSTAT Investigative D0Z8OD DRUG__ID D0Z8OD D0Z8OD DRUGTYPE Small molecular drug D0Z8OD DRUGINCH 1S/C22H34N4O3/c1-18(2)29-20-8-4-3-7-19(20)25-15-13-24(14-16-25)12-10-23-21(27)17-26-11-6-5-9-22(26)28/h3-4,7-8,18H,5-6,9-17H2,1-2H3,(H,23,27) D0Z8OD DRUGINKE IIRJWNCOXHFIBK-UHFFFAOYSA-N D0Z8OD DRUGSMIL CC(C)OC1=CC=CC=C1N2CCN(CC2)CCNC(=O)CN3CCCCC3=O D0Z8OD HIGHSTAT Investigative D0Z8PT DRUG__ID D0Z8PT D0Z8PT DRUGTYPE Small molecular drug D0Z8PT DRUGINCH 1S/C20H24N8O2/c1-13(11-27(2)3)30-20-16(7-21)22-10-19(26-20)25-18-6-17(29-5)15(9-23-18)14-8-24-28(4)12-14/h6,8-10,12-13H,11H2,1-5H3,(H,23,25,26)/t13-/m1/s1 D0Z8PT DRUGINKE IENLGMOXAQMNEH-CYBMUJFWSA-N D0Z8PT DRUGSMIL CC(CN(C)C)OC1=NC(=CN=C1C#N)NC2=NC=C(C(=C2)OC)C3=CN(N=C3)C D0Z8PT HIGHSTAT Investigative D0Z8PX DRUG__ID D0Z8PX D0Z8PX DRUGTYPE Small molecular drug D0Z8PX DRUGINCH 1S/C29H42N4O5S3/c1-5-6-7-8-9-13-24(35)39-14-11-10-12-20-15-22(34)30-16-23-31-21(17-40-23)26-33-29(4,18-41-26)28(37)32-25(19(2)3)27(36)38-20/h10,12,17,19-20,25H,5-9,11,13-16,18H2,1-4H3,(H,30,34)(H,32,37)/b12-10+/t20-,25+,29+/m1/s1 D0Z8PX DRUGINKE AXESYCSCGBQJBL-SZPBEECKSA-N D0Z8PX DRUGSMIL CCCCCCCC(=O)SCCC=CC1CC(=O)NCC2=NC(=CS2)C3=NC(CS3)(C(=O)NC(C(=O)O1)C(C)C)C D0Z8PX HIGHSTAT Investigative D0Z8RH DRUG__ID D0Z8RH D0Z8RH DRUGTYPE Small molecular drug D0Z8RH DRUGINCH 1S/C21H15F3N2/c22-21(23,24)18-13-7-12-17-19(18)25-26(14-15-8-3-1-4-9-15)20(17)16-10-5-2-6-11-16/h1-13H,14H2 D0Z8RH DRUGINKE LGRUCHCYEMOENE-UHFFFAOYSA-N D0Z8RH DRUGSMIL C1=CC=C(C=C1)CN2C(=C3C=CC=C(C3=N2)C(F)(F)F)C4=CC=CC=C4 D0Z8RH HIGHSTAT Investigative D0Z8RL DRUG__ID D0Z8RL D0Z8RL DRUGTYPE Small molecular drug D0Z8RL DRUGINCH 1S/C17H30N2O2/c20-6-4-2-1-3-5-18-16(21)19-17-10-13-7-14(11-17)9-15(8-13)12-17/h13-15,20H,1-12H2,(H2,18,19,21) D0Z8RL DRUGINKE FUMIBHNYGFMWPI-UHFFFAOYSA-N D0Z8RL DRUGSMIL C1C2CC3CC1CC(C2)(C3)NC(=O)NCCCCCCO D0Z8RL HIGHSTAT Investigative D0Z8TR DRUG__ID D0Z8TR D0Z8TR DRUGTYPE Small molecular drug D0Z8TR DRUGINCH 1S/C25H24N4O/c1-25(2,3)18-12-14-19(15-13-18)27-24-21-7-5-4-6-20(21)22(28-29-24)16-8-10-17(11-9-16)23(26)30/h4-15H,1-3H3,(H2,26,30)(H,27,29) D0Z8TR DRUGINKE FIQNADOCRLODMD-UHFFFAOYSA-N D0Z8TR DRUGSMIL CC(C)(C)C1=CC=C(C=C1)NC2=NN=C(C3=CC=CC=C32)C4=CC=C(C=C4)C(=O)N D0Z8TR HIGHSTAT Investigative D0Z8VP DRUG__ID D0Z8VP D0Z8VP DRUGTYPE Small molecular drug D0Z8VP DRUGINCH 1S/C4H7NO5/c5-1(3(7)8)2(6)4(9)10/h1-2,6H,5H2,(H,7,8)(H,9,10) D0Z8VP DRUGINKE YYLQUHNPNCGKJQ-UHFFFAOYSA-N D0Z8VP DRUGSMIL C(C(C(=O)O)O)(C(=O)O)N D0Z8VP HIGHSTAT Investigative D0Z8VU DRUG__ID D0Z8VU D0Z8VU DRUGTYPE Small molecular drug D0Z8VU DRUGINCH 1S/C9H12BrN5/c1-3-5(2)15-8-6(14-9(15)10)7(11)12-4-13-8/h4-5H,3H2,1-2H3,(H2,11,12,13) D0Z8VU DRUGINKE HDNHXVSBLXMYPH-UHFFFAOYSA-N D0Z8VU DRUGSMIL CCC(C)N1C2=NC=NC(=C2N=C1Br)N D0Z8VU HIGHSTAT Investigative D0Z8YM DRUG__ID D0Z8YM D0Z8YM DRUGTYPE Small molecular drug D0Z8YM DRUGINCH 1S/C24H17N3O6/c1-33-19-10-11-21-20(14-19)23(28)26(17-8-6-16(7-9-17)24(29)30)22(25-21)12-5-15-3-2-4-18(13-15)27(31)32/h2-14,20H,1H3/p+1/b12-5+ D0Z8YM DRUGINKE ZLXASDKCRPAANV-LFYBBSHMSA-O D0Z8YM DRUGSMIL COC1=CC2C(=NC(=[N+](C2=O)C3=CC=C(C=C3)C(=O)O)C=CC4=CC(=CC=C4)[N+](=O)[O-])C=C1 D0Z8YM HIGHSTAT Investigative D0Z8YZ DRUG__ID D0Z8YZ D0Z8YZ DRUGTYPE Small molecular drug D0Z8YZ DRUGINCH 1S/C17H17NOS/c1-11-8-9-13(12(2)10-11)17(3,19)16-18-14-6-4-5-7-15(14)20-16/h4-10,19H,1-3H3 D0Z8YZ DRUGINKE IGSZVEPQZANNAB-UHFFFAOYSA-N D0Z8YZ DRUGSMIL CC1=CC(=C(C=C1)C(C)(C2=NC3=CC=CC=C3S2)O)C D0Z8YZ HIGHSTAT Investigative D0Z9BN DRUG__ID D0Z9BN D0Z9BN DRUGCOMP Microbial Chemistry Research Foundation D0Z9BN DRUGINCH 1S/C18H30N4O8/c1-12(7-10-23)11-16(25)21(29)9-3-5-14-18(27)22(30)15(17(26)19-14)6-4-8-20(28)13(2)24/h11,14-15,23,28-30H,3-10H2,1-2H3,(H,19,26)/b12-11+/t14-,15-/m0/s1 D0Z9BN DRUGINKE MRHLRICNGQRBQN-NOQIOLJMSA-N D0Z9BN DRUGSMIL CC(=CC(=O)N(CCCC1C(=O)N(C(C(=O)N1)CCCN(C(=O)C)O)O)O)CCO D0Z9BN HIGHSTAT Investigative D0Z9DY DRUG__ID D0Z9DY D0Z9DY DRUGTYPE Small molecular drug D0Z9DY DRUGINCH 1S/C16H12N2O/c17-16(19)13-8-4-7-12-9-10-14(18-15(12)13)11-5-2-1-3-6-11/h1-10H,(H2,17,19) D0Z9DY DRUGINKE BNQJEMTZUOVMLM-UHFFFAOYSA-N D0Z9DY DRUGSMIL C1=CC=C(C=C1)C2=NC3=C(C=CC=C3C(=O)N)C=C2 D0Z9DY HIGHSTAT Investigative D0Z9GI DRUG__ID D0Z9GI D0Z9GI DRUGTYPE Small molecular drug D0Z9GI DRUGINCH 1S/C20H16Cl2N2S/c21-16-10-6-14(7-11-16)19(15-8-12-17(22)13-9-15)24-20(25)23-18-4-2-1-3-5-18/h1-13,19H,(H2,23,24,25) D0Z9GI DRUGINKE SYUQZYSPZLUEIG-UHFFFAOYSA-N D0Z9GI DRUGSMIL C1=CC=C(C=C1)NC(=S)NC(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl D0Z9GI HIGHSTAT Investigative D0Z9JO DRUG__ID D0Z9JO D0Z9JO DRUGTYPE Small molecular drug D0Z9JO DRUGINCH 1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12+,13-,14-/m1/s1 D0Z9JO DRUGINKE HSCJRCZFDFQWRP-NYYOCOOHSA-N D0Z9JO DRUGSMIL C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OC3C(C(C(C(O3)CO)O)O)O)O)O D0Z9JO HIGHSTAT Investigative D0Z9JS DRUG__ID D0Z9JS D0Z9JS DRUGTYPE Small molecular drug D0Z9JS DRUGINCH 1S/C7H11N3OS/c8-7(12)10-9-5-2-1-3-6(11)4-5/h4,9H,1-3H2,(H3,8,10,12) D0Z9JS DRUGINKE DGPXORDYODTKDF-UHFFFAOYSA-N D0Z9JS DRUGSMIL C1CC(=CC(=O)C1)NNC(=S)N D0Z9JS HIGHSTAT Investigative D0Z9JY DRUG__ID D0Z9JY D0Z9JY DRUGTYPE Small molecular drug D0Z9JY DRUGINCH 1S/C19H21NO4/c1-20-5-4-12-8-13(24-7-6-21)10-14-17(12)15(20)9-11-2-3-16(22)19(23)18(11)14/h2-3,8,10,15,21-23H,4-7,9H2,1H3/t15-/m1/s1 D0Z9JY DRUGINKE MLSWBRKIYGJEGT-OAHLLOKOSA-N D0Z9JY DRUGSMIL CN1CCC2=C3C1CC4=C(C3=CC(=C2)OCCO)C(=C(C=C4)O)O D0Z9JY HIGHSTAT Investigative D0Z9KR DRUG__ID D0Z9KR D0Z9KR DRUGTYPE Small molecular drug D0Z9KR DRUGINCH 1S/C33H28N6O6/c40-30-26-6-1-2-7-27(26)31(41)38(30)22-44-34-20-24-10-16-36(17-11-24)14-5-15-37-18-12-25(13-19-37)21-35-45-23-39-32(42)28-8-3-4-9-29(28)33(39)43/h1-4,6-13,16-21H,5,14-15,22-23H2/q+2/b34-20+,35-21+ D0Z9KR DRUGINKE OLTRDACQFPTOSK-VQGAUUQYSA-N D0Z9KR DRUGSMIL C1=CC=C2C(=C1)C(=O)N(C2=O)CON=CC3=CC=[N+](C=C3)CCC[N+]4=CC=C(C=C4)C=NOCN5C(=O)C6=CC=CC=C6C5=O D0Z9KR HIGHSTAT Investigative D0Z9MG DRUG__ID D0Z9MG D0Z9MG DRUGTYPE Small molecular drug D0Z9MG DRUGINCH 1S/C24H19N5O2/c25-23(26)15-10-12-18(13-11-15)28-29-21-19-9-5-4-6-16(19)14-20(22(21)30)24(31)27-17-7-2-1-3-8-17/h1-14,30H,(H3,25,26)(H,27,31) D0Z9MG DRUGINKE XLJUNSXIULBDTE-UHFFFAOYSA-N D0Z9MG DRUGSMIL C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=CC=C(C=C4)C(=N)N D0Z9MG HIGHSTAT Investigative D0Z9OX DRUG__ID D0Z9OX D0Z9OX DRUGTYPE Small molecular drug D0Z9OX DRUGINCH 1S/C18H21ClN2/c19-17-9-5-4-8-16(17)14-18(15-6-2-1-3-7-15)21-12-10-20-11-13-21/h1-9,18,20H,10-14H2 D0Z9OX DRUGINKE SDLVJPBOBLQFEW-UHFFFAOYSA-N D0Z9OX DRUGSMIL C1CN(CCN1)C(CC2=CC=CC=C2Cl)C3=CC=CC=C3 D0Z9OX HIGHSTAT Investigative D0Z9PB DRUG__ID D0Z9PB D0Z9PB DRUGTYPE Small molecular drug D0Z9PB DRUGINCH 1S/C27H46O/c1-23(2)13-9-16-26(5)19-10-17-24(3)14-7-8-15-25(4)18-11-20-27(6)21-12-22-28/h13-15,19-20,28H,7-12,16-18,21-22H2,1-6H3/b24-14+,25-15+,26-19+,27-20+ D0Z9PB DRUGINKE WAMKRSMPERYEBH-OGDZRKEVSA-N D0Z9PB DRUGSMIL CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCCO)C)C)C D0Z9PB HIGHSTAT Investigative D0Z9QC DRUG__ID D0Z9QC D0Z9QC DRUGTYPE Small molecular drug D0Z9QC DRUGINCH 1S/C21H21N5O6/c22-21-25-15-6-1-11(9-14(15)19(30)26-21)10-23-13-4-2-12(3-5-13)18(29)24-16(20(31)32)7-8-17(27)28/h1-6,9,16,23H,7-8,10H2,(H,24,29)(H,27,28)(H,31,32)(H3,22,25,26,30) D0Z9QC DRUGINKE UQFCLENKCDVITL-UHFFFAOYSA-N D0Z9QC DRUGSMIL C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CC3=C(C=C2)N=C(NC3=O)N D0Z9QC HIGHSTAT Investigative D0Z9QI DRUG__ID D0Z9QI D0Z9QI DRUGTYPE Small molecular drug D0Z9QI DRUGINCH 1S/C21H28NO6P/c1-15(17-5-4-6-18(11-17)21(24)25)22(2)12-19(23)14-29(26,27)13-16-7-9-20(28-3)10-8-16/h4-11,15,19,23H,12-14H2,1-3H3,(H,24,25)(H,26,27)/t15-,19+/m1/s1 D0Z9QI DRUGINKE AKUSEWDIEMJQBM-BEFAXECRSA-N D0Z9QI DRUGSMIL CC(C1=CC(=CC=C1)C(=O)O)N(C)CC(CP(=O)(CC2=CC=C(C=C2)OC)O)O D0Z9QI HIGHSTAT Investigative D0Z9QZ DRUG__ID D0Z9QZ D0Z9QZ DRUGTYPE Small molecular drug D0Z9QZ DRUGINCH 1S/C13H11NS/c1-10-3-5-12(6-4-10)7-8-13-9-15-11(2)14-13/h3-6,9H,1-2H3 D0Z9QZ DRUGINKE AIMMPGMZHVMWCT-UHFFFAOYSA-N D0Z9QZ DRUGSMIL CC1=CC=C(C=C1)C#CC2=CSC(=N2)C D0Z9QZ HIGHSTAT Investigative D0Z9TM DRUG__ID D0Z9TM D0Z9TM DRUGTYPE Small molecular drug D0Z9TM DRUGINCH 1S/C9H16N3O13P3/c13-5-3-8(12-2-1-7(14)10-9(12)15)24-6(5)4-23-26(16,17)11-27(18,19)25-28(20,21)22/h1-2,5-6,8,13H,3-4H2,(H,10,14,15)(H2,20,21,22)(H3,11,16,17,18,19)/t5-,6+,8+/m0/s1 D0Z9TM DRUGINKE XZLLMTSKYYYJLH-SHYZEUOFSA-N D0Z9TM DRUGSMIL C1C(C(OC1N2C=CC(=O)NC2=O)COP(=O)(NP(=O)(O)OP(=O)(O)O)O)O D0Z9TM HIGHSTAT Investigative D0Z9TO DRUG__ID D0Z9TO D0Z9TO DRUGTYPE Small molecular drug D0Z9TO DRUGINCH 1S/C28H36N2O6/c1-17(2)20-9-7-18(3)21-14-24(35-25(31)10-8-19-15-30(5)16-29-19)27(4)11-12-28(33,36-27)23(13-22(20)21)26(32)34-6/h7-8,10-13,15-17,20-22,24,33H,9,14H2,1-6H3/b10-8+,23-13-/t20-,21+,22-,24+,27+,28-/m1/s1 D0Z9TO DRUGINKE VHZOZCRALQEBDG-BEMXCNERSA-N D0Z9TO DRUGSMIL CC1=CCC(C2C1CC(C3(C=CC(O3)(C(=C2)C(=O)OC)O)C)OC(=O)C=CC4=CN(C=N4)C)C(C)C D0Z9TO HIGHSTAT Investigative D0Z9WK DRUG__ID D0Z9WK D0Z9WK DRUGTYPE Small molecular drug D0Z9WK DRUGINCH 1S/C26H34IN7O2/c27-23-17-21(8-9-24(23)29)25(35)30-11-12-32-26(33-19-28)31-10-5-15-36-22-7-4-6-20(16-22)18-34-13-2-1-3-14-34/h4,6-9,16-17H,1-3,5,10-15,18,29H2,(H,30,35)(H2,31,32,33) D0Z9WK DRUGINKE VJTYCMQYDRXNNY-UHFFFAOYSA-N D0Z9WK DRUGSMIL C1CCN(CC1)CC2=CC(=CC=C2)OCCCN=C(NCCNC(=O)C3=CC(=C(C=C3)N)I)NC#N D0Z9WK HIGHSTAT Investigative D0Z9WS DRUG__ID D0Z9WS D0Z9WS DRUGTYPE Small molecular drug D0Z9WS DRUGINCH 1S/C17H22N4O8S/c18-11(16(26)27)6-7-13(22)20-12(15(25)19-8-14(23)24)9-30-17(28)21(29)10-4-2-1-3-5-10/h1-5,11-12,29H,6-9,18H2,(H,19,25)(H,20,22)(H,23,24)(H,26,27)/t11-,12-/m0/s1 D0Z9WS DRUGINKE GAALWJSKDIUONK-RYUDHWBXSA-N D0Z9WS DRUGSMIL C1=CC=C(C=C1)N(C(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)O D0Z9WS HIGHSTAT Investigative D0Z9XV DRUG__ID D0Z9XV D0Z9XV DRUGTYPE Small molecular drug D0Z9XV DRUGINCH 1S/C19H23N3O/c1-14(2)23-18-9-5-16(6-10-18)13-15-3-7-17(8-4-15)22-19-20-11-12-21-19/h3-10,14H,11-13H2,1-2H3,(H2,20,21,22) D0Z9XV DRUGINKE GYYRMJMXXLJZAB-UHFFFAOYSA-N D0Z9XV DRUGSMIL CC(C)OC1=CC=C(C=C1)CC2=CC=C(C=C2)NC3=NCCN3 D0Z9XV HIGHSTAT Investigative D0Z9YE DRUG__ID D0Z9YE D0Z9YE DRUGTYPE Small molecular drug D0Z9YE DRUGINCH 1S/C46H53N7O8/c47-35(25-31-15-19-33(54)20-16-31)45(60)52-23-7-13-39(52)44(59)50-37(27-30-11-5-2-6-12-30)42(57)51-38(28-32-17-21-34(55)22-18-32)46(61)53-24-8-14-40(53)43(58)49-36(41(48)56)26-29-9-3-1-4-10-29/h1-6,9-12,15-22,35-40,54-55H,7-8,13-14,23-28,47H2,(H2,48,56)(H,49,58)(H,50,59)(H,51,57)/t35-,36-,37-,38-,39-,40-/m0/s1 D0Z9YE DRUGINKE PMYWZDRRZPJWHV-UNHORJANSA-N D0Z9YE DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CC6=CC=CC=C6)C(=O)N D0Z9YE HIGHSTAT Investigative D0Z9YK DRUG__ID D0Z9YK D0Z9YK DRUGTYPE Small molecular drug D0Z9YK DRUGINCH 1S/C41H32O27/c42-15-1-10(2-16(43)26(15)51)35(56)62-9-22-31-33(66-36(57)11-3-17(44)27(52)18(45)4-11)34(41(63-22)68-37(58)12-5-19(46)28(53)20(47)6-12)67-38(59)13-7-21(48)29(54)32-25(13)24(30(55)40(61)65-32)14(8-23(49)50)39(60)64-31/h1-7,14,22,24,30-31,33-34,41-48,51-55H,8-9H2,(H,49,50)/t14-,22+,24-,30-,31+,33-,34+,41-/m0/s1 D0Z9YK DRUGINKE YGVHOSGNOYKRIH-FJPMMHPYSA-N D0Z9YK DRUGSMIL C1=C(C=C(C(=C1O)O)O)C(=O)OCC2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C(C(C(=O)O3)CC(=O)O)C(C(=O)O6)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O D0Z9YK HIGHSTAT Investigative D0Z9ZY DRUG__ID D0Z9ZY D0Z9ZY DRUGTYPE Small molecular drug D0Z9ZY DRUGINCH 1S/C18H15NO3S/c20-17-11-13-18(14-12-17)23(21,22)19(15-7-3-1-4-8-15)16-9-5-2-6-10-16/h1-14,20H D0Z9ZY DRUGINKE KLZORRIEDRGOHR-UHFFFAOYSA-N D0Z9ZY DRUGSMIL C1=CC=C(C=C1)N(C2=CC=CC=C2)S(=O)(=O)C3=CC=C(C=C3)O D0Z9ZY HIGHSTAT Investigative D0ZA4J DRUG__ID D0ZA4J D0ZA4J DRUGTYPE Small molecular drug D0ZA4J DRUGINCH 1S/C13H17Cl2N3O2/c14-11-8-10(9-17-12(11)15)13(19)16-2-1-3-18-4-6-20-7-5-18/h8-9H,1-7H2,(H,16,19) D0ZA4J DRUGINKE TZOXTUGEEZYMTF-UHFFFAOYSA-N D0ZA4J DRUGSMIL C1COCCN1CCCNC(=O)C2=CC(=C(N=C2)Cl)Cl D0ZA4J HIGHSTAT Investigative D0ZA6G DRUG__ID D0ZA6G D0ZA6G DRUGTYPE Small molecular drug D0ZA6G DRUGINCH 1S/C18H17ClO6/c1-9-6-15-14(25-15)5-3-2-4-10(20)7-11-16(18(23)24-9)12(21)8-13(22)17(11)19/h2-5,8-9,14-15,21-22H,6-7H2,1H3/b4-2+,5-3-/t9-,14-,15-/m1/s1 D0ZA6G DRUGINKE WYZWZEOGROVVHK-GTMNPGAYSA-N D0ZA6G DRUGSMIL CC1CC2C(O2)C=CC=CC(=O)CC3=C(C(=CC(=C3Cl)O)O)C(=O)O1 D0ZA6G HIGHSTAT Investigative D0ZB6O DRUG__ID D0ZB6O D0ZB6O DRUGTYPE Small molecular drug D0ZB6O DRUGINCH 1S/C24H27N9O7/c25-24-30-19-18(22(37)31-24)28-14(11-27-19)10-26-13-5-3-12(4-6-13)20(35)29-15(23(38)39)7-8-17(34)33-9-1-2-16(33)21(36)32-40/h3-6,11,15-16,18,26,40H,1-2,7-10H2,(H,29,35)(H,32,36)(H,38,39)(H2,25,31,37)/t15-,16-,18?/m0/s1 D0ZB6O DRUGINKE RDZUJKVCOZNTDE-MZQXSQAVSA-N D0ZB6O DRUGSMIL C1CC(N(C1)C(=O)CCC(C(=O)O)NC(=O)C2=CC=C(C=C2)NCC3=NC4C(=NC(=NC4=O)N)N=C3)C(=O)NO D0ZB6O HIGHSTAT Investigative D0ZB7Z DRUG__ID D0ZB7Z D0ZB7Z DRUGTYPE Small molecular drug D0ZB7Z DRUGINCH 1S/C23H13F9N4O3S/c1-38-17-7-11(6-13(9-33)18(37)34-20-36-35-19(40-20)23(30,31)32)2-5-16(17)39-10-12-3-4-14(21(24,25)26)8-15(12)22(27,28)29/h2-8H,10H2,1H3,(H,34,36,37)/b13-6+ D0ZB7Z DRUGINKE HQFNFOOGGLSBBT-AWNIVKPZSA-N D0ZB7Z DRUGSMIL COC1=C(C=CC(=C1)C=C(C#N)C(=O)NC2=NN=C(S2)C(F)(F)F)OCC3=C(C=C(C=C3)C(F)(F)F)C(F)(F)F D0ZB7Z HIGHSTAT Investigative D0ZB8S DRUG__ID D0ZB8S D0ZB8S DRUGTYPE Small molecular drug D0ZB8S DRUGINCH 1S/C31H41NO7/c1-4-9-22-25(14-11-21-12-15-27(31(34)35)39-28(21)22)37-19-8-20-38-26-16-13-24(29(36-3)23(26)10-5-2)30(33)32-17-6-7-18-32/h11,13-14,16,27H,4-10,12,15,17-20H2,1-3H3,(H,34,35) D0ZB8S DRUGINKE POSHDLOOHKRLEK-UHFFFAOYSA-N D0ZB8S DRUGSMIL CCCC1=C(C=CC2=C1OC(CC2)C(=O)O)OCCCOC3=C(C(=C(C=C3)C(=O)N4CCCC4)OC)CCC D0ZB8S HIGHSTAT Investigative D0ZC3Q DRUG__ID D0ZC3Q D0ZC3Q DRUGTYPE Small molecular drug D0ZC3Q DRUGINCH 1S/C19H20N2/c1-2-4-15(5-3-1)13-19(9-11-20-14-19)17-6-7-18-16(12-17)8-10-21-18/h1-8,10,12,20-21H,9,11,13-14H2 D0ZC3Q DRUGINKE UZKWACFLBGIUSH-UHFFFAOYSA-N D0ZC3Q DRUGSMIL C1CNCC1(CC2=CC=CC=C2)C3=CC4=C(C=C3)NC=C4 D0ZC3Q HIGHSTAT Investigative D0ZC3W DRUG__ID D0ZC3W D0ZC3W DRUGTYPE Small molecular drug D0ZC3W DRUGINCH 1S/C7H9NO2S/c1-6-2-4-7(5-3-6)11(8,9)10/h2-5H,1H3,(H2,8,9,10) D0ZC3W DRUGINKE LMYRWZFENFIFIT-UHFFFAOYSA-N D0ZC3W DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)N D0ZC3W HIGHSTAT Investigative D0ZC4S DRUG__ID D0ZC4S D0ZC4S DRUGTYPE Small molecular drug D0ZC4S DRUGINCH 1S/C11H9N5/c1-2-9-10(13-4-3-12-9)7-8(1)16-11-14-5-6-15-11/h1-7H,(H2,14,15,16) D0ZC4S DRUGINKE CDFWKVORAWOKDO-UHFFFAOYSA-N D0ZC4S DRUGSMIL C1=CC2=NC=CN=C2C=C1NC3=NC=CN3 D0ZC4S HIGHSTAT Investigative D0ZC7V DRUG__ID D0ZC7V D0ZC7V DRUGTYPE Small molecular drug D0ZC7V DRUGINCH 1S/C7H15NO4/c1-3-5(10)7(12)6(11)4(2-9)8-3/h3-12H,2H2,1H3/t3-,4-,5+,6-,7-/m1/s1 D0ZC7V DRUGINKE ZEWFPWKROPWRKE-XUUWZHRGSA-N D0ZC7V DRUGSMIL CC1C(C(C(C(N1)CO)O)O)O D0ZC7V HIGHSTAT Investigative D0ZC8K DRUG__ID D0ZC8K D0ZC8K DRUGTYPE Small molecular drug D0ZC8K DRUGINCH 1S/C12H9N5/c1-5-13-6-2-9(1)11-15-12(17-16-11)10-3-7-14-8-4-10/h1-8H,(H,15,16,17) D0ZC8K DRUGINKE QUKGHTHKDNHSOX-UHFFFAOYSA-N D0ZC8K DRUGSMIL C1=CN=CC=C1C2=NC(=NN2)C3=CC=NC=C3 D0ZC8K HIGHSTAT Investigative D0ZC9Q DRUG__ID D0ZC9Q D0ZC9Q DRUGTYPE Small molecular drug D0ZC9Q DRUGINCH 1S/C12H17N2/c1-13(2)9-10-14-8-7-11-5-3-4-6-12(11)14/h3-6,8H,7,9-10H2,1-2H3/q+1 D0ZC9Q DRUGINKE YJCMFAZIOVDTLE-UHFFFAOYSA-N D0ZC9Q DRUGSMIL CN(C)CC[N+]1=CCC2=CC=CC=C21 D0ZC9Q HIGHSTAT Investigative D0ZD1B DRUG__ID D0ZD1B D0ZD1B DRUGTYPE Small molecular drug D0ZD1B DRUGINCH 1S/C21H27NO/c1-4-9-20-16-19(18-10-6-5-7-11-18)12-13-21(20)23-15-8-14-22-17(2)3/h4-7,10-13,16-17,22H,1,8-9,14-15H2,2-3H3 D0ZD1B DRUGINKE CKIDETHAWPUGOQ-UHFFFAOYSA-N D0ZD1B DRUGSMIL CC(C)NCCCOC1=C(C=C(C=C1)C2=CC=CC=C2)CC=C D0ZD1B HIGHSTAT Investigative D0ZD4F DRUG__ID D0ZD4F D0ZD4F DRUGTYPE Small molecular drug D0ZD4F DRUGINCH 1S/C25H37N3/c1-3-5-7-9-11-21-13-17-23(18-14-21)27-25(26)28-24-19-15-22(16-20-24)12-10-8-6-4-2/h13-20H,3-12H2,1-2H3,(H3,26,27,28) D0ZD4F DRUGINKE UVGVWBZLIZBOEY-UHFFFAOYSA-N D0ZD4F DRUGSMIL CCCCCCC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)CCCCCC)N D0ZD4F HIGHSTAT Investigative D0ZD4M DRUG__ID D0ZD4M D0ZD4M DRUGTYPE Small molecular drug D0ZD4M DRUGINCH 1S/C15H12N2O2/c1-9-5-7-10(8-6-9)17-14(18)11-3-2-4-12(16)13(11)15(17)19/h2-8H,16H2,1H3 D0ZD4M DRUGINKE LTZXDGYVXKFIET-UHFFFAOYSA-N D0ZD4M DRUGSMIL CC1=CC=C(C=C1)N2C(=O)C3=C(C2=O)C(=CC=C3)N D0ZD4M HIGHSTAT Investigative D0ZD6Z DRUG__ID D0ZD6Z D0ZD6Z DRUGTYPE Small molecular drug D0ZD6Z DRUGINCH 1S/C7H9BO3/c1-11-7-4-2-3-6(5-7)8(9)10/h2-5,9-10H,1H3 D0ZD6Z DRUGINKE NLLGFYPSWCMUIV-UHFFFAOYSA-N D0ZD6Z DRUGSMIL B(C1=CC(=CC=C1)OC)(O)O D0ZD6Z HIGHSTAT Investigative D0ZE2W DRUG__ID D0ZE2W D0ZE2W DRUGTYPE Small molecular drug D0ZE2W DRUGINCH 1S/C25H27NO/c27-25(20-21-10-4-1-5-11-21)16-18-26(19-17-25)24(22-12-6-2-7-13-22)23-14-8-3-9-15-23/h1-15,24,27H,16-20H2 D0ZE2W DRUGINKE DJXDWBRLMRAPJG-UHFFFAOYSA-N D0ZE2W DRUGSMIL C1CN(CCC1(CC2=CC=CC=C2)O)C(C3=CC=CC=C3)C4=CC=CC=C4 D0ZE2W HIGHSTAT Investigative D0ZE4C DRUG__ID D0ZE4C D0ZE4C DRUGTYPE Small molecular drug D0ZE4C DRUGINCH 1S/C15H21NO2/c1-11(16-13-7-3-4-8-13)15(17)12-6-5-9-14(10-12)18-2/h5-6,9-11,13,16H,3-4,7-8H2,1-2H3 D0ZE4C DRUGINKE ZMRXSORFBXMBCB-UHFFFAOYSA-N D0ZE4C DRUGSMIL CC(C(=O)C1=CC(=CC=C1)OC)NC2CCCC2 D0ZE4C HIGHSTAT Investigative D0ZE8C DRUG__ID D0ZE8C D0ZE8C DRUGTYPE Small molecular drug D0ZE8C DRUGINCH 1S/C23H16O6/c24-11-6-3-5-10-15(11)17-12(25)8-13(26)18-19(17)20-16(21(27)22(18)28)9-4-1-2-7-14(9)29-23(10)20/h1-8,16,20-21,23-27H/t16-,20+,21-,23+/m1/s1 D0ZE8C DRUGINKE JFOHOILWNMBZGW-QSABTFIQSA-N D0ZE8C DRUGSMIL C1=CC=C2C(=C1)C3C4C(O2)C5=C(C(=CC=C5)O)C6=C4C(=C(C=C6O)O)C(=O)C3O D0ZE8C HIGHSTAT Investigative D0ZE9M DRUG__ID D0ZE9M D0ZE9M DRUGTYPE Small molecular drug D0ZE9M DRUGINCH 1S/C16H17N3S/c1-16(2,3)14-10-20-15(19-14)18-13-6-4-5-11-9-17-8-7-12(11)13/h4-10H,1-3H3,(H,18,19) D0ZE9M DRUGINKE JVTUKUHMGYMFFT-UHFFFAOYSA-N D0ZE9M DRUGSMIL CC(C)(C)C1=CSC(=N1)NC2=CC=CC3=C2C=CN=C3 D0ZE9M HIGHSTAT Investigative D0ZF1W DRUG__ID D0ZF1W D0ZF1W DRUGTYPE Small molecular drug D0ZF1W DRUGINCH 1S/C13H18N2/c1-10(2)15-9-11(7-8-14)12-5-3-4-6-13(12)15/h3-6,9-10H,7-8,14H2,1-2H3 D0ZF1W DRUGINKE ARHHZLRATAUACE-UHFFFAOYSA-N D0ZF1W DRUGSMIL CC(C)N1C=C(C2=CC=CC=C21)CCN D0ZF1W HIGHSTAT Investigative D0ZF8N DRUG__ID D0ZF8N D0ZF8N DRUGTYPE Small molecular drug D0ZF8N DRUGINCH 1S/C17H13N3O/c1-21-17-14-11-20(12-7-3-2-4-8-12)19-16(14)13-9-5-6-10-15(13)18-17/h2-11H,1H3 D0ZF8N DRUGINKE LBRDTSFKAURCRO-UHFFFAOYSA-N D0ZF8N DRUGSMIL COC1=NC2=CC=CC=C2C3=NN(C=C31)C4=CC=CC=C4 D0ZF8N HIGHSTAT Investigative D0ZG3O DRUG__ID D0ZG3O D0ZG3O DRUGTYPE Small molecular drug D0ZG3O DRUGINCH 1S/C16H14N2O2/c1-2-20-16(19)12-3-4-13-14(10-18-15(13)9-12)11-5-7-17-8-6-11/h3-10,18H,2H2,1H3 D0ZG3O DRUGINKE HFXZBVKGWWNQBD-UHFFFAOYSA-N D0ZG3O DRUGSMIL CCOC(=O)C1=CC2=C(C=C1)C(=CN2)C3=CC=NC=C3 D0ZG3O HIGHSTAT Investigative D0ZG3Q DRUG__ID D0ZG3Q D0ZG3Q DRUGTYPE Small molecular drug D0ZG3Q DRUGINCH 1S/C17H26N2O2/c1-3-17(4-2)14(20)18-15(21-17)19-16-8-11-5-12(9-16)7-13(6-11)10-16/h11-13H,3-10H2,1-2H3,(H,18,19,20) D0ZG3Q DRUGINKE RHBIZJSBQCBDJJ-UHFFFAOYSA-N D0ZG3Q DRUGSMIL CCC1(C(=O)NC(=NC23CC4CC(C2)CC(C4)C3)O1)CC D0ZG3Q HIGHSTAT Investigative D0ZG4G DRUG__ID D0ZG4G D0ZG4G DRUGTYPE Small molecular drug D0ZG4G DRUGINCH 1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23) D0ZG4G DRUGINKE XVECMUKVOMUNLE-UHFFFAOYSA-N D0ZG4G DRUGSMIL C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N D0ZG4G HIGHSTAT Investigative D0ZG7W DRUG__ID D0ZG7W D0ZG7W DRUGTYPE Small molecular drug D0ZG7W DRUGINCH 1S/C23H28N6O2/c1-23(2,3)29-22(30)26-17-11-9-16(10-12-17)19-18(27-21(25)28-20(19)24)14-31-13-15-7-5-4-6-8-15/h4-12H,13-14H2,1-3H3,(H2,26,29,30)(H4,24,25,27,28) D0ZG7W DRUGINKE MLBYOWASRACYDH-UHFFFAOYSA-N D0ZG7W DRUGSMIL CC(C)(C)NC(=O)NC1=CC=C(C=C1)C2=C(N=C(N=C2N)N)COCC3=CC=CC=C3 D0ZG7W HIGHSTAT Investigative D0ZG9I DRUG__ID D0ZG9I D0ZG9I DRUGTYPE Small molecular drug D0ZG9I DRUGINCH 1S/C23H28O8/c1-12(24)30-16-9-15(20(26)28-4)22(2)7-5-14-21(27)31-17(13-6-8-29-11-13)10-23(14,3)19(22)18(16)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3/t14-,15+,16+,17+,19+,22+,23+/m1/s1 D0ZG9I DRUGINKE OBSYBRPAKCASQB-FBCTZMOOSA-N D0ZG9I DRUGSMIL CC(=O)OC1CC(C2(CCC3C(=O)OC(CC3(C2C1=O)C)C4=COC=C4)C)C(=O)OC D0ZG9I HIGHSTAT Investigative D0ZH0I DRUG__ID D0ZH0I D0ZH0I DRUGTYPE Small molecular drug D0ZH0I DRUGINCH 1S/C10H15N2O8P/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(20-8)4-19-21(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,11,14,15)(H2,16,17,18)/t6-,7+,8+/m0/s1 D0ZH0I DRUGINKE GYOZYWVXFNDGLU-XLPZGREQSA-N D0ZH0I DRUGSMIL CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)O)O D0ZH0I HIGHSTAT Investigative D0ZH0K DRUG__ID D0ZH0K D0ZH0K DRUGTYPE Small molecular drug D0ZH0K DRUGINCH 1S/C23H41NO4/c1-3-4-7-10-19(26)13-14-20-18(2)17-22(27)21(20)11-8-5-6-9-12-23(28)24-15-16-25/h5,8,13-14,18-22,25-27H,3-4,6-7,9-12,15-17H2,1-2H3,(H,24,28)/b8-5-,14-13+/t18-,19+,20+,21-,22+/m1/s1 D0ZH0K DRUGINKE YUKILNRONMAMTM-NKDIASRKSA-N D0ZH0K DRUGSMIL CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)NCCO)O)C)O D0ZH0K HIGHSTAT Investigative D0ZH0T DRUG__ID D0ZH0T D0ZH0T DRUGTYPE Small molecular drug D0ZH0T DRUGINCH 1S/C15H11FO2/c16-11-7-5-10(6-8-11)15-9-13(17)12-3-1-2-4-14(12)18-15/h1-8,15H,9H2 D0ZH0T DRUGINKE RFDPVHCUOLBALB-UHFFFAOYSA-N D0ZH0T DRUGSMIL C1C(OC2=CC=CC=C2C1=O)C3=CC=C(C=C3)F D0ZH0T HIGHSTAT Investigative D0ZH1U DRUG__ID D0ZH1U D0ZH1U DRUGTYPE Small molecular drug D0ZH1U DRUGINCH 1S/C16H14ClN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20) D0ZH1U DRUGINKE GFNNBHLJANVSQV-UHFFFAOYSA-N D0ZH1U DRUGSMIL COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC D0ZH1U HIGHSTAT Investigative D0ZH3G DRUG__ID D0ZH3G D0ZH3G DRUGTYPE Small molecular drug D0ZH3G DRUGINCH 1S/C23H30N2O/c1-3-23(26)25(21-12-8-5-9-13-21)22-15-17-24(18-19(22)2)16-14-20-10-6-4-7-11-20/h4-13,19,22H,3,14-18H2,1-2H3 D0ZH3G DRUGINKE MLQRZXNZHAOCHQ-UHFFFAOYSA-N D0ZH3G DRUGSMIL CCC(=O)N(C1CCN(CC1C)CCC2=CC=CC=C2)C3=CC=CC=C3 D0ZH3G HIGHSTAT Investigative D0ZH9W DRUG__ID D0ZH9W D0ZH9W DRUGTYPE Small molecular drug D0ZH9W DRUGINCH 1S/C14H25NO/c1-4-5-6-7-8-9-10-11-14(16)15-12-13(2)3/h8-11,13H,4-7,12H2,1-3H3,(H,15,16)/b9-8+,11-10+ D0ZH9W DRUGINKE MAGQQZHFHJDIRE-BNFZFUHLSA-N D0ZH9W DRUGSMIL CCCCCC=CC=CC(=O)NCC(C)C D0ZH9W HIGHSTAT Investigative D0ZI0S DRUG__ID D0ZI0S D0ZI0S DRUGTYPE Small molecular drug D0ZI0S DRUGINCH 1S/C17H14O3/c1-11-3-5-12(6-4-11)16-10-15(18)14-8-7-13(19-2)9-17(14)20-16/h3-10H,1-2H3 D0ZI0S DRUGINKE OBNQAKAHHNLJHT-UHFFFAOYSA-N D0ZI0S DRUGSMIL CC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)OC D0ZI0S HIGHSTAT Investigative D0ZI5Z DRUG__ID D0ZI5Z D0ZI5Z DRUGTYPE Small molecular drug D0ZI5Z DRUGINCH 1S/C40H43N7O7/c1-45(2)27-13-12-25-20-29-30(21-26(25)19-27)39(53)47(38(29)52)22-33(36(50)43-32(35(42)49)18-23-7-4-3-5-8-23)44-37(51)34-9-6-16-46(34)40(54)31(41)17-24-10-14-28(48)15-11-24/h3-5,7-8,10-15,19-21,31-34,48H,6,9,16-18,22,41H2,1-2H3,(H2,42,49)(H,43,50)(H,44,51)/t31-,32-,33?,34-/m0/s1 D0ZI5Z DRUGINKE OHGKVUSMHZDAKH-SHROADRVSA-N D0ZI5Z DRUGSMIL CN(C)C1=CC2=CC3=C(C=C2C=C1)C(=O)N(C3=O)CC(C(=O)NC(CC4=CC=CC=C4)C(=O)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=C(C=C6)O)N D0ZI5Z HIGHSTAT Investigative D0ZI7F DRUG__ID D0ZI7F D0ZI7F DRUGTYPE Small molecular drug D0ZI7F DRUGINCH 1S/C14H14N2O/c1-9-14-11(6-7-15-9)12-8-10(17-3)4-5-13(12)16(14)2/h4-8H,1-3H3 D0ZI7F DRUGINKE AJSYZGYPCGTQSU-UHFFFAOYSA-N D0ZI7F DRUGSMIL CC1=NC=CC2=C1N(C3=C2C=C(C=C3)OC)C D0ZI7F HIGHSTAT Investigative D0ZI8Y DRUG__ID D0ZI8Y D0ZI8Y DRUGTYPE Small molecular drug D0ZI8Y DRUGINCH 1S/C32H50O4/c1-27(2)15-17-32(26(34)35)18-16-30(6)20(22(32)19-27)9-10-24-29(5)13-11-21(25(33)36-8)28(3,4)23(29)12-14-31(24,30)7/h9,21-24H,10-19H2,1-8H3,(H,34,35)/t21-,22+,23+,24-,29+,30-,31-,32+/m1/s1 D0ZI8Y DRUGINKE HDWYAPCZHCDUNP-JVZQWSIASA-N D0ZI8Y DRUGSMIL CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)C(=O)OC)C)C)C2C1)C)C(=O)O)C D0ZI8Y HIGHSTAT Investigative D0ZJ5K DRUG__ID D0ZJ5K D0ZJ5K DRUGTYPE Small molecular drug D0ZJ5K DRUGINCH 1S/C32H29N3O3/c1-21-10-12-22(13-11-21)27-6-2-3-7-28(27)31(37)33-24-16-14-23(15-17-24)32(38)35-19-25-18-26(36)20-34(25)29-8-4-5-9-30(29)35/h2-17,25-26,36H,18-20H2,1H3,(H,33,37)/t25-,26+/m1/s1 D0ZJ5K DRUGINKE UACMTQPSUBFZOR-FTJBHMTQSA-N D0ZJ5K DRUGSMIL CC1=CC=C(C=C1)C2=CC=CC=C2C(=O)NC3=CC=C(C=C3)C(=O)N4CC5CC(CN5C6=CC=CC=C64)O D0ZJ5K HIGHSTAT Investigative D0ZJ5V DRUG__ID D0ZJ5V D0ZJ5V DRUGTYPE Small molecular drug D0ZJ5V DRUGINCH 1S/C12H9N3O/c16-7-14-12-5-9-8-3-1-2-4-10(8)15-11(9)6-13-12/h1-7,15H,(H,13,14,16) D0ZJ5V DRUGINKE YLIKNFBWEFRNOD-UHFFFAOYSA-N D0ZJ5V DRUGSMIL C1=CC=C2C(=C1)C3=CC(=NC=C3N2)NC=O D0ZJ5V HIGHSTAT Investigative D0ZJ6Y DRUG__ID D0ZJ6Y D0ZJ6Y DRUGTYPE Small molecular drug D0ZJ6Y DRUGINCH 1S/C34H39Cl2N3O5/c1-38(33(41)25-18-29(42-2)32(44-4)30(19-25)43-3)21-24(22-9-10-27(35)28(36)17-22)11-14-39-15-12-34(13-16-39)26-8-6-5-7-23(26)20-31(40)37-34/h5-10,17-19,24H,11-16,20-21H2,1-4H3,(H,37,40) D0ZJ6Y DRUGINKE RMRHFQVHSFCBEO-UHFFFAOYSA-N D0ZJ6Y DRUGSMIL CN(CC(CCN1CCC2(CC1)C3=CC=CC=C3CC(=O)N2)C4=CC(=C(C=C4)Cl)Cl)C(=O)C5=CC(=C(C(=C5)OC)OC)OC D0ZJ6Y HIGHSTAT Investigative D0ZJ9S DRUG__ID D0ZJ9S D0ZJ9S DRUGTYPE Small molecular drug D0ZJ9S DRUGINCH 1S/C9H15NO6/c11-7(10-16)3-1-2-6(9(14)15)4-5-8(12)13/h6,16H,1-5H2,(H,10,11)(H,12,13)(H,14,15) D0ZJ9S DRUGINKE SFUVFBUNWNKLJH-UHFFFAOYSA-N D0ZJ9S DRUGSMIL C(CC(CCC(=O)O)C(=O)O)CC(=O)NO D0ZJ9S HIGHSTAT Investigative D0ZK2F DRUG__ID D0ZK2F D0ZK2F DRUGTYPE Small molecular drug D0ZK2F DRUGINCH 1S/C16H16N2O6/c17-15(21)12(6-10-4-2-1-3-5-10)18-16(22)24-8-11-7-13(19)14(20)9-23-11/h1-5,7,9,12,20H,6,8H2,(H2,17,21)(H,18,22)/t12-/m0/s1 D0ZK2F DRUGINKE FIDUCYJXWXTROD-LBPRGKRZSA-N D0ZK2F DRUGSMIL C1=CC=C(C=C1)CC(C(=O)N)NC(=O)OCC2=CC(=O)C(=CO2)O D0ZK2F HIGHSTAT Investigative D0ZK2G DRUG__ID D0ZK2G D0ZK2G DRUGTYPE Small molecular drug D0ZK2G DRUGINCH 1S/C14H16N2O3S/c1-3-19-13(18)11-8(2)15-14(20)16-12(11)9-5-4-6-10(17)7-9/h4-7,12,17H,3H2,1-2H3,(H2,15,16,20) D0ZK2G DRUGINKE LOBCDGHHHHGHFA-UHFFFAOYSA-N D0ZK2G DRUGSMIL CCOC(=O)C1=C(NC(=S)NC1C2=CC(=CC=C2)O)C D0ZK2G HIGHSTAT Investigative D0ZL2A DRUG__ID D0ZL2A D0ZL2A DRUGTYPE Small molecular drug D0ZL2A DRUGINCH 1S/C23H29NO3S/c1-5-12-17-19(23(26)28-8-4)18(7-3)24-21(16-13-10-9-11-14-16)20(17)22(25)27-15-6-2/h9-11,13-14H,5-8,12,15H2,1-4H3 D0ZL2A DRUGINKE UUSHFEVEROROSP-UHFFFAOYSA-N D0ZL2A DRUGSMIL CCCC1=C(C(=NC(=C1C(=O)SCC)CC)C2=CC=CC=C2)C(=O)OCCC D0ZL2A HIGHSTAT Investigative D0ZL2P DRUG__ID D0ZL2P D0ZL2P DRUGTYPE Small molecular drug D0ZL2P DRUGINCH 1S/C26H24ClNO/c1-2-3-8-16-28-18-20(17-25(28)23-13-6-7-15-24(23)27)26(29)22-14-9-11-19-10-4-5-12-21(19)22/h4-7,9-15,17-18H,2-3,8,16H2,1H3 D0ZL2P DRUGINKE SUELCWQJMQQCTF-UHFFFAOYSA-N D0ZL2P DRUGSMIL CCCCCN1C=C(C=C1C2=CC=CC=C2Cl)C(=O)C3=CC=CC4=CC=CC=C43 D0ZL2P HIGHSTAT Investigative D0ZL5U DRUG__ID D0ZL5U D0ZL5U DRUGTYPE Small molecular drug D0ZL5U DRUGINCH 1S/C14H21N3O6/c15-7-10(18)17-8-3-5-14(17,6-4-8)13(23)16-9(12(21)22)1-2-11(19)20/h8-9H,1-7,15H2,(H,16,23)(H,19,20)(H,21,22)/t8?,9-,14?/m0/s1 D0ZL5U DRUGINKE AXVZKZJJSLXCSR-PUUHTONNSA-N D0ZL5U DRUGSMIL C1CC2(CCC1N2C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O D0ZL5U HIGHSTAT Investigative D0ZL6B DRUG__ID D0ZL6B D0ZL6B DRUGTYPE Small molecular drug D0ZL6B DRUGINCH 1S/C24H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17-20-25-22-19-16-15-18-21(22)23(26)24(25)27/h15-16,18-19H,2-14,17,20H2,1H3 D0ZL6B DRUGINKE JLUGWHXZCKLPBY-UHFFFAOYSA-N D0ZL6B DRUGSMIL CCCCCCCCCCCCCCCCN1C2=CC=CC=C2C(=O)C1=O D0ZL6B HIGHSTAT Investigative D0ZL9I DRUG__ID D0ZL9I D0ZL9I DRUGTYPE Small molecular drug D0ZL9I DRUGINCH 1S/C29H27BrNO5/c1-32-26-9-4-19-14-25-23-16-28-27(35-18-36-28)15-20(23)10-11-31(25)17-24(19)29(26)34-13-3-2-12-33-22-7-5-21(30)6-8-22/h4-9,14-17H,2-3,10-13,18H2,1H3/q+1 D0ZL9I DRUGINKE XSYYQOISAKERBC-UHFFFAOYSA-N D0ZL9I DRUGSMIL COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCCOC6=CC=C(C=C6)Br D0ZL9I HIGHSTAT Investigative D0ZM1Q DRUG__ID D0ZM1Q D0ZM1Q DRUGTYPE Small molecular drug D0ZM1Q DRUGINCH 1S/C19H20ClNO/c20-18-8-4-7-17(14-18)19(22)21-11-9-16(10-12-21)13-15-5-2-1-3-6-15/h1-8,14,16H,9-13H2 D0ZM1Q DRUGINKE GHPWLZRRFXHNMA-UHFFFAOYSA-N D0ZM1Q DRUGSMIL C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC(=CC=C3)Cl D0ZM1Q HIGHSTAT Investigative D0ZM1T DRUG__ID D0ZM1T D0ZM1T DRUGTYPE Small molecular drug D0ZM1T DRUGINCH 1S/C21H23Cl2N3O2/c22-16-8-6-15(7-9-16)19(18-5-4-10-24-20(18)23)28-17-13-26(14-17)21(27)25-11-2-1-3-12-25/h4-10,17,19H,1-3,11-14H2/t19-/m1/s1 D0ZM1T DRUGINKE QEKKZTBXSULKCC-LJQANCHMSA-N D0ZM1T DRUGSMIL C1CCN(CC1)C(=O)N2CC(C2)OC(C3=CC=C(C=C3)Cl)C4=C(N=CC=C4)Cl D0ZM1T HIGHSTAT Investigative D0ZM6R DRUG__ID D0ZM6R D0ZM6R DRUGTYPE Small molecular drug D0ZM6R DRUGINCH 1S/C18H19N/c1-13-12-18(2,3)19-17-10-9-15(11-16(13)17)14-7-5-4-6-8-14/h4-12,19H,1-3H3 D0ZM6R DRUGINKE XKBGEVHKVFIMLY-UHFFFAOYSA-N D0ZM6R DRUGSMIL CC1=CC(NC2=C1C=C(C=C2)C3=CC=CC=C3)(C)C D0ZM6R HIGHSTAT Investigative D0ZM9M DRUG__ID D0ZM9M D0ZM9M DRUGTYPE Small molecular drug D0ZM9M DRUGINCH 1S/C15H15N3O/c16-15(17)18-13-8-6-11(7-9-13)10-14(19)12-4-2-1-3-5-12/h1-9H,10H2,(H4,16,17,18) D0ZM9M DRUGINKE MERNPSIIBFTCAI-UHFFFAOYSA-N D0ZM9M DRUGSMIL C1=CC=C(C=C1)C(=O)CC2=CC=C(C=C2)N=C(N)N D0ZM9M HIGHSTAT Investigative D0ZO1R DRUG__ID D0ZO1R D0ZO1R DRUGTYPE Small molecular drug D0ZO1R DRUGINCH 1S/C23H24O11/c1-30-15-8-14-17(19(27)22(15)31-2)12(25)7-13(33-14)10-3-5-11(6-4-10)32-23-21(29)20(28)18(26)16(9-24)34-23/h3-8,16,18,20-21,23-24,26-29H,9H2,1-2H3/t16-,18-,20+,21-,23-/m1/s1 D0ZO1R DRUGINKE RETJLKUBHXTIGH-FZFRBNDOSA-N D0ZO1R DRUGSMIL COC1=C(C(=C2C(=C1)OC(=CC2=O)C3=CC=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O)O)OC D0ZO1R HIGHSTAT Investigative D0ZO3C DRUG__ID D0ZO3C D0ZO3C DRUGTYPE Small molecular drug D0ZO3C DRUGINCH 1S/C36H47N11O6/c37-35(38)41-15-3-7-26-32(51)45-27(8-4-16-42-36(39)40)33(52)47-28(18-21-10-13-25(48)14-11-21)31(50)43-20-30(49)44-29(34(53)46-26)19-22-9-12-23-5-1-2-6-24(23)17-22/h1-2,5-6,9-14,17,26-29,48H,3-4,7-8,15-16,18-20H2,(H,43,50)(H,44,49)(H,45,51)(H,46,53)(H,47,52)(H4,37,38,41)(H4,39,40,42)/t26-,27+,28+,29-/m0/s1 D0ZO3C DRUGINKE YASYVKCWJGCXLS-AUAHOFGGSA-N D0ZO3C DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCN=C(N)N)CCCN=C(N)N)CC3=CC4=CC=CC=C4C=C3 D0ZO3C HIGHSTAT Investigative D0ZO8Z DRUG__ID D0ZO8Z D0ZO8Z DRUGTYPE Small molecular drug D0ZO8Z DRUGINCH 1S/C14H14N2O4S/c1-19-10-4-3-8(7-11(10)20-2)13(18)16-14-9(12(15)17)5-6-21-14/h3-7H,1-2H3,(H2,15,17)(H,16,18) D0ZO8Z DRUGINKE LORRZRFBMUDPOE-UHFFFAOYSA-N D0ZO8Z DRUGSMIL COC1=C(C=C(C=C1)C(=O)NC2=C(C=CS2)C(=O)N)OC D0ZO8Z HIGHSTAT Investigative D0ZP2D DRUG__ID D0ZP2D D0ZP2D DRUGTYPE Small molecular drug D0ZP2D DRUGINCH 1S/C14H20N2O/c1-10(2)16-9-11(6-7-15)13-8-12(17-3)4-5-14(13)16/h4-5,8-10H,6-7,15H2,1-3H3 D0ZP2D DRUGINKE WFNIDMQOBQYSBC-UHFFFAOYSA-N D0ZP2D DRUGSMIL CC(C)N1C=C(C2=C1C=CC(=C2)OC)CCN D0ZP2D HIGHSTAT Investigative D0ZP5X DRUG__ID D0ZP5X D0ZP5X DRUGTYPE Small molecular drug D0ZP5X DRUGINCH 1S/C16H16N2/c1-2-13(16-10-17-11-18-16)15-9-5-7-12-6-3-4-8-14(12)15/h3-11,13H,2H2,1H3,(H,17,18) D0ZP5X DRUGINKE LDZDVSZUAUUBGV-UHFFFAOYSA-N D0ZP5X DRUGSMIL CCC(C1=CC=CC2=CC=CC=C21)C3=CN=CN3 D0ZP5X HIGHSTAT Investigative D0ZQ3B DRUG__ID D0ZQ3B D0ZQ3B DRUGTYPE Small molecular drug D0ZQ3B DRUGINCH 1S/C26H29FN2O3/c1-17(2)25-23(13-12-22-14-21(30)15-24(31)32-22)26(19-8-10-20(27)11-9-19)29(28-25)16-18-6-4-3-5-7-18/h3-11,17,21-22,30H,12-16H2,1-2H3/t21-,22-/m0/s1 D0ZQ3B DRUGINKE SFTVYVGIXNZCEX-VXKWHMMOSA-N D0ZQ3B DRUGSMIL CC(C)C1=NN(C(=C1CCC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F)CC4=CC=CC=C4 D0ZQ3B HIGHSTAT Investigative D0ZQ3Q DRUG__ID D0ZQ3Q D0ZQ3Q DRUGTYPE Small molecular drug D0ZQ3Q DRUGINCH 1S/C13H21NO2/c1-5-10-7-13(16-4)11(6-9(2)14)8-12(10)15-3/h7-9H,5-6,14H2,1-4H3 D0ZQ3Q DRUGINKE HXJKWPGVENNMCC-UHFFFAOYSA-N D0ZQ3Q DRUGSMIL CCC1=CC(=C(C=C1OC)CC(C)N)OC D0ZQ3Q HIGHSTAT Investigative D0ZQ7L DRUG__ID D0ZQ7L D0ZQ7L DRUGTYPE Small molecular drug D0ZQ7L DRUGINCH 1S/C40H51N5O5/c1-24-18-31(46)19-25(2)32(24)22-33(41)40(50)45-23-30-17-11-10-16-29(30)21-35(45)38(48)44-36(26(3)28-14-8-5-9-15-28)39(49)43-34(37(42)47)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,46H,5,8-9,14-15,20-23,41H2,1-3H3,(H2,42,47)(H,43,49)(H,44,48)/t26-,33-,34-,35?,36+/m0/s1 D0ZQ7L DRUGINKE KIHHZGQBWZPIMS-FVTMYMNWSA-N D0ZQ7L DRUGSMIL CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CCCCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)N)N)C)O D0ZQ7L HIGHSTAT Investigative D0ZQ8Z DRUG__ID D0ZQ8Z D0ZQ8Z DRUGTYPE Small molecular drug D0ZQ8Z DRUGINCH 1S/C14H15NO4/c1-17-10-2-3-11-12(16)9-14(19-13(11)8-10)15-4-6-18-7-5-15/h2-3,8-9H,4-7H2,1H3 D0ZQ8Z DRUGINKE TVHCBKPEOVWUEQ-UHFFFAOYSA-N D0ZQ8Z DRUGSMIL COC1=CC2=C(C=C1)C(=O)C=C(O2)N3CCOCC3 D0ZQ8Z HIGHSTAT Investigative D0ZR1V DRUG__ID D0ZR1V D0ZR1V DRUGTYPE Small molecular drug D0ZR1V DRUGINCH 1S/C28H39NO6/c1-26(2)11-12-28(34-25(26)31)10-8-22-19-6-5-17-15-23(33-14-13-32-4)21(24(30)35-29)16-20(17)18(19)7-9-27(22,28)3/h15-16,18-19,22H,5-14,29H2,1-4H3/t18?,19?,22?,27-,28+/m0/s1 D0ZR1V DRUGINKE CUTJLDJFYWQIRX-LFCNJKSUSA-N D0ZR1V DRUGSMIL CC1(CCC2(CCC3C2(CCC4C3CCC5=CC(=C(C=C45)C(=O)ON)OCCOC)C)OC1=O)C D0ZR1V HIGHSTAT Investigative D0ZR2T DRUG__ID D0ZR2T D0ZR2T DRUGTYPE Small molecular drug D0ZR2T DRUGINCH 1S/C9H4F3NO3/c10-9(11,12)16-4-1-2-6-5(3-4)7(14)8(15)13-6/h1-3H,(H,13,14,15) D0ZR2T DRUGINKE XHAJMVPMNOBILF-UHFFFAOYSA-N D0ZR2T DRUGSMIL C1=CC2=C(C=C1OC(F)(F)F)C(=O)C(=O)N2 D0ZR2T HIGHSTAT Investigative D0ZR4M DRUG__ID D0ZR4M D0ZR4M DRUGTYPE Small molecular drug D0ZR4M DRUGINCH 1S/C15H14O6/c16-11-3-1-9(2-4-11)5-6-21-15(20)10-7-12(17)14(19)13(18)8-10/h1-4,7-8,16-19H,5-6H2 D0ZR4M DRUGINKE WSPSAXWXELZFQI-UHFFFAOYSA-N D0ZR4M DRUGSMIL C1=CC(=CC=C1CCOC(=O)C2=CC(=C(C(=C2)O)O)O)O D0ZR4M HIGHSTAT Investigative D0ZS3F DRUG__ID D0ZS3F D0ZS3F DRUGTYPE Small molecular drug D0ZS3F DRUGINCH 1S/C17H14N2O5/c1-22-16-9-13-14(10-17(16)23-2)18-7-6-15(13)24-12-5-3-4-11(8-12)19(20)21/h3-10H,1-2H3 D0ZS3F DRUGINKE OMYGYNKHKZLDSH-UHFFFAOYSA-N D0ZS3F DRUGSMIL COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=CC(=C3)[N+](=O)[O-] D0ZS3F HIGHSTAT Investigative D0ZS3M DRUG__ID D0ZS3M D0ZS3M DRUGTYPE Small molecular drug D0ZS3M DRUGINCH 1S/C16H13N3/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19/h1,3-11,13H,12H2 D0ZS3M DRUGINKE KUBLGYWISNGZNK-UHFFFAOYSA-N D0ZS3M DRUGSMIL C#CCN(C1=CC=NC=C1)N2C=CC3=CC=CC=C32 D0ZS3M HIGHSTAT Investigative D0ZS5F DRUG__ID D0ZS5F D0ZS5F DRUGTYPE Small molecular drug D0ZS5F DRUGINCH 1S/C7H11O8P/c8-4-1-3(7(10)11)2-5(6(4)9)15-16(12,13)14/h2,4-6,8-9H,1H2,(H,10,11)(H2,12,13,14)/t4-,5-,6+/m1/s1 D0ZS5F DRUGINKE QYOJSKGCWNAKGW-PBXRRBTRSA-N D0ZS5F DRUGSMIL C1C(C(C(C=C1C(=O)O)OP(=O)(O)O)O)O D0ZS5F HIGHSTAT Investigative D0ZS7M DRUG__ID D0ZS7M D0ZS7M DRUGTYPE Small molecular drug D0ZS7M DRUGINCH 1S/C25H26O4/c1-14(2)5-6-16-20(26)9-7-18-22(16)27-13-19-15-8-10-21-17(23(15)28-24(18)19)11-12-25(3,4)29-21/h5,7-12,19,24,26H,6,13H2,1-4H3/t19-,24-/m0/s1 D0ZS7M DRUGINKE XDRMVDDOBVPELW-CYFREDJKSA-N D0ZS7M DRUGSMIL CC(=CCC1=C(C=CC2=C1OCC3C2OC4=C3C=CC5=C4C=CC(O5)(C)C)O)C D0ZS7M HIGHSTAT Investigative D0ZS8N DRUG__ID D0ZS8N D0ZS8N DRUGTYPE Small molecular drug D0ZS8N DRUGINCH 1S/C8H9NO5/c10-5-1-4(9-3-7(12)13)2-6(11)8(5)14/h1-2,9-11,14H,3H2,(H,12,13) D0ZS8N DRUGINKE ZXXHFFMAINKZSZ-UHFFFAOYSA-N D0ZS8N DRUGSMIL C1=C(C=C(C(=C1O)O)O)NCC(=O)O D0ZS8N HIGHSTAT Investigative D0ZT0F DRUG__ID D0ZT0F D0ZT0F DRUGTYPE Small molecular drug D0ZT0F DRUGINCH 1S/C39H58O13/c1-5-6-7-8-9-10-11-12-13-14-15-19-24-49-32-31(41)37(51-33(34(42)43)38(48,35(44)45)39(32,52-37)36(46)47)23-22-26(2)30(50-28(4)40)27(3)25-29-20-17-16-18-21-29/h16-18,20-21,27,30-33,41,48H,2,5-15,19,22-25H2,1,3-4H3,(H,42,43)(H,44,45)(H,46,47)/t27-,30-,31-,32-,33?,37?,38?,39?/m1/s1 D0ZT0F DRUGINKE UXKLQDCALAWFIU-VKNDCNMPSA-N D0ZT0F DRUGSMIL CCCCCCCCCCCCCCOC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCC(=C)C(C(C)CC3=CC=CC=C3)OC(=O)C)O D0ZT0F HIGHSTAT Investigative D0ZT4U DRUG__ID D0ZT4U D0ZT4U DRUGTYPE Small molecular drug D0ZT4U DRUGINCH 1S/C16H11FO2/c17-16-14-7-3-11(9-12(14)4-8-15(16)19)10-1-5-13(18)6-2-10/h1-9,18-19H D0ZT4U DRUGINKE VQATUPWMFYRKSD-UHFFFAOYSA-N D0ZT4U DRUGSMIL C1=CC(=CC=C1C2=CC3=C(C=C2)C(=C(C=C3)O)F)O D0ZT4U HIGHSTAT Investigative D0ZT5C DRUG__ID D0ZT5C D0ZT5C DRUGTYPE Small molecular drug D0ZT5C DRUGINCH 1S/C14H8F4O2/c15-7-1-3-9(11(17)5-7)13(19)14(20)10-4-2-8(16)6-12(10)18/h1-6,13,19H D0ZT5C DRUGINKE MOZRQJUPHVESBZ-UHFFFAOYSA-N D0ZT5C DRUGSMIL C1=CC(=C(C=C1F)F)C(C(=O)C2=C(C=C(C=C2)F)F)O D0ZT5C HIGHSTAT Investigative D0ZT8D DRUG__ID D0ZT8D D0ZT8D DRUGTYPE Small molecular drug D0ZT8D DRUGINCH 1S/C13H17N3/c1-2-6-11-10(4-1)5-3-7-12(11)16-13-14-8-9-15-13/h3,5,7H,1-2,4,6,8-9H2,(H2,14,15,16) D0ZT8D DRUGINKE QQJLHRRUATVHED-UHFFFAOYSA-N D0ZT8D DRUGSMIL C1CCC2=C(C1)C=CC=C2NC3=NCCN3 D0ZT8D HIGHSTAT Investigative D0ZT9D DRUG__ID D0ZT9D D0ZT9D DRUGTYPE Small molecular drug D0ZT9D DRUGINCH 1S/C25H30O6/c1-3-19(2)16-17-22(27)21(26)15-13-11-9-7-5-4-6-8-10-12-14-20-18-23(28)24(31-20)25(29)30/h4-17,19-20,23-24,28H,3,18H2,1-2H3,(H,29,30)/b6-4+,7-5+,10-8+,11-9+,14-12+,15-13+,17-16+/t19?,20-,23-,24-/m1/s1 D0ZT9D DRUGINKE UWFRQOWLUPERFN-WUSQRGMKSA-N D0ZT9D DRUGSMIL CCC(C)C=CC(=O)C(=O)C=CC=CC=CC=CC=CC=CC1CC(C(O1)C(=O)O)O D0ZT9D HIGHSTAT Investigative D0ZU0O DRUG__ID D0ZU0O D0ZU0O DRUGTYPE Small molecular drug D0ZU0O DRUGINCH 1S/C20H10F6N2OS/c21-19(22,23)13-8-4-7-12(9-13)17-27-18(29-28-17)15-10-14(11-5-2-1-3-6-11)16(30-15)20(24,25)26/h1-10H D0ZU0O DRUGINKE OYMNPJXKQVTQTR-UHFFFAOYSA-N D0ZU0O DRUGSMIL C1=CC=C(C=C1)C2=C(SC(=C2)C3=NC(=NO3)C4=CC(=CC=C4)C(F)(F)F)C(F)(F)F D0ZU0O HIGHSTAT Investigative D0ZU3S DRUG__ID D0ZU3S D0ZU3S DRUGTYPE Small molecular drug D0ZU3S DRUGINCH 1S/C30H45N3O5/c1-6-8-15-31-27(35)18-26(34)25(16-20(3)4)32-30(37)29(21(5)7-2)33-28(36)19-38-24-14-13-22-11-9-10-12-23(22)17-24/h9-14,17,20-21,25-26,29,34H,6-8,15-16,18-19H2,1-5H3,(H,31,35)(H,32,37)(H,33,36)/t21?,25-,26-,29-/m0/s1 D0ZU3S DRUGINKE ZOZZWZVOMAKBJD-BGRUSPQTSA-N D0ZU3S DRUGSMIL CCCCNC(=O)CC(C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)COC1=CC2=CC=CC=C2C=C1)O D0ZU3S HIGHSTAT Investigative D0ZU4S DRUG__ID D0ZU4S D0ZU4S DRUGTYPE Small molecular drug D0ZU4S DRUGINCH 1S/C5H8F3NO2S/c6-5(7,8)12-2-1-3(9)4(10)11/h3H,1-2,9H2,(H,10,11)/t3-/m0/s1 D0ZU4S DRUGINKE YLJLTSVBCXYTQK-VKHMYHEASA-N D0ZU4S DRUGSMIL C(CSC(F)(F)F)C(C(=O)O)N D0ZU4S HIGHSTAT Investigative D0ZU5K DRUG__ID D0ZU5K D0ZU5K DRUGTYPE Small molecular drug D0ZU5K DRUGINCH 1S/C22H20N2O3/c1-14-12-22(2,3)24(18-11-7-6-8-15(14)18)19(25)13-23-20(26)16-9-4-5-10-17(16)21(23)27/h4-12H,13H2,1-3H3 D0ZU5K DRUGINKE WKXGGFCOIKORMM-UHFFFAOYSA-N D0ZU5K DRUGSMIL CC1=CC(N(C2=CC=CC=C12)C(=O)CN3C(=O)C4=CC=CC=C4C3=O)(C)C D0ZU5K HIGHSTAT Investigative D0ZU5W DRUG__ID D0ZU5W D0ZU5W DRUGTYPE Small molecular drug D0ZU5W DRUGINCH 1S/C17H20N2O/c1-2-6-15(7-3-1)14-20-17-9-5-4-8-16(17)19-12-10-18-11-13-19/h1-9,18H,10-14H2 D0ZU5W DRUGINKE PPQUPQGZDGZYJI-UHFFFAOYSA-N D0ZU5W DRUGSMIL C1CN(CCN1)C2=CC=CC=C2OCC3=CC=CC=C3 D0ZU5W HIGHSTAT Investigative D0ZU6O DRUG__ID D0ZU6O D0ZU6O DRUGTYPE Small molecular drug D0ZU6O DRUGINCH 1S/C10H13N3O6/c11-8(17)5-9(18)13(2-1-12-5)10-7(16)6(15)4(3-14)19-10/h1-2,4,6-7,10,14-16H,3H2,(H2,11,17)/t4-,6-,7-,10-/m1/s1 D0ZU6O DRUGINKE XVXWUBIIHFDOJO-KQYNXXCUSA-N D0ZU6O DRUGSMIL C1=CN(C(=O)C(=N1)C(=O)N)C2C(C(C(O2)CO)O)O D0ZU6O HIGHSTAT Investigative D0ZU9P DRUG__ID D0ZU9P D0ZU9P DRUGTYPE Small molecular drug D0ZU9P DRUGINCH 1S/C17H13NO3/c1-18-10-12(9-15(18)17(20)21)16(19)14-8-4-6-11-5-2-3-7-13(11)14/h2-10H,1H3,(H,20,21) D0ZU9P DRUGINKE CNUPQURTHORUGH-UHFFFAOYSA-N D0ZU9P DRUGSMIL CN1C=C(C=C1C(=O)O)C(=O)C2=CC=CC3=CC=CC=C32 D0ZU9P HIGHSTAT Investigative D0ZU9Z DRUG__ID D0ZU9Z D0ZU9Z DRUGTYPE Small molecular drug D0ZU9Z DRUGINCH 1S/C24H17NO4/c1-27-18-9-7-17(8-10-18)24-22(20-12-11-19(28-2)13-21(20)29-24)23(26)16-5-3-15(14-25)4-6-16/h3-13H,1-2H3 D0ZU9Z DRUGINKE RYNSGDFWBJWWSZ-UHFFFAOYSA-N D0ZU9Z DRUGSMIL COC1=CC=C(C=C1)C2=C(C3=C(O2)C=C(C=C3)OC)C(=O)C4=CC=C(C=C4)C#N D0ZU9Z HIGHSTAT Investigative D0ZV1T DRUG__ID D0ZV1T D0ZV1T DRUGTYPE Small molecular drug D0ZV1T DRUGINCH 1S/C22H23N3O/c1-3-16(4-2)22(26)25-20-15-19(17-11-7-5-8-12-17)23-21(24-20)18-13-9-6-10-14-18/h5-16H,3-4H2,1-2H3,(H,23,24,25,26) D0ZV1T DRUGINKE ZMYSFVQFZFGCMP-UHFFFAOYSA-N D0ZV1T DRUGSMIL CCC(CC)C(=O)NC1=NC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3 D0ZV1T HIGHSTAT Investigative D0ZW2F DRUG__ID D0ZW2F D0ZW2F DRUGTYPE Small molecular drug D0ZW2F DRUGINCH 1S/C20H18O7/c21-13-7-5-11-15(9-3-1-2-4-10(9)20(25)26)12-6-8-14(22)17(24)19(12)27-18(11)16(13)23/h5-10,21,23-24H,1-4H2,(H,25,26) D0ZW2F DRUGINKE CAVIJGGXNIURPI-UHFFFAOYSA-N D0ZW2F DRUGSMIL C1CCC(C(C1)C2=C3C=CC(=O)C(=C3OC4=C2C=CC(=C4O)O)O)C(=O)O D0ZW2F HIGHSTAT Investigative D0ZW8E DRUG__ID D0ZW8E D0ZW8E DRUGTYPE Small molecular drug D0ZW8E DRUGINCH 1S/C11H21N3O2/c1-3-7(2)9(12)11(16)14-6-4-5-8(14)10(13)15/h7-9H,3-6,12H2,1-2H3,(H2,13,15)/t7?,8-,9-/m0/s1 D0ZW8E DRUGINKE HCKIVERTZIJTOT-NPPUSCPJSA-N D0ZW8E DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)N)N D0ZW8E HIGHSTAT Investigative D0ZW9L DRUG__ID D0ZW9L D0ZW9L DRUGTYPE Small molecular drug D0ZW9L DRUGINCH 1S/C18H13N3O/c22-18-20-16-14(12-7-3-1-4-8-12)11-15(19-17(16)21-18)13-9-5-2-6-10-13/h1-11H,(H2,19,20,21,22) D0ZW9L DRUGINKE SHTZPAWLYJASHR-UHFFFAOYSA-N D0ZW9L DRUGSMIL C1=CC=C(C=C1)C2=CC(=NC3=C2NC(=O)N3)C4=CC=CC=C4 D0ZW9L HIGHSTAT Investigative D0ZX0Y DRUG__ID D0ZX0Y D0ZX0Y DRUGTYPE Small molecular drug D0ZX0Y DRUGINCH 1S/C15H18O2/c1-3-5-6-7-8-13-9-11-14(12-10-13)17-15(16)4-2/h2,9-12H,3,5-8H2,1H3 D0ZX0Y DRUGINKE IAEVDNHEIHTNJR-UHFFFAOYSA-N D0ZX0Y DRUGSMIL CCCCCCC1=CC=C(C=C1)OC(=O)C#C D0ZX0Y HIGHSTAT Investigative D0ZY2T DRUG__ID D0ZY2T D0ZY2T DRUGTYPE Small molecular drug D0ZY2T DRUGINCH 1S/C19H25N2O6P/c1-12(2)10-16(21-28(25,26)27)18(22)20-17(19(23)24)11-14-8-5-7-13-6-3-4-9-15(13)14/h3-9,12,16-17H,10-11H2,1-2H3,(H,20,22)(H,23,24)(H3,21,25,26,27)/p-3/t16-,17-/m0/s1 D0ZY2T DRUGINKE RGBJIKYRFMBDCB-IRXDYDNUSA-K D0ZY2T DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-])[O-] D0ZY2T HIGHSTAT Investigative D0ZY3C DRUG__ID D0ZY3C D0ZY3C DRUGTYPE Small molecular drug D0ZY3C DRUGINCH 1S/C14H10N2O/c17-14-13-8-15-7-6-11(13)12(9-16-14)10-4-2-1-3-5-10/h1-9H,(H,16,17) D0ZY3C DRUGINKE JIWHQPVTDQXELV-UHFFFAOYSA-N D0ZY3C DRUGSMIL C1=CC=C(C=C1)C2=CNC(=O)C3=C2C=CN=C3 D0ZY3C HIGHSTAT Investigative D0ZY4C DRUG__ID D0ZY4C D0ZY4C DRUGTYPE Small molecular drug D0ZY4C DRUGINCH 1S/C16H20N4/c1-2-6-14(7-3-1)8-10-17-15-9-11-18-16(19-15)20-12-4-5-13-20/h1-3,6-7,9,11H,4-5,8,10,12-13H2,(H,17,18,19) D0ZY4C DRUGINKE MIALFBONYMMUFB-UHFFFAOYSA-N D0ZY4C DRUGSMIL C1CCN(C1)C2=NC=CC(=N2)NCCC3=CC=CC=C3 D0ZY4C HIGHSTAT Investigative D0ZY7X DRUG__ID D0ZY7X D0ZY7X DRUGTYPE Small molecular drug D0ZY7X DRUGINCH 1S/C18H24N4/c1-14-12-17(21-16-10-6-3-7-11-16)22-18(20-14)19-13-15-8-4-2-5-9-15/h2,4-5,8-9,12,16H,3,6-7,10-11,13H2,1H3,(H2,19,20,21,22) D0ZY7X DRUGINKE GDKCAAWSNQLXNX-UHFFFAOYSA-N D0ZY7X DRUGSMIL CC1=CC(=NC(=N1)NCC2=CC=CC=C2)NC3CCCCC3 D0ZY7X HIGHSTAT Investigative D0ZY8G DRUG__ID D0ZY8G D0ZY8G DRUGTYPE Small molecular drug D0ZY8G DRUGINCH 1S/C21H13ClFN3O3/c22-13-7-8-16(25-19(27)17-6-1-2-9-24-17)12(10-13)11-26-20(28)14-4-3-5-15(23)18(14)21(26)29/h1-10H,11H2,(H,25,27) D0ZY8G DRUGINKE WBXKMHFMMCOTOK-UHFFFAOYSA-N D0ZY8G DRUGSMIL C1=CC=NC(=C1)C(=O)NC2=C(C=C(C=C2)Cl)CN3C(=O)C4=C(C3=O)C(=CC=C4)F D0ZY8G HIGHSTAT Investigative D0ZY8H DRUG__ID D0ZY8H D0ZY8H DRUGTYPE Small molecular drug D0ZY8H DRUGINCH 1S/C17H21NOS2/c1-12(2)16-14(9-13-7-5-4-6-8-13)10-15(18-17(16)19)21-11-20-3/h4-8,10,12H,9,11H2,1-3H3,(H,18,19) D0ZY8H DRUGINKE CCFCAWLPLYLQBS-UHFFFAOYSA-N D0ZY8H DRUGSMIL CC(C)C1=C(C=C(NC1=O)SCSC)CC2=CC=CC=C2 D0ZY8H HIGHSTAT Investigative D0ZY8V DRUG__ID D0ZY8V D0ZY8V DRUGTYPE Small molecular drug D0ZY8V DRUGINCH 1S/C21H35NO/c1-2-3-9-21-13-16-22(17-14-21)15-8-19-23-18-7-12-20-10-5-4-6-11-20/h4-6,10-11,21H,2-3,7-9,12-19H2,1H3 D0ZY8V DRUGINKE OFZZAFXTRYWAHX-UHFFFAOYSA-N D0ZY8V DRUGSMIL CCCCC1CCN(CC1)CCCOCCCC2=CC=CC=C2 D0ZY8V HIGHSTAT Investigative D0ZZ2L DRUG__ID D0ZZ2L D0ZZ2L DRUGTYPE Small molecular drug D0ZZ2L DRUGINCH 1S/C23H23NS/c1-2-8-18(9-3-1)14-16-24-17-15-19-20-10-4-6-12-22(20)25-23-13-7-5-11-21(19)23/h1-13,19,24H,14-17H2 D0ZZ2L DRUGINKE BTFWDABQNDILAN-UHFFFAOYSA-N D0ZZ2L DRUGSMIL C1=CC=C(C=C1)CCNCCC2C3=CC=CC=C3SC4=CC=CC=C24 D0ZZ2L HIGHSTAT Investigative D0ZZ4S DRUG__ID D0ZZ4S D0ZZ4S DRUGTYPE Small molecular drug D0ZZ4S DRUGINCH 1S/C16H17NO/c1-18-15-8-4-6-12-9-11-5-2-3-7-13(11)14(10-17)16(12)15/h2-8,14H,9-10,17H2,1H3 D0ZZ4S DRUGINKE MVQHAVPXHRGPMI-UHFFFAOYSA-N D0ZZ4S DRUGSMIL COC1=CC=CC2=C1C(C3=CC=CC=C3C2)CN D0ZZ4S HIGHSTAT Investigative D0ZZ4Z DRUG__ID D0ZZ4Z D0ZZ4Z DRUGTYPE Small molecular drug D0ZZ4Z DRUGINCH 1S/C14H18N2O/c17-13-5-3-4-12-14(13)11(10-15-12)6-9-16-7-1-2-8-16/h3-5,10,15,17H,1-2,6-9H2 D0ZZ4Z DRUGINKE XASLPZWIPBCAPF-UHFFFAOYSA-N D0ZZ4Z DRUGSMIL C1CCN(C1)CCC2=CNC3=C2C(=CC=C3)O D0ZZ4Z HIGHSTAT Investigative D0ZZ9M DRUG__ID D0ZZ9M D0ZZ9M DRUGTYPE Small molecular drug D0ZZ9M DRUGINCH 1S/C9H16N2S/c1-8-10-7-9(12-8)3-5-11(2)6-4-9/h3-7H2,1-2H3 D0ZZ9M DRUGINKE VGGGBQVTSUMURJ-UHFFFAOYSA-N D0ZZ9M DRUGSMIL CC1=NCC2(S1)CCN(CC2)C D0ZZ9M HIGHSTAT Investigative D14NDZ DRUG__ID D14NDZ D14NDZ DRUGTYPE Small molecular drug D14NDZ DRUGINCH 1S/C23H22O6/c1-23(2)8-7-12-15(29-23)6-5-13-21(24)20-14-9-17(25-3)18(26-4)10-16(14)27-11-19(20)28-22(12)13/h5-10,19-20H,11H2,1-4H3/t19-,20+/m1/s1 D14NDZ DRUGINKE ORDAZKGHSNRHTD-UXHICEINSA-N D14NDZ DRUGSMIL CC1(C=CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC)C D14NDZ HIGHSTAT Investigative D1BCW8 DRUG__ID D1BCW8 D1BCW8 DRUGTYPE Small molecular drug D1BCW8 DRUGINCH 1S/C17H16N8/c1-2-10(1)13-8-16(25-24-13)22-15-5-6-18-17(23-15)21-11-3-4-12-14(7-11)20-9-19-12/h3-10H,1-2H2,(H,19,20)(H3,18,21,22,23,24,25) D1BCW8 DRUGINKE WJNBSTLIALIIEW-UHFFFAOYSA-N D1BCW8 DRUGSMIL C1CC1C2=CC(=NN2)NC3=NC(=NC=C3)NC4=CC5=C(C=C4)N=CN5 D1BCW8 HIGHSTAT Investigative D2B7WM DRUG__ID D2B7WM D2B7WM DRUGTYPE Small molecular drug D2B7WM DRUGINCH 1S/C24H15F3N4O/c25-24(26,27)17-2-1-3-18(11-17)31-22(32)9-6-16-13-29-20-7-4-14(10-19(20)23(16)31)15-5-8-21(28)30-12-15/h1-13H,(H2,28,30) D2B7WM DRUGINKE GUXXEUUYCAYESJ-UHFFFAOYSA-N D2B7WM DRUGSMIL C1=CC(=CC(=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CN=C(C=C5)N)C(F)(F)F D2B7WM HIGHSTAT Investigative D2SJZ9 DRUG__ID D2SJZ9 D2SJZ9 DRUGTYPE Small molecular drug D2SJZ9 DRUGINCH 1S/C19H18N4/c1-20-18-19-21-13-15(12-11-14-7-3-2-4-8-14)23(19)17-10-6-5-9-16(17)22-18/h2-10,13H,11-12H2,1H3,(H,20,22) D2SJZ9 DRUGINKE HOACPUXUWCASLE-UHFFFAOYSA-N D2SJZ9 DRUGSMIL CNC1=NC2=CC=CC=C2N3C1=NC=C3CCC4=CC=CC=C4 D2SJZ9 HIGHSTAT Investigative D2U4RX DRUG__ID D2U4RX D2U4RX DRUGTYPE Small molecular drug D2U4RX DRUGINCH 1S/C22H34NO2.HI/c1-23(15-9-4-10-16-23)17-21-18-24-22(25-21,19-11-5-2-6-12-19)20-13-7-3-8-14-20;/h2,5-6,11-12,20-21H,3-4,7-10,13-18H2,1H3;1H/q+1;/p-1 D2U4RX DRUGINKE YHEWVHONOOWLMW-UHFFFAOYSA-M D2U4RX DRUGSMIL C[N+]1(CCCCC1)CC2COC(O2)(C3CCCCC3)C4=CC=CC=C4.[I-] D2U4RX HIGHSTAT Investigative D3GD1L DRUG__ID D3GD1L D3GD1L DRUGTYPE Small molecular drug D3GD1L DRUGINCH 1S/C21H28O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,16-17,22-25H,3-4,7-8,13H2,1-2H3 D3GD1L DRUGINKE OELMAFBLFOKZJD-UHFFFAOYSA-N D3GD1L DRUGSMIL COC1=C(C=CC(=C1)CCC(CC(CCC2=CC(=C(C=C2)O)OC)O)O)O D3GD1L HIGHSTAT Investigative D3U1LH DRUG__ID D3U1LH D3U1LH DRUGTYPE Small molecular drug D3U1LH DRUGINCH 1S/C31H34N6O3/c1-31(2,19-36(3)4)20-40-25-10-11-27-22(12-25)13-28(35-27)26-14-24(16-32-30(26)39)34-29(38)23-15-33-37(18-23)17-21-8-6-5-7-9-21/h5-16,18,35H,17,19-20H2,1-4H3,(H,32,39)(H,34,38) D3U1LH DRUGINKE REQMZUHAMVOEON-UHFFFAOYSA-N D3U1LH DRUGSMIL CC(C)(CN(C)C)COC1=CC2=C(C=C1)NC(=C2)C3=CC(=CNC3=O)NC(=O)C4=CN(N=C4)CC5=CC=CC=C5 D3U1LH HIGHSTAT Investigative D4RMB0 DRUG__ID D4RMB0 D4RMB0 DRUGTYPE Small molecular drug D4RMB0 DRUGINCH 1S/C13H10N2O/c16-13(12-5-8-14-9-6-12)4-3-11-2-1-7-15-10-11/h1-10H/b4-3+ D4RMB0 DRUGINKE UOWGYMNWMDNSTL-ONEGZZNKSA-N D4RMB0 DRUGSMIL C1=CC(=CN=C1)C=CC(=O)C2=CC=NC=C2 D4RMB0 HIGHSTAT Investigative D4VBY6 DRUG__ID D4VBY6 D4VBY6 DRUGTYPE Small molecular drug D4VBY6 DRUGINCH 1S/C35H58O9/c1-19(2)32-24(7)27(36)18-35(40,44-32)26(9)31(38)25(8)33-28(41-10)14-12-13-20(3)15-22(5)30(37)23(6)16-21(4)17-29(42-11)34(39)43-33/h12-14,16-17,19,22-28,30-33,36-38,40H,15,18H2,1-11H3/b14-12+,20-13+,21-16+,29-17-/t22-,23+,24-,25-,26-,27+,28-,30-,31+,32+,33+,35+/m0/s1 D4VBY6 DRUGINKE XDHNQDDQEHDUTM-JQWOJBOSSA-N D4VBY6 DRUGSMIL CC1CC(=CC=CC(C(OC(=O)C(=CC(=CC(C1O)C)C)OC)C(C)C(C(C)C2(CC(C(C(O2)C(C)C)C)O)O)O)OC)C D4VBY6 HIGHSTAT Investigative D65IMT DRUG__ID D65IMT D65IMT DRUGTYPE Small molecular drug D65IMT DRUGINCH 1S/C42H54N8O3/c1-26(2)50-37-18-33(17-34(36(37)25-46-50)40(52)45-24-35-27(3)13-28(4)47-41(35)53)32-5-6-38(44-23-32)49-11-9-48(10-12-49)8-7-43-39(51)22-42-19-29-14-30(20-42)16-31(15-29)21-42/h5-6,13,17-18,23,25-26,29-31H,7-12,14-16,19-22,24H2,1-4H3,(H,43,51)(H,45,52)(H,47,53) D65IMT DRUGINKE WQIQJFXBAJJKNT-UHFFFAOYSA-N D65IMT DRUGSMIL CC1=CC(=C(C(=O)N1)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CN=C(C=C4)N5CCN(CC5)CCNC(=O)CC67CC8CC(C6)CC(C8)C7)C(C)C)C D65IMT HIGHSTAT Investigative D7CI5F DRUG__ID D7CI5F D7CI5F DRUGTYPE Small molecular drug D7CI5F DRUGINCH 1S/C17H10N2O5/c20-17(14-7-8-16(24-14)19(21)22)18-10-5-6-12-11-3-1-2-4-13(11)23-15(12)9-10/h1-9H,(H,18,20) D7CI5F DRUGINKE URUVDCCYSJEGQQ-UHFFFAOYSA-N D7CI5F DRUGSMIL C1=CC=C2C(=C1)C3=C(O2)C=C(C=C3)NC(=O)C4=CC=C(O4)[N+](=O)[O-] D7CI5F HIGHSTAT Investigative D7RK2M DRUG__ID D7RK2M D7RK2M DRUGTYPE Small molecular drug D7RK2M DRUGINCH 1S/C30H32ClN7O2/c1-37(2)15-6-10-27(39)34-21-13-11-20(12-14-21)29(40)38-16-5-7-22(19-38)35-30-33-18-25(31)28(36-30)24-17-32-26-9-4-3-8-23(24)26/h3-4,6,8-14,17-18,22,32H,5,7,15-16,19H2,1-2H3,(H,34,39)(H,33,35,36)/b10-6+/t22-/m1/s1 D7RK2M DRUGINKE RUBYHLPRZRMTJO-MOVYNIQHSA-N D7RK2M DRUGSMIL CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)N2CCCC(C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl D7RK2M HIGHSTAT Investigative D83QVW DRUG__ID D83QVW D83QVW DRUGTYPE Small molecular drug D83QVW DRUGINCH 1S/C20H27N5O3/c1-4-18(26)21-8-7-9-22-19-14-12-16(27-2)17(28-3)13-15(14)23-20(24-19)25-10-5-6-11-25/h4,12-13H,1,5-11H2,2-3H3,(H,21,26)(H,22,23,24) D83QVW DRUGINKE QTHRXIUTSUVNPH-UHFFFAOYSA-N D83QVW DRUGSMIL COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCCC3)NCCCNC(=O)C=C)OC D83QVW HIGHSTAT Investigative D9ILC1 DRUG__ID D9ILC1 D9ILC1 DRUGTYPE Small molecular drug D9ILC1 DRUGINCH 1S/C16H13NO3/c1-19-14-8-4-6-11(16(14)17)15-9-12(18)10-5-2-3-7-13(10)20-15/h2-9H,17H2,1H3 D9ILC1 DRUGINKE QFWCYNPOPKQOKV-UHFFFAOYSA-N D9ILC1 DRUGSMIL COC1=CC=CC(=C1N)C2=CC(=O)C3=CC=CC=C3O2 D9ILC1 HIGHSTAT Investigative DAJ3D2 DRUG__ID DAJ3D2 DAJ3D2 DRUGTYPE Small molecular drug DAJ3D2 DRUGINCH 1S/C11H6F3NO2S/c12-11(13,14)7-3-1-2-6(4-7)5-8-9(16)15-10(17)18-8/h1-5H,(H,15,16,17)/b8-5- DAJ3D2 DRUGINKE NGJLOFCOEOHFKQ-YVMONPNESA-N DAJ3D2 DRUGSMIL C1=CC(=CC(=C1)C(F)(F)F)C=C2C(=O)NC(=O)S2 DAJ3D2 HIGHSTAT Investigative DAQ31P DRUG__ID DAQ31P DAQ31P DRUGTYPE Small molecular drug DAQ31P DRUGINCH 1S/C12H8N2O2/c13-7-5-9-12(6-10(7)15)16-11-4-2-1-3-8(11)14-9/h1-6H,13H2 DAQ31P DRUGINKE RDJXPXHQENRCNG-UHFFFAOYSA-N DAQ31P DRUGSMIL C1=CC=C2C(=C1)N=C3C=C(C(=O)C=C3O2)N DAQ31P HIGHSTAT Investigative DCVO04 DRUG__ID DCVO04 DCVO04 DRUGTYPE Small molecular drug DCVO04 DRUGINCH 1S/C25H24F3N3O6S2/c1-24(11-3-2-4-12-24)15-30-22(32)21(38-23(30)33)13-16-5-7-17(8-6-16)29-39(36,37)18-9-10-20(31(34)35)19(14-18)25(26,27)28/h5-10,13-14,29H,2-4,11-12,15H2,1H3/b21-13- DCVO04 DRUGINKE FANMQRSNMHKZCR-BKUYFWCQSA-N DCVO04 DRUGSMIL CC1(CCCCC1)CN2C(=O)C(=CC3=CC=C(C=C3)NS(=O)(=O)C4=CC(=C(C=C4)[N+](=O)[O-])C(F)(F)F)SC2=O DCVO04 HIGHSTAT Investigative DFBJ28 DRUG__ID DFBJ28 DFBJ28 DRUGTYPE Small molecular drug DFBJ28 DRUGINCH 1S/C19H10N2O/c22-10-14-18-12-6-2-4-8-16(12)20-17(18)9-13-11-5-1-3-7-15(11)21-19(13)14/h1-10H DFBJ28 DRUGINKE OTWFDHQTFRXSAK-UHFFFAOYSA-N DFBJ28 DRUGSMIL C1=CC=C2C(=C1)C3=CC4=NC5=CC=CC=C5C4=C(C3=N2)C=O DFBJ28 HIGHSTAT Investigative DGZ38L DRUG__ID DGZ38L DGZ38L DRUGTYPE Small molecular drug DGZ38L DRUGINCH 1S/C22H19NO4.ClH/c1-25-17-7-6-13-14-5-4-12-9-18-19(27-11-26-18)10-15(12)21(14)23-8-2-3-16(23)20(13)22(17)24;/h4-7,9-10,12,15H,2-3,8,11H2,1H3;1H DGZ38L DRUGINKE YLNMBOMTXKNYDO-UHFFFAOYSA-N DGZ38L DRUGSMIL COC1=C(C2=C3CCC[N+]3=C4C5C=C6C(=CC5C=CC4=C2C=C1)OCO6)O.[Cl-] DGZ38L HIGHSTAT Investigative DHG36S DRUG__ID DHG36S DHG36S DRUGTYPE Small molecular drug DHG36S DRUGINCH 1S/C16H17N5O2/c1-20-15-13(10-17-20)16(21-5-7-23-8-6-21)19-14(18-15)11-3-2-4-12(22)9-11/h2-4,9-10,22H,5-8H2,1H3 DHG36S DRUGINKE BJVRNXSHJLDZJR-UHFFFAOYSA-N DHG36S DRUGSMIL CN1C2=C(C=N1)C(=NC(=N2)C3=CC(=CC=C3)O)N4CCOCC4 DHG36S HIGHSTAT Investigative DI81LW DRUG__ID DI81LW DI81LW DRUGTYPE Small molecular drug DI81LW DRUGINCH 1S/C22H29FN6/c1-2-3-12-25-22-26-13-19-20(16-6-8-17(23)9-7-16)28-29(21(19)27-22)14-15-4-10-18(24)11-5-15/h6-9,13,15,18H,2-5,10-12,14,24H2,1H3,(H,25,26,27) DI81LW DRUGINKE OGEBRHQLRGFBNV-UHFFFAOYSA-N DI81LW DRUGSMIL CCCCNC1=NC=C2C(=NN(C2=N1)CC3CCC(CC3)N)C4=CC=C(C=C4)F DI81LW HIGHSTAT Investigative DL36FJ DRUG__ID DL36FJ DL36FJ DRUGTYPE Small molecular drug DL36FJ DRUGINCH 1S/C19H19N5O/c1-13-6-4-5-7-17(13)23-22-15-8-9-16(14(2)12-15)21-19(25)18-10-11-20-24(18)3/h4-12H,1-3H3,(H,21,25) DL36FJ DRUGINKE LKTNEXPODAWWFM-UHFFFAOYSA-N DL36FJ DRUGSMIL CC1=CC=CC=C1N=NC2=CC(=C(C=C2)NC(=O)C3=CC=NN3C)C DL36FJ HIGHSTAT Investigative DLW69V DRUG__ID DLW69V DLW69V DRUGTYPE Small molecular drug DLW69V DRUGINCH 1S/C6H6Br6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H DLW69V DRUGINKE QFQZKISCBJKVHI-UHFFFAOYSA-N DLW69V DRUGSMIL C1(C(C(C(C(C1Br)Br)Br)Br)Br)Br DLW69V HIGHSTAT Investigative DNY16U DRUG__ID DNY16U DNY16U DRUGTYPE Small molecular drug DNY16U DRUGINCH 1S/C27H32Cl2FN3O4/c1-26(2,3)12-21-27(17-10-19(30)18(29)11-20(17)32-25(27)37)22(14-5-4-6-15(28)9-14)23(33-21)24(36)31-8-7-16(35)13-34/h4-6,9-11,16,21-23,33-35H,7-8,12-13H2,1-3H3,(H,31,36)(H,32,37)/t16-,21+,22-,23+,27-/m0/s1 DNY16U DRUGINKE UNXQGBMZYKHQCO-NVHWNKAKSA-N DNY16U DRUGSMIL CC(C)(C)CC1C2(C(C(N1)C(=O)NCCC(CO)O)C3=CC(=CC=C3)Cl)C4=CC(=C(C=C4NC2=O)Cl)F DNY16U HIGHSTAT Investigative DOR1I0 DRUG__ID DOR1I0 DOR1I0 DRUGTYPE Small molecular drug DOR1I0 DRUGINCH 1S/C20H27N9O3S/c1-33(30,31)29-4-2-26(3-5-29)12-16-13-28-14-17(15-10-22-20(21)23-11-15)25-19(18(28)24-16)27-6-8-32-9-7-27/h10-11,13-14H,2-9,12H2,1H3,(H2,21,22,23) DOR1I0 DRUGINKE OHKDVDMWRKFZRB-UHFFFAOYSA-N DOR1I0 DRUGSMIL CS(=O)(=O)N1CCN(CC1)CC2=CN3C=C(N=C(C3=N2)N4CCOCC4)C5=CN=C(N=C5)N DOR1I0 HIGHSTAT Investigative DP2F6W DRUG__ID DP2F6W DP2F6W DRUGTYPE Small molecular drug DP2F6W DRUGINCH 1S/C11H7IN2O4/c12-7-1-3-8(4-2-7)13-11(15)9-5-6-10(18-9)14(16)17/h1-6H,(H,13,15) DP2F6W DRUGINKE JBIKQXOZLBLMKI-UHFFFAOYSA-N DP2F6W DRUGSMIL C1=CC(=CC=C1NC(=O)C2=CC=C(O2)[N+](=O)[O-])I DP2F6W HIGHSTAT Investigative DQ0V7Y DRUG__ID DQ0V7Y DQ0V7Y DRUGTYPE Small molecular drug DQ0V7Y DRUGINCH 1S/C26H35FN4O2S/c1-28(2)25-18-30(24-12-9-20-5-4-6-23(27)26(20)24)17-22(25)19-7-10-21(11-8-19)29-13-15-31(16-14-29)34(3,32)33/h4-8,10-11,22,24-25H,9,12-18H2,1-3H3/t22-,24?,25+/m1/s1 DQ0V7Y DRUGINKE REVJNSVNICWODC-KIDMSAQOSA-N DQ0V7Y DRUGSMIL CN(C)C1CN(CC1C2=CC=C(C=C2)N3CCN(CC3)S(=O)(=O)C)C4CCC5=C4C(=CC=C5)F DQ0V7Y HIGHSTAT Investigative DTP85B DRUG__ID DTP85B DTP85B DRUGTYPE Small molecular drug DTP85B DRUGINCH 1S/C28H46O5/c1-15-13-28(33-24(15,2)3)27(6,31)23-21(32-28)12-19-18-8-7-16-11-17(29)9-10-25(16,4)22(18)20(30)14-26(19,23)5/h15-23,29-31H,7-14H2,1-6H3/t15-,16-,17+,18-,19-,20-,21-,22+,23-,25-,26-,27+,28+/m0/s1 DTP85B DRUGINKE HPHXKNOXVBFETI-SHCCRYCOSA-N DTP85B DRUGSMIL CC1CC2(C(C3C(O2)CC4C3(CC(C5C4CCC6C5(CCC(C6)O)C)O)C)(C)O)OC1(C)C DTP85B HIGHSTAT Investigative DVZ6M1 DRUG__ID DVZ6M1 DVZ6M1 DRUGTYPE Small molecular drug DVZ6M1 DRUGINCH 1S/C20H23N3O3/c1-22(2)11-17-18(25-4)8-13(9-19(17)26-5)16-12-23(3)20(24)15-10-21-7-6-14(15)16/h6-10,12H,11H2,1-5H3 DVZ6M1 DRUGINKE RBUYFHLQNPJMQM-UHFFFAOYSA-N DVZ6M1 DRUGSMIL CN1C=C(C2=C(C1=O)C=NC=C2)C3=CC(=C(C(=C3)OC)CN(C)C)OC DVZ6M1 HIGHSTAT Investigative DW56QV DRUG__ID DW56QV DW56QV DRUGTYPE Small molecular drug DW56QV DRUGINCH 1S/C31H23Cl6N2O/c32-23-6-1-20(2-7-23)31(21-3-8-24(33)9-4-21)39-14-13-38(19-39)17-30(27-12-11-26(35)16-29(27)37)40-18-22-5-10-25(34)15-28(22)36/h1-16,19,30-31H,17-18H2/q+1 DW56QV DRUGINKE CTKNMSVWMRRCPW-UHFFFAOYSA-N DW56QV DRUGSMIL C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)N3C=C[N+](=C3)CC(C4=C(C=C(C=C4)Cl)Cl)OCC5=C(C=C(C=C5)Cl)Cl)Cl DW56QV HIGHSTAT Investigative DYS56C DRUG__ID DYS56C DYS56C DRUGTYPE Small molecular drug DYS56C DRUGINCH 1S/C24H15N3O3/c28-23-19-17-11-5-1-3-7-13(11)26-15-9-10-16(30-15)27-14-8-4-2-6-12(14)18(22(27)21(17)26)20(19)24(29)25-23/h1-8,15-16H,9-10H2,(H,25,28,29)/t15-,16+ DYS56C DRUGINKE OTPNDVKVEAIXTI-IYBDPMFKSA-N DYS56C DRUGSMIL C1CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C1O2)C7=C53)C(=O)NC6=O DYS56C HIGHSTAT Investigative D00BCO DRUG__ID D00BCO D00BCO DRUGINCH 1S/C71H98N20O19S3/c1-9-34(4)56(81-37(7)93)66(106)87-50-31-113-112-30-49(65(105)90-57(36(6)92)68(108)109)86-60(100)44(18-14-22-76-70(73)74)82-62(102)47(24-39-27-75-32-79-39)83-58(98)35(5)80-53(95)28-78-59(99)46(23-38-26-77-43-17-12-10-15-40(38)43)84-63(103)48(25-54(96)97)85-61(101)45(20-21-52(72)94)88-69(110)71(8,42-29-111-51-19-13-11-16-41(42)51)91-67(107)55(33(2)3)89-64(50)104/h10-13,15-17,19,26-27,29,32-36,44-50,55-57,77,92H,9,14,18,20-25,28,30-31H2,1-8H3,(H2,72,94)(H,75,79)(H,78,99)(H,80,95)(H,81,93)(H,82,102)(H,83,98)(H,84,103)(H,85,101)(H,86,100)(H,87,106)(H,88,110)(H,89,104)(H,90,105)(H,91,107)(H,96,97)(H,108,109)(H4,73,74,76)/t34-,35-,36+,44-,45-,46-,47+,48+,49-,50-,55-,56-,57-,71-/m0/s1 D00BCO DRUGINKE JSPKWLRQUPIDRS-NWJDZPOUSA-N D00BCO DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)(C)C2=CSC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D00BCO HIGHSTAT Investigative D00BIE DRUG__ID D00BIE D00BIE DRUGINCH 1S/C66H107N23O15/c1-37(55(95)84-46(25-16-30-76-65(71)72)59(99)83-43(54(70)94)22-10-13-27-67)80-58(98)44-24-12-15-29-75-50(91)34-49(62(102)81-38(2)56(96)85-47(26-17-31-77-66(73)74)61(101)87-45(60(100)86-44)23-11-14-28-68)88-64(104)53(39(3)90)89-63(103)48(33-41-20-8-5-9-21-41)82-52(93)36-78-51(92)35-79-57(97)42(69)32-40-18-6-4-7-19-40/h4-9,18-21,37-39,42-49,53,90H,10-17,22-36,67-69H2,1-3H3,(H2,70,94)(H,75,91)(H,78,92)(H,79,97)(H,80,98)(H,81,102)(H,82,93)(H,83,99)(H,84,95)(H,85,96)(H,86,100)(H,87,101)(H,88,104)(H,89,103)(H4,71,72,76)(H4,73,74,77)/t37-,38-,39+,42-,43-,44-,45-,46-,47-,48-,49-,53-/m0/s1 D00BIE DRUGINKE QRTPPIOAYQKBJN-WYNMOEERSA-N D00BIE DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(CCCCNC(=O)CC(C(=O)N1)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)CCCCN)CCCN=C(N)N D00BIE HIGHSTAT Investigative D00CYF DRUG__ID D00CYF D00CYF DRUGINCH 1S/C79H105N23O18S2/c1-7-39(4)65(91-41(6)104)78(120)100-60-36-122-121-35-59(76(118)102-66(40(5)103)67(81)109)99-69(111)52(21-14-24-85-79(82)83)93-73(115)57(28-45-33-84-37-90-45)96-71(113)55(26-43-31-87-50-19-12-9-16-47(43)50)92-62(106)34-89-68(110)54(25-42-30-86-49-18-11-8-15-46(42)49)95-74(116)58(29-63(107)108)97-70(112)53(22-23-61(80)105)94-72(114)56(98-77(119)64(38(2)3)101-75(60)117)27-44-32-88-51-20-13-10-17-48(44)51/h8-13,15-20,30-33,37-40,52-60,64-66,86-88,103H,7,14,21-29,34-36H2,1-6H3,(H2,80,105)(H2,81,109)(H,84,90)(H,89,110)(H,91,104)(H,92,106)(H,93,115)(H,94,114)(H,95,116)(H,96,113)(H,97,112)(H,98,119)(H,99,111)(H,100,120)(H,101,117)(H,102,118)(H,107,108)(H4,82,83,85)/t39-,40+,52-,53-,54-,55-,56+,57+,58+,59-,60-,64-,65-,66-/m0/s1 D00CYF DRUGINKE FLYCCQRIADFTOH-RHIYSSTNSA-N D00CYF DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CNC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)CC6=CNC7=CC=CC=C76)CC8=CN=CN8)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D00CYF HIGHSTAT Investigative D00DDR DRUG__ID D00DDR D00DDR THERCLAS Antisense D00DDR DRUGTYPE Combination drug (Antisense drug) D00DDR DRUGSMIL failed D00DDR HIGHSTAT Investigative D00EEU DRUG__ID D00EEU D00EEU DRUGINCH 1S/C59H92N16O12S/c1-35(2)30-42(52(81)69-40(49(62)78)24-29-88-4)68-48(77)33-66-51(80)43(31-37-16-7-5-8-17-37)71-53(82)44(32-38-18-9-6-10-19-38)72-54(83)45(34-76)73-50(79)36(3)67-55(84)46-22-15-28-75(46)58(87)41(21-11-12-25-60)70-56(85)47-23-14-27-74(47)57(86)39(61)20-13-26-65-59(63)64/h5-10,16-19,35-36,39-47,76H,11-15,20-34,60-61H2,1-4H3,(H2,62,78)(H,66,80)(H,67,84)(H,68,77)(H,69,81)(H,70,85)(H,71,82)(H,72,83)(H,73,79)(H4,63,64,65)/t36-,39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1 D00EEU DRUGINKE HMZBUUAKDIVOFX-KWWDQKRUSA-N D00EEU DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(C)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D00EEU HIGHSTAT Investigative D00FAE DRUG__ID D00FAE D00FAE DRUGINCH 1S/C49H69N15O12S/c50-30(10-5-15-55-48(51)52)41(70)58-31(11-6-16-56-49(53)54)45(74)62-17-7-13-35(62)47(76)63-22-29(66)20-36(63)43(72)57-21-38(67)61-40(28-18-26-8-1-2-9-27(26)19-28)44(73)59-32(24-65)42(71)60-33-25-77-37-14-4-3-12-34(37)64(46(33)75)23-39(68)69/h1-4,8-9,12,14,28-33,35-36,40,65-66H,5-7,10-11,13,15-25,50H2,(H,57,72)(H,58,70)(H,59,73)(H,60,71)(H,61,67)(H,68,69)(H4,51,52,55)(H4,53,54,56)/t29?,30?,31-,32+,33-,35+,36+,40?/m1/s1 D00FAE DRUGINKE BBKUNIDRTSPPPW-XBNUIVHSSA-N D00FAE DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(C3CC4=CC=CC=C4C3)C(=O)NC(CO)C(=O)NC5CSC6=CC=CC=C6N(C5=O)CC(=O)O)O D00FAE HIGHSTAT Investigative D00FHV DRUG__ID D00FHV D00FHV DRUGINCH 1S/C57H80N12O9/c1-35(2)23-44(53(74)66-43(52(58)73)26-38-17-10-6-11-18-38)63-51(72)30-49(70)42(25-37-15-8-5-9-16-37)65-55(76)46(28-40-31-59-33-61-40)67-54(75)45(27-39-19-12-7-13-20-39)68-56(77)48-21-14-22-69(48)57(78)47(29-41-32-60-34-62-41)64-50(71)24-36(3)4/h6-7,10-13,17-20,31-37,42-49,70H,5,8-9,14-16,21-30H2,1-4H3,(H2,58,73)(H,59,61)(H,60,62)(H,63,72)(H,64,71)(H,65,76)(H,66,74)(H,67,75)(H,68,77) D00FHV DRUGINKE ZOAVSRHEYNKAIW-UHFFFAOYSA-N D00FHV DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)CC(C(CC2CCCCC2)NC(=O)C(CC3=CN=CN3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CCCN5C(=O)C(CC6=CN=CN6)NC(=O)CC(C)C)O D00FHV HIGHSTAT Investigative D00HVZ DRUG__ID D00HVZ D00HVZ DRUGINCH 1S/C17H16O4/c1-19-12-5-3-11(4-6-12)16-10-15(18)14-8-7-13(20-2)9-17(14)21-16/h3-9,16H,10H2,1-2H3 D00HVZ DRUGINKE YAEYGSBLDUIDTP-UHFFFAOYSA-N D00HVZ DRUGSMIL COC1=CC=C(C=C1)C2CC(=O)C3=C(O2)C=C(C=C3)OC D00HVZ HIGHSTAT Investigative D00HYL DRUG__ID D00HYL D00HYL DRUGINCH 1S/C80H132N28O21/c1-42(2)34-55(74(125)97-44(4)67(118)104-57(37-60(85)112)75(126)99-50(65(86)116)28-29-59(84)111)105-72(123)51(24-14-16-30-81)102-71(122)54(27-19-33-92-80(89)90)101-68(119)45(5)108(7)78(129)58(41-109)106-73(124)52(25-15-17-31-82)103-70(121)53(26-18-32-91-79(87)88)100-66(117)43(3)96-62(114)40-95-77(128)64(46(6)110)107-76(127)56(36-48-22-12-9-13-23-48)98-63(115)39-93-61(113)38-94-69(120)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,109-110H,14-19,24-41,81-83H2,1-7H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,120)(H,95,128)(H,96,114)(H,97,125)(H,98,115)(H,99,126)(H,100,117)(H,101,119)(H,102,122)(H,103,121)(H,104,118)(H,105,123)(H,106,124)(H,107,127)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D00HYL DRUGINKE JRFVGOSSKZWBRX-FKPOJLNCSA-N D00HYL DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)N(C)C(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D00HYL HIGHSTAT Investigative D00JEO DRUG__ID D00JEO D00JEO DRUGINCH 1S/C145H242N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99(63-239)181-142(235)114(74(16)197)187-135(228)98(61-193)180-129(222)90(49-69(9)10)172-131(224)92(52-104(151)202)174-134(227)96(59-191)178-117(210)79(148)62-238)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199,238-239H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157)/t71-,72-,73-,74-,75-,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100-,101-,110+,111+,112+,113+,114+,115+/m1/s1 D00JEO DRUGINKE AZCMZZXDDMAXIT-KOYPLZMPSA-N D00JEO DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N3CCCC3C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N D00JEO HIGHSTAT Investigative D00JKB DRUG__ID D00JKB D00JKB DRUGINCH 1S/C14H20N2O2/c1-9-7-10-8-11(15)5-6-12(10)16(9)13(17)18-14(2,3)4/h5-6,8-9H,7,15H2,1-4H3 D00JKB DRUGINKE YOELJPDARJMOOO-UHFFFAOYSA-N D00JKB DRUGSMIL CC1CC2=C(N1C(=O)OC(C)(C)C)C=CC(=C2)N D00JKB HIGHSTAT Investigative D00JYL DRUG__ID D00JYL D00JYL DRUGINCH 1S/C79H100ClN15O14S/c1-45(2)83-35-12-11-18-61(79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)88-77(108)78(110-46(3)4)94-74(105)65(40-53-25-32-60(33-26-53)86-49(7)98)90-72(103)64(39-52-23-30-59(31-24-52)85-48(6)97)92-75(106)67(44-96)93-73(104)66(42-55-15-13-34-82-43-55)91-71(102)63(38-51-21-28-58(80)29-22-51)89-70(101)62(87-50(8)99)41-54-20-27-56-16-9-10-17-57(56)37-54/h9-10,13,15-17,20-34,37,43,45-47,61-68,78,83,96H,11-12,14,18-19,35-36,38-42,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,108)(H,89,101)(H,90,103)(H,91,102)(H,92,106)(H,93,104)(H,94,105)/t47-,61+,62-,63-,64+,65-,66-,67+,68+,78-/m1/s1 D00JYL DRUGINKE GFSHJVRBLLVKAZ-UQWNDQPVSA-N D00JYL DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)SC(C)C D00JYL HIGHSTAT Investigative D00LVW DRUG__ID D00LVW D00LVW DRUGINCH 1S/C53H82N14O8/c1-3-31(2)43(49(74)62-38(44(55)69)13-7-8-20-54)67-46(71)39(14-9-21-60-51(56)57)63-47(72)42(27-33-16-18-37(68)19-17-33)65-48(73)41(26-32-11-5-4-6-12-32)64-45(70)40(15-10-22-61-52(58)59)66-50(75)53-28-34-23-35(29-53)25-36(24-34)30-53/h4-6,11-12,16-19,31,34-36,38-43,68H,3,7-10,13-15,20-30,54H2,1-2H3,(H2,55,69)(H,62,74)(H,63,72)(H,64,70)(H,65,73)(H,66,75)(H,67,71)(H4,56,57,60)(H4,58,59,61)/t31-,34?,35?,36?,38-,39-,40-,41-,42-,43-,53?/m0/s1 D00LVW DRUGINKE CHQPBFJDZBBZJD-OGHQQVQQSA-N D00LVW DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCCN=C(N)N)NC(=O)C34CC5CC(C3)CC(C5)C4 D00LVW HIGHSTAT Investigative D00LWG DRUG__ID D00LWG D00LWG DRUGINCH 1S/C51H70F3N15O10/c1-6-28(4)41(66-43(73)35(21-30-13-17-33(70)18-14-30)62-45(75)40(27(2)3)65-42(72)34(61-39(71)25-57-5)9-7-19-59-49(55)56)46(76)63-36(23-32-24-58-26-60-32)47(77)69-20-8-10-38(69)44(74)64-37(48(78)79)22-29-11-15-31(16-12-29)50(67-68-50)51(52,53)54/h11-18,24,26-28,34-38,40-41,57,70H,6-10,19-23,25H2,1-5H3,(H,58,60)(H,61,71)(H,62,75)(H,63,76)(H,64,74)(H,65,72)(H,66,73)(H,78,79)(H4,55,56,59)/t28-,34-,35-,36-,37-,38-,40-,41-/m0/s1 D00LWG DRUGINKE KSJIPXWEUUGTIY-LNEAKYCGSA-N D00LWG DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=C(C=C3)C4(N=N4)C(F)(F)F)C(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D00LWG HIGHSTAT Investigative D00MIG DRUG__ID D00MIG D00MIG DRUGINCH 1S/C17H20N2O4/c1-17(2)16(22)15(19-11(9-20)4-6-14(19)21)12-7-10(8-18)3-5-13(12)23-17/h3,5,7,11,15-16,20,22H,4,6,9H2,1-2H3/t11-,15+,16-/m0/s1 D00MIG DRUGINKE PBEGNZBJXJTFMB-XZJROXQQSA-N D00MIG DRUGSMIL CC1(C(C(C2=C(O1)C=CC(=C2)C#N)N3C(CCC3=O)CO)O)C D00MIG HIGHSTAT Investigative D00OCS DRUG__ID D00OCS D00OCS DRUGINCH 1S/C46H84N24O9/c47-17-5-1-2-6-18-57-37(74)26(12-8-20-59-43(49)50)67-39(76)28(14-10-22-61-45(53)54)69-40(77)29(15-11-23-62-46(55)56)68-38(75)27(13-9-21-60-44(51)52)66-30(71)16-4-3-7-19-58-41(78)34-32(72)33(73)42(79-34)70-25-65-31-35(48)63-24-64-36(31)70/h24-29,32-34,42,72-73H,1-23,47H2,(H,57,74)(H,58,78)(H,66,71)(H,67,76)(H,68,75)(H,69,77)(H2,48,63,64)(H4,49,50,59)(H4,51,52,60)(H4,53,54,61)(H4,55,56,62)/t26-,27-,28-,29-,32-,33+,34-,42+/m0/s1 D00OCS DRUGINKE AKYVNHGFJFUSDY-HYKQOWLKSA-N D00OCS DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NCCCCCCN)O)O)N D00OCS HIGHSTAT Investigative D00OLA DRUG__ID D00OLA D00OLA DRUGINCH 1S/C111H159N37O18/c1-4-19-77(136-96(157)80(28-13-46-126-106(114)115)135-92(153)73(112)55-64-58-132-74-25-10-7-22-70(64)74)94(155)140-84(32-17-50-130-110(122)123)100(161)145-87(53-62-36-42-68(150)43-37-62)102(163)148-90(57-66-60-134-76-27-12-9-24-72(66)76)105(166)143-82(30-15-48-128-108(118)119)98(159)138-79(21-6-3)95(156)141-85(33-18-51-131-111(124)125)101(162)146-88(54-63-38-44-69(151)45-39-63)103(164)147-89(56-65-59-133-75-26-11-8-23-71(65)75)104(165)142-81(29-14-47-127-107(116)117)97(158)137-78(20-5-2)93(154)139-83(31-16-49-129-109(120)121)99(160)144-86(91(113)152)52-61-34-40-67(149)41-35-61/h7-12,22-27,34-45,58-60,73,77-90,132-134,149-151H,4-6,13-21,28-33,46-57,112H2,1-3H3,(H2,113,152)(H,135,153)(H,136,157)(H,137,158)(H,138,159)(H,139,154)(H,140,155)(H,141,156)(H,142,165)(H,143,166)(H,144,160)(H,145,161)(H,146,162)(H,147,164)(H,148,163)(H4,114,115,126)(H4,116,117,127)(H4,118,119,128)(H4,120,121,129)(H4,122,123,130)(H4,124,125,131)/t73-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-/m0/s1 D00OLA DRUGINKE DRBRBJSYRQHXHE-TWUBVJIJSA-N D00OLA DRUGSMIL CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC8=CNC9=CC=CC=C98)N D00OLA HIGHSTAT Investigative D00OSB DRUG__ID D00OSB D00OSB DRUGINCH 1S/C70H101N19O18S2/c1-36(73)59(96)77-32-55(94)79-53-35-109-108-34-52(58(75)95)87-67(104)51(33-90)86-70(107)57(39(4)92)89-66(103)48(28-41-19-9-6-10-20-41)85-69(106)56(38(3)91)88-62(99)46(24-14-16-26-72)80-64(101)49(29-42-31-76-44-22-12-11-21-43(42)44)82-60(97)37(2)78-63(100)47(27-40-17-7-5-8-18-40)83-65(102)50(30-54(74)93)84-61(98)45(81-68(53)105)23-13-15-25-71/h5-12,17-22,31,36-39,45-53,56-57,76,90-92H,13-16,23-30,32-35,71-73H2,1-4H3,(H2,74,93)(H2,75,95)(H,77,96)(H,78,100)(H,79,94)(H,80,101)(H,81,105)(H,82,97)(H,83,102)(H,84,98)(H,85,106)(H,86,107)(H,87,104)(H,88,99)(H,89,103)/t36-,37+,38?,39?,45-,46+,47-,48-,49-,50+,51-,52-,53-,56+,57+/m0/s1 D00OSB DRUGINKE IMPCJRRYNLCKNP-IORPGQRLSA-N D00OSB DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)N)CO)C(C)O)CC3=CC=CC=C3)C(C)O)CCCCN)CC4=CNC5=CC=CC=C54 D00OSB HIGHSTAT Investigative D00RGL DRUG__ID D00RGL D00RGL DRUGINCH 1S/C62H63N9O12/c63-55(74)33-52(70-58(77)49(28-37-13-5-2-6-14-37)67-56(75)48(27-36-11-3-1-4-12-36)66-53(61(80)81)31-40-34-64-46-17-9-7-15-44(40)46)60(79)69-50(29-38-19-23-42(72)24-20-38)57(76)68-51(30-39-21-25-43(73)26-22-39)59(78)71-54(62(82)83)32-41-35-65-47-18-10-8-16-45(41)47/h1-26,34-35,48-54,64-66,72-73H,27-33H2,(H2,63,74)(H,67,75)(H,68,76)(H,69,79)(H,70,77)(H,71,78)(H,80,81)(H,82,83)/t48-,49-,50-,51-,52-,53+,54-/m0/s1 D00RGL DRUGINKE NXCOTRHNIBGFLM-ZYWWURNJSA-N D00RGL DRUGSMIL C1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(=O)N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)O)NC(CC7=CNC8=CC=CC=C87)C(=O)O D00RGL HIGHSTAT Investigative D00RWP DRUG__ID D00RWP D00RWP DRUGINCH 1S/C139H211N43O42/c1-65(2)38-84(166-122(208)86(40-67(5)6)167-124(210)88(43-75-31-33-79(189)34-32-75)162-106(194)55-152-115(201)70(11)158-132(218)98(60-184)177-128(214)95(49-104(144)192)171-123(209)87(41-68(7)8)174-137(223)112(72(13)187)181-131(217)90(160-105(193)51-141)44-76-52-151-81-27-19-18-26-80(76)81)117(203)155-58-109(197)182-37-23-30-101(182)135(221)173-91(45-77-53-148-63-156-77)121(207)159-71(12)116(202)179-111(69(9)10)136(222)154-57-108(196)163-94(48-103(143)191)127(213)169-92(46-78-54-149-64-157-78)126(212)165-83(29-22-36-150-139(146)147)120(206)176-99(61-185)133(219)168-89(42-74-24-16-15-17-25-74)125(211)178-100(62-186)134(220)172-96(50-110(198)199)129(215)164-82(28-20-21-35-140)119(205)170-93(47-102(142)190)118(204)153-56-107(195)161-85(39-66(3)4)130(216)180-113(73(14)188)138(224)175-97(59-183)114(145)200/h15-19,24-27,31-34,52-54,63-73,82-101,111-113,151,183-189H,20-23,28-30,35-51,55-62,140-141H2,1-14H3,(H2,142,190)(H2,143,191)(H2,144,192)(H2,145,200)(H,148,156)(H,149,157)(H,152,201)(H,153,204)(H,154,222)(H,155,203)(H,158,218)(H,159,207)(H,160,193)(H,161,195)(H,162,194)(H,163,196)(H,164,215)(H,165,212)(H,166,208)(H,167,210)(H,168,219)(H,169,213)(H,170,205)(H,171,209)(H,172,220)(H,173,221)(H,174,223)(H,175,224)(H,176,206)(H,177,214)(H,178,211)(H,179,202)(H,180,216)(H,181,217)(H,198,199)(H4,146,147,150)/t70-,71-,72+,73+,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,111-,112-,113-/m0/s1 D00RWP DRUGINKE VYHIHGYPAVCHDV-RUKUCZSXSA-N D00RWP DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)N)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN D00RWP HIGHSTAT Investigative D00SBX DRUG__ID D00SBX D00SBX DRUGINCH 1S/C14H11Cl2NO4/c15-8-3-7(13(19)11(16)4-8)6-17-9-1-2-10(14(20)21)12(18)5-9/h1-5,17-19H,6H2,(H,20,21) D00SBX DRUGINKE RTEYSQSXRFVKTJ-UHFFFAOYSA-N D00SBX DRUGSMIL C1=CC(=C(C=C1NCC2=C(C(=CC(=C2)Cl)Cl)O)O)C(=O)O D00SBX HIGHSTAT Investigative D00SOE DRUG__ID D00SOE D00SOE DRUGINCH 1S/C66H108N16O26/c1-7-34(6)53(65(106)74-40(19-21-50(91)92)58(99)78-45(29-84)62(103)76-43(26-51(93)94)61(102)81-52(33(4)5)66(107)108)82-64(105)47(31-86)80-63(104)46(30-85)79-59(100)41(24-32(2)3)75-56(97)38(13-9-11-23-68)72-57(98)39(18-20-49(89)90)73-60(101)42(25-35-14-16-36(87)17-15-35)71-48(88)27-70-55(96)44(28-83)77-54(95)37(69)12-8-10-22-67/h14-17,32-34,37-47,52-53,83-87H,7-13,18-31,67-69H2,1-6H3,(H,70,96)(H,71,88)(H,72,98)(H,73,101)(H,74,106)(H,75,97)(H,76,103)(H,77,95)(H,78,99)(H,79,100)(H,80,104)(H,81,102)(H,82,105)(H,89,90)(H,91,92)(H,93,94)(H,107,108)/t34-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,52-,53-/m0/s1 D00SOE DRUGINKE OYOJPGJCPOXGEB-QBAAMSOUSA-N D00SOE DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCCN)N D00SOE HIGHSTAT Investigative D00TSY DRUG__ID D00TSY D00TSY DRUGINCH 1S/C79H104ClN19O18/c1-42(2)33-56(68(105)89-55(15-10-11-31-83-43(3)4)76(113)99-32-12-16-64(99)75(112)85-44(5)66(81)103)90-70(107)58(36-48-22-29-54(30-23-48)88-77(82)114)92-71(108)59(37-47-20-27-53(28-21-47)87-67(104)61-39-65(102)97-79(116)96-61)93-74(111)63(41-100)95-73(110)62(40-84-78(115)98-117-7)94-72(109)60(35-46-18-25-52(80)26-19-46)91-69(106)57(86-45(6)101)38-49-17-24-50-13-8-9-14-51(50)34-49/h8-9,13-14,17-30,34,42-44,55-64,83,100H,10-12,15-16,31-33,35-41H2,1-7H3,(H2,81,103)(H,85,112)(H,86,101)(H,87,104)(H,89,105)(H,90,107)(H,91,106)(H,92,108)(H,93,111)(H,94,109)(H,95,110)(H3,82,88,114)(H2,84,98,115)(H2,96,97,102,116)/t44-,55+,56+,57-,58-,59+,60-,61+,62-,63+,64+/m1/s1 D00TSY DRUGINKE AJPARKCOZVUOMV-NOXGGNAKSA-N D00TSY DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CNC(=O)NOC)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D00TSY HIGHSTAT Investigative D00TVY DRUG__ID D00TVY D00TVY DRUGINCH 1S/C67H97F2N12O23P/c1-7-35(5)54(63(97)76-46(33-38-15-19-40(82)20-16-38)60(94)77-47(66(100)101)31-34(3)4)78-62(96)49-12-10-30-81(49)65(99)55(36(6)8-2)79-58(92)44(24-28-53(88)89)72-56(90)43(23-27-52(86)87)73-59(93)45(32-37-13-17-39(18-14-37)67(68,69)105(102,103)104)75-57(91)42(22-25-50(71)83)74-61(95)48-11-9-29-80(48)64(98)41(70)21-26-51(84)85/h13-20,34-36,41-49,54-55,82H,7-12,21-33,70H2,1-6H3,(H2,71,83)(H,72,90)(H,73,93)(H,74,95)(H,75,91)(H,76,97)(H,77,94)(H,78,96)(H,79,92)(H,84,85)(H,86,87)(H,88,89)(H,100,101)(H2,102,103,104)/t35-,36-,41-,42-,43-,44-,45-,46-,47-,48-,49-,54-,55-/m0/s1 D00TVY DRUGINKE FOSUHZNVGWOSJD-VBIHGRSYSA-N D00TVY DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C2CCCN2C(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=C(C=C3)C(F)(F)P(=O)(O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCC(=O)O)N D00TVY HIGHSTAT Investigative D00UCX DRUG__ID D00UCX D00UCX DRUGINCH 1S/C149H225N39O46/c1-17-76(10)119(145(230)179-101(57-83-31-20-18-21-32-83)133(218)166-80(14)125(210)174-104(60-86-63-158-91-36-25-24-35-89(86)91)136(221)176-100(56-73(4)5)137(222)185-117(74(6)7)143(228)173-92(37-26-28-52-150)127(212)159-66-111(197)168-98(148(233)234)39-30-54-157-149(154)155)187-132(217)97(47-51-115(203)204)172-131(216)93(38-27-29-53-151)169-123(208)78(12)163-122(207)77(11)165-130(215)96(44-48-109(153)195)167-110(196)65-160-129(214)95(46-50-114(201)202)171-134(219)99(55-72(2)3)175-135(220)102(59-85-40-42-88(194)43-41-85)177-140(225)106(68-189)181-142(227)108(70-191)182-144(229)118(75(8)9)186-139(224)105(62-116(205)206)178-141(226)107(69-190)183-147(232)121(82(16)193)188-138(223)103(58-84-33-22-19-23-34-84)180-146(231)120(81(15)192)184-112(198)67-161-128(213)94(45-49-113(199)200)170-124(209)79(13)164-126(211)90(152)61-87-64-156-71-162-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,158,189-194H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,195)(H,156,162)(H,159,212)(H,160,214)(H,161,213)(H,163,207)(H,164,211)(H,165,215)(H,166,218)(H,167,196)(H,168,197)(H,169,208)(H,170,209)(H,171,219)(H,172,216)(H,173,228)(H,174,210)(H,175,220)(H,176,221)(H,177,225)(H,178,226)(H,179,230)(H,180,231)(H,181,227)(H,182,229)(H,183,232)(H,184,198)(H,185,222)(H,186,224)(H,187,217)(H,188,223)(H,199,200)(H,201,202)(H,203,204)(H,205,206)(H,233,234)(H4,154,155,157)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1 D00UCX DRUGINKE UVENJQHDPZDEHP-KTKZVXAJSA-N D00UCX DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N D00UCX HIGHSTAT Investigative D00UKA DRUG__ID D00UKA D00UKA DRUGINCH 1S/C61H84N10O18S/c1-7-10-21-42(65-57(81)47(32-37-25-27-39(28-26-37)89-90(85,86)87)68-56(80)45(29-30-50(72)73)71-60(84)88-61(4,5)6)53(77)64-43(22-11-8-2)54(78)69-48(33-38-35-63-41-24-17-16-20-40(38)41)58(82)66-44(23-12-9-3)55(79)70-49(34-51(74)75)59(83)67-46(52(62)76)31-36-18-14-13-15-19-36/h13-20,24-28,35,42-49,63H,7-12,21-23,29-34H2,1-6H3,(H2,62,76)(H,64,77)(H,65,81)(H,66,82)(H,67,83)(H,68,80)(H,69,78)(H,70,79)(H,71,84)(H,72,73)(H,74,75)(H,85,86,87)/t42-,43-,44-,45+,46-,47-,48-,49-/m0/s1 D00UKA DRUGINKE JFEDUJOXWDESON-LMZFJFGWSA-N D00UKA DRUGSMIL CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CCCC)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CCC(=O)O)NC(=O)OC(C)(C)C D00UKA HIGHSTAT Investigative D00VYC DRUG__ID D00VYC D00VYC DRUGINCH 1S/C60H79N19O13S2/c1-32(80)71-43(24-34-15-17-37(81)18-16-34)54(88)72-41(14-8-22-68-60(64)65)52(86)79-48-30-94-93-29-47(50(61)84)78-56(90)45(25-35-27-69-39-12-6-5-11-38(35)39)76-51(85)40(13-7-21-67-59(62)63)73-55(89)44(23-33-9-3-2-4-10-33)75-57(91)46(26-36-28-66-31-70-36)77-53(87)42(74-58(48)92)19-20-49(82)83/h2-6,9-12,15-18,27-28,31,40-48,69,81H,7-8,13-14,19-26,29-30H2,1H3,(H2,61,84)(H,66,70)(H,71,80)(H,72,88)(H,73,89)(H,74,92)(H,75,91)(H,76,85)(H,77,87)(H,78,90)(H,79,86)(H,82,83)(H4,62,63,67)(H4,64,65,68)/t40-,41-,42+,43-,44-,45+,46-,47+,48+/m0/s1 D00VYC DRUGINKE FEKXKTLLBDRSQH-XVRHLUALSA-N D00VYC DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D00VYC HIGHSTAT Investigative D00XIB DRUG__ID D00XIB D00XIB DRUGINCH 1S/C11H14N2O3S/c1-7(14)13-11-5-2-8-6-9(17(12,15)16)3-4-10(8)11/h3-4,6,11H,2,5H2,1H3,(H,13,14)(H2,12,15,16) D00XIB DRUGINKE RUUYVLNZHGCPRP-UHFFFAOYSA-N D00XIB DRUGSMIL CC(=O)NC1CCC2=C1C=CC(=C2)S(=O)(=O)N D00XIB HIGHSTAT Investigative D00ZBZ DRUG__ID D00ZBZ D00ZBZ THERCLAS Antisense D00ZBZ DRUGTYPE Combination drug (Antisense drug) D00ZBZ DRUGSMIL failed D00ZBZ HIGHSTAT Investigative D01APZ DRUG__ID D01APZ D01APZ DRUGINCH 1S/C61H88N20O13S3/c62-38(17-7-21-69-59(63)64)49(84)74-39(18-8-22-70-60(65)66)56(91)80-24-10-20-46(80)57(92)81-31-36(82)28-47(81)55(90)72-30-48(83)73-43(29-37-16-11-25-95-37)52(87)79-45-33-97-96-32-44(53(88)75-40(58(93)94)19-9-23-71-61(67)68)78-51(86)42(27-35-14-5-2-6-15-35)76-50(85)41(77-54(45)89)26-34-12-3-1-4-13-34/h1-6,11-16,25,36,38-47,82H,7-10,17-24,26-33,62H2,(H,72,90)(H,73,83)(H,74,84)(H,75,88)(H,76,85)(H,77,89)(H,78,86)(H,79,87)(H,93,94)(H4,63,64,69)(H4,65,66,70)(H4,67,68,71)/t36?,38-,39-,40?,41-,42?,43?,44?,45-,46-,47-/m1/s1 D01APZ DRUGINKE QRPRDXXCSGEGJN-AAAINLOGSA-N D01APZ DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC4CSSCC(NC(=O)C(NC(=O)C(NC4=O)CC5=CC=CC=C5)CC6=CC=CC=C6)C(=O)NC(CCCN=C(N)N)C(=O)O)O D01APZ HIGHSTAT Investigative D01ARY DRUG__ID D01ARY D01ARY DRUGINCH 1S/C108H158N26O41S/c1-8-56(4)89(105(171)134-41-15-20-77(134)103(169)126-64(32-37-86(150)151)95(161)123-63(31-36-85(148)149)96(162)129-70(44-58-21-25-60(139)26-22-58)100(166)128-68(42-55(2)3)98(164)127-67(106(172)173)29-34-78(109)140)131-97(163)65(33-38-87(152)153)124-94(160)62(30-35-84(146)147)125-99(165)69(43-57-16-10-9-11-17-57)130-101(167)71(45-88(154)155)118-79(141)46-113-90(156)72(51-135)119-80(142)47-114-91(157)73(52-136)120-81(143)48-115-92(158)74(53-137)121-82(144)49-116-93(159)75(54-138)122-83(145)50-117-102(168)76-19-12-13-40-133(76)104(170)66(18-14-39-112-107(110)111)132-176(174,175)61-27-23-59(24-28-61)108(5,6)7/h9-11,16-17,21-28,55-56,62-77,89,132,135-139H,8,12-15,18-20,29-54H2,1-7H3,(H2,109,140)(H,113,156)(H,114,157)(H,115,158)(H,116,159)(H,117,168)(H,118,141)(H,119,142)(H,120,143)(H,121,144)(H,122,145)(H,123,161)(H,124,160)(H,125,165)(H,126,169)(H,127,164)(H,128,166)(H,129,162)(H,130,167)(H,131,163)(H,146,147)(H,148,149)(H,150,151)(H,152,153)(H,154,155)(H,172,173)(H4,110,111,112)/t56-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76+,77-,89-/m0/s1 D01ARY DRUGINKE QVAVWYLBNALTPM-TVNHPFTQSA-N D01ARY DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D01ARY HIGHSTAT Investigative D01BGW DRUG__ID D01BGW D01BGW DRUGINCH 1S/C11H15N3O/c1-8(12)7-14-11-5-10(15-2)4-3-9(11)6-13-14/h3-6,8H,7,12H2,1-2H3/t8-/m0/s1 D01BGW DRUGINKE WSEWULCWBQDNEH-QMMMGPOBSA-N D01BGW DRUGSMIL CC(CN1C2=C(C=CC(=C2)OC)C=N1)N D01BGW HIGHSTAT Investigative D01DBW DRUG__ID D01DBW D01DBW DRUGINCH 1S/C79H100ClN15O14S/c1-45(2)83-35-12-11-18-61(79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)88-77(108)78(110-46(3)4)94-74(105)65(40-53-25-32-60(33-26-53)86-49(7)98)90-72(103)64(39-52-23-30-59(31-24-52)85-48(6)97)92-75(106)67(44-96)93-73(104)66(42-55-15-13-34-82-43-55)91-71(102)63(38-51-21-28-58(80)29-22-51)89-70(101)62(87-50(8)99)41-54-20-27-56-16-9-10-17-57(56)37-54/h9-10,13,15-17,20-34,37,43,45-47,61-68,78,83,96H,11-12,14,18-19,35-36,38-42,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,108)(H,89,101)(H,90,103)(H,91,102)(H,92,106)(H,93,104)(H,94,105)/t47-,61+,62-,63-,64+,65-,66-,67+,68+,78+/m1/s1 D01DBW DRUGINKE GFSHJVRBLLVKAZ-FYZIRFIYSA-N D01DBW DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)SC(C)C D01DBW HIGHSTAT Investigative D01DNN DRUG__ID D01DNN D01DNN DRUGINCH 1S/C53H68N8O12/c1-30(62)45(51(69)61-24-8-12-43(61)50(68)57-41(11-6-7-23-54)48(66)60-46(31(2)63)53(72)73)59-49(67)42(29-35-17-22-44(64)38(26-35)25-32-9-4-3-5-10-32)58-47(65)39(55)27-33-13-18-36(19-14-33)37-20-15-34(16-21-37)28-40(56)52(70)71/h3-5,9-10,13-22,26,30-31,39-43,45-46,62-64H,6-8,11-12,23-25,27-29,54-56H2,1-2H3,(H,57,68)(H,58,65)(H,59,67)(H,60,66)(H,70,71)(H,72,73)/t30-,31-,39+,40+,41+,42+,43+,45+,46+/m1/s1 D01DNN DRUGINKE VGTTXQUWJIRLOZ-PMDNFMOISA-N D01DNN DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC2=CC(=C(C=C2)O)CC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)C5=CC=C(C=C5)CC(C(=O)O)N)N)O D01DNN HIGHSTAT Investigative D01DQT DRUG__ID D01DQT D01DQT DRUGINCH 1S/C70H101N21O18S2/c1-8-34(4)57(69(108)109-7)91-66(105)51(31-111)89-68(107)56(33(2)3)90-64(103)47(23-38-27-78-43-17-12-10-15-41(38)43)85-60(99)45(19-20-52(71)93)84-63(102)49(25-54(95)96)87-62(101)46(22-37-26-77-42-16-11-9-14-40(37)42)82-53(94)29-79-58(97)35(5)81-61(100)48(24-39-28-75-32-80-39)86-59(98)44(18-13-21-76-70(73)74)83-65(104)50(30-110)88-67(106)55(72)36(6)92/h9-12,14-17,26-28,32-36,44-51,55-57,77-78,92,110-111H,8,13,18-25,29-31,72H2,1-7H3,(H2,71,93)(H,75,80)(H,79,97)(H,81,100)(H,82,94)(H,83,104)(H,84,102)(H,85,99)(H,86,98)(H,87,101)(H,88,106)(H,89,107)(H,90,103)(H,91,105)(H,95,96)(H4,73,74,76)/t34?,35-,36+,44-,45-,46-,47-,48-,49-,50-,51-,55-,56-,57-/m0/s1 D01DQT DRUGINKE UQCBIVMMKZHRCG-CREZQNEJSA-N D01DQT DRUGSMIL CCC(C)C(C(=O)OC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CNC(=O)C(C)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCCN=C(N)N)NC(=O)C(CS)NC(=O)C(C(C)O)N D01DQT HIGHSTAT Investigative D01EDA DRUG__ID D01EDA D01EDA DRUGINCH 1S/C46H71N11O12S2/c1-6-26(5)39-45(67)52-29(15-16-35(47)58)41(63)53-32(22-36(48)59)42(64)55-33(24-71-70-19-17-38(61)51-31(43(65)56-39)21-27-11-13-28(14-12-27)69-7-2)46(68)57-18-9-8-10-34(57)44(66)54-30(20-25(3)4)40(62)50-23-37(49)60/h11-14,25-26,29-34,39H,6-10,15-24H2,1-5H3,(H2,47,58)(H2,48,59)(H2,49,60)(H,50,62)(H,51,61)(H,52,67)(H,53,63)(H,54,66)(H,55,64)(H,56,65)/t26-,29-,30-,31-,32-,33-,34-,39-/m0/s1 D01EDA DRUGINKE NMLWRIDSUBGNGP-IHJZLXGESA-N D01EDA DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D01EDA HIGHSTAT Investigative D01EQU DRUG__ID D01EQU D01EQU DRUGINCH 1S/C62H104O30S/c1-23(2)12-11-17-62(10,76)36-14-13-31-30-21-35(33-20-29(92-93(77,78)79)15-18-60(33,8)32(30)16-19-61(31,36)9)86-57-48(75)51(39(66)26(5)83-57)89-59-53(91-56-45(72)42(69)38(65)25(4)82-56)47(74)50(28(7)85-59)88-58-52(90-55-44(71)41(68)37(64)24(3)81-55)46(73)49(27(6)84-58)87-54-43(70)40(67)34(63)22-80-54/h16,23-31,33-59,63-76H,11-15,17-22H2,1-10H3,(H,77,78,79)/t24-,25-,26-,27-,28-,29+,30+,31+,33-,34+,35+,36+,37+,38-,39-,40+,41+,42+,43-,44-,45-,46+,47+,48-,49-,50-,51+,52-,53-,54+,55+,56+,57+,58+,59+,60-,61+,62-/m1/s1 D01EQU DRUGINKE RRDLUYKZNPWVNX-HVARHZHCSA-N D01EQU DRUGSMIL CC1C(C(C(C(O1)OC2C(C(C(OC2OC3C(OC(C(C3O)OC4C(C(C(C(O4)C)O)O)O)OC5C(C(OC(C5O)OC6CC7C8CCC(C8(CC=C7C9(C6CC(CC9)OS(=O)(=O)O)C)C)C(C)(CCCC(C)C)O)C)O)C)C)OC1C(C(C(CO1)O)O)O)O)O)O)O D01EQU HIGHSTAT Investigative D01ESN DRUG__ID D01ESN D01ESN DRUGINCH 1S/C64H71N9O10/c65-49(35-45-25-29-47(74)30-26-45)63(82)72-33-13-23-55(72)61(80)70-53(39-44-21-11-4-12-22-44)59(78)68-51(37-42-17-7-2-8-18-42)60(79)71-54(40-46-27-31-48(75)32-28-46)64(83)73-34-14-24-56(73)62(81)69-52(38-43-19-9-3-10-20-43)58(77)67-50(57(66)76)36-41-15-5-1-6-16-41/h1-12,15-22,25-32,49-56,74-75H,13-14,23-24,33-40,65H2,(H2,66,76)(H,67,77)(H,68,78)(H,69,81)(H,70,80)(H,71,79)/t49-,50-,51-,52-,53-,54-,55-,56-/m0/s1 D01ESN DRUGINKE DEEQOLBYTQLJHH-MENCHSDRSA-N D01ESN DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N6CCCC6C(=O)NC(CC7=CC=CC=C7)C(=O)NC(CC8=CC=CC=C8)C(=O)N D01ESN HIGHSTAT Investigative D01FDW DRUG__ID D01FDW D01FDW DRUGINCH 1S/C46H65N15O12S2/c47-27-22-74-75-23-33(45(73)61-17-5-9-34(61)44(72)56-28(8-4-16-53-46(51)52)39(67)54-21-37(50)65)60-43(71)32(20-36(49)64)59-40(68)29(14-15-35(48)63)55-41(69)31(18-24-6-2-1-3-7-24)58-42(70)30(57-38(27)66)19-25-10-12-26(62)13-11-25/h1-3,6-7,10-13,27-34,62H,4-5,8-9,14-23,47H2,(H2,48,63)(H2,49,64)(H2,50,65)(H,54,67)(H,55,69)(H,56,72)(H,57,66)(H,58,70)(H,59,68)(H,60,71)(H4,51,52,53)/t27-,28+,29-,30-,31+,32+,33+,34-/m1/s1 D01FDW DRUGINKE KBZOIRJILGZLEJ-BOXDWKHASA-N D01FDW DRUGSMIL C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D01FDW HIGHSTAT Investigative D01FHK DRUG__ID D01FHK D01FHK DRUGINCH 1S/C52H69N9O15S/c1-6-8-18-37(57-48(68)40(61-51(71)75-52(3,4)5)26-32-21-23-34(24-22-32)76-77(72,73)74)46(66)55-30-43(62)56-41(27-33-29-54-36-20-14-13-17-35(33)36)49(69)58-38(19-9-7-2)47(67)60-42(28-44(63)64)50(70)59-39(45(53)65)25-31-15-11-10-12-16-31/h10-17,20-24,29,37-42,54H,6-9,18-19,25-28,30H2,1-5H3,(H2,53,65)(H,55,66)(H,56,62)(H,57,68)(H,58,69)(H,59,70)(H,60,67)(H,61,71)(H,63,64)(H,72,73,74)/t37-,38-,39-,40-,41-,42-/m0/s1 D01FHK DRUGINKE CSXIDZJPJYRGSK-UJKKYYSESA-N D01FHK DRUGSMIL CCCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)OC(C)(C)C D01FHK HIGHSTAT Investigative D01FJQ DRUG__ID D01FJQ D01FJQ DRUGINCH 1S/C63H75N13O11/c1-38(2)54(61(84)74-52(63(86)87)31-42-22-24-45(77)25-23-42)75-59(82)49(30-41-18-10-5-11-19-41)70-56(79)47(28-39-14-6-3-7-15-39)69-58(81)50(32-43-34-64-36-67-43)71-57(80)48(29-40-16-8-4-9-17-40)72-60(83)53-21-13-27-76(53)62(85)51(33-44-35-65-37-68-44)73-55(78)46-20-12-26-66-46/h3-11,14-19,22-25,34-38,46-54,66,77H,12-13,20-21,26-33H2,1-2H3,(H,64,67)(H,65,68)(H,69,81)(H,70,79)(H,71,80)(H,72,83)(H,73,78)(H,74,84)(H,75,82)(H,86,87)/t46-,47+,48+,49+,50+,51+,52+,53-,54+/m1/s1 D01FJQ DRUGINKE LZANPSMBIHLZRC-UNOFDIFTSA-N D01FJQ DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CN=CN4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCCN6C(=O)C(CC7=CN=CN7)NC(=O)C8CCCN8 D01FJQ HIGHSTAT Investigative D01GYS DRUG__ID D01GYS D01GYS DRUGINCH 1S/C58H92N18O13S2/c1-5-33(4)47-55(87)71-38(16-11-23-65-57(61)62)49(81)74-44(54(86)72-40(56(88)89)15-9-10-22-59)31-91-90-30-43(53(85)70-39(50(82)76-47)17-12-24-66-58(63)64)75-51(83)41(25-32(2)3)73-52(84)42(27-34-13-7-6-8-14-34)69-46(79)29-67-45(78)28-68-48(80)37(60)26-35-18-20-36(77)21-19-35/h6-8,13-14,18-21,32-33,37-44,47,77H,5,9-12,15-17,22-31,59-60H2,1-4H3,(H,67,78)(H,68,80)(H,69,79)(H,70,85)(H,71,87)(H,72,86)(H,73,84)(H,74,81)(H,75,83)(H,76,82)(H,88,89)(H4,61,62,65)(H4,63,64,66)/t33-,37-,38-,39-,40-,41-,42-,43-,44-,47+/m0/s1 D01GYS DRUGINKE JYEKWXODJFQZIP-HSIOXNDMSA-N D01GYS DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N)C(=O)NC(CCCCN)C(=O)O)CCCN=C(N)N D01GYS HIGHSTAT Investigative D01HZE DRUG__ID D01HZE D01HZE DRUGINCH 1S/C22H26ClN3O2/c1-28-21-12-20(24)19(23)11-18(21)22(27)25-15-9-16-7-8-17(10-15)26(16)13-14-5-3-2-4-6-14/h2-6,11-12,15-17H,7-10,13,24H2,1H3,(H,25,27) D01HZE DRUGINKE BQHYHGXYIOWFJL-UHFFFAOYSA-N D01HZE DRUGSMIL COC1=CC(=C(C=C1C(=O)NC2CC3CCC(C2)N3CC4=CC=CC=C4)Cl)N D01HZE HIGHSTAT Investigative D01IAT DRUG__ID D01IAT D01IAT DRUGINCH 1S/C16H12O2/c17-15-3-1-2-12(9-15)13-5-4-11-6-7-16(18)10-14(11)8-13/h1-10,17-18H D01IAT DRUGINKE VEQWNMMVQWDERW-UHFFFAOYSA-N D01IAT DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)C=CC(=C3)O D01IAT HIGHSTAT Investigative D01IZN DRUG__ID D01IZN D01IZN DRUGINCH 1S/C49H69N13O10S2/c1-28(64)56-40-47(72)61-35(24-30-18-19-31-14-7-8-15-32(31)22-30)42(67)55-25-39(65)57-37(26-63)45(70)60-36(23-29-12-5-4-6-13-29)44(69)62-38(27-73-74-49(40,2)3)46(71)59-34(16-9-10-20-50)43(68)58-33(41(51)66)17-11-21-54-48(52)53/h4-8,12-15,18-19,22,33-38,40,63H,9-11,16-17,20-21,23-27,50H2,1-3H3,(H2,51,66)(H,55,67)(H,56,64)(H,57,65)(H,58,68)(H,59,71)(H,60,70)(H,61,72)(H,62,69)(H4,52,53,54)/t33-,34-,35-,36+,37-,38+,40-/m0/s1 D01IZN DRUGINKE RLMDVJMHWZVFEI-BQQBDQLKSA-N D01IZN DRUGSMIL CC(=O)NC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC1(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC2=CC=CC=C2)CO)CC3=CC4=CC=CC=C4C=C3 D01IZN HIGHSTAT Investigative D01JXM DRUG__ID D01JXM D01JXM DRUGINCH 1S/C15H20N2S/c1-15(2,3)12-4-6-14(7-5-12)18-9-8-13-10-16-11-17-13/h4-7,10-11H,8-9H2,1-3H3,(H,16,17) D01JXM DRUGINKE PQPVHIHIJVIEQG-UHFFFAOYSA-N D01JXM DRUGSMIL CC(C)(C)C1=CC=C(C=C1)SCCC2=CN=CN2 D01JXM HIGHSTAT Investigative D01LAP DRUG__ID D01LAP D01LAP THERCLAS Antisense D01LAP DRUGTYPE Combination drug (Antisense drug) D01LAP DRUGSMIL C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N D01LAP HIGHSTAT Investigative D01LMH DRUG__ID D01LMH D01LMH DRUGINCH 1S/C103H172N24O22/c1-10-11-12-13-14-15-16-17-18-19-20-21-22-41-85(132)110-49-32-28-39-74(93(139)117-72(90(109)136)36-25-29-46-104)119-94(140)73(37-26-30-47-105)118-95(141)75(38-27-31-48-106)120-102(148)83-40-33-50-127(83)88(135)60-113-92(138)76(51-62(2)3)121-96(142)77(52-63(4)5)122-98(144)79(54-67-42-44-69(130)45-43-67)116-87(134)59-112-91(137)65(8)114-101(147)82(61-128)125-99(145)81(56-84(108)131)123-97(143)78(53-64(6)7)124-103(149)89(66(9)129)126-100(146)80(115-86(133)57-107)55-68-58-111-71-35-24-23-34-70(68)71/h23-24,34-35,42-45,58,62-66,72-83,89,111,128-130H,10-22,25-33,36-41,46-57,59-61,104-107H2,1-9H3,(H2,108,131)(H2,109,136)(H,110,132)(H,112,137)(H,113,138)(H,114,147)(H,115,133)(H,116,134)(H,117,139)(H,118,141)(H,119,140)(H,120,148)(H,121,142)(H,122,144)(H,123,143)(H,124,149)(H,125,145)(H,126,146)/t65-,66+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,89-/m0/s1 D01LMH DRUGINKE FUVBWPLFMCRKPJ-RUUCUJBTSA-N D01LMH DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CN D01LMH HIGHSTAT Investigative D01NID DRUG__ID D01NID D01NID DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)39-60-72(99)88-65(46(3)92)75(102)86-61(38-50-23-13-8-14-24-50)73(100)89-66(47(4)93)76(103)90(5)64(42-91)74(101)87-63(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-62(71(98)84-60)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,98)(H,85,97)(H,86,102)(H,87,101)(H,88,99)(H,89,100)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D01NID DRUGINKE XJZZHUHCSZMQGG-PCKPOTSRSA-N D01NID DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C)C(C)O)CC7=CC=CC=C7)C(C)O D01NID HIGHSTAT Investigative D01OYG DRUG__ID D01OYG D01OYG DRUGINCH 1S/C35H37NO3/c1-33-20-30-28-9-7-24(23-5-3-22(21-36)4-6-23)17-25(28)19-34-14-11-27(38)18-26(34)8-10-29(32(30)34)31(33)12-15-35(33,39)13-2-16-37/h2-7,9,13,17-18,29-32,37,39H,8,10-12,14-16,19-20H2,1H3/b13-2+/t29-,30-,31+,32-,33+,34-,35+/m1/s1 D01OYG DRUGINKE QHTHVOAGHYSJSF-DVNFVMEUSA-N D01OYG DRUGSMIL CC12CC3C4C(C1CCC2(C=CCO)O)CCC5=CC(=O)CCC45CC6=C3C=CC(=C6)C7=CC=C(C=C7)C#N D01OYG HIGHSTAT Investigative D01STY DRUG__ID D01STY D01STY DRUGINCH 1S/C6H7IN2O2S/c7-5-3-4(12(9,10)11)1-2-6(5)8/h1-3H,8H2,(H2,9,10,11) D01STY DRUGINKE HCODCRHNVCTCTR-UHFFFAOYSA-N D01STY DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)I)N D01STY HIGHSTAT Investigative D01TUB DRUG__ID D01TUB D01TUB DRUGINCH 1S/C15H10ClNO2/c16-13-8-15(9-1-3-10(18)4-2-9)17-14-6-5-11(19)7-12(13)14/h1-8,18-19H D01TUB DRUGINKE MJJDANHWHHWHME-UHFFFAOYSA-N D01TUB DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C(C=C3)O)C(=C2)Cl)O D01TUB HIGHSTAT Investigative D01VUY DRUG__ID D01VUY D01VUY DRUGINCH 1S/C84H132N28O19/c1-7-8-9-16-55(71(90)119)104-78(126)59(33-45(2)3)108-79(127)62(36-51-41-95-44-100-51)102-69(118)43-99-82(130)70(46(4)5)111-72(120)47(6)101-77(125)61(35-49-40-97-54-15-11-10-14-53(49)54)110-76(124)57(23-25-65(87)114)106-80(128)63(37-67(89)116)103-68(117)42-98-73(121)60(34-48-19-21-52(113)22-20-48)109-74(122)56(17-12-29-96-84(91)92)105-75(123)58(24-26-66(88)115)107-81(129)64-18-13-32-112(64)83(131)50(38-93-30-27-85)39-94-31-28-86/h10-11,14-15,19-22,40-41,44-47,50,55-64,70,93-94,97,113H,7-9,12-13,16-18,23-39,42-43,85-86H2,1-6H3,(H2,87,114)(H2,88,115)(H2,89,116)(H2,90,119)(H,95,100)(H,98,121)(H,99,130)(H,101,125)(H,102,118)(H,103,117)(H,104,126)(H,105,123)(H,106,128)(H,107,129)(H,108,127)(H,109,122)(H,110,124)(H,111,120)(H4,91,92,96)/t47-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64?,70-/m0/s1 D01VUY DRUGINKE KQHZZRQJOXXKSD-LJBQZBCTSA-N D01VUY DRUGSMIL CCCCCC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C5CCCN5C(=O)C(CNCCN)CNCCN D01VUY HIGHSTAT Investigative D01YPT DRUG__ID D01YPT D01YPT DRUGINCH 1S/C69H106N28O20S6/c1-31-53(103)87-41(17-33-20-78-30-82-33)59(109)90-43(21-98)61(111)85-39(12-7-15-80-69(76)77)57(107)95-50-29-123-122-26-47-65(115)89-42(18-51(72)101)60(110)97-49(28-121-119-25-46(52(73)102)93-67(50)117)66(116)92-45(23-100)63(113)91-44(22-99)62(112)84-37(10-4-5-13-70)56(106)88-40(16-32-19-81-36-9-3-2-8-34(32)36)58(108)96-48(27-120-118-24-35(71)54(104)94-47)64(114)86-38(55(105)83-31)11-6-14-79-68(74)75/h2-3,8-9,19-20,30-31,35,37-50,81,98-100H,4-7,10-18,21-29,70-71H2,1H3,(H2,72,101)(H2,73,102)(H,78,82)(H,83,105)(H,84,112)(H,85,111)(H,86,114)(H,87,103)(H,88,106)(H,89,115)(H,90,109)(H,91,113)(H,92,116)(H,93,117)(H,94,104)(H,95,107)(H,96,108)(H,97,110)(H4,74,75,79)(H4,76,77,80)/t31-,35-,37-,38-,39-,40-,41-,42+,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D01YPT DRUGINKE RFBOHZPDDZVGLQ-CPQFHPGLSA-N D01YPT DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(CSSCC(NC2=O)C(=O)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N1)CCCNC(=N)N)CC4=CNC5=CC=CC=C54)CCCCN)CO)CO)CC(=O)N)CCCNC(=N)N)CO)CC6=CN=CN6 D01YPT HIGHSTAT Investigative D01ZRJ DRUG__ID D01ZRJ D01ZRJ DRUGINCH 1S/C71H99N21O18S3/c1-9-34(4)56(82-37(7)94)67(108)88-50-31-113-112-30-49(66(107)91-57(36(6)93)58(73)99)87-61(102)44(18-14-22-77-70(74)75)83-63(104)47(24-39-27-76-32-80-39)84-59(100)35(5)81-53(96)28-79-60(101)46(23-38-26-78-43-17-12-10-15-40(38)43)85-64(105)48(25-54(97)98)86-62(103)45(20-21-52(72)95)89-69(110)71(8,42-29-111-51-19-13-11-16-41(42)51)92-68(109)55(33(2)3)90-65(50)106/h10-13,15-17,19,26-27,29,32-36,44-50,55-57,78,93H,9,14,18,20-25,28,30-31H2,1-8H3,(H2,72,95)(H2,73,99)(H,76,80)(H,79,101)(H,81,96)(H,82,94)(H,83,104)(H,84,100)(H,85,105)(H,86,103)(H,87,102)(H,88,108)(H,89,110)(H,90,106)(H,91,107)(H,92,109)(H,97,98)(H4,74,75,77)/t34-,35-,36+,44-,45-,46-,47+,48+,49-,50-,55-,56-,57-,71-/m0/s1 D01ZRJ DRUGINKE OCTUQYZUSWCCJV-NWJDZPOUSA-N D01ZRJ DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)(C)C2=CSC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D01ZRJ HIGHSTAT Investigative D02AWT DRUG__ID D02AWT D02AWT DRUGINCH 1S/C76H102N20O20S2/c1-8-38(4)61(86-41(7)98)74(114)94-56-35-118-117-34-55(72(112)96-62(40(6)97)75(115)116)93-66(106)49(19-14-26-81-76(78)79)87-69(109)53(29-46-32-80-36-84-46)89-64(104)39(5)85-58(100)33-83-65(105)52(28-45-31-82-48-18-13-12-17-47(45)48)90-70(110)54(30-59(101)102)91-67(107)50(24-25-57(77)99)88-68(108)51(92-73(113)60(37(2)3)95-71(56)111)27-42-20-22-44(23-21-42)63(103)43-15-10-9-11-16-43/h9-13,15-18,20-23,31-32,36-40,49-56,60-62,82,97H,8,14,19,24-30,33-35H2,1-7H3,(H2,77,99)(H,80,84)(H,83,105)(H,85,100)(H,86,98)(H,87,109)(H,88,108)(H,89,104)(H,90,110)(H,91,107)(H,92,113)(H,93,106)(H,94,114)(H,95,111)(H,96,112)(H,101,102)(H,115,116)(H4,78,79,81)/t38-,39-,40+,49-,50-,51-,52-,53+,54?,55-,56-,60-,61-,62-/m0/s1 D02AWT DRUGINKE PWSUDTBGJHZYGB-MPCJNSQXSA-N D02AWT DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC=C(C=C2)C(=O)C3=CC=CC=C3)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D02AWT HIGHSTAT Investigative D02CSO DRUG__ID D02CSO D02CSO DRUGINCH 1S/C72H101N21O19S2/c1-8-35(5)58(82-37(7)95)70(110)91-53-32-114-113-31-52(68(108)93-59(36(6)94)71(111)112)90-62(102)46(19-14-22-77-72(74)75)84-65(105)50(25-40-29-76-33-81-40)87-61(101)43(9-2)83-55(97)30-80-60(100)48(23-38-27-78-44-17-12-10-15-41(38)44)86-66(106)51(26-56(98)99)88-63(103)47(20-21-54(73)96)85-64(104)49(89-69(109)57(34(3)4)92-67(53)107)24-39-28-79-45-18-13-11-16-42(39)45/h10-13,15-18,27-29,33-36,43,46-53,57-59,78-79,94H,8-9,14,19-26,30-32H2,1-7H3,(H2,73,96)(H,76,81)(H,80,100)(H,82,95)(H,83,97)(H,84,105)(H,85,104)(H,86,106)(H,87,101)(H,88,103)(H,89,109)(H,90,102)(H,91,110)(H,92,107)(H,93,108)(H,98,99)(H,111,112)(H4,74,75,77)/t35-,36+,43?,46+,47-,48-,49+,50-,51+,52+,53-,57-,58-,59-/m0/s1 D02CSO DRUGINKE IRAHVUBILQLJJK-POSIHDSISA-N D02CSO DRUGSMIL CCC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N1)CC2=CNC3=CC=CC=C32)CC(=O)O)CCC(=O)N)CC4=CNC5=CC=CC=C54)C(C)C)NC(=O)C(C(C)CC)NC(=O)C)C(=O)NC(C(C)O)C(=O)O)CCCNC(=N)N)CC6=CN=CN6 D02CSO HIGHSTAT Investigative D02DGP DRUG__ID D02DGP D02DGP DRUGINCH 1S/C45H65N13O12S2/c46-14-4-3-9-27(47)38(64)53-28(10-5-15-50-45(48)49)42(68)56-16-6-12-33(56)44(70)57-21-25(60)18-34(57)41(67)51-20-36(61)52-29(19-26-8-7-17-71-26)39(65)54-30(23-59)40(66)55-31-24-72-35-13-2-1-11-32(35)58(43(31)69)22-37(62)63/h1-2,7-8,11,13,17,25,27-31,33-34,59-60H,3-6,9-10,12,14-16,18-24,46-47H2,(H,51,67)(H,52,61)(H,53,64)(H,54,65)(H,55,66)(H,62,63)(H4,48,49,50)/t25?,27?,28-,29?,30+,31-,33+,34+/m1/s1 D02DGP DRUGINKE UXMVCNAZMAVIBE-SXGBRQJCSA-N D02DGP DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC(CO)C(=O)NC4CSC5=CC=CC=C5N(C4=O)CC(=O)O)O D02DGP HIGHSTAT Investigative D02FXZ DRUG__ID D02FXZ D02FXZ DRUGINCH 1S/C64H75N9O18S2/c1-4-32(2)51-57(83)72-52(33(3)74)58(84)68-44(29-49(65)78)55(81)69-45(31-92-93-63(22-6-5-7-23-63)30-50(79)70-53(59(85)71-51)34-12-15-36(75)16-13-34)60(86)73-25-9-11-46(73)56(82)67-43(61(87)88)10-8-24-66-54(80)35-14-19-39-42(26-35)64(91-62(39)89)40-20-17-37(76)27-47(40)90-48-28-38(77)18-21-41(48)64/h12-21,26-28,32-33,43-46,51-53,74-77H,4-11,22-25,29-31H2,1-3H3,(H2,65,78)(H,66,80)(H,67,82)(H,68,84)(H,69,81)(H,70,79)(H,71,85)(H,72,83)(H,87,88)/t32?,33?,43-,44+,45+,46+,51+,52+,53-/m0/s1 D02FXZ DRUGINKE YDQFMQKHNPCEQF-AMPJLWALSA-N D02FXZ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)N1)C3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=O)C5=CC6=C(C=C5)C(=O)OC67C8=C(C=C(C=C8)O)OC9=C7C=CC(=C9)O)C(=O)O)CC(=O)N)C(C)O D02FXZ HIGHSTAT Investigative D02GEW DRUG__ID D02GEW D02GEW DRUGINCH 1S/C51H93N25O12/c1-86-25-26-87-24-23-63-41(80)29(11-4-5-17-52)72-43(82)31(13-8-20-65-49(56)57)74-45(84)33(15-10-22-67-51(60)61)75-44(83)32(14-9-21-66-50(58)59)73-42(81)30(12-7-19-64-48(54)55)71-34(77)16-3-2-6-18-62-46(85)38-36(78)37(79)47(88-38)76-28-70-35-39(53)68-27-69-40(35)76/h27-33,36-38,47,78-79H,2-26,52H2,1H3,(H,62,85)(H,63,80)(H,71,77)(H,72,82)(H,73,81)(H,74,84)(H,75,83)(H2,53,68,69)(H4,54,55,64)(H4,56,57,65)(H4,58,59,66)(H4,60,61,67)/t29?,30-,31-,32-,33-,36-,37+,38-,47+/m0/s1 D02GEW DRUGINKE JBQKHDQXRCCDGW-NZDGIOGASA-N D02GEW DRUGSMIL COCCOCCNC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CCCCCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D02GEW HIGHSTAT Investigative D02GOE DRUG__ID D02GOE D02GOE DRUGINCH 1S/C100H165N23O23/c1-11-12-13-14-15-16-17-18-19-38-82(128)107-46-29-25-36-71(90(135)113-69(87(105)132)33-22-26-43-101)115-91(136)70(34-23-27-44-102)114-92(137)72(35-24-28-45-103)116-98(143)79-37-30-47-123(79)84(130)56-110-89(134)73(48-59(2)3)117-93(138)74(49-60(4)5)118-95(140)76(51-64-39-41-66(126)42-40-64)112-83(129)55-109-88(133)62(8)111-97(142)78(58-124)121-96(141)77(53-81(104)127)119-94(139)75(50-61(6)7)120-100(145)86(63(9)125)122-99(144)80(146-85(131)57-106-10)52-65-54-108-68-32-21-20-31-67(65)68/h20-21,31-32,39-42,54,59-63,69-80,86,106,108,124-126H,11-19,22-30,33-38,43-53,55-58,101-103H2,1-10H3,(H2,104,127)(H2,105,132)(H,107,128)(H,109,133)(H,110,134)(H,111,142)(H,112,129)(H,113,135)(H,114,137)(H,115,136)(H,116,143)(H,117,138)(H,118,140)(H,119,139)(H,120,145)(H,121,141)(H,122,144)/t62-,63+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,86-/m0/s1 D02GOE DRUGINKE MNPLGRICQVXCSX-IUVNOECISA-N D02GOE DRUGSMIL CCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D02GOE HIGHSTAT Investigative D02IMK DRUG__ID D02IMK D02IMK DRUGINCH 1S/C85H147N33O20/c1-48(106-65(122)46-105-80(136)67(50(3)120)118-78(134)62(43-52-24-8-5-9-25-52)108-66(123)45-103-64(121)44-104-70(126)53(90)42-51-22-6-4-7-23-51)68(124)109-57(30-18-38-99-82(91)92)73(129)113-56(28-12-16-36-88)77(133)117-63(47-119)79(135)107-49(2)69(125)110-58(31-19-39-100-83(93)94)74(130)111-54(26-10-14-34-86)71(127)114-59(32-20-40-101-84(95)96)75(131)112-55(27-11-15-35-87)72(128)115-60(33-21-41-102-85(97)98)76(132)116-61(81(137)138)29-13-17-37-89/h4-9,22-25,48-50,53-63,67,119-120H,10-21,26-47,86-90H2,1-3H3,(H,103,121)(H,104,126)(H,105,136)(H,106,122)(H,107,135)(H,108,123)(H,109,124)(H,110,125)(H,111,130)(H,112,131)(H,113,129)(H,114,127)(H,115,128)(H,116,132)(H,117,133)(H,118,134)(H,137,138)(H4,91,92,99)(H4,93,94,100)(H4,95,96,101)(H4,97,98,102)/t48-,49-,50+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,67-/m0/s1 D02IMK DRUGINKE UJJPEJMTOWTFSE-VDORGCAASA-N D02IMK DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D02IMK HIGHSTAT Investigative D02IWH DRUG__ID D02IWH D02IWH DRUGINCH 1S/C80H131N27O22/c1-42(2)34-55(73(123)96-44(4)66(116)103-57(37-60(85)111)74(124)102-54(78(128)129)28-29-59(84)110)104-71(121)50(24-14-16-30-81)100-70(120)53(27-19-33-91-80(88)89)99-67(117)45(5)107(7)77(127)58(41-108)105-72(122)51(25-15-17-31-82)101-69(119)52(26-18-32-90-79(86)87)98-65(115)43(3)95-62(113)40-94-76(126)64(46(6)109)106-75(125)56(36-48-22-12-9-13-23-48)97-63(114)39-92-61(112)38-93-68(118)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,108-109H,14-19,24-41,81-83H2,1-7H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,118)(H,94,126)(H,95,113)(H,96,123)(H,97,114)(H,98,115)(H,99,117)(H,100,120)(H,101,119)(H,102,124)(H,103,116)(H,104,121)(H,105,122)(H,106,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D02IWH DRUGINKE MJZVYHXPHQEPQQ-FKPOJLNCSA-N D02IWH DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)N(C)C(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D02IWH HIGHSTAT Investigative D02IXC DRUG__ID D02IXC D02IXC DRUGINCH 1S/C50H65N11O11S2/c1-27(2)42-50(72)60-40(48(70)56-36(43(53)65)23-41(63)64)26-74-73-25-39(59-44(66)33(52)20-28-10-4-3-5-11-28)49(71)57-37(21-29-15-17-31(62)18-16-29)46(68)58-38(22-30-24-54-34-13-7-6-12-32(30)34)47(69)55-35(45(67)61-42)14-8-9-19-51/h3-7,10-13,15-18,24,27,33,35-40,42,54,62H,8-9,14,19-23,25-26,51-52H2,1-2H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,71)(H,58,68)(H,59,66)(H,60,72)(H,61,67)(H,63,64)/t33-,35-,36-,37-,38+,39-,40+,42+/m0/s1 D02IXC DRUGINKE HFLJXACCXCUGOQ-OZHBEKPPSA-N D02IXC DRUGSMIL CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CC(=O)O)C(=O)N D02IXC HIGHSTAT Investigative D02JFF DRUG__ID D02JFF D02JFF DRUGCOMP Isis Pharmaceuticals D02JFF THERCLAS Anticancer Agents D02JFF DRUGTYPE Antisense drug D02JFF HIGHSTAT Investigative D02JQP DRUG__ID D02JQP D02JQP DRUGINCH 1S/C104H173N23O23/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-42-86(132)110-50-33-29-39-74(95(140)120-76(104(149)150)40-28-32-49-107)118-93(138)73(37-26-30-47-105)117-94(139)75(38-27-31-48-106)119-102(147)84-41-34-51-127(84)89(135)61-113-92(137)77(52-63(2)3)121-96(141)78(53-64(4)5)122-98(143)80(55-68-43-45-70(130)46-44-68)115-88(134)60-112-91(136)66(8)114-101(146)83(62-128)125-99(144)82(57-85(108)131)123-97(142)79(54-65(6)7)124-103(148)90(67(9)129)126-100(145)81(116-87(133)59-109-10)56-69-58-111-72-36-25-24-35-71(69)72/h24-25,35-36,43-46,58,63-67,73-84,90,109,111,128-130H,11-23,26-34,37-42,47-57,59-62,105-107H2,1-10H3,(H2,108,131)(H,110,132)(H,112,136)(H,113,137)(H,114,146)(H,115,134)(H,116,133)(H,117,139)(H,118,138)(H,119,147)(H,120,140)(H,121,141)(H,122,143)(H,123,142)(H,124,148)(H,125,144)(H,126,145)(H,149,150)/t66-,67+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,90-/m0/s1 D02JQP DRUGINKE DWLPZUABYQBJIQ-CMDPNKGGSA-N D02JQP DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CNC D02JQP HIGHSTAT Investigative D02LML DRUG__ID D02LML D02LML DRUGINCH 1S/C21H19NO/c1-22-20(23)21(17-11-5-2-6-12-17,18-13-7-3-8-14-18)19-15-9-4-10-16-19/h2-16H,1H3,(H,22,23) D02LML DRUGINKE IYPLXBZQQJCIRI-UHFFFAOYSA-N D02LML DRUGSMIL CNC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3 D02LML HIGHSTAT Investigative D02LWF DRUG__ID D02LWF D02LWF DRUGINCH 1S/C61H96N24O20S4/c1-5-26(2)47(60(104)81-37(20-106)48(66)92)84-54(98)32(11-29-16-67-24-70-29)77-51(95)31(8-9-42(63)87)76-53(97)34(14-44(65)89)78-52(96)33(13-43(64)88)74-46(91)18-69-49(93)27(3)72-56(100)39(22-108)82-50(94)28(4)73-59(103)41-7-6-10-85(41)61(105)35(12-30-17-68-25-71-30)79-55(99)36(19-86)80-58(102)40(23-109)83-57(101)38(21-107)75-45(90)15-62/h16-17,24-28,31-41,47,86,106-109H,5-15,18-23,62H2,1-4H3,(H2,63,87)(H2,64,88)(H2,65,89)(H2,66,92)(H,67,70)(H,68,71)(H,69,93)(H,72,100)(H,73,103)(H,74,91)(H,75,90)(H,76,97)(H,77,95)(H,78,96)(H,79,99)(H,80,102)(H,81,104)(H,82,94)(H,83,101)(H,84,98)/t26-,27-,28-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,47-/m0/s1 D02LWF DRUGINKE UCMCIMRDJCGRNT-KLMBZYLCSA-N D02LWF DRUGSMIL CCC(C)C(C(=O)NC(CS)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CS)NC(=O)C(C)NC(=O)C2CCCN2C(=O)C(CC3=CN=CN3)NC(=O)C(CO)NC(=O)C(CS)NC(=O)C(CS)NC(=O)CN D02LWF HIGHSTAT Investigative D02MFK DRUG__ID D02MFK D02MFK THERCLAS Antisense D02MFK DRUGTYPE Combination drug (Antisense drug) D02MFK DRUGSMIL failed D02MFK HIGHSTAT Investigative D02MKP DRUG__ID D02MKP D02MKP DRUGINCH 1S/C86H139N29O22/c1-41(2)31-58(109-81(135)64(39-116)113-70(124)45(9)101-47(11)118)75(129)103-54(16-13-29-98-85(92)93)73(127)111-62(36-50-38-96-40-100-50)78(132)110-61(35-49-20-24-52(120)25-21-49)77(131)107-59(32-42(3)4)76(130)112-63(37-66(88)122)79(133)108-60(33-43(5)6)80(134)114-67(44(7)8)82(136)115-68(46(10)117)83(137)105-55(17-14-30-99-86(94)95)71(125)104-56(26-27-65(87)121)74(128)102-53(15-12-28-97-84(90)91)72(126)106-57(69(89)123)34-48-18-22-51(119)23-19-48/h18-25,38,40-46,53-64,67-68,116-117,119-120H,12-17,26-37,39H2,1-11H3,(H2,87,121)(H2,88,122)(H2,89,123)(H,96,100)(H,101,118)(H,102,128)(H,103,129)(H,104,125)(H,105,137)(H,106,126)(H,107,131)(H,108,133)(H,109,135)(H,110,132)(H,111,127)(H,112,130)(H,113,124)(H,114,134)(H,115,136)(H4,90,91,97)(H4,92,93,98)(H4,94,95,99)/t45-,46+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,67-,68-/m0/s1 D02MKP DRUGINKE NDQIPMDOGHILHE-UXUJTPOBSA-N D02MKP DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CNC=N3)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C)NC(=O)C D02MKP HIGHSTAT Investigative D02NJV DRUG__ID D02NJV D02NJV DRUGINCH 1S/C67H84N12O11S2/c1-40(2)70-36-46-28-26-45(27-29-46)34-55-65(87)79-58(41(3)80)66(88)77-54(33-44-21-11-6-12-22-44)63(85)78-57(67(89)90)39-92-91-38-49(69)59(81)72-51(25-15-16-30-68)60(82)73-52(31-42-17-7-4-8-18-42)61(83)74-53(32-43-19-9-5-10-20-43)62(84)76-56(64(86)75-55)35-47-37-71-50-24-14-13-23-48(47)50/h4-14,17-24,26-29,37,40-41,49,51-58,70-71,80H,15-16,25,30-36,38-39,68-69H2,1-3H3,(H,72,81)(H,73,82)(H,74,83)(H,75,86)(H,76,84)(H,77,88)(H,78,85)(H,79,87)(H,89,90)/t41-,49-,51-,52-,53+,54+,55+,56+,57+,58-/m1/s1 D02NJV DRUGINKE CRBKELXXBMEXSB-BHKHLLRWSA-N D02NJV DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CC7=CC=CC=C7)C(C)O D02NJV HIGHSTAT Investigative D02NMK DRUG__ID D02NMK D02NMK DRUGINCH 1S/C58H79N11O15/c1-31(2)46(55(80)60-30-44(71)61-33(5)49(74)63-40(27-37-20-13-9-14-21-37)52(77)62-34(6)50(75)65-42(58(83)84)28-38-22-15-10-16-23-38)66-53(78)41(29-45(72)73)64-56(81)48(35(7)70)68-54(79)43-24-17-25-69(43)57(82)47(32(3)4)67-51(76)39(59)26-36-18-11-8-12-19-36/h8-16,18-23,31-35,39-43,46-48,70H,17,24-30,59H2,1-7H3,(H,60,80)(H,61,71)(H,62,77)(H,63,74)(H,64,81)(H,65,75)(H,66,78)(H,67,76)(H,68,79)(H,72,73)(H,83,84)/t33-,34-,35+,39-,40-,41-,42-,43-,46-,47-,48-/m0/s1 D02NMK DRUGINKE SQQZSWBNZZDEAJ-ILJNECBNSA-N D02NMK DRUGSMIL CC(C)C(C(=O)NCC(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC2=CC=CC=C2)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C3CCCN3C(=O)C(C(C)C)NC(=O)C(CC4=CC=CC=C4)N D02NMK HIGHSTAT Investigative D02NZG DRUG__ID D02NZG D02NZG DRUGINCH 1S/C49H68N10O17/c1-25(2)21-34-46(73)55-32(15-18-39(63)64)44(71)53-30(42(51)69)14-17-38(62)52-35(22-26-6-10-28(60)11-7-26)47(74)58-36(23-27-8-12-29(61)13-9-27)48(75)59-37(24-41(67)68)49(76)56-33(16-19-40(65)66)45(72)54-31(43(70)57-34)5-3-4-20-50/h6-13,25,30-37,60-61H,3-5,14-24,50H2,1-2H3,(H2,51,69)(H,52,62)(H,53,71)(H,54,72)(H,55,73)(H,56,76)(H,57,70)(H,58,74)(H,59,75)(H,63,64)(H,65,66)(H,67,68)/t30-,31-,32-,33-,34-,35-,36-,37-/m0/s1 D02NZG DRUGINKE UHCDRMNHCPWMSL-MDKUUQCZSA-N D02NZG DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CCC(=O)O)CC(=O)O)CC2=CC=C(C=C2)O)CC3=CC=C(C=C3)O)C(=O)N)CCC(=O)O D02NZG HIGHSTAT Investigative D02OJQ DRUG__ID D02OJQ D02OJQ DRUGINCH 1S/C67H90N14O16S2/c1-37(83)55-65(94)77-51(31-41-23-25-43(85)26-24-41)63(92)81-56(38(2)84)66(95)78-53(34-82)64(93)79-54(67(96)97)36-99-98-35-45(70)57(86)72-47(21-11-13-27-68)58(87)74-49(29-39-15-5-3-6-16-39)60(89)75-50(30-40-17-7-4-8-18-40)61(90)76-52(32-42-33-71-46-20-10-9-19-44(42)46)62(91)73-48(59(88)80-55)22-12-14-28-69/h3-10,15-20,23-26,33,37-38,45,47-56,71,82-85H,11-14,21-22,27-32,34-36,68-70H2,1-2H3,(H,72,86)(H,73,91)(H,74,87)(H,75,89)(H,76,90)(H,77,94)(H,78,95)(H,79,93)(H,80,88)(H,81,92)(H,96,97)/t37-,38-,45-,47-,48+,49-,50+,51+,52+,53+,54+,55-,56-/m1/s1 D02OJQ DRUGINKE NIVBKEGMFSFLSD-KGVPGVLISA-N D02OJQ DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CCCCN)N)C(=O)O)CO)C(C)O)CC6=CC=C(C=C6)O)O D02OJQ HIGHSTAT Investigative D02SRA DRUG__ID D02SRA D02SRA DRUGINCH 1S/C49H69N13O10S2/c1-28(64)56-40-47(72)61-35(24-30-18-19-31-14-7-8-15-32(31)22-30)42(67)55-25-39(65)57-37(26-63)45(70)60-36(23-29-12-5-4-6-13-29)44(69)62-38(27-73-74-49(40,2)3)46(71)59-34(16-9-10-20-50)43(68)58-33(41(51)66)17-11-21-54-48(52)53/h4-8,12-15,18-19,22,33-38,40,63H,9-11,16-17,20-21,23-27,50H2,1-3H3,(H2,51,66)(H,55,67)(H,56,64)(H,57,65)(H,58,68)(H,59,71)(H,60,70)(H,61,72)(H,62,69)(H4,52,53,54)/t33-,34-,35+,36+,37-,38+,40-/m0/s1 D02SRA DRUGINKE RLMDVJMHWZVFEI-LNZYVXNRSA-N D02SRA DRUGSMIL CC(=O)NC1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC1(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC2=CC=CC=C2)CO)CC3=CC4=CC=CC=C4C=C3 D02SRA HIGHSTAT Investigative D02TCF DRUG__ID D02TCF D02TCF DRUGINCH 1S/C59H84N2O12/c1-34-17-12-11-13-18-35(2)46(45-20-16-19-44-40(7)33-60-52(44)45)31-43-24-22-41(8)59(69,73-43)56(66)57(67)61-26-15-14-21-47(61)58(68)72-50(37(4)29-42-23-25-48(62)51(30-42)70-9)32-49(63)36(3)28-39(6)54(65)55(71-10)53(64)38(5)27-34/h11-13,16-20,28,33-34,36-38,41-43,46-48,50-51,54-55,60,62,65,69H,14-15,21-27,29-32H2,1-10H3/b13-11+,17-12+,35-18+,39-28+/t34-,36-,37-,38-,41-,42+,43+,46+,47+,48-,50+,51-,54-,55+,59-/m1/s1 D02TCF DRUGINKE MYMSKXFGXABEON-OYYFJIJNSA-N D02TCF DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)C5=CC=CC6=C5NC=C6C D02TCF HIGHSTAT Investigative D02TKT DRUG__ID D02TKT D02TKT DRUGINCH 1S/C151H229N41O46/c1-17-77(10)121(148(236)170-81(14)127(215)178-105(60-87-63-161-92-36-25-24-35-90(87)92)138(226)180-101(56-74(4)5)139(227)189-119(75(6)7)146(234)177-94(37-26-28-52-152)130(218)163-66-112(201)171-93(39-30-54-160-151(157)158)129(217)162-65-111(156)200)191-140(228)103(57-84-31-20-18-21-32-84)181-135(223)99(47-51-117(208)209)176-134(222)95(38-27-29-53-153)173-125(213)79(12)167-124(212)78(11)169-133(221)98(44-48-110(155)199)172-113(202)67-164-132(220)97(46-50-116(206)207)175-136(224)100(55-73(2)3)179-137(225)102(59-86-40-42-89(198)43-41-86)182-143(231)107(69-193)185-145(233)109(71-195)186-147(235)120(76(8)9)190-142(230)106(62-118(210)211)183-144(232)108(70-194)187-150(238)123(83(16)197)192-141(229)104(58-85-33-22-19-23-34-85)184-149(237)122(82(15)196)188-114(203)68-165-131(219)96(45-49-115(204)205)174-126(214)80(13)168-128(216)91(154)61-88-64-159-72-166-88/h18-25,31-36,40-43,63-64,72-83,91,93-109,119-123,161,193-198H,17,26-30,37-39,44-62,65-71,152-154H2,1-16H3,(H2,155,199)(H2,156,200)(H,159,166)(H,162,217)(H,163,218)(H,164,220)(H,165,219)(H,167,212)(H,168,216)(H,169,221)(H,170,236)(H,171,201)(H,172,202)(H,173,213)(H,174,214)(H,175,224)(H,176,222)(H,177,234)(H,178,215)(H,179,225)(H,180,226)(H,181,223)(H,182,231)(H,183,232)(H,184,237)(H,185,233)(H,186,235)(H,187,238)(H,188,203)(H,189,227)(H,190,230)(H,191,228)(H,192,229)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H4,157,158,160)/t77-,78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,119-,120-,121-,122-,123-/m0/s1 D02TKT DRUGINKE FZWMHWVGNYURLN-AAEALURTSA-N D02TKT DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N D02TKT HIGHSTAT Investigative D02TNK DRUG__ID D02TNK D02TNK DRUGINCH 1S/C44H46Br8N20O9.4C2HF3O2/c45-13-1-17(61-25(13)49)29(73)57-5-9-11(7-59-31(75)19-3-15(47)27(51)63-19)23(41-21(9)43(77)35(67-39(55)71-43)80-33(41)65-37(53)69-41)79-24-12(8-60-32(76)20-4-16(48)28(52)64-20)10(6-58-30(74)18-2-14(46)26(50)62-18)22-42(24)34(66-38(54)70-42)81-36-44(22,78)72-40(56)68-36;4*3-2(4,5)1(6)7/h1-4,9-12,21-24,33-36,61-64,77-78H,5-8H2,(H,57,73)(H,58,74)(H,59,75)(H,60,76)(H3,53,65,69)(H3,54,66,70)(H3,55,67,71)(H3,56,68,72);4*(H,6,7)/t9-,10-,11-,12-,21-,22+,23+,24+,33+,34+,35-,36-,41+,42+,43-,44-;;;;/m1..../s1 D02TNK DRUGINKE PWAQCZXQKIUIBJ-JGPXLICKSA-N D02TNK DRUGSMIL C1=C(NC(=C1Br)Br)C(=O)NCC2C(C(C34C2C5(C(N=C(N5)N)OC3N=C(N4)N)O)OC6C(C(C7C68C(N=C(N8)N)OC9C7(NC(=N9)N)O)CNC(=O)C1=CC(=C(N1)Br)Br)CNC(=O)C1=CC(=C(N1)Br)Br)CNC(=O)C1=CC(=C(N1)Br)Br.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O D02TNK HIGHSTAT Investigative D02TPK DRUG__ID D02TPK D02TPK DRUGINCH 1S/C85H130N28O19/c1-3-49(2)72(113-79(129)62(20-13-38-100-85(94)95)108-80(130)65(43-53-25-31-56(116)32-26-53)112-81(131)64(42-52-23-29-55(115)30-24-52)110-74(124)57(87)16-11-36-98-83(90)91)82(132)109-60(18-7-9-34-86)76(126)105-47-70(121)103-46-69(120)104-48-71(122)106-59(73(89)123)17-8-10-35-96-67(118)44-102-68(119)45-101-66(117)33-39-97-77(127)63(41-50-14-5-4-6-15-50)111-78(128)61(19-12-37-99-84(92)93)107-75(125)58(88)40-51-21-27-54(114)28-22-51/h4-6,14-15,21-32,49,57-65,72,114-116H,3,7-13,16-20,33-48,86-88H2,1-2H3,(H2,89,123)(H,96,118)(H,97,127)(H,101,117)(H,102,119)(H,103,121)(H,104,120)(H,105,126)(H,106,122)(H,107,125)(H,108,130)(H,109,132)(H,110,124)(H,111,128)(H,112,131)(H,113,129)(H4,90,91,98)(H4,92,93,99)(H4,94,95,100)/t49-,57-,58-,59-,60-,61+,62-,63-,64-,65-,72-/m0/s1 D02TPK DRUGINKE FJZYPQNKFGDFEG-NWGZXSTASA-N D02TPK DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CNC(=O)CNC(=O)CCNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CC=C(C=C2)O)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCN=C(N)N)N D02TPK HIGHSTAT Investigative D02UCT DRUG__ID D02UCT D02UCT DRUGINCH 1S/C30H30N4O4/c1-33(18-20-10-4-2-5-11-20)30(38)27(21-12-6-3-7-13-21)32-28(36)26-16-22(35)19-34(26)29(37)24-17-31-25-15-9-8-14-23(24)25/h2-15,17,22,26-27,31,35H,16,18-19H2,1H3,(H,32,36)/t22-,26+,27+/m1/s1 D02UCT DRUGINKE JSNQZGVYABLKPW-ICTDUYRTSA-N D02UCT DRUGSMIL CN(CC1=CC=CC=C1)C(=O)C(C2=CC=CC=C2)NC(=O)C3CC(CN3C(=O)C4=CNC5=CC=CC=C54)O D02UCT HIGHSTAT Investigative D02VVG DRUG__ID D02VVG D02VVG DRUGINCH 1S/C61H72N12O17S2/c1-3-30(2)50-57(85)68-41(18-19-47(63)77)54(82)69-42(27-48(64)78)55(83)70-43(28-92-91-23-20-49(79)71-51(58(86)72-50)31-8-11-33(74)12-9-31)59(87)73-22-5-7-44(73)56(84)67-40(53(81)66-29-62)6-4-21-65-52(80)32-10-15-36-39(24-32)61(90-60(36)88)37-16-13-34(75)25-45(37)89-46-26-35(76)14-17-38(46)61/h8-17,24-26,30,40-44,50-51,74-76H,3-7,18-23,27-29,62H2,1-2H3,(H2,63,77)(H2,64,78)(H,65,80)(H,66,81)(H,67,84)(H,68,85)(H,69,82)(H,70,83)(H,71,79)(H,72,86)/t30?,40-,41+,42+,43+,44+,50+,51-/m0/s1 D02VVG DRUGINKE JOVDCZXVGAWIKQ-VUINKVIFSA-N D02VVG DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)CCC(=O)N D02VVG HIGHSTAT Investigative D02WKZ DRUG__ID D02WKZ D02WKZ DRUGINCH 1S/C80H132N28O21/c1-42(2)34-55(74(125)96-44(4)67(118)104-57(37-60(85)112)75(126)99-50(65(86)116)28-29-59(84)111)105-72(123)51(24-14-16-30-81)102-70(121)53(26-18-32-91-79(87)88)100-66(117)43(3)97-77(128)58(41-109)106-73(124)52(25-15-17-31-82)103-71(122)54(27-19-33-92-80(89)90)101-68(119)45(5)108(7)63(115)40-95-78(129)64(46(6)110)107-76(127)56(36-48-22-12-9-13-23-48)98-62(114)39-93-61(113)38-94-69(120)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,109-110H,14-19,24-41,81-83H2,1-7H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,120)(H,95,129)(H,96,125)(H,97,128)(H,98,114)(H,99,126)(H,100,117)(H,101,119)(H,102,121)(H,103,122)(H,104,118)(H,105,123)(H,106,124)(H,107,127)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D02WKZ DRUGINKE JKAMREUJRZWECK-FKPOJLNCSA-N D02WKZ DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)N(C)C(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D02WKZ HIGHSTAT Investigative D02WOX DRUG__ID D02WOX D02WOX DRUGINCH 1S/C74H96N14O15S2/c1-42(2)77-37-49-29-27-48(28-30-49)35-57-69(97)87-62(43(3)90)72(100)84-58(34-47-22-12-7-13-23-47)70(98)88-63(44(4)91)73(101)85-60(39-89)71(99)86-61(74(102)103)41-105-104-40-52(76)64(92)79-54(26-16-17-31-75)65(93)80-55(32-45-18-8-5-9-19-45)66(94)81-56(33-46-20-10-6-11-21-46)67(95)83-59(68(96)82-57)36-50-38-78-53-25-15-14-24-51(50)53/h5-15,18-25,27-30,38,42-44,52,54-63,77-78,89-91H,16-17,26,31-37,39-41,75-76H2,1-4H3,(H,79,92)(H,80,93)(H,81,94)(H,82,96)(H,83,95)(H,84,100)(H,85,101)(H,86,99)(H,87,97)(H,88,98)(H,102,103)/t43-,44-,52-,54-,55-,56+,57+,58+,59+,60+,61+,62-,63-/m1/s1 D02WOX DRUGINKE SYHQUPOPQRNSKD-ZDFJKKNGSA-N D02WOX DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D02WOX HIGHSTAT Investigative D02YXI DRUG__ID D02YXI D02YXI DRUGINCH 1S/C161H250N46O39/c1-81(2)62-106(184-121(215)76-177-133(221)89(17)181-140(228)107(63-82(3)4)190-137(225)102(51-34-37-57-172-159(165)166)186-144(232)112(69-98-73-171-80-180-98)195-157(245)131(92(20)211)205-155(243)128(87(13)14)201-147(235)111(183-93(21)212)68-97-72-175-100-49-32-31-48-99(97)100)142(230)191-108(64-83(5)6)143(231)198-116(79-209)149(237)187-103(52-35-38-58-173-160(167)168)139(227)197-115(78-208)135(223)178-74-120(214)176-75-122(216)199-126(85(9)10)154(242)202-127(86(11)12)153(241)188-104(53-39-59-174-161(169)170)136(224)185-101(50-33-36-56-162)138(226)193-113(70-119(163)213)145(233)192-110(67-96-46-29-24-30-47-96)146(234)203-129(88(15)16)158(246)207-61-41-55-118(207)151(239)204-130(91(19)210)156(244)196-114(71-124(218)219)148(236)200-125(84(7)8)152(240)179-77-123(217)206-60-40-54-117(206)150(238)194-109(66-95-44-27-23-28-45-95)141(229)182-90(18)134(222)189-105(132(164)220)65-94-42-25-22-26-43-94/h22-32,42-49,72-73,80-92,101-118,125-131,175,208-211H,33-41,50-71,74-79,162H2,1-21H3,(H2,163,213)(H2,164,220)(H,171,180)(H,176,214)(H,177,221)(H,178,223)(H,179,240)(H,181,228)(H,182,229)(H,183,212)(H,184,215)(H,185,224)(H,186,232)(H,187,237)(H,188,241)(H,189,222)(H,190,225)(H,191,230)(H,192,233)(H,193,226)(H,194,238)(H,195,245)(H,196,244)(H,197,227)(H,198,231)(H,199,216)(H,200,236)(H,201,235)(H,202,242)(H,203,234)(H,204,239)(H,205,243)(H,218,219)(H4,165,166,172)(H4,167,168,173)(H4,169,170,174)/t89-,90-,91+,92+,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,125-,126-,127-,128-,129-,130-,131-/m0/s1 D02YXI DRUGINKE DJNZEIOMSBZSIW-DTFUFJKDSA-N D02YXI DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCCN=C(N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN=C(N)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C D02YXI HIGHSTAT Investigative D02ZIQ DRUG__ID D02ZIQ D02ZIQ DRUGINCH 1S/C14H18ClNO/c1-11(16-8-3-2-4-9-16)14(17)12-6-5-7-13(15)10-12/h5-7,10-11H,2-4,8-9H2,1H3 D02ZIQ DRUGINKE LOWDJVQAZMFOLZ-UHFFFAOYSA-N D02ZIQ DRUGSMIL CC(C(=O)C1=CC(=CC=C1)Cl)N2CCCCC2 D02ZIQ HIGHSTAT Investigative D02ZWX DRUG__ID D02ZWX D02ZWX DRUGINCH 1S/C50H90N30O12/c51-35-31-36(72-22-71-35)80(23-73-31)43-33(83)32(82)34(92-43)42(89)64-15-7-14-30(81)74-24(8-1-16-65-45(52)53)37(84)75-25(9-2-17-66-46(54)55)38(85)76-26(10-3-18-67-47(56)57)39(86)77-27(11-4-19-68-48(58)59)40(87)78-28(12-5-20-69-49(60)61)41(88)79-29(44(90)91)13-6-21-70-50(62)63/h22-29,32-34,43,82-83H,1-21H2,(H,64,89)(H,74,81)(H,75,84)(H,76,85)(H,77,86)(H,78,87)(H,79,88)(H,90,91)(H2,51,71,72)(H4,52,53,65)(H4,54,55,66)(H4,56,57,67)(H4,58,59,68)(H4,60,61,69)(H4,62,63,70)/t24-,25-,26-,27-,28-,29-,32+,33-,34+,43?/m1/s1 D02ZWX DRUGINKE RAWZLEKTUTUGLH-PYGBFABJSA-N D02ZWX DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D02ZWX HIGHSTAT Investigative D03AZC DRUG__ID D03AZC D03AZC DRUGINCH 1S/C61H83N19O13S/c1-34(81)73-46(27-36-16-18-39(82)19-17-36)57(91)74-42(14-8-23-68-60(63)64)53(87)77-45(22-25-94-2)56(90)76-44(20-21-51(84)85)55(89)80-49(29-38-31-67-33-72-38)59(93)78-47(26-35-10-4-3-5-11-35)58(92)75-43(15-9-24-69-61(65)66)54(88)79-48(52(86)71-32-50(62)83)28-37-30-70-41-13-7-6-12-40(37)41/h3-7,10-13,16-19,30-31,33,42-49,70,82H,8-9,14-15,20-29,32H2,1-2H3,(H2,62,83)(H,67,72)(H,71,86)(H,73,81)(H,74,91)(H,75,92)(H,76,90)(H,77,87)(H,78,93)(H,79,88)(H,80,89)(H,84,85)(H4,63,64,68)(H4,65,66,69)/t42-,43-,44-,45-,46-,47+,48-,49-/m0/s1 D03AZC DRUGINKE ZSONGANRJTVTCP-FHYJZJLOSA-N D03AZC DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NCC(=O)N D03AZC HIGHSTAT Investigative D03BVC DRUG__ID D03BVC D03BVC DRUGINCH 1S/C46H66N14O11S2/c47-17-4-9-29(39(65)53-24-37(49)63)56-44(70)35-11-6-19-60(35)45(71)34-25-73-72-20-16-38(64)54-31(22-27-12-14-28(61)15-13-27)41(67)57-32(21-26-7-2-1-3-8-26)42(68)55-30(10-5-18-52-46(50)51)40(66)58-33(23-36(48)62)43(69)59-34/h1-3,7-8,12-15,29-35,61H,4-6,9-11,16-25,47H2,(H2,48,62)(H2,49,63)(H,53,65)(H,54,64)(H,55,68)(H,56,70)(H,57,67)(H,58,66)(H,59,69)(H4,50,51,52)/t29-,30-,31-,32-,33-,34-,35-/m0/s1 D03BVC DRUGINKE FEMJEHRQGCUGEY-POFDKVPJSA-N D03BVC DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN=C(N)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN)C(=O)NCC(=O)N D03BVC HIGHSTAT Investigative D03CBX DRUG__ID D03CBX D03CBX DRUGINCH 1S/C15H10BrNO2/c16-13-8-15(9-1-3-10(18)4-2-9)17-14-6-5-11(19)7-12(13)14/h1-8,18-19H D03CBX DRUGINKE XRUZUCBHVAMRMC-UHFFFAOYSA-N D03CBX DRUGSMIL C1=CC(=CC=C1C2=NC3=C(C=C(C=C3)O)C(=C2)Br)O D03CBX HIGHSTAT Investigative D03CEP DRUG__ID D03CEP D03CEP DRUGINCH 1S/C146H225N39O44S3/c1-17-72(8)114(138(221)158-64-110(199)177-113(71(6)7)137(220)157-61-108(197)160-74(10)144(227)184-48-27-35-102(184)121(153)204)179-122(205)73(9)161-139(222)117(77(13)189)180-127(210)88(42-44-105(150)194)166-136(219)103-36-28-49-185(103)145(228)97(55-81-31-22-19-23-32-81)174-140(223)115(75(11)187)163-98(56-83-60-154-68-159-83)146(229)183-47-26-34-101(183)120(203)86(33-24-25-46-147)164-131(214)95(58-107(152)196)171-129(212)92(53-80-29-20-18-21-30-80)170-132(215)96(59-112(201)202)172-125(208)87(41-43-104(149)193)167-142(225)118(78(14)190)181-133(216)93(54-82-37-39-84(192)40-38-82)173-141(224)116(76(12)188)178-111(200)63-156-124(207)90(51-69(2)3)168-126(209)89(45-50-232-16)165-135(218)100(67-231)176-143(226)119(79(15)191)182-134(217)99(65-186)175-128(211)91(52-70(4)5)169-130(213)94(57-106(151)195)162-109(198)62-155-123(206)85(148)66-230/h18-23,29-32,37-40,60,68-79,85-103,113-119,163,186-192,230-231H,17,24-28,33-36,41-59,61-67,147-148H2,1-16H3,(H2,149,193)(H2,150,194)(H2,151,195)(H2,152,196)(H2,153,204)(H,154,159)(H,155,206)(H,156,207)(H,157,220)(H,158,221)(H,160,197)(H,161,222)(H,162,198)(H,164,214)(H,165,218)(H,166,219)(H,167,225)(H,168,209)(H,169,213)(H,170,215)(H,171,212)(H,172,208)(H,173,224)(H,174,223)(H,175,211)(H,176,226)(H,177,199)(H,178,200)(H,179,205)(H,180,210)(H,181,216)(H,182,217)(H,201,202)/t72-,73-,74-,75+,76+,77+,78+,79+,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102+,103+,113-,114-,115-,116-,117-,118-,119-/m0/s1 D03CEP DRUGINKE NKZSJXPCNXUROW-ZRSYVJPOSA-N D03CEP DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(CC4=CNC=N4)C(=O)N5CCCC5C(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D03CEP HIGHSTAT Investigative D03DPD DRUG__ID D03DPD D03DPD DRUGINCH 1S/C152H229N39O43S2/c1-16-18-39-94(171-143(225)108(73-236)183-150(232)125(84(15)196)189-142(224)107(71-192)182-135(217)99(57-76(5)6)176-138(220)103(63-113(157)200)169-116(203)68-161-129(211)91(154)72-235)132(214)175-98(56-75(3)4)130(212)162-69-118(205)185-122(81(12)193)148(230)180-101(60-87-37-26-21-27-38-87)141(223)188-124(83(14)195)149(231)173-95(48-50-111(155)198)133(215)179-105(65-119(206)207)140(222)177-100(59-86-35-24-20-25-36-86)136(218)178-104-64-114(201)160-53-30-41-93(168-102(62-89-66-159-74-165-89)137(219)174-97(58-85-33-22-19-23-34-85)126(208)92(170-139(104)221)40-28-29-52-153)131(213)181-106(61-88-44-46-90(197)47-45-88)152(234)191-55-32-43-110(191)144(226)172-96(49-51-112(156)199)134(216)187-123(82(13)194)147(229)167-79(10)128(210)186-121(78(9)17-2)146(228)164-70-117(204)184-120(77(7)8)145(227)163-67-115(202)166-80(11)151(233)190-54-31-42-109(190)127(158)209/h19-27,33-38,44-47,66,74-84,91-110,120-125,168,192-197,235-236H,16-18,28-32,39-43,48-65,67-73,153-154H2,1-15H3,(H2,155,198)(H2,156,199)(H2,157,200)(H2,158,209)(H,159,165)(H,160,201)(H,161,211)(H,162,212)(H,163,227)(H,164,228)(H,166,202)(H,167,229)(H,169,203)(H,170,221)(H,171,225)(H,172,226)(H,173,231)(H,174,219)(H,175,214)(H,176,220)(H,177,222)(H,178,218)(H,179,215)(H,180,230)(H,181,213)(H,182,217)(H,183,232)(H,184,204)(H,185,205)(H,186,210)(H,187,216)(H,188,223)(H,189,224)(H,206,207)/t78-,79-,80-,81+,82+,83+,84+,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102?,103-,104-,105-,106-,107-,108-,109+,110+,120-,121-,122-,123-,124-,125-/m0/s1 D03DPD DRUGINKE NRTVMMGXEUIAJK-VZBVTIHGSA-N D03DPD DRUGSMIL CCCCC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C(C)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC3CC(=O)NCCCC(NC(C(=O)NC(C(=O)C(NC3=O)CCCCN)CC4=CC=CC=C4)CC5=CNC=N5)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)N7CCCC7C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N8CCCC8C(=O)N)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D03DPD HIGHSTAT Investigative D03DRL DRUG__ID D03DRL D03DRL DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)38-60-72(99)89-65(46(3)92)74(101)86-62(39-50-23-13-8-14-24-50)76(103)90(5)66(47(4)93)75(102)87-63(42-91)73(100)88-64(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-61(71(98)84-60)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,98)(H,85,97)(H,86,101)(H,87,102)(H,88,100)(H,89,99)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D03DRL DRUGINKE NJKZOMFLMSOAAY-PCKPOTSRSA-N D03DRL DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)C)CC7=CC=CC=C7)C(C)O D03DRL HIGHSTAT Investigative D03DSG DRUG__ID D03DSG D03DSG DRUGINCH 1S/C47H68N14O9S/c1-24(2)15-35(44(67)57-34(40(48)63)13-14-71-8)59-46(69)38(18-31-21-50-23-53-31)58-41(64)26(5)55-47(70)39(25(3)4)61-42(65)27(6)54-43(66)36(16-29-19-51-33-12-10-9-11-32(29)33)60-45(68)37(56-28(7)62)17-30-20-49-22-52-30/h9-12,19-27,34-39,51H,13-18H2,1-8H3,(H2,48,63)(H,49,52)(H,50,53)(H,54,66)(H,55,70)(H,56,62)(H,57,67)(H,58,64)(H,59,69)(H,60,68)(H,61,65)/t26-,27+,34+,35+,36+,37+,38+,39+/m1/s1 D03DSG DRUGINKE FLMAIOAFTCGWGR-UGUXQERMSA-N D03DSG DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C D03DSG HIGHSTAT Investigative D03DXK DRUG__ID D03DXK D03DXK DRUGINCH 1S/C47H67N11O11S2/c1-27(2)21-32-42(64)56-35(24-38(49)60)45(67)57-36(47(69)58-19-8-12-37(58)46(68)53-31(11-6-7-18-48)41(63)51-25-39(50)61)26-71-70-20-17-40(62)52-33(23-29-13-15-30(59)16-14-29)43(65)55-34(44(66)54-32)22-28-9-4-3-5-10-28/h3-5,9-10,13-16,27,31-37,59H,6-8,11-12,17-26,48H2,1-2H3,(H2,49,60)(H2,50,61)(H,51,63)(H,52,62)(H,53,68)(H,54,66)(H,55,65)(H,56,64)(H,57,67)/t31-,32-,33-,34-,35-,36-,37-/m0/s1 D03DXK DRUGINKE QGZMLGLFLYCDQT-PEAOEFARSA-N D03DXK DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCCN)C(=O)NCC(=O)N)CC(=O)N D03DXK HIGHSTAT Investigative D03EBH DRUG__ID D03EBH D03EBH DRUGINCH 1S/C52H75N11O13S2/c1-5-28(2)40-47(73)59-41(29(3)64)48(74)57-35(25-38(54)67)45(71)58-36(27-77-78-52(21-7-6-8-22-52)26-39(68)62-51(4,50(76)61-40)31-15-19-33(66)20-16-31)49(75)63-24-10-12-37(63)46(72)56-34(11-9-23-53)44(70)60-42(43(55)69)30-13-17-32(65)18-14-30/h13-20,28-29,34-37,40-42,64-66H,5-12,21-27,53H2,1-4H3,(H2,54,67)(H2,55,69)(H,56,72)(H,57,74)(H,58,71)(H,59,73)(H,60,70)(H,61,76)(H,62,68)/t28?,29?,34-,35+,36+,37+,40+,41+,42-,51+/m0/s1 D03EBH DRUGINKE MRGPBAZYRUEDDT-YHXQAOAKSA-N D03EBH DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)N1)(C)C3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCN)C(=O)NC(C5=CC=C(C=C5)O)C(=O)N)CC(=O)N)C(C)O D03EBH HIGHSTAT Investigative D03ECE DRUG__ID D03ECE D03ECE DRUGINCH 1S/C96H157N23O23/c1-11-12-13-14-15-34-78(124)103-42-25-21-32-67(86(131)109-65(83(101)128)29-18-22-39-97)111-87(132)66(30-19-23-40-98)110-88(133)68(31-20-24-41-99)112-94(139)75-33-26-43-119(75)80(126)52-106-85(130)69(44-55(2)3)113-89(134)70(45-56(4)5)114-91(136)72(47-60-35-37-62(122)38-36-60)108-79(125)51-105-84(129)58(8)107-93(138)74(54-120)117-92(137)73(49-77(100)123)115-90(135)71(46-57(6)7)116-96(141)82(59(9)121)118-95(140)76(142-81(127)53-102-10)48-61-50-104-64-28-17-16-27-63(61)64/h16-17,27-28,35-38,50,55-59,65-76,82,102,104,120-122H,11-15,18-26,29-34,39-49,51-54,97-99H2,1-10H3,(H2,100,123)(H2,101,128)(H,103,124)(H,105,129)(H,106,130)(H,107,138)(H,108,125)(H,109,131)(H,110,133)(H,111,132)(H,112,139)(H,113,134)(H,114,136)(H,115,135)(H,116,141)(H,117,137)(H,118,140)/t58-,59+,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,82-/m0/s1 D03ECE DRUGINKE XODIEYZRWNAUJL-MBNUXEJASA-N D03ECE DRUGSMIL CCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D03ECE HIGHSTAT Investigative D03EHS DRUG__ID D03EHS D03EHS DRUGINCH 1S/C61H85N11O18S/c1-6-8-20-42(66-57(82)47(32-37-24-26-39(27-25-37)90-91(86,87)88)69-56(81)45(28-29-50(73)74)72-60(85)89-61(3,4)5)53(78)65-44(23-15-16-30-62)55(80)70-48(33-38-35-64-41-22-14-13-19-40(38)41)58(83)67-43(21-9-7-2)54(79)71-49(34-51(75)76)59(84)68-46(52(63)77)31-36-17-11-10-12-18-36/h10-14,17-19,22,24-27,35,42-49,64H,6-9,15-16,20-21,23,28-34,62H2,1-5H3,(H2,63,77)(H,65,78)(H,66,82)(H,67,83)(H,68,84)(H,69,81)(H,70,80)(H,71,79)(H,72,85)(H,73,74)(H,75,76)(H,86,87,88)/t42-,43-,44-,45+,46-,47-,48-,49-/m0/s1 D03EHS DRUGINKE NLVKBXFAISROGJ-LMZFJFGWSA-N D03EHS DRUGSMIL CCCCC(C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CCC(=O)O)NC(=O)OC(C)(C)C D03EHS HIGHSTAT Investigative D03GNM DRUG__ID D03GNM D03GNM DRUGINCH 1S/C61H107N27O14S/c1-100-29-30-101-28-27-73-50(93)34(13-6-8-21-71-41(89)19-5-4-18-40-43-39(31-103-40)86-61(99)87-43)82-52(95)36(15-10-24-75-58(65)66)84-54(97)38(17-12-26-77-60(69)70)85-53(96)37(16-11-25-76-59(67)68)83-51(94)35(14-9-23-74-57(63)64)81-42(90)20-3-2-7-22-72-55(98)47-45(91)46(92)56(102-47)88-33-80-44-48(62)78-32-79-49(44)88/h32-40,43,45-47,56,91-92H,2-31H2,1H3,(H,71,89)(H,72,98)(H,73,93)(H,81,90)(H,82,95)(H,83,94)(H,84,97)(H,85,96)(H2,62,78,79)(H4,63,64,74)(H4,65,66,75)(H4,67,68,76)(H4,69,70,77)(H2,86,87,99)/t34?,35-,36-,37-,38-,39-,40-,43-,45-,46+,47-,56+/m0/s1 D03GNM DRUGINKE HKRIJYTUBFTJDB-GQHJETKOSA-N D03GNM DRUGSMIL COCCOCCNC(=O)C(CCCCNC(=O)CCCCC1C2C(CS1)NC(=O)N2)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CCCCCNC(=O)C3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O D03GNM HIGHSTAT Investigative D03JDY DRUG__ID D03JDY D03JDY DRUGINCH 1S/C80H102ClN15O14S/c1-46(2)38-63(71(101)89-62(19-12-13-36-84-47(3)4)80(109)96-37-15-20-69(96)77(107)85-48(5)70(82)100)90-73(103)66(41-53-24-31-60(32-25-53)86-49(6)97)92-75(105)67(42-54-26-33-61(34-27-54)87-50(7)98)94-78(108)79(111(9)110)95-76(106)68(44-56-16-14-35-83-45-56)93-74(104)65(40-52-22-29-59(81)30-23-52)91-72(102)64(88-51(8)99)43-55-21-28-57-17-10-11-18-58(57)39-55/h10-11,14,16-18,21-35,39,45-48,62-69,79,84H,12-13,15,19-20,36-38,40-44H2,1-9H3,(H2,82,100)(H,85,107)(H,86,97)(H,87,98)(H,88,99)(H,89,101)(H,90,103)(H,91,102)(H,92,105)(H,93,104)(H,94,108)(H,95,106)/t48-,62+,63+,64-,65-,66-,67+,68-,69+,79+,111?/m1/s1 D03JDY DRUGINKE VCYXYVFYPVPVGF-SBGSYDNWSA-N D03JDY DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)S(=O)C D03JDY HIGHSTAT Investigative D03JRA DRUG__ID D03JRA D03JRA DRUGINCH 1S/C3H5NO/c5-3-1-2-4-3/h1-2H2,(H,4,5) D03JRA DRUGINKE MNFORVFSTILPAW-UHFFFAOYSA-N D03JRA DRUGSMIL C1CNC1=O D03JRA HIGHSTAT Investigative D03JYD DRUG__ID D03JYD D03JYD DRUGINCH 1S/C16H26N2O3S/c1-4-21-10-18-15(22-12-8-6-5-7-9-12)13(11(2)3)14(19)17-16(18)20/h11-12H,4-10H2,1-3H3,(H,17,19,20) D03JYD DRUGINKE JKXLRLDPSLZEDD-UHFFFAOYSA-N D03JYD DRUGSMIL CCOCN1C(=C(C(=O)NC1=O)C(C)C)SC2CCCCC2 D03JYD HIGHSTAT Investigative D03SHO DRUG__ID D03SHO D03SHO DRUGINCH 1S/C65H99N21O18S2/c1-10-31(6)51(76-34(9)88)64(104)83-45-27-106-105-26-44(61(101)86-52(33(8)87)53(67)93)82-56(96)39(16-13-19-71-65(68)69)77-58(98)42(21-36-24-70-28-74-36)79-54(94)32(7)75-47(90)25-73-55(95)41(20-35-23-72-38-15-12-11-14-37(35)38)80-59(99)43(22-48(91)92)81-57(97)40(17-18-46(66)89)78-62(102)49(29(2)3)85-63(103)50(30(4)5)84-60(45)100/h11-12,14-15,23-24,28-33,39-45,49-52,72,87H,10,13,16-22,25-27H2,1-9H3,(H2,66,89)(H2,67,93)(H,70,74)(H,73,95)(H,75,90)(H,76,88)(H,77,98)(H,78,102)(H,79,94)(H,80,99)(H,81,97)(H,82,96)(H,83,104)(H,84,100)(H,85,103)(H,86,101)(H,91,92)(H4,68,69,71)/t31-,32-,33+,39-,40-,41-,42+,43+,44-,45-,49+,50-,51-,52-/m0/s1 D03SHO DRUGINKE OSAZHXWZENYRCV-WKOWKQLHSA-N D03SHO DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C(C)C)CCC(=O)N)CC(=O)O)CC2=CNC3=CC=CC=C32)C)CC4=CN=CN4)CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D03SHO HIGHSTAT Investigative D03SXC DRUG__ID D03SXC D03SXC DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)38-59-70(97)88-65(46(3)92)74(101)84-60(37-49-21-11-7-12-22-49)71(98)89-66(47(4)93)75(102)86-62(42-91)72(99)87-63(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)85-61(39-50-23-13-8-14-24-50)76(103)90(5)64(73(100)83-59)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,100)(H,84,101)(H,85,96)(H,86,102)(H,87,99)(H,88,97)(H,89,98)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D03SXC DRUGINKE QWPPERHSUFQZTH-PCKPOTSRSA-N D03SXC DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)C)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D03SXC HIGHSTAT Investigative D03VDJ DRUG__ID D03VDJ D03VDJ DRUGINCH 1S/H3NO3S/c1-5(2,3)4/h(H3,1,2,3,4)/p-1 D03VDJ DRUGINKE IIACRCGMVDHOTQ-UHFFFAOYSA-M D03VDJ DRUGSMIL NS(=O)(=O)[O-] D03VDJ HIGHSTAT Investigative D03VEQ DRUG__ID D03VEQ D03VEQ DRUGINCH 1S/C58H93N21O13S2/c1-3-32(2)46-54(90)78-43(53(89)75-38(16-10-24-68-57(63)64)49(85)76-40(55(91)92)14-7-8-22-59)31-94-93-30-42(52(88)74-37(15-9-23-67-56(61)62)48(84)73-39(50(86)79-46)17-11-25-69-58(65)66)77-51(87)41(27-33-12-5-4-6-13-33)72-45(82)29-70-44(81)28-71-47(83)36(60)26-34-18-20-35(80)21-19-34/h4-6,12-13,18-21,32,36-43,46,80H,3,7-11,14-17,22-31,59-60H2,1-2H3,(H,70,81)(H,71,83)(H,72,82)(H,73,84)(H,74,88)(H,75,89)(H,76,85)(H,77,87)(H,78,90)(H,79,86)(H,91,92)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t32-,36-,37+,38+,39-,40+,41-,42+,43+,46+/m0/s1 D03VEQ DRUGINKE MRWXDNZOCJXRHP-KCSCKQEISA-N D03VEQ DRUGSMIL CCC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCN=C(N)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)O D03VEQ HIGHSTAT Investigative D03VFP DRUG__ID D03VFP D03VFP DRUGINCH 1S/C166H254N48O39/c1-86(2)69-112-148(238)192-104(51-31-35-63-178-125(220)60-58-110(146(236)202-117(75-100-79-176-85-187-100)150(240)194-108(144(234)199-112)54-38-66-181-166(174)175)197-159(249)133(90(9)10)209-153(243)116(189-95(17)217)74-99-78-182-102-48-28-27-47-101(99)102)140(230)185-82-127(222)190-109-57-59-124(219)177-62-34-30-50-103(191-142(232)107(53-37-65-180-165(172)173)195-155(245)120(84-215)206-149(239)113(70-87(3)4)200-145(109)235)139(229)184-80-126(221)183-81-128(223)207-132(89(7)8)161(251)210-134(91(11)12)160(250)196-106(52-32-36-64-179-164(170)171)141(231)193-105(49-29-33-61-167)143(233)203-118(76-123(168)218)151(241)201-115(73-98-45-25-20-26-46-98)152(242)211-135(92(13)14)163(253)214-68-40-56-122(214)157(247)212-136(94(16)216)162(252)205-119(77-130(225)226)154(244)208-131(88(5)6)158(248)186-83-129(224)213-67-39-55-121(213)156(246)204-114(72-97-43-23-19-24-44-97)147(237)188-93(15)138(228)198-111(137(169)227)71-96-41-21-18-22-42-96/h18-28,41-48,78-79,85-94,103-122,131-136,182,215-216H,29-40,49-77,80-84,167H2,1-17H3,(H2,168,218)(H2,169,227)(H,176,187)(H,177,219)(H,178,220)(H,183,221)(H,184,229)(H,185,230)(H,186,248)(H,188,237)(H,189,217)(H,190,222)(H,191,232)(H,192,238)(H,193,231)(H,194,240)(H,195,245)(H,196,250)(H,197,249)(H,198,228)(H,199,234)(H,200,235)(H,201,241)(H,202,236)(H,203,233)(H,204,246)(H,205,252)(H,206,239)(H,207,223)(H,208,244)(H,209,243)(H,210,251)(H,211,242)(H,212,247)(H,225,226)(H4,170,171,179)(H4,172,173,180)(H4,174,175,181)/t93-,94+,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,131-,132-,133-,134-,135-,136-/m0/s1 D03VFP DRUGINKE WKTOEIRIAWMLPL-KFCCYEGLSA-N D03VFP DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(C(=O)NC(CCCCNC(=O)CCC(C(=O)N1)NC(=O)CNC(=O)C2CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(C)C)CCCN=C(N)N)CC3=CN=CN3)NC(=O)C(C(C)C)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(C(C)C)C(=O)N7CCCC7C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N8CCCC8C(=O)NC(CC9=CC=CC=C9)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)N)CCCN=C(N)N)CO D03VFP HIGHSTAT Investigative D03VHX DRUG__ID D03VHX D03VHX DRUGINCH 1S/C77H99N13O16S2/c1-44(2)80-40-51-25-23-50(24-26-51)39-64-73(101)89-66(46(4)93)74(102)84-60(37-49-28-31-55(94)32-29-49)71(99)88-65(45(3)92)75(103)86-62(41-91)72(100)87-63(77(105)106)43-108-107-42-56(79)67(95)81-57(22-14-15-33-78)68(96)82-58(35-47-16-8-6-9-17-47)69(97)83-59(36-48-18-10-7-11-19-48)70(98)85-61(76(104)90(64)5)38-52-27-30-53-20-12-13-21-54(53)34-52/h6-13,16-21,23-32,34,44-46,56-66,80,91-94H,14-15,22,33,35-43,78-79H2,1-5H3,(H,81,95)(H,82,96)(H,83,97)(H,84,102)(H,85,98)(H,86,103)(H,87,100)(H,88,99)(H,89,101)(H,105,106)/t45-,46-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D03VHX DRUGINKE UJXURZZWDWWNQY-SKAXSEQXSA-N D03VHX DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=C(C=C7)O)C(C)O D03VHX HIGHSTAT Investigative D03VUQ DRUG__ID D03VUQ D03VUQ DRUGINCH 1S/C13H12N2O3S/c14-19(17,18)13-7-3-11(4-8-13)15-9-10-1-5-12(16)6-2-10/h1-9,16H,(H2,14,17,18) D03VUQ DRUGINKE QEZYWFVOEUVTBF-UHFFFAOYSA-N D03VUQ DRUGSMIL C1=CC(=CC=C1C=NC2=CC=C(C=C2)S(=O)(=O)N)O D03VUQ HIGHSTAT Investigative D03WBD DRUG__ID D03WBD D03WBD DRUGINCH 1S/C60H81N11O16/c1-32(2)48(57(83)62-30-46(74)70-24-16-23-44(70)55(81)64-41(26-37-19-12-8-13-20-37)53(79)63-34(5)51(77)66-43(60(86)87)27-38-21-14-9-15-22-38)67-54(80)42(29-47(75)76)65-58(84)50(35(6)72)69-56(82)45-28-39(73)31-71(45)59(85)49(33(3)4)68-52(78)40(61)25-36-17-10-7-11-18-36/h7-15,17-22,32-35,39-45,48-50,72-73H,16,23-31,61H2,1-6H3,(H,62,83)(H,63,79)(H,64,81)(H,65,84)(H,66,77)(H,67,80)(H,68,78)(H,69,82)(H,75,76)(H,86,87)/t34-,35+,39+,40-,41-,42-,43-,44-,45-,48-,49-,50-/m0/s1 D03WBD DRUGINKE RYURPNQKLUHMSX-UVHAUATQSA-N D03WBD DRUGSMIL CC(C)C(C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C4CC(CN4C(=O)C(C(C)C)NC(=O)C(CC5=CC=CC=C5)N)O D03WBD HIGHSTAT Investigative D03WGS DRUG__ID D03WGS D03WGS DRUGINCH 1S/C55H65N9O14/c1-4-5-19-40(51(72)61-45(55(77)78)28-37-31-64(33(3)65)46-20-13-12-18-39(37)46)58-52(73)41(29-48(68)69)59-53(74)43(26-35-16-10-7-11-17-35)63-62-42(25-34-14-8-6-9-15-34)50(71)56-30-47(67)57-32(2)49(70)60-44(54(75)76)27-36-21-23-38(66)24-22-36/h6-18,20-24,31-32,40-45,62-63,66H,4-5,19,25-30H2,1-3H3,(H,56,71)(H,57,67)(H,58,73)(H,59,74)(H,60,70)(H,61,72)(H,68,69)(H,75,76)(H,77,78)/t32-,40+,41+,42+,43+,44+,45+/m1/s1 D03WGS DRUGINKE RBNPCZIQGBMFDV-FPWNPRTMSA-N D03WGS DRUGSMIL CCCCC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C(=O)C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=CC=C3)NNC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O D03WGS HIGHSTAT Investigative D03XYG DRUG__ID D03XYG D03XYG DRUGINCH 1S/C9H9NO/c1-10-8-5-3-2-4-7(8)6-9(10)11/h2-5H,6H2,1H3 D03XYG DRUGINKE RSQUAQMIGSMNNE-UHFFFAOYSA-N D03XYG DRUGSMIL CN1C(=O)CC2=CC=CC=C21 D03XYG HIGHSTAT Investigative D03YDP DRUG__ID D03YDP D03YDP DRUGINCH 1S/C152H227N41O47/c1-16-77(10)122(149(238)170-80(13)127(216)179-105(60-86-63-162-91-34-24-23-33-89(86)91)139(228)181-101(56-74(4)5)140(229)190-120(75(6)7)147(236)178-93(35-25-26-52-153)130(219)165-67-114(204)171-92(36-28-54-161-152(157)158)129(218)163-65-111(156)201)192-141(230)103(57-83-29-19-17-20-30-83)182-136(225)99(46-51-118(210)211)176-133(222)94-37-27-53-160-112(202)48-43-97(134(223)174-96(42-47-110(155)200)132(221)169-78(11)125(214)168-79(12)126(215)173-94)175-135(224)98(45-50-117(208)209)177-137(226)100(55-73(2)3)180-138(227)102(59-85-38-40-88(199)41-39-85)183-144(233)107(69-194)186-146(235)109(71-196)187-148(237)121(76(8)9)191-143(232)106(62-119(212)213)184-145(234)108(70-195)188-151(240)124(82(15)198)193-142(231)104(58-84-31-21-18-22-32-84)185-150(239)123(81(14)197)189-115(205)68-166-131(220)95(44-49-116(206)207)172-113(203)66-164-128(217)90(154)61-87-64-159-72-167-87/h17-24,29-34,38-41,63-64,72-82,90,92-109,120-124,162,194-199H,16,25-28,35-37,42-62,65-71,153-154H2,1-15H3,(H2,155,200)(H2,156,201)(H,159,167)(H,160,202)(H,163,218)(H,164,217)(H,165,219)(H,166,220)(H,168,214)(H,169,221)(H,170,238)(H,171,204)(H,172,203)(H,173,215)(H,174,223)(H,175,224)(H,176,222)(H,177,226)(H,178,236)(H,179,216)(H,180,227)(H,181,228)(H,182,225)(H,183,233)(H,184,234)(H,185,239)(H,186,235)(H,187,237)(H,188,240)(H,189,205)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,206,207)(H,208,209)(H,210,211)(H,212,213)(H4,157,158,161)/t77-,78-,79-,80-,81-,82-,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,120-,121-,122-,123-,124-/m0/s1 D03YDP DRUGINKE KMMGHNYLBGRIJN-NINLSKNRSA-N D03YDP DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C4CCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)C)C)CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D03YDP HIGHSTAT Investigative D03YHT DRUG__ID D03YHT D03YHT DRUGINCH 1S/C80H102ClN15O15S/c1-46(2)37-62(71(102)88-61(18-11-12-35-84-47(3)4)80(110)96-36-14-19-69(96)78(109)95-79(70(82)101)112(8)111)89-73(104)65(40-52-23-30-59(31-24-52)85-48(5)98)91-75(106)66(41-53-25-32-60(33-26-53)86-49(6)99)93-77(108)68(45-97)94-76(107)67(43-55-15-13-34-83-44-55)92-74(105)64(39-51-21-28-58(81)29-22-51)90-72(103)63(87-50(7)100)42-54-20-27-56-16-9-10-17-57(56)38-54/h9-10,13,15-17,20-34,38,44,46-47,61-69,79,84,97H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,98)(H,86,99)(H,87,100)(H,88,102)(H,89,104)(H,90,103)(H,91,106)(H,92,105)(H,93,108)(H,94,107)(H,95,109)/t61-,62-,63+,64+,65+,66-,67+,68-,69-,79-,112?/m0/s1 D03YHT DRUGINKE SELUBVJEWYERMJ-DDPYUAONSA-N D03YHT DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)N)S(=O)C)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D03YHT HIGHSTAT Investigative D03YVX DRUG__ID D03YVX D03YVX DRUGINCH 1S/C18H16N2O/c21-18-16(12-14-4-8-19-9-5-14)2-1-3-17(18)13-15-6-10-20-11-7-15/h4-13H,1-3H2/b16-12+,17-13+ D03YVX DRUGINKE CYVVJSKZRBZHAV-UNZYHPAISA-N D03YVX DRUGSMIL C1CC(=CC2=CC=NC=C2)C(=O)C(=CC3=CC=NC=C3)C1 D03YVX HIGHSTAT Investigative D04BVX DRUG__ID D04BVX D04BVX DRUGINCH 1S/C80H102ClN15O15S/c1-46(2)37-62(71(102)88-61(18-11-12-35-84-47(3)4)80(110)96-36-14-19-69(96)78(109)95-79(70(82)101)112(8)111)89-73(104)65(40-52-23-30-59(31-24-52)85-48(5)98)91-75(106)66(41-53-25-32-60(33-26-53)86-49(6)99)93-77(108)68(45-97)94-76(107)67(43-55-15-13-34-83-44-55)92-74(105)64(39-51-21-28-58(81)29-22-51)90-72(103)63(87-50(7)100)42-54-20-27-56-16-9-10-17-57(56)38-54/h9-10,13,15-17,20-34,38,44,46-47,61-69,79,84,97H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,98)(H,86,99)(H,87,100)(H,88,102)(H,89,104)(H,90,103)(H,91,106)(H,92,105)(H,93,108)(H,94,107)(H,95,109)/t61-,62-,63+,64+,65+,66-,67+,68-,69-,79+,112?/m0/s1 D04BVX DRUGINKE SELUBVJEWYERMJ-PGGNZVFSSA-N D04BVX DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)N)S(=O)C)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D04BVX HIGHSTAT Investigative D04CVC DRUG__ID D04CVC D04CVC DRUGINCH 1S/C6H7FN2O2S/c7-5-3-4(12(9,10)11)1-2-6(5)8/h1-3H,8H2,(H2,9,10,11) D04CVC DRUGINKE HVFBADWBKHAPKV-UHFFFAOYSA-N D04CVC DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)F)N D04CVC HIGHSTAT Investigative D04DZP DRUG__ID D04DZP D04DZP DRUGINCH 1S/C54H80N14O11/c1-10-32(6)44(50(74)64-41(52(76)77)23-36-26-57-29-60-36)67-49(73)43(31(4)5)66-47(71)37(19-30(2)3)61-46(70)39(21-34-24-55-27-58-34)62-45(69)38(20-33-15-12-11-13-16-33)63-48(72)42-17-14-18-68(42)51(75)40(22-35-25-56-28-59-35)65-53(78)79-54(7,8)9/h11-13,15-16,24-32,37-44,47,66,71H,10,14,17-23H2,1-9H3,(H,55,58)(H,56,59)(H,57,60)(H,61,70)(H,62,69)(H,63,72)(H,64,74)(H,65,78)(H,67,73)(H,76,77) D04DZP DRUGINKE UIOXZRLXAROYRL-UHFFFAOYSA-N D04DZP DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)O)NC(=O)C(C(C)C)NC(C(CC(C)C)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)OC(C)(C)C)O D04DZP HIGHSTAT Investigative D04EWA DRUG__ID D04EWA D04EWA DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)39-59-70(97)88-65(46(3)92)74(101)85-60(38-50-23-13-8-14-24-50)71(98)89-66(47(4)93)75(102)86-62(42-91)72(99)87-63(77(104)105)44-107-106-43-56(79)76(103)90(5)64(27-17-18-34-78)73(100)84-58(37-49-21-11-7-12-22-49)68(95)81-57(36-48-19-9-6-10-20-48)67(94)83-61(69(96)82-59)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,95)(H,82,96)(H,83,94)(H,84,100)(H,85,101)(H,86,102)(H,87,99)(H,88,97)(H,89,98)(H,104,105)/t46-,47-,56-,57+,58-,59+,60+,61+,62+,63+,64-,65-,66-/m1/s1 D04EWA DRUGINKE MQVPKOMHWCOKLK-DXVDGIIASA-N D04EWA DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)C)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D04EWA HIGHSTAT Investigative D04FPW DRUG__ID D04FPW D04FPW DRUGINCH 1S/C74H88N12O14S2/c1-42(2)76-38-50-26-24-49(25-27-50)36-58-69(94)85-63(43(3)87)72(97)82-59(35-47-20-12-7-13-21-47)70(95)86-64(44(4)88)73(98)84-62(74(99)100)41-102-101-40-61(83-65(90)54(75)32-48-28-30-52(89)31-29-48)71(96)80-57(34-46-18-10-6-11-19-46)66(91)78-56(33-45-16-8-5-9-17-45)67(92)81-60(68(93)79-58)37-51-39-77-55-23-15-14-22-53(51)55/h5-31,39,42-44,54,56-64,76-77,87-89H,32-38,40-41,75H2,1-4H3,(H,78,91)(H,79,93)(H,80,96)(H,81,92)(H,82,97)(H,83,90)(H,84,98)(H,85,94)(H,86,95)(H,99,100)/t43-,44-,54+,56+,57-,58+,59+,60+,61-,62+,63-,64-/m1/s1 D04FPW DRUGINKE GYAXOXYXFASSKI-GAZSGENXSA-N D04FPW DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)NC(=O)C(CC7=CC=C(C=C7)O)N)C(=O)O)C(C)O)CC8=CC=CC=C8)C(C)O D04FPW HIGHSTAT Investigative D04FQA DRUG__ID D04FQA D04FQA DRUGINCH 1S/C21H25NO2/c1-15-4-8-17(9-5-15)20(23)19-14-22(3)13-12-21(19,24)18-10-6-16(2)7-11-18/h4-11,19,24H,12-14H2,1-3H3 D04FQA DRUGINKE SWFNNRQTSSTAGB-UHFFFAOYSA-N D04FQA DRUGSMIL CC1=CC=C(C=C1)C(=O)C2CN(CCC2(C3=CC=C(C=C3)C)O)C D04FQA HIGHSTAT Investigative D04GXL DRUG__ID D04GXL D04GXL DRUGINCH 1S/C56H86N10O12S.Na/c1-9-39(6)51(55(73)58-35-42-22-17-18-27-66(42)75)62-52(70)43(38(4)5)33-48(67)44(30-37(2)3)60-54(72)47(32-41-34-57-36-59-41)64(8)56(74)45(31-40-20-13-12-14-21-40)61-53(71)46-23-19-26-65(46)50(69)25-16-11-10-15-24-49(68)63(7)28-29-79(76,77)78;/h12-14,17-18,20-22,27,34,36-39,43-48,51,67H,9-11,15-16,19,23-26,28-33,35H2,1-8H3,(H,57,59)(H,58,73)(H,60,72)(H,61,71)(H,62,70)(H,76,77,78);/q;+1/p-1 D04GXL DRUGINKE RWEIQAJIARNFKO-UHFFFAOYSA-M D04GXL DRUGSMIL CCC(C)C(C(=O)NCC1=CC=CC=[N+]1[O-])NC(=O)C(CC(C(CC(C)C)NC(=O)C(CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)CCCCCCC(=O)N(C)CCS(=O)(=O)[O-])O)C(C)C.[Na+] D04GXL HIGHSTAT Investigative D04HPP DRUG__ID D04HPP D04HPP DRUGINCH 1S/C76H100ClN15O15S/c1-42(2)80-34-12-11-16-58(76(107)92-35-13-17-64(92)73(105)81-44(5)66(79)98)86-74(106)75(108-43(3)4)91-71(103)62(39-50-23-30-56(31-24-50)83-46(7)95)88-70(102)61(38-49-21-28-55(29-22-49)82-45(6)94)89-72(104)63(41-93)90-67(99)57(32-33-65(78)97)85-69(101)60(37-48-19-26-54(77)27-20-48)87-68(100)59(84-47(8)96)40-51-18-25-52-14-9-10-15-53(52)36-51/h9-10,14-15,18-31,36,42-44,57-64,75,80,93H,11-13,16-17,32-35,37-41H2,1-8H3,(H2,78,97)(H2,79,98)(H,81,105)(H,82,94)(H,83,95)(H,84,96)(H,85,101)(H,86,106)(H,87,100)(H,88,102)(H,89,104)(H,90,99)(H,91,103)/t44-,57-,58+,59-,60-,61+,62-,63+,64+,75-/m1/s1 D04HPP DRUGINKE JPMOBCPTBLZEAW-YSZAJMORSA-N D04HPP DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)SC(C)C D04HPP HIGHSTAT Investigative D04IUW DRUG__ID D04IUW D04IUW DRUGINCH 1S/C95H125N23O24S2/c1-7-48(4)78-93(139)117-30-14-24-69(117)87(133)102-43-75(123)104-61(34-52-39-98-58-22-12-9-19-55(52)58)84(130)107-63(36-73(96)121)85(131)114-79(50(6)120)94(140)118-31-17-27-72(118)89(135)110-62(35-53-40-99-59-23-13-10-20-56(53)59)83(129)103-49(5)80(126)112-68(95(141)142)46-144-143-45-67-92(138)116-29-16-26-71(116)90(136)111-66(44-119)86(132)108-64(37-74(122)113-78)82(128)101-41-76(124)105-65(32-47(2)3)91(137)115-28-15-25-70(115)88(134)109-60(81(127)100-42-77(125)106-67)33-51-38-97-57-21-11-8-18-54(51)57/h8-13,18-23,38-40,47-50,60-72,78-79,97-99,119-120H,7,14-17,24-37,41-46H2,1-6H3,(H2,96,121)(H,100,127)(H,101,128)(H,102,133)(H,103,129)(H,104,123)(H,105,124)(H,106,125)(H,107,130)(H,108,132)(H,109,134)(H,110,135)(H,111,136)(H,112,126)(H,113,122)(H,114,131)(H,141,142)/t48-,49-,50+,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,78-,79-/m0/s1 D04IUW DRUGINKE VXOKYTDMQDFAQT-VJFZWUEESA-N D04IUW DRUGSMIL CCC(C)C1C(=O)N2CCCC2C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(CC(=O)N1)C(=O)NCC(=O)NC(C(=O)N6CCCC6C(=O)NC(C(=O)NCC(=O)N4)CC7=CNC8=CC=CC=C87)CC(C)C)CO)C(=O)O)C)CC9=CNC1=CC=CC=C19)C(C)O)CC(=O)N)CC1=CNC2=CC=CC=C21 D04IUW HIGHSTAT Investigative D04LSW DRUG__ID D04LSW D04LSW DRUGINCH 1S/C153H232N42O45/c1-15-80(10)124(150(238)172-82(12)128(216)181-107(62-88-65-164-93-36-23-22-35-91(88)93)140(228)183-103(58-77(4)5)141(229)192-122(78(6)7)148(236)180-95(37-24-27-53-154)131(219)167-69-116(206)173-94(40-30-56-163-153(159)160)130(218)165-67-113(158)203)194-142(230)105(59-85-31-18-16-19-32-85)184-137(225)101(48-52-120(211)212)179-136(224)97(38-25-28-54-155)177-135(223)96-39-26-29-55-162-114(204)50-46-99(133(221)168-70-117(207)175-100(45-49-112(157)202)134(222)171-81(11)127(215)176-96)178-138(226)102(57-76(2)3)182-139(227)104(61-87-41-43-90(201)44-42-87)185-145(233)109(72-196)188-147(235)111(74-198)189-149(237)123(79(8)9)193-144(232)108(64-121(213)214)186-146(234)110(73-197)190-152(240)126(84(14)200)195-143(231)106(60-86-33-20-17-21-34-86)187-151(239)125(83(13)199)191-118(208)71-169-132(220)98(47-51-119(209)210)174-115(205)68-166-129(217)92(156)63-89-66-161-75-170-89/h16-23,31-36,41-44,65-66,75-84,92,94-111,122-126,164,196-201H,15,24-30,37-40,45-64,67-74,154-156H2,1-14H3,(H2,157,202)(H2,158,203)(H,161,170)(H,162,204)(H,165,218)(H,166,217)(H,167,219)(H,168,221)(H,169,220)(H,171,222)(H,172,238)(H,173,206)(H,174,205)(H,175,207)(H,176,215)(H,177,223)(H,178,226)(H,179,224)(H,180,236)(H,181,216)(H,182,227)(H,183,228)(H,184,225)(H,185,233)(H,186,234)(H,187,239)(H,188,235)(H,189,237)(H,190,240)(H,191,208)(H,192,229)(H,193,232)(H,194,230)(H,195,231)(H,209,210)(H,211,212)(H,213,214)(H4,159,160,163)/t80-,81-,82-,83+,84+,92-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,122-,123-,124-,125-,126-/m0/s1 D04LSW DRUGINKE QOGYXVBERDYIBU-ZKFPJBBCSA-N D04LSW DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C4CCCCNC(=O)CCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N4)C)CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D04LSW HIGHSTAT Investigative D04MCL DRUG__ID D04MCL D04MCL DRUGINCH 1S/C88H120N28O22/c1-87(2)61(115(59-30-28-47-18-10-12-20-49(47)73(59)87)37-32-63(117)107-51(22-14-33-99-83(91)92)77(133)103-44-66(120)111-57(40-71(127)128)81(137)113-53(24-16-35-101-85(95)96)79(135)105-42-64(118)109-55(75(89)131)38-69(123)124)26-8-6-5-7-9-27-62-88(3,4)74-50-21-13-11-19-48(50)29-31-60(74)116(62)46-68(122)108-52(23-15-34-100-84(93)94)78(134)104-45-67(121)112-58(41-72(129)130)82(138)114-54(25-17-36-102-86(97)98)80(136)106-43-65(119)110-56(76(90)132)39-70(125)126/h5-13,18-21,26-31,51-58H,14-17,22-25,32-46H2,1-4H3,(H35-,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138)/p+1/t51-,52-,53-,54-,55+,56+,57+,58+/m0/s1 D04MCL DRUGINKE UFEFOGNPPROIQU-SESQYOPQSA-O D04MCL DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N)C=CC=CC=CC=C4C(C5=C(N4CCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N)C=CC6=CC=CC=C65)(C)C)C D04MCL HIGHSTAT Investigative D04MMD DRUG__ID D04MMD D04MMD DRUGINCH 1S/C47H68N14O11S2/c48-18-5-4-10-30(40(66)54-25-38(50)64)57-45(71)36-12-7-20-61(36)46(72)35-26-74-73-21-17-39(65)55-32(23-28-13-15-29(62)16-14-28)42(68)58-33(22-27-8-2-1-3-9-27)43(69)56-31(11-6-19-53-47(51)52)41(67)59-34(24-37(49)63)44(70)60-35/h1-3,8-9,13-16,30-36,62H,4-7,10-12,17-26,48H2,(H2,49,63)(H2,50,64)(H,54,66)(H,55,65)(H,56,69)(H,57,71)(H,58,68)(H,59,67)(H,60,70)(H4,51,52,53)/t30-,31-,32-,33-,34-,35-,36-/m0/s1 D04MMD DRUGINKE KYQCNVIVUUQTRA-QJCLFNHPSA-N D04MMD DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN=C(N)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCCN)C(=O)NCC(=O)N D04MMD HIGHSTAT Investigative D04NUZ DRUG__ID D04NUZ D04NUZ DRUGINCH 1S/C152H227N41O47/c1-15-78(10)123-149(238)178-94(134(223)183-105(60-86-63-162-91-34-23-22-33-89(86)91)139(228)180-101(56-75(4)5)140(229)190-121(76(6)7)147(236)177-93(35-24-26-52-153)130(219)165-67-114(204)171-92(37-28-54-161-152(157)158)129(218)163-65-111(156)201)36-25-27-53-160-112(202)48-43-98(135(224)176-99(46-51-119(211)212)136(225)181-103(141(230)192-123)57-83-29-18-16-19-30-83)174-127(216)80(12)169-126(215)79(11)170-133(222)97(42-47-110(155)200)173-115(205)68-166-132(221)96(45-50-118(209)210)175-137(226)100(55-74(2)3)179-138(227)102(59-85-38-40-88(199)41-39-85)182-144(233)107(70-194)186-146(235)109(72-196)187-148(237)122(77(8)9)191-143(232)106(62-120(213)214)184-145(234)108(71-195)188-151(240)125(82(14)198)193-142(231)104(58-84-31-20-17-21-32-84)185-150(239)124(81(13)197)189-116(206)69-167-131(220)95(44-49-117(207)208)172-113(203)66-164-128(217)90(154)61-87-64-159-73-168-87/h16-23,29-34,38-41,63-64,73-82,90,92-109,121-125,162,194-199H,15,24-28,35-37,42-62,65-72,153-154H2,1-14H3,(H2,155,200)(H2,156,201)(H,159,168)(H,160,202)(H,163,218)(H,164,217)(H,165,219)(H,166,221)(H,167,220)(H,169,215)(H,170,222)(H,171,204)(H,172,203)(H,173,205)(H,174,216)(H,175,226)(H,176,224)(H,177,236)(H,178,238)(H,179,227)(H,180,228)(H,181,225)(H,182,233)(H,183,223)(H,184,234)(H,185,239)(H,186,235)(H,187,237)(H,188,240)(H,189,206)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,207,208)(H,209,210)(H,211,212)(H,213,214)(H4,157,158,161)/t78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,121-,122-,123-,124-,125-/m0/s1 D04NUZ DRUGINKE JGAQRLVKKDZZTH-KXYXCEFHSA-N D04NUZ DRUGSMIL CCC(C)C1C(=O)NC(CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D04NUZ HIGHSTAT Investigative D04NYQ DRUG__ID D04NYQ D04NYQ DRUGINCH 1S/C50H61N15O11S/c1-3-7-34(43(53)69)57-46(72)38(23-29-10-14-32(66)15-11-29)61-48(74)39(24-30-12-16-33(67)17-13-30)62-47(73)37(22-28-8-5-4-6-9-28)60-45(71)36(20-21-77-2)59-44(70)35(18-19-41(51)68)58-49(75)40(25-31-26-55-27-56-31)63-50(76)42(52)64-65-54/h1,4-6,8-17,26-27,34-40,42,66-67H,7,18-25,52H2,2H3,(H2,51,68)(H2,53,69)(H,55,56)(H,57,72)(H,58,75)(H,59,70)(H,60,71)(H,61,74)(H,62,73)(H,63,76)/t34?,35-,36-,37-,38-,39-,40-,42?/m0/s1 D04NYQ DRUGINKE WFAPVEQHLBEDFX-OPPKEQMHSA-N D04NYQ DRUGSMIL CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC#C)C(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CN=CN4)NC(=O)C(N)N=[N+]=[N-] D04NYQ HIGHSTAT Investigative D04ORV DRUG__ID D04ORV D04ORV DRUGINCH 1S/C60H78N12O11S2/c1-36(73)51-59(81)70-48(31-39-21-9-4-10-22-39)57(79)71-50(60(82)83)35-85-84-34-42(63)52(74)65-44(25-13-15-27-61)53(75)67-46(29-37-17-5-2-6-18-37)55(77)68-47(30-38-19-7-3-8-20-38)56(78)69-49(32-40-33-64-43-24-12-11-23-41(40)43)58(80)66-45(54(76)72-51)26-14-16-28-62/h2-12,17-24,33,36,42,44-51,64,73H,13-16,25-32,34-35,61-63H2,1H3,(H,65,74)(H,66,80)(H,67,75)(H,68,77)(H,69,78)(H,70,81)(H,71,79)(H,72,76)(H,82,83)/t36-,42-,44-,45+,46-,47+,48+,49+,50+,51-/m1/s1 D04ORV DRUGINKE ANCUAJMQRRZZNC-JFMJRBFYSA-N D04ORV DRUGSMIL CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CCCCN)N)C(=O)O)CC6=CC=CC=C6)O D04ORV HIGHSTAT Investigative D04PEM DRUG__ID D04PEM D04PEM DRUGINCH 1S/C96H161N31O30/c1-12-50(10)75(125-83(145)55(18-13-14-28-97)113-87(149)64(36-52-39-104-44-109-52)120-80(142)56(19-15-29-106-95(100)101)112-82(144)60(24-27-73(135)136)117-92(154)76(51(11)130)126-77(139)54(98)32-46(2)3)91(153)122-63(35-49(8)9)86(148)121-65(37-53-40-105-45-110-53)88(150)114-57(20-16-30-107-96(102)103)79(141)118-62(34-48(6)7)85(147)119-61(33-47(4)5)84(146)116-59(22-25-70(99)131)81(143)115-58(23-26-72(133)134)78(140)108-41-71(132)111-68(43-129)93(155)127-31-17-21-69(127)90(152)124-67(42-128)89(151)123-66(94(156)157)38-74(137)138/h39-40,44-51,54-69,75-76,128-130H,12-38,41-43,97-98H2,1-11H3,(H2,99,131)(H,104,109)(H,105,110)(H,108,140)(H,111,132)(H,112,144)(H,113,149)(H,114,150)(H,115,143)(H,116,146)(H,117,154)(H,118,141)(H,119,147)(H,120,142)(H,121,148)(H,122,153)(H,123,151)(H,124,152)(H,125,145)(H,126,139)(H,133,134)(H,135,136)(H,137,138)(H,156,157)(H4,100,101,106)(H4,102,103,107)/t50-,51+,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69?,75-,76-/m0/s1 D04PEM DRUGINKE QPHCCOQIWMPOQX-KTGODZLYSA-N D04PEM DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)N D04PEM HIGHSTAT Investigative D04PGW DRUG__ID D04PGW D04PGW DRUGINCH 1S/C62H111N11O13/c1-25-27-28-39(13)51(75)50-55(79)65-42(26-2)57(81)67(18)33-47(74)68(19)46(32-62(16,17)86)54(78)66-48(37(9)10)60(84)69(20)43(29-34(3)4)53(77)63-40(14)52(76)64-41(15)56(80)70(21)44(30-35(5)6)58(82)71(22)45(31-36(7)8)59(83)72(23)49(38(11)12)61(85)73(50)24/h25,27,34-46,48-51,75,86H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t39-,40+,41-,42+,43+,44+,45+,46+,48+,49+,50?,51-/m1/s1 D04PGW DRUGINKE DFZMWWCBMPCKFD-DTLHCQOUSA-N D04PGW DRUGSMIL CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)(C)O)C)C D04PGW HIGHSTAT Investigative D04QEW DRUG__ID D04QEW D04QEW DRUGINCH 1S/C44H58IN7O10S/c1-4-25(2)38(52-42(59)37(24-63)47-26(3)53)43(60)50-35(22-28-10-16-31(54)17-11-28)40(57)48-33(7-5-6-20-46)39(56)49-34(21-27-8-14-30(45)15-9-27)41(58)51-36(44(61)62)23-29-12-18-32(55)19-13-29/h8-19,25,33-38,54-55,63H,4-7,20-24,46H2,1-3H3,(H,47,53)(H,48,57)(H,49,56)(H,50,60)(H,51,58)(H,52,59)(H,61,62)/t25?,33-,34-,35-,36-,37-,38-/m0/s1 D04QEW DRUGINKE SFPMFCZXYBGJAR-LBNFHWTGSA-N D04QEW DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)I)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)O)NC(=O)C(CS)NC(=O)C D04QEW HIGHSTAT Investigative D04QXM DRUG__ID D04QXM D04QXM DRUGINCH 1S/C47H69N9O17/c1-21(2)34(45(70)55-35(22(3)4)46(71)56-36(44(69)50-19-32(49)59)24(6)72-47-39(64)38(63)37(62)31(20-57)73-47)54-43(68)30(18-33(60)61)53-42(67)29(17-25-10-8-7-9-11-25)52-40(65)23(5)51-41(66)28(48)16-26-12-14-27(58)15-13-26/h7-15,21-24,28-31,34-39,47,57-58,62-64H,16-20,48H2,1-6H3,(H2,49,59)(H,50,69)(H,51,66)(H,52,65)(H,53,67)(H,54,68)(H,55,70)(H,56,71)(H,60,61)/t23-,24-,28+,29+,30+,31-,34+,35+,36+,37-,38+,39-,47+/m1/s1 D04QXM DRUGINKE QTEVIWGWCOWBNP-CNGXOXJSSA-N D04QXM DRUGSMIL CC(C)C(C(=O)NC(C(C)C)C(=O)NC(C(C)OC1C(C(C(C(O1)CO)O)O)O)C(=O)NCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N D04QXM HIGHSTAT Investigative D04QZR DRUG__ID D04QZR D04QZR DRUGINCH 1S/C15H12F3NO4S/c1-24(22,23)12-6-9(15(16,17)18)4-5-10(12)14(21)11(7-19)13(20)8-2-3-8/h4-6,8,11H,2-3H2,1H3 D04QZR DRUGINKE ZTTKDUXKVPEXCG-UHFFFAOYSA-N D04QZR DRUGSMIL CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C(C#N)C(=O)C2CC2 D04QZR HIGHSTAT Investigative D04RGN DRUG__ID D04RGN D04RGN DRUGINCH 1S/C60H100O23S.Na/c1-5-6-7-8-9-10-11-12-13-14-17-20-26-44(65)54(73)59-57(76)48(69)36-50(83-59)58(77)51(70)38(3)29-31-42(63)49-35-47(68)56(75)60(82-49)55(74)45(66)33-37(2)28-30-41(62)34-46(67)53(72)39(4)52(71)43(64)27-22-21-25-40(61)24-19-16-15-18-23-32-81-84(78,79)80;/h5,8-13,19-22,24,26,33,39-77H,1,3,6-7,14-18,23,25,27-32,34-36H2,2,4H3,(H,78,79,80);/q;+1/p-1/b9-8+,11-10+,13-12+,22-21+,24-19+,26-20+,37-33+;/t39?,40?,41-,42+,43?,44+,45+,46-,47+,48+,49+,50+,51-,52?,53+,54-,55-,56+,57+,58-,59-,60-;/m0./s1 D04RGN DRUGINKE FTLCRLMIOGRCRI-ZJJHBUFWSA-M D04RGN DRUGSMIL CC(C(C(CC=CCC(C=CCCCCCOS(=O)(=O)[O-])O)O)O)C(C(CC(CCC(=CC(C(C1C(C(CC(O1)C(CCC(=C)C(C(C2CC(C(C(O2)C(C(C=CCCC=CC=CC=CCCC=C)O)O)O)O)O)O)O)O)O)O)O)C)O)O)O.[Na+] D04RGN HIGHSTAT Investigative D04TDF DRUG__ID D04TDF D04TDF DRUGINCH 1S/C80H104ClN17O16/c1-46(2)37-61(70(102)89-60(18-11-12-35-84-47(3)4)78(110)98-36-14-19-68(98)77(109)85-48(5)69(82)101)90-72(104)64(40-51-23-30-58(31-24-51)87-79(111)96-113-7)92-74(106)65(41-52-25-32-59(33-26-52)88-80(112)97-114-8)94-76(108)67(45-99)95-75(107)66(43-54-15-13-34-83-44-54)93-73(105)63(39-50-21-28-57(81)29-22-50)91-71(103)62(86-49(6)100)42-53-20-27-55-16-9-10-17-56(55)38-53/h9-10,13,15-17,20-34,38,44,46-48,60-68,84,99H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,109)(H,86,100)(H,89,102)(H,90,104)(H,91,103)(H,92,106)(H,93,105)(H,94,108)(H,95,107)(H2,87,96,111)(H2,88,97,112)/t48-,60+,61+,62-,63-,64-,65+,66-,67+,68+/m1/s1 D04TDF DRUGINKE MBXSPUXZEDANHS-KHEFCMSFSA-N D04TDF DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)NOC)NC(=O)C(CC3=CC=C(C=C3)NC(=O)NOC)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D04TDF HIGHSTAT Investigative D04TZA DRUG__ID D04TZA D04TZA DRUGINCH 1S/C14H15F3N8OS/c15-14(16,17)13-20-11(18)10-12(21-13)25(23-22-10)6-8-5-24(2-3-26-8)7-9-19-1-4-27-9/h1,4,8H,2-3,5-7H2,(H2,18,20,21)/t8-/m1/s1 D04TZA DRUGINKE VNLPYEMGHGDRRZ-MRVPVSSYSA-N D04TZA DRUGSMIL C1COC(CN1CC2=NC=CS2)CN3C4=NC(=NC(=C4N=N3)N)C(F)(F)F D04TZA HIGHSTAT Investigative D04UMT DRUG__ID D04UMT D04UMT DRUGINCH 1S/C17H19N3O2/c1-18-9-11-5-7-12(8-6-11)20-17(22)13-10-19-14-3-2-4-15(21)16(13)14/h5-8,10,18-19H,2-4,9H2,1H3,(H,20,22) D04UMT DRUGINKE XFJIYNUISLDNLP-UHFFFAOYSA-N D04UMT DRUGSMIL CNCC1=CC=C(C=C1)NC(=O)C2=CNC3=C2C(=O)CCC3 D04UMT HIGHSTAT Investigative D04VYT DRUG__ID D04VYT D04VYT DRUGINCH 1S/C128H190N34O53S/c1-8-64(4)105(125(211)162-41-15-20-89(162)123(209)154-72(32-37-102(186)187)115(201)151-71(31-36-101(184)185)116(202)157-78(44-66-21-25-68(171)26-22-66)120(206)156-76(42-63(2)3)118(204)155-75(126(212)213)29-34-90(129)172)159-117(203)73(33-38-103(188)189)152-114(200)70(30-35-100(182)183)153-119(205)77(43-65-16-10-9-11-17-65)158-121(207)79(45-104(190)191)142-91(173)46-133-106(192)80(55-163)143-92(174)47-134-107(193)81(56-164)144-93(175)48-135-108(194)82(57-165)145-94(176)49-136-109(195)83(58-166)146-95(177)50-137-110(196)84(59-167)147-96(178)51-138-111(197)85(60-168)148-97(179)52-139-112(198)86(61-169)149-98(180)53-140-113(199)87(62-170)150-99(181)54-141-122(208)88-19-12-13-40-161(88)124(210)74(18-14-39-132-127(130)131)160-216(214,215)69-27-23-67(24-28-69)128(5,6)7/h9-11,16-17,21-28,63-64,70-89,105,160,163-171H,8,12-15,18-20,29-62H2,1-7H3,(H2,129,172)(H,133,192)(H,134,193)(H,135,194)(H,136,195)(H,137,196)(H,138,197)(H,139,198)(H,140,199)(H,141,208)(H,142,173)(H,143,174)(H,144,175)(H,145,176)(H,146,177)(H,147,178)(H,148,179)(H,149,180)(H,150,181)(H,151,201)(H,152,200)(H,153,205)(H,154,209)(H,155,204)(H,156,206)(H,157,202)(H,158,207)(H,159,203)(H,182,183)(H,184,185)(H,186,187)(H,188,189)(H,190,191)(H,212,213)(H4,130,131,132)/t64-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88?,89-,105-/m0/s1 D04VYT DRUGINKE WEYFLOFTQVOIIG-JSWHDTCYSA-N D04VYT DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D04VYT HIGHSTAT Investigative D05AIB DRUG__ID D05AIB D05AIB DRUGINCH 1S/C69H99N25O18S2/c1-7-33(4)55(83-35(6)96)68(112)92-50-28-114-113-27-49(66(110)94-56(34(5)95)57(71)101)91-59(103)42(13-10-16-77-69(72)73)85-62(106)46(19-38-24-75-30-81-38)88-61(105)45(18-37-23-74-29-80-37)84-52(98)26-79-58(102)44(17-36-22-78-41-12-9-8-11-40(36)41)87-64(108)48(21-53(99)100)89-60(104)43(14-15-51(70)97)86-63(107)47(20-39-25-76-31-82-39)90-67(111)54(32(2)3)93-65(50)109/h8-9,11-12,22-25,29-34,42-50,54-56,78,95H,7,10,13-21,26-28H2,1-6H3,(H2,70,97)(H2,71,101)(H,74,80)(H,75,81)(H,76,82)(H,79,102)(H,83,96)(H,84,98)(H,85,106)(H,86,107)(H,87,108)(H,88,105)(H,89,104)(H,90,111)(H,91,103)(H,92,112)(H,93,109)(H,94,110)(H,99,100)(H4,72,73,77)/t33-,34+,42-,43-,44-,45-,46+,47+,48+,49-,50-,54-,55-,56-/m0/s1 D05AIB DRUGINKE BOKLLRIGSLYOHT-OYMOBXHASA-N D05AIB DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CN=CN2)CCC(=O)N)CC(=O)O)CC3=CNC4=CC=CC=C43)CC5=CN=CN5)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D05AIB HIGHSTAT Investigative D05AIM DRUG__ID D05AIM D05AIM DRUGINCH 1S/C145H241N45O47S2/c1-66(2)45-86(176-140(233)111(71(11)12)184-137(230)100(64-239)182-142(235)114(74(15)197)187-136(229)99(62-194)181-129(222)90(49-70(9)10)172-131(224)92(52-104(150)201)174-135(228)97(60-192)179-117(210)79(148)63-238)118(211)158-55-107(204)162-80(25-17-19-39-146)120(213)169-89(48-69(7)8)128(221)180-98(61-193)134(227)167-84(35-37-103(149)200)123(216)166-85(36-38-110(207)208)124(217)171-88(47-68(5)6)127(220)175-94-54-106(203)156-41-21-27-82(165-130(223)91(51-77-58-188(155)65-161-77)173-126(219)87(46-67(3)4)170-121(214)81(164-132(94)225)26-18-20-40-147)122(215)178-95(50-76-31-33-78(199)34-32-76)143(236)190-44-24-30-102(190)138(231)168-83(28-22-42-157-145(153)154)125(218)186-113(73(14)196)141(234)177-93(53-105(151)202)133(226)185-112(72(13)195)139(232)160-56-108(205)163-96(59-191)119(212)159-57-109(206)183-115(75(16)198)144(237)189-43-23-29-101(189)116(152)209/h31-34,58,65-75,79-102,111-115,191-199,238-239H,17-30,35-57,59-64,146-148,155H2,1-16H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,209)(H,156,203)(H,158,211)(H,159,212)(H,160,232)(H,162,204)(H,163,205)(H,164,225)(H,165,223)(H,166,216)(H,167,227)(H,168,231)(H,169,213)(H,170,214)(H,171,217)(H,172,224)(H,173,219)(H,174,228)(H,175,220)(H,176,233)(H,177,234)(H,178,215)(H,179,210)(H,180,221)(H,181,222)(H,182,235)(H,183,206)(H,184,230)(H,185,226)(H,186,218)(H,187,229)(H,207,208)(H4,153,154,157)/t72-,73-,74-,75-,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101-,102-,111+,112+,113+,114+,115+/m1/s1 D05AIM DRUGINKE YQLRYCAIJODBIC-AIKTXAPFSA-N D05AIM DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CCCNC(=O)CC(C(=O)NC(C(=O)N1)CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N4CCCC4C(=O)N)CC5=CN(C=N5)N D05AIM HIGHSTAT Investigative D05BHL DRUG__ID D05BHL D05BHL DRUGINCH 1S/C50H71N11O11S2/c51-21-8-7-14-34(44(66)54-28-42(53)64)56-49(71)40-15-9-22-61(40)50(72)39-29-74-73-23-20-43(65)55-35(26-32-16-18-33(62)19-17-32)45(67)57-36(24-30-10-3-1-4-11-30)46(68)58-37(25-31-12-5-2-6-13-31)47(69)59-38(27-41(52)63)48(70)60-39/h1,3-4,10-11,16-19,31,34-40,62H,2,5-9,12-15,20-29,51H2,(H2,52,63)(H2,53,64)(H,54,66)(H,55,65)(H,56,71)(H,57,67)(H,58,68)(H,59,69)(H,60,70)/t34-,35-,36-,37-,38-,39-,40-/m0/s1 D05BHL DRUGINKE RJWLIPGRNZUUNS-OAKHNGAUSA-N D05BHL DRUGSMIL C1CCC(CC1)CC2C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)NCC(=O)N)CC(=O)N D05BHL HIGHSTAT Investigative D05COQ DRUG__ID D05COQ D05COQ DRUGINCH 1S/C49H65N11O10S2/c1-27(61)40(42(52)63)59-48(69)39-26-72-71-25-38(57-43(64)33(51)21-29-13-5-3-6-14-29)47(68)55-36(22-30-15-7-4-8-16-30)45(66)56-37(23-31-24-53-34-18-10-9-17-32(31)34)46(67)54-35(19-11-12-20-50)44(65)60-41(28(2)62)49(70)58-39/h3-10,13-18,24,27-28,33,35-41,53,61-62H,11-12,19-23,25-26,50-51H2,1-2H3,(H2,52,63)(H,54,67)(H,55,68)(H,56,66)(H,57,64)(H,58,70)(H,59,69)(H,60,65)/t27-,28-,33-,35+,36+,37-,38+,39+,40+,41+/m1/s1 D05COQ DRUGINKE SGYDRBBPYPDBRO-WNIOSIORSA-N D05COQ DRUGSMIL CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(C(C)O)C(=O)N)O D05COQ HIGHSTAT Investigative D05DLI DRUG__ID D05DLI D05DLI DRUGINCH 1S/C44H46Br8N20O9.4C2HF3O2/c45-13-1-17(61-25(13)49)29(73)57-5-9-11(7-59-31(75)19-3-15(47)27(51)63-19)23(41-21(9)43(77)35(67-39(55)71-43)80-33(41)65-37(53)69-41)79-24-12(8-60-32(76)20-4-16(48)28(52)64-20)10(6-58-30(74)18-2-14(46)26(50)62-18)22-42(24)34(66-38(54)70-42)81-36-44(22,78)72-40(56)68-36;4*3-2(4,5)1(6)7/h1-4,9-12,21-24,33-36,61-64,77-78H,5-8H2,(H,57,73)(H,58,74)(H,59,75)(H,60,76)(H3,53,65,69)(H3,54,66,70)(H3,55,67,71)(H3,56,68,72);4*(H,6,7)/t9-,10-,11-,12-,21+,22+,23+,24+,33+,34+,35-,36-,41+,42+,43-,44-;;;;/m1..../s1 D05DLI DRUGINKE PWAQCZXQKIUIBJ-AACIOKPJSA-N D05DLI DRUGSMIL C1=C(NC(=C1Br)Br)C(=O)NCC2C(C(C34C2C5(C(N=C(N5)N)OC3N=C(N4)N)O)OC6C(C(C7C68C(N=C(N8)N)OC9C7(NC(=N9)N)O)CNC(=O)C1=CC(=C(N1)Br)Br)CNC(=O)C1=CC(=C(N1)Br)Br)CNC(=O)C1=CC(=C(N1)Br)Br.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O D05DLI HIGHSTAT Investigative D05DNW DRUG__ID D05DNW D05DNW DRUGINCH 1S/C18H14N2O2S/c19-18(20)17-9-13-12(2-1-3-16(13)23-17)6-4-11-5-7-14-15(8-11)22-10-21-14/h1-9H,10H2,(H3,19,20)/b6-4+ D05DNW DRUGINKE BGFUKOBHJOFLNH-GQCTYLIASA-N D05DNW DRUGSMIL C1OC2=C(O1)C=C(C=C2)C=CC3=C4C=C(SC4=CC=C3)C(=N)N D05DNW HIGHSTAT Investigative D05ELQ DRUG__ID D05ELQ D05ELQ DRUGINCH 1S/C79H100ClN15O15S/c1-45(2)83-35-12-11-18-61(79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)88-77(108)78(111(110)46(3)4)94-74(105)65(40-53-25-32-60(33-26-53)86-49(7)98)90-72(103)64(39-52-23-30-59(31-24-52)85-48(6)97)92-75(106)67(44-96)93-73(104)66(42-55-15-13-34-82-43-55)91-71(102)63(38-51-21-28-58(80)29-22-51)89-70(101)62(87-50(8)99)41-54-20-27-56-16-9-10-17-57(56)37-54/h9-10,13,15-17,20-34,37,43,45-47,61-68,78,83,96H,11-12,14,18-19,35-36,38-42,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,108)(H,89,101)(H,90,103)(H,91,102)(H,92,106)(H,93,104)(H,94,105)/t47-,61+,62-,63-,64+,65-,66-,67+,68+,78+,111?/m1/s1 D05ELQ DRUGINKE KEFJIAHSOLWSII-RUFKGVBESA-N D05ELQ DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)S(=O)C(C)C D05ELQ HIGHSTAT Investigative D05EUV DRUG__ID D05EUV D05EUV DRUGINCH 1S/C82H137N33O22/c1-43(103-62(121)41-102-77(135)64(45(3)117)115-75(133)56(37-47-20-8-5-9-21-47)105-63(122)40-100-61(120)39-101-67(125)48(85)36-46-18-6-4-7-19-46)65(123)106-51(24-14-32-96-79(88)89)69(127)109-50(23-11-13-31-84)73(131)114-58(42-116)76(134)104-44(2)66(124)107-52(25-15-33-97-80(90)91)70(128)108-49(22-10-12-30-83)68(126)110-53(26-16-34-98-81(92)93)71(129)111-54(27-17-35-99-82(94)95)72(130)113-57(38-60(87)119)74(132)112-55(78(136)137)28-29-59(86)118/h4-9,18-21,43-45,48-58,64,116-117H,10-17,22-42,83-85H2,1-3H3,(H2,86,118)(H2,87,119)(H,100,120)(H,101,125)(H,102,135)(H,103,121)(H,104,134)(H,105,122)(H,106,123)(H,107,124)(H,108,128)(H,109,127)(H,110,126)(H,111,129)(H,112,132)(H,113,130)(H,114,131)(H,115,133)(H,136,137)(H4,88,89,96)(H4,90,91,97)(H4,92,93,98)(H4,94,95,99)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D05EUV DRUGINKE DJPBHOCLMOWQPP-KMOVSZGYSA-N D05EUV DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D05EUV HIGHSTAT Investigative D05FFY DRUG__ID D05FFY D05FFY DRUGINCH 1S/C12H11N3/c1-10-7-14-9-15(10)8-12-4-2-11(6-13)3-5-12/h2-5,7,9H,8H2,1H3 D05FFY DRUGINKE JYTDMONWVZXEMX-UHFFFAOYSA-N D05FFY DRUGSMIL CC1=CN=CN1CC2=CC=C(C=C2)C#N D05FFY HIGHSTAT Investigative D05GFD DRUG__ID D05GFD D05GFD DRUGINCH 1S/C98H161N23O23/c1-11-12-13-14-15-16-17-36-80(126)105-44-27-23-34-69(88(133)111-67(85(103)130)31-20-24-41-99)113-89(134)68(32-21-25-42-100)112-90(135)70(33-22-26-43-101)114-96(141)77-35-28-45-121(77)82(128)54-108-87(132)71(46-57(2)3)115-91(136)72(47-58(4)5)116-93(138)74(49-62-37-39-64(124)40-38-62)110-81(127)53-107-86(131)60(8)109-95(140)76(56-122)119-94(139)75(51-79(102)125)117-92(137)73(48-59(6)7)118-98(143)84(61(9)123)120-97(142)78(144-83(129)55-104-10)50-63-52-106-66-30-19-18-29-65(63)66/h18-19,29-30,37-40,52,57-61,67-78,84,104,106,122-124H,11-17,20-28,31-36,41-51,53-56,99-101H2,1-10H3,(H2,102,125)(H2,103,130)(H,105,126)(H,107,131)(H,108,132)(H,109,140)(H,110,127)(H,111,133)(H,112,135)(H,113,134)(H,114,141)(H,115,136)(H,116,138)(H,117,137)(H,118,143)(H,119,139)(H,120,142)/t60-,61+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,84-/m0/s1 D05GFD DRUGINKE PSJWDZZPEFDHOW-QSNPNBGOSA-N D05GFD DRUGSMIL CCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D05GFD HIGHSTAT Investigative D05GXA DRUG__ID D05GXA D05GXA DRUGINCH 1S/C80H131N27O22/c1-7-49(68(118)100-53(27-19-33-91-80(88)89)70(120)101-50(24-14-16-30-81)71(121)105-55(34-42(2)3)73(123)96-44(5)66(116)104-57(37-60(85)111)74(124)103-54(78(128)129)28-29-59(84)110)98-76(126)58(41-108)106-72(122)51(25-15-17-31-82)102-69(119)52(26-18-32-90-79(86)87)99-65(115)43(4)95-62(113)40-94-77(127)64(45(6)109)107-75(125)56(36-47-22-12-9-13-23-47)97-63(114)39-92-61(112)38-93-67(117)48(83)35-46-20-10-8-11-21-46/h8-13,20-23,42-45,48-58,64,108-109H,7,14-19,24-41,81-83H2,1-6H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,117)(H,94,127)(H,95,113)(H,96,123)(H,97,114)(H,98,126)(H,99,115)(H,100,118)(H,101,120)(H,102,119)(H,103,124)(H,104,116)(H,105,121)(H,106,122)(H,107,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D05GXA DRUGINKE FBSIFFHLVXSJIC-KMOVSZGYSA-N D05GXA DRUGSMIL CCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D05GXA HIGHSTAT Investigative D05HIH DRUG__ID D05HIH D05HIH DRUGINCH 1S/C103H117N23O24/c1-54(113-101(147)89(55(2)127)125-87(133)52-111-90(136)78(43-63-51-107-53-112-63)121-96(142)77(41-61-49-109-70-24-13-10-21-67(61)70)119-97(143)79(44-84(105)130)114-86(132)47-104)102(148)126-35-15-26-83(126)100(146)123-81(46-88(134)135)99(145)120-76(40-60-48-108-69-23-12-9-20-66(60)69)95(141)117-72(36-56-16-5-3-6-17-56)91(137)115-73(37-57-18-7-4-8-19-57)93(139)122-80(45-85(106)131)98(144)118-74(38-58-27-31-64(128)32-28-58)92(138)116-75(39-59-29-33-65(129)34-30-59)94(140)124-82(103(149)150)42-62-50-110-71-25-14-11-22-68(62)71/h3-14,16-25,27-34,48-51,53-55,72-83,89,108-110,127-129H,15,26,35-47,52,104H2,1-2H3,(H2,105,130)(H2,106,131)(H,107,112)(H,111,136)(H,113,147)(H,114,132)(H,115,137)(H,116,138)(H,117,141)(H,118,144)(H,119,143)(H,120,145)(H,121,142)(H,122,139)(H,123,146)(H,124,140)(H,125,133)(H,134,135)(H,149,150)/t54-,55+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,89-/m0/s1 D05HIH DRUGINKE ZUENRBCVCNXGQC-RYIFUXPHSA-N D05HIH DRUGSMIL CC(C(C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(CC(=O)O)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(CC8=CNC9=CC=CC=C98)C(=O)O)NC(=O)CNC(=O)C(CC1=CN=CN1)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)CN)O D05HIH HIGHSTAT Investigative D05IAN DRUG__ID D05IAN D05IAN THERCLAS Antisense D05IAN DRUGTYPE Combination drug (Antisense drug) D05IAN DRUGSMIL failed D05IAN HIGHSTAT Investigative D05IBQ DRUG__ID D05IBQ D05IBQ DRUGINCH 1S/C60H85N19O13S/c61-39(15-5-19-68-58(62)63)49(83)73-40(16-6-20-69-59(64)65)53(87)76-22-8-18-44(76)55(89)79-31-37(81)26-46(79)51(85)71-28-48(82)72-42(27-38-14-9-23-93-38)50(84)75-43(32-80)54(88)78-30-36-13-4-2-11-34(36)25-47(78)56(90)77-29-35-12-3-1-10-33(35)24-45(77)52(86)74-41(57(91)92)17-7-21-70-60(66)67/h1-4,9-14,23,37,39-47,80-81H,5-8,15-22,24-32,61H2,(H,71,85)(H,72,82)(H,73,83)(H,74,86)(H,75,84)(H,91,92)(H4,62,63,68)(H4,64,65,69)(H4,66,67,70)/t37?,39-,40-,41?,42?,43-,44-,45?,46-,47?/m1/s1 D05IBQ DRUGINKE GFWURPIOGZMEAS-RFHUBXOQSA-N D05IBQ DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC(CO)C(=O)N4CC5=CC=CC=C5CC4C(=O)N6CC7=CC=CC=C7CC6C(=O)NC(CCCN=C(N)N)C(=O)O)O D05IBQ HIGHSTAT Investigative D05JLG DRUG__ID D05JLG D05JLG DRUGCOMP CTG Pharma Srl D05JLG DRUGTYPE Small molecular drug D05JLG DRUGSMIL CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC(=O)OC5=CC=C(C=C5)C6=CC(=S)SS6)OCC)C D05JLG HIGHSTAT Investigative D05JRA DRUG__ID D05JRA D05JRA DRUGINCH 1S/C64H118N34O13/c65-24-6-5-15-36(91-42(99)22-4-2-8-26-81-57(110)47-45(101)46(102)58(111-47)98-34-90-44-48(66)88-33-89-50(44)98)51(104)80-25-7-1-3-23-43(100)92-37(17-10-28-83-60(70)71)52(105)94-39(19-12-30-85-62(74)75)54(107)96-41(21-14-32-87-64(78)79)56(109)97-40(20-13-31-86-63(76)77)55(108)95-38(18-11-29-84-61(72)73)53(106)93-35(49(67)103)16-9-27-82-59(68)69/h33-41,45-47,58,101-102H,1-32,65H2,(H2,67,103)(H,80,104)(H,81,110)(H,91,99)(H,92,100)(H,93,106)(H,94,105)(H,95,108)(H,96,107)(H,97,109)(H2,66,88,89)(H4,68,69,82)(H4,70,71,83)(H4,72,73,84)(H4,74,75,85)(H4,76,77,86)(H4,78,79,87)/t35-,36-,37-,38-,39-,40-,41-,45+,46-,47+,58-/m1/s1 D05JRA DRUGINKE FBAPHDWTBAGCKW-LJDCWIOTSA-N D05JRA DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCC(=O)NC(CCCCN)C(=O)NCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)N)O)O)N D05JRA HIGHSTAT Investigative D05KIS DRUG__ID D05KIS D05KIS DRUGINCH 1S/C53H65N11O11/c1-3-4-18-41(60-49(71)39(55)28-36-27-35-17-11-12-19-40(35)58-36)50(72)62-44(29-46(67)68)51(73)61-43(26-33-15-9-6-10-16-33)53(75)64-63-52(74)42(25-32-13-7-5-8-14-32)59-45(66)30-56-47(69)31(2)57-48(70)38(54)24-34-20-22-37(65)23-21-34/h5-17,19-23,27,31,38-39,41-44,58,65H,3-4,18,24-26,28-30,54-55H2,1-2H3,(H,56,69)(H,57,70)(H,59,66)(H,60,71)(H,61,73)(H,62,72)(H,63,74)(H,64,75)(H,67,68)/t31-,38+,39+,41-,42+,43-,44-/m1/s1 D05KIS DRUGINKE NXHWDEQNHXTHJU-KDWYPSCJSA-N D05KIS DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NNC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)C(C)NC(=O)C(CC3=CC=C(C=C3)O)N)NC(=O)C(CC4=CC5=CC=CC=C5N4)N D05KIS HIGHSTAT Investigative D05LJY DRUG__ID D05LJY D05LJY DRUGINCH 1S/C73H100N20O19S2/c1-8-36(4)59(83-39(7)95)71(110)91-54-33-114-113-32-53(69(108)93-60(38(6)94)72(111)112)90-63(102)47(18-13-23-78-73(75)76)84-66(105)51(27-44-30-77-34-81-44)86-61(100)37(5)82-56(97)31-80-62(101)50(26-43-29-79-46-17-12-11-16-45(43)46)87-67(106)52(28-57(98)99)88-64(103)48(21-22-55(74)96)85-65(104)49(89-70(109)58(35(2)3)92-68(54)107)25-40-19-20-41-14-9-10-15-42(41)24-40/h9-12,14-17,19-20,24,29-30,34-38,47-54,58-60,79,94H,8,13,18,21-23,25-28,31-33H2,1-7H3,(H2,74,96)(H,77,81)(H,80,101)(H,82,97)(H,83,95)(H,84,105)(H,85,104)(H,86,100)(H,87,106)(H,88,103)(H,89,109)(H,90,102)(H,91,110)(H,92,107)(H,93,108)(H,98,99)(H,111,112)(H4,75,76,78)/t36-,37-,38+,47-,48-,49-,50-,51+,52+,53-,54-,58-,59-,60-/m0/s1 D05LJY DRUGINKE UCWQZBKPQJMNPR-UZUHPOSNSA-N D05LJY DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC3=CC=CC=C3C=C2)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D05LJY HIGHSTAT Investigative D05LMD DRUG__ID D05LMD D05LMD DRUGINCH 1S/C139H230N44O38/c1-66(2)48-86(161-102(193)60-155-113(197)74(17)159-120(204)87(49-67(3)4)168-118(202)83(40-31-45-152-138(147)148)163-123(207)90(53-80-57-151-65-158-80)173-136(220)111(77(20)188)182-131(215)105(145)69(7)8)121(205)169-88(50-68(5)6)122(206)176-96(64-186)129(213)165-84(41-32-46-153-139(149)150)119(203)175-94(62-184)115(199)156-58-101(192)154-59-104(195)177-107(71(11)12)134(218)179-108(72(13)14)133(217)166-82(39-28-30-44-141)117(201)171-91(54-98(142)189)125(209)172-92(55-99(143)190)124(208)170-89(52-79-36-25-22-26-37-79)126(210)180-109(73(15)16)137(221)183-47-33-42-97(183)130(214)181-110(76(19)187)135(219)174-93(56-100(144)191)127(211)178-106(70(9)10)132(216)157-61-103(194)162-95(63-185)128(212)164-81(38-27-29-43-140)116(200)160-75(18)114(198)167-85(112(146)196)51-78-34-23-21-24-35-78/h21-26,34-37,57,65-77,81-97,105-111,184-188H,27-33,38-56,58-64,140-141,145H2,1-20H3,(H2,142,189)(H2,143,190)(H2,144,191)(H2,146,196)(H,151,158)(H,154,192)(H,155,197)(H,156,199)(H,157,216)(H,159,204)(H,160,200)(H,161,193)(H,162,194)(H,163,207)(H,164,212)(H,165,213)(H,166,217)(H,167,198)(H,168,202)(H,169,205)(H,170,208)(H,171,201)(H,172,209)(H,173,220)(H,174,219)(H,175,203)(H,176,206)(H,177,195)(H,178,211)(H,179,218)(H,180,210)(H,181,214)(H,182,215)(H4,147,148,152)(H4,149,150,153)/t74-,75-,76+,77+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,105-,106-,107-,108-,109-,110-,111-/m0/s1 D05LMD DRUGINKE NDACAFBDTQIYCQ-YVQXRMNASA-N D05LMD DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CN=CN4)NC(=O)C(C(C)O)NC(=O)C(C(C)C)N D05LMD HIGHSTAT Investigative D05MJG DRUG__ID D05MJG D05MJG DRUGINCH 1S/C62H91N19O20/c63-61(64)69-24-5-9-37-53(94)71-31-48(87)74-44(29-50(89)90)59(100)80-42(27-33-11-15-35(83)16-12-33)57(98)78-39(55(96)76-37)7-1-3-22-67-46(85)20-19-41(73-47(86)21-26-82)52(93)68-23-4-2-8-40-56(97)77-38(10-6-25-70-62(65)66)54(95)72-32-49(88)75-45(30-51(91)92)60(101)81-43(58(99)79-40)28-34-13-17-36(84)18-14-34/h11-18,37-45,82-84H,1-10,19-32H2,(H,67,85)(H,68,93)(H,71,94)(H,72,95)(H,73,86)(H,74,87)(H,75,88)(H,76,96)(H,77,97)(H,78,98)(H,79,99)(H,80,100)(H,81,101)(H,89,90)(H,91,92)(H4,63,64,69)(H4,65,66,70)/t37-,38-,39-,40?,41?,42+,43+,44-,45-/m1/s1 D05MJG DRUGINKE ACEBGKIPKRNNIW-JMIOTQLUSA-N D05MJG DRUGSMIL C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCCCNC(=O)CCC(C(=O)NCCCCC2C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=C(C=C3)O)CC(=O)O)CCCN=C(N)N)NC(=O)CCO)CC4=CC=C(C=C4)O)CC(=O)O D05MJG HIGHSTAT Investigative D05MTD DRUG__ID D05MTD D05MTD DRUGINCH 1S/C57H86N14O12S/c1-34(2)30-42(54(80)65-37(49(61)75)25-29-84-3)64-48(74)33-63-50(76)43(31-35-14-6-4-7-15-35)69-55(81)44(32-36-16-8-5-9-17-36)70-53(79)39(21-23-46(59)72)66-52(78)40(22-24-47(60)73)67-56(82)45-20-13-28-71(45)57(83)41(18-10-11-26-58)68-51(77)38-19-12-27-62-38/h4-9,14-17,34,37-45,62H,10-13,18-33,58H2,1-3H3,(H2,59,72)(H2,60,73)(H2,61,75)(H,63,76)(H,64,74)(H,65,80)(H,66,78)(H,67,82)(H,68,77)(H,69,81)(H,70,79)/t37-,38-,39-,40-,41-,42-,43-,44-,45-/m0/s1 D05MTD DRUGINKE HGUMOPZYRIFNRE-NVAZTIMOSA-N D05MTD DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4 D05MTD HIGHSTAT Investigative D05NHR DRUG__ID D05NHR D05NHR DRUGINCH 1S/C82H137N31O22/c1-44(101-63(119)42-100-78(133)65(46(3)115)113-76(131)57(38-48-21-8-5-9-22-48)103-64(120)41-98-62(118)40-99-68(123)49(86)37-47-19-6-4-7-20-47)66(121)104-53(26-16-34-95-80(89)90)71(126)108-52(25-12-15-33-85)74(129)112-59(43-114)77(132)102-45(2)67(122)105-54(27-17-35-96-81(91)92)72(127)107-50(23-10-13-31-83)69(124)106-51(24-11-14-32-84)70(125)109-55(28-18-36-97-82(93)94)73(128)111-58(39-61(88)117)75(130)110-56(79(134)135)29-30-60(87)116/h4-9,19-22,44-46,49-59,65,114-115H,10-18,23-43,83-86H2,1-3H3,(H2,87,116)(H2,88,117)(H,98,118)(H,99,123)(H,100,133)(H,101,119)(H,102,132)(H,103,120)(H,104,121)(H,105,122)(H,106,124)(H,107,127)(H,108,126)(H,109,125)(H,110,130)(H,111,128)(H,112,129)(H,113,131)(H,134,135)(H4,89,90,95)(H4,91,92,96)(H4,93,94,97)/t44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,65-/m0/s1 D05NHR DRUGINKE LIKGHYIDQTYXFY-VUXBHJHDSA-N D05NHR DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D05NHR HIGHSTAT Investigative D05NQX DRUG__ID D05NQX D05NQX DRUGINCH 1S/C46H54N6O2/c1-7-27-49(28-8-1)31-13-35-53-39-23-19-37(20-24-39)45-47-41-15-3-5-17-43(41)51(45)33-11-12-34-52-44-18-6-4-16-42(44)48-46(52)38-21-25-40(26-22-38)54-36-14-32-50-29-9-2-10-30-50/h3-6,11-12,15-26H,1-2,7-10,13-14,27-36H2/b12-11+ D05NQX DRUGINKE RTRBUDIKCGJLKP-VAWYXSNFSA-N D05NQX DRUGSMIL C1CCN(CC1)CCCOC2=CC=C(C=C2)C3=NC4=CC=CC=C4N3CC=CCN5C6=CC=CC=C6N=C5C7=CC=C(C=C7)OCCCN8CCCCC8 D05NQX HIGHSTAT Investigative D05PRQ DRUG__ID D05PRQ D05PRQ DRUGINCH 1S/C69H105N27O21S6/c1-31-53(103)93-48-27-121-119-25-46(52(72)102)92-67(117)50-29-123-122-26-47(64(114)82-31)94-54(104)35(71)24-118-120-28-49(96-58(108)40(16-32-19-80-36-9-3-2-8-34(32)36)86-55(105)37(10-4-5-13-70)83-62(112)44(22-98)90-63(113)45(23-99)91-66(48)116)65(115)85-38(11-6-14-78-68(73)74)56(106)88-42(18-51(100)101)60(110)87-41(17-33-20-77-30-81-33)59(109)89-43(21-97)61(111)84-39(57(107)95-50)12-7-15-79-69(75)76/h2-3,8-9,19-20,30-31,35,37-50,80,97-99H,4-7,10-18,21-29,70-71H2,1H3,(H2,72,102)(H,77,81)(H,82,114)(H,83,112)(H,84,111)(H,85,115)(H,86,105)(H,87,110)(H,88,106)(H,89,109)(H,90,113)(H,91,116)(H,92,117)(H,93,103)(H,94,104)(H,95,107)(H,96,108)(H,100,101)(H4,73,74,78)(H4,75,76,79)/t31-,35+,37+,38+,39+,40+,41+,42+,43+,44+,45+,46+,47+,48+,49+,50+/m1/s1 D05PRQ DRUGINKE DSVGHPDROAIMFA-YDQMBMOMSA-N D05PRQ DRUGSMIL CC1C(=O)NC2CSSCC(NC(=O)C3CSSCC(C(=O)N1)NC(=O)C(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CCCNC(=N)N)CO)CC4=CN=CN4)CC(=O)O)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CO)CCCCN)CC5=CNC6=CC=CC=C65)N)C(=O)N D05PRQ HIGHSTAT Investigative D05QAA DRUG__ID D05QAA D05QAA DRUGINCH 1S/C22H19ClO5S2.Na/c23-18-10-6-16(7-11-18)17-8-12-20(13-9-17)30(27,28)15-22(26,21(24)25)14-29-19-4-2-1-3-5-19;/h1-13,26H,14-15H2,(H,24,25);/t22-;/m1./s1 D05QAA DRUGINKE YQPKCDPUTCALSX-VZYDHVRKSA-N D05QAA DRUGSMIL C1=CC=C(C=C1)SCC(CS(=O)(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)Cl)(C(=O)O)O.[Na] D05QAA HIGHSTAT Investigative D05RNF DRUG__ID D05RNF D05RNF DRUGINCH 1S/C49H69N11O11S2/c50-20-7-13-33(43(65)53-27-41(52)63)55-48(70)39-14-8-21-60(39)49(71)38-28-73-72-22-19-42(64)54-34(25-31-15-17-32(61)18-16-31)44(66)56-35(23-29-9-3-1-4-10-29)45(67)57-36(24-30-11-5-2-6-12-30)46(68)58-37(26-40(51)62)47(69)59-38/h1,3-4,9-10,15-18,30,33-39,61H,2,5-8,11-14,19-28,50H2,(H2,51,62)(H2,52,63)(H,53,65)(H,54,64)(H,55,70)(H,56,66)(H,57,67)(H,58,68)(H,59,69)/t33-,34-,35-,36-,37-,38-,39-/m0/s1 D05RNF DRUGINKE CADGMGWLZUBCQD-ZTYVOHGWSA-N D05RNF DRUGSMIL C1CCC(CC1)CC2C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N D05RNF HIGHSTAT Investigative D05TNI DRUG__ID D05TNI D05TNI DRUGINCH 1S/C107H136N22O27S3/c1-10-55(5)88(103(151)125-79(51-85(111)135)99(147)116-68(35-37-82(108)132)91(139)119-73(44-58-21-14-12-15-22-58)98(146)121-74(46-60-29-31-62(130)32-30-60)97(145)118-70(39-41-158-8)93(141)120-75(45-59-23-16-13-17-24-59)101(149)129-89(104(152)153)56(6)11-2)128-102(150)76(47-61-52-112-53-113-61)122-92(140)69(36-38-86(136)137)115-90(138)57(7)114-95(143)77(49-83(109)133)124-100(148)78(50-84(110)134)123-94(142)71(40-42-159-9)117-96(144)72(43-54(3)4)127-106(157)126-67-27-20-26-66-87(67)105(154)156-107(66)64-25-18-19-28-80(64)155-81-48-63(131)33-34-65(81)107/h12-34,48,52-57,68-79,88-89,130-131H,10-11,35-47,49-51H2,1-9H3,(H2,108,132)(H2,109,133)(H2,110,134)(H2,111,135)(H,112,113)(H,114,143)(H,115,138)(H,116,147)(H,117,144)(H,118,145)(H,119,139)(H,120,141)(H,121,146)(H,122,140)(H,123,142)(H,124,148)(H,125,151)(H,128,150)(H,129,149)(H,136,137)(H,152,153)(H2,126,127,157)/t55-,56-,57-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,88?,89?,107?/m0/s1 D05TNI DRUGINKE IHNJXISEZYRUDB-YDQBPDQJSA-N D05TNI DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCSC)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C(C)CC)C(=O)O)NC(=O)C(CC4=CN=CN4)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CC(C)C)NC(=S)NC5=CC=CC6=C5C(=O)OC67C8=C(C=C(C=C8)O)OC9=CC=CC=C79 D05TNI HIGHSTAT Investigative D05UTO DRUG__ID D05UTO D05UTO DRUGINCH 1S/C78H102ClN19O18/c1-41(2)32-55(67(104)88-54(14-9-10-30-82-42(3)4)75(112)98-31-11-15-63(98)74(111)84-43(5)65(80)102)89-69(106)57(35-47-21-28-53(29-22-47)87-76(81)113)91-70(107)58(36-46-19-26-52(27-20-46)86-66(103)60-38-64(101)96-78(115)95-60)92-73(110)62(40-99)94-72(109)61(39-83-77(114)97-116)93-71(108)59(34-45-17-24-51(79)25-18-45)90-68(105)56(85-44(6)100)37-48-16-23-49-12-7-8-13-50(49)33-48/h7-8,12-13,16-29,33,41-43,54-63,82,99,116H,9-11,14-15,30-32,34-40H2,1-6H3,(H2,80,102)(H,84,111)(H,85,100)(H,86,103)(H,88,104)(H,89,106)(H,90,105)(H,91,107)(H,92,110)(H,93,108)(H,94,109)(H3,81,87,113)(H2,83,97,114)(H2,95,96,101,115)/t43-,54+,55+,56-,57-,58+,59-,60+,61-,62+,63+/m1/s1 D05UTO DRUGINKE QJTXGVWJYSNZTE-PTPJWVMESA-N D05UTO DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CNC(=O)NO)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D05UTO HIGHSTAT Investigative D05WDM DRUG__ID D05WDM D05WDM DRUGINCH 1S/C27H35F2N7O3/c1-34-12-10-18(11-13-34)31-24(37)17-8-9-20(22(14-17)39-3)32-26-30-15-21-23(33-26)36(19-6-4-5-7-19)16-27(28,29)25(38)35(21)2/h8-9,14-15,18-19H,4-7,10-13,16H2,1-3H3,(H,31,37)(H,30,32,33) D05WDM DRUGINKE DJNZZLZKAXGMMC-UHFFFAOYSA-N D05WDM DRUGSMIL CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC D05WDM HIGHSTAT Investigative D05XRI DRUG__ID D05XRI D05XRI DRUGINCH 1S/C51H70N18O11S2/c1-27(70)62-33(13-7-17-58-50(53)54)43(74)69-40-25-82-81-24-39(42(52)73)68-47(78)37(20-29-22-60-32-12-6-5-11-31(29)32)66-44(75)34(14-8-18-59-51(55)56)63-46(77)36(19-28-9-3-2-4-10-28)65-48(79)38(21-30-23-57-26-61-30)67-45(76)35(64-49(40)80)15-16-41(71)72/h2-6,9-12,22-23,26,33-40,60H,7-8,13-21,24-25H2,1H3,(H2,52,73)(H,57,61)(H,62,70)(H,63,77)(H,64,80)(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,74)(H,71,72)(H4,53,54,58)(H4,55,56,59)/t33-,34-,35+,36-,37+,38-,39+,40+/m1/s1 D05XRI DRUGINKE UNXFCHHFXJFRRB-VYZFECEFSA-N D05XRI DRUGSMIL CC(=O)NC(CCCN=C(N)N)C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCC(=O)O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N D05XRI HIGHSTAT Investigative D05XZA DRUG__ID D05XZA D05XZA DRUGINCH 1S/C75H98N14O15S2/c1-43(2)78-38-50-30-28-49(29-31-50)36-57-69(97)88-63(44(3)91)73(101)85-58(35-48-23-13-8-14-24-48)70(98)89-64(45(4)92)74(102)86-60(40-90)71(99)87-62(75(103)104)42-106-105-41-61(77-5)72(100)80-54(27-17-18-32-76)65(93)81-55(33-46-19-9-6-10-20-46)66(94)82-56(34-47-21-11-7-12-22-47)67(95)84-59(68(96)83-57)37-51-39-79-53-26-16-15-25-52(51)53/h6-16,19-26,28-31,39,43-45,54-64,77-79,90-92H,17-18,27,32-38,40-42,76H2,1-5H3,(H,80,100)(H,81,93)(H,82,94)(H,83,96)(H,84,95)(H,85,101)(H,86,102)(H,87,99)(H,88,97)(H,89,98)(H,103,104)/t44-,45-,54-,55-,56+,57+,58+,59+,60+,61-,62+,63-,64-/m1/s1 D05XZA DRUGINKE TUTDPAIJDZFFHJ-NLGCSLGGSA-N D05XZA DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)NC)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D05XZA HIGHSTAT Investigative D05YHE DRUG__ID D05YHE D05YHE DRUGINCH 1S/C61H73N11O17S2/c1-4-30(2)49-56(83)71-50(31(3)73)57(84)67-42(27-47(63)77)54(81)68-43(28-91-90-23-20-48(78)69-51(58(85)70-49)32-10-13-34(74)14-11-32)59(86)72-22-7-9-44(72)55(82)66-41(53(80)65-29-62)8-5-6-21-64-52(79)33-12-17-37-40(24-33)61(89-60(37)87)38-18-15-35(75)25-45(38)88-46-26-36(76)16-19-39(46)61/h10-19,24-26,30-31,41-44,49-51,73-76H,4-9,20-23,27-29,62H2,1-3H3,(H2,63,77)(H,64,79)(H,65,80)(H,66,82)(H,67,84)(H,68,81)(H,69,78)(H,70,85)(H,71,83)/t30?,31?,41-,42+,43+,44+,49+,50+,51-/m0/s1 D05YHE DRUGINKE NBPSKZJBUIXUIP-IAPRXICDSA-N D05YHE DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)C(C)O D05YHE HIGHSTAT Investigative D06ARL DRUG__ID D06ARL D06ARL DRUGINCH 1S/C153H223N41O47S/c1-74(2)57-100(136(226)177-99(52-56-242-10)135(225)186-108(65-117(159)207)146(236)193-123(78(8)199)125(160)215)180-141(231)107(64-85-68-167-91-28-18-17-27-89(85)91)185-133(223)97(46-50-116(158)206)178-150(240)122(76(5)6)192-144(234)105(59-80-23-13-11-14-24-80)184-142(232)109(66-120(211)212)187-132(222)96(45-49-115(157)205)171-126(216)77(7)169-129(219)93(30-21-54-165-152(161)162)173-130(220)94(31-22-55-166-153(163)164)175-148(238)112(72-197)190-143(233)110(67-121(213)214)188-137(227)101(58-75(3)4)179-139(229)103(62-83-34-40-87(202)41-35-83)181-131(221)92(29-19-20-53-154)174-147(237)111(71-196)189-140(230)104(63-84-36-42-88(203)43-37-84)182-134(224)98(47-51-119(209)210)176-149(239)113(73-198)191-151(241)124(79(9)200)194-145(235)106(60-81-25-15-12-16-26-81)183-138(228)102(61-82-32-38-86(201)39-33-82)170-118(208)69-168-128(218)95(44-48-114(156)204)172-127(217)90(155)70-195/h11-18,23-28,32-43,68,74-79,90,92-113,122-124,167,195-203H,19-22,29-31,44-67,69-73,154-155H2,1-10H3,(H2,156,204)(H2,157,205)(H2,158,206)(H2,159,207)(H2,160,215)(H,168,218)(H,169,219)(H,170,208)(H,171,216)(H,172,217)(H,173,220)(H,174,237)(H,175,238)(H,176,239)(H,177,226)(H,178,240)(H,179,229)(H,180,231)(H,181,221)(H,182,224)(H,183,228)(H,184,232)(H,185,223)(H,186,225)(H,187,222)(H,188,227)(H,189,230)(H,190,233)(H,191,241)(H,192,234)(H,193,236)(H,194,235)(H,209,210)(H,211,212)(H,213,214)(H4,161,162,165)(H4,163,164,166)/t77-,78+,79+,90-,92-,93-,94-,95-,96-,97-,98+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,122-,123-,124-/m0/s1 D06ARL DRUGINKE SNCODYSDFYHLPQ-HYDYTQAJSA-N D06ARL DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)N D06ARL HIGHSTAT Investigative D06BCG DRUG__ID D06BCG D06BCG DRUGINCH 1S/C33H42Br2N10O4/c34-21-5-7-23-19(17-43-25(23)14-21)13-27-32(48,16-20-18-44-26-15-22(35)6-8-24(20)26)29(47)45(12-4-3-11-42-31(38)39)33(27,49)28(46)40-9-1-2-10-41-30(36)37/h5-8,14-15,17-18,27,43-44,48-49H,1-4,9-13,16H2,(H,40,46)(H4,36,37,41)(H4,38,39,42)/t27-,32+,33+/m1/s1 D06BCG DRUGINKE FWIZAEZOEFOBCD-LGBXHZPNSA-N D06BCG DRUGSMIL C1=CC2=C(C=C1Br)NC=C2CC3C(C(=O)N(C3(C(=O)NCCCCN=C(N)N)O)CCCCN=C(N)N)(CC4=CNC5=C4C=CC(=C5)Br)O D06BCG HIGHSTAT Investigative D06CYG DRUG__ID D06CYG D06CYG DRUGINCH 1S/C66H97N12O24P/c1-7-35(5)54(63(94)73-46(32-37-13-17-39(79)18-14-37)60(91)74-47(66(97)98)31-34(3)4)75-62(93)49-12-10-30-78(49)65(96)55(36(6)8-2)76-58(89)44(24-28-53(85)86)69-56(87)43(23-27-52(83)84)70-59(90)45(33-38-15-19-40(20-16-38)102-103(99,100)101)72-57(88)42(22-25-50(68)80)71-61(92)48-11-9-29-77(48)64(95)41(67)21-26-51(81)82/h13-20,34-36,41-49,54-55,79H,7-12,21-33,67H2,1-6H3,(H2,68,80)(H,69,87)(H,70,90)(H,71,92)(H,72,88)(H,73,94)(H,74,91)(H,75,93)(H,76,89)(H,81,82)(H,83,84)(H,85,86)(H,97,98)(H2,99,100,101)/t35-,36-,41-,42-,43-,44-,45-,46-,47-,48-,49-,54-,55-/m0/s1 D06CYG DRUGINKE DLNQPUNIZRZGQD-VBIHGRSYSA-N D06CYG DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C2CCCN2C(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C(CCC(=O)N)NC(=O)C4CCCN4C(=O)C(CCC(=O)O)N D06CYG HIGHSTAT Investigative D06DPJ DRUG__ID D06DPJ D06DPJ DRUGINCH 1S/C20H11N5OS/c21-11-13-16-10-12(22-20(26)17-6-3-9-27-17)7-8-25(16)19-18(13)23-14-4-1-2-5-15(14)24-19/h1-10H,(H,22,26) D06DPJ DRUGINKE BCSBXWKRZUPFHW-UHFFFAOYSA-N D06DPJ DRUGSMIL C1=CC=C2C(=C1)N=C3C(=C4C=C(C=CN4C3=N2)NC(=O)C5=CC=CS5)C#N D06DPJ HIGHSTAT Investigative D06DRC DRUG__ID D06DRC D06DRC DRUGINCH 1S/C55H70F3N15O10/c1-4-31(2)45(50(80)68-41(27-36-28-62-30-64-36)51(81)73-23-9-13-43(73)49(79)69-42(52(82)83)26-32-10-6-5-7-11-32)70-48(78)40(25-34-16-20-37(74)21-17-34)67-47(77)39(24-33-14-18-35(19-15-33)54(71-72-54)55(56,57)58)66-46(76)38(65-44(75)29-61-3)12-8-22-63-53(59)60/h5-7,10-11,14-21,28,30-31,38-43,45,61,74H,4,8-9,12-13,22-27,29H2,1-3H3,(H,62,64)(H,65,75)(H,66,76)(H,67,77)(H,68,80)(H,69,79)(H,70,78)(H,82,83)(H4,59,60,63)/t31-,38-,39-,40-,41-,42-,43-,45-/m0/s1 D06DRC DRUGINKE SMLIEFKCEBMVHX-YUDJOFGFSA-N D06DRC DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=C(C=C5)C6(N=N6)C(F)(F)F)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D06DRC HIGHSTAT Investigative D06DWA DRUG__ID D06DWA D06DWA DRUGINCH 1S/C99H163N23O28/c1-58(2)46-72(88(133)109-54-83(129)122-37-21-28-78(122)97(142)115-71(26-15-19-35-102)91(136)113-69(25-14-18-34-101)90(135)114-70(89(134)112-68(86(104)131)24-13-17-33-100)27-16-20-36-106-82(128)57-149-45-44-148-43-42-147-41-40-146-39-38-145-10)116-92(137)73(47-59(3)4)117-94(139)75(49-63-29-31-65(125)32-30-63)111-81(127)53-108-87(132)61(7)110-96(141)77(56-123)120-95(140)76(51-80(103)126)118-93(138)74(48-60(5)6)119-99(144)85(62(8)124)121-98(143)79(150-84(130)55-105-9)50-64-52-107-67-23-12-11-22-66(64)67/h11-12,22-23,29-32,52,58-62,68-79,85,105,107,123-125H,13-21,24-28,33-51,53-57,100-102H2,1-10H3,(H2,103,126)(H2,104,131)(H,106,128)(H,108,132)(H,109,133)(H,110,141)(H,111,127)(H,112,134)(H,113,136)(H,114,135)(H,115,142)(H,116,137)(H,117,139)(H,118,138)(H,119,144)(H,120,140)(H,121,143)/t61-,62+,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,85-/m0/s1 D06DWA DRUGINKE MJZZQPFMLULOPB-UJNSRDRFSA-N D06DWA DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCNC(=O)COCCOCCOCCOCCOC)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D06DWA HIGHSTAT Investigative D06EEJ DRUG__ID D06EEJ D06EEJ DRUGINCH 1S/C10H8O4/c11-9(12)6-3-7-1-4-8(5-2-7)10(13)14/h1-6H,(H,11,12)(H,13,14)/b6-3+ D06EEJ DRUGINKE HAEJSGLKJYIYTB-ZZXKWVIFSA-N D06EEJ DRUGSMIL C1=CC(=CC=C1C=CC(=O)O)C(=O)O D06EEJ HIGHSTAT Investigative D06EMC DRUG__ID D06EMC D06EMC DRUGINCH 1S/C15H20Cl2N2O/c1-10(2)9-19(11-6-7-18-8-11)15(20)12-4-3-5-13(16)14(12)17/h3-5,10-11,18H,6-9H2,1-2H3/t11-/m0/s1 D06EMC DRUGINKE PIKCALBGLDBAKK-NSHDSACASA-N D06EMC DRUGSMIL CC(C)CN(C1CCNC1)C(=O)C2=C(C(=CC=C2)Cl)Cl D06EMC HIGHSTAT Investigative D06ERA DRUG__ID D06ERA D06ERA DRUGINCH 1S/C76H119N27O18/c1-6-40(4)61-73(121)97-52(68(116)93-49(14-10-30-89-75(82)83)64(112)96-51(24-26-58(77)107)67(115)94-50(15-11-31-90-76(84)85)65(113)98-53(62(79)110)33-42-16-20-45(105)21-17-42)25-27-60(109)87-28-8-7-12-48(66(114)102-57(36-59(78)108)71(119)99-54(32-39(2)3)72(120)103-61)95-69(117)55(34-43-18-22-46(106)23-19-43)100-70(118)56(35-44-37-86-38-91-44)101-63(111)47(92-41(5)104)13-9-29-88-74(80)81/h16-23,37-40,47-57,61,105-106H,6-15,24-36H2,1-5H3,(H2,77,107)(H2,78,108)(H2,79,110)(H,86,91)(H,87,109)(H,92,104)(H,93,116)(H,94,115)(H,95,117)(H,96,112)(H,97,121)(H,98,113)(H,99,119)(H,100,118)(H,101,111)(H,102,114)(H,103,120)(H4,80,81,88)(H4,82,83,89)(H4,84,85,90)/t40-,47+,48+,49+,50+,51+,52+,53+,54+,55+,56+,57+,61+/m1/s1 D06ERA DRUGINKE RDOFKMDVEDQFIJ-WQSAXVMWSA-N D06ERA DRUGSMIL CCC(C)C1C(=O)NC(CCC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(C)C)CC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N D06ERA HIGHSTAT Investigative D06FTK DRUG__ID D06FTK D06FTK DRUGINCH 1S/C60H99N15O18S2/c1-10-31(6)46-56(89)71-38(24-33-17-19-34(77)20-18-33)52(85)69-40(26-44(80)81)54(87)75-47(32(7)76)57(90)67-35(15-11-13-21-61)49(82)65-27-43(79)66-36(16-12-14-22-62)50(83)68-39(25-42(63)78)53(86)73-45(30(4)5)55(88)70-37(23-29(2)3)51(84)72-41(59(92)93)28-94-95-60(8,9)48(64)58(91)74-46/h17-20,29-32,35-41,45-48,76-77H,10-16,21-28,61-62,64H2,1-9H3,(H2,63,78)(H,65,82)(H,66,79)(H,67,90)(H,68,83)(H,69,85)(H,70,88)(H,71,89)(H,72,84)(H,73,86)(H,74,91)(H,75,87)(H,80,81)(H,92,93)/t31-,32+,35-,36-,37+,38+,39+,40-,41+,45-,46-,47+,48?/m0/s1 D06FTK DRUGINKE PADTZYYZHQSVHY-JPKRNNDPSA-N D06FTK DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSC(C(C(=O)N1)N)(C)C)C(=O)O)CC(C)C)C(C)C)CC(=O)N)CCCCN)CCCCN)C(C)O)CC(=O)O)CC2=CC=C(C=C2)O D06FTK HIGHSTAT Investigative D06IAT DRUG__ID D06IAT D06IAT DRUGINCH 1S/C25H44N2O/c1-17(6-5-15-27(4)26)21-9-10-22-20-8-7-18-16-19(28)11-13-24(18,2)23(20)12-14-25(21,22)3/h7,17,19-23,28H,5-6,8-16,26H2,1-4H3/t17-,19+,20+,21-,22+,23+,24+,25-/m1/s1 D06IAT DRUGINKE CAVTXXDDLXAFFB-NMQWMWRVSA-N D06IAT DRUGSMIL CC(CCCN(C)N)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C D06IAT HIGHSTAT Investigative D06IZZ DRUG__ID D06IZZ D06IZZ DRUGINCH 1S/C61H95N17O12S/c1-36(2)32-44(55(85)72-41(51(65)81)26-31-91-4)71-50(80)35-69-53(83)45(33-38-16-7-5-8-17-38)75-56(86)46(34-39-18-9-6-10-19-39)76-54(84)42(24-25-49(64)79)73-52(82)37(3)70-57(87)47-22-15-30-78(47)60(90)43(21-11-12-27-62)74-58(88)48-23-14-29-77(48)59(89)40(63)20-13-28-68-61(66)67/h5-10,16-19,36-37,40-48H,11-15,20-35,62-63H2,1-4H3,(H2,64,79)(H2,65,81)(H,69,83)(H,70,87)(H,71,80)(H,72,85)(H,73,82)(H,74,88)(H,75,86)(H,76,84)(H4,66,67,68)/t37-,40-,41-,42-,43-,44-,45-,46-,47-,48-/m0/s1 D06IZZ DRUGINKE VWZGDJIFNOBMMB-DYIQZKFVSA-N D06IZZ DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D06IZZ HIGHSTAT Investigative D06JUN DRUG__ID D06JUN D06JUN DRUGINCH 1S/C74H108N24O19S/c1-36(2)26-50(70(114)91-45(62(78)106)23-25-118-6)95-71(115)53(29-41-32-81-35-86-41)89-60(105)34-85-73(117)61(37(3)4)98-63(107)38(5)87-69(113)52(28-40-31-83-44-11-8-7-10-43(40)44)97-68(112)49(18-21-56(76)101)94-72(116)54(30-57(77)102)90-59(104)33-84-64(108)51(27-39-13-15-42(99)16-14-39)96-65(109)46(12-9-24-82-74(79)80)92-67(111)48(17-20-55(75)100)93-66(110)47-19-22-58(103)88-47/h7-8,10-11,13-16,31-32,35-38,45-54,61,83,99H,9,12,17-30,33-34H2,1-6H3,(H2,75,100)(H2,76,101)(H2,77,102)(H2,78,106)(H,81,86)(H,84,108)(H,85,117)(H,87,113)(H,88,103)(H,89,105)(H,90,104)(H,91,114)(H,92,111)(H,93,110)(H,94,116)(H,95,115)(H,96,109)(H,97,112)(H,98,107)(H4,79,80,82)/t38-,45-,46-,47?,48-,49-,50-,51-,52-,53-,54-,61-/m0/s1 D06JUN DRUGINKE QORXQELQSJVKIL-MOPZKQSYSA-N D06JUN DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CNC=N1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)N)NC(=O)C5CCC(=O)N5 D06JUN HIGHSTAT Investigative D06JWT DRUG__ID D06JWT D06JWT DRUGINCH 1S/C75H98N14O15S2/c1-43(2)78-38-50-30-28-49(29-31-50)35-58-70(98)88-63(44(3)91)72(100)85-60(36-48-23-13-8-14-24-48)74(102)89(5)64(45(4)92)73(101)86-61(40-90)71(99)87-62(75(103)104)42-106-105-41-53(77)65(93)80-55(27-17-18-32-76)66(94)81-56(33-46-19-9-6-10-20-46)67(95)82-57(34-47-21-11-7-12-22-47)68(96)84-59(69(97)83-58)37-51-39-79-54-26-16-15-25-52(51)54/h6-16,19-26,28-31,39,43-45,53,55-64,78-79,90-92H,17-18,27,32-38,40-42,76-77H2,1-5H3,(H,80,93)(H,81,94)(H,82,95)(H,83,97)(H,84,96)(H,85,100)(H,86,101)(H,87,99)(H,88,98)(H,103,104)/t44-,45-,53-,55-,56-,57+,58+,59+,60+,61+,62+,63-,64-/m1/s1 D06JWT DRUGINKE YZXQZTRDHNBZMS-YNBIXHCXSA-N D06JWT DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)C)CC7=CC=CC=C7)C(C)O D06JWT HIGHSTAT Investigative D06JYM DRUG__ID D06JYM D06JYM DRUGINCH 1S/C157H238N42O41/c1-77(2)58-102(176-119(209)72-169-131(215)85(17)173-138(222)103(59-78(3)4)182-136(220)99(50-52-115(159)205)178-142(226)108(65-94-69-165-76-172-94)187-155(239)129(88(20)203)197-153(237)126(83(13)14)193-145(229)107(175-89(21)204)64-93-68-167-96-45-32-31-44-95(93)96)140(224)183-104(60-79(5)6)141(225)190-112(75-201)147(231)179-100(51-53-116(160)206)137(221)189-111(74-200)133(217)170-70-118(208)168-71-120(210)191-124(81(9)10)152(236)194-125(82(11)12)151(235)180-98(47-35-55-166-157(163)164)134(218)177-97(46-33-34-54-158)135(219)185-109(66-117(161)207)143(227)184-106(63-92-42-29-24-30-43-92)144(228)195-127(84(15)16)156(240)199-57-37-49-114(199)149(233)196-128(87(19)202)154(238)188-110(67-122(212)213)146(230)192-123(80(7)8)150(234)171-73-121(211)198-56-36-48-113(198)148(232)186-105(62-91-40-27-23-28-41-91)139(223)174-86(18)132(216)181-101(130(162)214)61-90-38-25-22-26-39-90/h22-32,38-45,68-69,76-88,97-114,123-129,167,200-203H,33-37,46-67,70-75,158H2,1-21H3,(H2,159,205)(H2,160,206)(H2,161,207)(H2,162,214)(H,165,172)(H,168,208)(H,169,215)(H,170,217)(H,171,234)(H,173,222)(H,174,223)(H,175,204)(H,176,209)(H,177,218)(H,178,226)(H,179,231)(H,180,235)(H,181,216)(H,182,220)(H,183,224)(H,184,227)(H,185,219)(H,186,232)(H,187,239)(H,188,238)(H,189,221)(H,190,225)(H,191,210)(H,192,230)(H,193,229)(H,194,236)(H,195,228)(H,196,233)(H,197,237)(H,212,213)(H4,163,164,166)/t85-,86-,87+,88+,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,123-,124-,125-,126-,127-,128-,129-/m0/s1 D06JYM DRUGINKE NNTUVPALHRZTKJ-BHNOSDEFSA-N D06JYM DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C D06JYM HIGHSTAT Investigative D06KAD DRUG__ID D06KAD D06KAD DRUGINCH 1S/C70H106N28O21S6/c1-31-54(105)92-44(22-99)63(114)85-37(10-4-5-13-71)56(107)88-40(16-32-20-82-36-9-3-2-8-34(32)36)59(110)98-49-28-122-120-24-35(72)55(106)95-48-27-124-125-29-50(68(119)94-46(53(74)104)25-121-123-26-47(65(116)84-31)97-61(112)42(18-51(73)101)90-67(48)118)96-58(109)39(12-7-15-81-70(77)78)86-64(115)45(23-100)93-60(111)41(17-33-21-79-30-83-33)89-62(113)43(19-52(102)103)91-57(108)38(87-66(49)117)11-6-14-80-69(75)76/h2-3,8-9,20-21,30-31,35,37-50,82,99-100H,4-7,10-19,22-29,71-72H2,1H3,(H2,73,101)(H2,74,104)(H,79,83)(H,84,116)(H,85,114)(H,86,115)(H,87,117)(H,88,107)(H,89,113)(H,90,118)(H,91,108)(H,92,105)(H,93,111)(H,94,119)(H,95,106)(H,96,109)(H,97,112)(H,98,110)(H,102,103)(H4,75,76,80)(H4,77,78,81)/t31-,35-,37-,38-,39-,40-,41-,42+,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D06KAD DRUGINKE SAPIXEQVQIRZOT-CPQFHPGLSA-N D06KAD DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC2CSSCC(C(=O)NC3CSSCC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(NC3=O)CC(=O)N)C(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCCNC(=N)N)CC(=O)O)CC4=CN=CN4)CO)CCCNC(=N)N)N)CC5=CNC6=CC=CC=C65)CCCCN)CO D06KAD HIGHSTAT Investigative D06LUT DRUG__ID D06LUT D06LUT DRUGINCH 1S/C45H75N19O14S2/c1-21(2)12-26-37(72)62-25(9-7-11-53-44(49)50)36(71)64-29(40(75)58-22(3)42(77)78)19-79-80-45(4,5)34(46)41(76)56-16-30(65)54-17-31(66)59-27(13-23-15-51-20-57-23)38(73)61-24(8-6-10-52-43(47)48)35(70)55-18-32(67)60-28(14-33(68)69)39(74)63-26/h15,20-22,24-29,34H,6-14,16-19,46H2,1-5H3,(H,51,57)(H,54,65)(H,55,70)(H,56,76)(H,58,75)(H,59,66)(H,60,67)(H,61,73)(H,62,72)(H,63,74)(H,64,71)(H,68,69)(H,77,78)(H4,47,48,52)(H4,49,50,53)/t22-,24-,25-,26+,27+,28-,29-,34-/m0/s1 D06LUT DRUGINKE RGCFJZZTHIGGDJ-UHZMXWKHSA-N D06LUT DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CSSC(C(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)CC(=O)O)CCCN=C(N)N)CC2=CN=CN2)N)(C)C)C(=O)NC(C)C(=O)O)CCCN=C(N)N D06LUT HIGHSTAT Investigative D06MKE DRUG__ID D06MKE D06MKE DRUGINCH 1S/C69H127N2O19P/c1-7-13-19-22-25-28-31-34-40-43-54(85-61(75)46-37-16-10-4)49-59(73)70-57(68(79)80)53-84-69-65(71-60(74)50-55(86-62(76)47-38-17-11-5)44-41-35-32-29-26-23-20-14-8-2)67(66(58(52-72)88-69)90-91(81,82)83)89-64(78)51-56(87-63(77)48-39-18-12-6)45-42-36-33-30-27-24-21-15-9-3/h54-58,65-67,69,72H,7-53H2,1-6H3,(H,70,73)(H,71,74)(H,79,80)(H2,81,82,83)/t54-,55-,56-,57+,58-,65-,66-,67-,69-/m1/s1 D06MKE DRUGINKE PRIXXGNJDNLMBH-DPGPRPECSA-N D06MKE DRUGSMIL CCCCCCCCCCCC(CC(=O)NC1C(C(C(OC1OCC(C(=O)O)NC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCC)CO)OP(=O)(O)O)OC(=O)CC(CCCCCCCCCCC)OC(=O)CCCCC)OC(=O)CCCCC D06MKE HIGHSTAT Investigative D06ONC DRUG__ID D06ONC D06ONC DRUGINCH 1S/C56H96N6O14/c1-14-44-56(10,69)49(65)38(6)60(11)31-34(2)29-54(8,68)51(36(4)48(37(5)52(67)74-44)75-46-30-55(9,71-13)50(66)39(7)73-46)76-53-47(64)43(28-35(3)72-53)61(12)32-40-23-25-41(26-24-40)42-33-62(59-57-42)27-21-19-17-15-16-18-20-22-45(63)58-70/h23-26,33-39,43-44,46-51,53,64-66,68-70H,14-22,27-32H2,1-13H3,(H,58,63)/t34-,35-,36+,37-,38-,39+,43+,44-,46+,47-,48+,49-,50+,51-,53+,54-,55-,56-/m1/s1 D06ONC DRUGINKE PVDBHHHRLSRBII-GJUNKSMQSA-N D06ONC DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O D06ONC HIGHSTAT Investigative D06OSN DRUG__ID D06OSN D06OSN DRUGINCH 1S/C59H60N8O10/c60-51(70)32-49(65-55(72)48(28-34-10-2-1-3-11-34)66-58(75)53(61)52-43-15-6-4-12-37(43)22-23-38-13-5-7-16-44(38)52)57(74)64-46(29-35-18-24-40(68)25-19-35)54(71)63-47(30-36-20-26-41(69)27-21-36)56(73)67-50(59(76)77)31-39-33-62-45-17-9-8-14-42(39)45/h1-21,24-27,33,46-50,52-53,62,68-69H,22-23,28-32,61H2,(H2,60,70)(H,63,71)(H,64,74)(H,65,72)(H,66,75)(H,67,73)(H,76,77)/t46-,47-,48-,49-,50-,53-/m0/s1 D06OSN DRUGINKE ODHKJPGCAWIPPT-ZQJLCUDRSA-N D06OSN DRUGSMIL C1CC2=CC=CC=C2C(C3=CC=CC=C31)C(C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)O)N D06OSN HIGHSTAT Investigative D06PJZ DRUG__ID D06PJZ D06PJZ DRUGINCH 1S/C59H72N10O11/c1-6-36(4)51(57(77)65-46(31-42-32-61-34-62-42)58(78)69-27-13-18-48(69)55(75)66-47(59(79)80)30-37-14-9-7-10-15-37)68-54(74)45(29-39-21-25-43(70)26-22-39)64-56(76)50(35(2)3)67-53(73)44(63-49(71)33-60-5)28-38-19-23-41(24-20-38)52(72)40-16-11-8-12-17-40/h7-12,14-17,19-26,32,34-36,44-48,50-51,60,70H,6,13,18,27-31,33H2,1-5H3,(H,61,62)(H,63,71)(H,64,76)(H,65,77)(H,66,75)(H,67,73)(H,68,74)(H,79,80)/t36-,44-,45-,46-,47-,48-,50-,51-/m0/s1 D06PJZ DRUGINKE BXRVAHMUUBZAPK-RUFDXANVSA-N D06PJZ DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CC5=CC=C(C=C5)C(=O)C6=CC=CC=C6)NC(=O)CNC D06PJZ HIGHSTAT Investigative D06PLG DRUG__ID D06PLG D06PLG DRUGINCH 1S/C22H12F9NO5S/c23-20(24,25)11-5-6-18(37-17-4-2-1-3-15(17)19(33)34)16(10-11)32-38(35,36)14-8-12(21(26,27)28)7-13(9-14)22(29,30)31/h1-10,32H,(H,33,34) D06PLG DRUGINKE VWKSVPJJPNTCFZ-UHFFFAOYSA-N D06PLG DRUGSMIL C1=CC=C(C(=C1)C(=O)O)OC2=C(C=C(C=C2)C(F)(F)F)NS(=O)(=O)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F D06PLG HIGHSTAT Investigative D06PZJ DRUG__ID D06PZJ D06PZJ DRUGINCH 1S/C152H231N41O46/c1-18-78(10)121(147(236)170-81(13)126(215)177-105(61-87-64-162-92-37-26-25-36-90(87)92)136(225)179-101(57-75(4)5)137(226)189-119(76(6)7)145(234)176-94(38-27-29-53-153)129(218)165-68-113(203)171-93(40-31-55-161-151(158)159)128(217)163-66-111(157)201)191-138(227)103(58-84-32-21-19-22-33-84)180-133(222)97(47-51-116(207)208)174-132(221)95(39-28-30-54-154)173-125(214)80(12)168-124(213)79(11)169-131(220)98(45-49-110(156)200)187-150(239)152(16,17)193-144(233)99(48-52-117(209)210)175-134(223)100(56-74(2)3)178-135(224)102(60-86-41-43-89(199)44-42-86)181-141(230)107(70-194)184-143(232)109(72-196)185-146(235)120(77(8)9)190-140(229)106(63-118(211)212)182-142(231)108(71-195)186-149(238)123(83(15)198)192-139(228)104(59-85-34-23-20-24-35-85)183-148(237)122(82(14)197)188-114(204)69-166-130(219)96(46-50-115(205)206)172-112(202)67-164-127(216)91(155)62-88-65-160-73-167-88/h19-26,32-37,41-44,64-65,73-83,91,93-109,119-123,162,194-199H,18,27-31,38-40,45-63,66-72,153-155H2,1-17H3,(H2,156,200)(H2,157,201)(H,160,167)(H,163,217)(H,164,216)(H,165,218)(H,166,219)(H,168,213)(H,169,220)(H,170,236)(H,171,203)(H,172,202)(H,173,214)(H,174,221)(H,175,223)(H,176,234)(H,177,215)(H,178,224)(H,179,225)(H,180,222)(H,181,230)(H,182,231)(H,183,237)(H,184,232)(H,185,235)(H,186,238)(H,187,239)(H,188,204)(H,189,226)(H,190,229)(H,191,227)(H,192,228)(H,193,233)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,158,159,161)/t78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,119-,120-,121-,122-,123-/m0/s1 D06PZJ DRUGINKE SNUALFGPRGVVPK-CCGBATFTSA-N D06PZJ DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N D06PZJ HIGHSTAT Investigative D06SMJ DRUG__ID D06SMJ D06SMJ DRUGINCH 1S/C46H73N11O12S2/c1-10-69-26-13-11-25(12-14-26)20-29-41(65)56-36(45(4,5)6)43(67)52-27(15-16-32(47)58)39(63)53-30(21-33(48)59)40(64)55-31(23-71-70-18-17-35(61)51-29)42(66)57-37(46(7,8)9)44(68)54-28(19-24(2)3)38(62)50-22-34(49)60/h11-14,24,27-31,36-37H,10,15-23H2,1-9H3,(H2,47,58)(H2,48,59)(H2,49,60)(H,50,62)(H,51,61)(H,52,67)(H,53,63)(H,54,68)(H,55,64)(H,56,65)(H,57,66)/t27-,28-,29-,30-,31-,36+,37+/m0/s1 D06SMJ DRUGINKE DUQYFIXOZDQOES-CQRJDLEJSA-N D06SMJ DRUGSMIL CCOC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)N2)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N)C(C)(C)C)CC(=O)N)CCC(=O)N)C(C)(C)C D06SMJ HIGHSTAT Investigative D06UYC DRUG__ID D06UYC D06UYC DRUGINCH 1S/C10H14O6/c11-7(3-5-9(13)14)1-2-8(12)4-6-10(15)16/h1-6H2,(H,13,14)(H,15,16) D06UYC DRUGINKE DUAWJQCMZICMIK-UHFFFAOYSA-N D06UYC DRUGSMIL C(CC(=O)CCC(=O)O)C(=O)CCC(=O)O D06UYC HIGHSTAT Investigative D06WNY DRUG__ID D06WNY D06WNY DRUGINCH 1S/C93H163N31O28/c1-41(2)34-57(82(142)108-47(13)73(133)112-55(26-28-63(96)126)78(138)114-53(22-17-18-30-94)79(139)120-69(44(7)8)88(148)109-48(14)74(134)111-54(24-20-32-105-93(102)103)80(140)123-72(50(16)125)91(151)152)119-89(149)70(45(9)10)121-81(141)56(27-29-64(97)127)115-84(144)59(36-43(5)6)117-86(146)61(39-68(131)132)110-67(130)40-106-77(137)52(23-19-31-104-92(100)101)113-83(143)58(35-42(3)4)116-85(145)60(38-66(99)129)118-87(147)62-25-21-33-124(62)90(150)71(46(11)12)122-75(135)49(15)107-76(136)51(95)37-65(98)128/h41-62,69-72,125H,17-40,94-95H2,1-16H3,(H2,96,126)(H2,97,127)(H2,98,128)(H2,99,129)(H,106,137)(H,107,136)(H,108,142)(H,109,148)(H,110,130)(H,111,134)(H,112,133)(H,113,143)(H,114,138)(H,115,144)(H,116,145)(H,117,146)(H,118,147)(H,119,149)(H,120,139)(H,121,141)(H,122,135)(H,123,140)(H,131,132)(H,151,152)(H4,100,101,104)(H4,102,103,105)/t47-,48-,49-,50+,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,69-,70-,71-,72-/m0/s1 D06WNY DRUGINKE BIPRZBFRCFOBDQ-KAGUSELOSA-N D06WNY DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC(=O)N)N D06WNY HIGHSTAT Investigative D06ZJQ DRUG__ID D06ZJQ D06ZJQ DRUGINCH 1S/C47H66N8O16S/c1-24(2)20-31(51-45(68)38(25(3)4)55-41(64)29(48)16-18-35(56)57)44(67)54-34(23-72-28-14-10-7-11-15-28)39(62)46(69)52-32(22-37(60)61)43(66)49-26(5)40(63)50-30(17-19-36(58)59)42(65)53-33(47(70)71)21-27-12-8-6-9-13-27/h6-15,24-26,29-34,38-39,62H,16-23,48H2,1-5H3,(H,49,66)(H,50,63)(H,51,68)(H,52,69)(H,53,65)(H,54,67)(H,55,64)(H,56,57)(H,58,59)(H,60,61)(H,70,71)/t26-,29-,30-,31-,32-,33-,34-,38-,39+/m0/s1 D06ZJQ DRUGINKE FTFBGPHXUHIRHS-OGBCTUIFSA-N D06ZJQ DRUGSMIL CC(C)CC(C(=O)NC(CSC1=CC=CC=C1)C(C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)O)O)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)N D06ZJQ HIGHSTAT Investigative D06ZTU DRUG__ID D06ZTU D06ZTU DRUGINCH 1S/C82H135N27O22/c1-43(2)34-56(74(124)106-57(35-44(3)4)75(125)107-59(38-62(87)113)76(126)104-55(80(130)131)28-29-61(86)112)105-72(122)51(24-14-16-30-83)102-71(121)54(27-19-33-93-82(90)91)101-68(118)46(6)98-78(128)60(42-110)108-73(123)52(25-15-17-31-84)103-70(120)53(26-18-32-92-81(88)89)100-67(117)45(5)97-64(115)41-96-79(129)66(47(7)111)109-77(127)58(37-49-22-12-9-13-23-49)99-65(116)40-94-63(114)39-95-69(119)50(85)36-48-20-10-8-11-21-48/h8-13,20-23,43-47,50-60,66,110-111H,14-19,24-42,83-85H2,1-7H3,(H2,86,112)(H2,87,113)(H,94,114)(H,95,119)(H,96,129)(H,97,115)(H,98,128)(H,99,116)(H,100,117)(H,101,118)(H,102,121)(H,103,120)(H,104,126)(H,105,122)(H,106,124)(H,107,125)(H,108,123)(H,109,127)(H,130,131)(H4,88,89,92)(H4,90,91,93)/t45-,46-,47+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,66-/m0/s1 D06ZTU DRUGINKE OQBMVKTZJNOYNF-WBMOPDPASA-N D06ZTU DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D06ZTU HIGHSTAT Investigative D07ABJ DRUG__ID D07ABJ D07ABJ DRUGINCH 1S/C63H113N11O14/c1-25-27-28-39(13)51(76)50-55(80)66-42(26-2)57(82)72(22)47(33-75)60(85)71(21)46(32-63(16,17)88)54(79)67-48(37(9)10)61(86)68(18)43(29-34(3)4)53(78)64-40(14)52(77)65-41(15)56(81)69(19)44(30-35(5)6)58(83)70(20)45(31-36(7)8)59(84)73(23)49(38(11)12)62(87)74(50)24/h25,27,34-51,75-76,88H,26,28-33H2,1-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/b27-25+/t39-,40+,41-,42+,43+,44+,45+,46+,47-,48+,49+,50?,51-/m1/s1 D07ABJ DRUGINKE XCXAXJCKONNWJE-HXEFTPTGSA-N D07ABJ DRUGSMIL CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)(C)O)C)CO)C D07ABJ HIGHSTAT Investigative D07AUG DRUG__ID D07AUG D07AUG DRUGINCH 1S/C53H70N14O11S2/c1-26(68)41(44(55)71)65-51(78)43-53(3,4)80-79-25-40(64-45(72)34(54)21-29-23-59-35-12-7-5-10-32(29)35)49(76)62-38(20-28-15-17-31(70)18-16-28)47(74)63-39(22-30-24-60-36-13-8-6-11-33(30)36)48(75)61-37(14-9-19-58-52(56)57)46(73)66-42(27(2)69)50(77)67-43/h5-8,10-13,15-18,23-24,26-27,34,37-43,59-60,68-70H,9,14,19-22,25,54H2,1-4H3,(H2,55,71)(H,61,75)(H,62,76)(H,63,74)(H,64,72)(H,65,78)(H,66,73)(H,67,77)(H4,56,57,58)/t26-,27-,34-,37+,38+,39+,40+,41+,42-,43+/m1/s1 D07AUG DRUGINKE UGJHJTQROKIYLL-CCDPMWLASA-N D07AUG DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CNC6=CC=CC=C65)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D07AUG HIGHSTAT Investigative D07BCH DRUG__ID D07BCH D07BCH DRUGINCH 1S/C80H118N28O14S2/c1-3-13-55(69(115)101-59(21-11-33-95-79(89)90)73(119)105-61(65(83)111)35-43-23-27-47(109)28-24-43)99-71(117)57(19-9-31-93-77(85)86)103-75(121)63(37-45-39-97-53-17-7-5-15-49(45)53)107-67(113)51(81)41-123-124-42-52(82)68(114)108-64(38-46-40-98-54-18-8-6-16-50(46)54)76(122)104-58(20-10-32-94-78(87)88)72(118)100-56(14-4-2)70(116)102-60(22-12-34-96-80(91)92)74(120)106-62(66(84)112)36-44-25-29-48(110)30-26-44/h5-8,15-18,23-30,39-40,51-52,55-64,97-98,109-110H,3-4,9-14,19-22,31-38,41-42,81-82H2,1-2H3,(H2,83,111)(H2,84,112)(H,99,117)(H,100,118)(H,101,115)(H,102,116)(H,103,121)(H,104,122)(H,105,119)(H,106,120)(H,107,113)(H,108,114)(H4,85,86,93)(H4,87,88,94)(H4,89,90,95)(H4,91,92,96)/t51-,52-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-/m0/s1 D07BCH DRUGINKE QUIHYEFPGVPGCQ-HCHGDIHTSA-N D07BCH DRUGSMIL CCCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CSSCC(C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)N)N)N D07BCH HIGHSTAT Investigative D07BJZ DRUG__ID D07BJZ D07BJZ DRUGINCH 1S/C148H222N42O65S/c1-8-72(4)121(145(251)190-41-15-20-101(190)143(249)182-80(32-37-118(222)223)135(241)179-79(31-36-117(220)221)136(242)185-86(44-74-21-25-76(203)26-22-74)140(246)184-84(42-71(2)3)138(244)183-83(146(252)253)29-34-102(149)204)187-137(243)81(33-38-119(224)225)180-134(240)78(30-35-116(218)219)181-139(245)85(43-73-16-10-9-11-17-73)186-141(247)87(45-120(226)227)166-103(205)46-153-122(228)88(59-191)167-104(206)47-154-123(229)89(60-192)168-105(207)48-155-124(230)90(61-193)169-106(208)49-156-125(231)91(62-194)170-107(209)50-157-126(232)92(63-195)171-108(210)51-158-127(233)93(64-196)172-109(211)52-159-128(234)94(65-197)173-110(212)53-160-129(235)95(66-198)174-111(213)54-161-130(236)96(67-199)175-112(214)55-162-131(237)97(68-200)176-113(215)56-163-132(238)98(69-201)177-114(216)57-164-133(239)99(70-202)178-115(217)58-165-142(248)100-19-12-13-40-189(100)144(250)82(18-14-39-152-147(150)151)188-256(254,255)77-27-23-75(24-28-77)148(5,6)7/h9-11,16-17,21-28,71-72,78-101,121,188,191-203H,8,12-15,18-20,29-70H2,1-7H3,(H2,149,204)(H,153,228)(H,154,229)(H,155,230)(H,156,231)(H,157,232)(H,158,233)(H,159,234)(H,160,235)(H,161,236)(H,162,237)(H,163,238)(H,164,239)(H,165,248)(H,166,205)(H,167,206)(H,168,207)(H,169,208)(H,170,209)(H,171,210)(H,172,211)(H,173,212)(H,174,213)(H,175,214)(H,176,215)(H,177,216)(H,178,217)(H,179,241)(H,180,240)(H,181,245)(H,182,249)(H,183,244)(H,184,246)(H,185,242)(H,186,247)(H,187,243)(H,218,219)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,252,253)(H4,150,151,152)/t72-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100?,101-,121-/m0/s1 D07BJZ DRUGINKE CZTBIQRSYJGOBZ-NBINKJFGSA-N D07BJZ DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D07BJZ HIGHSTAT Investigative D07BMA DRUG__ID D07BMA D07BMA DRUGINCH 1S/C118H174N30O47S/c1-8-60(4)97(115(191)148-41-15-20-83(148)113(189)140-68(32-37-94(168)169)105(181)137-67(31-36-93(166)167)106(182)143-74(44-62-21-25-64(155)26-22-62)110(186)142-72(42-59(2)3)108(184)141-71(116(192)193)29-34-84(119)156)145-107(183)69(33-38-95(170)171)138-104(180)66(30-35-92(164)165)139-109(185)73(43-61-16-10-9-11-17-61)144-111(187)75(45-96(172)173)130-85(157)46-123-98(174)76(53-149)131-86(158)47-124-99(175)77(54-150)132-87(159)48-125-100(176)78(55-151)133-88(160)49-126-101(177)79(56-152)134-89(161)50-127-102(178)80(57-153)135-90(162)51-128-103(179)81(58-154)136-91(163)52-129-112(188)82-19-12-13-40-147(82)114(190)70(18-14-39-122-117(120)121)146-196(194,195)65-27-23-63(24-28-65)118(5,6)7/h9-11,16-17,21-28,59-60,66-83,97,146,149-155H,8,12-15,18-20,29-58H2,1-7H3,(H2,119,156)(H,123,174)(H,124,175)(H,125,176)(H,126,177)(H,127,178)(H,128,179)(H,129,188)(H,130,157)(H,131,158)(H,132,159)(H,133,160)(H,134,161)(H,135,162)(H,136,163)(H,137,181)(H,138,180)(H,139,185)(H,140,189)(H,141,184)(H,142,186)(H,143,182)(H,144,187)(H,145,183)(H,164,165)(H,166,167)(H,168,169)(H,170,171)(H,172,173)(H,192,193)(H4,120,121,122)/t60-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82?,83-,97-/m0/s1 D07BMA DRUGINKE PUATYUGHSGBOAZ-BSPCXEMDSA-N D07BMA DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D07BMA HIGHSTAT Investigative D07DJT DRUG__ID D07DJT D07DJT DRUGINCH 1S/C81H131N27O19/c1-40(2)30-56(96-45(10)110)71(120)98-52(15-12-28-93-80(87)88)69(118)106-61(36-48-38-91-39-95-48)75(124)105-60(35-47-19-23-50(112)24-20-47)74(123)102-58(32-42(5)6)73(122)107-62(37-64(83)114)76(125)103-57(31-41(3)4)72(121)104-59(33-43(7)8)77(126)108-65(44(9)109)78(127)100-53(16-13-29-94-81(89)90)67(116)99-54(25-26-63(82)113)70(119)97-51(14-11-27-92-79(85)86)68(117)101-55(66(84)115)34-46-17-21-49(111)22-18-46/h17-24,38-44,51-62,65,109,111-112H,11-16,25-37H2,1-10H3,(H2,82,113)(H2,83,114)(H2,84,115)(H,91,95)(H,96,110)(H,97,119)(H,98,120)(H,99,116)(H,100,127)(H,101,117)(H,102,123)(H,103,125)(H,104,121)(H,105,124)(H,106,118)(H,107,122)(H,108,126)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t44-,51+,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+,65+/m1/s1 D07DJT DRUGINKE LZKBNKKHNKAGAE-ZQWBWPFKSA-N D07DJT DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C D07DJT HIGHSTAT Investigative D07DPW DRUG__ID D07DPW D07DPW DRUGINCH 1S/C79H100ClN15O15S/c1-45(2)83-35-12-11-18-61(79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)88-77(108)78(111(110)46(3)4)94-74(105)65(40-53-25-32-60(33-26-53)86-49(7)98)90-72(103)64(39-52-23-30-59(31-24-52)85-48(6)97)92-75(106)67(44-96)93-73(104)66(42-55-15-13-34-82-43-55)91-71(102)63(38-51-21-28-58(80)29-22-51)89-70(101)62(87-50(8)99)41-54-20-27-56-16-9-10-17-57(56)37-54/h9-10,13,15-17,20-34,37,43,45-47,61-68,78,83,96H,11-12,14,18-19,35-36,38-42,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,108)(H,89,101)(H,90,103)(H,91,102)(H,92,106)(H,93,104)(H,94,105)/t47-,61+,62-,63-,64+,65-,66-,67+,68+,78-,111?/m1/s1 D07DPW DRUGINKE KEFJIAHSOLWSII-JBSZQXIRSA-N D07DPW DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)S(=O)C(C)C D07DPW HIGHSTAT Investigative D07DUF DRUG__ID D07DUF D07DUF DRUGINCH 1S/C76H97N13O15S2/c1-44(2)79-40-51-29-27-50(28-30-51)38-59-71(98)88-64(45(3)91)74(101)85-60(37-49-22-12-7-13-23-49)72(99)89-65(46(4)92)75(102)86-62(41-90)73(100)87-63(76(103)104)43-106-105-42-55(78)66(93)80-56(26-16-17-33-77)67(94)81-57(35-47-18-8-5-9-19-47)68(95)82-58(36-48-20-10-6-11-21-48)69(96)84-61(70(97)83-59)39-52-31-32-53-24-14-15-25-54(53)34-52/h5-15,18-25,27-32,34,44-46,55-65,79,90-92H,16-17,26,33,35-43,77-78H2,1-4H3,(H,80,93)(H,81,94)(H,82,95)(H,83,97)(H,84,96)(H,85,101)(H,86,102)(H,87,100)(H,88,98)(H,89,99)(H,103,104)/t45-,46-,55-,56-,57-,58+,59+,60+,61+,62+,63+,64-,65-/m1/s1 D07DUF DRUGINKE VQFBJGSUDSOXIC-MKQNODHSSA-N D07DUF DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D07DUF HIGHSTAT Investigative D07DWH DRUG__ID D07DWH D07DWH DRUGINCH 1S/C51H70N18O11S2/c1-27(70)62-33(13-7-17-58-50(53)54)43(74)69-40-25-82-81-24-39(42(52)73)68-47(78)37(20-29-22-60-32-12-6-5-11-31(29)32)66-44(75)34(14-8-18-59-51(55)56)63-46(77)36(19-28-9-3-2-4-10-28)65-48(79)38(21-30-23-57-26-61-30)67-45(76)35(64-49(40)80)15-16-41(71)72/h2-6,9-12,22-23,26,33-40,60H,7-8,13-21,24-25H2,1H3,(H2,52,73)(H,57,61)(H,62,70)(H,63,77)(H,64,80)(H,65,79)(H,66,75)(H,67,76)(H,68,78)(H,69,74)(H,71,72)(H4,53,54,58)(H4,55,56,59)/t33-,34+,35-,36+,37-,38+,39-,40-/m0/s1 D07DWH DRUGINKE UNXFCHHFXJFRRB-ABRXVHCYSA-N D07DWH DRUGSMIL CC(=O)NC(CCCN=C(N)N)C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCC(=O)O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N D07DWH HIGHSTAT Investigative D07ERV DRUG__ID D07ERV D07ERV DRUGINCH 1S/C52H72I2N14O12S2/c1-52(2)42(68-44(74)33(56)21-28-13-15-30(70)16-14-28)50(80)66-36(23-29-19-31(53)41(72)32(54)20-29)45(75)61-24-40(71)62-38(25-69)48(78)65-37(22-27-9-4-3-5-10-27)47(77)67-39(26-81-82-52)49(79)64-35(11-6-7-17-55)46(76)63-34(43(57)73)12-8-18-60-51(58)59/h3-5,9-10,13-16,19-20,33-39,42,69-70,72H,6-8,11-12,17-18,21-26,55-56H2,1-2H3,(H2,57,73)(H,61,75)(H,62,71)(H,63,76)(H,64,79)(H,65,78)(H,66,80)(H,67,77)(H,68,74)(H4,58,59,60)/t33-,34-,35-,36-,37+,38-,39+,42-/m0/s1 D07ERV DRUGINKE ZHARLIJAVUCVJG-YLYTWGDESA-N D07ERV DRUGSMIL CC1(C(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC2=CC=CC=C2)CO)CC3=CC(=C(C(=C3)I)O)I)NC(=O)C(CC4=CC=C(C=C4)O)N)C D07ERV HIGHSTAT Investigative D07EWK DRUG__ID D07EWK D07EWK DRUGINCH 1S/C60H75N13O11/c1-4-36(2)51(57(81)70-47(32-42-33-64-35-66-42)58(82)73-28-12-18-49(73)56(80)71-48(59(83)84)31-37-13-7-5-8-14-37)72-55(79)46(30-39-21-25-43(74)26-22-39)69-54(78)45(29-38-19-23-41(24-20-38)52(76)40-15-9-6-10-16-40)68-53(77)44(67-50(75)34-63-3)17-11-27-65-60(61)62/h5-10,13-16,19-26,33,35-36,44-49,51,63,74H,4,11-12,17-18,27-32,34H2,1-3H3,(H,64,66)(H,67,75)(H,68,77)(H,69,78)(H,70,81)(H,71,80)(H,72,79)(H,83,84)(H4,61,62,65)/t36-,44-,45-,46-,47-,48-,49-,51-/m0/s1 D07EWK DRUGINKE PXNIGPMZOUUXMA-FSKISDTGSA-N D07EWK DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=C(C=C5)C(=O)C6=CC=CC=C6)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D07EWK HIGHSTAT Investigative D07FYX DRUG__ID D07FYX D07FYX DRUGINCH 1S/C74H102N20O19S2/c1-39(77)62(100)82-35-59(99)83-56-37-114-115-38-57(74(112)113)92-70(108)55(36-95)91-73(111)61(41(3)97)94-69(107)51(29-43-18-8-5-9-19-43)90-72(110)60(40(2)96)93-64(102)49(23-13-15-25-76)84-66(104)52(30-44-33-81-47-21-11-10-20-46(44)47)87-67(105)53(31-45-34-79-26-27-80-45)88-65(103)50(28-42-16-6-4-7-17-42)86-68(106)54(32-58(78)98)89-63(101)48(85-71(56)109)22-12-14-24-75/h4-11,16-21,26-27,33-34,39-41,48-57,60-61,81,95-97H,12-15,22-25,28-32,35-38,75-77H2,1-3H3,(H2,78,98)(H,82,100)(H,83,99)(H,84,104)(H,85,109)(H,86,106)(H,87,105)(H,88,103)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t39-,40?,41?,48-,49+,50-,51-,52-,53+,54+,55-,56-,57-,60+,61+/m0/s1 D07FYX DRUGINKE BUGNDGJWDYBQHT-BKUMYXSWSA-N D07FYX DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=NC=CN=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O D07FYX HIGHSTAT Investigative D07HKJ DRUG__ID D07HKJ D07HKJ DRUGINCH 1S/C92H142O46/c1-34-52(98)60(106)65(111)77(124-34)121-33-47-59(105)74(133-51(97)17-13-37-12-15-42(119-11)40(95)26-37)70(116)84(131-47)136-75-58(104)43(28-93)127-83(71(75)117)130-46-32-123-79(64(110)57(46)103)135-73-54(100)36(3)126-82(69(73)115)137-76-55(101)41(96)30-120-85(76)132-50-19-20-89(8)48(88(50,6)7)18-21-91(10)49(89)16-14-38-39-27-87(4,5)22-24-92(39,25-23-90(38,91)9)86(118)138-81-67(113)62(108)56(102)45(129-81)31-122-78-68(114)63(109)72(44(29-94)128-78)134-80-66(112)61(107)53(99)35(2)125-80/h12-15,17,26,34-36,39,41,43-50,52-85,93-96,98-117H,16,18-25,27-33H2,1-11H3/b17-13+/t34-,35-,36-,39-,41-,43+,44+,45+,46+,47+,48-,49+,50-,52-,53-,54-,55-,56+,57+,58+,59+,60+,61+,62-,63+,64+,65+,66+,67+,68+,69+,70+,71+,72+,73+,74-,75-,76+,77+,78+,79-,80-,81-,82-,83-,84-,85-,89-,90+,91+,92-/m0/s1 D07HKJ DRUGINKE NPRWMYIWVVAUEC-KQFZDZHOSA-N D07HKJ DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(C(OC(C3O)OC4COC(C(C4O)O)OC5C(C(OC(C5O)OC6C(C(COC6OC7CCC8(C(C7(C)C)CCC9(C8CC=C1C9(CCC2(C1CC(CC2)(C)C)C(=O)OC1C(C(C(C(O1)COC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)C)O)O)O)O)O)O)O)O)C)C)C)O)O)C)O)CO)O)O)OC(=O)C=CC1=CC(=C(C=C1)OC)O)O)O)O)O D07HKJ HIGHSTAT Investigative D07HTH DRUG__ID D07HTH D07HTH DRUGINCH 1S/C50H71N11O12S2/c1-6-28(5)43-49(71)56-33(16-17-39(51)62)45(67)57-36(23-40(52)63)46(68)59-37(26-75-74-19-18-42(65)55-35(47(69)60-43)21-29-12-14-32(15-13-29)73-7-2)50(72)61-25-31-11-9-8-10-30(31)22-38(61)48(70)58-34(20-27(3)4)44(66)54-24-41(53)64/h8-15,27-28,33-38,43H,6-7,16-26H2,1-5H3,(H2,51,62)(H2,52,63)(H2,53,64)(H,54,66)(H,55,65)(H,56,71)(H,57,67)(H,58,70)(H,59,68)(H,60,69)/t28-,33-,34-,35-,36-,37-,38+,43-/m0/s1 D07HTH DRUGINKE XCBFBYRYXJOIRC-ABNDKVESSA-N D07HTH DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D07HTH HIGHSTAT Investigative D07HWJ DRUG__ID D07HWJ D07HWJ DRUGINCH 1S/C82H137N31O22/c1-44(101-63(119)42-100-78(133)65(46(3)115)113-76(131)57(38-48-21-8-5-9-22-48)103-64(120)41-98-62(118)40-99-68(123)49(86)37-47-19-6-4-7-20-47)66(121)104-53(26-16-34-95-80(89)90)70(125)108-52(25-12-15-33-85)74(129)112-59(43-114)77(132)102-45(2)67(122)105-54(27-17-35-96-81(91)92)71(126)106-50(23-10-13-31-83)69(124)109-55(28-18-36-97-82(93)94)72(127)107-51(24-11-14-32-84)73(128)111-58(39-61(88)117)75(130)110-56(79(134)135)29-30-60(87)116/h4-9,19-22,44-46,49-59,65,114-115H,10-18,23-43,83-86H2,1-3H3,(H2,87,116)(H2,88,117)(H,98,118)(H,99,123)(H,100,133)(H,101,119)(H,102,132)(H,103,120)(H,104,121)(H,105,122)(H,106,126)(H,107,127)(H,108,125)(H,109,124)(H,110,130)(H,111,128)(H,112,129)(H,113,131)(H,134,135)(H4,89,90,95)(H4,91,92,96)(H4,93,94,97)/t44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,65-/m0/s1 D07HWJ DRUGINKE VULLMZOQBGUKAT-VUXBHJHDSA-N D07HWJ DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D07HWJ HIGHSTAT Investigative D07HZU DRUG__ID D07HZU D07HZU DRUGINCH 1S/C81H133N27O22/c1-42(2)34-55(74(124)107-64(43(3)4)78(128)105-57(37-60(86)112)73(123)103-54(79(129)130)28-29-59(85)111)104-71(121)50(24-14-16-30-82)101-70(120)53(27-19-33-92-81(89)90)100-67(117)45(6)97-76(126)58(41-109)106-72(122)51(25-15-17-31-83)102-69(119)52(26-18-32-91-80(87)88)99-66(116)44(5)96-62(114)40-95-77(127)65(46(7)110)108-75(125)56(36-48-22-12-9-13-23-48)98-63(115)39-93-61(113)38-94-68(118)49(84)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64-65,109-110H,14-19,24-41,82-84H2,1-7H3,(H2,85,111)(H2,86,112)(H,93,113)(H,94,118)(H,95,127)(H,96,114)(H,97,126)(H,98,115)(H,99,116)(H,100,117)(H,101,120)(H,102,119)(H,103,123)(H,104,121)(H,105,128)(H,106,122)(H,107,124)(H,108,125)(H,129,130)(H4,87,88,91)(H4,89,90,92)/t44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-,65-/m0/s1 D07HZU DRUGINKE ONIQWXAYTYHYLD-BEIYNOPZSA-N D07HZU DRUGSMIL CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D07HZU HIGHSTAT Investigative D07IBF DRUG__ID D07IBF D07IBF DRUGINCH 1S/C61H81N19O13S2/c1-33(81)71-44(25-35-16-18-38(82)19-17-35)55(89)72-42(15-9-23-69-61(65)66)53(87)79-49-31-95-94-30-48(51(62)85)78-57(91)46(26-36-28-70-40-13-7-6-12-39(36)40)76-52(86)41(14-8-22-68-60(63)64)73-56(90)45(24-34-10-4-3-5-11-34)75-58(92)47(27-37-29-67-32-80(37)2)77-54(88)43(74-59(49)93)20-21-50(83)84/h3-7,10-13,16-19,28-29,32,41-49,70,82H,8-9,14-15,20-27,30-31H2,1-2H3,(H2,62,85)(H,71,81)(H,72,89)(H,73,90)(H,74,93)(H,75,92)(H,76,86)(H,77,88)(H,78,91)(H,79,87)(H,83,84)(H4,63,64,68)(H4,65,66,69)/t41-,42-,43+,44-,45-,46+,47-,48+,49+/m0/s1 D07IBF DRUGINKE JCRBBWBYSVHLIT-PYPSSTHSSA-N D07IBF DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3C)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D07IBF HIGHSTAT Investigative D07IBU DRUG__ID D07IBU D07IBU DRUGINCH 1S/C30H40O5/c1-16(2)13-17(31)14-18-24-21(34-25(18)32)15-29(5)20-7-8-22-27(3,19(20)9-12-28(24,29)4)11-10-23-30(22,6)26(33)35-23/h7,13,18-19,21-24H,8-12,14-15H2,1-6H3/t18-,19+,21+,22-,23-,24-,27-,28+,29-,30+/m1/s1 D07IBU DRUGINKE UAKRLLAUOQEYFN-PQNCNOJFSA-N D07IBU DRUGSMIL CC(=CC(=O)CC1C2C(CC3(C2(CCC4C3=CCC5C4(CCC6C5(C(=O)O6)C)C)C)C)OC1=O)C D07IBU HIGHSTAT Investigative D07KDH DRUG__ID D07KDH D07KDH DRUGINCH 1S/C64H100N18O15S/c1-37(2)34-46(58(90)74-42(53(69)85)28-33-98(4,96)97)78-54(86)38(3)73-57(89)47(35-39-16-7-5-8-17-39)80-59(91)48(36-40-18-9-6-10-19-40)79-56(88)43(24-26-51(67)83)75-55(87)44(25-27-52(68)84)76-60(92)50-23-15-32-82(50)63(95)45(21-11-12-29-65)77-61(93)49-22-14-31-81(49)62(94)41(66)20-13-30-72-64(70)71/h5-10,16-19,37-38,41-50H,11-15,20-36,65-66H2,1-4H3,(H2,67,83)(H2,68,84)(H2,69,85)(H,73,89)(H,74,90)(H,75,87)(H,76,92)(H,77,93)(H,78,86)(H,79,88)(H,80,91)(H4,70,71,72)/t38?,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D07KDH DRUGINKE VRAGPHDTXRPMRS-RGKHVPTMSA-N D07KDH DRUGSMIL CC(C)CC(C(=O)NC(CCS(=O)(=O)C)C(=O)N)NC(=O)C(C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D07KDH HIGHSTAT Investigative D07KNS DRUG__ID D07KNS D07KNS DRUGINCH 1S/C82H136N28O22/c1-44(2)36-57(75(126)105-52(25-13-16-32-84)73(124)108-59(39-62(88)114)76(127)106-56(80(131)132)29-30-61(87)113)107-72(123)51(24-12-15-31-83)103-71(122)55(28-19-35-94-82(91)92)102-68(119)46(4)99-78(129)60(43-111)109-74(125)53(26-14-17-33-85)104-70(121)54(27-18-34-93-81(89)90)101-67(118)45(3)98-64(116)42-97-79(130)66(47(5)112)110-77(128)58(38-49-22-10-7-11-23-49)100-65(117)41-95-63(115)40-96-69(120)50(86)37-48-20-8-6-9-21-48/h6-11,20-23,44-47,50-60,66,111-112H,12-19,24-43,83-86H2,1-5H3,(H2,87,113)(H2,88,114)(H,95,115)(H,96,120)(H,97,130)(H,98,116)(H,99,129)(H,100,117)(H,101,118)(H,102,119)(H,103,122)(H,104,121)(H,105,126)(H,106,127)(H,107,123)(H,108,124)(H,109,125)(H,110,128)(H,131,132)(H4,89,90,93)(H4,91,92,94)/t45-,46-,47+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,66-/m0/s1 D07KNS DRUGINKE PODXIWAAMNUDTK-WBMOPDPASA-N D07KNS DRUGSMIL CC(C)CC(C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D07KNS HIGHSTAT Investigative D07MMG DRUG__ID D07MMG D07MMG DRUGINCH 1S/C58H101N31O13/c1-28(87-24-9-17-36(87)50(99)88-25-8-16-35(88)38(90)41-39(91)40(92)51(102-41)89-27-80-37-42(59)78-26-79-43(37)89)44(93)81-29(10-2-18-72-53(60)61)45(94)82-30(11-3-19-73-54(62)63)46(95)83-31(12-4-20-74-55(64)65)47(96)84-32(13-5-21-75-56(66)67)48(97)85-33(14-6-22-76-57(68)69)49(98)86-34(52(100)101)15-7-23-77-58(70)71/h26-36,39-41,51,91-92H,2-25H2,1H3,(H,81,93)(H,82,94)(H,83,95)(H,84,96)(H,85,97)(H,86,98)(H,100,101)(H2,59,78,79)(H4,60,61,72)(H4,62,63,73)(H4,64,65,74)(H4,66,67,75)(H4,68,69,76)(H4,70,71,77)/t28-,29-,30-,31-,32-,33-,34-,35-,36+,39+,40-,41-,51?/m1/s1 D07MMG DRUGINKE MKVGDINXVXQIHD-OALVHANWSA-N D07MMG DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)N1CCCC1C(=O)N2CCCC2C(=O)C3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O D07MMG HIGHSTAT Investigative D07NBK DRUG__ID D07NBK D07NBK DRUGINCH 1S/C80H102ClN23O12/c1-44(2)35-59(68(108)91-58(16-9-10-33-86-45(3)4)76(116)104-34-12-17-66(104)75(115)87-46(5)67(82)107)92-70(110)62(38-49-21-28-56(29-22-49)89-79-98-77(83)100-102-79)94-72(112)63(39-50-23-30-57(31-24-50)90-80-99-78(84)101-103-80)96-74(114)65(43-105)97-73(113)64(41-52-13-11-32-85-42-52)95-71(111)61(37-48-19-26-55(81)27-20-48)93-69(109)60(88-47(6)106)40-51-18-25-53-14-7-8-15-54(53)36-51/h7-8,11,13-15,18-32,36,42,44-46,58-66,86,105H,9-10,12,16-17,33-35,37-41,43H2,1-6H3,(H2,82,107)(H,87,115)(H,88,106)(H,91,108)(H,92,110)(H,93,109)(H,94,112)(H,95,111)(H,96,114)(H,97,113)(H4,83,89,98,100,102)(H4,84,90,99,101,103)/t46-,58-,59-,60-,61-,62+,63-,64+,65-,66-/m0/s1 D07NBK DRUGINKE VLGKQBGBPIVGBX-SIHJNPAHSA-N D07NBK DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC3=NC(=NN3)N)NC(=O)C(CC4=CC=C(C=C4)NC5=NC(=NN5)N)NC(=O)C(CO)NC(=O)C(CC6=CN=CC=C6)NC(=O)C(CC7=CC=C(C=C7)Cl)NC(=O)C(CC8=CC9=CC=CC=C9C=C8)NC(=O)C D07NBK HIGHSTAT Investigative D07NOJ DRUG__ID D07NOJ D07NOJ DRUGINCH 1S/C104H174N24O22/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-42-86(133)111-50-33-29-40-75(94(140)117-73(90(110)136)37-26-30-47-105)119-95(141)74(38-27-31-48-106)118-96(142)76(39-28-32-49-107)120-103(149)84-41-34-51-128(84)88(135)60-114-93(139)77(52-62(2)3)122-97(143)78(53-63(4)5)123-99(145)80(55-68-43-45-70(131)46-44-68)116-87(134)59-113-92(138)66(9)115-102(148)83(61-129)126-100(146)82(57-85(109)132)124-98(144)79(54-64(6)7)125-104(150)89(67(10)130)127-101(147)81(121-91(137)65(8)108)56-69-58-112-72-36-25-24-35-71(69)72/h24-25,35-36,43-46,58,62-67,73-84,89,112,129-131H,11-23,26-34,37-42,47-57,59-61,105-108H2,1-10H3,(H2,109,132)(H2,110,136)(H,111,133)(H,113,138)(H,114,139)(H,115,148)(H,116,134)(H,117,140)(H,118,142)(H,119,141)(H,120,149)(H,121,137)(H,122,143)(H,123,145)(H,124,144)(H,125,150)(H,126,146)(H,127,147)/t65-,66-,67+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,89-/m0/s1 D07NOJ DRUGINKE SYZGVJVRSWLTDO-ZYVMWFDRSA-N D07NOJ DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(C)N D07NOJ HIGHSTAT Investigative D07NPZ DRUG__ID D07NPZ D07NPZ DRUGINCH 1S/C46H73N11O12S2/c1-9-25(5)37-44(67)52-28(15-16-33(47)58)40(63)53-31(21-34(48)59)41(64)55-32(43(66)57-38(46(6,7)8)45(68)54-29(19-24(3)4)39(62)50-22-35(49)60)23-71-70-18-17-36(61)51-30(42(65)56-37)20-26-11-13-27(14-12-26)69-10-2/h11-14,24-25,28-32,37-38H,9-10,15-23H2,1-8H3,(H2,47,58)(H2,48,59)(H2,49,60)(H,50,62)(H,51,61)(H,52,67)(H,53,63)(H,54,68)(H,55,64)(H,56,65)(H,57,66)/t25-,28-,29-,30-,31-,32-,37-,38+/m0/s1 D07NPZ DRUGINKE BTBKJAGQCVEVDA-GDQBDYHJSA-N D07NPZ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N)C(C)(C)C)CC(=O)N)CCC(=O)N D07NPZ HIGHSTAT Investigative D07OAR DRUG__ID D07OAR D07OAR DRUGINCH 1S/C49H72N14O9S/c1-26(2)16-35(44(68)59-34(41(50)65)14-15-73-9)60-45(69)37(18-30-21-51-24-55-30)58-39(64)23-54-47(71)40(27(3)4)63-42(66)28(5)57-43(67)36(17-29-20-53-33-13-11-10-12-32(29)33)61-46(70)38(19-31-22-52-25-56-31)62-48(72)49(6,7)8/h10-13,20-22,24-28,34-38,40,53H,14-19,23H2,1-9H3,(H2,50,65)(H,51,55)(H,52,56)(H,54,71)(H,57,67)(H,58,64)(H,59,68)(H,60,69)(H,61,70)(H,62,72)(H,63,66)/t28-,34-,35-,36-,37-,38-,40-/m0/s1 D07OAR DRUGINKE PKBMJVZFJGPSPI-MEIFHOCSSA-N D07OAR DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C(C)(C)C D07OAR HIGHSTAT Investigative D07OOG DRUG__ID D07OOG D07OOG DRUGINCH 1S/C82H122N28O14/c1-3-15-57(71(117)103-61(25-13-37-97-81(91)92)75(121)107-63(67(85)113)39-45-27-31-49(111)32-28-45)101-73(119)59(23-11-35-95-79(87)88)105-77(123)65(41-47-43-99-55-21-9-5-17-51(47)55)109-69(115)53(83)19-7-8-20-54(84)70(116)110-66(42-48-44-100-56-22-10-6-18-52(48)56)78(124)106-60(24-12-36-96-80(89)90)74(120)102-58(16-4-2)72(118)104-62(26-14-38-98-82(93)94)76(122)108-64(68(86)114)40-46-29-33-50(112)34-30-46/h5-6,9-10,17-18,21-22,27-34,43-44,53-54,57-66,99-100,111-112H,3-4,7-8,11-16,19-20,23-26,35-42,83-84H2,1-2H3,(H2,85,113)(H2,86,114)(H,101,119)(H,102,120)(H,103,117)(H,104,118)(H,105,123)(H,106,124)(H,107,121)(H,108,122)(H,109,115)(H,110,116)(H4,87,88,95)(H4,89,90,96)(H4,91,92,97)(H4,93,94,98)/t53-,54-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-/m0/s1 D07OOG DRUGINKE OWXAFDOATMPIJT-ITDOKHEHSA-N D07OOG DRUGSMIL CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCCC(C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)N)N)N D07OOG HIGHSTAT Investigative D07OSF DRUG__ID D07OSF D07OSF DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)38-60-72(99)89-66(47(4)93)76(103)90(5)64(40-50-23-13-8-14-24-50)74(101)88-65(46(3)92)75(102)86-62(42-91)73(100)87-63(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-61(71(98)84-60)39-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,98)(H,85,97)(H,86,102)(H,87,100)(H,88,101)(H,89,99)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D07OSF DRUGINKE VSHSVJQIYKFIKJ-PCKPOTSRSA-N D07OSF DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C)C(C)O D07OSF HIGHSTAT Investigative D07RRN DRUG__ID D07RRN D07RRN DRUGINCH 1S/C68H88N16O14/c1-6-35(2)54-67(98)84-27-13-21-53(84)63(94)83-56(37(4)86)65(96)78-49(28-39-22-24-44(88)25-23-39)61(92)81-55(36(3)85)64(95)79-52(31-43-33-71-34-74-43)60(91)77-50(29-41-16-11-15-40-14-7-8-17-45(40)41)59(90)75-48(20-12-26-72-68(69)70)58(89)76-51(62(93)82-57(38(5)87)66(97)80-54)30-42-32-73-47-19-10-9-18-46(42)47/h7-11,14-19,22-25,32-38,48-57,73,85-88H,6,12-13,20-21,26-31H2,1-5H3,(H,71,74)(H,75,90)(H,76,89)(H,77,91)(H,78,96)(H,79,95)(H,80,97)(H,81,92)(H,82,93)(H,83,94)(H4,69,70,72)/t35-,36-,37-,38-,48+,49+,50-,51-,52+,53-,54-,55+,56+,57-/m1/s1 D07RRN DRUGINKE JUOTYAXVJMXIJJ-RTWQMTKCSA-N D07RRN DRUGSMIL CCC(C)C1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC=CC6=CC=CC=C65)CC7=CN=CN7)C(C)O)CC8=CC=C(C=C8)O)C(C)O D07RRN HIGHSTAT Investigative D07SIV DRUG__ID D07SIV D07SIV DRUGINCH 1S/C153H223N41O47S/c1-74(2)57-100(136(226)177-99(52-56-242-10)135(225)186-108(65-117(159)207)146(236)193-123(78(8)199)125(160)215)180-141(231)107(64-85-68-167-91-28-18-17-27-89(85)91)185-133(223)97(46-50-116(158)206)178-150(240)122(76(5)6)192-144(234)105(59-80-23-13-11-14-24-80)184-142(232)109(66-120(211)212)187-132(222)96(45-49-115(157)205)171-126(216)77(7)169-129(219)93(30-21-54-165-152(161)162)173-130(220)94(31-22-55-166-153(163)164)175-148(238)112(72-197)190-143(233)110(67-121(213)214)188-137(227)101(58-75(3)4)179-139(229)103(62-83-34-40-87(202)41-35-83)181-131(221)92(29-19-20-53-154)174-147(237)111(71-196)189-140(230)104(63-84-36-42-88(203)43-37-84)182-134(224)98(47-51-119(209)210)176-149(239)113(73-198)191-151(241)124(79(9)200)194-145(235)106(60-81-25-15-12-16-26-81)183-138(228)102(61-82-32-38-86(201)39-33-82)170-118(208)69-168-128(218)95(44-48-114(156)204)172-127(217)90(155)70-195/h11-18,23-28,32-43,68,74-79,90,92-113,122-124,167,195-203H,19-22,29-31,44-67,69-73,154-155H2,1-10H3,(H2,156,204)(H2,157,205)(H2,158,206)(H2,159,207)(H2,160,215)(H,168,218)(H,169,219)(H,170,208)(H,171,216)(H,172,217)(H,173,220)(H,174,237)(H,175,238)(H,176,239)(H,177,226)(H,178,240)(H,179,229)(H,180,231)(H,181,221)(H,182,224)(H,183,228)(H,184,232)(H,185,223)(H,186,225)(H,187,222)(H,188,227)(H,189,230)(H,190,233)(H,191,241)(H,192,234)(H,193,236)(H,194,235)(H,209,210)(H,211,212)(H,213,214)(H4,161,162,165)(H4,163,164,166)/t77-,78?,79+,90-,92-,93-,94-,95-,96-,97-,98+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,122-,123-,124-/m0/s1 D07SIV DRUGINKE SNCODYSDFYHLPQ-MBYQMCMRSA-N D07SIV DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)N D07SIV HIGHSTAT Investigative D07TBR DRUG__ID D07TBR D07TBR DRUGINCH 1S/C64H81N19O13S2/c1-34(84)75-47(25-35-15-18-41(85)19-16-35)58(92)76-45(13-7-23-72-64(68)69)56(90)83-52-32-98-97-31-51(54(65)88)82-60(94)49(27-39-29-73-43-11-5-4-10-42(39)43)80-55(89)44(12-6-22-71-63(66)67)77-59(93)48(26-36-14-17-37-8-2-3-9-38(37)24-36)79-61(95)50(28-40-30-70-33-74-40)81-57(91)46(78-62(52)96)20-21-53(86)87/h2-5,8-11,14-19,24,29-30,33,44-52,73,85H,6-7,12-13,20-23,25-28,31-32H2,1H3,(H2,65,88)(H,70,74)(H,75,84)(H,76,92)(H,77,93)(H,78,96)(H,79,95)(H,80,89)(H,81,91)(H,82,94)(H,83,90)(H,86,87)(H4,66,67,71)(H4,68,69,72)/t44-,45-,46+,47-,48-,49+,50-,51+,52+/m0/s1 D07TBR DRUGINKE LZYYGZAXFMYSBE-UHFDWKIASA-N D07TBR DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC5=CC=CC=C5C=C4)CCCNC(=N)N)CC6=CNC7=CC=CC=C76)C(=O)N D07TBR HIGHSTAT Investigative D07VEA DRUG__ID D07VEA D07VEA DRUGINCH 1S/C72H102FN21O19S2/c1-9-34(4)58(83-37(7)96)70(111)91-52(31-115)67(108)92-57(33(2)3)69(110)89-48(22-39-29-94(8)53-15-11-10-13-42(39)53)64(105)85-46(18-19-54(74)97)63(104)88-50(25-56(99)100)66(107)87-47(21-38-26-79-44-17-16-40(73)23-43(38)44)61(102)80-28-55(98)82-35(5)60(101)86-49(24-41-27-77-32-81-41)65(106)84-45(14-12-20-78-72(75)76)62(103)90-51(30-114)68(109)93-59(36(6)95)71(112)113/h10-11,13,15-17,23,26-27,29,32-36,45-52,57-59,79,95,114-115H,9,12,14,18-22,24-25,28,30-31H2,1-8H3,(H2,74,97)(H,77,81)(H,80,102)(H,82,98)(H,83,96)(H,84,106)(H,85,105)(H,86,101)(H,87,107)(H,88,104)(H,89,110)(H,90,103)(H,91,111)(H,92,108)(H,93,109)(H,99,100)(H,112,113)(H4,75,76,78)/t34-,35-,36+,45-,46-,47-,48-,49-,50-,51-,52-,57-,58-,59-/m0/s1 D07VEA DRUGINKE ZTPZPGGQKAOPSL-ULRAUGTQSA-N D07VEA DRUGSMIL CCC(C)C(C(=O)NC(CS)C(=O)NC(C(C)C)C(=O)NC(CC1=CN(C2=CC=CC=C21)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CNC4=C3C=C(C=C4)F)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CCCN=C(N)N)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D07VEA HIGHSTAT Investigative D07VEW DRUG__ID D07VEW D07VEW DRUGINCH 1S/C12H17N5O3/c13-12-15-9-6(1-14-10(9)11(20)16-12)2-17-3-7(5-18)8(19)4-17/h1,7-8,14,18-19H,2-5H2,(H3,13,15,16,20)/t7-,8+/m1/s1 D07VEW DRUGINKE GSPTUGDLYPMLCQ-SFYZADRCSA-N D07VEW DRUGSMIL C1C(C(CN1CC2=CNC3=C2N=C(NC3=O)N)O)CO D07VEW HIGHSTAT Investigative D07WDB DRUG__ID D07WDB D07WDB DRUGINCH 1S/C12H22N6O6/c13-6(2-1-3-16-12(14)15)10(22)17-5-8(19)18-7(11(23)24)4-9(20)21/h6-7H,1-5,13H2,(H,17,22)(H,18,19)(H,20,21)(H,23,24)(H4,14,15,16)/t6-,7-/m0/s1 D07WDB DRUGINKE IYMAXBFPHPZYIK-BQBZGAKWSA-N D07WDB DRUGSMIL C(CC(C(=O)NCC(=O)NC(CC(=O)O)C(=O)O)N)CN=C(N)N D07WDB HIGHSTAT Investigative D07WQG DRUG__ID D07WQG D07WQG DRUGINCH 1S/C79H128N26O23/c1-41(2)33-54(73(124)94-44(5)67(118)102-56(36-62(113)114)74(125)97-49(64(83)115)27-28-61(111)112)103-71(122)50(23-13-15-29-80)100-70(121)53(26-18-32-89-79(86)87)99-66(117)43(4)95-76(127)57(40-106)104-72(123)51(24-14-16-30-81)101-69(120)52(25-17-31-88-78(84)85)98-65(116)42(3)93-59(109)39-92-77(128)63(45(6)107)105-75(126)55(35-47-21-11-8-12-22-47)96-60(110)38-90-58(108)37-91-68(119)48(82)34-46-19-9-7-10-20-46/h7-12,19-22,41-45,48-57,63,106-107H,13-18,23-40,80-82H2,1-6H3,(H2,83,115)(H,90,108)(H,91,119)(H,92,128)(H,93,109)(H,94,124)(H,95,127)(H,96,110)(H,97,125)(H,98,116)(H,99,117)(H,100,121)(H,101,120)(H,102,118)(H,103,122)(H,104,123)(H,105,126)(H,111,112)(H,113,114)(H4,84,85,88)(H4,86,87,89)/t42-,43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-/m0/s1 D07WQG DRUGINKE PUPSFQBPHILNGY-SMFNREODSA-N D07WQG DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D07WQG HIGHSTAT Investigative D07XFF DRUG__ID D07XFF D07XFF DRUGINCH 1S/C78H100ClN17O15/c1-44(2)35-59(68(100)88-58(16-9-10-33-83-45(3)4)76(108)96-34-12-17-66(96)75(107)84-46(5)67(80)99)89-70(102)62(38-49-21-28-56(29-22-49)86-77(81)109)91-72(104)63(39-50-23-30-57(31-24-50)87-78(110)95-111)93-74(106)65(43-97)94-73(105)64(41-52-13-11-32-82-42-52)92-71(103)61(37-48-19-26-55(79)27-20-48)90-69(101)60(85-47(6)98)40-51-18-25-53-14-7-8-15-54(53)36-51/h7-8,11,13-15,18-32,36,42,44-46,58-66,83,97,111H,9-10,12,16-17,33-35,37-41,43H2,1-6H3,(H2,80,99)(H,84,107)(H,85,98)(H,88,100)(H,89,102)(H,90,101)(H,91,104)(H,92,103)(H,93,106)(H,94,105)(H3,81,86,109)(H2,87,95,110)/t46-,58+,59+,60-,61-,62-,63+,64-,65+,66+/m1/s1 D07XFF DRUGINKE WHBXYDIDMRDUDF-ZVSGBDDQSA-N D07XFF DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)NO)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D07XFF HIGHSTAT Investigative D07XKF DRUG__ID D07XKF D07XKF DRUGINCH 1S/C48H67N11O12S2/c1-5-26(4)41-47(70)54-31(14-15-37(49)61)43(66)55-34(21-38(50)62)44(67)57-35(24-73-72-17-16-40(64)53-33(45(68)58-41)19-27-10-12-30(60)13-11-27)48(71)59-23-29-9-7-6-8-28(29)20-36(59)46(69)56-32(18-25(2)3)42(65)52-22-39(51)63/h6-13,25-26,31-36,41,60H,5,14-24H2,1-4H3,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,64)(H,54,70)(H,55,66)(H,56,69)(H,57,67)(H,58,68)/t26-,31-,32-,33-,34-,35-,36-,41-/m0/s1 D07XKF DRUGINKE BEKGLOSGJVQNHG-JSRVRBLWSA-N D07XKF DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D07XKF HIGHSTAT Investigative D07ZFH DRUG__ID D07ZFH D07ZFH DRUGINCH 1S/C86H145N31O22/c1-46(2)39-60(78(133)104-48(4)70(125)114-62(42-65(92)121)79(134)113-59(83(138)139)31-32-64(91)120)115-76(131)54(26-13-16-34-88)109-73(128)56(28-18-36-99-84(93)94)107-69(124)47(3)105-81(136)63(45-118)116-77(132)55(27-14-17-35-89)110-74(129)57(29-19-37-100-85(95)96)111-72(127)53(25-12-15-33-87)108-75(130)58(30-20-38-101-86(97)98)112-82(137)68(49(5)119)117-80(135)61(41-51-23-10-7-11-24-51)106-67(123)44-102-66(122)43-103-71(126)52(90)40-50-21-8-6-9-22-50/h6-11,21-24,46-49,52-63,68,118-119H,12-20,25-45,87-90H2,1-5H3,(H2,91,120)(H2,92,121)(H,102,122)(H,103,126)(H,104,133)(H,105,136)(H,106,123)(H,107,124)(H,108,130)(H,109,128)(H,110,129)(H,111,127)(H,112,137)(H,113,134)(H,114,125)(H,115,131)(H,116,132)(H,117,135)(H,138,139)(H4,93,94,99)(H4,95,96,100)(H4,97,98,101)/t47-,48-,49+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,68-/m0/s1 D07ZFH DRUGINKE SNTZLYOXEWYFBE-UTPVZXCMSA-N D07ZFH DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D07ZFH HIGHSTAT Investigative D07ZZZ DRUG__ID D07ZZZ D07ZZZ DRUGINCH 1S/C65H83N11O15/c1-36(2)53(62(87)67-34-51(78)75-28-18-27-49(75)60(85)69-46(30-41-21-12-8-13-22-41)58(83)68-38(5)56(81)71-48(65(90)91)31-42-23-14-9-15-24-42)72-59(84)47(33-52(79)80)70-63(88)55(39(6)77)74-61(86)50-32-43-25-16-17-26-44(43)35-76(50)64(89)54(37(3)4)73-57(82)45(66)29-40-19-10-7-11-20-40/h7-17,19-26,36-39,45-50,53-55,77H,18,27-35,66H2,1-6H3,(H,67,87)(H,68,83)(H,69,85)(H,70,88)(H,71,81)(H,72,84)(H,73,82)(H,74,86)(H,79,80)(H,90,91)/t38-,39+,45-,46-,47-,48-,49-,50-,53-,54-,55-/m0/s1 D07ZZZ DRUGINKE RFOPIEIJLKLOPX-HGULNMISSA-N D07ZZZ DRUGSMIL CC(C)C(C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C4CC5=CC=CC=C5CN4C(=O)C(C(C)C)NC(=O)C(CC6=CC=CC=C6)N D07ZZZ HIGHSTAT Investigative D08BOD DRUG__ID D08BOD D08BOD DRUGINCH 1S/C51H69N13O11S2/c1-26(65)39(42(53)68)62-49(75)41-51(3,4)77-76-25-38(61-43(69)33(52)21-28-11-6-5-7-12-28)47(73)59-36(22-29-16-18-31(67)19-17-29)45(71)60-37(23-30-24-57-34-14-9-8-13-32(30)34)46(72)58-35(15-10-20-56-50(54)55)44(70)63-40(27(2)66)48(74)64-41/h5-9,11-14,16-19,24,26-27,33,35-41,57,65-67H,10,15,20-23,25,52H2,1-4H3,(H2,53,68)(H,58,72)(H,59,73)(H,60,71)(H,61,69)(H,62,75)(H,63,70)(H,64,74)(H4,54,55,56)/t26-,27-,33-,35+,36+,37-,38+,39+,40-,41+/m1/s1 D08BOD DRUGINKE OFMQLVRLOGHAJI-JGPYJKKXSA-N D08BOD DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D08BOD HIGHSTAT Investigative D08BRJ DRUG__ID D08BRJ D08BRJ DRUGINCH 1S/C60H77N13O11/c1-35(2)25-44(53(76)67-46(27-38-15-9-6-10-16-38)56(79)72-51(36(3)4)58(81)71-49(60(83)84)28-39-19-21-42(74)22-20-39)66-55(78)47(29-40-31-61-33-64-40)68-54(77)45(26-37-13-7-5-8-14-37)69-57(80)50-18-12-24-73(50)59(82)48(30-41-32-62-34-65-41)70-52(75)43-17-11-23-63-43/h5-10,13-16,19-22,31-36,43-51,63,74H,11-12,17-18,23-30H2,1-4H3,(H,61,64)(H,62,65)(H,66,78)(H,67,76)(H,68,77)(H,69,80)(H,70,75)(H,71,81)(H,72,79)(H,83,84)/t43-,44+,45+,46+,47+,48+,49+,50-,51+/m1/s1 D08BRJ DRUGINKE SGQUWHDGWRVGGP-XPEIQDACSA-N D08BRJ DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CCCN5C(=O)C(CC6=CN=CN6)NC(=O)C7CCCN7 D08BRJ HIGHSTAT Investigative D08CHK DRUG__ID D08CHK D08CHK DRUGINCH 1S/C37H38N6O4/c1-20(2)16-26-32(46)42-28(30(44)38-26)18-36(22-12-6-8-14-24(22)40-34(36)42)37-19-29-31(45)39-27(17-21-10-4-3-5-11-21)33(47)43(29)35(37)41-25-15-9-7-13-23(25)37/h3-15,20,26-29,34-35,40-41H,16-19H2,1-2H3,(H,38,44)(H,39,45)/t26-,27-,28-,29-,34+,35+,36?,37?/m0/s1 D08CHK DRUGINKE QQLUWDJRGUSAKT-PEFRYSBJSA-N D08CHK DRUGSMIL CC(C)CC1C(=O)N2C(CC3(C2NC4=CC=CC=C43)C56CC7C(=O)NC(C(=O)N7C5NC8=CC=CC=C68)CC9=CC=CC=C9)C(=O)N1 D08CHK HIGHSTAT Investigative D08EBV DRUG__ID D08EBV D08EBV DRUGINCH 1S/C63H84N16O14/c1-5-33(2)50-62(93)79-24-12-18-49(79)59(90)75-48(31-80)58(89)72-45(26-37-19-21-40(83)22-20-37)56(87)77-51(34(3)81)60(91)74-47(28-39-30-66-32-69-39)55(86)71-44(25-36-13-7-6-8-14-36)54(85)70-43(17-11-23-67-63(64)65)53(84)73-46(57(88)78-52(35(4)82)61(92)76-50)27-38-29-68-42-16-10-9-15-41(38)42/h6-10,13-16,19-22,29-30,32-35,43-52,68,80-83H,5,11-12,17-18,23-28,31H2,1-4H3,(H,66,69)(H,70,85)(H,71,86)(H,72,89)(H,73,84)(H,74,91)(H,75,90)(H,76,92)(H,77,87)(H,78,88)(H4,64,65,67)/t33-,34-,35-,43+,44-,45+,46-,47+,48+,49+,50-,51+,52-/m1/s1 D08EBV DRUGINKE FTGJNWCPPLBYMR-VTQDGRDPSA-N D08EBV DRUGSMIL CCC(C)C1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CC3=CNC4=CC=CC=C43)CCCN=C(N)N)CC5=CC=CC=C5)CC6=CN=CN6)C(C)O)CC7=CC=C(C=C7)O)CO D08EBV HIGHSTAT Investigative D08EFH DRUG__ID D08EFH D08EFH DRUGINCH 1S/C12H16N2O/c1-8(13)5-9-7-14-12-4-3-10(15-2)6-11(9)12/h3-4,6-8,14H,5,13H2,1-2H3 D08EFH DRUGINKE OGNJZVNNKBZFRM-UHFFFAOYSA-N D08EFH DRUGSMIL CC(CC1=CNC2=C1C=C(C=C2)OC)N D08EFH HIGHSTAT Investigative D08FDY DRUG__ID D08FDY D08FDY DRUGINCH 1S/C105H188N42O30/c1-7-55(6)80(98(175)140-69(34-36-77(154)155)92(169)143-72(50-148)95(172)142-71(48-78(156)157)94(171)146-79(54(4)5)99(176)177)147-97(174)74(52-150)145-96(173)73(51-149)144-93(170)70(46-53(2)3)141-90(167)62(22-10-13-39-108)133-85(162)63(24-15-41-124-101(113)114)135-87(164)65(26-17-43-126-103(117)118)136-88(165)66(27-18-44-127-104(119)120)138-91(168)68(33-35-75(110)152)139-89(166)67(28-19-45-128-105(121)122)137-86(163)64(25-16-42-125-102(115)116)134-84(161)61(21-9-12-38-107)132-83(160)60(20-8-11-37-106)131-82(159)59(23-14-40-123-100(111)112)130-76(153)49-129-81(158)58(109)47-56-29-31-57(151)32-30-56/h29-32,53-55,58-74,79-80,148-151H,7-28,33-52,106-109H2,1-6H3,(H2,110,152)(H,129,158)(H,130,153)(H,131,159)(H,132,160)(H,133,162)(H,134,161)(H,135,164)(H,136,165)(H,137,163)(H,138,168)(H,139,166)(H,140,175)(H,141,167)(H,142,172)(H,143,169)(H,144,170)(H,145,173)(H,146,171)(H,147,174)(H,154,155)(H,156,157)(H,176,177)(H4,111,112,123)(H4,113,114,124)(H4,115,116,125)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)/t55-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,79-,80-/m0/s1 D08FDY DRUGINKE XWQVQFBTSBCKLI-FKXNDIMNSA-N D08FDY DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(CC1=CC=C(C=C1)O)N D08FDY HIGHSTAT Investigative D08GIG DRUG__ID D08GIG D08GIG DRUGINCH 1S/C57H104N30O12/c58-42-38-43(79-29-78-42)87(30-80-38)50-40(90)39(89)41(99-50)49(96)71-22-8-6-4-2-1-3-5-7-21-37(88)81-31(15-9-23-72-52(59)60)44(91)82-32(16-10-24-73-53(61)62)45(92)83-33(17-11-25-74-54(63)64)46(93)84-34(18-12-26-75-55(65)66)47(94)85-35(19-13-27-76-56(67)68)48(95)86-36(51(97)98)20-14-28-77-57(69)70/h29-36,39-41,50,89-90H,1-28H2,(H,71,96)(H,81,88)(H,82,91)(H,83,92)(H,84,93)(H,85,94)(H,86,95)(H,97,98)(H2,58,78,79)(H4,59,60,72)(H4,61,62,73)(H4,63,64,74)(H4,65,66,75)(H4,67,68,76)(H4,69,70,77)/t31-,32-,33-,34-,35-,36-,39+,40-,41+,50?/m1/s1 D08GIG DRUGINKE VPJLJWJUVPAMHK-MOSAXMBESA-N D08GIG DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D08GIG HIGHSTAT Investigative D08KOD DRUG__ID D08KOD D08KOD DRUGCOMP Isis Pharmaceuticals D08KOD THERCLAS Anticancer Agents D08KOD DRUGTYPE Antisense drug D08KOD HIGHSTAT Investigative D08KSJ DRUG__ID D08KSJ D08KSJ DRUGINCH 1S/C54H60F6N8O9/c1-30(2)20-42(49(73)67-44(25-35-27-62-41-13-8-7-12-39(35)41)52(76)77-29-34-21-36(53(55,56)57)26-37(22-34)54(58,59)60)66-50(74)45-14-9-19-68(45)51(75)43(24-32-10-5-4-6-11-32)65-46(70)28-63-47(71)31(3)64-48(72)40(61)23-33-15-17-38(69)18-16-33/h4-8,10-13,15-18,21-22,26-27,30-31,40,42-45,62,69H,9,14,19-20,23-25,28-29,61H2,1-3H3,(H,63,71)(H,64,72)(H,65,70)(H,66,74)(H,67,73)/t31-,40+,42+,43+,44+,45+/m1/s1 D08KSJ DRUGINKE XHJXRHNUFXHMEV-REAJPLCASA-N D08KSJ DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)NC(=O)C4CCCN4C(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D08KSJ HIGHSTAT Investigative D08LCD DRUG__ID D08LCD D08LCD DRUGINCH 1S/C54H75N13O11/c1-30(2)22-41(48(56)72)64-52(76)42(23-31(3)4)65-53(77)44(25-35-27-57-29-59-35)62-47(71)28-67-21-9-8-12-40(54(67)78)63-49(73)32(5)60-51(75)43(24-34-26-58-38-11-7-6-10-37(34)38)66-50(74)39(18-19-45(55)69)61-46(70)20-15-33-13-16-36(68)17-14-33/h6-7,10-11,13-14,16-17,26-27,29-32,39-44,58,68H,8-9,12,15,18-25,28H2,1-5H3,(H2,55,69)(H2,56,72)(H,57,59)(H,60,75)(H,61,70)(H,62,71)(H,63,73)(H,64,76)(H,65,77)(H,66,74) D08LCD DRUGINKE HCLOOVPFXYLTPB-UHFFFAOYSA-N D08LCD DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)CCC5=CC=C(C=C5)O D08LCD HIGHSTAT Investigative D08MTW DRUG__ID D08MTW D08MTW DRUGINCH 1S/C44H68N12O12S2/c1-5-23(4)36-43(67)50-27(13-14-33(46)58)39(63)52-30(18-34(47)59)40(64)54-31(21-70-69-20-26(45)37(61)51-29(41(65)55-36)17-24-9-11-25(57)12-10-24)44(68)56-15-7-6-8-32(56)42(66)53-28(16-22(2)3)38(62)49-19-35(48)60/h9-12,22-23,26-32,36,57H,5-8,13-21,45H2,1-4H3,(H2,46,58)(H2,47,59)(H2,48,60)(H,49,62)(H,50,67)(H,51,61)(H,52,63)(H,53,66)(H,54,64)(H,55,65)/t23-,26-,27-,28-,29-,30-,31-,32-,36-/m0/s1 D08MTW DRUGINKE AEGMQTAGVURKHK-CKNUHMDMSA-N D08MTW DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D08MTW HIGHSTAT Investigative D08NDP DRUG__ID D08NDP D08NDP DRUGINCH 1S/C61H98N22O14S2/c1-34(51(89)79-41(21-13-25-70-60(66)67)53(91)78-39(50(65)88)19-9-11-23-62)75-57(95)45-33-99-98-32-44(58(96)81-42(22-14-26-71-61(68)69)54(92)80-40(55(93)82-45)20-10-12-24-63)77-48(87)31-74-59(97)49(35(2)84)83-56(94)43(28-37-17-7-4-8-18-37)76-47(86)30-72-46(85)29-73-52(90)38(64)27-36-15-5-3-6-16-36/h3-8,15-18,34-35,38-45,49,84H,9-14,19-33,62-64H2,1-2H3,(H2,65,88)(H,72,85)(H,73,90)(H,74,97)(H,75,95)(H,76,86)(H,77,87)(H,78,91)(H,79,89)(H,80,92)(H,81,96)(H,82,93)(H,83,94)(H4,66,67,70)(H4,68,69,71)/t34-,35+,38-,39-,40-,41-,42-,43-,44-,45-,49-/m0/s1 D08NDP DRUGINKE ZCRGDVZWIYXXNX-QAOCYNJESA-N D08NDP DRUGSMIL CC(C(C(=O)NCC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC1=O)CCCN=C(N)N)CCCCN)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)O D08NDP HIGHSTAT Investigative D08RIW DRUG__ID D08RIW D08RIW DRUGINCH 1S/C80H132N28O21/c1-7-49(98-63(115)40-95-78(129)64(45(6)110)108-76(127)56(36-47-22-12-9-13-23-47)99-62(114)39-93-61(113)38-94-68(119)48(83)35-46-20-10-8-11-21-46)69(120)102-54(27-19-33-92-80(89)90)71(122)104-52(25-15-17-31-82)73(124)107-58(41-109)77(128)97-43(4)66(117)101-53(26-18-32-91-79(87)88)70(121)103-51(24-14-16-30-81)72(123)106-55(34-42(2)3)74(125)96-44(5)67(118)105-57(37-60(85)112)75(126)100-50(65(86)116)28-29-59(84)111/h8-13,20-23,42-45,48-58,64,109-110H,7,14-19,24-41,81-83H2,1-6H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,119)(H,95,129)(H,96,125)(H,97,128)(H,98,115)(H,99,114)(H,100,126)(H,101,117)(H,102,120)(H,103,121)(H,104,122)(H,105,118)(H,106,123)(H,107,124)(H,108,127)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D08RIW DRUGINKE UWYRKSVDCJMXNB-KMOVSZGYSA-N D08RIW DRUGSMIL CCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D08RIW HIGHSTAT Investigative D08RTR DRUG__ID D08RTR D08RTR DRUGINCH 1S/C147H219N41O46S/c1-70(2)54-95(131(220)172-94(49-53-235-11)130(219)180-102(61-111(153)200)140(229)187-117(75(9)193)119(154)208)175-135(224)101(60-81-64-161-86-29-19-18-28-84(81)86)179-129(218)92(43-47-110(152)199)173-144(233)116(72(5)6)186-138(227)99(56-77-24-14-12-15-25-77)178-136(225)103(62-114(204)205)181-128(217)91(42-46-109(151)198)166-120(209)73(7)163-124(213)88(31-22-51-159-146(155)156)168-126(215)89(32-23-52-160-147(157)158)170-142(231)106(68-191)184-137(226)104(63-115(206)207)182-132(221)96(55-71(3)4)174-134(223)98(59-80-35-39-83(196)40-36-80)176-127(216)87(30-20-21-50-148)169-141(230)105(67-190)183-121(210)74(8)164-125(214)93(44-48-113(202)203)171-143(232)107(69-192)185-145(234)118(76(10)194)188-139(228)100(57-78-26-16-13-17-27-78)177-133(222)97(58-79-33-37-82(195)38-34-79)165-112(201)65-162-123(212)90(41-45-108(150)197)167-122(211)85(149)66-189/h12-19,24-29,33-40,64,70-76,85,87-107,116-118,161,189-196H,20-23,30-32,41-63,65-69,148-149H2,1-11H3,(H2,150,197)(H2,151,198)(H2,152,199)(H2,153,200)(H2,154,208)(H,162,212)(H,163,213)(H,164,214)(H,165,201)(H,166,209)(H,167,211)(H,168,215)(H,169,230)(H,170,231)(H,171,232)(H,172,220)(H,173,233)(H,174,223)(H,175,224)(H,176,216)(H,177,222)(H,178,225)(H,179,218)(H,180,219)(H,181,217)(H,182,221)(H,183,210)(H,184,226)(H,185,234)(H,186,227)(H,187,229)(H,188,228)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,159)(H4,157,158,160)/t73-,74-,75+,76+,85-,87-,88-,89-,90-,91-,92-,93+,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,116-,117-,118-/m0/s1 D08RTR DRUGINKE PSHWUKAXGHEOPB-XGBCNKCESA-N D08RTR DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)N D08RTR HIGHSTAT Investigative D08SCG DRUG__ID D08SCG D08SCG DRUGINCH 1S/C32H48N4O4/c1-6-23(4)30(36-31(39)26-16-14-25(15-17-26)21-33-5)32(40)35-27(19-22(2)3)28(37)20-29(38)34-18-10-13-24-11-8-7-9-12-24/h7-9,11-12,14-17,22-23,27-28,30,33,37H,6,10,13,18-21H2,1-5H3,(H,34,38)(H,35,40)(H,36,39) D08SCG DRUGINKE POMPAVNXKGHLHK-UHFFFAOYSA-N D08SCG DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(CC(=O)NCCCC1=CC=CC=C1)O)NC(=O)C2=CC=C(C=C2)CNC D08SCG HIGHSTAT Investigative D08SJL DRUG__ID D08SJL D08SJL DRUGINCH 1S/C17H11NO2/c1-2-11-9-17(12-3-5-13(19)6-4-12)18-16-8-7-14(20)10-15(11)16/h1,3-10,19-20H D08SJL DRUGINKE LZRCWCHYOCKNED-UHFFFAOYSA-N D08SJL DRUGSMIL C#CC1=CC(=NC2=C1C=C(C=C2)O)C3=CC=C(C=C3)O D08SJL HIGHSTAT Investigative D08SYL DRUG__ID D08SYL D08SYL DRUGINCH 1S/C153H223N41O46S/c1-75(2)58-100(136(225)177-99(53-57-241-10)135(224)186-108(66-117(159)206)146(235)193-123(79(8)199)125(160)214)180-141(230)107(65-86-69-167-91-33-21-20-32-89(86)91)185-133(222)97(47-51-116(158)205)178-150(239)122(77(5)6)192-144(233)105(61-82-28-16-12-17-29-82)184-142(231)109(67-120(210)211)187-132(221)96(46-50-115(157)204)171-126(215)78(7)169-129(218)93(35-24-55-165-152(161)162)173-130(219)94(36-25-56-166-153(163)164)175-148(237)112(73-197)190-143(232)110(68-121(212)213)188-137(226)101(59-76(3)4)179-139(228)104(64-85-39-43-88(202)44-40-85)181-131(220)92(34-22-23-54-154)174-147(236)111(72-196)189-140(229)103(60-81-26-14-11-15-27-81)182-134(223)98(48-52-119(208)209)176-149(238)113(74-198)191-151(240)124(80(9)200)194-145(234)106(62-83-30-18-13-19-31-83)183-138(227)102(63-84-37-41-87(201)42-38-84)170-118(207)70-168-128(217)95(45-49-114(156)203)172-127(216)90(155)71-195/h11-21,26-33,37-44,69,75-80,90,92-113,122-124,167,195-202H,22-25,34-36,45-68,70-74,154-155H2,1-10H3,(H2,156,203)(H2,157,204)(H2,158,205)(H2,159,206)(H2,160,214)(H,168,217)(H,169,218)(H,170,207)(H,171,215)(H,172,216)(H,173,219)(H,174,236)(H,175,237)(H,176,238)(H,177,225)(H,178,239)(H,179,228)(H,180,230)(H,181,220)(H,182,223)(H,183,227)(H,184,231)(H,185,222)(H,186,224)(H,187,221)(H,188,226)(H,189,229)(H,190,232)(H,191,240)(H,192,233)(H,193,235)(H,194,234)(H,208,209)(H,210,211)(H,212,213)(H4,161,162,165)(H4,163,164,166)/t78-,79+,80+,90-,92-,93-,94-,95-,96-,97-,98+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,122-,123-,124-/m0/s1 D08SYL DRUGINKE MBFPGOMXVAUTEP-VXJQVJGISA-N D08SYL DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)N D08SYL HIGHSTAT Investigative D08URJ DRUG__ID D08URJ D08URJ DRUGINCH 1S/C150H227N39O44S3/c1-17-75(8)118(143(226)162-67-114(203)182-117(74(6)7)142(225)161-64-112(201)164-77(10)149(232)188-50-29-38-106(188)125(157)208)184-126(209)76(9)165-144(227)121(80(13)193)185-131(214)92(45-47-109(154)198)170-141(224)107-39-30-51-189(107)150(233)103(58-85-35-25-20-26-36-85)179-145(228)119(78(11)191)167-99(59-87-63-158-71-163-87)134(217)172-94(55-83-31-21-18-22-32-83)124(207)90(37-27-28-49-151)168-136(219)101(61-111(156)200)176-133(216)97(56-84-33-23-19-24-34-84)175-137(220)102(62-116(205)206)177-129(212)91(44-46-108(153)197)171-147(230)122(81(14)194)186-138(221)98(57-86-40-42-88(196)43-41-86)178-146(229)120(79(12)192)183-115(204)66-160-128(211)95(53-72(2)3)173-130(213)93(48-52-236-16)169-140(223)105(70-235)181-148(231)123(82(15)195)187-139(222)104(68-190)180-132(215)96(54-73(4)5)174-135(218)100(60-110(155)199)166-113(202)65-159-127(210)89(152)69-234/h18-26,31-36,40-43,63,71-82,89-107,117-123,167,190-196,234-235H,17,27-30,37-39,44-62,64-70,151-152H2,1-16H3,(H2,153,197)(H2,154,198)(H2,155,199)(H2,156,200)(H2,157,208)(H,158,163)(H,159,210)(H,160,211)(H,161,225)(H,162,226)(H,164,201)(H,165,227)(H,166,202)(H,168,219)(H,169,223)(H,170,224)(H,171,230)(H,172,217)(H,173,213)(H,174,218)(H,175,220)(H,176,216)(H,177,212)(H,178,229)(H,179,228)(H,180,215)(H,181,231)(H,182,203)(H,183,204)(H,184,209)(H,185,214)(H,186,221)(H,187,222)(H,205,206)/t75-,76-,77-,78+,79+,80+,81+,82+,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99?,100-,101-,102-,103-,104-,105-,106+,107+,117-,118-,119-,120-,121-,122-,123-/m0/s1 D08URJ DRUGINKE LHKCIEAVJUMENU-LTFZDLSNSA-N D08URJ DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(CC4=CNC=N4)C(=O)NC(CC5=CC=CC=C5)C(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D08URJ HIGHSTAT Investigative D08VVC DRUG__ID D08VVC D08VVC DRUGINCH 1S/C77H115N21O13/c1-5-49(4)65(72(108)93-57(30-19-39-87-77(83)84)73(109)98-40-20-31-61(98)71(107)94-58(74(110)111)27-15-16-36-78)96-67(103)56(29-18-38-86-76(81)82)91-66(102)55(28-17-37-85-75(79)80)92-68(104)59(41-48(2)3)95-69(105)60(42-50-21-9-6-10-22-50)90-64(101)45-88-63(100)44-89-70(106)62(43-51-32-34-54(99)35-33-51)97(46-52-23-11-7-12-24-52)47-53-25-13-8-14-26-53/h6-14,21-26,32-35,48-49,55-62,65,99H,5,15-20,27-31,36-47,78H2,1-4H3,(H,88,100)(H,89,106)(H,90,101)(H,91,102)(H,92,104)(H,93,108)(H,94,107)(H,95,105)(H,96,103)(H,110,111)(H4,79,80,85)(H4,81,82,86)(H4,83,84,87)/t49-,55-,56-,57-,58-,59-,60-,61-,62-,65-/m0/s1 D08VVC DRUGINKE OHPCANLMUJRLSF-GOWLZWIFSA-N D08VVC DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N(CC4=CC=CC=C4)CC5=CC=CC=C5 D08VVC HIGHSTAT Investigative D08WZV DRUG__ID D08WZV D08WZV DRUGINCH 1S/C146H230N42O39/c1-71(2)53-92(166-108(197)66-159-120(203)79(17)163-126(209)93(54-72(3)4)171-124(207)89(44-33-49-156-145(151)152)167-130(213)97(59-87-63-155-70-162-87)177-143(226)118(82(20)192)186-140(223)113(75(9)10)165-83(21)193)128(211)172-94(55-73(5)6)129(212)180-102(69-190)135(218)168-90(45-34-50-157-146(153)154)125(208)179-101(68-189)122(205)160-64-107(196)158-65-109(198)181-114(76(11)12)141(224)183-115(77(13)14)139(222)169-88(43-31-32-48-147)123(206)174-98(60-105(148)194)132(215)175-99(61-106(149)195)131(214)173-96(58-86-41-29-24-30-42-86)133(216)184-116(78(15)16)144(227)188-52-36-47-104(188)137(220)185-117(81(19)191)142(225)178-100(62-111(200)201)134(217)182-112(74(7)8)138(221)161-67-110(199)187-51-35-46-103(187)136(219)176-95(57-85-39-27-23-28-40-85)127(210)164-80(18)121(204)170-91(119(150)202)56-84-37-25-22-26-38-84/h22-30,37-42,63,70-82,88-104,112-118,189-192H,31-36,43-62,64-69,147H2,1-21H3,(H2,148,194)(H2,149,195)(H2,150,202)(H,155,162)(H,158,196)(H,159,203)(H,160,205)(H,161,221)(H,163,209)(H,164,210)(H,165,193)(H,166,197)(H,167,213)(H,168,218)(H,169,222)(H,170,204)(H,171,207)(H,172,211)(H,173,214)(H,174,206)(H,175,215)(H,176,219)(H,177,226)(H,178,225)(H,179,208)(H,180,212)(H,181,198)(H,182,217)(H,183,224)(H,184,216)(H,185,220)(H,186,223)(H,200,201)(H4,151,152,156)(H4,153,154,157)/t79-,80-,81+,82+,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,112-,113-,114-,115-,116-,117-,118-/m0/s1 D08WZV DRUGINKE OYUUVTJIINDYIH-ZCHJXOKKSA-N D08WZV DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C D08WZV HIGHSTAT Investigative D08XDH DRUG__ID D08XDH D08XDH DRUGINCH 1S/C88H119ClN18O19/c1-53(2)44-68(78(112)99-67(17-10-11-35-93-54(3)4)86(120)107-37-13-18-75(107)85(119)95-55(5)77(90)111)100-80(114)71(47-59-24-31-66(32-25-59)98-87(91)121)102-82(116)72(48-58-22-29-65(30-23-58)97-76(110)33-38-124-40-42-126-43-41-125-39-36-94-88(122)106-123-7)104-84(118)74(52-108)105-83(117)73(50-61-14-12-34-92-51-61)103-81(115)70(46-57-20-27-64(89)28-21-57)101-79(113)69(96-56(6)109)49-60-19-26-62-15-8-9-16-63(62)45-60/h8-9,12,14-16,19-32,34,45,51,53-55,67-75,93,108H,10-11,13,17-18,33,35-44,46-50,52H2,1-7H3,(H2,90,111)(H,95,119)(H,96,109)(H,97,110)(H,99,112)(H,100,114)(H,101,113)(H,102,116)(H,103,115)(H,104,118)(H,105,117)(H3,91,98,121)(H2,94,106,122)/t55-,67+,68+,69-,70-,71-,72+,73-,74+,75+/m1/s1 D08XDH DRUGINKE UZNPTQUBATXHSV-POQOSWQFSA-N D08XDH DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)CCOCCOCCOCCNC(=O)NOC)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D08XDH HIGHSTAT Investigative D08YAF DRUG__ID D08YAF D08YAF DRUGINCH 1S/C93H142N22O28/c1-46(2)35-61(83(133)108-65(40-52-43-99-54-22-14-13-21-53(52)54)87(137)100-56(23-15-16-32-94)79(129)106-62(36-47(3)4)84(134)111-67(38-49(7)8)93(143)115-34-18-25-70(115)91(141)103-58(27-30-73(121)122)81(131)104-60(77(97)127)41-72(96)120)107-88(138)66(42-75(125)126)109-90(140)69(45-117)113-86(136)64(39-51-19-11-10-12-20-51)110-92(142)76(50(9)118)114-82(132)59(28-31-74(123)124)101-80(130)57(26-29-71(95)119)102-89(139)68(44-116)112-85(135)63(37-48(5)6)105-78(128)55-24-17-33-98-55/h10-14,19-22,43,46-50,55-70,76,98-99,116-118H,15-18,23-42,44-45,94H2,1-9H3,(H2,95,119)(H2,96,120)(H2,97,127)(H,100,137)(H,101,130)(H,102,139)(H,103,141)(H,104,131)(H,105,128)(H,106,129)(H,107,138)(H,108,133)(H,109,140)(H,110,142)(H,111,134)(H,112,135)(H,113,136)(H,114,132)(H,121,122)(H,123,124)(H,125,126)/t50-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,76-/m0/s1 D08YAF DRUGINKE JGQYEMDYGMNCJX-RDLTZJDDSA-N D08YAF DRUGSMIL CC(C)CC(C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N4CCCC4C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C5CCCN5 D08YAF HIGHSTAT Investigative D08YWE DRUG__ID D08YWE D08YWE DRUGINCH 1S/C81H120N28O14/c1-3-14-56(70(116)102-60(24-12-36-96-80(90)91)74(120)106-62(66(84)112)38-44-26-30-48(110)31-27-44)100-72(118)58(22-10-34-94-78(86)87)104-76(122)64(40-46-42-98-54-20-7-5-16-50(46)54)108-68(114)52(82)18-9-19-53(83)69(115)109-65(41-47-43-99-55-21-8-6-17-51(47)55)77(123)105-59(23-11-35-95-79(88)89)73(119)101-57(15-4-2)71(117)103-61(25-13-37-97-81(92)93)75(121)107-63(67(85)113)39-45-28-32-49(111)33-29-45/h5-8,16-17,20-21,26-33,42-43,52-53,56-65,98-99,110-111H,3-4,9-15,18-19,22-25,34-41,82-83H2,1-2H3,(H2,84,112)(H2,85,113)(H,100,118)(H,101,119)(H,102,116)(H,103,117)(H,104,122)(H,105,123)(H,106,120)(H,107,121)(H,108,114)(H,109,115)(H4,86,87,94)(H4,88,89,95)(H4,90,91,96)(H4,92,93,97)/t52-,53-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-/m0/s1 D08YWE DRUGINKE LTYROZHCAWVGIV-IGPFWFIDSA-N D08YWE DRUGSMIL CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCC(C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)N)N)N D08YWE HIGHSTAT Investigative D08ZIR DRUG__ID D08ZIR D08ZIR DRUGINCH 1S/C85H133N27O22/c1-46(2)37-59(77(127)109-61(40-52-25-13-8-14-26-52)78(128)110-62(41-65(90)116)79(129)107-58(83(133)134)31-32-64(89)115)108-75(125)54(27-15-17-33-86)105-74(124)57(30-20-36-96-85(93)94)104-71(121)48(4)101-81(131)63(45-113)111-76(126)55(28-16-18-34-87)106-73(123)56(29-19-35-95-84(91)92)103-70(120)47(3)100-67(118)44-99-82(132)69(49(5)114)112-80(130)60(39-51-23-11-7-12-24-51)102-68(119)43-97-66(117)42-98-72(122)53(88)38-50-21-9-6-10-22-50/h6-14,21-26,46-49,53-63,69,113-114H,15-20,27-45,86-88H2,1-5H3,(H2,89,115)(H2,90,116)(H,97,117)(H,98,122)(H,99,132)(H,100,118)(H,101,131)(H,102,119)(H,103,120)(H,104,121)(H,105,124)(H,106,123)(H,107,129)(H,108,125)(H,109,127)(H,110,128)(H,111,126)(H,112,130)(H,133,134)(H4,91,92,95)(H4,93,94,96)/t47-,48-,49+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,69-/m0/s1 D08ZIR DRUGINKE KCPGYTKGECMLMX-UAOIWBIESA-N D08ZIR DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N D08ZIR HIGHSTAT Investigative D08ZJR DRUG__ID D08ZJR D08ZJR DRUGINCH 1S/C87H135N29O22/c1-47(104-69(122)45-103-84(136)71(49(3)118)116-82(134)62(39-51-22-8-5-9-23-51)106-70(123)44-101-68(121)43-102-74(126)54(91)38-50-20-6-4-7-21-50)72(124)107-59(29-18-36-98-86(94)95)75(127)110-58(28-14-17-35-90)79(131)115-65(46-117)83(135)105-48(2)73(125)108-60(30-19-37-99-87(96)97)76(128)109-56(26-12-15-33-88)77(129)113-63(40-52-42-100-55-25-11-10-24-53(52)55)80(132)111-57(27-13-16-34-89)78(130)114-64(41-67(93)120)81(133)112-61(85(137)138)31-32-66(92)119/h4-11,20-25,42,47-49,54,56-65,71,100,117-118H,12-19,26-41,43-46,88-91H2,1-3H3,(H2,92,119)(H2,93,120)(H,101,121)(H,102,126)(H,103,136)(H,104,122)(H,105,135)(H,106,123)(H,107,124)(H,108,125)(H,109,128)(H,110,127)(H,111,132)(H,112,133)(H,113,129)(H,114,130)(H,115,131)(H,116,134)(H,137,138)(H4,94,95,98)(H4,96,97,99)/t47-,48-,49+,54-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,71-/m0/s1 D08ZJR DRUGINKE ZXXWZZVFRTXDSC-PBUARHPHSA-N D08ZJR DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=CC=C4)N)O D08ZJR HIGHSTAT Investigative D08ZRC DRUG__ID D08ZRC D08ZRC DRUGINCH 1S/C74H118N26O18/c1-36(2)28-51(94-66(113)53(31-42-17-21-45(104)22-18-42)96-67(114)54(32-43-34-84-35-88-43)97-61(108)46(89-40(8)102)12-9-25-85-72(78)79)65(112)98-55(33-57(76)106)68(115)95-52(29-37(3)4)69(116)99-58(38(5)6)70(117)100-59(39(7)101)71(118)92-48(14-11-27-87-74(82)83)62(109)91-49(23-24-56(75)105)64(111)90-47(13-10-26-86-73(80)81)63(110)93-50(60(77)107)30-41-15-19-44(103)20-16-41/h15-22,34-39,46-55,58-59,101,103-104H,9-14,23-33H2,1-8H3,(H2,75,105)(H2,76,106)(H2,77,107)(H,84,88)(H,89,102)(H,90,111)(H,91,109)(H,92,118)(H,93,110)(H,94,113)(H,95,115)(H,96,114)(H,97,108)(H,98,112)(H,99,116)(H,100,117)(H4,78,79,85)(H4,80,81,86)(H4,82,83,87)/t39-,46+,47+,48+,49+,50+,51+,52+,53+,54+,55+,58+,59+/m1/s1 D08ZRC DRUGINKE AQWCJJKYINAYIM-QIRMFHLNSA-N D08ZRC DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)NC(=O)C D08ZRC HIGHSTAT Investigative D08ZRP DRUG__ID D08ZRP D08ZRP DRUGINCH 1S/C23H23FN4O5S/c24-19-11-17-20(28(15-3-4-15)13-18(22(17)29)23(30)31)12-21(19)26-7-9-27(10-8-26)34(32,33)16-5-1-14(25)2-6-16/h1-2,5-6,11-13,15H,3-4,7-10,25H2,(H,30,31) D08ZRP DRUGINKE LHQCNYXFOFNLNV-UHFFFAOYSA-N D08ZRP DRUGSMIL C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCN(CC4)S(=O)(=O)C5=CC=C(C=C5)N)F)C(=O)O D08ZRP HIGHSTAT Investigative D09BKS DRUG__ID D09BKS D09BKS DRUGINCH 1S/C62H73N13O17/c1-32(63)53(81)71-42(16-9-27-68-62(65)66)59(87)74-28-10-17-45(74)57(85)73-44(29-34-11-4-3-5-12-34)56(84)69-33(2)54(82)70-41(22-23-48(64)78)55(83)72-43(60(88)89)15-6-7-26-67-58(86)52-39(13-8-14-40(52)61(90)92-75-49(79)24-25-50(75)80)51-37-20-18-35(76)30-46(37)91-47-31-36(77)19-21-38(47)51/h3-5,8,11-14,18-21,30-33,41-45,76H,6-7,9-10,15-17,22-29,63H2,1-2H3,(H2,64,78)(H,67,86)(H,69,84)(H,70,82)(H,71,81)(H,72,83)(H,73,85)(H,88,89)(H4,65,66,68)/t32-,33-,41-,42-,43-,44-,45-/m0/s1 D09BKS DRUGINKE IVWCINIISIMQBR-IPQUOSPJSA-N D09BKS DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)C3=C(C=CC=C3C(=O)ON4C(=O)CCC4=O)C5=C6C=CC(=O)C=C6OC7=C5C=CC(=C7)O)C(=O)O)N D09BKS HIGHSTAT Investigative D09BWP DRUG__ID D09BWP D09BWP DRUGINCH 1S/C61H72N12O18S2/c1-3-29(2)49-57(86)68-40(18-19-47(63)78)53(82)69-41(25-48(64)79)54(83)70-42(26-92-93-27-44(77)56(85)72-50(58(87)71-49)30-8-11-32(74)12-9-30)59(88)73-21-5-7-43(73)55(84)67-39(52(81)66-28-62)6-4-20-65-51(80)31-10-15-35-38(22-31)61(91-60(35)89)36-16-13-33(75)23-45(36)90-46-24-34(76)14-17-37(46)61/h8-17,22-24,29,39-44,49-50,74-77H,3-7,18-21,25-28,62H2,1-2H3,(H2,63,78)(H2,64,79)(H,65,80)(H,66,81)(H,67,84)(H,68,86)(H,69,82)(H,70,83)(H,71,87)(H,72,85)/t29?,39-,40+,41+,42+,43+,44?,49+,50-/m0/s1 D09BWP DRUGINKE AKOGSKPWCBYRCU-IRJYFLAISA-N D09BWP DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)O)C(=O)N3CCCC3C(=O)NC(CCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)CCC(=O)N D09BWP HIGHSTAT Investigative D09CPC DRUG__ID D09CPC D09CPC DRUGINCH 1S/C14H12N2O/c17-14-6-4-11-8-10(3-5-13(11)16-14)12-2-1-7-15-9-12/h1-3,5,7-9H,4,6H2,(H,16,17) D09CPC DRUGINKE MPGBYGNPFRLHAO-UHFFFAOYSA-N D09CPC DRUGSMIL C1CC(=O)NC2=C1C=C(C=C2)C3=CN=CC=C3 D09CPC HIGHSTAT Investigative D09CTG DRUG__ID D09CTG D09CTG DRUGINCH 1S/C77H117N23O15/c1-4-45(2)64(100-71(112)59(21-14-39-91-77(85)86)95-72(113)61(43-49-24-30-52(103)31-25-49)99-73(114)62(44-50-26-32-53(104)33-27-50)98-68(109)56(92-46(3)101)19-12-37-89-75(81)82)74(115)96-57(18-8-10-35-78)69(110)93-55(65(80)106)17-9-11-36-87-63(105)34-40-88-67(108)60(42-47-15-6-5-7-16-47)97-70(111)58(20-13-38-90-76(83)84)94-66(107)54(79)41-48-22-28-51(102)29-23-48/h5-7,15-16,22-33,45,54-62,64,102-104H,4,8-14,17-21,34-44,78-79H2,1-3H3,(H2,80,106)(H,87,105)(H,88,108)(H,92,101)(H,93,110)(H,94,107)(H,95,113)(H,96,115)(H,97,111)(H,98,109)(H,99,114)(H,100,112)(H4,81,82,89)(H4,83,84,90)(H4,85,86,91)/t45-,54-,55-,56-,57-,58+,59-,60-,61-,62-,64-/m0/s1 D09CTG DRUGINKE XLFHOYFYEWSAKV-OKFGKCNJSA-N D09CTG DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)NC(CCCCNC(=O)CCNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CC=C(C=C2)O)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCN=C(N)N)NC(=O)C D09CTG HIGHSTAT Investigative D09DAC DRUG__ID D09DAC D09DAC DRUGINCH 1S/C58H72N12O12S2/c1-33(71)49-57(80)68-44(27-36-19-9-4-10-20-36)54(77)69-47(58(81)82)32-84-83-31-39(60)50(73)64-46(29-48(61)72)56(79)66-42(25-34-15-5-2-6-16-34)52(75)65-43(26-35-17-7-3-8-18-35)53(76)67-45(28-37-30-62-40-22-12-11-21-38(37)40)55(78)63-41(51(74)70-49)23-13-14-24-59/h2-12,15-22,30,33,39,41-47,49,62,71H,13-14,23-29,31-32,59-60H2,1H3,(H2,61,72)(H,63,78)(H,64,73)(H,65,75)(H,66,79)(H,67,76)(H,68,80)(H,69,77)(H,70,74)(H,81,82)/t33-,39-,41+,42-,43+,44+,45+,46+,47+,49-/m1/s1 D09DAC DRUGINKE LAZNVYHNZZBPSL-ZXQPUDBWSA-N D09DAC DRUGSMIL CC(C1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)N)C(=O)O)CC6=CC=CC=C6)O D09DAC HIGHSTAT Investigative D09DFD DRUG__ID D09DFD D09DFD DRUGINCH 1S/C21H34O2/c1-4-5-6-7-13-21(2,3)17-11-12-19(20(23)15-17)16-9-8-10-18(22)14-16/h11-12,15-16,18,22-23H,4-10,13-14H2,1-3H3/t16-,18+/m0/s1 D09DFD DRUGINKE ZWWRREXSUJTKNN-FUHWJXTLSA-N D09DFD DRUGSMIL CCCCCCC(C)(C)C1=CC(=C(C=C1)C2CCCC(C2)O)O D09DFD HIGHSTAT Investigative D09DNJ DRUG__ID D09DNJ D09DNJ DRUGINCH 1S/C50H80N8O15/c1-5-27(2)20-28(3)12-10-8-6-7-9-11-13-40(67)53-34-22-32(61)25-52-48(71)44-36(63)18-19-57(44)50(73)43(38(65)24-39(51)66)56-47(70)42(37(64)21-30-14-16-31(60)17-15-30)55-46(69)35-23-33(62)26-58(35)49(72)41(29(4)59)54-45(34)68/h14-17,27-29,32-38,41-44,59-65H,5-13,18-26H2,1-4H3,(H2,51,66)(H,52,71)(H,53,67)(H,54,68)(H,55,69)(H,56,70)/t27?,28?,29-,32-,33-,34+,35+,36+,37-,38-,41+,42+,43+,44+/m1/s1 D09DNJ DRUGINKE ZDGSWUBIMMFISL-IQTRWBIESA-N D09DNJ DRUGSMIL CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(CNC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(CC4=CC=C(C=C4)O)O)C(CC(=O)N)O)O)O D09DNJ HIGHSTAT Investigative D09DVB DRUG__ID D09DVB D09DVB DRUGINCH 1S/C57H78N14O11S2/c1-32(36-21-20-35-14-7-8-15-37(35)28-36)46-54(81)64-29-45(74)65-43(30-72)52(79)68-42(27-33-12-5-4-6-13-33)51(78)69-44(53(80)67-41(16-9-10-24-58)50(77)66-40(48(60)75)17-11-25-63-56(61)62)31-83-84-57(2,3)47(55(82)70-46)71-49(76)39(59)26-34-18-22-38(73)23-19-34/h4-8,12-15,18-23,28,32,39-44,46-47,72-73H,9-11,16-17,24-27,29-31,58-59H2,1-3H3,(H2,60,75)(H,64,81)(H,65,74)(H,66,77)(H,67,80)(H,68,79)(H,69,78)(H,70,82)(H,71,76)(H4,61,62,63)/t32-,39-,40-,41-,42+,43-,44+,46+,47-/m0/s1 D09DVB DRUGINKE HWTDVIKHJPOWJP-YOGAMANKSA-N D09DVB DRUGSMIL CC(C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC(C(C(=O)N1)NC(=O)C(CC2=CC=C(C=C2)O)N)(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC3=CC=CC=C3)CO)C4=CC5=CC=CC=C5C=C4 D09DVB HIGHSTAT Investigative D09EIG DRUG__ID D09EIG D09EIG DRUGINCH 1S/C74H102N20O19S2/c1-39(77)62(100)82-35-59(99)83-56-37-114-115-38-57(74(112)113)92-70(108)55(36-95)91-73(111)61(41(3)97)94-69(107)51(29-43-18-8-5-9-19-43)90-72(110)60(40(2)96)93-64(102)49(23-13-15-25-76)84-66(104)52(30-44-33-81-47-21-11-10-20-46(44)47)87-65(103)50(28-42-16-6-4-7-17-42)86-67(105)53(31-45-34-79-26-27-80-45)88-68(106)54(32-58(78)98)89-63(101)48(85-71(56)109)22-12-14-24-75/h4-11,16-21,26-27,33-34,39-41,48-57,60-61,81,95-97H,12-15,22-25,28-32,35-38,75-77H2,1-3H3,(H2,78,98)(H,82,100)(H,83,99)(H,84,104)(H,85,109)(H,86,105)(H,87,103)(H,88,106)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t39-,40?,41?,48-,49+,50+,51-,52-,53-,54+,55-,56-,57-,60+,61+/m0/s1 D09EIG DRUGINKE JDTSWTCDRKKTPI-DOAKGFBDSA-N D09EIG DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=NC=CN=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O D09EIG HIGHSTAT Investigative D09EJG DRUG__ID D09EJG D09EJG DRUGINCH 1S/C159H246N46O39/c1-79(2)60-104(182-119(213)74-175-131(219)87(17)179-138(226)105(61-80(3)4)188-136(224)100(49-35-55-170-157(163)164)184-142(230)110(67-96-71-169-78-178-96)193-155(243)129(90(20)209)203-153(241)126(85(13)14)199-145(233)109(181-91(21)210)66-95-70-173-98-47-32-31-46-97(95)98)140(228)189-106(62-81(5)6)141(229)196-114(77-207)147(235)185-101(50-36-56-171-158(165)166)137(225)195-113(76-206)133(221)176-72-118(212)174-73-120(214)197-124(83(9)10)152(240)200-125(84(11)12)151(239)186-102(51-37-57-172-159(167)168)134(222)183-99(48-33-34-54-160)135(223)191-111(68-117(161)211)143(231)190-108(65-94-44-29-24-30-45-94)144(232)201-127(86(15)16)156(244)205-59-39-53-116(205)149(237)202-128(89(19)208)154(242)194-112(69-122(216)217)146(234)198-123(82(7)8)150(238)177-75-121(215)204-58-38-52-115(204)148(236)192-107(64-93-42-27-23-28-43-93)139(227)180-88(18)132(220)187-103(130(162)218)63-92-40-25-22-26-41-92/h22-32,40-47,70-71,78-90,99-116,123-129,173,206-209H,33-39,48-69,72-77,160H2,1-21H3,(H2,161,211)(H2,162,218)(H,169,178)(H,174,212)(H,175,219)(H,176,221)(H,177,238)(H,179,226)(H,180,227)(H,181,210)(H,182,213)(H,183,222)(H,184,230)(H,185,235)(H,186,239)(H,187,220)(H,188,224)(H,189,228)(H,190,231)(H,191,223)(H,192,236)(H,193,243)(H,194,242)(H,195,225)(H,196,229)(H,197,214)(H,198,234)(H,199,233)(H,200,240)(H,201,232)(H,202,237)(H,203,241)(H,216,217)(H4,163,164,170)(H4,165,166,171)(H4,167,168,172)/t87-,88-,89+,90+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,123-,124-,125-,126-,127-,128-,129-/m0/s1 D09EJG DRUGINKE LVJLXLXVWDOXCC-BQWGFPJXSA-N D09EJG DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C D09EJG HIGHSTAT Investigative D09FWS DRUG__ID D09FWS D09FWS DRUGINCH 1S/C17H15NO2/c1-2-11-9-17(12-3-5-13(19)6-4-12)18-16-8-7-14(20)10-15(11)16/h3-10,19-20H,2H2,1H3 D09FWS DRUGINKE JHGHNHLKUJDBRE-UHFFFAOYSA-N D09FWS DRUGSMIL CCC1=CC(=NC2=C1C=C(C=C2)O)C3=CC=C(C=C3)O D09FWS HIGHSTAT Investigative D09HEA DRUG__ID D09HEA D09HEA DRUGINCH 1S/C11H9N3/c12-7-10-1-3-11(4-2-10)8-14-6-5-13-9-14/h1-6,9H,8H2 D09HEA DRUGINKE LUSFCTSUDCCYLQ-UHFFFAOYSA-N D09HEA DRUGSMIL C1=CC(=CC=C1CN2C=CN=C2)C#N D09HEA HIGHSTAT Investigative D09HFC DRUG__ID D09HFC D09HFC DRUGINCH 1S/C158H238N46O71S/c1-8-76(4)129(155(271)204-41-15-20-107(204)153(269)196-84(32-37-126(240)241)145(261)193-83(31-36-125(238)239)146(262)199-90(44-78-21-25-80(219)26-22-78)150(266)198-88(42-75(2)3)148(264)197-87(156(272)273)29-34-108(159)220)201-147(263)85(33-38-127(242)243)194-144(260)82(30-35-124(236)237)195-149(265)89(43-77-16-10-9-11-17-77)200-151(267)91(45-128(244)245)178-109(221)46-163-130(246)92(61-205)179-110(222)47-164-131(247)93(62-206)180-111(223)48-165-132(248)94(63-207)181-112(224)49-166-133(249)95(64-208)182-113(225)50-167-134(250)96(65-209)183-114(226)51-168-135(251)97(66-210)184-115(227)52-169-136(252)98(67-211)185-116(228)53-170-137(253)99(68-212)186-117(229)54-171-138(254)100(69-213)187-118(230)55-172-139(255)101(70-214)188-119(231)56-173-140(256)102(71-215)189-120(232)57-174-141(257)103(72-216)190-121(233)58-175-142(258)104(73-217)191-122(234)59-176-143(259)105(74-218)192-123(235)60-177-152(268)106-19-12-13-40-203(106)154(270)86(18-14-39-162-157(160)161)202-276(274,275)81-27-23-79(24-28-81)158(5,6)7/h9-11,16-17,21-28,75-76,82-107,129,202,205-219H,8,12-15,18-20,29-74H2,1-7H3,(H2,159,220)(H,163,246)(H,164,247)(H,165,248)(H,166,249)(H,167,250)(H,168,251)(H,169,252)(H,170,253)(H,171,254)(H,172,255)(H,173,256)(H,174,257)(H,175,258)(H,176,259)(H,177,268)(H,178,221)(H,179,222)(H,180,223)(H,181,224)(H,182,225)(H,183,226)(H,184,227)(H,185,228)(H,186,229)(H,187,230)(H,188,231)(H,189,232)(H,190,233)(H,191,234)(H,192,235)(H,193,261)(H,194,260)(H,195,265)(H,196,269)(H,197,264)(H,198,266)(H,199,262)(H,200,267)(H,201,263)(H,236,237)(H,238,239)(H,240,241)(H,242,243)(H,244,245)(H,272,273)(H4,160,161,162)/t76-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106?,107-,129-/m0/s1 D09HFC DRUGINKE UZMGIFBITDOUBH-GDGQYZPBSA-N D09HFC DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D09HFC HIGHSTAT Investigative D09HMT DRUG__ID D09HMT D09HMT DRUGINCH 1S/C65H84N14O16S2/c1-7-33(2)54-62(90)72-44(22-23-51(67)82)58(86)73-45(29-52(68)83)59(87)74-46(30-96-97-31-48(81)61(89)76-55(63(91)75-54)34-12-17-38(80)18-13-34)64(92)79-25-9-11-47(79)60(88)71-43(57(85)70-32-66)10-8-24-69-56(84)35-14-19-39(42(26-35)65(93)94)53-40-20-15-36(77(3)4)27-49(40)95-50-28-37(78(5)6)16-21-41(50)53/h12-21,26-28,33,40,43-48,50,54-55,81H,7-11,22-25,29-32,66H2,1-6H3,(H13-,67,68,69,70,71,72,73,74,75,76,80,82,83,84,85,86,87,88,89,90,91,93,94)/p+1/t33?,40?,43-,44+,45+,46+,47+,48?,50?,54+,55-/m0/s1 D09HMT DRUGINKE XSTBAVMTSHGRBE-CEBVGXOVSA-O D09HMT DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)O)C(=O)N3CCCC3C(=O)NC(CCCNC(=O)C4=CC(=C(C=C4)C5=C6C=CC(=CC6OC7=CC(=[N+](C)C)C=CC75)N(C)C)C(=O)O)C(=O)NCN)CC(=O)N)CCC(=O)N D09HMT HIGHSTAT Investigative D09HXG DRUG__ID D09HXG D09HXG DRUGINCH 1S/C57H71N9O11S2/c1-5-64(6-2)41-19-22-45-50(37-41)77-51-38-42(65(7-3)8-4)20-23-46(51)55(45)47-24-21-43(39-52(47)79(72,73)74)78(70,71)60-26-13-9-10-18-53(67)58-27-33-75-35-36-76-34-32-62-28-30-63(31-29-62)40-54(68)66-49-17-12-11-15-44(49)57(69)61-48-16-14-25-59-56(48)66/h11-12,14-17,19-25,37-39,60H,5-10,13,18,26-36,40H2,1-4H3,(H2-,58,61,67,69,72,73,74) D09HXG DRUGINKE ZILZAZLHMFYYBB-UHFFFAOYSA-N D09HXG DRUGSMIL CCN(CC)C1=CC2=C(C=C1)C(=C3C=CC(=[N+](CC)CC)C=C3O2)C4=C(C=C(C=C4)S(=O)(=O)NCCCCCC(=O)NCCOCCOCCN5CCN(CC5)CC(=O)N6C7=CC=CC=C7C(=O)NC8=C6N=CC=C8)S(=O)(=O)[O-] D09HXG HIGHSTAT Investigative D09JXT DRUG__ID D09JXT D09JXT DRUGINCH 1S/C66H107N21O13/c1-6-29-74-48(35-42-24-26-43(88)27-25-42)55(91)79-37-52(89)78-38-53(90)80-50(36-41-17-9-8-10-18-41)59(95)85-49(34-39(3)4)58(94)82-44(20-13-30-75-64(68)69)56(92)81-45(21-14-31-76-65(70)71)57(93)86-54(40(5)7-2)61(97)83-46(22-15-32-77-66(72)73)62(98)87-33-16-23-51(87)60(96)84-47(63(99)100)19-11-12-28-67/h6,8-10,17-18,24-27,39-40,44-51,54,74,88H,1,7,11-16,19-23,28-38,67H2,2-5H3,(H,78,89)(H,79,91)(H,80,90)(H,81,92)(H,82,94)(H,83,97)(H,84,96)(H,85,95)(H,86,93)(H,99,100)(H4,68,69,75)(H4,70,71,76)(H4,72,73,77)/t40-,44-,45-,46-,47-,48-,49-,50-,51-,54-/m0/s1 D09JXT DRUGINKE MKKPRLAUMQVIGT-QNKLTTAESA-N D09JXT DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)NCC=C D09JXT HIGHSTAT Investigative D09LHN DRUG__ID D09LHN D09LHN DRUGINCH 1S/C74H96N14O16S2/c1-41(2)77-36-48-24-22-46(23-25-48)33-57-69(98)87-62(42(3)90)72(101)84-58(34-47-26-28-50(92)29-27-47)70(99)88-63(43(4)91)73(102)85-60(38-89)71(100)86-61(74(103)104)40-106-105-39-52(76)64(93)79-54(21-13-14-30-75)65(94)80-55(31-44-15-7-5-8-16-44)66(95)81-56(32-45-17-9-6-10-18-45)67(96)83-59(68(97)82-57)35-49-37-78-53-20-12-11-19-51(49)53/h5-12,15-20,22-29,37,41-43,52,54-63,77-78,89-92H,13-14,21,30-36,38-40,75-76H2,1-4H3,(H,79,93)(H,80,94)(H,81,95)(H,82,97)(H,83,96)(H,84,101)(H,85,102)(H,86,100)(H,87,98)(H,88,99)(H,103,104)/t42-,43-,52-,54-,55-,56+,57+,58+,59-,60+,61+,62-,63-/m1/s1 D09LHN DRUGINKE FJRAPOZDHJLSPN-KVMFXWMESA-N D09LHN DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=C(C=C7)O)C(C)O D09LHN HIGHSTAT Investigative D09LXI DRUG__ID D09LXI D09LXI DRUGINCH 1S/C58H77N11O12S2/c1-6-33(5)50-56(78)63-40(20-21-47(59)70)52(74)64-42(28-48(60)71)53(75)66-44(31-83-82-23-22-49(72)62-41(54(76)67-50)25-34-16-18-39(19-17-34)81-7-2)58(80)69-30-38-15-11-9-13-36(38)27-46(69)55(77)65-43(24-32(3)4)57(79)68-29-37-14-10-8-12-35(37)26-45(68)51(61)73/h8-19,32-33,40-46,50H,6-7,20-31H2,1-5H3,(H2,59,70)(H2,60,71)(H2,61,73)(H,62,72)(H,63,78)(H,64,74)(H,65,77)(H,66,75)(H,67,76)/t33-,40-,41-,42-,43-,44-,45+,46+,50-/m0/s1 D09LXI DRUGINKE WNQPWZVGNWMXJD-YJDWKIOXSA-N D09LXI DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)N5CC6=CC=CC=C6CC5C(=O)N)CC(=O)N)CCC(=O)N D09LXI HIGHSTAT Investigative D09OMI DRUG__ID D09OMI D09OMI DRUGINCH 1S/C60H79N17O13S2/c1-33(78)69-44(25-35-16-18-38(79)19-17-35)55(86)70-41(14-7-8-22-61)53(84)77-49-31-92-91-30-48(51(62)82)76-57(88)46(26-36-28-67-40-13-6-5-12-39(36)40)74-52(83)42(15-9-23-66-60(63)64)71-56(87)45(24-34-10-3-2-4-11-34)73-58(89)47(27-37-29-65-32-68-37)75-54(85)43(72-59(49)90)20-21-50(80)81/h2-6,10-13,16-19,28-29,32,41-49,67,79H,7-9,14-15,20-27,30-31,61H2,1H3,(H2,62,82)(H,65,68)(H,69,78)(H,70,86)(H,71,87)(H,72,90)(H,73,89)(H,74,83)(H,75,85)(H,76,88)(H,77,84)(H,80,81)(H4,63,64,66)/t41-,42-,43+,44-,45-,46+,47-,48+,49+/m0/s1 D09OMI DRUGINKE ASUAOIWGQADQOH-PYPSSTHSSA-N D09OMI DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D09OMI HIGHSTAT Investigative D09OML DRUG__ID D09OML D09OML DRUGINCH 1S/C45H63N15O11S2/c46-34(61)13-12-28-39(66)58-31(21-35(47)62)42(69)59-32(44(71)60-17-6-11-33(60)43(70)56-27(10-5-16-52-45(49)50)38(65)53-23-36(48)63)24-73-72-18-14-37(64)54-29(20-26-9-4-15-51-22-26)40(67)57-30(41(68)55-28)19-25-7-2-1-3-8-25/h1-4,7-9,15,22,27-33H,5-6,10-14,16-21,23-24H2,(H2,46,61)(H2,47,62)(H2,48,63)(H,53,65)(H,54,64)(H,55,68)(H,56,70)(H,57,67)(H,58,66)(H,59,69)(H4,49,50,52)/t27-,28-,29+,30-,31-,32-,33-/m0/s1 D09OML DRUGINKE KEAHYTRPVNOHKL-ZHFJCBJKSA-N D09OML DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CN=CC=C4)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D09OML HIGHSTAT Investigative D09POP DRUG__ID D09POP D09POP DRUGINCH 1S/C85H143N31O21/c1-46(2)39-60(78(132)105-48(4)70(124)114-62(42-64(91)119)79(133)113-59(82(136)137)31-32-63(90)118)115-77(131)55(27-14-17-35-88)110-76(130)58(30-20-38-100-85(96)97)112-73(127)54(26-13-16-34-87)109-75(129)57(29-19-37-99-84(94)95)111-72(126)53(25-12-15-33-86)108-74(128)56(28-18-36-98-83(92)93)107-69(123)47(3)104-66(121)45-103-81(135)68(49(5)117)116-80(134)61(41-51-23-10-7-11-24-51)106-67(122)44-101-65(120)43-102-71(125)52(89)40-50-21-8-6-9-22-50/h6-11,21-24,46-49,52-62,68,117H,12-20,25-45,86-89H2,1-5H3,(H2,90,118)(H2,91,119)(H,101,120)(H,102,125)(H,103,135)(H,104,121)(H,105,132)(H,106,122)(H,107,123)(H,108,128)(H,109,129)(H,110,130)(H,111,126)(H,112,127)(H,113,133)(H,114,124)(H,115,131)(H,116,134)(H,136,137)(H4,92,93,98)(H4,94,95,99)(H4,96,97,100)/t47-,48-,49+,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,68-/m0/s1 D09POP DRUGINKE OPYGIVVZZPRQCO-BANXXPNRSA-N D09POP DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D09POP HIGHSTAT Investigative D09RIE DRUG__ID D09RIE D09RIE DRUGINCH 1S/C50H71N13O11S2/c51-40(65)26-37-47(72)62-38(49(74)63-21-8-14-39(63)48(73)58-33(13-7-20-55-50(53)54)43(68)56-27-41(52)66)28-76-75-22-19-42(67)57-34(25-31-15-17-32(64)18-16-31)44(69)59-35(23-29-9-3-1-4-10-29)45(70)60-36(46(71)61-37)24-30-11-5-2-6-12-30/h1,3-4,9-10,15-18,30,33-39,64H,2,5-8,11-14,19-28H2,(H2,51,65)(H2,52,66)(H,56,68)(H,57,67)(H,58,73)(H,59,69)(H,60,70)(H,61,71)(H,62,72)(H4,53,54,55)/t33-,34-,35-,36-,37-,38-,39-/m0/s1 D09RIE DRUGINKE ZKYCVZNKBXGNEK-ZTYVOHGWSA-N D09RIE DRUGSMIL C1CCC(CC1)CC2C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N D09RIE HIGHSTAT Investigative D09RSU DRUG__ID D09RSU D09RSU DRUGINCH 1S/C67H109N21O13/c1-5-40(4)55(62(98)84-47(20-13-31-77-67(73)74)63(99)88-32-14-21-52(88)61(97)85-48(64(100)101)17-9-10-28-68)87-58(94)46(19-12-30-76-66(71)72)82-57(93)45(18-11-29-75-65(69)70)83-59(95)50(33-39(2)3)86-60(96)51(35-41-15-7-6-8-16-41)81-54(91)38-79-53(90)37-80-56(92)49(78-36-43-22-23-43)34-42-24-26-44(89)27-25-42/h6-8,15-16,24-27,39-40,43,45-52,55,78,89H,5,9-14,17-23,28-38,68H2,1-4H3,(H,79,90)(H,80,92)(H,81,91)(H,82,93)(H,83,95)(H,84,98)(H,85,97)(H,86,96)(H,87,94)(H,100,101)(H4,69,70,75)(H4,71,72,76)(H4,73,74,77)/t40-,45-,46-,47-,48-,49-,50-,51-,52-,55-/m0/s1 D09RSU DRUGINKE CFPWTFGNSPUUJD-RWKXLGHPSA-N D09RSU DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)NCC4CC4 D09RSU HIGHSTAT Investigative D09SDZ DRUG__ID D09SDZ D09SDZ DRUGINCH 1S/C77H115N21O20/c1-37(2)23-50(68(109)84-34-62(105)98-22-14-17-58(98)76(117)93-55(28-46-32-81-36-85-46)69(110)87-42(10)67(108)96-63(40(7)8)65(80)106)90-70(111)51(24-38(3)4)91-72(113)53(26-44-18-20-47(101)21-19-44)89-61(104)33-83-66(107)41(9)86-75(116)57(35-99)95-73(114)56(29-59(79)102)92-71(112)52(25-39(5)6)94-77(118)64(43(11)100)97-74(115)54(88-60(103)30-78)27-45-31-82-49-16-13-12-15-48(45)49/h12-13,15-16,18-21,31-32,36-43,50-58,63-64,82,99-101H,14,17,22-30,33-35,78H2,1-11H3,(H2,79,102)(H2,80,106)(H,81,85)(H,83,107)(H,84,109)(H,86,116)(H,87,110)(H,88,103)(H,89,104)(H,90,111)(H,91,113)(H,92,112)(H,93,117)(H,94,118)(H,95,114)(H,96,108)(H,97,115)/t41-,42-,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,63-,64-/m0/s1 D09SDZ DRUGINKE QWMBNRVWDTXENF-LJQDGMHUSA-N D09SDZ DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(C)C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)CN D09SDZ HIGHSTAT Investigative D09UXO DRUG__ID D09UXO D09UXO DRUGINCH 1S/C80H106ClN19O18/c1-43(2)35-58(70(107)91-57(15-10-11-32-84-44(3)4)77(114)100-34-12-16-65(100)76(113)86-45(5)67(82)104)92-73(110)61(38-49-22-29-55(30-23-49)89-78(83)115)94-74(111)62(39-48-20-27-54(28-21-48)88-69(106)63-41-66(103)98-80(117)97-63)95-75(112)64(42-101)96-68(105)56(31-33-85-79(116)99-118-7)90-72(109)60(37-47-18-25-53(81)26-19-47)93-71(108)59(87-46(6)102)40-50-17-24-51-13-8-9-14-52(51)36-50/h8-9,13-14,17-30,36,43-45,56-65,84,101H,10-12,15-16,31-35,37-42H2,1-7H3,(H2,82,104)(H,86,113)(H,87,102)(H,88,106)(H,90,109)(H,91,107)(H,92,110)(H,93,108)(H,94,111)(H,95,112)(H,96,105)(H3,83,89,115)(H2,85,99,116)(H2,97,98,103,117)/t45-,56-,57+,58+,59-,60-,61-,62+,63+,64+,65+/m1/s1 D09UXO DRUGINKE DBLYRXMPBSXJDM-GOZSSGHVSA-N D09UXO DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CCNC(=O)NOC)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D09UXO HIGHSTAT Investigative D09WRS DRUG__ID D09WRS D09WRS DRUGINCH 1S/C159H245N45O40/c1-79(2)60-104(181-119(212)74-174-131(218)87(17)178-138(225)105(61-80(3)4)187-136(223)100(51-37-57-171-159(167)244)183-142(229)110(67-96-71-168-78-177-96)192-155(242)129(90(20)208)202-153(240)126(85(13)14)198-145(232)109(180-91(21)209)66-95-70-172-98-47-32-31-46-97(95)98)140(227)188-106(62-81(5)6)141(228)195-114(77-206)147(234)184-101(49-35-55-169-157(163)164)137(224)194-113(76-205)133(220)175-72-118(211)173-73-120(213)196-124(83(9)10)152(239)199-125(84(11)12)151(238)185-102(50-36-56-170-158(165)166)134(221)182-99(48-33-34-54-160)135(222)190-111(68-117(161)210)143(230)189-108(65-94-44-29-24-30-45-94)144(231)200-127(86(15)16)156(243)204-59-39-53-116(204)149(236)201-128(89(19)207)154(241)193-112(69-122(215)216)146(233)197-123(82(7)8)150(237)176-75-121(214)203-58-38-52-115(203)148(235)191-107(64-93-42-27-23-28-43-93)139(226)179-88(18)132(219)186-103(130(162)217)63-92-40-25-22-26-41-92/h22-32,40-47,70-71,78-90,99-116,123-129,172,205-208H,33-39,48-69,72-77,160H2,1-21H3,(H2,161,210)(H2,162,217)(H,168,177)(H,173,211)(H,174,218)(H,175,220)(H,176,237)(H,178,225)(H,179,226)(H,180,209)(H,181,212)(H,182,221)(H,183,229)(H,184,234)(H,185,238)(H,186,219)(H,187,223)(H,188,227)(H,189,230)(H,190,222)(H,191,235)(H,192,242)(H,193,241)(H,194,224)(H,195,228)(H,196,213)(H,197,233)(H,198,232)(H,199,239)(H,200,231)(H,201,236)(H,202,240)(H,215,216)(H4,163,164,169)(H4,165,166,170)(H3,167,171,244)/t87-,88-,89+,90+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,123-,124-,125-,126-,127-,128-,129-/m0/s1 D09WRS DRUGINKE CSCIPTVNDXPCSL-BQWGFPJXSA-N D09WRS DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C D09WRS HIGHSTAT Investigative D09XCH DRUG__ID D09XCH D09XCH DRUGINCH 1S/C60H79N19O13S2/c1-32(80)71-43(24-34-15-17-37(81)18-16-34)54(88)72-41(14-8-22-68-60(64)65)52(86)79-48-30-94-93-29-47(50(61)84)78-56(90)45(25-35-27-69-39-12-6-5-11-38(35)39)76-51(85)40(13-7-21-67-59(62)63)73-55(89)44(23-33-9-3-2-4-10-33)75-57(91)46(26-36-28-66-31-70-36)77-53(87)42(74-58(48)92)19-20-49(82)83/h2-6,9-12,15-18,27-28,31,40-48,69,81H,7-8,13-14,19-26,29-30H2,1H3,(H2,61,84)(H,66,70)(H,71,80)(H,72,88)(H,73,89)(H,74,92)(H,75,91)(H,76,85)(H,77,87)(H,78,90)(H,79,86)(H,82,83)(H4,62,63,67)(H4,64,65,68)/t40-,41-,42+,43-,44+,45+,46-,47+,48+/m0/s1 D09XCH DRUGINKE FEKXKTLLBDRSQH-JUYCQENKSA-N D09XCH DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D09XCH HIGHSTAT Investigative D09XWA DRUG__ID D09XWA D09XWA DRUGINCH 1S/C47H65N11O11S2/c48-24-35(41(63)51-25-39(50)61)56-46(68)37-12-7-18-58(37)47(69)36-26-71-70-19-17-40(62)52-31(22-29-13-15-30(59)16-14-29)42(64)53-32(20-27-8-3-1-4-9-27)43(65)54-33(21-28-10-5-2-6-11-28)44(66)55-34(23-38(49)60)45(67)57-36/h1,3-4,8-9,13-16,28,31-37,59H,2,5-7,10-12,17-26,48H2,(H2,49,60)(H2,50,61)(H,51,63)(H,52,62)(H,53,64)(H,54,65)(H,55,66)(H,56,68)(H,57,67)/t31-,32-,33-,34-,35-,36-,37-/m0/s1 D09XWA DRUGINKE XABCPBOFMBSCDK-PEAOEFARSA-N D09XWA DRUGSMIL C1CCC(CC1)CC2C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CN)C(=O)NCC(=O)N)CC(=O)N D09XWA HIGHSTAT Investigative D09XZM DRUG__ID D09XZM D09XZM DRUGINCH 1S/C62H102N22O14S2/c1-34(51(89)79-42(22-14-26-71-61(67)68)54(92)78-40(50(66)88)20-10-12-24-63)75-58(96)45(32-99)82-56(94)41(21-11-13-25-64)81-55(93)43(23-15-27-72-62(69)70)80-52(90)35(2)76-59(97)46(33-100)83-60(98)49(36(3)85)84-57(95)44(29-38-18-8-5-9-19-38)77-48(87)31-73-47(86)30-74-53(91)39(65)28-37-16-6-4-7-17-37/h4-9,16-19,34-36,39-46,49,85,99-100H,10-15,20-33,63-65H2,1-3H3,(H2,66,88)(H,73,86)(H,74,91)(H,75,96)(H,76,97)(H,77,87)(H,78,92)(H,79,89)(H,80,90)(H,81,93)(H,82,94)(H,83,98)(H,84,95)(H4,67,68,71)(H4,69,70,72)/t34-,35-,36+,39-,40-,41-,42-,43-,44-,45-,46-,49-/m0/s1 D09XZM DRUGINKE APYUYQWYKXKSOW-JOEKKRFNSA-N D09XZM DRUGSMIL CC(C(C(=O)NC(CS)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CS)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D09XZM HIGHSTAT Investigative D09YOU DRUG__ID D09YOU D09YOU DRUGINCH 1S/C19H17F2N7O/c1-27-16(22-10-23-27)9-29-19-12(11-4-2-5-11)8-15-24-25-18(28(15)26-19)17-13(20)6-3-7-14(17)21/h3,6-8,10-11H,2,4-5,9H2,1H3 D09YOU DRUGINKE GOIFCXRIFSYPFG-UHFFFAOYSA-N D09YOU DRUGSMIL CN1C(=NC=N1)COC2=NN3C(=NN=C3C4=C(C=CC=C4F)F)C=C2C5CCC5 D09YOU HIGHSTAT Investigative D09ZIC DRUG__ID D09ZIC D09ZIC DRUGINCH 1S/C5H12N4O3/c6-3(4(10)11)1-2-8-5(7)9-12/h3,12H,1-2,6H2,(H,10,11)(H3,7,8,9)/t3-/m0/s1 D09ZIC DRUGINKE KOBHCUDVWOTEKO-VKHMYHEASA-N D09ZIC DRUGSMIL C(CN=C(N)NO)C(C(=O)O)N D09ZIC HIGHSTAT Investigative D09ZTU DRUG__ID D09ZTU D09ZTU DRUGINCH 1S/C87H135N31O22/c1-46(106-68(124)44-105-83(138)70(48(3)120)118-81(136)61(38-50-21-8-5-9-22-50)108-69(125)43-103-67(123)42-104-73(128)53(90)37-49-19-6-4-7-20-49)71(126)109-57(27-16-34-99-85(93)94)74(129)112-56(26-13-15-33-89)78(133)117-64(45-119)82(137)107-47(2)72(127)110-58(28-17-35-100-86(95)96)75(130)111-55(25-12-14-32-88)76(131)115-62(39-51-41-102-54-24-11-10-23-52(51)54)79(134)113-59(29-18-36-101-87(97)98)77(132)116-63(40-66(92)122)80(135)114-60(84(139)140)30-31-65(91)121/h4-11,19-24,41,46-48,53,55-64,70,102,119-120H,12-18,25-40,42-45,88-90H2,1-3H3,(H2,91,121)(H2,92,122)(H,103,123)(H,104,128)(H,105,138)(H,106,124)(H,107,137)(H,108,125)(H,109,126)(H,110,127)(H,111,130)(H,112,129)(H,113,134)(H,114,135)(H,115,131)(H,116,132)(H,117,133)(H,118,136)(H,139,140)(H4,93,94,99)(H4,95,96,100)(H4,97,98,101)/t46-,47-,48+,53-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,70-/m0/s1 D09ZTU DRUGINKE KUDFNAMEWORXOZ-UWALROLSSA-N D09ZTU DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=CC=C4)N)O D09ZTU HIGHSTAT Investigative D0A0DO DRUG__ID D0A0DO D0A0DO DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)39-60-72(99)88-65(46(3)92)74(101)86-61(38-50-23-13-8-14-24-50)73(100)89-66(47(4)93)75(102)87-63(42-91)76(103)90(5)64(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-62(71(98)84-60)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,98)(H,85,97)(H,86,101)(H,87,102)(H,88,99)(H,89,100)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D0A0DO DRUGINKE OCBPOFXOMWHIND-PCKPOTSRSA-N D0A0DO DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)C)CO)C(C)O)CC7=CC=CC=C7)C(C)O D0A0DO HIGHSTAT Investigative D0A1XX DRUG__ID D0A1XX D0A1XX DRUGINCH 1S/C84H108N16O16S2/c1-48(2)88-43-56-30-28-55(29-31-56)41-70-81(113)99-72(50(4)103)82(114)93-65(40-53-23-13-8-14-24-53)78(110)98-71(49(3)102)83(115)95-67(45-101)79(111)96-68(73(87)105)46-117-118-47-69(97-74(106)60(86)37-54-32-34-58(104)35-33-54)80(112)90-62(27-17-18-36-85)75(107)91-63(38-51-19-9-6-10-20-51)76(108)92-64(39-52-21-11-7-12-22-52)77(109)94-66(84(116)100(70)5)42-57-44-89-61-26-16-15-25-59(57)61/h6-16,19-26,28-35,44,48-50,60,62-72,88-89,101-104H,17-18,27,36-43,45-47,85-86H2,1-5H3,(H2,87,105)(H,90,112)(H,91,107)(H,92,108)(H,93,114)(H,94,109)(H,95,115)(H,96,111)(H,97,106)(H,98,110)(H,99,113)/t49-,50-,60+,62-,63-,64+,65+,66+,67+,68+,69-,70+,71-,72-/m1/s1 D0A1XX DRUGINKE UTASAEBFJXWNHX-PIBSBZCFSA-N D0A1XX DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)NC(=O)C(CC7=CC=C(C=C7)O)N)C(=O)N)CO)C(C)O)CC8=CC=CC=C8)C(C)O D0A1XX HIGHSTAT Investigative D0A2FO DRUG__ID D0A2FO D0A2FO DRUGINCH 1S/C16H14O3/c1-18-12-7-8-13-14(17)10-15(19-16(13)9-12)11-5-3-2-4-6-11/h2-9,15H,10H2,1H3 D0A2FO DRUGINKE VYESEQLQFXUROZ-UHFFFAOYSA-N D0A2FO DRUGSMIL COC1=CC2=C(C=C1)C(=O)CC(O2)C3=CC=CC=C3 D0A2FO HIGHSTAT Investigative D0A2LX DRUG__ID D0A2LX D0A2LX DRUGINCH 1S/C52H73IN14O12S2/c1-52(2)42(67-44(73)33(55)22-29-13-16-31(69)17-14-29)50(79)65-36(24-30-15-18-40(70)32(53)21-30)45(74)60-25-41(71)61-38(26-68)48(77)64-37(23-28-9-4-3-5-10-28)47(76)66-39(27-80-81-52)49(78)63-35(11-6-7-19-54)46(75)62-34(43(56)72)12-8-20-59-51(57)58/h3-5,9-10,13-18,21,33-39,42,68-70H,6-8,11-12,19-20,22-27,54-55H2,1-2H3,(H2,56,72)(H,60,74)(H,61,71)(H,62,75)(H,63,78)(H,64,77)(H,65,79)(H,66,76)(H,67,73)(H4,57,58,59)/t33-,34-,35-,36-,37+,38-,39+,42-/m0/s1 D0A2LX DRUGINKE NXLJKZAAHWHFCS-YLYTWGDESA-N D0A2LX DRUGSMIL CC1(C(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC2=CC=CC=C2)CO)CC3=CC(=C(C=C3)O)I)NC(=O)C(CC4=CC=C(C=C4)O)N)C D0A2LX HIGHSTAT Investigative D0A3LJ DRUG__ID D0A3LJ D0A3LJ DRUGINCH 1S/C56H86N10O11S.Na/c1-9-39(6)51(55(73)59-35-41-22-17-18-26-58-41)63-52(70)43(38(4)5)33-48(67)44(30-37(2)3)61-54(72)47(32-42-34-57-36-60-42)65(8)56(74)45(31-40-20-13-12-14-21-40)62-53(71)46-23-19-27-66(46)50(69)25-16-11-10-15-24-49(68)64(7)28-29-78(75,76)77;/h12-14,17-18,20-22,26,34,36-39,43-48,51,67H,9-11,15-16,19,23-25,27-33,35H2,1-8H3,(H,57,60)(H,59,73)(H,61,72)(H,62,71)(H,63,70)(H,75,76,77);/q;+1/p-1 D0A3LJ DRUGINKE RCOSBSCBKACBAF-UHFFFAOYSA-M D0A3LJ DRUGSMIL CCC(C)C(C(=O)NCC1=CC=CC=N1)NC(=O)C(CC(C(CC(C)C)NC(=O)C(CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)CCCCCCC(=O)N(C)CCS(=O)(=O)[O-])O)C(C)C.[Na+] D0A3LJ HIGHSTAT Investigative D0A5YR DRUG__ID D0A5YR D0A5YR DRUGINCH 1S/C48H86N30O12/c49-33-29-34(70-20-69-33)78(21-71-29)41-31(81)30(80)32(90-41)40(87)68-19-28(79)72-22(7-1-13-62-43(50)51)35(82)73-23(8-2-14-63-44(52)53)36(83)74-24(9-3-15-64-45(54)55)37(84)75-25(10-4-16-65-46(56)57)38(85)76-26(11-5-17-66-47(58)59)39(86)77-27(42(88)89)12-6-18-67-48(60)61/h20-27,30-32,41,80-81H,1-19H2,(H,68,87)(H,72,79)(H,73,82)(H,74,83)(H,75,84)(H,76,85)(H,77,86)(H,88,89)(H2,49,69,70)(H4,50,51,62)(H4,52,53,63)(H4,54,55,64)(H4,56,57,65)(H4,58,59,66)(H4,60,61,67)/t22-,23-,24-,25-,26-,27-,30+,31-,32+,41?/m1/s1 D0A5YR DRUGINKE RQOKDGUOYJQMIS-CUDNWQCBSA-N D0A5YR DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D0A5YR HIGHSTAT Investigative D0A6FK DRUG__ID D0A6FK D0A6FK DRUGINCH 1S/C47H67N13O11S2/c1-26(2)20-31-41(66)58-34(23-37(48)62)44(69)59-35(46(71)60-18-7-11-36(60)45(70)55-30(10-6-17-52-47(50)51)40(65)53-24-38(49)63)25-73-72-19-16-39(64)54-32(22-28-12-14-29(61)15-13-28)42(67)57-33(43(68)56-31)21-27-8-4-3-5-9-27/h3-5,8-9,12-15,26,30-36,61H,6-7,10-11,16-25H2,1-2H3,(H2,48,62)(H2,49,63)(H,53,65)(H,54,64)(H,55,70)(H,56,68)(H,57,67)(H,58,66)(H,59,69)(H4,50,51,52)/t30-,31-,32-,33-,34-,35-,36-/m0/s1 D0A6FK DRUGINKE CYOLRNSRVHAZDY-QJCLFNHPSA-N D0A6FK DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N D0A6FK HIGHSTAT Investigative D0A7RT DRUG__ID D0A7RT D0A7RT DRUGINCH 1S/C55H74N14O17S3/c1-87-21-18-37(64-51(79)40(24-31-14-16-33(17-15-31)86-89(83,84)85)68-54(82)42(26-45(71)72)67-48(76)35(56)12-8-20-60-55(58)59)49(77)62-29-44(70)63-41(25-32-28-61-36-13-7-6-11-34(32)36)52(80)65-38(19-22-88-2)50(78)69-43(27-46(73)74)53(81)66-39(47(57)75)23-30-9-4-3-5-10-30/h3-7,9-11,13-17,28,35,37-43,61H,8,12,18-27,29,56H2,1-2H3,(H2,57,75)(H,62,77)(H,63,70)(H,64,79)(H,65,80)(H,66,81)(H,67,76)(H,68,82)(H,69,78)(H,71,72)(H,73,74)(H4,58,59,60)(H,83,84,85)/t35-,37-,38-,39-,40-,41-,42-,43-/m0/s1 D0A7RT DRUGINKE AOVFOMQIRNOPOR-LVHVEONVSA-N D0A7RT DRUGSMIL CSCCC(C(=O)NCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCN=C(N)N)N D0A7RT HIGHSTAT Investigative D0A8ME DRUG__ID D0A8ME D0A8ME DRUGINCH 1S/C45H58N14O10S2/c1-24(60)53-36-22-71-70-21-35(38(46)63)59-42(67)33(17-26-19-51-29-11-6-5-10-28(26)29)57-39(64)30(12-7-15-50-45(47)48)54-41(66)32(16-25-8-3-2-4-9-25)56-43(68)34(18-27-20-49-23-52-27)58-40(65)31(55-44(36)69)13-14-37(61)62/h2-6,8-11,19-20,23,30-36,51H,7,12-18,21-22H2,1H3,(H2,46,63)(H,49,52)(H,53,60)(H,54,66)(H,55,69)(H,56,68)(H,57,64)(H,58,65)(H,59,67)(H,61,62)(H4,47,48,50)/t30-,31+,32-,33+,34-,35+,36+/m0/s1 D0A8ME DRUGINKE DCRRHKOGXQUJTJ-VCFUPWAGSA-N D0A8ME DRUGSMIL CC(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCC(=O)O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)N D0A8ME HIGHSTAT Investigative D0A8NZ DRUG__ID D0A8NZ D0A8NZ DRUGINCH 1S/C65H105N23O15/c1-37(55(95)84-45(24-15-29-75-64(70)71)58(98)83-42(54(69)94)21-9-12-26-66)80-57(97)43-23-11-14-28-74-49(90)33-48(61(101)87-46(25-16-30-76-65(72)73)60(100)86-44(59(99)85-43)22-10-13-27-67)82-52(93)36-79-63(103)53(38(2)89)88-62(102)47(32-40-19-7-4-8-20-40)81-51(92)35-77-50(91)34-78-56(96)41(68)31-39-17-5-3-6-18-39/h3-8,17-20,37-38,41-48,53,89H,9-16,21-36,66-68H2,1-2H3,(H2,69,94)(H,74,90)(H,77,91)(H,78,96)(H,79,103)(H,80,97)(H,81,92)(H,82,93)(H,83,98)(H,84,95)(H,85,99)(H,86,100)(H,87,101)(H,88,102)(H4,70,71,75)(H4,72,73,76)/t37-,38+,41-,42-,43-,44-,45-,46-,47-,48-,53-/m0/s1 D0A8NZ DRUGINKE MUJYKGBDMXOPCE-CFUMCULZSA-N D0A8NZ DRUGSMIL CC(C(C(=O)NCC(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC1=O)CCCN=C(N)N)CCCCN)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)O D0A8NZ HIGHSTAT Investigative D0A8VZ DRUG__ID D0A8VZ D0A8VZ DRUGINCH 1S/C146H244N44O47S2/c1-18-19-27-82(123(215)179-96(51-77-33-35-79(199)36-34-77)144(236)190-45-26-32-103(190)139(231)169-84(30-24-43-158-146(155)156)126(218)187-114(74(15)196)142(234)178-95(55-107(153)203)134(226)186-113(73(14)195)140(232)161-58-109(205)164-97(60-191)120(212)160-59-110(206)184-116(76(17)198)145(237)189-44-25-31-102(189)117(154)209)165-131(223)92(52-78-56-157-66-162-78)174-127(219)88(47-68(4)5)171-122(214)83(29-21-23-42-148)166-132(224)93(53-105(151)201)175-128(220)89(48-69(6)7)172-125(217)86(38-40-111(207)208)167-124(216)85(37-39-104(150)200)168-135(227)99(62-193)181-129(221)90(49-70(8)9)170-121(213)81(28-20-22-41-147)163-108(204)57-159-119(211)87(46-67(2)3)177-141(233)112(72(12)13)185-138(230)101(65-239)183-143(235)115(75(16)197)188-137(229)100(63-194)182-130(222)91(50-71(10)11)173-133(225)94(54-106(152)202)176-136(228)98(61-192)180-118(210)80(149)64-238/h33-36,56,66-76,80-103,112-116,191-199,238-239H,18-32,37-55,57-65,147-149H2,1-17H3,(H2,150,200)(H2,151,201)(H2,152,202)(H2,153,203)(H2,154,209)(H,157,162)(H,159,211)(H,160,212)(H,161,232)(H,163,204)(H,164,205)(H,165,223)(H,166,224)(H,167,216)(H,168,227)(H,169,231)(H,170,213)(H,171,214)(H,172,217)(H,173,225)(H,174,219)(H,175,220)(H,176,228)(H,177,233)(H,178,234)(H,179,215)(H,180,210)(H,181,221)(H,182,222)(H,183,235)(H,184,206)(H,185,230)(H,186,226)(H,187,218)(H,188,229)(H,207,208)(H4,155,156,158)/t73-,74-,75-,76-,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102-,103-,112+,113+,114+,115+,116+/m1/s1 D0A8VZ DRUGINKE YNPHTODKUNFPBE-PQRPONEFSA-N D0A8VZ DRUGSMIL CCCCC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N3CCCC3C(=O)N)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N D0A8VZ HIGHSTAT Investigative D0A9LX DRUG__ID D0A9LX D0A9LX DRUGINCH 1S/C10H13FN2O4/c1-6-4-13(9(16)12-8(6)15)10(11)3-2-7(5-14)17-10/h4,7,14H,2-3,5H2,1H3,(H,12,15,16)/t7-,10-/m0/s1 D0A9LX DRUGINKE KKBCCKWJPCJQLO-XVKPBYJWSA-N D0A9LX DRUGSMIL CC1=CN(C(=O)NC1=O)C2(CCC(O2)CO)F D0A9LX HIGHSTAT Investigative D0A9VZ DRUG__ID D0A9VZ D0A9VZ DRUGINCH 1S/C80H131N27O22/c1-7-49(68(118)105-57(37-60(85)111)74(124)103-54(78(128)129)28-29-59(84)110)98-73(123)55(34-42(2)3)104-71(121)50(24-14-16-30-81)101-70(120)53(27-19-33-91-80(88)89)100-66(116)44(5)96-76(126)58(41-108)106-72(122)51(25-15-17-31-82)102-69(119)52(26-18-32-90-79(86)87)99-65(115)43(4)95-62(113)40-94-77(127)64(45(6)109)107-75(125)56(36-47-22-12-9-13-23-47)97-63(114)39-92-61(112)38-93-67(117)48(83)35-46-20-10-8-11-21-46/h8-13,20-23,42-45,48-58,64,108-109H,7,14-19,24-41,81-83H2,1-6H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,117)(H,94,127)(H,95,113)(H,96,126)(H,97,114)(H,98,123)(H,99,115)(H,100,116)(H,101,120)(H,102,119)(H,103,124)(H,104,121)(H,105,118)(H,106,122)(H,107,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0A9VZ DRUGINKE CBBZIEAUVSBRPS-KMOVSZGYSA-N D0A9VZ DRUGSMIL CCC(C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0A9VZ HIGHSTAT Investigative D0AK9V DRUG__ID D0AK9V D0AK9V DRUGINCH 1S/C19H27N3O3S.K/c1-13(2)22-18(25)15(16(23)14-7-12-26-19(14)22)17(24)20-8-6-11-21-9-4-3-5-10-21;/h7,12-13,23H,3-6,8-11H2,1-2H3,(H,20,24);/q;+1/p-1 D0AK9V DRUGINKE JWRDEPYIIBDWDI-UHFFFAOYSA-M D0AK9V DRUGSMIL CC(C)N1C2=C(C=CS2)C(=C(C1=O)C(=O)NCCCN3CCCCC3)[O-].[K+] D0AK9V HIGHSTAT Investigative D0AU4C DRUG__ID D0AU4C D0AU4C DRUGINCH 1S/C118H174N34O35S/c1-63(122)97(167)135-77(36-39-93(159)160)105(175)137-71(23-8-11-42-119)100(170)136-72(24-9-12-43-120)102(172)147-84(55-95(163)164)111(181)140-76(35-38-92(157)158)98(168)132-60-91(156)150-47-16-28-87(150)112(182)148-81(52-65-31-33-68(154)34-32-65)109(179)138-74(26-14-45-128-117(123)124)101(171)142-79(41-50-188-2)107(177)141-78(37-40-94(161)162)106(176)146-83(54-67-58-127-62-133-67)110(180)144-80(51-64-19-4-3-5-20-64)108(178)139-75(27-15-46-129-118(125)126)103(173)145-82(53-66-57-130-70-22-7-6-21-69(66)70)99(169)131-59-90(155)134-86(61-153)114(184)152-49-18-30-89(152)115(185)151-48-17-29-88(151)113(183)143-73(25-10-13-44-121)104(174)149-85(116(186)187)56-96(165)166/h3-7,19-22,31-34,57-58,62-63,71-89,130,153-154H,8-18,23-30,35-56,59-61,119-122H2,1-2H3,(H,127,133)(H,131,169)(H,132,168)(H,134,155)(H,135,167)(H,136,170)(H,137,175)(H,138,179)(H,139,178)(H,140,181)(H,141,177)(H,142,171)(H,143,183)(H,144,180)(H,145,173)(H,146,176)(H,147,172)(H,148,182)(H,149,174)(H,157,158)(H,159,160)(H,161,162)(H,163,164)(H,165,166)(H,186,187)(H4,123,124,128)(H4,125,126,129)/t63-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-/m0/s1 D0AU4C DRUGINKE XLLJFSCSXTYVTN-UPWOUFKKSA-N D0AU4C DRUGSMIL CC(C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CN=CN3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NCC(=O)NC(CO)C(=O)N7CCCC7C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)O)N D0AU4C HIGHSTAT Investigative D0B0LG DRUG__ID D0B0LG D0B0LG DRUGCOMP Oncaidia Ltd D0B0LG DRUGTYPE Small molecular drug D0B0LG DRUGSMIL C(C1C(C(C(O1)N2C3=C(C(=O)N=C(N3)N)SC2=O)O)O)O.O D0B0LG HIGHSTAT Investigative D0B3BS DRUG__ID D0B3BS D0B3BS DRUGINCH 1S/C152H227N41O47/c1-16-77(10)122(149(238)170-80(13)127(216)178-104(59-86-63-162-91-35-24-23-34-89(86)91)138(227)180-100(55-74(4)5)140(229)190-120(75(6)7)147(236)177-93(36-25-27-51-153)130(219)165-67-114(204)171-92(38-29-53-161-152(157)158)129(218)163-65-111(156)201)192-141(230)102(56-83-30-19-17-20-31-83)181-134(223)97(45-49-117(208)209)174-133(222)94-37-26-28-52-160-112(202)61-105(139(228)175-96(43-47-110(155)200)132(221)169-78(11)125(214)168-79(12)126(215)173-94)183-135(224)98(46-50-118(210)211)176-136(225)99(54-73(2)3)179-137(226)101(58-85-39-41-88(199)42-40-85)182-144(233)107(69-194)186-146(235)109(71-196)187-148(237)121(76(8)9)191-143(232)106(62-119(212)213)184-145(234)108(70-195)188-151(240)124(82(15)198)193-142(231)103(57-84-32-21-18-22-33-84)185-150(239)123(81(14)197)189-115(205)68-166-131(220)95(44-48-116(206)207)172-113(203)66-164-128(217)90(154)60-87-64-159-72-167-87/h17-24,30-35,39-42,63-64,72-82,90,92-109,120-124,162,194-199H,16,25-29,36-38,43-62,65-71,153-154H2,1-15H3,(H2,155,200)(H2,156,201)(H,159,167)(H,160,202)(H,163,218)(H,164,217)(H,165,219)(H,166,220)(H,168,214)(H,169,221)(H,170,238)(H,171,204)(H,172,203)(H,173,215)(H,174,222)(H,175,228)(H,176,225)(H,177,236)(H,178,216)(H,179,226)(H,180,227)(H,181,223)(H,182,233)(H,183,224)(H,184,234)(H,185,239)(H,186,235)(H,187,237)(H,188,240)(H,189,205)(H,190,229)(H,191,232)(H,192,230)(H,193,231)(H,206,207)(H,208,209)(H,210,211)(H,212,213)(H4,157,158,161)/t77-,78-,79-,80-,81-,82-,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,120-,121-,122-,123-,124-/m0/s1 D0B3BS DRUGINKE XYYFVCKJZJFHBW-NINLSKNRSA-N D0B3BS DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C4CCCCNC(=O)CC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)C)C)CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D0B3BS HIGHSTAT Investigative D0B4JO DRUG__ID D0B4JO D0B4JO DRUGINCH 1S/C71H99N21O19S2/c1-8-34(4)57(82-37(7)94)69(109)90-52-31-113-112-30-51(67(107)92-58(36(6)93)70(110)111)89-61(101)45(18-13-21-76-71(73)74)83-64(104)49(24-40-28-75-32-80-40)85-59(99)35(5)81-54(96)29-79-60(100)47(22-38-26-77-43-16-11-9-14-41(38)43)86-65(105)50(25-55(97)98)87-62(102)46(19-20-53(72)95)84-63(103)48(88-68(108)56(33(2)3)91-66(52)106)23-39-27-78-44-17-12-10-15-42(39)44/h9-12,14-17,26-28,32-36,45-52,56-58,77-78,93H,8,13,18-25,29-31H2,1-7H3,(H2,72,95)(H,75,80)(H,79,100)(H,81,96)(H,82,94)(H,83,104)(H,84,103)(H,85,99)(H,86,105)(H,87,102)(H,88,108)(H,89,101)(H,90,109)(H,91,106)(H,92,107)(H,97,98)(H,110,111)(H4,73,74,76)/t34-,35-,36+,45-,46-,47-,48+,49+,50+,51-,52-,56-,57-,58-/m0/s1 D0B4JO DRUGINKE XVHYFABBPDIZAN-DRXBSEAFSA-N D0B4JO DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CNC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D0B4JO HIGHSTAT Investigative D0B4OL DRUG__ID D0B4OL D0B4OL DRUGINCH 1S/C84H119N25O21S/c1-46(111)97-60(37-48-23-25-51(112)26-24-48)77(125)99-55(19-10-31-92-83(87)88)72(120)102-58(29-35-131-2)76(124)101-57(27-28-68(114)115)75(123)107-63(39-50-42-91-45-96-50)79(127)105-61(36-47-14-4-3-5-15-47)78(126)100-56(20-11-32-93-84(89)90)74(122)106-62(38-49-41-94-53-17-7-6-16-52(49)53)71(119)95-43-67(113)98-64(44-110)81(129)109-34-13-22-66(109)82(130)108-33-12-21-65(108)80(128)103-54(18-8-9-30-85)73(121)104-59(70(86)118)40-69(116)117/h3-7,14-17,23-26,41-42,45,54-66,94,110,112H,8-13,18-22,27-40,43-44,85H2,1-2H3,(H2,86,118)(H,91,96)(H,95,119)(H,97,111)(H,98,113)(H,99,125)(H,100,126)(H,101,124)(H,102,120)(H,103,128)(H,104,121)(H,105,127)(H,106,122)(H,107,123)(H,114,115)(H,116,117)(H4,87,88,92)(H4,89,90,93)/t54-,55-,56-,57-,58-,59-,60-,61+,62-,63-,64-,65-,66-/m0/s1 D0B4OL DRUGINKE XDLJELQQEILLFZ-URRWLXDFSA-N D0B4OL DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NCC(=O)NC(CO)C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)N D0B4OL HIGHSTAT Investigative D0B4PI DRUG__ID D0B4PI D0B4PI DRUGINCH 1S/C57H78N14O11S2/c1-32(36-21-20-35-14-7-8-15-37(35)28-36)46-54(81)64-29-45(74)65-43(30-72)52(79)68-42(27-33-12-5-4-6-13-33)51(78)69-44(53(80)67-41(16-9-10-24-58)50(77)66-40(48(60)75)17-11-25-63-56(61)62)31-83-84-57(2,3)47(55(82)70-46)71-49(76)39(59)26-34-18-22-38(73)23-19-34/h4-8,12-15,18-23,28,32,39-44,46-47,72-73H,9-11,16-17,24-27,29-31,58-59H2,1-3H3,(H2,60,75)(H,64,81)(H,65,74)(H,66,77)(H,67,80)(H,68,79)(H,69,78)(H,70,82)(H,71,76)(H4,61,62,63)/t32-,39+,40+,41+,42-,43+,44-,46-,47+/m1/s1 D0B4PI DRUGINKE HWTDVIKHJPOWJP-JDMNTRJUSA-N D0B4PI DRUGSMIL CC(C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC(C(C(=O)N1)NC(=O)C(CC2=CC=C(C=C2)O)N)(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC3=CC=CC=C3)CO)C4=CC5=CC=CC=C5C=C4 D0B4PI HIGHSTAT Investigative D0B4VV DRUG__ID D0B4VV D0B4VV DRUGINCH 1S/C26H29NO2/c1-4-25(20-10-14-23(28)15-11-20)26(21-8-6-5-7-9-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25- D0B4VV DRUGINKE DODQJNMQWMSYGS-QPLCGJKRSA-N D0B4VV DRUGSMIL CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=C(C=C3)O D0B4VV HIGHSTAT Investigative D0B4WW DRUG__ID D0B4WW D0B4WW DRUGINCH 1S/C156H236N42O46/c1-16-81(10)126(153(242)175-84(13)131(220)185-110(65-90-68-167-95-37-24-23-36-93(90)95)144(233)187-106(61-78(4)5)145(234)195-124(79(6)7)151(240)184-97(38-25-28-56-157)134(223)170-72-118(208)176-96(41-31-59-166-156(162)163)133(222)168-70-115(161)205)197-146(235)108(62-87-32-19-17-20-33-87)189-141(230)104(50-55-122(214)215)181-137(226)98(39-26-29-57-158)178-130(219)83(12)173-129(218)82(11)174-136(225)101(46-51-114(160)204)180-138(227)99-40-27-30-58-165-116(206)52-47-102(140(229)188-107(64-89-42-44-92(203)45-43-89)143(232)186-105(60-77(2)3)142(231)182-103(139(228)179-99)49-54-121(212)213)183-149(238)112(74-199)192-152(241)125(80(8)9)196-148(237)111(67-123(216)217)190-150(239)113(75-200)193-155(244)128(86(15)202)198-147(236)109(63-88-34-21-18-22-35-88)191-154(243)127(85(14)201)194-119(209)73-171-135(224)100(48-53-120(210)211)177-117(207)71-169-132(221)94(159)66-91-69-164-76-172-91/h17-24,32-37,42-45,68-69,76-86,94,96-113,124-128,167,199-203H,16,25-31,38-41,46-67,70-75,157-159H2,1-15H3,(H2,160,204)(H2,161,205)(H,164,172)(H,165,206)(H,168,222)(H,169,221)(H,170,223)(H,171,224)(H,173,218)(H,174,225)(H,175,242)(H,176,208)(H,177,207)(H,178,219)(H,179,228)(H,180,227)(H,181,226)(H,182,231)(H,183,238)(H,184,240)(H,185,220)(H,186,232)(H,187,233)(H,188,229)(H,189,230)(H,190,239)(H,191,243)(H,192,241)(H,193,244)(H,194,209)(H,195,234)(H,196,237)(H,197,235)(H,198,236)(H,210,211)(H,212,213)(H,214,215)(H,216,217)(H4,162,163,166)/t81-,82-,83-,84-,85+,86+,94-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,124-,125-,126-,127-,128-/m0/s1 D0B4WW DRUGINKE GOARADSSYIPKJH-IJFSHCFJSA-N D0B4WW DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C4CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CCC(=O)O)CC(C)C)CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D0B4WW HIGHSTAT Investigative D0B6LL DRUG__ID D0B6LL D0B6LL DRUGINCH 1S/C79H102ClN17O15/c1-45(2)36-60(69(101)89-59(17-10-11-34-84-46(3)4)77(109)97-35-13-18-67(97)76(108)85-47(5)68(81)100)90-71(103)63(39-50-22-29-57(30-23-50)87-78(82)110)92-73(105)64(40-51-24-31-58(32-25-51)88-79(111)96-112-7)94-75(107)66(44-98)95-74(106)65(42-53-14-12-33-83-43-53)93-72(104)62(38-49-20-27-56(80)28-21-49)91-70(102)61(86-48(6)99)41-52-19-26-54-15-8-9-16-55(54)37-52/h8-9,12,14-16,19-33,37,43,45-47,59-67,84,98H,10-11,13,17-18,34-36,38-42,44H2,1-7H3,(H2,81,100)(H,85,108)(H,86,99)(H,89,101)(H,90,103)(H,91,102)(H,92,105)(H,93,104)(H,94,107)(H,95,106)(H3,82,87,110)(H2,88,96,111)/t47-,59+,60+,61-,62-,63-,64+,65-,66+,67+/m1/s1 D0B6LL DRUGINKE UXIBYNMMLXYZBN-PQAUVRRKSA-N D0B6LL DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)NOC)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0B6LL HIGHSTAT Investigative D0B8HD DRUG__ID D0B8HD D0B8HD DRUGINCH 1S/C60H81N11O15/c1-33(2)48(67-54(79)42(31-47(74)75)65-58(83)50(36(6)72)69-56(81)45-25-17-27-71(45)59(84)49(34(3)4)68-52(77)40(61)28-37-18-10-7-11-19-37)57(82)62-32-46(73)70-26-16-24-44(70)55(80)64-41(29-38-20-12-8-13-21-38)53(78)63-35(5)51(76)66-43(60(85)86)30-39-22-14-9-15-23-39/h7-15,18-23,33-36,40-45,48-50,72H,16-17,24-32,61H2,1-6H3,(H,62,82)(H,63,78)(H,64,80)(H,65,83)(H,66,76)(H,67,79)(H,68,77)(H,69,81)(H,74,75)(H,85,86)/t35-,36+,40-,41-,42-,43-,44-,45-,48-,49-,50-/m0/s1 D0B8HD DRUGINKE COFTYEBEOOYCDC-KTHKGSMISA-N D0B8HD DRUGSMIL CC(C)C(C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C4CCCN4C(=O)C(C(C)C)NC(=O)C(CC5=CC=CC=C5)N D0B8HD HIGHSTAT Investigative D0BE3D DRUG__ID D0BE3D D0BE3D DRUGINCH 1S/C74H97N15O15S2/c1-41(2)78-36-48-24-22-46(23-25-48)33-57-70(100)88-62(42(3)91)73(103)85-58(34-47-26-28-50(93)29-27-47)71(101)89-63(43(4)92)74(104)86-60(38-90)72(102)87-61(64(77)94)40-106-105-39-52(76)65(95)80-54(21-13-14-30-75)66(96)81-55(31-44-15-7-5-8-16-44)67(97)82-56(32-45-17-9-6-10-18-45)68(98)84-59(69(99)83-57)35-49-37-79-53-20-12-11-19-51(49)53/h5-12,15-20,22-29,37,41-43,52,54-63,78-79,90-93H,13-14,21,30-36,38-40,75-76H2,1-4H3,(H2,77,94)(H,80,95)(H,81,96)(H,82,97)(H,83,99)(H,84,98)(H,85,103)(H,86,104)(H,87,102)(H,88,100)(H,89,101)/t42-,43-,52-,54-,55-,56+,57+,58+,59+,60+,61+,62-,63-/m1/s1 D0BE3D DRUGINKE CLYXKNIFFVWQGI-HXVVHKOFSA-N D0BE3D DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)N)CO)C(C)O)CC7=CC=C(C=C7)O)C(C)O D0BE3D HIGHSTAT Investigative D0BH3Y DRUG__ID D0BH3Y D0BH3Y DRUGINCH 1S/C82H136N30O22/c1-43(2)35-56(74(128)107-54(27-18-34-96-82(92)93)72(126)110-58(38-61(87)116)75(129)108-55(79(133)134)28-29-60(86)115)109-71(125)50(23-12-14-30-83)105-70(124)53(26-17-33-95-81(90)91)104-67(121)45(4)101-77(131)59(42-113)111-73(127)51(24-13-15-31-84)106-69(123)52(25-16-32-94-80(88)89)103-66(120)44(3)100-63(118)41-99-78(132)65(46(5)114)112-76(130)57(37-48-21-10-7-11-22-48)102-64(119)40-97-62(117)39-98-68(122)49(85)36-47-19-8-6-9-20-47/h6-11,19-22,43-46,49-59,65,113-114H,12-18,23-42,83-85H2,1-5H3,(H2,86,115)(H2,87,116)(H,97,117)(H,98,122)(H,99,132)(H,100,118)(H,101,131)(H,102,119)(H,103,120)(H,104,121)(H,105,124)(H,106,123)(H,107,128)(H,108,129)(H,109,125)(H,110,126)(H,111,127)(H,112,130)(H,133,134)(H4,88,89,94)(H4,90,91,95)(H4,92,93,96)/t44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,65-/m0/s1 D0BH3Y DRUGINKE YWJIJXCRNQLPGY-VUXBHJHDSA-N D0BH3Y DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0BH3Y HIGHSTAT Investigative D0BI4H DRUG__ID D0BI4H D0BI4H DRUGINCH 1S/C3H7NO3/c1-2(4-7)3(5)6/h2,4,7H,1H3,(H,5,6)/t2-/m0/s1 D0BI4H DRUGINKE AWOUERYHOVSIAI-REOHCLBHSA-N D0BI4H DRUGSMIL CC(C(=O)O)NO D0BI4H HIGHSTAT Investigative D0BL8S DRUG__ID D0BL8S D0BL8S DRUGINCH 1S/C153H230N40O49/c1-16-78(10)123(150(240)170-81(13)128(218)179-106(61-87-64-162-92-35-24-23-34-90(87)92)140(230)181-102(57-75(4)5)141(231)190-121(76(6)7)148(238)178-94(36-25-27-53-154)131(221)164-67-113(202)171-93(38-29-55-161-153(158)159)130(220)166-69-120(214)215)192-142(232)104(58-84-30-19-17-20-31-84)182-137(227)100(47-52-118(210)211)175-134(224)95(37-26-28-54-155)173-127(217)80(12)168-126(216)79(11)169-133(223)97(43-48-111(157)200)174-135(225)98(45-50-116(206)207)176-136(226)99(46-51-117(208)209)177-138(228)101(56-74(2)3)180-139(229)103(60-86-39-41-89(199)42-40-86)183-145(235)108(70-194)186-147(237)110(72-196)187-149(239)122(77(8)9)191-144(234)107(63-119(212)213)184-146(236)109(71-195)188-152(242)125(83(15)198)193-143(233)105(59-85-32-21-18-22-33-85)185-151(241)124(82(14)197)189-114(203)68-165-132(222)96(44-49-115(204)205)172-112(201)66-163-129(219)91(156)62-88-65-160-73-167-88/h17-24,30-35,39-42,64-65,73-83,91,93-110,121-125,162,194-199H,16,25-29,36-38,43-63,66-72,154-156H2,1-15H3,(H2,157,200)(H,160,167)(H,163,219)(H,164,221)(H,165,222)(H,166,220)(H,168,216)(H,169,223)(H,170,240)(H,171,202)(H,172,201)(H,173,217)(H,174,225)(H,175,224)(H,176,226)(H,177,228)(H,178,238)(H,179,218)(H,180,229)(H,181,230)(H,182,227)(H,183,235)(H,184,236)(H,185,241)(H,186,237)(H,187,239)(H,188,242)(H,189,203)(H,190,231)(H,191,234)(H,192,232)(H,193,233)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H,212,213)(H,214,215)(H4,158,159,161)/t78-,79-,80-,81-,82+,83+,91-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,121-,122-,123-,124-,125-/m0/s1 D0BL8S DRUGINKE PDPPZBIGLPYQFY-KYYFCHEUSA-N D0BL8S DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N D0BL8S HIGHSTAT Investigative D0BP1S DRUG__ID D0BP1S D0BP1S DRUGINCH 1S/C64H93N11O17S/c1-7-9-26-41(56(84)69-45(33-50(81)82)60(88)72-52(35(3)4)55(65)83)68-61(89)47-27-19-30-75(47)64(92)46(34-93)71-58(86)43(31-38-20-13-10-14-21-38)70-62(90)53(36(5)8-2)73-63(91)54(51(39-22-15-11-16-23-39)40-24-17-12-18-25-40)74-57(85)42(28-29-48(77)78)67-59(87)44(32-49(79)80)66-37(6)76/h11-12,15-18,22-25,35-36,38,41-47,51-54,93H,7-10,13-14,19-21,26-34H2,1-6H3,(H2,65,83)(H,66,76)(H,67,87)(H,68,89)(H,69,84)(H,70,90)(H,71,86)(H,72,88)(H,73,91)(H,74,85)(H,77,78)(H,79,80)(H,81,82)/t36?,41?,42-,43-,44-,45-,46-,47+,52-,53-,54-/m0/s1 D0BP1S DRUGINKE BZVYIEQNRWILPS-CPLDFCFASA-N D0BP1S DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)N)NC(=O)C1CCCN1C(=O)C(CS)NC(=O)C(CC2CCCCC2)NC(=O)C(C(C)CC)NC(=O)C(C(C3=CC=CC=C3)C4=CC=CC=C4)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0BP1S HIGHSTAT Investigative D0BW2C DRUG__ID D0BW2C D0BW2C DRUGINCH 1S/C44H57N9O5/c1-30(50-43(57)39(23-32-14-6-3-7-15-32)52-41(55)20-19-34-26-46-29-49-34)42(56)53-40(24-33-25-48-38-18-9-8-17-37(33)38)44(58)51-36(22-31-12-4-2-5-13-31)27-47-35(28-54)16-10-11-21-45/h2-9,12-15,17-18,25-26,29-30,35-36,39-40,47-48,54H,10-11,16,19-24,27-28,45H2,1H3,(H,46,49)(H,50,57)(H,51,58)(H,52,55)(H,53,56)/t30-,35-,36+,39+,40-/m0/s1 D0BW2C DRUGINKE JSMAHBKHVYKVJD-CIUDAOKXSA-N D0BW2C DRUGSMIL CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CC=CC=C3)CNC(CCCCN)CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)CCC5=CN=CN5 D0BW2C HIGHSTAT Investigative D0C1US DRUG__ID D0C1US D0C1US DRUGINCH 1S/C87H134N28O22/c1-46(2)36-61(79(130)112-63(39-52-41-99-55-25-13-12-24-53(52)55)80(131)113-64(40-67(92)119)81(132)110-60(85(136)137)30-31-66(91)118)111-77(128)56(26-14-16-32-88)108-76(127)59(29-19-35-98-87(95)96)107-73(124)48(4)104-83(134)65(45-116)114-78(129)57(27-15-17-33-89)109-75(126)58(28-18-34-97-86(93)94)106-72(123)47(3)103-69(121)44-102-84(135)71(49(5)117)115-82(133)62(38-51-22-10-7-11-23-51)105-70(122)43-100-68(120)42-101-74(125)54(90)37-50-20-8-6-9-21-50/h6-13,20-25,41,46-49,54,56-65,71,99,116-117H,14-19,26-40,42-45,88-90H2,1-5H3,(H2,91,118)(H2,92,119)(H,100,120)(H,101,125)(H,102,135)(H,103,121)(H,104,134)(H,105,122)(H,106,123)(H,107,124)(H,108,127)(H,109,126)(H,110,132)(H,111,128)(H,112,130)(H,113,131)(H,114,129)(H,115,133)(H,136,137)(H4,93,94,97)(H4,95,96,98)/t47-,48-,49+,54-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,71-/m0/s1 D0C1US DRUGINKE IXCVHRQJQPARCV-PBUARHPHSA-N D0C1US DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=CC=C4)N D0C1US HIGHSTAT Investigative D0C2JJ DRUG__ID D0C2JJ D0C2JJ DRUGINCH 1S/C83H105ClN18O17/c1-46(2)36-61(73(108)92-60(17-10-11-34-87-47(3)4)81(116)102-35-13-18-69(102)80(115)88-48(5)71(85)106)93-75(110)64(39-52-24-31-59(32-25-52)91-83(118)101-119-7)95-77(112)65(40-51-22-29-58(30-23-51)90-72(107)67-43-70(105)100-82(117)99-67)97-79(114)68(45-103)98-78(113)66(42-54-14-12-33-86-44-54)96-76(111)63(38-50-20-27-57(84)28-21-50)94-74(109)62(89-49(6)104)41-53-19-26-55-15-8-9-16-56(55)37-53/h8-9,12,14-16,19-33,37,44,46-48,60-69,87,103H,10-11,13,17-18,34-36,38-43,45H2,1-7H3,(H2,85,106)(H,88,115)(H,89,104)(H,90,107)(H,92,108)(H,93,110)(H,94,109)(H,95,112)(H,96,111)(H,97,114)(H,98,113)(H2,91,101,118)(H2,99,100,105,117)/t48-,60+,61+,62-,63-,64-,65+,66-,67+,68+,69+/m1/s1 D0C2JJ DRUGINKE GSLYUOBUEBSTPA-BWBLBVTNSA-N D0C2JJ DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)NOC)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C D0C2JJ HIGHSTAT Investigative D0C3KW DRUG__ID D0C3KW D0C3KW DRUGINCH 1S/C49H69N13O12S/c50-16-6-5-11-31(51)42(68)56-32(12-7-17-54-49(52)53)46(72)60-18-8-14-36(60)48(74)61-23-30(64)21-37(61)44(70)55-22-39(65)59-41(29-19-27-9-1-2-10-28(27)20-29)45(71)57-33(25-63)43(69)58-34-26-75-38-15-4-3-13-35(38)62(47(34)73)24-40(66)67/h1-4,9-10,13,15,29-34,36-37,41,63-64H,5-8,11-12,14,16-26,50-51H2,(H,55,70)(H,56,68)(H,57,71)(H,58,69)(H,59,65)(H,66,67)(H4,52,53,54)/t30?,31?,32-,33+,34-,36+,37+,41?/m1/s1 D0C3KW DRUGINKE DSKXSKYPLRUWNI-XISDYZNSSA-N D0C3KW DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(C3CC4=CC=CC=C4C3)C(=O)NC(CO)C(=O)NC5CSC6=CC=CC=C6N(C5=O)CC(=O)O)O D0C3KW HIGHSTAT Investigative D0C3OY DRUG__ID D0C3OY D0C3OY DRUGINCH 1S/C79H109N19O12/c1-46(2)38-59(68(83)100)91-70(102)60(39-47(3)4)92-73(105)64(43-51-45-88-56-28-14-12-25-53(51)56)95-72(104)61(40-48-20-7-5-8-21-48)93-74(106)63(42-50-44-87-55-27-13-11-24-52(50)55)94-69(101)57(32-33-67(82)99)89-71(103)62(41-49-22-9-6-10-23-49)96-76(108)66-31-19-37-98(66)78(110)58(29-15-16-34-80)90-75(107)65-30-18-36-97(65)77(109)54(81)26-17-35-86-79(84)85/h5-14,20-25,27-28,44-47,54,57-66,87-88H,15-19,26,29-43,80-81H2,1-4H3,(H2,82,99)(H2,83,100)(H,89,103)(H,90,107)(H,91,102)(H,92,105)(H,93,106)(H,94,101)(H,95,104)(H,96,108)(H4,84,85,86)/t54-,57+,58+,59+,60+,61+,62-,63-,64-,65+,66+/m1/s1 D0C3OY DRUGINKE XVOCEQLNJQGCQG-ACRSGXKRSA-N D0C3OY DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)C8CCCN8C(=O)C(CCCN=C(N)N)N D0C3OY HIGHSTAT Investigative D0C4QB DRUG__ID D0C4QB D0C4QB DRUGINCH 1S/C9H11NO3S/c10-8-3-6-1-2-9(14(11,12)13)5-7(6)4-8/h1-2,5,8H,3-4,10H2,(H,11,12,13) D0C4QB DRUGINKE NVRZETXANFNFEF-UHFFFAOYSA-N D0C4QB DRUGSMIL C1C(CC2=C1C=CC(=C2)S(=O)(=O)O)N D0C4QB HIGHSTAT Investigative D0C5RH DRUG__ID D0C5RH D0C5RH DRUGINCH 1S/C62H79N13O14S2/c1-34(76)51-60(86)72-46(28-38-20-10-5-11-21-38)59(85)75-52(35(2)77)61(87)73-49(62(88)89)33-91-90-32-41(64)53(79)68-48(30-50(65)78)58(84)70-44(26-36-16-6-3-7-17-36)55(81)69-45(27-37-18-8-4-9-19-37)56(82)71-47(29-39-31-66-42-23-13-12-22-40(39)42)57(83)67-43(54(80)74-51)24-14-15-25-63/h3-13,16-23,31,34-35,41,43-49,51-52,66,76-77H,14-15,24-30,32-33,63-64H2,1-2H3,(H2,65,78)(H,67,83)(H,68,79)(H,69,81)(H,70,84)(H,71,82)(H,72,86)(H,73,87)(H,74,80)(H,75,85)(H,88,89)/t34-,35-,41-,43+,44-,45+,46+,47+,48+,49+,51-,52-/m1/s1 D0C5RH DRUGINKE AQDRYTXOCJPYQG-WJYXJFIFSA-N D0C5RH DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)N)C(=O)O)C(C)O)CC6=CC=CC=C6)O D0C5RH HIGHSTAT Investigative D0C6RQ DRUG__ID D0C6RQ D0C6RQ DRUGINCH 1S/C55H63F6N9O8/c1-31(2)21-43(50(75)68-45(26-36-28-63-42-14-9-8-13-40(36)42)52(77)69(4)30-35-22-37(54(56,57)58)27-38(23-35)55(59,60)61)67-51(76)46-15-10-20-70(46)53(78)44(25-33-11-6-5-7-12-33)66-47(72)29-64-48(73)32(3)65-49(74)41(62)24-34-16-18-39(71)19-17-34/h5-9,11-14,16-19,22-23,27-28,31-32,41,43-46,63,71H,10,15,20-21,24-26,29-30,62H2,1-4H3,(H,64,73)(H,65,74)(H,66,72)(H,67,76)(H,68,75)/t32-,41+,43+,44+,45+,46+/m1/s1 D0C6RQ DRUGINKE IRIFESWSRQBRPW-CKWXOEDFSA-N D0C6RQ DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N(C)CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)NC(=O)C4CCCN4C(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D0C6RQ HIGHSTAT Investigative D0C7VI DRUG__ID D0C7VI D0C7VI DRUGINCH 1S/C83H115N25O21S2/c1-44(110)95-57(34-46-22-24-49(111)25-23-46)73(121)96-54(19-10-30-92-83(88)89)71(119)105-62-41-130-131-42-63(78(126)104-61(40-109)80(128)108-32-12-21-65(108)81(129)107-31-11-20-64(107)79(127)99-52(17-7-8-28-84)69(117)100-56(68(85)116)37-67(114)115)106-75(123)59(35-47-38-93-51-16-6-5-15-50(47)51)102-70(118)53(18-9-29-91-82(86)87)97-74(122)58(33-45-13-3-2-4-14-45)101-76(124)60(36-48-39-90-43-94-48)103-72(120)55(98-77(62)125)26-27-66(112)113/h2-6,13-16,22-25,38-39,43,52-65,93,109,111H,7-12,17-21,26-37,40-42,84H2,1H3,(H2,85,116)(H,90,94)(H,95,110)(H,96,121)(H,97,122)(H,98,125)(H,99,127)(H,100,117)(H,101,124)(H,102,118)(H,103,120)(H,104,126)(H,105,119)(H,106,123)(H,112,113)(H,114,115)(H4,86,87,91)(H4,88,89,92)/t52-,53-,54-,55+,56-,57-,58-,59+,60-,61-,62+,63+,64-,65-/m0/s1 D0C7VI DRUGINKE PPKIGEMCDOLKEY-AURDXFKRSA-N D0C7VI DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CNC=N3)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)NC(CO)C(=O)N7CCCC7C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)N D0C7VI HIGHSTAT Investigative D0C8XX DRUG__ID D0C8XX D0C8XX DRUGINCH 1S/C60H71N11O17S2/c1-4-29(2)48-55(82)70-49(30(3)72)56(83)66-41(26-46(62)76)53(80)67-42(27-90-89-22-19-47(77)68-50(57(84)69-48)31-9-12-33(73)13-10-31)58(85)71-21-6-8-43(71)54(81)65-40(52(79)64-28-61)7-5-20-63-51(78)32-11-16-36-39(23-32)60(88-59(36)86)37-17-14-34(74)24-44(37)87-45-25-35(75)15-18-38(45)60/h9-18,23-25,29-30,40-43,48-50,72-75H,4-8,19-22,26-28,61H2,1-3H3,(H2,62,76)(H,63,78)(H,64,79)(H,65,81)(H,66,83)(H,67,80)(H,68,77)(H,69,84)(H,70,82)/t29?,30?,40-,41+,42+,43+,48+,49+,50-/m0/s1 D0C8XX DRUGINKE JFIITURTLJMTOM-OPCZXTJTSA-N D0C8XX DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)C(C)O D0C8XX HIGHSTAT Investigative D0C9QV DRUG__ID D0C9QV D0C9QV DRUGINCH 1S/C80H131N27O22/c1-42(2)34-55(73(123)95-44(4)66(116)103-57(37-60(85)111)74(124)102-54(78(128)129)28-29-59(84)110)104-71(121)50(24-14-16-30-81)100-69(119)52(26-18-32-90-79(86)87)98-65(115)43(3)96-76(126)58(41-108)105-72(122)51(25-15-17-31-82)101-70(120)53(27-19-33-91-80(88)89)99-67(117)45(5)107(7)63(114)40-94-77(127)64(46(6)109)106-75(125)56(36-48-22-12-9-13-23-48)97-62(113)39-92-61(112)38-93-68(118)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,108-109H,14-19,24-41,81-83H2,1-7H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,118)(H,94,127)(H,95,123)(H,96,126)(H,97,113)(H,98,115)(H,99,117)(H,100,119)(H,101,120)(H,102,124)(H,103,116)(H,104,121)(H,105,122)(H,106,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0C9QV DRUGINKE AZDMRQCLZWWKEK-FKPOJLNCSA-N D0C9QV DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)N(C)C(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0C9QV HIGHSTAT Investigative D0C9XB DRUG__ID D0C9XB D0C9XB DRUGINCH 1S/C50H67N11O11S2/c1-26(62)39(42(53)65)59-49(72)41-50(3,4)74-73-25-37(58-47(70)38(52)29-12-6-5-7-13-29)46(69)56-35(22-28-17-19-31(64)20-18-28)44(67)57-36(23-30-24-54-33-15-9-8-14-32(30)33)45(68)55-34(16-10-11-21-51)43(66)60-40(27(2)63)48(71)61-41/h5-9,12-15,17-20,24,26-27,34-41,54,62-64H,10-11,16,21-23,25,51-52H2,1-4H3,(H2,53,65)(H,55,68)(H,56,69)(H,57,67)(H,58,70)(H,59,72)(H,60,66)(H,61,71)/t26-,27-,34+,35+,36-,37+,38-,39+,40-,41+/m1/s1 D0C9XB DRUGINKE MAYLVNQSAJCEEF-XGMLMNQMSA-N D0C9XB DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(C5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0C9XB HIGHSTAT Investigative D0CC1P DRUG__ID D0CC1P D0CC1P DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)40-64-73(100)89-66(47(4)93)74(101)84-60(38-50-23-13-8-14-24-50)71(98)88-65(46(3)92)75(102)86-62(42-91)72(99)87-63(77(104)105)44-107-106-43-56(79)67(94)81-57(27-17-18-34-78)68(95)82-58(36-48-19-9-6-10-20-48)69(96)83-59(37-49-21-11-7-12-22-49)70(97)85-61(76(103)90(64)5)39-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,80,91-93H,17-18,27,34,36-44,78-79H2,1-5H3,(H,81,94)(H,82,95)(H,83,96)(H,84,101)(H,85,97)(H,86,102)(H,87,99)(H,88,98)(H,89,100)(H,104,105)/t46-,47-,56-,57-,58-,59+,60+,61+,62+,63+,64+,65-,66-/m1/s1 D0CC1P DRUGINKE JNLTXZJTSBQWNR-PCKPOTSRSA-N D0CC1P DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D0CC1P HIGHSTAT Investigative D0CK0K DRUG__ID D0CK0K D0CK0K DRUGINCH 1S/C54H71N15O9/c1-3-4-15-40(63-31(2)70)48(73)69-45-27-46(71)59-21-10-9-17-39(47(55)72)64-51(76)43(25-35-28-61-38-16-8-7-14-37(35)38)67-49(74)41(18-11-22-60-54(56)57)65-50(75)42(24-32-19-20-33-12-5-6-13-34(33)23-32)66-52(77)44(68-53(45)78)26-36-29-58-30-62-36/h5-8,12-14,16,19-20,23,28-30,39-45,61H,3-4,9-11,15,17-18,21-22,24-27H2,1-2H3,(H2,55,72)(H,58,62)(H,59,71)(H,63,70)(H,64,76)(H,65,75)(H,66,77)(H,67,74)(H,68,78)(H,69,73)(H4,56,57,60)/t39-,40+,41+,42-,43-,44?,45+/m0/s1 D0CK0K DRUGINKE GGYWLZFXFKFWKL-ZCMLEEDBSA-N D0CK0K DRUGSMIL CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC4=CC=CC=C4C=C3)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N)NC(=O)C D0CK0K HIGHSTAT Investigative D0CM3O DRUG__ID D0CM3O D0CM3O DRUGINCH 1S/2CN.Au/c2*1-2;/q2*-1;+1 D0CM3O DRUGINKE QGIPNVHDSSGMAA-UHFFFAOYSA-N D0CM3O DRUGSMIL [C-]#N.[C-]#N.[Au+] D0CM3O HIGHSTAT Investigative D0CV4F DRUG__ID D0CV4F D0CV4F DRUGINCH 1S/C98H142N22O35S/c1-8-52(4)81(95(151)120-41-15-20-71(120)93(149)112-60(32-37-78(132)133)85(141)109-59(31-36-77(130)131)86(142)115-66(44-54-21-25-56(123)26-22-54)90(146)114-64(42-51(2)3)88(144)113-63(96(152)153)29-34-72(99)124)117-87(143)61(33-38-79(134)135)110-84(140)58(30-35-76(128)129)111-89(145)65(43-53-16-10-9-11-17-53)116-91(147)67(45-80(136)137)106-73(125)46-103-82(138)68(49-121)107-74(126)47-104-83(139)69(50-122)108-75(127)48-105-92(148)70-19-12-13-40-119(70)94(150)62(18-14-39-102-97(100)101)118-156(154,155)57-27-23-55(24-28-57)98(5,6)7/h9-11,16-17,21-28,51-52,58-71,81,118,121-123H,8,12-15,18-20,29-50H2,1-7H3,(H2,99,124)(H,103,138)(H,104,139)(H,105,148)(H,106,125)(H,107,126)(H,108,127)(H,109,141)(H,110,140)(H,111,145)(H,112,149)(H,113,144)(H,114,146)(H,115,142)(H,116,147)(H,117,143)(H,128,129)(H,130,131)(H,132,133)(H,134,135)(H,136,137)(H,152,153)(H4,100,101,102)/t52-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70+,71-,81-/m0/s1 D0CV4F DRUGINKE UHXXZAFTLUMNIB-KZKSJJABSA-N D0CV4F DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D0CV4F HIGHSTAT Investigative D0CX0I DRUG__ID D0CX0I D0CX0I DRUGINCH 1S/C75H117N23O14/c1-7-43(4)62(71(111)95-54(22-15-33-87-75(83)84)72(112)98-34-16-23-58(98)70(110)92-51(64(78)104)19-11-12-30-76)97-67(107)53(21-14-32-86-74(81)82)93-66(106)52(20-13-31-85-73(79)80)94-68(108)55(35-42(2)3)96-69(109)57(38-46-17-9-8-10-18-46)91-61(102)41-88-60(101)40-89-65(105)56(39-47-24-26-49(99)27-25-47)90-59(100)29-28-50-44(5)36-48(63(77)103)37-45(50)6/h8-10,17-18,24-27,36-37,42-43,51-58,62,99H,7,11-16,19-23,28-35,38-41,76H2,1-6H3,(H2,77,103)(H2,78,104)(H,88,101)(H,89,105)(H,90,100)(H,91,102)(H,92,110)(H,93,106)(H,94,108)(H,95,111)(H,96,109)(H,97,107)(H4,79,80,85)(H4,81,82,86)(H4,83,84,87)/t43-,51-,52-,53-,54-,55-,56-,57-,58-,62-/m0/s1 D0CX0I DRUGINKE YPSMIMXFFGKHRC-DJQAJQEISA-N D0CX0I DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)NC(=O)CCC4=C(C=C(C=C4C)C(=O)N)C D0CX0I HIGHSTAT Investigative D0D3CG DRUG__ID D0D3CG D0D3CG DRUGINCH 1S/C138H199N35O30/c1-72(2)54-95(117(144)183)160-122(188)97(56-74(5)6)163-127(193)104(63-83-68-150-90-35-21-18-32-87(83)90)166-126(192)101(59-79-28-14-13-15-29-79)164-128(194)103(62-82-67-149-89-34-20-17-31-86(82)89)165-121(187)91(45-47-110(141)177)156-120(186)92(46-48-111(142)178)157-133(199)108-39-26-52-172(108)136(202)93(36-22-23-49-139)158-134(200)109-40-27-53-173(109)137(203)94(37-24-50-147-138(145)146)159-132(198)107-38-25-51-171(107)115(182)70-152-119(185)96(55-73(3)4)161-123(189)98(57-75(7)8)162-125(191)100(60-80-41-43-84(176)44-42-80)155-114(181)69-151-118(184)77(11)153-131(197)106(71-174)169-129(195)105(64-112(143)179)167-124(190)99(58-76(9)10)168-135(201)116(78(12)175)170-130(196)102(154-113(180)65-140)61-81-66-148-88-33-19-16-30-85(81)88/h13-21,28-35,41-44,66-68,72-78,91-109,116,148-150,174-176H,22-27,36-40,45-65,69-71,139-140H2,1-12H3,(H2,141,177)(H2,142,178)(H2,143,179)(H2,144,183)(H,151,184)(H,152,185)(H,153,197)(H,154,180)(H,155,181)(H,156,186)(H,157,199)(H,158,200)(H,159,198)(H,160,188)(H,161,189)(H,162,191)(H,163,193)(H,164,194)(H,165,187)(H,166,192)(H,167,190)(H,168,201)(H,169,195)(H,170,196)(H4,145,146,147)/t77-,78+,91-,92-,93-,94+,95-,96-,97-,98-,99-,100-,101-,102-,103+,104+,105-,106-,107-,108-,109-,116-/m0/s1 D0D3CG DRUGINKE LTAFNTKZCARRFJ-HPWFANMZSA-N D0D3CG DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C6CCCN6C(=O)C(CCCCN)NC(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C8CCCN8C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)CN D0D3CG HIGHSTAT Investigative D0D3VF DRUG__ID D0D3VF D0D3VF DRUGINCH 1S/C70H100FN21O18S2/c1-8-33(4)57(69(109)110-7)92-66(106)51(30-112)90-68(108)56(32(2)3)91-64(104)47(21-37-26-79-43-16-15-38(71)22-41(37)43)86-60(100)45(17-18-52(72)94)85-63(103)49(24-54(96)97)88-62(102)46(20-36-25-78-42-13-10-9-12-40(36)42)83-53(95)28-80-58(98)34(5)82-61(101)48(23-39-27-76-31-81-39)87-59(99)44(14-11-19-77-70(74)75)84-65(105)50(29-111)89-67(107)55(73)35(6)93/h9-10,12-13,15-16,22,25-27,31-35,44-51,55-57,78-79,93,111-112H,8,11,14,17-21,23-24,28-30,73H2,1-7H3,(H2,72,94)(H,76,81)(H,80,98)(H,82,101)(H,83,95)(H,84,105)(H,85,103)(H,86,100)(H,87,99)(H,88,102)(H,89,107)(H,90,108)(H,91,104)(H,92,106)(H,96,97)(H4,74,75,77)/t33?,34-,35+,44-,45-,46-,47-,48-,49-,50-,51-,55-,56-,57-/m0/s1 D0D3VF DRUGINKE LNBPPCFNDRANJB-IIMWSTDNSA-N D0D3VF DRUGSMIL CCC(C)C(C(=O)OC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)C(CC1=CNC2=C1C=C(C=C2)F)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CNC(=O)C(C)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCCN=C(N)N)NC(=O)C(CS)NC(=O)C(C(C)O)N D0D3VF HIGHSTAT Investigative D0D4QZ DRUG__ID D0D4QZ D0D4QZ DRUGINCH 1S/C84H134N30O29S/c1-41(67(127)111-66(42(2)115)82(142)143)99-78(138)56-18-10-27-112(56)62(120)39-97-70(130)45(14-4-6-23-85)103-74(134)50(31-43-36-92-40-98-43)107-79(139)57-19-12-29-114(57)80(140)53(32-58(88)116)108-68(128)44(87)13-8-26-94-84(91)110-61(119)38-96-77(137)55-17-11-28-113(55)81(141)54(35-65(125)126)109-76(136)52(34-64(123)124)106-73(133)49(22-30-144-3)100-59(117)21-20-48-72(132)104-47(15-5-7-24-86)71(131)102-46(16-9-25-93-83(89)90)69(129)95-37-60(118)101-51(33-63(121)122)75(135)105-48/h36,40-42,44-57,66,115H,4-35,37-39,85-87H2,1-3H3,(H2,88,116)(H,92,98)(H,95,129)(H,96,137)(H,97,130)(H,99,138)(H,100,117)(H,101,118)(H,102,131)(H,103,134)(H,104,132)(H,105,135)(H,106,133)(H,107,139)(H,108,128)(H,109,136)(H,111,127)(H,121,122)(H,123,124)(H,125,126)(H,142,143)(H4,89,90,93)(H3,91,94,110,119)/t41-,42+,44-,45-,46?,47?,48?,49?,50-,51?,52?,53-,54?,55?,56-,57-,66-/m0/s1 D0D4QZ DRUGINKE IJKGLSUZCFGUEG-ODPTYIPQSA-N D0D4QZ DRUGSMIL CC(C(C(=O)O)NC(=O)C(C)NC(=O)C1CCCN1C(=O)CNC(=O)C(CCCCN)NC(=O)C(CC2=CN=CN2)NC(=O)C3CCCN3C(=O)C(CC(=O)N)NC(=O)C(CCCN=C(N)NC(=O)CNC(=O)C4CCCN4C(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCSC)NC(=O)CCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N5)CC(=O)O)CCCN=C(N)N)CCCCN)N)O D0D4QZ HIGHSTAT Investigative D0D6MO DRUG__ID D0D6MO D0D6MO DRUGINCH 1S/C64H98N18O19S2/c1-34-52(89)73-42(21-24-48(68)84)58(95)79-45(30-36-14-5-3-6-15-36)60(97)76-41(20-13-29-71-64(69)70)56(93)74-39(18-9-11-27-65)54(91)77-43(22-25-49(85)86)57(94)75-40(19-10-12-28-66)55(92)78-44(23-26-50(87)88)59(96)82-51(35(2)83)62(99)80-46(31-37-16-7-4-8-17-37)61(98)81-47(63(100)101)33-103-102-32-38(67)53(90)72-34/h3-8,14-17,34-35,38-47,51,83H,9-13,18-33,65-67H2,1-2H3,(H2,68,84)(H,72,90)(H,73,89)(H,74,93)(H,75,94)(H,76,97)(H,77,91)(H,78,92)(H,79,95)(H,80,99)(H,81,98)(H,82,96)(H,85,86)(H,87,88)(H,100,101)(H4,69,70,71)/t34-,35-,38-,39-,40-,41+,42+,43+,44+,45-,46+,47+,51-/m1/s1 D0D6MO DRUGINKE IYWWTDYPQATACO-BDUUBTEFSA-N D0D6MO DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)N)C(=O)O)CC2=CC=CC=C2)C(C)O)CCC(=O)O)CCCCN)CCC(=O)O)CCCCN)CCCN=C(N)N)CC3=CC=CC=C3)CCC(=O)N D0D6MO HIGHSTAT Investigative D0D7KH DRUG__ID D0D7KH D0D7KH DRUGINCH 1S/C54H92N6O14/c1-14-42-54(10,67)47(63)36(6)58(11)29-32(2)27-52(8,66)49(34(4)46(35(5)50(65)72-42)73-44-28-53(9,69-13)48(64)37(7)71-44)74-51-45(62)41(26-33(3)70-51)59(12)30-38-21-23-39(24-22-38)40-31-60(57-55-40)25-19-17-15-16-18-20-43(61)56-68/h21-24,31-37,41-42,44-49,51,62-64,66-68H,14-20,25-30H2,1-13H3,(H,56,61)/t32-,33-,34+,35-,36-,37+,41+,42-,44+,45-,46+,47-,48+,49-,51+,52-,53-,54-/m1/s1 D0D7KH DRUGINKE YOTANXLDCGWPPQ-QASXAQIXSA-N D0D7KH DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O D0D7KH HIGHSTAT Investigative D0D7ZA DRUG__ID D0D7ZA D0D7ZA DRUGINCH 1S/C76H108N20O19/c1-4-5-18-51(88-72(111)59(40-98)94-70(109)55(90-64(103)49(78)39-97)33-44-23-25-47(99)26-24-44)66(105)89-53(27-28-62(101)102)68(107)93-58(35-46-37-81-41-85-46)71(110)91-56(32-43-15-7-6-8-16-43)69(108)87-52(21-13-30-82-76(79)80)67(106)92-57(34-45-36-83-50-19-10-9-17-48(45)50)65(104)84-38-61(100)86-54(20-11-12-29-77)74(113)96-31-14-22-60(96)73(112)95-63(42(2)3)75(114)115/h6-10,15-17,19,23-26,36-37,41-42,49,51-60,63,83,97-99H,4-5,11-14,18,20-22,27-35,38-40,77-78H2,1-3H3,(H,81,85)(H,84,104)(H,86,100)(H,87,108)(H,88,111)(H,89,105)(H,90,103)(H,91,110)(H,92,106)(H,93,107)(H,94,109)(H,95,112)(H,101,102)(H,114,115)(H4,79,80,82)/t49-,51-,52-,53-,54-,55-,56+,57-,58-,59-,60-,63-/m0/s1 D0D7ZA DRUGINKE RLJQBYDPIVYMOS-PVTUMTKLSA-N D0D7ZA DRUGSMIL CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)N D0D7ZA HIGHSTAT Investigative D0DD3F DRUG__ID D0DD3F D0DD3F DRUGINCH 1S/C102H169N23O23/c1-11-12-13-14-15-16-17-18-19-20-21-40-84(130)109-48-31-27-38-73(92(137)115-71(89(107)134)35-24-28-45-103)117-93(138)72(36-25-29-46-104)116-94(139)74(37-26-30-47-105)118-100(145)81-39-32-49-125(81)86(132)58-112-91(136)75(50-61(2)3)119-95(140)76(51-62(4)5)120-97(142)78(53-66-41-43-68(128)44-42-66)114-85(131)57-111-90(135)64(8)113-99(144)80(60-126)123-98(143)79(55-83(106)129)121-96(141)77(52-63(6)7)122-102(147)88(65(9)127)124-101(146)82(148-87(133)59-108-10)54-67-56-110-70-34-23-22-33-69(67)70/h22-23,33-34,41-44,56,61-65,71-82,88,108,110,126-128H,11-21,24-32,35-40,45-55,57-60,103-105H2,1-10H3,(H2,106,129)(H2,107,134)(H,109,130)(H,111,135)(H,112,136)(H,113,144)(H,114,131)(H,115,137)(H,116,139)(H,117,138)(H,118,145)(H,119,140)(H,120,142)(H,121,141)(H,122,147)(H,123,143)(H,124,146)/t64-,65+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,88-/m0/s1 D0DD3F DRUGINKE KPRCBTZIVGRZHY-OPDXRYIWSA-N D0DD3F DRUGSMIL CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D0DD3F HIGHSTAT Investigative D0DR3X DRUG__ID D0DR3X D0DR3X DRUGINCH 1S/C71H100N20O19S2/c1-8-34(4)56(81-37(7)93)68(107)88-51-31-112-111-30-50(66(105)90-57(36(6)92)70(109)110)87-61(100)45(18-13-23-76-71(73)74)82-63(102)48(25-40-28-75-32-79-40)84-59(98)35(5)80-53(95)29-78-60(99)47(24-39-27-77-44-17-12-11-16-42(39)44)85-64(103)49(26-54(96)97)86-62(101)46(21-22-52(72)94)83-69(108)58(43-20-19-38-14-9-10-15-41(38)43)91-67(106)55(33(2)3)89-65(51)104/h9-12,14-17,27-28,32-36,43,45-51,55-58,77,92H,8,13,18-26,29-31H2,1-7H3,(H2,72,94)(H,75,79)(H,78,99)(H,80,95)(H,81,93)(H,82,102)(H,83,108)(H,84,98)(H,85,103)(H,86,101)(H,87,100)(H,88,107)(H,89,104)(H,90,105)(H,91,106)(H,96,97)(H,109,110)(H4,73,74,76)/t34-,35-,36+,43?,45-,46-,47-,48+,49+,50-,51-,55-,56-,57-,58-/m0/s1 D0DR3X DRUGINKE HDGDWRFDJRCNRO-FUQOBRPNSA-N D0DR3X DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C2CCC3=CC=CC=C23)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D0DR3X HIGHSTAT Investigative D0E3RQ DRUG__ID D0E3RQ D0E3RQ DRUGINCH 1S/C100H144N28O25/c1-5-56(2)85(127-93(148)72(21-14-42-110-100(106)107)121-94(149)74(46-61-25-33-65(132)34-26-61)125-95(150)75(47-62-27-35-66(133)36-28-62)124-92(147)71(118-58(4)130)20-13-41-109-99(104)105)97(152)122-70(19-9-11-39-101)89(144)114-51-81(137)112-50-80(136)113-53-83(139)119-69(86(103)141)18-10-12-40-108-79(135)49-111-82(138)52-115-91(146)77(55-129)126-96(151)78-22-15-43-128(78)98(153)76(48-63-29-37-67(134)38-30-63)120-84(140)54-116-90(145)73(45-59-16-7-6-8-17-59)123-87(142)57(3)117-88(143)68(102)44-60-23-31-64(131)32-24-60/h6-8,16-17,23-38,56-57,68-78,85,129,131-134H,5,9-15,18-22,39-55,101-102H2,1-4H3,(H2,103,141)(H,108,135)(H,111,138)(H,112,137)(H,113,136)(H,114,144)(H,115,146)(H,116,145)(H,117,143)(H,118,130)(H,119,139)(H,120,140)(H,121,149)(H,122,152)(H,123,142)(H,124,147)(H,125,150)(H,126,151)(H,127,148)(H4,104,105,109)(H4,106,107,110)/t56-,57-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,85-/m0/s1 D0E3RQ DRUGINKE JSLWGMSGFRFMOR-GCASCPCBSA-N D0E3RQ DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CNC(=O)CNC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CCCN=C(N)N)NC(=O)C D0E3RQ HIGHSTAT Investigative D0E4OS DRUG__ID D0E4OS D0E4OS DRUGINCH 1S/C50H81N7O16/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-36(63)51-33-24-35(62)46(69)55-48(71)40-41(64)27(2)25-57(40)50(73)38(29(4)59)53-47(70)39(43(66)42(65)30-19-21-31(60)22-20-30)54-45(68)34-23-32(61)26-56(34)49(72)37(28(3)58)52-44(33)67/h19-22,27-29,32-35,37-43,46,58-62,64-66,69H,5-18,23-26H2,1-4H3,(H,51,63)(H,52,67)(H,53,70)(H,54,68)(H,55,71)/t27-,28+,29+,32+,33-,34-,35+,37-,38-,39-,40-,41-,42-,43-,46+/m0/s1 D0E4OS DRUGINKE YKPHLXGEPNYRPY-ZIUFDZNVSA-N D0E4OS DRUGSMIL CCCCCCCCCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(C(CN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(C)O)C)O)O)O D0E4OS HIGHSTAT Investigative D0E5ON DRUG__ID D0E5ON D0E5ON DRUGINCH 1S/C6H11NO3/c8-5-1-2-7-3-4(5)6(9)10/h4-5,7-8H,1-3H2,(H,9,10)/t4-,5+/m1/s1 D0E5ON DRUGINKE DAMFVOCECLPLSI-UHNVWZDZSA-N D0E5ON DRUGSMIL C1CNCC(C1O)C(=O)O D0E5ON HIGHSTAT Investigative D0E7CA DRUG__ID D0E7CA D0E7CA DRUGINCH 1S/C56H72N8O20/c1-28(59-51(74)39(57)23-35-14-18-37(70)19-15-35)50(73)60-40(24-34-11-8-7-9-12-34)52(75)63-45(29(2)80-56-48(83-33(6)69)47(82-32(5)68)46(81-31(4)67)44(84-56)27-79-30(3)66)54(77)61-41(25-36-16-20-38(71)21-17-36)55(78)64-22-10-13-43(64)53(76)62-42(26-65)49(58)72/h7-9,11-12,14-21,28-29,39-48,56,65,70-71H,10,13,22-27,57H2,1-6H3,(H2,58,72)(H,59,74)(H,60,73)(H,61,77)(H,62,76)(H,63,75)/t28-,29-,39+,40+,41+,42+,43+,44-,45+,46+,47-,48-,56+/m1/s1 D0E7CA DRUGINKE OATORUSDYAEZJF-CARIVLHESA-N D0E7CA DRUGSMIL CC(C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CO)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)OC5C(C(C(C(O5)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C D0E7CA HIGHSTAT Investigative D0E7CV DRUG__ID D0E7CV D0E7CV DRUGINCH 1S/C58H79N11O15/c1-31(2)46(67-53(78)41(29-45(72)73)64-57(82)48(35(7)70)68-50(75)34(6)62-56(81)47(32(3)4)66-51(76)39(59)26-36-18-11-8-12-19-36)55(80)60-30-44(71)69-25-17-24-43(69)54(79)63-40(27-37-20-13-9-14-21-37)52(77)61-33(5)49(74)65-42(58(83)84)28-38-22-15-10-16-23-38/h8-16,18-23,31-35,39-43,46-48,70H,17,24-30,59H2,1-7H3,(H,60,80)(H,61,77)(H,62,81)(H,63,79)(H,64,82)(H,65,74)(H,66,76)(H,67,78)(H,68,75)(H,72,73)(H,83,84)/t33-,34-,35+,39-,40-,41-,42-,43-,46-,47-,48-/m0/s1 D0E7CV DRUGINKE WMTZDAHGKCEIAT-ILJNECBNSA-N D0E7CV DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=CC=C4)N D0E7CV HIGHSTAT Investigative D0E7NV DRUG__ID D0E7NV D0E7NV DRUGINCH 1S/C72H96N14O23/c1-7-36(4)60(84-67(101)50-18-13-31-85(50)70(104)59(35(2)3)83-61(95)37(5)74)69(103)77-38(6)62(96)78-46(23-25-53(75)90)64(98)79-45(16-8-10-29-73)63(97)82-49(34-87)66(100)80-47(24-28-56(93)94)65(99)81-48(71(105)106)17-9-11-30-76-68(102)58-43(14-12-15-44(58)72(107)109-86-54(91)26-27-55(86)92)57-41-21-19-39(88)32-51(41)108-52-33-40(89)20-22-42(52)57/h12,14-15,19-22,32-33,35-38,45-50,59-60,87-88H,7-11,13,16-18,23-31,34,73-74H2,1-6H3,(H2,75,90)(H,76,102)(H,77,103)(H,78,96)(H,79,98)(H,80,100)(H,81,99)(H,82,97)(H,83,95)(H,84,101)(H,93,94)(H,105,106)/t36-,37-,38-,45-,46-,47-,48-,49-,50-,59-,60-/m0/s1 D0E7NV DRUGINKE UIHIJARXXMWKOD-UVBGQCGDSA-N D0E7NV DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCNC(=O)C1=C(C=CC=C1C(=O)ON2C(=O)CCC2=O)C3=C4C=CC(=O)C=C4OC5=C3C=CC(=C5)O)C(=O)O)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)C(C)N D0E7NV HIGHSTAT Investigative D0EO5F DRUG__ID D0EO5F D0EO5F DRUGINCH 1S/C104H173N23O23/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-42-86(132)111-50-33-29-40-75(94(139)117-73(91(109)136)37-26-30-47-105)119-95(140)74(38-27-31-48-106)118-96(141)76(39-28-32-49-107)120-102(147)83-41-34-51-127(83)88(134)60-114-93(138)77(52-63(2)3)121-97(142)78(53-64(4)5)122-99(144)80(55-68-43-45-70(130)46-44-68)116-87(133)59-113-92(137)66(8)115-101(146)82(62-128)125-100(145)81(57-85(108)131)123-98(143)79(54-65(6)7)124-104(149)90(67(9)129)126-103(148)84(150-89(135)61-110-10)56-69-58-112-72-36-25-24-35-71(69)72/h24-25,35-36,43-46,58,63-67,73-84,90,110,112,128-130H,11-23,26-34,37-42,47-57,59-62,105-107H2,1-10H3,(H2,108,131)(H2,109,136)(H,111,132)(H,113,137)(H,114,138)(H,115,146)(H,116,133)(H,117,139)(H,118,141)(H,119,140)(H,120,147)(H,121,142)(H,122,144)(H,123,143)(H,124,149)(H,125,145)(H,126,148)/t66-,67+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,90-/m0/s1 D0EO5F DRUGINKE JPTGYQMVTVXYRV-CMDPNKGGSA-N D0EO5F DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D0EO5F HIGHSTAT Investigative D0F0CP DRUG__ID D0F0CP D0F0CP DRUGINCH 1S/C56H80O2/c1-42(2)22-14-23-43(3)24-15-25-44(4)26-16-27-45(5)28-17-29-46(6)30-18-31-47(7)32-19-33-48(8)34-20-35-49(9)36-21-37-50(10)40-41-52-51(11)55(57)53-38-12-13-39-54(53)56(52)58/h12-13,22,24,26,28,30,32,34,36,38-40H,14-21,23,25,27,29,31,33,35,37,41H2,1-11H3/b43-24+,44-26+,45-28+,46-30+,47-32+,48-34+,49-36+,50-40+ D0F0CP DRUGINKE WCRXHNIUHQUASO-UVZVDVBNSA-N D0F0CP DRUGSMIL CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C D0F0CP HIGHSTAT Investigative D0F0MN DRUG__ID D0F0MN D0F0MN DRUGINCH 1S/C61H85N11O18S/c1-6-8-20-42(66-57(82)47(32-37-24-26-39(27-25-37)90-91(86,87)88)69-56(81)45(28-29-50(73)74)72-60(85)89-61(3,4)5)53(78)65-44(23-15-16-30-62)55(80)70-48(33-38-35-64-41-22-14-13-19-40(38)41)58(83)67-43(21-9-7-2)54(79)71-49(34-51(75)76)59(84)68-46(52(63)77)31-36-17-11-10-12-18-36/h10-14,17-19,22,24-27,35,42-49,64H,6-9,15-16,20-21,23,28-34,62H2,1-5H3,(H2,63,77)(H,65,78)(H,66,82)(H,67,83)(H,68,84)(H,69,81)(H,70,80)(H,71,79)(H,72,85)(H,73,74)(H,75,76)(H,86,87,88)/t42-,43-,44-,45-,46-,47-,48-,49-/m0/s1 D0F0MN DRUGINKE NLVKBXFAISROGJ-XJIZABAQSA-N D0F0MN DRUGSMIL CCCCC(C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CCC(=O)O)NC(=O)OC(C)(C)C D0F0MN HIGHSTAT Investigative D0F1XY DRUG__ID D0F1XY D0F1XY DRUGINCH 1S/C58H71N9O15/c1-6-7-21-41(52(74)64-46(56(79)80)30-38-33-67(57(81)82-58(3,4)5)47-22-15-14-20-40(38)47)61-53(75)42(31-49(70)71)62-54(76)44(28-36-18-12-9-13-19-36)66-65-43(27-35-16-10-8-11-17-35)51(73)59-32-48(69)60-34(2)50(72)63-45(55(77)78)29-37-23-25-39(68)26-24-37/h8-20,22-26,33-34,41-46,65-66,68H,6-7,21,27-32H2,1-5H3,(H,59,73)(H,60,69)(H,61,75)(H,62,76)(H,63,72)(H,64,74)(H,70,71)(H,77,78)(H,79,80)/t34-,41+,42+,43+,44+,45+,46-/m1/s1 D0F1XY DRUGINKE IYNMVGGOTRCWGJ-KSEFKAEUSA-N D0F1XY DRUGSMIL CCCCC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C(=O)OC(C)(C)C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=CC=C3)NNC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O D0F1XY HIGHSTAT Investigative D0F2GY DRUG__ID D0F2GY D0F2GY DRUGINCH 1S/C152H228N42O47/c1-13-78(8)123(149(239)171-80(10)127(217)181-105(61-86-64-163-91-34-21-20-33-89(86)91)139(229)182-101(57-75(2)3)140(230)191-121(76(4)5)147(237)180-93(35-22-25-53-153)130(220)166-68-114(205)172-92(38-28-56-162-152(158)159)129(219)164-66-111(157)202)193-141(231)103(58-83-29-16-14-17-30-83)183-137(227)100(47-52-119(212)213)178-134(224)95(36-23-26-54-154)175-126(216)79(9)170-133(223)94-37-24-27-55-161-112(203)49-44-99(136(226)177-97(46-51-118(210)211)132(222)167-69-115(206)174-98(135(225)176-94)43-48-110(156)201)179-138(228)102(60-85-39-41-88(200)42-40-85)184-144(234)107(71-195)187-146(236)109(73-197)188-148(238)122(77(6)7)192-143(233)106(63-120(214)215)185-145(235)108(72-196)189-151(241)125(82(12)199)194-142(232)104(59-84-31-18-15-19-32-84)186-150(240)124(81(11)198)190-116(207)70-168-131(221)96(45-50-117(208)209)173-113(204)67-165-128(218)90(155)62-87-65-160-74-169-87/h14-21,29-34,39-42,64-65,74-82,90,92-109,121-125,163,195-200H,13,22-28,35-38,43-63,66-73,153-155H2,1-12H3,(H2,156,201)(H2,157,202)(H,160,169)(H,161,203)(H,164,219)(H,165,218)(H,166,220)(H,167,222)(H,168,221)(H,170,223)(H,171,239)(H,172,205)(H,173,204)(H,174,206)(H,175,216)(H,176,225)(H,177,226)(H,178,224)(H,179,228)(H,180,237)(H,181,217)(H,182,229)(H,183,227)(H,184,234)(H,185,235)(H,186,240)(H,187,236)(H,188,238)(H,189,241)(H,190,207)(H,191,230)(H,192,233)(H,193,231)(H,194,232)(H,208,209)(H,210,211)(H,212,213)(H,214,215)(H4,158,159,162)/t78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,121-,122-,123-,124-,125-/m0/s1 D0F2GY DRUGINKE PAMPKNPMNUNCAF-KXYXCEFHSA-N D0F2GY DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C4CCCCNC(=O)CCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N4)CCC(=O)N)CCC(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D0F2GY HIGHSTAT Investigative D0F2SA DRUG__ID D0F2SA D0F2SA DRUGINCH 1S/C21H28N6O/c22-21(28)16-12-18(26-20(14-16)27-10-8-23-9-11-27)15-6-7-24-19(13-15)25-17-4-2-1-3-5-17/h6-7,12-14,17,23H,1-5,8-11H2,(H2,22,28)(H,24,25) D0F2SA DRUGINKE XNWDRALEEPGBHB-UHFFFAOYSA-N D0F2SA DRUGSMIL C1CCC(CC1)NC2=NC=CC(=C2)C3=NC(=CC(=C3)C(=O)N)N4CCNCC4 D0F2SA HIGHSTAT Investigative D0F3XS DRUG__ID D0F3XS D0F3XS DRUGINCH 1S/C54H98N30O12/c55-39-35-40(76-26-75-39)84(27-77-35)47-37(87)36(86)38(96-47)46(93)68-19-5-3-1-2-4-18-34(85)78-28(12-6-20-69-49(56)57)41(88)79-29(13-7-21-70-50(58)59)42(89)80-30(14-8-22-71-51(60)61)43(90)81-31(15-9-23-72-52(62)63)44(91)82-32(16-10-24-73-53(64)65)45(92)83-33(48(94)95)17-11-25-74-54(66)67/h26-33,36-38,47,86-87H,1-25H2,(H,68,93)(H,78,85)(H,79,88)(H,80,89)(H,81,90)(H,82,91)(H,83,92)(H,94,95)(H2,55,75,76)(H4,56,57,69)(H4,58,59,70)(H4,60,61,71)(H4,62,63,72)(H4,64,65,73)(H4,66,67,74)/t28-,29-,30-,31-,32-,33-,36+,37-,38+,47?/m1/s1 D0F3XS DRUGINKE HBUMOBPTTFUJHS-FIYJFMLKSA-N D0F3XS DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D0F3XS HIGHSTAT Investigative D0F5WY DRUG__ID D0F5WY D0F5WY DRUGINCH 1S/C61H102O30S/c1-23(2)11-10-16-61(9,75)36-13-12-30-29-20-34(32-19-28(91-92(76,77)78)14-17-59(32,7)31(29)15-18-60(30,36)8)85-56-48(74)50(39(65)26(5)83-56)88-57-51(89-54-45(71)42(68)37(63)24(3)81-54)41(67)35(22-80-57)86-58-52(90-55-46(72)43(69)38(64)25(4)82-55)47(73)49(27(6)84-58)87-53-44(70)40(66)33(62)21-79-53/h15,23-30,32-58,62-75H,10-14,16-22H2,1-9H3,(H,76,77,78)/t24-,25-,26-,27-,28+,29+,30+,32-,33+,34+,35-,36+,37-,38+,39-,40+,41+,42+,43+,44-,45-,46-,47+,48-,49-,50+,51-,52-,53+,54+,55+,56+,57+,58+,59-,60+,61-/m1/s1 D0F5WY DRUGINKE YGJYYDTWXBCDRA-MIRNQWDESA-N D0F5WY DRUGSMIL CC1C(C(C(C(O1)OC2C(C(COC2OC3C(C(OC(C3O)OC4CC5C6CCC(C6(CC=C5C7(C4CC(CC7)OS(=O)(=O)O)C)C)C(C)(CCCC(C)C)O)C)O)OC8C(C(C(C(O8)C)OC9C(C(C(CO9)O)O)O)O)OC1C(C(C(C(O1)C)O)O)O)O)O)O)O D0F5WY HIGHSTAT Investigative D0F8BZ DRUG__ID D0F8BZ D0F8BZ DRUGINCH 1S/C61H62N8O11/c1-35(70)64-55(54-45-16-7-5-13-39(45)23-24-40-14-6-8-17-46(40)54)60(78)68-50(29-36-11-3-2-4-12-36)57(75)67-51(33-53(62)73)59(77)66-48(30-37-19-25-42(71)26-20-37)56(74)65-49(31-38-21-27-43(72)28-22-38)58(76)69-52(61(79)80)32-41-34-63-47-18-10-9-15-44(41)47/h2-22,25-28,34,48-52,54-55,63,71-72H,23-24,29-33H2,1H3,(H2,62,73)(H,64,70)(H,65,74)(H,66,77)(H,67,75)(H,68,78)(H,69,76)(H,79,80)/t48-,49-,50-,51-,52-,55-/m0/s1 D0F8BZ DRUGINKE DTNUUCGDOGDUBL-NHTZSVLLSA-N D0F8BZ DRUGSMIL CC(=O)NC(C1C2=CC=CC=C2CCC3=CC=CC=C13)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)O D0F8BZ HIGHSTAT Investigative D0F9QJ DRUG__ID D0F9QJ D0F9QJ DRUGINCH 1S/C44H70N12O12S2/c1-8-22(4)34-42(67)50-26(13-14-31(46)58)38(63)52-29(17-32(47)59)39(64)54-30(20-70-69-19-25(45)36(61)51-28(40(65)55-34)16-23-9-11-24(57)12-10-23)41(66)56-35(44(5,6)7)43(68)53-27(15-21(2)3)37(62)49-18-33(48)60/h9-12,21-22,25-30,34-35,57H,8,13-20,45H2,1-7H3,(H2,46,58)(H2,47,59)(H2,48,60)(H,49,62)(H,50,67)(H,51,61)(H,52,63)(H,53,68)(H,54,64)(H,55,65)(H,56,66)/t22-,25-,26-,27-,28-,29-,30-,34-,35-/m0/s1 D0F9QJ DRUGINKE ZQBKWQKQBINQEI-PJCZHVSHSA-N D0F9QJ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)NC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N)C(C)(C)C)CC(=O)N)CCC(=O)N D0F9QJ HIGHSTAT Investigative D0FI8L DRUG__ID D0FI8L D0FI8L DRUGINCH 1S/C8H20N4/c9-6-4-2-1-3-5-7-12-8(10)11/h1-7,9H2,(H4,10,11,12)/p+2 D0FI8L DRUGINKE YAOAMZOGXBMLFQ-UHFFFAOYSA-P D0FI8L DRUGSMIL C(CCC[NH3+])CCC[NH+]=C(N)N D0FI8L HIGHSTAT Investigative D0FU0K DRUG__ID D0FU0K D0FU0K DRUGINCH 1S/C8H4Cl2N2O3/c9-3-1-4(10)6-5(2-3)11-8(14)12(15)7(6)13/h1-2,15H,(H,11,14) D0FU0K DRUGINKE MVMRFDFKPNDLQJ-UHFFFAOYSA-N D0FU0K DRUGSMIL C1=C(C=C(C2=C1NC(=O)N(C2=O)O)Cl)Cl D0FU0K HIGHSTAT Investigative D0FY6N DRUG__ID D0FY6N D0FY6N DRUGINCH 1S/C83H130N28O19S/c1-44(2)32-58(77(125)103-54(70(89)118)15-11-31-131-6)107-78(126)61(35-50-40-94-43-99-50)101-68(117)42-98-81(129)69(45(3)4)110-71(119)46(5)100-76(124)60(34-48-39-96-53-13-8-7-12-52(48)53)109-75(123)56(21-23-64(86)113)105-79(127)62(36-66(88)115)102-67(116)41-97-72(120)59(33-47-17-19-51(112)20-18-47)108-73(121)55(14-9-27-95-83(90)91)104-74(122)57(22-24-65(87)114)106-80(128)63-16-10-30-111(63)82(130)49(37-92-28-25-84)38-93-29-26-85/h7-8,12-13,17-20,39-40,43-46,49,54-63,69,92-93,96,112H,9-11,14-16,21-38,41-42,84-85H2,1-6H3,(H2,86,113)(H2,87,114)(H2,88,115)(H2,89,118)(H,94,99)(H,97,120)(H,98,129)(H,100,124)(H,101,117)(H,102,116)(H,103,125)(H,104,122)(H,105,127)(H,106,128)(H,107,126)(H,108,121)(H,109,123)(H,110,119)(H4,90,91,95)/t46-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63?,69-/m0/s1 D0FY6N DRUGINKE WPAOEAXJLCSDBY-UKYQNQGLSA-N D0FY6N DRUGSMIL CC(C)CC(C(=O)NC(CCCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C5CCCN5C(=O)C(CNCCN)CNCCN D0FY6N HIGHSTAT Investigative D0G0WP DRUG__ID D0G0WP D0G0WP DRUGINCH 1S/C152H231N39O44S2/c1-17-20-36-94(171-143(226)108(72-237)183-150(233)125(83(16)196)189-142(225)107(70-192)182-135(218)99(56-75(6)7)176-138(221)103(62-113(157)201)169-116(204)67-161-129(212)91(154)71-236)132(215)175-98(55-74(4)5)130(213)162-68-118(206)185-122(80(13)193)148(231)180-101(59-86-40-44-89(197)45-41-86)141(224)188-124(82(15)195)149(232)173-95(48-50-111(155)199)133(216)179-105(64-119(207)208)140(223)177-100(58-85-34-25-22-26-35-85)136(219)178-104(63-114(158)202)139(222)170-92(37-27-28-52-153)126(209)97(57-84-32-23-21-24-33-84)174-137(220)102(61-88-65-160-73-165-88)168-93(31-18-2)131(214)181-106(60-87-42-46-90(198)47-43-87)152(235)191-54-30-39-110(191)144(227)172-96(49-51-112(156)200)134(217)187-123(81(14)194)147(230)167-78(11)128(211)186-121(77(10)19-3)146(229)164-69-117(205)184-120(76(8)9)145(228)163-66-115(203)166-79(12)151(234)190-53-29-38-109(190)127(159)210/h21-26,32-35,40-47,65,73-83,91-110,120-125,168,192-198,236-237H,17-20,27-31,36-39,48-64,66-72,153-154H2,1-16H3,(H2,155,199)(H2,156,200)(H2,157,201)(H2,158,202)(H2,159,210)(H,160,165)(H,161,212)(H,162,213)(H,163,228)(H,164,229)(H,166,203)(H,167,230)(H,169,204)(H,170,222)(H,171,226)(H,172,227)(H,173,232)(H,174,220)(H,175,215)(H,176,221)(H,177,223)(H,178,219)(H,179,216)(H,180,231)(H,181,214)(H,182,218)(H,183,233)(H,184,205)(H,185,206)(H,186,211)(H,187,217)(H,188,224)(H,189,225)(H,207,208)/t77-,78-,79-,80+,81+,82+,83+,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102?,103-,104-,105-,106-,107-,108-,109+,110+,120-,121-,122-,123-,124-,125-/m0/s1 D0G0WP DRUGINKE NUIBIJAKPBPKQM-RQTBQGNLSA-N D0G0WP DRUGSMIL CCCCC(C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CC(=O)N)C(=O)NC(CCCCN)C(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC=N4)NC(CCC)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N7CCCC7C(=O)N)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D0G0WP HIGHSTAT Investigative D0G0YT DRUG__ID D0G0YT D0G0YT DRUGINCH 1S/C163H267N51O49S2/c1-73(2)52-97(186-116(226)65-179-131(233)82(18)183-139(241)98(53-74(3)4)193-137(239)94(44-35-49-176-162(171)172)188-142(244)101(57-91-62-175-72-182-91)199-159(261)128(88(24)221)213-156(258)123(79(13)14)207-151(253)110-71-265-264-70-109(203-130(232)81(17)166)150(252)198-105(61-119(229)230)147(249)211-125(85(21)218)157(259)185-84(20)133(235)210-126(86(22)219)160(262)204-110)140(242)194-99(54-75(5)6)141(243)202-108(69-217)149(251)190-95(45-36-50-177-163(173)174)138(240)201-106(67-215)134(236)180-63-115(225)178-64-118(228)205-121(77(9)10)155(257)208-122(78(11)12)154(256)191-93(43-32-34-48-165)136(238)196-102(58-112(167)222)144(246)197-103(59-113(168)223)143(245)195-100(56-90-40-29-26-30-41-90)145(247)209-124(80(15)16)161(263)214-51-37-46-111(214)152(254)212-127(87(23)220)158(260)200-104(60-114(169)224)146(248)206-120(76(7)8)153(255)181-66-117(227)187-107(68-216)148(250)189-92(42-31-33-47-164)135(237)184-83(19)132(234)192-96(129(170)231)55-89-38-27-25-28-39-89/h25-30,38-41,62,72-88,92-111,120-128,215-221H,31-37,42-61,63-71,164-166H2,1-24H3,(H2,167,222)(H2,168,223)(H2,169,224)(H2,170,231)(H,175,182)(H,178,225)(H,179,233)(H,180,236)(H,181,255)(H,183,241)(H,184,237)(H,185,259)(H,186,226)(H,187,227)(H,188,244)(H,189,250)(H,190,251)(H,191,256)(H,192,234)(H,193,239)(H,194,242)(H,195,245)(H,196,238)(H,197,246)(H,198,252)(H,199,261)(H,200,260)(H,201,240)(H,202,243)(H,203,232)(H,204,262)(H,205,228)(H,206,248)(H,207,253)(H,208,257)(H,209,247)(H,210,235)(H,211,249)(H,212,254)(H,213,258)(H,229,230)(H4,171,172,176)(H4,173,174,177)/t81-,82+,83+,84-,85+,86+,87-,88-,92+,93+,94+,95+,96+,97+,98+,99+,100+,101+,102+,103+,104+,105-,106+,107+,108+,109-,110+,111?,120+,121+,122+,123+,124+,125+,126+,127+,128+/m1/s1 D0G0YT DRUGINKE JMJJWZFCOWFIBU-NFAXDPBFSA-N D0G0YT DRUGSMIL CC1C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CC(=O)O)NC(=O)C(C)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CC2=CNC=N2)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C(C)C)C(=O)N4CCCC4C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)C(C)O D0G0YT HIGHSTAT Investigative D0G2WI DRUG__ID D0G2WI D0G2WI DRUGINCH 1S/C24H27N3O2/c1-26-22-15-23-20(13-19(22)14-24(26)28)21(25-29-23)8-7-17-9-11-27(12-10-17)16-18-5-3-2-4-6-18/h2-6,13,15,17H,7-12,14,16H2,1H3 D0G2WI DRUGINKE GBRYDMXCJVBJHH-UHFFFAOYSA-N D0G2WI DRUGSMIL CN1C(=O)CC2=CC3=C(C=C21)ON=C3CCC4CCN(CC4)CC5=CC=CC=C5 D0G2WI HIGHSTAT Investigative D0G3RO DRUG__ID D0G3RO D0G3RO DRUGINCH 1S/C9H8N2S/c12-8-3-1-2-7(4-8)9-5-10-6-11-9/h1-6,9,12H D0G3RO DRUGINKE GGVYLSRKJAVBST-UHFFFAOYSA-N D0G3RO DRUGSMIL C1=CC(=CC(=C1)S)C2C=NC=N2 D0G3RO HIGHSTAT Investigative D0G4HT DRUG__ID D0G4HT D0G4HT DRUGINCH 1S/C80H122N24O18/c1-43(2)37-59(71(115)95-57(15-9-35-93-79(87)88)69(113)103-63(75(119)120)41-47-21-29-51(107)30-22-47)101-67(111)55(13-7-33-91-77(83)84)97-73(117)61(39-45-17-25-49(105)26-18-45)99-65(109)53(81)11-5-6-12-54(82)66(110)100-62(40-46-19-27-50(106)28-20-46)74(118)98-56(14-8-34-92-78(85)86)68(112)102-60(38-44(3)4)72(116)96-58(16-10-36-94-80(89)90)70(114)104-64(76(121)122)42-48-23-31-52(108)32-24-48/h17-32,43-44,53-64,105-108H,5-16,33-42,81-82H2,1-4H3,(H,95,115)(H,96,116)(H,97,117)(H,98,118)(H,99,109)(H,100,110)(H,101,111)(H,102,112)(H,103,113)(H,104,114)(H,119,120)(H,121,122)(H4,83,84,91)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-/m0/s1 D0G4HT DRUGINKE FPKKOJOGVASCPV-ODXRWUIZSA-N D0G4HT DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCCC(C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)N)N D0G4HT HIGHSTAT Investigative D0G4VH DRUG__ID D0G4VH D0G4VH DRUGINCH 1S/C66H97N23O19S2/c1-7-31(4)52(78-33(6)92)65(108)87-47-27-110-109-26-46(63(106)89-53(32(5)91)54(68)97)86-56(99)39(13-10-16-73-66(69)70)80-59(102)43(19-36-23-72-29-77-36)83-58(101)42(18-35-22-71-28-76-35)79-49(94)24-75-55(98)41(17-34-21-74-38-12-9-8-11-37(34)38)82-60(103)44(20-50(95)96)84-57(100)40(14-15-48(67)93)81-61(104)45(25-90)85-64(107)51(30(2)3)88-62(47)105/h8-9,11-12,21-23,28-32,39-47,51-53,74,90-91H,7,10,13-20,24-27H2,1-6H3,(H2,67,93)(H2,68,97)(H,71,76)(H,72,77)(H,75,98)(H,78,92)(H,79,94)(H,80,102)(H,81,104)(H,82,103)(H,83,101)(H,84,100)(H,85,107)(H,86,99)(H,87,108)(H,88,105)(H,89,106)(H,95,96)(H4,69,70,73)/t31-,32+,39-,40-,41-,42-,43+,44+,45+,46-,47-,51-,52-,53-/m0/s1 D0G4VH DRUGINKE HZUYXHSRYLPHAY-PSEHRYLKSA-N D0G4VH DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CO)CCC(=O)N)CC(=O)O)CC2=CNC3=CC=CC=C32)CC4=CN=CN4)CC5=CN=CN5)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0G4VH HIGHSTAT Investigative D0G6GC DRUG__ID D0G6GC D0G6GC DRUGINCH 1S/C57H72N10O9S/c1-35(2)28-46(54(73)65-48(53(72)60-32-39-16-9-6-10-17-39)31-40-33-59-44-19-12-11-18-42(40)44)66-56(75)49-20-13-26-67(49)57(76)45(25-27-77-4)64-55(74)47(30-37-14-7-5-8-15-37)63-50(69)34-61-51(70)36(3)62-52(71)43(58)29-38-21-23-41(68)24-22-38/h5-12,14-19,21-24,33,35-36,43,45-49,59,68H,13,20,25-32,34,58H2,1-4H3,(H,60,72)(H,61,70)(H,62,71)(H,63,69)(H,64,74)(H,65,73)(H,66,75)/t36-,43+,45+,46+,47+,48+,49+/m1/s1 D0G6GC DRUGINKE VUSRUVIDWSRKBU-POSUKJBFSA-N D0G6GC DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NCC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)C(CCSC)NC(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D0G6GC HIGHSTAT Investigative D0G6IX DRUG__ID D0G6IX D0G6IX DRUGINCH 1S/C76H100ClN15O16S/c1-42(2)80-34-12-11-16-58(76(107)92-35-13-17-64(92)73(105)81-44(5)66(79)98)86-74(106)75(109(108)43(3)4)91-71(103)62(39-50-23-30-56(31-24-50)83-46(7)95)88-70(102)61(38-49-21-28-55(29-22-49)82-45(6)94)89-72(104)63(41-93)90-67(99)57(32-33-65(78)97)85-69(101)60(37-48-19-26-54(77)27-20-48)87-68(100)59(84-47(8)96)40-51-18-25-52-14-9-10-15-53(52)36-51/h9-10,14-15,18-31,36,42-44,57-64,75,80,93H,11-13,16-17,32-35,37-41H2,1-8H3,(H2,78,97)(H2,79,98)(H,81,105)(H,82,94)(H,83,95)(H,84,96)(H,85,101)(H,86,106)(H,87,100)(H,88,102)(H,89,104)(H,90,99)(H,91,103)/t44-,57-,58+,59-,60-,61+,62-,63+,64+,75+,109?/m1/s1 D0G6IX DRUGINKE KYASUQFVWOOHIK-WEDCXYFKSA-N D0G6IX DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)S(=O)C(C)C D0G6IX HIGHSTAT Investigative D0G7CO DRUG__ID D0G7CO D0G7CO DRUGINCH 1S/C159H245N45O40/c1-79(2)60-104(181-119(212)74-174-131(218)87(17)178-138(225)105(61-80(3)4)187-136(223)100(49-35-55-169-157(163)164)183-142(229)110(67-96-71-168-78-177-96)192-155(242)129(90(20)208)202-153(240)126(85(13)14)198-145(232)109(180-91(21)209)66-95-70-172-98-47-32-31-46-97(95)98)140(227)188-106(62-81(5)6)141(228)195-114(77-206)147(234)184-101(51-37-57-171-159(167)244)137(224)194-113(76-205)133(220)175-72-118(211)173-73-120(213)196-124(83(9)10)152(239)199-125(84(11)12)151(238)185-102(50-36-56-170-158(165)166)134(221)182-99(48-33-34-54-160)135(222)190-111(68-117(161)210)143(230)189-108(65-94-44-29-24-30-45-94)144(231)200-127(86(15)16)156(243)204-59-39-53-116(204)149(236)201-128(89(19)207)154(241)193-112(69-122(215)216)146(233)197-123(82(7)8)150(237)176-75-121(214)203-58-38-52-115(203)148(235)191-107(64-93-42-27-23-28-43-93)139(226)179-88(18)132(219)186-103(130(162)217)63-92-40-25-22-26-41-92/h22-32,40-47,70-71,78-90,99-116,123-129,172,205-208H,33-39,48-69,72-77,160H2,1-21H3,(H2,161,210)(H2,162,217)(H,168,177)(H,173,211)(H,174,218)(H,175,220)(H,176,237)(H,178,225)(H,179,226)(H,180,209)(H,181,212)(H,182,221)(H,183,229)(H,184,234)(H,185,238)(H,186,219)(H,187,223)(H,188,227)(H,189,230)(H,190,222)(H,191,235)(H,192,242)(H,193,241)(H,194,224)(H,195,228)(H,196,213)(H,197,233)(H,198,232)(H,199,239)(H,200,231)(H,201,236)(H,202,240)(H,215,216)(H4,163,164,169)(H4,165,166,170)(H3,167,171,244)/t87-,88-,89+,90+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,123-,124-,125-,126-,127-,128-,129-/m0/s1 D0G7CO DRUGINKE APWOLIUOOPBJRZ-BQWGFPJXSA-N D0G7CO DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=O)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C D0G7CO HIGHSTAT Investigative D0G7MJ DRUG__ID D0G7MJ D0G7MJ DRUGINCH 1S/C28H20N4O3S/c1-19-27(26(33)17-14-20-12-15-23(16-13-20)32(34)35)36-28(29-19)31-25(22-10-6-3-7-11-22)18-24(30-31)21-8-4-2-5-9-21/h2-18H,1H3/b17-14+ D0G7MJ DRUGINKE IPRWXFAJXPKDLK-SAPNQHFASA-N D0G7MJ DRUGSMIL CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC=C(C=C5)[N+](=O)[O-] D0G7MJ HIGHSTAT Investigative D0G9DJ DRUG__ID D0G9DJ D0G9DJ DRUGINCH 1S/C57H74N12O9/c1-35(2)23-44(53(74)66-43(52(58)73)26-38-17-10-6-11-18-38)63-51(72)30-49(70)42(25-37-15-8-5-9-16-37)65-55(76)46(28-40-31-59-33-61-40)67-54(75)45(27-39-19-12-7-13-20-39)68-56(77)48-21-14-22-69(48)57(78)47(29-41-32-60-34-62-41)64-50(71)24-36(3)4/h5-13,15-20,31-36,42-49,70H,14,21-30H2,1-4H3,(H2,58,73)(H,59,61)(H,60,62)(H,63,72)(H,64,71)(H,65,76)(H,66,74)(H,67,75)(H,68,77) D0G9DJ DRUGINKE OXZWHUWYDVRMCP-UHFFFAOYSA-N D0G9DJ DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)CC(C(CC2=CC=CC=C2)NC(=O)C(CC3=CN=CN3)NC(=O)C(CC4=CC=CC=C4)NC(=O)C5CCCN5C(=O)C(CC6=CN=CN6)NC(=O)CC(C)C)O D0G9DJ HIGHSTAT Investigative D0GC3E DRUG__ID D0GC3E D0GC3E DRUGINCH 1S/C54H80N12O21/c1-5-26(3)43-51(83)59-31(54(86)87)10-7-8-18-56-38(69)17-16-30(55)45(77)63-36(25-67)49(81)65-44(27(4)6-2)52(84)61-32(20-28-12-14-29(68)15-13-28)46(78)62-35(23-42(75)76)53(85)66-19-9-11-37(66)50(82)57-24-39(70)58-33(21-40(71)72)47(79)60-34(22-41(73)74)48(80)64-43/h12-15,26-27,30-37,43-44,67-68H,5-11,16-25,55H2,1-4H3,(H,56,69)(H,57,82)(H,58,70)(H,59,83)(H,60,79)(H,61,84)(H,62,78)(H,63,77)(H,64,80)(H,65,81)(H,71,72)(H,73,74)(H,75,76)(H,86,87)/t26-,27-,30-,31-,32-,33-,34-,35-,36-,37-,43-,44-/m0/s1 D0GC3E DRUGINKE QVRGILAZQGYCSV-ZGJOQXBESA-N D0GC3E DRUGSMIL CCC(C)C1C(=O)NC(CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1)CC(=O)O)CC(=O)O)CC(=O)O)CC3=CC=C(C=C3)O)C(C)CC)CO)N)C(=O)O D0GC3E HIGHSTAT Investigative D0GD1A DRUG__ID D0GD1A D0GD1A DRUGINCH 1S/C51H75N11O19/c1-5-25(3)41-49(78)58-31(20-27-12-14-28(63)15-13-27)44(73)59-34(23-40(70)71)50(79)62-19-9-11-35(62)47(76)54-24-37(65)55-32(21-38(66)67)45(74)57-33(22-39(68)69)46(75)61-42(26(4)6-2)48(77)56-30(51(80)81)10-7-8-18-53-36(64)17-16-29(52)43(72)60-41/h12-15,25-26,29-35,41-42,63H,5-11,16-24,52H2,1-4H3,(H,53,64)(H,54,76)(H,55,65)(H,56,77)(H,57,74)(H,58,78)(H,59,73)(H,60,72)(H,61,75)(H,66,67)(H,68,69)(H,70,71)(H,80,81)/t25-,26-,29-,30-,31-,32-,33-,34-,35-,41-,42-/m0/s1 D0GD1A DRUGINKE NYVKKYBROIXDPN-ZGHCNQEKSA-N D0GD1A DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CCCCNC(=O)CCC(C(=O)N1)N)C(=O)O)C(C)CC)CC(=O)O)CC(=O)O)CC(=O)O)CC3=CC=C(C=C3)O D0GD1A HIGHSTAT Investigative D0GH5N DRUG__ID D0GH5N D0GH5N DRUGINCH 1S/C78H111N21O19/c1-5-6-19-52(91-75(116)61(41-101)97-72(113)57(34-46-24-26-49(103)27-25-46)94-74(115)60(40-100)88-44(4)102)68(109)92-54(28-29-64(105)106)70(111)96-59(36-48-38-83-42-87-48)73(114)93-56(33-45-16-8-7-9-17-45)71(112)90-53(22-14-31-84-78(81)82)69(110)95-58(35-47-37-85-51-20-11-10-18-50(47)51)67(108)86-39-63(104)89-55(21-12-13-30-79)77(118)99-32-15-23-62(99)76(117)98-65(43(2)3)66(80)107/h7-11,16-18,20,24-27,37-38,42-43,52-62,65,85,100-101,103H,5-6,12-15,19,21-23,28-36,39-41,79H2,1-4H3,(H2,80,107)(H,83,87)(H,86,108)(H,88,102)(H,89,104)(H,90,112)(H,91,116)(H,92,109)(H,93,114)(H,94,115)(H,95,110)(H,96,111)(H,97,113)(H,98,117)(H,105,106)(H4,81,82,84)/t52-,53-,54-,55-,56+,57-,58-,59-,60-,61-,62-,65-/m0/s1 D0GH5N DRUGINKE UAHFGYDRQSXQEB-LEBBXHLNSA-N D0GH5N DRUGSMIL CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C D0GH5N HIGHSTAT Investigative D0GN1A DRUG__ID D0GN1A D0GN1A DRUGINCH 1S/C53H67N9O13S/c1-4-31(2)46(61-51(70)45(30-76)55-32(3)63)52(71)59-43(28-36-17-23-39(65)24-18-36)48(67)56-40(12-8-9-25-54)47(66)57-41(26-34-13-19-37(20-14-34)62(74)75)49(68)58-42(27-35-15-21-38(64)22-16-35)50(69)60-44(53(72)73)29-33-10-6-5-7-11-33/h5-7,10-11,13-24,31,40-46,64-65,76H,4,8-9,12,25-30,54H2,1-3H3,(H,55,63)(H,56,67)(H,57,66)(H,58,68)(H,59,71)(H,60,69)(H,61,70)(H,72,73)/t31?,40-,41-,42-,43-,44-,45-,46-/m0/s1 D0GN1A DRUGINKE NYGFMHJKDBNTFT-GLNKEJAVSA-N D0GN1A DRUGSMIL CCC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CC2=CC=C(C=C2)[N+](=O)[O-])C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC4=CC=CC=C4)C(=O)O)NC(=O)C(CS)NC(=O)C D0GN1A HIGHSTAT Investigative D0GN3M DRUG__ID D0GN3M D0GN3M DRUGINCH 1S/C70H101N19O18S2/c1-36(73)59(96)77-32-55(94)79-53-35-109-108-34-52(58(75)95)87-67(104)51(33-90)86-70(107)57(39(4)92)88-60(97)37(2)78-69(106)56(38(3)91)89-62(99)46(24-14-16-26-72)80-65(102)49(29-42-31-76-44-22-12-11-21-43(42)44)84-64(101)48(28-41-19-9-6-10-20-41)82-63(100)47(27-40-17-7-5-8-18-40)83-66(103)50(30-54(74)93)85-61(98)45(81-68(53)105)23-13-15-25-71/h5-12,17-22,31,36-39,45-53,56-57,76,90-92H,13-16,23-30,32-35,71-73H2,1-4H3,(H2,74,93)(H2,75,95)(H,77,96)(H,78,106)(H,79,94)(H,80,102)(H,81,105)(H,82,100)(H,83,103)(H,84,101)(H,85,98)(H,86,107)(H,87,104)(H,88,97)(H,89,99)/t36-,37-,38?,39?,45-,46+,47-,48+,49-,50+,51-,52-,53-,56+,57+/m0/s1 D0GN3M DRUGINKE DWTUVBZITHQYDR-CFWAKGAOSA-N D0GN3M DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)O)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)N)CO)C(C)O D0GN3M HIGHSTAT Investigative D0GX3K DRUG__ID D0GX3K D0GX3K DRUGINCH 1S/C69H111N21O13/c1-7-34-89(35-8-2)54(39-45-26-28-46(91)29-27-45)62(98)81-40-55(92)80-41-56(93)82-52(38-44-19-11-10-12-20-44)61(97)87-51(37-42(4)5)60(96)84-47(22-15-31-77-67(71)72)58(94)83-48(23-16-32-78-68(73)74)59(95)88-57(43(6)9-3)64(100)85-49(24-17-33-79-69(75)76)65(101)90-36-18-25-53(90)63(99)86-50(66(102)103)21-13-14-30-70/h7-8,10-12,19-20,26-29,42-43,47-54,57,91H,1-2,9,13-18,21-25,30-41,70H2,3-6H3,(H,80,92)(H,81,98)(H,82,93)(H,83,94)(H,84,96)(H,85,100)(H,86,99)(H,87,97)(H,88,95)(H,102,103)(H4,71,72,77)(H4,73,74,78)(H4,75,76,79)/t43-,47-,48-,49-,50-,51-,52-,53-,54-,57-/m0/s1 D0GX3K DRUGINKE PUPCCTCXOWBBTI-JHLTVMAUSA-N D0GX3K DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N(CC=C)CC=C D0GX3K HIGHSTAT Investigative D0H0GJ DRUG__ID D0H0GJ D0H0GJ DRUGINCH 1S/C146H244N44O47S2/c1-18-19-27-82(123(215)179-96(51-77-33-35-79(199)36-34-77)144(236)190-45-26-32-103(190)139(231)169-84(30-24-43-158-146(155)156)126(218)187-114(74(15)196)142(234)178-95(55-107(153)203)134(226)186-113(73(14)195)140(232)161-58-109(205)164-97(60-191)120(212)160-59-110(206)184-116(76(17)198)145(237)189-44-25-31-102(189)117(154)209)165-131(223)92(52-78-56-157-66-162-78)174-127(219)88(47-68(4)5)171-122(214)83(29-21-23-42-148)166-132(224)93(53-105(151)201)175-128(220)89(48-69(6)7)172-125(217)86(38-40-111(207)208)167-124(216)85(37-39-104(150)200)168-135(227)99(62-193)181-129(221)90(49-70(8)9)170-121(213)81(28-20-22-41-147)163-108(204)57-159-119(211)87(46-67(2)3)177-141(233)112(72(12)13)185-138(230)101(65-239)183-143(235)115(75(16)197)188-137(229)100(63-194)182-130(222)91(50-71(10)11)173-133(225)94(54-106(152)202)176-136(228)98(61-192)180-118(210)80(149)64-238/h33-36,56,66-76,80-103,112-116,191-199,238-239H,18-32,37-55,57-65,147-149H2,1-17H3,(H2,150,200)(H2,151,201)(H2,152,202)(H2,153,203)(H2,154,209)(H,157,162)(H,159,211)(H,160,212)(H,161,232)(H,163,204)(H,164,205)(H,165,223)(H,166,224)(H,167,216)(H,168,227)(H,169,231)(H,170,213)(H,171,214)(H,172,217)(H,173,225)(H,174,219)(H,175,220)(H,176,228)(H,177,233)(H,178,234)(H,179,215)(H,180,210)(H,181,221)(H,182,222)(H,183,235)(H,184,206)(H,185,230)(H,186,226)(H,187,218)(H,188,229)(H,207,208)(H4,155,156,158)/t73-,74-,75-,76-,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96?,97+,98+,99+,100+,101+,102-,103-,112+,113+,114+,115+,116+/m1/s1 D0H0GJ DRUGINKE YNPHTODKUNFPBE-HJMCUHAQSA-N D0H0GJ DRUGSMIL CCCCC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N3CCCC3C(=O)N)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N D0H0GJ HIGHSTAT Investigative D0H0MK DRUG__ID D0H0MK D0H0MK DRUGINCH 1S/C44H69N11O12S2/c1-8-24(5)36-42(65)50-27(14-15-32(45)56)38(61)51-30(20-33(46)57)39(62)52-31(41(64)55-44(6,7)43(66)53-28(18-23(3)4)37(60)48-21-34(47)58)22-69-68-17-16-35(59)49-29(40(63)54-36)19-25-10-12-26(13-11-25)67-9-2/h10-13,23-24,27-31,36H,8-9,14-22H2,1-7H3,(H2,45,56)(H2,46,57)(H2,47,58)(H,48,60)(H,49,59)(H,50,65)(H,51,61)(H,52,62)(H,53,66)(H,54,63)(H,55,64)/t24-,27-,28-,29-,30-,31-,36-/m0/s1 D0H0MK DRUGINKE OGLIRWYQKYWIBI-YGTZAJLESA-N D0H0MK DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0H0MK HIGHSTAT Investigative D0H3IS DRUG__ID D0H3IS D0H3IS DRUGINCH 1S/C67H101N21O19/c1-5-34(4)54(86-60(100)44(26-35-29-76-39-12-7-6-11-37(35)39)83-57(97)42(18-21-53(93)94)78-59(99)45(28-52(71)92)82-55(95)38(68)31-89)63(103)81-43(17-20-51(70)91)64(104)87-23-9-14-48(87)61(101)79-40(13-8-22-75-67(72)73)56(96)84-46(25-33(2)3)65(105)88-24-10-15-49(88)62(102)80-41(16-19-50(69)90)58(98)85-47(66(106)107)27-36-30-74-32-77-36/h6-7,11-12,29-30,32-34,38,40-49,54,76,89H,5,8-10,13-28,31,68H2,1-4H3,(H2,69,90)(H2,70,91)(H2,71,92)(H,74,77)(H,78,99)(H,79,101)(H,80,102)(H,81,103)(H,82,95)(H,83,97)(H,84,96)(H,85,98)(H,86,100)(H,93,94)(H,106,107)(H4,72,73,75)/t34-,38-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,54-/m0/s1 D0H3IS DRUGINKE BMZQNOXMUPLPCR-PBLORMCUSA-N D0H3IS DRUGSMIL CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)N2CCCC2C(=O)NC(CCC(=O)N)C(=O)NC(CC3=CN=CN3)C(=O)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(CO)N D0H3IS HIGHSTAT Investigative D0H3RO DRUG__ID D0H3RO D0H3RO DRUGINCH 1S/C55H94N6O14/c1-14-43-55(10,68)48(64)37(6)59(11)30-33(2)28-53(8,67)50(35(4)47(36(5)51(66)73-43)74-45-29-54(9,70-13)49(65)38(7)72-45)75-52-46(63)42(27-34(3)71-52)60(12)31-39-22-24-40(25-23-39)41-32-61(58-56-41)26-20-18-16-15-17-19-21-44(62)57-69/h22-25,32-38,42-43,45-50,52,63-65,67-69H,14-21,26-31H2,1-13H3,(H,57,62)/t33-,34-,35+,36-,37-,38+,42+,43-,45+,46-,47+,48-,49+,50-,52+,53-,54-,55-/m1/s1 D0H3RO DRUGINKE ZZONRCLYCNUZKQ-IEOJUODTSA-N D0H3RO DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O D0H3RO HIGHSTAT Investigative D0H3UO DRUG__ID D0H3UO D0H3UO DRUGINCH 1S/C26H44N4O7/c1-2-30(23(32)10-6-9-18-11-13-27-14-12-18)17-22(31)28-20(16-24(33)34)25(35)29-21(26(36)37)15-19-7-4-3-5-8-19/h18-21,27H,2-17H2,1H3,(H,28,31)(H,29,35)(H,33,34)(H,36,37)/t20-,21-/m0/s1 D0H3UO DRUGINKE RCNHPBQFWAPIOX-SFTDATJTSA-N D0H3UO DRUGSMIL CCN(CC(=O)NC(CC(=O)O)C(=O)NC(CC1CCCCC1)C(=O)O)C(=O)CCCC2CCNCC2 D0H3UO HIGHSTAT Investigative D0H4WH DRUG__ID D0H4WH D0H4WH DRUGINCH 1S/C72H98N16O17S2/c1-40(75)61(93)77-36-58(92)78-56-38-106-107-39-57(72(104)105)86-68(100)55(37-89)85-71(103)60(42(3)91)88-67(99)53(33-45-23-11-6-12-24-45)84-70(102)59(41(2)90)87-63(95)50(28-16-18-30-74)79-66(98)54(34-46-35-76-48-26-14-13-25-47(46)48)83-65(97)52(32-44-21-9-5-10-22-44)82-64(96)51(31-43-19-7-4-8-20-43)81-62(94)49(80-69(56)101)27-15-17-29-73/h4-14,19-26,35,40-42,49-57,59-60,76,89-91H,15-18,27-34,36-39,73-75H2,1-3H3,(H,77,93)(H,78,92)(H,79,98)(H,80,101)(H,81,94)(H,82,96)(H,83,97)(H,84,102)(H,85,103)(H,86,100)(H,87,95)(H,88,99)(H,104,105)/t40-,41+,42+,49+,50-,51+,52-,53-,54-,55-,56+,57-,59+,60+/m0/s1 D0H4WH DRUGINKE ZIHRAPFYJSDXSV-BVGUNDCQSA-N D0H4WH DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O D0H4WH HIGHSTAT Investigative D0H5QU DRUG__ID D0H5QU D0H5QU DRUGINCH 1S/C79H117N31O26S6/c80-14-4-3-9-38-61(120)97-42(17-34-22-91-37-8-2-1-7-36(34)37)65(124)107-51-28-139-142-32-55(109-67(126)44(19-56(81)114)99-64(123)41-12-13-58(116)93-41)77(136)110-52-29-140-141-31-54(76(135)105-50(60(83)119)27-137-138-30-53(108-68(127)45(20-57(82)115)100-74(52)133)75(134)104-49(26-113)72(131)103-48(25-112)71(130)94-38)106-63(122)40(11-6-16-90-79(86)87)95-70(129)47(24-111)102-66(125)43(18-35-23-88-33-92-35)98-69(128)46(21-59(117)118)101-62(121)39(96-73(51)132)10-5-15-89-78(84)85/h1-2,7-8,22-23,33,38-55,91,111-113H,3-6,9-21,24-32,80H2,(H2,81,114)(H2,82,115)(H2,83,119)(H,88,92)(H,93,116)(H,94,130)(H,95,129)(H,96,132)(H,97,120)(H,98,128)(H,99,123)(H,100,133)(H,101,121)(H,102,125)(H,103,131)(H,104,134)(H,105,135)(H,106,122)(H,107,124)(H,108,127)(H,109,126)(H,110,136)(H,117,118)(H4,84,85,89)(H4,86,87,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-/m0/s1 D0H5QU DRUGINKE ZZZNHYZYRLIYMB-JPPSNFOMSA-N D0H5QU DRUGSMIL C1CC(=O)NC1C(=O)NC(CC(=O)N)C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC4CSSCC(C(=O)NC(C(=O)NC(CSSCC(NC4=O)C(=O)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC5=CNC6=CC=CC=C65)CCCCN)CO)CO)CC(=O)N)NC2=O)CCCNC(=N)N)CO)CC7=CN=CN7)CC(=O)O)CCCNC(=N)N D0H5QU HIGHSTAT Investigative D0H5WL DRUG__ID D0H5WL D0H5WL DRUGINCH 1S/C43H36N10O17S4.4Na/c1-52-19-23(13-35(52)41(56)50-31-7-9-37(73(65,66)67)29-15-25(71(59,60)61)3-5-27(29)31)46-39(54)33-11-21(17-44-33)48-43(58)49-22-12-34(45-18-22)40(55)47-24-14-36(53(2)20-24)42(57)51-32-8-10-38(74(68,69)70)30-16-26(72(62,63)64)4-6-28(30)32;;;;/h3-20,44-45H,1-2H3,(H,46,54)(H,47,55)(H,50,56)(H,51,57)(H2,48,49,58)(H,59,60,61)(H,62,63,64)(H,65,66,67)(H,68,69,70);;;;/q;4*+1/p-4 D0H5WL DRUGINKE QHDNOGPTZQFRDE-UHFFFAOYSA-J D0H5WL DRUGSMIL CN1C=C(C=C1C(=O)NC2=C3C=CC(=CC3=C(C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC(=CN4)NC(=O)NC5=CNC(=C5)C(=O)NC6=CN(C(=C6)C(=O)NC7=C8C=CC(=CC8=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+].[Na+] D0H5WL HIGHSTAT Investigative D0H6LR DRUG__ID D0H6LR D0H6LR DRUGINCH 1S/C59H77N11O10/c1-36(2)51-59(80)70(49(33-39-17-8-5-9-18-39)58(79)69-52(37(3)71)53(61)74)30-14-22-50(73)63-29-28-62-46(31-38-15-6-4-7-16-38)55(76)66-47(32-40-23-25-42(72)26-24-40)56(77)67-48(34-41-35-64-44-20-11-10-19-43(41)44)57(78)65-45(54(75)68-51)21-12-13-27-60/h4-11,15-20,23-26,35-37,45-49,51-52,62,64,71-72H,12-14,21-22,27-34,60H2,1-3H3,(H2,61,74)(H,63,73)(H,65,78)(H,66,76)(H,67,77)(H,68,75)(H,69,79)/t37-,45+,46+,47+,48+,49+,51+,52+/m1/s1 D0H6LR DRUGINKE LRUHWPFUOBQIRY-ANYMKNSJSA-N D0H6LR DRUGSMIL CC(C)C1C(=O)N(CCCC(=O)NCCNC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)CC5=CC=CC=C5)C(CC6=CC=CC=C6)C(=O)NC(C(C)O)C(=O)N D0H6LR HIGHSTAT Investigative D0H6TE DRUG__ID D0H6TE D0H6TE DRUGINCH 1S/C52H73N11O10/c1-5-6-14-44(65)41(24-31(2)3)61-51(72)43(26-35-28-54-30-56-35)59-47(68)29-63-23-10-9-13-40(52(63)73)60-48(69)32(4)57-50(71)42(25-34-27-55-38-12-8-7-11-37(34)38)62-49(70)39(20-21-45(53)66)58-46(67)22-17-33-15-18-36(64)19-16-33/h7-8,11-12,15-16,18-19,27-28,30-32,39-44,55,64-65H,5-6,9-10,13-14,17,20-26,29H2,1-4H3,(H2,53,66)(H,54,56)(H,57,71)(H,58,67)(H,59,68)(H,60,69)(H,61,72)(H,62,70)/t32?,39?,40?,41-,42?,43?,44?/m1/s1 D0H6TE DRUGINKE SXWFVLCWIVAJQD-FUEGDDJLSA-N D0H6TE DRUGSMIL CCCCC(C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)CCC5=CC=C(C=C5)O)O D0H6TE HIGHSTAT Investigative D0H6YL DRUG__ID D0H6YL D0H6YL DRUGINCH 1S/C109H159N23O44S8/c1-108(2,41-19-23-53-175-95-65-79(75-29-9-5-10-30-75)63-82(116-95)77-33-13-7-14-34-77)106-125-127-129-131(106)47-21-17-37-92(133)111-43-25-49-169-55-59-173-61-57-171-51-27-45-113-98(137)84(67-177(145,146)147)119-102(141)88(71-181(157,158)159)123-104(143)90(73-183(163,164)165)121-100(139)86(69-179(151,152)153)115-94(135)40-39-81(110)97(136)118-87(70-180(154,155)156)101(140)122-91(74-184(166,167)168)105(144)124-89(72-182(160,161)162)103(142)120-85(68-178(148,149)150)99(138)114-46-28-52-172-58-62-174-60-56-170-50-26-44-112-93(134)38-18-22-48-132-107(126-128-130-132)109(3,4)42-20-24-54-176-96-66-80(76-31-11-6-12-32-76)64-83(117-96)78-35-15-8-16-36-78/h5-16,29-36,63-66,81,84-91H,17-28,37-62,67-74,110H2,1-4H3,(H,111,133)(H,112,134)(H,113,137)(H,114,138)(H,115,135)(H,118,136)(H,119,141)(H,120,142)(H,121,139)(H,122,140)(H,123,143)(H,124,144)(H,145,146,147)(H,148,149,150)(H,151,152,153)(H,154,155,156)(H,157,158,159)(H,160,161,162)(H,163,164,165)(H,166,167,168)/t81-,84-,85-,86-,87-,88-,89-,90-,91-/m0/s1 D0H6YL DRUGINKE LBTVXEXIIAMTIW-WSJKXOGOSA-N D0H6YL DRUGSMIL CC(C)(CCCCOC1=CC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3)C4=NN=NN4CCCCC(=O)NCCCOCCOCCOCCCNC(=O)C(CS(=O)(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)CCC(C(=O)NC(CS(=O)(=O)O)C(=O)NC(CS(=O)(=O)O)C(=O)NC(CS(=O)(=O)O)C(=O)NC(CS(=O)(=O)O)C(=O)NCCCOCCOCCOCCCNC(=O)CCCCN5C(=NN=N5)C(C)(C)CCCCOC6=CC(=CC(=N6)C7=CC=CC=C7)C8=CC=CC=C8)N D0H6YL HIGHSTAT Investigative D0H6ZC DRUG__ID D0H6ZC D0H6ZC DRUGINCH 1S/C24H19N3O2/c28-24-17-5-1-2-6-19(17)26-22-18(24)14-27(21-7-3-4-11-25-21)23(22)16-8-9-20-15(13-16)10-12-29-20/h1-9,11,13,23H,10,12,14H2,(H,26,28)/t23-/m1/s1 D0H6ZC DRUGINKE NPQHDOLBQQVPMG-HSZRJFAPSA-N D0H6ZC DRUGSMIL C1COC2=C1C=C(C=C2)C3C4=C(CN3C5=CC=CC=N5)C(=O)C6=CC=CC=C6N4 D0H6ZC HIGHSTAT Investigative D0H7NY DRUG__ID D0H7NY D0H7NY DRUGINCH 1S/C76H123N27O22/c1-39(91-58(109)37-90-73(123)60(43(5)105)103-71(121)52(33-45-20-10-7-11-21-45)95-59(110)36-88-57(108)35-89-65(115)46(79)32-44-18-8-6-9-19-44)62(112)96-49(24-16-30-86-75(82)83)68(118)99-48(23-13-15-29-78)69(119)102-54(38-104)72(122)94-42(4)63(113)97-50(25-17-31-87-76(84)85)67(117)98-47(22-12-14-28-77)66(116)93-40(2)61(111)92-41(3)64(114)101-53(34-56(81)107)70(120)100-51(74(124)125)26-27-55(80)106/h6-11,18-21,39-43,46-54,60,104-105H,12-17,22-38,77-79H2,1-5H3,(H2,80,106)(H2,81,107)(H,88,108)(H,89,115)(H,90,123)(H,91,109)(H,92,111)(H,93,116)(H,94,122)(H,95,110)(H,96,112)(H,97,113)(H,98,117)(H,99,118)(H,100,120)(H,101,114)(H,102,119)(H,103,121)(H,124,125)(H4,82,83,86)(H4,84,85,87)/t39-,40-,41-,42-,43+,46-,47-,48-,49-,50-,51-,52-,53-,54-,60-/m0/s1 D0H7NY DRUGINKE FMVUBOOWCUPBBL-OVWUADNCSA-N D0H7NY DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0H7NY HIGHSTAT Investigative D0H8PI DRUG__ID D0H8PI D0H8PI DRUGINCH 1S/C16H12O2/c17-14-7-4-11(5-8-14)12-6-9-15-13(10-12)2-1-3-16(15)18/h1-10,17-18H D0H8PI DRUGINKE MBESMLNJQCOTRU-UHFFFAOYSA-N D0H8PI DRUGSMIL C1=CC2=C(C=CC(=C2)C3=CC=C(C=C3)O)C(=C1)O D0H8PI HIGHSTAT Investigative D0H8WV DRUG__ID D0H8WV D0H8WV DRUGINCH 1S/C49H65N9O16/c1-25(54-44(68)32(50)19-28-10-14-30(60)15-11-28)43(67)56-33(20-27-7-4-3-5-8-27)45(69)53-23-38(63)55-34(21-29-12-16-31(61)17-13-29)48(72)58-18-6-9-35(58)46(70)57-39(47(71)52-22-37(51)62)26(2)73-49-42(66)41(65)40(64)36(24-59)74-49/h3-5,7-8,10-17,25-26,32-36,39-42,49,59-61,64-66H,6,9,18-24,50H2,1-2H3,(H2,51,62)(H,52,71)(H,53,69)(H,54,68)(H,55,63)(H,56,67)(H,57,70)/t25-,26?,32+,33+,34+,35+,36?,39+,40?,41?,42?,49?/m1/s1 D0H8WV DRUGINKE ZXTWNLGGKJOAMK-XUDWIOABSA-N D0H8WV DRUGSMIL CC(C(C(=O)NCC(=O)N)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)OC5C(C(C(C(O5)CO)O)O)O D0H8WV HIGHSTAT Investigative D0H9AV DRUG__ID D0H9AV D0H9AV DRUGINCH 1S/C67H97N11O17S/c1-6-38(4)56(76-66(94)57(54(42-24-15-9-16-25-42)43-26-17-10-18-27-43)77-59(87)44(29-30-51(80)81)70-62(90)47(34-52(82)83)69-39(5)79)65(93)73-46(33-41-22-13-8-14-23-41)61(89)74-49(36-96)67(95)78-31-19-28-50(78)64(92)72-45(32-40-20-11-7-12-21-40)60(88)71-48(35-53(84)85)63(91)75-55(37(2)3)58(68)86/h9-10,15-18,24-27,37-38,40-41,44-50,54-57,96H,6-8,11-14,19-23,28-36H2,1-5H3,(H2,68,86)(H,69,79)(H,70,90)(H,71,88)(H,72,92)(H,73,93)(H,74,89)(H,75,91)(H,76,94)(H,77,87)(H,80,81)(H,82,83)(H,84,85)/t38?,44-,45?,46-,47-,48-,49-,50+,55-,56-,57-/m0/s1 D0H9AV DRUGINKE HHWSXWBIJCFKKB-VQTAYXAZSA-N D0H9AV DRUGSMIL CCC(C)C(C(=O)NC(CC1CCCCC1)C(=O)NC(CS)C(=O)N2CCCC2C(=O)NC(CC3CCCCC3)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)N)NC(=O)C(C(C4=CC=CC=C4)C5=CC=CC=C5)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0H9AV HIGHSTAT Investigative D0H9QA DRUG__ID D0H9QA D0H9QA DRUGINCH 1S/C101H169N23O21/c1-10-11-12-13-14-15-16-17-18-19-20-21-22-41-84(129)108-49-32-28-39-74(92(136)114-72(88(107)132)36-25-29-46-102)116-93(137)73(37-26-30-47-103)115-94(138)75(38-27-31-48-104)117-100(144)82-40-33-50-124(82)86(131)59-111-91(135)76(51-61(2)3)118-95(139)77(52-62(4)5)119-97(141)79(54-66-42-44-68(127)45-43-66)113-85(130)58-110-89(133)64(8)112-99(143)81(60-125)122-98(142)80(56-83(106)128)120-96(140)78(53-63(6)7)121-101(145)87(65(9)126)123-90(134)70(105)55-67-57-109-71-35-24-23-34-69(67)71/h23-24,34-35,42-45,57,61-65,70,72-82,87,109,125-127H,10-22,25-33,36-41,46-56,58-60,102-105H2,1-9H3,(H2,106,128)(H2,107,132)(H,108,129)(H,110,133)(H,111,135)(H,112,143)(H,113,130)(H,114,136)(H,115,138)(H,116,137)(H,117,144)(H,118,139)(H,119,141)(H,120,140)(H,121,145)(H,122,142)(H,123,134)/t64-,65+,70-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,87-/m0/s1 D0H9QA DRUGINKE CYRNKOJFIDMNMV-WCXAHCKYSA-N D0H9QA DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)N D0H9QA HIGHSTAT Investigative D0HI2N DRUG__ID D0HI2N D0HI2N DRUGINCH 1S/C48H67N11O11S2/c49-19-17-32(42(64)52-26-40(51)62)54-47(69)38-12-7-20-59(38)48(70)37-27-72-71-21-18-41(63)53-33(24-30-13-15-31(60)16-14-30)43(65)55-34(22-28-8-3-1-4-9-28)44(66)56-35(23-29-10-5-2-6-11-29)45(67)57-36(25-39(50)61)46(68)58-37/h1,3-4,8-9,13-16,29,32-38,60H,2,5-7,10-12,17-27,49H2,(H2,50,61)(H2,51,62)(H,52,64)(H,53,63)(H,54,69)(H,55,65)(H,56,66)(H,57,67)(H,58,68)/t32-,33-,34-,35-,36-,37-,38-/m0/s1 D0HI2N DRUGINKE DPVYQFBOSXXNLG-CXWHUAPYSA-N D0HI2N DRUGSMIL C1CCC(CC1)CC2C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N2)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N5CCCC5C(=O)NC(CCN)C(=O)NCC(=O)N)CC(=O)N D0HI2N HIGHSTAT Investigative D0HK7B DRUG__ID D0HK7B D0HK7B DRUGINCH 1S/C82H127N27O23/c1-43(97-64(116)41-96-79(130)66(46(4)111)109-77(128)57(36-48-19-9-6-10-20-48)100-65(117)40-94-63(115)39-95-70(121)51(85)35-47-17-7-5-8-18-47)67(118)101-54(23-15-33-92-81(88)89)71(122)104-53(22-12-14-32-84)74(125)108-60(42-110)78(129)99-44(2)68(119)102-55(24-16-34-93-82(90)91)72(123)103-52(21-11-13-31-83)73(124)107-58(37-49-25-27-50(112)28-26-49)75(126)98-45(3)69(120)106-59(38-62(87)114)76(127)105-56(80(131)132)29-30-61(86)113/h5-10,17-20,25-28,43-46,51-60,66,110-112H,11-16,21-24,29-42,83-85H2,1-4H3,(H2,86,113)(H2,87,114)(H,94,115)(H,95,121)(H,96,130)(H,97,116)(H,98,126)(H,99,129)(H,100,117)(H,101,118)(H,102,119)(H,103,123)(H,104,122)(H,105,127)(H,106,120)(H,107,124)(H,108,125)(H,109,128)(H,131,132)(H4,88,89,92)(H4,90,91,93)/t43-,44-,45-,46+,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,66-/m0/s1 D0HK7B DRUGINKE NTZGMAAQXGNGFH-VDVVPONDSA-N D0HK7B DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)O D0HK7B HIGHSTAT Investigative D0HN2U DRUG__ID D0HN2U D0HN2U DRUGINCH 1S/C54H76N14O10/c1-30(2)21-41(47(57)71)65-52(76)42(22-31(3)4)66-53(77)44(25-35-27-58-29-60-35)62-46(70)28-68-20-12-11-17-40(54(68)78)64-48(72)32(5)61-51(75)43(24-34-26-59-38-16-10-9-15-36(34)38)67-50(74)39(18-19-45(56)69)63-49(73)37(55)23-33-13-7-6-8-14-33/h6-10,13-16,26-27,29-32,37,39-44,59H,11-12,17-25,28,55H2,1-5H3,(H2,56,69)(H2,57,71)(H,58,60)(H,61,75)(H,62,70)(H,63,73)(H,64,72)(H,65,76)(H,66,77)(H,67,74)/t32?,37-,39?,40?,41?,42?,43?,44?/m1/s1 D0HN2U DRUGINKE FTAPYHDWDYGKIH-CJGWHWQJSA-N D0HN2U DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)C(CC5=CC=CC=C5)N D0HN2U HIGHSTAT Investigative D0I2HH DRUG__ID D0I2HH D0I2HH DRUGINCH 1S/C159H244N44O41/c1-79(2)60-104(180-119(211)74-173-131(217)87(17)177-138(224)105(61-80(3)4)186-136(222)100(50-36-56-169-158(165)243)182-142(228)110(67-96-71-167-78-176-96)191-155(241)129(90(20)207)201-153(239)126(85(13)14)197-145(231)109(179-91(21)208)66-95-70-171-98-47-32-31-46-97(95)98)140(226)187-106(62-81(5)6)141(227)194-114(77-205)147(233)183-101(51-37-57-170-159(166)244)137(223)193-113(76-204)133(219)174-72-118(210)172-73-120(212)195-124(83(9)10)152(238)198-125(84(11)12)151(237)184-102(49-35-55-168-157(163)164)134(220)181-99(48-33-34-54-160)135(221)189-111(68-117(161)209)143(229)188-108(65-94-44-29-24-30-45-94)144(230)199-127(86(15)16)156(242)203-59-39-53-116(203)149(235)200-128(89(19)206)154(240)192-112(69-122(214)215)146(232)196-123(82(7)8)150(236)175-75-121(213)202-58-38-52-115(202)148(234)190-107(64-93-42-27-23-28-43-93)139(225)178-88(18)132(218)185-103(130(162)216)63-92-40-25-22-26-41-92/h22-32,40-47,70-71,78-90,99-116,123-129,171,204-207H,33-39,48-69,72-77,160H2,1-21H3,(H2,161,209)(H2,162,216)(H,167,176)(H,172,210)(H,173,217)(H,174,219)(H,175,236)(H,177,224)(H,178,225)(H,179,208)(H,180,211)(H,181,220)(H,182,228)(H,183,233)(H,184,237)(H,185,218)(H,186,222)(H,187,226)(H,188,229)(H,189,221)(H,190,234)(H,191,241)(H,192,240)(H,193,223)(H,194,227)(H,195,212)(H,196,232)(H,197,231)(H,198,238)(H,199,230)(H,200,235)(H,201,239)(H,214,215)(H4,163,164,168)(H3,165,169,243)(H3,166,170,244)/t87-,88-,89+,90+,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,123-,124-,125-,126-,127-,128-,129-/m0/s1 D0I2HH DRUGINKE VDLYRUOYUCCKKR-BQWGFPJXSA-N D0I2HH DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=O)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC7=CNC8=CC=CC=C87)NC(=O)C D0I2HH HIGHSTAT Investigative D0I2KW DRUG__ID D0I2KW D0I2KW DRUGINCH 1S/C59H81N11O15/c1-32(2)46(67-52(78)41(30-45(73)74)64-55(81)48(35(6)71)68-58(85)59(7,8)69-56(82)47(33(3)4)66-50(76)39(60)27-36-19-12-9-13-20-36)54(80)61-31-44(72)70-26-18-25-43(70)53(79)63-40(28-37-21-14-10-15-22-37)51(77)62-34(5)49(75)65-42(57(83)84)29-38-23-16-11-17-24-38/h9-17,19-24,32-35,39-43,46-48,71H,18,25-31,60H2,1-8H3,(H,61,80)(H,62,77)(H,63,79)(H,64,81)(H,65,75)(H,66,76)(H,67,78)(H,68,85)(H,69,82)(H,73,74)(H,83,84)/t34-,35+,39-,40-,41-,42-,43-,46-,47-,48-/m0/s1 D0I2KW DRUGINKE GUILBDPDYMIGBQ-GBWZQAKSSA-N D0I2KW DRUGSMIL CC(C)C(C(=O)NC(C)(C)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=CC=C4)N D0I2KW HIGHSTAT Investigative D0I2PK DRUG__ID D0I2PK D0I2PK DRUGINCH 1S/C148H236N44O38/c1-73(2)56-95(170-109(200)68-163-121(206)81(17)167-128(213)96(57-74(3)4)176-126(211)91(45-33-51-159-146(152)153)172-132(217)100(62-89-65-158-72-166-89)181-144(229)119(84(20)196)190-141(226)114(77(9)10)169-85(21)197)130(215)177-97(58-75(5)6)131(216)184-104(71-194)136(221)173-92(46-34-52-160-147(154)155)127(212)183-103(70-193)123(208)164-66-108(199)162-67-110(201)185-115(78(11)12)142(227)187-116(79(13)14)140(225)174-93(47-35-53-161-148(156)157)124(209)171-90(44-31-32-50-149)125(210)179-101(63-107(150)198)133(218)178-99(61-88-42-29-24-30-43-88)134(219)188-117(80(15)16)145(230)192-55-37-49-106(192)138(223)189-118(83(19)195)143(228)182-102(64-112(203)204)135(220)186-113(76(7)8)139(224)165-69-111(202)191-54-36-48-105(191)137(222)180-98(60-87-40-27-23-28-41-87)129(214)168-82(18)122(207)175-94(120(151)205)59-86-38-25-22-26-39-86/h22-30,38-43,65,72-84,90-106,113-119,193-196H,31-37,44-64,66-71,149H2,1-21H3,(H2,150,198)(H2,151,205)(H,158,166)(H,162,199)(H,163,206)(H,164,208)(H,165,224)(H,167,213)(H,168,214)(H,169,197)(H,170,200)(H,171,209)(H,172,217)(H,173,221)(H,174,225)(H,175,207)(H,176,211)(H,177,215)(H,178,218)(H,179,210)(H,180,222)(H,181,229)(H,182,228)(H,183,212)(H,184,216)(H,185,201)(H,186,220)(H,187,227)(H,188,219)(H,189,223)(H,190,226)(H,203,204)(H4,152,153,159)(H4,154,155,160)(H4,156,157,161)/t81-,82-,83+,84+,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,113-,114-,115-,116-,117-,118-,119-/m0/s1 D0I2PK DRUGINKE KPPNHHWOHREFKE-POKONUJPSA-N D0I2PK DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NCC(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)NC(C)C(=O)NC(CC5=CC=CC=C5)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC6=CN=CN6)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C D0I2PK HIGHSTAT Investigative D0I3AH DRUG__ID D0I3AH D0I3AH DRUGINCH 1S/C70H109N21O13/c1-5-43(4)58(65(101)87-50(25-16-34-80-70(76)77)66(102)91-35-17-26-55(91)64(100)88-51(67(103)104)22-12-13-31-71)90-61(97)49(24-15-33-79-69(74)75)85-60(96)48(23-14-32-78-68(72)73)86-62(98)53(36-42(2)3)89-63(99)54(38-44-18-8-6-9-19-44)84-57(94)41-82-56(93)40-83-59(95)52(37-45-27-29-47(92)30-28-45)81-39-46-20-10-7-11-21-46/h6-11,18-21,27-30,42-43,48-55,58,81,92H,5,12-17,22-26,31-41,71H2,1-4H3,(H,82,93)(H,83,95)(H,84,94)(H,85,96)(H,86,98)(H,87,101)(H,88,100)(H,89,99)(H,90,97)(H,103,104)(H4,72,73,78)(H4,74,75,79)(H4,76,77,80)/t43-,48-,49-,50-,51-,52-,53-,54-,55-,58-/m0/s1 D0I3AH DRUGINKE SCUDNMPTYPZVCN-RSZDUZASSA-N D0I3AH DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)NCC4=CC=CC=C4 D0I3AH HIGHSTAT Investigative D0I3BL DRUG__ID D0I3BL D0I3BL DRUGINCH 1S/C21H27N3O6/c1-8-17(26)13-12(18(27)19(8)29-3)11(7-25)24-16-14-9(6-10(20(24)28)22(14)2)21-23(15(13)16)4-5-30-21/h9-11,14-16,20-21,25,28H,4-7H2,1-3H3/t9?,10?,11-,14?,15+,16+,20-,21+/m0/s1 D0I3BL DRUGINKE SXDWNOFDSOXRRM-KZXGJYSISA-N D0I3BL DRUGSMIL CC1=C(C(=O)C2=C(C1=O)C3C4C5C(CC(N5C)C(N4C2CO)O)C6N3CCO6)OC D0I3BL HIGHSTAT Investigative D0I3HV DRUG__ID D0I3HV D0I3HV DRUGINCH 1S/C50H71N11O12S2/c1-6-28(5)43-49(71)56-33(16-17-39(51)62)45(67)57-36(23-40(52)63)46(68)59-37(26-75-74-19-18-42(65)55-35(47(69)60-43)21-29-12-14-32(15-13-29)73-7-2)50(72)61-25-31-11-9-8-10-30(31)22-38(61)48(70)58-34(20-27(3)4)44(66)54-24-41(53)64/h8-15,27-28,33-38,43H,6-7,16-26H2,1-5H3,(H2,51,62)(H2,52,63)(H2,53,64)(H,54,66)(H,55,65)(H,56,71)(H,57,67)(H,58,70)(H,59,68)(H,60,69)/t28-,33-,34-,35-,36-,37-,38-,43-/m0/s1 D0I3HV DRUGINKE XCBFBYRYXJOIRC-SXXMFYQFSA-N D0I3HV DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0I3HV HIGHSTAT Investigative D0I3IR DRUG__ID D0I3IR D0I3IR DRUGINCH 1S/C35H34O12/c1-5-16(2)10-17(3)6-8-20(37)13-23-30(35(46,18(4)36)33(44)31(23)42)22-15-27(41)26(40)14-21(22)29-32(43)28(47-34(29)45)12-19-7-9-24(38)25(39)11-19/h6-12,14-16,33,38-41,43-44,46H,5,13H2,1-4H3/b8-6+,17-10+,28-12- D0I3IR DRUGINKE KFMTUTLQSGURRM-MARNYXESSA-N D0I3IR DRUGSMIL CCC(C)C=C(C)C=CC(=O)CC1=C(C(C(C1=O)O)(C(=O)C)O)C2=CC(=C(C=C2C3=C(C(=CC4=CC(=C(C=C4)O)O)OC3=O)O)O)O D0I3IR HIGHSTAT Investigative D0I3KG DRUG__ID D0I3KG D0I3KG DRUGINCH 1S/C87H135N29O22/c1-47(104-69(122)45-103-84(136)71(49(3)118)116-82(134)62(39-51-22-8-5-9-23-51)106-70(123)44-101-68(121)43-102-74(126)54(91)38-50-20-6-4-7-21-50)72(124)107-59(29-18-36-98-86(94)95)76(128)111-58(28-14-17-35-90)79(131)115-65(46-117)83(135)105-48(2)73(125)108-60(30-19-37-99-87(96)97)77(129)109-56(26-12-15-33-88)75(127)110-57(27-13-16-34-89)78(130)113-63(40-52-42-100-55-25-11-10-24-53(52)55)80(132)114-64(41-67(93)120)81(133)112-61(85(137)138)31-32-66(92)119/h4-11,20-25,42,47-49,54,56-65,71,100,117-118H,12-19,26-41,43-46,88-91H2,1-3H3,(H2,92,119)(H2,93,120)(H,101,121)(H,102,126)(H,103,136)(H,104,122)(H,105,135)(H,106,123)(H,107,124)(H,108,125)(H,109,129)(H,110,127)(H,111,128)(H,112,133)(H,113,130)(H,114,132)(H,115,131)(H,116,134)(H,137,138)(H4,94,95,98)(H4,96,97,99)/t47-,48-,49+,54-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,71-/m0/s1 D0I3KG DRUGINKE URYINPOXJIHSDS-PBUARHPHSA-N D0I3KG DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=CC=C4)N)O D0I3KG HIGHSTAT Investigative D0I3QU DRUG__ID D0I3QU D0I3QU DRUGCOMP Isis Pharmaceuticals D0I3QU THERCLAS Anticancer Agents D0I3QU DRUGTYPE Antisense drug D0I3QU HIGHSTAT Investigative D0I4MQ DRUG__ID D0I4MQ D0I4MQ DRUGINCH 1S/C52H94N30O12/c53-37-33-38(74-24-73-37)82(25-75-33)45-35(85)34(84)36(94-45)44(91)66-17-3-1-2-16-32(83)76-26(10-4-18-67-47(54)55)39(86)77-27(11-5-19-68-48(56)57)40(87)78-28(12-6-20-69-49(58)59)41(88)79-29(13-7-21-70-50(60)61)42(89)80-30(14-8-22-71-51(62)63)43(90)81-31(46(92)93)15-9-23-72-52(64)65/h24-31,34-36,45,84-85H,1-23H2,(H,66,91)(H,76,83)(H,77,86)(H,78,87)(H,79,88)(H,80,89)(H,81,90)(H,92,93)(H2,53,73,74)(H4,54,55,67)(H4,56,57,68)(H4,58,59,69)(H4,60,61,70)(H4,62,63,71)(H4,64,65,72)/t26-,27-,28-,29-,30-,31-,34-,35+,36-,45+/m0/s1 D0I4MQ DRUGINKE QLSCMEHEXBNFGR-HDLKDVBUSA-N D0I4MQ DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D0I4MQ HIGHSTAT Investigative D0I5XM DRUG__ID D0I5XM D0I5XM DRUGINCH 1S/C52H88N6O14/c1-14-40-52(10,65)45(61)34(6)56(11)27-30(2)25-50(8,64)47(32(4)44(33(5)48(63)70-40)71-42-26-51(9,67-13)46(62)35(7)69-42)72-49-43(60)39(24-31(3)68-49)57(12)28-36-19-21-37(22-20-36)38-29-58(55-53-38)23-17-15-16-18-41(59)54-66/h19-22,29-35,39-40,42-47,49,60-62,64-66H,14-18,23-28H2,1-13H3,(H,54,59)/t30-,31-,32+,33-,34-,35+,39+,40-,42+,43-,44+,45-,46+,47-,49+,50-,51-,52-/m1/s1 D0I5XM DRUGINKE BCHUJJCIGPEYFV-RAYHFQHHSA-N D0I5XM DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O D0I5XM HIGHSTAT Investigative D0I6XA DRUG__ID D0I6XA D0I6XA DRUGINCH 1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17)/t10-,11+/m1/s1 D0I6XA DRUGINKE IOSAAWHGJUZBOG-MNOVXSKESA-N D0I6XA DRUGSMIL CCCCCCC(C(C)O)N1C=NC2=C(N=CN=C21)N D0I6XA HIGHSTAT Investigative D0I7CE DRUG__ID D0I7CE D0I7CE DRUGINCH 1S/C13H13NO2S/c15-11-2-1-8(5-12(11)16)10-6-14-7-13-9(10)3-4-17-13/h1-5,10,14-16H,6-7H2/t10-/m0/s1 D0I7CE DRUGINKE QDKUSZZMIFQVPN-JTQLQIEISA-N D0I7CE DRUGSMIL C1C(C2=C(CN1)SC=C2)C3=CC(=C(C=C3)O)O D0I7CE HIGHSTAT Investigative D0I7WD DRUG__ID D0I7WD D0I7WD DRUGINCH 1S/C154H231N41O47/c1-16-79(10)124(151(240)172-82(13)129(218)181-107(62-88-65-164-93-36-24-23-35-91(88)93)141(230)183-103(58-76(4)5)142(231)192-122(77(6)7)149(238)180-95(37-25-27-54-155)132(221)167-69-116(206)173-94(40-30-56-163-154(159)160)131(220)165-67-113(158)203)194-143(232)105(59-85-31-19-17-20-32-85)184-138(227)101(49-53-120(212)213)178-135(224)96-38-26-28-55-162-114(204)41-29-39-97(136(225)177-99(46-50-112(157)202)134(223)171-80(11)127(216)170-81(12)128(217)175-96)176-137(226)100(48-52-119(210)211)179-139(228)102(57-75(2)3)182-140(229)104(61-87-42-44-90(201)45-43-87)185-146(235)109(71-196)188-148(237)111(73-198)189-150(239)123(78(8)9)193-145(234)108(64-121(214)215)186-147(236)110(72-197)190-153(242)126(84(15)200)195-144(233)106(60-86-33-21-18-22-34-86)187-152(241)125(83(14)199)191-117(207)70-168-133(222)98(47-51-118(208)209)174-115(205)68-166-130(219)92(156)63-89-66-161-74-169-89/h17-24,31-36,42-45,65-66,74-84,92,94-111,122-126,164,196-201H,16,25-30,37-41,46-64,67-73,155-156H2,1-15H3,(H2,157,202)(H2,158,203)(H,161,169)(H,162,204)(H,165,220)(H,166,219)(H,167,221)(H,168,222)(H,170,216)(H,171,223)(H,172,240)(H,173,206)(H,174,205)(H,175,217)(H,176,226)(H,177,225)(H,178,224)(H,179,228)(H,180,238)(H,181,218)(H,182,229)(H,183,230)(H,184,227)(H,185,235)(H,186,236)(H,187,241)(H,188,237)(H,189,239)(H,190,242)(H,191,207)(H,192,231)(H,193,234)(H,194,232)(H,195,233)(H,208,209)(H,210,211)(H,212,213)(H,214,215)(H4,159,160,163)/t79-,80-,81-,82-,83-,84-,92-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,122-,123-,124-,125-,126-/m0/s1 D0I7WD DRUGINKE FZOFJRYZQZCXIG-XPPJIRRWSA-N D0I7WD DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C4CCCCNC(=O)CCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)C)C)CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D0I7WD HIGHSTAT Investigative D0I8BC DRUG__ID D0I8BC D0I8BC DRUGCOMP Humanetics Corp D0I8BC DRUGTYPE Small molecular drug D0I8BC DRUGSMIL C1=CN(C=CC1=C[NH+]=O)COCN2C=CC(=C[NH+]=O)C=C2.[Br-].[Br-] D0I8BC HIGHSTAT Investigative D0I8HL DRUG__ID D0I8HL D0I8HL DRUGINCH 1S/C58H87N19O13S/c59-36(13-4-18-66-56(60)61)47(81)71-37(14-5-19-67-57(62)63)51(85)74-21-7-17-42(74)53(87)76-29-34(79)25-43(76)49(83)69-27-46(80)70-39(26-35-12-8-22-91-35)48(82)73-40(30-78)52(86)75-28-33-10-2-1-9-31(33)23-45(75)54(88)77-41-16-3-11-32(41)24-44(77)50(84)72-38(55(89)90)15-6-20-68-58(64)65/h1-2,8-10,12,22,32,34,36-45,78-79H,3-7,11,13-21,23-30,59H2,(H,69,83)(H,70,80)(H,71,81)(H,72,84)(H,73,82)(H,89,90)(H4,60,61,66)(H4,62,63,67)(H4,64,65,68)/t32?,34?,36-,37-,38?,39?,40-,41?,42-,43-,44?,45?/m1/s1 D0I8HL DRUGINKE TZXGWOFUQYJXKR-OSXXQWSASA-N D0I8HL DRUGSMIL C1CC2CC(N(C2C1)C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O D0I8HL HIGHSTAT Investigative D0I8HY DRUG__ID D0I8HY D0I8HY DRUGINCH 1S/C61H95N17O13S/c1-36(2)31-43(54(85)71-40(51(65)82)25-30-92-3)70-50(81)34-69-52(83)44(32-37-15-6-4-7-16-37)74-55(86)45(33-38-17-8-5-9-18-38)75-56(87)46(35-79)76-53(84)41(23-24-49(64)80)72-57(88)48-22-14-29-78(48)60(91)42(20-10-11-26-62)73-58(89)47-21-13-28-77(47)59(90)39(63)19-12-27-68-61(66)67/h4-9,15-18,36,39-48,79H,10-14,19-35,62-63H2,1-3H3,(H2,64,80)(H2,65,82)(H,69,83)(H,70,81)(H,71,85)(H,72,88)(H,73,89)(H,74,86)(H,75,87)(H,76,84)(H4,66,67,68)/t39-,40-,41-,42-,43-,44-,45-,46-,47-,48-/m0/s1 D0I8HY DRUGINKE MXTQBPBXNQHASJ-BHEJXMHWSA-N D0I8HY DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCCN)NC(=O)C4CCCN4C(=O)C(CCCN=C(N)N)N D0I8HY HIGHSTAT Investigative D0I8SJ DRUG__ID D0I8SJ D0I8SJ DRUGINCH 1S/C90H127N25O26S/c1-47(2)74(87(139)100-43-73(125)126)113-86(138)68-21-13-31-114(68)88(140)59(18-9-10-29-91)102-70(120)42-99-76(128)62(36-50-40-98-55-17-8-7-16-53(50)55)108-77(129)56(19-11-30-97-90(94)95)103-80(132)60(34-48-14-5-4-6-15-48)106-82(134)63(37-51-41-96-46-101-51)109-78(130)57(26-27-71(121)122)104-79(131)58(28-33-142-3)105-83(135)65(44-116)111-81(133)61(35-49-22-24-52(118)25-23-49)107-84(136)66(45-117)112-85(137)67-20-12-32-115(67)89(141)64(39-72(123)124)110-75(127)54(92)38-69(93)119/h4-8,14-17,22-25,40-41,46-47,54,56-68,74,98,116-118H,9-13,18-21,26-39,42-45,91-92H2,1-3H3,(H2,93,119)(H,96,101)(H,99,128)(H,100,139)(H,102,120)(H,103,132)(H,104,131)(H,105,135)(H,106,134)(H,107,136)(H,108,129)(H,109,130)(H,110,127)(H,111,133)(H,112,137)(H,113,138)(H,121,122)(H,123,124)(H,125,126)(H4,94,95,97)/t54-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,74-/m0/s1 D0I8SJ DRUGINKE BUVGQEXSQXRZQG-LBQSHGEUSA-N D0I8SJ DRUGSMIL CC(C)C(C(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C7CCCN7C(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N D0I8SJ HIGHSTAT Investigative D0I9IX DRUG__ID D0I9IX D0I9IX DRUGINCH 1S/C48H64N8O16/c1-24(51-43(66)31(49)19-27-10-14-29(59)15-11-27)42(65)52-32(20-26-7-4-3-5-8-26)44(67)55-37(25(2)71-48-40(63)39(62)38(61)36(23-58)72-48)46(69)53-33(21-28-12-16-30(60)17-13-28)47(70)56-18-6-9-35(56)45(68)54-34(22-57)41(50)64/h3-5,7-8,10-17,24-25,31-40,48,57-63H,6,9,18-23,49H2,1-2H3,(H2,50,64)(H,51,66)(H,52,65)(H,53,69)(H,54,68)(H,55,67)/t24-,25-,31+,32+,33+,34+,35+,36-,37+,38-,39+,40-,48+/m1/s1 D0I9IX DRUGINKE SAWFTOJFOXCLCQ-MHOYXDTBSA-N D0I9IX DRUGSMIL CC(C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CO)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)OC5C(C(C(C(O5)CO)O)O)O D0I9IX HIGHSTAT Investigative D0I9JL DRUG__ID D0I9JL D0I9JL DRUGINCH 1S/C80H102ClN15O13S/c1-46(2)38-63(71(101)89-62(19-12-13-36-84-47(3)4)80(109)96-37-15-20-69(96)77(107)85-48(5)70(82)100)90-73(103)66(41-53-24-31-60(32-25-53)86-49(6)97)92-75(105)67(42-54-26-33-61(34-27-54)87-50(7)98)94-78(108)79(110-9)95-76(106)68(44-56-16-14-35-83-45-56)93-74(104)65(40-52-22-29-59(81)30-23-52)91-72(102)64(88-51(8)99)43-55-21-28-57-17-10-11-18-58(57)39-55/h10-11,14,16-18,21-35,39,45-48,62-69,79,84H,12-13,15,19-20,36-38,40-44H2,1-9H3,(H2,82,100)(H,85,107)(H,86,97)(H,87,98)(H,88,99)(H,89,101)(H,90,103)(H,91,102)(H,92,105)(H,93,104)(H,94,108)(H,95,106)/t48-,62+,63+,64-,65-,66-,67+,68-,69+,79+/m1/s1 D0I9JL DRUGINKE HPTFWQIEIVLQOX-CYCWPGSHSA-N D0I9JL DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)SC D0I9JL HIGHSTAT Investigative D0I9ME DRUG__ID D0I9ME D0I9ME DRUGINCH 1S/C75H98N14O16S2/c1-42(2)78-37-49-25-23-48(24-26-49)35-62-71(100)88-64(44(4)92)72(101)83-58(34-47-27-29-51(93)30-28-47)69(98)87-63(43(3)91)73(102)85-60(39-90)70(99)86-61(75(104)105)41-107-106-40-53(77)65(94)80-55(22-14-15-31-76)66(95)81-56(32-45-16-8-6-9-17-45)67(96)82-57(33-46-18-10-7-11-19-46)68(97)84-59(74(103)89(62)5)36-50-38-79-54-21-13-12-20-52(50)54/h6-13,16-21,23-30,38,42-44,53,55-64,78-79,90-93H,14-15,22,31-37,39-41,76-77H2,1-5H3,(H,80,94)(H,81,95)(H,82,96)(H,83,101)(H,84,97)(H,85,102)(H,86,99)(H,87,98)(H,88,100)(H,104,105)/t43-,44-,53-,55-,56-,57+,58+,59+,60+,61+,62+,63-,64-/m1/s1 D0I9ME DRUGINKE HLFGUCDHVNBZCJ-SQPHWWHVSA-N D0I9ME DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=C(C=C7)O)C(C)O D0I9ME HIGHSTAT Investigative D0I9PH DRUG__ID D0I9PH D0I9PH DRUGINCH 1S/C53H65N11O11/c1-3-4-18-41(60-51(73)44(29-46(67)68)61-49(71)39(55)24-32-13-7-5-8-14-32)50(72)62-43(28-36-27-35-17-11-12-19-40(35)58-36)53(75)64-63-52(74)42(26-33-15-9-6-10-16-33)59-45(66)30-56-47(69)31(2)57-48(70)38(54)25-34-20-22-37(65)23-21-34/h5-17,19-23,27,31,38-39,41-44,58,65H,3-4,18,24-26,28-30,54-55H2,1-2H3,(H,56,69)(H,57,70)(H,59,66)(H,60,73)(H,61,71)(H,62,72)(H,63,74)(H,64,75)(H,67,68)/t31-,38+,39-,41-,42+,43+,44-/m1/s1 D0I9PH DRUGINKE KYWMQIRORZGHDH-KKSWQRHZSA-N D0I9PH DRUGSMIL CCCCC(C(=O)NC(CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC5=CC=CC=C5)N D0I9PH HIGHSTAT Investigative D0IB4H DRUG__ID D0IB4H D0IB4H DRUGINCH 1S/C48H67N11O12S2/c1-5-26(4)41-47(70)54-31(14-15-37(49)61)43(66)55-34(21-38(50)62)44(67)57-35(24-73-72-17-16-40(64)53-33(45(68)58-41)19-27-10-12-30(60)13-11-27)48(71)59-23-29-9-7-6-8-28(29)20-36(59)46(69)56-32(18-25(2)3)42(65)52-22-39(51)63/h6-13,25-26,31-36,41,60H,5,14-24H2,1-4H3,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,64)(H,54,70)(H,55,66)(H,56,69)(H,57,67)(H,58,68)/t26-,31-,32-,33-,34-,35-,36+,41-/m0/s1 D0IB4H DRUGINKE BEKGLOSGJVQNHG-CKIXOVHCSA-N D0IB4H DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0IB4H HIGHSTAT Investigative D0ID5M DRUG__ID D0ID5M D0ID5M DRUGINCH 1S/C89H127N27O22S/c1-139-37-30-60(107-76(127)57(19-9-32-98-88(93)94)104-82(133)63(39-50-24-26-53(118)27-25-50)113-84(135)67-21-11-34-114(67)71(120)43-91)80(131)106-59(28-29-72(121)122)79(130)112-65(41-52-45-97-48-102-52)83(134)110-62(38-49-14-3-2-4-15-49)81(132)105-58(20-10-33-99-89(95)96)78(129)111-64(40-51-44-100-55-17-6-5-16-54(51)55)75(126)101-46-70(119)103-66(47-117)86(137)116-36-13-23-69(116)87(138)115-35-12-22-68(115)85(136)108-56(18-7-8-31-90)77(128)109-61(74(92)125)42-73(123)124/h2-6,14-17,24-27,44-45,48,56-69,100,117-118H,7-13,18-23,28-43,46-47,90-91H2,1H3,(H2,92,125)(H,97,102)(H,101,126)(H,103,119)(H,104,133)(H,105,132)(H,106,131)(H,107,127)(H,108,136)(H,109,128)(H,110,134)(H,111,129)(H,112,130)(H,113,135)(H,121,122)(H,123,124)(H4,93,94,98)(H4,95,96,99)/t56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-/m0/s1 D0ID5M DRUGINKE XQMPAWYRHAOJTE-JLQTWWGSSA-N D0ID5M DRUGSMIL CSCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CO)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C8CCCN8C(=O)CN D0ID5M HIGHSTAT Investigative D0IL7F DRUG__ID D0IL7F D0IL7F DRUGINCH 1S/C71H115N21O13/c1-5-43(4)59(66(102)87-51(20-13-33-81-71(77)78)67(103)92-34-14-21-55(92)65(101)88-52(68(104)105)17-9-10-30-72)90-61(97)50(19-12-32-80-70(75)76)85-60(96)49(18-11-31-79-69(73)74)86-62(98)53(35-42(2)3)89-63(99)54(36-44-15-7-6-8-16-44)84-58(95)39-82-57(94)38-83-64(100)56(37-45-26-28-48(93)29-27-45)91(40-46-22-23-46)41-47-24-25-47/h6-8,15-16,26-29,42-43,46-47,49-56,59,93H,5,9-14,17-25,30-41,72H2,1-4H3,(H,82,94)(H,83,100)(H,84,95)(H,85,96)(H,86,98)(H,87,102)(H,88,101)(H,89,99)(H,90,97)(H,104,105)(H4,73,74,79)(H4,75,76,80)(H4,77,78,81)/t43-,49-,50-,51-,52-,53-,54-,55-,56-,59-/m0/s1 D0IL7F DRUGINKE XMFJUPAXGQSFIW-FOMVZIENSA-N D0IL7F DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N(CC4CC4)CC5CC5 D0IL7F HIGHSTAT Investigative D0J0KR DRUG__ID D0J0KR D0J0KR DRUGINCH 1S/C20H22N2O2S/c1-21-19(25)20(16-10-7-13-22-14-16)12-6-5-11-17(20)24-18(23)15-8-3-2-4-9-15/h2-4,7-10,13-14,17H,5-6,11-12H2,1H3,(H,21,25)/t17-,20+/m1/s1 D0J0KR DRUGINKE UHXSGUDTSLFJNZ-XLIONFOSSA-N D0J0KR DRUGSMIL CNC(=S)C1(CCCCC1OC(=O)C2=CC=CC=C2)C3=CN=CC=C3 D0J0KR HIGHSTAT Investigative D0J1QQ DRUG__ID D0J1QQ D0J1QQ DRUGINCH 1S/C82H54O52/c83-23-1-14(2-24(84)45(23)93)71(112)133-81-70-68(130-77(118)20-9-30(90)50(98)57(105)39(20)41-22(79(120)132-70)11-32(92)52(100)59(41)107)65-35(126-81)13-123-74(115)17-6-27(87)53(101)60(108)42(17)43-44(80(121)128-65)66(63(111)62(110)61(43)109)124-33-4-15(3-25(85)46(33)94)72(113)134-82-69-67(129-76(117)19-8-29(89)49(97)56(104)38(19)40-21(78(119)131-69)10-31(91)51(99)58(40)106)64-34(125-82)12-122-73(114)16-5-26(86)47(95)54(102)36(16)37-18(75(116)127-64)7-28(88)48(96)55(37)103/h1-11,34-35,64-65,67-70,81-111H,12-13H2/t34-,35-,64-,65-,67+,68+,69-,70-,81-,82+/m1/s1 D0J1QQ DRUGINKE FFZOOOCGCNFHAQ-GWOIDVGPSA-N D0J1QQ DRUGSMIL C1C2C(C3C(C(O2)OC(=O)C4=CC(=C(C(=C4)OC5=C(C(=C(C6=C5C(=O)OC7C(COC(=O)C8=CC(=C(C(=C86)O)O)O)OC(C9C7OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O9)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O3)O)O)O)O)O)O)OC(=O)C2=CC(=C(C(=C2C2=C(C(=C(C=C2C(=O)O1)O)O)O)O)O)O D0J1QQ HIGHSTAT Investigative D0J2UD DRUG__ID D0J2UD D0J2UD DRUGINCH 1S/C151H227N39O43S3/c1-16-77(8)120(145(227)163-69-116(203)183-119(76(6)7)144(226)162-66-114(201)165-79(10)150(232)189-52-29-39-108(189)126(157)208)185-127(209)78(9)166-146(228)122(81(12)193)186-133(215)94(46-48-111(155)198)171-143(225)109-40-30-53-190(109)151(233)105(60-86-35-24-19-25-36-86)180-130(212)92-38-28-51-159-113(200)63-103(138(220)169-91(37-26-27-50-152)125(207)96(57-84-31-20-17-21-32-84)173-136(218)101(167-92)61-88-65-158-73-164-88)177-135(217)99(58-85-33-22-18-23-34-85)176-139(221)104(64-118(205)206)178-131(213)93(45-47-110(154)197)172-148(230)123(82(13)194)187-140(222)100(59-87-41-43-89(196)44-42-87)179-147(229)121(80(11)192)184-117(204)68-161-129(211)97(55-74(2)3)174-132(214)95(49-54-236-15)170-142(224)107(72-235)182-149(231)124(83(14)195)188-141(223)106(70-191)181-134(216)98(56-75(4)5)175-137(219)102(62-112(156)199)168-115(202)67-160-128(210)90(153)71-234/h17-25,31-36,41-44,65,73-83,90-109,119-124,167,191-196,234-235H,16,26-30,37-40,45-64,66-72,152-153H2,1-15H3,(H2,154,197)(H2,155,198)(H2,156,199)(H2,157,208)(H,158,164)(H,159,200)(H,160,210)(H,161,211)(H,162,226)(H,163,227)(H,165,201)(H,166,228)(H,168,202)(H,169,220)(H,170,224)(H,171,225)(H,172,230)(H,173,218)(H,174,214)(H,175,219)(H,176,221)(H,177,217)(H,178,213)(H,179,229)(H,180,212)(H,181,216)(H,182,231)(H,183,203)(H,184,204)(H,185,209)(H,186,215)(H,187,222)(H,188,223)(H,205,206)/t77-,78-,79-,80+,81+,82+,83+,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108+,109+,119-,120-,121-,122-,123-,124-/m0/s1 D0J2UD DRUGINKE QYDBESOJOBAYMS-KPTDGZOOSA-N D0J2UD DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCNC(=O)CC(C(=O)NC(C(=O)C(NC(=O)C(N4)CC5=CNC=N5)CC6=CC=CC=C6)CCCCN)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D0J2UD HIGHSTAT Investigative D0J3BV DRUG__ID D0J3BV D0J3BV DRUGINCH 1S/C76H103N21O19S2/c1-8-38(4)61(87-41(7)99)75(116)95-56-35-118-117-34-55(73(114)97-62(40(6)98)64(78)105)94-67(108)49(19-14-26-82-76(79)80)88-70(111)53(29-46-32-81-36-85-46)90-65(106)39(5)86-58(101)33-84-66(107)52(28-45-31-83-48-18-13-12-17-47(45)48)91-71(112)54(30-59(102)103)92-68(109)50(24-25-57(77)100)89-69(110)51(93-74(115)60(37(2)3)96-72(56)113)27-42-20-22-44(23-21-42)63(104)43-15-10-9-11-16-43/h9-13,15-18,20-23,31-32,36-40,49-56,60-62,83,98H,8,14,19,24-30,33-35H2,1-7H3,(H2,77,100)(H2,78,105)(H,81,85)(H,84,107)(H,86,101)(H,87,99)(H,88,111)(H,89,110)(H,90,106)(H,91,112)(H,92,109)(H,93,115)(H,94,108)(H,95,116)(H,96,113)(H,97,114)(H,102,103)(H4,79,80,82)/t38-,39-,40+,49-,50-,51-,52-,53+,54+,55-,56-,60-,61-,62-/m0/s1 D0J3BV DRUGINKE WGQRWXBFHFOWBH-SORWEXASSA-N D0J3BV DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC=C(C=C2)C(=O)C3=CC=CC=C3)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0J3BV HIGHSTAT Investigative D0J3LR DRUG__ID D0J3LR D0J3LR DRUGINCH 1S/C24H20Cl2FN5O2/c1-13-10-29-24(31-19-6-5-17(27)9-18(19)26)32-22(13)15-8-20(28-11-15)23(34)30-21(12-33)14-3-2-4-16(25)7-14/h2-11,21,28,33H,12H2,1H3,(H,30,34)(H,29,31,32)/t21-/m1/s1 D0J3LR DRUGINKE WUTVMXLIGHTZJC-OAQYLSRUSA-N D0J3LR DRUGSMIL CC1=CN=C(N=C1C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)NC4=C(C=C(C=C4)F)Cl D0J3LR HIGHSTAT Investigative D0J4GG DRUG__ID D0J4GG D0J4GG DRUGINCH 1S/C35H36Cl2N6O5S/c1-21-19-22(2)40-32-25(21)5-3-7-29(32)48-20-26-27(36)12-13-30(31(26)37)49(46,47)43-14-4-6-28(43)35(45)42-17-15-41(16-18-42)34(44)24-10-8-23(9-11-24)33(38)39/h3,5,7-13,19,28H,4,6,14-18,20H2,1-2H3,(H3,38,39)/t28-/m0/s1 D0J4GG DRUGINKE XJEBAAYNUNGRSF-NDEPHWFRSA-N D0J4GG DRUGSMIL CC1=CC(=NC2=C1C=CC=C2OCC3=C(C=CC(=C3Cl)S(=O)(=O)N4CCCC4C(=O)N5CCN(CC5)C(=O)C6=CC=C(C=C6)C(=N)N)Cl)C D0J4GG HIGHSTAT Investigative D0J5OY DRUG__ID D0J5OY D0J5OY DRUGINCH 1S/C61H78N12O14S2/c1-34(75)50-59(84)69-46(28-38-20-10-5-11-21-38)57(82)73-51(35(2)76)60(85)70-48(31-74)58(83)71-49(61(86)87)33-89-88-32-41(63)52(77)66-44(26-36-16-6-3-7-17-36)54(79)67-45(27-37-18-8-4-9-19-37)55(80)68-47(29-39-30-64-42-23-13-12-22-40(39)42)56(81)65-43(53(78)72-50)24-14-15-25-62/h3-13,16-23,30,34-35,41,43-51,64,74-76H,14-15,24-29,31-33,62-63H2,1-2H3,(H,65,81)(H,66,77)(H,67,79)(H,68,80)(H,69,84)(H,70,85)(H,71,83)(H,72,78)(H,73,82)(H,86,87)/t34-,35-,41-,43+,44-,45+,46+,47+,48+,49+,50-,51-/m1/s1 D0J5OY DRUGINKE CGHVCXMPDMMIFL-JFJBRMBESA-N D0J5OY DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O D0J5OY HIGHSTAT Investigative D0J7CK DRUG__ID D0J7CK D0J7CK DRUGINCH 1S/C144H241N43O48S2/c1-65(2)47-85(174-139(231)110(70(11)12)182-136(228)98(64-237)180-141(233)113(73(15)194)185-135(227)97(62-191)179-129(221)89(51-69(9)10)171-130(222)90(53-103(150)199)172-134(226)95(60-189)177-116(208)77(147)63-236)117(209)157-56-106(202)160-78(25-17-19-41-145)119(211)168-88(50-68(7)8)128(220)178-96(61-190)133(225)166-83(36-39-102(149)198)123(215)164-84(37-40-109(205)206)124(216)170-87(49-67(5)6)127(219)173-92-55-105(201)155-43-21-27-80(162-122(214)82(35-38-101(148)197)165-126(218)86(48-66(3)4)169-120(212)79(163-131(92)223)26-18-20-42-146)121(213)176-93(52-75-31-33-76(196)34-32-75)142(234)187-46-24-30-100(187)137(229)167-81(28-22-44-156-144(153)154)125(217)184-112(72(14)193)140(232)175-91(54-104(151)200)132(224)183-111(71(13)192)138(230)159-57-107(203)161-94(59-188)118(210)158-58-108(204)181-114(74(16)195)143(235)186-45-23-29-99(186)115(152)207/h31-34,65-74,77-100,110-114,188-196,236-237H,17-30,35-64,145-147H2,1-16H3,(H2,148,197)(H2,149,198)(H2,150,199)(H2,151,200)(H2,152,207)(H,155,201)(H,157,209)(H,158,210)(H,159,230)(H,160,202)(H,161,203)(H,162,214)(H,163,223)(H,164,215)(H,165,218)(H,166,225)(H,167,229)(H,168,211)(H,169,212)(H,170,216)(H,171,222)(H,172,226)(H,173,219)(H,174,231)(H,175,232)(H,176,213)(H,177,208)(H,178,220)(H,179,221)(H,180,233)(H,181,204)(H,182,228)(H,183,224)(H,184,217)(H,185,227)(H,205,206)(H4,153,154,156)/t71-,72-,73-,74-,77+,78+,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94+,95+,96+,97+,98+,99-,100-,110+,111+,112+,113+,114+/m1/s1 D0J7CK DRUGINKE PPKRHPCXCVMULC-IFCDPWAYSA-N D0J7CK DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CCCNC(=O)CC(C(=O)NC(C(=O)N1)CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N4CCCC4C(=O)N)CCC(=O)N D0J7CK HIGHSTAT Investigative D0J7DN DRUG__ID D0J7DN D0J7DN DRUGINCH 1S/C80H132N28O21/c1-7-49(69(120)106-57(37-60(85)112)75(126)100-50(65(86)116)28-29-59(84)111)99-74(125)55(34-42(2)3)105-72(123)51(24-14-16-30-81)103-71(122)54(27-19-33-92-80(89)90)102-67(118)44(5)97-77(128)58(41-109)107-73(124)52(25-15-17-31-82)104-70(121)53(26-18-32-91-79(87)88)101-66(117)43(4)96-62(114)40-95-78(129)64(45(6)110)108-76(127)56(36-47-22-12-9-13-23-47)98-63(115)39-93-61(113)38-94-68(119)48(83)35-46-20-10-8-11-21-46/h8-13,20-23,42-45,48-58,64,109-110H,7,14-19,24-41,81-83H2,1-6H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,119)(H,95,129)(H,96,114)(H,97,128)(H,98,115)(H,99,125)(H,100,126)(H,101,117)(H,102,118)(H,103,122)(H,104,121)(H,105,123)(H,106,120)(H,107,124)(H,108,127)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0J7DN DRUGINKE FNRHKDQQWGJCOM-KMOVSZGYSA-N D0J7DN DRUGSMIL CCC(C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0J7DN HIGHSTAT Investigative D0J7GJ DRUG__ID D0J7GJ D0J7GJ DRUGINCH 1S/C53H63N9O13/c1-3-4-18-39(49(69)60-44(53(74)75)27-35-29-54-38-19-12-11-17-37(35)38)57-50(70)40(28-46(65)66)58-51(71)42(25-33-15-9-6-10-16-33)62-61-41(24-32-13-7-5-8-14-32)48(68)55-30-45(64)56-31(2)47(67)59-43(52(72)73)26-34-20-22-36(63)23-21-34/h5-17,19-23,29,31,39-44,54,61-63H,3-4,18,24-28,30H2,1-2H3,(H,55,68)(H,56,64)(H,57,70)(H,58,71)(H,59,67)(H,60,69)(H,65,66)(H,72,73)(H,74,75)/t31-,39+,40+,41+,42+,43+,44-/m1/s1 D0J7GJ DRUGINKE LHFDBKUCTFELLO-WMRIFXDUSA-N D0J7GJ DRUGSMIL CCCCC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=CC=C3)NNC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O D0J7GJ HIGHSTAT Investigative D0J7HS DRUG__ID D0J7HS D0J7HS DRUGINCH 1S/C62H84N14O17S2/c1-31(2)50(62(92)93)76-60(90)47-30-95-94-29-46(73-58(88)45(26-49(80)81)69-53(83)33(4)67-61(91)51(34(5)77)75-48(79)28-66-52(82)32(3)64)59(89)71-42(23-35-13-7-6-8-14-35)55(85)72-44(25-37-27-65-40-16-10-9-15-39(37)40)57(87)68-41(17-11-12-22-63)54(84)70-43(56(86)74-47)24-36-18-20-38(78)21-19-36/h6-10,13-16,18-21,27,31-34,41-47,50-51,65,77-78H,11-12,17,22-26,28-30,63-64H2,1-5H3,(H,66,82)(H,67,91)(H,68,87)(H,69,83)(H,70,84)(H,71,89)(H,72,85)(H,73,88)(H,74,86)(H,75,79)(H,76,90)(H,80,81)(H,92,93)/t32-,33-,34+,41-,42-,43-,44-,45-,46-,47-,50-,51-/m0/s1 D0J7HS DRUGINKE YNQKMDDGZLLKHF-SYGGZGJOSA-N D0J7HS DRUGSMIL CC(C)C(C(=O)O)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)CCCCN)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(C)N D0J7HS HIGHSTAT Investigative D0J9VA DRUG__ID D0J9VA D0J9VA DRUGINCH 1S/C74H107N25O12/c1-3-13-52(92-65(106)54(19-9-31-85-71(77)78)91-62(103)49(75)37-43-39-89-50-17-7-5-15-47(43)50)64(105)95-57(22-12-34-88-74(83)84)68(109)98-59(36-42-25-29-46(101)30-26-42)69(110)99-60(38-44-40-90-51-18-8-6-16-48(44)51)70(111)96-55(20-10-32-86-72(79)80)66(107)93-53(14-4-2)63(104)94-56(21-11-33-87-73(81)82)67(108)97-58(61(76)102)35-41-23-27-45(100)28-24-41/h5-8,15-18,23-30,39-40,49,52-60,89-90,100-101H,3-4,9-14,19-22,31-38,75H2,1-2H3,(H2,76,102)(H,91,103)(H,92,106)(H,93,107)(H,94,104)(H,95,105)(H,96,111)(H,97,108)(H,98,109)(H,99,110)(H4,77,78,85)(H4,79,80,86)(H4,81,82,87)(H4,83,84,88)/t49-,52-,53-,54-,55-,56-,57-,58-,59-,60-/m0/s1 D0J9VA DRUGINKE QTWWWOBSQULXHE-MTVPJWGZSA-N D0J9VA DRUGSMIL CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=CNC6=CC=CC=C65)N D0J9VA HIGHSTAT Investigative D0K0CJ DRUG__ID D0K0CJ D0K0CJ DRUGINCH 1S/C80H131N27O22/c1-7-49(97-63(114)40-94-77(127)64(45(6)109)107-75(125)56(36-47-22-12-9-13-23-47)98-62(113)39-92-61(112)38-93-67(117)48(83)35-46-20-10-8-11-21-46)68(118)100-53(27-19-33-91-80(88)89)70(120)102-51(25-15-17-31-82)72(122)106-58(41-108)76(126)96-43(4)65(115)99-52(26-18-32-90-79(86)87)69(119)101-50(24-14-16-30-81)71(121)105-55(34-42(2)3)73(123)95-44(5)66(116)104-57(37-60(85)111)74(124)103-54(78(128)129)28-29-59(84)110/h8-13,20-23,42-45,48-58,64,108-109H,7,14-19,24-41,81-83H2,1-6H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,117)(H,94,127)(H,95,123)(H,96,126)(H,97,114)(H,98,113)(H,99,115)(H,100,118)(H,101,119)(H,102,120)(H,103,124)(H,104,116)(H,105,121)(H,106,122)(H,107,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0K0CJ DRUGINKE XQBWITORWNZMQG-KMOVSZGYSA-N D0K0CJ DRUGSMIL CCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0K0CJ HIGHSTAT Investigative D0K0JJ DRUG__ID D0K0JJ D0K0JJ DRUGINCH 1S/C62H74N12O18S2/c1-3-30(2)50-58(87)69-41(19-20-48(64)79)54(83)70-42(26-49(65)80)55(84)71-43(27-93-94-28-45(78)57(86)73-51(59(88)72-50)31-9-12-33(75)13-10-31)60(89)74-22-6-8-44(74)56(85)68-40(53(82)67-29-63)7-4-5-21-66-52(81)32-11-16-36-39(23-32)62(92-61(36)90)37-17-14-34(76)24-46(37)91-47-25-35(77)15-18-38(47)62/h9-18,23-25,30,40-45,50-51,75-78H,3-8,19-22,26-29,63H2,1-2H3,(H2,64,79)(H2,65,80)(H,66,81)(H,67,82)(H,68,85)(H,69,87)(H,70,83)(H,71,84)(H,72,88)(H,73,86)/t30?,40-,41+,42+,43+,44+,45?,50+,51-/m0/s1 D0K0JJ DRUGINKE UHOYWVNHWOKOQC-USAPJFQBSA-N D0K0JJ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)O)C(=O)N3CCCC3C(=O)NC(CCCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)CCC(=O)N D0K0JJ HIGHSTAT Investigative D0K0OY DRUG__ID D0K0OY D0K0OY DRUGINCH 1S/C53H78N14O13/c1-3-29(2)43(51(78)66-25-9-16-39(66)50(77)67-26-10-17-40(67)52(79)80)63-45(72)34(19-20-41(55)68)60-46(73)37-14-7-23-64(37)48(75)35(13-6-22-58-53(56)57)61-47(74)38-15-8-24-65(38)49(76)36(62-44(71)32(54)18-21-42(69)70)27-30-28-59-33-12-5-4-11-31(30)33/h4-5,11-12,28-29,32,34-40,43,59H,3,6-10,13-27,54H2,1-2H3,(H2,55,68)(H,60,73)(H,61,74)(H,62,71)(H,63,72)(H,69,70)(H,79,80)(H4,56,57,58)/t29-,32-,34-,35-,36-,37-,38-,39-,40-,43-/m0/s1 D0K0OY DRUGINKE RDZJYRCUGADIDN-AXPLDACSSA-N D0K0OY DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C3CCCN3C(=O)C(CCCN=C(N)N)NC(=O)C4CCCN4C(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCC(=O)O)N D0K0OY HIGHSTAT Investigative D0K1AT DRUG__ID D0K1AT D0K1AT DRUGINCH 1S/C80H102ClN15O13S/c1-46(2)38-63(71(101)89-62(19-12-13-36-84-47(3)4)80(109)96-37-15-20-69(96)77(107)85-48(5)70(82)100)90-73(103)66(41-53-24-31-60(32-25-53)86-49(6)97)92-75(105)67(42-54-26-33-61(34-27-54)87-50(7)98)94-78(108)79(110-9)95-76(106)68(44-56-16-14-35-83-45-56)93-74(104)65(40-52-22-29-59(81)30-23-52)91-72(102)64(88-51(8)99)43-55-21-28-57-17-10-11-18-58(57)39-55/h10-11,14,16-18,21-35,39,45-48,62-69,79,84H,12-13,15,19-20,36-38,40-44H2,1-9H3,(H2,82,100)(H,85,107)(H,86,97)(H,87,98)(H,88,99)(H,89,101)(H,90,103)(H,91,102)(H,92,105)(H,93,104)(H,94,108)(H,95,106)/t48-,62+,63+,64-,65-,66-,67+,68-,69+,79-/m1/s1 D0K1AT DRUGINKE HPTFWQIEIVLQOX-GHGJXBRZSA-N D0K1AT DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)SC D0K1AT HIGHSTAT Investigative D0K1IE DRUG__ID D0K1IE D0K1IE DRUGINCH 1S/C149H222N38O44S3/c1-17-74(8)117(141(223)160-66-113(201)179-116(73(6)7)140(222)159-63-111(199)162-76(10)147(229)186-49-28-37-105(186)124(155)206)181-125(207)75(9)163-142(224)120(79(13)191)182-130(212)90(44-46-108(152)196)167-139(221)106-38-29-50-187(106)148(230)100(57-84-34-25-20-26-35-84)176-143(225)118(77(11)189)165-97(58-86-62-156-70-161-86)133(215)169-92(54-82-30-21-18-22-31-82)123(205)104-36-27-48-185(104)149(231)101(60-110(154)198)175-132(214)95(55-83-32-23-19-24-33-83)172-135(217)99(61-115(203)204)173-128(210)89(43-45-107(151)195)168-145(227)121(80(14)192)183-136(218)96(56-85-39-41-87(194)42-40-85)174-144(226)119(78(12)190)180-114(202)65-158-127(209)93(52-71(2)3)170-129(211)91(47-51-234-16)166-138(220)103(69-233)178-146(228)122(81(15)193)184-137(219)102(67-188)177-131(213)94(53-72(4)5)171-134(216)98(59-109(153)197)164-112(200)64-157-126(208)88(150)68-232/h18-26,30-35,39-42,62,70-81,88-106,116-122,165,188-194,232-233H,17,27-29,36-38,43-61,63-69,150H2,1-16H3,(H2,151,195)(H2,152,196)(H2,153,197)(H2,154,198)(H2,155,206)(H,156,161)(H,157,208)(H,158,209)(H,159,222)(H,160,223)(H,162,199)(H,163,224)(H,164,200)(H,166,220)(H,167,221)(H,168,227)(H,169,215)(H,170,211)(H,171,216)(H,172,217)(H,173,210)(H,174,226)(H,175,214)(H,176,225)(H,177,213)(H,178,228)(H,179,201)(H,180,202)(H,181,207)(H,182,212)(H,183,218)(H,184,219)(H,203,204)/t74-,75-,76-,77+,78+,79-,80+,81+,88-,89-,90-,91-,92?,93-,94-,95-,96-,97?,98-,99-,100-,101-,102-,103-,104?,105+,106+,116-,117-,118-,119-,120-,121-,122-/m0/s1 D0K1IE DRUGINKE HFYXIJPNTYGTQI-ZAGQHXPESA-N D0K1IE DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(CC4=CNC=N4)C(=O)NC(CC5=CC=CC=C5)C(=O)C6CCCN6C(=O)C(CC(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D0K1IE HIGHSTAT Investigative D0K2MC DRUG__ID D0K2MC D0K2MC DRUGINCH 1S/C80H102ClN15O14S/c1-46(2)37-62(71(102)88-61(18-11-12-35-84-47(3)4)80(110)96-36-14-19-69(96)78(109)95-79(111-8)70(82)101)89-73(104)65(40-52-23-30-59(31-24-52)85-48(5)98)91-75(106)66(41-53-25-32-60(33-26-53)86-49(6)99)93-77(108)68(45-97)94-76(107)67(43-55-15-13-34-83-44-55)92-74(105)64(39-51-21-28-58(81)29-22-51)90-72(103)63(87-50(7)100)42-54-20-27-56-16-9-10-17-57(56)38-54/h9-10,13,15-17,20-34,38,44,46-47,61-69,79,84,97H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,98)(H,86,99)(H,87,100)(H,88,102)(H,89,104)(H,90,103)(H,91,106)(H,92,105)(H,93,108)(H,94,107)(H,95,109)/t61-,62-,63+,64+,65+,66-,67+,68-,69-,79+/m0/s1 D0K2MC DRUGINKE MNOHGPTZCIGJAF-NNRJBHNWSA-N D0K2MC DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)N)SC)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0K2MC HIGHSTAT Investigative D0K4GD DRUG__ID D0K4GD D0K4GD DRUGINCH 1S/C11H14N2O2/c1-7-3-4-8(2)10-9(7)11(13-15-10)14-6-5-12/h3-4H,5-6,12H2,1-2H3 D0K4GD DRUGINKE ZTMODTQBGMQMDL-UHFFFAOYSA-N D0K4GD DRUGSMIL CC1=C2C(=C(C=C1)C)ON=C2OCCN D0K4GD HIGHSTAT Investigative D0K4GI DRUG__ID D0K4GI D0K4GI THERCLAS Antisense D0K4GI DRUGTYPE Combination drug (Antisense drug) D0K4GI DRUGSMIL failed D0K4GI HIGHSTAT Investigative D0K4XA DRUG__ID D0K4XA D0K4XA DRUGINCH 1S/C80H131N27O22/c1-42(2)34-57(77(127)107(7)45(5)67(117)103-56(37-60(85)111)73(123)102-54(78(128)129)28-29-59(84)110)104-71(121)50(24-14-16-30-81)100-70(120)53(27-19-33-91-80(88)89)99-66(116)44(4)96-75(125)58(41-108)105-72(122)51(25-15-17-31-82)101-69(119)52(26-18-32-90-79(86)87)98-65(115)43(3)95-62(113)40-94-76(126)64(46(6)109)106-74(124)55(36-48-22-12-9-13-23-48)97-63(114)39-92-61(112)38-93-68(118)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,108-109H,14-19,24-41,81-83H2,1-7H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,118)(H,94,126)(H,95,113)(H,96,125)(H,97,114)(H,98,115)(H,99,116)(H,100,120)(H,101,119)(H,102,123)(H,103,117)(H,104,121)(H,105,122)(H,106,124)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0K4XA DRUGINKE NQIPFWOYZKKZKS-FKPOJLNCSA-N D0K4XA DRUGSMIL CC(C)CC(C(=O)N(C)C(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0K4XA HIGHSTAT Investigative D0K5DM DRUG__ID D0K5DM D0K5DM DRUGINCH 1S/C109H140N20O33/c1-57-76(53-109(156)91(161-102(154)64-26-14-9-15-27-64)89-107(6,77(134)52-78-108(89,56-158-78)162-59(3)131)90(143)87(159-58(2)130)85(57)106(109,4)5)160-103(155)88(86(62-22-10-7-11-23-62)129-92(144)63-24-12-8-13-25-63)157-47-42-80(136)120-71(93(145)115-44-19-17-29-70-97(149)124-68(31-21-46-117-105(112)113)95(147)119-55-82(138)122-75(51-84(141)142)101(153)128-73(99(151)126-70)49-61-34-38-66(133)39-35-61)40-41-79(135)114-43-18-16-28-69-96(148)123-67(30-20-45-116-104(110)111)94(146)118-54-81(137)121-74(50-83(139)140)100(152)127-72(98(150)125-69)48-60-32-36-65(132)37-33-60/h7-15,22-27,32-39,67-78,86-89,91,132-134,156H,16-21,28-31,40-56H2,1-6H3,(H,114,135)(H,115,145)(H,118,146)(H,119,147)(H,120,136)(H,121,137)(H,122,138)(H,123,148)(H,124,149)(H,125,150)(H,126,151)(H,127,152)(H,128,153)(H,129,144)(H,139,140)(H,141,142)(H4,110,111,116)(H4,112,113,117)/t67-,68-,69-,70?,71?,72+,73+,74-,75-,76?,77+,78?,86+,87-,88+,89?,91+,107-,108+,109-/m1/s1 D0K5DM DRUGINKE YUHVDRZERRVMDC-XLKUZTQTSA-N D0K5DM DRUGSMIL CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)OCCC(=O)NC(CCC(=O)NCCCCC7C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=C(C=C8)O)CC(=O)O)CCCNC(=N)N)C(=O)NCCCCC9C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N9)CC1=CC=C(C=C1)O)CC(=O)O)CCCNC(=N)N)O)OC(=O)C1=CC=CC=C1)(CO4)OC(=O)C)O)C)OC(=O)C D0K5DM HIGHSTAT Investigative D0K5NV DRUG__ID D0K5NV D0K5NV DRUGINCH 1S/C75H88N16O22S2/c1-89(60(96)29-16-39-12-18-44(92)19-13-39)57(35-41-14-20-45(93)21-15-41)70(101)88-54(34-40-8-3-2-4-9-40)68(99)85-52(27-28-58(79)94)67(98)87-55(37-59(80)95)69(100)86-53(10-7-32-84-75(82)83)73(104)90-33-30-43(38-90)72(103)91(56(66(81)97)11-5-6-31-76)71(102)42-17-22-46(49(36-42)74(105)106)61-47-23-25-50(77)64(114(107,108)109)62(47)113-63-48(61)24-26-51(78)65(63)115(110,111)112/h2-4,8-9,12-15,17-26,36,43,52-57,77,92-93H,5-7,10-11,16,27-35,37-38,76,78H2,1H3,(H2,79,94)(H2,80,95)(H2,81,97)(H,85,99)(H,86,100)(H,87,98)(H,88,101)(H,105,106)(H4,82,83,84)(H,107,108,109)(H,110,111,112)/t43-,52-,53-,54-,55-,56-,57+/m0/s1 D0K5NV DRUGINKE JTPJNKPWLHDAAT-RHFIIQKYSA-N D0K5NV DRUGSMIL CN(C(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)N3CCC(C3)C(=O)N(C(CCCCN)C(=O)N)C(=O)C4=CC(=C(C=C4)C5=C6C=CC(=N)C(=C6OC7=C5C=CC(=C7S(=O)(=O)O)N)S(=O)(=O)O)C(=O)O)C(=O)CCC8=CC=C(C=C8)O D0K5NV HIGHSTAT Investigative D0K7HR DRUG__ID D0K7HR D0K7HR DRUGINCH 1S/C17H13NO2/c1-2-11-9-17(12-3-5-13(19)6-4-12)18-16-8-7-14(20)10-15(11)16/h2-10,19-20H,1H2 D0K7HR DRUGINKE MPGOJACGGLDRIE-UHFFFAOYSA-N D0K7HR DRUGSMIL C=CC1=CC(=NC2=C1C=C(C=C2)O)C3=CC=C(C=C3)O D0K7HR HIGHSTAT Investigative D0K8AP DRUG__ID D0K8AP D0K8AP DRUGINCH 1S/C84H112ClN17O16/c1-8-117-39-40-118-38-36-90-84(116)94-63-32-25-56(26-33-63)45-69(78(110)98-68(44-55-23-30-62(31-24-55)93-83(87)115)76(108)96-65(41-50(2)3)74(106)95-64(18-11-12-35-89-51(4)5)82(114)102-37-14-19-72(102)81(113)91-52(6)73(86)105)100-80(112)71(49-103)101-79(111)70(47-58-15-13-34-88-48-58)99-77(109)67(43-54-21-28-61(85)29-22-54)97-75(107)66(92-53(7)104)46-57-20-27-59-16-9-10-17-60(59)42-57/h9-10,13,15-17,20-34,42,48,50-52,64-72,89,103H,8,11-12,14,18-19,35-41,43-47,49H2,1-7H3,(H2,86,105)(H,91,113)(H,92,104)(H,95,106)(H,96,108)(H,97,107)(H,98,110)(H,99,109)(H,100,112)(H,101,111)(H3,87,93,115)(H2,90,94,116)/t52-,64+,65+,66-,67-,68-,69+,70-,71+,72+/m1/s1 D0K8AP DRUGINKE RTPDWFYCUSPDLA-CEUPRWEVSA-N D0K8AP DRUGSMIL CCOCCOCCNC(=O)NC1=CC=C(C=C1)CC(C(=O)NC(CC2=CC=C(C=C2)NC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCCCNC(C)C)C(=O)N3CCCC3C(=O)NC(C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0K8AP HIGHSTAT Investigative D0K8ZD DRUG__ID D0K8ZD D0K8ZD DRUGINCH 1S/C75H92N12O16/c1-42(2)62(82-68(95)55(38-61(90)91)80-72(99)64(45(6)88)84-69(96)57-31-20-32-85(57)74(101)63(43(3)4)83-66(93)53(76)33-46-21-10-7-11-22-46)71(98)77-39-60(89)86-40-51-29-18-16-27-49(51)36-58(86)70(97)79-54(34-47-23-12-8-13-24-47)67(94)78-44(5)65(92)81-56(35-48-25-14-9-15-26-48)73(100)87-41-52-30-19-17-28-50(52)37-59(87)75(102)103/h7-19,21-30,42-45,53-59,62-64,88H,20,31-41,76H2,1-6H3,(H,77,98)(H,78,94)(H,79,97)(H,80,99)(H,81,92)(H,82,95)(H,83,93)(H,84,96)(H,90,91)(H,102,103)/t44-,45+,53-,54-,55-,56-,57-,58-,59-,62-,63-,64-/m0/s1 D0K8ZD DRUGINKE LZESRBNZLWMEIJ-GKKQDZIBSA-N D0K8ZD DRUGSMIL CC(C)C(C(=O)NCC(=O)N1CC2=CC=CC=C2CC1C(=O)NC(CC3=CC=CC=C3)C(=O)NC(C)C(=O)NC(CC4=CC=CC=C4)C(=O)N5CC6=CC=CC=C6CC5C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C7CCCN7C(=O)C(C(C)C)NC(=O)C(CC8=CC=CC=C8)N D0K8ZD HIGHSTAT Investigative D0K9TS DRUG__ID D0K9TS D0K9TS DRUGINCH 1S/C74H102N20O19S2/c1-39(77)62(100)82-35-59(99)83-56-37-114-115-38-57(74(112)113)92-70(108)55(36-95)91-73(111)61(41(3)97)94-69(107)53(31-45-34-79-26-27-80-45)90-72(110)60(40(2)96)93-64(102)49(23-13-15-25-76)84-67(105)52(30-44-33-81-47-21-11-10-20-46(44)47)88-66(104)51(29-43-18-8-5-9-19-43)86-65(103)50(28-42-16-6-4-7-17-42)87-68(106)54(32-58(78)98)89-63(101)48(85-71(56)109)22-12-14-24-75/h4-11,16-21,26-27,33-34,39-41,48-57,60-61,81,95-97H,12-15,22-25,28-32,35-38,75-77H2,1-3H3,(H2,78,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t39-,40?,41?,48-,49+,50-,51+,52-,53-,54+,55-,56-,57-,60+,61+/m0/s1 D0K9TS DRUGINKE PBGRXJRISCBKBH-XNXKEXPOSA-N D0K9TS DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=NC=CN=C6)O D0K9TS HIGHSTAT Investigative D0KA9Y DRUG__ID D0KA9Y D0KA9Y DRUGINCH 1S/C80H102ClN15O14S/c1-46(2)37-62(71(102)88-61(18-11-12-35-84-47(3)4)80(110)96-36-14-19-69(96)78(109)95-79(111-8)70(82)101)89-73(104)65(40-52-23-30-59(31-24-52)85-48(5)98)91-75(106)66(41-53-25-32-60(33-26-53)86-49(6)99)93-77(108)68(45-97)94-76(107)67(43-55-15-13-34-83-44-55)92-74(105)64(39-51-21-28-58(81)29-22-51)90-72(103)63(87-50(7)100)42-54-20-27-56-16-9-10-17-57(56)38-54/h9-10,13,15-17,20-34,38,44,46-47,61-69,79,84,97H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,98)(H,86,99)(H,87,100)(H,88,102)(H,89,104)(H,90,103)(H,91,106)(H,92,105)(H,93,108)(H,94,107)(H,95,109)/t61-,62-,63+,64+,65+,66-,67+,68-,69-,79-/m0/s1 D0KA9Y DRUGINKE MNOHGPTZCIGJAF-SLOMUXTRSA-N D0KA9Y DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C(=O)N)SC)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0KA9Y HIGHSTAT Investigative D0KH9Z DRUG__ID D0KH9Z D0KH9Z DRUGINCH 1S/C60H91N17O10/c1-7-37(6)51(58(84)74-47(26-40-29-63-33-68-40)55(81)71-44(60(86)87)17-11-12-20-61)76-57(83)50(36(4)5)66-31-42(23-35(2)3)70-53(79)46(25-39-28-62-32-67-39)72-54(80)45(24-38-15-9-8-10-16-38)73-56(82)49-19-14-22-77(49)59(85)48(27-41-30-64-34-69-41)75-52(78)43-18-13-21-65-43/h8-10,15-16,28-30,32-37,42-51,65-66H,7,11-14,17-27,31,61H2,1-6H3,(H,62,67)(H,63,68)(H,64,69)(H,70,79)(H,71,81)(H,72,80)(H,73,82)(H,74,84)(H,75,78)(H,76,83)(H,86,87)/t37-,42-,43+,44-,45-,46-,47-,48-,49+,50-,51-/m0/s1 D0KH9Z DRUGINKE XIZSMQBWVQNHCA-XTAHDJANSA-N D0KH9Z DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(C(C)C)NCC(CC(C)C)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)C6CCCN6 D0KH9Z HIGHSTAT Investigative D0KQ1K DRUG__ID D0KQ1K D0KQ1K DRUGINCH 1S/C132H191N30O46PS/c1-10-71(6)109(129(200)162-56-20-27-98(162)124(195)149-84(44-50-105(175)176)113(184)145-83(43-49-104(173)174)114(185)152-91(59-73-28-34-77(165)35-29-73)120(191)151-88(57-69(2)3)117(188)150-87(130(201)202)40-46-99(134)166)158-116(187)85(45-51-106(177)178)146-112(183)82(42-48-103(171)172)148-118(189)89(58-72-21-12-11-13-22-72)154-122(193)93(62-107(179)180)142-100(167)64-139-110(181)94(66-163)156-126(197)108(70(4)5)157-115(186)80(23-14-16-52-133)144-111(182)81(41-47-102(169)170)147-119(190)90(60-74-30-36-78(37-31-74)208-209(203,204)205)153-121(192)92(61-76-63-137-68-141-76)155-125(196)97-26-19-55-161(97)128(199)95(67-164)143-101(168)65-140-123(194)96-25-15-17-54-160(96)127(198)86(24-18-53-138-131(135)136)159-210(206,207)79-38-32-75(33-39-79)132(7,8)9/h11-13,21-22,28-39,63,68-71,80-98,108-109,159,163-165H,10,14-20,23-27,40-62,64-67,133H2,1-9H3,(H2,134,166)(H,137,141)(H,139,181)(H,140,194)(H,142,167)(H,143,168)(H,144,182)(H,145,184)(H,146,183)(H,147,190)(H,148,189)(H,149,195)(H,150,188)(H,151,191)(H,152,185)(H,153,192)(H,154,193)(H,155,196)(H,156,197)(H,157,186)(H,158,187)(H,169,170)(H,171,172)(H,173,174)(H,175,176)(H,177,178)(H,179,180)(H,201,202)(H4,135,136,138)(H2,203,204,205)/t71-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96+,97-,98-,108-,109-/m0/s1 D0KQ1K DRUGINKE RUWSMOQBPSRIJB-OZHMLDCXSA-N D0KQ1K DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CC=C(C=C4)OP(=O)(O)O)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCCN6C(=O)C(CO)NC(=O)CNC(=O)C7CCCCN7C(=O)C(CCCN=C(N)N)NS(=O)(=O)C8=CC=C(C=C8)C(C)(C)C D0KQ1K HIGHSTAT Investigative D0KX3H DRUG__ID D0KX3H D0KX3H DRUGINCH 1S/C6H5N3/c1-2-8-6-3-7-4-9-5(1)6/h1-4,8H D0KX3H DRUGINKE KDOPAZIWBAHVJB-UHFFFAOYSA-N D0KX3H DRUGSMIL C1=CNC2=CN=CN=C21 D0KX3H HIGHSTAT Investigative D0KZ2I DRUG__ID D0KZ2I D0KZ2I DRUGINCH 1S/C57H98N32O18/c1-24(82-41(94)26(50(103)104)21-77-40(93)25(49(101)102)20-78-47(100)36-34(90)35(91)48(107-36)89-23-81-33-37(58)79-22-80-38(33)89)39(92)83-27(8-2-14-71-52(59)60)42(95)84-28(9-3-15-72-53(61)62)43(96)85-29(10-4-16-73-54(63)64)44(97)86-30(11-5-17-74-55(65)66)45(98)87-31(12-6-18-75-56(67)68)46(99)88-32(51(105)106)13-7-19-76-57(69)70/h22-32,34-36,48,90-91H,2-21H2,1H3,(H,77,93)(H,78,100)(H,82,94)(H,83,92)(H,84,95)(H,85,96)(H,86,97)(H,87,98)(H,88,99)(H,101,102)(H,103,104)(H,105,106)(H2,58,79,80)(H4,59,60,71)(H4,61,62,72)(H4,63,64,73)(H4,65,66,74)(H4,67,68,75)(H4,69,70,76)/t24-,25?,26?,27-,28-,29-,30-,31-,32-,34+,35-,36+,48?/m1/s1 D0KZ2I DRUGINKE RAUBYAYMEJMYTN-VDLZJJBUSA-N D0KZ2I DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CNC(=O)C(CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O)C(=O)O)C(=O)O D0KZ2I HIGHSTAT Investigative D0L0RP DRUG__ID D0L0RP D0L0RP DRUGINCH 1S/C94H122Cl3N17O23S3/c1-48-44-93(3,4)110-77-56(48)41-58-71(59-42-57-49(2)45-94(5,6)111-78(57)83(140(134,135)136)80(59)137-79(58)82(77)139(131,132)133)72-73(91(129)130)74(95)76(97)81(75(72)96)138-47-68(119)104-36-15-9-12-21-70(121)114(64(84(101)122)20-13-14-35-98)89(127)53-34-38-113(46-53)90(128)61(19-16-37-105-92(102)103)107-87(125)63(43-67(100)118)108-85(123)60(31-32-66(99)117)106-86(124)62(39-51-17-10-8-11-18-51)109-88(126)65(40-52-24-29-55(116)30-25-52)112(7)69(120)33-26-50-22-27-54(115)28-23-50/h8,10-11,17-18,22-25,27-30,41,48-49,53,57,60-65,80,83,110,115-116H,9,12-16,19-21,26,31-40,42-47,98H2,1-7H3,(H2,99,117)(H2,100,118)(H2,101,122)(H,104,119)(H,106,124)(H,107,125)(H,108,123)(H,109,126)(H,129,130)(H4,102,103,105)(H,131,132,133)(H,134,135,136)/t48?,49?,53-,57?,60-,61-,62-,63-,64-,65+,80?,83?/m0/s1 D0L0RP DRUGINKE SVLGRIWNJNOFJU-CRAMPYNJSA-N D0L0RP DRUGSMIL CC1CC(N=C2C1CC3=C(C4=C(C(=C5C(=C4)C(CC(N5)(C)C)C)S(=O)(=O)O)OC3C2S(=O)(=O)O)C6=C(C(=C(C(=C6Cl)SCC(=O)NCCCCCC(=O)N(C(CCCCN)C(=O)N)C(=O)C7CCN(C7)C(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(CC9=CC=C(C=C9)O)N(C)C(=O)CCC1=CC=C(C=C1)O)Cl)Cl)C(=O)O)(C)C D0L0RP HIGHSTAT Investigative D0L2CT DRUG__ID D0L2CT D0L2CT DRUGINCH 1S/C54H61F6N9O8/c1-30(2)20-42(50(75)67-43(25-35-28-62-41-13-8-7-12-39(35)41)49(74)63-27-34-21-36(53(55,56)57)26-37(22-34)54(58,59)60)68-51(76)45-14-9-19-69(45)52(77)44(24-32-10-5-4-6-11-32)66-46(71)29-64-47(72)31(3)65-48(73)40(61)23-33-15-17-38(70)18-16-33/h4-8,10-13,15-18,21-22,26,28,30-31,40,42-45,62,70H,9,14,19-20,23-25,27,29,61H2,1-3H3,(H,63,74)(H,64,72)(H,65,73)(H,66,71)(H,67,75)(H,68,76)/t31-,40+,42+,43+,44+,45+/m1/s1 D0L2CT DRUGINKE LWOMHJBSXPGKKS-REAJPLCASA-N D0L2CT DRUGSMIL CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NCC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)NC(=O)C4CCCN4C(=O)C(CC5=CC=CC=C5)NC(=O)CNC(=O)C(C)NC(=O)C(CC6=CC=C(C=C6)O)N D0L2CT HIGHSTAT Investigative D0L2GD DRUG__ID D0L2GD D0L2GD DRUGINCH 1S/2CN.Cu/c2*1-2;/q2*-1;+1 D0L2GD DRUGINKE FKUKJMKUXQUDHB-UHFFFAOYSA-N D0L2GD DRUGSMIL [C-]#N.[C-]#N.[Cu+] D0L2GD HIGHSTAT Investigative D0L2PQ DRUG__ID D0L2PQ D0L2PQ DRUGINCH 1S/C76H99N21O18/c1-75(2)54(96(34-30-61(103)104)52-28-26-42-17-10-12-19-44(42)64(52)75)24-8-6-5-7-9-25-55-76(3,4)65-45-20-13-11-18-43(45)27-29-53(65)97(55)41-60(102)90-46(21-14-31-84-72(78)79)66(109)87-38-57(99)91-49(36-62(105)106)69(112)94-47(22-15-32-85-73(80)81)67(110)88-39-58(100)92-50(37-63(107)108)70(113)95-48(23-16-33-86-74(82)83)68(111)89-40-59(101)93-51(71(114)115)35-56(77)98/h5-13,17-20,24-29,46-51H,14-16,21-23,30-41H2,1-4H3,(H26-,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115)/p+1/t46-,47-,48-,49+,50+,51+/m0/s1 D0L2PQ DRUGINKE JDBLOSLZCJNMOD-QCWHUYCXSA-O D0L2PQ DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)N)C(=O)O)C=CC=CC=CC=C4C(C5=C(N4CCC(=O)O)C=CC6=CC=CC=C65)(C)C)C D0L2PQ HIGHSTAT Investigative D0L3JC DRUG__ID D0L3JC D0L3JC DRUGINCH 1S/C79H130N30O22/c1-41(97-60(115)39-96-75(129)62(44(4)111)109-73(127)54(35-46-20-9-6-10-21-46)100-61(116)38-94-59(114)37-95-66(120)47(82)34-45-18-7-5-8-19-45)63(117)101-51(25-16-32-92-78(87)88)69(123)104-49(23-12-14-30-81)71(125)108-56(40-110)74(128)99-42(2)64(118)102-52(26-17-33-93-79(89)90)70(124)103-48(22-11-13-29-80)68(122)105-50(24-15-31-91-77(85)86)67(121)98-43(3)65(119)107-55(36-58(84)113)72(126)106-53(76(130)131)27-28-57(83)112/h5-10,18-21,41-44,47-56,62,110-111H,11-17,22-40,80-82H2,1-4H3,(H2,83,112)(H2,84,113)(H,94,114)(H,95,120)(H,96,129)(H,97,115)(H,98,121)(H,99,128)(H,100,116)(H,101,117)(H,102,118)(H,103,124)(H,104,123)(H,105,122)(H,106,126)(H,107,119)(H,108,125)(H,109,127)(H,130,131)(H4,85,86,91)(H4,87,88,92)(H4,89,90,93)/t41-,42-,43-,44+,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,62-/m0/s1 D0L3JC DRUGINKE YTLZMPJDUFYROB-YRFUXTPFSA-N D0L3JC DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0L3JC HIGHSTAT Investigative D0L5BC DRUG__ID D0L5BC D0L5BC DRUGINCH 1S/C82H127N27O22/c1-44(97-64(115)42-96-79(129)66(47(4)111)109-77(127)57(37-49-22-10-6-11-23-49)100-65(116)41-94-63(114)40-95-70(120)51(85)36-48-20-8-5-9-21-48)67(117)101-54(28-18-34-92-81(88)89)71(121)104-53(27-15-17-33-84)74(124)108-60(43-110)78(128)99-45(2)68(118)102-55(29-19-35-93-82(90)91)72(122)103-52(26-14-16-32-83)73(123)107-58(38-50-24-12-7-13-25-50)75(125)98-46(3)69(119)106-59(39-62(87)113)76(126)105-56(80(130)131)30-31-61(86)112/h5-13,20-25,44-47,51-60,66,110-111H,14-19,26-43,83-85H2,1-4H3,(H2,86,112)(H2,87,113)(H,94,114)(H,95,120)(H,96,129)(H,97,115)(H,98,125)(H,99,128)(H,100,116)(H,101,117)(H,102,118)(H,103,122)(H,104,121)(H,105,126)(H,106,119)(H,107,123)(H,108,124)(H,109,127)(H,130,131)(H4,88,89,92)(H4,90,91,93)/t44-,45-,46-,47+,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,66-/m0/s1 D0L5BC DRUGINKE XBCTWRVAMOVPCA-UUKLZGIWSA-N D0L5BC DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)O D0L5BC HIGHSTAT Investigative D0L5MW DRUG__ID D0L5MW D0L5MW DRUGINCH 1S/C20H21NO4/c1-21-5-4-11-7-17(22-2)20(23-3)19-13-9-16-15(24-10-25-16)8-12(13)6-14(21)18(11)19/h7-9,14H,4-6,10H2,1-3H3 D0L5MW DRUGINKE WSVWKHTVFGTTKJ-UHFFFAOYSA-N D0L5MW DRUGSMIL CN1CCC2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OC)OC D0L5MW HIGHSTAT Investigative D0L8VT DRUG__ID D0L8VT D0L8VT DRUGINCH 1S/C123H180N26O53S8/c1-122(2,41-19-23-57-201-105-69-88(84-29-9-5-10-30-84)67-91(130-105)86-33-13-7-14-34-86)120-139-141-143-148(120)47-21-17-37-101(150)124-43-25-53-195-59-63-199-65-61-197-55-27-45-126-111(162)93(76-203(171,172)173)132-115(166)97(80-207(183,184)185)136-118(169)99(82-209(189,190)191)135-114(165)95(78-205(177,178)179)129-103(152)40-39-90(128-104(153)71-146(73-108(156)157)51-49-145(72-107(154)155)50-52-147(74-109(158)159)75-110(160)161)113(164)134-96(79-206(180,181)182)117(168)138-100(83-210(192,193)194)119(170)137-98(81-208(186,187)188)116(167)133-94(77-204(174,175)176)112(163)127-46-28-56-198-62-66-200-64-60-196-54-26-44-125-102(151)38-18-22-48-149-121(140-142-144-149)123(3,4)42-20-24-58-202-106-70-89(85-31-11-6-12-32-85)68-92(131-106)87-35-15-8-16-36-87/h5-16,29-36,67-70,90,93-100H,17-28,37-66,71-83H2,1-4H3,(H,124,150)(H,125,151)(H,126,162)(H,127,163)(H,128,153)(H,129,152)(H,132,166)(H,133,167)(H,134,164)(H,135,165)(H,136,169)(H,137,170)(H,138,168)(H,154,155)(H,156,157)(H,158,159)(H,160,161)(H,171,172,173)(H,174,175,176)(H,177,178,179)(H,180,181,182)(H,183,184,185)(H,186,187,188)(H,189,190,191)(H,192,193,194)/t90-,93-,94-,95-,96-,97-,98-,99-,100-/m0/s1 D0L8VT DRUGINKE DIGMLMRBDDSXMD-MSOXLDFBSA-N D0L8VT DRUGSMIL CC(C)(CCCCOC1=CC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3)C4=NN=NN4CCCCC(=O)NCCCOCCOCCOCCCNC(=O)C(CS(=O)(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)C(CS(=O)(=O)O)NC(=O)CCC(C(=O)NC(CS(=O)(=O)O)C(=O)NC(CS(=O)(=O)O)C(=O)NC(CS(=O)(=O)O)C(=O)NC(CS(=O)(=O)O)C(=O)NCCCOCCOCCOCCCNC(=O)CCCCN5C(=NN=N5)C(C)(C)CCCCOC6=CC(=CC(=N6)C7=CC=CC=C7)C8=CC=CC=C8)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O D0L8VT HIGHSTAT Investigative D0L8WJ DRUG__ID D0L8WJ D0L8WJ DRUGINCH 1S/C82H103ClN18O17/c1-45(2)35-60(72(107)91-59(16-9-10-33-86-46(3)4)80(115)101-34-12-17-68(101)79(114)87-47(5)70(84)105)92-74(109)63(38-51-23-30-58(31-24-51)90-82(117)100-118)94-76(111)64(39-50-21-28-57(29-22-50)89-71(106)66-42-69(104)99-81(116)98-66)96-78(113)67(44-102)97-77(112)65(41-53-13-11-32-85-43-53)95-75(110)62(37-49-19-26-56(83)27-20-49)93-73(108)61(88-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52/h7-8,11,13-15,18-32,36,43,45-47,59-68,86,102,118H,9-10,12,16-17,33-35,37-42,44H2,1-6H3,(H2,84,105)(H,87,114)(H,88,103)(H,89,106)(H,91,107)(H,92,109)(H,93,108)(H,94,111)(H,95,110)(H,96,113)(H,97,112)(H2,90,100,117)(H2,98,99,104,116)/t47-,59+,60+,61-,62-,63-,64+,65-,66+,67+,68+/m1/s1 D0L8WJ DRUGINKE ZYLCANLEJMKHHC-XYAYPHGZSA-N D0L8WJ DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)NO)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C D0L8WJ HIGHSTAT Investigative D0LC2O DRUG__ID D0LC2O D0LC2O DRUGINCH 1S/C47H68N14O9S/c1-24(2)15-35(44(67)57-34(40(48)63)13-14-71-8)59-46(69)38(18-31-21-50-23-53-31)58-41(64)26(5)55-47(70)39(25(3)4)61-42(65)27(6)54-43(66)36(16-29-19-51-33-12-10-9-11-32(29)33)60-45(68)37(56-28(7)62)17-30-20-49-22-52-30/h9-12,19-27,34-39,51H,13-18H2,1-8H3,(H2,48,63)(H,49,52)(H,50,53)(H,54,66)(H,55,70)(H,56,62)(H,57,67)(H,58,64)(H,59,69)(H,60,68)(H,61,65)/t26-,27-,34-,35-,36-,37-,38-,39-/m0/s1 D0LC2O DRUGINKE FLMAIOAFTCGWGR-YDDHTLEASA-N D0LC2O DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CN=CN4)NC(=O)C D0LC2O HIGHSTAT Investigative D0LM3T DRUG__ID D0LM3T D0LM3T THERCLAS Antisense D0LM3T DRUGTYPE Combination drug (Antisense drug) D0LM3T DRUGSMIL failed D0LM3T HIGHSTAT Investigative D0LM7P DRUG__ID D0LM7P D0LM7P DRUGINCH 1S/C60H87N19O13/c61-39(20-10-24-68-58(62)63)49(83)73-40(21-11-25-69-59(64)65)55(89)78-27-13-23-46(78)56(90)79-33-38(81)31-47(79)54(88)71-32-48(82)72-42(28-35-14-4-1-5-15-35)50(84)77-45(34-80)53(87)76-44(30-37-18-8-3-9-19-37)52(86)75-43(29-36-16-6-2-7-17-36)51(85)74-41(57(91)92)22-12-26-70-60(66)67/h1-9,14-19,38-47,80-81H,10-13,20-34,61H2,(H,71,88)(H,72,82)(H,73,83)(H,74,85)(H,75,86)(H,76,87)(H,77,84)(H,91,92)(H4,62,63,68)(H4,64,65,69)(H4,66,67,70)/t38?,39-,40-,41?,42+,43?,44?,45?,46-,47-/m0/s1 D0LM7P DRUGINKE RBIXVHPHNGXTCI-QWTWDILDSA-N D0LM7P DRUGSMIL C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O)O D0LM7P HIGHSTAT Investigative D0M2EZ DRUG__ID D0M2EZ D0M2EZ DRUGINCH 1S/C34H34FN5O3S/c35-26-15-19-29(20-16-26)44(42,43)38-27-17-13-25(14-18-27)24-36-33(41)23-32-30-11-5-6-12-31(30)37-34(39-21-7-2-8-22-39)40(32)28-9-3-1-4-10-28/h1,3-6,9-20,32,38H,2,7-8,21-24H2,(H,36,41) D0M2EZ DRUGINKE RMQZAKOLGVUVAD-UHFFFAOYSA-N D0M2EZ DRUGSMIL C1CCN(CC1)C2=NC3=CC=CC=C3C(N2C4=CC=CC=C4)CC(=O)NCC5=CC=C(C=C5)NS(=O)(=O)C6=CC=C(C=C6)F D0M2EZ HIGHSTAT Investigative D0M2TB DRUG__ID D0M2TB D0M2TB DRUGINCH 1S/C71H97N15O17S2/c1-9-38(7)58(69(100)81-53(71(102)103)27-42-30-74-47-19-15-14-18-45(42)47)86-70(101)59(39(8)10-2)85-65(96)52(29-56(89)90)79-61(92)48(24-36(3)4)76-64(95)51(28-43-31-73-35-75-43)78-67(98)55-34-105-104-33-46(72)60(91)82-54(32-87)66(97)84-57(37(5)6)68(99)80-50(26-41-20-22-44(88)23-21-41)62(93)77-49(63(94)83-55)25-40-16-12-11-13-17-40/h11-23,30-31,35-39,46,48-55,57-59,74,87-88H,9-10,24-29,32-34,72H2,1-8H3,(H,73,75)(H,76,95)(H,77,93)(H,78,98)(H,79,92)(H,80,99)(H,81,100)(H,82,91)(H,83,94)(H,84,97)(H,85,96)(H,86,101)(H,89,90)(H,102,103)/t38-,39-,46-,48-,49-,50+,51-,52-,53-,54-,55+,57-,58-,59-/m0/s1 D0M2TB DRUGINKE NFALCSTYLUFIHX-TWAFHRHTSA-N D0M2TB DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC5=CC=CC=C5)CC6=CC=C(C=C6)O)C(C)C)CO)N D0M2TB HIGHSTAT Investigative D0M3BJ DRUG__ID D0M3BJ D0M3BJ DRUGINCH 1S/C62H74N12O17S2/c1-3-31(2)51-58(86)69-42(19-20-48(64)78)55(83)70-43(28-49(65)79)56(84)71-44(29-93-92-24-21-50(80)72-52(59(87)73-51)32-9-12-34(75)13-10-32)60(88)74-23-6-8-45(74)57(85)68-41(54(82)67-30-63)7-4-5-22-66-53(81)33-11-16-37-40(25-33)62(91-61(37)89)38-17-14-35(76)26-46(38)90-47-27-36(77)15-18-39(47)62/h9-18,25-27,31,41-45,51-52,75-77H,3-8,19-24,28-30,63H2,1-2H3,(H2,64,78)(H2,65,79)(H,66,81)(H,67,82)(H,68,85)(H,69,86)(H,70,83)(H,71,84)(H,72,80)(H,73,87)/t31?,41-,42+,43+,44+,45+,51+,52-/m0/s1 D0M3BJ DRUGINKE OXFDSXJSRLFTMF-NRQFMKBZSA-N D0M3BJ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)NC(CCCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)CCC(=O)N D0M3BJ HIGHSTAT Investigative D0M6ZF DRUG__ID D0M6ZF D0M6ZF DRUGINCH 1S/C55H72N10O18S/c1-6-8-18-37(47(71)62-42(28-44(66)67)51(75)60-39(46(56)70)25-31-15-11-10-12-16-31)58-50(74)41(27-33-30-57-36-20-14-13-17-35(33)36)63-53(77)65-48(72)38(19-9-7-2)59-49(73)40(26-32-21-23-34(24-22-32)83-84(79,80)81)61-52(76)43(29-45(68)69)64-54(78)82-55(3,4)5/h10-17,20-24,30,37-43,57H,6-9,18-19,25-29H2,1-5H3,(H2,56,70)(H,58,74)(H,59,73)(H,60,75)(H,61,76)(H,62,71)(H,64,78)(H,66,67)(H,68,69)(H,79,80,81)(H2,63,65,72,77)/t37-,38-,39-,40-,41-,42-,43-/m0/s1 D0M6ZF DRUGINKE LWZREZWAQQSATC-NKUVHBIJSA-N D0M6ZF DRUGSMIL CCCCC(C(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)NC(=O)C(CCCC)NC(=O)C(CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)C(CC(=O)O)NC(=O)OC(C)(C)C D0M6ZF HIGHSTAT Investigative D0M7KS DRUG__ID D0M7KS D0M7KS DRUGINCH 1S/C47H69N11O10S2/c1-44(2)21-28(22-45(3,4)57(44)67)52-36(60)26-69-33-18-12-10-15-30(33)41(64)56(9)32(17-14-20-50-43(48)49)39(62)51-25-35(59)55-38(42(65)66)40(63)54-31-16-11-13-19-34(31)70-27-37(61)53-29-23-46(5,6)58(68)47(7,8)24-29/h10-13,15-16,18-19,28-29,32,38H,14,17,20-27H2,1-9H3,(H,51,62)(H,52,60)(H,53,61)(H,54,63)(H,55,59)(H,65,66)(H4,48,49,50)/t32-,38+/m0/s1 D0M7KS DRUGINKE GUCPTRJTGNVVHA-SCAVLVJOSA-N D0M7KS DRUGSMIL CC1(CC(CC(N1[O])(C)C)NC(=O)CSC2=CC=CC=C2C(=O)N(C)C(CCCN=C(N)N)C(=O)NCC(=O)NC(C(=O)NC3=CC=CC=C3SCC(=O)NC4CC(N(C(C4)(C)C)[O])(C)C)C(=O)O)C D0M7KS HIGHSTAT Investigative D0M7LZ DRUG__ID D0M7LZ D0M7LZ DRUGINCH 1S/C151H229N41O44/c1-16-79(10)122(148(234)170-82(13)127(213)178-106(61-88-64-161-93-37-24-23-36-91(88)93)138(224)180-102(57-76(4)5)139(225)189-120(77(6)7)146(232)177-95(38-25-28-52-152)130(216)164-68-114(202)171-94(41-31-55-160-151(156)157)129(215)162-66-111(155)199)191-140(226)104(58-85-32-19-17-20-33-85)181-135(221)97-40-27-30-54-159-112(200)49-46-100(133(219)169-80(11)125(211)168-81(12)126(212)174-96(134(220)175-97)39-26-29-53-153)173-115(203)69-165-132(218)99(48-51-118(207)208)176-136(222)101(56-75(2)3)179-137(223)103(60-87-42-44-90(198)45-43-87)182-143(229)108(71-193)185-145(231)110(73-195)186-147(233)121(78(8)9)190-142(228)107(63-119(209)210)183-144(230)109(72-194)187-150(236)124(84(15)197)192-141(227)105(59-86-34-21-18-22-35-86)184-149(235)123(83(14)196)188-116(204)70-166-131(217)98(47-50-117(205)206)172-113(201)67-163-128(214)92(154)62-89-65-158-74-167-89/h17-24,32-37,42-45,64-65,74-84,92,94-110,120-124,161,193-198H,16,25-31,38-41,46-63,66-73,152-154H2,1-15H3,(H2,155,199)(H,158,167)(H,159,200)(H,162,215)(H,163,214)(H,164,216)(H,165,218)(H,166,217)(H,168,211)(H,169,219)(H,170,234)(H,171,202)(H,172,201)(H,173,203)(H,174,212)(H,175,220)(H,176,222)(H,177,232)(H,178,213)(H,179,223)(H,180,224)(H,181,221)(H,182,229)(H,183,230)(H,184,235)(H,185,231)(H,186,233)(H,187,236)(H,188,204)(H,189,225)(H,190,228)(H,191,226)(H,192,227)(H,205,206)(H,207,208)(H,209,210)(H4,156,157,160)/t79-,80-,81-,82-,83+,84+,92-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,120-,121-,122-,123-,124-/m0/s1 D0M7LZ DRUGINKE WPXDPFYLELBEJH-MAGRMNHLSA-N D0M7LZ DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CCCCN)C)C)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D0M7LZ HIGHSTAT Investigative D0MH6P DRUG__ID D0MH6P D0MH6P DRUGINCH 1S/C62H96N18O12/c1-7-8-12-46(56(66)85)77-60(89)48(24-36(2)3)78-61(90)50(27-43-31-69-35-72-43)76-52(82)32-71-62(91)55(37(4)5)80-57(86)38(6)73-59(88)49(26-41-30-70-45-13-10-9-11-44(41)45)79-58(87)47(18-19-51(65)81)75-54(84)34-92-33-53(83)74-42-16-14-39(15-17-42)25-40(28-67-22-20-63)29-68-23-21-64/h9-11,13-17,30-31,35-38,40,46-50,55,67-68,70H,7-8,12,18-29,32-34,63-64H2,1-6H3,(H2,65,81)(H2,66,85)(H,69,72)(H,71,91)(H,73,88)(H,74,83)(H,75,84)(H,76,82)(H,77,89)(H,78,90)(H,79,87)(H,80,86)/t38-,46-,47-,48-,49-,50-,55-/m0/s1 D0MH6P DRUGINKE XDFRCEDKCPCBTG-KGOWMPLXSA-N D0MH6P DRUGSMIL CCCCC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)COCC(=O)NC4=CC=C(C=C4)CC(CNCCN)CNCCN D0MH6P HIGHSTAT Investigative D0N0KO DRUG__ID D0N0KO D0N0KO DRUGINCH 1S/C70H106N28O22S6/c71-12-4-3-9-36-55(107)87-39(15-31-19-82-35-8-2-1-7-33(31)35)58(110)97-48-27-123-121-24-34(72)54(106)95-47-26-125-126-29-50(68(120)94-46(53(74)105)25-122-124-28-49(98-60(112)41(17-51(73)102)89-66(47)118)67(119)93-45(23-101)64(116)92-44(22-100)63(115)84-36)96-57(109)38(11-6-14-81-70(77)78)85-62(114)43(21-99)91-59(111)40(16-32-20-79-30-83-32)88-61(113)42(18-52(103)104)90-56(108)37(86-65(48)117)10-5-13-80-69(75)76/h1-2,7-8,19-20,30,34,36-50,82,99-101H,3-6,9-18,21-29,71-72H2,(H2,73,102)(H2,74,105)(H,79,83)(H,84,115)(H,85,114)(H,86,117)(H,87,107)(H,88,113)(H,89,118)(H,90,108)(H,91,111)(H,92,116)(H,93,119)(H,94,120)(H,95,106)(H,96,109)(H,97,110)(H,98,112)(H,103,104)(H4,75,76,80)(H4,77,78,81)/t34-,36-,37-,38-,39-,40-,41+,42-,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D0N0KO DRUGINKE PRXVBAUMWHTDJW-HEDOAMBMSA-N D0N0KO DRUGSMIL C1C(C(=O)NC2CSSCC3C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSS1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CCCN=C(N)N)CO)CC4=CN=CN4)CC(=O)O)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)CCCCN)CO)CO)NC(=O)C(NC2=O)CC(=O)N)C(=O)N)N D0N0KO HIGHSTAT Investigative D0N1CK DRUG__ID D0N1CK D0N1CK DRUGINCH 1S/C14H17F3O/c15-14(16,17)13(18)11-7-2-1-4-8-12-9-5-3-6-10-12/h3,5-6,9-10H,1-2,4,7-8,11H2 D0N1CK DRUGINKE LKXJGCHERZYPOU-UHFFFAOYSA-N D0N1CK DRUGSMIL C1=CC=C(C=C1)CCCCCCC(=O)C(F)(F)F D0N1CK HIGHSTAT Investigative D0N2MA DRUG__ID D0N2MA D0N2MA DRUGINCH 1S/C83H106N16O16S2/c1-47(2)87-42-55-29-27-54(28-30-55)40-64-78(110)98-70(48(3)101)82(114)94-65(39-52-22-12-7-13-23-52)79(111)99-71(49(4)102)83(115)95-67(44-100)80(112)96-68(72(86)104)45-116-117-46-69(97-73(105)59(85)36-53-31-33-57(103)34-32-53)81(113)89-61(26-16-17-35-84)74(106)90-62(37-50-18-8-5-9-19-50)75(107)91-63(38-51-20-10-6-11-21-51)76(108)93-66(77(109)92-64)41-56-43-88-60-25-15-14-24-58(56)60/h5-15,18-25,27-34,43,47-49,59,61-71,87-88,100-103H,16-17,26,35-42,44-46,84-85H2,1-4H3,(H2,86,104)(H,89,113)(H,90,106)(H,91,107)(H,92,109)(H,93,108)(H,94,114)(H,95,115)(H,96,112)(H,97,105)(H,98,110)(H,99,111)/t48-,49-,59+,61-,62-,63+,64+,65+,66+,67+,68+,69-,70-,71-/m1/s1 D0N2MA DRUGINKE GIGRDXKZXVSPEN-OFTQGXSVSA-N D0N2MA DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)NC(=O)C(CC7=CC=C(C=C7)O)N)C(=O)N)CO)C(C)O)CC8=CC=CC=C8)C(C)O D0N2MA HIGHSTAT Investigative D0N2WA DRUG__ID D0N2WA D0N2WA DRUGINCH 1S/C62H79N13O11/c1-5-37(4)52(59(83)71-48(33-43-34-66-35-68-43)60(84)75-29-13-19-50(75)57(81)72-49(61(85)86)32-38-14-8-6-9-15-38)74-56(80)47(31-40-22-26-44(76)27-23-40)70-58(82)51(36(2)3)73-55(79)46(18-12-28-67-62(64)65)69-54(78)45(63)30-39-20-24-42(25-21-39)53(77)41-16-10-7-11-17-41/h6-11,14-17,20-27,34-37,45-52,76H,5,12-13,18-19,28-33,63H2,1-4H3,(H,66,68)(H,69,78)(H,70,82)(H,71,83)(H,72,81)(H,73,79)(H,74,80)(H,85,86)(H4,64,65,67)/t37-,45-,46-,47-,48-,49-,50-,51-,52-/m0/s1 D0N2WA DRUGINKE SSPYRQDCPZQEBX-LWJOARRHSA-N D0N2WA DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=CC=C(C=C5)C(=O)C6=CC=CC=C6)N D0N2WA HIGHSTAT Investigative D0N4LH DRUG__ID D0N4LH D0N4LH DRUGINCH 1S/C75H98N14O15S2/c1-43(2)78-38-50-30-28-49(29-31-50)36-58-70(98)87-63(44(3)91)72(100)85-59(35-48-23-13-8-14-24-48)71(99)88-64(45(4)92)73(101)86-61(40-90)74(102)89(5)62(75(103)104)42-106-105-41-53(77)65(93)80-55(27-17-18-32-76)66(94)81-56(33-46-19-9-6-10-20-46)67(95)82-57(34-47-21-11-7-12-22-47)68(96)84-60(69(97)83-58)37-51-39-79-54-26-16-15-25-52(51)54/h6-16,19-26,28-31,39,43-45,53,55-64,78-79,90-92H,17-18,27,32-38,40-42,76-77H2,1-5H3,(H,80,93)(H,81,94)(H,82,95)(H,83,97)(H,84,96)(H,85,100)(H,86,101)(H,87,98)(H,88,99)(H,103,104)/t44-,45-,53-,55-,56-,57+,58+,59+,60+,61+,62+,63-,64-/m1/s1 D0N4LH DRUGINKE ZLXHFZGOMNAVTA-YNBIXHCXSA-N D0N4LH DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)C)CO)C(C)O)CC7=CC=CC=C7)C(C)O D0N4LH HIGHSTAT Investigative D0N4RF DRUG__ID D0N4RF D0N4RF DRUGINCH 1S/C48H87N15O9/c1-30(2)24-37(46(71)72)61-44(69)40(48(3,4)5)62-42(67)36(25-31-13-15-34(64)16-14-31)60-43(68)38-12-9-23-63(38)45(70)35(11-8-20-56-47(52)53)57-28-33(10-6-7-17-49)59-39(65)29-58-41(66)32(26-54-21-18-50)27-55-22-19-51/h13-16,30,32-33,35-38,40,54-55,57,64H,6-12,17-29,49-51H2,1-5H3,(H,58,66)(H,59,65)(H,60,68)(H,61,69)(H,62,67)(H,71,72)(H4,52,53,56)/t33?,35-,36-,37-,38-,40+/m0/s1 D0N4RF DRUGINKE XXQNJIPZSZMHCW-FZJJICHOSA-N D0N4RF DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NCC(CCCCN)NC(=O)CNC(=O)C(CNCCN)CNCCN D0N4RF HIGHSTAT Investigative D0N5RQ DRUG__ID D0N5RQ D0N5RQ DRUGINCH 1S/C35H37N5O3S/c1-26-14-20-30(21-15-26)44(42,43)38-28-18-16-27(17-19-28)25-36-34(41)24-33-31-12-6-7-13-32(31)37-35(39-22-8-3-9-23-39)40(33)29-10-4-2-5-11-29/h2,4-7,10-21,33,38H,3,8-9,22-25H2,1H3,(H,36,41) D0N5RQ DRUGINKE TWRWYNXGPAASHN-UHFFFAOYSA-N D0N5RQ DRUGSMIL CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)CNC(=O)CC3C4=CC=CC=C4N=C(N3C5=CC=CC=C5)N6CCCCC6 D0N5RQ HIGHSTAT Investigative D0N6DN DRUG__ID D0N6DN D0N6DN DRUGINCH 1S/C58H71N9O15/c1-6-7-21-41(52(74)64-46(56(79)80)30-38-33-67(57(81)82-58(3,4)5)47-22-15-14-20-40(38)47)61-53(75)42(31-49(70)71)62-54(76)44(28-36-18-12-9-13-19-36)66-65-43(27-35-16-10-8-11-17-35)51(73)59-32-48(69)60-34(2)50(72)63-45(55(77)78)29-37-23-25-39(68)26-24-37/h8-20,22-26,33-34,41-46,65-66,68H,6-7,21,27-32H2,1-5H3,(H,59,73)(H,60,69)(H,61,75)(H,62,76)(H,63,72)(H,64,74)(H,70,71)(H,77,78)(H,79,80)/t34-,41+,42+,43+,44+,45+,46+/m1/s1 D0N6DN DRUGINKE IYNMVGGOTRCWGJ-CHAGIDMDSA-N D0N6DN DRUGSMIL CCCCC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C(=O)OC(C)(C)C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=CC=C3)NNC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O D0N6DN HIGHSTAT Investigative D0N6LH DRUG__ID D0N6LH D0N6LH DRUGINCH 1S/C73H100N20O19S2/c1-8-36(4)59(83-39(7)95)71(110)91-54-33-114-113-32-53(69(108)93-60(38(6)94)72(111)112)90-63(102)47(21-14-24-78-73(75)76)84-66(105)51(27-43-30-77-34-81-43)86-61(100)37(5)82-56(97)31-80-62(101)49(26-42-29-79-46-20-12-11-19-45(42)46)87-67(106)52(28-57(98)99)88-64(103)48(22-23-55(74)96)85-65(104)50(89-70(109)58(35(2)3)92-68(54)107)25-41-17-13-16-40-15-9-10-18-44(40)41/h9-13,15-20,29-30,34-38,47-54,58-60,79,94H,8,14,21-28,31-33H2,1-7H3,(H2,74,96)(H,77,81)(H,80,101)(H,82,97)(H,83,95)(H,84,105)(H,85,104)(H,86,100)(H,87,106)(H,88,103)(H,89,109)(H,90,102)(H,91,110)(H,92,107)(H,93,108)(H,98,99)(H,111,112)(H4,75,76,78)/t36-,37-,38+,47-,48-,49-,50-,51+,52+,53-,54-,58-,59-,60-/m0/s1 D0N6LH DRUGINKE ACANXZYPSQGZJT-UZUHPOSNSA-N D0N6LH DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC=CC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D0N6LH HIGHSTAT Investigative D0N7FU DRUG__ID D0N7FU D0N7FU DRUGINCH 1S/C50H67N11O11S2/c1-26(62)39(42(53)65)59-49(72)41-50(3,4)74-73-25-38(58-43(66)33(52)21-28-11-6-5-7-12-28)47(70)56-36(22-29-16-18-31(64)19-17-29)45(68)57-37(23-30-24-54-34-14-9-8-13-32(30)34)46(69)55-35(15-10-20-51)44(67)60-40(27(2)63)48(71)61-41/h5-9,11-14,16-19,24,26-27,33,35-41,54,62-64H,10,15,20-23,25,51-52H2,1-4H3,(H2,53,65)(H,55,69)(H,56,70)(H,57,68)(H,58,66)(H,59,72)(H,60,67)(H,61,71)/t26-,27-,33-,35+,36+,37-,38+,39+,40-,41+/m1/s1 D0N7FU DRUGINKE PZWWYAHWHHNCHO-JGPYJKKXSA-N D0N7FU DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0N7FU HIGHSTAT Investigative D0N7ZF DRUG__ID D0N7ZF D0N7ZF DRUGINCH 1S/C84H128N28O22/c1-44(100-66(118)42-99-81(132)68(47(4)114)112-79(130)59(36-49-21-9-6-10-22-49)103-67(119)41-97-65(117)40-98-72(123)52(87)35-48-19-7-5-8-20-48)69(120)104-56(27-17-33-94-83(90)91)73(124)107-55(26-14-16-32-86)76(127)111-62(43-113)80(131)102-45(2)70(121)105-57(28-18-34-95-84(92)93)74(125)106-54(25-13-15-31-85)75(126)110-60(37-50-39-96-53-24-12-11-23-51(50)53)77(128)101-46(3)71(122)109-61(38-64(89)116)78(129)108-58(82(133)134)29-30-63(88)115/h5-12,19-24,39,44-47,52,54-62,68,96,113-114H,13-18,25-38,40-43,85-87H2,1-4H3,(H2,88,115)(H2,89,116)(H,97,117)(H,98,123)(H,99,132)(H,100,118)(H,101,128)(H,102,131)(H,103,119)(H,104,120)(H,105,121)(H,106,125)(H,107,124)(H,108,129)(H,109,122)(H,110,126)(H,111,127)(H,112,130)(H,133,134)(H4,90,91,94)(H4,92,93,95)/t44-,45-,46-,47+,52-,54-,55-,56-,57-,58-,59-,60-,61-,62-,68-/m0/s1 D0N7ZF DRUGINKE MRPJNGQFWWZSQY-FMCSKRGOSA-N D0N7ZF DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=CC=C4)N)O D0N7ZF HIGHSTAT Investigative D0N9NA DRUG__ID D0N9NA D0N9NA DRUGINCH 1S/C136H200N52O42/c1-135(2)89(187(87-38-36-67-22-10-12-24-69(67)109(87)135)49-40-91(189)171-71(26-14-41-155-127(139)140)113(215)165-60-96(194)177-81(54-105(205)206)121(223)183-75(30-18-45-159-131(147)148)117(219)167-62-98(196)179-83(56-107(209)210)123(225)185-77(32-20-47-161-133(151)152)119(221)169-64-100(198)181-85(125(227)228)50-92(190)172-72(27-15-42-156-128(141)142)114(216)163-58-94(192)175-79(111(137)213)52-103(201)202)34-8-6-5-7-9-35-90-136(3,4)110-70-25-13-11-23-68(70)37-39-88(110)188(90)66-102(200)174-74(29-17-44-158-130(145)146)116(218)166-61-97(195)178-82(55-106(207)208)122(224)184-76(31-19-46-160-132(149)150)118(220)168-63-99(197)180-84(57-108(211)212)124(226)186-78(33-21-48-162-134(153)154)120(222)170-65-101(199)182-86(126(229)230)51-93(191)173-73(28-16-43-157-129(143)144)115(217)164-59-95(193)176-80(112(138)214)53-104(203)204/h5-13,22-25,34-39,71-86H,14-21,26-33,40-66H2,1-4H3,(H67-,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151,152,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,185,186,189,190,191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218,219,220,221,222,223,224,225,226,227,228,229,230)/p+1/t71-,72-,73-,74-,75-,76-,77-,78-,79+,80+,81+,82+,83+,84+,85+,86+/m0/s1 D0N9NA DRUGINKE ZQQKMIYGRGPTIR-LKERAZDISA-O D0N9NA DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N)C(=O)O)C=CC=CC=CC=C4C(C5=C(N4CCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N)C(=O)O)C=CC6=CC=CC=C65)(C)C)C D0N9NA HIGHSTAT Investigative D0NI1W DRUG__ID D0NI1W D0NI1W DRUGINCH 1S/C68H92N14O15S2/c1-9-37(7)56(66(94)78-52(68(96)97)27-41-30-71-46-19-15-14-18-44(41)46)82-67(95)57(38(8)10-2)81-63(91)51(29-54(84)85)76-59(87)47(24-35(3)4)73-62(90)50(28-42-31-70-34-72-42)75-64(92)53-33-99-98-32-45(69)58(86)80-55(36(5)6)65(93)77-49(26-40-20-22-43(83)23-21-40)60(88)74-48(61(89)79-53)25-39-16-12-11-13-17-39/h11-23,30-31,34-38,45,47-53,55-57,71,83H,9-10,24-29,32-33,69H2,1-8H3,(H,70,72)(H,73,90)(H,74,88)(H,75,92)(H,76,87)(H,77,93)(H,78,94)(H,79,89)(H,80,86)(H,81,91)(H,82,95)(H,84,85)(H,96,97)/t37-,38-,45-,47-,48-,49+,50-,51-,52-,53+,55-,56-,57-/m0/s1 D0NI1W DRUGINKE OETKRDJJNWJFOP-OUBBGVQJSA-N D0NI1W DRUGSMIL CCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)CC5=CC=CC=C5)CC6=CC=C(C=C6)O)C(C)C)N D0NI1W HIGHSTAT Investigative D0NZ3Q DRUG__ID D0NZ3Q D0NZ3Q DRUGINCH 1S/C141H226N46O29S3/c1-11-77(6)111(133(212)186-112(80(9)189)134(213)183-106(74-218)130(209)184-110(76(4)5)132(211)176-97(49-32-61-161-141(155)156)120(199)170-93(45-28-57-157-137(147)148)116(195)166-78(7)113(192)180-103(136(215)216)66-82-36-16-13-17-37-82)185-128(207)104(72-188)181-131(210)107-50-33-62-187(107)135(214)79(8)165-109(191)71-164-115(194)100(64-75(2)3)177-121(200)92(44-24-27-56-144)168-117(196)91(43-23-26-55-143)169-125(204)99(53-63-219-10)175-119(198)94(46-29-58-158-138(149)150)172-126(205)101(67-83-69-162-88-40-20-18-38-85(83)88)179-124(203)98(51-52-108(146)190)174-127(206)102(68-84-70-163-89-41-21-19-39-86(84)89)178-122(201)96(48-31-60-160-140(153)154)171-118(197)95(47-30-59-159-139(151)152)173-129(208)105(73-217)182-123(202)90(42-22-25-54-142)167-114(193)87(145)65-81-34-14-12-15-35-81/h12-21,34-41,69-70,75-80,87,90-107,110-112,162-163,188-189,217-218H,11,22-33,42-68,71-74,142-145H2,1-10H3,(H2,146,190)(H,164,194)(H,165,191)(H,166,195)(H,167,193)(H,168,196)(H,169,204)(H,170,199)(H,171,197)(H,172,205)(H,173,208)(H,174,206)(H,175,198)(H,176,211)(H,177,200)(H,178,201)(H,179,203)(H,180,192)(H,181,210)(H,182,202)(H,183,213)(H,184,209)(H,185,207)(H,186,212)(H,215,216)(H4,147,148,157)(H4,149,150,158)(H4,151,152,159)(H4,153,154,160)(H4,155,156,161)/t77-,78-,79-,80+,87-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,110-,111-,112-/m0/s1 D0NZ3Q DRUGINKE CSSYQJWUGATIHM-IKGCZBKSSA-N D0NZ3Q DRUGSMIL CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O D0NZ3Q HIGHSTAT Investigative D0O0AR DRUG__ID D0O0AR D0O0AR DRUGINCH 1S/C30H28N6O4/c37-27(19-32-30(39)34-24-12-3-7-21(17-24)18-33-40)36(26-14-4-9-23-10-5-15-31-29(23)26)20-28(38)35-16-6-11-22-8-1-2-13-25(22)35/h1-5,7-10,12-15,17-18,40H,6,11,16,19-20H2,(H2,32,34,39)/b33-18- D0O0AR DRUGINKE MKQFGVTYYCUUEG-OHUYPAJKSA-N D0O0AR DRUGSMIL C1CC2=CC=CC=C2N(C1)C(=O)CN(C3=CC=CC4=C3N=CC=C4)C(=O)CNC(=O)NC5=CC=CC(=C5)C=NO D0O0AR HIGHSTAT Investigative D0O1PM DRUG__ID D0O1PM D0O1PM DRUGINCH 1S/C14H23N/c1-4-11-15(12-5-2)14-9-7-13(6-3)8-10-14/h3,7,14H,4-5,8-12H2,1-2H3 D0O1PM DRUGINKE IOUKEEFTYOZOKJ-UHFFFAOYSA-N D0O1PM DRUGSMIL CCCN(CCC)C1CCC(=CC1)C#C D0O1PM HIGHSTAT Investigative D0O1YO DRUG__ID D0O1YO D0O1YO DRUGINCH 1S/C54H67F3N12O10/c1-6-31(4)45(50(76)63-40(26-36-27-59-29-60-36)51(77)69-22-10-13-42(69)48(74)64-41(52(78)79)25-32-11-8-7-9-12-32)66-47(73)39(24-34-16-20-37(70)21-17-34)62-49(75)44(30(2)3)65-46(72)38(61-43(71)28-58-5)23-33-14-18-35(19-15-33)53(67-68-53)54(55,56)57/h7-9,11-12,14-21,27,29-31,38-42,44-45,58,70H,6,10,13,22-26,28H2,1-5H3,(H,59,60)(H,61,71)(H,62,75)(H,63,76)(H,64,74)(H,65,72)(H,66,73)(H,78,79)/t31-,38-,39-,40-,41-,42-,44-,45-/m0/s1 D0O1YO DRUGINKE IANMQZMQGQLRSI-LTTXXCTBSA-N D0O1YO DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CC5=CC=C(C=C5)C6(N=N6)C(F)(F)F)NC(=O)CNC D0O1YO HIGHSTAT Investigative D0O2BI DRUG__ID D0O2BI D0O2BI DRUGINCH 1S/C74H102N24O18S2/c1-7-36(4)60(87-38(6)100)73(116)96-55-32-118-117-31-54(71(114)98-61(37(5)99)62(76)105)95-64(107)47(17-12-20-81-74(77)78)89-68(111)52(24-42-29-80-34-86-42)92-67(110)51(23-41-28-79-33-85-41)88-57(102)30-84-63(106)49(21-39-26-82-45-15-10-8-13-43(39)45)91-69(112)53(25-58(103)104)93-65(108)48(18-19-56(75)101)90-66(109)50(94-72(115)59(35(2)3)97-70(55)113)22-40-27-83-46-16-11-9-14-44(40)46/h8-11,13-16,26-29,33-37,47-55,59-61,82-83,99H,7,12,17-25,30-32H2,1-6H3,(H2,75,101)(H2,76,105)(H,79,85)(H,80,86)(H,84,106)(H,87,100)(H,88,102)(H,89,111)(H,90,109)(H,91,112)(H,92,110)(H,93,108)(H,94,115)(H,95,107)(H,96,116)(H,97,113)(H,98,114)(H,103,104)(H4,77,78,81)/t36-,37+,47-,48-,49-,50+,51-,52+,53+,54-,55-,59-,60-,61-/m0/s1 D0O2BI DRUGINKE WCPUCPVVFQIWRA-BEXWAHHISA-N D0O2BI DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CNC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)CC6=CN=CN6)CC7=CN=CN7)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0O2BI HIGHSTAT Investigative D0O3SJ DRUG__ID D0O3SJ D0O3SJ DRUGINCH 1S/C85H133N27O23/c1-45(2)36-59(77(128)109-61(39-51-26-28-52(115)29-27-51)78(129)110-62(40-65(90)117)79(130)107-58(83(134)135)30-31-64(89)116)108-75(126)54(22-12-14-32-86)105-74(125)57(25-17-35-96-85(93)94)104-71(122)47(4)101-81(132)63(44-113)111-76(127)55(23-13-15-33-87)106-73(124)56(24-16-34-95-84(91)92)103-70(121)46(3)100-67(119)43-99-82(133)69(48(5)114)112-80(131)60(38-50-20-10-7-11-21-50)102-68(120)42-97-66(118)41-98-72(123)53(88)37-49-18-8-6-9-19-49/h6-11,18-21,26-29,45-48,53-63,69,113-115H,12-17,22-25,30-44,86-88H2,1-5H3,(H2,89,116)(H2,90,117)(H,97,118)(H,98,123)(H,99,133)(H,100,119)(H,101,132)(H,102,120)(H,103,121)(H,104,122)(H,105,125)(H,106,124)(H,107,130)(H,108,126)(H,109,128)(H,110,129)(H,111,127)(H,112,131)(H,134,135)(H4,91,92,95)(H4,93,94,96)/t46-,47-,48+,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,69-/m0/s1 D0O3SJ DRUGINKE BDVDLXKNELSDGP-RLSGEJHXSA-N D0O3SJ DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N D0O3SJ HIGHSTAT Investigative D0O4GU DRUG__ID D0O4GU D0O4GU DRUGINCH 1S/C50H66N10O10S2/c1-28(2)43-50(70)59-42(49(69)57-40(25-61)29(3)62)27-72-71-26-41(58-44(64)35(52)21-30-11-5-4-6-12-30)48(68)55-38(22-31-16-18-33(63)19-17-31)46(66)56-39(23-32-24-53-36-14-8-7-13-34(32)36)47(67)54-37(45(65)60-43)15-9-10-20-51/h4-8,11-14,16-19,24-25,28-29,35,37-43,53,62-63H,9-10,15,20-23,26-27,51-52H2,1-3H3,(H,54,67)(H,55,68)(H,56,66)(H,57,69)(H,58,64)(H,59,70)(H,60,65)/t29-,35+,37+,38+,39-,40-,41+,42-,43-/m1/s1 D0O4GU DRUGINKE KBXJEGQBFLLJFL-ILNSAXFWSA-N D0O4GU DRUGSMIL CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(C=O)C(C)O D0O4GU HIGHSTAT Investigative D0O5VA DRUG__ID D0O5VA D0O5VA DRUGINCH 1S/C55H76N16O15/c1-29(2)19-38(49(81)66-37(9-5-17-60-55(57)58)54(86)71-18-6-10-43(71)53(85)63-26-46(77)78)65-44(74)25-62-48(80)39(20-30-11-13-33(73)14-12-30)68-52(84)42(27-72)70-50(82)40(21-31-23-61-36-8-4-3-7-34(31)36)69-51(83)41(22-32-24-59-28-64-32)67-47(79)35(56)15-16-45(75)76/h3-4,7-8,11-14,23-24,28-29,35,37-43,61,72-73H,5-6,9-10,15-22,25-27,56H2,1-2H3,(H,59,64)(H,62,80)(H,63,85)(H,65,74)(H,66,81)(H,67,79)(H,68,84)(H,69,83)(H,70,82)(H,75,76)(H,77,78)(H4,57,58,60)/t35-,37-,38-,39-,40-,41-,42-,43-/m0/s1 D0O5VA DRUGINKE HLUQDWRHBPWVNT-LVHVEONVSA-N D0O5VA DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)N D0O5VA HIGHSTAT Investigative D0O5WV DRUG__ID D0O5WV D0O5WV DRUGINCH 1S/C174H280N52O49S/c1-17-90(10)137(168(271)209-109(40-25-30-68-179)146(249)205-113(56-60-129(180)235)151(254)202-106(37-22-27-65-176)144(247)203-111(42-32-70-192-173(186)187)149(252)214-120(76-99-46-52-103(233)53-47-99)159(262)221-128(84-276)171(274)275)224-165(268)127(83-228)219-153(256)115(58-62-131(182)237)207-157(260)118(73-87(4)5)212-158(261)119(75-98-44-50-102(232)51-45-98)213-148(251)108(39-24-29-67-178)201-143(246)105(36-21-26-64-175)199-141(244)92(12)195-140(243)91(11)197-166(269)135(88(6)7)223-154(257)116(59-63-132(183)238)206-145(248)107(38-23-28-66-177)200-147(250)110(41-31-69-191-172(184)185)204-156(259)117(72-86(2)3)211-150(253)112(43-33-71-193-174(188)189)210-169(272)138(94(14)229)225-162(265)121(77-100-48-54-104(234)55-49-100)215-152(255)114(57-61-130(181)236)208-161(264)125(80-134(241)242)218-170(273)139(95(15)230)226-163(266)122(74-97-34-19-18-20-35-97)217-167(270)136(89(8)9)222-142(245)93(13)196-155(258)124(79-133(239)240)216-164(267)126(82-227)220-160(263)123(198-96(16)231)78-101-81-190-85-194-101/h18-20,34-35,44-55,81,85-95,105-128,135-139,227-230,232-234,276H,17,21-33,36-43,56-80,82-84,175-179H2,1-16H3,(H2,180,235)(H2,181,236)(H2,182,237)(H2,183,238)(H,190,194)(H,195,243)(H,196,258)(H,197,269)(H,198,231)(H,199,244)(H,200,250)(H,201,246)(H,202,254)(H,203,247)(H,204,259)(H,205,249)(H,206,248)(H,207,260)(H,208,264)(H,209,271)(H,210,272)(H,211,253)(H,212,261)(H,213,251)(H,214,252)(H,215,255)(H,216,267)(H,217,270)(H,218,273)(H,219,256)(H,220,263)(H,221,262)(H,222,245)(H,223,257)(H,224,268)(H,225,265)(H,226,266)(H,239,240)(H,241,242)(H,274,275)(H4,184,185,191)(H4,186,187,192)(H4,188,189,193)/t90-,91-,92-,93-,94+,95+,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,135-,136-,137-,138-,139-/m0/s1 D0O5WV DRUGINKE IBAUXWGAMLDSHW-KCQDCZGMSA-N D0O5WV DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CS)C(=O)O)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(C(C)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC5=CN=CN5)NC(=O)C D0O5WV HIGHSTAT Investigative D0O6NZ DRUG__ID D0O6NZ D0O6NZ DRUGINCH 1S/C80H132N28O21/c1-7-49(69(120)102-54(27-19-33-92-80(89)90)71(122)103-51(24-14-16-30-81)72(123)106-55(34-42(2)3)74(125)97-44(5)67(118)105-57(37-60(85)112)75(126)100-50(65(86)116)28-29-59(84)111)99-77(128)58(41-109)107-73(124)52(25-15-17-31-82)104-70(121)53(26-18-32-91-79(87)88)101-66(117)43(4)96-62(114)40-95-78(129)64(45(6)110)108-76(127)56(36-47-22-12-9-13-23-47)98-63(115)39-93-61(113)38-94-68(119)48(83)35-46-20-10-8-11-21-46/h8-13,20-23,42-45,48-58,64,109-110H,7,14-19,24-41,81-83H2,1-6H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,119)(H,95,129)(H,96,114)(H,97,125)(H,98,115)(H,99,128)(H,100,126)(H,101,117)(H,102,120)(H,103,122)(H,104,121)(H,105,118)(H,106,123)(H,107,124)(H,108,127)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0O6NZ DRUGINKE BMXJNWVYNYOAHC-KMOVSZGYSA-N D0O6NZ DRUGSMIL CCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0O6NZ HIGHSTAT Investigative D0O6WN DRUG__ID D0O6WN D0O6WN DRUGINCH 1S/C60H71N11O18S2/c1-4-28(2)47-55(83)69-48(29(3)72)56(84)66-40(24-46(62)77)52(80)67-41(25-90-91-26-43(76)54(82)70-49(57(85)68-47)30-9-12-32(73)13-10-30)58(86)71-20-6-8-42(71)53(81)65-39(51(79)64-27-61)7-5-19-63-50(78)31-11-16-35-38(21-31)60(89-59(35)87)36-17-14-33(74)22-44(36)88-45-23-34(75)15-18-37(45)60/h9-18,21-23,28-29,39-43,47-49,72-76H,4-8,19-20,24-27,61H2,1-3H3,(H2,62,77)(H,63,78)(H,64,79)(H,65,81)(H,66,84)(H,67,80)(H,68,85)(H,69,83)(H,70,82)/t28?,29?,39-,40+,41+,42+,43?,47+,48+,49-/m0/s1 D0O6WN DRUGINKE QZZVYFFNKFRZQH-NYIBOZPTSA-N D0O6WN DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)O)C(=O)N3CCCC3C(=O)NC(CCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)C(C)O D0O6WN HIGHSTAT Investigative D0O7XU DRUG__ID D0O7XU D0O7XU DRUGINCH 1S/C66H75N9O10/c67-51(37-47-25-29-49(76)30-26-47)65(84)74-35-13-23-57(74)63(82)72-54(40-45-19-9-3-10-20-45)61(80)70-52(38-43-15-5-1-6-16-43)59(78)33-34-69-56(42-48-27-31-50(77)32-28-48)66(85)75-36-14-24-58(75)64(83)73-55(41-46-21-11-4-12-22-46)62(81)71-53(60(68)79)39-44-17-7-2-8-18-44/h1-12,15-22,25-32,51-58,69,76-77H,13-14,23-24,33-42,67H2,(H2,68,79)(H,70,80)(H,71,81)(H,72,82)(H,73,83)/t51-,52-,53-,54-,55-,56-,57-,58-/m0/s1 D0O7XU DRUGINKE YHWMMBKGEDGQFW-LEPIMFGVSA-N D0O7XU DRUGSMIL C1CC(N(C1)C(=O)C(CC2=CC=C(C=C2)O)N)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)CCNC(CC5=CC=C(C=C5)O)C(=O)N6CCCC6C(=O)NC(CC7=CC=CC=C7)C(=O)NC(CC8=CC=CC=C8)C(=O)N D0O7XU HIGHSTAT Investigative D0O8BP DRUG__ID D0O8BP D0O8BP DRUGCOMP Isis Pharmaceuticals D0O8BP THERCLAS Anticancer Agents D0O8BP DRUGTYPE Antisense drug D0O8BP HIGHSTAT Investigative D0O8OF DRUG__ID D0O8OF D0O8OF DRUGINCH 1S/C46H66N12O11S2/c47-18-5-4-10-30(40(63)51-25-38(50)61)54-45(68)36-12-7-20-58(36)46(69)35-26-71-70-21-17-39(62)52-32(23-28-13-15-29(59)16-14-28)42(65)55-33(22-27-8-2-1-3-9-27)43(66)53-31(11-6-19-48)41(64)56-34(24-37(49)60)44(67)57-35/h1-3,8-9,13-16,30-36,59H,4-7,10-12,17-26,47-48H2,(H2,49,60)(H2,50,61)(H,51,63)(H,52,62)(H,53,66)(H,54,68)(H,55,65)(H,56,64)(H,57,67)/t30-,31-,32-,33-,34-,35-,36-/m0/s1 D0O8OF DRUGINKE MYTIGVSAVZNLKG-QJCLFNHPSA-N D0O8OF DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCCN)C(=O)NCC(=O)N D0O8OF HIGHSTAT Investigative D0O9FA DRUG__ID D0O9FA D0O9FA DRUGINCH 1S/C48H75N11O12S2/c1-8-27(5)39-45(68)53-30(17-18-36(49)60)41(64)54-32(24-37(50)61)42(65)55-34(25-73-72-21-19-38(62)52-31(43(66)57-39)23-28-13-15-29(16-14-28)71-9-2)44(67)58-48(6,7)47(70)56-33(22-26(3)4)46(69)59-20-11-10-12-35(59)40(51)63/h13-16,26-27,30-35,39H,8-12,17-25H2,1-7H3,(H2,49,60)(H2,50,61)(H2,51,63)(H,52,62)(H,53,68)(H,54,64)(H,55,65)(H,56,70)(H,57,66)(H,58,67)/t27-,30-,31-,32-,33-,34-,35+,39-/m0/s1 D0O9FA DRUGINKE UMBCXADJMGHVRX-AYLPWDSMSA-N D0O9FA DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)NC(C)(C)C(=O)NC(CC(C)C)C(=O)N3CCCCC3C(=O)N)CC(=O)N)CCC(=O)N D0O9FA HIGHSTAT Investigative D0O9WG DRUG__ID D0O9WG D0O9WG DRUGINCH 1S/C145H242N44O48S2/c1-65(2)45-86(175-139(232)110(70(11)12)183-136(229)99(63-239)181-142(235)114(74(16)197)187-135(228)98(61-193)180-129(222)90(49-69(9)10)172-131(224)92(52-104(151)202)174-134(227)96(59-191)178-117(210)79(148)62-238)118(211)158-55-106(204)162-80(25-18-20-40-146)120(213)169-89(48-68(7)8)128(221)179-97(60-192)133(226)167-83(34-37-102(149)200)122(215)165-85(36-39-109(207)208)123(216)171-88(47-67(5)6)127(220)173-91(51-77-54-156-64-161-77)130(223)164-81(26-19-21-41-147)121(214)170-87(46-66(3)4)126(219)166-84(35-38-103(150)201)125(218)186-113(73(15)196)141(234)177-94(50-76-30-32-78(199)33-31-76)143(236)189-44-24-29-101(189)137(230)168-82(27-22-42-157-145(154)155)124(217)185-112(72(14)195)140(233)176-93(53-105(152)203)132(225)184-111(71(13)194)138(231)160-56-107(205)163-95(58-190)119(212)159-57-108(206)182-115(75(17)198)144(237)188-43-23-28-100(188)116(153)209/h30-33,54,64-75,79-101,110-115,190-199,238-239H,18-29,34-53,55-63,146-148H2,1-17H3,(H2,149,200)(H2,150,201)(H2,151,202)(H2,152,203)(H2,153,209)(H,156,161)(H,158,211)(H,159,212)(H,160,231)(H,162,204)(H,163,205)(H,164,223)(H,165,215)(H,166,219)(H,167,226)(H,168,230)(H,169,213)(H,170,214)(H,171,216)(H,172,224)(H,173,220)(H,174,227)(H,175,232)(H,176,233)(H,177,234)(H,178,210)(H,179,221)(H,180,222)(H,181,235)(H,182,206)(H,183,229)(H,184,225)(H,185,217)(H,186,218)(H,187,228)(H,207,208)(H4,154,155,157)/t71-,72-,73-,74-,75-,79+,80+,81+,82+,83+,84+,85+,86+,87+,88+,89+,90+,91+,92+,93+,94?,95+,96+,97+,98+,99+,100-,101-,110+,111+,112+,113+,114+,115+/m1/s1 D0O9WG DRUGINKE AZCMZZXDDMAXIT-SLFAFRAOSA-N D0O9WG DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CO)C(=O)NCC(=O)NC(C(C)O)C(=O)N3CCCC3C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC4=CNC=N4)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)N D0O9WG HIGHSTAT Investigative D0OF3M DRUG__ID D0OF3M D0OF3M DRUGINCH 1S/C49H71N13O10/c1-6-29(4)41(46(69)58-36(24-32-25-53-27-55-32)47(70)62-21-11-15-38(62)44(67)59-37(48(71)72)23-30-12-8-7-9-13-30)61-43(66)35(22-31-16-18-33(63)19-17-31)57-45(68)40(28(2)3)60-42(65)34(56-39(64)26-52-5)14-10-20-54-49(50)51/h7-9,12-13,16-19,25,27-29,34-38,40-41,52,63H,6,10-11,14-15,20-24,26H2,1-5H3,(H,53,55)(H,56,64)(H,57,68)(H,58,69)(H,59,67)(H,60,65)(H,61,66)(H,71,72)(H4,50,51,54)/t29-,34-,35-,36-,37-,38-,40-,41-/m0/s1 D0OF3M DRUGINKE WCYZYYURIHACQW-KOTWUFNXSA-N D0OF3M DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D0OF3M HIGHSTAT Investigative D0P0JW DRUG__ID D0P0JW D0P0JW DRUGINCH 1S/C270H401N73O83S7/c1-24-134(19)217(262(420)293-112-201(355)298-161(69-74-205(359)360)229(387)301-160(45-35-82-286-269(279)280)228(386)333-192(119-428)255(413)307-162(68-73-198(274)352)230(388)316-176(94-141-54-64-150(350)65-55-141)241(399)304-159(44-34-81-285-268(277)278)227(385)325-186(105-212(373)374)248(406)313-169(87-127(5)6)235(393)302-158(43-31-33-80-272)226(384)318-179(97-144-108-289-156-41-29-27-39-153(144)156)243(401)319-178(96-143-107-288-155-40-28-26-38-152(143)155)242(400)305-164(71-76-207(363)364)231(389)312-170(88-128(7)8)236(394)310-167(267(425)426)46-36-83-287-270(281)282)341-250(408)174(92-139-50-60-148(348)61-51-139)300-203(357)113-292-261(419)214(131(13)14)340-264(422)216(133(17)18)339-259(417)195(122-431)335-246(404)182(101-200(276)354)322-257(415)191(118-427)332-220(378)137(22)297-234(392)175(93-140-52-62-149(349)63-53-140)315-225(383)157(42-30-32-79-271)303-247(405)185(104-211(371)372)326-237(395)168(86-126(3)4)311-219(377)136(21)296-224(382)163(70-75-206(361)362)309-265(423)218(135(20)25-2)342-251(409)177(95-142-56-66-151(351)67-57-142)317-233(391)166(78-85-433-23)308-256(414)194(121-430)336-263(421)215(132(15)16)338-204(358)114-291-223(381)184(103-210(369)370)323-244(402)180(98-145-109-283-124-294-145)320-238(396)171(89-129(9)10)314-258(416)193(120-429)334-240(398)173(91-138-48-58-147(347)59-49-138)299-202(356)111-290-222(380)183(102-209(367)368)324-245(403)181(99-146-110-284-125-295-146)321-254(412)190(117-346)330-239(397)172(90-130(11)12)328-260(418)197-47-37-84-343(197)266(424)196(123-432)337-232(390)165(72-77-208(365)366)306-252(410)189(116-345)331-249(407)187(106-213(375)376)327-253(411)188(115-344)329-221(379)154(273)100-199(275)353/h26-29,38-41,48-67,107-110,124-137,154,157-197,214-218,288-289,344-351,427-432H,24-25,30-37,42-47,68-106,111-123,271-273H2,1-23H3,(H2,274,352)(H2,275,353)(H2,276,354)(H,283,294)(H,284,295)(H,290,380)(H,291,381)(H,292,419)(H,293,420)(H,296,382)(H,297,392)(H,298,355)(H,299,356)(H,300,357)(H,301,387)(H,302,393)(H,303,405)(H,304,399)(H,305,400)(H,306,410)(H,307,413)(H,308,414)(H,309,423)(H,310,394)(H,311,377)(H,312,389)(H,313,406)(H,314,416)(H,315,383)(H,316,388)(H,317,391)(H,318,384)(H,319,401)(H,320,396)(H,321,412)(H,322,415)(H,323,402)(H,324,403)(H,325,385)(H,326,395)(H,327,411)(H,328,418)(H,329,379)(H,330,397)(H,331,407)(H,332,378)(H,333,386)(H,334,398)(H,335,404)(H,336,421)(H,337,390)(H,338,358)(H,339,417)(H,340,422)(H,341,408)(H,342,409)(H,359,360)(H,361,362)(H,363,364)(H,365,366)(H,367,368)(H,369,370)(H,371,372)(H,373,374)(H,375,376)(H,425,426)(H4,277,278,285)(H4,279,280,286)(H4,281,282,287)/t134-,135-,136-,137-,154-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,185-,186-,187-,188-,189-,190-,191-,192-,193-,194-,195-,196-,197-,214-,215-,216-,217-,218-/m0/s1 D0P0JW DRUGINKE GVUGOAYIVIDWIO-UFWWTJHBSA-N D0P0JW DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CS)C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(CC(=O)N)NC(=O)C(CS)NC(=O)C(C)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC9=CN=CN9)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CS)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)N D0P0JW HIGHSTAT Investigative D0P0LG DRUG__ID D0P0LG D0P0LG DRUGINCH 1S/C132H190N30O43S/c1-10-71(6)109(129(201)162-56-20-27-98(162)124(196)149-84(44-50-105(176)177)113(185)145-83(43-49-104(174)175)114(186)152-91(60-74-30-36-78(166)37-31-74)120(192)151-88(57-69(2)3)117(189)150-87(130(202)203)40-46-99(134)167)158-116(188)85(45-51-106(178)179)146-112(184)82(42-48-103(172)173)148-118(190)89(58-72-21-12-11-13-22-72)154-122(194)93(62-107(180)181)142-100(168)64-139-110(182)94(66-163)156-126(198)108(70(4)5)157-115(187)80(23-14-16-52-133)144-111(183)81(41-47-102(170)171)147-119(191)90(59-73-28-34-77(165)35-29-73)153-121(193)92(61-76-63-137-68-141-76)155-125(197)97-26-19-55-161(97)128(200)95(67-164)143-101(169)65-140-123(195)96-25-15-17-54-160(96)127(199)86(24-18-53-138-131(135)136)159-206(204,205)79-38-32-75(33-39-79)132(7,8)9/h11-13,21-22,28-39,63,68-71,80-98,108-109,159,163-166H,10,14-20,23-27,40-62,64-67,133H2,1-9H3,(H2,134,167)(H,137,141)(H,139,182)(H,140,195)(H,142,168)(H,143,169)(H,144,183)(H,145,185)(H,146,184)(H,147,191)(H,148,190)(H,149,196)(H,150,189)(H,151,192)(H,152,186)(H,153,193)(H,154,194)(H,155,197)(H,156,198)(H,157,187)(H,158,188)(H,170,171)(H,172,173)(H,174,175)(H,176,177)(H,178,179)(H,180,181)(H,202,203)(H4,135,136,138)/t71-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96+,97-,98-,108-,109-/m0/s1 D0P0LG DRUGINKE GRDGGKZCNFVXJO-OZHMLDCXSA-N D0P0LG DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCCN6C(=O)C(CO)NC(=O)CNC(=O)C7CCCCN7C(=O)C(CCCN=C(N)N)NS(=O)(=O)C8=CC=C(C=C8)C(C)(C)C D0P0LG HIGHSTAT Investigative D0P4RB DRUG__ID D0P4RB D0P4RB DRUGINCH 1S/C64H79N15O13/c1-63(2)47(78(31-28-52(83)84)45-26-24-37-16-10-12-18-39(37)55(45)63)22-8-6-5-7-9-23-48-64(3,4)56-40-19-13-11-17-38(40)25-27-46(56)79(48)36-51(82)74-41(20-14-29-70-61(66)67)58(90)72-35-50(81)76-44(33-54(87)88)60(92)77-42(21-15-30-71-62(68)69)59(91)73-34-49(80)75-43(57(65)89)32-53(85)86/h5-13,16-19,22-27,41-44H,14-15,20-21,28-36H2,1-4H3,(H18-,65,66,67,68,69,70,71,72,73,74,75,76,77,80,81,82,83,84,85,86,87,88,89,90,91,92)/p+1/t41-,42-,43+,44+/m0/s1 D0P4RB DRUGINKE LXIIZUXXHZFFKQ-IYTFMMMVSA-O D0P4RB DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N)C=CC=CC=CC=C4C(C5=C(N4CCC(=O)O)C=CC6=CC=CC=C65)(C)C)C D0P4RB HIGHSTAT Investigative D0P5VL DRUG__ID D0P5VL D0P5VL DRUGINCH 1S/C48H85N17O10/c1-5-29(4)39(44(72)63-36(46(74)75)23-28(2)3)64-42(70)35(24-30-12-14-32(66)15-13-30)62-43(71)37-11-8-22-65(37)45(73)34(10-7-19-58-48(53)54)61-41(69)33(9-6-18-57-47(51)52)60-38(67)27-59-40(68)31(25-55-20-16-49)26-56-21-17-50/h12-15,28-29,31,33-37,39,55-56,66H,5-11,16-27,49-50H2,1-4H3,(H,59,68)(H,60,67)(H,61,69)(H,62,71)(H,63,72)(H,64,70)(H,74,75)(H4,51,52,57)(H4,53,54,58)/t29-,33-,34-,35-,36-,37-,39-/m0/s1 D0P5VL DRUGINKE HMOSHXNVAPZVAT-INYUMPDKSA-N D0P5VL DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(CNCCN)CNCCN D0P5VL HIGHSTAT Investigative D0P6AM DRUG__ID D0P6AM D0P6AM DRUGINCH 1S/C6H7BrN2O2S/c7-5-3-4(12(9,10)11)1-2-6(5)8/h1-3H,8H2,(H2,9,10,11) D0P6AM DRUGINKE KQEVQYJWCZRLTJ-UHFFFAOYSA-N D0P6AM DRUGSMIL C1=CC(=C(C=C1S(=O)(=O)N)Br)N D0P6AM HIGHSTAT Investigative D0P7YV DRUG__ID D0P7YV D0P7YV DRUGINCH 1S/C51H69N11O11S2/c1-27(63)40(43(54)66)60-50(73)42-51(3,4)75-74-26-39(59-44(67)34(53)22-29-12-6-5-7-13-29)48(71)57-37(23-30-17-19-32(65)20-18-30)46(69)58-38(24-31-25-55-35-15-9-8-14-33(31)35)47(70)56-36(16-10-11-21-52)45(68)61-41(28(2)64)49(72)62-42/h5-9,12-15,17-20,25,27-28,34,36-42,55,63-65H,10-11,16,21-24,26,52-53H2,1-4H3,(H2,54,66)(H,56,70)(H,57,71)(H,58,69)(H,59,67)(H,60,73)(H,61,68)(H,62,72)/t27-,28-,34-,36+,37+,38+,39+,40+,41-,42+/m1/s1 D0P7YV DRUGINKE VSEYLDNPHYTJMJ-AVTOYXFISA-N D0P7YV DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0P7YV HIGHSTAT Investigative D0P8PK DRUG__ID D0P8PK D0P8PK DRUGINCH 1S/C16H12O2/c17-15-3-1-2-11(9-15)12-4-5-14-10-16(18)7-6-13(14)8-12/h1-10,17-18H D0P8PK DRUGINKE VHWBXEUHUQDHDH-UHFFFAOYSA-N D0P8PK DRUGSMIL C1=CC(=CC(=C1)O)C2=CC3=C(C=C2)C=C(C=C3)O D0P8PK HIGHSTAT Investigative D0P9CQ DRUG__ID D0P9CQ D0P9CQ DRUGINCH 1S/C52H90N4O15/c1-14-39-52(10,64)45(60)34(6)55(11)28-30(2)26-50(8,63)47(32(4)44(33(5)48(62)69-39)70-42-27-51(9,66-13)46(61)35(7)68-42)71-49-43(59)38(25-31(3)67-49)56(12)29-36-21-23-37(24-22-36)53-40(57)19-17-15-16-18-20-41(58)54-65/h21-24,30-35,38-39,42-47,49,59-61,63-65H,14-20,25-29H2,1-13H3,(H,53,57)(H,54,58)/t30-,31-,32+,33-,34-,35+,38+,39-,42+,43-,44+,45-,46+,47-,49+,50-,51-,52-/m1/s1 D0P9CQ DRUGINKE FRRIWMVHMJBTRB-CSAKRERUSA-N D0P9CQ DRUGSMIL CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)NC(=O)CCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O D0P9CQ HIGHSTAT Investigative D0P9KP DRUG__ID D0P9KP D0P9KP DRUGINCH 1S/C84H137N29O21/c1-40(2)30-56(107-79(132)62(38-114)111-68(121)44(9)85)73(126)101-52(15-12-28-97-83(91)92)71(124)109-60(35-48-37-95-39-99-48)76(129)108-59(34-47-19-23-50(117)24-20-47)75(128)105-57(31-41(3)4)74(127)110-61(36-64(87)119)77(130)106-58(32-42(5)6)78(131)112-65(43(7)8)80(133)113-66(45(10)115)81(134)103-53(16-13-29-98-84(93)94)69(122)102-54(25-26-63(86)118)72(125)100-51(14-11-27-96-82(89)90)70(123)104-55(67(88)120)33-46-17-21-49(116)22-18-46/h17-24,37,39-45,51-62,65-66,114-117H,11-16,25-36,38,85H2,1-10H3,(H2,86,118)(H2,87,119)(H2,88,120)(H,95,99)(H,100,125)(H,101,126)(H,102,122)(H,103,134)(H,104,123)(H,105,128)(H,106,130)(H,107,132)(H,108,129)(H,109,124)(H,110,127)(H,111,121)(H,112,131)(H,113,133)(H4,89,90,96)(H4,91,92,97)(H4,93,94,98)/t44-,45+,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,65-,66-/m0/s1 D0P9KP DRUGINKE YGRCUVJOPKKCTH-PGLCTWMWSA-N D0P9KP DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C)N D0P9KP HIGHSTAT Investigative D0P9OL DRUG__ID D0P9OL D0P9OL DRUGINCH 1S/C61H83N11O14/c1-6-8-20-42-53(78)65-44(23-15-16-30-63-50(74)29-28-45(72-60(85)86-61(3,4)5)56(81)69-47(57(82)66-42)32-37-24-26-39(73)27-25-37)55(80)70-48(33-38-35-64-41-22-14-13-19-40(38)41)58(83)67-43(21-9-7-2)54(79)71-49(34-51(75)76)59(84)68-46(52(62)77)31-36-17-11-10-12-18-36/h10-14,17-19,22,24-27,35,42-49,64,73H,6-9,15-16,20-21,23,28-34H2,1-5H3,(H2,62,77)(H,63,74)(H,65,78)(H,66,82)(H,67,83)(H,68,84)(H,69,81)(H,70,80)(H,71,79)(H,72,85)(H,75,76)/t42-,43-,44-,45+,46-,47+,48-,49-/m0/s1 D0P9OL DRUGINKE RJGYFDISIBJKFO-UZLGZYMTSA-N D0P9OL DRUGSMIL CCCCC1C(=O)NC(CCCCNC(=O)CCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)NC(=O)OC(C)(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CCCC)C(=O)NC(CC(=O)O)C(=O)NC(CC5=CC=CC=C5)C(=O)N D0P9OL HIGHSTAT Investigative D0PD8G DRUG__ID D0PD8G D0PD8G DRUGINCH 1S/C71H99N21O19S2/c1-8-34(4)57(82-37(7)94)69(109)90-52-31-113-112-30-51(67(107)92-58(36(6)93)70(110)111)89-61(101)45(18-13-21-76-71(73)74)83-64(104)49(24-40-28-75-32-80-40)85-59(99)35(5)81-54(96)29-79-60(100)47(22-38-26-77-43-16-11-9-14-41(38)43)86-65(105)50(25-55(97)98)87-62(102)46(19-20-53(72)95)84-63(103)48(88-68(108)56(33(2)3)91-66(52)106)23-39-27-78-44-17-12-10-15-42(39)44/h9-12,14-17,26-28,32-36,45-52,56-58,77-78,93H,8,13,18-25,29-31H2,1-7H3,(H2,72,95)(H,75,80)(H,79,100)(H,81,96)(H,82,94)(H,83,104)(H,84,103)(H,85,99)(H,86,105)(H,87,102)(H,88,108)(H,89,101)(H,90,109)(H,91,106)(H,92,107)(H,97,98)(H,110,111)(H4,73,74,76)/t34-,35-,36+,45-,46-,47-,48-,49+,50+,51-,52-,56-,57-,58-/m0/s1 D0PD8G DRUGINKE XVHYFABBPDIZAN-YEKOCRBCSA-N D0PD8G DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CNC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D0PD8G HIGHSTAT Investigative D0PQ7A DRUG__ID D0PQ7A D0PQ7A DRUGINCH 1S/C58H78N14O10/c1-32(2)24-43(50(60)75)67-52(77)44(25-33(3)4)68-54(79)47(28-36-31-65-41-19-11-9-17-38(36)41)71-53(78)45(26-34-14-6-5-7-15-34)69-55(80)46(27-35-30-64-40-18-10-8-16-37(35)40)70-51(76)42(20-12-22-63-58(61)62)66-56(81)48-21-13-23-72(48)57(82)39(59)29-49(73)74/h5-11,14-19,30-33,39,42-48,64-65H,12-13,20-29,59H2,1-4H3,(H2,60,75)(H,66,81)(H,67,77)(H,68,79)(H,69,80)(H,70,76)(H,71,78)(H,73,74)(H4,61,62,63)/t39-,42+,43-,44-,45-,46+,47+,48+/m0/s1 D0PQ7A DRUGINKE CZJDWLOOIMAJCD-JXDKTPIUSA-N D0PQ7A DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCCN=C(N)N)NC(=O)C6CCCN6C(=O)C(CC(=O)O)N D0PQ7A HIGHSTAT Investigative D0PY7O DRUG__ID D0PY7O D0PY7O DRUGINCH 1S/C54H81N13O14/c1-26(2)17-37(46(57)73)62-49(76)38(18-27(3)4)63-51(78)40(20-31-13-15-33(70)16-14-31)61-44(72)24-59-47(74)29(7)60-53(80)42(25-68)66-52(79)41(22-43(56)71)64-50(77)39(19-28(5)6)65-54(81)45(30(8)69)67-48(75)35(55)21-32-23-58-36-12-10-9-11-34(32)36/h9-16,23,26-30,35,37-42,45,58,68-70H,17-22,24-25,55H2,1-8H3,(H2,56,71)(H2,57,73)(H,59,74)(H,60,80)(H,61,72)(H,62,76)(H,63,78)(H,64,77)(H,65,81)(H,66,79)(H,67,75)/t29-,30+,35-,37-,38-,39-,40-,41-,42-,45-/m0/s1 D0PY7O DRUGINKE SUJPPMXJCZETOA-ZKEPBWIVSA-N D0PY7O DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC2=CNC3=CC=CC=C32)N D0PY7O HIGHSTAT Investigative D0Q0HE DRUG__ID D0Q0HE D0Q0HE DRUGINCH 1S/C67H99N23O19S2/c1-8-31(4)52(79-34(7)93)65(108)87-47-27-111-110-26-46(63(106)89-53(32(5)91)55(69)98)86-57(100)40(14-11-17-74-67(70)71)81-60(103)44(20-37-24-73-29-78-37)84-59(102)43(19-36-23-72-28-77-36)80-49(95)25-76-56(99)42(18-35-22-75-39-13-10-9-12-38(35)39)83-61(104)45(21-50(96)97)85-58(101)41(15-16-48(68)94)82-66(109)54(33(6)92)90-64(107)51(30(2)3)88-62(47)105/h9-10,12-13,22-24,28-33,40-47,51-54,75,91-92H,8,11,14-21,25-27H2,1-7H3,(H2,68,94)(H2,69,98)(H,72,77)(H,73,78)(H,76,99)(H,79,93)(H,80,95)(H,81,103)(H,82,109)(H,83,104)(H,84,102)(H,85,101)(H,86,100)(H,87,108)(H,88,105)(H,89,106)(H,90,107)(H,96,97)(H4,70,71,74)/t31-,32+,33+,40-,41-,42-,43-,44+,45+,46-,47-,51-,52-,53-,54+/m0/s1 D0Q0HE DRUGINKE VOXWWAJOYBYONB-RTTZVKIOSA-N D0Q0HE DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C(C)O)CCC(=O)N)CC(=O)O)CC2=CNC3=CC=CC=C32)CC4=CN=CN4)CC5=CN=CN5)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0Q0HE HIGHSTAT Investigative D0Q0UQ DRUG__ID D0Q0UQ D0Q0UQ DRUGINCH 1S/C47H63N13O11S3/c1-23(61)35(38(48)64)58-45(71)37-47(3,4)74-73-22-34(57-42(68)33-21-72-17-16-51-33)43(69)55-31(18-25-11-13-27(63)14-12-25)40(66)56-32(19-26-20-53-29-9-6-5-8-28(26)29)41(67)54-30(10-7-15-52-46(49)50)39(65)59-36(24(2)62)44(70)60-37/h5-6,8-9,11-14,16,20-21,23-24,30-32,34-37,53,61-63H,7,10,15,17-19,22H2,1-4H3,(H2,48,64)(H,54,67)(H,55,69)(H,56,66)(H,57,68)(H,58,71)(H,59,65)(H,60,70)(H4,49,50,52)/t23-,24-,30+,31+,32+,34+,35+,36-,37+/m1/s1 D0Q0UQ DRUGINKE AVXONNNWRZHIKA-HVLWERHHSA-N D0Q0UQ DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C5=CSCC=N5)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0Q0UQ HIGHSTAT Investigative D0Q1PN DRUG__ID D0Q1PN D0Q1PN DRUGINCH 1S/C56H67N9O14/c1-5-6-20-41(52(73)62-45(56(78)79)29-38-32-65(34(3)66)46-21-14-13-19-40(38)46)59-53(74)42(30-49(69)70)60-54(75)47(28-36-17-11-8-12-18-36)64(4)63-43(26-35-15-9-7-10-16-35)51(72)57-31-48(68)58-33(2)50(71)61-44(55(76)77)27-37-22-24-39(67)25-23-37/h7-19,21-25,32-33,41-45,47,63,67H,5-6,20,26-31H2,1-4H3,(H,57,72)(H,58,68)(H,59,74)(H,60,75)(H,61,71)(H,62,73)(H,69,70)(H,76,77)(H,78,79)/t33-,41+,42+,43+,44+,45+,47+/m1/s1 D0Q1PN DRUGINKE DZRXMQMULMXHKQ-GDYSDZBQSA-N D0Q1PN DRUGSMIL CCCCC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C(=O)C)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CC=CC=C3)N(C)NC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O D0Q1PN HIGHSTAT Investigative D0Q2IU DRUG__ID D0Q2IU D0Q2IU DRUGINCH 1S/C68H106N22O17/c1-33(2)25-47(85-61(102)49(28-39-15-19-42(94)20-16-39)87-62(103)50(80-37(8)92)29-40-31-76-32-79-40)60(101)88-51(30-53(70)96)63(104)86-48(26-34(3)4)64(105)89-54(35(5)6)65(106)90-55(36(7)91)66(107)83-44(12-10-24-78-68(74)75)57(98)82-45(21-22-52(69)95)59(100)81-43(11-9-23-77-67(72)73)58(99)84-46(56(71)97)27-38-13-17-41(93)18-14-38/h13-20,31-36,43-51,54-55,91,93-94H,9-12,21-30H2,1-8H3,(H2,69,95)(H2,70,96)(H2,71,97)(H,76,79)(H,80,92)(H,81,100)(H,82,98)(H,83,107)(H,84,99)(H,85,102)(H,86,104)(H,87,103)(H,88,101)(H,89,105)(H,90,106)(H4,72,73,77)(H4,74,75,78)/t36-,43+,44+,45+,46+,47+,48+,49+,50+,51+,54+,55+/m1/s1 D0Q2IU DRUGINKE JFWAFYNFTBNEPH-XATDXXKLSA-N D0Q2IU DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C D0Q2IU HIGHSTAT Investigative D0Q2PO DRUG__ID D0Q2PO D0Q2PO DRUGINCH 1S/C66H109N23O16/c1-37(55(96)84-46(25-16-30-76-65(72)73)59(100)83-43(54(71)95)22-10-13-27-67)80-58(99)44(23-11-14-28-68)86-60(101)45(24-12-15-29-69)87-61(102)47(26-17-31-77-66(74)75)85-56(97)38(2)81-62(103)49(34-52(93)94)88-64(105)53(39(3)90)89-63(104)48(33-41-20-8-5-9-21-41)82-51(92)36-78-50(91)35-79-57(98)42(70)32-40-18-6-4-7-19-40/h4-9,18-21,37-39,42-49,53,90H,10-17,22-36,67-70H2,1-3H3,(H2,71,95)(H,78,91)(H,79,98)(H,80,99)(H,81,103)(H,82,92)(H,83,100)(H,84,96)(H,85,97)(H,86,101)(H,87,102)(H,88,105)(H,89,104)(H,93,94)(H4,72,73,76)(H4,74,75,77)/t37-,38-,39+,42-,43-,44-,45-,46-,47-,48-,49-,53-/m0/s1 D0Q2PO DRUGINKE WSFUYLTYXFNGET-WYNMOEERSA-N D0Q2PO DRUGSMIL CC(C(C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0Q2PO HIGHSTAT Investigative D0Q2UZ DRUG__ID D0Q2UZ D0Q2UZ DRUGINCH 1S/C57H78N14O11S2/c1-32(36-21-20-35-14-7-8-15-37(35)28-36)46-54(81)64-29-45(74)65-43(30-72)52(79)68-42(27-33-12-5-4-6-13-33)51(78)69-44(53(80)67-41(16-9-10-24-58)50(77)66-40(48(60)75)17-11-25-63-56(61)62)31-83-84-57(2,3)47(55(82)70-46)71-49(76)39(59)26-34-18-22-38(73)23-19-34/h4-8,12-15,18-23,28,32,39-44,46-47,72-73H,9-11,16-17,24-27,29-31,58-59H2,1-3H3,(H2,60,75)(H,64,81)(H,65,74)(H,66,77)(H,67,80)(H,68,79)(H,69,78)(H,70,82)(H,71,76)(H4,61,62,63)/t32-,39-,40-,41-,42+,43-,44+,46-,47-/m0/s1 D0Q2UZ DRUGINKE HWTDVIKHJPOWJP-WISPORKVSA-N D0Q2UZ DRUGSMIL CC(C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC(C(C(=O)N1)NC(=O)C(CC2=CC=C(C=C2)O)N)(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC3=CC=CC=C3)CO)C4=CC5=CC=CC=C5C=C4 D0Q2UZ HIGHSTAT Investigative D0Q3CB DRUG__ID D0Q3CB D0Q3CB DRUGINCH 1S/C94H145N23O24/c1-46(2)33-61(82(129)100-44-76(124)115-30-19-24-71(115)93(140)117-32-20-25-72(117)94(141)116-31-18-23-70(116)91(138)104-54(14)81(128)108-63(35-48(5)6)84(131)103-53(13)80(127)107-62(34-47(3)4)83(130)101-51(11)78(97)125)109-85(132)64(36-49(7)8)110-87(134)66(38-56-26-28-58(120)29-27-56)106-75(123)43-99-79(126)52(12)102-90(137)69(45-118)113-88(135)68(40-73(96)121)111-86(133)65(37-50(9)10)112-92(139)77(55(15)119)114-89(136)67(105-74(122)41-95)39-57-42-98-60-22-17-16-21-59(57)60/h16-17,21-22,26-29,42,46-55,61-72,77,98,118-120H,18-20,23-25,30-41,43-45,95H2,1-15H3,(H2,96,121)(H2,97,125)(H,99,126)(H,100,129)(H,101,130)(H,102,137)(H,103,131)(H,104,138)(H,105,122)(H,106,123)(H,107,127)(H,108,128)(H,109,132)(H,110,134)(H,111,133)(H,112,139)(H,113,135)(H,114,136)/t51-,52-,53-,54-,55+,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,77-/m0/s1 D0Q3CB DRUGINKE OSGCBUDLRBUEGW-JZCUZNMGSA-N D0Q3CB DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C3CCCN3C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)CN D0Q3CB HIGHSTAT Investigative D0Q3IE DRUG__ID D0Q3IE D0Q3IE DRUGINCH 1S/C69H87N15O12/c1-42(2)59(67(93)81-54(35-46-25-27-49(85)28-26-46)61(87)76-51(69(95)96)22-12-13-29-70)83-65(91)55(34-45-20-10-5-11-21-45)78-62(88)52(32-43-16-6-3-7-17-43)77-64(90)56(36-47-38-71-40-74-47)79-63(89)53(33-44-18-8-4-9-19-44)80-66(92)58-24-15-31-84(58)68(94)57(37-48-39-72-41-75-48)82-60(86)50-23-14-30-73-50/h3-11,16-21,25-28,38-42,50-59,73,85H,12-15,22-24,29-37,70H2,1-2H3,(H,71,74)(H,72,75)(H,76,87)(H,77,90)(H,78,88)(H,79,89)(H,80,92)(H,81,93)(H,82,86)(H,83,91)(H,95,96)/t50-,51+,52+,53+,54+,55+,56+,57+,58-,59+/m1/s1 D0Q3IE DRUGINKE AIRMFERKNRDUKD-KKFBCCNDSA-N D0Q3IE DRUGSMIL CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CN=CN4)NC(=O)C(CC5=CC=CC=C5)NC(=O)C6CCCN6C(=O)C(CC7=CN=CN7)NC(=O)C8CCCN8 D0Q3IE HIGHSTAT Investigative D0Q3VN DRUG__ID D0Q3VN D0Q3VN DRUGINCH 1S/C53H74N16O12/c1-68(44(74)27-32-13-17-35(71)18-14-32)41(26-31-11-15-34(70)16-12-31)50(80)67-39(25-30-7-3-2-4-8-30)48(78)64-37(19-20-42(54)72)47(77)66-40(28-43(55)73)49(79)65-38(10-6-23-62-53(59)60)51(81)69-24-21-33(29-69)46(76)63-36(45(56)75)9-5-22-61-52(57)58/h2-4,7-8,11-18,33,36-41,70-71H,5-6,9-10,19-29H2,1H3,(H2,54,72)(H2,55,73)(H2,56,75)(H,63,76)(H,64,78)(H,65,79)(H,66,77)(H,67,80)(H4,57,58,61)(H4,59,60,62)/t33-,36-,37-,38-,39-,40-,41+/m0/s1 D0Q3VN DRUGINKE QSWYUUWOWAFPRH-PDQNOIBYSA-N D0Q3VN DRUGSMIL CN(C(CC1=CC=C(C=C1)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)N3CCC(C3)C(=O)NC(CCCN=C(N)N)C(=O)N)C(=O)CC4=CC=C(C=C4)O D0Q3VN HIGHSTAT Investigative D0Q6BG DRUG__ID D0Q6BG D0Q6BG DRUGINCH 1S/C17H21N3O4/c1-19-10-6-7-11(19)9-12(8-10)24-17(23)20-15(21)13-4-2-3-5-14(13)18-16(20)22/h2-5,10-12,15,21H,6-9H2,1H3,(H,18,22) D0Q6BG DRUGINKE DCNXOLLXJNMTQB-UHFFFAOYSA-N D0Q6BG DRUGSMIL CN1C2CCC1CC(C2)OC(=O)N3C(C4=CC=CC=C4NC3=O)O D0Q6BG HIGHSTAT Investigative D0Q7GG DRUG__ID D0Q7GG D0Q7GG DRUGINCH 1S/C16H17N3O4/c1-8-2-4-10-13(14(8)21)18-15(22)11-6-9(3-5-12(17)20)7-19(11)16(10)23/h2-5,7,11,15,18,21-22H,6H2,1H3,(H2,17,20)/b5-3+ D0Q7GG DRUGINKE VGQOVCHZGQWAOI-HWKANZROSA-N D0Q7GG DRUGSMIL CC1=C(C2=C(C=C1)C(=O)N3C=C(CC3C(N2)O)C=CC(=O)N)O D0Q7GG HIGHSTAT Investigative D0Q9OR DRUG__ID D0Q9OR D0Q9OR DRUGINCH 1S/C14H18ClN3S/c15-12-6-7-13(17-10-12)18-14(19)16-9-8-11-4-2-1-3-5-11/h4,6-7,10H,1-3,5,8-9H2,(H2,16,17,18,19) D0Q9OR DRUGINKE DVTYONOGIMBZRG-UHFFFAOYSA-N D0Q9OR DRUGSMIL C1CCC(=CC1)CCNC(=S)NC2=NC=C(C=C2)Cl D0Q9OR HIGHSTAT Investigative D0QP2S DRUG__ID D0QP2S D0QP2S DRUGINCH 1S/C59H73N9O15/c1-7-8-22-48(54(76)64-46(57(80)81)31-39-34-68(58(82)83-59(3,4)5)47-23-16-15-21-41(39)47)67(6)55(77)44(32-50(71)72)62-53(75)43(29-37-19-13-10-14-20-37)66-65-42(28-36-17-11-9-12-18-36)52(74)60-33-49(70)61-35(2)51(73)63-45(56(78)79)30-38-24-26-40(69)27-25-38/h9-21,23-27,34-35,42-46,48,65-66,69H,7-8,22,28-33H2,1-6H3,(H,60,74)(H,61,70)(H,62,75)(H,63,73)(H,64,76)(H,71,72)(H,78,79)(H,80,81)/t35-,42+,43+,44+,45+,46-,48+/m1/s1 D0QP2S DRUGINKE CHVZZDMXXHMJNM-BPYPMLAUSA-N D0QP2S DRUGSMIL CCCCC(C(=O)NC(CC1=CN(C2=CC=CC=C21)C(=O)OC(C)(C)C)C(=O)O)N(C)C(=O)C(CC(=O)O)NC(=O)C(CC3=CC=CC=C3)NNC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O D0QP2S HIGHSTAT Investigative D0QR7C DRUG__ID D0QR7C D0QR7C DRUGINCH 1S/C70H100N18O16S2/c1-39(2)28-53(64(99)82-50(31-43-22-24-45(90)25-23-43)67(102)88-27-15-21-52(88)63(98)83-51(37-105)68(103)104)87(7)56(93)36-86(6)55(92)35-77-60(95)47(29-41-16-10-8-11-17-41)81-61(96)49(32-44-33-74-38-78-44)79-54(91)34-76-65(100)57(40(3)89)84-66(101)58(70(4,5)106)85-62(97)48(30-42-18-12-9-13-19-42)80-59(94)46(71)20-14-26-75-69(72)73/h8-13,16-19,22-25,33,38-40,46-53,57-58,89-90,105-106H,14-15,20-21,26-32,34-37,71H2,1-7H3,(H,74,78)(H,76,100)(H,77,95)(H,79,91)(H,80,94)(H,81,96)(H,82,99)(H,83,98)(H,84,101)(H,85,97)(H,103,104)(H4,72,73,75)/t40-,46+,47+,48+,49+,50+,51+,52+,53+,57+,58-/m1/s1 D0QR7C DRUGINKE AJONUWHGRIXLLX-SCOIVGQKSA-N D0QR7C DRUGSMIL CC(C)CC(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)NC(CS)C(=O)O)N(C)C(=O)CN(C)C(=O)CNC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CN=CN4)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(C(C)(C)S)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(CCCN=C(N)N)N D0QR7C HIGHSTAT Investigative D0QS6O DRUG__ID D0QS6O D0QS6O DRUGINCH 1S/C52H94N30O12/c53-37-33-38(74-24-73-37)82(25-75-33)45-35(85)34(84)36(94-45)44(91)66-17-3-1-2-16-32(83)76-26(10-4-18-67-47(54)55)39(86)77-27(11-5-19-68-48(56)57)40(87)78-28(12-6-20-69-49(58)59)41(88)79-29(13-7-21-70-50(60)61)42(89)80-30(14-8-22-71-51(62)63)43(90)81-31(46(92)93)15-9-23-72-52(64)65/h24-31,34-36,45,84-85H,1-23H2,(H,66,91)(H,76,83)(H,77,86)(H,78,87)(H,79,88)(H,80,89)(H,81,90)(H,92,93)(H2,53,73,74)(H4,54,55,67)(H4,56,57,68)(H4,58,59,69)(H4,60,61,70)(H4,62,63,71)(H4,64,65,72)/t26-,27-,28-,29-,30-,31-,34+,35-,36+,45?/m1/s1 D0QS6O DRUGINKE QLSCMEHEXBNFGR-FBEAYKSBSA-N D0QS6O DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCCCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D0QS6O HIGHSTAT Investigative D0R0BY DRUG__ID D0R0BY D0R0BY DRUGINCH 1S/C60H78ClN19O13S2/c1-31(81)72-43(22-33-12-16-37(82)17-13-33)54(89)73-41(9-5-21-69-60(65)66)52(87)80-48-29-95-94-28-47(50(62)85)79-56(91)45(24-34-26-70-39-7-3-2-6-38(34)39)77-51(86)40(8-4-20-68-59(63)64)74-55(90)44(23-32-10-14-35(61)15-11-32)76-57(92)46(25-36-27-67-30-71-36)78-53(88)42(75-58(48)93)18-19-49(83)84/h2-3,6-7,10-17,26-27,30,40-48,70,82H,4-5,8-9,18-25,28-29H2,1H3,(H2,62,85)(H,67,71)(H,72,81)(H,73,89)(H,74,90)(H,75,93)(H,76,92)(H,77,86)(H,78,88)(H,79,91)(H,80,87)(H,83,84)(H4,63,64,68)(H4,65,66,69)/t40-,41-,42+,43-,44-,45+,46-,47+,48+/m0/s1 D0R0BY DRUGINKE KIFNALNSUOJQPJ-XVRHLUALSA-N D0R0BY DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=C(C=C4)Cl)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D0R0BY HIGHSTAT Investigative D0R0OX DRUG__ID D0R0OX D0R0OX DRUGINCH 1S/C84H107N15O17S2/c1-48(2)87-43-56-30-28-55(29-31-56)41-70-80(111)98-72(50(4)102)81(112)92-65(40-53-23-13-8-14-24-53)77(108)97-71(49(3)101)82(113)94-67(45-100)78(109)96-69(84(115)116)47-118-117-46-68(95-73(104)60(86)37-54-32-34-58(103)35-33-54)79(110)89-62(27-17-18-36-85)74(105)90-63(38-51-19-9-6-10-20-51)75(106)91-64(39-52-21-11-7-12-22-52)76(107)93-66(83(114)99(70)5)42-57-44-88-61-26-16-15-25-59(57)61/h6-16,19-26,28-35,44,48-50,60,62-72,87-88,100-103H,17-18,27,36-43,45-47,85-86H2,1-5H3,(H,89,110)(H,90,105)(H,91,106)(H,92,112)(H,93,107)(H,94,113)(H,95,104)(H,96,109)(H,97,108)(H,98,111)(H,115,116)/t49-,50-,60+,62-,63-,64+,65+,66+,67+,68-,69+,70+,71-,72-/m1/s1 D0R0OX DRUGINKE MGQOSJMBSMGOOM-DNKCOYOSSA-N D0R0OX DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)NC(=O)C(CC7=CC=C(C=C7)O)N)C(=O)O)CO)C(C)O)CC8=CC=CC=C8)C(C)O D0R0OX HIGHSTAT Investigative D0R1MR DRUG__ID D0R1MR D0R1MR DRUGINCH 1S/C72H101N23O18S2/c1-7-36(4)58(84-38(6)97)71(113)93-53-32-115-114-31-52(69(111)95-59(37(5)96)60(74)102)92-62(104)45(18-13-21-79-72(75)76)86-66(108)50(25-42-29-78-34-83-42)89-65(107)49(24-41-28-77-33-82-41)85-55(99)30-81-61(103)48(23-40-27-80-44-17-12-11-16-43(40)44)88-67(109)51(26-56(100)101)90-63(105)46(19-20-54(73)98)87-64(106)47(22-39-14-9-8-10-15-39)91-70(112)57(35(2)3)94-68(53)110/h8-12,14-17,27-29,33-37,45-53,57-59,80,96H,7,13,18-26,30-32H2,1-6H3,(H2,73,98)(H2,74,102)(H,77,82)(H,78,83)(H,81,103)(H,84,97)(H,85,99)(H,86,108)(H,87,106)(H,88,109)(H,89,107)(H,90,105)(H,91,112)(H,92,104)(H,93,113)(H,94,110)(H,95,111)(H,100,101)(H4,75,76,79)/t36-,37+,45-,46-,47+,48-,49-,50+,51+,52-,53-,57-,58-,59-/m0/s1 D0R1MR DRUGINKE RBQLSOPILCDKPP-IJVDDTIBSA-N D0R1MR DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC=CC=C2)CCC(=O)N)CC(=O)O)CC3=CNC4=CC=CC=C43)CC5=CN=CN5)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0R1MR HIGHSTAT Investigative D0R1NH DRUG__ID D0R1NH D0R1NH DRUGINCH 1S/C149H230N42O47/c1-15-76(10)120(146(236)168-78(12)124(214)178-102(58-83-61-160-88-31-20-19-30-86(83)88)137(227)180-99(55-73(4)5)138(228)188-118(74(6)7)144(234)177-90(32-21-24-50-150)127(217)163-65-111(202)169-89(35-27-53-159-149(155)156)126(216)161-63-108(154)199)190-134(224)92-34-23-26-52-158-109(200)46-41-96(130(220)167-77(11)123(213)172-91(33-22-25-51-151)131(221)176-97(133(223)173-92)44-49-116(209)210)175-132(222)95(40-45-107(153)198)171-112(203)66-164-129(219)94(43-48-115(207)208)174-135(225)98(54-72(2)3)179-136(226)100(57-82-36-38-85(197)39-37-82)181-141(231)104(68-192)184-143(233)106(70-194)185-145(235)119(75(8)9)189-140(230)103(60-117(211)212)182-142(232)105(69-193)186-148(238)122(80(14)196)191-139(229)101(56-81-28-17-16-18-29-81)183-147(237)121(79(13)195)187-113(204)67-165-128(218)93(42-47-114(205)206)170-110(201)64-162-125(215)87(152)59-84-62-157-71-166-84/h16-20,28-31,36-39,61-62,71-80,87,89-106,118-122,160,192-197H,15,21-27,32-35,40-60,63-70,150-152H2,1-14H3,(H2,153,198)(H2,154,199)(H,157,166)(H,158,200)(H,161,216)(H,162,215)(H,163,217)(H,164,219)(H,165,218)(H,167,220)(H,168,236)(H,169,202)(H,170,201)(H,171,203)(H,172,213)(H,173,223)(H,174,225)(H,175,222)(H,176,221)(H,177,234)(H,178,214)(H,179,226)(H,180,227)(H,181,231)(H,182,232)(H,183,237)(H,184,233)(H,185,235)(H,186,238)(H,187,204)(H,188,228)(H,189,230)(H,190,224)(H,191,229)(H,205,206)(H,207,208)(H,209,210)(H,211,212)(H4,155,156,159)/t76-,77-,78-,79+,80-,87-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,118-,119-,120-,121-,122-/m0/s1 D0R1NH DRUGINKE KPGVUBCFEGSCNW-NNIIIAALSA-N D0R1NH DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C3CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CCC(=O)O)CCCCN)C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N D0R1NH HIGHSTAT Investigative D0R1WH DRUG__ID D0R1WH D0R1WH DRUGINCH 1S/C48H68N12O12S2/c1-5-25(4)40-47(71)54-31(14-15-37(50)62)43(67)56-34(19-38(51)63)44(68)58-35(23-74-73-22-30(49)41(65)55-33(45(69)59-40)17-26-10-12-29(61)13-11-26)48(72)60-21-28-9-7-6-8-27(28)18-36(60)46(70)57-32(16-24(2)3)42(66)53-20-39(52)64/h6-13,24-25,30-36,40,61H,5,14-23,49H2,1-4H3,(H2,50,62)(H2,51,63)(H2,52,64)(H,53,66)(H,54,71)(H,55,65)(H,56,67)(H,57,70)(H,58,68)(H,59,69)/t25-,30-,31-,32-,33-,34-,35-,36-,40-/m0/s1 D0R1WH DRUGINKE GJHLANNXTOQRKG-FGTHJCBLSA-N D0R1WH DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0R1WH HIGHSTAT Investigative D0R2FS DRUG__ID D0R2FS D0R2FS DRUGINCH 1S/C71H99N21O19S2/c1-8-34(4)57(82-37(7)94)69(109)90-52-31-113-112-30-51(67(107)92-58(36(6)93)70(110)111)89-61(101)45(18-13-21-76-71(73)74)83-64(104)49(24-40-28-75-32-80-40)85-59(99)35(5)81-54(96)29-79-60(100)47(22-38-26-77-43-16-11-9-14-41(38)43)86-65(105)50(25-55(97)98)87-62(102)46(19-20-53(72)95)84-63(103)48(88-68(108)56(33(2)3)91-66(52)106)23-39-27-78-44-17-12-10-15-42(39)44/h9-12,14-17,26-28,32-36,45-52,56-58,77-78,93H,8,13,18-25,29-31H2,1-7H3,(H2,72,95)(H,75,80)(H,79,100)(H,81,96)(H,82,94)(H,83,104)(H,84,103)(H,85,99)(H,86,105)(H,87,102)(H,88,108)(H,89,101)(H,90,109)(H,91,106)(H,92,107)(H,97,98)(H,110,111)(H4,73,74,76)/t34-,35-,36-,45-,46-,47-,48+,49+,50+,51-,52-,56-,57-,58-/m0/s1 D0R2FS DRUGINKE XVHYFABBPDIZAN-AHNXIUSDSA-N D0R2FS DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CNC3=CC=CC=C32)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D0R2FS HIGHSTAT Investigative D0R2ZG DRUG__ID D0R2ZG D0R2ZG DRUGINCH 1S/C150H226N40O47/c1-16-77(10)121(147(235)168-80(13)126(214)176-104(59-86-62-159-91-35-24-23-34-89(86)91)137(225)178-100(55-74(4)5)138(226)187-119(75(6)7)145(233)175-93(36-25-27-51-151)129(217)161-65-111(199)169-92(38-29-53-158-150(155)156)128(216)164-68-118(210)211)189-139(227)102(56-83-30-19-17-20-31-83)179-134(222)98(46-50-116(206)207)174-133(221)94(37-26-28-52-152)172-125(213)79(12)166-124(212)78(11)167-132(220)97(43-47-109(154)197)171-112(200)66-162-131(219)96(45-49-115(204)205)173-135(223)99(54-73(2)3)177-136(224)101(58-85-39-41-88(196)42-40-85)180-142(230)106(69-191)183-144(232)108(71-193)184-146(234)120(76(8)9)188-141(229)105(61-117(208)209)181-143(231)107(70-192)185-149(237)123(82(15)195)190-140(228)103(57-84-32-21-18-22-33-84)182-148(236)122(81(14)194)186-113(201)67-163-130(218)95(44-48-114(202)203)170-110(198)64-160-127(215)90(153)60-87-63-157-72-165-87/h17-24,30-35,39-42,62-63,72-82,90,92-108,119-123,159,191-196H,16,25-29,36-38,43-61,64-71,151-153H2,1-15H3,(H2,154,197)(H,157,165)(H,160,215)(H,161,217)(H,162,219)(H,163,218)(H,164,216)(H,166,212)(H,167,220)(H,168,235)(H,169,199)(H,170,198)(H,171,200)(H,172,213)(H,173,223)(H,174,221)(H,175,233)(H,176,214)(H,177,224)(H,178,225)(H,179,222)(H,180,230)(H,181,231)(H,182,236)(H,183,232)(H,184,234)(H,185,237)(H,186,201)(H,187,226)(H,188,229)(H,189,227)(H,190,228)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H4,155,156,158)/t77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,119-,120-,121-,122-,123-/m0/s1 D0R2ZG DRUGINKE XXYMTCGQDUSUOO-RHBBJNDVSA-N D0R2ZG DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N D0R2ZG HIGHSTAT Investigative D0R4IS DRUG__ID D0R4IS D0R4IS DRUGINCH 1S/C77H99N13O15S2/c1-45(2)80-41-52-30-28-51(29-31-52)39-59-71(98)89-65(46(3)92)75(102)86-60(38-50-23-13-8-14-24-50)72(99)90-66(47(4)93)76(103)87-62(42-91)73(100)88-64(77(104)105)44-107-106-43-63(79-5)74(101)81-56(27-17-18-34-78)67(94)82-57(36-48-19-9-6-10-20-48)68(95)83-58(37-49-21-11-7-12-22-49)69(96)85-61(70(97)84-59)40-53-32-33-54-25-15-16-26-55(54)35-53/h6-16,19-26,28-33,35,45-47,56-66,79-80,91-93H,17-18,27,34,36-44,78H2,1-5H3,(H,81,101)(H,82,94)(H,83,95)(H,84,97)(H,85,96)(H,86,102)(H,87,103)(H,88,100)(H,89,98)(H,90,99)(H,104,105)/t46-,47-,56-,57-,58+,59+,60+,61+,62+,63-,64+,65-,66-/m1/s1 D0R4IS DRUGINKE ZXYYWYGCHOCUCC-TWURSWGVSA-N D0R4IS DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CC4=CC=CC=C4C=C3)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)NC)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D0R4IS HIGHSTAT Investigative D0R5QX DRUG__ID D0R5QX D0R5QX DRUGINCH 1S/C72H95N11O17S/c1-5-7-27-50(64(92)79-55(39-84)68(96)77-52(63(73)91)34-44-28-30-49(86)31-29-44)76-69(97)57-36-47-25-17-18-26-48(47)38-83(57)72(100)56(40-101)80-66(94)53(35-43-19-11-8-12-20-43)78-70(98)61(41(3)6-2)81-71(99)62(60(45-21-13-9-14-22-45)46-23-15-10-16-24-46)82-65(93)51(32-33-58(87)88)75-67(95)54(37-59(89)90)74-42(4)85/h9-10,13-18,21-26,28-31,41,43,50-57,60-62,84,86,101H,5-8,11-12,19-20,27,32-40H2,1-4H3,(H2,73,91)(H,74,85)(H,75,95)(H,76,97)(H,77,96)(H,78,98)(H,79,92)(H,80,94)(H,81,99)(H,82,93)(H,87,88)(H,89,90)/t41?,50-,51-,52-,53-,54-,55-,56-,57+,61-,62-/m0/s1 D0R5QX DRUGINKE NAFMHFOWWVFCTM-BPJKRSAYSA-N D0R5QX DRUGSMIL CCCCC(C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C2CC3=CC=CC=C3CN2C(=O)C(CS)NC(=O)C(CC4CCCCC4)NC(=O)C(C(C)CC)NC(=O)C(C(C5=CC=CC=C5)C6=CC=CC=C6)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C D0R5QX HIGHSTAT Investigative D0R6GK DRUG__ID D0R6GK D0R6GK DRUGINCH 1S/C80H132N28O21/c1-42(2)34-57(78(129)108(7)45(5)68(119)104-56(37-60(85)112)74(125)99-50(65(86)116)28-29-59(84)111)105-72(123)51(24-14-16-30-81)102-71(122)54(27-19-33-92-80(89)90)101-67(118)44(4)97-76(127)58(41-109)106-73(124)52(25-15-17-31-82)103-70(121)53(26-18-32-91-79(87)88)100-66(117)43(3)96-62(114)40-95-77(128)64(46(6)110)107-75(126)55(36-48-22-12-9-13-23-48)98-63(115)39-93-61(113)38-94-69(120)49(83)35-47-20-10-8-11-21-47/h8-13,20-23,42-46,49-58,64,109-110H,14-19,24-41,81-83H2,1-7H3,(H2,84,111)(H2,85,112)(H2,86,116)(H,93,113)(H,94,120)(H,95,128)(H,96,114)(H,97,127)(H,98,115)(H,99,125)(H,100,117)(H,101,118)(H,102,122)(H,103,121)(H,104,119)(H,105,123)(H,106,124)(H,107,126)(H4,87,88,91)(H4,89,90,92)/t43-,44-,45-,46+,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-/m0/s1 D0R6GK DRUGINKE DLMXQMKGBYRHOA-FKPOJLNCSA-N D0R6GK DRUGSMIL CC(C)CC(C(=O)N(C)C(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0R6GK HIGHSTAT Investigative D0R6YP DRUG__ID D0R6YP D0R6YP DRUGINCH 1S/C17H32N4O3/c1-4-6-11(7-5-2)15(20-10(3)22)13-8-12(16(23)24)9-14(13)21-17(18)19/h11-15H,4-9H2,1-3H3,(H,20,22)(H,23,24)(H4,18,19,21) D0R6YP DRUGINKE VUROMZOEXLKRSQ-UHFFFAOYSA-N D0R6YP DRUGSMIL CCCC(CCC)C(C1CC(CC1N=C(N)N)C(=O)O)NC(=O)C D0R6YP HIGHSTAT Investigative D0R7QC DRUG__ID D0R7QC D0R7QC DRUGINCH 1S/C47H68N16O11S2/c48-36(65)23-33-43(72)62-34(45(74)63-19-6-11-35(63)44(73)59-29(9-4-17-54-46(50)51)39(68)56-24-37(49)66)25-76-75-20-16-38(67)57-31(22-27-12-14-28(64)15-13-27)41(70)60-32(21-26-7-2-1-3-8-26)42(71)58-30(40(69)61-33)10-5-18-55-47(52)53/h1-3,7-8,12-15,29-35,64H,4-6,9-11,16-25H2,(H2,48,65)(H2,49,66)(H,56,68)(H,57,67)(H,58,71)(H,59,73)(H,60,70)(H,61,69)(H,62,72)(H4,50,51,54)(H4,52,53,55)/t29-,30-,31-,32-,33-,34-,35-/m0/s1 D0R7QC DRUGINKE NZPQDNABVFGPNI-POFDKVPJSA-N D0R7QC DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN=C(N)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D0R7QC HIGHSTAT Investigative D0R8AZ DRUG__ID D0R8AZ D0R8AZ DRUGINCH 1S/C17H21N3O3.ClH/c1-19-12-6-7-13(19)9-14(8-12)23-17(22)20-10-11-4-2-3-5-15(11)18-16(20)21;/h2-5,12-14H,6-10H2,1H3,(H,18,21);1H/t12-,13+,14?; D0R8AZ DRUGINKE FDERDDSQHZRNGC-LIWIJTDLSA-N D0R8AZ DRUGSMIL CN1C2CCC1CC(C2)OC(=O)N3CC4=CC=CC=C4NC3=O.Cl D0R8AZ HIGHSTAT Investigative D0R8TG DRUG__ID D0R8TG D0R8TG DRUGINCH 1S/C61H94N18O12S/c1-35(2)23-47(59(88)76-45(55(65)84)17-22-92-6)77-60(89)49(26-42-30-68-34-71-42)75-51(81)31-70-61(90)54(36(3)4)79-56(85)37(5)72-58(87)48(25-40-29-69-44-10-8-7-9-43(40)44)78-57(86)46(15-16-50(64)80)74-53(83)33-91-32-52(82)73-41-13-11-38(12-14-41)24-39(27-66-20-18-62)28-67-21-19-63/h7-14,29-30,34-37,39,45-49,54,66-67,69H,15-28,31-33,62-63H2,1-6H3,(H2,64,80)(H2,65,84)(H,68,71)(H,70,90)(H,72,87)(H,73,82)(H,74,83)(H,75,81)(H,76,88)(H,77,89)(H,78,86)(H,79,85)/t37-,45-,46-,47-,48-,49-,54-/m0/s1 D0R8TG DRUGINKE IKKYIPCELZIPRY-RNXDXMLZSA-N D0R8TG DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)COCC(=O)NC4=CC=C(C=C4)CC(CNCCN)CNCCN D0R8TG HIGHSTAT Investigative D0R9JG DRUG__ID D0R9JG D0R9JG DRUGINCH 1S/C79H104ClN19O18/c1-42(2)34-57(69(106)90-56(14-9-10-31-83-43(3)4)76(113)99-33-11-15-64(99)75(112)85-44(5)66(81)103)91-72(109)60(37-48-21-28-54(29-22-48)88-77(82)114)93-73(110)61(38-47-19-26-53(27-20-47)87-68(105)62-40-65(102)97-79(116)96-62)94-74(111)63(41-100)95-67(104)55(30-32-84-78(115)98-117)89-71(108)59(36-46-17-24-52(80)25-18-46)92-70(107)58(86-45(6)101)39-49-16-23-50-12-7-8-13-51(50)35-49/h7-8,12-13,16-29,35,42-44,55-64,83,100,117H,9-11,14-15,30-34,36-41H2,1-6H3,(H2,81,103)(H,85,112)(H,86,101)(H,87,105)(H,89,108)(H,90,106)(H,91,109)(H,92,107)(H,93,110)(H,94,111)(H,95,104)(H3,82,88,114)(H2,84,98,115)(H2,96,97,102,116)/t44-,55-,56+,57+,58-,59-,60-,61+,62+,63+,64+/m1/s1 D0R9JG DRUGINKE GJGANCMMPWJOQC-UFLOVSMNSA-N D0R9JG DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CCNC(=O)NO)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0R9JG HIGHSTAT Investigative D0RB5Z DRUG__ID D0RB5Z D0RB5Z DRUGINCH 1S/C80H102ClN15O14/c1-46(2)37-63(72(102)89-62(18-11-12-35-84-47(3)4)80(110)96-36-14-19-70(96)79(109)85-48(5)71(82)101)90-74(104)66(40-53-23-30-60(31-24-53)86-49(6)98)92-76(106)67(41-54-25-32-61(33-26-54)87-50(7)99)94-78(108)69(45-97)95-77(107)68(43-56-15-13-34-83-44-56)93-75(105)65(39-52-21-28-59(81)29-22-52)91-73(103)64(88-51(8)100)42-55-20-27-57-16-9-10-17-58(57)38-55/h9-10,13,15-17,20-34,38,44,46-48,62-70,84,97H,11-12,14,18-19,35-37,39-43,45H2,1-8H3,(H2,82,101)(H,85,109)(H,86,98)(H,87,99)(H,88,100)(H,89,102)(H,90,104)(H,91,103)(H,92,106)(H,93,105)(H,94,108)(H,95,107)/t48-,62+,63+,64+,65-,66-,67+,68-,69+,70+/m1/s1 D0RB5Z DRUGINKE ZWNUQDJANZGVFO-ITULWGTLSA-N D0RB5Z DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C D0RB5Z HIGHSTAT Investigative D0RC8H DRUG__ID D0RC8H D0RC8H DRUGINCH 1S/C55H98N32O14/c1-26(80-34(89)15-22-69-33(88)14-23-70-47(98)38-36(90)37(91)48(101-38)87-25-79-35-39(56)77-24-78-40(35)87)41(92)81-27(8-2-16-71-50(57)58)42(93)82-28(9-3-17-72-51(59)60)43(94)83-29(10-4-18-73-52(61)62)44(95)84-30(11-5-19-74-53(63)64)45(96)85-31(12-6-20-75-54(65)66)46(97)86-32(49(99)100)13-7-21-76-55(67)68/h24-32,36-38,48,90-91H,2-23H2,1H3,(H,69,88)(H,70,98)(H,80,89)(H,81,92)(H,82,93)(H,83,94)(H,84,95)(H,85,96)(H,86,97)(H,99,100)(H2,56,77,78)(H4,57,58,71)(H4,59,60,72)(H4,61,62,73)(H4,63,64,74)(H4,65,66,75)(H4,67,68,76)/t26-,27-,28-,29-,30-,31-,32-,36+,37-,38+,48?/m1/s1 D0RC8H DRUGINKE QDXYEHKCQQMPGT-LSDLINHMSA-N D0RC8H DRUGSMIL CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)CCNC(=O)CCNC(=O)C1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O D0RC8H HIGHSTAT Investigative D0RF9B DRUG__ID D0RF9B D0RF9B DRUGINCH 1S/C72H116N26O17/c1-35(2)27-49(93-64(110)51(30-40-16-20-43(101)21-17-40)95-65(111)52(31-41-33-83-34-87-41)92-59(105)44(73)11-8-24-84-70(77)78)63(109)96-53(32-55(75)103)66(112)94-50(28-36(3)4)67(113)97-56(37(5)6)68(114)98-57(38(7)99)69(115)90-46(13-10-26-86-72(81)82)60(106)89-47(22-23-54(74)102)62(108)88-45(12-9-25-85-71(79)80)61(107)91-48(58(76)104)29-39-14-18-42(100)19-15-39/h14-21,33-38,44-53,56-57,99-101H,8-13,22-32,73H2,1-7H3,(H2,74,102)(H2,75,103)(H2,76,104)(H,83,87)(H,88,108)(H,89,106)(H,90,115)(H,91,107)(H,92,105)(H,93,110)(H,94,112)(H,95,111)(H,96,109)(H,97,113)(H,98,114)(H4,77,78,84)(H4,79,80,85)(H4,81,82,86)/t38-,44+,45+,46+,47+,48+,49+,50+,51+,52+,53+,56+,57+/m1/s1 D0RF9B DRUGINKE DSTSETSWKNIEJI-UAEPIRMISA-N D0RF9B DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)N D0RF9B HIGHSTAT Investigative D0RI6O DRUG__ID D0RI6O D0RI6O DRUGINCH 1S/C57H56F3N5O17/c1-6-10-41(68)81-37-16-13-29(26-79-18-8-7-17-64-54(76)65(53(75)55(64,3)4)31-15-14-30(24-61)35(20-31)57(58,59)60)19-33(37)52(74)63-27-62-36-21-42(80-28(2)47(36)69)82-39-23-56(77,40(67)25-66)22-34-44(39)51(73)46-45(49(34)71)48(70)32-11-9-12-38(78-5)43(32)50(46)72/h9,11-16,19-20,28,36,39,42,47,62,66,69,71,73,77H,6,10,17-18,21-23,25-27H2,1-5H3,(H,63,74)/t28-,36-,39?,42?,47+,56-/m0/s1 D0RI6O DRUGINKE WLZCINFVVNITPX-ZJLMMONESA-N D0RI6O DRUGSMIL CCCC(=O)OC1=C(C=C(C=C1)COCC#CCN2C(=O)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F)C(=O)NCNC4CC(OC(C4O)C)OC5CC(CC6=C5C(=C7C(=C6O)C(=O)C8=C(C7=O)C(=CC=C8)OC)O)(C(=O)CO)O D0RI6O HIGHSTAT Investigative D0RO2K DRUG__ID D0RO2K D0RO2K DRUGINCH 1S/C70H106N28O21S6/c1-31-54(105)85-38(11-6-14-80-69(75)76)58(109)96-50-29-125-124-26-47-66(117)90-42(18-51(73)101)61(112)98-49(28-123-121-25-46(53(74)104)94-68(50)119)67(118)93-45(23-100)64(115)92-44(22-99)63(114)86-37(10-4-5-13-71)56(107)88-40(16-32-20-82-36-9-3-2-8-34(32)36)60(111)97-48(27-122-120-24-35(72)55(106)95-47)65(116)87-39(12-7-15-81-70(77)78)57(108)91-43(19-52(102)103)62(113)89-41(59(110)84-31)17-33-21-79-30-83-33/h2-3,8-9,20-21,30-31,35,37-50,82,99-100H,4-7,10-19,22-29,71-72H2,1H3,(H2,73,101)(H2,74,104)(H,79,83)(H,84,110)(H,85,105)(H,86,114)(H,87,116)(H,88,107)(H,89,113)(H,90,117)(H,91,108)(H,92,115)(H,93,118)(H,94,119)(H,95,106)(H,96,109)(H,97,111)(H,98,112)(H,102,103)(H4,75,76,80)(H4,77,78,81)/t31-,35-,37-,38-,39-,40-,41-,42+,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D0RO2K DRUGINKE ILMKBHRRAVBBMV-CPQFHPGLSA-N D0RO2K DRUGSMIL CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(CSSCC(NC2=O)C(=O)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC4=CN=CN4)CC(=O)O)CCCNC(=N)N)CC5=CNC6=CC=CC=C65)CCCCN)CO)CO)CC(=O)N)CCCNC(=N)N D0RO2K HIGHSTAT Investigative D0RR4X DRUG__ID D0RR4X D0RR4X DRUGINCH 1S/C52H69N13O11S2/c1-26(66)40(43(53)69)63-50(76)42-52(3,4)78-77-25-39(62-45(71)36-21-29-10-5-6-11-30(29)23-58-36)48(74)60-37(20-28-15-17-32(68)18-16-28)46(72)61-38(22-31-24-57-34-13-8-7-12-33(31)34)47(73)59-35(14-9-19-56-51(54)55)44(70)64-41(27(2)67)49(75)65-42/h5-8,10-13,15-18,24,26-27,35-42,57-58,66-68H,9,14,19-23,25H2,1-4H3,(H2,53,69)(H,59,73)(H,60,74)(H,61,72)(H,62,71)(H,63,76)(H,64,70)(H,65,75)(H4,54,55,56)/t26-,27-,35+,36-,37+,38+,39+,40+,41-,42+/m1/s1 D0RR4X DRUGINKE VZDYOAZXFPOIMZ-MDTUBHLHSA-N D0RR4X DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C5CC6=CC=CC=C6CN5)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0RR4X HIGHSTAT Investigative D0RS4B DRUG__ID D0RS4B D0RS4B DRUGINCH 1S/C78H127N27O22/c1-40(2)61(75(125)95-43(5)65(115)102-54(35-57(83)109)71(121)101-52(76(126)127)27-28-56(82)108)104-70(120)49(24-14-16-30-80)100-68(118)51(26-18-32-89-78(86)87)98-64(114)42(4)94-73(123)55(39-106)103-69(119)48(23-13-15-29-79)99-67(117)50(25-17-31-88-77(84)85)97-63(113)41(3)93-59(111)38-92-74(124)62(44(6)107)105-72(122)53(34-46-21-11-8-12-22-46)96-60(112)37-90-58(110)36-91-66(116)47(81)33-45-19-9-7-10-20-45/h7-12,19-22,40-44,47-55,61-62,106-107H,13-18,23-39,79-81H2,1-6H3,(H2,82,108)(H2,83,109)(H,90,110)(H,91,116)(H,92,124)(H,93,111)(H,94,123)(H,95,125)(H,96,112)(H,97,113)(H,98,114)(H,99,117)(H,100,118)(H,101,121)(H,102,115)(H,103,119)(H,104,120)(H,105,122)(H,126,127)(H4,84,85,88)(H4,86,87,89)/t41-,42-,43-,44+,47-,48-,49-,50-,51-,52-,53-,54-,55-,61-,62-/m0/s1 D0RS4B DRUGINKE PLDGJAGJBNNRQP-OTYLYHRBSA-N D0RS4B DRUGSMIL CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0RS4B HIGHSTAT Investigative D0S0AK DRUG__ID D0S0AK D0S0AK DRUGINCH 1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42?,43?,50-,51+,52-,53+,54-,55-,56+,57-,58-,59-,62+,63+/m0/s1 D0S0AK DRUGINKE NHXLMOGPVYXJNR-VOWFNQDTSA-N D0S0AK DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O D0S0AK HIGHSTAT Investigative D0S0XK DRUG__ID D0S0XK D0S0XK DRUGINCH 1S/C20H20N4S/c1-2-5-16(6-3-1)15-22-10-12-23(13-11-22)19-18-7-4-9-24(18)20-17(21-19)8-14-25-20/h1-9,14H,10-13,15H2 D0S0XK DRUGINKE QYWDOJXSLBBWLE-UHFFFAOYSA-N D0S0XK DRUGSMIL C1CN(CCN1CC2=CC=CC=C2)C3=NC4=C(N5C3=CC=C5)SC=C4 D0S0XK HIGHSTAT Investigative D0S2GY DRUG__ID D0S2GY D0S2GY DRUGINCH 1S/C147H227N41O45/c1-16-76(10)118(144(231)166-79(13)123(210)175-101(58-84-61-157-88-37-24-23-36-86(84)88)134(221)177-98(55-73(4)5)135(222)185-116(74(6)7)142(229)174-90(38-25-28-50-148)126(213)160-65-109(197)167-89(41-31-53-156-147(152)153)125(212)158-63-106(151)194)187-136(223)99(56-82-32-19-17-20-33-82)178-132(219)96(45-49-114(204)205)172-130(217)92(39-26-29-51-149)170-122(209)78(12)164-121(208)77(11)165-129(216)91-40-27-30-52-155-107(195)46-42-95(131(218)176-97(54-72(2)3)133(220)171-94(44-48-113(202)203)128(215)161-66-110(198)168-91)173-139(226)103(68-189)181-141(228)105(70-191)182-143(230)117(75(8)9)186-138(225)102(60-115(206)207)179-140(227)104(69-190)183-146(233)120(81(15)193)188-137(224)100(57-83-34-21-18-22-35-83)180-145(232)119(80(14)192)184-111(199)67-162-127(214)93(43-47-112(200)201)169-108(196)64-159-124(211)87(150)59-85-62-154-71-163-85/h17-24,32-37,61-62,71-81,87,89-105,116-120,157,189-193H,16,25-31,38-60,63-70,148-150H2,1-15H3,(H2,151,194)(H,154,163)(H,155,195)(H,158,212)(H,159,211)(H,160,213)(H,161,215)(H,162,214)(H,164,208)(H,165,216)(H,166,231)(H,167,197)(H,168,198)(H,169,196)(H,170,209)(H,171,220)(H,172,217)(H,173,226)(H,174,229)(H,175,210)(H,176,218)(H,177,221)(H,178,219)(H,179,227)(H,180,232)(H,181,228)(H,182,230)(H,183,233)(H,184,199)(H,185,222)(H,186,225)(H,187,223)(H,188,224)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,152,153,156)/t76-,77-,78-,79-,80+,81+,87-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,116-,117-,118-,119-,120-/m0/s1 D0S2GY DRUGINKE OCOAZSDHBCONHT-VHWHDJENSA-N D0S2GY DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C4CCCCNC(=O)CCC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N4)CCC(=O)O)CC(C)C)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N D0S2GY HIGHSTAT Investigative D0S3GE DRUG__ID D0S3GE D0S3GE DRUGINCH 1S/C48H68N12O12S2/c1-5-25(4)40-47(71)54-31(14-15-37(50)62)43(67)56-34(19-38(51)63)44(68)58-35(23-74-73-22-30(49)41(65)55-33(45(69)59-40)17-26-10-12-29(61)13-11-26)48(72)60-21-28-9-7-6-8-27(28)18-36(60)46(70)57-32(16-24(2)3)42(66)53-20-39(52)64/h6-13,24-25,30-36,40,61H,5,14-23,49H2,1-4H3,(H2,50,62)(H2,51,63)(H2,52,64)(H,53,66)(H,54,71)(H,55,65)(H,56,67)(H,57,70)(H,58,68)(H,59,69)/t25-,30-,31-,32-,33-,34-,35-,36+,40-/m0/s1 D0S3GE DRUGINKE GJHLANNXTOQRKG-VLMAQVDPSA-N D0S3GE DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N D0S3GE HIGHSTAT Investigative D0S4VO DRUG__ID D0S4VO D0S4VO DRUGINCH 1S/C102H171N23O21/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-42-85(130)109-50-33-29-40-74(92(136)115-72(89(107)133)37-26-30-47-103)117-93(137)73(38-27-31-48-104)116-94(138)75(39-28-32-49-105)118-101(145)83-41-34-51-125(83)87(132)60-112-91(135)77(52-62(2)3)119-96(140)78(53-63(4)5)120-98(142)80(55-67-43-45-69(128)46-44-67)114-86(131)59-111-90(134)65(8)113-100(144)82(61-126)123-99(143)81(57-84(106)129)121-97(141)79(54-64(6)7)122-102(146)88(66(9)127)124-95(139)76(108-10)56-68-58-110-71-36-25-24-35-70(68)71/h24-25,35-36,43-46,58,62-66,72-83,88,108,110,126-128H,11-23,26-34,37-42,47-57,59-61,103-105H2,1-10H3,(H2,106,129)(H2,107,133)(H,109,130)(H,111,134)(H,112,135)(H,113,144)(H,114,131)(H,115,136)(H,116,138)(H,117,137)(H,118,145)(H,119,140)(H,120,142)(H,121,141)(H,122,146)(H,123,143)(H,124,139)/t65-,66+,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,88-/m0/s1 D0S4VO DRUGINKE WZUYPFZMVKTBDB-CWYLLMHLSA-N D0S4VO DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC D0S4VO HIGHSTAT Investigative D0S6IW DRUG__ID D0S6IW D0S6IW DRUGINCH 1S/C100H169N35O34S/c1-14-46(8)75(133-90(161)61(36-68(104)139)128-82(153)54(21-18-31-113-99(107)108)124-95(166)76(47(9)15-2)135-96(167)77(48(10)16-3)134-91(162)64(39-73(147)148)130-83(154)56(25-28-70(141)142)122-80(151)52(101)23-26-66(102)137)94(165)118-50(12)79(150)120-53(20-17-30-112-98(105)106)81(152)127-60(35-51-40-111-43-116-51)87(158)126-59(34-44(4)5)86(157)117-49(11)78(149)121-55(24-27-67(103)138)85(156)132-74(45(6)7)93(164)115-41-69(140)119-62(37-71(143)144)88(159)131-65(42-136)92(163)123-57(29-33-170-13)84(155)129-63(38-72(145)146)89(160)125-58(97(168)169)22-19-32-114-100(109)110/h40,43-50,52-65,74-77,136H,14-39,41-42,101H2,1-13H3,(H2,102,137)(H2,103,138)(H2,104,139)(H,111,116)(H,115,164)(H,117,157)(H,118,165)(H,119,140)(H,120,150)(H,121,149)(H,122,151)(H,123,163)(H,124,166)(H,125,160)(H,126,158)(H,127,152)(H,128,153)(H,129,155)(H,130,154)(H,131,159)(H,132,156)(H,133,161)(H,134,162)(H,135,167)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,168,169)(H4,105,106,112)(H4,107,108,113)(H4,109,110,114)/t46-,47-,48-,49-,50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,74-,75-,76-,77-/m0/s1 D0S6IW DRUGINKE LBBXBBBHAYODPZ-GVIMSCNFSA-N D0S6IW DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C(C)CC)NC(=O)C(C(C)CC)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)N D0S6IW HIGHSTAT Investigative D0S7SO DRUG__ID D0S7SO D0S7SO DRUGINCH 1S/C58H73N11O13/c1-6-7-21-43(64-54(78)47(32-49(72)73)66-53(77)44(28-35-16-10-8-11-17-35)67-57(81)82-58(3,4)5)52(76)65-46(31-39-30-38-20-14-15-22-42(38)62-39)56(80)69-68-55(79)45(29-36-18-12-9-13-19-36)63-48(71)33-60-50(74)34(2)61-51(75)41(59)27-37-23-25-40(70)26-24-37/h8-20,22-26,30,34,41,43-47,62,70H,6-7,21,27-29,31-33,59H2,1-5H3,(H,60,74)(H,61,75)(H,63,71)(H,64,78)(H,65,76)(H,66,77)(H,67,81)(H,68,79)(H,69,80)(H,72,73)/t34-,41+,43+,44+,45+,46-,47+/m1/s1 D0S7SO DRUGINKE FEOAQCGOOODCEB-RXFVQNAMSA-N D0S7SO DRUGSMIL CCCCC(C(=O)NC(CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)OC(C)(C)C D0S7SO HIGHSTAT Investigative D0S7YR DRUG__ID D0S7YR D0S7YR DRUGINCH 1S/C83H105N15O17S2/c1-47(2)86-42-55-29-27-54(28-30-55)40-64-77(108)97-70(48(3)100)81(112)93-65(39-52-22-12-7-13-23-52)78(109)98-71(49(4)101)82(113)94-67(44-99)79(110)96-69(83(114)115)46-117-116-45-68(95-72(103)59(85)36-53-31-33-57(102)34-32-53)80(111)88-61(26-16-17-35-84)73(104)89-62(37-50-18-8-5-9-19-50)74(105)90-63(38-51-20-10-6-11-21-51)75(106)92-66(76(107)91-64)41-56-43-87-60-25-15-14-24-58(56)60/h5-15,18-25,27-34,43,47-49,59,61-71,86-87,99-102H,16-17,26,35-42,44-46,84-85H2,1-4H3,(H,88,111)(H,89,104)(H,90,105)(H,91,107)(H,92,106)(H,93,112)(H,94,113)(H,95,103)(H,96,110)(H,97,108)(H,98,109)(H,114,115)/t48-,49-,59+,61-,62-,63+,64+,65+,66+,67+,68-,69+,70-,71-/m1/s1 D0S7YR DRUGINKE UKGIKHPFMXOGRF-UXDQVZPXSA-N D0S7YR DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)NC(=O)C(CC7=CC=C(C=C7)O)N)C(=O)O)CO)C(C)O)CC8=CC=CC=C8)C(C)O D0S7YR HIGHSTAT Investigative D0S9UH DRUG__ID D0S9UH D0S9UH DRUGINCH 1S/C65H96N20O13/c1-3-38(2)54-62(97)83-49(60(95)81-45(21-13-29-73-65(70)71)63(98)85-30-14-22-50(85)61(96)79-43(55(67)90)19-10-11-27-66)35-75-51(87)33-48(59(94)80-44(57(92)84-54)20-12-28-72-64(68)69)82-58(93)47(32-39-15-6-4-7-16-39)78-53(89)37-76-52(88)36-77-56(91)46(31-40-23-25-42(86)26-24-40)74-34-41-17-8-5-9-18-41/h4-9,15-18,23-26,38,43-50,54,74,86H,3,10-14,19-22,27-37,66H2,1-2H3,(H2,67,90)(H,75,87)(H,76,88)(H,77,91)(H,78,89)(H,79,96)(H,80,94)(H,81,95)(H,82,93)(H,83,97)(H,84,92)(H4,68,69,72)(H4,70,71,73)/t38?,43-,44-,45-,46-,47-,48-,49-,50-,54-/m0/s1 D0S9UH DRUGINKE UWLIKQFWZOPOAX-HRFULILYSA-N D0S9UH DRUGSMIL CCC(C)C1C(=O)NC(CNC(=O)CC(C(=O)NC(C(=O)N1)CCCN=C(N)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)NCC4=CC=CC=C4)C(=O)NC(CCCN=C(N)N)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N D0S9UH HIGHSTAT Investigative D0SF0U DRUG__ID D0SF0U D0SF0U DRUGCOMP HS Pharmaceuticals LLC D0SF0U DRUGTYPE Small molecular drug D0SF0U DRUGSMIL C1=CC(=C[N+](=C1)CCCN2C=CC(=C[NH+]=O)C=C2)C(=O)N.[Br-].[Br-] D0SF0U HIGHSTAT Investigative D0SG5A DRUG__ID D0SG5A D0SG5A DRUGINCH 1S/C87H135N31O22/c1-46(106-68(124)44-105-83(138)70(48(3)120)118-81(136)61(38-50-21-8-5-9-22-50)108-69(125)43-103-67(123)42-104-73(128)53(90)37-49-19-6-4-7-20-49)71(126)109-57(27-16-34-99-85(93)94)75(130)112-56(26-13-15-33-89)78(133)117-64(45-119)82(137)107-47(2)72(127)110-58(28-17-35-100-86(95)96)76(131)111-55(25-12-14-32-88)74(129)113-59(29-18-36-101-87(97)98)77(132)115-62(39-51-41-102-54-24-11-10-23-52(51)54)79(134)116-63(40-66(92)122)80(135)114-60(84(139)140)30-31-65(91)121/h4-11,19-24,41,46-48,53,55-64,70,102,119-120H,12-18,25-40,42-45,88-90H2,1-3H3,(H2,91,121)(H2,92,122)(H,103,123)(H,104,128)(H,105,138)(H,106,124)(H,107,137)(H,108,125)(H,109,126)(H,110,127)(H,111,131)(H,112,130)(H,113,129)(H,114,135)(H,115,132)(H,116,134)(H,117,133)(H,118,136)(H,139,140)(H4,93,94,99)(H4,95,96,100)(H4,97,98,101)/t46-,47-,48+,53-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,70-/m0/s1 D0SG5A DRUGINKE HCNFEYAQXGBVLO-UWALROLSSA-N D0SG5A DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)CNC(=O)C(CC4=CC=CC=C4)N)O D0SG5A HIGHSTAT Investigative D0SO9G DRUG__ID D0SO9G D0SO9G DRUGINCH 1S/C11H14N4O3S/c1-19-11-9(17)8(16)6(15-11)5-2-4-7(14-5)10(18)13-3-12-4/h2-3,6,8-9,11,14-17H,1H3,(H,12,13,18)/t6-,8-,9-,11+/m0/s1 D0SO9G DRUGINKE ZXECYVBSYKBAAH-MRQALGCZSA-N D0SO9G DRUGSMIL CSC1C(C(C(N1)C2=CC3=C(N2)C(=O)NC=N3)O)O D0SO9G HIGHSTAT Investigative D0SV5D DRUG__ID D0SV5D D0SV5D DRUGINCH 1S/C107H153N27O26/c1-57(2)42-70(123-93(147)71(43-58(3)4)124-95(149)74(47-64-33-35-66(138)36-34-64)121-86(141)52-115-91(145)60(7)118-100(154)78(55-135)128-98(152)77(49-84(109)139)125-94(148)72(44-59(5)6)127-103(157)89(61(8)137)130-99(153)76(119-85(140)50-108)48-65-51-114-68-27-16-15-26-67(65)68)92(146)117-54-88(143)131-38-20-31-82(131)105(159)134-41-21-32-83(134)106(160)133-40-18-29-80(133)101(155)116-53-87(142)120-73(45-62-22-11-9-12-23-62)96(150)129-79(56-136)104(158)132-39-19-30-81(132)102(156)126-75(46-63-24-13-10-14-25-63)97(151)122-69(90(110)144)28-17-37-113-107(111)112/h9-16,22-27,33-36,51,57-61,69-83,89,114,135-138H,17-21,28-32,37-50,52-56,108H2,1-8H3,(H2,109,139)(H2,110,144)(H,115,145)(H,116,155)(H,117,146)(H,118,154)(H,119,140)(H,120,142)(H,121,141)(H,122,151)(H,123,147)(H,124,149)(H,125,148)(H,126,156)(H,127,157)(H,128,152)(H,129,150)(H,130,153)(H4,111,112,113)/t60-,61+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,89-/m0/s1 D0SV5D DRUGINKE JWMXJVFGTXYBFM-AEXVMZOXSA-N D0SV5D DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N1CCCC1C(=O)N2CCCC2C(=O)N3CCCC3C(=O)NCC(=O)NC(CC4=CC=CC=C4)C(=O)NC(CO)C(=O)N5CCCC5C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)CN D0SV5D HIGHSTAT Investigative D0T0IL DRUG__ID D0T0IL D0T0IL DRUGINCH 1S/C36H44N8O9/c1-19(2)30-34(51)39-18-29(48)43-31(32(49)20-9-11-22(45)12-10-20)35(52)40-16-27(46)41-25(14-21-15-37-24-7-4-3-6-23(21)24)36(53)44-13-5-8-26(44)33(50)38-17-28(47)42-30/h3-4,6-7,9-12,15,19,25-26,30-32,37,45,49H,5,8,13-14,16-18H2,1-2H3,(H,38,50)(H,39,51)(H,40,52)(H,41,46)(H,42,47)(H,43,48)/t25-,26-,30-,31-,32?/m0/s1 D0T0IL DRUGINKE SYBLQDYULNRQHI-ZTRORRTFSA-N D0T0IL DRUGSMIL CC(C)C1C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)N2CCCC2C(=O)NCC(=O)N1)CC3=CNC4=CC=CC=C43)C(C5=CC=C(C=C5)O)O D0T0IL HIGHSTAT Investigative D0T0PR DRUG__ID D0T0PR D0T0PR DRUGINCH 1S/C71H104N21O21PS2/c1-9-35(5)57(59(73)98)92-68(107)51-31-115-116-32-52(90-70(109)58(36(6)10-2)82-38(8)93)67(106)91-56(34(3)4)69(108)88-47(24-39-17-19-42(20-18-39)113-114(110,111)112)64(103)84-46(21-22-53(72)94)63(102)87-50(27-55(96)97)66(105)86-48(25-40-28-78-44-15-12-11-14-43(40)44)61(100)79-30-54(95)81-37(7)60(99)85-49(26-41-29-76-33-80-41)65(104)83-45(62(101)89-51)16-13-23-77-71(74)75/h11-12,14-15,17-20,28-29,33-37,45-52,56-58,78H,9-10,13,16,21-27,30-32H2,1-8H3,(H2,72,94)(H2,73,98)(H,76,80)(H,79,100)(H,81,95)(H,82,93)(H,83,104)(H,84,103)(H,85,99)(H,86,105)(H,87,102)(H,88,108)(H,89,101)(H,90,109)(H,91,106)(H,92,107)(H,96,97)(H4,74,75,77)(H2,110,111,112)/t35-,36-,37-,45-,46-,47-,48-,49+,50+,51-,52-,56-,57-,58-/m0/s1 D0T0PR DRUGINKE GQCVZDSVWSDPKX-FWGFZLTPSA-N D0T0PR DRUGSMIL CCC(C)C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC2=CN=CN2)C)CC3=CNC4=CC=CC=C43)CC(=O)O)CCC(=O)N)CC5=CC=C(C=C5)OP(=O)(O)O)C(C)C)NC(=O)C(C(C)CC)NC(=O)C D0T0PR HIGHSTAT Investigative D0T1II DRUG__ID D0T1II D0T1II DRUGINCH 1S/C67H77N11O9/c1-66(2)54-28-11-6-5-7-12-29-55-67(3,4)60-46-25-16-14-23-44(46)31-33-52(60)78(55)41-57(81)73-48(27-19-36-71-65(69)70)62(85)72-40-56(80)74-50(39-58(82)83)64(87)76-49(38-42-20-9-8-10-21-42)63(86)75-47(26-17-18-35-68)61(84)53(79)34-37-77(54)51-32-30-43-22-13-15-24-45(43)59(51)66/h5-16,20-25,28-33,47-50H,17-19,26-27,34-41,68H2,1-4H3,(H9-,69,70,71,72,73,74,75,76,80,81,82,83,85,86,87)/p+1/t47-,48+,49+,50-/m1/s1 D0T1II DRUGINKE GCUFPHJXORLRLN-CZFAESEUSA-O D0T1II DRUGSMIL CC1(C2=[N+](CC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)C(=O)CCN3C4=C(C5=CC=CC=C5C=C4)C(C3=CC=CC=CC=C2)(C)C)CCCCN)CC6=CC=CC=C6)CC(=O)O)CCCN=C(N)N)C7=C1C8=CC=CC=C8C=C7)C D0T1II HIGHSTAT Investigative D0T1IK DRUG__ID D0T1IK D0T1IK DRUGINCH 1S/C53H66N10O9S/c1-53(2,26-12-14-32-72-50-38-45(41-17-5-3-6-18-41)37-46(58-50)42-19-7-4-8-20-42)52-60-61-62-63(52)29-13-11-23-49(64)54-27-15-30-69-33-35-71-36-34-70-31-16-28-55-51(65)44-24-25-48(56-39-44)59-57-40-43-21-9-10-22-47(43)73(66,67)68/h3-10,17-22,24-25,37-39H,11-16,23,26-36,40H2,1-2H3,(H,54,64)(H,55,65)(H,66,67,68)/p-1 D0T1IK DRUGINKE OPZKREHSQYOWCZ-UHFFFAOYSA-M D0T1IK DRUGSMIL CC(C)(CCCCOC1=CC(=CC(=N1)C2=CC=CC=C2)C3=CC=CC=C3)C4=NN=NN4CCCCC(=O)NCCCOCCOCCOCCCNC(=O)C5=CN=C(C=C5)N=NCC6=CC=CC=C6S(=O)(=O)[O-] D0T1IK HIGHSTAT Investigative D0T5RO DRUG__ID D0T5RO D0T5RO DRUGINCH 1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1 D0T5RO DRUGINKE NHXLMOGPVYXJNR-ATOGVRKGSA-N D0T5RO DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O D0T5RO HIGHSTAT Investigative D0T5WR DRUG__ID D0T5WR D0T5WR DRUGINCH 1S/C142H215N31O50S/c1-14-75(9)64-96(165-129(209)95(63-74(7)8)163-119(199)82(27-19-21-57-143)153-121(201)84(39-48-104(144)176)154-120(200)83(41-50-108(180)181)151-106(178)70-150-136(216)102-29-20-22-59-172(102)138(218)91(28-23-58-148-141(146)147)171-224(222,223)81-37-33-79(34-38-81)142(11,12)13)130(210)169-101(71-174)135(215)159-86(43-52-110(184)185)123(203)155-88(45-54-112(188)189)126(206)168-100(68-116(196)197)134(214)162-93(61-72(3)4)118(198)149-69-107(179)152-99(67-115(194)195)133(213)167-97(65-77-25-17-16-18-26-77)131(211)158-85(42-51-109(182)183)122(202)157-90(47-56-114(192)193)127(207)170-117(76(10)15-2)139(219)173-60-24-30-103(173)137(217)160-89(46-55-113(190)191)124(204)156-87(44-53-111(186)187)125(205)166-98(66-78-31-35-80(175)36-32-78)132(212)164-94(62-73(5)6)128(208)161-92(140(220)221)40-49-105(145)177/h16-18,25-26,31-38,72-76,82-103,117,171,174-175H,14-15,19-24,27-30,39-71,143H2,1-13H3,(H2,144,176)(H2,145,177)(H,149,198)(H,150,216)(H,151,178)(H,152,179)(H,153,201)(H,154,200)(H,155,203)(H,156,204)(H,157,202)(H,158,211)(H,159,215)(H,160,217)(H,161,208)(H,162,214)(H,163,199)(H,164,212)(H,165,209)(H,166,205)(H,167,213)(H,168,206)(H,169,210)(H,170,207)(H,180,181)(H,182,183)(H,184,185)(H,186,187)(H,188,189)(H,190,191)(H,192,193)(H,194,195)(H,196,197)(H,220,221)(H4,146,147,148)/t75-,76-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102+,103-,117-/m0/s1 D0T5WR DRUGINKE GEUGFPVPSWNWIJ-JOTHITJKSA-N D0T5WR DRUGSMIL CCC(C)CC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D0T5WR HIGHSTAT Investigative D0T6CU DRUG__ID D0T6CU D0T6CU DRUGINCH 1S/C137H207N41O42/c1-64(2)38-84(162-120(203)86(40-66(5)6)163-122(205)88(43-74-31-33-78(185)34-32-74)158-104(189)54-149-112(195)69(11)155-129(212)96(58-179)172-126(209)94(49-103(142)188)167-121(204)87(41-67(7)8)170-134(217)110(71(13)183)176-114(197)80(139)44-75-51-148-81-27-19-18-26-79(75)81)115(198)152-57-107(192)178-37-23-30-100(178)132(215)169-90(45-76-52-145-62-153-76)119(202)156-70(12)113(196)175-109(68(9)10)133(216)151-56-106(191)159-93(48-102(141)187)125(208)165-91(46-77-53-146-63-154-77)124(207)161-83(29-22-36-147-137(143)144)118(201)171-97(59-180)130(213)164-89(42-73-24-16-15-17-25-73)123(206)173-98(60-181)131(214)168-95(50-108(193)194)127(210)160-82(28-20-21-35-138)117(200)166-92(47-101(140)186)116(199)150-55-105(190)157-85(39-65(3)4)128(211)177-111(72(14)184)135(218)174-99(61-182)136(219)220/h15-19,24-27,31-34,51-53,62-72,80,82-100,109-111,148,179-185H,20-23,28-30,35-50,54-61,138-139H2,1-14H3,(H2,140,186)(H2,141,187)(H2,142,188)(H,145,153)(H,146,154)(H,149,195)(H,150,199)(H,151,216)(H,152,198)(H,155,212)(H,156,202)(H,157,190)(H,158,189)(H,159,191)(H,160,210)(H,161,207)(H,162,203)(H,163,205)(H,164,213)(H,165,208)(H,166,200)(H,167,204)(H,168,214)(H,169,215)(H,170,217)(H,171,201)(H,172,209)(H,173,206)(H,174,218)(H,175,196)(H,176,197)(H,177,211)(H,193,194)(H,219,220)(H4,143,144,147)/t69-,70-,71+,72+,80-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,109-,110-,111-/m0/s1 D0T6CU DRUGINKE UTHJXLJHUIVFLB-TYEKMZLMSA-N D0T6CU DRUGSMIL CC(C)CC(C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CO)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC3=CN=CN3)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)N D0T6CU HIGHSTAT Investigative D0T6NE DRUG__ID D0T6NE D0T6NE DRUGINCH 1S/C19H27ClFN3O2/c1-19(2,3)23-17(25)12-24-6-4-13(5-7-24)11-22-18(26)14-8-15(20)10-16(21)9-14/h8-10,13H,4-7,11-12H2,1-3H3,(H,22,26)(H,23,25) D0T6NE DRUGINKE JOCLITFYIMJMNK-UHFFFAOYSA-N D0T6NE DRUGSMIL CC(C)(C)NC(=O)CN1CCC(CC1)CNC(=O)C2=CC(=CC(=C2)Cl)F D0T6NE HIGHSTAT Investigative D0T6ST DRUG__ID D0T6ST D0T6ST DRUGINCH 1S/C73H101N21O18S2/c1-8-36(4)59(84-39(7)96)72(112)92-54-33-114-113-32-53(70(110)94-60(38(6)95)61(75)101)91-64(104)47(18-13-23-79-73(76)77)85-67(107)51(27-44-30-78-34-82-44)87-62(102)37(5)83-56(98)31-81-63(103)50(26-43-29-80-46-17-12-11-16-45(43)46)88-68(108)52(28-57(99)100)89-65(105)48(21-22-55(74)97)86-66(106)49(90-71(111)58(35(2)3)93-69(54)109)25-40-19-20-41-14-9-10-15-42(41)24-40/h9-12,14-17,19-20,24,29-30,34-38,47-54,58-60,80,95H,8,13,18,21-23,25-28,31-33H2,1-7H3,(H2,74,97)(H2,75,101)(H,78,82)(H,81,103)(H,83,98)(H,84,96)(H,85,107)(H,86,106)(H,87,102)(H,88,108)(H,89,105)(H,90,111)(H,91,104)(H,92,112)(H,93,109)(H,94,110)(H,99,100)(H4,76,77,79)/t36-,37-,38+,47-,48-,49-,50-,51+,52+,53-,54-,58-,59-,60-/m0/s1 D0T6ST DRUGINKE BFGQANAKHJAOQY-UZUHPOSNSA-N D0T6ST DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC3=CC=CC=C3C=C2)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0T6ST HIGHSTAT Investigative D0T7CN DRUG__ID D0T7CN D0T7CN DRUGINCH 1S/C71H100FN21O19S2/c1-8-33(4)57(83-36(7)95)69(110)91-52(30-114)66(107)92-56(32(2)3)68(109)89-48(20-37-25-78-43-13-10-9-12-41(37)43)63(104)85-46(17-18-53(73)96)62(103)88-50(24-55(98)99)65(106)87-47(21-38-26-79-44-16-15-39(72)22-42(38)44)60(101)80-28-54(97)82-34(5)59(100)86-49(23-40-27-76-31-81-40)64(105)84-45(14-11-19-77-71(74)75)61(102)90-51(29-113)67(108)93-58(35(6)94)70(111)112/h9-10,12-13,15-16,22,25-27,31-35,45-52,56-58,78-79,94,113-114H,8,11,14,17-21,23-24,28-30H2,1-7H3,(H2,73,96)(H,76,81)(H,80,101)(H,82,97)(H,83,95)(H,84,105)(H,85,104)(H,86,100)(H,87,106)(H,88,103)(H,89,109)(H,90,102)(H,91,110)(H,92,107)(H,93,108)(H,98,99)(H,111,112)(H4,74,75,77)/t33-,34-,35+,45-,46-,47-,48-,49-,50-,51-,52-,56-,57-,58-/m0/s1 D0T7CN DRUGINKE KSDNMEGNCSHTNC-MZUDAGKNSA-N D0T7CN DRUGSMIL CCC(C)C(C(=O)NC(CS)C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CNC4=C3C=C(C=C4)F)C(=O)NCC(=O)NC(C)C(=O)NC(CC5=CN=CN5)C(=O)NC(CCCN=C(N)N)C(=O)NC(CS)C(=O)NC(C(C)O)C(=O)O)NC(=O)C D0T7CN HIGHSTAT Investigative D0TF7R DRUG__ID D0TF7R D0TF7R DRUGINCH 1S/C88H143N23O22/c1-48(2)37-62(77(121)98-45-72(117)111-36-20-27-68(111)86(130)104-61(26-15-19-35-92)80(124)103-60(25-14-18-34-91)79(123)102-59(24-13-17-33-90)78(122)101-58(75(94)119)23-12-16-32-89)105-81(125)63(38-49(3)4)106-83(127)65(40-53-28-30-55(114)31-29-53)100-71(116)44-97-76(120)51(7)99-85(129)67(47-112)109-84(128)66(42-70(93)115)107-82(126)64(39-50(5)6)108-88(132)74(52(8)113)110-87(131)69(133-73(118)46-95-9)41-54-43-96-57-22-11-10-21-56(54)57/h10-11,21-22,28-31,43,48-52,58-69,74,95-96,112-114H,12-20,23-27,32-42,44-47,89-92H2,1-9H3,(H2,93,115)(H2,94,119)(H,97,120)(H,98,121)(H,99,129)(H,100,116)(H,101,122)(H,102,123)(H,103,124)(H,104,130)(H,105,125)(H,106,127)(H,107,126)(H,108,132)(H,109,128)(H,110,131)/t51-,52+,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,74-/m0/s1 D0TF7R DRUGINKE JTWAWYOTWKLDAO-GFUYWXIVSA-N D0TF7R DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NCC(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D0TF7R HIGHSTAT Investigative D0TL3X DRUG__ID D0TL3X D0TL3X DRUGINCH 1S/C51H75N11O19/c1-5-25(3)41-49(79)56-29(10-7-8-18-52)43(73)55-30(16-17-37(65)66)44(74)60-42(26(4)6-2)50(80)58-31(20-27-12-14-28(63)15-13-27)45(75)59-34(23-40(71)72)51(81)62-19-9-11-35(62)48(78)53-24-36(64)54-32(21-38(67)68)46(76)57-33(22-39(69)70)47(77)61-41/h12-15,25-26,29-35,41-42,63H,5-11,16-24,52H2,1-4H3,(H,53,78)(H,54,64)(H,55,73)(H,56,79)(H,57,76)(H,58,80)(H,59,75)(H,60,74)(H,61,77)(H,65,66)(H,67,68)(H,69,70)(H,71,72)/t25-,26-,29-,30-,31-,32+,33-,34-,35-,41-,42-/m0/s1 D0TL3X DRUGINKE JDTPYTFDRAQKHK-ZHDLRRBESA-N D0TL3X DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCC(=O)O)CCCCN)C(C)CC)CC(=O)O)CC(=O)O)CC(=O)O)CC3=CC=C(C=C3)O D0TL3X HIGHSTAT Investigative D0U4BO DRUG__ID D0U4BO D0U4BO DRUGINCH 1S/C150H240N46O39/c1-72(2)52-96(173-112(206)66-167-123(210)80(17)171-131(218)97(53-73(3)4)180-129(216)93(44-33-49-163-149(158)159)175-134(221)100(58-87-63-162-71-170-87)185-147(234)121(83(20)201)195-145(232)118(78(13)14)190-125(212)89(153)57-86-62-165-90-41-28-27-40-88(86)90)132(219)181-98(54-74(5)6)133(220)188-106(70-199)140(227)177-94(45-34-50-164-150(160)161)130(217)187-104(68-197)126(213)168-64-111(205)166-65-114(208)189-116(76(9)10)144(231)192-117(77(11)12)143(230)178-92(43-30-32-48-152)128(215)183-101(59-108(154)202)136(223)184-102(60-109(155)203)135(222)182-99(56-85-38-25-22-26-39-85)137(224)193-119(79(15)16)148(235)196-51-35-46-107(196)141(228)194-120(82(19)200)146(233)186-103(61-110(156)204)138(225)191-115(75(7)8)142(229)169-67-113(207)174-105(69-198)139(226)176-91(42-29-31-47-151)127(214)172-81(18)124(211)179-95(122(157)209)55-84-36-23-21-24-37-84/h21-28,36-41,62-63,71-83,89,91-107,115-121,165,197-201H,29-35,42-61,64-70,151-153H2,1-20H3,(H2,154,202)(H2,155,203)(H2,156,204)(H2,157,209)(H,162,170)(H,166,205)(H,167,210)(H,168,213)(H,169,229)(H,171,218)(H,172,214)(H,173,206)(H,174,207)(H,175,221)(H,176,226)(H,177,227)(H,178,230)(H,179,211)(H,180,216)(H,181,219)(H,182,222)(H,183,215)(H,184,223)(H,185,234)(H,186,233)(H,187,217)(H,188,220)(H,189,208)(H,190,212)(H,191,225)(H,192,231)(H,193,224)(H,194,228)(H,195,232)(H4,158,159,163)(H4,160,161,164)/t80-,81-,82+,83+,89-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,115-,116-,117-,118-,119-,120-,121-/m0/s1 D0U4BO DRUGINKE KABRZBKCOKQUKE-CFPQMTSYSA-N D0U4BO DRUGSMIL CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)NCC(=O)NCC(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC3=CC=CC=C3)C(=O)N)NC(=O)CNC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC4=CN=CN4)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)C(CC5=CNC6=CC=CC=C65)N D0U4BO HIGHSTAT Investigative D0U6PD DRUG__ID D0U6PD D0U6PD DRUGINCH 1S/C54H69N9O12/c1-32(53(72)63-26-8-12-45(63)51(70)60-43(11-6-7-25-55)49(68)62-47(52(71)58-30-46(65)66)33(2)75-31-37-9-4-3-5-10-37)59-50(69)44(29-36-17-23-40(64)24-18-36)61-48(67)41(56)27-34-13-19-38(20-14-34)39-21-15-35(16-22-39)28-42(57)54(73)74/h3-5,9-10,13-24,32-33,41-45,47,64H,6-8,11-12,25-31,55-57H2,1-2H3,(H,58,71)(H,59,69)(H,60,70)(H,61,67)(H,62,68)(H,65,66)(H,73,74)/t32-,33+,41-,42-,43-,44-,45-,47-/m0/s1 D0U6PD DRUGINKE WWXCYGORDIEWIZ-YAXCISKESA-N D0U6PD DRUGSMIL CC(C(C(=O)NCC(=O)O)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)C(C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CC=C(C=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N)OCC5=CC=CC=C5 D0U6PD HIGHSTAT Investigative D0U6XP DRUG__ID D0U6XP D0U6XP DRUGINCH 1S/C53H66N12O9/c1-3-4-15-40(59-31(2)66)48(69)62-43-27-46(67)56-21-10-9-17-39(47(54)68)60-49(70)41(25-35-28-57-38-16-8-7-14-37(35)38)63-52(73)45-18-11-22-65(45)53(74)44(24-32-19-20-33-12-5-6-13-34(33)23-32)64-50(71)42(61-51(43)72)26-36-29-55-30-58-36/h5-8,12-14,16,19-20,23,28-30,39-45,57H,3-4,9-11,15,17-18,21-22,24-27H2,1-2H3,(H2,54,68)(H,55,58)(H,56,67)(H,59,66)(H,60,70)(H,61,72)(H,62,69)(H,63,73)(H,64,71)/t39-,40-,41-,42-,43-,44+,45-/m0/s1 D0U6XP DRUGINKE NUEQNUVEEKTGQM-GTBIJRGCSA-N D0U6XP DRUGSMIL CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C2CCCN2C(=O)C(NC(=O)C(NC1=O)CC3=CN=CN3)CC4=CC5=CC=CC=C5C=C4)CC6=CNC7=CC=CC=C76)C(=O)N)NC(=O)C D0U6XP HIGHSTAT Investigative D0U7PT DRUG__ID D0U7PT D0U7PT DRUGINCH 1S/C75H126N24O15/c1-7-45(6)61(70(111)94-53(25-17-35-87-75(83)84)71(112)99-36-18-26-58(99)69(110)93-50(21-11-13-31-76)64(105)96-56(38-44(4)5)67(108)95-54(72(113)114)22-12-14-32-77)98-65(106)52(24-16-34-86-74(81)82)91-63(104)51(23-15-33-85-73(79)80)92-66(107)55(37-43(2)3)97-68(109)57(40-46-19-9-8-10-20-46)90-60(102)42-88-59(101)41-89-62(103)49(78)39-47-27-29-48(100)30-28-47/h8-10,19-20,27-30,43-45,49-58,61,100H,7,11-18,21-26,31-42,76-78H2,1-6H3,(H,88,101)(H,89,103)(H,90,102)(H,91,104)(H,92,107)(H,93,110)(H,94,111)(H,95,108)(H,96,105)(H,97,109)(H,98,106)(H,113,114)(H4,79,80,85)(H4,81,82,86)(H4,83,84,87)/t45-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,61-/m0/s1 D0U7PT DRUGINKE OVVIBUHLQIYUEU-IWIISZHXSA-N D0U7PT DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N D0U7PT HIGHSTAT Investigative D0U7QE DRUG__ID D0U7QE D0U7QE DRUGINCH 1S/C57H74F3N15O10/c1-5-32(4)46(52(82)69-42(28-37-29-64-30-66-37)53(83)75-24-10-14-44(75)50(80)70-43(54(84)85)27-33-11-7-6-8-12-33)72-49(79)41(26-35-17-21-38(76)22-18-35)68-51(81)45(31(2)3)71-48(78)40(13-9-23-65-55(62)63)67-47(77)39(61)25-34-15-19-36(20-16-34)56(73-74-56)57(58,59)60/h6-8,11-12,15-22,29-32,39-46,76H,5,9-10,13-14,23-28,61H2,1-4H3,(H,64,66)(H,67,77)(H,68,81)(H,69,82)(H,70,80)(H,71,78)(H,72,79)(H,84,85)(H4,62,63,65)/t32-,39-,40-,41-,42-,43-,44-,45-,46-/m0/s1 D0U7QE DRUGINKE OGNWPDVTXMDCHR-PYRLQILWSA-N D0U7QE DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=CC=C3)C(=O)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=CC=C(C=C5)C6(N=N6)C(F)(F)F)N D0U7QE HIGHSTAT Investigative D0U8CB DRUG__ID D0U8CB D0U8CB DRUGINCH 1S/C75H108N20O13/c1-42(2)35-55(64(80)98)89-67(101)56(36-43(3)4)90-69(103)59(39-46-41-85-51-23-11-9-20-48(46)51)93-68(102)57(37-44-17-6-5-7-18-44)91-70(104)58(38-45-40-84-50-22-10-8-19-47(45)50)92-66(100)52(27-29-62(78)96)86-65(99)53(28-30-63(79)97)87-71(105)61-26-16-34-95(61)74(108)54(24-12-13-31-76)88-72(106)60-25-15-33-94(60)73(107)49(77)21-14-32-83-75(81)82/h5-11,17-20,22-23,40-43,49,52-61,84-85H,12-16,21,24-39,76-77H2,1-4H3,(H2,78,96)(H2,79,97)(H2,80,98)(H,86,99)(H,87,105)(H,88,106)(H,89,101)(H,90,103)(H,91,104)(H,92,100)(H,93,102)(H4,81,82,83)/t49-,52+,53+,54+,55+,56+,57+,58-,59-,60+,61+/m1/s1 D0U8CB DRUGINKE SAPCBHPQLCZCDV-CHPWDEGWSA-N D0U8CB DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)N)NC(=O)C6CCCN6C(=O)C(CCCCN)NC(=O)C7CCCN7C(=O)C(CCCN=C(N)N)N D0U8CB HIGHSTAT Investigative D0U8GR DRUG__ID D0U8GR D0U8GR DRUGINCH 1S/C59H88N2O12/c1-34-17-12-11-13-18-35(2)45(46-33-60-52-36(3)19-16-20-44(46)52)31-43-24-22-41(8)59(69,73-43)56(66)57(67)61-26-15-14-21-47(61)58(68)72-50(38(5)29-42-23-25-48(62)51(30-42)70-9)32-49(63)37(4)28-40(7)54(65)55(71-10)53(64)39(6)27-34/h11-13,16-20,28,33-34,37-39,41-43,45,47-51,53-55,60,62-65,69H,14-15,21-27,29-32H2,1-10H3/b13-11+,17-12+,35-18+,40-28+/t34-,37-,38-,39-,41-,42+,43+,45+,47+,48-,49+,50+,51-,53+,54-,55+,59-/m1/s1 D0U8GR DRUGINKE PSLNMAUXUJLNBW-OUPLBGLBSA-N D0U8GR DRUGSMIL CC1CCC2CC(C(=CC=CC=CC(CC(C(C(C(C(=CC(C(CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)O)C)C)O)OC)O)C)C)C)C5=CNC6=C(C=CC=C56)C D0U8GR HIGHSTAT Investigative D0U8YN DRUG__ID D0U8YN D0U8YN DRUGINCH 1S/C11H17N5O2/c12-9-8(16-17)10(15-11(13)14-9)18-6-7-4-2-1-3-5-7/h7H,1-6H2,(H4,12,13,14,15) D0U8YN DRUGINKE DGWXOLHKVGDQLN-UHFFFAOYSA-N D0U8YN DRUGSMIL C1CCC(CC1)COC2=NC(=NC(=C2N=O)N)N D0U8YN HIGHSTAT Investigative D0UH8F DRUG__ID D0UH8F D0UH8F DRUGINCH 1S/C67H107N23O22S4/c1-29(2)12-35(55(100)77-34(9-10-51(96)97)54(99)80-38(15-33-20-73-28-75-33)58(103)84-41(21-91)60(105)82-39(16-48(69)93)59(104)79-36(13-30(3)4)56(101)86-43(23-113)53(71)98)78-57(102)37(14-32-19-72-27-74-32)81-63(108)46(26-116)88-66(111)52(31(5)6)89-65(110)47-8-7-11-90(47)67(112)40(17-49(70)94)83-61(106)42(22-92)85-64(109)45(25-115)87-62(107)44(24-114)76-50(95)18-68/h19-20,27-31,34-47,52,91-92,113-116H,7-18,21-26,68H2,1-6H3,(H2,69,93)(H2,70,94)(H2,71,98)(H,72,74)(H,73,75)(H,76,95)(H,77,100)(H,78,102)(H,79,104)(H,80,99)(H,81,108)(H,82,105)(H,83,106)(H,84,103)(H,85,109)(H,86,101)(H,87,107)(H,88,111)(H,89,110)(H,96,97)/t34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,52-/m0/s1 D0UH8F DRUGINKE MLPOWHAMUPIMTC-XCQLYXDWSA-N D0UH8F DRUGSMIL CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CS)C(=O)N)NC(=O)C(CC2=CN=CN2)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)C3CCCN3C(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CS)NC(=O)C(CS)NC(=O)CN D0UH8F HIGHSTAT Investigative D0UJ6V DRUG__ID D0UJ6V D0UJ6V DRUGINCH 1S/C67H113N19O24/c1-32(2)25-42(75-50(94)29-74-56(98)46(30-87)82-55(97)38(71)13-7-10-22-68)60(102)81-45(28-51(95)96)63(105)86-53(34(5)89)65(107)78-40(15-9-12-24-70)58(100)80-44(27-49(73)93)62(104)79-43(26-36-16-18-37(91)19-17-36)61(103)76-39(14-8-11-23-69)57(99)77-41(20-21-48(72)92)59(101)85-54(35(6)90)66(108)83-47(31-88)64(106)84-52(33(3)4)67(109)110/h16-19,32-35,38-47,52-54,87-91H,7-15,20-31,68-71H2,1-6H3,(H2,72,92)(H2,73,93)(H,74,98)(H,75,94)(H,76,103)(H,77,99)(H,78,107)(H,79,104)(H,80,100)(H,81,102)(H,82,97)(H,83,108)(H,84,106)(H,85,101)(H,86,105)(H,95,96)(H,109,110)/t34-,35-,38+,39+,40+,41+,42+,43+,44+,45+,46+,47+,52+,53+,54+/m1/s1 D0UJ6V DRUGINKE LZIFLRQJFWVNPC-NBGMAUTBSA-N D0UJ6V DRUGSMIL CC(C)CC(C(=O)NC(CC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)C(CCCCN)N D0UJ6V HIGHSTAT Investigative D0UK0O DRUG__ID D0UK0O D0UK0O DRUGINCH 1S/C45H64N14O11S2/c46-16-14-29(38(64)52-23-36(48)62)55-43(69)34-9-5-18-59(34)44(70)33-24-72-71-19-15-37(63)53-30(21-26-10-12-27(60)13-11-26)40(66)56-31(20-25-6-2-1-3-7-25)41(67)54-28(8-4-17-51-45(49)50)39(65)57-32(22-35(47)61)42(68)58-33/h1-3,6-7,10-13,28-34,60H,4-5,8-9,14-24,46H2,(H2,47,61)(H2,48,62)(H,52,64)(H,53,63)(H,54,67)(H,55,69)(H,56,66)(H,57,65)(H,58,68)(H4,49,50,51)/t28-,29-,30-,31-,32-,33-,34-/m0/s1 D0UK0O DRUGINKE JTUSVVYBCYZYRH-NXBWRCJVSA-N D0UK0O DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN=C(N)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCN)C(=O)NCC(=O)N D0UK0O HIGHSTAT Investigative D0UK9D DRUG__ID D0UK9D D0UK9D DRUGINCH 1S/C71H101N21O18S2/c1-8-34(4)56(82-37(7)94)69(109)89-51-31-112-111-30-50(67(107)91-57(36(6)93)59(73)99)88-62(102)45(18-13-23-77-71(74)75)83-64(104)48(25-40-28-76-32-80-40)85-60(100)35(5)81-53(96)29-79-61(101)47(24-39-27-78-44-17-12-11-16-42(39)44)86-65(105)49(26-54(97)98)87-63(103)46(21-22-52(72)95)84-70(110)58(43-20-19-38-14-9-10-15-41(38)43)92-68(108)55(33(2)3)90-66(51)106/h9-12,14-17,27-28,32-36,43,45-51,55-58,78,93H,8,13,18-26,29-31H2,1-7H3,(H2,72,95)(H2,73,99)(H,76,80)(H,79,101)(H,81,96)(H,82,94)(H,83,104)(H,84,110)(H,85,100)(H,86,105)(H,87,103)(H,88,102)(H,89,109)(H,90,106)(H,91,107)(H,92,108)(H,97,98)(H4,74,75,77)/t34-,35-,36+,43?,45-,46-,47-,48+,49+,50-,51-,55-,56-,57-,58-/m0/s1 D0UK9D DRUGINKE YYPFHDDBPCSRKO-FUQOBRPNSA-N D0UK9D DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C2CCC3=CC=CC=C23)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0UK9D HIGHSTAT Investigative D0UO0Y DRUG__ID D0UO0Y D0UO0Y DRUGINCH 1S/C112H160N40O32/c1-111(2)75(151(73-34-32-57-20-10-12-22-59(57)91(73)111)43-36-79(155)139-61(24-14-37-127-105(115)116)93(171)133-50-80(156)141-67(46-87(163)164)99(177)147-63(26-16-39-129-107(119)120)95(173)135-52-82(158)143-69(48-89(167)168)101(179)149-65(28-18-41-131-109(123)124)97(175)137-54-84(160)145-71(103(181)182)44-77(113)153)30-8-6-5-7-9-31-76-112(3,4)92-60-23-13-11-21-58(60)33-35-74(92)152(76)56-86(162)140-62(25-15-38-128-106(117)118)94(172)134-51-81(157)142-68(47-88(165)166)100(178)148-64(27-17-40-130-108(121)122)96(174)136-53-83(159)144-70(49-90(169)170)102(180)150-66(29-19-42-132-110(125)126)98(176)138-55-85(161)146-72(104(183)184)45-78(114)154/h5-13,20-23,30-35,61-72H,14-19,24-29,36-56H2,1-4H3,(H51-,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,153,154,155,156,157,158,159,160,161,162,163,164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184)/p+1/t61-,62-,63-,64-,65-,66-,67+,68+,69+,70+,71+,72+/m0/s1 D0UO0Y DRUGINKE RXCTZKKSKSPTFA-PRPZEPFNSA-O D0UO0Y DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)N)C(=O)O)C=CC=CC=CC=C4C(C5=C(N4CCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)N)C(=O)O)C=CC6=CC=CC=C65)(C)C)C D0UO0Y HIGHSTAT Investigative D0V0HM DRUG__ID D0V0HM D0V0HM DRUGINCH 1S/C80H118N28O14/c1-3-13-55(69(115)101-59(21-11-35-95-79(89)90)73(119)105-61(65(83)111)37-43-23-27-47(109)28-24-43)99-71(117)57(19-9-33-93-77(85)86)103-75(121)63(39-45-41-97-53-17-7-5-15-49(45)53)107-67(113)51(81)31-32-52(82)68(114)108-64(40-46-42-98-54-18-8-6-16-50(46)54)76(122)104-58(20-10-34-94-78(87)88)72(118)100-56(14-4-2)70(116)102-60(22-12-36-96-80(91)92)74(120)106-62(66(84)112)38-44-25-29-48(110)30-26-44/h5-8,15-18,23-30,41-42,51-52,55-64,97-98,109-110H,3-4,9-14,19-22,31-40,81-82H2,1-2H3,(H2,83,111)(H2,84,112)(H,99,117)(H,100,118)(H,101,115)(H,102,116)(H,103,121)(H,104,122)(H,105,119)(H,106,120)(H,107,113)(H,108,114)(H4,85,86,93)(H4,87,88,94)(H4,89,90,95)(H4,91,92,96)/t51-,52-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-/m0/s1 D0V0HM DRUGINKE TWBRLXCGQXCXSU-HCHGDIHTSA-N D0V0HM DRUGSMIL CCCC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)N)N)N D0V0HM HIGHSTAT Investigative D0V0RO DRUG__ID D0V0RO D0V0RO DRUGINCH 1S/C69H99N21O19S2/c1-8-33(4)55(80-36(7)92)68(109)88-50-30-111-110-29-49(66(107)90-56(35(6)91)57(71)98)87-60(101)43(14-11-21-75-69(72)73)81-63(104)47(24-39-27-74-31-78-39)83-58(99)34(5)79-52(95)28-77-59(100)46(23-38-26-76-42-13-10-9-12-41(38)42)84-64(105)48(25-53(96)97)85-61(102)44(19-20-51(70)94)82-62(103)45(22-37-15-17-40(93)18-16-37)86-67(108)54(32(2)3)89-65(50)106/h9-10,12-13,15-18,26-27,31-35,43-50,54-56,76,91,93H,8,11,14,19-25,28-30H2,1-7H3,(H2,70,94)(H2,71,98)(H,74,78)(H,77,100)(H,79,95)(H,80,92)(H,81,104)(H,82,103)(H,83,99)(H,84,105)(H,85,102)(H,86,108)(H,87,101)(H,88,109)(H,89,106)(H,90,107)(H,96,97)(H4,72,73,75)/t33-,34-,35+,43-,44-,45+,46-,47+,48+,49-,50-,54-,55-,56-/m0/s1 D0V0RO DRUGINKE PQVLDHFPSLWLQN-VEMXNSRSSA-N D0V0RO DRUGSMIL CCC(C)C(C(=O)NC1CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)CC2=CC=C(C=C2)O)CCC(=O)N)CC(=O)O)CC3=CNC4=CC=CC=C43)C)CC5=CNC=N5)CCCN=C(N)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C D0V0RO HIGHSTAT Investigative D0V3FF DRUG__ID D0V3FF D0V3FF DRUGINCH 1S/C46H65N11O11S2/c1-26(2)20-31-41(63)55-34(23-37(48)59)44(66)56-35(46(68)57-18-7-11-36(57)45(67)52-30(10-6-17-47)40(62)50-24-38(49)60)25-70-69-19-16-39(61)51-32(22-28-12-14-29(58)15-13-28)42(64)54-33(43(65)53-31)21-27-8-4-3-5-9-27/h3-5,8-9,12-15,26,30-36,58H,6-7,10-11,16-25,47H2,1-2H3,(H2,48,59)(H2,49,60)(H,50,62)(H,51,61)(H,52,67)(H,53,65)(H,54,64)(H,55,63)(H,56,66)/t30-,31-,32-,33-,34-,35-,36-/m0/s1 D0V3FF DRUGINKE FVVIZMMVAAKOOP-QJCLFNHPSA-N D0V3FF DRUGSMIL CC(C)CC1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCN)C(=O)NCC(=O)N)CC(=O)N D0V3FF HIGHSTAT Investigative D0V3TE DRUG__ID D0V3TE D0V3TE DRUGINCH 1S/C49H88N30O12/c50-34-30-35(71-21-70-34)79(22-72-30)42-32(82)31(81)33(91-42)41(88)63-20-13-29(80)73-23(7-1-14-64-44(51)52)36(83)74-24(8-2-15-65-45(53)54)37(84)75-25(9-3-16-66-46(55)56)38(85)76-26(10-4-17-67-47(57)58)39(86)77-27(11-5-18-68-48(59)60)40(87)78-28(43(89)90)12-6-19-69-49(61)62/h21-28,31-33,42,81-82H,1-20H2,(H,63,88)(H,73,80)(H,74,83)(H,75,84)(H,76,85)(H,77,86)(H,78,87)(H,89,90)(H2,50,70,71)(H4,51,52,64)(H4,53,54,65)(H4,55,56,66)(H4,57,58,67)(H4,59,60,68)(H4,61,62,69)/t23-,24-,25-,26-,27-,28-,31+,32-,33+,42?/m1/s1 D0V3TE DRUGINKE SKHJPFQNPQEHHQ-VOMWTDLXSA-N D0V3TE DRUGSMIL C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)C(=O)NCCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)O)O)N D0V3TE HIGHSTAT Investigative D0V3XU DRUG__ID D0V3XU D0V3XU DRUGINCH 1S/C10H13ClN2/c11-10-8-12-6-7-13(10)9-4-2-1-3-5-9/h1-5,10,12H,6-8H2 D0V3XU DRUGINKE JQQKTEXFNXKDIQ-UHFFFAOYSA-N D0V3XU DRUGSMIL C1CN(C(CN1)Cl)C2=CC=CC=C2 D0V3XU HIGHSTAT Investigative D0V4HB DRUG__ID D0V4HB D0V4HB DRUGINCH 1S/C48H87N15O9/c1-5-31(4)41(45(69)61-38(47(71)72)24-30(2)3)62-43(67)37(25-32-13-15-35(64)16-14-32)60-44(68)39-12-9-23-63(39)46(70)36(11-8-20-56-48(52)53)57-28-34(10-6-7-17-49)59-40(65)29-58-42(66)33(26-54-21-18-50)27-55-22-19-51/h13-16,30-31,33-34,36-39,41,54-55,57,64H,5-12,17-29,49-51H2,1-4H3,(H,58,66)(H,59,65)(H,60,68)(H,61,69)(H,62,67)(H,71,72)(H4,52,53,56)/t31-,34?,36-,37-,38-,39-,41-/m0/s1 D0V4HB DRUGINKE DMDCNLGMRLTMHD-PLXGHWBHSA-N D0V4HB DRUGSMIL CCC(C)C(C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NCC(CCCCN)NC(=O)CNC(=O)C(CNCCN)CNCCN D0V4HB HIGHSTAT Investigative D0V5YQ DRUG__ID D0V5YQ D0V5YQ THERCLAS Antisense D0V5YQ DRUGTYPE Combination drug (Antisense drug) D0V5YQ DRUGSMIL CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O D0V5YQ HIGHSTAT Investigative D0V6HE DRUG__ID D0V6HE D0V6HE DRUGINCH 1S/C73H130N28O19/c1-39(2)33-52(67(116)91-41(4)59(108)95-50(26-18-32-86-73(82)83)64(113)98-51(70(119)120)23-12-15-29-76)99-65(114)46(21-10-13-27-74)96-63(112)49(25-17-31-85-72(80)81)94-60(109)42(5)92-68(117)53(38-102)100-66(115)47(22-11-14-28-75)97-62(111)48(24-16-30-84-71(78)79)93-58(107)40(3)90-55(105)37-89-69(118)57(43(6)103)101-56(106)36-87-54(104)35-88-61(110)45(77)34-44-19-8-7-9-20-44/h7-9,19-20,39-43,45-53,57,102-103H,10-18,21-38,74-77H2,1-6H3,(H,87,104)(H,88,110)(H,89,118)(H,90,105)(H,91,116)(H,92,117)(H,93,107)(H,94,109)(H,95,108)(H,96,112)(H,97,111)(H,98,113)(H,99,114)(H,100,115)(H,101,106)(H,119,120)(H4,78,79,84)(H4,80,81,85)(H4,82,83,86)/t40-,41-,42-,43+,45-,46-,47-,48-,49-,50-,51-,52-,53-,57-/m0/s1 D0V6HE DRUGINKE UNHQLKTVYYARAV-VKORATPISA-N D0V6HE DRUGSMIL CC(C)CC(C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)CNC(=O)CNC(=O)C(CC1=CC=CC=C1)N D0V6HE HIGHSTAT Investigative D0V6KF DRUG__ID D0V6KF D0V6KF DRUGINCH 1S/C55H75N17O13/c1-29(2)19-38(49(80)67-37(9-5-17-60-55(57)58)54(85)72-18-6-10-43(72)53(84)62-25-44(56)75)66-46(77)26-63-47(78)39(20-30-11-13-33(74)14-12-30)68-52(83)42(27-73)71-50(81)40(21-31-23-61-35-8-4-3-7-34(31)35)69-51(82)41(22-32-24-59-28-64-32)70-48(79)36-15-16-45(76)65-36/h3-4,7-8,11-14,23-24,28-29,36-43,61,73-74H,5-6,9-10,15-22,25-27H2,1-2H3,(H2,56,75)(H,59,64)(H,62,84)(H,63,78)(H,65,76)(H,66,77)(H,67,80)(H,68,83)(H,69,82)(H,70,79)(H,71,81)(H4,57,58,60) D0V6KF DRUGINKE XLXSAKCOAKORKW-UHFFFAOYSA-N D0V6KF DRUGSMIL CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6 D0V6KF HIGHSTAT Investigative D0V7CD DRUG__ID D0V7CD D0V7CD DRUGINCH 1S/C42H67N13O18S/c1-18(2)33(54-37(67)25(16-56)47-19(3)57)40(70)50-22(7-11-29(44)59)41(71)55-14-4-5-27(55)39(69)53-26(17-74)38(68)49-20(6-10-28(43)58)34(64)48-21(9-13-32(62)63)35(65)52-24(15-31(46)61)36(66)51-23(42(72)73)8-12-30(45)60/h18,20-27,33,56,74H,4-17H2,1-3H3,(H2,43,58)(H2,44,59)(H2,45,60)(H2,46,61)(H,47,57)(H,48,64)(H,49,68)(H,50,70)(H,51,66)(H,52,65)(H,53,69)(H,54,67)(H,62,63)(H,72,73)/t20-,21-,22-,23-,24-,25-,26-,27-,33-/m0/s1 D0V7CD DRUGINKE GLSOSIFUCZBHCX-AYPRZOFJSA-N D0V7CD DRUGSMIL CC(C)C(C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NC(CS)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C D0V7CD HIGHSTAT Investigative D0V7UG DRUG__ID D0V7UG D0V7UG DRUGINCH 1S/C103H171N23O22/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-42-86(132)109-50-33-29-40-75(93(138)116-73(90(108)135)37-26-30-47-104)118-94(139)74(38-27-31-48-105)117-95(140)76(39-28-32-49-106)119-102(147)84-41-34-51-126(84)88(134)60-112-92(137)77(52-62(2)3)120-96(141)78(53-63(4)5)121-98(143)80(55-68-43-45-70(130)46-44-68)115-87(133)59-111-91(136)65(8)113-101(146)83(61-127)124-99(144)82(57-85(107)131)122-97(142)79(54-64(6)7)123-103(148)89(66(9)128)125-100(145)81(114-67(10)129)56-69-58-110-72-36-25-24-35-71(69)72/h24-25,35-36,43-46,58,62-66,73-84,89,110,127-128,130H,11-23,26-34,37-42,47-57,59-61,104-106H2,1-10H3,(H2,107,131)(H2,108,135)(H,109,132)(H,111,136)(H,112,137)(H,113,146)(H,114,129)(H,115,133)(H,116,138)(H,117,140)(H,118,139)(H,119,147)(H,120,141)(H,121,143)(H,122,142)(H,123,148)(H,124,144)(H,125,145)/t65-,66+,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,89-/m0/s1 D0V7UG DRUGINKE ODFVMHJVAFRRKO-QWBMYOKVSA-N D0V7UG DRUGSMIL CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C D0V7UG HIGHSTAT Investigative D0V9BB DRUG__ID D0V9BB D0V9BB DRUGINCH 1S/C155H230N44O48S/c1-74(2)55-100(137(231)180-98(50-54-248-12)135(229)188-107(63-117(160)212)146(240)198-123(78(8)204)126(161)220)183-141(235)106(61-85-66-170-90-30-20-19-29-89(85)90)187-133(227)96(44-48-116(159)211)181-151(245)122(76(5)6)197-144(238)104(57-81-25-15-13-16-26-81)186-142(236)108(64-120(216)217)189-132(226)95(43-47-115(158)210)174-127(221)77(7)173-129(223)92(32-23-52-168-154(162)163)175-130(224)93(33-24-53-169-155(164)165)177-148(242)112(71-202)194-143(237)109(65-121(218)219)190-138(232)101(56-75(3)4)182-139(233)102(59-83-34-38-87(207)39-35-83)184-131(225)91(31-21-22-51-156)176-147(241)111(70-201)193-140(234)103(60-84-36-40-88(208)41-37-84)185-134(228)97(45-49-119(214)215)179-150(244)113(72-203)195-153(247)125(80(10)206)199-145(239)105(58-82-27-17-14-18-28-82)191-152(246)124(79(9)205)196-118(213)68-171-128(222)94(42-46-114(157)209)178-149(243)110(69-200)192-136(230)99(166-11)62-86-67-167-73-172-86/h13-20,25-30,34-41,66-67,73-80,91-113,122-125,166,170,200-208H,21-24,31-33,42-65,68-72,156H2,1-12H3,(H2,157,209)(H2,158,210)(H2,159,211)(H2,160,212)(H2,161,220)(H,167,172)(H,171,222)(H,173,223)(H,174,221)(H,175,224)(H,176,241)(H,177,242)(H,178,243)(H,179,244)(H,180,231)(H,181,245)(H,182,233)(H,183,235)(H,184,225)(H,185,228)(H,186,236)(H,187,227)(H,188,229)(H,189,226)(H,190,232)(H,191,246)(H,192,230)(H,193,234)(H,194,237)(H,195,247)(H,196,213)(H,197,238)(H,198,240)(H,199,239)(H,214,215)(H,216,217)(H,218,219)(H4,162,163,168)(H4,164,165,169)/t77-,78+,79+,80+,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,122-,123-,124-,125-/m0/s1 D0V9BB DRUGINKE QAFHHWFRTULWIL-OQZBCNBHSA-N D0V9BB DRUGSMIL CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)N)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)NC D0V9BB HIGHSTAT Investigative D0V9DY DRUG__ID D0V9DY D0V9DY DRUGINCH 1S/C53H65N11O11/c1-3-4-18-41(60-51(73)44(29-46(67)68)61-49(71)39(55)24-32-13-7-5-8-14-32)50(72)62-43(28-36-27-35-17-11-12-19-40(35)58-36)53(75)64-63-52(74)42(26-33-15-9-6-10-16-33)59-45(66)30-56-47(69)31(2)57-48(70)38(54)25-34-20-22-37(65)23-21-34/h5-17,19-23,27,31,38-39,41-44,58,65H,3-4,18,24-26,28-30,54-55H2,1-2H3,(H,56,69)(H,57,70)(H,59,66)(H,60,73)(H,61,71)(H,62,72)(H,63,74)(H,64,75)(H,67,68)/t31-,38+,39+,41+,42+,43-,44+/m1/s1 D0V9DY DRUGINKE KYWMQIRORZGHDH-QOIWPSRPSA-N D0V9DY DRUGSMIL CCCCC(C(=O)NC(CC1=CC2=CC=CC=C2N1)C(=O)NNC(=O)C(CC3=CC=CC=C3)NC(=O)CNC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC5=CC=CC=C5)N D0V9DY HIGHSTAT Investigative D0VH3M DRUG__ID D0VH3M D0VH3M DRUGINCH 1S/C62H100N22O14S2/c1-34(51(89)79-42(22-14-26-71-61(67)68)54(92)78-40(50(66)88)20-10-12-24-63)75-58(96)45-32-99-100-33-46(59(97)76-35(2)52(90)80-43(23-15-27-72-62(69)70)55(93)81-41(56(94)82-45)21-11-13-25-64)83-60(98)49(36(3)85)84-57(95)44(29-38-18-8-5-9-19-38)77-48(87)31-73-47(86)30-74-53(91)39(65)28-37-16-6-4-7-17-37/h4-9,16-19,34-36,39-46,49,85H,10-15,20-33,63-65H2,1-3H3,(H2,66,88)(H,73,86)(H,74,91)(H,75,96)(H,76,97)(H,77,87)(H,78,92)(H,79,89)(H,80,90)(H,81,93)(H,82,94)(H,83,98)(H,84,95)(H4,67,68,71)(H4,69,70,72)/t34-,35-,36+,39-,40-,41-,42-,43-,44-,45-,46-,49-/m0/s1 D0VH3M DRUGINKE YCXQOGDEHMJXPM-JOEKKRFNSA-N D0VH3M DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=CC=C3)N)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)CCCCN)CCCN=C(N)N D0VH3M HIGHSTAT Investigative D0VI7P DRUG__ID D0VI7P D0VI7P DRUGINCH 1S/C49H74N9O12P/c1-8-33(6)44(48(64)51-29-36-18-12-13-22-58(36)66)55-45(61)37(32(4)5)27-42(59)38(24-31(2)3)53-47(63)41(26-35-28-50-30-52-35)56(7)49(65)39(25-34-16-10-9-11-17-34)54-46(62)40-19-14-21-57(40)43(60)20-15-23-70-71(67,68)69/h9-13,16-18,22,28,30-33,37-42,44,59H,8,14-15,19-21,23-27,29H2,1-7H3,(H,50,52)(H,51,64)(H,53,63)(H,54,62)(H,55,61)(H2,67,68,69) D0VI7P DRUGINKE KFCDLRKAUPBHBD-UHFFFAOYSA-N D0VI7P DRUGSMIL CCC(C)C(C(=O)NCC1=CC=CC=[N+]1[O-])NC(=O)C(CC(C(CC(C)C)NC(=O)C(CC2=CN=CN2)N(C)C(=O)C(CC3=CC=CC=C3)NC(=O)C4CCCN4C(=O)CCCOP(=O)(O)O)O)C(C)C D0VI7P HIGHSTAT Investigative D0VN0H DRUG__ID D0VN0H D0VN0H DRUGINCH 1S/C59H87N11O17S/c1-9-10-15-38(51(79)66-43(28-71)55(83)64-41(50(60)78)25-34-16-18-37(73)19-17-34)63-56(84)45-26-35-13-11-12-14-36(35)27-70(45)59(87)44(29-88)67-54(82)42(24-30(2)3)65-57(85)48(31(4)5)69-58(86)49(32(6)7)68-53(81)40(21-23-47(76)77)62-52(80)39(61-33(8)72)20-22-46(74)75/h11-14,16-19,30-32,38-45,48-49,71,73,88H,9-10,15,20-29H2,1-8H3,(H2,60,78)(H,61,72)(H,62,80)(H,63,84)(H,64,83)(H,65,85)(H,66,79)(H,67,82)(H,68,81)(H,69,86)(H,74,75)(H,76,77)/t38-,39-,40-,41-,42-,43-,44-,45+,48-,49-/m0/s1 D0VN0H DRUGINKE HGLKSJLIZCXTFK-SEAKOTFTSA-N D0VN0H DRUGSMIL CCCCC(C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C2CC3=CC=CC=C3CN2C(=O)C(CS)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C D0VN0H HIGHSTAT Investigative D0VO7C DRUG__ID D0VO7C D0VO7C DRUGINCH 1S/C63H104N22O12/c1-5-37(4)51(59(96)82-45(20-13-29-75-63(71)72)60(97)85-30-14-21-48(85)58(95)79-42(52(66)89)17-9-10-26-64)84-55(92)44(19-12-28-74-62(69)70)80-54(91)43(18-11-27-73-61(67)68)81-56(93)46(31-36(2)3)83-57(94)47(33-38-15-7-6-8-16-38)78-50(88)35-76-49(87)34-77-53(90)41(65)32-39-22-24-40(86)25-23-39/h6-8,15-16,22-25,36-37,41-48,51,86H,5,9-14,17-21,26-35,64-65H2,1-4H3,(H2,66,89)(H,76,87)(H,77,90)(H,78,88)(H,79,95)(H,80,91)(H,81,93)(H,82,96)(H,83,94)(H,84,92)(H4,67,68,73)(H4,69,70,74)(H4,71,72,75)/t37-,41-,42-,43-,44-,45-,46-,47-,48-,51-/m0/s1 D0VO7C DRUGINKE OKJAOUBQLSWUNX-QFIUEGLPSA-N D0VO7C DRUGSMIL CCC(C)C(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)CNC(=O)CNC(=O)C(CC3=CC=C(C=C3)O)N D0VO7C HIGHSTAT Investigative D0W0AF DRUG__ID D0W0AF D0W0AF DRUGINCH 1S/C75H98N14O15S2/c1-43(2)78-38-50-30-28-49(29-31-50)36-62-71(99)88-64(45(4)92)72(100)83-58(35-48-23-13-8-14-24-48)69(97)87-63(44(3)91)73(101)85-60(40-90)70(98)86-61(75(103)104)42-106-105-41-53(77)65(93)80-55(27-17-18-32-76)66(94)81-56(33-46-19-9-6-10-20-46)67(95)82-57(34-47-21-11-7-12-22-47)68(96)84-59(74(102)89(62)5)37-51-39-79-54-26-16-15-25-52(51)54/h6-16,19-26,28-31,39,43-45,53,55-64,78-79,90-92H,17-18,27,32-38,40-42,76-77H2,1-5H3,(H,80,93)(H,81,94)(H,82,95)(H,83,100)(H,84,96)(H,85,101)(H,86,98)(H,87,97)(H,88,99)(H,103,104)/t44-,45-,53-,55-,56-,57+,58+,59+,60+,61+,62+,63-,64-/m1/s1 D0W0AF DRUGINKE SRQXVUQUEBDWHI-YNBIXHCXSA-N D0W0AF DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C(C)O)CC7=CC=CC=C7)C(C)O D0W0AF HIGHSTAT Investigative D0W1BY DRUG__ID D0W1BY D0W1BY DRUGINCH 1S/C53H76N14O10/c1-28(2)19-39(46(56)70)64-51(75)40(20-29(3)4)65-52(76)42(23-34-25-57-27-60-34)62-44(69)26-59-53(77)45(30(5)6)67-47(71)31(7)61-50(74)41(22-33-24-58-37-16-12-11-15-35(33)37)66-49(73)38(17-18-43(55)68)63-48(72)36(54)21-32-13-9-8-10-14-32/h8-16,24-25,27-31,36,38-42,45,58H,17-23,26,54H2,1-7H3,(H2,55,68)(H2,56,70)(H,57,60)(H,59,77)(H,61,74)(H,62,69)(H,63,72)(H,64,75)(H,65,76)(H,66,73)(H,67,71)/t31-,36-,38-,39-,40-,41-,42-,45-/m0/s1 D0W1BY DRUGINKE HLAREJIMNCKKSS-CENAJWRVSA-N D0W1BY DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=CC=C4)N D0W1BY HIGHSTAT Investigative D0W2EI DRUG__ID D0W2EI D0W2EI DRUGINCH 1S/C150H225N41O45/c1-16-77(10)121(147(234)169-80(13)126(213)177-104(59-86-62-160-91-35-24-23-34-89(86)91)137(224)179-100(55-74(4)5)138(225)188-119(75(6)7)145(232)176-93(36-25-27-51-151)129(216)163-66-113(202)170-92(38-29-53-159-150(155)156)128(215)161-64-110(154)199)190-139(226)102(56-83-30-19-17-20-31-83)180-134(221)98(46-50-117(207)208)175-133(220)94-37-26-28-52-158-111(200)48-44-96(131(218)164-67-114(203)172-97(43-47-109(153)198)132(219)168-78(11)124(211)167-79(12)125(212)173-94)174-135(222)99(54-73(2)3)178-136(223)101(58-85-39-41-88(197)42-40-85)181-142(229)106(69-192)184-144(231)108(71-194)185-146(233)120(76(8)9)189-141(228)105(61-118(209)210)182-143(230)107(70-193)186-149(236)123(82(15)196)191-140(227)103(57-84-32-21-18-22-33-84)183-148(235)122(81(14)195)187-115(204)68-165-130(217)95(45-49-116(205)206)171-112(201)65-162-127(214)90(152)60-87-63-157-72-166-87/h17-24,30-35,39-42,62-63,72-82,90,92-108,119-123,160,192-197H,16,25-29,36-38,43-61,64-71,151-152H2,1-15H3,(H2,153,198)(H2,154,199)(H,157,166)(H,158,200)(H,161,215)(H,162,214)(H,163,216)(H,164,218)(H,165,217)(H,167,211)(H,168,219)(H,169,234)(H,170,202)(H,171,201)(H,172,203)(H,173,212)(H,174,222)(H,175,220)(H,176,232)(H,177,213)(H,178,223)(H,179,224)(H,180,221)(H,181,229)(H,182,230)(H,183,235)(H,184,231)(H,185,233)(H,186,236)(H,187,204)(H,188,225)(H,189,228)(H,190,226)(H,191,227)(H,205,206)(H,207,208)(H,209,210)(H4,155,156,159)/t77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,119-,120-,121-,122-,123-/m0/s1 D0W2EI DRUGINKE YLHNVPBGRUSXJQ-RHBBJNDVSA-N D0W2EI DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C4CCCCNC(=O)CCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)C)C)CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N D0W2EI HIGHSTAT Investigative D0W2EP DRUG__ID D0W2EP D0W2EP DRUGINCH 1S/C52H74N12O9/c1-5-6-19-44(65)41(23-31(2)3)62-51(72)43(26-35-28-55-30-57-35)59-46(67)29-64-22-13-12-18-40(52(64)73)61-47(68)32(4)58-50(71)42(25-34-27-56-38-17-11-10-16-36(34)38)63-49(70)39(20-21-45(54)66)60-48(69)37(53)24-33-14-8-7-9-15-33/h7-11,14-17,27-28,30-32,37,39-44,56,65H,5-6,12-13,18-26,29,53H2,1-4H3,(H2,54,66)(H,55,57)(H,58,71)(H,59,67)(H,60,69)(H,61,68)(H,62,72)(H,63,70)/t32?,37-,39?,40?,41-,42?,43?,44?/m1/s1 D0W2EP DRUGINKE FJZSPPBJQIVSSX-SCVQECHTSA-N D0W2EP DRUGSMIL CCCCC(C(CC(C)C)NC(=O)C(CC1=CN=CN1)NC(=O)CN2CCCCC(C2=O)NC(=O)C(C)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CCC(=O)N)NC(=O)C(CC5=CC=CC=C5)N)O D0W2EP HIGHSTAT Investigative D0W3IQ DRUG__ID D0W3IQ D0W3IQ DRUGINCH 1S/C46H65N13O11S2/c1-25(2)38-44(69)56-32(22-35(47)61)41(66)57-33(45(70)59-18-7-11-34(59)43(68)54-29(10-6-17-51-46(49)50)39(64)52-23-36(48)62)24-72-71-19-16-37(63)53-30(21-27-12-14-28(60)15-13-27)40(65)55-31(42(67)58-38)20-26-8-4-3-5-9-26/h3-5,8-9,12-15,25,29-34,38,60H,6-7,10-11,16-24H2,1-2H3,(H2,47,61)(H2,48,62)(H,52,64)(H,53,63)(H,54,68)(H,55,65)(H,56,69)(H,57,66)(H,58,67)(H4,49,50,51)/t29-,30-,31-,32-,33-,34-,38-/m0/s1 D0W3IQ DRUGINKE KEBRFHAVFOSSOX-CDKUOFBKSA-N D0W3IQ DRUGSMIL CC(C)C1C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)NC(C(=O)N1)CC2=CC=CC=C2)CC3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N D0W3IQ HIGHSTAT Investigative D0W3RR DRUG__ID D0W3RR D0W3RR DRUGINCH 1S/C21H17NO3/c23-19-15-20(22-11-13-24-14-12-22)25-21-17(7-4-8-18(19)21)10-9-16-5-2-1-3-6-16/h1-8,15H,11-14H2 D0W3RR DRUGINKE FVCZHPDXMMYSDW-UHFFFAOYSA-N D0W3RR DRUGSMIL C1COCCN1C2=CC(=O)C3=CC=CC(=C3O2)C#CC4=CC=CC=C4 D0W3RR HIGHSTAT Investigative D0W5JT DRUG__ID D0W5JT D0W5JT DRUGINCH 1S/C76H100ClN15O15S/c1-42(2)80-34-12-11-16-58(76(107)92-35-13-17-64(92)73(105)81-44(5)66(79)98)86-74(106)75(108-43(3)4)91-71(103)62(39-50-23-30-56(31-24-50)83-46(7)95)88-70(102)61(38-49-21-28-55(29-22-49)82-45(6)94)89-72(104)63(41-93)90-67(99)57(32-33-65(78)97)85-69(101)60(37-48-19-26-54(77)27-20-48)87-68(100)59(84-47(8)96)40-51-18-25-52-14-9-10-15-53(52)36-51/h9-10,14-15,18-31,36,42-44,57-64,75,80,93H,11-13,16-17,32-35,37-41H2,1-8H3,(H2,78,97)(H2,79,98)(H,81,105)(H,82,94)(H,83,95)(H,84,96)(H,85,101)(H,86,106)(H,87,100)(H,88,102)(H,89,104)(H,90,99)(H,91,103)/t44-,57-,58+,59-,60-,61+,62-,63+,64+,75+/m1/s1 D0W5JT DRUGINKE JPMOBCPTBLZEAW-RKSVTEAUSA-N D0W5JT DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)SC(C)C D0W5JT HIGHSTAT Investigative D0W7LW DRUG__ID D0W7LW D0W7LW DRUGINCH 1S/C57H78N14O11S2/c1-32(36-21-20-35-14-7-8-15-37(35)28-36)46-54(81)64-29-45(74)65-43(30-72)52(79)68-42(27-33-12-5-4-6-13-33)51(78)69-44(53(80)67-41(16-9-10-24-58)50(77)66-40(48(60)75)17-11-25-63-56(61)62)31-83-84-57(2,3)47(55(82)70-46)71-49(76)39(59)26-34-18-22-38(73)23-19-34/h4-8,12-15,18-23,28,32,39-44,46-47,72-73H,9-11,16-17,24-27,29-31,58-59H2,1-3H3,(H2,60,75)(H,64,81)(H,65,74)(H,66,77)(H,67,80)(H,68,79)(H,69,78)(H,70,82)(H,71,76)(H4,61,62,63)/t32-,39+,40+,41+,42-,43+,44-,46+,47+/m1/s1 D0W7LW DRUGINKE HWTDVIKHJPOWJP-DRSDNMEYSA-N D0W7LW DRUGSMIL CC(C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSC(C(C(=O)N1)NC(=O)C(CC2=CC=C(C=C2)O)N)(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)N)CC3=CC=CC=C3)CO)C4=CC5=CC=CC=C5C=C4 D0W7LW HIGHSTAT Investigative D0W8BP DRUG__ID D0W8BP D0W8BP DRUGINCH 1S/C151H225N41O46/c1-16-77(10)121(148(236)170-80(13)126(214)178-104(59-87-62-161-91-35-24-23-34-89(87)91)138(226)180-100(55-74(4)5)139(227)189-119(75(6)7)146(234)177-93(36-25-27-51-152)130(218)164-66-112(201)171-92(38-29-53-160-151(156)157)129(217)162-64-110(155)199)191-140(228)102(56-83-30-19-17-20-31-83)181-135(223)98(46-50-117(208)209)176-134(222)94-37-26-28-52-159-127(215)86-41-39-85(40-42-86)58-101(137(225)179-99(54-73(2)3)136(224)175-96(45-49-116(206)207)132(220)165-67-113(202)173-97(43-47-109(154)198)133(221)169-78(11)124(212)168-79(12)125(213)174-94)182-143(231)106(69-193)185-145(233)108(71-195)186-147(235)120(76(8)9)190-142(230)105(61-118(210)211)183-144(232)107(70-194)187-150(238)123(82(15)197)192-141(229)103(57-84-32-21-18-22-33-84)184-149(237)122(81(14)196)188-114(203)68-166-131(219)95(44-48-115(204)205)172-111(200)65-163-128(216)90(153)60-88-63-158-72-167-88/h17-24,30-35,39-42,62-63,72-82,90,92-108,119-123,161,193-197H,16,25-29,36-38,43-61,64-71,152-153H2,1-15H3,(H2,154,198)(H2,155,199)(H,158,167)(H,159,215)(H,162,217)(H,163,216)(H,164,218)(H,165,220)(H,166,219)(H,168,212)(H,169,221)(H,170,236)(H,171,201)(H,172,200)(H,173,202)(H,174,213)(H,175,224)(H,176,222)(H,177,234)(H,178,214)(H,179,225)(H,180,226)(H,181,223)(H,182,231)(H,183,232)(H,184,237)(H,185,233)(H,186,235)(H,187,238)(H,188,203)(H,189,227)(H,190,230)(H,191,228)(H,192,229)(H,204,205)(H,206,207)(H,208,209)(H,210,211)(H4,156,157,160)/t77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,119-,120-,121-,122-,123-/m0/s1 D0W8BP DRUGINKE NBZJWICSDFBTTN-RHBBJNDVSA-N D0W8BP DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C4CCCCNC(=O)C5=CC=C(CC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4)C)C)CCC(=O)N)CCC(=O)O)CC(C)C)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC7=CN=CN7)N)C=C5 D0W8BP HIGHSTAT Investigative D0W8ZE DRUG__ID D0W8ZE D0W8ZE THERCLAS Antisense D0W8ZE DRUGTYPE Combination drug (Antisense drug) D0W8ZE DRUGSMIL failed D0W8ZE HIGHSTAT Investigative D0WF2C DRUG__ID D0WF2C D0WF2C DRUGINCH 1S/C138H206N38O59S/c1-8-68(4)113(135(231)176-41-15-20-95(176)133(229)168-76(32-37-110(204)205)125(221)165-75(31-36-109(202)203)126(222)171-82(44-70-21-25-72(187)26-22-70)130(226)170-80(42-67(2)3)128(224)169-79(136(232)233)29-34-96(139)188)173-127(223)77(33-38-111(206)207)166-124(220)74(30-35-108(200)201)167-129(225)81(43-69-16-10-9-11-17-69)172-131(227)83(45-112(208)209)154-97(189)46-143-114(210)84(57-177)155-98(190)47-144-115(211)85(58-178)156-99(191)48-145-116(212)86(59-179)157-100(192)49-146-117(213)87(60-180)158-101(193)50-147-118(214)88(61-181)159-102(194)51-148-119(215)89(62-182)160-103(195)52-149-120(216)90(63-183)161-104(196)53-150-121(217)91(64-184)162-105(197)54-151-122(218)92(65-185)163-106(198)55-152-123(219)93(66-186)164-107(199)56-153-132(228)94-19-12-13-40-175(94)134(230)78(18-14-39-142-137(140)141)174-236(234,235)73-27-23-71(24-28-73)138(5,6)7/h9-11,16-17,21-28,67-68,74-95,113,174,177-187H,8,12-15,18-20,29-66H2,1-7H3,(H2,139,188)(H,143,210)(H,144,211)(H,145,212)(H,146,213)(H,147,214)(H,148,215)(H,149,216)(H,150,217)(H,151,218)(H,152,219)(H,153,228)(H,154,189)(H,155,190)(H,156,191)(H,157,192)(H,158,193)(H,159,194)(H,160,195)(H,161,196)(H,162,197)(H,163,198)(H,164,199)(H,165,221)(H,166,220)(H,167,225)(H,168,229)(H,169,224)(H,170,226)(H,171,222)(H,172,227)(H,173,223)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H,208,209)(H,232,233)(H4,140,141,142)/t68-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94?,95-,113-/m0/s1 D0WF2C DRUGINKE UFWRMLMUWLGVGM-PIMIKREUSA-N D0WF2C DRUGSMIL CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C4CCCCN4C(=O)C(CCCN=C(N)N)NS(=O)(=O)C5=CC=C(C=C5)C(C)(C)C D0WF2C HIGHSTAT Investigative D0WG8L DRUG__ID D0WG8L D0WG8L DRUGINCH 1S/C76H100ClN15O16S/c1-42(2)80-34-12-11-16-58(76(107)92-35-13-17-64(92)73(105)81-44(5)66(79)98)86-74(106)75(109(108)43(3)4)91-71(103)62(39-50-23-30-56(31-24-50)83-46(7)95)88-70(102)61(38-49-21-28-55(29-22-49)82-45(6)94)89-72(104)63(41-93)90-67(99)57(32-33-65(78)97)85-69(101)60(37-48-19-26-54(77)27-20-48)87-68(100)59(84-47(8)96)40-51-18-25-52-14-9-10-15-53(52)36-51/h9-10,14-15,18-31,36,42-44,57-64,75,80,93H,11-13,16-17,32-35,37-41H2,1-8H3,(H2,78,97)(H2,79,98)(H,81,105)(H,82,94)(H,83,95)(H,84,96)(H,85,101)(H,86,106)(H,87,100)(H,88,102)(H,89,104)(H,90,99)(H,91,103)/t44-,57-,58+,59-,60-,61+,62-,63+,64+,75-,109?/m1/s1 D0WG8L DRUGINKE KYASUQFVWOOHIK-JKWOHFGQSA-N D0WG8L DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)S(=O)C(C)C D0WG8L HIGHSTAT Investigative D0WG8P DRUG__ID D0WG8P D0WG8P DRUGINCH 1S/C60H78FN19O13S2/c1-31(81)72-43(22-33-12-16-37(82)17-13-33)54(89)73-41(9-5-21-69-60(65)66)52(87)80-48-29-95-94-28-47(50(62)85)79-56(91)45(24-34-26-70-39-7-3-2-6-38(34)39)77-51(86)40(8-4-20-68-59(63)64)74-55(90)44(23-32-10-14-35(61)15-11-32)76-57(92)46(25-36-27-67-30-71-36)78-53(88)42(75-58(48)93)18-19-49(83)84/h2-3,6-7,10-17,26-27,30,40-48,70,82H,4-5,8-9,18-25,28-29H2,1H3,(H2,62,85)(H,67,71)(H,72,81)(H,73,89)(H,74,90)(H,75,93)(H,76,92)(H,77,86)(H,78,88)(H,79,91)(H,80,87)(H,83,84)(H4,63,64,68)(H4,65,66,69)/t40-,41-,42+,43-,44-,45+,46-,47+,48+/m0/s1 D0WG8P DRUGINKE CHBTZNAADZTZLP-XVRHLUALSA-N D0WG8P DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=C(C=C4)F)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D0WG8P HIGHSTAT Investigative D0X1RZ DRUG__ID D0X1RZ D0X1RZ DRUGINCH 1S/C88H115ClN18O18/c1-8-124-39-40-125-38-36-93-87(122)97-64-32-25-57(26-33-64)44-69(80(115)99-66(41-51(2)3)78(113)98-65(18-11-12-35-92-52(4)5)86(121)107-37-14-19-74(107)85(120)94-53(6)76(90)111)101-82(117)70(45-56-23-30-63(31-24-56)96-77(112)72-48-75(110)106-88(123)105-72)103-84(119)73(50-108)104-83(118)71(47-59-15-13-34-91-49-59)102-81(116)68(43-55-21-28-62(89)29-22-55)100-79(114)67(95-54(7)109)46-58-20-27-60-16-9-10-17-61(60)42-58/h9-10,13,15-17,20-34,42,49,51-53,65-74,92,108H,8,11-12,14,18-19,35-41,43-48,50H2,1-7H3,(H2,90,111)(H,94,120)(H,95,109)(H,96,112)(H,98,113)(H,99,115)(H,100,114)(H,101,117)(H,102,116)(H,103,119)(H,104,118)(H2,93,97,122)(H2,105,106,110,123)/t53-,65+,66+,67-,68-,69-,70+,71-,72+,73+,74+/m1/s1 D0X1RZ DRUGINKE LXDBVFUKTKJYLL-UODKESISSA-N D0X1RZ DRUGSMIL CCOCCOCCNC(=O)NC1=CC=C(C=C1)CC(C(=O)NC(CC(C)C)C(=O)NC(CCCCNC(C)C)C(=O)N2CCCC2C(=O)NC(C)C(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C D0X1RZ HIGHSTAT Investigative D0X1YL DRUG__ID D0X1YL D0X1YL DRUGINCH 1S/C62H85N19O13S2/c1-34(82)73-45(26-36-17-19-39(83)20-18-36)56(90)74-43(16-10-24-70-62(66)67)54(88)81-50(32-96-3)60(94)76-44(21-22-51(84)85)55(89)79-48(28-38-30-68-33-72-38)59(93)77-46(25-35-11-5-4-6-12-35)57(91)75-42(15-9-23-69-61(64)65)53(87)78-47(58(92)80-49(31-95-2)52(63)86)27-37-29-71-41-14-8-7-13-40(37)41/h4-8,11-14,17-20,29-30,33,42-50,71,83H,9-10,15-16,21-28,31-32H2,1-3H3,(H2,63,86)(H,68,72)(H,73,82)(H,74,90)(H,75,91)(H,76,94)(H,77,93)(H,78,87)(H,79,89)(H,80,92)(H,81,88)(H,84,85)(H4,64,65,69)(H4,66,67,70)/t42-,43-,44-,45-,46+,47-,48-,49-,50-/m0/s1 D0X1YL DRUGINKE PWVUYOZSIWYFJW-MYBKRMQRSA-N D0X1YL DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CSC)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CN=CN2)C(=O)NC(CC3=CC=CC=C3)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CSC)C(=O)N D0X1YL HIGHSTAT Investigative D0X3RW DRUG__ID D0X3RW D0X3RW DRUGINCH 1S/C48H87N17O9/c1-29(2)23-36(45(73)74)63-43(71)39(48(3,4)5)64-41(69)35(24-30-12-14-33(66)15-13-30)62-42(70)37-11-8-22-65(37)44(72)34(10-7-19-58-47(53)54)59-27-32(9-6-18-57-46(51)52)61-38(67)28-60-40(68)31(25-55-20-16-49)26-56-21-17-50/h12-15,29,31-32,34-37,39,55-56,59,66H,6-11,16-28,49-50H2,1-5H3,(H,60,68)(H,61,67)(H,62,70)(H,63,71)(H,64,69)(H,73,74)(H4,51,52,57)(H4,53,54,58)/t32?,34-,35-,36-,37-,39+/m0/s1 D0X3RW DRUGINKE GDXILVHURHRHQL-DTKPYEPFSA-N D0X3RW DRUGSMIL CC(C)CC(C(=O)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C2CCCN2C(=O)C(CCCN=C(N)N)NCC(CCCN=C(N)N)NC(=O)CNC(=O)C(CNCCN)CNCCN D0X3RW HIGHSTAT Investigative D0X4IO DRUG__ID D0X4IO D0X4IO DRUGINCH 1S/C6H11NOS2/c1-10(8)5-3-2-4-7-6-9/h2-5H2,1H3 D0X4IO DRUGINKE SUVMJBTUFCVSAD-UHFFFAOYSA-N D0X4IO DRUGSMIL CS(=O)CCCCN=C=S D0X4IO HIGHSTAT Investigative D0X9MZ DRUG__ID D0X9MZ D0X9MZ DRUGINCH 1S/C59H72B2Cl2O10.4Na/c1-35(2)10-6-11-36(3)49-20-21-50-46-19-18-42-26-37(22-24-58(42,4)51(46)23-25-59(49,50)5)12-9-17-45(40-29-47(56(64)65)54(52(62)31-40)72-33-38-13-7-15-43(27-38)60(68)69)41-30-48(57(66)67)55(53(63)32-41)73-34-39-14-8-16-44(28-39)61(70)71;;;;/h7-8,13-17,27-32,35-37,42,46,49-51,68,70H,6,9-12,18-26,33-34H2,1-5H3,(H,64,65)(H,66,67);;;;/q-2;4*+1/p-2/t36?,37-,42?,46?,49+,50?,51?,58-,59+;;;;/m0..../s1 D0X9MZ DRUGINKE ABZNJZXRGKGMJC-MCUHGXDSSA-L D0X9MZ DRUGSMIL B(C1=CC(=CC=C1)COC2=C(C=C(C=C2Cl)C(=CCCC3CCC4(C(C3)CCC5C4CCC6(C5CCC6C(C)CCCC(C)C)C)C)C7=CC(=C(C(=C7)Cl)OCC8=CC=CC(=C8)B(O)[O-])C(=O)[O-])C(=O)[O-])(O)[O-].[Na+].[Na+].[Na+].[Na+] D0X9MZ HIGHSTAT Investigative D0X9SP DRUG__ID D0X9SP D0X9SP DRUGINCH 1S/C51H69N11O11S2/c1-27(63)40(43(54)66)60-50(73)42-51(3,4)75-74-26-39(59-44(67)34(53)22-29-12-6-5-7-13-29)48(71)57-37(23-30-17-19-32(65)20-18-30)46(69)58-38(24-31-25-55-35-15-9-8-14-33(31)35)47(70)56-36(16-10-11-21-52)45(68)61-41(28(2)64)49(72)62-42/h5-9,12-15,17-20,25,27-28,34,36-42,55,63-65H,10-11,16,21-24,26,52-53H2,1-4H3,(H2,54,66)(H,56,70)(H,57,71)(H,58,69)(H,59,67)(H,60,73)(H,61,68)(H,62,72)/t27-,28-,34-,36+,37+,38-,39+,40+,41-,42+/m1/s1 D0X9SP DRUGINKE VSEYLDNPHYTJMJ-MHKBYQEDSA-N D0X9SP DRUGSMIL CC(C1C(=O)NC(C(SSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)(C)C)C(=O)NC(C(C)O)C(=O)N)O D0X9SP HIGHSTAT Investigative D0XL0H DRUG__ID D0XL0H D0XL0H DRUGINCH 1S/C76H100ClN15O17S/c1-42(2)80-34-12-11-16-58(76(107)92-35-13-17-64(92)73(105)81-44(5)66(79)98)86-74(106)75(110(108,109)43(3)4)91-71(103)62(39-50-23-30-56(31-24-50)83-46(7)95)88-70(102)61(38-49-21-28-55(29-22-49)82-45(6)94)89-72(104)63(41-93)90-67(99)57(32-33-65(78)97)85-69(101)60(37-48-19-26-54(77)27-20-48)87-68(100)59(84-47(8)96)40-51-18-25-52-14-9-10-15-53(52)36-51/h9-10,14-15,18-31,36,42-44,57-64,75,80,93H,11-13,16-17,32-35,37-41H2,1-8H3,(H2,78,97)(H2,79,98)(H,81,105)(H,82,94)(H,83,95)(H,84,96)(H,85,101)(H,86,106)(H,87,100)(H,88,102)(H,89,104)(H,90,99)(H,91,103)/t44-,57-,58+,59-,60-,61+,62-,63+,64+,75-/m1/s1 D0XL0H DRUGINKE FVPKWKBSMZRQEW-YSZAJMORSA-N D0XL0H DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)S(=O)(=O)C(C)C D0XL0H HIGHSTAT Investigative D0XL7R DRUG__ID D0XL7R D0XL7R DRUGINCH 1S/C149H226N40O45/c1-17-76(10)119(146(232)167-80(14)126(212)175-104(60-86-63-159-91-36-25-24-35-89(86)91)136(222)177-100(56-73(4)5)137(223)186-117(74(6)7)144(230)174-93(37-26-28-52-150)128(214)160-65-110(197)168-92(122(154)208)39-30-54-158-149(155)156)188-138(224)102(57-83-31-20-18-21-32-83)178-133(219)98(47-51-115(204)205)173-132(218)94(38-27-29-53-151)170-124(210)78(12)164-123(209)77(11)166-131(217)97(44-48-109(153)196)169-111(198)66-161-130(216)96(46-50-114(202)203)172-134(220)99(55-72(2)3)176-135(221)101(59-85-40-42-88(195)43-41-85)179-141(227)106(68-190)182-143(229)108(70-192)183-145(231)118(75(8)9)187-140(226)105(62-116(206)207)180-142(228)107(69-191)184-148(234)121(82(16)194)189-139(225)103(58-84-33-22-19-23-34-84)181-147(233)120(81(15)193)185-112(199)67-162-129(215)95(45-49-113(200)201)171-125(211)79(13)165-127(213)90(152)61-87-64-157-71-163-87/h18-25,31-36,40-43,63-64,71-82,90,92-108,117-121,159,190-195H,17,26-30,37-39,44-62,65-70,150-152H2,1-16H3,(H2,153,196)(H2,154,208)(H,157,163)(H,160,214)(H,161,216)(H,162,215)(H,164,209)(H,165,213)(H,166,217)(H,167,232)(H,168,197)(H,169,198)(H,170,210)(H,171,211)(H,172,220)(H,173,218)(H,174,230)(H,175,212)(H,176,221)(H,177,222)(H,178,219)(H,179,227)(H,180,228)(H,181,233)(H,182,229)(H,183,231)(H,184,234)(H,185,199)(H,186,223)(H,187,226)(H,188,224)(H,189,225)(H,200,201)(H,202,203)(H,204,205)(H,206,207)(H4,155,156,158)/t76-,77-,78-,79-,80-,81+,82+,90-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,117-,118-,119-,120-,121-/m0/s1 D0XL7R DRUGINKE DTHNMHAUYICORS-KTKZVXAJSA-N D0XL7R DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N D0XL7R HIGHSTAT Investigative D0XO1T DRUG__ID D0XO1T D0XO1T DRUGINCH 1S/C56H75N13O11/c1-6-33(4)47(68-50(74)41(26-35-18-22-39(70)23-19-35)64-52(76)46(32(2)3)67-49(73)40(63-45(71)30-59-5)14-10-24-61-56(57)58)53(77)65-42(28-38-29-60-31-62-38)54(78)69-25-11-15-44(69)51(75)66-43(55(79)80)27-34-16-20-37(21-17-34)48(72)36-12-8-7-9-13-36/h7-9,12-13,16-23,29,31-33,40-44,46-47,59,70H,6,10-11,14-15,24-28,30H2,1-5H3,(H,60,62)(H,63,71)(H,64,76)(H,65,77)(H,66,75)(H,67,73)(H,68,74)(H,79,80)(H4,57,58,61)/t33-,40-,41-,42-,43-,44-,46-,47-/m0/s1 D0XO1T DRUGINKE CLBUUAFJDOTEBS-AAVPAQJNSA-N D0XO1T DRUGSMIL CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)NC(CC3=CC=C(C=C3)C(=O)C4=CC=CC=C4)C(=O)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)CNC D0XO1T HIGHSTAT Investigative D0XU1I DRUG__ID D0XU1I D0XU1I THERCLAS Antisense D0XU1I DRUGTYPE Combination drug (Antisense drug) D0XU1I DRUGSMIL failed D0XU1I HIGHSTAT Investigative D0XU9F DRUG__ID D0XU9F D0XU9F THERCLAS Antisense D0XU9F DRUGTYPE Combination drug (Antisense drug) D0XU9F DRUGSMIL failed D0XU9F HIGHSTAT Investigative D0Y0IE DRUG__ID D0Y0IE D0Y0IE DRUGINCH 1S/C67H111N23O16/c1-37(2)30-48(55(71)96)88-61(102)44(22-12-14-26-68)86-60(101)47(25-17-29-77-67(74)75)85-57(98)39(4)82-64(105)50(36-91)89-62(103)45(23-13-15-27-69)87-59(100)46(24-16-28-76-66(72)73)84-56(97)38(3)81-52(94)35-80-65(106)54(40(5)92)90-63(104)49(32-42-20-10-7-11-21-42)83-53(95)34-78-51(93)33-79-58(99)43(70)31-41-18-8-6-9-19-41/h6-11,18-21,37-40,43-50,54,91-92H,12-17,22-36,68-70H2,1-5H3,(H2,71,96)(H,78,93)(H,79,99)(H,80,106)(H,81,94)(H,82,105)(H,83,95)(H,84,97)(H,85,98)(H,86,101)(H,87,100)(H,88,102)(H,89,103)(H,90,104)(H4,72,73,76)(H4,74,75,77)/t38-,39-,40+,43-,44-,45-,46-,47-,48-,49-,50-,54-/m0/s1 D0Y0IE DRUGINKE LZQNOYOFRMAEJW-SYMNRJDYSA-N D0Y0IE DRUGSMIL CC(C)CC(C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0Y0IE HIGHSTAT Investigative D0Y0NM DRUG__ID D0Y0NM D0Y0NM DRUGINCH 1S/C142H216N38O44S3/c1-17-69(8)111(134(216)154-61-107(195)172-110(68(6)7)133(215)153-58-105(193)156-71(10)140(222)179-44-25-32-98(179)117(148)199)174-118(200)70(9)157-135(217)114(74(13)184)175-124(206)84(39-41-102(145)190)161-132(214)99-33-26-45-180(99)141(223)93(51-78-29-22-19-23-30-78)169-136(218)112(72(11)182)159-90(52-80-56-149-65-155-80)121(203)150-57-100(188)97-31-24-43-178(97)142(224)94(54-104(147)192)168-126(208)88(49-77-27-20-18-21-28-77)165-128(210)92(55-109(197)198)166-122(204)83(38-40-101(144)189)162-138(220)115(75(14)185)176-129(211)89(50-79-34-36-81(187)37-35-79)167-137(219)113(73(12)183)173-108(196)60-152-120(202)86(47-66(2)3)163-123(205)85(42-46-227-16)160-131(213)96(64-226)171-139(221)116(76(15)186)177-130(212)95(62-181)170-125(207)87(48-67(4)5)164-127(209)91(53-103(146)191)158-106(194)59-151-119(201)82(143)63-225/h18-23,27-30,34-37,56,65-76,82-99,110-116,159,181-187,225-226H,17,24-26,31-33,38-55,57-64,143H2,1-16H3,(H2,144,189)(H2,145,190)(H2,146,191)(H2,147,192)(H2,148,199)(H,149,155)(H,150,203)(H,151,201)(H,152,202)(H,153,215)(H,154,216)(H,156,193)(H,157,217)(H,158,194)(H,160,213)(H,161,214)(H,162,220)(H,163,205)(H,164,209)(H,165,210)(H,166,204)(H,167,219)(H,168,208)(H,169,218)(H,170,207)(H,171,221)(H,172,195)(H,173,196)(H,174,200)(H,175,206)(H,176,211)(H,177,212)(H,197,198)/t69-,70-,71-,72+,73+,74+,75+,76+,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98+,99+,110-,111-,112-,113-,114-,115-,116-/m0/s1 D0Y0NM DRUGINKE YYIDQLADSCSELD-ILODDJEPSA-N D0Y0NM DRUGSMIL CCC(C)C(C(=O)NCC(=O)NC(C(C)C)C(=O)NCC(=O)NC(C)C(=O)N1CCCC1C(=O)N)NC(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)O)NC(CC4=CNC=N4)C(=O)NCC(=O)C5CCCN5C(=O)C(CC(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CS)N D0Y0NM HIGHSTAT Investigative D0Y1AJ DRUG__ID D0Y1AJ D0Y1AJ DRUGINCH 1S/C73H85N11O19S2/c1-5-37(2)58-66(97)80-59(38(3)85)67(98)78-51(34-56(74)90)64(95)79-52(36-104-105-72(27-7-6-8-28-72)35-57(91)83-71(4,70(101)82-58)41-16-20-43(87)21-17-41)68(99)84-30-10-12-53(84)65(96)77-50(63(94)81-60(61(75)92)39-13-18-42(86)19-14-39)11-9-29-76-62(93)40-15-24-46-49(31-40)73(103-69(46)100)47-25-22-44(88)32-54(47)102-55-33-45(89)23-26-48(55)73/h13-26,31-33,37-38,50-53,58-60,85-89H,5-12,27-30,34-36H2,1-4H3,(H2,74,90)(H2,75,92)(H,76,93)(H,77,96)(H,78,98)(H,79,95)(H,80,97)(H,81,94)(H,82,101)(H,83,91)/t37?,38?,50-,51+,52+,53+,58+,59+,60-,71+/m0/s1 D0Y1AJ DRUGINKE BBABDJYQAOTGDM-JEIVZFIASA-N D0Y1AJ DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSC2(CCCCC2)CC(=O)NC(C(=O)N1)(C)C3=CC=C(C=C3)O)C(=O)N4CCCC4C(=O)NC(CCCNC(=O)C5=CC6=C(C=C5)C(=O)OC67C8=C(C=C(C=C8)O)OC9=C7C=CC(=C9)O)C(=O)NC(C1=CC=C(C=C1)O)C(=O)N)CC(=O)N)C(C)O D0Y1AJ HIGHSTAT Investigative D0Y1PT DRUG__ID D0Y1PT D0Y1PT DRUGINCH 1S/C70H101N19O18S2/c1-36(73)59(96)77-32-55(94)79-53-35-109-108-34-52(58(75)95)87-67(104)51(33-90)86-70(107)57(39(4)92)89-66(103)48(28-41-19-9-6-10-20-41)85-69(106)56(38(3)91)88-62(99)46(24-14-16-26-72)80-65(102)49(29-42-31-76-44-22-12-11-21-43(42)44)83-64(101)47(27-40-17-7-5-8-18-40)82-60(97)37(2)78-63(100)50(30-54(74)93)84-61(98)45(81-68(53)105)23-13-15-25-71/h5-12,17-22,31,36-39,45-53,56-57,76,90-92H,13-16,23-30,32-35,71-73H2,1-4H3,(H2,74,93)(H2,75,95)(H,77,96)(H,78,100)(H,79,94)(H,80,102)(H,81,105)(H,82,97)(H,83,101)(H,84,98)(H,85,106)(H,86,107)(H,87,104)(H,88,99)(H,89,103)/t36-,37-,38?,39?,45-,46+,47+,48-,49-,50+,51-,52-,53-,56+,57+/m0/s1 D0Y1PT DRUGINKE XOOYWFHODVEJSJ-XEOGGQMXSA-N D0Y1PT DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)N)CO)C(C)O)CC2=CC=CC=C2)C(C)O)CCCCN)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5 D0Y1PT HIGHSTAT Investigative D0Y1WD DRUG__ID D0Y1WD D0Y1WD DRUGINCH 1S/C79H100ClN15O14S/c1-45(2)37-62(70(101)88-61(18-11-12-35-83-46(3)4)79(109)95-36-14-19-68(95)76(107)84-47(5)69(81)100)89-71(102)63(39-52-22-29-58(30-23-52)85-48(6)97)90-72(103)64(40-53-24-31-59(32-25-53)86-49(7)98)92-75(106)67(44-96)94-74(105)66(41-54-15-13-34-82-43-54)91-73(104)65(38-51-20-27-57(80)28-21-51)93-77(108)78(87-50(8)99)110-60-33-26-55-16-9-10-17-56(55)42-60/h9-10,13,15-17,20-34,42-43,45-47,61-68,78,83,96H,11-12,14,18-19,35-41,44H2,1-8H3,(H2,81,100)(H,84,107)(H,85,97)(H,86,98)(H,87,99)(H,88,101)(H,89,102)(H,90,103)(H,91,104)(H,92,106)(H,93,108)(H,94,105)/t47-,61+,62+,63-,64+,65-,66-,67+,68+,78-/m1/s1 D0Y1WD DRUGINKE JRWSZLDRIJBUBZ-GJCYDJOFSA-N D0Y1WD DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(NC(=O)C)SC6=CC7=CC=CC=C7C=C6 D0Y1WD HIGHSTAT Investigative D0Y2MR DRUG__ID D0Y2MR D0Y2MR DRUGINCH 1S/C81H134N28O21/c1-7-49(98-64(116)41-96-79(130)65(45(6)111)109-77(128)57(37-47-23-13-10-14-24-47)99-63(115)40-94-62(114)39-95-68(119)48(84)36-46-21-11-9-12-22-46)69(120)102-54(27-19-33-92-80(88)89)71(122)105-53(26-16-18-32-83)74(125)108-59(42-110)78(129)100-50(8-2)70(121)103-55(28-20-34-93-81(90)91)72(123)104-52(25-15-17-31-82)73(124)107-56(35-43(3)4)75(126)97-44(5)67(118)106-58(38-61(86)113)76(127)101-51(66(87)117)29-30-60(85)112/h9-14,21-24,43-45,48-59,65,110-111H,7-8,15-20,25-42,82-84H2,1-6H3,(H2,85,112)(H2,86,113)(H2,87,117)(H,94,114)(H,95,119)(H,96,130)(H,97,126)(H,98,116)(H,99,115)(H,100,129)(H,101,127)(H,102,120)(H,103,121)(H,104,123)(H,105,122)(H,106,118)(H,107,124)(H,108,125)(H,109,128)(H4,88,89,92)(H4,90,91,93)/t44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,65-/m0/s1 D0Y2MR DRUGINKE JDXIHEXWMPKRIL-METNDEIASA-N D0Y2MR DRUGSMIL CCC(C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(CC)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)N)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N D0Y2MR HIGHSTAT Investigative D0Y2MT DRUG__ID D0Y2MT D0Y2MT DRUGINCH 1S/C90H129N23O20/c1-5-51(2)75(112-83(128)67(21-14-42-100-90(96)97)106-84(129)69(46-56-25-33-60(117)34-26-56)110-85(130)70(47-57-27-35-61(118)36-28-57)109-81(126)65(103-53(4)115)20-13-41-99-89(94)95)87(132)107-66(19-9-11-39-91)82(127)105-64(76(93)121)18-10-12-40-98-80(125)72(50-114)111-86(131)73-22-15-43-113(73)88(133)71(48-58-29-37-62(119)38-30-58)104-74(120)49-101-79(124)68(45-54-16-7-6-8-17-54)108-77(122)52(3)102-78(123)63(92)44-55-23-31-59(116)32-24-55/h6-8,16-17,23-38,51-52,63-73,75,114,116-119H,5,9-15,18-22,39-50,91-92H2,1-4H3,(H2,93,121)(H,98,125)(H,101,124)(H,102,123)(H,103,115)(H,104,120)(H,105,127)(H,106,129)(H,107,132)(H,108,122)(H,109,126)(H,110,130)(H,111,131)(H,112,128)(H4,94,95,99)(H4,96,97,100)/t51-,52-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,75-/m0/s1 D0Y2MT DRUGINKE DHDRBUQCZPZXNW-IJPMLFLGSA-N D0Y2MT DRUGSMIL CCC(C)C(C(=O)NC(CCCCN)C(=O)NC(CCCCNC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CC4=CC=C(C=C4)O)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CCCN=C(N)N)NC(=O)C D0Y2MT HIGHSTAT Investigative D0Y2NA DRUG__ID D0Y2NA D0Y2NA DRUGINCH 1S/C76H100ClN15O17S/c1-42(2)80-34-12-11-16-58(76(107)92-35-13-17-64(92)73(105)81-44(5)66(79)98)86-74(106)75(110(108,109)43(3)4)91-71(103)62(39-50-23-30-56(31-24-50)83-46(7)95)88-70(102)61(38-49-21-28-55(29-22-49)82-45(6)94)89-72(104)63(41-93)90-67(99)57(32-33-65(78)97)85-69(101)60(37-48-19-26-54(77)27-20-48)87-68(100)59(84-47(8)96)40-51-18-25-52-14-9-10-15-53(52)36-51/h9-10,14-15,18-31,36,42-44,57-64,75,80,93H,11-13,16-17,32-35,37-41H2,1-8H3,(H2,78,97)(H2,79,98)(H,81,105)(H,82,94)(H,83,95)(H,84,96)(H,85,101)(H,86,106)(H,87,100)(H,88,102)(H,89,104)(H,90,99)(H,91,103)/t44-,57-,58+,59-,60-,61+,62-,63+,64+,75+/m1/s1 D0Y2NA DRUGINKE FVPKWKBSMZRQEW-RKSVTEAUSA-N D0Y2NA DRUGSMIL CC(C)NCCCCC(C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CCC(=O)N)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)S(=O)(=O)C(C)C D0Y2NA HIGHSTAT Investigative D0Y3JR DRUG__ID D0Y3JR D0Y3JR DRUGCOMP Isis Pharmaceuticals D0Y3JR THERCLAS Anticancer Agents D0Y3JR DRUGTYPE Antisense drug D0Y3JR HIGHSTAT Investigative D0Y3OX DRUG__ID D0Y3OX D0Y3OX DRUGINCH 1S/C90H141N33O18S2/c91-35-5-3-17-59-75(130)117-64(18-4-6-36-92)84(139)123-43-13-24-70(123)83(138)120-66(46-51-28-33-56(125)34-29-51)79(134)116-61(21-10-40-108-88(101)102)74(129)114-63(23-12-42-110-90(104)141)77(132)121-68(81(136)111-58(71(94)126)19-8-38-106-86(97)98)48-142-143-49-69(82(137)119-65(45-50-26-31-55(124)32-27-50)78(133)115-62(73(128)113-59)22-11-41-109-89(103)140)122-80(135)67(47-52-25-30-53-14-1-2-15-54(53)44-52)118-76(131)60(20-9-39-107-87(99)100)112-72(127)57(93)16-7-37-105-85(95)96/h1-2,14-15,25-34,44,57-70,124-125H,3-13,16-24,35-43,45-49,91-93H2,(H2,94,126)(H,111,136)(H,112,127)(H,113,128)(H,114,129)(H,115,133)(H,116,134)(H,117,130)(H,118,131)(H,119,137)(H,120,138)(H,121,132)(H,122,135)(H4,95,96,105)(H4,97,98,106)(H4,99,100,107)(H4,101,102,108)(H3,103,109,140)(H3,104,110,141)/t57-,58-,59-,60-,61-,62-,63-,64+,65-,66-,67-,68-,69-,70-/m0/s1 D0Y3OX DRUGINKE DGQKRQOCJFODHN-OIHVMPBRSA-N D0Y3OX DRUGSMIL C1CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C1)CCCCN)CCCCN)CCCNC(=O)N)CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC5=CC=CC=C5C=C4)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)N)C(=O)NC(CCCNC(=N)N)C(=O)N)CCCNC(=O)N)CCCNC(=N)N)CC6=CC=C(C=C6)O D0Y3OX HIGHSTAT Investigative D0Y4AU DRUG__ID D0Y4AU D0Y4AU DRUGINCH 1S/C70H106N28O21S6/c1-31-54(105)85-37(10-4-5-13-71)56(107)88-40(16-32-20-82-36-9-3-2-8-34(32)36)59(110)97-48-27-122-120-24-35(72)55(106)95-47-26-124-125-29-50(68(119)94-46(53(74)104)25-121-123-28-49(67(118)93-44(22-99)63(114)84-31)98-61(112)42(18-51(73)101)90-66(47)117)96-58(109)39(12-7-15-81-70(77)78)86-64(115)45(23-100)92-60(111)41(17-33-21-79-30-83-33)89-62(113)43(19-52(102)103)91-57(108)38(87-65(48)116)11-6-14-80-69(75)76/h2-3,8-9,20-21,30-31,35,37-50,82,99-100H,4-7,10-19,22-29,71-72H2,1H3,(H2,73,101)(H2,74,104)(H,79,83)(H,84,114)(H,85,105)(H,86,115)(H,87,116)(H,88,107)(H,89,113)(H,90,117)(H,91,108)(H,92,111)(H,93,118)(H,94,119)(H,95,106)(H,96,109)(H,97,110)(H,98,112)(H,102,103)(H4,75,76,80)(H4,77,78,81)/t31-,35-,37-,38-,39-,40-,41-,42+,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1 D0Y4AU DRUGINKE AOAFXQNJFCOYGE-CPQFHPGLSA-N D0Y4AU DRUGSMIL CC1C(=O)NC(C(=O)NC(C(=O)NC2CSSCC(C(=O)NC3CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CO)NC(=O)C(NC3=O)CC(=O)N)C(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCCNC(=N)N)CC(=O)O)CC4=CN=CN4)CO)CCCNC(=N)N)N)CC5=CNC6=CC=CC=C65)CCCCN D0Y4AU HIGHSTAT Investigative D0Y5AT DRUG__ID D0Y5AT D0Y5AT DRUGINCH 1S/C82H137N29O22/c1-45(99-64(117)43-98-79(131)66(47(3)113)111-77(129)58(39-49-22-8-5-9-23-49)101-65(118)42-96-63(116)41-97-69(121)50(87)38-48-20-6-4-7-21-48)67(119)102-55(28-18-36-94-81(90)91)72(124)107-54(27-13-17-35-86)75(127)110-60(44-112)78(130)100-46(2)68(120)103-56(29-19-37-95-82(92)93)73(125)105-52(25-11-15-33-84)70(122)104-51(24-10-14-32-83)71(123)106-53(26-12-16-34-85)74(126)109-59(40-62(89)115)76(128)108-57(80(132)133)30-31-61(88)114/h4-9,20-23,45-47,50-60,66,112-113H,10-19,24-44,83-87H2,1-3H3,(H2,88,114)(H2,89,115)(H,96,116)(H,97,121)(H,98,131)(H,99,117)(H,100,130)(H,101,118)(H,102,119)(H,103,120)(H,104,122)(H,105,125)(H,106,123)(H,107,124)(H,108,128)(H,109,126)(H,110,127)(H,111,129)(H,132,133)(H4,90,91,94)(H4,92,93,95)/t45-,46-,47+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,66-/m0/s1 D0Y5AT DRUGINKE UDQRAMWZBFAZAV-WBMOPDPASA-N D0Y5AT DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0Y5AT HIGHSTAT Investigative D0Y5FO DRUG__ID D0Y5FO D0Y5FO DRUGINCH 1S/C61H73N11O18S2/c1-4-29(2)48-56(84)70-49(30(3)73)57(85)67-41(25-47(63)78)53(81)68-42(26-91-92-27-44(77)55(83)71-50(58(86)69-48)31-10-13-33(74)14-11-31)59(87)72-21-7-9-43(72)54(82)66-40(52(80)65-28-62)8-5-6-20-64-51(79)32-12-17-36-39(22-32)61(90-60(36)88)37-18-15-34(75)23-45(37)89-46-24-35(76)16-19-38(46)61/h10-19,22-24,29-30,40-44,48-50,73-77H,4-9,20-21,25-28,62H2,1-3H3,(H2,63,78)(H,64,79)(H,65,80)(H,66,82)(H,67,85)(H,68,81)(H,69,86)(H,70,84)(H,71,83)/t29?,30?,40-,41+,42+,43+,44?,48+,49+,50-/m0/s1 D0Y5FO DRUGINKE FKCHDAOTEPJVRR-FBPATOIMSA-N D0Y5FO DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)C2=CC=C(C=C2)O)O)C(=O)N3CCCC3C(=O)NC(CCCCNC(=O)C4=CC5=C(C=C4)C(=O)OC56C7=C(C=C(C=C7)O)OC8=C6C=CC(=C8)O)C(=O)NCN)CC(=O)N)C(C)O D0Y5FO HIGHSTAT Investigative D0Y5WA DRUG__ID D0Y5WA D0Y5WA DRUGINCH 1S/C55H71N9O13/c1-32(65)47(54(74)64-26-8-12-45(64)52(72)60-43(11-6-7-25-56)50(70)63-48(53(73)59-30-46(67)68)33(2)77-31-37-9-4-3-5-10-37)62-51(71)44(29-36-17-23-40(66)24-18-36)61-49(69)41(57)27-34-13-19-38(20-14-34)39-21-15-35(16-22-39)28-42(58)55(75)76/h3-5,9-10,13-24,32-33,41-45,47-48,65-66H,6-8,11-12,25-31,56-58H2,1-2H3,(H,59,73)(H,60,72)(H,61,69)(H,62,71)(H,63,70)(H,67,68)(H,75,76)/t32-,33-,41+,42+,43+,44+,45+,47+,48+/m1/s1 D0Y5WA DRUGINKE WVGBZWZFWUOODF-QHLFIVFVSA-N D0Y5WA DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(C(C)OCC2=CC=CC=C2)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=C(C=C4)C5=CC=C(C=C5)CC(C(=O)O)N)N)O D0Y5WA HIGHSTAT Investigative D0Y8UD DRUG__ID D0Y8UD D0Y8UD DRUGINCH 1S/C88H119N27O23/c1-87(2)61(26-8-6-5-7-9-27-62-88(3,4)74-50-21-13-11-19-48(50)29-31-60(74)115(62)46-72(128)129)114(59-30-28-47-18-10-12-20-49(47)73(59)87)37-32-63(116)106-51(22-14-33-98-83(90)91)76(131)103-43-66(119)109-56(40-70(124)125)80(135)112-53(24-16-35-100-85(94)95)78(133)104-44-67(120)110-57(41-71(126)127)81(136)113-54(25-17-36-101-86(96)97)79(134)105-45-68(121)111-58(82(137)138)38-64(117)107-52(23-15-34-99-84(92)93)77(132)102-42-65(118)108-55(75(89)130)39-69(122)123/h5-13,18-21,26-31,51-58H,14-17,22-25,32-46H2,1-4H3,(H34-,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138)/p+1/t51-,52-,53-,54-,55+,56+,57+,58+/m0/s1 D0Y8UD DRUGINKE GOWQHAYGNUHKIR-SESQYOPQSA-O D0Y8UD DRUGSMIL CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)N)C(=O)O)C=CC=CC=CC=C4C(C5=C(N4CC(=O)O)C=CC6=CC=CC=C65)(C)C)C D0Y8UD HIGHSTAT Investigative D0Y8UY DRUG__ID D0Y8UY D0Y8UY DRUGINCH 1S/C63H65N9O11/c1-37(73)50(32-42-35-65-48-18-10-8-16-46(42)48)67-51(28-38-12-4-2-5-13-38)58(77)68-52(29-39-14-6-3-7-15-39)60(79)71-55(34-57(64)76)62(81)70-53(30-40-20-24-44(74)25-21-40)59(78)69-54(31-41-22-26-45(75)27-23-41)61(80)72-56(63(82)83)33-43-36-66-49-19-11-9-17-47(43)49/h2-27,35-36,50-56,65-67,74-75H,28-34H2,1H3,(H2,64,76)(H,68,77)(H,69,78)(H,70,81)(H,71,79)(H,72,80)(H,82,83)/t50-,51+,52+,53+,54+,55+,56+/m1/s1 D0Y8UY DRUGINKE JNMRBSLUOYEORH-GMXKVRHKSA-N D0Y8UY DRUGSMIL CC(=O)C(CC1=CNC2=CC=CC=C21)NC(CC3=CC=CC=C3)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)NC(CC6=CC=C(C=C6)O)C(=O)NC(CC7=CNC8=CC=CC=C87)C(=O)O D0Y8UY HIGHSTAT Investigative D0Y9RD DRUG__ID D0Y9RD D0Y9RD DRUGINCH 1S/C26H33N5O5/c1-16(24(34)30-21(23(28)33)15-17-6-3-2-4-7-17)29-25(35)22-8-5-13-31(22)26(36)20(27)14-18-9-11-19(32)12-10-18/h2-4,6-7,9-12,16,20-22,32H,5,8,13-15,27H2,1H3,(H2,28,33)(H,29,35)(H,30,34)/t16-,20-,21-,22-/m0/s1 D0Y9RD DRUGINKE RZZXLHCBXYDTOF-KPQYALRZSA-N D0Y9RD DRUGSMIL CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)N D0Y9RD HIGHSTAT Investigative D0Y9TF DRUG__ID D0Y9TF D0Y9TF DRUGINCH 1S/C71H103N21O18S2/c1-9-35(5)58(70(109)110-8)92-67(106)52(31-112)90-69(108)57(33(2)3)91-65(104)48(23-39-27-79-44-17-16-34(4)21-42(39)44)86-61(100)46(18-19-53(72)94)85-64(103)50(25-55(96)97)88-63(102)47(22-38-26-78-43-14-11-10-13-41(38)43)83-54(95)29-80-59(98)36(6)82-62(101)49(24-40-28-76-32-81-40)87-60(99)45(15-12-20-77-71(74)75)84-66(105)51(30-111)89-68(107)56(73)37(7)93/h10-11,13-14,16-17,21,26-28,32-33,35-37,45-52,56-58,78-79,93,111-112H,9,12,15,18-20,22-25,29-31,73H2,1-8H3,(H2,72,94)(H,76,81)(H,80,98)(H,82,101)(H,83,95)(H,84,105)(H,85,103)(H,86,100)(H,87,99)(H,88,102)(H,89,107)(H,90,108)(H,91,104)(H,92,106)(H,96,97)(H4,74,75,77)/t35?,36-,37+,45-,46-,47-,48-,49-,50-,51-,52-,56-,57-,58-/m0/s1 D0Y9TF DRUGINKE BZCORVKMPCMYEF-LXVAIGNUSA-N D0Y9TF DRUGSMIL CCC(C)C(C(=O)OC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)C(CC1=CNC2=C1C=C(C=C2)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)CNC(=O)C(C)NC(=O)C(CC5=CNC=N5)NC(=O)C(CCCN=C(N)N)NC(=O)C(CS)NC(=O)C(C(C)O)N D0Y9TF HIGHSTAT Investigative D0YJ6C DRUG__ID D0YJ6C D0YJ6C DRUGINCH 1S/C45H64N12O11S2/c46-17-4-9-29(39(62)50-24-37(49)60)53-44(67)35-11-6-19-57(35)45(68)34-25-70-69-20-16-38(61)51-31(22-27-12-14-28(58)15-13-27)41(64)54-32(21-26-7-2-1-3-8-26)42(65)52-30(10-5-18-47)40(63)55-33(23-36(48)59)43(66)56-34/h1-3,7-8,12-15,29-35,58H,4-6,9-11,16-25,46-47H2,(H2,48,59)(H2,49,60)(H,50,62)(H,51,61)(H,52,65)(H,53,67)(H,54,64)(H,55,63)(H,56,66)/t29-,30-,31-,32-,33-,34-,35-/m0/s1 D0YJ6C DRUGINKE NLYHQDXERCUYHP-POFDKVPJSA-N D0YJ6C DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN)C(=O)NCC(=O)N D0YJ6C HIGHSTAT Investigative D0YM8F DRUG__ID D0YM8F D0YM8F DRUGINCH 1S/C65H107N23O16/c1-37(55(96)84-45(24-15-29-75-64(71)72)58(99)83-42(54(70)95)21-9-12-26-66)80-57(98)43(22-10-13-27-67)85-59(100)44(23-11-14-28-68)86-60(101)46(25-16-30-76-65(73)74)87-61(102)48(33-52(93)94)82-51(92)36-79-63(104)53(38(2)89)88-62(103)47(32-40-19-7-4-8-20-40)81-50(91)35-77-49(90)34-78-56(97)41(69)31-39-17-5-3-6-18-39/h3-8,17-20,37-38,41-48,53,89H,9-16,21-36,66-69H2,1-2H3,(H2,70,95)(H,77,90)(H,78,97)(H,79,104)(H,80,98)(H,81,91)(H,82,92)(H,83,99)(H,84,96)(H,85,100)(H,86,101)(H,87,102)(H,88,103)(H,93,94)(H4,71,72,75)(H4,73,74,76)/t37-,38+,41-,42-,43-,44-,45-,46-,47-,48+,53-/m0/s1 D0YM8F DRUGINKE RZSPAJQVMVZCJC-YRLNDPIWSA-N D0YM8F DRUGSMIL CC(C(C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0YM8F HIGHSTAT Investigative D0YS9E DRUG__ID D0YS9E D0YS9E DRUGINCH 1S/C14H16N2O2/c17-14-12(10-4-2-1-3-5-10)13(18-16-14)11-6-8-15-9-7-11/h1-5,11,15H,6-9H2,(H,16,17) D0YS9E DRUGINKE QTEBXBALJGPXEP-UHFFFAOYSA-N D0YS9E DRUGSMIL C1CNCCC1C2=C(C(=O)NO2)C3=CC=CC=C3 D0YS9E HIGHSTAT Investigative D0Z0OF DRUG__ID D0Z0OF D0Z0OF DRUGINCH 1S/C74H96IN15O15S2/c1-40(2)79-35-46-24-22-45(23-25-46)31-57-70(101)89-62(41(3)92)73(104)86-58(32-47-26-27-49(94)34-51(47)75)71(102)90-63(42(4)93)74(105)87-60(37-91)72(103)88-61(64(78)95)39-107-106-38-52(77)65(96)81-54(21-13-14-28-76)66(97)82-55(29-43-15-7-5-8-16-43)67(98)83-56(30-44-17-9-6-10-18-44)68(99)85-59(69(100)84-57)33-48-36-80-53-20-12-11-19-50(48)53/h5-12,15-20,22-27,34,36,40-42,52,54-63,79-80,91-94H,13-14,21,28-33,35,37-39,76-77H2,1-4H3,(H2,78,95)(H,81,96)(H,82,97)(H,83,98)(H,84,100)(H,85,99)(H,86,104)(H,87,105)(H,88,103)(H,89,101)(H,90,102)/t41-,42-,52-,54-,55-,56+,57+,58+,59+,60+,61+,62-,63-/m1/s1 D0Z0OF DRUGINKE LLJHRJNXPMGDKL-JFAFYCKWSA-N D0Z0OF DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)N)CO)C(C)O)CC7=C(C=C(C=C7)O)I)C(C)O D0Z0OF HIGHSTAT Investigative D0Z1XY DRUG__ID D0Z1XY D0Z1XY DRUGINCH 1S/C75H98N14O15S2/c1-43(2)78-38-50-30-28-49(29-31-50)36-58-70(98)87-63(44(3)91)73(101)85-59(35-48-23-13-8-14-24-48)71(99)88-64(45(4)92)74(102)89(5)62(40-90)72(100)86-61(75(103)104)42-106-105-41-53(77)65(93)80-55(27-17-18-32-76)66(94)81-56(33-46-19-9-6-10-20-46)67(95)82-57(34-47-21-11-7-12-22-47)68(96)84-60(69(97)83-58)37-51-39-79-54-26-16-15-25-52(51)54/h6-16,19-26,28-31,39,43-45,53,55-64,78-79,90-92H,17-18,27,32-38,40-42,76-77H2,1-5H3,(H,80,93)(H,81,94)(H,82,95)(H,83,97)(H,84,96)(H,85,101)(H,86,100)(H,87,98)(H,88,99)(H,103,104)/t44-,45-,53-,55-,56-,57+,58+,59+,60+,61+,62+,63-,64-/m1/s1 D0Z1XY DRUGINKE LSNMSNQCPXUTAH-YNBIXHCXSA-N D0Z1XY DRUGSMIL CC(C)NCC1=CC=C(C=C1)CC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC6=CC=CC=C6)CCCCN)N)C(=O)O)CO)C)C(C)O)CC7=CC=CC=C7)C(C)O D0Z1XY HIGHSTAT Investigative D0Z2EV DRUG__ID D0Z2EV D0Z2EV DRUGINCH 1S/C126H202N34O48S3/c1-15-57(8)93(115(189)141-62(13)96(170)145-71(24-16-19-36-127)100(174)136-51-89(165)143-83(52-209)111(185)147-73(26-18-21-38-129)104(178)157-92(56(6)7)114(188)154-80(48-86(131)162)108(182)156-84(53-210)112(186)155-82(43-63-29-31-64(161)32-30-63)116(190)160-40-23-28-85(160)125(207)208)159-110(184)81(49-87(132)163)150-99(173)65(44-66(117(191)192)118(193)194)70(27-22-39-135-126(133)134)144-95(169)60(11)139-105(179)76(42-54(2)3)151-106(180)77(45-67(119(195)196)120(197)198)149-98(172)59(10)137-94(168)58(9)138-101(175)75(35-41-211-14)148-102(176)72(25-17-20-37-128)146-97(171)61(12)140-113(187)91(55(4)5)158-109(183)79(47-69(123(203)204)124(205)206)153-107(181)78(46-68(121(199)200)122(201)202)152-103(177)74(33-34-90(166)167)142-88(164)50-130/h29-32,54-62,65-85,91-93,161,209-210H,15-28,33-53,127-130H2,1-14H3,(H2,131,162)(H2,132,163)(H,136,174)(H,137,168)(H,138,175)(H,139,179)(H,140,187)(H,141,189)(H,142,164)(H,143,165)(H,144,169)(H,145,170)(H,146,171)(H,147,185)(H,148,176)(H,149,172)(H,150,173)(H,151,180)(H,152,177)(H,153,181)(H,154,188)(H,155,186)(H,156,182)(H,157,178)(H,158,183)(H,159,184)(H,166,167)(H,191,192)(H,193,194)(H,195,196)(H,197,198)(H,199,200)(H,201,202)(H,203,204)(H,205,206)(H,207,208)(H4,133,134,135)/t57-,58-,59-,60-,61-,62-,65?,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,91-,92-,93-/m0/s1 D0Z2EV DRUGINKE XIRRXDGMZVHVEG-AZOPZXLDSA-N D0Z2EV DRUGSMIL CCC(C)C(C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CS)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC(=O)N)NC(=O)C(CC(C(=O)O)C(=O)O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C(C)C)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(CC(C(=O)O)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CN D0Z2EV HIGHSTAT Investigative D0Z3HM DRUG__ID D0Z3HM D0Z3HM DRUGINCH 1S/C79H130N28O22/c1-42(95-61(113)40-94-76(127)63(45(4)109)107-74(125)55(36-47-21-9-6-10-22-47)98-62(114)39-92-60(112)38-93-67(118)48(83)35-46-19-7-5-8-20-46)64(115)99-52(26-17-33-90-78(86)87)70(121)103-51(25-13-16-32-82)72(123)106-57(41-108)75(126)97-43(2)65(116)100-53(27-18-34-91-79(88)89)71(122)102-50(24-12-15-31-81)69(120)101-49(23-11-14-30-80)68(119)96-44(3)66(117)105-56(37-59(85)111)73(124)104-54(77(128)129)28-29-58(84)110/h5-10,19-22,42-45,48-57,63,108-109H,11-18,23-41,80-83H2,1-4H3,(H2,84,110)(H2,85,111)(H,92,112)(H,93,118)(H,94,127)(H,95,113)(H,96,119)(H,97,126)(H,98,114)(H,99,115)(H,100,116)(H,101,120)(H,102,122)(H,103,121)(H,104,124)(H,105,117)(H,106,123)(H,107,125)(H,128,129)(H4,86,87,90)(H4,88,89,91)/t42-,43-,44-,45+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,63-/m0/s1 D0Z3HM DRUGINKE OYXJMSJHGINGKM-SMFNREODSA-N D0Z3HM DRUGSMIL CC(C(C(=O)NCC(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=CC=C2)N)O D0Z3HM HIGHSTAT Investigative D0Z3LZ DRUG__ID D0Z3LZ D0Z3LZ DRUGINCH 1S/C58H73N11O12S2/c1-33(70)48-56(78)66-45(28-37-20-10-5-11-21-37)55(77)69-49(34(2)71)57(79)67-47(58(80)81)32-83-82-31-40(60)50(72)63-43(26-35-16-6-3-7-17-35)52(74)64-44(27-36-18-8-4-9-19-36)53(75)65-46(29-38-30-61-41-23-13-12-22-39(38)41)54(76)62-42(51(73)68-48)24-14-15-25-59/h3-13,16-23,30,33-34,40,42-49,61,70-71H,14-15,24-29,31-32,59-60H2,1-2H3,(H,62,76)(H,63,72)(H,64,74)(H,65,75)(H,66,78)(H,67,79)(H,68,73)(H,69,77)(H,80,81)/t33-,34-,40-,42+,43-,44+,45+,46+,47+,48-,49-/m1/s1 D0Z3LZ DRUGINKE IHKVTDBEFCOKGW-FNLAWZLKSA-N D0Z3LZ DRUGSMIL CC(C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)N)C(=O)O)C(C)O)CC6=CC=CC=C6)O D0Z3LZ HIGHSTAT Investigative D0Z3QG DRUG__ID D0Z3QG D0Z3QG DRUGINCH 1S/C106H177N23O23/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-44-88(134)113-52-35-31-42-77(96(141)119-75(93(111)138)39-28-32-49-107)121-97(142)76(40-29-33-50-108)120-98(143)78(41-30-34-51-109)122-104(149)85-43-36-53-129(85)90(136)62-116-95(140)79(54-65(2)3)123-99(144)80(55-66(4)5)124-101(146)82(57-70-45-47-72(132)48-46-70)118-89(135)61-115-94(139)68(8)117-103(148)84(64-130)127-102(147)83(59-87(110)133)125-100(145)81(56-67(6)7)126-106(151)92(69(9)131)128-105(150)86(152-91(137)63-112-10)58-71-60-114-74-38-27-26-37-73(71)74/h26-27,37-38,45-48,60,65-69,75-86,92,112,114,130-132H,11-25,28-36,39-44,49-59,61-64,107-109H2,1-10H3,(H2,110,133)(H2,111,138)(H,113,134)(H,115,139)(H,116,140)(H,117,148)(H,118,135)(H,119,141)(H,120,143)(H,121,142)(H,122,149)(H,123,144)(H,124,146)(H,125,145)(H,126,151)(H,127,147)(H,128,150)/t68-,69+,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,92-/m0/s1 D0Z3QG DRUGINKE IJKWJUNWQVNEKE-QPWLOKLFSA-N D0Z3QG DRUGSMIL CCCCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC D0Z3QG HIGHSTAT Investigative D0Z5LN DRUG__ID D0Z5LN D0Z5LN DRUGINCH 1S/C81H123N33O25S6/c82-16-4-3-10-40-62(123)102-45(20-36-24-95-39-9-2-1-8-38(36)39)67(128)112-53-30-142-145-34-57(111-64(125)42(12-6-18-93-80(87)88)98-66(127)44-14-15-59(119)97-44)78(139)114-54-31-143-144-33-56(77(138)109-52(61(84)122)29-140-141-32-55(113-69(130)47(22-58(83)118)104-75(54)136)76(137)108-51(28-117)73(134)107-50(27-116)72(133)99-40)110-65(126)43(13-7-19-94-81(89)90)100-71(132)49(26-115)106-68(129)46(21-37-25-91-35-96-37)103-70(131)48(23-60(120)121)105-63(124)41(101-74(53)135)11-5-17-92-79(85)86/h1-2,8-9,24-25,35,40-57,95,115-117H,3-7,10-23,26-34,82H2,(H2,83,118)(H2,84,122)(H,91,96)(H,97,119)(H,98,127)(H,99,133)(H,100,132)(H,101,135)(H,102,123)(H,103,131)(H,104,136)(H,105,124)(H,106,129)(H,107,134)(H,108,137)(H,109,138)(H,110,126)(H,111,125)(H,112,128)(H,113,130)(H,114,139)(H,120,121)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t40-,41-,42-,43-,44-,45-,46-,47+,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-/m0/s1 D0Z5LN DRUGINKE BDKVNCLFYNBTCE-RQJANPMLSA-N D0Z5LN DRUGSMIL C1CC(=O)NC1C(=O)NC(CCCNC(=N)N)C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC4CSSCC(C(=O)NC(C(=O)NC(CSSCC(NC4=O)C(=O)N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC5=CNC6=CC=CC=C65)CCCCN)CO)CO)CC(=O)N)NC2=O)CCCNC(=N)N)CO)CC7=CN=CN7)CC(=O)O)CCCNC(=N)N D0Z5LN HIGHSTAT Investigative D0Z5TP DRUG__ID D0Z5TP D0Z5TP DRUGINCH 1S/C80H102ClN15O14S/c1-46(2)38-63(71(101)89-62(19-12-13-36-84-47(3)4)80(109)96-37-15-20-69(96)77(107)85-48(5)70(82)100)90-73(103)66(41-53-24-31-60(32-25-53)86-49(6)97)92-75(105)67(42-54-26-33-61(34-27-54)87-50(7)98)94-78(108)79(111(9)110)95-76(106)68(44-56-16-14-35-83-45-56)93-74(104)65(40-52-22-29-59(81)30-23-52)91-72(102)64(88-51(8)99)43-55-21-28-57-17-10-11-18-58(57)39-55/h10-11,14,16-18,21-35,39,45-48,62-69,79,84H,12-13,15,19-20,36-38,40-44H2,1-9H3,(H2,82,100)(H,85,107)(H,86,97)(H,87,98)(H,88,99)(H,89,101)(H,90,103)(H,91,102)(H,92,105)(H,93,104)(H,94,108)(H,95,106)/t48-,62+,63+,64-,65-,66-,67+,68-,69+,79-,111?/m1/s1 D0Z5TP DRUGINKE VCYXYVFYPVPVGF-QUDAQTMVSA-N D0Z5TP DRUGSMIL CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C)S(=O)C D0Z5TP HIGHSTAT Investigative D0Z7BK DRUG__ID D0Z7BK D0Z7BK DRUGINCH 1S/C92H142O46/c1-34-52(98)59(105)66(112)77(124-34)121-32-46-57(103)62(108)76(133-51(97)17-13-37-12-15-42(119-11)40(95)26-37)85(131-46)135-73-44(29-94)128-81(70(116)64(73)110)129-47-33-123-79(65(111)58(47)104)136-74-54(100)36(3)126-83(71(74)117)137-75-55(101)41(96)30-120-84(75)132-50-19-20-89(8)48(88(50,6)7)18-21-91(10)49(89)16-14-38-39-27-87(4,5)22-24-92(39,25-23-90(38,91)9)86(118)138-82-68(114)61(107)56(102)45(130-82)31-122-78-69(115)63(109)72(43(28-93)127-78)134-80-67(113)60(106)53(99)35(2)125-80/h12-15,17,26,34-36,39,41,43-50,52-85,93-96,98-117H,16,18-25,27-33H2,1-11H3/b17-13+/t34-,35-,36-,39-,41-,43+,44+,45+,46+,47+,48-,49+,50-,52-,53-,54-,55-,56+,57+,58+,59+,60+,61-,62-,63+,64+,65+,66+,67+,68+,69+,70+,71+,72+,73+,74+,75+,76+,77+,78+,79-,80-,81-,82-,83-,84-,85-,89-,90+,91+,92-/m0/s1 D0Z7BK DRUGINKE NMYXWQYOXWOLSB-ZSBIDDPTSA-N D0Z7BK DRUGSMIL CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)O)OC4COC(C(C4O)O)OC5C(C(OC(C5O)OC6C(C(COC6OC7CCC8(C(C7(C)C)CCC9(C8CC=C1C9(CCC2(C1CC(CC2)(C)C)C(=O)OC1C(C(C(C(O1)COC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)C)O)O)O)O)O)O)O)O)C)C)C)O)O)C)O)CO)OC(=O)C=CC1=CC(=C(C=C1)OC)O)O)O)O)O)O D0Z7BK HIGHSTAT Investigative D0Z7QU DRUG__ID D0Z7QU D0Z7QU DRUGINCH 1S/C130H198N40O33/c1-14-67(10)104(125(201)165-95(55-100(134)179)118(194)160-89(48-66(8)9)120(196)168-105(69(12)172)126(202)156-83(25-19-43-145-130(140)141)110(186)154-84(39-40-98(132)177)113(189)153-81(23-17-41-143-128(136)137)111(187)157-85(107(135)183)49-71-27-33-76(174)34-28-71)167-121(197)91(51-73-31-37-78(176)38-32-73)161-117(193)93(53-75-58-142-62-149-75)162-112(188)82(24-18-42-144-129(138)139)155-124(200)97-26-20-44-170(97)103(182)60-148-109(185)86(45-63(2)3)158-114(190)87(46-64(4)5)159-116(192)90(50-72-29-35-77(175)36-30-72)152-102(181)59-147-108(184)68(11)150-123(199)96(61-171)166-119(195)94(54-99(133)178)163-115(191)88(47-65(6)7)164-127(203)106(70(13)173)169-122(198)92(151-101(180)56-131)52-74-57-146-80-22-16-15-21-79(74)80/h15-16,21-22,27-38,57-58,62-70,81-97,104-106,146,171-176H,14,17-20,23-26,39-56,59-61,131H2,1-13H3,(H2,132,177)(H2,133,178)(H2,134,179)(H2,135,183)(H,142,149)(H,147,184)(H,148,185)(H,150,199)(H,151,180)(H,152,181)(H,153,189)(H,154,186)(H,155,200)(H,156,202)(H,157,187)(H,158,190)(H,159,192)(H,160,194)(H,161,193)(H,162,188)(H,163,191)(H,164,203)(H,165,201)(H,166,195)(H,167,197)(H,168,196)(H,169,198)(H4,136,137,143)(H4,138,139,144)(H4,140,141,145)/t67-,68-,69+,70+,81-,82-,83-,84-,85-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,104-,105-,106-/m0/s1 D0Z7QU DRUGINKE SQXQKSDIKGRBPX-MNFZLFQXSA-N D0Z7QU DRUGSMIL CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCN=C(N)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CNC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)CN D0Z7QU HIGHSTAT Investigative D0Z8DJ DRUG__ID D0Z8DJ D0Z8DJ DRUGINCH 1S/C55H71N9O13/c1-32(65)47(54(74)64-26-8-12-45(64)52(72)60-43(11-6-7-25-56)50(70)63-48(53(73)59-30-46(67)68)33(2)77-31-37-9-4-3-5-10-37)62-51(71)44(29-36-17-23-40(66)24-18-36)61-49(69)41(57)27-34-13-19-38(20-14-34)39-21-15-35(16-22-39)28-42(58)55(75)76/h3-5,9-10,13-24,32-33,41-45,47-48,65-66H,6-8,11-12,25-31,56-58H2,1-2H3,(H,59,73)(H,60,72)(H,61,69)(H,62,71)(H,63,70)(H,67,68)(H,75,76)/t32-,33?,41+,42+,43+,44+,45+,47+,48+/m1/s1 D0Z8DJ DRUGINKE WVGBZWZFWUOODF-AWANZDLNSA-N D0Z8DJ DRUGSMIL CC(C(C(=O)N1CCCC1C(=O)NC(CCCCN)C(=O)NC(C(C)OCC2=CC=CC=C2)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CC4=CC=C(C=C4)C5=CC=C(C=C5)CC(C(=O)O)N)N)O D0Z8DJ HIGHSTAT Investigative D0ZD0W DRUG__ID D0ZD0W D0ZD0W DRUGINCH 1S/C46H66N14O11S2/c47-17-4-9-30-40(66)58-33(23-36(48)62)43(69)59-34(45(71)60-19-6-11-35(60)44(70)56-29(10-5-18-52-46(50)51)39(65)53-24-37(49)63)25-73-72-20-16-38(64)54-31(22-27-12-14-28(61)15-13-27)41(67)57-32(42(68)55-30)21-26-7-2-1-3-8-26/h1-3,7-8,12-15,29-35,61H,4-6,9-11,16-25,47H2,(H2,48,62)(H2,49,63)(H,53,65)(H,54,64)(H,55,68)(H,56,70)(H,57,67)(H,58,66)(H,59,69)(H4,50,51,52)/t29-,30-,31-,32-,33-,34-,35-/m0/s1 D0ZD0W DRUGINKE HBVZQPKQFUSYKR-POFDKVPJSA-N D0ZD0W DRUGSMIL C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCCN)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N D0ZD0W HIGHSTAT Investigative D0ZD3M DRUG__ID D0ZD3M D0ZD3M DRUGINCH 1S/C60H78N18O14S2/c1-32(79)70-43(24-34-15-17-37(80)18-16-34)54(87)71-41(14-8-22-67-60(64)92)52(85)78-48-30-94-93-29-47(50(61)83)77-56(89)45(25-35-27-68-39-12-6-5-11-38(35)39)75-51(84)40(13-7-21-66-59(62)63)72-55(88)44(23-33-9-3-2-4-10-33)74-57(90)46(26-36-28-65-31-69-36)76-53(86)42(73-58(48)91)19-20-49(81)82/h2-6,9-12,15-18,27-28,31,40-48,68,80H,7-8,13-14,19-26,29-30H2,1H3,(H2,61,83)(H,65,69)(H,70,79)(H,71,87)(H,72,88)(H,73,91)(H,74,90)(H,75,84)(H,76,86)(H,77,89)(H,78,85)(H,81,82)(H4,62,63,66)(H3,64,67,92)/t40-,41-,42+,43-,44-,45+,46-,47+,48+/m0/s1 D0ZD3M DRUGINKE OODHJMPCOPKKSM-XVRHLUALSA-N D0ZD3M DRUGSMIL CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=O)N)C(=O)NC2CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CNC6=CC=CC=C65)C(=O)N D0ZD3M HIGHSTAT Investigative D0ZK3L DRUG__ID D0ZK3L D0ZK3L DRUGINCH 1S/C16H16O6S/c17-11-7-16(22,15(20)21)10(13(18)14(11)19)6-8-1-2-12-9(5-8)3-4-23-12/h1-5,10-11,14,17,19,22H,6-7H2,(H,20,21)/t10-,11+,14-,16+/m0/s1 D0ZK3L DRUGINKE WFQJMZIPFQUOBR-FJXFWJLJSA-N D0ZK3L DRUGSMIL C1C(C(C(=O)C(C1(C(=O)O)O)CC2=CC3=C(C=C2)SC=C3)O)O D0ZK3L HIGHSTAT Investigative D0ZV3Y DRUG__ID D0ZV3Y D0ZV3Y DRUGINCH 1S/C52H75N11O12S2/c1-8-29(5)43-49(72)57-34(18-19-40(53)64)44(67)58-37(25-41(54)65)45(68)60-38(27-77-76-21-20-42(66)56-36(46(69)61-43)23-30-14-16-33(17-15-30)75-9-2)50(73)63-26-32-13-11-10-12-31(32)24-39(63)48(71)59-35(22-28(3)4)47(70)62-52(6,7)51(55)74/h10-17,28-29,34-39,43H,8-9,18-27H2,1-7H3,(H2,53,64)(H2,54,65)(H2,55,74)(H,56,66)(H,57,72)(H,58,67)(H,59,71)(H,60,68)(H,61,69)(H,62,70)/t29-,34-,35-,36-,37-,38-,39+,43-/m0/s1 D0ZV3Y DRUGINKE OKJBACYELSLYOC-QNDTVFEZSA-N D0ZV3Y DRUGSMIL CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CC4=CC=CC=C4CC3C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)N)CC(=O)N)CCC(=O)N D0ZV3Y HIGHSTAT Investigative D00ACP DRUG__ID D00ACP D00ACP DRUGCOMP Iterative Therapeutics Inc D00ACP DRUGTYPE Monoclonal antibody D00ACP HIGHSTAT Investigative D00AJF DRUG__ID D00AJF D00AJF DRUGCOMP Isis Pharmaceuticals D00AJF DRUGTYPE Antisense drug D00AJF HIGHSTAT Investigative D00AQP DRUG__ID D00AQP D00AQP THERCLAS Antiviral Agents D00AQP DRUGTYPE Combination drug D00AQP HIGHSTAT Investigative D00CWJ DRUG__ID D00CWJ D00CWJ DRUGCOMP Isis Pharmaceuticals D00CWJ DRUGTYPE Antisense drug D00CWJ HIGHSTAT Investigative D00DRY DRUG__ID D00DRY D00DRY DRUGCOMP Isis Pharmaceuticals D00DRY DRUGTYPE Antisense drug D00DRY HIGHSTAT Investigative D00DYQ DRUG__ID D00DYQ D00DYQ DRUGCOMP Isis Pharmaceuticals D00DYQ DRUGTYPE Antisense drug D00DYQ HIGHSTAT Investigative D00EPB DRUG__ID D00EPB D00EPB DRUGCOMP Isis Pharmaceuticals D00EPB DRUGTYPE Antisense drug D00EPB HIGHSTAT Investigative D00ERI DRUG__ID D00ERI D00ERI DRUGCOMP Isis Pharmaceuticals D00ERI DRUGTYPE Antisense drug D00ERI HIGHSTAT Investigative D00FAL DRUG__ID D00FAL D00FAL DRUGCOMP Isis Pharmaceuticals D00FAL DRUGTYPE Antisense drug D00FAL HIGHSTAT Investigative D00FEY DRUG__ID D00FEY D00FEY DRUGCOMP Isis Pharmaceuticals D00FEY DRUGTYPE Antisense drug D00FEY HIGHSTAT Investigative D00FZA DRUG__ID D00FZA D00FZA DRUGCOMP Alder Biopharmaceuticals Inc D00FZA DRUGTYPE Antibody D00FZA HIGHSTAT Investigative D00GKE DRUG__ID D00GKE D00GKE DRUGCOMP Isis Pharmaceuticals D00GKE DRUGTYPE Antisense drug D00GKE HIGHSTAT Investigative D00JHE DRUG__ID D00JHE D00JHE DRUGCOMP Isis Pharmaceuticals D00JHE DRUGTYPE Antisense drug D00JHE HIGHSTAT Investigative D00JXJ DRUG__ID D00JXJ D00JXJ DRUGCOMP Isis Pharmaceuticals D00JXJ DRUGTYPE Antisense drug D00JXJ HIGHSTAT Investigative D00JZS DRUG__ID D00JZS D00JZS DRUGCOMP Cardiovascular biotherapeutics D00JZS DRUGTYPE Antibody D00JZS HIGHSTAT Investigative D00KVH DRUG__ID D00KVH D00KVH DRUGCOMP Isis Pharmaceuticals D00KVH DRUGTYPE Antisense drug D00KVH HIGHSTAT Investigative D00LSM DRUG__ID D00LSM D00LSM DRUGCOMP Isis Pharmaceuticals D00LSM DRUGTYPE Antisense drug D00LSM HIGHSTAT Investigative D00NPN DRUG__ID D00NPN D00NPN DRUGCOMP Isis Pharmaceuticals D00NPN DRUGTYPE Antisense drug D00NPN HIGHSTAT Investigative D00NQN DRUG__ID D00NQN D00NQN DRUGCOMP Isis Pharmaceuticals D00NQN DRUGTYPE Antisense drug D00NQN HIGHSTAT Investigative D00ODF DRUG__ID D00ODF D00ODF DRUGCOMP Isis Pharmaceuticals D00ODF DRUGTYPE Antisense drug D00ODF HIGHSTAT Investigative D00OTQ DRUG__ID D00OTQ D00OTQ DRUGCOMP ProtAb Ltd D00OTQ DRUGTYPE Monoclonal antibody D00OTQ HIGHSTAT Investigative D00PYD DRUG__ID D00PYD D00PYD DRUGCOMP Isis Pharmaceuticals D00PYD DRUGTYPE Antisense drug D00PYD HIGHSTAT Investigative D00QGF DRUG__ID D00QGF D00QGF DRUGCOMP Isis Pharmaceuticals D00QGF DRUGTYPE Antisense drug D00QGF HIGHSTAT Investigative D00RTU DRUG__ID D00RTU D00RTU DRUGCOMP Algeta ASA D00RTU DRUGTYPE Antibody D00RTU HIGHSTAT Investigative D00RXS DRUG__ID D00RXS D00RXS DRUGTYPE Small molecular drug D00RXS DRUGSMIL C1=NC2=C(C1C3C(C(C(N3)CO)O)O)NC(=NC2=O)N D00RXS HIGHSTAT Investigative D00SIC DRUG__ID D00SIC D00SIC DRUGCOMP Isis Pharmaceuticals D00SIC DRUGTYPE Antisense drug D00SIC HIGHSTAT Investigative D00SJN DRUG__ID D00SJN D00SJN DRUGCOMP Immunomedics Inc D00SJN DRUGTYPE Vaccine D00SJN HIGHSTAT Investigative D00SNI DRUG__ID D00SNI D00SNI DRUGCOMP Isis Pharmaceuticals D00SNI DRUGTYPE Antisense drug D00SNI HIGHSTAT Investigative D00SQD DRUG__ID D00SQD D00SQD DRUGCOMP Isis Pharmaceuticals D00SQD DRUGTYPE Antisense drug D00SQD HIGHSTAT Investigative D00TKJ DRUG__ID D00TKJ D00TKJ DRUGTYPE Small molecular drug D00TKJ DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)F)NO D00TKJ HIGHSTAT Investigative D00TQI DRUG__ID D00TQI D00TQI DRUGCOMP Isis Pharmaceuticals D00TQI DRUGTYPE Antisense drug D00TQI HIGHSTAT Investigative D00UDD DRUG__ID D00UDD D00UDD DRUGCOMP Isis Pharmaceuticals D00UDD DRUGTYPE Antisense drug D00UDD HIGHSTAT Investigative D00UDL DRUG__ID D00UDL D00UDL DRUGCOMP Isis Pharmaceuticals D00UDL DRUGTYPE Antisense drug D00UDL HIGHSTAT Investigative D00UYB DRUG__ID D00UYB D00UYB DRUGCOMP Medlmmune LLC D00UYB DRUGTYPE Monoclonal antibody D00UYB HIGHSTAT Investigative D00VMX DRUG__ID D00VMX D00VMX DRUGTYPE Small molecule immunotherapy D00VMX HIGHSTAT Investigative D00VMX COMPCLAS Aromatic acetylene derivatives D00WZE DRUG__ID D00WZE D00WZE DRUGCOMP Isis Pharmaceuticals D00WZE DRUGTYPE Antisense drug D00WZE HIGHSTAT Investigative D00XFY DRUG__ID D00XFY D00XFY THERCLAS Antisense D00XFY DRUGTYPE Combination drug (Antisense drug) D00XFY HIGHSTAT Investigative D00XNC DRUG__ID D00XNC D00XNC DRUGCOMP Cambridge Antibody Technology Group plc D00XNC DRUGTYPE Antibody D00XNC HIGHSTAT Investigative D00XPD DRUG__ID D00XPD D00XPD DRUGCOMP Isis Pharmaceuticals D00XPD DRUGTYPE Antisense drug D00XPD HIGHSTAT Investigative D00XRM DRUG__ID D00XRM D00XRM DRUGCOMP Isis Pharmaceuticals D00XRM DRUGTYPE Antisense drug D00XRM HIGHSTAT Investigative D00YID DRUG__ID D00YID D00YID DRUGCOMP Isis Pharmaceuticals D00YID DRUGTYPE Antisense drug D00YID HIGHSTAT Investigative D00YNJ DRUG__ID D00YNJ D00YNJ DRUGCOMP X-BODY BioSciences D00YNJ DRUGTYPE Antibody D00YNJ HIGHSTAT Investigative D00YYQ DRUG__ID D00YYQ D00YYQ DRUGCOMP Isis Pharmaceuticals D00YYQ DRUGTYPE Antisense drug D00YYQ HIGHSTAT Investigative D01AUI DRUG__ID D01AUI D01AUI DRUGTYPE Small molecular drug D01AUI DRUGSMIL CCCCCN=C(N)NNC=C1C=NC2=C1C=C(C=C2)OC.C(=CC(=O)O)C(=O)O D01AUI HIGHSTAT Investigative D01BJK DRUG__ID D01BJK D01BJK DRUGCOMP AFFiRiS AG D01BJK DRUGTYPE Vaccine D01BJK HIGHSTAT Investigative D01DCZ DRUG__ID D01DCZ D01DCZ DRUGCOMP Isis Pharmaceuticals D01DCZ DRUGTYPE Antisense drug D01DCZ HIGHSTAT Investigative D01DDQ DRUG__ID D01DDQ D01DDQ DRUGCOMP Isis Pharmaceuticals D01DDQ DRUGTYPE Antisense drug D01DDQ HIGHSTAT Investigative D01DFK DRUG__ID D01DFK D01DFK DRUGCOMP Isis Pharmaceuticals D01DFK DRUGTYPE Antisense drug D01DFK HIGHSTAT Investigative D01DPC DRUG__ID D01DPC D01DPC THERCLAS Antiviral Agents D01DPC DRUGTYPE Combination drug D01DPC HIGHSTAT Investigative D01DVS DRUG__ID D01DVS D01DVS DRUGCOMP Isis Pharmaceuticals D01DVS DRUGTYPE Antisense drug D01DVS HIGHSTAT Investigative D01DVV DRUG__ID D01DVV D01DVV DRUGCOMP Isis Pharmaceuticals D01DVV DRUGTYPE Antisense drug D01DVV HIGHSTAT Investigative D01EAV DRUG__ID D01EAV D01EAV DRUGCOMP Isis Pharmaceuticals D01EAV DRUGTYPE Antisense drug D01EAV HIGHSTAT Investigative D01EPD DRUG__ID D01EPD D01EPD DRUGCOMP Isis Pharmaceuticals D01EPD DRUGTYPE Antisense drug D01EPD HIGHSTAT Investigative D01GLR DRUG__ID D01GLR D01GLR DRUGCOMP Isis Pharmaceuticals D01GLR DRUGTYPE Antisense drug D01GLR HIGHSTAT Investigative D01GTL DRUG__ID D01GTL D01GTL DRUGCOMP Isis Pharmaceuticals D01GTL DRUGTYPE Antisense drug D01GTL HIGHSTAT Investigative D01IHU DRUG__ID D01IHU D01IHU DRUGCOMP Isis Pharmaceuticals D01IHU DRUGTYPE Antisense drug D01IHU HIGHSTAT Investigative D01IRX DRUG__ID D01IRX D01IRX DRUGCOMP Isis Pharmaceuticals D01IRX DRUGTYPE Antisense drug D01IRX HIGHSTAT Investigative D01KCM DRUG__ID D01KCM D01KCM DRUGCOMP Isis Pharmaceuticals D01KCM DRUGTYPE Antisense drug D01KCM HIGHSTAT Investigative D01KEF DRUG__ID D01KEF D01KEF DRUGCOMP Isis Pharmaceuticals D01KEF DRUGTYPE Antisense drug D01KEF HIGHSTAT Investigative D01KTB DRUG__ID D01KTB D01KTB DRUGCOMP Isis Pharmaceuticals D01KTB DRUGTYPE Antisense drug D01KTB HIGHSTAT Investigative D01KTF DRUG__ID D01KTF D01KTF DRUGCOMP Isis Pharmaceuticals D01KTF DRUGTYPE Antisense drug D01KTF HIGHSTAT Investigative D01LYK DRUG__ID D01LYK D01LYK DRUGCOMP Isis Pharmaceuticals D01LYK DRUGTYPE Antisense drug D01LYK HIGHSTAT Investigative D01MCF DRUG__ID D01MCF D01MCF DRUGCOMP Isis Pharmaceuticals D01MCF DRUGTYPE Antisense drug D01MCF HIGHSTAT Investigative D01NSO DRUG__ID D01NSO D01NSO DRUGCOMP Isis Pharmaceuticals D01NSO DRUGTYPE Antisense drug D01NSO HIGHSTAT Investigative D01ODC DRUG__ID D01ODC D01ODC DRUGCOMP Taligen Therapeutics Inc D01ODC DRUGTYPE Antibody D01ODC HIGHSTAT Investigative D01OOI DRUG__ID D01OOI D01OOI DRUGCOMP Isis Pharmaceuticals D01OOI DRUGTYPE Antisense drug D01OOI HIGHSTAT Investigative D01PKX DRUG__ID D01PKX D01PKX DRUGCOMP Isis Pharmaceuticals D01PKX DRUGTYPE Antisense drug D01PKX HIGHSTAT Investigative D01PSU DRUG__ID D01PSU D01PSU DRUGTYPE Small molecular drug D01PSU DRUGSMIL C1=CC2=C(C=C1Cl)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)Cl)NO D01PSU HIGHSTAT Investigative D01QCJ DRUG__ID D01QCJ D01QCJ DRUGTYPE Small molecular drug D01QCJ DRUGSMIL C1=CC=C(C=C1)C2=CC(=C3C=CC(=O)C=C3)NC(=C2)C4=CC=C(C=C4)O D01QCJ HIGHSTAT Investigative D01QNF DRUG__ID D01QNF D01QNF DRUGCOMP Isis Pharmaceuticals D01QNF DRUGTYPE Antisense drug D01QNF HIGHSTAT Investigative D01QXW DRUG__ID D01QXW D01QXW DRUGCOMP MuriGen Therapeutics D01QXW DRUGTYPE Antibody D01QXW HIGHSTAT Investigative D01TAJ DRUG__ID D01TAJ D01TAJ DRUGCOMP Isis Pharmaceuticals D01TAJ DRUGTYPE Antisense drug D01TAJ HIGHSTAT Investigative D01TGF DRUG__ID D01TGF D01TGF DRUGTYPE Small molecule immunotherapy D01TGF HIGHSTAT Investigative D01TGF COMPCLAS Cyclic peptidomimetic derivatives D01TMK DRUG__ID D01TMK D01TMK DRUGCOMP Genexine Co Ltd D01TMK DRUGTYPE Antibody D01TMK HIGHSTAT Investigative D01TYO DRUG__ID D01TYO D01TYO DRUGTYPE Small molecular drug D01TYO DRUGSMIL CC=C(C)C1CCC2CC(CC(C2C1C(=O)C3=C(C(NC3=O)CC(C)(C(=O)O)O)O)C)C D01TYO HIGHSTAT Investigative D01UOK DRUG__ID D01UOK D01UOK DRUGCOMP Isis Pharmaceuticals D01UOK DRUGTYPE Antisense drug D01UOK HIGHSTAT Investigative D01VBU DRUG__ID D01VBU D01VBU DRUGCOMP Isis Pharmaceuticals D01VBU DRUGTYPE Antisense drug D01VBU HIGHSTAT Investigative D01VSM DRUG__ID D01VSM D01VSM DRUGTYPE Small molecular drug D01VSM DRUGSMIL CC(C)CSC1=NC(=O)C=C(N1)CC2=CC=CC=C2 D01VSM HIGHSTAT Investigative D01XJR DRUG__ID D01XJR D01XJR DRUGCOMP Isis Pharmaceuticals D01XJR DRUGTYPE Antisense drug D01XJR HIGHSTAT Investigative D01YJD DRUG__ID D01YJD D01YJD DRUGCOMP Isis Pharmaceuticals D01YJD DRUGTYPE Antisense drug D01YJD HIGHSTAT Investigative D01YRL DRUG__ID D01YRL D01YRL DRUGTYPE Small molecular drug D01YRL DRUGSMIL C1CCC(CC1)SC2=NC(=O)C=C(N2)CC3=CC=CC=C3 D01YRL HIGHSTAT Investigative D01YSX DRUG__ID D01YSX D01YSX DRUGCOMP Isis Pharmaceuticals D01YSX DRUGTYPE Antisense drug D01YSX HIGHSTAT Investigative D01ZCH DRUG__ID D01ZCH D01ZCH DRUGCOMP Isis Pharmaceuticals D01ZCH DRUGTYPE Antisense drug D01ZCH HIGHSTAT Investigative D01ZCK DRUG__ID D01ZCK D01ZCK DRUGCOMP Isis Pharmaceuticals D01ZCK DRUGTYPE Antisense drug D01ZCK HIGHSTAT Investigative D02AMI DRUG__ID D02AMI D02AMI DRUGCOMP Isis Pharmaceuticals D02AMI DRUGTYPE Antisense drug D02AMI HIGHSTAT Investigative D02AOC DRUG__ID D02AOC D02AOC DRUGCOMP Isis Pharmaceuticals D02AOC DRUGTYPE Antisense drug D02AOC HIGHSTAT Investigative D02AWB DRUG__ID D02AWB D02AWB THERCLAS Antiviral Agents D02AWB DRUGTYPE Vaccine D02AWB HIGHSTAT Investigative D02CBE DRUG__ID D02CBE D02CBE DRUGCOMP Isis Pharmaceuticals D02CBE DRUGTYPE Antisense drug D02CBE HIGHSTAT Investigative D02CNG DRUG__ID D02CNG D02CNG DRUGCOMP Isis Pharmaceuticals D02CNG DRUGTYPE Antisense drug D02CNG HIGHSTAT Investigative D02CTZ DRUG__ID D02CTZ D02CTZ DRUGCOMP Lilly D02CTZ THERCLAS Psychiatric D02CTZ HIGHSTAT Investigative D02DAU DRUG__ID D02DAU D02DAU DRUGCOMP Isis Pharmaceuticals D02DAU DRUGTYPE Antisense drug D02DAU HIGHSTAT Investigative D02DHS DRUG__ID D02DHS D02DHS DRUGCOMP Isis Pharmaceuticals D02DHS DRUGTYPE Antisense drug D02DHS HIGHSTAT Investigative D02DUM DRUG__ID D02DUM D02DUM DRUGCOMP Isis Pharmaceuticals D02DUM DRUGTYPE Antisense drug D02DUM HIGHSTAT Investigative D02DXI DRUG__ID D02DXI D02DXI DRUGCOMP Isis Pharmaceuticals D02DXI DRUGTYPE Antisense drug D02DXI HIGHSTAT Investigative D02DXY DRUG__ID D02DXY D02DXY DRUGCOMP Isis Pharmaceuticals D02DXY DRUGTYPE Antisense drug D02DXY HIGHSTAT Investigative D02EIC DRUG__ID D02EIC D02EIC DRUGCOMP Isis Pharmaceuticals D02EIC DRUGTYPE Antisense drug D02EIC HIGHSTAT Investigative D02FGG DRUG__ID D02FGG D02FGG DRUGCOMP Affimed Therapeutics AG D02FGG DRUGTYPE Antibody D02FGG HIGHSTAT Investigative D02FVN DRUG__ID D02FVN D02FVN DRUGCOMP Isis Pharmaceuticals D02FVN DRUGTYPE Antisense drug D02FVN HIGHSTAT Investigative D02GIB DRUG__ID D02GIB D02GIB DRUGCOMP Isis Pharmaceuticals D02GIB DRUGTYPE Antisense drug D02GIB HIGHSTAT Investigative D02HBI DRUG__ID D02HBI D02HBI DRUGCOMP Biocon Ltd D02HBI DRUGTYPE Monoclonal antibody D02HBI HIGHSTAT Investigative D02HQR DRUG__ID D02HQR D02HQR DRUGCOMP SC World Inc D02HQR DRUGTYPE Monoclonal antibody D02HQR HIGHSTAT Investigative D02HRB DRUG__ID D02HRB D02HRB DRUGTYPE Small molecular drug D02HRB DRUGSMIL C1CN2C3=CC=CC=C3NC2=C(C1=O)C(=O)NC4=CC=CC=C4 D02HRB HIGHSTAT Investigative D02IBE DRUG__ID D02IBE D02IBE DRUGCOMP Isis Pharmaceuticals D02IBE DRUGTYPE Antisense drug D02IBE HIGHSTAT Investigative D02IIL DRUG__ID D02IIL D02IIL DRUGCOMP Kosan Bioscience D02IIL THERCLAS Anticancer Agents D02IIL HIGHSTAT Investigative D02JBK DRUG__ID D02JBK D02JBK DRUGCOMP Isis Pharmaceuticals D02JBK DRUGTYPE Antisense drug D02JBK HIGHSTAT Investigative D02LLU DRUG__ID D02LLU D02LLU DRUGTYPE Small molecular drug D02LLU DRUGSMIL C1=CC=C(C=C1)C2=CC3=C4C=CC=CC4=NC(=O)N3N2 D02LLU HIGHSTAT Investigative D02LZA DRUG__ID D02LZA D02LZA DRUGCOMP Isis Pharmaceuticals D02LZA DRUGTYPE Antisense drug D02LZA HIGHSTAT Investigative D02MDK DRUG__ID D02MDK D02MDK DRUGCOMP Isis Pharmaceuticals D02MDK DRUGTYPE Antisense drug D02MDK HIGHSTAT Investigative D02MMY DRUG__ID D02MMY D02MMY DRUGTYPE Small molecular drug D02MMY DRUGSMIL COC1=C(C=C2C(=C1)C=CC3=C4C=CC(=O)C=C4NC=C32)OC D02MMY HIGHSTAT Investigative D02MYZ DRUG__ID D02MYZ D02MYZ DRUGCOMP Isis Pharmaceuticals D02MYZ DRUGTYPE Antisense drug D02MYZ HIGHSTAT Investigative D02NEY DRUG__ID D02NEY D02NEY DRUGCOMP Isis Pharmaceuticals D02NEY DRUGTYPE Antisense drug D02NEY HIGHSTAT Investigative D02NUN DRUG__ID D02NUN D02NUN DRUGCOMP Isis Pharmaceuticals D02NUN DRUGTYPE Antisense drug D02NUN HIGHSTAT Investigative D02OAS DRUG__ID D02OAS D02OAS DRUGTYPE Small molecule immunotherapy D02OAS HIGHSTAT Investigative D02OAS COMPCLAS Triaromatic compounds D02OHL DRUG__ID D02OHL D02OHL DRUGCOMP Isis Pharmaceuticals D02OHL DRUGTYPE Antisense drug D02OHL HIGHSTAT Investigative D02OYJ DRUG__ID D02OYJ D02OYJ THERCLAS Antiviral Agents D02OYJ DRUGTYPE Vaccine D02OYJ HIGHSTAT Investigative D02PGM DRUG__ID D02PGM D02PGM DRUGCOMP Isis Pharmaceuticals D02PGM DRUGTYPE Antisense drug D02PGM HIGHSTAT Investigative D02QOL DRUG__ID D02QOL D02QOL DRUGCOMP XOMA Ltd D02QOL DRUGTYPE Antibody D02QOL HIGHSTAT Investigative D02QWL DRUG__ID D02QWL D02QWL DRUGCOMP Isis Pharmaceuticals D02QWL DRUGTYPE Antisense drug D02QWL HIGHSTAT Investigative D02SDD DRUG__ID D02SDD D02SDD DRUGCOMP Isis Pharmaceuticals D02SDD DRUGTYPE Antisense drug D02SDD HIGHSTAT Investigative D02TKV DRUG__ID D02TKV D02TKV DRUGCOMP Isis Pharmaceuticals D02TKV DRUGTYPE Antisense drug D02TKV HIGHSTAT Investigative D02TPS DRUG__ID D02TPS D02TPS DRUGCOMP Isis Pharmaceuticals D02TPS DRUGTYPE Antisense drug D02TPS HIGHSTAT Investigative D02UHI DRUG__ID D02UHI D02UHI DRUGCOMP Isis Pharmaceuticals D02UHI DRUGTYPE Antisense drug D02UHI HIGHSTAT Investigative D02VLL DRUG__ID D02VLL D02VLL DRUGCOMP Isis Pharmaceuticals D02VLL DRUGTYPE Antisense drug D02VLL HIGHSTAT Investigative D02VPR DRUG__ID D02VPR D02VPR DRUGCOMP Isis Pharmaceuticals D02VPR DRUGTYPE Antisense drug D02VPR HIGHSTAT Investigative D02VPS DRUG__ID D02VPS D02VPS DRUGCOMP Galaxy Biotech LLC D02VPS DRUGTYPE Antibody D02VPS HIGHSTAT Investigative D02WXX DRUG__ID D02WXX D02WXX DRUGCOMP Isis Pharmaceuticals D02WXX DRUGTYPE Antisense drug D02WXX HIGHSTAT Investigative D02XQB DRUG__ID D02XQB D02XQB DRUGCOMP Isis Pharmaceuticals D02XQB DRUGTYPE Antisense drug D02XQB HIGHSTAT Investigative D02YNE DRUG__ID D02YNE D02YNE DRUGCOMP Isis Pharmaceuticals D02YNE DRUGTYPE Antisense drug D02YNE HIGHSTAT Investigative D02YSO DRUG__ID D02YSO D02YSO DRUGCOMP Genexine Co Ltd D02YSO DRUGTYPE Antibody D02YSO HIGHSTAT Investigative D02YVB DRUG__ID D02YVB D02YVB DRUGCOMP Isis Pharmaceuticals D02YVB DRUGTYPE Antisense drug D02YVB HIGHSTAT Investigative D02YXE DRUG__ID D02YXE D02YXE DRUGCOMP Isis Pharmaceuticals D02YXE DRUGTYPE Antisense drug D02YXE HIGHSTAT Investigative D02ZMH DRUG__ID D02ZMH D02ZMH DRUGCOMP Isis Pharmaceuticals D02ZMH DRUGTYPE Antisense drug D02ZMH HIGHSTAT Investigative D02ZPT DRUG__ID D02ZPT D02ZPT DRUGCOMP Isis Pharmaceuticals D02ZPT DRUGTYPE Antisense drug D02ZPT HIGHSTAT Investigative D02ZTS DRUG__ID D02ZTS D02ZTS DRUGCOMP Isis Pharmaceuticals D02ZTS DRUGTYPE Antisense drug D02ZTS HIGHSTAT Investigative D03ALC DRUG__ID D03ALC D03ALC DRUGTYPE Small molecular drug D03ALC DRUGSMIL C1CN2C(=NC(C3C2(C1(O)O)N=C(N3)N)COC(=O)N)N.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O D03ALC HIGHSTAT Investigative D03BQD DRUG__ID D03BQD D03BQD DRUGCOMP NeurAxon D03BQD THERCLAS Anticancer Agents D03BQD HIGHSTAT Investigative D03BSQ DRUG__ID D03BSQ D03BSQ DRUGCOMP Isis Pharmaceuticals D03BSQ DRUGTYPE Antisense drug D03BSQ HIGHSTAT Investigative D03ESU DRUG__ID D03ESU D03ESU DRUGCOMP Mapp Biopharmaceutical Inc D03ESU DRUGTYPE Monoclonal antibody D03ESU HIGHSTAT Investigative D03EYM DRUG__ID D03EYM D03EYM DRUGCOMP Isis Pharmaceuticals D03EYM DRUGTYPE Antisense drug D03EYM HIGHSTAT Investigative D03HGW DRUG__ID D03HGW D03HGW DRUGCOMP AVEO Pharmaceuticals Inc D03HGW DRUGTYPE Antibody D03HGW HIGHSTAT Investigative D03HVU DRUG__ID D03HVU D03HVU DRUGCOMP Isis Pharmaceuticals D03HVU DRUGTYPE Antisense drug D03HVU HIGHSTAT Investigative D03IPJ DRUG__ID D03IPJ D03IPJ DRUGCOMP Isis Pharmaceuticals D03IPJ DRUGTYPE Antisense drug D03IPJ HIGHSTAT Investigative D03IWY DRUG__ID D03IWY D03IWY DRUGCOMP Isis Pharmaceuticals D03IWY DRUGTYPE Antisense drug D03IWY HIGHSTAT Investigative D03JVY DRUG__ID D03JVY D03JVY DRUGCOMP Isis Pharmaceuticals D03JVY DRUGTYPE Antisense drug D03JVY HIGHSTAT Investigative D03KLM DRUG__ID D03KLM D03KLM DRUGTYPE Small molecular drug D03KLM DRUGSMIL CC1=CC2=C(C=C1)NC(=C2NO)C3=C4C=C(C=CC4=NC3=O)Cl D03KLM HIGHSTAT Investigative D03KWU DRUG__ID D03KWU D03KWU THERCLAS Antiviral Agents D03KWU DRUGTYPE Vaccine D03KWU HIGHSTAT Investigative D03MRO DRUG__ID D03MRO D03MRO DRUGCOMP Isis Pharmaceuticals D03MRO DRUGTYPE Antisense drug D03MRO HIGHSTAT Investigative D03MWW DRUG__ID D03MWW D03MWW DRUGCOMP Isis Pharmaceuticals D03MWW DRUGTYPE Antisense drug D03MWW HIGHSTAT Investigative D03NEA DRUG__ID D03NEA D03NEA DRUGCOMP Isis Pharmaceuticals D03NEA DRUGTYPE Antisense drug D03NEA HIGHSTAT Investigative D03NKE DRUG__ID D03NKE D03NKE DRUGTYPE Small molecular drug D03NKE DRUGSMIL CN1C(=O)C(=CC2=CNC3=C2C=CC(=C3)Br)N=C1N D03NKE HIGHSTAT Investigative D03NLG DRUG__ID D03NLG D03NLG DRUGCOMP Isis Pharmaceuticals D03NLG DRUGTYPE Antisense drug D03NLG HIGHSTAT Investigative D03NWC DRUG__ID D03NWC D03NWC DRUGCOMP Shenogen Pharma Group Ltd D03NWC DRUGTYPE Antibody D03NWC HIGHSTAT Investigative D03OGC DRUG__ID D03OGC D03OGC DRUGCOMP Isis Pharmaceuticals D03OGC DRUGTYPE Antisense drug D03OGC HIGHSTAT Investigative D03PCV DRUG__ID D03PCV D03PCV DRUGCOMP Isis Pharmaceuticals D03PCV DRUGTYPE Antisense drug D03PCV HIGHSTAT Investigative D03RER DRUG__ID D03RER D03RER DRUGCOMP Isis Pharmaceuticals D03RER DRUGTYPE Antisense drug D03RER HIGHSTAT Investigative D03RKU DRUG__ID D03RKU D03RKU DRUGCOMP Isis Pharmaceuticals D03RKU DRUGTYPE Antisense drug D03RKU HIGHSTAT Investigative D03SQZ DRUG__ID D03SQZ D03SQZ DRUGCOMP Isis Pharmaceuticals D03SQZ DRUGTYPE Antisense drug D03SQZ HIGHSTAT Investigative D03UCG DRUG__ID D03UCG D03UCG DRUGTYPE Small molecule immunotherapy D03UCG HIGHSTAT Investigative D03UCG COMPCLAS Benzyl phenyl ether derivatives D03YXG DRUG__ID D03YXG D03YXG DRUGCOMP Isis Pharmaceuticals D03YXG DRUGTYPE Antisense drug D03YXG HIGHSTAT Investigative D03ZHM DRUG__ID D03ZHM D03ZHM DRUGCOMP Isis Pharmaceuticals D03ZHM DRUGTYPE Antisense drug D03ZHM HIGHSTAT Investigative D03ZNK DRUG__ID D03ZNK D03ZNK DRUGCOMP The Center of Molecular Immunology D03ZNK DRUGTYPE Monoclonal antibody D03ZNK HIGHSTAT Investigative D04AGE DRUG__ID D04AGE D04AGE DRUGTYPE Small molecular drug D04AGE DRUGSMIL COC1=CC2=C(C=C1)NC(=C2NO)C3=C4C=C(C=CC4=NC3=O)F D04AGE HIGHSTAT Investigative D04AJS DRUG__ID D04AJS D04AJS DRUGCOMP Isis Pharmaceuticals D04AJS DRUGTYPE Antisense drug D04AJS HIGHSTAT Investigative D04BON DRUG__ID D04BON D04BON DRUGTYPE Small molecule immunotherapy D04BON HIGHSTAT Investigative D04BON COMPCLAS Oxadiazole/thiadiazole derivatives D04CLQ DRUG__ID D04CLQ D04CLQ DRUGCOMP Isis Pharmaceuticals D04CLQ DRUGTYPE Antisense drug D04CLQ HIGHSTAT Investigative D04CYY DRUG__ID D04CYY D04CYY DRUGCOMP Isis Pharmaceuticals D04CYY DRUGTYPE Antisense drug D04CYY HIGHSTAT Investigative D04DQT DRUG__ID D04DQT D04DQT THERCLAS Antiviral Agents D04DQT DRUGTYPE Combination drug D04DQT HIGHSTAT Investigative D04EVL DRUG__ID D04EVL D04EVL DRUGCOMP Isis Pharmaceuticals D04EVL DRUGTYPE Antisense drug D04EVL HIGHSTAT Investigative D04FHQ DRUG__ID D04FHQ D04FHQ DRUGCOMP Isis Pharmaceuticals D04FHQ DRUGTYPE Antisense drug D04FHQ HIGHSTAT Investigative D04GCH DRUG__ID D04GCH D04GCH DRUGCOMP Biocon Ltd D04GCH DRUGTYPE Antibody D04GCH HIGHSTAT Investigative D04GPC DRUG__ID D04GPC D04GPC DRUGCOMP Isis Pharmaceuticals D04GPC DRUGTYPE Antisense drug D04GPC HIGHSTAT Investigative D04GPF DRUG__ID D04GPF D04GPF DRUGCOMP Isis Pharmaceuticals D04GPF DRUGTYPE Antisense drug D04GPF HIGHSTAT Investigative D04IBO DRUG__ID D04IBO D04IBO DRUGCOMP Isis Pharmaceuticals D04IBO DRUGTYPE Antisense drug D04IBO HIGHSTAT Investigative D04KGB DRUG__ID D04KGB D04KGB DRUGCOMP Theraclone Sciences Inc D04KGB DRUGTYPE Monoclonal antibody D04KGB HIGHSTAT Investigative D04KSX DRUG__ID D04KSX D04KSX DRUGCOMP Isis Pharmaceuticals D04KSX DRUGTYPE Antisense drug D04KSX HIGHSTAT Investigative D04LHI DRUG__ID D04LHI D04LHI DRUGCOMP Isis Pharmaceuticals D04LHI DRUGTYPE Antisense drug D04LHI HIGHSTAT Investigative D04LLB DRUG__ID D04LLB D04LLB DRUGCOMP Isis Pharmaceuticals D04LLB DRUGTYPE Antisense drug D04LLB HIGHSTAT Investigative D04NBZ DRUG__ID D04NBZ D04NBZ DRUGCOMP Isis Pharmaceuticals D04NBZ DRUGTYPE Antisense drug D04NBZ HIGHSTAT Investigative D04NVK DRUG__ID D04NVK D04NVK DRUGCOMP Johns Hopkins University School of Medicine D04NVK DRUGTYPE Aptamer D04NVK HIGHSTAT Investigative D04OUT DRUG__ID D04OUT D04OUT DRUGCOMP Isis Pharmaceuticals D04OUT DRUGTYPE Antisense drug D04OUT HIGHSTAT Investigative D04PAF DRUG__ID D04PAF D04PAF DRUGCOMP AnaptysBio Inc D04PAF DRUGTYPE Antibody D04PAF HIGHSTAT Investigative D04PFD DRUG__ID D04PFD D04PFD DRUGCOMP Universite Libre de Bruxelles D04PFD DRUGTYPE Vaccine D04PFD HIGHSTAT Investigative D04PSH DRUG__ID D04PSH D04PSH DRUGCOMP Isis Pharmaceuticals D04PSH DRUGTYPE Antisense drug D04PSH HIGHSTAT Investigative D04PYV DRUG__ID D04PYV D04PYV DRUGCOMP Isis Pharmaceuticals D04PYV DRUGTYPE Antisense drug D04PYV HIGHSTAT Investigative D04QGF DRUG__ID D04QGF D04QGF DRUGTYPE Small molecule immunotherapy D04QGF HIGHSTAT Investigative D04QGF COMPCLAS Cyclic peptidomimetic derivatives D04QYU DRUG__ID D04QYU D04QYU DRUGCOMP Isis Pharmaceuticals D04QYU DRUGTYPE Antisense drug D04QYU HIGHSTAT Investigative D04REL DRUG__ID D04REL D04REL DRUGCOMP Isis Pharmaceuticals D04REL DRUGTYPE Antisense drug D04REL HIGHSTAT Investigative D04RGM DRUG__ID D04RGM D04RGM DRUGCOMP Isis Pharmaceuticals D04RGM DRUGTYPE Antisense drug D04RGM HIGHSTAT Investigative D04SUV DRUG__ID D04SUV D04SUV DRUGCOMP Isis Pharmaceuticals D04SUV DRUGTYPE Antisense drug D04SUV HIGHSTAT Investigative D04SWT DRUG__ID D04SWT D04SWT DRUGCOMP Vasculox Inc D04SWT DRUGTYPE Monoclonal antibody D04SWT HIGHSTAT Investigative D04UYY DRUG__ID D04UYY D04UYY DRUGCOMP Chinese Academy of Medical Science D04UYY DRUGTYPE Antibody D04UYY HIGHSTAT Investigative D04VQC DRUG__ID D04VQC D04VQC DRUGCOMP Isis Pharmaceuticals D04VQC DRUGTYPE Antisense drug D04VQC HIGHSTAT Investigative D04WJM DRUG__ID D04WJM D04WJM DRUGCOMP Isis Pharmaceuticals D04WJM DRUGTYPE Antisense drug D04WJM HIGHSTAT Investigative D04WRK DRUG__ID D04WRK D04WRK DRUGCOMP Isis Pharmaceuticals D04WRK DRUGTYPE Antisense drug D04WRK HIGHSTAT Investigative D04XOE DRUG__ID D04XOE D04XOE DRUGCOMP Isis Pharmaceuticals D04XOE DRUGTYPE Antisense drug D04XOE HIGHSTAT Investigative D04YKA DRUG__ID D04YKA D04YKA DRUGCOMP Isis Pharmaceuticals D04YKA DRUGTYPE Antisense drug D04YKA HIGHSTAT Investigative D04YQN DRUG__ID D04YQN D04YQN DRUGCOMP Isis Pharmaceuticals D04YQN DRUGTYPE Antisense drug D04YQN HIGHSTAT Investigative D04YWU DRUG__ID D04YWU D04YWU DRUGCOMP Isis Pharmaceuticals D04YWU DRUGTYPE Antisense drug D04YWU HIGHSTAT Investigative D04ZIA DRUG__ID D04ZIA D04ZIA DRUGCOMP Isis Pharmaceuticals D04ZIA DRUGTYPE Antisense drug D04ZIA HIGHSTAT Investigative D05AYU DRUG__ID D05AYU D05AYU DRUGCOMP Isis Pharmaceuticals D05AYU DRUGTYPE Antisense drug D05AYU HIGHSTAT Investigative D05BFX DRUG__ID D05BFX D05BFX DRUGCOMP Isis Pharmaceuticals D05BFX DRUGTYPE Antisense drug D05BFX HIGHSTAT Investigative D05BQE DRUG__ID D05BQE D05BQE DRUGTYPE Small molecular drug D05BQE DRUGSMIL C1=C(N=C2C(=N1)NC(=NC2=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC3C(C(C(O3)N4C=NC5=C(N=CN=C54)N)O)O D05BQE HIGHSTAT Investigative D05CCZ DRUG__ID D05CCZ D05CCZ DRUGCOMP Isis Pharmaceuticals D05CCZ DRUGTYPE Antisense drug D05CCZ HIGHSTAT Investigative D05DBJ DRUG__ID D05DBJ D05DBJ DRUGTYPE Small molecular drug D05DBJ DRUGSMIL CC1=CC(=O)N=C(N1)SCC2=CC=C(C=C2)OC D05DBJ HIGHSTAT Investigative D05EHP DRUG__ID D05EHP D05EHP DRUGCOMP Isis Pharmaceuticals D05EHP DRUGTYPE Antisense drug D05EHP HIGHSTAT Investigative D05EJO DRUG__ID D05EJO D05EJO DRUGCOMP Isis Pharmaceuticals D05EJO DRUGTYPE Antisense drug D05EJO HIGHSTAT Investigative D05FGY DRUG__ID D05FGY D05FGY DRUGCOMP Isis Pharmaceuticals D05FGY DRUGTYPE siRNA drug D05FGY HIGHSTAT Investigative D05FIN DRUG__ID D05FIN D05FIN DRUGCOMP Isis Pharmaceuticals D05FIN DRUGTYPE Antisense drug D05FIN HIGHSTAT Investigative D05GCI DRUG__ID D05GCI D05GCI DRUGCOMP Isis Pharmaceuticals D05GCI DRUGTYPE Antisense drug D05GCI HIGHSTAT Investigative D05GIO DRUG__ID D05GIO D05GIO DRUGCOMP Molecular Discoveries LLC D05GIO DRUGTYPE Antibody D05GIO HIGHSTAT Investigative D05GSI DRUG__ID D05GSI D05GSI DRUGCOMP Eli Lilly & Co D05GSI DRUGTYPE Antibody D05GSI HIGHSTAT Investigative D05HEJ DRUG__ID D05HEJ D05HEJ DRUGCOMP ImmuneXcite Inc D05HEJ DRUGTYPE Monoclonal antibody D05HEJ HIGHSTAT Investigative D05HUP DRUG__ID D05HUP D05HUP DRUGCOMP Isis Pharmaceuticals D05HUP DRUGTYPE Antisense drug D05HUP HIGHSTAT Investigative D05IUQ DRUG__ID D05IUQ D05IUQ DRUGCOMP Genomic Systems LLC D05IUQ DRUGTYPE Monoclonal antibody D05IUQ HIGHSTAT Investigative D05LSD DRUG__ID D05LSD D05LSD DRUGCOMP Isis Pharmaceuticals D05LSD DRUGTYPE Antisense drug D05LSD HIGHSTAT Investigative D05PDW DRUG__ID D05PDW D05PDW DRUGCOMP Isis Pharmaceuticals D05PDW DRUGTYPE Antisense drug D05PDW HIGHSTAT Investigative D05PRC DRUG__ID D05PRC D05PRC DRUGCOMP Isis Pharmaceuticals D05PRC DRUGTYPE Antisense drug D05PRC HIGHSTAT Investigative D05QQI DRUG__ID D05QQI D05QQI DRUGCOMP Isis Pharmaceuticals D05QQI DRUGTYPE Antisense drug D05QQI HIGHSTAT Investigative D05QWZ DRUG__ID D05QWZ D05QWZ DRUGCOMP Isis Pharmaceuticals D05QWZ DRUGTYPE Antisense drug D05QWZ HIGHSTAT Investigative D05RDM DRUG__ID D05RDM D05RDM DRUGCOMP Isis Pharmaceuticals D05RDM DRUGTYPE Antisense drug D05RDM HIGHSTAT Investigative D05RJQ DRUG__ID D05RJQ D05RJQ DRUGCOMP Isis Pharmaceuticals D05RJQ DRUGTYPE Antisense drug D05RJQ HIGHSTAT Investigative D05RSX DRUG__ID D05RSX D05RSX DRUGCOMP Isis Pharmaceuticals D05RSX DRUGTYPE Antisense drug D05RSX HIGHSTAT Investigative D05THV DRUG__ID D05THV D05THV DRUGCOMP Isis Pharmaceuticals D05THV DRUGTYPE Antisense drug D05THV HIGHSTAT Investigative D05UAO DRUG__ID D05UAO D05UAO DRUGCOMP Actinium Pharmaceuticals Inc D05UAO DRUGTYPE Antibody D05UAO HIGHSTAT Investigative D05VBN DRUG__ID D05VBN D05VBN DRUGCOMP Isis Pharmaceuticals D05VBN DRUGTYPE Antisense drug D05VBN HIGHSTAT Investigative D05WAM DRUG__ID D05WAM D05WAM DRUGCOMP Isis Pharmaceuticals D05WAM DRUGTYPE Antisense drug D05WAM HIGHSTAT Investigative D05WJI DRUG__ID D05WJI D05WJI DRUGCOMP Isis Pharmaceuticals D05WJI DRUGTYPE Antisense drug D05WJI HIGHSTAT Investigative D05YJU DRUG__ID D05YJU D05YJU DRUGCOMP Isis Pharmaceuticals D05YJU DRUGTYPE Antisense drug D05YJU HIGHSTAT Investigative D05ZKG DRUG__ID D05ZKG D05ZKG DRUGCOMP Isis Pharmaceuticals D05ZKG DRUGTYPE Antisense drug D05ZKG HIGHSTAT Investigative D05ZQZ DRUG__ID D05ZQZ D05ZQZ DRUGCOMP Isis Pharmaceuticals D05ZQZ DRUGTYPE Antisense drug D05ZQZ HIGHSTAT Investigative D05ZZH DRUG__ID D05ZZH D05ZZH DRUGCOMP Isis Pharmaceuticals D05ZZH DRUGTYPE Antisense drug D05ZZH HIGHSTAT Investigative D06AOQ DRUG__ID D06AOQ D06AOQ DRUGCOMP Isis Pharmaceuticals D06AOQ DRUGTYPE Antisense drug D06AOQ HIGHSTAT Investigative D06AZX DRUG__ID D06AZX D06AZX DRUGCOMP Isis Pharmaceuticals D06AZX DRUGTYPE Antisense drug D06AZX HIGHSTAT Investigative D06BPU DRUG__ID D06BPU D06BPU DRUGTYPE Small molecular drug D06BPU DRUGSMIL CN(C)CCNC1=C2C(=C3C=CC(=O)C=C3N1)C4=CC=CC=C4C2=O D06BPU HIGHSTAT Investigative D06CTD DRUG__ID D06CTD D06CTD DRUGCOMP Immuno-Biological Laboratories Co Ltd D06CTD DRUGTYPE Antibody D06CTD HIGHSTAT Investigative D06DMI DRUG__ID D06DMI D06DMI DRUGCOMP Isis Pharmaceuticals D06DMI DRUGTYPE Antisense drug D06DMI HIGHSTAT Investigative D06DMT DRUG__ID D06DMT D06DMT DRUGCOMP Isis Pharmaceuticals D06DMT DRUGTYPE Antisense drug D06DMT HIGHSTAT Investigative D06DVW DRUG__ID D06DVW D06DVW DRUGCOMP Isis Pharmaceuticals D06DVW DRUGTYPE Antisense drug D06DVW HIGHSTAT Investigative D06EBJ DRUG__ID D06EBJ D06EBJ DRUGCOMP Northwest Biotherapeutics Inc D06EBJ DRUGTYPE Antibody D06EBJ HIGHSTAT Investigative D06EPV DRUG__ID D06EPV D06EPV DRUGCOMP Isis Pharmaceuticals D06EPV DRUGTYPE Antisense drug D06EPV HIGHSTAT Investigative D06FJE DRUG__ID D06FJE D06FJE DRUGCOMP Isis Pharmaceuticals D06FJE DRUGTYPE Antisense drug D06FJE HIGHSTAT Investigative D06GGT DRUG__ID D06GGT D06GGT THERCLAS Antisense D06GGT DRUGTYPE Combination drug (Antisense drug) D06GGT HIGHSTAT Investigative D06GLV DRUG__ID D06GLV D06GLV DRUGTYPE Small molecular drug D06GLV DRUGSMIL C1=CC2=C(C=C1F)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)F)NO D06GLV HIGHSTAT Investigative D06GOO DRUG__ID D06GOO D06GOO DRUGCOMP Isis Pharmaceuticals D06GOO DRUGTYPE Antisense drug D06GOO HIGHSTAT Investigative D06HPB DRUG__ID D06HPB D06HPB DRUGCOMP Isis Pharmaceuticals D06HPB DRUGTYPE Antisense drug D06HPB HIGHSTAT Investigative D06IZU DRUG__ID D06IZU D06IZU DRUGCOMP Isis Pharmaceuticals D06IZU DRUGTYPE Antisense drug D06IZU HIGHSTAT Investigative D06JEJ DRUG__ID D06JEJ D06JEJ DRUGCOMP Isis Pharmaceuticals D06JEJ DRUGTYPE Antisense drug D06JEJ HIGHSTAT Investigative D06JUQ DRUG__ID D06JUQ D06JUQ DRUGCOMP Isis Pharmaceuticals D06JUQ DRUGTYPE Antisense drug D06JUQ HIGHSTAT Investigative D06LIA DRUG__ID D06LIA D06LIA DRUGTYPE Small molecular drug D06LIA DRUGSMIL CC1C2=CC=CC=C2NC(=N1)NC D06LIA HIGHSTAT Investigative D06LLJ DRUG__ID D06LLJ D06LLJ DRUGCOMP Isis Pharmaceuticals D06LLJ DRUGTYPE Antisense drug D06LLJ HIGHSTAT Investigative D06LOB DRUG__ID D06LOB D06LOB DRUGCOMP Isis Pharmaceuticals D06LOB DRUGTYPE Antisense drug D06LOB HIGHSTAT Investigative D06LVL DRUG__ID D06LVL D06LVL DRUGCOMP Isis Pharmaceuticals D06LVL DRUGTYPE Antisense drug D06LVL HIGHSTAT Investigative D06LWP DRUG__ID D06LWP D06LWP DRUGCOMP Isis Pharmaceuticals D06LWP DRUGTYPE Antisense drug D06LWP HIGHSTAT Investigative D06NHW DRUG__ID D06NHW D06NHW DRUGCOMP Isis Pharmaceuticals D06NHW DRUGTYPE Antisense drug D06NHW HIGHSTAT Investigative D06NSN DRUG__ID D06NSN D06NSN DRUGCOMP Isis Pharmaceuticals D06NSN DRUGTYPE Antisense drug D06NSN HIGHSTAT Investigative D06QZK DRUG__ID D06QZK D06QZK DRUGCOMP Isis Pharmaceuticals D06QZK DRUGTYPE Antisense drug D06QZK HIGHSTAT Investigative D06REI DRUG__ID D06REI D06REI DRUGCOMP Isis Pharmaceuticals D06REI DRUGTYPE Antisense drug D06REI HIGHSTAT Investigative D06RHG DRUG__ID D06RHG D06RHG DRUGCOMP Isis Pharmaceuticals D06RHG DRUGTYPE Antisense drug D06RHG HIGHSTAT Investigative D06RQD DRUG__ID D06RQD D06RQD DRUGCOMP MabVax Therapeutics Inc D06RQD DRUGTYPE Monoclonal antibody D06RQD HIGHSTAT Investigative D06SDT DRUG__ID D06SDT D06SDT DRUGCOMP Isis Pharmaceuticals D06SDT DRUGTYPE Antisense drug D06SDT HIGHSTAT Investigative D06TJI DRUG__ID D06TJI D06TJI DRUGCOMP Isis Pharmaceuticals D06TJI DRUGTYPE Antisense drug D06TJI HIGHSTAT Investigative D06UNC DRUG__ID D06UNC D06UNC DRUGCOMP Isis Pharmaceuticals D06UNC DRUGTYPE Antisense drug D06UNC HIGHSTAT Investigative D06VFH DRUG__ID D06VFH D06VFH DRUGCOMP Isis Pharmaceuticals D06VFH DRUGTYPE Antisense drug D06VFH HIGHSTAT Investigative D06XIW DRUG__ID D06XIW D06XIW DRUGTYPE Small molecular drug D06XIW DRUGSMIL C1=CC2=NC(=O)C(=C2C=C1F)C3=C(C4=C(N3)C=CC(=C4)Cl)NO D06XIW HIGHSTAT Investigative D06YDM DRUG__ID D06YDM D06YDM DRUGCOMP Isis Pharmaceuticals D06YDM DRUGTYPE Antisense drug D06YDM HIGHSTAT Investigative D06YSI DRUG__ID D06YSI D06YSI DRUGCOMP Isis Pharmaceuticals D06YSI DRUGTYPE Antisense drug D06YSI HIGHSTAT Investigative D06YZW DRUG__ID D06YZW D06YZW DRUGCOMP Isis Pharmaceuticals D06YZW DRUGTYPE Antisense drug D06YZW HIGHSTAT Investigative D06ZTM DRUG__ID D06ZTM D06ZTM DRUGCOMP Isis Pharmaceuticals D06ZTM DRUGTYPE Antisense drug D06ZTM HIGHSTAT Investigative D07AGD DRUG__ID D07AGD D07AGD DRUGCOMP Isis Pharmaceuticals D07AGD DRUGTYPE Antisense drug D07AGD HIGHSTAT Investigative D07AMO DRUG__ID D07AMO D07AMO DRUGCOMP Isis Pharmaceuticals D07AMO DRUGTYPE Antisense drug D07AMO HIGHSTAT Investigative D07AUV DRUG__ID D07AUV D07AUV DRUGCOMP Isis Pharmaceuticals D07AUV DRUGTYPE Antisense drug D07AUV HIGHSTAT Investigative D07BCS DRUG__ID D07BCS D07BCS DRUGCOMP Isis Pharmaceuticals D07BCS DRUGTYPE Antisense drug D07BCS HIGHSTAT Investigative D07BGQ DRUG__ID D07BGQ D07BGQ DRUGTYPE Small molecular drug D07BGQ DRUGSMIL CSCC1(CN(CC1O)CC2=CNC3=C2NC=NC3=O)F D07BGQ HIGHSTAT Investigative D07BOF DRUG__ID D07BOF D07BOF DRUGTYPE Small molecule immunotherapy D07BOF HIGHSTAT Investigative D07BOF COMPCLAS Cyclic peptidomimetic derivatives D07CCC DRUG__ID D07CCC D07CCC DRUGCOMP Isis Pharmaceuticals D07CCC DRUGTYPE Antisense drug D07CCC HIGHSTAT Investigative D07CFW DRUG__ID D07CFW D07CFW DRUGCOMP PharmAbcine D07CFW DRUGTYPE Monoclonal antibody D07CFW HIGHSTAT Investigative D07DLW DRUG__ID D07DLW D07DLW DRUGTYPE Small molecular drug D07DLW DRUGSMIL CCCNC1=NC(C2=CC=CC=C2N1)C D07DLW HIGHSTAT Investigative D07EFO DRUG__ID D07EFO D07EFO DRUGCOMP Isis Pharmaceuticals D07EFO DRUGTYPE Antisense drug D07EFO HIGHSTAT Investigative D07FEF DRUG__ID D07FEF D07FEF DRUGTYPE Small molecule immunotherapy D07FEF HIGHSTAT Investigative D07FEF COMPCLAS Macrocyclic peptide compounds D07FJI DRUG__ID D07FJI D07FJI DRUGCOMP Isis Pharmaceuticals D07FJI DRUGTYPE Antisense drug D07FJI HIGHSTAT Investigative D07FSX DRUG__ID D07FSX D07FSX DRUGCOMP Isis Pharmaceuticals D07FSX DRUGTYPE Antisense drug D07FSX HIGHSTAT Investigative D07GVC DRUG__ID D07GVC D07GVC DRUGCOMP Isis Pharmaceuticals D07GVC DRUGTYPE Antisense drug D07GVC HIGHSTAT Investigative D07HIJ DRUG__ID D07HIJ D07HIJ DRUGCOMP Isis Pharmaceuticals D07HIJ DRUGTYPE Antisense drug D07HIJ HIGHSTAT Investigative D07HSU DRUG__ID D07HSU D07HSU DRUGCOMP Isis Pharmaceuticals D07HSU DRUGTYPE Antisense drug D07HSU HIGHSTAT Investigative D07JFD DRUG__ID D07JFD D07JFD DRUGCOMP Isis Pharmaceuticals D07JFD DRUGTYPE Antisense drug D07JFD HIGHSTAT Investigative D07JHY DRUG__ID D07JHY D07JHY DRUGCOMP Isis Pharmaceuticals D07JHY DRUGTYPE Antisense drug D07JHY HIGHSTAT Investigative D07JOW DRUG__ID D07JOW D07JOW DRUGCOMP XTL Biopharmaceuticals Ltd D07JOW DRUGTYPE Monoclonal antibody D07JOW HIGHSTAT Investigative D07LCE DRUG__ID D07LCE D07LCE DRUGTYPE Small molecular drug D07LCE DRUGSMIL C1C2C(=NC(=O)N2)NC3=CC=CC=C31 D07LCE HIGHSTAT Investigative D07LZP DRUG__ID D07LZP D07LZP DRUGCOMP Isis Pharmaceuticals D07LZP DRUGTYPE Antisense drug D07LZP HIGHSTAT Investigative D07MGX DRUG__ID D07MGX D07MGX DRUGCOMP Isis Pharmaceuticals D07MGX DRUGTYPE Antisense drug D07MGX HIGHSTAT Investigative D07MZD DRUG__ID D07MZD D07MZD DRUGTYPE Small molecular drug D07MZD DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=NC4=NC3=O)NO D07MZD HIGHSTAT Investigative D07NAT DRUG__ID D07NAT D07NAT DRUGCOMP Isis Pharmaceuticals D07NAT DRUGTYPE Antisense drug D07NAT HIGHSTAT Investigative D07NIM DRUG__ID D07NIM D07NIM DRUGCOMP Isis Pharmaceuticals D07NIM DRUGTYPE Antisense drug D07NIM HIGHSTAT Investigative D07NMV DRUG__ID D07NMV D07NMV DRUGCOMP Isis Pharmaceuticals D07NMV DRUGTYPE Antisense drug D07NMV HIGHSTAT Investigative D07NRU DRUG__ID D07NRU D07NRU DRUGCOMP Isis Pharmaceuticals D07NRU DRUGTYPE Antisense drug D07NRU HIGHSTAT Investigative D07OIZ DRUG__ID D07OIZ D07OIZ DRUGCOMP Peregrine Pharmaceuticals Inc D07OIZ DRUGTYPE Antibody D07OIZ HIGHSTAT Investigative D07PVS DRUG__ID D07PVS D07PVS DRUGCOMP Isis Pharmaceuticals D07PVS DRUGTYPE Antisense drug D07PVS HIGHSTAT Investigative D07PWY DRUG__ID D07PWY D07PWY DRUGCOMP AVEO Pharmaceuticals Inc D07PWY DRUGTYPE Antibody D07PWY HIGHSTAT Investigative D07QCW DRUG__ID D07QCW D07QCW DRUGCOMP Isis Pharmaceuticals D07QCW DRUGTYPE Antisense drug D07QCW HIGHSTAT Investigative D07QMC DRUG__ID D07QMC D07QMC DRUGTYPE Small molecular drug D07QMC DRUGSMIL C1=CC=C2C(=C1)NC(=C3C=C4C=CC=CC4=NC3=O)N2 D07QMC HIGHSTAT Investigative D07QVR DRUG__ID D07QVR D07QVR DRUGCOMP Isis Pharmaceuticals D07QVR DRUGTYPE Antisense drug D07QVR HIGHSTAT Investigative D07QZA DRUG__ID D07QZA D07QZA DRUGCOMP Isis Pharmaceuticals D07QZA DRUGTYPE Antisense drug D07QZA HIGHSTAT Investigative D07RJW DRUG__ID D07RJW D07RJW DRUGCOMP Isis Pharmaceuticals D07RJW DRUGTYPE Antisense drug D07RJW HIGHSTAT Investigative D07RML DRUG__ID D07RML D07RML DRUGCOMP Isis Pharmaceuticals D07RML DRUGTYPE Antisense drug D07RML HIGHSTAT Investigative D07RUF DRUG__ID D07RUF D07RUF DRUGCOMP Isis Pharmaceuticals D07RUF DRUGTYPE Antisense drug D07RUF HIGHSTAT Investigative D07RVX DRUG__ID D07RVX D07RVX DRUGCOMP Isis Pharmaceuticals D07RVX DRUGTYPE Antisense drug D07RVX HIGHSTAT Investigative D07TDZ DRUG__ID D07TDZ D07TDZ DRUGCOMP Isis Pharmaceuticals D07TDZ DRUGTYPE Antisense drug D07TDZ HIGHSTAT Investigative D07TMI DRUG__ID D07TMI D07TMI DRUGCOMP Isis Pharmaceuticals D07TMI DRUGTYPE Antisense drug D07TMI HIGHSTAT Investigative D07UKR DRUG__ID D07UKR D07UKR DRUGCOMP Isis Pharmaceuticals D07UKR DRUGTYPE Antisense drug D07UKR HIGHSTAT Investigative D07VCG DRUG__ID D07VCG D07VCG DRUGCOMP PharmAbcine D07VCG DRUGTYPE Monoclonal antibody D07VCG HIGHSTAT Investigative D07WAF DRUG__ID D07WAF D07WAF DRUGCOMP Amorfix Life Sciences Ltd D07WAF DRUGTYPE Antibody D07WAF HIGHSTAT Investigative D07WBD DRUG__ID D07WBD D07WBD DRUGCOMP Isis Pharmaceuticals D07WBD DRUGTYPE Antisense drug D07WBD HIGHSTAT Investigative D07WCX DRUG__ID D07WCX D07WCX DRUGCOMP Isis Pharmaceuticals D07WCX DRUGTYPE Antisense drug D07WCX HIGHSTAT Investigative D07WFF DRUG__ID D07WFF D07WFF DRUGCOMP Isis Pharmaceuticals D07WFF DRUGTYPE Antisense drug D07WFF HIGHSTAT Investigative D07XKC DRUG__ID D07XKC D07XKC DRUGCOMP Isis Pharmaceuticals D07XKC DRUGTYPE Antisense drug D07XKC HIGHSTAT Investigative D07XNG DRUG__ID D07XNG D07XNG DRUGCOMP Isis Pharmaceuticals D07XNG DRUGTYPE Antisense drug D07XNG HIGHSTAT Investigative D07XNO DRUG__ID D07XNO D07XNO DRUGCOMP Isis Pharmaceuticals D07XNO DRUGTYPE Antisense drug D07XNO HIGHSTAT Investigative D07XRC DRUG__ID D07XRC D07XRC DRUGCOMP Isis Pharmaceuticals D07XRC DRUGTYPE Antisense drug D07XRC HIGHSTAT Investigative D07ZWS DRUG__ID D07ZWS D07ZWS DRUGCOMP Isis Pharmaceuticals D07ZWS DRUGTYPE Antisense drug D07ZWS HIGHSTAT Investigative D08AHE DRUG__ID D08AHE D08AHE DRUGCOMP Isis Pharmaceuticals D08AHE DRUGTYPE Antisense drug D08AHE HIGHSTAT Investigative D08BCH DRUG__ID D08BCH D08BCH DRUGTYPE Small molecular drug D08BCH DRUGSMIL C1CCC(C1)NC2=C3C(=NC(=N2)NN=NC(=O)NC4=CC=CC=C4)N(C=N3)C5C(C(C(O5)CO)O)O D08BCH HIGHSTAT Investigative D08CMT DRUG__ID D08CMT D08CMT DRUGCOMP Isis Pharmaceuticals D08CMT DRUGTYPE Antisense drug D08CMT HIGHSTAT Investigative D08CQR DRUG__ID D08CQR D08CQR DRUGCOMP Isis Pharmaceuticals D08CQR DRUGTYPE Antisense drug D08CQR HIGHSTAT Investigative D08CWX DRUG__ID D08CWX D08CWX DRUGCOMP Vaccinex Inc D08CWX DRUGTYPE Antibody D08CWX HIGHSTAT Investigative D08CYT DRUG__ID D08CYT D08CYT DRUGCOMP Isis Pharmaceuticals D08CYT DRUGTYPE Antisense drug D08CYT HIGHSTAT Investigative D08DCT DRUG__ID D08DCT D08DCT DRUGCOMP Isis Pharmaceuticals D08DCT DRUGTYPE Antisense drug D08DCT HIGHSTAT Investigative D08ENJ DRUG__ID D08ENJ D08ENJ DRUGCOMP Compugen Ltd D08ENJ DRUGTYPE Monoclonal antibody D08ENJ HIGHSTAT Investigative D08EVF DRUG__ID D08EVF D08EVF DRUGCOMP Pfizer Inc D08EVF DRUGTYPE Monoclonal antibody D08EVF HIGHSTAT Investigative D08FVO DRUG__ID D08FVO D08FVO DRUGCOMP Isis Pharmaceuticals D08FVO DRUGTYPE Antisense drug D08FVO HIGHSTAT Investigative D08FVS DRUG__ID D08FVS D08FVS DRUGCOMP Isis Pharmaceuticals D08FVS DRUGTYPE Antisense drug D08FVS HIGHSTAT Investigative D08HXB DRUG__ID D08HXB D08HXB THERCLAS Antiviral Agents D08HXB DRUGTYPE Combination drug D08HXB HIGHSTAT Investigative D08HZN DRUG__ID D08HZN D08HZN DRUGCOMP XOMA Ltd D08HZN DRUGTYPE Antibody D08HZN HIGHSTAT Investigative D08IBR DRUG__ID D08IBR D08IBR DRUGCOMP Isis Pharmaceuticals D08IBR DRUGTYPE Antisense drug D08IBR HIGHSTAT Investigative D08IDM DRUG__ID D08IDM D08IDM DRUGCOMP Isis Pharmaceuticals D08IDM DRUGTYPE Antisense drug D08IDM HIGHSTAT Investigative D08IOW DRUG__ID D08IOW D08IOW DRUGCOMP Isis Pharmaceuticals D08IOW DRUGTYPE Antisense drug D08IOW HIGHSTAT Investigative D08JIG DRUG__ID D08JIG D08JIG DRUGCOMP Isis Pharmaceuticals D08JIG DRUGTYPE Antisense drug D08JIG HIGHSTAT Investigative D08LZK DRUG__ID D08LZK D08LZK DRUGCOMP Isis Pharmaceuticals D08LZK DRUGTYPE Antisense drug D08LZK HIGHSTAT Investigative D08MOL DRUG__ID D08MOL D08MOL DRUGCOMP Trellis Bioscience Inc D08MOL DRUGTYPE Monoclonal antibody D08MOL HIGHSTAT Investigative D08MYP DRUG__ID D08MYP D08MYP DRUGCOMP Isis Pharmaceuticals D08MYP DRUGTYPE Antisense drug D08MYP HIGHSTAT Investigative D08NLU DRUG__ID D08NLU D08NLU DRUGCOMP Isis Pharmaceuticals D08NLU DRUGTYPE Antisense drug D08NLU HIGHSTAT Investigative D08NVD DRUG__ID D08NVD D08NVD DRUGCOMP Isis Pharmaceuticals D08NVD DRUGTYPE Antisense drug D08NVD HIGHSTAT Investigative D08OLG DRUG__ID D08OLG D08OLG DRUGCOMP Isis Pharmaceuticals D08OLG DRUGTYPE Antisense drug D08OLG HIGHSTAT Investigative D08PJN DRUG__ID D08PJN D08PJN DRUGCOMP Isis Pharmaceuticals D08PJN DRUGTYPE Antisense drug D08PJN HIGHSTAT Investigative D08RDK DRUG__ID D08RDK D08RDK DRUGCOMP Isis Pharmaceuticals D08RDK DRUGTYPE Antisense drug D08RDK HIGHSTAT Investigative D08SHY DRUG__ID D08SHY D08SHY DRUGCOMP Isis Pharmaceuticals D08SHY DRUGTYPE Antisense drug D08SHY HIGHSTAT Investigative D08SMF DRUG__ID D08SMF D08SMF DRUGCOMP Isis Pharmaceuticals D08SMF DRUGTYPE Antisense drug D08SMF HIGHSTAT Investigative D08SPM DRUG__ID D08SPM D08SPM DRUGCOMP Isis Pharmaceuticals D08SPM DRUGTYPE Antisense drug D08SPM HIGHSTAT Investigative D08TQK DRUG__ID D08TQK D08TQK DRUGCOMP NovelMed Therapeutics Inc D08TQK DRUGTYPE Antibody D08TQK HIGHSTAT Investigative D08VKT DRUG__ID D08VKT D08VKT THERCLAS Antisense D08VKT DRUGTYPE Antisense drug D08VKT HIGHSTAT Investigative D08WJY DRUG__ID D08WJY D08WJY DRUGCOMP Isis Pharmaceuticals D08WJY DRUGTYPE Antisense drug D08WJY HIGHSTAT Investigative D08WXD DRUG__ID D08WXD D08WXD DRUGCOMP Isis Pharmaceuticals D08WXD DRUGTYPE Antisense drug D08WXD HIGHSTAT Investigative D08XCL DRUG__ID D08XCL D08XCL DRUGCOMP Isis Pharmaceuticals D08XCL DRUGTYPE Antisense drug D08XCL HIGHSTAT Investigative D08YCI DRUG__ID D08YCI D08YCI DRUGCOMP Isis Pharmaceuticals D08YCI DRUGTYPE Antisense drug D08YCI HIGHSTAT Investigative D08YXP DRUG__ID D08YXP D08YXP DRUGCOMP Isis Pharmaceuticals D08YXP DRUGTYPE Antisense drug D08YXP HIGHSTAT Investigative D08ZWA DRUG__ID D08ZWA D08ZWA DRUGCOMP Isis Pharmaceuticals D08ZWA DRUGTYPE Antisense drug D08ZWA HIGHSTAT Investigative D09AIJ DRUG__ID D09AIJ D09AIJ DRUGCOMP Isis Pharmaceuticals D09AIJ DRUGTYPE Antisense drug D09AIJ HIGHSTAT Investigative D09BIH DRUG__ID D09BIH D09BIH DRUGCOMP Isis Pharmaceuticals D09BIH DRUGTYPE Antisense drug D09BIH HIGHSTAT Investigative D09BPT DRUG__ID D09BPT D09BPT DRUGCOMP Osaka University D09BPT DRUGTYPE Monoclonal antibody D09BPT HIGHSTAT Investigative D09BYN DRUG__ID D09BYN D09BYN DRUGTYPE Small molecule immunotherapy D09BYN HIGHSTAT Investigative D09BYN COMPCLAS Macrocyclic peptidomimetic compounds D09CBI DRUG__ID D09CBI D09CBI DRUGCOMP GTC Biotherapeutics Inc D09CBI DRUGTYPE Monoclonal antibody D09CBI HIGHSTAT Investigative D09CKT DRUG__ID D09CKT D09CKT DRUGCOMP Lilly D09CKT THERCLAS Psychiatric D09CKT HIGHSTAT Investigative D09DCJ DRUG__ID D09DCJ D09DCJ DRUGCOMP Isis Pharmaceuticals D09DCJ DRUGTYPE Antisense drug D09DCJ HIGHSTAT Investigative D09EQS DRUG__ID D09EQS D09EQS DRUGCOMP Isis Pharmaceuticals D09EQS DRUGTYPE Antisense drug D09EQS HIGHSTAT Investigative D09GRF DRUG__ID D09GRF D09GRF DRUGCOMP Isis Pharmaceuticals D09GRF DRUGTYPE Antisense drug D09GRF HIGHSTAT Investigative D09HDQ DRUG__ID D09HDQ D09HDQ DRUGCOMP Isis Pharmaceuticals D09HDQ DRUGTYPE Antisense drug D09HDQ HIGHSTAT Investigative D09HJE DRUG__ID D09HJE D09HJE DRUGCOMP Isis Pharmaceuticals D09HJE DRUGTYPE Antisense drug D09HJE HIGHSTAT Investigative D09IOO DRUG__ID D09IOO D09IOO DRUGCOMP Isis Pharmaceuticals D09IOO DRUGTYPE Antisense drug D09IOO HIGHSTAT Investigative D09IVP DRUG__ID D09IVP D09IVP DRUGCOMP Xencor Inc D09IVP DRUGTYPE Monoclonal antibody D09IVP HIGHSTAT Investigative D09JJF DRUG__ID D09JJF D09JJF DRUGCOMP Isis Pharmaceuticals D09JJF DRUGTYPE Antisense drug D09JJF HIGHSTAT Investigative D09JXY DRUG__ID D09JXY D09JXY DRUGCOMP Isis Pharmaceuticals D09JXY DRUGTYPE Antisense drug D09JXY HIGHSTAT Investigative D09KDC DRUG__ID D09KDC D09KDC DRUGCOMP Isis Pharmaceuticals D09KDC DRUGTYPE siRNA drug D09KDC HIGHSTAT Investigative D09KVB DRUG__ID D09KVB D09KVB DRUGCOMP Isis Pharmaceuticals D09KVB DRUGTYPE Antisense drug D09KVB HIGHSTAT Investigative D09LKE DRUG__ID D09LKE D09LKE DRUGCOMP Isis Pharmaceuticals D09LKE DRUGTYPE Antisense drug D09LKE HIGHSTAT Investigative D09LKZ DRUG__ID D09LKZ D09LKZ DRUGCOMP Isis Pharmaceuticals D09LKZ DRUGTYPE Antisense drug D09LKZ HIGHSTAT Investigative D09LXC DRUG__ID D09LXC D09LXC DRUGCOMP Isis Pharmaceuticals D09LXC DRUGTYPE Antisense drug D09LXC HIGHSTAT Investigative D09LXU DRUG__ID D09LXU D09LXU DRUGCOMP Isis Pharmaceuticals D09LXU DRUGTYPE Antisense drug D09LXU HIGHSTAT Investigative D09MAB DRUG__ID D09MAB D09MAB DRUGCOMP Xencor Inc D09MAB DRUGTYPE Monoclonal antibody D09MAB HIGHSTAT Investigative D09MRY DRUG__ID D09MRY D09MRY DRUGCOMP Acumen Pharmaceuticals Inc D09MRY DRUGTYPE Vaccine D09MRY HIGHSTAT Investigative D09NFR DRUG__ID D09NFR D09NFR DRUGCOMP Isis Pharmaceuticals D09NFR DRUGTYPE Antisense drug D09NFR HIGHSTAT Investigative D09NLT DRUG__ID D09NLT D09NLT DRUGCOMP Isis Pharmaceuticals D09NLT DRUGTYPE Antisense drug D09NLT HIGHSTAT Investigative D09PFL DRUG__ID D09PFL D09PFL DRUGCOMP Isis Pharmaceuticals D09PFL DRUGTYPE Antisense drug D09PFL HIGHSTAT Investigative D09PKJ DRUG__ID D09PKJ D09PKJ DRUGTYPE Small molecular drug D09PKJ DRUGSMIL C1=CC=C2C(=C1)C3=NC(=C4C=CON4)N=C3C=N2 D09PKJ HIGHSTAT Investigative D09PKZ DRUG__ID D09PKZ D09PKZ DRUGCOMP NovelMed Therapeutics Inc D09PKZ DRUGTYPE Antibody D09PKZ HIGHSTAT Investigative D09PLZ DRUG__ID D09PLZ D09PLZ DRUGCOMP NovImmune SA D09PLZ DRUGTYPE Antibody D09PLZ HIGHSTAT Investigative D09QRG DRUG__ID D09QRG D09QRG THERCLAS Antiviral Agents D09QRG DRUGTYPE Protein/peptide drug D09QRG HIGHSTAT Investigative D09RFD DRUG__ID D09RFD D09RFD DRUGCOMP Isis Pharmaceuticals D09RFD DRUGTYPE Antisense drug D09RFD HIGHSTAT Investigative D09RGS DRUG__ID D09RGS D09RGS DRUGCOMP University of Amsterdam D09RGS DRUGTYPE Monoclonal antibody D09RGS HIGHSTAT Investigative D09RTT DRUG__ID D09RTT D09RTT DRUGCOMP Isis Pharmaceuticals D09RTT DRUGTYPE Antisense drug D09RTT HIGHSTAT Investigative D09RXX DRUG__ID D09RXX D09RXX DRUGCOMP GTC Biotherapeutics Inc D09RXX DRUGTYPE Antibody D09RXX HIGHSTAT Investigative D09TIM DRUG__ID D09TIM D09TIM DRUGCOMP Isis Pharmaceuticals D09TIM DRUGTYPE Antisense drug D09TIM HIGHSTAT Investigative D09VLX DRUG__ID D09VLX D09VLX DRUGCOMP Isis Pharmaceuticals D09VLX DRUGTYPE Antisense drug D09VLX HIGHSTAT Investigative D09WIW DRUG__ID D09WIW D09WIW DRUGCOMP Isis Pharmaceuticals D09WIW DRUGTYPE Antisense drug D09WIW HIGHSTAT Investigative D09WUL DRUG__ID D09WUL D09WUL DRUGCOMP Isis Pharmaceuticals D09WUL DRUGTYPE Antisense drug D09WUL HIGHSTAT Investigative D09XIQ DRUG__ID D09XIQ D09XIQ DRUGCOMP Isis Pharmaceuticals D09XIQ DRUGTYPE Antisense drug D09XIQ HIGHSTAT Investigative D09YBP DRUG__ID D09YBP D09YBP DRUGCOMP Isis Pharmaceuticals D09YBP DRUGTYPE Antisense drug D09YBP HIGHSTAT Investigative D09YRP DRUG__ID D09YRP D09YRP DRUGCOMP Isis Pharmaceuticals D09YRP DRUGTYPE Antisense drug D09YRP HIGHSTAT Investigative D09ZWE DRUG__ID D09ZWE D09ZWE DRUGCOMP PharmAbcine D09ZWE DRUGTYPE Monoclonal antibody D09ZWE HIGHSTAT Investigative D0A0VB DRUG__ID D0A0VB D0A0VB DRUGCOMP Isis Pharmaceuticals D0A0VB DRUGTYPE Antisense drug D0A0VB HIGHSTAT Investigative D0A0ZY DRUG__ID D0A0ZY D0A0ZY DRUGCOMP Alder Biopharmaceuticals Inc D0A0ZY DRUGTYPE Antibody D0A0ZY HIGHSTAT Investigative D0A2MA DRUG__ID D0A2MA D0A2MA DRUGCOMP TcL Pharma D0A2MA DRUGTYPE Antibody D0A2MA HIGHSTAT Investigative D0A2OL DRUG__ID D0A2OL D0A2OL DRUGCOMP Isis Pharmaceuticals D0A2OL DRUGTYPE Antisense drug D0A2OL HIGHSTAT Investigative D0A2PN DRUG__ID D0A2PN D0A2PN DRUGCOMP Isis Pharmaceuticals D0A2PN DRUGTYPE Antisense drug D0A2PN HIGHSTAT Investigative D0A3PB DRUG__ID D0A3PB D0A3PB DRUGCOMP Isis Pharmaceuticals D0A3PB DRUGTYPE Antisense drug D0A3PB HIGHSTAT Investigative D0A3RM DRUG__ID D0A3RM D0A3RM DRUGCOMP Isis Pharmaceuticals D0A3RM DRUGTYPE Antisense drug D0A3RM HIGHSTAT Investigative D0A4MW DRUG__ID D0A4MW D0A4MW DRUGCOMP Isis Pharmaceuticals D0A4MW DRUGTYPE Antisense drug D0A4MW HIGHSTAT Investigative D0A5FV DRUG__ID D0A5FV D0A5FV DRUGCOMP Isis Pharmaceuticals D0A5FV DRUGTYPE Antisense drug D0A5FV HIGHSTAT Investigative D0A5LC DRUG__ID D0A5LC D0A5LC DRUGCOMP Isis Pharmaceuticals D0A5LC DRUGTYPE Antisense drug D0A5LC HIGHSTAT Investigative D0A5LZ DRUG__ID D0A5LZ D0A5LZ DRUGCOMP Isis Pharmaceuticals D0A5LZ DRUGTYPE Antisense drug D0A5LZ HIGHSTAT Investigative D0A5RM DRUG__ID D0A5RM D0A5RM DRUGTYPE Small molecular drug D0A5RM DRUGSMIL C1=CC(=O)C=CC1=NNC2=C(NN=C2N)N D0A5RM HIGHSTAT Investigative D0A6GY DRUG__ID D0A6GY D0A6GY DRUGCOMP Isis Pharmaceuticals D0A6GY DRUGTYPE Antisense drug D0A6GY HIGHSTAT Investigative D0A6NK DRUG__ID D0A6NK D0A6NK DRUGCOMP Isis Pharmaceuticals D0A6NK DRUGTYPE Antisense drug D0A6NK HIGHSTAT Investigative D0A7AV DRUG__ID D0A7AV D0A7AV DRUGCOMP Isis Pharmaceuticals D0A7AV DRUGTYPE Antisense drug D0A7AV HIGHSTAT Investigative D0A7SE DRUG__ID D0A7SE D0A7SE DRUGCOMP Isis Pharmaceuticals D0A7SE DRUGTYPE Antisense drug D0A7SE HIGHSTAT Investigative D0A9BO DRUG__ID D0A9BO D0A9BO DRUGCOMP PanGenetics BV D0A9BO DRUGTYPE Antibody D0A9BO HIGHSTAT Investigative D0A9EI DRUG__ID D0A9EI D0A9EI DRUGCOMP Isis Pharmaceuticals D0A9EI DRUGTYPE Antisense drug D0A9EI HIGHSTAT Investigative D0A9JA DRUG__ID D0A9JA D0A9JA DRUGCOMP INSERM D0A9JA DRUGTYPE Monoclonal antibody D0A9JA HIGHSTAT Investigative D0A9LB DRUG__ID D0A9LB D0A9LB DRUGCOMP Isis Pharmaceuticals D0A9LB DRUGTYPE Antisense drug D0A9LB HIGHSTAT Investigative D0AD6Z DRUG__ID D0AD6Z D0AD6Z DRUGCOMP Pierre Fabre SA D0AD6Z DRUGTYPE Antibody D0AD6Z HIGHSTAT Investigative D0AD7L DRUG__ID D0AD7L D0AD7L DRUGCOMP Isis Pharmaceuticals D0AD7L DRUGTYPE Antisense drug D0AD7L HIGHSTAT Investigative D0AH5P DRUG__ID D0AH5P D0AH5P DRUGCOMP Isis Pharmaceuticals D0AH5P DRUGTYPE Antisense drug D0AH5P HIGHSTAT Investigative D0AI1L DRUG__ID D0AI1L D0AI1L DRUGCOMP Isis Pharmaceuticals D0AI1L DRUGTYPE Antisense drug D0AI1L HIGHSTAT Investigative D0AJ0H DRUG__ID D0AJ0H D0AJ0H DRUGCOMP Isis Pharmaceuticals D0AJ0H DRUGTYPE Antisense drug D0AJ0H HIGHSTAT Investigative D0AJ5N DRUG__ID D0AJ5N D0AJ5N DRUGCOMP Isis Pharmaceuticals D0AJ5N DRUGTYPE Antisense drug D0AJ5N HIGHSTAT Investigative D0AL2R DRUG__ID D0AL2R D0AL2R DRUGCOMP Isis Pharmaceuticals D0AL2R DRUGTYPE Antisense drug D0AL2R HIGHSTAT Investigative D0AL8P DRUG__ID D0AL8P D0AL8P DRUGCOMP Isis Pharmaceuticals D0AL8P DRUGTYPE Antisense drug D0AL8P HIGHSTAT Investigative D0AM9O DRUG__ID D0AM9O D0AM9O DRUGCOMP Biocytogen D0AM9O DRUGTYPE Bispecific antibody-drug conjugate D0AM9O HIGHSTAT Investigative D0AY9R DRUG__ID D0AY9R D0AY9R THERCLAS Antiviral Agents D0AY9R DRUGTYPE Vaccine D0AY9R HIGHSTAT Investigative D0B0HK DRUG__ID D0B0HK D0B0HK THERCLAS Antisense D0B0HK DRUGTYPE Combination drug (Antisense drug) D0B0HK HIGHSTAT Investigative D0B0PX DRUG__ID D0B0PX D0B0PX DRUGCOMP Isis Pharmaceuticals D0B0PX DRUGTYPE Antisense drug D0B0PX HIGHSTAT Investigative D0B1CJ DRUG__ID D0B1CJ D0B1CJ DRUGCOMP Cytodesign Inc D0B1CJ DRUGTYPE Monoclonal antibody D0B1CJ HIGHSTAT Investigative D0B1LM DRUG__ID D0B1LM D0B1LM DRUGTYPE Small molecular drug D0B1LM DRUGSMIL C1=CC2=C(C=C1F)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)Cl)NO D0B1LM HIGHSTAT Investigative D0B1US DRUG__ID D0B1US D0B1US DRUGCOMP Isis Pharmaceuticals D0B1US DRUGTYPE Antisense drug D0B1US HIGHSTAT Investigative D0B2EL DRUG__ID D0B2EL D0B2EL DRUGCOMP Isis Pharmaceuticals D0B2EL DRUGTYPE Antisense drug D0B2EL HIGHSTAT Investigative D0B2UF DRUG__ID D0B2UF D0B2UF DRUGCOMP Isis Pharmaceuticals D0B2UF DRUGTYPE Antisense drug D0B2UF HIGHSTAT Investigative D0B4AH DRUG__ID D0B4AH D0B4AH DRUGCOMP Intellect Neurosciences Inc D0B4AH DRUGTYPE Vaccine D0B4AH HIGHSTAT Investigative D0B4WR DRUG__ID D0B4WR D0B4WR DRUGTYPE Small molecular drug D0B4WR DRUGSMIL C1=CC=C2C(=C1)C3=NC(=C4C=CNO4)N=C3C=N2 D0B4WR HIGHSTAT Investigative D0B5LQ DRUG__ID D0B5LQ D0B5LQ DRUGCOMP Isis Pharmaceuticals D0B5LQ DRUGTYPE Antisense drug D0B5LQ HIGHSTAT Investigative D0B5OL DRUG__ID D0B5OL D0B5OL DRUGCOMP Isis Pharmaceuticals D0B5OL DRUGTYPE Antisense drug D0B5OL HIGHSTAT Investigative D0B6MQ DRUG__ID D0B6MQ D0B6MQ DRUGTYPE Small molecular drug D0B6MQ DRUGSMIL C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC(=O)C2=C(N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O D0B6MQ HIGHSTAT Investigative D0B6WV DRUG__ID D0B6WV D0B6WV DRUGCOMP LG Life Sciences Ltd D0B6WV DRUGTYPE Antibody D0B6WV HIGHSTAT Investigative D0B7TH DRUG__ID D0B7TH D0B7TH DRUGCOMP Centocor Ortho Biotech Inc D0B7TH DRUGTYPE Monoclonal antibody D0B7TH HIGHSTAT Investigative D0B9MZ DRUG__ID D0B9MZ D0B9MZ DRUGCOMP Isis Pharmaceuticals D0B9MZ DRUGTYPE Antisense drug D0B9MZ HIGHSTAT Investigative D0BG2L DRUG__ID D0BG2L D0BG2L DRUGCOMP XOMA Ltd D0BG2L DRUGTYPE Antibody D0BG2L HIGHSTAT Investigative D0BJ0W DRUG__ID D0BJ0W D0BJ0W DRUGCOMP Isis Pharmaceuticals D0BJ0W DRUGTYPE Antisense drug D0BJ0W HIGHSTAT Investigative D0BP5T DRUG__ID D0BP5T D0BP5T DRUGTYPE Small molecular drug D0BP5T DRUGSMIL C1=C(C2=C(N1)C(=O)N=CN2)C3C(C(C(N3)CO)O)O D0BP5T HIGHSTAT Investigative D0BP6T DRUG__ID D0BP6T D0BP6T DRUGCOMP Isis Pharmaceuticals D0BP6T DRUGTYPE Antisense drug D0BP6T HIGHSTAT Investigative D0BR7X DRUG__ID D0BR7X D0BR7X DRUGCOMP Isis Pharmaceuticals D0BR7X DRUGTYPE Antisense drug D0BR7X HIGHSTAT Investigative D0BU2V DRUG__ID D0BU2V D0BU2V DRUGTYPE Small molecule immunotherapy D0BU2V HIGHSTAT Investigative D0BU2V COMPCLAS Oxadiazole/thiadiazole derivatives D0BX6Z DRUG__ID D0BX6Z D0BX6Z DRUGTYPE Small molecule immunotherapy D0BX6Z HIGHSTAT Investigative D0BX6Z COMPCLAS Oxadiazole/thiadiazole derivatives D0BX7G DRUG__ID D0BX7G D0BX7G DRUGCOMP Amorfix Life Sciences Ltd D0BX7G DRUGTYPE Monoclonal antibody D0BX7G HIGHSTAT Investigative D0BY0Y DRUG__ID D0BY0Y D0BY0Y DRUGCOMP Algeta ASA D0BY0Y DRUGTYPE Monoclonal antibody D0BY0Y HIGHSTAT Investigative D0BY9R DRUG__ID D0BY9R D0BY9R DRUGCOMP Isis Pharmaceuticals D0BY9R DRUGTYPE Antisense drug D0BY9R HIGHSTAT Investigative D0C0EE DRUG__ID D0C0EE D0C0EE DRUGCOMP Isis Pharmaceuticals D0C0EE DRUGTYPE Antisense drug D0C0EE HIGHSTAT Investigative D0C1BL DRUG__ID D0C1BL D0C1BL DRUGCOMP Boehringer Ingelheim Corp D0C1BL DRUGTYPE Monoclonal antibody D0C1BL HIGHSTAT Investigative D0C1CA DRUG__ID D0C1CA D0C1CA DRUGCOMP Isis Pharmaceuticals D0C1CA DRUGTYPE Antisense drug D0C1CA HIGHSTAT Investigative D0C1NA DRUG__ID D0C1NA D0C1NA DRUGCOMP Isis Pharmaceuticals D0C1NA DRUGTYPE Antisense drug D0C1NA HIGHSTAT Investigative D0C1YA DRUG__ID D0C1YA D0C1YA DRUGCOMP Isis Pharmaceuticals D0C1YA DRUGTYPE Antisense drug D0C1YA HIGHSTAT Investigative D0C1ZW DRUG__ID D0C1ZW D0C1ZW DRUGCOMP Isis Pharmaceuticals D0C1ZW DRUGTYPE Antisense drug D0C1ZW HIGHSTAT Investigative D0C2CP DRUG__ID D0C2CP D0C2CP DRUGCOMP IATRICa Inc D0C2CP DRUGTYPE Monoclonal antibody D0C2CP HIGHSTAT Investigative D0C2IG DRUG__ID D0C2IG D0C2IG DRUGCOMP Isis Pharmaceuticals D0C2IG DRUGTYPE Antisense drug D0C2IG HIGHSTAT Investigative D0C3LW DRUG__ID D0C3LW D0C3LW DRUGCOMP Isis Pharmaceuticals D0C3LW DRUGTYPE Antisense drug D0C3LW HIGHSTAT Investigative D0C3UV DRUG__ID D0C3UV D0C3UV DRUGCOMP Isis Pharmaceuticals D0C3UV DRUGTYPE Antisense drug D0C3UV HIGHSTAT Investigative D0C4ET DRUG__ID D0C4ET D0C4ET DRUGCOMP Isis Pharmaceuticals D0C4ET DRUGTYPE Antisense drug D0C4ET HIGHSTAT Investigative D0C5BL DRUG__ID D0C5BL D0C5BL DRUGCOMP Isis Pharmaceuticals D0C5BL DRUGTYPE Antisense drug D0C5BL HIGHSTAT Investigative D0C5SO DRUG__ID D0C5SO D0C5SO THERCLAS Antiviral Agents D0C5SO DRUGTYPE Small molecular drug D0C5SO HIGHSTAT Investigative D0C5VI DRUG__ID D0C5VI D0C5VI DRUGCOMP Isis Pharmaceuticals D0C5VI DRUGTYPE Antisense drug D0C5VI HIGHSTAT Investigative D0C7QW DRUG__ID D0C7QW D0C7QW DRUGCOMP XOMA Ltd D0C7QW DRUGTYPE Antibody D0C7QW HIGHSTAT Investigative D0C8WA DRUG__ID D0C8WA D0C8WA DRUGCOMP Isis Pharmaceuticals D0C8WA DRUGTYPE Antisense drug D0C8WA HIGHSTAT Investigative D0C9FX DRUG__ID D0C9FX D0C9FX DRUGCOMP Isis Pharmaceuticals D0C9FX DRUGTYPE Antisense drug D0C9FX HIGHSTAT Investigative D0CE4H DRUG__ID D0CE4H D0CE4H DRUGCOMP Isis Pharmaceuticals D0CE4H DRUGTYPE Antisense drug D0CE4H HIGHSTAT Investigative D0CE9S DRUG__ID D0CE9S D0CE9S THERCLAS Antiviral Agents D0CE9S DRUGTYPE Vaccine D0CE9S HIGHSTAT Investigative D0CS4K DRUG__ID D0CS4K D0CS4K DRUGCOMP Isis Pharmaceuticals D0CS4K DRUGTYPE Antisense drug D0CS4K HIGHSTAT Investigative D0CW7X DRUG__ID D0CW7X D0CW7X DRUGCOMP Isis Pharmaceuticals D0CW7X DRUGTYPE Antisense drug D0CW7X HIGHSTAT Investigative D0D0GS DRUG__ID D0D0GS D0D0GS DRUGCOMP ForHumanTech Co Ltd D0D0GS DRUGTYPE siRNA drug D0D0GS HIGHSTAT Investigative D0D0OO DRUG__ID D0D0OO D0D0OO DRUGCOMP Isis Pharmaceuticals D0D0OO DRUGTYPE Antisense drug D0D0OO HIGHSTAT Investigative D0D0YK DRUG__ID D0D0YK D0D0YK DRUGCOMP GlobeImmune Inc D0D0YK DRUGTYPE Vaccine D0D0YK HIGHSTAT Investigative D0D1WB DRUG__ID D0D1WB D0D1WB DRUGTYPE Small molecular drug D0D1WB DRUGSMIL CCC(C)C(C(=O)OC)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N D0D1WB HIGHSTAT Investigative D0D2SU DRUG__ID D0D2SU D0D2SU DRUGCOMP Delenex Therapeutics AG D0D2SU DRUGTYPE Antibody D0D2SU HIGHSTAT Investigative D0D3MV DRUG__ID D0D3MV D0D3MV DRUGCOMP Isis Pharmaceuticals D0D3MV DRUGTYPE Antisense drug D0D3MV HIGHSTAT Investigative D0D3QG DRUG__ID D0D3QG D0D3QG DRUGCOMP Isis Pharmaceuticals D0D3QG DRUGTYPE Antisense drug D0D3QG HIGHSTAT Investigative D0D4BR DRUG__ID D0D4BR D0D4BR DRUGCOMP Isis Pharmaceuticals D0D4BR DRUGTYPE Antisense drug D0D4BR HIGHSTAT Investigative D0D5HE DRUG__ID D0D5HE D0D5HE DRUGCOMP Isis Pharmaceuticals D0D5HE DRUGTYPE Antisense drug D0D5HE HIGHSTAT Investigative D0D6YO DRUG__ID D0D6YO D0D6YO DRUGCOMP Isis Pharmaceuticals D0D6YO DRUGTYPE Antisense drug D0D6YO HIGHSTAT Investigative D0D7NA DRUG__ID D0D7NA D0D7NA DRUGCOMP Isis Pharmaceuticals D0D7NA DRUGTYPE Antisense drug D0D7NA HIGHSTAT Investigative D0D8DV DRUG__ID D0D8DV D0D8DV DRUGTYPE Small molecule immunotherapy D0D8DV HIGHSTAT Investigative D0D8DV COMPCLAS Sulfamethizole derivatives D0D9OL DRUG__ID D0D9OL D0D9OL DRUGCOMP Isis Pharmaceuticals D0D9OL DRUGTYPE Antisense drug D0D9OL HIGHSTAT Investigative D0D9PL DRUG__ID D0D9PL D0D9PL DRUGCOMP Isis Pharmaceuticals D0D9PL DRUGTYPE Antisense drug D0D9PL HIGHSTAT Investigative D0D9QN DRUG__ID D0D9QN D0D9QN DRUGCOMP Isis Pharmaceuticals D0D9QN DRUGTYPE Antisense drug D0D9QN HIGHSTAT Investigative D0D9WM DRUG__ID D0D9WM D0D9WM DRUGCOMP Isis Pharmaceuticals D0D9WM DRUGTYPE Antisense drug D0D9WM HIGHSTAT Investigative D0DH8B DRUG__ID D0DH8B D0DH8B DRUGCOMP Isis Pharmaceuticals D0DH8B DRUGTYPE Antisense drug D0DH8B HIGHSTAT Investigative D0DO6G DRUG__ID D0DO6G D0DO6G DRUGCOMP Isis Pharmaceuticals D0DO6G DRUGTYPE Antisense drug D0DO6G HIGHSTAT Investigative D0DR3J DRUG__ID D0DR3J D0DR3J DRUGCOMP Isis Pharmaceuticals D0DR3J DRUGTYPE Antisense drug D0DR3J HIGHSTAT Investigative D0DR7W DRUG__ID D0DR7W D0DR7W DRUGTYPE Small molecular drug D0DR7W DRUGSMIL CN1C(C(=O)N(C1=O)C)C2=C(C3=C(C(=C2C4=C(C=CC(=O)C4=O)CCN(C)C)O)NC=C3CCN)O D0DR7W HIGHSTAT Investigative D0DS2V DRUG__ID D0DS2V D0DS2V DRUGCOMP Isis Pharmaceuticals D0DS2V DRUGTYPE Antisense drug D0DS2V HIGHSTAT Investigative D0DX4W DRUG__ID D0DX4W D0DX4W DRUGCOMP Isis Pharmaceuticals D0DX4W DRUGTYPE Antisense drug D0DX4W HIGHSTAT Investigative D0DY9I DRUG__ID D0DY9I D0DY9I THERCLAS Antiviral Agents D0DY9I DRUGTYPE Vaccine D0DY9I HIGHSTAT Investigative D0E0WX DRUG__ID D0E0WX D0E0WX DRUGCOMP Isis Pharmaceuticals D0E0WX DRUGTYPE Antisense drug D0E0WX HIGHSTAT Investigative D0E3AR DRUG__ID D0E3AR D0E3AR DRUGCOMP Isis Pharmaceuticals D0E3AR DRUGTYPE Antisense drug D0E3AR HIGHSTAT Investigative D0E3ID DRUG__ID D0E3ID D0E3ID DRUGTYPE Small molecular drug D0E3ID DRUGSMIL C1C2=C(C=CC(=C2)I)NC3=NC(=O)CN31 D0E3ID HIGHSTAT Investigative D0E3ZU DRUG__ID D0E3ZU D0E3ZU DRUGCOMP Isis Pharmaceuticals D0E3ZU DRUGTYPE Antisense drug D0E3ZU HIGHSTAT Investigative D0E4IZ DRUG__ID D0E4IZ D0E4IZ DRUGCOMP Isis Pharmaceuticals D0E4IZ DRUGTYPE Antisense drug D0E4IZ HIGHSTAT Investigative D0E4ON DRUG__ID D0E4ON D0E4ON DRUGTYPE Small molecular drug D0E4ON DRUGSMIL CCCCNC1=NC(C2=CC=CC=C2N1)C D0E4ON HIGHSTAT Investigative D0E4UM DRUG__ID D0E4UM D0E4UM DRUGTYPE Small molecule immunotherapy D0E4UM HIGHSTAT Investigative D0E4UM COMPCLAS Macrocyclic peptide compounds D0E5FG DRUG__ID D0E5FG D0E5FG DRUGCOMP Isis Pharmaceuticals D0E5FG DRUGTYPE Antisense drug D0E5FG HIGHSTAT Investigative D0E5TD DRUG__ID D0E5TD D0E5TD DRUGCOMP Isis Pharmaceuticals D0E5TD DRUGTYPE Antisense drug D0E5TD HIGHSTAT Investigative D0E6KA DRUG__ID D0E6KA D0E6KA DRUGCOMP Isis Pharmaceuticals D0E6KA DRUGTYPE Antisense drug D0E6KA HIGHSTAT Investigative D0E7WU DRUG__ID D0E7WU D0E7WU DRUGCOMP Isis Pharmaceuticals D0E7WU DRUGTYPE Antisense drug D0E7WU HIGHSTAT Investigative D0E8GT DRUG__ID D0E8GT D0E8GT DRUGCOMP Isis Pharmaceuticals D0E8GT DRUGTYPE Antisense drug D0E8GT HIGHSTAT Investigative D0E8HH DRUG__ID D0E8HH D0E8HH THERCLAS Antiviral Agents D0E8HH DRUGTYPE Protein/peptide drug D0E8HH HIGHSTAT Investigative D0E8IK DRUG__ID D0E8IK D0E8IK DRUGCOMP Isis Pharmaceuticals D0E8IK DRUGTYPE Antisense drug D0E8IK HIGHSTAT Investigative D0E8OO DRUG__ID D0E8OO D0E8OO DRUGCOMP Isis Pharmaceuticals D0E8OO DRUGTYPE Antisense drug D0E8OO HIGHSTAT Investigative D0E9BQ DRUG__ID D0E9BQ D0E9BQ DRUGCOMP Sialix Inc D0E9BQ DRUGTYPE Monoclonal antibody D0E9BQ HIGHSTAT Investigative D0EE7R DRUG__ID D0EE7R D0EE7R DRUGCOMP Isis Pharmaceuticals D0EE7R DRUGTYPE Antisense drug D0EE7R HIGHSTAT Investigative D0EJ7Q DRUG__ID D0EJ7Q D0EJ7Q DRUGCOMP Isis Pharmaceuticals D0EJ7Q DRUGTYPE Antisense drug D0EJ7Q HIGHSTAT Investigative D0EK3T DRUG__ID D0EK3T D0EK3T DRUGCOMP Isis Pharmaceuticals D0EK3T DRUGTYPE Antisense drug D0EK3T HIGHSTAT Investigative D0F2QP DRUG__ID D0F2QP D0F2QP DRUGCOMP Rottapharm Madaus D0F2QP DRUGTYPE Antibody D0F2QP HIGHSTAT Investigative D0F3OM DRUG__ID D0F3OM D0F3OM DRUGTYPE Small molecular drug D0F3OM DRUGSMIL C1=CC(=NNC2=C(NN=C2N)N)C(=O)C=C1 D0F3OM HIGHSTAT Investigative D0F3PC DRUG__ID D0F3PC D0F3PC DRUGCOMP Isis Pharmaceuticals D0F3PC DRUGTYPE Antisense drug D0F3PC HIGHSTAT Investigative D0F3VI DRUG__ID D0F3VI D0F3VI DRUGCOMP CEL-SCI Corp; Infexion D0F3VI DRUGTYPE Vaccine D0F3VI HIGHSTAT Investigative D0F4GU DRUG__ID D0F4GU D0F4GU DRUGCOMP Isis Pharmaceuticals D0F4GU DRUGTYPE Antisense drug D0F4GU HIGHSTAT Investigative D0F4SF DRUG__ID D0F4SF D0F4SF DRUGCOMP Isis Pharmaceuticals D0F4SF DRUGTYPE Antisense drug D0F4SF HIGHSTAT Investigative D0F4UV DRUG__ID D0F4UV D0F4UV DRUGCOMP Isis Pharmaceuticals D0F4UV DRUGTYPE Antisense drug D0F4UV HIGHSTAT Investigative D0F5SD DRUG__ID D0F5SD D0F5SD DRUGCOMP Isis Pharmaceuticals D0F5SD DRUGTYPE Antisense drug D0F5SD HIGHSTAT Investigative D0F5YL DRUG__ID D0F5YL D0F5YL DRUGCOMP Isis Pharmaceuticals D0F5YL DRUGTYPE Antisense drug D0F5YL HIGHSTAT Investigative D0F7AP DRUG__ID D0F7AP D0F7AP DRUGCOMP Isis Pharmaceuticals D0F7AP DRUGTYPE Antisense drug D0F7AP HIGHSTAT Investigative D0F7RU DRUG__ID D0F7RU D0F7RU DRUGCOMP Novartis AG D0F7RU DRUGTYPE Monoclonal antibody D0F7RU HIGHSTAT Investigative D0F7ZH DRUG__ID D0F7ZH D0F7ZH DRUGCOMP Isis Pharmaceuticals Inc D0F7ZH DRUGTYPE Antisense drug D0F7ZH HIGHSTAT Investigative D0F8GZ DRUG__ID D0F8GZ D0F8GZ DRUGCOMP Isis Pharmaceuticals D0F8GZ DRUGTYPE Antisense drug D0F8GZ HIGHSTAT Investigative D0F8HG DRUG__ID D0F8HG D0F8HG DRUGCOMP Isis Pharmaceuticals D0F8HG DRUGTYPE Antisense drug D0F8HG HIGHSTAT Investigative D0F8KX DRUG__ID D0F8KX D0F8KX DRUGCOMP Isis Pharmaceuticals D0F8KX DRUGTYPE Antisense drug D0F8KX HIGHSTAT Investigative D0F8LL DRUG__ID D0F8LL D0F8LL DRUGCOMP Isis Pharmaceuticals D0F8LL DRUGTYPE Antisense drug D0F8LL HIGHSTAT Investigative D0F8WV DRUG__ID D0F8WV D0F8WV DRUGCOMP Isis Pharmaceuticals D0F8WV DRUGTYPE Antisense drug D0F8WV HIGHSTAT Investigative D0F9AI DRUG__ID D0F9AI D0F9AI DRUGCOMP Isis Pharmaceuticals D0F9AI DRUGTYPE Antisense drug D0F9AI HIGHSTAT Investigative D0F9EM DRUG__ID D0F9EM D0F9EM DRUGCOMP Isis Pharmaceuticals D0F9EM DRUGTYPE Antisense drug D0F9EM HIGHSTAT Investigative D0FD3D DRUG__ID D0FD3D D0FD3D DRUGCOMP Austin Research Institute D0FD3D DRUGTYPE Monoclonal antibody D0FD3D HIGHSTAT Investigative D0FI9M DRUG__ID D0FI9M D0FI9M DRUGCOMP Isis Pharmaceuticals D0FI9M DRUGTYPE Antisense drug D0FI9M HIGHSTAT Investigative D0FV1R DRUG__ID D0FV1R D0FV1R DRUGCOMP AstraZeneca plc D0FV1R DRUGTYPE Monoclonal antibody D0FV1R HIGHSTAT Investigative D0G0JO DRUG__ID D0G0JO D0G0JO DRUGCOMP Isis Pharmaceuticals D0G0JO DRUGTYPE Antisense drug D0G0JO HIGHSTAT Investigative D0G1ML DRUG__ID D0G1ML D0G1ML THERCLAS Antisense D0G1ML DRUGTYPE Antisense drug D0G1ML HIGHSTAT Investigative D0G1SN DRUG__ID D0G1SN D0G1SN DRUGTYPE Aptamer D0G1SN DRUGSMIL CC(C)(C)OC(=O)N1CCC(CC1)CN(CCN(CC2=CN=CN2C)C3=CC=C(C=C3)C#N)S(=O)(=O)C4=CC=CC=C4C5=CC=CC(=C5)CCC(=O)O D0G1SN HIGHSTAT Investigative D0G2FY DRUG__ID D0G2FY D0G2FY DRUGCOMP Crystal Bioscience Inc D0G2FY DRUGTYPE Monoclonal antibody D0G2FY HIGHSTAT Investigative D0G3IV DRUG__ID D0G3IV D0G3IV DRUGCOMP Isis Pharmaceuticals D0G3IV DRUGTYPE Antisense drug D0G3IV HIGHSTAT Investigative D0G3PK DRUG__ID D0G3PK D0G3PK DRUGCOMP Fusion Antibodies Ltd D0G3PK DRUGTYPE Antibody D0G3PK HIGHSTAT Investigative D0G4AE DRUG__ID D0G4AE D0G4AE DRUGCOMP University of California Irvine D0G4AE DRUGTYPE Antibody D0G4AE HIGHSTAT Investigative D0G8CN DRUG__ID D0G8CN D0G8CN DRUGCOMP Isis Pharmaceuticals D0G8CN DRUGTYPE Antisense drug D0G8CN HIGHSTAT Investigative D0G9BP DRUG__ID D0G9BP D0G9BP DRUGCOMP Isis Pharmaceuticals D0G9BP DRUGTYPE Antisense drug D0G9BP HIGHSTAT Investigative D0G9JB DRUG__ID D0G9JB D0G9JB DRUGCOMP Isis Pharmaceuticals D0G9JB DRUGTYPE Antisense drug D0G9JB HIGHSTAT Investigative D0G9UO DRUG__ID D0G9UO D0G9UO DRUGCOMP Navigen Pharmaceuticals Inc D0G9UO DRUGTYPE Monoclonal antibody D0G9UO HIGHSTAT Investigative D0G9WZ DRUG__ID D0G9WZ D0G9WZ DRUGCOMP Isis Pharmaceuticals D0G9WZ DRUGTYPE Antisense drug D0G9WZ HIGHSTAT Investigative D0G9XS DRUG__ID D0G9XS D0G9XS DRUGCOMP Domantis Ltd D0G9XS DRUGTYPE Antibody D0G9XS HIGHSTAT Investigative D0GB7F DRUG__ID D0GB7F D0GB7F DRUGCOMP Ambrx Inc D0GB7F DRUGTYPE Antibody D0GB7F HIGHSTAT Investigative D0GD1R DRUG__ID D0GD1R D0GD1R DRUGCOMP Isis Pharmaceuticals D0GD1R DRUGTYPE Antisense drug D0GD1R HIGHSTAT Investigative D0GG2F DRUG__ID D0GG2F D0GG2F DRUGCOMP Isis Pharmaceuticals D0GG2F DRUGTYPE Antisense drug D0GG2F HIGHSTAT Investigative D0GG6N DRUG__ID D0GG6N D0GG6N DRUGTYPE Small molecule immunotherapy D0GG6N HIGHSTAT Investigative D0GG6N COMPCLAS Macrocyclic peptidomimetic compounds D0GO9G DRUG__ID D0GO9G D0GO9G DRUGCOMP Athera Biotechnologies AB D0GO9G DRUGTYPE Monoclonal antibody D0GO9G HIGHSTAT Investigative D0GP3R DRUG__ID D0GP3R D0GP3R DRUGTYPE Small molecular drug D0GP3R DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)[N+](=O)[O-])NO D0GP3R HIGHSTAT Investigative D0H0EN DRUG__ID D0H0EN D0H0EN DRUGTYPE Small molecular drug D0H0EN DRUGSMIL CC1=CC2=C(C=C1)NC(=C2NO)C3=C4C=C(C=CC4=NC3=O)[N+](=O)[O-] D0H0EN HIGHSTAT Investigative D0H0YU DRUG__ID D0H0YU D0H0YU DRUGCOMP Isis Pharmaceuticals D0H0YU DRUGTYPE Antisense drug D0H0YU HIGHSTAT Investigative D0H1OB DRUG__ID D0H1OB D0H1OB DRUGCOMP Isis Pharmaceuticals D0H1OB DRUGTYPE Antisense drug D0H1OB HIGHSTAT Investigative D0H1WT DRUG__ID D0H1WT D0H1WT THERCLAS Antiviral Agents D0H1WT DRUGTYPE Vaccine D0H1WT HIGHSTAT Investigative D0H2LG DRUG__ID D0H2LG D0H2LG DRUGCOMP Isis Pharmaceuticals D0H2LG DRUGTYPE Antisense drug D0H2LG HIGHSTAT Investigative D0H5MZ DRUG__ID D0H5MZ D0H5MZ DRUGCOMP Isis Pharmaceuticals D0H5MZ DRUGTYPE Antisense drug D0H5MZ HIGHSTAT Investigative D0H6DN DRUG__ID D0H6DN D0H6DN DRUGCOMP Isis Pharmaceuticals D0H6DN DRUGTYPE Antisense drug D0H6DN HIGHSTAT Investigative D0H6LU DRUG__ID D0H6LU D0H6LU DRUGCOMP Isis Pharmaceuticals D0H6LU DRUGTYPE Antisense drug D0H6LU HIGHSTAT Investigative D0H6OL DRUG__ID D0H6OL D0H6OL DRUGCOMP Isis Pharmaceuticals D0H6OL DRUGTYPE Antisense drug D0H6OL HIGHSTAT Investigative D0H7CG DRUG__ID D0H7CG D0H7CG DRUGCOMP Isis Pharmaceuticals D0H7CG DRUGTYPE Antisense drug D0H7CG HIGHSTAT Investigative D0H7MB DRUG__ID D0H7MB D0H7MB DRUGCOMP Lpath Inc D0H7MB DRUGTYPE Monoclonal antibody D0H7MB HIGHSTAT Investigative D0H8BJ DRUG__ID D0H8BJ D0H8BJ DRUGCOMP Isis Pharmaceuticals D0H8BJ DRUGTYPE Antisense drug D0H8BJ HIGHSTAT Investigative D0HU4L DRUG__ID D0HU4L D0HU4L DRUGCOMP Isis Pharmaceuticals D0HU4L DRUGTYPE Antisense drug D0HU4L HIGHSTAT Investigative D0HV7V DRUG__ID D0HV7V D0HV7V DRUGCOMP Isis Pharmaceuticals D0HV7V DRUGTYPE Antisense drug D0HV7V HIGHSTAT Investigative D0HY5G DRUG__ID D0HY5G D0HY5G THERCLAS Antiviral Agents D0HY5G DRUGTYPE Vaccine D0HY5G HIGHSTAT Investigative D0HY7G DRUG__ID D0HY7G D0HY7G DRUGTYPE Peptide D0HY7G HIGHSTAT Investigative D0HY7G COMPCLAS Peptidomimetics D0I0DE DRUG__ID D0I0DE D0I0DE DRUGCOMP Isis Pharmaceuticals D0I0DE DRUGTYPE Antisense drug D0I0DE HIGHSTAT Investigative D0I1AW DRUG__ID D0I1AW D0I1AW DRUGCOMP Isis Pharmaceuticals D0I1AW DRUGTYPE Antisense drug D0I1AW HIGHSTAT Investigative D0I1FS DRUG__ID D0I1FS D0I1FS DRUGCOMP Isis Pharmaceuticals D0I1FS DRUGTYPE Antisense drug D0I1FS HIGHSTAT Investigative D0I2SY DRUG__ID D0I2SY D0I2SY DRUGCOMP Isis Pharmaceuticals D0I2SY DRUGTYPE Antisense drug D0I2SY HIGHSTAT Investigative D0I2VG DRUG__ID D0I2VG D0I2VG DRUGCOMP Isis Pharmaceuticals D0I2VG DRUGTYPE Antisense drug D0I2VG HIGHSTAT Investigative D0I3QX DRUG__ID D0I3QX D0I3QX THERCLAS Antiviral Agents D0I3QX DRUGTYPE Monoclonal antibody D0I3QX HIGHSTAT Investigative D0I4JB DRUG__ID D0I4JB D0I4JB DRUGCOMP Isis Pharmaceuticals D0I4JB DRUGTYPE Antisense drug D0I4JB HIGHSTAT Investigative D0I6AE DRUG__ID D0I6AE D0I6AE DRUGTYPE Small molecular drug D0I6AE DRUGSMIL C1=CC2=NC(=O)C(=C2C=C1[N+](=O)[O-])C3=C(C4=C(N3)C=CC(=C4)Cl)NO D0I6AE HIGHSTAT Investigative D0I6HJ DRUG__ID D0I6HJ D0I6HJ DRUGCOMP Queen Mary University of London D0I6HJ DRUGTYPE Antibody D0I6HJ HIGHSTAT Investigative D0I8BN DRUG__ID D0I8BN D0I8BN DRUGCOMP Isis Pharmaceuticals D0I8BN DRUGTYPE Antisense drug D0I8BN HIGHSTAT Investigative D0I8KZ DRUG__ID D0I8KZ D0I8KZ DRUGCOMP Isis Pharmaceuticals D0I8KZ DRUGTYPE Antisense drug D0I8KZ HIGHSTAT Investigative D0I8NS DRUG__ID D0I8NS D0I8NS DRUGCOMP PharmAbcine D0I8NS DRUGTYPE Monoclonal antibody D0I8NS HIGHSTAT Investigative D0I8QC DRUG__ID D0I8QC D0I8QC DRUGCOMP Theraclone Sciences Inc D0I8QC DRUGTYPE Monoclonal antibody D0I8QC HIGHSTAT Investigative D0I9GE DRUG__ID D0I9GE D0I9GE DRUGCOMP Isis Pharmaceuticals D0I9GE DRUGTYPE Antisense drug D0I9GE HIGHSTAT Investigative D0J1DV DRUG__ID D0J1DV D0J1DV DRUGCOMP Isis Pharmaceuticals D0J1DV DRUGTYPE Antisense drug D0J1DV HIGHSTAT Investigative D0J1FW DRUG__ID D0J1FW D0J1FW DRUGCOMP Isis Pharmaceuticals D0J1FW DRUGTYPE Antisense drug D0J1FW HIGHSTAT Investigative D0J1RS DRUG__ID D0J1RS D0J1RS DRUGCOMP Emergent BioSolutions Inc D0J1RS DRUGTYPE Monoclonal antibody D0J1RS HIGHSTAT Investigative D0J1SU DRUG__ID D0J1SU D0J1SU DRUGCOMP Isis Pharmaceuticals D0J1SU DRUGTYPE Antisense drug D0J1SU HIGHSTAT Investigative D0J2VN DRUG__ID D0J2VN D0J2VN DRUGCOMP Isis Pharmaceuticals D0J2VN DRUGTYPE Antisense drug D0J2VN HIGHSTAT Investigative D0J2ZI DRUG__ID D0J2ZI D0J2ZI DRUGCOMP Isis Pharmaceuticals D0J2ZI DRUGTYPE Antisense drug D0J2ZI HIGHSTAT Investigative D0J3RS DRUG__ID D0J3RS D0J3RS DRUGTYPE Small molecular drug D0J3RS DRUGSMIL C1=CC2=C(C=C1O)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)F)NO D0J3RS HIGHSTAT Investigative D0J5EQ DRUG__ID D0J5EQ D0J5EQ DRUGCOMP Cytoguide ApS D0J5EQ DRUGTYPE Monoclonal antibody D0J5EQ HIGHSTAT Investigative D0J5PL DRUG__ID D0J5PL D0J5PL DRUGCOMP Isis Pharmaceuticals D0J5PL DRUGTYPE Antisense drug D0J5PL HIGHSTAT Investigative D0J7CD DRUG__ID D0J7CD D0J7CD DRUGCOMP Nventa Biopharmaceuticals Corp D0J7CD DRUGTYPE Vaccine D0J7CD HIGHSTAT Investigative D0J7EZ DRUG__ID D0J7EZ D0J7EZ DRUGCOMP Isis Pharmaceuticals D0J7EZ DRUGTYPE Antisense drug D0J7EZ HIGHSTAT Investigative D0J7IV DRUG__ID D0J7IV D0J7IV DRUGCOMP Isis Pharmaceuticals D0J7IV DRUGTYPE Antisense drug D0J7IV HIGHSTAT Investigative D0J9WO DRUG__ID D0J9WO D0J9WO DRUGTYPE Small molecular drug D0J9WO DRUGSMIL C1=CC(=CC(=C1)Br)NC2=C3C=C(C(=O)C=C3NC=N2)O D0J9WO HIGHSTAT Investigative D0JF0B DRUG__ID D0JF0B D0JF0B DRUGTYPE Small molecule immunotherapy D0JF0B HIGHSTAT Investigative D0JF0B COMPCLAS Resorcinol derivatives D0JR0G DRUG__ID D0JR0G D0JR0G DRUGTYPE Small molecular drug D0JR0G DRUGSMIL C1=CC2=C(C=C1O)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)Cl)NO D0JR0G HIGHSTAT Investigative D0JS2L DRUG__ID D0JS2L D0JS2L DRUGCOMP Trellis Bioscience Inc D0JS2L DRUGTYPE Monoclonal antibody D0JS2L HIGHSTAT Investigative D0JV0I DRUG__ID D0JV0I D0JV0I DRUGCOMP Isis Pharmaceuticals D0JV0I DRUGTYPE Antisense drug D0JV0I HIGHSTAT Investigative D0JW2Y DRUG__ID D0JW2Y D0JW2Y DRUGCOMP Mapp Biopharmaceutical Inc D0JW2Y DRUGTYPE Monoclonal antibody D0JW2Y HIGHSTAT Investigative D0JZ4R DRUG__ID D0JZ4R D0JZ4R DRUGCOMP Isis Pharmaceuticals D0JZ4R DRUGTYPE Antisense drug D0JZ4R HIGHSTAT Investigative D0K0OX DRUG__ID D0K0OX D0K0OX THERCLAS Antiviral Agents D0K0OX DRUGTYPE Small molecular drug D0K0OX HIGHSTAT Investigative D0K1JI DRUG__ID D0K1JI D0K1JI DRUGCOMP Isis Pharmaceuticals D0K1JI DRUGTYPE Antisense drug D0K1JI HIGHSTAT Investigative D0K1OM DRUG__ID D0K1OM D0K1OM THERCLAS Antiviral Agents D0K1OM DRUGTYPE Combination drug D0K1OM HIGHSTAT Investigative D0K2GT DRUG__ID D0K2GT D0K2GT DRUGCOMP Isis Pharmaceuticals D0K2GT DRUGTYPE Antisense drug D0K2GT HIGHSTAT Investigative D0K4HI DRUG__ID D0K4HI D0K4HI DRUGTYPE Small molecular drug D0K4HI DRUGSMIL C1=CC(=C(N=C1)C=NNC(=S)N)N.C1=NC2=C(N1COCCO)NC(=NC2=O)N D0K4HI HIGHSTAT Investigative D0K4WW DRUG__ID D0K4WW D0K4WW DRUGCOMP Tokyo Metropolitan Institute of Gerontology D0K4WW DRUGTYPE Antibody D0K4WW HIGHSTAT Investigative D0K4YE DRUG__ID D0K4YE D0K4YE THERCLAS Antiviral Agents D0K4YE DRUGTYPE Small molecular drug D0K4YE HIGHSTAT Investigative D0K5HO DRUG__ID D0K5HO D0K5HO THERCLAS Antiviral Agents D0K5HO DRUGTYPE Small molecular drug D0K5HO HIGHSTAT Investigative D0K5WH DRUG__ID D0K5WH D0K5WH DRUGCOMP Isis Pharmaceuticals D0K5WH DRUGTYPE Antisense drug D0K5WH HIGHSTAT Investigative D0K6VW DRUG__ID D0K6VW D0K6VW DRUGTYPE Small molecular drug D0K6VW DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)I)NO D0K6VW HIGHSTAT Investigative D0K7HI DRUG__ID D0K7HI D0K7HI DRUGCOMP Isis Pharmaceuticals D0K7HI DRUGTYPE Antisense drug D0K7HI HIGHSTAT Investigative D0K7PJ DRUG__ID D0K7PJ D0K7PJ DRUGCOMP Isis Pharmaceuticals D0K7PJ DRUGTYPE Antisense drug D0K7PJ HIGHSTAT Investigative D0K8NI DRUG__ID D0K8NI D0K8NI DRUGCOMP Isis Pharmaceuticals D0K8NI DRUGTYPE Antisense drug D0K8NI HIGHSTAT Investigative D0K8XK DRUG__ID D0K8XK D0K8XK DRUGCOMP Isis Pharmaceuticals D0K8XK DRUGTYPE Antisense drug D0K8XK HIGHSTAT Investigative D0K8YI DRUG__ID D0K8YI D0K8YI DRUGTYPE Small molecular drug D0K8YI DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)Cl)NO D0K8YI HIGHSTAT Investigative D0K9BQ DRUG__ID D0K9BQ D0K9BQ DRUGCOMP Isis Pharmaceuticals D0K9BQ DRUGTYPE Antisense drug D0K9BQ HIGHSTAT Investigative D0K9HF DRUG__ID D0K9HF D0K9HF DRUGCOMP EPIcyte Pharmaceutical Inc D0K9HF DRUGTYPE Antibody D0K9HF HIGHSTAT Investigative D0KC1N DRUG__ID D0KC1N D0KC1N THERCLAS Antiviral Agents D0KC1N DRUGTYPE Monoclonal antibody D0KC1N HIGHSTAT Investigative D0KF3D DRUG__ID D0KF3D D0KF3D DRUGCOMP Isis Pharmaceuticals D0KF3D DRUGTYPE Antisense drug D0KF3D HIGHSTAT Investigative D0KL5K DRUG__ID D0KL5K D0KL5K DRUGCOMP Isis Pharmaceuticals D0KL5K DRUGTYPE Antisense drug D0KL5K HIGHSTAT Investigative D0KL7G DRUG__ID D0KL7G D0KL7G THERCLAS Antisense D0KL7G DRUGTYPE Combination drug (Antisense drug) D0KL7G HIGHSTAT Investigative D0KO1E DRUG__ID D0KO1E D0KO1E DRUGCOMP Isis Pharmaceuticals D0KO1E DRUGTYPE Antisense drug D0KO1E HIGHSTAT Investigative D0KX4U DRUG__ID D0KX4U D0KX4U DRUGCOMP Isis Pharmaceuticals D0KX4U DRUGTYPE Antisense drug D0KX4U HIGHSTAT Investigative D0L0AI DRUG__ID D0L0AI D0L0AI THERCLAS Antisense D0L0AI DRUGTYPE Antisense drug D0L0AI HIGHSTAT Investigative D0L0DQ DRUG__ID D0L0DQ D0L0DQ DRUGTYPE Small molecule immunotherapy D0L0DQ HIGHSTAT Investigative D0L0DQ COMPCLAS Oxadiazole/thiadiazole derivatives D0L0IR DRUG__ID D0L0IR D0L0IR DRUGCOMP Isis Pharmaceuticals D0L0IR DRUGTYPE Antisense drug D0L0IR HIGHSTAT Investigative D0L0JX DRUG__ID D0L0JX D0L0JX DRUGCOMP Isis Pharmaceuticals D0L0JX DRUGTYPE Antisense drug D0L0JX HIGHSTAT Investigative D0L0UV DRUG__ID D0L0UV D0L0UV DRUGCOMP Isis Pharmaceuticals D0L0UV DRUGTYPE Antisense drug D0L0UV HIGHSTAT Investigative D0L0WC DRUG__ID D0L0WC D0L0WC DRUGCOMP Isis Pharmaceuticals D0L0WC DRUGTYPE Antisense drug D0L0WC HIGHSTAT Investigative D0L1BZ DRUG__ID D0L1BZ D0L1BZ DRUGTYPE Small molecule immunotherapy D0L1BZ HIGHSTAT Investigative D0L1BZ COMPCLAS Oxadiazole/thiadiazole derivatives D0L1ZC DRUG__ID D0L1ZC D0L1ZC DRUGCOMP Isis Pharmaceuticals D0L1ZC DRUGTYPE Antisense drug D0L1ZC HIGHSTAT Investigative D0L1ZD DRUG__ID D0L1ZD D0L1ZD DRUGCOMP Isis Pharmaceuticals D0L1ZD DRUGTYPE Antisense drug D0L1ZD HIGHSTAT Investigative D0L3HG DRUG__ID D0L3HG D0L3HG THERCLAS Antiviral Agents D0L3HG DRUGTYPE Small molecular drug D0L3HG HIGHSTAT Investigative D0L3NU DRUG__ID D0L3NU D0L3NU DRUGCOMP Isis Pharmaceuticals D0L3NU DRUGTYPE Antisense drug D0L3NU HIGHSTAT Investigative D0L3VY DRUG__ID D0L3VY D0L3VY DRUGCOMP NEMOD Biotherapeutics GmbH & Co KG D0L3VY DRUGTYPE Monoclonal antibody D0L3VY HIGHSTAT Investigative D0L4NE DRUG__ID D0L4NE D0L4NE DRUGCOMP Isis Pharmaceuticals D0L4NE DRUGTYPE Antisense drug D0L4NE HIGHSTAT Investigative D0L5ME DRUG__ID D0L5ME D0L5ME DRUGCOMP Isis Pharmaceuticals D0L5ME DRUGTYPE Antisense drug D0L5ME HIGHSTAT Investigative D0L5PI DRUG__ID D0L5PI D0L5PI DRUGTYPE Small molecular drug D0L5PI DRUGSMIL C1=CC2=NC(=O)C(=C2C=C1[N+](=O)[O-])C3=C(C4=C(N3)C=CC(=C4)F)NO D0L5PI HIGHSTAT Investigative D0L6LC DRUG__ID D0L6LC D0L6LC DRUGCOMP Isis Pharmaceuticals D0L6LC DRUGTYPE Antisense drug D0L6LC HIGHSTAT Investigative D0L6SQ DRUG__ID D0L6SQ D0L6SQ DRUGCOMP Isis Pharmaceuticals D0L6SQ DRUGTYPE Antisense drug D0L6SQ HIGHSTAT Investigative D0L7AG DRUG__ID D0L7AG D0L7AG DRUGCOMP Isis Pharmaceuticals D0L7AG DRUGTYPE Antisense drug D0L7AG HIGHSTAT Investigative D0L7DD DRUG__ID D0L7DD D0L7DD DRUGCOMP Isis Pharmaceuticals D0L7DD DRUGTYPE Antisense drug D0L7DD HIGHSTAT Investigative D0L8AJ DRUG__ID D0L8AJ D0L8AJ DRUGCOMP Isis Pharmaceuticals D0L8AJ DRUGTYPE Antisense drug D0L8AJ HIGHSTAT Investigative D0L8EO DRUG__ID D0L8EO D0L8EO DRUGCOMP Innate Pharma SA D0L8EO DRUGTYPE Monoclonal antibody D0L8EO HIGHSTAT Investigative D0L8WW DRUG__ID D0L8WW D0L8WW DRUGCOMP Isis Pharmaceuticals D0L8WW DRUGTYPE Antisense drug D0L8WW HIGHSTAT Investigative D0L9DW DRUG__ID D0L9DW D0L9DW DRUGCOMP Isis Pharmaceuticals D0L9DW DRUGTYPE Antisense drug D0L9DW HIGHSTAT Investigative D0L9KW DRUG__ID D0L9KW D0L9KW DRUGCOMP Isis Pharmaceuticals D0L9KW DRUGTYPE Antisense drug D0L9KW HIGHSTAT Investigative D0LD5B DRUG__ID D0LD5B D0LD5B THERCLAS Antiviral Agents D0LD5B DRUGTYPE Combination drug D0LD5B HIGHSTAT Investigative D0LD8U DRUG__ID D0LD8U D0LD8U DRUGCOMP Transgene SA D0LD8U DRUGTYPE Antibody D0LD8U HIGHSTAT Investigative D0LE4M DRUG__ID D0LE4M D0LE4M DRUGCOMP Medlmmune LLC D0LE4M DRUGTYPE Monoclonal antibody D0LE4M HIGHSTAT Investigative D0LF3W DRUG__ID D0LF3W D0LF3W DRUGCOMP Isis Pharmaceuticals D0LF3W DRUGTYPE Antisense drug D0LF3W HIGHSTAT Investigative D0LG0E DRUG__ID D0LG0E D0LG0E DRUGCOMP Isis Pharmaceuticals D0LG0E DRUGTYPE Antisense drug D0LG0E HIGHSTAT Investigative D0LH7O DRUG__ID D0LH7O D0LH7O DRUGCOMP Isis Pharmaceuticals D0LH7O DRUGTYPE Antisense drug D0LH7O HIGHSTAT Investigative D0LL1H DRUG__ID D0LL1H D0LL1H DRUGCOMP Isis Pharmaceuticals D0LL1H DRUGTYPE Antisense drug D0LL1H HIGHSTAT Investigative D0LS4V DRUG__ID D0LS4V D0LS4V DRUGCOMP Isis Pharmaceuticals D0LS4V DRUGTYPE Antisense drug D0LS4V HIGHSTAT Investigative D0LT4D DRUG__ID D0LT4D D0LT4D DRUGCOMP NovImmune SA D0LT4D DRUGTYPE Antibody D0LT4D HIGHSTAT Investigative D0LY0E DRUG__ID D0LY0E D0LY0E DRUGCOMP Isis Pharmaceuticals D0LY0E DRUGTYPE Antisense drug D0LY0E HIGHSTAT Investigative D0M0JF DRUG__ID D0M0JF D0M0JF DRUGCOMP Isis Pharmaceuticals D0M0JF DRUGTYPE Antisense drug D0M0JF HIGHSTAT Investigative D0M2JM DRUG__ID D0M2JM D0M2JM DRUGCOMP Isis Pharmaceuticals D0M2JM DRUGTYPE Antisense drug D0M2JM HIGHSTAT Investigative D0M2JX DRUG__ID D0M2JX D0M2JX DRUGCOMP Isis Pharmaceuticals D0M2JX DRUGTYPE Antisense drug D0M2JX HIGHSTAT Investigative D0M2PZ DRUG__ID D0M2PZ D0M2PZ DRUGCOMP Isis Pharmaceuticals D0M2PZ DRUGTYPE Antisense drug D0M2PZ HIGHSTAT Investigative D0M2SC DRUG__ID D0M2SC D0M2SC DRUGCOMP Isis Pharmaceuticals D0M2SC DRUGTYPE Antisense drug D0M2SC HIGHSTAT Investigative D0M3BA DRUG__ID D0M3BA D0M3BA DRUGCOMP Isis Pharmaceuticals D0M3BA DRUGTYPE Antisense drug D0M3BA HIGHSTAT Investigative D0M3UJ DRUG__ID D0M3UJ D0M3UJ DRUGCOMP Isis Pharmaceuticals D0M3UJ DRUGTYPE Antisense drug D0M3UJ HIGHSTAT Investigative D0M4LN DRUG__ID D0M4LN D0M4LN DRUGCOMP Isis Pharmaceuticals D0M4LN DRUGTYPE Antisense drug D0M4LN HIGHSTAT Investigative D0M4NN DRUG__ID D0M4NN D0M4NN DRUGCOMP Isis Pharmaceuticals D0M4NN DRUGTYPE Antisense drug D0M4NN HIGHSTAT Investigative D0M4XD DRUG__ID D0M4XD D0M4XD DRUGTYPE Small molecular drug D0M4XD DRUGSMIL COC1=CC2=C(C=C1)NC(=C2NO)C3=C4C=C(C=CC4=NC3=O)[N+](=O)[O-] D0M4XD HIGHSTAT Investigative D0M5DM DRUG__ID D0M5DM D0M5DM DRUGCOMP Isis Pharmaceuticals D0M5DM DRUGTYPE Antisense drug D0M5DM HIGHSTAT Investigative D0M5GP DRUG__ID D0M5GP D0M5GP DRUGCOMP Isis Pharmaceuticals D0M5GP DRUGTYPE Antisense drug D0M5GP HIGHSTAT Investigative D0M5OL DRUG__ID D0M5OL D0M5OL DRUGCOMP Isis Pharmaceuticals D0M5OL DRUGTYPE Antisense drug D0M5OL HIGHSTAT Investigative D0M6ZQ DRUG__ID D0M6ZQ D0M6ZQ DRUGCOMP Isis Pharmaceuticals D0M6ZQ DRUGTYPE Antisense drug D0M6ZQ HIGHSTAT Investigative D0M7DU DRUG__ID D0M7DU D0M7DU DRUGCOMP Genentech Inc D0M7DU DRUGTYPE Monoclonal antibody D0M7DU HIGHSTAT Investigative D0M7EP DRUG__ID D0M7EP D0M7EP DRUGCOMP Genentech Inc D0M7EP DRUGTYPE Antibody D0M7EP HIGHSTAT Investigative D0M7GB DRUG__ID D0M7GB D0M7GB DRUGTYPE Small molecular drug D0M7GB DRUGSMIL C1C[N+]2=C3C4=C(C(=O)C5=C3C6(CC(N5)O)C(C2C(CC6=O)O)O)NC=C41 D0M7GB HIGHSTAT Investigative D0M7OE DRUG__ID D0M7OE D0M7OE DRUGCOMP Isis Pharmaceuticals D0M7OE DRUGTYPE Antisense drug D0M7OE HIGHSTAT Investigative D0M7ZC DRUG__ID D0M7ZC D0M7ZC DRUGCOMP Isis Pharmaceuticals D0M7ZC DRUGTYPE Antisense drug D0M7ZC HIGHSTAT Investigative D0M8BV DRUG__ID D0M8BV D0M8BV DRUGCOMP Isis Pharmaceuticals D0M8BV DRUGTYPE Antisense drug D0M8BV HIGHSTAT Investigative D0M8KV DRUG__ID D0M8KV D0M8KV DRUGTYPE Small molecule immunotherapy D0M8KV HIGHSTAT Investigative D0M8KV COMPCLAS Triaromatic compounds D0M9JK DRUG__ID D0M9JK D0M9JK DRUGCOMP Isis Pharmaceuticals D0M9JK DRUGTYPE Antisense drug D0M9JK HIGHSTAT Investigative D0MJ5E DRUG__ID D0MJ5E D0MJ5E DRUGCOMP Tel Aviv University D0MJ5E DRUGTYPE Monoclonal antibody D0MJ5E HIGHSTAT Investigative D0MK3I DRUG__ID D0MK3I D0MK3I DRUGTYPE Peptide D0MK3I HIGHSTAT Investigative D0MK3I COMPCLAS Peptidomimetics D0ML0X DRUG__ID D0ML0X D0ML0X DRUGTYPE Small molecule immunotherapy D0ML0X HIGHSTAT Investigative D0ML0X COMPCLAS Triaromatic compounds D0ML3Q DRUG__ID D0ML3Q D0ML3Q DRUGCOMP Isis Pharmaceuticals D0ML3Q DRUGTYPE Antisense drug D0ML3Q HIGHSTAT Investigative D0MZ8E DRUG__ID D0MZ8E D0MZ8E DRUGCOMP Isis Pharmaceuticals D0MZ8E DRUGTYPE Antisense drug D0MZ8E HIGHSTAT Investigative D0N0MY DRUG__ID D0N0MY D0N0MY DRUGCOMP Isis Pharmaceuticals D0N0MY DRUGTYPE Antisense drug D0N0MY HIGHSTAT Investigative D0N1DG DRUG__ID D0N1DG D0N1DG DRUGCOMP IMED AB D0N1DG DRUGTYPE Antibody D0N1DG HIGHSTAT Investigative D0N1RP DRUG__ID D0N1RP D0N1RP DRUGCOMP Isis Pharmaceuticals D0N1RP DRUGTYPE Antisense drug D0N1RP HIGHSTAT Investigative D0N2AA DRUG__ID D0N2AA D0N2AA DRUGTYPE Small molecular drug D0N2AA DRUGSMIL C1C(C(C[NH+]1CC2=C3C(=NN2)C(=O)N=CN3)O)CO D0N2AA HIGHSTAT Investigative D0N4CJ DRUG__ID D0N4CJ D0N4CJ DRUGCOMP Isis Pharmaceuticals D0N4CJ DRUGTYPE Antisense drug D0N4CJ HIGHSTAT Investigative D0N4TF DRUG__ID D0N4TF D0N4TF DRUGCOMP Isis Pharmaceuticals D0N4TF DRUGTYPE Antisense drug D0N4TF HIGHSTAT Investigative D0N5AF DRUG__ID D0N5AF D0N5AF DRUGCOMP Isis Pharmaceuticals D0N5AF DRUGTYPE Antisense drug D0N5AF HIGHSTAT Investigative D0N5CF DRUG__ID D0N5CF D0N5CF DRUGCOMP Isis Pharmaceuticals D0N5CF DRUGTYPE Antisense drug D0N5CF HIGHSTAT Investigative D0N6MD DRUG__ID D0N6MD D0N6MD DRUGTYPE Small molecule immunotherapy D0N6MD HIGHSTAT Investigative D0N6MD COMPCLAS Oxadiazole/thiadiazole derivatives D0N7AB DRUG__ID D0N7AB D0N7AB DRUGCOMP Isis Pharmaceuticals D0N7AB DRUGTYPE Antisense drug D0N7AB HIGHSTAT Investigative D0N7AF DRUG__ID D0N7AF D0N7AF DRUGCOMP Isis Pharmaceuticals D0N7AF DRUGTYPE Antisense drug D0N7AF HIGHSTAT Investigative D0N7HT DRUG__ID D0N7HT D0N7HT DRUGCOMP Prosensa Therapeutics BV D0N7HT DRUGTYPE Antisense drug D0N7HT HIGHSTAT Investigative D0N7OK DRUG__ID D0N7OK D0N7OK DRUGCOMP Isis Pharmaceuticals D0N7OK DRUGTYPE Antisense drug D0N7OK HIGHSTAT Investigative D0N9AT DRUG__ID D0N9AT D0N9AT DRUGCOMP Isis Pharmaceuticals D0N9AT DRUGTYPE Antisense drug D0N9AT HIGHSTAT Investigative D0N9DU DRUG__ID D0N9DU D0N9DU DRUGTYPE Small molecular drug D0N9DU DRUGSMIL C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=CC4=NC3=O)NOCCC(CO)O D0N9DU HIGHSTAT Investigative D0N9VK DRUG__ID D0N9VK D0N9VK DRUGCOMP Isis Pharmaceuticals D0N9VK DRUGTYPE Antisense drug D0N9VK HIGHSTAT Investigative D0NB4V DRUG__ID D0NB4V D0NB4V DRUGCOMP University of Navarra D0NB4V DRUGTYPE Vaccine D0NB4V HIGHSTAT Investigative D0ND6Y DRUG__ID D0ND6Y D0ND6Y DRUGCOMP Isis Pharmaceuticals D0ND6Y DRUGTYPE Antisense drug D0ND6Y HIGHSTAT Investigative D0NH5A DRUG__ID D0NH5A D0NH5A DRUGCOMP Isis Pharmaceuticals D0NH5A DRUGTYPE Antisense drug D0NH5A HIGHSTAT Investigative D0NV8X DRUG__ID D0NV8X D0NV8X DRUGCOMP Isis Pharmaceuticals D0NV8X DRUGTYPE Antisense drug D0NV8X HIGHSTAT Investigative D0NW8N DRUG__ID D0NW8N D0NW8N DRUGCOMP Isis Pharmaceuticals D0NW8N DRUGTYPE Antisense drug D0NW8N HIGHSTAT Investigative D0O0BZ DRUG__ID D0O0BZ D0O0BZ DRUGCOMP Isis Pharmaceuticals D0O0BZ DRUGTYPE Antisense drug D0O0BZ HIGHSTAT Investigative D0O1CN DRUG__ID D0O1CN D0O1CN DRUGCOMP Isis Pharmaceuticals D0O1CN DRUGTYPE Antisense drug D0O1CN HIGHSTAT Investigative D0O2ZR DRUG__ID D0O2ZR D0O2ZR DRUGCOMP Isis Pharmaceuticals D0O2ZR DRUGTYPE Antisense drug D0O2ZR HIGHSTAT Investigative D0O3DZ DRUG__ID D0O3DZ D0O3DZ DRUGCOMP Isis Pharmaceuticals D0O3DZ DRUGTYPE Antisense drug D0O3DZ HIGHSTAT Investigative D0O3QM DRUG__ID D0O3QM D0O3QM DRUGCOMP Isis Pharmaceuticals D0O3QM DRUGTYPE Antisense drug D0O3QM HIGHSTAT Investigative D0O3WF DRUG__ID D0O3WF D0O3WF DRUGCOMP Isis Pharmaceuticals D0O3WF DRUGTYPE Antisense drug D0O3WF HIGHSTAT Investigative D0O4HL DRUG__ID D0O4HL D0O4HL DRUGCOMP Isis Pharmaceuticals D0O4HL DRUGTYPE Antisense drug D0O4HL HIGHSTAT Investigative D0O4MI DRUG__ID D0O4MI D0O4MI DRUGCOMP Isis Pharmaceuticals D0O4MI DRUGTYPE Antisense drug D0O4MI HIGHSTAT Investigative D0O7MX DRUG__ID D0O7MX D0O7MX DRUGCOMP Isis Pharmaceuticals D0O7MX DRUGTYPE Antisense drug D0O7MX HIGHSTAT Investigative D0O7OI DRUG__ID D0O7OI D0O7OI DRUGCOMP Isis Pharmaceuticals D0O7OI DRUGTYPE Antisense drug D0O7OI HIGHSTAT Investigative D0O8FS DRUG__ID D0O8FS D0O8FS DRUGCOMP Isis Pharmaceuticals D0O8FS DRUGTYPE Antisense drug D0O8FS HIGHSTAT Investigative D0O9XE DRUG__ID D0O9XE D0O9XE DRUGCOMP Isis Pharmaceuticals D0O9XE DRUGTYPE Antisense drug D0O9XE HIGHSTAT Investigative D0OQ2Q DRUG__ID D0OQ2Q D0OQ2Q DRUGCOMP Isis Pharmaceuticals D0OQ2Q DRUGTYPE Antisense drug D0OQ2Q HIGHSTAT Investigative D0OV0A DRUG__ID D0OV0A D0OV0A DRUGCOMP Isis Pharmaceuticals D0OV0A DRUGTYPE Antisense drug D0OV0A HIGHSTAT Investigative D0OV0E DRUG__ID D0OV0E D0OV0E DRUGCOMP Isis Pharmaceuticals D0OV0E DRUGTYPE Antisense drug D0OV0E HIGHSTAT Investigative D0OV7O DRUG__ID D0OV7O D0OV7O DRUGCOMP Isis Pharmaceuticals D0OV7O DRUGTYPE Antisense drug D0OV7O HIGHSTAT Investigative D0P0JE DRUG__ID D0P0JE D0P0JE DRUGCOMP Isis Pharmaceuticals D0P0JE DRUGTYPE Antisense drug D0P0JE HIGHSTAT Investigative D0P0SY DRUG__ID D0P0SY D0P0SY DRUGCOMP Isis Pharmaceuticals D0P0SY DRUGTYPE Antisense drug D0P0SY HIGHSTAT Investigative D0P2AR DRUG__ID D0P2AR D0P2AR DRUGCOMP Isis Pharmaceuticals D0P2AR DRUGTYPE Antisense drug D0P2AR HIGHSTAT Investigative D0P2EY DRUG__ID D0P2EY D0P2EY DRUGCOMP Isis Pharmaceuticals D0P2EY DRUGTYPE Antisense drug D0P2EY HIGHSTAT Investigative D0P2TB DRUG__ID D0P2TB D0P2TB DRUGCOMP Isis Pharmaceuticals D0P2TB DRUGTYPE Antisense drug D0P2TB HIGHSTAT Investigative D0P3FU DRUG__ID D0P3FU D0P3FU DRUGCOMP Isis Pharmaceuticals D0P3FU DRUGTYPE Antisense drug D0P3FU HIGHSTAT Investigative D0P4MA DRUG__ID D0P4MA D0P4MA DRUGCOMP Genzyme Corp D0P4MA DRUGTYPE Antisense drug D0P4MA HIGHSTAT Investigative D0P4WQ DRUG__ID D0P4WQ D0P4WQ DRUGCOMP Isis Pharmaceuticals D0P4WQ DRUGTYPE Antisense drug D0P4WQ HIGHSTAT Investigative D0P6AS DRUG__ID D0P6AS D0P6AS DRUGCOMP Isis Pharmaceuticals D0P6AS DRUGTYPE Antisense drug D0P6AS HIGHSTAT Investigative D0PE2Y DRUG__ID D0PE2Y D0PE2Y DRUGCOMP Isis Pharmaceuticals D0PE2Y DRUGTYPE Antisense drug D0PE2Y HIGHSTAT Investigative D0PI2A DRUG__ID D0PI2A D0PI2A DRUGCOMP Isis Pharmaceuticals D0PI2A DRUGTYPE Antisense drug D0PI2A HIGHSTAT Investigative D0PK2K DRUG__ID D0PK2K D0PK2K DRUGCOMP Isis Pharmaceuticals D0PK2K DRUGTYPE Antisense drug D0PK2K HIGHSTAT Investigative D0PP1I DRUG__ID D0PP1I D0PP1I DRUGCOMP Isis Pharmaceuticals D0PP1I DRUGTYPE Antisense drug D0PP1I HIGHSTAT Investigative D0PX5F DRUG__ID D0PX5F D0PX5F DRUGCOMP Nuclea Biotechnologies LLC D0PX5F DRUGTYPE Antibody D0PX5F HIGHSTAT Investigative D0PY4Z DRUG__ID D0PY4Z D0PY4Z DRUGCOMP Isis Pharmaceuticals D0PY4Z DRUGTYPE Antisense drug D0PY4Z HIGHSTAT Investigative D0Q0FZ DRUG__ID D0Q0FZ D0Q0FZ DRUGCOMP Isis Pharmaceuticals D0Q0FZ DRUGTYPE Antisense drug D0Q0FZ HIGHSTAT Investigative D0Q0IN DRUG__ID D0Q0IN D0Q0IN DRUGCOMP Isis Pharmaceuticals D0Q0IN DRUGTYPE Antisense drug D0Q0IN HIGHSTAT Investigative D0Q0XJ DRUG__ID D0Q0XJ D0Q0XJ DRUGCOMP Isis Pharmaceuticals D0Q0XJ DRUGTYPE Antisense drug D0Q0XJ HIGHSTAT Investigative D0Q1UM DRUG__ID D0Q1UM D0Q1UM DRUGCOMP Isis Pharmaceuticals D0Q1UM DRUGTYPE Antisense drug D0Q1UM HIGHSTAT Investigative D0Q2ZS DRUG__ID D0Q2ZS D0Q2ZS DRUGCOMP Isis Pharmaceuticals D0Q2ZS DRUGTYPE Antisense drug D0Q2ZS HIGHSTAT Investigative D0Q3KN DRUG__ID D0Q3KN D0Q3KN DRUGCOMP Isis Pharmaceuticals D0Q3KN DRUGTYPE Antisense drug D0Q3KN HIGHSTAT Investigative D0Q3RC DRUG__ID D0Q3RC D0Q3RC DRUGCOMP Aphios Corp D0Q3RC DRUGTYPE Monoclonal antibody D0Q3RC HIGHSTAT Investigative D0Q3WP DRUG__ID D0Q3WP D0Q3WP DRUGCOMP Cellective Therapeutics Inc D0Q3WP DRUGTYPE Antibody D0Q3WP HIGHSTAT Investigative D0Q4HW DRUG__ID D0Q4HW D0Q4HW DRUGCOMP Isis Pharmaceuticals D0Q4HW DRUGTYPE Antisense drug D0Q4HW HIGHSTAT Investigative D0Q4SJ DRUG__ID D0Q4SJ D0Q4SJ DRUGCOMP Isis Pharmaceuticals D0Q4SJ DRUGTYPE Antisense drug D0Q4SJ HIGHSTAT Investigative D0Q5NZ DRUG__ID D0Q5NZ D0Q5NZ DRUGCOMP Bio-Path Holdings Inc D0Q5NZ DRUGTYPE Antisense drug D0Q5NZ HIGHSTAT Investigative D0Q5TP DRUG__ID D0Q5TP D0Q5TP DRUGCOMP ContraFect Corporation D0Q5TP DRUGTYPE Monoclonal antibody D0Q5TP HIGHSTAT Investigative D0Q6GK DRUG__ID D0Q6GK D0Q6GK DRUGCOMP VasGene Therapeutics Inc D0Q6GK DRUGTYPE Antibody D0Q6GK HIGHSTAT Investigative D0Q6MK DRUG__ID D0Q6MK D0Q6MK DRUGCOMP Isis Pharmaceuticals D0Q6MK DRUGTYPE Antisense drug D0Q6MK HIGHSTAT Investigative D0Q6QW DRUG__ID D0Q6QW D0Q6QW DRUGTYPE Small molecular drug D0Q6QW DRUGSMIL C1=CC=C(C=C1)C(=C2C(=O)C3=C(C=C(C=C3)Cl)NC2=O)O D0Q6QW HIGHSTAT Investigative D0Q6XR DRUG__ID D0Q6XR D0Q6XR DRUGCOMP Isis Pharmaceuticals D0Q6XR DRUGTYPE Antisense drug D0Q6XR HIGHSTAT Investigative D0Q8PF DRUG__ID D0Q8PF D0Q8PF DRUGCOMP National Cancer Institute D0Q8PF DRUGTYPE Vaccine D0Q8PF HIGHSTAT Investigative D0Q8XG DRUG__ID D0Q8XG D0Q8XG DRUGCOMP Isis Pharmaceuticals D0Q8XG DRUGTYPE Antisense drug D0Q8XG HIGHSTAT Investigative D0QE7H DRUG__ID D0QE7H D0QE7H DRUGCOMP Isis Pharmaceuticals D0QE7H DRUGTYPE Antisense drug D0QE7H HIGHSTAT Investigative D0QH9X DRUG__ID D0QH9X D0QH9X DRUGCOMP Isis Pharmaceuticals D0QH9X DRUGTYPE Antisense drug D0QH9X HIGHSTAT Investigative D0QN9U DRUG__ID D0QN9U D0QN9U DRUGCOMP Gene Signal SAS D0QN9U DRUGTYPE Monoclonal antibody D0QN9U HIGHSTAT Investigative D0QP0H DRUG__ID D0QP0H D0QP0H DRUGCOMP Isis Pharmaceuticals D0QP0H DRUGTYPE Antisense drug D0QP0H HIGHSTAT Investigative D0QR1L DRUG__ID D0QR1L D0QR1L DRUGCOMP Isis Pharmaceuticals D0QR1L DRUGTYPE Antisense drug D0QR1L HIGHSTAT Investigative D0QU6S DRUG__ID D0QU6S D0QU6S DRUGCOMP Isis Pharmaceuticals D0QU6S DRUGTYPE Antisense drug D0QU6S HIGHSTAT Investigative D0QV8M DRUG__ID D0QV8M D0QV8M DRUGCOMP Isis Pharmaceuticals D0QV8M DRUGTYPE Antisense drug D0QV8M HIGHSTAT Investigative D0R0MM DRUG__ID D0R0MM D0R0MM DRUGCOMP A&G Pharmaceutical Inc D0R0MM DRUGTYPE Monoclonal antibody D0R0MM HIGHSTAT Investigative D0R0RW DRUG__ID D0R0RW D0R0RW DRUGCOMP Merck & Co Inc D0R0RW DRUGTYPE Antibody D0R0RW HIGHSTAT Investigative D0R2ES DRUG__ID D0R2ES D0R2ES DRUGTYPE Small molecular drug D0R2ES DRUGSMIL C1N=C2C=CC=CC2=C3N1NC(=C3)C4=CC=CC=C4 D0R2ES HIGHSTAT Investigative D0R2RV DRUG__ID D0R2RV D0R2RV DRUGCOMP Xencor Inc D0R2RV DRUGTYPE Antibody D0R2RV HIGHSTAT Investigative D0R3CV DRUG__ID D0R3CV D0R3CV DRUGCOMP Isis Pharmaceuticals D0R3CV DRUGTYPE Antisense drug D0R3CV HIGHSTAT Investigative D0R3DQ DRUG__ID D0R3DQ D0R3DQ DRUGCOMP Sylentis Sau D0R3DQ DRUGTYPE siRNA drug D0R3DQ HIGHSTAT Investigative D0R3KS DRUG__ID D0R3KS D0R3KS DRUGCOMP Dyax Corp D0R3KS DRUGTYPE Antibody D0R3KS HIGHSTAT Investigative D0R4BK DRUG__ID D0R4BK D0R4BK DRUGCOMP Isis Pharmaceuticals D0R4BK DRUGTYPE Antisense drug D0R4BK HIGHSTAT Investigative D0R4LX DRUG__ID D0R4LX D0R4LX DRUGCOMP Isis Pharmaceuticals D0R4LX DRUGTYPE Antisense drug D0R4LX HIGHSTAT Investigative D0R4QE DRUG__ID D0R4QE D0R4QE DRUGCOMP Isis Pharmaceuticals D0R4QE DRUGTYPE Antisense drug D0R4QE HIGHSTAT Investigative D0R5NX DRUG__ID D0R5NX D0R5NX DRUGCOMP Isis Pharmaceuticals D0R5NX DRUGTYPE Antisense drug D0R5NX HIGHSTAT Investigative D0R6UO DRUG__ID D0R6UO D0R6UO DRUGCOMP Isis Pharmaceuticals D0R6UO DRUGTYPE Antisense drug D0R6UO HIGHSTAT Investigative D0R9BP DRUG__ID D0R9BP D0R9BP DRUGCOMP Isis Pharmaceuticals D0R9BP DRUGTYPE Antisense drug D0R9BP HIGHSTAT Investigative D0R9JC DRUG__ID D0R9JC D0R9JC DRUGCOMP MacroGenics Inc D0R9JC DRUGTYPE Monoclonal antibody D0R9JC HIGHSTAT Investigative D0RD7X DRUG__ID D0RD7X D0RD7X DRUGCOMP Isis Pharmaceuticals D0RD7X DRUGTYPE Antisense drug D0RD7X HIGHSTAT Investigative D0RX1E DRUG__ID D0RX1E D0RX1E DRUGCOMP Isis Pharmaceuticals D0RX1E DRUGTYPE Antisense drug D0RX1E HIGHSTAT Investigative D0S0XV DRUG__ID D0S0XV D0S0XV DRUGCOMP Isis Pharmaceuticals D0S0XV DRUGTYPE Antisense drug D0S0XV HIGHSTAT Investigative D0S3AR DRUG__ID D0S3AR D0S3AR DRUGCOMP Isis Pharmaceuticals D0S3AR DRUGTYPE Antisense drug D0S3AR HIGHSTAT Investigative D0S3JF DRUG__ID D0S3JF D0S3JF DRUGCOMP Isis Pharmaceuticals D0S3JF DRUGTYPE Antisense drug D0S3JF HIGHSTAT Investigative D0S4BJ DRUG__ID D0S4BJ D0S4BJ DRUGCOMP Isis Pharmaceuticals D0S4BJ DRUGTYPE Antisense drug D0S4BJ HIGHSTAT Investigative D0S4RZ DRUG__ID D0S4RZ D0S4RZ DRUGCOMP Isis Pharmaceuticals D0S4RZ DRUGTYPE Antisense drug D0S4RZ HIGHSTAT Investigative D0S4SQ DRUG__ID D0S4SQ D0S4SQ DRUGTYPE Small molecular drug D0S4SQ DRUGSMIL C1=CC=C(C=C1)NC2=NC(=O)C3=C(N2)N(C=N3)CCCCO D0S4SQ HIGHSTAT Investigative D0S4ZZ DRUG__ID D0S4ZZ D0S4ZZ DRUGCOMP Immune Pharmaceuticals Corp D0S4ZZ DRUGTYPE Monoclonal antibody D0S4ZZ HIGHSTAT Investigative D0S5IV DRUG__ID D0S5IV D0S5IV DRUGCOMP Mapp Biopharmaceutical Inc D0S5IV DRUGTYPE Monoclonal antibody D0S5IV HIGHSTAT Investigative D0S5MC DRUG__ID D0S5MC D0S5MC DRUGCOMP Isis Pharmaceuticals D0S5MC DRUGTYPE Antisense drug D0S5MC HIGHSTAT Investigative D0S6MQ DRUG__ID D0S6MQ D0S6MQ DRUGCOMP Isis Pharmaceuticals D0S6MQ DRUGTYPE Antisense drug D0S6MQ HIGHSTAT Investigative D0S6OP DRUG__ID D0S6OP D0S6OP DRUGCOMP Isis Pharmaceuticals D0S6OP DRUGTYPE Antisense drug D0S6OP HIGHSTAT Investigative D0S7IQ DRUG__ID D0S7IQ D0S7IQ DRUGCOMP Xencor Inc D0S7IQ DRUGTYPE Monoclonal antibody D0S7IQ HIGHSTAT Investigative D0S7SN DRUG__ID D0S7SN D0S7SN DRUGCOMP Isis Pharmaceuticals D0S7SN DRUGTYPE Antisense drug D0S7SN HIGHSTAT Investigative D0SN5O DRUG__ID D0SN5O D0SN5O DRUGCOMP Isis Pharmaceuticals D0SN5O DRUGTYPE Antisense drug D0SN5O HIGHSTAT Investigative D0SN8K DRUG__ID D0SN8K D0SN8K DRUGCOMP PharmAbcine D0SN8K DRUGTYPE Monoclonal antibody D0SN8K HIGHSTAT Investigative D0T0SR DRUG__ID D0T0SR D0T0SR DRUGCOMP Isis Pharmaceuticals D0T0SR DRUGTYPE Antisense drug D0T0SR HIGHSTAT Investigative D0T0XZ DRUG__ID D0T0XZ D0T0XZ DRUGCOMP Isis Pharmaceuticals D0T0XZ DRUGTYPE Antisense drug D0T0XZ HIGHSTAT Investigative D0T1MT DRUG__ID D0T1MT D0T1MT DRUGCOMP University of Nebraska Medical Center D0T1MT DRUGTYPE Monoclonal antibody D0T1MT HIGHSTAT Investigative D0T1YH DRUG__ID D0T1YH D0T1YH DRUGCOMP Alder Biopharmaceuticals Inc D0T1YH DRUGTYPE Antibody D0T1YH HIGHSTAT Investigative D0T3BZ DRUG__ID D0T3BZ D0T3BZ DRUGCOMP Isis Pharmaceuticals D0T3BZ DRUGTYPE Antisense drug D0T3BZ HIGHSTAT Investigative D0T3FE DRUG__ID D0T3FE D0T3FE DRUGCOMP Isis Pharmaceuticals D0T3FE DRUGTYPE Antisense drug D0T3FE HIGHSTAT Investigative D0T3GH DRUG__ID D0T3GH D0T3GH DRUGCOMP Isis Pharmaceuticals D0T3GH DRUGTYPE Antisense drug D0T3GH HIGHSTAT Investigative D0T4ZW DRUG__ID D0T4ZW D0T4ZW DRUGCOMP MediaPharma Srl D0T4ZW DRUGTYPE Antibody D0T4ZW HIGHSTAT Investigative D0T5JP DRUG__ID D0T5JP D0T5JP DRUGCOMP Isis Pharmaceuticals D0T5JP DRUGTYPE Antisense drug D0T5JP HIGHSTAT Investigative D0T5NX DRUG__ID D0T5NX D0T5NX DRUGCOMP Isis Pharmaceuticals D0T5NX DRUGTYPE Antisense drug D0T5NX HIGHSTAT Investigative D0T5RJ DRUG__ID D0T5RJ D0T5RJ DRUGCOMP Isis Pharmaceuticals D0T5RJ DRUGTYPE Antisense drug D0T5RJ HIGHSTAT Investigative D0T7LB DRUG__ID D0T7LB D0T7LB DRUGTYPE Small molecular drug D0T7LB DRUGSMIL CSCC1(CN(CC1O)CC2=CNC3=C2NC=NC3=O)O D0T7LB HIGHSTAT Investigative D0T7SU DRUG__ID D0T7SU D0T7SU DRUGCOMP Isis Pharmaceuticals D0T7SU DRUGTYPE Antisense drug D0T7SU HIGHSTAT Investigative D0T8EL DRUG__ID D0T8EL D0T8EL DRUGCOMP Quark Pharmaceuticals Inc D0T8EL DRUGTYPE siRNA drug D0T8EL HIGHSTAT Investigative D0T9HE DRUG__ID D0T9HE D0T9HE DRUGTYPE Small molecule immunotherapy D0T9HE HIGHSTAT Investigative D0T9HE COMPCLAS Macrocyclic peptide compounds D0TC8O DRUG__ID D0TC8O D0TC8O DRUGCOMP Isis Pharmaceuticals D0TC8O DRUGTYPE Antisense drug D0TC8O HIGHSTAT Investigative D0TD0K DRUG__ID D0TD0K D0TD0K DRUGCOMP Isis Pharmaceuticals D0TD0K DRUGTYPE Antisense drug D0TD0K HIGHSTAT Investigative D0TE6A DRUG__ID D0TE6A D0TE6A DRUGTYPE Small molecular drug D0TE6A DRUGSMIL C1C2=CC=CC=C2NC3=NC(=O)CN31 D0TE6A HIGHSTAT Investigative D0TH1I DRUG__ID D0TH1I D0TH1I DRUGTYPE Small molecular drug D0TH1I DRUGSMIL C1=CC=C(C=C1)C2=CC(=C3C=CC(=O)C=C3)C=C(N2)C4=CC=NC=C4 D0TH1I HIGHSTAT Investigative D0TN4F DRUG__ID D0TN4F D0TN4F DRUGTYPE Small molecule immunotherapy D0TN4F HIGHSTAT Investigative D0TN4F COMPCLAS Cyclic peptidomimetic derivatives D0TQ1F DRUG__ID D0TQ1F D0TQ1F DRUGCOMP Isis Pharmaceuticals D0TQ1F DRUGTYPE Antisense drug D0TQ1F HIGHSTAT Investigative D0TS6S DRUG__ID D0TS6S D0TS6S DRUGCOMP Isis Pharmaceuticals D0TS6S DRUGTYPE Antisense drug D0TS6S HIGHSTAT Investigative D0TT6X DRUG__ID D0TT6X D0TT6X DRUGCOMP Isis Pharmaceuticals D0TT6X DRUGTYPE Antisense drug D0TT6X HIGHSTAT Investigative D0TY2O DRUG__ID D0TY2O D0TY2O DRUGCOMP Isis Pharmaceuticals D0TY2O DRUGTYPE Antisense drug D0TY2O HIGHSTAT Investigative D0U0OE DRUG__ID D0U0OE D0U0OE DRUGCOMP Isis Pharmaceuticals D0U0OE DRUGTYPE Antisense drug D0U0OE HIGHSTAT Investigative D0U1QU DRUG__ID D0U1QU D0U1QU DRUGCOMP Isis Pharmaceuticals D0U1QU DRUGTYPE Antisense drug D0U1QU HIGHSTAT Investigative D0U2HN DRUG__ID D0U2HN D0U2HN DRUGCOMP Isis Pharmaceuticals D0U2HN DRUGTYPE Antisense drug D0U2HN HIGHSTAT Investigative D0U3ML DRUG__ID D0U3ML D0U3ML DRUGCOMP Isis Pharmaceuticals D0U3ML DRUGTYPE Antisense drug D0U3ML HIGHSTAT Investigative D0U4ZT DRUG__ID D0U4ZT D0U4ZT DRUGCOMP Isis Pharmaceuticals D0U4ZT DRUGTYPE Antisense drug D0U4ZT HIGHSTAT Investigative D0U5PS DRUG__ID D0U5PS D0U5PS DRUGCOMP Isis Pharmaceuticals D0U5PS DRUGTYPE Antisense drug D0U5PS HIGHSTAT Investigative D0U5UY DRUG__ID D0U5UY D0U5UY DRUGTYPE Small molecule immunotherapy D0U5UY HIGHSTAT Investigative D0U5UY COMPCLAS Isonicotinic acid derivatives D0U5YJ DRUG__ID D0U5YJ D0U5YJ DRUGCOMP The Center of Molecular Immunology D0U5YJ DRUGTYPE Monoclonal antibody D0U5YJ HIGHSTAT Investigative D0U6HC DRUG__ID D0U6HC D0U6HC DRUGCOMP Isis Pharmaceuticals D0U6HC DRUGTYPE Antisense drug D0U6HC HIGHSTAT Investigative D0U7AA DRUG__ID D0U7AA D0U7AA DRUGCOMP Isis Pharmaceuticals D0U7AA DRUGTYPE Antisense drug D0U7AA HIGHSTAT Investigative D0U8DY DRUG__ID D0U8DY D0U8DY DRUGCOMP Isis Pharmaceuticals D0U8DY DRUGTYPE Antisense drug D0U8DY HIGHSTAT Investigative D0U8JD DRUG__ID D0U8JD D0U8JD DRUGCOMP Isis Pharmaceuticals D0U8JD DRUGTYPE Antisense drug D0U8JD HIGHSTAT Investigative D0U8XY DRUG__ID D0U8XY D0U8XY DRUGTYPE Small molecular drug D0U8XY DRUGSMIL C1=CC=C2C(=C1)C(=C3C=CC(=O)C=C3)NN=C2NC4=CC(=CC=C4)O D0U8XY HIGHSTAT Investigative D0U8YP DRUG__ID D0U8YP D0U8YP DRUGTYPE Small molecule immunotherapy D0U8YP HIGHSTAT Investigative D0U8YP COMPCLAS Benzyl phenyl ether derivatives D0U9JR DRUG__ID D0U9JR D0U9JR DRUGCOMP Isis Pharmaceuticals D0U9JR DRUGTYPE Antisense drug D0U9JR HIGHSTAT Investigative D0UH5I DRUG__ID D0UH5I D0UH5I DRUGCOMP Isis Pharmaceuticals D0UH5I DRUGTYPE Antisense drug D0UH5I HIGHSTAT Investigative D0UJ9J DRUG__ID D0UJ9J D0UJ9J DRUGTYPE Small molecule immunotherapy D0UJ9J HIGHSTAT Investigative D0UJ9J COMPCLAS Sulfamonomethoxine derivatives D0UZ9U DRUG__ID D0UZ9U D0UZ9U DRUGTYPE Small molecular drug D0UZ9U DRUGSMIL C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O D0UZ9U HIGHSTAT Investigative D0V0JV DRUG__ID D0V0JV D0V0JV DRUGCOMP Mabion Ltd D0V0JV DRUGTYPE Antibody D0V0JV HIGHSTAT Investigative D0V1PK DRUG__ID D0V1PK D0V1PK DRUGCOMP Isis Pharmaceuticals D0V1PK DRUGTYPE Antisense drug D0V1PK HIGHSTAT Investigative D0V2AQ DRUG__ID D0V2AQ D0V2AQ DRUGCOMP Isis Pharmaceuticals D0V2AQ DRUGTYPE Antisense drug D0V2AQ HIGHSTAT Investigative D0V2BG DRUG__ID D0V2BG D0V2BG DRUGCOMP Isis Pharmaceuticals D0V2BG DRUGTYPE Antisense drug D0V2BG HIGHSTAT Investigative D0V2GZ DRUG__ID D0V2GZ D0V2GZ DRUGCOMP University of California D0V2GZ DRUGTYPE Vaccine D0V2GZ HIGHSTAT Investigative D0V2QL DRUG__ID D0V2QL D0V2QL DRUGCOMP Isis Pharmaceuticals D0V2QL DRUGTYPE Antisense drug D0V2QL HIGHSTAT Investigative D0V2QU DRUG__ID D0V2QU D0V2QU DRUGCOMP Abiogen Pharma D0V2QU DRUGTYPE Monoclonal antibody D0V2QU HIGHSTAT Investigative D0V2VB DRUG__ID D0V2VB D0V2VB DRUGCOMP Isis Pharmaceuticals D0V2VB DRUGTYPE Antisense drug D0V2VB HIGHSTAT Investigative D0V4JV DRUG__ID D0V4JV D0V4JV DRUGTYPE Small molecule immunotherapy D0V4JV HIGHSTAT Investigative D0V4JV COMPCLAS Aromatic acetylene derivatives D0V7SZ DRUG__ID D0V7SZ D0V7SZ DRUGCOMP Isis Pharmaceuticals D0V7SZ DRUGTYPE Antisense drug D0V7SZ HIGHSTAT Investigative D0V8KH DRUG__ID D0V8KH D0V8KH DRUGCOMP Isis Pharmaceuticals D0V8KH DRUGTYPE Antisense drug D0V8KH HIGHSTAT Investigative D0V8KZ DRUG__ID D0V8KZ D0V8KZ DRUGCOMP Isis Pharmaceuticals D0V8KZ DRUGTYPE Antisense drug D0V8KZ HIGHSTAT Investigative D0V9LF DRUG__ID D0V9LF D0V9LF DRUGCOMP Bristol-Myers Squibb Co D0V9LF DRUGTYPE Antibody D0V9LF HIGHSTAT Investigative D0V9MH DRUG__ID D0V9MH D0V9MH DRUGCOMP Isis Pharmaceuticals D0V9MH DRUGTYPE Antisense drug D0V9MH HIGHSTAT Investigative D0VA3Z DRUG__ID D0VA3Z D0VA3Z DRUGCOMP GTC Biotherapeutics Inc D0VA3Z DRUGTYPE Monoclonal antibody D0VA3Z HIGHSTAT Investigative D0W0BL DRUG__ID D0W0BL D0W0BL DRUGTYPE Small molecular drug D0W0BL DRUGSMIL C1=CC(=CC(=C1)O)NN=C2C(=NN=C2N)N D0W0BL HIGHSTAT Investigative D0W0QO DRUG__ID D0W0QO D0W0QO DRUGCOMP Isis Pharmaceuticals D0W0QO DRUGTYPE Antisense drug D0W0QO HIGHSTAT Investigative D0W0QS DRUG__ID D0W0QS D0W0QS DRUGCOMP Isis Pharmaceuticals D0W0QS DRUGTYPE Antisense drug D0W0QS HIGHSTAT Investigative D0W0SS DRUG__ID D0W0SS D0W0SS DRUGCOMP Isis Pharmaceuticals D0W0SS DRUGTYPE Antisense drug D0W0SS HIGHSTAT Investigative D0W1XD DRUG__ID D0W1XD D0W1XD DRUGCOMP Isis Pharmaceuticals D0W1XD DRUGTYPE Antisense drug D0W1XD HIGHSTAT Investigative D0W2FM DRUG__ID D0W2FM D0W2FM DRUGTYPE Small molecular drug D0W2FM DRUGSMIL CC1=CC2=C(C=C1)NC(=C2NO)C3=C4C=C(C=CC4=NC3=O)F D0W2FM HIGHSTAT Investigative D0W2FY DRUG__ID D0W2FY D0W2FY DRUGCOMP Isis Pharmaceuticals D0W2FY DRUGTYPE Antisense drug D0W2FY HIGHSTAT Investigative D0W3RP DRUG__ID D0W3RP D0W3RP DRUGCOMP Isis Pharmaceuticals D0W3RP DRUGTYPE Antisense drug D0W3RP HIGHSTAT Investigative D0W3RV DRUG__ID D0W3RV D0W3RV DRUGCOMP Isis Pharmaceuticals D0W3RV DRUGTYPE Antisense drug D0W3RV HIGHSTAT Investigative D0W4XP DRUG__ID D0W4XP D0W4XP DRUGCOMP Isis Pharmaceuticals D0W4XP DRUGTYPE Antisense drug D0W4XP HIGHSTAT Investigative D0W5AW DRUG__ID D0W5AW D0W5AW DRUGTYPE Small molecular drug D0W5AW DRUGSMIL CN1CCC2=C(C1)C3=NC(=O)C(=C3C=C2C4=CC=C(C=C4)S(=O)(=O)N(C)C)NOC(CCO)C(=O)O.COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC D0W5AW HIGHSTAT Investigative D0W5FH DRUG__ID D0W5FH D0W5FH DRUGCOMP Isis Pharmaceuticals D0W5FH DRUGTYPE Antisense drug D0W5FH HIGHSTAT Investigative D0W5PG DRUG__ID D0W5PG D0W5PG DRUGCOMP PharmAbcine D0W5PG DRUGTYPE Monoclonal antibody D0W5PG HIGHSTAT Investigative D0W7DK DRUG__ID D0W7DK D0W7DK DRUGCOMP Isis Pharmaceuticals D0W7DK DRUGTYPE Antisense drug D0W7DK HIGHSTAT Investigative D0W7OF DRUG__ID D0W7OF D0W7OF THERCLAS Antiviral Agents D0W7OF DRUGTYPE Small molecular drug D0W7OF HIGHSTAT Investigative D0W7VQ DRUG__ID D0W7VQ D0W7VQ DRUGCOMP Ganymed Pharmaceuticals AG D0W7VQ DRUGTYPE Monoclonal antibody D0W7VQ HIGHSTAT Investigative D0W9JP DRUG__ID D0W9JP D0W9JP DRUGCOMP Mapp Biopharmaceutical Inc D0W9JP DRUGTYPE Monoclonal antibody D0W9JP HIGHSTAT Investigative D0WM1A DRUG__ID D0WM1A D0WM1A DRUGCOMP Isis Pharmaceuticals D0WM1A DRUGTYPE Antisense drug D0WM1A HIGHSTAT Investigative D0WM8R DRUG__ID D0WM8R D0WM8R DRUGCOMP Isis Pharmaceuticals D0WM8R DRUGTYPE Antisense drug D0WM8R HIGHSTAT Investigative D0WN1N DRUG__ID D0WN1N D0WN1N DRUGCOMP Sanomune Inc D0WN1N DRUGTYPE Antibody D0WN1N HIGHSTAT Investigative D0WO4V DRUG__ID D0WO4V D0WO4V DRUGCOMP Isis Pharmaceuticals D0WO4V DRUGTYPE Antisense drug D0WO4V HIGHSTAT Investigative D0WX6J DRUG__ID D0WX6J D0WX6J DRUGTYPE Peptide D0WX6J HIGHSTAT Investigative D0WX6J COMPCLAS Peptidomimetics D0X1NL DRUG__ID D0X1NL D0X1NL DRUGCOMP Isis Pharmaceuticals D0X1NL DRUGTYPE Antisense drug D0X1NL HIGHSTAT Investigative D0X1YZ DRUG__ID D0X1YZ D0X1YZ DRUGCOMP Kyowa Hakko Kirin Co Ltd D0X1YZ DRUGTYPE Antibody D0X1YZ HIGHSTAT Investigative D0X2HI DRUG__ID D0X2HI D0X2HI DRUGCOMP Isis Pharmaceuticals D0X2HI DRUGTYPE Antisense drug D0X2HI HIGHSTAT Investigative D0X3FC DRUG__ID D0X3FC D0X3FC DRUGCOMP Isis Pharmaceuticals D0X3FC DRUGTYPE Antisense drug D0X3FC HIGHSTAT Investigative D0X3PN DRUG__ID D0X3PN D0X3PN DRUGCOMP Crystal Bioscience Inc D0X3PN DRUGTYPE Antibody D0X3PN HIGHSTAT Investigative D0X3TX DRUG__ID D0X3TX D0X3TX DRUGCOMP Isis Pharmaceuticals D0X3TX DRUGTYPE Antisense drug D0X3TX HIGHSTAT Investigative D0X4VG DRUG__ID D0X4VG D0X4VG DRUGCOMP AVEO Pharmaceuticals Inc D0X4VG DRUGTYPE Monoclonal antibody D0X4VG HIGHSTAT Investigative D0X7DN DRUG__ID D0X7DN D0X7DN DRUGCOMP Isis Pharmaceuticals D0X7DN DRUGTYPE Antisense drug D0X7DN HIGHSTAT Investigative D0X7FV DRUG__ID D0X7FV D0X7FV DRUGCOMP Isis Pharmaceuticals D0X7FV DRUGTYPE Antisense drug D0X7FV HIGHSTAT Investigative D0X7MU DRUG__ID D0X7MU D0X7MU DRUGCOMP Isis Pharmaceuticals D0X7MU DRUGTYPE Antisense drug D0X7MU HIGHSTAT Investigative D0X7OE DRUG__ID D0X7OE D0X7OE THERCLAS Antiviral Agents D0X7OE DRUGTYPE Small molecular drug D0X7OE HIGHSTAT Investigative D0X8GB DRUG__ID D0X8GB D0X8GB DRUGCOMP Isis Pharmaceuticals D0X8GB DRUGTYPE Antisense drug D0X8GB HIGHSTAT Investigative D0X8RA DRUG__ID D0X8RA D0X8RA DRUGCOMP Genitope Corp D0X8RA DRUGTYPE Monoclonal antibody D0X8RA HIGHSTAT Investigative D0X8SM DRUG__ID D0X8SM D0X8SM DRUGCOMP Xencor Inc D0X8SM DRUGTYPE Antibody D0X8SM HIGHSTAT Investigative D0X9EH DRUG__ID D0X9EH D0X9EH DRUGCOMP Isis Pharmaceuticals D0X9EH DRUGTYPE Antisense drug D0X9EH HIGHSTAT Investigative D0XL3N DRUG__ID D0XL3N D0XL3N DRUGTYPE Small molecule immunotherapy D0XL3N HIGHSTAT Investigative D0XL3N COMPCLAS Macrocyclic peptidomimetic compounds D0XO0T DRUG__ID D0XO0T D0XO0T DRUGCOMP Isis Pharmaceuticals D0XO0T DRUGTYPE Antisense drug D0XO0T HIGHSTAT Investigative D0XV1M DRUG__ID D0XV1M D0XV1M DRUGCOMP Isis Pharmaceuticals D0XV1M DRUGTYPE Antisense drug D0XV1M HIGHSTAT Investigative D0Y0EJ DRUG__ID D0Y0EJ D0Y0EJ DRUGCOMP Isis Pharmaceuticals D0Y0EJ DRUGTYPE Antisense drug D0Y0EJ HIGHSTAT Investigative D0Y0WW DRUG__ID D0Y0WW D0Y0WW DRUGCOMP Femta Pharmaceuticals Inc D0Y0WW DRUGTYPE Antibody D0Y0WW HIGHSTAT Investigative D0Y3OV DRUG__ID D0Y3OV D0Y3OV DRUGCOMP Isis Pharmaceuticals D0Y3OV DRUGTYPE Antisense drug D0Y3OV HIGHSTAT Investigative D0Y4II DRUG__ID D0Y4II D0Y4II DRUGCOMP Isis Pharmaceuticals D0Y4II DRUGTYPE Antisense drug D0Y4II HIGHSTAT Investigative D0Y4RS DRUG__ID D0Y4RS D0Y4RS DRUGCOMP Isis Pharmaceuticals D0Y4RS DRUGTYPE Antisense drug D0Y4RS HIGHSTAT Investigative D0Y4TS DRUG__ID D0Y4TS D0Y4TS DRUGCOMP Isis Pharmaceuticals D0Y4TS DRUGTYPE Antisense drug D0Y4TS HIGHSTAT Investigative D0Y4ZF DRUG__ID D0Y4ZF D0Y4ZF DRUGTYPE Small molecular drug D0Y4ZF DRUGSMIL C1CCC(C1)SC2=NC(=O)C=C(N2)CC3=CC=CC=C3 D0Y4ZF HIGHSTAT Investigative D0Y5BV DRUG__ID D0Y5BV D0Y5BV DRUGCOMP Aronora Biopharmaceuticals D0Y5BV DRUGTYPE Monoclonal antibody D0Y5BV HIGHSTAT Investigative D0Y5GA DRUG__ID D0Y5GA D0Y5GA DRUGCOMP Isis Pharmaceuticals D0Y5GA DRUGTYPE Antisense drug D0Y5GA HIGHSTAT Investigative D0Y5KQ DRUG__ID D0Y5KQ D0Y5KQ DRUGTYPE Small molecular drug D0Y5KQ DRUGSMIL C1=NC2=C(N1COCCO)NC(=NC2=O)N.N.N.Cl[Pt] D0Y5KQ HIGHSTAT Investigative D0Y5UO DRUG__ID D0Y5UO D0Y5UO DRUGCOMP Isis Pharmaceuticals D0Y5UO DRUGTYPE Antisense drug D0Y5UO HIGHSTAT Investigative D0Y6NO DRUG__ID D0Y6NO D0Y6NO DRUGCOMP Xencor Inc D0Y6NO DRUGTYPE Monoclonal antibody D0Y6NO HIGHSTAT Investigative D0Y7VA DRUG__ID D0Y7VA D0Y7VA DRUGCOMP Isis Pharmaceuticals D0Y7VA DRUGTYPE Antisense drug D0Y7VA HIGHSTAT Investigative D0Y8VJ DRUG__ID D0Y8VJ D0Y8VJ DRUGCOMP Isis Pharmaceuticals D0Y8VJ DRUGTYPE Antisense drug D0Y8VJ HIGHSTAT Investigative D0Y9ES DRUG__ID D0Y9ES D0Y9ES DRUGCOMP Bioarctic Neuroscience AB D0Y9ES DRUGTYPE Vaccine D0Y9ES HIGHSTAT Investigative D0Y9ZR DRUG__ID D0Y9ZR D0Y9ZR DRUGCOMP Isis Pharmaceuticals D0Y9ZR DRUGTYPE Antisense drug D0Y9ZR HIGHSTAT Investigative D0YQ2K DRUG__ID D0YQ2K D0YQ2K THERCLAS Antiviral Agents D0YQ2K DRUGTYPE Monoclonal antibody D0YQ2K HIGHSTAT Investigative D0YZ9Y DRUG__ID D0YZ9Y D0YZ9Y DRUGTYPE Small molecular drug D0YZ9Y DRUGSMIL C1=CC2=NC(=O)C(=C2C=C1[N+](=O)[O-])C3=C(C4=C(N3)C=CC(=C4)O)NO D0YZ9Y HIGHSTAT Investigative D0Z0XJ DRUG__ID D0Z0XJ D0Z0XJ DRUGCOMP Isis Pharmaceuticals D0Z0XJ DRUGTYPE Antisense drug D0Z0XJ HIGHSTAT Investigative D0Z2IY DRUG__ID D0Z2IY D0Z2IY DRUGCOMP University of California San Diego D0Z2IY DRUGTYPE Vaccine D0Z2IY HIGHSTAT Investigative D0Z2OW DRUG__ID D0Z2OW D0Z2OW DRUGCOMP Isis Pharmaceuticals D0Z2OW DRUGTYPE Antisense drug D0Z2OW HIGHSTAT Investigative D0Z2QO DRUG__ID D0Z2QO D0Z2QO DRUGCOMP Isis Pharmaceuticals D0Z2QO DRUGTYPE Antisense drug D0Z2QO HIGHSTAT Investigative D0Z2RM DRUG__ID D0Z2RM D0Z2RM DRUGCOMP Isis Pharmaceuticals D0Z2RM DRUGTYPE Antisense drug D0Z2RM HIGHSTAT Investigative D0Z3AB DRUG__ID D0Z3AB D0Z3AB DRUGCOMP Advanced Immune Therapeutics Inc D0Z3AB DRUGTYPE Antibody D0Z3AB HIGHSTAT Investigative D0Z3KK DRUG__ID D0Z3KK D0Z3KK THERCLAS Antiviral Agents D0Z3KK DRUGTYPE Small molecular drug D0Z3KK HIGHSTAT Investigative D0Z3TU DRUG__ID D0Z3TU D0Z3TU DRUGCOMP Isis Pharmaceuticals D0Z3TU DRUGTYPE Antisense drug D0Z3TU HIGHSTAT Investigative D0Z4CC DRUG__ID D0Z4CC D0Z4CC DRUGCOMP Isis Pharmaceuticals D0Z4CC DRUGTYPE Antisense drug D0Z4CC HIGHSTAT Investigative D0Z4LP DRUG__ID D0Z4LP D0Z4LP DRUGCOMP Isis Pharmaceuticals D0Z4LP DRUGTYPE Antisense drug D0Z4LP HIGHSTAT Investigative D0Z4RI DRUG__ID D0Z4RI D0Z4RI DRUGCOMP Isis Pharmaceuticals D0Z4RI DRUGTYPE Antisense drug D0Z4RI HIGHSTAT Investigative D0Z4RX DRUG__ID D0Z4RX D0Z4RX DRUGCOMP Genmab A/S D0Z4RX DRUGTYPE Antibody D0Z4RX HIGHSTAT Investigative D0Z5NN DRUG__ID D0Z5NN D0Z5NN DRUGCOMP Isis Pharmaceuticals D0Z5NN DRUGTYPE Antisense drug D0Z5NN HIGHSTAT Investigative D0Z5SL DRUG__ID D0Z5SL D0Z5SL DRUGCOMP Isis Pharmaceuticals D0Z5SL DRUGTYPE Antisense drug D0Z5SL HIGHSTAT Investigative D0Z6AS DRUG__ID D0Z6AS D0Z6AS DRUGCOMP Isis Pharmaceuticals D0Z6AS DRUGTYPE Antisense drug D0Z6AS HIGHSTAT Investigative D0Z6ZA DRUG__ID D0Z6ZA D0Z6ZA DRUGCOMP Isis Pharmaceuticals D0Z6ZA DRUGTYPE Antisense drug D0Z6ZA HIGHSTAT Investigative D0Z7BO DRUG__ID D0Z7BO D0Z7BO DRUGCOMP Isis Pharmaceuticals D0Z7BO DRUGTYPE Antisense drug D0Z7BO HIGHSTAT Investigative D0Z8DM DRUG__ID D0Z8DM D0Z8DM DRUGCOMP Isis Pharmaceuticals D0Z8DM DRUGTYPE Antisense drug D0Z8DM HIGHSTAT Investigative D0Z8XJ DRUG__ID D0Z8XJ D0Z8XJ DRUGTYPE Small molecular drug D0Z8XJ DRUGSMIL CCC(C)SC1=NC(=O)C=C(N1)CC2=CC=CC=C2 D0Z8XJ HIGHSTAT Investigative D0Z9NS DRUG__ID D0Z9NS D0Z9NS DRUGCOMP Isis Pharmaceuticals D0Z9NS DRUGTYPE Antisense drug D0Z9NS HIGHSTAT Investigative D0ZC3K DRUG__ID D0ZC3K D0ZC3K DRUGCOMP Cangene Corp D0ZC3K DRUGTYPE Monoclonal antibody D0ZC3K HIGHSTAT Investigative D0ZF2W DRUG__ID D0ZF2W D0ZF2W DRUGCOMP Isis Pharmaceuticals D0ZF2W DRUGTYPE Antisense drug D0ZF2W HIGHSTAT Investigative D0ZL8O DRUG__ID D0ZL8O D0ZL8O DRUGCOMP Isis Pharmaceuticals D0ZL8O DRUGTYPE Antisense drug D0ZL8O HIGHSTAT Investigative D0ZQ0Y DRUG__ID D0ZQ0Y D0ZQ0Y DRUGCOMP Isis Pharmaceuticals D0ZQ0Y DRUGTYPE Antisense drug D0ZQ0Y HIGHSTAT Investigative D1N2BO DRUG__ID D1N2BO D1N2BO DRUGCOMP GlaxoSmithKline D1N2BO DRUGTYPE Small molecular drug D1N2BO HIGHSTAT Investigative D59BZJ DRUG__ID D59BZJ D59BZJ DRUGCOMP ABX GmbH D59BZJ DRUGTYPE Radiopharmaceutical therapy agent D59BZJ HIGHSTAT Investigative DA91UG DRUG__ID DA91UG DA91UG DRUGCOMP Biocytogen DA91UG DRUGTYPE Antibody DA91UG HIGHSTAT Investigative DBTI39 DRUG__ID DBTI39 DBTI39 DRUGCOMP Biocytogen DBTI39 DRUGTYPE Antibody DBTI39 HIGHSTAT Investigative DH0JW9 DRUG__ID DH0JW9 DH0JW9 DRUGCOMP Biocytogen DH0JW9 DRUGTYPE Bispecific antibody DH0JW9 HIGHSTAT Investigative DKHL40 DRUG__ID DKHL40 DKHL40 DRUGCOMP Biocytogen DKHL40 DRUGTYPE Bispecific antibody-drug conjugate DKHL40 HIGHSTAT Investigative DX45IW DRUG__ID DX45IW DX45IW DRUGCOMP Mallinckrodt Pharma DX45IW DRUGTYPE Small molecular drug DX45IW HIGHSTAT Investigative DY5AT2 DRUG__ID DY5AT2 DY5AT2 DRUGCOMP Biocytogen DY5AT2 DRUGTYPE Antibody DY5AT2 HIGHSTAT Investigative DZ7EG5 DRUG__ID DZ7EG5 DZ7EG5 DRUGCOMP Biocytogen DZ7EG5 DRUGTYPE Bispecific antibody DZ7EG5 HIGHSTAT Investigative D00AHV DRUG__ID D00AHV D00AHV DRUGCOMP SK Life Science D00AHV HIGHSTAT Investigative D00AIS DRUG__ID D00AIS D00AIS DRUGCOMP Antisense Pharma GmbH D00AIS HIGHSTAT Investigative D00AIZ DRUG__ID D00AIZ D00AIZ DRUGCOMP Snowdon Inc D00AIZ HIGHSTAT Investigative D00AJS DRUG__ID D00AJS D00AJS DRUGCOMP Allinky Biopharma D00AJS HIGHSTAT Investigative D00AQV DRUG__ID D00AQV D00AQV DRUGCOMP Critical Outcome Technologies Inc D00AQV HIGHSTAT Investigative D00ASX DRUG__ID D00ASX D00ASX DRUGCOMP Chodang Pharm Co Ltd D00ASX HIGHSTAT Investigative D00AUM DRUG__ID D00AUM D00AUM DRUGCOMP Aquilus Pharmaceuticals Inc D00AUM HIGHSTAT Investigative D00AUZ DRUG__ID D00AUZ D00AUZ DRUGCOMP TransGenex Nanobiotech Inc D00AUZ HIGHSTAT Investigative D00AVG DRUG__ID D00AVG D00AVG DRUGCOMP Genexine Co Ltd D00AVG HIGHSTAT Investigative D00AXG DRUG__ID D00AXG D00AXG DRUGCOMP Summit Corp plc D00AXG HIGHSTAT Investigative D00AXT DRUG__ID D00AXT D00AXT DRUGCOMP State University of New York Stony Brook D00AXT HIGHSTAT Investigative D00AXZ DRUG__ID D00AXZ D00AXZ DRUGCOMP Glycadia Inc D00AXZ HIGHSTAT Investigative D00BBB DRUG__ID D00BBB D00BBB DRUGCOMP MicroDose Therapeutx Inc D00BBB HIGHSTAT Investigative D00BCS DRUG__ID D00BCS D00BCS DRUGCOMP IntelGenx Corp D00BCS HIGHSTAT Investigative D00BCZ DRUG__ID D00BCZ D00BCZ DRUGCOMP Xaragen Pharma Ltd D00BCZ HIGHSTAT Investigative D00BMM DRUG__ID D00BMM D00BMM DRUGCOMP Galera Therapeutics LLC D00BMM HIGHSTAT Investigative D00BTZ DRUG__ID D00BTZ D00BTZ DRUGCOMP Cognition Therapeutics Inc D00BTZ HIGHSTAT Investigative D00BXZ DRUG__ID D00BXZ D00BXZ DRUGCOMP Momenta Pharmaceuticals Inc D00BXZ HIGHSTAT Investigative D00BZO DRUG__ID D00BZO D00BZO DRUGCOMP HanAll Biopharma Co Ltd D00BZO HIGHSTAT Investigative D00CBY DRUG__ID D00CBY D00CBY DRUGCOMP Celek Pharmaceuticals LLC D00CBY HIGHSTAT Investigative D00CED DRUG__ID D00CED D00CED DRUGCOMP Human Genome Sciences Inc D00CED HIGHSTAT Investigative D00CFU DRUG__ID D00CFU D00CFU DRUGCOMP Roche Holding AG D00CFU HIGHSTAT Investigative D00CMA DRUG__ID D00CMA D00CMA DRUGCOMP Vivozon Inc D00CMA HIGHSTAT Investigative D00CMC DRUG__ID D00CMC D00CMC DRUGCOMP Beijing Pason Pharmaceuticals Inc D00CMC HIGHSTAT Investigative D00DHT DRUG__ID D00DHT D00DHT DRUGCOMP Vasade Biosciences Inc D00DHT HIGHSTAT Investigative D00DRA DRUG__ID D00DRA D00DRA DRUGCOMP Wuhan Katygen Pharmaceuticals Inc D00DRA HIGHSTAT Investigative D00DSG DRUG__ID D00DSG D00DSG DRUGCOMP Pfizer Inc D00DSG HIGHSTAT Investigative D00DSN DRUG__ID D00DSN D00DSN DRUGCOMP NexBio Inc D00DSN HIGHSTAT Investigative D00DTP DRUG__ID D00DTP D00DTP DRUGCOMP Zambon Co SpA D00DTP HIGHSTAT Investigative D00EFD DRUG__ID D00EFD D00EFD DRUGCOMP CoNCERT Pharmaceuticals Inc D00EFD HIGHSTAT Investigative D00EKM DRUG__ID D00EKM D00EKM DRUGCOMP Vision 7 GmbH D00EKM HIGHSTAT Investigative D00ENU DRUG__ID D00ENU D00ENU DRUGCOMP Cellmid Ltd D00ENU HIGHSTAT Investigative D00EQD DRUG__ID D00EQD D00EQD DRUGCOMP Proneuron Biotechnologies Inc D00EQD HIGHSTAT Investigative D00EYF DRUG__ID D00EYF D00EYF DRUGCOMP Ambrx Inc D00EYF HIGHSTAT Investigative D00FMQ DRUG__ID D00FMQ D00FMQ DRUGCOMP Fibrex Medical R&D GmbH D00FMQ HIGHSTAT Investigative D00FOR DRUG__ID D00FOR D00FOR DRUGCOMP Almirall Prodesfarma SA D00FOR HIGHSTAT Investigative D00FRX DRUG__ID D00FRX D00FRX DRUGCOMP University of California Davis D00FRX HIGHSTAT Investigative D00FUD DRUG__ID D00FUD D00FUD DRUGCOMP HRA Pharma D00FUD HIGHSTAT Investigative D00FXQ DRUG__ID D00FXQ D00FXQ DRUGCOMP Indigene Pharmaceuticals Inc D00FXQ HIGHSTAT Investigative D00GFU DRUG__ID D00GFU D00GFU DRUGCOMP Receptagen Corp D00GFU HIGHSTAT Investigative D00GKH DRUG__ID D00GKH D00GKH DRUGCOMP Human Genome Sciences Inc D00GKH HIGHSTAT Investigative D00GLQ DRUG__ID D00GLQ D00GLQ DRUGCOMP Pfizer Inc D00GLQ HIGHSTAT Investigative D00GLW DRUG__ID D00GLW D00GLW DRUGCOMP OM Pharma D00GLW HIGHSTAT Investigative D00GNN DRUG__ID D00GNN D00GNN DRUGCOMP State University of New York D00GNN HIGHSTAT Investigative D00HBF DRUG__ID D00HBF D00HBF DRUGCOMP Cell Signals Inc D00HBF HIGHSTAT Investigative D00HCK DRUG__ID D00HCK D00HCK DRUGTYPE Peptide D00HCK HIGHSTAT Investigative D00HDC DRUG__ID D00HDC D00HDC DRUGCOMP Mt Cook Pharma D00HDC HIGHSTAT Investigative D00HDH DRUG__ID D00HDH D00HDH DRUGCOMP Merck & Co Inc D00HDH HIGHSTAT Investigative D00HEA DRUG__ID D00HEA D00HEA DRUGCOMP Kyto Biopharma Inc D00HEA HIGHSTAT Investigative D00HNQ DRUG__ID D00HNQ D00HNQ DRUGCOMP ALS Therapy Development Foundation Inc D00HNQ HIGHSTAT Investigative D00HPX DRUG__ID D00HPX D00HPX DRUGCOMP Onconova Therapeutics Inc D00HPX HIGHSTAT Investigative D00HQB DRUG__ID D00HQB D00HQB DRUGCOMP TxCell SA D00HQB HIGHSTAT Investigative D00HZO DRUG__ID D00HZO D00HZO DRUGCOMP Gene Signal SAS D00HZO HIGHSTAT Investigative D00IDV DRUG__ID D00IDV D00IDV DRUGCOMP Cornerstone Therapeutics Inc D00IDV HIGHSTAT Investigative D00IEB DRUG__ID D00IEB D00IEB DRUGCOMP Dr Reddy's Laboratories Ltd D00IEB HIGHSTAT Investigative D00IWE DRUG__ID D00IWE D00IWE DRUGCOMP Reviva Pharmaceuticals Inc D00IWE HIGHSTAT Investigative D00JBM DRUG__ID D00JBM D00JBM DRUGCOMP UBE Industries Ltd D00JBM HIGHSTAT Investigative D00JDP DRUG__ID D00JDP D00JDP DRUGCOMP Amunix Inc D00JDP HIGHSTAT Investigative D00JFN DRUG__ID D00JFN D00JFN DRUGCOMP State University of New York Stony Brook D00JFN HIGHSTAT Investigative D00JIX DRUG__ID D00JIX D00JIX DRUGCOMP Ikerchem D00JIX HIGHSTAT Investigative D00JME DRUG__ID D00JME D00JME DRUGCOMP Summit Corp plc D00JME HIGHSTAT Investigative D00JMG DRUG__ID D00JMG D00JMG DRUGCOMP HRA Pharma D00JMG HIGHSTAT Investigative D00JPK DRUG__ID D00JPK D00JPK DRUGCOMP Hygeia Therapeutics Inc D00JPK HIGHSTAT Investigative D00JXV DRUG__ID D00JXV D00JXV DRUGCOMP Incyte Corp D00JXV HIGHSTAT Investigative D00KCR DRUG__ID D00KCR D00KCR DRUGCOMP Multimmune GmbH D00KCR HIGHSTAT Investigative D00KIU DRUG__ID D00KIU D00KIU DRUGCOMP MannKind Corp D00KIU HIGHSTAT Investigative D00KMI DRUG__ID D00KMI D00KMI DRUGCOMP EvoGenix Pty Ltd D00KMI HIGHSTAT Investigative D00KSU DRUG__ID D00KSU D00KSU DRUGCOMP MaxThera Inc D00KSU HIGHSTAT Investigative D00LAA DRUG__ID D00LAA D00LAA DRUGCOMP Vantia Therapeutics D00LAA HIGHSTAT Investigative D00LDI DRUG__ID D00LDI D00LDI DRUGCOMP DNAVEC Corp D00LDI HIGHSTAT Investigative D00LEN DRUG__ID D00LEN D00LEN DRUGTYPE siRNA drug D00LEN HIGHSTAT Investigative D00LMR DRUG__ID D00LMR D00LMR DRUGCOMP Applied Protein Sciences LLC D00LMR HIGHSTAT Investigative D00LMY DRUG__ID D00LMY D00LMY DRUGCOMP Roche Holding AG D00LMY HIGHSTAT Investigative D00LPZ DRUG__ID D00LPZ D00LPZ DRUGCOMP BioTie Therapies Corp D00LPZ HIGHSTAT Investigative D00LSD DRUG__ID D00LSD D00LSD DRUGCOMP Genfit SA D00LSD HIGHSTAT Investigative D00LWD DRUG__ID D00LWD D00LWD DRUGCOMP Angelini Pharmaceuticals SpA D00LWD HIGHSTAT Investigative D00LXB DRUG__ID D00LXB D00LXB DRUGCOMP Aridis Pharmaceuticals LLC D00LXB HIGHSTAT Investigative D00LYE DRUG__ID D00LYE D00LYE DRUGCOMP Gamida Cell Ltd D00LYE HIGHSTAT Investigative D00LZO DRUG__ID D00LZO D00LZO DRUGCOMP Cellzome D00LZO HIGHSTAT Investigative D00LZY DRUG__ID D00LZY D00LZY DRUGCOMP Thrasos Therapeutics Inc D00LZY HIGHSTAT Investigative D00MAM DRUG__ID D00MAM D00MAM DRUGCOMP Amgen Inc D00MAM HIGHSTAT Investigative D00MCA DRUG__ID D00MCA D00MCA DRUGCOMP Michigan Technological University D00MCA HIGHSTAT Investigative D00MET DRUG__ID D00MET D00MET DRUGCOMP Metastatin Pharmaceuticals Inc D00MET HIGHSTAT Investigative D00MPX DRUG__ID D00MPX D00MPX DRUGCOMP Jennerex Inc D00MPX HIGHSTAT Investigative D00MRH DRUG__ID D00MRH D00MRH DRUGCOMP Reliance Life Sciences Group D00MRH HIGHSTAT Investigative D00MWE DRUG__ID D00MWE D00MWE DRUGCOMP Ultragenyx Pharmaceutical D00MWE HIGHSTAT Investigative D00MZC DRUG__ID D00MZC D00MZC DRUGCOMP Lytix Biopharma AS D00MZC HIGHSTAT Investigative D00NIV DRUG__ID D00NIV D00NIV DRUGCOMP ATyr Pharma Inc D00NIV HIGHSTAT Investigative D00NOY DRUG__ID D00NOY D00NOY DRUGCOMP Amcyte D00NOY HIGHSTAT Investigative D00NPE DRUG__ID D00NPE D00NPE DRUGCOMP Wyeth D00NPE HIGHSTAT Investigative D00NYL DRUG__ID D00NYL D00NYL DRUGCOMP Genzyme Corp D00NYL HIGHSTAT Investigative D00OAB DRUG__ID D00OAB D00OAB DRUGCOMP Epitomics Inc D00OAB HIGHSTAT Investigative D00OHP DRUG__ID D00OHP D00OHP DRUGCOMP Galectin Therapeutics Inc D00OHP HIGHSTAT Investigative D00OJL DRUG__ID D00OJL D00OJL DRUGCOMP Provid Pharmaceuticals Inc D00OJL HIGHSTAT Investigative D00OKK DRUG__ID D00OKK D00OKK DRUGCOMP Pico Pharmaceuticals Inc D00OKK HIGHSTAT Investigative D00OMJ DRUG__ID D00OMJ D00OMJ DRUGCOMP SJ Biomed Inc D00OMJ HIGHSTAT Investigative D00ONE DRUG__ID D00ONE D00ONE DRUGCOMP JW Pharmaceutical Corp D00ONE HIGHSTAT Investigative D00PBI DRUG__ID D00PBI D00PBI DRUGCOMP Suven Life Sciences Ltd D00PBI HIGHSTAT Investigative D00PDQ DRUG__ID D00PDQ D00PDQ DRUGCOMP BioZyme Inc D00PDQ HIGHSTAT Investigative D00PGA DRUG__ID D00PGA D00PGA DRUGCOMP RegenX Biosciences LLC D00PGA HIGHSTAT Investigative D00PGF DRUG__ID D00PGF D00PGF DRUGCOMP RespiVert Ltd D00PGF HIGHSTAT Investigative D00PJK DRUG__ID D00PJK D00PJK DRUGCOMP Southern Research Institute D00PJK HIGHSTAT Investigative D00PLX DRUG__ID D00PLX D00PLX DRUGCOMP Mystic Pharmaceuticals Inc D00PLX HIGHSTAT Investigative D00PQS DRUG__ID D00PQS D00PQS DRUGCOMP Diamyd Medical AB D00PQS HIGHSTAT Investigative D00QAQ DRUG__ID D00QAQ D00QAQ DRUGCOMP Terpenoid Therapeutics D00QAQ HIGHSTAT Investigative D00QBV DRUG__ID D00QBV D00QBV DRUGTYPE Aptamer D00QBV HIGHSTAT Investigative D00QCV DRUG__ID D00QCV D00QCV DRUGCOMP Green Cross Corp D00QCV HIGHSTAT Investigative D00QCX DRUG__ID D00QCX D00QCX DRUGCOMP Louisiana State University D00QCX HIGHSTAT Investigative D00QFV DRUG__ID D00QFV D00QFV DRUGCOMP ERYtech Pharma D00QFV HIGHSTAT Investigative D00QGB DRUG__ID D00QGB D00QGB DRUGCOMP Organix Inc D00QGB HIGHSTAT Investigative D00QLG DRUG__ID D00QLG D00QLG DRUGCOMP Advaxis Inc D00QLG HIGHSTAT Investigative D00QOH DRUG__ID D00QOH D00QOH DRUGCOMP Oscotec Inc D00QOH HIGHSTAT Investigative D00QTA DRUG__ID D00QTA D00QTA DRUGCOMP Arrow Therapeutics Ltd D00QTA HIGHSTAT Investigative D00QTL DRUG__ID D00QTL D00QTL DRUGCOMP ImCure Therapeutics D00QTL HIGHSTAT Investigative D00QTU DRUG__ID D00QTU D00QTU DRUGCOMP Threshold Pharmaceuticals Inc D00QTU HIGHSTAT Investigative D00QUJ DRUG__ID D00QUJ D00QUJ DRUGCOMP Kyorin Pharmaceutical Co Ltd D00QUJ HIGHSTAT Investigative D00QWP DRUG__ID D00QWP D00QWP DRUGCOMP Hygeia Therapeutics Inc D00QWP HIGHSTAT Investigative D00QZJ DRUG__ID D00QZJ D00QZJ DRUGCOMP Access Pharmaceuticals Inc D00QZJ HIGHSTAT Investigative D00RDI DRUG__ID D00RDI D00RDI DRUGCOMP Opsona Therapeutics Ltd D00RDI HIGHSTAT Investigative D00RIK DRUG__ID D00RIK D00RIK DRUGCOMP Compugen Ltd D00RIK HIGHSTAT Investigative D00RPV DRUG__ID D00RPV D00RPV DRUGCOMP Epiphany Biosciences D00RPV HIGHSTAT Investigative D00RQQ DRUG__ID D00RQQ D00RQQ DRUGCOMP Astellas Pharma Inc D00RQQ HIGHSTAT Investigative D00RWU DRUG__ID D00RWU D00RWU DRUGCOMP Ottawa Hospital Research Institute D00RWU HIGHSTAT Investigative D00RZA DRUG__ID D00RZA D00RZA DRUGCOMP Epiphany Biosciences D00RZA HIGHSTAT Investigative D00SJX DRUG__ID D00SJX D00SJX DRUGCOMP Boston University D00SJX HIGHSTAT Investigative D00SMC DRUG__ID D00SMC D00SMC DRUGCOMP Panacea Pharmaceuticals Inc D00SMC HIGHSTAT Investigative D00SML DRUG__ID D00SML D00SML DRUGCOMP Neumedicines Inc D00SML HIGHSTAT Investigative D00SNY DRUG__ID D00SNY D00SNY DRUGCOMP ALS Therapy Development Foundation Inc D00SNY HIGHSTAT Investigative D00SRE DRUG__ID D00SRE D00SRE DRUGCOMP Therapeutic Systems Research Laboratories D00SRE HIGHSTAT Investigative D00STZ DRUG__ID D00STZ D00STZ DRUGCOMP Marinomed Biotechnologie GmbH D00STZ HIGHSTAT Investigative D00SWN DRUG__ID D00SWN D00SWN DRUGCOMP MingSight Pharmaceuticals D00SWN HIGHSTAT Investigative D00TBJ DRUG__ID D00TBJ D00TBJ DRUGCOMP Pfizer Inc D00TBJ HIGHSTAT Investigative D00TBS DRUG__ID D00TBS D00TBS DRUGCOMP Sun Pharmaceutical Industries Ltd D00TBS HIGHSTAT Investigative D00TJV DRUG__ID D00TJV D00TJV DRUGCOMP Incozen Therapeutics Pvt Ltd D00TJV HIGHSTAT Investigative D00TPC DRUG__ID D00TPC D00TPC DRUGCOMP MAT Biopharma D00TPC HIGHSTAT Investigative D00TPQ DRUG__ID D00TPQ D00TPQ DRUGCOMP Viron Therapeutics Inc D00TPQ HIGHSTAT Investigative D00TYI DRUG__ID D00TYI D00TYI DRUGCOMP TG Biotech Inc D00TYI HIGHSTAT Investigative D00TYP DRUG__ID D00TYP D00TYP DRUGCOMP Kinentia Biosciences LLC D00TYP HIGHSTAT Investigative D00TYR DRUG__ID D00TYR D00TYR DRUGCOMP Jeil Pharmaceutical Co Ltd D00TYR HIGHSTAT Investigative D00UHK DRUG__ID D00UHK D00UHK DRUGCOMP Kuhnil Pharmaceutical Co Ltd D00UHK HIGHSTAT Investigative D00UMJ DRUG__ID D00UMJ D00UMJ DRUGCOMP Nanomerics D00UMJ HIGHSTAT Investigative D00UPU DRUG__ID D00UPU D00UPU DRUGCOMP Rhone-Poulenc Rorer Inc D00UPU HIGHSTAT Investigative D00VCH DRUG__ID D00VCH D00VCH DRUGCOMP FAES Farma SA D00VCH HIGHSTAT Investigative D00VCZ DRUG__ID D00VCZ D00VCZ DRUGCOMP Shire plc D00VCZ HIGHSTAT Investigative D00VGP DRUG__ID D00VGP D00VGP DRUGCOMP Xaragen Pharma Ltd D00VGP HIGHSTAT Investigative D00VMY DRUG__ID D00VMY D00VMY DRUGCOMP National Research Council of Canada D00VMY HIGHSTAT Investigative D00VOF DRUG__ID D00VOF D00VOF DRUGCOMP Polaris Pharmaceuticals Inc D00VOF HIGHSTAT Investigative D00VOK DRUG__ID D00VOK D00VOK DRUGTYPE Small molecule immunotherapy D00VOK HIGHSTAT Investigative D00VXZ DRUG__ID D00VXZ D00VXZ DRUGCOMP Yaupon Therapeutics Inc D00VXZ HIGHSTAT Investigative D00WDM DRUG__ID D00WDM D00WDM DRUGCOMP GCH&P D00WDM HIGHSTAT Investigative D00WEP DRUG__ID D00WEP D00WEP DRUGCOMP Biolex Therapeutics Inc D00WEP HIGHSTAT Investigative D00WHC DRUG__ID D00WHC D00WHC DRUGCOMP SICOR Inc D00WHC HIGHSTAT Investigative D00WKL DRUG__ID D00WKL D00WKL DRUGCOMP Pharmaxis Ltd D00WKL HIGHSTAT Investigative D00WUC DRUG__ID D00WUC D00WUC DRUGCOMP Polaris Pharmaceuticals Inc D00WUC HIGHSTAT Investigative D00XND DRUG__ID D00XND D00XND DRUGCOMP PharmedArtis GmbH D00XND HIGHSTAT Investigative D00XPZ DRUG__ID D00XPZ D00XPZ DRUGCOMP Elbion NV D00XPZ HIGHSTAT Investigative D00XSP DRUG__ID D00XSP D00XSP DRUGCOMP Servier D00XSP HIGHSTAT Investigative D00XSQ DRUG__ID D00XSQ D00XSQ DRUGCOMP Ipsen D00XSQ HIGHSTAT Investigative D00YJD DRUG__ID D00YJD D00YJD DRUGCOMP Selvita Life Sciences Solutions D00YJD HIGHSTAT Investigative D00YJI DRUG__ID D00YJI D00YJI DRUGCOMP Eos Neuroscience Inc D00YJI HIGHSTAT Investigative D00YMM DRUG__ID D00YMM D00YMM DRUGCOMP Novozymes A/S D00YMM HIGHSTAT Investigative D00YMN DRUG__ID D00YMN D00YMN DRUGCOMP Aiko Biotechnology Inc D00YMN HIGHSTAT Investigative D00YNK DRUG__ID D00YNK D00YNK DRUGCOMP MiRagen Therapeutics Inc D00YNK HIGHSTAT Investigative D00YRF DRUG__ID D00YRF D00YRF DRUGCOMP UCB SA D00YRF HIGHSTAT Investigative D00YTX DRUG__ID D00YTX D00YTX DRUGCOMP Oryzon Genomics SA D00YTX HIGHSTAT Investigative D00ZBQ DRUG__ID D00ZBQ D00ZBQ DRUGCOMP Taxolog Inc D00ZBQ HIGHSTAT Investigative D00ZFC DRUG__ID D00ZFC D00ZFC DRUGCOMP Pharmagenesis Inc D00ZFC HIGHSTAT Investigative D00ZHR DRUG__ID D00ZHR D00ZHR DRUGCOMP AntiCancer Inc D00ZHR HIGHSTAT Investigative D00ZSF DRUG__ID D00ZSF D00ZSF DRUGCOMP Abeille Pharmaceuticals Inc D00ZSF HIGHSTAT Investigative D00ZWE DRUG__ID D00ZWE D00ZWE DRUGCOMP Affitech A/S D00ZWE HIGHSTAT Investigative D00ZZB DRUG__ID D00ZZB D00ZZB DRUGCOMP Anacor Pharmaceuticals Inc D00ZZB HIGHSTAT Investigative D01ACE DRUG__ID D01ACE D01ACE DRUGCOMP Biofrontera Bioscience GmbH D01ACE HIGHSTAT Investigative D01ALJ DRUG__ID D01ALJ D01ALJ DRUGCOMP BioVersys GmbH D01ALJ HIGHSTAT Investigative D01ALP DRUG__ID D01ALP D01ALP DRUGCOMP MBC Pharma Inc D01ALP HIGHSTAT Investigative D01ANE DRUG__ID D01ANE D01ANE DRUGCOMP Arana Therapeutics Ltd D01ANE HIGHSTAT Investigative D01ARG DRUG__ID D01ARG D01ARG DRUGCOMP DARA BioSciences D01ARG HIGHSTAT Investigative D01ATS DRUG__ID D01ATS D01ATS DRUGCOMP LEO Pharma A/S D01ATS HIGHSTAT Investigative D01AVF DRUG__ID D01AVF D01AVF DRUGCOMP Sanofi D01AVF HIGHSTAT Investigative D01BEX DRUG__ID D01BEX D01BEX DRUGCOMP Pieris AG D01BEX HIGHSTAT Investigative D01BFA DRUG__ID D01BFA D01BFA DRUGCOMP BIKAM Pharmaceuticals Inc D01BFA HIGHSTAT Investigative D01BGU DRUG__ID D01BGU D01BGU DRUGCOMP Ultragenyx Pharmaceutical D01BGU HIGHSTAT Investigative D01BHC DRUG__ID D01BHC D01BHC DRUGCOMP Biota Holdings Ltd D01BHC HIGHSTAT Investigative D01BIQ DRUG__ID D01BIQ D01BIQ DRUGCOMP California Stem Cell Inc D01BIQ HIGHSTAT Investigative D01BJO DRUG__ID D01BJO D01BJO DRUGCOMP Medisyn Technologies Inc D01BJO HIGHSTAT Investigative D01BJS DRUG__ID D01BJS D01BJS DRUGCOMP HanAll Biopharma Co Ltd D01BJS HIGHSTAT Investigative D01BOD DRUG__ID D01BOD D01BOD DRUGCOMP ViaCyte Inc D01BOD HIGHSTAT Investigative D01BOE DRUG__ID D01BOE D01BOE DRUGCOMP University of Veterinary; Pharmaceutical Sciences Brno D01BOE HIGHSTAT Investigative D01BRX DRUG__ID D01BRX D01BRX DRUGCOMP Immuron Ltd D01BRX HIGHSTAT Investigative D01BWJ DRUG__ID D01BWJ D01BWJ DRUGCOMP MD Anderson Cancer Center D01BWJ HIGHSTAT Investigative D01BZP DRUG__ID D01BZP D01BZP DRUGCOMP IThemba Pharmaceuticals Pty Ltd D01BZP HIGHSTAT Investigative D01BZR DRUG__ID D01BZR D01BZR DRUGCOMP Intra-Cellular Therapies Inc D01BZR HIGHSTAT Investigative D01CFQ DRUG__ID D01CFQ D01CFQ DRUGCOMP Lixte Biotechnology Holdings Inc D01CFQ HIGHSTAT Investigative D01CLK DRUG__ID D01CLK D01CLK DRUGCOMP Chronogen D01CLK HIGHSTAT Investigative D01COH DRUG__ID D01COH D01COH DRUGCOMP Zambon Co SpA D01COH HIGHSTAT Investigative D01CQJ DRUG__ID D01CQJ D01CQJ DRUGCOMP Kolon Life Science Inc D01CQJ HIGHSTAT Investigative D01CYW DRUG__ID D01CYW D01CYW DRUGCOMP Obio Pharmaceutical Holdings Ltd D01CYW HIGHSTAT Investigative D01DBF DRUG__ID D01DBF D01DBF DRUGCOMP APIT Laboratories GmbH D01DBF HIGHSTAT Investigative D01DQI DRUG__ID D01DQI D01DQI DRUGCOMP Oryx GmbH D01DQI HIGHSTAT Investigative D01DRE DRUG__ID D01DRE D01DRE DRUGCOMP SOM Biotech SL D01DRE HIGHSTAT Investigative D01DSB DRUG__ID D01DSB D01DSB DRUGCOMP VentiRx Pharmaceuticals Inc D01DSB HIGHSTAT Investigative D01DVR DRUG__ID D01DVR D01DVR DRUGCOMP Neuroscience Technologies D01DVR HIGHSTAT Investigative D01ELC DRUG__ID D01ELC D01ELC DRUGCOMP NovelMed Therapeutics Inc D01ELC HIGHSTAT Investigative D01EPO DRUG__ID D01EPO D01EPO DRUGCOMP BTG plc D01EPO HIGHSTAT Investigative D01ESC DRUG__ID D01ESC D01ESC DRUGCOMP Bolder BioTechnology Inc D01ESC HIGHSTAT Investigative D01EZA DRUG__ID D01EZA D01EZA DRUGCOMP Entrechem D01EZA HIGHSTAT Investigative D01FJA DRUG__ID D01FJA D01FJA DRUGCOMP Umecrine AB D01FJA HIGHSTAT Investigative D01FJN DRUG__ID D01FJN D01FJN DRUGCOMP Bayer HealthCare AG D01FJN HIGHSTAT Investigative D01FRK DRUG__ID D01FRK D01FRK DRUGCOMP Neose Technologies Inc D01FRK HIGHSTAT Investigative D01FRP DRUG__ID D01FRP D01FRP DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D01FRP HIGHSTAT Investigative D01FTK DRUG__ID D01FTK D01FTK DRUGCOMP Wellstat Therapeutics Corp D01FTK HIGHSTAT Investigative D01FTU DRUG__ID D01FTU D01FTU DRUGCOMP Equispharm Co Ltd D01FTU HIGHSTAT Investigative D01GAG DRUG__ID D01GAG D01GAG DRUGCOMP Wellstat Biologics Corp D01GAG HIGHSTAT Investigative D01GBV DRUG__ID D01GBV D01GBV DRUGCOMP University of Toledo D01GBV HIGHSTAT Investigative D01GDB DRUG__ID D01GDB D01GDB DRUGCOMP Universite de la Mediterranee D01GDB HIGHSTAT Investigative D01GGB DRUG__ID D01GGB D01GGB DRUGCOMP Stemline Therapeutics Inc D01GGB HIGHSTAT Investigative D01GIG DRUG__ID D01GIG D01GIG DRUGCOMP IntraGene Sciences D01GIG HIGHSTAT Investigative D01GNW DRUG__ID D01GNW D01GNW DRUGCOMP NeuroGeneration Inc D01GNW HIGHSTAT Investigative D01GSA DRUG__ID D01GSA D01GSA DRUGCOMP ChemoCentryx Inc D01GSA HIGHSTAT Investigative D01HEN DRUG__ID D01HEN D01HEN DRUGCOMP Scripps Research Institute D01HEN HIGHSTAT Investigative D01HFP DRUG__ID D01HFP D01HFP DRUGCOMP HanAll Biopharma Co Ltd D01HFP HIGHSTAT Investigative D01HGI DRUG__ID D01HGI D01HGI DRUGCOMP Fabre Kramer Pharmaceuticals Inc D01HGI HIGHSTAT Investigative D01HHH DRUG__ID D01HHH D01HHH DRUGCOMP Chroma Therapeutics Ltd D01HHH HIGHSTAT Investigative D01HHL DRUG__ID D01HHL D01HHL DRUGTYPE Antibody D01HHL HIGHSTAT Investigative D01HLF DRUG__ID D01HLF D01HLF DRUGCOMP University of Arizona D01HLF HIGHSTAT Investigative D01HOI DRUG__ID D01HOI D01HOI DRUGCOMP Cardiff Biologicals D01HOI HIGHSTAT Investigative D01HOT DRUG__ID D01HOT D01HOT DRUGCOMP XBiotech Inc D01HOT HIGHSTAT Investigative D01HPP DRUG__ID D01HPP D01HPP DRUGCOMP EndGenitor Technologies Inc D01HPP HIGHSTAT Investigative D01HQQ DRUG__ID D01HQQ D01HQQ DRUGCOMP String Therapeutics Inc D01HQQ HIGHSTAT Investigative D01HSA DRUG__ID D01HSA D01HSA DRUGCOMP Human Genome Sciences Inc D01HSA HIGHSTAT Investigative D01HTJ DRUG__ID D01HTJ D01HTJ DRUGCOMP FibroGen Inc D01HTJ HIGHSTAT Investigative D01HTS DRUG__ID D01HTS D01HTS DRUGCOMP Molecular Insight Pharmaceuticals Inc D01HTS HIGHSTAT Investigative D01HVC DRUG__ID D01HVC D01HVC DRUGCOMP Morvus Technology Ltd D01HVC HIGHSTAT Investigative D01HWK DRUG__ID D01HWK D01HWK DRUGCOMP Arachnova Ltd D01HWK HIGHSTAT Investigative D01HXN DRUG__ID D01HXN D01HXN DRUGCOMP Toray Industries Inc D01HXN HIGHSTAT Investigative D01IHV DRUG__ID D01IHV D01IHV DRUGCOMP AdAlta Pty Ltd D01IHV HIGHSTAT Investigative D01IUD DRUG__ID D01IUD D01IUD DRUGCOMP Prothelia Inc D01IUD HIGHSTAT Investigative D01JLH DRUG__ID D01JLH D01JLH DRUGCOMP Respiratorius AB D01JLH HIGHSTAT Investigative D01JSG DRUG__ID D01JSG D01JSG DRUGCOMP Crucell NV D01JSG HIGHSTAT Investigative D01JSO DRUG__ID D01JSO D01JSO DRUGCOMP ViroMed Co Ltd D01JSO HIGHSTAT Investigative D01KER DRUG__ID D01KER D01KER DRUGCOMP AlphaRx Inc D01KER HIGHSTAT Investigative D01KIY DRUG__ID D01KIY D01KIY DRUGCOMP Epitomics Inc D01KIY HIGHSTAT Investigative D01KJM DRUG__ID D01KJM D01KJM DRUGCOMP Kent State University D01KJM HIGHSTAT Investigative D01KNO DRUG__ID D01KNO D01KNO DRUGCOMP University of Gothenburg D01KNO HIGHSTAT Investigative D01KRQ DRUG__ID D01KRQ D01KRQ DRUGCOMP EMC Microcollections GmbH D01KRQ HIGHSTAT Investigative D01KSO DRUG__ID D01KSO D01KSO DRUGCOMP Susavion Biosciences Inc D01KSO HIGHSTAT Investigative D01KYG DRUG__ID D01KYG D01KYG DRUGCOMP Inagen Aps D01KYG HIGHSTAT Investigative D01KZV DRUG__ID D01KZV D01KZV DRUGCOMP Meta-IQ Aps D01KZV HIGHSTAT Investigative D01LAX DRUG__ID D01LAX D01LAX DRUGCOMP Maroon Biotech Corp D01LAX HIGHSTAT Investigative D01LBD DRUG__ID D01LBD D01LBD DRUGCOMP Hawthorn Pharmaceuticals Inc D01LBD HIGHSTAT Investigative D01LBI DRUG__ID D01LBI D01LBI DRUGCOMP LivTech Inc D01LBI HIGHSTAT Investigative D01LEO DRUG__ID D01LEO D01LEO DRUGCOMP China Medical University D01LEO HIGHSTAT Investigative D01LFQ DRUG__ID D01LFQ D01LFQ DRUGCOMP Daewoong Pharmaceutical Co Ltd D01LFQ HIGHSTAT Investigative D01LNP DRUG__ID D01LNP D01LNP DRUGCOMP IsoTherapeutics Group Llc D01LNP HIGHSTAT Investigative D01LQJ DRUG__ID D01LQJ D01LQJ DRUGCOMP Amunix Inc D01LQJ HIGHSTAT Investigative D01LUH DRUG__ID D01LUH D01LUH DRUGCOMP Samaritan Pharmaceuticals Inc D01LUH HIGHSTAT Investigative D01LVM DRUG__ID D01LVM D01LVM DRUGCOMP PharmedArtis GmbH D01LVM HIGHSTAT Investigative D01LXZ DRUG__ID D01LXZ D01LXZ DRUGCOMP Daewoong Pharmaceutical Co Ltd D01LXZ HIGHSTAT Investigative D01LZB DRUG__ID D01LZB D01LZB DRUGCOMP Chugai Pharmaceutical D01LZB HIGHSTAT Investigative D01MBM DRUG__ID D01MBM D01MBM DRUGCOMP Laila Pharmaceuticals Pvt Ltd D01MBM HIGHSTAT Investigative D01MDH DRUG__ID D01MDH D01MDH DRUGCOMP CoLucid Pharmaceuticals Inc D01MDH HIGHSTAT Investigative D01MFG DRUG__ID D01MFG D01MFG DRUGCOMP Axis Genetics plc D01MFG HIGHSTAT Investigative D01MHT DRUG__ID D01MHT D01MHT DRUGCOMP Bolder BioTechnology Inc D01MHT HIGHSTAT Investigative D01MJT DRUG__ID D01MJT D01MJT DRUGCOMP MiRagen Therapeutics Inc D01MJT HIGHSTAT Investigative D01MMG DRUG__ID D01MMG D01MMG DRUGCOMP Bolder BioTechnology Inc D01MMG HIGHSTAT Investigative D01MND DRUG__ID D01MND D01MND DRUGCOMP James Cook University of North Queensland D01MND HIGHSTAT Investigative D01MWF DRUG__ID D01MWF D01MWF DRUGCOMP GTx Inc D01MWF HIGHSTAT Investigative D01MXG DRUG__ID D01MXG D01MXG DRUGCOMP Addex Pharmaceuticals SA D01MXG HIGHSTAT Investigative D01NCC DRUG__ID D01NCC D01NCC DRUGCOMP Amunix Inc D01NCC HIGHSTAT Investigative D01NDN DRUG__ID D01NDN D01NDN DRUGCOMP Shenogen Pharma Group Ltd D01NDN HIGHSTAT Investigative D01NFK DRUG__ID D01NFK D01NFK DRUGCOMP FivePrime Therapeutics Inc D01NFK HIGHSTAT Investigative D01NGB DRUG__ID D01NGB D01NGB DRUGCOMP Alligator Bioscience AB D01NGB HIGHSTAT Investigative D01NGF DRUG__ID D01NGF D01NGF DRUGCOMP BIOO Therapeutics D01NGF HIGHSTAT Investigative D01NJE DRUG__ID D01NJE D01NJE DRUGTYPE Aptamer D01NJE HIGHSTAT Investigative D01NKF DRUG__ID D01NKF D01NKF DRUGCOMP University of Tennessee D01NKF HIGHSTAT Investigative D01NOI DRUG__ID D01NOI D01NOI DRUGCOMP Innate Pharma SA D01NOI HIGHSTAT Investigative D01NPK DRUG__ID D01NPK D01NPK DRUGCOMP University of Arkansas D01NPK HIGHSTAT Investigative D01NTR DRUG__ID D01NTR D01NTR DRUGCOMP University of California San Diego D01NTR HIGHSTAT Investigative D01ODT DRUG__ID D01ODT D01ODT DRUGCOMP Biomedica Management Corporation D01ODT HIGHSTAT Investigative D01OHD DRUG__ID D01OHD D01OHD DRUGCOMP MediQuest Therapeutics Inc D01OHD HIGHSTAT Investigative D01OMO DRUG__ID D01OMO D01OMO DRUGCOMP GenVec Inc D01OMO HIGHSTAT Investigative D01OMY DRUG__ID D01OMY D01OMY DRUGCOMP Bayhill Therapeutics Inc D01OMY HIGHSTAT Investigative D01OVV DRUG__ID D01OVV D01OVV DRUGCOMP OncoVista Innovative Therapies Inc D01OVV HIGHSTAT Investigative D01PFX DRUG__ID D01PFX D01PFX DRUGCOMP ALS Therapy Development Foundation Inc D01PFX HIGHSTAT Investigative D01PNR DRUG__ID D01PNR D01PNR DRUGCOMP Aster Biopharmaceuticals Ltd D01PNR HIGHSTAT Investigative D01PRH DRUG__ID D01PRH D01PRH DRUGCOMP Epitomics Inc D01PRH HIGHSTAT Investigative D01PSY DRUG__ID D01PSY D01PSY DRUGCOMP Florida A & M University D01PSY HIGHSTAT Investigative D01PZJ DRUG__ID D01PZJ D01PZJ DRUGCOMP BigDNA Ltd D01PZJ HIGHSTAT Investigative D01QCY DRUG__ID D01QCY D01QCY DRUGCOMP Oncolys BioPharma Inc D01QCY HIGHSTAT Investigative D01QIV DRUG__ID D01QIV D01QIV DRUGCOMP Northwest Biotherapeutics Inc D01QIV HIGHSTAT Investigative D01QNJ DRUG__ID D01QNJ D01QNJ DRUGCOMP Kwang Dong Pharmaceutical Co Ltd D01QNJ HIGHSTAT Investigative D01QNO DRUG__ID D01QNO D01QNO DRUGCOMP L M College of Pharmacy D01QNO HIGHSTAT Investigative D01QRF DRUG__ID D01QRF D01QRF DRUGCOMP Ikerchem D01QRF HIGHSTAT Investigative D01QTD DRUG__ID D01QTD D01QTD DRUGCOMP Genable Technologies Ltd D01QTD HIGHSTAT Investigative D01QXS DRUG__ID D01QXS D01QXS DRUGCOMP Rexahn Pharmaceuticals Inc D01QXS HIGHSTAT Investigative D01RLA DRUG__ID D01RLA D01RLA DRUGCOMP Cyclacel Pharmaceuticals Inc D01RLA HIGHSTAT Investigative D01RNF DRUG__ID D01RNF D01RNF DRUGCOMP ZGene A/S D01RNF HIGHSTAT Investigative D01RSK DRUG__ID D01RSK D01RSK DRUGCOMP UCB Celltech D01RSK HIGHSTAT Investigative D01RSW DRUG__ID D01RSW D01RSW DRUGCOMP Tactical Therapeutics Inc D01RSW HIGHSTAT Investigative D01RYJ DRUG__ID D01RYJ D01RYJ DRUGCOMP Onco-Pharmakon Inc D01RYJ HIGHSTAT Investigative D01SAD DRUG__ID D01SAD D01SAD DRUGCOMP Thrombotargets Corp D01SAD HIGHSTAT Investigative D01SAK DRUG__ID D01SAK D01SAK DRUGCOMP TetraLogic Pharmaceuticals Corp D01SAK HIGHSTAT Investigative D01SQP DRUG__ID D01SQP D01SQP DRUGCOMP Hanmi Pharmaceutical Co Ltd D01SQP HIGHSTAT Investigative D01SSL DRUG__ID D01SSL D01SSL DRUGCOMP Armour Therapeutics Inc D01SSL HIGHSTAT Investigative D01SUF DRUG__ID D01SUF D01SUF DRUGCOMP GP Pharm SA D01SUF HIGHSTAT Investigative D01SUY DRUG__ID D01SUY D01SUY DRUGCOMP FoldLess Srl D01SUY HIGHSTAT Investigative D01SVG DRUG__ID D01SVG D01SVG DRUGCOMP Wuhan Katygen Pharmaceuticals Inc D01SVG HIGHSTAT Investigative D01SXE DRUG__ID D01SXE D01SXE DRUGCOMP Siemens medical solutions D01SXE HIGHSTAT Investigative D01SXG DRUG__ID D01SXG D01SXG DRUGCOMP BioRestorative Therapies Inc D01SXG HIGHSTAT Investigative D01TAQ DRUG__ID D01TAQ D01TAQ DRUGCOMP NovaLead Pharma D01TAQ HIGHSTAT Investigative D01TJV DRUG__ID D01TJV D01TJV DRUGCOMP Kowa Co Ltd D01TJV HIGHSTAT Investigative D01TRU DRUG__ID D01TRU D01TRU DRUGCOMP NanoForm Cardiovascular Therapeutics Ltd D01TRU HIGHSTAT Investigative D01TVT DRUG__ID D01TVT D01TVT DRUGCOMP Johns Hopkins University D01TVT HIGHSTAT Investigative D01UBV DRUG__ID D01UBV D01UBV DRUGCOMP InNexus Biotechnology Inc D01UBV HIGHSTAT Investigative D01UJS DRUG__ID D01UJS D01UJS DRUGCOMP ZaBeCor Pharmaceutical Co D01UJS HIGHSTAT Investigative D01UQJ DRUG__ID D01UQJ D01UQJ DRUGCOMP FORMAC Pharmaceuticals NV D01UQJ HIGHSTAT Investigative D01UQU DRUG__ID D01UQU D01UQU DRUGCOMP Medexgen Co Ltd D01UQU HIGHSTAT Investigative D01UUF DRUG__ID D01UUF D01UUF DRUGCOMP Essex Bio-Technology Ltd D01UUF HIGHSTAT Investigative D01VAA DRUG__ID D01VAA D01VAA DRUGCOMP Acretia Inc D01VAA HIGHSTAT Investigative D01VFQ DRUG__ID D01VFQ D01VFQ DRUGCOMP Compugen Ltd D01VFQ HIGHSTAT Investigative D01VMA DRUG__ID D01VMA D01VMA DRUGCOMP ITherX Pharmaceuticals Inc D01VMA HIGHSTAT Investigative D01VNQ DRUG__ID D01VNQ D01VNQ DRUGCOMP University of Alabama at Birmingham D01VNQ HIGHSTAT Investigative D01VOJ DRUG__ID D01VOJ D01VOJ DRUGCOMP Research Triangle Institute D01VOJ HIGHSTAT Investigative D01VZQ DRUG__ID D01VZQ D01VZQ DRUGCOMP Lentigen Corp D01VZQ HIGHSTAT Investigative D01WBT DRUG__ID D01WBT D01WBT DRUGCOMP Dynamis Therapeutics Inc D01WBT HIGHSTAT Investigative D01WCW DRUG__ID D01WCW D01WCW DRUGCOMP Keystone Biologics Inc D01WCW HIGHSTAT Investigative D01WFI DRUG__ID D01WFI D01WFI DRUGCOMP Vacciguard Ltd D01WFI HIGHSTAT Investigative D01WMI DRUG__ID D01WMI D01WMI DRUGCOMP Supratek Pharma Inc D01WMI HIGHSTAT Investigative D01WMW DRUG__ID D01WMW D01WMW DRUGCOMP Roche D01WMW HIGHSTAT Investigative D01WSL DRUG__ID D01WSL D01WSL DRUGCOMP NeoPharm Co Ltd D01WSL HIGHSTAT Investigative D01WYV DRUG__ID D01WYV D01WYV DRUGCOMP EntreMed D01WYV HIGHSTAT Investigative D01XAE DRUG__ID D01XAE D01XAE DRUGCOMP Prexa Pharmaceuticals Inc D01XAE HIGHSTAT Investigative D01XIK DRUG__ID D01XIK D01XIK DRUGCOMP Genzyme Corp D01XIK HIGHSTAT Investigative D01XMP DRUG__ID D01XMP D01XMP DRUGCOMP TissueGene Inc D01XMP HIGHSTAT Investigative D01XXF DRUG__ID D01XXF D01XXF DRUGCOMP Provasculon Inc D01XXF HIGHSTAT Investigative D01YCX DRUG__ID D01YCX D01YCX DRUGCOMP Yungjin Pharmaceutical Co Ltd D01YCX HIGHSTAT Investigative D01YFR DRUG__ID D01YFR D01YFR DRUGCOMP Daewoong Pharmaceutical Co Ltd D01YFR HIGHSTAT Investigative D01YGY DRUG__ID D01YGY D01YGY DRUGCOMP Umecrine AB D01YGY HIGHSTAT Investigative D01YHL DRUG__ID D01YHL D01YHL DRUGCOMP MondoBIOTECH Holding AG D01YHL HIGHSTAT Investigative D01YHO DRUG__ID D01YHO D01YHO DRUGCOMP MD Anderson Cancer Center D01YHO HIGHSTAT Investigative D01YJR DRUG__ID D01YJR D01YJR DRUGCOMP ImVisioN Therapeutics Inc D01YJR HIGHSTAT Investigative D01YLA DRUG__ID D01YLA D01YLA DRUGCOMP NovaBiotics Ltd D01YLA HIGHSTAT Investigative D01YSU DRUG__ID D01YSU D01YSU DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D01YSU HIGHSTAT Investigative D01YTX DRUG__ID D01YTX D01YTX DRUGCOMP Cleveland BioLabs Inc D01YTX HIGHSTAT Investigative D01ZDQ DRUG__ID D01ZDQ D01ZDQ DRUGCOMP Achillion Pharmaceuticals Inc D01ZDQ HIGHSTAT Investigative D01ZFM DRUG__ID D01ZFM D01ZFM DRUGCOMP Link Medicine Corp D01ZFM HIGHSTAT Investigative D01ZGS DRUG__ID D01ZGS D01ZGS DRUGCOMP TransGenex Nanobiotech Inc D01ZGS HIGHSTAT Investigative D01ZHQ DRUG__ID D01ZHQ D01ZHQ DRUGCOMP Mimetogen Pharmaceuticals Inc D01ZHQ HIGHSTAT Investigative D01ZLL DRUG__ID D01ZLL D01ZLL DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D01ZLL HIGHSTAT Investigative D01ZPK DRUG__ID D01ZPK D01ZPK DRUGCOMP BioAxone Therapeutic Inc D01ZPK HIGHSTAT Investigative D01ZQN DRUG__ID D01ZQN D01ZQN DRUGCOMP Alder Biopharmaceuticals Inc D01ZQN HIGHSTAT Investigative D01ZRR DRUG__ID D01ZRR D01ZRR DRUGCOMP REGiMMUNE Corp D01ZRR HIGHSTAT Investigative D01ZVK DRUG__ID D01ZVK D01ZVK DRUGCOMP Sam Chun Dang Pharm Co Ltd D01ZVK HIGHSTAT Investigative D01ZWF DRUG__ID D01ZWF D01ZWF DRUGCOMP Beta Pharma Inc D01ZWF HIGHSTAT Investigative D01ZZG DRUG__ID D01ZZG D01ZZG DRUGCOMP InVasc Therapeutics Inc D01ZZG HIGHSTAT Investigative D02AQL DRUG__ID D02AQL D02AQL DRUGCOMP Affitech A/S D02AQL HIGHSTAT Investigative D02BGZ DRUG__ID D02BGZ D02BGZ DRUGCOMP Axcentua Pharmaceuticals D02BGZ HIGHSTAT Investigative D02BJN DRUG__ID D02BJN D02BJN DRUGCOMP University of North Carolina D02BJN HIGHSTAT Investigative D02BMJ DRUG__ID D02BMJ D02BMJ DRUGCOMP NeED Pharmaceuticals Srl D02BMJ HIGHSTAT Investigative D02BVQ DRUG__ID D02BVQ D02BVQ DRUGCOMP Deutsches Krebsforschungszentrum D02BVQ HIGHSTAT Investigative D02CEO DRUG__ID D02CEO D02CEO DRUGCOMP Snowdon Inc D02CEO HIGHSTAT Investigative D02CFR DRUG__ID D02CFR D02CFR DRUGCOMP GlaxoSmithKline plc D02CFR HIGHSTAT Investigative D02CND DRUG__ID D02CND D02CND DRUGCOMP Kuhnil Pharmaceutical Co Ltd D02CND HIGHSTAT Investigative D02CRM DRUG__ID D02CRM D02CRM DRUGCOMP Kuhnil Pharmaceutical Co Ltd D02CRM HIGHSTAT Investigative D02CVF DRUG__ID D02CVF D02CVF DRUGCOMP Mucosis BV D02CVF HIGHSTAT Investigative D02CXA DRUG__ID D02CXA D02CXA DRUGCOMP Lentigen Corp D02CXA HIGHSTAT Investigative D02DOK DRUG__ID D02DOK D02DOK DRUGCOMP Samjin Pharmaceutical Co Ltd D02DOK HIGHSTAT Investigative D02DWN DRUG__ID D02DWN D02DWN DRUGCOMP Alethia Biotherapeutics Inc D02DWN HIGHSTAT Investigative D02DXV DRUG__ID D02DXV D02DXV DRUGCOMP Threshold Pharmaceuticals Inc D02DXV HIGHSTAT Investigative D02DZI DRUG__ID D02DZI D02DZI DRUGCOMP MiRagen Therapeutics Inc D02DZI HIGHSTAT Investigative D02ELN DRUG__ID D02ELN D02ELN DRUGCOMP Hutchison Medipharma Enterprises Ltd D02ELN HIGHSTAT Investigative D02ESX DRUG__ID D02ESX D02ESX DRUGCOMP Korea Institute of Oriental Medicine D02ESX HIGHSTAT Investigative D02ETJ DRUG__ID D02ETJ D02ETJ DRUGCOMP Silicos NV D02ETJ HIGHSTAT Investigative D02ETP DRUG__ID D02ETP D02ETP DRUGCOMP SOM Biotech SL D02ETP HIGHSTAT Investigative D02EVL DRUG__ID D02EVL D02EVL DRUGCOMP Idea AG D02EVL HIGHSTAT Investigative D02FAI DRUG__ID D02FAI D02FAI DRUGCOMP Gradalis Inc D02FAI HIGHSTAT Investigative D02FBG DRUG__ID D02FBG D02FBG DRUGCOMP Umecrine AB D02FBG HIGHSTAT Investigative D02FNJ DRUG__ID D02FNJ D02FNJ DRUGCOMP Allon Therapeutics Inc D02FNJ HIGHSTAT Investigative D02FTU DRUG__ID D02FTU D02FTU DRUGCOMP Itero Biopharmaceuticals Inc D02FTU HIGHSTAT Investigative D02GNL DRUG__ID D02GNL D02GNL DRUGCOMP Digital Biotech Co Ltd D02GNL HIGHSTAT Investigative D02GTT DRUG__ID D02GTT D02GTT DRUGCOMP Arena Pharmaceuticals Inc D02GTT HIGHSTAT Investigative D02HDP DRUG__ID D02HDP D02HDP DRUGCOMP 4SC AG D02HDP HIGHSTAT Investigative D02HPI DRUG__ID D02HPI D02HPI DRUGCOMP Functional Genetics Inc D02HPI HIGHSTAT Investigative D02HUU DRUG__ID D02HUU D02HUU DRUGCOMP ViraBiotech D02HUU HIGHSTAT Investigative D02HWR DRUG__ID D02HWR D02HWR DRUGCOMP Provid Pharmaceuticals Inc D02HWR HIGHSTAT Investigative D02IAR DRUG__ID D02IAR D02IAR DRUGCOMP Isis Pharmaceuticals Inc D02IAR HIGHSTAT Investigative D02IBS DRUG__ID D02IBS D02IBS DRUGCOMP University of Georgia D02IBS HIGHSTAT Investigative D02IKD DRUG__ID D02IKD D02IKD DRUGCOMP Human Genome Sciences Inc D02IKD HIGHSTAT Investigative D02ILI DRUG__ID D02ILI D02ILI DRUGCOMP Zosano Pharma Inc D02ILI HIGHSTAT Investigative D02IND DRUG__ID D02IND D02IND DRUGCOMP ImmunoVentis Inc D02IND HIGHSTAT Investigative D02IUO DRUG__ID D02IUO D02IUO DRUGCOMP Corcept Therapeutics Inc D02IUO HIGHSTAT Investigative D02IZN DRUG__ID D02IZN D02IZN DRUGCOMP Onconova Therapeutics Inc D02IZN HIGHSTAT Investigative D02JHW DRUG__ID D02JHW D02JHW DRUGCOMP Angion Biomedica Corp D02JHW HIGHSTAT Investigative D02JIF DRUG__ID D02JIF D02JIF DRUGCOMP Sheba Medical Center D02JIF HIGHSTAT Investigative D02JOI DRUG__ID D02JOI D02JOI DRUGCOMP Epistem Holdings plc D02JOI HIGHSTAT Investigative D02JRD DRUG__ID D02JRD D02JRD DRUGCOMP Viron Therapeutics Inc D02JRD HIGHSTAT Investigative D02JWN DRUG__ID D02JWN D02JWN DRUGCOMP Stelic Institute & Co D02JWN HIGHSTAT Investigative D02KTG DRUG__ID D02KTG D02KTG DRUGCOMP Compugen Ltd D02KTG HIGHSTAT Investigative D02KXE DRUG__ID D02KXE D02KXE DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D02KXE HIGHSTAT Investigative D02LAP DRUG__ID D02LAP D02LAP DRUGCOMP PhaseBio Pharmaceuticals Inc D02LAP HIGHSTAT Investigative D02LIY DRUG__ID D02LIY D02LIY THERCLAS Analgesics D02LIY HIGHSTAT Investigative D02LMR DRUG__ID D02LMR D02LMR DRUGCOMP Advanomics Corp D02LMR HIGHSTAT Investigative D02LOB DRUG__ID D02LOB D02LOB DRUGCOMP Jina Pharmaceuticals Inc D02LOB HIGHSTAT Investigative D02LQA DRUG__ID D02LQA D02LQA DRUGCOMP Tetra Therapeutics SL D02LQA HIGHSTAT Investigative D02MLA DRUG__ID D02MLA D02MLA DRUGCOMP Axcentua Pharmaceuticals D02MLA HIGHSTAT Investigative D02MTK DRUG__ID D02MTK D02MTK DRUGCOMP Affitech A/S D02MTK HIGHSTAT Investigative D02NJK DRUG__ID D02NJK D02NJK DRUGCOMP Galenea Corp D02NJK HIGHSTAT Investigative D02NUC DRUG__ID D02NUC D02NUC DRUGCOMP NovelMed Therapeutics Inc D02NUC HIGHSTAT Investigative D02NUS DRUG__ID D02NUS D02NUS DRUGCOMP Meridian Biopharmaceuticals D02NUS HIGHSTAT Investigative D02NXQ DRUG__ID D02NXQ D02NXQ DRUGCOMP Novexel SA D02NXQ HIGHSTAT Investigative D02NZF DRUG__ID D02NZF D02NZF DRUGCOMP Novozymes A/S D02NZF HIGHSTAT Investigative D02OBU DRUG__ID D02OBU D02OBU DRUGCOMP CEAMED SA D02OBU HIGHSTAT Investigative D02OEP DRUG__ID D02OEP D02OEP DRUGCOMP JW Pharmaceutical Corp D02OEP HIGHSTAT Investigative D02OGQ DRUG__ID D02OGQ D02OGQ DRUGCOMP RFS Pharma LLC D02OGQ HIGHSTAT Investigative D02OIP DRUG__ID D02OIP D02OIP DRUGCOMP Onco-Pharmakon Inc D02OIP HIGHSTAT Investigative D02OOB DRUG__ID D02OOB D02OOB DRUGCOMP Prexa Pharmaceuticals Inc D02OOB HIGHSTAT Investigative D02PKV DRUG__ID D02PKV D02PKV DRUGCOMP Inspiration Biopharmaceuticals Inc D02PKV HIGHSTAT Investigative D02PVS DRUG__ID D02PVS D02PVS DRUGCOMP Kuros Biosurgery AG D02PVS HIGHSTAT Investigative D02PXP DRUG__ID D02PXP D02PXP DRUGCOMP Center for Genetic Engineering and Biotechnology D02PXP HIGHSTAT Investigative D02QAO DRUG__ID D02QAO D02QAO DRUGCOMP ImmuPharma plc D02QAO HIGHSTAT Investigative D02QLH DRUG__ID D02QLH D02QLH DRUGCOMP Peptron Co Ltd D02QLH HIGHSTAT Investigative D02QND DRUG__ID D02QND D02QND DRUGCOMP Ferrer Internacional SA D02QND HIGHSTAT Investigative D02QUB DRUG__ID D02QUB D02QUB DRUGCOMP Galectin Therapeutics Inc D02QUB HIGHSTAT Investigative D02QXI DRUG__ID D02QXI D02QXI DRUGCOMP Scil Technology GmbH D02QXI HIGHSTAT Investigative D02RDC DRUG__ID D02RDC D02RDC DRUGCOMP Nanovector Ltd D02RDC HIGHSTAT Investigative D02REM DRUG__ID D02REM D02REM DRUGCOMP Ardent Pharmaceuticals Inc D02REM HIGHSTAT Investigative D02REO DRUG__ID D02REO D02REO DRUGCOMP ALS Therapy Development Foundation Inc D02REO HIGHSTAT Investigative D02RGZ DRUG__ID D02RGZ D02RGZ DRUGCOMP MannKind Corp D02RGZ HIGHSTAT Investigative D02RHU DRUG__ID D02RHU D02RHU DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D02RHU HIGHSTAT Investigative D02RYE DRUG__ID D02RYE D02RYE DRUGCOMP Amakem NV D02RYE HIGHSTAT Investigative D02RZC DRUG__ID D02RZC D02RZC DRUGCOMP AndroScience Corp D02RZC HIGHSTAT Investigative D02SGT DRUG__ID D02SGT D02SGT DRUGCOMP OM Pharma D02SGT HIGHSTAT Investigative D02SJG DRUG__ID D02SJG D02SJG DRUGCOMP Cambridge University D02SJG HIGHSTAT Investigative D02SLV DRUG__ID D02SLV D02SLV DRUGCOMP Canopus BioPharma Inc D02SLV HIGHSTAT Investigative D02SNE DRUG__ID D02SNE D02SNE DRUGCOMP AVI BioPharma Inc D02SNE HIGHSTAT Investigative D02SOL DRUG__ID D02SOL D02SOL DRUGCOMP Dana-Farber Cancer Institute Inc D02SOL HIGHSTAT Investigative D02SRB DRUG__ID D02SRB D02SRB DRUGCOMP Bradford Pharma Ltd D02SRB HIGHSTAT Investigative D02SSV DRUG__ID D02SSV D02SSV DRUGCOMP Alnylam Pharmaceuticals Inc D02SSV HIGHSTAT Investigative D02SUP DRUG__ID D02SUP D02SUP DRUGCOMP Thrombotargets Corp D02SUP HIGHSTAT Investigative D02SZF DRUG__ID D02SZF D02SZF DRUGCOMP Siemens Medical Solutions Molecular Imaging D02SZF HIGHSTAT Investigative D02TBU DRUG__ID D02TBU D02TBU DRUGCOMP Center for Genetic Engineering and Biotechnology D02TBU HIGHSTAT Investigative D02TGF DRUG__ID D02TGF D02TGF DRUGCOMP Ai2 Ltd D02TGF HIGHSTAT Investigative D02TKX DRUG__ID D02TKX D02TKX DRUGCOMP Yonsei University D02TKX HIGHSTAT Investigative D02TOK DRUG__ID D02TOK D02TOK DRUGCOMP AplaGen GmbH D02TOK HIGHSTAT Investigative D02TQE DRUG__ID D02TQE D02TQE DRUGCOMP Technophage SA D02TQE HIGHSTAT Investigative D02TTP DRUG__ID D02TTP D02TTP DRUGCOMP ALS Therapy Development Foundation Inc D02TTP HIGHSTAT Investigative D02UGL DRUG__ID D02UGL D02UGL DRUGCOMP Shin Nippon Biomedical Laboratories Ltd D02UGL HIGHSTAT Investigative D02UJG DRUG__ID D02UJG D02UJG DRUGCOMP Isis Pharmaceuticals Inc D02UJG HIGHSTAT Investigative D02UJQ DRUG__ID D02UJQ D02UJQ DRUGCOMP TikoMed AB D02UJQ HIGHSTAT Investigative D02ULG DRUG__ID D02ULG D02ULG DRUGCOMP Clavis Pharma AS D02ULG HIGHSTAT Investigative D02USV DRUG__ID D02USV D02USV DRUGCOMP AnaptysBio Inc D02USV HIGHSTAT Investigative D02UWX DRUG__ID D02UWX D02UWX DRUGCOMP Othera Pharmaceuticals Inc D02UWX HIGHSTAT Investigative D02UXK DRUG__ID D02UXK D02UXK DRUGCOMP Metabolex Inc D02UXK HIGHSTAT Investigative D02VET DRUG__ID D02VET D02VET DRUGCOMP Hygeia Therapeutics Inc D02VET HIGHSTAT Investigative D02VMC DRUG__ID D02VMC D02VMC DRUGCOMP Reviva Pharmaceuticals Inc D02VMC HIGHSTAT Investigative D02VNG DRUG__ID D02VNG D02VNG DRUGTYPE siRNA drug D02VNG HIGHSTAT Investigative D02VNY DRUG__ID D02VNY D02VNY DRUGCOMP Pharnext SAS D02VNY HIGHSTAT Investigative D02VUL DRUG__ID D02VUL D02VUL DRUGCOMP Aiko Biotechnology Inc D02VUL HIGHSTAT Investigative D02WDO DRUG__ID D02WDO D02WDO DRUGCOMP Mologen Holding AG D02WDO HIGHSTAT Investigative D02WQR DRUG__ID D02WQR D02WQR DRUGCOMP GlaxoSmithKline plc D02WQR HIGHSTAT Investigative D02WRE DRUG__ID D02WRE D02WRE DRUGCOMP Asahi Kasei Pharma Corp D02WRE HIGHSTAT Investigative D02XFA DRUG__ID D02XFA D02XFA DRUGCOMP Human Genome Sciences Inc D02XFA HIGHSTAT Investigative D02XNJ DRUG__ID D02XNJ D02XNJ DRUGCOMP Cardax Pharmaceuticals Inc D02XNJ HIGHSTAT Investigative D02XOM DRUG__ID D02XOM D02XOM DRUGCOMP Humanyx Ltd D02XOM HIGHSTAT Investigative D02XUE DRUG__ID D02XUE D02XUE DRUGCOMP ALS Therapy Development Foundation Inc D02XUE HIGHSTAT Investigative D02XUY DRUG__ID D02XUY D02XUY DRUGCOMP AstraZeneca plc D02XUY HIGHSTAT Investigative D02YAD DRUG__ID D02YAD D02YAD DRUGCOMP Vivia Biotech SL D02YAD HIGHSTAT Investigative D02YBD DRUG__ID D02YBD D02YBD DRUGCOMP Calmune Corp D02YBD HIGHSTAT Investigative D02YCL DRUG__ID D02YCL D02YCL DRUGCOMP Scottish Biomedical Ltd D02YCL HIGHSTAT Investigative D02YRX DRUG__ID D02YRX D02YRX DRUGCOMP ChemoCentryx Inc D02YRX HIGHSTAT Investigative D02YWE DRUG__ID D02YWE D02YWE DRUGCOMP Eiger BioPharmaceuticals Inc D02YWE HIGHSTAT Investigative D02YWM DRUG__ID D02YWM D02YWM DRUGCOMP Humanetics Corp D02YWM HIGHSTAT Investigative D02YYS DRUG__ID D02YYS D02YYS DRUGCOMP BigDNA Ltd D02YYS HIGHSTAT Investigative D02ZAT DRUG__ID D02ZAT D02ZAT DRUGCOMP Viral Genetics Inc D02ZAT HIGHSTAT Investigative D02ZMI DRUG__ID D02ZMI D02ZMI DRUGCOMP Lundbeck Research USA Inc D02ZMI HIGHSTAT Investigative D02ZNH DRUG__ID D02ZNH D02ZNH DRUGCOMP Thrombotargets Corp D02ZNH HIGHSTAT Investigative D02ZUT DRUG__ID D02ZUT D02ZUT DRUGCOMP Theraptosis D02ZUT HIGHSTAT Investigative D02ZWJ DRUG__ID D02ZWJ D02ZWJ DRUGCOMP Eribis Pharmaceuticals Ab D02ZWJ HIGHSTAT Investigative D02ZWO DRUG__ID D02ZWO D02ZWO DRUGCOMP Defyrus Inc D02ZWO HIGHSTAT Investigative D02ZYI DRUG__ID D02ZYI D02ZYI DRUGCOMP ImmuPharma plc D02ZYI HIGHSTAT Investigative D03AAV DRUG__ID D03AAV D03AAV DRUGCOMP Access Pharmaceuticals Inc D03AAV HIGHSTAT Investigative D03AEG DRUG__ID D03AEG D03AEG DRUGCOMP ImmunoVentis Inc D03AEG HIGHSTAT Investigative D03AIP DRUG__ID D03AIP D03AIP DRUGCOMP 3M Drug Delivery Systems D03AIP HIGHSTAT Investigative D03ATI DRUG__ID D03ATI D03ATI DRUGCOMP Immunotech Laboratories Inc D03ATI HIGHSTAT Investigative D03AVA DRUG__ID D03AVA D03AVA DRUGCOMP Shenogen Pharma Group Ltd D03AVA HIGHSTAT Investigative D03AZB DRUG__ID D03AZB D03AZB DRUGCOMP Neorphys D03AZB HIGHSTAT Investigative D03BCE DRUG__ID D03BCE D03BCE DRUGCOMP FivePrime Therapeutics Inc D03BCE HIGHSTAT Investigative D03BJX DRUG__ID D03BJX D03BJX DRUGCOMP Toxcure LLC D03BJX HIGHSTAT Investigative D03BMR DRUG__ID D03BMR D03BMR DRUGCOMP Proximagen Group plc D03BMR HIGHSTAT Investigative D03BND DRUG__ID D03BND D03BND DRUGCOMP Apointech SL D03BND HIGHSTAT Investigative D03BWQ DRUG__ID D03BWQ D03BWQ DRUGCOMP Attenuon LLC D03BWQ HIGHSTAT Investigative D03CAY DRUG__ID D03CAY D03CAY DRUGCOMP CMP Therapeutics Ltd D03CAY HIGHSTAT Investigative D03CBU DRUG__ID D03CBU D03CBU DRUGCOMP PhytoCeutica Inc D03CBU HIGHSTAT Investigative D03CKP DRUG__ID D03CKP D03CKP DRUGCOMP MondoBIOTECH Holding AG D03CKP HIGHSTAT Investigative D03CQN DRUG__ID D03CQN D03CQN DRUGCOMP Array BioPharma Inc D03CQN HIGHSTAT Investigative D03CWO DRUG__ID D03CWO D03CWO DRUGCOMP EndogenX Inc D03CWO HIGHSTAT Investigative D03CYF DRUG__ID D03CYF D03CYF DRUGCOMP Resverlogix Corp D03CYF HIGHSTAT Investigative D03CZE DRUG__ID D03CZE D03CZE DRUGCOMP Vanda Pharmaceuticals D03CZE HIGHSTAT Investigative D03CZX DRUG__ID D03CZX D03CZX DRUGCOMP PharmedArtis GmbH D03CZX HIGHSTAT Investigative D03DII DRUG__ID D03DII D03DII DRUGCOMP Roxall Medizin GmbH D03DII HIGHSTAT Investigative D03DOC DRUG__ID D03DOC D03DOC DRUGCOMP Deciphera Pharmaceuticals Inc D03DOC HIGHSTAT Investigative D03DOW DRUG__ID D03DOW D03DOW DRUGCOMP SWITCH Biotech LLC D03DOW HIGHSTAT Investigative D03DQK DRUG__ID D03DQK D03DQK DRUGCOMP Prolong Pharmaceuticals Inc D03DQK HIGHSTAT Investigative D03DTQ DRUG__ID D03DTQ D03DTQ DRUGCOMP Pharminox Ltd D03DTQ HIGHSTAT Investigative D03DTU DRUG__ID D03DTU D03DTU DRUGCOMP Botanic Century (Beijing) Co Ltd D03DTU HIGHSTAT Investigative D03DTW DRUG__ID D03DTW D03DTW DRUGCOMP Exonhit D03DTW HIGHSTAT Investigative D03DWZ DRUG__ID D03DWZ D03DWZ DRUGCOMP Sierra Neuropharmaceuticals Inc D03DWZ HIGHSTAT Investigative D03DZK DRUG__ID D03DZK D03DZK DRUGCOMP Western States Biopharmaceuticals D03DZK HIGHSTAT Investigative D03EBK DRUG__ID D03EBK D03EBK DRUGCOMP Massachusetts General Hospital D03EBK HIGHSTAT Investigative D03EIG DRUG__ID D03EIG D03EIG DRUGCOMP Cardio3 BioSciences SA D03EIG HIGHSTAT Investigative D03EIK DRUG__ID D03EIK D03EIK DRUGCOMP Nanovector Ltd D03EIK HIGHSTAT Investigative D03FEP DRUG__ID D03FEP D03FEP DRUGCOMP Nanotope Inc D03FEP HIGHSTAT Investigative D03FIS DRUG__ID D03FIS D03FIS DRUGCOMP Weizmann Institute of Science D03FIS HIGHSTAT Investigative D03FOT DRUG__ID D03FOT D03FOT DRUGCOMP RegenX Biosciences LLC D03FOT HIGHSTAT Investigative D03FSU DRUG__ID D03FSU D03FSU DRUGCOMP Medexgen Co Ltd D03FSU HIGHSTAT Investigative D03GAN DRUG__ID D03GAN D03GAN DRUGCOMP Knoll GmbH D03GAN HIGHSTAT Investigative D03GHR DRUG__ID D03GHR D03GHR THERCLAS Analgesics D03GHR HIGHSTAT Investigative D03GIV DRUG__ID D03GIV D03GIV DRUGCOMP Sierra Neuropharmaceuticals Inc D03GIV HIGHSTAT Investigative D03GLL DRUG__ID D03GLL D03GLL DRUGCOMP Integrated BioTherapeutics Inc D03GLL HIGHSTAT Investigative D03GWV DRUG__ID D03GWV D03GWV DRUGCOMP Zambon Co SpA D03GWV HIGHSTAT Investigative D03HGP DRUG__ID D03HGP D03HGP DRUGCOMP CreaGene Inc D03HGP HIGHSTAT Investigative D03HJZ DRUG__ID D03HJZ D03HJZ DRUGCOMP AstraZeneca plc D03HJZ HIGHSTAT Investigative D03HKA DRUG__ID D03HKA D03HKA DRUGCOMP Sangamo BioSciences Inc D03HKA HIGHSTAT Investigative D03HLK DRUG__ID D03HLK D03HLK DRUGCOMP Portola Pharmaceuticals Inc D03HLK HIGHSTAT Investigative D03HOP DRUG__ID D03HOP D03HOP DRUGCOMP Human Genome Sciences Inc D03HOP HIGHSTAT Investigative D03HOT DRUG__ID D03HOT D03HOT DRUGCOMP Biocortech D03HOT HIGHSTAT Investigative D03HQR DRUG__ID D03HQR D03HQR DRUGCOMP Sun Pharmaceutical Industries Ltd D03HQR HIGHSTAT Investigative D03HSQ DRUG__ID D03HSQ D03HSQ DRUGCOMP Glenmark Pharmaceuticals Ltd D03HSQ HIGHSTAT Investigative D03HSS DRUG__ID D03HSS D03HSS DRUGCOMP Lentigen Corp D03HSS HIGHSTAT Investigative D03HTZ DRUG__ID D03HTZ D03HTZ DRUGTYPE Aptamer D03HTZ HIGHSTAT Investigative D03HXO DRUG__ID D03HXO D03HXO DRUGCOMP NeoPharm Co Ltd D03HXO HIGHSTAT Investigative D03ICS DRUG__ID D03ICS D03ICS DRUGCOMP Nectid Inc D03ICS HIGHSTAT Investigative D03IDK DRUG__ID D03IDK D03IDK DRUGCOMP Cephalon Inc D03IDK HIGHSTAT Investigative D03IEB DRUG__ID D03IEB D03IEB DRUGCOMP Nuvo Research Inc D03IEB HIGHSTAT Investigative D03IJZ DRUG__ID D03IJZ D03IJZ DRUGCOMP Syntaxin Ltd D03IJZ HIGHSTAT Investigative D03ILU DRUG__ID D03ILU D03ILU DRUGTYPE Aptamer D03ILU HIGHSTAT Investigative D03IMU DRUG__ID D03IMU D03IMU DRUGCOMP Addex Pharmaceuticals SA D03IMU HIGHSTAT Investigative D03IQH DRUG__ID D03IQH D03IQH DRUGCOMP Edgemont Pharmaceuticals LLC D03IQH HIGHSTAT Investigative D03IQK DRUG__ID D03IQK D03IQK DRUGCOMP BioCancell Therapeutics Ltd D03IQK HIGHSTAT Investigative D03IWT DRUG__ID D03IWT D03IWT DRUGCOMP NiKem Research Srl D03IWT HIGHSTAT Investigative D03JBI DRUG__ID D03JBI D03JBI DRUGCOMP Prestwick Pharmaceuticals Inc D03JBI HIGHSTAT Investigative D03JCT DRUG__ID D03JCT D03JCT DRUGCOMP Maruho Co Ltd D03JCT HIGHSTAT Investigative D03JMF DRUG__ID D03JMF D03JMF DRUGCOMP Wyeth D03JMF HIGHSTAT Investigative D03JRL DRUG__ID D03JRL D03JRL DRUGCOMP ALS Therapy Development Foundation Inc D03JRL HIGHSTAT Investigative D03JUN DRUG__ID D03JUN D03JUN DRUGCOMP Bristol-myers squibb D03JUN HIGHSTAT Investigative D03JXN DRUG__ID D03JXN D03JXN DRUGCOMP GLYCOBIA INC D03JXN HIGHSTAT Investigative D03JXR DRUG__ID D03JXR D03JXR DRUGCOMP Nosopharm D03JXR HIGHSTAT Investigative D03KFJ DRUG__ID D03KFJ D03KFJ DRUGCOMP TROBIO AB D03KFJ HIGHSTAT Investigative D03KIK DRUG__ID D03KIK D03KIK DRUGCOMP Apoplogic Pharmaceuticals Inc D03KIK HIGHSTAT Investigative D03KOU DRUG__ID D03KOU D03KOU DRUGCOMP Xencor Inc D03KOU HIGHSTAT Investigative D03KRF DRUG__ID D03KRF D03KRF DRUGCOMP Inotek Pharmaceuticals Corp D03KRF HIGHSTAT Investigative D03LCX DRUG__ID D03LCX D03LCX DRUGCOMP ChemoCentryx Inc D03LCX HIGHSTAT Investigative D03LIE DRUG__ID D03LIE D03LIE DRUGCOMP Prosetta Antiviral Inc D03LIE HIGHSTAT Investigative D03LLL DRUG__ID D03LLL D03LLL DRUGCOMP Prexa Pharmaceuticals Inc D03LLL HIGHSTAT Investigative D03LMK DRUG__ID D03LMK D03LMK DRUGCOMP Instituto Biomar SA D03LMK HIGHSTAT Investigative D03LNM DRUG__ID D03LNM D03LNM DRUGCOMP Tosk Inc D03LNM HIGHSTAT Investigative D03LNV DRUG__ID D03LNV D03LNV DRUGCOMP Immunomic Therapeutics Inc D03LNV HIGHSTAT Investigative D03LXH DRUG__ID D03LXH D03LXH DRUGCOMP AlphaRx Inc D03LXH HIGHSTAT Investigative D03LZK DRUG__ID D03LZK D03LZK DRUGCOMP Atlas Pharmaceuticals Inc D03LZK HIGHSTAT Investigative D03MDV DRUG__ID D03MDV D03MDV DRUGCOMP Patrys Ltd D03MDV HIGHSTAT Investigative D03MER DRUG__ID D03MER D03MER DRUGCOMP Lipopeptide AB D03MER HIGHSTAT Investigative D03MLR DRUG__ID D03MLR D03MLR DRUGCOMP AdeTherapeutics Inc D03MLR HIGHSTAT Investigative D03MSN DRUG__ID D03MSN D03MSN DRUGCOMP DreamPharma Corp D03MSN HIGHSTAT Investigative D03MTY DRUG__ID D03MTY D03MTY DRUGCOMP Welson Pharmaceuticals Inc D03MTY HIGHSTAT Investigative D03NHZ DRUG__ID D03NHZ D03NHZ DRUGCOMP Molecular Templates Inc D03NHZ HIGHSTAT Investigative D03NJN DRUG__ID D03NJN D03NJN DRUGCOMP Patrys Ltd D03NJN HIGHSTAT Investigative D03NXS DRUG__ID D03NXS D03NXS DRUGCOMP GenKyoTex SA D03NXS HIGHSTAT Investigative D03OMK DRUG__ID D03OMK D03OMK DRUGCOMP Med Discovery SA D03OMK HIGHSTAT Investigative D03ONE DRUG__ID D03ONE D03ONE DRUGCOMP Bar-Ilan Research & Development Co Ltd D03ONE HIGHSTAT Investigative D03ONX DRUG__ID D03ONX D03ONX DRUGCOMP Charleston Laboratories Inc D03ONX HIGHSTAT Investigative D03OTX DRUG__ID D03OTX D03OTX DRUGCOMP Multimeric Biotherapeutics Inc D03OTX HIGHSTAT Investigative D03OYY DRUG__ID D03OYY D03OYY DRUGCOMP Marcadia Biotech Inc D03OYY HIGHSTAT Investigative D03PCP DRUG__ID D03PCP D03PCP DRUGCOMP Nectid Inc D03PCP HIGHSTAT Investigative D03PEF DRUG__ID D03PEF D03PEF DRUGCOMP Radiomedix Inc D03PEF HIGHSTAT Investigative D03PMB DRUG__ID D03PMB D03PMB DRUGCOMP Pain Therapeutics D03PMB HIGHSTAT Investigative D03PUG DRUG__ID D03PUG D03PUG DRUGCOMP State Research Center of Virology; Biotechnology VECTOR D03PUG HIGHSTAT Investigative D03PZY DRUG__ID D03PZY D03PZY DRUGCOMP Sanguine Corp D03PZY HIGHSTAT Investigative D03QAS DRUG__ID D03QAS D03QAS DRUGCOMP Oncotest GmbH D03QAS HIGHSTAT Investigative D03QEC DRUG__ID D03QEC D03QEC DRUGCOMP Astellas D03QEC HIGHSTAT Investigative D03QFO DRUG__ID D03QFO D03QFO DRUGCOMP Soricimed Biopharma Inc D03QFO HIGHSTAT Investigative D03QFY DRUG__ID D03QFY D03QFY DRUGCOMP NatureWise Biotech & Medicals Corp D03QFY HIGHSTAT Investigative D03QHR DRUG__ID D03QHR D03QHR DRUGCOMP Apointech SL D03QHR HIGHSTAT Investigative D03QNA DRUG__ID D03QNA D03QNA DRUGCOMP Center for Genetic Engineering and Biotechnology D03QNA HIGHSTAT Investigative D03QQP DRUG__ID D03QQP D03QQP DRUGCOMP BigDNA Ltd D03QQP HIGHSTAT Investigative D03QSC DRUG__ID D03QSC D03QSC DRUGCOMP Neurotec Pharma SL D03QSC HIGHSTAT Investigative D03QUJ DRUG__ID D03QUJ D03QUJ DRUGCOMP Phytopharm plc D03QUJ HIGHSTAT Investigative D03QVY DRUG__ID D03QVY D03QVY DRUGCOMP Santaris Pharma A/S D03QVY HIGHSTAT Investigative D03RAN DRUG__ID D03RAN D03RAN DRUGCOMP Cytokine PharmaSciences Inc D03RAN HIGHSTAT Investigative D03RKC DRUG__ID D03RKC D03RKC DRUGCOMP EyeGene Inc D03RKC HIGHSTAT Investigative D03RLC DRUG__ID D03RLC D03RLC DRUGCOMP Pfizer Inc D03RLC HIGHSTAT Investigative D03RRK DRUG__ID D03RRK D03RRK DRUGCOMP Pain Therapeutics Inc D03RRK HIGHSTAT Investigative D03RSI DRUG__ID D03RSI D03RSI DRUGCOMP Institute of Materia Medica Chinese Academy of Medical Science D03RSI HIGHSTAT Investigative D03RSQ DRUG__ID D03RSQ D03RSQ DRUGCOMP Vivia Biotech SL D03RSQ HIGHSTAT Investigative D03RTC DRUG__ID D03RTC D03RTC DRUGCOMP Bristol-Myers Squibb Co D03RTC HIGHSTAT Investigative D03RTR DRUG__ID D03RTR D03RTR DRUGCOMP Impel NeuroPharma D03RTR HIGHSTAT Investigative D03SCP DRUG__ID D03SCP D03SCP DRUGCOMP ProNAi Therapeutics Inc D03SCP HIGHSTAT Investigative D03SGF DRUG__ID D03SGF D03SGF DRUGCOMP MD Anderson Cancer Center D03SGF HIGHSTAT Investigative D03SHI DRUG__ID D03SHI D03SHI DRUGCOMP Roche Holding AG D03SHI HIGHSTAT Investigative D03SLO DRUG__ID D03SLO D03SLO DRUGCOMP Ohio State University D03SLO HIGHSTAT Investigative D03SMB DRUG__ID D03SMB D03SMB DRUGCOMP University of Pennsylvania D03SMB HIGHSTAT Investigative D03SSG DRUG__ID D03SSG D03SSG DRUGCOMP POZEN Inc D03SSG HIGHSTAT Investigative D03SSH DRUG__ID D03SSH D03SSH DRUGCOMP Incozen Therapeutics Pvt Ltd D03SSH HIGHSTAT Investigative D03SXQ DRUG__ID D03SXQ D03SXQ DRUGCOMP Medarex Inc D03SXQ HIGHSTAT Investigative D03SYC DRUG__ID D03SYC D03SYC DRUGCOMP Eli Lilly & Co D03SYC HIGHSTAT Investigative D03TAP DRUG__ID D03TAP D03TAP DRUGCOMP MultiCell Technologies Inc D03TAP HIGHSTAT Investigative D03TAT DRUG__ID D03TAT D03TAT DRUGCOMP Intarcia Therapeutics Inc D03TAT HIGHSTAT Investigative D03TDB DRUG__ID D03TDB D03TDB DRUGCOMP TaiMed Biologics Inc D03TDB HIGHSTAT Investigative D03TGB DRUG__ID D03TGB D03TGB DRUGCOMP PROLOR Biotech Inc D03TGB HIGHSTAT Investigative D03TKI DRUG__ID D03TKI D03TKI DRUGCOMP Femta Pharmaceuticals Inc D03TKI HIGHSTAT Investigative D03TOH DRUG__ID D03TOH D03TOH DRUGCOMP Accera Inc D03TOH HIGHSTAT Investigative D03TVE DRUG__ID D03TVE D03TVE DRUGCOMP Bristol-Myers Squibb Co D03TVE HIGHSTAT Investigative D03TXW DRUG__ID D03TXW D03TXW DRUGCOMP Bayer Healthcare LLC D03TXW HIGHSTAT Investigative D03TYT DRUG__ID D03TYT D03TYT DRUGCOMP Pfizer Inc D03TYT HIGHSTAT Investigative D03TZG DRUG__ID D03TZG D03TZG DRUGCOMP MiRagen Therapeutics Inc D03TZG HIGHSTAT Investigative D03UAO DRUG__ID D03UAO D03UAO DRUGCOMP Green Cross Corp D03UAO HIGHSTAT Investigative D03UOG DRUG__ID D03UOG D03UOG DRUGCOMP Pharma Two B Ltd D03UOG HIGHSTAT Investigative D03URV DRUG__ID D03URV D03URV DRUGCOMP Handok Pharmaceuticals D03URV HIGHSTAT Investigative D03UVX DRUG__ID D03UVX D03UVX DRUGCOMP Cytomics Pharmaceuticals D03UVX HIGHSTAT Investigative D03UWE DRUG__ID D03UWE D03UWE DRUGCOMP Catabasis Pharmaceuticals Inc D03UWE HIGHSTAT Investigative D03VDA DRUG__ID D03VDA D03VDA DRUGCOMP Pacific Therapeutics Ltd D03VDA HIGHSTAT Investigative D03VDX DRUG__ID D03VDX D03VDX DRUGCOMP University of North Carolina D03VDX HIGHSTAT Investigative D03VLO DRUG__ID D03VLO D03VLO DRUGCOMP Aquila Biopharmaceuticals Inc D03VLO HIGHSTAT Investigative D03VUV DRUG__ID D03VUV D03VUV DRUGCOMP Sigma-Tau SpA D03VUV HIGHSTAT Investigative D03WAX DRUG__ID D03WAX D03WAX DRUGCOMP Kent State University D03WAX HIGHSTAT Investigative D03WCT DRUG__ID D03WCT D03WCT DRUGCOMP Almirall Prodesfarma SA D03WCT HIGHSTAT Investigative D03WGM DRUG__ID D03WGM D03WGM DRUGCOMP SOM Biotech SL D03WGM HIGHSTAT Investigative D03WMT DRUG__ID D03WMT D03WMT DRUGCOMP Millennium Pharmaceuticals Inc D03WMT HIGHSTAT Investigative D03WTE DRUG__ID D03WTE D03WTE DRUGCOMP Oscotec Inc D03WTE HIGHSTAT Investigative D03WTX DRUG__ID D03WTX D03WTX DRUGCOMP Synageva BioPharma Corp D03WTX HIGHSTAT Investigative D03WUJ DRUG__ID D03WUJ D03WUJ DRUGTYPE Peptide D03WUJ HIGHSTAT Investigative D03WXL DRUG__ID D03WXL D03WXL DRUGCOMP Excelimmune Inc D03WXL HIGHSTAT Investigative D03WZJ DRUG__ID D03WZJ D03WZJ DRUGCOMP Actinium Pharmaceuticals Inc D03WZJ HIGHSTAT Investigative D03XBB DRUG__ID D03XBB D03XBB DRUGCOMP Dyax Corp D03XBB HIGHSTAT Investigative D03XBT DRUG__ID D03XBT D03XBT DRUGCOMP Cardax Pharmaceuticals Inc D03XBT HIGHSTAT Investigative D03XDD DRUG__ID D03XDD D03XDD DRUGCOMP Oryzon Genomics SA D03XDD HIGHSTAT Investigative D03XET DRUG__ID D03XET D03XET DRUGCOMP Peptron Co Ltd D03XET HIGHSTAT Investigative D03XEV DRUG__ID D03XEV D03XEV DRUGCOMP Endece LLC D03XEV HIGHSTAT Investigative D03XJP DRUG__ID D03XJP D03XJP DRUGCOMP Azano Pharmaceuticals Inc D03XJP HIGHSTAT Investigative D03XLO DRUG__ID D03XLO D03XLO DRUGCOMP Pevion Biotech Ltd D03XLO HIGHSTAT Investigative D03XRZ DRUG__ID D03XRZ D03XRZ DRUGCOMP Pfizer Inc D03XRZ HIGHSTAT Investigative D03XSX DRUG__ID D03XSX D03XSX DRUGCOMP CEL-SCI Corp D03XSX HIGHSTAT Investigative D03XWN DRUG__ID D03XWN D03XWN DRUGCOMP Stellar Biotechnologies Inc D03XWN HIGHSTAT Investigative D03YCT DRUG__ID D03YCT D03YCT DRUGCOMP TechnoVax Inc D03YCT HIGHSTAT Investigative D03YGX DRUG__ID D03YGX D03YGX DRUGCOMP Airway Therapeutics Inc D03YGX HIGHSTAT Investigative D03YKO DRUG__ID D03YKO D03YKO DRUGCOMP Viron Therapeutics Inc D03YKO HIGHSTAT Investigative D03YMD DRUG__ID D03YMD D03YMD DRUGCOMP Bristol-Myers Squibb Co D03YMD HIGHSTAT Investigative D03YPR DRUG__ID D03YPR D03YPR DRUGCOMP Handok Pharmaceuticals D03YPR HIGHSTAT Investigative D03YSJ DRUG__ID D03YSJ D03YSJ DRUGCOMP Shasun-NBI D03YSJ HIGHSTAT Investigative D03YSL DRUG__ID D03YSL D03YSL DRUGCOMP Catabasis Pharmaceuticals Inc D03YSL HIGHSTAT Investigative D03ZIK DRUG__ID D03ZIK D03ZIK DRUGCOMP Madeira Therapeutics LLC D03ZIK HIGHSTAT Investigative D03ZIW DRUG__ID D03ZIW D03ZIW DRUGTYPE Antibody D03ZIW HIGHSTAT Investigative D03ZJK DRUG__ID D03ZJK D03ZJK DRUGCOMP Neuren Pharmaceuticals Ltd D03ZJK HIGHSTAT Investigative D03ZMK DRUG__ID D03ZMK D03ZMK DRUGCOMP NeuroTherapeutics Pharma Inc D03ZMK HIGHSTAT Investigative D03ZMY DRUG__ID D03ZMY D03ZMY DRUGCOMP AnaMar Medical AB D03ZMY HIGHSTAT Investigative D03ZWR DRUG__ID D03ZWR D03ZWR DRUGCOMP Colby Pharmaceuticals D03ZWR HIGHSTAT Investigative D04ACD DRUG__ID D04ACD D04ACD DRUGCOMP National Institutes of Health D04ACD HIGHSTAT Investigative D04AGM DRUG__ID D04AGM D04AGM DRUGCOMP Protect Pharmaceuticals Corp D04AGM HIGHSTAT Investigative D04ALI DRUG__ID D04ALI D04ALI DRUGCOMP ForHumanTech Co Ltd D04ALI HIGHSTAT Investigative D04ARO DRUG__ID D04ARO D04ARO DRUGCOMP Pevion Biotech Ltd D04ARO HIGHSTAT Investigative D04ASA DRUG__ID D04ASA D04ASA DRUGCOMP XBiotech Inc D04ASA HIGHSTAT Investigative D04ATE DRUG__ID D04ATE D04ATE DRUGCOMP Affitech A/S D04ATE HIGHSTAT Investigative D04AYH DRUG__ID D04AYH D04AYH DRUGCOMP AdeTherapeutics Inc D04AYH HIGHSTAT Investigative D04BHY DRUG__ID D04BHY D04BHY DRUGCOMP Ontario Cancer Institute D04BHY HIGHSTAT Investigative D04BIY DRUG__ID D04BIY D04BIY DRUGCOMP Nektar Therapeutics D04BIY HIGHSTAT Investigative D04BMR DRUG__ID D04BMR D04BMR DRUGCOMP Alcon Inc D04BMR HIGHSTAT Investigative D04BRF DRUG__ID D04BRF D04BRF DRUGCOMP Technophage SA D04BRF HIGHSTAT Investigative D04BXH DRUG__ID D04BXH D04BXH DRUGCOMP Critical Outcome Technologies Inc D04BXH HIGHSTAT Investigative D04CCK DRUG__ID D04CCK D04CCK DRUGCOMP Chinese Academy of Sciences D04CCK HIGHSTAT Investigative D04CKB DRUG__ID D04CKB D04CKB DRUGCOMP Inhibikase Therapeutics D04CKB HIGHSTAT Investigative D04CKR DRUG__ID D04CKR D04CKR DRUGCOMP Calmune Corp D04CKR HIGHSTAT Investigative D04CTP DRUG__ID D04CTP D04CTP DRUGCOMP Esperance Pharmaceuticals Inc D04CTP HIGHSTAT Investigative D04DDW DRUG__ID D04DDW D04DDW DRUGCOMP MIKA Pharma GmbH D04DDW HIGHSTAT Investigative D04DQP DRUG__ID D04DQP D04DQP DRUGCOMP Adriacell Pharmacauticals D04DQP HIGHSTAT Investigative D04DVA DRUG__ID D04DVA D04DVA DRUGCOMP LTT Bio-Pharma Co Ltd D04DVA HIGHSTAT Investigative D04EAZ DRUG__ID D04EAZ D04EAZ DRUGCOMP National Cancer Institute D04EAZ HIGHSTAT Investigative D04EFB DRUG__ID D04EFB D04EFB DRUGCOMP Onco-Pharmakon Inc D04EFB HIGHSTAT Investigative D04EFG DRUG__ID D04EFG D04EFG DRUGCOMP Palau Pharma SA D04EFG HIGHSTAT Investigative D04EGE DRUG__ID D04EGE D04EGE DRUGCOMP Royal Prince Alfred Hospital D04EGE HIGHSTAT Investigative D04EHF DRUG__ID D04EHF D04EHF DRUGCOMP Da Volterra D04EHF HIGHSTAT Investigative D04ENF DRUG__ID D04ENF D04ENF DRUGCOMP Copernicus Therapeutics Inc D04ENF HIGHSTAT Investigative D04EPP DRUG__ID D04EPP D04EPP DRUGCOMP Oregon Health Sciences University D04EPP HIGHSTAT Investigative D04EXW DRUG__ID D04EXW D04EXW DRUGCOMP Moberg Derma AB D04EXW HIGHSTAT Investigative D04EZR DRUG__ID D04EZR D04EZR DRUGCOMP Signum Biosciences Inc D04EZR HIGHSTAT Investigative D04FAC DRUG__ID D04FAC D04FAC DRUGCOMP London Project to Cure Blindness D04FAC HIGHSTAT Investigative D04FHY DRUG__ID D04FHY D04FHY DRUGCOMP BioRap Technologies Ltd D04FHY HIGHSTAT Investigative D04FIO DRUG__ID D04FIO D04FIO DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D04FIO HIGHSTAT Investigative D04GCV DRUG__ID D04GCV D04GCV DRUGCOMP Atlas Pharmaceuticals Inc D04GCV HIGHSTAT Investigative D04GDI DRUG__ID D04GDI D04GDI DRUGCOMP NeurOp Corp D04GDI HIGHSTAT Investigative D04GGA DRUG__ID D04GGA D04GGA DRUGCOMP Codevax Inc D04GGA HIGHSTAT Investigative D04GGQ DRUG__ID D04GGQ D04GGQ DRUGCOMP Myrexis Inc D04GGQ HIGHSTAT Investigative D04GTW DRUG__ID D04GTW D04GTW DRUGCOMP ReMYND NV D04GTW HIGHSTAT Investigative D04HAA DRUG__ID D04HAA D04HAA DRUGCOMP University of Minnesota D04HAA HIGHSTAT Investigative D04HBH DRUG__ID D04HBH D04HBH DRUGCOMP Amura Therapeutics Ltd D04HBH HIGHSTAT Investigative D04HBJ DRUG__ID D04HBJ D04HBJ DRUGCOMP Adelaide Research & Innovation Pty Ltd D04HBJ HIGHSTAT Investigative D04HER DRUG__ID D04HER D04HER DRUGCOMP SOM Biotech SL D04HER HIGHSTAT Investigative D04HTL DRUG__ID D04HTL D04HTL DRUGCOMP Ablynx NV D04HTL HIGHSTAT Investigative D04HUC DRUG__ID D04HUC D04HUC DRUGCOMP Marina Biotech Inc D04HUC HIGHSTAT Investigative D04HXP DRUG__ID D04HXP D04HXP DRUGCOMP Wellstat Therapeutics Corp D04HXP HIGHSTAT Investigative D04HYR DRUG__ID D04HYR D04HYR DRUGCOMP Zhejiang University D04HYR HIGHSTAT Investigative D04IBI DRUG__ID D04IBI D04IBI DRUGCOMP Abxign Inc D04IBI HIGHSTAT Investigative D04IEK DRUG__ID D04IEK D04IEK DRUGTYPE Antibody D04IEK HIGHSTAT Investigative D04IFD DRUG__ID D04IFD D04IFD DRUGCOMP ERYtech Pharma D04IFD HIGHSTAT Investigative D04ILU DRUG__ID D04ILU D04ILU DRUGTYPE Small molecule immunotherapy D04ILU HIGHSTAT Investigative D04IPX DRUG__ID D04IPX D04IPX DRUGCOMP Walter and Eliza Hall Institute of Medical Research D04IPX HIGHSTAT Investigative D04IUY DRUG__ID D04IUY D04IUY DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D04IUY HIGHSTAT Investigative D04IWZ DRUG__ID D04IWZ D04IWZ DRUGCOMP Phico Therapeutics Ltd D04IWZ HIGHSTAT Investigative D04IXJ DRUG__ID D04IXJ D04IXJ THERCLAS Analgesics D04IXJ HIGHSTAT Investigative D04JAQ DRUG__ID D04JAQ D04JAQ DRUGCOMP RegenX Biosciences LLC D04JAQ HIGHSTAT Investigative D04JCT DRUG__ID D04JCT D04JCT DRUGCOMP Thrasos Therapeutics Inc D04JCT HIGHSTAT Investigative D04JIE DRUG__ID D04JIE D04JIE DRUGCOMP Serina Therapeutics Inc D04JIE HIGHSTAT Investigative D04JIS DRUG__ID D04JIS D04JIS DRUGCOMP Oryzon Genomics SA D04JIS HIGHSTAT Investigative D04JKG DRUG__ID D04JKG D04JKG DRUGCOMP GenVec Inc D04JKG HIGHSTAT Investigative D04JMG DRUG__ID D04JMG D04JMG DRUGCOMP Cequent Pharmaceuticals Inc D04JMG HIGHSTAT Investigative D04JNC DRUG__ID D04JNC D04JNC DRUGCOMP Zhejiang University D04JNC HIGHSTAT Investigative D04JRK DRUG__ID D04JRK D04JRK DRUGCOMP PharmaEssentia Corp D04JRK HIGHSTAT Investigative D04KEL DRUG__ID D04KEL D04KEL DRUGCOMP Evolva SA D04KEL HIGHSTAT Investigative D04KKX DRUG__ID D04KKX D04KKX DRUGCOMP Quorex Pharmaceuticals Inc D04KKX HIGHSTAT Investigative D04KYH DRUG__ID D04KYH D04KYH DRUGCOMP Multimeric Biotherapeutics Inc D04KYH HIGHSTAT Investigative D04KZH DRUG__ID D04KZH D04KZH DRUGCOMP Immunobiology Ltd D04KZH HIGHSTAT Investigative D04LGK DRUG__ID D04LGK D04LGK DRUGCOMP Vertex Pharmaceuticals Inc D04LGK HIGHSTAT Investigative D04LHG DRUG__ID D04LHG D04LHG DRUGCOMP Advanced Targeting Systems Inc D04LHG HIGHSTAT Investigative D04LRQ DRUG__ID D04LRQ D04LRQ DRUGCOMP ALS Therapy Development Foundation Inc D04LRQ HIGHSTAT Investigative D04LTO DRUG__ID D04LTO D04LTO DRUGCOMP Galmed Medical Research Ltd D04LTO HIGHSTAT Investigative D04LUG DRUG__ID D04LUG D04LUG DRUGCOMP BioSource Pharm Inc D04LUG HIGHSTAT Investigative D04MEB DRUG__ID D04MEB D04MEB DRUGCOMP LifePharms Inc D04MEB HIGHSTAT Investigative D04MEM DRUG__ID D04MEM D04MEM DRUGCOMP Oramed Pharmaceuticals Inc D04MEM HIGHSTAT Investigative D04MFQ DRUG__ID D04MFQ D04MFQ DRUGCOMP 4s3 Bioscience Inc D04MFQ HIGHSTAT Investigative D04MFW DRUG__ID D04MFW D04MFW DRUGCOMP University of Cincinnati D04MFW HIGHSTAT Investigative D04MOZ DRUG__ID D04MOZ D04MOZ DRUGCOMP New biotics D04MOZ HIGHSTAT Investigative D04MRX DRUG__ID D04MRX D04MRX DRUGCOMP ABC Seikagaku D04MRX HIGHSTAT Investigative D04MXO DRUG__ID D04MXO D04MXO DRUGCOMP BioCryst Pharmaceuticals Inc D04MXO HIGHSTAT Investigative D04MXV DRUG__ID D04MXV D04MXV DRUGCOMP Viral Genetics Inc D04MXV HIGHSTAT Investigative D04MYG DRUG__ID D04MYG D04MYG DRUGCOMP CEAMED SA D04MYG HIGHSTAT Investigative D04MZM DRUG__ID D04MZM D04MZM DRUGCOMP TechnoVax Inc D04MZM HIGHSTAT Investigative D04NBY DRUG__ID D04NBY D04NBY DRUGCOMP Scil Proteins GmbH D04NBY HIGHSTAT Investigative D04NNK DRUG__ID D04NNK D04NNK DRUGCOMP CSL Ltd D04NNK HIGHSTAT Investigative D04NRP DRUG__ID D04NRP D04NRP DRUGCOMP Alios BioPharma Inc D04NRP HIGHSTAT Investigative D04NYX DRUG__ID D04NYX D04NYX DRUGCOMP Antisense Pharma GmbH D04NYX HIGHSTAT Investigative D04OBS DRUG__ID D04OBS D04OBS DRUGCOMP Zambon Co SpA D04OBS HIGHSTAT Investigative D04OCO DRUG__ID D04OCO D04OCO DRUGCOMP Amylin Pharmaceuticals Inc D04OCO HIGHSTAT Investigative D04OGS DRUG__ID D04OGS D04OGS DRUGCOMP LivTech Inc D04OGS HIGHSTAT Investigative D04OGZ DRUG__ID D04OGZ D04OGZ DRUGCOMP Institute of Cancer Research UK D04OGZ HIGHSTAT Investigative D04OIG DRUG__ID D04OIG D04OIG DRUGCOMP Mologen Holding AG D04OIG HIGHSTAT Investigative D04OPS DRUG__ID D04OPS D04OPS DRUGCOMP MicroDose Therapeutx Inc D04OPS HIGHSTAT Investigative D04OUP DRUG__ID D04OUP D04OUP DRUGCOMP NeuroNascent Inc D04OUP HIGHSTAT Investigative D04OYW DRUG__ID D04OYW D04OYW DRUGCOMP Scil Technology GmbH D04OYW HIGHSTAT Investigative D04OZR DRUG__ID D04OZR D04OZR DRUGCOMP Tetra Therapeutics SL D04OZR HIGHSTAT Investigative D04PPE DRUG__ID D04PPE D04PPE DRUGCOMP Verseon D04PPE HIGHSTAT Investigative D04QDI DRUG__ID D04QDI D04QDI DRUGCOMP Nordic Vaccine A/S D04QDI HIGHSTAT Investigative D04QFX DRUG__ID D04QFX D04QFX DRUGCOMP Imagenetix Inc D04QFX HIGHSTAT Investigative D04QFY DRUG__ID D04QFY D04QFY DRUGCOMP GTx Inc D04QFY HIGHSTAT Investigative D04QHT DRUG__ID D04QHT D04QHT DRUGCOMP Royal College of Surgeons in Ireland D04QHT HIGHSTAT Investigative D04QIL DRUG__ID D04QIL D04QIL DRUGCOMP Immune Pharmaceuticals Corp D04QIL HIGHSTAT Investigative D04QWV DRUG__ID D04QWV D04QWV DRUGCOMP Epitomics Inc D04QWV HIGHSTAT Investigative D04QXW DRUG__ID D04QXW D04QXW DRUGCOMP Archer Pharmaceuticals D04QXW HIGHSTAT Investigative D04RBY DRUG__ID D04RBY D04RBY DRUGCOMP EffRx Pharmaceuticals SA D04RBY HIGHSTAT Investigative D04RJM DRUG__ID D04RJM D04RJM DRUGCOMP Daewon Pharm Co Ltd D04RJM HIGHSTAT Investigative D04RKH DRUG__ID D04RKH D04RKH DRUGCOMP Aphios Corp D04RKH HIGHSTAT Investigative D04RSZ DRUG__ID D04RSZ D04RSZ DRUGCOMP GlobeImmune Inc D04RSZ HIGHSTAT Investigative D04RUA DRUG__ID D04RUA D04RUA DRUGCOMP University of California D04RUA HIGHSTAT Investigative D04SWF DRUG__ID D04SWF D04SWF DRUGCOMP Faron Pharmaceuticals Ltd D04SWF HIGHSTAT Investigative D04SZG DRUG__ID D04SZG D04SZG DRUGCOMP Critical Outcome Technologies Inc D04SZG HIGHSTAT Investigative D04TBW DRUG__ID D04TBW D04TBW DRUGCOMP Virionics Corp D04TBW HIGHSTAT Investigative D04TCQ DRUG__ID D04TCQ D04TCQ DRUGCOMP JADO Technologies GmbH D04TCQ HIGHSTAT Investigative D04TGU DRUG__ID D04TGU D04TGU DRUGCOMP Merck & Co Inc D04TGU HIGHSTAT Investigative D04THK DRUG__ID D04THK D04THK DRUGCOMP Arteriocyte; compass biomedical D04THK HIGHSTAT Investigative D04THU DRUG__ID D04THU D04THU DRUGCOMP Obio Pharmaceutical Holdings Ltd D04THU HIGHSTAT Investigative D04TPF DRUG__ID D04TPF D04TPF DRUGCOMP ALS Therapy Development Foundation Inc D04TPF HIGHSTAT Investigative D04TPS DRUG__ID D04TPS D04TPS DRUGCOMP Abbott Laboratories D04TPS HIGHSTAT Investigative D04TXB DRUG__ID D04TXB D04TXB DRUGCOMP Maxim Pharmaceuticals D04TXB HIGHSTAT Investigative D04TZK DRUG__ID D04TZK D04TZK DRUGCOMP Link Medicine Corp D04TZK HIGHSTAT Investigative D04UPJ DRUG__ID D04UPJ D04UPJ DRUGCOMP MondoBIOTECH Holding AG D04UPJ HIGHSTAT Investigative D04UPM DRUG__ID D04UPM D04UPM DRUGCOMP Kenta Biotech Ltd D04UPM HIGHSTAT Investigative D04UQS DRUG__ID D04UQS D04UQS DRUGCOMP Nymox Pharmaceutical Corp D04UQS HIGHSTAT Investigative D04URZ DRUG__ID D04URZ D04URZ DRUGCOMP Avexxin AS D04URZ HIGHSTAT Investigative D04UYT DRUG__ID D04UYT D04UYT DRUGCOMP Cleveland BioLabs Inc D04UYT HIGHSTAT Investigative D04VAR DRUG__ID D04VAR D04VAR DRUGCOMP GlaxoSmithKline plc D04VAR HIGHSTAT Investigative D04VCF DRUG__ID D04VCF D04VCF DRUGTYPE Aptamer D04VCF HIGHSTAT Investigative D04VFW DRUG__ID D04VFW D04VFW DRUGCOMP Palumed SA D04VFW HIGHSTAT Investigative D04VHL DRUG__ID D04VHL D04VHL DRUGCOMP Mystic Pharmaceuticals Inc D04VHL HIGHSTAT Investigative D04VHQ DRUG__ID D04VHQ D04VHQ DRUGCOMP AVI BioPharma Inc D04VHQ HIGHSTAT Investigative D04VMK DRUG__ID D04VMK D04VMK DRUGCOMP Pain Therapeutics Inc D04VMK HIGHSTAT Investigative D04VPP DRUG__ID D04VPP D04VPP DRUGCOMP Azaya Therapeutics D04VPP HIGHSTAT Investigative D04VUM DRUG__ID D04VUM D04VUM DRUGCOMP Compugen Ltd D04VUM HIGHSTAT Investigative D04VWO DRUG__ID D04VWO D04VWO DRUGCOMP ImmunNovative Developments SL D04VWO HIGHSTAT Investigative D04WCA DRUG__ID D04WCA D04WCA DRUGCOMP AviPep Pty D04WCA HIGHSTAT Investigative D04WCO DRUG__ID D04WCO D04WCO DRUGCOMP Epiphany Biosciences D04WCO HIGHSTAT Investigative D04WLX DRUG__ID D04WLX D04WLX DRUGCOMP Allinky Biopharma D04WLX HIGHSTAT Investigative D04WNA DRUG__ID D04WNA D04WNA DRUGCOMP ARTYX Pharmaceuticals Inc D04WNA HIGHSTAT Investigative D04WSK DRUG__ID D04WSK D04WSK DRUGCOMP Immunomedics Inc D04WSK HIGHSTAT Investigative D04WSL DRUG__ID D04WSL D04WSL DRUGCOMP Celtic Biotech Ltd D04WSL HIGHSTAT Investigative D04XJV DRUG__ID D04XJV D04XJV DRUGCOMP Glenmark Pharmaceuticals Ltd D04XJV HIGHSTAT Investigative D04XJX DRUG__ID D04XJX D04XJX DRUGCOMP Gemmus Pharma Inc D04XJX HIGHSTAT Investigative D04XML DRUG__ID D04XML D04XML DRUGCOMP Trigemina Inc D04XML HIGHSTAT Investigative D04XOX DRUG__ID D04XOX D04XOX DRUGCOMP GlaxoSmithKline plc D04XOX HIGHSTAT Investigative D04XQG DRUG__ID D04XQG D04XQG DRUGCOMP NicOx SA D04XQG HIGHSTAT Investigative D04XVI DRUG__ID D04XVI D04XVI DRUGCOMP Johnson & Johnson D04XVI HIGHSTAT Investigative D04YGT DRUG__ID D04YGT D04YGT DRUGCOMP Valocor Therapeutics Ltd D04YGT HIGHSTAT Investigative D04YKQ DRUG__ID D04YKQ D04YKQ DRUGCOMP Haoma Medica Ltd D04YKQ HIGHSTAT Investigative D04YKY DRUG__ID D04YKY D04YKY DRUGCOMP Neurotech Pharmaceuticals Inc D04YKY HIGHSTAT Investigative D04YLU DRUG__ID D04YLU D04YLU DRUGCOMP AstraZeneca plc D04YLU HIGHSTAT Investigative D04YSQ DRUG__ID D04YSQ D04YSQ DRUGCOMP Lipoxen plc D04YSQ HIGHSTAT Investigative D04YSY DRUG__ID D04YSY D04YSY DRUGCOMP INSERM D04YSY HIGHSTAT Investigative D04YTT DRUG__ID D04YTT D04YTT DRUGCOMP Da Volterra D04YTT HIGHSTAT Investigative D04YTX DRUG__ID D04YTX D04YTX DRUGCOMP Avanti Therapeutics D04YTX HIGHSTAT Investigative D04YWS DRUG__ID D04YWS D04YWS DRUGCOMP Panorama Research Inc D04YWS HIGHSTAT Investigative D04ZEP DRUG__ID D04ZEP D04ZEP DRUGCOMP Abbott Laboratories D04ZEP HIGHSTAT Investigative D04ZJQ DRUG__ID D04ZJQ D04ZJQ DRUGCOMP University of Maryland Baltimore County D04ZJQ HIGHSTAT Investigative D04ZTA DRUG__ID D04ZTA D04ZTA DRUGCOMP Alzhyme Pty Ltd D04ZTA HIGHSTAT Investigative D04ZUU DRUG__ID D04ZUU D04ZUU DRUGCOMP Akthelia Pharmaceuticals D04ZUU HIGHSTAT Investigative D04ZWD DRUG__ID D04ZWD D04ZWD DRUGCOMP Santaris Pharma A/S D04ZWD HIGHSTAT Investigative D04ZZD DRUG__ID D04ZZD D04ZZD DRUGCOMP AviPep Pty D04ZZD HIGHSTAT Investigative D04ZZX DRUG__ID D04ZZX D04ZZX DRUGCOMP Multimmune GmbH D04ZZX HIGHSTAT Investigative D05AAQ DRUG__ID D05AAQ D05AAQ DRUGCOMP BioCure Pharma LLC D05AAQ HIGHSTAT Investigative D05ADE DRUG__ID D05ADE D05ADE DRUGCOMP Futura Medical plc D05ADE HIGHSTAT Investigative D05AFP DRUG__ID D05AFP D05AFP DRUGCOMP CytoGenix Inc D05AFP HIGHSTAT Investigative D05APM DRUG__ID D05APM D05APM DRUGCOMP Angion Biomedica Corp D05APM HIGHSTAT Investigative D05AQB DRUG__ID D05AQB D05AQB DRUGCOMP Johns Hopkins University D05AQB HIGHSTAT Investigative D05BKY DRUG__ID D05BKY D05BKY DRUGCOMP Nyken BV D05BKY HIGHSTAT Investigative D05BLG DRUG__ID D05BLG D05BLG DRUGCOMP M's Science Corp D05BLG HIGHSTAT Investigative D05BLQ DRUG__ID D05BLQ D05BLQ THERCLAS Analgesics D05BLQ HIGHSTAT Investigative D05BRZ DRUG__ID D05BRZ D05BRZ DRUGCOMP PanGenetics BV D05BRZ HIGHSTAT Investigative D05BWY DRUG__ID D05BWY D05BWY DRUGCOMP Clera Inc D05BWY HIGHSTAT Investigative D05CGH DRUG__ID D05CGH D05CGH DRUGCOMP University of Newcastle D05CGH HIGHSTAT Investigative D05CJN DRUG__ID D05CJN D05CJN DRUGCOMP Human Genome Sciences Inc D05CJN HIGHSTAT Investigative D05CPD DRUG__ID D05CPD D05CPD DRUGCOMP BIOO Therapeutics D05CPD HIGHSTAT Investigative D05CTY DRUG__ID D05CTY D05CTY DRUGCOMP Nanovector Ltd D05CTY HIGHSTAT Investigative D05CYX DRUG__ID D05CYX D05CYX DRUGCOMP Da Volterra D05CYX HIGHSTAT Investigative D05DAX DRUG__ID D05DAX D05DAX DRUGCOMP Thrombotargets Corp D05DAX HIGHSTAT Investigative D05DBT DRUG__ID D05DBT D05DBT DRUGCOMP EyeGene Inc D05DBT HIGHSTAT Investigative D05DCX DRUG__ID D05DCX D05DCX DRUGCOMP MandalMed Inc D05DCX HIGHSTAT Investigative D05DPE DRUG__ID D05DPE D05DPE DRUGCOMP Boryung Pharm Co Ltd D05DPE HIGHSTAT Investigative D05DRG DRUG__ID D05DRG D05DRG DRUGCOMP Theratechnologies Inc D05DRG HIGHSTAT Investigative D05DZJ DRUG__ID D05DZJ D05DZJ DRUGCOMP ALS Therapy Development Foundation Inc D05DZJ HIGHSTAT Investigative D05EAJ DRUG__ID D05EAJ D05EAJ DRUGCOMP ET Vaccine Technology Inc D05EAJ HIGHSTAT Investigative D05EMW DRUG__ID D05EMW D05EMW DRUGCOMP Lipoxen plc D05EMW HIGHSTAT Investigative D05EOT DRUG__ID D05EOT D05EOT DRUGCOMP Curemark LLC D05EOT HIGHSTAT Investigative D05FOB DRUG__ID D05FOB D05FOB DRUGCOMP Haplomic Technologies Pty Ltd D05FOB HIGHSTAT Investigative D05FRM DRUG__ID D05FRM D05FRM DRUGCOMP ApoVax Inc D05FRM HIGHSTAT Investigative D05FSK DRUG__ID D05FSK D05FSK DRUGCOMP Microbiotix Inc D05FSK HIGHSTAT Investigative D05GBR DRUG__ID D05GBR D05GBR DRUGCOMP European Malaria Vaccine Initiative D05GBR HIGHSTAT Investigative D05GJJ DRUG__ID D05GJJ D05GJJ DRUGCOMP JCR Pharmaceuticals Co Ltd D05GJJ HIGHSTAT Investigative D05GKN DRUG__ID D05GKN D05GKN DRUGCOMP Synageva BioPharma Corp D05GKN HIGHSTAT Investigative D05GKZ DRUG__ID D05GKZ D05GKZ DRUGCOMP Therosteon D05GKZ HIGHSTAT Investigative D05GMG DRUG__ID D05GMG D05GMG DRUGCOMP NeuroNascent Inc D05GMG HIGHSTAT Investigative D05GOA DRUG__ID D05GOA D05GOA DRUGCOMP Vivia Biotech SL D05GOA HIGHSTAT Investigative D05GPN DRUG__ID D05GPN D05GPN DRUGCOMP Optherion Inc D05GPN HIGHSTAT Investigative D05GQV DRUG__ID D05GQV D05GQV DRUGCOMP Reata Pharmaceuticals Inc D05GQV HIGHSTAT Investigative D05GVO DRUG__ID D05GVO D05GVO DRUGCOMP Patrys Ltd D05GVO HIGHSTAT Investigative D05HHZ DRUG__ID D05HHZ D05HHZ DRUGCOMP NephRx Corp D05HHZ HIGHSTAT Investigative D05HJO DRUG__ID D05HJO D05HJO DRUGCOMP P2D Biosciences D05HJO HIGHSTAT Investigative D05HLC DRUG__ID D05HLC D05HLC DRUGCOMP NovaBay Pharmaceuticals Inc D05HLC HIGHSTAT Investigative D05HRW DRUG__ID D05HRW D05HRW DRUGCOMP SK Life Science D05HRW HIGHSTAT Investigative D05HUZ DRUG__ID D05HUZ D05HUZ DRUGCOMP Trillium Therapeutics Inc D05HUZ HIGHSTAT Investigative D05IBV DRUG__ID D05IBV D05IBV DRUGCOMP Aerie Pharmaceuticals Inc D05IBV HIGHSTAT Investigative D05IIB DRUG__ID D05IIB D05IIB DRUGCOMP VAXX Inc D05IIB HIGHSTAT Investigative D05IJM DRUG__ID D05IJM D05IJM DRUGCOMP ZaBeCor Pharmaceutical Co D05IJM HIGHSTAT Investigative D05IXH DRUG__ID D05IXH D05IXH DRUGCOMP Tobira Therapeutics Inc D05IXH HIGHSTAT Investigative D05IZC DRUG__ID D05IZC D05IZC DRUGCOMP REGiMMUNE Corp D05IZC HIGHSTAT Investigative D05JBP DRUG__ID D05JBP D05JBP DRUGCOMP Infinity Pharmaceuticals Inc D05JBP HIGHSTAT Investigative D05JGR DRUG__ID D05JGR D05JGR DRUGCOMP GLSynthesis Inc D05JGR HIGHSTAT Investigative D05JMP DRUG__ID D05JMP D05JMP DRUGCOMP IDRTech Inc D05JMP HIGHSTAT Investigative D05JTJ DRUG__ID D05JTJ D05JTJ DRUGCOMP Intercell AG D05JTJ HIGHSTAT Investigative D05JXF DRUG__ID D05JXF D05JXF DRUGCOMP YD Life Science Inc D05JXF HIGHSTAT Investigative D05KGK DRUG__ID D05KGK D05KGK DRUGCOMP Chungbuk National University D05KGK HIGHSTAT Investigative D05KHP DRUG__ID D05KHP D05KHP DRUGCOMP XOMA Ltd D05KHP HIGHSTAT Investigative D05KKF DRUG__ID D05KKF D05KKF DRUGCOMP Nippon Chemiphar Co Ltd D05KKF HIGHSTAT Investigative D05KOY DRUG__ID D05KOY D05KOY DRUGCOMP Medipost Co Ltd D05KOY HIGHSTAT Investigative D05KRH DRUG__ID D05KRH D05KRH DRUGCOMP Coronado Biosciences Inc D05KRH HIGHSTAT Investigative D05KRS DRUG__ID D05KRS D05KRS DRUGCOMP Creabilis Therapeutics SpA D05KRS HIGHSTAT Investigative D05KSY DRUG__ID D05KSY D05KSY DRUGCOMP Limerick BioPharma Inc D05KSY HIGHSTAT Investigative D05KZV DRUG__ID D05KZV D05KZV DRUGCOMP Vectura Group plc D05KZV HIGHSTAT Investigative D05LST DRUG__ID D05LST D05LST DRUGCOMP Vision 7 GmbH D05LST HIGHSTAT Investigative D05LUT DRUG__ID D05LUT D05LUT DRUGCOMP Medical Research Council Technology D05LUT HIGHSTAT Investigative D05LXH DRUG__ID D05LXH D05LXH DRUGCOMP Phage Biotechnology Corp D05LXH HIGHSTAT Investigative D05LZG DRUG__ID D05LZG D05LZG DRUGCOMP AvidBiotics Corp D05LZG HIGHSTAT Investigative D05MBE DRUG__ID D05MBE D05MBE DRUGCOMP Neurokin SA D05MBE HIGHSTAT Investigative D05MDQ DRUG__ID D05MDQ D05MDQ DRUGCOMP CrystalGenomics Inc D05MDQ HIGHSTAT Investigative D05MKG DRUG__ID D05MKG D05MKG DRUGCOMP Janssen Pharmaceutica NV D05MKG HIGHSTAT Investigative D05MSM DRUG__ID D05MSM D05MSM DRUGCOMP University of Louisville D05MSM HIGHSTAT Investigative D05MUA DRUG__ID D05MUA D05MUA DRUGTYPE Aptamer D05MUA HIGHSTAT Investigative D05MXL DRUG__ID D05MXL D05MXL DRUGCOMP CHDI Foundation Inc D05MXL HIGHSTAT Investigative D05NCT DRUG__ID D05NCT D05NCT DRUGCOMP Altor BioScience Corp D05NCT HIGHSTAT Investigative D05NIO DRUG__ID D05NIO D05NIO DRUGCOMP Noscira SA D05NIO HIGHSTAT Investigative D05NJG DRUG__ID D05NJG D05NJG DRUGCOMP NanoCarrier Co Ltd D05NJG HIGHSTAT Investigative D05NJL DRUG__ID D05NJL D05NJL DRUGCOMP Alseres Pharmaceuticals Inc D05NJL HIGHSTAT Investigative D05NLR DRUG__ID D05NLR D05NLR DRUGCOMP Advanomics Corp D05NLR HIGHSTAT Investigative D05NMU DRUG__ID D05NMU D05NMU DRUGCOMP MondoBIOTECH Holding AG D05NMU HIGHSTAT Investigative D05NRX DRUG__ID D05NRX D05NRX DRUGCOMP University of Nottingham D05NRX HIGHSTAT Investigative D05NSF DRUG__ID D05NSF D05NSF DRUGCOMP Nycomed D05NSF HIGHSTAT Investigative D05NTQ DRUG__ID D05NTQ D05NTQ DRUGCOMP ProRetina Therapeutics SL D05NTQ HIGHSTAT Investigative D05OAJ DRUG__ID D05OAJ D05OAJ DRUGCOMP Ranbaxy Laboratories Ltd D05OAJ HIGHSTAT Investigative D05OHW DRUG__ID D05OHW D05OHW DRUGCOMP TechnoVax Inc D05OHW HIGHSTAT Investigative D05ORI DRUG__ID D05ORI D05ORI DRUGCOMP AGI Therapeutics plc D05ORI HIGHSTAT Investigative D05PFE DRUG__ID D05PFE D05PFE DRUGCOMP Chugai Pharmaceutical Co Ltd D05PFE HIGHSTAT Investigative D05PIP DRUG__ID D05PIP D05PIP DRUGCOMP POZEN Inc D05PIP HIGHSTAT Investigative D05PJJ DRUG__ID D05PJJ D05PJJ DRUGTYPE Aptamer D05PJJ HIGHSTAT Investigative D05PKF DRUG__ID D05PKF D05PKF DRUGCOMP SOM Biotech SL D05PKF HIGHSTAT Investigative D05PTL DRUG__ID D05PTL D05PTL DRUGCOMP NatureWise Biotech & Medicals Corp D05PTL HIGHSTAT Investigative D05PVW DRUG__ID D05PVW D05PVW DRUGCOMP Cortex Pharmaceuticals Inc D05PVW HIGHSTAT Investigative D05PWA DRUG__ID D05PWA D05PWA DRUGCOMP ProNAi Therapeutics Inc D05PWA HIGHSTAT Investigative D05QFO DRUG__ID D05QFO D05QFO DRUGCOMP Relypsa Inc D05QFO HIGHSTAT Investigative D05QGH DRUG__ID D05QGH D05QGH DRUGCOMP InNexus Biotechnology Inc D05QGH HIGHSTAT Investigative D05QIZ DRUG__ID D05QIZ D05QIZ DRUGCOMP GTx Inc D05QIZ HIGHSTAT Investigative D05QXW DRUG__ID D05QXW D05QXW DRUGCOMP Technophage SA D05QXW HIGHSTAT Investigative D05RFC DRUG__ID D05RFC D05RFC DRUGCOMP Medbiocom D05RFC HIGHSTAT Investigative D05RFI DRUG__ID D05RFI D05RFI DRUGCOMP Quintessence Biosciences Inc D05RFI HIGHSTAT Investigative D05RKV DRUG__ID D05RKV D05RKV DRUGCOMP Schering-Plough Research Institute D05RKV HIGHSTAT Investigative D05RPT DRUG__ID D05RPT D05RPT DRUGCOMP Mercia Pharma Inc D05RPT HIGHSTAT Investigative D05RSS DRUG__ID D05RSS D05RSS DRUGCOMP Wyeth Research D05RSS HIGHSTAT Investigative D05RTB DRUG__ID D05RTB D05RTB DRUGCOMP Integrated BioTherapeutics Inc D05RTB HIGHSTAT Investigative D05RTX DRUG__ID D05RTX D05RTX DRUGCOMP Roche Bioscience D05RTX HIGHSTAT Investigative D05RWN DRUG__ID D05RWN D05RWN DRUGCOMP China Nuokang Bio-Pharmaceutical Inc D05RWN HIGHSTAT Investigative D05RZJ DRUG__ID D05RZJ D05RZJ DRUGCOMP Clarassance Inc D05RZJ HIGHSTAT Investigative D05SCQ DRUG__ID D05SCQ D05SCQ DRUGCOMP ALS Therapy Development Foundation Inc D05SCQ HIGHSTAT Investigative D05SEW DRUG__ID D05SEW D05SEW DRUGCOMP Queen's University at Kingston D05SEW HIGHSTAT Investigative D05SHQ DRUG__ID D05SHQ D05SHQ DRUGCOMP Asphelia Pharmaceuticals Inc D05SHQ HIGHSTAT Investigative D05SJD DRUG__ID D05SJD D05SJD DRUGCOMP MondoBIOTECH Holding AG D05SJD HIGHSTAT Investigative D05SJY DRUG__ID D05SJY D05SJY DRUGCOMP National Research Council of Canada D05SJY HIGHSTAT Investigative D05SMV DRUG__ID D05SMV D05SMV DRUGCOMP Pharma Two B Ltd D05SMV HIGHSTAT Investigative D05SOW DRUG__ID D05SOW D05SOW DRUGCOMP Serometrix LLC D05SOW HIGHSTAT Investigative D05SQU DRUG__ID D05SQU D05SQU DRUGCOMP Ipsen D05SQU HIGHSTAT Investigative D05SVN DRUG__ID D05SVN D05SVN DRUGCOMP Sanofi Pasteur D05SVN HIGHSTAT Investigative D05SXB DRUG__ID D05SXB D05SXB DRUGCOMP Summit Corp plc D05SXB HIGHSTAT Investigative D05SXT DRUG__ID D05SXT D05SXT DRUGCOMP Impel NeuroPharma D05SXT HIGHSTAT Investigative D05SYO DRUG__ID D05SYO D05SYO DRUGCOMP Korea Research Institute of Chemical Technology D05SYO HIGHSTAT Investigative D05TBI DRUG__ID D05TBI D05TBI DRUGCOMP DeveloGen AG D05TBI HIGHSTAT Investigative D05TCC DRUG__ID D05TCC D05TCC DRUGCOMP University of California San Diego D05TCC HIGHSTAT Investigative D05TLQ DRUG__ID D05TLQ D05TLQ DRUGCOMP ET Transplant Inc D05TLQ HIGHSTAT Investigative D05TPA DRUG__ID D05TPA D05TPA DRUGCOMP Supratek Pharma Inc D05TPA HIGHSTAT Investigative D05TUQ DRUG__ID D05TUQ D05TUQ DRUGCOMP MAT Biopharma D05TUQ HIGHSTAT Investigative D05TVI DRUG__ID D05TVI D05TVI DRUGCOMP TARIS Biomedical Inc D05TVI HIGHSTAT Investigative D05TXS DRUG__ID D05TXS D05TXS DRUGCOMP BioMarin Pharmaceutical Inc D05TXS HIGHSTAT Investigative D05UAA DRUG__ID D05UAA D05UAA DRUGCOMP Serometrix LLC D05UAA HIGHSTAT Investigative D05UDU DRUG__ID D05UDU D05UDU DRUGCOMP Georgetown University D05UDU HIGHSTAT Investigative D05UEF DRUG__ID D05UEF D05UEF DRUGCOMP Dharma Biomedical D05UEF HIGHSTAT Investigative D05UFN DRUG__ID D05UFN D05UFN DRUGCOMP PharmaNova Inc D05UFN HIGHSTAT Investigative D05UQF DRUG__ID D05UQF D05UQF DRUGCOMP NicOx SA D05UQF HIGHSTAT Investigative D05UTF DRUG__ID D05UTF D05UTF DRUGCOMP Scottish Biomedical Ltd D05UTF HIGHSTAT Investigative D05UVL DRUG__ID D05UVL D05UVL DRUGCOMP Snowdon Inc D05UVL HIGHSTAT Investigative D05VLB DRUG__ID D05VLB D05VLB DRUGCOMP Shantha Biotechnics PVT Ltd D05VLB HIGHSTAT Investigative D05VNX DRUG__ID D05VNX D05VNX DRUGCOMP Interprotein Corp D05VNX HIGHSTAT Investigative D05VVT DRUG__ID D05VVT D05VVT DRUGCOMP Harvard Medical School D05VVT HIGHSTAT Investigative D05VWK DRUG__ID D05VWK D05VWK DRUGCOMP Axcentua Pharmaceuticals D05VWK HIGHSTAT Investigative D05VWX DRUG__ID D05VWX D05VWX DRUGCOMP Compugen Ltd D05VWX HIGHSTAT Investigative D05WKH DRUG__ID D05WKH D05WKH DRUGCOMP TechnoVax Inc D05WKH HIGHSTAT Investigative D05WKT DRUG__ID D05WKT D05WKT DRUGCOMP Peakdale Molecular D05WKT HIGHSTAT Investigative D05WRB DRUG__ID D05WRB D05WRB DRUGCOMP Marinova Pty Ltd D05WRB HIGHSTAT Investigative D05WSD DRUG__ID D05WSD D05WSD DRUGCOMP IBio Inc D05WSD HIGHSTAT Investigative D05WUZ DRUG__ID D05WUZ D05WUZ DRUGCOMP Thrombotargets Corp D05WUZ HIGHSTAT Investigative D05WVO DRUG__ID D05WVO D05WVO DRUGCOMP BioLineRx Ltd D05WVO HIGHSTAT Investigative D05XCZ DRUG__ID D05XCZ D05XCZ DRUGCOMP Catena Pharmaceuticals Inc D05XCZ HIGHSTAT Investigative D05XFQ DRUG__ID D05XFQ D05XFQ DRUGCOMP NovaLead Pharma D05XFQ HIGHSTAT Investigative D05XKN DRUG__ID D05XKN D05XKN DRUGCOMP Allostera Pharma Inc D05XKN HIGHSTAT Investigative D05XXQ DRUG__ID D05XXQ D05XXQ DRUGCOMP Melior Pharmaceuticals Inc D05XXQ HIGHSTAT Investigative D05XYH DRUG__ID D05XYH D05XYH DRUGCOMP Medigreen Biotechnology Inc D05XYH HIGHSTAT Investigative D05YEL DRUG__ID D05YEL D05YEL DRUGCOMP Chiroscience R&D Ltd D05YEL HIGHSTAT Investigative D05YRG DRUG__ID D05YRG D05YRG DRUGCOMP ALS Therapy Development Foundation Inc D05YRG HIGHSTAT Investigative D05YWN DRUG__ID D05YWN D05YWN DRUGCOMP Gene Signal SAS D05YWN HIGHSTAT Investigative D05YYB DRUG__ID D05YYB D05YYB DRUGCOMP Acceleron Pharma Inc D05YYB HIGHSTAT Investigative D05YYK DRUG__ID D05YYK D05YYK DRUGCOMP Apeptico Forschung und Entwicklung GmbH D05YYK HIGHSTAT Investigative D05ZCZ DRUG__ID D05ZCZ D05ZCZ DRUGCOMP Essex Bio-Technology Ltd D05ZCZ HIGHSTAT Investigative D05ZDA DRUG__ID D05ZDA D05ZDA DRUGCOMP Acenta Discovery D05ZDA HIGHSTAT Investigative D05ZIT DRUG__ID D05ZIT D05ZIT DRUGCOMP EyeCyte Inc D05ZIT HIGHSTAT Investigative D05ZLH DRUG__ID D05ZLH D05ZLH DRUGCOMP Immutep SA D05ZLH HIGHSTAT Investigative D05ZNA DRUG__ID D05ZNA D05ZNA DRUGCOMP ESBATech AG D05ZNA HIGHSTAT Investigative D05ZVU DRUG__ID D05ZVU D05ZVU DRUGCOMP Angion Biomedica Corp D05ZVU HIGHSTAT Investigative D06ACI DRUG__ID D06ACI D06ACI DRUGCOMP Zhejiang University D06ACI HIGHSTAT Investigative D06AES DRUG__ID D06AES D06AES DRUGCOMP Boston Biomedical Inc D06AES HIGHSTAT Investigative D06AKC DRUG__ID D06AKC D06AKC DRUGCOMP Invivis Pharmaceuticals D06AKC HIGHSTAT Investigative D06AQP DRUG__ID D06AQP D06AQP DRUGCOMP Endocyte Inc D06AQP HIGHSTAT Investigative D06ARI DRUG__ID D06ARI D06ARI DRUGCOMP NovaBiotics Ltd D06ARI HIGHSTAT Investigative D06BBF DRUG__ID D06BBF D06BBF DRUGCOMP Bioalvo SA D06BBF HIGHSTAT Investigative D06BEX DRUG__ID D06BEX D06BEX DRUGCOMP Expression Genetics Inc D06BEX HIGHSTAT Investigative D06BGK DRUG__ID D06BGK D06BGK DRUGCOMP Integrated BioTherapeutics Inc D06BGK HIGHSTAT Investigative D06BJP DRUG__ID D06BJP D06BJP DRUGCOMP Nymox Pharmaceutical Corp D06BJP HIGHSTAT Investigative D06BKF DRUG__ID D06BKF D06BKF DRUGCOMP Polytherics Ltd D06BKF HIGHSTAT Investigative D06BTD DRUG__ID D06BTD D06BTD DRUGCOMP 4-Antibody AG D06BTD HIGHSTAT Investigative D06BUS DRUG__ID D06BUS D06BUS DRUGCOMP Phoenicia Biosciences Inc D06BUS HIGHSTAT Investigative D06BVI DRUG__ID D06BVI D06BVI DRUGTYPE Small molecule immunotherapy D06BVI HIGHSTAT Investigative D06CDP DRUG__ID D06CDP D06CDP DRUGCOMP MaxThera Inc D06CDP HIGHSTAT Investigative D06CFJ DRUG__ID D06CFJ D06CFJ DRUGCOMP University of Leeds D06CFJ HIGHSTAT Investigative D06CFZ DRUG__ID D06CFZ D06CFZ DRUGCOMP ARigen Pharmaceuticals Inc D06CFZ HIGHSTAT Investigative D06CML DRUG__ID D06CML D06CML DRUGCOMP NovaLead Pharma D06CML HIGHSTAT Investigative D06CSR DRUG__ID D06CSR D06CSR DRUGCOMP Creative Antibiotics Sweden AB D06CSR HIGHSTAT Investigative D06CWM DRUG__ID D06CWM D06CWM DRUGCOMP AstraZeneca plc D06CWM HIGHSTAT Investigative D06DMV DRUG__ID D06DMV D06DMV DRUGCOMP Eurapharm Inc D06DMV HIGHSTAT Investigative D06DPQ DRUG__ID D06DPQ D06DPQ DRUGCOMP AIM Therapeutics Inc D06DPQ HIGHSTAT Investigative D06DRU DRUG__ID D06DRU D06DRU DRUGCOMP BioAlliance Pharma SA D06DRU HIGHSTAT Investigative D06DZZ DRUG__ID D06DZZ D06DZZ DRUGCOMP University of Southern California D06DZZ HIGHSTAT Investigative D06EBU DRUG__ID D06EBU D06EBU DRUGCOMP Altus Pharmaceuticals Inc D06EBU HIGHSTAT Investigative D06ECM DRUG__ID D06ECM D06ECM DRUGCOMP University of North Carolina D06ECM HIGHSTAT Investigative D06EEM DRUG__ID D06EEM D06EEM DRUGCOMP Jenrin Discovery Inc D06EEM HIGHSTAT Investigative D06EIM DRUG__ID D06EIM D06EIM DRUGCOMP Arbovax Inc D06EIM HIGHSTAT Investigative D06EIY DRUG__ID D06EIY D06EIY DRUGCOMP Anza Therapeutics Inc D06EIY HIGHSTAT Investigative D06ENH DRUG__ID D06ENH D06ENH DRUGCOMP CoNCERT Pharmaceuticals Inc D06ENH HIGHSTAT Investigative D06ENR DRUG__ID D06ENR D06ENR DRUGCOMP Human Genome Sciences Inc D06ENR HIGHSTAT Investigative D06EUC DRUG__ID D06EUC D06EUC DRUGCOMP PolyMedix Inc D06EUC HIGHSTAT Investigative D06EWW DRUG__ID D06EWW D06EWW DRUGCOMP GLSynthesis Inc D06EWW HIGHSTAT Investigative D06EYQ DRUG__ID D06EYQ D06EYQ DRUGCOMP ALS Therapy Development Foundation Inc D06EYQ HIGHSTAT Investigative D06FEQ DRUG__ID D06FEQ D06FEQ DRUGCOMP Wellstat ImmunoTherapeutics LLC D06FEQ HIGHSTAT Investigative D06FGM DRUG__ID D06FGM D06FGM DRUGCOMP Kamada Ltd D06FGM HIGHSTAT Investigative D06FOA DRUG__ID D06FOA D06FOA DRUGCOMP Affinergy Inc D06FOA HIGHSTAT Investigative D06FSV DRUG__ID D06FSV D06FSV DRUGCOMP Onco-D Therapeutics Inc D06FSV HIGHSTAT Investigative D06FTY DRUG__ID D06FTY D06FTY DRUGCOMP CisThera Inc D06FTY HIGHSTAT Investigative D06FUQ DRUG__ID D06FUQ D06FUQ DRUGCOMP Meta-IQ Aps D06FUQ HIGHSTAT Investigative D06GAQ DRUG__ID D06GAQ D06GAQ DRUGCOMP Silence Therapeutics plc D06GAQ HIGHSTAT Investigative D06GMM DRUG__ID D06GMM D06GMM DRUGCOMP Fibrotech Therapeutics Pty Ltd D06GMM HIGHSTAT Investigative D06GZW DRUG__ID D06GZW D06GZW DRUGCOMP Ambrx Inc D06GZW HIGHSTAT Investigative D06HGM DRUG__ID D06HGM D06HGM DRUGCOMP Laila Pharmaceuticals Pvt Ltd D06HGM HIGHSTAT Investigative D06HGO DRUG__ID D06HGO D06HGO DRUGCOMP Midway Pharmaceuticals Inc D06HGO HIGHSTAT Investigative D06HGY DRUG__ID D06HGY D06HGY DRUGCOMP Dartmouth College D06HGY HIGHSTAT Investigative D06HUH DRUG__ID D06HUH D06HUH DRUGCOMP Plant Vax Inc D06HUH HIGHSTAT Investigative D06HWU DRUG__ID D06HWU D06HWU DRUGCOMP Chroma Therapeutics Ltd D06HWU HIGHSTAT Investigative D06ICE DRUG__ID D06ICE D06ICE DRUGCOMP ImaginAb Inc D06ICE HIGHSTAT Investigative D06IGC DRUG__ID D06IGC D06IGC DRUGCOMP Arch Biopartners Inc D06IGC HIGHSTAT Investigative D06IGE DRUG__ID D06IGE D06IGE DRUGCOMP Amunix Inc D06IGE HIGHSTAT Investigative D06IZS DRUG__ID D06IZS D06IZS DRUGCOMP Xel Pharmaceuticals Inc D06IZS HIGHSTAT Investigative D06JHN DRUG__ID D06JHN D06JHN DRUGCOMP Vacciguard Ltd D06JHN HIGHSTAT Investigative D06JKV DRUG__ID D06JKV D06JKV DRUGCOMP Johns Hopkins University D06JKV HIGHSTAT Investigative D06JLQ DRUG__ID D06JLQ D06JLQ DRUGCOMP Kineta Inc D06JLQ HIGHSTAT Investigative D06JQM DRUG__ID D06JQM D06JQM DRUGCOMP Locus Pharmaceuticals Inc D06JQM HIGHSTAT Investigative D06KCM DRUG__ID D06KCM D06KCM DRUGCOMP Abiogen Pharma SpA D06KCM HIGHSTAT Investigative D06KGC DRUG__ID D06KGC D06KGC DRUGCOMP Universitat Wurzburg D06KGC HIGHSTAT Investigative D06KKL DRUG__ID D06KKL D06KKL DRUGCOMP Lipoxen plc D06KKL HIGHSTAT Investigative D06KOR DRUG__ID D06KOR D06KOR DRUGCOMP SWITCH Biotech LLC D06KOR HIGHSTAT Investigative D06KSA DRUG__ID D06KSA D06KSA DRUGCOMP Tosk Inc D06KSA HIGHSTAT Investigative D06KTF DRUG__ID D06KTF D06KTF DRUGCOMP HanAll Biopharma Co Ltd D06KTF HIGHSTAT Investigative D06LAX DRUG__ID D06LAX D06LAX DRUGCOMP Acenta Discovery D06LAX HIGHSTAT Investigative D06LCW DRUG__ID D06LCW D06LCW DRUGCOMP Kinentia Biosciences LLC D06LCW HIGHSTAT Investigative D06LEC DRUG__ID D06LEC D06LEC DRUGCOMP Lipideon Biotechnology AG D06LEC HIGHSTAT Investigative D06LGZ DRUG__ID D06LGZ D06LGZ DRUGCOMP Endocrine Technology LLC D06LGZ HIGHSTAT Investigative D06LHI DRUG__ID D06LHI D06LHI DRUGCOMP Gambro AB D06LHI HIGHSTAT Investigative D06LJG DRUG__ID D06LJG D06LJG DRUGCOMP Burke Pharmaceuticals LLC D06LJG HIGHSTAT Investigative D06LKA DRUG__ID D06LKA D06LKA DRUGCOMP L2 Diagnostics Llc D06LKA HIGHSTAT Investigative D06LKP DRUG__ID D06LKP D06LKP DRUGCOMP Osiris Therapeutics Inc D06LKP HIGHSTAT Investigative D06LRQ DRUG__ID D06LRQ D06LRQ DRUGCOMP The Open University D06LRQ HIGHSTAT Investigative D06MBR DRUG__ID D06MBR D06MBR DRUGCOMP AC Immune SA D06MBR HIGHSTAT Investigative D06MCH DRUG__ID D06MCH D06MCH DRUGCOMP Transgene SA D06MCH HIGHSTAT Investigative D06MDT DRUG__ID D06MDT D06MDT DRUGCOMP InVasc Therapeutics Inc D06MDT HIGHSTAT Investigative D06MEC DRUG__ID D06MEC D06MEC DRUGCOMP Theralpha SAS D06MEC HIGHSTAT Investigative D06MOB DRUG__ID D06MOB D06MOB DRUGCOMP Western States Biopharmaceuticals D06MOB HIGHSTAT Investigative D06MPJ DRUG__ID D06MPJ D06MPJ DRUGCOMP Mayo Foundation D06MPJ HIGHSTAT Investigative D06MQW DRUG__ID D06MQW D06MQW DRUGCOMP Gemmus Pharma Inc D06MQW HIGHSTAT Investigative D06MRR DRUG__ID D06MRR D06MRR DRUGCOMP Pharmagenesis Inc D06MRR HIGHSTAT Investigative D06MRS DRUG__ID D06MRS D06MRS DRUGCOMP NeuroSearch A/S D06MRS HIGHSTAT Investigative D06MTH DRUG__ID D06MTH D06MTH DRUGCOMP Kinentia Biosciences LLC D06MTH HIGHSTAT Investigative D06MUB DRUG__ID D06MUB D06MUB DRUGCOMP National Cancer Institute D06MUB HIGHSTAT Investigative D06MWU DRUG__ID D06MWU D06MWU DRUGCOMP Leiden; Amsterdam Center for Drug Research D06MWU HIGHSTAT Investigative D06MXB DRUG__ID D06MXB D06MXB DRUGCOMP Instituto Biomar SA D06MXB HIGHSTAT Investigative D06NJB DRUG__ID D06NJB D06NJB DRUGCOMP Amira Pharmaceuticals Inc D06NJB HIGHSTAT Investigative D06NLP DRUG__ID D06NLP D06NLP DRUGCOMP China Medical University Hospital D06NLP HIGHSTAT Investigative D06NMY DRUG__ID D06NMY D06NMY DRUGCOMP Medicon Inc D06NMY HIGHSTAT Investigative D06NVN DRUG__ID D06NVN D06NVN DRUGCOMP Bristol-Myers Squibb Co D06NVN HIGHSTAT Investigative D06OFJ DRUG__ID D06OFJ D06OFJ DRUGCOMP Nereus Pharmaceuticals Inc D06OFJ HIGHSTAT Investigative D06OMH DRUG__ID D06OMH D06OMH DRUGCOMP SemBioSys Genetics Inc D06OMH HIGHSTAT Investigative D06OUT DRUG__ID D06OUT D06OUT DRUGCOMP Angion Biomedica Corp D06OUT HIGHSTAT Investigative D06OUW DRUG__ID D06OUW D06OUW DRUGCOMP Planet Biotechnology Inc D06OUW HIGHSTAT Investigative D06OVM DRUG__ID D06OVM D06OVM DRUGCOMP Kyowa Hakko Kogyo Co Ltd D06OVM HIGHSTAT Investigative D06OWF DRUG__ID D06OWF D06OWF DRUGCOMP Ontario Inc D06OWF HIGHSTAT Investigative D06PFK DRUG__ID D06PFK D06PFK DRUGCOMP Idea AG D06PFK HIGHSTAT Investigative D06PJK DRUG__ID D06PJK D06PJK THERCLAS Analgesics D06PJK HIGHSTAT Investigative D06PKL DRUG__ID D06PKL D06PKL DRUGCOMP Bradford Pharma Ltd D06PKL HIGHSTAT Investigative D06PVN DRUG__ID D06PVN D06PVN DRUGCOMP Pharmagene plc D06PVN HIGHSTAT Investigative D06QCE DRUG__ID D06QCE D06QCE DRUGCOMP BeiGene D06QCE HIGHSTAT Investigative D06QEW DRUG__ID D06QEW D06QEW DRUGCOMP Charlesson LLC D06QEW HIGHSTAT Investigative D06QIP DRUG__ID D06QIP D06QIP DRUGCOMP PharmaNova Inc D06QIP HIGHSTAT Investigative D06QIW DRUG__ID D06QIW D06QIW DRUGCOMP AplaGen GmbH D06QIW HIGHSTAT Investigative D06QJG DRUG__ID D06QJG D06QJG DRUGCOMP The Procter & Gamble Co D06QJG HIGHSTAT Investigative D06QMA DRUG__ID D06QMA D06QMA DRUGCOMP Merck & Co Inc D06QMA HIGHSTAT Investigative D06QOD DRUG__ID D06QOD D06QOD DRUGCOMP Celltrion Inc D06QOD HIGHSTAT Investigative D06QUY DRUG__ID D06QUY D06QUY DRUGCOMP C&O Pharmaceutical Technology (Holdings) Ltd D06QUY HIGHSTAT Investigative D06RUD DRUG__ID D06RUD D06RUD DRUGCOMP Fibrotech Therapeutics Pty Ltd D06RUD HIGHSTAT Investigative D06RYG DRUG__ID D06RYG D06RYG DRUGCOMP ISA Pharmaceuticals BV D06RYG HIGHSTAT Investigative D06RYU DRUG__ID D06RYU D06RYU DRUGCOMP Molteni Therapeutics Srl D06RYU HIGHSTAT Investigative D06RZQ DRUG__ID D06RZQ D06RZQ DRUGCOMP Human Genome Sciences Inc D06RZQ HIGHSTAT Investigative D06SEA DRUG__ID D06SEA D06SEA DRUGCOMP Cylene Pharmaceuticals Inc D06SEA HIGHSTAT Investigative D06SEL DRUG__ID D06SEL D06SEL DRUGCOMP Korea Research Institute of Chemical Technology D06SEL HIGHSTAT Investigative D06SMP DRUG__ID D06SMP D06SMP DRUGCOMP Summit Corp plc D06SMP HIGHSTAT Investigative D06SMU DRUG__ID D06SMU D06SMU DRUGCOMP Summit Corp plc D06SMU HIGHSTAT Investigative D06SRB DRUG__ID D06SRB D06SRB DRUGCOMP Califia Bio Inc D06SRB HIGHSTAT Investigative D06SYA DRUG__ID D06SYA D06SYA DRUGCOMP MaxThera Inc D06SYA HIGHSTAT Investigative D06TAR DRUG__ID D06TAR D06TAR DRUGCOMP Hokkaido University D06TAR HIGHSTAT Investigative D06TLK DRUG__ID D06TLK D06TLK DRUGCOMP Epiphany Biosciences D06TLK HIGHSTAT Investigative D06TMH DRUG__ID D06TMH D06TMH DRUGCOMP Human Genome Sciences Inc D06TMH HIGHSTAT Investigative D06TVU DRUG__ID D06TVU D06TVU DRUGCOMP Quro Science Inc D06TVU HIGHSTAT Investigative D06UJD DRUG__ID D06UJD D06UJD DRUGCOMP Shanghai Sunway Biotech Co Ltd D06UJD HIGHSTAT Investigative D06UNW DRUG__ID D06UNW D06UNW DRUGCOMP ImVisioN Therapeutics Inc D06UNW HIGHSTAT Investigative D06UPW DRUG__ID D06UPW D06UPW DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D06UPW HIGHSTAT Investigative D06URK DRUG__ID D06URK D06URK DRUGCOMP Chong Kun Dang Pharmaceutical Corp D06URK HIGHSTAT Investigative D06UUE DRUG__ID D06UUE D06UUE DRUGCOMP RegenX Biosciences LLC D06UUE HIGHSTAT Investigative D06UUU DRUG__ID D06UUU D06UUU DRUGCOMP BEXEL Pharmaceuticals Inc D06UUU HIGHSTAT Investigative D06UVZ DRUG__ID D06UVZ D06UVZ DRUGCOMP Destiny Pharma Ltd D06UVZ HIGHSTAT Investigative D06UZS DRUG__ID D06UZS D06UZS DRUGCOMP ViDA Therapeutics Inc D06UZS HIGHSTAT Investigative D06VCJ DRUG__ID D06VCJ D06VCJ DRUGCOMP Anjin Group Inc D06VCJ HIGHSTAT Investigative D06VFI DRUG__ID D06VFI D06VFI DRUGCOMP Protect Pharmaceuticals Corp D06VFI HIGHSTAT Investigative D06VIZ DRUG__ID D06VIZ D06VIZ DRUGCOMP University of Southern California D06VIZ HIGHSTAT Investigative D06VPT DRUG__ID D06VPT D06VPT DRUGCOMP ALS Therapy Development Foundation Inc D06VPT HIGHSTAT Investigative D06VRS DRUG__ID D06VRS D06VRS DRUGCOMP Cardion AG D06VRS HIGHSTAT Investigative D06VTL DRUG__ID D06VTL D06VTL DRUGCOMP Zeria Pharmaceutical Co Ltd D06VTL HIGHSTAT Investigative D06VXE DRUG__ID D06VXE D06VXE DRUGCOMP Alios BioPharma Inc D06VXE HIGHSTAT Investigative D06WAA DRUG__ID D06WAA D06WAA DRUGCOMP CK Life Sciences International Holdings Inc D06WAA HIGHSTAT Investigative D06WCW DRUG__ID D06WCW D06WCW DRUGCOMP UCB SA D06WCW HIGHSTAT Investigative D06WDT DRUG__ID D06WDT D06WDT DRUGCOMP Bayer AG D06WDT HIGHSTAT Investigative D06WLG DRUG__ID D06WLG D06WLG DRUGCOMP GeneCopoeia Inc D06WLG HIGHSTAT Investigative D06WLY DRUG__ID D06WLY D06WLY DRUGCOMP Wellstat Therapeutics Corp D06WLY HIGHSTAT Investigative D06WRY DRUG__ID D06WRY D06WRY DRUGCOMP NanoForm Cardiovascular Therapeutics Ltd D06WRY HIGHSTAT Investigative D06WSG DRUG__ID D06WSG D06WSG DRUGCOMP Applied Protein Sciences LLC D06WSG HIGHSTAT Investigative D06WTI DRUG__ID D06WTI D06WTI DRUGCOMP Shire Pharmaceuticals D06WTI HIGHSTAT Investigative D06WXS DRUG__ID D06WXS D06WXS DRUGCOMP Epitomics Inc D06WXS HIGHSTAT Investigative D06WYG DRUG__ID D06WYG D06WYG DRUGCOMP Molecular Insight Pharmaceuticals Inc D06WYG HIGHSTAT Investigative D06WZQ DRUG__ID D06WZQ D06WZQ DRUGCOMP Laila Pharmaceuticals Pvt Ltd D06WZQ HIGHSTAT Investigative D06XBG DRUG__ID D06XBG D06XBG DRUGCOMP Molecular Insight Pharmaceuticals Inc D06XBG HIGHSTAT Investigative D06XIX DRUG__ID D06XIX D06XIX DRUGCOMP Intrexon Corp D06XIX HIGHSTAT Investigative D06XIZ DRUG__ID D06XIZ D06XIZ DRUGCOMP Hormos Medical Corp D06XIZ HIGHSTAT Investigative D06XLC DRUG__ID D06XLC D06XLC DRUGCOMP Bristol-Myers Squibb Co D06XLC HIGHSTAT Investigative D06XME DRUG__ID D06XME D06XME DRUGCOMP Thrombotargets Corp D06XME HIGHSTAT Investigative D06XNW DRUG__ID D06XNW D06XNW DRUGCOMP Niiki Pharma Inc D06XNW HIGHSTAT Investigative D06XPX DRUG__ID D06XPX D06XPX DRUGCOMP Ceregene Inc D06XPX HIGHSTAT Investigative D06XXA DRUG__ID D06XXA D06XXA DRUGCOMP European Malaria Vaccine Initiative D06XXA HIGHSTAT Investigative D06XXD DRUG__ID D06XXD D06XXD DRUGCOMP Indigene Pharmaceuticals Inc D06XXD HIGHSTAT Investigative D06YAI DRUG__ID D06YAI D06YAI DRUGCOMP SOM Biotech SL D06YAI HIGHSTAT Investigative D06YAK DRUG__ID D06YAK D06YAK DRUGCOMP University of Milan D06YAK HIGHSTAT Investigative D06YMT DRUG__ID D06YMT D06YMT DRUGCOMP Plexxikon Inc D06YMT HIGHSTAT Investigative D06YNK DRUG__ID D06YNK D06YNK DRUGCOMP Telios Pharmaceuticals Inc D06YNK HIGHSTAT Investigative D06YSK DRUG__ID D06YSK D06YSK DRUGCOMP Genmab A/S D06YSK HIGHSTAT Investigative D06YTE DRUG__ID D06YTE D06YTE DRUGCOMP NOXXON Pharma AG D06YTE HIGHSTAT Investigative D06YWA DRUG__ID D06YWA D06YWA DRUGCOMP Biovista Inc D06YWA HIGHSTAT Investigative D06YYY DRUG__ID D06YYY D06YYY DRUGCOMP Karus Therapeutics Ltd D06YYY HIGHSTAT Investigative D06ZAK DRUG__ID D06ZAK D06ZAK DRUGCOMP POZEN Inc D06ZAK HIGHSTAT Investigative D06ZCH DRUG__ID D06ZCH D06ZCH DRUGCOMP Mayo Foundation D06ZCH HIGHSTAT Investigative D06ZIL DRUG__ID D06ZIL D06ZIL DRUGCOMP CT Atlantic AG D06ZIL HIGHSTAT Investigative D06ZIS DRUG__ID D06ZIS D06ZIS DRUGCOMP Signum Biosciences Inc D06ZIS HIGHSTAT Investigative D06ZME DRUG__ID D06ZME D06ZME DRUGCOMP Artielle ImmunoTherapeutics Inc D06ZME HIGHSTAT Investigative D06ZXT DRUG__ID D06ZXT D06ZXT DRUGCOMP N30 Pharmaceuticals LLC D06ZXT HIGHSTAT Investigative D07ACP DRUG__ID D07ACP D07ACP DRUGCOMP JW Pharmaceutical Corp D07ACP HIGHSTAT Investigative D07AFK DRUG__ID D07AFK D07AFK DRUGCOMP AnaptysBio Inc D07AFK HIGHSTAT Investigative D07APX DRUG__ID D07APX D07APX THERCLAS Analgesics D07APX HIGHSTAT Investigative D07BAE DRUG__ID D07BAE D07BAE DRUGCOMP Sun Pharmaceutical Advanced Research Co Ltd D07BAE HIGHSTAT Investigative D07BLC DRUG__ID D07BLC D07BLC DRUGCOMP Amsterdam Molecular Therapeutics BV D07BLC HIGHSTAT Investigative D07BNL DRUG__ID D07BNL D07BNL DRUGCOMP Nanovector Ltd D07BNL HIGHSTAT Investigative D07BWU DRUG__ID D07BWU D07BWU DRUGCOMP PolyMedix Inc D07BWU HIGHSTAT Investigative D07CBY DRUG__ID D07CBY D07CBY DRUGCOMP VentriNova Inc D07CBY HIGHSTAT Investigative D07CIX DRUG__ID D07CIX D07CIX DRUGCOMP Femta Pharmaceuticals Inc D07CIX HIGHSTAT Investigative D07CNF DRUG__ID D07CNF D07CNF DRUGCOMP Medexgen Co Ltd D07CNF HIGHSTAT Investigative D07CUU DRUG__ID D07CUU D07CUU DRUGCOMP IGE Therapeutics Inc D07CUU HIGHSTAT Investigative D07DDK DRUG__ID D07DDK D07DDK DRUGCOMP Human Genome Sciences Inc D07DDK HIGHSTAT Investigative D07DGR DRUG__ID D07DGR D07DGR DRUGCOMP Selvita Life Sciences Solutions D07DGR HIGHSTAT Investigative D07DIS DRUG__ID D07DIS D07DIS DRUGCOMP Green Cross Corp D07DIS HIGHSTAT Investigative D07DQZ DRUG__ID D07DQZ D07DQZ DRUGCOMP Attogen Inc D07DQZ HIGHSTAT Investigative D07DRO DRUG__ID D07DRO D07DRO DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D07DRO HIGHSTAT Investigative D07DSK DRUG__ID D07DSK D07DSK DRUGCOMP BiPar Sciences Inc D07DSK HIGHSTAT Investigative D07DZT DRUG__ID D07DZT D07DZT DRUGCOMP Nagoya City University D07DZT HIGHSTAT Investigative D07ELC DRUG__ID D07ELC D07ELC DRUGCOMP Abraxis BioScience Inc D07ELC HIGHSTAT Investigative D07ENH DRUG__ID D07ENH D07ENH DRUGCOMP INSERM D07ENH HIGHSTAT Investigative D07FCA DRUG__ID D07FCA D07FCA DRUGCOMP NatImmune A/S D07FCA HIGHSTAT Investigative D07FIF DRUG__ID D07FIF D07FIF DRUGCOMP Boston University D07FIF HIGHSTAT Investigative D07FQS DRUG__ID D07FQS D07FQS DRUGCOMP Zambon Co SpA D07FQS HIGHSTAT Investigative D07FUH DRUG__ID D07FUH D07FUH DRUGCOMP Lipocine Inc D07FUH HIGHSTAT Investigative D07FUO DRUG__ID D07FUO D07FUO DRUGCOMP Activus Pharma Co Ltd D07FUO HIGHSTAT Investigative D07FYK DRUG__ID D07FYK D07FYK DRUGCOMP Genmab A/S D07FYK HIGHSTAT Investigative D07GET DRUG__ID D07GET D07GET DRUGCOMP Altus Pharmaceuticals Inc D07GET HIGHSTAT Investigative D07GFZ DRUG__ID D07GFZ D07GFZ DRUGCOMP Vivozon Inc D07GFZ HIGHSTAT Investigative D07GGQ DRUG__ID D07GGQ D07GGQ DRUGCOMP NeED Pharmaceuticals Srl D07GGQ HIGHSTAT Investigative D07GGT DRUG__ID D07GGT D07GGT DRUGCOMP Novo Nordisk A/S D07GGT HIGHSTAT Investigative D07GKS DRUG__ID D07GKS D07GKS DRUGCOMP Eureka Therapeutics Inc D07GKS HIGHSTAT Investigative D07GOY DRUG__ID D07GOY D07GOY DRUGCOMP Tufts University School of Medicine D07GOY HIGHSTAT Investigative D07GVE DRUG__ID D07GVE D07GVE DRUGCOMP BioLineRx Ltd D07GVE HIGHSTAT Investigative D07GYP DRUG__ID D07GYP D07GYP DRUGCOMP Virogenomics Inc D07GYP HIGHSTAT Investigative D07GZG DRUG__ID D07GZG D07GZG DRUGCOMP University of Bristol D07GZG HIGHSTAT Investigative D07IGQ DRUG__ID D07IGQ D07IGQ DRUGCOMP Virionics Corp D07IGQ HIGHSTAT Investigative D07INU DRUG__ID D07INU D07INU DRUGCOMP Sirtris Pharmaceuticals Inc D07INU HIGHSTAT Investigative D07ISD DRUG__ID D07ISD D07ISD DRUGCOMP Albany Medical College D07ISD HIGHSTAT Investigative D07IYC DRUG__ID D07IYC D07IYC DRUGCOMP ALS Therapy Development Foundation Inc D07IYC HIGHSTAT Investigative D07IZP DRUG__ID D07IZP D07IZP DRUGCOMP NeED Pharmaceuticals Srl D07IZP HIGHSTAT Investigative D07JCU DRUG__ID D07JCU D07JCU DRUGCOMP Pieris AG D07JCU HIGHSTAT Investigative D07JDR DRUG__ID D07JDR D07JDR DRUGCOMP Largren Ltd D07JDR HIGHSTAT Investigative D07JFU DRUG__ID D07JFU D07JFU DRUGCOMP Compugen Ltd D07JFU HIGHSTAT Investigative D07JMX DRUG__ID D07JMX D07JMX DRUGCOMP Xenon Pharmaceuticals Inc D07JMX HIGHSTAT Investigative D07JPL DRUG__ID D07JPL D07JPL DRUGCOMP Revance Therapeutics Inc D07JPL HIGHSTAT Investigative D07JUL DRUG__ID D07JUL D07JUL DRUGCOMP JCR Pharmaceuticals Co Ltd D07JUL HIGHSTAT Investigative D07JXR DRUG__ID D07JXR D07JXR DRUGCOMP Institute of Medicinal Molecular Design Inc D07JXR HIGHSTAT Investigative D07KGV DRUG__ID D07KGV D07KGV DRUGCOMP UAI D07KGV HIGHSTAT Investigative D07KIB DRUG__ID D07KIB D07KIB DRUGCOMP Chinoin Gyogyszer Es Vegyeszeti D07KIB HIGHSTAT Investigative D07KMA DRUG__ID D07KMA D07KMA DRUGCOMP Boston University D07KMA HIGHSTAT Investigative D07KMI DRUG__ID D07KMI D07KMI DRUGCOMP M.V. Lomonosov Moscow State University D07KMI HIGHSTAT Investigative D07KVD DRUG__ID D07KVD D07KVD DRUGCOMP ArGEN-X BV D07KVD HIGHSTAT Investigative D07KYI DRUG__ID D07KYI D07KYI DRUGCOMP Taiga Biotechnologies Inc D07KYI HIGHSTAT Investigative D07KYK DRUG__ID D07KYK D07KYK DRUGCOMP Boston University D07KYK HIGHSTAT Investigative D07KYZ DRUG__ID D07KYZ D07KYZ DRUGCOMP Addex Pharmaceuticals SA D07KYZ HIGHSTAT Investigative D07LBP DRUG__ID D07LBP D07LBP DRUGCOMP NanoViricides Inc D07LBP HIGHSTAT Investigative D07LFJ DRUG__ID D07LFJ D07LFJ DRUGCOMP University of Texas Health Science Center San Antonio D07LFJ HIGHSTAT Investigative D07LGU DRUG__ID D07LGU D07LGU DRUGCOMP MD Anderson Cancer Center D07LGU HIGHSTAT Investigative D07LJR DRUG__ID D07LJR D07LJR DRUGCOMP Central Drug Research Institute D07LJR HIGHSTAT Investigative D07LLI DRUG__ID D07LLI D07LLI DRUGCOMP GlycoMar Ltd D07LLI HIGHSTAT Investigative D07LRB DRUG__ID D07LRB D07LRB DRUGCOMP Amunix Inc D07LRB HIGHSTAT Investigative D07LSU DRUG__ID D07LSU D07LSU DRUGCOMP Central Drug Research Institute D07LSU HIGHSTAT Investigative D07LSV DRUG__ID D07LSV D07LSV DRUGCOMP Senju Pharmaceutical Co Ltd D07LSV HIGHSTAT Investigative D07MBQ DRUG__ID D07MBQ D07MBQ DRUGCOMP Centocor Ortho Biotech Inc D07MBQ HIGHSTAT Investigative D07MFY DRUG__ID D07MFY D07MFY DRUGCOMP University of California San Francisco D07MFY HIGHSTAT Investigative D07MHM DRUG__ID D07MHM D07MHM DRUGCOMP Psimei Pharmaceuticals plc D07MHM HIGHSTAT Investigative D07MLA DRUG__ID D07MLA D07MLA DRUGCOMP Center for Genetic Engineering and Biotechnology D07MLA HIGHSTAT Investigative D07MLP DRUG__ID D07MLP D07MLP DRUGCOMP Apeiron Biologics GmbH D07MLP HIGHSTAT Investigative D07MMC DRUG__ID D07MMC D07MMC DRUGCOMP Sirnaomics Inc D07MMC HIGHSTAT Investigative D07MOK DRUG__ID D07MOK D07MOK DRUGCOMP Morphotek Inc D07MOK HIGHSTAT Investigative D07MQY DRUG__ID D07MQY D07MQY DRUGCOMP Immunomic Therapeutics Inc D07MQY HIGHSTAT Investigative D07MSL DRUG__ID D07MSL D07MSL DRUGCOMP Taxolog Inc D07MSL HIGHSTAT Investigative D07MUS DRUG__ID D07MUS D07MUS DRUGCOMP Jericho Sciences LLC D07MUS HIGHSTAT Investigative D07MUT DRUG__ID D07MUT D07MUT DRUGCOMP ALS Therapy Development Foundation Inc D07MUT HIGHSTAT Investigative D07NCC DRUG__ID D07NCC D07NCC DRUGCOMP Genyous Biomed International Inc D07NCC HIGHSTAT Investigative D07NDK DRUG__ID D07NDK D07NDK DRUGCOMP Wyeth D07NDK HIGHSTAT Investigative D07NEE DRUG__ID D07NEE D07NEE DRUGCOMP AEterna Zentaris Inc D07NEE HIGHSTAT Investigative D07NFT DRUG__ID D07NFT D07NFT DRUGCOMP Piramal Life Sciences Ltd D07NFT HIGHSTAT Investigative D07NUH DRUG__ID D07NUH D07NUH DRUGCOMP Idenix Pharmaceuticals Inc D07NUH HIGHSTAT Investigative D07NUZ DRUG__ID D07NUZ D07NUZ DRUGCOMP State University of New York Stony Brook D07NUZ HIGHSTAT Investigative D07NWZ DRUG__ID D07NWZ D07NWZ DRUGCOMP Chlorion Pharma Inc D07NWZ HIGHSTAT Investigative D07OBK DRUG__ID D07OBK D07OBK DRUGCOMP Stemline Therapeutics Inc D07OBK HIGHSTAT Investigative D07OCM DRUG__ID D07OCM D07OCM DRUGCOMP Dendright Pty Ltd D07OCM HIGHSTAT Investigative D07OED DRUG__ID D07OED D07OED DRUGCOMP Hebrew University of Jerusalem D07OED HIGHSTAT Investigative D07OQJ DRUG__ID D07OQJ D07OQJ DRUGCOMP University of California Los Angeles D07OQJ HIGHSTAT Investigative D07OTU DRUG__ID D07OTU D07OTU DRUGCOMP Nyxis Neurotherapies Inc D07OTU HIGHSTAT Investigative D07OYT DRUG__ID D07OYT D07OYT DRUGCOMP NeoPharm Co Ltd D07OYT HIGHSTAT Investigative D07OZO DRUG__ID D07OZO D07OZO DRUGCOMP MabPrex Inc D07OZO HIGHSTAT Investigative D07PMH DRUG__ID D07PMH D07PMH DRUGCOMP Vect-Horus D07PMH HIGHSTAT Investigative D07PNQ DRUG__ID D07PNQ D07PNQ DRUGCOMP Trillium Therapeutics Inc D07PNQ HIGHSTAT Investigative D07POY DRUG__ID D07POY D07POY DRUGCOMP CoDa Therapeutics (NZ) Ltd D07POY HIGHSTAT Investigative D07PQO DRUG__ID D07PQO D07PQO DRUGCOMP RAPID Pharmaceuticals AG D07PQO HIGHSTAT Investigative D07PRA DRUG__ID D07PRA D07PRA DRUGCOMP Ultragenyx Pharmaceutical D07PRA HIGHSTAT Investigative D07PVT DRUG__ID D07PVT D07PVT DRUGCOMP NovaBay Pharmaceuticals Inc D07PVT HIGHSTAT Investigative D07QBJ DRUG__ID D07QBJ D07QBJ DRUGCOMP St Johns University D07QBJ HIGHSTAT Investigative D07QNH DRUG__ID D07QNH D07QNH DRUGTYPE Antibody D07QNH HIGHSTAT Investigative D07QVY DRUG__ID D07QVY D07QVY DRUGCOMP Seoul National University D07QVY HIGHSTAT Investigative D07QZO DRUG__ID D07QZO D07QZO DRUGCOMP RegenX Biosciences LLC D07QZO HIGHSTAT Investigative D07RIE DRUG__ID D07RIE D07RIE DRUGCOMP BioChemics Inc D07RIE HIGHSTAT Investigative D07RME DRUG__ID D07RME D07RME DRUGCOMP Genovax Srl D07RME HIGHSTAT Investigative D07RPC DRUG__ID D07RPC D07RPC DRUGCOMP RAPID Laboratories Inc D07RPC HIGHSTAT Investigative D07RPK DRUG__ID D07RPK D07RPK DRUGCOMP Nissan Chemical Industries Ltd D07RPK HIGHSTAT Investigative D07RUR DRUG__ID D07RUR D07RUR DRUGCOMP Helix BioMedix Inc D07RUR HIGHSTAT Investigative D07RXM DRUG__ID D07RXM D07RXM DRUGCOMP Hanmi Pharmaceutical Co Ltd D07RXM HIGHSTAT Investigative D07RXX DRUG__ID D07RXX D07RXX DRUGCOMP Human Genome Sciences Inc D07RXX HIGHSTAT Investigative D07SBX DRUG__ID D07SBX D07SBX DRUGCOMP Nexigen GmbH D07SBX HIGHSTAT Investigative D07SDT DRUG__ID D07SDT D07SDT DRUGCOMP High Point Pharmaceuticals Llc D07SDT HIGHSTAT Investigative D07SEZ DRUG__ID D07SEZ D07SEZ DRUGCOMP Human Genome Sciences Inc D07SEZ HIGHSTAT Investigative D07SHZ DRUG__ID D07SHZ D07SHZ DRUGCOMP Critical Outcome Technologies Inc D07SHZ HIGHSTAT Investigative D07SNN DRUG__ID D07SNN D07SNN DRUGCOMP ShigaMediX D07SNN HIGHSTAT Investigative D07SOJ DRUG__ID D07SOJ D07SOJ DRUGCOMP Digna Biotech SL D07SOJ HIGHSTAT Investigative D07SRN DRUG__ID D07SRN D07SRN DRUGCOMP Debiopharm SA D07SRN HIGHSTAT Investigative D07SXG DRUG__ID D07SXG D07SXG DRUGCOMP Portola Pharmaceuticals Inc D07SXG HIGHSTAT Investigative D07TBD DRUG__ID D07TBD D07TBD DRUGCOMP Domain Therapeutics SA D07TBD HIGHSTAT Investigative D07TEE DRUG__ID D07TEE D07TEE DRUGCOMP Fondazione Telethon D07TEE HIGHSTAT Investigative D07TIX DRUG__ID D07TIX D07TIX DRUGCOMP ALS Therapy Development Foundation Inc D07TIX HIGHSTAT Investigative D07TPL DRUG__ID D07TPL D07TPL DRUGCOMP Roche Holding AG D07TPL HIGHSTAT Investigative D07TQU DRUG__ID D07TQU D07TQU DRUGCOMP Escape Therapeutics Inc D07TQU HIGHSTAT Investigative D07TUT DRUG__ID D07TUT D07TUT DRUGCOMP GNT Pharma Co Ltd D07TUT HIGHSTAT Investigative D07TWZ DRUG__ID D07TWZ D07TWZ DRUGCOMP ALS Therapy Development Foundation Inc D07TWZ HIGHSTAT Investigative D07UBB DRUG__ID D07UBB D07UBB DRUGCOMP Intra-Cellular Therapies Inc D07UBB HIGHSTAT Investigative D07UDI DRUG__ID D07UDI D07UDI DRUGCOMP HealOr Ltd D07UDI HIGHSTAT Investigative D07UDO DRUG__ID D07UDO D07UDO DRUGCOMP Dynamix Pharmaceuticals Ltd D07UDO HIGHSTAT Investigative D07UDW DRUG__ID D07UDW D07UDW DRUGCOMP Cognosci Inc D07UDW HIGHSTAT Investigative D07UEJ DRUG__ID D07UEJ D07UEJ DRUGCOMP Boehringer ingelheim pharmaceuticals; eli lilly D07UEJ HIGHSTAT Investigative D07UFS DRUG__ID D07UFS D07UFS DRUGCOMP Fred Hutchinson Cancer Research Center D07UFS HIGHSTAT Investigative D07UGI DRUG__ID D07UGI D07UGI DRUGCOMP Matrivax Research & Development Corp D07UGI HIGHSTAT Investigative D07URH DRUG__ID D07URH D07URH DRUGCOMP Applied Protein Sciences LLC D07URH HIGHSTAT Investigative D07USR DRUG__ID D07USR D07USR DRUGCOMP Genfit SA D07USR HIGHSTAT Investigative D07UTC DRUG__ID D07UTC D07UTC DRUGCOMP BioAlliance Pharma SA D07UTC HIGHSTAT Investigative D07UXJ DRUG__ID D07UXJ D07UXJ DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D07UXJ HIGHSTAT Investigative D07UZX DRUG__ID D07UZX D07UZX DRUGCOMP Raptor Pharmaceuticals Corp D07UZX HIGHSTAT Investigative D07VDF DRUG__ID D07VDF D07VDF DRUGCOMP Scripps Research Institute D07VDF HIGHSTAT Investigative D07VHX DRUG__ID D07VHX D07VHX DRUGCOMP Compliment Corp D07VHX HIGHSTAT Investigative D07VJK DRUG__ID D07VJK D07VJK DRUGCOMP Indena SpA D07VJK HIGHSTAT Investigative D07VOF DRUG__ID D07VOF D07VOF DRUGCOMP Theralpha SAS D07VOF HIGHSTAT Investigative D07VRP DRUG__ID D07VRP D07VRP DRUGCOMP EyeGene Inc D07VRP HIGHSTAT Investigative D07VYO DRUG__ID D07VYO D07VYO DRUGCOMP AM-Pharma Holding BV D07VYO HIGHSTAT Investigative D07WGW DRUG__ID D07WGW D07WGW DRUGCOMP National Taiwan University D07WGW HIGHSTAT Investigative D07WNG DRUG__ID D07WNG D07WNG DRUGCOMP Anaphore Inc D07WNG HIGHSTAT Investigative D07WXQ DRUG__ID D07WXQ D07WXQ DRUGCOMP Chong Kun Dang Pharmaceutical Corp D07WXQ HIGHSTAT Investigative D07WYO DRUG__ID D07WYO D07WYO DRUGCOMP Korea Research Institute of Bioscience and Biotechnology D07WYO HIGHSTAT Investigative D07XBZ DRUG__ID D07XBZ D07XBZ DRUGCOMP Archer Biosciences Inc D07XBZ HIGHSTAT Investigative D07XCQ DRUG__ID D07XCQ D07XCQ DRUGCOMP Medarex Inc D07XCQ HIGHSTAT Investigative D07XLA DRUG__ID D07XLA D07XLA DRUGCOMP GlycoMedics Inc D07XLA HIGHSTAT Investigative D07XSD DRUG__ID D07XSD D07XSD DRUGCOMP Asubio Pharma Co Ltd D07XSD HIGHSTAT Investigative D07YAC DRUG__ID D07YAC D07YAC DRUGCOMP Pieris AG D07YAC HIGHSTAT Investigative D07YDO DRUG__ID D07YDO D07YDO DRUGCOMP GTx Inc D07YDO HIGHSTAT Investigative D07YJK DRUG__ID D07YJK D07YJK DRUGCOMP Amsterdam Molecular Therapeutics BV D07YJK HIGHSTAT Investigative D07YOP DRUG__ID D07YOP D07YOP DRUGCOMP Jinis Biopharmaceuticals Co D07YOP HIGHSTAT Investigative D07YPA DRUG__ID D07YPA D07YPA DRUGCOMP Compugen Ltd D07YPA HIGHSTAT Investigative D07YPP DRUG__ID D07YPP D07YPP DRUGCOMP Targa Therapeutics Corp D07YPP HIGHSTAT Investigative D07YRJ DRUG__ID D07YRJ D07YRJ DRUGCOMP Aeras Global TB Vaccine Foundation D07YRJ HIGHSTAT Investigative D07YXD DRUG__ID D07YXD D07YXD DRUGCOMP HanAll Biopharma Co Ltd D07YXD HIGHSTAT Investigative D07YZK DRUG__ID D07YZK D07YZK DRUGCOMP Cell Signals Inc D07YZK HIGHSTAT Investigative D07ZBO DRUG__ID D07ZBO D07ZBO DRUGCOMP University of California Irvine D07ZBO HIGHSTAT Investigative D07ZCU DRUG__ID D07ZCU D07ZCU DRUGCOMP Biokine Therapeutics Ltd D07ZCU HIGHSTAT Investigative D07ZDG DRUG__ID D07ZDG D07ZDG DRUGCOMP Edunn Biotechnology Inc D07ZDG HIGHSTAT Investigative D07ZES DRUG__ID D07ZES D07ZES DRUGCOMP Dharma Biomedical D07ZES HIGHSTAT Investigative D07ZTB DRUG__ID D07ZTB D07ZTB DRUGCOMP Human Genome Sciences Inc D07ZTB HIGHSTAT Investigative D07ZZX DRUG__ID D07ZZX D07ZZX DRUGCOMP Medarex Inc D07ZZX HIGHSTAT Investigative D08ADK DRUG__ID D08ADK D08ADK DRUGCOMP Alios BioPharma Inc D08ADK HIGHSTAT Investigative D08AOV DRUG__ID D08AOV D08AOV DRUGCOMP Inotek Pharmaceuticals Corp D08AOV HIGHSTAT Investigative D08AXM DRUG__ID D08AXM D08AXM DRUGCOMP National Biopreparations Center D08AXM HIGHSTAT Investigative D08BED DRUG__ID D08BED D08BED DRUGCOMP Ceregene Inc D08BED HIGHSTAT Investigative D08BTX DRUG__ID D08BTX D08BTX DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D08BTX HIGHSTAT Investigative D08BYJ DRUG__ID D08BYJ D08BYJ DRUGCOMP Korea Institute of Oriental Medicine D08BYJ HIGHSTAT Investigative D08CEU DRUG__ID D08CEU D08CEU DRUGCOMP Catalyst Biosciences Inc D08CEU HIGHSTAT Investigative D08CGE DRUG__ID D08CGE D08CGE DRUGCOMP InnoPharmaScreen Inc D08CGE HIGHSTAT Investigative D08CMF DRUG__ID D08CMF D08CMF DRUGCOMP Angelica Therapeutics Inc D08CMF HIGHSTAT Investigative D08CRO DRUG__ID D08CRO D08CRO DRUGCOMP Gilead Sciences Inc D08CRO HIGHSTAT Investigative D08DHR DRUG__ID D08DHR D08DHR DRUGCOMP Bar-Ilan University D08DHR HIGHSTAT Investigative D08DJE DRUG__ID D08DJE D08DJE DRUGCOMP Kowa Co Ltd D08DJE HIGHSTAT Investigative D08DJP DRUG__ID D08DJP D08DJP DRUGCOMP Antigen Express Inc D08DJP HIGHSTAT Investigative D08DNA DRUG__ID D08DNA D08DNA DRUGCOMP ProtAffin Biotechnologie AG D08DNA HIGHSTAT Investigative D08DPV DRUG__ID D08DPV D08DPV DRUGCOMP Prosensa Therapeutics BV D08DPV HIGHSTAT Investigative D08EAR DRUG__ID D08EAR D08EAR DRUGCOMP Hollis-Eden Pharmaceuticals D08EAR HIGHSTAT Investigative D08EDE DRUG__ID D08EDE D08EDE DRUGCOMP Yale University D08EDE HIGHSTAT Investigative D08EEA DRUG__ID D08EEA D08EEA DRUGTYPE Small molecule immunotherapy D08EEA HIGHSTAT Investigative D08ELL DRUG__ID D08ELL D08ELL DRUGCOMP Hawaii Biotechnology Group Inc D08ELL HIGHSTAT Investigative D08EPK DRUG__ID D08EPK D08EPK DRUGCOMP University of Nebraska Medical Center D08EPK HIGHSTAT Investigative D08EQQ DRUG__ID D08EQQ D08EQQ DRUGCOMP Laila Pharmaceuticals Pvt Ltd D08EQQ HIGHSTAT Investigative D08FDD DRUG__ID D08FDD D08FDD DRUGCOMP Handok Pharmaceuticals D08FDD HIGHSTAT Investigative D08FJG DRUG__ID D08FJG D08FJG DRUGCOMP Exonhit D08FJG HIGHSTAT Investigative D08FSR DRUG__ID D08FSR D08FSR DRUGCOMP Valocor Therapeutics Ltd D08FSR HIGHSTAT Investigative D08FWO DRUG__ID D08FWO D08FWO DRUGCOMP Lixte Biotechnology Holdings Inc D08FWO HIGHSTAT Investigative D08FXZ DRUG__ID D08FXZ D08FXZ DRUGCOMP RESprotect GmbH D08FXZ HIGHSTAT Investigative D08GAH DRUG__ID D08GAH D08GAH DRUGCOMP Evolva SA D08GAH HIGHSTAT Investigative D08GHI DRUG__ID D08GHI D08GHI DRUGCOMP Avid Radiopharmaceuticals Inc D08GHI HIGHSTAT Investigative D08GHX DRUG__ID D08GHX D08GHX DRUGCOMP Technophage SA D08GHX HIGHSTAT Investigative D08GLH DRUG__ID D08GLH D08GLH DRUGCOMP Meldex International plc D08GLH HIGHSTAT Investigative D08GNY DRUG__ID D08GNY D08GNY DRUGCOMP ActoGeniX NV D08GNY HIGHSTAT Investigative D08GSM DRUG__ID D08GSM D08GSM DRUGCOMP ActoGeniX NV D08GSM HIGHSTAT Investigative D08GSX DRUG__ID D08GSX D08GSX DRUGCOMP MorphoSys AG D08GSX HIGHSTAT Investigative D08GUX DRUG__ID D08GUX D08GUX DRUGCOMP TARIS Biomedical Inc D08GUX HIGHSTAT Investigative D08GZX DRUG__ID D08GZX D08GZX DRUGCOMP Pfizer Inc D08GZX HIGHSTAT Investigative D08HJI DRUG__ID D08HJI D08HJI DRUGCOMP Sunovion pharmaceuticals D08HJI HIGHSTAT Investigative D08HNA DRUG__ID D08HNA D08HNA DRUGCOMP DanioLabs Ltd D08HNA HIGHSTAT Investigative D08HQT DRUG__ID D08HQT D08HQT DRUGCOMP Lee's Pharmaceutical Holdings (Hong Kong) Ltd D08HQT HIGHSTAT Investigative D08HUB DRUG__ID D08HUB D08HUB DRUGCOMP AngioChem Inc D08HUB HIGHSTAT Investigative D08IAK DRUG__ID D08IAK D08IAK DRUGTYPE Peptide D08IAK HIGHSTAT Investigative D08IFG DRUG__ID D08IFG D08IFG DRUGCOMP Immunomedics Inc D08IFG HIGHSTAT Investigative D08IKV DRUG__ID D08IKV D08IKV DRUGCOMP Ludwig Institute for Cancer Research D08IKV HIGHSTAT Investigative D08IUW DRUG__ID D08IUW D08IUW DRUGCOMP VectorLogics Inc D08IUW HIGHSTAT Investigative D08JAH DRUG__ID D08JAH D08JAH DRUGCOMP Ohio State University D08JAH HIGHSTAT Investigative D08JEA DRUG__ID D08JEA D08JEA DRUGCOMP Akebia Therapeutics Inc D08JEA HIGHSTAT Investigative D08JLC DRUG__ID D08JLC D08JLC DRUGCOMP JADO Technologies GmbH D08JLC HIGHSTAT Investigative D08JLV DRUG__ID D08JLV D08JLV DRUGCOMP Threshold Pharmaceuticals Inc D08JLV HIGHSTAT Investigative D08JTN DRUG__ID D08JTN D08JTN DRUGCOMP Affimed Therapeutics AG D08JTN HIGHSTAT Investigative D08JXR DRUG__ID D08JXR D08JXR DRUGCOMP Human Genome Sciences Inc D08JXR HIGHSTAT Investigative D08JYW DRUG__ID D08JYW D08JYW DRUGCOMP Chemizon Inc D08JYW HIGHSTAT Investigative D08KBB DRUG__ID D08KBB D08KBB DRUGCOMP DormaTarg Inc D08KBB HIGHSTAT Investigative D08KEC DRUG__ID D08KEC D08KEC DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D08KEC HIGHSTAT Investigative D08KWV DRUG__ID D08KWV D08KWV DRUGCOMP Nymox Pharmaceutical Corp D08KWV HIGHSTAT Investigative D08KXX DRUG__ID D08KXX D08KXX DRUGCOMP Jinis Biopharmaceuticals Co D08KXX HIGHSTAT Investigative D08LJY DRUG__ID D08LJY D08LJY DRUGCOMP Meridian Biopharmaceuticals D08LJY HIGHSTAT Investigative D08LRU DRUG__ID D08LRU D08LRU DRUGCOMP AEterna Zentaris Inc D08LRU HIGHSTAT Investigative D08LSA DRUG__ID D08LSA D08LSA DRUGCOMP SCYNEXIS Inc D08LSA HIGHSTAT Investigative D08MCL DRUG__ID D08MCL D08MCL DRUGCOMP Tivorsan Pharmaceuticals Inc D08MCL HIGHSTAT Investigative D08MID DRUG__ID D08MID D08MID DRUGCOMP Snowdon Inc D08MID HIGHSTAT Investigative D08MMP DRUG__ID D08MMP D08MMP DRUGCOMP EndogenX Inc D08MMP HIGHSTAT Investigative D08MOZ DRUG__ID D08MOZ D08MOZ DRUGCOMP Pain Therapeutics Inc D08MOZ HIGHSTAT Investigative D08MTA DRUG__ID D08MTA D08MTA DRUGCOMP Kalahari Greentech Inc D08MTA HIGHSTAT Investigative D08MVV DRUG__ID D08MVV D08MVV DRUGCOMP Protalix BioTherapeutics Inc D08MVV HIGHSTAT Investigative D08MVY DRUG__ID D08MVY D08MVY DRUGCOMP Janssen Pharmaceutica NV D08MVY HIGHSTAT Investigative D08MXB DRUG__ID D08MXB D08MXB DRUGCOMP NicOx SA D08MXB HIGHSTAT Investigative D08MYW DRUG__ID D08MYW D08MYW DRUGCOMP University of Nebraska Medical Center D08MYW HIGHSTAT Investigative D08NLC DRUG__ID D08NLC D08NLC DRUGCOMP Molecular Targeting Technologies Inc D08NLC HIGHSTAT Investigative D08NRG DRUG__ID D08NRG D08NRG DRUGCOMP Ewha Woman's University D08NRG HIGHSTAT Investigative D08NUS DRUG__ID D08NUS D08NUS DRUGCOMP Xel Pharmaceuticals Inc D08NUS HIGHSTAT Investigative D08NWY DRUG__ID D08NWY D08NWY DRUGCOMP Alios BioPharma Inc D08NWY HIGHSTAT Investigative D08ODP DRUG__ID D08ODP D08ODP DRUGCOMP Cascade Therapeutics Inc D08ODP HIGHSTAT Investigative D08OIT DRUG__ID D08OIT D08OIT DRUGCOMP Savoy Pharmaceuticals Inc D08OIT HIGHSTAT Investigative D08OKW DRUG__ID D08OKW D08OKW DRUGCOMP Virginia Polytechnic Institute and State University D08OKW HIGHSTAT Investigative D08OLR DRUG__ID D08OLR D08OLR DRUGCOMP ARTYX Pharmaceuticals Inc D08OLR HIGHSTAT Investigative D08OLU DRUG__ID D08OLU D08OLU DRUGCOMP AviPep Pty D08OLU HIGHSTAT Investigative D08OPW DRUG__ID D08OPW D08OPW DRUGCOMP Array BioPharma Inc D08OPW HIGHSTAT Investigative D08OWA DRUG__ID D08OWA D08OWA DRUGCOMP NovaBay Pharmaceuticals Inc D08OWA HIGHSTAT Investigative D08OWW DRUG__ID D08OWW D08OWW DRUGCOMP SeaLife Pharma GmbH D08OWW HIGHSTAT Investigative D08OXC DRUG__ID D08OXC D08OXC DRUGCOMP Indus Biotech Pvt Ltd D08OXC HIGHSTAT Investigative D08PNW DRUG__ID D08PNW D08PNW DRUGCOMP J-Pharma Co Ltd D08PNW HIGHSTAT Investigative D08PSV DRUG__ID D08PSV D08PSV DRUGCOMP Center for Genetic Engineering and Biotechnology D08PSV HIGHSTAT Investigative D08PVL DRUG__ID D08PVL D08PVL DRUGCOMP Seoul National University D08PVL HIGHSTAT Investigative D08PYQ DRUG__ID D08PYQ D08PYQ DRUGCOMP ED Laboratories Inc D08PYQ HIGHSTAT Investigative D08PZF DRUG__ID D08PZF D08PZF DRUGCOMP Molecular Express Inc D08PZF HIGHSTAT Investigative D08QDB DRUG__ID D08QDB D08QDB DRUGCOMP Korea Research Institute of Chemical Technology D08QDB HIGHSTAT Investigative D08QHJ DRUG__ID D08QHJ D08QHJ DRUGCOMP European Institute of Oncology D08QHJ HIGHSTAT Investigative D08QKY DRUG__ID D08QKY D08QKY DRUGCOMP InNexus Biotechnology Inc D08QKY HIGHSTAT Investigative D08QLL DRUG__ID D08QLL D08QLL DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D08QLL HIGHSTAT Investigative D08QRE DRUG__ID D08QRE D08QRE DRUGCOMP Mazence Inc D08QRE HIGHSTAT Investigative D08QRO DRUG__ID D08QRO D08QRO DRUGCOMP MyoContract Pharmaceutical Research Ltd D08QRO HIGHSTAT Investigative D08QRT DRUG__ID D08QRT D08QRT DRUGCOMP Squibb Diagnostics D08QRT HIGHSTAT Investigative D08QUC DRUG__ID D08QUC D08QUC DRUGCOMP Oriel Therapeutics Inc D08QUC HIGHSTAT Investigative D08QVM DRUG__ID D08QVM D08QVM DRUGCOMP Nuron Biotech Inc D08QVM HIGHSTAT Investigative D08QXE DRUG__ID D08QXE D08QXE DRUGCOMP Stainwei Biotech Inc D08QXE HIGHSTAT Investigative D08QYL DRUG__ID D08QYL D08QYL DRUGCOMP InSite Vision Inc D08QYL HIGHSTAT Investigative D08RAK DRUG__ID D08RAK D08RAK DRUGCOMP Stallergenes SA D08RAK HIGHSTAT Investigative D08RAL DRUG__ID D08RAL D08RAL DRUGCOMP AnaptysBio Inc D08RAL HIGHSTAT Investigative D08RBS DRUG__ID D08RBS D08RBS DRUGCOMP UCB SA D08RBS HIGHSTAT Investigative D08RCI DRUG__ID D08RCI D08RCI DRUGCOMP Cornerstone Therapeutics Inc D08RCI HIGHSTAT Investigative D08RDB DRUG__ID D08RDB D08RDB DRUGCOMP MediQuest Therapeutics Inc D08RDB HIGHSTAT Investigative D08RDG DRUG__ID D08RDG D08RDG DRUGCOMP ProMetic Life Sciences Inc D08RDG HIGHSTAT Investigative D08RIL DRUG__ID D08RIL D08RIL DRUGCOMP GenKyoTex SA D08RIL HIGHSTAT Investigative D08RQE DRUG__ID D08RQE D08RQE DRUGCOMP Immunovaccine Inc D08RQE HIGHSTAT Investigative D08RXW DRUG__ID D08RXW D08RXW DRUGCOMP Medisyn Technologies Inc D08RXW HIGHSTAT Investigative D08RYN DRUG__ID D08RYN D08RYN DRUGCOMP RaQualia Pharma Inc D08RYN HIGHSTAT Investigative D08SAO DRUG__ID D08SAO D08SAO DRUGCOMP Zannan Pharma D08SAO HIGHSTAT Investigative D08SHI DRUG__ID D08SHI D08SHI DRUGCOMP SanoGene Therapeutics Inc D08SHI HIGHSTAT Investigative D08SHM DRUG__ID D08SHM D08SHM DRUGCOMP NanoBio Corp D08SHM HIGHSTAT Investigative D08SMN DRUG__ID D08SMN D08SMN DRUGCOMP Propanc Pty Ltd D08SMN HIGHSTAT Investigative D08SSO DRUG__ID D08SSO D08SSO DRUGCOMP Relevare Pharmaceuticals Ltd D08SSO HIGHSTAT Investigative D08STA DRUG__ID D08STA D08STA DRUGCOMP Calmune Corp D08STA HIGHSTAT Investigative D08SXS DRUG__ID D08SXS D08SXS DRUGCOMP Hybrid BioSystems Ltd D08SXS HIGHSTAT Investigative D08SZO DRUG__ID D08SZO D08SZO DRUGCOMP Pierre Fabre SA D08SZO HIGHSTAT Investigative D08TDK DRUG__ID D08TDK D08TDK DRUGCOMP AnaptysBio Inc D08TDK HIGHSTAT Investigative D08TIA DRUG__ID D08TIA D08TIA DRUGCOMP Intra-Cellular Therapies Inc D08TIA HIGHSTAT Investigative D08TPH DRUG__ID D08TPH D08TPH DRUGCOMP Targacept Inc D08TPH HIGHSTAT Investigative D08UAT DRUG__ID D08UAT D08UAT DRUGCOMP DermiPsor Ltd D08UAT HIGHSTAT Investigative D08UDB DRUG__ID D08UDB D08UDB DRUGCOMP GlaxoSmithKline plc D08UDB HIGHSTAT Investigative D08UDE DRUG__ID D08UDE D08UDE DRUGCOMP AVI BioPharma Inc D08UDE HIGHSTAT Investigative D08UDZ DRUG__ID D08UDZ D08UDZ DRUGCOMP Zenyth Therapeutics Ltd D08UDZ HIGHSTAT Investigative D08UEJ DRUG__ID D08UEJ D08UEJ THERCLAS Analgesics D08UEJ HIGHSTAT Investigative D08UHC DRUG__ID D08UHC D08UHC DRUGCOMP PharmedArtis GmbH D08UHC HIGHSTAT Investigative D08UXQ DRUG__ID D08UXQ D08UXQ DRUGCOMP ForHumanTech Co Ltd D08UXQ HIGHSTAT Investigative D08UZA DRUG__ID D08UZA D08UZA DRUGCOMP National Cancer Institute D08UZA HIGHSTAT Investigative D08VDJ DRUG__ID D08VDJ D08VDJ DRUGCOMP Idun Pharmaceuticals Inc D08VDJ HIGHSTAT Investigative D08VFX DRUG__ID D08VFX D08VFX DRUGCOMP Bayer Schering Pharma AG D08VFX HIGHSTAT Investigative D08VLN DRUG__ID D08VLN D08VLN DRUGCOMP Catabasis Pharmaceuticals Inc D08VLN HIGHSTAT Investigative D08VMW DRUG__ID D08VMW D08VMW DRUGCOMP Montigen Pharmaceuticals Inc D08VMW HIGHSTAT Investigative D08VRM DRUG__ID D08VRM D08VRM DRUGCOMP Roche Holding AG D08VRM HIGHSTAT Investigative D08VRQ DRUG__ID D08VRQ D08VRQ DRUGCOMP NanoOncology D08VRQ HIGHSTAT Investigative D08VVI DRUG__ID D08VVI D08VVI DRUGCOMP AltaRex Medical Corp D08VVI HIGHSTAT Investigative D08VWJ DRUG__ID D08VWJ D08VWJ DRUGCOMP TARIS Biomedical Inc D08VWJ HIGHSTAT Investigative D08VWM DRUG__ID D08VWM D08VWM DRUGCOMP Yanbian University D08VWM HIGHSTAT Investigative D08WDH DRUG__ID D08WDH D08WDH DRUGCOMP Haemostatix Ltd D08WDH HIGHSTAT Investigative D08WDP DRUG__ID D08WDP D08WDP DRUGCOMP Amura Therapeutics Ltd D08WDP HIGHSTAT Investigative D08WDT DRUG__ID D08WDT D08WDT DRUGCOMP OyaGen Inc D08WDT HIGHSTAT Investigative D08XFR DRUG__ID D08XFR D08XFR DRUGCOMP AEterna Zentaris Inc D08XFR HIGHSTAT Investigative D08XIF DRUG__ID D08XIF D08XIF DRUGCOMP GlaxoSmithKline plc D08XIF HIGHSTAT Investigative D08XLV DRUG__ID D08XLV D08XLV DRUGCOMP Ensoltek Co Ltd D08XLV HIGHSTAT Investigative D08XPI DRUG__ID D08XPI D08XPI DRUGCOMP Altor BioScience Corp D08XPI HIGHSTAT Investigative D08XRD DRUG__ID D08XRD D08XRD DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D08XRD HIGHSTAT Investigative D08XUP DRUG__ID D08XUP D08XUP DRUGCOMP Cubist Pharmaceuticals Inc D08XUP HIGHSTAT Investigative D08XVU DRUG__ID D08XVU D08XVU DRUGCOMP Bavarian Nordic A/S D08XVU HIGHSTAT Investigative D08YAD DRUG__ID D08YAD D08YAD DRUGCOMP ZaBeCor Pharmaceutical Co D08YAD HIGHSTAT Investigative D08YCS DRUG__ID D08YCS D08YCS DRUGCOMP TheraQuest D08YCS HIGHSTAT Investigative D08YGD DRUG__ID D08YGD D08YGD DRUGCOMP University of Queensland D08YGD HIGHSTAT Investigative D08YKD DRUG__ID D08YKD D08YKD DRUGCOMP Charlesson LLC D08YKD HIGHSTAT Investigative D08YNC DRUG__ID D08YNC D08YNC DRUGCOMP University of Florida D08YNC HIGHSTAT Investigative D08YQG DRUG__ID D08YQG D08YQG DRUGCOMP Hanlim Pharmaceutical Co Ltd D08YQG HIGHSTAT Investigative D08YRM DRUG__ID D08YRM D08YRM DRUGCOMP Hanmi Pharmaceutical Co Ltd D08YRM HIGHSTAT Investigative D08YRO DRUG__ID D08YRO D08YRO DRUGCOMP Ark Therapeutics Group plc D08YRO HIGHSTAT Investigative D08YSY DRUG__ID D08YSY D08YSY DRUGCOMP Vegenics Ltd D08YSY HIGHSTAT Investigative D08YXS DRUG__ID D08YXS D08YXS DRUGCOMP CellAct Pharma GmbH D08YXS HIGHSTAT Investigative D08ZHQ DRUG__ID D08ZHQ D08ZHQ DRUGCOMP Conformetrix D08ZHQ HIGHSTAT Investigative D08ZLL DRUG__ID D08ZLL D08ZLL DRUGCOMP Thermalin Diabetes LLC D08ZLL HIGHSTAT Investigative D08ZSQ DRUG__ID D08ZSQ D08ZSQ THERCLAS Analgesics D08ZSQ HIGHSTAT Investigative D08ZTH DRUG__ID D08ZTH D08ZTH DRUGCOMP SeaLife Pharma GmbH D08ZTH HIGHSTAT Investigative D08ZUG DRUG__ID D08ZUG D08ZUG DRUGCOMP Rodos BioTarget GmbH D08ZUG HIGHSTAT Investigative D08ZXG DRUG__ID D08ZXG D08ZXG DRUGCOMP Pharmacor Inc D08ZXG HIGHSTAT Investigative D09AFE DRUG__ID D09AFE D09AFE DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D09AFE HIGHSTAT Investigative D09AFV DRUG__ID D09AFV D09AFV DRUGCOMP H Lee Moffitt Cancer Center and Research Institute D09AFV HIGHSTAT Investigative D09AVX DRUG__ID D09AVX D09AVX DRUGCOMP WhanIn Pharmaceutical Co Ltd D09AVX HIGHSTAT Investigative D09AVZ DRUG__ID D09AVZ D09AVZ DRUGCOMP University of Pennsylvania D09AVZ HIGHSTAT Investigative D09AYA DRUG__ID D09AYA D09AYA DRUGCOMP Instituto Biomar SA D09AYA HIGHSTAT Investigative D09BDK DRUG__ID D09BDK D09BDK DRUGCOMP Shenogen Pharma Group Ltd D09BDK HIGHSTAT Investigative D09BEO DRUG__ID D09BEO D09BEO DRUGCOMP Meldex International plc D09BEO HIGHSTAT Investigative D09BSI DRUG__ID D09BSI D09BSI DRUGCOMP ALS Therapy Development Foundation Inc D09BSI HIGHSTAT Investigative D09BXJ DRUG__ID D09BXJ D09BXJ DRUGCOMP Pfizer Inc D09BXJ HIGHSTAT Investigative D09CHX DRUG__ID D09CHX D09CHX DRUGCOMP Albany Molecular Research Inc D09CHX HIGHSTAT Investigative D09CIB DRUG__ID D09CIB D09CIB DRUGCOMP Biocortech D09CIB HIGHSTAT Investigative D09CJO DRUG__ID D09CJO D09CJO DRUGCOMP PharmaNess Neurosciences D09CJO HIGHSTAT Investigative D09CLX DRUG__ID D09CLX D09CLX DRUGCOMP EPIX Pharmaceuticals Inc D09CLX HIGHSTAT Investigative D09CNR DRUG__ID D09CNR D09CNR DRUGCOMP Kolon Life Science Inc D09CNR HIGHSTAT Investigative D09CNV DRUG__ID D09CNV D09CNV DRUGCOMP Edgemont Pharmaceuticals LLC D09CNV HIGHSTAT Investigative D09CTF DRUG__ID D09CTF D09CTF DRUGCOMP Inspiration Biopharmaceuticals Inc D09CTF HIGHSTAT Investigative D09CTH DRUG__ID D09CTH D09CTH DRUGCOMP RESprotect GmbH D09CTH HIGHSTAT Investigative D09CYK DRUG__ID D09CYK D09CYK DRUGCOMP EndogenX Inc D09CYK HIGHSTAT Investigative D09DAJ DRUG__ID D09DAJ D09DAJ DRUGCOMP FibroGen Inc D09DAJ HIGHSTAT Investigative D09DEU DRUG__ID D09DEU D09DEU DRUGCOMP Hutchison Medipharma Enterprises Ltd D09DEU HIGHSTAT Investigative D09DHL DRUG__ID D09DHL D09DHL DRUGCOMP ALS Therapy Development Foundation Inc D09DHL HIGHSTAT Investigative D09DJS DRUG__ID D09DJS D09DJS DRUGCOMP InVasc Therapeutics Inc D09DJS HIGHSTAT Investigative D09DMQ DRUG__ID D09DMQ D09DMQ DRUGCOMP Samyang Corp D09DMQ HIGHSTAT Investigative D09DRM DRUG__ID D09DRM D09DRM DRUGCOMP Neurotune AG D09DRM HIGHSTAT Investigative D09DTY DRUG__ID D09DTY D09DTY DRUGCOMP Idenix Pharmaceuticals Inc D09DTY HIGHSTAT Investigative D09DYB DRUG__ID D09DYB D09DYB DRUGCOMP CHDI Foundation Inc D09DYB HIGHSTAT Investigative D09EED DRUG__ID D09EED D09EED DRUGCOMP Symphogen A/S D09EED HIGHSTAT Investigative D09EJC DRUG__ID D09EJC D09EJC DRUGCOMP Inflammatorx Inc D09EJC HIGHSTAT Investigative D09EMS DRUG__ID D09EMS D09EMS DRUGCOMP C&O Pharmaceutical Technology (Holdings) Ltd D09EMS HIGHSTAT Investigative D09ENF DRUG__ID D09ENF D09ENF DRUGCOMP ProNAi Therapeutics Inc D09ENF HIGHSTAT Investigative D09EPX DRUG__ID D09EPX D09EPX DRUGCOMP Antipodean Pharmaceuticals Inc D09EPX HIGHSTAT Investigative D09EVP DRUG__ID D09EVP D09EVP DRUGCOMP Neuren Pharmaceuticals Ltd D09EVP HIGHSTAT Investigative D09EYJ DRUG__ID D09EYJ D09EYJ DRUGCOMP IPierian Inc D09EYJ HIGHSTAT Investigative D09FFS DRUG__ID D09FFS D09FFS DRUGCOMP Fibrotech Therapeutics Pty Ltd D09FFS HIGHSTAT Investigative D09FGM DRUG__ID D09FGM D09FGM DRUGCOMP Zacharon Pharmaceuticals Inc D09FGM HIGHSTAT Investigative D09FRY DRUG__ID D09FRY D09FRY DRUGCOMP AnaptysBio Inc D09FRY HIGHSTAT Investigative D09FWK DRUG__ID D09FWK D09FWK DRUGCOMP Ensemble Therapeutics Corp D09FWK HIGHSTAT Investigative D09FZM DRUG__ID D09FZM D09FZM DRUGCOMP Targa Therapeutics Corp D09FZM HIGHSTAT Investigative D09GBM DRUG__ID D09GBM D09GBM DRUGCOMP RegenX Biosciences LLC D09GBM HIGHSTAT Investigative D09GMC DRUG__ID D09GMC D09GMC DRUGCOMP Genovax Srl D09GMC HIGHSTAT Investigative D09GQS DRUG__ID D09GQS D09GQS DRUGCOMP Jenrin Discovery Inc D09GQS HIGHSTAT Investigative D09HCE DRUG__ID D09HCE D09HCE DRUGCOMP Hanmi Pharmaceutical Co Ltd D09HCE HIGHSTAT Investigative D09HCR DRUG__ID D09HCR D09HCR DRUGCOMP Femta Pharmaceuticals Inc D09HCR HIGHSTAT Investigative D09HHA DRUG__ID D09HHA D09HHA DRUGCOMP National Institute of Biomedical Innovation D09HHA HIGHSTAT Investigative D09HUF DRUG__ID D09HUF D09HUF DRUGCOMP Palau Pharma SA D09HUF HIGHSTAT Investigative D09HVY DRUG__ID D09HVY D09HVY DRUGCOMP New York University D09HVY HIGHSTAT Investigative D09IGF DRUG__ID D09IGF D09IGF DRUGCOMP Institut Catala d'Oncologia D09IGF HIGHSTAT Investigative D09IIX DRUG__ID D09IIX D09IIX DRUGCOMP Woomera Therapeutics Inc D09IIX HIGHSTAT Investigative D09IMY DRUG__ID D09IMY D09IMY DRUGCOMP SeaLife Pharma GmbH D09IMY HIGHSTAT Investigative D09IOA DRUG__ID D09IOA D09IOA DRUGCOMP National Institutes of Health D09IOA HIGHSTAT Investigative D09ISJ DRUG__ID D09ISJ D09ISJ DRUGCOMP SOM Biotech SL D09ISJ HIGHSTAT Investigative D09JET DRUG__ID D09JET D09JET DRUGCOMP Neurogen Corporation D09JET HIGHSTAT Investigative D09JJG DRUG__ID D09JJG D09JJG DRUGCOMP Astral Inc D09JJG HIGHSTAT Investigative D09JPT DRUG__ID D09JPT D09JPT DRUGCOMP Illumigen Biosciences Inc D09JPT HIGHSTAT Investigative D09JTE DRUG__ID D09JTE D09JTE DRUGCOMP BIOO Therapeutics D09JTE HIGHSTAT Investigative D09JUL DRUG__ID D09JUL D09JUL DRUGCOMP AllTranz Inc D09JUL HIGHSTAT Investigative D09KEV DRUG__ID D09KEV D09KEV DRUGCOMP TechnoVax Inc D09KEV HIGHSTAT Investigative D09KLX DRUG__ID D09KLX D09KLX DRUGCOMP Medipost Co Ltd D09KLX HIGHSTAT Investigative D09KMA DRUG__ID D09KMA D09KMA DRUGCOMP Canopus BioPharma Inc D09KMA HIGHSTAT Investigative D09KSW DRUG__ID D09KSW D09KSW DRUGCOMP Adamed Sp zoo D09KSW HIGHSTAT Investigative D09KTE DRUG__ID D09KTE D09KTE DRUGCOMP BruCells D09KTE HIGHSTAT Investigative D09LGV DRUG__ID D09LGV D09LGV DRUGCOMP Micromet Inc D09LGV HIGHSTAT Investigative D09LMQ DRUG__ID D09LMQ D09LMQ DRUGCOMP ViroPan Inc D09LMQ HIGHSTAT Investigative D09LTC DRUG__ID D09LTC D09LTC DRUGCOMP Ironwood Pharmaceuticals Inc D09LTC HIGHSTAT Investigative D09LTO DRUG__ID D09LTO D09LTO DRUGCOMP Sankyo Co Ltd D09LTO HIGHSTAT Investigative D09LVK DRUG__ID D09LVK D09LVK DRUGCOMP ALS Therapy Development Foundation Inc D09LVK HIGHSTAT Investigative D09LZN DRUG__ID D09LZN D09LZN DRUGCOMP Acer Therapeutics Cambridge, MA D09LZN HIGHSTAT Investigative D09MEU DRUG__ID D09MEU D09MEU DRUGCOMP Debiopharm SA D09MEU HIGHSTAT Investigative D09MFV DRUG__ID D09MFV D09MFV DRUGCOMP Emory University D09MFV HIGHSTAT Investigative D09MJX DRUG__ID D09MJX D09MJX DRUGTYPE Small molecule immunotherapy D09MJX HIGHSTAT Investigative D09MPN DRUG__ID D09MPN D09MPN DRUGCOMP ALS Therapy Development Foundation Inc D09MPN HIGHSTAT Investigative D09MQU DRUG__ID D09MQU D09MQU DRUGCOMP OncoGenex Technologies Inc D09MQU HIGHSTAT Investigative D09MQY DRUG__ID D09MQY D09MQY DRUGCOMP Chong Kun Dang Pharmaceutical Corp D09MQY HIGHSTAT Investigative D09MRD DRUG__ID D09MRD D09MRD DRUGCOMP MiRagen Therapeutics Inc D09MRD HIGHSTAT Investigative D09MUS DRUG__ID D09MUS D09MUS DRUGCOMP Jinis Biopharmaceuticals Co D09MUS HIGHSTAT Investigative D09MXE DRUG__ID D09MXE D09MXE DRUGCOMP Oscotec Inc D09MXE HIGHSTAT Investigative D09NCH DRUG__ID D09NCH D09NCH DRUGCOMP AcurePharma AB D09NCH HIGHSTAT Investigative D09NEL DRUG__ID D09NEL D09NEL DRUGCOMP JW Pharmaceutical Corp D09NEL HIGHSTAT Investigative D09NJA DRUG__ID D09NJA D09NJA DRUGCOMP HanAll Biopharma Co Ltd D09NJA HIGHSTAT Investigative D09NKU DRUG__ID D09NKU D09NKU DRUGCOMP Human Genome Sciences Inc D09NKU HIGHSTAT Investigative D09NLK DRUG__ID D09NLK D09NLK DRUGCOMP Northwestern University D09NLK HIGHSTAT Investigative D09NQD DRUG__ID D09NQD D09NQD DRUGCOMP Center for Genetic Engineering and Biotechnology D09NQD HIGHSTAT Investigative D09NWL DRUG__ID D09NWL D09NWL DRUGCOMP Pain Therapeutics Inc D09NWL HIGHSTAT Investigative D09NWW DRUG__ID D09NWW D09NWW DRUGCOMP Amgen Inc D09NWW HIGHSTAT Investigative D09NXZ DRUG__ID D09NXZ D09NXZ DRUGCOMP HanAll Biopharma Co Ltd D09NXZ HIGHSTAT Investigative D09OBF DRUG__ID D09OBF D09OBF DRUGCOMP Polymed Therapeutics Inc D09OBF HIGHSTAT Investigative D09OLR DRUG__ID D09OLR D09OLR DRUGCOMP Marina Biotech Inc D09OLR HIGHSTAT Investigative D09OPH DRUG__ID D09OPH D09OPH DRUGCOMP NeoPharm Co Ltd D09OPH HIGHSTAT Investigative D09OSM DRUG__ID D09OSM D09OSM DRUGCOMP Genfit SA D09OSM HIGHSTAT Investigative D09PDK DRUG__ID D09PDK D09PDK DRUGCOMP Progenetics LLC D09PDK HIGHSTAT Investigative D09PGH DRUG__ID D09PGH D09PGH DRUGCOMP ProtAffin Biotechnologie AG D09PGH HIGHSTAT Investigative D09PIH DRUG__ID D09PIH D09PIH DRUGCOMP Nyken BV D09PIH HIGHSTAT Investigative D09PNS DRUG__ID D09PNS D09PNS DRUGCOMP Unigene Laboratories Inc D09PNS HIGHSTAT Investigative D09PON DRUG__ID D09PON D09PON DRUGCOMP Molteni Therapeutics Srl D09PON HIGHSTAT Investigative D09PWS DRUG__ID D09PWS D09PWS DRUGCOMP Kuhnil Pharmaceutical Co Ltd D09PWS HIGHSTAT Investigative D09PZV DRUG__ID D09PZV D09PZV DRUGCOMP Immunotech Laboratories Inc D09PZV HIGHSTAT Investigative D09QHU DRUG__ID D09QHU D09QHU DRUGCOMP Auspex Pharmaceuticals Inc D09QHU HIGHSTAT Investigative D09QLR DRUG__ID D09QLR D09QLR DRUGCOMP ACADIA Pharmaceuticals Inc D09QLR HIGHSTAT Investigative D09QPD DRUG__ID D09QPD D09QPD DRUGCOMP TransTech Pharma Inc D09QPD HIGHSTAT Investigative D09QPE DRUG__ID D09QPE D09QPE DRUGCOMP Action Pharma A/S D09QPE HIGHSTAT Investigative D09QQE DRUG__ID D09QQE D09QQE DRUGCOMP GP Pharm SA D09QQE HIGHSTAT Investigative D09QTS DRUG__ID D09QTS D09QTS DRUGCOMP National Eye Institute D09QTS HIGHSTAT Investigative D09QWK DRUG__ID D09QWK D09QWK DRUGCOMP Amgen Inc D09QWK HIGHSTAT Investigative D09QZK DRUG__ID D09QZK D09QZK DRUGCOMP Kineta Inc D09QZK HIGHSTAT Investigative D09RAB DRUG__ID D09RAB D09RAB DRUGCOMP ProCertus BioPharm Inc D09RAB HIGHSTAT Investigative D09RNI DRUG__ID D09RNI D09RNI DRUGCOMP Euroscreen SA D09RNI HIGHSTAT Investigative D09RSN DRUG__ID D09RSN D09RSN DRUGCOMP Special Phage Holdings Pty Ltd D09RSN HIGHSTAT Investigative D09RUJ DRUG__ID D09RUJ D09RUJ DRUGCOMP Serometrix LLC D09RUJ HIGHSTAT Investigative D09RZB DRUG__ID D09RZB D09RZB DRUGCOMP Biousian Biosystems Inc D09RZB HIGHSTAT Investigative D09SAU DRUG__ID D09SAU D09SAU DRUGCOMP Immuron Ltd D09SAU HIGHSTAT Investigative D09SBY DRUG__ID D09SBY D09SBY DRUGCOMP Center for Genetic Engineering and Biotechnology D09SBY HIGHSTAT Investigative D09SHC DRUG__ID D09SHC D09SHC DRUGCOMP Altor BioScience Corp D09SHC HIGHSTAT Investigative D09SOD DRUG__ID D09SOD D09SOD DRUGCOMP RAPID Pharmaceuticals AG D09SOD HIGHSTAT Investigative D09SVB DRUG__ID D09SVB D09SVB DRUGCOMP Integrated BioTherapeutics Inc D09SVB HIGHSTAT Investigative D09SXR DRUG__ID D09SXR D09SXR DRUGCOMP Chonbuk National University D09SXR HIGHSTAT Investigative D09TBM DRUG__ID D09TBM D09TBM DRUGCOMP Prexa Pharmaceuticals Inc D09TBM HIGHSTAT Investigative D09TDG DRUG__ID D09TDG D09TDG DRUGCOMP NanoForm Cardiovascular Therapeutics Ltd D09TDG HIGHSTAT Investigative D09TIW DRUG__ID D09TIW D09TIW DRUGCOMP SeaLife Pharma GmbH D09TIW HIGHSTAT Investigative D09TJV DRUG__ID D09TJV D09TJV DRUGCOMP PharmaIN Ltd D09TJV HIGHSTAT Investigative D09TOS DRUG__ID D09TOS D09TOS DRUGCOMP SIGA Technologies Inc D09TOS HIGHSTAT Investigative D09TPW DRUG__ID D09TPW D09TPW DRUGCOMP Pfizer Inc D09TPW HIGHSTAT Investigative D09TQI DRUG__ID D09TQI D09TQI DRUGCOMP Ottawa Health Research Institute D09TQI HIGHSTAT Investigative D09TSX DRUG__ID D09TSX D09TSX DRUGCOMP Celek Pharmaceuticals LLC D09TSX HIGHSTAT Investigative D09TXA DRUG__ID D09TXA D09TXA DRUGCOMP EpiVax Inc D09TXA HIGHSTAT Investigative D09TXU DRUG__ID D09TXU D09TXU DRUGCOMP Daiichi Sankyo Co Ltd D09TXU HIGHSTAT Investigative D09UCU DRUG__ID D09UCU D09UCU DRUGCOMP Inflazyme Pharmaceuticals D09UCU HIGHSTAT Investigative D09UCV DRUG__ID D09UCV D09UCV DRUGCOMP Immunomic Therapeutics Inc D09UCV HIGHSTAT Investigative D09UHY DRUG__ID D09UHY D09UHY DRUGCOMP Tacere Therapeutics Inc D09UHY HIGHSTAT Investigative D09UQS DRUG__ID D09UQS D09UQS DRUGCOMP Laila Pharmaceuticals Pvt Ltd D09UQS HIGHSTAT Investigative D09UTQ DRUG__ID D09UTQ D09UTQ DRUGCOMP Green Cross Corp D09UTQ HIGHSTAT Investigative D09UVX DRUG__ID D09UVX D09UVX DRUGCOMP Prexa Pharmaceuticals Inc D09UVX HIGHSTAT Investigative D09UXI DRUG__ID D09UXI D09UXI DRUGCOMP MiRagen Therapeutics Inc D09UXI HIGHSTAT Investigative D09UXU DRUG__ID D09UXU D09UXU DRUGCOMP Tulane University D09UXU HIGHSTAT Investigative D09UZB DRUG__ID D09UZB D09UZB DRUGCOMP Nagoya City University D09UZB HIGHSTAT Investigative D09VAB DRUG__ID D09VAB D09VAB DRUGCOMP National Health Research Institutes D09VAB HIGHSTAT Investigative D09VCC DRUG__ID D09VCC D09VCC DRUGCOMP Palatin Technologies Inc D09VCC HIGHSTAT Investigative D09VFU DRUG__ID D09VFU D09VFU DRUGCOMP MetaSignal Therapeutics D09VFU HIGHSTAT Investigative D09VQW DRUG__ID D09VQW D09VQW DRUGTYPE Small molecular drug D09VQW HIGHSTAT Investigative D09VYS DRUG__ID D09VYS D09VYS DRUGCOMP Lay Line Genomics SpA D09VYS HIGHSTAT Investigative D09VZR DRUG__ID D09VZR D09VZR DRUGCOMP SuperGen Inc D09VZR HIGHSTAT Investigative D09WAY DRUG__ID D09WAY D09WAY DRUGCOMP Trinity College Dublin D09WAY HIGHSTAT Investigative D09WGU DRUG__ID D09WGU D09WGU DRUGCOMP ViroMed Co Ltd D09WGU HIGHSTAT Investigative D09WIM DRUG__ID D09WIM D09WIM DRUGCOMP NanoViricides Inc D09WIM HIGHSTAT Investigative D09WJT DRUG__ID D09WJT D09WJT DRUGCOMP Wellstat ImmunoTherapeutics LLC D09WJT HIGHSTAT Investigative D09WKT DRUG__ID D09WKT D09WKT DRUGCOMP Ardent Pharmaceuticals Inc D09WKT HIGHSTAT Investigative D09WMV DRUG__ID D09WMV D09WMV DRUGCOMP Bristol-Myers Squibb Co D09WMV HIGHSTAT Investigative D09WNQ DRUG__ID D09WNQ D09WNQ DRUGCOMP Marval Biosciences Inc D09WNQ HIGHSTAT Investigative D09WOI DRUG__ID D09WOI D09WOI DRUGCOMP Novozymes A/S D09WOI HIGHSTAT Investigative D09WOY DRUG__ID D09WOY D09WOY DRUGCOMP GlaxoSmithKline plc D09WOY HIGHSTAT Investigative D09XEM DRUG__ID D09XEM D09XEM DRUGCOMP NeuroGeneration Inc D09XEM HIGHSTAT Investigative D09XGK DRUG__ID D09XGK D09XGK DRUGCOMP Pantarhei Bioscience BV D09XGK HIGHSTAT Investigative D09XKT DRUG__ID D09XKT D09XKT DRUGCOMP Kuhnil Pharmaceutical Co Ltd D09XKT HIGHSTAT Investigative D09XPD DRUG__ID D09XPD D09XPD DRUGCOMP AltaRex Medical Corp D09XPD HIGHSTAT Investigative D09XSH DRUG__ID D09XSH D09XSH DRUGCOMP Cytorex Biosciences Inc D09XSH HIGHSTAT Investigative D09XWT DRUG__ID D09XWT D09XWT DRUGCOMP Alize Pharma SAS D09XWT HIGHSTAT Investigative D09YBZ DRUG__ID D09YBZ D09YBZ DRUGCOMP C&O Pharmaceutical Technology (Holdings) Ltd D09YBZ HIGHSTAT Investigative D09YDC DRUG__ID D09YDC D09YDC DRUGCOMP HanAll Biopharma Co Ltd D09YDC HIGHSTAT Investigative D09YGK DRUG__ID D09YGK D09YGK DRUGCOMP Microgen State Scientific Industrial Company D09YGK HIGHSTAT Investigative D09YHL DRUG__ID D09YHL D09YHL DRUGCOMP Genfit SA D09YHL HIGHSTAT Investigative D09YJK DRUG__ID D09YJK D09YJK DRUGCOMP Bristol-Myers Squibb Co D09YJK HIGHSTAT Investigative D09YJR DRUG__ID D09YJR D09YJR DRUGTYPE Small molecular drug D09YJR HIGHSTAT Investigative D09YNJ DRUG__ID D09YNJ D09YNJ DRUGCOMP Samjin Pharmaceutical Co Ltd D09YNJ HIGHSTAT Investigative D09YUH DRUG__ID D09YUH D09YUH DRUGCOMP Nexigen GmbH D09YUH HIGHSTAT Investigative D09YXS DRUG__ID D09YXS D09YXS DRUGCOMP Genexine Co Ltd D09YXS HIGHSTAT Investigative D09YYQ DRUG__ID D09YYQ D09YYQ DRUGCOMP BioSphings AG D09YYQ HIGHSTAT Investigative D09ZBJ DRUG__ID D09ZBJ D09ZBJ DRUGCOMP Galactica Pharmaceuticals D09ZBJ HIGHSTAT Investigative D09ZKU DRUG__ID D09ZKU D09ZKU DRUGCOMP Universidade Federal de S o Carlos D09ZKU HIGHSTAT Investigative D09ZNQ DRUG__ID D09ZNQ D09ZNQ DRUGCOMP OPi SA D09ZNQ HIGHSTAT Investigative D09ZNS DRUG__ID D09ZNS D09ZNS DRUGCOMP PiKe Pharma GmbH D09ZNS HIGHSTAT Investigative D09ZUM DRUG__ID D09ZUM D09ZUM DRUGCOMP Rottapharm Madaus D09ZUM HIGHSTAT Investigative D09ZWI DRUG__ID D09ZWI D09ZWI DRUGCOMP Kuros Biosurgery AG D09ZWI HIGHSTAT Investigative D09ZZF DRUG__ID D09ZZF D09ZZF DRUGCOMP Universita Degli Studi di Genova D09ZZF HIGHSTAT Investigative D0A0FI DRUG__ID D0A0FI D0A0FI DRUGCOMP ForHumanTech Co Ltd D0A0FI HIGHSTAT Investigative D0A1DT DRUG__ID D0A1DT D0A1DT DRUGCOMP Zeneca Group plc D0A1DT HIGHSTAT Investigative D0A1FG DRUG__ID D0A1FG D0A1FG DRUGCOMP Morvus Technology Ltd D0A1FG HIGHSTAT Investigative D0A1KP DRUG__ID D0A1KP D0A1KP DRUGCOMP SWITCH Biotech LLC D0A1KP HIGHSTAT Investigative D0A1MK DRUG__ID D0A1MK D0A1MK DRUGCOMP HanAll Biopharma Co Ltd D0A1MK HIGHSTAT Investigative D0A2BK DRUG__ID D0A2BK D0A2BK DRUGCOMP Cellceutix Corp D0A2BK HIGHSTAT Investigative D0A2RF DRUG__ID D0A2RF D0A2RF DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0A2RF HIGHSTAT Investigative D0A2XV DRUG__ID D0A2XV D0A2XV DRUGCOMP HanAll Biopharma Co Ltd D0A2XV HIGHSTAT Investigative D0A3AJ DRUG__ID D0A3AJ D0A3AJ DRUGCOMP 4SC AG D0A3AJ HIGHSTAT Investigative D0A3LQ DRUG__ID D0A3LQ D0A3LQ DRUGTYPE Peptide D0A3LQ HIGHSTAT Investigative D0A3OA DRUG__ID D0A3OA D0A3OA DRUGCOMP TiGenix NV D0A3OA HIGHSTAT Investigative D0A3OS DRUG__ID D0A3OS D0A3OS DRUGCOMP PiKe Pharma GmbH D0A3OS HIGHSTAT Investigative D0A3PF DRUG__ID D0A3PF D0A3PF DRUGCOMP TechnoVax Inc D0A3PF HIGHSTAT Investigative D0A3SX DRUG__ID D0A3SX D0A3SX DRUGCOMP Anchor Therapeutics Inc D0A3SX HIGHSTAT Investigative D0A3VX DRUG__ID D0A3VX D0A3VX DRUGCOMP Boehringer Ingelheim Corp D0A3VX HIGHSTAT Investigative D0A3WZ DRUG__ID D0A3WZ D0A3WZ DRUGCOMP Kenta Biotech Ltd D0A3WZ HIGHSTAT Investigative D0A3XA DRUG__ID D0A3XA D0A3XA DRUGCOMP CeNeS Pharmaceuticals Inc D0A3XA HIGHSTAT Investigative D0A4JB DRUG__ID D0A4JB D0A4JB DRUGCOMP JDP Therapeutics Inc D0A4JB HIGHSTAT Investigative D0A4JI DRUG__ID D0A4JI D0A4JI DRUGCOMP Lypro Biosciences Inc D0A4JI HIGHSTAT Investigative D0A4KP DRUG__ID D0A4KP D0A4KP DRUGCOMP Numerate Inc D0A4KP HIGHSTAT Investigative D0A4MI DRUG__ID D0A4MI D0A4MI DRUGCOMP Kucera Pharmaceutical Co D0A4MI HIGHSTAT Investigative D0A4WL DRUG__ID D0A4WL D0A4WL DRUGCOMP CreaGene Inc D0A4WL HIGHSTAT Investigative D0A5CH DRUG__ID D0A5CH D0A5CH DRUGCOMP Vascular Pharmaceuticals Inc D0A5CH HIGHSTAT Investigative D0A5CL DRUG__ID D0A5CL D0A5CL DRUGCOMP Adrem Biotech D0A5CL HIGHSTAT Investigative D0A5CZ DRUG__ID D0A5CZ D0A5CZ DRUGCOMP Daewon Pharm Co Ltd D0A5CZ HIGHSTAT Investigative D0A5KF DRUG__ID D0A5KF D0A5KF DRUGCOMP ImmunoBiosciences Inc D0A5KF HIGHSTAT Investigative D0A5KO DRUG__ID D0A5KO D0A5KO DRUGCOMP TARIS Biomedical Inc D0A5KO HIGHSTAT Investigative D0A5KS DRUG__ID D0A5KS D0A5KS DRUGCOMP Xechem International D0A5KS HIGHSTAT Investigative D0A5NL DRUG__ID D0A5NL D0A5NL DRUGCOMP Heat Biologics D0A5NL HIGHSTAT Investigative D0A5OG DRUG__ID D0A5OG D0A5OG DRUGCOMP ReNeuron Group plc D0A5OG HIGHSTAT Investigative D0A6DK DRUG__ID D0A6DK D0A6DK DRUGCOMP Fundacao de Amparo a Pesquisa do Estado Sao Paulo D0A6DK HIGHSTAT Investigative D0A6MS DRUG__ID D0A6MS D0A6MS THERCLAS Analgesics D0A6MS HIGHSTAT Investigative D0A6NP DRUG__ID D0A6NP D0A6NP DRUGCOMP Sankyo Co Ltd D0A6NP HIGHSTAT Investigative D0A6PD DRUG__ID D0A6PD D0A6PD DRUGCOMP Fornix BioSciences NV D0A6PD HIGHSTAT Investigative D0A6RI DRUG__ID D0A6RI D0A6RI DRUGCOMP Cellectis SA D0A6RI HIGHSTAT Investigative D0A6RX DRUG__ID D0A6RX D0A6RX DRUGCOMP University of California Los Angeles D0A6RX HIGHSTAT Investigative D0A6WQ DRUG__ID D0A6WQ D0A6WQ DRUGCOMP F Hoffmann-La Roche Ltd D0A6WQ HIGHSTAT Investigative D0A7AG DRUG__ID D0A7AG D0A7AG DRUGCOMP Cytokine PharmaSciences Inc D0A7AG HIGHSTAT Investigative D0A7CH DRUG__ID D0A7CH D0A7CH DRUGCOMP WhanIn Pharmaceutical Co Ltd D0A7CH HIGHSTAT Investigative D0A7CZ DRUG__ID D0A7CZ D0A7CZ DRUGCOMP University of Minnesota D0A7CZ HIGHSTAT Investigative D0A7HY DRUG__ID D0A7HY D0A7HY DRUGCOMP Vasade Biosciences Inc D0A7HY HIGHSTAT Investigative D0A7NI DRUG__ID D0A7NI D0A7NI DRUGCOMP Limerick BioPharma Inc D0A7NI HIGHSTAT Investigative D0A7UK DRUG__ID D0A7UK D0A7UK DRUGCOMP PDS Biotechnology Corp D0A7UK HIGHSTAT Investigative D0A7WK DRUG__ID D0A7WK D0A7WK DRUGCOMP BIOO Therapeutics D0A7WK HIGHSTAT Investigative D0A8ES DRUG__ID D0A8ES D0A8ES DRUGCOMP Endocyte Inc D0A8ES HIGHSTAT Investigative D0A8IM DRUG__ID D0A8IM D0A8IM DRUGCOMP Cernofina Llc D0A8IM HIGHSTAT Investigative D0A8IQ DRUG__ID D0A8IQ D0A8IQ DRUGCOMP Apitope Technology (Bristol) Ltd D0A8IQ HIGHSTAT Investigative D0A9TA DRUG__ID D0A9TA D0A9TA DRUGCOMP Cardiff ProTides Ltd D0A9TA HIGHSTAT Investigative D0A9TR DRUG__ID D0A9TR D0A9TR DRUGCOMP Xalud Therapeutics Inc D0A9TR HIGHSTAT Investigative D0A9WW DRUG__ID D0A9WW D0A9WW DRUGCOMP Vantia Therapeutics D0A9WW HIGHSTAT Investigative D0A9YZ DRUG__ID D0A9YZ D0A9YZ DRUGCOMP APT Therapeutics Inc D0A9YZ HIGHSTAT Investigative D0AA2X DRUG__ID D0AA2X D0AA2X DRUGCOMP ProNAi Therapeutics Inc D0AA2X HIGHSTAT Investigative D0AB2G DRUG__ID D0AB2G D0AB2G DRUGCOMP HanAll Biopharma Co Ltd D0AB2G HIGHSTAT Investigative D0AC6O DRUG__ID D0AC6O D0AC6O DRUGCOMP Oncolys BioPharma Inc D0AC6O HIGHSTAT Investigative D0AC7C DRUG__ID D0AC7C D0AC7C DRUGCOMP InnoPharmaScreen Inc D0AC7C HIGHSTAT Investigative D0AD8L DRUG__ID D0AD8L D0AD8L DRUGCOMP Vivia Biotech SL D0AD8L HIGHSTAT Investigative D0AF4F DRUG__ID D0AF4F D0AF4F DRUGCOMP Ohio State University D0AF4F HIGHSTAT Investigative D0AF8R DRUG__ID D0AF8R D0AF8R DRUGCOMP Aquapharm Biodiscovery Ltd D0AF8R HIGHSTAT Investigative D0AG4J DRUG__ID D0AG4J D0AG4J DRUGCOMP Inflammatorx Inc D0AG4J HIGHSTAT Investigative D0AK0Z DRUG__ID D0AK0Z D0AK0Z DRUGCOMP ImmunoCellular Therapeutics Ltd D0AK0Z HIGHSTAT Investigative D0AK2V DRUG__ID D0AK2V D0AK2V DRUGCOMP Antigen Express Inc D0AK2V HIGHSTAT Investigative D0AK4H DRUG__ID D0AK4H D0AK4H DRUGCOMP Amgen Inc D0AK4H HIGHSTAT Investigative D0AQ8F DRUG__ID D0AQ8F D0AQ8F DRUGCOMP ET Vaccine Technology Inc D0AQ8F HIGHSTAT Investigative D0AT5Y DRUG__ID D0AT5Y D0AT5Y DRUGCOMP Stanford University D0AT5Y HIGHSTAT Investigative D0AW7H DRUG__ID D0AW7H D0AW7H DRUGCOMP Proteonomix Inc D0AW7H HIGHSTAT Investigative D0AX0V DRUG__ID D0AX0V D0AX0V DRUGCOMP SOM Biotech SL D0AX0V HIGHSTAT Investigative D0AY6U DRUG__ID D0AY6U D0AY6U DRUGCOMP Madeira Therapeutics LLC D0AY6U HIGHSTAT Investigative D0AZ0T DRUG__ID D0AZ0T D0AZ0T DRUGCOMP Neuraltus Pharmaceuticals Inc D0AZ0T HIGHSTAT Investigative D0AZ5O DRUG__ID D0AZ5O D0AZ5O DRUGCOMP Seoul National University D0AZ5O HIGHSTAT Investigative D0AZ7F DRUG__ID D0AZ7F D0AZ7F DRUGCOMP Neurologix Inc D0AZ7F HIGHSTAT Investigative D0B0EO DRUG__ID D0B0EO D0B0EO DRUGCOMP Celprogen Inc D0B0EO HIGHSTAT Investigative D0B0EZ DRUG__ID D0B0EZ D0B0EZ DRUGCOMP Daewoong Pharmaceutical Co Ltd D0B0EZ HIGHSTAT Investigative D0B0MQ DRUG__ID D0B0MQ D0B0MQ DRUGCOMP KemPharm Inc D0B0MQ HIGHSTAT Investigative D0B1JE DRUG__ID D0B1JE D0B1JE DRUGCOMP TechnoVax Inc D0B1JE HIGHSTAT Investigative D0B1PU DRUG__ID D0B1PU D0B1PU DRUGCOMP Compugen Ltd D0B1PU HIGHSTAT Investigative D0B1RM DRUG__ID D0B1RM D0B1RM DRUGCOMP Lipopharma Therapeutics SL D0B1RM HIGHSTAT Investigative D0B1RY DRUG__ID D0B1RY D0B1RY DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D0B1RY HIGHSTAT Investigative D0B1SA DRUG__ID D0B1SA D0B1SA DRUGCOMP Immune Design Corp D0B1SA HIGHSTAT Investigative D0B1TN DRUG__ID D0B1TN D0B1TN DRUGCOMP NovaLead Pharma D0B1TN HIGHSTAT Investigative D0B2IB DRUG__ID D0B2IB D0B2IB DRUGCOMP Kenta Biotech Ltd D0B2IB HIGHSTAT Investigative D0B2JL DRUG__ID D0B2JL D0B2JL DRUGCOMP Medical College of Georgia D0B2JL HIGHSTAT Investigative D0B2ZM DRUG__ID D0B2ZM D0B2ZM DRUGCOMP Gliknik Inc D0B2ZM HIGHSTAT Investigative D0B3DE DRUG__ID D0B3DE D0B3DE DRUGCOMP Azevan Pharmaceuticals Inc D0B3DE HIGHSTAT Investigative D0B3ID DRUG__ID D0B3ID D0B3ID DRUGCOMP Medicell Co D0B3ID HIGHSTAT Investigative D0B3IZ DRUG__ID D0B3IZ D0B3IZ DRUGCOMP AmProtein Corp D0B3IZ HIGHSTAT Investigative D0B3KI DRUG__ID D0B3KI D0B3KI DRUGCOMP YD Life Science Inc D0B3KI HIGHSTAT Investigative D0B3UU DRUG__ID D0B3UU D0B3UU DRUGCOMP Bristol-Myers Squibb Co D0B3UU HIGHSTAT Investigative D0B4DK DRUG__ID D0B4DK D0B4DK DRUGCOMP ChronTech Pharma AB D0B4DK HIGHSTAT Investigative D0B4EG DRUG__ID D0B4EG D0B4EG DRUGCOMP Microbiotix Inc D0B4EG HIGHSTAT Investigative D0B4MB DRUG__ID D0B4MB D0B4MB DRUGCOMP Prothelia Inc D0B4MB HIGHSTAT Investigative D0B4ME DRUG__ID D0B4ME D0B4ME DRUGCOMP Cortex Pharmaceuticals Inc D0B4ME HIGHSTAT Investigative D0B5CN DRUG__ID D0B5CN D0B5CN DRUGCOMP Newsummit Biopharma Co Ltd D0B5CN HIGHSTAT Investigative D0B5QK DRUG__ID D0B5QK D0B5QK DRUGCOMP Texas A&M University System D0B5QK HIGHSTAT Investigative D0B6BE DRUG__ID D0B6BE D0B6BE DRUGCOMP Oriel Therapeutics Inc D0B6BE HIGHSTAT Investigative D0B6BW DRUG__ID D0B6BW D0B6BW DRUGCOMP ZIOPHARM Oncology Inc D0B6BW HIGHSTAT Investigative D0B6DV DRUG__ID D0B6DV D0B6DV DRUGCOMP Duke University D0B6DV HIGHSTAT Investigative D0B6HE DRUG__ID D0B6HE D0B6HE DRUGCOMP SK Chemicals Co Ltd D0B6HE HIGHSTAT Investigative D0B6OG DRUG__ID D0B6OG D0B6OG DRUGCOMP Bolder BioTechnology Inc D0B6OG HIGHSTAT Investigative D0B6YR DRUG__ID D0B6YR D0B6YR DRUGCOMP Genmab A/S D0B6YR HIGHSTAT Investigative D0B7AF DRUG__ID D0B7AF D0B7AF DRUGCOMP Kolon Life Science Inc D0B7AF HIGHSTAT Investigative D0B7EF DRUG__ID D0B7EF D0B7EF DRUGCOMP Microbial Novoteqs Inc D0B7EF HIGHSTAT Investigative D0B7GE DRUG__ID D0B7GE D0B7GE DRUGCOMP Osta Biotechnologies Inc D0B7GE HIGHSTAT Investigative D0B7HH DRUG__ID D0B7HH D0B7HH DRUGCOMP Sun Yat-Sen University D0B7HH HIGHSTAT Investigative D0B7JZ DRUG__ID D0B7JZ D0B7JZ DRUGCOMP CuraVac Inc D0B7JZ HIGHSTAT Investigative D0B7XF DRUG__ID D0B7XF D0B7XF DRUGCOMP ZaBeCor Pharmaceutical Co D0B7XF HIGHSTAT Investigative D0B8ES DRUG__ID D0B8ES D0B8ES DRUGCOMP Thrasos Therapeutics Inc D0B8ES HIGHSTAT Investigative D0B8IN DRUG__ID D0B8IN D0B8IN DRUGCOMP Multimeric Biotherapeutics Inc D0B8IN HIGHSTAT Investigative D0B8JG DRUG__ID D0B8JG D0B8JG DRUGCOMP The Procter & Gamble Co D0B8JG HIGHSTAT Investigative D0B8KE DRUG__ID D0B8KE D0B8KE DRUGCOMP Medarex Inc D0B8KE HIGHSTAT Investigative D0B8XK DRUG__ID D0B8XK D0B8XK DRUGCOMP IGE Therapeutics Inc D0B8XK HIGHSTAT Investigative D0B9AQ DRUG__ID D0B9AQ D0B9AQ DRUGCOMP Wyeth D0B9AQ HIGHSTAT Investigative D0B9HH DRUG__ID D0B9HH D0B9HH DRUGCOMP Mivenion Gmbh D0B9HH HIGHSTAT Investigative D0B9IV DRUG__ID D0B9IV D0B9IV DRUGCOMP Xel Pharmaceuticals Inc D0B9IV HIGHSTAT Investigative D0B9RF DRUG__ID D0B9RF D0B9RF DRUGCOMP Daewon Pharm Co Ltd D0B9RF HIGHSTAT Investigative D0B9UB DRUG__ID D0B9UB D0B9UB DRUGCOMP UCB Celltech D0B9UB HIGHSTAT Investigative D0B9XD DRUG__ID D0B9XD D0B9XD DRUGCOMP Georgetown University D0B9XD HIGHSTAT Investigative D0B9XM DRUG__ID D0B9XM D0B9XM DRUGCOMP LTT Bio-Pharma Co Ltd D0B9XM HIGHSTAT Investigative D0BA8H DRUG__ID D0BA8H D0BA8H DRUGCOMP Texas Tech University D0BA8H HIGHSTAT Investigative D0BE5U DRUG__ID D0BE5U D0BE5U DRUGTYPE Small molecule immunotherapy D0BE5U HIGHSTAT Investigative D0BJ0Q DRUG__ID D0BJ0Q D0BJ0Q DRUGCOMP University of Dundee D0BJ0Q HIGHSTAT Investigative D0BJ3B DRUG__ID D0BJ3B D0BJ3B DRUGCOMP Dana-Farber Cancer Institute Inc D0BJ3B HIGHSTAT Investigative D0BJ7G DRUG__ID D0BJ7G D0BJ7G DRUGCOMP Western States Biopharmaceuticals D0BJ7G HIGHSTAT Investigative D0BK3Z DRUG__ID D0BK3Z D0BK3Z DRUGCOMP AltaRex Medical Corp D0BK3Z HIGHSTAT Investigative D0BL6W DRUG__ID D0BL6W D0BL6W DRUGCOMP Theralpha SAS D0BL6W HIGHSTAT Investigative D0BM8Z DRUG__ID D0BM8Z D0BM8Z DRUGCOMP SOM Biotech SL D0BM8Z HIGHSTAT Investigative D0BP6I DRUG__ID D0BP6I D0BP6I DRUGCOMP Prism Pharmaceuticals Inc D0BP6I HIGHSTAT Investigative D0BP7W DRUG__ID D0BP7W D0BP7W DRUGCOMP Virobay Inc D0BP7W HIGHSTAT Investigative D0BR0D DRUG__ID D0BR0D D0BR0D DRUGCOMP MGB Biopharma Ltd D0BR0D HIGHSTAT Investigative D0BR7M DRUG__ID D0BR7M D0BR7M DRUGCOMP University of Colorado System D0BR7M HIGHSTAT Investigative D0BR8N DRUG__ID D0BR8N D0BR8N DRUGCOMP Biovista Inc D0BR8N HIGHSTAT Investigative D0BS6B DRUG__ID D0BS6B D0BS6B DRUGCOMP Tiger Pharmatech D0BS6B HIGHSTAT Investigative D0BT4P DRUG__ID D0BT4P D0BT4P DRUGCOMP ALS Therapy Development Foundation Inc D0BT4P HIGHSTAT Investigative D0BT6B DRUG__ID D0BT6B D0BT6B DRUGCOMP Charlesson LLC D0BT6B HIGHSTAT Investigative D0BX0V DRUG__ID D0BX0V D0BX0V DRUGCOMP Selexys Pharmaceuticals Corp D0BX0V HIGHSTAT Investigative D0C0AA DRUG__ID D0C0AA D0C0AA DRUGCOMP Diatos SA D0C0AA HIGHSTAT Investigative D0C0AC DRUG__ID D0C0AC D0C0AC DRUGCOMP Ganial Immunotherapeutics D0C0AC HIGHSTAT Investigative D0C0CF DRUG__ID D0C0CF D0C0CF DRUGCOMP Curidium D0C0CF HIGHSTAT Investigative D0C0FA DRUG__ID D0C0FA D0C0FA DRUGCOMP Afraxis Inc D0C0FA HIGHSTAT Investigative D0C0FG DRUG__ID D0C0FG D0C0FG DRUGCOMP Nectid Inc D0C0FG HIGHSTAT Investigative D0C0FO DRUG__ID D0C0FO D0C0FO DRUGCOMP Amazon Biotech D0C0FO HIGHSTAT Investigative D0C0HF DRUG__ID D0C0HF D0C0HF DRUGCOMP Galectin Therapeutics Inc D0C0HF HIGHSTAT Investigative D0C0MH DRUG__ID D0C0MH D0C0MH DRUGCOMP SRI International D0C0MH HIGHSTAT Investigative D0C0ON DRUG__ID D0C0ON D0C0ON DRUGCOMP Geron Corp D0C0ON HIGHSTAT Investigative D0C0QK DRUG__ID D0C0QK D0C0QK DRUGCOMP Limerick BioPharma Inc D0C0QK HIGHSTAT Investigative D0C0TJ DRUG__ID D0C0TJ D0C0TJ DRUGCOMP Planet Biotechnology Inc D0C0TJ HIGHSTAT Investigative D0C0WI DRUG__ID D0C0WI D0C0WI DRUGCOMP PharmaNeuroBoost NV D0C0WI HIGHSTAT Investigative D0C0YR DRUG__ID D0C0YR D0C0YR DRUGCOMP Multimeric Biotherapeutics Inc D0C0YR HIGHSTAT Investigative D0C1GE DRUG__ID D0C1GE D0C1GE DRUGCOMP FusoGen Pharmaceuticals Inc D0C1GE HIGHSTAT Investigative D0C1LF DRUG__ID D0C1LF D0C1LF DRUGCOMP NovaLead Pharma D0C1LF HIGHSTAT Investigative D0C1OJ DRUG__ID D0C1OJ D0C1OJ DRUGCOMP Mercury Therapeutics Inc D0C1OJ HIGHSTAT Investigative D0C1RN DRUG__ID D0C1RN D0C1RN DRUGCOMP Circassia Ltd D0C1RN HIGHSTAT Investigative D0C1TO DRUG__ID D0C1TO D0C1TO DRUGCOMP Equispharm Co Ltd D0C1TO HIGHSTAT Investigative D0C1TT DRUG__ID D0C1TT D0C1TT DRUGCOMP Sucampo Group D0C1TT HIGHSTAT Investigative D0C1UP DRUG__ID D0C1UP D0C1UP DRUGCOMP Serometrix LLC D0C1UP HIGHSTAT Investigative D0C1WP DRUG__ID D0C1WP D0C1WP DRUGCOMP Schering-Plough Research Institute D0C1WP HIGHSTAT Investigative D0C2GN DRUG__ID D0C2GN D0C2GN DRUGCOMP SeaLife Pharma GmbH D0C2GN HIGHSTAT Investigative D0C2IR DRUG__ID D0C2IR D0C2IR DRUGCOMP MediaPharma Srl D0C2IR HIGHSTAT Investigative D0C2MS DRUG__ID D0C2MS D0C2MS DRUGCOMP Medesis Pharma SA D0C2MS HIGHSTAT Investigative D0C2ZI DRUG__ID D0C2ZI D0C2ZI DRUGCOMP Prosidion Ltd D0C2ZI HIGHSTAT Investigative D0C3FN DRUG__ID D0C3FN D0C3FN DRUGCOMP ActivX Biosciences Inc D0C3FN HIGHSTAT Investigative D0C3GW DRUG__ID D0C3GW D0C3GW DRUGCOMP TG Biotech Inc D0C3GW HIGHSTAT Investigative D0C3GZ DRUG__ID D0C3GZ D0C3GZ DRUGCOMP STATegics Inc D0C3GZ HIGHSTAT Investigative D0C3RP DRUG__ID D0C3RP D0C3RP DRUGCOMP ALS Therapy Development Foundation Inc D0C3RP HIGHSTAT Investigative D0C4CJ DRUG__ID D0C4CJ D0C4CJ DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0C4CJ HIGHSTAT Investigative D0C4EQ DRUG__ID D0C4EQ D0C4EQ DRUGCOMP ATyr Pharma Inc D0C4EQ HIGHSTAT Investigative D0C4JI DRUG__ID D0C4JI D0C4JI DRUGCOMP Charit | - Universit tsmedizin Berlin: Charit | D0C4JI HIGHSTAT Investigative D0C4JV DRUG__ID D0C4JV D0C4JV DRUGCOMP Penn State Hershey Medical Center D0C4JV HIGHSTAT Investigative D0C4KE DRUG__ID D0C4KE D0C4KE DRUGCOMP Mimetogen Pharmaceuticals Inc D0C4KE HIGHSTAT Investigative D0C4NF DRUG__ID D0C4NF D0C4NF DRUGCOMP Molecular Design International Inc D0C4NF HIGHSTAT Investigative D0C4SH DRUG__ID D0C4SH D0C4SH DRUGCOMP Santen Pharmaceutical Co Ltd D0C4SH HIGHSTAT Investigative D0C4UU DRUG__ID D0C4UU D0C4UU DRUGCOMP ALS Therapy Development Foundation Inc D0C4UU HIGHSTAT Investigative D0C4WY DRUG__ID D0C4WY D0C4WY DRUGCOMP Georgetown University D0C4WY HIGHSTAT Investigative D0C5ND DRUG__ID D0C5ND D0C5ND DRUGCOMP Laboratorios Farmaceuticos Rovi SA D0C5ND HIGHSTAT Investigative D0C5UE DRUG__ID D0C5UE D0C5UE DRUGCOMP Boston Therapeutics Inc D0C5UE HIGHSTAT Investigative D0C5VP DRUG__ID D0C5VP D0C5VP DRUGCOMP Abeille Pharmaceuticals Inc D0C5VP HIGHSTAT Investigative D0C5WE DRUG__ID D0C5WE D0C5WE DRUGCOMP ArmaGen Technologies Inc D0C5WE HIGHSTAT Investigative D0C5XF DRUG__ID D0C5XF D0C5XF DRUGCOMP GlaxoSmithKline plc D0C5XF HIGHSTAT Investigative D0C6BJ DRUG__ID D0C6BJ D0C6BJ DRUGCOMP Synvax Pharmaceuticals Inc D0C6BJ HIGHSTAT Investigative D0C6DU DRUG__ID D0C6DU D0C6DU DRUGCOMP TechnoVax Inc D0C6DU HIGHSTAT Investigative D0C6PL DRUG__ID D0C6PL D0C6PL DRUGCOMP Texas Tech University D0C6PL HIGHSTAT Investigative D0C6TL DRUG__ID D0C6TL D0C6TL DRUGCOMP Neurotez Inc D0C6TL HIGHSTAT Investigative D0C6VK DRUG__ID D0C6VK D0C6VK DRUGCOMP Aduro BioTech Inc D0C6VK HIGHSTAT Investigative D0C6XD DRUG__ID D0C6XD D0C6XD DRUGCOMP BruCells D0C6XD HIGHSTAT Investigative D0C7CS DRUG__ID D0C7CS D0C7CS DRUGCOMP Alnylam Pharmaceuticals Inc D0C7CS HIGHSTAT Investigative D0C7CV DRUG__ID D0C7CV D0C7CV DRUGCOMP Silence Therapeutics plc D0C7CV HIGHSTAT Investigative D0C7GJ DRUG__ID D0C7GJ D0C7GJ DRUGCOMP Baxter International Inc D0C7GJ HIGHSTAT Investigative D0C7KB DRUG__ID D0C7KB D0C7KB DRUGCOMP Genova Biotech Comp Ltd D0C7KB HIGHSTAT Investigative D0C7LR DRUG__ID D0C7LR D0C7LR DRUGTYPE Small molecular drug D0C7LR HIGHSTAT Investigative D0C7NU DRUG__ID D0C7NU D0C7NU DRUGCOMP Vanas Oncology D0C7NU HIGHSTAT Investigative D0C7TO DRUG__ID D0C7TO D0C7TO DRUGCOMP Trojantec Ltd D0C7TO HIGHSTAT Investigative D0C7YH DRUG__ID D0C7YH D0C7YH DRUGCOMP Pharminox Ltd D0C7YH HIGHSTAT Investigative D0C8LG DRUG__ID D0C8LG D0C8LG DRUGCOMP Charlesson LLC D0C8LG HIGHSTAT Investigative D0C8NK DRUG__ID D0C8NK D0C8NK DRUGCOMP Obio Pharmaceutical Holdings Ltd D0C8NK HIGHSTAT Investigative D0C8XT DRUG__ID D0C8XT D0C8XT DRUGCOMP Summit Corporation D0C8XT HIGHSTAT Investigative D0C9DB DRUG__ID D0C9DB D0C9DB DRUGCOMP Burroughs Wellcome Inc D0C9DB HIGHSTAT Investigative D0C9JI DRUG__ID D0C9JI D0C9JI DRUGCOMP Molecular Targeting Technologies Inc D0C9JI HIGHSTAT Investigative D0C9KW DRUG__ID D0C9KW D0C9KW DRUGCOMP Avineuro Pharmaceuticals Inc D0C9KW HIGHSTAT Investigative D0C9LE DRUG__ID D0C9LE D0C9LE DRUGCOMP Korea Research Institute of Bioscience and Biotechnology D0C9LE HIGHSTAT Investigative D0C9QM DRUG__ID D0C9QM D0C9QM DRUGCOMP Threshold Pharmaceuticals Inc D0C9QM HIGHSTAT Investigative D0C9RF DRUG__ID D0C9RF D0C9RF DRUGCOMP Compugen Ltd D0C9RF HIGHSTAT Investigative D0C9RM DRUG__ID D0C9RM D0C9RM DRUGCOMP LTT Bio-Pharma Co Ltd D0C9RM HIGHSTAT Investigative D0CA2S DRUG__ID D0CA2S D0CA2S DRUGCOMP Universita di Perugia D0CA2S HIGHSTAT Investigative D0CB7L DRUG__ID D0CB7L D0CB7L DRUGCOMP Kedrion SpA D0CB7L HIGHSTAT Investigative D0CC3O DRUG__ID D0CC3O D0CC3O DRUGCOMP Apogenix GmbH D0CC3O HIGHSTAT Investigative D0CE5S DRUG__ID D0CE5S D0CE5S DRUGCOMP P2D Biosciences D0CE5S HIGHSTAT Investigative D0CF3H DRUG__ID D0CF3H D0CF3H DRUGCOMP Human Genome Sciences Inc D0CF3H HIGHSTAT Investigative D0CI4B DRUG__ID D0CI4B D0CI4B DRUGCOMP Addiction Therapeutix Inc D0CI4B HIGHSTAT Investigative D0CK2C DRUG__ID D0CK2C D0CK2C DRUGCOMP Zacharon Pharmaceuticals Inc D0CK2C HIGHSTAT Investigative D0CK5J DRUG__ID D0CK5J D0CK5J DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0CK5J HIGHSTAT Investigative D0CL8Q DRUG__ID D0CL8Q D0CL8Q DRUGTYPE Peptide D0CL8Q HIGHSTAT Investigative D0CO3O DRUG__ID D0CO3O D0CO3O DRUGCOMP RAPID Pharmaceuticals AG D0CO3O HIGHSTAT Investigative D0CP3Z DRUG__ID D0CP3Z D0CP3Z DRUGCOMP Cleveland Clinic Foundation D0CP3Z HIGHSTAT Investigative D0CS2L DRUG__ID D0CS2L D0CS2L DRUGCOMP Rega Institute for Medical Research D0CS2L HIGHSTAT Investigative D0CT3I DRUG__ID D0CT3I D0CT3I DRUGCOMP NovaBay Pharmaceuticals Inc D0CT3I HIGHSTAT Investigative D0CT5Z DRUG__ID D0CT5Z D0CT5Z DRUGCOMP SeaLife Pharma GmbH D0CT5Z HIGHSTAT Investigative D0CV7Q DRUG__ID D0CV7Q D0CV7Q DRUGCOMP Isis Pharmaceuticals Inc D0CV7Q HIGHSTAT Investigative D0CW6S DRUG__ID D0CW6S D0CW6S DRUGCOMP The University of Liverpool D0CW6S HIGHSTAT Investigative D0CY3F DRUG__ID D0CY3F D0CY3F DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D0CY3F HIGHSTAT Investigative D0CY9O DRUG__ID D0CY9O D0CY9O DRUGCOMP Onconova Therapeutics Inc D0CY9O HIGHSTAT Investigative D0D0IF DRUG__ID D0D0IF D0D0IF DRUGCOMP Targa Therapeutics Corp D0D0IF HIGHSTAT Investigative D0D0JY DRUG__ID D0D0JY D0D0JY DRUGCOMP InViragen LLC D0D0JY HIGHSTAT Investigative D0D0NA DRUG__ID D0D0NA D0D0NA DRUGCOMP KinDEx Therapeutics D0D0NA HIGHSTAT Investigative D0D0US DRUG__ID D0D0US D0D0US DRUGCOMP Osta Biotechnologies Inc D0D0US HIGHSTAT Investigative D0D0XY DRUG__ID D0D0XY D0D0XY DRUGCOMP Morphogenesis Inc D0D0XY HIGHSTAT Investigative D0D1HR DRUG__ID D0D1HR D0D1HR DRUGCOMP Addex Pharmaceuticals SA D0D1HR HIGHSTAT Investigative D0D1IR DRUG__ID D0D1IR D0D1IR DRUGCOMP Human Genome Sciences Inc D0D1IR HIGHSTAT Investigative D0D1PQ DRUG__ID D0D1PQ D0D1PQ DRUGCOMP BioLineRx Ltd D0D1PQ HIGHSTAT Investigative D0D1TB DRUG__ID D0D1TB D0D1TB DRUGCOMP Colby Pharmaceuticals D0D1TB HIGHSTAT Investigative D0D1TX DRUG__ID D0D1TX D0D1TX DRUGCOMP Newsummit Biopharma Co Ltd D0D1TX HIGHSTAT Investigative D0D1XE DRUG__ID D0D1XE D0D1XE DRUGCOMP NovelMed Therapeutics Inc D0D1XE HIGHSTAT Investigative D0D2AR DRUG__ID D0D2AR D0D2AR DRUGCOMP SOM Biotech SL D0D2AR HIGHSTAT Investigative D0D2GZ DRUG__ID D0D2GZ D0D2GZ DRUGCOMP Allon Therapeutics Inc D0D2GZ HIGHSTAT Investigative D0D2RR DRUG__ID D0D2RR D0D2RR DRUGCOMP PPL Therapeutics D0D2RR HIGHSTAT Investigative D0D2UU DRUG__ID D0D2UU D0D2UU DRUGCOMP Xel Pharmaceuticals Inc D0D2UU HIGHSTAT Investigative D0D2VI DRUG__ID D0D2VI D0D2VI DRUGCOMP Hygeia Therapeutics Inc D0D2VI HIGHSTAT Investigative D0D2ZI DRUG__ID D0D2ZI D0D2ZI DRUGCOMP SOM Biotech SL D0D2ZI HIGHSTAT Investigative D0D3HF DRUG__ID D0D3HF D0D3HF DRUGCOMP Ontario Inc D0D3HF HIGHSTAT Investigative D0D3LZ DRUG__ID D0D3LZ D0D3LZ DRUGCOMP ImClone Systems Inc D0D3LZ HIGHSTAT Investigative D0D3QJ DRUG__ID D0D3QJ D0D3QJ DRUGCOMP Cornerstone Therapeutics Inc D0D3QJ HIGHSTAT Investigative D0D3TO DRUG__ID D0D3TO D0D3TO DRUGCOMP Phynova Group plc D0D3TO HIGHSTAT Investigative D0D3TU DRUG__ID D0D3TU D0D3TU DRUGCOMP Daewoong Pharmaceutical Co Ltd D0D3TU HIGHSTAT Investigative D0D4IL DRUG__ID D0D4IL D0D4IL DRUGCOMP Digna Biotech SL D0D4IL HIGHSTAT Investigative D0D4UO DRUG__ID D0D4UO D0D4UO DRUGCOMP Dominion-Pharmakine Ltd D0D4UO HIGHSTAT Investigative D0D4WA DRUG__ID D0D4WA D0D4WA DRUGCOMP PhytoCeutica Inc D0D4WA HIGHSTAT Investigative D0D4ZE DRUG__ID D0D4ZE D0D4ZE DRUGCOMP Jasco Pharmaceuticals LLC D0D4ZE HIGHSTAT Investigative D0D5FB DRUG__ID D0D5FB D0D5FB DRUGCOMP Araim Pharmaceuticals Inc D0D5FB HIGHSTAT Investigative D0D5KQ DRUG__ID D0D5KQ D0D5KQ THERCLAS Anticancer Agents D0D5KQ HIGHSTAT Investigative D0D5NI DRUG__ID D0D5NI D0D5NI DRUGCOMP GeneBlue Corporation D0D5NI HIGHSTAT Investigative D0D5XV DRUG__ID D0D5XV D0D5XV DRUGCOMP Axikin Pharmaceuticals Inc D0D5XV HIGHSTAT Investigative D0D6EK DRUG__ID D0D6EK D0D6EK DRUGCOMP Ardelyx Inc D0D6EK HIGHSTAT Investigative D0D6LF DRUG__ID D0D6LF D0D6LF DRUGCOMP Pfizer Inc D0D6LF HIGHSTAT Investigative D0D6PG DRUG__ID D0D6PG D0D6PG DRUGCOMP Microbion Corp D0D6PG HIGHSTAT Investigative D0D6WF DRUG__ID D0D6WF D0D6WF DRUGCOMP Noscira SA D0D6WF HIGHSTAT Investigative D0D6XD DRUG__ID D0D6XD D0D6XD DRUGCOMP MetronomX D0D6XD HIGHSTAT Investigative D0D7EL DRUG__ID D0D7EL D0D7EL DRUGCOMP Chroma Therapeutics Ltd D0D7EL HIGHSTAT Investigative D0D7KR DRUG__ID D0D7KR D0D7KR DRUGCOMP University of Toledo D0D7KR HIGHSTAT Investigative D0D7LP DRUG__ID D0D7LP D0D7LP DRUGCOMP RaQualia Pharma Inc D0D7LP HIGHSTAT Investigative D0D7OE DRUG__ID D0D7OE D0D7OE DRUGCOMP NatImmune A/S D0D7OE HIGHSTAT Investigative D0D7QY DRUG__ID D0D7QY D0D7QY DRUGCOMP Bradford Pharma Ltd D0D7QY HIGHSTAT Investigative D0D7RE DRUG__ID D0D7RE D0D7RE DRUGCOMP Boston Biomedical Inc D0D7RE HIGHSTAT Investigative D0D7WS DRUG__ID D0D7WS D0D7WS DRUGCOMP Midatech Ltd D0D7WS HIGHSTAT Investigative D0D7XS DRUG__ID D0D7XS D0D7XS DRUGCOMP Wyeth D0D7XS HIGHSTAT Investigative D0D7YF DRUG__ID D0D7YF D0D7YF DRUGCOMP Neurotec Pharma SL D0D7YF HIGHSTAT Investigative D0D7YR DRUG__ID D0D7YR D0D7YR DRUGCOMP AmProtein Corp D0D7YR HIGHSTAT Investigative D0D8GO DRUG__ID D0D8GO D0D8GO DRUGCOMP Melior Pharmaceuticals Inc D0D8GO HIGHSTAT Investigative D0D8MS DRUG__ID D0D8MS D0D8MS DRUGCOMP NeuroSearch A/S D0D8MS HIGHSTAT Investigative D0D9KK DRUG__ID D0D9KK D0D9KK DRUGCOMP Roche Holding AG D0D9KK HIGHSTAT Investigative D0D9KV DRUG__ID D0D9KV D0D9KV DRUGCOMP Sanwa Kagaku Kenkyusho Co Ltd D0D9KV HIGHSTAT Investigative D0D9OM DRUG__ID D0D9OM D0D9OM DRUGCOMP Vantia Therapeutics D0D9OM HIGHSTAT Investigative D0DA0C DRUG__ID D0DA0C D0DA0C DRUGCOMP Ensoltek Co Ltd D0DA0C HIGHSTAT Investigative D0DA3D DRUG__ID D0DA3D D0DA3D DRUGCOMP Melior Pharmaceuticals Inc D0DA3D HIGHSTAT Investigative D0DA6N DRUG__ID D0DA6N D0DA6N DRUGCOMP Planet Biotechnology Inc D0DA6N HIGHSTAT Investigative D0DB2F DRUG__ID D0DB2F D0DB2F DRUGCOMP Medexgen Co Ltd D0DB2F HIGHSTAT Investigative D0DD9T DRUG__ID D0DD9T D0DD9T DRUGCOMP Huons Co Ltd D0DD9T HIGHSTAT Investigative D0DF8Y DRUG__ID D0DF8Y D0DF8Y DRUGCOMP Cytochroma Inc D0DF8Y HIGHSTAT Investigative D0DK2X DRUG__ID D0DK2X D0DK2X DRUGCOMP GlaxoSmithKline plc D0DK2X HIGHSTAT Investigative D0DM4K DRUG__ID D0DM4K D0DM4K DRUGCOMP Immodulon Therapeutics Limited D0DM4K HIGHSTAT Investigative D0DN7K DRUG__ID D0DN7K D0DN7K DRUGCOMP F Hoffmann-La Roche Ltd D0DN7K HIGHSTAT Investigative D0DP7T DRUG__ID D0DP7T D0DP7T DRUGCOMP OncoCyte Corp D0DP7T HIGHSTAT Investigative D0DP8U DRUG__ID D0DP8U D0DP8U DRUGCOMP Ikerchem D0DP8U HIGHSTAT Investigative D0DQ2N DRUG__ID D0DQ2N D0DQ2N DRUGCOMP Monsanto Co D0DQ2N HIGHSTAT Investigative D0DS1L DRUG__ID D0DS1L D0DS1L DRUGCOMP Obio Pharmaceutical Holdings Ltd D0DS1L HIGHSTAT Investigative D0DS2M DRUG__ID D0DS2M D0DS2M DRUGCOMP Panorama Research Inc D0DS2M HIGHSTAT Investigative D0DU6X DRUG__ID D0DU6X D0DU6X DRUGCOMP Intercell AG D0DU6X HIGHSTAT Investigative D0DY1N DRUG__ID D0DY1N D0DY1N DRUGCOMP Amsterdam Molecular Therapeutics BV D0DY1N HIGHSTAT Investigative D0E0DL DRUG__ID D0E0DL D0E0DL DRUGCOMP Adjuvantix Ltd D0E0DL HIGHSTAT Investigative D0E0DS DRUG__ID D0E0DS D0E0DS DRUGCOMP WntResearch AB D0E0DS HIGHSTAT Investigative D0E0GC DRUG__ID D0E0GC D0E0GC DRUGCOMP Limerick BioPharma Inc D0E0GC HIGHSTAT Investigative D0E0IG DRUG__ID D0E0IG D0E0IG DRUGCOMP Tolerx Inc D0E0IG HIGHSTAT Investigative D0E0IK DRUG__ID D0E0IK D0E0IK DRUGCOMP Advanomics Corp D0E0IK HIGHSTAT Investigative D0E0JV DRUG__ID D0E0JV D0E0JV DRUGCOMP Central Drug Research Institute D0E0JV HIGHSTAT Investigative D0E0MU DRUG__ID D0E0MU D0E0MU DRUGCOMP Pharmagenesis Inc D0E0MU HIGHSTAT Investigative D0E0OI DRUG__ID D0E0OI D0E0OI DRUGCOMP Telluride Pharmaceutical D0E0OI HIGHSTAT Investigative D0E0UC DRUG__ID D0E0UC D0E0UC DRUGCOMP Dainippon Sumitomo Pharma Co Ltd D0E0UC HIGHSTAT Investigative D0E0UN DRUG__ID D0E0UN D0E0UN DRUGCOMP ProCell Therapeutics Inc D0E0UN HIGHSTAT Investigative D0E1AZ DRUG__ID D0E1AZ D0E1AZ DRUGCOMP Isu Abxis Inc D0E1AZ HIGHSTAT Investigative D0E1HY DRUG__ID D0E1HY D0E1HY DRUGCOMP Anchor Therapeutics Inc D0E1HY HIGHSTAT Investigative D0E1UY DRUG__ID D0E1UY D0E1UY DRUGCOMP TWi Biotechnology Inc D0E1UY HIGHSTAT Investigative D0E1YN DRUG__ID D0E1YN D0E1YN DRUGCOMP S*BIO Pte Ltd D0E1YN HIGHSTAT Investigative D0E1ZQ DRUG__ID D0E1ZQ D0E1ZQ DRUGCOMP Tel Aviv University D0E1ZQ HIGHSTAT Investigative D0E1ZR DRUG__ID D0E1ZR D0E1ZR DRUGCOMP NovaLead Pharma D0E1ZR HIGHSTAT Investigative D0E2EN DRUG__ID D0E2EN D0E2EN DRUGCOMP ALS Therapy Development Foundation Inc D0E2EN HIGHSTAT Investigative D0E2GH DRUG__ID D0E2GH D0E2GH DRUGCOMP Emergent BioSolutions Inc D0E2GH HIGHSTAT Investigative D0E2KE DRUG__ID D0E2KE D0E2KE DRUGCOMP Synageva BioPharma Corp D0E2KE HIGHSTAT Investigative D0E2MI DRUG__ID D0E2MI D0E2MI DRUGCOMP ARigen Pharmaceuticals Inc D0E2MI HIGHSTAT Investigative D0E2WE DRUG__ID D0E2WE D0E2WE DRUGCOMP Mapp Biopharmaceutical Inc D0E2WE HIGHSTAT Investigative D0E2YX DRUG__ID D0E2YX D0E2YX DRUGCOMP Novaremed Ltd D0E2YX HIGHSTAT Investigative D0E3EA DRUG__ID D0E3EA D0E3EA DRUGCOMP Arteria D0E3EA HIGHSTAT Investigative D0E3JF DRUG__ID D0E3JF D0E3JF DRUGCOMP Cellerix SL D0E3JF HIGHSTAT Investigative D0E3ZO DRUG__ID D0E3ZO D0E3ZO DRUGCOMP Allinky Biopharma D0E3ZO HIGHSTAT Investigative D0E4JB DRUG__ID D0E4JB D0E4JB DRUGCOMP Tetraphase Pharmaceuticals Inc D0E4JB HIGHSTAT Investigative D0E4PN DRUG__ID D0E4PN D0E4PN DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D0E4PN HIGHSTAT Investigative D0E4TD DRUG__ID D0E4TD D0E4TD DRUGCOMP Ensoltek Co Ltd D0E4TD HIGHSTAT Investigative D0E5CX DRUG__ID D0E5CX D0E5CX DRUGCOMP Virionics Corp D0E5CX HIGHSTAT Investigative D0E5IT DRUG__ID D0E5IT D0E5IT DRUGCOMP PharmedArtis GmbH D0E5IT HIGHSTAT Investigative D0E5MO DRUG__ID D0E5MO D0E5MO DRUGCOMP Amunix Inc D0E5MO HIGHSTAT Investigative D0E6GS DRUG__ID D0E6GS D0E6GS DRUGCOMP MondoBIOTECH Holding AG D0E6GS HIGHSTAT Investigative D0E6JY DRUG__ID D0E6JY D0E6JY DRUGCOMP Argos Therapeutics Inc D0E6JY HIGHSTAT Investigative D0E6QI DRUG__ID D0E6QI D0E6QI DRUGCOMP The Menarini Group D0E6QI HIGHSTAT Investigative D0E6RZ DRUG__ID D0E6RZ D0E6RZ DRUGCOMP Da Volterra D0E6RZ HIGHSTAT Investigative D0E6VN DRUG__ID D0E6VN D0E6VN DRUGCOMP NovaDigm Therapeutics Inc D0E6VN HIGHSTAT Investigative D0E6ZI DRUG__ID D0E6ZI D0E6ZI DRUGCOMP Central South University D0E6ZI HIGHSTAT Investigative D0E7BS DRUG__ID D0E7BS D0E7BS DRUGCOMP Prexa Pharmaceuticals Inc D0E7BS HIGHSTAT Investigative D0E7GN DRUG__ID D0E7GN D0E7GN DRUGCOMP Apointech SL D0E7GN HIGHSTAT Investigative D0E7IZ DRUG__ID D0E7IZ D0E7IZ DRUGCOMP Molecular Templates Inc D0E7IZ HIGHSTAT Investigative D0E7PZ DRUG__ID D0E7PZ D0E7PZ DRUGCOMP NOXXON Pharma AG D0E7PZ HIGHSTAT Investigative D0E7RV DRUG__ID D0E7RV D0E7RV DRUGCOMP Teva Pharmaceutical Industries Ltd D0E7RV HIGHSTAT Investigative D0E7TR DRUG__ID D0E7TR D0E7TR DRUGCOMP Therapure Biopharma Inc D0E7TR HIGHSTAT Investigative D0E7XO DRUG__ID D0E7XO D0E7XO DRUGCOMP Immuron Ltd D0E7XO HIGHSTAT Investigative D0E8BD DRUG__ID D0E8BD D0E8BD DRUGCOMP Nanomerics D0E8BD HIGHSTAT Investigative D0E8IG DRUG__ID D0E8IG D0E8IG DRUGCOMP BioAlliance Pharma SA D0E8IG HIGHSTAT Investigative D0E8KK DRUG__ID D0E8KK D0E8KK DRUGCOMP Inhibikase Therapeutics D0E8KK HIGHSTAT Investigative D0E8NW DRUG__ID D0E8NW D0E8NW DRUGCOMP Kuros Biosurgery AG D0E8NW HIGHSTAT Investigative D0E8YS DRUG__ID D0E8YS D0E8YS DRUGCOMP MorphoSys AG D0E8YS HIGHSTAT Investigative D0E9DP DRUG__ID D0E9DP D0E9DP DRUGCOMP Genzyme Corp D0E9DP HIGHSTAT Investigative D0E9KC DRUG__ID D0E9KC D0E9KC DRUGCOMP Affimed Therapeutics AG D0E9KC HIGHSTAT Investigative D0E9LH DRUG__ID D0E9LH D0E9LH DRUGCOMP IPCA Laboratories Ltd D0E9LH HIGHSTAT Investigative D0E9OI DRUG__ID D0E9OI D0E9OI DRUGCOMP Daewon Pharm Co Ltd D0E9OI HIGHSTAT Investigative D0E9QZ DRUG__ID D0E9QZ D0E9QZ DRUGCOMP Sungkyunkwan University D0E9QZ HIGHSTAT Investigative D0E9VL DRUG__ID D0E9VL D0E9VL DRUGCOMP Berolina Innovative Research and Development Services Pharma AG D0E9VL HIGHSTAT Investigative D0E9YI DRUG__ID D0E9YI D0E9YI DRUGCOMP Fred Hutchinson Cancer Research Center D0E9YI HIGHSTAT Investigative D0EC1Y DRUG__ID D0EC1Y D0EC1Y DRUGCOMP Signum Biosciences Inc D0EC1Y HIGHSTAT Investigative D0ED6E DRUG__ID D0ED6E D0ED6E DRUGCOMP Camurus AB D0ED6E HIGHSTAT Investigative D0EI7H DRUG__ID D0EI7H D0EI7H DRUGCOMP AplaGen GmbH D0EI7H HIGHSTAT Investigative D0EK5H DRUG__ID D0EK5H D0EK5H DRUGCOMP Roger Williams Medical Center D0EK5H HIGHSTAT Investigative D0EL2L DRUG__ID D0EL2L D0EL2L DRUGCOMP NovaLead Pharma D0EL2L HIGHSTAT Investigative D0EL6M DRUG__ID D0EL6M D0EL6M DRUGCOMP Repros Therapeutics Inc D0EL6M HIGHSTAT Investigative D0EN0F DRUG__ID D0EN0F D0EN0F DRUGCOMP Biotecnol SA D0EN0F HIGHSTAT Investigative D0EO3K DRUG__ID D0EO3K D0EO3K DRUGCOMP Elusys D0EO3K HIGHSTAT Investigative D0EQ1J DRUG__ID D0EQ1J D0EQ1J DRUGCOMP Sentinel Oncology Ltd D0EQ1J HIGHSTAT Investigative D0ES9J DRUG__ID D0ES9J D0ES9J DRUGCOMP Gene Vector Technologies Ltd D0ES9J HIGHSTAT Investigative D0ET5E DRUG__ID D0ET5E D0ET5E DRUGCOMP EyeCyte Inc D0ET5E HIGHSTAT Investigative D0ET6F DRUG__ID D0ET6F D0ET6F DRUGCOMP Affitech A/S D0ET6F HIGHSTAT Investigative D0EU9Z DRUG__ID D0EU9Z D0EU9Z DRUGCOMP University of Arkansas D0EU9Z HIGHSTAT Investigative D0EW2D DRUG__ID D0EW2D D0EW2D DRUGCOMP Institute of Medicinal Molecular Design Inc D0EW2D HIGHSTAT Investigative D0EW4M DRUG__ID D0EW4M D0EW4M DRUGCOMP PharmaNeuroBoost NV D0EW4M HIGHSTAT Investigative D0EY3X DRUG__ID D0EY3X D0EY3X DRUGCOMP Genexine Co Ltd D0EY3X HIGHSTAT Investigative D0EZ0M DRUG__ID D0EZ0M D0EZ0M DRUGCOMP Tetra Therapeutics SL D0EZ0M HIGHSTAT Investigative D0EZ9C DRUG__ID D0EZ9C D0EZ9C DRUGCOMP Amunix Inc D0EZ9C HIGHSTAT Investigative D0F0ET DRUG__ID D0F0ET D0F0ET DRUGCOMP King Pharmaceuticals Inc D0F0ET HIGHSTAT Investigative D0F0JZ DRUG__ID D0F0JZ D0F0JZ DRUGCOMP Celprogen Inc D0F0JZ HIGHSTAT Investigative D0F0LO DRUG__ID D0F0LO D0F0LO DRUGCOMP Human Genome Sciences Inc D0F0LO HIGHSTAT Investigative D0F0VQ DRUG__ID D0F0VQ D0F0VQ DRUGCOMP Bexion Pharmaceuticals LLC D0F0VQ HIGHSTAT Investigative D0F0YM DRUG__ID D0F0YM D0F0YM DRUGCOMP MiRagen Therapeutics Inc D0F0YM HIGHSTAT Investigative D0F1CN DRUG__ID D0F1CN D0F1CN DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D0F1CN HIGHSTAT Investigative D0F1EF DRUG__ID D0F1EF D0F1EF DRUGTYPE Small molecular drug D0F1EF HIGHSTAT Investigative D0F1GD DRUG__ID D0F1GD D0F1GD DRUGCOMP AuRx Inc D0F1GD HIGHSTAT Investigative D0F1HV DRUG__ID D0F1HV D0F1HV DRUGTYPE Peptide D0F1HV HIGHSTAT Investigative D0F1OG DRUG__ID D0F1OG D0F1OG DRUGCOMP Tumor Biology Investment Group Inc D0F1OG HIGHSTAT Investigative D0F1UW DRUG__ID D0F1UW D0F1UW DRUGCOMP National Institutes of Health D0F1UW HIGHSTAT Investigative D0F1WD DRUG__ID D0F1WD D0F1WD DRUGCOMP CoNCERT Pharmaceuticals Inc D0F1WD HIGHSTAT Investigative D0F2CH DRUG__ID D0F2CH D0F2CH DRUGCOMP JCR Pharmaceuticals D0F2CH HIGHSTAT Investigative D0F2CQ DRUG__ID D0F2CQ D0F2CQ DRUGCOMP TFChem SAS D0F2CQ HIGHSTAT Investigative D0F2DD DRUG__ID D0F2DD D0F2DD DRUGCOMP Korea Research Institute of Chemical Technology D0F2DD HIGHSTAT Investigative D0F2GK DRUG__ID D0F2GK D0F2GK DRUGCOMP REGiMMUNE Corp D0F2GK HIGHSTAT Investigative D0F2OG DRUG__ID D0F2OG D0F2OG DRUGCOMP Affimed Therapeutics AG D0F2OG HIGHSTAT Investigative D0F2RP DRUG__ID D0F2RP D0F2RP DRUGCOMP Targa Therapeutics Corp D0F2RP HIGHSTAT Investigative D0F3BP DRUG__ID D0F3BP D0F3BP DRUGCOMP PanOptica Inc D0F3BP HIGHSTAT Investigative D0F3GA DRUG__ID D0F3GA D0F3GA DRUGCOMP Rega Institute for Medical Research D0F3GA HIGHSTAT Investigative D0F3GK DRUG__ID D0F3GK D0F3GK DRUGCOMP Ensoltek Co Ltd D0F3GK HIGHSTAT Investigative D0F3IM DRUG__ID D0F3IM D0F3IM DRUGCOMP Imaxio D0F3IM HIGHSTAT Investigative D0F3JA DRUG__ID D0F3JA D0F3JA DRUGCOMP HanAll Biopharma Co Ltd D0F3JA HIGHSTAT Investigative D0F3ON DRUG__ID D0F3ON D0F3ON DRUGCOMP Advantagene Inc D0F3ON HIGHSTAT Investigative D0F4AP DRUG__ID D0F4AP D0F4AP DRUGCOMP Glycan Biosciences Pty Ltd D0F4AP HIGHSTAT Investigative D0F4CT DRUG__ID D0F4CT D0F4CT DRUGCOMP Molteni Therapeutics Srl D0F4CT HIGHSTAT Investigative D0F4DW DRUG__ID D0F4DW D0F4DW DRUGCOMP Human Genome Sciences Inc D0F4DW HIGHSTAT Investigative D0F4FN DRUG__ID D0F4FN D0F4FN DRUGCOMP Novo Nordisk A/S D0F4FN HIGHSTAT Investigative D0F4FV DRUG__ID D0F4FV D0F4FV DRUGCOMP Dyax Corp D0F4FV HIGHSTAT Investigative D0F4IC DRUG__ID D0F4IC D0F4IC DRUGCOMP AcurePharma AB D0F4IC HIGHSTAT Investigative D0F4MK DRUG__ID D0F4MK D0F4MK DRUGCOMP Vical Inc D0F4MK HIGHSTAT Investigative D0F4QJ DRUG__ID D0F4QJ D0F4QJ DRUGCOMP Rottapharm Madaus D0F4QJ HIGHSTAT Investigative D0F4RM DRUG__ID D0F4RM D0F4RM DRUGCOMP Aus Bio Ltd D0F4RM HIGHSTAT Investigative D0F4SI DRUG__ID D0F4SI D0F4SI DRUGCOMP N30 Pharmaceuticals LLC D0F4SI HIGHSTAT Investigative D0F4UI DRUG__ID D0F4UI D0F4UI DRUGCOMP Northeast Normal University D0F4UI HIGHSTAT Investigative D0F4VK DRUG__ID D0F4VK D0F4VK DRUGCOMP TROBIO AB D0F4VK HIGHSTAT Investigative D0F5AB DRUG__ID D0F5AB D0F5AB DRUGCOMP Pangene D0F5AB HIGHSTAT Investigative D0F5DK DRUG__ID D0F5DK D0F5DK DRUGCOMP Anaphore Inc D0F5DK HIGHSTAT Investigative D0F5IS DRUG__ID D0F5IS D0F5IS DRUGCOMP NeuroGeneration Inc D0F5IS HIGHSTAT Investigative D0F5NG DRUG__ID D0F5NG D0F5NG DRUGCOMP Kuros Biosurgery AG D0F5NG HIGHSTAT Investigative D0F5TM DRUG__ID D0F5TM D0F5TM DRUGCOMP Onco-Pharmakon Inc D0F5TM HIGHSTAT Investigative D0F5TS DRUG__ID D0F5TS D0F5TS DRUGCOMP Kyowa Hakko Kirin Co Ltd D0F5TS HIGHSTAT Investigative D0F5UO DRUG__ID D0F5UO D0F5UO DRUGCOMP Korea Institute of Science and Technology D0F5UO HIGHSTAT Investigative D0F5ZZ DRUG__ID D0F5ZZ D0F5ZZ DRUGCOMP Ensoltek Co Ltd D0F5ZZ HIGHSTAT Investigative D0F6AJ DRUG__ID D0F6AJ D0F6AJ DRUGCOMP Nventa Biopharmaceuticals Corp D0F6AJ HIGHSTAT Investigative D0F6DF DRUG__ID D0F6DF D0F6DF DRUGCOMP Alethia Biotherapeutics Inc D0F6DF HIGHSTAT Investigative D0F6IL DRUG__ID D0F6IL D0F6IL DRUGCOMP KunWha Pharmaceutical Co Ltd D0F6IL HIGHSTAT Investigative D0F6OF DRUG__ID D0F6OF D0F6OF DRUGCOMP Nerviano Medical Sciences Srl D0F6OF HIGHSTAT Investigative D0F6QN DRUG__ID D0F6QN D0F6QN DRUGCOMP SeaLife Pharma GmbH D0F6QN HIGHSTAT Investigative D0F6WW DRUG__ID D0F6WW D0F6WW DRUGCOMP H Lundbeck A/S D0F6WW HIGHSTAT Investigative D0F7FE DRUG__ID D0F7FE D0F7FE DRUGCOMP SYGNIS Pharma AG D0F7FE HIGHSTAT Investigative D0F8BR DRUG__ID D0F8BR D0F8BR DRUGCOMP Xaragen Pharma Ltd D0F8BR HIGHSTAT Investigative D0F8CS DRUG__ID D0F8CS D0F8CS DRUGCOMP Memgen LLC D0F8CS HIGHSTAT Investigative D0F8GT DRUG__ID D0F8GT D0F8GT DRUGCOMP AVI BioPharma Inc D0F8GT HIGHSTAT Investigative D0F8KR DRUG__ID D0F8KR D0F8KR DRUGCOMP R-Tech Ueno Ltd D0F8KR HIGHSTAT Investigative D0F8NE DRUG__ID D0F8NE D0F8NE DRUGCOMP Vicept Therapeutics Inc D0F8NE HIGHSTAT Investigative D0F8VH DRUG__ID D0F8VH D0F8VH DRUGCOMP Thrasos Therapeutics Inc D0F8VH HIGHSTAT Investigative D0F8ZD DRUG__ID D0F8ZD D0F8ZD DRUGCOMP Nestle SA D0F8ZD HIGHSTAT Investigative D0F9IK DRUG__ID D0F9IK D0F9IK DRUGCOMP Institute of Microbial Technology D0F9IK HIGHSTAT Investigative D0F9NN DRUG__ID D0F9NN D0F9NN DRUGCOMP Apeptico Forschung und Entwicklung GmbH D0F9NN HIGHSTAT Investigative D0F9YJ DRUG__ID D0F9YJ D0F9YJ DRUGCOMP Johns Hopkins University School of Medicine D0F9YJ HIGHSTAT Investigative D0FA4C DRUG__ID D0FA4C D0FA4C DRUGCOMP JDP Therapeutics Inc D0FA4C HIGHSTAT Investigative D0FA4Q DRUG__ID D0FA4Q D0FA4Q DRUGCOMP Addex Pharmaceuticals SA D0FA4Q HIGHSTAT Investigative D0FB1S DRUG__ID D0FB1S D0FB1S DRUGCOMP GTx Inc D0FB1S HIGHSTAT Investigative D0FH8R DRUG__ID D0FH8R D0FH8R DRUGCOMP DARA BioSciences D0FH8R HIGHSTAT Investigative D0FH9O DRUG__ID D0FH9O D0FH9O DRUGCOMP SynDevRx Inc D0FH9O HIGHSTAT Investigative D0FI1K DRUG__ID D0FI1K D0FI1K DRUGCOMP AlphaRx Inc D0FI1K HIGHSTAT Investigative D0FK6A DRUG__ID D0FK6A D0FK6A DRUGCOMP ALS Therapy Development Foundation Inc D0FK6A HIGHSTAT Investigative D0FL4G DRUG__ID D0FL4G D0FL4G DRUGCOMP Genentech Inc D0FL4G HIGHSTAT Investigative D0FL6C DRUG__ID D0FL6C D0FL6C DRUGCOMP HanAll Biopharma Co Ltd D0FL6C HIGHSTAT Investigative D0FM4T DRUG__ID D0FM4T D0FM4T DRUGCOMP Endocyte Inc D0FM4T HIGHSTAT Investigative D0FN9X DRUG__ID D0FN9X D0FN9X DRUGCOMP Compugen Ltd D0FN9X HIGHSTAT Investigative D0FO1P DRUG__ID D0FO1P D0FO1P DRUGCOMP HanAll Biopharma Co Ltd D0FO1P HIGHSTAT Investigative D0FY2N DRUG__ID D0FY2N D0FY2N DRUGCOMP Nectid Inc D0FY2N HIGHSTAT Investigative D0FZ8U DRUG__ID D0FZ8U D0FZ8U DRUGCOMP Selexys Pharmaceuticals Corp D0FZ8U HIGHSTAT Investigative D0FZ9N DRUG__ID D0FZ9N D0FZ9N DRUGCOMP ALS Therapy Development Foundation Inc D0FZ9N HIGHSTAT Investigative D0G0AQ DRUG__ID D0G0AQ D0G0AQ DRUGCOMP Alligator Bioscience AB D0G0AQ HIGHSTAT Investigative D0G0KZ DRUG__ID D0G0KZ D0G0KZ DRUGCOMP Zacharon Pharmaceuticals Inc D0G0KZ HIGHSTAT Investigative D0G1AA DRUG__ID D0G1AA D0G1AA DRUGCOMP ASKA Pharmaceutical Co Ltd D0G1AA HIGHSTAT Investigative D0G1AK DRUG__ID D0G1AK D0G1AK DRUGCOMP Grupo Uriach D0G1AK HIGHSTAT Investigative D0G1AQ DRUG__ID D0G1AQ D0G1AQ DRUGCOMP Kala Pharmaceuticals Inc D0G1AQ HIGHSTAT Investigative D0G1CB DRUG__ID D0G1CB D0G1CB DRUGCOMP Prosensa Therapeutics BV D0G1CB HIGHSTAT Investigative D0G1LP DRUG__ID D0G1LP D0G1LP DRUGCOMP Altor BioScience Corp D0G1LP HIGHSTAT Investigative D0G1OS DRUG__ID D0G1OS D0G1OS DRUGCOMP LTT Bio-Pharma Co Ltd D0G1OS HIGHSTAT Investigative D0G1QL DRUG__ID D0G1QL D0G1QL DRUGCOMP Endocrine Technology LLC D0G1QL HIGHSTAT Investigative D0G1SY DRUG__ID D0G1SY D0G1SY DRUGCOMP Impel NeuroPharma D0G1SY HIGHSTAT Investigative D0G1TX DRUG__ID D0G1TX D0G1TX DRUGCOMP BioAlliance Pharma SA D0G1TX HIGHSTAT Investigative D0G1VG DRUG__ID D0G1VG D0G1VG DRUGCOMP Hygeia Therapeutics Inc D0G1VG HIGHSTAT Investigative D0G1WR DRUG__ID D0G1WR D0G1WR DRUGCOMP MondoBIOTECH Holding AG D0G1WR HIGHSTAT Investigative D0G1YH DRUG__ID D0G1YH D0G1YH DRUGCOMP NeED Pharmaceuticals Srl D0G1YH HIGHSTAT Investigative D0G2AV DRUG__ID D0G2AV D0G2AV DRUGCOMP Lutran Industries Inc D0G2AV HIGHSTAT Investigative D0G2DR DRUG__ID D0G2DR D0G2DR DRUGCOMP Antyra Inc D0G2DR HIGHSTAT Investigative D0G2GZ DRUG__ID D0G2GZ D0G2GZ DRUGCOMP Xaragen Pharma Ltd D0G2GZ HIGHSTAT Investigative D0G2UP DRUG__ID D0G2UP D0G2UP DRUGCOMP Dafra Pharma R&D D0G2UP HIGHSTAT Investigative D0G3BK DRUG__ID D0G3BK D0G3BK DRUGCOMP Zealand Pharma A/S D0G3BK HIGHSTAT Investigative D0G3DD DRUG__ID D0G3DD D0G3DD DRUGCOMP Charleston Laboratories Inc D0G3DD HIGHSTAT Investigative D0G3DP DRUG__ID D0G3DP D0G3DP DRUGCOMP Pain Therapeutics Inc D0G3DP HIGHSTAT Investigative D0G3KP DRUG__ID D0G3KP D0G3KP DRUGCOMP Virginia Commonwealth University D0G3KP HIGHSTAT Investigative D0G3QF DRUG__ID D0G3QF D0G3QF DRUGCOMP Cytometix Inc D0G3QF HIGHSTAT Investigative D0G3RW DRUG__ID D0G3RW D0G3RW DRUGCOMP Amplyx Pharmaceuticals Inc D0G3RW HIGHSTAT Investigative D0G3UG DRUG__ID D0G3UG D0G3UG DRUGCOMP Human Genome Sciences Inc D0G3UG HIGHSTAT Investigative D0G3ZN DRUG__ID D0G3ZN D0G3ZN DRUGCOMP Pfizer Inc D0G3ZN HIGHSTAT Investigative D0G4DF DRUG__ID D0G4DF D0G4DF DRUGCOMP Atlantic Healthcare Ltd D0G4DF HIGHSTAT Investigative D0G4ID DRUG__ID D0G4ID D0G4ID DRUGCOMP Kuros Biosurgery AG D0G4ID HIGHSTAT Investigative D0G4KD DRUG__ID D0G4KD D0G4KD DRUGCOMP Inha University D0G4KD HIGHSTAT Investigative D0G4SO DRUG__ID D0G4SO D0G4SO DRUGCOMP Suven Life Sciences Ltd D0G4SO HIGHSTAT Investigative D0G5FR DRUG__ID D0G5FR D0G5FR DRUGCOMP Kent State University D0G5FR HIGHSTAT Investigative D0G5RQ DRUG__ID D0G5RQ D0G5RQ DRUGCOMP AngioGenex Inc D0G5RQ HIGHSTAT Investigative D0G5RT DRUG__ID D0G5RT D0G5RT DRUGCOMP M's Science Corp D0G5RT HIGHSTAT Investigative D0G5UH DRUG__ID D0G5UH D0G5UH DRUGCOMP Eurapharm Inc D0G5UH HIGHSTAT Investigative D0G5VT DRUG__ID D0G5VT D0G5VT DRUGCOMP INCELL Corp D0G5VT HIGHSTAT Investigative D0G6CH DRUG__ID D0G6CH D0G6CH DRUGCOMP Aus Bio Ltd D0G6CH HIGHSTAT Investigative D0G6KH DRUG__ID D0G6KH D0G6KH DRUGCOMP NOXXON Pharma AG D0G6KH HIGHSTAT Investigative D0G6RK DRUG__ID D0G6RK D0G6RK DRUGCOMP Eurapharm Inc D0G6RK HIGHSTAT Investigative D0G6TV DRUG__ID D0G6TV D0G6TV DRUGCOMP Lubris Llc D0G6TV HIGHSTAT Investigative D0G6TX DRUG__ID D0G6TX D0G6TX DRUGCOMP Phylogica Ltd D0G6TX HIGHSTAT Investigative D0G7KE DRUG__ID D0G7KE D0G7KE DRUGCOMP Jennerex Inc D0G7KE HIGHSTAT Investigative D0G7LT DRUG__ID D0G7LT D0G7LT DRUGCOMP RegenX Biosciences LLC D0G7LT HIGHSTAT Investigative D0G7UV DRUG__ID D0G7UV D0G7UV DRUGCOMP Vivus D0G7UV HIGHSTAT Investigative D0G7XT DRUG__ID D0G7XT D0G7XT DRUGCOMP Phico Therapeutics Ltd D0G7XT HIGHSTAT Investigative D0G7YF DRUG__ID D0G7YF D0G7YF DRUGCOMP Vertex Pharmaceuticals Inc D0G7YF HIGHSTAT Investigative D0G8BE DRUG__ID D0G8BE D0G8BE DRUGCOMP AmProtein Corp D0G8BE HIGHSTAT Investigative D0G8EI DRUG__ID D0G8EI D0G8EI DRUGCOMP Hanlim Pharmaceutical Co Ltd D0G8EI HIGHSTAT Investigative D0G8MW DRUG__ID D0G8MW D0G8MW DRUGCOMP Lascco SA D0G8MW HIGHSTAT Investigative D0G8MY DRUG__ID D0G8MY D0G8MY DRUGCOMP Simcere Pharmaceutical Group D0G8MY HIGHSTAT Investigative D0G8OB DRUG__ID D0G8OB D0G8OB DRUGCOMP PanThera Biopharma LLC D0G8OB HIGHSTAT Investigative D0G9BH DRUG__ID D0G9BH D0G9BH DRUGCOMP Pico Pharmaceuticals Inc D0G9BH HIGHSTAT Investigative D0G9CJ DRUG__ID D0G9CJ D0G9CJ DRUGCOMP XBiotech Inc D0G9CJ HIGHSTAT Investigative D0G9EX DRUG__ID D0G9EX D0G9EX DRUGCOMP Anchor Therapeutics Inc D0G9EX HIGHSTAT Investigative D0G9JL DRUG__ID D0G9JL D0G9JL DRUGCOMP Chinese Academy of Medical Science D0G9JL HIGHSTAT Investigative D0G9XG DRUG__ID D0G9XG D0G9XG DRUGCOMP NatureWise Biotech & Medicals Corp D0G9XG HIGHSTAT Investigative D0G9ZY DRUG__ID D0G9ZY D0G9ZY DRUGCOMP Washington University in St Louis D0G9ZY HIGHSTAT Investigative D0GD6J DRUG__ID D0GD6J D0GD6J DRUGCOMP ALS Therapy Development Foundation Inc D0GD6J HIGHSTAT Investigative D0GG8N DRUG__ID D0GG8N D0GG8N DRUGCOMP Lytix Biopharma AS D0GG8N HIGHSTAT Investigative D0GK1M DRUG__ID D0GK1M D0GK1M DRUGCOMP ProNAi Therapeutics Inc D0GK1M HIGHSTAT Investigative D0GK9J DRUG__ID D0GK9J D0GK9J DRUGCOMP Rigel Pharmaceuticals Inc D0GK9J HIGHSTAT Investigative D0GL0J DRUG__ID D0GL0J D0GL0J DRUGCOMP Genfit SA D0GL0J HIGHSTAT Investigative D0GL7O DRUG__ID D0GL7O D0GL7O DRUGCOMP HanAll Biopharma Co Ltd D0GL7O HIGHSTAT Investigative D0GM0N DRUG__ID D0GM0N D0GM0N DRUGCOMP EndogenX Inc D0GM0N HIGHSTAT Investigative D0GM9E DRUG__ID D0GM9E D0GM9E DRUGCOMP RaQualia Pharma Inc D0GM9E HIGHSTAT Investigative D0GO0T DRUG__ID D0GO0T D0GO0T DRUGCOMP Hygeia Therapeutics Inc D0GO0T HIGHSTAT Investigative D0GV0H DRUG__ID D0GV0H D0GV0H DRUGCOMP DermiPsor Ltd D0GV0H HIGHSTAT Investigative D0GV0O DRUG__ID D0GV0O D0GV0O DRUGCOMP Ensoltek Co Ltd D0GV0O HIGHSTAT Investigative D0GW2L DRUG__ID D0GW2L D0GW2L DRUGCOMP Anacor Pharmaceuticals Inc D0GW2L HIGHSTAT Investigative D0GW3R DRUG__ID D0GW3R D0GW3R DRUGCOMP Prosetta Antiviral Inc D0GW3R HIGHSTAT Investigative D0GY3R DRUG__ID D0GY3R D0GY3R DRUGCOMP CEAMED SA D0GY3R HIGHSTAT Investigative D0GZ5F DRUG__ID D0GZ5F D0GZ5F DRUGCOMP Celentyx Ltd D0GZ5F HIGHSTAT Investigative D0H0EP DRUG__ID D0H0EP D0H0EP DRUGCOMP BioLineRx Ltd D0H0EP HIGHSTAT Investigative D0H0SH DRUG__ID D0H0SH D0H0SH DRUGCOMP Antibe Therapeutics Inc D0H0SH HIGHSTAT Investigative D0H0VB DRUG__ID D0H0VB D0H0VB DRUGCOMP BioCancell Therapeutics Ltd D0H0VB HIGHSTAT Investigative D0H0VS DRUG__ID D0H0VS D0H0VS DRUGCOMP Synageva BioPharma Corp D0H0VS HIGHSTAT Investigative D0H1JN DRUG__ID D0H1JN D0H1JN DRUGCOMP NsGene A/S D0H1JN HIGHSTAT Investigative D0H1NI DRUG__ID D0H1NI D0H1NI DRUGCOMP NaniRx Inc D0H1NI HIGHSTAT Investigative D0H1OO DRUG__ID D0H1OO D0H1OO DRUGCOMP Asterion Ltd D0H1OO HIGHSTAT Investigative D0H1UB DRUG__ID D0H1UB D0H1UB DRUGCOMP Tarix Pharmaceuticals D0H1UB HIGHSTAT Investigative D0H1UY DRUG__ID D0H1UY D0H1UY DRUGCOMP Pfizer Inc D0H1UY HIGHSTAT Investigative D0H1XL DRUG__ID D0H1XL D0H1XL DRUGCOMP Newsummit Biopharma Co Ltd D0H1XL HIGHSTAT Investigative D0H2JS DRUG__ID D0H2JS D0H2JS DRUGCOMP Clear Vascular Inc D0H2JS HIGHSTAT Investigative D0H2LE DRUG__ID D0H2LE D0H2LE DRUGCOMP Medtronic Inc D0H2LE HIGHSTAT Investigative D0H2LJ DRUG__ID D0H2LJ D0H2LJ DRUGCOMP ALS Therapy Development Foundation Inc D0H2LJ HIGHSTAT Investigative D0H2VN DRUG__ID D0H2VN D0H2VN DRUGCOMP Purdue University D0H2VN HIGHSTAT Investigative D0H2ZN DRUG__ID D0H2ZN D0H2ZN DRUGCOMP Zambon Co SpA D0H2ZN HIGHSTAT Investigative D0H3FA DRUG__ID D0H3FA D0H3FA DRUGCOMP Balboa Biosciences Inc D0H3FA HIGHSTAT Investigative D0H3FX DRUG__ID D0H3FX D0H3FX DRUGCOMP NeuroRepair Inc D0H3FX HIGHSTAT Investigative D0H4DU DRUG__ID D0H4DU D0H4DU DRUGCOMP Kalypsys Inc D0H4DU HIGHSTAT Investigative D0H4KF DRUG__ID D0H4KF D0H4KF DRUGCOMP Endocyte Inc D0H4KF HIGHSTAT Investigative D0H4NN DRUG__ID D0H4NN D0H4NN DRUGCOMP New biotics D0H4NN HIGHSTAT Investigative D0H4RV DRUG__ID D0H4RV D0H4RV DRUGCOMP Endece LLC D0H4RV HIGHSTAT Investigative D0H5GU DRUG__ID D0H5GU D0H5GU DRUGCOMP Escape Therapeutics Inc D0H5GU HIGHSTAT Investigative D0H5HS DRUG__ID D0H5HS D0H5HS DRUGCOMP Pusan National University D0H5HS HIGHSTAT Investigative D0H5HT DRUG__ID D0H5HT D0H5HT DRUGCOMP ACADIA Pharmaceuticals Inc D0H5HT HIGHSTAT Investigative D0H5KG DRUG__ID D0H5KG D0H5KG DRUGCOMP Arete Therapeutics Inc D0H5KG HIGHSTAT Investigative D0H5LY DRUG__ID D0H5LY D0H5LY DRUGCOMP Stelic Institute & Co D0H5LY HIGHSTAT Investigative D0H5NF DRUG__ID D0H5NF D0H5NF DRUGCOMP PROLOR Biotech Inc D0H5NF HIGHSTAT Investigative D0H5TW DRUG__ID D0H5TW D0H5TW DRUGCOMP Hygeia Therapeutics Inc D0H5TW HIGHSTAT Investigative D0H6AT DRUG__ID D0H6AT D0H6AT DRUGCOMP Symphogen A/S D0H6AT HIGHSTAT Investigative D0H6BL DRUG__ID D0H6BL D0H6BL DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D0H6BL HIGHSTAT Investigative D0H6IG DRUG__ID D0H6IG D0H6IG DRUGCOMP Esperance Pharmaceuticals Inc D0H6IG HIGHSTAT Investigative D0H6LE DRUG__ID D0H6LE D0H6LE DRUGCOMP Lipopharma Therapeutics SL D0H6LE HIGHSTAT Investigative D0H6PH DRUG__ID D0H6PH D0H6PH DRUGCOMP GlaxoSmithKline plc D0H6PH HIGHSTAT Investigative D0H6UK DRUG__ID D0H6UK D0H6UK DRUGCOMP Dekk-Tec Inc D0H6UK HIGHSTAT Investigative D0H6VL DRUG__ID D0H6VL D0H6VL DRUGCOMP Cancer Research Technology Ltd D0H6VL HIGHSTAT Investigative D0H7OO DRUG__ID D0H7OO D0H7OO DRUGCOMP PDS Biotechnology Corp D0H7OO HIGHSTAT Investigative D0H7PS DRUG__ID D0H7PS D0H7PS DRUGCOMP MultiCell Technologies Inc D0H7PS HIGHSTAT Investigative D0H7SG DRUG__ID D0H7SG D0H7SG DRUGCOMP Wellstat Biologics Corp D0H7SG HIGHSTAT Investigative D0H7TB DRUG__ID D0H7TB D0H7TB DRUGCOMP Bayer Schering Pharma AG D0H7TB HIGHSTAT Investigative D0H7TD DRUG__ID D0H7TD D0H7TD DRUGCOMP Cytokinetics Inc D0H7TD HIGHSTAT Investigative D0H8BD DRUG__ID D0H8BD D0H8BD DRUGCOMP PharmedArtis GmbH D0H8BD HIGHSTAT Investigative D0H8JM DRUG__ID D0H8JM D0H8JM DRUGCOMP Viron Therapeutics Inc D0H8JM HIGHSTAT Investigative D0H8MR DRUG__ID D0H8MR D0H8MR DRUGCOMP Catabasis Pharmaceuticals Inc D0H8MR HIGHSTAT Investigative D0H8VM DRUG__ID D0H8VM D0H8VM DRUGCOMP UAI D0H8VM HIGHSTAT Investigative D0H9GH DRUG__ID D0H9GH D0H9GH DRUGCOMP NeoGenix Oncology Inc D0H9GH HIGHSTAT Investigative D0H9MR DRUG__ID D0H9MR D0H9MR DRUGCOMP MediaPharma Srl D0H9MR HIGHSTAT Investigative D0H9NO DRUG__ID D0H9NO D0H9NO DRUGCOMP NovelMed Therapeutics Inc D0H9NO HIGHSTAT Investigative D0H9QN DRUG__ID D0H9QN D0H9QN DRUGCOMP AstraZeneca plc D0H9QN HIGHSTAT Investigative D0HA2R DRUG__ID D0HA2R D0HA2R DRUGCOMP Bolder BioTechnology Inc D0HA2R HIGHSTAT Investigative D0HB2F DRUG__ID D0HB2F D0HB2F DRUGCOMP Affibody Holding AB D0HB2F HIGHSTAT Investigative D0HH9P DRUG__ID D0HH9P D0HH9P DRUGCOMP SK Chemicals Co Ltd D0HH9P HIGHSTAT Investigative D0HJ9U DRUG__ID D0HJ9U D0HJ9U DRUGCOMP Louisiana State University D0HJ9U HIGHSTAT Investigative D0HK7G DRUG__ID D0HK7G D0HK7G DRUGCOMP Digital Biotech Co Ltd D0HK7G HIGHSTAT Investigative D0HM1S DRUG__ID D0HM1S D0HM1S DRUGCOMP FORMAC Pharmaceuticals NV D0HM1S HIGHSTAT Investigative D0HM5Q DRUG__ID D0HM5Q D0HM5Q DRUGCOMP Lypro Biosciences Inc D0HM5Q HIGHSTAT Investigative D0HM7G DRUG__ID D0HM7G D0HM7G DRUGCOMP Suven Life Sciences Ltd D0HM7G HIGHSTAT Investigative D0HN6X DRUG__ID D0HN6X D0HN6X DRUGCOMP SK Chemicals Co Ltd D0HN6X HIGHSTAT Investigative D0HO9M DRUG__ID D0HO9M D0HO9M DRUGCOMP Altos Vision Ltd D0HO9M HIGHSTAT Investigative D0HR5Q DRUG__ID D0HR5Q D0HR5Q DRUGCOMP Cheminpharma LLC D0HR5Q HIGHSTAT Investigative D0HS2E DRUG__ID D0HS2E D0HS2E DRUGCOMP Rib-X Pharmaceuticals Inc D0HS2E HIGHSTAT Investigative D0HS9Y DRUG__ID D0HS9Y D0HS9Y DRUGCOMP Chemokine Therapeutics Corp D0HS9Y HIGHSTAT Investigative D0HT4H DRUG__ID D0HT4H D0HT4H DRUGCOMP SOM Biotech SL D0HT4H HIGHSTAT Investigative D0HW1I DRUG__ID D0HW1I D0HW1I DRUGCOMP Panacea Pharmaceuticals Inc D0HW1I HIGHSTAT Investigative D0HX0P DRUG__ID D0HX0P D0HX0P DRUGCOMP Impel NeuroPharma D0HX0P HIGHSTAT Investigative D0HY4Q DRUG__ID D0HY4Q D0HY4Q DRUGCOMP Molecular Insight Pharmaceuticals Inc D0HY4Q HIGHSTAT Investigative D0HZ1V DRUG__ID D0HZ1V D0HZ1V DRUGCOMP Kwang Dong Pharmaceutical Co Ltd D0HZ1V HIGHSTAT Investigative D0I0BJ DRUG__ID D0I0BJ D0I0BJ DRUGCOMP Kambridge Life Science Technology Co Ltd D0I0BJ HIGHSTAT Investigative D0I0SG DRUG__ID D0I0SG D0I0SG DRUGCOMP CureLab Inc D0I0SG HIGHSTAT Investigative D0I0XX DRUG__ID D0I0XX D0I0XX DRUGCOMP Pharma Two B Ltd D0I0XX HIGHSTAT Investigative D0I0ZY DRUG__ID D0I0ZY D0I0ZY DRUGCOMP ET Neuron Inc D0I0ZY HIGHSTAT Investigative D0I1OX DRUG__ID D0I1OX D0I1OX DRUGCOMP Sepal Pharma Ltd D0I1OX HIGHSTAT Investigative D0I1TM DRUG__ID D0I1TM D0I1TM DRUGCOMP Faron Pharmaceuticals Ltd D0I1TM HIGHSTAT Investigative D0I1ZB DRUG__ID D0I1ZB D0I1ZB DRUGCOMP EndogenX Inc D0I1ZB HIGHSTAT Investigative D0I1ZT DRUG__ID D0I1ZT D0I1ZT DRUGCOMP ET Vaccine Technology Inc D0I1ZT HIGHSTAT Investigative D0I2AD DRUG__ID D0I2AD D0I2AD DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0I2AD HIGHSTAT Investigative D0I2GT DRUG__ID D0I2GT D0I2GT DRUGCOMP Telormedix SA D0I2GT HIGHSTAT Investigative D0I2JY DRUG__ID D0I2JY D0I2JY DRUGCOMP Roche Holding AG D0I2JY HIGHSTAT Investigative D0I2KZ DRUG__ID D0I2KZ D0I2KZ DRUGCOMP Aus Bio Ltd D0I2KZ HIGHSTAT Investigative D0I2MD DRUG__ID D0I2MD D0I2MD DRUGCOMP Receptor Logic Inc D0I2MD HIGHSTAT Investigative D0I2PS DRUG__ID D0I2PS D0I2PS DRUGCOMP Medlmmune LLC D0I2PS HIGHSTAT Investigative D0I2TT DRUG__ID D0I2TT D0I2TT DRUGCOMP Spirogen Ltd D0I2TT HIGHSTAT Investigative D0I3CP DRUG__ID D0I3CP D0I3CP DRUGCOMP Harvard Medical School D0I3CP HIGHSTAT Investigative D0I3OX DRUG__ID D0I3OX D0I3OX DRUGCOMP Euroscreen SA D0I3OX HIGHSTAT Investigative D0I3TD DRUG__ID D0I3TD D0I3TD DRUGCOMP ChemBridge Research Laboratories LLC D0I3TD HIGHSTAT Investigative D0I4LQ DRUG__ID D0I4LQ D0I4LQ DRUGCOMP Baxter D0I4LQ HIGHSTAT Investigative D0I4MW DRUG__ID D0I4MW D0I4MW DRUGCOMP Daewoong Pharmaceutical Co Ltd D0I4MW HIGHSTAT Investigative D0I4OJ DRUG__ID D0I4OJ D0I4OJ DRUGCOMP Axcan Pharma D0I4OJ HIGHSTAT Investigative D0I4PB DRUG__ID D0I4PB D0I4PB DRUGCOMP MultiCell Technologies Inc D0I4PB HIGHSTAT Investigative D0I4UY DRUG__ID D0I4UY D0I4UY DRUGCOMP GlaxoSmithKline plc D0I4UY HIGHSTAT Investigative D0I4VX DRUG__ID D0I4VX D0I4VX DRUGCOMP Sosei Group Corp D0I4VX HIGHSTAT Investigative D0I4WH DRUG__ID D0I4WH D0I4WH DRUGCOMP NicOx SA D0I4WH HIGHSTAT Investigative D0I4YP DRUG__ID D0I4YP D0I4YP DRUGCOMP BIOO Therapeutics D0I4YP HIGHSTAT Investigative D0I5CO DRUG__ID D0I5CO D0I5CO DRUGCOMP NeuroNascent Inc D0I5CO HIGHSTAT Investigative D0I5ED DRUG__ID D0I5ED D0I5ED DRUGCOMP ThromboGenics NV D0I5ED HIGHSTAT Investigative D0I5GC DRUG__ID D0I5GC D0I5GC DRUGCOMP Pfizer Inc D0I5GC HIGHSTAT Investigative D0I5IS DRUG__ID D0I5IS D0I5IS DRUGCOMP Microbion Corp D0I5IS HIGHSTAT Investigative D0I5ND DRUG__ID D0I5ND D0I5ND DRUGCOMP Connexios Life Sciences Pvt Ltd D0I5ND HIGHSTAT Investigative D0I5TT DRUG__ID D0I5TT D0I5TT DRUGCOMP Epistem Holdings plc D0I5TT HIGHSTAT Investigative D0I5ZO DRUG__ID D0I5ZO D0I5ZO DRUGCOMP Astellas Pharma Inc D0I5ZO HIGHSTAT Investigative D0I6KC DRUG__ID D0I6KC D0I6KC DRUGCOMP Najit Technologies Inc D0I6KC HIGHSTAT Investigative D0I6LR DRUG__ID D0I6LR D0I6LR DRUGCOMP BioLineRx Ltd D0I6LR HIGHSTAT Investigative D0I6QN DRUG__ID D0I6QN D0I6QN DRUGCOMP Kyowa Hakko Kirin Co Ltd D0I6QN HIGHSTAT Investigative D0I6UN DRUG__ID D0I6UN D0I6UN DRUGCOMP AbGenomics Corp D0I6UN HIGHSTAT Investigative D0I6XJ DRUG__ID D0I6XJ D0I6XJ DRUGCOMP AurimMed Pharma Inc D0I6XJ HIGHSTAT Investigative D0I7FH DRUG__ID D0I7FH D0I7FH DRUGCOMP Pfizer Inc D0I7FH HIGHSTAT Investigative D0I7HG DRUG__ID D0I7HG D0I7HG DRUGCOMP Redbiotec AG D0I7HG HIGHSTAT Investigative D0I7MF DRUG__ID D0I7MF D0I7MF DRUGCOMP Simcere Pharmaceutical Group D0I7MF HIGHSTAT Investigative D0I7MK DRUG__ID D0I7MK D0I7MK DRUGCOMP MondoBIOTECH Holding AG D0I7MK HIGHSTAT Investigative D0I7VI DRUG__ID D0I7VI D0I7VI DRUGCOMP EnGene Inc D0I7VI HIGHSTAT Investigative D0I7YR DRUG__ID D0I7YR D0I7YR DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0I7YR HIGHSTAT Investigative D0I8GN DRUG__ID D0I8GN D0I8GN DRUGCOMP St Jude Children's Research Hospital D0I8GN HIGHSTAT Investigative D0I8LL DRUG__ID D0I8LL D0I8LL DRUGCOMP Xaragen Pharma Ltd D0I8LL HIGHSTAT Investigative D0I8PA DRUG__ID D0I8PA D0I8PA DRUGCOMP Mivenion Gmbh D0I8PA HIGHSTAT Investigative D0I8QY DRUG__ID D0I8QY D0I8QY DRUGCOMP Tamir Biotechnology Inc D0I8QY HIGHSTAT Investigative D0I8SA DRUG__ID D0I8SA D0I8SA DRUGCOMP Bioncotech Therapeutics SL D0I8SA HIGHSTAT Investigative D0I8SC DRUG__ID D0I8SC D0I8SC DRUGCOMP Western States Biopharmaceuticals D0I8SC HIGHSTAT Investigative D0I9FQ DRUG__ID D0I9FQ D0I9FQ DRUGCOMP Xaragen Pharma Ltd D0I9FQ HIGHSTAT Investigative D0I9GA DRUG__ID D0I9GA D0I9GA DRUGCOMP AbGenomics Corp D0I9GA HIGHSTAT Investigative D0I9RB DRUG__ID D0I9RB D0I9RB DRUGCOMP SOM Biotech SL D0I9RB HIGHSTAT Investigative D0I9TV DRUG__ID D0I9TV D0I9TV DRUGCOMP Daewon Pharm Co Ltd D0I9TV HIGHSTAT Investigative D0I9ZQ DRUG__ID D0I9ZQ D0I9ZQ DRUGCOMP Spider Biotech Srl D0I9ZQ HIGHSTAT Investigative D0IC2O DRUG__ID D0IC2O D0IC2O DRUGTYPE Antisense drug D0IC2O HIGHSTAT Investigative D0IC8P DRUG__ID D0IC8P D0IC8P DRUGCOMP HanAll Biopharma Co Ltd D0IC8P HIGHSTAT Investigative D0IJ0Q DRUG__ID D0IJ0Q D0IJ0Q DRUGCOMP Millennium Pharmaceuticals Inc D0IJ0Q HIGHSTAT Investigative D0IJ4G DRUG__ID D0IJ4G D0IJ4G DRUGCOMP Vakzine Projekt Management GmbH D0IJ4G HIGHSTAT Investigative D0IL7V DRUG__ID D0IL7V D0IL7V DRUGCOMP Kyorin Pharmaceutical Co Ltd D0IL7V HIGHSTAT Investigative D0IM7C DRUG__ID D0IM7C D0IM7C DRUGCOMP Ranbaxy Laboratories Ltd D0IM7C HIGHSTAT Investigative D0IP7M DRUG__ID D0IP7M D0IP7M DRUGCOMP Patrys Ltd D0IP7M HIGHSTAT Investigative D0IR8J DRUG__ID D0IR8J D0IR8J DRUGCOMP Indus Biotech Pvt Ltd D0IR8J HIGHSTAT Investigative D0IU0W DRUG__ID D0IU0W D0IU0W DRUGCOMP Quro Science Inc D0IU0W HIGHSTAT Investigative D0IV7J DRUG__ID D0IV7J D0IV7J DRUGCOMP NatImmune A/S D0IV7J HIGHSTAT Investigative D0IW1Y DRUG__ID D0IW1Y D0IW1Y DRUGCOMP Pierre Fabre SA D0IW1Y HIGHSTAT Investigative D0IW8I DRUG__ID D0IW8I D0IW8I DRUGCOMP Lipoxen plc D0IW8I HIGHSTAT Investigative D0IW9Q DRUG__ID D0IW9Q D0IW9Q DRUGCOMP Medarex Inc D0IW9Q HIGHSTAT Investigative D0IY2B DRUG__ID D0IY2B D0IY2B DRUGCOMP SomaGenics Inc D0IY2B HIGHSTAT Investigative D0IY2M DRUG__ID D0IY2M D0IY2M DRUGCOMP Angelini Pharmaceuticals SpA D0IY2M HIGHSTAT Investigative D0J0AN DRUG__ID D0J0AN D0J0AN DRUGCOMP Insert Therapeutics Inc D0J0AN HIGHSTAT Investigative D0J0BI DRUG__ID D0J0BI D0J0BI DRUGCOMP N-Gene Research Laboratories Inc D0J0BI HIGHSTAT Investigative D0J0GJ DRUG__ID D0J0GJ D0J0GJ DRUGCOMP PharmaEssentia Corp D0J0GJ HIGHSTAT Investigative D0J0HV DRUG__ID D0J0HV D0J0HV DRUGCOMP Virobay Inc D0J0HV HIGHSTAT Investigative D0J0OF DRUG__ID D0J0OF D0J0OF DRUGCOMP CytoSolv Inc D0J0OF HIGHSTAT Investigative D0J0ZU DRUG__ID D0J0ZU D0J0ZU DRUGCOMP Kinentia Biosciences LLC D0J0ZU HIGHSTAT Investigative D0J1CF DRUG__ID D0J1CF D0J1CF DRUGCOMP University of Missouri D0J1CF HIGHSTAT Investigative D0J1DE DRUG__ID D0J1DE D0J1DE DRUGCOMP Fresenius Medical Care AG D0J1DE HIGHSTAT Investigative D0J1HG DRUG__ID D0J1HG D0J1HG DRUGCOMP Human Genome Sciences Inc D0J1HG HIGHSTAT Investigative D0J1KG DRUG__ID D0J1KG D0J1KG DRUGCOMP P2D Biosciences D0J1KG HIGHSTAT Investigative D0J2GG DRUG__ID D0J2GG D0J2GG DRUGCOMP Scripps Research Institute D0J2GG HIGHSTAT Investigative D0J2IB DRUG__ID D0J2IB D0J2IB DRUGCOMP Angion Biomedica Corp D0J2IB HIGHSTAT Investigative D0J2NI DRUG__ID D0J2NI D0J2NI DRUGCOMP ALS Therapy Development Foundation Inc D0J2NI HIGHSTAT Investigative D0J2XP DRUG__ID D0J2XP D0J2XP DRUGCOMP Beta Pharma Inc D0J2XP HIGHSTAT Investigative D0J3AN DRUG__ID D0J3AN D0J3AN DRUGCOMP HanAll Biopharma Co Ltd D0J3AN HIGHSTAT Investigative D0J3AV DRUG__ID D0J3AV D0J3AV DRUGCOMP Boston Biomedical Research Inst D0J3AV HIGHSTAT Investigative D0J3FK DRUG__ID D0J3FK D0J3FK DRUGCOMP Dynamix Pharmaceuticals Ltd D0J3FK HIGHSTAT Investigative D0J3MY DRUG__ID D0J3MY D0J3MY DRUGCOMP Nereus Pharmaceuticals Inc D0J3MY HIGHSTAT Investigative D0J3QN DRUG__ID D0J3QN D0J3QN DRUGCOMP CircaGen Pharmaceutical D0J3QN HIGHSTAT Investigative D0J3ZA DRUG__ID D0J3ZA D0J3ZA DRUGCOMP Kenta Biotech Ltd D0J3ZA HIGHSTAT Investigative D0J4NR DRUG__ID D0J4NR D0J4NR DRUGCOMP Texas A&M University System D0J4NR HIGHSTAT Investigative D0J4TX DRUG__ID D0J4TX D0J4TX DRUGCOMP Avexxin AS D0J4TX HIGHSTAT Investigative D0J5KZ DRUG__ID D0J5KZ D0J5KZ DRUGCOMP Obecure Ltd D0J5KZ HIGHSTAT Investigative D0J5OS DRUG__ID D0J5OS D0J5OS DRUGCOMP Vasogenix Pharmaceuticals Inc D0J5OS HIGHSTAT Investigative D0J5QA DRUG__ID D0J5QA D0J5QA DRUGCOMP Geron Corp D0J5QA HIGHSTAT Investigative D0J5QD DRUG__ID D0J5QD D0J5QD DRUGCOMP Gliknik Inc D0J5QD HIGHSTAT Investigative D0J6JC DRUG__ID D0J6JC D0J6JC DRUGCOMP University of British Columbia D0J6JC HIGHSTAT Investigative D0J6VW DRUG__ID D0J6VW D0J6VW DRUGCOMP Clinuvel Pharmaceuticals Ltd D0J6VW HIGHSTAT Investigative D0J6WJ DRUG__ID D0J6WJ D0J6WJ DRUGCOMP Columbia University D0J6WJ HIGHSTAT Investigative D0J6YZ DRUG__ID D0J6YZ D0J6YZ DRUGCOMP NeoStem Inc D0J6YZ HIGHSTAT Investigative D0J7QX DRUG__ID D0J7QX D0J7QX DRUGCOMP Armour Therapeutics Inc D0J7QX HIGHSTAT Investigative D0J7RP DRUG__ID D0J7RP D0J7RP DRUGCOMP RegenX Biosciences LLC D0J7RP HIGHSTAT Investigative D0J7XN DRUG__ID D0J7XN D0J7XN DRUGCOMP UBE Industries Ltd D0J7XN HIGHSTAT Investigative D0J8ED DRUG__ID D0J8ED D0J8ED DRUGCOMP Joyant Pharmaceuticals Inc D0J8ED HIGHSTAT Investigative D0J8NC DRUG__ID D0J8NC D0J8NC DRUGCOMP Astellas Pharma Inc D0J8NC HIGHSTAT Investigative D0J8RV DRUG__ID D0J8RV D0J8RV DRUGCOMP Zhejiang University D0J8RV HIGHSTAT Investigative D0J8VV DRUG__ID D0J8VV D0J8VV DRUGCOMP Prosensa Therapeutics BV D0J8VV HIGHSTAT Investigative D0J9MH DRUG__ID D0J9MH D0J9MH DRUGTYPE Peptide D0J9MH HIGHSTAT Investigative D0J9TA DRUG__ID D0J9TA D0J9TA DRUGCOMP NanoCarrier Co Ltd D0J9TA HIGHSTAT Investigative D0J9TO DRUG__ID D0J9TO D0J9TO DRUGCOMP Human Genome Sciences Inc D0J9TO HIGHSTAT Investigative D0J9VK DRUG__ID D0J9VK D0J9VK DRUGCOMP University of Mississippi D0J9VK HIGHSTAT Investigative D0JB0N DRUG__ID D0JB0N D0JB0N DRUGCOMP Bioalvo SA D0JB0N HIGHSTAT Investigative D0JC4J DRUG__ID D0JC4J D0JC4J DRUGCOMP CEAMED SA D0JC4J HIGHSTAT Investigative D0JD1R DRUG__ID D0JD1R D0JD1R DRUGCOMP Molecular Targeting Technologies Inc D0JD1R HIGHSTAT Investigative D0JD4S DRUG__ID D0JD4S D0JD4S DRUGCOMP Curis Inc D0JD4S HIGHSTAT Investigative D0JG6T DRUG__ID D0JG6T D0JG6T DRUGCOMP Xenon Pharmaceuticals Inc D0JG6T HIGHSTAT Investigative D0JL3Y DRUG__ID D0JL3Y D0JL3Y DRUGCOMP Galaxy Biotech LLC D0JL3Y HIGHSTAT Investigative D0JO0I DRUG__ID D0JO0I D0JO0I DRUGCOMP Virobay Inc D0JO0I HIGHSTAT Investigative D0JO3X DRUG__ID D0JO3X D0JO3X DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0JO3X HIGHSTAT Investigative D0JQ4R DRUG__ID D0JQ4R D0JQ4R DRUGCOMP Arachnova Ltd D0JQ4R HIGHSTAT Investigative D0JR9V DRUG__ID D0JR9V D0JR9V DRUGCOMP Propanc Pty Ltd D0JR9V HIGHSTAT Investigative D0JS7E DRUG__ID D0JS7E D0JS7E DRUGCOMP Lamellar Biomedical Ltd D0JS7E HIGHSTAT Investigative D0JV4A DRUG__ID D0JV4A D0JV4A DRUGCOMP POZEN D0JV4A HIGHSTAT Investigative D0JV8Q DRUG__ID D0JV8Q D0JV8Q DRUGCOMP University of Louisville D0JV8Q HIGHSTAT Investigative D0JY6R DRUG__ID D0JY6R D0JY6R DRUGCOMP Midatech Ltd D0JY6R HIGHSTAT Investigative D0K0CK DRUG__ID D0K0CK D0K0CK DRUGCOMP Allozyne Inc D0K0CK HIGHSTAT Investigative D0K0LA DRUG__ID D0K0LA D0K0LA DRUGCOMP LG Life Sciences Ltd D0K0LA HIGHSTAT Investigative D0K0LG DRUG__ID D0K0LG D0K0LG DRUGCOMP Celprogen Inc D0K0LG HIGHSTAT Investigative D0K0MB DRUG__ID D0K0MB D0K0MB DRUGCOMP Lipopharma Therapeutics SL D0K0MB HIGHSTAT Investigative D0K0OB DRUG__ID D0K0OB D0K0OB DRUGCOMP Advenchen Laboratories LLC D0K0OB HIGHSTAT Investigative D0K0OU DRUG__ID D0K0OU D0K0OU DRUGCOMP Microbiotix Inc D0K0OU HIGHSTAT Investigative D0K0SW DRUG__ID D0K0SW D0K0SW DRUGCOMP VLST Corp D0K0SW HIGHSTAT Investigative D0K1BR DRUG__ID D0K1BR D0K1BR DRUGCOMP NovaLead Pharma D0K1BR HIGHSTAT Investigative D0K1OR DRUG__ID D0K1OR D0K1OR DRUGCOMP Instituto Biomar SA D0K1OR HIGHSTAT Investigative D0K1TM DRUG__ID D0K1TM D0K1TM DRUGCOMP AmpliMed Corp D0K1TM HIGHSTAT Investigative D0K2EC DRUG__ID D0K2EC D0K2EC DRUGCOMP Pfizer Inc D0K2EC HIGHSTAT Investigative D0K2LR DRUG__ID D0K2LR D0K2LR DRUGCOMP Lentigen Corp D0K2LR HIGHSTAT Investigative D0K2MT DRUG__ID D0K2MT D0K2MT DRUGCOMP Argenta Discovery Ltd D0K2MT HIGHSTAT Investigative D0K2UJ DRUG__ID D0K2UJ D0K2UJ DRUGCOMP Mutabilis SA D0K2UJ HIGHSTAT Investigative D0K2XB DRUG__ID D0K2XB D0K2XB DRUGCOMP Genexine Co Ltd D0K2XB HIGHSTAT Investigative D0K2ZG DRUG__ID D0K2ZG D0K2ZG DRUGCOMP Louisiana State University Medical Center Foundation D0K2ZG HIGHSTAT Investigative D0K3FG DRUG__ID D0K3FG D0K3FG DRUGCOMP BioLineRx Ltd D0K3FG HIGHSTAT Investigative D0K3GB DRUG__ID D0K3GB D0K3GB DRUGCOMP Molecular Insight Pharmaceuticals Inc D0K3GB HIGHSTAT Investigative D0K3JZ DRUG__ID D0K3JZ D0K3JZ DRUGCOMP University of Toronto D0K3JZ HIGHSTAT Investigative D0K3MU DRUG__ID D0K3MU D0K3MU DRUGCOMP Norgine BV D0K3MU HIGHSTAT Investigative D0K3QW DRUG__ID D0K3QW D0K3QW DRUGCOMP Recordati SpA D0K3QW HIGHSTAT Investigative D0K3RP DRUG__ID D0K3RP D0K3RP DRUGCOMP Fqubed Inc D0K3RP HIGHSTAT Investigative D0K4CH DRUG__ID D0K4CH D0K4CH DRUGCOMP ImmunoGen Inc D0K4CH HIGHSTAT Investigative D0K4GG DRUG__ID D0K4GG D0K4GG DRUGCOMP Sirnaomics Inc D0K4GG HIGHSTAT Investigative D0K4JS DRUG__ID D0K4JS D0K4JS DRUGCOMP Anaphore Inc D0K4JS HIGHSTAT Investigative D0K4MW DRUG__ID D0K4MW D0K4MW DRUGCOMP Lipopharma Therapeutics SL D0K4MW HIGHSTAT Investigative D0K4TG DRUG__ID D0K4TG D0K4TG DRUGCOMP Pharmacopeia Inc D0K4TG HIGHSTAT Investigative D0K4VN DRUG__ID D0K4VN D0K4VN DRUGCOMP Ono Pharmaceutical Co Ltd D0K4VN HIGHSTAT Investigative D0K5BY DRUG__ID D0K5BY D0K5BY DRUGCOMP Mimetogen Pharmaceuticals Inc D0K5BY HIGHSTAT Investigative D0K5NN DRUG__ID D0K5NN D0K5NN DRUGCOMP AntiCancer Inc D0K5NN HIGHSTAT Investigative D0K5QY DRUG__ID D0K5QY D0K5QY DRUGCOMP Aprogen Inc D0K5QY HIGHSTAT Investigative D0K5UK DRUG__ID D0K5UK D0K5UK DRUGCOMP Genmab A/S D0K5UK HIGHSTAT Investigative D0K6CG DRUG__ID D0K6CG D0K6CG DRUGCOMP Trubion Pharmaceuticals Inc D0K6CG HIGHSTAT Investigative D0K6ES DRUG__ID D0K6ES D0K6ES DRUGCOMP Cancer Research Technology Ltd D0K6ES HIGHSTAT Investigative D0K6LA DRUG__ID D0K6LA D0K6LA DRUGCOMP Otsuka Pharmaceutical Co Ltd D0K6LA HIGHSTAT Investigative D0K6UO DRUG__ID D0K6UO D0K6UO DRUGCOMP Neurokin SA D0K6UO HIGHSTAT Investigative D0K7BF DRUG__ID D0K7BF D0K7BF DRUGCOMP Nexgenix Pharmaceuticals Inc D0K7BF HIGHSTAT Investigative D0K7GN DRUG__ID D0K7GN D0K7GN DRUGCOMP Sunnyvale D0K7GN HIGHSTAT Investigative D0K7JC DRUG__ID D0K7JC D0K7JC DRUGCOMP Zambon Co SpA D0K7JC HIGHSTAT Investigative D0K7KV DRUG__ID D0K7KV D0K7KV DRUGCOMP OrPro Therapeutics Inc D0K7KV HIGHSTAT Investigative D0K7MY DRUG__ID D0K7MY D0K7MY DRUGCOMP Curis Inc D0K7MY HIGHSTAT Investigative D0K7NJ DRUG__ID D0K7NJ D0K7NJ DRUGCOMP Novozymes A/S D0K7NJ HIGHSTAT Investigative D0K7VM DRUG__ID D0K7VM D0K7VM DRUGCOMP Arisaph Pharmaceuticals Inc D0K7VM HIGHSTAT Investigative D0K8AL DRUG__ID D0K8AL D0K8AL DRUGCOMP Oryzon Genomics SA D0K8AL HIGHSTAT Investigative D0K8BO DRUG__ID D0K8BO D0K8BO DRUGCOMP TxCell SA D0K8BO HIGHSTAT Investigative D0K8CP DRUG__ID D0K8CP D0K8CP DRUGCOMP HealOr Ltd D0K8CP HIGHSTAT Investigative D0K8HA DRUG__ID D0K8HA D0K8HA DRUGCOMP Lupin Ltd D0K8HA HIGHSTAT Investigative D0K8JE DRUG__ID D0K8JE D0K8JE DRUGCOMP Thrombotargets Corp D0K8JE HIGHSTAT Investigative D0K8KA DRUG__ID D0K8KA D0K8KA DRUGCOMP Acaduceus Pharmaceutics Inc D0K8KA HIGHSTAT Investigative D0K8SH DRUG__ID D0K8SH D0K8SH DRUGCOMP Genexine Co Ltd D0K8SH HIGHSTAT Investigative D0K8UN DRUG__ID D0K8UN D0K8UN DRUGCOMP Scancell Ltd D0K8UN HIGHSTAT Investigative D0K8YK DRUG__ID D0K8YK D0K8YK DRUGCOMP Abbott Laboratories D0K8YK HIGHSTAT Investigative D0K9ES DRUG__ID D0K9ES D0K9ES DRUGCOMP CIS Pharma AG D0K9ES HIGHSTAT Investigative D0K9MB DRUG__ID D0K9MB D0K9MB DRUGCOMP Celentyx Ltd D0K9MB HIGHSTAT Investigative D0K9MN DRUG__ID D0K9MN D0K9MN DRUGCOMP Zosano Pharma Inc D0K9MN HIGHSTAT Investigative D0K9PG DRUG__ID D0K9PG D0K9PG DRUGCOMP University De Strasbourg D0K9PG HIGHSTAT Investigative D0K9PS DRUG__ID D0K9PS D0K9PS DRUGCOMP Chiesi Farmaceutici SpA D0K9PS HIGHSTAT Investigative D0K9UT DRUG__ID D0K9UT D0K9UT DRUGCOMP EpiVax Inc D0K9UT HIGHSTAT Investigative D0K9XI DRUG__ID D0K9XI D0K9XI DRUGCOMP China Pharmaceutical University D0K9XI HIGHSTAT Investigative D0K9ZU DRUG__ID D0K9ZU D0K9ZU DRUGCOMP H Lee Moffitt Cancer Center and Research Institute D0K9ZU HIGHSTAT Investigative D0KC7H DRUG__ID D0KC7H D0KC7H DRUGCOMP NicOx SA D0KC7H HIGHSTAT Investigative D0KC9V DRUG__ID D0KC9V D0KC9V DRUGCOMP Adamed Sp zoo D0KC9V HIGHSTAT Investigative D0KD7E DRUG__ID D0KD7E D0KD7E DRUGCOMP Xel Pharmaceuticals Inc D0KD7E HIGHSTAT Investigative D0KE0C DRUG__ID D0KE0C D0KE0C DRUGCOMP Sirnaomics Inc D0KE0C HIGHSTAT Investigative D0KE4C DRUG__ID D0KE4C D0KE4C DRUGCOMP Human Genome Sciences Inc D0KE4C HIGHSTAT Investigative D0KI3U DRUG__ID D0KI3U D0KI3U DRUGCOMP Nymox Pharmaceutical Corp D0KI3U HIGHSTAT Investigative D0KI9N DRUG__ID D0KI9N D0KI9N DRUGCOMP University of Nebraska Medical Center D0KI9N HIGHSTAT Investigative D0KL5U DRUG__ID D0KL5U D0KL5U DRUGCOMP Symphogen A/S D0KL5U HIGHSTAT Investigative D0KM1F DRUG__ID D0KM1F D0KM1F DRUGCOMP University of Toronto D0KM1F HIGHSTAT Investigative D0KM4T DRUG__ID D0KM4T D0KM4T DRUGCOMP UAI D0KM4T HIGHSTAT Investigative D0KP0L DRUG__ID D0KP0L D0KP0L DRUGCOMP NascaCell GmbH D0KP0L HIGHSTAT Investigative D0KP2R DRUG__ID D0KP2R D0KP2R DRUGCOMP ChemDiv Inc D0KP2R HIGHSTAT Investigative D0KQ2D DRUG__ID D0KQ2D D0KQ2D DRUGCOMP Resverlogix Corp D0KQ2D HIGHSTAT Investigative D0KR6E DRUG__ID D0KR6E D0KR6E DRUGCOMP Serina Therapeutics Inc D0KR6E HIGHSTAT Investigative D0KT4B DRUG__ID D0KT4B D0KT4B DRUGCOMP Sorbent Therapeutics Inc D0KT4B HIGHSTAT Investigative D0KW8U DRUG__ID D0KW8U D0KW8U DRUGCOMP Peptron Co Ltd D0KW8U HIGHSTAT Investigative D0KX7A DRUG__ID D0KX7A D0KX7A DRUGCOMP Rottapharm Madaus D0KX7A HIGHSTAT Investigative D0L0DO DRUG__ID D0L0DO D0L0DO DRUGCOMP ET Transplant Inc D0L0DO HIGHSTAT Investigative D0L0KI DRUG__ID D0L0KI D0L0KI DRUGCOMP NanoBio Corp D0L0KI HIGHSTAT Investigative D0L0LR DRUG__ID D0L0LR D0L0LR DRUGCOMP University College London D0L0LR HIGHSTAT Investigative D0L0SI DRUG__ID D0L0SI D0L0SI DRUGCOMP University of Queensland D0L0SI HIGHSTAT Investigative D0L0XV DRUG__ID D0L0XV D0L0XV DRUGCOMP Medesis Pharma SA D0L0XV HIGHSTAT Investigative D0L1EX DRUG__ID D0L1EX D0L1EX DRUGCOMP FluGen Inc D0L1EX HIGHSTAT Investigative D0L1NF DRUG__ID D0L1NF D0L1NF DRUGCOMP Development Centre for Biotechnology D0L1NF HIGHSTAT Investigative D0L1NU DRUG__ID D0L1NU D0L1NU DRUGCOMP Pfizer Inc D0L1NU HIGHSTAT Investigative D0L1OF DRUG__ID D0L1OF D0L1OF DRUGCOMP Paraquest Inc D0L1OF HIGHSTAT Investigative D0L1TB DRUG__ID D0L1TB D0L1TB DRUGCOMP NeoPharm Co Ltd D0L1TB HIGHSTAT Investigative D0L1YR DRUG__ID D0L1YR D0L1YR DRUGCOMP Immunomic Therapeutics Inc D0L1YR HIGHSTAT Investigative D0L2BT DRUG__ID D0L2BT D0L2BT DRUGCOMP Abbott Laboratories D0L2BT HIGHSTAT Investigative D0L2FR DRUG__ID D0L2FR D0L2FR DRUGCOMP University of Kansas D0L2FR HIGHSTAT Investigative D0L2NV DRUG__ID D0L2NV D0L2NV DRUGCOMP Pharmacia & Upjohn Co D0L2NV HIGHSTAT Investigative D0L2OS DRUG__ID D0L2OS D0L2OS DRUGCOMP Archemix Corp D0L2OS HIGHSTAT Investigative D0L2PV DRUG__ID D0L2PV D0L2PV DRUGCOMP MorphoSys AG D0L2PV HIGHSTAT Investigative D0L2TT DRUG__ID D0L2TT D0L2TT DRUGCOMP MondoBIOTECH Holding AG D0L2TT HIGHSTAT Investigative D0L2VB DRUG__ID D0L2VB D0L2VB DRUGCOMP Ferring Pharmaceuticals Inc D0L2VB HIGHSTAT Investigative D0L2WW DRUG__ID D0L2WW D0L2WW DRUGCOMP Adnexus Therapeutics Inc D0L2WW HIGHSTAT Investigative D0L2YA DRUG__ID D0L2YA D0L2YA DRUGCOMP TechnoVax Inc D0L2YA HIGHSTAT Investigative D0L3GH DRUG__ID D0L3GH D0L3GH DRUGCOMP Chemokine Therapeutics Corp D0L3GH HIGHSTAT Investigative D0L3KN DRUG__ID D0L3KN D0L3KN DRUGCOMP Cell Cure Neurosciences Ltd D0L3KN HIGHSTAT Investigative D0L3LO DRUG__ID D0L3LO D0L3LO DRUGCOMP Endocrine Technology LLC D0L3LO HIGHSTAT Investigative D0L3VC DRUG__ID D0L3VC D0L3VC DRUGCOMP Chinese Academy of Sciences D0L3VC HIGHSTAT Investigative D0L4CW DRUG__ID D0L4CW D0L4CW DRUGCOMP Theratechnologies Inc D0L4CW HIGHSTAT Investigative D0L4GH DRUG__ID D0L4GH D0L4GH DRUGCOMP Hibernaid Inc D0L4GH HIGHSTAT Investigative D0L4HK DRUG__ID D0L4HK D0L4HK DRUGCOMP TechnoVax Inc D0L4HK HIGHSTAT Investigative D0L5AK DRUG__ID D0L5AK D0L5AK DRUGCOMP Trillium Therapeutics Inc D0L5AK HIGHSTAT Investigative D0L5EA DRUG__ID D0L5EA D0L5EA DRUGCOMP Recoly NV D0L5EA HIGHSTAT Investigative D0L6BU DRUG__ID D0L6BU D0L6BU DRUGCOMP Chong Kun Dang Pharmaceutical Corp D0L6BU HIGHSTAT Investigative D0L6FF DRUG__ID D0L6FF D0L6FF DRUGCOMP Nanotherapeutics Inc D0L6FF HIGHSTAT Investigative D0L6HF DRUG__ID D0L6HF D0L6HF DRUGCOMP Medarex Inc D0L6HF HIGHSTAT Investigative D0L6IF DRUG__ID D0L6IF D0L6IF DRUGCOMP AxoGlia Therapeutics SA D0L6IF HIGHSTAT Investigative D0L6IJ DRUG__ID D0L6IJ D0L6IJ DRUGCOMP Human Genome Sciences Inc D0L6IJ HIGHSTAT Investigative D0L6PZ DRUG__ID D0L6PZ D0L6PZ DRUGCOMP Beth Israel Deaconess Medical Center D0L6PZ HIGHSTAT Investigative D0L6WT DRUG__ID D0L6WT D0L6WT DRUGCOMP Aus Bio Ltd D0L6WT HIGHSTAT Investigative D0L6ZE DRUG__ID D0L6ZE D0L6ZE DRUGCOMP Vastrata D0L6ZE HIGHSTAT Investigative D0L7FB DRUG__ID D0L7FB D0L7FB DRUGCOMP BioTHER Corp D0L7FB HIGHSTAT Investigative D0L7MK DRUG__ID D0L7MK D0L7MK DRUGCOMP Trojantec Ltd D0L7MK HIGHSTAT Investigative D0L7MO DRUG__ID D0L7MO D0L7MO DRUGCOMP FAES Farma SA D0L7MO HIGHSTAT Investigative D0L7PG DRUG__ID D0L7PG D0L7PG DRUGCOMP Chong Kun Dang Pharmaceutical Corp D0L7PG HIGHSTAT Investigative D0L7QR DRUG__ID D0L7QR D0L7QR DRUGCOMP 4SC AG D0L7QR HIGHSTAT Investigative D0L7UT DRUG__ID D0L7UT D0L7UT DRUGCOMP Imaxio D0L7UT HIGHSTAT Investigative D0L8KK DRUG__ID D0L8KK D0L8KK DRUGCOMP Albany Molecular Research Inc D0L8KK HIGHSTAT Investigative D0L8OZ DRUG__ID D0L8OZ D0L8OZ DRUGCOMP Ark Therapeutics Group plc D0L8OZ HIGHSTAT Investigative D0L8PG DRUG__ID D0L8PG D0L8PG DRUGCOMP SK Chemicals Life Science D0L8PG HIGHSTAT Investigative D0L8PO DRUG__ID D0L8PO D0L8PO DRUGCOMP C&O Pharmaceutical Technology (Holdings) Ltd D0L8PO HIGHSTAT Investigative D0L8SP DRUG__ID D0L8SP D0L8SP DRUGCOMP Morvus Technology Ltd D0L8SP HIGHSTAT Investigative D0L8TP DRUG__ID D0L8TP D0L8TP DRUGCOMP TRION Pharma GmbH D0L8TP HIGHSTAT Investigative D0L8UQ DRUG__ID D0L8UQ D0L8UQ DRUGCOMP Fujifilm Kyowa Kirin Biologics Tokyo, Japan D0L8UQ HIGHSTAT Investigative D0L8US DRUG__ID D0L8US D0L8US DRUGCOMP Cellgate Inc D0L8US HIGHSTAT Investigative D0L8YH DRUG__ID D0L8YH D0L8YH DRUGCOMP Amunix Inc D0L8YH HIGHSTAT Investigative D0L9BW DRUG__ID D0L9BW D0L9BW DRUGCOMP Johnson & Johnson D0L9BW HIGHSTAT Investigative D0L9GR DRUG__ID D0L9GR D0L9GR DRUGCOMP Pharmos D0L9GR HIGHSTAT Investigative D0L9XL DRUG__ID D0L9XL D0L9XL DRUGCOMP NeoPharm Co Ltd D0L9XL HIGHSTAT Investigative D0L9ZF DRUG__ID D0L9ZF D0L9ZF DRUGCOMP Escape Therapeutics Inc D0L9ZF HIGHSTAT Investigative D0LC8F DRUG__ID D0LC8F D0LC8F DRUGCOMP BioLineRx Ltd D0LC8F HIGHSTAT Investigative D0LD9P DRUG__ID D0LD9P D0LD9P DRUGCOMP ZelleRx Corp D0LD9P HIGHSTAT Investigative D0LE2E DRUG__ID D0LE2E D0LE2E DRUGTYPE Antibody D0LE2E HIGHSTAT Investigative D0LE3O DRUG__ID D0LE3O D0LE3O DRUGCOMP Arana Therapeutics Ltd D0LE3O HIGHSTAT Investigative D0LE6K DRUG__ID D0LE6K D0LE6K DRUGCOMP Tokyo University Of Agriculture & Technology Co Ltd D0LE6K HIGHSTAT Investigative D0LE8H DRUG__ID D0LE8H D0LE8H DRUGCOMP University of Bradford D0LE8H HIGHSTAT Investigative D0LH4P DRUG__ID D0LH4P D0LH4P DRUGCOMP Cortex Pharmaceuticals Inc D0LH4P HIGHSTAT Investigative D0LI3H DRUG__ID D0LI3H D0LI3H DRUGCOMP Bristol-Myers Squibb Pharma Co D0LI3H HIGHSTAT Investigative D0LI7L DRUG__ID D0LI7L D0LI7L DRUGCOMP Celecure AS D0LI7L HIGHSTAT Investigative D0LJ1Z DRUG__ID D0LJ1Z D0LJ1Z DRUGCOMP Chemizon Inc D0LJ1Z HIGHSTAT Investigative D0LL6K DRUG__ID D0LL6K D0LL6K DRUGCOMP Tolerx Inc D0LL6K HIGHSTAT Investigative D0LL7C DRUG__ID D0LL7C D0LL7C DRUGCOMP LFB Biotechnologies D0LL7C HIGHSTAT Investigative D0LP4X DRUG__ID D0LP4X D0LP4X DRUGCOMP Gene Signal SAS D0LP4X HIGHSTAT Investigative D0LQ2Y DRUG__ID D0LQ2Y D0LQ2Y DRUGCOMP Milkhaus Laboratory Inc D0LQ2Y HIGHSTAT Investigative D0LR4M DRUG__ID D0LR4M D0LR4M DRUGCOMP ET Neuron Inc D0LR4M HIGHSTAT Investigative D0LS6W DRUG__ID D0LS6W D0LS6W DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0LS6W HIGHSTAT Investigative D0LV7F DRUG__ID D0LV7F D0LV7F DRUGCOMP NicOx SA D0LV7F HIGHSTAT Investigative D0LX4K DRUG__ID D0LX4K D0LX4K DRUGCOMP ALS Therapy Development Foundation Inc D0LX4K HIGHSTAT Investigative D0M0CU DRUG__ID D0M0CU D0M0CU DRUGCOMP AdeTherapeutics Inc D0M0CU HIGHSTAT Investigative D0M0JR DRUG__ID D0M0JR D0M0JR DRUGCOMP Denmark Technical University D0M0JR HIGHSTAT Investigative D0M0KJ DRUG__ID D0M0KJ D0M0KJ DRUGCOMP XBiotech Inc D0M0KJ HIGHSTAT Investigative D0M0MX DRUG__ID D0M0MX D0M0MX DRUGCOMP Center for Genetic Engineering and Biotechnology D0M0MX HIGHSTAT Investigative D0M0SV DRUG__ID D0M0SV D0M0SV DRUGCOMP Pieris AG D0M0SV HIGHSTAT Investigative D0M0VP DRUG__ID D0M0VP D0M0VP DRUGCOMP Heat Biologics D0M0VP HIGHSTAT Investigative D0M0YE DRUG__ID D0M0YE D0M0YE DRUGCOMP Massachusetts General Hospital D0M0YE HIGHSTAT Investigative D0M1DE DRUG__ID D0M1DE D0M1DE DRUGCOMP PharmedArtis GmbH D0M1DE HIGHSTAT Investigative D0M1KH DRUG__ID D0M1KH D0M1KH DRUGCOMP Piramal Healthcare Ltd D0M1KH HIGHSTAT Investigative D0M1KK DRUG__ID D0M1KK D0M1KK DRUGCOMP PharmaNeuroBoost NV D0M1KK HIGHSTAT Investigative D0M1MB DRUG__ID D0M1MB D0M1MB DRUGCOMP PharmaNess Neurosciences D0M1MB HIGHSTAT Investigative D0M1NS DRUG__ID D0M1NS D0M1NS DRUGCOMP Cancer Targeted Technology Llc D0M1NS HIGHSTAT Investigative D0M1OX DRUG__ID D0M1OX D0M1OX DRUGCOMP National Cancer Institute D0M1OX HIGHSTAT Investigative D0M1WF DRUG__ID D0M1WF D0M1WF DRUGCOMP SRI International D0M1WF HIGHSTAT Investigative D0M1XY DRUG__ID D0M1XY D0M1XY DRUGCOMP Dybly AG D0M1XY HIGHSTAT Investigative D0M1YW DRUG__ID D0M1YW D0M1YW DRUGCOMP Angion Biomedica Corp D0M1YW HIGHSTAT Investigative D0M2AN DRUG__ID D0M2AN D0M2AN DRUGCOMP INSERM D0M2AN HIGHSTAT Investigative D0M2DP DRUG__ID D0M2DP D0M2DP DRUGCOMP Cytomics Pharmaceuticals D0M2DP HIGHSTAT Investigative D0M2EH DRUG__ID D0M2EH D0M2EH DRUGCOMP Nexia Biotechnologies Inc D0M2EH HIGHSTAT Investigative D0M2JA DRUG__ID D0M2JA D0M2JA DRUGCOMP ACADIA Pharmaceuticals Inc D0M2JA HIGHSTAT Investigative D0M2ME DRUG__ID D0M2ME D0M2ME DRUGCOMP Indus Biotech Pvt Ltd D0M2ME HIGHSTAT Investigative D0M2RZ DRUG__ID D0M2RZ D0M2RZ DRUGCOMP Enanta Pharmaceuticals Inc D0M2RZ HIGHSTAT Investigative D0M2ZG DRUG__ID D0M2ZG D0M2ZG DRUGCOMP Pharmacia & Upjohn Inc D0M2ZG HIGHSTAT Investigative D0M3FZ DRUG__ID D0M3FZ D0M3FZ DRUGCOMP Meristomics D0M3FZ HIGHSTAT Investigative D0M3IE DRUG__ID D0M3IE D0M3IE DRUGCOMP Vivozon Inc D0M3IE HIGHSTAT Investigative D0M3NF DRUG__ID D0M3NF D0M3NF DRUGCOMP NewSouth Innovations D0M3NF HIGHSTAT Investigative D0M3ON DRUG__ID D0M3ON D0M3ON THERCLAS Analgesics D0M3ON HIGHSTAT Investigative D0M3VU DRUG__ID D0M3VU D0M3VU DRUGCOMP Equispharm Co Ltd D0M3VU HIGHSTAT Investigative D0M3YC DRUG__ID D0M3YC D0M3YC DRUGCOMP Ottawa Hospital Research Institute D0M3YC HIGHSTAT Investigative D0M4DE DRUG__ID D0M4DE D0M4DE DRUGCOMP National Taiwan University D0M4DE HIGHSTAT Investigative D0M4JK DRUG__ID D0M4JK D0M4JK DRUGCOMP UCB SA D0M4JK HIGHSTAT Investigative D0M4MW DRUG__ID D0M4MW D0M4MW DRUGCOMP VivoQuest Inc D0M4MW HIGHSTAT Investigative D0M4PY DRUG__ID D0M4PY D0M4PY DRUGCOMP Central Drug Research Institute D0M4PY HIGHSTAT Investigative D0M4SV DRUG__ID D0M4SV D0M4SV DRUGCOMP Beta Pharma Inc D0M4SV HIGHSTAT Investigative D0M4TN DRUG__ID D0M4TN D0M4TN DRUGCOMP BioCure Pharma LLC D0M4TN HIGHSTAT Investigative D0M4UX DRUG__ID D0M4UX D0M4UX DRUGCOMP Neurotec Pharma SL D0M4UX HIGHSTAT Investigative D0M4YK DRUG__ID D0M4YK D0M4YK DRUGCOMP Glytrix Inc D0M4YK HIGHSTAT Investigative D0M5QD DRUG__ID D0M5QD D0M5QD DRUGCOMP Affitech A/S D0M5QD HIGHSTAT Investigative D0M5QU DRUG__ID D0M5QU D0M5QU DRUGCOMP Inhibikase Therapeutics D0M5QU HIGHSTAT Investigative D0M5UL DRUG__ID D0M5UL D0M5UL DRUGCOMP Tibotec BVBA D0M5UL HIGHSTAT Investigative D0M5ZF DRUG__ID D0M5ZF D0M5ZF DRUGCOMP TechnoVax Inc D0M5ZF HIGHSTAT Investigative D0M6EG DRUG__ID D0M6EG D0M6EG DRUGCOMP Roche Holding AG D0M6EG HIGHSTAT Investigative D0M6GP DRUG__ID D0M6GP D0M6GP DRUGCOMP Immunocore Ltd D0M6GP HIGHSTAT Investigative D0M6IG DRUG__ID D0M6IG D0M6IG DRUGCOMP Kalahari Greentech Inc D0M6IG HIGHSTAT Investigative D0M6TX DRUG__ID D0M6TX D0M6TX DRUGCOMP Thar Pharmaceuticals Inc D0M6TX HIGHSTAT Investigative D0M6XE DRUG__ID D0M6XE D0M6XE DRUGCOMP Zambon Co SpA D0M6XE HIGHSTAT Investigative D0M6XY DRUG__ID D0M6XY D0M6XY DRUGCOMP Symphogen A/S D0M6XY HIGHSTAT Investigative D0M6ZA DRUG__ID D0M6ZA D0M6ZA DRUGCOMP Fusion Antibodies Ltd D0M6ZA HIGHSTAT Investigative D0M7IG DRUG__ID D0M7IG D0M7IG DRUGCOMP Roche Holding AG D0M7IG HIGHSTAT Investigative D0M7IJ DRUG__ID D0M7IJ D0M7IJ DRUGCOMP Northeastern University D0M7IJ HIGHSTAT Investigative D0M7MH DRUG__ID D0M7MH D0M7MH DRUGCOMP Galantos Pharma GmbH D0M7MH HIGHSTAT Investigative D0M7SZ DRUG__ID D0M7SZ D0M7SZ DRUGCOMP Catabasis Pharmaceuticals Inc D0M7SZ HIGHSTAT Investigative D0M7TT DRUG__ID D0M7TT D0M7TT DRUGCOMP Shire Pharmaceutical Development Ltd D0M7TT HIGHSTAT Investigative D0M7TW DRUG__ID D0M7TW D0M7TW DRUGCOMP Pfizer Inc D0M7TW HIGHSTAT Investigative D0M8YQ DRUG__ID D0M8YQ D0M8YQ DRUGCOMP Genecure LLC D0M8YQ HIGHSTAT Investigative D0M9FA DRUG__ID D0M9FA D0M9FA DRUGCOMP Leiden University Medical Center D0M9FA HIGHSTAT Investigative D0M9NJ DRUG__ID D0M9NJ D0M9NJ DRUGCOMP SOM Biotech SL D0M9NJ HIGHSTAT Investigative D0M9PD DRUG__ID D0M9PD D0M9PD DRUGCOMP Psimei Pharmaceuticals plc D0M9PD HIGHSTAT Investigative D0M9PI DRUG__ID D0M9PI D0M9PI DRUGCOMP SeaLife Pharma GmbH D0M9PI HIGHSTAT Investigative D0M9SD DRUG__ID D0M9SD D0M9SD DRUGCOMP Vantia Therapeutics D0M9SD HIGHSTAT Investigative D0M9TD DRUG__ID D0M9TD D0M9TD DRUGCOMP Regulus Therapeutics Inc D0M9TD HIGHSTAT Investigative D0M9XH DRUG__ID D0M9XH D0M9XH DRUGCOMP XenoPort Inc D0M9XH HIGHSTAT Investigative D0M9ZL DRUG__ID D0M9ZL D0M9ZL DRUGCOMP InvivoGen Therapeutics D0M9ZL HIGHSTAT Investigative D0MF3F DRUG__ID D0MF3F D0MF3F DRUGCOMP Applied Genetic Technologies Corp D0MF3F HIGHSTAT Investigative D0MG0H DRUG__ID D0MG0H D0MG0H DRUGCOMP NovaBay Pharmaceuticals Inc D0MG0H HIGHSTAT Investigative D0MH8K DRUG__ID D0MH8K D0MH8K DRUGCOMP Laila Pharmaceuticals Pvt Ltd D0MH8K HIGHSTAT Investigative D0MI1N DRUG__ID D0MI1N D0MI1N DRUGCOMP Rottapharm Madaus D0MI1N HIGHSTAT Investigative D0MI8F DRUG__ID D0MI8F D0MI8F DRUGCOMP Hansa Medical AB D0MI8F HIGHSTAT Investigative D0MI9F DRUG__ID D0MI9F D0MI9F DRUGCOMP University of Minnesota D0MI9F HIGHSTAT Investigative D0MJ7W DRUG__ID D0MJ7W D0MJ7W DRUGCOMP Biorunx Co Ltd D0MJ7W HIGHSTAT Investigative D0MJ9L DRUG__ID D0MJ9L D0MJ9L DRUGCOMP Cancer Research UK D0MJ9L HIGHSTAT Investigative D0MM4X DRUG__ID D0MM4X D0MM4X DRUGCOMP Medivir AB D0MM4X HIGHSTAT Investigative D0MM6Q DRUG__ID D0MM6Q D0MM6Q DRUGCOMP Merrimack Pharmaceuticals Inc D0MM6Q HIGHSTAT Investigative D0N0DP DRUG__ID D0N0DP D0N0DP DRUGCOMP Folia Biotech Inc D0N0DP HIGHSTAT Investigative D0N0EB DRUG__ID D0N0EB D0N0EB DRUGCOMP Digna Biotech SL D0N0EB HIGHSTAT Investigative D0N0HO DRUG__ID D0N0HO D0N0HO DRUGCOMP Serometrix LLC D0N0HO HIGHSTAT Investigative D0N0KG DRUG__ID D0N0KG D0N0KG DRUGCOMP Central Drug Research Institute D0N0KG HIGHSTAT Investigative D0N0MZ DRUG__ID D0N0MZ D0N0MZ DRUGCOMP Innovative Technologies LLC D0N0MZ HIGHSTAT Investigative D0N0SC DRUG__ID D0N0SC D0N0SC DRUGCOMP Allinky Biopharma D0N0SC HIGHSTAT Investigative D0N0SO DRUG__ID D0N0SO D0N0SO DRUGCOMP Applied Genetic Technologies Corp D0N0SO HIGHSTAT Investigative D0N0VW DRUG__ID D0N0VW D0N0VW DRUGCOMP Indena SpA D0N0VW HIGHSTAT Investigative D0N0YT DRUG__ID D0N0YT D0N0YT DRUGCOMP Zacharon Pharmaceuticals Inc D0N0YT HIGHSTAT Investigative D0N1AH DRUG__ID D0N1AH D0N1AH DRUGCOMP GlaxoSmithKline plc D0N1AH HIGHSTAT Investigative D0N1AT DRUG__ID D0N1AT D0N1AT DRUGCOMP BIOO Therapeutics D0N1AT HIGHSTAT Investigative D0N1AY DRUG__ID D0N1AY D0N1AY DRUGCOMP University of Tasmania D0N1AY HIGHSTAT Investigative D0N1IL DRUG__ID D0N1IL D0N1IL DRUGCOMP Human Genome Sciences Inc D0N1IL HIGHSTAT Investigative D0N1NL DRUG__ID D0N1NL D0N1NL DRUGCOMP Children's Hospital of Los Angeles D0N1NL HIGHSTAT Investigative D0N1QH DRUG__ID D0N1QH D0N1QH DRUGCOMP Genmab Inc D0N1QH HIGHSTAT Investigative D0N1RE DRUG__ID D0N1RE D0N1RE DRUGCOMP Boehringer Ingelheim D0N1RE HIGHSTAT Investigative D0N1RM DRUG__ID D0N1RM D0N1RM DRUGCOMP JCR Pharmaceuticals Co Ltd D0N1RM HIGHSTAT Investigative D0N1SL DRUG__ID D0N1SL D0N1SL DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0N1SL HIGHSTAT Investigative D0N1ST DRUG__ID D0N1ST D0N1ST DRUGCOMP Affectis Pharmaceuticals AG D0N1ST HIGHSTAT Investigative D0N1UH DRUG__ID D0N1UH D0N1UH DRUGCOMP Vitala Therapeutics D0N1UH HIGHSTAT Investigative D0N1WG DRUG__ID D0N1WG D0N1WG DRUGCOMP GlaxoSmithKline plc D0N1WG HIGHSTAT Investigative D0N2AY DRUG__ID D0N2AY D0N2AY DRUGCOMP Aileron Therapeutics Inc D0N2AY HIGHSTAT Investigative D0N2CS DRUG__ID D0N2CS D0N2CS DRUGCOMP Reviva Pharmaceuticals Inc D0N2CS HIGHSTAT Investigative D0N2DD DRUG__ID D0N2DD D0N2DD DRUGCOMP PDL BioPharma Inc D0N2DD HIGHSTAT Investigative D0N2GS DRUG__ID D0N2GS D0N2GS DRUGCOMP Endece LLC D0N2GS HIGHSTAT Investigative D0N3RU DRUG__ID D0N3RU D0N3RU DRUGCOMP ChemRegen Inc D0N3RU HIGHSTAT Investigative D0N3YL DRUG__ID D0N3YL D0N3YL DRUGCOMP America Stem Cell Inc D0N3YL HIGHSTAT Investigative D0N4IU DRUG__ID D0N4IU D0N4IU DRUGCOMP Helsinki University D0N4IU HIGHSTAT Investigative D0N4LW DRUG__ID D0N4LW D0N4LW DRUGCOMP CEVEC Pharmaceuticals GmbH D0N4LW HIGHSTAT Investigative D0N4MK DRUG__ID D0N4MK D0N4MK DRUGCOMP Instituto Biomar SA D0N4MK HIGHSTAT Investigative D0N4ZS DRUG__ID D0N4ZS D0N4ZS DRUGCOMP Sigma-Tau Ind Farm Riunite SpA D0N4ZS HIGHSTAT Investigative D0N5AS DRUG__ID D0N5AS D0N5AS DRUGCOMP Intra-Cellular Therapies Inc D0N5AS HIGHSTAT Investigative D0N5DW DRUG__ID D0N5DW D0N5DW DRUGCOMP CrystalGenomics Inc D0N5DW HIGHSTAT Investigative D0N5DZ DRUG__ID D0N5DZ D0N5DZ DRUGCOMP ImmunoVentis Inc D0N5DZ HIGHSTAT Investigative D0N5OL DRUG__ID D0N5OL D0N5OL DRUGCOMP SunTen Phytotech Co Ltd D0N5OL HIGHSTAT Investigative D0N5TB DRUG__ID D0N5TB D0N5TB DRUGCOMP Industrial Technology Research Institute D0N5TB HIGHSTAT Investigative D0N5UU DRUG__ID D0N5UU D0N5UU DRUGCOMP Nectid Inc D0N5UU HIGHSTAT Investigative D0N6CC DRUG__ID D0N6CC D0N6CC DRUGCOMP Aphoenix Inc D0N6CC HIGHSTAT Investigative D0N6DD DRUG__ID D0N6DD D0N6DD DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0N6DD HIGHSTAT Investigative D0N6EL DRUG__ID D0N6EL D0N6EL DRUGCOMP Serometrix LLC D0N6EL HIGHSTAT Investigative D0N6HA DRUG__ID D0N6HA D0N6HA DRUGCOMP Columbia Laboratories Inc D0N6HA HIGHSTAT Investigative D0N6QO DRUG__ID D0N6QO D0N6QO DRUGCOMP Incozen Therapeutics Pvt Ltd D0N6QO HIGHSTAT Investigative D0N7CU DRUG__ID D0N7CU D0N7CU DRUGCOMP Human Genome Sciences Inc D0N7CU HIGHSTAT Investigative D0N7CY DRUG__ID D0N7CY D0N7CY DRUGCOMP NovaLead Pharma D0N7CY HIGHSTAT Investigative D0N7WB DRUG__ID D0N7WB D0N7WB DRUGCOMP Clera Inc D0N7WB HIGHSTAT Investigative D0N7XY DRUG__ID D0N7XY D0N7XY DRUGCOMP NuView Life Sciences D0N7XY HIGHSTAT Investigative D0N7YK DRUG__ID D0N7YK D0N7YK DRUGCOMP Xiamen Amoytop Biotech Co Ltd D0N7YK HIGHSTAT Investigative D0N8CM DRUG__ID D0N8CM D0N8CM DRUGCOMP Prosetta Antiviral Inc D0N8CM HIGHSTAT Investigative D0N8GR DRUG__ID D0N8GR D0N8GR DRUGCOMP Chemizon Inc D0N8GR HIGHSTAT Investigative D0N8TM DRUG__ID D0N8TM D0N8TM DRUGCOMP Xaragen Pharma Ltd D0N8TM HIGHSTAT Investigative D0N8UQ DRUG__ID D0N8UQ D0N8UQ DRUGCOMP InterMed Discovery GmbH D0N8UQ HIGHSTAT Investigative D0N9ET DRUG__ID D0N9ET D0N9ET DRUGCOMP University College London D0N9ET HIGHSTAT Investigative D0N9GC DRUG__ID D0N9GC D0N9GC DRUGCOMP Neorphys D0N9GC HIGHSTAT Investigative D0N9IN DRUG__ID D0N9IN D0N9IN DRUGCOMP Mitotix Inc D0N9IN HIGHSTAT Investigative D0N9TK DRUG__ID D0N9TK D0N9TK DRUGCOMP Array BioPharma Inc D0N9TK HIGHSTAT Investigative D0N9UP DRUG__ID D0N9UP D0N9UP DRUGCOMP Pharmaxon D0N9UP HIGHSTAT Investigative D0N9WY DRUG__ID D0N9WY D0N9WY DRUGCOMP Biotica Technology Ltd D0N9WY HIGHSTAT Investigative D0NC0G DRUG__ID D0NC0G D0NC0G DRUGCOMP RaQualia Pharma Inc D0NC0G HIGHSTAT Investigative D0NC8H DRUG__ID D0NC8H D0NC8H DRUGCOMP GlycoMimetics Inc D0NC8H HIGHSTAT Investigative D0NC8Z DRUG__ID D0NC8Z D0NC8Z DRUGTYPE Small molecule immunotherapy D0NC8Z HIGHSTAT Investigative D0ND8N DRUG__ID D0ND8N D0ND8N DRUGCOMP University of Queensland D0ND8N HIGHSTAT Investigative D0NE9W DRUG__ID D0NE9W D0NE9W DRUGCOMP Celentyx Ltd D0NE9W HIGHSTAT Investigative D0NF0P DRUG__ID D0NF0P D0NF0P DRUGCOMP Exodos Life Science Partners D0NF0P HIGHSTAT Investigative D0NH0U DRUG__ID D0NH0U D0NH0U DRUGCOMP Yale University D0NH0U HIGHSTAT Investigative D0NH1V DRUG__ID D0NH1V D0NH1V DRUGCOMP BioLineRx Ltd D0NH1V HIGHSTAT Investigative D0NI6M DRUG__ID D0NI6M D0NI6M DRUGTYPE Peptide D0NI6M HIGHSTAT Investigative D0NJ9W DRUG__ID D0NJ9W D0NJ9W DRUGCOMP Molecular Targeting Technologies Inc D0NJ9W HIGHSTAT Investigative D0NN7W DRUG__ID D0NN7W D0NN7W DRUGCOMP Molecular Targeting Technologies Inc D0NN7W HIGHSTAT Investigative D0NN9I DRUG__ID D0NN9I D0NN9I DRUGCOMP ImuThes Ltd D0NN9I HIGHSTAT Investigative D0NO7L DRUG__ID D0NO7L D0NO7L DRUGCOMP Prosensa Therapeutics BV D0NO7L HIGHSTAT Investigative D0NP8M DRUG__ID D0NP8M D0NP8M DRUGCOMP Ludwig Institute for Cancer Research D0NP8M HIGHSTAT Investigative D0NQ0W DRUG__ID D0NQ0W D0NQ0W DRUGCOMP Angitia AB D0NQ0W HIGHSTAT Investigative D0NT8Q DRUG__ID D0NT8Q D0NT8Q DRUGCOMP Daewon Pharm Co Ltd D0NT8Q HIGHSTAT Investigative D0NX6F DRUG__ID D0NX6F D0NX6F DRUGCOMP Bayer Schering Pharma AG D0NX6F HIGHSTAT Investigative D0NY4H DRUG__ID D0NY4H D0NY4H DRUGCOMP ReNeuron Group plc D0NY4H HIGHSTAT Investigative D0O0BR DRUG__ID D0O0BR D0O0BR DRUGCOMP Nventa Biopharmaceuticals Corp D0O0BR HIGHSTAT Investigative D0O0II DRUG__ID D0O0II D0O0II DRUGCOMP AndroScience Corp D0O0II HIGHSTAT Investigative D0O0LF DRUG__ID D0O0LF D0O0LF DRUGCOMP Kyoto University D0O0LF HIGHSTAT Investigative D0O0UM DRUG__ID D0O0UM D0O0UM DRUGCOMP Green Molecular D0O0UM HIGHSTAT Investigative D0O0YA DRUG__ID D0O0YA D0O0YA DRUGCOMP Roswell Park Cancer Institute D0O0YA HIGHSTAT Investigative D0O1DS DRUG__ID D0O1DS D0O1DS DRUGCOMP Kyoto University D0O1DS HIGHSTAT Investigative D0O1EI DRUG__ID D0O1EI D0O1EI DRUGCOMP Cancer Research Technology Ltd D0O1EI HIGHSTAT Investigative D0O1XO DRUG__ID D0O1XO D0O1XO DRUGCOMP Symphogen A/S D0O1XO HIGHSTAT Investigative D0O2LY DRUG__ID D0O2LY D0O2LY DRUGTYPE Antisense drug D0O2LY HIGHSTAT Investigative D0O2MW DRUG__ID D0O2MW D0O2MW DRUGCOMP Cleveland Clinic Foundation D0O2MW HIGHSTAT Investigative D0O2TG DRUG__ID D0O2TG D0O2TG DRUGCOMP RegenX Biosciences LLC D0O2TG HIGHSTAT Investigative D0O2UF DRUG__ID D0O2UF D0O2UF DRUGCOMP National Cancer Institute D0O2UF HIGHSTAT Investigative D0O3FS DRUG__ID D0O3FS D0O3FS DRUGCOMP Russian Academy of Sciences D0O3FS HIGHSTAT Investigative D0O3TE DRUG__ID D0O3TE D0O3TE DRUGCOMP Proteosys AG D0O3TE HIGHSTAT Investigative D0O3TW DRUG__ID D0O3TW D0O3TW DRUGCOMP Phico Therapeutics Ltd D0O3TW HIGHSTAT Investigative D0O3VK DRUG__ID D0O3VK D0O3VK DRUGCOMP University of Massachusetts Medical School D0O3VK HIGHSTAT Investigative D0O3ZI DRUG__ID D0O3ZI D0O3ZI DRUGCOMP Trinity College Dublin D0O3ZI HIGHSTAT Investigative D0O4MW DRUG__ID D0O4MW D0O4MW DRUGCOMP Nanovector Ltd D0O4MW HIGHSTAT Investigative D0O4RG DRUG__ID D0O4RG D0O4RG DRUGCOMP AdeTherapeutics Inc D0O4RG HIGHSTAT Investigative D0O4SZ DRUG__ID D0O4SZ D0O4SZ DRUGCOMP BioLineRx Ltd D0O4SZ HIGHSTAT Investigative D0O5CL DRUG__ID D0O5CL D0O5CL DRUGCOMP Aroule D0O5CL HIGHSTAT Investigative D0O5HB DRUG__ID D0O5HB D0O5HB DRUGCOMP Apitope Technology (Bristol) Ltd D0O5HB HIGHSTAT Investigative D0O5QT DRUG__ID D0O5QT D0O5QT DRUGCOMP Bioarctic Neuroscience AB D0O5QT HIGHSTAT Investigative D0O5UF DRUG__ID D0O5UF D0O5UF DRUGCOMP Connexios Life Sciences Pvt Ltd D0O5UF HIGHSTAT Investigative D0O5VR DRUG__ID D0O5VR D0O5VR DRUGCOMP Tetraphase Pharmaceuticals Inc D0O5VR HIGHSTAT Investigative D0O6JE DRUG__ID D0O6JE D0O6JE DRUGCOMP UCB Celltech D0O6JE HIGHSTAT Investigative D0O6LY DRUG__ID D0O6LY D0O6LY DRUGCOMP MAT Biopharma D0O6LY HIGHSTAT Investigative D0O6OM DRUG__ID D0O6OM D0O6OM DRUGCOMP Compugen Ltd D0O6OM HIGHSTAT Investigative D0O6TD DRUG__ID D0O6TD D0O6TD DRUGCOMP Bolder BioTechnology Inc D0O6TD HIGHSTAT Investigative D0O6WS DRUG__ID D0O6WS D0O6WS DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D0O6WS HIGHSTAT Investigative D0O7AK DRUG__ID D0O7AK D0O7AK DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0O7AK HIGHSTAT Investigative D0O7JK DRUG__ID D0O7JK D0O7JK DRUGCOMP Roche Kulmbach D0O7JK HIGHSTAT Investigative D0O7NF DRUG__ID D0O7NF D0O7NF DRUGCOMP Mt Cook Pharma D0O7NF HIGHSTAT Investigative D0O7NV DRUG__ID D0O7NV D0O7NV DRUGCOMP DOV Pharmaceutical Inc D0O7NV HIGHSTAT Investigative D0O7SC DRUG__ID D0O7SC D0O7SC DRUGCOMP Dartmouth College D0O7SC HIGHSTAT Investigative D0O7XG DRUG__ID D0O7XG D0O7XG DRUGCOMP University of Manchester D0O7XG HIGHSTAT Investigative D0O7ZR DRUG__ID D0O7ZR D0O7ZR DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D0O7ZR HIGHSTAT Investigative D0O8BQ DRUG__ID D0O8BQ D0O8BQ DRUGCOMP Neurotec Pharma SL D0O8BQ HIGHSTAT Investigative D0O8EH DRUG__ID D0O8EH D0O8EH DRUGCOMP NKT Therapeutics Inc D0O8EH HIGHSTAT Investigative D0O8FN DRUG__ID D0O8FN D0O8FN DRUGCOMP Indus Biotech Pvt Ltd D0O8FN HIGHSTAT Investigative D0O8GZ DRUG__ID D0O8GZ D0O8GZ DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0O8GZ HIGHSTAT Investigative D0O8HK DRUG__ID D0O8HK D0O8HK DRUGCOMP BruCells D0O8HK HIGHSTAT Investigative D0O8JM DRUG__ID D0O8JM D0O8JM DRUGCOMP Neuronax D0O8JM HIGHSTAT Investigative D0O8RL DRUG__ID D0O8RL D0O8RL DRUGCOMP Equispharm Co Ltd D0O8RL HIGHSTAT Investigative D0O8UM DRUG__ID D0O8UM D0O8UM DRUGCOMP Xel Pharmaceuticals Inc D0O8UM HIGHSTAT Investigative D0O8WM DRUG__ID D0O8WM D0O8WM DRUGCOMP PhytoPharmacon LLC D0O8WM HIGHSTAT Investigative D0O9RV DRUG__ID D0O9RV D0O9RV DRUGCOMP PROLOR Biotech Inc D0O9RV HIGHSTAT Investigative D0OA7W DRUG__ID D0OA7W D0OA7W DRUGCOMP Human Genome Sciences Inc D0OA7W HIGHSTAT Investigative D0OB9V DRUG__ID D0OB9V D0OB9V DRUGCOMP Yuyu Inc D0OB9V HIGHSTAT Investigative D0OC6H DRUG__ID D0OC6H D0OC6H DRUGCOMP Sentinel Oncology Ltd D0OC6H HIGHSTAT Investigative D0OE2G DRUG__ID D0OE2G D0OE2G DRUGCOMP Fusion Antibodies Ltd D0OE2G HIGHSTAT Investigative D0OH1O DRUG__ID D0OH1O D0OH1O DRUGCOMP Univerzity Komenskeho v Bratislave D0OH1O HIGHSTAT Investigative D0OH8O DRUG__ID D0OH8O D0OH8O DRUGCOMP Axis Genetics plc D0OH8O HIGHSTAT Investigative D0OI5Y DRUG__ID D0OI5Y D0OI5Y DRUGCOMP Pharming Group NV D0OI5Y HIGHSTAT Investigative D0OM0X DRUG__ID D0OM0X D0OM0X DRUGCOMP Innovative Biologics Inc D0OM0X HIGHSTAT Investigative D0ON4J DRUG__ID D0ON4J D0ON4J DRUGCOMP Eleven Biotherapeutics D0ON4J HIGHSTAT Investigative D0OP2E DRUG__ID D0OP2E D0OP2E DRUGCOMP AEterna Zentaris Inc D0OP2E HIGHSTAT Investigative D0OR7P DRUG__ID D0OR7P D0OR7P DRUGCOMP Molecular Partners AG D0OR7P HIGHSTAT Investigative D0OT1S DRUG__ID D0OT1S D0OT1S DRUGCOMP Clavis Pharma AS D0OT1S HIGHSTAT Investigative D0OT8O DRUG__ID D0OT8O D0OT8O DRUGCOMP Sirnaomics Inc D0OT8O HIGHSTAT Investigative D0OV4A DRUG__ID D0OV4A D0OV4A DRUGCOMP Summit Corp plc D0OV4A HIGHSTAT Investigative D0OW5Y DRUG__ID D0OW5Y D0OW5Y DRUGCOMP Newron Pharmaceuticals SpA D0OW5Y HIGHSTAT Investigative D0OW6V DRUG__ID D0OW6V D0OW6V DRUGCOMP AstraZeneca plc D0OW6V HIGHSTAT Investigative D0OX6I DRUG__ID D0OX6I D0OX6I DRUGCOMP Karo Bio AB D0OX6I HIGHSTAT Investigative D0OY7A DRUG__ID D0OY7A D0OY7A DRUGCOMP Ranbaxy Laboratories Ltd D0OY7A HIGHSTAT Investigative D0OZ3S DRUG__ID D0OZ3S D0OZ3S DRUGCOMP Central Drug Research Institute D0OZ3S HIGHSTAT Investigative D0P1BR DRUG__ID D0P1BR D0P1BR DRUGCOMP Synvax Pharmaceuticals Inc D0P1BR HIGHSTAT Investigative D0P1DP DRUG__ID D0P1DP D0P1DP DRUGCOMP Neurokin SA D0P1DP HIGHSTAT Investigative D0P1EB DRUG__ID D0P1EB D0P1EB DRUGCOMP Galileo Pharmaceuticals D0P1EB HIGHSTAT Investigative D0P1IJ DRUG__ID D0P1IJ D0P1IJ DRUGCOMP International Stem Cell Corp D0P1IJ HIGHSTAT Investigative D0P1QN DRUG__ID D0P1QN D0P1QN DRUGCOMP NeED Pharmaceuticals Srl D0P1QN HIGHSTAT Investigative D0P1RV DRUG__ID D0P1RV D0P1RV DRUGCOMP Apitope Technology (Bristol) Ltd D0P1RV HIGHSTAT Investigative D0P1WR DRUG__ID D0P1WR D0P1WR DRUGCOMP Zambon Co SpA D0P1WR HIGHSTAT Investigative D0P1XQ DRUG__ID D0P1XQ D0P1XQ DRUGCOMP Selvita Life Sciences Solutions D0P1XQ HIGHSTAT Investigative D0P1ZR DRUG__ID D0P1ZR D0P1ZR DRUGCOMP Boehringer Ingelheim Corp D0P1ZR HIGHSTAT Investigative D0P2AL DRUG__ID D0P2AL D0P2AL DRUGCOMP Yungjin Pharmaceutical Co Ltd D0P2AL HIGHSTAT Investigative D0P2CZ DRUG__ID D0P2CZ D0P2CZ DRUGCOMP Sinclair IS Pharma plc D0P2CZ HIGHSTAT Investigative D0P2FC DRUG__ID D0P2FC D0P2FC DRUGCOMP Applied Integrin Sciences Inc D0P2FC HIGHSTAT Investigative D0P2MD DRUG__ID D0P2MD D0P2MD DRUGCOMP MAT Biopharma D0P2MD HIGHSTAT Investigative D0P2TD DRUG__ID D0P2TD D0P2TD DRUGCOMP Falco BioTherapeutics BV D0P2TD HIGHSTAT Investigative D0P2ZM DRUG__ID D0P2ZM D0P2ZM DRUGCOMP Solixia Inc D0P2ZM HIGHSTAT Investigative D0P3DC DRUG__ID D0P3DC D0P3DC DRUGCOMP Lipella Pharmaceuticals Inc D0P3DC HIGHSTAT Investigative D0P3KH DRUG__ID D0P3KH D0P3KH DRUGCOMP Allergan Inc D0P3KH HIGHSTAT Investigative D0P3LQ DRUG__ID D0P3LQ D0P3LQ DRUGCOMP Silicos NV D0P3LQ HIGHSTAT Investigative D0P3PF DRUG__ID D0P3PF D0P3PF DRUGCOMP Amunix Inc D0P3PF HIGHSTAT Investigative D0P3UZ DRUG__ID D0P3UZ D0P3UZ DRUGCOMP Cangene D0P3UZ HIGHSTAT Investigative D0P3VP DRUG__ID D0P3VP D0P3VP DRUGCOMP Jenken Bioscience Inc D0P3VP HIGHSTAT Investigative D0P3ZA DRUG__ID D0P3ZA D0P3ZA DRUGCOMP Abeille Pharmaceuticals Inc D0P3ZA HIGHSTAT Investigative D0P4DG DRUG__ID D0P4DG D0P4DG DRUGCOMP Sentinel Oncology Ltd D0P4DG HIGHSTAT Investigative D0P4FK DRUG__ID D0P4FK D0P4FK DRUGCOMP Biotecnol SA D0P4FK HIGHSTAT Investigative D0P4KV DRUG__ID D0P4KV D0P4KV DRUGCOMP Escape Therapeutics Inc D0P4KV HIGHSTAT Investigative D0P4PS DRUG__ID D0P4PS D0P4PS DRUGCOMP Johns Hopkins University D0P4PS HIGHSTAT Investigative D0P4QX DRUG__ID D0P4QX D0P4QX DRUGCOMP Laila Pharmaceuticals Pvt Ltd D0P4QX HIGHSTAT Investigative D0P4WI DRUG__ID D0P4WI D0P4WI DRUGCOMP Taizhou Fudan-Zhangjiang Pharmaceutical Co Ltd D0P4WI HIGHSTAT Investigative D0P4ZA DRUG__ID D0P4ZA D0P4ZA DRUGCOMP University of Texas Southwestern Medical Center D0P4ZA HIGHSTAT Investigative D0P5BQ DRUG__ID D0P5BQ D0P5BQ DRUGCOMP Inhibikase Therapeutics D0P5BQ HIGHSTAT Investigative D0P5LX DRUG__ID D0P5LX D0P5LX DRUGCOMP N30 Pharmaceuticals LLC D0P5LX HIGHSTAT Investigative D0P5QR DRUG__ID D0P5QR D0P5QR DRUGCOMP Novartis AG D0P5QR HIGHSTAT Investigative D0P5RJ DRUG__ID D0P5RJ D0P5RJ DRUGCOMP Biofrontera Bioscience GmbH D0P5RJ HIGHSTAT Investigative D0P5TC DRUG__ID D0P5TC D0P5TC DRUGCOMP Burke Pharmaceuticals LLC D0P5TC HIGHSTAT Investigative D0P5VH DRUG__ID D0P5VH D0P5VH DRUGCOMP EpiVax Inc D0P5VH HIGHSTAT Investigative D0P5ZG DRUG__ID D0P5ZG D0P5ZG DRUGCOMP ADVENTRX Pharmaceuticals D0P5ZG HIGHSTAT Investigative D0P5ZJ DRUG__ID D0P5ZJ D0P5ZJ DRUGCOMP GP Pharm SA D0P5ZJ HIGHSTAT Investigative D0P6AL DRUG__ID D0P6AL D0P6AL DRUGCOMP Vapogenix Inc D0P6AL HIGHSTAT Investigative D0P6CQ DRUG__ID D0P6CQ D0P6CQ DRUGCOMP Advantageous Systems LLC D0P6CQ HIGHSTAT Investigative D0P6GX DRUG__ID D0P6GX D0P6GX DRUGCOMP Chemizon Inc D0P6GX HIGHSTAT Investigative D0P6YL DRUG__ID D0P6YL D0P6YL DRUGCOMP Ludwig Institute for Cancer Research D0P6YL HIGHSTAT Investigative D0P7GV DRUG__ID D0P7GV D0P7GV DRUGCOMP Athera Biotechnologies AB D0P7GV HIGHSTAT Investigative D0P7HM DRUG__ID D0P7HM D0P7HM DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D0P7HM HIGHSTAT Investigative D0P7RV DRUG__ID D0P7RV D0P7RV DRUGCOMP Avila Therapeutics Inc D0P7RV HIGHSTAT Investigative D0P7WW DRUG__ID D0P7WW D0P7WW DRUGCOMP Endocrine Technology LLC D0P7WW HIGHSTAT Investigative D0P8HU DRUG__ID D0P8HU D0P8HU DRUGCOMP ChemoCentryx Inc D0P8HU HIGHSTAT Investigative D0P8LR DRUG__ID D0P8LR D0P8LR DRUGCOMP InCode BioPharmaceutics Inc D0P8LR HIGHSTAT Investigative D0P8ME DRUG__ID D0P8ME D0P8ME DRUGCOMP Lentigen Corp D0P8ME HIGHSTAT Investigative D0P8NR DRUG__ID D0P8NR D0P8NR DRUGCOMP Pronova BioPharma ASA D0P8NR HIGHSTAT Investigative D0P8QC DRUG__ID D0P8QC D0P8QC DRUGCOMP University of Auckland D0P8QC HIGHSTAT Investigative D0P8VZ DRUG__ID D0P8VZ D0P8VZ DRUGCOMP CTG Pharma Srl D0P8VZ HIGHSTAT Investigative D0P9RV DRUG__ID D0P9RV D0P9RV DRUGTYPE Small molecule immunotherapy D0P9RV HIGHSTAT Investigative D0P9WF DRUG__ID D0P9WF D0P9WF DRUGCOMP Cardiff Biologicals D0P9WF HIGHSTAT Investigative D0PA2R DRUG__ID D0PA2R D0PA2R DRUGCOMP Jenrin Discovery Inc D0PA2R HIGHSTAT Investigative D0PC1A DRUG__ID D0PC1A D0PC1A DRUGCOMP Prosetta Antiviral Inc D0PC1A HIGHSTAT Investigative D0PG2W DRUG__ID D0PG2W D0PG2W DRUGCOMP C3 Jian Inc D0PG2W HIGHSTAT Investigative D0PH0G DRUG__ID D0PH0G D0PH0G DRUGCOMP Nektar Therapeutics D0PH0G HIGHSTAT Investigative D0PH0U DRUG__ID D0PH0U D0PH0U DRUGCOMP ALS Therapy Development Foundation Inc D0PH0U HIGHSTAT Investigative D0PI4T DRUG__ID D0PI4T D0PI4T DRUGCOMP BrainWatch Ltd D0PI4T HIGHSTAT Investigative D0PM3G DRUG__ID D0PM3G D0PM3G DRUGCOMP BioChemics Inc D0PM3G HIGHSTAT Investigative D0PO5W DRUG__ID D0PO5W D0PO5W DRUGCOMP Kolon Life Science Inc D0PO5W HIGHSTAT Investigative D0PP0Z DRUG__ID D0PP0Z D0PP0Z DRUGCOMP Calmune Corp D0PP0Z HIGHSTAT Investigative D0PR9I DRUG__ID D0PR9I D0PR9I DRUGTYPE Antibody D0PR9I HIGHSTAT Investigative D0PS2X DRUG__ID D0PS2X D0PS2X DRUGCOMP Gemac Bio D0PS2X HIGHSTAT Investigative D0PU1O DRUG__ID D0PU1O D0PU1O DRUGCOMP Geron Corp D0PU1O HIGHSTAT Investigative D0PU1W DRUG__ID D0PU1W D0PU1W DRUGCOMP MannKind Corp D0PU1W HIGHSTAT Investigative D0PV1U DRUG__ID D0PV1U D0PV1U DRUGCOMP FORMAC Pharmaceuticals NV D0PV1U HIGHSTAT Investigative D0PX7G DRUG__ID D0PX7G D0PX7G DRUGTYPE Small molecule immunotherapy D0PX7G HIGHSTAT Investigative D0PY5R DRUG__ID D0PY5R D0PY5R DRUGCOMP Medeia Therapeutics Ltd D0PY5R HIGHSTAT Investigative D0PZ5R DRUG__ID D0PZ5R D0PZ5R DRUGCOMP Bacilligen Inc D0PZ5R HIGHSTAT Investigative D0Q0GY DRUG__ID D0Q0GY D0Q0GY DRUGCOMP Ironwood Pharmaceuticals Inc D0Q0GY HIGHSTAT Investigative D0Q0MI DRUG__ID D0Q0MI D0Q0MI DRUGCOMP Molecular Targeting Technologies Inc D0Q0MI HIGHSTAT Investigative D0Q0OY DRUG__ID D0Q0OY D0Q0OY DRUGCOMP Novartis AG D0Q0OY HIGHSTAT Investigative D0Q0XH DRUG__ID D0Q0XH D0Q0XH DRUGCOMP Esperance Pharmaceuticals Inc D0Q0XH HIGHSTAT Investigative D0Q1EC DRUG__ID D0Q1EC D0Q1EC DRUGCOMP Battelle D0Q1EC HIGHSTAT Investigative D0Q1LH DRUG__ID D0Q1LH D0Q1LH DRUGCOMP AvidBiotics Corp D0Q1LH HIGHSTAT Investigative D0Q1TX DRUG__ID D0Q1TX D0Q1TX DRUGCOMP FusoGen Pharmaceuticals Inc D0Q1TX HIGHSTAT Investigative D0Q1YX DRUG__ID D0Q1YX D0Q1YX DRUGCOMP Simcere Pharmaceutical Group D0Q1YX HIGHSTAT Investigative D0Q1ZD DRUG__ID D0Q1ZD D0Q1ZD DRUGCOMP Ohio State University D0Q1ZD HIGHSTAT Investigative D0Q2CM DRUG__ID D0Q2CM D0Q2CM DRUGCOMP Rottapharm Madaus D0Q2CM HIGHSTAT Investigative D0Q2IV DRUG__ID D0Q2IV D0Q2IV DRUGCOMP Therion Biologics D0Q2IV HIGHSTAT Investigative D0Q2RJ DRUG__ID D0Q2RJ D0Q2RJ DRUGCOMP Rottapharm Madaus D0Q2RJ HIGHSTAT Investigative D0Q2UW DRUG__ID D0Q2UW D0Q2UW DRUGCOMP InDex Pharmaceuticals AB D0Q2UW HIGHSTAT Investigative D0Q2VA DRUG__ID D0Q2VA D0Q2VA DRUGCOMP Endotis Pharma D0Q2VA HIGHSTAT Investigative D0Q2XN DRUG__ID D0Q2XN D0Q2XN DRUGCOMP HerbalScience LLC D0Q2XN HIGHSTAT Investigative D0Q2ZQ DRUG__ID D0Q2ZQ D0Q2ZQ DRUGCOMP Visterra Inc D0Q2ZQ HIGHSTAT Investigative D0Q3OM DRUG__ID D0Q3OM D0Q3OM DRUGCOMP Sanwa Kagaku Kenkyusho Co Ltd D0Q3OM HIGHSTAT Investigative D0Q3TF DRUG__ID D0Q3TF D0Q3TF DRUGCOMP Avanti Therapeutics D0Q3TF HIGHSTAT Investigative D0Q3WW DRUG__ID D0Q3WW D0Q3WW DRUGCOMP Boston Biomedical Inc D0Q3WW HIGHSTAT Investigative D0Q3XN DRUG__ID D0Q3XN D0Q3XN DRUGCOMP Kyungpook National University D0Q3XN HIGHSTAT Investigative D0Q4AR DRUG__ID D0Q4AR D0Q4AR DRUGCOMP Arisaph Pharmaceuticals Inc D0Q4AR HIGHSTAT Investigative D0Q4BQ DRUG__ID D0Q4BQ D0Q4BQ DRUGCOMP Santen Pharmaceutical Co Ltd D0Q4BQ HIGHSTAT Investigative D0Q4BX DRUG__ID D0Q4BX D0Q4BX DRUGCOMP Technophage SA D0Q4BX HIGHSTAT Investigative D0Q4FA DRUG__ID D0Q4FA D0Q4FA DRUGCOMP Pharmaxon D0Q4FA HIGHSTAT Investigative D0Q4GT DRUG__ID D0Q4GT D0Q4GT DRUGCOMP Piramal Life Sciences Ltd D0Q4GT HIGHSTAT Investigative D0Q4HA DRUG__ID D0Q4HA D0Q4HA DRUGCOMP Edgemont Pharmaceuticals LLC D0Q4HA HIGHSTAT Investigative D0Q4IE DRUG__ID D0Q4IE D0Q4IE DRUGCOMP Ambrx Inc D0Q4IE HIGHSTAT Investigative D0Q4TW DRUG__ID D0Q4TW D0Q4TW DRUGCOMP SCYNEXIS Inc D0Q4TW HIGHSTAT Investigative D0Q4XG DRUG__ID D0Q4XG D0Q4XG DRUGCOMP PROLOR Biotech Inc D0Q4XG HIGHSTAT Investigative D0Q5FT DRUG__ID D0Q5FT D0Q5FT DRUGCOMP Phage Pharmaceuticals Inc D0Q5FT HIGHSTAT Investigative D0Q5TW DRUG__ID D0Q5TW D0Q5TW DRUGCOMP Thrombotargets Corp D0Q5TW HIGHSTAT Investigative D0Q5VC DRUG__ID D0Q5VC D0Q5VC DRUGCOMP Bioarctic Neuroscience AB D0Q5VC HIGHSTAT Investigative D0Q5XM DRUG__ID D0Q5XM D0Q5XM DRUGTYPE Small molecular drug D0Q5XM HIGHSTAT Investigative D0Q6AE DRUG__ID D0Q6AE D0Q6AE DRUGCOMP Epistem Holdings plc D0Q6AE HIGHSTAT Investigative D0Q6DV DRUG__ID D0Q6DV D0Q6DV DRUGCOMP Synthonics Inc D0Q6DV HIGHSTAT Investigative D0Q6EA DRUG__ID D0Q6EA D0Q6EA DRUGCOMP Schering-Plough Corp D0Q6EA HIGHSTAT Investigative D0Q6JY DRUG__ID D0Q6JY D0Q6JY DRUGCOMP Anthera Pharmaceuticals Inc D0Q6JY HIGHSTAT Investigative D0Q6KV DRUG__ID D0Q6KV D0Q6KV DRUGCOMP Spirogen Ltd D0Q6KV HIGHSTAT Investigative D0Q6MQ DRUG__ID D0Q6MQ D0Q6MQ DRUGCOMP Compugen Ltd D0Q6MQ HIGHSTAT Investigative D0Q6OL DRUG__ID D0Q6OL D0Q6OL DRUGCOMP KineMed Inc D0Q6OL HIGHSTAT Investigative D0Q6RX DRUG__ID D0Q6RX D0Q6RX DRUGCOMP INCELL Corp D0Q6RX HIGHSTAT Investigative D0Q6YT DRUG__ID D0Q6YT D0Q6YT DRUGCOMP Maroon Biotech Corp D0Q6YT HIGHSTAT Investigative D0Q7AZ DRUG__ID D0Q7AZ D0Q7AZ DRUGCOMP Sequoia Sciences Inc D0Q7AZ HIGHSTAT Investigative D0Q7MI DRUG__ID D0Q7MI D0Q7MI DRUGCOMP Kemin Pharma Europe D0Q7MI HIGHSTAT Investigative D0Q7OB DRUG__ID D0Q7OB D0Q7OB DRUGCOMP RESprotect GmbH D0Q7OB HIGHSTAT Investigative D0Q7OR DRUG__ID D0Q7OR D0Q7OR DRUGCOMP Defyrus Inc D0Q7OR HIGHSTAT Investigative D0Q7RJ DRUG__ID D0Q7RJ D0Q7RJ DRUGCOMP SeaLife Pharma GmbH D0Q7RJ HIGHSTAT Investigative D0Q7RV DRUG__ID D0Q7RV D0Q7RV DRUGCOMP GlaxoSmithKline plc D0Q7RV HIGHSTAT Investigative D0Q7TI DRUG__ID D0Q7TI D0Q7TI DRUGCOMP Human Genome Sciences Inc D0Q7TI HIGHSTAT Investigative D0Q7XA DRUG__ID D0Q7XA D0Q7XA DRUGCOMP Lentigen Corp D0Q7XA HIGHSTAT Investigative D0Q7XS DRUG__ID D0Q7XS D0Q7XS DRUGCOMP LEO Pharma A/S D0Q7XS HIGHSTAT Investigative D0Q8CA DRUG__ID D0Q8CA D0Q8CA DRUGCOMP Molecular Express Inc D0Q8CA HIGHSTAT Investigative D0Q8GX DRUG__ID D0Q8GX D0Q8GX DRUGCOMP Receptor BioLogix Inc D0Q8GX HIGHSTAT Investigative D0Q8PJ DRUG__ID D0Q8PJ D0Q8PJ DRUGCOMP NovaLead Pharma D0Q8PJ HIGHSTAT Investigative D0Q8QR DRUG__ID D0Q8QR D0Q8QR DRUGCOMP GTx Inc D0Q8QR HIGHSTAT Investigative D0Q8RH DRUG__ID D0Q8RH D0Q8RH DRUGCOMP NovelMed Therapeutics Inc D0Q8RH HIGHSTAT Investigative D0Q8SI DRUG__ID D0Q8SI D0Q8SI DRUGCOMP SOM Biotech SL D0Q8SI HIGHSTAT Investigative D0Q8SN DRUG__ID D0Q8SN D0Q8SN DRUGCOMP Endocrine Technology LLC D0Q8SN HIGHSTAT Investigative D0Q8TI DRUG__ID D0Q8TI D0Q8TI DRUGCOMP Funxional Therapeutics Ltd D0Q8TI HIGHSTAT Investigative D0Q8TX DRUG__ID D0Q8TX D0Q8TX THERCLAS Analgesics D0Q8TX HIGHSTAT Investigative D0Q8YI DRUG__ID D0Q8YI D0Q8YI DRUGCOMP Neovacs SA D0Q8YI HIGHSTAT Investigative D0Q8YU DRUG__ID D0Q8YU D0Q8YU DRUGCOMP Orexo AB D0Q8YU HIGHSTAT Investigative D0Q8ZP DRUG__ID D0Q8ZP D0Q8ZP DRUGCOMP ALS Therapy Development Foundation Inc D0Q8ZP HIGHSTAT Investigative D0Q9BV DRUG__ID D0Q9BV D0Q9BV DRUGCOMP Jina Pharmaceuticals Inc D0Q9BV HIGHSTAT Investigative D0Q9DL DRUG__ID D0Q9DL D0Q9DL DRUGCOMP Percipio Biotherapeutics Inc D0Q9DL HIGHSTAT Investigative D0Q9GJ DRUG__ID D0Q9GJ D0Q9GJ DRUGCOMP Meabco A/S D0Q9GJ HIGHSTAT Investigative D0Q9IP DRUG__ID D0Q9IP D0Q9IP DRUGCOMP Pain Therapeutics Inc D0Q9IP HIGHSTAT Investigative D0Q9MN DRUG__ID D0Q9MN D0Q9MN DRUGCOMP CoLucid Pharmaceuticals Inc D0Q9MN HIGHSTAT Investigative D0Q9PP DRUG__ID D0Q9PP D0Q9PP DRUGCOMP Navigen Pharmaceuticals Inc D0Q9PP HIGHSTAT Investigative D0Q9RW DRUG__ID D0Q9RW D0Q9RW DRUGCOMP HanAll Biopharma Co Ltd D0Q9RW HIGHSTAT Investigative D0Q9UL DRUG__ID D0Q9UL D0Q9UL DRUGCOMP Apitope Technology (Bristol) Ltd D0Q9UL HIGHSTAT Investigative D0Q9VS DRUG__ID D0Q9VS D0Q9VS DRUGCOMP University College London D0Q9VS HIGHSTAT Investigative D0Q9VW DRUG__ID D0Q9VW D0Q9VW DRUGCOMP Alios BioPharma Inc D0Q9VW HIGHSTAT Investigative D0QA0B DRUG__ID D0QA0B D0QA0B DRUGCOMP Ardelyx Inc D0QA0B HIGHSTAT Investigative D0QA1M DRUG__ID D0QA1M D0QA1M DRUGCOMP Mt Cook Pharma D0QA1M HIGHSTAT Investigative D0QA7X DRUG__ID D0QA7X D0QA7X DRUGCOMP Apogenix GmbH D0QA7X HIGHSTAT Investigative D0QB6M DRUG__ID D0QB6M D0QB6M DRUGCOMP NeED Pharmaceuticals Srl D0QB6M HIGHSTAT Investigative D0QC6Z DRUG__ID D0QC6Z D0QC6Z DRUGCOMP Galleon Pharmaceuticals LLC D0QC6Z HIGHSTAT Investigative D0QE8K DRUG__ID D0QE8K D0QE8K DRUGCOMP MD Anderson Cancer Center D0QE8K HIGHSTAT Investigative D0QE9F DRUG__ID D0QE9F D0QE9F DRUGCOMP Piramal Life Sciences Ltd D0QE9F HIGHSTAT Investigative D0QG3E DRUG__ID D0QG3E D0QG3E DRUGCOMP Center for Genetic Engineering and Biotechnology D0QG3E HIGHSTAT Investigative D0QI0Z DRUG__ID D0QI0Z D0QI0Z DRUGCOMP Indigene Pharmaceuticals Inc D0QI0Z HIGHSTAT Investigative D0QI1O DRUG__ID D0QI1O D0QI1O DRUGCOMP Stemline Therapeutics Inc D0QI1O HIGHSTAT Investigative D0QI6W DRUG__ID D0QI6W D0QI6W DRUGCOMP Shanghai Hengrui Pharmaceutical Co Ltd D0QI6W HIGHSTAT Investigative D0QJ4M DRUG__ID D0QJ4M D0QJ4M DRUGTYPE Peptide D0QJ4M HIGHSTAT Investigative D0QJ4Y DRUG__ID D0QJ4Y D0QJ4Y DRUGCOMP Resverlogix Corp D0QJ4Y HIGHSTAT Investigative D0QJ9Z DRUG__ID D0QJ9Z D0QJ9Z DRUGCOMP MiRagen Therapeutics Inc D0QJ9Z HIGHSTAT Investigative D0QM3Q DRUG__ID D0QM3Q D0QM3Q DRUGCOMP Elevation Pharmaceuticals D0QM3Q HIGHSTAT Investigative D0QM6Y DRUG__ID D0QM6Y D0QM6Y DRUGCOMP Inhibikase Therapeutics D0QM6Y HIGHSTAT Investigative D0QN3Q DRUG__ID D0QN3Q D0QN3Q DRUGCOMP Santaris Pharma A/S D0QN3Q HIGHSTAT Investigative D0QR3J DRUG__ID D0QR3J D0QR3J DRUGCOMP LegoChem Bioscience Inc D0QR3J HIGHSTAT Investigative D0QR8B DRUG__ID D0QR8B D0QR8B DRUGCOMP Sirnaomics Inc D0QR8B HIGHSTAT Investigative D0QT9B DRUG__ID D0QT9B D0QT9B DRUGCOMP Lipocine Inc D0QT9B HIGHSTAT Investigative D0QW1V DRUG__ID D0QW1V D0QW1V DRUGCOMP Madeleine Pharmaceuticals Pty Ltd D0QW1V HIGHSTAT Investigative D0QX0H DRUG__ID D0QX0H D0QX0H DRUGCOMP GTx Inc D0QX0H HIGHSTAT Investigative D0QZ9D DRUG__ID D0QZ9D D0QZ9D DRUGCOMP Geron Corp D0QZ9D HIGHSTAT Investigative D0R0AO DRUG__ID D0R0AO D0R0AO DRUGCOMP MorphoSys AG D0R0AO HIGHSTAT Investigative D0R0BJ DRUG__ID D0R0BJ D0R0BJ DRUGCOMP GenVec D0R0BJ HIGHSTAT Investigative D0R0FU DRUG__ID D0R0FU D0R0FU DRUGCOMP Pharmaxis Ltd D0R0FU HIGHSTAT Investigative D0R0PC DRUG__ID D0R0PC D0R0PC DRUGCOMP Hansa Medical AB D0R0PC HIGHSTAT Investigative D0R0UW DRUG__ID D0R0UW D0R0UW DRUGCOMP Salix Pharmaceuticals D0R0UW HIGHSTAT Investigative D0R1DX DRUG__ID D0R1DX D0R1DX DRUGCOMP Rigel Pharmaceuticals Inc D0R1DX HIGHSTAT Investigative D0R1HK DRUG__ID D0R1HK D0R1HK DRUGCOMP University of Alabama D0R1HK HIGHSTAT Investigative D0R1RK DRUG__ID D0R1RK D0R1RK THERCLAS Analgesics D0R1RK HIGHSTAT Investigative D0R1RQ DRUG__ID D0R1RQ D0R1RQ DRUGCOMP Jinan University D0R1RQ HIGHSTAT Investigative D0R1RV DRUG__ID D0R1RV D0R1RV DRUGCOMP Zambon Co SpA D0R1RV HIGHSTAT Investigative D0R1YJ DRUG__ID D0R1YJ D0R1YJ DRUGCOMP AfaSci Inc D0R1YJ HIGHSTAT Investigative D0R2MG DRUG__ID D0R2MG D0R2MG DRUGCOMP Helix BioMedix Inc D0R2MG HIGHSTAT Investigative D0R2MQ DRUG__ID D0R2MQ D0R2MQ DRUGCOMP Burroughs Wellcome Inc D0R2MQ HIGHSTAT Investigative D0R2PR DRUG__ID D0R2PR D0R2PR DRUGCOMP Molecular Targeting Technologies Inc D0R2PR HIGHSTAT Investigative D0R2YD DRUG__ID D0R2YD D0R2YD DRUGCOMP Aduro BioTech Inc D0R2YD HIGHSTAT Investigative D0R3DT DRUG__ID D0R3DT D0R3DT DRUGCOMP Affitech A/S D0R3DT HIGHSTAT Investigative D0R3GE DRUG__ID D0R3GE D0R3GE DRUGCOMP AngioChem Inc D0R3GE HIGHSTAT Investigative D0R3IK DRUG__ID D0R3IK D0R3IK DRUGCOMP Epitomics Inc D0R3IK HIGHSTAT Investigative D0R3JO DRUG__ID D0R3JO D0R3JO DRUGCOMP Prolong Pharmaceuticals Inc D0R3JO HIGHSTAT Investigative D0R3KN DRUG__ID D0R3KN D0R3KN DRUGCOMP Meiji Seika Kaisha Ltd D0R3KN HIGHSTAT Investigative D0R3LH DRUG__ID D0R3LH D0R3LH DRUGCOMP Tokyo University D0R3LH HIGHSTAT Investigative D0R3MA DRUG__ID D0R3MA D0R3MA DRUGCOMP IoGenetics Inc D0R3MA HIGHSTAT Investigative D0R3NR DRUG__ID D0R3NR D0R3NR DRUGCOMP Philipps-Universitat Marburg D0R3NR HIGHSTAT Investigative D0R3OQ DRUG__ID D0R3OQ D0R3OQ DRUGCOMP Bionevia Pharmaceuticals Inc D0R3OQ HIGHSTAT Investigative D0R3YT DRUG__ID D0R3YT D0R3YT DRUGCOMP Lipocine Inc D0R3YT HIGHSTAT Investigative D0R4NJ DRUG__ID D0R4NJ D0R4NJ DRUGCOMP Daewon Pharm Co Ltd D0R4NJ HIGHSTAT Investigative D0R4SE DRUG__ID D0R4SE D0R4SE DRUGCOMP Funxional Therapeutics Ltd D0R4SE HIGHSTAT Investigative D0R5IS DRUG__ID D0R5IS D0R5IS DRUGCOMP FAES Farma SA D0R5IS HIGHSTAT Investigative D0R5JP DRUG__ID D0R5JP D0R5JP DRUGCOMP Nabriva Therapeutics AG D0R5JP HIGHSTAT Investigative D0R5NB DRUG__ID D0R5NB D0R5NB DRUGCOMP 4SC AG D0R5NB HIGHSTAT Investigative D0R5PP DRUG__ID D0R5PP D0R5PP DRUGCOMP Pieris AG D0R5PP HIGHSTAT Investigative D0R5TZ DRUG__ID D0R5TZ D0R5TZ DRUGCOMP Simcere Pharmaceutical Group D0R5TZ HIGHSTAT Investigative D0R5UR DRUG__ID D0R5UR D0R5UR DRUGCOMP Allist Pharmaceutical Inc D0R5UR HIGHSTAT Investigative D0R5XL DRUG__ID D0R5XL D0R5XL DRUGCOMP Caprion Pharmaceuticals Inc D0R5XL HIGHSTAT Investigative D0R6GB DRUG__ID D0R6GB D0R6GB DRUGCOMP Ahn-Gook Pharmaceuticals Co Ltd D0R6GB HIGHSTAT Investigative D0R6GO DRUG__ID D0R6GO D0R6GO DRUGTYPE Small molecule immunotherapy D0R6GO HIGHSTAT Investigative D0R6ZB DRUG__ID D0R6ZB D0R6ZB DRUGCOMP BioLineRx Ltd D0R6ZB HIGHSTAT Investigative D0R7FS DRUG__ID D0R7FS D0R7FS DRUGCOMP Beta Pharma Inc D0R7FS HIGHSTAT Investigative D0R7LX DRUG__ID D0R7LX D0R7LX DRUGCOMP F Hoffmann-La Roche Ltd D0R7LX HIGHSTAT Investigative D0R7NP DRUG__ID D0R7NP D0R7NP DRUGCOMP Impel NeuroPharma D0R7NP HIGHSTAT Investigative D0R8CA DRUG__ID D0R8CA D0R8CA DRUGCOMP NovelMed Therapeutics Inc D0R8CA HIGHSTAT Investigative D0R8CN DRUG__ID D0R8CN D0R8CN DRUGCOMP Seneb Biosciences Inc D0R8CN HIGHSTAT Investigative D0R8JN DRUG__ID D0R8JN D0R8JN DRUGCOMP Angelini Pharmaceuticals SpA D0R8JN HIGHSTAT Investigative D0R8KF DRUG__ID D0R8KF D0R8KF DRUGCOMP Sirnaomics Inc D0R8KF HIGHSTAT Investigative D0R8VU DRUG__ID D0R8VU D0R8VU DRUGCOMP Lipoxen plc D0R8VU HIGHSTAT Investigative D0R9IL DRUG__ID D0R9IL D0R9IL DRUGCOMP Cytokinetics Inc D0R9IL HIGHSTAT Investigative D0R9UO DRUG__ID D0R9UO D0R9UO DRUGCOMP Panacea Pharmaceuticals Inc D0R9UO HIGHSTAT Investigative D0R9UQ DRUG__ID D0R9UQ D0R9UQ DRUGCOMP Hanmi Pharmaceutical Co Ltd D0R9UQ HIGHSTAT Investigative D0R9XX DRUG__ID D0R9XX D0R9XX DRUGCOMP TissueGene Inc D0R9XX HIGHSTAT Investigative D0RB2H DRUG__ID D0RB2H D0RB2H DRUGCOMP ProMetic Life Sciences Inc D0RB2H HIGHSTAT Investigative D0RC3L DRUG__ID D0RC3L D0RC3L DRUGCOMP HanAll Biopharma Co Ltd D0RC3L HIGHSTAT Investigative D0RD6X DRUG__ID D0RD6X D0RD6X DRUGCOMP Juvaris BioTherapeutics Inc D0RD6X HIGHSTAT Investigative D0RH0J DRUG__ID D0RH0J D0RH0J DRUGCOMP University of Nevada D0RH0J HIGHSTAT Investigative D0RK8E DRUG__ID D0RK8E D0RK8E DRUGCOMP Neurimmune Therapeutics AG D0RK8E HIGHSTAT Investigative D0RL4T DRUG__ID D0RL4T D0RL4T DRUGCOMP TDA Research Inc D0RL4T HIGHSTAT Investigative D0RR9O DRUG__ID D0RR9O D0RR9O DRUGCOMP New York University D0RR9O HIGHSTAT Investigative D0RV8L DRUG__ID D0RV8L D0RV8L DRUGCOMP Prosetta Antiviral Inc D0RV8L HIGHSTAT Investigative D0RW9P DRUG__ID D0RW9P D0RW9P DRUGCOMP NanoViricides Inc D0RW9P HIGHSTAT Investigative D0S0CW DRUG__ID D0S0CW D0S0CW DRUGCOMP Therimunex D0S0CW HIGHSTAT Investigative D0S0DY DRUG__ID D0S0DY D0S0DY DRUGCOMP Onco-Pharmakon Inc D0S0DY HIGHSTAT Investigative D0S0RE DRUG__ID D0S0RE D0S0RE DRUGCOMP Genmab A/S D0S0RE HIGHSTAT Investigative D0S0RX DRUG__ID D0S0RX D0S0RX DRUGCOMP Avanti Therapeutics D0S0RX HIGHSTAT Investigative D0S0TR DRUG__ID D0S0TR D0S0TR DRUGCOMP Pharmagenesis Inc D0S0TR HIGHSTAT Investigative D0S1HX DRUG__ID D0S1HX D0S1HX DRUGCOMP Taiho Pharmaceutical Co Ltd D0S1HX HIGHSTAT Investigative D0S1JV DRUG__ID D0S1JV D0S1JV DRUGCOMP AnaMar Medical AB D0S1JV HIGHSTAT Investigative D0S1ZY DRUG__ID D0S1ZY D0S1ZY DRUGCOMP University of Washington D0S1ZY HIGHSTAT Investigative D0S2BL DRUG__ID D0S2BL D0S2BL DRUGCOMP Cornerstone Therapeutics Inc D0S2BL HIGHSTAT Investigative D0S2MQ DRUG__ID D0S2MQ D0S2MQ DRUGCOMP Pulmatrix Inc D0S2MQ HIGHSTAT Investigative D0S2QP DRUG__ID D0S2QP D0S2QP DRUGCOMP Cognosci Inc D0S2QP HIGHSTAT Investigative D0S2RZ DRUG__ID D0S2RZ D0S2RZ DRUGCOMP Xel Pharmaceuticals Inc D0S2RZ HIGHSTAT Investigative D0S3EF DRUG__ID D0S3EF D0S3EF DRUGCOMP CardioVascular BioTherapeutics Las Vegas; NV D0S3EF HIGHSTAT Investigative D0S3HR DRUG__ID D0S3HR D0S3HR DRUGCOMP ARigen Pharmaceuticals Inc D0S3HR HIGHSTAT Investigative D0S3IG DRUG__ID D0S3IG D0S3IG DRUGCOMP Schering-Plough Corp D0S3IG HIGHSTAT Investigative D0S3LF DRUG__ID D0S3LF D0S3LF DRUGCOMP Molecules for Health Inc D0S3LF HIGHSTAT Investigative D0S3PX DRUG__ID D0S3PX D0S3PX DRUGCOMP Bionex Pharmaceuticals Llc D0S3PX HIGHSTAT Investigative D0S3QK DRUG__ID D0S3QK D0S3QK DRUGCOMP JW Pharmaceutical Corp D0S3QK HIGHSTAT Investigative D0S3UH DRUG__ID D0S3UH D0S3UH DRUGCOMP Suven Life Sciences Ltd D0S3UH HIGHSTAT Investigative D0S3YG DRUG__ID D0S3YG D0S3YG DRUGCOMP Senex Biotechnology Inc D0S3YG HIGHSTAT Investigative D0S4BP DRUG__ID D0S4BP D0S4BP DRUGCOMP Deciphera Pharmaceuticals Inc D0S4BP HIGHSTAT Investigative D0S4GR DRUG__ID D0S4GR D0S4GR DRUGCOMP ET Vaccine Technology Inc D0S4GR HIGHSTAT Investigative D0S4IK DRUG__ID D0S4IK D0S4IK DRUGCOMP Phytomedics Inc D0S4IK HIGHSTAT Investigative D0S4MX DRUG__ID D0S4MX D0S4MX DRUGCOMP MiRagen Therapeutics Inc D0S4MX HIGHSTAT Investigative D0S4NZ DRUG__ID D0S4NZ D0S4NZ DRUGCOMP Avineuro Pharmaceuticals Inc D0S4NZ HIGHSTAT Investigative D0S4OH DRUG__ID D0S4OH D0S4OH DRUGCOMP Molecular Templates Inc D0S4OH HIGHSTAT Investigative D0S4PZ DRUG__ID D0S4PZ D0S4PZ DRUGCOMP SWITCH Biotech LLC D0S4PZ HIGHSTAT Investigative D0S4RB DRUG__ID D0S4RB D0S4RB DRUGCOMP ITherX Pharmaceuticals Inc D0S4RB HIGHSTAT Investigative D0S4RR DRUG__ID D0S4RR D0S4RR DRUGCOMP American Gene Technologies D0S4RR HIGHSTAT Investigative D0S5MJ DRUG__ID D0S5MJ D0S5MJ DRUGCOMP Cleveland Clinic Foundation D0S5MJ HIGHSTAT Investigative D0S5NN DRUG__ID D0S5NN D0S5NN DRUGCOMP American BioScience Inc D0S5NN HIGHSTAT Investigative D0S5TT DRUG__ID D0S5TT D0S5TT DRUGCOMP Acceleron Pharma Inc D0S5TT HIGHSTAT Investigative D0S6AH DRUG__ID D0S6AH D0S6AH DRUGCOMP HMGene Inc D0S6AH HIGHSTAT Investigative D0S6CD DRUG__ID D0S6CD D0S6CD DRUGCOMP NPS Pharmaceuticals Inc D0S6CD HIGHSTAT Investigative D0S6MA DRUG__ID D0S6MA D0S6MA DRUGCOMP Orchid Chemicals & Pharmaceuticals Ltd D0S6MA HIGHSTAT Investigative D0S6NH DRUG__ID D0S6NH D0S6NH DRUGCOMP SmithKline Beecham plc D0S6NH HIGHSTAT Investigative D0S6NJ DRUG__ID D0S6NJ D0S6NJ DRUGCOMP Tamir Biotechnology Inc D0S6NJ HIGHSTAT Investigative D0S6OY DRUG__ID D0S6OY D0S6OY DRUGCOMP Dompe Farmaceutici SpA D0S6OY HIGHSTAT Investigative D0S6QJ DRUG__ID D0S6QJ D0S6QJ DRUGCOMP C10 Pharma D0S6QJ HIGHSTAT Investigative D0S6SP DRUG__ID D0S6SP D0S6SP DRUGCOMP Bradford Pharma Ltd D0S6SP HIGHSTAT Investigative D0S6UH DRUG__ID D0S6UH D0S6UH DRUGCOMP B & C Biopharm D0S6UH HIGHSTAT Investigative D0S6WW DRUG__ID D0S6WW D0S6WW DRUGCOMP H Lee Moffitt Cancer Center and Research Institute D0S6WW HIGHSTAT Investigative D0S6YO DRUG__ID D0S6YO D0S6YO THERCLAS Analgesics D0S6YO HIGHSTAT Investigative D0S7CP DRUG__ID D0S7CP D0S7CP DRUGCOMP Prana Biotechnology Ltd D0S7CP HIGHSTAT Investigative D0S7HW DRUG__ID D0S7HW D0S7HW DRUGCOMP Vasade Biosciences Inc D0S7HW HIGHSTAT Investigative D0S7QB DRUG__ID D0S7QB D0S7QB DRUGCOMP Johnson & Johnson D0S7QB HIGHSTAT Investigative D0S7XR DRUG__ID D0S7XR D0S7XR DRUGCOMP University of Liege D0S7XR HIGHSTAT Investigative D0S8BU DRUG__ID D0S8BU D0S8BU DRUGTYPE Aptamer D0S8BU HIGHSTAT Investigative D0S8MN DRUG__ID D0S8MN D0S8MN DRUGCOMP Amsterdam Molecular Therapeutics BV D0S8MN HIGHSTAT Investigative D0S8RN DRUG__ID D0S8RN D0S8RN DRUGCOMP ImmunoBiosciences Inc D0S8RN HIGHSTAT Investigative D0S9HV DRUG__ID D0S9HV D0S9HV DRUGCOMP Antipodean Pharmaceuticals Inc D0S9HV HIGHSTAT Investigative D0S9PV DRUG__ID D0S9PV D0S9PV DRUGCOMP University of Southern California D0S9PV HIGHSTAT Investigative D0S9VG DRUG__ID D0S9VG D0S9VG DRUGCOMP Conformetrix D0S9VG HIGHSTAT Investigative D0S9YP DRUG__ID D0S9YP D0S9YP DRUGCOMP Zacharon Pharmaceuticals Inc D0S9YP HIGHSTAT Investigative D0SB0X DRUG__ID D0SB0X D0SB0X DRUGCOMP Celentyx Ltd D0SB0X HIGHSTAT Investigative D0SB8E DRUG__ID D0SB8E D0SB8E DRUGCOMP Unitech Pharmaceuticals Inc D0SB8E HIGHSTAT Investigative D0SD8V DRUG__ID D0SD8V D0SD8V DRUGCOMP ALS Therapy Development Foundation Inc D0SD8V HIGHSTAT Investigative D0SI1Z DRUG__ID D0SI1Z D0SI1Z DRUGCOMP Lascco SA D0SI1Z HIGHSTAT Investigative D0SK9J DRUG__ID D0SK9J D0SK9J DRUGCOMP Anacor Pharmaceuticals Inc D0SK9J HIGHSTAT Investigative D0SL4P DRUG__ID D0SL4P D0SL4P DRUGCOMP Ensoltek Co Ltd D0SL4P HIGHSTAT Investigative D0SM6Y DRUG__ID D0SM6Y D0SM6Y DRUGCOMP Microbial Novoteqs Inc D0SM6Y HIGHSTAT Investigative D0SN0U DRUG__ID D0SN0U D0SN0U DRUGCOMP Kotobuki Pharmaceutical Co Ltd D0SN0U HIGHSTAT Investigative D0SO0U DRUG__ID D0SO0U D0SO0U DRUGCOMP Pfizer Inc D0SO0U HIGHSTAT Investigative D0SO1Z DRUG__ID D0SO1Z D0SO1Z DRUGCOMP PharmaNova Inc D0SO1Z HIGHSTAT Investigative D0SO4M DRUG__ID D0SO4M D0SO4M DRUGCOMP ISA Pharmaceuticals BV D0SO4M HIGHSTAT Investigative D0SP5Q DRUG__ID D0SP5Q D0SP5Q DRUGCOMP Portola Pharmaceuticals Inc D0SP5Q HIGHSTAT Investigative D0SR3T DRUG__ID D0SR3T D0SR3T DRUGCOMP Novartis AG D0SR3T HIGHSTAT Investigative D0SV6V DRUG__ID D0SV6V D0SV6V DRUGCOMP Pacific Pharmaceuticals Co Ltd D0SV6V HIGHSTAT Investigative D0SW8L DRUG__ID D0SW8L D0SW8L DRUGCOMP LG Life Sciences Ltd D0SW8L HIGHSTAT Investigative D0SY2O DRUG__ID D0SY2O D0SY2O DRUGCOMP Angion Biomedica Corp D0SY2O HIGHSTAT Investigative D0SZ8Q DRUG__ID D0SZ8Q D0SZ8Q DRUGCOMP Cascade Therapeutics Inc D0SZ8Q HIGHSTAT Investigative D0T0BA DRUG__ID D0T0BA D0T0BA DRUGCOMP Celentyx Ltd D0T0BA HIGHSTAT Investigative D0T0BP DRUG__ID D0T0BP D0T0BP DRUGCOMP Immunobiology Ltd D0T0BP HIGHSTAT Investigative D0T0IE DRUG__ID D0T0IE D0T0IE DRUGCOMP InSite Vision Inc D0T0IE HIGHSTAT Investigative D0T0KQ DRUG__ID D0T0KQ D0T0KQ DRUGCOMP Selcia Ltd D0T0KQ HIGHSTAT Investigative D0T0LR DRUG__ID D0T0LR D0T0LR DRUGCOMP MSM Protein Technologies D0T0LR HIGHSTAT Investigative D0T0MY DRUG__ID D0T0MY D0T0MY DRUGCOMP DormaTarg Inc D0T0MY HIGHSTAT Investigative D0T0PU DRUG__ID D0T0PU D0T0PU DRUGCOMP Oxford BioMedica plc D0T0PU HIGHSTAT Investigative D0T0RU DRUG__ID D0T0RU D0T0RU DRUGCOMP Calmune Corp D0T0RU HIGHSTAT Investigative D0T0UM DRUG__ID D0T0UM D0T0UM DRUGCOMP Erimos Pharmaceutical LLC D0T0UM HIGHSTAT Investigative D0T0VZ DRUG__ID D0T0VZ D0T0VZ DRUGCOMP Xention Ltd D0T0VZ HIGHSTAT Investigative D0T1AO DRUG__ID D0T1AO D0T1AO DRUGCOMP Mystic Pharmaceuticals Inc D0T1AO HIGHSTAT Investigative D0T1EU DRUG__ID D0T1EU D0T1EU DRUGCOMP NeoDiagnostic Research Ltd D0T1EU HIGHSTAT Investigative D0T1LX DRUG__ID D0T1LX D0T1LX DRUGCOMP BioChemics Inc D0T1LX HIGHSTAT Investigative D0T1MI DRUG__ID D0T1MI D0T1MI DRUGCOMP Impel NeuroPharma D0T1MI HIGHSTAT Investigative D0T1OR DRUG__ID D0T1OR D0T1OR DRUGCOMP Biorunx Co Ltd D0T1OR HIGHSTAT Investigative D0T1RJ DRUG__ID D0T1RJ D0T1RJ DRUGCOMP MicroDose Therapeutx Inc D0T1RJ HIGHSTAT Investigative D0T1UH DRUG__ID D0T1UH D0T1UH DRUGCOMP Recordati SpA D0T1UH HIGHSTAT Investigative D0T2GP DRUG__ID D0T2GP D0T2GP DRUGCOMP Deciphera Pharmaceuticals Inc D0T2GP HIGHSTAT Investigative D0T2NG DRUG__ID D0T2NG D0T2NG DRUGCOMP SOM Biotech SL D0T2NG HIGHSTAT Investigative D0T2PT DRUG__ID D0T2PT D0T2PT DRUGCOMP Vaxil BioTherapeutics Ltd D0T2PT HIGHSTAT Investigative D0T2SK DRUG__ID D0T2SK D0T2SK DRUGCOMP Renuvia Pharmaceuticals D0T2SK HIGHSTAT Investigative D0T2ST DRUG__ID D0T2ST D0T2ST DRUGCOMP InfiMed Therapeutics Inc D0T2ST HIGHSTAT Investigative D0T2UB DRUG__ID D0T2UB D0T2UB DRUGCOMP MD Anderson Cancer Center D0T2UB HIGHSTAT Investigative D0T3BX DRUG__ID D0T3BX D0T3BX DRUGCOMP Cancer Research Technology Ltd D0T3BX HIGHSTAT Investigative D0T3CB DRUG__ID D0T3CB D0T3CB THERCLAS Analgesics D0T3CB HIGHSTAT Investigative D0T3KW DRUG__ID D0T3KW D0T3KW DRUGCOMP University of Nebraska Medical Center D0T3KW HIGHSTAT Investigative D0T3NH DRUG__ID D0T3NH D0T3NH DRUGCOMP Microbion Corp D0T3NH HIGHSTAT Investigative D0T3VY DRUG__ID D0T3VY D0T3VY DRUGCOMP Redbiotec AG D0T3VY HIGHSTAT Investigative D0T4CD DRUG__ID D0T4CD D0T4CD DRUGCOMP NeuroGeneration Inc D0T4CD HIGHSTAT Investigative D0T4EA DRUG__ID D0T4EA D0T4EA DRUGCOMP Roswell Park Cancer Institute D0T4EA HIGHSTAT Investigative D0T4LT DRUG__ID D0T4LT D0T4LT DRUGCOMP Praecis Pharmaceuticals Inc D0T4LT HIGHSTAT Investigative D0T4UQ DRUG__ID D0T4UQ D0T4UQ DRUGCOMP GlaxoSmithKline plc D0T4UQ HIGHSTAT Investigative D0T5FO DRUG__ID D0T5FO D0T5FO DRUGCOMP University of Newcastle D0T5FO HIGHSTAT Investigative D0T5JG DRUG__ID D0T5JG D0T5JG DRUGCOMP ALS Therapy Development Foundation Inc D0T5JG HIGHSTAT Investigative D0T5ZM DRUG__ID D0T5ZM D0T5ZM DRUGCOMP Galantos Pharma GmbH D0T5ZM HIGHSTAT Investigative D0T6AY DRUG__ID D0T6AY D0T6AY DRUGCOMP Wintherix LLC D0T6AY HIGHSTAT Investigative D0T6FY DRUG__ID D0T6FY D0T6FY DRUGCOMP Kwang Dong Pharmaceutical Co Ltd D0T6FY HIGHSTAT Investigative D0T6LF DRUG__ID D0T6LF D0T6LF DRUGCOMP Pfizer Inc D0T6LF HIGHSTAT Investigative D0T6PF DRUG__ID D0T6PF D0T6PF DRUGCOMP Imaxio D0T6PF HIGHSTAT Investigative D0T6TH DRUG__ID D0T6TH D0T6TH DRUGCOMP Evotec AG D0T6TH HIGHSTAT Investigative D0T6TQ DRUG__ID D0T6TQ D0T6TQ DRUGCOMP ForHumanTech Co Ltd D0T6TQ HIGHSTAT Investigative D0T6UW DRUG__ID D0T6UW D0T6UW DRUGCOMP The University of Liverpool D0T6UW HIGHSTAT Investigative D0T7AE DRUG__ID D0T7AE D0T7AE DRUGCOMP Omeros Corp D0T7AE HIGHSTAT Investigative D0T7DW DRUG__ID D0T7DW D0T7DW DRUGTYPE Peptide D0T7DW HIGHSTAT Investigative D0T7FO DRUG__ID D0T7FO D0T7FO DRUGCOMP PROLOR Biotech Inc D0T7FO HIGHSTAT Investigative D0T7OS DRUG__ID D0T7OS D0T7OS DRUGCOMP Advenchen Laboratories LLC D0T7OS HIGHSTAT Investigative D0T7PZ DRUG__ID D0T7PZ D0T7PZ DRUGCOMP Vicuron Pharmaceuticals Inc D0T7PZ HIGHSTAT Investigative D0T7XO DRUG__ID D0T7XO D0T7XO DRUGTYPE Aptamer D0T7XO HIGHSTAT Investigative D0T8CQ DRUG__ID D0T8CQ D0T8CQ DRUGCOMP Pfizer Inc D0T8CQ HIGHSTAT Investigative D0T8QM DRUG__ID D0T8QM D0T8QM DRUGCOMP MediQuest Therapeutics Inc D0T8QM HIGHSTAT Investigative D0T8QY DRUG__ID D0T8QY D0T8QY DRUGCOMP Phytomedics Inc D0T8QY HIGHSTAT Investigative D0T8RQ DRUG__ID D0T8RQ D0T8RQ DRUGCOMP Semmelweis University D0T8RQ HIGHSTAT Investigative D0T8TC DRUG__ID D0T8TC D0T8TC DRUGCOMP Catena Pharmaceuticals Inc D0T8TC HIGHSTAT Investigative D0T9CD DRUG__ID D0T9CD D0T9CD DRUGCOMP Bebaas Inc D0T9CD HIGHSTAT Investigative D0T9GQ DRUG__ID D0T9GQ D0T9GQ DRUGCOMP Autoimmune Technologies D0T9GQ HIGHSTAT Investigative D0T9JK DRUG__ID D0T9JK D0T9JK DRUGCOMP Vernalis plc D0T9JK HIGHSTAT Investigative D0T9LH DRUG__ID D0T9LH D0T9LH DRUGCOMP Merrimack Pharmaceuticals Inc D0T9LH HIGHSTAT Investigative D0T9PL DRUG__ID D0T9PL D0T9PL DRUGCOMP Bioalvo SA D0T9PL HIGHSTAT Investigative D0T9YU DRUG__ID D0T9YU D0T9YU DRUGCOMP Enantigen Therapeutics Inc D0T9YU HIGHSTAT Investigative D0T9YV DRUG__ID D0T9YV D0T9YV DRUGCOMP SunTen Phytotech Co Ltd D0T9YV HIGHSTAT Investigative D0TA3V DRUG__ID D0TA3V D0TA3V DRUGCOMP Adolor Corp D0TA3V HIGHSTAT Investigative D0TE8W DRUG__ID D0TE8W D0TE8W DRUGCOMP NeuroSearch A/S D0TE8W HIGHSTAT Investigative D0TJ9I DRUG__ID D0TJ9I D0TJ9I DRUGCOMP Southern Methodist University D0TJ9I HIGHSTAT Investigative D0TN0G DRUG__ID D0TN0G D0TN0G DRUGTYPE Small molecule immunotherapy D0TN0G HIGHSTAT Investigative D0TN0O DRUG__ID D0TN0O D0TN0O DRUGCOMP Protect Pharmaceuticals Corp D0TN0O HIGHSTAT Investigative D0TO0F DRUG__ID D0TO0F D0TO0F DRUGCOMP NovaLead Pharma D0TO0F HIGHSTAT Investigative D0TQ9U DRUG__ID D0TQ9U D0TQ9U DRUGCOMP Delenex Therapeutics AG D0TQ9U HIGHSTAT Investigative D0TS0R DRUG__ID D0TS0R D0TS0R DRUGCOMP MacroGenics Inc D0TS0R HIGHSTAT Investigative D0TT5I DRUG__ID D0TT5I D0TT5I DRUGCOMP FASgen Inc D0TT5I HIGHSTAT Investigative D0TU0F DRUG__ID D0TU0F D0TU0F DRUGCOMP HealthLinx Ltd D0TU0F HIGHSTAT Investigative D0TU7G DRUG__ID D0TU7G D0TU7G DRUGCOMP Suven Life Sciences Ltd D0TU7G HIGHSTAT Investigative D0TW1Q DRUG__ID D0TW1Q D0TW1Q DRUGCOMP Diakron Pharmaceuticals Inc D0TW1Q HIGHSTAT Investigative D0TY1U DRUG__ID D0TY1U D0TY1U DRUGCOMP ALS Therapy Development Foundation Inc D0TY1U HIGHSTAT Investigative D0TY8B DRUG__ID D0TY8B D0TY8B DRUGCOMP Nitto Denko Corp D0TY8B HIGHSTAT Investigative D0U0GC DRUG__ID D0U0GC D0U0GC DRUGCOMP Zambon Co SpA D0U0GC HIGHSTAT Investigative D0U0IS DRUG__ID D0U0IS D0U0IS DRUGCOMP Medesis Pharma SA D0U0IS HIGHSTAT Investigative D0U0JL DRUG__ID D0U0JL D0U0JL DRUGCOMP Neorphys D0U0JL HIGHSTAT Investigative D0U1BW DRUG__ID D0U1BW D0U1BW DRUGCOMP Rockefeller University D0U1BW HIGHSTAT Investigative D0U1GM DRUG__ID D0U1GM D0U1GM DRUGCOMP Resverlogix Corp D0U1GM HIGHSTAT Investigative D0U1HE DRUG__ID D0U1HE D0U1HE DRUGCOMP Hoffmann-La Roche Inc D0U1HE HIGHSTAT Investigative D0U1TJ DRUG__ID D0U1TJ D0U1TJ DRUGCOMP Nektar Therapeutics D0U1TJ HIGHSTAT Investigative D0U2DY DRUG__ID D0U2DY D0U2DY DRUGCOMP Trophogen Inc D0U2DY HIGHSTAT Investigative D0U2EF DRUG__ID D0U2EF D0U2EF DRUGCOMP Acorn Biomedical Inc D0U2EF HIGHSTAT Investigative D0U2FD DRUG__ID D0U2FD D0U2FD DRUGCOMP Loyola University of Chicago D0U2FD HIGHSTAT Investigative D0U2GT DRUG__ID D0U2GT D0U2GT DRUGCOMP Dharma Biomedical D0U2GT HIGHSTAT Investigative D0U2MP DRUG__ID D0U2MP D0U2MP DRUGCOMP Beijing Pason Pharmaceuticals Inc D0U2MP HIGHSTAT Investigative D0U2OQ DRUG__ID D0U2OQ D0U2OQ DRUGCOMP XBiotech Inc D0U2OQ HIGHSTAT Investigative D0U2OS DRUG__ID D0U2OS D0U2OS DRUGCOMP Genentech Inc D0U2OS HIGHSTAT Investigative D0U2QX DRUG__ID D0U2QX D0U2QX DRUGCOMP Yamasa Shoyu Co Ltd D0U2QX HIGHSTAT Investigative D0U2RR DRUG__ID D0U2RR D0U2RR DRUGCOMP NovaLead Pharma D0U2RR HIGHSTAT Investigative D0U2XB DRUG__ID D0U2XB D0U2XB DRUGCOMP PharmaIN Ltd D0U2XB HIGHSTAT Investigative D0U3DE DRUG__ID D0U3DE D0U3DE DRUGCOMP Neurotec Pharma SL D0U3DE HIGHSTAT Investigative D0U3JZ DRUG__ID D0U3JZ D0U3JZ DRUGCOMP PolyMedix Inc D0U3JZ HIGHSTAT Investigative D0U3KF DRUG__ID D0U3KF D0U3KF DRUGCOMP Nectid Inc D0U3KF HIGHSTAT Investigative D0U3RM DRUG__ID D0U3RM D0U3RM DRUGCOMP Allon Therapeutics Inc D0U3RM HIGHSTAT Investigative D0U3TE DRUG__ID D0U3TE D0U3TE DRUGCOMP JADO Technologies GmbH D0U3TE HIGHSTAT Investigative D0U3XI DRUG__ID D0U3XI D0U3XI DRUGCOMP Fibrotech Therapeutics Pty Ltd D0U3XI HIGHSTAT Investigative D0U3YW DRUG__ID D0U3YW D0U3YW DRUGCOMP Argenta Discovery Ltd D0U3YW HIGHSTAT Investigative D0U4IG DRUG__ID D0U4IG D0U4IG DRUGCOMP AviPep Pty D0U4IG HIGHSTAT Investigative D0U4JP DRUG__ID D0U4JP D0U4JP DRUGTYPE Small molecule immunotherapy D0U4JP HIGHSTAT Investigative D0U4JY DRUG__ID D0U4JY D0U4JY DRUGCOMP Medbiocom D0U4JY HIGHSTAT Investigative D0U4LP DRUG__ID D0U4LP D0U4LP DRUGCOMP Lypro Biosciences Inc D0U4LP HIGHSTAT Investigative D0U4QQ DRUG__ID D0U4QQ D0U4QQ DRUGCOMP LG Life Sciences Ltd D0U4QQ HIGHSTAT Investigative D0U4QZ DRUG__ID D0U4QZ D0U4QZ DRUGCOMP Harvard Medical School D0U4QZ HIGHSTAT Investigative D0U5BV DRUG__ID D0U5BV D0U5BV DRUGCOMP Akthelia Pharmaceuticals D0U5BV HIGHSTAT Investigative D0U5GX DRUG__ID D0U5GX D0U5GX DRUGCOMP CeNeRx BioPharma Inc D0U5GX HIGHSTAT Investigative D0U5HY DRUG__ID D0U5HY D0U5HY DRUGCOMP ViroMed Co Ltd D0U5HY HIGHSTAT Investigative D0U5JJ DRUG__ID D0U5JJ D0U5JJ DRUGCOMP Kylin Therapeutics Inc D0U5JJ HIGHSTAT Investigative D0U5SU DRUG__ID D0U5SU D0U5SU DRUGCOMP Femta Pharmaceuticals Inc D0U5SU HIGHSTAT Investigative D0U5VM DRUG__ID D0U5VM D0U5VM DRUGCOMP University of North Carolina D0U5VM HIGHSTAT Investigative D0U5VX DRUG__ID D0U5VX D0U5VX DRUGCOMP TheraSource LLC D0U5VX HIGHSTAT Investigative D0U5WB DRUG__ID D0U5WB D0U5WB DRUGCOMP University of Pittsburgh D0U5WB HIGHSTAT Investigative D0U5ZV DRUG__ID D0U5ZV D0U5ZV DRUGCOMP Amicus Therapeutics Inc D0U5ZV HIGHSTAT Investigative D0U6NC DRUG__ID D0U6NC D0U6NC DRUGCOMP Chodang Pharm Co Ltd D0U6NC HIGHSTAT Investigative D0U6PZ DRUG__ID D0U6PZ D0U6PZ DRUGCOMP Universita degli Studi di Siena D0U6PZ HIGHSTAT Investigative D0U6TV DRUG__ID D0U6TV D0U6TV DRUGCOMP Multimeric Biotherapeutics Inc D0U6TV HIGHSTAT Investigative D0U6WC DRUG__ID D0U6WC D0U6WC DRUGCOMP Romark Laboratories LC D0U6WC HIGHSTAT Investigative D0U7CP DRUG__ID D0U7CP D0U7CP DRUGCOMP Kinex Pharmaceuticals LLC D0U7CP HIGHSTAT Investigative D0U7GA DRUG__ID D0U7GA D0U7GA DRUGCOMP Pharming Group NV D0U7GA HIGHSTAT Investigative D0U7GE DRUG__ID D0U7GE D0U7GE DRUGCOMP Kuros Biosurgery AG D0U7GE HIGHSTAT Investigative D0U7IG DRUG__ID D0U7IG D0U7IG DRUGCOMP Sosei Group Corp D0U7IG HIGHSTAT Investigative D0U8AD DRUG__ID D0U8AD D0U8AD DRUGCOMP TLV Pharma Ltd D0U8AD HIGHSTAT Investigative D0U8EA DRUG__ID D0U8EA D0U8EA DRUGCOMP Servier D0U8EA HIGHSTAT Investigative D0U8GH DRUG__ID D0U8GH D0U8GH DRUGCOMP Lipocine Inc D0U8GH HIGHSTAT Investigative D0U8IF DRUG__ID D0U8IF D0U8IF DRUGTYPE Small molecular drug D0U8IF HIGHSTAT Investigative D0U8TW DRUG__ID D0U8TW D0U8TW DRUGCOMP Shanghai Ambrosia Pharmaceutical Co Ltd D0U8TW HIGHSTAT Investigative D0U8WW DRUG__ID D0U8WW D0U8WW DRUGCOMP Evanston Hospital Corp D0U8WW HIGHSTAT Investigative D0U9AE DRUG__ID D0U9AE D0U9AE DRUGCOMP Allinky Biopharma D0U9AE HIGHSTAT Investigative D0U9FJ DRUG__ID D0U9FJ D0U9FJ DRUGCOMP Wuhan Katygen Pharmaceuticals Inc D0U9FJ HIGHSTAT Investigative D0U9QT DRUG__ID D0U9QT D0U9QT DRUGCOMP Techno Network Shikoku Co Ltd D0U9QT HIGHSTAT Investigative D0U9YV DRUG__ID D0U9YV D0U9YV DRUGCOMP OncoMab GmbH D0U9YV HIGHSTAT Investigative D0UA0Y DRUG__ID D0UA0Y D0UA0Y DRUGCOMP Deutsches Krebsforschungszentrum D0UA0Y HIGHSTAT Investigative D0UD5P DRUG__ID D0UD5P D0UD5P DRUGCOMP National Health Research Institutes D0UD5P HIGHSTAT Investigative D0UI0B DRUG__ID D0UI0B D0UI0B DRUGCOMP VentiRx Pharmaceuticals Inc D0UI0B HIGHSTAT Investigative D0UI4S DRUG__ID D0UI4S D0UI4S DRUGCOMP Pfizer Inc D0UI4S HIGHSTAT Investigative D0UM1Y DRUG__ID D0UM1Y D0UM1Y DRUGCOMP Senex Biotechnology Inc D0UM1Y HIGHSTAT Investigative D0UM7H DRUG__ID D0UM7H D0UM7H DRUGCOMP BIAL Group D0UM7H HIGHSTAT Investigative D0UO6M DRUG__ID D0UO6M D0UO6M DRUGCOMP ReNeuron Group plc D0UO6M HIGHSTAT Investigative D0UO7V DRUG__ID D0UO7V D0UO7V DRUGCOMP Daewon Pharm Co Ltd D0UO7V HIGHSTAT Investigative D0UP0A DRUG__ID D0UP0A D0UP0A DRUGCOMP Calmune Corp D0UP0A HIGHSTAT Investigative D0UP1U DRUG__ID D0UP1U D0UP1U DRUGCOMP Talecris Biotherapeutics Holdings Inc D0UP1U HIGHSTAT Investigative D0UP5N DRUG__ID D0UP5N D0UP5N DRUGCOMP Wellstat Therapeutics Corp D0UP5N HIGHSTAT Investigative D0UR4L DRUG__ID D0UR4L D0UR4L DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0UR4L HIGHSTAT Investigative D0US8M DRUG__ID D0US8M D0US8M DRUGCOMP Biolipox AB D0US8M HIGHSTAT Investigative D0UU4D DRUG__ID D0UU4D D0UU4D DRUGCOMP Ensoltek Co Ltd D0UU4D HIGHSTAT Investigative D0UX2H DRUG__ID D0UX2H D0UX2H DRUGCOMP Human Genome Sciences Inc D0UX2H HIGHSTAT Investigative D0UY8U DRUG__ID D0UY8U D0UY8U DRUGCOMP SeneXta Therapeutics SA D0UY8U HIGHSTAT Investigative D0UZ0X DRUG__ID D0UZ0X D0UZ0X DRUGCOMP Achillion Pharmaceuticals Inc D0UZ0X HIGHSTAT Investigative D0V0BD DRUG__ID D0V0BD D0V0BD DRUGCOMP Genfit SA D0V0BD HIGHSTAT Investigative D0V0UX DRUG__ID D0V0UX D0V0UX DRUGCOMP CZ BioMed Corp D0V0UX HIGHSTAT Investigative D0V1BY DRUG__ID D0V1BY D0V1BY DRUGCOMP Epistem Holdings plc D0V1BY HIGHSTAT Investigative D0V1CW DRUG__ID D0V1CW D0V1CW DRUGTYPE Small molecule immunotherapy D0V1CW HIGHSTAT Investigative D0V1DG DRUG__ID D0V1DG D0V1DG DRUGCOMP EyeGene Inc D0V1DG HIGHSTAT Investigative D0V1ES DRUG__ID D0V1ES D0V1ES DRUGCOMP Almac Discovery Ltd D0V1ES HIGHSTAT Investigative D0V1KA DRUG__ID D0V1KA D0V1KA DRUGCOMP Midatech Ltd D0V1KA HIGHSTAT Investigative D0V1KD DRUG__ID D0V1KD D0V1KD DRUGCOMP Altacor Ltd D0V1KD HIGHSTAT Investigative D0V1NK DRUG__ID D0V1NK D0V1NK DRUGCOMP Vernalis plc D0V1NK HIGHSTAT Investigative D0V1OG DRUG__ID D0V1OG D0V1OG DRUGCOMP GlycoMar Ltd D0V1OG HIGHSTAT Investigative D0V1OY DRUG__ID D0V1OY D0V1OY DRUGCOMP BioChemics Inc D0V1OY HIGHSTAT Investigative D0V1QX DRUG__ID D0V1QX D0V1QX DRUGCOMP Children's Hospital Boston D0V1QX HIGHSTAT Investigative D0V1TV DRUG__ID D0V1TV D0V1TV DRUGCOMP Compugen Ltd D0V1TV HIGHSTAT Investigative D0V1UQ DRUG__ID D0V1UQ D0V1UQ DRUGCOMP Ottawa Hospital Research Institute D0V1UQ HIGHSTAT Investigative D0V1UV DRUG__ID D0V1UV D0V1UV DRUGCOMP MerLion Pharmaceuticals Pte Ltd D0V1UV HIGHSTAT Investigative D0V1UZ DRUG__ID D0V1UZ D0V1UZ DRUGCOMP Biofrontera Bioscience GmbH D0V1UZ HIGHSTAT Investigative D0V1VG DRUG__ID D0V1VG D0V1VG DRUGCOMP Amarantus BioSciences Inc D0V1VG HIGHSTAT Investigative D0V1WL DRUG__ID D0V1WL D0V1WL DRUGCOMP Ecole Polytechnique Federale de Lausanne D0V1WL HIGHSTAT Investigative D0V2DC DRUG__ID D0V2DC D0V2DC DRUGCOMP Trinity College Dublin D0V2DC HIGHSTAT Investigative D0V2KD DRUG__ID D0V2KD D0V2KD DRUGCOMP Catabasis Pharmaceuticals Inc D0V2KD HIGHSTAT Investigative D0V2MB DRUG__ID D0V2MB D0V2MB DRUGCOMP Geron Corp D0V2MB HIGHSTAT Investigative D0V2PG DRUG__ID D0V2PG D0V2PG DRUGCOMP Alder Biopharmaceuticals Inc D0V2PG HIGHSTAT Investigative D0V2PK DRUG__ID D0V2PK D0V2PK DRUGCOMP PhytoCeutica Inc D0V2PK HIGHSTAT Investigative D0V2YE DRUG__ID D0V2YE D0V2YE DRUGCOMP Vivia Biotech SL D0V2YE HIGHSTAT Investigative D0V2ZH DRUG__ID D0V2ZH D0V2ZH DRUGCOMP Prosetta Antiviral Inc D0V2ZH HIGHSTAT Investigative D0V3BI DRUG__ID D0V3BI D0V3BI DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D0V3BI HIGHSTAT Investigative D0V3BS DRUG__ID D0V3BS D0V3BS DRUGCOMP Affitech A/S D0V3BS HIGHSTAT Investigative D0V3HC DRUG__ID D0V3HC D0V3HC DRUGCOMP Amunix Inc D0V3HC HIGHSTAT Investigative D0V3HZ DRUG__ID D0V3HZ D0V3HZ DRUGCOMP BioSource Pharm Inc D0V3HZ HIGHSTAT Investigative D0V3WN DRUG__ID D0V3WN D0V3WN DRUGCOMP BioMarin Pharmaceutical Inc D0V3WN HIGHSTAT Investigative D0V3ZK DRUG__ID D0V3ZK D0V3ZK DRUGCOMP Genexine Co Ltd D0V3ZK HIGHSTAT Investigative D0V4DH DRUG__ID D0V4DH D0V4DH DRUGCOMP Effective Pharmaceuticals Inc D0V4DH HIGHSTAT Investigative D0V4WG DRUG__ID D0V4WG D0V4WG DRUGCOMP Vectura Group plc D0V4WG HIGHSTAT Investigative D0V4XA DRUG__ID D0V4XA D0V4XA DRUGCOMP Athersys Inc D0V4XA HIGHSTAT Investigative D0V4YT DRUG__ID D0V4YT D0V4YT DRUGCOMP International Stem Cell Corp D0V4YT HIGHSTAT Investigative D0V5VA DRUG__ID D0V5VA D0V5VA DRUGCOMP Center for Genetic Engineering and Biotechnology D0V5VA HIGHSTAT Investigative D0V5YA DRUG__ID D0V5YA D0V5YA DRUGCOMP Activus Pharma Co Ltd D0V5YA HIGHSTAT Investigative D0V6CY DRUG__ID D0V6CY D0V6CY DRUGCOMP Endocrine Technology LLC D0V6CY HIGHSTAT Investigative D0V6CZ DRUG__ID D0V6CZ D0V6CZ DRUGCOMP Xigen SA D0V6CZ HIGHSTAT Investigative D0V6FV DRUG__ID D0V6FV D0V6FV DRUGCOMP Cardax Pharmaceuticals Inc D0V6FV HIGHSTAT Investigative D0V6GT DRUG__ID D0V6GT D0V6GT DRUGCOMP Indena SpA D0V6GT HIGHSTAT Investigative D0V6JJ DRUG__ID D0V6JJ D0V6JJ DRUGCOMP Lipopharma Therapeutics SL D0V6JJ HIGHSTAT Investigative D0V6KL DRUG__ID D0V6KL D0V6KL DRUGCOMP Chlorion Pharma Inc D0V6KL HIGHSTAT Investigative D0V6KV DRUG__ID D0V6KV D0V6KV DRUGCOMP Handok Pharmaceuticals D0V6KV HIGHSTAT Investigative D0V6SI DRUG__ID D0V6SI D0V6SI DRUGCOMP Respiratorius AB D0V6SI HIGHSTAT Investigative D0V6WZ DRUG__ID D0V6WZ D0V6WZ DRUGCOMP PharmaNova Inc D0V6WZ HIGHSTAT Investigative D0V6ZQ DRUG__ID D0V6ZQ D0V6ZQ DRUGCOMP Vacciguard Ltd D0V6ZQ HIGHSTAT Investigative D0V7BH DRUG__ID D0V7BH D0V7BH DRUGCOMP FibroGen Inc D0V7BH HIGHSTAT Investigative D0V7ES DRUG__ID D0V7ES D0V7ES DRUGCOMP Dong Kook Pharmaceutical Co Ltd D0V7ES HIGHSTAT Investigative D0V7FX DRUG__ID D0V7FX D0V7FX DRUGCOMP Molteni Therapeutics Srl D0V7FX HIGHSTAT Investigative D0V7HB DRUG__ID D0V7HB D0V7HB DRUGCOMP Helix Therapeutics Inc D0V7HB HIGHSTAT Investigative D0V7HQ DRUG__ID D0V7HQ D0V7HQ DRUGCOMP AnaptysBio Inc D0V7HQ HIGHSTAT Investigative D0V7SU DRUG__ID D0V7SU D0V7SU DRUGCOMP DiverDrugs SL D0V7SU HIGHSTAT Investigative D0V7YG DRUG__ID D0V7YG D0V7YG DRUGCOMP Exonhit D0V7YG HIGHSTAT Investigative D0V7YK DRUG__ID D0V7YK D0V7YK DRUGCOMP Vaxil BioTherapeutics Ltd D0V7YK HIGHSTAT Investigative D0V8HK DRUG__ID D0V8HK D0V8HK DRUGCOMP Omniox Inc D0V8HK HIGHSTAT Investigative D0V8KB DRUG__ID D0V8KB D0V8KB DRUGCOMP Curemark LLC D0V8KB HIGHSTAT Investigative D0V8PQ DRUG__ID D0V8PQ D0V8PQ DRUGCOMP NeuroGeneration Inc D0V8PQ HIGHSTAT Investigative D0V9BX DRUG__ID D0V9BX D0V9BX DRUGCOMP TARIS Biomedical Inc D0V9BX HIGHSTAT Investigative D0V9MO DRUG__ID D0V9MO D0V9MO THERCLAS Analgesics D0V9MO HIGHSTAT Investigative D0V9MV DRUG__ID D0V9MV D0V9MV DRUGCOMP Boehringer Ingelheim Corp D0V9MV HIGHSTAT Investigative D0V9UR DRUG__ID D0V9UR D0V9UR DRUGCOMP University of Pennsylvania D0V9UR HIGHSTAT Investigative D0VB2K DRUG__ID D0VB2K D0VB2K DRUGCOMP Seoul Pharma Co Ltd D0VB2K HIGHSTAT Investigative D0VC3H DRUG__ID D0VC3H D0VC3H DRUGCOMP Protheon Inc D0VC3H HIGHSTAT Investigative D0VC4F DRUG__ID D0VC4F D0VC4F DRUGCOMP Human Genome Sciences Inc D0VC4F HIGHSTAT Investigative D0VC8H DRUG__ID D0VC8H D0VC8H DRUGCOMP Kereos Inc D0VC8H HIGHSTAT Investigative D0VC8T DRUG__ID D0VC8T D0VC8T DRUGCOMP Allozyne Inc D0VC8T HIGHSTAT Investigative D0VD5X DRUG__ID D0VD5X D0VD5X DRUGCOMP Kereos Inc D0VD5X HIGHSTAT Investigative D0VE4O DRUG__ID D0VE4O D0VE4O DRUGCOMP Bayer AG D0VE4O HIGHSTAT Investigative D0VG0G DRUG__ID D0VG0G D0VG0G DRUGCOMP Haemostatix Ltd D0VG0G HIGHSTAT Investigative D0VH9C DRUG__ID D0VH9C D0VH9C DRUGCOMP ProteoTech Inc D0VH9C HIGHSTAT Investigative D0VM8B DRUG__ID D0VM8B D0VM8B DRUGCOMP NeuroTherapeutics Pharma Inc D0VM8B HIGHSTAT Investigative D0VN2N DRUG__ID D0VN2N D0VN2N DRUGCOMP University of Manchester D0VN2N HIGHSTAT Investigative D0VN4W DRUG__ID D0VN4W D0VN4W DRUGCOMP ForHumanTech Co Ltd D0VN4W HIGHSTAT Investigative D0VN6O DRUG__ID D0VN6O D0VN6O DRUGCOMP EyeRx Research Inc D0VN6O HIGHSTAT Investigative D0VO5V DRUG__ID D0VO5V D0VO5V DRUGCOMP Neuren Pharmaceuticals Ltd D0VO5V HIGHSTAT Investigative D0VP7D DRUG__ID D0VP7D D0VP7D DRUGCOMP Histocell Sl D0VP7D HIGHSTAT Investigative D0VS1P DRUG__ID D0VS1P D0VS1P DRUGCOMP Dr Reddy's Laboratories Ltd D0VS1P HIGHSTAT Investigative D0VV2D DRUG__ID D0VV2D D0VV2D DRUGCOMP Karolinska Institute D0VV2D HIGHSTAT Investigative D0VV5X DRUG__ID D0VV5X D0VV5X DRUGCOMP Santaris Pharma A/S D0VV5X HIGHSTAT Investigative D0VW7E DRUG__ID D0VW7E D0VW7E DRUGCOMP Futura Medical plc D0VW7E HIGHSTAT Investigative D0W0BN DRUG__ID D0W0BN D0W0BN DRUGCOMP NovelMed Therapeutics Inc D0W0BN HIGHSTAT Investigative D0W0HZ DRUG__ID D0W0HZ D0W0HZ DRUGCOMP Technophage SA D0W0HZ HIGHSTAT Investigative D0W0JJ DRUG__ID D0W0JJ D0W0JJ DRUGCOMP Akebia Therapeutics Inc D0W0JJ HIGHSTAT Investigative D0W0UU DRUG__ID D0W0UU D0W0UU DRUGCOMP Celprogen Inc D0W0UU HIGHSTAT Investigative D0W0UW DRUG__ID D0W0UW D0W0UW DRUGCOMP Charlesson LLC D0W0UW HIGHSTAT Investigative D0W1YX DRUG__ID D0W1YX D0W1YX DRUGCOMP Bolder BioTechnology Inc D0W1YX HIGHSTAT Investigative D0W1YZ DRUG__ID D0W1YZ D0W1YZ DRUGCOMP Bionovo Inc D0W1YZ HIGHSTAT Investigative D0W2EG DRUG__ID D0W2EG D0W2EG DRUGCOMP Adenosine Therapeutics LLC D0W2EG HIGHSTAT Investigative D0W2FN DRUG__ID D0W2FN D0W2FN DRUGCOMP Bolder BioTechnology Inc D0W2FN HIGHSTAT Investigative D0W2KG DRUG__ID D0W2KG D0W2KG DRUGCOMP Mayo Foundation D0W2KG HIGHSTAT Investigative D0W2NZ DRUG__ID D0W2NZ D0W2NZ DRUGCOMP VectorLogics Inc D0W2NZ HIGHSTAT Investigative D0W2SX DRUG__ID D0W2SX D0W2SX DRUGCOMP Noscira SA D0W2SX HIGHSTAT Investigative D0W2VS DRUG__ID D0W2VS D0W2VS DRUGCOMP REGiMMUNE Corp D0W2VS HIGHSTAT Investigative D0W2ZX DRUG__ID D0W2ZX D0W2ZX DRUGCOMP Pfizer Inc D0W2ZX HIGHSTAT Investigative D0W3JA DRUG__ID D0W3JA D0W3JA DRUGCOMP Lacer SA D0W3JA HIGHSTAT Investigative D0W3NR DRUG__ID D0W3NR D0W3NR DRUGCOMP Beta-Cell NV D0W3NR HIGHSTAT Investigative D0W3SX DRUG__ID D0W3SX D0W3SX DRUGCOMP Addex Pharmaceuticals SA D0W3SX HIGHSTAT Investigative D0W3TC DRUG__ID D0W3TC D0W3TC DRUGCOMP Immunotech Laboratories Inc D0W3TC HIGHSTAT Investigative D0W3TZ DRUG__ID D0W3TZ D0W3TZ DRUGCOMP Transgeneron Therapeutics Inc D0W3TZ HIGHSTAT Investigative D0W3WB DRUG__ID D0W3WB D0W3WB DRUGCOMP JW Pharmaceutical Corp D0W3WB HIGHSTAT Investigative D0W4CC DRUG__ID D0W4CC D0W4CC DRUGCOMP Capricor Inc D0W4CC HIGHSTAT Investigative D0W4HO DRUG__ID D0W4HO D0W4HO DRUGCOMP Immunotech SA D0W4HO HIGHSTAT Investigative D0W4HW DRUG__ID D0W4HW D0W4HW DRUGCOMP OriGenix Technologies Inc D0W4HW HIGHSTAT Investigative D0W4RB DRUG__ID D0W4RB D0W4RB DRUGCOMP BIOO Therapeutics D0W4RB HIGHSTAT Investigative D0W4SS DRUG__ID D0W4SS D0W4SS DRUGCOMP Fraunhofer-Gesellschaft zur Foerderung der Angewandten Forschung eV D0W4SS HIGHSTAT Investigative D0W4WN DRUG__ID D0W4WN D0W4WN DRUGCOMP Oscotec Inc D0W4WN HIGHSTAT Investigative D0W5CI DRUG__ID D0W5CI D0W5CI DRUGCOMP Daewoong Pharmaceutical Co Ltd D0W5CI HIGHSTAT Investigative D0W5EY DRUG__ID D0W5EY D0W5EY DRUGCOMP Achaogen Inc D0W5EY HIGHSTAT Investigative D0W5HA DRUG__ID D0W5HA D0W5HA DRUGCOMP Atheris Laboratories D0W5HA HIGHSTAT Investigative D0W5IC DRUG__ID D0W5IC D0W5IC DRUGCOMP SIFI Societa Industria Farmaceutica Italiana SpA D0W5IC HIGHSTAT Investigative D0W5KO DRUG__ID D0W5KO D0W5KO DRUGCOMP American Gene Technologies D0W5KO HIGHSTAT Investigative D0W5WH DRUG__ID D0W5WH D0W5WH DRUGCOMP Endocrine Technology LLC D0W5WH HIGHSTAT Investigative D0W6AQ DRUG__ID D0W6AQ D0W6AQ DRUGCOMP Tranzyme Pharma Inc D0W6AQ HIGHSTAT Investigative D0W6EP DRUG__ID D0W6EP D0W6EP DRUGCOMP Amgen Inc D0W6EP HIGHSTAT Investigative D0W6EV DRUG__ID D0W6EV D0W6EV DRUGCOMP Vision 7 GmbH D0W6EV HIGHSTAT Investigative D0W6UV DRUG__ID D0W6UV D0W6UV DRUGCOMP Forward Pharma A/S D0W6UV HIGHSTAT Investigative D0W6YQ DRUG__ID D0W6YQ D0W6YQ DRUGCOMP Discovery Genomics Inc D0W6YQ HIGHSTAT Investigative D0W6ZV DRUG__ID D0W6ZV D0W6ZV DRUGCOMP Loyola University of Chicago D0W6ZV HIGHSTAT Investigative D0W7CR DRUG__ID D0W7CR D0W7CR DRUGCOMP Santaris Pharma A/S D0W7CR HIGHSTAT Investigative D0W7DP DRUG__ID D0W7DP D0W7DP DRUGCOMP ALS Therapy Development Foundation Inc D0W7DP HIGHSTAT Investigative D0W7FG DRUG__ID D0W7FG D0W7FG DRUGCOMP Alfama D0W7FG HIGHSTAT Investigative D0W7NV DRUG__ID D0W7NV D0W7NV DRUGCOMP ALS Therapy Development Foundation Inc D0W7NV HIGHSTAT Investigative D0W7OG DRUG__ID D0W7OG D0W7OG DRUGCOMP Rexahn Pharmaceuticals Inc D0W7OG HIGHSTAT Investigative D0W7PP DRUG__ID D0W7PP D0W7PP DRUGCOMP Trinity College Dublin D0W7PP HIGHSTAT Investigative D0W7RZ DRUG__ID D0W7RZ D0W7RZ DRUGCOMP Scil Technology GmbH D0W7RZ HIGHSTAT Investigative D0W7TK DRUG__ID D0W7TK D0W7TK DRUGCOMP PharmaEssentia Corp D0W7TK HIGHSTAT Investigative D0W7UC DRUG__ID D0W7UC D0W7UC DRUGCOMP ValiPharma D0W7UC HIGHSTAT Investigative D0W7XX DRUG__ID D0W7XX D0W7XX DRUGCOMP Heat Biologics D0W7XX HIGHSTAT Investigative D0W7YA DRUG__ID D0W7YA D0W7YA DRUGCOMP Pacific Pharmaceuticals Co Ltd D0W7YA HIGHSTAT Investigative D0W7ZS DRUG__ID D0W7ZS D0W7ZS DRUGTYPE Aptamer D0W7ZS HIGHSTAT Investigative D0W8AI DRUG__ID D0W8AI D0W8AI DRUGCOMP GTx Inc D0W8AI HIGHSTAT Investigative D0W8DG DRUG__ID D0W8DG D0W8DG DRUGCOMP Philogen SpA D0W8DG HIGHSTAT Investigative D0W8GP DRUG__ID D0W8GP D0W8GP DRUGCOMP Deciphera Pharmaceuticals Inc D0W8GP HIGHSTAT Investigative D0W8HW DRUG__ID D0W8HW D0W8HW DRUGCOMP Calmune Corp D0W8HW HIGHSTAT Investigative D0W8JY DRUG__ID D0W8JY D0W8JY DRUGCOMP Cosmix Therapeutics Llc D0W8JY HIGHSTAT Investigative D0W8UV DRUG__ID D0W8UV D0W8UV DRUGCOMP National Taiwan University D0W8UV HIGHSTAT Investigative D0W8VC DRUG__ID D0W8VC D0W8VC DRUGCOMP Palumed SA D0W8VC HIGHSTAT Investigative D0W8YZ DRUG__ID D0W8YZ D0W8YZ DRUGCOMP Interprotein Corp D0W8YZ HIGHSTAT Investigative D0W9CU DRUG__ID D0W9CU D0W9CU DRUGCOMP H Lee Moffitt Cancer Center and Research Institute D0W9CU HIGHSTAT Investigative D0W9KE DRUG__ID D0W9KE D0W9KE DRUGCOMP Astellas Pharma Inc D0W9KE HIGHSTAT Investigative D0W9OW DRUG__ID D0W9OW D0W9OW DRUGCOMP RAPID Pharmaceuticals AG D0W9OW HIGHSTAT Investigative D0W9XF DRUG__ID D0W9XF D0W9XF DRUGCOMP Largren Ltd D0W9XF HIGHSTAT Investigative D0W9ZS DRUG__ID D0W9ZS D0W9ZS DRUGCOMP Molecular Targeting Technologies Inc D0W9ZS HIGHSTAT Investigative D0WA3T DRUG__ID D0WA3T D0WA3T DRUGCOMP Chungbuk National University D0WA3T HIGHSTAT Investigative D0WC7S DRUG__ID D0WC7S D0WC7S DRUGCOMP Nuraging Biotech Srl D0WC7S HIGHSTAT Investigative D0WD8R DRUG__ID D0WD8R D0WD8R DRUGCOMP Med Discovery SA D0WD8R HIGHSTAT Investigative D0WF7H DRUG__ID D0WF7H D0WF7H DRUGCOMP ImmunoCellular Therapeutics Ltd D0WF7H HIGHSTAT Investigative D0WI1L DRUG__ID D0WI1L D0WI1L DRUGCOMP BioChem Solutions D0WI1L HIGHSTAT Investigative D0WK7B DRUG__ID D0WK7B D0WK7B DRUGCOMP FORMAC Pharmaceuticals NV D0WK7B HIGHSTAT Investigative D0WM5H DRUG__ID D0WM5H D0WM5H DRUGCOMP Onco-Pharmakon Inc D0WM5H HIGHSTAT Investigative D0WN7T DRUG__ID D0WN7T D0WN7T DRUGCOMP Molecules for Health Inc D0WN7T HIGHSTAT Investigative D0WO8I DRUG__ID D0WO8I D0WO8I DRUGCOMP P2D Biosciences D0WO8I HIGHSTAT Investigative D0WP1L DRUG__ID D0WP1L D0WP1L DRUGCOMP NeoPharm Co Ltd D0WP1L HIGHSTAT Investigative D0WS5L DRUG__ID D0WS5L D0WS5L DRUGCOMP BIAL Group D0WS5L HIGHSTAT Investigative D0WT0E DRUG__ID D0WT0E D0WT0E DRUGCOMP FluoroPharma Inc D0WT0E HIGHSTAT Investigative D0WT8Z DRUG__ID D0WT8Z D0WT8Z DRUGCOMP ALS Therapy Development Foundation Inc D0WT8Z HIGHSTAT Investigative D0WU2Y DRUG__ID D0WU2Y D0WU2Y DRUGCOMP Escape Therapeutics Inc D0WU2Y HIGHSTAT Investigative D0WW7U DRUG__ID D0WW7U D0WW7U DRUGCOMP BaroFold Inc D0WW7U HIGHSTAT Investigative D0WX1I DRUG__ID D0WX1I D0WX1I DRUGCOMP Progenics Pharmaceuticals Inc D0WX1I HIGHSTAT Investigative D0WX1N DRUG__ID D0WX1N D0WX1N DRUGCOMP Ensemble Therapeutics Corp D0WX1N HIGHSTAT Investigative D0WX3N DRUG__ID D0WX3N D0WX3N DRUGCOMP Kyorin Pharmaceutical Co Ltd D0WX3N HIGHSTAT Investigative D0WX5V DRUG__ID D0WX5V D0WX5V DRUGCOMP Lipopharma Therapeutics SL D0WX5V HIGHSTAT Investigative D0X0EF DRUG__ID D0X0EF D0X0EF DRUGCOMP Xaragen Pharma Ltd D0X0EF HIGHSTAT Investigative D0X0IQ DRUG__ID D0X0IQ D0X0IQ DRUGCOMP Eli Lilly & Co D0X0IQ HIGHSTAT Investigative D0X0NA DRUG__ID D0X0NA D0X0NA DRUGCOMP Rigel Pharmaceuticals Inc D0X0NA HIGHSTAT Investigative D0X0ZD DRUG__ID D0X0ZD D0X0ZD DRUGCOMP Boehringer Ingelheim Corp D0X0ZD HIGHSTAT Investigative D0X0ZK DRUG__ID D0X0ZK D0X0ZK DRUGCOMP Human Genome Sciences Inc D0X0ZK HIGHSTAT Investigative D0X1IB DRUG__ID D0X1IB D0X1IB DRUGCOMP University of New Mexico D0X1IB HIGHSTAT Investigative D0X1LE DRUG__ID D0X1LE D0X1LE DRUGCOMP SIGA Technologies Inc D0X1LE HIGHSTAT Investigative D0X1NX DRUG__ID D0X1NX D0X1NX DRUGCOMP ACE BioSciences A/S D0X1NX HIGHSTAT Investigative D0X1OV DRUG__ID D0X1OV D0X1OV DRUGCOMP HealOr Ltd D0X1OV HIGHSTAT Investigative D0X1QN DRUG__ID D0X1QN D0X1QN DRUGCOMP BrainStorm Cell Therapeutics Inc D0X1QN HIGHSTAT Investigative D0X2GM DRUG__ID D0X2GM D0X2GM DRUGCOMP Prexa Pharmaceuticals Inc D0X2GM HIGHSTAT Investigative D0X2HD DRUG__ID D0X2HD D0X2HD DRUGCOMP Exodos Life Science Partners D0X2HD HIGHSTAT Investigative D0X2MZ DRUG__ID D0X2MZ D0X2MZ DRUGCOMP Synvax Pharmaceuticals Inc D0X2MZ HIGHSTAT Investigative D0X2NB DRUG__ID D0X2NB D0X2NB DRUGCOMP AstraZeneca plc D0X2NB HIGHSTAT Investigative D0X2NE DRUG__ID D0X2NE D0X2NE DRUGCOMP Patrys Ltd D0X2NE HIGHSTAT Investigative D0X2PR DRUG__ID D0X2PR D0X2PR DRUGCOMP Critical Therapeutics Inc D0X2PR HIGHSTAT Investigative D0X2RI DRUG__ID D0X2RI D0X2RI DRUGCOMP Hygeia Therapeutics Inc D0X2RI HIGHSTAT Investigative D0X2SY DRUG__ID D0X2SY D0X2SY DRUGCOMP Rottapharm Madaus D0X2SY HIGHSTAT Investigative D0X3GD DRUG__ID D0X3GD D0X3GD DRUGCOMP Laila Pharmaceuticals Pvt Ltd D0X3GD HIGHSTAT Investigative D0X3NK DRUG__ID D0X3NK D0X3NK DRUGCOMP MediaPharma Srl D0X3NK HIGHSTAT Investigative D0X3OF DRUG__ID D0X3OF D0X3OF DRUGCOMP NGM Biopharmaceuticals Inc D0X3OF HIGHSTAT Investigative D0X3QL DRUG__ID D0X3QL D0X3QL DRUGCOMP P2D Biosciences D0X3QL HIGHSTAT Investigative D0X3UW DRUG__ID D0X3UW D0X3UW DRUGCOMP Strox Biopharmaceuticals LLC D0X3UW HIGHSTAT Investigative D0X4AN DRUG__ID D0X4AN D0X4AN DRUGCOMP Compugen Ltd D0X4AN HIGHSTAT Investigative D0X4DJ DRUG__ID D0X4DJ D0X4DJ DRUGCOMP Medbiocom D0X4DJ HIGHSTAT Investigative D0X4JO DRUG__ID D0X4JO D0X4JO DRUGCOMP Oxford BioMedica plc D0X4JO HIGHSTAT Investigative D0X4MO DRUG__ID D0X4MO D0X4MO DRUGCOMP Scil Proteins GmbH D0X4MO HIGHSTAT Investigative D0X4RU DRUG__ID D0X4RU D0X4RU DRUGCOMP Kyorin Holdings Inc D0X4RU HIGHSTAT Investigative D0X4WV DRUG__ID D0X4WV D0X4WV DRUGCOMP Institut de la Vision D0X4WV HIGHSTAT Investigative D0X5BC DRUG__ID D0X5BC D0X5BC DRUGCOMP DormaTarg Inc D0X5BC HIGHSTAT Investigative D0X5LL DRUG__ID D0X5LL D0X5LL DRUGCOMP Welichem Biotech Inc D0X5LL HIGHSTAT Investigative D0X5UY DRUG__ID D0X5UY D0X5UY DRUGCOMP HanAll Biopharma Co Ltd D0X5UY HIGHSTAT Investigative D0X6AU DRUG__ID D0X6AU D0X6AU DRUGCOMP Johns Hopkins University D0X6AU HIGHSTAT Investigative D0X6DK DRUG__ID D0X6DK D0X6DK DRUGCOMP ALS Therapy Development Foundation Inc D0X6DK HIGHSTAT Investigative D0X6EX DRUG__ID D0X6EX D0X6EX DRUGCOMP Biolipox AB D0X6EX HIGHSTAT Investigative D0X6FB DRUG__ID D0X6FB D0X6FB DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0X6FB HIGHSTAT Investigative D0X6NU DRUG__ID D0X6NU D0X6NU DRUGCOMP Debiopharm SA D0X6NU HIGHSTAT Investigative D0X6OX DRUG__ID D0X6OX D0X6OX DRUGCOMP Biotecnol SA D0X6OX HIGHSTAT Investigative D0X6XC DRUG__ID D0X6XC D0X6XC DRUGCOMP Cerus Corp D0X6XC HIGHSTAT Investigative D0X6XP DRUG__ID D0X6XP D0X6XP DRUGCOMP Jina Pharmaceuticals Inc D0X6XP HIGHSTAT Investigative D0X7GA DRUG__ID D0X7GA D0X7GA DRUGCOMP Roche Holding AG D0X7GA HIGHSTAT Investigative D0X7ZG DRUG__ID D0X7ZG D0X7ZG DRUGCOMP Catholic University of Leuven D0X7ZG HIGHSTAT Investigative D0X7ZS DRUG__ID D0X7ZS D0X7ZS DRUGCOMP MAT Biopharma D0X7ZS HIGHSTAT Investigative D0X8DV DRUG__ID D0X8DV D0X8DV DRUGCOMP Merck & Co Inc D0X8DV HIGHSTAT Investigative D0X8EE DRUG__ID D0X8EE D0X8EE DRUGCOMP GammaCan D0X8EE HIGHSTAT Investigative D0X8JN DRUG__ID D0X8JN D0X8JN DRUGCOMP Apointech SL D0X8JN HIGHSTAT Investigative D0X8PD DRUG__ID D0X8PD D0X8PD DRUGCOMP Xaragen Pharma Ltd D0X8PD HIGHSTAT Investigative D0X8PU DRUG__ID D0X8PU D0X8PU DRUGCOMP ZaBeCor Pharmaceutical Co D0X8PU HIGHSTAT Investigative D0X8UW DRUG__ID D0X8UW D0X8UW DRUGCOMP Theron Pharmaceuticals Inc D0X8UW HIGHSTAT Investigative D0X8ZY DRUG__ID D0X8ZY D0X8ZY DRUGCOMP BIAL Group D0X8ZY HIGHSTAT Investigative D0X9GV DRUG__ID D0X9GV D0X9GV DRUGCOMP AnaptysBio Inc D0X9GV HIGHSTAT Investigative D0X9IQ DRUG__ID D0X9IQ D0X9IQ DRUGCOMP NiKem Research Srl D0X9IQ HIGHSTAT Investigative D0X9IS DRUG__ID D0X9IS D0X9IS DRUGCOMP Functional Genetics Inc D0X9IS HIGHSTAT Investigative D0X9NG DRUG__ID D0X9NG D0X9NG DRUGCOMP FluGen Inc D0X9NG HIGHSTAT Investigative D0X9PB DRUG__ID D0X9PB D0X9PB DRUGCOMP HealOr Ltd D0X9PB HIGHSTAT Investigative D0X9TM DRUG__ID D0X9TM D0X9TM DRUGCOMP Laila Pharmaceuticals Pvt Ltd D0X9TM HIGHSTAT Investigative D0XA2G DRUG__ID D0XA2G D0XA2G DRUGCOMP Indus Biotech Pvt Ltd D0XA2G HIGHSTAT Investigative D0XA5N DRUG__ID D0XA5N D0XA5N DRUGCOMP Novartis AG D0XA5N HIGHSTAT Investigative D0XC1F DRUG__ID D0XC1F D0XC1F DRUGCOMP National Taiwan University D0XC1F HIGHSTAT Investigative D0XD4N DRUG__ID D0XD4N D0XD4N DRUGCOMP ACADIA Pharmaceuticals Inc D0XD4N HIGHSTAT Investigative D0XG0Z DRUG__ID D0XG0Z D0XG0Z DRUGCOMP Abbott Laboratories D0XG0Z HIGHSTAT Investigative D0XG4K DRUG__ID D0XG4K D0XG4K DRUGCOMP Kuhnil Pharmaceutical Co Ltd D0XG4K HIGHSTAT Investigative D0XG7H DRUG__ID D0XG7H D0XG7H DRUGCOMP Instituto Biomar SA D0XG7H HIGHSTAT Investigative D0XG8I DRUG__ID D0XG8I D0XG8I DRUGCOMP Pharmasset Inc D0XG8I HIGHSTAT Investigative D0XI1B DRUG__ID D0XI1B D0XI1B DRUGCOMP NeoCytex Biopharma Inc D0XI1B HIGHSTAT Investigative D0XJ8K DRUG__ID D0XJ8K D0XJ8K DRUGCOMP ImmunNovative Developments SL D0XJ8K HIGHSTAT Investigative D0XK6O DRUG__ID D0XK6O D0XK6O DRUGCOMP Intronn Inc D0XK6O HIGHSTAT Investigative D0XK6P DRUG__ID D0XK6P D0XK6P DRUGCOMP Heat Biologics D0XK6P HIGHSTAT Investigative D0XL0E DRUG__ID D0XL0E D0XL0E DRUGCOMP Novelix Pharmaceuticals Inc D0XL0E HIGHSTAT Investigative D0XM3W DRUG__ID D0XM3W D0XM3W DRUGCOMP HRA Pharma D0XM3W HIGHSTAT Investigative D0XM6L DRUG__ID D0XM6L D0XM6L DRUGCOMP Oriel Therapeutics Inc D0XM6L HIGHSTAT Investigative D0XN8W DRUG__ID D0XN8W D0XN8W DRUGCOMP Lifelike Biomatic D0XN8W HIGHSTAT Investigative D0XO3E DRUG__ID D0XO3E D0XO3E DRUGCOMP Lascco SA D0XO3E HIGHSTAT Investigative D0XO8D DRUG__ID D0XO8D D0XO8D DRUGCOMP Osaka University of Pharmaceutical Sciences D0XO8D HIGHSTAT Investigative D0XP3A DRUG__ID D0XP3A D0XP3A DRUGCOMP BaroFold Inc D0XP3A HIGHSTAT Investigative D0XQ0V DRUG__ID D0XQ0V D0XQ0V DRUGCOMP Obio Pharmaceutical Holdings Ltd D0XQ0V HIGHSTAT Investigative D0XQ8A DRUG__ID D0XQ8A D0XQ8A DRUGCOMP Shanghai Institute of Materia Medica of the Chinese Academy of Sciences D0XQ8A HIGHSTAT Investigative D0XR0V DRUG__ID D0XR0V D0XR0V DRUGCOMP Daewoong Pharmaceutical Co Ltd D0XR0V HIGHSTAT Investigative D0XR6B DRUG__ID D0XR6B D0XR6B DRUGCOMP Achillion Pharmaceuticals Inc D0XR6B HIGHSTAT Investigative D0XR6I DRUG__ID D0XR6I D0XR6I DRUGCOMP ALS Therapy Development Foundation Inc D0XR6I HIGHSTAT Investigative D0XR7V DRUG__ID D0XR7V D0XR7V DRUGCOMP TissueGene Inc D0XR7V HIGHSTAT Investigative D0XS3T DRUG__ID D0XS3T D0XS3T DRUGCOMP Cordex Pharma Inc D0XS3T HIGHSTAT Investigative D0XT3G DRUG__ID D0XT3G D0XT3G DRUGCOMP Endocrine Technology LLC D0XT3G HIGHSTAT Investigative D0XT8V DRUG__ID D0XT8V D0XT8V DRUGCOMP BioLink Life Sciences Inc D0XT8V HIGHSTAT Investigative D0XU4O DRUG__ID D0XU4O D0XU4O DRUGCOMP Novelix Pharmaceuticals Inc D0XU4O HIGHSTAT Investigative D0XU5Y DRUG__ID D0XU5Y D0XU5Y DRUGCOMP HanAll Biopharma Co Ltd D0XU5Y HIGHSTAT Investigative D0XV8M DRUG__ID D0XV8M D0XV8M DRUGCOMP Gilead Palo Alto Inc D0XV8M HIGHSTAT Investigative D0XW8R DRUG__ID D0XW8R D0XW8R DRUGCOMP Johnson & Johnson Pharmaceutical Research & Development LLC D0XW8R HIGHSTAT Investigative D0XX7E DRUG__ID D0XX7E D0XX7E DRUGCOMP University of Kentucky D0XX7E HIGHSTAT Investigative D0XY8K DRUG__ID D0XY8K D0XY8K DRUGCOMP Zambon Co SpA D0XY8K HIGHSTAT Investigative D0XZ3W DRUG__ID D0XZ3W D0XZ3W DRUGCOMP Selvita Life Sciences Solutions D0XZ3W HIGHSTAT Investigative D0Y0BZ DRUG__ID D0Y0BZ D0Y0BZ DRUGCOMP Abiogen Pharma SpA D0Y0BZ HIGHSTAT Investigative D0Y0GS DRUG__ID D0Y0GS D0Y0GS DRUGCOMP PharmedArtis GmbH D0Y0GS HIGHSTAT Investigative D0Y0LA DRUG__ID D0Y0LA D0Y0LA DRUGCOMP Pharmagenesis Inc D0Y0LA HIGHSTAT Investigative D0Y0TQ DRUG__ID D0Y0TQ D0Y0TQ DRUGCOMP Memorial Sloan-Kettering Cancer Center D0Y0TQ HIGHSTAT Investigative D0Y1BF DRUG__ID D0Y1BF D0Y1BF DRUGCOMP Apogenix Biotechnology AG D0Y1BF HIGHSTAT Investigative D0Y1BI DRUG__ID D0Y1BI D0Y1BI DRUGCOMP Thrombotargets Corp D0Y1BI HIGHSTAT Investigative D0Y1BS DRUG__ID D0Y1BS D0Y1BS DRUGCOMP Genfit SA D0Y1BS HIGHSTAT Investigative D0Y1FI DRUG__ID D0Y1FI D0Y1FI DRUGCOMP Samaritan Pharmaceuticals Inc D0Y1FI HIGHSTAT Investigative D0Y1HZ DRUG__ID D0Y1HZ D0Y1HZ DRUGCOMP InterMed Discovery GmbH D0Y1HZ HIGHSTAT Investigative D0Y1IO DRUG__ID D0Y1IO D0Y1IO DRUGCOMP MandalMed Inc D0Y1IO HIGHSTAT Investigative D0Y1LD DRUG__ID D0Y1LD D0Y1LD DRUGCOMP Rexahn Pharmaceuticals Inc D0Y1LD HIGHSTAT Investigative D0Y1RU DRUG__ID D0Y1RU D0Y1RU DRUGCOMP Calmune Corp D0Y1RU HIGHSTAT Investigative D0Y1VI DRUG__ID D0Y1VI D0Y1VI DRUGCOMP Samjin Pharmaceutical Co Ltd D0Y1VI HIGHSTAT Investigative D0Y1XR DRUG__ID D0Y1XR D0Y1XR DRUGCOMP CytoGenix Inc D0Y1XR HIGHSTAT Investigative D0Y1YA DRUG__ID D0Y1YA D0Y1YA DRUGCOMP Geron Corp D0Y1YA HIGHSTAT Investigative D0Y2EN DRUG__ID D0Y2EN D0Y2EN DRUGCOMP Instituto Biomar SA D0Y2EN HIGHSTAT Investigative D0Y2KX DRUG__ID D0Y2KX D0Y2KX DRUGCOMP Columbia Laboratories Inc D0Y2KX HIGHSTAT Investigative D0Y3KR DRUG__ID D0Y3KR D0Y3KR DRUGCOMP GlaxoSmithKline plc D0Y3KR HIGHSTAT Investigative D0Y3MW DRUG__ID D0Y3MW D0Y3MW DRUGCOMP Kent State University D0Y3MW HIGHSTAT Investigative D0Y3QR DRUG__ID D0Y3QR D0Y3QR DRUGCOMP Novartis AG D0Y3QR HIGHSTAT Investigative D0Y3TB DRUG__ID D0Y3TB D0Y3TB DRUGCOMP Anesiva D0Y3TB HIGHSTAT Investigative D0Y3TX DRUG__ID D0Y3TX D0Y3TX DRUGCOMP Cardigant Medical Inc D0Y3TX HIGHSTAT Investigative D0Y3VN DRUG__ID D0Y3VN D0Y3VN DRUGCOMP Antigen Express Inc D0Y3VN HIGHSTAT Investigative D0Y3XF DRUG__ID D0Y3XF D0Y3XF DRUGCOMP University of California San Diego D0Y3XF HIGHSTAT Investigative D0Y4BF DRUG__ID D0Y4BF D0Y4BF DRUGCOMP Promedior Inc D0Y4BF HIGHSTAT Investigative D0Y4IX DRUG__ID D0Y4IX D0Y4IX DRUGCOMP Xel Pharmaceuticals Inc D0Y4IX HIGHSTAT Investigative D0Y4QY DRUG__ID D0Y4QY D0Y4QY DRUGCOMP Bolder BioTechnology Inc D0Y4QY HIGHSTAT Investigative D0Y4TQ DRUG__ID D0Y4TQ D0Y4TQ DRUGCOMP Prana Biotechnology Ltd D0Y4TQ HIGHSTAT Investigative D0Y4XN DRUG__ID D0Y4XN D0Y4XN DRUGCOMP Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences D0Y4XN HIGHSTAT Investigative D0Y4ZI DRUG__ID D0Y4ZI D0Y4ZI DRUGCOMP Silamed Inc D0Y4ZI HIGHSTAT Investigative D0Y5DC DRUG__ID D0Y5DC D0Y5DC DRUGCOMP China Pharmaceutical University D0Y5DC HIGHSTAT Investigative D0Y5MF DRUG__ID D0Y5MF D0Y5MF DRUGCOMP NiKem Research Srl D0Y5MF HIGHSTAT Investigative D0Y5NT DRUG__ID D0Y5NT D0Y5NT DRUGCOMP Viron Therapeutics Inc D0Y5NT HIGHSTAT Investigative D0Y5OP DRUG__ID D0Y5OP D0Y5OP DRUGCOMP Indiana University D0Y5OP HIGHSTAT Investigative D0Y5WL DRUG__ID D0Y5WL D0Y5WL DRUGCOMP University of Virginia D0Y5WL HIGHSTAT Investigative D0Y6OC DRUG__ID D0Y6OC D0Y6OC DRUGCOMP Recordati SpA D0Y6OC HIGHSTAT Investigative D0Y6QO DRUG__ID D0Y6QO D0Y6QO DRUGCOMP Epigen Biosciences Inc D0Y6QO HIGHSTAT Investigative D0Y6QX DRUG__ID D0Y6QX D0Y6QX DRUGCOMP Foligo Therapeutics Inc D0Y6QX HIGHSTAT Investigative D0Y6XD DRUG__ID D0Y6XD D0Y6XD DRUGCOMP Bonenta Inc D0Y6XD HIGHSTAT Investigative D0Y6XG DRUG__ID D0Y6XG D0Y6XG DRUGCOMP Silence Therapeutics plc D0Y6XG HIGHSTAT Investigative D0Y7PJ DRUG__ID D0Y7PJ D0Y7PJ DRUGCOMP Exodos Life Science Partners D0Y7PJ HIGHSTAT Investigative D0Y7RR DRUG__ID D0Y7RR D0Y7RR DRUGCOMP Xaragen Pharma Ltd D0Y7RR HIGHSTAT Investigative D0Y7WA DRUG__ID D0Y7WA D0Y7WA DRUGCOMP Synta Pharma D0Y7WA HIGHSTAT Investigative D0Y7YR DRUG__ID D0Y7YR D0Y7YR DRUGCOMP Catabasis Pharmaceuticals Inc D0Y7YR HIGHSTAT Investigative D0Y8KM DRUG__ID D0Y8KM D0Y8KM DRUGCOMP Sirnaomics Inc D0Y8KM HIGHSTAT Investigative D0Y8KZ DRUG__ID D0Y8KZ D0Y8KZ DRUGCOMP University of Western Ontario D0Y8KZ HIGHSTAT Investigative D0Y8SS DRUG__ID D0Y8SS D0Y8SS DRUGCOMP NovaBiotics Ltd D0Y8SS HIGHSTAT Investigative D0Y8ZZ DRUG__ID D0Y8ZZ D0Y8ZZ DRUGCOMP GlobeImmune Inc D0Y8ZZ HIGHSTAT Investigative D0Y9JY DRUG__ID D0Y9JY D0Y9JY DRUGCOMP Xaragen Pharma Ltd D0Y9JY HIGHSTAT Investigative D0Y9NA DRUG__ID D0Y9NA D0Y9NA DRUGCOMP Mivenion Gmbh D0Y9NA HIGHSTAT Investigative D0Y9OS DRUG__ID D0Y9OS D0Y9OS THERCLAS Analgesics D0Y9OS HIGHSTAT Investigative D0Y9PQ DRUG__ID D0Y9PQ D0Y9PQ DRUGCOMP Amalyte Pharmaceuticals LLC D0Y9PQ HIGHSTAT Investigative D0YA6U DRUG__ID D0YA6U D0YA6U DRUGCOMP Elan Corp plc D0YA6U HIGHSTAT Investigative D0YB3D DRUG__ID D0YB3D D0YB3D DRUGCOMP Cytorex Biosciences Inc D0YB3D HIGHSTAT Investigative D0YB5Z DRUG__ID D0YB5Z D0YB5Z DRUGCOMP Ambrx Inc D0YB5Z HIGHSTAT Investigative D0YC1R DRUG__ID D0YC1R D0YC1R DRUGCOMP Bristol-Myers Squibb Co D0YC1R HIGHSTAT Investigative D0YC6Z DRUG__ID D0YC6Z D0YC6Z DRUGTYPE Small molecule immunotherapy D0YC6Z HIGHSTAT Investigative D0YD6K DRUG__ID D0YD6K D0YD6K DRUGCOMP University of Wisconsin-Madison D0YD6K HIGHSTAT Investigative D0YF2T DRUG__ID D0YF2T D0YF2T DRUGCOMP ViRexx Medical Corp D0YF2T HIGHSTAT Investigative D0YF6L DRUG__ID D0YF6L D0YF6L DRUGCOMP Seoul National University D0YF6L HIGHSTAT Investigative D0YF9W DRUG__ID D0YF9W D0YF9W DRUGCOMP Foresight Biotherapeutics Inc D0YF9W HIGHSTAT Investigative D0YG4Q DRUG__ID D0YG4Q D0YG4Q DRUGCOMP Oryzon Genomics SA D0YG4Q HIGHSTAT Investigative D0YH8T DRUG__ID D0YH8T D0YH8T DRUGCOMP Mithridion Inc D0YH8T HIGHSTAT Investigative D0YJ5H DRUG__ID D0YJ5H D0YJ5H DRUGCOMP Elixir Pharmaceuticals Inc D0YJ5H HIGHSTAT Investigative D0YK4L DRUG__ID D0YK4L D0YK4L DRUGCOMP Pacific Pharmaceuticals Co Ltd D0YK4L HIGHSTAT Investigative D0YM8K DRUG__ID D0YM8K D0YM8K DRUGCOMP National Cancer Institute D0YM8K HIGHSTAT Investigative D0YN2F DRUG__ID D0YN2F D0YN2F DRUGCOMP Human Genome Sciences Inc D0YN2F HIGHSTAT Investigative D0YN9H DRUG__ID D0YN9H D0YN9H DRUGCOMP Verva Pharmaceuticals Ltd D0YN9H HIGHSTAT Investigative D0YO0Z DRUG__ID D0YO0Z D0YO0Z DRUGCOMP Instituto Biomar SA D0YO0Z HIGHSTAT Investigative D0YR4O DRUG__ID D0YR4O D0YR4O DRUGCOMP Chiron Corp D0YR4O HIGHSTAT Investigative D0YS3H DRUG__ID D0YS3H D0YS3H DRUGCOMP Debiopharm SA D0YS3H HIGHSTAT Investigative D0YT3Z DRUG__ID D0YT3Z D0YT3Z DRUGCOMP Array BioPharma Inc D0YT3Z HIGHSTAT Investigative D0YX8X DRUG__ID D0YX8X D0YX8X DRUGCOMP Green Cross Corp D0YX8X HIGHSTAT Investigative D0YZ0B DRUG__ID D0YZ0B D0YZ0B DRUGCOMP Helicon Therapeutics Inc D0YZ0B HIGHSTAT Investigative D0YZ1J DRUG__ID D0YZ1J D0YZ1J DRUGCOMP Allostera Pharma Inc D0YZ1J HIGHSTAT Investigative D0YZ5T DRUG__ID D0YZ5T D0YZ5T DRUGCOMP Neurotune AG D0YZ5T HIGHSTAT Investigative D0Z0EH DRUG__ID D0Z0EH D0Z0EH DRUGCOMP GlaxoSmithKline plc D0Z0EH HIGHSTAT Investigative D0Z0JA DRUG__ID D0Z0JA D0Z0JA DRUGCOMP ALS Therapy Development Foundation Inc D0Z0JA HIGHSTAT Investigative D0Z0JC DRUG__ID D0Z0JC D0Z0JC DRUGCOMP Neuronax D0Z0JC HIGHSTAT Investigative D0Z0LZ DRUG__ID D0Z0LZ D0Z0LZ DRUGCOMP Intezyne Technologies Inc D0Z0LZ HIGHSTAT Investigative D0Z0QO DRUG__ID D0Z0QO D0Z0QO DRUGCOMP Serometrix LLC D0Z0QO HIGHSTAT Investigative D0Z0RR DRUG__ID D0Z0RR D0Z0RR DRUGCOMP Viral Genetics Inc D0Z0RR HIGHSTAT Investigative D0Z0SI DRUG__ID D0Z0SI D0Z0SI DRUGCOMP TB Drug Boost D0Z0SI HIGHSTAT Investigative D0Z0ZJ DRUG__ID D0Z0ZJ D0Z0ZJ DRUGCOMP Maruho Co Ltd D0Z0ZJ HIGHSTAT Investigative D0Z1CQ DRUG__ID D0Z1CQ D0Z1CQ DRUGCOMP Intracel Corp D0Z1CQ HIGHSTAT Investigative D0Z1CS DRUG__ID D0Z1CS D0Z1CS DRUGCOMP Protalix BioTherapeutics Inc D0Z1CS HIGHSTAT Investigative D0Z1EN DRUG__ID D0Z1EN D0Z1EN DRUGCOMP Center for Genetic Engineering and Biotechnology D0Z1EN HIGHSTAT Investigative D0Z1HA DRUG__ID D0Z1HA D0Z1HA DRUGCOMP ALS Therapy Development Foundation Inc D0Z1HA HIGHSTAT Investigative D0Z1MM DRUG__ID D0Z1MM D0Z1MM DRUGCOMP Obio Pharmaceutical Holdings Ltd D0Z1MM HIGHSTAT Investigative D0Z1PA DRUG__ID D0Z1PA D0Z1PA DRUGCOMP Glaxo Wellcome plc D0Z1PA HIGHSTAT Investigative D0Z1VE DRUG__ID D0Z1VE D0Z1VE DRUGCOMP Serina Therapeutics Inc D0Z1VE HIGHSTAT Investigative D0Z1WH DRUG__ID D0Z1WH D0Z1WH DRUGCOMP Abiogen Pharma SpA D0Z1WH HIGHSTAT Investigative D0Z2AY DRUG__ID D0Z2AY D0Z2AY DRUGCOMP University of Texas System D0Z2AY HIGHSTAT Investigative D0Z2BT DRUG__ID D0Z2BT D0Z2BT DRUGCOMP D-Pharm Ltd D0Z2BT HIGHSTAT Investigative D0Z2FX DRUG__ID D0Z2FX D0Z2FX DRUGCOMP Allon Therapeutics Inc D0Z2FX HIGHSTAT Investigative D0Z2JR DRUG__ID D0Z2JR D0Z2JR DRUGCOMP Lentigen Corp D0Z2JR HIGHSTAT Investigative D0Z2NY DRUG__ID D0Z2NY D0Z2NY DRUGCOMP Hangzhou Adamerck Pharmlabs Inc D0Z2NY HIGHSTAT Investigative D0Z2TH DRUG__ID D0Z2TH D0Z2TH DRUGCOMP InterMed Discovery GmbH D0Z2TH HIGHSTAT Investigative D0Z2UT DRUG__ID D0Z2UT D0Z2UT DRUGCOMP Asklepios Biopharmaceutical Inc D0Z2UT HIGHSTAT Investigative D0Z3LN DRUG__ID D0Z3LN D0Z3LN DRUGCOMP Lumen Therapeutics LLC D0Z3LN HIGHSTAT Investigative D0Z3LY DRUG__ID D0Z3LY D0Z3LY DRUGCOMP SOM Biotech SL D0Z3LY HIGHSTAT Investigative D0Z3OO DRUG__ID D0Z3OO D0Z3OO DRUGCOMP BiOMaDe Technology D0Z3OO HIGHSTAT Investigative D0Z3PD DRUG__ID D0Z3PD D0Z3PD DRUGCOMP Neolac Inc D0Z3PD HIGHSTAT Investigative D0Z3ZF DRUG__ID D0Z3ZF D0Z3ZF DRUGCOMP Tocagen Inc D0Z3ZF HIGHSTAT Investigative D0Z4BP DRUG__ID D0Z4BP D0Z4BP DRUGCOMP StemCells Inc D0Z4BP HIGHSTAT Investigative D0Z4VG DRUG__ID D0Z4VG D0Z4VG DRUGCOMP Human Genome Sciences Inc D0Z4VG HIGHSTAT Investigative D0Z4YK DRUG__ID D0Z4YK D0Z4YK DRUGCOMP Summit Corp plc D0Z4YK HIGHSTAT Investigative D0Z5DJ DRUG__ID D0Z5DJ D0Z5DJ DRUGCOMP PROLOR Biotech Inc D0Z5DJ HIGHSTAT Investigative D0Z5JC DRUG__ID D0Z5JC D0Z5JC DRUGCOMP HanAll Biopharma Co Ltd D0Z5JC HIGHSTAT Investigative D0Z5UB DRUG__ID D0Z5UB D0Z5UB DRUGCOMP Cortex Pharmaceuticals Inc D0Z5UB HIGHSTAT Investigative D0Z5UD DRUG__ID D0Z5UD D0Z5UD DRUGCOMP Molecular Insight Pharmaceuticals Inc D0Z5UD HIGHSTAT Investigative D0Z5VL DRUG__ID D0Z5VL D0Z5VL DRUGCOMP Perseus Proteomics Inc D0Z5VL HIGHSTAT Investigative D0Z5YI DRUG__ID D0Z5YI D0Z5YI DRUGCOMP AVI BioPharma Inc D0Z5YI HIGHSTAT Investigative D0Z6EQ DRUG__ID D0Z6EQ D0Z6EQ DRUGCOMP Zambon Co SpA D0Z6EQ HIGHSTAT Investigative D0Z6LQ DRUG__ID D0Z6LQ D0Z6LQ DRUGTYPE Peptide D0Z6LQ HIGHSTAT Investigative D0Z6MW DRUG__ID D0Z6MW D0Z6MW DRUGCOMP Oscotec Inc D0Z6MW HIGHSTAT Investigative D0Z6WN DRUG__ID D0Z6WN D0Z6WN DRUGCOMP Newgex Inc D0Z6WN HIGHSTAT Investigative D0Z6XQ DRUG__ID D0Z6XQ D0Z6XQ DRUGCOMP Halsa Pharmaceuticals Inc D0Z6XQ HIGHSTAT Investigative D0Z6ZF DRUG__ID D0Z6ZF D0Z6ZF DRUGCOMP Polytherics Ltd D0Z6ZF HIGHSTAT Investigative D0Z7FY DRUG__ID D0Z7FY D0Z7FY DRUGCOMP Cempra Pharmaceuticals Inc D0Z7FY HIGHSTAT Investigative D0Z7FZ DRUG__ID D0Z7FZ D0Z7FZ DRUGCOMP Vironova AB D0Z7FZ HIGHSTAT Investigative D0Z7GX DRUG__ID D0Z7GX D0Z7GX DRUGCOMP Bolder BioTechnology Inc D0Z7GX HIGHSTAT Investigative D0Z7KB DRUG__ID D0Z7KB D0Z7KB DRUGCOMP Rexahn Pharmaceuticals Inc D0Z7KB HIGHSTAT Investigative D0Z7LK DRUG__ID D0Z7LK D0Z7LK DRUGCOMP Dharma Biomedical D0Z7LK HIGHSTAT Investigative D0Z7RA DRUG__ID D0Z7RA D0Z7RA DRUGCOMP Glycadia Inc D0Z7RA HIGHSTAT Investigative D0Z7RR DRUG__ID D0Z7RR D0Z7RR DRUGCOMP Array BioPharma Inc D0Z7RR HIGHSTAT Investigative D0Z8BI DRUG__ID D0Z8BI D0Z8BI DRUGCOMP ImmunoGen Inc D0Z8BI HIGHSTAT Investigative D0Z8UJ DRUG__ID D0Z8UJ D0Z8UJ DRUGCOMP ALS Therapy Development Foundation Inc D0Z8UJ HIGHSTAT Investigative D0Z8XI DRUG__ID D0Z8XI D0Z8XI DRUGCOMP Human Genome Sciences Inc D0Z8XI HIGHSTAT Investigative D0Z8ZW DRUG__ID D0Z8ZW D0Z8ZW DRUGCOMP SibTech Inc D0Z8ZW HIGHSTAT Investigative D0Z9BU DRUG__ID D0Z9BU D0Z9BU DRUGCOMP Endocyte Inc D0Z9BU HIGHSTAT Investigative D0Z9WP DRUG__ID D0Z9WP D0Z9WP DRUGCOMP Zealand Pharma A/S D0Z9WP HIGHSTAT Investigative D0Z9WV DRUG__ID D0Z9WV D0Z9WV DRUGCOMP Ensoltek Co Ltd D0Z9WV HIGHSTAT Investigative D0Z9YV DRUG__ID D0Z9YV D0Z9YV DRUGCOMP Protheon Inc D0Z9YV HIGHSTAT Investigative D0ZB2E DRUG__ID D0ZB2E D0ZB2E DRUGCOMP Novogen Ltd D0ZB2E HIGHSTAT Investigative D0ZB9D DRUG__ID D0ZB9D D0ZB9D DRUGCOMP Eurapharm Inc D0ZB9D HIGHSTAT Investigative D0ZE3S DRUG__ID D0ZE3S D0ZE3S DRUGCOMP Respiratorius AB D0ZE3S HIGHSTAT Investigative D0ZE7B DRUG__ID D0ZE7B D0ZE7B DRUGCOMP NovaLead Pharma D0ZE7B HIGHSTAT Investigative D0ZE9T DRUG__ID D0ZE9T D0ZE9T DRUGCOMP Dong-A Pharmaceutical Co Ltd D0ZE9T HIGHSTAT Investigative D0ZG7S DRUG__ID D0ZG7S D0ZG7S DRUGCOMP BioXell SpA D0ZG7S HIGHSTAT Investigative D0ZH0X DRUG__ID D0ZH0X D0ZH0X DRUGCOMP Innate Pharma SA D0ZH0X HIGHSTAT Investigative D0ZJ8G DRUG__ID D0ZJ8G D0ZJ8G DRUGCOMP Femta Pharmaceuticals Inc D0ZJ8G HIGHSTAT Investigative D0ZK5H DRUG__ID D0ZK5H D0ZK5H DRUGCOMP Penwest Pharmaceuticals Co D0ZK5H HIGHSTAT Investigative D0ZO7D DRUG__ID D0ZO7D D0ZO7D DRUGTYPE Small molecule immunotherapy D0ZO7D HIGHSTAT Investigative D0ZP4B DRUG__ID D0ZP4B D0ZP4B DRUGCOMP Incozen Therapeutics Pvt Ltd D0ZP4B HIGHSTAT Investigative D0ZP7D DRUG__ID D0ZP7D D0ZP7D DRUGCOMP ImmunoGenetix Therapeutics D0ZP7D HIGHSTAT Investigative D0ZR2W DRUG__ID D0ZR2W D0ZR2W DRUGCOMP Cortex Pharmaceuticals Inc D0ZR2W HIGHSTAT Investigative D0ZR4Q DRUG__ID D0ZR4Q D0ZR4Q DRUGCOMP 3SBio Inc D0ZR4Q HIGHSTAT Investigative D0ZS8S DRUG__ID D0ZS8S D0ZS8S DRUGCOMP Creabilis Therapeutics SpA D0ZS8S HIGHSTAT Investigative D0ZU2X DRUG__ID D0ZU2X D0ZU2X DRUGCOMP Medical Research Council Technology D0ZU2X HIGHSTAT Investigative D0ZV4I DRUG__ID D0ZV4I D0ZV4I DRUGCOMP HanAll Biopharma Co Ltd D0ZV4I HIGHSTAT Investigative D0ZV7Y DRUG__ID D0ZV7Y D0ZV7Y DRUGCOMP University of Queensland D0ZV7Y HIGHSTAT Investigative D1JS9X DRUG__ID D1JS9X D1JS9X DRUGTYPE Antibody D1JS9X HIGHSTAT Investigative D5S7JL DRUG__ID D5S7JL D5S7JL DRUGTYPE Oligonucleotide D5S7JL HIGHSTAT Investigative DD3MB0 DRUG__ID DD3MB0 DD3MB0 DRUGTYPE Peptide DD3MB0 HIGHSTAT Investigative DF5LB8 DRUG__ID DF5LB8 DF5LB8 DRUGTYPE Small molecular drug DF5LB8 HIGHSTAT Investigative DFHC16 DRUG__ID DFHC16 DFHC16 DRUGTYPE Vaccine DFHC16 HIGHSTAT Investigative DT6N0O DRUG__ID DT6N0O DT6N0O DRUGTYPE Oligonucleotide DT6N0O HIGHSTAT Investigative D00AVS DRUG__ID D00AVS D00AVS HIGHSTAT Investigative D00DIJ DRUG__ID D00DIJ D00DIJ HIGHSTAT Investigative D00FLZ DRUG__ID D00FLZ D00FLZ HIGHSTAT Investigative D00GBP DRUG__ID D00GBP D00GBP HIGHSTAT Investigative D00GWR DRUG__ID D00GWR D00GWR HIGHSTAT Investigative D00HAM DRUG__ID D00HAM D00HAM HIGHSTAT Investigative D00JNH DRUG__ID D00JNH D00JNH HIGHSTAT Investigative D00LHN DRUG__ID D00LHN D00LHN HIGHSTAT Investigative D00LZM DRUG__ID D00LZM D00LZM HIGHSTAT Investigative D00MIM DRUG__ID D00MIM D00MIM HIGHSTAT Investigative D00TPI DRUG__ID D00TPI D00TPI HIGHSTAT Investigative D00UCE DRUG__ID D00UCE D00UCE HIGHSTAT Investigative D00XSL DRUG__ID D00XSL D00XSL HIGHSTAT Investigative D00YTS DRUG__ID D00YTS D00YTS HIGHSTAT Investigative D01AQN DRUG__ID D01AQN D01AQN HIGHSTAT Investigative D01CHD DRUG__ID D01CHD D01CHD HIGHSTAT Investigative D01DEU DRUG__ID D01DEU D01DEU HIGHSTAT Investigative D01EAG DRUG__ID D01EAG D01EAG HIGHSTAT Investigative D01EKO DRUG__ID D01EKO D01EKO HIGHSTAT Investigative D01FSW DRUG__ID D01FSW D01FSW HIGHSTAT Investigative D01FYY DRUG__ID D01FYY D01FYY HIGHSTAT Investigative D01GJI DRUG__ID D01GJI D01GJI HIGHSTAT Investigative D01JCX DRUG__ID D01JCX D01JCX HIGHSTAT Investigative D01KLI DRUG__ID D01KLI D01KLI HIGHSTAT Investigative D01LEP DRUG__ID D01LEP D01LEP HIGHSTAT Investigative D01LZL DRUG__ID D01LZL D01LZL HIGHSTAT Investigative D01NIJ DRUG__ID D01NIJ D01NIJ HIGHSTAT Investigative D01QDB DRUG__ID D01QDB D01QDB HIGHSTAT Investigative D01SWJ DRUG__ID D01SWJ D01SWJ HIGHSTAT Investigative D01VGQ DRUG__ID D01VGQ D01VGQ HIGHSTAT Investigative D01YCW DRUG__ID D01YCW D01YCW HIGHSTAT Investigative D01ZMR DRUG__ID D01ZMR D01ZMR HIGHSTAT Investigative D02BPV DRUG__ID D02BPV D02BPV HIGHSTAT Investigative D02BRA DRUG__ID D02BRA D02BRA HIGHSTAT Investigative D02DGT DRUG__ID D02DGT D02DGT HIGHSTAT Investigative D02GCE DRUG__ID D02GCE D02GCE HIGHSTAT Investigative D02JHE DRUG__ID D02JHE D02JHE HIGHSTAT Investigative D02LMJ DRUG__ID D02LMJ D02LMJ HIGHSTAT Investigative D02TFB DRUG__ID D02TFB D02TFB HIGHSTAT Investigative D02TOS DRUG__ID D02TOS D02TOS HIGHSTAT Investigative D02TXD DRUG__ID D02TXD D02TXD HIGHSTAT Investigative D02TYC DRUG__ID D02TYC D02TYC HIGHSTAT Investigative D02YDM DRUG__ID D02YDM D02YDM HIGHSTAT Investigative D03BFX DRUG__ID D03BFX D03BFX HIGHSTAT Investigative D03DKG DRUG__ID D03DKG D03DKG HIGHSTAT Investigative D03EAQ DRUG__ID D03EAQ D03EAQ HIGHSTAT Investigative D03END DRUG__ID D03END D03END HIGHSTAT Investigative D03FZG DRUG__ID D03FZG D03FZG HIGHSTAT Investigative D03IDX DRUG__ID D03IDX D03IDX HIGHSTAT Investigative D03INC DRUG__ID D03INC D03INC HIGHSTAT Investigative D03JAF DRUG__ID D03JAF D03JAF HIGHSTAT Investigative D03MXZ DRUG__ID D03MXZ D03MXZ HIGHSTAT Investigative D03OPW DRUG__ID D03OPW D03OPW HIGHSTAT Investigative D03RSA DRUG__ID D03RSA D03RSA HIGHSTAT Investigative D03WHC DRUG__ID D03WHC D03WHC HIGHSTAT Investigative D03XMR DRUG__ID D03XMR D03XMR HIGHSTAT Investigative D04ACC DRUG__ID D04ACC D04ACC HIGHSTAT Investigative D04BCG DRUG__ID D04BCG D04BCG HIGHSTAT Investigative D04IIT DRUG__ID D04IIT D04IIT HIGHSTAT Investigative D04IMF DRUG__ID D04IMF D04IMF HIGHSTAT Investigative D04KGP DRUG__ID D04KGP D04KGP HIGHSTAT Investigative D04KWA DRUG__ID D04KWA D04KWA HIGHSTAT Investigative D04LRA DRUG__ID D04LRA D04LRA HIGHSTAT Investigative D04ODF DRUG__ID D04ODF D04ODF HIGHSTAT Investigative D04PRM DRUG__ID D04PRM D04PRM HIGHSTAT Investigative D04QZF DRUG__ID D04QZF D04QZF HIGHSTAT Investigative D04SXH DRUG__ID D04SXH D04SXH HIGHSTAT Investigative D04VLI DRUG__ID D04VLI D04VLI HIGHSTAT Investigative D04YJO DRUG__ID D04YJO D04YJO HIGHSTAT Investigative D04ZQL DRUG__ID D04ZQL D04ZQL HIGHSTAT Investigative D05ABK DRUG__ID D05ABK D05ABK HIGHSTAT Investigative D05BGM DRUG__ID D05BGM D05BGM HIGHSTAT Investigative D05CNB DRUG__ID D05CNB D05CNB HIGHSTAT Investigative D05DTJ DRUG__ID D05DTJ D05DTJ HIGHSTAT Investigative D05KKV DRUG__ID D05KKV D05KKV HIGHSTAT Investigative D05LMT DRUG__ID D05LMT D05LMT HIGHSTAT Investigative D05MWB DRUG__ID D05MWB D05MWB HIGHSTAT Investigative D05NMK DRUG__ID D05NMK D05NMK HIGHSTAT Investigative D05NRZ DRUG__ID D05NRZ D05NRZ HIGHSTAT Investigative D05PMU DRUG__ID D05PMU D05PMU HIGHSTAT Investigative D05TNY DRUG__ID D05TNY D05TNY HIGHSTAT Investigative D05TSP DRUG__ID D05TSP D05TSP HIGHSTAT Investigative D05TZJ DRUG__ID D05TZJ D05TZJ HIGHSTAT Investigative D05WZL DRUG__ID D05WZL D05WZL HIGHSTAT Investigative D06BHK DRUG__ID D06BHK D06BHK HIGHSTAT Investigative D06CYQ DRUG__ID D06CYQ D06CYQ HIGHSTAT Investigative D06FCP DRUG__ID D06FCP D06FCP HIGHSTAT Investigative D06JVZ DRUG__ID D06JVZ D06JVZ HIGHSTAT Investigative D06KOJ DRUG__ID D06KOJ D06KOJ HIGHSTAT Investigative D06KWH DRUG__ID D06KWH D06KWH HIGHSTAT Investigative D06LVG DRUG__ID D06LVG D06LVG HIGHSTAT Investigative D06PYZ DRUG__ID D06PYZ D06PYZ HIGHSTAT Investigative D06QEQ DRUG__ID D06QEQ D06QEQ HIGHSTAT Investigative D06TJO DRUG__ID D06TJO D06TJO HIGHSTAT Investigative D06TPT DRUG__ID D06TPT D06TPT HIGHSTAT Investigative D06UOE DRUG__ID D06UOE D06UOE HIGHSTAT Investigative D06VXD DRUG__ID D06VXD D06VXD HIGHSTAT Investigative D06WOQ DRUG__ID D06WOQ D06WOQ HIGHSTAT Investigative D06WWN DRUG__ID D06WWN D06WWN HIGHSTAT Investigative D06YJX DRUG__ID D06YJX D06YJX HIGHSTAT Investigative D06ZQK DRUG__ID D06ZQK D06ZQK HIGHSTAT Investigative D07AAK DRUG__ID D07AAK D07AAK HIGHSTAT Investigative D07DQD DRUG__ID D07DQD D07DQD HIGHSTAT Investigative D07IAU DRUG__ID D07IAU D07IAU HIGHSTAT Investigative D07JHD DRUG__ID D07JHD D07JHD HIGHSTAT Investigative D07KCC DRUG__ID D07KCC D07KCC HIGHSTAT Investigative D07KXE DRUG__ID D07KXE D07KXE HIGHSTAT Investigative D07PUS DRUG__ID D07PUS D07PUS HIGHSTAT Investigative D07PWA DRUG__ID D07PWA D07PWA HIGHSTAT Investigative D07TIH DRUG__ID D07TIH D07TIH HIGHSTAT Investigative D08HSQ DRUG__ID D08HSQ D08HSQ HIGHSTAT Investigative D08HTW DRUG__ID D08HTW D08HTW HIGHSTAT Investigative D08KAL DRUG__ID D08KAL D08KAL HIGHSTAT Investigative D08MEC DRUG__ID D08MEC D08MEC HIGHSTAT Investigative D08MTN DRUG__ID D08MTN D08MTN HIGHSTAT Investigative D08RYE DRUG__ID D08RYE D08RYE HIGHSTAT Investigative D08SKX DRUG__ID D08SKX D08SKX HIGHSTAT Investigative D08TBP DRUG__ID D08TBP D08TBP HIGHSTAT Investigative D08TDQ DRUG__ID D08TDQ D08TDQ HIGHSTAT Investigative D08TGB DRUG__ID D08TGB D08TGB HIGHSTAT Investigative D08TLJ DRUG__ID D08TLJ D08TLJ HIGHSTAT Investigative D08TRN DRUG__ID D08TRN D08TRN HIGHSTAT Investigative D08UNZ DRUG__ID D08UNZ D08UNZ HIGHSTAT Investigative D08VFY DRUG__ID D08VFY D08VFY HIGHSTAT Investigative D08VKN DRUG__ID D08VKN D08VKN HIGHSTAT Investigative D08VPK DRUG__ID D08VPK D08VPK HIGHSTAT Investigative D08WVJ DRUG__ID D08WVJ D08WVJ HIGHSTAT Investigative D09BWD DRUG__ID D09BWD D09BWD HIGHSTAT Investigative D09GBA DRUG__ID D09GBA D09GBA HIGHSTAT Investigative D09HAD DRUG__ID D09HAD D09HAD HIGHSTAT Investigative D09HYG DRUG__ID D09HYG D09HYG HIGHSTAT Investigative D09JCF DRUG__ID D09JCF D09JCF HIGHSTAT Investigative D09LFY DRUG__ID D09LFY D09LFY HIGHSTAT Investigative D09OFM DRUG__ID D09OFM D09OFM HIGHSTAT Investigative D09POE DRUG__ID D09POE D09POE HIGHSTAT Investigative D09SSY DRUG__ID D09SSY D09SSY HIGHSTAT Investigative D09SZJ DRUG__ID D09SZJ D09SZJ HIGHSTAT Investigative D09TSB DRUG__ID D09TSB D09TSB HIGHSTAT Investigative D09WBQ DRUG__ID D09WBQ D09WBQ HIGHSTAT Investigative D09WFG DRUG__ID D09WFG D09WFG HIGHSTAT Investigative D09XYA DRUG__ID D09XYA D09XYA HIGHSTAT Investigative D0A3EA DRUG__ID D0A3EA D0A3EA HIGHSTAT Investigative D0A3SQ DRUG__ID D0A3SQ D0A3SQ HIGHSTAT Investigative D0A3WQ DRUG__ID D0A3WQ D0A3WQ HIGHSTAT Investigative D0A9RZ DRUG__ID D0A9RZ D0A9RZ HIGHSTAT Investigative D0AE1E DRUG__ID D0AE1E D0AE1E HIGHSTAT Investigative D0AJ7H DRUG__ID D0AJ7H D0AJ7H HIGHSTAT Investigative D0B0IU DRUG__ID D0B0IU D0B0IU HIGHSTAT Investigative D0B0PW DRUG__ID D0B0PW D0B0PW HIGHSTAT Investigative D0B1SO DRUG__ID D0B1SO D0B1SO HIGHSTAT Investigative D0B4DB DRUG__ID D0B4DB D0B4DB HIGHSTAT Investigative D0B4NU DRUG__ID D0B4NU D0B4NU HIGHSTAT Investigative D0B5AZ DRUG__ID D0B5AZ D0B5AZ HIGHSTAT Investigative D0B6EG DRUG__ID D0B6EG D0B6EG HIGHSTAT Investigative D0B6VF DRUG__ID D0B6VF D0B6VF HIGHSTAT Investigative D0C0WE DRUG__ID D0C0WE D0C0WE HIGHSTAT Investigative D0C1LW DRUG__ID D0C1LW D0C1LW HIGHSTAT Investigative D0C1OZ DRUG__ID D0C1OZ D0C1OZ HIGHSTAT Investigative D0C2CY DRUG__ID D0C2CY D0C2CY HIGHSTAT Investigative D0C7EI DRUG__ID D0C7EI D0C7EI HIGHSTAT Investigative D0C7SC DRUG__ID D0C7SC D0C7SC HIGHSTAT Investigative D0C8UN DRUG__ID D0C8UN D0C8UN HIGHSTAT Investigative D0CE9U DRUG__ID D0CE9U D0CE9U HIGHSTAT Investigative D0CV7C DRUG__ID D0CV7C D0CV7C HIGHSTAT Investigative D0D1WN DRUG__ID D0D1WN D0D1WN HIGHSTAT Investigative D0D2WV DRUG__ID D0D2WV D0D2WV HIGHSTAT Investigative D0D3TK DRUG__ID D0D3TK D0D3TK HIGHSTAT Investigative D0D6AC DRUG__ID D0D6AC D0D6AC HIGHSTAT Investigative D0D8QN DRUG__ID D0D8QN D0D8QN HIGHSTAT Investigative D0D9ES DRUG__ID D0D9ES D0D9ES HIGHSTAT Investigative D0DD8I DRUG__ID D0DD8I D0DD8I HIGHSTAT Investigative D0DN4W DRUG__ID D0DN4W D0DN4W HIGHSTAT Investigative D0E0PD DRUG__ID D0E0PD D0E0PD HIGHSTAT Investigative D0E1YT DRUG__ID D0E1YT D0E1YT HIGHSTAT Investigative D0E3UW DRUG__ID D0E3UW D0E3UW HIGHSTAT Investigative D0E4GJ DRUG__ID D0E4GJ D0E4GJ HIGHSTAT Investigative D0E6ZY DRUG__ID D0E6ZY D0E6ZY HIGHSTAT Investigative D0EW8Y DRUG__ID D0EW8Y D0EW8Y HIGHSTAT Investigative D0F0RO DRUG__ID D0F0RO D0F0RO HIGHSTAT Investigative D0F1CP DRUG__ID D0F1CP D0F1CP HIGHSTAT Investigative D0F9RE DRUG__ID D0F9RE D0F9RE HIGHSTAT Investigative D0FY4M DRUG__ID D0FY4M D0FY4M HIGHSTAT Investigative D0FZ7D DRUG__ID D0FZ7D D0FZ7D HIGHSTAT Investigative D0G0EA DRUG__ID D0G0EA D0G0EA HIGHSTAT Investigative D0G5PK DRUG__ID D0G5PK D0G5PK HIGHSTAT Investigative D0G6OU DRUG__ID D0G6OU D0G6OU HIGHSTAT Investigative D0G6TR DRUG__ID D0G6TR D0G6TR HIGHSTAT Investigative D0G7FS DRUG__ID D0G7FS D0G7FS HIGHSTAT Investigative D0G8ZX DRUG__ID D0G8ZX D0G8ZX HIGHSTAT Investigative D0G9ME DRUG__ID D0G9ME D0G9ME HIGHSTAT Investigative D0GB4V DRUG__ID D0GB4V D0GB4V HIGHSTAT Investigative D0GF2L DRUG__ID D0GF2L D0GF2L HIGHSTAT Investigative D0GK2Q DRUG__ID D0GK2Q D0GK2Q HIGHSTAT Investigative D0GT6I DRUG__ID D0GT6I D0GT6I HIGHSTAT Investigative D0GX8F DRUG__ID D0GX8F D0GX8F HIGHSTAT Investigative D0H2UU DRUG__ID D0H2UU D0H2UU HIGHSTAT Investigative D0H5JV DRUG__ID D0H5JV D0H5JV HIGHSTAT Investigative D0H6OS DRUG__ID D0H6OS D0H6OS HIGHSTAT Investigative D0H8OB DRUG__ID D0H8OB D0H8OB HIGHSTAT Investigative D0HP6W DRUG__ID D0HP6W D0HP6W HIGHSTAT Investigative D0I0NP DRUG__ID D0I0NP D0I0NP HIGHSTAT Investigative D0I0RT DRUG__ID D0I0RT D0I0RT HIGHSTAT Investigative D0I6DO DRUG__ID D0I6DO D0I6DO HIGHSTAT Investigative D0I6GC DRUG__ID D0I6GC D0I6GC HIGHSTAT Investigative D0I6QZ DRUG__ID D0I6QZ D0I6QZ HIGHSTAT Investigative D0I8FY DRUG__ID D0I8FY D0I8FY HIGHSTAT Investigative D0I8ON DRUG__ID D0I8ON D0I8ON HIGHSTAT Investigative D0I8QF DRUG__ID D0I8QF D0I8QF HIGHSTAT Investigative D0IO8G DRUG__ID D0IO8G D0IO8G HIGHSTAT Investigative D0IW6G DRUG__ID D0IW6G D0IW6G HIGHSTAT Investigative D0J0UT DRUG__ID D0J0UT D0J0UT HIGHSTAT Investigative D0J0ZG DRUG__ID D0J0ZG D0J0ZG HIGHSTAT Investigative D0J2CP DRUG__ID D0J2CP D0J2CP HIGHSTAT Investigative D0J2FJ DRUG__ID D0J2FJ D0J2FJ HIGHSTAT Investigative D0J2RW DRUG__ID D0J2RW D0J2RW HIGHSTAT Investigative D0J3EU DRUG__ID D0J3EU D0J3EU HIGHSTAT Investigative D0J6WV DRUG__ID D0J6WV D0J6WV HIGHSTAT Investigative D0K0SA DRUG__ID D0K0SA D0K0SA HIGHSTAT Investigative D0K4QL DRUG__ID D0K4QL D0K4QL HIGHSTAT Investigative D0K4ZX DRUG__ID D0K4ZX D0K4ZX HIGHSTAT Investigative D0K5EP DRUG__ID D0K5EP D0K5EP HIGHSTAT Investigative D0K9CL DRUG__ID D0K9CL D0K9CL HIGHSTAT Investigative D0K9TT DRUG__ID D0K9TT D0K9TT HIGHSTAT Investigative D0L4OT DRUG__ID D0L4OT D0L4OT HIGHSTAT Investigative D0L7GN DRUG__ID D0L7GN D0L7GN HIGHSTAT Investigative D0LE6M DRUG__ID D0LE6M D0LE6M HIGHSTAT Investigative D0M5DY DRUG__ID D0M5DY D0M5DY HIGHSTAT Investigative D0M7SD DRUG__ID D0M7SD D0M7SD HIGHSTAT Investigative D0M8SQ DRUG__ID D0M8SQ D0M8SQ HIGHSTAT Investigative D0MP7Z DRUG__ID D0MP7Z D0MP7Z HIGHSTAT Investigative D0MS4R DRUG__ID D0MS4R D0MS4R HIGHSTAT Investigative D0N3IP DRUG__ID D0N3IP D0N3IP HIGHSTAT Investigative D0N3LY DRUG__ID D0N3LY D0N3LY HIGHSTAT Investigative D0N6JE DRUG__ID D0N6JE D0N6JE HIGHSTAT Investigative D0N7HN DRUG__ID D0N7HN D0N7HN HIGHSTAT Investigative D0N8JJ DRUG__ID D0N8JJ D0N8JJ HIGHSTAT Investigative D0NJ4R DRUG__ID D0NJ4R D0NJ4R HIGHSTAT Investigative D0NT2W DRUG__ID D0NT2W D0NT2W HIGHSTAT Investigative D0O0UU DRUG__ID D0O0UU D0O0UU HIGHSTAT Investigative D0O3VH DRUG__ID D0O3VH D0O3VH HIGHSTAT Investigative D0O6AH DRUG__ID D0O6AH D0O6AH HIGHSTAT Investigative D0O6ZH DRUG__ID D0O6ZH D0O6ZH HIGHSTAT Investigative D0O7HD DRUG__ID D0O7HD D0O7HD HIGHSTAT Investigative D0OC3P DRUG__ID D0OC3P D0OC3P HIGHSTAT Investigative D0P0UM DRUG__ID D0P0UM D0P0UM HIGHSTAT Investigative D0P0XX DRUG__ID D0P0XX D0P0XX HIGHSTAT Investigative D0P1MI DRUG__ID D0P1MI D0P1MI HIGHSTAT Investigative D0P5VF DRUG__ID D0P5VF D0P5VF HIGHSTAT Investigative D0P8KQ DRUG__ID D0P8KQ D0P8KQ HIGHSTAT Investigative D0P9KI DRUG__ID D0P9KI D0P9KI HIGHSTAT Investigative D0PB3X DRUG__ID D0PB3X D0PB3X HIGHSTAT Investigative D0Q0KD DRUG__ID D0Q0KD D0Q0KD HIGHSTAT Investigative D0Q2LL DRUG__ID D0Q2LL D0Q2LL HIGHSTAT Investigative D0Q4HQ DRUG__ID D0Q4HQ D0Q4HQ HIGHSTAT Investigative D0Q5GS DRUG__ID D0Q5GS D0Q5GS HIGHSTAT Investigative D0Q5II DRUG__ID D0Q5II D0Q5II HIGHSTAT Investigative D0Q5UM DRUG__ID D0Q5UM D0Q5UM HIGHSTAT Investigative D0Q8VT DRUG__ID D0Q8VT D0Q8VT HIGHSTAT Investigative D0QV0K DRUG__ID D0QV0K D0QV0K HIGHSTAT Investigative D0R3GC DRUG__ID D0R3GC D0R3GC HIGHSTAT Investigative D0R4BS DRUG__ID D0R4BS D0R4BS HIGHSTAT Investigative D0R6LU DRUG__ID D0R6LU D0R6LU HIGHSTAT Investigative D0S0YV DRUG__ID D0S0YV D0S0YV HIGHSTAT Investigative D0S1HT DRUG__ID D0S1HT D0S1HT HIGHSTAT Investigative D0S5VU DRUG__ID D0S5VU D0S5VU HIGHSTAT Investigative D0S7FP DRUG__ID D0S7FP D0S7FP HIGHSTAT Investigative D0S8KA DRUG__ID D0S8KA D0S8KA HIGHSTAT Investigative D0SE8T DRUG__ID D0SE8T D0SE8T HIGHSTAT Investigative D0SK5C DRUG__ID D0SK5C D0SK5C HIGHSTAT Investigative D0T2IX DRUG__ID D0T2IX D0T2IX HIGHSTAT Investigative D0T3PR DRUG__ID D0T3PR D0T3PR HIGHSTAT Investigative D0T6NS DRUG__ID D0T6NS D0T6NS HIGHSTAT Investigative D0T7ZN DRUG__ID D0T7ZN D0T7ZN HIGHSTAT Investigative D0T8UH DRUG__ID D0T8UH D0T8UH HIGHSTAT Investigative D0TE9G DRUG__ID D0TE9G D0TE9G HIGHSTAT Investigative D0U0EX DRUG__ID D0U0EX D0U0EX HIGHSTAT Investigative D0U0HO DRUG__ID D0U0HO D0U0HO HIGHSTAT Investigative D0U3EA DRUG__ID D0U3EA D0U3EA HIGHSTAT Investigative D0U4IV DRUG__ID D0U4IV D0U4IV HIGHSTAT Investigative D0U6NR DRUG__ID D0U6NR D0U6NR HIGHSTAT Investigative D0UI3G DRUG__ID D0UI3G D0UI3G HIGHSTAT Investigative D0V0PY DRUG__ID D0V0PY D0V0PY HIGHSTAT Investigative D0V3YB DRUG__ID D0V3YB D0V3YB HIGHSTAT Investigative D0V4IH DRUG__ID D0V4IH D0V4IH HIGHSTAT Investigative D0V5PR DRUG__ID D0V5PR D0V5PR HIGHSTAT Investigative D0V7YD DRUG__ID D0V7YD D0V7YD HIGHSTAT Investigative D0V7YM DRUG__ID D0V7YM D0V7YM HIGHSTAT Investigative D0V8DT DRUG__ID D0V8DT D0V8DT HIGHSTAT Investigative D0VF4Q DRUG__ID D0VF4Q D0VF4Q HIGHSTAT Investigative D0VM0T DRUG__ID D0VM0T D0VM0T HIGHSTAT Investigative D0VZ0I DRUG__ID D0VZ0I D0VZ0I HIGHSTAT Investigative D0W1TU DRUG__ID D0W1TU D0W1TU HIGHSTAT Investigative D0W3KR DRUG__ID D0W3KR D0W3KR HIGHSTAT Investigative D0W8RS DRUG__ID D0W8RS D0W8RS HIGHSTAT Investigative D0X3SE DRUG__ID D0X3SE D0X3SE HIGHSTAT Investigative D0X4YY DRUG__ID D0X4YY D0X4YY HIGHSTAT Investigative D0X5SQ DRUG__ID D0X5SQ D0X5SQ HIGHSTAT Investigative D0X9PA DRUG__ID D0X9PA D0X9PA HIGHSTAT Investigative D0XI2Z DRUG__ID D0XI2Z D0XI2Z HIGHSTAT Investigative D0XQ2T DRUG__ID D0XQ2T D0XQ2T HIGHSTAT Investigative D0Y3PP DRUG__ID D0Y3PP D0Y3PP HIGHSTAT Investigative D0Y6EL DRUG__ID D0Y6EL D0Y6EL HIGHSTAT Investigative D0Y8LO DRUG__ID D0Y8LO D0Y8LO HIGHSTAT Investigative D0Y9MP DRUG__ID D0Y9MP D0Y9MP HIGHSTAT Investigative D0YM5S DRUG__ID D0YM5S D0YM5S HIGHSTAT Investigative D0Z2NN DRUG__ID D0Z2NN D0Z2NN HIGHSTAT Investigative D0Z4GF DRUG__ID D0Z4GF D0Z4GF HIGHSTAT Investigative D0Z4MH DRUG__ID D0Z4MH D0Z4MH HIGHSTAT Investigative D0Z9TY DRUG__ID D0Z9TY D0Z9TY HIGHSTAT Investigative